id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
163039948|NCT03638466|588855847|FG000|Overall Study|Early Termination|0|||
163039949|NCT03638466|588855848|FG001|Overall Study|Early Termination|1|||
163039950|NCT02576977|588855849|FG000|Overall Study|Adverse Event|13|||
163039951|NCT02576977|588855850|FG001|Overall Study|Adverse Event|2|||
163039952|NCT02576977|588855849|FG000|Overall Study|Death|73|||
163039953|NCT02576977|588855850|FG001|Overall Study|Death|60|||
163039954|NCT02576977|588855849|FG000|Overall Study|Screen failure|1|||
163039955|NCT02576977|588855850|FG001|Overall Study|Screen failure|0|||
163039956|NCT02576977|588855849|FG000|Overall Study|Study Terminated at Selected Sites|27|||
163039957|NCT02576977|588855850|FG001|Overall Study|Study Terminated at Selected Sites|50|||
163039958|NCT02576977|588855849|FG000|Overall Study|Withdrawal by Subject|11|||
163039959|NCT02576977|588855850|FG001|Overall Study|Withdrawal by Subject|11|||
163039960|NCT02576977|588855849|FG000|Overall Study|Final Disposition Unknown|0|||
163039961|NCT02576977|588855850|FG001|Overall Study|Final Disposition Unknown|1|||
163039962|NCT02576977|588855849|FG000|Overall Study|Lost to Follow-up|1|||
163039963|NCT02576977|588855850|FG001|Overall Study|Lost to Follow-up|0|||
163039964|NCT02576977|588855849|FG000|Overall Study|Progressive Disease|0|||
163039965|NCT02576977|588855850|FG001|Overall Study|Progressive Disease|1|||
163039966|NCT02447328|588855855|FG000|Overall Study|Withdrawal by Subject|1|||
163039967|NCT02362425|588855856|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
163039968|NCT02362425|588855857|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
163039969|NCT02362425|588855858|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
163039970|NCT02362425|588855859|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
162925581|NCT01607398|588430331|FG000|Overall Study|Adverse Event|0|||
163039971|NCT02362425|588855856|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
163039972|NCT02362425|588855857|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
163039973|NCT02362425|588855858|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
163039974|NCT02362425|588855859|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
163039975|NCT02362425|588855856|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
163039976|NCT02362425|588855857|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
163039977|NCT02362425|588855858|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
163039978|NCT02362425|588855859|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
163039979|NCT02362425|588855856|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
163039980|NCT02362425|588855857|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
163039981|NCT02362425|588855858|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
163039982|NCT02362425|588855859|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
163039983|NCT02362425|588855856|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
163039984|NCT02362425|588855857|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
163039985|NCT02362425|588855858|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
163039986|NCT02362425|588855859|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
163039987|NCT02362425|588855856|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
163039988|NCT02362425|588855857|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
163039989|NCT02362425|588855858|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
163039990|NCT02362425|588855859|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
163039991|NCT02362425|588855856|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
163039992|NCT02362425|588855857|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
163039993|NCT02362425|588855858|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
163039994|NCT02362425|588855859|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
163039995|NCT02362425|588855856|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
163039996|NCT02362425|588855857|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
163039997|NCT02362425|588855858|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
163039998|NCT02362425|588855859|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
163039999|NCT02688764|588855869|FG000|Overall Study|Adverse Event|3|||
163040000|NCT02688764|588855870|FG001|Overall Study|Adverse Event|3|||
163040001|NCT02688764|588855869|FG000|Overall Study|AE/Kidney transplant|1|||
163040002|NCT02688764|588855870|FG001|Overall Study|AE/Kidney transplant|0|||
163040003|NCT02688764|588855869|FG000|Overall Study|AE/Lack of efficacy|1|||
163040004|NCT02688764|588855870|FG001|Overall Study|AE/Lack of efficacy|0|||
163040005|NCT02688764|588855869|FG000|Overall Study|AE/Non-compl.|1|||
163040006|NCT02688764|588855870|FG001|Overall Study|AE/Non-compl.|0|||
163040007|NCT02688764|588855869|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
163040008|NCT02688764|588855870|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
163040009|NCT02688764|588855869|FG000|Overall Study|AE/Other|0|||
163040010|NCT02688764|588855870|FG001|Overall Study|AE/Other|1|||
163040011|NCT02688764|588855869|FG000|Overall Study|AE/Physician decision|1|||
163040012|NCT02688764|588855870|FG001|Overall Study|AE/Physician decision|0|||
163040013|NCT02688764|588855869|FG000|Overall Study|AE/Withd. parent|3|||
163040014|NCT02688764|588855870|FG001|Overall Study|AE/Withd. parent|0|||
163040015|NCT02688764|588855869|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
163040016|NCT02688764|588855870|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
163040017|NCT02688764|588855869|FG000|Overall Study|AE/Withd. subject|1|||
163154859|NCT02079246|589283631|FG000|OLEX|Withdrawal before treatment|1|||
163040018|NCT02688764|588855870|FG001|Overall Study|AE/Withd. subject|0|||
163040019|NCT02688764|588855869|FG000|Overall Study|Kidney transplant|10|||
163040020|NCT02688764|588855870|FG001|Overall Study|Kidney transplant|4|||
163040021|NCT02688764|588855869|FG000|Overall Study|Lack of Efficacy|3|||
163040022|NCT02688764|588855870|FG001|Overall Study|Lack of Efficacy|2|||
163040023|NCT02688764|588855869|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
163040024|NCT02688764|588855870|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
163040025|NCT02688764|588855869|FG000|Overall Study|Non-compliance with study drug|4|||
163040026|NCT02688764|588855870|FG001|Overall Study|Non-compliance with study drug|0|||
163040027|NCT02688764|588855869|FG000|Overall Study|Non-compl./Physician decision|2|||
163040028|NCT02688764|588855870|FG001|Overall Study|Non-compl./Physician decision|0|||
163040029|NCT02688764|588855869|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
163040030|NCT02688764|588855870|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
163040031|NCT02688764|588855869|FG000|Overall Study|Non-compl./Withd. subject|0|||
163040032|NCT02688764|588855870|FG001|Overall Study|Non-compl./Withd. subject|2|||
163040033|NCT02688764|588855869|FG000|Overall Study|Phosphorus level outside safe range|0|||
163040034|NCT02688764|588855870|FG001|Overall Study|Phosphorus level outside safe range|1|||
163040035|NCT02688764|588855869|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
163040036|NCT02688764|588855870|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
163040037|NCT02688764|588855869|FG000|Overall Study|Study drug taste/Withd. parent|1|||
163040038|NCT02688764|588855870|FG001|Overall Study|Study drug taste/Withd. parent|0|||
163040039|NCT02688764|588855869|FG000|Overall Study|Subject moving out|2|||
163040040|NCT02688764|588855870|FG001|Overall Study|Subject moving out|0|||
163040041|NCT02688764|588855869|FG000|Overall Study|Subject taken off dialysis|1|||
163040042|NCT02688764|588855870|FG001|Overall Study|Subject taken off dialysis|0|||
163040043|NCT02688764|588855869|FG000|Overall Study|Withdrawal by parent|3|||
163040044|NCT02688764|588855870|FG001|Overall Study|Withdrawal by parent|0|||
163040045|NCT02579382|588855871|FG000|Main Study Phase|Lost to Follow-up|0|||
163040046|NCT02579382|588855872|FG001|Main Study Phase|Lost to Follow-up|0|||
163040047|NCT02579382|588855873|FG002|Main Study Phase|Lost to Follow-up|2|||
163040048|NCT02579382|588855874|FG003|Main Study Phase|Lost to Follow-up|0|||
163040049|NCT02579382|588855871|FG000|Main Study Phase|Withdrew Consent|0|||
163040050|NCT02579382|588855872|FG001|Main Study Phase|Withdrew Consent|0|||
163040051|NCT02579382|588855873|FG002|Main Study Phase|Withdrew Consent|0|||
163040052|NCT02579382|588855874|FG003|Main Study Phase|Withdrew Consent|2|||
163040053|NCT02579382|588855871|FG000|Main Study Phase|Lack of Efficacy|0|||
163040054|NCT02579382|588855872|FG001|Main Study Phase|Lack of Efficacy|0|||
163040055|NCT02579382|588855873|FG002|Main Study Phase|Lack of Efficacy|0|||
163040056|NCT02579382|588855874|FG003|Main Study Phase|Lack of Efficacy|1|||
163040057|NCT02579382|588855871|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
163040058|NCT02579382|588855872|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
163040059|NCT02579382|588855873|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
163040060|NCT02579382|588855874|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
163040061|NCT02579382|588855871|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
163040062|NCT02579382|588855872|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
163040063|NCT02579382|588855873|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
163040064|NCT02579382|588855874|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
163040065|NCT02579382|588855871|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
163040066|NCT02579382|588855872|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
163040067|NCT02579382|588855873|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
163040068|NCT02579382|588855874|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
163040069|NCT02579382|588855871|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
163040070|NCT02579382|588855872|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
163040071|NCT02579382|588855873|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
163040072|NCT02579382|588855874|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
163040073|NCT02579382|588855871|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
163385059|NCT02425644|590120762|FG000|Overall Study|Lost to Follow-up|2|||
163385060|NCT02425644|590120763|FG001|Overall Study|Lost to Follow-up|3|||
163385061|NCT02425644|590120762|FG000|Overall Study|Withdrawal by Subject|41|||
163385062|NCT02425644|590120763|FG001|Overall Study|Withdrawal by Subject|36|||
163385063|NCT02425644|590120762|FG000|Overall Study|Lack of Efficacy|3|||
162925582|NCT01607398|588430332|FG001|Overall Study|Adverse Event|2|||
162925583|NCT01607398|588430331|FG000|Overall Study|Severe COPD|2|||
162925584|NCT01607398|588430332|FG001|Overall Study|Severe COPD|0|||
162925585|NCT01211613|588430333|FG000|Overall Study|Lost to Follow-up|2|||
162925586|NCT01211613|588430334|FG001|Overall Study|Lost to Follow-up|2|||
162925587|NCT01211613|588430335|FG002|Overall Study|Lost to Follow-up|2|||
162925588|NCT01211613|588430333|FG000|Overall Study|Withdrawal by Subject|1|||
162925589|NCT01211613|588430334|FG001|Overall Study|Withdrawal by Subject|0|||
162925590|NCT01211613|588430335|FG002|Overall Study|Withdrawal by Subject|0|||
162925591|NCT03853213|588430336|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
162925592|NCT03853213|588430337|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
163040074|NCT02579382|588855872|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
163040075|NCT02579382|588855873|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
163040076|NCT02579382|588855874|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
163040077|NCT02579382|588855871|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
163040078|NCT02579382|588855872|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
163040079|NCT02579382|588855873|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
163040080|NCT02579382|588855874|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
163040081|NCT03026283|588855875|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
162925593|NCT03853213|588430336|FG000|Overall Study|Other (e.g., too busy)|0|||
162925594|NCT03853213|588430337|FG001|Overall Study|Other (e.g., too busy)|2|||
162925595|NCT03044431|588430340|FG000|Overall Study|Lost to Follow-up|59|||
162925596|NCT04470622|588430341|FG000|Overall Study|Withdrawal by Subject|0|||
162925597|NCT04470622|588430342|FG001|Overall Study|Withdrawal by Subject|1|||
162925598|NCT04470622|588430341|FG000|Overall Study|Screen Failure|0|||
163040082|NCT03026283|588855876|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
163040083|NCT03026283|588855877|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
163040084|NCT03026283|588855878|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
162925599|NCT04470622|588430342|FG001|Overall Study|Screen Failure|1|||
162925600|NCT04470622|588430341|FG000|Overall Study|Death|0|||
162925601|NCT04470622|588430342|FG001|Overall Study|Death|1|||
162925602|NCT02576054|588430345|FG000|Overall Study|Withdrawal by Subject|1|||
162925603|NCT00791154|588430346|FG000|Overall Study|Noncompliance|0|||
162925604|NCT00791154|588430347|FG001|Overall Study|Noncompliance|1|||
162925605|NCT00791154|588430348|FG002|Overall Study|Noncompliance|0|||
162925606|NCT00791154|588430349|FG003|Overall Study|Noncompliance|0|||
162925607|NCT00791154|588430350|FG004|Overall Study|Noncompliance|1|||
162925608|NCT00791154|588430351|FG005|Overall Study|Noncompliance|1|||
162925609|NCT00791154|588430352|FG006|Overall Study|Noncompliance|1|||
162925610|NCT00791154|588430346|FG000|Overall Study|Adverse Event|0|||
162925611|NCT00791154|588430347|FG001|Overall Study|Adverse Event|0|||
162925612|NCT00791154|588430348|FG002|Overall Study|Adverse Event|0|||
162925613|NCT00791154|588430349|FG003|Overall Study|Adverse Event|0|||
162925614|NCT00791154|588430350|FG004|Overall Study|Adverse Event|2|||
162925615|NCT00791154|588430351|FG005|Overall Study|Adverse Event|0|||
162925616|NCT00791154|588430352|FG006|Overall Study|Adverse Event|1|||
162925617|NCT00791154|588430346|FG000|Overall Study|Full Consent withdrawn|1|||
162925618|NCT00791154|588430347|FG001|Overall Study|Full Consent withdrawn|3|||
162925619|NCT00791154|588430348|FG002|Overall Study|Full Consent withdrawn|0|||
162925620|NCT00791154|588430349|FG003|Overall Study|Full Consent withdrawn|0|||
162925621|NCT00791154|588430350|FG004|Overall Study|Full Consent withdrawn|1|||
162925622|NCT00791154|588430351|FG005|Overall Study|Full Consent withdrawn|3|||
163040085|NCT03026283|588855879|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
163040086|NCT03026283|588855880|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
163040087|NCT03026283|588855881|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
162925623|NCT00791154|588430352|FG006|Overall Study|Full Consent withdrawn|1|||
162925624|NCT00791154|588430346|FG000|Overall Study|Lost to Follow-up|0|||
162925625|NCT00791154|588430347|FG001|Overall Study|Lost to Follow-up|0|||
162925626|NCT00791154|588430348|FG002|Overall Study|Lost to Follow-up|0|||
162925627|NCT00791154|588430349|FG003|Overall Study|Lost to Follow-up|1|||
162925628|NCT00791154|588430350|FG004|Overall Study|Lost to Follow-up|2|||
162925629|NCT00791154|588430351|FG005|Overall Study|Lost to Follow-up|0|||
162925630|NCT00791154|588430352|FG006|Overall Study|Lost to Follow-up|4|||
162925631|NCT00791154|588430346|FG000|Overall Study|Death|5|||
162925632|NCT00791154|588430347|FG001|Overall Study|Death|4|||
162925633|NCT00791154|588430348|FG002|Overall Study|Death|4|||
162925634|NCT00791154|588430349|FG003|Overall Study|Death|7|||
162925635|NCT00791154|588430350|FG004|Overall Study|Death|54|||
162925636|NCT00791154|588430351|FG005|Overall Study|Death|54|||
162925637|NCT00791154|588430352|FG006|Overall Study|Death|52|||
162925638|NCT00791154|588430346|FG000|Overall Study|Other event|0|||
162925639|NCT00791154|588430347|FG001|Overall Study|Other event|0|||
162925640|NCT00791154|588430348|FG002|Overall Study|Other event|2|||
163040088|NCT03026283|588855882|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
163040089|NCT03026283|588855875|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
163040090|NCT03026283|588855876|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
162925641|NCT00791154|588430349|FG003|Overall Study|Other event|0|||
162925642|NCT00791154|588430350|FG004|Overall Study|Other event|2|||
162925643|NCT00791154|588430351|FG005|Overall Study|Other event|4|||
163040091|NCT03026283|588855877|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
163040092|NCT03026283|588855878|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
163040093|NCT03026283|588855879|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
163385064|NCT02425644|590120763|FG001|Overall Study|Lack of Efficacy|10|||
163040094|NCT03026283|588855880|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
163040095|NCT03026283|588855881|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
162925644|NCT00791154|588430352|FG006|Overall Study|Other event|2|||
162925645|NCT00953927|588430353|FG000|Overall Study|Lost to Follow-up|61|||
162925646|NCT00953927|588430354|FG001|Overall Study|Lost to Follow-up|65|||
163040096|NCT03026283|588855882|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
163040097|NCT03026283|588855875|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
163040098|NCT03026283|588855876|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
163040099|NCT03026283|588855877|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
163040100|NCT03026283|588855878|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
163040101|NCT03026283|588855879|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
163040102|NCT03026283|588855880|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
163040103|NCT03026283|588855881|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
163040104|NCT03026283|588855882|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
163040105|NCT03026283|588855875|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
163040106|NCT03026283|588855876|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
163040107|NCT03026283|588855877|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
163040108|NCT03026283|588855878|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
163040109|NCT03026283|588855879|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
163040110|NCT03026283|588855880|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
163040111|NCT03026283|588855881|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
163040112|NCT03026283|588855882|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
163040113|NCT03026283|588855875|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
163040114|NCT03026283|588855876|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
163040115|NCT03026283|588855877|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
163040116|NCT03026283|588855878|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
163040117|NCT03026283|588855879|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
163040118|NCT03026283|588855880|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
163040119|NCT03026283|588855881|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
163040120|NCT03026283|588855882|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
163040121|NCT03026283|588855875|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
163040122|NCT03026283|588855876|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
163040123|NCT03026283|588855877|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
163040124|NCT03026283|588855878|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
163040125|NCT03026283|588855879|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
163040126|NCT03026283|588855880|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
163040127|NCT03026283|588855881|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
163040128|NCT03026283|588855882|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
163040129|NCT03026283|588855875|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
163040130|NCT03026283|588855876|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
163040131|NCT03026283|588855877|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
163040132|NCT03026283|588855878|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
163040133|NCT03026283|588855879|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
163040134|NCT03026283|588855880|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
163040135|NCT03026283|588855881|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
163040136|NCT03026283|588855882|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
163040137|NCT03026283|588855875|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
163040138|NCT03026283|588855876|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
163040139|NCT03026283|588855877|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
163040140|NCT03026283|588855878|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
163040141|NCT03026283|588855879|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
163040142|NCT03026283|588855880|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
163040143|NCT03026283|588855881|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
163040144|NCT03026283|588855882|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
163040145|NCT03026283|588855875|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
163040146|NCT03026283|588855876|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
163040147|NCT03026283|588855877|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
163040148|NCT03026283|588855878|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
163040149|NCT03026283|588855879|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
163040150|NCT03026283|588855880|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
163040151|NCT03026283|588855881|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
163040152|NCT03026283|588855882|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
163040153|NCT00824655|588855883|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
163040154|NCT00824655|588855884|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
163040155|NCT00824655|588855883|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
163040156|NCT00824655|588855884|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
163040157|NCT02906579|588855891|FG000|Overall Study|Adverse Event|1|||
163269837|NCT02959138|589699910|FG000|Overall Study|Enrolled but Never Treated|0|||
163040158|NCT02906579|588855891|FG000|Overall Study|Physician Decision|1|||
163040159|NCT01826981|588855892|FG000|Overall Study|Lack of Efficacy|0|||
163040160|NCT01826981|588855893|FG001|Overall Study|Lack of Efficacy|1|||
163040161|NCT01826981|588855894|FG002|Overall Study|Lack of Efficacy|0|||
163040162|NCT01826981|588855895|FG003|Overall Study|Lack of Efficacy|0|||
163040163|NCT01826981|588855896|FG004|Overall Study|Lack of Efficacy|5|||
163040164|NCT01826981|588855897|FG005|Overall Study|Lack of Efficacy|0|||
163040165|NCT01826981|588855898|FG006|Overall Study|Lack of Efficacy|0|||
163040166|NCT01826981|588855899|FG007|Overall Study|Lack of Efficacy|8|||
163040167|NCT01826981|588855900|FG008|Overall Study|Lack of Efficacy|7|||
163040168|NCT01826981|588855901|FG009|Overall Study|Lack of Efficacy|0|||
163040169|NCT01826981|588855902|FG010|Overall Study|Lack of Efficacy|1|||
163040170|NCT01826981|588855903|FG011|Overall Study|Lack of Efficacy|0|||
163040171|NCT01826981|588855904|FG012|Overall Study|Lack of Efficacy|0|||
163040172|NCT01826981|588855905|FG013|Overall Study|Lack of Efficacy|3|||
163040173|NCT01826981|588855906|FG014|Overall Study|Lack of Efficacy|0|||
163040174|NCT01826981|588855892|FG000|Overall Study|Lost to Follow-up|0|||
163040175|NCT01826981|588855893|FG001|Overall Study|Lost to Follow-up|0|||
163040176|NCT01826981|588855894|FG002|Overall Study|Lost to Follow-up|0|||
163040177|NCT01826981|588855895|FG003|Overall Study|Lost to Follow-up|0|||
163040178|NCT01826981|588855896|FG004|Overall Study|Lost to Follow-up|1|||
163040179|NCT01826981|588855897|FG005|Overall Study|Lost to Follow-up|1|||
163040180|NCT01826981|588855898|FG006|Overall Study|Lost to Follow-up|0|||
163040181|NCT01826981|588855899|FG007|Overall Study|Lost to Follow-up|1|||
163040182|NCT01826981|588855900|FG008|Overall Study|Lost to Follow-up|0|||
163040183|NCT01826981|588855901|FG009|Overall Study|Lost to Follow-up|1|||
163040184|NCT01826981|588855902|FG010|Overall Study|Lost to Follow-up|1|||
163040185|NCT01826981|588855903|FG011|Overall Study|Lost to Follow-up|1|||
163040186|NCT01826981|588855904|FG012|Overall Study|Lost to Follow-up|1|||
163040187|NCT01826981|588855905|FG013|Overall Study|Lost to Follow-up|0|||
163040188|NCT01826981|588855906|FG014|Overall Study|Lost to Follow-up|0|||
163040189|NCT01826981|588855892|FG000|Overall Study|Withdrew Consent|0|||
163040190|NCT01826981|588855893|FG001|Overall Study|Withdrew Consent|0|||
163040191|NCT01826981|588855894|FG002|Overall Study|Withdrew Consent|0|||
163040192|NCT01826981|588855895|FG003|Overall Study|Withdrew Consent|0|||
163040193|NCT01826981|588855896|FG004|Overall Study|Withdrew Consent|0|||
163040194|NCT01826981|588855897|FG005|Overall Study|Withdrew Consent|0|||
163040195|NCT01826981|588855898|FG006|Overall Study|Withdrew Consent|1|||
163040196|NCT01826981|588855899|FG007|Overall Study|Withdrew Consent|1|||
163040197|NCT01826981|588855900|FG008|Overall Study|Withdrew Consent|0|||
163040198|NCT01826981|588855901|FG009|Overall Study|Withdrew Consent|0|||
163040199|NCT01826981|588855902|FG010|Overall Study|Withdrew Consent|0|||
163040200|NCT01826981|588855903|FG011|Overall Study|Withdrew Consent|1|||
163040201|NCT01826981|588855904|FG012|Overall Study|Withdrew Consent|0|||
163040202|NCT01826981|588855905|FG013|Overall Study|Withdrew Consent|1|||
163040203|NCT01826981|588855906|FG014|Overall Study|Withdrew Consent|0|||
163040204|NCT01826981|588855892|FG000|Overall Study|Adverse Event|0|||
163040205|NCT01826981|588855893|FG001|Overall Study|Adverse Event|0|||
163040206|NCT01826981|588855894|FG002|Overall Study|Adverse Event|0|||
163040207|NCT01826981|588855895|FG003|Overall Study|Adverse Event|0|||
163040208|NCT01826981|588855896|FG004|Overall Study|Adverse Event|1|||
163040209|NCT01826981|588855897|FG005|Overall Study|Adverse Event|0|||
163040210|NCT01826981|588855898|FG006|Overall Study|Adverse Event|0|||
163040211|NCT01826981|588855899|FG007|Overall Study|Adverse Event|0|||
163040212|NCT01826981|588855900|FG008|Overall Study|Adverse Event|0|||
163040213|NCT01826981|588855901|FG009|Overall Study|Adverse Event|0|||
163040214|NCT01826981|588855902|FG010|Overall Study|Adverse Event|0|||
163040215|NCT01826981|588855903|FG011|Overall Study|Adverse Event|0|||
163040216|NCT01826981|588855904|FG012|Overall Study|Adverse Event|0|||
163040217|NCT01826981|588855905|FG013|Overall Study|Adverse Event|0|||
163040218|NCT01826981|588855906|FG014|Overall Study|Adverse Event|0|||
163040219|NCT01826981|588855892|FG000|Overall Study|Upper G-I Haemorrhage|0|||
163040220|NCT01826981|588855893|FG001|Overall Study|Upper G-I Haemorrhage|0|||
163040221|NCT01826981|588855894|FG002|Overall Study|Upper G-I Haemorrhage|0|||
163385065|NCT02425644|590120762|FG000|Overall Study|Adverse Event|13|||
163385066|NCT02425644|590120763|FG001|Overall Study|Adverse Event|3|||
163040222|NCT01826981|588855895|FG003|Overall Study|Upper G-I Haemorrhage|0|||
163040223|NCT01826981|588855896|FG004|Overall Study|Upper G-I Haemorrhage|0|||
163040224|NCT01826981|588855897|FG005|Overall Study|Upper G-I Haemorrhage|0|||
163040225|NCT01826981|588855898|FG006|Overall Study|Upper G-I Haemorrhage|0|||
163040226|NCT01826981|588855899|FG007|Overall Study|Upper G-I Haemorrhage|0|||
163040227|NCT01826981|588855900|FG008|Overall Study|Upper G-I Haemorrhage|0|||
163040228|NCT01826981|588855901|FG009|Overall Study|Upper G-I Haemorrhage|0|||
163040229|NCT01826981|588855902|FG010|Overall Study|Upper G-I Haemorrhage|0|||
163040230|NCT01826981|588855903|FG011|Overall Study|Upper G-I Haemorrhage|0|||
163040231|NCT01826981|588855904|FG012|Overall Study|Upper G-I Haemorrhage|0|||
163040232|NCT01826981|588855905|FG013|Overall Study|Upper G-I Haemorrhage|1|||
163040233|NCT01826981|588855906|FG014|Overall Study|Upper G-I Haemorrhage|0|||
163040234|NCT01826981|588855892|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040235|NCT01826981|588855893|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040236|NCT01826981|588855894|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040237|NCT01826981|588855895|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040238|NCT01826981|588855896|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040239|NCT01826981|588855897|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040240|NCT01826981|588855898|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040241|NCT01826981|588855899|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
163040242|NCT01826981|588855900|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040243|NCT01826981|588855901|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040244|NCT01826981|588855902|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040245|NCT01826981|588855903|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040246|NCT01826981|588855904|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040247|NCT01826981|588855905|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040248|NCT01826981|588855906|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040249|NCT00759655|588855907|FG000|Overall Study|Termination of the study by sponsor|1|||
163040250|NCT02753816|588855910|FG000|Overall Study|Protocol Violation|0|||
163040251|NCT02753816|588855911|FG001|Overall Study|Protocol Violation|1|||
163040252|NCT02753816|588855912|FG002|Overall Study|Protocol Violation|0|||
163040253|NCT01704755|588855915|FG000|Overall Study|Adverse Event|4|||
163040254|NCT01704755|588855916|FG001|Overall Study|Adverse Event|1|||
163040255|NCT01704755|588855915|FG000|Overall Study|Lost to Follow-up|3|||
163040256|NCT01704755|588855916|FG001|Overall Study|Lost to Follow-up|4|||
163040257|NCT01704755|588855915|FG000|Overall Study|Withdrew consent|1|||
163040258|NCT01704755|588855916|FG001|Overall Study|Withdrew consent|1|||
163040259|NCT01704755|588855915|FG000|Overall Study|Other (not specified)|3|||
163040260|NCT01704755|588855916|FG001|Overall Study|Other (not specified)|1|||
163040261|NCT01704755|588855915|FG000|Overall Study|Withdrew consent and personal issues|1|||
163040262|NCT01704755|588855916|FG001|Overall Study|Withdrew consent and personal issues|0|||
163040263|NCT02821416|588855923|FG000|Overall Study|Adverse Event|0|||
163040264|NCT02821416|588855924|FG001|Overall Study|Adverse Event|1|||
163040265|NCT02821416|588855923|FG000|Overall Study|Withdrawal by Subject|2|||
163040266|NCT02821416|588855924|FG001|Overall Study|Withdrawal by Subject|0|||
163040267|NCT02821416|588855923|FG000|Overall Study|Lost to Follow-up|1|||
163040268|NCT02821416|588855924|FG001|Overall Study|Lost to Follow-up|0|||
163040269|NCT01763203|588855927|FG000|Overall Study|Death|4|||
163040270|NCT01763203|588855928|FG001|Overall Study|Death|7|||
163040271|NCT01763203|588855927|FG000|Overall Study|Lost to Follow-up|12|||
163040272|NCT01763203|588855928|FG001|Overall Study|Lost to Follow-up|12|||
163040273|NCT01763203|588855927|FG000|Overall Study|Withdrawal by Subject|8|||
163040274|NCT01763203|588855928|FG001|Overall Study|Withdrawal by Subject|12|||
163040275|NCT01763203|588855927|FG000|Overall Study|Moved out of study region|7|||
163040276|NCT01763203|588855928|FG001|Overall Study|Moved out of study region|10|||
163040277|NCT01763203|588855927|FG000|Overall Study|Physician Decision|2|||
163040278|NCT01763203|588855928|FG001|Overall Study|Physician Decision|1|||
163040279|NCT02256917|588855929|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
163040280|NCT02256917|588855929|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
163040281|NCT02256917|588855929|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
163040282|NCT02256917|588855929|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
163040283|NCT02256917|588855929|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
163040284|NCT02933528|588855930|FG000|Overall Study|Lost to Follow-up|2|||
163040285|NCT01639703|588855931|FG000|Overall Study|Withdrawal by Subject|5|||
163040286|NCT01639703|588855931|FG000|Overall Study|Other reason|7|||
162925647|NCT00953927|588430353|FG000|Overall Study|Withdrawal by Subject|36|||
162925648|NCT00953927|588430354|FG001|Overall Study|Withdrawal by Subject|25|||
162925649|NCT00953927|588430353|FG000|Overall Study|Death|7|||
162925650|NCT00953927|588430354|FG001|Overall Study|Death|4|||
162925651|NCT00953927|588430353|FG000|Overall Study|Other study discontinuation|1|||
162925652|NCT00953927|588430354|FG001|Overall Study|Other study discontinuation|1|||
162925653|NCT01396161|588430355|FG000|Overall Study|Withdrawal by Subject|0|||
162925654|NCT01396161|588430356|FG001|Overall Study|Withdrawal by Subject|0|||
162925655|NCT01396161|588430357|FG002|Overall Study|Withdrawal by Subject|0|||
162925656|NCT01396161|588430358|FG003|Overall Study|Withdrawal by Subject|0|||
162925657|NCT01396161|588430359|FG004|Overall Study|Withdrawal by Subject|1|||
162925658|NCT01396161|588430360|FG005|Overall Study|Withdrawal by Subject|0|||
162925659|NCT01396161|588430361|FG006|Overall Study|Withdrawal by Subject|0|||
162925660|NCT01396161|588430355|FG000|Overall Study|Other|0|||
163040287|NCT02982863|588855933|FG000|Overall Study|Not eligible patients|809|||
163040288|NCT02982863|588855934|FG001|Overall Study|Not eligible patients|4261|||
163040289|NCT02982863|588855935|FG002|Overall Study|Not eligible patients|1852|||
163040290|NCT02982863|588855936|FG003|Overall Study|Not eligible patients|1400|||
163040291|NCT02982863|588855937|FG004|Overall Study|Not eligible patients|492|||
163040292|NCT03739710|588855938|FG000|Overall Study|Screen Failed|81|||
163040293|NCT01753115|588855939|FG000|Overall Study|Lost to Follow-up|3|||
162925661|NCT01396161|588430356|FG001|Overall Study|Other|0|||
162925662|NCT01396161|588430357|FG002|Overall Study|Other|0|||
162925663|NCT01396161|588430358|FG003|Overall Study|Other|0|||
162925664|NCT01396161|588430359|FG004|Overall Study|Other|0|||
163040294|NCT01753115|588855940|FG001|Overall Study|Lost to Follow-up|6|||
163040295|NCT01753115|588855941|FG002|Overall Study|Lost to Follow-up|8|||
163040296|NCT01753115|588855939|FG000|Overall Study|Withdrawal by Subject|6|||
163040297|NCT01753115|588855940|FG001|Overall Study|Withdrawal by Subject|5|||
163040298|NCT01753115|588855941|FG002|Overall Study|Withdrawal by Subject|6|||
163040299|NCT01753115|588855939|FG000|Overall Study|Subject non-compliant|3|||
163040300|NCT01753115|588855940|FG001|Overall Study|Subject non-compliant|3|||
163040301|NCT01753115|588855941|FG002|Overall Study|Subject non-compliant|0|||
163040302|NCT01753115|588855939|FG000|Overall Study|Used excluded drug|0|||
163040303|NCT01753115|588855940|FG001|Overall Study|Used excluded drug|1|||
163040304|NCT01753115|588855941|FG002|Overall Study|Used excluded drug|0|||
163040305|NCT04313400|588855947|FG000|Overall Study|Withdrawal by Subject|0|||
163040306|NCT04313400|588855948|FG001|Overall Study|Withdrawal by Subject|0|||
163040307|NCT04313400|588855949|FG002|Overall Study|Withdrawal by Subject|0|||
163040308|NCT04313400|588855950|FG003|Overall Study|Withdrawal by Subject|0|||
163040309|NCT04313400|588855951|FG004|Overall Study|Withdrawal by Subject|0|||
163040310|NCT04313400|588855952|FG005|Overall Study|Withdrawal by Subject|4|||
163040311|NCT04313400|588855953|FG006|Overall Study|Withdrawal by Subject|1|||
163040312|NCT04313400|588855947|FG000|Overall Study|Adverse Event|0|||
163040313|NCT04313400|588855948|FG001|Overall Study|Adverse Event|0|||
163040314|NCT04313400|588855949|FG002|Overall Study|Adverse Event|0|||
163040315|NCT04313400|588855950|FG003|Overall Study|Adverse Event|0|||
163040316|NCT04313400|588855951|FG004|Overall Study|Adverse Event|0|||
163040317|NCT04313400|588855952|FG005|Overall Study|Adverse Event|1|||
162925665|NCT01396161|588430360|FG005|Overall Study|Other|0|||
162925666|NCT01396161|588430361|FG006|Overall Study|Other|1|||
163040318|NCT04313400|588855953|FG006|Overall Study|Adverse Event|0|||
163040319|NCT04313400|588855947|FG000|Overall Study|Lost to Follow-up|0|||
163040320|NCT04313400|588855948|FG001|Overall Study|Lost to Follow-up|0|||
163040321|NCT04313400|588855949|FG002|Overall Study|Lost to Follow-up|0|||
163040322|NCT04313400|588855950|FG003|Overall Study|Lost to Follow-up|0|||
163040323|NCT04313400|588855951|FG004|Overall Study|Lost to Follow-up|0|||
163040324|NCT04313400|588855952|FG005|Overall Study|Lost to Follow-up|1|||
163040325|NCT04313400|588855953|FG006|Overall Study|Lost to Follow-up|0|||
163040326|NCT02091414|588855954|FG000|Overall Study|Withdrawal by Subject|2|||
163040327|NCT02091414|588855954|FG000|Overall Study|Death|2|||
163040328|NCT02521792|588855957|FG000|Overall Study|Study Terminated|6|||
162925667|NCT03976076|588430362|FG000|Overall Study|Withdrawal by Subject|2|||
162925668|NCT02962739|588430363|FG000|Overall Study|Withdrawal by Subject|0|||
162925669|NCT02962739|588430364|FG001|Overall Study|Withdrawal by Subject|1|||
163040329|NCT00902746|588855958|FG000|Overall Study|Protocol Violation|7|||
163040330|NCT00902746|588855958|FG000|Overall Study|Withdrawal by Subject|16|||
163040331|NCT00902746|588855958|FG000|Overall Study|Adverse Event|8|||
163040332|NCT00902746|588855958|FG000|Overall Study|Lost to Follow-up|3|||
163040333|NCT00902746|588855958|FG000|Overall Study|Physician Decision|2|||
163040334|NCT02081001|588855959|FG000|Overall Study|Adverse Event|0|||
163040335|NCT02081001|588855960|FG001|Overall Study|Adverse Event|0|||
163040336|NCT02081001|588855961|FG002|Overall Study|Adverse Event|0|||
163040337|NCT02081001|588855962|FG003|Overall Study|Adverse Event|0|||
163040338|NCT02081001|588855963|FG004|Overall Study|Adverse Event|1|||
163040339|NCT02081001|588855964|FG005|Overall Study|Adverse Event|0|||
163040340|NCT02081001|588855965|FG006|Overall Study|Adverse Event|0|||
163040341|NCT02081001|588855966|FG007|Overall Study|Adverse Event|0|||
163040342|NCT02081001|588855967|FG008|Overall Study|Adverse Event|0|||
163040343|NCT02081001|588855968|FG009|Overall Study|Adverse Event|0|||
163040344|NCT02081001|588855969|FG010|Overall Study|Adverse Event|0|||
163040345|NCT02081001|588855970|FG011|Overall Study|Adverse Event|0|||
163040346|NCT02937636|588855971|FG000|Overall Study|Other (Not specified)|3|||
163040347|NCT02937636|588855972|FG001|Overall Study|Other (Not specified)|2|||
163040348|NCT00359294|588855973|FG000|Overall Study|Progressive disease|1|||
163040349|NCT00359294|588855974|FG001|Overall Study|Progressive disease|1|||
163040350|NCT00359294|588855975|FG002|Overall Study|Progressive disease|2|||
163040351|NCT00359294|588855976|FG003|Overall Study|Progressive disease|3|||
163040352|NCT00359294|588855977|FG004|Overall Study|Progressive disease|2|||
163040353|NCT00359294|588855973|FG000|Overall Study|Withdrawal by Subject|0|||
163040354|NCT00359294|588855974|FG001|Overall Study|Withdrawal by Subject|0|||
162925670|NCT02962739|588430365|FG002|Overall Study|Withdrawal by Subject|0|||
162925671|NCT02962739|588430366|FG003|Overall Study|Withdrawal by Subject|0|||
162925672|NCT02962739|588430367|FG004|Overall Study|Withdrawal by Subject|0|||
163040355|NCT00359294|588855975|FG002|Overall Study|Withdrawal by Subject|0|||
163040356|NCT00359294|588855976|FG003|Overall Study|Withdrawal by Subject|0|||
163040357|NCT00359294|588855977|FG004|Overall Study|Withdrawal by Subject|1|||
163040358|NCT00359294|588855973|FG000|Overall Study|Not treated|0|||
163040359|NCT00359294|588855974|FG001|Overall Study|Not treated|0|||
163040360|NCT00359294|588855975|FG002|Overall Study|Not treated|0|||
163040361|NCT00359294|588855976|FG003|Overall Study|Not treated|1|||
163040362|NCT00359294|588855977|FG004|Overall Study|Not treated|0|||
163040363|NCT00359294|588855973|FG000|Overall Study|Physician Decision|0|||
163040364|NCT00359294|588855974|FG001|Overall Study|Physician Decision|0|||
163040365|NCT00359294|588855975|FG002|Overall Study|Physician Decision|1|||
163040366|NCT00359294|588855976|FG003|Overall Study|Physician Decision|0|||
163040367|NCT00359294|588855977|FG004|Overall Study|Physician Decision|0|||
163040368|NCT04208412|588855978|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
163040369|NCT04208412|588855979|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
163040370|NCT04208412|588855978|FG000|Overall Study|Withdrawal by Subject|1|||
163040371|NCT04208412|588855979|FG001|Overall Study|Withdrawal by Subject|0|||
163040372|NCT04208412|588855978|FG000|Overall Study|Lost to Follow-up|0|||
163040373|NCT04208412|588855979|FG001|Overall Study|Lost to Follow-up|1|||
163040374|NCT03762681|588855980|FG000|Part 1|Withdrawal by Subject|0|||
163040375|NCT03762681|588855981|FG001|Part 1|Withdrawal by Subject|0|||
163040376|NCT03762681|588855982|FG002|Part 1|Withdrawal by Subject|0|||
163040377|NCT03762681|588855983|FG003|Part 1|Withdrawal by Subject|1|||
163040378|NCT03762681|588855984|FG004|Part 1|Withdrawal by Subject|0|||
163040379|NCT03762681|588855985|FG005|Part 1|Withdrawal by Subject|0|||
163040380|NCT03762681|588855986|FG006|Part 1|Withdrawal by Subject|0|||
163040381|NCT03762681|588855987|FG007|Part 1|Withdrawal by Subject|0|||
163040382|NCT03762681|588855980|FG000|Part 2a|Pandemic Travel Restrictions|0|||
163040383|NCT03762681|588855981|FG001|Part 2a|Pandemic Travel Restrictions|0|||
163040384|NCT03762681|588855982|FG002|Part 2a|Pandemic Travel Restrictions|0|||
163040385|NCT03762681|588855983|FG003|Part 2a|Pandemic Travel Restrictions|0|||
163040386|NCT03762681|588855984|FG004|Part 2a|Pandemic Travel Restrictions|0|||
163040387|NCT03762681|588855985|FG005|Part 2a|Pandemic Travel Restrictions|0|||
163040388|NCT03762681|588855986|FG006|Part 2a|Pandemic Travel Restrictions|0|||
163040389|NCT03762681|588855987|FG007|Part 2a|Pandemic Travel Restrictions|1|||
163040390|NCT03148067|588855988|FG000|Overall Study|Lost to Follow-up|3|||
163040391|NCT03148067|588855988|FG000|Overall Study|Death|1|||
163040392|NCT00435188|588855990|FG000|Overall Study|Death|1|||
163040393|NCT00435188|588855991|FG001|Overall Study|Death|6|||
163040394|NCT00435188|588855990|FG000|Overall Study|Withdrawal by Subject|16|||
163040395|NCT00435188|588855991|FG001|Overall Study|Withdrawal by Subject|11|||
163040396|NCT00435188|588855990|FG000|Overall Study|Lost to Follow-up|5|||
163040397|NCT00435188|588855991|FG001|Overall Study|Lost to Follow-up|6|||
163040398|NCT01915771|588855992|FG000|Day 1|Withdrawal by Subject|1|||
163040399|NCT01915771|588855992|FG000|Day 15|Withdrawal by Subject|1|||
163040400|NCT02774005|588855999|FG000|Overall Study|Adverse Event|8|||
163040401|NCT02774005|588855999|FG000|Overall Study|Withdrawal by Subject|23|||
163040402|NCT02774005|588855999|FG000|Overall Study|Lost to Follow-up|7|||
163040403|NCT02774005|588855999|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
163040404|NCT02774005|588855999|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
163040405|NCT02774005|588855999|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
163040406|NCT02774005|588855999|FG000|Overall Study|Death|1|||
163040407|NCT02774005|588855999|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
163040408|NCT02774005|588855999|FG000|Overall Study|Lack of compliance with study medication|4|||
163040409|NCT02774005|588855999|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
163040410|NCT02774005|588855999|FG000|Overall Study|another study|1|||
163385067|NCT02425644|590120762|FG000|Overall Study|Death|0|||
163385068|NCT02425644|590120763|FG001|Overall Study|Death|2|||
163385069|NCT02425644|590120762|FG000|Overall Study|Other|18|||
163385070|NCT02425644|590120763|FG001|Overall Study|Other|17|||
163385071|NCT02720536|590120764|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
163385072|NCT02720536|590120764|FG000|Overall Study|PR - pregnancy|2|||
163385073|NCT02720536|590120764|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
163385074|NCT02720536|590120764|FG000|Overall Study|PR - death|1|||
163385075|NCT02720536|590120764|FG000|Overall Study|PR - adverse event|1|||
163385076|NCT02720536|590120764|FG000|Overall Study|PR - abnormal lab value(s)|1|||
163385077|NCT02720536|590120764|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
163385078|NCT02525861|590120765|FG000|Overall Study|Adverse Event|1|||
163385079|NCT02525861|590120766|FG001|Overall Study|Adverse Event|0|||
163385080|NCT02525861|590120765|FG000|Overall Study|Withdrawal by Subject|0|||
163385081|NCT02525861|590120766|FG001|Overall Study|Withdrawal by Subject|1|||
163385082|NCT02525861|590120765|FG000|Overall Study|Physician Decision|0|||
163385083|NCT02525861|590120766|FG001|Overall Study|Physician Decision|1|||
163385084|NCT01607554|590120770|FG000|Overall Study|Disease progression|2|||
163385085|NCT05580588|590120771|FG000|Overall Study|Lack of Efficacy|12|||
163269838|NCT02959138|589699911|FG001|Overall Study|Enrolled but Never Treated|1|||
163269839|NCT02959138|589699912|FG002|Overall Study|Enrolled but Never Treated|0|||
163385086|NCT00756470|590120774|FG000|Overall Study|Withdrawal by Subject|1|||
163385087|NCT00756470|590120774|FG000|Overall Study|Adverse Event|4|||
163040411|NCT02774005|588855999|FG000|Overall Study|cardiologist imposed travel restriction|1|||
163040412|NCT00723697|588856000|FG000|Overall Study|Physician questionnaires not received|2|||
163040413|NCT00723697|588856000|FG000|Overall Study|Missing Informed Consent Form|10|||
163040414|NCT00723697|588856000|FG000|Overall Study|Other exclusion criteria applied|6|||
163040415|NCT03275389|588856001|FG000|Overall Study|Lost to Follow-up|10|||
163040416|NCT03275389|588856002|FG001|Overall Study|Lost to Follow-up|10|||
163269840|NCT02391038|589699913|FG000|Overall Study|Progressive disease|3|||
163269841|NCT02391038|589699914|FG001|Overall Study|Progressive disease|3|||
163269842|NCT02391038|589699915|FG002|Overall Study|Progressive disease|6|||
163269843|NCT04213989|589699916|FG000|Overall Study|Withdrawal by Subject|3|||
163269844|NCT04213989|589699917|FG001|Overall Study|Withdrawal by Subject|2|||
163269845|NCT04213989|589699916|FG000|Overall Study|Physician Decision|1|||
163269846|NCT04213989|589699917|FG001|Overall Study|Physician Decision|0|||
163269847|NCT04213989|589699916|FG000|Overall Study|Lost to Follow-up|0|||
163269848|NCT04213989|589699917|FG001|Overall Study|Lost to Follow-up|4|||
163269849|NCT01327547|589699918|FG000|Overall Study|Adverse Event|4|||
163269850|NCT01327547|589699919|FG001|Overall Study|Adverse Event|1|||
163269851|NCT01327547|589699918|FG000|Overall Study|Death|1|||
163385088|NCT00325039|590120775|FG000|Overall Study|Lost to Follow-up|18|||
163385089|NCT00325039|590120776|FG001|Overall Study|Lost to Follow-up|14|||
163385090|NCT01009203|590120778|FG000|Overall Study|Withdrawal by Subject|1|||
163385091|NCT01009203|590120778|FG000|Overall Study|Adverse Event|5|||
163385092|NCT01009203|590120778|FG000|Overall Study|Treatment-unrelated death|1|||
163385093|NCT02974088|590120782|FG000|Overall Study|Lost to Follow-up|0|||
163385094|NCT02974088|590120783|FG001|Overall Study|Lost to Follow-up|2|||
163385095|NCT02974088|590120782|FG000|Overall Study|Adverse Event|0|||
163385096|NCT02974088|590120783|FG001|Overall Study|Adverse Event|1|||
163385097|NCT00892723|590120784|FG000|Overall Study|Lost to Follow-up|1|||
163385098|NCT00892723|590120785|FG001|Overall Study|Lost to Follow-up|3|||
163385099|NCT00892723|590120786|FG002|Overall Study|Lost to Follow-up|1|||
163385100|NCT00892723|590120784|FG000|Overall Study|Withdrawal by Subject|1|||
163385101|NCT00892723|590120785|FG001|Overall Study|Withdrawal by Subject|1|||
163385102|NCT00892723|590120786|FG002|Overall Study|Withdrawal by Subject|1|||
163385103|NCT00150969|590120789|FG000|24 Month Main Study|Adverse Event|3|||
163385104|NCT00150969|590120790|FG001|24 Month Main Study|Adverse Event|4|||
163040417|NCT03275389|588856003|FG002|Overall Study|Lost to Follow-up|19|||
163040418|NCT03275389|588856004|FG003|Overall Study|Lost to Follow-up|12|||
163040419|NCT03275389|588856005|FG004|Overall Study|Lost to Follow-up|11|||
163040420|NCT03275389|588856006|FG005|Overall Study|Lost to Follow-up|12|||
163040421|NCT03275389|588856007|FG006|Overall Study|Lost to Follow-up|21|||
163040422|NCT03275389|588856008|FG007|Overall Study|Lost to Follow-up|15|||
163040423|NCT03275389|588856009|FG008|Overall Study|Lost to Follow-up|12|||
163040424|NCT03275389|588856010|FG009|Overall Study|Lost to Follow-up|14|||
163040425|NCT03275389|588856001|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163040426|NCT03275389|588856002|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163040427|NCT03275389|588856003|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163040428|NCT03275389|588856004|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163040429|NCT03275389|588856005|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163040430|NCT03275389|588856006|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
163154860|NCT02079246|589283632|FG001|OLEX|Withdrawal before treatment|0|||
163154861|NCT02079246|589283631|FG000|OLEX|Death|11|||
163040431|NCT03275389|588856007|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163154862|NCT02079246|589283632|FG001|OLEX|Death|0|||
163154863|NCT02079246|589283631|FG000|OLEX|Adverse Event|66|||
163154864|NCT02079246|589283632|FG001|OLEX|Adverse Event|0|||
163154865|NCT02079246|589283631|FG000|OLEX|Withdrawal by Subject|60|||
163154866|NCT02079246|589283632|FG001|OLEX|Withdrawal by Subject|0|||
163154867|NCT02079246|589283631|FG000|OLEX|Lost to Follow-up|6|||
163154868|NCT02079246|589283632|FG001|OLEX|Lost to Follow-up|0|||
163154869|NCT02079246|589283631|FG000|OLEX|Protocol Violation|6|||
163154870|NCT02079246|589283632|FG001|OLEX|Protocol Violation|0|||
163154871|NCT02079246|589283631|FG000|OLEX|Lack of Efficacy|3|||
163154872|NCT02079246|589283632|FG001|OLEX|Lack of Efficacy|0|||
163154873|NCT02079246|589283631|FG000|OLEX|Results of the lead-in studies|58|||
163154874|NCT02079246|589283632|FG001|OLEX|Results of the lead-in studies|0|||
163154875|NCT02079246|589283631|FG000|OLEX|Other: Disallowed medication|8|||
163154876|NCT02079246|589283632|FG001|OLEX|Other: Disallowed medication|0|||
163154877|NCT02079246|589283631|FG000|OLEX|Other: Insufficient compliance|2|||
163154878|NCT02079246|589283632|FG001|OLEX|Other: Insufficient compliance|0|||
163154879|NCT02079246|589283631|FG000|OLEX|Other: Caregiver unavailable|3|||
163154880|NCT02079246|589283632|FG001|OLEX|Other: Caregiver unavailable|0|||
163154881|NCT02079246|589283631|FG000|OLEX|Other: Coordinator decision|1|||
163154882|NCT02079246|589283632|FG001|OLEX|Other: Coordinator decision|0|||
163154883|NCT02079246|589283631|FG000|OLEX|Other: Worsening of condition|1|||
163385105|NCT00150969|590120789|FG000|24 Month Main Study|Death|1|||
163154884|NCT02079246|589283632|FG001|OLEX|Other: Worsening of condition|0|||
163154885|NCT02079246|589283631|FG000|OLEX|Other: Moved to nursing home|1|||
163154886|NCT02079246|589283632|FG001|OLEX|Other: Moved to nursing home|0|||
163385106|NCT00150969|590120790|FG001|24 Month Main Study|Death|1|||
163385107|NCT00150969|590120789|FG000|24 Month Main Study|Lack of Efficacy|1|||
163040432|NCT03275389|588856008|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163040433|NCT03275389|588856009|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163154887|NCT02079246|589283631|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
163154888|NCT02079246|589283632|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
163269852|NCT01327547|589699919|FG001|Overall Study|Death|2|||
163385108|NCT00150969|590120790|FG001|24 Month Main Study|Lack of Efficacy|8|||
163154889|NCT02079246|589283631|FG000|OLEX-MEM|Adverse Event|0|||
163154890|NCT02079246|589283632|FG001|OLEX-MEM|Adverse Event|6|||
163154891|NCT02079246|589283631|FG000|OLEX-MEM|Withdrawal by Subject|0|||
163154892|NCT02079246|589283632|FG001|OLEX-MEM|Withdrawal by Subject|7|||
163154893|NCT02079246|589283631|FG000|OLEX-MEM|Protocol Violation|0|||
163154894|NCT02079246|589283632|FG001|OLEX-MEM|Protocol Violation|2|||
163154895|NCT02079246|589283631|FG000|OLEX-MEM|Lost to Follow-up|0|||
163154896|NCT02079246|589283632|FG001|OLEX-MEM|Lost to Follow-up|1|||
163154897|NCT02079246|589283631|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
163154898|NCT02079246|589283632|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
163385109|NCT00150969|590120789|FG000|24 Month Main Study|Lost to Follow-up|3|||
163385110|NCT00150969|590120790|FG001|24 Month Main Study|Lost to Follow-up|2|||
163385111|NCT00150969|590120789|FG000|24 Month Main Study|Protocol Violation|4|||
163385112|NCT00150969|590120790|FG001|24 Month Main Study|Protocol Violation|2|||
163385113|NCT00150969|590120789|FG000|24 Month Main Study|Withdrawal by Subject|7|||
163385114|NCT00150969|590120790|FG001|24 Month Main Study|Withdrawal by Subject|4|||
163385115|NCT00150969|590120789|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
163385116|NCT00150969|590120790|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
163385117|NCT00150969|590120789|FG000|24-48 Month Extension|Lack of Efficacy|0|||
163385118|NCT00150969|590120790|FG001|24-48 Month Extension|Lack of Efficacy|1|||
163385119|NCT00150969|590120789|FG000|24-48 Month Extension|Adverse Event|1|||
163385120|NCT00150969|590120790|FG001|24-48 Month Extension|Adverse Event|3|||
163385121|NCT00150969|590120789|FG000|24-48 Month Extension|Other Reason|81|||
163385122|NCT00150969|590120790|FG001|24-48 Month Extension|Other Reason|91|||
163385123|NCT00615836|590120791|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
163385124|NCT00615836|590120792|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
163385125|NCT00615836|590120793|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
163385126|NCT00615836|590120794|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
163385127|NCT00615836|590120795|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
163385128|NCT00615836|590120791|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
163385129|NCT00615836|590120792|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
163385130|NCT00615836|590120793|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
163385131|NCT00615836|590120794|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
163385132|NCT00615836|590120795|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
163385133|NCT00615836|590120791|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
163385134|NCT00615836|590120792|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
163385135|NCT00615836|590120793|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
163385136|NCT00615836|590120794|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
163385137|NCT00615836|590120795|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
163385138|NCT00615836|590120791|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
163385139|NCT00615836|590120792|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
163385140|NCT00615836|590120793|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
163385141|NCT00615836|590120794|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
163385142|NCT00615836|590120795|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
163385143|NCT00615836|590120791|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
163385144|NCT00615836|590120792|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
163385145|NCT00615836|590120793|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
163385146|NCT00615836|590120794|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
163385147|NCT00615836|590120795|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
163385148|NCT00615836|590120791|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
163385149|NCT00615836|590120792|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
163385150|NCT00615836|590120793|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
163385151|NCT00615836|590120794|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
163385152|NCT00615836|590120795|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
163385153|NCT00615836|590120791|FG000|Extension Study (FE992026 CS31)|Other|10|||
163385154|NCT00615836|590120792|FG001|Extension Study (FE992026 CS31)|Other|7|||
163385155|NCT00615836|590120793|FG002|Extension Study (FE992026 CS31)|Other|8|||
163385156|NCT00615836|590120794|FG003|Extension Study (FE992026 CS31)|Other|8|||
163385157|NCT00615836|590120795|FG004|Extension Study (FE992026 CS31)|Other|0|||
163385158|NCT00615836|590120791|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
163385159|NCT00615836|590120792|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
163385160|NCT00615836|590120793|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
163385161|NCT00615836|590120794|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
163385162|NCT00615836|590120795|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
163385163|NCT00615836|590120791|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
163385164|NCT00615836|590120792|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
163385165|NCT00615836|590120793|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
163385166|NCT00615836|590120794|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
163154899|NCT03591406|589283637|FG000|Overall Study|Adverse Event|5|||
163154900|NCT03591406|589283638|FG001|Overall Study|Adverse Event|3|||
163385167|NCT00615836|590120795|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
163385168|NCT01630434|590120796|FG000|Overall Study|Donor lungs turned down|1|||
163385169|NCT01630434|590120797|FG001|Overall Study|Donor lungs turned down|0|||
163385170|NCT01630434|590120796|FG000|Overall Study|Protocol Violation|9|||
163385171|NCT01630434|590120797|FG001|Overall Study|Protocol Violation|4|||
163385172|NCT01630434|590120796|FG000|Overall Study|Death|20|||
163385173|NCT01630434|590120797|FG001|Overall Study|Death|26|||
163154901|NCT03591406|589283637|FG000|Overall Study|Protocol Violation|2|||
163154902|NCT03591406|589283638|FG001|Overall Study|Protocol Violation|1|||
163154903|NCT03591406|589283637|FG000|Overall Study|Withdrawal by Subject|0|||
163154904|NCT03591406|589283638|FG001|Overall Study|Withdrawal by Subject|5|||
163385174|NCT00687973|590120798|FG000|Overall Study|Adverse Event|18|||
163385175|NCT00687973|590120799|FG001|Overall Study|Adverse Event|28|||
163385176|NCT00687973|590120798|FG000|Overall Study|Lack of Efficacy|2|||
163385177|NCT00687973|590120799|FG001|Overall Study|Lack of Efficacy|3|||
163385178|NCT00687973|590120798|FG000|Overall Study|Protocol Violation|1|||
163385179|NCT00687973|590120799|FG001|Overall Study|Protocol Violation|2|||
163385180|NCT00687973|590120798|FG000|Overall Study|Administrative Reasons|0|||
163385181|NCT00687973|590120799|FG001|Overall Study|Administrative Reasons|2|||
163385182|NCT00687973|590120798|FG000|Overall Study|Withdrawal by Subject|3|||
163385183|NCT00687973|590120799|FG001|Overall Study|Withdrawal by Subject|3|||
163385184|NCT00511472|590120806|FG000|Overall Study|Clinical Adverse Event|1|||
163385185|NCT00511472|590120807|FG001|Overall Study|Clinical Adverse Event|2|||
163385186|NCT00511472|590120806|FG000|Overall Study|Laboratory Adverse Event|0|||
163385187|NCT00511472|590120807|FG001|Overall Study|Laboratory Adverse Event|2|||
163385188|NCT00511472|590120806|FG000|Overall Study|Not reported|2|||
163385189|NCT00511472|590120807|FG001|Overall Study|Not reported|2|||
163385190|NCT01079741|590120808|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
163385191|NCT01079741|590120809|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
163385192|NCT01079741|590120810|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
163385193|NCT01079741|590120811|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
163385194|NCT01079741|590120812|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
163385195|NCT01079741|590120808|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
163385196|NCT01079741|590120809|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
163385197|NCT01079741|590120810|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
163385198|NCT01079741|590120811|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
163385199|NCT01079741|590120812|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
163385200|NCT00406653|590120813|FG000|Induction Period|Adverse Event|1|||
163385201|NCT00406653|590120814|FG001|Induction Period|Adverse Event|10|||
163385202|NCT00406653|590120815|FG002|Induction Period|Adverse Event|4|||
163385203|NCT00406653|590120816|FG003|Induction Period|Adverse Event|11|||
163385204|NCT00406653|590120817|FG004|Induction Period|Adverse Event|0|||
163385205|NCT00406653|590120818|FG005|Induction Period|Adverse Event|0|||
163385206|NCT00406653|590120819|FG006|Induction Period|Adverse Event|0|||
163385207|NCT00406653|590120813|FG000|Induction Period|Lack of Efficacy|11|||
163385208|NCT00406653|590120814|FG001|Induction Period|Lack of Efficacy|14|||
163385209|NCT00406653|590120815|FG002|Induction Period|Lack of Efficacy|8|||
163385210|NCT00406653|590120816|FG003|Induction Period|Lack of Efficacy|10|||
163385211|NCT00406653|590120817|FG004|Induction Period|Lack of Efficacy|0|||
163385212|NCT00406653|590120818|FG005|Induction Period|Lack of Efficacy|0|||
163385213|NCT00406653|590120819|FG006|Induction Period|Lack of Efficacy|0|||
163385214|NCT00406653|590120813|FG000|Induction Period|Lost to Follow-up|0|||
163385215|NCT00406653|590120814|FG001|Induction Period|Lost to Follow-up|2|||
163385216|NCT00406653|590120815|FG002|Induction Period|Lost to Follow-up|0|||
163385217|NCT00406653|590120816|FG003|Induction Period|Lost to Follow-up|0|||
163385218|NCT00406653|590120817|FG004|Induction Period|Lost to Follow-up|0|||
163385219|NCT00406653|590120818|FG005|Induction Period|Lost to Follow-up|0|||
163385220|NCT00406653|590120819|FG006|Induction Period|Lost to Follow-up|0|||
163385221|NCT00406653|590120813|FG000|Induction Period|Withdrawal of Consent|2|||
163385222|NCT00406653|590120814|FG001|Induction Period|Withdrawal of Consent|5|||
163385223|NCT00406653|590120815|FG002|Induction Period|Withdrawal of Consent|1|||
163385224|NCT00406653|590120816|FG003|Induction Period|Withdrawal of Consent|2|||
163385225|NCT00406653|590120817|FG004|Induction Period|Withdrawal of Consent|0|||
163385226|NCT00406653|590120818|FG005|Induction Period|Withdrawal of Consent|0|||
163385227|NCT00406653|590120819|FG006|Induction Period|Withdrawal of Consent|0|||
163385228|NCT00406653|590120813|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
163385229|NCT00406653|590120814|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
163385230|NCT00406653|590120815|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
163385231|NCT00406653|590120816|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
163385232|NCT00406653|590120817|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
163385233|NCT00406653|590120818|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
163385234|NCT00406653|590120819|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
163154905|NCT01389596|589283639|FG000|Overall Study|Protocol Violation|3|||
163385235|NCT00406653|590120813|FG000|Induction Period|Pregnancy|1|||
163385236|NCT00406653|590120814|FG001|Induction Period|Pregnancy|0|||
163154906|NCT01389596|589283640|FG001|Overall Study|Protocol Violation|4|||
163154907|NCT01389596|589283641|FG002|Overall Study|Protocol Violation|3|||
163154908|NCT01389596|589283639|FG000|Overall Study|Withdrawal by Subject|1|||
163154909|NCT01389596|589283640|FG001|Overall Study|Withdrawal by Subject|2|||
163154910|NCT01389596|589283641|FG002|Overall Study|Withdrawal by Subject|2|||
163154911|NCT01389596|589283639|FG000|Overall Study|Insufficient Clinical Response|3|||
163154912|NCT01389596|589283640|FG001|Overall Study|Insufficient Clinical Response|4|||
163154913|NCT01389596|589283641|FG002|Overall Study|Insufficient Clinical Response|5|||
163154914|NCT01389596|589283639|FG000|Overall Study|Adverse Event|1|||
163154915|NCT01389596|589283640|FG001|Overall Study|Adverse Event|4|||
163154916|NCT01389596|589283641|FG002|Overall Study|Adverse Event|0|||
163154917|NCT01389596|589283639|FG000|Overall Study|Death|0|||
163154918|NCT01389596|589283640|FG001|Overall Study|Death|1|||
163154919|NCT01389596|589283641|FG002|Overall Study|Death|0|||
163154920|NCT01389596|589283639|FG000|Overall Study|Other Unspecified|2|||
163154921|NCT01389596|589283640|FG001|Overall Study|Other Unspecified|1|||
163154922|NCT01389596|589283641|FG002|Overall Study|Other Unspecified|0|||
163154923|NCT01709084|589283642|FG000|Overall Study|Lost to Follow-up|4|||
163154924|NCT01709084|589283643|FG001|Overall Study|Lost to Follow-up|7|||
163154925|NCT01709084|589283642|FG000|Overall Study|Withdrawal by Subject|2|||
163154926|NCT01709084|589283643|FG001|Overall Study|Withdrawal by Subject|2|||
163154927|NCT01709084|589283642|FG000|Overall Study|Adverse Event|5|||
163154928|NCT01709084|589283643|FG001|Overall Study|Adverse Event|0|||
163154929|NCT01709084|589283642|FG000|Overall Study|Other|5|||
163154930|NCT01709084|589283643|FG001|Overall Study|Other|3|||
163154931|NCT01709084|589283642|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
163154932|NCT01709084|589283643|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
163154933|NCT01709084|589283642|FG000|Overall Study|Not Treated|0|||
163154934|NCT01709084|589283643|FG001|Overall Study|Not Treated|2|||
163154935|NCT00214201|589283644|FG000|Overall Study|Withdrawal by Subject|2|||
163154936|NCT00214201|589283645|FG001|Overall Study|Withdrawal by Subject|0|||
163154937|NCT00214201|589283644|FG000|Overall Study|Death|0|||
163154938|NCT00214201|589283645|FG001|Overall Study|Death|2|||
163154939|NCT00463567|589283649|FG000|Overall Study|Adverse Event|29|||
163154940|NCT00463567|589283650|FG001|Overall Study|Adverse Event|26|||
163154941|NCT00463567|589283651|FG002|Overall Study|Adverse Event|17|||
163154942|NCT00463567|589283652|FG003|Overall Study|Adverse Event|46|||
163154943|NCT00463567|589283653|FG004|Overall Study|Adverse Event|10|||
163154944|NCT00463567|589283654|FG005|Overall Study|Adverse Event|10|||
163154945|NCT00463567|589283655|FG006|Overall Study|Adverse Event|4|||
163154946|NCT00463567|589283649|FG000|Overall Study|Withdrawal by Subject|29|||
163154947|NCT00463567|589283650|FG001|Overall Study|Withdrawal by Subject|22|||
163154948|NCT00463567|589283651|FG002|Overall Study|Withdrawal by Subject|20|||
163154949|NCT00463567|589283652|FG003|Overall Study|Withdrawal by Subject|37|||
163154950|NCT00463567|589283653|FG004|Overall Study|Withdrawal by Subject|6|||
163154951|NCT00463567|589283654|FG005|Overall Study|Withdrawal by Subject|5|||
163154952|NCT00463567|589283655|FG006|Overall Study|Withdrawal by Subject|1|||
163154953|NCT00463567|589283649|FG000|Overall Study|Protocol Deviation|13|||
163154954|NCT00463567|589283650|FG001|Overall Study|Protocol Deviation|9|||
163154955|NCT00463567|589283651|FG002|Overall Study|Protocol Deviation|14|||
163154956|NCT00463567|589283652|FG003|Overall Study|Protocol Deviation|11|||
163154957|NCT00463567|589283653|FG004|Overall Study|Protocol Deviation|1|||
163154958|NCT00463567|589283654|FG005|Overall Study|Protocol Deviation|1|||
163154959|NCT00463567|589283655|FG006|Overall Study|Protocol Deviation|2|||
163154960|NCT00463567|589283649|FG000|Overall Study|Lost to Follow-up|12|||
163154961|NCT00463567|589283650|FG001|Overall Study|Lost to Follow-up|6|||
163154962|NCT00463567|589283651|FG002|Overall Study|Lost to Follow-up|13|||
163040434|NCT03275389|588856010|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
163040435|NCT03275389|588856001|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
163040436|NCT03275389|588856002|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
163040437|NCT03275389|588856003|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
163040438|NCT03275389|588856004|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
163040439|NCT03275389|588856005|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
163040440|NCT03275389|588856006|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
163040441|NCT03275389|588856007|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
163040442|NCT03275389|588856008|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
163040443|NCT03275389|588856009|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
163154963|NCT00463567|589283652|FG003|Overall Study|Lost to Follow-up|8|||
163154964|NCT00463567|589283653|FG004|Overall Study|Lost to Follow-up|1|||
163154965|NCT00463567|589283654|FG005|Overall Study|Lost to Follow-up|1|||
163154966|NCT00463567|589283655|FG006|Overall Study|Lost to Follow-up|1|||
163154967|NCT00463567|589283649|FG000|Overall Study|Administrative problems|5|||
163154968|NCT00463567|589283650|FG001|Overall Study|Administrative problems|3|||
163154969|NCT00463567|589283651|FG002|Overall Study|Administrative problems|6|||
163154970|NCT00463567|589283652|FG003|Overall Study|Administrative problems|9|||
163154971|NCT00463567|589283653|FG004|Overall Study|Administrative problems|3|||
163154972|NCT00463567|589283654|FG005|Overall Study|Administrative problems|2|||
163385237|NCT00406653|590120815|FG002|Induction Period|Pregnancy|0|||
163385238|NCT00406653|590120816|FG003|Induction Period|Pregnancy|0|||
163385239|NCT00406653|590120817|FG004|Induction Period|Pregnancy|0|||
163385240|NCT00406653|590120818|FG005|Induction Period|Pregnancy|0|||
163385241|NCT00406653|590120819|FG006|Induction Period|Pregnancy|0|||
163385242|NCT00406653|590120813|FG000|Induction Period|Declined participation but followup done|0|||
163385243|NCT00406653|590120814|FG001|Induction Period|Declined participation but followup done|2|||
163385244|NCT00406653|590120815|FG002|Induction Period|Declined participation but followup done|1|||
163385245|NCT00406653|590120816|FG003|Induction Period|Declined participation but followup done|1|||
163385246|NCT00406653|590120817|FG004|Induction Period|Declined participation but followup done|0|||
163385247|NCT00406653|590120818|FG005|Induction Period|Declined participation but followup done|0|||
163385248|NCT00406653|590120819|FG006|Induction Period|Declined participation but followup done|0|||
163385249|NCT00406653|590120813|FG000|Induction Period|Given prohibited drug|0|||
163385250|NCT00406653|590120814|FG001|Induction Period|Given prohibited drug|1|||
163385251|NCT00406653|590120815|FG002|Induction Period|Given prohibited drug|2|||
163385252|NCT00406653|590120816|FG003|Induction Period|Given prohibited drug|0|||
163385253|NCT00406653|590120817|FG004|Induction Period|Given prohibited drug|0|||
163385254|NCT00406653|590120818|FG005|Induction Period|Given prohibited drug|0|||
163385255|NCT00406653|590120819|FG006|Induction Period|Given prohibited drug|0|||
163385256|NCT00406653|590120813|FG000|Induction Period|Incarcerated|0|||
163385257|NCT00406653|590120814|FG001|Induction Period|Incarcerated|0|||
163385258|NCT00406653|590120815|FG002|Induction Period|Incarcerated|1|||
163385259|NCT00406653|590120816|FG003|Induction Period|Incarcerated|0|||
163385260|NCT00406653|590120817|FG004|Induction Period|Incarcerated|0|||
163385261|NCT00406653|590120818|FG005|Induction Period|Incarcerated|0|||
163385262|NCT00406653|590120819|FG006|Induction Period|Incarcerated|0|||
163385263|NCT00406653|590120813|FG000|Induction Period|Patient relocated|0|||
163385264|NCT00406653|590120814|FG001|Induction Period|Patient relocated|0|||
163385265|NCT00406653|590120815|FG002|Induction Period|Patient relocated|1|||
163385266|NCT00406653|590120816|FG003|Induction Period|Patient relocated|0|||
163385267|NCT00406653|590120817|FG004|Induction Period|Patient relocated|0|||
163385268|NCT00406653|590120818|FG005|Induction Period|Patient relocated|0|||
163385269|NCT00406653|590120819|FG006|Induction Period|Patient relocated|0|||
163385270|NCT00406653|590120813|FG000|Maintenance Period|Adverse Event|0|||
163385271|NCT00406653|590120814|FG001|Maintenance Period|Adverse Event|0|||
163385272|NCT00406653|590120815|FG002|Maintenance Period|Adverse Event|0|||
163385273|NCT00406653|590120816|FG003|Maintenance Period|Adverse Event|0|||
163385274|NCT00406653|590120817|FG004|Maintenance Period|Adverse Event|1|||
163385275|NCT00406653|590120818|FG005|Maintenance Period|Adverse Event|1|||
163385276|NCT00406653|590120819|FG006|Maintenance Period|Adverse Event|0|||
163385277|NCT00406653|590120813|FG000|Maintenance Period|Lack of Efficacy|0|||
163385278|NCT00406653|590120814|FG001|Maintenance Period|Lack of Efficacy|0|||
163385279|NCT00406653|590120815|FG002|Maintenance Period|Lack of Efficacy|0|||
163385280|NCT00406653|590120816|FG003|Maintenance Period|Lack of Efficacy|0|||
163385281|NCT00406653|590120817|FG004|Maintenance Period|Lack of Efficacy|20|||
163385282|NCT00406653|590120818|FG005|Maintenance Period|Lack of Efficacy|26|||
163385283|NCT00406653|590120819|FG006|Maintenance Period|Lack of Efficacy|0|||
163385284|NCT00406653|590120813|FG000|Maintenance Period|Lost to Follow-up|0|||
163385285|NCT00406653|590120814|FG001|Maintenance Period|Lost to Follow-up|0|||
163385286|NCT00406653|590120815|FG002|Maintenance Period|Lost to Follow-up|0|||
163385287|NCT00406653|590120816|FG003|Maintenance Period|Lost to Follow-up|0|||
163385288|NCT00406653|590120817|FG004|Maintenance Period|Lost to Follow-up|2|||
163385289|NCT00406653|590120818|FG005|Maintenance Period|Lost to Follow-up|1|||
163385290|NCT00406653|590120819|FG006|Maintenance Period|Lost to Follow-up|0|||
163385291|NCT00406653|590120813|FG000|Maintenance Period|Withdrawal of Consent|0|||
163385292|NCT00406653|590120814|FG001|Maintenance Period|Withdrawal of Consent|0|||
163385293|NCT00406653|590120815|FG002|Maintenance Period|Withdrawal of Consent|0|||
163385294|NCT00406653|590120816|FG003|Maintenance Period|Withdrawal of Consent|0|||
163385295|NCT00406653|590120817|FG004|Maintenance Period|Withdrawal of Consent|2|||
163385296|NCT00406653|590120818|FG005|Maintenance Period|Withdrawal of Consent|0|||
163385297|NCT00406653|590120819|FG006|Maintenance Period|Withdrawal of Consent|0|||
163385298|NCT00406653|590120813|FG000|Maintenance Period|Pregnancy|0|||
163385299|NCT00406653|590120814|FG001|Maintenance Period|Pregnancy|0|||
163385300|NCT00406653|590120815|FG002|Maintenance Period|Pregnancy|0|||
163385301|NCT00406653|590120816|FG003|Maintenance Period|Pregnancy|0|||
163385302|NCT00406653|590120817|FG004|Maintenance Period|Pregnancy|0|||
163385303|NCT00406653|590120818|FG005|Maintenance Period|Pregnancy|1|||
163385304|NCT00406653|590120819|FG006|Maintenance Period|Pregnancy|0|||
163385305|NCT00406653|590120813|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
163385306|NCT00406653|590120814|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
163385307|NCT00406653|590120815|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
163385308|NCT00406653|590120816|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
163385309|NCT00406653|590120817|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
163385310|NCT00406653|590120818|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
163385311|NCT00406653|590120819|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
163385312|NCT00406653|590120813|FG000|Maintenance Period|Error in disease score evaluation|0|||
163385313|NCT00406653|590120814|FG001|Maintenance Period|Error in disease score evaluation|0|||
163385314|NCT00406653|590120815|FG002|Maintenance Period|Error in disease score evaluation|0|||
163385315|NCT00406653|590120816|FG003|Maintenance Period|Error in disease score evaluation|0|||
163385316|NCT00406653|590120817|FG004|Maintenance Period|Error in disease score evaluation|1|||
163385317|NCT00406653|590120818|FG005|Maintenance Period|Error in disease score evaluation|0|||
163385318|NCT00406653|590120819|FG006|Maintenance Period|Error in disease score evaluation|0|||
163385319|NCT00406653|590120813|FG000|Open-Label Period|Death|0|||
163385320|NCT00406653|590120814|FG001|Open-Label Period|Death|0|||
163385321|NCT00406653|590120815|FG002|Open-Label Period|Death|0|||
163385322|NCT00406653|590120816|FG003|Open-Label Period|Death|0|||
163385323|NCT00406653|590120817|FG004|Open-Label Period|Death|0|||
163385324|NCT00406653|590120818|FG005|Open-Label Period|Death|0|||
163385325|NCT00406653|590120819|FG006|Open-Label Period|Death|1|||
163385326|NCT00406653|590120813|FG000|Open-Label Period|Adverse Event|0|||
163385327|NCT00406653|590120814|FG001|Open-Label Period|Adverse Event|0|||
163385328|NCT00406653|590120815|FG002|Open-Label Period|Adverse Event|0|||
163385329|NCT00406653|590120816|FG003|Open-Label Period|Adverse Event|0|||
163385330|NCT00406653|590120817|FG004|Open-Label Period|Adverse Event|0|||
163385331|NCT00406653|590120818|FG005|Open-Label Period|Adverse Event|0|||
163385332|NCT00406653|590120819|FG006|Open-Label Period|Adverse Event|18|||
163385333|NCT00406653|590120813|FG000|Open-Label Period|Lack of Efficacy|0|||
163385334|NCT00406653|590120814|FG001|Open-Label Period|Lack of Efficacy|0|||
163385335|NCT00406653|590120815|FG002|Open-Label Period|Lack of Efficacy|0|||
163385336|NCT00406653|590120816|FG003|Open-Label Period|Lack of Efficacy|0|||
163385337|NCT00406653|590120817|FG004|Open-Label Period|Lack of Efficacy|0|||
163385338|NCT00406653|590120818|FG005|Open-Label Period|Lack of Efficacy|0|||
163385339|NCT00406653|590120819|FG006|Open-Label Period|Lack of Efficacy|160|||
163385340|NCT00406653|590120813|FG000|Open-Label Period|Lost to Follow-up|0|||
163385341|NCT00406653|590120814|FG001|Open-Label Period|Lost to Follow-up|0|||
163385342|NCT00406653|590120815|FG002|Open-Label Period|Lost to Follow-up|0|||
163385343|NCT00406653|590120816|FG003|Open-Label Period|Lost to Follow-up|0|||
163385344|NCT00406653|590120817|FG004|Open-Label Period|Lost to Follow-up|0|||
163385345|NCT00406653|590120818|FG005|Open-Label Period|Lost to Follow-up|0|||
163385346|NCT00406653|590120819|FG006|Open-Label Period|Lost to Follow-up|6|||
163385347|NCT00406653|590120813|FG000|Open-Label Period|Withdrawal of Consent|0|||
163385348|NCT00406653|590120814|FG001|Open-Label Period|Withdrawal of Consent|0|||
163385349|NCT00406653|590120815|FG002|Open-Label Period|Withdrawal of Consent|0|||
163385350|NCT00406653|590120816|FG003|Open-Label Period|Withdrawal of Consent|0|||
163385351|NCT00406653|590120817|FG004|Open-Label Period|Withdrawal of Consent|0|||
163385352|NCT00406653|590120818|FG005|Open-Label Period|Withdrawal of Consent|0|||
163385353|NCT00406653|590120819|FG006|Open-Label Period|Withdrawal of Consent|11|||
163385354|NCT00406653|590120813|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
163385355|NCT00406653|590120814|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
163385356|NCT00406653|590120815|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
163385357|NCT00406653|590120816|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
163385358|NCT00406653|590120817|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
163385359|NCT00406653|590120818|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
163385360|NCT00406653|590120819|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
163385361|NCT00406653|590120813|FG000|Open-Label Period|Pregnancy|0|||
163385362|NCT00406653|590120814|FG001|Open-Label Period|Pregnancy|0|||
163385363|NCT00406653|590120815|FG002|Open-Label Period|Pregnancy|0|||
163385364|NCT00406653|590120816|FG003|Open-Label Period|Pregnancy|0|||
163385365|NCT00406653|590120817|FG004|Open-Label Period|Pregnancy|0|||
163385366|NCT00406653|590120818|FG005|Open-Label Period|Pregnancy|0|||
163385367|NCT00406653|590120819|FG006|Open-Label Period|Pregnancy|2|||
163385368|NCT00406653|590120813|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
163385369|NCT00406653|590120814|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
163385370|NCT00406653|590120815|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
163385371|NCT00406653|590120816|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
163385372|NCT00406653|590120817|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
163385373|NCT00406653|590120818|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
163385374|NCT00406653|590120819|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
163385375|NCT00406653|590120813|FG000|Open-Label Period|Declined participation but followup done|0|||
163385376|NCT00406653|590120814|FG001|Open-Label Period|Declined participation but followup done|0|||
163385377|NCT00406653|590120815|FG002|Open-Label Period|Declined participation but followup done|0|||
163385378|NCT00406653|590120816|FG003|Open-Label Period|Declined participation but followup done|0|||
163385379|NCT00406653|590120817|FG004|Open-Label Period|Declined participation but followup done|0|||
163385380|NCT00406653|590120818|FG005|Open-Label Period|Declined participation but followup done|0|||
163040444|NCT03275389|588856010|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
163040445|NCT03275389|588856001|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163385381|NCT00406653|590120819|FG006|Open-Label Period|Declined participation but followup done|8|||
163385382|NCT00406653|590120813|FG000|Open-Label Period|Discontinued by Sponsor|0|||
163385383|NCT00406653|590120814|FG001|Open-Label Period|Discontinued by Sponsor|0|||
163385384|NCT00406653|590120815|FG002|Open-Label Period|Discontinued by Sponsor|0|||
163385385|NCT00406653|590120816|FG003|Open-Label Period|Discontinued by Sponsor|0|||
163385386|NCT00406653|590120817|FG004|Open-Label Period|Discontinued by Sponsor|0|||
163385387|NCT00406653|590120818|FG005|Open-Label Period|Discontinued by Sponsor|0|||
163385388|NCT00406653|590120819|FG006|Open-Label Period|Discontinued by Sponsor|1|||
163385389|NCT00406653|590120813|FG000|Open-Label Period|Refused followup|0|||
163385390|NCT00406653|590120814|FG001|Open-Label Period|Refused followup|0|||
163385391|NCT00406653|590120815|FG002|Open-Label Period|Refused followup|0|||
163385392|NCT00406653|590120816|FG003|Open-Label Period|Refused followup|0|||
163385393|NCT00406653|590120817|FG004|Open-Label Period|Refused followup|0|||
163385394|NCT00406653|590120818|FG005|Open-Label Period|Refused followup|0|||
163385395|NCT00406653|590120819|FG006|Open-Label Period|Refused followup|1|||
163385396|NCT00446992|590120820|FG000|Overall Study|Adverse Event|11|||
163385397|NCT00446992|590120820|FG000|Overall Study|Lost to Follow-up|5|||
163385398|NCT02075541|590120821|FG000|Overall Study|Serious Adverse Event|1|||
163385399|NCT02075541|590120822|FG001|Overall Study|Serious Adverse Event|4|||
163385400|NCT02075541|590120821|FG000|Overall Study|Protocol Violation|1|||
163385401|NCT02075541|590120822|FG001|Overall Study|Protocol Violation|0|||
163385402|NCT02075541|590120821|FG000|Overall Study|Withdrawal by Subject|1|||
163385403|NCT02075541|590120822|FG001|Overall Study|Withdrawal by Subject|3|||
163385404|NCT02075541|590120821|FG000|Overall Study|Sponsor study termination|0|||
163385405|NCT02075541|590120822|FG001|Overall Study|Sponsor study termination|1|||
163385406|NCT02075541|590120821|FG000|Overall Study|Other- unable to perform study procedure|1|||
163385407|NCT02075541|590120822|FG001|Overall Study|Other- unable to perform study procedure|0|||
163385408|NCT00731120|590120823|FG000|Overall Study|Adverse Event|7|||
163385409|NCT00731120|590120824|FG001|Overall Study|Adverse Event|6|||
163385410|NCT00731120|590120825|FG002|Overall Study|Adverse Event|8|||
163385411|NCT00731120|590120823|FG000|Overall Study|Lack of Efficacy|4|||
163385412|NCT00731120|590120824|FG001|Overall Study|Lack of Efficacy|5|||
163385413|NCT00731120|590120825|FG002|Overall Study|Lack of Efficacy|4|||
163385414|NCT00731120|590120823|FG000|Overall Study|Noncompliance with Study Drug|3|||
163385415|NCT00731120|590120824|FG001|Overall Study|Noncompliance with Study Drug|3|||
163385416|NCT00731120|590120825|FG002|Overall Study|Noncompliance with Study Drug|1|||
163385417|NCT00731120|590120823|FG000|Overall Study|Protocol Deviations|1|||
163385418|NCT00731120|590120824|FG001|Overall Study|Protocol Deviations|6|||
163385419|NCT00731120|590120825|FG002|Overall Study|Protocol Deviations|1|||
163385420|NCT00731120|590120823|FG000|Overall Study|Withdrawal of Consent|13|||
163385421|NCT00731120|590120824|FG001|Overall Study|Withdrawal of Consent|8|||
163385422|NCT00731120|590120825|FG002|Overall Study|Withdrawal of Consent|4|||
163385423|NCT00731120|590120823|FG000|Overall Study|Lost to Follow-up|10|||
163385424|NCT00731120|590120824|FG001|Overall Study|Lost to Follow-up|15|||
163385425|NCT00731120|590120825|FG002|Overall Study|Lost to Follow-up|17|||
163385426|NCT00731120|590120823|FG000|Overall Study|Other|4|||
163385427|NCT00731120|590120824|FG001|Overall Study|Other|0|||
163385428|NCT00731120|590120825|FG002|Overall Study|Other|1|||
163385429|NCT02349360|590120826|FG000|Overall Study|Withdrawal by Subject|0|||
163385430|NCT02349360|590120827|FG001|Overall Study|Withdrawal by Subject|1|||
163385431|NCT01054846|590120828|FG000|Overall Study|Lost to Follow-up|76|||
163385432|NCT01054846|590120829|FG001|Overall Study|Lost to Follow-up|17|||
163385433|NCT02434939|590120832|FG000|Overall Study|Lack of Efficacy|34|||
163385434|NCT02434939|590120833|FG001|Overall Study|Lack of Efficacy|48|||
163385435|NCT02434939|590120832|FG000|Overall Study|Withdrawal by Subject|3|||
163385436|NCT02434939|590120833|FG001|Overall Study|Withdrawal by Subject|0|||
163385437|NCT02434939|590120832|FG000|Overall Study|Adverse Event|0|||
163385438|NCT02434939|590120833|FG001|Overall Study|Adverse Event|1|||
163385439|NCT00394953|590120834|FG000|First Treatment Period|Adverse Event|1|||
163385440|NCT00394953|590120835|FG001|First Treatment Period|Adverse Event|2|||
163385441|NCT00394953|590120834|FG000|First Treatment Period|Death|6|||
163385442|NCT00394953|590120835|FG001|First Treatment Period|Death|7|||
163385443|NCT00394953|590120834|FG000|First Treatment Period|Lack of Efficacy|1|||
163385444|NCT00394953|590120835|FG001|First Treatment Period|Lack of Efficacy|1|||
163385445|NCT00394953|590120834|FG000|First Treatment Period|Withdrawal by Subject|6|||
163385446|NCT00394953|590120835|FG001|First Treatment Period|Withdrawal by Subject|3|||
163385447|NCT00394953|590120834|FG000|First Treatment Period|Lost to Follow-up|0|||
163385448|NCT00394953|590120835|FG001|First Treatment Period|Lost to Follow-up|1|||
163040446|NCT03275389|588856002|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
163040447|NCT03275389|588856003|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163040448|NCT03275389|588856004|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
163385449|NCT00394953|590120834|FG000|First Treatment Period|Renal transplant|11|||
163385450|NCT00394953|590120835|FG001|First Treatment Period|Renal transplant|7|||
163385451|NCT00394953|590120834|FG000|First Treatment Period|Not defined|4|||
163385452|NCT00394953|590120835|FG001|First Treatment Period|Not defined|1|||
163385453|NCT00394953|590120834|FG000|Second Treatment Period|Adverse Event|2|||
163385454|NCT00394953|590120835|FG001|Second Treatment Period|Adverse Event|5|||
163385455|NCT00394953|590120834|FG000|Second Treatment Period|Death|8|||
163385456|NCT00394953|590120835|FG001|Second Treatment Period|Death|4|||
163385457|NCT00394953|590120834|FG000|Second Treatment Period|Lack of Efficacy|9|||
163385458|NCT00394953|590120835|FG001|Second Treatment Period|Lack of Efficacy|47|||
163385459|NCT00394953|590120834|FG000|Second Treatment Period|Withdrawal by Subject|3|||
163385460|NCT00394953|590120835|FG001|Second Treatment Period|Withdrawal by Subject|3|||
163385461|NCT00394953|590120834|FG000|Second Treatment Period|Lost to Follow-up|0|||
163385462|NCT00394953|590120835|FG001|Second Treatment Period|Lost to Follow-up|1|||
163385463|NCT00394953|590120834|FG000|Second Treatment Period|Renal transplant|4|||
163385464|NCT00394953|590120835|FG001|Second Treatment Period|Renal transplant|6|||
163385465|NCT00394953|590120834|FG000|Second Treatment Period|Not defined|3|||
163385466|NCT00394953|590120835|FG001|Second Treatment Period|Not defined|8|||
163385467|NCT02446886|590120844|FG000|Overall Study|Adverse Event|1|||
163385468|NCT02446886|590120845|FG001|Overall Study|Adverse Event|3|||
163385469|NCT02446886|590120844|FG000|Overall Study|Withdrawal by Subject|1|||
163385470|NCT02446886|590120845|FG001|Overall Study|Withdrawal by Subject|1|||
163385471|NCT03021954|590120853|FG000|Overall Study|Lost to Follow-up|10|||
163385472|NCT03021954|590120854|FG001|Overall Study|Lost to Follow-up|43|||
163385473|NCT03021954|590120853|FG000|Overall Study|Subjects had avulsion trauma|4|||
163385474|NCT03021954|590120854|FG001|Overall Study|Subjects had avulsion trauma|1|||
163385475|NCT02196714|590120857|FG000|Overall Study|Protocol Violation|0|||
163385476|NCT02196714|590120858|FG001|Overall Study|Protocol Violation|0|||
163385477|NCT02196714|590120859|FG002|Overall Study|Protocol Violation|1|||
163385478|NCT02196714|590120860|FG003|Overall Study|Protocol Violation|0|||
163385479|NCT04079803|590120864|FG000|Overall Study|Withdrawal by Subject|0|||
163385480|NCT04079803|590120865|FG001|Overall Study|Withdrawal by Subject|0|||
163385481|NCT04079803|590120866|FG002|Overall Study|Withdrawal by Subject|1|||
163385482|NCT00807235|590120871|FG000|Overall Study|Adverse Event|1|||
163385483|NCT00807235|590120872|FG001|Overall Study|Adverse Event|0|||
163385484|NCT04677179|590120875|FG000|Induction Treatment Period|Adverse Event|1|||
163385485|NCT04677179|590120876|FG001|Induction Treatment Period|Adverse Event|0|||
163385486|NCT04677179|590120877|FG002|Induction Treatment Period|Adverse Event|0|||
163385487|NCT04677179|590120878|FG003|Induction Treatment Period|Adverse Event|0|||
163385488|NCT04677179|590120879|FG004|Induction Treatment Period|Adverse Event|0|||
163385489|NCT04677179|590120880|FG005|Induction Treatment Period|Adverse Event|0|||
163385490|NCT04677179|590120881|FG006|Induction Treatment Period|Adverse Event|0|||
163385491|NCT04677179|590120882|FG007|Induction Treatment Period|Adverse Event|0|||
163385492|NCT04677179|590120883|FG008|Induction Treatment Period|Adverse Event|0|||
163385493|NCT04677179|590120884|FG009|Induction Treatment Period|Adverse Event|0|||
163385494|NCT04677179|590120875|FG000|Induction Treatment Period|Physician Decision|1|||
163385495|NCT04677179|590120876|FG001|Induction Treatment Period|Physician Decision|0|||
163385496|NCT04677179|590120877|FG002|Induction Treatment Period|Physician Decision|1|||
163385497|NCT04677179|590120878|FG003|Induction Treatment Period|Physician Decision|0|||
162925673|NCT02962739|588430368|FG005|Overall Study|Withdrawal by Subject|0|||
162925674|NCT02962739|588430363|FG000|Overall Study|Protocol Violation|0|||
162925675|NCT02962739|588430364|FG001|Overall Study|Protocol Violation|0|||
162925676|NCT02962739|588430365|FG002|Overall Study|Protocol Violation|1|||
162925677|NCT02962739|588430366|FG003|Overall Study|Protocol Violation|0|||
162925678|NCT02962739|588430367|FG004|Overall Study|Protocol Violation|1|||
162925679|NCT02962739|588430368|FG005|Overall Study|Protocol Violation|0|||
162925680|NCT00414011|588430369|FG000|Overall Study|Physician Decision|3|||
162925681|NCT00414011|588430369|FG000|Overall Study|Withdrawal by Subject|2|||
162925682|NCT00981409|588430374|FG000|Overall Study|Adverse Event|4|||
162925683|NCT00981409|588430375|FG001|Overall Study|Adverse Event|0|||
162925684|NCT00981409|588430374|FG000|Overall Study|Protocol Violation|0|||
162925685|NCT00981409|588430375|FG001|Overall Study|Protocol Violation|1|||
162925686|NCT00981409|588430374|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
162925687|NCT00981409|588430375|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
162925688|NCT00450177|588430376|FG000|Overall Study|Adverse Event|7|||
162925689|NCT00450177|588430377|FG001|Overall Study|Adverse Event|4|||
162925690|NCT00450177|588430376|FG000|Overall Study|Withdrawal by Subject|1|||
163040449|NCT03275389|588856005|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162925691|NCT00450177|588430377|FG001|Overall Study|Withdrawal by Subject|6|||
162925692|NCT00450177|588430376|FG000|Overall Study|Withdrawal by Primary Team|1|||
162925693|NCT00450177|588430377|FG001|Overall Study|Withdrawal by Primary Team|1|||
162925694|NCT03869684|588430382|FG000|Overall Study|Adverse Event|0|||
162925695|NCT03869684|588430383|FG001|Overall Study|Adverse Event|3|||
162925696|NCT03869684|588430384|FG002|Overall Study|Adverse Event|1|||
162925697|NCT03869684|588430382|FG000|Overall Study|Withdrawal by Subject|1|||
163040450|NCT03275389|588856006|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162925698|NCT03869684|588430383|FG001|Overall Study|Withdrawal by Subject|0|||
162925699|NCT03869684|588430384|FG002|Overall Study|Withdrawal by Subject|0|||
162925700|NCT03869684|588430382|FG000|Overall Study|Lost to Follow-up|1|||
162925701|NCT03869684|588430383|FG001|Overall Study|Lost to Follow-up|0|||
162925702|NCT03869684|588430384|FG002|Overall Study|Lost to Follow-up|0|||
163385498|NCT04677179|590120879|FG004|Induction Treatment Period|Physician Decision|0|||
163385499|NCT04677179|590120880|FG005|Induction Treatment Period|Physician Decision|0|||
163385500|NCT04677179|590120881|FG006|Induction Treatment Period|Physician Decision|0|||
163385501|NCT04677179|590120882|FG007|Induction Treatment Period|Physician Decision|0|||
163385502|NCT04677179|590120883|FG008|Induction Treatment Period|Physician Decision|0|||
163385503|NCT04677179|590120884|FG009|Induction Treatment Period|Physician Decision|0|||
163385504|NCT04677179|590120875|FG000|Induction Treatment Period|Protocol Violation|0|||
163385505|NCT04677179|590120876|FG001|Induction Treatment Period|Protocol Violation|1|||
163385506|NCT04677179|590120877|FG002|Induction Treatment Period|Protocol Violation|0|||
163385507|NCT04677179|590120878|FG003|Induction Treatment Period|Protocol Violation|0|||
163385508|NCT04677179|590120879|FG004|Induction Treatment Period|Protocol Violation|0|||
163385509|NCT04677179|590120880|FG005|Induction Treatment Period|Protocol Violation|0|||
163385510|NCT04677179|590120881|FG006|Induction Treatment Period|Protocol Violation|0|||
163385511|NCT04677179|590120882|FG007|Induction Treatment Period|Protocol Violation|0|||
163385512|NCT04677179|590120883|FG008|Induction Treatment Period|Protocol Violation|0|||
163385513|NCT04677179|590120884|FG009|Induction Treatment Period|Protocol Violation|0|||
163385514|NCT04677179|590120875|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
163385515|NCT04677179|590120876|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
163385516|NCT04677179|590120877|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
163385517|NCT04677179|590120878|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
163385518|NCT04677179|590120879|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
163385519|NCT04677179|590120880|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
163385520|NCT04677179|590120881|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
163385521|NCT04677179|590120882|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
163385522|NCT04677179|590120883|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
163385523|NCT04677179|590120884|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
163385524|NCT04677179|590120875|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
163385525|NCT04677179|590120876|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
163385526|NCT04677179|590120877|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
163385527|NCT04677179|590120878|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
163385528|NCT04677179|590120879|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
163385529|NCT04677179|590120880|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
163385530|NCT04677179|590120881|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
163385531|NCT04677179|590120882|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
163385532|NCT04677179|590120883|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
163385533|NCT04677179|590120884|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
163385534|NCT04677179|590120875|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
163385535|NCT04677179|590120876|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
163385536|NCT04677179|590120877|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
163385537|NCT04677179|590120878|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
163385538|NCT04677179|590120879|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
163385539|NCT04677179|590120880|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
163385540|NCT04677179|590120881|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
163385541|NCT04677179|590120882|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
163385542|NCT04677179|590120883|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
163385543|NCT04677179|590120884|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
163385544|NCT04677179|590120875|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
163385545|NCT04677179|590120876|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
163385546|NCT04677179|590120877|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
163385547|NCT04677179|590120878|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
163385548|NCT04677179|590120879|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
163385549|NCT04677179|590120880|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
163385550|NCT04677179|590120881|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
163385551|NCT04677179|590120882|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
163385552|NCT04677179|590120883|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
163040451|NCT03275389|588856007|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163040452|NCT03275389|588856008|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163385553|NCT04677179|590120884|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
163385554|NCT04677179|590120875|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
163385555|NCT04677179|590120876|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
163385556|NCT04677179|590120877|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
163385557|NCT04677179|590120878|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
163385558|NCT04677179|590120879|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
163385559|NCT04677179|590120880|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
163385560|NCT04677179|590120881|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
163385561|NCT04677179|590120882|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
163385562|NCT04677179|590120883|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
163385563|NCT04677179|590120884|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
163040453|NCT03275389|588856009|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163040454|NCT03275389|588856010|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163040455|NCT03275389|588856001|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040456|NCT03275389|588856002|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040457|NCT03275389|588856003|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
163040458|NCT03275389|588856004|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040459|NCT03275389|588856005|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040460|NCT03275389|588856006|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040461|NCT03275389|588856007|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040462|NCT03275389|588856008|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040463|NCT03275389|588856009|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040464|NCT03275389|588856010|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
163040465|NCT03275389|588856001|FG000|Overall Study|Other|0|||
163040466|NCT03275389|588856002|FG001|Overall Study|Other|4|||
163040467|NCT03275389|588856003|FG002|Overall Study|Other|3|||
163040468|NCT03275389|588856004|FG003|Overall Study|Other|2|||
163040469|NCT03275389|588856005|FG004|Overall Study|Other|2|||
163040470|NCT03275389|588856006|FG005|Overall Study|Other|2|||
163040471|NCT03275389|588856007|FG006|Overall Study|Other|0|||
163040472|NCT03275389|588856008|FG007|Overall Study|Other|0|||
163040473|NCT03275389|588856009|FG008|Overall Study|Other|1|||
163040474|NCT03275389|588856010|FG009|Overall Study|Other|0|||
163040475|NCT00978341|588856015|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
163040476|NCT00978341|588856016|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
163040477|NCT03035916|588856017|FG000|Overall Study|Puncture failed|0|||
163040478|NCT03035916|588856018|FG001|Overall Study|Puncture failed|2|||
163040479|NCT03035916|588856019|FG002|Overall Study|Puncture failed|0|||
163040480|NCT03885999|588856020|FG000|Overall Study|Adverse Event|1|||
163385564|NCT04677179|590120875|FG000|Extension Treatment Period|Lack of Efficacy|0|||
163385565|NCT04677179|590120876|FG001|Extension Treatment Period|Lack of Efficacy|0|||
163385566|NCT04677179|590120877|FG002|Extension Treatment Period|Lack of Efficacy|0|||
163385567|NCT04677179|590120878|FG003|Extension Treatment Period|Lack of Efficacy|0|||
163385568|NCT04677179|590120879|FG004|Extension Treatment Period|Lack of Efficacy|0|||
163385569|NCT04677179|590120880|FG005|Extension Treatment Period|Lack of Efficacy|0|||
163385570|NCT04677179|590120881|FG006|Extension Treatment Period|Lack of Efficacy|6|||
163385571|NCT04677179|590120882|FG007|Extension Treatment Period|Lack of Efficacy|0|||
163385572|NCT04677179|590120883|FG008|Extension Treatment Period|Lack of Efficacy|0|||
163385573|NCT04677179|590120884|FG009|Extension Treatment Period|Lack of Efficacy|0|||
163385574|NCT04677179|590120875|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
163385575|NCT04677179|590120876|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
163385576|NCT04677179|590120877|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
163385577|NCT04677179|590120878|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
163385578|NCT04677179|590120879|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
163385579|NCT04677179|590120880|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
163385580|NCT04677179|590120881|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
163385581|NCT04677179|590120882|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
163385582|NCT04677179|590120883|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
163385583|NCT04677179|590120884|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
163385584|NCT04677179|590120875|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
163385585|NCT04677179|590120876|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
163385586|NCT04677179|590120877|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
163385587|NCT04677179|590120878|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
163385588|NCT04677179|590120879|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
163385589|NCT04677179|590120880|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
163385590|NCT04677179|590120881|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
163385591|NCT04677179|590120882|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
163385592|NCT04677179|590120883|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
163385593|NCT04677179|590120884|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
163385594|NCT04677179|590120875|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
163385595|NCT04677179|590120876|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
163385596|NCT04677179|590120877|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
163385597|NCT04677179|590120878|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
163385598|NCT04677179|590120879|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
163385599|NCT04677179|590120880|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
163040481|NCT02452554|588856021|FG000|Overall Study|Death|2|||
163040482|NCT02452554|588856022|FG001|Overall Study|Death|1|||
163040483|NCT02452554|588856023|FG002|Overall Study|Death|0|||
163040484|NCT02452554|588856024|FG003|Overall Study|Death|0|||
163040485|NCT02452554|588856025|FG004|Overall Study|Death|0|||
163040486|NCT02452554|588856026|FG005|Overall Study|Death|0|||
163040487|NCT02452554|588856021|FG000|Overall Study|Lack of Efficacy|13|||
163040488|NCT02452554|588856022|FG001|Overall Study|Lack of Efficacy|14|||
163040489|NCT02452554|588856023|FG002|Overall Study|Lack of Efficacy|9|||
163040490|NCT02452554|588856024|FG003|Overall Study|Lack of Efficacy|1|||
163385600|NCT04677179|590120881|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
163385601|NCT04677179|590120882|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
163385602|NCT04677179|590120883|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
163385603|NCT04677179|590120884|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
163385604|NCT04677179|590120875|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163385605|NCT04677179|590120876|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163385606|NCT04677179|590120877|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163385607|NCT04677179|590120878|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163385608|NCT04677179|590120879|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163385609|NCT04677179|590120880|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163385610|NCT04677179|590120881|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163385611|NCT04677179|590120882|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
163385612|NCT04677179|590120883|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
163385613|NCT04677179|590120884|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163385614|NCT04677179|590120875|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163385615|NCT04677179|590120876|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163385616|NCT04677179|590120877|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163385617|NCT04677179|590120878|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163385618|NCT04677179|590120879|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163385619|NCT04677179|590120880|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163385620|NCT04677179|590120881|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163385621|NCT04677179|590120882|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
163385622|NCT04677179|590120883|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163385623|NCT04677179|590120884|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163385624|NCT04677179|590120875|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163385625|NCT04677179|590120876|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163385626|NCT04677179|590120877|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163385627|NCT04677179|590120878|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163385628|NCT04677179|590120879|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163385629|NCT04677179|590120880|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163385630|NCT04677179|590120881|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163385631|NCT04677179|590120882|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
163385632|NCT04677179|590120883|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
162925703|NCT03869684|588430382|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
162925704|NCT03869684|588430383|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
163385633|NCT04677179|590120884|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162925705|NCT03869684|588430384|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
162925706|NCT04056299|588430385|FG000|Overall Study|Sponsor discontinued study|3|||
162925707|NCT04056299|588430386|FG001|Overall Study|Sponsor discontinued study|3|||
162925708|NCT01227954|588430391|FG000|Overall Study|Protocol Violation|6|||
162925709|NCT01227954|588430391|FG000|Overall Study|No protocol treatment|7|||
162925710|NCT00078312|588430394|FG000|Overall Study|Adverse Event|43|||
162925711|NCT00078312|588430394|FG000|Overall Study|Lack of Efficacy|15|||
162925712|NCT00078312|588430394|FG000|Overall Study|Lost to Follow-up|41|||
162925713|NCT00078312|588430394|FG000|Overall Study|Physician Decision|9|||
162925714|NCT00078312|588430394|FG000|Overall Study|Protocol Violation|3|||
162925715|NCT00078312|588430394|FG000|Overall Study|Withdrawal by Subject|33|||
162925716|NCT00078312|588430394|FG000|Overall Study|Miscellaneous|33|||
162925717|NCT01268683|588430395|FG000|Overall Study|Lost to Follow-up|1|||
162925718|NCT01268683|588430395|FG000|Overall Study|Death|1|||
162925719|NCT04256759|588430396|FG000|Overall Study|Physician Decision|1|||
162925720|NCT04256759|588430396|FG000|Overall Study|Lack of Efficacy|1|||
163385634|NCT04677179|590120875|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
163385635|NCT04677179|590120876|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
163385636|NCT04677179|590120877|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
162925721|NCT03901352|588430401|FG000|Double-blind Phase|Adverse Event|6|||
162925722|NCT03901352|588430402|FG001|Double-blind Phase|Adverse Event|4|||
163385637|NCT04677179|590120878|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
163385638|NCT04677179|590120879|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
163385639|NCT04677179|590120880|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
163385640|NCT04677179|590120881|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
163385641|NCT04677179|590120882|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
162925723|NCT03901352|588430401|FG000|Double-blind Phase|Death|1|||
162925724|NCT03901352|588430402|FG001|Double-blind Phase|Death|0|||
163385642|NCT04677179|590120883|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
163385643|NCT04677179|590120884|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
162925725|NCT03901352|588430401|FG000|Double-blind Phase|Lack of Efficacy|0|||
162925726|NCT03901352|588430402|FG001|Double-blind Phase|Lack of Efficacy|1|||
162925727|NCT03901352|588430401|FG000|Double-blind Phase|Protocol Violation|0|||
162925728|NCT03901352|588430402|FG001|Double-blind Phase|Protocol Violation|1|||
163385644|NCT01536015|590120885|FG000|Overall Study|Adverse Event|1|||
163385645|NCT01536015|590120886|FG001|Overall Study|Adverse Event|4|||
163385646|NCT01536015|590120885|FG000|Overall Study|Lost to Follow-up|0|||
163385647|NCT01536015|590120886|FG001|Overall Study|Lost to Follow-up|1|||
163385648|NCT01536015|590120885|FG000|Overall Study|Inclusion Criterion not met|2|||
163385649|NCT01536015|590120886|FG001|Overall Study|Inclusion Criterion not met|0|||
163385650|NCT01536015|590120885|FG000|Overall Study|Study closure|5|||
163385651|NCT01536015|590120886|FG001|Overall Study|Study closure|5|||
163385652|NCT01204398|590120887|FG000|Overall Study|Adverse Event|1|||
163385653|NCT03261700|590120888|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
163385654|NCT03261700|590120889|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
163385655|NCT01723254|590120890|FG000|Overall Study|Conflict with work schedule|0|||
163385656|NCT01723254|590120891|FG001|Overall Study|Conflict with work schedule|0|||
163385657|NCT01723254|590120892|FG002|Overall Study|Conflict with work schedule|0|||
163385658|NCT01723254|590120893|FG003|Overall Study|Conflict with work schedule|0|||
163385659|NCT01723254|590120894|FG004|Overall Study|Conflict with work schedule|0|||
163385660|NCT01723254|590120895|FG005|Overall Study|Conflict with work schedule|0|||
163385661|NCT01723254|590120896|FG006|Overall Study|Conflict with work schedule|0|||
163385662|NCT01723254|590120897|FG007|Overall Study|Conflict with work schedule|1|||
163385663|NCT01723254|590120890|FG000|Overall Study|Personal issues|0|||
163385664|NCT01723254|590120891|FG001|Overall Study|Personal issues|0|||
163385665|NCT01723254|590120892|FG002|Overall Study|Personal issues|0|||
163385666|NCT01723254|590120893|FG003|Overall Study|Personal issues|0|||
163385667|NCT01723254|590120894|FG004|Overall Study|Personal issues|0|||
163385668|NCT01723254|590120895|FG005|Overall Study|Personal issues|1|||
163385669|NCT01723254|590120896|FG006|Overall Study|Personal issues|0|||
163385670|NCT01723254|590120897|FG007|Overall Study|Personal issues|0|||
163385671|NCT01723254|590120890|FG000|Overall Study|No longer have time to participate|0|||
163385672|NCT01723254|590120891|FG001|Overall Study|No longer have time to participate|0|||
163385673|NCT01723254|590120892|FG002|Overall Study|No longer have time to participate|0|||
163385674|NCT01723254|590120893|FG003|Overall Study|No longer have time to participate|1|||
162925729|NCT03901352|588430401|FG000|Double-blind Phase|Withdrawal by Subject|10|||
162925730|NCT03901352|588430402|FG001|Double-blind Phase|Withdrawal by Subject|8|||
162925731|NCT03901352|588430401|FG000|Open-label Extension Phase|Adverse Event|24|||
162925732|NCT03901352|588430402|FG001|Open-label Extension Phase|Adverse Event|0|||
163385675|NCT01723254|590120894|FG004|Overall Study|No longer have time to participate|0|||
163385676|NCT01723254|590120895|FG005|Overall Study|No longer have time to participate|0|||
163385677|NCT01723254|590120896|FG006|Overall Study|No longer have time to participate|0|||
163385678|NCT01723254|590120897|FG007|Overall Study|No longer have time to participate|0|||
163385679|NCT01723254|590120890|FG000|Overall Study|Move/Left to another country/city|0|||
163385680|NCT01723254|590120891|FG001|Overall Study|Move/Left to another country/city|0|||
163385681|NCT01723254|590120892|FG002|Overall Study|Move/Left to another country/city|2|||
163385682|NCT01723254|590120893|FG003|Overall Study|Move/Left to another country/city|1|||
163385683|NCT01723254|590120894|FG004|Overall Study|Move/Left to another country/city|1|||
163385684|NCT01723254|590120895|FG005|Overall Study|Move/Left to another country/city|0|||
163385685|NCT01723254|590120896|FG006|Overall Study|Move/Left to another country/city|0|||
163385686|NCT01723254|590120897|FG007|Overall Study|Move/Left to another country/city|0|||
163385687|NCT01723254|590120890|FG000|Overall Study|Protocol Violation|0|||
162925733|NCT03901352|588430401|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
162925734|NCT03901352|588430402|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
162925735|NCT03901352|588430401|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
162925736|NCT03901352|588430402|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
162925737|NCT03901352|588430401|FG000|Open-label Extension Phase|Other|1|||
162925738|NCT03901352|588430402|FG001|Open-label Extension Phase|Other|0|||
162925739|NCT01826201|588430405|FG000|Overall Study|Non compliance with protocol|4|||
162925740|NCT02742818|588430406|FG000|Overall Study|Adverse Event|0|||
162925741|NCT02742818|588430407|FG001|Overall Study|Adverse Event|1|||
162925742|NCT02742818|588430406|FG000|Overall Study|Protocol Violation|0|||
162925743|NCT02742818|588430407|FG001|Overall Study|Protocol Violation|1|||
162925744|NCT04701658|588430408|FG000|Overall Study|Lost to Follow-up|6|||
162925745|NCT00756652|588430409|FG000|Original Phase|Withdrawal by Subject|864|||
162925746|NCT00756652|588430410|FG001|Original Phase|Withdrawal by Subject|23|||
162925747|NCT00756652|588430409|FG000|Original Phase|Lost to Follow-up|601|||
163385688|NCT01723254|590120891|FG001|Overall Study|Protocol Violation|1|||
162925748|NCT00756652|588430410|FG001|Original Phase|Lost to Follow-up|0|||
162925749|NCT00756652|588430409|FG000|Original Phase|Other Discontinuation|797|||
162925750|NCT00756652|588430410|FG001|Original Phase|Other Discontinuation|5|||
162925751|NCT00756652|588430409|FG000|Original Phase|Participant Noncompliance|18622|||
162925752|NCT00756652|588430410|FG001|Original Phase|Participant Noncompliance|424|||
162925753|NCT00756652|588430409|FG000|Original Phase|Unknown Discontinuation Reason|2|||
162925754|NCT00756652|588430410|FG001|Original Phase|Unknown Discontinuation Reason|0|||
162925755|NCT00756652|588430409|FG000|Original Phase|Participants without data|3259|||
163385689|NCT01723254|590120892|FG002|Overall Study|Protocol Violation|0|||
163385690|NCT01723254|590120893|FG003|Overall Study|Protocol Violation|0|||
163385691|NCT01723254|590120894|FG004|Overall Study|Protocol Violation|0|||
163385692|NCT01723254|590120895|FG005|Overall Study|Protocol Violation|0|||
163385693|NCT01723254|590120896|FG006|Overall Study|Protocol Violation|0|||
163385694|NCT01723254|590120897|FG007|Overall Study|Protocol Violation|0|||
163385695|NCT01723254|590120890|FG000|Overall Study|Withdrawal by Subject|1|||
163385696|NCT01723254|590120891|FG001|Overall Study|Withdrawal by Subject|2|||
163385697|NCT01723254|590120892|FG002|Overall Study|Withdrawal by Subject|1|||
163385698|NCT01723254|590120893|FG003|Overall Study|Withdrawal by Subject|0|||
163385699|NCT01723254|590120894|FG004|Overall Study|Withdrawal by Subject|1|||
163385700|NCT01723254|590120895|FG005|Overall Study|Withdrawal by Subject|1|||
163385701|NCT01723254|590120896|FG006|Overall Study|Withdrawal by Subject|1|||
163385702|NCT01723254|590120897|FG007|Overall Study|Withdrawal by Subject|2|||
163385703|NCT01257425|590120898|FG000|Overall Study|Lack of Efficacy|3|||
163385704|NCT01257425|590120899|FG001|Overall Study|Lack of Efficacy|3|||
163385705|NCT01257425|590120898|FG000|Overall Study|Adverse Event|1|||
163385706|NCT01257425|590120899|FG001|Overall Study|Adverse Event|1|||
163385707|NCT01257425|590120898|FG000|Overall Study|Protocol Violation|1|||
163385708|NCT01257425|590120899|FG001|Overall Study|Protocol Violation|1|||
163385709|NCT01257425|590120898|FG000|Overall Study|Withdrawal by Subject|0|||
163385710|NCT01257425|590120899|FG001|Overall Study|Withdrawal by Subject|1|||
163385711|NCT01257425|590120898|FG000|Overall Study|Death|1|||
163385712|NCT01257425|590120899|FG001|Overall Study|Death|0|||
163385713|NCT02656823|590120904|FG000|Overall Study|Adverse Event|3|||
163385714|NCT02656823|590120904|FG000|Overall Study|Lost to Follow-up|2|||
163401954|NCT01840579|590182956|FG003|Overall Study|Progressive disease|0|||
163401955|NCT01840579|590182957|FG004|Overall Study|Progressive disease|0|||
163401956|NCT01840579|590182958|FG005|Overall Study|Progressive disease|0|||
163401957|NCT01840579|590182959|FG006|Overall Study|Progressive disease|0|||
163401958|NCT01840579|590182960|FG007|Overall Study|Progressive disease|0|||
163401959|NCT01840579|590182961|FG008|Overall Study|Progressive disease|0|||
163401960|NCT01840579|590182962|FG009|Overall Study|Progressive disease|0|||
163401961|NCT01840579|590182953|FG000|Overall Study|Ongoing in study|0|||
163401962|NCT01840579|590182954|FG001|Overall Study|Ongoing in study|1|||
163401963|NCT01840579|590182955|FG002|Overall Study|Ongoing in study|0|||
163401964|NCT01840579|590182956|FG003|Overall Study|Ongoing in study|0|||
163401965|NCT01840579|590182957|FG004|Overall Study|Ongoing in study|0|||
163401966|NCT01840579|590182958|FG005|Overall Study|Ongoing in study|0|||
163401967|NCT01840579|590182959|FG006|Overall Study|Ongoing in study|0|||
163401968|NCT01840579|590182960|FG007|Overall Study|Ongoing in study|0|||
163401969|NCT01840579|590182961|FG008|Overall Study|Ongoing in study|0|||
162925756|NCT00756652|588430410|FG001|Original Phase|Participants without data|466|||
162925757|NCT00756652|588430409|FG000|Original Phase|Death|168|||
162925758|NCT00756652|588430410|FG001|Original Phase|Death|1|||
162925759|NCT00756652|588430409|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
162925760|NCT00756652|588430410|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
162925761|NCT00756652|588430409|FG000|Re-Op Phase|Withdrawal by Subject|62|||
162925762|NCT00756652|588430410|FG001|Re-Op Phase|Withdrawal by Subject|0|||
162925763|NCT00756652|588430409|FG000|Re-Op Phase|Death|6|||
162925764|NCT00756652|588430410|FG001|Re-Op Phase|Death|0|||
162925765|NCT00756652|588430409|FG000|Re-Op Phase|Lost to Follow-up|340|||
162925766|NCT00756652|588430410|FG001|Re-Op Phase|Lost to Follow-up|0|||
162925767|NCT00756652|588430409|FG000|Re-Op Phase|Site Closed|2454|||
162925768|NCT00756652|588430410|FG001|Re-Op Phase|Site Closed|0|||
162925769|NCT00756652|588430409|FG000|Re-Op Phase|Withdrawn after explant|14|||
162925770|NCT00756652|588430410|FG001|Re-Op Phase|Withdrawn after explant|0|||
162925771|NCT05349188|588430411|FG000|Overall Study|Withdrawal by Subject|1|||
163401970|NCT01840579|590182962|FG009|Overall Study|Ongoing in study|0|||
163401971|NCT01840579|590182953|FG000|Overall Study|Death|0|||
163401972|NCT01840579|590182954|FG001|Overall Study|Death|0|||
163401973|NCT01840579|590182955|FG002|Overall Study|Death|0|||
163401974|NCT01840579|590182956|FG003|Overall Study|Death|0|||
163401975|NCT01840579|590182957|FG004|Overall Study|Death|0|||
163401976|NCT01840579|590182958|FG005|Overall Study|Death|1|||
163401977|NCT01840579|590182959|FG006|Overall Study|Death|0|||
163401978|NCT01840579|590182960|FG007|Overall Study|Death|0|||
163401979|NCT01840579|590182961|FG008|Overall Study|Death|0|||
163401980|NCT01840579|590182962|FG009|Overall Study|Death|0|||
163401981|NCT01840579|590182953|FG000|Overall Study|Adverse Event|0|||
163401982|NCT01840579|590182954|FG001|Overall Study|Adverse Event|1|||
163401983|NCT01840579|590182955|FG002|Overall Study|Adverse Event|0|||
163401984|NCT01840579|590182956|FG003|Overall Study|Adverse Event|0|||
163401985|NCT01840579|590182957|FG004|Overall Study|Adverse Event|0|||
163401986|NCT01840579|590182958|FG005|Overall Study|Adverse Event|0|||
163401987|NCT01840579|590182959|FG006|Overall Study|Adverse Event|0|||
163401988|NCT01840579|590182960|FG007|Overall Study|Adverse Event|0|||
163040491|NCT02452554|588856025|FG004|Overall Study|Lack of Efficacy|5|||
163401989|NCT01840579|590182961|FG008|Overall Study|Adverse Event|0|||
163401990|NCT01840579|590182962|FG009|Overall Study|Adverse Event|0|||
162925772|NCT05349188|588430412|FG001|Overall Study|Withdrawal by Subject|0|||
162925773|NCT03889197|588430419|FG000|Overall Study|Withdrawal by Subject|1|||
163401991|NCT01840579|590182953|FG000|Overall Study|Follow-up ended by Sponsor|0|||
163401992|NCT01840579|590182954|FG001|Overall Study|Follow-up ended by Sponsor|0|||
163385715|NCT03769181|590123223|FG000|Overall Study|Adverse Event|1|||
163385716|NCT03769181|590123224|FG001|Overall Study|Adverse Event|0|||
163385717|NCT03769181|590123225|FG002|Overall Study|Adverse Event|2|||
163385718|NCT03769181|590123226|FG003|Overall Study|Adverse Event|4|||
163385719|NCT03769181|590123223|FG000|Overall Study|Withdrawal by Subject|1|||
163385720|NCT03769181|590123224|FG001|Overall Study|Withdrawal by Subject|0|||
163385721|NCT03769181|590123225|FG002|Overall Study|Withdrawal by Subject|2|||
163385722|NCT03769181|590123226|FG003|Overall Study|Withdrawal by Subject|1|||
163385723|NCT03769181|590123223|FG000|Overall Study|Progressive disease|9|||
163385724|NCT03769181|590123224|FG001|Overall Study|Progressive disease|7|||
163385725|NCT03769181|590123225|FG002|Overall Study|Progressive disease|13|||
163385726|NCT03769181|590123226|FG003|Overall Study|Progressive disease|6|||
163385727|NCT03769181|590123223|FG000|Overall Study|Other - Unspecified|2|||
163385728|NCT03769181|590123224|FG001|Overall Study|Other - Unspecified|1|||
163385729|NCT03769181|590123225|FG002|Overall Study|Other - Unspecified|0|||
163385730|NCT03769181|590123226|FG003|Overall Study|Other - Unspecified|0|||
163385731|NCT00826111|590123233|FG000|Overall Study|Lost to Follow-up|0|||
163385732|NCT00826111|590123234|FG001|Overall Study|Lost to Follow-up|1|||
162925774|NCT03889197|588430420|FG001|Overall Study|Withdrawal by Subject|0|||
162925775|NCT03889197|588430419|FG000|Overall Study|Physician Decision|0|||
162925776|NCT03889197|588430420|FG001|Overall Study|Physician Decision|1|||
162925777|NCT03889197|588430419|FG000|Overall Study|met exclusion criteria|0|||
162925778|NCT03889197|588430420|FG001|Overall Study|met exclusion criteria|1|||
162925779|NCT03889197|588430419|FG000|Overall Study|Protocol Violation|1|||
162925780|NCT03889197|588430420|FG001|Overall Study|Protocol Violation|0|||
163385733|NCT00826111|590123233|FG000|Overall Study|Protocol Violation|1|||
163385734|NCT00826111|590123234|FG001|Overall Study|Protocol Violation|0|||
163385735|NCT00826111|590123233|FG000|Overall Study|Withdrawal by Subject|5|||
163385736|NCT00826111|590123234|FG001|Overall Study|Withdrawal by Subject|0|||
163385737|NCT00826111|590123233|FG000|Overall Study|Physician Decision|1|||
163385738|NCT00826111|590123234|FG001|Overall Study|Physician Decision|1|||
163385739|NCT01195545|590123235|FG000|Overall Study|Protocol Violation|4|||
163385740|NCT01929980|590123236|FG000|Overall Study|Physician Decision|1|||
163385741|NCT01028222|590123237|FG000|Overall Study|Protocol deviation|1|||
163385742|NCT01028222|590123238|FG001|Overall Study|Protocol deviation|0|||
163385743|NCT01028222|590123237|FG000|Overall Study|Disease progression|33|||
163385744|NCT01028222|590123238|FG001|Overall Study|Disease progression|9|||
163385745|NCT01028222|590123237|FG000|Overall Study|Administrative problems|1|||
163385746|NCT01028222|590123238|FG001|Overall Study|Administrative problems|1|||
163385747|NCT01028222|590123237|FG000|Overall Study|Lost to Follow-up|0|||
163385748|NCT01028222|590123238|FG001|Overall Study|Lost to Follow-up|1|||
163385749|NCT01028222|590123237|FG000|Overall Study|Withdrawal by Subject|1|||
163385750|NCT01028222|590123238|FG001|Overall Study|Withdrawal by Subject|0|||
163385751|NCT01028222|590123237|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
163385752|NCT01028222|590123238|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
163385753|NCT01028222|590123237|FG000|Overall Study|Adverse Event|2|||
162925781|NCT03193190|588430426|FG000|Stage 1|Arm Terminated by Sponsor|0|||
162925782|NCT03193190|588430427|FG001|Stage 1|Arm Terminated by Sponsor|0|||
163040492|NCT02452554|588856026|FG005|Overall Study|Lack of Efficacy|8|||
163040493|NCT02452554|588856021|FG000|Overall Study|Physician Decision|0|||
163040494|NCT02452554|588856022|FG001|Overall Study|Physician Decision|1|||
163040495|NCT02452554|588856023|FG002|Overall Study|Physician Decision|0|||
163040496|NCT02452554|588856024|FG003|Overall Study|Physician Decision|0|||
163040497|NCT02452554|588856025|FG004|Overall Study|Physician Decision|0|||
163040498|NCT02452554|588856026|FG005|Overall Study|Physician Decision|0|||
163040499|NCT02452554|588856021|FG000|Overall Study|Withdrawal by Subject|1|||
162925783|NCT03193190|588430428|FG002|Stage 1|Arm Terminated by Sponsor|0|||
162925784|NCT03193190|588430429|FG003|Stage 1|Arm Terminated by Sponsor|1|||
163040500|NCT02452554|588856022|FG001|Overall Study|Withdrawal by Subject|0|||
163040501|NCT02452554|588856023|FG002|Overall Study|Withdrawal by Subject|2|||
163040502|NCT02452554|588856024|FG003|Overall Study|Withdrawal by Subject|0|||
162925785|NCT03193190|588430430|FG004|Stage 1|Arm Terminated by Sponsor|0|||
162925786|NCT03193190|588430431|FG005|Stage 1|Arm Terminated by Sponsor|2|||
162925787|NCT03193190|588430432|FG006|Stage 1|Arm Terminated by Sponsor|0|||
162925788|NCT03193190|588430433|FG007|Stage 1|Arm Terminated by Sponsor|0|||
162925789|NCT03193190|588430434|FG008|Stage 1|Arm Terminated by Sponsor|0|||
162925790|NCT03193190|588430435|FG009|Stage 1|Arm Terminated by Sponsor|0|||
162925791|NCT03193190|588430436|FG010|Stage 1|Arm Terminated by Sponsor|0|||
163040503|NCT02452554|588856025|FG004|Overall Study|Withdrawal by Subject|0|||
163040504|NCT02452554|588856026|FG005|Overall Study|Withdrawal by Subject|1|||
163040505|NCT02452554|588856021|FG000|Overall Study|Ineligible|0|||
162925792|NCT03193190|588430437|FG011|Stage 1|Arm Terminated by Sponsor|0|||
162925793|NCT03193190|588430438|FG012|Stage 1|Arm Terminated by Sponsor|0|||
162925794|NCT03193190|588430439|FG013|Stage 1|Arm Terminated by Sponsor|0|||
162925795|NCT03193190|588430440|FG014|Stage 1|Arm Terminated by Sponsor|0|||
162925796|NCT03193190|588430441|FG015|Stage 1|Arm Terminated by Sponsor|0|||
163040506|NCT02452554|588856022|FG001|Overall Study|Ineligible|1|||
163040507|NCT02452554|588856023|FG002|Overall Study|Ineligible|0|||
162925797|NCT03193190|588430426|FG000|Stage 1|Death|22|||
163385754|NCT01028222|590123238|FG001|Overall Study|Adverse Event|0|||
162925798|NCT03193190|588430427|FG001|Stage 1|Death|8|||
162925799|NCT03193190|588430428|FG002|Stage 1|Death|23|||
163040508|NCT02452554|588856024|FG003|Overall Study|Ineligible|0|||
163040509|NCT02452554|588856025|FG004|Overall Study|Ineligible|0|||
163040510|NCT02452554|588856026|FG005|Overall Study|Ineligible|0|||
163040511|NCT02452554|588856021|FG000|Overall Study|Never Received Treatment|1|||
163040512|NCT02452554|588856022|FG001|Overall Study|Never Received Treatment|0|||
163040513|NCT02452554|588856023|FG002|Overall Study|Never Received Treatment|0|||
163040514|NCT02452554|588856024|FG003|Overall Study|Never Received Treatment|0|||
163040515|NCT02452554|588856025|FG004|Overall Study|Never Received Treatment|0|||
163040516|NCT02452554|588856026|FG005|Overall Study|Never Received Treatment|0|||
163040517|NCT01790516|588856027|FG000|Overall Study|Physician Decision|1|||
163040518|NCT01790516|588856028|FG001|Overall Study|Physician Decision|0|||
163040519|NCT01402986|588856029|FG000|Overall Study|Withdrawal by Subject|7|||
163040520|NCT01402986|588856030|FG001|Overall Study|Withdrawal by Subject|10|||
163040521|NCT01402986|588856031|FG002|Overall Study|Withdrawal by Subject|7|||
163040522|NCT01402986|588856032|FG003|Overall Study|Withdrawal by Subject|13|||
163040523|NCT01402986|588856029|FG000|Overall Study|Death|0|||
163040524|NCT01402986|588856030|FG001|Overall Study|Death|0|||
163040525|NCT01402986|588856031|FG002|Overall Study|Death|0|||
163040526|NCT01402986|588856032|FG003|Overall Study|Death|2|||
163040527|NCT01402986|588856029|FG000|Overall Study|Lost to Follow-up|0|||
163040528|NCT01402986|588856030|FG001|Overall Study|Lost to Follow-up|0|||
163040529|NCT01402986|588856031|FG002|Overall Study|Lost to Follow-up|0|||
163040530|NCT01402986|588856032|FG003|Overall Study|Lost to Follow-up|1|||
163040531|NCT01402986|588856029|FG000|Overall Study|Other|2|||
163040532|NCT01402986|588856030|FG001|Overall Study|Other|5|||
163040533|NCT01402986|588856031|FG002|Overall Study|Other|1|||
163040534|NCT01402986|588856032|FG003|Overall Study|Other|6|||
163040535|NCT01085084|588856033|FG000|Overall Study|Withdrawal by Subject|1|||
163040536|NCT01085084|588856034|FG001|Overall Study|Withdrawal by Subject|0|||
163040537|NCT01085084|588856035|FG002|Overall Study|Withdrawal by Subject|0|||
163040538|NCT01085084|588856033|FG000|Overall Study|Lost to Follow-up|2|||
163040539|NCT01085084|588856034|FG001|Overall Study|Lost to Follow-up|1|||
163040540|NCT01085084|588856035|FG002|Overall Study|Lost to Follow-up|1|||
163040541|NCT01085084|588856033|FG000|Overall Study|Adverse Event|4|||
163040542|NCT01085084|588856034|FG001|Overall Study|Adverse Event|3|||
163040543|NCT01085084|588856035|FG002|Overall Study|Adverse Event|6|||
163040544|NCT01085084|588856033|FG000|Overall Study|Treatment Failure|0|||
163040545|NCT01085084|588856034|FG001|Overall Study|Treatment Failure|1|||
163040546|NCT01085084|588856035|FG002|Overall Study|Treatment Failure|2|||
163040547|NCT02749799|588856036|FG000|Overall Study|Adverse Event|2|||
163040548|NCT02749799|588856036|FG000|Overall Study|Lost to Follow-up|4|||
163040549|NCT02749799|588856036|FG000|Overall Study|Protocol Violation|1|||
163040550|NCT02749799|588856036|FG000|Overall Study|Withdrawal by Subject|1|||
163040551|NCT02070978|588856037|FG000|Overall Study|Adverse Event|6|||
163040552|NCT02070978|588856038|FG001|Overall Study|Adverse Event|2|||
163040553|NCT02070978|588856039|FG002|Overall Study|Adverse Event|0|||
163040554|NCT02070978|588856037|FG000|Overall Study|Lost to Follow-up|1|||
163040555|NCT02070978|588856038|FG001|Overall Study|Lost to Follow-up|3|||
163040556|NCT02070978|588856039|FG002|Overall Study|Lost to Follow-up|4|||
163040557|NCT02070978|588856037|FG000|Overall Study|Withdrawal by Subject|3|||
163154973|NCT00463567|589283655|FG006|Overall Study|Administrative problems|2|||
162925800|NCT03193190|588430429|FG003|Stage 1|Death|14|||
162925801|NCT03193190|588430430|FG004|Stage 1|Death|34|||
162925802|NCT03193190|588430431|FG005|Stage 1|Death|28|||
162925803|NCT03193190|588430432|FG006|Stage 1|Death|19|||
162925804|NCT03193190|588430433|FG007|Stage 1|Death|21|||
162925805|NCT03193190|588430434|FG008|Stage 1|Death|14|||
162925806|NCT03193190|588430435|FG009|Stage 1|Death|10|||
162925807|NCT03193190|588430436|FG010|Stage 1|Death|59|||
162925808|NCT03193190|588430437|FG011|Stage 1|Death|14|||
162925809|NCT03193190|588430438|FG012|Stage 1|Death|14|||
162925810|NCT03193190|588430439|FG013|Stage 1|Death|0|||
162925811|NCT03193190|588430440|FG014|Stage 1|Death|0|||
162925812|NCT03193190|588430441|FG015|Stage 1|Death|0|||
163040558|NCT02070978|588856038|FG001|Overall Study|Withdrawal by Subject|5|||
163040559|NCT02070978|588856039|FG002|Overall Study|Withdrawal by Subject|3|||
163040560|NCT02070978|588856037|FG000|Overall Study|Protocol Violation|1|||
163040561|NCT02070978|588856038|FG001|Overall Study|Protocol Violation|0|||
163040562|NCT02070978|588856039|FG002|Overall Study|Protocol Violation|3|||
163040563|NCT02070978|588856037|FG000|Overall Study|Lack of Efficacy|0|||
163040564|NCT02070978|588856038|FG001|Overall Study|Lack of Efficacy|1|||
163040565|NCT02070978|588856039|FG002|Overall Study|Lack of Efficacy|0|||
163040566|NCT02070978|588856037|FG000|Overall Study|Death|0|||
163040567|NCT02070978|588856038|FG001|Overall Study|Death|0|||
163154974|NCT00463567|589283649|FG000|Overall Study|Lack of Efficacy|4|||
162925813|NCT03193190|588430426|FG000|Stage 1|Lost to Follow-up|2|||
162925814|NCT03193190|588430427|FG001|Stage 1|Lost to Follow-up|1|||
162925815|NCT03193190|588430428|FG002|Stage 1|Lost to Follow-up|1|||
162925816|NCT03193190|588430429|FG003|Stage 1|Lost to Follow-up|0|||
163040568|NCT02070978|588856039|FG002|Overall Study|Death|2|||
163040569|NCT02070978|588856037|FG000|Overall Study|Un-specified|3|||
163040570|NCT02070978|588856038|FG001|Overall Study|Un-specified|2|||
162925817|NCT03193190|588430430|FG004|Stage 1|Lost to Follow-up|0|||
162925818|NCT03193190|588430431|FG005|Stage 1|Lost to Follow-up|0|||
162925819|NCT03193190|588430432|FG006|Stage 1|Lost to Follow-up|1|||
162925820|NCT03193190|588430433|FG007|Stage 1|Lost to Follow-up|0|||
162925821|NCT03193190|588430434|FG008|Stage 1|Lost to Follow-up|0|||
162925822|NCT03193190|588430435|FG009|Stage 1|Lost to Follow-up|0|||
162925823|NCT03193190|588430436|FG010|Stage 1|Lost to Follow-up|0|||
162925824|NCT03193190|588430437|FG011|Stage 1|Lost to Follow-up|0|||
162925825|NCT03193190|588430438|FG012|Stage 1|Lost to Follow-up|0|||
162925826|NCT03193190|588430439|FG013|Stage 1|Lost to Follow-up|0|||
162925827|NCT03193190|588430440|FG014|Stage 1|Lost to Follow-up|0|||
162925828|NCT03193190|588430441|FG015|Stage 1|Lost to Follow-up|0|||
162925829|NCT03193190|588430426|FG000|Stage 1|Reason not Specified|1|||
162925830|NCT03193190|588430427|FG001|Stage 1|Reason not Specified|0|||
162925831|NCT03193190|588430428|FG002|Stage 1|Reason not Specified|0|||
162925832|NCT03193190|588430429|FG003|Stage 1|Reason not Specified|1|||
162925833|NCT03193190|588430430|FG004|Stage 1|Reason not Specified|0|||
162925834|NCT03193190|588430431|FG005|Stage 1|Reason not Specified|1|||
162925835|NCT03193190|588430432|FG006|Stage 1|Reason not Specified|2|||
162925836|NCT03193190|588430433|FG007|Stage 1|Reason not Specified|2|||
162925837|NCT03193190|588430434|FG008|Stage 1|Reason not Specified|0|||
162925838|NCT03193190|588430435|FG009|Stage 1|Reason not Specified|1|||
163040571|NCT02070978|588856039|FG002|Overall Study|Un-specified|2|||
163040572|NCT02070978|588856037|FG000|Overall Study|Terminated by Sponsor|33|||
163040573|NCT02070978|588856038|FG001|Overall Study|Terminated by Sponsor|40|||
163040574|NCT02070978|588856039|FG002|Overall Study|Terminated by Sponsor|39|||
163040575|NCT03749109|588856040|FG000|Overall Study|Adverse Event|2|||
163040576|NCT03749109|588856041|FG001|Overall Study|Adverse Event|0|||
163040577|NCT03951753|588856042|FG000|Overall Study|Adverse Event|1|||
163040578|NCT03951753|588856043|FG001|Overall Study|Adverse Event|0|||
163040579|NCT03951753|588856044|FG002|Overall Study|Adverse Event|3|||
163040580|NCT03951753|588856042|FG000|Overall Study|Withdrawal by Subject|3|||
163040581|NCT03951753|588856043|FG001|Overall Study|Withdrawal by Subject|1|||
163040582|NCT03951753|588856044|FG002|Overall Study|Withdrawal by Subject|0|||
163040583|NCT03951753|588856042|FG000|Overall Study|Lost to Follow-up|0|||
163040584|NCT03951753|588856043|FG001|Overall Study|Lost to Follow-up|0|||
163040585|NCT03951753|588856044|FG002|Overall Study|Lost to Follow-up|1|||
163040586|NCT03178851|588856045|FG000|Overall Study|Death|48|||
163040587|NCT03178851|588856046|FG001|Overall Study|Death|2|||
163040588|NCT03178851|588856047|FG002|Overall Study|Death|25|||
163040589|NCT03178851|588856045|FG000|Overall Study|Withdrawal by Subject|8|||
163154975|NCT00463567|589283650|FG001|Overall Study|Lack of Efficacy|9|||
162925839|NCT03193190|588430436|FG010|Stage 1|Reason not Specified|3|||
162925840|NCT03193190|588430437|FG011|Stage 1|Reason not Specified|0|||
162925841|NCT03193190|588430438|FG012|Stage 1|Reason not Specified|1|||
162925842|NCT03193190|588430439|FG013|Stage 1|Reason not Specified|0|||
162925843|NCT03193190|588430440|FG014|Stage 1|Reason not Specified|0|||
162925844|NCT03193190|588430441|FG015|Stage 1|Reason not Specified|0|||
162925845|NCT03193190|588430426|FG000|Stage 1|Physician Decision|0|||
162925846|NCT03193190|588430427|FG001|Stage 1|Physician Decision|0|||
162925847|NCT03193190|588430428|FG002|Stage 1|Physician Decision|0|||
162925848|NCT03193190|588430429|FG003|Stage 1|Physician Decision|0|||
162925849|NCT03193190|588430430|FG004|Stage 1|Physician Decision|0|||
162925850|NCT03193190|588430431|FG005|Stage 1|Physician Decision|0|||
162925851|NCT03193190|588430432|FG006|Stage 1|Physician Decision|0|||
162925852|NCT03193190|588430433|FG007|Stage 1|Physician Decision|0|||
162925853|NCT03193190|588430434|FG008|Stage 1|Physician Decision|0|||
162925854|NCT03193190|588430435|FG009|Stage 1|Physician Decision|0|||
162925855|NCT03193190|588430436|FG010|Stage 1|Physician Decision|0|||
162925856|NCT03193190|588430437|FG011|Stage 1|Physician Decision|1|||
162925857|NCT03193190|588430438|FG012|Stage 1|Physician Decision|0|||
162925858|NCT03193190|588430439|FG013|Stage 1|Physician Decision|0|||
162925859|NCT03193190|588430440|FG014|Stage 1|Physician Decision|0|||
162925860|NCT03193190|588430441|FG015|Stage 1|Physician Decision|0|||
162925861|NCT03193190|588430426|FG000|Stage 1|Progressive Disease|1|||
162925862|NCT03193190|588430427|FG001|Stage 1|Progressive Disease|0|||
162925863|NCT03193190|588430428|FG002|Stage 1|Progressive Disease|0|||
162925864|NCT03193190|588430429|FG003|Stage 1|Progressive Disease|0|||
162925865|NCT03193190|588430430|FG004|Stage 1|Progressive Disease|0|||
162925866|NCT03193190|588430431|FG005|Stage 1|Progressive Disease|0|||
162925867|NCT03193190|588430432|FG006|Stage 1|Progressive Disease|0|||
162925868|NCT03193190|588430433|FG007|Stage 1|Progressive Disease|0|||
162925869|NCT03193190|588430434|FG008|Stage 1|Progressive Disease|0|||
163040590|NCT03178851|588856046|FG001|Overall Study|Withdrawal by Subject|0|||
162925870|NCT03193190|588430435|FG009|Stage 1|Progressive Disease|0|||
162925871|NCT03193190|588430436|FG010|Stage 1|Progressive Disease|0|||
162925872|NCT03193190|588430437|FG011|Stage 1|Progressive Disease|0|||
163040591|NCT03178851|588856047|FG002|Overall Study|Withdrawal by Subject|0|||
163040592|NCT03178851|588856045|FG000|Overall Study|Lost to Follow-up|5|||
163040593|NCT03178851|588856046|FG001|Overall Study|Lost to Follow-up|2|||
163040594|NCT03178851|588856047|FG002|Overall Study|Lost to Follow-up|0|||
163040595|NCT03178851|588856045|FG000|Overall Study|Adverse Event|0|||
163040596|NCT03178851|588856046|FG001|Overall Study|Adverse Event|0|||
163040597|NCT03178851|588856047|FG002|Overall Study|Adverse Event|1|||
163040598|NCT03178851|588856045|FG000|Overall Study|Study Termination by Sponsor|31|||
162925873|NCT03193190|588430438|FG012|Stage 1|Progressive Disease|0|||
162925874|NCT03193190|588430439|FG013|Stage 1|Progressive Disease|0|||
163040599|NCT03178851|588856046|FG001|Overall Study|Study Termination by Sponsor|7|||
163040600|NCT03178851|588856047|FG002|Overall Study|Study Termination by Sponsor|26|||
163040601|NCT01905592|588856050|FG000|Overall Study|Disease Progression|51|||
163040602|NCT01905592|588856051|FG001|Overall Study|Disease Progression|110|||
163040603|NCT01905592|588856050|FG000|Overall Study|Toxicity|1|||
163040604|NCT01905592|588856051|FG001|Overall Study|Toxicity|16|||
163040605|NCT01905592|588856050|FG000|Overall Study|Physician Decision|0|||
163040606|NCT01905592|588856051|FG001|Overall Study|Physician Decision|2|||
163040607|NCT01905592|588856050|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
163040608|NCT01905592|588856051|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
163040609|NCT01905592|588856050|FG000|Overall Study|Protocol Violation|0|||
163040610|NCT01905592|588856051|FG001|Overall Study|Protocol Violation|1|||
163040611|NCT01905592|588856050|FG000|Overall Study|Sponsor's decision|1|||
163040612|NCT01905592|588856051|FG001|Overall Study|Sponsor's decision|1|||
163040613|NCT01905592|588856050|FG000|Overall Study|Not treated|7|||
163040614|NCT01905592|588856051|FG001|Overall Study|Not treated|3|||
163040615|NCT01905592|588856050|FG000|Overall Study|Withdrawal by Subject|10|||
163040616|NCT01905592|588856051|FG001|Overall Study|Withdrawal by Subject|2|||
163040617|NCT02669043|588856052|FG000|Overall Study|Didn't meet I/E criteria|4|||
163040618|NCT01483599|588856053|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
163040619|NCT01483599|588856054|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040620|NCT01483599|588856055|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040621|NCT01483599|588856056|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
163040622|NCT01483599|588856057|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
163040623|NCT01483599|588856058|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
163040624|NCT01483599|588856059|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
163040625|NCT01483599|588856060|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040626|NCT01483599|588856061|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040627|NCT01483599|588856062|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040628|NCT01483599|588856063|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040629|NCT01483599|588856064|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040630|NCT01483599|588856065|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040631|NCT01483599|588856066|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040632|NCT01483599|588856053|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040633|NCT01483599|588856054|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
163040634|NCT01483599|588856055|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040635|NCT01483599|588856056|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
163040636|NCT01483599|588856057|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040637|NCT01483599|588856058|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040638|NCT01483599|588856059|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
163040639|NCT01483599|588856060|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040640|NCT01483599|588856061|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040641|NCT01483599|588856062|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040642|NCT01483599|588856063|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040643|NCT01483599|588856064|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040644|NCT01483599|588856065|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040645|NCT01483599|588856066|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040646|NCT01483599|588856053|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
163040647|NCT01483599|588856054|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040648|NCT01483599|588856055|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040649|NCT01483599|588856056|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040650|NCT01483599|588856057|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040651|NCT01483599|588856058|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040652|NCT01483599|588856059|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040653|NCT01483599|588856060|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040654|NCT01483599|588856061|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040655|NCT01483599|588856062|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040656|NCT01483599|588856063|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040657|NCT01483599|588856064|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040658|NCT01483599|588856065|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
162925875|NCT03193190|588430440|FG014|Stage 1|Progressive Disease|0|||
162925876|NCT03193190|588430441|FG015|Stage 1|Progressive Disease|0|||
162925877|NCT03193190|588430426|FG000|Stage 1|Study Terminated By Sponsor|3|||
163040659|NCT01483599|588856066|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040660|NCT01483599|588856053|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
163040661|NCT01483599|588856054|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
163040662|NCT01483599|588856055|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
163040663|NCT01483599|588856056|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
163154976|NCT00463567|589283651|FG002|Overall Study|Lack of Efficacy|9|||
163154977|NCT00463567|589283652|FG003|Overall Study|Lack of Efficacy|17|||
163154978|NCT00463567|589283653|FG004|Overall Study|Lack of Efficacy|1|||
163154979|NCT00463567|589283654|FG005|Overall Study|Lack of Efficacy|0|||
163040664|NCT01483599|588856057|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
163040665|NCT01483599|588856058|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
163040666|NCT01483599|588856059|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
163040667|NCT01483599|588856060|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
163040668|NCT01483599|588856061|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
163040669|NCT01483599|588856062|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
163040670|NCT01483599|588856063|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
163040671|NCT01483599|588856064|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
163040672|NCT01483599|588856065|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
163040673|NCT01483599|588856066|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
163040674|NCT01483599|588856053|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
163040675|NCT01483599|588856054|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
163040676|NCT01483599|588856055|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
163040677|NCT01483599|588856056|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
163040678|NCT01483599|588856057|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
163040679|NCT01483599|588856058|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
163040680|NCT01483599|588856059|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
163040681|NCT01483599|588856060|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
163040682|NCT01483599|588856061|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
163040683|NCT01483599|588856062|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
163040684|NCT01483599|588856063|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
163040685|NCT01483599|588856064|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
163040686|NCT01483599|588856065|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
163040687|NCT01483599|588856066|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
163154980|NCT00463567|589283655|FG006|Overall Study|Lack of Efficacy|1|||
163154981|NCT00463567|589283649|FG000|Overall Study|Abnormal lab value(s)|1|||
163154982|NCT00463567|589283650|FG001|Overall Study|Abnormal lab value(s)|1|||
163154983|NCT00463567|589283651|FG002|Overall Study|Abnormal lab value(s)|2|||
163154984|NCT00463567|589283652|FG003|Overall Study|Abnormal lab value(s)|1|||
163154985|NCT00463567|589283653|FG004|Overall Study|Abnormal lab value(s)|1|||
163154986|NCT00463567|589283654|FG005|Overall Study|Abnormal lab value(s)|0|||
163154987|NCT00463567|589283655|FG006|Overall Study|Abnormal lab value(s)|0|||
163154988|NCT00463567|589283649|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163154989|NCT00463567|589283650|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163154990|NCT00463567|589283651|FG002|Overall Study|Abnormal test procedure result(s)|6|||
163154991|NCT00463567|589283652|FG003|Overall Study|Abnormal test procedure result(s)|2|||
163154992|NCT00463567|589283653|FG004|Overall Study|Abnormal test procedure result(s)|0|||
163154993|NCT00463567|589283654|FG005|Overall Study|Abnormal test procedure result(s)|2|||
163154994|NCT00463567|589283655|FG006|Overall Study|Abnormal test procedure result(s)|0|||
163154995|NCT00463567|589283649|FG000|Overall Study|Death|1|||
163154996|NCT00463567|589283650|FG001|Overall Study|Death|0|||
163154997|NCT00463567|589283651|FG002|Overall Study|Death|2|||
163154998|NCT00463567|589283652|FG003|Overall Study|Death|0|||
163154999|NCT00463567|589283653|FG004|Overall Study|Death|0|||
163155000|NCT00463567|589283654|FG005|Overall Study|Death|0|||
163155001|NCT00463567|589283655|FG006|Overall Study|Death|0|||
163155002|NCT01712399|589283660|FG000|Overall Study|Lost to Follow-up|1|||
163155003|NCT01712399|589283660|FG000|Overall Study|Withdrawal by Subject|39|||
163155004|NCT01712399|589283660|FG000|Overall Study|Death|1|||
163155005|NCT01712399|589283660|FG000|Overall Study|Adverse Event|11|||
163155006|NCT01712399|589283660|FG000|Overall Study|Study closure|345|||
163155007|NCT01705509|589283666|FG000|Inclusion CPET|Screen Failure|5|||
163155008|NCT01705509|589283666|FG000|Inclusion CPET|Withdrawal by Subject|2|||
163155009|NCT01705509|589283666|FG000|CPET w/ Ranexa|Screen Failure|2|||
163155010|NCT00904033|589283667|FG000|Overall Study|Withdrawal by Subject|1|||
163155011|NCT00904033|589283668|FG001|Overall Study|Withdrawal by Subject|1|||
163155012|NCT00904033|589283669|FG002|Overall Study|Withdrawal by Subject|0|||
163155013|NCT00904033|589283670|FG003|Overall Study|Withdrawal by Subject|0|||
163155014|NCT00904033|589283667|FG000|Overall Study|Physician Decision|0|||
163155015|NCT00904033|589283668|FG001|Overall Study|Physician Decision|0|||
163155016|NCT00904033|589283669|FG002|Overall Study|Physician Decision|1|||
163155017|NCT00904033|589283670|FG003|Overall Study|Physician Decision|0|||
163155018|NCT00904033|589283667|FG000|Overall Study|Unable to obtain final blood draw|0|||
163155019|NCT00904033|589283668|FG001|Overall Study|Unable to obtain final blood draw|0|||
163040688|NCT01483599|588856053|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040689|NCT01483599|588856054|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040690|NCT01483599|588856055|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163155020|NCT00904033|589283669|FG002|Overall Study|Unable to obtain final blood draw|0|||
163155021|NCT00904033|589283670|FG003|Overall Study|Unable to obtain final blood draw|2|||
163155022|NCT01357850|589283671|FG000|Overall Study|Lost to Follow-up|1|||
163155023|NCT01357850|589283672|FG001|Overall Study|Lost to Follow-up|0|||
163155024|NCT01357850|589283673|FG002|Overall Study|Lost to Follow-up|0|||
163155025|NCT01357850|589283674|FG003|Overall Study|Lost to Follow-up|0|||
163155026|NCT02736890|589283675|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
163155027|NCT02736890|589283676|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
163155028|NCT02736890|589283675|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
163155029|NCT02736890|589283676|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
163155030|NCT01803607|589283678|FG000|Overall Study|Adverse Event|5|||
163155031|NCT01803607|589283679|FG001|Overall Study|Adverse Event|3|||
163155032|NCT01803607|589283678|FG000|Overall Study|Lack of Efficacy|0|||
163155033|NCT01803607|589283679|FG001|Overall Study|Lack of Efficacy|1|||
163155034|NCT01803607|589283678|FG000|Overall Study|Protocol Violation|3|||
163155035|NCT01803607|589283679|FG001|Overall Study|Protocol Violation|2|||
163155036|NCT01803607|589283678|FG000|Overall Study|Study terminated by sponsor|54|||
163155037|NCT01803607|589283679|FG001|Overall Study|Study terminated by sponsor|56|||
163155038|NCT01803607|589283678|FG000|Overall Study|Withdrawal by Subject|6|||
163155039|NCT01803607|589283679|FG001|Overall Study|Withdrawal by Subject|5|||
163155040|NCT03077412|589283680|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
163155041|NCT03077412|589283681|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
163155042|NCT03077412|589283682|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
163155043|NCT03077412|589283680|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
163155044|NCT03077412|589283681|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
163155045|NCT03077412|589283682|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
163155046|NCT03077412|589283680|FG000|Overall Study|Adverse Event|1|||
163155047|NCT03077412|589283681|FG001|Overall Study|Adverse Event|2|||
163155048|NCT03077412|589283682|FG002|Overall Study|Adverse Event|2|||
163155049|NCT03077412|589283680|FG000|Overall Study|Investigator's Discretion|0|||
163155050|NCT03077412|589283681|FG001|Overall Study|Investigator's Discretion|1|||
163155051|NCT03077412|589283682|FG002|Overall Study|Investigator's Discretion|1|||
163155052|NCT03077412|589283680|FG000|Overall Study|Withdrew Consent|0|||
163155053|NCT03077412|589283681|FG001|Overall Study|Withdrew Consent|2|||
163155054|NCT03077412|589283682|FG002|Overall Study|Withdrew Consent|0|||
163155055|NCT02351856|589283686|FG000|Overall Study|Adverse Event|2|||
163155056|NCT02351856|589283686|FG000|Overall Study|Physician Decision|5|||
163155057|NCT02351856|589283686|FG000|Overall Study|Study terminated by sponsor|1|||
163155058|NCT03038100|589283697|FG000|Overall Study|Death|289|||
163155059|NCT03038100|589283698|FG001|Overall Study|Death|272|||
163155060|NCT03038100|589283697|FG000|Overall Study|Lost to Follow-up|9|||
162925878|NCT03193190|588430427|FG001|Stage 1|Study Terminated By Sponsor|0|||
163155061|NCT03038100|589283698|FG001|Overall Study|Lost to Follow-up|10|||
163155062|NCT03038100|589283697|FG000|Overall Study|Protocol Deviation|1|||
163155063|NCT03038100|589283698|FG001|Overall Study|Protocol Deviation|4|||
163155064|NCT03038100|589283697|FG000|Overall Study|Withdrawal by Subject|45|||
163155065|NCT03038100|589283698|FG001|Overall Study|Withdrawal by Subject|51|||
163155066|NCT03038100|589283697|FG000|Overall Study|Study Terminated By Sponsor|305|||
163155067|NCT03038100|589283698|FG001|Overall Study|Study Terminated By Sponsor|311|||
163155068|NCT03038100|589283697|FG000|Overall Study|Physician Decision|1|||
163155069|NCT03038100|589283698|FG001|Overall Study|Physician Decision|3|||
163155070|NCT01774721|589283702|FG000|Overall Study|Death|133|||
163155071|NCT01774721|589283703|FG001|Overall Study|Death|152|||
163155072|NCT01774721|589283702|FG000|Overall Study|Withdrawal by Subject|20|||
163155073|NCT01774721|589283703|FG001|Overall Study|Withdrawal by Subject|14|||
163155074|NCT01774721|589283702|FG000|Overall Study|Lost to Follow-up|6|||
163155075|NCT01774721|589283703|FG001|Overall Study|Lost to Follow-up|7|||
163155076|NCT01774721|589283702|FG000|Overall Study|Did not meet eligibility criteria|0|||
163155077|NCT01774721|589283703|FG001|Overall Study|Did not meet eligibility criteria|3|||
163155078|NCT01774721|589283702|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
163155079|NCT01774721|589283703|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
163155080|NCT01774721|589283702|FG000|Overall Study|Study terminated by sponsor|5|||
163155081|NCT01774721|589283703|FG001|Overall Study|Study terminated by sponsor|0|||
163155082|NCT01774721|589283702|FG000|Overall Study|Disease progression|5|||
163155083|NCT01774721|589283703|FG001|Overall Study|Disease progression|0|||
163155084|NCT01936870|589283704|FG000|Overall Study|No Visit After Treatment|176|||
163155085|NCT01936870|589283704|FG000|Overall Study|Protocol Violation|12|||
163155086|NCT01936870|589283704|FG000|Overall Study|No Drug Administration|1|||
163155087|NCT00248040|589283705|FG000|Overall Study|transplantectomy|2|||
162925879|NCT03193190|588430428|FG002|Stage 1|Study Terminated By Sponsor|0|||
163155088|NCT00248040|589283706|FG001|Overall Study|transplantectomy|1|||
163155089|NCT00248040|589283707|FG002|Overall Study|transplantectomy|3|||
163155090|NCT00248040|589283705|FG000|Overall Study|transplant cancelled post treat start|1|||
163155091|NCT00248040|589283706|FG001|Overall Study|transplant cancelled post treat start|0|||
163155092|NCT00248040|589283707|FG002|Overall Study|transplant cancelled post treat start|0|||
163155093|NCT00248040|589283705|FG000|Overall Study|Death|0|||
163155094|NCT00248040|589283706|FG001|Overall Study|Death|0|||
163155095|NCT00248040|589283707|FG002|Overall Study|Death|1|||
163155096|NCT00118417|589283710|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
163155097|NCT00118417|589283711|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
163155098|NCT00118417|589283710|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
163155099|NCT00118417|589283711|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
163155100|NCT00118417|589283710|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
163155101|NCT00118417|589283711|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
163155102|NCT00118417|589283710|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
163155103|NCT00118417|589283711|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
163155104|NCT00118417|589283710|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
163155105|NCT00118417|589283711|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
163155106|NCT02978781|589283712|FG000|Part A|Adverse Event|1|||
163155107|NCT02978781|589283713|FG001|Part A|Adverse Event|1|||
163155108|NCT02978781|589283714|FG002|Part A|Adverse Event|0|||
163155109|NCT02978781|589283715|FG003|Part A|Adverse Event|0|||
163155110|NCT02978781|589283716|FG004|Part A|Adverse Event|0|||
163155111|NCT02978781|589283712|FG000|Part A|Withdrawal by Subject|0|||
163155112|NCT02978781|589283713|FG001|Part A|Withdrawal by Subject|1|||
163155113|NCT02978781|589283714|FG002|Part A|Withdrawal by Subject|0|||
163155114|NCT02978781|589283715|FG003|Part A|Withdrawal by Subject|0|||
163155115|NCT02978781|589283716|FG004|Part A|Withdrawal by Subject|0|||
163155116|NCT02978781|589283712|FG000|Part B|Withdrawal by Subject|0|||
163155117|NCT02978781|589283713|FG001|Part B|Withdrawal by Subject|0|||
163155118|NCT02978781|589283714|FG002|Part B|Withdrawal by Subject|0|||
163155119|NCT02978781|589283715|FG003|Part B|Withdrawal by Subject|1|||
163155120|NCT02978781|589283716|FG004|Part B|Withdrawal by Subject|0|||
163155121|NCT02978781|589283712|FG000|Part C|Adverse Event|0|||
163155122|NCT02978781|589283713|FG001|Part C|Adverse Event|0|||
163155123|NCT02978781|589283714|FG002|Part C|Adverse Event|0|||
163155124|NCT02978781|589283715|FG003|Part C|Adverse Event|0|||
163155125|NCT02978781|589283716|FG004|Part C|Adverse Event|2|||
163155126|NCT02978781|589283712|FG000|Part C|Withdrawal by Subject|0|||
163155127|NCT02978781|589283713|FG001|Part C|Withdrawal by Subject|0|||
163155128|NCT02978781|589283714|FG002|Part C|Withdrawal by Subject|0|||
163155129|NCT02978781|589283715|FG003|Part C|Withdrawal by Subject|0|||
163155130|NCT02978781|589283716|FG004|Part C|Withdrawal by Subject|1|||
163155131|NCT02978781|589283712|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
163155132|NCT02978781|589283713|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
163155133|NCT02978781|589283714|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
163155134|NCT02978781|589283715|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
163155135|NCT02978781|589283716|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
163155136|NCT01383356|589283717|FG000|Period 1|Adverse Event|5|||
163155137|NCT01383356|589283718|FG001|Period 1|Adverse Event|3|||
163155138|NCT01383356|589283717|FG000|Period 1|Non-compliance|3|||
163155139|NCT01383356|589283718|FG001|Period 1|Non-compliance|0|||
163155140|NCT01383356|589283717|FG000|Period 1|Out of Range Mid-study-Test|0|||
163155141|NCT01383356|589283718|FG001|Period 1|Out of Range Mid-study-Test|1|||
163155142|NCT01383356|589283717|FG000|Period 1|Personal|0|||
163155143|NCT01383356|589283718|FG001|Period 1|Personal|2|||
163155144|NCT02054104|589283720|FG000|Overall Study|Did not want to continue due to college classes|1|||
163155145|NCT02054104|589283721|FG001|Overall Study|Did not want to continue due to college classes|0|||
163155146|NCT02054104|589283720|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
163155147|NCT02054104|589283721|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
163155148|NCT02054104|589283720|FG000|Overall Study|No evidence of immunologic response|2|||
163155149|NCT02054104|589283721|FG001|Overall Study|No evidence of immunologic response|2|||
163155150|NCT02054104|589283720|FG000|Overall Study|Disease Progression On Study|4|||
163155151|NCT02054104|589283721|FG001|Overall Study|Disease Progression On Study|5|||
163155152|NCT02054104|589283720|FG000|Overall Study|Diagnosis of lymphoma|0|||
163155153|NCT02054104|589283721|FG001|Overall Study|Diagnosis of lymphoma|1|||
163155154|NCT02054104|589283720|FG000|Overall Study|Inconclusive response|0|||
163155155|NCT02054104|589283721|FG001|Overall Study|Inconclusive response|1|||
163155156|NCT00084136|589283724|FG000|PI Comparison|Death|10|||
163155157|NCT00084136|589283725|FG001|PI Comparison|Death|9|||
163155158|NCT00084136|589283726|FG002|PI Comparison|Death|0|||
163155159|NCT00084136|589283724|FG000|PI Comparison|Lost to Follow-up|11|||
163155160|NCT00084136|589283725|FG001|PI Comparison|Lost to Follow-up|8|||
163155161|NCT00084136|589283726|FG002|PI Comparison|Lost to Follow-up|0|||
163155162|NCT00084136|589283724|FG000|PI Comparison|Withdrawal by Subject|33|||
163155163|NCT00084136|589283725|FG001|PI Comparison|Withdrawal by Subject|30|||
163155164|NCT00084136|589283726|FG002|PI Comparison|Withdrawal by Subject|0|||
163155165|NCT00084136|589283724|FG000|PI Comparison|Clinic site closed|1|||
163155166|NCT00084136|589283725|FG001|PI Comparison|Clinic site closed|0|||
163155167|NCT00084136|589283726|FG002|PI Comparison|Clinic site closed|0|||
163155168|NCT00084136|589283724|FG000|NRTI Comparison|Death|20|||
163155169|NCT00084136|589283725|FG001|NRTI Comparison|Death|0|||
163155170|NCT00084136|589283726|FG002|NRTI Comparison|Death|18|||
163155171|NCT00084136|589283724|FG000|NRTI Comparison|Lost to Follow-up|14|||
163155172|NCT00084136|589283725|FG001|NRTI Comparison|Lost to Follow-up|0|||
163155173|NCT00084136|589283726|FG002|NRTI Comparison|Lost to Follow-up|12|||
163155174|NCT00084136|589283724|FG000|NRTI Comparison|Withdrawal by Subject|54|||
163155175|NCT00084136|589283725|FG001|NRTI Comparison|Withdrawal by Subject|0|||
163155176|NCT00084136|589283726|FG002|NRTI Comparison|Withdrawal by Subject|38|||
163155177|NCT00084136|589283724|FG000|NRTI Comparison|Clinic site closed|12|||
163155178|NCT00084136|589283725|FG001|NRTI Comparison|Clinic site closed|0|||
163155179|NCT00084136|589283726|FG002|NRTI Comparison|Clinic site closed|14|||
163155180|NCT00084136|589283724|FG000|NRTI Comparison|Not reason above|1|||
163155181|NCT00084136|589283725|FG001|NRTI Comparison|Not reason above|0|||
163155182|NCT00084136|589283726|FG002|NRTI Comparison|Not reason above|0|||
163155183|NCT02633306|589283732|FG000|Overall Study|Withdrawal by Subject|3|||
163155184|NCT02131259|589283733|FG000|Overall Study|Progressive disease|751|||
163155185|NCT02131259|589283733|FG000|Overall Study|Adverse Event|341|||
163155186|NCT02131259|589283733|FG000|Overall Study|Lost to Follow-up|7|||
163155187|NCT02131259|589283733|FG000|Overall Study|Relocation|32|||
163155188|NCT02131259|589283733|FG000|Overall Study|Other|63|||
163155189|NCT02131259|589283733|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
163155190|NCT02131259|589283733|FG000|Overall Study|Progressive disease/relocation|1|||
163155191|NCT02131259|589283733|FG000|Overall Study|Progressive disease/other|2|||
163155192|NCT02131259|589283733|FG000|Overall Study|AE/lost to follow-up|1|||
163155193|NCT02131259|589283733|FG000|Overall Study|AE/other|1|||
163155194|NCT02131259|589283733|FG000|Overall Study|Progressive disease/AE/other|1|||
163155195|NCT02131259|589283733|FG000|Overall Study|Missing|3|||
163155196|NCT01472289|589283738|FG000|Overall Study|Death|2|||
163155197|NCT00907335|589283739|FG000|Overall Study|Withdrawal by Subject|2|||
163155198|NCT00907335|589283740|FG001|Overall Study|Withdrawal by Subject|0|||
163155199|NCT00907335|589283739|FG000|Overall Study|Adverse Event|4|||
163155200|NCT00907335|589283740|FG001|Overall Study|Adverse Event|1|||
163155201|NCT00907335|589283739|FG000|Overall Study|Lost to Follow-up|2|||
163155202|NCT00907335|589283740|FG001|Overall Study|Lost to Follow-up|0|||
163155203|NCT03879772|589283741|FG000|Overall Study|Adverse Event|2|||
163155204|NCT03879772|589283742|FG001|Overall Study|Adverse Event|2|||
163155205|NCT03879772|589283743|FG002|Overall Study|Adverse Event|3|||
163155206|NCT03879772|589283744|FG003|Overall Study|Adverse Event|4|||
163155207|NCT03879772|589283745|FG004|Overall Study|Adverse Event|3|||
163155208|NCT03879772|589283741|FG000|Overall Study|Treatment Failure|1|||
163155209|NCT03879772|589283742|FG001|Overall Study|Treatment Failure|0|||
163155210|NCT03879772|589283743|FG002|Overall Study|Treatment Failure|0|||
163155211|NCT03879772|589283744|FG003|Overall Study|Treatment Failure|2|||
163155212|NCT03879772|589283745|FG004|Overall Study|Treatment Failure|1|||
163155213|NCT03879772|589283741|FG000|Overall Study|Lost to Follow-up|0|||
163155214|NCT03879772|589283742|FG001|Overall Study|Lost to Follow-up|0|||
163155215|NCT03879772|589283743|FG002|Overall Study|Lost to Follow-up|0|||
163155216|NCT03879772|589283744|FG003|Overall Study|Lost to Follow-up|0|||
163155217|NCT03879772|589283745|FG004|Overall Study|Lost to Follow-up|1|||
163155218|NCT03879772|589283741|FG000|Overall Study|Withdrawal by Subject|0|||
163155219|NCT03879772|589283742|FG001|Overall Study|Withdrawal by Subject|1|||
163155220|NCT03879772|589283743|FG002|Overall Study|Withdrawal by Subject|3|||
163155221|NCT03879772|589283744|FG003|Overall Study|Withdrawal by Subject|1|||
163155222|NCT03879772|589283745|FG004|Overall Study|Withdrawal by Subject|1|||
163155223|NCT03879772|589283741|FG000|Overall Study|Protocol Violation|0|||
163155224|NCT03879772|589283742|FG001|Overall Study|Protocol Violation|0|||
163155225|NCT03879772|589283743|FG002|Overall Study|Protocol Violation|3|||
163155226|NCT03879772|589283744|FG003|Overall Study|Protocol Violation|1|||
163155227|NCT03879772|589283745|FG004|Overall Study|Protocol Violation|2|||
163155228|NCT03879772|589283741|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
163155229|NCT03879772|589283742|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
163155230|NCT03879772|589283743|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
163155231|NCT03879772|589283744|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
163155232|NCT03879772|589283745|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
163155233|NCT00389610|589283757|FG000|Overall Study|Disease Progression|0|||
163155234|NCT00389610|589283758|FG001|Overall Study|Disease Progression|19|||
163155235|NCT00389610|589283757|FG000|Overall Study|Death|0|||
163155236|NCT00389610|589283758|FG001|Overall Study|Death|1|||
163155237|NCT00389610|589283757|FG000|Overall Study|Physician Decision|0|||
163155238|NCT00389610|589283758|FG001|Overall Study|Physician Decision|1|||
163155239|NCT00389610|589283757|FG000|Overall Study|Withdrawal by Subject|0|||
163155240|NCT00389610|589283758|FG001|Overall Study|Withdrawal by Subject|1|||
163155241|NCT00887809|589283759|FG000|Overall Study|Patient Not Treated|3|||
163155242|NCT00887809|589283760|FG001|Overall Study|Patient Not Treated|0|||
163155243|NCT00887809|589283759|FG000|Overall Study|Death|1|||
163155244|NCT00887809|589283760|FG001|Overall Study|Death|0|||
163155245|NCT03131570|589283761|FG000|Overall Study|Adverse Event|1|||
163155246|NCT03131570|589283762|FG001|Overall Study|Adverse Event|0|||
163155247|NCT04596267|589283763|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
163155248|NCT04596267|589283764|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
163155249|NCT04596267|589283763|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
163155250|NCT04596267|589283764|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
163155251|NCT00071058|589283765|FG000|Overall Study|brain tumor-removed from study|1|||
163155252|NCT04189952|589283771|FG000|Follow-up Period|Death|1|||
163155253|NCT04189952|589283771|FG000|Follow-up Period|Withdrawal by Subject|1|||
163155254|NCT00870740|589283772|FG000|Overall Study|Adverse Event|2|||
163155255|NCT00870740|589283773|FG001|Overall Study|Adverse Event|1|||
163155256|NCT00870740|589283774|FG002|Overall Study|Adverse Event|3|||
163155257|NCT00870740|589283775|FG003|Overall Study|Adverse Event|2|||
163155258|NCT00870740|589283776|FG004|Overall Study|Adverse Event|1|||
163155259|NCT00870740|589283777|FG005|Overall Study|Adverse Event|6|||
163155260|NCT00870740|589283772|FG000|Overall Study|Consent Withdrawn|6|||
163155261|NCT00870740|589283773|FG001|Overall Study|Consent Withdrawn|3|||
163155262|NCT00870740|589283774|FG002|Overall Study|Consent Withdrawn|4|||
163155263|NCT00870740|589283775|FG003|Overall Study|Consent Withdrawn|6|||
163155264|NCT00870740|589283776|FG004|Overall Study|Consent Withdrawn|6|||
163155265|NCT00870740|589283777|FG005|Overall Study|Consent Withdrawn|5|||
163155266|NCT00870740|589283772|FG000|Overall Study|Investigator Decision|2|||
163155267|NCT00870740|589283773|FG001|Overall Study|Investigator Decision|0|||
163155268|NCT00870740|589283774|FG002|Overall Study|Investigator Decision|1|||
163155269|NCT00870740|589283775|FG003|Overall Study|Investigator Decision|0|||
163155270|NCT00870740|589283776|FG004|Overall Study|Investigator Decision|0|||
163155271|NCT00870740|589283777|FG005|Overall Study|Investigator Decision|0|||
163155272|NCT00870740|589283772|FG000|Overall Study|Subject Non-compliance|0|||
163155273|NCT00870740|589283773|FG001|Overall Study|Subject Non-compliance|0|||
163155274|NCT00870740|589283774|FG002|Overall Study|Subject Non-compliance|0|||
163155275|NCT00870740|589283775|FG003|Overall Study|Subject Non-compliance|0|||
163155276|NCT00870740|589283776|FG004|Overall Study|Subject Non-compliance|0|||
163155277|NCT00870740|589283777|FG005|Overall Study|Subject Non-compliance|1|||
163155278|NCT00870740|589283772|FG000|Overall Study|Death|0|||
163155279|NCT00870740|589283773|FG001|Overall Study|Death|0|||
163155280|NCT00870740|589283774|FG002|Overall Study|Death|0|||
163155281|NCT00870740|589283775|FG003|Overall Study|Death|0|||
163155282|NCT00870740|589283776|FG004|Overall Study|Death|1|||
163155283|NCT00870740|589283777|FG005|Overall Study|Death|0|||
163155284|NCT00870740|589283772|FG000|Overall Study|Other|2|||
163155285|NCT00870740|589283773|FG001|Overall Study|Other|5|||
163155286|NCT00870740|589283774|FG002|Overall Study|Other|2|||
163155287|NCT00870740|589283775|FG003|Overall Study|Other|4|||
163155288|NCT00870740|589283776|FG004|Overall Study|Other|3|||
163155289|NCT00870740|589283777|FG005|Overall Study|Other|5|||
163155290|NCT00453206|589283785|FG000|Overall Study|Death|1|||
163155291|NCT04672239|589283790|FG000|Week 2 Survey|Failed survey check items|1|||
163155292|NCT04672239|589283791|FG001|Week 2 Survey|Failed survey check items|2|||
163155293|NCT04672239|589283792|FG002|Week 2 Survey|Failed survey check items|3|||
163155294|NCT04672239|589283790|FG000|Week 2 Survey|Partially completed survey|7|||
163155295|NCT04672239|589283791|FG001|Week 2 Survey|Partially completed survey|1|||
163155296|NCT04672239|589283792|FG002|Week 2 Survey|Partially completed survey|4|||
163155297|NCT04672239|589283790|FG000|Week 2 Survey|Withdrawal by Subject|0|||
163155298|NCT04672239|589283791|FG001|Week 2 Survey|Withdrawal by Subject|1|||
163155299|NCT04672239|589283792|FG002|Week 2 Survey|Withdrawal by Subject|0|||
163155300|NCT04672239|589283790|FG000|Week 2 Survey|Lost to Follow-up|3|||
163155301|NCT04672239|589283791|FG001|Week 2 Survey|Lost to Follow-up|2|||
163155302|NCT04672239|589283792|FG002|Week 2 Survey|Lost to Follow-up|5|||
163155303|NCT04672239|589283790|FG000|Week 6 Survey|Failed survey check items|2|||
163155304|NCT04672239|589283791|FG001|Week 6 Survey|Failed survey check items|2|||
163155305|NCT04672239|589283792|FG002|Week 6 Survey|Failed survey check items|2|||
163155306|NCT04672239|589283790|FG000|Week 6 Survey|Partially completed survey|3|||
163155307|NCT04672239|589283791|FG001|Week 6 Survey|Partially completed survey|3|||
163155308|NCT04672239|589283792|FG002|Week 6 Survey|Partially completed survey|2|||
163155309|NCT04672239|589283790|FG000|Week 6 Survey|Withdrawal by Subject|1|||
163155310|NCT04672239|589283791|FG001|Week 6 Survey|Withdrawal by Subject|1|||
163155311|NCT04672239|589283792|FG002|Week 6 Survey|Withdrawal by Subject|1|||
163155312|NCT04672239|589283790|FG000|Week 6 Survey|Withdrawn by PI|0|||
163155313|NCT04672239|589283791|FG001|Week 6 Survey|Withdrawn by PI|1|||
163155314|NCT04672239|589283792|FG002|Week 6 Survey|Withdrawn by PI|0|||
163155315|NCT04672239|589283790|FG000|Week 6 Survey|Lost to Follow-up|12|||
163155316|NCT04672239|589283791|FG001|Week 6 Survey|Lost to Follow-up|2|||
163155317|NCT04672239|589283792|FG002|Week 6 Survey|Lost to Follow-up|5|||
163155318|NCT04672239|589283790|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
163155319|NCT04672239|589283791|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
163155320|NCT04672239|589283792|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
163155321|NCT04672239|589283790|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
163155322|NCT04672239|589283791|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
163155323|NCT04672239|589283792|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
163155324|NCT04672239|589283790|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
163155325|NCT04672239|589283791|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
163155326|NCT04672239|589283792|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
163155327|NCT04672239|589283790|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
163155328|NCT04672239|589283791|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
163155329|NCT04672239|589283792|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
163155330|NCT04672239|589283790|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
163155331|NCT04672239|589283791|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
163155332|NCT04672239|589283792|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
163155333|NCT04672239|589283790|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
163155334|NCT04672239|589283791|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
163155335|NCT04672239|589283792|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
163155336|NCT04672239|589283790|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
163155337|NCT04672239|589283791|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
163040691|NCT01483599|588856056|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040692|NCT01483599|588856057|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040693|NCT01483599|588856058|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040694|NCT01483599|588856059|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040695|NCT01483599|588856060|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
163040696|NCT01483599|588856061|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
163040697|NCT01483599|588856062|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040698|NCT01483599|588856063|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040699|NCT01483599|588856064|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040700|NCT01483599|588856065|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
163040701|NCT01483599|588856066|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
163040702|NCT01483599|588856053|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040703|NCT01483599|588856054|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040704|NCT01483599|588856055|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040705|NCT01483599|588856056|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040706|NCT01483599|588856057|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040707|NCT01483599|588856058|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040708|NCT01483599|588856059|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040709|NCT01483599|588856060|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040710|NCT01483599|588856061|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
163040711|NCT01483599|588856062|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040712|NCT01483599|588856063|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040713|NCT01483599|588856064|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
163040714|NCT01483599|588856065|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040715|NCT01483599|588856066|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
163040716|NCT01483599|588856053|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040717|NCT01483599|588856054|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040718|NCT01483599|588856055|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163155338|NCT04672239|589283792|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
163155339|NCT03866577|589283795|FG000|Overall Study|Protocol Violation|0|||
163155340|NCT03866577|589283796|FG001|Overall Study|Protocol Violation|0|||
163155341|NCT03866577|589283797|FG002|Overall Study|Protocol Violation|0|||
163155342|NCT03866577|589283798|FG003|Overall Study|Protocol Violation|0|||
163155343|NCT03866577|589283799|FG004|Overall Study|Protocol Violation|0|||
163155344|NCT03866577|589283800|FG005|Overall Study|Protocol Violation|0|||
163155345|NCT03866577|589283801|FG006|Overall Study|Protocol Violation|0|||
163155346|NCT03866577|589283802|FG007|Overall Study|Protocol Violation|0|||
163155347|NCT03866577|589283803|FG008|Overall Study|Protocol Violation|0|||
163155348|NCT03866577|589283804|FG009|Overall Study|Protocol Violation|0|||
163155349|NCT03866577|589283805|FG010|Overall Study|Protocol Violation|0|||
163155350|NCT03866577|589283806|FG011|Overall Study|Protocol Violation|1|||
163155351|NCT03866577|589283807|FG012|Overall Study|Protocol Violation|0|||
163155352|NCT03866577|589283795|FG000|Overall Study|Withdrawal by Subject|0|||
163155353|NCT03866577|589283796|FG001|Overall Study|Withdrawal by Subject|0|||
163155354|NCT03866577|589283797|FG002|Overall Study|Withdrawal by Subject|0|||
163155355|NCT03866577|589283798|FG003|Overall Study|Withdrawal by Subject|0|||
163155356|NCT03866577|589283799|FG004|Overall Study|Withdrawal by Subject|0|||
163155357|NCT03866577|589283800|FG005|Overall Study|Withdrawal by Subject|0|||
163155358|NCT03866577|589283801|FG006|Overall Study|Withdrawal by Subject|0|||
163155359|NCT03866577|589283802|FG007|Overall Study|Withdrawal by Subject|0|||
163155360|NCT03866577|589283803|FG008|Overall Study|Withdrawal by Subject|1|||
163155361|NCT03866577|589283804|FG009|Overall Study|Withdrawal by Subject|1|||
163155362|NCT03866577|589283805|FG010|Overall Study|Withdrawal by Subject|0|||
163155363|NCT03866577|589283806|FG011|Overall Study|Withdrawal by Subject|0|||
163155364|NCT03866577|589283807|FG012|Overall Study|Withdrawal by Subject|0|||
163155365|NCT03866577|589283795|FG000|Overall Study|Not qualified for IVIg infusion|0|||
163155366|NCT03866577|589283796|FG001|Overall Study|Not qualified for IVIg infusion|0|||
163155367|NCT03866577|589283797|FG002|Overall Study|Not qualified for IVIg infusion|0|||
163155368|NCT03866577|589283798|FG003|Overall Study|Not qualified for IVIg infusion|0|||
163155369|NCT03866577|589283799|FG004|Overall Study|Not qualified for IVIg infusion|0|||
163155370|NCT03866577|589283800|FG005|Overall Study|Not qualified for IVIg infusion|0|||
163155371|NCT03866577|589283801|FG006|Overall Study|Not qualified for IVIg infusion|0|||
163155372|NCT03866577|589283802|FG007|Overall Study|Not qualified for IVIg infusion|0|||
163155373|NCT03866577|589283803|FG008|Overall Study|Not qualified for IVIg infusion|0|||
163155374|NCT03866577|589283804|FG009|Overall Study|Not qualified for IVIg infusion|1|||
163155375|NCT03866577|589283805|FG010|Overall Study|Not qualified for IVIg infusion|0|||
163155376|NCT03866577|589283806|FG011|Overall Study|Not qualified for IVIg infusion|0|||
163155377|NCT03866577|589283807|FG012|Overall Study|Not qualified for IVIg infusion|0|||
163155378|NCT04825678|589283808|FG000|Overall Study|Decision by Sponsor|2|||
163155379|NCT04825678|589283809|FG001|Overall Study|Decision by Sponsor|3|||
163155380|NCT04825678|589283808|FG000|Overall Study|Withdrawal of Consent From Study|7|||
163155381|NCT04825678|589283809|FG001|Overall Study|Withdrawal of Consent From Study|9|||
163155382|NCT04825678|589283808|FG000|Overall Study|Lost to Follow-up|3|||
163155383|NCT04825678|589283809|FG001|Overall Study|Lost to Follow-up|4|||
163155384|NCT04825678|589283808|FG000|Overall Study|Never Received Investigational Product|1|||
163155385|NCT04825678|589283809|FG001|Overall Study|Never Received Investigational Product|1|||
163155386|NCT01342211|589283810|FG000|Overall Study|Lost to Follow-up|0|||
163155387|NCT01342211|589283811|FG001|Overall Study|Lost to Follow-up|0|||
163155388|NCT01342211|589283812|FG002|Overall Study|Lost to Follow-up|0|||
163155389|NCT01342211|589283813|FG003|Overall Study|Lost to Follow-up|1|||
163155390|NCT01342211|589283814|FG004|Overall Study|Lost to Follow-up|0|||
163155391|NCT01342211|589283810|FG000|Overall Study|Adverse Event|0|||
163155392|NCT01342211|589283811|FG001|Overall Study|Adverse Event|0|||
163155393|NCT01342211|589283812|FG002|Overall Study|Adverse Event|0|||
163155394|NCT01342211|589283813|FG003|Overall Study|Adverse Event|0|||
163155395|NCT01342211|589283814|FG004|Overall Study|Adverse Event|1|||
163155396|NCT01342211|589283810|FG000|Overall Study|Withdrawal by Subject|0|||
163155397|NCT01342211|589283811|FG001|Overall Study|Withdrawal by Subject|0|||
163155398|NCT01342211|589283812|FG002|Overall Study|Withdrawal by Subject|0|||
163155399|NCT01342211|589283813|FG003|Overall Study|Withdrawal by Subject|1|||
163155400|NCT01342211|589283814|FG004|Overall Study|Withdrawal by Subject|0|||
163155401|NCT01342211|589283810|FG000|Overall Study|Randomized, but not Treated|0|||
163155402|NCT01342211|589283811|FG001|Overall Study|Randomized, but not Treated|2|||
163155403|NCT01342211|589283812|FG002|Overall Study|Randomized, but not Treated|0|||
163155404|NCT01342211|589283813|FG003|Overall Study|Randomized, but not Treated|0|||
163155405|NCT01342211|589283814|FG004|Overall Study|Randomized, but not Treated|1|||
163155406|NCT05430854|589283815|FG000|Overall Study|Trial terminated by Sponsor|39|||
163155407|NCT05430854|589283816|FG001|Overall Study|Trial terminated by Sponsor|50|||
163155408|NCT05430854|589283817|FG002|Overall Study|Trial terminated by Sponsor|46|||
163155409|NCT05430854|589283815|FG000|Overall Study|Withdrawal by Subject|0|||
163155410|NCT05430854|589283816|FG001|Overall Study|Withdrawal by Subject|3|||
163155411|NCT05430854|589283817|FG002|Overall Study|Withdrawal by Subject|0|||
163155412|NCT01824836|589283820|FG000|Overall Study|Adverse Event|48|||
163155413|NCT01824836|589283820|FG000|Overall Study|Withdrawal by Subject|63|||
163155414|NCT01824836|589283820|FG000|Overall Study|Other complicating disease|116|||
163269853|NCT01327547|589699918|FG000|Overall Study|Lost to Follow-up|6|||
163269854|NCT01327547|589699919|FG001|Overall Study|Lost to Follow-up|6|||
163269855|NCT01327547|589699918|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
163269856|NCT01327547|589699919|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
163269857|NCT01327547|589699918|FG000|Overall Study|Withdrawal by Subject|3|||
163269858|NCT01327547|589699919|FG001|Overall Study|Withdrawal by Subject|7|||
163269859|NCT01327547|589699918|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
163269860|NCT01327547|589699919|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
163269861|NCT01327547|589699918|FG000|Overall Study|Protocol Violation|1|||
163269862|NCT01327547|589699919|FG001|Overall Study|Protocol Violation|0|||
163269863|NCT01327547|589699918|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
162925880|NCT03193190|588430429|FG003|Stage 1|Study Terminated By Sponsor|0|||
162925881|NCT03193190|588430430|FG004|Stage 1|Study Terminated By Sponsor|6|||
162925882|NCT03193190|588430431|FG005|Stage 1|Study Terminated By Sponsor|0|||
162925883|NCT03193190|588430432|FG006|Stage 1|Study Terminated By Sponsor|0|||
162925884|NCT03193190|588430433|FG007|Stage 1|Study Terminated By Sponsor|0|||
162925885|NCT03193190|588430434|FG008|Stage 1|Study Terminated By Sponsor|0|||
162925886|NCT03193190|588430435|FG009|Stage 1|Study Terminated By Sponsor|0|||
163269864|NCT01327547|589699919|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
162925887|NCT03193190|588430436|FG010|Stage 1|Study Terminated By Sponsor|0|||
162925888|NCT03193190|588430437|FG011|Stage 1|Study Terminated By Sponsor|0|||
163155415|NCT01824836|589283820|FG000|Overall Study|Disease progression|5|||
163155416|NCT01824836|589283820|FG000|Overall Study|Alternative therapy|2|||
163155417|NCT01824836|589283820|FG000|Overall Study|Depression|1|||
163155418|NCT01824836|589283820|FG000|Overall Study|Non-compliance|3|||
163155419|NCT01824836|589283820|FG000|Overall Study|Patient regained ovarian function|3|||
163155420|NCT01824836|589283820|FG000|Overall Study|Lost to Follow-up|8|||
163155421|NCT01824836|589283820|FG000|Overall Study|Physician Decision|2|||
163155422|NCT01824836|589283820|FG000|Overall Study|Research office was closed|3|||
163155423|NCT01824836|589283820|FG000|Overall Study|Relocation|3|||
163155424|NCT01824836|589283820|FG000|Overall Study|Insurance-related issue|1|||
163155425|NCT01824836|589283820|FG000|Overall Study|Transportation issue|1|||
163155426|NCT01824836|589283820|FG000|Overall Study|Patient transferred care|1|||
163155427|NCT01824836|589283820|FG000|Overall Study|Unknown reasons|4|||
163155428|NCT01824836|589283820|FG000|Overall Study|Never started treatment|16|||
163155429|NCT03253393|589283821|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
163155430|NCT03253393|589283822|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
163155431|NCT03253393|589283823|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
163210477|NCT00708643|589485253|FG000|Overall Study|Adverse Event|0|||
163210478|NCT00708643|589485254|FG001|Overall Study|Adverse Event|1|||
163210479|NCT01594125|589485255|FG000|Overall Study|Withdrawal by Subject|1|||
163210480|NCT01594125|589485256|FG001|Overall Study|Withdrawal by Subject|0|||
163210481|NCT01594125|589485257|FG002|Overall Study|Withdrawal by Subject|0|||
163210482|NCT01594125|589485258|FG003|Overall Study|Withdrawal by Subject|1|||
163210483|NCT01594125|589485259|FG004|Overall Study|Withdrawal by Subject|0|||
163210484|NCT01594125|589485255|FG000|Overall Study|Progressive Disease|3|||
163210485|NCT01594125|589485256|FG001|Overall Study|Progressive Disease|12|||
163210486|NCT01594125|589485257|FG002|Overall Study|Progressive Disease|3|||
163210487|NCT01594125|589485258|FG003|Overall Study|Progressive Disease|3|||
163210488|NCT01594125|589485259|FG004|Overall Study|Progressive Disease|7|||
163210489|NCT03635957|589485262|FG000|Run-In Period|Lost to Follow-up|1|||
163210490|NCT03635957|589485262|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
163210491|NCT01710033|589485263|FG000|Stage 2|Adverse Event|0|||
163210492|NCT01710033|589485264|FG001|Stage 2|Adverse Event|0|||
163210493|NCT01710033|589485265|FG002|Stage 2|Adverse Event|0|||
163210494|NCT01710033|589485266|FG003|Stage 2|Adverse Event|0|||
163210495|NCT01710033|589485267|FG004|Stage 2|Adverse Event|1|||
163210496|NCT01525550|589485269|FG000|Overall Study|Lost to Follow-up|8|||
163210497|NCT01525550|589485270|FG001|Overall Study|Lost to Follow-up|2|||
163210498|NCT01525550|589485269|FG000|Overall Study|Death|19|||
163210499|NCT01525550|589485270|FG001|Overall Study|Death|28|||
162925889|NCT03193190|588430438|FG012|Stage 1|Study Terminated By Sponsor|0|||
163210500|NCT01525550|589485269|FG000|Overall Study|Other|0|||
163210501|NCT01525550|589485270|FG001|Overall Study|Other|4|||
163210502|NCT01525550|589485269|FG000|Overall Study|Sponsor's Decision|30|||
163210503|NCT01525550|589485270|FG001|Overall Study|Sponsor's Decision|11|||
163210504|NCT01525550|589485269|FG000|Overall Study|Withdrawal by Subject|4|||
163210505|NCT01525550|589485270|FG001|Overall Study|Withdrawal by Subject|0|||
163210506|NCT00460031|589485273|FG000|Overall Study|Adverse Event|5|||
163210507|NCT00460031|589485273|FG000|Overall Study|Withdrawal by Subject|5|||
163210508|NCT00460031|589485273|FG000|Overall Study|Death|1|||
163210509|NCT03045887|589485282|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
163210510|NCT03045887|589485283|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
163210511|NCT03045887|589485284|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
163210512|NCT03045887|589485285|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
163210513|NCT03045887|589485286|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
163210514|NCT03045887|589485287|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
163210515|NCT03045887|589485288|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
163210516|NCT03045887|589485289|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
163210517|NCT03045887|589485290|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
163210518|NCT03045887|589485291|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
163210519|NCT03045887|589485282|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
163210520|NCT03045887|589485283|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
163210521|NCT03045887|589485284|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
163210522|NCT03045887|589485285|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
163210523|NCT03045887|589485286|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
163210524|NCT03045887|589485287|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
163210525|NCT03045887|589485288|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
163210526|NCT03045887|589485289|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
163210527|NCT03045887|589485290|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
163269865|NCT01327547|589699918|FG000|Overall Study|Required prohibited medication|2|||
162925890|NCT03193190|588430439|FG013|Stage 1|Study Terminated By Sponsor|0|||
162925891|NCT03193190|588430440|FG014|Stage 1|Study Terminated By Sponsor|0|||
162925892|NCT03193190|588430441|FG015|Stage 1|Study Terminated By Sponsor|0|||
162925893|NCT03193190|588430426|FG000|Stage 1|Withdrawal by Subject|6|||
163210528|NCT03045887|589485291|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
163210529|NCT03045887|589485282|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
163210530|NCT03045887|589485283|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
163210531|NCT03045887|589485284|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
163210532|NCT03045887|589485285|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
163155432|NCT00554216|589285688|FG000|Overall Study|Lost to Follow-up|92|||
163155433|NCT00554216|589285689|FG001|Overall Study|Lost to Follow-up|31|||
163155434|NCT00554216|589285690|FG002|Overall Study|Lost to Follow-up|63|||
163155435|NCT00554216|589285688|FG000|Overall Study|Adverse Event|16|||
163155436|NCT00554216|589285689|FG001|Overall Study|Adverse Event|16|||
163155437|NCT00554216|589285690|FG002|Overall Study|Adverse Event|36|||
163155438|NCT00554216|589285688|FG000|Overall Study|Withdrawal by Subject|92|||
163155439|NCT00554216|589285689|FG001|Overall Study|Withdrawal by Subject|31|||
163155440|NCT00554216|589285690|FG002|Overall Study|Withdrawal by Subject|43|||
163155441|NCT00554216|589285688|FG000|Overall Study|Non compliance|10|||
163155442|NCT00554216|589285689|FG001|Overall Study|Non compliance|4|||
163155443|NCT00554216|589285690|FG002|Overall Study|Non compliance|5|||
163155444|NCT00554216|589285688|FG000|Overall Study|Pregnancy|2|||
163155445|NCT00554216|589285689|FG001|Overall Study|Pregnancy|1|||
163155446|NCT00554216|589285690|FG002|Overall Study|Pregnancy|14|||
163155447|NCT00554216|589285688|FG000|Overall Study|Restricted med|3|||
163155448|NCT00554216|589285689|FG001|Overall Study|Restricted med|1|||
163155449|NCT00554216|589285690|FG002|Overall Study|Restricted med|1|||
163155450|NCT00554216|589285688|FG000|Overall Study|Other|12|||
163155451|NCT00554216|589285689|FG001|Overall Study|Other|7|||
163155452|NCT00554216|589285690|FG002|Overall Study|Other|10|||
163155453|NCT00554216|589285688|FG000|Overall Study|Lack of Efficacy|15|||
163155454|NCT00554216|589285689|FG001|Overall Study|Lack of Efficacy|3|||
163155455|NCT00554216|589285690|FG002|Overall Study|Lack of Efficacy|0|||
163155456|NCT05291520|589285691|FG000|Overall Study|Lost to Follow-up|0|||
163155457|NCT05291520|589285692|FG001|Overall Study|Lost to Follow-up|0|||
163155458|NCT05291520|589285693|FG002|Overall Study|Lost to Follow-up|1|||
163155459|NCT01347112|589285694|FG000|Overall Study|Withdrawal by Subject|1|||
163155460|NCT01347112|589285695|FG001|Overall Study|Withdrawal by Subject|7|||
163155461|NCT01347112|589285694|FG000|Overall Study|Lost to Follow-up|3|||
163155462|NCT01347112|589285695|FG001|Overall Study|Lost to Follow-up|5|||
163155463|NCT05462756|589285698|FG000|Treatment Period|Adverse Event|3|||
163155464|NCT05462756|589285699|FG001|Treatment Period|Adverse Event|0|||
163155465|NCT05462756|589285698|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
163155466|NCT05462756|589285699|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
163155467|NCT05462756|589285698|FG000|Treatment Period|Death|0|||
163155468|NCT05462756|589285699|FG001|Treatment Period|Death|1|||
163155469|NCT05462756|589285698|FG000|Treatment Period|Lost to Follow-up|2|||
163155470|NCT05462756|589285699|FG001|Treatment Period|Lost to Follow-up|1|||
163155471|NCT05462756|589285698|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
163155472|NCT05462756|589285699|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
163155473|NCT05462756|589285698|FG000|Treatment Period|Physician Decision|2|||
163155474|NCT05462756|589285699|FG001|Treatment Period|Physician Decision|0|||
163155475|NCT05462756|589285698|FG000|Treatment Period|Protocol Violation|0|||
163155476|NCT05462756|589285699|FG001|Treatment Period|Protocol Violation|1|||
163155477|NCT05462756|589285698|FG000|Treatment Period|Withdrawal by Subject|5|||
163155478|NCT05462756|589285699|FG001|Treatment Period|Withdrawal by Subject|12|||
163155479|NCT05462756|589285698|FG000|Follow-Up Period|Adverse Event|1|||
163155480|NCT05462756|589285699|FG001|Follow-Up Period|Adverse Event|0|||
163155481|NCT05462756|589285698|FG000|Follow-Up Period|Death|1|||
163155482|NCT05462756|589285699|FG001|Follow-Up Period|Death|0|||
163155483|NCT05462756|589285698|FG000|Follow-Up Period|Lost to Follow-up|3|||
163155484|NCT05462756|589285699|FG001|Follow-Up Period|Lost to Follow-up|1|||
163155485|NCT05462756|589285698|FG000|Follow-Up Period|Withdrawal by Subject|0|||
163155486|NCT05462756|589285699|FG001|Follow-Up Period|Withdrawal by Subject|4|||
163155487|NCT02144610|589285702|FG000|Overall Study|Physician Decision|1|||
163155488|NCT02144610|589285703|FG001|Overall Study|Physician Decision|0|||
163155489|NCT02144610|589285702|FG000|Overall Study|Withdrawal by Subject|1|||
163155490|NCT02144610|589285703|FG001|Overall Study|Withdrawal by Subject|5|||
163155491|NCT02144610|589285702|FG000|Overall Study|Death|2|||
163155492|NCT02144610|589285703|FG001|Overall Study|Death|2|||
163155493|NCT02144610|589285702|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
163155494|NCT02144610|589285703|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
163155495|NCT02144610|589285702|FG000|Overall Study|Other|0|||
163155496|NCT02144610|589285703|FG001|Overall Study|Other|1|||
163155497|NCT01354899|589285708|FG000|Overall Study|discharge from the hospital|2|||
163155498|NCT01354899|589285708|FG000|Overall Study|Protocol Violation|1|||
163155499|NCT01432730|589285711|FG000|Period 1|Adverse Event|2|||
163155500|NCT01432730|589285712|FG001|Period 1|Adverse Event|0|||
163155501|NCT01432730|589285711|FG000|Period 2|Adverse Event|0|||
163155502|NCT01432730|589285712|FG001|Period 2|Adverse Event|4|||
163155503|NCT00641667|589285715|FG000|Overall Study|Withdrawal by Subject|1|||
163155504|NCT00641667|589285715|FG000|Overall Study|Adverse Event|1|||
163385755|NCT00146328|590123239|FG000|Overall Study|Adverse Event|39|||
163155505|NCT00641667|589285715|FG000|Overall Study|Physician Decision|1|||
163155506|NCT00641667|589285715|FG000|Overall Study|Worsening of underlying disease|3|||
163155507|NCT01235741|589285716|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
163155508|NCT01235741|589285717|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
163155509|NCT01235741|589285718|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
163155510|NCT01235741|589285716|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
163155511|NCT01235741|589285717|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
163155512|NCT01235741|589285718|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
163155513|NCT01235741|589285716|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
163155514|NCT01235741|589285717|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
163155515|NCT01235741|589285718|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
163155516|NCT01235741|589285716|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
163155517|NCT01235741|589285717|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
163155518|NCT01235741|589285718|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
163155519|NCT01235741|589285716|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
163155520|NCT01235741|589285717|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
163155521|NCT01235741|589285718|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
163155522|NCT01235741|589285716|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
163155523|NCT01235741|589285717|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
163155524|NCT01235741|589285718|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
163155525|NCT01235741|589285716|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
163155526|NCT01235741|589285717|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
163155527|NCT01235741|589285718|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
163155528|NCT01235741|589285716|FG000|Randomized to Treatment|Adverse Event|0|||
163155529|NCT01235741|589285717|FG001|Randomized to Treatment|Adverse Event|1|||
163155530|NCT01235741|589285718|FG002|Randomized to Treatment|Adverse Event|1|||
163155531|NCT01235741|589285716|FG000|Randomized to Treatment|Sponsor terminated study|0|||
163155532|NCT01235741|589285717|FG001|Randomized to Treatment|Sponsor terminated study|35|||
163155533|NCT01235741|589285718|FG002|Randomized to Treatment|Sponsor terminated study|34|||
163155534|NCT01235741|589285716|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
163155535|NCT01235741|589285717|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
163155536|NCT01235741|589285718|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
163155537|NCT01235741|589285716|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
163155538|NCT01235741|589285717|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
163155539|NCT01235741|589285718|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
163155540|NCT01235741|589285716|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
163155541|NCT01235741|589285717|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
163155542|NCT01235741|589285718|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
163155543|NCT01421719|589285719|FG000|Overall Study|Withdrawal by Subject|4|||
163155544|NCT01124006|589285720|FG000|Overall Study|Withdrawal by Subject|2|||
163155545|NCT01124006|589285721|FG001|Overall Study|Withdrawal by Subject|2|||
163155546|NCT01124006|589285722|FG002|Overall Study|Withdrawal by Subject|0|||
163155547|NCT01124006|589285720|FG000|Overall Study|Lost to Follow-up|1|||
163155548|NCT01124006|589285721|FG001|Overall Study|Lost to Follow-up|0|||
163155549|NCT01124006|589285722|FG002|Overall Study|Lost to Follow-up|1|||
163155550|NCT01124006|589285720|FG000|Overall Study|Other|0|||
163155551|NCT01124006|589285721|FG001|Overall Study|Other|0|||
163155552|NCT01124006|589285722|FG002|Overall Study|Other|1|||
163155553|NCT03847896|589285736|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
163155554|NCT03847896|589285737|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
163155555|NCT03847896|589285738|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
163155556|NCT03847896|589285739|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
163155557|NCT03847896|589285740|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
163155558|NCT03847896|589285736|FG000|Overall Study|Withdrawal by Subject|2|||
163155559|NCT03847896|589285737|FG001|Overall Study|Withdrawal by Subject|10|||
163155560|NCT03847896|589285738|FG002|Overall Study|Withdrawal by Subject|5|||
163155561|NCT03847896|589285739|FG003|Overall Study|Withdrawal by Subject|9|||
163155562|NCT03847896|589285740|FG004|Overall Study|Withdrawal by Subject|8|||
163155563|NCT03847896|589285736|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163155564|NCT03847896|589285737|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163155565|NCT03847896|589285738|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163155566|NCT03847896|589285739|FG003|Overall Study|Withdrawal by parent/guardian|0|||
163155567|NCT03847896|589285740|FG004|Overall Study|Withdrawal by parent/guardian|0|||
163155568|NCT03847896|589285736|FG000|Overall Study|Adverse Event|2|||
163155569|NCT03847896|589285737|FG001|Overall Study|Adverse Event|1|||
163155570|NCT03847896|589285738|FG002|Overall Study|Adverse Event|3|||
163155571|NCT03847896|589285739|FG003|Overall Study|Adverse Event|2|||
162925894|NCT03193190|588430427|FG001|Stage 1|Withdrawal by Subject|0|||
163155572|NCT03847896|589285740|FG004|Overall Study|Adverse Event|4|||
163155573|NCT03847896|589285736|FG000|Overall Study|A severe exacerbation event|0|||
163155574|NCT03847896|589285737|FG001|Overall Study|A severe exacerbation event|0|||
163155575|NCT03847896|589285738|FG002|Overall Study|A severe exacerbation event|0|||
162925895|NCT03193190|588430428|FG002|Stage 1|Withdrawal by Subject|1|||
162925896|NCT03193190|588430429|FG003|Stage 1|Withdrawal by Subject|0|||
163155576|NCT03847896|589285739|FG003|Overall Study|A severe exacerbation event|0|||
163155577|NCT03847896|589285740|FG004|Overall Study|A severe exacerbation event|3|||
163155578|NCT03847896|589285736|FG000|Overall Study|Protocol Violation|0|||
163155579|NCT03847896|589285737|FG001|Overall Study|Protocol Violation|2|||
163155580|NCT03847896|589285738|FG002|Overall Study|Protocol Violation|1|||
163155581|NCT03847896|589285739|FG003|Overall Study|Protocol Violation|0|||
163155582|NCT03847896|589285740|FG004|Overall Study|Protocol Violation|2|||
162925897|NCT03193190|588430430|FG004|Stage 1|Withdrawal by Subject|2|||
162925898|NCT03193190|588430431|FG005|Stage 1|Withdrawal by Subject|0|||
163155583|NCT03847896|589285736|FG000|Overall Study|Lost to Follow-up|0|||
163155584|NCT03847896|589285737|FG001|Overall Study|Lost to Follow-up|0|||
163155585|NCT03847896|589285738|FG002|Overall Study|Lost to Follow-up|0|||
163155586|NCT03847896|589285739|FG003|Overall Study|Lost to Follow-up|1|||
163155587|NCT03847896|589285740|FG004|Overall Study|Lost to Follow-up|0|||
163155588|NCT03847896|589285736|FG000|Overall Study|Condition under investigation worsened|0|||
163155589|NCT03847896|589285737|FG001|Overall Study|Condition under investigation worsened|0|||
163155590|NCT03847896|589285738|FG002|Overall Study|Condition under investigation worsened|0|||
163155591|NCT03847896|589285739|FG003|Overall Study|Condition under investigation worsened|1|||
163155592|NCT03847896|589285740|FG004|Overall Study|Condition under investigation worsened|1|||
163155593|NCT03847896|589285736|FG000|Overall Study|Lack of Efficacy|0|||
163155594|NCT03847896|589285737|FG001|Overall Study|Lack of Efficacy|0|||
163155595|NCT03847896|589285738|FG002|Overall Study|Lack of Efficacy|0|||
163155596|NCT03847896|589285739|FG003|Overall Study|Lack of Efficacy|2|||
163155597|NCT03847896|589285740|FG004|Overall Study|Lack of Efficacy|2|||
163155598|NCT03847896|589285736|FG000|Overall Study|Other reasons|3|||
163155599|NCT03847896|589285737|FG001|Overall Study|Other reasons|3|||
163155600|NCT03847896|589285738|FG002|Overall Study|Other reasons|1|||
163155601|NCT03847896|589285739|FG003|Overall Study|Other reasons|2|||
163155602|NCT03847896|589285740|FG004|Overall Study|Other reasons|1|||
163155603|NCT02395471|589285741|FG000|Overall Study|Lost to Follow-up|2|||
163155604|NCT02395471|589285742|FG001|Overall Study|Lost to Follow-up|0|||
163155605|NCT02395471|589285741|FG000|Overall Study|Withdrawal by Subject|2|||
163155606|NCT02395471|589285742|FG001|Overall Study|Withdrawal by Subject|1|||
163155607|NCT02395471|589285741|FG000|Overall Study|Physician Decision|1|||
163155608|NCT02395471|589285742|FG001|Overall Study|Physician Decision|0|||
163155609|NCT02395471|589285741|FG000|Overall Study|Protocol Violation|0|||
163155610|NCT02395471|589285742|FG001|Overall Study|Protocol Violation|1|||
163155611|NCT02395471|589285741|FG000|Overall Study|Failure to swollow sponge twice|1|||
163155612|NCT02395471|589285742|FG001|Overall Study|Failure to swollow sponge twice|0|||
163155613|NCT02395471|589285741|FG000|Overall Study|Patient did not return for procedure|0|||
163155614|NCT02395471|589285742|FG001|Overall Study|Patient did not return for procedure|1|||
163155615|NCT02395471|589285741|FG000|Overall Study|Subject not eligible|1|||
163155616|NCT02395471|589285742|FG001|Overall Study|Subject not eligible|0|||
163155617|NCT02035267|589285743|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
163155618|NCT02035267|589285744|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
163155619|NCT02035267|589285745|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
163155620|NCT02035267|589285746|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
163155621|NCT02035267|589285743|FG000|Overall Study|Adverse Event|0|||
163155622|NCT02035267|589285744|FG001|Overall Study|Adverse Event|0|||
163155623|NCT02035267|589285745|FG002|Overall Study|Adverse Event|1|||
163155624|NCT02035267|589285746|FG003|Overall Study|Adverse Event|0|||
163155625|NCT02035267|589285743|FG000|Overall Study|Lost to Follow-up|0|||
163155626|NCT02035267|589285744|FG001|Overall Study|Lost to Follow-up|0|||
163155627|NCT02035267|589285745|FG002|Overall Study|Lost to Follow-up|0|||
163155628|NCT02035267|589285746|FG003|Overall Study|Lost to Follow-up|1|||
163155629|NCT02035267|589285743|FG000|Overall Study|Other unspecified|0|||
163155630|NCT02035267|589285744|FG001|Overall Study|Other unspecified|1|||
163155631|NCT02035267|589285745|FG002|Overall Study|Other unspecified|0|||
163155632|NCT02035267|589285746|FG003|Overall Study|Other unspecified|0|||
163155633|NCT03038880|589285752|FG000|Overall Study|Death|1|||
163155634|NCT03038880|589285753|FG001|Overall Study|Death|2|||
163155635|NCT03038880|589285754|FG002|Overall Study|Death|0|||
163155636|NCT03038880|589285752|FG000|Overall Study|Physician Decision|2|||
162925899|NCT03193190|588430432|FG006|Stage 1|Withdrawal by Subject|3|||
162925900|NCT03193190|588430433|FG007|Stage 1|Withdrawal by Subject|2|||
163155637|NCT03038880|589285753|FG001|Overall Study|Physician Decision|1|||
163155638|NCT03038880|589285754|FG002|Overall Study|Physician Decision|0|||
163155639|NCT03926611|589285759|FG000|Overall Study|Adverse Event|0|||
163155640|NCT03926611|589285760|FG001|Overall Study|Adverse Event|0|||
163155641|NCT03926611|589285761|FG002|Overall Study|Adverse Event|0|||
163155642|NCT03926611|589285762|FG003|Overall Study|Adverse Event|3|||
163155643|NCT03926611|589285763|FG004|Overall Study|Adverse Event|1|||
163155644|NCT03926611|589285764|FG005|Overall Study|Adverse Event|3|||
163155645|NCT03926611|589285765|FG006|Overall Study|Adverse Event|0|||
163155646|NCT03926611|589285759|FG000|Overall Study|Lack of Efficacy|1|||
163155647|NCT03926611|589285760|FG001|Overall Study|Lack of Efficacy|2|||
163155648|NCT03926611|589285761|FG002|Overall Study|Lack of Efficacy|0|||
163155649|NCT03926611|589285762|FG003|Overall Study|Lack of Efficacy|0|||
163155650|NCT03926611|589285763|FG004|Overall Study|Lack of Efficacy|1|||
163155651|NCT03926611|589285764|FG005|Overall Study|Lack of Efficacy|0|||
163155652|NCT03926611|589285765|FG006|Overall Study|Lack of Efficacy|1|||
163155653|NCT03926611|589285759|FG000|Overall Study|Physician Decision|0|||
163155654|NCT03926611|589285760|FG001|Overall Study|Physician Decision|0|||
163155655|NCT03926611|589285761|FG002|Overall Study|Physician Decision|0|||
163155656|NCT03926611|589285762|FG003|Overall Study|Physician Decision|0|||
163155657|NCT03926611|589285763|FG004|Overall Study|Physician Decision|0|||
163155658|NCT03926611|589285764|FG005|Overall Study|Physician Decision|1|||
163155659|NCT03926611|589285765|FG006|Overall Study|Physician Decision|0|||
163155660|NCT03926611|589285759|FG000|Overall Study|Protocol Violation|1|||
163155661|NCT03926611|589285760|FG001|Overall Study|Protocol Violation|0|||
163155662|NCT03926611|589285761|FG002|Overall Study|Protocol Violation|0|||
163155663|NCT03926611|589285762|FG003|Overall Study|Protocol Violation|1|||
163155664|NCT03926611|589285763|FG004|Overall Study|Protocol Violation|1|||
163155665|NCT03926611|589285764|FG005|Overall Study|Protocol Violation|1|||
163155666|NCT03926611|589285765|FG006|Overall Study|Protocol Violation|1|||
163155667|NCT03926611|589285759|FG000|Overall Study|Technical problems|0|||
163155668|NCT03926611|589285760|FG001|Overall Study|Technical problems|0|||
163155669|NCT03926611|589285761|FG002|Overall Study|Technical problems|0|||
163155670|NCT03926611|589285762|FG003|Overall Study|Technical problems|0|||
163155671|NCT03926611|589285763|FG004|Overall Study|Technical problems|0|||
163155672|NCT03926611|589285764|FG005|Overall Study|Technical problems|1|||
163155673|NCT03926611|589285765|FG006|Overall Study|Technical problems|0|||
163155674|NCT03926611|589285759|FG000|Overall Study|Withdrawal by Subject|1|||
163155675|NCT03926611|589285760|FG001|Overall Study|Withdrawal by Subject|1|||
163155676|NCT03926611|589285761|FG002|Overall Study|Withdrawal by Subject|1|||
163155677|NCT03926611|589285762|FG003|Overall Study|Withdrawal by Subject|0|||
163155678|NCT03926611|589285763|FG004|Overall Study|Withdrawal by Subject|0|||
163155679|NCT03926611|589285764|FG005|Overall Study|Withdrawal by Subject|1|||
163155680|NCT03926611|589285765|FG006|Overall Study|Withdrawal by Subject|3|||
163155681|NCT03926611|589285759|FG000|Overall Study|Covid-19 pandemic|0|||
163155682|NCT03926611|589285760|FG001|Overall Study|Covid-19 pandemic|0|||
163155683|NCT03926611|589285761|FG002|Overall Study|Covid-19 pandemic|1|||
163155684|NCT03926611|589285762|FG003|Overall Study|Covid-19 pandemic|0|||
163155685|NCT03926611|589285763|FG004|Overall Study|Covid-19 pandemic|1|||
163155686|NCT03926611|589285764|FG005|Overall Study|Covid-19 pandemic|2|||
163155687|NCT03926611|589285765|FG006|Overall Study|Covid-19 pandemic|0|||
163155688|NCT00836693|589285766|FG000|Overall Study|Adverse Event|4|||
163155689|NCT00836693|589285767|FG001|Overall Study|Adverse Event|1|||
163155690|NCT00836693|589285766|FG000|Overall Study|Sponsor Decision|0|||
163155691|NCT00836693|589285767|FG001|Overall Study|Sponsor Decision|1|||
163155692|NCT00836693|589285766|FG000|Overall Study|Physician Decision|2|||
163155693|NCT00836693|589285767|FG001|Overall Study|Physician Decision|0|||
163155694|NCT00836693|589285766|FG000|Overall Study|Withdrawal by Subject|9|||
163155695|NCT00836693|589285767|FG001|Overall Study|Withdrawal by Subject|4|||
163155696|NCT00836693|589285766|FG000|Overall Study|Protocol Violation|1|||
163155697|NCT00836693|589285767|FG001|Overall Study|Protocol Violation|0|||
163155698|NCT00836693|589285766|FG000|Overall Study|Lost to Follow-up|1|||
163155699|NCT00836693|589285767|FG001|Overall Study|Lost to Follow-up|0|||
163155700|NCT02612779|589285768|FG000|Overall Study|Administrative reason by sponsor|4|||
163155701|NCT02612779|589285769|FG001|Overall Study|Administrative reason by sponsor|1|||
163155702|NCT02612779|589285768|FG000|Overall Study|No longer meet study criteria|0|||
163155703|NCT02612779|589285769|FG001|Overall Study|No longer meet study criteria|1|||
163155704|NCT02612779|589285768|FG000|Overall Study|Disease progression|29|||
163155705|NCT02612779|589285769|FG001|Overall Study|Disease progression|2|||
163155706|NCT02612779|589285768|FG000|Overall Study|Study drug toxicity|10|||
163155707|NCT02612779|589285769|FG001|Overall Study|Study drug toxicity|1|||
163155708|NCT02612779|589285768|FG000|Overall Study|Death|1|||
163155709|NCT02612779|589285769|FG001|Overall Study|Death|0|||
163155710|NCT02612779|589285768|FG000|Overall Study|Adverse event unrelated to study drug|5|||
163155711|NCT02612779|589285769|FG001|Overall Study|Adverse event unrelated to study drug|0|||
163155712|NCT02612779|589285768|FG000|Overall Study|Participant withdrew consent|4|||
163155713|NCT02612779|589285769|FG001|Overall Study|Participant withdrew consent|0|||
163155714|NCT02612779|589285768|FG000|Overall Study|Lost to Follow-up|1|||
163155715|NCT02612779|589285769|FG001|Overall Study|Lost to Follow-up|0|||
163155716|NCT02612779|589285768|FG000|Overall Study|Maximum clinical benefit|10|||
163155717|NCT02612779|589285769|FG001|Overall Study|Maximum clinical benefit|1|||
163155718|NCT02612779|589285768|FG000|Overall Study|Other reasons|4|||
163155719|NCT02612779|589285769|FG001|Overall Study|Other reasons|0|||
163155720|NCT01657019|589285772|FG000|Overall Study|Withdrawal by Subject|65|||
163155721|NCT01657019|589285772|FG000|Overall Study|Adverse Event|55|||
163155722|NCT01657019|589285772|FG000|Overall Study|Lost to Follow-up|48|||
163155723|NCT01657019|589285772|FG000|Overall Study|Protocol Violation|6|||
163155724|NCT01657019|589285772|FG000|Overall Study|Lack of Efficacy|3|||
163155725|NCT01657019|589285772|FG000|Overall Study|Other|58|||
163155726|NCT00129402|589285789|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
163155727|NCT00129402|589285790|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
163385756|NCT00146328|590123240|FG001|Overall Study|Adverse Event|48|||
163155728|NCT00129402|589285791|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
163155729|NCT00129402|589285792|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
163155730|NCT00129402|589285793|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
163155731|NCT00129402|589285794|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
163155732|NCT00129402|589285795|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
163155733|NCT00129402|589285789|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
163155734|NCT00129402|589285790|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
163155735|NCT00129402|589285791|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
163155736|NCT00129402|589285792|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
163155737|NCT00129402|589285793|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
163155738|NCT00129402|589285794|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
163155739|NCT00129402|589285795|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
163155740|NCT00129402|589285789|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
163155741|NCT00129402|589285790|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
163155742|NCT00129402|589285791|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
163155743|NCT00129402|589285792|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
163155744|NCT00129402|589285793|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
163155745|NCT00129402|589285794|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
163155746|NCT00129402|589285795|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
163155747|NCT00129402|589285789|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
163155748|NCT00129402|589285790|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
163155749|NCT00129402|589285791|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
163155750|NCT00129402|589285792|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
163155751|NCT00129402|589285793|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
163155752|NCT00129402|589285794|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
163155753|NCT00129402|589285795|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
163155754|NCT00129402|589285789|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
163155755|NCT00129402|589285790|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
163155756|NCT00129402|589285791|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
163040719|NCT01483599|588856056|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040720|NCT01483599|588856057|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040721|NCT01483599|588856058|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040722|NCT01483599|588856059|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040723|NCT01483599|588856060|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040724|NCT01483599|588856061|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
163040725|NCT01483599|588856062|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040726|NCT01483599|588856063|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
163040727|NCT01483599|588856064|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040728|NCT01483599|588856065|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040729|NCT01483599|588856066|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
163040730|NCT01483599|588856053|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040731|NCT01483599|588856054|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040732|NCT01483599|588856055|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040733|NCT01483599|588856056|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040734|NCT01483599|588856057|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040735|NCT01483599|588856058|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040736|NCT01483599|588856059|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040737|NCT01483599|588856060|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040738|NCT01483599|588856061|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
163040739|NCT01483599|588856062|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040740|NCT01483599|588856063|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040741|NCT01483599|588856064|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040742|NCT01483599|588856065|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
163040743|NCT01483599|588856066|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
163040744|NCT01483599|588856053|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
163040745|NCT01483599|588856054|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
163040746|NCT01483599|588856055|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
163040747|NCT01483599|588856056|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
163040748|NCT01483599|588856057|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
163040749|NCT01483599|588856058|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
163040750|NCT01483599|588856059|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
163040751|NCT01483599|588856060|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
163040752|NCT01483599|588856061|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
163040753|NCT01483599|588856062|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
163155757|NCT00129402|589285792|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
163155758|NCT00129402|589285793|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
163155759|NCT00129402|589285794|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
163155760|NCT00129402|589285795|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
163155761|NCT00129402|589285789|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
163155762|NCT00129402|589285790|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
163155763|NCT00129402|589285791|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
163155764|NCT00129402|589285792|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
163155765|NCT00129402|589285793|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
163155766|NCT00129402|589285794|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
163155767|NCT00129402|589285795|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
163155768|NCT00129402|589285789|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
163155769|NCT00129402|589285790|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
163155770|NCT00129402|589285791|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
163155771|NCT00129402|589285792|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
163155772|NCT00129402|589285793|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
163155773|NCT00129402|589285794|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
163155774|NCT00129402|589285795|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
163155775|NCT00129402|589285789|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
163155776|NCT00129402|589285790|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
163155777|NCT00129402|589285791|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
163155778|NCT00129402|589285792|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
163155779|NCT00129402|589285793|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
163155780|NCT00129402|589285794|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
163155781|NCT00129402|589285795|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
163155782|NCT00129402|589285789|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
163155783|NCT00129402|589285790|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
163155784|NCT00129402|589285791|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
163155785|NCT00129402|589285792|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
163155786|NCT00129402|589285793|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
163155787|NCT00129402|589285794|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
162925901|NCT03193190|588430434|FG008|Stage 1|Withdrawal by Subject|2|||
162925902|NCT03193190|588430435|FG009|Stage 1|Withdrawal by Subject|4|||
162925903|NCT03193190|588430436|FG010|Stage 1|Withdrawal by Subject|9|||
162925904|NCT03193190|588430437|FG011|Stage 1|Withdrawal by Subject|1|||
162925905|NCT03193190|588430438|FG012|Stage 1|Withdrawal by Subject|0|||
162925906|NCT03193190|588430439|FG013|Stage 1|Withdrawal by Subject|0|||
162925907|NCT03193190|588430440|FG014|Stage 1|Withdrawal by Subject|0|||
162925908|NCT03193190|588430441|FG015|Stage 1|Withdrawal by Subject|0|||
162925909|NCT03193190|588430426|FG000|Stage 2|Death|0|||
162925910|NCT03193190|588430427|FG001|Stage 2|Death|0|||
162925911|NCT03193190|588430428|FG002|Stage 2|Death|0|||
162925912|NCT03193190|588430429|FG003|Stage 2|Death|0|||
162925913|NCT03193190|588430430|FG004|Stage 2|Death|0|||
162925914|NCT03193190|588430431|FG005|Stage 2|Death|0|||
162925915|NCT03193190|588430432|FG006|Stage 2|Death|0|||
162925916|NCT03193190|588430433|FG007|Stage 2|Death|0|||
162925917|NCT03193190|588430434|FG008|Stage 2|Death|0|||
162925918|NCT03193190|588430435|FG009|Stage 2|Death|0|||
162925919|NCT03193190|588430436|FG010|Stage 2|Death|0|||
162925920|NCT03193190|588430437|FG011|Stage 2|Death|0|||
162925921|NCT03193190|588430438|FG012|Stage 2|Death|0|||
162925922|NCT03193190|588430439|FG013|Stage 2|Death|14|||
162925923|NCT03193190|588430440|FG014|Stage 2|Death|4|||
162925924|NCT03193190|588430441|FG015|Stage 2|Death|1|||
162925925|NCT03193190|588430426|FG000|Stage 2|Lost to Follow-up|0|||
162925926|NCT03193190|588430427|FG001|Stage 2|Lost to Follow-up|0|||
162925927|NCT03193190|588430428|FG002|Stage 2|Lost to Follow-up|0|||
162925928|NCT03193190|588430429|FG003|Stage 2|Lost to Follow-up|0|||
162925929|NCT03193190|588430430|FG004|Stage 2|Lost to Follow-up|0|||
162925930|NCT03193190|588430431|FG005|Stage 2|Lost to Follow-up|0|||
162925931|NCT03193190|588430432|FG006|Stage 2|Lost to Follow-up|0|||
162925932|NCT03193190|588430433|FG007|Stage 2|Lost to Follow-up|0|||
162925933|NCT03193190|588430434|FG008|Stage 2|Lost to Follow-up|0|||
162925934|NCT03193190|588430435|FG009|Stage 2|Lost to Follow-up|0|||
162925935|NCT03193190|588430436|FG010|Stage 2|Lost to Follow-up|0|||
162925936|NCT03193190|588430437|FG011|Stage 2|Lost to Follow-up|0|||
162925937|NCT03193190|588430438|FG012|Stage 2|Lost to Follow-up|0|||
162925938|NCT03193190|588430439|FG013|Stage 2|Lost to Follow-up|0|||
162925939|NCT03193190|588430440|FG014|Stage 2|Lost to Follow-up|1|||
162925940|NCT03193190|588430441|FG015|Stage 2|Lost to Follow-up|0|||
162925941|NCT03193190|588430426|FG000|Stage 2|Withdrawal by Subject|0|||
162925942|NCT03193190|588430427|FG001|Stage 2|Withdrawal by Subject|0|||
162925943|NCT03193190|588430428|FG002|Stage 2|Withdrawal by Subject|0|||
162925944|NCT03193190|588430429|FG003|Stage 2|Withdrawal by Subject|0|||
162925945|NCT03193190|588430430|FG004|Stage 2|Withdrawal by Subject|0|||
162925946|NCT03193190|588430431|FG005|Stage 2|Withdrawal by Subject|0|||
162925947|NCT03193190|588430432|FG006|Stage 2|Withdrawal by Subject|0|||
162925948|NCT03193190|588430433|FG007|Stage 2|Withdrawal by Subject|0|||
162925949|NCT03193190|588430434|FG008|Stage 2|Withdrawal by Subject|0|||
162925950|NCT03193190|588430435|FG009|Stage 2|Withdrawal by Subject|0|||
162925951|NCT03193190|588430436|FG010|Stage 2|Withdrawal by Subject|0|||
162925952|NCT03193190|588430437|FG011|Stage 2|Withdrawal by Subject|0|||
162925953|NCT03193190|588430438|FG012|Stage 2|Withdrawal by Subject|0|||
162925954|NCT03193190|588430439|FG013|Stage 2|Withdrawal by Subject|1|||
162925955|NCT03193190|588430440|FG014|Stage 2|Withdrawal by Subject|1|||
162925956|NCT03193190|588430441|FG015|Stage 2|Withdrawal by Subject|0|||
162925957|NCT03532295|588430442|FG000|Overall Study|Did not start treatment|0|||
162925958|NCT03532295|588430443|FG001|Overall Study|Did not start treatment|2|||
162925959|NCT05004181|588430447|FG000|Overall Study|Withdrawal of consent|0|||
162925960|NCT05004181|588430448|FG001|Overall Study|Withdrawal of consent|0|||
162925961|NCT05004181|588430449|FG002|Overall Study|Withdrawal of consent|1|||
162925962|NCT05004181|588430450|FG003|Overall Study|Withdrawal of consent|3|||
162925963|NCT05004181|588430451|FG004|Overall Study|Withdrawal of consent|3|||
162925964|NCT05004181|588430452|FG005|Overall Study|Withdrawal of consent|0|||
162925965|NCT05004181|588430453|FG006|Overall Study|Withdrawal of consent|30|||
162925966|NCT05004181|588430454|FG007|Overall Study|Withdrawal of consent|9|||
162925967|NCT05004181|588430455|FG008|Overall Study|Withdrawal of consent|3|||
162925968|NCT05004181|588430456|FG009|Overall Study|Withdrawal of consent|2|||
162925969|NCT05004181|588430457|FG010|Overall Study|Withdrawal of consent|5|||
162925970|NCT05004181|588430458|FG011|Overall Study|Withdrawal of consent|1|||
162925971|NCT05004181|588430447|FG000|Overall Study|Lost to Follow-up|2|||
162925972|NCT05004181|588430448|FG001|Overall Study|Lost to Follow-up|4|||
162925973|NCT05004181|588430449|FG002|Overall Study|Lost to Follow-up|2|||
162925974|NCT05004181|588430450|FG003|Overall Study|Lost to Follow-up|3|||
162925975|NCT05004181|588430451|FG004|Overall Study|Lost to Follow-up|5|||
162925976|NCT05004181|588430452|FG005|Overall Study|Lost to Follow-up|2|||
162925977|NCT05004181|588430453|FG006|Overall Study|Lost to Follow-up|15|||
162925978|NCT05004181|588430454|FG007|Overall Study|Lost to Follow-up|12|||
162925979|NCT05004181|588430455|FG008|Overall Study|Lost to Follow-up|38|||
162925980|NCT05004181|588430456|FG009|Overall Study|Lost to Follow-up|6|||
162925981|NCT05004181|588430457|FG010|Overall Study|Lost to Follow-up|6|||
162925982|NCT05004181|588430458|FG011|Overall Study|Lost to Follow-up|0|||
162925983|NCT05004181|588430447|FG000|Overall Study|Death|0|||
162925984|NCT05004181|588430448|FG001|Overall Study|Death|0|||
162925985|NCT05004181|588430449|FG002|Overall Study|Death|0|||
162925986|NCT05004181|588430450|FG003|Overall Study|Death|0|||
162925987|NCT05004181|588430451|FG004|Overall Study|Death|0|||
162925988|NCT05004181|588430452|FG005|Overall Study|Death|0|||
162925989|NCT05004181|588430453|FG006|Overall Study|Death|1|||
162925990|NCT05004181|588430454|FG007|Overall Study|Death|0|||
162925991|NCT05004181|588430455|FG008|Overall Study|Death|2|||
162925992|NCT05004181|588430456|FG009|Overall Study|Death|0|||
162925993|NCT05004181|588430457|FG010|Overall Study|Death|0|||
162925994|NCT05004181|588430458|FG011|Overall Study|Death|0|||
163155788|NCT00129402|589285795|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
163155789|NCT00129402|589285789|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
163155790|NCT00129402|589285790|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
163155791|NCT00129402|589285791|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
163155792|NCT00129402|589285792|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
163155793|NCT00129402|589285793|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
163155794|NCT00129402|589285794|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
163155795|NCT00129402|589285795|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
163155796|NCT00129402|589285789|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
163155797|NCT00129402|589285790|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
163155798|NCT00129402|589285791|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
163155799|NCT00129402|589285792|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
163155800|NCT00129402|589285793|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
162925995|NCT05004181|588430447|FG000|Overall Study|Physician Decision|0|||
162925996|NCT05004181|588430448|FG001|Overall Study|Physician Decision|0|||
162925997|NCT05004181|588430449|FG002|Overall Study|Physician Decision|0|||
162925998|NCT05004181|588430450|FG003|Overall Study|Physician Decision|0|||
162925999|NCT05004181|588430451|FG004|Overall Study|Physician Decision|0|||
162926000|NCT05004181|588430452|FG005|Overall Study|Physician Decision|0|||
162926001|NCT05004181|588430453|FG006|Overall Study|Physician Decision|2|||
162926002|NCT05004181|588430454|FG007|Overall Study|Physician Decision|0|||
162926003|NCT05004181|588430455|FG008|Overall Study|Physician Decision|7|||
162926004|NCT05004181|588430456|FG009|Overall Study|Physician Decision|0|||
162926005|NCT05004181|588430457|FG010|Overall Study|Physician Decision|0|||
162926006|NCT05004181|588430458|FG011|Overall Study|Physician Decision|0|||
162926007|NCT05004181|588430447|FG000|Overall Study|Withdrawal by Subject|2|||
162926008|NCT05004181|588430448|FG001|Overall Study|Withdrawal by Subject|3|||
163155801|NCT00129402|589285794|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
163155802|NCT00129402|589285795|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
163155803|NCT00129402|589285789|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
163155804|NCT00129402|589285790|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
163155805|NCT00129402|589285791|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
163155806|NCT00129402|589285792|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
163155807|NCT00129402|589285793|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
163155808|NCT00129402|589285794|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
163155809|NCT00129402|589285795|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
163155810|NCT00129402|589285789|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
163155811|NCT00129402|589285790|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
163155812|NCT00129402|589285791|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
163155813|NCT00129402|589285792|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
163155814|NCT00129402|589285793|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
163155815|NCT00129402|589285794|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
163155816|NCT00129402|589285795|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
163155817|NCT00763035|589285796|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
163155818|NCT00763035|589285797|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
163155819|NCT00763035|589285796|FG000|First Intervention|Adverse Event|0|||
163155820|NCT00763035|589285797|FG001|First Intervention|Adverse Event|1|||
163155821|NCT00763035|589285796|FG000|Second Intervention|Adverse Event|1|||
163155822|NCT00763035|589285797|FG001|Second Intervention|Adverse Event|0|||
163155823|NCT00763035|589285796|FG000|Second Intervention|Physician Decision|2|||
163155824|NCT00763035|589285797|FG001|Second Intervention|Physician Decision|0|||
163155825|NCT00702221|589285800|FG000|Overall Study|Adverse Event|4|||
163155826|NCT00702221|589285801|FG001|Overall Study|Adverse Event|3|||
163155827|NCT02900378|589285802|FG000|Randomization (Visit 2)|Adverse Event|14|||
163155828|NCT02900378|589285803|FG001|Randomization (Visit 2)|Adverse Event|11|||
163155829|NCT02900378|589285802|FG000|Randomization (Visit 2)|Death|1|||
163155830|NCT02900378|589285803|FG001|Randomization (Visit 2)|Death|4|||
163155831|NCT02900378|589285802|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
163155832|NCT02900378|589285803|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
163155833|NCT02900378|589285802|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
163155834|NCT02900378|589285803|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
163155835|NCT02900378|589285802|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
163155836|NCT02900378|589285803|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
163155837|NCT02900378|589285802|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
163155838|NCT02900378|589285803|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
163155839|NCT02900378|589285802|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
163155840|NCT02900378|589285803|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
163155841|NCT01134055|589285804|FG000|Overall Study|Adverse Event|5|||
163155842|NCT01134055|589285805|FG001|Overall Study|Adverse Event|2|||
163155843|NCT01134055|589285806|FG002|Overall Study|Adverse Event|2|||
163155844|NCT01134055|589285807|FG003|Overall Study|Adverse Event|2|||
163155845|NCT01134055|589285808|FG004|Overall Study|Adverse Event|5|||
163155846|NCT01134055|589285809|FG005|Overall Study|Adverse Event|7|||
163155847|NCT01134055|589285810|FG006|Overall Study|Adverse Event|2|||
163155848|NCT01134055|589285804|FG000|Overall Study|Lost to Follow-up|0|||
163155849|NCT01134055|589285805|FG001|Overall Study|Lost to Follow-up|1|||
163155850|NCT01134055|589285806|FG002|Overall Study|Lost to Follow-up|0|||
163155851|NCT01134055|589285807|FG003|Overall Study|Lost to Follow-up|1|||
163155852|NCT01134055|589285808|FG004|Overall Study|Lost to Follow-up|0|||
163155853|NCT01134055|589285809|FG005|Overall Study|Lost to Follow-up|0|||
163155854|NCT01134055|589285810|FG006|Overall Study|Lost to Follow-up|0|||
163155855|NCT01134055|589285804|FG000|Overall Study|Withdrawal by Subject|3|||
163155856|NCT01134055|589285805|FG001|Overall Study|Withdrawal by Subject|3|||
163155857|NCT01134055|589285806|FG002|Overall Study|Withdrawal by Subject|1|||
163155858|NCT01134055|589285807|FG003|Overall Study|Withdrawal by Subject|2|||
163155859|NCT01134055|589285808|FG004|Overall Study|Withdrawal by Subject|0|||
163155860|NCT01134055|589285809|FG005|Overall Study|Withdrawal by Subject|0|||
163155861|NCT01134055|589285810|FG006|Overall Study|Withdrawal by Subject|8|||
163155862|NCT01134055|589285804|FG000|Overall Study|Protocol Violation|0|||
163155863|NCT01134055|589285805|FG001|Overall Study|Protocol Violation|0|||
163155864|NCT01134055|589285806|FG002|Overall Study|Protocol Violation|0|||
163155865|NCT01134055|589285807|FG003|Overall Study|Protocol Violation|1|||
163155866|NCT01134055|589285808|FG004|Overall Study|Protocol Violation|1|||
163155867|NCT01134055|589285809|FG005|Overall Study|Protocol Violation|0|||
163155868|NCT01134055|589285810|FG006|Overall Study|Protocol Violation|0|||
163155869|NCT01134055|589285804|FG000|Overall Study|Physician Decision|0|||
163155870|NCT01134055|589285805|FG001|Overall Study|Physician Decision|0|||
163155871|NCT01134055|589285806|FG002|Overall Study|Physician Decision|0|||
163155872|NCT01134055|589285807|FG003|Overall Study|Physician Decision|0|||
163269866|NCT01327547|589699919|FG001|Overall Study|Required prohibited medication|0|||
163155873|NCT01134055|589285808|FG004|Overall Study|Physician Decision|0|||
163155874|NCT01134055|589285809|FG005|Overall Study|Physician Decision|0|||
163155875|NCT01134055|589285810|FG006|Overall Study|Physician Decision|1|||
163155876|NCT03345784|589285813|FG000|Overall Study|Withdrawal by Subject|2|||
163155877|NCT03345784|589285814|FG001|Overall Study|Withdrawal by Subject|1|||
163155878|NCT00001959|589285822|FG000|Overall Study|newly diagnosed colon cancer|1|||
163155879|NCT00001959|589285822|FG000|Overall Study|disabling sedation|1|||
163040754|NCT01483599|588856063|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
163155880|NCT00001959|589285822|FG000|Overall Study|non-compliance|1|||
163155881|NCT04298697|589285825|FG000|Overall Study|Lost to Follow-up|5|||
163155882|NCT04298697|589285826|FG001|Overall Study|Lost to Follow-up|5|||
163155883|NCT04298697|589285827|FG002|Overall Study|Lost to Follow-up|1|||
163155884|NCT04298697|589285828|FG003|Overall Study|Lost to Follow-up|0|||
163155885|NCT04298697|589285825|FG000|Overall Study|Withdrawal by Subject|0|||
163155886|NCT04298697|589285826|FG001|Overall Study|Withdrawal by Subject|3|||
163155887|NCT04298697|589285827|FG002|Overall Study|Withdrawal by Subject|2|||
163155888|NCT04298697|589285828|FG003|Overall Study|Withdrawal by Subject|3|||
163155889|NCT03995368|589285829|FG000|Overall Study|Lost to Follow-up|1|||
163155890|NCT03995368|589285830|FG001|Overall Study|Lost to Follow-up|4|||
163155891|NCT03995368|589285831|FG002|Overall Study|Lost to Follow-up|1|||
163155892|NCT03995368|589285829|FG000|Overall Study|Did not meet inclusion criteria|1|||
163155893|NCT03995368|589285830|FG001|Overall Study|Did not meet inclusion criteria|6|||
163155894|NCT03995368|589285831|FG002|Overall Study|Did not meet inclusion criteria|3|||
163155895|NCT03995368|589285829|FG000|Overall Study|Withdrawal by Subject|0|||
163155896|NCT03995368|589285830|FG001|Overall Study|Withdrawal by Subject|1|||
163155897|NCT03995368|589285831|FG002|Overall Study|Withdrawal by Subject|1|||
163155898|NCT03592186|589285832|FG000|Overall Study|Withdrawal by Subject|1|||
163155899|NCT03592186|589285833|FG001|Overall Study|Withdrawal by Subject|0|||
163155900|NCT03592186|589285832|FG000|Overall Study|Lost to Follow-up|16|||
163155901|NCT03592186|589285833|FG001|Overall Study|Lost to Follow-up|11|||
163155902|NCT03755934|589285834|FG000|Overall Study|Adverse Event|4|||
163155903|NCT03755934|589285835|FG001|Overall Study|Adverse Event|1|||
163155904|NCT03755934|589285836|FG002|Overall Study|Adverse Event|1|||
163155905|NCT03755934|589285837|FG003|Overall Study|Adverse Event|3|||
163155906|NCT03755934|589285834|FG000|Overall Study|Physician Decision|2|||
163155907|NCT03755934|589285835|FG001|Overall Study|Physician Decision|0|||
163155908|NCT03755934|589285836|FG002|Overall Study|Physician Decision|0|||
163155909|NCT03755934|589285837|FG003|Overall Study|Physician Decision|1|||
163155910|NCT03755934|589285834|FG000|Overall Study|Withdrawal by Subject|5|||
163155911|NCT03755934|589285835|FG001|Overall Study|Withdrawal by Subject|0|||
163155912|NCT03755934|589285836|FG002|Overall Study|Withdrawal by Subject|0|||
163040755|NCT01483599|588856064|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
163040756|NCT01483599|588856065|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
163155913|NCT03755934|589285837|FG003|Overall Study|Withdrawal by Subject|1|||
163155914|NCT03755934|589285834|FG000|Overall Study|Other|3|||
163155915|NCT03755934|589285835|FG001|Overall Study|Other|1|||
163155916|NCT03755934|589285836|FG002|Overall Study|Other|3|||
163155917|NCT03755934|589285837|FG003|Overall Study|Other|1|||
163155918|NCT01498068|589285838|FG000|Overall Study|Withdrawal by Subject|1|||
163155919|NCT01498068|589285839|FG001|Overall Study|Withdrawal by Subject|1|||
163155920|NCT00361296|589285842|FG000|Overall Study|Physician Decision|1|||
163155921|NCT00361296|589285842|FG000|Overall Study|Lack of Efficacy|2|||
163155922|NCT02594124|589285843|FG000|Overall Study|Adverse Event|0|||
163155923|NCT02594124|589285844|FG001|Overall Study|Adverse Event|5|||
163155924|NCT02594124|589285845|FG002|Overall Study|Adverse Event|8|||
163155925|NCT02594124|589285846|FG003|Overall Study|Adverse Event|1|||
163155926|NCT02594124|589285847|FG004|Overall Study|Adverse Event|0|||
163155927|NCT02594124|589285848|FG005|Overall Study|Adverse Event|0|||
163155928|NCT02594124|589285849|FG006|Overall Study|Adverse Event|2|||
163155929|NCT02594124|589285850|FG007|Overall Study|Adverse Event|2|||
163155930|NCT02594124|589285851|FG008|Overall Study|Adverse Event|0|||
163155931|NCT02594124|589285843|FG000|Overall Study|Withdrawal by Subject|2|||
163155932|NCT02594124|589285844|FG001|Overall Study|Withdrawal by Subject|3|||
163155933|NCT02594124|589285845|FG002|Overall Study|Withdrawal by Subject|5|||
163155934|NCT02594124|589285846|FG003|Overall Study|Withdrawal by Subject|1|||
163155935|NCT02594124|589285847|FG004|Overall Study|Withdrawal by Subject|8|||
163155936|NCT02594124|589285848|FG005|Overall Study|Withdrawal by Subject|4|||
163155937|NCT02594124|589285849|FG006|Overall Study|Withdrawal by Subject|13|||
163155938|NCT02594124|589285850|FG007|Overall Study|Withdrawal by Subject|19|||
163155939|NCT02594124|589285851|FG008|Overall Study|Withdrawal by Subject|0|||
163155940|NCT02594124|589285843|FG000|Overall Study|Physician Decision|0|||
163155941|NCT02594124|589285844|FG001|Overall Study|Physician Decision|2|||
163155942|NCT02594124|589285845|FG002|Overall Study|Physician Decision|0|||
163155943|NCT02594124|589285846|FG003|Overall Study|Physician Decision|0|||
163155944|NCT02594124|589285847|FG004|Overall Study|Physician Decision|0|||
163155945|NCT02594124|589285848|FG005|Overall Study|Physician Decision|0|||
163155946|NCT02594124|589285849|FG006|Overall Study|Physician Decision|0|||
163155947|NCT02594124|589285850|FG007|Overall Study|Physician Decision|1|||
163155948|NCT02594124|589285851|FG008|Overall Study|Physician Decision|0|||
163155949|NCT02594124|589285843|FG000|Overall Study|Commercial drug|0|||
163155950|NCT02594124|589285844|FG001|Overall Study|Commercial drug|1|||
163155951|NCT02594124|589285845|FG002|Overall Study|Commercial drug|6|||
163155952|NCT02594124|589285846|FG003|Overall Study|Commercial drug|3|||
163155953|NCT02594124|589285847|FG004|Overall Study|Commercial drug|0|||
163155954|NCT02594124|589285848|FG005|Overall Study|Commercial drug|0|||
163155955|NCT02594124|589285849|FG006|Overall Study|Commercial drug|7|||
163155956|NCT02594124|589285850|FG007|Overall Study|Commercial drug|11|||
163155957|NCT02594124|589285851|FG008|Overall Study|Commercial drug|2|||
163155958|NCT02594124|589285843|FG000|Overall Study|Reason Not Specified|1|||
163155959|NCT02594124|589285844|FG001|Overall Study|Reason Not Specified|3|||
163155960|NCT02594124|589285845|FG002|Overall Study|Reason Not Specified|4|||
163155961|NCT02594124|589285846|FG003|Overall Study|Reason Not Specified|0|||
163155962|NCT02594124|589285847|FG004|Overall Study|Reason Not Specified|0|||
163155963|NCT02594124|589285848|FG005|Overall Study|Reason Not Specified|1|||
163155964|NCT02594124|589285849|FG006|Overall Study|Reason Not Specified|1|||
163155965|NCT02594124|589285850|FG007|Overall Study|Reason Not Specified|6|||
162926009|NCT05004181|588430449|FG002|Overall Study|Withdrawal by Subject|2|||
162926010|NCT05004181|588430450|FG003|Overall Study|Withdrawal by Subject|2|||
162926011|NCT05004181|588430451|FG004|Overall Study|Withdrawal by Subject|4|||
162926012|NCT05004181|588430452|FG005|Overall Study|Withdrawal by Subject|2|||
162926013|NCT05004181|588430453|FG006|Overall Study|Withdrawal by Subject|4|||
162926014|NCT05004181|588430454|FG007|Overall Study|Withdrawal by Subject|22|||
162926015|NCT05004181|588430455|FG008|Overall Study|Withdrawal by Subject|8|||
162926016|NCT05004181|588430456|FG009|Overall Study|Withdrawal by Subject|1|||
162926017|NCT05004181|588430457|FG010|Overall Study|Withdrawal by Subject|3|||
162926018|NCT05004181|588430458|FG011|Overall Study|Withdrawal by Subject|2|||
162926019|NCT05004181|588430447|FG000|Overall Study|Protocol Violation|2|||
162926020|NCT05004181|588430448|FG001|Overall Study|Protocol Violation|3|||
162926021|NCT05004181|588430449|FG002|Overall Study|Protocol Violation|0|||
162926022|NCT05004181|588430450|FG003|Overall Study|Protocol Violation|0|||
162926023|NCT05004181|588430451|FG004|Overall Study|Protocol Violation|1|||
162926024|NCT05004181|588430452|FG005|Overall Study|Protocol Violation|0|||
162926025|NCT05004181|588430453|FG006|Overall Study|Protocol Violation|16|||
162926026|NCT05004181|588430454|FG007|Overall Study|Protocol Violation|18|||
162926027|NCT05004181|588430455|FG008|Overall Study|Protocol Violation|2|||
162926028|NCT05004181|588430456|FG009|Overall Study|Protocol Violation|2|||
162926029|NCT05004181|588430457|FG010|Overall Study|Protocol Violation|2|||
162926030|NCT05004181|588430458|FG011|Overall Study|Protocol Violation|1|||
162926031|NCT05004181|588430447|FG000|Overall Study|Not further specified|1|||
162926032|NCT05004181|588430448|FG001|Overall Study|Not further specified|0|||
162926033|NCT05004181|588430449|FG002|Overall Study|Not further specified|0|||
162926034|NCT05004181|588430450|FG003|Overall Study|Not further specified|0|||
162926035|NCT05004181|588430451|FG004|Overall Study|Not further specified|0|||
162926036|NCT05004181|588430452|FG005|Overall Study|Not further specified|0|||
162926037|NCT05004181|588430453|FG006|Overall Study|Not further specified|1|||
162926038|NCT05004181|588430454|FG007|Overall Study|Not further specified|0|||
162926039|NCT05004181|588430455|FG008|Overall Study|Not further specified|2|||
162926040|NCT05004181|588430456|FG009|Overall Study|Not further specified|1|||
162926041|NCT05004181|588430457|FG010|Overall Study|Not further specified|0|||
162926042|NCT05004181|588430458|FG011|Overall Study|Not further specified|1|||
162926043|NCT03868059|588430460|FG000|Overall Study|Adverse Event|3|||
162926044|NCT03868059|588430460|FG000|Overall Study|Lost to Follow-up|3|||
162926045|NCT03868059|588430460|FG000|Overall Study|Withdrawal by Subject|6|||
163155966|NCT02594124|589285851|FG008|Overall Study|Reason Not Specified|1|||
163155967|NCT05523089|589285852|FG000|Overall Study|Withdrawal by Subject|1|||
162926046|NCT04278872|588430461|FG000|Overall Study|Adverse Event|1|||
162926047|NCT04278872|588430462|FG001|Overall Study|Adverse Event|0|||
162926048|NCT04278872|588430461|FG000|Overall Study|Protocol Violation|0|||
162926049|NCT04278872|588430462|FG001|Overall Study|Protocol Violation|1|||
162926050|NCT04278872|588430461|FG000|Overall Study|Study Termination|2|||
162926051|NCT04278872|588430462|FG001|Overall Study|Study Termination|0|||
162926052|NCT02392377|588430463|FG000|Overall Study|Withdrawal by Subject|0|||
162926053|NCT02392377|588430464|FG001|Overall Study|Withdrawal by Subject|1|||
162926054|NCT01298661|588430465|FG000|Overall Study|Withdrawal by Subject|2|||
162926055|NCT01298661|588430466|FG001|Overall Study|Withdrawal by Subject|0|||
162926056|NCT01298661|588430467|FG002|Overall Study|Withdrawal by Subject|2|||
162978976|NCT01660022|588623539|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
162978977|NCT01660022|588623540|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
163155968|NCT05523089|589285853|FG001|Overall Study|Withdrawal by Subject|0|||
163155969|NCT05523089|589285854|FG002|Overall Study|Withdrawal by Subject|0|||
162978978|NCT01660022|588623541|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
162978979|NCT01660022|588623542|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
162978980|NCT01660022|588623543|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
162978981|NCT01660022|588623538|FG000|First Sequence (7 Days)|Adverse Event|0|||
163155970|NCT05523089|589285852|FG000|Overall Study|Lost to Follow-up|1|||
162926057|NCT02239692|588431731|FG000|Overall Study|Incomplete colonoscopy|1|||
162926058|NCT02239692|588431732|FG001|Overall Study|Incomplete colonoscopy|2|||
162926059|NCT02239692|588431731|FG000|Overall Study|Adverse Event|0|||
162926060|NCT02239692|588431732|FG001|Overall Study|Adverse Event|1|||
162926061|NCT02239692|588431731|FG000|Overall Study|Physician Decision|0|||
162926062|NCT02239692|588431732|FG001|Overall Study|Physician Decision|1|||
162926063|NCT02239692|588431731|FG000|Overall Study|Lost to Follow-up|1|||
162926064|NCT02239692|588431732|FG001|Overall Study|Lost to Follow-up|4|||
162926065|NCT02239692|588431731|FG000|Overall Study|Withdrawal by Subject|3|||
162926066|NCT02239692|588431732|FG001|Overall Study|Withdrawal by Subject|5|||
162926067|NCT02239692|588431731|FG000|Overall Study|Other reason|1|||
162926068|NCT02239692|588431732|FG001|Overall Study|Other reason|0|||
162926069|NCT01901146|588431737|FG000|Neoadjuvant Phase|Death|1|||
162926070|NCT01901146|588431738|FG001|Neoadjuvant Phase|Death|2|||
162926071|NCT01901146|588431739|FG002|Neoadjuvant Phase|Death|0|||
162926072|NCT01901146|588431740|FG003|Neoadjuvant Phase|Death|0|||
162926073|NCT01901146|588431741|FG004|Neoadjuvant Phase|Death|0|||
162926074|NCT01901146|588431737|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
162926075|NCT01901146|588431738|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
162926076|NCT01901146|588431739|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
162926077|NCT01901146|588431740|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
162926078|NCT01901146|588431741|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
162926079|NCT01901146|588431737|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
162926080|NCT01901146|588431738|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
162926081|NCT01901146|588431739|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
162926082|NCT01901146|588431740|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
162926083|NCT01901146|588431741|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
162926084|NCT01901146|588431737|FG000|Neoadjuvant Phase|Physician Decision|1|||
162926085|NCT01901146|588431738|FG001|Neoadjuvant Phase|Physician Decision|2|||
162926086|NCT01901146|588431739|FG002|Neoadjuvant Phase|Physician Decision|0|||
162926087|NCT01901146|588431740|FG003|Neoadjuvant Phase|Physician Decision|0|||
162926088|NCT01901146|588431741|FG004|Neoadjuvant Phase|Physician Decision|0|||
162926089|NCT01901146|588431737|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
162926090|NCT01901146|588431738|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
162926091|NCT01901146|588431739|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
162926092|NCT01901146|588431740|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
162926093|NCT01901146|588431741|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
162926094|NCT01901146|588431737|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
162926095|NCT01901146|588431738|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
162926096|NCT01901146|588431739|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
162926097|NCT01901146|588431740|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
162926098|NCT01901146|588431741|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
162926099|NCT01901146|588431737|FG000|Adjuvant Phase|Other|0|||
162926100|NCT01901146|588431738|FG001|Adjuvant Phase|Other|0|||
162926101|NCT01901146|588431739|FG002|Adjuvant Phase|Other|1|||
162926102|NCT01901146|588431740|FG003|Adjuvant Phase|Other|0|||
162926103|NCT01901146|588431741|FG004|Adjuvant Phase|Other|0|||
162926104|NCT01901146|588431737|FG000|Adjuvant Phase|Death|0|||
162926105|NCT01901146|588431738|FG001|Adjuvant Phase|Death|0|||
162926106|NCT01901146|588431739|FG002|Adjuvant Phase|Death|0|||
162926107|NCT01901146|588431740|FG003|Adjuvant Phase|Death|0|||
162926108|NCT01901146|588431741|FG004|Adjuvant Phase|Death|3|||
162926109|NCT01901146|588431737|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
162926110|NCT01901146|588431738|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
162926111|NCT01901146|588431739|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
162926112|NCT01901146|588431740|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
162926113|NCT01901146|588431741|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
162926114|NCT01901146|588431737|FG000|Adjuvant Phase|Physician Decision|0|||
162926115|NCT01901146|588431738|FG001|Adjuvant Phase|Physician Decision|0|||
162926116|NCT01901146|588431739|FG002|Adjuvant Phase|Physician Decision|9|||
162926117|NCT01901146|588431740|FG003|Adjuvant Phase|Physician Decision|2|||
162926118|NCT01901146|588431741|FG004|Adjuvant Phase|Physician Decision|4|||
162926119|NCT01901146|588431737|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
162926120|NCT01901146|588431738|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
162926121|NCT01901146|588431739|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
162926122|NCT01901146|588431740|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
162926123|NCT01901146|588431741|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
162926124|NCT00297492|588431742|FG000|Set Quit Date|Lost to Follow-up|7|||
162926125|NCT00297492|588431743|FG001|Set Quit Date|Lost to Follow-up|13|||
162926126|NCT00297492|588431744|FG002|Set Quit Date|Lost to Follow-up|5|||
162926127|NCT00297492|588431742|FG000|6 Month Follow-up|Lost to Follow-up|63|||
162926128|NCT00297492|588431743|FG001|6 Month Follow-up|Lost to Follow-up|49|||
162926129|NCT00297492|588431744|FG002|6 Month Follow-up|Lost to Follow-up|27|||
162926130|NCT02675426|588431745|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
162926131|NCT02675426|588431746|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
162926132|NCT02675426|588431747|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
162926133|NCT02675426|588431748|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
162926134|NCT02675426|588431745|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
162926135|NCT02675426|588431746|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
162926136|NCT02675426|588431747|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
162926137|NCT02675426|588431748|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
162926138|NCT02675426|588431745|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
162926139|NCT02675426|588431746|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
162926140|NCT02675426|588431747|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
162926141|NCT02675426|588431748|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
162926142|NCT02675426|588431745|FG000|Period 1: Week 1 to Week 12|Other|2|||
162926143|NCT02675426|588431746|FG001|Period 1: Week 1 to Week 12|Other|1|||
162926144|NCT02675426|588431747|FG002|Period 1: Week 1 to Week 12|Other|0|||
162926145|NCT02675426|588431748|FG003|Period 1: Week 1 to Week 12|Other|2|||
162926146|NCT02675426|588431745|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
162926147|NCT02675426|588431746|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
162926148|NCT02675426|588431747|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
162926149|NCT02675426|588431748|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
162926150|NCT02675426|588431745|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
162926151|NCT02675426|588431746|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
162926152|NCT02675426|588431747|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
162926153|NCT02675426|588431748|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
162926154|NCT02675426|588431745|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
162926155|NCT02675426|588431746|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
162926156|NCT02675426|588431747|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
162926157|NCT02675426|588431748|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
162926158|NCT02675426|588431745|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
162926159|NCT02675426|588431746|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
162926160|NCT02675426|588431747|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
162926161|NCT02675426|588431748|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
162926162|NCT02675426|588431745|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
162926163|NCT02675426|588431746|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
162926164|NCT02675426|588431747|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
162926165|NCT02675426|588431748|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
162926166|NCT02675426|588431745|FG000|Period 2: Week 12 to Week 260|Other|8|||
162926167|NCT02675426|588431746|FG001|Period 2: Week 12 to Week 260|Other|12|||
162926168|NCT02675426|588431747|FG002|Period 2: Week 12 to Week 260|Other|23|||
162926169|NCT02675426|588431748|FG003|Period 2: Week 12 to Week 260|Other|15|||
162926170|NCT03724968|588431751|FG000|Overall Study|Insurance issues|0|||
162926171|NCT03724968|588431752|FG001|Overall Study|Insurance issues|1|||
162926172|NCT03724968|588431751|FG000|Overall Study|Study closed|0|||
162926173|NCT03724968|588431752|FG001|Overall Study|Study closed|1|||
162926174|NCT01784419|588431753|FG000|Overall Study|Adverse Event|3|||
162926175|NCT02237118|588431754|FG000|Overall Study|Protocol Violation|0|||
162926176|NCT02237118|588431755|FG001|Overall Study|Protocol Violation|1|||
162926177|NCT02237118|588431754|FG000|Overall Study|consent withdrawn|1|||
162926178|NCT02237118|588431755|FG001|Overall Study|consent withdrawn|0|||
162926179|NCT00080288|588431756|FG000|Overall Study|Adverse Event|7|||
162926180|NCT00080288|588431757|FG001|Overall Study|Adverse Event|4|||
162926181|NCT00080288|588431756|FG000|Overall Study|Lost to Follow-up|3|||
162926182|NCT00080288|588431757|FG001|Overall Study|Lost to Follow-up|5|||
162926183|NCT00080288|588431756|FG000|Overall Study|Physician Decision|6|||
162926184|NCT00080288|588431757|FG001|Overall Study|Physician Decision|2|||
162926185|NCT00080288|588431756|FG000|Overall Study|Withdrawal by Subject|3|||
162926186|NCT00080288|588431757|FG001|Overall Study|Withdrawal by Subject|16|||
162926187|NCT00080288|588431756|FG000|Overall Study|Miscellaneous|11|||
162926188|NCT00080288|588431757|FG001|Overall Study|Miscellaneous|11|||
162926189|NCT00569231|588431758|FG000|Overall Study|Study unrelated surgery|1|||
162926190|NCT00569231|588431758|FG000|Overall Study|Airfare expense|2|||
162926191|NCT00569231|588431758|FG000|Overall Study|Withdrawal by Subject|1|||
162926192|NCT00569231|588431758|FG000|Overall Study|Car accident injury|1|||
162926193|NCT00569231|588431758|FG000|Overall Study|Non-compliance|2|||
162926194|NCT03456726|588431759|FG000|Overall Study|Disease Progression|6|||
162926195|NCT03456726|588431760|FG001|Overall Study|Disease Progression|1|||
162926196|NCT03456726|588431759|FG000|Overall Study|Adverse Event|4|||
162926197|NCT03456726|588431760|FG001|Overall Study|Adverse Event|2|||
163269867|NCT01327547|589699918|FG000|Overall Study|Non-compliance with study procedures|1|||
162926198|NCT03456726|588431759|FG000|Overall Study|Withdrawal by Subject|1|||
162926199|NCT03456726|588431760|FG001|Overall Study|Withdrawal by Subject|0|||
162926200|NCT03456726|588431759|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
162926201|NCT03456726|588431760|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
162926202|NCT03978117|588431763|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
162926203|NCT03978117|588431764|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
162926204|NCT03978117|588431763|FG000|Overall Study|Lost to Follow-up|4|||
162926205|NCT03978117|588431764|FG001|Overall Study|Lost to Follow-up|4|||
162926206|NCT02923115|588431765|FG000|Overall Study|Lost to Follow-up|0|||
162926207|NCT02923115|588431766|FG001|Overall Study|Lost to Follow-up|0|||
162926208|NCT02923115|588431767|FG002|Overall Study|Lost to Follow-up|0|||
162926209|NCT02923115|588431768|FG003|Overall Study|Lost to Follow-up|1|||
162926210|NCT02923115|588431769|FG004|Overall Study|Lost to Follow-up|0|||
162926211|NCT02923115|588431770|FG005|Overall Study|Lost to Follow-up|0|||
162926212|NCT02923115|588431765|FG000|Overall Study|Withdrawal by Subject|0|||
162926213|NCT02923115|588431766|FG001|Overall Study|Withdrawal by Subject|1|||
162926214|NCT02923115|588431767|FG002|Overall Study|Withdrawal by Subject|0|||
162926215|NCT02923115|588431768|FG003|Overall Study|Withdrawal by Subject|0|||
162926216|NCT02923115|588431769|FG004|Overall Study|Withdrawal by Subject|0|||
162926217|NCT02923115|588431770|FG005|Overall Study|Withdrawal by Subject|0|||
162926218|NCT02923115|588431765|FG000|Overall Study|Randomized, but not dosed|0|||
162926219|NCT02923115|588431766|FG001|Overall Study|Randomized, but not dosed|0|||
162926220|NCT02923115|588431767|FG002|Overall Study|Randomized, but not dosed|3|||
162926221|NCT02923115|588431768|FG003|Overall Study|Randomized, but not dosed|1|||
162926222|NCT02923115|588431769|FG004|Overall Study|Randomized, but not dosed|5|||
162926223|NCT02923115|588431770|FG005|Overall Study|Randomized, but not dosed|0|||
162926224|NCT01296152|588431771|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
162926225|NCT01875991|588431772|FG000|Overall Study|Withdrawal by Subject|6|||
162926226|NCT01875991|588431773|FG001|Overall Study|Withdrawal by Subject|6|||
162926227|NCT01875991|588431772|FG000|Overall Study|Sponsor Decision|1|||
162926228|NCT01875991|588431773|FG001|Overall Study|Sponsor Decision|0|||
162926229|NCT03981614|588431774|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
162926230|NCT03981614|588431775|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
162926231|NCT03981614|588431776|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
162926232|NCT04732728|588431777|FG000|Overall Study|Death|12|||
162926233|NCT04732728|588431777|FG000|Overall Study|Withdrawn|136|||
162926234|NCT04971226|588431778|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
162926235|NCT04971226|588431779|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
162926236|NCT04971226|588431780|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
162926237|NCT04971226|588431781|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
162926238|NCT04971226|588431778|FG000|Overall Study|Adverse Event|6|||
162926239|NCT04971226|588431779|FG001|Overall Study|Adverse Event|5|||
162926240|NCT04971226|588431780|FG002|Overall Study|Adverse Event|11|||
162926241|NCT04971226|588431781|FG003|Overall Study|Adverse Event|10|||
162926242|NCT04971226|588431778|FG000|Overall Study|Progressive disease|2|||
162926243|NCT04971226|588431779|FG001|Overall Study|Progressive disease|0|||
162926244|NCT04971226|588431780|FG002|Overall Study|Progressive disease|3|||
162926245|NCT04971226|588431781|FG003|Overall Study|Progressive disease|1|||
162926246|NCT04971226|588431778|FG000|Overall Study|Protocol Deviation|1|||
162926247|NCT04971226|588431779|FG001|Overall Study|Protocol Deviation|0|||
162926248|NCT04971226|588431780|FG002|Overall Study|Protocol Deviation|1|||
162926249|NCT04971226|588431781|FG003|Overall Study|Protocol Deviation|1|||
162926250|NCT04971226|588431778|FG000|Overall Study|Subject Decision|0|||
162926251|NCT04971226|588431779|FG001|Overall Study|Subject Decision|1|||
162926252|NCT04971226|588431780|FG002|Overall Study|Subject Decision|1|||
162926253|NCT04971226|588431781|FG003|Overall Study|Subject Decision|1|||
162926254|NCT04971226|588431778|FG000|Overall Study|Pregnancy|0|||
162926255|NCT04971226|588431779|FG001|Overall Study|Pregnancy|0|||
162926256|NCT04971226|588431780|FG002|Overall Study|Pregnancy|0|||
162926257|NCT04971226|588431781|FG003|Overall Study|Pregnancy|1|||
162926258|NCT04971226|588431778|FG000|Overall Study|Participants not treated|1|||
162926259|NCT04971226|588431779|FG001|Overall Study|Participants not treated|0|||
162926260|NCT04971226|588431780|FG002|Overall Study|Participants not treated|2|||
162926261|NCT04971226|588431781|FG003|Overall Study|Participants not treated|1|||
162926262|NCT06065176|588431786|FG000|Overall Study|Lost to Follow-up|11|||
162926263|NCT06065176|588431787|FG001|Overall Study|Lost to Follow-up|11|||
162926264|NCT06065176|588431788|FG002|Overall Study|Lost to Follow-up|10|||
162926265|NCT06065176|588431786|FG000|Overall Study|Withdrawal by Subject|1|||
162926266|NCT06065176|588431787|FG001|Overall Study|Withdrawal by Subject|1|||
162926267|NCT06065176|588431788|FG002|Overall Study|Withdrawal by Subject|2|||
162926268|NCT06065176|588431786|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
162926269|NCT06065176|588431787|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
162926270|NCT06065176|588431788|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
162926271|NCT04521608|588431789|FG000|Overall Study|Death|8|||
162926272|NCT04521608|588431790|FG001|Overall Study|Death|9|||
162926273|NCT04521608|588431789|FG000|Overall Study|Withdrawal by Subject|25|||
162926274|NCT04521608|588431790|FG001|Overall Study|Withdrawal by Subject|18|||
162926275|NCT04521608|588431789|FG000|Overall Study|Disease Progression|3|||
162926276|NCT04521608|588431790|FG001|Overall Study|Disease Progression|10|||
162926277|NCT04521608|588431789|FG000|Overall Study|Complicating Disease|6|||
162926278|NCT04521608|588431790|FG001|Overall Study|Complicating Disease|3|||
162926279|NCT04521608|588431789|FG000|Overall Study|Lost Contact|25|||
162926280|NCT04521608|588431790|FG001|Overall Study|Lost Contact|27|||
162926281|NCT04521608|588431789|FG000|Overall Study|Ineligible|1|||
162926282|NCT04521608|588431790|FG001|Overall Study|Ineligible|0|||
162926283|NCT04521608|588431789|FG000|Overall Study|Refused Further Study Participation|13|||
162926284|NCT04521608|588431790|FG001|Overall Study|Refused Further Study Participation|7|||
162926285|NCT04083378|588431793|FG000|Overall Study|Death|18|||
162926286|NCT04083378|588431794|FG001|Overall Study|Death|4|||
162926287|NCT04083378|588431793|FG000|Overall Study|Lost to Follow-up|4|||
162926288|NCT04083378|588431794|FG001|Overall Study|Lost to Follow-up|0|||
162926289|NCT05824273|588431795|FG000|Overall Study|Lost to Follow-up|16|||
162926290|NCT05824273|588431796|FG001|Overall Study|Lost to Follow-up|13|||
162926291|NCT04050293|588431797|FG000|Overall Study|Lost to Follow-up|1|||
162926292|NCT04050293|588431798|FG001|Overall Study|Lost to Follow-up|2|||
162926293|NCT04050293|588431797|FG000|Overall Study|Withdrawal by Subject|2|||
162926294|NCT04050293|588431798|FG001|Overall Study|Withdrawal by Subject|0|||
162926295|NCT04644237|588431801|FG000|Overall Study|Death|4|||
162926296|NCT04644237|588431802|FG001|Overall Study|Death|2|||
162926297|NCT04644237|588431801|FG000|Overall Study|Adverse Event|18|||
162926298|NCT04644237|588431802|FG001|Overall Study|Adverse Event|19|||
162926299|NCT04644237|588431801|FG000|Overall Study|Progressive Disease|61|||
162926300|NCT04644237|588431802|FG001|Overall Study|Progressive Disease|23|||
162926301|NCT04644237|588431801|FG000|Overall Study|Clinical Progression|4|||
162926302|NCT04644237|588431802|FG001|Overall Study|Clinical Progression|1|||
162926303|NCT04644237|588431801|FG000|Overall Study|Withdrawal by Subject|4|||
162926304|NCT04644237|588431802|FG001|Overall Study|Withdrawal by Subject|2|||
162926305|NCT04644237|588431801|FG000|Overall Study|Physician Decision|4|||
162926306|NCT04644237|588431802|FG001|Overall Study|Physician Decision|0|||
162926307|NCT04644237|588431801|FG000|Overall Study|Other|6|||
162926308|NCT04644237|588431802|FG001|Overall Study|Other|3|||
162926309|NCT04644237|588431801|FG000|Overall Study|Randomized but not Treated|1|||
162926310|NCT04644237|588431802|FG001|Overall Study|Randomized but not Treated|0|||
162926311|NCT03131817|588431803|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
162926312|NCT02061293|588431805|FG000|Overall Study|Elevated Blood Pressure|1|||
162926313|NCT02061293|588431806|FG001|Overall Study|Elevated Blood Pressure|1|||
162926314|NCT02949219|588431813|FG000|Overall Study|Withdrawal by Subject|1|||
162926315|NCT03494816|588431814|FG000|Overall Study|Protocol Violation|2|||
162926316|NCT03494816|588431814|FG000|Overall Study|Physician Decision|2|||
162926317|NCT03494816|588431814|FG000|Overall Study|Did not start trial treatment|1|||
162926318|NCT03494816|588431814|FG000|Overall Study|Adverse Event|1|||
162926319|NCT00633217|588431828|FG000|Overall Study|Adverse Event|5|||
162926320|NCT00633217|588431829|FG001|Overall Study|Adverse Event|9|||
162926321|NCT00633217|588431828|FG000|Overall Study|Lack of Efficacy|0|||
162926322|NCT00633217|588431829|FG001|Overall Study|Lack of Efficacy|2|||
162926323|NCT00633217|588431828|FG000|Overall Study|Protocol Violation|3|||
162926324|NCT00633217|588431829|FG001|Overall Study|Protocol Violation|7|||
162926325|NCT00633217|588431828|FG000|Overall Study|Lost to Follow-up|2|||
162926326|NCT00633217|588431829|FG001|Overall Study|Lost to Follow-up|2|||
162926327|NCT00633217|588431828|FG000|Overall Study|Investigator Discretion|2|||
162926328|NCT00633217|588431829|FG001|Overall Study|Investigator Discretion|0|||
162926329|NCT00633217|588431828|FG000|Overall Study|Withdrew Consent|3|||
162926330|NCT00633217|588431829|FG001|Overall Study|Withdrew Consent|3|||
162926331|NCT05838755|588431830|FG000|Overall Study|Adverse Event|1|||
162926332|NCT05838755|588431831|FG001|Overall Study|Adverse Event|0|||
162926333|NCT05838755|588431832|FG002|Overall Study|Adverse Event|0|||
162926334|NCT05838755|588431830|FG000|Overall Study|Lack of Efficacy|1|||
162926335|NCT05838755|588431831|FG001|Overall Study|Lack of Efficacy|0|||
162926336|NCT05838755|588431832|FG002|Overall Study|Lack of Efficacy|1|||
162926337|NCT05838755|588431830|FG000|Overall Study|Lost to Follow-up|0|||
162926338|NCT05838755|588431831|FG001|Overall Study|Lost to Follow-up|1|||
162926339|NCT05838755|588431832|FG002|Overall Study|Lost to Follow-up|4|||
162926340|NCT05838755|588431830|FG000|Overall Study|Withdrawal by Subject|0|||
162926341|NCT05838755|588431831|FG001|Overall Study|Withdrawal by Subject|2|||
162926342|NCT05838755|588431832|FG002|Overall Study|Withdrawal by Subject|0|||
162926343|NCT05838755|588431830|FG000|Overall Study|Study terminated by sponsor|26|||
162926344|NCT05838755|588431831|FG001|Overall Study|Study terminated by sponsor|27|||
162926345|NCT05838755|588431832|FG002|Overall Study|Study terminated by sponsor|26|||
162926346|NCT05838755|588431830|FG000|Overall Study|Randomized, not treated|2|||
162926347|NCT05838755|588431831|FG001|Overall Study|Randomized, not treated|0|||
162926348|NCT05838755|588431832|FG002|Overall Study|Randomized, not treated|1|||
162926349|NCT05838755|588431830|FG000|Overall Study|Pregnancy|0|||
162926350|NCT05838755|588431831|FG001|Overall Study|Pregnancy|1|||
162926351|NCT05838755|588431832|FG002|Overall Study|Pregnancy|0|||
162926352|NCT01283282|588431833|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
162926353|NCT01283282|588431834|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
162926354|NCT01283282|588431833|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
162926355|NCT01283282|588431834|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
162926356|NCT01283282|588431833|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
162926357|NCT01283282|588431834|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
162926358|NCT01682681|588431841|FG000|Overall Study|Lack of Efficacy|62|||
162926359|NCT01682681|588431841|FG000|Overall Study|Withdrawal by Subject|1|||
162926360|NCT01682681|588431841|FG000|Overall Study|Moved to other hospital|10|||
162926361|NCT01682681|588431841|FG000|Overall Study|Lost to Follow-up|174|||
162926362|NCT01682681|588431841|FG000|Overall Study|Adverse Event|46|||
162926363|NCT01682681|588431841|FG000|Overall Study|tapering of topiramate|5|||
162926364|NCT01682681|588431841|FG000|Overall Study|Other|21|||
162926365|NCT01682681|588431841|FG000|Overall Study|Low compliance|13|||
162926366|NCT02044094|588431842|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
162926367|NCT02044094|588431842|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
162926368|NCT02044094|588431842|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
162926369|NCT02044094|588431842|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
162926370|NCT02044094|588431842|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
162926371|NCT02044094|588431842|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
162926372|NCT02044094|588431842|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
162926373|NCT02044094|588431842|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
162926374|NCT03205163|588431845|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
162926375|NCT03205163|588431846|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
162926376|NCT00005879|588431847|FG000|Overall Study|Withdrawal by Subject|8|||
162926377|NCT00005879|588431848|FG001|Overall Study|Withdrawal by Subject|10|||
162926378|NCT01238172|588431849|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
162926379|NCT01238172|588431850|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
162926380|NCT01238172|588431849|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
162926381|NCT01238172|588431850|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
162926382|NCT05022121|588431851|FG000|Overall Study|Lack of Efficacy|1|||
162926383|NCT05022121|588431852|FG001|Overall Study|Lack of Efficacy|0|||
162926384|NCT05022121|588431851|FG000|Overall Study|Lost to Follow-up|0|||
162926385|NCT05022121|588431852|FG001|Overall Study|Lost to Follow-up|2|||
162926386|NCT01020773|588433712|FG000|Overall Study|Withdrawal by Subject|4|||
162926387|NCT01020773|588433713|FG001|Overall Study|Withdrawal by Subject|3|||
162926388|NCT03302299|588433714|FG000|Overall Study|Protocol Violation|1|||
162926389|NCT01458132|588433715|FG000|Overall Study|Other|15|||
162926390|NCT01458132|588433716|FG001|Overall Study|Other|3|||
162926391|NCT01788163|588433722|FG000|Overall Study|Other|53|||
162926392|NCT01788163|588433723|FG001|Overall Study|Other|0|||
162926393|NCT01788163|588433724|FG002|Overall Study|Other|0|||
162926394|NCT01788163|588433725|FG003|Overall Study|Other|0|||
162926395|NCT01788163|588433726|FG004|Overall Study|Other|0|||
162926396|NCT01788163|588433727|FG005|Overall Study|Other|7|||
162926397|NCT01788163|588433728|FG006|Overall Study|Other|1|||
162926398|NCT01788163|588433729|FG007|Overall Study|Other|48|||
162926399|NCT01788163|588433730|FG008|Overall Study|Other|15|||
162926400|NCT01788163|588433722|FG000|Overall Study|Withdrawal by Subject|2|||
162926401|NCT01788163|588433723|FG001|Overall Study|Withdrawal by Subject|0|||
162926402|NCT01788163|588433724|FG002|Overall Study|Withdrawal by Subject|0|||
162926403|NCT01788163|588433725|FG003|Overall Study|Withdrawal by Subject|0|||
162926404|NCT01788163|588433726|FG004|Overall Study|Withdrawal by Subject|0|||
162926405|NCT01788163|588433727|FG005|Overall Study|Withdrawal by Subject|0|||
162926406|NCT01788163|588433728|FG006|Overall Study|Withdrawal by Subject|0|||
162926407|NCT01788163|588433729|FG007|Overall Study|Withdrawal by Subject|0|||
162926408|NCT01788163|588433730|FG008|Overall Study|Withdrawal by Subject|1|||
162926409|NCT02803138|588433733|FG000|Overall Study|Failure to return|38|||
162926410|NCT02803138|588433733|FG000|Overall Study|Insufficient virological response|2|||
162926411|NCT02803138|588433733|FG000|Overall Study|Withdrawn consent|1|||
162926412|NCT02803138|588433733|FG000|Overall Study|Death|1|||
162926413|NCT02803138|588433733|FG000|Overall Study|Other, not specified|28|||
162926414|NCT00424515|588433734|FG000|Overall Study|Progressive Disease|10|||
162926415|NCT00424515|588433735|FG001|Overall Study|Progressive Disease|11|||
162926416|NCT00424515|588433734|FG000|Overall Study|Adverse Event|0|||
162926417|NCT00424515|588433735|FG001|Overall Study|Adverse Event|1|||
162926418|NCT00424515|588433734|FG000|Overall Study|Intercurrent Illness|0|||
162926419|NCT00424515|588433735|FG001|Overall Study|Intercurrent Illness|1|||
162926420|NCT00424515|588433734|FG000|Overall Study|Withdrawal by Subject|1|||
162926421|NCT00424515|588433735|FG001|Overall Study|Withdrawal by Subject|0|||
162926422|NCT04318535|588433736|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
162926423|NCT04318535|588433737|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
162926424|NCT04318535|588433738|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
162926425|NCT00021229|588433742|FG000|Overall Study|Adverse Event|10|||
162926426|NCT00021229|588433743|FG001|Overall Study|Adverse Event|5|||
162926427|NCT00021229|588433744|FG002|Overall Study|Adverse Event|2|||
162926428|NCT00021229|588433742|FG000|Overall Study|Death|0|||
162926429|NCT00021229|588433743|FG001|Overall Study|Death|1|||
162926430|NCT00021229|588433744|FG002|Overall Study|Death|0|||
162926431|NCT00021229|588433742|FG000|Overall Study|Withdrawal by Subject|7|||
162926432|NCT00021229|588433743|FG001|Overall Study|Withdrawal by Subject|7|||
162926433|NCT00021229|588433744|FG002|Overall Study|Withdrawal by Subject|1|||
162926434|NCT00021229|588433742|FG000|Overall Study|Progressive Disease|15|||
162926435|NCT00021229|588433743|FG001|Overall Study|Progressive Disease|19|||
162926436|NCT00021229|588433744|FG002|Overall Study|Progressive Disease|12|||
162926437|NCT00021229|588433742|FG000|Overall Study|Protocol Violation|1|||
162926438|NCT00021229|588433743|FG001|Overall Study|Protocol Violation|1|||
162926439|NCT00021229|588433744|FG002|Overall Study|Protocol Violation|0|||
162926440|NCT00021229|588433742|FG000|Overall Study|Physician Decision|0|||
162926441|NCT00021229|588433743|FG001|Overall Study|Physician Decision|0|||
162926442|NCT00021229|588433744|FG002|Overall Study|Physician Decision|1|||
162926443|NCT00021229|588433742|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
162926444|NCT00021229|588433743|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
162926445|NCT00021229|588433744|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
162926446|NCT02156466|588433745|FG000|Overall Study|Adverse Event|0|||
162926447|NCT02156466|588433746|FG001|Overall Study|Adverse Event|0|||
162926448|NCT02156466|588433747|FG002|Overall Study|Adverse Event|1|||
162926449|NCT02156466|588433748|FG003|Overall Study|Adverse Event|1|||
162926450|NCT02156466|588433749|FG004|Overall Study|Adverse Event|0|||
162926451|NCT02156466|588433745|FG000|Overall Study|Quantiferon Positivity|0|||
162926452|NCT02156466|588433746|FG001|Overall Study|Quantiferon Positivity|0|||
162926453|NCT02156466|588433747|FG002|Overall Study|Quantiferon Positivity|0|||
162926454|NCT02156466|588433748|FG003|Overall Study|Quantiferon Positivity|1|||
162926455|NCT02156466|588433749|FG004|Overall Study|Quantiferon Positivity|0|||
162926456|NCT00306852|588433750|FG000|Overall Study|Death|14|||
162926457|NCT00306852|588433751|FG001|Overall Study|Death|14|||
162926458|NCT00306852|588433750|FG000|Overall Study|Lost to Follow-up|15|||
162926459|NCT00306852|588433751|FG001|Overall Study|Lost to Follow-up|24|||
162926460|NCT00817778|588433752|FG000|Overall Study|Adverse Event|1|||
162926461|NCT00817778|588433753|FG001|Overall Study|Adverse Event|0|||
162926462|NCT00817778|588433752|FG000|Overall Study|Withdrawal by Subject|1|||
162926463|NCT00817778|588433753|FG001|Overall Study|Withdrawal by Subject|1|||
162926464|NCT00817778|588433752|FG000|Overall Study|Protocol Violation|0|||
162926465|NCT00817778|588433753|FG001|Overall Study|Protocol Violation|1|||
162926466|NCT00817778|588433752|FG000|Overall Study|Study-specific discontinuation criteria|0|||
162926467|NCT00817778|588433753|FG001|Overall Study|Study-specific discontinuation criteria|1|||
162926468|NCT00817778|588433752|FG000|Overall Study|Poor venous access|1|||
162926469|NCT00817778|588433753|FG001|Overall Study|Poor venous access|0|||
162926470|NCT00883740|588433754|FG000|First Intervention|Lost to Follow-up|1|||
162926471|NCT00883740|588433755|FG001|First Intervention|Lost to Follow-up|0|||
162926472|NCT00883740|588433754|FG000|First Intervention|No longer willing to participate|2|||
162926473|NCT00883740|588433755|FG001|First Intervention|No longer willing to participate|0|||
162926474|NCT00883740|588433754|FG000|First Intervention|Protocol Violation|3|||
162926475|NCT00883740|588433755|FG001|First Intervention|Protocol Violation|6|||
162926476|NCT00883740|588433754|FG000|First Intervention|Adverse Event|1|||
162926477|NCT00883740|588433755|FG001|First Intervention|Adverse Event|2|||
162926478|NCT00883740|588433754|FG000|Second Intervention|Protocol Violation|1|||
162926479|NCT00883740|588433755|FG001|Second Intervention|Protocol Violation|0|||
162926480|NCT00883740|588433754|FG000|Second Intervention|No longer willing to participate|0|||
162926481|NCT00883740|588433755|FG001|Second Intervention|No longer willing to participate|1|||
162926482|NCT01286207|588433756|FG000|Overall Study|Adverse Event|27|||
162926483|NCT01286207|588433757|FG001|Overall Study|Adverse Event|41|||
162926484|NCT01286207|588433758|FG002|Overall Study|Adverse Event|8|||
162926485|NCT01286207|588433756|FG000|Overall Study|Lost to Follow-up|49|||
162926486|NCT01286207|588433757|FG001|Overall Study|Lost to Follow-up|43|||
162926487|NCT01286207|588433758|FG002|Overall Study|Lost to Follow-up|20|||
162926488|NCT01286207|588433756|FG000|Overall Study|Withdrawal by Subject|93|||
162926489|NCT01286207|588433757|FG001|Overall Study|Withdrawal by Subject|79|||
162926490|NCT01286207|588433758|FG002|Overall Study|Withdrawal by Subject|41|||
162926491|NCT01286207|588433756|FG000|Overall Study|Lack of Response|92|||
162926492|NCT01286207|588433757|FG001|Overall Study|Lack of Response|38|||
162926493|NCT01286207|588433758|FG002|Overall Study|Lack of Response|8|||
162926494|NCT01286207|588433756|FG000|Overall Study|Other|37|||
162926495|NCT01286207|588433757|FG001|Overall Study|Other|47|||
162926496|NCT01286207|588433758|FG002|Overall Study|Other|13|||
162926497|NCT00103259|588433763|FG000|Overall Study|Death|3|||
162926498|NCT00103259|588433764|FG001|Overall Study|Death|2|||
162926499|NCT00103259|588433763|FG000|Overall Study|Withdrawal by Subject|2|||
162926500|NCT00103259|588433764|FG001|Overall Study|Withdrawal by Subject|3|||
162926501|NCT00103259|588433763|FG000|Overall Study|alternative therapy|1|||
162926502|NCT00103259|588433764|FG001|Overall Study|alternative therapy|0|||
162926503|NCT00103259|588433763|FG000|Overall Study|other (reasons were not specified)|2|||
162926504|NCT00103259|588433764|FG001|Overall Study|other (reasons were not specified)|1|||
162926505|NCT00103259|588433763|FG000|Overall Study|ineligible/no protocol therapy|4|||
162926506|NCT00103259|588433764|FG001|Overall Study|ineligible/no protocol therapy|6|||
162926507|NCT03224234|588433765|FG000|Main Study|Lost to Follow-up|5|||
162926508|NCT03224234|588433766|FG001|Main Study|Lost to Follow-up|5|||
162926509|NCT02610842|588433767|FG000|Overall Study|Lost to Follow-up|5|||
162926510|NCT02494583|588433770|FG000|Overall Study|Death|224|||
162926511|NCT02494583|588433771|FG001|Overall Study|Death|214|||
162926512|NCT02494583|588433772|FG002|Overall Study|Death|225|||
162926513|NCT02494583|588433770|FG000|Overall Study|Lost to Follow-up|1|||
162926514|NCT02494583|588433771|FG001|Overall Study|Lost to Follow-up|0|||
162926515|NCT02494583|588433772|FG002|Overall Study|Lost to Follow-up|0|||
162926516|NCT02494583|588433770|FG000|Overall Study|Protocol Violation|1|||
162926517|NCT02494583|588433771|FG001|Overall Study|Protocol Violation|2|||
162926518|NCT02494583|588433772|FG002|Overall Study|Protocol Violation|0|||
162926519|NCT02494583|588433770|FG000|Overall Study|Screen Failure|0|||
162926520|NCT02494583|588433771|FG001|Overall Study|Screen Failure|1|||
162926521|NCT02494583|588433772|FG002|Overall Study|Screen Failure|0|||
162926522|NCT02494583|588433770|FG000|Overall Study|Transferred to Extension Study|15|||
162926523|NCT02494583|588433771|FG001|Overall Study|Transferred to Extension Study|15|||
162926524|NCT02494583|588433772|FG002|Overall Study|Transferred to Extension Study|6|||
162926525|NCT02494583|588433770|FG000|Overall Study|Did Not Continue on Extension Study|8|||
162926526|NCT02494583|588433771|FG001|Overall Study|Did Not Continue on Extension Study|10|||
162926527|NCT02494583|588433772|FG002|Overall Study|Did Not Continue on Extension Study|4|||
162926528|NCT02494583|588433770|FG000|Overall Study|Withdrawal by Subject|7|||
162926529|NCT02494583|588433771|FG001|Overall Study|Withdrawal by Subject|15|||
162926530|NCT02494583|588433772|FG002|Overall Study|Withdrawal by Subject|15|||
162926531|NCT00627458|588433773|FG000|Overall Study|Migrated from study area|1|||
162926532|NCT00627458|588433774|FG001|Overall Study|Migrated from study area|0|||
162926533|NCT00627458|588433775|FG002|Overall Study|Migrated from study area|1|||
162926534|NCT00627458|588433773|FG000|Overall Study|Withdrawal by Subject|2|||
162926535|NCT00627458|588433774|FG001|Overall Study|Withdrawal by Subject|6|||
162926536|NCT00627458|588433775|FG002|Overall Study|Withdrawal by Subject|5|||
162926537|NCT00627458|588433773|FG000|Overall Study|Lost to Follow-up|1|||
162926538|NCT00627458|588433774|FG001|Overall Study|Lost to Follow-up|1|||
162926539|NCT00627458|588433775|FG002|Overall Study|Lost to Follow-up|0|||
162926540|NCT03151707|588433776|FG000|Overall Study|Lost to Follow-up|6|||
162926541|NCT04439149|588433777|FG000|Overall Study|Ineligible|1|||
162926542|NCT04439149|588433777|FG000|Overall Study|Never start protocol therapy|1|||
162926543|NCT04439149|588433777|FG000|Overall Study|Adverse Event|4|||
162926544|NCT04439149|588433777|FG000|Overall Study|Disease Progression|14|||
162926545|NCT04439149|588433777|FG000|Overall Study|Complicating disease|1|||
162926546|NCT04439149|588433777|FG000|Overall Study|Withdrawal by Subject|3|||
162926547|NCT02617446|588433778|FG000|Overall Study|Withdrawal by Subject|0|||
162926548|NCT02617446|588433779|FG001|Overall Study|Withdrawal by Subject|2|||
162926549|NCT02617446|588433780|FG002|Overall Study|Withdrawal by Subject|0|||
162926550|NCT02617446|588433778|FG000|Overall Study|Adverse Event|1|||
162926551|NCT02617446|588433779|FG001|Overall Study|Adverse Event|0|||
162926552|NCT02617446|588433780|FG002|Overall Study|Adverse Event|5|||
162926553|NCT02617446|588433778|FG000|Overall Study|Lost to Follow-up|3|||
162926554|NCT02617446|588433779|FG001|Overall Study|Lost to Follow-up|0|||
162926555|NCT02617446|588433780|FG002|Overall Study|Lost to Follow-up|0|||
162926556|NCT02617446|588433778|FG000|Overall Study|Death|0|||
162926557|NCT02617446|588433779|FG001|Overall Study|Death|0|||
162926558|NCT02617446|588433780|FG002|Overall Study|Death|2|||
162926559|NCT00530088|588433789|FG000|Overall Study|Disease Progression|4|||
162926560|NCT00530088|588433789|FG000|Overall Study|Physician Decision|4|||
162926561|NCT00530088|588433789|FG000|Overall Study|Other Not Specified|2|||
162926562|NCT05264506|588433792|FG000|Overall Study|Adverse Event|59|||
162926563|NCT05264506|588433792|FG000|Overall Study|Lost to Follow-up|204|||
162926564|NCT05264506|588433792|FG000|Overall Study|Protocol Violation|185|||
162926565|NCT05264506|588433792|FG000|Overall Study|Pregnancy|60|||
162926566|NCT05264506|588433792|FG000|Overall Study|Physician Decision|6|||
162926567|NCT05264506|588433792|FG000|Overall Study|Non-compliance with Study Drug|29|||
162926568|NCT05264506|588433792|FG000|Overall Study|Study termination|677|||
162926569|NCT05264506|588433792|FG000|Overall Study|Withdrawal by Subject|208|||
162926570|NCT05264506|588433792|FG000|Overall Study|Discontinued prior treatment|89|||
162926571|NCT00644228|588433793|FG000|Randomization & Eligibility|Ineligible|31|||
162926572|NCT00644228|588433794|FG001|Randomization & Eligibility|Ineligible|21|||
162926573|NCT00644228|588433793|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
162926574|NCT00644228|588433794|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
162926575|NCT00644228|588433793|FG000|Randomization & Eligibility|Invalid Consent|0|||
162926576|NCT00644228|588433794|FG001|Randomization & Eligibility|Invalid Consent|1|||
162926577|NCT00644228|588433793|FG000|Induction Therapy|Adverse Event|22|||
162926578|NCT00644228|588433794|FG001|Induction Therapy|Adverse Event|55|||
162926579|NCT00644228|588433793|FG000|Induction Therapy|Withdrawal by Subject|10|||
162926580|NCT00644228|588433794|FG001|Induction Therapy|Withdrawal by Subject|3|||
162926581|NCT00644228|588433793|FG000|Induction Therapy|Progression/Relapse|24|||
162926582|NCT00644228|588433794|FG001|Induction Therapy|Progression/Relapse|12|||
162926583|NCT00644228|588433793|FG000|Induction Therapy|Death|3|||
162926584|NCT00644228|588433794|FG001|Induction Therapy|Death|7|||
162926585|NCT00644228|588433793|FG000|Induction Therapy|Not Protocol-Specified|24|||
162926586|NCT00644228|588433794|FG001|Induction Therapy|Not Protocol-Specified|28|||
162926587|NCT00644228|588433793|FG000|Maintenance|Adverse Event|27|||
162926588|NCT00644228|588433794|FG001|Maintenance|Adverse Event|31|||
162926589|NCT00644228|588433793|FG000|Maintenance|Withdrawal by Subject|6|||
162926590|NCT00644228|588433794|FG001|Maintenance|Withdrawal by Subject|4|||
162926591|NCT00644228|588433793|FG000|Maintenance|Progression/Relapse|67|||
162926592|NCT00644228|588433794|FG001|Maintenance|Progression/Relapse|42|||
162926593|NCT00644228|588433793|FG000|Maintenance|Death|3|||
162926594|NCT00644228|588433794|FG001|Maintenance|Death|3|||
162926595|NCT00644228|588433793|FG000|Maintenance|Not Protocol-Specified|14|||
162926596|NCT00644228|588433794|FG001|Maintenance|Not Protocol-Specified|15|||
162926597|NCT00644228|588433793|FG000|Maintenance|On Treatment|26|||
162926598|NCT00644228|588433794|FG001|Maintenance|On Treatment|40|||
162926599|NCT06078124|588433795|FG000|Overall Study|Lost to Follow-up|14|||
162926600|NCT06078124|588433796|FG001|Overall Study|Lost to Follow-up|14|||
162926601|NCT03252756|588433805|FG000|Overall Study|Protocol Violation|2|||
162926602|NCT03252756|588433806|FG001|Overall Study|Protocol Violation|4|||
162926603|NCT03252756|588433805|FG000|Overall Study|COVID-19 Pandemic|1|||
162926604|NCT03252756|588433806|FG001|Overall Study|COVID-19 Pandemic|1|||
162926605|NCT03252756|588433805|FG000|Overall Study|Study Drug Expiration|0|||
162926606|NCT03252756|588433806|FG001|Overall Study|Study Drug Expiration|1|||
162926607|NCT04223193|588433807|FG000|Overall Study|Adverse Event|6|||
162926608|NCT04223193|588433808|FG001|Overall Study|Adverse Event|36|||
162926609|NCT04223193|588433807|FG000|Overall Study|Lack of Efficacy|2|||
162926610|NCT04223193|588433808|FG001|Overall Study|Lack of Efficacy|2|||
162926611|NCT04223193|588433807|FG000|Overall Study|Lost to Follow-up|1|||
162926612|NCT04223193|588433808|FG001|Overall Study|Lost to Follow-up|1|||
162926613|NCT04223193|588433807|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
162926614|NCT04223193|588433808|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
162926615|NCT04223193|588433807|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
162926616|NCT04223193|588433808|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
162926617|NCT04223193|588433807|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162926618|NCT04223193|588433808|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162926619|NCT04223193|588433807|FG000|Overall Study|Physician Decision|0|||
162926620|NCT04223193|588433808|FG001|Overall Study|Physician Decision|1|||
162926621|NCT04223193|588433807|FG000|Overall Study|Protocol Violation|1|||
162926622|NCT04223193|588433808|FG001|Overall Study|Protocol Violation|1|||
162926623|NCT04223193|588433807|FG000|Overall Study|Site Terminated by Sponsor|1|||
162926624|NCT04223193|588433808|FG001|Overall Study|Site Terminated by Sponsor|3|||
162926625|NCT04223193|588433807|FG000|Overall Study|Withdrawal by Subject|5|||
162926626|NCT04223193|588433808|FG001|Overall Study|Withdrawal by Subject|6|||
162926627|NCT04223193|588433807|FG000|Overall Study|Other|3|||
162926628|NCT04223193|588433808|FG001|Overall Study|Other|6|||
162926629|NCT03594175|588433809|FG000|Overall Study|Not treated|8|||
162926630|NCT03594175|588433810|FG001|Overall Study|Not treated|1|||
162926631|NCT03594175|588433811|FG002|Overall Study|Not treated|5|||
162926632|NCT03594175|588433809|FG000|Overall Study|Adverse Event|3|||
162926633|NCT03594175|588433810|FG001|Overall Study|Adverse Event|0|||
162926634|NCT03594175|588433811|FG002|Overall Study|Adverse Event|0|||
162926635|NCT03594175|588433809|FG000|Overall Study|Withdrawal by Subject|3|||
162926636|NCT03594175|588433810|FG001|Overall Study|Withdrawal by Subject|0|||
162926637|NCT03594175|588433811|FG002|Overall Study|Withdrawal by Subject|0|||
162926638|NCT03594175|588433809|FG000|Overall Study|Protocol Violation|2|||
162926639|NCT03594175|588433810|FG001|Overall Study|Protocol Violation|2|||
162926640|NCT03594175|588433811|FG002|Overall Study|Protocol Violation|2|||
162926641|NCT03732677|588433812|FG000|Overall Study|Terminated the study|154|||
162926642|NCT03732677|588433813|FG001|Overall Study|Terminated the study|197|||
162926643|NCT03732677|588433812|FG000|Overall Study|Continuing study off treatment|379|||
162926644|NCT03732677|588433813|FG001|Overall Study|Continuing study off treatment|333|||
162926645|NCT04066894|588433815|FG000|Overall Study|Lack of Efficacy|1|||
162926646|NCT04066894|588433815|FG000|Overall Study|Screen Failure|1|||
162926647|NCT01500434|588433816|FG000|Overall Study|Death|1|||
162926648|NCT01500434|588433816|FG000|Overall Study|Withdrawal by Subject|1|||
162926649|NCT01500434|588433816|FG000|Overall Study|Missed 12-month follow-up|5|||
162926650|NCT00096031|588433817|FG000|Overall Study|Adverse Event|3|||
162926651|NCT00096031|588433817|FG000|Overall Study|Lack of Efficacy|42|||
162926652|NCT00096031|588433817|FG000|Overall Study|Death|4|||
162926653|NCT00096031|588433817|FG000|Overall Study|Withdrawal by Subject|1|||
162926654|NCT00096031|588433817|FG000|Overall Study|Ineligible|8|||
162926655|NCT00096031|588433817|FG000|Overall Study|Not protocol specified|5|||
162926656|NCT00483717|588433818|FG000|Overall Study|Protocol Violation|5|||
162926657|NCT00483717|588433819|FG001|Overall Study|Protocol Violation|7|||
162926658|NCT00483717|588433818|FG000|Overall Study|Time of dosing missing|1|||
162926659|NCT00483717|588433819|FG001|Overall Study|Time of dosing missing|1|||
162926660|NCT00483717|588433818|FG000|Overall Study|No treatment for migraine|16|||
162926661|NCT00483717|588433819|FG001|Overall Study|No treatment for migraine|13|||
162926662|NCT00483717|588433818|FG000|Overall Study|Lost to Follow-up|1|||
162926663|NCT00483717|588433819|FG001|Overall Study|Lost to Follow-up|0|||
162926664|NCT00483717|588433818|FG000|Overall Study|Withdrawal by Subject|1|||
162926665|NCT00483717|588433819|FG001|Overall Study|Withdrawal by Subject|0|||
162926666|NCT00083226|588433820|FG000|Overall Study|Lack of Efficacy|19|||
162926667|NCT00083226|588433820|FG000|Overall Study|Adverse Event|9|||
162926668|NCT00083226|588433820|FG000|Overall Study|Death|4|||
162926669|NCT00083226|588433820|FG000|Overall Study|Withdrawal by Subject|4|||
162926670|NCT00083226|588433820|FG000|Overall Study|Other|2|||
162926671|NCT00083226|588433820|FG000|Overall Study|ineligible or not receiving treatment|4|||
162926672|NCT00909857|588433821|FG000|Overall Study|Withdrawal by Subject|6|||
162926673|NCT00909857|588433822|FG001|Overall Study|Withdrawal by Subject|10|||
162926674|NCT00909857|588433821|FG000|Overall Study|Adverse Event|5|||
162926675|NCT00909857|588433822|FG001|Overall Study|Adverse Event|5|||
162926676|NCT00909857|588433821|FG000|Overall Study|Lost to Follow-up|2|||
162926677|NCT00909857|588433822|FG001|Overall Study|Lost to Follow-up|5|||
162926678|NCT00909857|588433821|FG000|Overall Study|Protocol Violation|2|||
162926679|NCT00909857|588433822|FG001|Overall Study|Protocol Violation|1|||
162926680|NCT00909857|588433821|FG000|Overall Study|Pregnancy|1|||
162926681|NCT00909857|588433822|FG001|Overall Study|Pregnancy|0|||
162926682|NCT00909857|588433821|FG000|Overall Study|Other|1|||
162926683|NCT00909857|588433822|FG001|Overall Study|Other|0|||
162926684|NCT00909857|588433821|FG000|Overall Study|Did not receive study medication|19|||
162926685|NCT00909857|588433822|FG001|Overall Study|Did not receive study medication|24|||
162926686|NCT03878108|588433823|FG000|Overall Study|Adverse Event|1|||
162926687|NCT03878108|588433824|FG001|Overall Study|Adverse Event|0|||
162926688|NCT00604175|588433825|FG000|Entry Through Week 28|Death|2|||
162926689|NCT00604175|588433826|FG001|Entry Through Week 28|Death|0|||
162926690|NCT00604175|588433827|FG002|Entry Through Week 28|Death|0|||
162926691|NCT00604175|588433825|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
162926692|NCT00604175|588433826|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
162926693|NCT00604175|588433827|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
162926694|NCT00604175|588433825|FG000|Entry Through Week 28|Lost to Follow-up|4|||
162926695|NCT00604175|588433826|FG001|Entry Through Week 28|Lost to Follow-up|3|||
162926696|NCT00604175|588433827|FG002|Entry Through Week 28|Lost to Follow-up|0|||
162926697|NCT00604175|588433825|FG000|Entry Through Week 28|Ineligible|1|||
162926698|NCT00604175|588433826|FG001|Entry Through Week 28|Ineligible|0|||
162926699|NCT00604175|588433827|FG002|Entry Through Week 28|Ineligible|0|||
162926700|NCT00604175|588433825|FG000|Entry Through Week 28|Did not start intervention|2|||
162926701|NCT00604175|588433826|FG001|Entry Through Week 28|Did not start intervention|0|||
162926702|NCT00604175|588433827|FG002|Entry Through Week 28|Did not start intervention|1|||
162926703|NCT00604175|588433825|FG000|Week 29 Through Week 72|Death|0|||
162926704|NCT00604175|588433826|FG001|Week 29 Through Week 72|Death|0|||
162926705|NCT00604175|588433827|FG002|Week 29 Through Week 72|Death|1|||
162926706|NCT00604175|588433825|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
162926707|NCT00604175|588433826|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
162926708|NCT00604175|588433827|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
162926709|NCT00604175|588433825|FG000|Week 29 Through Week 72|Site closure|0|||
162926710|NCT00604175|588433826|FG001|Week 29 Through Week 72|Site closure|1|||
162926711|NCT00604175|588433827|FG002|Week 29 Through Week 72|Site closure|0|||
162926712|NCT00604175|588433825|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
162926713|NCT00604175|588433826|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
162926714|NCT00604175|588433827|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
162926715|NCT03353415|588433828|FG000|Masked CGM Wear|Lost to Follow-up|2|||
162926716|NCT03353415|588433828|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
162926717|NCT00131937|588433829|FG000|Overall Study|Adverse Event|3|||
162926718|NCT00131937|588433829|FG000|Overall Study|Withdrawal by Subject|2|||
162926719|NCT00131937|588433829|FG000|Overall Study|Physician Decision|1|||
162926720|NCT00131937|588433829|FG000|Overall Study|Disease Progression|7|||
162926721|NCT00131937|588433829|FG000|Overall Study|Alternative therapy|1|||
162926722|NCT04647253|588433836|FG000|Overall Study|Death ≤ 365 Days|16|||
162926723|NCT04647253|588433837|FG001|Overall Study|Death ≤ 365 Days|7|||
162926724|NCT04647253|588433836|FG000|Overall Study|Physician Decision|0|||
162926725|NCT04647253|588433837|FG001|Overall Study|Physician Decision|1|||
162926726|NCT04647253|588433836|FG000|Overall Study|Withdrawal by Subject|7|||
162926727|NCT04647253|588433837|FG001|Overall Study|Withdrawal by Subject|2|||
162926728|NCT04647253|588433836|FG000|Overall Study|Missed 12-Month Visit|9|||
162926729|NCT04647253|588433837|FG001|Overall Study|Missed 12-Month Visit|7|||
162926730|NCT04647253|588433836|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
162926731|NCT04647253|588433837|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
162926732|NCT04502862|588433840|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
162926733|NCT04502862|588433841|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
162926734|NCT04502862|588433840|FG000|Overall Study|Withdrawal by Subject|1|||
162926735|NCT04502862|588433841|FG001|Overall Study|Withdrawal by Subject|0|||
162926736|NCT04502862|588433840|FG000|Overall Study|Adverse Event|1|||
162926737|NCT04502862|588433841|FG001|Overall Study|Adverse Event|1|||
162926738|NCT02038959|588435143|FG000|Overall Study|Withdrawal by Subject|6|||
162926739|NCT02038959|588435144|FG001|Overall Study|Withdrawal by Subject|8|||
162926740|NCT00819091|588435150|FG000|Overall Study|Adverse Event|3|||
162926741|NCT00819091|588435151|FG001|Overall Study|Adverse Event|5|||
162926742|NCT00819091|588435150|FG000|Overall Study|Protocol Violation|0|||
162926743|NCT00819091|588435151|FG001|Overall Study|Protocol Violation|1|||
162926744|NCT00819091|588435150|FG000|Overall Study|Lost to Follow-up|2|||
162926745|NCT00819091|588435151|FG001|Overall Study|Lost to Follow-up|0|||
162926746|NCT00819091|588435150|FG000|Overall Study|Withdrawal by Subject|1|||
162926747|NCT00819091|588435151|FG001|Overall Study|Withdrawal by Subject|2|||
162926748|NCT00819091|588435150|FG000|Overall Study|Other|1|||
162926749|NCT00819091|588435151|FG001|Overall Study|Other|2|||
162926750|NCT00545441|588435152|FG000|Overall Study|Fistula draining at 6 months|2|||
162926751|NCT00545441|588435153|FG001|Overall Study|Fistula draining at 6 months|4|||
162926752|NCT00545441|588435152|FG000|Overall Study|Lost to Follow-up|9|||
162926753|NCT00545441|588435153|FG001|Overall Study|Lost to Follow-up|5|||
162926754|NCT00545441|588435152|FG000|Overall Study|Technical failure|0|||
162926755|NCT00545441|588435153|FG001|Overall Study|Technical failure|1|||
162926756|NCT00545441|588435152|FG000|Overall Study|Withdrawal by Subject|1|||
162926757|NCT00545441|588435153|FG001|Overall Study|Withdrawal by Subject|1|||
162926758|NCT00545441|588435152|FG000|Overall Study|Persistence or recurrence of fistula|5|||
162926759|NCT00545441|588435153|FG001|Overall Study|Persistence or recurrence of fistula|2|||
162926760|NCT00545441|588435152|FG000|Overall Study|Patients were not treated|1|||
162926761|NCT00545441|588435153|FG001|Overall Study|Patients were not treated|3|||
162926762|NCT03911960|588435154|FG000|Overall Study|Lost to Follow-up|5|||
162926763|NCT03911960|588435155|FG001|Overall Study|Lost to Follow-up|3|||
162926764|NCT00265239|588435156|FG000|Overall Study|Adverse Event|2|||
162926765|NCT00265239|588435157|FG001|Overall Study|Adverse Event|1|||
162926766|NCT04071366|588435158|FG000|Part 1: Open-label (29 Days)|Death|4|||
162926767|NCT04071366|588435159|FG001|Part 1: Open-label (29 Days)|Death|2|||
162926768|NCT04071366|588435160|FG002|Part 1: Open-label (29 Days)|Death|8|||
162926769|NCT04071366|588435161|FG003|Part 1: Open-label (29 Days)|Death|0|||
162926770|NCT04071366|588435162|FG004|Part 1: Open-label (29 Days)|Death|0|||
162926771|NCT04071366|588435158|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
162926772|NCT04071366|588435159|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
162926773|NCT04071366|588435160|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
162926774|NCT04071366|588435161|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
162926775|NCT04071366|588435162|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
162926776|NCT04071366|588435158|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
162926777|NCT04071366|588435159|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
162926778|NCT04071366|588435160|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
162926779|NCT04071366|588435161|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
162926780|NCT04071366|588435162|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
162926781|NCT04071366|588435158|FG000|Part 2: Randomized (29 Days)|Death|0|||
162926782|NCT04071366|588435159|FG001|Part 2: Randomized (29 Days)|Death|0|||
162926783|NCT04071366|588435160|FG002|Part 2: Randomized (29 Days)|Death|0|||
162926784|NCT04071366|588435161|FG003|Part 2: Randomized (29 Days)|Death|2|||
162926785|NCT04071366|588435162|FG004|Part 2: Randomized (29 Days)|Death|2|||
162926786|NCT04071366|588435158|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
162926787|NCT04071366|588435159|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
162926788|NCT04071366|588435160|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
162926789|NCT04071366|588435161|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
162926790|NCT04071366|588435162|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
162926791|NCT04071366|588435158|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
162926792|NCT04071366|588435159|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
162926793|NCT04071366|588435160|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
162926794|NCT04071366|588435161|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
162926795|NCT04071366|588435162|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
162926796|NCT04071366|588435158|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
162926797|NCT04071366|588435159|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
162926798|NCT04071366|588435160|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
162926799|NCT04071366|588435161|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
162926800|NCT04071366|588435162|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
162926801|NCT04071366|588435158|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
162926802|NCT04071366|588435159|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
162926803|NCT04071366|588435160|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
162926804|NCT04071366|588435161|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
162926805|NCT04071366|588435162|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
162926806|NCT04071366|588435158|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
162926807|NCT04071366|588435159|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
162926808|NCT04071366|588435160|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
162926809|NCT04071366|588435161|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
162926810|NCT04071366|588435162|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
162926811|NCT04071366|588435158|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
162926812|NCT04071366|588435159|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
162926813|NCT04071366|588435160|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
162926814|NCT04071366|588435161|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
162926815|NCT04071366|588435162|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
162926816|NCT01858558|588435163|FG000|Overall Study|Death|1|||
162926817|NCT01858558|588435164|FG001|Overall Study|Death|1|||
162926818|NCT01858558|588435163|FG000|Overall Study|Lost to Follow-up|1|||
162926819|NCT01858558|588435164|FG001|Overall Study|Lost to Follow-up|0|||
162926820|NCT01858558|588435163|FG000|Overall Study|Disease progression|3|||
162926821|NCT01858558|588435164|FG001|Overall Study|Disease progression|1|||
162926822|NCT01858558|588435163|FG000|Overall Study|Product contamination|2|||
162926823|NCT01858558|588435164|FG001|Overall Study|Product contamination|0|||
162926824|NCT01858558|588435163|FG000|Overall Study|Failed expansion of cell product|2|||
162926825|NCT01858558|588435164|FG001|Overall Study|Failed expansion of cell product|0|||
162926826|NCT01336608|588435165|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
162926827|NCT01336608|588435166|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
162926828|NCT01336608|588435167|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
162926829|NCT01336608|588435168|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
162926830|NCT01336608|588435165|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
162926831|NCT01336608|588435166|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
162926832|NCT01336608|588435167|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
162926833|NCT01336608|588435168|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
162926834|NCT01336608|588435165|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
162926835|NCT01336608|588435166|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
162926836|NCT01336608|588435167|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
162926837|NCT01336608|588435168|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
162926838|NCT01336608|588435165|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
162926839|NCT01336608|588435166|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
162926840|NCT01336608|588435167|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
162926841|NCT01336608|588435168|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
162926842|NCT01336608|588435165|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
162926843|NCT01336608|588435166|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
162926844|NCT01336608|588435167|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
162926845|NCT01336608|588435168|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
162926846|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
162926847|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
162926848|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
162926849|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
162926850|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
162926851|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
162926852|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
162926853|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
162926854|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
162926855|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
162926856|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
162926857|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
162926858|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
162926859|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
162926860|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
162926861|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
162926862|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
162926863|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
162926864|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
162926865|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
162926866|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162926867|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
162926868|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162926869|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162926870|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
162926871|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
162926872|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
162926873|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
162926874|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
162926875|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
162926876|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
162926877|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
162926878|NCT00399490|588435173|FG000|Overall Study|Adverse Event|19|||
162926879|NCT00399490|588435173|FG000|Overall Study|Lack of Efficacy|31|||
162926880|NCT00399490|588435173|FG000|Overall Study|Lost to Follow-up|5|||
162926881|NCT00399490|588435173|FG000|Overall Study|Withdrawal by Subject|18|||
162926882|NCT00399490|588435173|FG000|Overall Study|Other|25|||
162926883|NCT02437890|588435174|FG000|Overall Study|Non-compliance to study drug|0|||
162926884|NCT02437890|588435175|FG001|Overall Study|Non-compliance to study drug|1|||
162926885|NCT02437890|588435176|FG002|Overall Study|Non-compliance to study drug|0|||
162926886|NCT02437890|588435177|FG003|Overall Study|Non-compliance to study drug|0|||
162926887|NCT02437890|588435178|FG004|Overall Study|Non-compliance to study drug|1|||
162926888|NCT02437890|588435174|FG000|Overall Study|Sponsor's decision|1|||
162926889|NCT02437890|588435175|FG001|Overall Study|Sponsor's decision|1|||
162926890|NCT02437890|588435176|FG002|Overall Study|Sponsor's decision|4|||
162926891|NCT02437890|588435177|FG003|Overall Study|Sponsor's decision|0|||
162926892|NCT02437890|588435178|FG004|Overall Study|Sponsor's decision|2|||
162926893|NCT02437890|588435174|FG000|Overall Study|Physician Decision|0|||
162926894|NCT02437890|588435175|FG001|Overall Study|Physician Decision|0|||
162926895|NCT02437890|588435176|FG002|Overall Study|Physician Decision|0|||
162926896|NCT02437890|588435177|FG003|Overall Study|Physician Decision|1|||
162926897|NCT02437890|588435178|FG004|Overall Study|Physician Decision|0|||
162926898|NCT02437890|588435174|FG000|Overall Study|Unable to attend visit(s)|1|||
162926899|NCT02437890|588435175|FG001|Overall Study|Unable to attend visit(s)|0|||
162926900|NCT02437890|588435176|FG002|Overall Study|Unable to attend visit(s)|0|||
162926901|NCT02437890|588435177|FG003|Overall Study|Unable to attend visit(s)|0|||
162926902|NCT02437890|588435178|FG004|Overall Study|Unable to attend visit(s)|0|||
162926903|NCT02437890|588435174|FG000|Overall Study|Lack of Efficacy|1|||
162926904|NCT02437890|588435175|FG001|Overall Study|Lack of Efficacy|3|||
162926905|NCT02437890|588435176|FG002|Overall Study|Lack of Efficacy|0|||
162926906|NCT02437890|588435177|FG003|Overall Study|Lack of Efficacy|3|||
162926907|NCT02437890|588435178|FG004|Overall Study|Lack of Efficacy|1|||
162926908|NCT02437890|588435174|FG000|Overall Study|Adverse Event|4|||
162926909|NCT02437890|588435175|FG001|Overall Study|Adverse Event|9|||
162926910|NCT02437890|588435176|FG002|Overall Study|Adverse Event|5|||
162926911|NCT02437890|588435177|FG003|Overall Study|Adverse Event|11|||
162926912|NCT02437890|588435178|FG004|Overall Study|Adverse Event|7|||
162926913|NCT02437890|588435174|FG000|Overall Study|Withdrawal by Subject|1|||
162926914|NCT02437890|588435175|FG001|Overall Study|Withdrawal by Subject|2|||
162926915|NCT02437890|588435176|FG002|Overall Study|Withdrawal by Subject|6|||
162926916|NCT02437890|588435177|FG003|Overall Study|Withdrawal by Subject|5|||
162926917|NCT02437890|588435178|FG004|Overall Study|Withdrawal by Subject|5|||
162926918|NCT02437890|588435174|FG000|Overall Study|Death|0|||
162926919|NCT02437890|588435175|FG001|Overall Study|Death|0|||
162926920|NCT02437890|588435176|FG002|Overall Study|Death|0|||
162926921|NCT02437890|588435177|FG003|Overall Study|Death|2|||
162926922|NCT02437890|588435178|FG004|Overall Study|Death|0|||
163385757|NCT00146328|590123241|FG002|Overall Study|Adverse Event|79|||
162926923|NCT02328547|588435179|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
162926924|NCT02328547|588435180|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
162926925|NCT02328547|588435179|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
162926926|NCT02328547|588435180|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
162926927|NCT00344305|588435181|FG000|Overall Study|Lost to Follow-up|2|||
162926928|NCT00344305|588435182|FG001|Overall Study|Lost to Follow-up|0|||
162926929|NCT00344305|588435181|FG000|Overall Study|Participant was not contacted in window|0|||
162926930|NCT00344305|588435182|FG001|Overall Study|Participant was not contacted in window|1|||
162926931|NCT01422720|588435184|FG000|Overall Study|Adverse Event|16|||
162926932|NCT01422720|588435184|FG000|Overall Study|Lack of Efficacy|1|||
162926933|NCT01422720|588435184|FG000|Overall Study|Withdrawal by Subject|4|||
162926934|NCT01422720|588435184|FG000|Overall Study|Ineligibility|1|||
162926935|NCT01796860|588435188|FG000|Overall Study|Withdrawal by Subject|3|||
162926936|NCT00647426|588435196|FG000|Overall Study|Withdrawal by Subject|2|||
162926937|NCT01537549|588435198|FG000|Overall Study|Lost to Follow-up|1|||
162926938|NCT01537549|588435198|FG000|Overall Study|Withdrawal by Subject|2|||
162926939|NCT00068406|588435201|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
162926940|NCT00068406|588435201|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
162926941|NCT02609178|588435202|FG000|First Crown|Withdrawal by Subject|0|||
162926942|NCT02609178|588435203|FG001|First Crown|Withdrawal by Subject|0|||
162926943|NCT02609178|588435204|FG002|First Crown|Withdrawal by Subject|1|||
162926944|NCT02609178|588435205|FG003|First Crown|Withdrawal by Subject|1|||
162926945|NCT02609178|588435206|FG004|First Crown|Withdrawal by Subject|0|||
162926946|NCT02609178|588435207|FG005|First Crown|Withdrawal by Subject|0|||
162926947|NCT00902265|588435210|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
162926948|NCT00902265|588435210|FG000|Overall Study|Adverse Event|2|||
162926949|NCT00902265|588435210|FG000|Overall Study|Lack of Efficacy|2|||
162926950|NCT00902265|588435210|FG000|Overall Study|Protocol Violation|1|||
162926951|NCT02866695|588435211|FG000|Overall Study|Adverse Event|1|||
162926952|NCT02866695|588435211|FG000|Overall Study|Lost to Follow-up|1|||
162926953|NCT05016765|588435212|FG000|Overall Study|Lost to Follow-up|4|||
162926954|NCT03891875|588435215|FG000|Overall Study|Withdrawal by Subject|20|||
162926955|NCT03891875|588435216|FG001|Overall Study|Withdrawal by Subject|3|||
162926956|NCT03891875|588435215|FG000|Overall Study|Adverse Event|10|||
162926957|NCT03891875|588435216|FG001|Overall Study|Adverse Event|4|||
162926958|NCT03891875|588435215|FG000|Overall Study|Physician Decision|1|||
162926959|NCT03891875|588435216|FG001|Overall Study|Physician Decision|1|||
162926960|NCT03891875|588435215|FG000|Overall Study|Protocol Violation|1|||
162926961|NCT03891875|588435216|FG001|Overall Study|Protocol Violation|0|||
162926962|NCT03891875|588435215|FG000|Overall Study|Lost to Follow-up|1|||
162926963|NCT03891875|588435216|FG001|Overall Study|Lost to Follow-up|0|||
162926964|NCT03891875|588435215|FG000|Overall Study|COVID-19 infection|1|||
162926965|NCT03891875|588435216|FG001|Overall Study|COVID-19 infection|0|||
162926966|NCT00285012|588435235|FG000|Assigned to Study Treatment (Tx)|Other|2|||
162926967|NCT00285012|588435236|FG001|Assigned to Study Treatment (Tx)|Other|3|||
162926968|NCT00285012|588435235|FG000|Received Study Tx|Death|2|||
162926969|NCT00285012|588435236|FG001|Received Study Tx|Death|1|||
162926970|NCT00285012|588435235|FG000|Received Study Tx|Adverse Event|5|||
162926971|NCT00285012|588435236|FG001|Received Study Tx|Adverse Event|11|||
162926972|NCT00285012|588435235|FG000|Received Study Tx|Lack of Efficacy|0|||
162926973|NCT00285012|588435236|FG001|Received Study Tx|Lack of Efficacy|3|||
162926974|NCT00285012|588435235|FG000|Received Study Tx|Lost to Follow-up|29|||
162926975|NCT00285012|588435236|FG001|Received Study Tx|Lost to Follow-up|31|||
162926976|NCT00285012|588435235|FG000|Received Study Tx|Withdrawal by Subject|31|||
162926977|NCT00285012|588435236|FG001|Received Study Tx|Withdrawal by Subject|43|||
162926978|NCT00285012|588435235|FG000|Received Study Tx|Other|5|||
162926979|NCT00285012|588435236|FG001|Received Study Tx|Other|5|||
162926980|NCT05631093|588435239|FG000|Overall Study|Death|0|||
162926981|NCT05631093|588435240|FG001|Overall Study|Death|1|||
162926982|NCT05631093|588435239|FG000|Overall Study|Lost to Follow-up|1|||
162926983|NCT05631093|588435240|FG001|Overall Study|Lost to Follow-up|2|||
162926984|NCT05631093|588435239|FG000|Overall Study|Physician Decision|1|||
162926985|NCT05631093|588435240|FG001|Overall Study|Physician Decision|0|||
162926986|NCT05631093|588435239|FG000|Overall Study|Withdrawal by Subject|4|||
162926987|NCT05631093|588435240|FG001|Overall Study|Withdrawal by Subject|1|||
162926988|NCT05631093|588435239|FG000|Overall Study|Ongoing|353|||
162926989|NCT05631093|588435240|FG001|Overall Study|Ongoing|177|||
162926990|NCT05631093|588435239|FG000|Overall Study|Adverse Event|0|||
162926991|NCT05631093|588435240|FG001|Overall Study|Adverse Event|1|||
162926992|NCT02873195|588435241|FG000|Overall Study|Ineligible|5|||
162926993|NCT02873195|588435242|FG001|Overall Study|Ineligible|0|||
162926994|NCT03107715|588435243|FG000|Overall Study|did not deliver at the home hospital|4|||
162926995|NCT03107715|588435244|FG001|Overall Study|did not deliver at the home hospital|6|||
162926996|NCT03107715|588435243|FG000|Overall Study|infant stillborn|0|||
162926997|NCT03107715|588435244|FG001|Overall Study|infant stillborn|1|||
162926998|NCT04822701|588435247|FG000|Overall Study|Not treated|2|||
162926999|NCT04822701|588435248|FG001|Overall Study|Not treated|0|||
162927000|NCT04822701|588435247|FG000|Overall Study|Lost to Follow-up|1|||
162927001|NCT04822701|588435248|FG001|Overall Study|Lost to Follow-up|0|||
162927002|NCT04822701|588435247|FG000|Overall Study|Withdrawal by Subject|1|||
162927003|NCT04822701|588435248|FG001|Overall Study|Withdrawal by Subject|0|||
162927004|NCT02706353|588435249|FG000|Dose Level 1|Disease Progression|1|||
162927005|NCT02706353|588435250|FG001|Dose Level 1|Disease Progression|0|||
162927006|NCT02706353|588435251|FG002|Dose Level 1|Disease Progression|0|||
162927007|NCT02706353|588435252|FG003|Dose Level 1|Disease Progression|0|||
162927008|NCT02706353|588435253|FG004|Dose Level 1|Disease Progression|0|||
162927009|NCT02706353|588435254|FG005|Dose Level 1|Disease Progression|0|||
162927010|NCT02706353|588435249|FG000|Dose Level 3|Disease Progression|0|||
162927011|NCT02706353|588435250|FG001|Dose Level 3|Disease Progression|0|||
162927012|NCT02706353|588435251|FG002|Dose Level 3|Disease Progression|2|||
162927013|NCT02706353|588435252|FG003|Dose Level 3|Disease Progression|0|||
162927014|NCT02706353|588435253|FG004|Dose Level 3|Disease Progression|0|||
162927015|NCT02706353|588435254|FG005|Dose Level 3|Disease Progression|0|||
162927016|NCT02706353|588435249|FG000|Dose Level 4|Disease Progression|0|||
162927017|NCT02706353|588435250|FG001|Dose Level 4|Disease Progression|0|||
162927018|NCT02706353|588435251|FG002|Dose Level 4|Disease Progression|0|||
162927019|NCT02706353|588435252|FG003|Dose Level 4|Disease Progression|1|||
162927020|NCT02706353|588435253|FG004|Dose Level 4|Disease Progression|0|||
162927021|NCT02706353|588435254|FG005|Dose Level 4|Disease Progression|0|||
162927022|NCT02706353|588435249|FG000|Dose Level 4|Toxicity|0|||
162927023|NCT02706353|588435250|FG001|Dose Level 4|Toxicity|0|||
162927024|NCT02706353|588435251|FG002|Dose Level 4|Toxicity|0|||
162927025|NCT02706353|588435252|FG003|Dose Level 4|Toxicity|1|||
162927026|NCT02706353|588435253|FG004|Dose Level 4|Toxicity|0|||
162927027|NCT02706353|588435254|FG005|Dose Level 4|Toxicity|0|||
162927028|NCT02706353|588435249|FG000|Dose Level 4|Death|0|||
162927029|NCT02706353|588435250|FG001|Dose Level 4|Death|0|||
162927030|NCT02706353|588435251|FG002|Dose Level 4|Death|0|||
162927031|NCT02706353|588435252|FG003|Dose Level 4|Death|1|||
162927032|NCT02706353|588435253|FG004|Dose Level 4|Death|0|||
162927033|NCT02706353|588435254|FG005|Dose Level 4|Death|0|||
162927034|NCT02706353|588435249|FG000|Dose Level 5|Toxicity|0|||
162927035|NCT02706353|588435250|FG001|Dose Level 5|Toxicity|0|||
162927036|NCT02706353|588435251|FG002|Dose Level 5|Toxicity|0|||
162927037|NCT02706353|588435252|FG003|Dose Level 5|Toxicity|0|||
162927038|NCT02706353|588435253|FG004|Dose Level 5|Toxicity|1|||
162927039|NCT02706353|588435254|FG005|Dose Level 5|Toxicity|0|||
162927040|NCT02706353|588435249|FG000|Dose Level 5|Disease Progression|0|||
162927041|NCT02706353|588435250|FG001|Dose Level 5|Disease Progression|0|||
162927042|NCT02706353|588435251|FG002|Dose Level 5|Disease Progression|0|||
162927043|NCT02706353|588435252|FG003|Dose Level 5|Disease Progression|0|||
162927044|NCT02706353|588435253|FG004|Dose Level 5|Disease Progression|3|||
162927045|NCT02706353|588435254|FG005|Dose Level 5|Disease Progression|2|||
162927046|NCT02706353|588435249|FG000|Dose Level 5|Death|0|||
162927047|NCT02706353|588435250|FG001|Dose Level 5|Death|0|||
162927048|NCT02706353|588435251|FG002|Dose Level 5|Death|0|||
162927049|NCT02706353|588435252|FG003|Dose Level 5|Death|0|||
162927050|NCT02706353|588435253|FG004|Dose Level 5|Death|1|||
162927051|NCT02706353|588435254|FG005|Dose Level 5|Death|6|||
162927052|NCT02706353|588435249|FG000|Dose Level 5|Withdrawal by Subject|0|||
162927053|NCT02706353|588435250|FG001|Dose Level 5|Withdrawal by Subject|0|||
162927054|NCT02706353|588435251|FG002|Dose Level 5|Withdrawal by Subject|0|||
162927055|NCT02706353|588435252|FG003|Dose Level 5|Withdrawal by Subject|0|||
162927056|NCT02706353|588435253|FG004|Dose Level 5|Withdrawal by Subject|0|||
162927057|NCT02706353|588435254|FG005|Dose Level 5|Withdrawal by Subject|2|||
162927058|NCT03560466|588435255|FG000|Overall Study|Adverse Event|1|||
162927059|NCT03560466|588435256|FG001|Overall Study|Adverse Event|2|||
162927060|NCT03560466|588435257|FG002|Overall Study|Adverse Event|0|||
162927061|NCT03560466|588435255|FG000|Overall Study|Poor Compliance to Protocol|0|||
162927062|NCT03560466|588435256|FG001|Overall Study|Poor Compliance to Protocol|2|||
162927063|NCT03560466|588435257|FG002|Overall Study|Poor Compliance to Protocol|0|||
162927064|NCT03560466|588435255|FG000|Overall Study|Other|6|||
162927065|NCT03560466|588435256|FG001|Overall Study|Other|8|||
162927066|NCT03560466|588435257|FG002|Overall Study|Other|1|||
162927067|NCT01190098|588437051|FG000|Overall Study|Adverse Event|2|||
162927068|NCT01190098|588437052|FG001|Overall Study|Adverse Event|0|||
162927069|NCT01190098|588437051|FG000|Overall Study|Patient coomorbidity|0|||
162927070|NCT01190098|588437052|FG001|Overall Study|Patient coomorbidity|1|||
162927071|NCT01190098|588437051|FG000|Overall Study|Lack of transportation|1|||
162927072|NCT01190098|588437052|FG001|Overall Study|Lack of transportation|0|||
162927073|NCT01190098|588437051|FG000|Overall Study|Other|0|||
162927074|NCT01190098|588437052|FG001|Overall Study|Other|1|||
162927075|NCT04723173|588437057|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
162927076|NCT02996448|588437058|FG000|Overall Study|Study terminated due to adverse effects|3|||
163040757|NCT01483599|588856066|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
163040758|NCT02109445|588856068|FG000|Overall Study|Symptomatic deterioration|2|||
163040759|NCT02109445|588856068|FG000|Overall Study|Adverse Event|1|||
163040760|NCT00966355|588856073|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
163040761|NCT00966355|588856074|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
163040762|NCT00966355|588856075|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
163040763|NCT00966355|588856073|FG000|Overall Study|newly diagnosed advanced HCC|11|||
163040764|NCT00966355|588856074|FG001|Overall Study|newly diagnosed advanced HCC|12|||
163040765|NCT00966355|588856075|FG002|Overall Study|newly diagnosed advanced HCC|10|||
163040766|NCT00966355|588856073|FG000|Overall Study|Lost to Follow-up|5|||
163040767|NCT00966355|588856074|FG001|Overall Study|Lost to Follow-up|4|||
163040768|NCT00966355|588856075|FG002|Overall Study|Lost to Follow-up|3|||
163058529|NCT00042289|588924263|FG028|Overall Study|Severe debilitation, unable to continue|0|||
163058530|NCT00042289|588924264|FG029|Overall Study|Severe debilitation, unable to continue|0|||
163058531|NCT00042289|588924265|FG030|Overall Study|Severe debilitation, unable to continue|0|||
163058532|NCT00042289|588924266|FG031|Overall Study|Severe debilitation, unable to continue|1|||
162927077|NCT00606801|588437059|FG000|Intervention|Protocol Violation|3|||
162927078|NCT00606801|588437060|FG001|Intervention|Protocol Violation|3|||
162927079|NCT02082262|588437061|FG000|Overall Study|Withdrawal by Subject|3|||
162927080|NCT02082262|588437061|FG000|Overall Study|Adverse Event|48|||
162927081|NCT02748616|588437078|FG000|Overall Study|Lost to Follow-up|1|||
162927082|NCT02748616|588437078|FG000|Overall Study|Withdrawal by Subject|2|||
162927083|NCT02748616|588437078|FG000|Overall Study|Physician Decision|2|||
162927084|NCT02748616|588437078|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
162927085|NCT02018042|588437079|FG000|Overall Study|Withdrawal by Subject|1|||
162927086|NCT03231709|588437080|FG000|Treatment Period 1|Reason not Specified|0|||
162927087|NCT03231709|588437081|FG001|Treatment Period 1|Reason not Specified|1|||
162927088|NCT03231709|588437080|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
163058533|NCT00042289|588924267|FG032|Overall Study|Severe debilitation, unable to continue|1|||
163058534|NCT00042289|588924268|FG033|Overall Study|Severe debilitation, unable to continue|0|||
162927089|NCT03231709|588437081|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
162927090|NCT02419469|588437082|FG000|Overall Study|Withdrawal by Subject|1|||
162927091|NCT01785875|588437083|FG000|Overall Study|Withdrawal by Subject|41|||
162927092|NCT01785875|588437084|FG001|Overall Study|Withdrawal by Subject|34|||
162927093|NCT01785875|588437085|FG002|Overall Study|Withdrawal by Subject|36|||
163058535|NCT00042289|588924269|FG034|Overall Study|Severe debilitation, unable to continue|0|||
163058536|NCT00042289|588924270|FG035|Overall Study|Severe debilitation, unable to continue|0|||
162927094|NCT01785875|588437083|FG000|Overall Study|Lost to Follow-up|19|||
162927095|NCT01785875|588437084|FG001|Overall Study|Lost to Follow-up|22|||
162927096|NCT01785875|588437085|FG002|Overall Study|Lost to Follow-up|6|||
162927097|NCT01785875|588437083|FG000|Overall Study|Death|27|||
162927098|NCT01785875|588437084|FG001|Overall Study|Death|16|||
162927099|NCT01785875|588437085|FG002|Overall Study|Death|7|||
162927100|NCT01785875|588437083|FG000|Overall Study|Sponsor Decision|0|||
162927101|NCT01785875|588437084|FG001|Overall Study|Sponsor Decision|2|||
162927102|NCT01785875|588437085|FG002|Overall Study|Sponsor Decision|0|||
162927103|NCT01785875|588437083|FG000|Overall Study|Protocol Specified Criteria|207|||
162927104|NCT01785875|588437084|FG001|Overall Study|Protocol Specified Criteria|214|||
162927105|NCT01785875|588437085|FG002|Overall Study|Protocol Specified Criteria|55|||
162927106|NCT01785875|588437083|FG000|Overall Study|Missing|0|||
162927107|NCT01785875|588437084|FG001|Overall Study|Missing|1|||
162927108|NCT01785875|588437085|FG002|Overall Study|Missing|3|||
162927109|NCT04840901|588437088|FG000|Overall Study|Lost to Follow-up|3|||
162927110|NCT04840901|588437089|FG001|Overall Study|Lost to Follow-up|1|||
162927111|NCT04840901|588437088|FG000|Overall Study|Moved|1|||
162927112|NCT04840901|588437089|FG001|Overall Study|Moved|0|||
162927113|NCT04840901|588437088|FG000|Overall Study|Unable to comply with study schedule|0|||
162927114|NCT04840901|588437089|FG001|Overall Study|Unable to comply with study schedule|1|||
162927115|NCT04840901|588437088|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
162927116|NCT04840901|588437089|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
162927117|NCT01414062|588437090|FG000|Overall Study|Lost to Follow-up|3|||
162927118|NCT01414062|588437091|FG001|Overall Study|Lost to Follow-up|2|||
162927119|NCT01414062|588437090|FG000|Overall Study|Left Country|1|||
162927120|NCT01414062|588437091|FG001|Overall Study|Left Country|1|||
162927121|NCT01414062|588437090|FG000|Overall Study|Family Disapproval|1|||
162927122|NCT01414062|588437091|FG001|Overall Study|Family Disapproval|0|||
162927123|NCT01414062|588437090|FG000|Overall Study|Withdrawal by Subject|0|||
162927124|NCT01414062|588437091|FG001|Overall Study|Withdrawal by Subject|1|||
162927125|NCT04075292|588437092|FG000|Overall Study|Withdrawal by Subject|1|||
162927126|NCT04075292|588437093|FG001|Overall Study|Withdrawal by Subject|9|||
162927127|NCT04075292|588437092|FG000|Overall Study|Death|2|||
162927128|NCT04075292|588437093|FG001|Overall Study|Death|5|||
162927129|NCT04075292|588437092|FG000|Overall Study|Remained on study at time of DCO|74|||
163040769|NCT00401193|588857900|FG000|Overall Study|Adverse Event|1|||
163040770|NCT00401193|588857901|FG001|Overall Study|Adverse Event|3|||
162927130|NCT04075292|588437093|FG001|Overall Study|Remained on study at time of DCO|64|||
162927131|NCT01988493|588437095|FG000|Overall Study|Randomized but not treated|0|||
162927132|NCT01988493|588437096|FG001|Overall Study|Randomized but not treated|0|||
162927133|NCT01988493|588437097|FG002|Overall Study|Randomized but not treated|0|||
162927134|NCT01988493|588437098|FG003|Overall Study|Randomized but not treated|0|||
162927135|NCT01988493|588437099|FG004|Overall Study|Randomized but not treated|1|||
162927136|NCT00185731|588437104|FG000|Overall Study|Withdrawal by Subject|1|||
162927137|NCT00185731|588437104|FG000|Overall Study|Not Eligible|1|||
162927138|NCT03087773|588437105|FG000|Overall Study|Withdrawal by Subject|8|||
162927139|NCT03087773|588437106|FG001|Overall Study|Withdrawal by Subject|4|||
162927140|NCT03087773|588437105|FG000|Overall Study|Lost to Follow-up|12|||
162927141|NCT03087773|588437106|FG001|Overall Study|Lost to Follow-up|8|||
162927142|NCT05144477|588437109|FG000|Overall Study|Withdrawal by Subject|1|||
162927143|NCT05144477|588437110|FG001|Overall Study|Withdrawal by Subject|1|||
162927144|NCT01787188|588437115|FG000|Overall Study|Adverse Event|2|||
162927145|NCT01787188|588437116|FG001|Overall Study|Adverse Event|4|||
162927146|NCT01787188|588437117|FG002|Overall Study|Adverse Event|6|||
162927147|NCT01787188|588437115|FG000|Overall Study|Lack of Efficacy|7|||
162927148|NCT01787188|588437116|FG001|Overall Study|Lack of Efficacy|3|||
162927149|NCT01787188|588437117|FG002|Overall Study|Lack of Efficacy|5|||
162927150|NCT01787188|588437115|FG000|Overall Study|Non-compliance with Study Drug|0|||
162927151|NCT01787188|588437116|FG001|Overall Study|Non-compliance with Study Drug|1|||
162927152|NCT01787188|588437117|FG002|Overall Study|Non-compliance with Study Drug|0|||
162927153|NCT01787188|588437115|FG000|Overall Study|Withdrawal by Subject|4|||
162927154|NCT01787188|588437116|FG001|Overall Study|Withdrawal by Subject|3|||
162927155|NCT01787188|588437117|FG002|Overall Study|Withdrawal by Subject|2|||
162927156|NCT01787188|588437115|FG000|Overall Study|Protocol Violation|3|||
162927157|NCT01787188|588437116|FG001|Overall Study|Protocol Violation|2|||
162927158|NCT01787188|588437117|FG002|Overall Study|Protocol Violation|3|||
162927159|NCT01787188|588437115|FG000|Overall Study|Lost to Follow-up|1|||
162927160|NCT01787188|588437116|FG001|Overall Study|Lost to Follow-up|2|||
162927161|NCT01787188|588437117|FG002|Overall Study|Lost to Follow-up|2|||
162927162|NCT01787188|588437115|FG000|Overall Study|Other, including patient moved|0|||
162927163|NCT01787188|588437116|FG001|Overall Study|Other, including patient moved|3|||
162927164|NCT01787188|588437117|FG002|Overall Study|Other, including patient moved|0|||
162927165|NCT00854607|588437118|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
162927166|NCT01783483|588437124|FG000|Overall Study|Death|3|||
163040771|NCT00401193|588857902|FG002|Overall Study|Adverse Event|1|||
162927167|NCT01783483|588437125|FG001|Overall Study|Death|3|||
162927168|NCT01783483|588437124|FG000|Overall Study|Lost to Follow-up|14|||
162927169|NCT01783483|588437125|FG001|Overall Study|Lost to Follow-up|10|||
163040772|NCT00401193|588857900|FG000|Overall Study|Protocol Violation|3|||
162927170|NCT01783483|588437124|FG000|Overall Study|Withdrawal by Subject|2|||
163040773|NCT00401193|588857901|FG001|Overall Study|Protocol Violation|1|||
163040774|NCT00401193|588857902|FG002|Overall Study|Protocol Violation|1|||
163040775|NCT00401193|588857900|FG000|Overall Study|Lost to Follow-up|6|||
163040776|NCT00401193|588857901|FG001|Overall Study|Lost to Follow-up|5|||
163040777|NCT00401193|588857902|FG002|Overall Study|Lost to Follow-up|1|||
163040778|NCT00401193|588857900|FG000|Overall Study|Withdrawal by Subject|2|||
163040779|NCT00401193|588857901|FG001|Overall Study|Withdrawal by Subject|0|||
163040780|NCT00401193|588857902|FG002|Overall Study|Withdrawal by Subject|1|||
162927171|NCT01783483|588437125|FG001|Overall Study|Withdrawal by Subject|1|||
162927172|NCT01783483|588437124|FG000|Overall Study|Physician Decision|1|||
162927173|NCT01783483|588437125|FG001|Overall Study|Physician Decision|1|||
162927174|NCT02268045|588437126|FG000|Overall Study|Death|4|||
162927175|NCT02268045|588437127|FG001|Overall Study|Death|4|||
162927176|NCT02268045|588437126|FG000|Overall Study|Disease Progression|2|||
162927177|NCT02268045|588437127|FG001|Overall Study|Disease Progression|1|||
162927178|NCT02268045|588437126|FG000|Overall Study|Adverse Event|7|||
162927179|NCT02268045|588437127|FG001|Overall Study|Adverse Event|7|||
162927180|NCT02268045|588437126|FG000|Overall Study|Withdrawal by Subject|2|||
162927181|NCT02268045|588437127|FG001|Overall Study|Withdrawal by Subject|6|||
162927182|NCT02268045|588437126|FG000|Overall Study|Physician Decision|0|||
162927183|NCT02268045|588437127|FG001|Overall Study|Physician Decision|1|||
162927184|NCT02268045|588437126|FG000|Overall Study|Protocol Violation|1|||
162927185|NCT02268045|588437127|FG001|Overall Study|Protocol Violation|1|||
162927186|NCT01766310|588437128|FG000|Overall Study|Lost to Follow-up|1|||
162927187|NCT01766310|588437129|FG001|Overall Study|Lost to Follow-up|3|||
162927188|NCT00835068|588437130|FG000|Overall Study|Death|1|||
163040781|NCT00401193|588857900|FG000|Overall Study|Other Event|3|||
163040782|NCT00401193|588857901|FG001|Overall Study|Other Event|2|||
163040783|NCT00401193|588857902|FG002|Overall Study|Other Event|2|||
163040784|NCT04378569|588857904|FG000|Overall Study|Adverse Event|0|||
163040785|NCT04378569|588857905|FG001|Overall Study|Adverse Event|0|||
163040786|NCT04378569|588857906|FG002|Overall Study|Adverse Event|2|||
163040787|NCT04378569|588857907|FG003|Overall Study|Adverse Event|0|||
163040788|NCT04378569|588857908|FG004|Overall Study|Adverse Event|3|||
163040789|NCT04378569|588857909|FG005|Overall Study|Adverse Event|3|||
163040790|NCT04378569|588857904|FG000|Overall Study|Lost to Follow-up|0|||
163040791|NCT04378569|588857905|FG001|Overall Study|Lost to Follow-up|3|||
163040792|NCT04378569|588857906|FG002|Overall Study|Lost to Follow-up|1|||
163155971|NCT05523089|589285853|FG001|Overall Study|Lost to Follow-up|0|||
163155972|NCT05523089|589285854|FG002|Overall Study|Lost to Follow-up|0|||
163155973|NCT05530252|589285855|FG000|Overall Study|Lost to Follow-up|1|||
163155974|NCT05530252|589285856|FG001|Overall Study|Lost to Follow-up|1|||
163155975|NCT05530252|589285857|FG002|Overall Study|Lost to Follow-up|1|||
162927189|NCT00835068|588437131|FG001|Overall Study|Death|0|||
163155976|NCT01350999|589285858|FG000|Overall Study|Adverse Event|4|||
163155977|NCT01350999|589285859|FG001|Overall Study|Adverse Event|9|||
163155978|NCT01350999|589285860|FG002|Overall Study|Adverse Event|10|||
163155979|NCT01350999|589285858|FG000|Overall Study|Voluntary withdrawal|3|||
163155980|NCT01350999|589285859|FG001|Overall Study|Voluntary withdrawal|4|||
163155981|NCT01350999|589285860|FG002|Overall Study|Voluntary withdrawal|6|||
163155982|NCT01350999|589285858|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
163155983|NCT01350999|589285859|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
163155984|NCT01350999|589285860|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
162927190|NCT00835068|588437130|FG000|Overall Study|Adverse Event|0|||
162927191|NCT00835068|588437131|FG001|Overall Study|Adverse Event|1|||
162927192|NCT00835068|588437130|FG000|Overall Study|Other|8|||
162927193|NCT00835068|588437131|FG001|Overall Study|Other|0|||
162927194|NCT00835068|588437130|FG000|Overall Study|Withdrawal by Subject|1|||
162927195|NCT00835068|588437131|FG001|Overall Study|Withdrawal by Subject|0|||
162927196|NCT01591499|588437132|FG000|Baseline Visit|Withdrawal by Subject|0|||
162927197|NCT01591499|588437133|FG001|Baseline Visit|Withdrawal by Subject|2|||
162927198|NCT01591499|588437134|FG002|Baseline Visit|Withdrawal by Subject|0|||
162927199|NCT01591499|588437135|FG003|Baseline Visit|Withdrawal by Subject|2|||
163155985|NCT01987453|589287728|FG000|Overall Study|Death|0|||
163155986|NCT01987453|589287729|FG001|Overall Study|Death|0|||
163155987|NCT01987453|589287730|FG002|Overall Study|Death|1|||
163155988|NCT01987453|589287728|FG000|Overall Study|Lack of Efficacy|1|||
162927200|NCT01591499|588437132|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
162927201|NCT01591499|588437133|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
162927202|NCT01591499|588437134|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
162927203|NCT01591499|588437135|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
162927204|NCT01591499|588437132|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
162927205|NCT01591499|588437133|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
163040793|NCT04378569|588857907|FG003|Overall Study|Lost to Follow-up|0|||
163040794|NCT04378569|588857908|FG004|Overall Study|Lost to Follow-up|1|||
163155989|NCT01987453|589287729|FG001|Overall Study|Lack of Efficacy|12|||
163155990|NCT01987453|589287730|FG002|Overall Study|Lack of Efficacy|0|||
163155991|NCT04040933|589287736|FG000|Overall Study|Protocol Violation|1|||
162927206|NCT01591499|588437134|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
162927207|NCT01591499|588437135|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
162927208|NCT02125734|588437136|FG000|Period 2|Adverse Event|0|||
162927209|NCT02125734|588437137|FG001|Period 2|Adverse Event|1|||
162927210|NCT01308762|588437138|FG000|Overall Study|Protocol Violation|0|||
162927211|NCT01308762|588437139|FG001|Overall Study|Protocol Violation|1|||
162927212|NCT01308762|588437140|FG002|Overall Study|Protocol Violation|0|||
162927213|NCT00646282|588437141|FG000|Overall Study|Protocol terminated|4|||
162927214|NCT00646282|588437142|FG001|Overall Study|Protocol terminated|4|||
162927215|NCT01556490|588437143|FG000|Randomized Patients Summary|Protocol Violation|22|||
162927216|NCT01556490|588437144|FG001|Randomized Patients Summary|Protocol Violation|23|||
162927217|NCT01556490|588437143|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
162927218|NCT01556490|588437144|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
162927219|NCT00902278|588437145|FG000|Overall Study|Physician Decision|1|||
162927220|NCT00902278|588437146|FG001|Overall Study|Physician Decision|0|||
162927221|NCT00902278|588437147|FG002|Overall Study|Physician Decision|2|||
162927222|NCT00902278|588437148|FG003|Overall Study|Physician Decision|0|||
162927223|NCT00902278|588437149|FG004|Overall Study|Physician Decision|1|||
162927224|NCT00902278|588437145|FG000|Overall Study|Lost to Follow-up|3|||
162927225|NCT00902278|588437146|FG001|Overall Study|Lost to Follow-up|2|||
162927226|NCT00902278|588437147|FG002|Overall Study|Lost to Follow-up|3|||
162927227|NCT00902278|588437148|FG003|Overall Study|Lost to Follow-up|0|||
162927228|NCT00902278|588437149|FG004|Overall Study|Lost to Follow-up|1|||
162927229|NCT01652872|588437152|FG000|Overall Study|Death|36|||
162927230|NCT01652872|588437153|FG001|Overall Study|Death|39|||
162927231|NCT01652872|588437152|FG000|Overall Study|Lost to Follow-up|28|||
162927232|NCT01652872|588437153|FG001|Overall Study|Lost to Follow-up|23|||
162927233|NCT01652872|588437152|FG000|Overall Study|Decision by sponsor|5|||
162927234|NCT01652872|588437153|FG001|Overall Study|Decision by sponsor|7|||
162927235|NCT01652872|588437152|FG000|Overall Study|Withdrawal by Subject|76|||
162927236|NCT01652872|588437153|FG001|Overall Study|Withdrawal by Subject|84|||
162927237|NCT00758706|588437154|FG000|Overall Study|Adverse Event|4|||
162927238|NCT00758706|588437155|FG001|Overall Study|Adverse Event|4|||
162927239|NCT03985293|588437159|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
162927240|NCT03985293|588437160|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
162927241|NCT03985293|588437161|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
162927242|NCT03985293|588437162|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
162927243|NCT03985293|588437163|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
162927244|NCT03985293|588437164|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
162927245|NCT03985293|588437159|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
162927246|NCT03985293|588437160|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
162927247|NCT03985293|588437161|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
162927248|NCT03985293|588437162|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
162927249|NCT03985293|588437163|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
162927250|NCT03985293|588437164|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
162927251|NCT03985293|588437159|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
162927252|NCT03985293|588437160|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
162927253|NCT03985293|588437161|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
162927254|NCT03985293|588437162|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
162927255|NCT03985293|588437163|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
162927256|NCT03985293|588437164|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
162927257|NCT03985293|588437159|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
162927258|NCT03985293|588437160|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
162927259|NCT03985293|588437161|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
162927260|NCT03985293|588437162|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
162927261|NCT03985293|588437163|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
162927262|NCT03985293|588437164|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
162927263|NCT03985293|588437159|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
162927264|NCT03985293|588437160|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
162927265|NCT03985293|588437161|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
162927266|NCT03985293|588437162|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
163155992|NCT04040933|589287736|FG000|Overall Study|Withdrawal by Subject|2|||
163269868|NCT01327547|589699919|FG001|Overall Study|Non-compliance with study procedures|0|||
162927267|NCT03985293|588437163|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
162927268|NCT03985293|588437164|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
162927269|NCT03985293|588437159|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
162927270|NCT03985293|588437160|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
162927271|NCT03985293|588437161|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
162927272|NCT03985293|588437162|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
162927273|NCT03985293|588437163|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
162927274|NCT03985293|588437164|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
162927275|NCT03985293|588437159|FG000|FOLLOW-UP|Lost to Follow-up|0|||
162927276|NCT03985293|588437160|FG001|FOLLOW-UP|Lost to Follow-up|0|||
162927277|NCT03985293|588437161|FG002|FOLLOW-UP|Lost to Follow-up|1|||
162927278|NCT03985293|588437162|FG003|FOLLOW-UP|Lost to Follow-up|0|||
162927279|NCT03985293|588437163|FG004|FOLLOW-UP|Lost to Follow-up|0|||
162927280|NCT03985293|588437164|FG005|FOLLOW-UP|Lost to Follow-up|0|||
162927281|NCT02588651|588437165|FG000|Overall Study|Adverse Event|1|||
162927282|NCT02588651|588437165|FG000|Overall Study|Withdrawal by Subject|2|||
162927283|NCT02588651|588437165|FG000|Overall Study|Death|1|||
162927284|NCT02588651|588437165|FG000|Overall Study|Lack of Efficacy|13|||
162927285|NCT02588651|588437165|FG000|Overall Study|Lost to Follow-up|1|||
162927286|NCT02588651|588437165|FG000|Overall Study|Physician Decision|1|||
162927287|NCT02588651|588437165|FG000|Overall Study|Disease progression|2|||
162927288|NCT05899218|588437166|FG000|Overall Study|Lost to Follow-up|2|||
162927289|NCT05899218|588437167|FG001|Overall Study|Lost to Follow-up|2|||
162927290|NCT05899218|588437166|FG000|Overall Study|deemed ineligible out of country|1|||
162927291|NCT05899218|588437167|FG001|Overall Study|deemed ineligible out of country|0|||
162927292|NCT02587325|588437172|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
162927293|NCT02587325|588437173|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
162927294|NCT02587325|588437174|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
162927295|NCT02587325|588437175|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
163155993|NCT02066181|589287737|FG000|Overall Study|Withdrawal by Subject|1|||
163155994|NCT02066181|589287738|FG001|Overall Study|Withdrawal by Subject|1|||
163155995|NCT00775190|589287743|FG000|Overall Study|Lost to Follow-up|2|||
163155996|NCT00775190|589287744|FG001|Overall Study|Lost to Follow-up|3|||
163155997|NCT00775190|589287743|FG000|Overall Study|Withdrawal by Subject|1|||
163155998|NCT00775190|589287744|FG001|Overall Study|Withdrawal by Subject|2|||
163155999|NCT00775190|589287743|FG000|Overall Study|Protocol Violation|1|||
163156000|NCT00775190|589287744|FG001|Overall Study|Protocol Violation|0|||
163156001|NCT02141295|589287745|FG000|Overall Study|Adverse Event|1|||
163156002|NCT02141295|589287746|FG001|Overall Study|Adverse Event|18|||
163156003|NCT02141295|589287747|FG002|Overall Study|Adverse Event|11|||
163156004|NCT02141295|589287745|FG000|Overall Study|Physician Decision|2|||
163156005|NCT02141295|589287746|FG001|Overall Study|Physician Decision|19|||
163156006|NCT02141295|589287747|FG002|Overall Study|Physician Decision|14|||
163156007|NCT02141295|589287745|FG000|Overall Study|Study terminated by sponsor|0|||
163156008|NCT02141295|589287746|FG001|Overall Study|Study terminated by sponsor|6|||
163156009|NCT02141295|589287747|FG002|Overall Study|Study terminated by sponsor|6|||
163156010|NCT02141295|589287745|FG000|Overall Study|Non-compliance|0|||
163156011|NCT02141295|589287746|FG001|Overall Study|Non-compliance|1|||
163156012|NCT02141295|589287747|FG002|Overall Study|Non-compliance|0|||
163156013|NCT02141295|589287745|FG000|Overall Study|Progressive disease|3|||
163156014|NCT02141295|589287746|FG001|Overall Study|Progressive disease|32|||
163156015|NCT02141295|589287747|FG002|Overall Study|Progressive disease|50|||
163156016|NCT02141295|589287745|FG000|Overall Study|Reason not specified|0|||
163156017|NCT02141295|589287746|FG001|Overall Study|Reason not specified|9|||
163156018|NCT02141295|589287747|FG002|Overall Study|Reason not specified|10|||
163156019|NCT02141295|589287745|FG000|Overall Study|Withdrawal by Subject|0|||
163156020|NCT02141295|589287746|FG001|Overall Study|Withdrawal by Subject|9|||
163156021|NCT02141295|589287747|FG002|Overall Study|Withdrawal by Subject|4|||
163156022|NCT01710501|589287748|FG000|Overall Study|Lost to Follow-up|2|||
163156023|NCT01710501|589287749|FG001|Overall Study|Lost to Follow-up|0|||
163156024|NCT01710501|589287750|FG002|Overall Study|Lost to Follow-up|0|||
163156025|NCT02536976|589287751|FG000|Overall Study|Physician Decision|0|||
163156026|NCT02536976|589287752|FG001|Overall Study|Physician Decision|1|||
163156027|NCT01671319|589287755|FG000|Overall Study|Withdrawal by Subject|1|||
163156028|NCT01376804|589287756|FG000|Treatment Period|Withdrawal by Subject|1|||
163156029|NCT01376804|589287756|FG000|Treatment Period|Adverse Event|6|||
163156030|NCT01376804|589287756|FG000|Treatment Period|Patient did not receive study drug|1|||
163156031|NCT02904954|589287761|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
163156032|NCT02904954|589287762|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
163156033|NCT02904954|589287761|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
163156034|NCT02904954|589287762|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
163156035|NCT02904954|589287761|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
163156036|NCT02904954|589287762|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
163156037|NCT02904954|589287761|FG000|Adjuvant Durvalumab|Recurrence|2|||
163156038|NCT02904954|589287762|FG001|Adjuvant Durvalumab|Recurrence|0|||
163156039|NCT02904954|589287761|FG000|Adjuvant Durvalumab|Adverse Event|2|||
163156040|NCT02904954|589287762|FG001|Adjuvant Durvalumab|Adverse Event|6|||
163156041|NCT02904954|589287761|FG000|Adjuvant Durvalumab|Participant wishes|12|||
162927296|NCT02587325|588437176|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
162927297|NCT02587325|588437172|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
162927298|NCT02587325|588437173|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
162927299|NCT02587325|588437174|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
162927300|NCT02587325|588437175|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
162927301|NCT02587325|588437176|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
163156042|NCT02904954|589287762|FG001|Adjuvant Durvalumab|Participant wishes|7|||
162927302|NCT02587325|588437172|FG000|32-Week Optional Extension Part|Adverse Event|0|||
163040795|NCT04378569|588857909|FG005|Overall Study|Lost to Follow-up|1|||
163156043|NCT02904954|589287761|FG000|Adjuvant Durvalumab|Physician Decision|2|||
162927303|NCT02587325|588437173|FG001|32-Week Optional Extension Part|Adverse Event|0|||
162927304|NCT02587325|588437174|FG002|32-Week Optional Extension Part|Adverse Event|1|||
162927305|NCT02587325|588437175|FG003|32-Week Optional Extension Part|Adverse Event|0|||
162927306|NCT02587325|588437176|FG004|32-Week Optional Extension Part|Adverse Event|0|||
162927307|NCT02587325|588437172|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
162927308|NCT02587325|588437173|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
162927309|NCT02587325|588437174|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
162927310|NCT02587325|588437175|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
162927311|NCT02587325|588437176|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
162927312|NCT00390572|588437177|FG000|Overall Study|Lost to Follow-up|8|||
163156044|NCT02904954|589287762|FG001|Adjuvant Durvalumab|Physician Decision|1|||
163156045|NCT02904954|589287761|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
163156046|NCT02904954|589287762|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
163156047|NCT02904954|589287761|FG000|Adjuvant Durvalumab|Death|0|||
163156048|NCT02904954|589287762|FG001|Adjuvant Durvalumab|Death|1|||
163156049|NCT02904954|589287761|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
163156050|NCT02904954|589287762|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
163156051|NCT01281124|589287763|FG000|Overall Study|Death|1|||
163156052|NCT01198795|589287764|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
163040796|NCT04378569|588857904|FG000|Overall Study|Protocol Violation|0|||
163040797|NCT04378569|588857905|FG001|Overall Study|Protocol Violation|0|||
163040798|NCT04378569|588857906|FG002|Overall Study|Protocol Violation|0|||
163040799|NCT04378569|588857907|FG003|Overall Study|Protocol Violation|0|||
163040800|NCT04378569|588857908|FG004|Overall Study|Protocol Violation|0|||
163040801|NCT04378569|588857909|FG005|Overall Study|Protocol Violation|1|||
163040802|NCT04378569|588857904|FG000|Overall Study|Withdrawal by Subject|0|||
163040803|NCT04378569|588857905|FG001|Overall Study|Withdrawal by Subject|6|||
163040804|NCT04378569|588857906|FG002|Overall Study|Withdrawal by Subject|7|||
163040805|NCT04378569|588857907|FG003|Overall Study|Withdrawal by Subject|4|||
163040806|NCT04378569|588857908|FG004|Overall Study|Withdrawal by Subject|5|||
163040807|NCT04378569|588857909|FG005|Overall Study|Withdrawal by Subject|4|||
163040808|NCT04378569|588857904|FG000|Overall Study|Lack of response|0|||
163040809|NCT04378569|588857905|FG001|Overall Study|Lack of response|0|||
163040810|NCT04378569|588857906|FG002|Overall Study|Lack of response|1|||
163040811|NCT04378569|588857907|FG003|Overall Study|Lack of response|0|||
163040812|NCT04378569|588857908|FG004|Overall Study|Lack of response|1|||
163040813|NCT04378569|588857909|FG005|Overall Study|Lack of response|1|||
163040814|NCT01844817|588857910|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
163040815|NCT01844817|588857911|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
163040816|NCT01844817|588857910|FG000|Treatment|Progressive Disease|27|||
163040817|NCT01844817|588857911|FG001|Treatment|Progressive Disease|36|||
163040818|NCT01844817|588857910|FG000|Treatment|Adverse Event|17|||
163040819|NCT01844817|588857911|FG001|Treatment|Adverse Event|9|||
163040820|NCT01844817|588857910|FG000|Treatment|Withdrawal by Subject|10|||
163040821|NCT01844817|588857911|FG001|Treatment|Withdrawal by Subject|6|||
163040822|NCT01844817|588857910|FG000|Treatment|Death|10|||
163040823|NCT01844817|588857911|FG001|Treatment|Death|8|||
163040824|NCT01844817|588857910|FG000|Treatment|Lost to Follow-up|0|||
163040825|NCT01844817|588857911|FG001|Treatment|Lost to Follow-up|1|||
163040826|NCT01844817|588857910|FG000|Treatment|Other|0|||
163040827|NCT01844817|588857911|FG001|Treatment|Other|3|||
163040828|NCT04530838|588857914|FG000|Overall Study|Other|2|||
163156053|NCT01198795|589287764|FG000|Overall Study|Withdrawal by Subject|17|||
163156054|NCT01198795|589287764|FG000|Overall Study|Lost to Follow-up|15|||
163156055|NCT01198795|589287764|FG000|Overall Study|Adverse Event|9|||
163156056|NCT01198795|589287764|FG000|Overall Study|Lack of Efficacy|5|||
163156057|NCT01198795|589287764|FG000|Overall Study|Protocol Violation|2|||
163156058|NCT01198795|589287764|FG000|Overall Study|Other Reason|4|||
163156059|NCT00706238|589287765|FG000|Overall Study|Disease progression|4|||
163156060|NCT00706238|589287765|FG000|Overall Study|Other|1|||
163156061|NCT00753506|589287766|FG000|Overall Study|Withdrawal by Subject|4|||
163156062|NCT00753506|589287767|FG001|Overall Study|Withdrawal by Subject|1|||
163156063|NCT00753506|589287766|FG000|Overall Study|Lost to Follow-up|2|||
163156064|NCT00753506|589287767|FG001|Overall Study|Lost to Follow-up|0|||
163156065|NCT00753506|589287766|FG000|Overall Study|Other reason|1|||
163156066|NCT00753506|589287767|FG001|Overall Study|Other reason|1|||
163156067|NCT03819114|589287768|FG000|Overall Study|Protocol Violation|0|||
163156068|NCT03819114|589287769|FG001|Overall Study|Protocol Violation|1|||
163156069|NCT03819114|589287770|FG002|Overall Study|Protocol Violation|1|||
163156070|NCT03819114|589287771|FG003|Overall Study|Protocol Violation|0|||
163156071|NCT03819114|589287768|FG000|Overall Study|Lost to Follow-up|0|||
163156072|NCT03819114|589287769|FG001|Overall Study|Lost to Follow-up|0|||
163156073|NCT03819114|589287770|FG002|Overall Study|Lost to Follow-up|1|||
163040829|NCT04530838|588857915|FG001|Overall Study|Other|1|||
163040830|NCT04530838|588857916|FG002|Overall Study|Other|0|||
163040831|NCT04530838|588857914|FG000|Overall Study|Physician Decision|0|||
163040832|NCT04530838|588857915|FG001|Overall Study|Physician Decision|0|||
163040833|NCT04530838|588857916|FG002|Overall Study|Physician Decision|1|||
163156074|NCT03819114|589287771|FG003|Overall Study|Lost to Follow-up|0|||
163040834|NCT04530838|588857914|FG000|Overall Study|Death|0|||
163040835|NCT04530838|588857915|FG001|Overall Study|Death|0|||
163040836|NCT04530838|588857916|FG002|Overall Study|Death|1|||
163040837|NCT04530838|588857914|FG000|Overall Study|Adverse Event|0|||
163040838|NCT04530838|588857915|FG001|Overall Study|Adverse Event|1|||
163040839|NCT04530838|588857916|FG002|Overall Study|Adverse Event|0|||
163040840|NCT04530838|588857914|FG000|Overall Study|No longer meets eligibility criteria|1|||
163040841|NCT04530838|588857915|FG001|Overall Study|No longer meets eligibility criteria|0|||
163040842|NCT04530838|588857916|FG002|Overall Study|No longer meets eligibility criteria|2|||
163040843|NCT04530838|588857914|FG000|Overall Study|Withdrawal by parent/guardian|5|||
163040844|NCT04530838|588857915|FG001|Overall Study|Withdrawal by parent/guardian|2|||
163040845|NCT04530838|588857916|FG002|Overall Study|Withdrawal by parent/guardian|2|||
163040846|NCT02155309|588857921|FG000|Overall Study|Protocol Violation|0|||
163040847|NCT02155309|588857922|FG001|Overall Study|Protocol Violation|0|||
163040848|NCT02155309|588857923|FG002|Overall Study|Protocol Violation|1|||
163040849|NCT02501161|588857925|FG000|Overall Study|Adverse Event|2|||
163040850|NCT02501161|588857926|FG001|Overall Study|Adverse Event|6|||
163040851|NCT02501161|588857925|FG000|Overall Study|Lost to Follow-up|7|||
163040852|NCT02501161|588857926|FG001|Overall Study|Lost to Follow-up|4|||
163040853|NCT02501161|588857925|FG000|Overall Study|Withdrawal by Subject|10|||
163040854|NCT02501161|588857926|FG001|Overall Study|Withdrawal by Subject|15|||
163040855|NCT02501161|588857925|FG000|Overall Study|Other|3|||
163040856|NCT02501161|588857926|FG001|Overall Study|Other|0|||
163040857|NCT04336475|588857927|FG000|Overall Study|pain|1|||
163040858|NCT04336475|588857928|FG001|Overall Study|pain|0|||
163040859|NCT04336475|588857927|FG000|Overall Study|upper respiratory infection|1|||
163040860|NCT04336475|588857928|FG001|Overall Study|upper respiratory infection|0|||
163040861|NCT04336475|588857927|FG000|Overall Study|Lost to Follow-up|0|||
163040862|NCT04336475|588857928|FG001|Overall Study|Lost to Follow-up|2|||
163040863|NCT02030119|588857937|FG000|Overall Study|Withdrawal by Subject|3|||
163040864|NCT02030119|588857938|FG001|Overall Study|Withdrawal by Subject|1|||
163040865|NCT02030119|588857939|FG002|Overall Study|Withdrawal by Subject|5|||
163040866|NCT02030119|588857940|FG003|Overall Study|Withdrawal by Subject|3|||
163040867|NCT02030119|588857937|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
163040868|NCT02030119|588857938|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
163040869|NCT02030119|588857939|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
163040870|NCT02030119|588857940|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
163040871|NCT02213380|588857945|FG000|Underwent Randomization|Withdrawal by Subject|2|||
163040872|NCT02213380|588857946|FG001|Underwent Randomization|Withdrawal by Subject|0|||
163040873|NCT02213380|588857945|FG000|Underwent Randomization|Not treated|3|||
163040874|NCT02213380|588857946|FG001|Underwent Randomization|Not treated|3|||
163040875|NCT02213380|588857945|FG000|Per-protocol Analysis|Protocol Violation|32|||
163040876|NCT02213380|588857946|FG001|Per-protocol Analysis|Protocol Violation|36|||
163040877|NCT00905567|588857955|FG000|Washout|Withdrawal by Subject|0|||
163040878|NCT00905567|588857956|FG001|Washout|Withdrawal by Subject|1|||
163040879|NCT01465230|588857957|FG000|Overall Study|Withdrawal by Subject|2|||
163040880|NCT01738919|588857963|FG000|Overall Study|Lost to Follow-up|1|||
163040881|NCT01738919|588857964|FG001|Overall Study|Lost to Follow-up|0|||
163040882|NCT01738919|588857963|FG000|Overall Study|Immigrated|0|||
163040883|NCT01738919|588857964|FG001|Overall Study|Immigrated|1|||
163040884|NCT01738919|588857963|FG000|Overall Study|Withdrawal by Subject|0|||
163040885|NCT01738919|588857964|FG001|Overall Study|Withdrawal by Subject|1|||
163040886|NCT01738919|588857963|FG000|Overall Study|Not treated in accordance to guidelines|0|||
163040887|NCT01738919|588857964|FG001|Overall Study|Not treated in accordance to guidelines|1|||
162927313|NCT00390572|588437178|FG001|Overall Study|Lost to Follow-up|4|||
162927314|NCT00390572|588437177|FG000|Overall Study|health condition|0|||
162927315|NCT00390572|588437178|FG001|Overall Study|health condition|1|||
162927316|NCT02913261|588437185|FG000|Overall Study|Technical problems|0|||
162927317|NCT02913261|588437186|FG001|Overall Study|Technical problems|1|||
162927318|NCT02913261|588437185|FG000|Overall Study|Lack of Efficacy|32|||
162927319|NCT02913261|588437186|FG001|Overall Study|Lack of Efficacy|69|||
162927320|NCT02913261|588437185|FG000|Overall Study|Adverse Event|27|||
162927321|NCT02913261|588437186|FG001|Overall Study|Adverse Event|5|||
162927322|NCT02913261|588437185|FG000|Overall Study|Death|25|||
163040888|NCT01473940|588857965|FG000|Induction Therapy|Death|0|||
162927323|NCT02913261|588437186|FG001|Overall Study|Death|22|||
162927324|NCT02913261|588437185|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
163040889|NCT01473940|588857966|FG001|Induction Therapy|Death|0|||
163040890|NCT01473940|588857967|FG002|Induction Therapy|Death|1|||
163040891|NCT01473940|588857968|FG003|Induction Therapy|Death|1|||
163040892|NCT01473940|588857965|FG000|Induction Therapy|Progressive Disease|0|||
163040893|NCT01473940|588857966|FG001|Induction Therapy|Progressive Disease|1|||
163040894|NCT01473940|588857967|FG002|Induction Therapy|Progressive Disease|1|||
163040895|NCT01473940|588857968|FG003|Induction Therapy|Progressive Disease|0|||
163040896|NCT01473940|588857965|FG000|Maintenance Therapy|Progressive Disease|1|||
163040897|NCT01473940|588857966|FG001|Maintenance Therapy|Progressive Disease|2|||
163040898|NCT01473940|588857967|FG002|Maintenance Therapy|Progressive Disease|1|||
162927325|NCT02913261|588437186|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
162927326|NCT02913261|588437185|FG000|Overall Study|Disease relapse|8|||
162927327|NCT02913261|588437186|FG001|Overall Study|Disease relapse|13|||
162927328|NCT02913261|588437185|FG000|Overall Study|Physician Decision|8|||
163040899|NCT01473940|588857968|FG003|Maintenance Therapy|Progressive Disease|4|||
163040900|NCT00534248|588857969|FG000|Overall Study|Adverse Event|19|||
163040901|NCT00534248|588857970|FG001|Overall Study|Adverse Event|29|||
163040902|NCT00534248|588857969|FG000|Overall Study|Lost to Follow-up|353|||
163040903|NCT00534248|588857970|FG001|Overall Study|Lost to Follow-up|375|||
163040904|NCT00534248|588857969|FG000|Overall Study|Other protocol specified criteria|13|||
163040905|NCT00534248|588857970|FG001|Overall Study|Other protocol specified criteria|3|||
163040906|NCT00534248|588857969|FG000|Overall Study|Physician Decision|10|||
163040907|NCT00534248|588857970|FG001|Overall Study|Physician Decision|7|||
163040908|NCT00534248|588857969|FG000|Overall Study|Protocol Violation|3|||
163040909|NCT00534248|588857970|FG001|Overall Study|Protocol Violation|4|||
163040910|NCT00534248|588857969|FG000|Overall Study|Withdrawal by Subject|263|||
163040911|NCT00534248|588857970|FG001|Overall Study|Withdrawal by Subject|255|||
163040912|NCT02849171|588857971|FG000|Overall Study|Withdrawal by Subject|1|||
163040913|NCT02849171|588857971|FG000|Overall Study|Not treated|1|||
163040914|NCT02532257|588857972|FG000|Overall Study|Adverse Event|2|||
163040915|NCT02532257|588857972|FG000|Overall Study|Physician Decision|4|||
163040916|NCT02532257|588857972|FG000|Overall Study|Withdrawal by Subject|3|||
163040917|NCT02532257|588857972|FG000|Overall Study|Progressive Disease|10|||
163040918|NCT02259400|588857973|FG000|Overall Study|Death|0|||
163040919|NCT02259400|588857974|FG001|Overall Study|Death|2|||
163040920|NCT03498313|588857978|FG000|Experimental Period 1|Adverse Event|1|||
163040921|NCT03498313|588857979|FG001|Experimental Period 1|Adverse Event|0|||
163040922|NCT03498313|588857980|FG002|Experimental Period 1|Adverse Event|0|||
163040923|NCT03498313|588857981|FG003|Experimental Period 1|Adverse Event|1|||
163040924|NCT03498313|588857982|FG004|Experimental Period 1|Adverse Event|0|||
163040925|NCT03498313|588857983|FG005|Experimental Period 1|Adverse Event|0|||
163040926|NCT03498313|588857978|FG000|Experimental Period 1|Withdrawal by Subject|0|||
163040927|NCT03498313|588857979|FG001|Experimental Period 1|Withdrawal by Subject|1|||
163040928|NCT03498313|588857980|FG002|Experimental Period 1|Withdrawal by Subject|0|||
163040929|NCT03498313|588857981|FG003|Experimental Period 1|Withdrawal by Subject|0|||
163040930|NCT03498313|588857982|FG004|Experimental Period 1|Withdrawal by Subject|0|||
163040931|NCT03498313|588857983|FG005|Experimental Period 1|Withdrawal by Subject|0|||
163040932|NCT03498313|588857978|FG000|Washout Period 1|Anovulation|1|||
163040933|NCT03498313|588857979|FG001|Washout Period 1|Anovulation|0|||
163040934|NCT03498313|588857980|FG002|Washout Period 1|Anovulation|0|||
163040935|NCT03498313|588857981|FG003|Washout Period 1|Anovulation|0|||
163040936|NCT03498313|588857982|FG004|Washout Period 1|Anovulation|0|||
163040937|NCT03498313|588857983|FG005|Washout Period 1|Anovulation|0|||
163040938|NCT03498313|588857978|FG000|Washout Period 1|Withdrawal by Subject|0|||
163040939|NCT03498313|588857979|FG001|Washout Period 1|Withdrawal by Subject|3|||
163040940|NCT03498313|588857980|FG002|Washout Period 1|Withdrawal by Subject|0|||
163040941|NCT03498313|588857981|FG003|Washout Period 1|Withdrawal by Subject|1|||
163156075|NCT04226742|589287772|FG000|Overall Study|Lost to Follow-up|16|||
162927329|NCT02913261|588437186|FG001|Overall Study|Physician Decision|9|||
162927330|NCT02913261|588437185|FG000|Overall Study|Subject/guardian decision|4|||
162927331|NCT02913261|588437186|FG001|Overall Study|Subject/guardian decision|6|||
162927332|NCT02913261|588437185|FG000|Overall Study|Graft loss|2|||
162927333|NCT02913261|588437186|FG001|Overall Study|Graft loss|0|||
162927334|NCT02304302|588437211|FG000|Overall Study|Adverse Event|2|||
162927335|NCT02304302|588437212|FG001|Overall Study|Adverse Event|3|||
162927336|NCT02304302|588437211|FG000|Overall Study|Lost to Follow-up|1|||
162927337|NCT02304302|588437212|FG001|Overall Study|Lost to Follow-up|4|||
162927338|NCT02304302|588437211|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
162927339|NCT02304302|588437212|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
162927340|NCT00391118|588437213|FG000|Overall Study|Adverse Event|3|||
162927341|NCT00391118|588437214|FG001|Overall Study|Adverse Event|10|||
162927342|NCT00391118|588437215|FG002|Overall Study|Adverse Event|7|||
162927343|NCT00391118|588437213|FG000|Overall Study|Lost to Follow-up|0|||
162927344|NCT00391118|588437214|FG001|Overall Study|Lost to Follow-up|2|||
162927345|NCT00391118|588437215|FG002|Overall Study|Lost to Follow-up|3|||
162927346|NCT00391118|588437213|FG000|Overall Study|Withdrawal by Subject|0|||
163040942|NCT03498313|588857982|FG004|Washout Period 1|Withdrawal by Subject|0|||
163040943|NCT03498313|588857983|FG005|Washout Period 1|Withdrawal by Subject|1|||
163269869|NCT01327547|589699918|FG000|Overall Study|By investigator in subject's interest|0|||
162927347|NCT00391118|588437214|FG001|Overall Study|Withdrawal by Subject|9|||
163040944|NCT03498313|588857978|FG000|Experimental Period 2|Adverse Event|0|||
163040945|NCT03498313|588857979|FG001|Experimental Period 2|Adverse Event|0|||
163040946|NCT03498313|588857980|FG002|Experimental Period 2|Adverse Event|0|||
163040947|NCT03498313|588857981|FG003|Experimental Period 2|Adverse Event|0|||
163040948|NCT03498313|588857982|FG004|Experimental Period 2|Adverse Event|1|||
163040949|NCT03498313|588857983|FG005|Experimental Period 2|Adverse Event|2|||
163040950|NCT03498313|588857978|FG000|Washout Period 2|Physician Decision|1|||
162927348|NCT00391118|588437215|FG002|Overall Study|Withdrawal by Subject|1|||
162927349|NCT00391118|588437213|FG000|Overall Study|Death|0|||
162927350|NCT00391118|588437214|FG001|Overall Study|Death|1|||
162927351|NCT00391118|588437215|FG002|Overall Study|Death|0|||
162927352|NCT00391118|588437213|FG000|Overall Study|Physician Decision|0|||
162927353|NCT00391118|588437214|FG001|Overall Study|Physician Decision|3|||
162927354|NCT00391118|588437215|FG002|Overall Study|Physician Decision|0|||
162927355|NCT00391118|588437213|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
162927356|NCT00391118|588437214|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
162927357|NCT00391118|588437215|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
162927358|NCT00391118|588437213|FG000|Overall Study|Progressive Disease|7|||
162927359|NCT00391118|588437214|FG001|Overall Study|Progressive Disease|26|||
162927360|NCT00391118|588437215|FG002|Overall Study|Progressive Disease|43|||
162927361|NCT00391118|588437213|FG000|Overall Study|Sponsor Decision|0|||
162927362|NCT00391118|588437214|FG001|Overall Study|Sponsor Decision|1|||
162927363|NCT00391118|588437215|FG002|Overall Study|Sponsor Decision|3|||
163040951|NCT03498313|588857979|FG001|Washout Period 2|Physician Decision|0|||
163040952|NCT03498313|588857980|FG002|Washout Period 2|Physician Decision|0|||
163040953|NCT03498313|588857981|FG003|Washout Period 2|Physician Decision|1|||
163040954|NCT03498313|588857982|FG004|Washout Period 2|Physician Decision|0|||
163040955|NCT03498313|588857983|FG005|Washout Period 2|Physician Decision|1|||
163040956|NCT03498313|588857978|FG000|Washout Period 2|Withdrawal by Subject|3|||
163040957|NCT03498313|588857979|FG001|Washout Period 2|Withdrawal by Subject|2|||
163040958|NCT03498313|588857980|FG002|Washout Period 2|Withdrawal by Subject|0|||
163040959|NCT03498313|588857981|FG003|Washout Period 2|Withdrawal by Subject|0|||
163040960|NCT03498313|588857982|FG004|Washout Period 2|Withdrawal by Subject|2|||
163040961|NCT03498313|588857983|FG005|Washout Period 2|Withdrawal by Subject|0|||
163040962|NCT03498313|588857978|FG000|Washout Period 2|Anovulation|0|||
163040963|NCT03498313|588857979|FG001|Washout Period 2|Anovulation|0|||
163040964|NCT03498313|588857980|FG002|Washout Period 2|Anovulation|0|||
163040965|NCT03498313|588857981|FG003|Washout Period 2|Anovulation|0|||
163040966|NCT03498313|588857982|FG004|Washout Period 2|Anovulation|0|||
163040967|NCT03498313|588857983|FG005|Washout Period 2|Anovulation|1|||
163040968|NCT02372383|588857989|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
163040969|NCT02372383|588857990|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
163040970|NCT02372383|588857991|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
163040971|NCT03084302|588857994|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
163040972|NCT03084302|588857994|FG000|Overall Study|No valid objective monitor data|6|||
163040973|NCT00621257|588857995|FG000|Overall Study|Lost to Follow-up|4|||
163040974|NCT00621257|588857996|FG001|Overall Study|Lost to Follow-up|0|||
163040975|NCT00621257|588857997|FG002|Overall Study|Lost to Follow-up|2|||
163040976|NCT00621257|588857998|FG003|Overall Study|Lost to Follow-up|4|||
163040977|NCT00621257|588857999|FG004|Overall Study|Lost to Follow-up|7|||
163040978|NCT00621257|588857995|FG000|Overall Study|Adverse Event|0|||
163040979|NCT00621257|588857996|FG001|Overall Study|Adverse Event|1|||
163040980|NCT00621257|588857997|FG002|Overall Study|Adverse Event|1|||
163040981|NCT00621257|588857998|FG003|Overall Study|Adverse Event|0|||
163040982|NCT00621257|588857999|FG004|Overall Study|Adverse Event|0|||
163040983|NCT00621257|588857995|FG000|Overall Study|Physician Decision|0|||
163040984|NCT00621257|588857996|FG001|Overall Study|Physician Decision|2|||
163040985|NCT00621257|588857997|FG002|Overall Study|Physician Decision|0|||
163040986|NCT00621257|588857998|FG003|Overall Study|Physician Decision|1|||
163040987|NCT00621257|588857999|FG004|Overall Study|Physician Decision|1|||
163040988|NCT00621257|588857995|FG000|Overall Study|Withdrawal by Subject|0|||
163040989|NCT00621257|588857996|FG001|Overall Study|Withdrawal by Subject|0|||
163040990|NCT00621257|588857997|FG002|Overall Study|Withdrawal by Subject|0|||
163040991|NCT00621257|588857998|FG003|Overall Study|Withdrawal by Subject|1|||
163040992|NCT00621257|588857999|FG004|Overall Study|Withdrawal by Subject|1|||
163040993|NCT01255904|588858000|FG000|Overall Study|Physician Decision|1|||
163040994|NCT01255904|588858001|FG001|Overall Study|Physician Decision|4|||
163040995|NCT02075008|588858011|FG000|Overall Study|Technical problems|1|||
163040996|NCT02075008|588858011|FG000|Overall Study|Pregnancy|1|||
162927364|NCT00391118|588437213|FG000|Overall Study|Protocol Violation|1|||
162927365|NCT00391118|588437214|FG001|Overall Study|Protocol Violation|0|||
163040997|NCT02075008|588858011|FG000|Overall Study|Physician Decision|1|||
163040998|NCT02075008|588858011|FG000|Overall Study|Lost to Follow-up|1|||
163156076|NCT04226742|589287773|FG001|Overall Study|Lost to Follow-up|13|||
163269870|NCT01327547|589699919|FG001|Overall Study|By investigator in subject's interest|1|||
162927366|NCT00391118|588437215|FG002|Overall Study|Protocol Violation|0|||
162927367|NCT03078192|588437218|FG000|Overall Study|Withdrawal by Subject|2|||
162927368|NCT03078192|588437219|FG001|Overall Study|Withdrawal by Subject|1|||
163040999|NCT02075008|588858011|FG000|Overall Study|Lack of Efficacy|1|||
163041000|NCT02075008|588858011|FG000|Overall Study|Death|1|||
163041001|NCT02075008|588858011|FG000|Overall Study|Adverse Event|5|||
163041002|NCT02075008|588858011|FG000|Overall Study|Withdrawal by Subject|6|||
163041003|NCT02075008|588858011|FG000|Overall Study|Study terminated by Sponsor|159|||
163041004|NCT02328937|588858018|FG000|Period 1|Lost to Follow-up|0|||
163041005|NCT02328937|588858019|FG001|Period 1|Lost to Follow-up|0|||
162927369|NCT03078192|588437218|FG000|Overall Study|screen failure|0|||
162927370|NCT03078192|588437219|FG001|Overall Study|screen failure|3|||
162927371|NCT01311505|588437220|FG000|First Intervention Period|Protocol Violation|0|||
162927372|NCT01311505|588437221|FG001|First Intervention Period|Protocol Violation|1|||
162927373|NCT00532779|588437225|FG000|Overall Study|Adverse Event|122|||
162927374|NCT00532779|588437226|FG001|Overall Study|Adverse Event|112|||
162927375|NCT00532779|588437227|FG002|Overall Study|Adverse Event|56|||
162927376|NCT00532779|588437225|FG000|Overall Study|Lost to Follow-up|76|||
162927377|NCT00532779|588437226|FG001|Overall Study|Lost to Follow-up|65|||
162927378|NCT00532779|588437227|FG002|Overall Study|Lost to Follow-up|66|||
162927379|NCT00532779|588437225|FG000|Overall Study|Withdrawal by Subject|63|||
162927380|NCT00532779|588437226|FG001|Overall Study|Withdrawal by Subject|60|||
162927381|NCT00532779|588437227|FG002|Overall Study|Withdrawal by Subject|90|||
162927382|NCT00532779|588437225|FG000|Overall Study|Lack of Efficacy|12|||
162927383|NCT00532779|588437226|FG001|Overall Study|Lack of Efficacy|12|||
162927384|NCT00532779|588437227|FG002|Overall Study|Lack of Efficacy|40|||
162927385|NCT00532779|588437225|FG000|Overall Study|Protocol Violation|5|||
162927386|NCT00532779|588437226|FG001|Overall Study|Protocol Violation|9|||
162927387|NCT00532779|588437227|FG002|Overall Study|Protocol Violation|7|||
162927388|NCT00532779|588437225|FG000|Overall Study|Pregnancy|2|||
162927389|NCT00532779|588437226|FG001|Overall Study|Pregnancy|5|||
162927390|NCT00532779|588437227|FG002|Overall Study|Pregnancy|3|||
162927391|NCT00532779|588437225|FG000|Overall Study|Death|0|||
162927392|NCT00532779|588437226|FG001|Overall Study|Death|1|||
162927393|NCT00532779|588437227|FG002|Overall Study|Death|0|||
162927394|NCT00532779|588437225|FG000|Overall Study|Drug noncompliance, moved, other|14|||
162927395|NCT00532779|588437226|FG001|Overall Study|Drug noncompliance, moved, other|23|||
162927396|NCT00532779|588437227|FG002|Overall Study|Drug noncompliance, moved, other|29|||
162927397|NCT00828516|588437234|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
162927398|NCT00689273|588437235|FG000|Overall Study|Adverse Event|3|||
162927399|NCT00689273|588437236|FG001|Overall Study|Adverse Event|1|||
162927400|NCT00689273|588437235|FG000|Overall Study|Lack of Efficacy|3|||
162927401|NCT00689273|588437236|FG001|Overall Study|Lack of Efficacy|0|||
162927402|NCT00689273|588437235|FG000|Overall Study|Lost to Follow-up|0|||
162927403|NCT00689273|588437236|FG001|Overall Study|Lost to Follow-up|2|||
162927404|NCT00689273|588437235|FG000|Overall Study|Other|6|||
162927405|NCT00689273|588437236|FG001|Overall Study|Other|2|||
162927406|NCT00689273|588437235|FG000|Overall Study|Randomized but not Treated|1|||
162927407|NCT00689273|588437236|FG001|Overall Study|Randomized but not Treated|0|||
162927408|NCT03703297|588437240|FG000|Overall Study|Death|115|||
162927409|NCT03703297|588437241|FG001|Overall Study|Death|0|||
162927410|NCT03703297|588437242|FG002|Overall Study|Death|144|||
162927411|NCT03703297|588437240|FG000|Overall Study|Withdrawal by Subject|9|||
162927412|NCT03703297|588437241|FG001|Overall Study|Withdrawal by Subject|0|||
162927413|NCT03703297|588437242|FG002|Overall Study|Withdrawal by Subject|11|||
162927414|NCT03703297|588437240|FG000|Overall Study|Ongoing at the time of DCO|140|||
162927415|NCT03703297|588437241|FG001|Overall Study|Ongoing at the time of DCO|200|||
162927416|NCT03703297|588437242|FG002|Overall Study|Ongoing at the time of DCO|111|||
162927417|NCT02414854|588439112|FG000|Overall Study|Adverse Event|9|||
162927418|NCT02414854|588439113|FG001|Overall Study|Adverse Event|7|||
162927419|NCT02414854|588439114|FG002|Overall Study|Adverse Event|1|||
162927420|NCT02414854|588439115|FG003|Overall Study|Adverse Event|12|||
162927421|NCT02414854|588439112|FG000|Overall Study|Poor compliance to protocol|1|||
162927422|NCT02414854|588439113|FG001|Overall Study|Poor compliance to protocol|1|||
162927423|NCT02414854|588439114|FG002|Overall Study|Poor compliance to protocol|2|||
162927424|NCT02414854|588439115|FG003|Overall Study|Poor compliance to protocol|2|||
162927425|NCT02414854|588439112|FG000|Overall Study|Other than specified above|12|||
162927426|NCT02414854|588439113|FG001|Overall Study|Other than specified above|37|||
162927427|NCT02414854|588439114|FG002|Overall Study|Other than specified above|17|||
162927428|NCT02414854|588439115|FG003|Overall Study|Other than specified above|37|||
162927429|NCT01355523|588439116|FG000|Overall Study|Withdrawal by Subject|1|||
162927430|NCT01355523|588439117|FG001|Overall Study|Withdrawal by Subject|4|||
162927431|NCT01355523|588439116|FG000|Overall Study|Lost to Follow-up|0|||
162927432|NCT01355523|588439117|FG001|Overall Study|Lost to Follow-up|2|||
162927433|NCT01355523|588439116|FG000|Overall Study|Protocol Violation|0|||
162927434|NCT01355523|588439117|FG001|Overall Study|Protocol Violation|2|||
162927435|NCT01355523|588439116|FG000|Overall Study|Adverse Event|0|||
162927436|NCT01355523|588439117|FG001|Overall Study|Adverse Event|2|||
162927437|NCT01726335|588439120|FG000|Overall Study|Lost to Follow-up|2|||
162927438|NCT01726335|588439120|FG000|Overall Study|Withdrawal by Subject|15|||
162927439|NCT01726335|588439120|FG000|Overall Study|Adverse Event|4|||
162927440|NCT01726335|588439120|FG000|Overall Study|Lost to Follow-up|2|||
162927441|NCT01726335|588439120|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
162927442|NCT01586624|588439121|FG000|Overall Study|Adverse Event|3|||
162927443|NCT01586624|588439122|FG001|Overall Study|Adverse Event|0|||
162927444|NCT01586624|588439123|FG002|Overall Study|Adverse Event|2|||
162927445|NCT01586624|588439124|FG003|Overall Study|Adverse Event|1|||
162927446|NCT01586624|588439125|FG004|Overall Study|Adverse Event|3|||
162927447|NCT01586624|588439126|FG005|Overall Study|Adverse Event|3|||
162927448|NCT01586624|588439127|FG006|Overall Study|Adverse Event|2|||
162927449|NCT01586624|588439128|FG007|Overall Study|Adverse Event|3|||
162927450|NCT01586624|588439121|FG000|Overall Study|Physician Decision|0|||
162927451|NCT01586624|588439122|FG001|Overall Study|Physician Decision|1|||
162927452|NCT01586624|588439123|FG002|Overall Study|Physician Decision|1|||
162927453|NCT01586624|588439124|FG003|Overall Study|Physician Decision|0|||
162927454|NCT01586624|588439125|FG004|Overall Study|Physician Decision|2|||
162927455|NCT01586624|588439126|FG005|Overall Study|Physician Decision|0|||
162927456|NCT01586624|588439127|FG006|Overall Study|Physician Decision|1|||
162927457|NCT01586624|588439128|FG007|Overall Study|Physician Decision|1|||
162927458|NCT01586624|588439121|FG000|Overall Study|Withdrawal by Subject|0|||
162927459|NCT01586624|588439122|FG001|Overall Study|Withdrawal by Subject|0|||
162927460|NCT01586624|588439123|FG002|Overall Study|Withdrawal by Subject|0|||
162927461|NCT01586624|588439124|FG003|Overall Study|Withdrawal by Subject|1|||
162927462|NCT01586624|588439125|FG004|Overall Study|Withdrawal by Subject|0|||
162927463|NCT01586624|588439126|FG005|Overall Study|Withdrawal by Subject|0|||
162927464|NCT01586624|588439127|FG006|Overall Study|Withdrawal by Subject|0|||
162927465|NCT01586624|588439128|FG007|Overall Study|Withdrawal by Subject|0|||
162927466|NCT01586624|588439121|FG000|Overall Study|Evidence of disease progression|1|||
162927467|NCT01586624|588439122|FG001|Overall Study|Evidence of disease progression|3|||
162927468|NCT01586624|588439123|FG002|Overall Study|Evidence of disease progression|2|||
162927469|NCT01586624|588439124|FG003|Overall Study|Evidence of disease progression|5|||
162927470|NCT01586624|588439125|FG004|Overall Study|Evidence of disease progression|3|||
162927471|NCT01586624|588439126|FG005|Overall Study|Evidence of disease progression|5|||
162927472|NCT01586624|588439127|FG006|Overall Study|Evidence of disease progression|4|||
162927473|NCT01586624|588439128|FG007|Overall Study|Evidence of disease progression|6|||
162927474|NCT01586624|588439121|FG000|Overall Study|Screen failure (no treatment received)|0|||
162927475|NCT01586624|588439122|FG001|Overall Study|Screen failure (no treatment received)|0|||
162927476|NCT01586624|588439123|FG002|Overall Study|Screen failure (no treatment received)|0|||
162927477|NCT01586624|588439124|FG003|Overall Study|Screen failure (no treatment received)|0|||
162927478|NCT01586624|588439125|FG004|Overall Study|Screen failure (no treatment received)|0|||
162927479|NCT01586624|588439126|FG005|Overall Study|Screen failure (no treatment received)|0|||
162927480|NCT01586624|588439127|FG006|Overall Study|Screen failure (no treatment received)|1|||
162927481|NCT01586624|588439128|FG007|Overall Study|Screen failure (no treatment received)|0|||
162927482|NCT01074307|588439130|FG000|Overall Study|No primary endpoint evaluation|14|||
162927483|NCT01074307|588439131|FG001|Overall Study|No primary endpoint evaluation|6|||
162927484|NCT01074307|588439130|FG000|Overall Study|Exclusion criterion|0|||
162927485|NCT01074307|588439131|FG001|Overall Study|Exclusion criterion|1|||
162927486|NCT01074307|588439130|FG000|Overall Study|Protocol Violation|8|||
162927487|NCT01074307|588439131|FG001|Overall Study|Protocol Violation|5|||
162927488|NCT01408576|588439136|FG000|Overall Study|Lack of Efficacy|17|||
162927489|NCT01408576|588439137|FG001|Overall Study|Lack of Efficacy|30|||
162927490|NCT01408576|588439138|FG002|Overall Study|Lack of Efficacy|48|||
162927491|NCT01408576|588439136|FG000|Overall Study|Protocol Violation|1|||
162927492|NCT01408576|588439137|FG001|Overall Study|Protocol Violation|2|||
162927493|NCT01408576|588439138|FG002|Overall Study|Protocol Violation|2|||
162927494|NCT01408576|588439136|FG000|Overall Study|Lost to Follow-up|10|||
162927495|NCT01408576|588439137|FG001|Overall Study|Lost to Follow-up|9|||
162927496|NCT01408576|588439138|FG002|Overall Study|Lost to Follow-up|17|||
162927497|NCT01408576|588439136|FG000|Overall Study|Withdrawal by Subject|34|||
162927498|NCT01408576|588439137|FG001|Overall Study|Withdrawal by Subject|60|||
162927499|NCT01408576|588439138|FG002|Overall Study|Withdrawal by Subject|66|||
162927500|NCT01408576|588439136|FG000|Overall Study|Sponsor terminated study|89|||
162927501|NCT01408576|588439137|FG001|Overall Study|Sponsor terminated study|333|||
162927502|NCT01408576|588439138|FG002|Overall Study|Sponsor terminated study|330|||
162927503|NCT01408576|588439136|FG000|Overall Study|AE, serious fatal|4|||
162927504|NCT01408576|588439137|FG001|Overall Study|AE, serious fatal|4|||
162927505|NCT01408576|588439138|FG002|Overall Study|AE, serious fatal|1|||
162927506|NCT01408576|588439136|FG000|Overall Study|SAE, non-fatal|11|||
162927507|NCT01408576|588439137|FG001|Overall Study|SAE, non-fatal|23|||
162927508|NCT01408576|588439138|FG002|Overall Study|SAE, non-fatal|14|||
162927509|NCT01408576|588439136|FG000|Overall Study|AE, non-serious non-fatal|12|||
162927510|NCT01408576|588439137|FG001|Overall Study|AE, non-serious non-fatal|19|||
162927511|NCT01408576|588439138|FG002|Overall Study|AE, non-serious non-fatal|11|||
162927512|NCT01408576|588439136|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
162927513|NCT01408576|588439137|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
162927514|NCT01408576|588439138|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
162927515|NCT01408576|588439136|FG000|Overall Study|AE, unknown type|0|||
162927516|NCT01408576|588439137|FG001|Overall Study|AE, unknown type|1|||
162927517|NCT01408576|588439138|FG002|Overall Study|AE, unknown type|0|||
162927518|NCT01408576|588439136|FG000|Overall Study|Other|10|||
162927519|NCT01408576|588439137|FG001|Overall Study|Other|16|||
162927520|NCT01408576|588439138|FG002|Overall Study|Other|18|||
162927521|NCT02703454|588439142|FG000|Overall Study|Not treated|1|||
162927522|NCT02703454|588439143|FG001|Overall Study|Not treated|3|||
162927523|NCT02703454|588439142|FG000|Overall Study|Withdrawal by Subject|4|||
162927524|NCT02703454|588439143|FG001|Overall Study|Withdrawal by Subject|3|||
162927525|NCT02703454|588439142|FG000|Overall Study|Lost to Follow-up|1|||
162927526|NCT02703454|588439143|FG001|Overall Study|Lost to Follow-up|2|||
162927527|NCT02703454|588439142|FG000|Overall Study|Study discontinuation|5|||
162927528|NCT02703454|588439143|FG001|Overall Study|Study discontinuation|8|||
162927529|NCT02284373|588439144|FG000|Overall Study|Withdrawal by Subject|0|||
162927530|NCT02284373|588439145|FG001|Overall Study|Withdrawal by Subject|1|||
162927531|NCT02284373|588439146|FG002|Overall Study|Withdrawal by Subject|0|||
162927532|NCT02284373|588439144|FG000|Overall Study|Other|0|||
162927533|NCT02284373|588439145|FG001|Overall Study|Other|1|||
162927534|NCT02284373|588439146|FG002|Overall Study|Other|0|||
162927535|NCT02284373|588439144|FG000|Overall Study|Lost to Follow-up|0|||
162927536|NCT02284373|588439145|FG001|Overall Study|Lost to Follow-up|1|||
162927537|NCT02284373|588439146|FG002|Overall Study|Lost to Follow-up|0|||
162927538|NCT02016755|588439147|FG000|Overall Study|Major amputation of index limb|2|||
162927539|NCT02016755|588439147|FG000|Overall Study|Adverse Event|2|||
162927540|NCT02016755|588439147|FG000|Overall Study|Physician Decision|1|||
162927541|NCT02016755|588439147|FG000|Overall Study|Death|2|||
162927542|NCT02476851|588439148|FG000|Overall Study|Protocol Violation|1|||
162927543|NCT02476851|588439149|FG001|Overall Study|Protocol Violation|1|||
162927544|NCT02360397|588439157|FG000|Overall Study|Incomplete screening|3|||
162927545|NCT02360397|588439157|FG000|Overall Study|Adverse Event|1|||
162927546|NCT03543046|588439160|FG000|Overall Study|Adverse Event|1|||
162927547|NCT03543046|588439161|FG001|Overall Study|Adverse Event|1|||
162927548|NCT03543046|588439160|FG000|Overall Study|Physician Decision|1|||
162927549|NCT03543046|588439161|FG001|Overall Study|Physician Decision|1|||
162927550|NCT03543046|588439160|FG000|Overall Study|Protocol Violation|1|||
162927551|NCT03543046|588439161|FG001|Overall Study|Protocol Violation|0|||
162927552|NCT03174925|588439162|FG000|Overall Study|Elastographic images not retrievable|2|||
162927553|NCT03174925|588439162|FG000|Overall Study|Elastography image not interpretable|1|||
162927554|NCT04247594|588439163|FG000|Overall Study|Withdrawal by Subject|4|||
162927555|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
162927556|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
162927557|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
162927558|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
162927559|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
162927560|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
162927561|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
162927562|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
162927563|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
162927564|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
162927565|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
162927566|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
162927567|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
162927568|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
162927569|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
162927570|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
162927571|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
162927572|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
162927573|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
162927574|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
162927575|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
162927576|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
162927577|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
162927578|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
162927579|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
162927580|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
162927581|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
162927582|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
162927583|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
162927584|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
162927585|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
162927586|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
162927587|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
162927588|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
162927589|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
162927590|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
162927591|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
163041006|NCT02328937|588858020|FG002|Period 1|Lost to Follow-up|0|||
163041007|NCT02328937|588858021|FG003|Period 1|Lost to Follow-up|1|||
163041008|NCT02328937|588858022|FG004|Period 1|Lost to Follow-up|0|||
163041009|NCT02328937|588858023|FG005|Period 1|Lost to Follow-up|0|||
163041010|NCT02328937|588858018|FG000|Period 2|Adverse Event|0|||
163041011|NCT02328937|588858019|FG001|Period 2|Adverse Event|0|||
163041012|NCT02328937|588858020|FG002|Period 2|Adverse Event|1|||
163041013|NCT02328937|588858021|FG003|Period 2|Adverse Event|0|||
163041014|NCT02328937|588858022|FG004|Period 2|Adverse Event|0|||
163041015|NCT02328937|588858023|FG005|Period 2|Adverse Event|0|||
163041016|NCT00435461|588858028|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
163041017|NCT00435461|588858029|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
163041018|NCT00435461|588858030|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
163041019|NCT00435461|588858028|FG000|Overall Study|Protocol Violation|6|||
163041020|NCT00435461|588858029|FG001|Overall Study|Protocol Violation|9|||
163041021|NCT00435461|588858030|FG002|Overall Study|Protocol Violation|10|||
163041022|NCT00435461|588858028|FG000|Overall Study|Participant randomized(inadequate score)|1|||
163041023|NCT00435461|588858029|FG001|Overall Study|Participant randomized(inadequate score)|0|||
163041024|NCT00435461|588858030|FG002|Overall Study|Participant randomized(inadequate score)|0|||
163041025|NCT00435461|588858028|FG000|Overall Study|Compliance less than 80 percent|1|||
163041026|NCT00435461|588858029|FG001|Overall Study|Compliance less than 80 percent|0|||
163041027|NCT00435461|588858030|FG002|Overall Study|Compliance less than 80 percent|0|||
163041028|NCT00435461|588858028|FG000|Overall Study|In error, two study medications switched|1|||
163041029|NCT00435461|588858029|FG001|Overall Study|In error, two study medications switched|0|||
163041030|NCT00435461|588858030|FG002|Overall Study|In error, two study medications switched|0|||
163041031|NCT00435461|588858028|FG000|Overall Study|Lack of Efficacy|2|||
163041032|NCT00435461|588858029|FG001|Overall Study|Lack of Efficacy|1|||
163041033|NCT00435461|588858030|FG002|Overall Study|Lack of Efficacy|0|||
163041034|NCT00435461|588858028|FG000|Overall Study|Withdrawal by Subject|1|||
163041035|NCT00435461|588858029|FG001|Overall Study|Withdrawal by Subject|0|||
163041036|NCT00435461|588858030|FG002|Overall Study|Withdrawal by Subject|2|||
163041037|NCT00435461|588858028|FG000|Overall Study|Randomized in error|1|||
163041038|NCT00435461|588858029|FG001|Overall Study|Randomized in error|0|||
163041039|NCT00435461|588858030|FG002|Overall Study|Randomized in error|0|||
163041040|NCT00435461|588858028|FG000|Overall Study|Participant could not tolerate symptoms|0|||
163041041|NCT00435461|588858029|FG001|Overall Study|Participant could not tolerate symptoms|0|||
163041042|NCT00435461|588858030|FG002|Overall Study|Participant could not tolerate symptoms|1|||
163041043|NCT00435461|588858028|FG000|Overall Study|Participant could not swallow capsule|0|||
163041044|NCT00435461|588858029|FG001|Overall Study|Participant could not swallow capsule|0|||
163041045|NCT00435461|588858030|FG002|Overall Study|Participant could not swallow capsule|1|||
163041046|NCT00435461|588858028|FG000|Overall Study|Pregnancy|2|||
163041047|NCT00435461|588858029|FG001|Overall Study|Pregnancy|0|||
163041048|NCT00435461|588858030|FG002|Overall Study|Pregnancy|0|||
163041049|NCT00435461|588858028|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
163041050|NCT00435461|588858029|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
163041051|NCT00435461|588858030|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
163041052|NCT00435461|588858028|FG000|Overall Study|Participant ended study one day early|1|||
163041053|NCT00435461|588858029|FG001|Overall Study|Participant ended study one day early|0|||
163041054|NCT00435461|588858030|FG002|Overall Study|Participant ended study one day early|0|||
163041055|NCT00435461|588858028|FG000|Overall Study|Noncompliance with study requirements|1|||
163041056|NCT00435461|588858029|FG001|Overall Study|Noncompliance with study requirements|1|||
163041057|NCT00435461|588858030|FG002|Overall Study|Noncompliance with study requirements|1|||
163041058|NCT00435461|588858028|FG000|Overall Study|Adverse Event|1|||
163041059|NCT00435461|588858029|FG001|Overall Study|Adverse Event|2|||
163041060|NCT00435461|588858030|FG002|Overall Study|Adverse Event|6|||
163041061|NCT00435461|588858028|FG000|Overall Study|Non-Compliance of diary|2|||
163041062|NCT00435461|588858029|FG001|Overall Study|Non-Compliance of diary|0|||
163041063|NCT00435461|588858030|FG002|Overall Study|Non-Compliance of diary|1|||
163041064|NCT00435461|588858028|FG000|Overall Study|Lost to Follow-up|1|||
163041065|NCT00435461|588858029|FG001|Overall Study|Lost to Follow-up|1|||
163041066|NCT00435461|588858030|FG002|Overall Study|Lost to Follow-up|2|||
163041067|NCT02782377|588858033|FG000|Overall Study|Physician Decision|5|||
163041068|NCT01188668|588858037|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
163041069|NCT01188668|588858037|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
163269871|NCT03390036|589699922|FG000|Overall Study|Lost to Follow-up|1|||
163269872|NCT03390036|589699923|FG001|Overall Study|Lost to Follow-up|0|||
163041070|NCT01188668|588858037|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
163041071|NCT02588092|588858051|FG000|Overall Study|Death|4|||
163041072|NCT02588092|588858052|FG001|Overall Study|Death|3|||
163041073|NCT02588092|588858053|FG002|Overall Study|Death|3|||
163041074|NCT02588092|588858054|FG003|Overall Study|Death|3|||
163041075|NCT02588092|588858055|FG004|Overall Study|Death|2|||
163041076|NCT02588092|588858056|FG005|Overall Study|Death|2|||
163041077|NCT02588092|588858057|FG006|Overall Study|Death|2|||
163041078|NCT02588092|588858058|FG007|Overall Study|Death|1|||
163041079|NCT02588092|588858059|FG008|Overall Study|Death|5|||
163041080|NCT02588092|588858060|FG009|Overall Study|Death|2|||
163041081|NCT02588092|588858051|FG000|Overall Study|Withdrawal by Subject|0|||
163156077|NCT04226742|589287772|FG000|Overall Study|Withdrawal by Subject|5|||
163156078|NCT04226742|589287773|FG001|Overall Study|Withdrawal by Subject|3|||
163156079|NCT05097963|589287776|FG000|Overall Study|Protocol Violation|13|||
163156080|NCT05097963|589287776|FG000|Overall Study|Withdrawal by Subject|21|||
163156081|NCT02492763|589287777|FG000|Overall Study|Withdrawal by Subject|0|||
163156082|NCT02492763|589287778|FG001|Overall Study|Withdrawal by Subject|2|||
163156083|NCT02492763|589287779|FG002|Overall Study|Withdrawal by Subject|1|||
163156084|NCT02492763|589287780|FG003|Overall Study|Withdrawal by Subject|0|||
163156085|NCT02492763|589287777|FG000|Overall Study|Adverse Event|3|||
163156086|NCT02492763|589287778|FG001|Overall Study|Adverse Event|1|||
163156087|NCT02492763|589287779|FG002|Overall Study|Adverse Event|1|||
163156088|NCT02492763|589287780|FG003|Overall Study|Adverse Event|2|||
163156089|NCT02492763|589287777|FG000|Overall Study|Death|0|||
163156090|NCT02492763|589287778|FG001|Overall Study|Death|0|||
163156091|NCT02492763|589287779|FG002|Overall Study|Death|1|||
163156092|NCT02492763|589287780|FG003|Overall Study|Death|0|||
163156093|NCT02492763|589287777|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
163156094|NCT02492763|589287778|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
163156095|NCT02492763|589287779|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
163156096|NCT02492763|589287780|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
162927592|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
162927593|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
162927594|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
162927595|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
162927596|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
162927597|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
162927598|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
162927599|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
162927600|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
162927601|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
162927602|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
162927603|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
162927604|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
162927605|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
162927606|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
162927607|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
162927608|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
162927609|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
162927610|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
162927611|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
162927612|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
162927613|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
162927614|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
162927615|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
162927616|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
162927617|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
162927618|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
162927619|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
162927620|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
162927621|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
162927622|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
162927623|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
162927624|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
163156097|NCT02492763|589287777|FG000|Overall Study|Lost to Follow-up|0|||
163156098|NCT02492763|589287778|FG001|Overall Study|Lost to Follow-up|0|||
163156099|NCT02492763|589287779|FG002|Overall Study|Lost to Follow-up|1|||
163156100|NCT02492763|589287780|FG003|Overall Study|Lost to Follow-up|0|||
163156101|NCT02492763|589287777|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163156102|NCT02492763|589287778|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163156103|NCT02492763|589287779|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163156104|NCT02492763|589287780|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163156105|NCT02492763|589287777|FG000|Overall Study|Screen Failure|0|||
163156106|NCT02492763|589287778|FG001|Overall Study|Screen Failure|0|||
163156107|NCT02492763|589287779|FG002|Overall Study|Screen Failure|0|||
163156108|NCT02492763|589287780|FG003|Overall Study|Screen Failure|1|||
163156109|NCT02492763|589287777|FG000|Overall Study|Study Terminated by Sponsor|13|||
163156110|NCT02492763|589287778|FG001|Overall Study|Study Terminated by Sponsor|10|||
163156111|NCT02492763|589287779|FG002|Overall Study|Study Terminated by Sponsor|6|||
163156112|NCT02492763|589287780|FG003|Overall Study|Study Terminated by Sponsor|10|||
163156113|NCT01193244|589287781|FG000|Overall Study|Withdrawal by Subject|79|||
163156114|NCT01193244|589287782|FG001|Overall Study|Withdrawal by Subject|97|||
163156115|NCT01193244|589287781|FG000|Overall Study|Other|303|||
163156116|NCT01193244|589287782|FG001|Overall Study|Other|278|||
163156117|NCT01193244|589287781|FG000|Overall Study|Lost to Follow-up|6|||
163156118|NCT01193244|589287782|FG001|Overall Study|Lost to Follow-up|15|||
163156119|NCT03848832|589287783|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
163156120|NCT03848832|589287784|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
163156121|NCT03848832|589287785|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
163156122|NCT03848832|589287783|FG000|Overall Study|Withdrawal by Subject|0|||
163156123|NCT03848832|589287784|FG001|Overall Study|Withdrawal by Subject|0|||
163156124|NCT03848832|589287785|FG002|Overall Study|Withdrawal by Subject|1|||
163156125|NCT03848832|589287783|FG000|Overall Study|Withdrawal (Covid-19)|0|||
163156126|NCT03848832|589287784|FG001|Overall Study|Withdrawal (Covid-19)|2|||
163156127|NCT03848832|589287785|FG002|Overall Study|Withdrawal (Covid-19)|0|||
163156128|NCT03848832|589287783|FG000|Overall Study|Physician Decision|2|||
163156129|NCT03848832|589287784|FG001|Overall Study|Physician Decision|1|||
163156130|NCT03848832|589287785|FG002|Overall Study|Physician Decision|3|||
163156131|NCT03848832|589287783|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
163156132|NCT03848832|589287784|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
163156133|NCT03848832|589287785|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
163156134|NCT03848832|589287783|FG000|Overall Study|Adverse Event|1|||
163156135|NCT03848832|589287784|FG001|Overall Study|Adverse Event|0|||
163156136|NCT03848832|589287785|FG002|Overall Study|Adverse Event|0|||
163156137|NCT00865566|589287786|FG000|Overall Study|Death|1|||
163156138|NCT00865566|589287787|FG001|Overall Study|Death|11|||
163156139|NCT00865566|589287786|FG000|Overall Study|Lost to Follow-up|314|||
163156140|NCT00865566|589287787|FG001|Overall Study|Lost to Follow-up|315|||
163156141|NCT00865566|589287786|FG000|Overall Study|Withdrawal by Subject|45|||
163156142|NCT00865566|589287787|FG001|Overall Study|Withdrawal by Subject|65|||
163156143|NCT00865566|589287786|FG000|Overall Study|Physician Decision|0|||
163156144|NCT00865566|589287787|FG001|Overall Study|Physician Decision|1|||
163156145|NCT00865566|589287786|FG000|Overall Study|Participant relocated|78|||
163156146|NCT00865566|589287787|FG001|Overall Study|Participant relocated|107|||
163156147|NCT00865566|589287786|FG000|Overall Study|Participant unable to adhere|27|||
163156148|NCT00865566|589287787|FG001|Overall Study|Participant unable to adhere|42|||
163156149|NCT00865566|589287786|FG000|Overall Study|Other; N=245 due to early study closure|154|||
163156150|NCT00865566|589287787|FG001|Overall Study|Other; N=245 due to early study closure|139|||
163156151|NCT00865566|589287786|FG000|Overall Study|HIV infection|5|||
163156152|NCT00865566|589287787|FG001|Overall Study|HIV infection|7|||
163156153|NCT01039376|589287788|FG000|Overall Study|Lost to Follow-up|5|||
163156154|NCT01039376|589287789|FG001|Overall Study|Lost to Follow-up|12|||
163156155|NCT01039376|589287788|FG000|Overall Study|Physician Decision|15|||
163156156|NCT01039376|589287789|FG001|Overall Study|Physician Decision|10|||
163156157|NCT01039376|589287788|FG000|Overall Study|Withdrawal by Subject|20|||
163156158|NCT01039376|589287789|FG001|Overall Study|Withdrawal by Subject|32|||
163156159|NCT01039376|589287788|FG000|Overall Study|Study terminated by Sponsor|90|||
163156160|NCT01039376|589287789|FG001|Overall Study|Study terminated by Sponsor|72|||
163156161|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
163156162|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
163156163|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Adverse Event|31|||
163156164|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Adverse Event|21|||
163156165|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
163156166|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
163156167|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
163156168|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
163156169|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
163156170|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
163156171|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
163156172|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
163156173|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Administrative problems|3|||
163156174|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Administrative problems|3|||
163156175|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Death|5|||
163156176|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Death|8|||
163156177|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Disease progression|139|||
163156178|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Disease progression|119|||
163156179|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
163156180|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
163156181|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
163156182|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
163156183|NCT00785785|589287790|FG000|Optional Extension Phase|Adverse Event|4|||
163156184|NCT00785785|589287791|FG001|Optional Extension Phase|Adverse Event|5|||
163156185|NCT00785785|589287790|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
163156186|NCT00785785|589287791|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
163156187|NCT00785785|589287790|FG000|Optional Extension Phase|Lost to Follow-up|1|||
163156188|NCT00785785|589287791|FG001|Optional Extension Phase|Lost to Follow-up|0|||
163156189|NCT00785785|589287790|FG000|Optional Extension Phase|Administrative problems|2|||
163156190|NCT00785785|589287791|FG001|Optional Extension Phase|Administrative problems|0|||
163156191|NCT00785785|589287790|FG000|Optional Extension Phase|Death|1|||
163156192|NCT00785785|589287791|FG001|Optional Extension Phase|Death|5|||
163156193|NCT00785785|589287790|FG000|Optional Extension Phase|Disease progression|22|||
163156194|NCT00785785|589287791|FG001|Optional Extension Phase|Disease progression|70|||
163156195|NCT00785785|589287790|FG000|Optional Extension Phase|Protocol deviation|0|||
163156196|NCT00785785|589287791|FG001|Optional Extension Phase|Protocol deviation|2|||
163156197|NCT00785785|589287790|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
163156198|NCT00785785|589287791|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
163156199|NCT03252925|589287792|FG000|Overall Study|Withdrawal by Subject|1|||
163156200|NCT03252925|589287793|FG001|Overall Study|Withdrawal by Subject|0|||
163156201|NCT03252925|589287792|FG000|Overall Study|Protocol Violation|6|||
163156202|NCT03252925|589287793|FG001|Overall Study|Protocol Violation|0|||
163156203|NCT03252925|589287792|FG000|Overall Study|Adverse Event|1|||
163156204|NCT03252925|589287793|FG001|Overall Study|Adverse Event|0|||
163156205|NCT03252925|589287792|FG000|Overall Study|Lost to Follow-up|6|||
163156206|NCT03252925|589287793|FG001|Overall Study|Lost to Follow-up|6|||
163156207|NCT01244893|589287794|FG000|Baseline|Protocol Violation|0|||
163156208|NCT01244893|589287795|FG001|Baseline|Protocol Violation|1|||
163156209|NCT01244893|589287794|FG000|1-Week Follow Up|Lost to Follow-up|1|||
163156210|NCT01244893|589287795|FG001|1-Week Follow Up|Lost to Follow-up|0|||
163156211|NCT00357552|589287796|FG000|Screening|Did not meet eligibility criteria|84|||
163156212|NCT00357552|589287796|FG000|Weeks 0 to 24|Death|1|||
163156213|NCT00357552|589287796|FG000|Weeks 24 to 104|Death|3|||
163156214|NCT00357552|589287796|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
163156215|NCT00521404|589287799|FG000|Overall Study|Adverse Event|13|||
163156216|NCT00521404|589287799|FG000|Overall Study|Disease Progression|33|||
163156217|NCT00521404|589287799|FG000|Overall Study|Investigator decision|5|||
163156218|NCT00521404|589287799|FG000|Overall Study|Withdrawal of consent|3|||
163156219|NCT00521404|589287799|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
163156220|NCT00521404|589287799|FG000|Overall Study|Other|7|||
163156221|NCT04555616|589287800|FG000|Overall Study|Death|1|||
163156222|NCT04555616|589287801|FG001|Overall Study|Death|0|||
163156223|NCT04555616|589287802|FG002|Overall Study|Death|1|||
163156224|NCT04555616|589287800|FG000|Overall Study|Withdrawal by Subject|2|||
163156225|NCT04555616|589287801|FG001|Overall Study|Withdrawal by Subject|1|||
163156226|NCT04555616|589287802|FG002|Overall Study|Withdrawal by Subject|0|||
163156227|NCT00882557|589287805|FG000|Overall Study|Withdrawal by Subject|1|||
163156228|NCT00882557|589287806|FG001|Overall Study|Withdrawal by Subject|0|||
163156229|NCT00882557|589287805|FG000|Overall Study|Trouble with Vein Access|1|||
163156230|NCT00882557|589287806|FG001|Overall Study|Trouble with Vein Access|0|||
163156231|NCT00882557|589287805|FG000|Overall Study|Randomized Not Treated|0|||
163156232|NCT00882557|589287806|FG001|Overall Study|Randomized Not Treated|1|||
163156233|NCT02282605|589287807|FG000|Overall Study|negative SA result on Day -1|3|||
163156234|NCT02282605|589287808|FG001|Overall Study|negative SA result on Day -1|0|||
163156235|NCT02282605|589287809|FG002|Overall Study|negative SA result on Day -1|0|||
163156236|NCT00711191|589287810|FG000|Overall Study|Adverse Event|1|||
163156237|NCT00711191|589287811|FG001|Overall Study|Adverse Event|1|||
163156238|NCT00711191|589287812|FG002|Overall Study|Adverse Event|2|||
163156239|NCT00711191|589287810|FG000|Overall Study|Objective progression or relapse|2|||
163156240|NCT00711191|589287811|FG001|Overall Study|Objective progression or relapse|3|||
163156241|NCT00711191|589287812|FG002|Overall Study|Objective progression or relapse|7|||
163156242|NCT00711191|589287810|FG000|Overall Study|Withdrawal by Subject|0|||
163156243|NCT00711191|589287811|FG001|Overall Study|Withdrawal by Subject|1|||
163156244|NCT00711191|589287812|FG002|Overall Study|Withdrawal by Subject|3|||
163156245|NCT02404025|589287813|FG000|Overall Study|Adverse Event|1|||
163156246|NCT02404025|589287813|FG000|Overall Study|Lack of Efficacy|3|||
163156247|NCT01744977|589287815|FG000|Overall Study|Withdrawal by Subject|1|||
163156248|NCT01744977|589287816|FG001|Overall Study|Withdrawal by Subject|2|||
163156249|NCT01744977|589287815|FG000|Overall Study|Death|2|||
163156250|NCT01744977|589287816|FG001|Overall Study|Death|3|||
163156251|NCT01744977|589287815|FG000|Overall Study|Lost to Follow-up|2|||
163156252|NCT01744977|589287816|FG001|Overall Study|Lost to Follow-up|0|||
163156253|NCT01744977|589287815|FG000|Overall Study|No longer meets inclusion|6|||
163156254|NCT01744977|589287816|FG001|Overall Study|No longer meets inclusion|0|||
163156255|NCT01750229|589287819|FG000|Randomized Crossover Phase|Adverse Event|1|||
163156256|NCT01750229|589287819|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
163156257|NCT01750229|589287819|FG000|Long-term Follow-up Phase|Adverse Event|2|||
163156258|NCT01750229|589287819|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
163156259|NCT03774576|589287820|FG000|Period 2|Adverse Event|1|||
163156260|NCT01746901|589287821|FG000|Naloxone Challenge Phase|Adverse Event|2|||
163156261|NCT01746901|589287822|FG001|Naloxone Challenge Phase|Adverse Event|0|||
163156262|NCT01746901|589287823|FG002|Naloxone Challenge Phase|Adverse Event|0|||
163156263|NCT01746901|589287824|FG003|Naloxone Challenge Phase|Adverse Event|0|||
163156264|NCT01746901|589287825|FG004|Naloxone Challenge Phase|Adverse Event|0|||
163156265|NCT01746901|589287826|FG005|Naloxone Challenge Phase|Adverse Event|0|||
163156266|NCT01746901|589287827|FG006|Naloxone Challenge Phase|Adverse Event|0|||
163156267|NCT01746901|589287828|FG007|Naloxone Challenge Phase|Adverse Event|0|||
163156268|NCT01746901|589287829|FG008|Naloxone Challenge Phase|Adverse Event|0|||
163156269|NCT01746901|589287821|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
163156270|NCT01746901|589287822|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156271|NCT01746901|589287823|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156272|NCT01746901|589287824|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156273|NCT01746901|589287825|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156274|NCT01746901|589287826|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156275|NCT01746901|589287827|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156276|NCT01746901|589287828|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156277|NCT01746901|589287829|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156278|NCT01746901|589287821|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
163156279|NCT01746901|589287822|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
163156280|NCT01746901|589287823|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
163156281|NCT01746901|589287824|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162927625|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
162927626|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
162927627|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
162927628|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
162927629|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
162927630|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
162927631|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
162927632|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
162927633|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
162927634|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
162927635|NCT04440163|588439165|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
162927636|NCT04440163|588439166|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
162927637|NCT04440163|588439167|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
162927638|NCT04440163|588439168|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
162927639|NCT04440163|588439169|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
163156282|NCT01746901|589287825|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162927640|NCT04440163|588439170|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
162927641|NCT04440163|588439171|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
162927642|NCT04440163|588439172|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
162927643|NCT04440163|588439165|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
162927644|NCT04440163|588439166|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
162927645|NCT04440163|588439167|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
162927646|NCT04440163|588439168|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
162927647|NCT04440163|588439169|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
162927648|NCT04440163|588439170|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
162927649|NCT04440163|588439171|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
162927650|NCT04440163|588439172|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
162927651|NCT00589693|588439176|FG000|Overall Study|randomized in error|12|||
162927652|NCT00589693|588439177|FG001|Overall Study|randomized in error|6|||
162927653|NCT00589693|588439176|FG000|Overall Study|Adverse Event|4|||
162927654|NCT00589693|588439177|FG001|Overall Study|Adverse Event|4|||
162927655|NCT00589693|588439176|FG000|Overall Study|Death|26|||
162927656|NCT00589693|588439177|FG001|Overall Study|Death|16|||
162927657|NCT00589693|588439176|FG000|Overall Study|Lack of Efficacy|0|||
162927658|NCT00589693|588439177|FG001|Overall Study|Lack of Efficacy|1|||
162927659|NCT00589693|588439176|FG000|Overall Study|Lost to Follow-up|1|||
162927660|NCT00589693|588439177|FG001|Overall Study|Lost to Follow-up|0|||
162927661|NCT00589693|588439176|FG000|Overall Study|Physician Decision|0|||
162927662|NCT00589693|588439177|FG001|Overall Study|Physician Decision|1|||
163156283|NCT01746901|589287826|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
163156284|NCT01746901|589287827|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
163156285|NCT01746901|589287828|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
163156286|NCT01746901|589287829|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
163156287|NCT01746901|589287821|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
163269873|NCT03390036|589699924|FG002|Overall Study|Lost to Follow-up|0|||
163269874|NCT03390036|589699922|FG000|Overall Study|Lack of Efficacy|1|||
162927663|NCT00589693|588439176|FG000|Overall Study|Protocol Violation|1|||
162927664|NCT00589693|588439177|FG001|Overall Study|Protocol Violation|1|||
162927665|NCT01128153|588439178|FG000|Overall Study|Adverse Event|1|||
163156288|NCT01746901|589287822|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
163156289|NCT01746901|589287823|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
163156290|NCT01746901|589287824|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
163156291|NCT01746901|589287825|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
163156292|NCT01746901|589287826|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
163156293|NCT01746901|589287827|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
163156294|NCT01746901|589287828|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
163156295|NCT01746901|589287829|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
163156296|NCT01746901|589287821|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
163156297|NCT01746901|589287822|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
163156298|NCT01746901|589287823|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
163156299|NCT01746901|589287824|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
163156300|NCT01746901|589287825|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
163156301|NCT01746901|589287826|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
163156302|NCT01746901|589287827|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
163156303|NCT01746901|589287828|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
163156304|NCT01746901|589287829|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
163156305|NCT01746901|589287821|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
163156306|NCT01746901|589287822|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
163156307|NCT01746901|589287823|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
163156308|NCT01746901|589287824|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
163156309|NCT01746901|589287825|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162927666|NCT01128153|588439179|FG001|Overall Study|Adverse Event|3|||
162927667|NCT01128153|588439178|FG000|Overall Study|Condition under investigation worsened|8|||
162927668|NCT01128153|588439179|FG001|Overall Study|Condition under investigation worsened|7|||
162927669|NCT01128153|588439178|FG000|Overall Study|Withdrawal by Subject|2|||
162927670|NCT01128153|588439179|FG001|Overall Study|Withdrawal by Subject|3|||
162927671|NCT01128153|588439178|FG000|Overall Study|Incorrect enrolment to study|2|||
162927672|NCT01128153|588439179|FG001|Overall Study|Incorrect enrolment to study|1|||
162927673|NCT01128153|588439178|FG000|Overall Study|Protocol Violation|2|||
162927674|NCT01128153|588439179|FG001|Overall Study|Protocol Violation|0|||
162927675|NCT01128153|588439178|FG000|Overall Study|Developed discontinuation criteria|1|||
162927676|NCT01128153|588439179|FG001|Overall Study|Developed discontinuation criteria|1|||
162927677|NCT01954082|588439180|FG000|Overall Study|Study Suspension|42|||
162927678|NCT01954082|588439181|FG001|Overall Study|Study Suspension|36|||
162927679|NCT01954082|588439180|FG000|Overall Study|Adverse Event|10|||
162927680|NCT01954082|588439181|FG001|Overall Study|Adverse Event|4|||
162927681|NCT01954082|588439180|FG000|Overall Study|Intolerance|0|||
162927682|NCT01954082|588439181|FG001|Overall Study|Intolerance|1|||
162927683|NCT01954082|588439180|FG000|Overall Study|Non-compliance|6|||
162927684|NCT01954082|588439181|FG001|Overall Study|Non-compliance|4|||
162927685|NCT01954082|588439180|FG000|Overall Study|Physician Decision|2|||
162927686|NCT01954082|588439181|FG001|Overall Study|Physician Decision|0|||
162927687|NCT01954082|588439180|FG000|Overall Study|Parent Decision|1|||
162927688|NCT01954082|588439181|FG001|Overall Study|Parent Decision|0|||
162927689|NCT01954082|588439180|FG000|Overall Study|Withdrawal by Subject|0|||
162927690|NCT01954082|588439181|FG001|Overall Study|Withdrawal by Subject|1|||
162927691|NCT01954082|588439180|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
162927692|NCT01954082|588439181|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
162927693|NCT01954082|588439180|FG000|Overall Study|Redirection of Care|0|||
162927694|NCT01954082|588439181|FG001|Overall Study|Redirection of Care|2|||
162927695|NCT01954082|588439180|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
162927696|NCT01954082|588439181|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
162927697|NCT01954082|588439180|FG000|Overall Study|Comfort Care|0|||
162927698|NCT01954082|588439181|FG001|Overall Study|Comfort Care|1|||
162927699|NCT01954082|588439180|FG000|Overall Study|Infant Moved|0|||
162927700|NCT01954082|588439181|FG001|Overall Study|Infant Moved|1|||
162927701|NCT01954082|588439180|FG000|Overall Study|Randomized not Treated|4|||
162927702|NCT01954082|588439181|FG001|Overall Study|Randomized not Treated|2|||
162927703|NCT01682512|588439182|FG000|Overall Study|Adverse Event|6|||
163156310|NCT01746901|589287826|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
163156311|NCT01746901|589287827|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
163156312|NCT01746901|589287828|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
163156313|NCT01746901|589287829|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162927704|NCT01682512|588439183|FG001|Overall Study|Adverse Event|5|||
162927705|NCT01682512|588439184|FG002|Overall Study|Adverse Event|2|||
162927706|NCT01682512|588439182|FG000|Overall Study|Withdrawal by Subject|2|||
162927707|NCT01682512|588439183|FG001|Overall Study|Withdrawal by Subject|6|||
162927708|NCT01682512|588439184|FG002|Overall Study|Withdrawal by Subject|3|||
162927709|NCT01682512|588439182|FG000|Overall Study|Physician Decision|0|||
162927710|NCT01682512|588439183|FG001|Overall Study|Physician Decision|2|||
162927711|NCT01682512|588439184|FG002|Overall Study|Physician Decision|0|||
162927712|NCT01682512|588439182|FG000|Overall Study|Study terminated by sponsor|46|||
162927713|NCT01682512|588439183|FG001|Overall Study|Study terminated by sponsor|43|||
162927714|NCT01682512|588439184|FG002|Overall Study|Study terminated by sponsor|0|||
162927715|NCT01682512|588439182|FG000|Overall Study|Lost to Follow-up|3|||
162927716|NCT01682512|588439183|FG001|Overall Study|Lost to Follow-up|0|||
162927717|NCT01682512|588439184|FG002|Overall Study|Lost to Follow-up|2|||
162927718|NCT01682512|588439182|FG000|Overall Study|Protocol Violation|2|||
162927719|NCT01682512|588439183|FG001|Overall Study|Protocol Violation|3|||
162927720|NCT01682512|588439184|FG002|Overall Study|Protocol Violation|2|||
162927721|NCT01682512|588439182|FG000|Overall Study|Primary lack of efficacy|10|||
162927722|NCT01682512|588439183|FG001|Overall Study|Primary lack of efficacy|7|||
162927723|NCT01682512|588439184|FG002|Overall Study|Primary lack of efficacy|7|||
162927724|NCT01682512|588439182|FG000|Overall Study|Secondary lack of efficacy|1|||
162927725|NCT01682512|588439183|FG001|Overall Study|Secondary lack of efficacy|1|||
162927726|NCT01682512|588439184|FG002|Overall Study|Secondary lack of efficacy|0|||
162927727|NCT01682512|588439182|FG000|Overall Study|Other than stated above|2|||
162927728|NCT01682512|588439183|FG001|Overall Study|Other than stated above|4|||
162927729|NCT01682512|588439184|FG002|Overall Study|Other than stated above|2|||
162927730|NCT01377233|588439185|FG000|Open-label|Adverse Event|1|||
162927731|NCT01377233|588439186|FG001|Open-label|Adverse Event|0|||
162927732|NCT01377233|588439187|FG002|Open-label|Adverse Event|0|||
162927733|NCT01377233|588439188|FG003|Open-label|Adverse Event|0|||
162927734|NCT01377233|588439189|FG004|Open-label|Adverse Event|0|||
162927735|NCT01377233|588439185|FG000|Open-label|Withdrawal by Subject|3|||
162927736|NCT01377233|588439186|FG001|Open-label|Withdrawal by Subject|0|||
162927737|NCT01377233|588439187|FG002|Open-label|Withdrawal by Subject|0|||
162927738|NCT01377233|588439188|FG003|Open-label|Withdrawal by Subject|0|||
162927739|NCT01377233|588439189|FG004|Open-label|Withdrawal by Subject|0|||
162927740|NCT01377233|588439185|FG000|Double-blind|Adverse Event|0|||
162927741|NCT01377233|588439186|FG001|Double-blind|Adverse Event|1|||
162927742|NCT01377233|588439187|FG002|Double-blind|Adverse Event|2|||
162927743|NCT01377233|588439188|FG003|Double-blind|Adverse Event|2|||
162927744|NCT01377233|588439189|FG004|Double-blind|Adverse Event|0|||
162927745|NCT01377233|588439185|FG000|Double-blind|Protocol Violation|0|||
162927746|NCT01377233|588439186|FG001|Double-blind|Protocol Violation|0|||
162927747|NCT01377233|588439187|FG002|Double-blind|Protocol Violation|0|||
162927748|NCT01377233|588439188|FG003|Double-blind|Protocol Violation|0|||
162927749|NCT01377233|588439189|FG004|Double-blind|Protocol Violation|1|||
162927750|NCT01377233|588439185|FG000|Double-blind|Withdrawal by Subject|0|||
162927751|NCT01377233|588439186|FG001|Double-blind|Withdrawal by Subject|0|||
162927752|NCT01377233|588439187|FG002|Double-blind|Withdrawal by Subject|0|||
163156314|NCT01746901|589287821|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
163156315|NCT01746901|589287822|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
163156316|NCT01746901|589287823|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
163156317|NCT01746901|589287824|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
163156318|NCT01746901|589287825|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
163156319|NCT01746901|589287826|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
163156320|NCT01746901|589287827|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
163156321|NCT01746901|589287828|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
163156322|NCT01746901|589287829|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
163156323|NCT01746901|589287821|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156324|NCT01746901|589287822|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156325|NCT01746901|589287823|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156326|NCT01746901|589287824|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156327|NCT01746901|589287825|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156328|NCT01746901|589287826|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156329|NCT01746901|589287827|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156330|NCT01746901|589287828|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
163156331|NCT01746901|589287829|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156332|NCT01746901|589287821|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
163156333|NCT01746901|589287822|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
163156334|NCT01746901|589287823|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
163156335|NCT01746901|589287824|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
163156336|NCT01746901|589287825|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
163156337|NCT01746901|589287826|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
163156338|NCT01746901|589287827|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
163156339|NCT01746901|589287828|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
163156340|NCT01746901|589287829|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
163269875|NCT03390036|589699923|FG001|Overall Study|Lack of Efficacy|0|||
162927753|NCT01377233|588439188|FG003|Double-blind|Withdrawal by Subject|1|||
162927754|NCT01377233|588439189|FG004|Double-blind|Withdrawal by Subject|0|||
162927755|NCT01377233|588439185|FG000|Double-blind|Administrative or other|0|||
162927756|NCT01377233|588439186|FG001|Double-blind|Administrative or other|0|||
163156341|NCT01746901|589287821|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
163269876|NCT03390036|589699924|FG002|Overall Study|Lack of Efficacy|0|||
163269877|NCT01681368|589699927|FG000|Overall Study|Refused further treatment|1|||
163269878|NCT01681368|589699927|FG000|Overall Study|Refused further follow up|1|||
163269879|NCT03884231|589699930|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
163269880|NCT03884231|589699930|FG000|Overall Study|Subject Withdrew Consent|1|||
163269881|NCT03884231|589699930|FG000|Overall Study|MRI Scan Not Performed|1|||
163269882|NCT00900627|589699931|FG000|Overall Study|Condition under investigation worsened|4|||
162927757|NCT01377233|588439187|FG002|Double-blind|Administrative or other|0|||
163269883|NCT00900627|589699932|FG001|Overall Study|Condition under investigation worsened|0|||
163269884|NCT00900627|589699933|FG002|Overall Study|Condition under investigation worsened|5|||
163269885|NCT00900627|589699934|FG003|Overall Study|Condition under investigation worsened|3|||
163269886|NCT00900627|589699935|FG004|Overall Study|Condition under investigation worsened|0|||
163156342|NCT01746901|589287822|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
163156343|NCT01746901|589287823|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
163156344|NCT01746901|589287824|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
163156345|NCT01746901|589287825|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
163156346|NCT01746901|589287826|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
163156347|NCT01746901|589287827|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
163156348|NCT01746901|589287828|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
163156349|NCT01746901|589287829|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
163156350|NCT01746901|589287821|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
163156351|NCT01746901|589287822|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
163156352|NCT01746901|589287823|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
163156353|NCT01746901|589287824|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
163156354|NCT01746901|589287825|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
163156355|NCT01746901|589287826|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
162927758|NCT01377233|588439188|FG003|Double-blind|Administrative or other|1|||
162927759|NCT01377233|588439189|FG004|Double-blind|Administrative or other|1|||
162927760|NCT00417027|588439190|FG000|Overall Study|Protocol Violation|0|||
162927761|NCT00417027|588439191|FG001|Overall Study|Protocol Violation|5|||
162927762|NCT00417027|588439192|FG002|Overall Study|Protocol Violation|5|||
162927763|NCT03137082|588439193|FG000|Overall Study|Withdrawal by Subject|1|||
162927764|NCT03137082|588439194|FG001|Overall Study|Withdrawal by Subject|1|||
162927765|NCT03137082|588439193|FG000|Overall Study|Lost to Follow-up|1|||
162927766|NCT03137082|588439194|FG001|Overall Study|Lost to Follow-up|0|||
162927767|NCT02787785|588439195|FG000|Overall Study|Death|3|||
162927768|NCT02787785|588439196|FG001|Overall Study|Death|4|||
162927769|NCT02787785|588439195|FG000|Overall Study|Lost to Follow-up|1|||
162927770|NCT02787785|588439196|FG001|Overall Study|Lost to Follow-up|1|||
162927771|NCT02787785|588439195|FG000|Overall Study|Withdrawal by Subject|0|||
162927772|NCT02787785|588439196|FG001|Overall Study|Withdrawal by Subject|5|||
162927773|NCT01440595|588439207|FG000|Overall Study|Lost to Follow-up|0|||
162927774|NCT01440595|588439208|FG001|Overall Study|Lost to Follow-up|1|||
162927775|NCT01440595|588439209|FG002|Overall Study|Lost to Follow-up|0|||
162927776|NCT01440595|588439207|FG000|Overall Study|Study terminated by sponsor.|1|||
162927777|NCT01440595|588439208|FG001|Overall Study|Study terminated by sponsor.|2|||
162927778|NCT01440595|588439209|FG002|Overall Study|Study terminated by sponsor.|1|||
162927779|NCT01447628|588439212|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
162927780|NCT01447628|588439213|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
162927781|NCT01447628|588439214|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
162927782|NCT01447628|588439215|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
162927783|NCT00965263|588439226|FG000|Overall Study|Physician Decision|2|||
162927784|NCT00965263|588439227|FG001|Overall Study|Physician Decision|0|||
162927785|NCT00965263|588439226|FG000|Overall Study|Family emergency|0|||
162927786|NCT00965263|588439227|FG001|Overall Study|Family emergency|1|||
162927787|NCT00965263|588439226|FG000|Overall Study|Protocol Violation|0|||
162927788|NCT00965263|588439227|FG001|Overall Study|Protocol Violation|2|||
162927789|NCT03959137|588439228|FG000|Overall Study|Protocol Violation|6|||
162927790|NCT03496207|588439229|FG000|Base Study|Adverse Event|0|||
162927791|NCT03496207|588439230|FG001|Base Study|Adverse Event|0|||
162927792|NCT03496207|588439231|FG002|Base Study|Adverse Event|1|||
162927793|NCT03496207|588439232|FG003|Base Study|Adverse Event|1|||
162927794|NCT03496207|588439233|FG004|Base Study|Adverse Event|4|||
162927795|NCT03496207|588439229|FG000|Base Study|Death|0|||
162927796|NCT03496207|588439230|FG001|Base Study|Death|0|||
162927797|NCT03496207|588439231|FG002|Base Study|Death|0|||
162927798|NCT03496207|588439232|FG003|Base Study|Death|0|||
162927799|NCT03496207|588439233|FG004|Base Study|Death|1|||
162927800|NCT03496207|588439229|FG000|Base Study|Withdrawal by Subject|0|||
162927801|NCT03496207|588439230|FG001|Base Study|Withdrawal by Subject|0|||
162927802|NCT03496207|588439231|FG002|Base Study|Withdrawal by Subject|1|||
162927803|NCT03496207|588439232|FG003|Base Study|Withdrawal by Subject|0|||
162927804|NCT03496207|588439233|FG004|Base Study|Withdrawal by Subject|1|||
162927805|NCT03496207|588439229|FG000|Extension Period|Adverse Event|0|||
162927806|NCT03496207|588439230|FG001|Extension Period|Adverse Event|0|||
162927807|NCT03496207|588439231|FG002|Extension Period|Adverse Event|0|||
162927808|NCT03496207|588439232|FG003|Extension Period|Adverse Event|1|||
162927809|NCT03496207|588439233|FG004|Extension Period|Adverse Event|1|||
162927810|NCT03496207|588439229|FG000|Extension Period|Death|1|||
162927811|NCT03496207|588439230|FG001|Extension Period|Death|0|||
162927812|NCT03496207|588439231|FG002|Extension Period|Death|0|||
162927813|NCT03496207|588439232|FG003|Extension Period|Death|1|||
162927814|NCT03496207|588439233|FG004|Extension Period|Death|2|||
162927815|NCT03496207|588439229|FG000|Extension Period|Withdrawal by Subject|1|||
162927816|NCT03496207|588439230|FG001|Extension Period|Withdrawal by Subject|0|||
162927817|NCT03496207|588439231|FG002|Extension Period|Withdrawal by Subject|0|||
162927818|NCT03496207|588439232|FG003|Extension Period|Withdrawal by Subject|1|||
162927819|NCT03496207|588439233|FG004|Extension Period|Withdrawal by Subject|1|||
162927820|NCT03496207|588439229|FG000|Extension Period|Elevated hemoglobin levels|0|||
162927821|NCT03496207|588439230|FG001|Extension Period|Elevated hemoglobin levels|0|||
162927822|NCT03496207|588439231|FG002|Extension Period|Elevated hemoglobin levels|0|||
162927823|NCT03496207|588439232|FG003|Extension Period|Elevated hemoglobin levels|0|||
162927824|NCT03496207|588439233|FG004|Extension Period|Elevated hemoglobin levels|1|||
162927825|NCT02756078|588439234|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
162927826|NCT02756078|588439235|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
162927827|NCT02756078|588439234|FG000|Period 1|Lost to Follow-up|0|||
162927828|NCT02756078|588439235|FG001|Period 1|Lost to Follow-up|2|||
162927829|NCT02756078|588439234|FG000|Period 1|Protocol Violation|0|||
162927830|NCT02756078|588439235|FG001|Period 1|Protocol Violation|1|||
162927831|NCT02756078|588439234|FG000|Period 1|Adverse Event|1|||
162927832|NCT02756078|588439235|FG001|Period 1|Adverse Event|10|||
162927833|NCT02756078|588439234|FG000|Period 1|Withdrawal by Subject|6|||
162927834|NCT02756078|588439235|FG001|Period 1|Withdrawal by Subject|6|||
162927835|NCT02756078|588439234|FG000|Period 1|Lens Discomfort|2|||
162927836|NCT02756078|588439235|FG001|Period 1|Lens Discomfort|2|||
162927837|NCT02756078|588439234|FG000|Period 2|Adverse Event|3|||
162927838|NCT02756078|588439235|FG001|Period 2|Adverse Event|5|||
162927839|NCT02756078|588439234|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
162927840|NCT02756078|588439235|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
162927841|NCT02756078|588439234|FG000|Period 2|Withdrawal by Subject|3|||
162927842|NCT02756078|588439235|FG001|Period 2|Withdrawal by Subject|1|||
162927843|NCT00810615|588439236|FG000|Overall Study|Withdrawal by Subject|1|||
162927844|NCT00810615|588439237|FG001|Overall Study|Withdrawal by Subject|1|||
162927845|NCT02058368|588439241|FG000|Overall Study|Adverse Event|15|||
162927846|NCT02058368|588439242|FG001|Overall Study|Adverse Event|20|||
162927847|NCT02058368|588439241|FG000|Overall Study|Lack of Efficacy|0|||
162927848|NCT02058368|588439242|FG001|Overall Study|Lack of Efficacy|1|||
162927849|NCT02058368|588439241|FG000|Overall Study|Protocol Violation|0|||
162927850|NCT02058368|588439242|FG001|Overall Study|Protocol Violation|4|||
162927851|NCT02058368|588439241|FG000|Overall Study|Lost to Follow-up|2|||
162927852|NCT02058368|588439242|FG001|Overall Study|Lost to Follow-up|0|||
162927853|NCT02058368|588439241|FG000|Overall Study|Physician Decision|2|||
162927854|NCT02058368|588439242|FG001|Overall Study|Physician Decision|3|||
162927855|NCT02058368|588439241|FG000|Overall Study|Withdrawal by Subject|22|||
162927856|NCT02058368|588439242|FG001|Overall Study|Withdrawal by Subject|26|||
162927857|NCT02181842|588439243|FG000|Overall Study|Case Report Forms Uncollected|2|||
163041082|NCT02588092|588858052|FG001|Overall Study|Withdrawal by Subject|0|||
163041083|NCT02588092|588858053|FG002|Overall Study|Withdrawal by Subject|0|||
163041084|NCT02588092|588858054|FG003|Overall Study|Withdrawal by Subject|0|||
163041085|NCT02588092|588858055|FG004|Overall Study|Withdrawal by Subject|0|||
163041086|NCT02588092|588858056|FG005|Overall Study|Withdrawal by Subject|1|||
163041087|NCT02588092|588858057|FG006|Overall Study|Withdrawal by Subject|1|||
163041088|NCT02588092|588858058|FG007|Overall Study|Withdrawal by Subject|2|||
163041089|NCT02588092|588858059|FG008|Overall Study|Withdrawal by Subject|0|||
163041090|NCT02588092|588858060|FG009|Overall Study|Withdrawal by Subject|0|||
163041091|NCT02588092|588858051|FG000|Overall Study|Started Another Treatment|0|||
163041092|NCT02588092|588858052|FG001|Overall Study|Started Another Treatment|0|||
163041093|NCT02588092|588858053|FG002|Overall Study|Started Another Treatment|0|||
163041094|NCT02588092|588858054|FG003|Overall Study|Started Another Treatment|0|||
163041095|NCT02588092|588858055|FG004|Overall Study|Started Another Treatment|1|||
163041096|NCT02588092|588858056|FG005|Overall Study|Started Another Treatment|0|||
163041097|NCT02588092|588858057|FG006|Overall Study|Started Another Treatment|0|||
163041098|NCT02588092|588858058|FG007|Overall Study|Started Another Treatment|1|||
163041099|NCT02588092|588858059|FG008|Overall Study|Started Another Treatment|0|||
163041100|NCT02588092|588858060|FG009|Overall Study|Started Another Treatment|0|||
163041101|NCT02588092|588858051|FG000|Overall Study|Sponsor Decision|0|||
163041102|NCT02588092|588858052|FG001|Overall Study|Sponsor Decision|0|||
163156356|NCT01746901|589287827|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
163156357|NCT01746901|589287828|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
162927858|NCT02441179|588439244|FG000|Overall Study|Withdrawal by Subject|1|||
162927859|NCT02441179|588439245|FG001|Overall Study|Withdrawal by Subject|1|||
162927860|NCT01488071|588439246|FG000|Overall Study|Adverse Event|15|||
163156358|NCT01746901|589287829|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
163156359|NCT01746901|589287821|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
163156360|NCT01746901|589287822|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
163156361|NCT01746901|589287823|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
163156362|NCT01746901|589287824|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
163156363|NCT01746901|589287825|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
163156364|NCT01746901|589287826|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
163156365|NCT01746901|589287827|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
163156366|NCT01746901|589287828|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
163156367|NCT01746901|589287829|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
163156368|NCT03594110|589287830|FG000|Interventional Part|Participant concerned about study treatment|23|||
163156369|NCT03594110|589287831|FG001|Interventional Part|Participant concerned about study treatment|28|||
163156370|NCT03594110|589287830|FG000|Interventional Part|Doctor advice|38|||
163156371|NCT03594110|589287831|FG001|Interventional Part|Doctor advice|40|||
163156372|NCT03594110|589287830|FG000|Interventional Part|Participants' wish|89|||
163156373|NCT03594110|589287831|FG001|Interventional Part|Participants' wish|68|||
163156374|NCT03594110|589287830|FG000|Interventional Part|Adverse event-non-fatal events|119|||
163156375|NCT03594110|589287831|FG001|Interventional Part|Adverse event-non-fatal events|116|||
163156376|NCT03594110|589287830|FG000|Interventional Part|Study drug stopped, reason missing|336|||
163156377|NCT03594110|589287831|FG001|Interventional Part|Study drug stopped, reason missing|294|||
163156378|NCT03594110|589287830|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
163156379|NCT03594110|589287831|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
163156380|NCT03594110|589287830|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
163156381|NCT03594110|589287831|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
163156382|NCT03594110|589287830|FG000|Interventional Part|Contraindicated drug started|32|||
163156383|NCT03594110|589287831|FG001|Interventional Part|Contraindicated drug started|18|||
163156384|NCT03594110|589287830|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
163156385|NCT03594110|589287831|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
163156386|NCT03594110|589287830|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
163156387|NCT03594110|589287831|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
163156388|NCT03594110|589287830|FG000|Non-interventional Part|Withdrawal by Subject|3|||
163156389|NCT03594110|589287831|FG001|Non-interventional Part|Withdrawal by Subject|4|||
163156390|NCT03594110|589287830|FG000|Non-interventional Part|Lost to Follow-up|45|||
163156391|NCT03594110|589287831|FG001|Non-interventional Part|Lost to Follow-up|41|||
163156392|NCT03041038|589287832|FG000|Overall Study|Withdrawal by Subject|4|||
163156393|NCT03041038|589287833|FG001|Overall Study|Withdrawal by Subject|0|||
163156394|NCT03041038|589287832|FG000|Overall Study|Lost to Follow-up|1|||
163156395|NCT03041038|589287833|FG001|Overall Study|Lost to Follow-up|1|||
163156396|NCT03041038|589287832|FG000|Overall Study|Protocol Violation|1|||
163156397|NCT03041038|589287833|FG001|Overall Study|Protocol Violation|1|||
163156398|NCT02796170|589287834|FG000|Overall Study|Lost to Follow-up|3|||
163156399|NCT02796170|589287835|FG001|Overall Study|Lost to Follow-up|0|||
163156400|NCT01527370|589287836|FG000|Overall Study|Withdrawal by Subject|4|||
163156401|NCT01527370|589287836|FG000|Overall Study|Physician Decision|1|||
163156402|NCT01527370|589287836|FG000|Overall Study|Death|1|||
163156403|NCT02177032|589287837|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
163156404|NCT02177032|589287838|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
163156405|NCT02177032|589287839|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
163156406|NCT02177032|589287840|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
163156407|NCT02177032|589287837|FG000|Overall Study|Lost to Follow-up|0|||
163156408|NCT02177032|589287838|FG001|Overall Study|Lost to Follow-up|2|||
163156409|NCT02177032|589287839|FG002|Overall Study|Lost to Follow-up|0|||
163156410|NCT02177032|589287840|FG003|Overall Study|Lost to Follow-up|0|||
163156411|NCT02177032|589287837|FG000|Overall Study|OTHER|2|||
163156412|NCT02177032|589287838|FG001|Overall Study|OTHER|0|||
163156413|NCT02177032|589287839|FG002|Overall Study|OTHER|1|||
163156414|NCT02177032|589287840|FG003|Overall Study|OTHER|0|||
163156415|NCT02177032|589287837|FG000|Overall Study|Withdrawal by Subject|1|||
163156416|NCT02177032|589287838|FG001|Overall Study|Withdrawal by Subject|0|||
163156417|NCT02177032|589287839|FG002|Overall Study|Withdrawal by Subject|1|||
163156418|NCT02177032|589287840|FG003|Overall Study|Withdrawal by Subject|0|||
163156419|NCT00930046|589287841|FG000|Overall Study|Wound catheter malfunctioned|1|||
163156420|NCT00930046|589287842|FG001|Overall Study|Wound catheter malfunctioned|2|||
163156421|NCT01598532|589287843|FG000|Overall Study|Lost to Follow-up|3|||
163156422|NCT01598532|589287843|FG000|Overall Study|Did not meet inclusion criteria|8|||
163156423|NCT00912808|589287844|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
163156424|NCT00912808|589287845|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
163156425|NCT00912808|589287844|FG000|Washout|Withdrawal by Subject|0|||
163156426|NCT00912808|589287845|FG001|Washout|Withdrawal by Subject|1|||
163156427|NCT00912808|589287844|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
163156428|NCT00912808|589287845|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
163156429|NCT00912808|589287844|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
163156430|NCT00912808|589287845|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
163156431|NCT04798196|589287849|FG000|Overall Study|Lost to Follow-up|3|||
163156432|NCT04798196|589287850|FG001|Overall Study|Lost to Follow-up|1|||
163156433|NCT04798196|589287851|FG002|Overall Study|Lost to Follow-up|3|||
163156434|NCT01249261|589287852|FG000|Overall Study|Withdrawal by Subject|1|||
163156435|NCT01249261|589287853|FG001|Overall Study|Withdrawal by Subject|0|||
163156436|NCT01967940|589287860|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
163156437|NCT01967940|589287861|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
163156438|NCT01967940|589287862|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
163156439|NCT01967940|589287863|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
163156440|NCT01967940|589287860|FG000|Part 2|Adverse Event|0|||
163156441|NCT01967940|589287861|FG001|Part 2|Adverse Event|0|||
163156442|NCT01967940|589287862|FG002|Part 2|Adverse Event|0|||
163156443|NCT01967940|589287863|FG003|Part 2|Adverse Event|1|||
163156444|NCT01967940|589287860|FG000|Part 2|Unknown Reason|0|||
163156445|NCT01967940|589287861|FG001|Part 2|Unknown Reason|0|||
163156446|NCT01967940|589287862|FG002|Part 2|Unknown Reason|0|||
163156447|NCT01967940|589287863|FG003|Part 2|Unknown Reason|1|||
163156448|NCT01550003|589287864|FG000|Overall Study|Adverse Event|0|||
163156449|NCT01550003|589287865|FG001|Overall Study|Adverse Event|9|||
163156450|NCT01550003|589287866|FG002|Overall Study|Adverse Event|15|||
163156451|NCT01550003|589287864|FG000|Overall Study|Lack of Efficacy|4|||
163156452|NCT01550003|589287865|FG001|Overall Study|Lack of Efficacy|11|||
163156453|NCT01550003|589287866|FG002|Overall Study|Lack of Efficacy|15|||
163156454|NCT01550003|589287864|FG000|Overall Study|Protocol Violation|0|||
163156455|NCT01550003|589287865|FG001|Overall Study|Protocol Violation|3|||
163156456|NCT01550003|589287866|FG002|Overall Study|Protocol Violation|2|||
163156457|NCT01550003|589287864|FG000|Overall Study|Lost to Follow-up|1|||
163156458|NCT01550003|589287865|FG001|Overall Study|Lost to Follow-up|4|||
163156459|NCT01550003|589287866|FG002|Overall Study|Lost to Follow-up|8|||
163156460|NCT01550003|589287864|FG000|Overall Study|Consent withdrawn|2|||
163156461|NCT01550003|589287865|FG001|Overall Study|Consent withdrawn|11|||
163156462|NCT01550003|589287866|FG002|Overall Study|Consent withdrawn|23|||
163156463|NCT01550003|589287864|FG000|Overall Study|Missing|1|||
163156464|NCT01550003|589287865|FG001|Overall Study|Missing|0|||
163156465|NCT01550003|589287866|FG002|Overall Study|Missing|2|||
163156466|NCT01550003|589287864|FG000|Overall Study|Study closure as announced by sponsor|7|||
163156467|NCT01550003|589287865|FG001|Overall Study|Study closure as announced by sponsor|6|||
163156468|NCT01550003|589287866|FG002|Overall Study|Study closure as announced by sponsor|24|||
163156469|NCT01550003|589287864|FG000|Overall Study|Protocol Noncompliance|1|||
163156470|NCT01550003|589287865|FG001|Overall Study|Protocol Noncompliance|0|||
163156471|NCT01550003|589287866|FG002|Overall Study|Protocol Noncompliance|0|||
163156472|NCT01550003|589287864|FG000|Overall Study|Study closure|0|||
163156473|NCT01550003|589287865|FG001|Overall Study|Study closure|1|||
163156474|NCT01550003|589287866|FG002|Overall Study|Study closure|1|||
163156475|NCT01550003|589287864|FG000|Overall Study|Patient reached adulthood|0|||
163156476|NCT01550003|589287865|FG001|Overall Study|Patient reached adulthood|1|||
163156477|NCT01550003|589287866|FG002|Overall Study|Patient reached adulthood|0|||
163156478|NCT01550003|589287864|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
163156479|NCT01550003|589287865|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
163156480|NCT01550003|589287866|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
163156481|NCT01550003|589287864|FG000|Overall Study|Sponsor's order|0|||
163156482|NCT01550003|589287865|FG001|Overall Study|Sponsor's order|3|||
163156483|NCT01550003|589287866|FG002|Overall Study|Sponsor's order|3|||
163156484|NCT01550003|589287864|FG000|Overall Study|Sponsor's decision|1|||
163156485|NCT01550003|589287865|FG001|Overall Study|Sponsor's decision|5|||
163156486|NCT01550003|589287866|FG002|Overall Study|Sponsor's decision|4|||
163156487|NCT01550003|589287864|FG000|Overall Study|Subject mother passed away|0|||
163156488|NCT01550003|589287865|FG001|Overall Study|Subject mother passed away|1|||
163156489|NCT01550003|589287866|FG002|Overall Study|Subject mother passed away|0|||
163156490|NCT01550003|589287864|FG000|Overall Study|Discontinuation|0|||
163156491|NCT01550003|589287865|FG001|Overall Study|Discontinuation|1|||
163156492|NCT01550003|589287866|FG002|Overall Study|Discontinuation|0|||
163156493|NCT01550003|589287864|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
162927861|NCT01488071|588439247|FG001|Overall Study|Adverse Event|23|||
163156494|NCT01550003|589287865|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
163156495|NCT01550003|589287866|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
163156496|NCT01550003|589287864|FG000|Overall Study|Site closure|0|||
163156497|NCT01550003|589287865|FG001|Overall Study|Site closure|2|||
163156498|NCT01550003|589287866|FG002|Overall Study|Site closure|0|||
163156499|NCT01550003|589287864|FG000|Overall Study|Pregnancy|0|||
163156500|NCT01550003|589287865|FG001|Overall Study|Pregnancy|1|||
163156501|NCT01550003|589287866|FG002|Overall Study|Pregnancy|0|||
163156502|NCT01550003|589287864|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
163156503|NCT01550003|589287865|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
163156504|NCT01550003|589287866|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
163041103|NCT02588092|588858053|FG002|Overall Study|Sponsor Decision|0|||
163041104|NCT02588092|588858054|FG003|Overall Study|Sponsor Decision|0|||
163041105|NCT02588092|588858055|FG004|Overall Study|Sponsor Decision|0|||
163041106|NCT02588092|588858056|FG005|Overall Study|Sponsor Decision|0|||
163041107|NCT02588092|588858057|FG006|Overall Study|Sponsor Decision|0|||
163041108|NCT02588092|588858058|FG007|Overall Study|Sponsor Decision|0|||
163041109|NCT02588092|588858059|FG008|Overall Study|Sponsor Decision|1|||
163041110|NCT02588092|588858060|FG009|Overall Study|Sponsor Decision|1|||
163041111|NCT01348100|588858061|FG000|Overall Study|Subject Withdrew Consent|0|||
163041112|NCT01348100|588858062|FG001|Overall Study|Subject Withdrew Consent|0|||
163041113|NCT01348100|588858063|FG002|Overall Study|Subject Withdrew Consent|2|||
163041114|NCT01348100|588858064|FG003|Overall Study|Subject Withdrew Consent|0|||
163041115|NCT01348100|588858065|FG004|Overall Study|Subject Withdrew Consent|1|||
163041116|NCT01348100|588858066|FG005|Overall Study|Subject Withdrew Consent|0|||
163041117|NCT01348100|588858067|FG006|Overall Study|Subject Withdrew Consent|1|||
163041118|NCT01348100|588858061|FG000|Overall Study|Protocol Deviation|0|||
163041119|NCT01348100|588858062|FG001|Overall Study|Protocol Deviation|0|||
163041120|NCT01348100|588858063|FG002|Overall Study|Protocol Deviation|0|||
163041121|NCT01348100|588858064|FG003|Overall Study|Protocol Deviation|1|||
163041122|NCT01348100|588858065|FG004|Overall Study|Protocol Deviation|0|||
163041123|NCT01348100|588858066|FG005|Overall Study|Protocol Deviation|0|||
163041124|NCT01348100|588858067|FG006|Overall Study|Protocol Deviation|0|||
163041125|NCT01348100|588858061|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163156505|NCT01550003|589287864|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
163156506|NCT01550003|589287865|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
163156507|NCT01550003|589287866|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
163156508|NCT01550003|589287864|FG000|Overall Study|Switching to adult rheumatologist|0|||
163156509|NCT01550003|589287865|FG001|Overall Study|Switching to adult rheumatologist|0|||
163156510|NCT01550003|589287866|FG002|Overall Study|Switching to adult rheumatologist|1|||
163156511|NCT01550003|589287864|FG000|Overall Study|Patient transition to adult care|0|||
163156512|NCT01550003|589287865|FG001|Overall Study|Patient transition to adult care|0|||
163156513|NCT01550003|589287866|FG002|Overall Study|Patient transition to adult care|1|||
163156514|NCT01550003|589287864|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
163156515|NCT01550003|589287865|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
163156516|NCT01550003|589287866|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
163156517|NCT01550003|589287864|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
163156518|NCT01550003|589287865|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
163156519|NCT01550003|589287866|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
163156520|NCT01550003|589287864|FG000|Overall Study|Per Sponsor request|1|||
163156521|NCT01550003|589287865|FG001|Overall Study|Per Sponsor request|0|||
163156522|NCT01550003|589287866|FG002|Overall Study|Per Sponsor request|1|||
163156523|NCT01550003|589287864|FG000|Overall Study|Patient not compliance|0|||
163156524|NCT01550003|589287865|FG001|Overall Study|Patient not compliance|0|||
163156525|NCT01550003|589287866|FG002|Overall Study|Patient not compliance|1|||
163156526|NCT01550003|589287864|FG000|Overall Study|Non-compliance|0|||
163156527|NCT01550003|589287865|FG001|Overall Study|Non-compliance|0|||
163156528|NCT01550003|589287866|FG002|Overall Study|Non-compliance|1|||
163156529|NCT01550003|589287864|FG000|Overall Study|Study closed|0|||
163156530|NCT01550003|589287865|FG001|Overall Study|Study closed|1|||
163156531|NCT01550003|589287866|FG002|Overall Study|Study closed|0|||
163156532|NCT01550003|589287864|FG000|Overall Study|Transitioned to adult rheumatology|0|||
163156533|NCT01550003|589287865|FG001|Overall Study|Transitioned to adult rheumatology|0|||
163156534|NCT01550003|589287866|FG002|Overall Study|Transitioned to adult rheumatology|1|||
163156535|NCT05567783|589287867|FG000|Overall Study|Death|2|||
163156536|NCT05567783|589287868|FG001|Overall Study|Death|3|||
163156537|NCT05567783|589287869|FG002|Overall Study|Death|0|||
163156538|NCT05567783|589287867|FG000|Overall Study|Lost to Follow-up|25|||
163156539|NCT05567783|589287868|FG001|Overall Study|Lost to Follow-up|19|||
163041126|NCT01348100|588858062|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163041127|NCT01348100|588858063|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163041128|NCT01348100|588858064|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163041129|NCT01348100|588858065|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163041130|NCT01348100|588858066|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
163041131|NCT01348100|588858067|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163041132|NCT01348100|588858061|FG000|Overall Study|Lost to Follow-up|0|||
163041133|NCT01348100|588858062|FG001|Overall Study|Lost to Follow-up|0|||
163041134|NCT01348100|588858063|FG002|Overall Study|Lost to Follow-up|0|||
163041135|NCT01348100|588858064|FG003|Overall Study|Lost to Follow-up|0|||
163041136|NCT01348100|588858065|FG004|Overall Study|Lost to Follow-up|0|||
163041137|NCT01348100|588858066|FG005|Overall Study|Lost to Follow-up|0|||
163041138|NCT01348100|588858067|FG006|Overall Study|Lost to Follow-up|1|||
163041139|NCT01348100|588858061|FG000|Overall Study|Administrative Problems|0|||
163041140|NCT01348100|588858062|FG001|Overall Study|Administrative Problems|0|||
163041141|NCT01348100|588858063|FG002|Overall Study|Administrative Problems|0|||
163041142|NCT01348100|588858064|FG003|Overall Study|Administrative Problems|0|||
163156540|NCT05567783|589287869|FG002|Overall Study|Lost to Follow-up|17|||
163156541|NCT05567783|589287867|FG000|Overall Study|Physician Decision|10|||
163156542|NCT05567783|589287868|FG001|Overall Study|Physician Decision|7|||
163156543|NCT05567783|589287869|FG002|Overall Study|Physician Decision|9|||
163156544|NCT05567783|589287867|FG000|Overall Study|Study Terminated by Sponsor|924|||
163156545|NCT05567783|589287868|FG001|Overall Study|Study Terminated by Sponsor|937|||
163156546|NCT05567783|589287869|FG002|Overall Study|Study Terminated by Sponsor|941|||
163156547|NCT05567783|589287867|FG000|Overall Study|Withdrawal by Subject|23|||
163156548|NCT05567783|589287868|FG001|Overall Study|Withdrawal by Subject|27|||
163156549|NCT05567783|589287869|FG002|Overall Study|Withdrawal by Subject|24|||
163156550|NCT05567783|589287867|FG000|Overall Study|Incarcerated|1|||
163156551|NCT05567783|589287868|FG001|Overall Study|Incarcerated|0|||
163156552|NCT05567783|589287869|FG002|Overall Study|Incarcerated|0|||
163156553|NCT05567783|589287867|FG000|Overall Study|Participant randomized in error|4|||
163156554|NCT05567783|589287868|FG001|Overall Study|Participant randomized in error|2|||
163156555|NCT05567783|589287869|FG002|Overall Study|Participant randomized in error|2|||
163156556|NCT03675126|589287872|FG000|Overall Study|Study Terminated by Sponsor|9|||
163156557|NCT03675126|589287872|FG000|Overall Study|Death|2|||
163156558|NCT03675126|589287872|FG000|Overall Study|Withdrawal by Subject|4|||
163156559|NCT00904982|589287874|FG000|Overall Study|Withdrawal by Subject|2|||
163156560|NCT00904982|589287875|FG001|Overall Study|Withdrawal by Subject|0|||
163156561|NCT00904982|589287876|FG002|Overall Study|Withdrawal by Subject|0|||
163156562|NCT00904982|589287877|FG003|Overall Study|Withdrawal by Subject|0|||
163156563|NCT02072668|589287883|FG000|Second Intervention|Lost to Follow-up|1|||
163156564|NCT02072668|589287884|FG001|Second Intervention|Lost to Follow-up|0|||
163156565|NCT01353898|589287885|FG000|Overall Study|Study site terminated|0|||
163156566|NCT01353898|589287886|FG001|Overall Study|Study site terminated|0|||
163156567|NCT01353898|589287887|FG002|Overall Study|Study site terminated|0|||
163156568|NCT01353898|589287888|FG003|Overall Study|Study site terminated|0|||
163156569|NCT01353898|589287889|FG004|Overall Study|Study site terminated|0|||
163156570|NCT01353898|589287890|FG005|Overall Study|Study site terminated|1|||
163156571|NCT01352793|589287892|FG000|Overall Study|Lost to Follow-up|289|||
163156572|NCT01352793|589287893|FG001|Overall Study|Lost to Follow-up|125|||
163156573|NCT01352793|589287892|FG000|Overall Study|Withdrawal by Subject|120|||
163156574|NCT01352793|589287893|FG001|Overall Study|Withdrawal by Subject|55|||
163156575|NCT01352793|589287892|FG000|Overall Study|Protocol Violation|44|||
163156576|NCT01352793|589287893|FG001|Overall Study|Protocol Violation|23|||
163156577|NCT01352793|589287892|FG000|Overall Study|Adverse Event|44|||
163156578|NCT01352793|589287893|FG001|Overall Study|Adverse Event|10|||
163156579|NCT01352793|589287892|FG000|Overall Study|Physician Decision|1|||
163269887|NCT00900627|589699936|FG005|Overall Study|Condition under investigation worsened|0|||
163269888|NCT00900627|589699931|FG000|Overall Study|Withdrawal by Subject|1|||
163269889|NCT00900627|589699932|FG001|Overall Study|Withdrawal by Subject|0|||
163269890|NCT00900627|589699933|FG002|Overall Study|Withdrawal by Subject|1|||
163269891|NCT00900627|589699934|FG003|Overall Study|Withdrawal by Subject|0|||
163269892|NCT00900627|589699935|FG004|Overall Study|Withdrawal by Subject|1|||
163269893|NCT00900627|589699936|FG005|Overall Study|Withdrawal by Subject|2|||
163269894|NCT00900627|589699931|FG000|Overall Study|Adverse Event|1|||
163269895|NCT00900627|589699932|FG001|Overall Study|Adverse Event|2|||
163269896|NCT00900627|589699933|FG002|Overall Study|Adverse Event|0|||
163269897|NCT00900627|589699934|FG003|Overall Study|Adverse Event|3|||
163269898|NCT00900627|589699935|FG004|Overall Study|Adverse Event|0|||
163269899|NCT00900627|589699936|FG005|Overall Study|Adverse Event|0|||
163269900|NCT00900627|589699931|FG000|Overall Study|Death|0|||
163269901|NCT00900627|589699932|FG001|Overall Study|Death|0|||
163269902|NCT00900627|589699933|FG002|Overall Study|Death|0|||
163269903|NCT00900627|589699934|FG003|Overall Study|Death|0|||
163269904|NCT00900627|589699935|FG004|Overall Study|Death|28|||
163269905|NCT00900627|589699936|FG005|Overall Study|Death|24|||
163269906|NCT00373295|589699937|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
163269907|NCT00373295|589699938|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
163269908|NCT00373295|589699939|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
163269909|NCT00373295|589699940|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
163269910|NCT00373295|589699941|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
163269911|NCT00373295|589699942|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
163269912|NCT00830947|589699943|FG000|Overall Study|Lost to Follow-up|4|||
163269913|NCT00830947|589699944|FG001|Overall Study|Lost to Follow-up|4|||
163269914|NCT01474512|589699956|FG000|Induction Period|Adverse Event|6|||
163269915|NCT01474512|589699957|FG001|Induction Period|Adverse Event|10|||
163269916|NCT01474512|589699958|FG002|Induction Period|Adverse Event|10|||
163269917|NCT01474512|589699959|FG003|Induction Period|Adverse Event|0|||
163269918|NCT01474512|589699960|FG004|Induction Period|Adverse Event|0|||
163269919|NCT01474512|589699961|FG005|Induction Period|Adverse Event|0|||
163269920|NCT01474512|589699962|FG006|Induction Period|Adverse Event|0|||
163269921|NCT01474512|589699963|FG007|Induction Period|Adverse Event|0|||
163269922|NCT01474512|589699964|FG008|Induction Period|Adverse Event|0|||
163156580|NCT01352793|589287893|FG001|Overall Study|Physician Decision|0|||
163156581|NCT01352793|589287892|FG000|Overall Study|Pregnancy|26|||
163269923|NCT01474512|589699965|FG009|Induction Period|Adverse Event|0|||
163269924|NCT01474512|589699966|FG010|Induction Period|Adverse Event|0|||
163269925|NCT01474512|589699967|FG011|Induction Period|Adverse Event|0|||
163269926|NCT01474512|589699968|FG012|Induction Period|Adverse Event|0|||
163269927|NCT01474512|589699969|FG013|Induction Period|Adverse Event|0|||
163269928|NCT01474512|589699970|FG014|Induction Period|Adverse Event|0|||
163269929|NCT01474512|589699971|FG015|Induction Period|Adverse Event|0|||
163269930|NCT01474512|589699972|FG016|Induction Period|Adverse Event|0|||
163269931|NCT01474512|589699973|FG017|Induction Period|Adverse Event|0|||
163269932|NCT01474512|589699956|FG000|Induction Period|Lack of Efficacy|7|||
163269933|NCT01474512|589699957|FG001|Induction Period|Lack of Efficacy|1|||
163269934|NCT01474512|589699958|FG002|Induction Period|Lack of Efficacy|0|||
163269935|NCT01474512|589699959|FG003|Induction Period|Lack of Efficacy|0|||
163269936|NCT01474512|589699960|FG004|Induction Period|Lack of Efficacy|0|||
163269937|NCT01474512|589699961|FG005|Induction Period|Lack of Efficacy|0|||
163269938|NCT01474512|589699962|FG006|Induction Period|Lack of Efficacy|0|||
163269939|NCT01474512|589699963|FG007|Induction Period|Lack of Efficacy|0|||
163269940|NCT01474512|589699964|FG008|Induction Period|Lack of Efficacy|0|||
163269941|NCT01474512|589699965|FG009|Induction Period|Lack of Efficacy|0|||
163269942|NCT01474512|589699966|FG010|Induction Period|Lack of Efficacy|0|||
163269943|NCT01474512|589699967|FG011|Induction Period|Lack of Efficacy|0|||
163269944|NCT01474512|589699968|FG012|Induction Period|Lack of Efficacy|0|||
163269945|NCT01474512|589699969|FG013|Induction Period|Lack of Efficacy|0|||
163269946|NCT01474512|589699970|FG014|Induction Period|Lack of Efficacy|0|||
163269947|NCT01474512|589699971|FG015|Induction Period|Lack of Efficacy|0|||
163269948|NCT01474512|589699972|FG016|Induction Period|Lack of Efficacy|0|||
163269949|NCT01474512|589699973|FG017|Induction Period|Lack of Efficacy|0|||
163269950|NCT01474512|589699956|FG000|Induction Period|Withdrawal by Subject|6|||
163269951|NCT01474512|589699957|FG001|Induction Period|Withdrawal by Subject|6|||
163269952|NCT01474512|589699958|FG002|Induction Period|Withdrawal by Subject|5|||
163269953|NCT01474512|589699959|FG003|Induction Period|Withdrawal by Subject|0|||
163269954|NCT01474512|589699960|FG004|Induction Period|Withdrawal by Subject|0|||
163269955|NCT01474512|589699961|FG005|Induction Period|Withdrawal by Subject|0|||
163269956|NCT01474512|589699962|FG006|Induction Period|Withdrawal by Subject|0|||
163269957|NCT01474512|589699963|FG007|Induction Period|Withdrawal by Subject|0|||
163269958|NCT01474512|589699964|FG008|Induction Period|Withdrawal by Subject|0|||
163269959|NCT01474512|589699965|FG009|Induction Period|Withdrawal by Subject|0|||
163269960|NCT01474512|589699966|FG010|Induction Period|Withdrawal by Subject|0|||
163269961|NCT01474512|589699967|FG011|Induction Period|Withdrawal by Subject|0|||
163269962|NCT01474512|589699968|FG012|Induction Period|Withdrawal by Subject|0|||
163269963|NCT01474512|589699969|FG013|Induction Period|Withdrawal by Subject|0|||
163269964|NCT01474512|589699970|FG014|Induction Period|Withdrawal by Subject|0|||
163269965|NCT01474512|589699971|FG015|Induction Period|Withdrawal by Subject|0|||
163269966|NCT01474512|589699972|FG016|Induction Period|Withdrawal by Subject|0|||
163269967|NCT01474512|589699973|FG017|Induction Period|Withdrawal by Subject|0|||
163269968|NCT01474512|589699956|FG000|Induction Period|Protocol Violation|3|||
163269969|NCT01474512|589699957|FG001|Induction Period|Protocol Violation|6|||
163269970|NCT01474512|589699958|FG002|Induction Period|Protocol Violation|0|||
163269971|NCT01474512|589699959|FG003|Induction Period|Protocol Violation|0|||
163269972|NCT01474512|589699960|FG004|Induction Period|Protocol Violation|0|||
163269973|NCT01474512|589699961|FG005|Induction Period|Protocol Violation|0|||
163269974|NCT01474512|589699962|FG006|Induction Period|Protocol Violation|0|||
163269975|NCT01474512|589699963|FG007|Induction Period|Protocol Violation|0|||
163269976|NCT01474512|589699964|FG008|Induction Period|Protocol Violation|0|||
163269977|NCT01474512|589699965|FG009|Induction Period|Protocol Violation|0|||
163269978|NCT01474512|589699966|FG010|Induction Period|Protocol Violation|0|||
163269979|NCT01474512|589699967|FG011|Induction Period|Protocol Violation|0|||
163269980|NCT01474512|589699968|FG012|Induction Period|Protocol Violation|0|||
163269981|NCT01474512|589699969|FG013|Induction Period|Protocol Violation|0|||
163269982|NCT01474512|589699970|FG014|Induction Period|Protocol Violation|0|||
163269983|NCT01474512|589699971|FG015|Induction Period|Protocol Violation|0|||
163269984|NCT01474512|589699972|FG016|Induction Period|Protocol Violation|0|||
163269985|NCT01474512|589699973|FG017|Induction Period|Protocol Violation|0|||
163269986|NCT01474512|589699956|FG000|Induction Period|Sponsor Decision|1|||
163269987|NCT01474512|589699957|FG001|Induction Period|Sponsor Decision|1|||
163269988|NCT01474512|589699958|FG002|Induction Period|Sponsor Decision|1|||
163269989|NCT01474512|589699959|FG003|Induction Period|Sponsor Decision|0|||
163269990|NCT01474512|589699960|FG004|Induction Period|Sponsor Decision|0|||
163269991|NCT01474512|589699961|FG005|Induction Period|Sponsor Decision|0|||
163269992|NCT01474512|589699962|FG006|Induction Period|Sponsor Decision|0|||
163269993|NCT01474512|589699963|FG007|Induction Period|Sponsor Decision|0|||
163269994|NCT01474512|589699964|FG008|Induction Period|Sponsor Decision|0|||
163269995|NCT01474512|589699965|FG009|Induction Period|Sponsor Decision|0|||
163269996|NCT01474512|589699966|FG010|Induction Period|Sponsor Decision|0|||
163269997|NCT01474512|589699967|FG011|Induction Period|Sponsor Decision|0|||
163269998|NCT01474512|589699968|FG012|Induction Period|Sponsor Decision|0|||
163269999|NCT01474512|589699969|FG013|Induction Period|Sponsor Decision|0|||
163270000|NCT01474512|589699970|FG014|Induction Period|Sponsor Decision|0|||
163270001|NCT01474512|589699971|FG015|Induction Period|Sponsor Decision|0|||
163270002|NCT01474512|589699972|FG016|Induction Period|Sponsor Decision|0|||
163270003|NCT01474512|589699973|FG017|Induction Period|Sponsor Decision|0|||
163270004|NCT01474512|589699956|FG000|Induction Period|Lost to Follow-up|1|||
163270005|NCT01474512|589699957|FG001|Induction Period|Lost to Follow-up|0|||
163270006|NCT01474512|589699958|FG002|Induction Period|Lost to Follow-up|2|||
163270007|NCT01474512|589699959|FG003|Induction Period|Lost to Follow-up|0|||
163270008|NCT01474512|589699960|FG004|Induction Period|Lost to Follow-up|0|||
163270009|NCT01474512|589699961|FG005|Induction Period|Lost to Follow-up|0|||
163270010|NCT01474512|589699962|FG006|Induction Period|Lost to Follow-up|0|||
163270011|NCT01474512|589699963|FG007|Induction Period|Lost to Follow-up|0|||
163270012|NCT01474512|589699964|FG008|Induction Period|Lost to Follow-up|0|||
163270013|NCT01474512|589699965|FG009|Induction Period|Lost to Follow-up|0|||
163270014|NCT01474512|589699966|FG010|Induction Period|Lost to Follow-up|0|||
163270015|NCT01474512|589699967|FG011|Induction Period|Lost to Follow-up|0|||
163270016|NCT01474512|589699968|FG012|Induction Period|Lost to Follow-up|0|||
163270017|NCT01474512|589699969|FG013|Induction Period|Lost to Follow-up|0|||
163270018|NCT01474512|589699970|FG014|Induction Period|Lost to Follow-up|0|||
163270019|NCT01474512|589699971|FG015|Induction Period|Lost to Follow-up|0|||
163270020|NCT01474512|589699972|FG016|Induction Period|Lost to Follow-up|0|||
163270021|NCT01474512|589699973|FG017|Induction Period|Lost to Follow-up|0|||
163270022|NCT01474512|589699956|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163270023|NCT01474512|589699957|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163270024|NCT01474512|589699958|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163270025|NCT01474512|589699959|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
163270026|NCT01474512|589699960|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
163270027|NCT01474512|589699961|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
163270028|NCT01474512|589699962|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
163270029|NCT01474512|589699963|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163270030|NCT01474512|589699964|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163270031|NCT01474512|589699965|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163270032|NCT01474512|589699966|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163270033|NCT01474512|589699967|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163270034|NCT01474512|589699968|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163270035|NCT01474512|589699969|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163270036|NCT01474512|589699970|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163270037|NCT01474512|589699971|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163270038|NCT01474512|589699972|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163270039|NCT01474512|589699973|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163270040|NCT01474512|589699956|FG000|Maintenance Period|Adverse Event|0|||
163270041|NCT01474512|589699957|FG001|Maintenance Period|Adverse Event|0|||
163270042|NCT01474512|589699958|FG002|Maintenance Period|Adverse Event|0|||
163270043|NCT01474512|589699959|FG003|Maintenance Period|Adverse Event|4|||
163270044|NCT01474512|589699960|FG004|Maintenance Period|Adverse Event|2|||
163270045|NCT01474512|589699961|FG005|Maintenance Period|Adverse Event|7|||
163270046|NCT01474512|589699962|FG006|Maintenance Period|Adverse Event|0|||
163270047|NCT01474512|589699963|FG007|Maintenance Period|Adverse Event|19|||
163270048|NCT01474512|589699964|FG008|Maintenance Period|Adverse Event|1|||
163270049|NCT01474512|589699965|FG009|Maintenance Period|Adverse Event|3|||
163270050|NCT01474512|589699966|FG010|Maintenance Period|Adverse Event|0|||
163270051|NCT01474512|589699967|FG011|Maintenance Period|Adverse Event|0|||
163270052|NCT01474512|589699968|FG012|Maintenance Period|Adverse Event|0|||
163270053|NCT01474512|589699969|FG013|Maintenance Period|Adverse Event|0|||
163270054|NCT01474512|589699970|FG014|Maintenance Period|Adverse Event|0|||
163270055|NCT01474512|589699971|FG015|Maintenance Period|Adverse Event|0|||
163270056|NCT01474512|589699972|FG016|Maintenance Period|Adverse Event|0|||
163270057|NCT01474512|589699973|FG017|Maintenance Period|Adverse Event|0|||
163270058|NCT01474512|589699956|FG000|Maintenance Period|Withdrawal by Subject|0|||
163270059|NCT01474512|589699957|FG001|Maintenance Period|Withdrawal by Subject|0|||
163041143|NCT01348100|588858065|FG004|Overall Study|Administrative Problems|0|||
163041144|NCT01348100|588858066|FG005|Overall Study|Administrative Problems|1|||
163041145|NCT01348100|588858067|FG006|Overall Study|Administrative Problems|1|||
163041146|NCT03882957|588858070|FG000|Overall Study|Did not complete all three arms|1|||
163270060|NCT01474512|589699958|FG002|Maintenance Period|Withdrawal by Subject|0|||
163270061|NCT01474512|589699959|FG003|Maintenance Period|Withdrawal by Subject|6|||
163270062|NCT01474512|589699960|FG004|Maintenance Period|Withdrawal by Subject|2|||
163270063|NCT01474512|589699961|FG005|Maintenance Period|Withdrawal by Subject|3|||
163270064|NCT01474512|589699962|FG006|Maintenance Period|Withdrawal by Subject|1|||
163270065|NCT01474512|589699963|FG007|Maintenance Period|Withdrawal by Subject|6|||
163270066|NCT01474512|589699964|FG008|Maintenance Period|Withdrawal by Subject|3|||
163270067|NCT01474512|589699965|FG009|Maintenance Period|Withdrawal by Subject|1|||
163270068|NCT01474512|589699966|FG010|Maintenance Period|Withdrawal by Subject|0|||
163270069|NCT01474512|589699967|FG011|Maintenance Period|Withdrawal by Subject|0|||
163270070|NCT01474512|589699968|FG012|Maintenance Period|Withdrawal by Subject|0|||
163041147|NCT00531947|588858074|FG000|Overall Study|Adverse Event|5|||
163270071|NCT01474512|589699969|FG013|Maintenance Period|Withdrawal by Subject|0|||
163270072|NCT01474512|589699970|FG014|Maintenance Period|Withdrawal by Subject|0|||
163270073|NCT01474512|589699971|FG015|Maintenance Period|Withdrawal by Subject|0|||
163270074|NCT01474512|589699972|FG016|Maintenance Period|Withdrawal by Subject|0|||
163270075|NCT01474512|589699973|FG017|Maintenance Period|Withdrawal by Subject|0|||
163270076|NCT01474512|589699956|FG000|Maintenance Period|Lost to Follow-up|0|||
163270077|NCT01474512|589699957|FG001|Maintenance Period|Lost to Follow-up|0|||
163270078|NCT01474512|589699958|FG002|Maintenance Period|Lost to Follow-up|0|||
163270079|NCT01474512|589699959|FG003|Maintenance Period|Lost to Follow-up|3|||
163270080|NCT01474512|589699960|FG004|Maintenance Period|Lost to Follow-up|3|||
163270081|NCT01474512|589699961|FG005|Maintenance Period|Lost to Follow-up|0|||
163270082|NCT01474512|589699962|FG006|Maintenance Period|Lost to Follow-up|0|||
163270083|NCT01474512|589699963|FG007|Maintenance Period|Lost to Follow-up|2|||
163270084|NCT01474512|589699964|FG008|Maintenance Period|Lost to Follow-up|1|||
163270085|NCT01474512|589699965|FG009|Maintenance Period|Lost to Follow-up|1|||
163270086|NCT01474512|589699966|FG010|Maintenance Period|Lost to Follow-up|0|||
163270087|NCT01474512|589699967|FG011|Maintenance Period|Lost to Follow-up|0|||
163270088|NCT01474512|589699968|FG012|Maintenance Period|Lost to Follow-up|0|||
163270089|NCT01474512|589699969|FG013|Maintenance Period|Lost to Follow-up|0|||
163270090|NCT01474512|589699970|FG014|Maintenance Period|Lost to Follow-up|0|||
163270091|NCT01474512|589699971|FG015|Maintenance Period|Lost to Follow-up|0|||
163270092|NCT01474512|589699972|FG016|Maintenance Period|Lost to Follow-up|0|||
163270093|NCT01474512|589699973|FG017|Maintenance Period|Lost to Follow-up|0|||
163270094|NCT01474512|589699956|FG000|Maintenance Period|Death|0|||
163270095|NCT01474512|589699957|FG001|Maintenance Period|Death|0|||
163270096|NCT01474512|589699958|FG002|Maintenance Period|Death|0|||
163270097|NCT01474512|589699959|FG003|Maintenance Period|Death|0|||
163270098|NCT01474512|589699960|FG004|Maintenance Period|Death|0|||
163270099|NCT01474512|589699961|FG005|Maintenance Period|Death|2|||
163270100|NCT01474512|589699962|FG006|Maintenance Period|Death|0|||
163270101|NCT01474512|589699963|FG007|Maintenance Period|Death|0|||
163270102|NCT01474512|589699964|FG008|Maintenance Period|Death|0|||
163270103|NCT01474512|589699965|FG009|Maintenance Period|Death|0|||
163270104|NCT01474512|589699966|FG010|Maintenance Period|Death|0|||
163270105|NCT01474512|589699967|FG011|Maintenance Period|Death|0|||
163270106|NCT01474512|589699968|FG012|Maintenance Period|Death|0|||
163270107|NCT01474512|589699969|FG013|Maintenance Period|Death|0|||
163270108|NCT01474512|589699970|FG014|Maintenance Period|Death|0|||
163270109|NCT01474512|589699971|FG015|Maintenance Period|Death|0|||
163270110|NCT01474512|589699972|FG016|Maintenance Period|Death|0|||
163270111|NCT01474512|589699973|FG017|Maintenance Period|Death|0|||
163270112|NCT01474512|589699956|FG000|Maintenance Period|Physician Decision|0|||
163270113|NCT01474512|589699957|FG001|Maintenance Period|Physician Decision|0|||
163270114|NCT01474512|589699958|FG002|Maintenance Period|Physician Decision|0|||
163270115|NCT01474512|589699959|FG003|Maintenance Period|Physician Decision|0|||
163270116|NCT01474512|589699960|FG004|Maintenance Period|Physician Decision|0|||
163270117|NCT01474512|589699961|FG005|Maintenance Period|Physician Decision|1|||
163270118|NCT01474512|589699962|FG006|Maintenance Period|Physician Decision|0|||
163270119|NCT01474512|589699963|FG007|Maintenance Period|Physician Decision|2|||
163270120|NCT01474512|589699964|FG008|Maintenance Period|Physician Decision|0|||
163270121|NCT01474512|589699965|FG009|Maintenance Period|Physician Decision|0|||
163270122|NCT01474512|589699966|FG010|Maintenance Period|Physician Decision|0|||
163270123|NCT01474512|589699967|FG011|Maintenance Period|Physician Decision|0|||
163270124|NCT01474512|589699968|FG012|Maintenance Period|Physician Decision|0|||
163270125|NCT01474512|589699969|FG013|Maintenance Period|Physician Decision|0|||
163270126|NCT01474512|589699970|FG014|Maintenance Period|Physician Decision|0|||
163270127|NCT01474512|589699971|FG015|Maintenance Period|Physician Decision|0|||
163270128|NCT01474512|589699972|FG016|Maintenance Period|Physician Decision|0|||
163270129|NCT01474512|589699973|FG017|Maintenance Period|Physician Decision|0|||
163270130|NCT01474512|589699956|FG000|Maintenance Period|Clinical Relapse|0|||
163270131|NCT01474512|589699957|FG001|Maintenance Period|Clinical Relapse|0|||
163270132|NCT01474512|589699958|FG002|Maintenance Period|Clinical Relapse|0|||
163270133|NCT01474512|589699959|FG003|Maintenance Period|Clinical Relapse|1|||
163270134|NCT01474512|589699960|FG004|Maintenance Period|Clinical Relapse|0|||
163270135|NCT01474512|589699961|FG005|Maintenance Period|Clinical Relapse|0|||
163270136|NCT01474512|589699962|FG006|Maintenance Period|Clinical Relapse|0|||
163270137|NCT01474512|589699963|FG007|Maintenance Period|Clinical Relapse|0|||
163270138|NCT01474512|589699964|FG008|Maintenance Period|Clinical Relapse|0|||
163270139|NCT01474512|589699965|FG009|Maintenance Period|Clinical Relapse|0|||
163270140|NCT01474512|589699966|FG010|Maintenance Period|Clinical Relapse|0|||
163385758|NCT00146328|590123239|FG000|Overall Study|Protocol Violation|11|||
163270141|NCT01474512|589699967|FG011|Maintenance Period|Clinical Relapse|0|||
163270142|NCT01474512|589699968|FG012|Maintenance Period|Clinical Relapse|0|||
163270143|NCT01474512|589699969|FG013|Maintenance Period|Clinical Relapse|0|||
163270144|NCT01474512|589699970|FG014|Maintenance Period|Clinical Relapse|0|||
163270145|NCT01474512|589699971|FG015|Maintenance Period|Clinical Relapse|0|||
163270146|NCT01474512|589699972|FG016|Maintenance Period|Clinical Relapse|0|||
163270147|NCT01474512|589699973|FG017|Maintenance Period|Clinical Relapse|0|||
163270148|NCT01474512|589699956|FG000|Maintenance Period|Lack of Efficacy|0|||
163270149|NCT01474512|589699957|FG001|Maintenance Period|Lack of Efficacy|0|||
163270150|NCT01474512|589699958|FG002|Maintenance Period|Lack of Efficacy|0|||
163270151|NCT01474512|589699959|FG003|Maintenance Period|Lack of Efficacy|1|||
163270152|NCT01474512|589699960|FG004|Maintenance Period|Lack of Efficacy|0|||
163270153|NCT01474512|589699961|FG005|Maintenance Period|Lack of Efficacy|0|||
163270154|NCT01474512|589699962|FG006|Maintenance Period|Lack of Efficacy|0|||
163270155|NCT01474512|589699963|FG007|Maintenance Period|Lack of Efficacy|11|||
163270156|NCT01474512|589699964|FG008|Maintenance Period|Lack of Efficacy|11|||
163270157|NCT01474512|589699965|FG009|Maintenance Period|Lack of Efficacy|12|||
163270158|NCT01474512|589699966|FG010|Maintenance Period|Lack of Efficacy|0|||
163270159|NCT01474512|589699967|FG011|Maintenance Period|Lack of Efficacy|0|||
163270160|NCT01474512|589699968|FG012|Maintenance Period|Lack of Efficacy|0|||
163270161|NCT01474512|589699969|FG013|Maintenance Period|Lack of Efficacy|0|||
163270162|NCT01474512|589699970|FG014|Maintenance Period|Lack of Efficacy|0|||
163270163|NCT01474512|589699971|FG015|Maintenance Period|Lack of Efficacy|0|||
163270164|NCT01474512|589699972|FG016|Maintenance Period|Lack of Efficacy|0|||
163270165|NCT01474512|589699973|FG017|Maintenance Period|Lack of Efficacy|0|||
163270166|NCT01474512|589699956|FG000|Maintenance Period|Protocol Violation|0|||
163270167|NCT01474512|589699957|FG001|Maintenance Period|Protocol Violation|0|||
163270168|NCT01474512|589699958|FG002|Maintenance Period|Protocol Violation|0|||
163270169|NCT01474512|589699959|FG003|Maintenance Period|Protocol Violation|1|||
163270170|NCT01474512|589699960|FG004|Maintenance Period|Protocol Violation|0|||
163270171|NCT01474512|589699961|FG005|Maintenance Period|Protocol Violation|0|||
163270172|NCT01474512|589699962|FG006|Maintenance Period|Protocol Violation|0|||
163270173|NCT01474512|589699963|FG007|Maintenance Period|Protocol Violation|1|||
163270174|NCT01474512|589699964|FG008|Maintenance Period|Protocol Violation|0|||
163270175|NCT01474512|589699965|FG009|Maintenance Period|Protocol Violation|1|||
163270176|NCT01474512|589699966|FG010|Maintenance Period|Protocol Violation|0|||
163270177|NCT01474512|589699967|FG011|Maintenance Period|Protocol Violation|0|||
163270178|NCT01474512|589699968|FG012|Maintenance Period|Protocol Violation|0|||
163270179|NCT01474512|589699969|FG013|Maintenance Period|Protocol Violation|0|||
163270180|NCT01474512|589699970|FG014|Maintenance Period|Protocol Violation|0|||
163270181|NCT01474512|589699971|FG015|Maintenance Period|Protocol Violation|0|||
163270182|NCT01474512|589699972|FG016|Maintenance Period|Protocol Violation|0|||
163270183|NCT01474512|589699973|FG017|Maintenance Period|Protocol Violation|0|||
163270184|NCT01474512|589699956|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
163270185|NCT01474512|589699957|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
163270186|NCT01474512|589699958|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
163270187|NCT01474512|589699959|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
163270188|NCT01474512|589699960|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
163270189|NCT01474512|589699961|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
163270190|NCT01474512|589699962|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
163270191|NCT01474512|589699963|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
163270192|NCT01474512|589699964|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
163270193|NCT01474512|589699965|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
163270194|NCT01474512|589699966|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
163270195|NCT01474512|589699967|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
163270196|NCT01474512|589699968|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
163270197|NCT01474512|589699969|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
163270198|NCT01474512|589699970|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
163270199|NCT01474512|589699971|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
163270200|NCT01474512|589699972|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
163270201|NCT01474512|589699973|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
163270202|NCT01474512|589699956|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
163270203|NCT01474512|589699957|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
163270204|NCT01474512|589699958|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
163270205|NCT01474512|589699959|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
163270206|NCT01474512|589699960|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
163270207|NCT01474512|589699961|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
163270208|NCT01474512|589699962|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
163270209|NCT01474512|589699963|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
163270210|NCT01474512|589699964|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
163270211|NCT01474512|589699965|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
163270212|NCT01474512|589699966|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
163270213|NCT01474512|589699967|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
163270214|NCT01474512|589699968|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
163270215|NCT01474512|589699969|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
163270216|NCT01474512|589699970|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
163270217|NCT01474512|589699971|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
163270218|NCT01474512|589699972|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
163270219|NCT01474512|589699973|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
163270220|NCT01474512|589699956|FG000|Long-Term Extension Period|Adverse Event|0|||
163270221|NCT01474512|589699957|FG001|Long-Term Extension Period|Adverse Event|0|||
163270222|NCT01474512|589699958|FG002|Long-Term Extension Period|Adverse Event|0|||
163270223|NCT01474512|589699959|FG003|Long-Term Extension Period|Adverse Event|0|||
163270224|NCT01474512|589699960|FG004|Long-Term Extension Period|Adverse Event|0|||
163270225|NCT01474512|589699961|FG005|Long-Term Extension Period|Adverse Event|0|||
163270226|NCT01474512|589699962|FG006|Long-Term Extension Period|Adverse Event|0|||
163270227|NCT01474512|589699963|FG007|Long-Term Extension Period|Adverse Event|0|||
163270228|NCT01474512|589699964|FG008|Long-Term Extension Period|Adverse Event|0|||
163270229|NCT01474512|589699965|FG009|Long-Term Extension Period|Adverse Event|0|||
163270230|NCT01474512|589699966|FG010|Long-Term Extension Period|Adverse Event|0|||
163270231|NCT01474512|589699967|FG011|Long-Term Extension Period|Adverse Event|1|||
163270232|NCT01474512|589699968|FG012|Long-Term Extension Period|Adverse Event|57|||
163270233|NCT01474512|589699969|FG013|Long-Term Extension Period|Adverse Event|58|||
163270234|NCT01474512|589699970|FG014|Long-Term Extension Period|Adverse Event|0|||
163270235|NCT01474512|589699971|FG015|Long-Term Extension Period|Adverse Event|0|||
163270236|NCT01474512|589699972|FG016|Long-Term Extension Period|Adverse Event|0|||
163270237|NCT01474512|589699973|FG017|Long-Term Extension Period|Adverse Event|0|||
163270238|NCT01474512|589699956|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
163270239|NCT01474512|589699957|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
163270240|NCT01474512|589699958|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
163270241|NCT01474512|589699959|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
163270242|NCT01474512|589699960|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
163270243|NCT01474512|589699961|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
163270244|NCT01474512|589699962|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
163270245|NCT01474512|589699963|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
163270246|NCT01474512|589699964|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
163270247|NCT01474512|589699965|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
163270248|NCT01474512|589699966|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
163270249|NCT01474512|589699967|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
163270250|NCT01474512|589699968|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
163270251|NCT01474512|589699969|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
163270252|NCT01474512|589699970|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
163270253|NCT01474512|589699971|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
163270254|NCT01474512|589699972|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
163270255|NCT01474512|589699973|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
163270256|NCT01474512|589699956|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
163270257|NCT01474512|589699957|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
163270258|NCT01474512|589699958|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
163270259|NCT01474512|589699959|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
163270260|NCT01474512|589699960|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
163270261|NCT01474512|589699961|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
163270262|NCT01474512|589699962|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
163270263|NCT01474512|589699963|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
163270264|NCT01474512|589699964|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
163270265|NCT01474512|589699965|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
163270266|NCT01474512|589699966|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
163270267|NCT01474512|589699967|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
163270268|NCT01474512|589699968|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
163270269|NCT01474512|589699969|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
163270270|NCT01474512|589699970|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
163270271|NCT01474512|589699971|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
163270272|NCT01474512|589699972|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
163270273|NCT01474512|589699973|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
163270274|NCT01474512|589699956|FG000|Long-Term Extension Period|Physician Decision|0|||
163270275|NCT01474512|589699957|FG001|Long-Term Extension Period|Physician Decision|0|||
163270276|NCT01474512|589699958|FG002|Long-Term Extension Period|Physician Decision|0|||
163270277|NCT01474512|589699959|FG003|Long-Term Extension Period|Physician Decision|0|||
163270278|NCT01474512|589699960|FG004|Long-Term Extension Period|Physician Decision|0|||
163270279|NCT01474512|589699961|FG005|Long-Term Extension Period|Physician Decision|0|||
163270280|NCT01474512|589699962|FG006|Long-Term Extension Period|Physician Decision|0|||
163270281|NCT01474512|589699963|FG007|Long-Term Extension Period|Physician Decision|0|||
163270282|NCT01474512|589699964|FG008|Long-Term Extension Period|Physician Decision|0|||
163270283|NCT01474512|589699965|FG009|Long-Term Extension Period|Physician Decision|0|||
163270284|NCT01474512|589699966|FG010|Long-Term Extension Period|Physician Decision|0|||
162927862|NCT01488071|588439246|FG000|Overall Study|Lack of Efficacy|11|||
163270285|NCT01474512|589699967|FG011|Long-Term Extension Period|Physician Decision|0|||
163270286|NCT01474512|589699968|FG012|Long-Term Extension Period|Physician Decision|21|||
163270287|NCT01474512|589699969|FG013|Long-Term Extension Period|Physician Decision|21|||
163270288|NCT01474512|589699970|FG014|Long-Term Extension Period|Physician Decision|0|||
163270289|NCT01474512|589699971|FG015|Long-Term Extension Period|Physician Decision|0|||
163270290|NCT01474512|589699972|FG016|Long-Term Extension Period|Physician Decision|0|||
163270291|NCT01474512|589699973|FG017|Long-Term Extension Period|Physician Decision|0|||
163270292|NCT01474512|589699956|FG000|Long-Term Extension Period|Clinical Relapse|0|||
163270293|NCT01474512|589699957|FG001|Long-Term Extension Period|Clinical Relapse|0|||
163270294|NCT01474512|589699958|FG002|Long-Term Extension Period|Clinical Relapse|0|||
163270295|NCT01474512|589699959|FG003|Long-Term Extension Period|Clinical Relapse|0|||
163270296|NCT01474512|589699960|FG004|Long-Term Extension Period|Clinical Relapse|0|||
163270297|NCT01474512|589699961|FG005|Long-Term Extension Period|Clinical Relapse|0|||
163270298|NCT01474512|589699962|FG006|Long-Term Extension Period|Clinical Relapse|0|||
163270299|NCT01474512|589699963|FG007|Long-Term Extension Period|Clinical Relapse|0|||
163270300|NCT01474512|589699964|FG008|Long-Term Extension Period|Clinical Relapse|0|||
163270301|NCT01474512|589699965|FG009|Long-Term Extension Period|Clinical Relapse|0|||
163270302|NCT01474512|589699966|FG010|Long-Term Extension Period|Clinical Relapse|0|||
163270303|NCT01474512|589699967|FG011|Long-Term Extension Period|Clinical Relapse|0|||
163270304|NCT01474512|589699968|FG012|Long-Term Extension Period|Clinical Relapse|9|||
163270305|NCT01474512|589699969|FG013|Long-Term Extension Period|Clinical Relapse|9|||
163270306|NCT01474512|589699970|FG014|Long-Term Extension Period|Clinical Relapse|0|||
163270307|NCT01474512|589699971|FG015|Long-Term Extension Period|Clinical Relapse|0|||
162927863|NCT01488071|588439247|FG001|Overall Study|Lack of Efficacy|17|||
162927864|NCT01488071|588439246|FG000|Overall Study|Non-compliance with study drug|2|||
162927865|NCT01488071|588439247|FG001|Overall Study|Non-compliance with study drug|0|||
162927866|NCT01488071|588439246|FG000|Overall Study|Protocol Violation|5|||
162927867|NCT01488071|588439247|FG001|Overall Study|Protocol Violation|7|||
162927868|NCT01488071|588439246|FG000|Overall Study|Withdrawal of Consent|14|||
162927869|NCT01488071|588439247|FG001|Overall Study|Withdrawal of Consent|12|||
162927870|NCT01488071|588439246|FG000|Overall Study|Lost to Follow-up|1|||
162927871|NCT01488071|588439247|FG001|Overall Study|Lost to Follow-up|0|||
162927872|NCT01488071|588439246|FG000|Overall Study|Administrative or Other Reason(s)|5|||
162927873|NCT01488071|588439247|FG001|Overall Study|Administrative or Other Reason(s)|4|||
162927874|NCT02139306|588439248|FG000|Overall Study|Withdrawal by Subject|4|||
162927875|NCT02139306|588439249|FG001|Overall Study|Withdrawal by Subject|6|||
162927876|NCT02139306|588439248|FG000|Overall Study|Adverse Event|3|||
162927877|NCT02139306|588439249|FG001|Overall Study|Adverse Event|4|||
162927878|NCT02139306|588439248|FG000|Overall Study|Physician Decision|0|||
162927879|NCT02139306|588439249|FG001|Overall Study|Physician Decision|1|||
162927880|NCT02139306|588439248|FG000|Overall Study|Other Unspecified|2|||
162927881|NCT02139306|588439249|FG001|Overall Study|Other Unspecified|3|||
162927882|NCT02139306|588439248|FG000|Overall Study|Protocol Violation|4|||
162927883|NCT02139306|588439249|FG001|Overall Study|Protocol Violation|0|||
162927884|NCT04449354|588439250|FG000|Overall Study|Withdrawal by Subject|1|||
163270308|NCT01474512|589699972|FG016|Long-Term Extension Period|Clinical Relapse|0|||
163270309|NCT01474512|589699973|FG017|Long-Term Extension Period|Clinical Relapse|0|||
163270310|NCT01474512|589699956|FG000|Long-Term Extension Period|Death|0|||
163270311|NCT01474512|589699957|FG001|Long-Term Extension Period|Death|0|||
163270312|NCT01474512|589699958|FG002|Long-Term Extension Period|Death|0|||
163270313|NCT01474512|589699959|FG003|Long-Term Extension Period|Death|0|||
163270314|NCT01474512|589699960|FG004|Long-Term Extension Period|Death|0|||
163270315|NCT01474512|589699961|FG005|Long-Term Extension Period|Death|0|||
163270316|NCT01474512|589699962|FG006|Long-Term Extension Period|Death|0|||
163270317|NCT01474512|589699963|FG007|Long-Term Extension Period|Death|0|||
163270318|NCT01474512|589699964|FG008|Long-Term Extension Period|Death|0|||
163270319|NCT01474512|589699965|FG009|Long-Term Extension Period|Death|0|||
163270320|NCT01474512|589699966|FG010|Long-Term Extension Period|Death|0|||
163270321|NCT01474512|589699967|FG011|Long-Term Extension Period|Death|0|||
163270322|NCT01474512|589699968|FG012|Long-Term Extension Period|Death|9|||
163270323|NCT01474512|589699969|FG013|Long-Term Extension Period|Death|9|||
163270324|NCT01474512|589699970|FG014|Long-Term Extension Period|Death|0|||
163270325|NCT01474512|589699971|FG015|Long-Term Extension Period|Death|0|||
163270326|NCT01474512|589699972|FG016|Long-Term Extension Period|Death|0|||
163270327|NCT01474512|589699973|FG017|Long-Term Extension Period|Death|0|||
163270328|NCT01474512|589699956|FG000|Long-Term Extension Period|Sponsor Decision|0|||
163270329|NCT01474512|589699957|FG001|Long-Term Extension Period|Sponsor Decision|0|||
163270330|NCT01474512|589699958|FG002|Long-Term Extension Period|Sponsor Decision|0|||
163270331|NCT01474512|589699959|FG003|Long-Term Extension Period|Sponsor Decision|0|||
163270332|NCT01474512|589699960|FG004|Long-Term Extension Period|Sponsor Decision|0|||
163270333|NCT01474512|589699961|FG005|Long-Term Extension Period|Sponsor Decision|0|||
163270334|NCT01474512|589699962|FG006|Long-Term Extension Period|Sponsor Decision|0|||
163270335|NCT01474512|589699963|FG007|Long-Term Extension Period|Sponsor Decision|0|||
163270336|NCT01474512|589699964|FG008|Long-Term Extension Period|Sponsor Decision|0|||
163270337|NCT01474512|589699965|FG009|Long-Term Extension Period|Sponsor Decision|0|||
163270338|NCT01474512|589699966|FG010|Long-Term Extension Period|Sponsor Decision|0|||
163270339|NCT01474512|589699967|FG011|Long-Term Extension Period|Sponsor Decision|0|||
163270340|NCT01474512|589699968|FG012|Long-Term Extension Period|Sponsor Decision|6|||
163270341|NCT01474512|589699969|FG013|Long-Term Extension Period|Sponsor Decision|6|||
162927885|NCT05789420|588439251|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
163041148|NCT00531947|588858075|FG001|Overall Study|Adverse Event|10|||
163041149|NCT00531947|588858074|FG000|Overall Study|Lost to Follow-up|12|||
163041150|NCT00531947|588858075|FG001|Overall Study|Lost to Follow-up|9|||
163041151|NCT00531947|588858074|FG000|Overall Study|Withdrawal by Subject|14|||
163041152|NCT00531947|588858075|FG001|Overall Study|Withdrawal by Subject|19|||
163041153|NCT00531947|588858074|FG000|Overall Study|Protocol Violation|2|||
163041154|NCT00531947|588858075|FG001|Overall Study|Protocol Violation|1|||
163041155|NCT00531947|588858074|FG000|Overall Study|Non-Compliance|4|||
163270342|NCT01474512|589699970|FG014|Long-Term Extension Period|Sponsor Decision|0|||
163041156|NCT00531947|588858075|FG001|Overall Study|Non-Compliance|7|||
163041157|NCT00531947|588858074|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
163041158|NCT00531947|588858075|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
163041159|NCT02383355|588858079|FG000|Overall Study|Adverse Event|2|||
163041160|NCT02383355|588858080|FG001|Overall Study|Adverse Event|0|||
163041161|NCT00334295|588858084|FG000|Overall Study|Patients received fewer than 3 injection|5|||
163041162|NCT00893971|588858085|FG000|Overall Study|Physician Decision|3|||
163270343|NCT01474512|589699971|FG015|Long-Term Extension Period|Sponsor Decision|0|||
163270344|NCT01474512|589699972|FG016|Long-Term Extension Period|Sponsor Decision|0|||
163270345|NCT01474512|589699973|FG017|Long-Term Extension Period|Sponsor Decision|0|||
163270346|NCT01474512|589699956|FG000|Long-Term Extension Period|Protocol Violation|0|||
163270347|NCT01474512|589699957|FG001|Long-Term Extension Period|Protocol Violation|0|||
163270348|NCT01474512|589699958|FG002|Long-Term Extension Period|Protocol Violation|0|||
163270349|NCT01474512|589699959|FG003|Long-Term Extension Period|Protocol Violation|0|||
163270350|NCT01474512|589699960|FG004|Long-Term Extension Period|Protocol Violation|0|||
163270351|NCT01474512|589699961|FG005|Long-Term Extension Period|Protocol Violation|0|||
163270352|NCT01474512|589699962|FG006|Long-Term Extension Period|Protocol Violation|0|||
163270353|NCT01474512|589699963|FG007|Long-Term Extension Period|Protocol Violation|0|||
163270354|NCT01474512|589699964|FG008|Long-Term Extension Period|Protocol Violation|0|||
163270355|NCT01474512|589699965|FG009|Long-Term Extension Period|Protocol Violation|0|||
163270356|NCT01474512|589699966|FG010|Long-Term Extension Period|Protocol Violation|0|||
163270357|NCT01474512|589699967|FG011|Long-Term Extension Period|Protocol Violation|0|||
163270358|NCT01474512|589699968|FG012|Long-Term Extension Period|Protocol Violation|5|||
163270359|NCT01474512|589699969|FG013|Long-Term Extension Period|Protocol Violation|5|||
163270360|NCT01474512|589699970|FG014|Long-Term Extension Period|Protocol Violation|0|||
163270361|NCT01474512|589699971|FG015|Long-Term Extension Period|Protocol Violation|0|||
163270362|NCT01474512|589699972|FG016|Long-Term Extension Period|Protocol Violation|0|||
163270363|NCT01474512|589699973|FG017|Long-Term Extension Period|Protocol Violation|0|||
163270364|NCT01474512|589699956|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270365|NCT01474512|589699957|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270366|NCT01474512|589699958|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270367|NCT01474512|589699959|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270368|NCT01474512|589699960|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270369|NCT01474512|589699961|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270370|NCT01474512|589699962|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270371|NCT01474512|589699963|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270372|NCT01474512|589699964|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270373|NCT01474512|589699965|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270374|NCT01474512|589699966|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270375|NCT01474512|589699967|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270376|NCT01474512|589699968|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
163270377|NCT01474512|589699969|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
163270378|NCT01474512|589699970|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270379|NCT01474512|589699971|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270380|NCT01474512|589699972|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270381|NCT01474512|589699973|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163270382|NCT01474512|589699956|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270383|NCT01474512|589699957|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270384|NCT01474512|589699958|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270385|NCT01474512|589699959|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270386|NCT01474512|589699960|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270387|NCT01474512|589699961|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270388|NCT01474512|589699962|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270389|NCT01474512|589699963|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270390|NCT01474512|589699964|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270391|NCT01474512|589699965|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270392|NCT01474512|589699966|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270393|NCT01474512|589699967|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
163270394|NCT01474512|589699968|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163041163|NCT04811664|588858086|FG000|Overall Study|Lost to Follow-up|78|||
163270395|NCT01474512|589699969|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270396|NCT01474512|589699970|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270397|NCT01474512|589699971|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270398|NCT01474512|589699972|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270399|NCT01474512|589699973|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163270400|NCT01474512|589699956|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
163270401|NCT01474512|589699957|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
163270402|NCT01474512|589699958|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
163270403|NCT01474512|589699959|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
163270404|NCT01474512|589699960|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
163270405|NCT01474512|589699961|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
163270406|NCT01474512|589699962|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
163270407|NCT01474512|589699963|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
162927886|NCT05789420|588439251|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
162927887|NCT02278952|588439252|FG000|Overall Study|Insufficient Sample|6|||
162927888|NCT01220128|588439253|FG000|Overall Study|Progressive disease|0|||
162927889|NCT01220128|588439254|FG001|Overall Study|Progressive disease|0|||
162927890|NCT01220128|588439255|FG002|Overall Study|Progressive disease|2|||
162927891|NCT01220128|588439256|FG003|Overall Study|Progressive disease|0|||
162927892|NCT01220128|588439257|FG004|Overall Study|Progressive disease|0|||
162927893|NCT01220128|588439258|FG005|Overall Study|Progressive disease|0|||
162927894|NCT01220128|588439259|FG006|Overall Study|Progressive disease|0|||
162927895|NCT01220128|588439253|FG000|Overall Study|Sponsor study termination|0|||
163270408|NCT01474512|589699964|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
163270409|NCT01474512|589699965|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
162927896|NCT01220128|588439254|FG001|Overall Study|Sponsor study termination|1|||
162927897|NCT01220128|588439255|FG002|Overall Study|Sponsor study termination|0|||
162927898|NCT01220128|588439256|FG003|Overall Study|Sponsor study termination|0|||
162927899|NCT01220128|588439257|FG004|Overall Study|Sponsor study termination|0|||
162927900|NCT01220128|588439258|FG005|Overall Study|Sponsor study termination|0|||
162927901|NCT01220128|588439259|FG006|Overall Study|Sponsor study termination|1|||
162927902|NCT01220128|588439253|FG000|Overall Study|Adverse event, serious fatal|2|||
162927903|NCT01220128|588439254|FG001|Overall Study|Adverse event, serious fatal|0|||
162927904|NCT01220128|588439255|FG002|Overall Study|Adverse event, serious fatal|0|||
162927905|NCT01220128|588439256|FG003|Overall Study|Adverse event, serious fatal|0|||
162927906|NCT01220128|588439257|FG004|Overall Study|Adverse event, serious fatal|0|||
162927907|NCT01220128|588439258|FG005|Overall Study|Adverse event, serious fatal|0|||
162927908|NCT01220128|588439259|FG006|Overall Study|Adverse event, serious fatal|1|||
162927909|NCT01220128|588439253|FG000|Overall Study|Adverse event, non-fatal|1|||
162927910|NCT01220128|588439254|FG001|Overall Study|Adverse event, non-fatal|0|||
162927911|NCT01220128|588439255|FG002|Overall Study|Adverse event, non-fatal|0|||
162927912|NCT01220128|588439256|FG003|Overall Study|Adverse event, non-fatal|0|||
162927913|NCT01220128|588439257|FG004|Overall Study|Adverse event, non-fatal|0|||
162927914|NCT01220128|588439258|FG005|Overall Study|Adverse event, non-fatal|0|||
162927915|NCT01220128|588439259|FG006|Overall Study|Adverse event, non-fatal|3|||
162927916|NCT01220128|588439253|FG000|Overall Study|Other|0|||
162927917|NCT01220128|588439254|FG001|Overall Study|Other|0|||
162927918|NCT01220128|588439255|FG002|Overall Study|Other|1|||
162927919|NCT01220128|588439256|FG003|Overall Study|Other|0|||
162927920|NCT01220128|588439257|FG004|Overall Study|Other|0|||
162927921|NCT01220128|588439258|FG005|Overall Study|Other|0|||
162927922|NCT01220128|588439259|FG006|Overall Study|Other|0|||
162927923|NCT01220128|588439253|FG000|Overall Study|Consent withdrawn by subject|1|||
162927924|NCT01220128|588439254|FG001|Overall Study|Consent withdrawn by subject|0|||
162927925|NCT01220128|588439255|FG002|Overall Study|Consent withdrawn by subject|0|||
162927926|NCT01220128|588439256|FG003|Overall Study|Consent withdrawn by subject|0|||
162927927|NCT01220128|588439257|FG004|Overall Study|Consent withdrawn by subject|0|||
162927928|NCT01220128|588439258|FG005|Overall Study|Consent withdrawn by subject|0|||
162927929|NCT01220128|588439259|FG006|Overall Study|Consent withdrawn by subject|0|||
162927930|NCT02787746|588439261|FG000|Overall Study|Adverse Event|42|||
162927931|NCT02787746|588439261|FG000|Overall Study|Withdrawal by Subject|65|||
162927932|NCT02787746|588439261|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
162927933|NCT01142466|588441200|FG000|Overall Study|Adverse Event|2|||
162927934|NCT01142466|588441201|FG001|Overall Study|Adverse Event|1|||
162927935|NCT01142466|588441200|FG000|Overall Study|Withdrawal by Subject|1|||
162927936|NCT01142466|588441201|FG001|Overall Study|Withdrawal by Subject|1|||
162927937|NCT00700310|588441206|FG000|Overall Study|Adverse Event|6|||
162927938|NCT00700310|588441207|FG001|Overall Study|Adverse Event|10|||
163270410|NCT01474512|589699966|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
162927939|NCT00700310|588441208|FG002|Overall Study|Adverse Event|5|||
162927940|NCT00700310|588441209|FG003|Overall Study|Adverse Event|11|||
162927941|NCT00700310|588441206|FG000|Overall Study|Lost to Follow-up|4|||
163270411|NCT01474512|589699967|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
163270412|NCT01474512|589699968|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
163270413|NCT01474512|589699969|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
162927942|NCT00700310|588441207|FG001|Overall Study|Lost to Follow-up|1|||
162927943|NCT00700310|588441208|FG002|Overall Study|Lost to Follow-up|0|||
162927944|NCT00700310|588441209|FG003|Overall Study|Lost to Follow-up|1|||
162927945|NCT00700310|588441206|FG000|Overall Study|Withdrawal by Subject|8|||
162927946|NCT00700310|588441207|FG001|Overall Study|Withdrawal by Subject|9|||
162927947|NCT00700310|588441208|FG002|Overall Study|Withdrawal by Subject|8|||
162927948|NCT00700310|588441209|FG003|Overall Study|Withdrawal by Subject|8|||
162927949|NCT00700310|588441206|FG000|Overall Study|Lack of Efficacy|0|||
162927950|NCT00700310|588441207|FG001|Overall Study|Lack of Efficacy|3|||
162927951|NCT00700310|588441208|FG002|Overall Study|Lack of Efficacy|0|||
162927952|NCT00700310|588441209|FG003|Overall Study|Lack of Efficacy|1|||
162927953|NCT00700310|588441206|FG000|Overall Study|Administrative/Other|1|||
162927954|NCT00700310|588441207|FG001|Overall Study|Administrative/Other|3|||
162927955|NCT00700310|588441208|FG002|Overall Study|Administrative/Other|1|||
162927956|NCT00700310|588441209|FG003|Overall Study|Administrative/Other|3|||
162927957|NCT00700310|588441206|FG000|Overall Study|Randomized, Not Treated|2|||
162927958|NCT00700310|588441207|FG001|Overall Study|Randomized, Not Treated|0|||
162927959|NCT00700310|588441208|FG002|Overall Study|Randomized, Not Treated|2|||
163270414|NCT01474512|589699970|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
163270415|NCT01474512|589699971|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
163270416|NCT01474512|589699972|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
163270417|NCT01474512|589699973|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
163270418|NCT01474512|589699956|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163270419|NCT01474512|589699957|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163270420|NCT01474512|589699958|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163270421|NCT01474512|589699959|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163270422|NCT01474512|589699960|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163270423|NCT01474512|589699961|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163270424|NCT01474512|589699962|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162927960|NCT00700310|588441209|FG003|Overall Study|Randomized, Not Treated|2|||
162927961|NCT00303316|588441210|FG000|Overall Study|Protocol Violation|1|||
162927962|NCT00303316|588441211|FG001|Overall Study|Protocol Violation|0|||
162927963|NCT00303316|588441210|FG000|Overall Study|Lost to Follow-up|0|||
162927964|NCT00303316|588441211|FG001|Overall Study|Lost to Follow-up|1|||
162927965|NCT00303316|588441210|FG000|Overall Study|Withdrawal by Subject|1|||
162927966|NCT00303316|588441211|FG001|Overall Study|Withdrawal by Subject|2|||
162927967|NCT02162511|588441214|FG000|Overall Study|Lack of Efficacy|0|||
162927968|NCT02162511|588441215|FG001|Overall Study|Lack of Efficacy|0|||
162927969|NCT02162511|588441216|FG002|Overall Study|Lack of Efficacy|2|||
163270425|NCT01474512|589699963|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163270426|NCT01474512|589699964|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163270427|NCT01474512|589699965|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163270428|NCT01474512|589699966|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163270429|NCT01474512|589699967|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163270430|NCT01474512|589699968|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163270431|NCT01474512|589699969|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163270432|NCT01474512|589699970|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
163270433|NCT01474512|589699971|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
163270434|NCT01474512|589699972|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
163270435|NCT01474512|589699973|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
163270436|NCT01474512|589699956|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163270437|NCT01474512|589699957|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163270438|NCT01474512|589699958|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163270439|NCT01474512|589699959|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163270440|NCT01474512|589699960|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163270441|NCT01474512|589699961|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163270442|NCT01474512|589699962|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163270443|NCT01474512|589699963|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162927970|NCT01160198|588441217|FG000|Overall Study|Withdrawal by Subject|2|||
162927971|NCT01160198|588441218|FG001|Overall Study|Withdrawal by Subject|1|||
162927972|NCT01160198|588441219|FG002|Overall Study|Withdrawal by Subject|0|||
162927973|NCT01160198|588441217|FG000|Overall Study|Adverse Event|0|||
162927974|NCT01160198|588441218|FG001|Overall Study|Adverse Event|1|||
163270444|NCT01474512|589699964|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163270445|NCT01474512|589699965|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163270446|NCT01474512|589699966|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163270447|NCT01474512|589699967|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163270448|NCT01474512|589699968|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163270449|NCT01474512|589699969|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163270450|NCT01474512|589699970|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
162927975|NCT01160198|588441219|FG002|Overall Study|Adverse Event|0|||
162927976|NCT01160198|588441217|FG000|Overall Study|Lost to Follow-up|0|||
162927977|NCT01160198|588441218|FG001|Overall Study|Lost to Follow-up|1|||
162927978|NCT01160198|588441219|FG002|Overall Study|Lost to Follow-up|0|||
162927979|NCT01160198|588441217|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
162927980|NCT01160198|588441218|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
162927981|NCT01160198|588441219|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
162927982|NCT00802529|588441220|FG000|Overall Study|Lost to Follow-up|0|||
162927983|NCT00802529|588441221|FG001|Overall Study|Lost to Follow-up|1|||
162927984|NCT00552617|588441224|FG000|Overall Study|Not Treated|0|||
162927985|NCT00552617|588441225|FG001|Overall Study|Not Treated|0|||
162927986|NCT00552617|588441226|FG002|Overall Study|Not Treated|1|||
162927987|NCT00552617|588441227|FG003|Overall Study|Not Treated|0|||
162927988|NCT00552617|588441228|FG004|Overall Study|Not Treated|0|||
162927989|NCT00552617|588441229|FG005|Overall Study|Not Treated|0|||
162927990|NCT00552617|588441230|FG006|Overall Study|Not Treated|0|||
162927991|NCT00552617|588441231|FG007|Overall Study|Not Treated|0|||
162927992|NCT00552617|588441232|FG008|Overall Study|Not Treated|0|||
162927993|NCT00552617|588441233|FG009|Overall Study|Not Treated|1|||
162927994|NCT00552617|588441224|FG000|Overall Study|Lost to Follow-up|0|||
162927995|NCT00552617|588441225|FG001|Overall Study|Lost to Follow-up|0|||
162927996|NCT00552617|588441226|FG002|Overall Study|Lost to Follow-up|0|||
162927997|NCT00552617|588441227|FG003|Overall Study|Lost to Follow-up|1|||
162927998|NCT00552617|588441228|FG004|Overall Study|Lost to Follow-up|0|||
162927999|NCT00552617|588441229|FG005|Overall Study|Lost to Follow-up|2|||
162928000|NCT00552617|588441230|FG006|Overall Study|Lost to Follow-up|0|||
162928001|NCT00552617|588441231|FG007|Overall Study|Lost to Follow-up|0|||
162928002|NCT00552617|588441232|FG008|Overall Study|Lost to Follow-up|2|||
162928003|NCT00552617|588441233|FG009|Overall Study|Lost to Follow-up|0|||
162928004|NCT04651218|588441234|FG000|Overall Study|Withdrawal by Subject|0|||
162928005|NCT04651218|588441235|FG001|Overall Study|Withdrawal by Subject|2|||
162928006|NCT01399125|588441238|FG000|Overall Study|Adverse Event|32|||
162928007|NCT01399125|588441239|FG001|Overall Study|Adverse Event|30|||
162928008|NCT01399125|588441238|FG000|Overall Study|Abnormal Lab values|0|||
162928009|NCT01399125|588441239|FG001|Overall Study|Abnormal Lab values|1|||
162928010|NCT01399125|588441238|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
162928011|NCT01399125|588441239|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
162928012|NCT01399125|588441238|FG000|Overall Study|Withdrawal by Subject|5|||
162928013|NCT01399125|588441239|FG001|Overall Study|Withdrawal by Subject|8|||
162928014|NCT01399125|588441238|FG000|Overall Study|Lost to Follow-up|2|||
162928015|NCT01399125|588441239|FG001|Overall Study|Lost to Follow-up|3|||
162928016|NCT01399125|588441238|FG000|Overall Study|Administrative Problems|7|||
162928017|NCT01399125|588441239|FG001|Overall Study|Administrative Problems|11|||
162928018|NCT01399125|588441238|FG000|Overall Study|Death|0|||
162928019|NCT01399125|588441239|FG001|Overall Study|Death|1|||
162928020|NCT01399125|588441238|FG000|Overall Study|Protocol Deviation|5|||
162928021|NCT01399125|588441239|FG001|Overall Study|Protocol Deviation|2|||
162928022|NCT01902134|588441240|FG000|Overall Study|Adverse Event|3|||
162928023|NCT01902134|588441241|FG001|Overall Study|Adverse Event|1|||
162928024|NCT01902134|588441242|FG002|Overall Study|Adverse Event|2|||
162928025|NCT01902134|588441243|FG003|Overall Study|Adverse Event|1|||
162928026|NCT01902134|588441244|FG004|Overall Study|Adverse Event|1|||
162928027|NCT01902134|588441245|FG005|Overall Study|Adverse Event|3|||
162928028|NCT01902134|588441240|FG000|Overall Study|Lack of Efficacy|0|||
162928029|NCT01902134|588441241|FG001|Overall Study|Lack of Efficacy|0|||
162928030|NCT01902134|588441242|FG002|Overall Study|Lack of Efficacy|2|||
162928031|NCT01902134|588441243|FG003|Overall Study|Lack of Efficacy|0|||
162928032|NCT01902134|588441244|FG004|Overall Study|Lack of Efficacy|0|||
162928033|NCT01902134|588441245|FG005|Overall Study|Lack of Efficacy|1|||
162928034|NCT01902134|588441240|FG000|Overall Study|Physician Decision|0|||
162928035|NCT01902134|588441241|FG001|Overall Study|Physician Decision|1|||
162928036|NCT01902134|588441242|FG002|Overall Study|Physician Decision|0|||
162928037|NCT01902134|588441243|FG003|Overall Study|Physician Decision|0|||
162928038|NCT01902134|588441244|FG004|Overall Study|Physician Decision|0|||
162928039|NCT01902134|588441245|FG005|Overall Study|Physician Decision|0|||
162928040|NCT01902134|588441240|FG000|Overall Study|Protocol Violation|0|||
162928041|NCT01902134|588441241|FG001|Overall Study|Protocol Violation|0|||
162928042|NCT01902134|588441242|FG002|Overall Study|Protocol Violation|0|||
162928043|NCT01902134|588441243|FG003|Overall Study|Protocol Violation|0|||
162928044|NCT01902134|588441244|FG004|Overall Study|Protocol Violation|0|||
162928045|NCT01902134|588441245|FG005|Overall Study|Protocol Violation|1|||
162928046|NCT01902134|588441240|FG000|Overall Study|Withdrawal by Subject|4|||
162928047|NCT01902134|588441241|FG001|Overall Study|Withdrawal by Subject|8|||
163041164|NCT04811664|588858087|FG001|Overall Study|Lost to Follow-up|125|||
162928048|NCT01902134|588441242|FG002|Overall Study|Withdrawal by Subject|9|||
162928049|NCT01902134|588441243|FG003|Overall Study|Withdrawal by Subject|1|||
163041165|NCT04811664|588858088|FG002|Overall Study|Lost to Follow-up|46|||
162928050|NCT01902134|588441244|FG004|Overall Study|Withdrawal by Subject|5|||
162928051|NCT01902134|588441245|FG005|Overall Study|Withdrawal by Subject|4|||
162928052|NCT01902134|588441240|FG000|Overall Study|no compliance|1|||
162928053|NCT01902134|588441241|FG001|Overall Study|no compliance|0|||
162928054|NCT01902134|588441242|FG002|Overall Study|no compliance|0|||
162928055|NCT01902134|588441243|FG003|Overall Study|no compliance|0|||
162928056|NCT01902134|588441244|FG004|Overall Study|no compliance|0|||
162928057|NCT01902134|588441245|FG005|Overall Study|no compliance|0|||
162928058|NCT01902134|588441240|FG000|Overall Study|Other|0|||
162928059|NCT01902134|588441241|FG001|Overall Study|Other|1|||
162928060|NCT01902134|588441242|FG002|Overall Study|Other|2|||
162928061|NCT01902134|588441243|FG003|Overall Study|Other|0|||
162928062|NCT01902134|588441244|FG004|Overall Study|Other|1|||
162928063|NCT01902134|588441245|FG005|Overall Study|Other|0|||
162928064|NCT00305110|588441246|FG000|Overall Study|Missing data|29|||
162928065|NCT00337129|588441247|FG000|Overall Study|Adverse Event|4|||
162928066|NCT00337129|588441247|FG000|Overall Study|Withdrawal by Subject|1|||
162928067|NCT00337129|588441247|FG000|Overall Study|Lack of Efficacy|32|||
162928068|NCT00337129|588441247|FG000|Overall Study|Death|2|||
162928069|NCT00337129|588441247|FG000|Overall Study|not protocol specified|1|||
162928070|NCT01272193|588441253|FG000|Overall Study|Adverse Event|1|||
162928071|NCT01272193|588441254|FG001|Overall Study|Adverse Event|1|||
162928072|NCT01272193|588441253|FG000|Overall Study|Lack of Efficacy|0|||
162928073|NCT01272193|588441254|FG001|Overall Study|Lack of Efficacy|3|||
162928074|NCT01272193|588441253|FG000|Overall Study|Withdrawal Criteria|1|||
162928075|NCT01272193|588441254|FG001|Overall Study|Withdrawal Criteria|1|||
162928076|NCT01272193|588441253|FG000|Overall Study|Unclassified|8|||
162928077|NCT01272193|588441254|FG001|Overall Study|Unclassified|7|||
162928078|NCT03578276|588441261|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
162928079|NCT03578276|588441262|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
162928080|NCT02626182|588441263|FG000|Overall Study|Adverse Event|2|||
162928081|NCT02626182|588441264|FG001|Overall Study|Adverse Event|0|||
162928082|NCT01084603|588441269|FG000|Baseline|Withdrawal by Subject|2|||
162928083|NCT01084603|588441269|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
162928084|NCT01084603|588441269|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
162928085|NCT01084603|588441269|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
162928086|NCT01084603|588441269|FG000|Washout Period 4|Adverse Event|1|||
162928087|NCT02766088|588441272|FG000|Overall Study|Sponsor study termination|498|||
162928088|NCT02766088|588441272|FG000|Overall Study|Migrated/moved from the study area|1|||
162928089|NCT02766088|588441272|FG000|Overall Study|Lost to Follow-up|5|||
162928090|NCT02766088|588441272|FG000|Overall Study|Other|1|||
162928091|NCT02766088|588441272|FG000|Overall Study|Death|1|||
162928092|NCT01508325|588441275|FG000|Overall Study|Withdrawal by Subject|8|||
162928093|NCT01508325|588441276|FG001|Overall Study|Withdrawal by Subject|9|||
162928094|NCT01508325|588441275|FG000|Overall Study|Protocol Violation|0|||
162928095|NCT01508325|588441276|FG001|Overall Study|Protocol Violation|3|||
162928096|NCT01508325|588441275|FG000|Overall Study|Physician Decision|2|||
162928097|NCT01508325|588441276|FG001|Overall Study|Physician Decision|1|||
162928098|NCT01508325|588441275|FG000|Overall Study|Adverse Event|1|||
162928099|NCT01508325|588441276|FG001|Overall Study|Adverse Event|0|||
162928100|NCT01508325|588441275|FG000|Overall Study|Lost to Follow-up|5|||
162928101|NCT01508325|588441276|FG001|Overall Study|Lost to Follow-up|6|||
162928102|NCT01508325|588441275|FG000|Overall Study|Other|2|||
162928103|NCT01508325|588441276|FG001|Overall Study|Other|2|||
162928104|NCT01392170|588441277|FG000|Overall Study|Withdrawal by Subject|1|||
162928105|NCT01392170|588441277|FG000|Overall Study|Ineligible|1|||
162928106|NCT00763269|588441285|FG000|Overall Study|Lost to Follow-up|12|||
162928107|NCT00763269|588441286|FG001|Overall Study|Lost to Follow-up|13|||
162928108|NCT04285983|588441293|FG000|Overall Study|Protocol Violation|6|||
162928109|NCT04936334|588441294|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
162928110|NCT01347879|588441295|FG000|Overall Study|Adverse Event|0|||
162928111|NCT01347879|588441296|FG001|Overall Study|Adverse Event|12|||
162928112|NCT01347879|588441295|FG000|Overall Study|Lost to Follow-up|2|||
162928113|NCT01347879|588441296|FG001|Overall Study|Lost to Follow-up|0|||
162928114|NCT01347879|588441295|FG000|Overall Study|Withdrawal by Subject|3|||
162928115|NCT01347879|588441296|FG001|Overall Study|Withdrawal by Subject|2|||
162928116|NCT01347879|588441295|FG000|Overall Study|Other|2|||
162928117|NCT01347879|588441296|FG001|Overall Study|Other|3|||
162928118|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
162928119|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
162928120|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
162928121|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
162928122|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
162928123|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
162928124|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
162928125|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
162928126|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
162928127|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
162928128|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
162928129|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
162928130|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
162928131|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
162928132|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
162928133|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
162978982|NCT01660022|588623539|FG001|First Sequence (7 Days)|Adverse Event|0|||
162928134|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
162928135|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
162928136|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
162928137|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
162928138|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
162928139|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
162928140|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
162928141|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
162928142|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
162928143|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
162928144|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
162928145|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
162928146|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
162928147|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
162928148|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
162928149|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
162928150|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
162928151|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
162928152|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
162928153|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
162928154|NCT03747939|588441297|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
162928155|NCT03747939|588441298|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
162928156|NCT03747939|588441299|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
162928157|NCT03747939|588441300|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
162928158|NCT03747939|588441297|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
162928159|NCT03747939|588441298|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
162928160|NCT03747939|588441299|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
162928161|NCT03747939|588441300|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
162928162|NCT03747939|588441297|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
162928163|NCT03747939|588441298|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
162928164|NCT03747939|588441299|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
162928165|NCT03747939|588441300|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
162928166|NCT03747939|588441297|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
162928167|NCT03747939|588441298|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
162928168|NCT03747939|588441299|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
162928169|NCT03747939|588441300|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
162928170|NCT03747939|588441297|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
162928171|NCT03747939|588441298|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
162928172|NCT03747939|588441299|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
162928173|NCT03747939|588441300|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
162928174|NCT01850108|588441301|FG000|Overall Study|Lost to Follow-up|4|||
162928175|NCT01850108|588441301|FG000|Overall Study|Not eligible|1|||
162928176|NCT01850108|588441301|FG000|Overall Study|Failed engraftment|2|||
162928177|NCT01850108|588441301|FG000|Overall Study|Physician Decision|1|||
162928178|NCT03273712|588441302|FG000|Overall Study|Death|5|||
162928179|NCT03273712|588441302|FG000|Overall Study|Adverse Event|1|||
162928180|NCT03273712|588441302|FG000|Overall Study|Disease Progression|1|||
162928181|NCT01542736|588441303|FG000|Overall Study|Death|1|||
162928182|NCT03674827|588441304|FG000|Treatment Phase|Adverse Event|0|||
162928183|NCT03674827|588441305|FG001|Treatment Phase|Adverse Event|0|||
162928184|NCT03674827|588441306|FG002|Treatment Phase|Adverse Event|0|||
162928185|NCT03674827|588441307|FG003|Treatment Phase|Adverse Event|0|||
162928186|NCT03674827|588441308|FG004|Treatment Phase|Adverse Event|0|||
162928187|NCT03674827|588441309|FG005|Treatment Phase|Adverse Event|2|||
162928188|NCT03674827|588441304|FG000|Treatment Phase|Death|2|||
162928189|NCT03674827|588441305|FG001|Treatment Phase|Death|0|||
162928190|NCT03674827|588441306|FG002|Treatment Phase|Death|0|||
162928191|NCT03674827|588441307|FG003|Treatment Phase|Death|0|||
162928192|NCT03674827|588441308|FG004|Treatment Phase|Death|1|||
162928193|NCT03674827|588441309|FG005|Treatment Phase|Death|0|||
162928194|NCT03674827|588441304|FG000|Treatment Phase|Progressive Disease|0|||
162928195|NCT03674827|588441305|FG001|Treatment Phase|Progressive Disease|4|||
162928196|NCT03674827|588441306|FG002|Treatment Phase|Progressive Disease|3|||
162928197|NCT03674827|588441307|FG003|Treatment Phase|Progressive Disease|4|||
162928198|NCT03674827|588441308|FG004|Treatment Phase|Progressive Disease|4|||
162928199|NCT03674827|588441309|FG005|Treatment Phase|Progressive Disease|9|||
162928200|NCT03674827|588441304|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
162928201|NCT03674827|588441305|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
162928202|NCT03674827|588441306|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
162928203|NCT03674827|588441307|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
162928204|NCT03674827|588441308|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
162928205|NCT03674827|588441309|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
162928206|NCT03674827|588441304|FG000|Treatment Phase|Withdrawal by Subject|0|||
162928207|NCT03674827|588441305|FG001|Treatment Phase|Withdrawal by Subject|0|||
162928208|NCT03674827|588441306|FG002|Treatment Phase|Withdrawal by Subject|0|||
162928209|NCT03674827|588441307|FG003|Treatment Phase|Withdrawal by Subject|0|||
162928210|NCT03674827|588441308|FG004|Treatment Phase|Withdrawal by Subject|0|||
162928211|NCT03674827|588441309|FG005|Treatment Phase|Withdrawal by Subject|1|||
162928212|NCT03674827|588441304|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
162928213|NCT03674827|588441305|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
162928214|NCT03674827|588441306|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
162928215|NCT03674827|588441307|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
162928216|NCT03674827|588441308|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
163041166|NCT04811664|588858086|FG000|Overall Study|Withdrawal by Subject|39|||
163041167|NCT04811664|588858087|FG001|Overall Study|Withdrawal by Subject|76|||
163041168|NCT04811664|588858088|FG002|Overall Study|Withdrawal by Subject|12|||
163270451|NCT01474512|589699971|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
163270452|NCT01474512|589699972|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
163270453|NCT01474512|589699973|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
163270454|NCT01474512|589699956|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270455|NCT01474512|589699957|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270456|NCT01474512|589699958|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270457|NCT01474512|589699959|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270458|NCT01474512|589699960|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270459|NCT01474512|589699961|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270460|NCT01474512|589699962|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270461|NCT01474512|589699963|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270462|NCT01474512|589699964|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270463|NCT01474512|589699965|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270464|NCT01474512|589699966|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270465|NCT01474512|589699967|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270466|NCT01474512|589699968|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270467|NCT01474512|589699969|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270468|NCT01474512|589699970|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270469|NCT01474512|589699971|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163270470|NCT01474512|589699972|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
163270471|NCT01474512|589699973|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
163270472|NCT01474512|589699956|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
163270473|NCT01474512|589699957|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
163270474|NCT01474512|589699958|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
163270475|NCT01474512|589699959|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
163270476|NCT01474512|589699960|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
163270477|NCT01474512|589699961|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
163270478|NCT01474512|589699962|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
163270479|NCT01474512|589699963|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
163270480|NCT01474512|589699964|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
163270481|NCT01474512|589699965|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
163270482|NCT01474512|589699966|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
163270483|NCT01474512|589699967|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
163270484|NCT01474512|589699968|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
162928217|NCT03674827|588441309|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
162928218|NCT03674827|588441304|FG000|Treatment Phase|Other|0|||
162928219|NCT03674827|588441305|FG001|Treatment Phase|Other|1|||
162928220|NCT03674827|588441306|FG002|Treatment Phase|Other|0|||
162928221|NCT03674827|588441307|FG003|Treatment Phase|Other|0|||
162928222|NCT03674827|588441308|FG004|Treatment Phase|Other|0|||
163270485|NCT01474512|589699969|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
163270486|NCT01474512|589699970|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
163270487|NCT01474512|589699971|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
163270488|NCT01474512|589699972|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
163270489|NCT01474512|589699973|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
163270490|NCT01474512|589699956|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
162928223|NCT03674827|588441309|FG005|Treatment Phase|Other|1|||
162928224|NCT03674827|588441304|FG000|Long-Term Follow-up Phase|Death|2|||
163041169|NCT04811664|588858086|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
163041170|NCT04811664|588858087|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
163270491|NCT01474512|589699957|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
163270492|NCT01474512|589699958|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
163270493|NCT01474512|589699959|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
163270494|NCT01474512|589699960|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
163270495|NCT01474512|589699961|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
162928225|NCT03674827|588441305|FG001|Long-Term Follow-up Phase|Death|4|||
162928226|NCT03674827|588441306|FG002|Long-Term Follow-up Phase|Death|2|||
162928227|NCT03674827|588441307|FG003|Long-Term Follow-up Phase|Death|3|||
162928228|NCT03674827|588441308|FG004|Long-Term Follow-up Phase|Death|2|||
162928229|NCT03674827|588441309|FG005|Long-Term Follow-up Phase|Death|6|||
162928230|NCT03674827|588441304|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
162928231|NCT03674827|588441305|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
162928232|NCT03674827|588441306|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
162928233|NCT03674827|588441307|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
162928234|NCT03674827|588441308|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
162928235|NCT03674827|588441309|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
162928236|NCT03674827|588441304|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
162928237|NCT03674827|588441305|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
162928238|NCT03674827|588441306|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
162928239|NCT03674827|588441307|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
162928240|NCT03674827|588441308|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
162928241|NCT03674827|588441309|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
162928242|NCT01289990|588441310|FG000|Overall Study|Death|0|||
162928243|NCT01289990|588441311|FG001|Overall Study|Death|0|||
162928244|NCT01289990|588441312|FG002|Overall Study|Death|0|||
162928245|NCT01289990|588441313|FG003|Overall Study|Death|1|||
162928246|NCT01289990|588441314|FG004|Overall Study|Death|2|||
162928247|NCT01289990|588441315|FG005|Overall Study|Death|1|||
162928248|NCT01289990|588441316|FG006|Overall Study|Death|0|||
162928249|NCT01289990|588441317|FG007|Overall Study|Death|0|||
162928250|NCT01289990|588441318|FG008|Overall Study|Death|0|||
162928251|NCT01289990|588441319|FG009|Overall Study|Death|0|||
162928252|NCT01289990|588441320|FG010|Overall Study|Death|0|||
162928253|NCT01289990|588441321|FG011|Overall Study|Death|1|||
162928254|NCT01289990|588441322|FG012|Overall Study|Death|0|||
162928255|NCT01289990|588441310|FG000|Overall Study|Lost to Follow-up|3|||
162928256|NCT01289990|588441311|FG001|Overall Study|Lost to Follow-up|2|||
162928257|NCT01289990|588441312|FG002|Overall Study|Lost to Follow-up|5|||
162928258|NCT01289990|588441313|FG003|Overall Study|Lost to Follow-up|5|||
162928259|NCT01289990|588441314|FG004|Overall Study|Lost to Follow-up|3|||
162928260|NCT01289990|588441315|FG005|Overall Study|Lost to Follow-up|4|||
162928261|NCT01289990|588441316|FG006|Overall Study|Lost to Follow-up|2|||
162928262|NCT01289990|588441317|FG007|Overall Study|Lost to Follow-up|2|||
162928263|NCT01289990|588441318|FG008|Overall Study|Lost to Follow-up|1|||
162928264|NCT01289990|588441319|FG009|Overall Study|Lost to Follow-up|4|||
162928265|NCT01289990|588441320|FG010|Overall Study|Lost to Follow-up|2|||
162928266|NCT01289990|588441321|FG011|Overall Study|Lost to Follow-up|1|||
162928267|NCT01289990|588441322|FG012|Overall Study|Lost to Follow-up|2|||
162928268|NCT01289990|588441310|FG000|Overall Study|Withdrawal by Subject|15|||
162928269|NCT01289990|588441311|FG001|Overall Study|Withdrawal by Subject|14|||
162928270|NCT01289990|588441312|FG002|Overall Study|Withdrawal by Subject|12|||
162928271|NCT01289990|588441313|FG003|Overall Study|Withdrawal by Subject|13|||
162928272|NCT01289990|588441314|FG004|Overall Study|Withdrawal by Subject|8|||
162928273|NCT01289990|588441315|FG005|Overall Study|Withdrawal by Subject|7|||
162928274|NCT01289990|588441316|FG006|Overall Study|Withdrawal by Subject|13|||
162928275|NCT01289990|588441317|FG007|Overall Study|Withdrawal by Subject|9|||
162928276|NCT01289990|588441318|FG008|Overall Study|Withdrawal by Subject|12|||
162928277|NCT01289990|588441319|FG009|Overall Study|Withdrawal by Subject|13|||
162928278|NCT01289990|588441320|FG010|Overall Study|Withdrawal by Subject|11|||
162928279|NCT01289990|588441321|FG011|Overall Study|Withdrawal by Subject|13|||
162928280|NCT01289990|588441322|FG012|Overall Study|Withdrawal by Subject|16|||
162928281|NCT01289990|588441310|FG000|Overall Study|discontinued in preceding trial|18|||
162928282|NCT01289990|588441311|FG001|Overall Study|discontinued in preceding trial|20|||
162928283|NCT01289990|588441312|FG002|Overall Study|discontinued in preceding trial|41|||
162928284|NCT01289990|588441313|FG003|Overall Study|discontinued in preceding trial|17|||
162928285|NCT01289990|588441314|FG004|Overall Study|discontinued in preceding trial|11|||
162928286|NCT01289990|588441315|FG005|Overall Study|discontinued in preceding trial|12|||
162928287|NCT01289990|588441316|FG006|Overall Study|discontinued in preceding trial|18|||
162928288|NCT01289990|588441317|FG007|Overall Study|discontinued in preceding trial|8|||
162928289|NCT01289990|588441318|FG008|Overall Study|discontinued in preceding trial|17|||
162928290|NCT01289990|588441319|FG009|Overall Study|discontinued in preceding trial|21|||
162928291|NCT01289990|588441320|FG010|Overall Study|discontinued in preceding trial|17|||
162928292|NCT01289990|588441321|FG011|Overall Study|discontinued in preceding trial|17|||
162928293|NCT01289990|588441322|FG012|Overall Study|discontinued in preceding trial|24|||
162928294|NCT01289990|588441310|FG000|Overall Study|did not continue in extension|41|||
162928295|NCT01289990|588441311|FG001|Overall Study|did not continue in extension|45|||
162928296|NCT01289990|588441312|FG002|Overall Study|did not continue in extension|51|||
162928297|NCT01289990|588441313|FG003|Overall Study|did not continue in extension|51|||
162928298|NCT01289990|588441314|FG004|Overall Study|did not continue in extension|48|||
162928299|NCT01289990|588441315|FG005|Overall Study|did not continue in extension|50|||
162928300|NCT01289990|588441316|FG006|Overall Study|did not continue in extension|54|||
163156582|NCT01352793|589287893|FG001|Overall Study|Pregnancy|8|||
162928301|NCT01289990|588441317|FG007|Overall Study|did not continue in extension|36|||
162928302|NCT01289990|588441318|FG008|Overall Study|did not continue in extension|44|||
162928303|NCT01289990|588441319|FG009|Overall Study|did not continue in extension|48|||
162928304|NCT01289990|588441320|FG010|Overall Study|did not continue in extension|45|||
162928305|NCT01289990|588441321|FG011|Overall Study|did not continue in extension|34|||
162928306|NCT01289990|588441322|FG012|Overall Study|did not continue in extension|56|||
162928307|NCT01289990|588441310|FG000|Overall Study|Not treated|0|||
162928308|NCT01289990|588441311|FG001|Overall Study|Not treated|0|||
162928309|NCT01289990|588441312|FG002|Overall Study|Not treated|0|||
162928310|NCT01289990|588441313|FG003|Overall Study|Not treated|0|||
162928311|NCT01289990|588441314|FG004|Overall Study|Not treated|0|||
162928312|NCT01289990|588441315|FG005|Overall Study|Not treated|0|||
162928313|NCT01289990|588441316|FG006|Overall Study|Not treated|1|||
162928314|NCT01289990|588441317|FG007|Overall Study|Not treated|0|||
162928315|NCT01289990|588441318|FG008|Overall Study|Not treated|1|||
162928316|NCT01289990|588441319|FG009|Overall Study|Not treated|0|||
162928317|NCT01289990|588441320|FG010|Overall Study|Not treated|1|||
162928318|NCT01289990|588441321|FG011|Overall Study|Not treated|2|||
162928319|NCT01289990|588441322|FG012|Overall Study|Not treated|0|||
162928320|NCT00363129|588441325|FG000|Overall Study|Withdrawal by Subject|11|||
162928321|NCT00363129|588441326|FG001|Overall Study|Withdrawal by Subject|18|||
162928322|NCT00363129|588441325|FG000|Overall Study|Adverse Event|8|||
162928323|NCT00363129|588441326|FG001|Overall Study|Adverse Event|3|||
162928324|NCT00363129|588441325|FG000|Overall Study|Alternate Treatment|2|||
162928325|NCT00363129|588441326|FG001|Overall Study|Alternate Treatment|4|||
162928326|NCT00363129|588441325|FG000|Overall Study|Other Medical Problems|2|||
162928327|NCT00363129|588441326|FG001|Overall Study|Other Medical Problems|4|||
162928328|NCT00363129|588441325|FG000|Overall Study|Death|0|||
162928329|NCT00363129|588441326|FG001|Overall Study|Death|1|||
162928330|NCT00363129|588441325|FG000|Overall Study|Other Reasons|6|||
162928331|NCT00363129|588441326|FG001|Overall Study|Other Reasons|3|||
162928332|NCT03454672|588441327|FG000|Overall Study|Adverse Event|1|||
162928333|NCT03454672|588441328|FG001|Overall Study|Adverse Event|1|||
162928334|NCT03454672|588441327|FG000|Overall Study|Lost to Follow-up|1|||
162928335|NCT03454672|588441328|FG001|Overall Study|Lost to Follow-up|3|||
162928336|NCT03454672|588441327|FG000|Overall Study|painful|1|||
162928337|NCT03454672|588441328|FG001|Overall Study|painful|2|||
162928338|NCT03454672|588441327|FG000|Overall Study|Non-compliance|2|||
162928339|NCT03454672|588441328|FG001|Overall Study|Non-compliance|4|||
162928340|NCT03454672|588441327|FG000|Overall Study|personal reasons|3|||
162928341|NCT03454672|588441328|FG001|Overall Study|personal reasons|2|||
162928342|NCT03454672|588441327|FG000|Overall Study|Withdrawal by Subject|1|||
162928343|NCT03454672|588441328|FG001|Overall Study|Withdrawal by Subject|0|||
162928344|NCT05166512|588441329|FG000|Randomized|Lost to Follow-up|2|||
162928345|NCT05166512|588441330|FG001|Randomized|Lost to Follow-up|0|||
162928346|NCT05166512|588441329|FG000|Randomized|Withdrawal by Subject|1|||
162928347|NCT05166512|588441330|FG001|Randomized|Withdrawal by Subject|0|||
162928348|NCT05166512|588441329|FG000|Baseline Data Collection|Lost to Follow-up|0|||
162928349|NCT05166512|588441330|FG001|Baseline Data Collection|Lost to Follow-up|3|||
162928350|NCT05166512|588441329|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
162928351|NCT05166512|588441330|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
162928352|NCT05166512|588441329|FG000|Baseline Data Collection|Protocol Violation|2|||
162928353|NCT05166512|588441330|FG001|Baseline Data Collection|Protocol Violation|0|||
162928354|NCT05166512|588441329|FG000|4 Month Data Collection|Lost to Follow-up|1|||
162928355|NCT05166512|588441330|FG001|4 Month Data Collection|Lost to Follow-up|0|||
162928356|NCT05166512|588441329|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
162928357|NCT05166512|588441330|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
162928358|NCT05166512|588441329|FG000|12 Month Data Collection|Lost to Follow-up|3|||
162928359|NCT05166512|588441330|FG001|12 Month Data Collection|Lost to Follow-up|1|||
162928360|NCT05166512|588441329|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
162928361|NCT05166512|588441330|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
162928362|NCT00420849|588441331|FG000|Overall Study|Lack of Efficacy|154|||
162928363|NCT00420849|588441331|FG000|Overall Study|Adverse Event|107|||
162928364|NCT00420849|588441331|FG000|Overall Study|Withdrawal by Subject|28|||
162928365|NCT00420849|588441331|FG000|Overall Study|Death|18|||
162928366|NCT00420849|588441331|FG000|Overall Study|Other|14|||
162928367|NCT00420849|588441331|FG000|Overall Study|Transplant|8|||
162928368|NCT00420849|588441331|FG000|Overall Study|Protocol Violation|1|||
162928369|NCT00420849|588441331|FG000|Overall Study|Lost to Follow-up|1|||
162928370|NCT00659581|588441332|FG000|Overall Study|Adverse Event|1006|||
162928371|NCT00659581|588441332|FG000|Overall Study|Lack of Efficacy|1183|||
162928372|NCT00659581|588441332|FG000|Overall Study|Other|6393|||
162928373|NCT05473247|588441336|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
162928374|NCT01345058|588441337|FG000|Overall Study|Withdrawal by Subject|1|||
162928375|NCT01345058|588441338|FG001|Overall Study|Withdrawal by Subject|0|||
162928376|NCT01345058|588441337|FG000|Overall Study|Participant Reported Increase in Events|1|||
162928377|NCT01345058|588441338|FG001|Overall Study|Participant Reported Increase in Events|0|||
162928378|NCT01345058|588441337|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
162928379|NCT01345058|588441338|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
162928380|NCT01345058|588441337|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
162928381|NCT01345058|588441338|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
162928382|NCT01345058|588441337|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
162928383|NCT01345058|588441338|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
162928384|NCT01892020|588441340|FG000|Period 1|Adverse Event|1|||
162928385|NCT01892020|588441341|FG001|Period 1|Adverse Event|1|||
162928386|NCT01892020|588441340|FG000|Period 1|Protocol Violation|2|||
162928387|NCT01892020|588441341|FG001|Period 1|Protocol Violation|4|||
162928388|NCT01892020|588441340|FG000|Period 1|Unclassified|0|||
162928389|NCT01892020|588441341|FG001|Period 1|Unclassified|1|||
162928390|NCT01892020|588441340|FG000|Period 2|Protocol Violation|1|||
162928391|NCT01892020|588441341|FG001|Period 2|Protocol Violation|0|||
162928392|NCT00000135|588441342|FG000|Overall Study|Death|27|||
162928393|NCT00000135|588441343|FG001|Overall Study|Death|14|||
162928394|NCT01831596|588441345|FG000|Overall Study|Other|8|||
162928395|NCT02149199|588441351|FG000|Overall Study|Study specific withdrawal criteria|4|||
162928396|NCT02149199|588441352|FG001|Overall Study|Study specific withdrawal criteria|21|||
162928397|NCT02149199|588441353|FG002|Overall Study|Study specific withdrawal criteria|6|||
162928398|NCT02149199|588441351|FG000|Overall Study|Other|20|||
162928399|NCT02149199|588441352|FG001|Overall Study|Other|25|||
162928400|NCT02149199|588441353|FG002|Overall Study|Other|20|||
162928401|NCT02149199|588441351|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
162928402|NCT02149199|588441352|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
162928403|NCT02149199|588441353|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
162928404|NCT02149199|588441351|FG000|Overall Study|Withdrawal by Subject|75|||
162928405|NCT02149199|588441352|FG001|Overall Study|Withdrawal by Subject|93|||
162928406|NCT02149199|588441353|FG002|Overall Study|Withdrawal by Subject|77|||
162928407|NCT02149199|588441351|FG000|Overall Study|Protocol Violation|16|||
162928408|NCT02149199|588441352|FG001|Overall Study|Protocol Violation|13|||
162928409|NCT02149199|588441353|FG002|Overall Study|Protocol Violation|15|||
162928410|NCT02149199|588441351|FG000|Overall Study|Lost to Follow-up|3|||
162928411|NCT02149199|588441352|FG001|Overall Study|Lost to Follow-up|12|||
162928412|NCT02149199|588441353|FG002|Overall Study|Lost to Follow-up|11|||
162928413|NCT02149199|588441351|FG000|Overall Study|Death|0|||
162928414|NCT02149199|588441352|FG001|Overall Study|Death|0|||
162928415|NCT02149199|588441353|FG002|Overall Study|Death|1|||
162928416|NCT02149199|588441351|FG000|Overall Study|Adverse Event|6|||
162928417|NCT02149199|588441352|FG001|Overall Study|Adverse Event|15|||
162928418|NCT02149199|588441353|FG002|Overall Study|Adverse Event|9|||
162928419|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928420|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928421|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928422|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
162928423|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
162928424|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928425|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928426|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928427|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928428|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
162928429|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928430|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928431|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
162928432|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
162928433|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
162928434|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
162928435|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
162928436|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
162928437|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928438|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928439|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928440|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928441|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928442|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928443|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
162928444|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928445|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928446|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928447|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
162928448|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928449|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928450|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928451|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
162928452|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
162928453|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
162928454|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
162928455|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
162928456|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928457|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
162928458|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928459|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928460|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928461|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928462|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
162928463|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928464|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928465|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928466|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928467|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928468|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928469|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928470|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928471|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
162928472|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928473|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928474|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
162928475|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928476|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928477|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928478|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928479|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928480|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928481|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928482|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928483|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928484|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928485|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928486|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
162928487|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928488|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928489|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
162928490|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928491|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928492|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
162928493|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
162928494|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928495|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
162928496|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
162928497|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928498|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
162928499|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928500|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928501|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
162928502|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928503|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928504|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928505|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
162928506|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928507|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
162928508|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
162928509|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
162928510|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
162928511|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
162928512|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
162928513|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928514|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928515|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
162928516|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
162928517|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928518|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928519|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928520|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928521|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
162928522|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
162928523|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
162928524|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928525|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
162928526|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928527|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
162928528|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928529|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
162928530|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
162928531|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
162928532|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928533|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928534|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928535|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928536|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928537|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
162928538|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928539|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928540|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928541|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928542|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
162928543|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928544|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928545|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928546|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928547|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928548|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928549|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928550|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928551|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928552|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
162928553|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
162928554|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
162928555|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
162928556|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
162928557|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
162928558|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
162928559|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
162928560|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
162928561|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
162928562|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
162928563|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
162928564|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
162928565|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
162928566|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
162928567|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
162928568|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
162928569|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
162928570|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
162928571|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928572|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928573|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928574|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928575|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928576|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928577|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928578|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928579|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928580|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928581|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
162928582|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928583|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928584|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928585|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928586|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928587|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928588|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928589|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928590|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
162928591|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
162928592|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
162928593|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
162928594|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
162928595|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
162928596|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
162928597|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
162928598|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
162928599|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
162928600|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
162928601|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
162928602|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
162928603|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
162928604|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
162928605|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
162928606|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
162928607|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
162928608|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
162928609|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
162928610|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
162928611|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
162928612|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
162928613|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
162928614|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
162928615|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
162928616|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
162928617|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
162928618|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
162928619|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
162928620|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
162928621|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
162928622|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
162928623|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
162928624|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
162928625|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
162928626|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
162928627|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
162928628|NCT01915498|588441356|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928629|NCT01915498|588441357|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928630|NCT01915498|588441358|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928631|NCT01915498|588441359|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928632|NCT01915498|588441360|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928633|NCT01915498|588441361|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928634|NCT01915498|588441362|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928635|NCT01915498|588441363|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928636|NCT01915498|588441364|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928637|NCT01915498|588441365|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
163041171|NCT04811664|588858088|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
163041172|NCT04811664|588858086|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
163156583|NCT01352793|589287892|FG000|Overall Study|Other|25|||
162928638|NCT01915498|588441366|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928639|NCT01915498|588441367|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928640|NCT01915498|588441368|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928641|NCT01915498|588441369|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928642|NCT01915498|588441370|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928643|NCT01915498|588441371|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928644|NCT01915498|588441372|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928645|NCT01915498|588441373|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928646|NCT01915498|588441374|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
162928647|NCT01915498|588441356|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928648|NCT01915498|588441357|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928649|NCT01915498|588441358|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928650|NCT01915498|588441359|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928651|NCT01915498|588441360|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928652|NCT01915498|588441361|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928653|NCT01915498|588441362|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928654|NCT01915498|588441363|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928655|NCT01915498|588441364|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928656|NCT01915498|588441365|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928657|NCT01915498|588441366|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928658|NCT01915498|588441367|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928659|NCT01915498|588441368|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928660|NCT01915498|588441369|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928661|NCT01915498|588441370|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928662|NCT01915498|588441371|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928663|NCT01915498|588441372|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928664|NCT01915498|588441373|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928665|NCT01915498|588441374|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
162928666|NCT01915498|588441356|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928667|NCT01915498|588441357|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928668|NCT01915498|588441358|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928669|NCT01915498|588441359|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928670|NCT01915498|588441360|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928671|NCT01915498|588441361|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928672|NCT01915498|588441362|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928673|NCT01915498|588441363|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928674|NCT01915498|588441364|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928675|NCT01915498|588441365|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928676|NCT01915498|588441366|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928677|NCT01915498|588441367|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928678|NCT01915498|588441368|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928679|NCT01915498|588441369|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928680|NCT01915498|588441370|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928681|NCT01915498|588441371|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928682|NCT01915498|588441372|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928683|NCT01915498|588441373|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928684|NCT01915498|588441374|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
162928685|NCT00314262|588441380|FG000|Overall Study|Adverse Event|2|||
162928686|NCT00314262|588441380|FG000|Overall Study|Withdrawal by Subject|2|||
162928687|NCT00314262|588441380|FG000|Overall Study|Physician Decision|1|||
162928688|NCT01185639|588441381|FG000|Overall Study|Progressed and didn't receive therapy|2|||
162928689|NCT02662556|588441382|FG000|Overall Study|Adverse Event|4|||
162928690|NCT02662556|588441382|FG000|Overall Study|Lack of Efficacy|4|||
162928691|NCT00563524|588443704|FG000|Overall Study|Adverse Event|0|||
162928692|NCT00563524|588443705|FG001|Overall Study|Adverse Event|1|||
162928693|NCT00563524|588443706|FG002|Overall Study|Adverse Event|0|||
162928694|NCT00563524|588443707|FG003|Overall Study|Adverse Event|0|||
162928695|NCT00563524|588443708|FG004|Overall Study|Adverse Event|2|||
162928696|NCT00563524|588443709|FG005|Overall Study|Adverse Event|0|||
162928697|NCT00563524|588443704|FG000|Overall Study|Lost to Follow-up|1|||
162928698|NCT00563524|588443705|FG001|Overall Study|Lost to Follow-up|0|||
162928699|NCT00563524|588443706|FG002|Overall Study|Lost to Follow-up|0|||
162928700|NCT00563524|588443707|FG003|Overall Study|Lost to Follow-up|0|||
162928701|NCT00563524|588443708|FG004|Overall Study|Lost to Follow-up|0|||
162928702|NCT00563524|588443709|FG005|Overall Study|Lost to Follow-up|0|||
162928703|NCT00563524|588443704|FG000|Overall Study|Protocol Violation|0|||
162928704|NCT00563524|588443705|FG001|Overall Study|Protocol Violation|1|||
162928705|NCT00563524|588443706|FG002|Overall Study|Protocol Violation|0|||
162928706|NCT00563524|588443707|FG003|Overall Study|Protocol Violation|0|||
162928707|NCT00563524|588443708|FG004|Overall Study|Protocol Violation|0|||
162928708|NCT00563524|588443709|FG005|Overall Study|Protocol Violation|0|||
162928709|NCT00563524|588443704|FG000|Overall Study|Withdrawal by Subject|1|||
162928710|NCT00563524|588443705|FG001|Overall Study|Withdrawal by Subject|1|||
162928711|NCT00563524|588443706|FG002|Overall Study|Withdrawal by Subject|3|||
162928712|NCT00563524|588443707|FG003|Overall Study|Withdrawal by Subject|0|||
162928713|NCT00563524|588443708|FG004|Overall Study|Withdrawal by Subject|0|||
162928714|NCT00563524|588443709|FG005|Overall Study|Withdrawal by Subject|1|||
162928715|NCT01467570|588443711|FG000|Overall Study|Lost to Follow-up|8|||
162928716|NCT01467570|588443712|FG001|Overall Study|Lost to Follow-up|9|||
162928717|NCT01222715|588443717|FG000|Overall Study|Adverse Event|0|||
162928718|NCT01222715|588443718|FG001|Overall Study|Adverse Event|4|||
162928719|NCT01222715|588443717|FG000|Overall Study|Death|0|||
162928720|NCT01222715|588443718|FG001|Overall Study|Death|1|||
162928721|NCT01222715|588443717|FG000|Overall Study|Lack of Efficacy|22|||
162928722|NCT01222715|588443718|FG001|Overall Study|Lack of Efficacy|14|||
162928723|NCT01222715|588443717|FG000|Overall Study|Physician Decision|12|||
162928724|NCT01222715|588443718|FG001|Overall Study|Physician Decision|2|||
162928725|NCT01222715|588443717|FG000|Overall Study|Refusal of further protocol therapy|0|||
162928726|NCT01222715|588443718|FG001|Overall Study|Refusal of further protocol therapy|4|||
162928727|NCT01222715|588443717|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
162928728|NCT01222715|588443718|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
162928729|NCT01222715|588443717|FG000|Overall Study|Ineligible|0|||
162928730|NCT01222715|588443718|FG001|Overall Study|Ineligible|1|||
162928731|NCT01222715|588443717|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
162928732|NCT01222715|588443718|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
162928733|NCT03836729|588443719|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
162928734|NCT00520494|588443727|FG000|Overall Study|Withdrawal by Subject|1|||
162928735|NCT00544557|588443730|FG000|Overall Study|Adverse Event|140|||
162928736|NCT00544557|588443730|FG000|Overall Study|Lack of Efficacy|196|||
162928737|NCT00544557|588443730|FG000|Overall Study|Other|98|||
162928738|NCT00467818|588443731|FG000|Overall Study|Adverse Event|1|||
162928739|NCT00467818|588443732|FG001|Overall Study|Adverse Event|0|||
162928740|NCT00467818|588443731|FG000|Overall Study|Lost to Follow-up|2|||
162928741|NCT00467818|588443732|FG001|Overall Study|Lost to Follow-up|2|||
162928742|NCT01830920|588443734|FG000|Overall Study|Adverse Event|1|||
162928743|NCT01830920|588443735|FG001|Overall Study|Adverse Event|0|||
162928744|NCT01830920|588443736|FG002|Overall Study|Adverse Event|1|||
162928745|NCT01830920|588443737|FG003|Overall Study|Adverse Event|0|||
162928746|NCT01830920|588443738|FG004|Overall Study|Adverse Event|0|||
162928747|NCT01830920|588443734|FG000|Overall Study|Withdrawal by Subject|2|||
162928748|NCT01830920|588443735|FG001|Overall Study|Withdrawal by Subject|2|||
162928749|NCT01830920|588443736|FG002|Overall Study|Withdrawal by Subject|1|||
162928750|NCT01830920|588443737|FG003|Overall Study|Withdrawal by Subject|7|||
162928751|NCT01830920|588443738|FG004|Overall Study|Withdrawal by Subject|1|||
162928752|NCT01830920|588443734|FG000|Overall Study|Death|3|||
162928753|NCT01830920|588443735|FG001|Overall Study|Death|3|||
162928754|NCT01830920|588443736|FG002|Overall Study|Death|5|||
162928755|NCT01830920|588443737|FG003|Overall Study|Death|4|||
162928756|NCT01830920|588443738|FG004|Overall Study|Death|4|||
162928757|NCT01830920|588443734|FG000|Overall Study|Other|15|||
162928758|NCT01830920|588443735|FG001|Overall Study|Other|1|||
162928759|NCT01830920|588443736|FG002|Overall Study|Other|1|||
162928760|NCT01830920|588443737|FG003|Overall Study|Other|5|||
162928761|NCT01830920|588443738|FG004|Overall Study|Other|3|||
162928762|NCT01313728|588443739|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
162928763|NCT02216214|588443740|FG000|Overall Study|Randomized Never Received Study Drug|1|||
162928764|NCT02216214|588443741|FG001|Overall Study|Randomized Never Received Study Drug|0|||
162928765|NCT02216214|588443740|FG000|Overall Study|Adverse Event|10|||
162928766|NCT02216214|588443741|FG001|Overall Study|Adverse Event|8|||
162928767|NCT02216214|588443740|FG000|Overall Study|Lack of Efficacy|2|||
162928768|NCT02216214|588443741|FG001|Overall Study|Lack of Efficacy|2|||
162928769|NCT02216214|588443740|FG000|Overall Study|Lost to Follow-up|3|||
162928770|NCT02216214|588443741|FG001|Overall Study|Lost to Follow-up|2|||
162928771|NCT02216214|588443740|FG000|Overall Study|Protocol Violation|4|||
162928772|NCT02216214|588443741|FG001|Overall Study|Protocol Violation|2|||
162928773|NCT02216214|588443740|FG000|Overall Study|Withdrawal by Subject|22|||
162928774|NCT02216214|588443741|FG001|Overall Study|Withdrawal by Subject|20|||
162928775|NCT02216214|588443740|FG000|Overall Study|Study Terminated By Sponsor|0|||
162928776|NCT02216214|588443741|FG001|Overall Study|Study Terminated By Sponsor|1|||
162928777|NCT02216214|588443740|FG000|Overall Study|Miscellaneous|1|||
163385759|NCT00146328|590123240|FG001|Overall Study|Protocol Violation|6|||
162928778|NCT02216214|588443741|FG001|Overall Study|Miscellaneous|1|||
162928779|NCT05354206|588443743|FG000|Overall Study|Withdrawal by Subject|1|||
162928780|NCT05354206|588443744|FG001|Overall Study|Withdrawal by Subject|0|||
162928781|NCT00713830|588443747|FG000|Overall Study|Adverse Event|23|||
162928782|NCT00713830|588443748|FG001|Overall Study|Adverse Event|71|||
163270496|NCT01474512|589699962|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
163270497|NCT01474512|589699963|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
163270498|NCT01474512|589699964|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
163270499|NCT01474512|589699965|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
163270500|NCT01474512|589699966|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
163270501|NCT01474512|589699967|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
163270502|NCT01474512|589699968|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
163270503|NCT01474512|589699969|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
163270504|NCT01474512|589699970|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
163270505|NCT01474512|589699971|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
163270506|NCT01474512|589699972|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
163270507|NCT01474512|589699973|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
163270508|NCT01474512|589699956|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
162928783|NCT00713830|588443747|FG000|Overall Study|Lack of Efficacy|24|||
162928784|NCT00713830|588443748|FG001|Overall Study|Lack of Efficacy|16|||
162928785|NCT00713830|588443747|FG000|Overall Study|Lost to Follow-up|2|||
162928786|NCT00713830|588443748|FG001|Overall Study|Lost to Follow-up|9|||
162928787|NCT00713830|588443747|FG000|Overall Study|Withdrawal by Subject|13|||
162928788|NCT00713830|588443748|FG001|Overall Study|Withdrawal by Subject|23|||
162928789|NCT00713830|588443747|FG000|Overall Study|Poor Compliance to Protocol|7|||
162928790|NCT00713830|588443748|FG001|Overall Study|Poor Compliance to Protocol|14|||
162928791|NCT00713830|588443747|FG000|Overall Study|Familial and Personal Reasons|9|||
162928792|NCT00713830|588443748|FG001|Overall Study|Familial and Personal Reasons|34|||
162928793|NCT00713830|588443747|FG000|Overall Study|Sponsor Decision|4|||
162928794|NCT00713830|588443748|FG001|Overall Study|Sponsor Decision|10|||
162928795|NCT04057118|588443751|FG000|Overall Study|Adverse Event|1|||
162928796|NCT04057118|588443752|FG001|Overall Study|Adverse Event|0|||
162928797|NCT04057118|588443753|FG002|Overall Study|Adverse Event|1|||
162928798|NCT04057118|588443754|FG003|Overall Study|Adverse Event|1|||
162928799|NCT04057118|588443751|FG000|Overall Study|Physician Decision|0|||
162928800|NCT04057118|588443752|FG001|Overall Study|Physician Decision|0|||
162928801|NCT04057118|588443753|FG002|Overall Study|Physician Decision|1|||
162928802|NCT04057118|588443754|FG003|Overall Study|Physician Decision|1|||
162928803|NCT04057118|588443751|FG000|Overall Study|Withdrawal by Subject|2|||
163270509|NCT01474512|589699957|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
163270510|NCT01474512|589699958|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
163270511|NCT01474512|589699959|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
163270512|NCT01474512|589699960|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
163270513|NCT01474512|589699961|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
163270514|NCT01474512|589699962|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
163270515|NCT01474512|589699963|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
163270516|NCT01474512|589699964|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
163270517|NCT01474512|589699965|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
163270518|NCT01474512|589699966|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
163270519|NCT01474512|589699967|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
163270520|NCT01474512|589699968|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
163270521|NCT01474512|589699969|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
163270522|NCT01474512|589699970|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
163270523|NCT01474512|589699971|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
163270524|NCT01474512|589699972|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
163270525|NCT01474512|589699973|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
163270526|NCT01474512|589699956|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
163270527|NCT01474512|589699957|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
163270528|NCT01474512|589699958|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
163270529|NCT01474512|589699959|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
163270530|NCT01474512|589699960|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
163270531|NCT01474512|589699961|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
163270532|NCT01474512|589699962|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
163270533|NCT01474512|589699963|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
163270534|NCT01474512|589699964|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
162928804|NCT04057118|588443752|FG001|Overall Study|Withdrawal by Subject|2|||
163270535|NCT01474512|589699965|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
163270536|NCT01474512|589699966|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
163270537|NCT01474512|589699967|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
163270538|NCT01474512|589699968|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
163270539|NCT01474512|589699969|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
163041173|NCT04811664|588858087|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
163270540|NCT01474512|589699970|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
163385760|NCT00146328|590123241|FG002|Overall Study|Protocol Violation|12|||
162928805|NCT04057118|588443753|FG002|Overall Study|Withdrawal by Subject|0|||
162928806|NCT04057118|588443754|FG003|Overall Study|Withdrawal by Subject|2|||
162928807|NCT04057118|588443751|FG000|Overall Study|Not Specific|0|||
162928808|NCT04057118|588443752|FG001|Overall Study|Not Specific|0|||
162928809|NCT04057118|588443753|FG002|Overall Study|Not Specific|1|||
162928810|NCT04057118|588443754|FG003|Overall Study|Not Specific|1|||
162928811|NCT03402126|588443757|FG000|Overall Study|Lost to Follow-up|6|||
163270541|NCT01474512|589699971|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
163270542|NCT01474512|589699972|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
163270543|NCT01474512|589699973|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
163270544|NCT01474512|589699956|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163270545|NCT01474512|589699957|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163270546|NCT01474512|589699958|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163270547|NCT01474512|589699959|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163270548|NCT01474512|589699960|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163270549|NCT01474512|589699961|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163270550|NCT01474512|589699962|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163270551|NCT01474512|589699963|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163270552|NCT01474512|589699964|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163270553|NCT01474512|589699965|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163270554|NCT01474512|589699966|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163270555|NCT01474512|589699967|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163270556|NCT01474512|589699968|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163270557|NCT01474512|589699969|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163270558|NCT01474512|589699970|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
163270559|NCT01474512|589699971|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162928812|NCT03402126|588443757|FG000|Overall Study|Protocol Violation|10|||
162928813|NCT03402126|588443757|FG000|Overall Study|Sponsor request/Study termination|29|||
162928814|NCT03402126|588443757|FG000|Overall Study|Study product no longer in use|1|||
162928815|NCT03402126|588443757|FG000|Overall Study|Technical problems|1|||
162928816|NCT03402126|588443757|FG000|Overall Study|Withdrawal by Subject|6|||
162928817|NCT03402126|588443757|FG000|Overall Study|Physician Decision|2|||
162928818|NCT03402126|588443757|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
162928819|NCT03402126|588443757|FG000|Overall Study|Death|4|||
162928820|NCT02261974|588443758|FG000|Overall Study|Withdrawal by Subject|3|||
162928821|NCT02261974|588443759|FG001|Overall Study|Withdrawal by Subject|2|||
162928822|NCT02261974|588443758|FG000|Overall Study|Pregnancy|0|||
162928823|NCT02261974|588443759|FG001|Overall Study|Pregnancy|1|||
162928824|NCT02261974|588443758|FG000|Overall Study|Missed treatment cut-off date|6|||
162928825|NCT02261974|588443759|FG001|Overall Study|Missed treatment cut-off date|3|||
162928826|NCT02261974|588443758|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
162928827|NCT02261974|588443759|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
162928828|NCT02261974|588443758|FG000|Overall Study|Lost to Follow-up|2|||
162928829|NCT02261974|588443759|FG001|Overall Study|Lost to Follow-up|0|||
163270560|NCT01474512|589699972|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163270561|NCT01474512|589699973|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
163270562|NCT01474512|589699956|FG000|Post-Treatment Follow-Up|Death|0|||
163270563|NCT01474512|589699957|FG001|Post-Treatment Follow-Up|Death|0|||
163270564|NCT01474512|589699958|FG002|Post-Treatment Follow-Up|Death|0|||
163270565|NCT01474512|589699959|FG003|Post-Treatment Follow-Up|Death|0|||
163270566|NCT01474512|589699960|FG004|Post-Treatment Follow-Up|Death|0|||
163270567|NCT01474512|589699961|FG005|Post-Treatment Follow-Up|Death|0|||
163270568|NCT01474512|589699962|FG006|Post-Treatment Follow-Up|Death|0|||
163270569|NCT01474512|589699963|FG007|Post-Treatment Follow-Up|Death|0|||
163270570|NCT01474512|589699964|FG008|Post-Treatment Follow-Up|Death|0|||
163270571|NCT01474512|589699965|FG009|Post-Treatment Follow-Up|Death|0|||
163270572|NCT01474512|589699966|FG010|Post-Treatment Follow-Up|Death|0|||
163270573|NCT01474512|589699967|FG011|Post-Treatment Follow-Up|Death|0|||
163270574|NCT01474512|589699968|FG012|Post-Treatment Follow-Up|Death|0|||
163270575|NCT01474512|589699969|FG013|Post-Treatment Follow-Up|Death|0|||
163270576|NCT01474512|589699970|FG014|Post-Treatment Follow-Up|Death|0|||
163270577|NCT01474512|589699971|FG015|Post-Treatment Follow-Up|Death|0|||
163270578|NCT01474512|589699972|FG016|Post-Treatment Follow-Up|Death|1|||
162928830|NCT02261974|588443758|FG000|Overall Study|Adverse Event|1|||
162928831|NCT02261974|588443759|FG001|Overall Study|Adverse Event|0|||
163270579|NCT01474512|589699973|FG017|Post-Treatment Follow-Up|Death|0|||
163270580|NCT01118962|589699976|FG000|Overall Study|Adverse Event|2|||
163270581|NCT01118962|589699976|FG000|Overall Study|Lack of Efficacy|1|||
162928832|NCT02030834|588443760|FG000|Overall Study|Death|4|||
162928833|NCT02030834|588443761|FG001|Overall Study|Death|0|||
162928834|NCT02030834|588443762|FG002|Overall Study|Death|0|||
162928835|NCT02030834|588443760|FG000|Overall Study|Manufacturing failure|2|||
162928836|NCT02030834|588443761|FG001|Overall Study|Manufacturing failure|0|||
162928837|NCT02030834|588443762|FG002|Overall Study|Manufacturing failure|1|||
162928838|NCT02030834|588443760|FG000|Overall Study|Disease progression|2|||
162928839|NCT02030834|588443761|FG001|Overall Study|Disease progression|0|||
162928840|NCT02030834|588443762|FG002|Overall Study|Disease progression|2|||
162928841|NCT02030834|588443760|FG000|Overall Study|Lost to Follow-up|1|||
162928842|NCT02030834|588443761|FG001|Overall Study|Lost to Follow-up|0|||
162928843|NCT02030834|588443762|FG002|Overall Study|Lost to Follow-up|0|||
162928844|NCT02030834|588443760|FG000|Overall Study|Withdrawal by Subject|1|||
162928845|NCT02030834|588443761|FG001|Overall Study|Withdrawal by Subject|0|||
162928846|NCT02030834|588443762|FG002|Overall Study|Withdrawal by Subject|0|||
162928847|NCT02030834|588443760|FG000|Overall Study|Lack of funding|1|||
162928848|NCT02030834|588443761|FG001|Overall Study|Lack of funding|0|||
162928849|NCT02030834|588443762|FG002|Overall Study|Lack of funding|0|||
162928850|NCT04440007|588443763|FG000|Overall Study|Adverse Event|0|||
163270582|NCT01118962|589699976|FG000|Overall Study|Protocol Violation|1|||
163270583|NCT01118962|589699976|FG000|Overall Study|Withdrawal by Subject|4|||
162928851|NCT04440007|588443764|FG001|Overall Study|Adverse Event|1|||
162928852|NCT04440007|588443763|FG000|Overall Study|Lost to Follow-up|1|||
162928853|NCT04440007|588443764|FG001|Overall Study|Lost to Follow-up|3|||
162928854|NCT04440007|588443763|FG000|Overall Study|Death|7|||
162928855|NCT04440007|588443764|FG001|Overall Study|Death|2|||
163270584|NCT01118962|589699976|FG000|Overall Study|Pregnancy|1|||
163270585|NCT01118962|589699976|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
163270586|NCT01089556|589699979|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
163270587|NCT01089556|589699980|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
163270588|NCT01089556|589699981|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
163270589|NCT01089556|589699982|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
163270590|NCT01089556|589699983|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
163270591|NCT01089556|589699984|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
163270592|NCT01089556|589699979|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
163270593|NCT01089556|589699980|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
163270594|NCT01089556|589699981|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
163270595|NCT01089556|589699982|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
163270596|NCT01089556|589699983|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
163270597|NCT01089556|589699984|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
163270598|NCT01089556|589699979|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
163270599|NCT01089556|589699980|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
162928856|NCT04440007|588443763|FG000|Overall Study|Physician Decision|1|||
162928857|NCT04440007|588443764|FG001|Overall Study|Physician Decision|1|||
162928858|NCT04440007|588443763|FG000|Overall Study|Withdrawal by Subject|2|||
162928859|NCT04440007|588443764|FG001|Overall Study|Withdrawal by Subject|1|||
162928860|NCT04440007|588443763|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
162928861|NCT04440007|588443764|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
162928862|NCT04440007|588443763|FG000|Overall Study|Discontinued prior to dosing|0|||
162928863|NCT04440007|588443764|FG001|Overall Study|Discontinued prior to dosing|2|||
162928864|NCT01466673|588443765|FG000|Overall Study|Non-compliance with study treatment|2|||
162928865|NCT01466673|588443766|FG001|Overall Study|Non-compliance with study treatment|0|||
162928866|NCT01466673|588443765|FG000|Overall Study|Lost to Follow-up|3|||
162928867|NCT01466673|588443766|FG001|Overall Study|Lost to Follow-up|5|||
162928868|NCT01466673|588443765|FG000|Overall Study|Adverse Event|2|||
162928869|NCT01466673|588443766|FG001|Overall Study|Adverse Event|1|||
163270600|NCT01089556|589699981|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
163270601|NCT01089556|589699982|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
163270602|NCT01089556|589699983|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
163270603|NCT01089556|589699984|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
163270604|NCT01089556|589699979|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
163270605|NCT01089556|589699980|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
163270606|NCT01089556|589699981|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
163270607|NCT01089556|589699982|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
163270608|NCT01089556|589699983|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
163270609|NCT01089556|589699984|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
163270610|NCT01089556|589699979|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
163270611|NCT01089556|589699980|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
163270612|NCT01089556|589699981|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
163270613|NCT01089556|589699982|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
163270614|NCT01089556|589699983|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
163270615|NCT01089556|589699984|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
162928870|NCT04529499|588443770|FG000|Overall Study|Withdrawal by Subject|9|||
162928871|NCT04529499|588443771|FG001|Overall Study|Withdrawal by Subject|11|||
162928872|NCT04529499|588443770|FG000|Overall Study|Physician Decision|1|||
162928873|NCT04529499|588443771|FG001|Overall Study|Physician Decision|2|||
162928874|NCT04529499|588443770|FG000|Overall Study|Adverse Event|4|||
162928875|NCT04529499|588443771|FG001|Overall Study|Adverse Event|4|||
162928876|NCT04529499|588443770|FG000|Overall Study|Death|14|||
162928877|NCT04529499|588443771|FG001|Overall Study|Death|11|||
162928878|NCT04529499|588443770|FG000|Overall Study|Lost to Follow-up|1|||
162928879|NCT04529499|588443771|FG001|Overall Study|Lost to Follow-up|1|||
162928880|NCT04529499|588443770|FG000|Overall Study|Others|7|||
162928881|NCT04529499|588443771|FG001|Overall Study|Others|11|||
162928882|NCT00683904|588443772|FG000|Dose Level 1|Disease progression|2|||
162928883|NCT00683904|588443773|FG001|Dose Level 1|Disease progression|0|||
162928884|NCT00683904|588443772|FG000|Dose Level 1|Adverse Event|1|||
162928885|NCT00683904|588443773|FG001|Dose Level 1|Adverse Event|0|||
162928886|NCT00683904|588443772|FG000|Dose Level 2|Adverse Event|0|||
162928887|NCT00683904|588443773|FG001|Dose Level 2|Adverse Event|2|||
162928888|NCT02702271|588443774|FG000|Overall Study|Death|36|||
162928889|NCT02702271|588443775|FG001|Overall Study|Death|7|||
162928890|NCT02702271|588443774|FG000|Overall Study|Lost to Follow-up|12|||
162928891|NCT02702271|588443775|FG001|Overall Study|Lost to Follow-up|0|||
163270616|NCT01089556|589699979|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
163270617|NCT01089556|589699980|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
163270618|NCT01089556|589699981|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
163270619|NCT01089556|589699982|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
163270620|NCT01089556|589699983|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
163270621|NCT01089556|589699984|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
162928892|NCT02702271|588443774|FG000|Overall Study|Withdrawal by Subject|8|||
162928893|NCT02702271|588443775|FG001|Overall Study|Withdrawal by Subject|1|||
162928894|NCT02702271|588443774|FG000|Overall Study|Physician Decision|2|||
162928895|NCT02702271|588443775|FG001|Overall Study|Physician Decision|0|||
162928896|NCT02702271|588443774|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
162928897|NCT02702271|588443775|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
162928898|NCT01494649|588443776|FG000|Overall Study|Lost to Follow-up|0|||
162928899|NCT01494649|588443777|FG001|Overall Study|Lost to Follow-up|1|||
162928900|NCT03091400|588443778|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
162928901|NCT03091400|588443779|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
162928902|NCT00975884|588443780|FG000|Overall Study|Adverse Event|1|||
162928903|NCT00975884|588443781|FG001|Overall Study|Adverse Event|0|||
162928904|NCT00975884|588443780|FG000|Overall Study|Lost to Follow-up|5|||
162928905|NCT00975884|588443781|FG001|Overall Study|Lost to Follow-up|3|||
162928906|NCT00975884|588443780|FG000|Overall Study|Withdrawal by Subject|9|||
162928907|NCT00975884|588443781|FG001|Overall Study|Withdrawal by Subject|9|||
162928908|NCT00975884|588443780|FG000|Overall Study|Other|1|||
162928909|NCT00975884|588443781|FG001|Overall Study|Other|3|||
162928910|NCT03707522|588443782|FG000|Overall Study|Lost to Follow-up|24|||
162928911|NCT03707522|588443783|FG001|Overall Study|Lost to Follow-up|27|||
162928912|NCT03707522|588443784|FG002|Overall Study|Lost to Follow-up|41|||
162928913|NCT03707522|588443785|FG003|Overall Study|Lost to Follow-up|36|||
162928914|NCT00383019|588443786|FG000|Overall Study|Adverse Event|5|||
162928915|NCT00383019|588443787|FG001|Overall Study|Adverse Event|1|||
162928916|NCT00383019|588443786|FG000|Overall Study|Withdrawal by Subject|0|||
162928917|NCT00383019|588443787|FG001|Overall Study|Withdrawal by Subject|1|||
162928918|NCT02508649|588443788|FG000|Overall Study|Withdrawal by Subject|4|||
162928919|NCT02508649|588443789|FG001|Overall Study|Withdrawal by Subject|6|||
162928920|NCT02508649|588443790|FG002|Overall Study|Withdrawal by Subject|5|||
162928921|NCT02508649|588443791|FG003|Overall Study|Withdrawal by Subject|6|||
162928922|NCT02508649|588443788|FG000|Overall Study|Investigator withdrew the subject|1|||
162928923|NCT02508649|588443789|FG001|Overall Study|Investigator withdrew the subject|2|||
162928924|NCT02508649|588443790|FG002|Overall Study|Investigator withdrew the subject|1|||
162928925|NCT02508649|588443791|FG003|Overall Study|Investigator withdrew the subject|0|||
162928926|NCT02508649|588443788|FG000|Overall Study|Post randomization screening failure|12|||
162928927|NCT02508649|588443789|FG001|Overall Study|Post randomization screening failure|4|||
163270622|NCT01089556|589699979|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
163270623|NCT01089556|589699980|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
163270624|NCT01089556|589699981|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
163270625|NCT01089556|589699982|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
163270626|NCT01089556|589699983|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
163270627|NCT01089556|589699984|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
163270628|NCT01089556|589699979|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
163270629|NCT01089556|589699980|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
163270630|NCT01089556|589699981|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
163270631|NCT01089556|589699982|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
163270632|NCT01089556|589699983|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
163270633|NCT01089556|589699984|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
163270634|NCT01089556|589699979|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
163270635|NCT01089556|589699980|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
163270636|NCT01089556|589699981|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
163270637|NCT01089556|589699982|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
163270638|NCT01089556|589699983|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
163270639|NCT01089556|589699984|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
163270640|NCT01089556|589699979|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
163270641|NCT01089556|589699980|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
163270642|NCT01089556|589699981|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
163270643|NCT01089556|589699982|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
163270644|NCT01089556|589699983|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
163270645|NCT01089556|589699984|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
163270646|NCT01089556|589699979|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
162928928|NCT02508649|588443790|FG002|Overall Study|Post randomization screening failure|9|||
162928929|NCT02508649|588443791|FG003|Overall Study|Post randomization screening failure|3|||
162928930|NCT02508649|588443788|FG000|Overall Study|Lost to Follow-up|1|||
162928931|NCT02508649|588443789|FG001|Overall Study|Lost to Follow-up|1|||
162928932|NCT02508649|588443790|FG002|Overall Study|Lost to Follow-up|0|||
162928933|NCT02508649|588443791|FG003|Overall Study|Lost to Follow-up|1|||
162928934|NCT00446134|588443792|FG000|Overall Study|Adverse Event|7|||
162928935|NCT00446134|588443793|FG001|Overall Study|Adverse Event|17|||
162928936|NCT00446134|588443794|FG002|Overall Study|Adverse Event|13|||
162928937|NCT00446134|588443795|FG003|Overall Study|Adverse Event|18|||
162928938|NCT00446134|588443792|FG000|Overall Study|Lack of Efficacy|19|||
162928939|NCT00446134|588443793|FG001|Overall Study|Lack of Efficacy|19|||
162928940|NCT00446134|588443794|FG002|Overall Study|Lack of Efficacy|24|||
162928941|NCT00446134|588443795|FG003|Overall Study|Lack of Efficacy|19|||
162928942|NCT00446134|588443792|FG000|Overall Study|Protocol Violation|0|||
162928943|NCT00446134|588443793|FG001|Overall Study|Protocol Violation|2|||
162928944|NCT00446134|588443794|FG002|Overall Study|Protocol Violation|1|||
162928945|NCT00446134|588443795|FG003|Overall Study|Protocol Violation|0|||
162928946|NCT00446134|588443792|FG000|Overall Study|Lost to Follow-up|1|||
162928947|NCT00446134|588443793|FG001|Overall Study|Lost to Follow-up|3|||
162928948|NCT00446134|588443794|FG002|Overall Study|Lost to Follow-up|1|||
162928949|NCT00446134|588443795|FG003|Overall Study|Lost to Follow-up|1|||
162928950|NCT00446134|588443792|FG000|Overall Study|Withdrawal by Subject|3|||
162928951|NCT00446134|588443793|FG001|Overall Study|Withdrawal by Subject|3|||
162928952|NCT00446134|588443794|FG002|Overall Study|Withdrawal by Subject|1|||
162928953|NCT00446134|588443795|FG003|Overall Study|Withdrawal by Subject|3|||
162928954|NCT00446134|588443792|FG000|Overall Study|Physician Decision|0|||
162928955|NCT00446134|588443793|FG001|Overall Study|Physician Decision|0|||
162928956|NCT00446134|588443794|FG002|Overall Study|Physician Decision|0|||
162928957|NCT00446134|588443795|FG003|Overall Study|Physician Decision|2|||
162928958|NCT00446134|588443792|FG000|Overall Study|Adverse Event-Diarrhea|1|||
162928959|NCT00446134|588443793|FG001|Overall Study|Adverse Event-Diarrhea|1|||
162928960|NCT00446134|588443794|FG002|Overall Study|Adverse Event-Diarrhea|2|||
162928961|NCT00446134|588443795|FG003|Overall Study|Adverse Event-Diarrhea|0|||
162928962|NCT00446134|588443792|FG000|Overall Study|Reason Not Completed|3|||
162928963|NCT00446134|588443793|FG001|Overall Study|Reason Not Completed|0|||
162928964|NCT00446134|588443794|FG002|Overall Study|Reason Not Completed|1|||
162928965|NCT00446134|588443795|FG003|Overall Study|Reason Not Completed|2|||
162928966|NCT00567996|588443799|FG000|Overall Study|Adverse Event|18|||
162928967|NCT00567996|588443800|FG001|Overall Study|Adverse Event|16|||
163270647|NCT01089556|589699980|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
163270648|NCT01089556|589699981|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
163270649|NCT01089556|589699982|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
163270650|NCT01089556|589699983|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
162928968|NCT00567996|588443801|FG002|Overall Study|Adverse Event|13|||
162928969|NCT00567996|588443799|FG000|Overall Study|Protocol Deviation|9|||
163270651|NCT01089556|589699984|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
163270652|NCT01089556|589699979|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
163270653|NCT01089556|589699980|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
163270654|NCT01089556|589699981|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
163270655|NCT01089556|589699982|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
163270656|NCT01089556|589699983|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
163270657|NCT01089556|589699984|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
163270658|NCT01089556|589699979|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
163270659|NCT01089556|589699980|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
163270660|NCT01089556|589699981|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
163270661|NCT01089556|589699982|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
163270662|NCT01089556|589699983|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
163270663|NCT01089556|589699984|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
162928970|NCT00567996|588443800|FG001|Overall Study|Protocol Deviation|11|||
162928971|NCT00567996|588443801|FG002|Overall Study|Protocol Deviation|13|||
163270664|NCT01089556|589699979|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
163270665|NCT01089556|589699980|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
162928972|NCT00567996|588443799|FG000|Overall Study|Withdrawal by Subject|8|||
163270666|NCT01089556|589699981|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
163270667|NCT01089556|589699982|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
163270668|NCT01089556|589699983|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
163270669|NCT01089556|589699984|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
163270670|NCT01089556|589699979|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
163270671|NCT01089556|589699980|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
163270672|NCT01089556|589699981|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
163270673|NCT01089556|589699982|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
163270674|NCT01089556|589699983|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
163270675|NCT01089556|589699984|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
163270676|NCT00594906|589699985|FG000|Overall Study|Physician Decision|1|||
163270677|NCT00594906|589699986|FG001|Overall Study|Physician Decision|0|||
163270678|NCT00594906|589699985|FG000|Overall Study|Physician Decision|0|||
163270679|NCT00594906|589699986|FG001|Overall Study|Physician Decision|1|||
163270680|NCT00594906|589699985|FG000|Overall Study|Death|0|||
163270681|NCT00594906|589699986|FG001|Overall Study|Death|1|||
163270682|NCT01027364|589699992|FG000|Overall Study|Adverse Event|1|||
163270683|NCT01027364|589699993|FG001|Overall Study|Adverse Event|0|||
163270684|NCT01027364|589699994|FG002|Overall Study|Adverse Event|1|||
163270685|NCT01027364|589699995|FG003|Overall Study|Adverse Event|0|||
163270686|NCT01027364|589699992|FG000|Overall Study|Lost to Follow-up|1|||
163270687|NCT01027364|589699993|FG001|Overall Study|Lost to Follow-up|0|||
163270688|NCT01027364|589699994|FG002|Overall Study|Lost to Follow-up|0|||
163270689|NCT01027364|589699995|FG003|Overall Study|Lost to Follow-up|0|||
163270690|NCT01027364|589699992|FG000|Overall Study|Protocol Violation|1|||
162928973|NCT00567996|588443800|FG001|Overall Study|Withdrawal by Subject|12|||
163270691|NCT01027364|589699993|FG001|Overall Study|Protocol Violation|0|||
163270692|NCT01027364|589699994|FG002|Overall Study|Protocol Violation|0|||
163270693|NCT01027364|589699995|FG003|Overall Study|Protocol Violation|1|||
163270694|NCT01027364|589699992|FG000|Overall Study|Withdrawal by Subject|1|||
163270695|NCT01027364|589699993|FG001|Overall Study|Withdrawal by Subject|2|||
163270696|NCT01027364|589699994|FG002|Overall Study|Withdrawal by Subject|0|||
162928974|NCT00567996|588443801|FG002|Overall Study|Withdrawal by Subject|22|||
162928975|NCT00567996|588443799|FG000|Overall Study|Abnormal Lab value(s)|2|||
162928976|NCT00567996|588443800|FG001|Overall Study|Abnormal Lab value(s)|1|||
162928977|NCT00567996|588443801|FG002|Overall Study|Abnormal Lab value(s)|2|||
162928978|NCT00567996|588443799|FG000|Overall Study|Abnormal test procedure result(s)|2|||
162928979|NCT00567996|588443800|FG001|Overall Study|Abnormal test procedure result(s)|1|||
162928980|NCT00567996|588443801|FG002|Overall Study|Abnormal test procedure result(s)|1|||
162928981|NCT00567996|588443799|FG000|Overall Study|Lost to Follow-up|2|||
162928982|NCT00567996|588443800|FG001|Overall Study|Lost to Follow-up|5|||
162928983|NCT00567996|588443801|FG002|Overall Study|Lost to Follow-up|2|||
162928984|NCT00567996|588443799|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162928985|NCT00567996|588443800|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162928986|NCT00567996|588443801|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
162928987|NCT00567996|588443799|FG000|Overall Study|Administrative problems|1|||
162928988|NCT00567996|588443800|FG001|Overall Study|Administrative problems|1|||
162928989|NCT00567996|588443801|FG002|Overall Study|Administrative problems|0|||
162928990|NCT00567996|588443799|FG000|Overall Study|Death|1|||
162928991|NCT00567996|588443800|FG001|Overall Study|Death|0|||
163270697|NCT01027364|589699995|FG003|Overall Study|Withdrawal by Subject|0|||
163270698|NCT01394250|589699996|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
163270699|NCT01394250|589699997|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
163270700|NCT01394250|589699996|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
163270701|NCT01394250|589699997|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
163270702|NCT02222896|589699998|FG000|Abdomen|Did not qualify|34|||
163270703|NCT02222896|589699999|FG001|Abdomen|Did not qualify|10|||
163270704|NCT02222896|589700000|FG002|Abdomen|Did not qualify|32|||
163270705|NCT02222896|589699998|FG000|Groin|Did not qualify|43|||
162928992|NCT00567996|588443801|FG002|Overall Study|Death|2|||
162928993|NCT00567996|588443799|FG000|Overall Study|Patient's inability to use the device|0|||
162928994|NCT00567996|588443800|FG001|Overall Study|Patient's inability to use the device|1|||
162928995|NCT00567996|588443801|FG002|Overall Study|Patient's inability to use the device|0|||
162928996|NCT02956005|588443803|FG000|Overall Study|Not eligible|1|||
162928997|NCT02956005|588443803|FG000|Overall Study|Withdrawal by Subject|3|||
163270706|NCT02222896|589699999|FG001|Groin|Did not qualify|9|||
163270707|NCT02222896|589700000|FG002|Groin|Did not qualify|40|||
163270708|NCT01865617|589700002|FG000|Overall Study|Death|27|||
163270709|NCT01865617|589700003|FG001|Overall Study|Death|3|||
163270710|NCT01865617|589700004|FG002|Overall Study|Death|1|||
163270711|NCT01865617|589700005|FG003|Overall Study|Death|1|||
163270712|NCT01865617|589700006|FG004|Overall Study|Death|5|||
163270713|NCT01865617|589700007|FG005|Overall Study|Death|1|||
163270714|NCT01865617|589700008|FG006|Overall Study|Death|11|||
163270715|NCT01865617|589700009|FG007|Overall Study|Death|1|||
163270716|NCT01865617|589700010|FG008|Overall Study|Death|11|||
163270717|NCT01865617|589700011|FG009|Overall Study|Death|3|||
163270718|NCT01865617|589700012|FG010|Overall Study|Death|32|||
163270719|NCT01865617|589700013|FG011|Overall Study|Death|6|||
163270720|NCT01865617|589700014|FG012|Overall Study|Death|13|||
163270721|NCT01865617|589700002|FG000|Overall Study|Lost to Follow-up|2|||
163270722|NCT01865617|589700003|FG001|Overall Study|Lost to Follow-up|0|||
162928998|NCT02956005|588443803|FG000|Overall Study|Physician Decision|12|||
163270723|NCT01865617|589700004|FG002|Overall Study|Lost to Follow-up|0|||
163270724|NCT01865617|589700005|FG003|Overall Study|Lost to Follow-up|0|||
163270725|NCT01865617|589700006|FG004|Overall Study|Lost to Follow-up|0|||
163270726|NCT01865617|589700007|FG005|Overall Study|Lost to Follow-up|0|||
163270727|NCT01865617|589700008|FG006|Overall Study|Lost to Follow-up|0|||
162928999|NCT03125629|588443804|FG000|Overall Study|Withdrawal by Subject|2|||
162929000|NCT03125629|588443804|FG000|Overall Study|Equipment malfunction|1|||
163270728|NCT01865617|589700009|FG007|Overall Study|Lost to Follow-up|0|||
162929001|NCT00743119|588443805|FG000|Overall Study|unreliable|3|||
163270729|NCT01865617|589700010|FG008|Overall Study|Lost to Follow-up|0|||
163270730|NCT01865617|589700011|FG009|Overall Study|Lost to Follow-up|0|||
163270731|NCT01865617|589700012|FG010|Overall Study|Lost to Follow-up|0|||
163270732|NCT01865617|589700013|FG011|Overall Study|Lost to Follow-up|0|||
163270733|NCT01865617|589700014|FG012|Overall Study|Lost to Follow-up|0|||
163270734|NCT01865617|589700002|FG000|Overall Study|Withdrawal by Subject|1|||
163270735|NCT01865617|589700003|FG001|Overall Study|Withdrawal by Subject|0|||
163270736|NCT01865617|589700004|FG002|Overall Study|Withdrawal by Subject|0|||
163270737|NCT01865617|589700005|FG003|Overall Study|Withdrawal by Subject|0|||
163270738|NCT01865617|589700006|FG004|Overall Study|Withdrawal by Subject|0|||
163270739|NCT01865617|589700007|FG005|Overall Study|Withdrawal by Subject|0|||
163270740|NCT01865617|589700008|FG006|Overall Study|Withdrawal by Subject|0|||
163270741|NCT01865617|589700009|FG007|Overall Study|Withdrawal by Subject|0|||
163270742|NCT01865617|589700010|FG008|Overall Study|Withdrawal by Subject|0|||
163270743|NCT01865617|589700011|FG009|Overall Study|Withdrawal by Subject|0|||
163270744|NCT01865617|589700012|FG010|Overall Study|Withdrawal by Subject|0|||
163270745|NCT01865617|589700013|FG011|Overall Study|Withdrawal by Subject|0|||
163270746|NCT01865617|589700014|FG012|Overall Study|Withdrawal by Subject|0|||
163270747|NCT01865617|589700002|FG000|Overall Study|Patient proceeded to new therapy|0|||
163270748|NCT01865617|589700003|FG001|Overall Study|Patient proceeded to new therapy|0|||
163270749|NCT01865617|589700004|FG002|Overall Study|Patient proceeded to new therapy|0|||
163270750|NCT01865617|589700005|FG003|Overall Study|Patient proceeded to new therapy|0|||
163270751|NCT01865617|589700006|FG004|Overall Study|Patient proceeded to new therapy|2|||
163270752|NCT01865617|589700007|FG005|Overall Study|Patient proceeded to new therapy|0|||
163270753|NCT01865617|589700008|FG006|Overall Study|Patient proceeded to new therapy|0|||
163270754|NCT01865617|589700009|FG007|Overall Study|Patient proceeded to new therapy|0|||
163270755|NCT01865617|589700010|FG008|Overall Study|Patient proceeded to new therapy|0|||
162929002|NCT00743119|588443805|FG000|Overall Study|Withdrawal by Subject|1|||
162929003|NCT02524665|588443806|FG000|Overall Study|Lost to Follow-up|1|||
162929004|NCT02989610|588443807|FG000|Overall Study|Withdrawal by Subject|20|||
162929005|NCT02989610|588443807|FG000|Overall Study|Departure of PI from Site|8|||
162929006|NCT02989610|588443807|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
162929007|NCT02989610|588443807|FG000|Overall Study|Lost to Follow-up|3|||
162929008|NCT02989610|588443807|FG000|Overall Study|Death|3|||
162929009|NCT02989610|588443807|FG000|Overall Study|System Explant|3|||
162929010|NCT02989610|588443807|FG000|Overall Study|Subject Non-Compliance|2|||
162929011|NCT02989610|588443807|FG000|Overall Study|System Revision|2|||
162929012|NCT02989610|588443807|FG000|Overall Study|PI Left, Study Closing|1|||
162929013|NCT02989610|588443807|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
162929014|NCT02989610|588443807|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
162929015|NCT02602080|588443810|FG000|Overall Study|Protocol Violation|6|||
162929016|NCT02602080|588443811|FG001|Overall Study|Protocol Violation|1|||
163270756|NCT01865617|589700011|FG009|Overall Study|Patient proceeded to new therapy|0|||
163270757|NCT01865617|589700012|FG010|Overall Study|Patient proceeded to new therapy|0|||
163270758|NCT01865617|589700013|FG011|Overall Study|Patient proceeded to new therapy|0|||
162929017|NCT02602080|588443812|FG002|Overall Study|Protocol Violation|3|||
162929018|NCT04508621|588443820|FG000|Overall Study|Adverse Event|39|||
162929019|NCT04508621|588443821|FG001|Overall Study|Adverse Event|16|||
162929020|NCT04508621|588443820|FG000|Overall Study|Lack of Efficacy|2|||
162929021|NCT04508621|588443821|FG001|Overall Study|Lack of Efficacy|8|||
162929022|NCT04508621|588443820|FG000|Overall Study|Physician Decision|0|||
162929023|NCT04508621|588443821|FG001|Overall Study|Physician Decision|1|||
162929024|NCT04508621|588443820|FG000|Overall Study|Withdrawal by Subject|10|||
162929025|NCT04508621|588443821|FG001|Overall Study|Withdrawal by Subject|14|||
162929026|NCT04508621|588443820|FG000|Overall Study|Lost to Follow-up|12|||
162929027|NCT04508621|588443821|FG001|Overall Study|Lost to Follow-up|9|||
162929028|NCT04508621|588443820|FG000|Overall Study|COVID-19 related crisis|3|||
162929029|NCT04508621|588443821|FG001|Overall Study|COVID-19 related crisis|0|||
162929030|NCT04508621|588443820|FG000|Overall Study|Subject non-compliance|1|||
162929031|NCT04508621|588443821|FG001|Overall Study|Subject non-compliance|0|||
162929032|NCT01066039|588443822|FG000|Overall Study|Adverse Event|6|||
162929033|NCT01066039|588443822|FG000|Overall Study|Withdrawal by Subject|17|||
162929034|NCT01066039|588443822|FG000|Overall Study|Protocol Violation|2|||
162929035|NCT01066039|588443822|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
162929036|NCT01066039|588443822|FG000|Overall Study|Investigator's Request|1|||
162929037|NCT01066039|588443822|FG000|Overall Study|Dropout due to Insulin Administration|1|||
162929038|NCT01066039|588443822|FG000|Overall Study|Additional Antihypertensive Required|4|||
163156584|NCT01352793|589287893|FG001|Overall Study|Other|7|||
163270759|NCT01865617|589700014|FG012|Overall Study|Patient proceeded to new therapy|0|||
163270760|NCT01865617|589700002|FG000|Overall Study|Other|0|||
163270761|NCT01865617|589700003|FG001|Overall Study|Other|0|||
163270762|NCT01865617|589700004|FG002|Overall Study|Other|0|||
162929039|NCT01066039|588443822|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
162929040|NCT01066039|588443822|FG000|Overall Study|Failure to Control Blood Pressure|1|||
162929041|NCT01066039|588443822|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
163270763|NCT01865617|589700005|FG003|Overall Study|Other|0|||
163270764|NCT01865617|589700006|FG004|Overall Study|Other|0|||
163270765|NCT01865617|589700007|FG005|Overall Study|Other|0|||
163270766|NCT01865617|589700008|FG006|Overall Study|Other|1|||
163270767|NCT01865617|589700009|FG007|Overall Study|Other|0|||
163270768|NCT01865617|589700010|FG008|Overall Study|Other|0|||
163270769|NCT01865617|589700011|FG009|Overall Study|Other|0|||
163270770|NCT01865617|589700012|FG010|Overall Study|Other|0|||
163270771|NCT01865617|589700013|FG011|Overall Study|Other|0|||
163270772|NCT01865617|589700014|FG012|Overall Study|Other|0|||
162929042|NCT02574260|588443823|FG000|Overall Study|Disease Progression|1|||
162929043|NCT00752895|588443824|FG000|Overall Study|Withdrawal by Subject|8|||
162929044|NCT00752895|588443825|FG001|Overall Study|Withdrawal by Subject|3|||
162929045|NCT03022799|588443826|FG000|Overall Study|Adverse Event|0|||
162929046|NCT03022799|588443827|FG001|Overall Study|Adverse Event|0|||
162929047|NCT03022799|588443828|FG002|Overall Study|Adverse Event|0|||
162929048|NCT03022799|588443829|FG003|Overall Study|Adverse Event|0|||
162929049|NCT03022799|588443830|FG004|Overall Study|Adverse Event|0|||
162929050|NCT03022799|588443831|FG005|Overall Study|Adverse Event|0|||
162929051|NCT03022799|588443832|FG006|Overall Study|Adverse Event|0|||
162929052|NCT03022799|588443833|FG007|Overall Study|Adverse Event|0|||
162929053|NCT03022799|588443834|FG008|Overall Study|Adverse Event|0|||
162929054|NCT03022799|588443835|FG009|Overall Study|Adverse Event|1|||
162929055|NCT03022799|588443836|FG010|Overall Study|Adverse Event|1|||
162929056|NCT03022799|588443837|FG011|Overall Study|Adverse Event|0|||
162929057|NCT03022799|588443838|FG012|Overall Study|Adverse Event|0|||
162929058|NCT04881448|588443839|FG000|Overall Study|Study cancelled by sponsor|220|||
163270773|NCT02500979|589700015|FG000|Period 1|Hyperglycemia|1|||
163270774|NCT02500979|589700016|FG001|Period 1|Hyperglycemia|0|||
163270775|NCT02500979|589700015|FG000|Period 1|Severe non-compliance to protocol|0|||
163270776|NCT02500979|589700016|FG001|Period 1|Severe non-compliance to protocol|1|||
163270777|NCT02500979|589700015|FG000|Period 1|Adverse Event|1|||
163270778|NCT02500979|589700016|FG001|Period 1|Adverse Event|0|||
163270779|NCT02500979|589700015|FG000|Period 1|Subject decision|2|||
163270780|NCT02500979|589700016|FG001|Period 1|Subject decision|0|||
163270781|NCT02500979|589700015|FG000|Period 2|Change in risk|1|||
163270782|NCT02500979|589700016|FG001|Period 2|Change in risk|0|||
163270783|NCT03772314|589700019|FG000|Overall Study|Adverse Event|7|||
163270784|NCT03772314|589700020|FG001|Overall Study|Adverse Event|2|||
163270785|NCT01613027|589700021|FG000|Overall Study|Lost to Follow-up|5|||
163270786|NCT01613027|589700021|FG000|Overall Study|Switched Physician|1|||
163270787|NCT01613027|589700021|FG000|Overall Study|Lack of Efficacy|1|||
163270788|NCT01613027|589700021|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
163270789|NCT04267614|589700024|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
163270790|NCT04267614|589700024|FG000|Overall Study|Lost to Follow-up|115|||
163270791|NCT00119262|589700028|FG000|Overall Study|Lack of Efficacy|0|||
163270792|NCT00119262|589700029|FG001|Overall Study|Lack of Efficacy|3|||
163270793|NCT00119262|589700028|FG000|Overall Study|Withdrawal by Subject|12|||
163270794|NCT00119262|589700029|FG001|Overall Study|Withdrawal by Subject|11|||
163270795|NCT00119262|589700028|FG000|Overall Study|Adverse Event|33|||
163270796|NCT00119262|589700029|FG001|Overall Study|Adverse Event|35|||
163270797|NCT00119262|589700028|FG000|Overall Study|other disease|0|||
163270798|NCT00119262|589700029|FG001|Overall Study|other disease|2|||
163270799|NCT00119262|589700028|FG000|Overall Study|ineligble|1|||
162929059|NCT04881448|588443839|FG000|Overall Study|Withdrawal by Subject|2|||
162929060|NCT04881448|588443839|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
162929061|NCT01966107|588443841|FG000|Overall Study|excluded from FAS|21|||
162929062|NCT01966107|588443842|FG001|Overall Study|excluded from FAS|20|||
162929063|NCT01966107|588443841|FG000|Overall Study|discontinued treatment|345|||
162929064|NCT01966107|588443842|FG001|Overall Study|discontinued treatment|372|||
162929065|NCT01966107|588443841|FG000|Overall Study|due to study closure|164|||
162929066|NCT01966107|588443842|FG001|Overall Study|due to study closure|186|||
162929067|NCT01966107|588443841|FG000|Overall Study|withdrew from the study|272|||
162929068|NCT01966107|588443842|FG001|Overall Study|withdrew from the study|303|||
162929069|NCT02200614|588443843|FG000|Double Blind Treatment|Adverse Event|86|||
162929070|NCT02200614|588443844|FG001|Double Blind Treatment|Adverse Event|48|||
162929071|NCT02200614|588443843|FG000|Double Blind Treatment|Confirmed metastasis|120|||
163270800|NCT00119262|589700029|FG001|Overall Study|ineligble|2|||
163270801|NCT00119262|589700028|FG000|Overall Study|others|0|||
163270802|NCT00119262|589700029|FG001|Overall Study|others|5|||
163270803|NCT03853317|589700030|FG000|Overall Study|Progressive Disease|5|||
163270804|NCT03853317|589700030|FG000|Overall Study|Adverse Event|1|||
163270805|NCT03853317|589700030|FG000|Overall Study|Death|1|||
163270806|NCT03853317|589700030|FG000|Overall Study|other event|2|||
163270807|NCT02141659|589700033|FG000|Overall Study|Major Protocol Deviation|0|||
163270808|NCT02141659|589700034|FG001|Overall Study|Major Protocol Deviation|1|||
163270809|NCT02141659|589700035|FG002|Overall Study|Major Protocol Deviation|0|||
163270810|NCT02141659|589700036|FG003|Overall Study|Major Protocol Deviation|0|||
163270811|NCT02141659|589700037|FG004|Overall Study|Major Protocol Deviation|0|||
163270812|NCT02141659|589700038|FG005|Overall Study|Major Protocol Deviation|0|||
163270813|NCT02141659|589700033|FG000|Overall Study|Lack of Efficacy|0|||
163270814|NCT02141659|589700034|FG001|Overall Study|Lack of Efficacy|0|||
163270815|NCT02141659|589700035|FG002|Overall Study|Lack of Efficacy|0|||
163270816|NCT02141659|589700036|FG003|Overall Study|Lack of Efficacy|0|||
163270817|NCT02141659|589700037|FG004|Overall Study|Lack of Efficacy|0|||
163270818|NCT02141659|589700038|FG005|Overall Study|Lack of Efficacy|1|||
163270819|NCT02141659|589700033|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
163270820|NCT02141659|589700034|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
163270821|NCT02141659|589700035|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
163270822|NCT02141659|589700036|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
163270823|NCT02141659|589700037|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
163270824|NCT02141659|589700038|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
163270825|NCT01927731|589700039|FG000|Overall Study|Graft Failure|1|||
163270826|NCT01927731|589700040|FG001|Overall Study|Graft Failure|2|||
163270827|NCT01927731|589700039|FG000|Overall Study|Physician Decision|2|||
163270828|NCT01927731|589700040|FG001|Overall Study|Physician Decision|3|||
163270829|NCT01927731|589700039|FG000|Overall Study|Withdrawal by Subject|0|||
163270830|NCT01927731|589700040|FG001|Overall Study|Withdrawal by Subject|2|||
163270831|NCT01927731|589700039|FG000|Overall Study|Death|0|||
163270832|NCT01927731|589700040|FG001|Overall Study|Death|3|||
163270833|NCT00305864|589700043|FG000|Overall Study|Ineligible / No protocol treatment|0|||
163270834|NCT00305864|589700044|FG001|Overall Study|Ineligible / No protocol treatment|1|||
163270835|NCT00305864|589700045|FG002|Overall Study|Ineligible / No protocol treatment|1|||
163270836|NCT00305864|589700046|FG003|Overall Study|Ineligible / No protocol treatment|13|||
163270837|NCT03881059|589700047|FG000|Treatment Period - Part A|Adverse Event|1|||
163270838|NCT03881059|589700048|FG001|Treatment Period - Part A|Adverse Event|3|||
163270839|NCT03881059|589700049|FG002|Treatment Period - Part A|Adverse Event|4|||
163270840|NCT03881059|589700047|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
163270841|NCT03881059|589700048|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
163270842|NCT03881059|589700049|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
163270843|NCT03881059|589700047|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
163270844|NCT03881059|589700048|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
163270845|NCT03881059|589700049|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
163270846|NCT03881059|589700047|FG000|Treatment Period - Part A|Other reasons|2|||
163270847|NCT03881059|589700048|FG001|Treatment Period - Part A|Other reasons|1|||
163270848|NCT03881059|589700049|FG002|Treatment Period - Part A|Other reasons|0|||
163270849|NCT03881059|589700047|FG000|Treatment Period - Part B|Adverse Event|0|||
163270850|NCT03881059|589700048|FG001|Treatment Period - Part B|Adverse Event|0|||
163270851|NCT03881059|589700049|FG002|Treatment Period - Part B|Adverse Event|3|||
163270852|NCT03881059|589700047|FG000|Treatment Period - Part B|Death|0|||
163270853|NCT03881059|589700048|FG001|Treatment Period - Part B|Death|1|||
163270854|NCT03881059|589700049|FG002|Treatment Period - Part B|Death|1|||
163270855|NCT03881059|589700047|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
163270856|NCT03881059|589700048|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
163270857|NCT03881059|589700049|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
163270858|NCT03881059|589700047|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
163270859|NCT03881059|589700048|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
163270860|NCT03881059|589700049|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
163270861|NCT03881059|589700047|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
163270862|NCT03881059|589700048|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
163270863|NCT03881059|589700049|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
163270864|NCT03881059|589700047|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
163270865|NCT03881059|589700048|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
163270866|NCT03881059|589700049|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
163270867|NCT03881059|589700047|FG000|Treatment Period - Part B|Other reasons|4|||
163270868|NCT03881059|589700048|FG001|Treatment Period - Part B|Other reasons|3|||
163270869|NCT03881059|589700049|FG002|Treatment Period - Part B|Other reasons|3|||
163270870|NCT02743793|589700050|FG000|Overall Study|Death|1|||
163270871|NCT02743793|589700051|FG001|Overall Study|Death|1|||
163270872|NCT02743793|589700050|FG000|Overall Study|Withdrawal by Subject|0|||
163270873|NCT02743793|589700051|FG001|Overall Study|Withdrawal by Subject|1|||
163270874|NCT02743793|589700050|FG000|Overall Study|Screen Failure|4|||
163270875|NCT02743793|589700051|FG001|Overall Study|Screen Failure|0|||
163270876|NCT02743793|589700050|FG000|Overall Study|No Primary Care Physician|0|||
163270877|NCT02743793|589700051|FG001|Overall Study|No Primary Care Physician|1|||
163270878|NCT02743793|589700050|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
163270879|NCT02743793|589700051|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
163270880|NCT02743793|589700050|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
163270881|NCT02743793|589700051|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
163270882|NCT02065570|589700052|FG000|Induction Study|Adverse Event|5|||
163270883|NCT02065570|589700053|FG001|Induction Study|Adverse Event|12|||
163270884|NCT02065570|589700054|FG002|Induction Study|Adverse Event|0|||
163270885|NCT02065570|589700055|FG003|Induction Study|Adverse Event|0|||
163270886|NCT02065570|589700052|FG000|Induction Study|Withdrawal by Subject|2|||
163270887|NCT02065570|589700053|FG001|Induction Study|Withdrawal by Subject|3|||
163270888|NCT02065570|589700054|FG002|Induction Study|Withdrawal by Subject|0|||
163270889|NCT02065570|589700055|FG003|Induction Study|Withdrawal by Subject|0|||
163041174|NCT04811664|588858088|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
163041175|NCT04811664|588858086|FG000|Overall Study|Protocol Violation|0|||
163041176|NCT04811664|588858087|FG001|Overall Study|Protocol Violation|5|||
163041177|NCT04811664|588858088|FG002|Overall Study|Protocol Violation|11|||
163041178|NCT04811664|588858086|FG000|Overall Study|Study Terminated by Sponsor|4|||
163041179|NCT04811664|588858087|FG001|Overall Study|Study Terminated by Sponsor|3|||
163041180|NCT04811664|588858088|FG002|Overall Study|Study Terminated by Sponsor|34|||
163041181|NCT04811664|588858086|FG000|Overall Study|Early Study Closure|3|||
163041182|NCT04811664|588858087|FG001|Overall Study|Early Study Closure|7|||
163041183|NCT04811664|588858088|FG002|Overall Study|Early Study Closure|79|||
163041184|NCT04811664|588858086|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
163041185|NCT04811664|588858087|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
163041186|NCT04811664|588858088|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
163041187|NCT02717442|588858089|FG000|Overall Study|Study Terminated by Sponsor|31|||
163270890|NCT02065570|589700052|FG000|Induction Study|Lost to Follow-up|1|||
163270891|NCT02065570|589700053|FG001|Induction Study|Lost to Follow-up|1|||
162929072|NCT02200614|588443844|FG001|Double Blind Treatment|Confirmed metastasis|140|||
162929073|NCT02200614|588443843|FG000|Double Blind Treatment|Judgment of the investigator|59|||
162929074|NCT02200614|588443844|FG001|Double Blind Treatment|Judgment of the investigator|99|||
162929075|NCT02200614|588443843|FG000|Double Blind Treatment|Metastasis by local reading|1|||
162929076|NCT02200614|588443844|FG001|Double Blind Treatment|Metastasis by local reading|3|||
162929077|NCT02200614|588443843|FG000|Double Blind Treatment|Other reason|6|||
162929078|NCT02200614|588443844|FG001|Double Blind Treatment|Other reason|2|||
162929079|NCT02200614|588443843|FG000|Double Blind Treatment|Personal reason|77|||
162929080|NCT02200614|588443844|FG001|Double Blind Treatment|Personal reason|85|||
162929081|NCT02200614|588443843|FG000|Double Blind Treatment|Protocol deviation|14|||
162929082|NCT02200614|588443844|FG001|Double Blind Treatment|Protocol deviation|7|||
162929083|NCT02200614|588443843|FG000|Double Blind Treatment|Not treated|1|||
162929084|NCT02200614|588443844|FG001|Double Blind Treatment|Not treated|0|||
162929085|NCT02200614|588443843|FG000|Open Label|Adverse Event|41|||
162929086|NCT02200614|588443844|FG001|Open Label|Adverse Event|11|||
162929087|NCT02200614|588443843|FG000|Open Label|Confirmed metastasis|1|||
162929088|NCT02200614|588443844|FG001|Open Label|Confirmed metastasis|0|||
162929089|NCT02200614|588443843|FG000|Open Label|Judgment of the investigator|29|||
162929090|NCT02200614|588443844|FG001|Open Label|Judgment of the investigator|2|||
162929091|NCT02200614|588443843|FG000|Open Label|Metastasis by local reading|138|||
162929092|NCT02200614|588443844|FG001|Open Label|Metastasis by local reading|27|||
162929093|NCT02200614|588443843|FG000|Open Label|Other reason|22|||
162929094|NCT02200614|588443844|FG001|Open Label|Other reason|4|||
162929095|NCT02200614|588443843|FG000|Open Label|Personal reason|60|||
162929096|NCT02200614|588443844|FG001|Open Label|Personal reason|8|||
162929097|NCT02200614|588443843|FG000|Open Label|Protocol deviation|3|||
162929098|NCT02200614|588443844|FG001|Open Label|Protocol deviation|2|||
162929099|NCT02200614|588443843|FG000|Open Label|Missing|2|||
162929100|NCT02200614|588443844|FG001|Open Label|Missing|2|||
162929101|NCT01898884|588443845|FG000|Multiple Dose Period|Adverse Event|0|||
162929102|NCT01898884|588443846|FG001|Multiple Dose Period|Adverse Event|0|||
162929103|NCT01898884|588443847|FG002|Multiple Dose Period|Adverse Event|0|||
162929104|NCT01898884|588443848|FG003|Multiple Dose Period|Adverse Event|0|||
162929105|NCT01898884|588443849|FG004|Multiple Dose Period|Adverse Event|0|||
162929106|NCT01898884|588443850|FG005|Multiple Dose Period|Adverse Event|0|||
162929107|NCT01898884|588443851|FG006|Multiple Dose Period|Adverse Event|1|||
162929108|NCT01898884|588443852|FG007|Multiple Dose Period|Adverse Event|0|||
162929109|NCT01898884|588443853|FG008|Multiple Dose Period|Adverse Event|0|||
162929110|NCT01898884|588443845|FG000|Multiple Dose Period|Randomized Not Treated|0|||
162929111|NCT01898884|588443846|FG001|Multiple Dose Period|Randomized Not Treated|0|||
162929112|NCT01898884|588443847|FG002|Multiple Dose Period|Randomized Not Treated|0|||
162929113|NCT01898884|588443848|FG003|Multiple Dose Period|Randomized Not Treated|0|||
162929114|NCT01898884|588443849|FG004|Multiple Dose Period|Randomized Not Treated|0|||
162929115|NCT01898884|588443850|FG005|Multiple Dose Period|Randomized Not Treated|0|||
162929116|NCT01898884|588443851|FG006|Multiple Dose Period|Randomized Not Treated|0|||
162929117|NCT01898884|588443852|FG007|Multiple Dose Period|Randomized Not Treated|0|||
162929118|NCT01898884|588443853|FG008|Multiple Dose Period|Randomized Not Treated|1|||
162929119|NCT00434148|588443854|FG000|Overall Study|Adverse Event|18|||
162929120|NCT00434148|588443855|FG001|Overall Study|Adverse Event|18|||
162929121|NCT00434148|588443854|FG000|Overall Study|Lack of Efficacy|25|||
163041188|NCT02717442|588858090|FG001|Overall Study|Study Terminated by Sponsor|29|||
163270892|NCT02065570|589700054|FG002|Induction Study|Lost to Follow-up|0|||
162929122|NCT00434148|588443855|FG001|Overall Study|Lack of Efficacy|28|||
162929123|NCT00434148|588443854|FG000|Overall Study|Withdrawal by Subject|15|||
162929124|NCT00434148|588443855|FG001|Overall Study|Withdrawal by Subject|15|||
162929125|NCT00434148|588443854|FG000|Overall Study|Protocol Violation|4|||
162929126|NCT00434148|588443855|FG001|Overall Study|Protocol Violation|0|||
162929127|NCT00434148|588443854|FG000|Overall Study|Administrative problems|6|||
162929128|NCT00434148|588443855|FG001|Overall Study|Administrative problems|10|||
162929129|NCT00434148|588443854|FG000|Overall Study|Lost to Follow-up|0|||
162929130|NCT00434148|588443855|FG001|Overall Study|Lost to Follow-up|1|||
162929131|NCT00434148|588443854|FG000|Overall Study|Condition no longer requires study drug|1|||
162929132|NCT00434148|588443855|FG001|Overall Study|Condition no longer requires study drug|0|||
162929133|NCT00434148|588443854|FG000|Overall Study|Abnormal test procedure result|0|||
162929134|NCT00434148|588443855|FG001|Overall Study|Abnormal test procedure result|1|||
162929135|NCT00759759|588443856|FG000|Overall Study|didn't return for period 2|1|||
162929136|NCT00759759|588443857|FG001|Overall Study|didn't return for period 2|0|||
162929137|NCT00759759|588443856|FG000|Overall Study|Didn't receive drug in period 2|1|||
162929138|NCT00759759|588443857|FG001|Overall Study|Didn't receive drug in period 2|0|||
162929139|NCT00759759|588443856|FG000|Overall Study|Withdrawal by Subject|2|||
162929140|NCT00759759|588443857|FG001|Overall Study|Withdrawal by Subject|1|||
162929141|NCT01556165|588443861|FG000|Overall Study|Adverse Event|5|||
162929142|NCT01556165|588443862|FG001|Overall Study|Adverse Event|3|||
162929143|NCT01556165|588443861|FG000|Overall Study|Protocol Violation|0|||
162929144|NCT01556165|588443862|FG001|Overall Study|Protocol Violation|3|||
162929145|NCT01556165|588443861|FG000|Overall Study|Withdrawal of Consent|7|||
162929146|NCT01556165|588443862|FG001|Overall Study|Withdrawal of Consent|1|||
162929147|NCT02531698|588443865|FG000|Overall Study|Adverse Event|2|||
162929148|NCT02531698|588443866|FG001|Overall Study|Adverse Event|1|||
162929149|NCT02531698|588443865|FG000|Overall Study|Withdrawal by Subject|6|||
162929150|NCT02531698|588443866|FG001|Overall Study|Withdrawal by Subject|1|||
162929151|NCT02531698|588443865|FG000|Overall Study|Protocol Violation|2|||
162929152|NCT02531698|588443866|FG001|Overall Study|Protocol Violation|0|||
162929153|NCT02531698|588443865|FG000|Overall Study|Lost to Follow-up|1|||
162929154|NCT02531698|588443866|FG001|Overall Study|Lost to Follow-up|0|||
162929155|NCT01861717|588443867|FG000|Overall Study|Lost to Follow-up|1|||
162929156|NCT01861717|588443867|FG000|Overall Study|Withdrawal by Subject|1|||
162929157|NCT02395536|588443873|FG000|Overall Study|Lost to Follow-up|4|||
162929158|NCT02395536|588443874|FG001|Overall Study|Lost to Follow-up|4|||
162929159|NCT02395536|588443873|FG000|Overall Study|Death|2|||
162929160|NCT02395536|588443874|FG001|Overall Study|Death|0|||
162929161|NCT02395536|588443873|FG000|Overall Study|Physician Decision|4|||
162929162|NCT02395536|588443874|FG001|Overall Study|Physician Decision|6|||
162929163|NCT02395536|588443873|FG000|Overall Study|Withdrawal by Subject|9|||
162929164|NCT02395536|588443874|FG001|Overall Study|Withdrawal by Subject|17|||
162929165|NCT02395536|588443873|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
162929166|NCT02395536|588443874|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
162929167|NCT02395536|588443873|FG000|Overall Study|Insurance issue|0|||
162929168|NCT02395536|588443874|FG001|Overall Study|Insurance issue|1|||
162929169|NCT00701558|588443875|FG000|Overall Study|Death|7|||
162929170|NCT00701558|588443875|FG000|Overall Study|Lost to Follow-up|8|||
162929171|NCT01640964|588443878|FG000|Overall Study|Lost to Follow-up|0|||
162929172|NCT01640964|588443879|FG001|Overall Study|Lost to Follow-up|0|||
162929173|NCT01640964|588443880|FG002|Overall Study|Lost to Follow-up|1|||
162929174|NCT01640964|588443878|FG000|Overall Study|Protocol Deviation|1|||
162929175|NCT01640964|588443879|FG001|Overall Study|Protocol Deviation|1|||
162929176|NCT01640964|588443880|FG002|Overall Study|Protocol Deviation|2|||
162929177|NCT01416142|588445689|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
162929178|NCT01416142|588445690|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
162929179|NCT01416142|588445691|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
162929180|NCT02464059|588445692|FG000|Overall Study|Lost to Follow-up|6|||
162929181|NCT02499406|588445695|FG000|Overall Study|missed 3 treatment sessions|4|||
162929182|NCT03591107|588445699|FG000|Overall Study|Same patient in both arms|1|||
162929183|NCT03591107|588445700|FG001|Overall Study|Same patient in both arms|1|||
162929184|NCT03591107|588445699|FG000|Overall Study|Sought care at other clinics|0|||
162929185|NCT03591107|588445700|FG001|Overall Study|Sought care at other clinics|2|||
162929186|NCT03591107|588445699|FG000|Overall Study|Discharged from clinic|0|||
162929187|NCT03591107|588445700|FG001|Overall Study|Discharged from clinic|1|||
162929188|NCT03591107|588445699|FG000|Overall Study|Withdrawal by Subject|0|||
162929189|NCT03591107|588445700|FG001|Overall Study|Withdrawal by Subject|1|||
162929190|NCT00304954|588445701|FG000|Overall Study|Withdrawal by Subject|0|||
162929191|NCT00304954|588445702|FG001|Overall Study|Withdrawal by Subject|0|||
162929192|NCT00304954|588445703|FG002|Overall Study|Withdrawal by Subject|1|||
162929193|NCT00304954|588445704|FG003|Overall Study|Withdrawal by Subject|0|||
162929194|NCT00304954|588445701|FG000|Overall Study|Adverse Event|1|||
162929195|NCT00304954|588445702|FG001|Overall Study|Adverse Event|0|||
162929196|NCT00304954|588445703|FG002|Overall Study|Adverse Event|0|||
162929197|NCT00304954|588445704|FG003|Overall Study|Adverse Event|0|||
162929198|NCT00350519|588445705|FG000|Overall Study|Death|0|||
162929199|NCT00350519|588445706|FG001|Overall Study|Death|1|||
162929200|NCT00350519|588445705|FG000|Overall Study|Physician Decision|0|||
162929201|NCT00350519|588445706|FG001|Overall Study|Physician Decision|1|||
162929202|NCT00350519|588445705|FG000|Overall Study|Protocol Violation|1|||
162929203|NCT00350519|588445706|FG001|Overall Study|Protocol Violation|2|||
162929204|NCT00350519|588445705|FG000|Overall Study|Withdrawal by Subject|3|||
162929205|NCT00350519|588445706|FG001|Overall Study|Withdrawal by Subject|2|||
162929206|NCT00736099|588445708|FG000|Overall Study|Adverse Event|61|||
162929207|NCT00736099|588445709|FG001|Overall Study|Adverse Event|18|||
162929208|NCT00736099|588445708|FG000|Overall Study|Protocol Violation|10|||
162929209|NCT00736099|588445709|FG001|Overall Study|Protocol Violation|4|||
162929210|NCT00736099|588445708|FG000|Overall Study|Lost to Follow-up|12|||
162929211|NCT00736099|588445709|FG001|Overall Study|Lost to Follow-up|5|||
162929212|NCT00736099|588445708|FG000|Overall Study|Withdrawal by Subject|42|||
162929213|NCT00736099|588445709|FG001|Overall Study|Withdrawal by Subject|13|||
162929214|NCT00736099|588445708|FG000|Overall Study|Lack of Efficacy|15|||
162929215|NCT00736099|588445709|FG001|Overall Study|Lack of Efficacy|8|||
162929216|NCT00736099|588445708|FG000|Overall Study|Other reason|43|||
162929217|NCT00736099|588445709|FG001|Overall Study|Other reason|10|||
162929218|NCT00948025|588445710|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
162929219|NCT00948025|588445711|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
162929220|NCT00948025|588445710|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
162929221|NCT00948025|588445711|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
162929222|NCT00948025|588445710|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
162929223|NCT00948025|588445711|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
162929224|NCT04006847|588445714|FG000|Overall Study|Product issue|1|||
162929225|NCT03555890|588445722|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162929226|NCT03555890|588445723|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162929227|NCT03555890|588445724|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162929228|NCT03555890|588445725|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
162929229|NCT03372369|588445726|FG000|Qualification Period|Withdrawal by Subject|16|||
162929230|NCT03372369|588445727|FG001|Qualification Period|Withdrawal by Subject|13|||
162929231|NCT03372369|588445726|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
162929232|NCT03372369|588445727|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
162929233|NCT03372369|588445726|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
162929234|NCT03372369|588445727|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
162929235|NCT01383954|588445728|FG000|Overall Study|Lack of Efficacy|2|||
162929236|NCT01383954|588445728|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
162929237|NCT01383954|588445728|FG000|Overall Study|Adverse Event|1|||
162929238|NCT01383954|588445728|FG000|Overall Study|Reason Not Specified|9|||
162929239|NCT01791127|588445729|FG000|Overall Study|Death|356|||
162929240|NCT01791127|588445729|FG000|Overall Study|Patient has withdrawn from study|293|||
162929241|NCT01791127|588445729|FG000|Overall Study|Lost to Follow-up|42|||
162929242|NCT01791127|588445729|FG000|Overall Study|All Siello leads are explanted|31|||
162929243|NCT01791127|588445729|FG000|Overall Study|Completion of 30 day safety registry|1|||
162929244|NCT01791127|588445729|FG000|Overall Study|Study terminated for EP Passion|749|||
162929245|NCT04023994|588445738|FG000|Overall Study|Lost to Follow-up|0|||
162929246|NCT04023994|588445739|FG001|Overall Study|Lost to Follow-up|1|||
162929247|NCT04023994|588445740|FG002|Overall Study|Lost to Follow-up|2|||
162929248|NCT04023994|588445741|FG003|Overall Study|Lost to Follow-up|0|||
162929249|NCT04023994|588445742|FG004|Overall Study|Lost to Follow-up|0|||
162929250|NCT04023994|588445743|FG005|Overall Study|Lost to Follow-up|0|||
162929251|NCT04023994|588445738|FG000|Overall Study|Withdrawal by Subject|0|||
162929252|NCT04023994|588445739|FG001|Overall Study|Withdrawal by Subject|0|||
162929253|NCT04023994|588445740|FG002|Overall Study|Withdrawal by Subject|0|||
162929254|NCT04023994|588445741|FG003|Overall Study|Withdrawal by Subject|1|||
162929255|NCT04023994|588445742|FG004|Overall Study|Withdrawal by Subject|0|||
162929256|NCT04023994|588445743|FG005|Overall Study|Withdrawal by Subject|0|||
162929257|NCT00707174|588445744|FG000|Overall Study|Adverse Event|1|||
162929258|NCT00707174|588445745|FG001|Overall Study|Adverse Event|6|||
162929259|NCT00707174|588445744|FG000|Overall Study|Withdrawal by Subject|4|||
162929260|NCT00707174|588445745|FG001|Overall Study|Withdrawal by Subject|1|||
162929261|NCT01017029|588445746|FG000|Overall Study|Lost to Follow-up|1|||
162929262|NCT01017029|588445747|FG001|Overall Study|Lost to Follow-up|0|||
162929263|NCT01017029|588445746|FG000|Overall Study|Administrative problem|0|||
162929264|NCT01017029|588445747|FG001|Overall Study|Administrative problem|1|||
162929265|NCT01017029|588445746|FG000|Overall Study|Death|3|||
162929266|NCT01017029|588445747|FG001|Overall Study|Death|1|||
162929267|NCT00422058|588445748|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
162929268|NCT00422058|588445749|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
162929269|NCT00422058|588445750|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
162929270|NCT00422058|588445751|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
162929271|NCT00422058|588445752|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
162929272|NCT00422058|588445753|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
162929273|NCT00422058|588445748|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
163156585|NCT01352793|589287892|FG000|Overall Study|Medication error|2|||
163041189|NCT02717442|588858089|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
163041190|NCT02717442|588858090|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
163041191|NCT02717442|588858089|FG000|Overall Study|Other - Not Specified|2|||
163270893|NCT02065570|589700055|FG003|Induction Study|Lost to Follow-up|0|||
162929274|NCT00422058|588445749|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
162929275|NCT00422058|588445750|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
162929276|NCT00422058|588445751|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
162929277|NCT00422058|588445752|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
162929278|NCT00422058|588445753|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
162929279|NCT00422058|588445748|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
162929280|NCT00422058|588445749|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
162929281|NCT00422058|588445750|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
162929282|NCT00422058|588445751|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
162929283|NCT00422058|588445752|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
162929284|NCT00422058|588445753|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
162929285|NCT00422058|588445748|FG000|Double-Blind, Week 0-20|Other|11|||
162929286|NCT00422058|588445749|FG001|Double-Blind, Week 0-20|Other|3|||
162929287|NCT00422058|588445750|FG002|Double-Blind, Week 0-20|Other|8|||
162929288|NCT00422058|588445751|FG003|Double-Blind, Week 0-20|Other|8|||
162929289|NCT00422058|588445752|FG004|Double-Blind, Week 0-20|Other|4|||
162929290|NCT00422058|588445753|FG005|Double-Blind, Week 0-20|Other|10|||
162929291|NCT00422058|588445748|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
162929292|NCT00422058|588445749|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
162929293|NCT00422058|588445750|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
162929294|NCT00422058|588445751|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
162929295|NCT00422058|588445752|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
162929296|NCT00422058|588445753|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
162929297|NCT00422058|588445748|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
162929298|NCT00422058|588445749|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
162929299|NCT00422058|588445750|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
162929300|NCT00422058|588445751|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
162929301|NCT00422058|588445752|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
162929302|NCT00422058|588445753|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
162929303|NCT00422058|588445748|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
162929304|NCT00422058|588445749|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
162929305|NCT00422058|588445750|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
162929306|NCT00422058|588445751|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
162929307|NCT00422058|588445752|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
162929308|NCT00422058|588445753|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
162929309|NCT00422058|588445748|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
162929310|NCT00422058|588445749|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
162929311|NCT00422058|588445750|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
162929312|NCT00422058|588445751|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
162929313|NCT00422058|588445752|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
162929314|NCT00422058|588445753|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
162929315|NCT00422058|588445748|FG000|Open-Label Extension, Week 20-104|Other|13|||
162929316|NCT00422058|588445749|FG001|Open-Label Extension, Week 20-104|Other|14|||
162929317|NCT00422058|588445750|FG002|Open-Label Extension, Week 20-104|Other|6|||
162929318|NCT00422058|588445751|FG003|Open-Label Extension, Week 20-104|Other|13|||
162929319|NCT00422058|588445752|FG004|Open-Label Extension, Week 20-104|Other|16|||
162929320|NCT00422058|588445753|FG005|Open-Label Extension, Week 20-104|Other|18|||
162929321|NCT00572156|588445754|FG000|Overall Study|Adverse Event|3|||
162929322|NCT00572156|588445755|FG001|Overall Study|Adverse Event|1|||
162929323|NCT00572156|588445756|FG002|Overall Study|Adverse Event|5|||
162929324|NCT00572156|588445757|FG003|Overall Study|Adverse Event|1|||
162929325|NCT00572156|588445754|FG000|Overall Study|Lost to Follow-up|1|||
162929326|NCT00572156|588445755|FG001|Overall Study|Lost to Follow-up|1|||
162929327|NCT00572156|588445756|FG002|Overall Study|Lost to Follow-up|1|||
162929328|NCT00572156|588445757|FG003|Overall Study|Lost to Follow-up|0|||
162929329|NCT00572156|588445754|FG000|Overall Study|Protocol Violation|1|||
162929330|NCT00572156|588445755|FG001|Overall Study|Protocol Violation|2|||
162929331|NCT00572156|588445756|FG002|Overall Study|Protocol Violation|0|||
162929332|NCT00572156|588445757|FG003|Overall Study|Protocol Violation|2|||
162929333|NCT00572156|588445754|FG000|Overall Study|Patient/Parent Decision|1|||
162929334|NCT00572156|588445755|FG001|Overall Study|Patient/Parent Decision|6|||
162929335|NCT00572156|588445756|FG002|Overall Study|Patient/Parent Decision|4|||
162929336|NCT00572156|588445757|FG003|Overall Study|Patient/Parent Decision|3|||
162929337|NCT00572156|588445754|FG000|Overall Study|Sponsor Decision|20|||
162929338|NCT00572156|588445755|FG001|Overall Study|Sponsor Decision|16|||
162929339|NCT00572156|588445756|FG002|Overall Study|Sponsor Decision|17|||
163270894|NCT02065570|589700052|FG000|Induction Study|Other, Not Specified|6|||
163270895|NCT02065570|589700053|FG001|Induction Study|Other, Not Specified|5|||
162929340|NCT00572156|588445757|FG003|Overall Study|Sponsor Decision|19|||
162929341|NCT03216954|588445760|FG000|Overall Study|Adverse Event|0|||
162929342|NCT03216954|588445761|FG001|Overall Study|Adverse Event|0|||
162929343|NCT03216954|588445762|FG002|Overall Study|Adverse Event|1|||
162929344|NCT03216954|588445763|FG003|Overall Study|Adverse Event|0|||
162929345|NCT03216954|588445764|FG004|Overall Study|Adverse Event|1|||
162929346|NCT03216954|588445760|FG000|Overall Study|Withdrawal by Subject|2|||
162929347|NCT03216954|588445761|FG001|Overall Study|Withdrawal by Subject|0|||
162929348|NCT03216954|588445762|FG002|Overall Study|Withdrawal by Subject|0|||
162929349|NCT03216954|588445763|FG003|Overall Study|Withdrawal by Subject|0|||
162929350|NCT03216954|588445764|FG004|Overall Study|Withdrawal by Subject|0|||
162929351|NCT03216954|588445760|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
162929352|NCT03216954|588445761|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
162929353|NCT03216954|588445762|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
162929354|NCT03216954|588445763|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
162929355|NCT03216954|588445764|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
162929356|NCT04333199|588445767|FG000|Evaluated Patients|Lost to Follow-up|0|||
162929357|NCT04333199|588445768|FG001|Evaluated Patients|Lost to Follow-up|1|||
162929358|NCT04333199|588445769|FG002|Evaluated Patients|Lost to Follow-up|2|||
162929359|NCT01333475|588445771|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
162929360|NCT01333475|588445772|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
162929361|NCT01333475|588445771|FG000|Overall Study|Toxicity|1|||
162929362|NCT01333475|588445772|FG001|Overall Study|Toxicity|3|||
162929363|NCT02981602|588445773|FG000|Overall Study|Adverse Event|0|||
162929364|NCT02981602|588445774|FG001|Overall Study|Adverse Event|0|||
163270896|NCT02065570|589700054|FG002|Induction Study|Other, Not Specified|0|||
163270897|NCT02065570|589700055|FG003|Induction Study|Other, Not Specified|0|||
163270898|NCT02065570|589700052|FG000|Maintenance Study|Adverse Event|0|||
163270899|NCT02065570|589700053|FG001|Maintenance Study|Adverse Event|0|||
163270900|NCT02065570|589700054|FG002|Maintenance Study|Adverse Event|8|||
163270901|NCT02065570|589700055|FG003|Maintenance Study|Adverse Event|8|||
163270902|NCT02065570|589700052|FG000|Maintenance Study|Withdrawal by Subject|0|||
163270903|NCT02065570|589700053|FG001|Maintenance Study|Withdrawal by Subject|0|||
162929365|NCT02981602|588445775|FG002|Overall Study|Adverse Event|0|||
162929366|NCT02981602|588445776|FG003|Overall Study|Adverse Event|1|||
162929367|NCT02981602|588445777|FG004|Overall Study|Adverse Event|0|||
162929368|NCT00666718|588445778|FG000|Overall Study|Adverse Event|0|||
162929369|NCT00666718|588445779|FG001|Overall Study|Adverse Event|1|||
162929370|NCT00666718|588445778|FG000|Overall Study|Death|1|||
162929371|NCT00666718|588445779|FG001|Overall Study|Death|0|||
162929372|NCT00666718|588445778|FG000|Overall Study|Lost to Follow-up|1|||
162929373|NCT00666718|588445779|FG001|Overall Study|Lost to Follow-up|0|||
162929374|NCT00666718|588445778|FG000|Overall Study|Entry Criteria Not Met|2|||
162929375|NCT00666718|588445779|FG001|Overall Study|Entry Criteria Not Met|0|||
162929376|NCT00666718|588445778|FG000|Overall Study|Protocol Violation|1|||
162929377|NCT00666718|588445779|FG001|Overall Study|Protocol Violation|3|||
162929378|NCT00666718|588445778|FG000|Overall Study|Withdrawal by Subject|7|||
162929379|NCT00666718|588445779|FG001|Overall Study|Withdrawal by Subject|12|||
162929380|NCT00666718|588445778|FG000|Overall Study|Physician Decision|0|||
162929381|NCT00666718|588445779|FG001|Overall Study|Physician Decision|2|||
162929382|NCT02567266|588445789|FG000|Overall Study|Withdrawal by Subject|10|||
162929383|NCT02567266|588445790|FG001|Overall Study|Withdrawal by Subject|7|||
162929384|NCT02567266|588445791|FG002|Overall Study|Withdrawal by Subject|6|||
162929385|NCT02567266|588445789|FG000|Overall Study|Lost to Follow-up|13|||
162929386|NCT02567266|588445790|FG001|Overall Study|Lost to Follow-up|8|||
162929387|NCT02567266|588445791|FG002|Overall Study|Lost to Follow-up|10|||
162929388|NCT02983227|588445792|FG000|Overall Study|Adverse Event|21|||
162929389|NCT02983227|588445793|FG001|Overall Study|Adverse Event|3|||
162929390|NCT02983227|588445792|FG000|Overall Study|Death|3|||
162929391|NCT02983227|588445793|FG001|Overall Study|Death|0|||
162929392|NCT02983227|588445792|FG000|Overall Study|Lack of Efficacy|8|||
162929393|NCT02983227|588445793|FG001|Overall Study|Lack of Efficacy|1|||
162929394|NCT02983227|588445792|FG000|Overall Study|Lost to Follow-up|3|||
162929395|NCT02983227|588445793|FG001|Overall Study|Lost to Follow-up|0|||
162929396|NCT02983227|588445792|FG000|Overall Study|Multiple Reasons|2|||
162929397|NCT02983227|588445793|FG001|Overall Study|Multiple Reasons|1|||
162929398|NCT02983227|588445792|FG000|Overall Study|Physician Decision|3|||
162929399|NCT02983227|588445793|FG001|Overall Study|Physician Decision|1|||
162929400|NCT02983227|588445792|FG000|Overall Study|Withdrawal by Subject|19|||
162929401|NCT02983227|588445793|FG001|Overall Study|Withdrawal by Subject|8|||
162929402|NCT02164539|588445796|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
162929403|NCT02164539|588445797|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
162929404|NCT02164539|588445798|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
163270904|NCT02065570|589700054|FG002|Maintenance Study|Withdrawal by Subject|1|||
163270905|NCT02065570|589700055|FG003|Maintenance Study|Withdrawal by Subject|4|||
163270906|NCT02065570|589700052|FG000|Maintenance Study|Lost to Follow-up|0|||
162929405|NCT02164539|588445799|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
162929406|NCT02164539|588445800|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
162929407|NCT02164539|588445801|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
162929408|NCT02164539|588445802|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
162929409|NCT02164539|588445796|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
162929410|NCT02164539|588445797|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
162929411|NCT02164539|588445798|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
162929412|NCT02164539|588445799|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
162929413|NCT02164539|588445800|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
162929414|NCT02164539|588445801|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
162929415|NCT02164539|588445802|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
162929416|NCT02164539|588445796|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
162929417|NCT02164539|588445797|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
162929418|NCT02164539|588445798|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
162929419|NCT02164539|588445799|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
162929420|NCT02164539|588445800|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
162929421|NCT02164539|588445801|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
162929422|NCT02164539|588445802|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
162929423|NCT02164539|588445796|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
162929424|NCT02164539|588445797|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
162929425|NCT02164539|588445798|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
162929426|NCT02164539|588445799|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
162929427|NCT02164539|588445800|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
162929428|NCT02164539|588445801|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
162929429|NCT02164539|588445802|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
162929430|NCT02164539|588445796|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
162929431|NCT02164539|588445797|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
162929432|NCT02164539|588445798|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
162929433|NCT02164539|588445799|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
162929434|NCT02164539|588445800|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
162929435|NCT02164539|588445801|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
162929436|NCT02164539|588445802|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
162929437|NCT02164539|588445796|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
162929438|NCT02164539|588445797|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
162929439|NCT02164539|588445798|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
162929440|NCT02164539|588445799|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
162929441|NCT02164539|588445800|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
162929442|NCT02164539|588445801|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
162929443|NCT02164539|588445802|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
162929444|NCT01255722|588445803|FG000|Overall Study|Adverse Event|0|||
162929445|NCT01255722|588445804|FG001|Overall Study|Adverse Event|1|||
162929446|NCT01255722|588445805|FG002|Overall Study|Adverse Event|1|||
162929447|NCT01255722|588445803|FG000|Overall Study|asymptomatic patient|1|||
162929448|NCT01255722|588445804|FG001|Overall Study|asymptomatic patient|0|||
162929449|NCT01255722|588445805|FG002|Overall Study|asymptomatic patient|0|||
162929450|NCT01255722|588445803|FG000|Overall Study|beta-blocker contraindicated|2|||
162929451|NCT01255722|588445804|FG001|Overall Study|beta-blocker contraindicated|0|||
162929452|NCT01255722|588445805|FG002|Overall Study|beta-blocker contraindicated|0|||
162929453|NCT00527397|588445808|FG000|Overall Study|Adverse Event|3|||
162929454|NCT00527397|588445808|FG000|Overall Study|Lack of Efficacy|1|||
162929455|NCT00527397|588445808|FG000|Overall Study|Protocol Violation|1|||
162929456|NCT00527397|588445808|FG000|Overall Study|Withdrawal by Subject|6|||
162929457|NCT00527397|588445808|FG000|Overall Study|Study terminated by sponsor|13|||
162929458|NCT02065791|588445812|FG000|Overall Study|Closed Site|1|||
162929459|NCT02065791|588445813|FG001|Overall Study|Closed Site|1|||
162929460|NCT02065791|588445812|FG000|Overall Study|Withdrawal by Subject|11|||
162929461|NCT02065791|588445813|FG001|Overall Study|Withdrawal by Subject|5|||
162929462|NCT02065791|588445812|FG000|Overall Study|Lost to Follow-up|13|||
162929463|NCT02065791|588445813|FG001|Overall Study|Lost to Follow-up|9|||
162929464|NCT04529096|588445814|FG000|Overall Study|Adverse Event|6|||
162929465|NCT04529096|588445815|FG001|Overall Study|Adverse Event|1|||
162929466|NCT04529096|588445814|FG000|Overall Study|Lack of Efficacy|1|||
162929467|NCT04529096|588445815|FG001|Overall Study|Lack of Efficacy|0|||
162929468|NCT04529096|588445814|FG000|Overall Study|Lost to Follow-up|1|||
162929469|NCT04529096|588445815|FG001|Overall Study|Lost to Follow-up|1|||
162929470|NCT04529096|588445814|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162929471|NCT04529096|588445815|FG001|Overall Study|Non-Compliance With Study Drug|1|||
162929472|NCT04529096|588445814|FG000|Overall Study|Physician Decision|1|||
162929473|NCT04529096|588445815|FG001|Overall Study|Physician Decision|3|||
162929474|NCT04529096|588445814|FG000|Overall Study|Withdrawal by Subject|5|||
162929475|NCT04529096|588445815|FG001|Overall Study|Withdrawal by Subject|0|||
162929476|NCT03467971|588445816|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162929477|NCT03467971|588445817|FG001|Treatment Period 2|Withdrawal by Subject|1|||
162929478|NCT01619085|588445818|FG000|Overall Study|Adverse Event|231|||
162929479|NCT01619085|588445818|FG000|Overall Study|Protocol Violation|4|||
163041192|NCT02717442|588858090|FG001|Overall Study|Other - Not Specified|0|||
163041193|NCT03251482|588860644|FG000|Overall Study|Withdrawal by Subject|0|||
163041194|NCT03251482|588860645|FG001|Overall Study|Withdrawal by Subject|1|||
163041195|NCT03251482|588860646|FG002|Overall Study|Withdrawal by Subject|0|||
163041196|NCT03251482|588860647|FG003|Overall Study|Withdrawal by Subject|0|||
163041197|NCT03251482|588860648|FG004|Overall Study|Withdrawal by Subject|0|||
163041198|NCT02823470|588860649|FG000|Overall Study|Adverse Event|1|||
163041199|NCT02823470|588860650|FG001|Overall Study|Adverse Event|0|||
163041200|NCT02823470|588860649|FG000|Overall Study|Study terminated by sponsor|8|||
163041201|NCT02823470|588860650|FG001|Overall Study|Study terminated by sponsor|15|||
163041202|NCT01490840|588860651|FG000|Phase 1|Lost to Follow-up|1|||
163041203|NCT01490840|588860652|FG001|Phase 1|Lost to Follow-up|0|||
163041204|NCT01490840|588860651|FG000|Phase 1|Adverse Event|2|||
163041205|NCT01490840|588860652|FG001|Phase 1|Adverse Event|1|||
163041206|NCT01490840|588860651|FG000|Phase 1|Withdrawal by Subject|6|||
163041207|NCT01490840|588860652|FG001|Phase 1|Withdrawal by Subject|5|||
163041208|NCT01490840|588860651|FG000|Phase 1|Visit 6a omitted|1|||
163041209|NCT01490840|588860652|FG001|Phase 1|Visit 6a omitted|0|||
163041210|NCT01490840|588860651|FG000|Phase 2|Withdrawal by Subject|4|||
163041211|NCT01490840|588860652|FG001|Phase 2|Withdrawal by Subject|3|||
163041212|NCT01490840|588860651|FG000|Phase 2|Permanent interruption of fingolimod|0|||
163041213|NCT01490840|588860652|FG001|Phase 2|Permanent interruption of fingolimod|1|||
163041214|NCT01490840|588860651|FG000|Phase 2|Lost to Follow-up|1|||
163041215|NCT01490840|588860652|FG001|Phase 2|Lost to Follow-up|1|||
163041216|NCT01490840|588860651|FG000|Phase 2|Adverse Event|1|||
163041217|NCT01490840|588860652|FG001|Phase 2|Adverse Event|1|||
163041218|NCT00184002|588860653|FG000|Overall Study|Adverse Event|9|||
163041219|NCT00184002|588860653|FG000|Overall Study|Death|3|||
163041220|NCT00184002|588860653|FG000|Overall Study|Physician Decision|1|||
163041221|NCT00184002|588860653|FG000|Overall Study|Withdrawal by Subject|4|||
163041222|NCT00694356|588860654|FG000|Overall Study|Adverse Event|1|||
163041223|NCT00694356|588860655|FG001|Overall Study|Adverse Event|0|||
163041224|NCT00694356|588860656|FG002|Overall Study|Adverse Event|0|||
163041225|NCT00694356|588860654|FG000|Overall Study|Progressive Disease|2|||
163041226|NCT00694356|588860655|FG001|Overall Study|Progressive Disease|6|||
163041227|NCT00694356|588860656|FG002|Overall Study|Progressive Disease|6|||
163041228|NCT02756819|588860657|FG000|Overall Study|Lost for observation|23|||
163041229|NCT02756819|588860657|FG000|Overall Study|Patient's unwillingness|16|||
163041230|NCT02756819|588860657|FG000|Overall Study|Insufficient efficacy|2|||
163041231|NCT02756819|588860657|FG000|Overall Study|Adverse Event|2|||
163041232|NCT02756819|588860657|FG000|Overall Study|Reason not Specified|9|||
162929480|NCT01619085|588445818|FG000|Overall Study|Lost to Follow-up|3|||
162929481|NCT01619085|588445818|FG000|Overall Study|Withdrawal by Subject|45|||
162929482|NCT01619085|588445818|FG000|Overall Study|Other than specified|96|||
162929483|NCT01619085|588445818|FG000|Overall Study|Not treated|1|||
162929484|NCT01619085|588445818|FG000|Overall Study|Death|145|||
162929485|NCT00883129|588445821|FG000|Overall Study|Adverse Event|7|||
162929486|NCT00883129|588445822|FG001|Overall Study|Adverse Event|15|||
162929487|NCT00883129|588445821|FG000|Overall Study|Withdrawal by Subject|8|||
162929488|NCT00883129|588445822|FG001|Overall Study|Withdrawal by Subject|9|||
162929489|NCT00883129|588445821|FG000|Overall Study|Non-compliance|3|||
162929490|NCT00883129|588445822|FG001|Overall Study|Non-compliance|6|||
162929491|NCT00883129|588445821|FG000|Overall Study|Lost to Follow-up|1|||
162929492|NCT00883129|588445822|FG001|Overall Study|Lost to Follow-up|2|||
162929493|NCT00883129|588445821|FG000|Overall Study|Death|1|||
162929494|NCT00883129|588445822|FG001|Overall Study|Death|2|||
162929495|NCT00883129|588445821|FG000|Overall Study|Defined Treatment Failure|0|||
162929496|NCT00883129|588445822|FG001|Overall Study|Defined Treatment Failure|2|||
162929497|NCT03273257|588445823|FG000|Overall Study|Death|0|||
162929498|NCT03273257|588445824|FG001|Overall Study|Death|1|||
162929499|NCT03273257|588445823|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
162929500|NCT03273257|588445824|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
162929501|NCT03273257|588445823|FG000|Overall Study|Study terminated|3|||
162929502|NCT03273257|588445824|FG001|Overall Study|Study terminated|2|||
162929503|NCT00833976|588447366|FG000|Overall Study|Withdrawal by Subject|5|||
162929504|NCT00833976|588447366|FG000|Overall Study|Lost to Follow-up|4|||
162929505|NCT00833976|588447366|FG000|Overall Study|Did not meet eligibility criteria|41|||
162929506|NCT00833976|588447366|FG000|Overall Study|Physician Decision|1|||
162929507|NCT01246973|588447371|FG000|Overall Study|Other|38|||
162929508|NCT01246973|588447372|FG001|Overall Study|Other|25|||
163041233|NCT00741598|588860658|FG000|Overall Study|Lost to Follow-up|3|||
163041234|NCT00741598|588860659|FG001|Overall Study|Lost to Follow-up|4|||
163041235|NCT00741598|588860658|FG000|Overall Study|Lack of Efficacy|1|||
163041236|NCT00741598|588860659|FG001|Overall Study|Lack of Efficacy|2|||
163041237|NCT00741598|588860658|FG000|Overall Study|Physician Decision|1|||
163041238|NCT00741598|588860659|FG001|Overall Study|Physician Decision|1|||
163041239|NCT00741598|588860658|FG000|Overall Study|Pregnancy|1|||
163041240|NCT00741598|588860659|FG001|Overall Study|Pregnancy|0|||
163041241|NCT00741598|588860658|FG000|Overall Study|Withdrawal by Subject|3|||
162929509|NCT01246973|588447371|FG000|Overall Study|Adverse Event|16|||
162929510|NCT01246973|588447372|FG001|Overall Study|Adverse Event|9|||
162929511|NCT01246973|588447371|FG000|Overall Study|Withdrawal by Subject|7|||
162929512|NCT01246973|588447372|FG001|Overall Study|Withdrawal by Subject|13|||
162929513|NCT02598622|588447373|FG000|Overall Study|Withdrawal by Subject|3|||
162929514|NCT02598622|588447374|FG001|Overall Study|Withdrawal by Subject|0|||
162929515|NCT02598622|588447373|FG000|Overall Study|Physician Decision|3|||
162929516|NCT02598622|588447374|FG001|Overall Study|Physician Decision|0|||
162929517|NCT00678379|588447375|FG000|Overall Study|Injection performed after tonsillectomy|2|||
162929518|NCT00678379|588447376|FG001|Overall Study|Injection performed after tonsillectomy|0|||
162929519|NCT00678379|588447377|FG002|Overall Study|Injection performed after tonsillectomy|1|||
162929520|NCT00678379|588447375|FG000|Overall Study|Incomplete Data|4|||
162929521|NCT00678379|588447376|FG001|Overall Study|Incomplete Data|3|||
162929522|NCT00678379|588447377|FG002|Overall Study|Incomplete Data|3|||
162929523|NCT01835470|588447378|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
162929524|NCT01835470|588447378|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
162929525|NCT01011907|588447379|FG000|Overall Study|Withdrawal by Subject|13|||
162929526|NCT01011907|588447380|FG001|Overall Study|Withdrawal by Subject|11|||
162929527|NCT01011907|588447379|FG000|Overall Study|Adverse Event|1|||
162929528|NCT01011907|588447380|FG001|Overall Study|Adverse Event|4|||
162929529|NCT01637961|588447385|FG000|Overall Study|Ineligible: wrong primary|1|||
162929530|NCT01637961|588447385|FG000|Overall Study|Ineligible: inadequate pathology|1|||
162929531|NCT02239601|588447386|FG000|Overall Study|Withdrawal by Subject|3|||
162929532|NCT02239601|588447387|FG001|Overall Study|Withdrawal by Subject|4|||
162929533|NCT02239601|588447386|FG000|Overall Study|Protocol Violation|4|||
162929534|NCT02239601|588447387|FG001|Overall Study|Protocol Violation|2|||
162929535|NCT04682639|588447388|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
162929536|NCT04682639|588447389|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
162929537|NCT04682639|588447390|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
162929538|NCT04682639|588447391|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
162929539|NCT04682639|588447392|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
163041242|NCT00741598|588860659|FG001|Overall Study|Withdrawal by Subject|2|||
163041243|NCT02087670|588860662|FG000|Overall Study|Withdrawal by Subject|3|||
163041244|NCT02087670|588860663|FG001|Overall Study|Withdrawal by Subject|2|||
163041245|NCT03117361|588860665|FG000|Overall Study|Progressive disease|5|||
163041246|NCT03117361|588860665|FG000|Overall Study|Death|1|||
163041247|NCT03117361|588860665|FG000|Overall Study|Physician Decision|2|||
163041248|NCT03117361|588860665|FG000|Overall Study|On study treatment at the end of study|1|||
163041249|NCT03117361|588860665|FG000|Overall Study|Treatment-related adverse event|1|||
163041250|NCT00878800|588860666|FG000|Overall Study|Adverse Event|0|||
163041251|NCT00878800|588860667|FG001|Overall Study|Adverse Event|0|||
163041252|NCT00878800|588860668|FG002|Overall Study|Adverse Event|2|||
163041253|NCT00878800|588860669|FG003|Overall Study|Adverse Event|0|||
163041254|NCT00878800|588860670|FG004|Overall Study|Adverse Event|1|||
163041255|NCT00878800|588860666|FG000|Overall Study|Progressive disease|1|||
163041256|NCT00878800|588860667|FG001|Overall Study|Progressive disease|5|||
163041257|NCT00878800|588860668|FG002|Overall Study|Progressive disease|6|||
163041258|NCT00878800|588860669|FG003|Overall Study|Progressive disease|5|||
163041259|NCT00878800|588860670|FG004|Overall Study|Progressive disease|13|||
163041260|NCT00878800|588860666|FG000|Overall Study|Withdrew consent|1|||
163041261|NCT00878800|588860667|FG001|Overall Study|Withdrew consent|1|||
163041262|NCT00878800|588860668|FG002|Overall Study|Withdrew consent|0|||
163041263|NCT00878800|588860669|FG003|Overall Study|Withdrew consent|1|||
163041264|NCT00878800|588860670|FG004|Overall Study|Withdrew consent|1|||
163041265|NCT00878800|588860666|FG000|Overall Study|Death|0|||
163041266|NCT00878800|588860667|FG001|Overall Study|Death|0|||
163041267|NCT00878800|588860668|FG002|Overall Study|Death|1|||
163041268|NCT00878800|588860669|FG003|Overall Study|Death|0|||
163041269|NCT00878800|588860670|FG004|Overall Study|Death|0|||
163041270|NCT00878800|588860666|FG000|Overall Study|Other|1|||
163041271|NCT00878800|588860667|FG001|Overall Study|Other|1|||
163041272|NCT00878800|588860668|FG002|Overall Study|Other|0|||
163041273|NCT00878800|588860669|FG003|Overall Study|Other|0|||
163041274|NCT00878800|588860670|FG004|Overall Study|Other|1|||
163041275|NCT02072941|588860671|FG000|Overall Study|Withdrawal by Subject|29|||
163041276|NCT02072941|588860672|FG001|Overall Study|Withdrawal by Subject|21|||
163041277|NCT02072941|588860671|FG000|Overall Study|Lost to Follow-up|4|||
163041278|NCT02072941|588860672|FG001|Overall Study|Lost to Follow-up|4|||
163041279|NCT02072941|588860671|FG000|Overall Study|Death|3|||
163041280|NCT02072941|588860672|FG001|Overall Study|Death|2|||
163041281|NCT02072941|588860671|FG000|Overall Study|Removed by Study Staff|2|||
163041282|NCT02072941|588860672|FG001|Overall Study|Removed by Study Staff|2|||
163041283|NCT01247350|588860675|FG000|Overall Study|Adverse Event|0|||
163041284|NCT01247350|588860676|FG001|Overall Study|Adverse Event|0|||
163041285|NCT01247350|588860677|FG002|Overall Study|Adverse Event|1|||
163041286|NCT01247350|588860678|FG003|Overall Study|Adverse Event|0|||
163041287|NCT01247350|588860679|FG004|Overall Study|Adverse Event|0|||
163041288|NCT01247350|588860675|FG000|Overall Study|Withdrawal by Subject|0|||
163041289|NCT01247350|588860676|FG001|Overall Study|Withdrawal by Subject|0|||
163041290|NCT01247350|588860677|FG002|Overall Study|Withdrawal by Subject|0|||
163041291|NCT01247350|588860678|FG003|Overall Study|Withdrawal by Subject|1|||
163041292|NCT01247350|588860679|FG004|Overall Study|Withdrawal by Subject|0|||
163041293|NCT01247350|588860675|FG000|Overall Study|Entry criteria not met|0|||
163041294|NCT01247350|588860676|FG001|Overall Study|Entry criteria not met|0|||
163041295|NCT01247350|588860677|FG002|Overall Study|Entry criteria not met|0|||
163041296|NCT01247350|588860678|FG003|Overall Study|Entry criteria not met|0|||
163041297|NCT01247350|588860679|FG004|Overall Study|Entry criteria not met|1|||
163041298|NCT00169104|588860680|FG000|Overall Study|Withdrawal by Subject|2|||
163041299|NCT00169104|588860681|FG001|Overall Study|Withdrawal by Subject|0|||
163041300|NCT00169104|588860680|FG000|Overall Study|Protocol Violation|0|||
163041301|NCT00169104|588860681|FG001|Overall Study|Protocol Violation|1|||
163041302|NCT00169104|588860680|FG000|Overall Study|Physician Decision|0|||
163041303|NCT00169104|588860681|FG001|Overall Study|Physician Decision|1|||
163041304|NCT00715299|588860687|FG000|Overall Study|Withdrawal by Subject|1|||
163041305|NCT00715299|588860687|FG000|Overall Study|Adverse Event|3|||
163041306|NCT00715299|588860687|FG000|Overall Study|failed the pre-screen exercise test|2|||
163041307|NCT02020889|588860688|FG000|Overall Study|Adverse Event|0|||
163041308|NCT02020889|588860689|FG001|Overall Study|Adverse Event|1|||
163041309|NCT02020889|588860688|FG000|Overall Study|Lack of Efficacy|1|||
163041310|NCT02020889|588860689|FG001|Overall Study|Lack of Efficacy|0|||
163041311|NCT02020889|588860688|FG000|Overall Study|Lost to Follow-up|1|||
163041312|NCT02020889|588860689|FG001|Overall Study|Lost to Follow-up|0|||
163041313|NCT02020889|588860688|FG000|Overall Study|Physician Decision|2|||
163041314|NCT02020889|588860689|FG001|Overall Study|Physician Decision|0|||
163041315|NCT02020889|588860688|FG000|Overall Study|Withdrawal by Subject|3|||
163041316|NCT02020889|588860689|FG001|Overall Study|Withdrawal by Subject|2|||
163041317|NCT01540981|588860690|FG000|Overall Study|Withdrawal by Subject|1|||
163041318|NCT01540981|588860691|FG001|Overall Study|Withdrawal by Subject|0|||
163041319|NCT00809094|588860692|FG000|Overall Study|Lost to Follow-up|0|||
163041320|NCT00809094|588860693|FG001|Overall Study|Lost to Follow-up|1|||
163041321|NCT00232557|588860694|FG000|Overall Study|Lost to Follow-up|3|||
163041322|NCT00232557|588860695|FG001|Overall Study|Lost to Follow-up|5|||
163041323|NCT02457195|588860700|FG000|Overall Study|Adverse Event|3|||
163041324|NCT02457195|588860700|FG000|Overall Study|Protocol Violation|2|||
163041325|NCT02457195|588860700|FG000|Overall Study|Withdrawal by Subject|4|||
163041326|NCT05980013|588860702|FG000|Overall Study|Withdrawal by Subject|0|||
163041327|NCT05980013|588860703|FG001|Overall Study|Withdrawal by Subject|1|||
163041328|NCT05980013|588860702|FG000|Overall Study|Device Error|0|||
163041329|NCT05980013|588860703|FG001|Overall Study|Device Error|1|||
163041330|NCT04892446|588860704|FG000|Overall Study|Death|4|||
163041331|NCT04892446|588860705|FG001|Overall Study|Death|4|||
163041332|NCT04892446|588860706|FG002|Overall Study|Death|0|||
163041333|NCT04892446|588860704|FG000|Overall Study|Withdrew consent|3|||
163041334|NCT04892446|588860705|FG001|Overall Study|Withdrew consent|0|||
163041335|NCT04892446|588860706|FG002|Overall Study|Withdrew consent|1|||
163041336|NCT04892446|588860704|FG000|Overall Study|Investigator's discretion|1|||
163041337|NCT04892446|588860705|FG001|Overall Study|Investigator's discretion|1|||
163041338|NCT04892446|588860706|FG002|Overall Study|Investigator's discretion|0|||
163041339|NCT04892446|588860704|FG000|Overall Study|Study terminated by sponsor|0|||
163041340|NCT04892446|588860705|FG001|Overall Study|Study terminated by sponsor|0|||
163041341|NCT04892446|588860706|FG002|Overall Study|Study terminated by sponsor|2|||
163041342|NCT04676724|588860709|FG000|Overall Study|Adverse Event|2|||
163041343|NCT04676724|588860710|FG001|Overall Study|Adverse Event|0|||
163041344|NCT04676724|588860709|FG000|Overall Study|Lost to Follow-up|1|||
163041345|NCT04676724|588860710|FG001|Overall Study|Lost to Follow-up|0|||
163041346|NCT04676724|588860709|FG000|Overall Study|Physician Decision|0|||
163041347|NCT04676724|588860710|FG001|Overall Study|Physician Decision|1|||
163041348|NCT04676724|588860709|FG000|Overall Study|Withdrawal by Subject|3|||
163041349|NCT04676724|588860710|FG001|Overall Study|Withdrawal by Subject|2|||
163041350|NCT00398047|588860711|FG000|Overall Study|all patient progressed before completion|3|||
163041351|NCT00237692|588860712|FG000|Overall Study|Lost to Follow-up|9|||
163041352|NCT00237692|588860713|FG001|Overall Study|Lost to Follow-up|3|||
163041353|NCT00237692|588860714|FG002|Overall Study|Lost to Follow-up|5|||
163041354|NCT00237692|588860715|FG003|Overall Study|Lost to Follow-up|3|||
163041355|NCT00237692|588860712|FG000|Overall Study|Death|1|||
163041356|NCT00237692|588860713|FG001|Overall Study|Death|2|||
163041357|NCT00237692|588860714|FG002|Overall Study|Death|2|||
163041358|NCT00237692|588860715|FG003|Overall Study|Death|3|||
163041359|NCT00237692|588860712|FG000|Overall Study|Excluded - did not meet criteria|4|||
163041360|NCT00237692|588860713|FG001|Overall Study|Excluded - did not meet criteria|3|||
163041361|NCT00237692|588860714|FG002|Overall Study|Excluded - did not meet criteria|5|||
163041362|NCT00237692|588860715|FG003|Overall Study|Excluded - did not meet criteria|9|||
163041363|NCT00237692|588860712|FG000|Overall Study|Withdrawal by Subject|4|||
163041364|NCT00237692|588860713|FG001|Overall Study|Withdrawal by Subject|6|||
163041365|NCT00237692|588860714|FG002|Overall Study|Withdrawal by Subject|10|||
163041366|NCT00237692|588860715|FG003|Overall Study|Withdrawal by Subject|4|||
163041367|NCT00685360|588860716|FG000|Overall Study|Lost to Follow-up|0|||
163041368|NCT00685360|588860717|FG001|Overall Study|Lost to Follow-up|1|||
163041369|NCT00685360|588860718|FG002|Overall Study|Lost to Follow-up|2|||
163041370|NCT00685360|588860716|FG000|Overall Study|Adverse Event|4|||
163041371|NCT00685360|588860717|FG001|Overall Study|Adverse Event|6|||
163041372|NCT00685360|588860718|FG002|Overall Study|Adverse Event|4|||
163041373|NCT00685360|588860716|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
163041374|NCT00685360|588860717|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
163041375|NCT00685360|588860718|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
163041376|NCT00685360|588860716|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
163041377|NCT00685360|588860717|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
163041378|NCT00685360|588860718|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
163041379|NCT00685360|588860716|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
163041380|NCT00685360|588860717|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
163041381|NCT00685360|588860718|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
163041382|NCT00685360|588860716|FG000|Overall Study|Protocol Deviation|0|||
163270907|NCT02065570|589700053|FG001|Maintenance Study|Lost to Follow-up|0|||
163270908|NCT02065570|589700054|FG002|Maintenance Study|Lost to Follow-up|2|||
163270909|NCT02065570|589700055|FG003|Maintenance Study|Lost to Follow-up|2|||
163270910|NCT02065570|589700052|FG000|Maintenance Study|Other, Not Specified|0|||
163270911|NCT02065570|589700053|FG001|Maintenance Study|Other, Not Specified|0|||
163270912|NCT02065570|589700054|FG002|Maintenance Study|Other, Not Specified|11|||
163270913|NCT02065570|589700055|FG003|Maintenance Study|Other, Not Specified|5|||
163270914|NCT00786474|589700060|FG000|Overall Study|Death|5|||
163270915|NCT00786474|589700061|FG001|Overall Study|Death|4|||
163270916|NCT00786474|589700060|FG000|Overall Study|Withdrawal by Subject|23|||
163270917|NCT00786474|589700061|FG001|Overall Study|Withdrawal by Subject|31|||
163270918|NCT00786474|589700060|FG000|Overall Study|Lost to Follow-up|3|||
163270919|NCT00786474|589700061|FG001|Overall Study|Lost to Follow-up|3|||
163270920|NCT00786474|589700060|FG000|Overall Study|Physician Decision|2|||
163270921|NCT00786474|589700061|FG001|Overall Study|Physician Decision|1|||
163270922|NCT00786474|589700060|FG000|Overall Study|Other|4|||
163270923|NCT00786474|589700061|FG001|Overall Study|Other|4|||
163270924|NCT04642469|589700062|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
163270925|NCT04642469|589700063|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
163270926|NCT04642469|589700062|FG000|Overall Study|Death|1|||
163270927|NCT04642469|589700063|FG001|Overall Study|Death|2|||
163270928|NCT04642469|589700062|FG000|Overall Study|Study/site closed following amendment 1|11|||
163270929|NCT04642469|589700063|FG001|Overall Study|Study/site closed following amendment 1|11|||
163270930|NCT04642469|589700062|FG000|Overall Study|Other|1|||
163270931|NCT04642469|589700063|FG001|Overall Study|Other|1|||
163270932|NCT04642469|589700062|FG000|Overall Study|Withdrawal by Subject|1|||
163270933|NCT04642469|589700063|FG001|Overall Study|Withdrawal by Subject|0|||
163270934|NCT02733042|589700064|FG000|Overall Study|Adverse Event|1|||
163270935|NCT02733042|589700065|FG001|Overall Study|Adverse Event|0|||
163270936|NCT02733042|589700066|FG002|Overall Study|Adverse Event|1|||
163270937|NCT02733042|589700067|FG003|Overall Study|Adverse Event|1|||
163270938|NCT02733042|589700068|FG004|Overall Study|Adverse Event|0|||
163270939|NCT02733042|589700069|FG005|Overall Study|Adverse Event|0|||
163270940|NCT02733042|589700070|FG006|Overall Study|Adverse Event|0|||
163270941|NCT02733042|589700071|FG007|Overall Study|Adverse Event|0|||
163270942|NCT02733042|589700072|FG008|Overall Study|Adverse Event|0|||
163270943|NCT02733042|589700073|FG009|Overall Study|Adverse Event|0|||
163270944|NCT02733042|589700074|FG010|Overall Study|Adverse Event|2|||
163270945|NCT02733042|589700075|FG011|Overall Study|Adverse Event|2|||
163270946|NCT02733042|589700076|FG012|Overall Study|Adverse Event|0|||
163270947|NCT02733042|589700077|FG013|Overall Study|Adverse Event|2|||
163270948|NCT02733042|589700078|FG014|Overall Study|Adverse Event|0|||
163270949|NCT02733042|589700079|FG015|Overall Study|Adverse Event|0|||
163270950|NCT02733042|589700080|FG016|Overall Study|Adverse Event|0|||
163270951|NCT02733042|589700081|FG017|Overall Study|Adverse Event|1|||
163270952|NCT02733042|589700082|FG018|Overall Study|Adverse Event|0|||
163270953|NCT02733042|589700064|FG000|Overall Study|Progressive Disease|2|||
163270954|NCT02733042|589700065|FG001|Overall Study|Progressive Disease|1|||
163270955|NCT02733042|589700066|FG002|Overall Study|Progressive Disease|3|||
163270956|NCT02733042|589700067|FG003|Overall Study|Progressive Disease|1|||
163270957|NCT02733042|589700068|FG004|Overall Study|Progressive Disease|2|||
163041383|NCT00685360|588860717|FG001|Overall Study|Protocol Deviation|1|||
163041384|NCT00685360|588860718|FG002|Overall Study|Protocol Deviation|1|||
163041385|NCT01386944|588860725|FG000|Overall Study|Adverse Event|26|||
163270958|NCT02733042|589700069|FG005|Overall Study|Progressive Disease|3|||
163270959|NCT02733042|589700070|FG006|Overall Study|Progressive Disease|0|||
163270960|NCT02733042|589700071|FG007|Overall Study|Progressive Disease|3|||
163270961|NCT02733042|589700072|FG008|Overall Study|Progressive Disease|3|||
163270962|NCT02733042|589700073|FG009|Overall Study|Progressive Disease|2|||
163041386|NCT01386944|588860725|FG000|Overall Study|Lack of Efficacy|14|||
163041387|NCT01386944|588860725|FG000|Overall Study|Lost to Follow-up|8|||
163041388|NCT01386944|588860725|FG000|Overall Study|Unspecified reason|8|||
163041389|NCT00524680|588860726|FG000|Overall Study|progression|0|||
163041390|NCT00524680|588860727|FG001|Overall Study|progression|0|||
163041391|NCT00524680|588860728|FG002|Overall Study|progression|0|||
163041392|NCT00524680|588860729|FG003|Overall Study|progression|1|||
163041393|NCT00524680|588860726|FG000|Overall Study|Adverse Event|2|||
163041394|NCT00524680|588860727|FG001|Overall Study|Adverse Event|0|||
163041395|NCT00524680|588860728|FG002|Overall Study|Adverse Event|0|||
163041396|NCT00524680|588860729|FG003|Overall Study|Adverse Event|1|||
163041397|NCT00524680|588860726|FG000|Overall Study|Other|0|||
163041398|NCT00524680|588860727|FG001|Overall Study|Other|1|||
163041399|NCT00524680|588860728|FG002|Overall Study|Other|2|||
163041400|NCT00524680|588860729|FG003|Overall Study|Other|3|||
163041401|NCT00524680|588860726|FG000|Overall Study|Withdrawal by Subject|1|||
163041402|NCT00524680|588860727|FG001|Overall Study|Withdrawal by Subject|0|||
163041403|NCT00524680|588860728|FG002|Overall Study|Withdrawal by Subject|1|||
163041404|NCT00524680|588860729|FG003|Overall Study|Withdrawal by Subject|1|||
163041405|NCT01146561|588860732|FG000|Overall Study|Withdrawal by Subject|1|||
163041406|NCT01146561|588860732|FG000|Overall Study|Lost to Follow-up|1|||
163041407|NCT03092791|588860738|FG000|Overall Study|Lost to Follow-up|0|||
163041408|NCT03092791|588860739|FG001|Overall Study|Lost to Follow-up|0|||
163041409|NCT03092791|588860740|FG002|Overall Study|Lost to Follow-up|0|||
163041410|NCT03092791|588860741|FG003|Overall Study|Lost to Follow-up|0|||
163041411|NCT03092791|588860742|FG004|Overall Study|Lost to Follow-up|0|||
163041412|NCT03092791|588860743|FG005|Overall Study|Lost to Follow-up|0|||
163041413|NCT03092791|588860744|FG006|Overall Study|Lost to Follow-up|1|||
163041414|NCT03092791|588860745|FG007|Overall Study|Lost to Follow-up|0|||
163041415|NCT03092791|588860738|FG000|Overall Study|Withdrawal of Consent|0|||
163270963|NCT02733042|589700074|FG010|Overall Study|Progressive Disease|2|||
163041416|NCT03092791|588860739|FG001|Overall Study|Withdrawal of Consent|0|||
163041417|NCT03092791|588860740|FG002|Overall Study|Withdrawal of Consent|0|||
163041418|NCT03092791|588860741|FG003|Overall Study|Withdrawal of Consent|0|||
163041419|NCT03092791|588860742|FG004|Overall Study|Withdrawal of Consent|4|||
163041420|NCT03092791|588860743|FG005|Overall Study|Withdrawal of Consent|12|||
163041421|NCT03092791|588860744|FG006|Overall Study|Withdrawal of Consent|6|||
163041422|NCT03092791|588860745|FG007|Overall Study|Withdrawal of Consent|4|||
163041423|NCT03092791|588860738|FG000|Overall Study|Study Termination|0|||
163041424|NCT03092791|588860739|FG001|Overall Study|Study Termination|0|||
163041425|NCT03092791|588860740|FG002|Overall Study|Study Termination|0|||
163041426|NCT03092791|588860741|FG003|Overall Study|Study Termination|0|||
163041427|NCT03092791|588860742|FG004|Overall Study|Study Termination|55|||
163041428|NCT03092791|588860743|FG005|Overall Study|Study Termination|46|||
163041429|NCT03092791|588860744|FG006|Overall Study|Study Termination|53|||
163041430|NCT03092791|588860745|FG007|Overall Study|Study Termination|55|||
163041431|NCT03092791|588860738|FG000|Overall Study|Death|0|||
163041432|NCT03092791|588860739|FG001|Overall Study|Death|0|||
163041433|NCT03092791|588860740|FG002|Overall Study|Death|0|||
163041434|NCT03092791|588860741|FG003|Overall Study|Death|0|||
163041435|NCT03092791|588860742|FG004|Overall Study|Death|0|||
163041436|NCT03092791|588860743|FG005|Overall Study|Death|1|||
163041437|NCT03092791|588860744|FG006|Overall Study|Death|0|||
163041438|NCT03092791|588860745|FG007|Overall Study|Death|1|||
163041439|NCT03092791|588860738|FG000|Overall Study|Reason Not Specified|0|||
163041440|NCT03092791|588860739|FG001|Overall Study|Reason Not Specified|0|||
163041441|NCT03092791|588860740|FG002|Overall Study|Reason Not Specified|0|||
163041442|NCT03092791|588860741|FG003|Overall Study|Reason Not Specified|0|||
163041443|NCT03092791|588860742|FG004|Overall Study|Reason Not Specified|1|||
163041444|NCT03092791|588860743|FG005|Overall Study|Reason Not Specified|1|||
163041445|NCT03092791|588860744|FG006|Overall Study|Reason Not Specified|0|||
163041446|NCT03092791|588860745|FG007|Overall Study|Reason Not Specified|0|||
163041447|NCT02182830|588860749|FG000|Overall Study|Not Treated|1|||
163041448|NCT02182830|588860750|FG001|Overall Study|Not Treated|1|||
163041449|NCT02182830|588860749|FG000|Overall Study|Trial stopped, reason missing|3|||
163041450|NCT02182830|588860750|FG001|Overall Study|Trial stopped, reason missing|3|||
163041451|NCT02182830|588860749|FG000|Overall Study|Consent withdrawn|8|||
163041452|NCT02182830|588860750|FG001|Overall Study|Consent withdrawn|8|||
163041453|NCT02182830|588860749|FG000|Overall Study|Lost to Follow-up|3|||
163041454|NCT02182830|588860750|FG001|Overall Study|Lost to Follow-up|3|||
163041455|NCT04399538|588860751|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
163041456|NCT04399538|588860752|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
163041457|NCT04399538|588860753|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
163041458|NCT04399538|588860754|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
163041459|NCT04399538|588860755|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
163041460|NCT04399538|588860751|FG000|Double-Blind Treatment|Adverse Event|0|||
163041461|NCT04399538|588860752|FG001|Double-Blind Treatment|Adverse Event|0|||
163041462|NCT04399538|588860753|FG002|Double-Blind Treatment|Adverse Event|0|||
163041463|NCT04399538|588860754|FG003|Double-Blind Treatment|Adverse Event|0|||
163041464|NCT04399538|588860755|FG004|Double-Blind Treatment|Adverse Event|1|||
163041465|NCT04399538|588860751|FG000|Follow-Up|Adverse Event|0|||
163041466|NCT04399538|588860752|FG001|Follow-Up|Adverse Event|0|||
163041467|NCT04399538|588860753|FG002|Follow-Up|Adverse Event|0|||
163041468|NCT04399538|588860754|FG003|Follow-Up|Adverse Event|0|||
163041469|NCT04399538|588860755|FG004|Follow-Up|Adverse Event|1|||
163041470|NCT04399538|588860751|FG000|Follow-Up|Withdrawal by Subject|0|||
163041471|NCT04399538|588860752|FG001|Follow-Up|Withdrawal by Subject|0|||
163041472|NCT04399538|588860753|FG002|Follow-Up|Withdrawal by Subject|0|||
163041473|NCT04399538|588860754|FG003|Follow-Up|Withdrawal by Subject|2|||
163041474|NCT04399538|588860755|FG004|Follow-Up|Withdrawal by Subject|0|||
163041475|NCT00586898|588860760|FG000|Overall Study|Adverse Event|1|||
163041476|NCT00586898|588860760|FG000|Overall Study|Patiemt Non-compliance|1|||
163041477|NCT00586898|588860760|FG000|Overall Study|Evaluable for Toxicity Only|5|||
163041478|NCT01588405|588860761|FG000|Overall Study|Adverse Event|1|||
163041479|NCT01588405|588860761|FG000|Overall Study|Clinical Worsening|1|||
163041480|NCT03268005|588860762|FG000|Overall Study|Death|2|||
163041481|NCT03268005|588860763|FG001|Overall Study|Death|1|||
163041482|NCT03268005|588860762|FG000|Overall Study|Lost to Follow-up|2|||
163041483|NCT03268005|588860763|FG001|Overall Study|Lost to Follow-up|2|||
163041484|NCT03268005|588860762|FG000|Overall Study|Withdrawal by Subject|11|||
163041485|NCT03268005|588860763|FG001|Overall Study|Withdrawal by Subject|11|||
163041486|NCT01926197|588860764|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
163041487|NCT01926197|588860765|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
163041488|NCT01926197|588860764|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
163041489|NCT01926197|588860765|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
163041490|NCT00492232|588860766|FG000|Placebo Run-in|Adverse Event|0|||
163041491|NCT00492232|588860767|FG001|Placebo Run-in|Adverse Event|2|||
163041492|NCT00492232|588860766|FG000|Placebo Run-in|Protocol Violation|0|||
163041493|NCT00492232|588860767|FG001|Placebo Run-in|Protocol Violation|3|||
163041494|NCT00492232|588860766|FG000|Placebo Run-in|Lost to Follow-up|0|||
163041495|NCT00492232|588860767|FG001|Placebo Run-in|Lost to Follow-up|3|||
163041496|NCT00492232|588860766|FG000|Placebo Run-in|Withdrawal by Subject|0|||
163041497|NCT00492232|588860767|FG001|Placebo Run-in|Withdrawal by Subject|8|||
163041498|NCT00492232|588860766|FG000|Placebo Run-in|Pregnancy|0|||
163041499|NCT00492232|588860767|FG001|Placebo Run-in|Pregnancy|1|||
163041500|NCT00492232|588860766|FG000|Placebo Run-in|Entrance criteria not met|0|||
163041501|NCT00492232|588860767|FG001|Placebo Run-in|Entrance criteria not met|45|||
163041502|NCT00492232|588860766|FG000|Placebo Run-in|Other|0|||
163041503|NCT00492232|588860767|FG001|Placebo Run-in|Other|6|||
163041504|NCT00492232|588860766|FG000|Placebo Run-in|Missing|0|||
163041505|NCT00492232|588860767|FG001|Placebo Run-in|Missing|2|||
163041506|NCT00492232|588860766|FG000|Double-Blind Treatment|Adverse Event|1|||
163041507|NCT00492232|588860767|FG001|Double-Blind Treatment|Adverse Event|2|||
163041508|NCT00492232|588860766|FG000|Double-Blind Treatment|Protocol Violation|3|||
163041509|NCT00492232|588860767|FG001|Double-Blind Treatment|Protocol Violation|7|||
163041510|NCT00492232|588860766|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
163041511|NCT00492232|588860767|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
163041512|NCT00492232|588860766|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
163041513|NCT00492232|588860767|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
163041514|NCT00492232|588860766|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
163041515|NCT00492232|588860767|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
163041516|NCT00492232|588860766|FG000|Double-Blind Treatment|Other|6|||
163041517|NCT00492232|588860767|FG001|Double-Blind Treatment|Other|5|||
163041518|NCT00492232|588860766|FG000|Double-Blind Treatment|Randomized not treated|1|||
163041519|NCT00492232|588860767|FG001|Double-Blind Treatment|Randomized not treated|0|||
163041520|NCT00492232|588860766|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
163041521|NCT00492232|588860767|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
163041522|NCT00980655|588860768|FG000|Overall Study|Adverse Event|13|||
163041523|NCT00980655|588860769|FG001|Overall Study|Adverse Event|31|||
163041524|NCT00980655|588860768|FG000|Overall Study|Death|0|||
163041525|NCT00980655|588860769|FG001|Overall Study|Death|7|||
163041526|NCT00980655|588860768|FG000|Overall Study|Protocol Violation|2|||
163041527|NCT00980655|588860769|FG001|Overall Study|Protocol Violation|7|||
163041528|NCT00980655|588860768|FG000|Overall Study|Withdrawal by Subject|0|||
163041529|NCT00980655|588860769|FG001|Overall Study|Withdrawal by Subject|4|||
163041530|NCT00980655|588860768|FG000|Overall Study|Lost to Follow-up|0|||
163041531|NCT00980655|588860769|FG001|Overall Study|Lost to Follow-up|1|||
163041532|NCT00980655|588860768|FG000|Overall Study|Parent/legal guardian request|1|||
163041533|NCT00980655|588860769|FG001|Overall Study|Parent/legal guardian request|0|||
163041534|NCT00980655|588860768|FG000|Overall Study|Other|0|||
163041535|NCT00980655|588860769|FG001|Overall Study|Other|1|||
163041536|NCT04162795|588860770|FG000|Overall Study|Other|16|||
163041537|NCT04162795|588860770|FG000|Overall Study|Screen failures|10|||
163041538|NCT01416155|588860774|FG000|Overall Study|Adverse Event|8|||
163041539|NCT01416155|588860774|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
163041540|NCT01416155|588860774|FG000|Overall Study|Withdrawal by Subject|33|||
163041541|NCT01416155|588860774|FG000|Overall Study|Investigator decision|8|||
163041542|NCT01416155|588860774|FG000|Overall Study|Other|7|||
163041543|NCT00829829|588860778|FG000|Overall Study|Protocol Violation|0|||
163041544|NCT00829829|588860779|FG001|Overall Study|Protocol Violation|3|||
163041545|NCT00829829|588860780|FG002|Overall Study|Protocol Violation|0|||
163041546|NCT00829829|588860778|FG000|Overall Study|Adverse Event|4|||
163041547|NCT00829829|588860779|FG001|Overall Study|Adverse Event|4|||
163041548|NCT00829829|588860780|FG002|Overall Study|Adverse Event|3|||
163041549|NCT00829829|588860778|FG000|Overall Study|Withdrawal by Subject|8|||
163041550|NCT00829829|588860779|FG001|Overall Study|Withdrawal by Subject|4|||
163041551|NCT00829829|588860780|FG002|Overall Study|Withdrawal by Subject|2|||
163041552|NCT00829829|588860778|FG000|Overall Study|Decision by the Sponsor|1|||
163041553|NCT00829829|588860779|FG001|Overall Study|Decision by the Sponsor|0|||
163041554|NCT00829829|588860780|FG002|Overall Study|Decision by the Sponsor|2|||
163041555|NCT00829829|588860778|FG000|Overall Study|Lost to Follow-up|7|||
163041556|NCT00829829|588860779|FG001|Overall Study|Lost to Follow-up|3|||
163041557|NCT00829829|588860780|FG002|Overall Study|Lost to Follow-up|3|||
163041558|NCT00829829|588860778|FG000|Overall Study|Other than specified above|2|||
163041559|NCT00829829|588860779|FG001|Overall Study|Other than specified above|2|||
163041560|NCT00829829|588860780|FG002|Overall Study|Other than specified above|1|||
163041561|NCT00382109|588860781|FG000|Overall Study|Adverse Event|3|||
163041562|NCT00382109|588860782|FG001|Overall Study|Adverse Event|0|||
163041563|NCT00382109|588860781|FG000|Overall Study|Physician Decision|6|||
163041564|NCT00382109|588860782|FG001|Overall Study|Physician Decision|1|||
163041565|NCT00382109|588860781|FG000|Overall Study|Withdrawal by Subject|1|||
163041566|NCT00382109|588860782|FG001|Overall Study|Withdrawal by Subject|0|||
163041567|NCT00382109|588860781|FG000|Overall Study|ineligible|2|||
163041568|NCT00382109|588860782|FG001|Overall Study|ineligible|0|||
163041569|NCT00382109|588860781|FG000|Overall Study|Other|0|||
163041570|NCT00382109|588860782|FG001|Overall Study|Other|2|||
163041571|NCT00382109|588860781|FG000|Overall Study|consent withdrawal|0|||
163041572|NCT00382109|588860782|FG001|Overall Study|consent withdrawal|1|||
163041573|NCT05052697|588860783|FG000|Substudy A|Lost to Follow-up|0|||
163041574|NCT05052697|588860784|FG001|Substudy A|Lost to Follow-up|0|||
163041575|NCT05052697|588860785|FG002|Substudy A|Lost to Follow-up|0|||
163041576|NCT05052697|588860786|FG003|Substudy A|Lost to Follow-up|0|||
163041577|NCT05052697|588860787|FG004|Substudy A|Lost to Follow-up|0|||
163041578|NCT05052697|588860788|FG005|Substudy A|Lost to Follow-up|1|||
163041579|NCT05052697|588860789|FG006|Substudy A|Lost to Follow-up|0|||
163041580|NCT05052697|588860790|FG007|Substudy A|Lost to Follow-up|0|||
163041581|NCT05052697|588860791|FG008|Substudy A|Lost to Follow-up|0|||
163041582|NCT05052697|588860792|FG009|Substudy A|Lost to Follow-up|0|||
163041583|NCT05052697|588860793|FG010|Substudy A|Lost to Follow-up|0|||
163041584|NCT05052697|588860794|FG011|Substudy A|Lost to Follow-up|0|||
163041585|NCT05052697|588860795|FG012|Substudy A|Lost to Follow-up|0|||
163041586|NCT05052697|588860796|FG013|Substudy A|Lost to Follow-up|0|||
163041587|NCT05052697|588860797|FG014|Substudy A|Lost to Follow-up|0|||
163041588|NCT05052697|588860798|FG015|Substudy A|Lost to Follow-up|2|||
163041589|NCT05052697|588860799|FG016|Substudy A|Lost to Follow-up|0|||
163041590|NCT05052697|588860800|FG017|Substudy A|Lost to Follow-up|0|||
163041591|NCT05052697|588860801|FG018|Substudy A|Lost to Follow-up|0|||
163041592|NCT05052697|588860802|FG019|Substudy A|Lost to Follow-up|0|||
163041593|NCT05052697|588860803|FG020|Substudy A|Lost to Follow-up|0|||
163041594|NCT05052697|588860804|FG021|Substudy A|Lost to Follow-up|0|||
163041595|NCT05052697|588860805|FG022|Substudy A|Lost to Follow-up|0|||
163041596|NCT05052697|588860806|FG023|Substudy A|Lost to Follow-up|0|||
163041597|NCT05052697|588860807|FG024|Substudy A|Lost to Follow-up|0|||
163041598|NCT05052697|588860808|FG025|Substudy A|Lost to Follow-up|0|||
163041599|NCT05052697|588860809|FG026|Substudy A|Lost to Follow-up|0|||
163041600|NCT05052697|588860810|FG027|Substudy A|Lost to Follow-up|0|||
163041601|NCT05052697|588860811|FG028|Substudy A|Lost to Follow-up|0|||
163041602|NCT05052697|588860812|FG029|Substudy A|Lost to Follow-up|0|||
163041603|NCT05052697|588860813|FG030|Substudy A|Lost to Follow-up|0|||
163041604|NCT05052697|588860814|FG031|Substudy A|Lost to Follow-up|0|||
163041605|NCT05052697|588860815|FG032|Substudy A|Lost to Follow-up|0|||
163041606|NCT05052697|588860816|FG033|Substudy A|Lost to Follow-up|0|||
163041607|NCT05052697|588860783|FG000|Substudy A|No longer met eligibility criteria|0|||
163041608|NCT05052697|588860784|FG001|Substudy A|No longer met eligibility criteria|0|||
163041609|NCT05052697|588860785|FG002|Substudy A|No longer met eligibility criteria|0|||
163041610|NCT05052697|588860786|FG003|Substudy A|No longer met eligibility criteria|0|||
163041611|NCT05052697|588860787|FG004|Substudy A|No longer met eligibility criteria|0|||
163041612|NCT05052697|588860788|FG005|Substudy A|No longer met eligibility criteria|0|||
163041613|NCT05052697|588860789|FG006|Substudy A|No longer met eligibility criteria|0|||
163041614|NCT05052697|588860790|FG007|Substudy A|No longer met eligibility criteria|0|||
163041615|NCT05052697|588860791|FG008|Substudy A|No longer met eligibility criteria|0|||
163041616|NCT05052697|588860792|FG009|Substudy A|No longer met eligibility criteria|0|||
163041617|NCT05052697|588860793|FG010|Substudy A|No longer met eligibility criteria|0|||
163041618|NCT05052697|588860794|FG011|Substudy A|No longer met eligibility criteria|0|||
163041619|NCT05052697|588860795|FG012|Substudy A|No longer met eligibility criteria|0|||
163156586|NCT01352793|589287893|FG001|Overall Study|Medication error|2|||
163156587|NCT01352793|589287892|FG000|Overall Study|Death|1|||
163156588|NCT01352793|589287893|FG001|Overall Study|Death|0|||
163156589|NCT01352793|589287892|FG000|Overall Study|Randomized but not vaccinated|8|||
163156590|NCT01352793|589287893|FG001|Overall Study|Randomized but not vaccinated|0|||
163156591|NCT01352793|589287892|FG000|Overall Study|No longer meets eligibility criteria|25|||
163156592|NCT01352793|589287893|FG001|Overall Study|No longer meets eligibility criteria|15|||
163156593|NCT04322526|589287896|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
163156594|NCT04322526|589287897|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
163156595|NCT04322526|589287896|FG000|Washout (1 Week)|Lost to Follow-up|1|||
163156596|NCT04322526|589287897|FG001|Washout (1 Week)|Lost to Follow-up|2|||
163156597|NCT03205423|589287898|FG000|Overall Study|Personal|1|||
163156598|NCT03205423|589287899|FG001|Overall Study|Personal|1|||
163156599|NCT03205423|589287898|FG000|Overall Study|Physician Decision|0|||
163156600|NCT03205423|589287899|FG001|Overall Study|Physician Decision|2|||
163156601|NCT02083354|589289695|FG000|Overall Study|Withdrawal by Subject|9|||
163156602|NCT02083354|589289695|FG000|Overall Study|Lost to Follow-up|1|||
163156603|NCT02083354|589289695|FG000|Overall Study|Adverse Event|3|||
163156604|NCT02083354|589289695|FG000|Overall Study|Disease progression|46|||
163156605|NCT02083354|589289695|FG000|Overall Study|Study closed/terminated|5|||
163156606|NCT00628108|589289696|FG000|Overall Study|Adverse Event|0|||
163156607|NCT00628108|589289697|FG001|Overall Study|Adverse Event|3|||
163156608|NCT00628108|589289696|FG000|Overall Study|Withdrawal by Subject|1|||
163156609|NCT00628108|589289697|FG001|Overall Study|Withdrawal by Subject|0|||
163041620|NCT05052697|588860796|FG013|Substudy A|No longer met eligibility criteria|1|||
163041621|NCT05052697|588860797|FG014|Substudy A|No longer met eligibility criteria|0|||
163041622|NCT05052697|588860798|FG015|Substudy A|No longer met eligibility criteria|0|||
163041623|NCT05052697|588860799|FG016|Substudy A|No longer met eligibility criteria|0|||
163041624|NCT05052697|588860800|FG017|Substudy A|No longer met eligibility criteria|0|||
163041625|NCT05052697|588860801|FG018|Substudy A|No longer met eligibility criteria|0|||
163041626|NCT05052697|588860802|FG019|Substudy A|No longer met eligibility criteria|0|||
163041627|NCT05052697|588860803|FG020|Substudy A|No longer met eligibility criteria|0|||
163041628|NCT05052697|588860804|FG021|Substudy A|No longer met eligibility criteria|0|||
163041629|NCT05052697|588860805|FG022|Substudy A|No longer met eligibility criteria|0|||
163041630|NCT05052697|588860806|FG023|Substudy A|No longer met eligibility criteria|0|||
163041631|NCT05052697|588860807|FG024|Substudy A|No longer met eligibility criteria|0|||
163041632|NCT05052697|588860808|FG025|Substudy A|No longer met eligibility criteria|0|||
163041633|NCT05052697|588860809|FG026|Substudy A|No longer met eligibility criteria|0|||
163041634|NCT05052697|588860810|FG027|Substudy A|No longer met eligibility criteria|0|||
163041635|NCT05052697|588860811|FG028|Substudy A|No longer met eligibility criteria|0|||
163041636|NCT05052697|588860812|FG029|Substudy A|No longer met eligibility criteria|0|||
163041637|NCT05052697|588860813|FG030|Substudy A|No longer met eligibility criteria|0|||
163041638|NCT05052697|588860814|FG031|Substudy A|No longer met eligibility criteria|0|||
163041639|NCT05052697|588860815|FG032|Substudy A|No longer met eligibility criteria|0|||
163041640|NCT05052697|588860816|FG033|Substudy A|No longer met eligibility criteria|0|||
163041641|NCT05052697|588860783|FG000|Substudy A|Not vaccinated|0|||
163041642|NCT05052697|588860784|FG001|Substudy A|Not vaccinated|0|||
163041643|NCT05052697|588860785|FG002|Substudy A|Not vaccinated|0|||
163156610|NCT02453321|589289698|FG000|Overall Study|Weakness|1|||
163156611|NCT02453321|589289699|FG001|Overall Study|Weakness|1|||
163041644|NCT05052697|588860786|FG003|Substudy A|Not vaccinated|1|||
163041645|NCT05052697|588860787|FG004|Substudy A|Not vaccinated|0|||
163041646|NCT05052697|588860788|FG005|Substudy A|Not vaccinated|0|||
163041647|NCT05052697|588860789|FG006|Substudy A|Not vaccinated|0|||
163041648|NCT05052697|588860790|FG007|Substudy A|Not vaccinated|0|||
163041649|NCT05052697|588860791|FG008|Substudy A|Not vaccinated|1|||
163041650|NCT05052697|588860792|FG009|Substudy A|Not vaccinated|0|||
163041651|NCT05052697|588860793|FG010|Substudy A|Not vaccinated|0|||
163041652|NCT05052697|588860794|FG011|Substudy A|Not vaccinated|0|||
163041653|NCT05052697|588860795|FG012|Substudy A|Not vaccinated|0|||
163041654|NCT05052697|588860796|FG013|Substudy A|Not vaccinated|0|||
163041655|NCT05052697|588860797|FG014|Substudy A|Not vaccinated|0|||
163041656|NCT05052697|588860798|FG015|Substudy A|Not vaccinated|0|||
163041657|NCT05052697|588860799|FG016|Substudy A|Not vaccinated|0|||
163041658|NCT05052697|588860800|FG017|Substudy A|Not vaccinated|0|||
163041659|NCT05052697|588860801|FG018|Substudy A|Not vaccinated|0|||
163041660|NCT05052697|588860802|FG019|Substudy A|Not vaccinated|0|||
163041661|NCT05052697|588860803|FG020|Substudy A|Not vaccinated|0|||
163041662|NCT05052697|588860804|FG021|Substudy A|Not vaccinated|0|||
163041663|NCT05052697|588860805|FG022|Substudy A|Not vaccinated|0|||
163041664|NCT05052697|588860806|FG023|Substudy A|Not vaccinated|0|||
163041665|NCT05052697|588860807|FG024|Substudy A|Not vaccinated|0|||
163041666|NCT05052697|588860808|FG025|Substudy A|Not vaccinated|0|||
163041667|NCT05052697|588860809|FG026|Substudy A|Not vaccinated|0|||
163041668|NCT05052697|588860810|FG027|Substudy A|Not vaccinated|0|||
163041669|NCT05052697|588860811|FG028|Substudy A|Not vaccinated|0|||
163041670|NCT05052697|588860812|FG029|Substudy A|Not vaccinated|0|||
163041671|NCT05052697|588860813|FG030|Substudy A|Not vaccinated|0|||
163041672|NCT05052697|588860814|FG031|Substudy A|Not vaccinated|0|||
163041673|NCT05052697|588860815|FG032|Substudy A|Not vaccinated|0|||
163041674|NCT05052697|588860816|FG033|Substudy A|Not vaccinated|0|||
163041675|NCT05052697|588860783|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041676|NCT05052697|588860784|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041677|NCT05052697|588860785|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041678|NCT05052697|588860786|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041679|NCT05052697|588860787|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041680|NCT05052697|588860788|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041681|NCT05052697|588860789|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041682|NCT05052697|588860790|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041683|NCT05052697|588860791|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041684|NCT05052697|588860792|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041685|NCT05052697|588860793|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041686|NCT05052697|588860794|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041687|NCT05052697|588860795|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041688|NCT05052697|588860796|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041689|NCT05052697|588860797|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041690|NCT05052697|588860798|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041691|NCT05052697|588860799|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041692|NCT05052697|588860800|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041693|NCT05052697|588860801|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
163041694|NCT05052697|588860802|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
163041695|NCT05052697|588860803|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041696|NCT05052697|588860804|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
163041697|NCT05052697|588860805|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
163041698|NCT05052697|588860806|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041699|NCT05052697|588860807|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041700|NCT05052697|588860808|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041701|NCT05052697|588860809|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041702|NCT05052697|588860810|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041703|NCT05052697|588860811|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041704|NCT05052697|588860812|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041705|NCT05052697|588860813|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041706|NCT05052697|588860814|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041707|NCT05052697|588860815|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041708|NCT05052697|588860816|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041709|NCT05052697|588860783|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041710|NCT05052697|588860784|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041711|NCT05052697|588860785|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041712|NCT05052697|588860786|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041713|NCT05052697|588860787|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041714|NCT05052697|588860788|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041715|NCT05052697|588860789|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041716|NCT05052697|588860790|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041717|NCT05052697|588860791|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041718|NCT05052697|588860792|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041719|NCT05052697|588860793|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041720|NCT05052697|588860794|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041721|NCT05052697|588860795|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041722|NCT05052697|588860796|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041723|NCT05052697|588860797|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041724|NCT05052697|588860798|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041725|NCT05052697|588860799|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041726|NCT05052697|588860800|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
163041727|NCT05052697|588860801|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
163270964|NCT02733042|589700075|FG011|Overall Study|Progressive Disease|2|||
163041728|NCT05052697|588860802|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041729|NCT05052697|588860803|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041730|NCT05052697|588860804|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041731|NCT05052697|588860805|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041732|NCT05052697|588860806|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041733|NCT05052697|588860807|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041734|NCT05052697|588860808|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041735|NCT05052697|588860809|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041736|NCT05052697|588860810|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041737|NCT05052697|588860811|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041738|NCT05052697|588860812|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041739|NCT05052697|588860813|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
163156612|NCT02453321|589289700|FG002|Overall Study|Weakness|2|||
163156613|NCT02453321|589289698|FG000|Overall Study|Deep Venous Thrombosis|0|||
163156614|NCT02453321|589289699|FG001|Overall Study|Deep Venous Thrombosis|1|||
163156615|NCT02453321|589289700|FG002|Overall Study|Deep Venous Thrombosis|0|||
163156616|NCT00098813|589289701|FG000|Overall Study|Death|8|||
163156617|NCT00098813|589289701|FG000|Overall Study|Protocol Violation|1|||
163156618|NCT00098813|589289701|FG000|Overall Study|Withdrawal by Subject|7|||
163156619|NCT00098813|589289701|FG000|Overall Study|Progression of Disease|1|||
163156620|NCT00098813|589289701|FG000|Overall Study|Other complicating disease|1|||
163156621|NCT00098813|589289701|FG000|Overall Study|Reversal of RAI resistance|1|||
163156622|NCT02230670|589289702|FG000|Overall Study|Adverse Event|1|||
163156623|NCT02230670|589289703|FG001|Overall Study|Adverse Event|2|||
163156624|NCT02230670|589289702|FG000|Overall Study|Withdrawal by Subject|2|||
163156625|NCT02230670|589289703|FG001|Overall Study|Withdrawal by Subject|2|||
163156626|NCT02230670|589289702|FG000|Overall Study|Physician Decision|0|||
163156627|NCT02230670|589289703|FG001|Overall Study|Physician Decision|1|||
163156628|NCT02230670|589289702|FG000|Overall Study|Protocol Violation|0|||
163156629|NCT02230670|589289703|FG001|Overall Study|Protocol Violation|1|||
163156630|NCT02230670|589289702|FG000|Overall Study|Progression to Child-Pugh C|1|||
163156631|NCT02230670|589289703|FG001|Overall Study|Progression to Child-Pugh C|2|||
163156632|NCT01907854|589289708|FG000|Overall Study|Protocol Violation|1|||
163156633|NCT01907854|589289709|FG001|Overall Study|Protocol Violation|1|||
163156634|NCT01907854|589289708|FG000|Overall Study|Withdrawal by Subject|9|||
163156635|NCT01907854|589289709|FG001|Overall Study|Withdrawal by Subject|7|||
163156636|NCT01907854|589289708|FG000|Overall Study|Lost to Follow-up|2|||
163156637|NCT01907854|589289709|FG001|Overall Study|Lost to Follow-up|2|||
163156638|NCT01907854|589289708|FG000|Overall Study|Unclassified|4|||
163156639|NCT01907854|589289709|FG001|Overall Study|Unclassified|3|||
163156640|NCT02106390|589289710|FG000|Overall Study|Withdrawal by Subject|15|||
163156641|NCT02106390|589289711|FG001|Overall Study|Withdrawal by Subject|16|||
163156642|NCT02106390|589289712|FG002|Overall Study|Withdrawal by Subject|15|||
163156643|NCT02106390|589289710|FG000|Overall Study|Lost to Follow-up|25|||
163156644|NCT02106390|589289711|FG001|Overall Study|Lost to Follow-up|20|||
163156645|NCT02106390|589289712|FG002|Overall Study|Lost to Follow-up|13|||
163156646|NCT02106390|589289710|FG000|Overall Study|Other: Administrative Reason|8|||
163156647|NCT02106390|589289711|FG001|Overall Study|Other: Administrative Reason|5|||
163156648|NCT02106390|589289712|FG002|Overall Study|Other: Administrative Reason|12|||
163156649|NCT02106390|589289710|FG000|Overall Study|Other: Unspecified|1|||
163156650|NCT02106390|589289711|FG001|Overall Study|Other: Unspecified|4|||
163156651|NCT02106390|589289712|FG002|Overall Study|Other: Unspecified|2|||
163156652|NCT02106390|589289710|FG000|Overall Study|Adverse Event|0|||
163156653|NCT02106390|589289711|FG001|Overall Study|Adverse Event|2|||
163156654|NCT02106390|589289712|FG002|Overall Study|Adverse Event|1|||
163156655|NCT02106390|589289710|FG000|Overall Study|Protocol Violation|0|||
163156656|NCT02106390|589289711|FG001|Overall Study|Protocol Violation|1|||
163156657|NCT02106390|589289712|FG002|Overall Study|Protocol Violation|0|||
163156658|NCT02968004|589289713|FG000|Main Study Phase|Adverse Event|1|||
163156659|NCT02968004|589289714|FG001|Main Study Phase|Adverse Event|0|||
163156660|NCT02968004|589289713|FG000|Main Study Phase|Withdrawal by Subject|0|||
163156661|NCT02968004|589289714|FG001|Main Study Phase|Withdrawal by Subject|1|||
163156662|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
163156663|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
163156664|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
163156665|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
163156666|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
163156667|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
163156668|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
163156669|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
163156670|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
163156671|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
163156672|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
163156673|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
163156674|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
163156675|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
163156676|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
163156677|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
163156678|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
163156679|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
163156680|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
163156681|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
163156682|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
163156683|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
163156684|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
163156685|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
163156686|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
163156687|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
163156688|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
163156689|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
163156690|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
163156691|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
163156692|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
163156693|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
163156694|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
163156695|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
163156696|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
163156697|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
163156698|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
163156699|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
163156700|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
163156701|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
163156702|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
163156703|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
163156704|NCT00803569|589289716|FG000|Overall Study|Progressive Disease|3|||
163156705|NCT00803569|589289716|FG000|Overall Study|Noncompliance|1|||
163156706|NCT02504151|589289717|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
163156707|NCT02504151|589289718|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
163156708|NCT02504151|589289717|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
163156709|NCT02504151|589289718|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
163156710|NCT02504151|589289717|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
163156711|NCT02504151|589289718|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
163156712|NCT02504151|589289717|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
163156713|NCT02504151|589289718|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
163156714|NCT00538902|589289719|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
163156715|NCT00538902|589289720|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
163156716|NCT00538902|589289721|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
163156717|NCT00538902|589289719|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
163156718|NCT00538902|589289720|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
163156719|NCT00538902|589289721|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
163156720|NCT00538902|589289719|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
163156721|NCT00538902|589289720|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
163156722|NCT00538902|589289721|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
163156723|NCT00538902|589289719|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
163156724|NCT00538902|589289720|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
163156725|NCT00538902|589289721|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
163156726|NCT00538902|589289719|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
163156727|NCT00538902|589289720|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
163156728|NCT00538902|589289721|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
163156729|NCT00538902|589289719|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
163156730|NCT00538902|589289720|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
163156731|NCT00538902|589289721|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
163156732|NCT00538902|589289719|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
163156733|NCT00538902|589289720|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
163156734|NCT00538902|589289721|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
163156735|NCT00538902|589289719|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
163156736|NCT00538902|589289720|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
163156737|NCT00538902|589289721|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
163156738|NCT01454102|589289722|FG000|Overall Study|Continuing in the treatment period|0|||
163156739|NCT01454102|589289723|FG001|Overall Study|Continuing in the treatment period|0|||
163156740|NCT01454102|589289724|FG002|Overall Study|Continuing in the treatment period|0|||
163156741|NCT01454102|589289725|FG003|Overall Study|Continuing in the treatment period|0|||
163156742|NCT01454102|589289726|FG004|Overall Study|Continuing in the treatment period|3|||
163156743|NCT01454102|589289727|FG005|Overall Study|Continuing in the treatment period|3|||
163156744|NCT01454102|589289728|FG006|Overall Study|Continuing in the treatment period|2|||
163156745|NCT01454102|589289729|FG007|Overall Study|Continuing in the treatment period|0|||
163156746|NCT01454102|589289730|FG008|Overall Study|Continuing in the treatment period|1|||
163156747|NCT01454102|589289731|FG009|Overall Study|Continuing in the treatment period|0|||
163156748|NCT01454102|589289732|FG010|Overall Study|Continuing in the treatment period|0|||
163156749|NCT01454102|589289733|FG011|Overall Study|Continuing in the treatment period|4|||
163156750|NCT01454102|589289734|FG012|Overall Study|Continuing in the treatment period|7|||
163156751|NCT01454102|589289735|FG013|Overall Study|Continuing in the treatment period|4|||
163270965|NCT02733042|589700076|FG012|Overall Study|Progressive Disease|8|||
163156752|NCT01454102|589289736|FG014|Overall Study|Continuing in the treatment period|3|||
163156753|NCT01454102|589289737|FG015|Overall Study|Continuing in the treatment period|1|||
163156754|NCT01782378|589289740|FG000|First Series|Lost to Follow-up|7|||
163156755|NCT01782378|589289741|FG001|First Series|Lost to Follow-up|8|||
163156756|NCT01782378|589289740|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
163156757|NCT01782378|589289741|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
163270966|NCT02733042|589700077|FG013|Overall Study|Progressive Disease|1|||
163156758|NCT01782378|589289740|FG000|Second Series|Lost to Follow-up|8|||
163156759|NCT01782378|589289741|FG001|Second Series|Lost to Follow-up|7|||
163156760|NCT01782378|589289740|FG000|Second Series|Did not choose to complete S2 Optional|18|||
163156761|NCT01782378|589289741|FG001|Second Series|Did not choose to complete S2 Optional|0|||
163156762|NCT00705016|589289742|FG000|Overall Study|Adverse Event|6|||
163156763|NCT00705016|589289743|FG001|Overall Study|Adverse Event|11|||
163156764|NCT00705016|589289744|FG002|Overall Study|Adverse Event|10|||
163156765|NCT00705016|589289742|FG000|Overall Study|Death|5|||
163156766|NCT00705016|589289743|FG001|Overall Study|Death|7|||
163156767|NCT00705016|589289744|FG002|Overall Study|Death|5|||
163156768|NCT00705016|589289742|FG000|Overall Study|Protocol Violation|0|||
163156769|NCT00705016|589289743|FG001|Overall Study|Protocol Violation|1|||
163156770|NCT00705016|589289744|FG002|Overall Study|Protocol Violation|1|||
163156771|NCT00705016|589289742|FG000|Overall Study|Withdrawal by Subject|4|||
163156772|NCT00705016|589289743|FG001|Overall Study|Withdrawal by Subject|3|||
163156773|NCT00705016|589289744|FG002|Overall Study|Withdrawal by Subject|2|||
163156774|NCT00705016|589289742|FG000|Overall Study|Progressive Disease|33|||
163156775|NCT00705016|589289743|FG001|Overall Study|Progressive Disease|29|||
163156776|NCT00705016|589289744|FG002|Overall Study|Progressive Disease|33|||
163156777|NCT00705016|589289742|FG000|Overall Study|Symptomatic Deterioration|3|||
163156778|NCT00705016|589289743|FG001|Overall Study|Symptomatic Deterioration|1|||
163156779|NCT00705016|589289744|FG002|Overall Study|Symptomatic Deterioration|1|||
163156780|NCT00705016|589289742|FG000|Overall Study|Other|9|||
163156781|NCT00705016|589289743|FG001|Overall Study|Other|6|||
163156782|NCT00705016|589289744|FG002|Overall Study|Other|6|||
163156783|NCT00942604|589289747|FG000|Overall Study|Protocol Violation|1|||
163156784|NCT00942604|589289748|FG001|Overall Study|Protocol Violation|1|||
163156785|NCT00942604|589289747|FG000|Overall Study|Adverse Event|0|||
163156786|NCT00942604|589289748|FG001|Overall Study|Adverse Event|1|||
163156787|NCT00942604|589289747|FG000|Overall Study|Withdrawal by Subject|0|||
163156788|NCT00942604|589289748|FG001|Overall Study|Withdrawal by Subject|1|||
163156789|NCT00942604|589289747|FG000|Overall Study|Patient relocation|1|||
163156790|NCT00942604|589289748|FG001|Overall Study|Patient relocation|1|||
163156791|NCT01188343|589289749|FG000|Overall Study|Not vaccinated|0|||
163156792|NCT01188343|589289750|FG001|Overall Study|Not vaccinated|2|||
163156793|NCT01188343|589289751|FG002|Overall Study|Not vaccinated|1|||
163156794|NCT01188343|589289749|FG000|Overall Study|Withdrawal by Subject|1|||
163156795|NCT01188343|589289750|FG001|Overall Study|Withdrawal by Subject|24|||
163156796|NCT01188343|589289751|FG002|Overall Study|Withdrawal by Subject|0|||
163156797|NCT04109547|589289752|FG000|Overall Study|Withdrawal by Subject|3|||
163156798|NCT04109547|589289753|FG001|Overall Study|Withdrawal by Subject|2|||
163156799|NCT04109547|589289754|FG002|Overall Study|Withdrawal by Subject|6|||
163156800|NCT04109547|589289755|FG003|Overall Study|Withdrawal by Subject|6|||
163156801|NCT04109547|589289752|FG000|Overall Study|Lost to Follow-up|0|||
163156802|NCT04109547|589289753|FG001|Overall Study|Lost to Follow-up|0|||
163156803|NCT04109547|589289754|FG002|Overall Study|Lost to Follow-up|0|||
163156804|NCT04109547|589289755|FG003|Overall Study|Lost to Follow-up|1|||
163156805|NCT04109547|589289752|FG000|Overall Study|Physician Decision|1|||
163156806|NCT04109547|589289753|FG001|Overall Study|Physician Decision|2|||
163156807|NCT04109547|589289754|FG002|Overall Study|Physician Decision|0|||
163156808|NCT04109547|589289755|FG003|Overall Study|Physician Decision|0|||
163156809|NCT01663103|589289756|FG000|Overall Study|Withdrawal by Subject|1|||
163156810|NCT01663103|589289757|FG001|Overall Study|Withdrawal by Subject|2|||
163156811|NCT01663103|589289756|FG000|Overall Study|Adverse Event|1|||
163156812|NCT01663103|589289757|FG001|Overall Study|Adverse Event|0|||
163156813|NCT01663103|589289756|FG000|Overall Study|dog bite|1|||
163156814|NCT01663103|589289757|FG001|Overall Study|dog bite|0|||
163156815|NCT01499355|589289762|FG000|Run-In Period|Study Termination|15|||
163156816|NCT01499355|589289763|FG001|Run-In Period|Study Termination|0|||
163156817|NCT01499355|589289764|FG002|Run-In Period|Study Termination|0|||
163156818|NCT01499355|589289765|FG003|Run-In Period|Study Termination|0|||
163156819|NCT01499355|589289762|FG000|Run-In Period|Other|3|||
163156820|NCT01499355|589289763|FG001|Run-In Period|Other|0|||
163156821|NCT01499355|589289764|FG002|Run-In Period|Other|0|||
163156822|NCT01499355|589289765|FG003|Run-In Period|Other|0|||
163156823|NCT01499355|589289762|FG000|Run-In Period|Death|2|||
163156824|NCT01499355|589289763|FG001|Run-In Period|Death|0|||
163156825|NCT01499355|589289764|FG002|Run-In Period|Death|0|||
163156826|NCT01499355|589289765|FG003|Run-In Period|Death|0|||
163156827|NCT01499355|589289762|FG000|Run-In Period|Investigator Decision|2|||
163156828|NCT01499355|589289763|FG001|Run-In Period|Investigator Decision|0|||
163156829|NCT01499355|589289764|FG002|Run-In Period|Investigator Decision|0|||
163270967|NCT02733042|589700078|FG014|Overall Study|Progressive Disease|4|||
163041740|NCT05052697|588860814|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041741|NCT05052697|588860815|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041742|NCT05052697|588860816|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041743|NCT05052697|588860783|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041744|NCT05052697|588860784|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041745|NCT05052697|588860785|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041746|NCT05052697|588860786|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041747|NCT05052697|588860787|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041748|NCT05052697|588860788|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041749|NCT05052697|588860789|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041750|NCT05052697|588860790|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041751|NCT05052697|588860791|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041752|NCT05052697|588860792|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041753|NCT05052697|588860793|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163156830|NCT01499355|589289765|FG003|Run-In Period|Investigator Decision|0|||
163156831|NCT01499355|589289762|FG000|Run-In Period|Consent Withdrawn|1|||
163156832|NCT01499355|589289763|FG001|Run-In Period|Consent Withdrawn|0|||
163156833|NCT01499355|589289764|FG002|Run-In Period|Consent Withdrawn|0|||
163156834|NCT01499355|589289765|FG003|Run-In Period|Consent Withdrawn|0|||
163156835|NCT01499355|589289762|FG000|Run-In Period|Adverse Event|8|||
163156836|NCT01499355|589289763|FG001|Run-In Period|Adverse Event|0|||
163156837|NCT01499355|589289764|FG002|Run-In Period|Adverse Event|0|||
163156838|NCT01499355|589289765|FG003|Run-In Period|Adverse Event|0|||
163156839|NCT01499355|589289762|FG000|Double-Blind Period|Adverse Event|0|||
163156840|NCT01499355|589289763|FG001|Double-Blind Period|Adverse Event|2|||
163156841|NCT01499355|589289764|FG002|Double-Blind Period|Adverse Event|3|||
163156842|NCT01499355|589289765|FG003|Double-Blind Period|Adverse Event|2|||
163156843|NCT01499355|589289762|FG000|Double-Blind Period|Study Termination|0|||
163156844|NCT01499355|589289763|FG001|Double-Blind Period|Study Termination|18|||
163156845|NCT01499355|589289764|FG002|Double-Blind Period|Study Termination|16|||
163156846|NCT01499355|589289765|FG003|Double-Blind Period|Study Termination|14|||
163156847|NCT01499355|589289762|FG000|Double-Blind Period|Other|0|||
163156848|NCT01499355|589289763|FG001|Double-Blind Period|Other|1|||
163156849|NCT01499355|589289764|FG002|Double-Blind Period|Other|2|||
163156850|NCT01499355|589289765|FG003|Double-Blind Period|Other|2|||
163156851|NCT01499355|589289762|FG000|Double-Blind Period|Death|0|||
163156852|NCT01499355|589289763|FG001|Double-Blind Period|Death|1|||
163156853|NCT01499355|589289764|FG002|Double-Blind Period|Death|0|||
163156854|NCT01499355|589289765|FG003|Double-Blind Period|Death|0|||
163156855|NCT01499355|589289762|FG000|Double-Blind Period|Investigator Decision|0|||
163156856|NCT01499355|589289763|FG001|Double-Blind Period|Investigator Decision|0|||
163156857|NCT01499355|589289764|FG002|Double-Blind Period|Investigator Decision|3|||
163156858|NCT01499355|589289765|FG003|Double-Blind Period|Investigator Decision|3|||
163156859|NCT01499355|589289762|FG000|Double-Blind Period|Consent Withdrawn|0|||
163156860|NCT01499355|589289763|FG001|Double-Blind Period|Consent Withdrawn|0|||
163156861|NCT01499355|589289764|FG002|Double-Blind Period|Consent Withdrawn|1|||
163156862|NCT01499355|589289765|FG003|Double-Blind Period|Consent Withdrawn|2|||
163156863|NCT01499355|589289762|FG000|Double-Blind Period|Lost to Follow-up|0|||
163156864|NCT01499355|589289763|FG001|Double-Blind Period|Lost to Follow-up|1|||
163156865|NCT01499355|589289764|FG002|Double-Blind Period|Lost to Follow-up|0|||
163156866|NCT01499355|589289765|FG003|Double-Blind Period|Lost to Follow-up|0|||
163156867|NCT02668653|589289766|FG000|Overall Study|Refractory disease|41|||
163156868|NCT02668653|589289767|FG001|Overall Study|Refractory disease|70|||
163156869|NCT02668653|589289766|FG000|Overall Study|Relapse|44|||
163156870|NCT02668653|589289767|FG001|Overall Study|Relapse|65|||
163156871|NCT02668653|589289766|FG000|Overall Study|Adverse Event|58|||
163156872|NCT02668653|589289767|FG001|Overall Study|Adverse Event|23|||
163156873|NCT02668653|589289766|FG000|Overall Study|Subject decision to stop study drug|25|||
163156874|NCT02668653|589289767|FG001|Overall Study|Subject decision to stop study drug|23|||
163156875|NCT02668653|589289766|FG000|Overall Study|Other reasons not specified|16|||
163156876|NCT02668653|589289767|FG001|Overall Study|Other reasons not specified|11|||
163156877|NCT02668653|589289766|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
163156878|NCT02668653|589289767|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
163156879|NCT02668653|589289766|FG000|Overall Study|Investigator decision|10|||
163156880|NCT02668653|589289767|FG001|Overall Study|Investigator decision|7|||
163270968|NCT02733042|589700079|FG015|Overall Study|Progressive Disease|7|||
163041754|NCT05052697|588860794|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041755|NCT05052697|588860795|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163156881|NCT02668653|589289766|FG000|Overall Study|Failure to meet continuation criteria|5|||
163156882|NCT02668653|589289767|FG001|Overall Study|Failure to meet continuation criteria|12|||
163156883|NCT02668653|589289766|FG000|Overall Study|Lost to Follow-up|1|||
163156884|NCT02668653|589289767|FG001|Overall Study|Lost to Follow-up|0|||
163156885|NCT02668653|589289766|FG000|Overall Study|Pregnancy|0|||
163156886|NCT02668653|589289767|FG001|Overall Study|Pregnancy|1|||
163156887|NCT02668653|589289766|FG000|Overall Study|Death|0|||
163156888|NCT02668653|589289767|FG001|Overall Study|Death|1|||
163156889|NCT00686712|589289768|FG000|Overall Study|Protocol Violation|8|||
163041756|NCT05052697|588860796|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041757|NCT05052697|588860797|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041758|NCT05052697|588860798|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041759|NCT05052697|588860799|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041760|NCT05052697|588860800|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041761|NCT05052697|588860801|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041762|NCT05052697|588860802|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
163041763|NCT05052697|588860803|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041764|NCT05052697|588860804|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041765|NCT05052697|588860805|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041766|NCT05052697|588860806|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041767|NCT05052697|588860807|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041768|NCT05052697|588860808|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041769|NCT05052697|588860809|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041770|NCT05052697|588860810|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041771|NCT05052697|588860811|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041772|NCT05052697|588860812|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041773|NCT05052697|588860813|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041774|NCT05052697|588860814|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041775|NCT05052697|588860815|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041776|NCT05052697|588860816|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041777|NCT05052697|588860783|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041778|NCT05052697|588860784|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041779|NCT05052697|588860785|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041780|NCT05052697|588860786|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041781|NCT05052697|588860787|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041782|NCT05052697|588860788|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041783|NCT05052697|588860789|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041784|NCT05052697|588860790|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041785|NCT05052697|588860791|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041786|NCT05052697|588860792|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041787|NCT05052697|588860793|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041788|NCT05052697|588860794|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041789|NCT05052697|588860795|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041790|NCT05052697|588860796|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041791|NCT05052697|588860797|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041792|NCT05052697|588860798|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041793|NCT05052697|588860799|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041794|NCT05052697|588860800|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
163041795|NCT05052697|588860801|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041796|NCT05052697|588860802|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041797|NCT05052697|588860803|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041798|NCT05052697|588860804|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041799|NCT05052697|588860805|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041800|NCT05052697|588860806|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041801|NCT05052697|588860807|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041802|NCT05052697|588860808|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
163041803|NCT05052697|588860809|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041804|NCT05052697|588860810|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
163041805|NCT05052697|588860811|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041806|NCT05052697|588860812|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041807|NCT05052697|588860813|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041808|NCT05052697|588860814|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041809|NCT05052697|588860815|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041810|NCT05052697|588860816|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041811|NCT05052697|588860783|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041812|NCT05052697|588860784|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041813|NCT05052697|588860785|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041814|NCT05052697|588860786|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041815|NCT05052697|588860787|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041816|NCT05052697|588860788|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041817|NCT05052697|588860789|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041818|NCT05052697|588860790|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041819|NCT05052697|588860791|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041820|NCT05052697|588860792|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041821|NCT05052697|588860793|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041822|NCT05052697|588860794|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041823|NCT05052697|588860795|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041824|NCT05052697|588860796|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163156890|NCT00686712|589289769|FG001|Overall Study|Protocol Violation|8|||
163156891|NCT00686712|589289770|FG002|Overall Study|Protocol Violation|10|||
163156892|NCT00686712|589289768|FG000|Overall Study|Lost to Follow-up|1|||
163156893|NCT00686712|589289769|FG001|Overall Study|Lost to Follow-up|2|||
163156894|NCT00686712|589289770|FG002|Overall Study|Lost to Follow-up|3|||
163156895|NCT00686712|589289768|FG000|Overall Study|Adverse Event|1|||
163156896|NCT00686712|589289769|FG001|Overall Study|Adverse Event|1|||
163156897|NCT00686712|589289770|FG002|Overall Study|Adverse Event|0|||
163156898|NCT04119414|589289771|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
163156899|NCT01929317|589289785|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
163156900|NCT01929317|589289786|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
163156901|NCT01929317|589289785|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
163156902|NCT01929317|589289786|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
163156903|NCT01929317|589289785|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
163156904|NCT01929317|589289786|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
163156905|NCT01929317|589289785|FG000|Long-term Phase|Adverse Event|5|||
163156906|NCT01929317|589289786|FG001|Long-term Phase|Adverse Event|1|||
163156907|NCT01929317|589289785|FG000|Long-term Phase|Physician Decision|3|||
163156908|NCT01929317|589289786|FG001|Long-term Phase|Physician Decision|0|||
163156909|NCT01929317|589289785|FG000|Long-term Phase|Withdrawal by Subject|4|||
163156910|NCT01929317|589289786|FG001|Long-term Phase|Withdrawal by Subject|0|||
163156911|NCT01929317|589289785|FG000|Long-term Phase|Protocol Violation|1|||
163156912|NCT01929317|589289786|FG001|Long-term Phase|Protocol Violation|0|||
163156913|NCT01929317|589289785|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
163156914|NCT01929317|589289786|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
163156915|NCT01929317|589289785|FG000|Long-term Phase|Study Closed/Terminated|5|||
163156916|NCT01929317|589289786|FG001|Long-term Phase|Study Closed/Terminated|3|||
163156917|NCT00993967|589289790|FG000|Overall Study|Adverse Event|8|||
163156918|NCT00993967|589289790|FG000|Overall Study|Death|1|||
163156919|NCT00993967|589289790|FG000|Overall Study|Lost to Follow-up|14|||
163156920|NCT00993967|589289790|FG000|Overall Study|Withdrawal by Subject|36|||
163156921|NCT00993967|589289790|FG000|Overall Study|Protocol Violation|2|||
163156922|NCT03815929|589289799|FG000|Overall Study|Lost to Follow-up|2|||
163156923|NCT03815929|589289800|FG001|Overall Study|Lost to Follow-up|1|||
163156924|NCT03815929|589289801|FG002|Overall Study|Lost to Follow-up|0|||
163156925|NCT03815929|589289799|FG000|Overall Study|Physician Decision|2|||
163156926|NCT03815929|589289800|FG001|Overall Study|Physician Decision|2|||
163156927|NCT03815929|589289801|FG002|Overall Study|Physician Decision|0|||
163156928|NCT03815929|589289799|FG000|Overall Study|Withdrawal by Subject|0|||
163156929|NCT03815929|589289800|FG001|Overall Study|Withdrawal by Subject|0|||
163156930|NCT03815929|589289801|FG002|Overall Study|Withdrawal by Subject|1|||
163156931|NCT03313037|589289802|FG000|Overall Study|Protocol Violation|4|||
163156932|NCT03313037|589289803|FG001|Overall Study|Protocol Violation|1|||
163156933|NCT03313037|589289802|FG000|Overall Study|Other|1|||
163156934|NCT03313037|589289803|FG001|Overall Study|Other|1|||
163156935|NCT03313037|589289802|FG000|Overall Study|Withdrawal by Subject|4|||
163156936|NCT03313037|589289803|FG001|Overall Study|Withdrawal by Subject|3|||
163156937|NCT03313037|589289802|FG000|Overall Study|No longer meets eligibility criteria|1|||
163156938|NCT03313037|589289803|FG001|Overall Study|No longer meets eligibility criteria|7|||
163156939|NCT03313037|589289802|FG000|Overall Study|Lost to Follow-up|9|||
163156940|NCT03313037|589289803|FG001|Overall Study|Lost to Follow-up|8|||
163156941|NCT03313037|589289802|FG000|Overall Study|Randomized but not treated|1|||
163156942|NCT03313037|589289803|FG001|Overall Study|Randomized but not treated|0|||
163156943|NCT02760498|589289804|FG000|Overall Study|Adverse Event|3|||
163156944|NCT02760498|589289805|FG001|Overall Study|Adverse Event|3|||
163156945|NCT02760498|589289806|FG002|Overall Study|Adverse Event|1|||
163156946|NCT02760498|589289807|FG003|Overall Study|Adverse Event|1|||
163156947|NCT02760498|589289808|FG004|Overall Study|Adverse Event|0|||
163156948|NCT02760498|589289809|FG005|Overall Study|Adverse Event|6|||
163156949|NCT02760498|589289804|FG000|Overall Study|Death|7|||
163270969|NCT02733042|589700080|FG016|Overall Study|Progressive Disease|2|||
163156950|NCT02760498|589289805|FG001|Overall Study|Death|5|||
163156951|NCT02760498|589289806|FG002|Overall Study|Death|5|||
163156952|NCT02760498|589289807|FG003|Overall Study|Death|7|||
163156953|NCT02760498|589289808|FG004|Overall Study|Death|0|||
163156954|NCT02760498|589289809|FG005|Overall Study|Death|23|||
163156955|NCT02760498|589289804|FG000|Overall Study|Lost to Follow-up|0|||
163156956|NCT02760498|589289805|FG001|Overall Study|Lost to Follow-up|0|||
163156957|NCT02760498|589289806|FG002|Overall Study|Lost to Follow-up|0|||
163156958|NCT02760498|589289807|FG003|Overall Study|Lost to Follow-up|0|||
163270970|NCT02733042|589700081|FG017|Overall Study|Progressive Disease|3|||
163156959|NCT02760498|589289808|FG004|Overall Study|Lost to Follow-up|0|||
163156960|NCT02760498|589289809|FG005|Overall Study|Lost to Follow-up|3|||
163156961|NCT02760498|589289804|FG000|Overall Study|Non-compliance with study drug|0|||
163156962|NCT02760498|589289805|FG001|Overall Study|Non-compliance with study drug|2|||
163156963|NCT02760498|589289806|FG002|Overall Study|Non-compliance with study drug|0|||
163156964|NCT02760498|589289807|FG003|Overall Study|Non-compliance with study drug|0|||
163041825|NCT05052697|588860797|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041826|NCT05052697|588860798|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041827|NCT05052697|588860799|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041828|NCT05052697|588860800|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041829|NCT05052697|588860801|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041830|NCT05052697|588860802|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041831|NCT05052697|588860803|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041832|NCT05052697|588860804|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041833|NCT05052697|588860805|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041834|NCT05052697|588860806|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041835|NCT05052697|588860807|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041836|NCT05052697|588860808|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041837|NCT05052697|588860809|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041838|NCT05052697|588860810|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041839|NCT05052697|588860811|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
163041840|NCT05052697|588860812|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041841|NCT05052697|588860813|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
163041842|NCT05052697|588860814|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
163041843|NCT05052697|588860815|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
163041844|NCT05052697|588860816|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041845|NCT05052697|588860783|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041846|NCT05052697|588860784|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041847|NCT05052697|588860785|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041848|NCT05052697|588860786|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041849|NCT05052697|588860787|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041850|NCT05052697|588860788|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041851|NCT05052697|588860789|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041852|NCT05052697|588860790|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041853|NCT05052697|588860791|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041854|NCT05052697|588860792|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041855|NCT05052697|588860793|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041856|NCT05052697|588860794|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041857|NCT05052697|588860795|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041858|NCT05052697|588860796|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041859|NCT05052697|588860797|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041860|NCT05052697|588860798|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041861|NCT05052697|588860799|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041862|NCT05052697|588860800|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041863|NCT05052697|588860801|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041864|NCT05052697|588860802|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041865|NCT05052697|588860803|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041866|NCT05052697|588860804|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041867|NCT05052697|588860805|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041868|NCT05052697|588860806|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041869|NCT05052697|588860807|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041870|NCT05052697|588860808|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041871|NCT05052697|588860809|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041872|NCT05052697|588860810|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041873|NCT05052697|588860811|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
163041874|NCT05052697|588860812|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
163041875|NCT05052697|588860813|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
163041876|NCT05052697|588860814|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
163041877|NCT05052697|588860815|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
163041878|NCT05052697|588860816|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041879|NCT05052697|588860783|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041880|NCT05052697|588860784|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041881|NCT05052697|588860785|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041882|NCT05052697|588860786|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041883|NCT05052697|588860787|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041884|NCT05052697|588860788|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041885|NCT05052697|588860789|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163156965|NCT02760498|589289808|FG004|Overall Study|Non-compliance with study drug|0|||
163041886|NCT05052697|588860790|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041887|NCT05052697|588860791|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163156966|NCT02760498|589289809|FG005|Overall Study|Non-compliance with study drug|0|||
163041888|NCT05052697|588860792|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041889|NCT05052697|588860793|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041890|NCT05052697|588860794|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163156967|NCT02760498|589289804|FG000|Overall Study|Participant decision|1|||
163156968|NCT02760498|589289805|FG001|Overall Study|Participant decision|4|||
163156969|NCT02760498|589289806|FG002|Overall Study|Participant decision|2|||
163156970|NCT02760498|589289807|FG003|Overall Study|Participant decision|2|||
163156971|NCT02760498|589289808|FG004|Overall Study|Participant decision|1|||
163156972|NCT02760498|589289809|FG005|Overall Study|Participant decision|6|||
163156973|NCT02760498|589289804|FG000|Overall Study|Sponsor decision|0|||
163156974|NCT02760498|589289805|FG001|Overall Study|Sponsor decision|0|||
163156975|NCT02760498|589289806|FG002|Overall Study|Sponsor decision|0|||
163156976|NCT02760498|589289807|FG003|Overall Study|Sponsor decision|3|||
163156977|NCT02760498|589289808|FG004|Overall Study|Sponsor decision|0|||
163156978|NCT02760498|589289809|FG005|Overall Study|Sponsor decision|0|||
163156979|NCT02760498|589289804|FG000|Overall Study|Physician Decision|3|||
163156980|NCT02760498|589289805|FG001|Overall Study|Physician Decision|4|||
163156981|NCT02760498|589289806|FG002|Overall Study|Physician Decision|1|||
163156982|NCT02760498|589289807|FG003|Overall Study|Physician Decision|4|||
163156983|NCT02760498|589289808|FG004|Overall Study|Physician Decision|0|||
163156984|NCT02760498|589289809|FG005|Overall Study|Physician Decision|2|||
163156985|NCT02760498|589289804|FG000|Overall Study|Disease progression|21|||
163156986|NCT02760498|589289805|FG001|Overall Study|Disease progression|19|||
163156987|NCT02760498|589289806|FG002|Overall Study|Disease progression|20|||
163156988|NCT02760498|589289807|FG003|Overall Study|Disease progression|18|||
163156989|NCT02760498|589289808|FG004|Overall Study|Disease progression|4|||
163270971|NCT02733042|589700082|FG018|Overall Study|Progressive Disease|4|||
163270972|NCT02733042|589700064|FG000|Overall Study|Withdrawal by Subject|0|||
163270973|NCT02733042|589700065|FG001|Overall Study|Withdrawal by Subject|1|||
163270974|NCT02733042|589700066|FG002|Overall Study|Withdrawal by Subject|2|||
163270975|NCT02733042|589700067|FG003|Overall Study|Withdrawal by Subject|1|||
163270976|NCT02733042|589700068|FG004|Overall Study|Withdrawal by Subject|1|||
163270977|NCT02733042|589700069|FG005|Overall Study|Withdrawal by Subject|0|||
163270978|NCT02733042|589700070|FG006|Overall Study|Withdrawal by Subject|0|||
163270979|NCT02733042|589700071|FG007|Overall Study|Withdrawal by Subject|0|||
163270980|NCT02733042|589700072|FG008|Overall Study|Withdrawal by Subject|1|||
163270981|NCT02733042|589700073|FG009|Overall Study|Withdrawal by Subject|1|||
163270982|NCT02733042|589700074|FG010|Overall Study|Withdrawal by Subject|0|||
163270983|NCT02733042|589700075|FG011|Overall Study|Withdrawal by Subject|2|||
163270984|NCT02733042|589700076|FG012|Overall Study|Withdrawal by Subject|1|||
163270985|NCT02733042|589700077|FG013|Overall Study|Withdrawal by Subject|1|||
163270986|NCT02733042|589700078|FG014|Overall Study|Withdrawal by Subject|0|||
163270987|NCT02733042|589700079|FG015|Overall Study|Withdrawal by Subject|0|||
163270988|NCT02733042|589700080|FG016|Overall Study|Withdrawal by Subject|0|||
163270989|NCT02733042|589700081|FG017|Overall Study|Withdrawal by Subject|0|||
163270990|NCT02733042|589700082|FG018|Overall Study|Withdrawal by Subject|0|||
163270991|NCT02733042|589700064|FG000|Overall Study|Other Reasons|0|||
163270992|NCT02733042|589700065|FG001|Overall Study|Other Reasons|0|||
163270993|NCT02733042|589700066|FG002|Overall Study|Other Reasons|1|||
163270994|NCT02733042|589700067|FG003|Overall Study|Other Reasons|0|||
163270995|NCT02733042|589700068|FG004|Overall Study|Other Reasons|0|||
163270996|NCT02733042|589700069|FG005|Overall Study|Other Reasons|0|||
163270997|NCT02733042|589700070|FG006|Overall Study|Other Reasons|0|||
163270998|NCT02733042|589700071|FG007|Overall Study|Other Reasons|0|||
163270999|NCT02733042|589700072|FG008|Overall Study|Other Reasons|0|||
163271000|NCT02733042|589700073|FG009|Overall Study|Other Reasons|1|||
163271001|NCT02733042|589700074|FG010|Overall Study|Other Reasons|1|||
163271002|NCT02733042|589700075|FG011|Overall Study|Other Reasons|0|||
163271003|NCT02733042|589700076|FG012|Overall Study|Other Reasons|0|||
163271004|NCT02733042|589700077|FG013|Overall Study|Other Reasons|0|||
163271005|NCT02733042|589700078|FG014|Overall Study|Other Reasons|0|||
163271006|NCT02733042|589700079|FG015|Overall Study|Other Reasons|1|||
163271007|NCT02733042|589700080|FG016|Overall Study|Other Reasons|0|||
163271008|NCT02733042|589700081|FG017|Overall Study|Other Reasons|1|||
163271009|NCT02733042|589700082|FG018|Overall Study|Other Reasons|0|||
163271010|NCT02733042|589700064|FG000|Overall Study|Death|0|||
163271011|NCT02733042|589700065|FG001|Overall Study|Death|0|||
163271012|NCT02733042|589700066|FG002|Overall Study|Death|0|||
163271013|NCT02733042|589700067|FG003|Overall Study|Death|0|||
163271014|NCT02733042|589700068|FG004|Overall Study|Death|0|||
163271015|NCT02733042|589700069|FG005|Overall Study|Death|0|||
163271016|NCT02733042|589700070|FG006|Overall Study|Death|1|||
163271017|NCT02733042|589700071|FG007|Overall Study|Death|0|||
163271018|NCT02733042|589700072|FG008|Overall Study|Death|1|||
163156990|NCT02760498|589289809|FG005|Overall Study|Disease progression|55|||
163156991|NCT02760498|589289804|FG000|Overall Study|Withdrawal by Subject|4|||
163156992|NCT02760498|589289805|FG001|Overall Study|Withdrawal by Subject|7|||
163156993|NCT02760498|589289806|FG002|Overall Study|Withdrawal by Subject|5|||
163271019|NCT02733042|589700073|FG009|Overall Study|Death|0|||
163271020|NCT02733042|589700074|FG010|Overall Study|Death|1|||
163271021|NCT02733042|589700075|FG011|Overall Study|Death|0|||
163271022|NCT02733042|589700076|FG012|Overall Study|Death|0|||
163271023|NCT02733042|589700077|FG013|Overall Study|Death|0|||
163041891|NCT05052697|588860795|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041892|NCT05052697|588860796|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041893|NCT05052697|588860797|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041894|NCT05052697|588860798|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041895|NCT05052697|588860799|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041896|NCT05052697|588860800|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041897|NCT05052697|588860801|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041898|NCT05052697|588860802|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041899|NCT05052697|588860803|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041900|NCT05052697|588860804|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041901|NCT05052697|588860805|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041902|NCT05052697|588860806|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041903|NCT05052697|588860807|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041904|NCT05052697|588860808|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041905|NCT05052697|588860809|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041906|NCT05052697|588860810|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041907|NCT05052697|588860811|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041908|NCT05052697|588860812|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041909|NCT05052697|588860813|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041910|NCT05052697|588860814|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041911|NCT05052697|588860815|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
163041912|NCT05052697|588860816|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041913|NCT05052697|588860783|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041914|NCT05052697|588860784|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041915|NCT05052697|588860785|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041916|NCT05052697|588860786|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041917|NCT05052697|588860787|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041918|NCT05052697|588860788|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041919|NCT05052697|588860789|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041920|NCT05052697|588860790|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041921|NCT05052697|588860791|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041922|NCT05052697|588860792|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041923|NCT05052697|588860793|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041924|NCT05052697|588860794|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041925|NCT05052697|588860795|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041926|NCT05052697|588860796|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041927|NCT05052697|588860797|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041928|NCT05052697|588860798|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041929|NCT05052697|588860799|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041930|NCT05052697|588860800|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041931|NCT05052697|588860801|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041932|NCT05052697|588860802|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041933|NCT05052697|588860803|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041934|NCT05052697|588860804|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041935|NCT05052697|588860805|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041936|NCT05052697|588860806|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163271024|NCT02733042|589700078|FG014|Overall Study|Death|1|||
163041937|NCT05052697|588860807|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041938|NCT05052697|588860808|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041939|NCT05052697|588860809|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041940|NCT05052697|588860810|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041941|NCT05052697|588860811|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
163041942|NCT05052697|588860812|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
163041943|NCT05052697|588860813|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
163041944|NCT05052697|588860814|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041945|NCT05052697|588860815|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041946|NCT05052697|588860816|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041947|NCT03796676|588860817|FG000|Overall Study|Adverse Event|2|||
163041948|NCT03796676|588860818|FG001|Overall Study|Adverse Event|1|||
163041949|NCT03796676|588860819|FG002|Overall Study|Adverse Event|2|||
163041950|NCT03796676|588860817|FG000|Overall Study|Lost to Follow-up|2|||
163041951|NCT03796676|588860818|FG001|Overall Study|Lost to Follow-up|1|||
163041952|NCT03796676|588860819|FG002|Overall Study|Lost to Follow-up|0|||
163041953|NCT03796676|588860817|FG000|Overall Study|Protocol Violation|0|||
163041954|NCT03796676|588860818|FG001|Overall Study|Protocol Violation|0|||
163041955|NCT03796676|588860819|FG002|Overall Study|Protocol Violation|1|||
163041956|NCT03796676|588860817|FG000|Overall Study|Withdrawal by Subject|1|||
163041957|NCT03796676|588860818|FG001|Overall Study|Withdrawal by Subject|1|||
163041958|NCT03796676|588860819|FG002|Overall Study|Withdrawal by Subject|0|||
163041959|NCT03796676|588860817|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
163156994|NCT02760498|589289807|FG003|Overall Study|Withdrawal by Subject|1|||
163156995|NCT02760498|589289808|FG004|Overall Study|Withdrawal by Subject|0|||
163156996|NCT02760498|589289809|FG005|Overall Study|Withdrawal by Subject|6|||
163156997|NCT02760498|589289804|FG000|Overall Study|Other than specified|1|||
163156998|NCT02760498|589289805|FG001|Overall Study|Other than specified|6|||
163156999|NCT02760498|589289806|FG002|Overall Study|Other than specified|0|||
163157000|NCT02760498|589289807|FG003|Overall Study|Other than specified|3|||
163157001|NCT02760498|589289808|FG004|Overall Study|Other than specified|1|||
163157002|NCT02760498|589289809|FG005|Overall Study|Other than specified|0|||
163157003|NCT02760498|589289804|FG000|Overall Study|Not treated|0|||
163157004|NCT02760498|589289805|FG001|Overall Study|Not treated|0|||
163157005|NCT02760498|589289806|FG002|Overall Study|Not treated|0|||
163157006|NCT02760498|589289807|FG003|Overall Study|Not treated|0|||
163157007|NCT02760498|589289808|FG004|Overall Study|Not treated|0|||
163157008|NCT02760498|589289809|FG005|Overall Study|Not treated|2|||
163157009|NCT02205736|589289810|FG000|Overall Study|Lost to Follow-up|106|||
163157010|NCT01198977|589289814|FG000|Overall Study|Lost to Follow-up|1|||
163157011|NCT01198977|589289815|FG001|Overall Study|Lost to Follow-up|0|||
163157012|NCT01899040|589289817|FG000|Overall Study|Randomized in error|0|||
163157013|NCT01899040|589289818|FG001|Overall Study|Randomized in error|1|||
163157014|NCT01899040|589289819|FG002|Overall Study|Randomized in error|1|||
163157015|NCT01899040|589289817|FG000|Overall Study|Adverse Event|3|||
163157016|NCT01899040|589289818|FG001|Overall Study|Adverse Event|1|||
163157017|NCT01899040|589289819|FG002|Overall Study|Adverse Event|2|||
163157018|NCT01899040|589289817|FG000|Overall Study|Unspecified reasons|4|||
163157019|NCT01899040|589289818|FG001|Overall Study|Unspecified reasons|4|||
163157020|NCT01899040|589289819|FG002|Overall Study|Unspecified reasons|0|||
163157021|NCT01899040|589289817|FG000|Overall Study|Compliance issues|1|||
163157022|NCT01899040|589289818|FG001|Overall Study|Compliance issues|2|||
163157023|NCT01899040|589289819|FG002|Overall Study|Compliance issues|0|||
163157024|NCT02638220|589289825|FG000|Overall Study|Lost to Follow-up|6|||
163157025|NCT02638220|589289825|FG000|Overall Study|Withdrawal by Subject|3|||
163157026|NCT02638220|589289825|FG000|Overall Study|Physician Decision|1|||
163157027|NCT02638220|589289825|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
163157028|NCT04323124|589289834|FG000|Overall Study|Adverse Event|0|||
163157029|NCT04323124|589289835|FG001|Overall Study|Adverse Event|0|||
163157030|NCT04323124|589289836|FG002|Overall Study|Adverse Event|0|||
163157031|NCT04323124|589289837|FG003|Overall Study|Adverse Event|0|||
163157032|NCT04323124|589289838|FG004|Overall Study|Adverse Event|0|||
163157033|NCT04323124|589289839|FG005|Overall Study|Adverse Event|1|||
163157034|NCT04323124|589289840|FG006|Overall Study|Adverse Event|0|||
163157035|NCT04323124|589289841|FG007|Overall Study|Adverse Event|1|||
163157036|NCT04323124|589289842|FG008|Overall Study|Adverse Event|1|||
163157037|NCT04323124|589289843|FG009|Overall Study|Adverse Event|0|||
163157038|NCT04323124|589289844|FG010|Overall Study|Adverse Event|0|||
163157039|NCT04323124|589289845|FG011|Overall Study|Adverse Event|0|||
163157040|NCT04323124|589289846|FG012|Overall Study|Adverse Event|0|||
163157041|NCT04323124|589289847|FG013|Overall Study|Adverse Event|0|||
163157042|NCT04323124|589289848|FG014|Overall Study|Adverse Event|0|||
163157043|NCT04323124|589289834|FG000|Overall Study|Other|0|||
163157044|NCT04323124|589289835|FG001|Overall Study|Other|0|||
163157045|NCT04323124|589289836|FG002|Overall Study|Other|0|||
163157046|NCT04323124|589289837|FG003|Overall Study|Other|0|||
163157047|NCT04323124|589289838|FG004|Overall Study|Other|1|||
163157048|NCT04323124|589289839|FG005|Overall Study|Other|0|||
163157049|NCT04323124|589289840|FG006|Overall Study|Other|0|||
163157050|NCT04323124|589289841|FG007|Overall Study|Other|0|||
163157051|NCT04323124|589289842|FG008|Overall Study|Other|1|||
163157052|NCT04323124|589289843|FG009|Overall Study|Other|0|||
163157053|NCT04323124|589289844|FG010|Overall Study|Other|0|||
163157054|NCT04323124|589289845|FG011|Overall Study|Other|0|||
163157055|NCT04323124|589289846|FG012|Overall Study|Other|0|||
163157056|NCT04323124|589289847|FG013|Overall Study|Other|0|||
163157057|NCT04323124|589289848|FG014|Overall Study|Other|0|||
163157058|NCT04323124|589289834|FG000|Overall Study|Coming from a red zone (COVID)|0|||
163157059|NCT04323124|589289835|FG001|Overall Study|Coming from a red zone (COVID)|0|||
163157060|NCT04323124|589289836|FG002|Overall Study|Coming from a red zone (COVID)|0|||
163157061|NCT04323124|589289837|FG003|Overall Study|Coming from a red zone (COVID)|0|||
163157062|NCT04323124|589289838|FG004|Overall Study|Coming from a red zone (COVID)|1|||
163271025|NCT02733042|589700079|FG015|Overall Study|Death|2|||
163157063|NCT04323124|589289839|FG005|Overall Study|Coming from a red zone (COVID)|1|||
163157064|NCT04323124|589289840|FG006|Overall Study|Coming from a red zone (COVID)|0|||
163157065|NCT04323124|589289841|FG007|Overall Study|Coming from a red zone (COVID)|0|||
163157066|NCT04323124|589289842|FG008|Overall Study|Coming from a red zone (COVID)|0|||
163157067|NCT04323124|589289843|FG009|Overall Study|Coming from a red zone (COVID)|0|||
163157068|NCT04323124|589289844|FG010|Overall Study|Coming from a red zone (COVID)|0|||
163157069|NCT04323124|589289845|FG011|Overall Study|Coming from a red zone (COVID)|0|||
163157070|NCT04323124|589289846|FG012|Overall Study|Coming from a red zone (COVID)|0|||
163157071|NCT04323124|589289847|FG013|Overall Study|Coming from a red zone (COVID)|0|||
163271026|NCT02733042|589700080|FG016|Overall Study|Death|0|||
163157072|NCT04323124|589289848|FG014|Overall Study|Coming from a red zone (COVID)|0|||
163157073|NCT04323124|589289834|FG000|Overall Study|No longer meets eligibility criteria|0|||
163157074|NCT04323124|589289835|FG001|Overall Study|No longer meets eligibility criteria|0|||
163157075|NCT04323124|589289836|FG002|Overall Study|No longer meets eligibility criteria|0|||
163157076|NCT04323124|589289837|FG003|Overall Study|No longer meets eligibility criteria|0|||
163157077|NCT04323124|589289838|FG004|Overall Study|No longer meets eligibility criteria|0|||
163157078|NCT04323124|589289839|FG005|Overall Study|No longer meets eligibility criteria|0|||
163157079|NCT04323124|589289840|FG006|Overall Study|No longer meets eligibility criteria|0|||
163157080|NCT04323124|589289841|FG007|Overall Study|No longer meets eligibility criteria|1|||
163157081|NCT04323124|589289842|FG008|Overall Study|No longer meets eligibility criteria|0|||
163157082|NCT04323124|589289843|FG009|Overall Study|No longer meets eligibility criteria|0|||
163157083|NCT04323124|589289844|FG010|Overall Study|No longer meets eligibility criteria|0|||
163157084|NCT04323124|589289845|FG011|Overall Study|No longer meets eligibility criteria|0|||
163157085|NCT04323124|589289846|FG012|Overall Study|No longer meets eligibility criteria|0|||
163157086|NCT04323124|589289847|FG013|Overall Study|No longer meets eligibility criteria|1|||
163157087|NCT04323124|589289848|FG014|Overall Study|No longer meets eligibility criteria|1|||
163157088|NCT04323124|589289834|FG000|Overall Study|Study terminated by sponsor|0|||
163157089|NCT04323124|589289835|FG001|Overall Study|Study terminated by sponsor|0|||
163157090|NCT04323124|589289836|FG002|Overall Study|Study terminated by sponsor|0|||
163157091|NCT04323124|589289837|FG003|Overall Study|Study terminated by sponsor|0|||
163157092|NCT04323124|589289838|FG004|Overall Study|Study terminated by sponsor|0|||
163157093|NCT04323124|589289839|FG005|Overall Study|Study terminated by sponsor|0|||
163157094|NCT04323124|589289840|FG006|Overall Study|Study terminated by sponsor|0|||
163157095|NCT04323124|589289841|FG007|Overall Study|Study terminated by sponsor|0|||
163157096|NCT04323124|589289842|FG008|Overall Study|Study terminated by sponsor|0|||
163157097|NCT04323124|589289843|FG009|Overall Study|Study terminated by sponsor|0|||
163157098|NCT04323124|589289844|FG010|Overall Study|Study terminated by sponsor|0|||
163157099|NCT04323124|589289845|FG011|Overall Study|Study terminated by sponsor|2|||
163157100|NCT04323124|589289846|FG012|Overall Study|Study terminated by sponsor|1|||
163157101|NCT04323124|589289847|FG013|Overall Study|Study terminated by sponsor|0|||
163157102|NCT04323124|589289848|FG014|Overall Study|Study terminated by sponsor|0|||
163157103|NCT04586205|589289849|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
163157104|NCT04586205|589289850|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
163157105|NCT01417377|589291640|FG000|Overall Study|Lost to Follow-up|12|||
163157106|NCT01417377|589291640|FG000|Overall Study|Enrolled, but not treated|1|||
163157107|NCT01772316|589291642|FG000|Overall Study|Serious adverse event|1|||
163157108|NCT01772316|589291642|FG000|Overall Study|Inform consent withdrawn|1|||
163157109|NCT01772316|589291642|FG000|Overall Study|Withdrawn by sponsor decision|5|||
163157110|NCT02113982|589291643|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
163157111|NCT02113982|589291644|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
163157112|NCT02113982|589291645|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
163157113|NCT02113982|589291646|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
163157114|NCT02113982|589291647|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
163157115|NCT02113982|589291648|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
163157116|NCT02113982|589291649|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
163157117|NCT02113982|589291650|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
163157118|NCT02113982|589291651|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
163157119|NCT02113982|589291652|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
163157120|NCT02113982|589291653|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
163157121|NCT02113982|589291654|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
163157122|NCT02113982|589291655|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
163157123|NCT02113982|589291656|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
163157124|NCT02113982|589291643|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
163157125|NCT02113982|589291644|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
163157126|NCT02113982|589291645|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
163157127|NCT02113982|589291646|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
163157128|NCT02113982|589291647|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
163157129|NCT02113982|589291648|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
163157130|NCT02113982|589291649|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
163157131|NCT02113982|589291650|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
163157132|NCT02113982|589291651|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
163157133|NCT02113982|589291652|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
163157134|NCT02113982|589291653|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
163157135|NCT02113982|589291654|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
163157136|NCT02113982|589291655|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
163157137|NCT02113982|589291656|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
163157138|NCT02113982|589291643|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157139|NCT02113982|589291644|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157140|NCT02113982|589291645|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157141|NCT02113982|589291646|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157142|NCT02113982|589291647|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157143|NCT02113982|589291648|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157144|NCT02113982|589291649|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
163157145|NCT02113982|589291650|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157146|NCT02113982|589291651|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157147|NCT02113982|589291652|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157148|NCT02113982|589291653|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157149|NCT02113982|589291654|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157150|NCT02113982|589291655|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157151|NCT02113982|589291656|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163041960|NCT03796676|588860818|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
163041961|NCT03796676|588860819|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
163041962|NCT01900899|588860822|FG000|Overall Study|Withdrawal by Subject|7|||
163041963|NCT01900899|588860823|FG001|Overall Study|Withdrawal by Subject|1|||
163041964|NCT01900899|588860822|FG000|Overall Study|Migrated from study area|2|||
163041965|NCT01900899|588860823|FG001|Overall Study|Migrated from study area|0|||
163041966|NCT02772809|588860829|FG000|Overall Study|not completed some tasks|6|||
163157152|NCT02113982|589291643|FG000|Stage 1: Dose Escalation|Transplant|0|||
163157153|NCT02113982|589291644|FG001|Stage 1: Dose Escalation|Transplant|1|||
163157154|NCT02113982|589291645|FG002|Stage 1: Dose Escalation|Transplant|0|||
163157155|NCT02113982|589291646|FG003|Stage 1: Dose Escalation|Transplant|0|||
163157156|NCT02113982|589291647|FG004|Stage 1: Dose Escalation|Transplant|0|||
163157157|NCT02113982|589291648|FG005|Stage 1: Dose Escalation|Transplant|1|||
163157158|NCT02113982|589291649|FG006|Stage 1: Dose Escalation|Transplant|0|||
163157159|NCT02113982|589291650|FG007|Stage 1: Dose Escalation|Transplant|0|||
163157160|NCT02113982|589291651|FG008|Stage 1: Dose Escalation|Transplant|0|||
163157161|NCT02113982|589291652|FG009|Stage 1: Dose Escalation|Transplant|0|||
163157162|NCT02113982|589291653|FG010|Stage 1: Dose Escalation|Transplant|0|||
163157163|NCT02113982|589291654|FG011|Stage 1: Dose Escalation|Transplant|0|||
163157164|NCT02113982|589291655|FG012|Stage 1: Dose Escalation|Transplant|0|||
163271027|NCT02733042|589700081|FG017|Overall Study|Death|0|||
163041967|NCT00534105|588860830|FG000|Overall Study|Lost to Follow-up|23|||
163041968|NCT00534105|588860831|FG001|Overall Study|Lost to Follow-up|39|||
163041969|NCT02226120|588860832|FG000|Overall Study|Adverse Event|60|||
163041970|NCT02226120|588860832|FG000|Overall Study|Death|172|||
163041971|NCT02226120|588860832|FG000|Overall Study|Study terminated by sponsor|1|||
163041972|NCT02226120|588860832|FG000|Overall Study|Technical problems|4|||
163041973|NCT02226120|588860832|FG000|Overall Study|Lost to Follow-up|13|||
163041974|NCT02226120|588860832|FG000|Overall Study|Physician Decision|21|||
163041975|NCT02226120|588860832|FG000|Overall Study|Withdrawal by parent/guardian|36|||
163041976|NCT02226120|588860832|FG000|Overall Study|Non-compliance with study drug|10|||
163041977|NCT02226120|588860832|FG000|Overall Study|Protocol deviation|1|||
163041978|NCT02226120|588860832|FG000|Overall Study|missing treatment disposition pages|2|||
163041979|NCT03034135|588860834|FG000|Overall Study|Withdrawal by Subject|2|||
163041980|NCT00467558|588860837|FG000|Overall Study|Lost to Follow-up|2|||
163041981|NCT00467558|588860838|FG001|Overall Study|Lost to Follow-up|0|||
163041982|NCT02636439|588860839|FG000|Overall Study|Adverse Event|2|||
163041983|NCT02636439|588860840|FG001|Overall Study|Adverse Event|2|||
163041984|NCT02636439|588860839|FG000|Overall Study|Lost to Follow-up|1|||
163041985|NCT02636439|588860840|FG001|Overall Study|Lost to Follow-up|0|||
163041986|NCT02636439|588860839|FG000|Overall Study|Non-compliance|1|||
163041987|NCT02636439|588860840|FG001|Overall Study|Non-compliance|1|||
163041988|NCT02636439|588860839|FG000|Overall Study|Personal reasons|2|||
163041989|NCT02636439|588860840|FG001|Overall Study|Personal reasons|0|||
163041990|NCT02494401|588860842|FG000|Overall Study|Lost to Follow-up|22|||
163041991|NCT02494401|588860843|FG001|Overall Study|Lost to Follow-up|25|||
163041992|NCT02494401|588860842|FG000|Overall Study|Withdrawal by Subject|3|||
163041993|NCT02494401|588860843|FG001|Overall Study|Withdrawal by Subject|2|||
163041994|NCT05188729|588860844|FG000|Overall Study|Withdrawal by Subject|0|||
163041995|NCT05188729|588860845|FG001|Overall Study|Withdrawal by Subject|0|||
163041996|NCT05188729|588860846|FG002|Overall Study|Withdrawal by Subject|0|||
163041997|NCT05188729|588860847|FG003|Overall Study|Withdrawal by Subject|0|||
163041998|NCT05188729|588860848|FG004|Overall Study|Withdrawal by Subject|0|||
163041999|NCT05188729|588860849|FG005|Overall Study|Withdrawal by Subject|0|||
163042000|NCT05188729|588860850|FG006|Overall Study|Withdrawal by Subject|0|||
163042001|NCT05188729|588860851|FG007|Overall Study|Withdrawal by Subject|0|||
163042002|NCT05188729|588860852|FG008|Overall Study|Withdrawal by Subject|0|||
163042003|NCT05188729|588860853|FG009|Overall Study|Withdrawal by Subject|1|||
163042004|NCT05188729|588860854|FG010|Overall Study|Withdrawal by Subject|0|||
163042005|NCT05188729|588860855|FG011|Overall Study|Withdrawal by Subject|0|||
163042006|NCT05188729|588860856|FG012|Overall Study|Withdrawal by Subject|0|||
163042007|NCT05188729|588860844|FG000|Overall Study|Lost to Follow-up|0|||
163042008|NCT05188729|588860845|FG001|Overall Study|Lost to Follow-up|0|||
163042009|NCT05188729|588860846|FG002|Overall Study|Lost to Follow-up|0|||
163042010|NCT05188729|588860847|FG003|Overall Study|Lost to Follow-up|0|||
163042011|NCT05188729|588860848|FG004|Overall Study|Lost to Follow-up|0|||
163042012|NCT05188729|588860849|FG005|Overall Study|Lost to Follow-up|0|||
163157165|NCT02113982|589291656|FG013|Stage 1: Dose Escalation|Transplant|0|||
163157166|NCT02113982|589291643|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
163157167|NCT02113982|589291644|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
163157168|NCT02113982|589291645|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
163157169|NCT02113982|589291646|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
163157170|NCT02113982|589291647|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
163157171|NCT02113982|589291648|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
163157172|NCT02113982|589291649|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
163157173|NCT02113982|589291650|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
163157174|NCT02113982|589291651|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
163157175|NCT02113982|589291652|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
163157176|NCT02113982|589291653|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
163157177|NCT02113982|589291654|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
163157178|NCT02113982|589291655|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
163157179|NCT02113982|589291656|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
163157180|NCT02113982|589291643|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
163157181|NCT02113982|589291644|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
163157182|NCT02113982|589291645|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
163157183|NCT02113982|589291646|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
163157184|NCT02113982|589291647|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
163157185|NCT02113982|589291648|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
163157186|NCT02113982|589291649|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
163157187|NCT02113982|589291650|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
163157188|NCT02113982|589291651|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
163157189|NCT02113982|589291652|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
163157190|NCT02113982|589291653|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
163157191|NCT02113982|589291654|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
163157192|NCT02113982|589291655|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
163157193|NCT02113982|589291656|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
163157194|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
163157195|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
163157196|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
163157197|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
163157198|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
163157199|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
163157200|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
163157201|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
163157202|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
163157203|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
163157204|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
163157205|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
163042013|NCT05188729|588860850|FG006|Overall Study|Lost to Follow-up|0|||
163042014|NCT05188729|588860851|FG007|Overall Study|Lost to Follow-up|0|||
163042015|NCT05188729|588860852|FG008|Overall Study|Lost to Follow-up|0|||
163042016|NCT05188729|588860853|FG009|Overall Study|Lost to Follow-up|0|||
163042017|NCT05188729|588860854|FG010|Overall Study|Lost to Follow-up|1|||
163042018|NCT05188729|588860855|FG011|Overall Study|Lost to Follow-up|1|||
163042019|NCT05188729|588860856|FG012|Overall Study|Lost to Follow-up|0|||
163042020|NCT00520767|588860858|FG000|Overall Study|Death|2|||
163042021|NCT00803712|588862409|FG000|Overall Study|Noncompliance|3|||
163042022|NCT00803712|588862410|FG001|Overall Study|Noncompliance|0|||
163042023|NCT00803712|588862409|FG000|Overall Study|Adverse Event|5|||
163042024|NCT00803712|588862410|FG001|Overall Study|Adverse Event|0|||
163042025|NCT00803712|588862409|FG000|Overall Study|Death|8|||
163042026|NCT00803712|588862410|FG001|Overall Study|Death|7|||
163042027|NCT00803712|588862409|FG000|Overall Study|Lost to Follow-up|3|||
163042028|NCT00803712|588862410|FG001|Overall Study|Lost to Follow-up|1|||
163042029|NCT00803712|588862409|FG000|Overall Study|Withdrawal by Subject|2|||
163042030|NCT00803712|588862410|FG001|Overall Study|Withdrawal by Subject|4|||
163042031|NCT00803712|588862409|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
163042032|NCT00803712|588862410|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
163042033|NCT00803712|588862409|FG000|Overall Study|Protocol criteria (other)|0|||
163157206|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
163157207|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
163042034|NCT00803712|588862410|FG001|Overall Study|Protocol criteria (other)|2|||
163157208|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
163042035|NCT00803712|588862409|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
163042036|NCT00803712|588862410|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
163042037|NCT00803712|588862409|FG000|Overall Study|Administrative decision|2|||
163271028|NCT02733042|589700082|FG018|Overall Study|Death|0|||
163271029|NCT01088529|589700084|FG000|Overall Study|Did not receive study treatment|0|||
163271030|NCT01088529|589700085|FG001|Overall Study|Did not receive study treatment|1|||
163271031|NCT02838628|589700087|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
163271032|NCT02838628|589700088|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
163042038|NCT00803712|588862410|FG001|Overall Study|Administrative decision|3|||
163042039|NCT00803712|588862409|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
163042040|NCT00803712|588862410|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
163042041|NCT01310127|588862411|FG000|Overall Study|Protocol Violation|1|||
163042042|NCT01310127|588862412|FG001|Overall Study|Protocol Violation|1|||
163042043|NCT01310127|588862411|FG000|Overall Study|advanced psc cataract outlier|1|||
163042044|NCT01310127|588862412|FG001|Overall Study|advanced psc cataract outlier|0|||
163042045|NCT01025284|588862416|FG000|Overall Study|Investigator Decision|0|||
163042046|NCT01025284|588862417|FG001|Overall Study|Investigator Decision|1|||
163042047|NCT01025284|588862418|FG002|Overall Study|Investigator Decision|0|||
163042048|NCT01025284|588862416|FG000|Overall Study|Withdrawal by Subject|0|||
163042049|NCT01025284|588862417|FG001|Overall Study|Withdrawal by Subject|1|||
163042050|NCT01025284|588862418|FG002|Overall Study|Withdrawal by Subject|0|||
163042051|NCT00547248|588862423|FG000|Overall Study|Protocol Violation|0|||
163042052|NCT00547248|588862424|FG001|Overall Study|Protocol Violation|0|||
163042053|NCT00547248|588862425|FG002|Overall Study|Protocol Violation|1|||
163042054|NCT00547248|588862426|FG003|Overall Study|Protocol Violation|1|||
163042055|NCT00547248|588862423|FG000|Overall Study|Migrated/moved from study area|0|||
163042056|NCT00547248|588862424|FG001|Overall Study|Migrated/moved from study area|0|||
163042057|NCT00547248|588862425|FG002|Overall Study|Migrated/moved from study area|2|||
163042058|NCT00547248|588862426|FG003|Overall Study|Migrated/moved from study area|0|||
163042059|NCT00547248|588862423|FG000|Overall Study|Withdrawal by Subject|0|||
163042060|NCT00547248|588862424|FG001|Overall Study|Withdrawal by Subject|0|||
163042061|NCT00547248|588862425|FG002|Overall Study|Withdrawal by Subject|7|||
163042062|NCT00547248|588862426|FG003|Overall Study|Withdrawal by Subject|1|||
163042063|NCT00305227|588862430|FG000|Overall Study|Lost to Follow-up|7|||
163042064|NCT00305227|588862431|FG001|Overall Study|Lost to Follow-up|6|||
163042065|NCT05133323|588862433|FG000|Overall Study|Lack of Efficacy|0|||
163042066|NCT05133323|588862434|FG001|Overall Study|Lack of Efficacy|0|||
163042067|NCT05133323|588862435|FG002|Overall Study|Lack of Efficacy|1|||
163042068|NCT05133323|588862433|FG000|Overall Study|Withdrawal by Subject|2|||
163042069|NCT05133323|588862434|FG001|Overall Study|Withdrawal by Subject|1|||
163042070|NCT05133323|588862435|FG002|Overall Study|Withdrawal by Subject|0|||
163042071|NCT04152083|588862442|FG000|Overall Study|Lost to Follow-up|2|||
163042072|NCT04152083|588862443|FG001|Overall Study|Lost to Follow-up|1|||
163042073|NCT04152083|588862442|FG000|Overall Study|Adverse Event|1|||
163042074|NCT04152083|588862443|FG001|Overall Study|Adverse Event|0|||
163042075|NCT04152083|588862442|FG000|Overall Study|Randomized but not treated|3|||
163042076|NCT04152083|588862443|FG001|Overall Study|Randomized but not treated|2|||
163042077|NCT01042392|588862444|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
163042078|NCT01042392|588862445|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
163042079|NCT01042392|588862446|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
163042080|NCT01042392|588862447|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
163042081|NCT01042392|588862444|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
163042082|NCT01042392|588862445|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
163042083|NCT01042392|588862446|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
163042084|NCT01042392|588862447|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
163042085|NCT01042392|588862444|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
163042086|NCT01042392|588862445|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
163042087|NCT01042392|588862446|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
163042088|NCT01042392|588862447|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
163042089|NCT01042392|588862444|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
163042090|NCT01042392|588862445|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
163042091|NCT01042392|588862446|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
163042092|NCT01042392|588862447|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
163042093|NCT01042392|588862444|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
163042094|NCT01042392|588862445|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
163042095|NCT01042392|588862446|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
163042096|NCT01042392|588862447|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
163042097|NCT01042392|588862444|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
163042098|NCT01042392|588862445|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
163271033|NCT02838628|589700087|FG000|Recurrence Follow-up Period|Adverse Event|1|||
163271034|NCT02838628|589700088|FG001|Recurrence Follow-up Period|Adverse Event|0|||
163271035|NCT02838628|589700087|FG000|Recurrence Follow-up Period|Non-compliance|0|||
163271036|NCT02838628|589700088|FG001|Recurrence Follow-up Period|Non-compliance|1|||
163271037|NCT02838628|589700087|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
163271038|NCT02838628|589700088|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
163385761|NCT00146328|590123239|FG000|Overall Study|Lost to Follow-up|7|||
163385762|NCT00146328|590123240|FG001|Overall Study|Lost to Follow-up|4|||
163042099|NCT01042392|588862446|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
163042100|NCT01042392|588862447|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
163042101|NCT01042392|588862444|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
163042102|NCT01042392|588862445|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
163042103|NCT01042392|588862446|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
163042104|NCT01042392|588862447|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
163042105|NCT01042392|588862444|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
163042106|NCT01042392|588862445|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
163042107|NCT01042392|588862446|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
163042108|NCT01042392|588862447|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
163042109|NCT01042392|588862444|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
163042110|NCT01042392|588862445|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
163042111|NCT01042392|588862446|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
163042112|NCT01042392|588862447|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
163042113|NCT03318003|588862448|FG000|Overall Study|Withdrawal by Subject|1|||
163042114|NCT03318003|588862449|FG001|Overall Study|Withdrawal by Subject|1|||
163042115|NCT03318003|588862448|FG000|Overall Study|fetal loss|0|||
163042116|NCT03318003|588862449|FG001|Overall Study|fetal loss|1|||
163042117|NCT02768792|588862454|FG000|Overall Study|Adverse Event|1|||
163042118|NCT04819438|588862455|FG000|Overall Study|Withdrawal by Subject|1|||
163042119|NCT04819438|588862456|FG001|Overall Study|Withdrawal by Subject|0|||
163042120|NCT04819438|588862455|FG000|Overall Study|Adverse Event|0|||
163042121|NCT04819438|588862456|FG001|Overall Study|Adverse Event|1|||
163042122|NCT04819438|588862455|FG000|Overall Study|Protocol Violation|0|||
163042123|NCT04819438|588862456|FG001|Overall Study|Protocol Violation|1|||
163042124|NCT04607135|588862458|FG000|Overall Study|Physician Decision|1|||
163042125|NCT04607135|588862458|FG000|Overall Study|Withdrawal by Subject|1|||
163042126|NCT04607135|588862458|FG000|Overall Study|Equipment not working|3|||
163042127|NCT03465709|588862459|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
163042128|NCT03465709|588862459|FG000|Overall Study|Withdrawal by Subject|3|||
163042129|NCT05359952|588862460|FG000|Overall Study|Lost to Follow-up|1|||
163042130|NCT05359952|588862461|FG001|Overall Study|Lost to Follow-up|0|||
163042131|NCT03836209|588862462|FG000|Overall Study|Adverse Event|5|||
163042132|NCT03836209|588862463|FG001|Overall Study|Adverse Event|2|||
163042133|NCT03836209|588862462|FG000|Overall Study|Death|4|||
163042134|NCT03836209|588862463|FG001|Overall Study|Death|1|||
163042135|NCT03836209|588862462|FG000|Overall Study|Lack of Efficacy|7|||
163042136|NCT03836209|588862463|FG001|Overall Study|Lack of Efficacy|10|||
163042137|NCT03836209|588862462|FG000|Overall Study|Physician Decision|7|||
163042138|NCT03836209|588862463|FG001|Overall Study|Physician Decision|11|||
163042139|NCT03836209|588862462|FG000|Overall Study|Protocol Violation|0|||
163042140|NCT03836209|588862463|FG001|Overall Study|Protocol Violation|3|||
163042141|NCT03836209|588862462|FG000|Overall Study|Withdrawal by Subject|2|||
163042142|NCT03836209|588862463|FG001|Overall Study|Withdrawal by Subject|10|||
163042143|NCT03836209|588862462|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
163042144|NCT03836209|588862463|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
163042145|NCT01768559|588862465|FG000|Overall Study|Randomized but not treated|0|||
163042146|NCT01768559|588862466|FG001|Overall Study|Randomized but not treated|0|||
163042147|NCT01768559|588862467|FG002|Overall Study|Randomized but not treated|1|||
163042148|NCT01768559|588862465|FG000|Overall Study|Adverse Event|15|||
163042149|NCT01768559|588862466|FG001|Overall Study|Adverse Event|2|||
163042150|NCT01768559|588862467|FG002|Overall Study|Adverse Event|5|||
163042151|NCT01768559|588862465|FG000|Overall Study|Lack of Efficacy|6|||
163042152|NCT01768559|588862466|FG001|Overall Study|Lack of Efficacy|4|||
163042153|NCT01768559|588862467|FG002|Overall Study|Lack of Efficacy|0|||
163042154|NCT01768559|588862465|FG000|Overall Study|Poor compliance to protocol|0|||
163042155|NCT01768559|588862466|FG001|Overall Study|Poor compliance to protocol|3|||
163042156|NCT01768559|588862467|FG002|Overall Study|Poor compliance to protocol|2|||
163042157|NCT01768559|588862465|FG000|Overall Study|Other than specified|9|||
163042158|NCT01768559|588862466|FG001|Overall Study|Other than specified|8|||
163042159|NCT01768559|588862467|FG002|Overall Study|Other than specified|5|||
163042160|NCT01737879|588862470|FG000|Overall Study|Death|1|||
163042161|NCT01737879|588862470|FG000|Overall Study|Sponsor decision|40|||
163042162|NCT04978337|588862471|FG000|Overall Study|Withdrawal by Subject|0|||
163042163|NCT04978337|588862472|FG001|Overall Study|Withdrawal by Subject|1|||
163042164|NCT01436227|588862478|FG000|Overall Study|Adverse Event|7|||
163042165|NCT01436227|588862478|FG000|Overall Study|Death|1|||
163042166|NCT01436227|588862478|FG000|Overall Study|Lack of Efficacy|1|||
163042167|NCT01436227|588862478|FG000|Overall Study|Lost to Follow-up|3|||
163042168|NCT01436227|588862478|FG000|Overall Study|Physician Decision|1|||
163042169|NCT01436227|588862478|FG000|Overall Study|Withdrawal by Subject|7|||
163271039|NCT02838628|589700087|FG000|Recurrence Follow-up Period|Other un-specified|1|||
163042170|NCT01436227|588862478|FG000|Overall Study|Disease progression, relapse|6|||
163042171|NCT04865419|588862481|FG000|Overall Study|Other|1|||
163042172|NCT04865419|588862482|FG001|Overall Study|Other|2|||
163042173|NCT04865419|588862483|FG002|Overall Study|Other|2|||
163271040|NCT02838628|589700088|FG001|Recurrence Follow-up Period|Other un-specified|1|||
163271041|NCT02303626|589700090|FG000|Overall Study|Lack of Efficacy|1|||
163271042|NCT02303626|589700091|FG001|Overall Study|Lack of Efficacy|0|||
163271043|NCT02303626|589700092|FG002|Overall Study|Lack of Efficacy|1|||
163271044|NCT02303626|589700090|FG000|Overall Study|Adverse Event|0|||
163271045|NCT02303626|589700091|FG001|Overall Study|Adverse Event|2|||
163042174|NCT04865419|588862484|FG003|Overall Study|Other|1|||
163042175|NCT04865419|588862485|FG004|Overall Study|Other|3|||
163042176|NCT04865419|588862486|FG005|Overall Study|Other|0|||
163042177|NCT04865419|588862487|FG006|Overall Study|Other|0|||
163042178|NCT04865419|588862488|FG007|Overall Study|Other|1|||
163042179|NCT04865419|588862489|FG008|Overall Study|Other|0|||
163042180|NCT04865419|588862490|FG009|Overall Study|Other|0|||
163042181|NCT04865419|588862491|FG010|Overall Study|Other|0|||
163042182|NCT04865419|588862481|FG000|Overall Study|Withdrawal by Subject|0|||
163042183|NCT04865419|588862482|FG001|Overall Study|Withdrawal by Subject|1|||
163042184|NCT04865419|588862483|FG002|Overall Study|Withdrawal by Subject|1|||
163042185|NCT04865419|588862484|FG003|Overall Study|Withdrawal by Subject|0|||
163042186|NCT04865419|588862485|FG004|Overall Study|Withdrawal by Subject|0|||
163042187|NCT04865419|588862486|FG005|Overall Study|Withdrawal by Subject|0|||
163042188|NCT04865419|588862487|FG006|Overall Study|Withdrawal by Subject|0|||
163042189|NCT04865419|588862488|FG007|Overall Study|Withdrawal by Subject|1|||
163042190|NCT04865419|588862489|FG008|Overall Study|Withdrawal by Subject|2|||
163042191|NCT04865419|588862490|FG009|Overall Study|Withdrawal by Subject|1|||
163042192|NCT04865419|588862491|FG010|Overall Study|Withdrawal by Subject|0|||
163042193|NCT04865419|588862481|FG000|Overall Study|Study terminated by Sponsor|0|||
163042194|NCT04865419|588862482|FG001|Overall Study|Study terminated by Sponsor|0|||
163042195|NCT04865419|588862483|FG002|Overall Study|Study terminated by Sponsor|0|||
163042196|NCT04865419|588862484|FG003|Overall Study|Study terminated by Sponsor|2|||
163042197|NCT04865419|588862485|FG004|Overall Study|Study terminated by Sponsor|2|||
163042198|NCT04865419|588862486|FG005|Overall Study|Study terminated by Sponsor|0|||
163042199|NCT04865419|588862487|FG006|Overall Study|Study terminated by Sponsor|0|||
163042200|NCT04865419|588862488|FG007|Overall Study|Study terminated by Sponsor|0|||
163042201|NCT04865419|588862489|FG008|Overall Study|Study terminated by Sponsor|0|||
163042202|NCT04865419|588862490|FG009|Overall Study|Study terminated by Sponsor|0|||
163042203|NCT04865419|588862491|FG010|Overall Study|Study terminated by Sponsor|1|||
163042204|NCT04865419|588862481|FG000|Overall Study|Death|3|||
163042205|NCT04865419|588862482|FG001|Overall Study|Death|1|||
163042206|NCT04865419|588862483|FG002|Overall Study|Death|4|||
163042207|NCT04865419|588862484|FG003|Overall Study|Death|2|||
163042208|NCT04865419|588862485|FG004|Overall Study|Death|5|||
163042209|NCT04865419|588862486|FG005|Overall Study|Death|2|||
163042210|NCT04865419|588862487|FG006|Overall Study|Death|1|||
163042211|NCT04865419|588862488|FG007|Overall Study|Death|1|||
163042212|NCT04865419|588862489|FG008|Overall Study|Death|2|||
163042213|NCT04865419|588862490|FG009|Overall Study|Death|2|||
163042214|NCT04865419|588862491|FG010|Overall Study|Death|1|||
163042215|NCT04865419|588862481|FG000|Overall Study|Lost to Follow-up|0|||
163042216|NCT04865419|588862482|FG001|Overall Study|Lost to Follow-up|0|||
163042217|NCT04865419|588862483|FG002|Overall Study|Lost to Follow-up|0|||
163042218|NCT04865419|588862484|FG003|Overall Study|Lost to Follow-up|0|||
163042219|NCT04865419|588862485|FG004|Overall Study|Lost to Follow-up|0|||
163042220|NCT04865419|588862486|FG005|Overall Study|Lost to Follow-up|0|||
163042221|NCT04865419|588862487|FG006|Overall Study|Lost to Follow-up|0|||
163042222|NCT04865419|588862488|FG007|Overall Study|Lost to Follow-up|0|||
163042223|NCT04865419|588862489|FG008|Overall Study|Lost to Follow-up|0|||
163042224|NCT04865419|588862490|FG009|Overall Study|Lost to Follow-up|1|||
163042225|NCT04865419|588862491|FG010|Overall Study|Lost to Follow-up|0|||
163042226|NCT05446142|588862492|FG000|Period 2|Adverse Event|1|||
163042227|NCT05446142|588862493|FG001|Period 2|Adverse Event|0|||
163042228|NCT05446142|588862494|FG002|Period 2|Adverse Event|0|||
163042229|NCT05446142|588862495|FG003|Period 2|Adverse Event|0|||
163042230|NCT05446142|588862496|FG004|Period 2|Adverse Event|0|||
163042231|NCT05446142|588862497|FG005|Period 2|Adverse Event|0|||
163042232|NCT00547157|588862502|FG000|Overall Study|Other|1|||
163042233|NCT00547157|588862503|FG001|Overall Study|Other|0|||
163042234|NCT00547157|588862502|FG000|Overall Study|Death|38|||
163042235|NCT00547157|588862503|FG001|Overall Study|Death|18|||
163042236|NCT00547157|588862502|FG000|Overall Study|Withdrawal by Subject|3|||
163042237|NCT00547157|588862503|FG001|Overall Study|Withdrawal by Subject|1|||
163042238|NCT00547157|588862502|FG000|Overall Study|Administrative decision|3|||
163042239|NCT00547157|588862503|FG001|Overall Study|Administrative decision|2|||
163042240|NCT00547157|588862502|FG000|Overall Study|Lost to Follow-up|4|||
163042241|NCT00547157|588862503|FG001|Overall Study|Lost to Follow-up|2|||
163042242|NCT03853291|588862504|FG000|Overall Study|Lost to Follow-up|1|||
163042243|NCT03853291|588862505|FG001|Overall Study|Lost to Follow-up|2|||
163042244|NCT03853291|588862506|FG002|Overall Study|Lost to Follow-up|0|||
163042245|NCT03853291|588862507|FG003|Overall Study|Lost to Follow-up|0|||
163042246|NCT03853291|588862508|FG004|Overall Study|Lost to Follow-up|0|||
163042247|NCT03853291|588862509|FG005|Overall Study|Lost to Follow-up|0|||
163042248|NCT03853291|588862504|FG000|Overall Study|Determined to be ineligible|1|||
163157209|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
163157210|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
163157211|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
163157212|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
163157213|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
163157214|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
163157215|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
163157216|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
163157217|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
163157218|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
163157219|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
163157220|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
163157221|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
163157222|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157223|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157224|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157225|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157226|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157227|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157228|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157229|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
163157230|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157231|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
163157232|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
163157233|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157234|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157235|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157236|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157237|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157238|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157239|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157240|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157241|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157242|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157243|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
163157244|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157245|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
163157246|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157247|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157248|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157249|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157250|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157251|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157252|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157253|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157254|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157255|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157256|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157257|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
163157258|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157259|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157260|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157261|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157262|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157263|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157264|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Transplant|0|||
163157265|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Transplant|0|||
163157266|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Transplant|0|||
163157267|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Transplant|0|||
163157268|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Transplant|0|||
163157269|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Transplant|0|||
163157270|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Transplant|0|||
163157271|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Transplant|0|||
163157272|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Transplant|0|||
163157273|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Transplant|4|||
163157274|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Transplant|2|||
163157275|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Transplant|0|||
163157276|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Transplant|0|||
163157277|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Transplant|0|||
163157278|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
163385763|NCT00146328|590123241|FG002|Overall Study|Lost to Follow-up|7|||
163157279|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
163157280|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
163157281|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
163157282|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
163157283|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
163157284|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
163157285|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
163157286|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
163157287|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
163157288|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
163157289|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
163157290|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
163157291|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
163157292|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
163157293|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
163157294|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
163157295|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
163157296|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
163157297|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
163157298|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
163157299|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
163157300|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
163157301|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
163157302|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
163157303|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
163157304|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
163157305|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
163157306|NCT02113982|589291643|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157307|NCT02113982|589291644|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157308|NCT02113982|589291645|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157309|NCT02113982|589291646|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157310|NCT02113982|589291647|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157311|NCT02113982|589291648|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157312|NCT02113982|589291649|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157313|NCT02113982|589291650|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157314|NCT02113982|589291651|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157315|NCT02113982|589291652|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157316|NCT02113982|589291653|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157317|NCT02113982|589291654|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
163157318|NCT02113982|589291655|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157319|NCT02113982|589291656|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157320|NCT02113982|589291643|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157321|NCT02113982|589291644|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157322|NCT02113982|589291645|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157323|NCT02113982|589291646|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157324|NCT02113982|589291647|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157325|NCT02113982|589291648|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157326|NCT02113982|589291649|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157327|NCT02113982|589291650|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157328|NCT02113982|589291651|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157329|NCT02113982|589291652|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157330|NCT02113982|589291653|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157331|NCT02113982|589291654|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
163157332|NCT02113982|589291655|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157333|NCT02113982|589291656|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157334|NCT02113982|589291643|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157335|NCT02113982|589291644|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157336|NCT02113982|589291645|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157337|NCT02113982|589291646|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157338|NCT02113982|589291647|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157339|NCT02113982|589291648|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157340|NCT02113982|589291649|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157341|NCT02113982|589291650|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163271046|NCT02303626|589700092|FG002|Overall Study|Adverse Event|0|||
163157342|NCT02113982|589291651|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157343|NCT02113982|589291652|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157344|NCT02113982|589291653|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157345|NCT02113982|589291654|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
163271047|NCT02303626|589700090|FG000|Overall Study|Protocol Violation|0|||
163157346|NCT02113982|589291655|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157347|NCT02113982|589291656|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163271048|NCT02303626|589700091|FG001|Overall Study|Protocol Violation|1|||
163157348|NCT02113982|589291643|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
163157349|NCT02113982|589291644|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
163157350|NCT02113982|589291645|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
163157351|NCT02113982|589291646|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
163157352|NCT02113982|589291647|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
163157353|NCT02113982|589291648|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
163157354|NCT02113982|589291649|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
163157355|NCT02113982|589291650|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
163157356|NCT02113982|589291651|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
163157357|NCT02113982|589291652|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
163157358|NCT02113982|589291653|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
163157359|NCT02113982|589291654|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
163157360|NCT02113982|589291655|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
163157361|NCT02113982|589291656|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
163157362|NCT02113982|589291643|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157363|NCT02113982|589291644|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157364|NCT02113982|589291645|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157365|NCT02113982|589291646|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157366|NCT02113982|589291647|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157367|NCT02113982|589291648|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157368|NCT02113982|589291649|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157369|NCT02113982|589291650|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157370|NCT02113982|589291651|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157371|NCT02113982|589291652|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157372|NCT02113982|589291653|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157373|NCT02113982|589291654|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157374|NCT02113982|589291655|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
163157375|NCT02113982|589291656|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157376|NCT02113982|589291643|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157377|NCT02113982|589291644|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157378|NCT02113982|589291645|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157379|NCT02113982|589291646|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157380|NCT02113982|589291647|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157381|NCT02113982|589291648|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157382|NCT02113982|589291649|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157383|NCT02113982|589291650|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157384|NCT02113982|589291651|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157385|NCT02113982|589291652|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157386|NCT02113982|589291653|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157387|NCT02113982|589291654|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157388|NCT02113982|589291655|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
163157389|NCT02113982|589291656|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
163157390|NCT02113982|589291643|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157391|NCT02113982|589291644|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157392|NCT02113982|589291645|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157393|NCT02113982|589291646|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157394|NCT02113982|589291647|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157395|NCT02113982|589291648|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157396|NCT02113982|589291649|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157397|NCT02113982|589291650|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157398|NCT02113982|589291651|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157399|NCT02113982|589291652|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157400|NCT02113982|589291653|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157401|NCT02113982|589291654|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157402|NCT02113982|589291655|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
163157403|NCT02113982|589291656|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
163157404|NCT02113982|589291643|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157405|NCT02113982|589291644|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157406|NCT02113982|589291645|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157407|NCT02113982|589291646|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157408|NCT02113982|589291647|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157409|NCT02113982|589291648|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157410|NCT02113982|589291649|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157411|NCT02113982|589291650|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157412|NCT02113982|589291651|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157413|NCT02113982|589291652|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157414|NCT02113982|589291653|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157415|NCT02113982|589291654|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157416|NCT02113982|589291655|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
163157417|NCT02113982|589291656|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
163157418|NCT02113982|589291643|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157419|NCT02113982|589291644|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157420|NCT02113982|589291645|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157421|NCT02113982|589291646|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157422|NCT02113982|589291647|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157423|NCT02113982|589291648|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157424|NCT02113982|589291649|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157425|NCT02113982|589291650|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157426|NCT02113982|589291651|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157427|NCT02113982|589291652|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157428|NCT02113982|589291653|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157429|NCT02113982|589291654|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157430|NCT02113982|589291655|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
163157431|NCT02113982|589291656|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157432|NCT02113982|589291643|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157433|NCT02113982|589291644|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157434|NCT02113982|589291645|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157435|NCT02113982|589291646|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157436|NCT02113982|589291647|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157437|NCT02113982|589291648|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157438|NCT02113982|589291649|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157439|NCT02113982|589291650|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157440|NCT02113982|589291651|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157441|NCT02113982|589291652|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157442|NCT02113982|589291653|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157443|NCT02113982|589291654|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157444|NCT02113982|589291655|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
163157445|NCT02113982|589291656|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157446|NCT02113982|589291643|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157447|NCT02113982|589291644|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157448|NCT02113982|589291645|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157449|NCT02113982|589291646|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157450|NCT02113982|589291647|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157451|NCT02113982|589291648|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157452|NCT02113982|589291649|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157453|NCT02113982|589291650|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157454|NCT02113982|589291651|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157455|NCT02113982|589291652|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157456|NCT02113982|589291653|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157457|NCT02113982|589291654|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157458|NCT02113982|589291655|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
163157459|NCT02113982|589291656|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157460|NCT02085161|589291657|FG000|Overall Study|Not Treated|1|||
163157461|NCT02085161|589291658|FG001|Overall Study|Not Treated|0|||
163157462|NCT02085161|589291659|FG002|Overall Study|Not Treated|0|||
163157463|NCT02085161|589291660|FG003|Overall Study|Not Treated|0|||
163157464|NCT02085161|589291657|FG000|Overall Study|Adverse Event|8|||
163157465|NCT02085161|589291658|FG001|Overall Study|Adverse Event|5|||
163157466|NCT02085161|589291659|FG002|Overall Study|Adverse Event|4|||
163157467|NCT02085161|589291660|FG003|Overall Study|Adverse Event|5|||
163157468|NCT02085161|589291657|FG000|Overall Study|Protocol Violation|0|||
163157469|NCT02085161|589291658|FG001|Overall Study|Protocol Violation|1|||
163157470|NCT02085161|589291659|FG002|Overall Study|Protocol Violation|0|||
163157471|NCT02085161|589291660|FG003|Overall Study|Protocol Violation|1|||
163157472|NCT02085161|589291657|FG000|Overall Study|Withdrawal by Subject|2|||
163157473|NCT02085161|589291658|FG001|Overall Study|Withdrawal by Subject|4|||
163157474|NCT02085161|589291659|FG002|Overall Study|Withdrawal by Subject|0|||
163157475|NCT02085161|589291660|FG003|Overall Study|Withdrawal by Subject|3|||
163157476|NCT02085161|589291657|FG000|Overall Study|Other Reason|1|||
163157477|NCT02085161|589291658|FG001|Overall Study|Other Reason|0|||
163157478|NCT02085161|589291659|FG002|Overall Study|Other Reason|1|||
163157479|NCT02085161|589291660|FG003|Overall Study|Other Reason|1|||
163157480|NCT00068692|589291671|FG000|Step 1: Registration|Disese progression/relapse|5|||
163157481|NCT00068692|589291672|FG001|Step 1: Registration|Disese progression/relapse|0|||
163157482|NCT00068692|589291673|FG002|Step 1: Registration|Disese progression/relapse|0|||
163157483|NCT00068692|589291674|FG003|Step 1: Registration|Disese progression/relapse|0|||
163157484|NCT00068692|589291675|FG004|Step 1: Registration|Disese progression/relapse|0|||
163157485|NCT00068692|589291676|FG005|Step 1: Registration|Disese progression/relapse|0|||
163157486|NCT00068692|589291677|FG006|Step 1: Registration|Disese progression/relapse|0|||
163157487|NCT00068692|589291678|FG007|Step 1: Registration|Disese progression/relapse|0|||
163157488|NCT00068692|589291671|FG000|Step 1: Registration|Adverse Event|7|||
163157489|NCT00068692|589291672|FG001|Step 1: Registration|Adverse Event|0|||
163157490|NCT00068692|589291673|FG002|Step 1: Registration|Adverse Event|0|||
163157491|NCT00068692|589291674|FG003|Step 1: Registration|Adverse Event|0|||
163157492|NCT00068692|589291675|FG004|Step 1: Registration|Adverse Event|0|||
163157493|NCT00068692|589291676|FG005|Step 1: Registration|Adverse Event|0|||
163157494|NCT00068692|589291677|FG006|Step 1: Registration|Adverse Event|0|||
163157495|NCT00068692|589291678|FG007|Step 1: Registration|Adverse Event|0|||
163157496|NCT00068692|589291671|FG000|Step 1: Registration|Death|1|||
163157497|NCT00068692|589291672|FG001|Step 1: Registration|Death|0|||
163157498|NCT00068692|589291673|FG002|Step 1: Registration|Death|0|||
163157499|NCT00068692|589291674|FG003|Step 1: Registration|Death|0|||
163157500|NCT00068692|589291675|FG004|Step 1: Registration|Death|0|||
163157501|NCT00068692|589291676|FG005|Step 1: Registration|Death|0|||
163157502|NCT00068692|589291677|FG006|Step 1: Registration|Death|0|||
163157503|NCT00068692|589291678|FG007|Step 1: Registration|Death|0|||
163157504|NCT00068692|589291671|FG000|Step 1: Registration|Withdrawal by Subject|11|||
163157505|NCT00068692|589291672|FG001|Step 1: Registration|Withdrawal by Subject|0|||
163157506|NCT00068692|589291673|FG002|Step 1: Registration|Withdrawal by Subject|0|||
163157507|NCT00068692|589291674|FG003|Step 1: Registration|Withdrawal by Subject|0|||
163157508|NCT00068692|589291675|FG004|Step 1: Registration|Withdrawal by Subject|0|||
163157509|NCT00068692|589291676|FG005|Step 1: Registration|Withdrawal by Subject|0|||
163157510|NCT00068692|589291677|FG006|Step 1: Registration|Withdrawal by Subject|0|||
163157511|NCT00068692|589291678|FG007|Step 1: Registration|Withdrawal by Subject|0|||
163157512|NCT00068692|589291671|FG000|Step 1: Registration|Alternative therapy|2|||
163157513|NCT00068692|589291672|FG001|Step 1: Registration|Alternative therapy|0|||
163157514|NCT00068692|589291673|FG002|Step 1: Registration|Alternative therapy|0|||
163157515|NCT00068692|589291674|FG003|Step 1: Registration|Alternative therapy|0|||
163157516|NCT00068692|589291675|FG004|Step 1: Registration|Alternative therapy|0|||
163157517|NCT00068692|589291676|FG005|Step 1: Registration|Alternative therapy|0|||
163157518|NCT00068692|589291677|FG006|Step 1: Registration|Alternative therapy|0|||
163157519|NCT00068692|589291678|FG007|Step 1: Registration|Alternative therapy|0|||
163157520|NCT00068692|589291671|FG000|Step 1: Registration|Complicating disease|2|||
163157521|NCT00068692|589291672|FG001|Step 1: Registration|Complicating disease|0|||
163157522|NCT00068692|589291673|FG002|Step 1: Registration|Complicating disease|0|||
163157523|NCT00068692|589291674|FG003|Step 1: Registration|Complicating disease|0|||
163157524|NCT00068692|589291675|FG004|Step 1: Registration|Complicating disease|0|||
163157525|NCT00068692|589291676|FG005|Step 1: Registration|Complicating disease|0|||
163157526|NCT00068692|589291677|FG006|Step 1: Registration|Complicating disease|0|||
163157527|NCT00068692|589291678|FG007|Step 1: Registration|Complicating disease|0|||
163157528|NCT00068692|589291671|FG000|Step 1: Registration|Protocol Violation|1|||
163157529|NCT00068692|589291672|FG001|Step 1: Registration|Protocol Violation|0|||
163157530|NCT00068692|589291673|FG002|Step 1: Registration|Protocol Violation|0|||
163157531|NCT00068692|589291674|FG003|Step 1: Registration|Protocol Violation|0|||
163157532|NCT00068692|589291675|FG004|Step 1: Registration|Protocol Violation|0|||
163157533|NCT00068692|589291676|FG005|Step 1: Registration|Protocol Violation|0|||
163157534|NCT00068692|589291677|FG006|Step 1: Registration|Protocol Violation|0|||
163157535|NCT00068692|589291678|FG007|Step 1: Registration|Protocol Violation|0|||
163157536|NCT00068692|589291671|FG000|Step 1: Registration|Not eligible|6|||
163157537|NCT00068692|589291672|FG001|Step 1: Registration|Not eligible|0|||
163157538|NCT00068692|589291673|FG002|Step 1: Registration|Not eligible|0|||
163157539|NCT00068692|589291674|FG003|Step 1: Registration|Not eligible|0|||
163157540|NCT00068692|589291675|FG004|Step 1: Registration|Not eligible|0|||
163157541|NCT00068692|589291676|FG005|Step 1: Registration|Not eligible|0|||
163157542|NCT00068692|589291677|FG006|Step 1: Registration|Not eligible|0|||
163157543|NCT00068692|589291678|FG007|Step 1: Registration|Not eligible|0|||
163157544|NCT00068692|589291671|FG000|Step 1: Registration|Other|2|||
163157545|NCT00068692|589291672|FG001|Step 1: Registration|Other|0|||
163157546|NCT00068692|589291673|FG002|Step 1: Registration|Other|0|||
163157547|NCT00068692|589291674|FG003|Step 1: Registration|Other|0|||
163157548|NCT00068692|589291675|FG004|Step 1: Registration|Other|0|||
163157549|NCT00068692|589291676|FG005|Step 1: Registration|Other|0|||
163157550|NCT00068692|589291677|FG006|Step 1: Registration|Other|0|||
163157551|NCT00068692|589291678|FG007|Step 1: Registration|Other|0|||
163157552|NCT00068692|589291671|FG000|Step 1: Registration|Not start protocol therapy|3|||
163157553|NCT00068692|589291672|FG001|Step 1: Registration|Not start protocol therapy|0|||
163157554|NCT00068692|589291673|FG002|Step 1: Registration|Not start protocol therapy|0|||
163157555|NCT00068692|589291674|FG003|Step 1: Registration|Not start protocol therapy|0|||
163157556|NCT00068692|589291675|FG004|Step 1: Registration|Not start protocol therapy|0|||
163157557|NCT00068692|589291676|FG005|Step 1: Registration|Not start protocol therapy|0|||
163157558|NCT00068692|589291677|FG006|Step 1: Registration|Not start protocol therapy|0|||
163157559|NCT00068692|589291678|FG007|Step 1: Registration|Not start protocol therapy|0|||
163157560|NCT00068692|589291671|FG000|Step 1: Registration|Registered but not randomized|0|||
163157561|NCT00068692|589291672|FG001|Step 1: Registration|Registered but not randomized|1|||
163042249|NCT03853291|588862505|FG001|Overall Study|Determined to be ineligible|1|||
163042250|NCT03853291|588862506|FG002|Overall Study|Determined to be ineligible|0|||
163042251|NCT03853291|588862507|FG003|Overall Study|Determined to be ineligible|0|||
163042252|NCT03853291|588862508|FG004|Overall Study|Determined to be ineligible|0|||
163042253|NCT03853291|588862509|FG005|Overall Study|Determined to be ineligible|0|||
163042254|NCT03883477|588862510|FG000|Overall Study|Death|1|||
163042255|NCT03883477|588862511|FG001|Overall Study|Death|0|||
163042256|NCT03883477|588862510|FG000|Overall Study|Protocol Violation|0|||
163042257|NCT03883477|588862511|FG001|Overall Study|Protocol Violation|1|||
163042258|NCT04186221|588862512|FG000|Overall Study|Death|1|||
163042259|NCT00972283|588862518|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
163042260|NCT00972283|588862519|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
163042261|NCT00972283|588862518|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
163042262|NCT00972283|588862519|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
163042263|NCT00972283|588862518|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
163042264|NCT00972283|588862519|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
163042265|NCT00972283|588862518|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
163042266|NCT00972283|588862519|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
163042267|NCT00972283|588862518|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
163042268|NCT00972283|588862519|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
163042269|NCT00972283|588862518|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
163042270|NCT00972283|588862519|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
163042271|NCT00972283|588862518|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
163042272|NCT00972283|588862519|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
163042273|NCT00972283|588862518|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
163042274|NCT00972283|588862519|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
163042275|NCT00972283|588862518|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
163042276|NCT00972283|588862519|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
163042277|NCT00972283|588862518|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
163042278|NCT00972283|588862519|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
163042279|NCT03124537|588862520|FG000|Overall Study|Lost to Follow-up|3|||
163042280|NCT03124537|588862521|FG001|Overall Study|Lost to Follow-up|5|||
163042281|NCT03124537|588862520|FG000|Overall Study|App Crash, Incomplete Data|7|||
163042282|NCT03124537|588862521|FG001|Overall Study|App Crash, Incomplete Data|8|||
163042283|NCT00830518|588862524|FG000|Overall Study|Progressive Disease|18|||
163042284|NCT00830518|588862525|FG001|Overall Study|Progressive Disease|8|||
163042285|NCT00830518|588862524|FG000|Overall Study|Symptomatic Deterioration|4|||
163042286|NCT00830518|588862525|FG001|Overall Study|Symptomatic Deterioration|1|||
163042287|NCT00830518|588862524|FG000|Overall Study|Adverse Event|14|||
163042288|NCT00830518|588862525|FG001|Overall Study|Adverse Event|1|||
163042289|NCT00830518|588862524|FG000|Overall Study|Withdrawal by Patient|2|||
163042290|NCT00830518|588862525|FG001|Overall Study|Withdrawal by Patient|0|||
163042291|NCT00830518|588862524|FG000|Overall Study|Reason not Specified|8|||
163042292|NCT00830518|588862525|FG001|Overall Study|Reason not Specified|1|||
163042293|NCT02348008|588862526|FG000|Overall Study|Adverse Event|2|||
163042294|NCT02348008|588862527|FG001|Overall Study|Adverse Event|3|||
163042295|NCT02348008|588862528|FG002|Overall Study|Adverse Event|3|||
163042296|NCT02348008|588862526|FG000|Overall Study|Disease Progression|1|||
163042297|NCT02348008|588862527|FG001|Overall Study|Disease Progression|5|||
163042298|NCT02348008|588862528|FG002|Overall Study|Disease Progression|16|||
163042299|NCT02348008|588862526|FG000|Overall Study|Withdrawal by Subject|0|||
163042300|NCT02348008|588862527|FG001|Overall Study|Withdrawal by Subject|1|||
163042301|NCT02348008|588862528|FG002|Overall Study|Withdrawal by Subject|0|||
163042302|NCT02348008|588862526|FG000|Overall Study|Symptomatic Deterioration|0|||
163042303|NCT02348008|588862527|FG001|Overall Study|Symptomatic Deterioration|1|||
163042304|NCT02348008|588862528|FG002|Overall Study|Symptomatic Deterioration|0|||
163042305|NCT02029274|588862531|FG000|Overall Study|Adverse Event|1|||
163042306|NCT02029274|588862532|FG001|Overall Study|Adverse Event|0|||
163042307|NCT02029274|588862533|FG002|Overall Study|Adverse Event|2|||
163042308|NCT02029274|588862534|FG003|Overall Study|Adverse Event|2|||
163042309|NCT02756364|588862535|FG000|Overall Study|Site Terminated by Sponsor|24|||
163042310|NCT02756364|588862536|FG001|Overall Study|Site Terminated by Sponsor|30|||
163042311|NCT02756364|588862537|FG002|Overall Study|Site Terminated by Sponsor|21|||
163042312|NCT02756364|588862535|FG000|Overall Study|Death|20|||
163042313|NCT02756364|588862536|FG001|Overall Study|Death|15|||
163042314|NCT02756364|588862537|FG002|Overall Study|Death|18|||
163042315|NCT02756364|588862535|FG000|Overall Study|Withdrawal by Patient|2|||
163042316|NCT02756364|588862536|FG001|Overall Study|Withdrawal by Patient|1|||
163042317|NCT02756364|588862537|FG002|Overall Study|Withdrawal by Patient|8|||
163042318|NCT02756364|588862535|FG000|Overall Study|Lost to Follow-up|0|||
163042319|NCT02756364|588862536|FG001|Overall Study|Lost to Follow-up|1|||
163042320|NCT02756364|588862537|FG002|Overall Study|Lost to Follow-up|1|||
163042321|NCT02223364|588862538|FG000|Overall Study|Protocol Violation|3|||
163042322|NCT02223364|588862539|FG001|Overall Study|Protocol Violation|0|||
163042323|NCT02223364|588862540|FG002|Overall Study|Protocol Violation|3|||
163157562|NCT00068692|589291673|FG002|Step 1: Registration|Registered but not randomized|0|||
163157563|NCT00068692|589291674|FG003|Step 1: Registration|Registered but not randomized|0|||
163157564|NCT00068692|589291675|FG004|Step 1: Registration|Registered but not randomized|0|||
163157565|NCT00068692|589291676|FG005|Step 1: Registration|Registered but not randomized|0|||
163157566|NCT00068692|589291677|FG006|Step 1: Registration|Registered but not randomized|0|||
163157567|NCT00068692|589291678|FG007|Step 1: Registration|Registered but not randomized|0|||
163157568|NCT00068692|589291671|FG000|Step 2: Randomization|Disesae progression/replase|0|||
163157569|NCT00068692|589291672|FG001|Step 2: Randomization|Disesae progression/replase|0|||
163157570|NCT00068692|589291673|FG002|Step 2: Randomization|Disesae progression/replase|1|||
163157571|NCT00068692|589291674|FG003|Step 2: Randomization|Disesae progression/replase|1|||
163157572|NCT00068692|589291675|FG004|Step 2: Randomization|Disesae progression/replase|0|||
163157573|NCT00068692|589291676|FG005|Step 2: Randomization|Disesae progression/replase|0|||
163157574|NCT00068692|589291677|FG006|Step 2: Randomization|Disesae progression/replase|0|||
163157575|NCT00068692|589291678|FG007|Step 2: Randomization|Disesae progression/replase|0|||
163157576|NCT00068692|589291671|FG000|Step 2: Randomization|Adverse Event|0|||
163157577|NCT00068692|589291672|FG001|Step 2: Randomization|Adverse Event|0|||
163157578|NCT00068692|589291673|FG002|Step 2: Randomization|Adverse Event|4|||
163157579|NCT00068692|589291674|FG003|Step 2: Randomization|Adverse Event|2|||
163157580|NCT00068692|589291675|FG004|Step 2: Randomization|Adverse Event|2|||
163157581|NCT00068692|589291676|FG005|Step 2: Randomization|Adverse Event|3|||
163157582|NCT00068692|589291677|FG006|Step 2: Randomization|Adverse Event|4|||
163157583|NCT00068692|589291678|FG007|Step 2: Randomization|Adverse Event|4|||
163157584|NCT00068692|589291671|FG000|Step 2: Randomization|Death|0|||
163157585|NCT00068692|589291672|FG001|Step 2: Randomization|Death|0|||
163157586|NCT00068692|589291673|FG002|Step 2: Randomization|Death|0|||
163157587|NCT00068692|589291674|FG003|Step 2: Randomization|Death|0|||
163157588|NCT00068692|589291675|FG004|Step 2: Randomization|Death|1|||
163157589|NCT00068692|589291676|FG005|Step 2: Randomization|Death|0|||
163157590|NCT00068692|589291677|FG006|Step 2: Randomization|Death|0|||
163157591|NCT00068692|589291678|FG007|Step 2: Randomization|Death|1|||
163157592|NCT00068692|589291671|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
163157593|NCT00068692|589291672|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
163157594|NCT00068692|589291673|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
163157595|NCT00068692|589291674|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
163157596|NCT00068692|589291675|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
163157597|NCT00068692|589291676|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
163157598|NCT00068692|589291677|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
163157599|NCT00068692|589291678|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
163157600|NCT00068692|589291671|FG000|Step 2: Randomization|alternative therapy|0|||
163157601|NCT00068692|589291672|FG001|Step 2: Randomization|alternative therapy|0|||
163157602|NCT00068692|589291673|FG002|Step 2: Randomization|alternative therapy|0|||
163157603|NCT00068692|589291674|FG003|Step 2: Randomization|alternative therapy|1|||
163157604|NCT00068692|589291675|FG004|Step 2: Randomization|alternative therapy|1|||
163157605|NCT00068692|589291676|FG005|Step 2: Randomization|alternative therapy|0|||
163157606|NCT00068692|589291677|FG006|Step 2: Randomization|alternative therapy|0|||
163157607|NCT00068692|589291678|FG007|Step 2: Randomization|alternative therapy|0|||
163157608|NCT00068692|589291671|FG000|Step 2: Randomization|Physician Decision|0|||
163157609|NCT00068692|589291672|FG001|Step 2: Randomization|Physician Decision|0|||
163157610|NCT00068692|589291673|FG002|Step 2: Randomization|Physician Decision|0|||
163157611|NCT00068692|589291674|FG003|Step 2: Randomization|Physician Decision|1|||
163157612|NCT00068692|589291675|FG004|Step 2: Randomization|Physician Decision|1|||
163157613|NCT00068692|589291676|FG005|Step 2: Randomization|Physician Decision|0|||
163157614|NCT00068692|589291677|FG006|Step 2: Randomization|Physician Decision|0|||
163157615|NCT00068692|589291678|FG007|Step 2: Randomization|Physician Decision|0|||
163157616|NCT00068692|589291671|FG000|Step 2: Randomization|Other|0|||
163157617|NCT00068692|589291672|FG001|Step 2: Randomization|Other|0|||
163157618|NCT00068692|589291673|FG002|Step 2: Randomization|Other|0|||
163157619|NCT00068692|589291674|FG003|Step 2: Randomization|Other|1|||
163157620|NCT00068692|589291675|FG004|Step 2: Randomization|Other|0|||
163157621|NCT00068692|589291676|FG005|Step 2: Randomization|Other|1|||
163157622|NCT00068692|589291677|FG006|Step 2: Randomization|Other|0|||
163157623|NCT00068692|589291678|FG007|Step 2: Randomization|Other|0|||
163157624|NCT00068692|589291671|FG000|Step 2: Randomization|never start protocol therapy|0|||
163157625|NCT00068692|589291672|FG001|Step 2: Randomization|never start protocol therapy|0|||
163157626|NCT00068692|589291673|FG002|Step 2: Randomization|never start protocol therapy|1|||
163157627|NCT00068692|589291674|FG003|Step 2: Randomization|never start protocol therapy|0|||
163157628|NCT00068692|589291675|FG004|Step 2: Randomization|never start protocol therapy|1|||
163157629|NCT00068692|589291676|FG005|Step 2: Randomization|never start protocol therapy|0|||
163157630|NCT00068692|589291677|FG006|Step 2: Randomization|never start protocol therapy|0|||
163157631|NCT00068692|589291678|FG007|Step 2: Randomization|never start protocol therapy|0|||
163157632|NCT01600716|589291680|FG000|Overall Study|Other Reasons|3|||
163157633|NCT01600716|589291681|FG001|Overall Study|Other Reasons|1|||
163157634|NCT01600716|589291680|FG000|Overall Study|Personal Reasons|0|||
163157635|NCT01600716|589291681|FG001|Overall Study|Personal Reasons|2|||
163157636|NCT01600716|589291680|FG000|Overall Study|Lost to Follow-up|0|||
163157637|NCT01600716|589291681|FG001|Overall Study|Lost to Follow-up|2|||
163157638|NCT01600716|589291680|FG000|Overall Study|Pregnancy|1|||
163157639|NCT01600716|589291681|FG001|Overall Study|Pregnancy|0|||
163157640|NCT01600716|589291680|FG000|Overall Study|Lack of Efficacy|2|||
163157641|NCT01600716|589291681|FG001|Overall Study|Lack of Efficacy|1|||
163157642|NCT01600716|589291680|FG000|Overall Study|Adverse Event|1|||
163157643|NCT01600716|589291681|FG001|Overall Study|Adverse Event|1|||
163157644|NCT03557034|589291684|FG000|Overall Study|Withdrawal by Subject|1|||
163157645|NCT03557034|589291685|FG001|Overall Study|Withdrawal by Subject|0|||
163157646|NCT00123422|589291686|FG000|Overall Study|Physician Decision|2|||
163157647|NCT00123422|589291687|FG001|Overall Study|Physician Decision|2|||
163157648|NCT00123422|589291688|FG002|Overall Study|Physician Decision|6|||
163157649|NCT00123422|589291686|FG000|Overall Study|Withdrawal by Subject|1|||
163157650|NCT00123422|589291687|FG001|Overall Study|Withdrawal by Subject|2|||
163157651|NCT00123422|589291688|FG002|Overall Study|Withdrawal by Subject|2|||
163157652|NCT00123422|589291686|FG000|Overall Study|Lost to Follow-up|1|||
163157653|NCT00123422|589291687|FG001|Overall Study|Lost to Follow-up|2|||
163157654|NCT00123422|589291688|FG002|Overall Study|Lost to Follow-up|2|||
163157655|NCT01938716|589291693|FG000|Overall Study|Physician Decision|2|||
163157656|NCT01938716|589291693|FG000|Overall Study|Withdrawal by Subject|2|||
163157657|NCT00823615|589291694|FG000|Period 2|Lost to Follow-up|2|||
163157658|NCT00823615|589291695|FG001|Period 2|Lost to Follow-up|0|||
163157659|NCT00823615|589291694|FG000|Period 2|Time/Job Conflict|1|||
163157660|NCT00823615|589291695|FG001|Period 2|Time/Job Conflict|2|||
163157661|NCT02446899|589291696|FG000|Overall Study|Adverse Event|4|||
163157662|NCT02446899|589291697|FG001|Overall Study|Adverse Event|7|||
163157663|NCT02446899|589291696|FG000|Overall Study|Condition Under Investigation Worsened|1|||
163157664|NCT02446899|589291697|FG001|Overall Study|Condition Under Investigation Worsened|4|||
163157665|NCT02446899|589291696|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
163157666|NCT02446899|589291697|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
163157667|NCT02446899|589291696|FG000|Overall Study|Lack of Efficacy|2|||
163157668|NCT02446899|589291697|FG001|Overall Study|Lack of Efficacy|8|||
163157669|NCT02446899|589291696|FG000|Overall Study|Lost to Follow-up|1|||
163157670|NCT02446899|589291697|FG001|Overall Study|Lost to Follow-up|3|||
163157671|NCT02446899|589291696|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
163157672|NCT02446899|589291697|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
163157673|NCT02446899|589291696|FG000|Overall Study|Withdrawal by Subject|11|||
163157674|NCT02446899|589291697|FG001|Overall Study|Withdrawal by Subject|19|||
163157675|NCT02446899|589291696|FG000|Overall Study|Miscellaneous|5|||
163157676|NCT02446899|589291697|FG001|Overall Study|Miscellaneous|4|||
163157677|NCT02446899|589291696|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
163157678|NCT02446899|589291697|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
163157679|NCT01002339|589291698|FG000|Overall Study|Withdrawal by Subject|0|||
163157680|NCT01002339|589291699|FG001|Overall Study|Withdrawal by Subject|1|||
163157681|NCT01002339|589291700|FG002|Overall Study|Withdrawal by Subject|0|||
163157682|NCT01002339|589291698|FG000|Overall Study|Incorrect treatment assignment|0|||
163157683|NCT01002339|589291699|FG001|Overall Study|Incorrect treatment assignment|0|||
163157684|NCT01002339|589291700|FG002|Overall Study|Incorrect treatment assignment|1|||
163157685|NCT01002339|589291698|FG000|Overall Study|Protocol Violation|0|||
163157686|NCT01002339|589291699|FG001|Overall Study|Protocol Violation|0|||
163157687|NCT01002339|589291700|FG002|Overall Study|Protocol Violation|2|||
163157688|NCT01002339|589291698|FG000|Overall Study|Lung cancer detected before transplant|0|||
163157689|NCT01002339|589291699|FG001|Overall Study|Lung cancer detected before transplant|0|||
163157690|NCT01002339|589291700|FG002|Overall Study|Lung cancer detected before transplant|1|||
163157691|NCT01002339|589291698|FG000|Overall Study|Randomized. Not transplanted|0|||
163157692|NCT01002339|589291699|FG001|Overall Study|Randomized. Not transplanted|0|||
163157693|NCT01002339|589291700|FG002|Overall Study|Randomized. Not transplanted|1|||
163157694|NCT02215252|589291701|FG000|Overall Study|Adverse Event|1|||
163157695|NCT02215252|589291702|FG001|Overall Study|Adverse Event|5|||
163157696|NCT02215252|589291703|FG002|Overall Study|Adverse Event|2|||
163157697|NCT02215252|589291701|FG000|Overall Study|Lost to Follow-up|0|||
163157698|NCT02215252|589291702|FG001|Overall Study|Lost to Follow-up|0|||
163157699|NCT02215252|589291703|FG002|Overall Study|Lost to Follow-up|1|||
163157700|NCT02215252|589291701|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
163157701|NCT02215252|589291702|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
163157702|NCT02215252|589291703|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
163157703|NCT02215252|589291701|FG000|Overall Study|Protocol Violation|0|||
163157704|NCT02215252|589291702|FG001|Overall Study|Protocol Violation|1|||
163157705|NCT02215252|589291703|FG002|Overall Study|Protocol Violation|0|||
163157706|NCT02215252|589291701|FG000|Overall Study|Withdrawal by Subject|1|||
163157707|NCT02215252|589291702|FG001|Overall Study|Withdrawal by Subject|0|||
163157708|NCT02215252|589291703|FG002|Overall Study|Withdrawal by Subject|0|||
163157709|NCT02215252|589291701|FG000|Overall Study|Other|0|||
163157710|NCT02215252|589291702|FG001|Overall Study|Other|1|||
163157711|NCT02215252|589291703|FG002|Overall Study|Other|1|||
163042324|NCT02223364|588862538|FG000|Overall Study|subject expired before surgery|1|||
163042325|NCT02223364|588862539|FG001|Overall Study|subject expired before surgery|0|||
163042326|NCT02223364|588862540|FG002|Overall Study|subject expired before surgery|0|||
163042327|NCT02223364|588862538|FG000|Overall Study|Physician Decision|1|||
163042328|NCT02223364|588862539|FG001|Overall Study|Physician Decision|0|||
163042329|NCT02223364|588862540|FG002|Overall Study|Physician Decision|0|||
163042330|NCT02984267|588862542|FG000|Overall Study|Protocol Violation|1|||
163042331|NCT02984267|588862543|FG001|Overall Study|Protocol Violation|0|||
163042332|NCT02984267|588862542|FG000|Overall Study|Withdrawal by Subject|0|||
163157712|NCT00892099|589291705|FG000|Overall Study|Death|1|||
163042333|NCT02984267|588862543|FG001|Overall Study|Withdrawal by Subject|1|||
163042334|NCT02685072|588862544|FG000|Treatment Period|Lost to Follow-up|12|||
163042335|NCT02685072|588862545|FG001|Treatment Period|Lost to Follow-up|6|||
163042336|NCT02685072|588862544|FG000|Treatment Period|Withdrawal by Subject|1|||
163042337|NCT02685072|588862545|FG001|Treatment Period|Withdrawal by Subject|3|||
163042338|NCT02685072|588862544|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
163042339|NCT02685072|588862545|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
163042340|NCT01994902|588862546|FG000|Test Period 1|Withdrawal by Subject|3|||
163042341|NCT01994902|588862547|FG001|Test Period 1|Withdrawal by Subject|0|||
163042342|NCT01994902|588862546|FG000|Test Period 1|device deficiency with adverse event|0|||
163042343|NCT01994902|588862547|FG001|Test Period 1|device deficiency with adverse event|1|||
163042344|NCT01994902|588862546|FG000|Test Period 1|Adverse Event|2|||
163042345|NCT01994902|588862547|FG001|Test Period 1|Adverse Event|1|||
163042346|NCT01994902|588862546|FG000|Test Period 1|Lack of Efficacy|0|||
163042347|NCT01994902|588862547|FG001|Test Period 1|Lack of Efficacy|1|||
163157713|NCT00892099|589291706|FG001|Overall Study|Death|0|||
163157714|NCT00892099|589291707|FG002|Overall Study|Death|1|||
163157715|NCT00892099|589291705|FG000|Overall Study|Adverse Event|1|||
163157716|NCT00892099|589291706|FG001|Overall Study|Adverse Event|0|||
163157717|NCT00892099|589291707|FG002|Overall Study|Adverse Event|0|||
163157718|NCT00892099|589291705|FG000|Overall Study|replocated|1|||
163157719|NCT00892099|589291706|FG001|Overall Study|replocated|0|||
163157720|NCT00892099|589291707|FG002|Overall Study|replocated|2|||
163157721|NCT00892099|589291705|FG000|Overall Study|Prolonged hospitalization|1|||
163157722|NCT00892099|589291706|FG001|Overall Study|Prolonged hospitalization|0|||
163157723|NCT00892099|589291707|FG002|Overall Study|Prolonged hospitalization|1|||
163157724|NCT00892099|589291705|FG000|Overall Study|no further details|1|||
163157725|NCT00892099|589291706|FG001|Overall Study|no further details|0|||
163042348|NCT01994902|588862546|FG000|Test Period 1|bag too small|1|||
163042349|NCT01994902|588862547|FG001|Test Period 1|bag too small|0|||
163042350|NCT01994902|588862546|FG000|Test Period 2|Withdrawal by Subject|0|||
163157726|NCT00892099|589291707|FG002|Overall Study|no further details|1|||
163157727|NCT00892099|589291705|FG000|Overall Study|kidney function recovered|0|||
163157728|NCT00892099|589291706|FG001|Overall Study|kidney function recovered|1|||
163157729|NCT00892099|589291707|FG002|Overall Study|kidney function recovered|0|||
163157730|NCT00892099|589291705|FG000|Overall Study|investigator decision|0|||
163157731|NCT00892099|589291706|FG001|Overall Study|investigator decision|0|||
163157732|NCT00892099|589291707|FG002|Overall Study|investigator decision|1|||
163157733|NCT00892099|589291705|FG000|Overall Study|Lost to Follow-up|0|||
163157734|NCT00892099|589291706|FG001|Overall Study|Lost to Follow-up|0|||
163157735|NCT00892099|589291707|FG002|Overall Study|Lost to Follow-up|1|||
163157736|NCT00433004|589291708|FG000|Overall Study|Lost to Follow-up|5|||
163157737|NCT00433004|589291709|FG001|Overall Study|Lost to Follow-up|7|||
163157738|NCT03910244|589291710|FG000|Overall Study|Adverse Event|14|||
163157739|NCT03910244|589291711|FG001|Overall Study|Adverse Event|0|||
163157740|NCT03910244|589291710|FG000|Overall Study|Death|1|||
163157741|NCT03910244|589291711|FG001|Overall Study|Death|0|||
163157742|NCT03910244|589291710|FG000|Overall Study|Lost to Follow-up|0|||
163157743|NCT03910244|589291711|FG001|Overall Study|Lost to Follow-up|2|||
163157744|NCT03910244|589291710|FG000|Overall Study|Joint withdrawal decision|1|||
163157745|NCT03910244|589291711|FG001|Overall Study|Joint withdrawal decision|0|||
163157746|NCT03910244|589291710|FG000|Overall Study|Study Terminated by Sponsor|7|||
163042351|NCT01994902|588862547|FG001|Test Period 2|Withdrawal by Subject|2|||
163042352|NCT01994902|588862546|FG000|Test Period 2|Lack of Efficacy|0|||
163042353|NCT01994902|588862547|FG001|Test Period 2|Lack of Efficacy|1|||
163042354|NCT01994902|588862546|FG000|Test Period 2|Other|0|||
163042355|NCT01994902|588862547|FG001|Test Period 2|Other|3|||
163042356|NCT03597139|588862549|FG000|Overall Study|Adverse Event|3|||
163042357|NCT03597139|588862550|FG001|Overall Study|Adverse Event|0|||
163042358|NCT03597139|588862549|FG000|Overall Study|Protocol Non-compliance|1|||
163157747|NCT03910244|589291711|FG001|Overall Study|Study Terminated by Sponsor|4|||
163157748|NCT03910244|589291710|FG000|Overall Study|Physician Decision|1|||
163157749|NCT03910244|589291711|FG001|Overall Study|Physician Decision|0|||
163157750|NCT03910244|589291710|FG000|Overall Study|Protocol Violation|1|||
163157751|NCT03910244|589291711|FG001|Overall Study|Protocol Violation|0|||
163157752|NCT03910244|589291710|FG000|Overall Study|Withdrawal by Subject|7|||
163157753|NCT03910244|589291711|FG001|Overall Study|Withdrawal by Subject|2|||
163157754|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
163271049|NCT02303626|589700092|FG002|Overall Study|Protocol Violation|0|||
163157755|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
163157756|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
163157757|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
163157758|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
163157759|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
163157760|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
163157761|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
163157762|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
163157763|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
163157764|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
163157765|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
163157766|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
163157767|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
163157768|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
163157769|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
163157770|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
163157771|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
163157772|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
163157773|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
163157774|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
163157775|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
163157776|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
163157777|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
163157778|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Other|10|||
163157779|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Other|2|||
163157780|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Other|6|||
163157781|NCT01106690|589291712|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
163157782|NCT01106690|589291713|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
163157783|NCT01106690|589291714|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
163157784|NCT01106690|589291712|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
163157785|NCT01106690|589291713|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
163157786|NCT01106690|589291714|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
163157787|NCT01106690|589291712|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
163157788|NCT01106690|589291713|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
163157789|NCT01106690|589291714|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
163157790|NCT01106690|589291712|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
163157791|NCT01106690|589291713|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
163157792|NCT01106690|589291714|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
163157793|NCT01106690|589291712|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
163157794|NCT01106690|589291713|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
163157795|NCT01106690|589291714|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
163157796|NCT01106690|589291712|FG000|Extension Period: Week 26 to Week 52|Other|8|||
163157797|NCT01106690|589291713|FG001|Extension Period: Week 26 to Week 52|Other|3|||
163157798|NCT01106690|589291714|FG002|Extension Period: Week 26 to Week 52|Other|4|||
163157799|NCT01106690|589291712|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
163157800|NCT01106690|589291713|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
163157801|NCT01106690|589291714|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
163157802|NCT04455815|589291715|FG000|Randomisation Phase|Adverse Event|1|||
163157803|NCT04455815|589291716|FG001|Randomisation Phase|Adverse Event|0|||
163157804|NCT04455815|589291715|FG000|Treatment Phase|Adverse Event|0|||
163157805|NCT04455815|589291716|FG001|Treatment Phase|Adverse Event|1|||
163157806|NCT04455815|589291715|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
163157807|NCT04455815|589291716|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
163157808|NCT04455815|589291715|FG000|Treatment Phase|Withdrawal by Subject|1|||
163157809|NCT04455815|589291716|FG001|Treatment Phase|Withdrawal by Subject|1|||
163157810|NCT03219528|589291721|FG000|Overall Study|Lost to Follow-up|5|||
163157811|NCT03219528|589291722|FG001|Overall Study|Lost to Follow-up|4|||
163157812|NCT03219528|589291721|FG000|Overall Study|Withdrawal by Subject|4|||
163157813|NCT03219528|589291722|FG001|Overall Study|Withdrawal by Subject|4|||
163157814|NCT03809104|589291723|FG000|Overall Study|Withdrawal by Subject|3|||
163157815|NCT00790842|589291724|FG000|Dose Level 1|Adverse Event|1|||
163157816|NCT00790842|589291725|FG001|Dose Level 1|Adverse Event|0|||
163157817|NCT00790842|589291726|FG002|Dose Level 1|Adverse Event|0|||
163157818|NCT00790842|589291727|FG003|Dose Level 1|Adverse Event|2|||
163157819|NCT00790842|589291728|FG004|Dose Level 1|Adverse Event|0|||
163157820|NCT00790842|589291729|FG005|Dose Level 1|Adverse Event|0|||
163157821|NCT00790842|589291730|FG006|Dose Level 1|Adverse Event|0|||
163042359|NCT03597139|588862550|FG001|Overall Study|Protocol Non-compliance|0|||
163042360|NCT01249833|588862551|FG000|Overall Study|Lost to Follow-up|0|||
163042361|NCT01249833|588862552|FG001|Overall Study|Lost to Follow-up|1|||
163042362|NCT02427802|588862553|FG000|Overall Study|Adverse Event|11|||
163042363|NCT02427802|588862554|FG001|Overall Study|Adverse Event|3|||
163042364|NCT02427802|588862555|FG002|Overall Study|Adverse Event|7|||
163042365|NCT02427802|588862553|FG000|Overall Study|Death|0|||
163042366|NCT02427802|588862554|FG001|Overall Study|Death|4|||
163042367|NCT02427802|588862555|FG002|Overall Study|Death|1|||
163042368|NCT02427802|588862553|FG000|Overall Study|Lost to Follow-up|13|||
163042369|NCT02427802|588862554|FG001|Overall Study|Lost to Follow-up|8|||
163042370|NCT02427802|588862555|FG002|Overall Study|Lost to Follow-up|8|||
163042371|NCT02427802|588862553|FG000|Overall Study|Physician Decision|4|||
163042372|NCT02427802|588862554|FG001|Overall Study|Physician Decision|2|||
163042373|NCT02427802|588862555|FG002|Overall Study|Physician Decision|4|||
163042374|NCT02427802|588862553|FG000|Overall Study|Withdrawal by Subject|10|||
163042375|NCT02427802|588862554|FG001|Overall Study|Withdrawal by Subject|5|||
163042376|NCT02427802|588862555|FG002|Overall Study|Withdrawal by Subject|11|||
163042377|NCT02427802|588862553|FG000|Overall Study|Protocol Violation|3|||
163042378|NCT02427802|588862554|FG001|Overall Study|Protocol Violation|1|||
163042379|NCT02427802|588862555|FG002|Overall Study|Protocol Violation|1|||
163042380|NCT02427802|588862553|FG000|Overall Study|protocol specific treatment unrelated|18|||
163042381|NCT02427802|588862554|FG001|Overall Study|protocol specific treatment unrelated|11|||
163042382|NCT02427802|588862555|FG002|Overall Study|protocol specific treatment unrelated|11|||
163042383|NCT01073163|588863844|FG000|Overall Study|Adverse Event|1|||
163042384|NCT01073163|588863844|FG000|Overall Study|Disease Progression|1|||
163042385|NCT01073163|588863844|FG000|Overall Study|Early termination|1|||
163042386|NCT00802672|588863845|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
163042387|NCT00802672|588863846|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
163042388|NCT00802672|588863847|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
163042389|NCT00802672|588863845|FG000|Overall Study|Adverse Event|1|||
163042390|NCT00802672|588863846|FG001|Overall Study|Adverse Event|1|||
163042391|NCT00802672|588863847|FG002|Overall Study|Adverse Event|1|||
163042392|NCT00802672|588863845|FG000|Overall Study|Protocol Violation|2|||
163042393|NCT00802672|588863846|FG001|Overall Study|Protocol Violation|1|||
163042394|NCT00802672|588863847|FG002|Overall Study|Protocol Violation|1|||
163042395|NCT00802672|588863845|FG000|Overall Study|Lost to Follow-up|5|||
163042396|NCT00802672|588863846|FG001|Overall Study|Lost to Follow-up|5|||
163042397|NCT00802672|588863847|FG002|Overall Study|Lost to Follow-up|3|||
163042398|NCT00802672|588863845|FG000|Overall Study|Withdrawal by Subject|1|||
163042399|NCT00802672|588863846|FG001|Overall Study|Withdrawal by Subject|1|||
163042400|NCT00802672|588863847|FG002|Overall Study|Withdrawal by Subject|2|||
163042401|NCT00802672|588863845|FG000|Overall Study|other|3|||
163042402|NCT00802672|588863846|FG001|Overall Study|other|1|||
163042403|NCT00802672|588863847|FG002|Overall Study|other|2|||
163042404|NCT00703677|588863848|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
163042405|NCT03859648|588863853|FG000|Overall Study|Lost to Follow-up|1|||
163042406|NCT03859648|588863853|FG000|Overall Study|Adverse Event|1|||
163042407|NCT01990573|588863858|FG000|Overall Study|Physician Decision|0|||
163042408|NCT01990573|588863859|FG001|Overall Study|Physician Decision|0|||
163042409|NCT01990573|588863860|FG002|Overall Study|Physician Decision|1|||
163042410|NCT03335813|588863874|FG000|Overall Study|Withdrawal by Subject|1|||
163042411|NCT00697593|588863877|FG000|Overall Study|Adverse Event|3|||
163157822|NCT00790842|589291731|FG007|Dose Level 1|Adverse Event|1|||
163042412|NCT00697593|588863877|FG000|Overall Study|Protocol Violation|1|||
163042413|NCT00697593|588863877|FG000|Overall Study|Lack of Efficacy|3|||
163157823|NCT00790842|589291732|FG008|Dose Level 1|Adverse Event|0|||
163157824|NCT00790842|589291733|FG009|Dose Level 1|Adverse Event|0|||
163157825|NCT00790842|589291734|FG010|Dose Level 1|Adverse Event|0|||
163157826|NCT00790842|589291724|FG000|Dose Level 1|Physician Decision|1|||
163157827|NCT00790842|589291725|FG001|Dose Level 1|Physician Decision|0|||
163157828|NCT00790842|589291726|FG002|Dose Level 1|Physician Decision|0|||
163157829|NCT00790842|589291727|FG003|Dose Level 1|Physician Decision|0|||
163157830|NCT00790842|589291728|FG004|Dose Level 1|Physician Decision|0|||
163157831|NCT00790842|589291729|FG005|Dose Level 1|Physician Decision|0|||
163157832|NCT00790842|589291730|FG006|Dose Level 1|Physician Decision|0|||
163157833|NCT00790842|589291731|FG007|Dose Level 1|Physician Decision|1|||
163157834|NCT00790842|589291732|FG008|Dose Level 1|Physician Decision|0|||
163157835|NCT00790842|589291733|FG009|Dose Level 1|Physician Decision|0|||
163157836|NCT00790842|589291734|FG010|Dose Level 1|Physician Decision|0|||
163157837|NCT00790842|589291724|FG000|Dose Level 1|Withdrawal by Subject|1|||
163157838|NCT00790842|589291725|FG001|Dose Level 1|Withdrawal by Subject|0|||
163157839|NCT00790842|589291726|FG002|Dose Level 1|Withdrawal by Subject|0|||
163042414|NCT00697593|588863877|FG000|Overall Study|Suspension of the study by sponsor|12|||
163042415|NCT00411450|588863886|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
163042416|NCT00614874|588863887|FG000|Overall Study|Protocol Violation|1|||
163157840|NCT00790842|589291727|FG003|Dose Level 1|Withdrawal by Subject|0|||
163042417|NCT00614874|588863887|FG000|Overall Study|Withdrawal by Subject|1|||
163042418|NCT03904420|588863888|FG000|Overall Study|Study terminated|2|||
163271050|NCT02303626|589700090|FG000|Overall Study|Pregnancy|0|||
163271051|NCT02303626|589700091|FG001|Overall Study|Pregnancy|0|||
163271052|NCT02303626|589700092|FG002|Overall Study|Pregnancy|1|||
163271053|NCT02303626|589700090|FG000|Overall Study|Subject Non-Compliance|0|||
163271054|NCT02303626|589700091|FG001|Overall Study|Subject Non-Compliance|0|||
163271055|NCT02303626|589700092|FG002|Overall Study|Subject Non-Compliance|1|||
163271056|NCT05832437|589700093|FG000|Overall Study|time off work|1|||
163271057|NCT05832437|589700094|FG001|Overall Study|time off work|0|||
163271058|NCT05832437|589700095|FG002|Overall Study|time off work|0|||
163271059|NCT05832437|589700096|FG003|Overall Study|time off work|0|||
163271060|NCT00337662|589700097|FG000|Study Period II|Lost to Follow-up|0|||
163271061|NCT00337662|589700098|FG001|Study Period II|Lost to Follow-up|0|||
163271062|NCT00337662|589700099|FG002|Study Period II|Lost to Follow-up|0|||
163271063|NCT00337662|589700100|FG003|Study Period II|Lost to Follow-up|35|||
163271064|NCT00337662|589700097|FG000|Study Period II|Withdrawal by Subject|0|||
163271065|NCT00337662|589700098|FG001|Study Period II|Withdrawal by Subject|0|||
163271066|NCT00337662|589700099|FG002|Study Period II|Withdrawal by Subject|0|||
163271067|NCT00337662|589700100|FG003|Study Period II|Withdrawal by Subject|20|||
163271068|NCT00337662|589700097|FG000|Study Period II|Adverse Event|0|||
163271069|NCT00337662|589700098|FG001|Study Period II|Adverse Event|0|||
163271070|NCT00337662|589700099|FG002|Study Period II|Adverse Event|0|||
163271071|NCT00337662|589700100|FG003|Study Period II|Adverse Event|16|||
163271072|NCT00337662|589700097|FG000|Study Period II|Physician Decision|0|||
163271073|NCT00337662|589700098|FG001|Study Period II|Physician Decision|0|||
163271074|NCT00337662|589700099|FG002|Study Period II|Physician Decision|0|||
163271075|NCT00337662|589700100|FG003|Study Period II|Physician Decision|13|||
163271076|NCT00337662|589700097|FG000|Study Period II|Entry Criteria Not Met|0|||
163271077|NCT00337662|589700098|FG001|Study Period II|Entry Criteria Not Met|0|||
163271078|NCT00337662|589700099|FG002|Study Period II|Entry Criteria Not Met|0|||
163271079|NCT00337662|589700100|FG003|Study Period II|Entry Criteria Not Met|6|||
163271080|NCT00337662|589700097|FG000|Study Period II|Protocol Violation|0|||
163271081|NCT00337662|589700098|FG001|Study Period II|Protocol Violation|0|||
163271082|NCT00337662|589700099|FG002|Study Period II|Protocol Violation|0|||
163271083|NCT00337662|589700100|FG003|Study Period II|Protocol Violation|6|||
163271084|NCT00337662|589700097|FG000|Study Period II|Lack of Efficacy|0|||
163271085|NCT00337662|589700098|FG001|Study Period II|Lack of Efficacy|0|||
163271086|NCT00337662|589700099|FG002|Study Period II|Lack of Efficacy|0|||
163271087|NCT00337662|589700100|FG003|Study Period II|Lack of Efficacy|7|||
163271088|NCT00337662|589700097|FG000|Study Period II|Sponsor Decision|0|||
163271089|NCT00337662|589700098|FG001|Study Period II|Sponsor Decision|0|||
163271090|NCT00337662|589700099|FG002|Study Period II|Sponsor Decision|0|||
163271091|NCT00337662|589700100|FG003|Study Period II|Sponsor Decision|2|||
163271092|NCT00337662|589700097|FG000|Study Period II|Parent/Caregiver Decision|0|||
163271093|NCT00337662|589700098|FG001|Study Period II|Parent/Caregiver Decision|0|||
163271094|NCT00337662|589700099|FG002|Study Period II|Parent/Caregiver Decision|0|||
163271095|NCT00337662|589700100|FG003|Study Period II|Parent/Caregiver Decision|1|||
163271096|NCT00337662|589700097|FG000|Study Period III|Lost to Follow-up|14|||
163271097|NCT00337662|589700098|FG001|Study Period III|Lost to Follow-up|16|||
163271098|NCT00337662|589700099|FG002|Study Period III|Lost to Follow-up|14|||
163271099|NCT00337662|589700100|FG003|Study Period III|Lost to Follow-up|0|||
163271100|NCT00337662|589700097|FG000|Study Period III|Withdrawal by Subject|18|||
163271101|NCT00337662|589700098|FG001|Study Period III|Withdrawal by Subject|14|||
163271102|NCT00337662|589700099|FG002|Study Period III|Withdrawal by Subject|12|||
163271103|NCT00337662|589700100|FG003|Study Period III|Withdrawal by Subject|0|||
163271104|NCT00337662|589700097|FG000|Study Period III|Adverse Event|9|||
163271105|NCT00337662|589700098|FG001|Study Period III|Adverse Event|10|||
163271106|NCT00337662|589700099|FG002|Study Period III|Adverse Event|8|||
163271107|NCT00337662|589700100|FG003|Study Period III|Adverse Event|0|||
163271108|NCT00337662|589700097|FG000|Study Period III|Protocol Violation|3|||
163271109|NCT00337662|589700098|FG001|Study Period III|Protocol Violation|8|||
163271110|NCT00337662|589700099|FG002|Study Period III|Protocol Violation|2|||
163271111|NCT00337662|589700100|FG003|Study Period III|Protocol Violation|0|||
163271112|NCT00337662|589700097|FG000|Study Period III|Physician Decision|6|||
163271113|NCT00337662|589700098|FG001|Study Period III|Physician Decision|5|||
163271114|NCT00337662|589700099|FG002|Study Period III|Physician Decision|0|||
163271115|NCT00337662|589700100|FG003|Study Period III|Physician Decision|0|||
163271116|NCT00337662|589700097|FG000|Study Period III|Entry Criteria Not Met|4|||
163271117|NCT00337662|589700098|FG001|Study Period III|Entry Criteria Not Met|1|||
163271118|NCT00337662|589700099|FG002|Study Period III|Entry Criteria Not Met|3|||
163271119|NCT00337662|589700100|FG003|Study Period III|Entry Criteria Not Met|0|||
163271120|NCT00337662|589700097|FG000|Study Period III|Lack of Efficacy|4|||
163271121|NCT00337662|589700098|FG001|Study Period III|Lack of Efficacy|4|||
163271122|NCT00337662|589700099|FG002|Study Period III|Lack of Efficacy|2|||
163271123|NCT00337662|589700100|FG003|Study Period III|Lack of Efficacy|0|||
163271124|NCT00337662|589700097|FG000|Study Period III|Parent/Caregiver Decision|0|||
163271125|NCT00337662|589700098|FG001|Study Period III|Parent/Caregiver Decision|0|||
163271126|NCT00337662|589700099|FG002|Study Period III|Parent/Caregiver Decision|2|||
163271127|NCT00337662|589700100|FG003|Study Period III|Parent/Caregiver Decision|0|||
163271128|NCT00337662|589700097|FG000|Study Period III|Sponsor Decision|1|||
163271129|NCT00337662|589700098|FG001|Study Period III|Sponsor Decision|0|||
163271130|NCT00337662|589700099|FG002|Study Period III|Sponsor Decision|1|||
163271131|NCT00337662|589700100|FG003|Study Period III|Sponsor Decision|0|||
163271132|NCT00337662|589700097|FG000|Study Period III|Clinical Relapse|1|||
163271133|NCT00337662|589700098|FG001|Study Period III|Clinical Relapse|0|||
163271134|NCT00337662|589700099|FG002|Study Period III|Clinical Relapse|0|||
163271135|NCT00337662|589700100|FG003|Study Period III|Clinical Relapse|0|||
163271136|NCT00882921|589700101|FG000|Overall Study|Death|2|||
163271137|NCT00882921|589700101|FG000|Overall Study|Other|3|||
163271138|NCT00882921|589700101|FG000|Overall Study|Lost to Follow-up|2|||
163271139|NCT00882921|589700101|FG000|Overall Study|Termination By Investigator|3|||
163271140|NCT00882921|589700101|FG000|Overall Study|Withdrawal Of Consent|1|||
163271141|NCT03391960|589700113|FG000|Overall Study|Protocol Violation|0|||
163271142|NCT03391960|589700114|FG001|Overall Study|Protocol Violation|0|||
163271143|NCT00581113|589701366|FG000|Overall Study|Withdrawal by Subject|0|||
163271144|NCT00581113|589701367|FG001|Overall Study|Withdrawal by Subject|1|||
163271145|NCT04834362|589701368|FG000|Overall Study|Death|1|||
163271146|NCT04834362|589701369|FG001|Overall Study|Death|2|||
163271147|NCT00329719|589701372|FG000|Overall Study|Lost to Follow-up|0|||
163271148|NCT00329719|589701373|FG001|Overall Study|Lost to Follow-up|0|||
163271149|NCT00329719|589701374|FG002|Overall Study|Lost to Follow-up|0|||
163271150|NCT00329719|589701375|FG003|Overall Study|Lost to Follow-up|1|||
163271151|NCT06017999|589701376|FG000|Overall Study|Withdrawal by Subject|0|||
163271152|NCT06017999|589701377|FG001|Overall Study|Withdrawal by Subject|4|||
163271153|NCT06017999|589701378|FG002|Overall Study|Withdrawal by Subject|3|||
163271154|NCT06017999|589701376|FG000|Overall Study|Adverse Event|2|||
163271155|NCT06017999|589701377|FG001|Overall Study|Adverse Event|1|||
163271156|NCT06017999|589701378|FG002|Overall Study|Adverse Event|1|||
163271157|NCT06017999|589701376|FG000|Overall Study|Lost to Follow-up|0|||
163271158|NCT06017999|589701377|FG001|Overall Study|Lost to Follow-up|0|||
163271159|NCT06017999|589701378|FG002|Overall Study|Lost to Follow-up|1|||
163271160|NCT06017999|589701376|FG000|Overall Study|Physician Decision|1|||
163271161|NCT06017999|589701377|FG001|Overall Study|Physician Decision|1|||
163271162|NCT06017999|589701378|FG002|Overall Study|Physician Decision|0|||
163271163|NCT06017999|589701376|FG000|Overall Study|Non-Compliance|0|||
163271164|NCT06017999|589701377|FG001|Overall Study|Non-Compliance|0|||
163271165|NCT06017999|589701378|FG002|Overall Study|Non-Compliance|1|||
163271166|NCT06017999|589701376|FG000|Overall Study|Lack of Efficacy|1|||
163271167|NCT06017999|589701377|FG001|Overall Study|Lack of Efficacy|0|||
163271168|NCT06017999|589701378|FG002|Overall Study|Lack of Efficacy|7|||
163271169|NCT06017999|589701376|FG000|Overall Study|COVID Positive|0|||
163271170|NCT06017999|589701377|FG001|Overall Study|COVID Positive|1|||
163271171|NCT06017999|589701378|FG002|Overall Study|COVID Positive|0|||
163271172|NCT06017999|589701376|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
163271173|NCT06017999|589701377|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
163271174|NCT06017999|589701378|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
163271175|NCT01155388|589701379|FG000|Overall Study|Adverse Event|1|||
163271176|NCT01155388|589701380|FG001|Overall Study|Adverse Event|0|||
163271177|NCT03943589|589701381|FG000|Overall Study|Death|1|||
163271178|NCT03943589|589701381|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
163271179|NCT04329104|589701382|FG000|Efficacy Study|Withdrawal by Subject|0|||
163271180|NCT04329104|589701383|FG001|Efficacy Study|Withdrawal by Subject|0|||
163271181|NCT04329104|589701384|FG002|Efficacy Study|Withdrawal by Subject|0|||
163271182|NCT04329104|589701385|FG003|Efficacy Study|Withdrawal by Subject|5|||
163271183|NCT04329104|589701386|FG004|Efficacy Study|Withdrawal by Subject|6|||
163271184|NCT04329104|589701387|FG005|Efficacy Study|Withdrawal by Subject|8|||
163271185|NCT01702428|589701388|FG000|Overall Study|Adverse Event|2|||
163271186|NCT01702428|589701389|FG001|Overall Study|Adverse Event|0|||
163271187|NCT01702428|589701390|FG002|Overall Study|Adverse Event|0|||
163271188|NCT01702428|589701391|FG003|Overall Study|Adverse Event|0|||
163271189|NCT01702428|589701388|FG000|Overall Study|Lost to Follow-up|33|||
163271190|NCT01702428|589701389|FG001|Overall Study|Lost to Follow-up|41|||
163271191|NCT01702428|589701390|FG002|Overall Study|Lost to Follow-up|37|||
163271192|NCT01702428|589701391|FG003|Overall Study|Lost to Follow-up|44|||
163271193|NCT01702428|589701388|FG000|Overall Study|Parents cannot assist to site|1|||
163271194|NCT01702428|589701389|FG001|Overall Study|Parents cannot assist to site|0|||
163271195|NCT01702428|589701390|FG002|Overall Study|Parents cannot assist to site|1|||
163271196|NCT01702428|589701391|FG003|Overall Study|Parents cannot assist to site|0|||
163271197|NCT01702428|589701388|FG000|Overall Study|Lost Coverage|0|||
163271198|NCT01702428|589701389|FG001|Overall Study|Lost Coverage|0|||
163271199|NCT01702428|589701390|FG002|Overall Study|Lost Coverage|0|||
163271200|NCT01702428|589701391|FG003|Overall Study|Lost Coverage|1|||
163271201|NCT01702428|589701388|FG000|Overall Study|Lost Health Plan|3|||
163271202|NCT01702428|589701389|FG001|Overall Study|Lost Health Plan|5|||
163271203|NCT01702428|589701390|FG002|Overall Study|Lost Health Plan|0|||
162929540|NCT04682639|588447388|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
163271204|NCT01702428|589701391|FG003|Overall Study|Lost Health Plan|2|||
163271205|NCT01702428|589701388|FG000|Overall Study|Mother transferred care|0|||
163271206|NCT01702428|589701389|FG001|Overall Study|Mother transferred care|1|||
163271207|NCT01702428|589701390|FG002|Overall Study|Mother transferred care|0|||
163271208|NCT01702428|589701391|FG003|Overall Study|Mother transferred care|0|||
163271209|NCT01702428|589701388|FG000|Overall Study|Parents too busy|1|||
163271210|NCT01702428|589701389|FG001|Overall Study|Parents too busy|0|||
163271211|NCT01702428|589701390|FG002|Overall Study|Parents too busy|0|||
163271212|NCT01702428|589701391|FG003|Overall Study|Parents too busy|0|||
163271213|NCT01702428|589701388|FG000|Overall Study|Protocol Violation|3|||
163271214|NCT01702428|589701389|FG001|Overall Study|Protocol Violation|0|||
163271215|NCT01702428|589701390|FG002|Overall Study|Protocol Violation|1|||
163271216|NCT01702428|589701391|FG003|Overall Study|Protocol Violation|0|||
163271217|NCT01702428|589701388|FG000|Overall Study|Withdrawal by Subject|21|||
163271218|NCT01702428|589701389|FG001|Overall Study|Withdrawal by Subject|23|||
163271219|NCT01702428|589701390|FG002|Overall Study|Withdrawal by Subject|14|||
163271220|NCT01702428|589701391|FG003|Overall Study|Withdrawal by Subject|10|||
163271221|NCT02091869|589701392|FG000|Overall Study|Withdrawal by Subject|0|||
163271222|NCT02091869|589701393|FG001|Overall Study|Withdrawal by Subject|3|||
163271223|NCT03685708|589701397|FG000|Overall Study|Withdrawal by Subject|0|||
163271224|NCT03685708|589701398|FG001|Overall Study|Withdrawal by Subject|0|||
163271225|NCT03685708|589701399|FG002|Overall Study|Withdrawal by Subject|1|||
163271226|NCT03685708|589701397|FG000|Overall Study|Screen Fail|0|||
163271227|NCT03685708|589701398|FG001|Overall Study|Screen Fail|1|||
163271228|NCT03685708|589701399|FG002|Overall Study|Screen Fail|1|||
163271229|NCT03685708|589701397|FG000|Overall Study|COVID 19 Pandemic|1|||
163271230|NCT03685708|589701398|FG001|Overall Study|COVID 19 Pandemic|1|||
163271231|NCT03685708|589701399|FG002|Overall Study|COVID 19 Pandemic|6|||
163271232|NCT03685708|589701397|FG000|Overall Study|Disease Progression|0|||
163271233|NCT03685708|589701398|FG001|Overall Study|Disease Progression|0|||
163271234|NCT03685708|589701399|FG002|Overall Study|Disease Progression|1|||
163042419|NCT03904420|588863889|FG001|Overall Study|Study terminated|2|||
163042420|NCT04435808|588863890|FG000|Overall Study|Study stopped by DSMB|0|||
163271235|NCT02771210|589701401|FG000|Period 1|Adverse Event|5|||
163271236|NCT02771210|589701402|FG001|Period 1|Adverse Event|3|||
163271237|NCT02771210|589701401|FG000|Period 1|Lack of Efficacy|3|||
163042421|NCT04435808|588863891|FG001|Overall Study|Study stopped by DSMB|1|||
163042422|NCT00807612|588863892|FG000|Overall Study|Death|8|||
163042423|NCT00807612|588863892|FG000|Overall Study|Study early termination|5|||
163042424|NCT00807612|588863892|FG000|Overall Study|Withdrawal by Subject|1|||
163042425|NCT00705341|588863893|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
163042426|NCT00705341|588863894|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
163042427|NCT00705341|588863895|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
163042428|NCT00705341|588863896|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
163042429|NCT00705341|588863893|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
163042430|NCT00705341|588863894|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
163042431|NCT00705341|588863895|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
163042432|NCT00705341|588863896|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
163042433|NCT02959918|588863899|FG000|Overall Study|Adverse Event|1|||
163042434|NCT02959918|588863900|FG001|Overall Study|Adverse Event|1|||
163042435|NCT02959918|588863901|FG002|Overall Study|Adverse Event|2|||
163042436|NCT02959918|588863902|FG003|Overall Study|Adverse Event|0|||
163042437|NCT02959918|588863903|FG004|Overall Study|Adverse Event|0|||
163042438|NCT02959918|588863904|FG005|Overall Study|Adverse Event|2|||
163042439|NCT02959918|588863905|FG006|Overall Study|Adverse Event|2|||
163042440|NCT02959918|588863906|FG007|Overall Study|Adverse Event|1|||
163042441|NCT02959918|588863907|FG008|Overall Study|Adverse Event|2|||
163042442|NCT02959918|588863908|FG009|Overall Study|Adverse Event|1|||
163042443|NCT02959918|588863909|FG010|Overall Study|Adverse Event|1|||
163042444|NCT02959918|588863910|FG011|Overall Study|Adverse Event|3|||
163042445|NCT02959918|588863911|FG012|Overall Study|Adverse Event|2|||
163042446|NCT02959918|588863912|FG013|Overall Study|Adverse Event|4|||
163042447|NCT02959918|588863899|FG000|Overall Study|Lost to Follow-up|0|||
163042448|NCT02959918|588863900|FG001|Overall Study|Lost to Follow-up|0|||
163042449|NCT02959918|588863901|FG002|Overall Study|Lost to Follow-up|0|||
163042450|NCT02959918|588863902|FG003|Overall Study|Lost to Follow-up|0|||
163042451|NCT02959918|588863903|FG004|Overall Study|Lost to Follow-up|0|||
163271238|NCT02771210|589701402|FG001|Period 1|Lack of Efficacy|6|||
163271239|NCT02771210|589701401|FG000|Period 1|Lost to Follow-up|2|||
163042452|NCT02959918|588863904|FG005|Overall Study|Lost to Follow-up|0|||
163042453|NCT02959918|588863905|FG006|Overall Study|Lost to Follow-up|0|||
163042454|NCT02959918|588863906|FG007|Overall Study|Lost to Follow-up|0|||
163042455|NCT02959918|588863907|FG008|Overall Study|Lost to Follow-up|0|||
163042456|NCT02959918|588863908|FG009|Overall Study|Lost to Follow-up|1|||
163042457|NCT02959918|588863909|FG010|Overall Study|Lost to Follow-up|0|||
163271240|NCT02771210|589701402|FG001|Period 1|Lost to Follow-up|0|||
163271241|NCT02771210|589701401|FG000|Period 1|Physician Decision|0|||
163271242|NCT02771210|589701402|FG001|Period 1|Physician Decision|1|||
163271243|NCT02771210|589701401|FG000|Period 1|Withdrawal by Subject|0|||
163271244|NCT02771210|589701402|FG001|Period 1|Withdrawal by Subject|3|||
163042458|NCT02959918|588863910|FG011|Overall Study|Lost to Follow-up|0|||
163042459|NCT02959918|588863911|FG012|Overall Study|Lost to Follow-up|1|||
163042460|NCT02959918|588863912|FG013|Overall Study|Lost to Follow-up|0|||
163042461|NCT02959918|588863899|FG000|Overall Study|Withdrawal by Subject|0|||
163042462|NCT02959918|588863900|FG001|Overall Study|Withdrawal by Subject|0|||
163042463|NCT02959918|588863901|FG002|Overall Study|Withdrawal by Subject|1|||
163042464|NCT02959918|588863902|FG003|Overall Study|Withdrawal by Subject|2|||
163042465|NCT02959918|588863903|FG004|Overall Study|Withdrawal by Subject|0|||
163042466|NCT02959918|588863904|FG005|Overall Study|Withdrawal by Subject|0|||
163042467|NCT02959918|588863905|FG006|Overall Study|Withdrawal by Subject|1|||
163042468|NCT02959918|588863906|FG007|Overall Study|Withdrawal by Subject|0|||
163042469|NCT02959918|588863907|FG008|Overall Study|Withdrawal by Subject|1|||
163042470|NCT02959918|588863908|FG009|Overall Study|Withdrawal by Subject|1|||
163042471|NCT02959918|588863909|FG010|Overall Study|Withdrawal by Subject|2|||
163042472|NCT02959918|588863910|FG011|Overall Study|Withdrawal by Subject|3|||
163042473|NCT02959918|588863911|FG012|Overall Study|Withdrawal by Subject|1|||
163042474|NCT02959918|588863912|FG013|Overall Study|Withdrawal by Subject|1|||
163042475|NCT02959918|588863899|FG000|Overall Study|Protocol Violation|0|||
163042476|NCT02959918|588863900|FG001|Overall Study|Protocol Violation|0|||
163042477|NCT02959918|588863901|FG002|Overall Study|Protocol Violation|1|||
163042478|NCT02959918|588863902|FG003|Overall Study|Protocol Violation|0|||
163042479|NCT02959918|588863903|FG004|Overall Study|Protocol Violation|0|||
163042480|NCT02959918|588863904|FG005|Overall Study|Protocol Violation|1|||
163042481|NCT02959918|588863905|FG006|Overall Study|Protocol Violation|0|||
163042482|NCT02959918|588863906|FG007|Overall Study|Protocol Violation|0|||
163042483|NCT02959918|588863907|FG008|Overall Study|Protocol Violation|2|||
163042484|NCT02959918|588863908|FG009|Overall Study|Protocol Violation|1|||
163042485|NCT02959918|588863909|FG010|Overall Study|Protocol Violation|0|||
163042486|NCT02959918|588863910|FG011|Overall Study|Protocol Violation|1|||
163042487|NCT02959918|588863911|FG012|Overall Study|Protocol Violation|1|||
163042488|NCT02959918|588863912|FG013|Overall Study|Protocol Violation|0|||
163042489|NCT02959918|588863899|FG000|Overall Study|Stopping Rule Met|1|||
163042490|NCT02959918|588863900|FG001|Overall Study|Stopping Rule Met|0|||
163042491|NCT02959918|588863901|FG002|Overall Study|Stopping Rule Met|3|||
163042492|NCT02959918|588863902|FG003|Overall Study|Stopping Rule Met|4|||
163042493|NCT02959918|588863903|FG004|Overall Study|Stopping Rule Met|5|||
163042494|NCT02959918|588863904|FG005|Overall Study|Stopping Rule Met|3|||
163042495|NCT02959918|588863905|FG006|Overall Study|Stopping Rule Met|2|||
163042496|NCT02959918|588863906|FG007|Overall Study|Stopping Rule Met|4|||
163042497|NCT02959918|588863907|FG008|Overall Study|Stopping Rule Met|1|||
163042498|NCT02959918|588863908|FG009|Overall Study|Stopping Rule Met|1|||
163042499|NCT02959918|588863909|FG010|Overall Study|Stopping Rule Met|3|||
163157841|NCT00790842|589291728|FG004|Dose Level 1|Withdrawal by Subject|0|||
163042500|NCT02959918|588863910|FG011|Overall Study|Stopping Rule Met|5|||
163157842|NCT00790842|589291729|FG005|Dose Level 1|Withdrawal by Subject|0|||
163157843|NCT00790842|589291730|FG006|Dose Level 1|Withdrawal by Subject|0|||
163157844|NCT00790842|589291731|FG007|Dose Level 1|Withdrawal by Subject|0|||
163157845|NCT00790842|589291732|FG008|Dose Level 1|Withdrawal by Subject|0|||
163157846|NCT00790842|589291733|FG009|Dose Level 1|Withdrawal by Subject|0|||
163157847|NCT00790842|589291734|FG010|Dose Level 1|Withdrawal by Subject|0|||
163157848|NCT00790842|589291724|FG000|Dose Level 2|Death|0|||
163157849|NCT00790842|589291725|FG001|Dose Level 2|Death|1|||
163157850|NCT00790842|589291726|FG002|Dose Level 2|Death|0|||
163157851|NCT00790842|589291727|FG003|Dose Level 2|Death|0|||
163157852|NCT00790842|589291728|FG004|Dose Level 2|Death|1|||
163157853|NCT00790842|589291729|FG005|Dose Level 2|Death|0|||
163157854|NCT00790842|589291730|FG006|Dose Level 2|Death|0|||
163157855|NCT00790842|589291731|FG007|Dose Level 2|Death|0|||
163157856|NCT00790842|589291732|FG008|Dose Level 2|Death|0|||
163157857|NCT00790842|589291733|FG009|Dose Level 2|Death|0|||
163157858|NCT00790842|589291734|FG010|Dose Level 2|Death|0|||
163157859|NCT00790842|589291724|FG000|Dose Level 2|Physician Decision|0|||
163157860|NCT00790842|589291725|FG001|Dose Level 2|Physician Decision|1|||
163157861|NCT00790842|589291726|FG002|Dose Level 2|Physician Decision|0|||
163157862|NCT00790842|589291727|FG003|Dose Level 2|Physician Decision|0|||
163157863|NCT00790842|589291728|FG004|Dose Level 2|Physician Decision|0|||
163157864|NCT00790842|589291729|FG005|Dose Level 2|Physician Decision|0|||
163157865|NCT00790842|589291730|FG006|Dose Level 2|Physician Decision|0|||
163157866|NCT00790842|589291731|FG007|Dose Level 2|Physician Decision|0|||
163157867|NCT00790842|589291732|FG008|Dose Level 2|Physician Decision|0|||
163157868|NCT00790842|589291733|FG009|Dose Level 2|Physician Decision|0|||
163157869|NCT00790842|589291734|FG010|Dose Level 2|Physician Decision|0|||
163042501|NCT02959918|588863911|FG012|Overall Study|Stopping Rule Met|2|||
163042502|NCT02959918|588863912|FG013|Overall Study|Stopping Rule Met|1|||
163042503|NCT02959918|588863899|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
163042504|NCT02959918|588863900|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
163042505|NCT02959918|588863901|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
163157870|NCT00790842|589291724|FG000|Dose Level 2|Withdrawal by Subject|0|||
163157871|NCT00790842|589291725|FG001|Dose Level 2|Withdrawal by Subject|1|||
163271245|NCT02771210|589701401|FG000|Period 1|Withdrawal of informed consent|1|||
163271246|NCT02771210|589701402|FG001|Period 1|Withdrawal of informed consent|5|||
163271247|NCT02771210|589701401|FG000|Period 2|Adverse Event|1|||
163271248|NCT02771210|589701402|FG001|Period 2|Adverse Event|0|||
163271249|NCT02771210|589701401|FG000|Period 2|Lack of Efficacy|0|||
163271250|NCT02771210|589701402|FG001|Period 2|Lack of Efficacy|1|||
163271251|NCT02771210|589701401|FG000|Period 2|Withdrawal by Subject|1|||
163271252|NCT02771210|589701402|FG001|Period 2|Withdrawal by Subject|0|||
163271253|NCT02771210|589701401|FG000|Period 2|Withdrawal of informed consent|0|||
163271254|NCT02771210|589701402|FG001|Period 2|Withdrawal of informed consent|2|||
163271255|NCT04397523|589701403|FG000|Overall Study|Lost to Follow-up|3|||
163271256|NCT04397523|589701403|FG000|Overall Study|Transfer from/to other hospital|8|||
163271257|NCT01275196|589701404|FG000|Overall Study|Adverse Event|3|||
163271258|NCT01275196|589701405|FG001|Overall Study|Adverse Event|5|||
163271259|NCT01275196|589701404|FG000|Overall Study|Withdrawal by Subject|4|||
163271260|NCT01275196|589701405|FG001|Overall Study|Withdrawal by Subject|5|||
163271261|NCT01275196|589701404|FG000|Overall Study|Lost to Follow-up|1|||
163271262|NCT01275196|589701405|FG001|Overall Study|Lost to Follow-up|0|||
163271263|NCT01275196|589701404|FG000|Overall Study|Disease Progression|6|||
163271264|NCT01275196|589701405|FG001|Overall Study|Disease Progression|5|||
163271265|NCT01275196|589701404|FG000|Overall Study|Protocol Violation|1|||
163271266|NCT01275196|589701405|FG001|Overall Study|Protocol Violation|0|||
163271267|NCT01275196|589701404|FG000|Overall Study|Suboptimal response/treatment failure|5|||
163271268|NCT01275196|589701405|FG001|Overall Study|Suboptimal response/treatment failure|6|||
163271269|NCT01744496|589701407|FG000|Titration Period|Adverse Event|2|||
163271270|NCT01744496|589701408|FG001|Titration Period|Adverse Event|1|||
163271271|NCT01744496|589701407|FG000|Titration Period|Personal reasons|0|||
163271272|NCT01744496|589701408|FG001|Titration Period|Personal reasons|1|||
163271273|NCT01744496|589701407|FG000|Maintenance Period|Adverse Event|1|||
163271274|NCT01744496|589701408|FG001|Maintenance Period|Adverse Event|3|||
163271275|NCT01744496|589701407|FG000|Maintenance Period|Protocol Violation|1|||
163271276|NCT01744496|589701408|FG001|Maintenance Period|Protocol Violation|0|||
163271277|NCT01744496|589701407|FG000|Maintenance Period|Withdrawal by Subject|1|||
163271278|NCT01744496|589701408|FG001|Maintenance Period|Withdrawal by Subject|1|||
163271279|NCT01744496|589701407|FG000|Maintenance Period|Subject left town|1|||
163271280|NCT01744496|589701408|FG001|Maintenance Period|Subject left town|0|||
163271281|NCT01284140|589701409|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
163271282|NCT01284140|589701410|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
163042506|NCT02959918|588863902|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
163042507|NCT02959918|588863903|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042508|NCT02959918|588863904|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042509|NCT02959918|588863905|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042510|NCT02959918|588863906|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042511|NCT02959918|588863907|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042512|NCT02959918|588863908|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042513|NCT02959918|588863909|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042514|NCT02959918|588863910|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042515|NCT02959918|588863911|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042516|NCT02959918|588863912|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042517|NCT02959918|588863899|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042518|NCT02959918|588863900|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042519|NCT02959918|588863901|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042520|NCT02959918|588863902|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042521|NCT02959918|588863903|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042522|NCT02959918|588863904|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163058537|NCT00042289|588924271|FG036|Overall Study|Severe debilitation, unable to continue|0|||
163058538|NCT00042289|588924272|FG037|Overall Study|Severe debilitation, unable to continue|0|||
163058539|NCT00042289|588924273|FG038|Overall Study|Severe debilitation, unable to continue|0|||
163058540|NCT00042289|588924274|FG039|Overall Study|Severe debilitation, unable to continue|0|||
163058541|NCT00042289|588924275|FG040|Overall Study|Severe debilitation, unable to continue|0|||
163271283|NCT01284140|589701409|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
163058542|NCT00042289|588924276|FG041|Overall Study|Severe debilitation, unable to continue|0|||
163058543|NCT00042289|588924277|FG042|Overall Study|Severe debilitation, unable to continue|0|||
163058544|NCT00042289|588924278|FG043|Overall Study|Severe debilitation, unable to continue|0|||
163058545|NCT00042289|588924279|FG044|Overall Study|Severe debilitation, unable to continue|0|||
163058546|NCT00042289|588924280|FG045|Overall Study|Severe debilitation, unable to continue|0|||
163058547|NCT00042289|588924281|FG046|Overall Study|Severe debilitation, unable to continue|0|||
163058548|NCT00042289|588924235|FG000|Overall Study|Site closed|0|||
163058549|NCT00042289|588924236|FG001|Overall Study|Site closed|0|||
163058550|NCT00042289|588924237|FG002|Overall Study|Site closed|0|||
163157872|NCT00790842|589291726|FG002|Dose Level 2|Withdrawal by Subject|0|||
163157873|NCT00790842|589291727|FG003|Dose Level 2|Withdrawal by Subject|0|||
163157874|NCT00790842|589291728|FG004|Dose Level 2|Withdrawal by Subject|0|||
163157875|NCT00790842|589291729|FG005|Dose Level 2|Withdrawal by Subject|0|||
163157876|NCT00790842|589291730|FG006|Dose Level 2|Withdrawal by Subject|0|||
163157877|NCT00790842|589291731|FG007|Dose Level 2|Withdrawal by Subject|0|||
163157878|NCT00790842|589291732|FG008|Dose Level 2|Withdrawal by Subject|0|||
163157879|NCT00790842|589291733|FG009|Dose Level 2|Withdrawal by Subject|0|||
163157880|NCT00790842|589291734|FG010|Dose Level 2|Withdrawal by Subject|0|||
163271284|NCT01284140|589701410|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
163271285|NCT01551303|589701420|FG000|Overall Study|failed awareness check on vision test|4|||
163271286|NCT01551303|589701421|FG001|Overall Study|failed awareness check on vision test|7|||
163271287|NCT02589392|589701425|FG000|Overall Study|Adverse Event|1|||
163271288|NCT02589392|589701426|FG001|Overall Study|Adverse Event|1|||
163271289|NCT02589392|589701425|FG000|Overall Study|Withdrawal by Subject|1|||
163271290|NCT02589392|589701426|FG001|Overall Study|Withdrawal by Subject|2|||
163271291|NCT02589392|589701425|FG000|Overall Study|Protocol Violation|1|||
163271292|NCT02589392|589701426|FG001|Overall Study|Protocol Violation|1|||
163271293|NCT02589392|589701425|FG000|Overall Study|Lost to Follow-up|2|||
163271294|NCT02589392|589701426|FG001|Overall Study|Lost to Follow-up|2|||
163271295|NCT02589392|589701425|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
163271296|NCT02589392|589701426|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
163271297|NCT00322374|589701428|FG000|Starting Dose|Physician Decision|2|||
163271298|NCT00322374|589701429|FG001|Starting Dose|Physician Decision|0|||
163271299|NCT00322374|589701430|FG002|Starting Dose|Physician Decision|0|||
163271300|NCT00322374|589701431|FG003|Starting Dose|Physician Decision|0|||
163271301|NCT00322374|589701428|FG000|Starting Dose|Study Drug Toxicity|4|||
163271302|NCT00322374|589701429|FG001|Starting Dose|Study Drug Toxicity|0|||
163271303|NCT00322374|589701430|FG002|Starting Dose|Study Drug Toxicity|0|||
163271304|NCT00322374|589701431|FG003|Starting Dose|Study Drug Toxicity|0|||
163271305|NCT00322374|589701428|FG000|First Escalation|Documented Disease Progression|0|||
163271306|NCT00322374|589701429|FG001|First Escalation|Documented Disease Progression|6|||
163271307|NCT00322374|589701430|FG002|First Escalation|Documented Disease Progression|0|||
163271308|NCT00322374|589701431|FG003|First Escalation|Documented Disease Progression|0|||
163271309|NCT00322374|589701428|FG000|First Escalation|Physician Decision|0|||
163271310|NCT00322374|589701429|FG001|First Escalation|Physician Decision|12|||
163271311|NCT00322374|589701430|FG002|First Escalation|Physician Decision|0|||
163271312|NCT00322374|589701431|FG003|First Escalation|Physician Decision|0|||
163271313|NCT00322374|589701428|FG000|First Escalation|Study Drug Toxicity|0|||
163271314|NCT00322374|589701429|FG001|First Escalation|Study Drug Toxicity|11|||
163271315|NCT00322374|589701430|FG002|First Escalation|Study Drug Toxicity|0|||
163271316|NCT00322374|589701431|FG003|First Escalation|Study Drug Toxicity|0|||
163271317|NCT00322374|589701428|FG000|First Escalation|Participant Request|0|||
163271318|NCT00322374|589701429|FG001|First Escalation|Participant Request|1|||
163271319|NCT00322374|589701430|FG002|First Escalation|Participant Request|0|||
163271320|NCT00322374|589701431|FG003|First Escalation|Participant Request|0|||
163271321|NCT00322374|589701428|FG000|Second Escalation|Physician Decision|0|||
163271322|NCT00322374|589701429|FG001|Second Escalation|Physician Decision|0|||
163271323|NCT00322374|589701430|FG002|Second Escalation|Physician Decision|5|||
163271324|NCT00322374|589701431|FG003|Second Escalation|Physician Decision|0|||
163271325|NCT00322374|589701428|FG000|Second Escalation|Study Drug Toxicity|0|||
163271326|NCT00322374|589701429|FG001|Second Escalation|Study Drug Toxicity|0|||
163271327|NCT00322374|589701430|FG002|Second Escalation|Study Drug Toxicity|1|||
163271328|NCT00322374|589701431|FG003|Second Escalation|Study Drug Toxicity|0|||
162929541|NCT04682639|588447389|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
162929542|NCT04682639|588447390|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
162929543|NCT04682639|588447391|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162929544|NCT04682639|588447392|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162929545|NCT04682639|588447388|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
162929546|NCT04682639|588447389|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162929547|NCT04682639|588447390|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162929548|NCT04682639|588447391|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162929549|NCT04682639|588447392|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162929550|NCT04682639|588447388|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
162929551|NCT04682639|588447389|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
162929552|NCT04682639|588447390|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
162929553|NCT04682639|588447391|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
162929554|NCT04682639|588447392|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
162929555|NCT04682639|588447388|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
163271329|NCT03382600|589701432|FG000|Overall Study|Adverse Event|3|||
163271330|NCT03382600|589701433|FG001|Overall Study|Adverse Event|3|||
163271331|NCT03382600|589701432|FG000|Overall Study|Clinical Disease Progression|2|||
163157881|NCT00790842|589291724|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157882|NCT00790842|589291725|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157883|NCT00790842|589291726|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157884|NCT00790842|589291727|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157885|NCT00790842|589291728|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157886|NCT00790842|589291729|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157887|NCT00790842|589291730|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157888|NCT00790842|589291731|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157889|NCT00790842|589291732|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
163157890|NCT00790842|589291733|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157891|NCT00790842|589291734|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157892|NCT00790842|589291724|FG000|Dose Level 3|Adverse Event|0|||
163157893|NCT00790842|589291725|FG001|Dose Level 3|Adverse Event|0|||
163157894|NCT00790842|589291726|FG002|Dose Level 3|Adverse Event|1|||
163157895|NCT00790842|589291727|FG003|Dose Level 3|Adverse Event|0|||
163271332|NCT03382600|589701433|FG001|Overall Study|Clinical Disease Progression|4|||
163271333|NCT03382600|589701432|FG000|Overall Study|Radiological Progression|40|||
163271334|NCT03382600|589701433|FG001|Overall Study|Radiological Progression|31|||
163271335|NCT03382600|589701432|FG000|Overall Study|Withdrawal by Subject|0|||
163271336|NCT03382600|589701433|FG001|Overall Study|Withdrawal by Subject|1|||
163271337|NCT03382600|589701432|FG000|Overall Study|Other|9|||
163271338|NCT03382600|589701433|FG001|Overall Study|Other|7|||
163271339|NCT02269943|589701434|FG000|Treatment Period|Death|0|||
163271340|NCT02269943|589701435|FG001|Treatment Period|Death|1|||
163271341|NCT02269943|589701434|FG000|Treatment Period|Adverse Event|1|||
163271342|NCT02269943|589701435|FG001|Treatment Period|Adverse Event|10|||
163271343|NCT02269943|589701434|FG000|Treatment Period|Progressive Disease|5|||
163271344|NCT02269943|589701435|FG001|Treatment Period|Progressive Disease|17|||
163271345|NCT02269943|589701434|FG000|Treatment Period|Symptomatic Deterioration|0|||
163271346|NCT02269943|589701435|FG001|Treatment Period|Symptomatic Deterioration|2|||
163271347|NCT02269943|589701434|FG000|Follow-Up Survival Period|Death|3|||
163271348|NCT02269943|589701435|FG001|Follow-Up Survival Period|Death|16|||
163271349|NCT02269943|589701434|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
163271350|NCT02269943|589701435|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
163271351|NCT02269943|589701434|FG000|Follow-Up Survival Period|Alive|2|||
163271352|NCT02269943|589701435|FG001|Follow-Up Survival Period|Alive|8|||
163271353|NCT02066532|589701440|FG000|Phase II|Withdrawal by Subject|1|||
163271354|NCT02066532|589701441|FG001|Phase II|Withdrawal by Subject|0|||
163271355|NCT02066532|589701442|FG002|Phase II|Withdrawal by Subject|0|||
163271356|NCT02066532|589701443|FG003|Phase II|Withdrawal by Subject|0|||
163271357|NCT05033080|589701444|FG000|Overall Study|Adverse Event|4|||
163271358|NCT05033080|589701445|FG001|Overall Study|Adverse Event|4|||
163271359|NCT05033080|589701444|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
163271360|NCT05033080|589701445|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
163271361|NCT05033080|589701444|FG000|Overall Study|Lost to Follow-up|1|||
163271362|NCT05033080|589701445|FG001|Overall Study|Lost to Follow-up|0|||
163271363|NCT05033080|589701444|FG000|Overall Study|Other non-compliance|0|||
163271364|NCT05033080|589701445|FG001|Overall Study|Other non-compliance|1|||
163271365|NCT05033080|589701444|FG000|Overall Study|Physician Decision|0|||
163271366|NCT05033080|589701445|FG001|Overall Study|Physician Decision|1|||
163271367|NCT05033080|589701444|FG000|Overall Study|Other|1|||
163271368|NCT05033080|589701445|FG001|Overall Study|Other|1|||
163271369|NCT05376371|589701446|FG000|Overall Study|change in release date|10|||
163271370|NCT04159415|589701447|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163271371|NCT04159415|589701448|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163271372|NCT04159415|589701449|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163271373|NCT04159415|589701450|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163271374|NCT04159415|589701451|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163271375|NCT04159415|589701452|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163271376|NCT04159415|589701453|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
163157896|NCT00790842|589291728|FG004|Dose Level 3|Adverse Event|0|||
163271377|NCT04159415|589701454|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
163271378|NCT04159415|589701455|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163271379|NCT04159415|589701456|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163271380|NCT04159415|589701447|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163271381|NCT04159415|589701448|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163271382|NCT04159415|589701449|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163271383|NCT04159415|589701450|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163318861|NCT01208662|589878794|FG000|Induction and Consolidation|Disease Progression|23|||
163385764|NCT00146328|590123239|FG000|Overall Study|Withdrawal by Subject|16|||
163042523|NCT02959918|588863905|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042524|NCT02959918|588863906|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
163042525|NCT02959918|588863907|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042526|NCT02959918|588863908|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042527|NCT02959918|588863909|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042528|NCT02959918|588863910|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042529|NCT02959918|588863911|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042530|NCT02959918|588863912|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042531|NCT02959918|588863899|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042532|NCT02959918|588863900|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042533|NCT02959918|588863901|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042534|NCT02959918|588863902|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042535|NCT02959918|588863903|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042536|NCT02959918|588863904|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042537|NCT02959918|588863905|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042538|NCT02959918|588863906|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042539|NCT02959918|588863907|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
163042540|NCT02959918|588863908|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042541|NCT02959918|588863909|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042542|NCT02959918|588863910|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042543|NCT02959918|588863911|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042544|NCT02959918|588863912|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042545|NCT02959918|588863899|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042546|NCT02959918|588863900|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042547|NCT02959918|588863901|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042548|NCT02959918|588863902|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042549|NCT02959918|588863903|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042550|NCT02959918|588863904|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042551|NCT02959918|588863905|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042552|NCT02959918|588863906|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042553|NCT02959918|588863907|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042554|NCT02959918|588863908|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
163042555|NCT02959918|588863909|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042556|NCT02959918|588863910|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042557|NCT02959918|588863911|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042558|NCT02959918|588863912|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042559|NCT03173456|588863914|FG000|Baseline|Medication dispensing system malfunction'|0|||
163042560|NCT03173456|588863915|FG001|Baseline|Medication dispensing system malfunction'|1|||
163042561|NCT03173456|588863916|FG002|Baseline|Medication dispensing system malfunction'|0|||
163042562|NCT03173456|588863917|FG003|Baseline|Medication dispensing system malfunction'|0|||
163042563|NCT03173456|588863918|FG004|Baseline|Medication dispensing system malfunction'|2|||
163042564|NCT03173456|588863914|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
163042565|NCT03173456|588863915|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
163042566|NCT03173456|588863916|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
163042567|NCT03173456|588863917|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
163042568|NCT03173456|588863918|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
163042569|NCT01733121|588863919|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
163042570|NCT01733121|588863920|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
163042571|NCT01733121|588863919|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
163042572|NCT01733121|588863920|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
163042573|NCT01733121|588863919|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
163042574|NCT01733121|588863920|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
163042575|NCT01733121|588863919|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
163042576|NCT01733121|588863920|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
163042577|NCT03061188|588863921|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
163042578|NCT03061188|588863922|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
163042579|NCT03061188|588863923|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
163042580|NCT03061188|588863924|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
163042581|NCT03061188|588863921|FG000|On Follow-up for 3 Years|Death|0|||
163042582|NCT03061188|588863922|FG001|On Follow-up for 3 Years|Death|3|||
163042583|NCT03061188|588863923|FG002|On Follow-up for 3 Years|Death|5|||
163042584|NCT03061188|588863924|FG003|On Follow-up for 3 Years|Death|4|||
163042585|NCT03061188|588863921|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
163271384|NCT04159415|589701451|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163042586|NCT03061188|588863922|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
163042587|NCT03061188|588863923|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
163042588|NCT03061188|588863924|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
163042589|NCT01151345|588863926|FG000|First Intervention Period|Protocol Violation|0|||
163042590|NCT01151345|588863927|FG001|First Intervention Period|Protocol Violation|1|||
163042591|NCT01658904|588863929|FG000|Overall Study|Principal Investigator discretion|2|||
163042592|NCT01658904|588863930|FG001|Overall Study|Principal Investigator discretion|0|||
163042593|NCT01658904|588863931|FG002|Overall Study|Principal Investigator discretion|0|||
163042594|NCT01087203|588863934|FG000|Overall Study|Lost to Follow-up|2|||
163042595|NCT01087203|588863935|FG001|Overall Study|Lost to Follow-up|0|||
163042596|NCT01087203|588863934|FG000|Overall Study|Withdrawal by Subject|2|||
163042597|NCT01087203|588863935|FG001|Overall Study|Withdrawal by Subject|6|||
163042598|NCT01087203|588863934|FG000|Overall Study|Lack of Efficacy|1|||
163042599|NCT01087203|588863935|FG001|Overall Study|Lack of Efficacy|2|||
163042600|NCT01087203|588863934|FG000|Overall Study|Study terminated by sponsor|27|||
163042601|NCT01087203|588863935|FG001|Overall Study|Study terminated by sponsor|27|||
163042602|NCT04074330|588863939|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
163042603|NCT04074330|588863940|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
163042604|NCT04074330|588863941|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
163042605|NCT04074330|588863942|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
163042606|NCT04074330|588863943|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
163042607|NCT04074330|588863944|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
163042608|NCT04074330|588863945|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
163042609|NCT04074330|588863946|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
163042610|NCT04074330|588863947|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
163042611|NCT04074330|588863948|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
163042612|NCT04074330|588863939|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
163042613|NCT04074330|588863940|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
163042614|NCT04074330|588863941|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
163042615|NCT04074330|588863942|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
163042616|NCT04074330|588863943|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
163042617|NCT04074330|588863944|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
163042618|NCT04074330|588863945|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
163042619|NCT04074330|588863946|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
163042620|NCT04074330|588863947|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
163042621|NCT04074330|588863948|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
163042622|NCT04074330|588863939|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042623|NCT04074330|588863940|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042624|NCT04074330|588863941|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
163042625|NCT04074330|588863942|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042626|NCT04074330|588863943|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042627|NCT04074330|588863944|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042628|NCT04074330|588863945|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042629|NCT04074330|588863946|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042630|NCT04074330|588863947|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042631|NCT04074330|588863948|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042632|NCT04074330|588863939|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042633|NCT04074330|588863940|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042634|NCT04074330|588863941|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042635|NCT04074330|588863942|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042636|NCT04074330|588863943|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042637|NCT04074330|588863944|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
163042638|NCT04074330|588863945|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042639|NCT04074330|588863946|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
163042640|NCT04074330|588863947|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042641|NCT04074330|588863948|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042642|NCT04074330|588863939|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
163042643|NCT04074330|588863940|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
163042644|NCT04074330|588863941|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
163042645|NCT04074330|588863942|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
163042646|NCT04074330|588863943|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
163042647|NCT04074330|588863944|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
163042648|NCT04074330|588863945|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
163042649|NCT04074330|588863946|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
163042650|NCT04074330|588863947|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
163058551|NCT00042289|588924238|FG003|Overall Study|Site closed|0|||
163271385|NCT04159415|589701452|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163271386|NCT04159415|589701453|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163271387|NCT04159415|589701454|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
163271388|NCT04159415|589701455|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163271389|NCT04159415|589701456|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163271390|NCT04159415|589701447|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163271391|NCT04159415|589701448|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163271392|NCT04159415|589701449|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163271393|NCT04159415|589701450|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163271394|NCT04159415|589701451|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163271395|NCT04159415|589701452|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163271396|NCT04159415|589701453|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163271397|NCT04159415|589701454|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
163271398|NCT04159415|589701455|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163271399|NCT04159415|589701456|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163271400|NCT04159415|589701447|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163271401|NCT04159415|589701448|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163271402|NCT04159415|589701449|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163271403|NCT04159415|589701450|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163271404|NCT04159415|589701451|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163271405|NCT04159415|589701452|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163271406|NCT04159415|589701453|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163271407|NCT04159415|589701454|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163271408|NCT04159415|589701455|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163271409|NCT04159415|589701456|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
163271410|NCT03560245|589701457|FG000|Overall Study|Withdrawal by Subject|3|||
163271411|NCT03560245|589701458|FG001|Overall Study|Withdrawal by Subject|2|||
163271412|NCT03560245|589701457|FG000|Overall Study|Adverse Event|1|||
163271413|NCT03560245|589701458|FG001|Overall Study|Adverse Event|1|||
163271414|NCT03560245|589701457|FG000|Overall Study|Protocol Violation|1|||
163271415|NCT03560245|589701458|FG001|Overall Study|Protocol Violation|0|||
163271416|NCT03560245|589701457|FG000|Overall Study|Death|0|||
163271417|NCT03560245|589701458|FG001|Overall Study|Death|1|||
163271418|NCT03560245|589701457|FG000|Overall Study|Lost to Follow-up|0|||
163271419|NCT03560245|589701458|FG001|Overall Study|Lost to Follow-up|1|||
163271420|NCT03560245|589701457|FG000|Overall Study|Physician Decision|0|||
163042651|NCT04074330|588863948|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
163042652|NCT04074330|588863939|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
163042653|NCT04074330|588863940|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
163042654|NCT04074330|588863941|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
163042655|NCT04074330|588863942|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
163042656|NCT04074330|588863943|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
163042657|NCT04074330|588863944|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
163042658|NCT04074330|588863945|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
163042659|NCT04074330|588863946|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
163042660|NCT04074330|588863947|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
163042661|NCT04074330|588863948|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
163042662|NCT04074330|588863939|FG000|Dose Expansion (up to 42 Months)|Death|0|||
163042663|NCT04074330|588863940|FG001|Dose Expansion (up to 42 Months)|Death|0|||
163042664|NCT04074330|588863941|FG002|Dose Expansion (up to 42 Months)|Death|0|||
163042665|NCT04074330|588863942|FG003|Dose Expansion (up to 42 Months)|Death|0|||
163157897|NCT00790842|589291729|FG005|Dose Level 3|Adverse Event|0|||
163157898|NCT00790842|589291730|FG006|Dose Level 3|Adverse Event|0|||
163157899|NCT00790842|589291731|FG007|Dose Level 3|Adverse Event|0|||
163157900|NCT00790842|589291732|FG008|Dose Level 3|Adverse Event|0|||
163157901|NCT00790842|589291733|FG009|Dose Level 3|Adverse Event|0|||
163157902|NCT00790842|589291734|FG010|Dose Level 3|Adverse Event|0|||
163157903|NCT00790842|589291724|FG000|Dose Level 3|Withdrawal by Subject|0|||
163157904|NCT00790842|589291725|FG001|Dose Level 3|Withdrawal by Subject|0|||
163157905|NCT00790842|589291726|FG002|Dose Level 3|Withdrawal by Subject|3|||
163157906|NCT00790842|589291727|FG003|Dose Level 3|Withdrawal by Subject|0|||
163157907|NCT00790842|589291728|FG004|Dose Level 3|Withdrawal by Subject|0|||
163157908|NCT00790842|589291729|FG005|Dose Level 3|Withdrawal by Subject|0|||
163157909|NCT00790842|589291730|FG006|Dose Level 3|Withdrawal by Subject|0|||
163042666|NCT04074330|588863943|FG004|Dose Expansion (up to 42 Months)|Death|0|||
163042667|NCT04074330|588863944|FG005|Dose Expansion (up to 42 Months)|Death|0|||
163042668|NCT04074330|588863945|FG006|Dose Expansion (up to 42 Months)|Death|0|||
163042669|NCT04074330|588863946|FG007|Dose Expansion (up to 42 Months)|Death|0|||
163042670|NCT04074330|588863947|FG008|Dose Expansion (up to 42 Months)|Death|1|||
163042671|NCT04074330|588863948|FG009|Dose Expansion (up to 42 Months)|Death|0|||
163042672|NCT04074330|588863939|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042673|NCT04074330|588863940|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042674|NCT04074330|588863941|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042675|NCT04074330|588863942|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042676|NCT04074330|588863943|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042677|NCT04074330|588863944|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042678|NCT04074330|588863945|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042679|NCT04074330|588863946|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042680|NCT04074330|588863947|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
163042681|NCT04074330|588863948|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
163042682|NCT01429298|588863953|FG000|Overall Study|Protocol Violation|4|||
163042683|NCT01429298|588863954|FG001|Overall Study|Protocol Violation|6|||
163042684|NCT02903420|588863955|FG000|Overall Study|Death|3|||
163042685|NCT00181883|588863958|FG000|Overall Study|Lack of Efficacy|2|||
163042686|NCT00181883|588863958|FG000|Overall Study|Treatment Limiting AEs|3|||
163042687|NCT00181883|588863958|FG000|Overall Study|Withdrawal by Subject|4|||
163042688|NCT00181883|588863958|FG000|Overall Study|Lost to Follow-up|1|||
163042689|NCT05305989|588863959|FG000|Overall Study|Other|3|||
163042690|NCT05305989|588863960|FG001|Overall Study|Other|2|||
163042691|NCT05305989|588863961|FG002|Overall Study|Other|0|||
163042692|NCT05305989|588863959|FG000|Overall Study|Sponsor decision|2|||
163042693|NCT05305989|588863960|FG001|Overall Study|Sponsor decision|1|||
163042694|NCT05305989|588863961|FG002|Overall Study|Sponsor decision|0|||
163042695|NCT05305989|588863959|FG000|Overall Study|Protocol Violation|0|||
163042696|NCT05305989|588863960|FG001|Overall Study|Protocol Violation|1|||
163042697|NCT05305989|588863961|FG002|Overall Study|Protocol Violation|0|||
163042698|NCT05305989|588863959|FG000|Overall Study|Investigator decision|1|||
163042699|NCT05305989|588863960|FG001|Overall Study|Investigator decision|2|||
163042700|NCT05305989|588863961|FG002|Overall Study|Investigator decision|0|||
163042701|NCT05305989|588863959|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
163271421|NCT03560245|589701458|FG001|Overall Study|Physician Decision|1|||
163271422|NCT03560245|589701457|FG000|Overall Study|Other|0|||
163271423|NCT03560245|589701458|FG001|Overall Study|Other|1|||
163271424|NCT00960752|589701464|FG000|Overall Study|Adverse Event|0|||
163271425|NCT00960752|589701465|FG001|Overall Study|Adverse Event|0|||
163271426|NCT00960752|589701466|FG002|Overall Study|Adverse Event|1|||
163271427|NCT00960752|589701464|FG000|Overall Study|Progression|0|||
163271428|NCT00960752|589701465|FG001|Overall Study|Progression|0|||
163271429|NCT00960752|589701466|FG002|Overall Study|Progression|1|||
163271430|NCT02058290|589701470|FG000|Overall Study|Protocol Violation|2|||
163271431|NCT02058290|589701471|FG001|Overall Study|Protocol Violation|1|||
163271432|NCT02058290|589701470|FG000|Overall Study|Physician Decision|1|||
163271433|NCT02058290|589701471|FG001|Overall Study|Physician Decision|0|||
163042702|NCT05305989|588863960|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
163042703|NCT05305989|588863961|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
163042704|NCT05305989|588863959|FG000|Overall Study|Adverse Event|1|||
163042705|NCT05305989|588863960|FG001|Overall Study|Adverse Event|1|||
163042706|NCT05305989|588863961|FG002|Overall Study|Adverse Event|0|||
163042707|NCT05305989|588863959|FG000|Overall Study|Enrolled but never dosed|3|||
163042708|NCT05305989|588863960|FG001|Overall Study|Enrolled but never dosed|2|||
163042709|NCT05305989|588863961|FG002|Overall Study|Enrolled but never dosed|1|||
163042710|NCT03162328|588863962|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
163042711|NCT03162328|588863963|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
163042712|NCT03162328|588863964|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
163042713|NCT03162328|588863962|FG000|Screening Period|Withdrawal by Subject|1|||
163042714|NCT03162328|588863963|FG001|Screening Period|Withdrawal by Subject|0|||
163042715|NCT03162328|588863964|FG002|Screening Period|Withdrawal by Subject|0|||
163042716|NCT03162328|588863962|FG000|Study Period|Withdrawal by Subject|0|||
163042717|NCT03162328|588863963|FG001|Study Period|Withdrawal by Subject|0|||
163042718|NCT03162328|588863964|FG002|Study Period|Withdrawal by Subject|1|||
163042719|NCT00913770|588863965|FG000|Overall Study|Unable to contact|24|||
163042720|NCT00913770|588863966|FG001|Overall Study|Unable to contact|19|||
163042721|NCT00913770|588863967|FG002|Overall Study|Unable to contact|13|||
163042722|NCT00913770|588863965|FG000|Overall Study|Refused|11|||
163042723|NCT00913770|588863966|FG001|Overall Study|Refused|10|||
163271434|NCT02058290|589701470|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
163271435|NCT02058290|589701471|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
163271436|NCT02058290|589701470|FG000|Overall Study|Withdrawal by Subject|0|||
163271437|NCT02058290|589701471|FG001|Overall Study|Withdrawal by Subject|1|||
163271438|NCT00105586|589701475|FG000|Overall Study|Adverse Event|4|||
163271439|NCT00105586|589701476|FG001|Overall Study|Adverse Event|3|||
163271440|NCT00105586|589701475|FG000|Overall Study|Physician Decision|13|||
163271441|NCT00105586|589701476|FG001|Overall Study|Physician Decision|13|||
163271442|NCT02262260|589701477|FG000|Overall Study|Adverse Event|4|||
163271443|NCT02262260|589701478|FG001|Overall Study|Adverse Event|1|||
163271444|NCT02262260|589701477|FG000|Overall Study|Withdrawal of consent|4|||
163271445|NCT02262260|589701478|FG001|Overall Study|Withdrawal of consent|2|||
163271446|NCT02262260|589701477|FG000|Overall Study|Lost to Follow-up|1|||
163271447|NCT02262260|589701478|FG001|Overall Study|Lost to Follow-up|2|||
163271448|NCT02262260|589701477|FG000|Overall Study|Protocol deviation|2|||
163271449|NCT02262260|589701478|FG001|Overall Study|Protocol deviation|5|||
163271450|NCT01794117|589701481|FG000|Overall Study|Adverse Event|1|||
163042724|NCT00913770|588863967|FG002|Overall Study|Refused|8|||
163271451|NCT01794117|589701482|FG001|Overall Study|Adverse Event|0|||
163271452|NCT01794117|589701483|FG002|Overall Study|Adverse Event|0|||
163271453|NCT01794117|589701484|FG003|Overall Study|Adverse Event|0|||
163271454|NCT01794117|589701481|FG000|Overall Study|Participant noncompliance|0|||
163271455|NCT01794117|589701482|FG001|Overall Study|Participant noncompliance|1|||
163271456|NCT01794117|589701483|FG002|Overall Study|Participant noncompliance|0|||
163271457|NCT01794117|589701484|FG003|Overall Study|Participant noncompliance|0|||
163271458|NCT01794117|589701481|FG000|Overall Study|Refused further treatment|0|||
163271459|NCT01794117|589701482|FG001|Overall Study|Refused further treatment|2|||
163271460|NCT01794117|589701483|FG002|Overall Study|Refused further treatment|0|||
163271461|NCT01794117|589701484|FG003|Overall Study|Refused further treatment|0|||
163271462|NCT03406702|589701485|FG000|Overall Study|Missed Day 27 Dosing|1|||
163271463|NCT01233609|589701488|FG000|Overall Study|Death|1|||
163271464|NCT01233609|589701489|FG001|Overall Study|Death|0|||
163271465|NCT01233609|589701488|FG000|Overall Study|Lost to Follow-up|3|||
163271466|NCT01233609|589701489|FG001|Overall Study|Lost to Follow-up|1|||
163271467|NCT01233609|589701488|FG000|Overall Study|Adverse Event|2|||
163271468|NCT01233609|589701489|FG001|Overall Study|Adverse Event|1|||
163271469|NCT01233609|589701488|FG000|Overall Study|Withdrawal by Subject|3|||
163271470|NCT01233609|589701489|FG001|Overall Study|Withdrawal by Subject|0|||
163271471|NCT01668147|589702838|FG000|Overall Study|Withdrawal by Subject|6|||
163042725|NCT01990768|588863968|FG000|Intervention Started|Found to be ineligible|14|||
163042726|NCT01990768|588863969|FG001|Intervention Started|Found to be ineligible|13|||
163042727|NCT01990768|588863970|FG002|Intervention Started|Found to be ineligible|11|||
163042728|NCT01990768|588863968|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
163042729|NCT01990768|588863969|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
163042730|NCT01990768|588863970|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
163042731|NCT01990768|588863968|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
163042732|NCT01990768|588863969|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
163042733|NCT01990768|588863970|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
163042734|NCT01990768|588863968|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
163042735|NCT01990768|588863969|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
163042736|NCT01990768|588863970|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
163042737|NCT01990768|588863968|FG000|Intervention Started|Patient care priority|1|||
163042738|NCT01990768|588863969|FG001|Intervention Started|Patient care priority|2|||
163042739|NCT01990768|588863970|FG002|Intervention Started|Patient care priority|3|||
163042740|NCT01990768|588863968|FG000|Intervention Started|IV lost|2|||
163042741|NCT01990768|588863969|FG001|Intervention Started|IV lost|2|||
163042742|NCT01990768|588863970|FG002|Intervention Started|IV lost|2|||
163042743|NCT01990768|588863968|FG000|Intervention Started|Required CPR|1|||
163042744|NCT01990768|588863969|FG001|Intervention Started|Required CPR|1|||
163042745|NCT01990768|588863970|FG002|Intervention Started|Required CPR|0|||
163042746|NCT01990768|588863968|FG000|Intervention Started|Seizure or hx of seizure|0|||
163042747|NCT01990768|588863969|FG001|Intervention Started|Seizure or hx of seizure|0|||
163042748|NCT01990768|588863970|FG002|Intervention Started|Seizure or hx of seizure|2|||
163042749|NCT01990768|588863968|FG000|Intervention Started|Discovered to be pregnant|0|||
163042750|NCT01990768|588863969|FG001|Intervention Started|Discovered to be pregnant|1|||
163042751|NCT01990768|588863970|FG002|Intervention Started|Discovered to be pregnant|0|||
163042752|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
163042753|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
163042754|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
163042755|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
163058552|NCT00042289|588924239|FG004|Overall Study|Site closed|0|||
163271472|NCT00224133|589702841|FG000|Overall Study|Adverse Event|93|||
163271473|NCT00224133|589702841|FG000|Overall Study|Protocol Violation|6|||
163271474|NCT00224133|589702841|FG000|Overall Study|Withdrawal by Subject|33|||
163271475|NCT00224133|589702841|FG000|Overall Study|Lack of Efficacy|58|||
163271476|NCT00224133|589702841|FG000|Overall Study|Lost to Follow-up|21|||
163271477|NCT00224133|589702841|FG000|Overall Study|Physician Decision|1|||
163271478|NCT00224133|589702841|FG000|Overall Study|Other|14|||
163271479|NCT01238575|589702843|FG000|Overall Study|Lack of Efficacy|2|||
163271480|NCT01238575|589702844|FG001|Overall Study|Lack of Efficacy|4|||
163271481|NCT01238575|589702843|FG000|Overall Study|Adverse Event|2|||
163271482|NCT01238575|589702844|FG001|Overall Study|Adverse Event|0|||
163271483|NCT00593554|589702846|FG000|Overall Study|Death|1|||
163271484|NCT00593554|589702847|FG001|Overall Study|Death|2|||
163271485|NCT00593554|589702846|FG000|Overall Study|Physician Decision|0|||
163271486|NCT00593554|589702847|FG001|Overall Study|Physician Decision|1|||
163271487|NCT00593554|589702846|FG000|Overall Study|Withdrawal by Subject|1|||
163271488|NCT00593554|589702847|FG001|Overall Study|Withdrawal by Subject|0|||
163271489|NCT00593554|589702846|FG000|Overall Study|Disease Progression|1|||
163271490|NCT00593554|589702847|FG001|Overall Study|Disease Progression|2|||
163157910|NCT00790842|589291731|FG007|Dose Level 3|Withdrawal by Subject|0|||
163157911|NCT00790842|589291732|FG008|Dose Level 3|Withdrawal by Subject|0|||
163157912|NCT00790842|589291733|FG009|Dose Level 3|Withdrawal by Subject|2|||
163157913|NCT00790842|589291734|FG010|Dose Level 3|Withdrawal by Subject|0|||
163157914|NCT00790842|589291724|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157915|NCT00790842|589291725|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157916|NCT00790842|589291726|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157917|NCT00790842|589291727|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157918|NCT00790842|589291728|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157919|NCT00790842|589291729|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
163157920|NCT00790842|589291730|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157921|NCT00790842|589291731|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157922|NCT00790842|589291732|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157923|NCT00790842|589291733|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157924|NCT00790842|589291734|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157925|NCT00790842|589291724|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157926|NCT00790842|589291725|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157927|NCT00790842|589291726|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
163157928|NCT00790842|589291727|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157929|NCT00790842|589291728|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157930|NCT00790842|589291729|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157931|NCT00790842|589291730|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157932|NCT00790842|589291731|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157933|NCT00790842|589291732|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157934|NCT00790842|589291733|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157935|NCT00790842|589291734|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157936|NCT00790842|589291724|FG000|Dose Level 4|Adverse Event|0|||
163157937|NCT00790842|589291725|FG001|Dose Level 4|Adverse Event|0|||
163157938|NCT00790842|589291726|FG002|Dose Level 4|Adverse Event|0|||
163157939|NCT00790842|589291727|FG003|Dose Level 4|Adverse Event|0|||
163157940|NCT00790842|589291728|FG004|Dose Level 4|Adverse Event|0|||
163157941|NCT00790842|589291729|FG005|Dose Level 4|Adverse Event|0|||
163157942|NCT00790842|589291730|FG006|Dose Level 4|Adverse Event|1|||
163157943|NCT00790842|589291731|FG007|Dose Level 4|Adverse Event|0|||
163157944|NCT00790842|589291732|FG008|Dose Level 4|Adverse Event|0|||
163157945|NCT00790842|589291733|FG009|Dose Level 4|Adverse Event|0|||
163157946|NCT00790842|589291734|FG010|Dose Level 4|Adverse Event|0|||
163157947|NCT00790842|589291724|FG000|Dose Level 4|Physician Decision|0|||
163157948|NCT00790842|589291725|FG001|Dose Level 4|Physician Decision|0|||
163157949|NCT00790842|589291726|FG002|Dose Level 4|Physician Decision|0|||
163157950|NCT00790842|589291727|FG003|Dose Level 4|Physician Decision|0|||
163157951|NCT00790842|589291728|FG004|Dose Level 4|Physician Decision|0|||
163271491|NCT00795132|589702850|FG000|Overall Study|Death|1|||
163042756|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
163042757|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
163042758|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
163042759|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
163042760|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
163042761|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
163042762|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
163042763|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
163042764|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Death|3|||
163042765|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Death|1|||
163157952|NCT00790842|589291729|FG005|Dose Level 4|Physician Decision|0|||
163157953|NCT00790842|589291730|FG006|Dose Level 4|Physician Decision|1|||
163157954|NCT00790842|589291731|FG007|Dose Level 4|Physician Decision|0|||
163157955|NCT00790842|589291732|FG008|Dose Level 4|Physician Decision|0|||
163157956|NCT00790842|589291733|FG009|Dose Level 4|Physician Decision|0|||
163157957|NCT00790842|589291734|FG010|Dose Level 4|Physician Decision|1|||
163271492|NCT00795132|589702850|FG000|Overall Study|Relapse|2|||
163271493|NCT00358150|589702855|FG000|Overall Study|Adverse Event|3|||
163271494|NCT00358150|589702855|FG000|Overall Study|Withdrawal by Subject|1|||
163271495|NCT00358150|589702855|FG000|Overall Study|Undefined|3|||
163271496|NCT04254679|589702878|FG000|Overall Study|Protocol Violation|1|||
163271497|NCT04254679|589702879|FG001|Overall Study|Protocol Violation|1|||
163271498|NCT04254679|589702878|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
163271499|NCT04254679|589702879|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
163271500|NCT04076020|589702888|FG000|Overall Study|Death|4|||
163271501|NCT04076020|589702889|FG001|Overall Study|Death|6|||
163271502|NCT04076020|589702888|FG000|Overall Study|Withdrawal by Subject|12|||
163271503|NCT04076020|589702889|FG001|Overall Study|Withdrawal by Subject|8|||
163042766|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Death|1|||
163042767|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Discharged|2|||
163042768|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Discharged|1|||
163042769|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Discharged|0|||
163271504|NCT03230864|589702891|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
163271505|NCT03230864|589702892|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
163271506|NCT03230864|589702893|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
163271507|NCT03230864|589702894|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
163271508|NCT03230864|589702891|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
163271509|NCT03230864|589702892|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
163271510|NCT03230864|589702893|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
163271511|NCT03230864|589702894|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
163271512|NCT03230864|589702891|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
163271513|NCT03230864|589702892|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
163271514|NCT03230864|589702893|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
163271515|NCT03230864|589702894|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
163271516|NCT03230864|589702891|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
163271517|NCT03230864|589702892|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
163271518|NCT03230864|589702893|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
163271519|NCT03230864|589702894|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
163271520|NCT03230864|589702891|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
163271521|NCT03230864|589702892|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
163271522|NCT03230864|589702893|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
163271523|NCT03230864|589702894|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
163271524|NCT03230864|589702891|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
163042770|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
163042771|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
163271525|NCT03230864|589702892|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
163271526|NCT03230864|589702893|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
163271527|NCT03230864|589702894|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
163271528|NCT03230864|589702891|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
163271529|NCT03230864|589702892|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
163271530|NCT03230864|589702893|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
163271531|NCT03230864|589702894|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
163271532|NCT03230864|589702891|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
163271533|NCT03230864|589702892|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
163271534|NCT03230864|589702893|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
163271535|NCT03230864|589702894|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
163271536|NCT03230864|589702891|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
163271537|NCT03230864|589702892|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
163271538|NCT03230864|589702893|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
163271539|NCT03230864|589702894|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
163271540|NCT03230864|589702891|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
163271541|NCT03230864|589702892|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
163271542|NCT03230864|589702893|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
163271543|NCT03230864|589702894|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
163271544|NCT00502996|589702909|FG000|Overall Study|Lost to Follow-up|9|||
163271545|NCT00502996|589702909|FG000|Overall Study|Protocol Violation|2|||
163271546|NCT00502996|589702909|FG000|Overall Study|Treatment failure|25|||
163271547|NCT00502996|589702909|FG000|Overall Study|Withdrawal Informed Consent|6|||
163271548|NCT00502996|589702909|FG000|Overall Study|Adverse Event|2|||
163271549|NCT01316692|589702910|FG000|Overall Study|Adverse Event|5|||
163271550|NCT01316692|589702910|FG000|Overall Study|Disease Progression|7|||
163271551|NCT02001974|589702919|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
163042772|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
163058553|NCT00042289|588924240|FG005|Overall Study|Site closed|0|||
163271552|NCT02001974|589702920|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
163271553|NCT02001974|589702921|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
163271554|NCT02001974|589702919|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
163042773|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
163042774|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
163042775|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
163042776|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
163042777|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
163042778|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
163042779|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
163042780|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
163042781|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
163042782|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
163042783|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
163157958|NCT00790842|589291724|FG000|Dose Level 4|Withdrawal by Subject|0|||
163157959|NCT00790842|589291725|FG001|Dose Level 4|Withdrawal by Subject|0|||
163157960|NCT00790842|589291726|FG002|Dose Level 4|Withdrawal by Subject|0|||
163157961|NCT00790842|589291727|FG003|Dose Level 4|Withdrawal by Subject|0|||
163157962|NCT00790842|589291728|FG004|Dose Level 4|Withdrawal by Subject|0|||
163157963|NCT00790842|589291729|FG005|Dose Level 4|Withdrawal by Subject|0|||
163157964|NCT00790842|589291730|FG006|Dose Level 4|Withdrawal by Subject|0|||
163157965|NCT00790842|589291731|FG007|Dose Level 4|Withdrawal by Subject|0|||
163157966|NCT00790842|589291732|FG008|Dose Level 4|Withdrawal by Subject|0|||
163157967|NCT00790842|589291733|FG009|Dose Level 4|Withdrawal by Subject|0|||
163157968|NCT00790842|589291734|FG010|Dose Level 4|Withdrawal by Subject|1|||
163157969|NCT00790842|589291724|FG000|Expansion Cohort|Adverse Event|0|||
163157970|NCT00790842|589291725|FG001|Expansion Cohort|Adverse Event|0|||
163157971|NCT00790842|589291726|FG002|Expansion Cohort|Adverse Event|0|||
163157972|NCT00790842|589291727|FG003|Expansion Cohort|Adverse Event|0|||
163157973|NCT00790842|589291728|FG004|Expansion Cohort|Adverse Event|0|||
163157974|NCT00790842|589291729|FG005|Expansion Cohort|Adverse Event|0|||
163157975|NCT00790842|589291730|FG006|Expansion Cohort|Adverse Event|1|||
163157976|NCT00790842|589291731|FG007|Expansion Cohort|Adverse Event|0|||
163157977|NCT00790842|589291732|FG008|Expansion Cohort|Adverse Event|0|||
163157978|NCT00790842|589291733|FG009|Expansion Cohort|Adverse Event|0|||
163157979|NCT00790842|589291734|FG010|Expansion Cohort|Adverse Event|0|||
163157980|NCT00790842|589291724|FG000|Expansion Cohort|Death|0|||
163157981|NCT00790842|589291725|FG001|Expansion Cohort|Death|0|||
163157982|NCT00790842|589291726|FG002|Expansion Cohort|Death|2|||
163157983|NCT00790842|589291727|FG003|Expansion Cohort|Death|0|||
163157984|NCT00790842|589291728|FG004|Expansion Cohort|Death|0|||
163157985|NCT00790842|589291729|FG005|Expansion Cohort|Death|0|||
163157986|NCT00790842|589291730|FG006|Expansion Cohort|Death|0|||
163157987|NCT00790842|589291731|FG007|Expansion Cohort|Death|0|||
163157988|NCT00790842|589291732|FG008|Expansion Cohort|Death|0|||
163157989|NCT00790842|589291733|FG009|Expansion Cohort|Death|0|||
163157990|NCT00790842|589291734|FG010|Expansion Cohort|Death|0|||
163157991|NCT00790842|589291724|FG000|Expansion Cohort|Physician Decision|0|||
163157992|NCT00790842|589291725|FG001|Expansion Cohort|Physician Decision|0|||
163157993|NCT00790842|589291726|FG002|Expansion Cohort|Physician Decision|1|||
163157994|NCT00790842|589291727|FG003|Expansion Cohort|Physician Decision|0|||
163157995|NCT00790842|589291728|FG004|Expansion Cohort|Physician Decision|0|||
163271555|NCT02001974|589702920|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
163271556|NCT02001974|589702921|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
163271557|NCT02001974|589702919|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
163271558|NCT02001974|589702920|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
163271559|NCT02001974|589702921|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
163271560|NCT02001974|589702919|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
163271561|NCT02001974|589702920|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
163271562|NCT02001974|589702921|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
163271563|NCT00993317|589702922|FG000|Overall Study|Adverse Event|2|||
163157996|NCT00790842|589291729|FG005|Expansion Cohort|Physician Decision|0|||
163157997|NCT00790842|589291730|FG006|Expansion Cohort|Physician Decision|0|||
163157998|NCT00790842|589291731|FG007|Expansion Cohort|Physician Decision|0|||
163157999|NCT00790842|589291732|FG008|Expansion Cohort|Physician Decision|0|||
163158000|NCT00790842|589291733|FG009|Expansion Cohort|Physician Decision|0|||
163158001|NCT00790842|589291734|FG010|Expansion Cohort|Physician Decision|0|||
163158002|NCT00790842|589291724|FG000|Expansion Cohort|Withdrawal by Subject|0|||
163271564|NCT00993317|589702923|FG001|Overall Study|Adverse Event|4|||
163271565|NCT00993317|589702922|FG000|Overall Study|Lack of Efficacy|18|||
163158003|NCT00790842|589291725|FG001|Expansion Cohort|Withdrawal by Subject|0|||
163158004|NCT00790842|589291726|FG002|Expansion Cohort|Withdrawal by Subject|3|||
163158005|NCT00790842|589291727|FG003|Expansion Cohort|Withdrawal by Subject|0|||
163158006|NCT00790842|589291728|FG004|Expansion Cohort|Withdrawal by Subject|0|||
163158007|NCT00790842|589291729|FG005|Expansion Cohort|Withdrawal by Subject|0|||
163271566|NCT00993317|589702923|FG001|Overall Study|Lack of Efficacy|18|||
163158008|NCT00790842|589291730|FG006|Expansion Cohort|Withdrawal by Subject|0|||
163271567|NCT00993317|589702922|FG000|Overall Study|Withdrawal by Subject|0|||
163271568|NCT00993317|589702923|FG001|Overall Study|Withdrawal by Subject|2|||
163271569|NCT00993317|589702922|FG000|Overall Study|Investigator's opinion|0|||
163271570|NCT00993317|589702923|FG001|Overall Study|Investigator's opinion|1|||
163271571|NCT00993317|589702922|FG000|Overall Study|Early study termination at the site|1|||
163271572|NCT00993317|589702923|FG001|Overall Study|Early study termination at the site|0|||
163271573|NCT01380990|589702924|FG000|Overall Study|Treatment Failure|1|||
163271574|NCT01380990|589702925|FG001|Overall Study|Treatment Failure|0|||
163271575|NCT01380990|589702924|FG000|Overall Study|Death|0|||
163271576|NCT01380990|589702925|FG001|Overall Study|Death|1|||
163271577|NCT04422639|589702926|FG000|Overall Study|Death|1|||
163271578|NCT04422639|589702927|FG001|Overall Study|Death|0|||
163271579|NCT04422639|589702926|FG000|Overall Study|study closed prior to completion of FU visits|0|||
163271580|NCT04422639|589702927|FG001|Overall Study|study closed prior to completion of FU visits|2|||
163271581|NCT01964521|589702928|FG000|Overall Study|Lost to Follow-up|4|||
163271582|NCT01463293|589702930|FG000|Overall Study|Lost to Follow-up|1|||
163271583|NCT01463293|589702931|FG001|Overall Study|Lost to Follow-up|4|||
163271584|NCT01463293|589702932|FG002|Overall Study|Lost to Follow-up|5|||
163271585|NCT01463293|589702930|FG000|Overall Study|Adverse Event|1|||
163271586|NCT01463293|589702931|FG001|Overall Study|Adverse Event|2|||
163271587|NCT01463293|589702932|FG002|Overall Study|Adverse Event|0|||
163271588|NCT01463293|589702930|FG000|Overall Study|Withdrawal by Subject|4|||
163271589|NCT01463293|589702931|FG001|Overall Study|Withdrawal by Subject|10|||
163271590|NCT01463293|589702932|FG002|Overall Study|Withdrawal by Subject|5|||
163271591|NCT01463293|589702930|FG000|Overall Study|Other|0|||
163271592|NCT01463293|589702931|FG001|Overall Study|Other|0|||
163271593|NCT01463293|589702932|FG002|Overall Study|Other|2|||
163271594|NCT02796963|589702933|FG000|Overall Study|Lost to Follow-up|89|||
163271595|NCT02796963|589702934|FG001|Overall Study|Lost to Follow-up|76|||
163271596|NCT02796963|589702935|FG002|Overall Study|Lost to Follow-up|69|||
163271597|NCT02796963|589702936|FG003|Overall Study|Lost to Follow-up|72|||
163271598|NCT03192215|589702937|FG000|Overall Study|Death|28|||
163271599|NCT03192215|589702938|FG001|Overall Study|Death|23|||
163271600|NCT03192215|589702937|FG000|Overall Study|Lost to Follow-up|10|||
163271601|NCT03192215|589702938|FG001|Overall Study|Lost to Follow-up|15|||
163271602|NCT03192215|589702937|FG000|Overall Study|Withdrawal by Subject|49|||
163271603|NCT03192215|589702938|FG001|Overall Study|Withdrawal by Subject|48|||
163271604|NCT03192215|589702937|FG000|Overall Study|Other as reported in analysis|4|||
163271605|NCT03192215|589702938|FG001|Overall Study|Other as reported in analysis|1|||
163271606|NCT04844918|589702939|FG000|Overall Study|Adverse Event|7|||
163271607|NCT04844918|589702940|FG001|Overall Study|Adverse Event|8|||
163271608|NCT04844918|589702941|FG002|Overall Study|Adverse Event|5|||
163271609|NCT04844918|589702939|FG000|Overall Study|Physician Decision|0|||
163271610|NCT04844918|589702940|FG001|Overall Study|Physician Decision|1|||
163158009|NCT00790842|589291731|FG007|Expansion Cohort|Withdrawal by Subject|0|||
163158010|NCT00790842|589291732|FG008|Expansion Cohort|Withdrawal by Subject|0|||
163158011|NCT00790842|589291733|FG009|Expansion Cohort|Withdrawal by Subject|0|||
163158012|NCT00790842|589291734|FG010|Expansion Cohort|Withdrawal by Subject|0|||
163158013|NCT00790842|589291724|FG000|Expansion Cohort|Study Closure|0|||
163158014|NCT00790842|589291725|FG001|Expansion Cohort|Study Closure|0|||
163158015|NCT00790842|589291726|FG002|Expansion Cohort|Study Closure|1|||
163158016|NCT00790842|589291727|FG003|Expansion Cohort|Study Closure|0|||
163158017|NCT00790842|589291728|FG004|Expansion Cohort|Study Closure|0|||
163158018|NCT00790842|589291729|FG005|Expansion Cohort|Study Closure|0|||
163158019|NCT00790842|589291730|FG006|Expansion Cohort|Study Closure|0|||
163158020|NCT00790842|589291731|FG007|Expansion Cohort|Study Closure|0|||
163158021|NCT00790842|589291732|FG008|Expansion Cohort|Study Closure|0|||
163158022|NCT00790842|589291733|FG009|Expansion Cohort|Study Closure|0|||
163158023|NCT00790842|589291734|FG010|Expansion Cohort|Study Closure|0|||
163158024|NCT05029362|589291735|FG000|Overall Study|Lost to Follow-up|9|||
163158025|NCT00419952|589291739|FG000|Overall Study|Adverse Event|8|||
163158026|NCT00419952|589291740|FG001|Overall Study|Adverse Event|10|||
163158027|NCT00419952|589291739|FG000|Overall Study|Withdrawal by Subject|44|||
163158028|NCT00419952|589291740|FG001|Overall Study|Withdrawal by Subject|43|||
163158029|NCT00419952|589291739|FG000|Overall Study|Lost to Follow-up|43|||
163158030|NCT00419952|589291740|FG001|Overall Study|Lost to Follow-up|34|||
163158031|NCT00419952|589291739|FG000|Overall Study|Protocol Violation|32|||
163271611|NCT04844918|589702941|FG002|Overall Study|Physician Decision|0|||
163271612|NCT04844918|589702939|FG000|Overall Study|Withdrawal by Subject|6|||
163271613|NCT04844918|589702940|FG001|Overall Study|Withdrawal by Subject|3|||
163271614|NCT04844918|589702941|FG002|Overall Study|Withdrawal by Subject|3|||
163158032|NCT00419952|589291740|FG001|Overall Study|Protocol Violation|24|||
163158033|NCT00419952|589291739|FG000|Overall Study|Pregnancy|4|||
163271615|NCT04844918|589702939|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
163271616|NCT04844918|589702940|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
163271617|NCT04844918|589702941|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
163271618|NCT00735644|589702952|FG000|Overall Study|Did not receive study vaccine|0|||
163271619|NCT00735644|589702953|FG001|Overall Study|Did not receive study vaccine|1|||
163271620|NCT00735644|589702954|FG002|Overall Study|Did not receive study vaccine|0|||
163158034|NCT00419952|589291740|FG001|Overall Study|Pregnancy|2|||
163158035|NCT00419952|589291739|FG000|Overall Study|Physician Decision|1|||
163158036|NCT00419952|589291740|FG001|Overall Study|Physician Decision|3|||
163158037|NCT00419952|589291739|FG000|Overall Study|Incorrectly enrolled|10|||
163158038|NCT00419952|589291740|FG001|Overall Study|Incorrectly enrolled|3|||
163158039|NCT00419952|589291739|FG000|Overall Study|Intake of prohibited medication|2|||
163158040|NCT00419952|589291740|FG001|Overall Study|Intake of prohibited medication|2|||
163158041|NCT00419952|589291739|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
163158042|NCT00419952|589291740|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
163158043|NCT00419952|589291739|FG000|Overall Study|Diary or medication non-compliance|2|||
163158044|NCT00419952|589291740|FG001|Overall Study|Diary or medication non-compliance|4|||
163158045|NCT00419952|589291739|FG000|Overall Study|Abnormal ECG|1|||
163158046|NCT00419952|589291740|FG001|Overall Study|Abnormal ECG|0|||
163158047|NCT03126591|589291745|FG000|Overall Study|Death|6|||
163158048|NCT03126591|589291746|FG001|Overall Study|Death|3|||
163158049|NCT03126591|589291747|FG002|Overall Study|Death|17|||
163158050|NCT03126591|589291745|FG000|Overall Study|Progressive Disease|0|||
163158051|NCT03126591|589291746|FG001|Overall Study|Progressive Disease|1|||
163158052|NCT03126591|589291747|FG002|Overall Study|Progressive Disease|2|||
163158053|NCT03126591|589291745|FG000|Overall Study|Terminated by Sponsor|0|||
163158054|NCT03126591|589291746|FG001|Overall Study|Terminated by Sponsor|1|||
163158055|NCT03126591|589291747|FG002|Overall Study|Terminated by Sponsor|4|||
163158056|NCT03126591|589291745|FG000|Overall Study|Withdrawal by Subject|1|||
163158057|NCT03126591|589291746|FG001|Overall Study|Withdrawal by Subject|1|||
163158058|NCT03126591|589291747|FG002|Overall Study|Withdrawal by Subject|4|||
163158059|NCT03722238|589291750|FG000|Overall Study|Protocol Violation|1|||
163158060|NCT03722238|589291751|FG001|Overall Study|Protocol Violation|0|||
163158061|NCT03722238|589291750|FG000|Overall Study|Physician Decision|1|||
163158062|NCT03722238|589291751|FG001|Overall Study|Physician Decision|0|||
163158063|NCT03722238|589291750|FG000|Overall Study|Death|1|||
163158064|NCT03722238|589291751|FG001|Overall Study|Death|0|||
163158065|NCT03722238|589291750|FG000|Overall Study|Lost to Follow-up|6|||
163158066|NCT03722238|589291751|FG001|Overall Study|Lost to Follow-up|0|||
163158067|NCT03722238|589291750|FG000|Overall Study|Partial missing data|44|||
163158068|NCT03722238|589291751|FG001|Overall Study|Partial missing data|1|||
163158069|NCT03722238|589291750|FG000|Overall Study|Withdrawal by Subject|2|||
163158070|NCT03722238|589291751|FG001|Overall Study|Withdrawal by Subject|0|||
163158071|NCT03722238|589291750|FG000|Overall Study|Other|4|||
163158072|NCT03722238|589291751|FG001|Overall Study|Other|0|||
163158073|NCT03722238|589291750|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
163158074|NCT03722238|589291751|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
163158075|NCT03722238|589291750|FG000|Overall Study|Did not meet risk classification group criteria|90|||
163158076|NCT03722238|589291751|FG001|Overall Study|Did not meet risk classification group criteria|0|||
163158077|NCT03722238|589291750|FG000|Overall Study|Did not sign consent|17|||
163158078|NCT03722238|589291751|FG001|Overall Study|Did not sign consent|0|||
163158079|NCT03722238|589291750|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
163158080|NCT03722238|589291751|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
163158081|NCT03722238|589291750|FG000|Overall Study|Not willing to purchase study medication|142|||
163158082|NCT03722238|589291751|FG001|Overall Study|Not willing to purchase study medication|0|||
163158083|NCT03722238|589291750|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
163158084|NCT03722238|589291751|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
163158085|NCT02085460|589291752|FG000|Overall Study|Adverse Event|2|||
163158086|NCT02085460|589291753|FG001|Overall Study|Adverse Event|2|||
163158087|NCT02085460|589291754|FG002|Overall Study|Adverse Event|1|||
163158088|NCT02085460|589291752|FG000|Overall Study|Physician Decision|1|||
163158089|NCT02085460|589291753|FG001|Overall Study|Physician Decision|1|||
163158090|NCT02085460|589291754|FG002|Overall Study|Physician Decision|2|||
163158091|NCT02085460|589291752|FG000|Overall Study|Withdrawal by Subject|11|||
163158092|NCT02085460|589291753|FG001|Overall Study|Withdrawal by Subject|5|||
163158093|NCT02085460|589291754|FG002|Overall Study|Withdrawal by Subject|7|||
163158094|NCT01285323|589291755|FG000|Overall Study|Adverse Event|9|||
163158095|NCT01285323|589291756|FG001|Overall Study|Adverse Event|8|||
163158096|NCT01285323|589291755|FG000|Overall Study|Lack of Efficacy|4|||
163158097|NCT01285323|589291756|FG001|Overall Study|Lack of Efficacy|2|||
163158098|NCT01285323|589291755|FG000|Overall Study|Withdrawal by Subject|15|||
163158099|NCT01285323|589291756|FG001|Overall Study|Withdrawal by Subject|11|||
163158100|NCT01285323|589291755|FG000|Overall Study|Protocol Violation|1|||
163158101|NCT01285323|589291756|FG001|Overall Study|Protocol Violation|2|||
163158102|NCT01285323|589291755|FG000|Overall Study|Non-compliance with study procedures|2|||
163158103|NCT01285323|589291756|FG001|Overall Study|Non-compliance with study procedures|3|||
163158104|NCT01285323|589291755|FG000|Overall Study|Lost to Follow-up|1|||
163158105|NCT01285323|589291756|FG001|Overall Study|Lost to Follow-up|1|||
163158106|NCT01285323|589291755|FG000|Overall Study|Other|1|||
163158107|NCT01285323|589291756|FG001|Overall Study|Other|3|||
163271621|NCT00735644|589702955|FG003|Overall Study|Did not receive study vaccine|0|||
163271622|NCT00735644|589702956|FG004|Overall Study|Did not receive study vaccine|0|||
163271623|NCT00735644|589702952|FG000|Overall Study|Withdrawal by Subject|0|||
163271624|NCT00735644|589702953|FG001|Overall Study|Withdrawal by Subject|1|||
163271625|NCT00735644|589702954|FG002|Overall Study|Withdrawal by Subject|1|||
163271626|NCT00735644|589702955|FG003|Overall Study|Withdrawal by Subject|1|||
163271627|NCT00735644|589702956|FG004|Overall Study|Withdrawal by Subject|0|||
163271628|NCT00514046|589702957|FG000|Overall Study|transferred to another protocol|2|||
163271629|NCT00514046|589702958|FG001|Overall Study|transferred to another protocol|1|||
163271630|NCT00514046|589702959|FG002|Overall Study|transferred to another protocol|3|||
163271631|NCT00514046|589702960|FG003|Overall Study|transferred to another protocol|0|||
163271632|NCT00514046|589702961|FG004|Overall Study|transferred to another protocol|1|||
163271633|NCT00514046|589702962|FG005|Overall Study|transferred to another protocol|0|||
163271634|NCT00514046|589702963|FG006|Overall Study|transferred to another protocol|0|||
163271635|NCT00514046|589702964|FG007|Overall Study|transferred to another protocol|0|||
163271636|NCT00514046|589702965|FG008|Overall Study|transferred to another protocol|0|||
163271637|NCT00514046|589702957|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
163271638|NCT00514046|589702958|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
163271639|NCT00514046|589702959|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
163271640|NCT00514046|589702960|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
163271641|NCT00514046|589702961|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
163271642|NCT00514046|589702962|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
163271643|NCT00514046|589702963|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
163271644|NCT00514046|589702964|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
163271645|NCT00514046|589702965|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
163271646|NCT00514046|589702957|FG000|Overall Study|Disease progression on study|0|||
163271647|NCT00514046|589702958|FG001|Overall Study|Disease progression on study|0|||
163271648|NCT00514046|589702959|FG002|Overall Study|Disease progression on study|2|||
163271649|NCT00514046|589702960|FG003|Overall Study|Disease progression on study|0|||
163271650|NCT00514046|589702961|FG004|Overall Study|Disease progression on study|0|||
163271651|NCT00514046|589702962|FG005|Overall Study|Disease progression on study|1|||
163271652|NCT00514046|589702963|FG006|Overall Study|Disease progression on study|0|||
163271653|NCT00514046|589702964|FG007|Overall Study|Disease progression on study|0|||
163271654|NCT00514046|589702965|FG008|Overall Study|Disease progression on study|0|||
163271655|NCT00655551|589702966|FG000|All Periods Combined|Adverse Event|0|||
163271656|NCT00655551|589702967|FG001|All Periods Combined|Adverse Event|3|||
163271657|NCT00655551|589702968|FG002|All Periods Combined|Adverse Event|4|||
163271658|NCT00655551|589702966|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
163271659|NCT00655551|589702967|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
163271660|NCT00655551|589702968|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
163271661|NCT00655551|589702966|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
163271662|NCT00655551|589702967|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
163271663|NCT00655551|589702968|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
163271664|NCT00655551|589702966|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
163271665|NCT00655551|589702967|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
163271666|NCT00655551|589702968|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
163271667|NCT02855164|589702970|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
163271668|NCT02855164|589702971|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
163271669|NCT02855164|589702972|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
163271670|NCT02855164|589702973|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
163271671|NCT02855164|589702974|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
163271672|NCT02855164|589702975|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
163271673|NCT02855164|589702976|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
163271674|NCT02855164|589702977|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
163271675|NCT02855164|589702970|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
163271676|NCT02855164|589702971|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
163271677|NCT02855164|589702972|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
163271678|NCT02855164|589702973|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
163271679|NCT02855164|589702974|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
163271680|NCT02855164|589702975|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
163271681|NCT02855164|589702976|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
163271682|NCT02855164|589702977|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
163271683|NCT02855164|589702970|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
163271684|NCT02855164|589702971|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
163271685|NCT02855164|589702972|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
163271686|NCT02855164|589702973|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
163271687|NCT02855164|589702974|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
163271688|NCT02855164|589702975|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
163271689|NCT02855164|589702976|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
163271690|NCT02855164|589702977|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
163158108|NCT02606643|589291757|FG000|Overall Study|did not meet inclusion criteria|1|||
163158109|NCT02606643|589291758|FG001|Overall Study|did not meet inclusion criteria|3|||
163158110|NCT02158546|589291765|FG000|Overall Study|Physician Decision|0|||
163158111|NCT02158546|589291766|FG001|Overall Study|Physician Decision|1|||
163158112|NCT02158546|589291767|FG002|Overall Study|Physician Decision|0|||
163158113|NCT02158546|589291768|FG003|Overall Study|Physician Decision|0|||
163158114|NCT02158546|589291765|FG000|Overall Study|Non-compliance|0|||
163158115|NCT02158546|589291766|FG001|Overall Study|Non-compliance|1|||
163158116|NCT02158546|589291767|FG002|Overall Study|Non-compliance|0|||
163158117|NCT02158546|589291768|FG003|Overall Study|Non-compliance|1|||
163158118|NCT02158546|589291765|FG000|Overall Study|Failure to meet eligibility criteria|0|||
163158119|NCT02158546|589291766|FG001|Overall Study|Failure to meet eligibility criteria|1|||
163158120|NCT02158546|589291767|FG002|Overall Study|Failure to meet eligibility criteria|0|||
163158121|NCT02158546|589291768|FG003|Overall Study|Failure to meet eligibility criteria|0|||
163158122|NCT02158546|589291765|FG000|Overall Study|Lack of Efficacy|1|||
163158123|NCT02158546|589291766|FG001|Overall Study|Lack of Efficacy|1|||
163158124|NCT02158546|589291767|FG002|Overall Study|Lack of Efficacy|0|||
163158125|NCT02158546|589291768|FG003|Overall Study|Lack of Efficacy|0|||
163158126|NCT02158546|589291765|FG000|Overall Study|Adverse Event|2|||
163158127|NCT02158546|589291766|FG001|Overall Study|Adverse Event|2|||
163158128|NCT02158546|589291767|FG002|Overall Study|Adverse Event|0|||
163158129|NCT02158546|589291768|FG003|Overall Study|Adverse Event|0|||
163158130|NCT02158546|589291765|FG000|Overall Study|Withdrawal by Subject|6|||
163158131|NCT02158546|589291766|FG001|Overall Study|Withdrawal by Subject|2|||
163158132|NCT02158546|589291767|FG002|Overall Study|Withdrawal by Subject|1|||
163158133|NCT02158546|589291768|FG003|Overall Study|Withdrawal by Subject|0|||
163158134|NCT02158546|589291765|FG000|Overall Study|Lost to Follow-up|5|||
163158135|NCT02158546|589291766|FG001|Overall Study|Lost to Follow-up|4|||
163158136|NCT02158546|589291767|FG002|Overall Study|Lost to Follow-up|0|||
163158137|NCT02158546|589291768|FG003|Overall Study|Lost to Follow-up|1|||
163158138|NCT02158546|589291765|FG000|Overall Study|Site Excluded|5|||
163158139|NCT02158546|589291766|FG001|Overall Study|Site Excluded|5|||
163271691|NCT02855164|589702970|FG000|Part C (Randomized Set)|Adverse Event|0|||
163271692|NCT02855164|589702971|FG001|Part C (Randomized Set)|Adverse Event|0|||
163271693|NCT02855164|589702972|FG002|Part C (Randomized Set)|Adverse Event|0|||
163271694|NCT02855164|589702973|FG003|Part C (Randomized Set)|Adverse Event|0|||
163271695|NCT02855164|589702974|FG004|Part C (Randomized Set)|Adverse Event|0|||
163271696|NCT02855164|589702975|FG005|Part C (Randomized Set)|Adverse Event|5|||
163271697|NCT02855164|589702976|FG006|Part C (Randomized Set)|Adverse Event|9|||
163271698|NCT02855164|589702977|FG007|Part C (Randomized Set)|Adverse Event|2|||
163271699|NCT02855164|589702970|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
163271700|NCT02855164|589702971|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
163271701|NCT02855164|589702972|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
163271702|NCT02855164|589702973|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
163271703|NCT02855164|589702974|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
163271704|NCT02855164|589702975|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
163271705|NCT02855164|589702976|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
163158140|NCT02158546|589291767|FG002|Overall Study|Site Excluded|3|||
163158141|NCT02158546|589291768|FG003|Overall Study|Site Excluded|4|||
163158142|NCT02351817|589291770|FG000|Period 1|Adverse Event|1|||
163158143|NCT02351817|589291771|FG001|Period 1|Adverse Event|2|||
163158144|NCT02351817|589291770|FG000|Period 1|Lack of Efficacy|0|||
163158145|NCT02351817|589291771|FG001|Period 1|Lack of Efficacy|1|||
163158146|NCT02351817|589291770|FG000|Period 2|Adverse Event|0|||
163158147|NCT02351817|589291771|FG001|Period 2|Adverse Event|2|||
163158148|NCT02351817|589291770|FG000|Period 2|Protocol Violation|1|||
163158149|NCT02351817|589291771|FG001|Period 2|Protocol Violation|0|||
163158150|NCT00891904|589291776|FG000|Overall Study|Death|1|||
163158151|NCT00891904|589291776|FG000|Overall Study|Adverse Event|1|||
163158152|NCT01208207|589291777|FG000|Part I|Adverse Event|19|||
163158153|NCT01208207|589291778|FG001|Part I|Adverse Event|2|||
163158154|NCT01208207|589291779|FG002|Part I|Adverse Event|6|||
163158155|NCT01208207|589291780|FG003|Part I|Adverse Event|0|||
163158156|NCT01208207|589291781|FG004|Part I|Adverse Event|0|||
163158157|NCT01208207|589291782|FG005|Part I|Adverse Event|0|||
163158158|NCT01208207|589291783|FG006|Part I|Adverse Event|0|||
163158159|NCT01208207|589291777|FG000|Part I|Lack of Efficacy|21|||
163158160|NCT01208207|589291778|FG001|Part I|Lack of Efficacy|3|||
163158161|NCT01208207|589291779|FG002|Part I|Lack of Efficacy|2|||
163158162|NCT01208207|589291780|FG003|Part I|Lack of Efficacy|0|||
163158163|NCT01208207|589291781|FG004|Part I|Lack of Efficacy|0|||
163158164|NCT01208207|589291782|FG005|Part I|Lack of Efficacy|0|||
163158165|NCT01208207|589291783|FG006|Part I|Lack of Efficacy|0|||
163158166|NCT01208207|589291777|FG000|Part I|Lost to Follow-up|6|||
163158167|NCT01208207|589291778|FG001|Part I|Lost to Follow-up|1|||
163158168|NCT01208207|589291779|FG002|Part I|Lost to Follow-up|0|||
163271706|NCT02855164|589702977|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
163158169|NCT01208207|589291780|FG003|Part I|Lost to Follow-up|0|||
163158170|NCT01208207|589291781|FG004|Part I|Lost to Follow-up|0|||
163158171|NCT01208207|589291782|FG005|Part I|Lost to Follow-up|0|||
163158172|NCT01208207|589291783|FG006|Part I|Lost to Follow-up|0|||
163158173|NCT01208207|589291777|FG000|Part I|Non-Compliance With Study Drug|1|||
163158174|NCT01208207|589291778|FG001|Part I|Non-Compliance With Study Drug|0|||
163158175|NCT01208207|589291779|FG002|Part I|Non-Compliance With Study Drug|1|||
163158176|NCT01208207|589291780|FG003|Part I|Non-Compliance With Study Drug|0|||
163158177|NCT01208207|589291781|FG004|Part I|Non-Compliance With Study Drug|0|||
163158178|NCT01208207|589291782|FG005|Part I|Non-Compliance With Study Drug|0|||
163158179|NCT01208207|589291783|FG006|Part I|Non-Compliance With Study Drug|0|||
163158180|NCT01208207|589291777|FG000|Part I|Physician Decision|0|||
163158181|NCT01208207|589291778|FG001|Part I|Physician Decision|1|||
163158182|NCT01208207|589291779|FG002|Part I|Physician Decision|0|||
163158183|NCT01208207|589291780|FG003|Part I|Physician Decision|0|||
163158184|NCT01208207|589291781|FG004|Part I|Physician Decision|0|||
163158185|NCT01208207|589291782|FG005|Part I|Physician Decision|0|||
163158186|NCT01208207|589291783|FG006|Part I|Physician Decision|0|||
163158187|NCT01208207|589291777|FG000|Part I|Progressive Disease|1|||
163158188|NCT01208207|589291778|FG001|Part I|Progressive Disease|0|||
163158189|NCT01208207|589291779|FG002|Part I|Progressive Disease|0|||
163158190|NCT01208207|589291780|FG003|Part I|Progressive Disease|0|||
163158191|NCT01208207|589291781|FG004|Part I|Progressive Disease|0|||
163158192|NCT01208207|589291782|FG005|Part I|Progressive Disease|0|||
163158193|NCT01208207|589291783|FG006|Part I|Progressive Disease|0|||
163158194|NCT01208207|589291777|FG000|Part I|Protocol Violation|8|||
163158195|NCT01208207|589291778|FG001|Part I|Protocol Violation|0|||
163158196|NCT01208207|589291779|FG002|Part I|Protocol Violation|2|||
163158197|NCT01208207|589291780|FG003|Part I|Protocol Violation|0|||
163158198|NCT01208207|589291781|FG004|Part I|Protocol Violation|0|||
163158199|NCT01208207|589291782|FG005|Part I|Protocol Violation|0|||
163158200|NCT01208207|589291783|FG006|Part I|Protocol Violation|0|||
163158201|NCT01208207|589291777|FG000|Part I|Withdrawal by Subject|14|||
163158202|NCT01208207|589291778|FG001|Part I|Withdrawal by Subject|4|||
163158203|NCT01208207|589291779|FG002|Part I|Withdrawal by Subject|4|||
163158204|NCT01208207|589291780|FG003|Part I|Withdrawal by Subject|0|||
163158205|NCT01208207|589291781|FG004|Part I|Withdrawal by Subject|0|||
163158206|NCT01208207|589291782|FG005|Part I|Withdrawal by Subject|0|||
163158207|NCT01208207|589291783|FG006|Part I|Withdrawal by Subject|0|||
163158208|NCT01208207|589291777|FG000|Part II|Withdrawal by Subject|0|||
163158209|NCT01208207|589291778|FG001|Part II|Withdrawal by Subject|0|||
163158210|NCT01208207|589291779|FG002|Part II|Withdrawal by Subject|0|||
163158211|NCT01208207|589291780|FG003|Part II|Withdrawal by Subject|10|||
163158212|NCT01208207|589291781|FG004|Part II|Withdrawal by Subject|9|||
163158213|NCT01208207|589291782|FG005|Part II|Withdrawal by Subject|3|||
163158214|NCT01208207|589291783|FG006|Part II|Withdrawal by Subject|5|||
163158215|NCT01208207|589291777|FG000|Part II|Adverse Event|0|||
163158216|NCT01208207|589291778|FG001|Part II|Adverse Event|0|||
163158217|NCT01208207|589291779|FG002|Part II|Adverse Event|0|||
163158218|NCT01208207|589291780|FG003|Part II|Adverse Event|5|||
163158219|NCT01208207|589291781|FG004|Part II|Adverse Event|9|||
163158220|NCT01208207|589291782|FG005|Part II|Adverse Event|4|||
163158221|NCT01208207|589291783|FG006|Part II|Adverse Event|2|||
163158222|NCT01208207|589291777|FG000|Part II|Lack of Efficacy|0|||
163158223|NCT01208207|589291778|FG001|Part II|Lack of Efficacy|0|||
163158224|NCT01208207|589291779|FG002|Part II|Lack of Efficacy|0|||
163158225|NCT01208207|589291780|FG003|Part II|Lack of Efficacy|6|||
163158226|NCT01208207|589291781|FG004|Part II|Lack of Efficacy|4|||
163158227|NCT01208207|589291782|FG005|Part II|Lack of Efficacy|3|||
163158228|NCT01208207|589291783|FG006|Part II|Lack of Efficacy|3|||
163158229|NCT01208207|589291777|FG000|Part II|Lost to Follow-up|0|||
163158230|NCT01208207|589291778|FG001|Part II|Lost to Follow-up|0|||
163158231|NCT01208207|589291779|FG002|Part II|Lost to Follow-up|0|||
163158232|NCT01208207|589291780|FG003|Part II|Lost to Follow-up|4|||
163271707|NCT02855164|589702970|FG000|Part C (Randomized Set)|Physician Decision|0|||
163271708|NCT02855164|589702971|FG001|Part C (Randomized Set)|Physician Decision|0|||
163271709|NCT02855164|589702972|FG002|Part C (Randomized Set)|Physician Decision|0|||
163158233|NCT01208207|589291781|FG004|Part II|Lost to Follow-up|0|||
163158234|NCT01208207|589291782|FG005|Part II|Lost to Follow-up|2|||
163158235|NCT01208207|589291783|FG006|Part II|Lost to Follow-up|1|||
163158236|NCT01208207|589291777|FG000|Part II|Non-Compliance With Study Drug|0|||
163158237|NCT01208207|589291778|FG001|Part II|Non-Compliance With Study Drug|0|||
163158238|NCT01208207|589291779|FG002|Part II|Non-Compliance With Study Drug|0|||
163271710|NCT02855164|589702973|FG003|Part C (Randomized Set)|Physician Decision|0|||
163271711|NCT02855164|589702974|FG004|Part C (Randomized Set)|Physician Decision|0|||
163158239|NCT01208207|589291780|FG003|Part II|Non-Compliance With Study Drug|4|||
163158240|NCT01208207|589291781|FG004|Part II|Non-Compliance With Study Drug|1|||
163158241|NCT01208207|589291782|FG005|Part II|Non-Compliance With Study Drug|1|||
163158242|NCT01208207|589291783|FG006|Part II|Non-Compliance With Study Drug|0|||
163158243|NCT01208207|589291777|FG000|Part II|Physician Decision|0|||
163158244|NCT01208207|589291778|FG001|Part II|Physician Decision|0|||
163158245|NCT01208207|589291779|FG002|Part II|Physician Decision|0|||
163158246|NCT01208207|589291780|FG003|Part II|Physician Decision|1|||
163158247|NCT01208207|589291781|FG004|Part II|Physician Decision|0|||
163158248|NCT01208207|589291782|FG005|Part II|Physician Decision|2|||
163158249|NCT01208207|589291783|FG006|Part II|Physician Decision|0|||
163158250|NCT01208207|589291777|FG000|Part II|Protocol Violation|0|||
163271712|NCT02855164|589702975|FG005|Part C (Randomized Set)|Physician Decision|1|||
163158251|NCT01208207|589291778|FG001|Part II|Protocol Violation|0|||
163158252|NCT01208207|589291779|FG002|Part II|Protocol Violation|0|||
163158253|NCT01208207|589291780|FG003|Part II|Protocol Violation|1|||
163158254|NCT01208207|589291781|FG004|Part II|Protocol Violation|0|||
163158255|NCT01208207|589291782|FG005|Part II|Protocol Violation|0|||
163158256|NCT01208207|589291783|FG006|Part II|Protocol Violation|0|||
163158257|NCT01208207|589291777|FG000|Part II|Technical Problems|0|||
163158258|NCT01208207|589291778|FG001|Part II|Technical Problems|0|||
163158259|NCT01208207|589291779|FG002|Part II|Technical Problems|0|||
163158260|NCT01208207|589291780|FG003|Part II|Technical Problems|1|||
163158261|NCT01208207|589291781|FG004|Part II|Technical Problems|0|||
163158262|NCT01208207|589291782|FG005|Part II|Technical Problems|1|||
163158263|NCT01208207|589291783|FG006|Part II|Technical Problems|0|||
163158264|NCT04041414|589291786|FG000|Overall Study|Lost to Follow-up|1|||
163158265|NCT04041414|589291787|FG001|Overall Study|Lost to Follow-up|2|||
163158266|NCT00665652|589291788|FG000|Overall Study|Adverse Event|4|||
163158267|NCT00665652|589291788|FG000|Overall Study|Death|1|||
163158268|NCT00665652|589291788|FG000|Overall Study|No longer met inclusion criteria.|1|||
163158269|NCT01055197|589291799|FG000|Overall Study|Protocol Violation|7|||
163158270|NCT01055197|589291800|FG001|Overall Study|Protocol Violation|2|||
163158271|NCT01055197|589291799|FG000|Overall Study|Withdrawal by Subject|2|||
163158272|NCT01055197|589291800|FG001|Overall Study|Withdrawal by Subject|0|||
163158273|NCT00734539|589291801|FG000|Main Study|Death|33|||
163158274|NCT00734539|589291802|FG001|Main Study|Death|32|||
163158275|NCT00734539|589291801|FG000|Main Study|Physician Decision|2|||
163158276|NCT00734539|589291802|FG001|Main Study|Physician Decision|0|||
163158277|NCT00734539|589291801|FG000|Main Study|Withdrawal by Subject|1|||
163158278|NCT00734539|589291802|FG001|Main Study|Withdrawal by Subject|3|||
163158279|NCT00734539|589291801|FG000|Main Study|Enrolled in error; ineligible|1|||
163158280|NCT00734539|589291802|FG001|Main Study|Enrolled in error; ineligible|0|||
163158281|NCT00830440|589291803|FG000|Overall Study|Protocol Violation|1|||
163158282|NCT00830440|589291804|FG001|Overall Study|Protocol Violation|0|||
163158283|NCT00830440|589291803|FG000|Overall Study|Withdrawal by Subject|1|||
163158284|NCT00830440|589291804|FG001|Overall Study|Withdrawal by Subject|0|||
163158285|NCT00830440|589291803|FG000|Overall Study|unsuccessful procedure|4|||
163158286|NCT00830440|589291804|FG001|Overall Study|unsuccessful procedure|0|||
163158287|NCT00830440|589291803|FG000|Overall Study|Adverse Event|2|||
163158288|NCT00830440|589291804|FG001|Overall Study|Adverse Event|0|||
163158289|NCT01721044|589291805|FG000|Treatment Period|Adverse Event|7|||
163158290|NCT01721044|589291806|FG001|Treatment Period|Adverse Event|7|||
163158291|NCT01721044|589291807|FG002|Treatment Period|Adverse Event|10|||
163158292|NCT01721044|589291805|FG000|Treatment Period|Death|0|||
163158293|NCT01721044|589291806|FG001|Treatment Period|Death|0|||
163158294|NCT01721044|589291807|FG002|Treatment Period|Death|1|||
163158295|NCT01721044|589291805|FG000|Treatment Period|Lack of Efficacy|16|||
163158296|NCT01721044|589291806|FG001|Treatment Period|Lack of Efficacy|4|||
163158297|NCT01721044|589291807|FG002|Treatment Period|Lack of Efficacy|4|||
163158298|NCT01721044|589291805|FG000|Treatment Period|Lost to Follow-up|0|||
163158299|NCT01721044|589291806|FG001|Treatment Period|Lost to Follow-up|0|||
163158300|NCT01721044|589291807|FG002|Treatment Period|Lost to Follow-up|1|||
163158301|NCT01721044|589291805|FG000|Treatment Period|Physician Decision|1|||
163158302|NCT01721044|589291806|FG001|Treatment Period|Physician Decision|0|||
163158303|NCT01721044|589291807|FG002|Treatment Period|Physician Decision|2|||
163158304|NCT01721044|589291805|FG000|Treatment Period|Protocol Violation|1|||
163158305|NCT01721044|589291806|FG001|Treatment Period|Protocol Violation|0|||
163158306|NCT01721044|589291807|FG002|Treatment Period|Protocol Violation|0|||
163158307|NCT01721044|589291805|FG000|Treatment Period|Withdrawal by Subject|7|||
163158308|NCT01721044|589291806|FG001|Treatment Period|Withdrawal by Subject|6|||
163158309|NCT01721044|589291807|FG002|Treatment Period|Withdrawal by Subject|1|||
163158310|NCT02420821|589291818|FG000|Overall Study|Lost to Follow-up|6|||
163158311|NCT02420821|589291819|FG001|Overall Study|Lost to Follow-up|6|||
163158312|NCT02420821|589291818|FG000|Overall Study|Non-compliance|0|||
163158313|NCT02420821|589291819|FG001|Overall Study|Non-compliance|2|||
163158314|NCT02420821|589291818|FG000|Overall Study|Physician Decision|6|||
163158315|NCT02420821|589291819|FG001|Overall Study|Physician Decision|2|||
163158316|NCT02420821|589291818|FG000|Overall Study|Withdrawal by Subject|32|||
163158317|NCT02420821|589291819|FG001|Overall Study|Withdrawal by Subject|25|||
163158318|NCT02420821|589291818|FG000|Overall Study|Death|270|||
163158319|NCT02420821|589291819|FG001|Overall Study|Death|263|||
163158320|NCT02420821|589291818|FG000|Overall Study|Study Terminated By Sponsor|145|||
163158321|NCT02420821|589291819|FG001|Overall Study|Study Terminated By Sponsor|149|||
163158322|NCT02420821|589291818|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
163158323|NCT02420821|589291819|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
163158324|NCT02420821|589291818|FG000|Overall Study|Adverse Event|0|||
163158325|NCT02420821|589291819|FG001|Overall Study|Adverse Event|1|||
163158326|NCT02420821|589291818|FG000|Overall Study|Protinuria|0|||
163158327|NCT02420821|589291819|FG001|Overall Study|Protinuria|1|||
163158328|NCT02420821|589291818|FG000|Overall Study|Progressive Disease|1|||
163158329|NCT02420821|589291819|FG001|Overall Study|Progressive Disease|1|||
163158330|NCT02420821|589291818|FG000|Overall Study|Disease Progression|0|||
163158331|NCT02420821|589291819|FG001|Overall Study|Disease Progression|1|||
163158332|NCT02420821|589291818|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
163158333|NCT02420821|589291819|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
163158334|NCT01318915|589291821|FG000|Overall Study|Lost to Follow-up|1|||
163158335|NCT03987503|589291822|FG000|Overall Study|Lost to Follow-up|20|||
163158336|NCT03987503|589291822|FG000|Overall Study|Withdrawal by Subject|2|||
163158337|NCT01588522|589291836|FG000|Overall Study|Withdrawal by Subject|1|||
163158338|NCT01588522|589291837|FG001|Overall Study|Withdrawal by Subject|5|||
163158339|NCT01588522|589291838|FG002|Overall Study|Withdrawal by Subject|3|||
163158340|NCT01588522|589291839|FG003|Overall Study|Withdrawal by Subject|1|||
163158341|NCT01588522|589291840|FG004|Overall Study|Withdrawal by Subject|2|||
163158342|NCT01588522|589291841|FG005|Overall Study|Withdrawal by Subject|0|||
163158343|NCT01588522|589291836|FG000|Overall Study|Lack of Efficacy|0|||
163158344|NCT01588522|589291837|FG001|Overall Study|Lack of Efficacy|0|||
163158345|NCT01588522|589291838|FG002|Overall Study|Lack of Efficacy|0|||
163158346|NCT01588522|589291839|FG003|Overall Study|Lack of Efficacy|0|||
163158347|NCT01588522|589291840|FG004|Overall Study|Lack of Efficacy|1|||
163158348|NCT01588522|589291841|FG005|Overall Study|Lack of Efficacy|0|||
163158349|NCT01588522|589291836|FG000|Overall Study|Adverse Event|0|||
163158350|NCT01588522|589291837|FG001|Overall Study|Adverse Event|0|||
163158351|NCT01588522|589291838|FG002|Overall Study|Adverse Event|0|||
163158352|NCT01588522|589291839|FG003|Overall Study|Adverse Event|1|||
163158353|NCT01588522|589291840|FG004|Overall Study|Adverse Event|0|||
163158354|NCT01588522|589291841|FG005|Overall Study|Adverse Event|0|||
163158355|NCT01588522|589291836|FG000|Overall Study|Grade 2 alopecia|1|||
163158356|NCT01588522|589291837|FG001|Overall Study|Grade 2 alopecia|0|||
163158357|NCT01588522|589291838|FG002|Overall Study|Grade 2 alopecia|0|||
163158358|NCT01588522|589291839|FG003|Overall Study|Grade 2 alopecia|0|||
163158359|NCT01588522|589291840|FG004|Overall Study|Grade 2 alopecia|0|||
163158360|NCT01588522|589291841|FG005|Overall Study|Grade 2 alopecia|0|||
163158361|NCT01588522|589291836|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
163158362|NCT01588522|589291837|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
163158363|NCT01588522|589291838|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
163158364|NCT01588522|589291839|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
163158365|NCT01588522|589291840|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
163158366|NCT01588522|589291841|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
163158367|NCT01588522|589291836|FG000|Overall Study|Taken off taxane-based regimen|0|||
163158368|NCT01588522|589291837|FG001|Overall Study|Taken off taxane-based regimen|0|||
163158369|NCT01588522|589291838|FG002|Overall Study|Taken off taxane-based regimen|0|||
163158370|NCT01588522|589291839|FG003|Overall Study|Taken off taxane-based regimen|1|||
163158371|NCT01588522|589291840|FG004|Overall Study|Taken off taxane-based regimen|0|||
163158372|NCT01588522|589291841|FG005|Overall Study|Taken off taxane-based regimen|0|||
163158373|NCT01588522|589291836|FG000|Overall Study|Did not initiate chemotherapy|0|||
163158374|NCT01588522|589291837|FG001|Overall Study|Did not initiate chemotherapy|0|||
163158375|NCT01588522|589291838|FG002|Overall Study|Did not initiate chemotherapy|0|||
163158376|NCT01588522|589291839|FG003|Overall Study|Did not initiate chemotherapy|0|||
163158377|NCT01588522|589291840|FG004|Overall Study|Did not initiate chemotherapy|1|||
163158378|NCT01588522|589291841|FG005|Overall Study|Did not initiate chemotherapy|0|||
163158379|NCT02855125|589291846|FG000|Overall Study|Withdrawal by Subject|2|||
163158380|NCT02855125|589291847|FG001|Overall Study|Withdrawal by Subject|2|||
163158381|NCT02855125|589291846|FG000|Overall Study|Clinical Disease Progression|5|||
163158382|NCT02855125|589291847|FG001|Overall Study|Clinical Disease Progression|4|||
163158383|NCT02855125|589291846|FG000|Overall Study|Radiologic Disease Progression|36|||
163158384|NCT02855125|589291847|FG001|Overall Study|Radiologic Disease Progression|39|||
163158385|NCT02855125|589291846|FG000|Overall Study|Adverse Event|11|||
163158386|NCT02855125|589291847|FG001|Overall Study|Adverse Event|7|||
163158387|NCT02855125|589291846|FG000|Overall Study|Physician Decision|1|||
163158388|NCT02855125|589291847|FG001|Overall Study|Physician Decision|0|||
163158389|NCT02855125|589291846|FG000|Overall Study|On Treatment|9|||
163271713|NCT02855164|589702976|FG006|Part C (Randomized Set)|Physician Decision|0|||
163271714|NCT02855164|589702977|FG007|Part C (Randomized Set)|Physician Decision|1|||
163158390|NCT02855125|589291847|FG001|Overall Study|On Treatment|11|||
163158391|NCT02855125|589291846|FG000|Overall Study|Randomized but not treated|0|||
163158392|NCT02855125|589291847|FG001|Overall Study|Randomized but not treated|1|||
163158393|NCT04467905|589291848|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
163158394|NCT04467905|589291849|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
163158395|NCT04467905|589291850|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
163158396|NCT04467905|589291848|FG000|Overall Study|Conversion to SR|0|||
163158397|NCT04467905|589291849|FG001|Overall Study|Conversion to SR|0|||
163158398|NCT04467905|589291850|FG002|Overall Study|Conversion to SR|3|||
163158399|NCT04467905|589291848|FG000|Overall Study|Technical issue with Holter ECG|0|||
163158400|NCT04467905|589291849|FG001|Overall Study|Technical issue with Holter ECG|0|||
163158401|NCT04467905|589291850|FG002|Overall Study|Technical issue with Holter ECG|3|||
163158402|NCT04467905|589291848|FG000|Overall Study|Hemodynamic instability|0|||
163158403|NCT04467905|589291849|FG001|Overall Study|Hemodynamic instability|0|||
163158404|NCT04467905|589291850|FG002|Overall Study|Hemodynamic instability|1|||
163158405|NCT04467905|589291848|FG000|Overall Study|Site misinterpretation of protocol|0|||
163158406|NCT04467905|589291849|FG001|Overall Study|Site misinterpretation of protocol|0|||
163158407|NCT04467905|589291850|FG002|Overall Study|Site misinterpretation of protocol|1|||
163158408|NCT02514083|589291855|FG000|Overall Study|Adverse Event|1|||
163158409|NCT02017405|589291856|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
163158410|NCT02017405|589291857|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
163158411|NCT02017405|589291858|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
163158412|NCT02017405|589291859|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
163158413|NCT02017405|589291860|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
163158414|NCT02017405|589291861|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
163158415|NCT02017405|589291856|FG000|Open-label Phase|Adverse Event|1|||
163158416|NCT02017405|589291857|FG001|Open-label Phase|Adverse Event|1|||
163158417|NCT02017405|589291858|FG002|Open-label Phase|Adverse Event|0|||
163158418|NCT02017405|589291859|FG003|Open-label Phase|Adverse Event|0|||
163158419|NCT02017405|589291860|FG004|Open-label Phase|Adverse Event|0|||
163158420|NCT02017405|589291861|FG005|Open-label Phase|Adverse Event|0|||
163158421|NCT02202759|589293146|FG000|Overall Study|Study Terminated by Sponsor|3|||
163158422|NCT02202759|589293147|FG001|Overall Study|Study Terminated by Sponsor|3|||
163158423|NCT02202759|589293148|FG002|Overall Study|Study Terminated by Sponsor|3|||
163158424|NCT02202759|589293146|FG000|Overall Study|Withdrawal by Subject|2|||
163158425|NCT02202759|589293147|FG001|Overall Study|Withdrawal by Subject|1|||
163158426|NCT02202759|589293148|FG002|Overall Study|Withdrawal by Subject|1|||
163158427|NCT02202759|589293146|FG000|Overall Study|Reason not Specified|4|||
163158428|NCT02202759|589293147|FG001|Overall Study|Reason not Specified|11|||
163158429|NCT02202759|589293148|FG002|Overall Study|Reason not Specified|10|||
163158430|NCT01590888|589293149|FG000|Overall Study|Adverse Event|3|||
163158431|NCT01590888|589293150|FG001|Overall Study|Adverse Event|0|||
163158432|NCT01590888|589293151|FG002|Overall Study|Adverse Event|1|||
163158433|NCT01590888|589293149|FG000|Overall Study|Lost to Follow-up|1|||
163158434|NCT01590888|589293150|FG001|Overall Study|Lost to Follow-up|0|||
163158435|NCT01590888|589293151|FG002|Overall Study|Lost to Follow-up|0|||
163158436|NCT04953728|589293152|FG000|Overall Study|Withdrawal by Subject|3|||
163158437|NCT04953728|589293152|FG000|Overall Study|Physician Decision|1|||
163158438|NCT01646125|589293153|FG000|Overall Study|Untreated|2|||
163158439|NCT01646125|589293154|FG001|Overall Study|Untreated|5|||
163158440|NCT01646125|589293153|FG000|Overall Study|Adverse Event|2|||
163158441|NCT01646125|589293154|FG001|Overall Study|Adverse Event|1|||
163158442|NCT01646125|589293153|FG000|Overall Study|Death|1|||
163158443|NCT01646125|589293154|FG001|Overall Study|Death|1|||
163158444|NCT01646125|589293153|FG000|Overall Study|Physician Decision|1|||
163158445|NCT01646125|589293154|FG001|Overall Study|Physician Decision|3|||
163158446|NCT01646125|589293153|FG000|Overall Study|Progressive disease|22|||
163158447|NCT01646125|589293154|FG001|Overall Study|Progressive disease|16|||
163158448|NCT01646125|589293153|FG000|Overall Study|Study terminated by sponsor|2|||
163158449|NCT01646125|589293154|FG001|Overall Study|Study terminated by sponsor|1|||
163158450|NCT01646125|589293153|FG000|Overall Study|Subject/Guardian decision|1|||
163158451|NCT01646125|589293154|FG001|Overall Study|Subject/Guardian decision|1|||
163158452|NCT02105662|589293155|FG000|Overall Study|Lost to Follow-up|5|||
163158453|NCT02105662|589293155|FG000|Overall Study|Withdrawal by Subject|1|||
163158454|NCT03349034|589293160|FG000|Overall Study|catheters dislodged during transport|2|||
163158455|NCT03349034|589293161|FG001|Overall Study|catheters dislodged during transport|0|||
163158456|NCT03349034|589293160|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
163158457|NCT03349034|589293161|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
163158458|NCT03349034|589293160|FG000|Overall Study|soft tissue flap used|1|||
163158459|NCT03349034|589293161|FG001|Overall Study|soft tissue flap used|0|||
163158460|NCT03349034|589293160|FG000|Overall Study|Other|0|||
163158461|NCT03349034|589293161|FG001|Overall Study|Other|1|||
163158462|NCT01759446|589293162|FG000|Overall Study|Protocol Violation|1|||
163158463|NCT01759446|589293163|FG001|Overall Study|Protocol Violation|0|||
163158464|NCT01759446|589293164|FG002|Overall Study|Protocol Violation|1|||
163158465|NCT01759446|589293165|FG003|Overall Study|Protocol Violation|0|||
163158466|NCT01759446|589293166|FG004|Overall Study|Protocol Violation|0|||
163158467|NCT01759446|589293162|FG000|Overall Study|Withdrawal by Subject|0|||
163158468|NCT01759446|589293163|FG001|Overall Study|Withdrawal by Subject|1|||
163158469|NCT01759446|589293164|FG002|Overall Study|Withdrawal by Subject|0|||
163158470|NCT01759446|589293165|FG003|Overall Study|Withdrawal by Subject|1|||
163158471|NCT01759446|589293166|FG004|Overall Study|Withdrawal by Subject|0|||
163158472|NCT01760733|589293167|FG000|Waiting List|Death|18|||
163158473|NCT01760733|589293167|FG000|Waiting List|Removed from waiting list|41|||
163158474|NCT01760733|589293167|FG000|Waiting List|Not received a transplant yet|13|||
163158475|NCT01760733|589293167|FG000|Transplanted|Not reached 10 years post transplant|184|||
163158476|NCT01760733|589293167|FG000|Transplanted|Death|26|||
163158477|NCT01760733|589293167|FG000|Transplanted|Graft loss|7|||
163158478|NCT00719472|589293170|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
163158479|NCT00719472|589293170|FG000|Enrolled in Study|Subject decision to withdraw|8|||
163158480|NCT00719472|589293170|FG000|Enrolled in Study|Various Reasons|17|||
163158481|NCT00719472|589293170|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
163158482|NCT00719472|589293170|FG000|Received Cycle 1 Treatment|Death|5|||
163158483|NCT00719472|589293170|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
163158484|NCT00719472|589293170|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
163158485|NCT00719472|589293170|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
163158486|NCT00719472|589293170|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
163158487|NCT00719472|589293170|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
163158488|NCT00719472|589293170|FG000|Received Cycle 2 Treatment|Death|6|||
163158489|NCT00719472|589293170|FG000|Received Cycle 2 Treatment|Disease progression|3|||
163158490|NCT00719472|589293170|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
163158491|NCT00719472|589293170|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
163158492|NCT00719472|589293170|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
163158493|NCT00719472|589293170|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
163158494|NCT00815659|589293171|FG000|Overall Study|Adverse Event|9|||
163158495|NCT00815659|589293171|FG000|Overall Study|Withdrawal by Subject|9|||
163158496|NCT00815659|589293171|FG000|Overall Study|Lost to Follow-up|4|||
163158497|NCT00815659|589293171|FG000|Overall Study|Protocol Violation|1|||
163158498|NCT03584789|589293175|FG000|Overall Study|refused EHR permission|19|||
163158499|NCT03584789|589293176|FG001|Overall Study|refused EHR permission|28|||
163158500|NCT03584789|589293177|FG002|Overall Study|refused EHR permission|23|||
163158501|NCT03584789|589293175|FG000|Overall Study|patients tied to a provider who retired|0|||
163158502|NCT03584789|589293176|FG001|Overall Study|patients tied to a provider who retired|0|||
163158503|NCT03584789|589293177|FG002|Overall Study|patients tied to a provider who retired|3|||
163158504|NCT04646044|589293179|FG000|Overall Study|Lost to Follow-up|0|||
163158505|NCT04646044|589293180|FG001|Overall Study|Lost to Follow-up|0|||
163158506|NCT04646044|589293181|FG002|Overall Study|Lost to Follow-up|1|||
163158507|NCT04646044|589293182|FG003|Overall Study|Lost to Follow-up|0|||
163158508|NCT04646044|589293179|FG000|Overall Study|Withdrawal by Subject|0|||
163158509|NCT04646044|589293180|FG001|Overall Study|Withdrawal by Subject|1|||
163158510|NCT04646044|589293181|FG002|Overall Study|Withdrawal by Subject|0|||
163158511|NCT04646044|589293182|FG003|Overall Study|Withdrawal by Subject|0|||
163158512|NCT00602472|589293183|FG000|Overall Study|Adverse Event|5|||
163158513|NCT00602472|589293184|FG001|Overall Study|Adverse Event|23|||
163158514|NCT00602472|589293183|FG000|Overall Study|Protocol Violation|4|||
163158515|NCT00602472|589293184|FG001|Overall Study|Protocol Violation|19|||
163158516|NCT00602472|589293183|FG000|Overall Study|Withdrawal by Subject|8|||
163158517|NCT00602472|589293184|FG001|Overall Study|Withdrawal by Subject|14|||
163158518|NCT00602472|589293183|FG000|Overall Study|Other incl. lack of efficacy|4|||
163158519|NCT00602472|589293184|FG001|Overall Study|Other incl. lack of efficacy|2|||
163158520|NCT01908803|589293185|FG000|Overall Study|Adverse Event|1|||
163158521|NCT01908803|589293186|FG001|Overall Study|Adverse Event|0|||
163158522|NCT01908803|589293185|FG000|Overall Study|Physician Decision|0|||
163271715|NCT02855164|589702970|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
163271716|NCT02855164|589702971|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
163271717|NCT02855164|589702972|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
163271718|NCT02855164|589702973|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
163271719|NCT02855164|589702974|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
163271720|NCT02855164|589702975|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
163271721|NCT02855164|589702976|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
163271722|NCT02855164|589702977|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
163271723|NCT00383240|589702978|FG000|Overall Study|Adverse Event|4|||
163271724|NCT00383240|589702979|FG001|Overall Study|Adverse Event|6|||
163271725|NCT00383240|589702980|FG002|Overall Study|Adverse Event|9|||
163271726|NCT00383240|589702981|FG003|Overall Study|Adverse Event|7|||
163271727|NCT00383240|589702978|FG000|Overall Study|Treatment Failure|8|||
163271728|NCT00383240|589702979|FG001|Overall Study|Treatment Failure|13|||
163271729|NCT00383240|589702980|FG002|Overall Study|Treatment Failure|47|||
163271730|NCT00383240|589702981|FG003|Overall Study|Treatment Failure|46|||
163271731|NCT00383240|589702978|FG000|Overall Study|Lost to Follow-up|3|||
163158523|NCT01908803|589293186|FG001|Overall Study|Physician Decision|1|||
163158524|NCT01908803|589293185|FG000|Overall Study|Withdrawal by Subject|1|||
163158525|NCT01908803|589293186|FG001|Overall Study|Withdrawal by Subject|0|||
163158526|NCT01908803|589293185|FG000|Overall Study|Randomization Error|1|||
163158527|NCT01908803|589293186|FG001|Overall Study|Randomization Error|0|||
163158528|NCT01908803|589293185|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
163158529|NCT01908803|589293186|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
163158530|NCT00742235|589293187|FG000|Overall Study|Lost to Follow-up|0|||
163158531|NCT00742235|589293188|FG001|Overall Study|Lost to Follow-up|31|||
163271732|NCT00383240|589702979|FG001|Overall Study|Lost to Follow-up|0|||
163158532|NCT04730271|589293190|FG000|Overall Study|Adverse Event|0|||
163158533|NCT04730271|589293191|FG001|Overall Study|Adverse Event|2|||
163158534|NCT04730271|589293190|FG000|Overall Study|Withdrawal by Subject|1|||
163158535|NCT04730271|589293191|FG001|Overall Study|Withdrawal by Subject|1|||
163158536|NCT04730271|589293190|FG000|Overall Study|Protocol Violation|7|||
163271733|NCT00383240|589702980|FG002|Overall Study|Lost to Follow-up|0|||
163271734|NCT00383240|589702981|FG003|Overall Study|Lost to Follow-up|2|||
163271735|NCT00383240|589702978|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
163271736|NCT00383240|589702979|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
163271737|NCT00383240|589702980|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
163271738|NCT00383240|589702981|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
163271739|NCT00383240|589702978|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
163271740|NCT00383240|589702979|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
163271741|NCT00383240|589702980|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
163271742|NCT00383240|589702981|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
163271743|NCT00383240|589702978|FG000|Overall Study|Protocol Violation|4|||
163271744|NCT00383240|589702979|FG001|Overall Study|Protocol Violation|5|||
163271745|NCT00383240|589702980|FG002|Overall Study|Protocol Violation|9|||
163271746|NCT00383240|589702981|FG003|Overall Study|Protocol Violation|6|||
163271747|NCT00383240|589702978|FG000|Overall Study|Did not meet protocol eligibility|9|||
163271748|NCT00383240|589702979|FG001|Overall Study|Did not meet protocol eligibility|4|||
163271749|NCT00383240|589702980|FG002|Overall Study|Did not meet protocol eligibility|9|||
163271750|NCT00383240|589702981|FG003|Overall Study|Did not meet protocol eligibility|3|||
163271751|NCT00383240|589702978|FG000|Overall Study|Administrative|1|||
163271752|NCT00383240|589702979|FG001|Overall Study|Administrative|1|||
163271753|NCT00383240|589702980|FG002|Overall Study|Administrative|0|||
163271754|NCT00383240|589702981|FG003|Overall Study|Administrative|0|||
163271755|NCT02049710|589702982|FG000|Overall Study|Lost to Follow-up|319|||
163271756|NCT02049710|589702983|FG001|Overall Study|Lost to Follow-up|324|||
163271757|NCT06385483|589702987|FG000|Overall Study|Withdrawal by Subject|2|||
163271758|NCT06385483|589702987|FG000|Overall Study|Never start protocol therapy|2|||
163271759|NCT06385483|589702987|FG000|Overall Study|Disease progression|15|||
163271760|NCT01216293|589702988|FG000|Main Study|Adverse Event|1|||
163271761|NCT01216293|589702989|FG001|Main Study|Adverse Event|4|||
163158537|NCT04730271|589293191|FG001|Overall Study|Protocol Violation|13|||
163158538|NCT04730271|589293190|FG000|Overall Study|Lost to Follow-up|3|||
163158539|NCT04730271|589293191|FG001|Overall Study|Lost to Follow-up|3|||
163158540|NCT04730271|589293190|FG000|Overall Study|Death|1|||
163158541|NCT04730271|589293191|FG001|Overall Study|Death|0|||
163158542|NCT00998296|589293192|FG000|Overall Study|Progressive disease|0|||
163158543|NCT00998296|589293193|FG001|Overall Study|Progressive disease|1|||
163158544|NCT00998296|589293194|FG002|Overall Study|Progressive disease|0|||
163158545|NCT00998296|589293195|FG003|Overall Study|Progressive disease|0|||
163158546|NCT00998296|589293196|FG004|Overall Study|Progressive disease|0|||
163158547|NCT00998296|589293197|FG005|Overall Study|Progressive disease|0|||
163158548|NCT00998296|589293198|FG006|Overall Study|Progressive disease|1|||
163158549|NCT00998296|589293199|FG007|Overall Study|Progressive disease|0|||
163158550|NCT00998296|589293200|FG008|Overall Study|Progressive disease|0|||
163158551|NCT00998296|589293201|FG009|Overall Study|Progressive disease|14|||
163158552|NCT00998296|589293202|FG010|Overall Study|Progressive disease|5|||
163158553|NCT00998296|589293192|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158554|NCT00998296|589293193|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158555|NCT00998296|589293194|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158556|NCT00998296|589293195|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158557|NCT00998296|589293196|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
163158558|NCT00998296|589293197|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158559|NCT00998296|589293198|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158560|NCT00998296|589293199|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
163158561|NCT00998296|589293200|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
163158562|NCT00998296|589293201|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158563|NCT00998296|589293202|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158564|NCT00998296|589293192|FG000|Overall Study|Other adverse event|0|||
163158565|NCT00998296|589293193|FG001|Overall Study|Other adverse event|0|||
163271762|NCT01216293|589702990|FG002|Main Study|Adverse Event|2|||
163271763|NCT01216293|589702988|FG000|Main Study|Major Protocol Deviation|1|||
163271764|NCT01216293|589702989|FG001|Main Study|Major Protocol Deviation|0|||
163271765|NCT01216293|589702990|FG002|Main Study|Major Protocol Deviation|1|||
163158566|NCT00998296|589293194|FG002|Overall Study|Other adverse event|0|||
163158567|NCT00998296|589293195|FG003|Overall Study|Other adverse event|0|||
163158568|NCT00998296|589293196|FG004|Overall Study|Other adverse event|1|||
163158569|NCT00998296|589293197|FG005|Overall Study|Other adverse event|0|||
163158570|NCT00998296|589293198|FG006|Overall Study|Other adverse event|0|||
163271766|NCT01216293|589702988|FG000|Main Study|Lost to Follow-up|3|||
163271767|NCT01216293|589702989|FG001|Main Study|Lost to Follow-up|1|||
163271768|NCT01216293|589702990|FG002|Main Study|Lost to Follow-up|0|||
163271769|NCT01216293|589702988|FG000|Main Study|Voluntary Withdrawal|2|||
163271770|NCT01216293|589702989|FG001|Main Study|Voluntary Withdrawal|2|||
163271771|NCT01216293|589702990|FG002|Main Study|Voluntary Withdrawal|2|||
163271772|NCT01216293|589702988|FG000|Main Study|Other Reason Not Specified|0|||
163271773|NCT01216293|589702989|FG001|Main Study|Other Reason Not Specified|1|||
163271774|NCT01216293|589702990|FG002|Main Study|Other Reason Not Specified|1|||
163271775|NCT01216293|589702988|FG000|Main Study|Randomized, Not Treated|1|||
163271776|NCT01216293|589702989|FG001|Main Study|Randomized, Not Treated|0|||
163271777|NCT01216293|589702990|FG002|Main Study|Randomized, Not Treated|0|||
163271778|NCT01216293|589702988|FG000|Calcium Absorption Substudy|Adverse Event|0|||
163271779|NCT01216293|589702989|FG001|Calcium Absorption Substudy|Adverse Event|2|||
163271780|NCT01216293|589702990|FG002|Calcium Absorption Substudy|Adverse Event|0|||
163271781|NCT01216293|589702988|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
163271782|NCT01216293|589702989|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
163271783|NCT01216293|589702990|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
163271784|NCT01216293|589702988|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
163271785|NCT01216293|589702989|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
163271786|NCT01216293|589702990|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
163271787|NCT01040780|589704973|FG000|Overall Study|Protocol Violation|1|||
163271788|NCT01040780|589704974|FG001|Overall Study|Protocol Violation|3|||
163271789|NCT03681639|589704975|FG000|Overall Study|Death|4|||
163271790|NCT03681639|589704975|FG000|Overall Study|Lost to Follow-up|2|||
163271791|NCT03681639|589704975|FG000|Overall Study|Withdrawal by Subject|1|||
163271792|NCT03681639|589704975|FG000|Overall Study|Adverse Event|2|||
163271793|NCT00654940|589704976|FG000|Period 1|Adverse Event|0|||
163271794|NCT00654940|589704977|FG001|Period 1|Adverse Event|1|||
163271795|NCT00654940|589704976|FG000|Period 1|Intolerable Pain Level|1|||
163271796|NCT00654940|589704977|FG001|Period 1|Intolerable Pain Level|0|||
163271797|NCT01818141|589704978|FG000|Overall Study|Withdrawal by Subject|2|||
163271798|NCT01818141|589704979|FG001|Overall Study|Withdrawal by Subject|0|||
163271799|NCT01818141|589704978|FG000|Overall Study|No baseline C.diff colonies|1|||
163271800|NCT01818141|589704979|FG001|Overall Study|No baseline C.diff colonies|1|||
163271801|NCT01818141|589704978|FG000|Overall Study|Lost to Follow-up|0|||
163158571|NCT00998296|589293199|FG007|Overall Study|Other adverse event|0|||
163271802|NCT01818141|589704979|FG001|Overall Study|Lost to Follow-up|2|||
163271803|NCT02169830|589704983|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
163271804|NCT02169830|589704984|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
163271805|NCT02169830|589704985|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
163271806|NCT02169830|589704983|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
163271807|NCT02169830|589704984|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
163271808|NCT02169830|589704985|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
163271809|NCT02169830|589704983|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
163271810|NCT02169830|589704984|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
163271811|NCT02169830|589704985|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
163271812|NCT02169830|589704983|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
163271813|NCT02169830|589704984|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
163158572|NCT00998296|589293200|FG008|Overall Study|Other adverse event|0|||
163158573|NCT00998296|589293201|FG009|Overall Study|Other adverse event|1|||
163158574|NCT00998296|589293202|FG010|Overall Study|Other adverse event|2|||
163158575|NCT00998296|589293192|FG000|Overall Study|Refused to continue taking trial med.|0|||
163158576|NCT00998296|589293193|FG001|Overall Study|Refused to continue taking trial med.|0|||
163158577|NCT00998296|589293194|FG002|Overall Study|Refused to continue taking trial med.|0|||
163158578|NCT00998296|589293195|FG003|Overall Study|Refused to continue taking trial med.|0|||
163158579|NCT00998296|589293196|FG004|Overall Study|Refused to continue taking trial med.|0|||
163158580|NCT00998296|589293197|FG005|Overall Study|Refused to continue taking trial med.|0|||
163158581|NCT00998296|589293198|FG006|Overall Study|Refused to continue taking trial med.|0|||
163158582|NCT00998296|589293199|FG007|Overall Study|Refused to continue taking trial med.|0|||
163158583|NCT00998296|589293200|FG008|Overall Study|Refused to continue taking trial med.|0|||
163158584|NCT00998296|589293201|FG009|Overall Study|Refused to continue taking trial med.|2|||
163158585|NCT00998296|589293202|FG010|Overall Study|Refused to continue taking trial med.|0|||
163158586|NCT00998296|589293192|FG000|Overall Study|Reason other than those specified above|0|||
163158587|NCT00998296|589293193|FG001|Overall Study|Reason other than those specified above|0|||
163158588|NCT00998296|589293194|FG002|Overall Study|Reason other than those specified above|0|||
163158589|NCT00998296|589293195|FG003|Overall Study|Reason other than those specified above|0|||
163158590|NCT00998296|589293196|FG004|Overall Study|Reason other than those specified above|0|||
163158591|NCT00998296|589293197|FG005|Overall Study|Reason other than those specified above|0|||
163158592|NCT00998296|589293198|FG006|Overall Study|Reason other than those specified above|0|||
163158593|NCT00998296|589293199|FG007|Overall Study|Reason other than those specified above|0|||
163271814|NCT02169830|589704985|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
163271815|NCT02169830|589704983|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
163271816|NCT02169830|589704984|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
163271817|NCT02169830|589704985|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
163158594|NCT00998296|589293200|FG008|Overall Study|Reason other than those specified above|0|||
163158595|NCT00998296|589293201|FG009|Overall Study|Reason other than those specified above|1|||
163158596|NCT00998296|589293202|FG010|Overall Study|Reason other than those specified above|0|||
163158597|NCT02346721|589293203|FG000|Overall Study|Withdrew Consent|3|||
163158598|NCT02346721|589293203|FG000|Overall Study|Lack of Efficacy|1|||
163158599|NCT04396639|589293206|FG000|Overall Study|Withdrawal by Subject|1|||
163158600|NCT04396639|589293206|FG000|Overall Study|Other|1|||
163158601|NCT01544335|589293207|FG000|Overall Study|Lost to Follow-up|27|||
163158602|NCT01544335|589293207|FG000|Overall Study|Death|4|||
163158603|NCT01544335|589293207|FG000|Overall Study|Disease progression|3|||
163158604|NCT01544335|589293207|FG000|Overall Study|Baseline Measurements not Available|19|||
163158605|NCT02488915|589293213|FG000|Overall Study|Death|21|||
163158606|NCT02488915|589293213|FG000|Overall Study|Lost to Follow-up|4|||
163158607|NCT02488915|589293213|FG000|Overall Study|Withdrawal by Subject|1|||
163158608|NCT01532986|589293214|FG000|Overall Study|Death|9|||
163158609|NCT01532986|589293215|FG001|Overall Study|Death|9|||
163158610|NCT01532986|589293214|FG000|Overall Study|Withdrawal by Subject|7|||
163158611|NCT01532986|589293215|FG001|Overall Study|Withdrawal by Subject|10|||
163158612|NCT01532986|589293214|FG000|Overall Study|Physician Decision|7|||
163158613|NCT01532986|589293215|FG001|Overall Study|Physician Decision|5|||
163158614|NCT00885170|589293220|FG000|Overall Study|Adverse Event|12|||
163158615|NCT00885170|589293221|FG001|Overall Study|Adverse Event|4|||
163158616|NCT00885170|589293220|FG000|Overall Study|Excessive bone loss|6|||
163158617|NCT00885170|589293221|FG001|Overall Study|Excessive bone loss|3|||
163158618|NCT00885170|589293220|FG000|Overall Study|Lost to Follow-up|2|||
163158619|NCT00885170|589293221|FG001|Overall Study|Lost to Follow-up|1|||
163158620|NCT00885170|589293220|FG000|Overall Study|Physician Decision|2|||
163158621|NCT00885170|589293221|FG001|Overall Study|Physician Decision|1|||
163158622|NCT00885170|589293220|FG000|Overall Study|Protocol Violation|3|||
163158623|NCT00885170|589293221|FG001|Overall Study|Protocol Violation|1|||
163158624|NCT00885170|589293220|FG000|Overall Study|Withdrawal by Subject|13|||
163158625|NCT00885170|589293221|FG001|Overall Study|Withdrawal by Subject|13|||
163158626|NCT03771664|589293222|FG000|Overall Study|Adverse Event|1|||
163158627|NCT03771664|589293223|FG001|Overall Study|Adverse Event|0|||
163158628|NCT03771664|589293222|FG000|Overall Study|Lost to Follow-up|1|||
163158629|NCT03771664|589293223|FG001|Overall Study|Lost to Follow-up|0|||
163158630|NCT03771664|589293222|FG000|Overall Study|Withdrawal by Participant|1|||
163158631|NCT03771664|589293223|FG001|Overall Study|Withdrawal by Participant|4|||
163158632|NCT03771664|589293222|FG000|Overall Study|Randomized but not Treated|0|||
163158633|NCT03771664|589293223|FG001|Overall Study|Randomized but not Treated|1|||
163158634|NCT02120898|589293224|FG000|Overall Study|Withdrawal by Subject|4|||
163158635|NCT02120898|589293225|FG001|Overall Study|Withdrawal by Subject|2|||
163158636|NCT02120898|589293226|FG002|Overall Study|Withdrawal by Subject|2|||
163158637|NCT02120898|589293224|FG000|Overall Study|Non-compliance with study drug|3|||
163158638|NCT02120898|589293225|FG001|Overall Study|Non-compliance with study drug|0|||
163158639|NCT02120898|589293226|FG002|Overall Study|Non-compliance with study drug|0|||
163158640|NCT02120898|589293224|FG000|Overall Study|Adverse Event|1|||
163158641|NCT02120898|589293225|FG001|Overall Study|Adverse Event|2|||
163158642|NCT02120898|589293226|FG002|Overall Study|Adverse Event|1|||
163158643|NCT02120898|589293224|FG000|Overall Study|Protocol Violation|1|||
163158644|NCT02120898|589293225|FG001|Overall Study|Protocol Violation|2|||
163158645|NCT02120898|589293226|FG002|Overall Study|Protocol Violation|0|||
163158646|NCT02120898|589293224|FG000|Overall Study|Lost to Follow-up|0|||
163158647|NCT02120898|589293225|FG001|Overall Study|Lost to Follow-up|0|||
163158648|NCT02120898|589293226|FG002|Overall Study|Lost to Follow-up|1|||
163158649|NCT00561925|589293227|FG000|14 Day Lead-In Period|Adverse Event|38|||
163158650|NCT00561925|589293228|FG001|14 Day Lead-In Period|Adverse Event|0|||
163158651|NCT00561925|589293229|FG002|14 Day Lead-In Period|Adverse Event|0|||
163158652|NCT00561925|589293230|FG003|14 Day Lead-In Period|Adverse Event|0|||
163158653|NCT00561925|589293231|FG004|14 Day Lead-In Period|Adverse Event|0|||
163158654|NCT00561925|589293227|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
163158655|NCT00561925|589293228|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
163158656|NCT00561925|589293229|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
163158657|NCT00561925|589293230|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
163158658|NCT00561925|589293231|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
163158659|NCT00561925|589293227|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
163158660|NCT00561925|589293228|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
163158661|NCT00561925|589293229|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
163158662|NCT00561925|589293230|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
163158663|NCT00561925|589293231|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
163158664|NCT00561925|589293227|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
163158665|NCT00561925|589293228|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
163158666|NCT00561925|589293229|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
163158667|NCT00561925|589293230|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
163158668|NCT00561925|589293231|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
163158669|NCT00561925|589293227|FG000|14 Day Lead-In Period|Other|5|||
163158670|NCT00561925|589293228|FG001|14 Day Lead-In Period|Other|0|||
163158671|NCT00561925|589293229|FG002|14 Day Lead-In Period|Other|0|||
163158672|NCT00561925|589293230|FG003|14 Day Lead-In Period|Other|0|||
163158673|NCT00561925|589293231|FG004|14 Day Lead-In Period|Other|0|||
163158674|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
163158675|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
163158676|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
163158677|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
163158678|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
163158679|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
163158680|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
163158681|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
163158682|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
163158683|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
163158684|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
163158685|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
163158686|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
163158687|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
163158688|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
163158689|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
163158690|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
163158691|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
163158692|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
163158693|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
163158694|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
163158695|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
163158696|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
163158697|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
163158698|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
163158699|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
163158700|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
163158701|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
163158702|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
163158703|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
163158704|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Death|0|||
163158705|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Death|6|||
163158706|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Death|3|||
163158707|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Death|0|||
163158708|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Death|0|||
163158709|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
163158710|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
163158711|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
163158712|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
163158713|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
163158714|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Other|0|||
163158715|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Other|8|||
163158716|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Other|11|||
163158717|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Other|0|||
163158718|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Other|0|||
163158719|NCT00561925|589293227|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
163158720|NCT00561925|589293228|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
163158721|NCT00561925|589293229|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
163158722|NCT00561925|589293230|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
163158723|NCT00561925|589293231|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
163158724|NCT00684021|589293234|FG000|Overall Study|MRI Contraindicated|1|||
163158725|NCT00684021|589293235|FG001|Overall Study|MRI Contraindicated|1|||
163158726|NCT00684021|589293236|FG002|Overall Study|MRI Contraindicated|1|||
163158727|NCT00684021|589293237|FG003|Overall Study|MRI Contraindicated|0|||
163158728|NCT00684021|589293234|FG000|Overall Study|MRI not performed|0|||
163158729|NCT00684021|589293235|FG001|Overall Study|MRI not performed|1|||
163158730|NCT00684021|589293236|FG002|Overall Study|MRI not performed|1|||
163158731|NCT00684021|589293237|FG003|Overall Study|MRI not performed|2|||
163158732|NCT00684021|589293234|FG000|Overall Study|Death|1|||
163158733|NCT00684021|589293235|FG001|Overall Study|Death|0|||
163158734|NCT00684021|589293236|FG002|Overall Study|Death|0|||
163158735|NCT00684021|589293237|FG003|Overall Study|Death|0|||
163158736|NCT01046396|589293238|FG000|Overall Study|Withdrawal by Subject|5|||
163158737|NCT02161016|589293242|FG000|Overall Study|withdrawn by IRB|1|||
163158738|NCT02556177|589293246|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
163158739|NCT02556177|589293247|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
163158740|NCT03818321|589293250|FG000|Overall Study|Withdrawal by Subject|1|||
163158741|NCT03818321|589293251|FG001|Overall Study|Withdrawal by Subject|2|||
163158742|NCT00275509|589293252|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
163158743|NCT00275509|589293253|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
163158744|NCT00380367|589293255|FG000|Overall Study|Lost to Follow-up|1|||
163158745|NCT00380367|589293255|FG000|Overall Study|Withdrawal by Subject|1|||
163158746|NCT01605799|589293256|FG000|Overall Study|Withdrawal by Subject|2|||
163158747|NCT01605799|589293257|FG001|Overall Study|Withdrawal by Subject|1|||
163158748|NCT01457703|589293261|FG000|Overall Study|Screen Failure|5|||
163158749|NCT01457703|589293262|FG001|Overall Study|Screen Failure|7|||
163158750|NCT01457703|589293261|FG000|Overall Study|Withdrawal by Subject|1|||
163158751|NCT01457703|589293262|FG001|Overall Study|Withdrawal by Subject|4|||
163158752|NCT01658436|589293263|FG000|Overall Study|Adverse Event|6|||
163158753|NCT01658436|589293264|FG001|Overall Study|Adverse Event|5|||
163158754|NCT01658436|589293263|FG000|Overall Study|Physician Decision|1|||
163158755|NCT01658436|589293264|FG001|Overall Study|Physician Decision|0|||
163158756|NCT01658436|589293263|FG000|Overall Study|Progressive disease|12|||
163158757|NCT01658436|589293264|FG001|Overall Study|Progressive disease|4|||
163158758|NCT01658436|589293263|FG000|Overall Study|Study terminated by sponsor|0|||
163158759|NCT01658436|589293264|FG001|Overall Study|Study terminated by sponsor|1|||
163158760|NCT01658436|589293263|FG000|Overall Study|Subject/guardian decision|0|||
163158761|NCT01658436|589293264|FG001|Overall Study|Subject/guardian decision|1|||
163158762|NCT01658436|589293263|FG000|Overall Study|Death|1|||
163158763|NCT01658436|589293264|FG001|Overall Study|Death|0|||
163158764|NCT00926237|589293267|FG000|Overall Study|Withdrawal by Subject|2|||
163158765|NCT00926237|589293268|FG001|Overall Study|Withdrawal by Subject|1|||
163158766|NCT00432172|589293273|FG000|Overall Study|Physician Decision|0|||
163158767|NCT00432172|589293274|FG001|Overall Study|Physician Decision|0|||
163158768|NCT00432172|589293275|FG002|Overall Study|Physician Decision|2|||
163158769|NCT00432172|589293276|FG003|Overall Study|Physician Decision|0|||
163271818|NCT03204695|589704986|FG000|Overall Study|Death|1|||
163271819|NCT03204695|589704986|FG000|Overall Study|Participant was treated with another device|1|||
163271820|NCT03204695|589704986|FG000|Overall Study|Physician Decision|2|||
163271821|NCT04781647|589704990|FG000|Overall Study|Study terminated by Sponsor|11|||
163271822|NCT04781647|589704991|FG001|Overall Study|Study terminated by Sponsor|9|||
163271823|NCT04781647|589704992|FG002|Overall Study|Study terminated by Sponsor|9|||
163271824|NCT04781647|589704990|FG000|Overall Study|Withdrawal by Subject|1|||
163271825|NCT04781647|589704991|FG001|Overall Study|Withdrawal by Subject|2|||
163271826|NCT04781647|589704992|FG002|Overall Study|Withdrawal by Subject|0|||
163271827|NCT04781647|589704990|FG000|Overall Study|Adverse Event|0|||
163271828|NCT04781647|589704991|FG001|Overall Study|Adverse Event|1|||
163271829|NCT04781647|589704992|FG002|Overall Study|Adverse Event|1|||
163271830|NCT04781647|589704990|FG000|Overall Study|Protocol Violation|1|||
163271831|NCT04781647|589704991|FG001|Overall Study|Protocol Violation|0|||
163271832|NCT04781647|589704992|FG002|Overall Study|Protocol Violation|0|||
163271833|NCT04781647|589704990|FG000|Overall Study|Pregnancy|0|||
163271834|NCT04781647|589704991|FG001|Overall Study|Pregnancy|0|||
163271835|NCT04781647|589704992|FG002|Overall Study|Pregnancy|1|||
163271836|NCT04781647|589704990|FG000|Overall Study|Virology rebounded|1|||
163271837|NCT04781647|589704991|FG001|Overall Study|Virology rebounded|0|||
163271838|NCT04781647|589704992|FG002|Overall Study|Virology rebounded|0|||
163271839|NCT00777803|589704993|FG000|Overall Study|Lost to Follow-up|12|||
163271840|NCT00777803|589704994|FG001|Overall Study|Lost to Follow-up|5|||
163271841|NCT00777803|589704993|FG000|Overall Study|Adverse Event|1|||
163271842|NCT00777803|589704994|FG001|Overall Study|Adverse Event|0|||
163271843|NCT00777803|589704993|FG000|Overall Study|Non-compliance|2|||
163271844|NCT00777803|589704994|FG001|Overall Study|Non-compliance|2|||
163271845|NCT01755689|589704995|FG000|Overall Study|Withdrawal by Subject|1|||
163271846|NCT01755689|589704996|FG001|Overall Study|Withdrawal by Subject|3|||
163271847|NCT01755689|589704997|FG002|Overall Study|Withdrawal by Subject|2|||
163271848|NCT01755689|589704998|FG003|Overall Study|Withdrawal by Subject|1|||
163271849|NCT01755689|589704999|FG004|Overall Study|Withdrawal by Subject|1|||
163271850|NCT01755689|589704995|FG000|Overall Study|Migrated/moved from study area|0|||
163271851|NCT01755689|589704996|FG001|Overall Study|Migrated/moved from study area|1|||
163271852|NCT01755689|589704997|FG002|Overall Study|Migrated/moved from study area|1|||
163271853|NCT01755689|589704998|FG003|Overall Study|Migrated/moved from study area|1|||
163158770|NCT00432172|589293273|FG000|Overall Study|Adverse Event|4|||
163158771|NCT00432172|589293274|FG001|Overall Study|Adverse Event|2|||
163158772|NCT00432172|589293275|FG002|Overall Study|Adverse Event|4|||
163158773|NCT00432172|589293276|FG003|Overall Study|Adverse Event|3|||
163158774|NCT00432172|589293273|FG000|Overall Study|Disease progression|0|||
163271854|NCT01755689|589704999|FG004|Overall Study|Migrated/moved from study area|1|||
163271855|NCT01755689|589704995|FG000|Overall Study|Lost to Follow-up|1|||
163271856|NCT01755689|589704996|FG001|Overall Study|Lost to Follow-up|0|||
163385765|NCT00146328|590123240|FG001|Overall Study|Withdrawal by Subject|16|||
163158775|NCT00432172|589293274|FG001|Overall Study|Disease progression|2|||
163158776|NCT00432172|589293275|FG002|Overall Study|Disease progression|5|||
163271857|NCT01755689|589704997|FG002|Overall Study|Lost to Follow-up|1|||
163271858|NCT01755689|589704998|FG003|Overall Study|Lost to Follow-up|0|||
163158777|NCT00432172|589293276|FG003|Overall Study|Disease progression|1|||
163158778|NCT00432172|589293273|FG000|Overall Study|Withdrawal by Subject|0|||
163158779|NCT00432172|589293274|FG001|Overall Study|Withdrawal by Subject|1|||
163158780|NCT00432172|589293275|FG002|Overall Study|Withdrawal by Subject|0|||
163158781|NCT00432172|589293276|FG003|Overall Study|Withdrawal by Subject|2|||
163158782|NCT00432172|589293273|FG000|Overall Study|No treatment received|2|||
163158783|NCT00432172|589293274|FG001|Overall Study|No treatment received|2|||
163158784|NCT00432172|589293275|FG002|Overall Study|No treatment received|0|||
163158785|NCT00432172|589293276|FG003|Overall Study|No treatment received|1|||
163158786|NCT02331277|589294862|FG000|Overall Study|Withdrawal by Subject|1|||
163158787|NCT02331277|589294863|FG001|Overall Study|Withdrawal by Subject|0|||
163158788|NCT01071798|589294865|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
163158789|NCT01071798|589294865|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
163158790|NCT01071798|589294865|FG000|Participants Who Received One Cycle|Patient requirement|20|||
163158791|NCT01071798|589294865|FG000|Participants Who Received One Cycle|Death|5|||
163158792|NCT01071798|589294865|FG000|Participants Who Received One Cycle|Change of therapy|6|||
163158793|NCT01071798|589294865|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
163158794|NCT01071798|589294865|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
163158795|NCT01071798|589294865|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
163158796|NCT01071798|589294865|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
163158797|NCT01071798|589294865|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
163158798|NCT04050202|589294872|FG000|Overall Study|Lost to Follow-up|2|||
163158799|NCT01411891|589294879|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
163158800|NCT01411891|589294880|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
163158801|NCT01075685|589294881|FG000|Overall Study|Protocol Violation|9|||
163158802|NCT01075685|589294882|FG001|Overall Study|Protocol Violation|1|||
163158803|NCT01075685|589294881|FG000|Overall Study|Withdrawal by Subject|20|||
163158804|NCT01075685|589294882|FG001|Overall Study|Withdrawal by Subject|5|||
163158805|NCT01075685|589294881|FG000|Overall Study|Lost to Follow-up|563|||
163158806|NCT01075685|589294882|FG001|Overall Study|Lost to Follow-up|220|||
163158807|NCT03196349|589294885|FG000|Overall Study|Did not receive study drug|0|||
163158808|NCT03196349|589294886|FG001|Overall Study|Did not receive study drug|1|||
163158809|NCT03196349|589294887|FG002|Overall Study|Did not receive study drug|2|||
163158810|NCT03196349|589294885|FG000|Overall Study|No data entered|2|||
163158811|NCT03196349|589294886|FG001|Overall Study|No data entered|4|||
163158812|NCT03196349|589294887|FG002|Overall Study|No data entered|0|||
163158813|NCT03196349|589294885|FG000|Overall Study|Study Terminated early|15|||
163158814|NCT03196349|589294886|FG001|Overall Study|Study Terminated early|9|||
163158815|NCT03196349|589294887|FG002|Overall Study|Study Terminated early|11|||
163158816|NCT03388164|589294892|FG000|Overall Study|Withdrawal by Subject|3|||
163158817|NCT03388164|589294893|FG001|Overall Study|Withdrawal by Subject|1|||
163158818|NCT00499083|589294896|FG000|Overall Study|Not evaluable|3|||
163158819|NCT00477386|589294897|FG000|Overall Study|Adverse Event|4|||
163158820|NCT00477386|589294898|FG001|Overall Study|Adverse Event|8|||
163158821|NCT00477386|589294897|FG000|Overall Study|Disease progression, relapse|3|||
163158822|NCT00477386|589294898|FG001|Overall Study|Disease progression, relapse|4|||
163158823|NCT00477386|589294897|FG000|Overall Study|Disease progression, refractory|1|||
163158824|NCT00477386|589294898|FG001|Overall Study|Disease progression, refractory|3|||
163158825|NCT00477386|589294897|FG000|Overall Study|Other|1|||
163158826|NCT00477386|589294898|FG001|Overall Study|Other|2|||
163158827|NCT00477386|589294897|FG000|Overall Study|Physician Decision|1|||
163158828|NCT00477386|589294898|FG001|Overall Study|Physician Decision|0|||
163158829|NCT00477386|589294897|FG000|Overall Study|Withdrawal by Subject|1|||
163158830|NCT00477386|589294898|FG001|Overall Study|Withdrawal by Subject|0|||
163158831|NCT01254422|589294899|FG000|Overall Study|Protocol Violation|1|||
163158832|NCT01254422|589294900|FG001|Overall Study|Protocol Violation|0|||
163158833|NCT01254422|589294899|FG000|Overall Study|Adverse Event|1|||
163158834|NCT01254422|589294900|FG001|Overall Study|Adverse Event|0|||
163158835|NCT01254422|589294899|FG000|Overall Study|Serious adverse event|0|||
163158836|NCT01254422|589294900|FG001|Overall Study|Serious adverse event|1|||
163158837|NCT01254422|589294899|FG000|Overall Study|Lost to Follow-up|1|||
163158838|NCT01254422|589294900|FG001|Overall Study|Lost to Follow-up|0|||
163271859|NCT01755689|589704999|FG004|Overall Study|Lost to Follow-up|2|||
163271860|NCT01755689|589704995|FG000|Overall Study|Pregnancy|1|||
163158839|NCT00643162|589294901|FG000|Overall Study|Withdrawal by Subject|1|||
163271861|NCT01755689|589704996|FG001|Overall Study|Pregnancy|1|||
163271862|NCT01755689|589704997|FG002|Overall Study|Pregnancy|2|||
163158840|NCT00643162|589294902|FG001|Overall Study|Withdrawal by Subject|1|||
163158841|NCT01812252|589294909|FG000|Overall Study|Persistent Disease|1|||
163158842|NCT01812252|589294910|FG001|Overall Study|Persistent Disease|0|||
163158843|NCT01812252|589294909|FG000|Overall Study|Not transplanted|11|||
163158844|NCT01812252|589294910|FG001|Overall Study|Not transplanted|11|||
163158845|NCT01812252|589294909|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
163158846|NCT01812252|589294910|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
163271863|NCT01755689|589704998|FG003|Overall Study|Pregnancy|4|||
163158847|NCT01812252|589294909|FG000|Overall Study|Withdrawal by Subject|1|||
163158848|NCT01812252|589294910|FG001|Overall Study|Withdrawal by Subject|1|||
163158849|NCT01812252|589294909|FG000|Overall Study|Screen Failure|1|||
163158850|NCT01812252|589294910|FG001|Overall Study|Screen Failure|0|||
163158851|NCT03023397|589294911|FG000|Run-In|Failed screening allergen challenge|1|||
163158852|NCT03023397|589294912|FG001|Run-In|Failed screening allergen challenge|0|||
163158853|NCT03023397|589294913|FG002|Run-In|Failed screening allergen challenge|0|||
163158854|NCT03023397|589294911|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
163158855|NCT03023397|589294912|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
163158856|NCT03023397|589294913|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
163158857|NCT01656408|589294914|FG000|Overall Study|Adverse Event|0|||
163158858|NCT01656408|589294915|FG001|Overall Study|Adverse Event|0|||
163158859|NCT01656408|589294916|FG002|Overall Study|Adverse Event|1|||
163158860|NCT01656408|589294917|FG003|Overall Study|Adverse Event|0|||
163158861|NCT01656408|589294918|FG004|Overall Study|Adverse Event|0|||
163158862|NCT01656408|589294919|FG005|Overall Study|Adverse Event|1|||
163158863|NCT01656408|589294920|FG006|Overall Study|Adverse Event|1|||
163158864|NCT01656408|589294921|FG007|Overall Study|Adverse Event|0|||
163158865|NCT01656408|589294922|FG008|Overall Study|Adverse Event|1|||
163158866|NCT01656408|589294923|FG009|Overall Study|Adverse Event|0|||
163158867|NCT01656408|589294914|FG000|Overall Study|Physician Decision|1|||
163158868|NCT01656408|589294915|FG001|Overall Study|Physician Decision|0|||
163158869|NCT01656408|589294916|FG002|Overall Study|Physician Decision|1|||
163158870|NCT01656408|589294917|FG003|Overall Study|Physician Decision|0|||
163158871|NCT01656408|589294918|FG004|Overall Study|Physician Decision|1|||
163158872|NCT01656408|589294919|FG005|Overall Study|Physician Decision|1|||
163158873|NCT01656408|589294920|FG006|Overall Study|Physician Decision|0|||
163158874|NCT01656408|589294921|FG007|Overall Study|Physician Decision|1|||
163158875|NCT01656408|589294922|FG008|Overall Study|Physician Decision|1|||
163158876|NCT01656408|589294923|FG009|Overall Study|Physician Decision|3|||
163158877|NCT00363480|589294924|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
163158878|NCT00363480|589294924|FG000|Overall Study|Adverse Event|4|||
163271864|NCT01755689|589704999|FG004|Overall Study|Pregnancy|2|||
163271865|NCT02930122|589705002|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
163271866|NCT02930122|589705003|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
163271867|NCT01995357|589705004|FG000|Period 5|Lack of Efficacy|1|||
163271868|NCT01995357|589705005|FG001|Period 5|Lack of Efficacy|0|||
163271869|NCT01995357|589705006|FG002|Period 5|Lack of Efficacy|0|||
163271870|NCT01995357|589705007|FG003|Period 5|Lack of Efficacy|0|||
163271871|NCT01995357|589705008|FG004|Period 5|Lack of Efficacy|0|||
163271872|NCT01995357|589705009|FG005|Period 5|Lack of Efficacy|0|||
163271873|NCT01995357|589705004|FG000|Period 5|Adverse Event|1|||
163271874|NCT01995357|589705005|FG001|Period 5|Adverse Event|0|||
163271875|NCT01995357|589705006|FG002|Period 5|Adverse Event|1|||
163271876|NCT01995357|589705007|FG003|Period 5|Adverse Event|0|||
163271877|NCT01995357|589705008|FG004|Period 5|Adverse Event|0|||
163271878|NCT01995357|589705009|FG005|Period 5|Adverse Event|0|||
163271879|NCT02609659|589705010|FG000|Overall Study|Adverse Event|1|||
163271880|NCT02609659|589705010|FG000|Overall Study|Lost to Follow-up|6|||
163271881|NCT02609659|589705010|FG000|Overall Study|Other|1|||
163271882|NCT01004250|589705013|FG000|Induction Therapy Period|Adverse Event|10|||
163271883|NCT01004250|589705013|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
163271884|NCT01004250|589705013|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
163271885|NCT01004250|589705013|FG000|Induction Therapy Period|Physician Decision|2|||
163271886|NCT01004250|589705013|FG000|Maintenance Therapy Period|Adverse Event|15|||
163271887|NCT01004250|589705013|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
163271888|NCT01004250|589705013|FG000|Maintenance Therapy Period|Protocol Violation|1|||
163271889|NCT01004250|589705013|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
163271890|NCT01004250|589705013|FG000|Maintenance Therapy Period|Physician Decision|4|||
163271891|NCT01004250|589705013|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
163271892|NCT01853254|589705014|FG000|Overall Study|Abnormal Laboratory Test|1|||
163271893|NCT01853254|589705014|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
163271894|NCT01853254|589705014|FG000|Overall Study|Death|1|||
163158879|NCT00363480|589294924|FG000|Overall Study|Lost to Follow-up|5|||
163158880|NCT00363480|589294924|FG000|Overall Study|Withdrawal by Subject|5|||
163158881|NCT00363480|589294924|FG000|Overall Study|Non-compliance of subject|1|||
163158882|NCT00363480|589294924|FG000|Overall Study|Participant discontinued on its own|1|||
163158883|NCT04634253|589294927|FG000|Overall Study|Adverse Event|1|||
163271895|NCT01853254|589705014|FG000|Overall Study|Failure to Return|43|||
163158884|NCT04634253|589294928|FG001|Overall Study|Adverse Event|1|||
163158885|NCT04634253|589294929|FG002|Overall Study|Adverse Event|0|||
163158886|NCT04634253|589294927|FG000|Overall Study|Physician Decision|0|||
163271896|NCT01853254|589705014|FG000|Overall Study|Insufficient Therapeutic Response|22|||
163271897|NCT01853254|589705014|FG000|Overall Study|Refusal of Treatment|1|||
163271898|NCT01853254|589705014|FG000|Overall Study|Other Protocol Violation|1|||
163271899|NCT01853254|589705014|FG000|Overall Study|Withdrawal of Consent|16|||
163158887|NCT04634253|589294928|FG001|Overall Study|Physician Decision|1|||
163158888|NCT04634253|589294929|FG002|Overall Study|Physician Decision|0|||
163158889|NCT04634253|589294927|FG000|Overall Study|Withdrawal by Subject|1|||
163158890|NCT04634253|589294928|FG001|Overall Study|Withdrawal by Subject|0|||
163158891|NCT04634253|589294929|FG002|Overall Study|Withdrawal by Subject|3|||
163158892|NCT03133793|589294930|FG000|Overall Study|Withdrawal by Subject|0|||
163158893|NCT03133793|589294931|FG001|Overall Study|Withdrawal by Subject|4|||
163158894|NCT03133793|589294932|FG002|Overall Study|Withdrawal by Subject|2|||
163158895|NCT03133793|589294933|FG003|Overall Study|Withdrawal by Subject|4|||
163158896|NCT03133793|589294930|FG000|Overall Study|Lost to Follow-up|1|||
163158897|NCT03133793|589294931|FG001|Overall Study|Lost to Follow-up|0|||
163158898|NCT03133793|589294932|FG002|Overall Study|Lost to Follow-up|2|||
163158899|NCT03133793|589294933|FG003|Overall Study|Lost to Follow-up|0|||
163158900|NCT03133793|589294930|FG000|Overall Study|Death|0|||
163158901|NCT03133793|589294931|FG001|Overall Study|Death|0|||
163158902|NCT03133793|589294932|FG002|Overall Study|Death|0|||
163158903|NCT03133793|589294933|FG003|Overall Study|Death|1|||
163158904|NCT03486834|589294934|FG000|Overall Study|Withdrawal by Subject|46|||
163158905|NCT03486834|589294935|FG001|Overall Study|Withdrawal by Subject|46|||
163158906|NCT03486834|589294936|FG002|Overall Study|Withdrawal by Subject|52|||
163158907|NCT03486834|589294934|FG000|Overall Study|Adverse Event|8|||
163158908|NCT03486834|589294935|FG001|Overall Study|Adverse Event|7|||
163158909|NCT03486834|589294936|FG002|Overall Study|Adverse Event|0|||
163158910|NCT03486834|589294934|FG000|Overall Study|Lost to Follow-up|41|||
163158911|NCT03486834|589294935|FG001|Overall Study|Lost to Follow-up|24|||
163158912|NCT03486834|589294936|FG002|Overall Study|Lost to Follow-up|39|||
163158913|NCT03486834|589294934|FG000|Overall Study|Non-compliance with Study Drug|2|||
163158914|NCT03486834|589294935|FG001|Overall Study|Non-compliance with Study Drug|2|||
163158915|NCT03486834|589294936|FG002|Overall Study|Non-compliance with Study Drug|0|||
163158916|NCT03486834|589294934|FG000|Overall Study|Physician Decision|5|||
163158917|NCT03486834|589294935|FG001|Overall Study|Physician Decision|2|||
163158918|NCT03486834|589294936|FG002|Overall Study|Physician Decision|3|||
163158919|NCT03486834|589294934|FG000|Overall Study|Pregnancy|10|||
163158920|NCT03486834|589294935|FG001|Overall Study|Pregnancy|12|||
163158921|NCT03486834|589294936|FG002|Overall Study|Pregnancy|12|||
163158922|NCT03486834|589294934|FG000|Overall Study|Protocol Deviation|2|||
163158923|NCT03486834|589294935|FG001|Overall Study|Protocol Deviation|3|||
163158924|NCT03486834|589294936|FG002|Overall Study|Protocol Deviation|3|||
163158925|NCT03486834|589294934|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163158926|NCT03486834|589294935|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
163158927|NCT03486834|589294936|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
163158928|NCT03486834|589294934|FG000|Overall Study|Randomized but not treated|4|||
163158929|NCT03486834|589294935|FG001|Overall Study|Randomized but not treated|4|||
163158930|NCT03486834|589294936|FG002|Overall Study|Randomized but not treated|1|||
163158931|NCT00888940|589294937|FG000|Overall Study|Adverse Event|12|||
163158932|NCT00888940|589294938|FG001|Overall Study|Adverse Event|3|||
163158933|NCT00888940|589294937|FG000|Overall Study|Lost to Follow-up|5|||
163158934|NCT00888940|589294938|FG001|Overall Study|Lost to Follow-up|5|||
163158935|NCT00888940|589294937|FG000|Overall Study|Randomized Not Treated|11|||
163158936|NCT00888940|589294938|FG001|Overall Study|Randomized Not Treated|13|||
163158937|NCT00515619|589294939|FG000|Overall Study|Adverse Event|34|||
163158938|NCT00515619|589294939|FG000|Overall Study|Lack of Efficacy|92|||
163158939|NCT00515619|589294939|FG000|Overall Study|Withdrawal by Subject|66|||
163158940|NCT00515619|589294939|FG000|Overall Study|Protocol Violation|3|||
163158941|NCT00515619|589294939|FG000|Overall Study|Lost to Follow-up|4|||
163158942|NCT00515619|589294939|FG000|Overall Study|Unsatisfactory compliance|6|||
163158943|NCT00515619|589294939|FG000|Overall Study|Other: Site discontinuing trials|2|||
163158944|NCT00515619|589294939|FG000|Overall Study|Other: Subject cannot attend visits|2|||
163158945|NCT00515619|589294939|FG000|Overall Study|Other: Subject required surgery|1|||
163158946|NCT00515619|589294939|FG000|Overall Study|Other: Subject moved to another country|1|||
163158947|NCT00515619|589294939|FG000|Overall Study|Other: Investigator decision|1|||
163158948|NCT00515619|589294939|FG000|Overall Study|Other: Subject became pregnant|1|||
163158949|NCT00515619|589294939|FG000|Overall Study|Other: Request from sponsor|1|||
163158950|NCT00515619|589294939|FG000|Overall Study|Other: Drug available on license|1|||
163158951|NCT00515619|589294939|FG000|Overall Study|Other: Subject interested in other AED|1|||
163158952|NCT02379091|589294940|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
163158953|NCT02379091|589294941|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
163158954|NCT02379091|589294942|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
163158955|NCT02379091|589294943|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
163158956|NCT02379091|589294940|FG000|Overall Study|Principal Investigator Discretion|0|||
163158957|NCT02379091|589294941|FG001|Overall Study|Principal Investigator Discretion|1|||
163158958|NCT02379091|589294942|FG002|Overall Study|Principal Investigator Discretion|0|||
163158959|NCT02379091|589294943|FG003|Overall Study|Principal Investigator Discretion|0|||
163158960|NCT02379091|589294940|FG000|Overall Study|Lost to Follow-up|0|||
163158961|NCT02379091|589294941|FG001|Overall Study|Lost to Follow-up|0|||
163158962|NCT02379091|589294942|FG002|Overall Study|Lost to Follow-up|0|||
163158963|NCT02379091|589294943|FG003|Overall Study|Lost to Follow-up|1|||
163271900|NCT01853254|589705014|FG000|Overall Study|Administrative/Other|16|||
163271901|NCT02462083|589705015|FG000|Overall Study|Sponsor request|39|||
163271902|NCT02462083|589705015|FG000|Overall Study|Withdrawal by Subject|87|||
163271903|NCT02462083|589705015|FG000|Overall Study|Lost to Follow-up|41|||
163271904|NCT02462083|589705015|FG000|Overall Study|Lack of Efficacy|151|||
163271905|NCT02462083|589705015|FG000|Overall Study|Pregnancy|1|||
163271906|NCT02462083|589705015|FG000|Overall Study|Protocol Violation|6|||
163271907|NCT02462083|589705015|FG000|Overall Study|Adverse Event|33|||
163271908|NCT02462083|589705015|FG000|Overall Study|Worsening condition|16|||
163271909|NCT02462083|589705015|FG000|Overall Study|Other than specified|45|||
163271910|NCT02711995|589705018|FG000|Washout (90 Days)|Conflicting medication|1|||
163271911|NCT01809210|589705021|FG000|Overall Study|Withdrawal by Subject|0|||
163271912|NCT01809210|589705022|FG001|Overall Study|Withdrawal by Subject|0|||
163271913|NCT01809210|589705023|FG002|Overall Study|Withdrawal by Subject|1|||
163271914|NCT01809210|589705024|FG003|Overall Study|Withdrawal by Subject|1|||
163271915|NCT01809210|589705025|FG004|Overall Study|Withdrawal by Subject|1|||
163271916|NCT01809210|589705026|FG005|Overall Study|Withdrawal by Subject|0|||
163271917|NCT01809210|589705027|FG006|Overall Study|Withdrawal by Subject|4|||
163271918|NCT01809210|589705021|FG000|Overall Study|Death|1|||
163271919|NCT01809210|589705022|FG001|Overall Study|Death|1|||
163271920|NCT01809210|589705023|FG002|Overall Study|Death|2|||
163158964|NCT02379091|589294940|FG000|Overall Study|Voluntary Withdrawal|2|||
163158965|NCT02379091|589294941|FG001|Overall Study|Voluntary Withdrawal|5|||
163158966|NCT02379091|589294942|FG002|Overall Study|Voluntary Withdrawal|2|||
163158967|NCT02379091|589294943|FG003|Overall Study|Voluntary Withdrawal|4|||
163158968|NCT02379091|589294940|FG000|Overall Study|Study Termination|7|||
163158969|NCT02379091|589294941|FG001|Overall Study|Study Termination|2|||
163158970|NCT02379091|589294942|FG002|Overall Study|Study Termination|5|||
163158971|NCT02379091|589294943|FG003|Overall Study|Study Termination|8|||
163158972|NCT02379091|589294940|FG000|Overall Study|Lack of Efficacy|3|||
163158973|NCT02379091|589294941|FG001|Overall Study|Lack of Efficacy|0|||
163158974|NCT02379091|589294942|FG002|Overall Study|Lack of Efficacy|0|||
163158975|NCT02379091|589294943|FG003|Overall Study|Lack of Efficacy|0|||
163158976|NCT03326713|589294945|FG000|Overall Study|Death|2|||
163158977|NCT03326713|589294946|FG001|Overall Study|Death|1|||
163158978|NCT03326713|589294947|FG002|Overall Study|Death|0|||
163158979|NCT03326713|589294945|FG000|Overall Study|Lost to Follow-up|20|||
163158980|NCT03326713|589294946|FG001|Overall Study|Lost to Follow-up|21|||
163158981|NCT03326713|589294947|FG002|Overall Study|Lost to Follow-up|33|||
163158982|NCT03326713|589294945|FG000|Overall Study|Withdrawal by Subject|1|||
163158983|NCT03326713|589294946|FG001|Overall Study|Withdrawal by Subject|2|||
163158984|NCT03326713|589294947|FG002|Overall Study|Withdrawal by Subject|11|||
163158985|NCT03326713|589294945|FG000|Overall Study|Found Ineligible|11|||
163158986|NCT03326713|589294946|FG001|Overall Study|Found Ineligible|11|||
163158987|NCT03326713|589294947|FG002|Overall Study|Found Ineligible|8|||
163158988|NCT00771758|589294948|FG000|Overall Study|Adverse Event|2|||
163158989|NCT00771758|589294949|FG001|Overall Study|Adverse Event|8|||
163158990|NCT00771758|589294950|FG002|Overall Study|Adverse Event|1|||
163158991|NCT00771758|589294948|FG000|Overall Study|Lack of Efficacy|0|||
163158992|NCT00771758|589294949|FG001|Overall Study|Lack of Efficacy|2|||
163158993|NCT00771758|589294950|FG002|Overall Study|Lack of Efficacy|1|||
163158994|NCT00771758|589294948|FG000|Overall Study|Lost to Follow-up|1|||
163158995|NCT00771758|589294949|FG001|Overall Study|Lost to Follow-up|0|||
163158996|NCT00771758|589294950|FG002|Overall Study|Lost to Follow-up|0|||
163158997|NCT00771758|589294948|FG000|Overall Study|Protocol Violation|1|||
163158998|NCT00771758|589294949|FG001|Overall Study|Protocol Violation|0|||
163158999|NCT00771758|589294950|FG002|Overall Study|Protocol Violation|0|||
163159000|NCT00771758|589294948|FG000|Overall Study|Withdrawal by Subject|1|||
163159001|NCT00771758|589294949|FG001|Overall Study|Withdrawal by Subject|0|||
163159002|NCT00771758|589294950|FG002|Overall Study|Withdrawal by Subject|0|||
163159003|NCT00771758|589294948|FG000|Overall Study|Other|3|||
163271921|NCT01809210|589705024|FG003|Overall Study|Death|0|||
163271922|NCT01809210|589705025|FG004|Overall Study|Death|1|||
163159004|NCT00771758|589294949|FG001|Overall Study|Other|2|||
163159005|NCT00771758|589294950|FG002|Overall Study|Other|0|||
163159006|NCT03067077|589294951|FG000|Overall Study|Did not receive surgery|4|||
163159007|NCT03067077|589294952|FG001|Overall Study|Did not receive surgery|5|||
163159008|NCT03067077|589294951|FG000|Overall Study|Lost to Follow-up|3|||
163159009|NCT03067077|589294952|FG001|Overall Study|Lost to Follow-up|2|||
163159010|NCT00935584|589294955|FG000|Overall Study|Withdrawal by Subject|9|||
163159011|NCT00935584|589294956|FG001|Overall Study|Withdrawal by Subject|0|||
163159012|NCT00935584|589294955|FG000|Overall Study|Death|3|||
163159013|NCT00935584|589294956|FG001|Overall Study|Death|0|||
163159014|NCT00935584|589294955|FG000|Overall Study|Lost to Follow-up|8|||
163159015|NCT00935584|589294956|FG001|Overall Study|Lost to Follow-up|0|||
163159016|NCT00935584|589294955|FG000|Overall Study|No show|9|||
163271923|NCT01809210|589705026|FG005|Overall Study|Death|3|||
163271924|NCT01809210|589705027|FG006|Overall Study|Death|1|||
163271925|NCT01115998|589705028|FG000|Overall Study|Lost to Follow-up|6|||
163271926|NCT01115998|589705029|FG001|Overall Study|Lost to Follow-up|6|||
163271927|NCT01383993|589705035|FG000|Overall Study|Adverse Event|1|||
163159017|NCT00935584|589294956|FG001|Overall Study|No show|0|||
163159018|NCT00935584|589294955|FG000|Overall Study|Relocated|3|||
163159019|NCT00935584|589294956|FG001|Overall Study|Relocated|0|||
163159020|NCT00935584|589294955|FG000|Overall Study|Patient changed provider|3|||
163159021|NCT00935584|589294956|FG001|Overall Study|Patient changed provider|0|||
163159022|NCT00935584|589294955|FG000|Overall Study|Provider dropped out of study|14|||
163159023|NCT00935584|589294956|FG001|Overall Study|Provider dropped out of study|4|||
163159024|NCT00687193|589294957|FG000|Overall Study|Adverse Event|0|||
163159025|NCT00687193|589294958|FG001|Overall Study|Adverse Event|1|||
163159026|NCT00687193|589294959|FG002|Overall Study|Adverse Event|2|||
163159027|NCT00687193|589294960|FG003|Overall Study|Adverse Event|3|||
163159028|NCT00687193|589294961|FG004|Overall Study|Adverse Event|0|||
163159029|NCT00687193|589294962|FG005|Overall Study|Adverse Event|2|||
163159030|NCT00687193|589294957|FG000|Overall Study|Lack of Efficacy|1|||
163159031|NCT00687193|589294958|FG001|Overall Study|Lack of Efficacy|1|||
163159032|NCT00687193|589294959|FG002|Overall Study|Lack of Efficacy|0|||
163159033|NCT00687193|589294960|FG003|Overall Study|Lack of Efficacy|0|||
163159034|NCT00687193|589294961|FG004|Overall Study|Lack of Efficacy|0|||
163159035|NCT00687193|589294962|FG005|Overall Study|Lack of Efficacy|2|||
163159036|NCT00687193|589294957|FG000|Overall Study|Protocol Violation|1|||
163159037|NCT00687193|589294958|FG001|Overall Study|Protocol Violation|2|||
163159038|NCT00687193|589294959|FG002|Overall Study|Protocol Violation|0|||
163159039|NCT00687193|589294960|FG003|Overall Study|Protocol Violation|1|||
163159040|NCT00687193|589294961|FG004|Overall Study|Protocol Violation|2|||
163159041|NCT00687193|589294962|FG005|Overall Study|Protocol Violation|0|||
163159042|NCT02129699|589294963|FG000|Overall Study|Did not start treatment|3|||
163159043|NCT02129699|589294964|FG001|Overall Study|Did not start treatment|2|||
163159044|NCT01394016|589294965|FG000|Overall Study|Progressive Disease|2|||
163159045|NCT01394016|589294966|FG001|Overall Study|Progressive Disease|0|||
163159046|NCT01394016|589294967|FG002|Overall Study|Progressive Disease|0|||
163159047|NCT01394016|589294968|FG003|Overall Study|Progressive Disease|0|||
163159048|NCT01394016|589294969|FG004|Overall Study|Progressive Disease|0|||
163159049|NCT01394016|589294970|FG005|Overall Study|Progressive Disease|0|||
163159050|NCT01394016|589294971|FG006|Overall Study|Progressive Disease|0|||
163159051|NCT01394016|589294972|FG007|Overall Study|Progressive Disease|0|||
163159052|NCT01394016|589294973|FG008|Overall Study|Progressive Disease|0|||
163159053|NCT01394016|589294974|FG009|Overall Study|Progressive Disease|0|||
163159054|NCT01394016|589294975|FG010|Overall Study|Progressive Disease|0|||
163159055|NCT01394016|589294976|FG011|Overall Study|Progressive Disease|0|||
163159056|NCT01394016|589294977|FG012|Overall Study|Progressive Disease|0|||
163159057|NCT01394016|589294978|FG013|Overall Study|Progressive Disease|0|||
163159058|NCT01394016|589294979|FG014|Overall Study|Progressive Disease|0|||
163159059|NCT01394016|589294980|FG015|Overall Study|Progressive Disease|0|||
163159060|NCT01394016|589294981|FG016|Overall Study|Progressive Disease|0|||
163159061|NCT01394016|589294982|FG017|Overall Study|Progressive Disease|0|||
163159062|NCT01394016|589294983|FG018|Overall Study|Progressive Disease|0|||
163159063|NCT01394016|589294965|FG000|Overall Study|Withdrawal by Subject|0|||
163159064|NCT01394016|589294966|FG001|Overall Study|Withdrawal by Subject|0|||
163159065|NCT01394016|589294967|FG002|Overall Study|Withdrawal by Subject|0|||
163159066|NCT01394016|589294968|FG003|Overall Study|Withdrawal by Subject|0|||
163159067|NCT01394016|589294969|FG004|Overall Study|Withdrawal by Subject|0|||
163159068|NCT01394016|589294970|FG005|Overall Study|Withdrawal by Subject|0|||
163159069|NCT01394016|589294971|FG006|Overall Study|Withdrawal by Subject|0|||
163159070|NCT01394016|589294972|FG007|Overall Study|Withdrawal by Subject|1|||
163159071|NCT01394016|589294973|FG008|Overall Study|Withdrawal by Subject|1|||
163159072|NCT01394016|589294974|FG009|Overall Study|Withdrawal by Subject|1|||
163159073|NCT01394016|589294975|FG010|Overall Study|Withdrawal by Subject|4|||
163159074|NCT01394016|589294976|FG011|Overall Study|Withdrawal by Subject|0|||
163159075|NCT01394016|589294977|FG012|Overall Study|Withdrawal by Subject|0|||
163159076|NCT01394016|589294978|FG013|Overall Study|Withdrawal by Subject|3|||
163159077|NCT01394016|589294979|FG014|Overall Study|Withdrawal by Subject|1|||
163159078|NCT01394016|589294980|FG015|Overall Study|Withdrawal by Subject|3|||
163159079|NCT01394016|589294981|FG016|Overall Study|Withdrawal by Subject|1|||
163159080|NCT01394016|589294982|FG017|Overall Study|Withdrawal by Subject|1|||
163159081|NCT01394016|589294983|FG018|Overall Study|Withdrawal by Subject|2|||
163159082|NCT01394016|589294965|FG000|Overall Study|Adverse Event|0|||
163159083|NCT01394016|589294966|FG001|Overall Study|Adverse Event|0|||
163271928|NCT01383993|589705036|FG001|Overall Study|Adverse Event|1|||
163159084|NCT01394016|589294967|FG002|Overall Study|Adverse Event|0|||
163159085|NCT01394016|589294968|FG003|Overall Study|Adverse Event|0|||
163159086|NCT01394016|589294969|FG004|Overall Study|Adverse Event|0|||
163159087|NCT01394016|589294970|FG005|Overall Study|Adverse Event|0|||
163159088|NCT01394016|589294971|FG006|Overall Study|Adverse Event|0|||
163159089|NCT01394016|589294972|FG007|Overall Study|Adverse Event|0|||
163159090|NCT01394016|589294973|FG008|Overall Study|Adverse Event|0|||
163159091|NCT01394016|589294974|FG009|Overall Study|Adverse Event|1|||
163159092|NCT01394016|589294975|FG010|Overall Study|Adverse Event|0|||
163159093|NCT01394016|589294976|FG011|Overall Study|Adverse Event|0|||
163159094|NCT01394016|589294977|FG012|Overall Study|Adverse Event|0|||
163159095|NCT01394016|589294978|FG013|Overall Study|Adverse Event|0|||
163159096|NCT01394016|589294979|FG014|Overall Study|Adverse Event|0|||
163159097|NCT01394016|589294980|FG015|Overall Study|Adverse Event|0|||
163159098|NCT01394016|589294981|FG016|Overall Study|Adverse Event|1|||
163159099|NCT01394016|589294982|FG017|Overall Study|Adverse Event|1|||
163159100|NCT01394016|589294983|FG018|Overall Study|Adverse Event|0|||
163159101|NCT01394016|589294965|FG000|Overall Study|Sponsor Decision|0|||
163159102|NCT01394016|589294966|FG001|Overall Study|Sponsor Decision|0|||
163159103|NCT01394016|589294967|FG002|Overall Study|Sponsor Decision|0|||
163159104|NCT01394016|589294968|FG003|Overall Study|Sponsor Decision|0|||
163159105|NCT01394016|589294969|FG004|Overall Study|Sponsor Decision|0|||
163159106|NCT01394016|589294970|FG005|Overall Study|Sponsor Decision|0|||
163159107|NCT01394016|589294971|FG006|Overall Study|Sponsor Decision|0|||
163159108|NCT01394016|589294972|FG007|Overall Study|Sponsor Decision|0|||
163159109|NCT01394016|589294973|FG008|Overall Study|Sponsor Decision|0|||
163159110|NCT01394016|589294974|FG009|Overall Study|Sponsor Decision|0|||
163159111|NCT01394016|589294975|FG010|Overall Study|Sponsor Decision|0|||
163159112|NCT01394016|589294976|FG011|Overall Study|Sponsor Decision|0|||
163159113|NCT01394016|589294977|FG012|Overall Study|Sponsor Decision|1|||
163159114|NCT01394016|589294978|FG013|Overall Study|Sponsor Decision|0|||
163159115|NCT01394016|589294979|FG014|Overall Study|Sponsor Decision|0|||
163159116|NCT01394016|589294980|FG015|Overall Study|Sponsor Decision|0|||
163159117|NCT01394016|589294981|FG016|Overall Study|Sponsor Decision|0|||
163159118|NCT01394016|589294982|FG017|Overall Study|Sponsor Decision|0|||
163159119|NCT01394016|589294983|FG018|Overall Study|Sponsor Decision|0|||
163159120|NCT01394016|589294965|FG000|Overall Study|Lost to Follow-up|0|||
163159121|NCT01394016|589294966|FG001|Overall Study|Lost to Follow-up|0|||
163271929|NCT01383993|589705037|FG002|Overall Study|Adverse Event|0|||
163271930|NCT01383993|589705035|FG000|Overall Study|Withdrawal by Subject|0|||
163271931|NCT01383993|589705036|FG001|Overall Study|Withdrawal by Subject|0|||
163271932|NCT01383993|589705037|FG002|Overall Study|Withdrawal by Subject|1|||
163271933|NCT01383993|589705035|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
163271934|NCT01383993|589705036|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
163271935|NCT01383993|589705037|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
163271936|NCT01489020|589705042|FG000|Overall Study|Withdrawal by Subject|1|||
163271937|NCT01489020|589705043|FG001|Overall Study|Withdrawal by Subject|0|||
163271938|NCT01489020|589705044|FG002|Overall Study|Withdrawal by Subject|0|||
163271939|NCT01489020|589705045|FG003|Overall Study|Withdrawal by Subject|0|||
163271940|NCT01489020|589705046|FG004|Overall Study|Withdrawal by Subject|0|||
163271941|NCT01489020|589705047|FG005|Overall Study|Withdrawal by Subject|0|||
163271942|NCT01489020|589705042|FG000|Overall Study|Adverse Event|0|||
163271943|NCT01489020|589705043|FG001|Overall Study|Adverse Event|0|||
163271944|NCT01489020|589705044|FG002|Overall Study|Adverse Event|3|||
163271945|NCT01489020|589705045|FG003|Overall Study|Adverse Event|0|||
163271946|NCT01489020|589705046|FG004|Overall Study|Adverse Event|3|||
163271947|NCT01489020|589705047|FG005|Overall Study|Adverse Event|0|||
163271948|NCT01489020|589705042|FG000|Overall Study|Concomitant disease|0|||
163271949|NCT01489020|589705043|FG001|Overall Study|Concomitant disease|0|||
163271950|NCT01489020|589705044|FG002|Overall Study|Concomitant disease|0|||
163271951|NCT01489020|589705045|FG003|Overall Study|Concomitant disease|0|||
163271952|NCT01489020|589705046|FG004|Overall Study|Concomitant disease|3|||
163271953|NCT01489020|589705047|FG005|Overall Study|Concomitant disease|0|||
163271954|NCT00262743|589705049|FG000|Overall Study|Adverse Event|0|||
163271955|NCT00262743|589705050|FG001|Overall Study|Adverse Event|9|||
163271956|NCT00262743|589705049|FG000|Overall Study|Disease progression|0|||
163271957|NCT00262743|589705050|FG001|Overall Study|Disease progression|3|||
163271958|NCT02485353|589705053|FG000|Overall Study|Death|1|||
163271959|NCT02485353|589705053|FG000|Overall Study|Disease Progression|1|||
163271960|NCT04747275|589705056|FG000|Overall Study|Study terminated|0|||
163271961|NCT04747275|589705057|FG001|Overall Study|Study terminated|1|||
163271962|NCT03268590|589705060|FG000|Overall Study|Previously unknown exclusion criteria|1|||
163271963|NCT00531011|589705061|FG000|Overall Study|Withdrawal by Subject|2|||
163271964|NCT00531011|589705062|FG001|Overall Study|Withdrawal by Subject|4|||
163271965|NCT00531011|589705061|FG000|Overall Study|Death|1|||
163271966|NCT00531011|589705062|FG001|Overall Study|Death|0|||
163159122|NCT01394016|589294967|FG002|Overall Study|Lost to Follow-up|0|||
163159123|NCT01394016|589294968|FG003|Overall Study|Lost to Follow-up|0|||
163159124|NCT01394016|589294969|FG004|Overall Study|Lost to Follow-up|0|||
163159125|NCT01394016|589294970|FG005|Overall Study|Lost to Follow-up|0|||
163159126|NCT01394016|589294971|FG006|Overall Study|Lost to Follow-up|0|||
163159127|NCT01394016|589294972|FG007|Overall Study|Lost to Follow-up|0|||
163159128|NCT01394016|589294973|FG008|Overall Study|Lost to Follow-up|0|||
163159129|NCT01394016|589294974|FG009|Overall Study|Lost to Follow-up|0|||
163271967|NCT00531011|589705061|FG000|Overall Study|Lost to Follow-up|1|||
163271968|NCT00531011|589705062|FG001|Overall Study|Lost to Follow-up|0|||
163271969|NCT00531011|589705061|FG000|Overall Study|Physician Decision|0|||
163271970|NCT00531011|589705062|FG001|Overall Study|Physician Decision|3|||
163271971|NCT02823964|589705065|FG000|Overall Study|Adverse Event|2|||
163271972|NCT02823964|589705065|FG000|Overall Study|Physician Decision|1|||
163271973|NCT02823964|589705065|FG000|Overall Study|Lack of Efficacy|1|||
163271974|NCT02823964|589705065|FG000|Overall Study|Withdrawal by Subject|1|||
163271975|NCT03537261|589705066|FG000|Overall Study|Lost to Follow-up|4|||
163271976|NCT03537261|589705067|FG001|Overall Study|Lost to Follow-up|5|||
163271977|NCT03537261|589705066|FG000|Overall Study|Withdrawal by Subject|4|||
163271978|NCT03537261|589705067|FG001|Overall Study|Withdrawal by Subject|6|||
163271979|NCT03537261|589705066|FG000|Overall Study|Did not return study questionnaires|0|||
163271980|NCT03537261|589705067|FG001|Overall Study|Did not return study questionnaires|1|||
163271981|NCT01729728|589705070|FG000|Overall Study|Adverse Event|0|||
163271982|NCT01729728|589705071|FG001|Overall Study|Adverse Event|6|||
163271983|NCT01729728|589705072|FG002|Overall Study|Adverse Event|0|||
163271984|NCT01729728|589705070|FG000|Overall Study|Protocol Violation|1|||
163271985|NCT01729728|589705071|FG001|Overall Study|Protocol Violation|0|||
163271986|NCT01729728|589705072|FG002|Overall Study|Protocol Violation|1|||
163271987|NCT00610675|589705073|FG000|Overall Study|Untreated|4|||
163271988|NCT00610675|589705073|FG000|Overall Study|Adverse Event|67|||
163271989|NCT00610675|589705073|FG000|Overall Study|Insufficient Effect|31|||
163271990|NCT00610675|589705073|FG000|Overall Study|Withdrawal by Subject|28|||
163271991|NCT00610675|589705073|FG000|Overall Study|Reasons unrelated to trial|27|||
163271992|NCT00610675|589705073|FG000|Overall Study|Lack of Compliance|7|||
163271993|NCT00610675|589705073|FG000|Overall Study|Lost to Follow-up|31|||
163271994|NCT00610675|589705073|FG000|Overall Study|Other reason (not specified)|25|||
163271995|NCT00983619|589705080|FG000|Overall Study|Lost to Follow-up|0|||
163271996|NCT00983619|589705081|FG001|Overall Study|Lost to Follow-up|1|||
163271997|NCT00983619|589705082|FG002|Overall Study|Lost to Follow-up|0|||
163271998|NCT00983619|589705083|FG003|Overall Study|Lost to Follow-up|0|||
163271999|NCT00983619|589705084|FG004|Overall Study|Lost to Follow-up|0|||
163272000|NCT00983619|589705085|FG005|Overall Study|Lost to Follow-up|2|||
163272001|NCT00983619|589705086|FG006|Overall Study|Lost to Follow-up|0|||
163272002|NCT00983619|589705087|FG007|Overall Study|Lost to Follow-up|0|||
163272003|NCT00983619|589705088|FG008|Overall Study|Lost to Follow-up|0|||
163272004|NCT00983619|589705089|FG009|Overall Study|Lost to Follow-up|0|||
163272005|NCT00983619|589705090|FG010|Overall Study|Lost to Follow-up|0|||
163272006|NCT00983619|589705091|FG011|Overall Study|Lost to Follow-up|2|||
163272007|NCT00983619|589705080|FG000|Overall Study|Withdrawal by Subject|2|||
163272008|NCT00983619|589705081|FG001|Overall Study|Withdrawal by Subject|1|||
163272009|NCT00983619|589705082|FG002|Overall Study|Withdrawal by Subject|1|||
163272010|NCT00983619|589705083|FG003|Overall Study|Withdrawal by Subject|3|||
163272011|NCT00983619|589705084|FG004|Overall Study|Withdrawal by Subject|1|||
163272012|NCT00983619|589705085|FG005|Overall Study|Withdrawal by Subject|23|||
163272013|NCT00983619|589705086|FG006|Overall Study|Withdrawal by Subject|0|||
163272014|NCT00983619|589705087|FG007|Overall Study|Withdrawal by Subject|0|||
163272015|NCT00983619|589705088|FG008|Overall Study|Withdrawal by Subject|0|||
163272016|NCT00983619|589705089|FG009|Overall Study|Withdrawal by Subject|0|||
163272017|NCT00983619|589705090|FG010|Overall Study|Withdrawal by Subject|1|||
163272018|NCT00983619|589705091|FG011|Overall Study|Withdrawal by Subject|1|||
163272019|NCT00983619|589705080|FG000|Overall Study|Death|0|||
163272020|NCT00983619|589705081|FG001|Overall Study|Death|2|||
163272021|NCT00983619|589705082|FG002|Overall Study|Death|2|||
163272022|NCT00983619|589705083|FG003|Overall Study|Death|1|||
163272023|NCT00983619|589705084|FG004|Overall Study|Death|2|||
163272024|NCT00983619|589705085|FG005|Overall Study|Death|30|||
163272025|NCT00983619|589705086|FG006|Overall Study|Death|1|||
163272026|NCT00983619|589705087|FG007|Overall Study|Death|0|||
163272027|NCT00983619|589705088|FG008|Overall Study|Death|1|||
163272028|NCT00983619|589705089|FG009|Overall Study|Death|2|||
163272029|NCT00983619|589705090|FG010|Overall Study|Death|9|||
163272030|NCT00983619|589705091|FG011|Overall Study|Death|8|||
163272031|NCT00983619|589705080|FG000|Overall Study|Other|1|||
163272032|NCT00983619|589705081|FG001|Overall Study|Other|0|||
163272033|NCT00983619|589705082|FG002|Overall Study|Other|0|||
163272034|NCT00983619|589705083|FG003|Overall Study|Other|1|||
163272035|NCT00983619|589705084|FG004|Overall Study|Other|0|||
163272036|NCT00983619|589705085|FG005|Overall Study|Other|12|||
163272037|NCT00983619|589705086|FG006|Overall Study|Other|2|||
163272038|NCT00983619|589705087|FG007|Overall Study|Other|2|||
163272039|NCT00983619|589705088|FG008|Overall Study|Other|0|||
163272040|NCT00983619|589705089|FG009|Overall Study|Other|1|||
163272041|NCT00983619|589705090|FG010|Overall Study|Other|1|||
163272042|NCT00983619|589705091|FG011|Overall Study|Other|0|||
163272043|NCT00672958|589705092|FG000|Overall Study|Adverse Event|11|||
163272044|NCT00672958|589705093|FG001|Overall Study|Adverse Event|9|||
163272045|NCT00672958|589705092|FG000|Overall Study|Lack of Efficacy|6|||
163272046|NCT00672958|589705093|FG001|Overall Study|Lack of Efficacy|11|||
163272047|NCT00672958|589705092|FG000|Overall Study|Non-compliance with study drug|2|||
163272048|NCT00672958|589705093|FG001|Overall Study|Non-compliance with study drug|3|||
163272049|NCT00672958|589705092|FG000|Overall Study|Protocol deviations|11|||
163272050|NCT00672958|589705093|FG001|Overall Study|Protocol deviations|5|||
163272051|NCT00672958|589705092|FG000|Overall Study|Voluntary withdrawal|12|||
163272052|NCT00672958|589705093|FG001|Overall Study|Voluntary withdrawal|8|||
163272053|NCT00672958|589705092|FG000|Overall Study|Lost to Follow-up|22|||
163272054|NCT00672958|589705093|FG001|Overall Study|Lost to Follow-up|17|||
163159130|NCT01394016|589294975|FG010|Overall Study|Lost to Follow-up|0|||
163159131|NCT01394016|589294976|FG011|Overall Study|Lost to Follow-up|0|||
163159132|NCT01394016|589294977|FG012|Overall Study|Lost to Follow-up|0|||
163159133|NCT01394016|589294978|FG013|Overall Study|Lost to Follow-up|0|||
163159134|NCT01394016|589294979|FG014|Overall Study|Lost to Follow-up|0|||
163159135|NCT01394016|589294980|FG015|Overall Study|Lost to Follow-up|0|||
163159136|NCT01394016|589294981|FG016|Overall Study|Lost to Follow-up|0|||
163159137|NCT01394016|589294982|FG017|Overall Study|Lost to Follow-up|0|||
163159138|NCT01394016|589294983|FG018|Overall Study|Lost to Follow-up|1|||
163159139|NCT03534804|589294984|FG000|Overall Study|Withdrawal by Subject|1|||
163159140|NCT04161157|589294988|FG000|Overall Study|Lost to Follow-up|4|||
163159141|NCT04161157|589294988|FG000|Overall Study|Death|3|||
163159142|NCT04161157|589294988|FG000|Overall Study|Ineligible|2|||
163159143|NCT04161157|589294988|FG000|Overall Study|Withdrawal by Subject|4|||
163159144|NCT02991768|589294997|FG000|Overall Study|Physician Decision|4|||
163159145|NCT05786651|589295000|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
163159146|NCT02273596|589296407|FG000|24-Week Treatment Period|Adverse Event|3|||
163159147|NCT02273596|589296407|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
163159148|NCT02273596|589296407|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
163159149|NCT02273596|589296407|FG000|24-Week Treatment Period|Physician Decision|1|||
163159150|NCT02273596|589296407|FG000|24-Week Treatment Period|Protocol Deviation|1|||
163159151|NCT02273596|589296407|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
163159152|NCT02273596|589296407|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
163159153|NCT02273596|589296407|FG000|Extension Period|Lost to Follow-up|1|||
163159154|NCT02273596|589296407|FG000|Extension Period|Protocol Deviation|1|||
163159155|NCT02139592|589296409|FG000|Overall Study|Case Report Forms Uncollected|8|||
163159156|NCT02873702|589296414|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
163159157|NCT02873702|589296415|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
163159158|NCT02873702|589296416|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
163159159|NCT02873702|589296417|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
163159160|NCT02873702|589296414|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
163159161|NCT02873702|589296415|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
163159162|NCT02873702|589296416|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
163159163|NCT02873702|589296417|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
163159164|NCT02873702|589296414|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
163159165|NCT02873702|589296415|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
163159166|NCT02873702|589296416|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
163159167|NCT02873702|589296417|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
163159168|NCT02873702|589296414|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
163159169|NCT02873702|589296415|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
163159170|NCT02873702|589296416|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
163159171|NCT02873702|589296417|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
163159172|NCT02873702|589296414|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
163159173|NCT02873702|589296415|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
163159174|NCT02873702|589296416|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
163159175|NCT02873702|589296417|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
163159176|NCT01177397|589296418|FG000|Overall Study|Protocol Violation|0|||
163159177|NCT01177397|589296419|FG001|Overall Study|Protocol Violation|0|||
163159178|NCT01177397|589296420|FG002|Overall Study|Protocol Violation|0|||
163159179|NCT01177397|589296421|FG003|Overall Study|Protocol Violation|0|||
163159180|NCT01177397|589296422|FG004|Overall Study|Protocol Violation|0|||
163159181|NCT01177397|589296423|FG005|Overall Study|Protocol Violation|1|||
163159182|NCT01177397|589296424|FG006|Overall Study|Protocol Violation|0|||
163159183|NCT01177397|589296425|FG007|Overall Study|Protocol Violation|0|||
163159184|NCT01177397|589296426|FG008|Overall Study|Protocol Violation|0|||
163159185|NCT01177397|589296427|FG009|Overall Study|Protocol Violation|0|||
163159186|NCT01177397|589296428|FG010|Overall Study|Protocol Violation|0|||
163159187|NCT01177397|589296429|FG011|Overall Study|Protocol Violation|0|||
163159188|NCT01177397|589296418|FG000|Overall Study|Lost to Follow-up|0|||
163159189|NCT01177397|589296419|FG001|Overall Study|Lost to Follow-up|0|||
163159190|NCT01177397|589296420|FG002|Overall Study|Lost to Follow-up|0|||
163159191|NCT01177397|589296421|FG003|Overall Study|Lost to Follow-up|0|||
163159192|NCT01177397|589296422|FG004|Overall Study|Lost to Follow-up|1|||
163159193|NCT01177397|589296423|FG005|Overall Study|Lost to Follow-up|0|||
163159194|NCT01177397|589296424|FG006|Overall Study|Lost to Follow-up|0|||
163159195|NCT01177397|589296425|FG007|Overall Study|Lost to Follow-up|2|||
163159196|NCT01177397|589296426|FG008|Overall Study|Lost to Follow-up|0|||
163159197|NCT01177397|589296427|FG009|Overall Study|Lost to Follow-up|0|||
163159198|NCT01177397|589296428|FG010|Overall Study|Lost to Follow-up|0|||
163159199|NCT01177397|589296429|FG011|Overall Study|Lost to Follow-up|0|||
163159200|NCT01177397|589296418|FG000|Overall Study|Death|0|||
163159201|NCT01177397|589296419|FG001|Overall Study|Death|0|||
163159202|NCT01177397|589296420|FG002|Overall Study|Death|1|||
163159203|NCT01177397|589296421|FG003|Overall Study|Death|1|||
163159204|NCT01177397|589296422|FG004|Overall Study|Death|0|||
163159205|NCT01177397|589296423|FG005|Overall Study|Death|0|||
163159206|NCT01177397|589296424|FG006|Overall Study|Death|0|||
163159207|NCT01177397|589296425|FG007|Overall Study|Death|5|||
163159208|NCT01177397|589296426|FG008|Overall Study|Death|2|||
163159209|NCT01177397|589296427|FG009|Overall Study|Death|1|||
163159210|NCT01177397|589296428|FG010|Overall Study|Death|0|||
163159211|NCT01177397|589296429|FG011|Overall Study|Death|0|||
163159212|NCT01177397|589296418|FG000|Overall Study|Withdrawal by Subject|0|||
163159213|NCT01177397|589296419|FG001|Overall Study|Withdrawal by Subject|0|||
163272055|NCT00672958|589705092|FG000|Overall Study|Reason not specified|0|||
163272056|NCT00672958|589705093|FG001|Overall Study|Reason not specified|3|||
163272057|NCT02374593|589705094|FG000|Overall Study|non-compliant|2|||
163272058|NCT02374593|589705095|FG001|Overall Study|non-compliant|0|||
163272059|NCT01009047|589705098|FG000|Overall Study|Adverse Event|5|||
163272060|NCT01009047|589705099|FG001|Overall Study|Adverse Event|0|||
163272061|NCT01009047|589705098|FG000|Overall Study|Lost to Follow-up|0|||
163272062|NCT01009047|589705099|FG001|Overall Study|Lost to Follow-up|2|||
163272063|NCT01009047|589705098|FG000|Overall Study|Lack of Efficacy|4|||
163272064|NCT01009047|589705099|FG001|Overall Study|Lack of Efficacy|11|||
163272065|NCT01009047|589705098|FG000|Overall Study|Withdrawal by consent|16|||
163272066|NCT01009047|589705099|FG001|Overall Study|Withdrawal by consent|11|||
163272067|NCT01009047|589705098|FG000|Overall Study|Other|3|||
163272068|NCT01009047|589705099|FG001|Overall Study|Other|2|||
163272069|NCT02443103|589705102|FG000|Overall Study|Adverse Event|2|||
163272070|NCT02443103|589705102|FG000|Overall Study|Noncompliance|1|||
163272071|NCT02366936|589705104|FG000|Overall Study|Withdrawal by Subject|2|||
163272072|NCT02366936|589705104|FG000|Overall Study|Lost to Follow-up|4|||
163272073|NCT02366936|589705104|FG000|Overall Study|Physician Decision|2|||
163272074|NCT02878213|589705105|FG000|Overall Study|Withdrawal by Subject|2|||
163272075|NCT02878213|589705105|FG000|Overall Study|Adverse Event|1|||
163272076|NCT01558674|589705106|FG000|Part 1|Study Terminated by Sponsor|10|||
163272077|NCT01558674|589705107|FG001|Part 1|Study Terminated by Sponsor|0|||
163272078|NCT01558674|589705106|FG000|Part 1|Withdrawal by Subject|1|||
163272079|NCT01558674|589705107|FG001|Part 1|Withdrawal by Subject|0|||
163272080|NCT01555021|589705110|FG000|Overall Study|Lost to Follow-up|1|||
163272081|NCT01555021|589705111|FG001|Overall Study|Lost to Follow-up|2|||
163272082|NCT01313923|589705112|FG000|Overall Study|Physician Decision|3|||
163272083|NCT01388530|589705113|FG000|Overall Study|Lost to Follow-up|5|||
163272084|NCT02204293|589705114|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
163272085|NCT02204293|589705115|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
163272086|NCT02204293|589705116|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
163272087|NCT02204293|589705117|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
163272088|NCT02204293|589705118|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
163272089|NCT02204293|589705119|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
163272090|NCT02204293|589705114|FG000|Core Study Part I|Adverse Event|1|||
163272091|NCT02204293|589705115|FG001|Core Study Part I|Adverse Event|0|||
163272092|NCT02204293|589705116|FG002|Core Study Part I|Adverse Event|0|||
163272093|NCT02204293|589705117|FG003|Core Study Part I|Adverse Event|0|||
163272094|NCT02204293|589705118|FG004|Core Study Part I|Adverse Event|0|||
163272095|NCT02204293|589705119|FG005|Core Study Part I|Adverse Event|0|||
163272096|NCT02204293|589705114|FG000|Core Study Part I|Physician Decision|0|||
163272097|NCT02204293|589705115|FG001|Core Study Part I|Physician Decision|3|||
163272098|NCT02204293|589705116|FG002|Core Study Part I|Physician Decision|0|||
163272099|NCT02204293|589705117|FG003|Core Study Part I|Physician Decision|0|||
163272100|NCT02204293|589705118|FG004|Core Study Part I|Physician Decision|0|||
163272101|NCT02204293|589705119|FG005|Core Study Part I|Physician Decision|0|||
163272102|NCT02204293|589705114|FG000|LTE Phase|Study Suspended|0|||
163272103|NCT02204293|589705115|FG001|LTE Phase|Study Suspended|0|||
163159214|NCT01177397|589296420|FG002|Overall Study|Withdrawal by Subject|1|||
163272104|NCT02204293|589705116|FG002|LTE Phase|Study Suspended|0|||
163272105|NCT02204293|589705117|FG003|LTE Phase|Study Suspended|0|||
163272106|NCT02204293|589705118|FG004|LTE Phase|Study Suspended|0|||
163272107|NCT02204293|589705119|FG005|LTE Phase|Study Suspended|7|||
163272108|NCT02420327|589705120|FG000|Overall Study|Adverse Event|7|||
163272109|NCT02420327|589705120|FG000|Overall Study|Pregnancy|1|||
163272110|NCT02420327|589705120|FG000|Overall Study|Withdrawal by Subject|6|||
163272111|NCT02420327|589705120|FG000|Overall Study|Lost to Follow-up|1|||
163272112|NCT02420327|589705120|FG000|Overall Study|Protocol Violation|1|||
163272113|NCT01225835|589705123|FG000|Overall Study|Completed protocol|2|||
163272114|NCT01225835|589705124|FG001|Overall Study|Completed protocol|1|||
163159215|NCT01177397|589296421|FG003|Overall Study|Withdrawal by Subject|1|||
163272115|NCT01225835|589705123|FG000|Overall Study|Did not meet hCG criterion|2|||
163272116|NCT01225835|589705124|FG001|Overall Study|Did not meet hCG criterion|0|||
163272117|NCT01225835|589705123|FG000|Overall Study|Adverse Event|2|||
163272118|NCT01225835|589705124|FG001|Overall Study|Adverse Event|1|||
163272119|NCT01225835|589705123|FG000|Overall Study|Other|1|||
163159216|NCT01177397|589296422|FG004|Overall Study|Withdrawal by Subject|1|||
163272120|NCT01225835|589705124|FG001|Overall Study|Other|1|||
163272121|NCT01146574|589705125|FG000|Overall Study|Death|0|||
163272122|NCT01146574|589705126|FG001|Overall Study|Death|1|||
163272123|NCT01146574|589705127|FG002|Overall Study|Death|1|||
163272124|NCT01146574|589705128|FG003|Overall Study|Death|0|||
163272125|NCT01146574|589705129|FG004|Overall Study|Death|0|||
163272126|NCT01146574|589705130|FG005|Overall Study|Death|0|||
163272127|NCT01146574|589705131|FG006|Overall Study|Death|0|||
163272128|NCT01146574|589705125|FG000|Overall Study|Other reasons|0|||
163272129|NCT01146574|589705126|FG001|Overall Study|Other reasons|0|||
163272130|NCT01146574|589705127|FG002|Overall Study|Other reasons|3|||
163272131|NCT01146574|589705128|FG003|Overall Study|Other reasons|0|||
163272132|NCT01146574|589705129|FG004|Overall Study|Other reasons|0|||
163272133|NCT01146574|589705130|FG005|Overall Study|Other reasons|0|||
163272134|NCT01146574|589705131|FG006|Overall Study|Other reasons|0|||
163272135|NCT01146574|589705125|FG000|Overall Study|Kidney transplant|0|||
163272136|NCT01146574|589705126|FG001|Overall Study|Kidney transplant|0|||
163272137|NCT01146574|589705127|FG002|Overall Study|Kidney transplant|1|||
163272138|NCT01146574|589705128|FG003|Overall Study|Kidney transplant|1|||
163272139|NCT01146574|589705129|FG004|Overall Study|Kidney transplant|0|||
163272140|NCT01146574|589705130|FG005|Overall Study|Kidney transplant|0|||
163272141|NCT01146574|589705131|FG006|Overall Study|Kidney transplant|0|||
163272142|NCT01146574|589705125|FG000|Overall Study|Withdrew consent|0|||
163272143|NCT01146574|589705126|FG001|Overall Study|Withdrew consent|0|||
163272144|NCT01146574|589705127|FG002|Overall Study|Withdrew consent|1|||
163272145|NCT01146574|589705128|FG003|Overall Study|Withdrew consent|1|||
163272146|NCT01146574|589705129|FG004|Overall Study|Withdrew consent|2|||
163272147|NCT01146574|589705130|FG005|Overall Study|Withdrew consent|1|||
163272148|NCT01146574|589705131|FG006|Overall Study|Withdrew consent|1|||
163272149|NCT01266993|589705132|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
163272150|NCT01266993|589705133|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
163272151|NCT01266993|589705132|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
163272152|NCT01266993|589705133|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
163272153|NCT00876460|589705140|FG000|Combination Therapy Phase|Progressive disease|2|||
163272154|NCT00876460|589705141|FG001|Combination Therapy Phase|Progressive disease|3|||
163272155|NCT00876460|589705142|FG002|Combination Therapy Phase|Progressive disease|3|||
163272156|NCT00876460|589705143|FG003|Combination Therapy Phase|Progressive disease|3|||
163272157|NCT00876460|589705144|FG004|Combination Therapy Phase|Progressive disease|3|||
163272158|NCT00876460|589705145|FG005|Combination Therapy Phase|Progressive disease|1|||
163272159|NCT00876460|589705146|FG006|Combination Therapy Phase|Progressive disease|1|||
163272160|NCT00876460|589705147|FG007|Combination Therapy Phase|Progressive disease|1|||
163272161|NCT00876460|589705140|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
163272162|NCT00876460|589705141|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
163272163|NCT00876460|589705142|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
163272164|NCT00876460|589705143|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
163272165|NCT00876460|589705144|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
163272166|NCT00876460|589705145|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
163272167|NCT00876460|589705146|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
163272168|NCT00876460|589705147|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
163272169|NCT00876460|589705140|FG000|Combination Therapy Phase|Adverse Event|0|||
163272170|NCT00876460|589705141|FG001|Combination Therapy Phase|Adverse Event|2|||
163272171|NCT00876460|589705142|FG002|Combination Therapy Phase|Adverse Event|0|||
163272172|NCT00876460|589705143|FG003|Combination Therapy Phase|Adverse Event|2|||
163272173|NCT00876460|589705144|FG004|Combination Therapy Phase|Adverse Event|2|||
163272174|NCT00876460|589705145|FG005|Combination Therapy Phase|Adverse Event|0|||
163272175|NCT00876460|589705146|FG006|Combination Therapy Phase|Adverse Event|3|||
163272176|NCT00876460|589705147|FG007|Combination Therapy Phase|Adverse Event|2|||
163272177|NCT00876460|589705140|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
163272178|NCT00876460|589705141|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
163272179|NCT00876460|589705142|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
163272180|NCT00876460|589705143|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
163272181|NCT00876460|589705144|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
163272182|NCT00876460|589705145|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
163272183|NCT00876460|589705146|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
163272184|NCT00876460|589705147|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
163272185|NCT00876460|589705140|FG000|Combination Therapy Phase|Other reason not defined above|0|||
163272186|NCT00876460|589705141|FG001|Combination Therapy Phase|Other reason not defined above|0|||
163272187|NCT00876460|589705142|FG002|Combination Therapy Phase|Other reason not defined above|0|||
163272188|NCT00876460|589705143|FG003|Combination Therapy Phase|Other reason not defined above|0|||
163272189|NCT00876460|589705144|FG004|Combination Therapy Phase|Other reason not defined above|0|||
163272190|NCT00876460|589705145|FG005|Combination Therapy Phase|Other reason not defined above|0|||
163272191|NCT00876460|589705146|FG006|Combination Therapy Phase|Other reason not defined above|1|||
163272192|NCT00876460|589705147|FG007|Combination Therapy Phase|Other reason not defined above|2|||
163272193|NCT00876460|589705140|FG000|Combination Therapy Phase|Not treated|0|||
163272194|NCT00876460|589705141|FG001|Combination Therapy Phase|Not treated|0|||
163272195|NCT00876460|589705142|FG002|Combination Therapy Phase|Not treated|0|||
163272196|NCT00876460|589705143|FG003|Combination Therapy Phase|Not treated|0|||
163159217|NCT01177397|589296423|FG005|Overall Study|Withdrawal by Subject|2|||
163159218|NCT01177397|589296424|FG006|Overall Study|Withdrawal by Subject|0|||
163159219|NCT01177397|589296425|FG007|Overall Study|Withdrawal by Subject|5|||
163159220|NCT01177397|589296426|FG008|Overall Study|Withdrawal by Subject|9|||
163159221|NCT01177397|589296427|FG009|Overall Study|Withdrawal by Subject|1|||
163159222|NCT01177397|589296428|FG010|Overall Study|Withdrawal by Subject|1|||
163159223|NCT01177397|589296429|FG011|Overall Study|Withdrawal by Subject|0|||
163159224|NCT01177397|589296418|FG000|Overall Study|Adverse Event|0|||
163159225|NCT01177397|589296419|FG001|Overall Study|Adverse Event|0|||
163159226|NCT01177397|589296420|FG002|Overall Study|Adverse Event|1|||
163159227|NCT01177397|589296421|FG003|Overall Study|Adverse Event|2|||
163159228|NCT01177397|589296422|FG004|Overall Study|Adverse Event|0|||
163159229|NCT01177397|589296423|FG005|Overall Study|Adverse Event|12|||
163159230|NCT01177397|589296424|FG006|Overall Study|Adverse Event|1|||
163159231|NCT01177397|589296425|FG007|Overall Study|Adverse Event|14|||
163159232|NCT01177397|589296426|FG008|Overall Study|Adverse Event|8|||
163159233|NCT01177397|589296427|FG009|Overall Study|Adverse Event|6|||
163159234|NCT01177397|589296428|FG010|Overall Study|Adverse Event|3|||
163159235|NCT01177397|589296429|FG011|Overall Study|Adverse Event|7|||
163159236|NCT01177397|589296418|FG000|Overall Study|Disease progression|1|||
163159237|NCT01177397|589296419|FG001|Overall Study|Disease progression|2|||
163159238|NCT01177397|589296420|FG002|Overall Study|Disease progression|5|||
163159239|NCT01177397|589296421|FG003|Overall Study|Disease progression|5|||
163159240|NCT01177397|589296422|FG004|Overall Study|Disease progression|4|||
163159241|NCT01177397|589296423|FG005|Overall Study|Disease progression|10|||
163159242|NCT01177397|589296424|FG006|Overall Study|Disease progression|10|||
163159243|NCT01177397|589296425|FG007|Overall Study|Disease progression|21|||
163159244|NCT01177397|589296426|FG008|Overall Study|Disease progression|18|||
163159245|NCT01177397|589296427|FG009|Overall Study|Disease progression|12|||
163159246|NCT01177397|589296428|FG010|Overall Study|Disease progression|10|||
163159247|NCT01177397|589296429|FG011|Overall Study|Disease progression|8|||
163159248|NCT01177397|589296418|FG000|Overall Study|Other reasons|0|||
163159249|NCT01177397|589296419|FG001|Overall Study|Other reasons|0|||
163159250|NCT01177397|589296420|FG002|Overall Study|Other reasons|1|||
163159251|NCT01177397|589296421|FG003|Overall Study|Other reasons|0|||
163159252|NCT01177397|589296422|FG004|Overall Study|Other reasons|1|||
163159253|NCT01177397|589296423|FG005|Overall Study|Other reasons|1|||
163159254|NCT01177397|589296424|FG006|Overall Study|Other reasons|2|||
163159255|NCT01177397|589296425|FG007|Overall Study|Other reasons|6|||
163159256|NCT01177397|589296426|FG008|Overall Study|Other reasons|10|||
163159257|NCT01177397|589296427|FG009|Overall Study|Other reasons|8|||
163159258|NCT01177397|589296428|FG010|Overall Study|Other reasons|0|||
163159259|NCT01177397|589296429|FG011|Overall Study|Other reasons|2|||
163159260|NCT01528969|589296430|FG000|Overall Study|absent from the school at baseline|2|||
163159261|NCT01528969|589296431|FG001|Overall Study|absent from the school at baseline|0|||
163159262|NCT03085797|589296432|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
163159263|NCT03085797|589296433|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
163159264|NCT03085797|589296432|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
163159265|NCT03085797|589296433|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
163159266|NCT03085797|589296432|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
163159267|NCT03085797|589296433|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
163159268|NCT01554241|589296436|FG000|Overall Study|Death|3|||
163159269|NCT01554241|589296437|FG001|Overall Study|Death|1|||
163159270|NCT01554241|589296438|FG002|Overall Study|Death|1|||
163159271|NCT01554241|589296439|FG003|Overall Study|Death|0|||
163159272|NCT01554241|589296436|FG000|Overall Study|protocol specified renal stone|0|||
163159273|NCT01554241|589296437|FG001|Overall Study|protocol specified renal stone|0|||
163159274|NCT01554241|589296438|FG002|Overall Study|protocol specified renal stone|0|||
163159275|NCT01554241|589296439|FG003|Overall Study|protocol specified renal stone|1|||
163159276|NCT01554241|589296436|FG000|Overall Study|protocol specified change in eGFR|0|||
163159277|NCT01554241|589296437|FG001|Overall Study|protocol specified change in eGFR|0|||
163159278|NCT01554241|589296438|FG002|Overall Study|protocol specified change in eGFR|1|||
163159279|NCT01554241|589296439|FG003|Overall Study|protocol specified change in eGFR|0|||
163159280|NCT01554241|589296436|FG000|Overall Study|Withdrawal by Subject|0|||
163159281|NCT01554241|589296437|FG001|Overall Study|Withdrawal by Subject|0|||
163159282|NCT01554241|589296438|FG002|Overall Study|Withdrawal by Subject|2|||
163159283|NCT01554241|589296439|FG003|Overall Study|Withdrawal by Subject|0|||
163159284|NCT05661409|589296440|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
163159285|NCT05661409|589296441|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
163159286|NCT05661409|589296442|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
163159287|NCT05661409|589296443|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
163159288|NCT05661409|589296444|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
163159289|NCT05661409|589296445|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
163159290|NCT05661409|589296440|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
163159291|NCT05661409|589296441|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
163159292|NCT05661409|589296442|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
163159293|NCT05661409|589296443|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
163159294|NCT05661409|589296444|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
163159295|NCT05661409|589296445|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
163159296|NCT05661409|589296440|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
163159297|NCT05661409|589296441|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
163159298|NCT05661409|589296442|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
163159299|NCT05661409|589296443|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
163159300|NCT05661409|589296444|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
163159301|NCT05661409|589296445|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
163159302|NCT05661409|589296440|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
163159303|NCT05661409|589296441|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
163159304|NCT05661409|589296442|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
163159305|NCT05661409|589296443|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
163159306|NCT05661409|589296444|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
163159307|NCT05661409|589296445|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
163159308|NCT05661409|589296440|FG000|Overall Study|Miscommu-nication about administration|0|||
163159309|NCT05661409|589296441|FG001|Overall Study|Miscommu-nication about administration|0|||
163159310|NCT05661409|589296442|FG002|Overall Study|Miscommu-nication about administration|0|||
163159311|NCT05661409|589296443|FG003|Overall Study|Miscommu-nication about administration|0|||
163159312|NCT05661409|589296444|FG004|Overall Study|Miscommu-nication about administration|0|||
163159313|NCT05661409|589296445|FG005|Overall Study|Miscommu-nication about administration|1|||
163159314|NCT03198507|589296446|FG000|Overall Study|Withdrawal by Subject|1|||
163159315|NCT03198507|589296447|FG001|Overall Study|Withdrawal by Subject|0|||
163159316|NCT00724698|589296448|FG000|Overall Study|Adverse Event|9|||
163159317|NCT00724698|589296448|FG000|Overall Study|Failure of Therapy|4|||
163159318|NCT00724698|589296448|FG000|Overall Study|Poor Compliance|16|||
163159319|NCT00724698|589296448|FG000|Overall Study|Lost to Follow-up|36|||
163159320|NCT00724698|589296448|FG000|Overall Study|No Info|25|||
163159321|NCT04614974|589296449|FG000|Overall Study|Lost to Follow-up|14|||
163159322|NCT04614974|589296450|FG001|Overall Study|Lost to Follow-up|11|||
163159323|NCT00658359|589296452|FG000|Overall Study|Death|3|||
163159324|NCT00658359|589296453|FG001|Overall Study|Death|1|||
163159325|NCT00658359|589296454|FG002|Overall Study|Death|2|||
163159326|NCT00658359|589296452|FG000|Overall Study|Adverse Event|13|||
163159327|NCT00658359|589296453|FG001|Overall Study|Adverse Event|6|||
163159328|NCT00658359|589296454|FG002|Overall Study|Adverse Event|9|||
163159329|NCT00658359|589296452|FG000|Overall Study|Protocol Violation|1|||
163159330|NCT00658359|589296453|FG001|Overall Study|Protocol Violation|0|||
163159331|NCT00658359|589296454|FG002|Overall Study|Protocol Violation|0|||
163159332|NCT00658359|589296452|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
163159333|NCT00658359|589296453|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
163159334|NCT00658359|589296454|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
163159335|NCT00658359|589296452|FG000|Overall Study|Withdrawal by Subject|7|||
163159336|NCT00658359|589296453|FG001|Overall Study|Withdrawal by Subject|4|||
163272197|NCT00876460|589705144|FG004|Combination Therapy Phase|Not treated|0|||
163272198|NCT00876460|589705145|FG005|Combination Therapy Phase|Not treated|0|||
163272199|NCT00876460|589705146|FG006|Combination Therapy Phase|Not treated|1|||
163272200|NCT00876460|589705147|FG007|Combination Therapy Phase|Not treated|0|||
163272201|NCT00876460|589705140|FG000|Mono Therapy Phase|Progressive disease|0|||
163272202|NCT00876460|589705141|FG001|Mono Therapy Phase|Progressive disease|0|||
163272203|NCT00876460|589705142|FG002|Mono Therapy Phase|Progressive disease|0|||
163272204|NCT00876460|589705143|FG003|Mono Therapy Phase|Progressive disease|0|||
163159337|NCT00658359|589296454|FG002|Overall Study|Withdrawal by Subject|2|||
163159338|NCT00658359|589296452|FG000|Overall Study|Lost to Follow-up|2|||
163159339|NCT00658359|589296453|FG001|Overall Study|Lost to Follow-up|2|||
163159340|NCT00658359|589296454|FG002|Overall Study|Lost to Follow-up|4|||
163159341|NCT00658359|589296452|FG000|Overall Study|Lack of Efficacy|0|||
163159342|NCT00658359|589296453|FG001|Overall Study|Lack of Efficacy|1|||
163159343|NCT00658359|589296454|FG002|Overall Study|Lack of Efficacy|0|||
163159344|NCT02560558|589296455|FG000|Overall Study|Adverse Event|1|||
163159345|NCT02560558|589296456|FG001|Overall Study|Adverse Event|0|||
163159346|NCT02560558|589296455|FG000|Overall Study|Death|0|||
163159347|NCT02560558|589296456|FG001|Overall Study|Death|2|||
163159348|NCT02560558|589296455|FG000|Overall Study|Lost to Follow-up|0|||
163159349|NCT02560558|589296456|FG001|Overall Study|Lost to Follow-up|4|||
163159350|NCT02560558|589296455|FG000|Overall Study|Protocol Violation|3|||
163159351|NCT02560558|589296456|FG001|Overall Study|Protocol Violation|0|||
163159352|NCT02560558|589296455|FG000|Overall Study|Withdrawal by Subject|3|||
163272205|NCT00876460|589705144|FG004|Mono Therapy Phase|Progressive disease|2|||
163272206|NCT00876460|589705145|FG005|Mono Therapy Phase|Progressive disease|0|||
163159353|NCT02560558|589296456|FG001|Overall Study|Withdrawal by Subject|0|||
163159354|NCT02819804|589296457|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
163159355|NCT02858362|589296458|FG000|Overall Study|Protocol Violation|0|||
163159356|NCT02858362|589296459|FG001|Overall Study|Protocol Violation|1|||
163159357|NCT02858362|589296460|FG002|Overall Study|Protocol Violation|0|||
163159358|NCT02858362|589296458|FG000|Overall Study|Withdrawal by Subject|1|||
163159359|NCT02858362|589296459|FG001|Overall Study|Withdrawal by Subject|0|||
163159360|NCT02858362|589296460|FG002|Overall Study|Withdrawal by Subject|0|||
163159361|NCT02858362|589296458|FG000|Overall Study|Early Study Termination|0|||
163159362|NCT02858362|589296459|FG001|Overall Study|Early Study Termination|0|||
163159363|NCT02858362|589296460|FG002|Overall Study|Early Study Termination|3|||
163159364|NCT02858362|589296458|FG000|Overall Study|Lost to Follow-up|1|||
163159365|NCT02858362|589296459|FG001|Overall Study|Lost to Follow-up|0|||
163159366|NCT02858362|589296460|FG002|Overall Study|Lost to Follow-up|0|||
163159367|NCT03967444|589296461|FG000|Overall Study|Lost to Follow-up|1|||
163159368|NCT03967444|589296462|FG001|Overall Study|Lost to Follow-up|2|||
163159369|NCT01821118|589296468|FG000|Overall Study|Death|0|||
163159370|NCT01821118|589296469|FG001|Overall Study|Death|1|||
163159371|NCT00686686|589296470|FG000|Overall Study|Non-compliance|1|||
163159372|NCT00686686|589296470|FG000|Overall Study|Adverse Event|2|||
163159373|NCT00686686|589296470|FG000|Overall Study|Lost to Follow-up|3|||
163159374|NCT00131248|589296471|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
163159375|NCT00131248|589296472|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
163159376|NCT05038982|589296475|FG000|Overall Study|Withdrawal by Subject|0|||
163159377|NCT05038982|589296476|FG001|Overall Study|Withdrawal by Subject|2|||
163159378|NCT01519921|589296486|FG000|Overall Study|Adverse Event|10|||
163159379|NCT01519921|589296487|FG001|Overall Study|Adverse Event|9|||
163159380|NCT01519921|589296486|FG000|Overall Study|Lack of Efficacy|4|||
163159381|NCT01519921|589296487|FG001|Overall Study|Lack of Efficacy|3|||
163159382|NCT01519921|589296486|FG000|Overall Study|Withdrawal by Subject|3|||
163159383|NCT01519921|589296487|FG001|Overall Study|Withdrawal by Subject|0|||
163159384|NCT01519921|589296486|FG000|Overall Study|Lost to Follow-up|2|||
163159385|NCT01519921|589296487|FG001|Overall Study|Lost to Follow-up|1|||
163159386|NCT01519921|589296486|FG000|Overall Study|Treatment refusal|2|||
163159387|NCT01519921|589296487|FG001|Overall Study|Treatment refusal|1|||
163159388|NCT01519921|589296486|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
163159389|NCT01519921|589296487|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
163159390|NCT04032093|589296490|FG000|Overall Study|Lost to Follow-up|7|||
163159391|NCT04032093|589296491|FG001|Overall Study|Lost to Follow-up|7|||
163159392|NCT04032093|589296492|FG002|Overall Study|Lost to Follow-up|6|||
163159393|NCT04032093|589296493|FG003|Overall Study|Lost to Follow-up|10|||
163159394|NCT04032093|589296494|FG004|Overall Study|Lost to Follow-up|13|||
163159395|NCT04032093|589296495|FG005|Overall Study|Lost to Follow-up|7|||
163159396|NCT04032093|589296496|FG006|Overall Study|Lost to Follow-up|7|||
163159397|NCT04032093|589296497|FG007|Overall Study|Lost to Follow-up|5|||
163159398|NCT04032093|589296498|FG008|Overall Study|Lost to Follow-up|9|||
163159399|NCT04032093|589296499|FG009|Overall Study|Lost to Follow-up|12|||
163159400|NCT04032093|589296490|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
163159401|NCT04032093|589296491|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
163159402|NCT04032093|589296492|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
163159403|NCT04032093|589296493|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
163159404|NCT04032093|589296494|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
163159405|NCT04032093|589296495|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
163159406|NCT04032093|589296496|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
163159407|NCT04032093|589296497|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
163159408|NCT04032093|589296498|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
163159409|NCT04032093|589296499|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
163159410|NCT04032093|589296490|FG000|Overall Study|Other|1|||
163159411|NCT04032093|589296491|FG001|Overall Study|Other|0|||
163159412|NCT04032093|589296492|FG002|Overall Study|Other|0|||
163159413|NCT04032093|589296493|FG003|Overall Study|Other|1|||
163272207|NCT00876460|589705146|FG006|Mono Therapy Phase|Progressive disease|1|||
163272208|NCT00876460|589705147|FG007|Mono Therapy Phase|Progressive disease|3|||
163272209|NCT00876460|589705140|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
163272210|NCT00876460|589705141|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
163272211|NCT00876460|589705142|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
163159414|NCT04032093|589296494|FG004|Overall Study|Other|1|||
163159415|NCT04032093|589296495|FG005|Overall Study|Other|0|||
163159416|NCT04032093|589296496|FG006|Overall Study|Other|0|||
163159417|NCT04032093|589296497|FG007|Overall Study|Other|0|||
163159418|NCT04032093|589296498|FG008|Overall Study|Other|0|||
163159419|NCT04032093|589296499|FG009|Overall Study|Other|1|||
163159420|NCT04032093|589296490|FG000|Overall Study|Withdrawal by Subject|1|||
163159421|NCT04032093|589296491|FG001|Overall Study|Withdrawal by Subject|3|||
163159422|NCT04032093|589296492|FG002|Overall Study|Withdrawal by Subject|2|||
163159423|NCT04032093|589296493|FG003|Overall Study|Withdrawal by Subject|2|||
163159424|NCT04032093|589296494|FG004|Overall Study|Withdrawal by Subject|3|||
163159425|NCT04032093|589296495|FG005|Overall Study|Withdrawal by Subject|0|||
163159426|NCT04032093|589296496|FG006|Overall Study|Withdrawal by Subject|0|||
163159427|NCT04032093|589296497|FG007|Overall Study|Withdrawal by Subject|0|||
163159428|NCT04032093|589296498|FG008|Overall Study|Withdrawal by Subject|0|||
163159429|NCT04032093|589296499|FG009|Overall Study|Withdrawal by Subject|0|||
163159430|NCT04032093|589296490|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163159431|NCT04032093|589296491|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163159432|NCT04032093|589296492|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163159433|NCT04032093|589296493|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163159434|NCT04032093|589296494|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
163159435|NCT04032093|589296495|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
163159436|NCT04032093|589296496|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
163159437|NCT04032093|589296497|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
163159438|NCT04032093|589296498|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
163159439|NCT04032093|589296499|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
163159440|NCT04032093|589296490|FG000|Overall Study|Adverse Event|0|||
163159441|NCT04032093|589296491|FG001|Overall Study|Adverse Event|0|||
163159442|NCT04032093|589296492|FG002|Overall Study|Adverse Event|0|||
163159443|NCT04032093|589296493|FG003|Overall Study|Adverse Event|0|||
163159444|NCT04032093|589296494|FG004|Overall Study|Adverse Event|0|||
163159445|NCT04032093|589296495|FG005|Overall Study|Adverse Event|0|||
163159446|NCT04032093|589296496|FG006|Overall Study|Adverse Event|0|||
163159447|NCT04032093|589296497|FG007|Overall Study|Adverse Event|0|||
163159448|NCT04032093|589296498|FG008|Overall Study|Adverse Event|0|||
163159449|NCT04032093|589296499|FG009|Overall Study|Adverse Event|1|||
163159450|NCT04032093|589296490|FG000|Overall Study|Physician Decision|0|||
163159451|NCT04032093|589296491|FG001|Overall Study|Physician Decision|0|||
163159452|NCT04032093|589296492|FG002|Overall Study|Physician Decision|0|||
163159453|NCT04032093|589296493|FG003|Overall Study|Physician Decision|0|||
163159454|NCT04032093|589296494|FG004|Overall Study|Physician Decision|0|||
163159455|NCT04032093|589296495|FG005|Overall Study|Physician Decision|1|||
163159456|NCT04032093|589296496|FG006|Overall Study|Physician Decision|0|||
163159457|NCT04032093|589296497|FG007|Overall Study|Physician Decision|0|||
163159458|NCT04032093|589296498|FG008|Overall Study|Physician Decision|0|||
163159459|NCT04032093|589296499|FG009|Overall Study|Physician Decision|0|||
163159460|NCT02565108|589296502|FG000|Overall Study|Adverse Event|1|||
163159461|NCT02565108|589296503|FG001|Overall Study|Adverse Event|0|||
163159462|NCT02565108|589296502|FG000|Overall Study|Withdrew Consent|1|||
163159463|NCT02565108|589296503|FG001|Overall Study|Withdrew Consent|0|||
163159464|NCT01310075|589296504|FG000|Overall Study|Lost to Follow-up|1|||
163159465|NCT01310075|589296505|FG001|Overall Study|Lost to Follow-up|0|||
163159466|NCT01310075|589296504|FG000|Overall Study|Physician Decision|10|||
163159467|NCT01310075|589296505|FG001|Overall Study|Physician Decision|7|||
163159468|NCT01310075|589296504|FG000|Overall Study|Protocol Violation|2|||
163159469|NCT01310075|589296505|FG001|Overall Study|Protocol Violation|2|||
163159470|NCT01310075|589296504|FG000|Overall Study|Withdrawal by Subject|1|||
163159471|NCT01310075|589296505|FG001|Overall Study|Withdrawal by Subject|1|||
163159472|NCT02745119|589296510|FG000|Overall Study|Adverse Event|1|||
163159473|NCT02745119|589296511|FG001|Overall Study|Adverse Event|0|||
163159474|NCT02745119|589296512|FG002|Overall Study|Adverse Event|1|||
163159475|NCT02745119|589296513|FG003|Overall Study|Adverse Event|3|||
163159476|NCT02745119|589296510|FG000|Overall Study|Death|3|||
163159477|NCT02745119|589296511|FG001|Overall Study|Death|3|||
163159478|NCT02745119|589296512|FG002|Overall Study|Death|0|||
163159479|NCT02745119|589296513|FG003|Overall Study|Death|4|||
163159480|NCT02745119|589296510|FG000|Overall Study|Lost to Follow-up|0|||
163159481|NCT02745119|589296511|FG001|Overall Study|Lost to Follow-up|0|||
163159482|NCT02745119|589296512|FG002|Overall Study|Lost to Follow-up|0|||
163159483|NCT02745119|589296513|FG003|Overall Study|Lost to Follow-up|1|||
163159484|NCT02745119|589296510|FG000|Overall Study|Protocol Deviation|0|||
163159485|NCT02745119|589296511|FG001|Overall Study|Protocol Deviation|0|||
163159486|NCT02745119|589296512|FG002|Overall Study|Protocol Deviation|0|||
163159487|NCT02745119|589296513|FG003|Overall Study|Protocol Deviation|1|||
163159488|NCT02745119|589296510|FG000|Overall Study|Withdrawal by Subject|7|||
163159489|NCT02745119|589296511|FG001|Overall Study|Withdrawal by Subject|15|||
163159490|NCT02745119|589296512|FG002|Overall Study|Withdrawal by Subject|8|||
163159491|NCT02745119|589296513|FG003|Overall Study|Withdrawal by Subject|14|||
163159492|NCT02745119|589296510|FG000|Overall Study|Study Terminated by Sponsor|134|||
163159493|NCT02745119|589296511|FG001|Overall Study|Study Terminated by Sponsor|252|||
163159494|NCT02745119|589296512|FG002|Overall Study|Study Terminated by Sponsor|135|||
163159495|NCT02745119|589296513|FG003|Overall Study|Study Terminated by Sponsor|251|||
163159496|NCT02745119|589296510|FG000|Overall Study|Physician Decision|0|||
163159497|NCT02745119|589296511|FG001|Overall Study|Physician Decision|2|||
163159498|NCT02745119|589296512|FG002|Overall Study|Physician Decision|2|||
163159499|NCT02745119|589296513|FG003|Overall Study|Physician Decision|2|||
163159500|NCT02745119|589296510|FG000|Overall Study|Reason Not Specified|0|||
163159501|NCT02745119|589296511|FG001|Overall Study|Reason Not Specified|2|||
163159502|NCT02745119|589296512|FG002|Overall Study|Reason Not Specified|0|||
163159503|NCT02745119|589296513|FG003|Overall Study|Reason Not Specified|1|||
163159504|NCT01696188|589296514|FG000|Overall Study|Protocol Violation|1|||
163159505|NCT01696188|589296515|FG001|Overall Study|Protocol Violation|1|||
163159506|NCT00960999|589296516|FG000|Overall Study|Withdrawal by Subject|1|||
163159507|NCT00960999|589296517|FG001|Overall Study|Withdrawal by Subject|0|||
163159508|NCT00960999|589296516|FG000|Overall Study|Protocol Violation|5|||
163159509|NCT00960999|589296517|FG001|Overall Study|Protocol Violation|2|||
163159510|NCT00960999|589296516|FG000|Overall Study|RT dose constraints not met|2|||
163159511|NCT00960999|589296517|FG001|Overall Study|RT dose constraints not met|0|||
163159512|NCT02536963|589296518|FG000|Overall Study|Withdrawal by Subject|18|||
163159513|NCT02425943|589296519|FG000|Overall Study|Adverse Event|3|||
163159514|NCT02425943|589296520|FG001|Overall Study|Adverse Event|1|||
163159515|NCT02425943|589296519|FG000|Overall Study|Lost to Follow-up|59|||
163159516|NCT02425943|589296520|FG001|Overall Study|Lost to Follow-up|37|||
163159517|NCT02425943|589296519|FG000|Overall Study|Protocol Violation|4|||
163159518|NCT02425943|589296520|FG001|Overall Study|Protocol Violation|1|||
163159519|NCT02425943|589296519|FG000|Overall Study|Withdrawal by Subject|64|||
163159520|NCT02425943|589296520|FG001|Overall Study|Withdrawal by Subject|31|||
163159521|NCT02425943|589296519|FG000|Overall Study|Other|6|||
163159522|NCT02425943|589296520|FG001|Overall Study|Other|0|||
163159523|NCT02668393|589296521|FG000|Overall Study|Progressive disease|6|||
163159524|NCT02668393|589296522|FG001|Overall Study|Progressive disease|3|||
163159525|NCT02668393|589296521|FG000|Overall Study|Adverse Event|0|||
163159526|NCT02668393|589296522|FG001|Overall Study|Adverse Event|2|||
163159527|NCT02668393|589296521|FG000|Overall Study|Withdrawal from the trial|0|||
163159528|NCT02668393|589296522|FG001|Overall Study|Withdrawal from the trial|1|||
163159529|NCT02668393|589296521|FG000|Overall Study|Lack of benefit and side effects|1|||
163159530|NCT02668393|589296522|FG001|Overall Study|Lack of benefit and side effects|0|||
163159531|NCT02141204|589296523|FG000|Overall Study|Lost to Follow-up|2|||
163159532|NCT02141204|589296524|FG001|Overall Study|Lost to Follow-up|1|||
163159533|NCT02141204|589296523|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
163159534|NCT02141204|589296524|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
163159535|NCT02141204|589296523|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
163159536|NCT02141204|589296524|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
163159537|NCT02141204|589296523|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
163159538|NCT02141204|589296524|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
163159539|NCT01209325|589296527|FG000|Overall Study|Lost to Follow-up|24|||
163159540|NCT01209325|589296527|FG000|Overall Study|Adverse Event|1|||
163159541|NCT01209325|589296527|FG000|Overall Study|Relocated|3|||
163159542|NCT01209325|589296527|FG000|Overall Study|Refusal after starting therapy|8|||
163159543|NCT01209325|589296527|FG000|Overall Study|Protocol Violation|4|||
163159544|NCT01209325|589296527|FG000|Overall Study|Refusal prior to therapy|1|||
163159545|NCT01209325|589296527|FG000|Overall Study|Incarceration|2|||
163159546|NCT00174187|589296528|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
163159547|NCT00174187|589296529|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
163159548|NCT00174187|589296530|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
163159549|NCT00174187|589296528|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
163159550|NCT00174187|589296529|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
163159551|NCT00174187|589296530|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
163159552|NCT00174187|589296528|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
163159553|NCT00174187|589296529|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
163159554|NCT00174187|589296530|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
163159555|NCT00174187|589296528|FG000|Period 1 (up to 3 Years)|Other|0|||
163159556|NCT00174187|589296529|FG001|Period 1 (up to 3 Years)|Other|1|||
163159557|NCT00174187|589296530|FG002|Period 1 (up to 3 Years)|Other|0|||
163159558|NCT00174187|589296528|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
163159559|NCT00174187|589296529|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
163159560|NCT00174187|589296530|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
163159561|NCT00174187|589296528|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
163159562|NCT00174187|589296529|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
163159563|NCT00174187|589296530|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
163159564|NCT00174187|589296528|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
163159565|NCT00174187|589296529|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
163159566|NCT00174187|589296530|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
163159567|NCT00174187|589296528|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
163159568|NCT00174187|589296529|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
163159569|NCT00174187|589296530|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
163159570|NCT00174187|589296528|FG000|Period 2 (After 3 Years)|Other|0|||
163159571|NCT00174187|589296529|FG001|Period 2 (After 3 Years)|Other|0|||
163159572|NCT00174187|589296530|FG002|Period 2 (After 3 Years)|Other|5|||
163159573|NCT01285557|589296531|FG000|Overall Study|Death|173|||
163159574|NCT01285557|589296532|FG001|Overall Study|Death|90|||
163159575|NCT01285557|589296531|FG000|Overall Study|Lost to Follow-up|6|||
163159576|NCT01285557|589296532|FG001|Overall Study|Lost to Follow-up|2|||
163159577|NCT01285557|589296531|FG000|Overall Study|Withdrew Consent|6|||
163159578|NCT01285557|589296532|FG001|Overall Study|Withdrew Consent|1|||
163159579|NCT01285557|589296531|FG000|Overall Study|Sponsor Study Termination|23|||
163159580|NCT01285557|589296532|FG001|Overall Study|Sponsor Study Termination|13|||
163159581|NCT01285557|589296531|FG000|Overall Study|Randomized but not treated|1|||
163159582|NCT01285557|589296532|FG001|Overall Study|Randomized but not treated|1|||
163159583|NCT01285557|589296531|FG000|Overall Study|Study follow-up ongoing|28|||
163159584|NCT01285557|589296532|FG001|Overall Study|Study follow-up ongoing|14|||
163159585|NCT01285557|589296531|FG000|Overall Study|Sponsor Decision|2|||
163159586|NCT01285557|589296532|FG001|Overall Study|Sponsor Decision|1|||
163159587|NCT03529422|589296541|FG000|Overall Study|Withdrawal by Subject|1|||
163159588|NCT03529422|589296541|FG000|Overall Study|Protocol Violation|1|||
163159589|NCT03529422|589296541|FG000|Overall Study|Disease progression|2|||
163159590|NCT02000115|589296542|FG000|Overall Study|Death|56|||
163159591|NCT02000115|589296543|FG001|Overall Study|Death|45|||
163159592|NCT02000115|589296544|FG002|Overall Study|Death|0|||
163159593|NCT02000115|589296545|FG003|Overall Study|Death|0|||
163159594|NCT02000115|589296542|FG000|Overall Study|Missed Visit|6|||
163159595|NCT02000115|589296543|FG001|Overall Study|Missed Visit|8|||
163159596|NCT02000115|589296544|FG002|Overall Study|Missed Visit|1|||
163159597|NCT02000115|589296545|FG003|Overall Study|Missed Visit|0|||
163159598|NCT02000115|589296542|FG000|Overall Study|Protocol Violation|2|||
163159599|NCT02000115|589296543|FG001|Overall Study|Protocol Violation|1|||
163159600|NCT02000115|589296544|FG002|Overall Study|Protocol Violation|0|||
163159601|NCT02000115|589296545|FG003|Overall Study|Protocol Violation|0|||
163159602|NCT02000115|589296542|FG000|Overall Study|Physician Decision|2|||
163159603|NCT02000115|589296543|FG001|Overall Study|Physician Decision|0|||
163159604|NCT02000115|589296544|FG002|Overall Study|Physician Decision|0|||
163159605|NCT02000115|589296545|FG003|Overall Study|Physician Decision|0|||
163159606|NCT02000115|589296542|FG000|Overall Study|Withdrawal by Subject|11|||
163159607|NCT02000115|589296543|FG001|Overall Study|Withdrawal by Subject|11|||
163159608|NCT02000115|589296544|FG002|Overall Study|Withdrawal by Subject|0|||
163159609|NCT02000115|589296545|FG003|Overall Study|Withdrawal by Subject|0|||
163159610|NCT02000115|589296542|FG000|Overall Study|Lost to Follow-up|0|||
163159611|NCT02000115|589296543|FG001|Overall Study|Lost to Follow-up|1|||
163159612|NCT02000115|589296544|FG002|Overall Study|Lost to Follow-up|0|||
163159613|NCT02000115|589296545|FG003|Overall Study|Lost to Follow-up|0|||
163159614|NCT02000115|589296542|FG000|Overall Study|Non-compliance|2|||
163159615|NCT02000115|589296543|FG001|Overall Study|Non-compliance|1|||
163159616|NCT02000115|589296544|FG002|Overall Study|Non-compliance|0|||
163159617|NCT02000115|589296545|FG003|Overall Study|Non-compliance|0|||
163159618|NCT02000115|589296542|FG000|Overall Study|Withdrawn on day of randomization|0|||
163159619|NCT02000115|589296543|FG001|Overall Study|Withdrawn on day of randomization|1|||
163159620|NCT02000115|589296544|FG002|Overall Study|Withdrawn on day of randomization|0|||
163159621|NCT02000115|589296545|FG003|Overall Study|Withdrawn on day of randomization|0|||
163159622|NCT02000115|589296542|FG000|Overall Study|Still on Study|0|||
163159623|NCT02000115|589296543|FG001|Overall Study|Still on Study|0|||
163159624|NCT02000115|589296544|FG002|Overall Study|Still on Study|0|||
163159625|NCT02000115|589296545|FG003|Overall Study|Still on Study|53|||
163159626|NCT02484391|589296548|FG000|Overall Study|Lack of Efficacy|15|||
163159627|NCT02484391|589296549|FG001|Overall Study|Lack of Efficacy|14|||
163159628|NCT02484391|589296550|FG002|Overall Study|Lack of Efficacy|3|||
163159629|NCT02484391|589296548|FG000|Overall Study|Lost to Follow-up|0|||
163159630|NCT02484391|589296549|FG001|Overall Study|Lost to Follow-up|0|||
163159631|NCT02484391|589296550|FG002|Overall Study|Lost to Follow-up|2|||
163159632|NCT02484391|589296548|FG000|Overall Study|Physician Decision|1|||
163159633|NCT02484391|589296549|FG001|Overall Study|Physician Decision|3|||
163159634|NCT02484391|589296550|FG002|Overall Study|Physician Decision|0|||
163159635|NCT02484391|589296548|FG000|Overall Study|Went to Transplant|5|||
163159636|NCT02484391|589296549|FG001|Overall Study|Went to Transplant|3|||
163159637|NCT02484391|589296550|FG002|Overall Study|Went to Transplant|2|||
163159638|NCT04922216|589296551|FG000|Overall Study|Withdrawal by Subject|0|||
163159639|NCT04922216|589296552|FG001|Overall Study|Withdrawal by Subject|1|||
163159640|NCT04922216|589296553|FG002|Overall Study|Withdrawal by Subject|0|||
163159641|NCT04922216|589296554|FG003|Overall Study|Withdrawal by Subject|0|||
163159642|NCT04922216|589296555|FG004|Overall Study|Withdrawal by Subject|0|||
163159643|NCT04922216|589296556|FG005|Overall Study|Withdrawal by Subject|0|||
163159644|NCT04922216|589296557|FG006|Overall Study|Withdrawal by Subject|0|||
163159645|NCT04922216|589296558|FG007|Overall Study|Withdrawal by Subject|2|||
163159646|NCT04922216|589296559|FG008|Overall Study|Withdrawal by Subject|0|||
163159647|NCT04922216|589296560|FG009|Overall Study|Withdrawal by Subject|0|||
163159648|NCT04922216|589296561|FG010|Overall Study|Withdrawal by Subject|0|||
163159649|NCT04922216|589296562|FG011|Overall Study|Withdrawal by Subject|0|||
163159650|NCT04922216|589296563|FG012|Overall Study|Withdrawal by Subject|1|||
163159651|NCT04922216|589296564|FG013|Overall Study|Withdrawal by Subject|1|||
163159652|NCT04922216|589296565|FG014|Overall Study|Withdrawal by Subject|1|||
163159653|NCT04922216|589296566|FG015|Overall Study|Withdrawal by Subject|0|||
163159654|NCT04922216|589296567|FG016|Overall Study|Withdrawal by Subject|0|||
163159655|NCT04922216|589296568|FG017|Overall Study|Withdrawal by Subject|1|||
163159656|NCT04922216|589296569|FG018|Overall Study|Withdrawal by Subject|1|||
163159657|NCT04922216|589296570|FG019|Overall Study|Withdrawal by Subject|1|||
163159658|NCT04922216|589296571|FG020|Overall Study|Withdrawal by Subject|1|||
163159659|NCT04922216|589296572|FG021|Overall Study|Withdrawal by Subject|0|||
163159660|NCT04922216|589296573|FG022|Overall Study|Withdrawal by Subject|0|||
163159661|NCT04922216|589296574|FG023|Overall Study|Withdrawal by Subject|2|||
163159662|NCT04922216|589296575|FG024|Overall Study|Withdrawal by Subject|0|||
163159663|NCT04922216|589296576|FG025|Overall Study|Withdrawal by Subject|0|||
163159664|NCT04922216|589296577|FG026|Overall Study|Withdrawal by Subject|1|||
163159665|NCT04922216|589296578|FG027|Overall Study|Withdrawal by Subject|0|||
163159666|NCT04922216|589296579|FG028|Overall Study|Withdrawal by Subject|0|||
163159667|NCT04922216|589296580|FG029|Overall Study|Withdrawal by Subject|0|||
163159668|NCT04922216|589296581|FG030|Overall Study|Withdrawal by Subject|1|||
163159669|NCT04922216|589296582|FG031|Overall Study|Withdrawal by Subject|0|||
163159670|NCT04922216|589296551|FG000|Overall Study|Lost to Follow-up|1|||
163159671|NCT04922216|589296552|FG001|Overall Study|Lost to Follow-up|0|||
163159672|NCT04922216|589296553|FG002|Overall Study|Lost to Follow-up|2|||
163159673|NCT04922216|589296554|FG003|Overall Study|Lost to Follow-up|0|||
163159674|NCT04922216|589296555|FG004|Overall Study|Lost to Follow-up|0|||
163159675|NCT04922216|589296556|FG005|Overall Study|Lost to Follow-up|2|||
163159676|NCT04922216|589296557|FG006|Overall Study|Lost to Follow-up|0|||
163159677|NCT04922216|589296558|FG007|Overall Study|Lost to Follow-up|1|||
163159678|NCT04922216|589296559|FG008|Overall Study|Lost to Follow-up|1|||
163159679|NCT04922216|589296560|FG009|Overall Study|Lost to Follow-up|2|||
163159680|NCT04922216|589296561|FG010|Overall Study|Lost to Follow-up|2|||
163159681|NCT04922216|589296562|FG011|Overall Study|Lost to Follow-up|1|||
163159682|NCT04922216|589296563|FG012|Overall Study|Lost to Follow-up|1|||
163159683|NCT04922216|589296564|FG013|Overall Study|Lost to Follow-up|0|||
163159684|NCT04922216|589296565|FG014|Overall Study|Lost to Follow-up|1|||
163159685|NCT04922216|589296566|FG015|Overall Study|Lost to Follow-up|0|||
163159686|NCT04922216|589296567|FG016|Overall Study|Lost to Follow-up|0|||
163159687|NCT04922216|589296568|FG017|Overall Study|Lost to Follow-up|2|||
163159688|NCT04922216|589296569|FG018|Overall Study|Lost to Follow-up|1|||
163159689|NCT04922216|589296570|FG019|Overall Study|Lost to Follow-up|0|||
163159690|NCT04922216|589296571|FG020|Overall Study|Lost to Follow-up|1|||
163159691|NCT04922216|589296572|FG021|Overall Study|Lost to Follow-up|0|||
163159692|NCT04922216|589296573|FG022|Overall Study|Lost to Follow-up|2|||
163159693|NCT04922216|589296574|FG023|Overall Study|Lost to Follow-up|1|||
163159694|NCT04922216|589296575|FG024|Overall Study|Lost to Follow-up|0|||
163159695|NCT04922216|589296576|FG025|Overall Study|Lost to Follow-up|2|||
163159696|NCT04922216|589296577|FG026|Overall Study|Lost to Follow-up|0|||
163159697|NCT04922216|589296578|FG027|Overall Study|Lost to Follow-up|0|||
163159698|NCT04922216|589296579|FG028|Overall Study|Lost to Follow-up|1|||
163159699|NCT04922216|589296580|FG029|Overall Study|Lost to Follow-up|0|||
163159700|NCT04922216|589296581|FG030|Overall Study|Lost to Follow-up|2|||
163159701|NCT04922216|589296582|FG031|Overall Study|Lost to Follow-up|1|||
163159702|NCT03278249|589296583|FG000|Overall Study|Withdrawal by Subject|2|||
163159703|NCT03278249|589296583|FG000|Overall Study|Lost to Follow-up|1|||
163159704|NCT01442103|589297986|FG000|Overall Study|Lost to Follow-up|2|||
163159705|NCT03207763|589297992|FG000|Overall Study|Lost to Follow-up|1|||
163159706|NCT03207763|589297993|FG001|Overall Study|Lost to Follow-up|0|||
163159707|NCT02102204|589297994|FG000|Overall Study|Withdrawal by Subject|137|||
163159708|NCT02102204|589297994|FG000|Overall Study|Death|92|||
163159709|NCT02102204|589297994|FG000|Overall Study|Lost to Follow-up|65|||
163159710|NCT02102204|589297994|FG000|Overall Study|Sponsor Decision|5|||
163159711|NCT02102204|589297994|FG000|Overall Study|Ongoing|5|||
163159712|NCT02605122|589297995|FG000|Overall Study|Withdrawal by Subject|4|||
163159713|NCT02605122|589297996|FG001|Overall Study|Withdrawal by Subject|1|||
163159714|NCT02605122|589297995|FG000|Overall Study|Lost to Follow-up|1|||
163159715|NCT02605122|589297996|FG001|Overall Study|Lost to Follow-up|1|||
163159716|NCT00990704|589297997|FG000|Overall Study|Adverse Event|1|||
163159717|NCT00990704|589297998|FG001|Overall Study|Adverse Event|1|||
163159718|NCT00990704|589297997|FG000|Overall Study|Physician Decision|0|||
163159719|NCT00990704|589297998|FG001|Overall Study|Physician Decision|1|||
163159720|NCT00807001|589298000|FG000|Overall Study|Non-compliance|0|||
163159721|NCT00807001|589298001|FG001|Overall Study|Non-compliance|1|||
163272212|NCT00876460|589705143|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
163159722|NCT00807001|589298002|FG002|Overall Study|Non-compliance|0|||
163159723|NCT00807001|589298003|FG003|Overall Study|Non-compliance|0|||
163159724|NCT00807001|589298004|FG004|Overall Study|Non-compliance|0|||
163159725|NCT01399372|589298006|FG000|Overall Study|Protocol Violation|3|||
163159726|NCT01399372|589298007|FG001|Overall Study|Protocol Violation|1|||
163159727|NCT03773796|589298008|FG000|Overall Study|Adverse Event|1|||
163159728|NCT03773796|589298008|FG000|Overall Study|Withdrawal by Subject|1|||
163159729|NCT03773796|589298008|FG000|Overall Study|Lack of Efficacy|1|||
163159730|NCT03805659|589298010|FG000|Overall Study|Withdrawal by Subject|0|||
163159731|NCT03805659|589298011|FG001|Overall Study|Withdrawal by Subject|1|||
163159732|NCT01027273|589298013|FG000|Overall Study|Lost to Follow-up|57|||
163159733|NCT01027273|589298014|FG001|Overall Study|Lost to Follow-up|31|||
163159734|NCT01027273|589298013|FG000|Overall Study|Death|2|||
163159735|NCT01027273|589298014|FG001|Overall Study|Death|2|||
163159736|NCT00499616|589298022|FG000|Overall Study|Death|1|||
163159737|NCT00499616|589298023|FG001|Overall Study|Death|5|||
163159738|NCT00499616|589298024|FG002|Overall Study|Death|3|||
163159739|NCT00499616|589298025|FG003|Overall Study|Death|1|||
163159740|NCT00499616|589298022|FG000|Overall Study|Lack of Efficacy|5|||
163159741|NCT00499616|589298023|FG001|Overall Study|Lack of Efficacy|0|||
163159742|NCT00499616|589298024|FG002|Overall Study|Lack of Efficacy|19|||
163159743|NCT00499616|589298025|FG003|Overall Study|Lack of Efficacy|0|||
163159744|NCT00499616|589298022|FG000|Overall Study|Lost to Follow-up|0|||
163159745|NCT00499616|589298023|FG001|Overall Study|Lost to Follow-up|0|||
163159746|NCT00499616|589298024|FG002|Overall Study|Lost to Follow-up|1|||
163159747|NCT00499616|589298025|FG003|Overall Study|Lost to Follow-up|0|||
163159748|NCT00499616|589298022|FG000|Overall Study|Physician Decision|6|||
163159749|NCT00499616|589298023|FG001|Overall Study|Physician Decision|16|||
163159750|NCT00499616|589298024|FG002|Overall Study|Physician Decision|9|||
163159751|NCT00499616|589298025|FG003|Overall Study|Physician Decision|0|||
163159752|NCT00499616|589298022|FG000|Overall Study|Withdrawal by Subject|1|||
163159753|NCT00499616|589298023|FG001|Overall Study|Withdrawal by Subject|0|||
163159754|NCT00499616|589298024|FG002|Overall Study|Withdrawal by Subject|1|||
163159755|NCT00499616|589298025|FG003|Overall Study|Withdrawal by Subject|0|||
163159756|NCT00499616|589298022|FG000|Overall Study|Ineligible|1|||
163159757|NCT00499616|589298023|FG001|Overall Study|Ineligible|2|||
163159758|NCT00499616|589298024|FG002|Overall Study|Ineligible|0|||
163159759|NCT00499616|589298025|FG003|Overall Study|Ineligible|15|||
163159760|NCT00499616|589298022|FG000|Overall Study|Not evaluable|0|||
163159761|NCT00499616|589298023|FG001|Overall Study|Not evaluable|0|||
163159762|NCT00499616|589298024|FG002|Overall Study|Not evaluable|0|||
163159763|NCT00499616|589298025|FG003|Overall Study|Not evaluable|41|||
163159764|NCT00499616|589298022|FG000|Overall Study|Patient/Parent Refusal|1|||
163159765|NCT00499616|589298023|FG001|Overall Study|Patient/Parent Refusal|5|||
163159766|NCT00499616|589298024|FG002|Overall Study|Patient/Parent Refusal|3|||
163159767|NCT00499616|589298025|FG003|Overall Study|Patient/Parent Refusal|0|||
163159768|NCT02803580|589298026|FG000|Overall Study|Death|13|||
163159769|NCT02803580|589298026|FG000|Overall Study|Lost to Follow-up|19|||
163159770|NCT02803580|589298026|FG000|Overall Study|Withdrawal by Subject|3|||
163159771|NCT02803580|589298026|FG000|Overall Study|Inclusion in clinical trial|1|||
163159772|NCT01358721|589298027|FG000|Overall Study|Withdrawal by Subject|0|||
163159773|NCT01358721|589298028|FG001|Overall Study|Withdrawal by Subject|0|||
163159774|NCT01358721|589298029|FG002|Overall Study|Withdrawal by Subject|0|||
163159775|NCT01358721|589298030|FG003|Overall Study|Withdrawal by Subject|1|||
163159776|NCT01358721|589298027|FG000|Overall Study|Death|0|||
163159777|NCT01358721|589298028|FG001|Overall Study|Death|2|||
163159778|NCT01358721|589298029|FG002|Overall Study|Death|0|||
163159779|NCT01358721|589298030|FG003|Overall Study|Death|0|||
163159780|NCT01358721|589298027|FG000|Overall Study|Study Drug Toxicity|1|||
163159781|NCT01358721|589298028|FG001|Overall Study|Study Drug Toxicity|3|||
163159782|NCT01358721|589298029|FG002|Overall Study|Study Drug Toxicity|4|||
163159783|NCT01358721|589298030|FG003|Overall Study|Study Drug Toxicity|5|||
163159784|NCT01358721|589298027|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
163159785|NCT01358721|589298028|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
163159786|NCT01358721|589298029|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
163159787|NCT01358721|589298030|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
163159788|NCT01358721|589298027|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
163159789|NCT01358721|589298028|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
163159790|NCT01358721|589298029|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
163159791|NCT01358721|589298030|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
163159792|NCT01358721|589298027|FG000|Overall Study|Adverse Event related to study drug|1|||
163159793|NCT01358721|589298028|FG001|Overall Study|Adverse Event related to study drug|0|||
163159794|NCT01358721|589298029|FG002|Overall Study|Adverse Event related to study drug|0|||
163159795|NCT01358721|589298030|FG003|Overall Study|Adverse Event related to study drug|1|||
163159796|NCT01358721|589298027|FG000|Overall Study|Disease Progression|19|||
163159797|NCT01358721|589298028|FG001|Overall Study|Disease Progression|15|||
163159798|NCT01358721|589298029|FG002|Overall Study|Disease Progression|17|||
163159799|NCT01358721|589298030|FG003|Overall Study|Disease Progression|15|||
163159800|NCT01358721|589298027|FG000|Overall Study|Out of State/Unmet Criteria|0|||
163159801|NCT01358721|589298028|FG001|Overall Study|Out of State/Unmet Criteria|0|||
163159802|NCT01358721|589298029|FG002|Overall Study|Out of State/Unmet Criteria|1|||
163159803|NCT01358721|589298030|FG003|Overall Study|Out of State/Unmet Criteria|0|||
163159804|NCT02636595|589298031|FG000|Overall Study|Lost to Follow-up|1|||
163159805|NCT02636595|589298031|FG000|Overall Study|Other|1|||
163159806|NCT02223858|589298032|FG000|Overall Study|Death|1|||
163159807|NCT02223858|589298033|FG001|Overall Study|Death|1|||
163159808|NCT02223858|589298032|FG000|Overall Study|Lost to Follow-up|6|||
163159809|NCT02223858|589298033|FG001|Overall Study|Lost to Follow-up|11|||
163159810|NCT02223858|589298032|FG000|Overall Study|Withdrawal by Subject|8|||
163159811|NCT02223858|589298033|FG001|Overall Study|Withdrawal by Subject|5|||
163159812|NCT02223858|589298032|FG000|Overall Study|Refused|9|||
163159813|NCT02223858|589298033|FG001|Overall Study|Refused|9|||
163159814|NCT00241839|589298035|FG000|Overall Study|Withdrawal by Subject|18|||
163159815|NCT00241839|589298036|FG001|Overall Study|Withdrawal by Subject|17|||
163159816|NCT00241839|589298035|FG000|Overall Study|Adverse Event|1|||
163159817|NCT00241839|589298036|FG001|Overall Study|Adverse Event|1|||
163159818|NCT00831181|589298039|FG000|Overall Study|Adverse Event|12|||
163159819|NCT04313244|589298040|FG000|Overall Study|Withdrawal of Consent|3|||
163159820|NCT04313244|589298041|FG001|Overall Study|Withdrawal of Consent|3|||
163159821|NCT04313244|589298040|FG000|Overall Study|Met Exclusion Criteria|1|||
163159822|NCT04313244|589298041|FG001|Overall Study|Met Exclusion Criteria|0|||
163159823|NCT04313244|589298040|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
163159824|NCT04313244|589298041|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
163159825|NCT02976038|589298042|FG000|Overall Study|Physician Decision|22|||
163159826|NCT02976038|589298042|FG000|Overall Study|Withdrawal by Subject|3|||
163159827|NCT02976038|589298042|FG000|Overall Study|Lost to Follow-up|2|||
163159828|NCT02976038|589298042|FG000|Overall Study|Adverse Event|1|||
163159829|NCT05021978|589298045|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
163159830|NCT05021978|589298046|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
163159831|NCT05021978|589298047|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
163159832|NCT05021978|589298048|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
163159833|NCT05021978|589298045|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
163159834|NCT05021978|589298046|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
163159835|NCT05021978|589298047|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
163159836|NCT05021978|589298048|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
163159837|NCT00196313|589298049|FG000|Overall Study|Protocol Violation|2|||
163159838|NCT00196313|589298050|FG001|Overall Study|Protocol Violation|3|||
163159839|NCT00196313|589298049|FG000|Overall Study|Withdrawal by Subject|3|||
163159840|NCT00196313|589298050|FG001|Overall Study|Withdrawal by Subject|1|||
163159841|NCT00196313|589298049|FG000|Overall Study|Adverse Event|3|||
163159842|NCT00196313|589298050|FG001|Overall Study|Adverse Event|1|||
163159843|NCT00196313|589298049|FG000|Overall Study|Subject Pregnant|1|||
163159844|NCT00196313|589298050|FG001|Overall Study|Subject Pregnant|1|||
163159845|NCT00196313|589298049|FG000|Overall Study|Lost to Follow-up|2|||
163159846|NCT00196313|589298050|FG001|Overall Study|Lost to Follow-up|2|||
163159847|NCT00043979|589298051|FG000|Period 1|recipient with progressive disease|7|||
163159848|NCT00043979|589298052|FG001|Period 1|recipient with progressive disease|4|||
163159849|NCT00043979|589298053|FG002|Period 1|recipient with progressive disease|3|||
163159850|NCT03096288|589298055|FG000|Overall Study|Withdrawal by Subject|0|||
163159851|NCT03096288|589298056|FG001|Overall Study|Withdrawal by Subject|1|||
163159852|NCT03096288|589298057|FG002|Overall Study|Withdrawal by Subject|0|||
163159853|NCT03096288|589298058|FG003|Overall Study|Withdrawal by Subject|1|||
163159854|NCT00414596|589298060|FG000|Overall Study|Protocol Violation|2|||
163159855|NCT04639258|589298061|FG000|Overall Study|Screen failure|5|||
163159856|NCT04639258|589298061|FG000|Overall Study|Physician Decision|2|||
163159857|NCT04639258|589298061|FG000|Overall Study|Early study termination|3|||
163159858|NCT04639258|589298061|FG000|Overall Study|Withdrawal by Subject|1|||
163159859|NCT01635153|589298063|FG000|Overall Study|Lost to Follow-up|40|||
163159860|NCT01635153|589298064|FG001|Overall Study|Lost to Follow-up|43|||
163159861|NCT02754440|589298065|FG000|Overall Study|Protocol Violation|3|||
163159862|NCT02754440|589298066|FG001|Overall Study|Protocol Violation|2|||
163159863|NCT02754440|589298067|FG002|Overall Study|Protocol Violation|2|||
163159864|NCT02754440|589298068|FG003|Overall Study|Protocol Violation|6|||
163159865|NCT02754440|589298065|FG000|Overall Study|Adverse Event|3|||
163159866|NCT02754440|589298066|FG001|Overall Study|Adverse Event|1|||
163159867|NCT02754440|589298067|FG002|Overall Study|Adverse Event|0|||
163159868|NCT02754440|589298068|FG003|Overall Study|Adverse Event|9|||
163159869|NCT02754440|589298065|FG000|Overall Study|Withdrawal by Subject|0|||
163159870|NCT02754440|589298066|FG001|Overall Study|Withdrawal by Subject|0|||
163159871|NCT02754440|589298067|FG002|Overall Study|Withdrawal by Subject|0|||
163159872|NCT02754440|589298068|FG003|Overall Study|Withdrawal by Subject|1|||
163159873|NCT02754440|589298065|FG000|Overall Study|Equipment failure|0|||
163159874|NCT02754440|589298066|FG001|Overall Study|Equipment failure|5|||
163272213|NCT00876460|589705144|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
163272214|NCT00876460|589705145|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
163272215|NCT00876460|589705146|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
163272216|NCT00876460|589705147|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
163272217|NCT00876460|589705140|FG000|Mono Therapy Phase|Adverse Event|0|||
163272218|NCT00876460|589705141|FG001|Mono Therapy Phase|Adverse Event|0|||
163272219|NCT00876460|589705142|FG002|Mono Therapy Phase|Adverse Event|0|||
163272220|NCT00876460|589705143|FG003|Mono Therapy Phase|Adverse Event|1|||
163272221|NCT00876460|589705144|FG004|Mono Therapy Phase|Adverse Event|0|||
163272222|NCT00876460|589705145|FG005|Mono Therapy Phase|Adverse Event|0|||
163272223|NCT00876460|589705146|FG006|Mono Therapy Phase|Adverse Event|0|||
163272224|NCT00876460|589705147|FG007|Mono Therapy Phase|Adverse Event|0|||
163272225|NCT00003458|589705152|FG000|Overall Study|Not evaluable|4|||
163272226|NCT04714216|589707127|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
163272227|NCT04714216|589707127|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
163272228|NCT01349829|589707128|FG000|Overall Study|Lost to Follow-up|4|||
163272229|NCT01349829|589707129|FG001|Overall Study|Lost to Follow-up|8|||
163159875|NCT02754440|589298067|FG002|Overall Study|Equipment failure|5|||
163272230|NCT01349829|589707128|FG000|Overall Study|Consent withdrawal|3|||
163272231|NCT01349829|589707129|FG001|Overall Study|Consent withdrawal|8|||
163159876|NCT02754440|589298068|FG003|Overall Study|Equipment failure|7|||
163159877|NCT02754440|589298065|FG000|Overall Study|Subject issues not resulting in AE|0|||
163159878|NCT02754440|589298066|FG001|Overall Study|Subject issues not resulting in AE|0|||
163159879|NCT02754440|589298067|FG002|Overall Study|Subject issues not resulting in AE|0|||
163159880|NCT02754440|589298068|FG003|Overall Study|Subject issues not resulting in AE|12|||
163159881|NCT01189032|589298073|FG000|Overall Study|Adverse Event|1|||
163159882|NCT01189032|589298074|FG001|Overall Study|Adverse Event|3|||
163159883|NCT01189032|589298075|FG002|Overall Study|Adverse Event|4|||
163159884|NCT01189032|589298073|FG000|Overall Study|Lack of Efficacy|2|||
163159885|NCT01189032|589298074|FG001|Overall Study|Lack of Efficacy|3|||
163159886|NCT01189032|589298075|FG002|Overall Study|Lack of Efficacy|0|||
163159887|NCT01189032|589298073|FG000|Overall Study|Withdrawal by Subject|1|||
163159888|NCT01189032|589298074|FG001|Overall Study|Withdrawal by Subject|0|||
163159889|NCT01189032|589298075|FG002|Overall Study|Withdrawal by Subject|1|||
163159890|NCT01189032|589298073|FG000|Overall Study|Protocol Violation|1|||
163159891|NCT01189032|589298074|FG001|Overall Study|Protocol Violation|1|||
163159892|NCT01189032|589298075|FG002|Overall Study|Protocol Violation|1|||
163159893|NCT01995838|589298080|FG000|Overall Study|Lost to Follow-up|0|||
163159894|NCT01995838|589298081|FG001|Overall Study|Lost to Follow-up|1|||
163159895|NCT01995838|589298082|FG002|Overall Study|Lost to Follow-up|0|||
163159896|NCT01995838|589298083|FG003|Overall Study|Lost to Follow-up|0|||
163159897|NCT01995838|589298084|FG004|Overall Study|Lost to Follow-up|0|||
163159898|NCT01995838|589298085|FG005|Overall Study|Lost to Follow-up|0|||
163159899|NCT01995838|589298086|FG006|Overall Study|Lost to Follow-up|1|||
163159900|NCT01995838|589298080|FG000|Overall Study|Participant choice|2|||
163159901|NCT01995838|589298081|FG001|Overall Study|Participant choice|0|||
163159902|NCT01995838|589298082|FG002|Overall Study|Participant choice|0|||
163159903|NCT01995838|589298083|FG003|Overall Study|Participant choice|0|||
163159904|NCT01995838|589298084|FG004|Overall Study|Participant choice|0|||
163159905|NCT01995838|589298085|FG005|Overall Study|Participant choice|1|||
163159906|NCT01995838|589298086|FG006|Overall Study|Participant choice|1|||
163159907|NCT01995838|589298080|FG000|Overall Study|Adverse Event|0|||
163159908|NCT01995838|589298081|FG001|Overall Study|Adverse Event|0|||
163159909|NCT01995838|589298082|FG002|Overall Study|Adverse Event|0|||
163159910|NCT01995838|589298083|FG003|Overall Study|Adverse Event|0|||
163159911|NCT01995838|589298084|FG004|Overall Study|Adverse Event|0|||
163159912|NCT01995838|589298085|FG005|Overall Study|Adverse Event|0|||
163159913|NCT01995838|589298086|FG006|Overall Study|Adverse Event|1|||
163159914|NCT01995838|589298080|FG000|Overall Study|Withdrawal by Subject|0|||
163159915|NCT01995838|589298081|FG001|Overall Study|Withdrawal by Subject|0|||
163159916|NCT01995838|589298082|FG002|Overall Study|Withdrawal by Subject|0|||
163159917|NCT01995838|589298083|FG003|Overall Study|Withdrawal by Subject|0|||
163159918|NCT01995838|589298084|FG004|Overall Study|Withdrawal by Subject|1|||
163159919|NCT01995838|589298085|FG005|Overall Study|Withdrawal by Subject|0|||
163159920|NCT01995838|589298086|FG006|Overall Study|Withdrawal by Subject|0|||
163159921|NCT01995838|589298080|FG000|Overall Study|Other|3|||
163159922|NCT01995838|589298081|FG001|Overall Study|Other|1|||
163159923|NCT01995838|589298082|FG002|Overall Study|Other|0|||
163159924|NCT01995838|589298083|FG003|Overall Study|Other|2|||
163159925|NCT01995838|589298084|FG004|Overall Study|Other|1|||
163159926|NCT01995838|589298085|FG005|Overall Study|Other|1|||
163159927|NCT01995838|589298086|FG006|Overall Study|Other|2|||
163159928|NCT01967576|589298087|FG000|Overall Study|Withdrawal by Subject|3|||
163159929|NCT01967576|589298087|FG000|Overall Study|Progressed/Removed from treatment|1|||
163159930|NCT01967576|589298087|FG000|Overall Study|Study closing at site|1|||
163159931|NCT01967576|589298087|FG000|Overall Study|Adverse Event|1|||
163159932|NCT01967576|589298087|FG000|Overall Study|Refused further treatment|1|||
163159933|NCT00345358|589298088|FG000|Primary Vaccination Phase|Other|0|||
163159934|NCT00345358|589298089|FG001|Primary Vaccination Phase|Other|1|||
163159935|NCT00345358|589298090|FG002|Primary Vaccination Phase|Other|1|||
163159936|NCT00345358|589298091|FG003|Primary Vaccination Phase|Other|0|||
163159937|NCT00345358|589298088|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
163159938|NCT00345358|589298089|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
163159939|NCT00345358|589298090|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
163159940|NCT00345358|589298091|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
163159941|NCT00345358|589298088|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
163159942|NCT00345358|589298089|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
163159943|NCT00345358|589298090|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
163159944|NCT00345358|589298091|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
163159945|NCT00345358|589298088|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
163159946|NCT00345358|589298089|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
163159947|NCT00345358|589298090|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
163159948|NCT00345358|589298091|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
163159949|NCT00345358|589298088|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
163159950|NCT00345358|589298089|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
163272232|NCT01349829|589707128|FG000|Overall Study|Migrated/moved|2|||
163272233|NCT01349829|589707129|FG001|Overall Study|Migrated/moved|7|||
163272234|NCT02555371|589707130|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
163272235|NCT02555371|589707131|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
163272236|NCT02555371|589707132|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
163272237|NCT02555371|589707133|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
163272238|NCT02555371|589707134|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
163272239|NCT02555371|589707130|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
163272240|NCT02555371|589707131|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
163272241|NCT02555371|589707132|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
163272242|NCT02555371|589707133|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
163272243|NCT02555371|589707134|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
163272244|NCT02555371|589707130|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
163272245|NCT02555371|589707131|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
163272246|NCT02555371|589707132|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
163272247|NCT02555371|589707133|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
163272248|NCT02555371|589707134|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
163272249|NCT02555371|589707130|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
163272250|NCT02555371|589707131|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
163272251|NCT02555371|589707132|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
163272252|NCT02555371|589707133|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
163272253|NCT02555371|589707134|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
163272254|NCT02555371|589707130|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
163272255|NCT02555371|589707131|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
163272256|NCT02555371|589707132|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
163272257|NCT02555371|589707133|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
163272258|NCT02555371|589707134|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
163272259|NCT02555371|589707130|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
163272260|NCT02555371|589707131|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
163272261|NCT02555371|589707132|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
163272262|NCT02555371|589707133|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
163272263|NCT02555371|589707134|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
163272264|NCT02555371|589707130|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
163272265|NCT02555371|589707131|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
163272266|NCT02555371|589707132|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
163272267|NCT02555371|589707133|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
163272268|NCT02555371|589707134|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
163272269|NCT02555371|589707130|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
163272270|NCT02555371|589707131|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
163272271|NCT02555371|589707132|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
163272272|NCT02555371|589707133|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
163272273|NCT02555371|589707134|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
163272274|NCT02555371|589707130|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
163272275|NCT02555371|589707131|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
163272276|NCT02555371|589707132|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
163272277|NCT02555371|589707133|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
163272278|NCT02555371|589707134|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
163272279|NCT02555371|589707130|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
163272280|NCT02555371|589707131|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
163272281|NCT02555371|589707132|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
163272282|NCT02555371|589707133|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
163272283|NCT02555371|589707134|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
163272284|NCT02555371|589707130|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
163272285|NCT02555371|589707131|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
163272286|NCT02555371|589707132|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
163272287|NCT02555371|589707133|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
163272288|NCT02555371|589707134|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
163272289|NCT02555371|589707130|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
163272290|NCT02555371|589707131|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
163272291|NCT02555371|589707132|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
163272292|NCT02555371|589707133|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
163272293|NCT02555371|589707134|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
163272294|NCT02555371|589707130|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
163272295|NCT02555371|589707131|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
163272296|NCT02555371|589707132|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
163159951|NCT00345358|589298090|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
163159952|NCT00345358|589298091|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
163159953|NCT00345358|589298088|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
163159954|NCT00345358|589298089|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
163159955|NCT00345358|589298090|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
163159956|NCT00345358|589298091|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
163159957|NCT00346697|589298092|FG000|Overall Study|Lost to Follow-up|0|||
163159958|NCT00346697|589298093|FG001|Overall Study|Lost to Follow-up|1|||
163159959|NCT00318643|589298096|FG000|Overall Study|Adverse Event|0|||
163159960|NCT00318643|589298097|FG001|Overall Study|Adverse Event|0|||
163159961|NCT00318643|589298098|FG002|Overall Study|Adverse Event|0|||
163159962|NCT00318643|589298099|FG003|Overall Study|Adverse Event|0|||
163159963|NCT00318643|589298100|FG004|Overall Study|Adverse Event|1|||
163159964|NCT00318643|589298096|FG000|Overall Study|Participant's Decision|0|||
163159965|NCT00318643|589298097|FG001|Overall Study|Participant's Decision|0|||
163159966|NCT00318643|589298098|FG002|Overall Study|Participant's Decision|0|||
163159967|NCT00318643|589298099|FG003|Overall Study|Participant's Decision|0|||
163159968|NCT00318643|589298100|FG004|Overall Study|Participant's Decision|1|||
163159969|NCT00318643|589298096|FG000|Overall Study|Investigator's Decision|0|||
163159970|NCT00318643|589298097|FG001|Overall Study|Investigator's Decision|0|||
163159971|NCT00318643|589298098|FG002|Overall Study|Investigator's Decision|0|||
163159972|NCT00318643|589298099|FG003|Overall Study|Investigator's Decision|0|||
163159973|NCT00318643|589298100|FG004|Overall Study|Investigator's Decision|1|||
163159974|NCT02691507|589298103|FG000|Overall Study|Missed Visit 3|0|||
163159975|NCT02691507|589298104|FG001|Overall Study|Missed Visit 3|1|||
163159976|NCT03739203|589298105|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
163159977|NCT03739203|589298106|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
163159978|NCT03739203|589298107|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
163159979|NCT03739203|589298105|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
163159980|NCT03739203|589298106|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
163159981|NCT03739203|589298107|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
163159982|NCT03739203|589298105|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
163159983|NCT03739203|589298106|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
163159984|NCT03739203|589298107|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
163159985|NCT03739203|589298105|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
163159986|NCT03739203|589298106|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
163159987|NCT03739203|589298107|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
163159988|NCT03739203|589298105|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
163159989|NCT03739203|589298106|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
163159990|NCT03739203|589298107|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
163159991|NCT03739203|589298105|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
163159992|NCT03739203|589298106|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
163159993|NCT03739203|589298107|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
163159994|NCT03739203|589298105|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
163159995|NCT03739203|589298106|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
163159996|NCT03739203|589298107|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
163159997|NCT03739203|589298105|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
163159998|NCT03739203|589298106|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
163159999|NCT03739203|589298107|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
163160000|NCT03739203|589298105|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
163160001|NCT03739203|589298106|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
163160002|NCT03739203|589298107|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
163160003|NCT03739203|589298105|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
163160004|NCT03739203|589298106|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
163160005|NCT03739203|589298107|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
163160006|NCT03739203|589298105|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
163160007|NCT03739203|589298106|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
163160008|NCT03739203|589298107|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
163160009|NCT02592798|589298108|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
163160010|NCT02592798|589298109|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
163160011|NCT02592798|589298108|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
163160012|NCT02592798|589298109|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
163160013|NCT02592798|589298108|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
163160014|NCT02592798|589298109|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
163160015|NCT02592798|589298108|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
163160016|NCT02592798|589298109|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
163272297|NCT02555371|589707133|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
163272298|NCT02555371|589707134|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
163272299|NCT02555371|589707130|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
163160017|NCT02592798|589298108|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
163160018|NCT02592798|589298109|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
163160019|NCT02592798|589298108|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
163160020|NCT02592798|589298109|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
163160021|NCT02592798|589298108|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
163160022|NCT02592798|589298109|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
163160023|NCT02592798|589298108|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
163160024|NCT02592798|589298109|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
163160025|NCT02592798|589298108|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
163160026|NCT02592798|589298109|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
163160027|NCT02592798|589298108|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
163160028|NCT02592798|589298109|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
163160029|NCT02592798|589298108|FG000|Transition From DB2 to OLE|Other reasons|1|||
163160030|NCT02592798|589298109|FG001|Transition From DB2 to OLE|Other reasons|0|||
163160031|NCT02592798|589298108|FG000|Open Label Period (OLE)|Other reasons|0|||
163160032|NCT02592798|589298109|FG001|Open Label Period (OLE)|Other reasons|2|||
163160033|NCT02592798|589298108|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
163160034|NCT02592798|589298109|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
163160035|NCT02592798|589298108|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
163160036|NCT02592798|589298109|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
163160037|NCT02592798|589298108|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
163160038|NCT02592798|589298109|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
163160039|NCT02592798|589298108|FG000|Open Label Period (OLE)|Adverse Event|0|||
163160040|NCT02592798|589298109|FG001|Open Label Period (OLE)|Adverse Event|1|||
163160041|NCT01216189|589298110|FG000|Overall Study|Lost to Follow-up|21|||
163160042|NCT01216189|589298111|FG001|Overall Study|Lost to Follow-up|3|||
163160043|NCT01216189|589298110|FG000|Overall Study|Death|4|||
163160044|NCT01216189|589298111|FG001|Overall Study|Death|2|||
163160045|NCT01143246|589298112|FG000|Overall Study|Adverse Event|24|||
163160046|NCT01143246|589298113|FG001|Overall Study|Adverse Event|28|||
163160047|NCT01143246|589298112|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
163160048|NCT01143246|589298113|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
163160049|NCT01143246|589298112|FG000|Overall Study|Lost to Follow-up|0|||
163160050|NCT01143246|589298113|FG001|Overall Study|Lost to Follow-up|1|||
163160051|NCT01143246|589298112|FG000|Overall Study|Death|16|||
163160052|NCT01143246|589298113|FG001|Overall Study|Death|15|||
163160053|NCT01143246|589298112|FG000|Overall Study|Reason not Specified|3|||
163160054|NCT01143246|589298113|FG001|Overall Study|Reason not Specified|5|||
163160055|NCT01146795|589298114|FG000|Overall Study|Withdrawal by Subject|4|||
163160056|NCT01146795|589298114|FG000|Overall Study|Adverse Event|6|||
163160057|NCT01146795|589298114|FG000|Overall Study|Still in treatment at study closure|10|||
163160058|NCT05375760|589298115|FG000|Overall Study|Adverse Event|1|||
163160059|NCT05375760|589298116|FG001|Overall Study|Adverse Event|0|||
163160060|NCT05375760|589298115|FG000|Overall Study|Death|0|||
163160061|NCT05375760|589298116|FG001|Overall Study|Death|1|||
163160062|NCT05375760|589298115|FG000|Overall Study|Lost to Follow-up|6|||
163160063|NCT05375760|589298116|FG001|Overall Study|Lost to Follow-up|6|||
163160064|NCT05375760|589298115|FG000|Overall Study|Withdrawal by Subject|17|||
163160065|NCT05375760|589298116|FG001|Overall Study|Withdrawal by Subject|19|||
163160066|NCT05375760|589298115|FG000|Overall Study|Dosing halted by FDA|96|||
163160067|NCT05375760|589298116|FG001|Overall Study|Dosing halted by FDA|100|||
163160068|NCT05375760|589298115|FG000|Overall Study|Not compliant with study visit|2|||
163160069|NCT05375760|589298116|FG001|Overall Study|Not compliant with study visit|0|||
163160070|NCT05375760|589298115|FG000|Overall Study|Physician Decision|1|||
163160071|NCT05375760|589298116|FG001|Overall Study|Physician Decision|0|||
163160072|NCT05375760|589298115|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
163160073|NCT05375760|589298116|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
163160074|NCT05375760|589298115|FG000|Overall Study|Participant moved|1|||
163160075|NCT05375760|589298116|FG001|Overall Study|Participant moved|0|||
163160076|NCT03853109|589298117|FG000|Overall Study|Withdrawal by Subject|0|||
163160077|NCT03853109|589298118|FG001|Overall Study|Withdrawal by Subject|0|||
163160078|NCT03853109|589298119|FG002|Overall Study|Withdrawal by Subject|1|||
163160079|NCT03853109|589298120|FG003|Overall Study|Withdrawal by Subject|2|||
163160080|NCT03853109|589298121|FG004|Overall Study|Withdrawal by Subject|1|||
163160081|NCT03853109|589298122|FG005|Overall Study|Withdrawal by Subject|4|||
163160082|NCT03853109|589298123|FG006|Overall Study|Withdrawal by Subject|5|||
163160083|NCT03853109|589298124|FG007|Overall Study|Withdrawal by Subject|3|||
163160084|NCT03853109|589298117|FG000|Overall Study|Decision by Sponsor|0|||
163160085|NCT03853109|589298118|FG001|Overall Study|Decision by Sponsor|0|||
163160086|NCT03853109|589298119|FG002|Overall Study|Decision by Sponsor|1|||
163160087|NCT03853109|589298120|FG003|Overall Study|Decision by Sponsor|0|||
163160088|NCT03853109|589298121|FG004|Overall Study|Decision by Sponsor|1|||
163160089|NCT03853109|589298122|FG005|Overall Study|Decision by Sponsor|1|||
163160090|NCT03853109|589298123|FG006|Overall Study|Decision by Sponsor|10|||
163160091|NCT03853109|589298124|FG007|Overall Study|Decision by Sponsor|2|||
163160092|NCT03853109|589298117|FG000|Overall Study|Lost to Follow-up|0|||
163160093|NCT03853109|589298118|FG001|Overall Study|Lost to Follow-up|0|||
163160094|NCT03853109|589298119|FG002|Overall Study|Lost to Follow-up|0|||
163160095|NCT03853109|589298120|FG003|Overall Study|Lost to Follow-up|0|||
163160096|NCT03853109|589298121|FG004|Overall Study|Lost to Follow-up|1|||
163160097|NCT03853109|589298122|FG005|Overall Study|Lost to Follow-up|3|||
163160098|NCT03853109|589298123|FG006|Overall Study|Lost to Follow-up|0|||
163160099|NCT03853109|589298124|FG007|Overall Study|Lost to Follow-up|0|||
163160100|NCT03853109|589298117|FG000|Overall Study|Death|2|||
163160101|NCT03853109|589298118|FG001|Overall Study|Death|5|||
163160102|NCT03853109|589298119|FG002|Overall Study|Death|8|||
163160103|NCT03853109|589298120|FG003|Overall Study|Death|10|||
163160104|NCT03853109|589298121|FG004|Overall Study|Death|3|||
163160105|NCT03853109|589298122|FG005|Overall Study|Death|20|||
163160106|NCT03853109|589298123|FG006|Overall Study|Death|10|||
163160107|NCT03853109|589298124|FG007|Overall Study|Death|5|||
163160108|NCT03751657|589300222|FG000|Overall Study|Physician Decision|0|||
163160109|NCT03751657|589300223|FG001|Overall Study|Physician Decision|1|||
163160110|NCT03751657|589300222|FG000|Overall Study|Withdrawal by Subject|1|||
163160111|NCT03751657|589300223|FG001|Overall Study|Withdrawal by Subject|1|||
163160112|NCT03751657|589300222|FG000|Overall Study|Lost to Follow-up|2|||
163160113|NCT03751657|589300223|FG001|Overall Study|Lost to Follow-up|1|||
163160114|NCT03894813|589300230|FG000|Overall Study|Adverse Event|1|||
163160115|NCT03894813|589300231|FG001|Overall Study|Adverse Event|1|||
163160116|NCT03894813|589300230|FG000|Overall Study|Lack of Efficacy|3|||
163160117|NCT03894813|589300231|FG001|Overall Study|Lack of Efficacy|3|||
163160118|NCT03894813|589300230|FG000|Overall Study|Lost to Follow-up|1|||
163160119|NCT03894813|589300231|FG001|Overall Study|Lost to Follow-up|0|||
163160120|NCT03894813|589300230|FG000|Overall Study|Pregnancy|2|||
163160121|NCT03894813|589300231|FG001|Overall Study|Pregnancy|1|||
163160122|NCT03894813|589300230|FG000|Overall Study|Protocol Violation|3|||
163160123|NCT03894813|589300231|FG001|Overall Study|Protocol Violation|7|||
163160124|NCT03894813|589300230|FG000|Overall Study|Withdrawal by Subject|1|||
163160125|NCT03894813|589300231|FG001|Overall Study|Withdrawal by Subject|3|||
163160126|NCT03894813|589300230|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
163160127|NCT03894813|589300231|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
163160128|NCT02269267|589300233|FG000|Overall Study|Death|5|||
163160129|NCT00145158|589300236|FG000|Overall Study|premature withdrawal|2|||
163160130|NCT00145158|589300237|FG001|Overall Study|premature withdrawal|3|||
163160131|NCT02741518|589300238|FG000|Overall Study|Withdrawal by Subject|1|||
163160132|NCT02741518|589300239|FG001|Overall Study|Withdrawal by Subject|1|||
163160133|NCT00476008|589300240|FG000|Overall Study|Adverse Event|4|||
163160134|NCT00476008|589300241|FG001|Overall Study|Adverse Event|4|||
163160135|NCT00476008|589300240|FG000|Overall Study|Placebo concerns|2|||
163160136|NCT00476008|589300241|FG001|Overall Study|Placebo concerns|2|||
163160137|NCT00476008|589300240|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
163160138|NCT00476008|589300241|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
163160139|NCT00476008|589300240|FG000|Overall Study|Withdrawal by Subject|0|||
163160140|NCT00476008|589300241|FG001|Overall Study|Withdrawal by Subject|1|||
163160141|NCT00476008|589300240|FG000|Overall Study|Death|1|||
163160142|NCT00476008|589300241|FG001|Overall Study|Death|0|||
163160143|NCT01788358|589300242|FG000|Overall Study|Other|11|||
163160144|NCT01788358|589300242|FG000|Overall Study|Logistical difficulties|1|||
163160145|NCT01788358|589300242|FG000|Overall Study|Lost to Follow-up|5|||
163160146|NCT01788358|589300242|FG000|Overall Study|Protocol Violation|3|||
163160147|NCT01788358|589300242|FG000|Overall Study|Withdrawal by Subject|26|||
163160148|NCT01788358|589300242|FG000|Overall Study|Lack of Efficacy|1|||
163160149|NCT01788358|589300242|FG000|Overall Study|Adverse Event|51|||
163160150|NCT01227018|589300243|FG000|Overall Study|Disease progression|9|||
163160151|NCT01227018|589300243|FG000|Overall Study|Toxicity|2|||
163160152|NCT01227018|589300243|FG000|Overall Study|Withdrew after beginning treatment|4|||
163160153|NCT02948634|589300246|FG000|Overall Study|Lack of efficacy and study suspended|10|||
163160154|NCT02948634|589300247|FG001|Overall Study|Lack of efficacy and study suspended|2|||
163160155|NCT00753649|589300252|FG000|Overall Study|Migrated/moved from study area|1|||
163160156|NCT00753649|589300253|FG001|Overall Study|Migrated/moved from study area|0|||
163160157|NCT00753649|589300252|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
163160158|NCT00753649|589300253|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
163160159|NCT00753649|589300252|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
163160160|NCT00753649|589300253|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
163160161|NCT00753649|589300252|FG000|Overall Study|Protocol Violation|2|||
163160162|NCT00753649|589300253|FG001|Overall Study|Protocol Violation|0|||
163160163|NCT01039519|589300259|FG000|Treatment|Progressive disease|20|||
163160164|NCT01039519|589300259|FG000|Treatment|Treatment failure|2|||
163160165|NCT01039519|589300259|FG000|Treatment|Adverse Event|3|||
163160166|NCT01039519|589300259|FG000|Treatment|Physician Decision|2|||
163160167|NCT01039519|589300259|FG000|Survival Follow-up|Death|23|||
163160168|NCT01039519|589300259|FG000|Survival Follow-up|Sponsor decision|4|||
163160169|NCT01255436|589300262|FG000|Overall Study|Lost to Follow-up|178|||
163160170|NCT01255436|589300263|FG001|Overall Study|Lost to Follow-up|191|||
163160171|NCT01255436|589300262|FG000|Overall Study|Death, stroke, or MI|4|||
163160172|NCT01255436|589300263|FG001|Overall Study|Death, stroke, or MI|3|||
163160173|NCT04816669|589300264|FG000|Part 1|Adverse Event|1|||
163160174|NCT04816669|589300265|FG001|Part 1|Adverse Event|1|||
163160175|NCT04816669|589300266|FG002|Part 1|Adverse Event|0|||
163160176|NCT04816669|589300267|FG003|Part 1|Adverse Event|0|||
163160177|NCT04816669|589300264|FG000|Part 1|Lost to Follow-up|2|||
163160178|NCT04816669|589300265|FG001|Part 1|Lost to Follow-up|2|||
163160179|NCT04816669|589300266|FG002|Part 1|Lost to Follow-up|0|||
163160180|NCT04816669|589300267|FG003|Part 1|Lost to Follow-up|0|||
163160181|NCT04816669|589300264|FG000|Part 1|Protocol Violation|0|||
163160182|NCT04816669|589300265|FG001|Part 1|Protocol Violation|1|||
163160183|NCT04816669|589300266|FG002|Part 1|Protocol Violation|0|||
163160184|NCT04816669|589300267|FG003|Part 1|Protocol Violation|0|||
163160185|NCT04816669|589300264|FG000|Part 1|Withdrawal by Subject|1|||
163160186|NCT04816669|589300265|FG001|Part 1|Withdrawal by Subject|2|||
163160187|NCT04816669|589300266|FG002|Part 1|Withdrawal by Subject|0|||
163160188|NCT04816669|589300267|FG003|Part 1|Withdrawal by Subject|0|||
163160189|NCT04816669|589300264|FG000|Part 2|Other|0|||
163160190|NCT04816669|589300265|FG001|Part 2|Other|0|||
163160191|NCT04816669|589300266|FG002|Part 2|Other|1|||
163160192|NCT04816669|589300267|FG003|Part 2|Other|0|||
163160193|NCT04816669|589300264|FG000|Part 2|Withdrawal by Subject|0|||
163160194|NCT04816669|589300265|FG001|Part 2|Withdrawal by Subject|0|||
163160195|NCT04816669|589300266|FG002|Part 2|Withdrawal by Subject|0|||
163160196|NCT04816669|589300267|FG003|Part 2|Withdrawal by Subject|1|||
163160197|NCT04816669|589300264|FG000|Part 2|Lost to Follow-up|0|||
163160198|NCT04816669|589300265|FG001|Part 2|Lost to Follow-up|0|||
163160199|NCT04816669|589300266|FG002|Part 2|Lost to Follow-up|1|||
163160200|NCT04816669|589300267|FG003|Part 2|Lost to Follow-up|0|||
163160201|NCT01229267|589300268|FG000|Overall Study|Adverse Event|4|||
163160202|NCT01229267|589300269|FG001|Overall Study|Adverse Event|6|||
163160203|NCT01229267|589300270|FG002|Overall Study|Adverse Event|3|||
163160204|NCT01229267|589300271|FG003|Overall Study|Adverse Event|2|||
163160205|NCT01229267|589300272|FG004|Overall Study|Adverse Event|10|||
163160206|NCT01229267|589300268|FG000|Overall Study|Death|40|||
163160207|NCT01229267|589300269|FG001|Overall Study|Death|37|||
163160208|NCT01229267|589300270|FG002|Overall Study|Death|35|||
163160209|NCT01229267|589300271|FG003|Overall Study|Death|13|||
163160210|NCT01229267|589300272|FG004|Overall Study|Death|103|||
163160211|NCT01229267|589300268|FG000|Overall Study|Withdrawal by Subject|23|||
163160212|NCT01229267|589300269|FG001|Overall Study|Withdrawal by Subject|22|||
163160213|NCT01229267|589300270|FG002|Overall Study|Withdrawal by Subject|32|||
163160214|NCT01229267|589300271|FG003|Overall Study|Withdrawal by Subject|14|||
163160215|NCT01229267|589300272|FG004|Overall Study|Withdrawal by Subject|59|||
163160216|NCT01229267|589300268|FG000|Overall Study|Protocol Violation|0|||
163160217|NCT01229267|589300269|FG001|Overall Study|Protocol Violation|1|||
163160218|NCT01229267|589300270|FG002|Overall Study|Protocol Violation|0|||
163160219|NCT01229267|589300271|FG003|Overall Study|Protocol Violation|0|||
163160220|NCT01229267|589300272|FG004|Overall Study|Protocol Violation|0|||
163160221|NCT01229267|589300268|FG000|Overall Study|Progressive disease|0|||
163160222|NCT01229267|589300269|FG001|Overall Study|Progressive disease|0|||
163160223|NCT01229267|589300270|FG002|Overall Study|Progressive disease|0|||
163160224|NCT01229267|589300271|FG003|Overall Study|Progressive disease|0|||
163160225|NCT01229267|589300272|FG004|Overall Study|Progressive disease|1|||
163160226|NCT01229267|589300268|FG000|Overall Study|Physician Decision|8|||
163160227|NCT01229267|589300269|FG001|Overall Study|Physician Decision|11|||
163160228|NCT01229267|589300270|FG002|Overall Study|Physician Decision|8|||
163160229|NCT01229267|589300271|FG003|Overall Study|Physician Decision|3|||
163160230|NCT01229267|589300272|FG004|Overall Study|Physician Decision|25|||
163160231|NCT01229267|589300268|FG000|Overall Study|Lost to Follow-up|6|||
163160232|NCT01229267|589300269|FG001|Overall Study|Lost to Follow-up|5|||
163160233|NCT01229267|589300270|FG002|Overall Study|Lost to Follow-up|8|||
163160234|NCT01229267|589300271|FG003|Overall Study|Lost to Follow-up|3|||
163160235|NCT01229267|589300272|FG004|Overall Study|Lost to Follow-up|22|||
163272300|NCT02555371|589707131|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
163272301|NCT02555371|589707132|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
163160236|NCT00808080|589300276|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
163160237|NCT01837823|589300279|FG000|Overall Study|Lost to Follow-up|6|||
163160238|NCT03052400|589300280|FG000|Overall Study|Lost to Follow-up|1|||
163160239|NCT03052400|589300281|FG001|Overall Study|Lost to Follow-up|0|||
163272302|NCT02555371|589707133|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
163160240|NCT03052400|589300280|FG000|Overall Study|Withdrawal by Subject|0|||
163160241|NCT03052400|589300281|FG001|Overall Study|Withdrawal by Subject|1|||
163160242|NCT00867815|589300282|FG000|Overall Study|Lost to Follow-up|1|||
163160243|NCT00001213|589300283|FG000|Overall Study|Death|18|||
163160244|NCT05782179|589300284|FG000|Overall Study|Adverse Event|0|||
163160245|NCT05782179|589300285|FG001|Overall Study|Adverse Event|0|||
163160246|NCT05782179|589300286|FG002|Overall Study|Adverse Event|2|||
163160247|NCT05782179|589300287|FG003|Overall Study|Adverse Event|0|||
163160248|NCT05782179|589300288|FG004|Overall Study|Adverse Event|0|||
163160249|NCT05782179|589300289|FG005|Overall Study|Adverse Event|0|||
163160250|NCT06170242|589300290|FG000|Overall Study|Lost to Follow-up|0|||
163160251|NCT06170242|589300291|FG001|Overall Study|Lost to Follow-up|0|||
163160252|NCT06170242|589300292|FG002|Overall Study|Lost to Follow-up|1|||
163160253|NCT06170242|589300293|FG003|Overall Study|Lost to Follow-up|1|||
163160254|NCT02558296|589300294|FG000|Completed the Study Through Week 24|Adverse Event|9|||
163160255|NCT02558296|589300295|FG001|Completed the Study Through Week 24|Adverse Event|3|||
163160256|NCT02558296|589300294|FG000|Completed the Study Through Week 24|Death|7|||
163160257|NCT02558296|589300295|FG001|Completed the Study Through Week 24|Death|7|||
163160258|NCT02558296|589300294|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
163160259|NCT02558296|589300295|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
163160260|NCT02558296|589300294|FG000|Completed the Study Through Week 24|Physician Decision|1|||
163160261|NCT02558296|589300295|FG001|Completed the Study Through Week 24|Physician Decision|0|||
163160262|NCT02558296|589300294|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
163160263|NCT02558296|589300295|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
163160264|NCT02558296|589300294|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
163160265|NCT02558296|589300295|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
163160266|NCT02558296|589300294|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
163160267|NCT02558296|589300295|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
163160268|NCT02558296|589300294|FG000|Completed the Study|Adverse Event|14|||
163160269|NCT02558296|589300295|FG001|Completed the Study|Adverse Event|5|||
163160270|NCT02558296|589300294|FG000|Completed the Study|Death|39|||
163160271|NCT02558296|589300295|FG001|Completed the Study|Death|25|||
163160272|NCT02558296|589300294|FG000|Completed the Study|Lost to Follow-up|31|||
163160273|NCT02558296|589300295|FG001|Completed the Study|Lost to Follow-up|23|||
163160274|NCT02558296|589300294|FG000|Completed the Study|Physician Decision|6|||
163160275|NCT02558296|589300295|FG001|Completed the Study|Physician Decision|0|||
163160276|NCT02558296|589300294|FG000|Completed the Study|Protocol Violation|2|||
163160277|NCT02558296|589300295|FG001|Completed the Study|Protocol Violation|1|||
163160278|NCT02558296|589300294|FG000|Completed the Study|Withdrawal by Subject|53|||
163160279|NCT02558296|589300295|FG001|Completed the Study|Withdrawal by Subject|31|||
163160280|NCT02558296|589300294|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
163160281|NCT02558296|589300295|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
163160282|NCT02919995|589300298|FG000|Overall Study|Adverse Event|0|||
163160283|NCT02919995|589300299|FG001|Overall Study|Adverse Event|0|||
163160284|NCT02919995|589300300|FG002|Overall Study|Adverse Event|0|||
163160285|NCT02919995|589300301|FG003|Overall Study|Adverse Event|0|||
163160286|NCT02919995|589300302|FG004|Overall Study|Adverse Event|0|||
163160287|NCT02919995|589300303|FG005|Overall Study|Adverse Event|1|||
163160288|NCT01263197|589300315|FG000|First Intervention (Period 1)|Adverse Event|0|||
163160289|NCT01263197|589300316|FG001|First Intervention (Period 1)|Adverse Event|0|||
163160290|NCT01263197|589300317|FG002|First Intervention (Period 1)|Adverse Event|0|||
163160291|NCT01263197|589300318|FG003|First Intervention (Period 1)|Adverse Event|0|||
163160292|NCT01263197|589300319|FG004|First Intervention (Period 1)|Adverse Event|0|||
163160293|NCT01263197|589300320|FG005|First Intervention (Period 1)|Adverse Event|1|||
163160294|NCT01263197|589300315|FG000|Washout Period 1|Protocol Violation|0|||
163160295|NCT01263197|589300316|FG001|Washout Period 1|Protocol Violation|0|||
163160296|NCT01263197|589300317|FG002|Washout Period 1|Protocol Violation|0|||
163160297|NCT01263197|589300318|FG003|Washout Period 1|Protocol Violation|0|||
163160298|NCT01263197|589300319|FG004|Washout Period 1|Protocol Violation|1|||
163160299|NCT01263197|589300320|FG005|Washout Period 1|Protocol Violation|0|||
163160300|NCT01263197|589300315|FG000|Washout Period 2|Physician Decision|0|||
163160301|NCT01263197|589300316|FG001|Washout Period 2|Physician Decision|0|||
163160302|NCT01263197|589300317|FG002|Washout Period 2|Physician Decision|0|||
163160303|NCT01263197|589300318|FG003|Washout Period 2|Physician Decision|0|||
163160304|NCT01263197|589300319|FG004|Washout Period 2|Physician Decision|0|||
163160305|NCT01263197|589300320|FG005|Washout Period 2|Physician Decision|1|||
163160306|NCT01263197|589300315|FG000|Washout Period 2|Protocol Violation|0|||
163160307|NCT01263197|589300316|FG001|Washout Period 2|Protocol Violation|0|||
163160308|NCT01263197|589300317|FG002|Washout Period 2|Protocol Violation|0|||
163160309|NCT01263197|589300318|FG003|Washout Period 2|Protocol Violation|1|||
163160310|NCT01263197|589300319|FG004|Washout Period 2|Protocol Violation|0|||
163160311|NCT01263197|589300320|FG005|Washout Period 2|Protocol Violation|0|||
163160312|NCT01263197|589300315|FG000|Third Intervention (Period 3)|Adverse Event|0|||
163160313|NCT01263197|589300316|FG001|Third Intervention (Period 3)|Adverse Event|1|||
163160314|NCT01263197|589300317|FG002|Third Intervention (Period 3)|Adverse Event|0|||
163160315|NCT01263197|589300318|FG003|Third Intervention (Period 3)|Adverse Event|0|||
163272303|NCT02555371|589707134|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
163160316|NCT01263197|589300319|FG004|Third Intervention (Period 3)|Adverse Event|0|||
163160317|NCT01263197|589300320|FG005|Third Intervention (Period 3)|Adverse Event|0|||
163160318|NCT02577718|589300321|FG000|Overall Study|Death|6|||
163160319|NCT02577718|589300321|FG000|Overall Study|Withdrawal by Subject|2|||
163160320|NCT02194985|589300323|FG000|Overall Study|Adverse Event|1|||
163160321|NCT02194985|589300323|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
163160322|NCT02194985|589300323|FG000|Overall Study|Physician Decision|4|||
163160323|NCT02194985|589300323|FG000|Overall Study|Lost to Follow-up|1|||
163160324|NCT02194985|589300323|FG000|Overall Study|Withdrawal by Subject|2|||
163160325|NCT01012440|589300326|FG000|Overall Study|Withdrawal by Subject|2|||
163160326|NCT00594815|589300327|FG000|Overall Study|Never Treated|3|||
163160327|NCT00594815|589300327|FG000|Overall Study|Withdrawal by Subject|2|||
163160328|NCT00594815|589300327|FG000|Overall Study|Toxicity|4|||
163160329|NCT02557139|589300328|FG000|Overall Study|Significant liver elevation|1|||
163160330|NCT02557139|589300329|FG001|Overall Study|Significant liver elevation|0|||
163160331|NCT02557139|589300330|FG002|Overall Study|Significant liver elevation|1|||
163160332|NCT02557139|589300328|FG000|Overall Study|Withdrawal by Subject|1|||
163160333|NCT02557139|589300329|FG001|Overall Study|Withdrawal by Subject|0|||
163160334|NCT02557139|589300330|FG002|Overall Study|Withdrawal by Subject|0|||
163160335|NCT02557139|589300328|FG000|Overall Study|Illness of prohibited medication|0|||
163160336|NCT02557139|589300329|FG001|Overall Study|Illness of prohibited medication|0|||
163160337|NCT02557139|589300330|FG002|Overall Study|Illness of prohibited medication|1|||
163160338|NCT02284243|589300331|FG000|Overall Study|Lack of Efficacy|3|||
163160339|NCT02284243|589300332|FG001|Overall Study|Lack of Efficacy|3|||
163160340|NCT02284243|589300331|FG000|Overall Study|Adverse Event|1|||
163160341|NCT02284243|589300332|FG001|Overall Study|Adverse Event|0|||
163160342|NCT01932437|589300334|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
163160343|NCT01932437|589300335|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
163160344|NCT01932437|589300336|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
163160345|NCT01932437|589300337|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
163160346|NCT01932437|589300338|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
163160347|NCT01932437|589300339|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
163160348|NCT04269889|589300340|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
163160349|NCT00949702|589300345|FG000|Overall Study|Death|40|||
163160350|NCT00949702|589300345|FG000|Overall Study|Disease progression|7|||
163160351|NCT00949702|589300345|FG000|Overall Study|Withdrawal of consent|1|||
163160352|NCT01654302|589300346|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
163160353|NCT01654302|589300347|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
163160354|NCT02699749|589300350|FG000|Overall Study|Other|0|||
163160355|NCT02699749|589300351|FG001|Overall Study|Other|0|||
163160356|NCT02699749|589300352|FG002|Overall Study|Other|2|||
163160357|NCT02699749|589300353|FG003|Overall Study|Other|0|||
163160358|NCT02699749|589300354|FG004|Overall Study|Other|0|||
163160359|NCT02699749|589300355|FG005|Overall Study|Other|1|||
163160360|NCT02699749|589300356|FG006|Overall Study|Other|1|||
163160361|NCT02699749|589300357|FG007|Overall Study|Other|0|||
163160362|NCT02699749|589300358|FG008|Overall Study|Other|0|||
163272304|NCT03095599|589707135|FG000|Overall Study|Withdrawal by Subject|1|||
163272305|NCT03095599|589707136|FG001|Overall Study|Withdrawal by Subject|0|||
163160363|NCT02699749|589300359|FG009|Overall Study|Other|0|||
163160364|NCT02699749|589300360|FG010|Overall Study|Other|1|||
163160365|NCT02699749|589300361|FG011|Overall Study|Other|0|||
163160366|NCT02699749|589300362|FG012|Overall Study|Other|0|||
163160367|NCT02699749|589300363|FG013|Overall Study|Other|0|||
163160368|NCT02699749|589300350|FG000|Overall Study|Progressive Disease|3|||
163160369|NCT02699749|589300351|FG001|Overall Study|Progressive Disease|3|||
163160370|NCT02699749|589300352|FG002|Overall Study|Progressive Disease|14|||
163160371|NCT02699749|589300353|FG003|Overall Study|Progressive Disease|3|||
163160372|NCT02699749|589300354|FG004|Overall Study|Progressive Disease|3|||
163160373|NCT02699749|589300355|FG005|Overall Study|Progressive Disease|7|||
163160374|NCT02699749|589300356|FG006|Overall Study|Progressive Disease|5|||
163160375|NCT02699749|589300357|FG007|Overall Study|Progressive Disease|5|||
163160376|NCT02699749|589300358|FG008|Overall Study|Progressive Disease|6|||
163272306|NCT03095599|589707135|FG000|Overall Study|Lost to Follow-up|1|||
163272307|NCT03095599|589707136|FG001|Overall Study|Lost to Follow-up|0|||
163272308|NCT03095599|589707135|FG000|Overall Study|Withdrawal prior to vaccination|1|||
163160377|NCT02699749|589300359|FG009|Overall Study|Progressive Disease|6|||
163160378|NCT02699749|589300360|FG010|Overall Study|Progressive Disease|5|||
163160379|NCT02699749|589300361|FG011|Overall Study|Progressive Disease|4|||
163160380|NCT02699749|589300362|FG012|Overall Study|Progressive Disease|3|||
163160381|NCT02699749|589300363|FG013|Overall Study|Progressive Disease|5|||
163160382|NCT02699749|589300350|FG000|Overall Study|Death|0|||
163160383|NCT02699749|589300351|FG001|Overall Study|Death|0|||
163160384|NCT02699749|589300352|FG002|Overall Study|Death|0|||
163160385|NCT02699749|589300353|FG003|Overall Study|Death|0|||
163160386|NCT02699749|589300354|FG004|Overall Study|Death|0|||
163160387|NCT02699749|589300355|FG005|Overall Study|Death|0|||
163160388|NCT02699749|589300356|FG006|Overall Study|Death|0|||
163160389|NCT02699749|589300357|FG007|Overall Study|Death|0|||
163160390|NCT02699749|589300358|FG008|Overall Study|Death|0|||
163160391|NCT02699749|589300359|FG009|Overall Study|Death|0|||
163160392|NCT02699749|589300360|FG010|Overall Study|Death|0|||
163160393|NCT02699749|589300361|FG011|Overall Study|Death|0|||
163272309|NCT03095599|589707136|FG001|Overall Study|Withdrawal prior to vaccination|0|||
163160394|NCT02699749|589300362|FG012|Overall Study|Death|0|||
163160395|NCT02699749|589300363|FG013|Overall Study|Death|1|||
163160396|NCT02699749|589300350|FG000|Overall Study|Lost to Follow-up|0|||
163160397|NCT02699749|589300351|FG001|Overall Study|Lost to Follow-up|0|||
163160398|NCT02699749|589300352|FG002|Overall Study|Lost to Follow-up|0|||
163160399|NCT02699749|589300353|FG003|Overall Study|Lost to Follow-up|0|||
163160400|NCT02699749|589300354|FG004|Overall Study|Lost to Follow-up|0|||
163160401|NCT02699749|589300355|FG005|Overall Study|Lost to Follow-up|1|||
163160402|NCT02699749|589300356|FG006|Overall Study|Lost to Follow-up|0|||
163272310|NCT00742885|589707137|FG000|Overall Study|Lost to Follow-up|1|||
163272311|NCT00742885|589707138|FG001|Overall Study|Lost to Follow-up|0|||
163272312|NCT03615482|589707141|FG000|Overall Study|Death|1|||
163272313|NCT03615482|589707142|FG001|Overall Study|Death|0|||
163272314|NCT03615482|589707141|FG000|Overall Study|Lost to Follow-up|7|||
163272315|NCT03615482|589707142|FG001|Overall Study|Lost to Follow-up|7|||
163272316|NCT03615482|589707141|FG000|Overall Study|Physician Decision|2|||
163272317|NCT03615482|589707142|FG001|Overall Study|Physician Decision|3|||
163272318|NCT03615482|589707141|FG000|Overall Study|Withdrawal by Subject|7|||
163272319|NCT03615482|589707142|FG001|Overall Study|Withdrawal by Subject|7|||
163272320|NCT04212169|589707144|FG000|Overall Study|Adverse Event|0|||
163272321|NCT04212169|589707145|FG001|Overall Study|Adverse Event|0|||
163272322|NCT04212169|589707146|FG002|Overall Study|Adverse Event|0|||
163272323|NCT04212169|589707147|FG003|Overall Study|Adverse Event|2|||
163272324|NCT04212169|589707144|FG000|Overall Study|Lost to Follow-up|1|||
163272325|NCT04212169|589707145|FG001|Overall Study|Lost to Follow-up|0|||
163272326|NCT04212169|589707146|FG002|Overall Study|Lost to Follow-up|0|||
163272327|NCT04212169|589707147|FG003|Overall Study|Lost to Follow-up|2|||
163272328|NCT04212169|589707144|FG000|Overall Study|Withdrawal by Subject|10|||
163272329|NCT04212169|589707145|FG001|Overall Study|Withdrawal by Subject|2|||
163272330|NCT04212169|589707146|FG002|Overall Study|Withdrawal by Subject|5|||
163272331|NCT04212169|589707147|FG003|Overall Study|Withdrawal by Subject|7|||
163272332|NCT04212169|589707144|FG000|Overall Study|Other reason, unspecified|3|||
163272333|NCT04212169|589707145|FG001|Overall Study|Other reason, unspecified|1|||
163272334|NCT04212169|589707146|FG002|Overall Study|Other reason, unspecified|0|||
163272335|NCT04212169|589707147|FG003|Overall Study|Other reason, unspecified|2|||
163272336|NCT02018861|589707155|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
163272337|NCT02018861|589707156|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
163272338|NCT02018861|589707157|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
163272339|NCT02018861|589707158|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
163272340|NCT02018861|589707159|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
163272341|NCT02018861|589707160|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
163272342|NCT02018861|589707161|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
163272343|NCT02018861|589707162|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
163272344|NCT02018861|589707163|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
163272345|NCT02018861|589707164|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
163272346|NCT02018861|589707155|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163272347|NCT02018861|589707156|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163272348|NCT02018861|589707157|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163272349|NCT02018861|589707158|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
163272350|NCT02018861|589707159|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
163272351|NCT02018861|589707160|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163272352|NCT02018861|589707161|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163272353|NCT02018861|589707162|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163272354|NCT02018861|589707163|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163272355|NCT02018861|589707164|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163272356|NCT02018861|589707155|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
163272357|NCT02018861|589707156|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
163272358|NCT02018861|589707157|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
163272359|NCT02018861|589707158|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
163272360|NCT02018861|589707159|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
163272361|NCT02018861|589707160|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
163272362|NCT02018861|589707161|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
163272363|NCT02018861|589707162|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
163272364|NCT02018861|589707163|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
163160403|NCT02699749|589300357|FG007|Overall Study|Lost to Follow-up|1|||
163272365|NCT02018861|589707164|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
163272366|NCT02018861|589707155|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
163160404|NCT02699749|589300358|FG008|Overall Study|Lost to Follow-up|0|||
163160405|NCT02699749|589300359|FG009|Overall Study|Lost to Follow-up|0|||
163160406|NCT02699749|589300360|FG010|Overall Study|Lost to Follow-up|0|||
163160407|NCT02699749|589300361|FG011|Overall Study|Lost to Follow-up|0|||
163272367|NCT02018861|589707156|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
163160408|NCT02699749|589300362|FG012|Overall Study|Lost to Follow-up|0|||
163160409|NCT02699749|589300363|FG013|Overall Study|Lost to Follow-up|0|||
163160410|NCT02377817|589300365|FG000|Overall Study|Transportation/childcare barriers.|2|||
163160411|NCT02377817|589300366|FG001|Overall Study|Transportation/childcare barriers.|0|||
163160412|NCT02377817|589300365|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
163160413|NCT02377817|589300366|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
163160414|NCT04139018|589300367|FG000|Overall Study|Screen fail|1|||
163160415|NCT04139018|589300368|FG001|Overall Study|Screen fail|0|||
163160416|NCT04139018|589300367|FG000|Overall Study|Withdrawal by Subject|2|||
163160417|NCT04139018|589300368|FG001|Overall Study|Withdrawal by Subject|0|||
163160418|NCT04139018|589300367|FG000|Overall Study|Lost to Follow-up|0|||
163160419|NCT04139018|589300368|FG001|Overall Study|Lost to Follow-up|1|||
163160420|NCT01094119|589300385|FG000|Overall Study|Lack of Efficacy|2|||
163160421|NCT01094119|589300386|FG001|Overall Study|Lack of Efficacy|4|||
163160422|NCT01106248|589300389|FG000|Overall Study|Adverse Event|1|||
163160423|NCT01106248|589300389|FG000|Overall Study|Administrative|2|||
163160424|NCT00357903|589300390|FG000|Overall Study|Adverse Event|87|||
163160425|NCT00357903|589300391|FG001|Overall Study|Adverse Event|4|||
163160426|NCT00357903|589300390|FG000|Overall Study|Death|33|||
163160427|NCT00357903|589300391|FG001|Overall Study|Death|0|||
163160428|NCT00357903|589300390|FG000|Overall Study|Lost to Follow-up|23|||
163160429|NCT00357903|589300391|FG001|Overall Study|Lost to Follow-up|4|||
163160430|NCT00357903|589300390|FG000|Overall Study|Physician Decision|39|||
163160431|NCT00357903|589300391|FG001|Overall Study|Physician Decision|5|||
163160432|NCT00357903|589300390|FG000|Overall Study|Withdrawal by Subject|57|||
163160433|NCT00357903|589300391|FG001|Overall Study|Withdrawal by Subject|7|||
163160434|NCT00357903|589300390|FG000|Overall Study|Completed month 12 only|0|||
163160435|NCT00357903|589300391|FG001|Overall Study|Completed month 12 only|1|||
163160436|NCT00357903|589300390|FG000|Overall Study|Protocol issues|14|||
163160437|NCT00357903|589300391|FG001|Overall Study|Protocol issues|3|||
163160438|NCT00357903|589300390|FG000|Overall Study|Response status|61|||
163160439|NCT00357903|589300391|FG001|Overall Study|Response status|9|||
163160440|NCT00357903|589300390|FG000|Overall Study|Other|49|||
163160441|NCT00357903|589300391|FG001|Overall Study|Other|10|||
163160442|NCT01160822|589300392|FG000|Overall Study|Adverse Event|0|||
163160443|NCT01160822|589300393|FG001|Overall Study|Adverse Event|0|||
163160444|NCT01160822|589300394|FG002|Overall Study|Adverse Event|0|||
163160445|NCT01160822|589300395|FG003|Overall Study|Adverse Event|0|||
163160446|NCT01160822|589300396|FG004|Overall Study|Adverse Event|1|||
163160447|NCT01160822|589300397|FG005|Overall Study|Adverse Event|2|||
163160448|NCT01160822|589300398|FG006|Overall Study|Adverse Event|5|||
163160449|NCT01160822|589300392|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163160450|NCT01160822|589300393|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163160451|NCT01160822|589300394|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
163160452|NCT01160822|589300395|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
163160453|NCT01160822|589300396|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
163160454|NCT01160822|589300397|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
163160455|NCT01160822|589300398|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
163160456|NCT01160822|589300392|FG000|Overall Study|Withdrawal by Subject|0|||
163160457|NCT01160822|589300393|FG001|Overall Study|Withdrawal by Subject|0|||
163160458|NCT01160822|589300394|FG002|Overall Study|Withdrawal by Subject|0|||
163160459|NCT01160822|589300395|FG003|Overall Study|Withdrawal by Subject|0|||
163160460|NCT01160822|589300396|FG004|Overall Study|Withdrawal by Subject|0|||
163160461|NCT01160822|589300397|FG005|Overall Study|Withdrawal by Subject|0|||
163160462|NCT01160822|589300398|FG006|Overall Study|Withdrawal by Subject|1|||
163160463|NCT01160822|589300392|FG000|Overall Study|Lost to Follow-up|0|||
163160464|NCT01160822|589300393|FG001|Overall Study|Lost to Follow-up|0|||
163160465|NCT01160822|589300394|FG002|Overall Study|Lost to Follow-up|0|||
163160466|NCT01160822|589300395|FG003|Overall Study|Lost to Follow-up|0|||
163160467|NCT01160822|589300396|FG004|Overall Study|Lost to Follow-up|1|||
163160468|NCT01160822|589300397|FG005|Overall Study|Lost to Follow-up|0|||
163160469|NCT01160822|589300398|FG006|Overall Study|Lost to Follow-up|0|||
163160470|NCT01160822|589300392|FG000|Overall Study|Administrative problems|0|||
163160471|NCT01160822|589300393|FG001|Overall Study|Administrative problems|0|||
163160472|NCT01160822|589300394|FG002|Overall Study|Administrative problems|0|||
163160473|NCT01160822|589300395|FG003|Overall Study|Administrative problems|0|||
163160474|NCT01160822|589300396|FG004|Overall Study|Administrative problems|1|||
163160475|NCT01160822|589300397|FG005|Overall Study|Administrative problems|0|||
163160476|NCT01160822|589300398|FG006|Overall Study|Administrative problems|0|||
163160477|NCT01160822|589300392|FG000|Overall Study|Protocol deviation|0|||
163160478|NCT01160822|589300393|FG001|Overall Study|Protocol deviation|0|||
163160479|NCT01160822|589300394|FG002|Overall Study|Protocol deviation|0|||
163160480|NCT01160822|589300395|FG003|Overall Study|Protocol deviation|0|||
163160481|NCT01160822|589300396|FG004|Overall Study|Protocol deviation|2|||
163160482|NCT01160822|589300397|FG005|Overall Study|Protocol deviation|0|||
163160483|NCT01160822|589300398|FG006|Overall Study|Protocol deviation|0|||
163160484|NCT01648751|589300403|FG000|Overall Study|Withdrawal by Subject|2|||
163160485|NCT01648751|589300404|FG001|Overall Study|Withdrawal by Subject|3|||
163160486|NCT03467750|589300406|FG000|Overall Study|Surgery canceled|1|||
163160487|NCT03467750|589300407|FG001|Overall Study|Surgery canceled|0|||
163160488|NCT03467750|589300406|FG000|Overall Study|Protocol Violation|1|||
163160489|NCT03467750|589300407|FG001|Overall Study|Protocol Violation|1|||
163160490|NCT03467750|589300406|FG000|Overall Study|Withdrawal by Subject|0|||
163160491|NCT03467750|589300407|FG001|Overall Study|Withdrawal by Subject|1|||
163160492|NCT05673876|589300408|FG000|Overall Study|Death|3|||
163160493|NCT05673876|589300409|FG001|Overall Study|Death|1|||
163160494|NCT05673876|589300408|FG000|Overall Study|Study Terminated by Sponsor|0|||
163160495|NCT05673876|589300409|FG001|Overall Study|Study Terminated by Sponsor|1|||
163160496|NCT05673876|589300408|FG000|Overall Study|Physician Decision|0|||
163160497|NCT05673876|589300409|FG001|Overall Study|Physician Decision|1|||
163160498|NCT05006573|589300412|FG000|Double-blind Treatment Period|Physician Decision|2|||
163160499|NCT05006573|589300413|FG001|Double-blind Treatment Period|Physician Decision|0|||
163160500|NCT05006573|589300412|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
163160501|NCT05006573|589300413|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
163160502|NCT05006573|589300412|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
163160503|NCT05006573|589300413|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
163160504|NCT05006573|589300412|FG000|Double-blind Treatment Period|Protocol Violation|2|||
163160505|NCT05006573|589300413|FG001|Double-blind Treatment Period|Protocol Violation|0|||
163160506|NCT05006573|589300412|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
163160507|NCT05006573|589300413|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
163160508|NCT05006573|589300412|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
163160509|NCT05006573|589300413|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
163160510|NCT01967238|589300414|FG000|Overall Study|Adverse Event|1|||
163160511|NCT01967238|589300415|FG001|Overall Study|Adverse Event|1|||
163160512|NCT01967238|589300416|FG002|Overall Study|Adverse Event|0|||
163160513|NCT01967238|589300414|FG000|Overall Study|Lost to Follow-up|1|||
163160514|NCT01967238|589300415|FG001|Overall Study|Lost to Follow-up|0|||
163160515|NCT01967238|589300416|FG002|Overall Study|Lost to Follow-up|1|||
163160516|NCT01967238|589300414|FG000|Overall Study|Withdrawal by Subject|0|||
163160517|NCT01967238|589300415|FG001|Overall Study|Withdrawal by Subject|0|||
163160518|NCT01967238|589300416|FG002|Overall Study|Withdrawal by Subject|1|||
163160519|NCT02864394|589300423|FG000|Overall Study|Death|184|||
163160520|NCT02864394|589300424|FG001|Overall Study|Death|189|||
163160521|NCT02864394|589300423|FG000|Overall Study|Lost to Follow-up|0|||
163160522|NCT02864394|589300424|FG001|Overall Study|Lost to Follow-up|2|||
163160523|NCT02864394|589300423|FG000|Overall Study|Sponsor Decision|26|||
163160524|NCT02864394|589300424|FG001|Overall Study|Sponsor Decision|11|||
163160525|NCT02864394|589300423|FG000|Overall Study|Withdrawal by Subject|3|||
163160526|NCT02864394|589300424|FG001|Overall Study|Withdrawal by Subject|10|||
163160527|NCT02656693|589302221|FG000|Overall Study|Pregnancy|1|||
163160528|NCT02656693|589302222|FG001|Overall Study|Pregnancy|1|||
163160529|NCT02656693|589302223|FG002|Overall Study|Pregnancy|1|||
163160530|NCT02656693|589302221|FG000|Overall Study|Bariatric surgery|0|||
163160531|NCT02656693|589302222|FG001|Overall Study|Bariatric surgery|1|||
163160532|NCT02656693|589302223|FG002|Overall Study|Bariatric surgery|2|||
163160533|NCT02565784|589302224|FG000|First Treatment|Adverse Event|1|||
163160534|NCT02565784|589302224|FG000|First Treatment|Withdrawal by Subject|1|||
163160535|NCT02565784|589302224|FG000|Second Treatment|Withdrawal by Subject|2|||
163160536|NCT02604160|589302225|FG000|Overall Study|Protocol Violation|0|||
163160537|NCT02604160|589302226|FG001|Overall Study|Protocol Violation|1|||
163160538|NCT02604160|589302225|FG000|Overall Study|Physician Decision|0|||
163160539|NCT02604160|589302226|FG001|Overall Study|Physician Decision|1|||
163160540|NCT01596062|589302227|FG000|Overall Study|Adverse Event|1|||
163160541|NCT01596062|589302228|FG001|Overall Study|Adverse Event|0|||
163272368|NCT02018861|589707157|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
163272369|NCT02018861|589707158|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
163272370|NCT02018861|589707159|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
163272371|NCT02018861|589707160|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
163272372|NCT02018861|589707161|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
163272373|NCT02018861|589707162|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
163160542|NCT01596062|589302229|FG002|Overall Study|Adverse Event|2|||
163160543|NCT01596062|589302227|FG000|Overall Study|Lack of Efficacy|0|||
163160544|NCT01596062|589302228|FG001|Overall Study|Lack of Efficacy|0|||
163160545|NCT01596062|589302229|FG002|Overall Study|Lack of Efficacy|1|||
163160546|NCT01069900|589302230|FG000|Overall Study|Technical problems|0|||
163160547|NCT01069900|589302231|FG001|Overall Study|Technical problems|1|||
163160548|NCT01069900|589302230|FG000|Overall Study|Lost to Follow-up|7|||
163160549|NCT01069900|589302231|FG001|Overall Study|Lost to Follow-up|1|||
163160550|NCT01069900|589302230|FG000|Overall Study|Withdrawal by Subject|6|||
163160551|NCT01069900|589302231|FG001|Overall Study|Withdrawal by Subject|1|||
163160552|NCT01069900|589302230|FG000|Overall Study|Protocol Violation|4|||
163160553|NCT01069900|589302231|FG001|Overall Study|Protocol Violation|1|||
163160554|NCT01069900|589302230|FG000|Overall Study|Insufficient Therapeutic effect|1|||
163160555|NCT01069900|589302231|FG001|Overall Study|Insufficient Therapeutic effect|0|||
163160556|NCT03180840|589302232|FG000|Overall Study|Withdrawal by Subject|1|||
163160557|NCT01168219|589302238|FG000|Overall Study|off study before starting treatment|2|||
163160558|NCT01168219|589302238|FG000|Overall Study|withdrew before transplant|1|||
163160559|NCT01168219|589302238|FG000|Overall Study|ineligible due to CML|2|||
163160560|NCT00859456|589302239|FG000|Overall Study|Adverse Event|3|||
163160561|NCT00859456|589302239|FG000|Overall Study|Progressive disease|2|||
163160562|NCT00859456|589302239|FG000|Overall Study|Non-compliance|3|||
163160563|NCT00927953|589302246|FG000|Overall Study|Death|2|||
163160564|NCT00927953|589302247|FG001|Overall Study|Death|1|||
163160565|NCT02863419|589302248|FG000|Overall Study|Lost to Follow-up|0|||
163160566|NCT02863419|589302249|FG001|Overall Study|Lost to Follow-up|1|||
163160567|NCT02863419|589302250|FG002|Overall Study|Lost to Follow-up|4|||
163160568|NCT02863419|589302248|FG000|Overall Study|Withdrawal by Subject|5|||
163160569|NCT02863419|589302249|FG001|Overall Study|Withdrawal by Subject|5|||
163160570|NCT02863419|589302250|FG002|Overall Study|Withdrawal by Subject|3|||
163160571|NCT02863419|589302248|FG000|Overall Study|Died|3|||
163160572|NCT02863419|589302249|FG001|Overall Study|Died|4|||
163160573|NCT02863419|589302250|FG002|Overall Study|Died|1|||
163160574|NCT01491607|589302251|FG000|Overall Study|Lost to Follow-up|7|||
163160575|NCT01491607|589302251|FG000|Overall Study|Withdrawal by Subject|3|||
163160576|NCT00297258|589302252|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
163160577|NCT00297258|589302252|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
163160578|NCT00297258|589302252|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
163160579|NCT00297258|589302252|FG000|Overall Study|Intercurrent Illness|3|||
163160580|NCT00297258|589302252|FG000|Overall Study|Intercurrent Death|2|||
163160581|NCT00297258|589302252|FG000|Overall Study|Deteriorization of General Condition|1|||
163160582|NCT00297258|589302252|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
163160583|NCT00297258|589302252|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
163160584|NCT00297258|589302252|FG000|Overall Study|Switch to Commercial Treatment|1|||
163160585|NCT00297258|589302252|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
163160586|NCT01470326|589302253|FG000|Overall Study|Protocol Violation|32|||
163160587|NCT01470326|589302253|FG000|Overall Study|No Drug Administration Information|2|||
163160588|NCT01470326|589302253|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
163160589|NCT02561832|589302254|FG000|Overall Study|Withdrawal by Subject|1|||
163160590|NCT02561832|589302255|FG001|Overall Study|Withdrawal by Subject|1|||
163160591|NCT02561832|589302254|FG000|Overall Study|Adverse Event|3|||
163160592|NCT02561832|589302255|FG001|Overall Study|Adverse Event|0|||
163160593|NCT02561832|589302254|FG000|Overall Study|Disease progression|3|||
163160594|NCT02561832|589302255|FG001|Overall Study|Disease progression|3|||
163160595|NCT02839200|589302256|FG000|Overall Study|Withdrawal by Subject|2|||
163160596|NCT02839200|589302257|FG001|Overall Study|Withdrawal by Subject|0|||
163160597|NCT02839200|589302258|FG002|Overall Study|Withdrawal by Subject|1|||
163160598|NCT02839200|589302259|FG003|Overall Study|Withdrawal by Subject|0|||
163160599|NCT02839200|589302260|FG004|Overall Study|Withdrawal by Subject|0|||
163160600|NCT02839200|589302261|FG005|Overall Study|Withdrawal by Subject|1|||
163160601|NCT02839200|589302256|FG000|Overall Study|Lost to Follow-up|2|||
163160602|NCT02839200|589302257|FG001|Overall Study|Lost to Follow-up|0|||
163160603|NCT02839200|589302258|FG002|Overall Study|Lost to Follow-up|0|||
163160604|NCT02839200|589302259|FG003|Overall Study|Lost to Follow-up|0|||
163160605|NCT02839200|589302260|FG004|Overall Study|Lost to Follow-up|1|||
163160606|NCT02839200|589302261|FG005|Overall Study|Lost to Follow-up|0|||
163160607|NCT02839200|589302256|FG000|Overall Study|Adverse Event|0|||
163272374|NCT02018861|589707163|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
163160608|NCT02839200|589302257|FG001|Overall Study|Adverse Event|0|||
163160609|NCT02839200|589302258|FG002|Overall Study|Adverse Event|0|||
163272375|NCT02018861|589707164|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
163272376|NCT02018861|589707155|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163272377|NCT02018861|589707156|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163272378|NCT02018861|589707157|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
163272379|NCT02018861|589707158|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
163272380|NCT02018861|589707159|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163272381|NCT02018861|589707160|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163272382|NCT02018861|589707161|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163272383|NCT02018861|589707162|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163160610|NCT02839200|589302259|FG003|Overall Study|Adverse Event|0|||
163160611|NCT02839200|589302260|FG004|Overall Study|Adverse Event|1|||
163160612|NCT02839200|589302261|FG005|Overall Study|Adverse Event|0|||
163160613|NCT02839200|589302256|FG000|Overall Study|Randomized in error|0|||
163160614|NCT02839200|589302257|FG001|Overall Study|Randomized in error|1|||
163160615|NCT02839200|589302258|FG002|Overall Study|Randomized in error|0|||
163160616|NCT02839200|589302259|FG003|Overall Study|Randomized in error|0|||
163160617|NCT02839200|589302260|FG004|Overall Study|Randomized in error|0|||
163160618|NCT02839200|589302261|FG005|Overall Study|Randomized in error|0|||
163160619|NCT03614156|589302262|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
163272384|NCT02018861|589707163|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163272385|NCT02018861|589707164|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163272386|NCT02018861|589707155|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163272387|NCT02018861|589707156|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163272388|NCT02018861|589707157|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163272389|NCT02018861|589707158|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163160620|NCT03614156|589302263|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
163160621|NCT03614156|589302264|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
163160622|NCT03614156|589302265|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
163160623|NCT03614156|589302262|FG000|Open-Label Treatment Period|Adverse Event|7|||
163160624|NCT03614156|589302263|FG001|Open-Label Treatment Period|Adverse Event|0|||
163160625|NCT03614156|589302264|FG002|Open-Label Treatment Period|Adverse Event|0|||
163160626|NCT03614156|589302265|FG003|Open-Label Treatment Period|Adverse Event|0|||
163160627|NCT03614156|589302262|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
163160628|NCT03614156|589302263|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
163160629|NCT03614156|589302264|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
163160630|NCT03614156|589302265|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
163160631|NCT03614156|589302262|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
163160632|NCT03614156|589302263|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
163160633|NCT03614156|589302264|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
163160634|NCT03614156|589302265|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
163160635|NCT03614156|589302262|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
163160636|NCT03614156|589302263|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
163160637|NCT03614156|589302264|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
163160638|NCT03614156|589302265|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
163160639|NCT03614156|589302262|FG000|Open-Label Treatment Period|Protocol Violation|2|||
163160640|NCT03614156|589302263|FG001|Open-Label Treatment Period|Protocol Violation|0|||
163160641|NCT03614156|589302264|FG002|Open-Label Treatment Period|Protocol Violation|0|||
163160642|NCT03614156|589302265|FG003|Open-Label Treatment Period|Protocol Violation|0|||
163160643|NCT03614156|589302262|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
163160644|NCT03614156|589302263|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
163160645|NCT03614156|589302264|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
163160646|NCT03614156|589302265|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
163160647|NCT03614156|589302262|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
163160648|NCT03614156|589302263|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
163160649|NCT03614156|589302264|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
163160650|NCT03614156|589302265|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
163160651|NCT03614156|589302262|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
163160652|NCT03614156|589302263|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
163160653|NCT03614156|589302264|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
163160654|NCT03614156|589302265|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
163160655|NCT03614156|589302262|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
163160656|NCT03614156|589302263|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
163160657|NCT03614156|589302264|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
163160658|NCT03614156|589302265|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
163160659|NCT03614156|589302262|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163160660|NCT03614156|589302263|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163160661|NCT03614156|589302264|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
163160662|NCT03614156|589302265|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
163160663|NCT03614156|589302262|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
163160664|NCT03614156|589302263|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
163160665|NCT03614156|589302264|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
163160666|NCT03614156|589302265|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
163160667|NCT03614156|589302262|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
163160668|NCT03614156|589302263|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
163160669|NCT03614156|589302264|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
163160670|NCT03614156|589302265|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
163160671|NCT03614156|589302262|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
163160672|NCT03614156|589302263|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
163160673|NCT03614156|589302264|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
163160674|NCT03614156|589302265|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
163160675|NCT03614156|589302262|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
163160676|NCT03614156|589302263|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
163272390|NCT02018861|589707159|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
163385766|NCT00146328|590123241|FG002|Overall Study|Withdrawal by Subject|22|||
163160677|NCT03614156|589302264|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
163160678|NCT03614156|589302265|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
163160679|NCT03614156|589302262|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
163160680|NCT03614156|589302263|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
163160681|NCT03614156|589302264|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
163160682|NCT03614156|589302265|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
163160683|NCT03614156|589302262|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
163160684|NCT03614156|589302263|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
163160685|NCT03614156|589302264|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
163160686|NCT03614156|589302265|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
163160687|NCT01286480|589302267|FG000|Overall Study|Withdrawal by Subject|5|||
163160688|NCT01286480|589302268|FG001|Overall Study|Withdrawal by Subject|3|||
163160689|NCT00834093|589302269|FG000|Overall Study|Progressive Disease|3|||
163160690|NCT00834093|589302269|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
163160691|NCT00885534|589302270|FG000|Overall Study|Patient deemed ineligible|1|||
163160692|NCT02453711|589302271|FG000|Overall Study|Withdrawal by Subject|5|||
163160693|NCT02453711|589302272|FG001|Overall Study|Withdrawal by Subject|4|||
163160694|NCT02453711|589302273|FG002|Overall Study|Withdrawal by Subject|6|||
163160695|NCT02453711|589302274|FG003|Overall Study|Withdrawal by Subject|4|||
163160696|NCT02453711|589302275|FG004|Overall Study|Withdrawal by Subject|1|||
163160697|NCT02453711|589302276|FG005|Overall Study|Withdrawal by Subject|1|||
163160698|NCT02453711|589302277|FG006|Overall Study|Withdrawal by Subject|0|||
163160699|NCT02453711|589302278|FG007|Overall Study|Withdrawal by Subject|1|||
163160700|NCT02453711|589302279|FG008|Overall Study|Withdrawal by Subject|7|||
163160701|NCT02453711|589302271|FG000|Overall Study|Lost to Follow-up|5|||
163160702|NCT02453711|589302272|FG001|Overall Study|Lost to Follow-up|3|||
163160703|NCT02453711|589302273|FG002|Overall Study|Lost to Follow-up|2|||
163160704|NCT02453711|589302274|FG003|Overall Study|Lost to Follow-up|3|||
163160705|NCT02453711|589302275|FG004|Overall Study|Lost to Follow-up|1|||
163160706|NCT02453711|589302276|FG005|Overall Study|Lost to Follow-up|5|||
163160707|NCT02453711|589302277|FG006|Overall Study|Lost to Follow-up|2|||
163160708|NCT02453711|589302278|FG007|Overall Study|Lost to Follow-up|6|||
163160709|NCT02453711|589302279|FG008|Overall Study|Lost to Follow-up|6|||
163160710|NCT02453711|589302271|FG000|Overall Study|Death|0|||
163160711|NCT02453711|589302272|FG001|Overall Study|Death|0|||
163160712|NCT02453711|589302273|FG002|Overall Study|Death|0|||
163160713|NCT02453711|589302274|FG003|Overall Study|Death|0|||
163160714|NCT02453711|589302275|FG004|Overall Study|Death|0|||
163160715|NCT02453711|589302276|FG005|Overall Study|Death|0|||
163272391|NCT02018861|589707160|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163272392|NCT02018861|589707161|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163272393|NCT02018861|589707162|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163272394|NCT02018861|589707163|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163272395|NCT02018861|589707164|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163272396|NCT02018861|589707155|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
163160716|NCT02453711|589302277|FG006|Overall Study|Death|1|||
163160717|NCT02453711|589302278|FG007|Overall Study|Death|0|||
163160718|NCT02453711|589302279|FG008|Overall Study|Death|0|||
163160719|NCT02453711|589302271|FG000|Overall Study|Unclassified|1|||
163160720|NCT02453711|589302272|FG001|Overall Study|Unclassified|0|||
163160721|NCT02453711|589302273|FG002|Overall Study|Unclassified|1|||
163160722|NCT02453711|589302274|FG003|Overall Study|Unclassified|0|||
163160723|NCT02453711|589302275|FG004|Overall Study|Unclassified|0|||
163160724|NCT02453711|589302276|FG005|Overall Study|Unclassified|0|||
163160725|NCT02453711|589302277|FG006|Overall Study|Unclassified|0|||
163160726|NCT02453711|589302278|FG007|Overall Study|Unclassified|0|||
163160727|NCT02453711|589302279|FG008|Overall Study|Unclassified|0|||
163160728|NCT01587924|589302280|FG000|Overall Study|Adverse Event|0|||
163160729|NCT01587924|589302281|FG001|Overall Study|Adverse Event|2|||
163160730|NCT01587924|589302282|FG002|Overall Study|Adverse Event|0|||
163160731|NCT01587924|589302283|FG003|Overall Study|Adverse Event|0|||
163160732|NCT01587924|589302280|FG000|Overall Study|Protocol Violation|2|||
163160733|NCT01587924|589302281|FG001|Overall Study|Protocol Violation|1|||
163160734|NCT01587924|589302282|FG002|Overall Study|Protocol Violation|2|||
163160735|NCT01587924|589302283|FG003|Overall Study|Protocol Violation|1|||
163160736|NCT01587924|589302280|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
163160737|NCT01587924|589302281|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
163160738|NCT01587924|589302282|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
163160739|NCT01587924|589302283|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
163160740|NCT01587924|589302280|FG000|Overall Study|Withdrawal by Subject|0|||
163160741|NCT01587924|589302281|FG001|Overall Study|Withdrawal by Subject|1|||
163160742|NCT01587924|589302282|FG002|Overall Study|Withdrawal by Subject|1|||
163160743|NCT01587924|589302283|FG003|Overall Study|Withdrawal by Subject|0|||
163160744|NCT01578486|589302284|FG000|Overall Study|Physician Decision|3|||
163160745|NCT01578486|589302284|FG000|Overall Study|Withdrawal by Subject|2|||
163272397|NCT02018861|589707156|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
163160746|NCT00606593|589302285|FG000|Overall Study|Adverse Event|0|||
163160747|NCT00606593|589302286|FG001|Overall Study|Adverse Event|0|||
163160748|NCT00606593|589302287|FG002|Overall Study|Adverse Event|0|||
163160749|NCT00606593|589302288|FG003|Overall Study|Adverse Event|1|||
163160750|NCT00606593|589302289|FG004|Overall Study|Adverse Event|1|||
163160751|NCT00606593|589302290|FG005|Overall Study|Adverse Event|0|||
163160752|NCT00606593|589302291|FG006|Overall Study|Adverse Event|1|||
163160753|NCT00606593|589302292|FG007|Overall Study|Adverse Event|2|||
163160754|NCT00606593|589302293|FG008|Overall Study|Adverse Event|1|||
163160755|NCT00606593|589302294|FG009|Overall Study|Adverse Event|0|||
163160756|NCT00606593|589302285|FG000|Overall Study|Withdrawal of consent|1|||
163160757|NCT00606593|589302286|FG001|Overall Study|Withdrawal of consent|0|||
163160758|NCT00606593|589302287|FG002|Overall Study|Withdrawal of consent|1|||
163160759|NCT00606593|589302288|FG003|Overall Study|Withdrawal of consent|0|||
163160760|NCT00606593|589302289|FG004|Overall Study|Withdrawal of consent|0|||
163160761|NCT00606593|589302290|FG005|Overall Study|Withdrawal of consent|0|||
163160762|NCT00606593|589302291|FG006|Overall Study|Withdrawal of consent|0|||
163160763|NCT00606593|589302292|FG007|Overall Study|Withdrawal of consent|0|||
163160764|NCT00606593|589302293|FG008|Overall Study|Withdrawal of consent|0|||
163160765|NCT00606593|589302294|FG009|Overall Study|Withdrawal of consent|0|||
163160766|NCT00606593|589302285|FG000|Overall Study|Administrative/Other|0|||
163160767|NCT00606593|589302286|FG001|Overall Study|Administrative/Other|0|||
163160768|NCT00606593|589302287|FG002|Overall Study|Administrative/Other|1|||
163160769|NCT00606593|589302288|FG003|Overall Study|Administrative/Other|0|||
163160770|NCT00606593|589302289|FG004|Overall Study|Administrative/Other|0|||
163160771|NCT00606593|589302290|FG005|Overall Study|Administrative/Other|0|||
163160772|NCT00606593|589302291|FG006|Overall Study|Administrative/Other|0|||
163160773|NCT00606593|589302292|FG007|Overall Study|Administrative/Other|0|||
163160774|NCT00606593|589302293|FG008|Overall Study|Administrative/Other|0|||
163160775|NCT00606593|589302294|FG009|Overall Study|Administrative/Other|0|||
163160776|NCT03181529|589302295|FG000|Overall Study|Withdrawal by Subject|1|||
163160777|NCT03181529|589302296|FG001|Overall Study|Withdrawal by Subject|1|||
163160778|NCT03181529|589302295|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
163160779|NCT03181529|589302296|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
163160780|NCT00607373|589302297|FG000|Treatment Period|Adverse Event|0|||
163160781|NCT00607373|589302298|FG001|Treatment Period|Adverse Event|4|||
163160782|NCT00607373|589302297|FG000|Treatment Period|Physician Decision|0|||
163160783|NCT00607373|589302298|FG001|Treatment Period|Physician Decision|1|||
163160784|NCT00607373|589302297|FG000|Treatment Period|Withdrawal by Subject|0|||
163160785|NCT00607373|589302298|FG001|Treatment Period|Withdrawal by Subject|1|||
163160786|NCT00607373|589302297|FG000|Follow-up Period|Other|0|||
163160787|NCT00607373|589302298|FG001|Follow-up Period|Other|1|||
163160788|NCT00607373|589302297|FG000|Follow-up Period|Protocol Violation|0|||
163160789|NCT00607373|589302298|FG001|Follow-up Period|Protocol Violation|1|||
163160790|NCT00607373|589302297|FG000|Follow-up Period|Withdrawal by Subject|1|||
163272398|NCT02018861|589707157|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
163272399|NCT02018861|589707158|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
163272400|NCT02018861|589707159|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
163272401|NCT02018861|589707160|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
163272402|NCT02018861|589707161|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
163272403|NCT02018861|589707162|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
163272404|NCT02018861|589707163|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
163272405|NCT02018861|589707164|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
163272406|NCT02018861|589707155|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163272407|NCT02018861|589707156|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163272408|NCT02018861|589707157|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163272409|NCT02018861|589707158|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
163272410|NCT02018861|589707159|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
163160791|NCT00607373|589302298|FG001|Follow-up Period|Withdrawal by Subject|3|||
163160792|NCT01918306|589302299|FG000|Overall Study|progresive disease|4|||
163160793|NCT01918306|589302300|FG001|Overall Study|progresive disease|0|||
163160794|NCT01918306|589302301|FG002|Overall Study|progresive disease|1|||
163160795|NCT01918306|589302302|FG003|Overall Study|progresive disease|1|||
163160796|NCT01918306|589302299|FG000|Overall Study|Withdrawal by Subject|0|||
163160797|NCT01918306|589302300|FG001|Overall Study|Withdrawal by Subject|0|||
163160798|NCT01918306|589302301|FG002|Overall Study|Withdrawal by Subject|0|||
163160799|NCT01918306|589302302|FG003|Overall Study|Withdrawal by Subject|2|||
163160800|NCT01918306|589302299|FG000|Overall Study|neutropenia|1|||
163160801|NCT01918306|589302300|FG001|Overall Study|neutropenia|0|||
163160802|NCT01918306|589302301|FG002|Overall Study|neutropenia|0|||
163160803|NCT01918306|589302302|FG003|Overall Study|neutropenia|0|||
163160804|NCT01918306|589302299|FG000|Overall Study|Lack of Efficacy|1|||
163160805|NCT01918306|589302300|FG001|Overall Study|Lack of Efficacy|0|||
163160806|NCT01918306|589302301|FG002|Overall Study|Lack of Efficacy|0|||
163160807|NCT01918306|589302302|FG003|Overall Study|Lack of Efficacy|0|||
163160808|NCT01918306|589302299|FG000|Overall Study|progress disease, crossover|0|||
163160809|NCT01918306|589302300|FG001|Overall Study|progress disease, crossover|0|||
163160810|NCT01918306|589302301|FG002|Overall Study|progress disease, crossover|1|||
163160811|NCT01918306|589302302|FG003|Overall Study|progress disease, crossover|0|||
163160812|NCT00314795|589302310|FG000|Overall Study|Adverse Event|8|||
163160813|NCT00314795|589302310|FG000|Overall Study|Death|4|||
163160814|NCT00314795|589302310|FG000|Overall Study|Reason not Specified|3|||
163160815|NCT00314795|589302310|FG000|Overall Study|Renal Transplant|3|||
163160816|NCT00314795|589302310|FG000|Overall Study|Participants Withdrew Consent|2|||
163160817|NCT02908672|589302320|FG000|Run-in Period|Death|12|||
163160818|NCT02908672|589302321|FG001|Run-in Period|Death|10|||
163160819|NCT02908672|589302322|FG002|Run-in Period|Death|0|||
163160820|NCT02908672|589302323|FG003|Run-in Period|Death|0|||
163160821|NCT02908672|589302320|FG000|Run-in Period|Lost to Follow-up|1|||
163160822|NCT02908672|589302321|FG001|Run-in Period|Lost to Follow-up|1|||
163160823|NCT02908672|589302322|FG002|Run-in Period|Lost to Follow-up|0|||
163160824|NCT02908672|589302323|FG003|Run-in Period|Lost to Follow-up|0|||
163160825|NCT02908672|589302320|FG000|Run-in Period|Reason Not Specified|2|||
163160826|NCT02908672|589302321|FG001|Run-in Period|Reason Not Specified|0|||
163160827|NCT02908672|589302322|FG002|Run-in Period|Reason Not Specified|0|||
163272411|NCT02018861|589707160|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163385767|NCT00146328|590123239|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
163160828|NCT02908672|589302323|FG003|Run-in Period|Reason Not Specified|0|||
163160829|NCT02908672|589302320|FG000|Run-in Period|Protocol Violation|1|||
163160830|NCT02908672|589302321|FG001|Run-in Period|Protocol Violation|1|||
163160831|NCT02908672|589302322|FG002|Run-in Period|Protocol Violation|0|||
163160832|NCT02908672|589302323|FG003|Run-in Period|Protocol Violation|0|||
163160833|NCT02908672|589302320|FG000|Run-in Period|Study Ended by Sponsor|5|||
163160834|NCT02908672|589302321|FG001|Run-in Period|Study Ended by Sponsor|1|||
163160835|NCT02908672|589302322|FG002|Run-in Period|Study Ended by Sponsor|0|||
163160836|NCT02908672|589302323|FG003|Run-in Period|Study Ended by Sponsor|0|||
163160837|NCT02908672|589302320|FG000|Run-in Period|Withdrawal by Subject|3|||
163160838|NCT02908672|589302321|FG001|Run-in Period|Withdrawal by Subject|9|||
163160839|NCT02908672|589302322|FG002|Run-in Period|Withdrawal by Subject|0|||
163160840|NCT02908672|589302323|FG003|Run-in Period|Withdrawal by Subject|0|||
163160841|NCT02908672|589302320|FG000|Triple Combination Period|Death|0|||
163160842|NCT02908672|589302321|FG001|Triple Combination Period|Death|0|||
163160843|NCT02908672|589302322|FG002|Triple Combination Period|Death|150|||
163160844|NCT02908672|589302323|FG003|Triple Combination Period|Death|127|||
163160845|NCT02908672|589302320|FG000|Triple Combination Period|Lost to Follow-up|0|||
163160846|NCT02908672|589302321|FG001|Triple Combination Period|Lost to Follow-up|0|||
163160847|NCT02908672|589302322|FG002|Triple Combination Period|Lost to Follow-up|6|||
163160848|NCT02908672|589302323|FG003|Triple Combination Period|Lost to Follow-up|8|||
163160849|NCT02908672|589302320|FG000|Triple Combination Period|Reason Not Specified|0|||
163160850|NCT02908672|589302321|FG001|Triple Combination Period|Reason Not Specified|0|||
163160851|NCT02908672|589302322|FG002|Triple Combination Period|Reason Not Specified|0|||
163160852|NCT02908672|589302323|FG003|Triple Combination Period|Reason Not Specified|1|||
163160853|NCT02908672|589302320|FG000|Triple Combination Period|Physician Decision|0|||
163160854|NCT02908672|589302321|FG001|Triple Combination Period|Physician Decision|0|||
163160855|NCT02908672|589302322|FG002|Triple Combination Period|Physician Decision|1|||
163160856|NCT02908672|589302323|FG003|Triple Combination Period|Physician Decision|1|||
163160857|NCT02908672|589302320|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
163160858|NCT02908672|589302321|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
163160859|NCT02908672|589302322|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
163160860|NCT02908672|589302323|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
163160861|NCT02908672|589302320|FG000|Triple Combination Period|Withdrawal by Subject|0|||
163160862|NCT02908672|589302321|FG001|Triple Combination Period|Withdrawal by Subject|0|||
163160863|NCT02908672|589302322|FG002|Triple Combination Period|Withdrawal by Subject|13|||
163160864|NCT02908672|589302323|FG003|Triple Combination Period|Withdrawal by Subject|16|||
163160865|NCT02876601|589302327|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
163160866|NCT02876601|589302328|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
163160867|NCT02876601|589302329|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
163160868|NCT02876601|589302330|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
163160869|NCT00759941|589302331|FG000|Overall Study|Use of medication|1|||
163160870|NCT00759941|589302332|FG001|Overall Study|Use of medication|0|||
163160871|NCT00759941|589302331|FG000|Overall Study|Adverse Event|1|||
163160872|NCT00759941|589302332|FG001|Overall Study|Adverse Event|0|||
163160873|NCT00759941|589302331|FG000|Overall Study|Exited in error by site|1|||
163160874|NCT00759941|589302332|FG001|Overall Study|Exited in error by site|1|||
163160875|NCT00354432|589302333|FG000|Overall Study|Adverse Event|3|||
163160876|NCT00354432|589302334|FG001|Overall Study|Adverse Event|1|||
163160877|NCT00354432|589302335|FG002|Overall Study|Adverse Event|5|||
163272412|NCT02018861|589707161|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163272413|NCT02018861|589707162|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163272414|NCT02018861|589707163|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163272415|NCT02018861|589707164|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163272416|NCT02018861|589707155|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163272417|NCT02018861|589707156|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163272418|NCT02018861|589707157|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163272419|NCT02018861|589707158|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163272420|NCT02018861|589707159|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163272421|NCT02018861|589707160|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163272422|NCT02018861|589707161|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
163272423|NCT02018861|589707162|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
163272424|NCT02018861|589707163|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163272425|NCT02018861|589707164|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163272426|NCT02018861|589707155|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163272427|NCT02018861|589707156|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163272428|NCT02018861|589707157|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163272429|NCT02018861|589707158|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163272430|NCT02018861|589707159|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163272431|NCT02018861|589707160|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163272432|NCT02018861|589707161|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
163272433|NCT02018861|589707162|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
163272434|NCT02018861|589707163|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163272435|NCT02018861|589707164|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163272436|NCT02018861|589707155|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163272437|NCT02018861|589707156|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163272438|NCT02018861|589707157|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163272439|NCT02018861|589707158|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163272440|NCT02018861|589707159|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163272441|NCT02018861|589707160|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163272442|NCT02018861|589707161|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163272443|NCT02018861|589707162|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163272444|NCT02018861|589707163|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
163272445|NCT02018861|589707164|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163272446|NCT02018861|589707155|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163272447|NCT02018861|589707156|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163272448|NCT02018861|589707157|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163272449|NCT02018861|589707158|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163272450|NCT02018861|589707159|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163272451|NCT02018861|589707160|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163272452|NCT02018861|589707161|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163272453|NCT02018861|589707162|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163272454|NCT02018861|589707163|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
163272455|NCT02018861|589707164|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163272456|NCT02018861|589707155|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163272457|NCT02018861|589707156|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163272458|NCT02018861|589707157|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163272459|NCT02018861|589707158|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163272460|NCT02018861|589707159|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163272461|NCT02018861|589707160|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163272462|NCT02018861|589707161|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163272463|NCT02018861|589707162|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163272464|NCT02018861|589707163|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
163272465|NCT02018861|589707164|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163272466|NCT00163215|589707165|FG000|Overall Study|Lack of Efficacy|3|||
163272467|NCT00163215|589707165|FG000|Overall Study|Withdrawal by Subject|5|||
163272468|NCT00163215|589707165|FG000|Overall Study|Other|7|||
163272469|NCT00590980|589707168|FG000|Overall Study|Did not meet all inclusion criteria|10|||
163272470|NCT01023308|589707170|FG000|Overall Study|Abnormal test proceedure results|3|||
163272471|NCT01023308|589707171|FG001|Overall Study|Abnormal test proceedure results|8|||
163272472|NCT01023308|589707170|FG000|Overall Study|Administrative problems|2|||
163272473|NCT01023308|589707171|FG001|Overall Study|Administrative problems|1|||
163272474|NCT01023308|589707170|FG000|Overall Study|Adverse Event|130|||
163272475|NCT01023308|589707171|FG001|Overall Study|Adverse Event|66|||
163272476|NCT01023308|589707170|FG000|Overall Study|Death|21|||
163272477|NCT01023308|589707171|FG001|Overall Study|Death|17|||
163272478|NCT01023308|589707170|FG000|Overall Study|Disease progression|82|||
163272479|NCT01023308|589707171|FG001|Overall Study|Disease progression|153|||
163272480|NCT01023308|589707170|FG000|Overall Study|New Cancer therapy|4|||
163272481|NCT01023308|589707171|FG001|Overall Study|New Cancer therapy|7|||
163272482|NCT01023308|589707170|FG000|Overall Study|Protocol Violation|3|||
163272483|NCT01023308|589707171|FG001|Overall Study|Protocol Violation|4|||
163272484|NCT01023308|589707170|FG000|Overall Study|Untreated|5|||
163272485|NCT01023308|589707171|FG001|Overall Study|Untreated|5|||
163272486|NCT01023308|589707170|FG000|Overall Study|Lost to Follow-up|1|||
163272487|NCT01023308|589707171|FG001|Overall Study|Lost to Follow-up|0|||
163272488|NCT01023308|589707170|FG000|Overall Study|Withdrawal by Subject|34|||
163272489|NCT01023308|589707171|FG001|Overall Study|Withdrawal by Subject|18|||
163272490|NCT01646320|589707172|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
163272491|NCT01646320|589707173|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
163272492|NCT01646320|589707172|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
163272493|NCT01646320|589707173|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
163272494|NCT01646320|589707172|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
163272495|NCT01646320|589707173|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
163272496|NCT01646320|589707172|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
163272497|NCT01646320|589707173|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
163272498|NCT01646320|589707172|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
163272499|NCT01646320|589707173|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
163272500|NCT01646320|589707172|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
163272501|NCT01646320|589707173|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
163272502|NCT01646320|589707172|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
163272503|NCT01646320|589707173|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
163272504|NCT01646320|589707172|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
163272505|NCT01646320|589707173|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
163272506|NCT01646320|589707172|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
163272507|NCT01646320|589707173|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
163272508|NCT01646320|589707172|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
163272509|NCT01646320|589707173|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
163272510|NCT01646320|589707172|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
163272511|NCT01646320|589707173|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
163272512|NCT02451930|589707176|FG000|Overall Study|Death|0|||
163272513|NCT02451930|589707177|FG001|Overall Study|Death|15|||
163272514|NCT02451930|589707176|FG000|Overall Study|Lost to Follow-up|0|||
163272515|NCT02451930|589707177|FG001|Overall Study|Lost to Follow-up|3|||
163272516|NCT02451930|589707176|FG000|Overall Study|Sponsor Decision|2|||
163272517|NCT02451930|589707177|FG001|Overall Study|Sponsor Decision|10|||
163272518|NCT02451930|589707176|FG000|Overall Study|Withdrawal by Subject|0|||
163272519|NCT02451930|589707177|FG001|Overall Study|Withdrawal by Subject|1|||
163272520|NCT02451930|589707176|FG000|Overall Study|Other|0|||
163272521|NCT02451930|589707177|FG001|Overall Study|Other|1|||
163272522|NCT00962585|589707178|FG000|Overall Study|Adverse Event|0|||
163272523|NCT00962585|589707179|FG001|Overall Study|Adverse Event|2|||
163272524|NCT00962585|589707180|FG002|Overall Study|Adverse Event|1|||
163272525|NCT00962585|589707181|FG003|Overall Study|Adverse Event|0|||
163272526|NCT00962585|589707178|FG000|Overall Study|Lost to Follow-up|3|||
163272527|NCT00962585|589707179|FG001|Overall Study|Lost to Follow-up|0|||
163272528|NCT00962585|589707180|FG002|Overall Study|Lost to Follow-up|1|||
163272529|NCT00962585|589707181|FG003|Overall Study|Lost to Follow-up|0|||
163272530|NCT00962585|589707178|FG000|Overall Study|Protocol Violation|0|||
163272531|NCT00962585|589707179|FG001|Overall Study|Protocol Violation|0|||
163272532|NCT00962585|589707180|FG002|Overall Study|Protocol Violation|1|||
163272533|NCT00962585|589707181|FG003|Overall Study|Protocol Violation|0|||
163272534|NCT00962585|589707178|FG000|Overall Study|Withdrawal by Subject|1|||
163272535|NCT00962585|589707179|FG001|Overall Study|Withdrawal by Subject|0|||
163272536|NCT00962585|589707180|FG002|Overall Study|Withdrawal by Subject|0|||
163272537|NCT00962585|589707181|FG003|Overall Study|Withdrawal by Subject|0|||
163272538|NCT00962585|589707178|FG000|Overall Study|Withdrew Consent|2|||
163272539|NCT00962585|589707179|FG001|Overall Study|Withdrew Consent|0|||
163272540|NCT00962585|589707180|FG002|Overall Study|Withdrew Consent|0|||
163272541|NCT00962585|589707181|FG003|Overall Study|Withdrew Consent|0|||
163272542|NCT01950273|589707192|FG000|Overall Study|Protocol Violation|1|||
163272543|NCT01950273|589707193|FG001|Overall Study|Protocol Violation|0|||
163272544|NCT01950273|589707192|FG000|Overall Study|Withdrawal by Subject|2|||
163272545|NCT01950273|589707193|FG001|Overall Study|Withdrawal by Subject|0|||
163272546|NCT01950273|589707192|FG000|Overall Study|Other not defined above|1|||
163272547|NCT01950273|589707193|FG001|Overall Study|Other not defined above|0|||
163272548|NCT04430335|589707196|FG000|Overall Study|Withdrawal by Subject|1|||
163272549|NCT00179010|589707199|FG000|Overall Study|Muscle probe defective|1|||
163272550|NCT00179010|589707200|FG001|Overall Study|Muscle probe defective|1|||
163272551|NCT00179010|589707199|FG000|Overall Study|Failure to place arterial line|0|||
163272552|NCT00179010|589707200|FG001|Overall Study|Failure to place arterial line|1|||
163272553|NCT03249376|589707215|FG000|Overall Study|Adverse Event|11|||
163272554|NCT03249376|589707216|FG001|Overall Study|Adverse Event|5|||
163272555|NCT03249376|589707215|FG000|Overall Study|Lack of Efficacy|2|||
163272556|NCT03249376|589707216|FG001|Overall Study|Lack of Efficacy|4|||
163272557|NCT03249376|589707215|FG000|Overall Study|Protocol Violation|3|||
163272558|NCT03249376|589707216|FG001|Overall Study|Protocol Violation|2|||
163272559|NCT03249376|589707215|FG000|Overall Study|Physician Decision|0|||
163272560|NCT03249376|589707216|FG001|Overall Study|Physician Decision|2|||
163272561|NCT03249376|589707215|FG000|Overall Study|Withdrawal by Subject|3|||
163272562|NCT03249376|589707216|FG001|Overall Study|Withdrawal by Subject|9|||
163272563|NCT03249376|589707215|FG000|Overall Study|LTFU|2|||
163272564|NCT03249376|589707216|FG001|Overall Study|LTFU|1|||
163272565|NCT00627042|589707220|FG000|Overall Study|Withdrawal by Subject|2|||
163272566|NCT00794820|589707228|FG000|Overall Study|Adverse Event|11|||
163272567|NCT00794820|589707228|FG000|Overall Study|Secondary Malignancies|2|||
163272568|NCT00794820|589707228|FG000|Overall Study|Resistant Disease|2|||
163272569|NCT00794820|589707228|FG000|Overall Study|Ineligible/Screen Failure|1|||
163272570|NCT00432679|589707232|FG000|Overall Study|Adverse Event|2|||
163272571|NCT00432679|589707233|FG001|Overall Study|Adverse Event|1|||
163272572|NCT00432679|589707232|FG000|Overall Study|Withdrawal by Subject|3|||
163272573|NCT00432679|589707233|FG001|Overall Study|Withdrawal by Subject|2|||
163272574|NCT03405662|589707235|FG000|Overall Study|COVID-19 restriction|1|||
163272575|NCT03405662|589707236|FG001|Overall Study|COVID-19 restriction|0|||
163272576|NCT03405662|589707235|FG000|Overall Study|unblinding|0|||
163272577|NCT03405662|589707236|FG001|Overall Study|unblinding|1|||
163272578|NCT03405662|589707235|FG000|Overall Study|placement in memory care facility|0|||
163272579|NCT03405662|589707236|FG001|Overall Study|placement in memory care facility|2|||
163272580|NCT00280293|589707237|FG000|Overall Study|Protocol Violation|3|||
163272581|NCT00280293|589707238|FG001|Overall Study|Protocol Violation|0|||
163272582|NCT00280293|589707237|FG000|Overall Study|Physician Decision|5|||
163272583|NCT00280293|589707238|FG001|Overall Study|Physician Decision|4|||
163272584|NCT00280293|589707237|FG000|Overall Study|Lost to Follow-up|14|||
163272585|NCT00280293|589707238|FG001|Overall Study|Lost to Follow-up|12|||
163272586|NCT00280293|589707237|FG000|Overall Study|Withdrawal by Subject|3|||
163272587|NCT00280293|589707238|FG001|Overall Study|Withdrawal by Subject|5|||
163272588|NCT00280293|589707237|FG000|Overall Study|Incarceration/Legal Reasons|1|||
163272589|NCT00280293|589707238|FG001|Overall Study|Incarceration/Legal Reasons|1|||
163272590|NCT00280293|589707237|FG000|Overall Study|Adverse Event|0|||
163272591|NCT00280293|589707238|FG001|Overall Study|Adverse Event|1|||
163272592|NCT01177813|589707239|FG000|Overall Study|Adverse Event|8|||
163272593|NCT01177813|589707240|FG001|Overall Study|Adverse Event|2|||
163272594|NCT01177813|589707241|FG002|Overall Study|Adverse Event|4|||
163272595|NCT01177813|589707242|FG003|Overall Study|Adverse Event|6|||
163272596|NCT01177813|589707243|FG004|Overall Study|Adverse Event|3|||
163272597|NCT01177813|589707239|FG000|Overall Study|Lack of Efficacy|1|||
163272598|NCT01177813|589707240|FG001|Overall Study|Lack of Efficacy|0|||
163272599|NCT01177813|589707241|FG002|Overall Study|Lack of Efficacy|0|||
163272600|NCT01177813|589707242|FG003|Overall Study|Lack of Efficacy|0|||
163272601|NCT01177813|589707243|FG004|Overall Study|Lack of Efficacy|0|||
163272602|NCT01177813|589707239|FG000|Overall Study|Protocol Violation|3|||
163272603|NCT01177813|589707240|FG001|Overall Study|Protocol Violation|2|||
163272604|NCT01177813|589707241|FG002|Overall Study|Protocol Violation|2|||
163272605|NCT01177813|589707242|FG003|Overall Study|Protocol Violation|0|||
163272606|NCT01177813|589707243|FG004|Overall Study|Protocol Violation|1|||
163272607|NCT01177813|589707239|FG000|Overall Study|Lost to Follow-up|12|||
163272608|NCT01177813|589707240|FG001|Overall Study|Lost to Follow-up|5|||
163272609|NCT01177813|589707241|FG002|Overall Study|Lost to Follow-up|6|||
163272610|NCT01177813|589707242|FG003|Overall Study|Lost to Follow-up|3|||
163272611|NCT01177813|589707243|FG004|Overall Study|Lost to Follow-up|0|||
163272612|NCT01177813|589707239|FG000|Overall Study|Withdrawal by Subject|12|||
163272613|NCT01177813|589707240|FG001|Overall Study|Withdrawal by Subject|7|||
163272614|NCT01177813|589707241|FG002|Overall Study|Withdrawal by Subject|6|||
163272615|NCT01177813|589707242|FG003|Overall Study|Withdrawal by Subject|5|||
163272616|NCT01177813|589707243|FG004|Overall Study|Withdrawal by Subject|3|||
163272617|NCT01177813|589707239|FG000|Overall Study|Other reason not defined above|5|||
163272618|NCT01177813|589707240|FG001|Overall Study|Other reason not defined above|2|||
163272619|NCT01177813|589707241|FG002|Overall Study|Other reason not defined above|2|||
163272620|NCT01177813|589707242|FG003|Overall Study|Other reason not defined above|3|||
163272621|NCT01177813|589707243|FG004|Overall Study|Other reason not defined above|2|||
163272622|NCT01458249|589707246|FG000|Overall Study|Not treated|1|||
163272623|NCT01458249|589707246|FG000|Overall Study|Adverse Event|4|||
163272624|NCT01458249|589707246|FG000|Overall Study|Other|2|||
163272625|NCT01458249|589707246|FG000|Overall Study|Ongoing|1|||
163272626|NCT02056119|589707249|FG000|Overall Study|Death|1|||
163272627|NCT02056119|589707250|FG001|Overall Study|Death|2|||
163272628|NCT02056119|589707249|FG000|Overall Study|Intubated for less than 24 hrs|2|||
163272629|NCT02056119|589707250|FG001|Overall Study|Intubated for less than 24 hrs|7|||
163272630|NCT02056119|589707249|FG000|Overall Study|No aerosol treatments were given.|3|||
163272631|NCT02056119|589707250|FG001|Overall Study|No aerosol treatments were given.|2|||
163272632|NCT02056119|589707249|FG000|Overall Study|Received Metaneb treatment|0|||
163272633|NCT02056119|589707250|FG001|Overall Study|Received Metaneb treatment|2|||
163272634|NCT02056119|589707249|FG000|Overall Study|Protocol Violation|4|||
163272635|NCT02056119|589707250|FG001|Overall Study|Protocol Violation|7|||
163272636|NCT01348854|589707251|FG000|Overall Study|Lost to Follow-up|2|||
163272637|NCT01348854|589707252|FG001|Overall Study|Lost to Follow-up|1|||
163272638|NCT01348854|589707251|FG000|Overall Study|Withdrawal by Subject|1|||
163272639|NCT01348854|589707252|FG001|Overall Study|Withdrawal by Subject|0|||
163272640|NCT03220737|589707253|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
163272641|NCT03220737|589707254|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
163272642|NCT03220737|589707255|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
163272643|NCT03220737|589707256|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
163272644|NCT03220737|589707257|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
163272645|NCT03220737|589707258|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
163272646|NCT03220737|589707259|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
163272647|NCT03220737|589707253|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
163272648|NCT03220737|589707254|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
163272649|NCT03220737|589707255|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
163272650|NCT03220737|589707256|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
163272651|NCT03220737|589707257|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
163272652|NCT03220737|589707258|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
163272653|NCT03220737|589707259|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
163272654|NCT03220737|589707253|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
163272655|NCT03220737|589707254|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
163272656|NCT03220737|589707255|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
163272657|NCT03220737|589707256|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
163272658|NCT03220737|589707257|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
163272659|NCT03220737|589707258|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
163272660|NCT03220737|589707259|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
163272661|NCT03220737|589707253|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
163272662|NCT03220737|589707254|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
163272663|NCT03220737|589707255|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
163272664|NCT03220737|589707256|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
163272665|NCT03220737|589707257|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
163272666|NCT03220737|589707258|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
163272667|NCT03220737|589707259|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
163272668|NCT03220737|589707253|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
163272669|NCT03220737|589707254|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
163272670|NCT03220737|589707255|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
163272671|NCT03220737|589707256|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
163272672|NCT03220737|589707257|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
163272673|NCT03220737|589707258|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
163272674|NCT03220737|589707259|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
163272675|NCT03220737|589707253|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
163272676|NCT03220737|589707254|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
163272677|NCT03220737|589707255|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
163272678|NCT03220737|589707256|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
163272679|NCT03220737|589707257|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
163272680|NCT03220737|589707258|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
163272681|NCT03220737|589707259|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
163272682|NCT03220737|589707253|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
163272683|NCT03220737|589707254|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
163272684|NCT03220737|589707255|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
163272685|NCT03220737|589707256|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
163272686|NCT03220737|589707257|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
163272687|NCT03220737|589707258|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
163272688|NCT03220737|589707259|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
163272689|NCT03220737|589707253|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
163272690|NCT03220737|589707254|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
163272691|NCT03220737|589707255|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
163272692|NCT03220737|589707256|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
163272693|NCT03220737|589707257|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
163272694|NCT03220737|589707258|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
163272695|NCT03220737|589707259|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
163272696|NCT04011384|589707265|FG000|Overall Study|Withdrawal by Subject|2|||
163272697|NCT04011384|589707266|FG001|Overall Study|Withdrawal by Subject|0|||
163272698|NCT04716881|589707267|FG000|Overall Study|Adverse Event|1|||
163272699|NCT04716881|589707267|FG000|Overall Study|Lost to Follow-up|1|||
163272700|NCT01630590|589707268|FG000|Overall Study|Adverse Event|9|||
163272701|NCT01630590|589707268|FG000|Overall Study|Lack of Efficacy|37|||
163272702|NCT01630590|589707268|FG000|Overall Study|Withdrawal by Subject|4|||
163272703|NCT01630590|589707268|FG000|Overall Study|2nd primary tumor|2|||
163272704|NCT01630590|589707268|FG000|Overall Study|Automobile accident|1|||
163272705|NCT01630590|589707268|FG000|Overall Study|Maximum benefit|4|||
163272706|NCT01751113|589707269|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
163272707|NCT01751113|589707270|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
163272708|NCT01751113|589707271|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
163272709|NCT01751113|589707272|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
163272710|NCT01751113|589707273|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
163272711|NCT01751113|589707274|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
163272712|NCT01751113|589707269|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
163272713|NCT01751113|589707270|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
163272714|NCT01751113|589707271|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
163272715|NCT01751113|589707272|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
163272716|NCT01751113|589707273|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
163272717|NCT01751113|589707274|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
163272718|NCT00363896|589707275|FG000|Overall Study|Withdrawal by Subject|29|||
163272719|NCT00363896|589707276|FG001|Overall Study|Withdrawal by Subject|16|||
163272720|NCT00363896|589707275|FG000|Overall Study|Adverse Event|24|||
163272721|NCT00363896|589707276|FG001|Overall Study|Adverse Event|13|||
163272722|NCT00363896|589707275|FG000|Overall Study|COPD exacerbation|13|||
163272723|NCT00363896|589707276|FG001|Overall Study|COPD exacerbation|7|||
163272724|NCT00363896|589707275|FG000|Overall Study|Lack of Efficacy|12|||
163272725|NCT00363896|589707276|FG001|Overall Study|Lack of Efficacy|8|||
163272726|NCT00363896|589707275|FG000|Overall Study|Protocol Violation|6|||
163272727|NCT00363896|589707276|FG001|Overall Study|Protocol Violation|1|||
163272728|NCT00363896|589707275|FG000|Overall Study|Lost to Follow-up|3|||
163272729|NCT00363896|589707276|FG001|Overall Study|Lost to Follow-up|0|||
163272730|NCT00363896|589707275|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
163272731|NCT00363896|589707276|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
163272732|NCT00363896|589707275|FG000|Overall Study|Other|1|||
163272733|NCT00363896|589707276|FG001|Overall Study|Other|2|||
163272734|NCT04147260|589707277|FG000|Overall Study|Adverse Event|1|||
163272735|NCT04147260|589707278|FG001|Overall Study|Adverse Event|0|||
163272736|NCT04147260|589707279|FG002|Overall Study|Adverse Event|1|||
163272737|NCT04147260|589707280|FG003|Overall Study|Adverse Event|2|||
163272738|NCT04147260|589707281|FG004|Overall Study|Adverse Event|0|||
163272739|NCT04147260|589707277|FG000|Overall Study|Withdrawal by Subject|0|||
163272740|NCT04147260|589707278|FG001|Overall Study|Withdrawal by Subject|0|||
163272741|NCT04147260|589707279|FG002|Overall Study|Withdrawal by Subject|1|||
163272742|NCT04147260|589707280|FG003|Overall Study|Withdrawal by Subject|1|||
163272743|NCT04147260|589707281|FG004|Overall Study|Withdrawal by Subject|0|||
163272744|NCT02471404|589707289|FG000|Overall Study|Adverse Event|7|||
163272745|NCT02471404|589707290|FG001|Overall Study|Adverse Event|1|||
163272746|NCT02471404|589707291|FG002|Overall Study|Adverse Event|2|||
163272747|NCT02471404|589707289|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
163272748|NCT02471404|589707290|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
163272749|NCT02471404|589707291|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
163272750|NCT02471404|589707289|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
163272751|NCT02471404|589707290|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
163272752|NCT02471404|589707291|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
163272753|NCT02471404|589707289|FG000|Overall Study|Lost to Follow-up|1|||
163272754|NCT02471404|589707290|FG001|Overall Study|Lost to Follow-up|1|||
163272755|NCT02471404|589707291|FG002|Overall Study|Lost to Follow-up|3|||
163272756|NCT02471404|589707289|FG000|Overall Study|Protocol Violation|1|||
163272757|NCT02471404|589707290|FG001|Overall Study|Protocol Violation|0|||
163272758|NCT02471404|589707291|FG002|Overall Study|Protocol Violation|0|||
163272759|NCT02471404|589707289|FG000|Overall Study|Withdrawal by Subject|8|||
163272760|NCT02471404|589707290|FG001|Overall Study|Withdrawal by Subject|4|||
163272761|NCT02471404|589707291|FG002|Overall Study|Withdrawal by Subject|5|||
163272762|NCT02471404|589707289|FG000|Overall Study|Other reasons not specified|10|||
163272763|NCT02471404|589707290|FG001|Overall Study|Other reasons not specified|7|||
163272764|NCT02471404|589707291|FG002|Overall Study|Other reasons not specified|12|||
163272765|NCT03051659|589707292|FG000|Treatment Period|Withdrawal by Subject|0|||
163272766|NCT03051659|589707293|FG001|Treatment Period|Withdrawal by Subject|2|||
163272767|NCT03051659|589707292|FG000|Survival Follow-up|Lost to Follow-up|23|||
163272768|NCT03051659|589707293|FG001|Survival Follow-up|Lost to Follow-up|22|||
163272769|NCT04779242|589707294|FG000|Overall Study|Adverse Event|1|||
163272770|NCT04779242|589707295|FG001|Overall Study|Adverse Event|1|||
163272771|NCT04779242|589707294|FG000|Overall Study|Lost to Follow-up|2|||
163272772|NCT04779242|589707295|FG001|Overall Study|Lost to Follow-up|4|||
163272773|NCT04779242|589707294|FG000|Overall Study|Withdrawal by Subject|7|||
163272774|NCT04779242|589707295|FG001|Overall Study|Withdrawal by Subject|9|||
163272775|NCT04779242|589707294|FG000|Overall Study|Death|6|||
163272776|NCT04779242|589707295|FG001|Overall Study|Death|6|||
163272777|NCT04779242|589707294|FG000|Overall Study|COVID-19 related reasons|2|||
163272778|NCT04779242|589707295|FG001|Overall Study|COVID-19 related reasons|1|||
163272779|NCT04779242|589707294|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
163272780|NCT04779242|589707295|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
163272781|NCT04779242|589707294|FG000|Overall Study|Martial Law in Ukraine|2|||
163272782|NCT04779242|589707295|FG001|Overall Study|Martial Law in Ukraine|3|||
163272783|NCT00849680|589707300|FG000|Overall Study|Adverse Event|0|||
163272784|NCT00849680|589707301|FG001|Overall Study|Adverse Event|0|||
163272785|NCT00849680|589707302|FG002|Overall Study|Adverse Event|0|||
163272786|NCT00849680|589707303|FG003|Overall Study|Adverse Event|0|||
163272787|NCT00849680|589707304|FG004|Overall Study|Adverse Event|0|||
163272788|NCT00849680|589707305|FG005|Overall Study|Adverse Event|0|||
163272789|NCT00849680|589707306|FG006|Overall Study|Adverse Event|2|||
163272790|NCT00849680|589707307|FG007|Overall Study|Adverse Event|0|||
163272791|NCT00849680|589707300|FG000|Overall Study|Lost to Follow-up|7|||
163272792|NCT00849680|589707301|FG001|Overall Study|Lost to Follow-up|3|||
163272793|NCT00849680|589707302|FG002|Overall Study|Lost to Follow-up|12|||
163272794|NCT00849680|589707303|FG003|Overall Study|Lost to Follow-up|11|||
163272795|NCT00849680|589707304|FG004|Overall Study|Lost to Follow-up|8|||
163272796|NCT00849680|589707305|FG005|Overall Study|Lost to Follow-up|11|||
163272797|NCT00849680|589707306|FG006|Overall Study|Lost to Follow-up|12|||
163272798|NCT00849680|589707307|FG007|Overall Study|Lost to Follow-up|5|||
163272799|NCT00849680|589707300|FG000|Overall Study|Subject moved|1|||
163272800|NCT00849680|589707301|FG001|Overall Study|Subject moved|0|||
163272801|NCT00849680|589707302|FG002|Overall Study|Subject moved|3|||
163272802|NCT00849680|589707303|FG003|Overall Study|Subject moved|1|||
163272803|NCT00849680|589707304|FG004|Overall Study|Subject moved|0|||
163272804|NCT00849680|589707305|FG005|Overall Study|Subject moved|2|||
163272805|NCT00849680|589707306|FG006|Overall Study|Subject moved|2|||
163272806|NCT00849680|589707307|FG007|Overall Study|Subject moved|2|||
163272807|NCT00849680|589707300|FG000|Overall Study|Withdrawal by Subject|2|||
163272808|NCT00849680|589707301|FG001|Overall Study|Withdrawal by Subject|0|||
163272809|NCT00849680|589707302|FG002|Overall Study|Withdrawal by Subject|0|||
163272810|NCT00849680|589707303|FG003|Overall Study|Withdrawal by Subject|2|||
163272811|NCT00849680|589707304|FG004|Overall Study|Withdrawal by Subject|2|||
163272812|NCT00849680|589707305|FG005|Overall Study|Withdrawal by Subject|2|||
163272813|NCT00849680|589707306|FG006|Overall Study|Withdrawal by Subject|1|||
163272814|NCT00849680|589707307|FG007|Overall Study|Withdrawal by Subject|1|||
163272815|NCT00849680|589707300|FG000|Overall Study|Subject unable to comply with protocol|1|||
163272816|NCT00849680|589707301|FG001|Overall Study|Subject unable to comply with protocol|0|||
163272817|NCT00849680|589707302|FG002|Overall Study|Subject unable to comply with protocol|0|||
163272818|NCT00849680|589707303|FG003|Overall Study|Subject unable to comply with protocol|0|||
163272819|NCT00849680|589707304|FG004|Overall Study|Subject unable to comply with protocol|0|||
163272820|NCT00849680|589707305|FG005|Overall Study|Subject unable to comply with protocol|0|||
163272821|NCT00849680|589707306|FG006|Overall Study|Subject unable to comply with protocol|0|||
163272822|NCT00849680|589707307|FG007|Overall Study|Subject unable to comply with protocol|0|||
163272823|NCT02207374|589707308|FG000|Overall Study|Withdrawal by Subject|5|||
163272824|NCT02207374|589707309|FG001|Overall Study|Withdrawal by Subject|9|||
163272825|NCT02207374|589707310|FG002|Overall Study|Withdrawal by Subject|4|||
163272826|NCT02207374|589707308|FG000|Overall Study|Death|1|||
163272827|NCT02207374|589707309|FG001|Overall Study|Death|0|||
163272828|NCT02207374|589707310|FG002|Overall Study|Death|1|||
163272829|NCT02207374|589707308|FG000|Overall Study|Missing follow-up information|0|||
163272830|NCT02207374|589707309|FG001|Overall Study|Missing follow-up information|1|||
163272831|NCT02207374|589707310|FG002|Overall Study|Missing follow-up information|1|||
163272832|NCT02087150|589707311|FG000|Overall Study|Death|0|||
163272833|NCT02087150|589707312|FG001|Overall Study|Death|1|||
163272834|NCT02087150|589707313|FG002|Overall Study|Death|0|||
163272835|NCT02087150|589707311|FG000|Overall Study|Lost to Follow-up|6|||
163272836|NCT02087150|589707312|FG001|Overall Study|Lost to Follow-up|13|||
163272837|NCT02087150|589707313|FG002|Overall Study|Lost to Follow-up|7|||
163272838|NCT02087150|589707311|FG000|Overall Study|Withdrawal by Subject|2|||
163272839|NCT02087150|589707312|FG001|Overall Study|Withdrawal by Subject|5|||
163272840|NCT02087150|589707313|FG002|Overall Study|Withdrawal by Subject|3|||
163272841|NCT02087150|589707311|FG000|Overall Study|Physician Decision|0|||
163272842|NCT02087150|589707312|FG001|Overall Study|Physician Decision|1|||
163272843|NCT02087150|589707313|FG002|Overall Study|Physician Decision|0|||
163272844|NCT02087150|589707311|FG000|Overall Study|Procedure not done|1|||
163272845|NCT02087150|589707312|FG001|Overall Study|Procedure not done|13|||
163272846|NCT02087150|589707313|FG002|Overall Study|Procedure not done|0|||
163272847|NCT02087150|589707311|FG000|Overall Study|F/U not completed w/in study window|0|||
163272848|NCT02087150|589707312|FG001|Overall Study|F/U not completed w/in study window|0|||
163272849|NCT02087150|589707313|FG002|Overall Study|F/U not completed w/in study window|1|||
163272850|NCT02087150|589707311|FG000|Overall Study|Other|1|||
163272851|NCT02087150|589707312|FG001|Overall Study|Other|0|||
163272852|NCT02087150|589707313|FG002|Overall Study|Other|0|||
163272853|NCT02087150|589707311|FG000|Overall Study|Pt moved out of town|0|||
163272854|NCT02087150|589707312|FG001|Overall Study|Pt moved out of town|1|||
163272855|NCT02087150|589707313|FG002|Overall Study|Pt moved out of town|0|||
163272856|NCT00785538|589707314|FG000|Treatment Period|Adverse Event|1|||
163272857|NCT00785538|589707315|FG001|Treatment Period|Adverse Event|2|||
163272858|NCT00785538|589707316|FG002|Treatment Period|Adverse Event|2|||
163272859|NCT00785538|589707317|FG003|Treatment Period|Adverse Event|0|||
163272860|NCT00785538|589707314|FG000|Treatment Period|Withdrawal by Subject|0|||
163272861|NCT00785538|589707315|FG001|Treatment Period|Withdrawal by Subject|0|||
163272862|NCT00785538|589707316|FG002|Treatment Period|Withdrawal by Subject|0|||
163272863|NCT00785538|589707317|FG003|Treatment Period|Withdrawal by Subject|1|||
163272864|NCT00683449|589707318|FG000|Overall Study|Lost to Follow-up|0|||
163272865|NCT00683449|589707319|FG001|Overall Study|Lost to Follow-up|1|||
163272866|NCT00683449|589707320|FG002|Overall Study|Lost to Follow-up|0|||
163272867|NCT00683449|589707321|FG003|Overall Study|Lost to Follow-up|0|||
163272868|NCT00683449|589707322|FG004|Overall Study|Lost to Follow-up|0|||
163272869|NCT01000376|589707328|FG000|Cycle 1 Day 1|Adverse Event|1|||
163272870|NCT01000376|589707329|FG001|Cycle 1 Day 1|Adverse Event|0|||
163272871|NCT01000376|589707328|FG000|Cycle 1 Day 1|Progressive Disease|1|||
163272872|NCT01000376|589707329|FG001|Cycle 1 Day 1|Progressive Disease|0|||
163272873|NCT00507026|589707330|FG000|Overall Study|Lack of Efficacy|6|||
163272874|NCT00507026|589707331|FG001|Overall Study|Lack of Efficacy|4|||
163272875|NCT00507026|589707332|FG002|Overall Study|Lack of Efficacy|21|||
163272876|NCT00507026|589707330|FG000|Overall Study|Withdrawal by Subject|2|||
163272877|NCT00507026|589707331|FG001|Overall Study|Withdrawal by Subject|0|||
163272878|NCT00507026|589707332|FG002|Overall Study|Withdrawal by Subject|0|||
163272879|NCT00507026|589707330|FG000|Overall Study|Investigator Decision|1|||
163272880|NCT00507026|589707331|FG001|Overall Study|Investigator Decision|0|||
163272881|NCT00507026|589707332|FG002|Overall Study|Investigator Decision|0|||
163272882|NCT00507026|589707330|FG000|Overall Study|Adverse Event|2|||
163272883|NCT00507026|589707331|FG001|Overall Study|Adverse Event|0|||
163272884|NCT00507026|589707332|FG002|Overall Study|Adverse Event|0|||
163272885|NCT00507026|589707330|FG000|Overall Study|Protocol Violation|1|||
163272886|NCT00507026|589707331|FG001|Overall Study|Protocol Violation|0|||
163272887|NCT00507026|589707332|FG002|Overall Study|Protocol Violation|0|||
163272888|NCT00507026|589707330|FG000|Overall Study|Other|1|||
163272889|NCT00507026|589707331|FG001|Overall Study|Other|0|||
163272890|NCT00507026|589707332|FG002|Overall Study|Other|0|||
163272891|NCT04230980|589707333|FG000|Overall Study|Lost to Follow-up|1|||
163272892|NCT04230980|589707334|FG001|Overall Study|Lost to Follow-up|2|||
163272893|NCT04230980|589707333|FG000|Overall Study|Adverse Event|0|||
163272894|NCT04230980|589707334|FG001|Overall Study|Adverse Event|1|||
163272895|NCT04285229|589707335|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
163272896|NCT04285229|589707336|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163272897|NCT04285229|589707337|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163272898|NCT04285229|589707338|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163272899|NCT04285229|589707339|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163272900|NCT04285229|589707340|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163272901|NCT04285229|589707335|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
163272902|NCT04285229|589707336|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
163272903|NCT04285229|589707337|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
163272904|NCT04285229|589707338|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
163272905|NCT04285229|589707339|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
163272906|NCT04285229|589707340|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
163272907|NCT04285229|589707335|FG000|Extended Treatment Period|Adverse Event|0|||
163272908|NCT04285229|589707336|FG001|Extended Treatment Period|Adverse Event|0|||
163272909|NCT04285229|589707337|FG002|Extended Treatment Period|Adverse Event|0|||
163272910|NCT04285229|589707338|FG003|Extended Treatment Period|Adverse Event|1|||
163272911|NCT04285229|589707339|FG004|Extended Treatment Period|Adverse Event|0|||
163272912|NCT04285229|589707340|FG005|Extended Treatment Period|Adverse Event|0|||
163272913|NCT04285229|589707335|FG000|Extended Treatment Period|Physician Decision|0|||
163272914|NCT04285229|589707336|FG001|Extended Treatment Period|Physician Decision|0|||
163272915|NCT04285229|589707337|FG002|Extended Treatment Period|Physician Decision|1|||
163272916|NCT04285229|589707338|FG003|Extended Treatment Period|Physician Decision|0|||
163272917|NCT04285229|589707339|FG004|Extended Treatment Period|Physician Decision|0|||
163272918|NCT04285229|589707340|FG005|Extended Treatment Period|Physician Decision|0|||
163272919|NCT04285229|589707335|FG000|Follow-up Period|Adverse Event|0|||
163272920|NCT04285229|589707336|FG001|Follow-up Period|Adverse Event|0|||
163272921|NCT04285229|589707337|FG002|Follow-up Period|Adverse Event|0|||
163272922|NCT04285229|589707338|FG003|Follow-up Period|Adverse Event|0|||
163272923|NCT04285229|589707339|FG004|Follow-up Period|Adverse Event|1|||
163272924|NCT04285229|589707340|FG005|Follow-up Period|Adverse Event|4|||
163272925|NCT04285229|589707335|FG000|Follow-up Period|Withdrawal by Subject|0|||
163272926|NCT04285229|589707336|FG001|Follow-up Period|Withdrawal by Subject|0|||
163272927|NCT04285229|589707337|FG002|Follow-up Period|Withdrawal by Subject|0|||
163272928|NCT04285229|589707338|FG003|Follow-up Period|Withdrawal by Subject|0|||
163272929|NCT04285229|589707339|FG004|Follow-up Period|Withdrawal by Subject|0|||
163272930|NCT04285229|589707340|FG005|Follow-up Period|Withdrawal by Subject|5|||
163272931|NCT04285229|589707335|FG000|Follow-up Period|Covid-19|0|||
163272932|NCT04285229|589707336|FG001|Follow-up Period|Covid-19|0|||
163272933|NCT04285229|589707337|FG002|Follow-up Period|Covid-19|0|||
163272934|NCT04285229|589707338|FG003|Follow-up Period|Covid-19|0|||
163272935|NCT04285229|589707339|FG004|Follow-up Period|Covid-19|0|||
163272936|NCT04285229|589707340|FG005|Follow-up Period|Covid-19|2|||
163272937|NCT04285229|589707335|FG000|Follow-up Period|Physician Decision|0|||
163272938|NCT04285229|589707336|FG001|Follow-up Period|Physician Decision|0|||
163272939|NCT04285229|589707337|FG002|Follow-up Period|Physician Decision|0|||
163272940|NCT04285229|589707338|FG003|Follow-up Period|Physician Decision|0|||
163272941|NCT04285229|589707339|FG004|Follow-up Period|Physician Decision|0|||
163272942|NCT04285229|589707340|FG005|Follow-up Period|Physician Decision|1|||
163272943|NCT00513019|589709620|FG000|Overall Study|Adverse Event|1|||
163272944|NCT00513019|589709621|FG001|Overall Study|Adverse Event|0|||
163272945|NCT00513019|589709620|FG000|Overall Study|Withdrawal by Subject|4|||
163272946|NCT00513019|589709621|FG001|Overall Study|Withdrawal by Subject|5|||
163272947|NCT04129580|589709622|FG000|Overall Study|Lost to Follow-up|14|||
163272948|NCT04129580|589709623|FG001|Overall Study|Lost to Follow-up|25|||
163272949|NCT00322868|589709624|FG000|Overall Study|disease progression|1|||
163272950|NCT01852162|589709625|FG000|Overall Study|Adverse Event|1|||
163272951|NCT01852162|589709626|FG001|Overall Study|Adverse Event|0|||
163272952|NCT01852162|589709625|FG000|Overall Study|Withdrawal by Subject|3|||
163272953|NCT01852162|589709626|FG001|Overall Study|Withdrawal by Subject|1|||
163272954|NCT01500226|589709629|FG000|Overall Study|Adverse Event|31|||
163272955|NCT01500226|589709630|FG001|Overall Study|Adverse Event|38|||
163272956|NCT01500226|589709629|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
163272957|NCT01500226|589709630|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
163272958|NCT01500226|589709629|FG000|Overall Study|Withdrawal by Subject|93|||
163272959|NCT01500226|589709630|FG001|Overall Study|Withdrawal by Subject|96|||
163272960|NCT01500226|589709629|FG000|Overall Study|Death|12|||
163272961|NCT01500226|589709630|FG001|Overall Study|Death|4|||
163272962|NCT01500226|589709629|FG000|Overall Study|Disease Progression|16|||
163272963|NCT01500226|589709630|FG001|Overall Study|Disease Progression|14|||
163272964|NCT01500226|589709629|FG000|Overall Study|Protocol Violation|53|||
163272965|NCT01500226|589709630|FG001|Overall Study|Protocol Violation|39|||
163272966|NCT01500226|589709629|FG000|Overall Study|Physician Decision|17|||
163272967|NCT01500226|589709630|FG001|Overall Study|Physician Decision|15|||
163272968|NCT01500226|589709629|FG000|Overall Study|Lack of Efficacy|14|||
163272969|NCT01500226|589709630|FG001|Overall Study|Lack of Efficacy|30|||
163272970|NCT01500226|589709629|FG000|Overall Study|Lost to Follow-up|9|||
163272971|NCT01500226|589709630|FG001|Overall Study|Lost to Follow-up|5|||
163272972|NCT01500226|589709629|FG000|Overall Study|Other Reasons|19|||
163272973|NCT01500226|589709630|FG001|Overall Study|Other Reasons|16|||
163272974|NCT02955277|589709631|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
163272975|NCT02955277|589709632|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
163272976|NCT02955277|589709631|FG000|Post to Follow-up|Lost to Follow-up|8|||
163272977|NCT02955277|589709632|FG001|Post to Follow-up|Lost to Follow-up|11|||
163272978|NCT02176928|589709635|FG000|Overall Study|Lost to Follow-up|2|||
163272979|NCT02176928|589709636|FG001|Overall Study|Lost to Follow-up|4|||
163160878|NCT00354432|589302336|FG003|Overall Study|Adverse Event|5|||
163160879|NCT00354432|589302333|FG000|Overall Study|Off/Toxicity|3|||
163160880|NCT00354432|589302334|FG001|Overall Study|Off/Toxicity|7|||
163160881|NCT00354432|589302335|FG002|Overall Study|Off/Toxicity|5|||
163160882|NCT00354432|589302336|FG003|Overall Study|Off/Toxicity|5|||
163160883|NCT03863080|589302337|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
163160884|NCT03863080|589302338|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
163160885|NCT03863080|589302339|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
163160886|NCT03863080|589302340|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
163160887|NCT03863080|589302337|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
163160888|NCT03863080|589302338|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
163160889|NCT03863080|589302339|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
163160890|NCT03863080|589302340|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
163160891|NCT03863080|589302337|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
163160892|NCT03863080|589302338|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
163160893|NCT03863080|589302339|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
163160894|NCT03863080|589302340|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
163272980|NCT01642186|589709637|FG000|Overall Study|Death|0|||
163272981|NCT01642186|589709638|FG001|Overall Study|Death|2|||
163272982|NCT01642186|589709639|FG002|Overall Study|Death|2|||
163272983|NCT01642186|589709637|FG000|Overall Study|Lost to Follow-up|0|||
163385768|NCT00146328|590123240|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
163160895|NCT00802945|589302342|FG000|Overall Study|Death|27|||
163160896|NCT00802945|589302343|FG001|Overall Study|Death|23|||
163160897|NCT00802945|589302342|FG000|Overall Study|Terminated by sponsor|8|||
163272984|NCT01642186|589709638|FG001|Overall Study|Lost to Follow-up|0|||
163272985|NCT01642186|589709639|FG002|Overall Study|Lost to Follow-up|1|||
163272986|NCT00504348|589709640|FG000|Overall Study|Adverse Event|3|||
163272987|NCT00504348|589709640|FG000|Overall Study|Lack of Efficacy|4|||
163272988|NCT00504348|589709640|FG000|Overall Study|Physician Decision|1|||
163272989|NCT02254421|589709641|FG000|Overall Study|Randomized but Not Treated|1|||
163272990|NCT02254421|589709642|FG001|Overall Study|Randomized but Not Treated|0|||
163272991|NCT02254421|589709641|FG000|Overall Study|Death|0|||
163272992|NCT02254421|589709642|FG001|Overall Study|Death|2|||
163272993|NCT02254421|589709641|FG000|Overall Study|Withdrew Consent|1|||
163272994|NCT02254421|589709642|FG001|Overall Study|Withdrew Consent|1|||
163272995|NCT01154036|589709645|FG000|Phase I|Physician Decision|0|||
163272996|NCT01154036|589709646|FG001|Phase I|Physician Decision|1|||
163272997|NCT01154036|589709647|FG002|Phase I|Physician Decision|0|||
163272998|NCT01154036|589709648|FG003|Phase I|Physician Decision|0|||
163272999|NCT01154036|589709649|FG004|Phase I|Physician Decision|0|||
163273000|NCT01154036|589709650|FG005|Phase I|Physician Decision|0|||
163273001|NCT01154036|589709651|FG006|Phase I|Physician Decision|0|||
163273002|NCT01154036|589709652|FG007|Phase I|Physician Decision|0|||
163273003|NCT01154036|589709645|FG000|Phase I|Lost to Follow-up|0|||
163273004|NCT01154036|589709646|FG001|Phase I|Lost to Follow-up|3|||
163273005|NCT01154036|589709647|FG002|Phase I|Lost to Follow-up|6|||
163273006|NCT01154036|589709648|FG003|Phase I|Lost to Follow-up|0|||
163273007|NCT01154036|589709649|FG004|Phase I|Lost to Follow-up|0|||
163273008|NCT01154036|589709650|FG005|Phase I|Lost to Follow-up|0|||
163273009|NCT01154036|589709651|FG006|Phase I|Lost to Follow-up|0|||
163273010|NCT01154036|589709652|FG007|Phase I|Lost to Follow-up|0|||
163273011|NCT01154036|589709645|FG000|Phase I|Protocol Violation|0|||
163273012|NCT01154036|589709646|FG001|Phase I|Protocol Violation|3|||
163273013|NCT01154036|589709647|FG002|Phase I|Protocol Violation|9|||
163273014|NCT01154036|589709648|FG003|Phase I|Protocol Violation|0|||
163273015|NCT01154036|589709649|FG004|Phase I|Protocol Violation|0|||
163273016|NCT01154036|589709650|FG005|Phase I|Protocol Violation|0|||
163273017|NCT01154036|589709651|FG006|Phase I|Protocol Violation|0|||
163273018|NCT01154036|589709652|FG007|Phase I|Protocol Violation|0|||
163273019|NCT01154036|589709645|FG000|Phase I|Withdrawal by Subject|2|||
163273020|NCT01154036|589709646|FG001|Phase I|Withdrawal by Subject|10|||
163273021|NCT01154036|589709647|FG002|Phase I|Withdrawal by Subject|29|||
163273022|NCT01154036|589709648|FG003|Phase I|Withdrawal by Subject|0|||
163273023|NCT01154036|589709649|FG004|Phase I|Withdrawal by Subject|0|||
163273024|NCT01154036|589709650|FG005|Phase I|Withdrawal by Subject|0|||
163273025|NCT01154036|589709651|FG006|Phase I|Withdrawal by Subject|0|||
163273026|NCT01154036|589709652|FG007|Phase I|Withdrawal by Subject|0|||
163273027|NCT01154036|589709645|FG000|Phase I|Adverse Event|1|||
163273028|NCT01154036|589709646|FG001|Phase I|Adverse Event|11|||
163273029|NCT01154036|589709647|FG002|Phase I|Adverse Event|12|||
163273030|NCT01154036|589709648|FG003|Phase I|Adverse Event|0|||
163273031|NCT01154036|589709649|FG004|Phase I|Adverse Event|0|||
163273032|NCT01154036|589709650|FG005|Phase I|Adverse Event|0|||
163273033|NCT01154036|589709651|FG006|Phase I|Adverse Event|0|||
163273034|NCT01154036|589709652|FG007|Phase I|Adverse Event|0|||
163273035|NCT01154036|589709645|FG000|Phase II|Adverse Event|0|||
163273036|NCT01154036|589709646|FG001|Phase II|Adverse Event|0|||
163273037|NCT01154036|589709647|FG002|Phase II|Adverse Event|0|||
163273038|NCT01154036|589709648|FG003|Phase II|Adverse Event|0|||
163273039|NCT01154036|589709649|FG004|Phase II|Adverse Event|1|||
163273040|NCT01154036|589709650|FG005|Phase II|Adverse Event|1|||
163273041|NCT01154036|589709651|FG006|Phase II|Adverse Event|1|||
163273042|NCT01154036|589709652|FG007|Phase II|Adverse Event|1|||
163273043|NCT01154036|589709645|FG000|Phase II|Physician Decision|0|||
163273044|NCT01154036|589709646|FG001|Phase II|Physician Decision|0|||
163273045|NCT01154036|589709647|FG002|Phase II|Physician Decision|0|||
163273046|NCT01154036|589709648|FG003|Phase II|Physician Decision|0|||
163273047|NCT01154036|589709649|FG004|Phase II|Physician Decision|0|||
163273048|NCT01154036|589709650|FG005|Phase II|Physician Decision|0|||
163273049|NCT01154036|589709651|FG006|Phase II|Physician Decision|1|||
163273050|NCT01154036|589709652|FG007|Phase II|Physician Decision|0|||
163273051|NCT01154036|589709645|FG000|Phase II|Lost to Follow-up|0|||
163273052|NCT01154036|589709646|FG001|Phase II|Lost to Follow-up|0|||
163273053|NCT01154036|589709647|FG002|Phase II|Lost to Follow-up|0|||
163273054|NCT01154036|589709648|FG003|Phase II|Lost to Follow-up|1|||
163273055|NCT01154036|589709649|FG004|Phase II|Lost to Follow-up|2|||
163273056|NCT01154036|589709650|FG005|Phase II|Lost to Follow-up|0|||
163273057|NCT01154036|589709651|FG006|Phase II|Lost to Follow-up|2|||
163273058|NCT01154036|589709652|FG007|Phase II|Lost to Follow-up|1|||
163273059|NCT01154036|589709645|FG000|Phase II|Protocol Violation|0|||
163273060|NCT01154036|589709646|FG001|Phase II|Protocol Violation|0|||
163273061|NCT01154036|589709647|FG002|Phase II|Protocol Violation|0|||
163273062|NCT01154036|589709648|FG003|Phase II|Protocol Violation|0|||
163273063|NCT01154036|589709649|FG004|Phase II|Protocol Violation|1|||
163273064|NCT01154036|589709650|FG005|Phase II|Protocol Violation|2|||
163273065|NCT01154036|589709651|FG006|Phase II|Protocol Violation|0|||
163273066|NCT01154036|589709652|FG007|Phase II|Protocol Violation|0|||
163273067|NCT01154036|589709645|FG000|Phase II|Withdrawal by Subject|0|||
163273068|NCT01154036|589709646|FG001|Phase II|Withdrawal by Subject|0|||
163273069|NCT01154036|589709647|FG002|Phase II|Withdrawal by Subject|0|||
163273070|NCT01154036|589709648|FG003|Phase II|Withdrawal by Subject|0|||
163273071|NCT01154036|589709649|FG004|Phase II|Withdrawal by Subject|4|||
163273072|NCT01154036|589709650|FG005|Phase II|Withdrawal by Subject|2|||
163273073|NCT01154036|589709651|FG006|Phase II|Withdrawal by Subject|5|||
163273074|NCT01154036|589709652|FG007|Phase II|Withdrawal by Subject|4|||
163273075|NCT00390455|589709653|FG000|Overall Study|Adverse Event|17|||
163273076|NCT00390455|589709654|FG001|Overall Study|Adverse Event|3|||
163273077|NCT00390455|589709653|FG000|Overall Study|Withdrawal by Subject|8|||
163273078|NCT00390455|589709654|FG001|Overall Study|Withdrawal by Subject|8|||
163273079|NCT00390455|589709653|FG000|Overall Study|Alternate Treatment|0|||
163273080|NCT00390455|589709654|FG001|Overall Study|Alternate Treatment|1|||
163273081|NCT00390455|589709653|FG000|Overall Study|Other Medical Reasons|7|||
163273082|NCT00390455|589709654|FG001|Overall Study|Other Medical Reasons|11|||
163273083|NCT01591460|589709660|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
163273084|NCT01591460|589709660|FG000|Overall Study|Futility Rule (Week 12)|7|||
163273085|NCT01591460|589709660|FG000|Overall Study|Futility Rule (Week 24)|3|||
163273086|NCT01591460|589709660|FG000|Overall Study|Rebound or Breakthrough|3|||
163273087|NCT01591460|589709660|FG000|Overall Study|Treatment Discontinued by Error|1|||
163273088|NCT01591460|589709660|FG000|Overall Study|Lost to Follow-up|1|||
163273089|NCT01591460|589709660|FG000|Overall Study|Noncompliance|1|||
163273090|NCT01591460|589709660|FG000|Overall Study|Participant Refusal|3|||
163273091|NCT01591460|589709660|FG000|Overall Study|Withdrawal by Subject|1|||
163273092|NCT01591460|589709660|FG000|Overall Study|Protocol Violation|1|||
163273093|NCT01686932|589709665|FG000|Period 1|Adverse Event|1|||
163273094|NCT01686932|589709666|FG001|Period 1|Adverse Event|1|||
163273095|NCT04827134|589709669|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
163273096|NCT04827134|589709670|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
163273097|NCT04827134|589709671|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
163273098|NCT04827134|589709672|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
163273099|NCT00924469|589709681|FG000|Overall Study|Adverse Event|2|||
163273100|NCT00924469|589709682|FG001|Overall Study|Adverse Event|0|||
163273101|NCT00924469|589709681|FG000|Overall Study|Withdrawal by Subject|0|||
163273102|NCT00924469|589709682|FG001|Overall Study|Withdrawal by Subject|1|||
163273103|NCT00924469|589709681|FG000|Overall Study|Lost to Follow-up|0|||
163273104|NCT00924469|589709682|FG001|Overall Study|Lost to Follow-up|1|||
163273105|NCT01651936|589709684|FG000|Base Study|Adverse Event|3|||
163273106|NCT01651936|589709685|FG001|Base Study|Adverse Event|0|||
163273107|NCT01651936|589709686|FG002|Base Study|Adverse Event|0|||
163273108|NCT01651936|589709684|FG000|Base Study|Withdrawal by Subject|1|||
163273109|NCT01651936|589709685|FG001|Base Study|Withdrawal by Subject|1|||
163273110|NCT01651936|589709686|FG002|Base Study|Withdrawal by Subject|0|||
163273111|NCT01651936|589709684|FG000|Base Study|Early Escape|2|||
163273112|NCT01651936|589709685|FG001|Base Study|Early Escape|8|||
163273113|NCT01651936|589709686|FG002|Base Study|Early Escape|0|||
163273114|NCT01651936|589709684|FG000|Base Study|Study terminated by sponsor|21|||
163273115|NCT01651936|589709685|FG001|Base Study|Study terminated by sponsor|16|||
163273116|NCT01651936|589709686|FG002|Base Study|Study terminated by sponsor|0|||
163273117|NCT01651936|589709684|FG000|Extension Study|Lack of Efficacy|0|||
163273118|NCT01651936|589709685|FG001|Extension Study|Lack of Efficacy|0|||
163273119|NCT01651936|589709686|FG002|Extension Study|Lack of Efficacy|1|||
163273120|NCT01651936|589709684|FG000|Extension Study|Study terminated by sponsor|0|||
163273121|NCT01651936|589709685|FG001|Extension Study|Study terminated by sponsor|0|||
163273122|NCT01651936|589709686|FG002|Extension Study|Study terminated by sponsor|13|||
163273123|NCT03044353|589709687|FG000|Overall Study|Adverse Event|0|||
163273124|NCT03044353|589709688|FG001|Overall Study|Adverse Event|1|||
163273125|NCT03044353|589709689|FG002|Overall Study|Adverse Event|0|||
163273126|NCT03358329|589709690|FG000|Overall Study|Lost to Follow-up|2|||
163273127|NCT03358329|589709690|FG000|Overall Study|Withdrawal by Subject|2|||
163273128|NCT03875911|589709693|FG000|Overall Study|Lost to Follow-up|3|||
163273129|NCT03875911|589709694|FG001|Overall Study|Lost to Follow-up|6|||
163273130|NCT03875911|589709695|FG002|Overall Study|Lost to Follow-up|2|||
163273131|NCT03875911|589709693|FG000|Overall Study|Surgery cancelled|1|||
163273132|NCT03875911|589709694|FG001|Overall Study|Surgery cancelled|0|||
163273133|NCT03875911|589709695|FG002|Overall Study|Surgery cancelled|1|||
163273134|NCT03875911|589709693|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
163273135|NCT03875911|589709694|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
163273136|NCT03875911|589709695|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
163273137|NCT05284019|589709696|FG000|Overall Study|Study terminated|2|||
163273138|NCT05284019|589709697|FG001|Overall Study|Study terminated|2|||
163273139|NCT05284019|589709698|FG002|Overall Study|Study terminated|2|||
163273140|NCT05284019|589709699|FG003|Overall Study|Study terminated|5|||
163273141|NCT05284019|589709700|FG004|Overall Study|Study terminated|15|||
163273142|NCT05284019|589709696|FG000|Overall Study|Withdrawal by Subject|0|||
163273143|NCT05284019|589709697|FG001|Overall Study|Withdrawal by Subject|0|||
163273144|NCT05284019|589709698|FG002|Overall Study|Withdrawal by Subject|0|||
163273145|NCT05284019|589709699|FG003|Overall Study|Withdrawal by Subject|1|||
163273146|NCT05284019|589709700|FG004|Overall Study|Withdrawal by Subject|1|||
163273147|NCT05284019|589709696|FG000|Overall Study|Lost to Follow-up|1|||
163273148|NCT05284019|589709697|FG001|Overall Study|Lost to Follow-up|0|||
163273149|NCT05284019|589709698|FG002|Overall Study|Lost to Follow-up|0|||
163273150|NCT05284019|589709699|FG003|Overall Study|Lost to Follow-up|2|||
163273151|NCT05284019|589709700|FG004|Overall Study|Lost to Follow-up|1|||
163273152|NCT01990300|589709701|FG000|Overall Study|Case Report Forms Uncollected|89|||
163273153|NCT01990300|589709701|FG000|Overall Study|Protocol Deviation|53|||
163273154|NCT01231503|589709702|FG000|Overall Study|Adverse Event|0|||
163273155|NCT01231503|589709703|FG001|Overall Study|Adverse Event|0|||
163273156|NCT01231503|589709704|FG002|Overall Study|Adverse Event|0|||
163273157|NCT01231503|589709705|FG003|Overall Study|Adverse Event|0|||
163273158|NCT01231503|589709706|FG004|Overall Study|Adverse Event|0|||
163273159|NCT01231503|589709707|FG005|Overall Study|Adverse Event|1|||
163273160|NCT01231503|589709708|FG006|Overall Study|Adverse Event|0|||
163273161|NCT01231503|589709709|FG007|Overall Study|Adverse Event|0|||
163273162|NCT01231503|589709702|FG000|Overall Study|Adverse event, serious fatal|0|||
163273163|NCT01231503|589709703|FG001|Overall Study|Adverse event, serious fatal|0|||
163273164|NCT01231503|589709704|FG002|Overall Study|Adverse event, serious fatal|1|||
163273165|NCT01231503|589709705|FG003|Overall Study|Adverse event, serious fatal|1|||
163273166|NCT01231503|589709706|FG004|Overall Study|Adverse event, serious fatal|0|||
163273167|NCT01231503|589709707|FG005|Overall Study|Adverse event, serious fatal|1|||
163273168|NCT01231503|589709708|FG006|Overall Study|Adverse event, serious fatal|0|||
163273169|NCT01231503|589709709|FG007|Overall Study|Adverse event, serious fatal|0|||
163273170|NCT01231503|589709702|FG000|Overall Study|Withdrawal by Subject|6|||
163273171|NCT01231503|589709703|FG001|Overall Study|Withdrawal by Subject|3|||
163273172|NCT01231503|589709704|FG002|Overall Study|Withdrawal by Subject|3|||
163273173|NCT01231503|589709705|FG003|Overall Study|Withdrawal by Subject|1|||
163273174|NCT01231503|589709706|FG004|Overall Study|Withdrawal by Subject|3|||
163273175|NCT01231503|589709707|FG005|Overall Study|Withdrawal by Subject|5|||
163273176|NCT01231503|589709708|FG006|Overall Study|Withdrawal by Subject|1|||
163273177|NCT01231503|589709709|FG007|Overall Study|Withdrawal by Subject|2|||
163273178|NCT01231503|589709702|FG000|Overall Study|Lost to Follow-up|8|||
163273179|NCT01231503|589709703|FG001|Overall Study|Lost to Follow-up|10|||
163273180|NCT01231503|589709704|FG002|Overall Study|Lost to Follow-up|8|||
163273181|NCT01231503|589709705|FG003|Overall Study|Lost to Follow-up|5|||
163273182|NCT01231503|589709706|FG004|Overall Study|Lost to Follow-up|7|||
163273183|NCT01231503|589709707|FG005|Overall Study|Lost to Follow-up|9|||
163273184|NCT01231503|589709708|FG006|Overall Study|Lost to Follow-up|6|||
163273185|NCT01231503|589709709|FG007|Overall Study|Lost to Follow-up|6|||
163273186|NCT01231503|589709702|FG000|Overall Study|Protocol Violation|0|||
163273187|NCT01231503|589709703|FG001|Overall Study|Protocol Violation|0|||
163273188|NCT01231503|589709704|FG002|Overall Study|Protocol Violation|0|||
163273189|NCT01231503|589709705|FG003|Overall Study|Protocol Violation|1|||
163273190|NCT01231503|589709706|FG004|Overall Study|Protocol Violation|0|||
163273191|NCT01231503|589709707|FG005|Overall Study|Protocol Violation|0|||
163273192|NCT01231503|589709708|FG006|Overall Study|Protocol Violation|0|||
163273193|NCT01231503|589709709|FG007|Overall Study|Protocol Violation|0|||
163273194|NCT02293837|589709710|FG000|Overall Study|Lost to Follow-up|0|||
163273195|NCT02293837|589709711|FG001|Overall Study|Lost to Follow-up|2|||
163273196|NCT02293837|589709712|FG002|Overall Study|Lost to Follow-up|1|||
163273197|NCT02293837|589709713|FG003|Overall Study|Lost to Follow-up|0|||
163273198|NCT02293837|589709710|FG000|Overall Study|Withdrawal by Subject|2|||
163273199|NCT02293837|589709711|FG001|Overall Study|Withdrawal by Subject|1|||
163273200|NCT02293837|589709712|FG002|Overall Study|Withdrawal by Subject|2|||
163273201|NCT02293837|589709713|FG003|Overall Study|Withdrawal by Subject|1|||
163273202|NCT02293837|589709710|FG000|Overall Study|COVID-19 Related|1|||
163273203|NCT02293837|589709711|FG001|Overall Study|COVID-19 Related|1|||
163273204|NCT02293837|589709712|FG002|Overall Study|COVID-19 Related|0|||
163273205|NCT02293837|589709713|FG003|Overall Study|COVID-19 Related|0|||
163273206|NCT02293837|589709710|FG000|Overall Study|Participant ill and could not be infused|0|||
163273207|NCT02293837|589709711|FG001|Overall Study|Participant ill and could not be infused|0|||
163273208|NCT02293837|589709712|FG002|Overall Study|Participant ill and could not be infused|1|||
163273209|NCT02293837|589709713|FG003|Overall Study|Participant ill and could not be infused|0|||
163273210|NCT01076088|589709714|FG000|Overall Study|Adverse Event|1|||
163273211|NCT01076088|589709715|FG001|Overall Study|Adverse Event|6|||
163273212|NCT01076088|589709716|FG002|Overall Study|Adverse Event|3|||
163273213|NCT01076088|589709717|FG003|Overall Study|Adverse Event|2|||
163273214|NCT01076088|589709718|FG004|Overall Study|Adverse Event|3|||
163273215|NCT01076088|589709719|FG005|Overall Study|Adverse Event|3|||
163273216|NCT01076088|589709714|FG000|Overall Study|Lost to Follow-up|1|||
163273217|NCT01076088|589709715|FG001|Overall Study|Lost to Follow-up|1|||
163273218|NCT01076088|589709716|FG002|Overall Study|Lost to Follow-up|0|||
163273219|NCT01076088|589709717|FG003|Overall Study|Lost to Follow-up|1|||
163273220|NCT01076088|589709718|FG004|Overall Study|Lost to Follow-up|1|||
163273221|NCT01076088|589709719|FG005|Overall Study|Lost to Follow-up|2|||
163273222|NCT01076088|589709714|FG000|Overall Study|Non-compliance with study drug|0|||
163273223|NCT01076088|589709715|FG001|Overall Study|Non-compliance with study drug|0|||
163273224|NCT01076088|589709716|FG002|Overall Study|Non-compliance with study drug|0|||
163273225|NCT01076088|589709717|FG003|Overall Study|Non-compliance with study drug|1|||
163273226|NCT01076088|589709718|FG004|Overall Study|Non-compliance with study drug|0|||
163273227|NCT01076088|589709719|FG005|Overall Study|Non-compliance with study drug|0|||
163273228|NCT01076088|589709714|FG000|Overall Study|Physician Decision|1|||
163273229|NCT01076088|589709715|FG001|Overall Study|Physician Decision|3|||
163273230|NCT01076088|589709716|FG002|Overall Study|Physician Decision|0|||
163273231|NCT01076088|589709717|FG003|Overall Study|Physician Decision|1|||
163273232|NCT01076088|589709718|FG004|Overall Study|Physician Decision|1|||
163273233|NCT01076088|589709719|FG005|Overall Study|Physician Decision|0|||
163273234|NCT01076088|589709714|FG000|Overall Study|Withdrawal by Subject|8|||
163273235|NCT01076088|589709715|FG001|Overall Study|Withdrawal by Subject|8|||
163273236|NCT01076088|589709716|FG002|Overall Study|Withdrawal by Subject|14|||
163273237|NCT01076088|589709717|FG003|Overall Study|Withdrawal by Subject|10|||
163273238|NCT01076088|589709718|FG004|Overall Study|Withdrawal by Subject|11|||
163273239|NCT01076088|589709719|FG005|Overall Study|Withdrawal by Subject|17|||
163273240|NCT01076088|589709714|FG000|Overall Study|Other protocol specified criteria|0|||
163273241|NCT01076088|589709715|FG001|Overall Study|Other protocol specified criteria|0|||
163273242|NCT01076088|589709716|FG002|Overall Study|Other protocol specified criteria|0|||
163273243|NCT01076088|589709717|FG003|Overall Study|Other protocol specified criteria|0|||
163273244|NCT01076088|589709718|FG004|Overall Study|Other protocol specified criteria|0|||
163273245|NCT01076088|589709719|FG005|Overall Study|Other protocol specified criteria|1|||
163273246|NCT03285113|589709720|FG000|Overall Study|Unable to implant leads|2|||
163273247|NCT03053492|589709721|FG000|Overall Study|Adverse Event|1|||
163273248|NCT03053492|589709722|FG001|Overall Study|Adverse Event|1|||
163273249|NCT03053492|589709721|FG000|Overall Study|Withdrawal by Subject|7|||
163273250|NCT03053492|589709722|FG001|Overall Study|Withdrawal by Subject|5|||
163273251|NCT01448044|589709727|FG000|Treatment Period|Adverse Event|4|||
163273252|NCT01448044|589709728|FG001|Treatment Period|Adverse Event|3|||
163273253|NCT01448044|589709727|FG000|Treatment Period|Lack of Efficacy|5|||
163273254|NCT01448044|589709728|FG001|Treatment Period|Lack of Efficacy|12|||
163273255|NCT01448044|589709727|FG000|Treatment Period|Subject requested discontinue study drug|1|||
163273256|NCT01448044|589709728|FG001|Treatment Period|Subject requested discontinue study drug|0|||
163273257|NCT01448044|589709727|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
163273258|NCT01448044|589709728|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
163273259|NCT01448044|589709727|FG000|Treatment Period|Participant does not meet study criteria|1|||
163273260|NCT01448044|589709728|FG001|Treatment Period|Participant does not meet study criteria|0|||
163273261|NCT01448044|589709727|FG000|Treatment Period|Lost to Follow-up|2|||
163273262|NCT01448044|589709728|FG001|Treatment Period|Lost to Follow-up|1|||
163273263|NCT01448044|589709727|FG000|Treatment Period|Other reason|2|||
163273264|NCT01448044|589709728|FG001|Treatment Period|Other reason|0|||
163273265|NCT01448044|589709727|FG000|Follow Up Period|Withdrawal by Subject|1|||
163273266|NCT01448044|589709728|FG001|Follow Up Period|Withdrawal by Subject|1|||
163273267|NCT01448044|589709727|FG000|Follow Up Period|Lost to Follow-up|6|||
163273268|NCT01448044|589709728|FG001|Follow Up Period|Lost to Follow-up|2|||
163273269|NCT01448044|589709727|FG000|Follow Up Period|Other|5|||
163273270|NCT01448044|589709728|FG001|Follow Up Period|Other|11|||
163273271|NCT03018106|589709730|FG000|Overall Study|Lost to Follow-up|0|||
163273272|NCT03018106|589709731|FG001|Overall Study|Lost to Follow-up|1|||
163273273|NCT01994720|589709732|FG000|Overall Study|Withdrawal by Subject|46|||
163273274|NCT01994720|589709733|FG001|Overall Study|Withdrawal by Subject|56|||
163273275|NCT01010217|589709735|FG000|Overall Study|Lost to Follow-up|4|||
163273276|NCT01010217|589709736|FG001|Overall Study|Lost to Follow-up|5|||
163273277|NCT01010217|589709737|FG002|Overall Study|Lost to Follow-up|1|||
163273278|NCT01010217|589709738|FG003|Overall Study|Lost to Follow-up|0|||
163273279|NCT01010217|589709739|FG004|Overall Study|Lost to Follow-up|0|||
163273280|NCT01010217|589709735|FG000|Overall Study|Withdrawal by Subject|1|||
163273281|NCT01010217|589709736|FG001|Overall Study|Withdrawal by Subject|0|||
163273282|NCT01010217|589709737|FG002|Overall Study|Withdrawal by Subject|0|||
163273283|NCT01010217|589709738|FG003|Overall Study|Withdrawal by Subject|0|||
163273284|NCT01010217|589709739|FG004|Overall Study|Withdrawal by Subject|0|||
163273285|NCT01010217|589709735|FG000|Overall Study|Physician Decision|0|||
163273286|NCT01010217|589709736|FG001|Overall Study|Physician Decision|0|||
163273287|NCT01010217|589709737|FG002|Overall Study|Physician Decision|0|||
163273288|NCT01010217|589709738|FG003|Overall Study|Physician Decision|6|||
163273289|NCT01010217|589709739|FG004|Overall Study|Physician Decision|3|||
163273290|NCT02213055|589709740|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
163273291|NCT02213055|589709741|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
163058554|NCT00042289|588924241|FG006|Overall Study|Site closed|0|||
163273292|NCT02213055|589709740|FG000|Overall Study|Protocol was not Followed during Study|1|||
163273293|NCT02213055|589709741|FG001|Overall Study|Protocol was not Followed during Study|0|||
163273294|NCT02213055|589709740|FG000|Overall Study|Documentation Issue at Enrollment|1|||
163273295|NCT02213055|589709741|FG001|Overall Study|Documentation Issue at Enrollment|0|||
163273296|NCT02213055|589709740|FG000|Overall Study|Documentation Issue during Study|10|||
163273297|NCT02213055|589709741|FG001|Overall Study|Documentation Issue during Study|0|||
163273298|NCT02213055|589709740|FG000|Overall Study|Did not have Live Lice|8|||
163273299|NCT02213055|589709741|FG001|Overall Study|Did not have Live Lice|0|||
163273300|NCT02213055|589709740|FG000|Overall Study|Had another Treatment during the Study|3|||
163273301|NCT02213055|589709741|FG001|Overall Study|Had another Treatment during the Study|0|||
163273302|NCT02213055|589709740|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
163273303|NCT02213055|589709741|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
163273304|NCT02213055|589709740|FG000|Overall Study|Did not Return to School|5|||
163273305|NCT02213055|589709741|FG001|Overall Study|Did not Return to School|0|||
163273306|NCT02061761|589709742|FG000|Overall Study|Disease progression|2|||
163273307|NCT02061761|589709743|FG001|Overall Study|Disease progression|8|||
163273308|NCT02061761|589709744|FG002|Overall Study|Disease progression|4|||
163273309|NCT02061761|589709745|FG003|Overall Study|Disease progression|5|||
163273310|NCT02061761|589709746|FG004|Overall Study|Disease progression|9|||
163273311|NCT02061761|589709747|FG005|Overall Study|Disease progression|3|||
163273312|NCT02061761|589709748|FG006|Overall Study|Disease progression|1|||
163273313|NCT02061761|589709749|FG007|Overall Study|Disease progression|2|||
163273314|NCT02061761|589709750|FG008|Overall Study|Disease progression|28|||
163273315|NCT02061761|589709742|FG000|Overall Study|Study Drug toxicity|0|||
163273316|NCT02061761|589709743|FG001|Overall Study|Study Drug toxicity|0|||
163273317|NCT02061761|589709744|FG002|Overall Study|Study Drug toxicity|0|||
163273318|NCT02061761|589709745|FG003|Overall Study|Study Drug toxicity|0|||
163273319|NCT02061761|589709746|FG004|Overall Study|Study Drug toxicity|0|||
163273320|NCT02061761|589709747|FG005|Overall Study|Study Drug toxicity|1|||
163273321|NCT02061761|589709748|FG006|Overall Study|Study Drug toxicity|0|||
163273322|NCT02061761|589709749|FG007|Overall Study|Study Drug toxicity|2|||
163273323|NCT02061761|589709750|FG008|Overall Study|Study Drug toxicity|6|||
163273324|NCT02061761|589709742|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
163273325|NCT02061761|589709743|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
163273326|NCT02061761|589709744|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
163273327|NCT02061761|589709745|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
163273328|NCT02061761|589709746|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
163273329|NCT02061761|589709747|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
163273330|NCT02061761|589709748|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
163273331|NCT02061761|589709749|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
163273332|NCT02061761|589709750|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
163273333|NCT02061761|589709742|FG000|Overall Study|Participant request to discontinue study treatment|0|||
163273334|NCT02061761|589709743|FG001|Overall Study|Participant request to discontinue study treatment|0|||
163273335|NCT02061761|589709744|FG002|Overall Study|Participant request to discontinue study treatment|2|||
163273336|NCT02061761|589709745|FG003|Overall Study|Participant request to discontinue study treatment|2|||
163273337|NCT02061761|589709746|FG004|Overall Study|Participant request to discontinue study treatment|0|||
163273338|NCT02061761|589709747|FG005|Overall Study|Participant request to discontinue study treatment|1|||
163273339|NCT02061761|589709748|FG006|Overall Study|Participant request to discontinue study treatment|0|||
163273340|NCT02061761|589709749|FG007|Overall Study|Participant request to discontinue study treatment|0|||
163273341|NCT02061761|589709750|FG008|Overall Study|Participant request to discontinue study treatment|2|||
163273342|NCT02061761|589709742|FG000|Overall Study|Withdrawal by Subject|0|||
163273343|NCT02061761|589709743|FG001|Overall Study|Withdrawal by Subject|0|||
163273344|NCT02061761|589709744|FG002|Overall Study|Withdrawal by Subject|0|||
163273345|NCT02061761|589709745|FG003|Overall Study|Withdrawal by Subject|0|||
163273346|NCT02061761|589709746|FG004|Overall Study|Withdrawal by Subject|0|||
163273347|NCT02061761|589709747|FG005|Overall Study|Withdrawal by Subject|0|||
163273348|NCT02061761|589709748|FG006|Overall Study|Withdrawal by Subject|0|||
163273349|NCT02061761|589709749|FG007|Overall Study|Withdrawal by Subject|0|||
163273350|NCT02061761|589709750|FG008|Overall Study|Withdrawal by Subject|2|||
163273351|NCT02061761|589709742|FG000|Overall Study|Maximum clinical benefit|0|||
163273352|NCT02061761|589709743|FG001|Overall Study|Maximum clinical benefit|0|||
163273353|NCT02061761|589709744|FG002|Overall Study|Maximum clinical benefit|0|||
163273354|NCT02061761|589709745|FG003|Overall Study|Maximum clinical benefit|1|||
163273355|NCT02061761|589709746|FG004|Overall Study|Maximum clinical benefit|0|||
163273356|NCT02061761|589709747|FG005|Overall Study|Maximum clinical benefit|0|||
163273357|NCT02061761|589709748|FG006|Overall Study|Maximum clinical benefit|0|||
163273358|NCT02061761|589709749|FG007|Overall Study|Maximum clinical benefit|0|||
163273359|NCT02061761|589709750|FG008|Overall Study|Maximum clinical benefit|6|||
163273360|NCT02061761|589709742|FG000|Overall Study|Participant no longer meets study criteria|0|||
163273361|NCT02061761|589709743|FG001|Overall Study|Participant no longer meets study criteria|0|||
163273362|NCT02061761|589709744|FG002|Overall Study|Participant no longer meets study criteria|0|||
163273363|NCT02061761|589709745|FG003|Overall Study|Participant no longer meets study criteria|0|||
163273364|NCT02061761|589709746|FG004|Overall Study|Participant no longer meets study criteria|0|||
163273365|NCT02061761|589709747|FG005|Overall Study|Participant no longer meets study criteria|0|||
163273366|NCT02061761|589709748|FG006|Overall Study|Participant no longer meets study criteria|0|||
163273367|NCT02061761|589709749|FG007|Overall Study|Participant no longer meets study criteria|0|||
163273368|NCT02061761|589709750|FG008|Overall Study|Participant no longer meets study criteria|1|||
163160898|NCT00802945|589302343|FG001|Overall Study|Terminated by sponsor|12|||
163160899|NCT05307692|589302344|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
163160900|NCT05307692|589302345|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
163160901|NCT05307692|589302346|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
163160902|NCT05307692|589302347|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
163160903|NCT05307692|589302344|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
163160904|NCT05307692|589302345|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
163160905|NCT05307692|589302346|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
163160906|NCT05307692|589302347|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
163160907|NCT05307692|589302344|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
163160908|NCT05307692|589302345|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
163160909|NCT05307692|589302346|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
163160910|NCT05307692|589302347|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
163160911|NCT05307692|589302344|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
163160912|NCT05307692|589302345|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
163160913|NCT05307692|589302346|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
163160914|NCT05307692|589302347|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
163160915|NCT05307692|589302344|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
163160916|NCT05307692|589302345|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
163160917|NCT05307692|589302346|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
163160918|NCT05307692|589302347|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
163160919|NCT05307692|589302344|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
163160920|NCT05307692|589302345|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
163160921|NCT05307692|589302346|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
163160922|NCT05307692|589302347|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
163160923|NCT05307692|589302344|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
163160924|NCT05307692|589302345|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
163160925|NCT05307692|589302346|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
163160926|NCT05307692|589302347|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
163160927|NCT05307692|589302344|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
163160928|NCT05307692|589302345|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
163160929|NCT05307692|589302346|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
163160930|NCT05307692|589302347|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
163160931|NCT03493464|589302350|FG000|Overall Study|Surgery not performed|1|||
163160932|NCT04949490|589302351|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
163160933|NCT04949490|589302352|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
163160934|NCT04949490|589302353|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
163160935|NCT04949490|589302354|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
163160936|NCT04949490|589302355|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
163160937|NCT04949490|589302356|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
163160938|NCT04949490|589302351|FG000|Group A and Group B|Withdrawal by Subject|0|||
163160939|NCT04949490|589302352|FG001|Group A and Group B|Withdrawal by Subject|0|||
163160940|NCT04949490|589302353|FG002|Group A and Group B|Withdrawal by Subject|1|||
163160941|NCT04949490|589302354|FG003|Group A and Group B|Withdrawal by Subject|0|||
163160942|NCT04949490|589302355|FG004|Group A and Group B|Withdrawal by Subject|0|||
163160943|NCT04949490|589302356|FG005|Group A and Group B|Withdrawal by Subject|0|||
163160944|NCT04949490|589302351|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
163160945|NCT04949490|589302352|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
163160946|NCT04949490|589302353|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
163160947|NCT04949490|589302354|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
163160948|NCT04949490|589302355|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
163160949|NCT04949490|589302356|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
163160950|NCT04949490|589302351|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
163160951|NCT04949490|589302352|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
163160952|NCT04949490|589302353|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
163160953|NCT04949490|589302354|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
163160954|NCT04949490|589302355|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
163160955|NCT04949490|589302356|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
163160956|NCT05232682|589302357|FG000|Overall Study|Lost to Follow-up|2|||
163160957|NCT00905164|589302358|FG000|Period 1|Protocol Violation|0|||
163160958|NCT00905164|589302359|FG001|Period 1|Protocol Violation|1|||
163160959|NCT04730804|589302360|FG000|Overall Study|Physician Decision|0|||
163160960|NCT04730804|589302361|FG001|Overall Study|Physician Decision|0|||
163160961|NCT04730804|589302362|FG002|Overall Study|Physician Decision|0|||
163160962|NCT04730804|589302363|FG003|Overall Study|Physician Decision|0|||
163273369|NCT02061761|589709742|FG000|Overall Study|Other reasons|0|||
163273370|NCT02061761|589709743|FG001|Overall Study|Other reasons|0|||
163273371|NCT02061761|589709744|FG002|Overall Study|Other reasons|0|||
163273372|NCT02061761|589709745|FG003|Overall Study|Other reasons|0|||
163273373|NCT02061761|589709746|FG004|Overall Study|Other reasons|2|||
163273374|NCT02061761|589709747|FG005|Overall Study|Other reasons|0|||
163273375|NCT02061761|589709748|FG006|Overall Study|Other reasons|0|||
163273376|NCT02061761|589709749|FG007|Overall Study|Other reasons|0|||
163273377|NCT02061761|589709750|FG008|Overall Study|Other reasons|6|||
163273378|NCT01024751|589709751|FG000|Enrolled Participants|Ineligible at baseline|3|||
163273379|NCT01024751|589709752|FG001|Enrolled Participants|Ineligible at baseline|4|||
163273380|NCT01024751|589709751|FG000|Eligible Participants|Withdrawal by Subject|0|||
163273381|NCT01024751|589709752|FG001|Eligible Participants|Withdrawal by Subject|1|||
163273382|NCT01024751|589709751|FG000|Eligible Participants|Lost to Follow-up|0|||
163273383|NCT01024751|589709752|FG001|Eligible Participants|Lost to Follow-up|1|||
163273384|NCT01024751|589709751|FG000|Eligible Participants|Ineligible|0|||
163273385|NCT01024751|589709752|FG001|Eligible Participants|Ineligible|1|||
163273386|NCT00577720|589709757|FG000|Overall Study|Adverse Event|2|||
163273387|NCT00577720|589709758|FG001|Overall Study|Adverse Event|1|||
163273388|NCT00577720|589709759|FG002|Overall Study|Adverse Event|0|||
163273389|NCT00577720|589709760|FG003|Overall Study|Adverse Event|4|||
163273390|NCT00577720|589709757|FG000|Overall Study|Lost to Follow-up|0|||
163273391|NCT00577720|589709758|FG001|Overall Study|Lost to Follow-up|0|||
163273392|NCT00577720|589709759|FG002|Overall Study|Lost to Follow-up|1|||
163273393|NCT00577720|589709760|FG003|Overall Study|Lost to Follow-up|0|||
163273394|NCT00577720|589709757|FG000|Overall Study|Protocol Violation|0|||
163273395|NCT00577720|589709758|FG001|Overall Study|Protocol Violation|0|||
163273396|NCT00577720|589709759|FG002|Overall Study|Protocol Violation|0|||
163273397|NCT00577720|589709760|FG003|Overall Study|Protocol Violation|1|||
163273398|NCT00577720|589709757|FG000|Overall Study|Withdrawal by Subject|2|||
163273399|NCT00577720|589709758|FG001|Overall Study|Withdrawal by Subject|0|||
163273400|NCT00577720|589709759|FG002|Overall Study|Withdrawal by Subject|0|||
163273401|NCT00577720|589709760|FG003|Overall Study|Withdrawal by Subject|2|||
163273402|NCT03246672|589709761|FG000|Overall Study|Lost to Follow-up|2|||
163273403|NCT03260504|589709762|FG000|Overall Study|Adverse Event|0|||
163273404|NCT03260504|589709763|FG001|Overall Study|Adverse Event|1|||
163273405|NCT00967018|589709764|FG000|Overall Study|Adverse Event|2|||
163273406|NCT00967018|589709764|FG000|Overall Study|Physician Decision|7|||
163273407|NCT00967018|589709764|FG000|Overall Study|Lost to Follow-up|2|||
163273408|NCT00967018|589709764|FG000|Overall Study|Withdrawal by Subject|1|||
163273409|NCT00967018|589709764|FG000|Overall Study|Miscellaneous Reasons|9|||
163273410|NCT05868954|589709770|FG000|Overall Study|Lost to Follow-up|0|||
163273411|NCT05868954|589709771|FG001|Overall Study|Lost to Follow-up|1|||
163273412|NCT05868954|589709770|FG000|Overall Study|Withdrawal by Subject|2|||
163273413|NCT05868954|589709771|FG001|Overall Study|Withdrawal by Subject|2|||
163273414|NCT05868954|589709770|FG000|Overall Study|Participant delivered|1|||
163273415|NCT05868954|589709771|FG001|Overall Study|Participant delivered|1|||
163273416|NCT05868954|589709770|FG000|Overall Study|Miscarriage|0|||
163273417|NCT05868954|589709771|FG001|Overall Study|Miscarriage|1|||
163273418|NCT01680458|589709781|FG000|Overall Study|Protocol Violation|3|||
163273419|NCT02138747|589709782|FG000|Treatment Period 1|Adverse Event|10|||
163273420|NCT02138747|589709783|FG001|Treatment Period 1|Adverse Event|14|||
163273421|NCT02138747|589709784|FG002|Treatment Period 1|Adverse Event|2|||
163273422|NCT02138747|589709785|FG003|Treatment Period 1|Adverse Event|1|||
163273423|NCT02138747|589709782|FG000|Treatment Period 1|Lost to Follow-up|0|||
163273424|NCT02138747|589709783|FG001|Treatment Period 1|Lost to Follow-up|1|||
163273425|NCT02138747|589709784|FG002|Treatment Period 1|Lost to Follow-up|1|||
163273426|NCT02138747|589709785|FG003|Treatment Period 1|Lost to Follow-up|0|||
163273427|NCT02138747|589709782|FG000|Treatment Period 1|Protocol Violation|0|||
163273428|NCT02138747|589709783|FG001|Treatment Period 1|Protocol Violation|2|||
163273429|NCT02138747|589709784|FG002|Treatment Period 1|Protocol Violation|0|||
163273430|NCT02138747|589709785|FG003|Treatment Period 1|Protocol Violation|0|||
163273431|NCT02138747|589709782|FG000|Treatment Period 1|Withdrawal by Subject|8|||
163273432|NCT02138747|589709783|FG001|Treatment Period 1|Withdrawal by Subject|4|||
163273433|NCT02138747|589709784|FG002|Treatment Period 1|Withdrawal by Subject|1|||
163273434|NCT02138747|589709785|FG003|Treatment Period 1|Withdrawal by Subject|3|||
163273435|NCT02138747|589709782|FG000|Treatment Period 1|Other - Miscellaneous|2|||
163273436|NCT02138747|589709783|FG001|Treatment Period 1|Other - Miscellaneous|4|||
163273437|NCT02138747|589709784|FG002|Treatment Period 1|Other - Miscellaneous|0|||
163273438|NCT02138747|589709785|FG003|Treatment Period 1|Other - Miscellaneous|0|||
163273439|NCT02138747|589709782|FG000|Treatment Period 2|Adverse Event|6|||
163273440|NCT02138747|589709783|FG001|Treatment Period 2|Adverse Event|3|||
163273441|NCT02138747|589709784|FG002|Treatment Period 2|Adverse Event|1|||
163273442|NCT02138747|589709785|FG003|Treatment Period 2|Adverse Event|1|||
163273443|NCT02138747|589709782|FG000|Treatment Period 2|Lost to Follow-up|2|||
163273444|NCT02138747|589709783|FG001|Treatment Period 2|Lost to Follow-up|0|||
163273445|NCT02138747|589709784|FG002|Treatment Period 2|Lost to Follow-up|0|||
163273446|NCT02138747|589709785|FG003|Treatment Period 2|Lost to Follow-up|0|||
163160963|NCT04730804|589302364|FG004|Overall Study|Physician Decision|0|||
163160964|NCT04730804|589302365|FG005|Overall Study|Physician Decision|1|||
163160965|NCT04730804|589302360|FG000|Overall Study|Withdrawal by Subject|0|||
163160966|NCT04730804|589302361|FG001|Overall Study|Withdrawal by Subject|0|||
163160967|NCT04730804|589302362|FG002|Overall Study|Withdrawal by Subject|0|||
163160968|NCT04730804|589302363|FG003|Overall Study|Withdrawal by Subject|0|||
163160969|NCT04730804|589302364|FG004|Overall Study|Withdrawal by Subject|1|||
163160970|NCT04730804|589302365|FG005|Overall Study|Withdrawal by Subject|2|||
163160971|NCT01077050|589304024|FG000|Overall Study|Subjects signed ICF could not be located|1|||
163160972|NCT01077050|589304024|FG000|Overall Study|Screen failure|8|||
163160973|NCT00684060|589304025|FG000|Overall Study|Lost to Follow-up|1|||
163160974|NCT00684060|589304026|FG001|Overall Study|Lost to Follow-up|0|||
163160975|NCT00684060|589304025|FG000|Overall Study|New stenosis identified|1|||
163160976|NCT00684060|589304026|FG001|Overall Study|New stenosis identified|0|||
163160977|NCT00684060|589304025|FG000|Overall Study|Unable to collect MRI|1|||
163160978|NCT00684060|589304026|FG001|Overall Study|Unable to collect MRI|2|||
163160979|NCT00684060|589304025|FG000|Overall Study|Death|0|||
163160980|NCT00684060|589304026|FG001|Overall Study|Death|1|||
163160981|NCT00702715|589304031|FG000|Overall Study|Lost to Follow-up|1|||
163160982|NCT00702715|589304032|FG001|Overall Study|Lost to Follow-up|0|||
163160983|NCT03126344|589304043|FG000|Overall Study|Lost to Follow-up|0|||
163160984|NCT03126344|589304044|FG001|Overall Study|Lost to Follow-up|0|||
163160985|NCT03126344|589304045|FG002|Overall Study|Lost to Follow-up|5|||
163160986|NCT01715857|589304046|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
163160987|NCT02563067|589304047|FG000|Overall Study|Subject/guardian decision|14|||
163160988|NCT02563067|589304048|FG001|Overall Study|Subject/guardian decision|20|||
163160989|NCT02563067|589304049|FG002|Overall Study|Subject/guardian decision|16|||
163160990|NCT02563067|589304047|FG000|Overall Study|Physician Decision|0|||
163160991|NCT02563067|589304048|FG001|Overall Study|Physician Decision|1|||
163160992|NCT02563067|589304049|FG002|Overall Study|Physician Decision|3|||
163160993|NCT02563067|589304047|FG000|Overall Study|Lost to Follow-up|1|||
163160994|NCT02563067|589304048|FG001|Overall Study|Lost to Follow-up|2|||
163160995|NCT02563067|589304049|FG002|Overall Study|Lost to Follow-up|0|||
163160996|NCT02563067|589304047|FG000|Overall Study|Technical problems|0|||
163160997|NCT02563067|589304048|FG001|Overall Study|Technical problems|1|||
163160998|NCT02563067|589304049|FG002|Overall Study|Technical problems|0|||
163160999|NCT02563067|589304047|FG000|Overall Study|Lack of Efficacy|1|||
163161000|NCT02563067|589304048|FG001|Overall Study|Lack of Efficacy|0|||
163161001|NCT02563067|589304049|FG002|Overall Study|Lack of Efficacy|0|||
163161002|NCT02563067|589304047|FG000|Overall Study|Death|0|||
163161003|NCT02563067|589304048|FG001|Overall Study|Death|1|||
163161004|NCT02563067|589304049|FG002|Overall Study|Death|1|||
163161005|NCT02563067|589304047|FG000|Overall Study|Adverse Event|2|||
163161006|NCT02563067|589304048|FG001|Overall Study|Adverse Event|1|||
163161007|NCT02563067|589304049|FG002|Overall Study|Adverse Event|0|||
163161008|NCT02563067|589304047|FG000|Overall Study|Death post Treatment/safety period|1|||
163161009|NCT02563067|589304048|FG001|Overall Study|Death post Treatment/safety period|0|||
163161010|NCT02563067|589304049|FG002|Overall Study|Death post Treatment/safety period|0|||
163161011|NCT03544333|589304050|FG000|Overall Study|Withdrawal by Subject|1|||
163161012|NCT03544333|589304051|FG001|Overall Study|Withdrawal by Subject|0|||
163161013|NCT00475306|589304059|FG000|Overall Study|Protocol Violation|1|||
163161014|NCT00475306|589304060|FG001|Overall Study|Protocol Violation|1|||
163161015|NCT00475306|589304061|FG002|Overall Study|Protocol Violation|0|||
163161016|NCT00475306|589304062|FG003|Overall Study|Protocol Violation|1|||
163161017|NCT02405442|589304064|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
163161018|NCT02405442|589304065|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
163161019|NCT02405442|589304066|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
163161020|NCT02405442|589304067|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
163161021|NCT02405442|589304064|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
163161022|NCT02405442|589304065|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
163161023|NCT02405442|589304066|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
163161024|NCT02405442|589304067|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
163161025|NCT02405442|589304064|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
163161026|NCT02405442|589304065|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
163161027|NCT02405442|589304066|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
163161028|NCT02405442|589304067|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
163161029|NCT02405442|589304064|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
163161030|NCT02405442|589304065|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
163161031|NCT02405442|589304066|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
163161032|NCT02405442|589304067|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
163161033|NCT02405442|589304064|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
163161034|NCT02405442|589304065|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
163161035|NCT02405442|589304066|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
163273447|NCT02138747|589709782|FG000|Treatment Period 2|Protocol Violation|1|||
163273448|NCT02138747|589709783|FG001|Treatment Period 2|Protocol Violation|0|||
163273449|NCT02138747|589709784|FG002|Treatment Period 2|Protocol Violation|0|||
163273450|NCT02138747|589709785|FG003|Treatment Period 2|Protocol Violation|0|||
163273451|NCT02138747|589709782|FG000|Treatment Period 2|Withdrawal by Subject|5|||
163273452|NCT02138747|589709783|FG001|Treatment Period 2|Withdrawal by Subject|4|||
163273453|NCT02138747|589709784|FG002|Treatment Period 2|Withdrawal by Subject|1|||
163273454|NCT02138747|589709785|FG003|Treatment Period 2|Withdrawal by Subject|2|||
163273455|NCT02138747|589709782|FG000|Treatment Period 2|Other - Miscellaneous|3|||
163273456|NCT02138747|589709783|FG001|Treatment Period 2|Other - Miscellaneous|0|||
163273457|NCT02138747|589709784|FG002|Treatment Period 2|Other - Miscellaneous|0|||
163273458|NCT02138747|589709785|FG003|Treatment Period 2|Other - Miscellaneous|0|||
163273459|NCT02302066|589709789|FG000|Overall Study|Adverse Event|1|||
163273460|NCT02302066|589709790|FG001|Overall Study|Adverse Event|1|||
163273461|NCT02302066|589709791|FG002|Overall Study|Adverse Event|3|||
163273462|NCT02302066|589709792|FG003|Overall Study|Adverse Event|0|||
163273463|NCT02302066|589709789|FG000|Overall Study|Lost to Follow-up|4|||
163273464|NCT02302066|589709790|FG001|Overall Study|Lost to Follow-up|5|||
163273465|NCT02302066|589709791|FG002|Overall Study|Lost to Follow-up|24|||
163273466|NCT02302066|589709792|FG003|Overall Study|Lost to Follow-up|7|||
163273467|NCT02302066|589709789|FG000|Overall Study|Withdrawal by Subject|25|||
163273468|NCT02302066|589709790|FG001|Overall Study|Withdrawal by Subject|58|||
163273469|NCT02302066|589709791|FG002|Overall Study|Withdrawal by Subject|124|||
163273470|NCT02302066|589709792|FG003|Overall Study|Withdrawal by Subject|33|||
163273471|NCT02302066|589709789|FG000|Overall Study|Pregnancy|2|||
163273472|NCT02302066|589709790|FG001|Overall Study|Pregnancy|10|||
163273473|NCT02302066|589709791|FG002|Overall Study|Pregnancy|12|||
163273474|NCT02302066|589709792|FG003|Overall Study|Pregnancy|0|||
163273475|NCT02302066|589709789|FG000|Overall Study|Reason Not Specified|1|||
163273476|NCT02302066|589709790|FG001|Overall Study|Reason Not Specified|1|||
163273477|NCT02302066|589709791|FG002|Overall Study|Reason Not Specified|9|||
163273478|NCT02302066|589709792|FG003|Overall Study|Reason Not Specified|1|||
163273479|NCT04793464|589709794|FG000|Overall Study|Lost to Follow-up|458|||
163273480|NCT04793464|589709795|FG001|Overall Study|Lost to Follow-up|168|||
163273481|NCT04793464|589709796|FG002|Overall Study|Lost to Follow-up|5|||
163273482|NCT04793464|589709794|FG000|Overall Study|Withdrawal by Subject|43|||
163273483|NCT04793464|589709795|FG001|Overall Study|Withdrawal by Subject|15|||
163273484|NCT04793464|589709796|FG002|Overall Study|Withdrawal by Subject|0|||
163273485|NCT02696902|589709800|FG000|Overall Study|Lost to Follow-up|0|||
163273486|NCT02696902|589709801|FG001|Overall Study|Lost to Follow-up|1|||
163273487|NCT02696902|589709802|FG002|Overall Study|Lost to Follow-up|1|||
163273488|NCT02696902|589709800|FG000|Overall Study|Withdrawal by Subject|0|||
163273489|NCT02696902|589709801|FG001|Overall Study|Withdrawal by Subject|0|||
163273490|NCT02696902|589709802|FG002|Overall Study|Withdrawal by Subject|1|||
163273491|NCT02696902|589709800|FG000|Overall Study|Death|19|||
163273492|NCT02696902|589709801|FG001|Overall Study|Death|3|||
163273493|NCT02696902|589709802|FG002|Overall Study|Death|24|||
163273494|NCT02696902|589709800|FG000|Overall Study|Participant not fit post-randomization|0|||
163273495|NCT02696902|589709801|FG001|Overall Study|Participant not fit post-randomization|0|||
163273496|NCT02696902|589709802|FG002|Overall Study|Participant not fit post-randomization|1|||
163273497|NCT02696902|589709800|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
163273498|NCT02696902|589709801|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
163273499|NCT02696902|589709802|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
163273500|NCT02696902|589709800|FG000|Overall Study|Principal investigator's decision|1|||
163273501|NCT02696902|589709801|FG001|Overall Study|Principal investigator's decision|0|||
163273502|NCT02696902|589709802|FG002|Overall Study|Principal investigator's decision|0|||
163273503|NCT02696902|589709800|FG000|Overall Study|Sponsor's decision|1|||
163273504|NCT02696902|589709801|FG001|Overall Study|Sponsor's decision|0|||
163273505|NCT02696902|589709802|FG002|Overall Study|Sponsor's decision|0|||
163273506|NCT02696902|589709800|FG000|Overall Study|Transferred to other hospital|1|||
163273507|NCT02696902|589709801|FG001|Overall Study|Transferred to other hospital|0|||
163273508|NCT02696902|589709802|FG002|Overall Study|Transferred to other hospital|0|||
163273509|NCT00845871|589709806|FG000|Assessment Period|Adverse Event|2|||
163273510|NCT00845871|589709806|FG000|Assessment Period|Abnormal laboratory values|1|||
163273511|NCT00845871|589709806|FG000|Assessment Period|Abnormal test procedure results|1|||
163273512|NCT00845871|589709806|FG000|Assessment Period|Patient withdrew consent|3|||
163273513|NCT01857622|589709807|FG000|Overall Study|Adverse Event|5|||
163273514|NCT01857622|589709808|FG001|Overall Study|Adverse Event|0|||
163273515|NCT01857622|589709809|FG002|Overall Study|Adverse Event|2|||
163273516|NCT01857622|589709807|FG000|Overall Study|Physician Decision|1|||
163273517|NCT01857622|589709808|FG001|Overall Study|Physician Decision|0|||
163273518|NCT01857622|589709809|FG002|Overall Study|Physician Decision|0|||
163273519|NCT01857622|589709807|FG000|Overall Study|Protocol Violation|4|||
163273520|NCT01857622|589709808|FG001|Overall Study|Protocol Violation|1|||
163273521|NCT01857622|589709809|FG002|Overall Study|Protocol Violation|0|||
163273522|NCT01857622|589709807|FG000|Overall Study|Withdrawal by Subject|1|||
163273523|NCT01857622|589709808|FG001|Overall Study|Withdrawal by Subject|0|||
163273524|NCT01857622|589709809|FG002|Overall Study|Withdrawal by Subject|0|||
163273525|NCT01291225|589709812|FG000|Overall Study|Lost to Follow-up|85|||
163273526|NCT01291225|589709813|FG001|Overall Study|Lost to Follow-up|39|||
163273527|NCT01734434|589709814|FG000|Overall Study|Death Infant|3|||
163273528|NCT01734434|589709815|FG001|Overall Study|Death Infant|1|||
163273529|NCT01734434|589709816|FG002|Overall Study|Death Infant|17|||
163273530|NCT01734434|589709817|FG003|Overall Study|Death Infant|5|||
163273531|NCT01734434|589709814|FG000|Overall Study|Lost to Follow-up|2|||
163273532|NCT01734434|589709815|FG001|Overall Study|Lost to Follow-up|9|||
163273533|NCT01734434|589709816|FG002|Overall Study|Lost to Follow-up|67|||
163273534|NCT01734434|589709817|FG003|Overall Study|Lost to Follow-up|11|||
163273535|NCT01734434|589709814|FG000|Overall Study|No Live Birth|1|||
163273536|NCT01734434|589709815|FG001|Overall Study|No Live Birth|2|||
163273537|NCT01734434|589709816|FG002|Overall Study|No Live Birth|32|||
163273538|NCT01734434|589709817|FG003|Overall Study|No Live Birth|6|||
163273539|NCT01734434|589709814|FG000|Overall Study|Withdrawal by Subject|4|||
163273540|NCT01734434|589709815|FG001|Overall Study|Withdrawal by Subject|0|||
163273541|NCT01734434|589709816|FG002|Overall Study|Withdrawal by Subject|8|||
163273542|NCT01734434|589709817|FG003|Overall Study|Withdrawal by Subject|1|||
163273543|NCT01734434|589709814|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
163273544|NCT01734434|589709815|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
163273545|NCT01734434|589709816|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
163273546|NCT01734434|589709817|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
163273547|NCT01734434|589709814|FG000|Overall Study|Subject Not Reachable|0|||
163273548|NCT01734434|589709815|FG001|Overall Study|Subject Not Reachable|0|||
163273549|NCT01734434|589709816|FG002|Overall Study|Subject Not Reachable|1|||
163273550|NCT01734434|589709817|FG003|Overall Study|Subject Not Reachable|0|||
163273551|NCT01734434|589709814|FG000|Overall Study|Treatment Defaulter|0|||
163273552|NCT01734434|589709815|FG001|Overall Study|Treatment Defaulter|0|||
163273553|NCT01734434|589709816|FG002|Overall Study|Treatment Defaulter|1|||
163273554|NCT01734434|589709817|FG003|Overall Study|Treatment Defaulter|0|||
163273555|NCT01734434|589709814|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
163273556|NCT01734434|589709815|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
163273557|NCT01734434|589709816|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
163273558|NCT01734434|589709817|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
163273559|NCT01734434|589709814|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
163273560|NCT01734434|589709815|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
163273561|NCT01734434|589709816|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
163273562|NCT01734434|589709817|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
163273563|NCT02819479|589711418|FG000|Overall Study|Adverse Event|2|||
163273564|NCT02718417|589711420|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
163273565|NCT02718417|589711421|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
163273566|NCT02718417|589711422|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
163273567|NCT02718417|589711420|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
163273568|NCT02718417|589711421|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
163273569|NCT02718417|589711422|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
163273570|NCT02718417|589711420|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
163273571|NCT02718417|589711421|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
163273572|NCT02718417|589711422|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
163273573|NCT02718417|589711420|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
163273574|NCT02718417|589711421|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
163273575|NCT02718417|589711422|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
163273576|NCT02718417|589711420|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
163273577|NCT02718417|589711421|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
163273578|NCT02718417|589711422|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
163273579|NCT02718417|589711420|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
163273580|NCT02718417|589711421|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
163273581|NCT02718417|589711422|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
163273582|NCT02718417|589711420|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
163273583|NCT02718417|589711421|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
163273584|NCT02718417|589711422|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
163273585|NCT02718417|589711420|FG000|Chemotherapy Phase (CP)|Other|2|||
163273586|NCT02718417|589711421|FG001|Chemotherapy Phase (CP)|Other|0|||
163273587|NCT02718417|589711422|FG002|Chemotherapy Phase (CP)|Other|1|||
163273588|NCT02718417|589711420|FG000|Maintenance Phase (MP)|Adverse Event|21|||
163273589|NCT02718417|589711421|FG001|Maintenance Phase (MP)|Adverse Event|26|||
163273590|NCT02718417|589711422|FG002|Maintenance Phase (MP)|Adverse Event|0|||
163273591|NCT02718417|589711420|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
163273592|NCT02718417|589711421|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
163273593|NCT02718417|589711422|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
163273594|NCT02718417|589711420|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
163273595|NCT02718417|589711421|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
163273596|NCT02718417|589711422|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
163273597|NCT02718417|589711420|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
163273598|NCT02718417|589711421|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
163273599|NCT02718417|589711422|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
163273600|NCT02718417|589711420|FG000|Maintenance Phase (MP)|Physician's decision|6|||
163273601|NCT02718417|589711421|FG001|Maintenance Phase (MP)|Physician's decision|7|||
163273602|NCT02718417|589711422|FG002|Maintenance Phase (MP)|Physician's decision|0|||
163273603|NCT02718417|589711420|FG000|Maintenance Phase (MP)|Progressive disease|100|||
163273604|NCT02718417|589711421|FG001|Maintenance Phase (MP)|Progressive disease|88|||
163273605|NCT02718417|589711422|FG002|Maintenance Phase (MP)|Progressive disease|0|||
163273606|NCT02718417|589711420|FG000|Maintenance Phase (MP)|Other|2|||
163273607|NCT02718417|589711421|FG001|Maintenance Phase (MP)|Other|1|||
163273608|NCT02718417|589711422|FG002|Maintenance Phase (MP)|Other|0|||
163273609|NCT02718417|589711420|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
163273610|NCT02718417|589711421|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
163273611|NCT02718417|589711422|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
163273612|NCT02718417|589711420|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
163273613|NCT02718417|589711421|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
163273614|NCT02718417|589711422|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
163273615|NCT02718417|589711420|FG000|Observation Phase (OP)|Adverse Event|0|||
163273616|NCT02718417|589711421|FG001|Observation Phase (OP)|Adverse Event|0|||
163273617|NCT02718417|589711422|FG002|Observation Phase (OP)|Adverse Event|1|||
163273618|NCT02718417|589711420|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
163273619|NCT02718417|589711421|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
163273620|NCT02718417|589711422|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
163273621|NCT02718417|589711420|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
163273622|NCT02718417|589711421|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
163273623|NCT02718417|589711422|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
163273624|NCT02718417|589711420|FG000|Observation Phase (OP)|Physician Decision|0|||
163273625|NCT02718417|589711421|FG001|Observation Phase (OP)|Physician Decision|0|||
163273626|NCT02718417|589711422|FG002|Observation Phase (OP)|Physician Decision|9|||
163273627|NCT02718417|589711420|FG000|Observation Phase (OP)|Progressive disease|0|||
163273628|NCT02718417|589711421|FG001|Observation Phase (OP)|Progressive disease|0|||
163273629|NCT02718417|589711422|FG002|Observation Phase (OP)|Progressive disease|92|||
163273630|NCT02718417|589711420|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
163273631|NCT02718417|589711421|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
163273632|NCT02718417|589711422|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
163273633|NCT02718417|589711420|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
163273634|NCT02718417|589711421|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
163273635|NCT02718417|589711422|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
163273636|NCT02718417|589711420|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
163273637|NCT02718417|589711421|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
163273638|NCT02718417|589711422|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
163273639|NCT02718417|589711420|FG000|Observation Phase (OP)|Other|0|||
163273640|NCT02718417|589711421|FG001|Observation Phase (OP)|Other|0|||
163273641|NCT02718417|589711422|FG002|Observation Phase (OP)|Other|7|||
163273642|NCT02718417|589711420|FG000|Follow-up Phase|Adverse Event|3|||
163273643|NCT02718417|589711421|FG001|Follow-up Phase|Adverse Event|1|||
163273644|NCT02718417|589711422|FG002|Follow-up Phase|Adverse Event|1|||
163273645|NCT02718417|589711420|FG000|Follow-up Phase|Other|4|||
163273646|NCT02718417|589711421|FG001|Follow-up Phase|Other|6|||
163273647|NCT02718417|589711422|FG002|Follow-up Phase|Other|4|||
163273648|NCT02718417|589711420|FG000|Follow-up Phase|Withdrawal by Subject|19|||
163273649|NCT02718417|589711421|FG001|Follow-up Phase|Withdrawal by Subject|17|||
163273650|NCT02718417|589711422|FG002|Follow-up Phase|Withdrawal by Subject|5|||
163273651|NCT02718417|589711420|FG000|Follow-up Phase|Study terminated by sponsor|100|||
163273652|NCT02718417|589711421|FG001|Follow-up Phase|Study terminated by sponsor|138|||
163273653|NCT02718417|589711422|FG002|Follow-up Phase|Study terminated by sponsor|6|||
163273654|NCT02718417|589711420|FG000|Follow-up Phase|Lost to Follow-up|2|||
163273655|NCT02718417|589711421|FG001|Follow-up Phase|Lost to Follow-up|3|||
163273656|NCT02718417|589711422|FG002|Follow-up Phase|Lost to Follow-up|0|||
163273657|NCT02718417|589711420|FG000|Follow-up Phase|Death leading to discontinuation|7|||
163273658|NCT02718417|589711421|FG001|Follow-up Phase|Death leading to discontinuation|7|||
163273659|NCT02718417|589711422|FG002|Follow-up Phase|Death leading to discontinuation|3|||
163273660|NCT02718417|589711420|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
163273661|NCT02718417|589711421|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
163273662|NCT02718417|589711422|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
163273663|NCT02718417|589711420|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
163273664|NCT02718417|589711421|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
163273665|NCT02718417|589711422|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
163273666|NCT02718417|589711420|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
163273667|NCT02718417|589711421|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
163273668|NCT02718417|589711422|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
163273669|NCT02718417|589711420|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
163273670|NCT02718417|589711421|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
163273671|NCT02718417|589711422|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
163273672|NCT02718417|589711420|FG000|Long-term Follow-up Phase|Other|0|||
163273673|NCT02718417|589711421|FG001|Long-term Follow-up Phase|Other|2|||
163273674|NCT02718417|589711422|FG002|Long-term Follow-up Phase|Other|0|||
163273675|NCT00506285|589711423|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
163273676|NCT00506285|589711424|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
163273677|NCT00506285|589711423|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
163273678|NCT00506285|589711424|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
163273679|NCT00506285|589711423|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
163273680|NCT00506285|589711424|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
163273681|NCT00506285|589711423|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
163273682|NCT00506285|589711424|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
163273683|NCT00506285|589711423|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
163273684|NCT00506285|589711424|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
163273685|NCT00551213|589711427|FG000|Overall Study|Adverse Event|6|||
163273686|NCT00551213|589711428|FG001|Overall Study|Adverse Event|3|||
163273687|NCT00551213|589711427|FG000|Overall Study|Progressive Disease|41|||
163273688|NCT00551213|589711428|FG001|Overall Study|Progressive Disease|12|||
163273689|NCT00551213|589711427|FG000|Overall Study|Withdrawal by Subject|2|||
163273690|NCT00551213|589711428|FG001|Overall Study|Withdrawal by Subject|0|||
163273691|NCT00551213|589711427|FG000|Overall Study|Not Treated|1|||
163273692|NCT00551213|589711428|FG001|Overall Study|Not Treated|2|||
163273693|NCT01890967|589711429|FG000|Overall Study|Adverse Event|3|||
163273694|NCT01890967|589711430|FG001|Overall Study|Adverse Event|3|||
163273695|NCT01890967|589711431|FG002|Overall Study|Adverse Event|3|||
163273696|NCT01890967|589711432|FG003|Overall Study|Adverse Event|2|||
163273697|NCT01890967|589711433|FG004|Overall Study|Adverse Event|1|||
163273698|NCT01890967|589711434|FG005|Overall Study|Adverse Event|7|||
163273699|NCT01890967|589711429|FG000|Overall Study|Death|1|||
163273700|NCT01890967|589711430|FG001|Overall Study|Death|0|||
163273701|NCT01890967|589711431|FG002|Overall Study|Death|0|||
163273702|NCT01890967|589711432|FG003|Overall Study|Death|0|||
163273703|NCT01890967|589711433|FG004|Overall Study|Death|0|||
163273704|NCT01890967|589711434|FG005|Overall Study|Death|0|||
163273705|NCT01890967|589711429|FG000|Overall Study|Lost to Follow-up|1|||
163273706|NCT01890967|589711430|FG001|Overall Study|Lost to Follow-up|1|||
163273707|NCT01890967|589711431|FG002|Overall Study|Lost to Follow-up|1|||
163273708|NCT01890967|589711432|FG003|Overall Study|Lost to Follow-up|1|||
163273709|NCT01890967|589711433|FG004|Overall Study|Lost to Follow-up|0|||
163273710|NCT01890967|589711434|FG005|Overall Study|Lost to Follow-up|1|||
163273711|NCT01890967|589711429|FG000|Overall Study|Protocol Violation|0|||
163273712|NCT01890967|589711430|FG001|Overall Study|Protocol Violation|3|||
163273713|NCT01890967|589711431|FG002|Overall Study|Protocol Violation|3|||
163273714|NCT01890967|589711432|FG003|Overall Study|Protocol Violation|2|||
163273715|NCT01890967|589711433|FG004|Overall Study|Protocol Violation|4|||
163273716|NCT01890967|589711434|FG005|Overall Study|Protocol Violation|1|||
163273717|NCT01890967|589711429|FG000|Overall Study|Sponsor Decision|2|||
163273718|NCT01890967|589711430|FG001|Overall Study|Sponsor Decision|0|||
163273719|NCT01890967|589711431|FG002|Overall Study|Sponsor Decision|1|||
163273720|NCT01890967|589711432|FG003|Overall Study|Sponsor Decision|3|||
163273721|NCT01890967|589711433|FG004|Overall Study|Sponsor Decision|2|||
163273722|NCT01890967|589711434|FG005|Overall Study|Sponsor Decision|3|||
163273723|NCT01890967|589711429|FG000|Overall Study|Withdrawal by Subject|3|||
163273724|NCT01890967|589711430|FG001|Overall Study|Withdrawal by Subject|4|||
163273725|NCT01890967|589711431|FG002|Overall Study|Withdrawal by Subject|2|||
163273726|NCT01890967|589711432|FG003|Overall Study|Withdrawal by Subject|3|||
163273727|NCT01890967|589711433|FG004|Overall Study|Withdrawal by Subject|3|||
163273728|NCT01890967|589711434|FG005|Overall Study|Withdrawal by Subject|1|||
163273729|NCT02892409|589711435|FG000|Overall Study|Adverse Event|1|||
163273730|NCT02892409|589711436|FG001|Overall Study|Adverse Event|0|||
163273731|NCT02892409|589711435|FG000|Overall Study|Withdrawal by Subject|2|||
163273732|NCT02892409|589711436|FG001|Overall Study|Withdrawal by Subject|1|||
163273733|NCT00867490|589711437|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
163273734|NCT00867490|589711437|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
163273735|NCT00867490|589711437|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
163273736|NCT00867490|589711437|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
163273737|NCT00867490|589711437|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
163273738|NCT02264574|589711444|FG000|Overall Study|Death|21|||
163273739|NCT02264574|589711445|FG001|Overall Study|Death|21|||
163273740|NCT02264574|589711444|FG000|Overall Study|Withdrawal by Subject|8|||
163273741|NCT02264574|589711445|FG001|Overall Study|Withdrawal by Subject|6|||
163273742|NCT02264574|589711444|FG000|Overall Study|Other, Not Specified|0|||
163385769|NCT00146328|590123241|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
163273743|NCT02264574|589711445|FG001|Overall Study|Other, Not Specified|3|||
163161036|NCT02405442|589304067|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
163161037|NCT02405442|589304064|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
163161038|NCT02405442|589304065|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
163161039|NCT02405442|589304066|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
163161040|NCT02405442|589304067|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
163161041|NCT02405442|589304064|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
163161042|NCT02405442|589304065|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
163161043|NCT02405442|589304066|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
163161044|NCT02405442|589304067|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
163161045|NCT02405442|589304064|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
163161046|NCT02405442|589304065|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
163161047|NCT02405442|589304066|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
163161048|NCT02405442|589304067|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
163161049|NCT02405442|589304064|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
163161050|NCT02405442|589304065|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
163161051|NCT02405442|589304066|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
163161052|NCT02405442|589304067|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
163161053|NCT02405442|589304064|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
163161054|NCT02405442|589304065|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
163161055|NCT02405442|589304066|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
163161056|NCT02405442|589304067|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
163161057|NCT02405442|589304064|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
163161058|NCT02405442|589304065|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
163161059|NCT02405442|589304066|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
163161060|NCT02405442|589304067|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
163161061|NCT02405442|589304064|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
163161062|NCT02405442|589304065|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
163161063|NCT02405442|589304066|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
163161064|NCT02405442|589304067|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
163161065|NCT02405442|589304064|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
163161066|NCT02405442|589304065|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
163273744|NCT02080520|589711446|FG000|Overall Study|Self-reported symptoms|5|||
163273745|NCT02080520|589711447|FG001|Overall Study|Self-reported symptoms|6|||
163273746|NCT02080520|589711446|FG000|Overall Study|Unable to contact|2|||
163273747|NCT02080520|589711447|FG001|Overall Study|Unable to contact|1|||
163273748|NCT02080520|589711446|FG000|Overall Study|Initiated aspirin|2|||
163273749|NCT02080520|589711447|FG001|Overall Study|Initiated aspirin|0|||
163273750|NCT02080520|589711446|FG000|Overall Study|Atrial fibrillation|1|||
163273751|NCT02080520|589711447|FG001|Overall Study|Atrial fibrillation|1|||
163273752|NCT02080520|589711446|FG000|Overall Study|Cancer|1|||
163273753|NCT02080520|589711447|FG001|Overall Study|Cancer|2|||
163273754|NCT02080520|589711446|FG000|Overall Study|Not interested in study|1|||
163273755|NCT02080520|589711447|FG001|Overall Study|Not interested in study|3|||
163273756|NCT02080520|589711446|FG000|Overall Study|Too busy|1|||
163273757|NCT02080520|589711447|FG001|Overall Study|Too busy|1|||
163273758|NCT02080520|589711446|FG000|Overall Study|Work-related injury|1|||
163273759|NCT02080520|589711447|FG001|Overall Study|Work-related injury|0|||
163273760|NCT02080520|589711446|FG000|Overall Study|Personal reasons|0|||
163273761|NCT02080520|589711447|FG001|Overall Study|Personal reasons|3|||
163273762|NCT02406261|589711448|FG000|Period 1|Lost to Follow-up|2|||
163273763|NCT02406261|589711449|FG001|Period 1|Lost to Follow-up|0|||
163273764|NCT02406261|589711448|FG000|Period 1|Adverse Event|1|||
163273765|NCT02406261|589711449|FG001|Period 1|Adverse Event|0|||
163273766|NCT02406261|589711448|FG000|Period 2|Physician Decision|0|||
163273767|NCT02406261|589711449|FG001|Period 2|Physician Decision|1|||
163273768|NCT02406261|589711448|FG000|Period 2|Protocol Violation|0|||
163273769|NCT02406261|589711449|FG001|Period 2|Protocol Violation|1|||
163273770|NCT02406261|589711448|FG000|Period 2|Withdrawal by Subject|0|||
163273771|NCT02406261|589711449|FG001|Period 2|Withdrawal by Subject|1|||
163273772|NCT04102540|589711452|FG000|Overall Study|Withdrawn by PI|2|||
163273773|NCT04102540|589711452|FG000|Overall Study|Lost to Follow-up|6|||
163273774|NCT01567163|589711453|FG000|Overall Study|Progressive Disease|2|||
163273775|NCT01567163|589711453|FG000|Overall Study|Lost to Follow-up|2|||
163273776|NCT01720797|589711454|FG000|Overall Study|Withdrawal by Subject|3|||
163273777|NCT01720797|589711455|FG001|Overall Study|Withdrawal by Subject|0|||
163273778|NCT00393094|589711459|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
163273779|NCT00393094|589711459|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
163273780|NCT02019602|589711460|FG000|Screening Period|Ineligibility|4|||
163273781|NCT02019602|589711461|FG001|Screening Period|Ineligibility|0|||
163273782|NCT02019602|589711460|FG000|Screening Period|Adverse Event|1|||
163273783|NCT02019602|589711461|FG001|Screening Period|Adverse Event|0|||
163273784|NCT03207711|589711464|FG000|Overall Study|Withdrawal by Subject|1|||
163273785|NCT03207711|589711465|FG001|Overall Study|Withdrawal by Subject|2|||
163273786|NCT02372058|589711468|FG000|Overall Study|Withdrawal by Subject|3|||
163273787|NCT02788006|589711472|FG000|Overall Study|Patient not treated|1|||
163273788|NCT00318149|589711473|FG000|Overall Study|Adverse Event|0|||
163273789|NCT00318149|589711474|FG001|Overall Study|Adverse Event|0|||
163273790|NCT00318149|589711475|FG002|Overall Study|Adverse Event|0|||
163273791|NCT00318149|589711476|FG003|Overall Study|Adverse Event|0|||
163273792|NCT00318149|589711477|FG004|Overall Study|Adverse Event|0|||
163273793|NCT00318149|589711478|FG005|Overall Study|Adverse Event|2|||
163273794|NCT03541642|589711481|FG000|Overall Study|Withdrawal by Subject|1|||
163273795|NCT03541642|589711482|FG001|Overall Study|Withdrawal by Subject|2|||
163273796|NCT03541642|589711481|FG000|Overall Study|Lost to Follow-up|16|||
163273797|NCT03541642|589711482|FG001|Overall Study|Lost to Follow-up|12|||
163273798|NCT03541642|589711481|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
163273799|NCT03541642|589711482|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
163273800|NCT03050398|589711487|FG000|Overall Study|Study terminated by sponsor|8|||
163273801|NCT05108649|589711488|FG000|Overall Study|Lost to Follow-up|0|||
163273802|NCT05108649|589711489|FG001|Overall Study|Lost to Follow-up|4|||
163273803|NCT05108649|589711490|FG002|Overall Study|Lost to Follow-up|3|||
163273804|NCT05108649|589711491|FG003|Overall Study|Lost to Follow-up|6|||
163273805|NCT05108649|589711488|FG000|Overall Study|Not Interested|1|||
163273806|NCT05108649|589711489|FG001|Overall Study|Not Interested|1|||
163273807|NCT05108649|589711490|FG002|Overall Study|Not Interested|0|||
163273808|NCT05108649|589711491|FG003|Overall Study|Not Interested|1|||
163273809|NCT05108649|589711488|FG000|Overall Study|Out of area|0|||
163273810|NCT05108649|589711489|FG001|Overall Study|Out of area|0|||
163273811|NCT05108649|589711490|FG002|Overall Study|Out of area|0|||
163273812|NCT05108649|589711491|FG003|Overall Study|Out of area|1|||
163273813|NCT05108649|589711488|FG000|Overall Study|PI decision|1|||
163273814|NCT05108649|589711489|FG001|Overall Study|PI decision|0|||
163273815|NCT05108649|589711490|FG002|Overall Study|PI decision|0|||
163273816|NCT05108649|589711491|FG003|Overall Study|PI decision|0|||
163273817|NCT05108649|589711488|FG000|Overall Study|Significant Non-Compliance|0|||
163273818|NCT05108649|589711489|FG001|Overall Study|Significant Non-Compliance|1|||
163273819|NCT05108649|589711490|FG002|Overall Study|Significant Non-Compliance|0|||
163273820|NCT05108649|589711491|FG003|Overall Study|Significant Non-Compliance|0|||
163273821|NCT05108649|589711488|FG000|Overall Study|Unable to adhere to study protocol|0|||
163273822|NCT05108649|589711489|FG001|Overall Study|Unable to adhere to study protocol|2|||
163273823|NCT05108649|589711490|FG002|Overall Study|Unable to adhere to study protocol|0|||
163273824|NCT05108649|589711491|FG003|Overall Study|Unable to adhere to study protocol|0|||
163273825|NCT03523871|589711492|FG000|Overall Study|Death|1|||
163273826|NCT01083160|589711493|FG000|Overall Study|Adverse Event|1|||
163273827|NCT00918749|589711494|FG000|Overall Study|Adverse Event|1|||
163273828|NCT00918749|589711495|FG001|Overall Study|Adverse Event|0|||
163273829|NCT00918749|589711496|FG002|Overall Study|Adverse Event|1|||
163273830|NCT00918749|589711494|FG000|Overall Study|Lost to Follow-up|0|||
163273831|NCT00918749|589711495|FG001|Overall Study|Lost to Follow-up|0|||
163273832|NCT00918749|589711496|FG002|Overall Study|Lost to Follow-up|1|||
163273833|NCT00918749|589711494|FG000|Overall Study|Withdrawal by Subject|5|||
163273834|NCT00918749|589711495|FG001|Overall Study|Withdrawal by Subject|3|||
163273835|NCT00918749|589711496|FG002|Overall Study|Withdrawal by Subject|5|||
163273836|NCT00918749|589711494|FG000|Overall Study|No Study Medication Taken|1|||
163273837|NCT00918749|589711495|FG001|Overall Study|No Study Medication Taken|0|||
163273838|NCT00918749|589711496|FG002|Overall Study|No Study Medication Taken|0|||
163273839|NCT01951092|589711497|FG000|Overall Study|Lost to Follow-up|10|||
163273840|NCT01951092|589711497|FG000|Overall Study|Incarceration|1|||
163273841|NCT01951092|589711497|FG000|Overall Study|Transfer of Care|1|||
163273842|NCT01712789|589711498|FG000|Overall Study|Lack of Efficacy|2|||
163273843|NCT01712789|589711498|FG000|Overall Study|Lost to Follow-up|1|||
163273844|NCT01712789|589711498|FG000|Overall Study|Progressive Disease|504|||
163273845|NCT01712789|589711498|FG000|Overall Study|Death|57|||
163273846|NCT01712789|589711498|FG000|Overall Study|Adverse Event|52|||
163273847|NCT01712789|589711498|FG000|Overall Study|Miscellaneous|31|||
163273848|NCT01712789|589711498|FG000|Overall Study|Withdrawal by Subject|21|||
163273849|NCT01712789|589711498|FG000|Overall Study|Transition to Commercial Treatment|8|||
163273850|NCT01712789|589711498|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
163273851|NCT00219141|589711499|FG000|Overall Study|Adverse Event|4|||
163273852|NCT00219141|589711500|FG001|Overall Study|Adverse Event|10|||
163273853|NCT00219141|589711501|FG002|Overall Study|Adverse Event|5|||
163273854|NCT00219141|589711499|FG000|Overall Study|Lack of Efficacy|3|||
163273855|NCT00219141|589711500|FG001|Overall Study|Lack of Efficacy|2|||
163273856|NCT00219141|589711501|FG002|Overall Study|Lack of Efficacy|0|||
163273857|NCT00219141|589711499|FG000|Overall Study|Administrative problems|0|||
163273858|NCT00219141|589711500|FG001|Overall Study|Administrative problems|1|||
162924203|NCT02426125|588423829|FG000|Overall Study|Death|185|||
163273859|NCT00219141|589711501|FG002|Overall Study|Administrative problems|0|||
163273860|NCT00219141|589711499|FG000|Overall Study|Lost to Follow-up|2|||
163273861|NCT00219141|589711500|FG001|Overall Study|Lost to Follow-up|4|||
163273862|NCT00219141|589711501|FG002|Overall Study|Lost to Follow-up|1|||
163273863|NCT00219141|589711499|FG000|Overall Study|Protocol Violation|3|||
163273864|NCT00219141|589711500|FG001|Overall Study|Protocol Violation|1|||
163273865|NCT00219141|589711501|FG002|Overall Study|Protocol Violation|1|||
163273866|NCT00219141|589711499|FG000|Overall Study|Withdrawal by Subject|1|||
163273867|NCT00219141|589711500|FG001|Overall Study|Withdrawal by Subject|3|||
163273868|NCT00219141|589711501|FG002|Overall Study|Withdrawal by Subject|5|||
163273869|NCT00219141|589711499|FG000|Overall Study|Condition no longer requires study drug|1|||
163273870|NCT00219141|589711500|FG001|Overall Study|Condition no longer requires study drug|0|||
163273871|NCT00219141|589711501|FG002|Overall Study|Condition no longer requires study drug|0|||
163273872|NCT00972179|589711502|FG000|Overall Study|Noncompliance|1|||
163273873|NCT00972179|589711503|FG001|Overall Study|Noncompliance|0|||
163273874|NCT00972179|589711504|FG002|Overall Study|Noncompliance|0|||
163273875|NCT00972179|589711505|FG003|Overall Study|Noncompliance|0|||
163273876|NCT00972179|589711506|FG004|Overall Study|Noncompliance|1|||
163273877|NCT00972179|589711507|FG005|Overall Study|Noncompliance|0|||
163273878|NCT00972179|589711508|FG006|Overall Study|Noncompliance|1|||
163273879|NCT00972179|589711502|FG000|Overall Study|Withdrawal by Subject|0|||
163273880|NCT00972179|589711503|FG001|Overall Study|Withdrawal by Subject|3|||
163273881|NCT00972179|589711504|FG002|Overall Study|Withdrawal by Subject|0|||
163273882|NCT00972179|589711505|FG003|Overall Study|Withdrawal by Subject|1|||
163273883|NCT00972179|589711506|FG004|Overall Study|Withdrawal by Subject|0|||
163273884|NCT00972179|589711507|FG005|Overall Study|Withdrawal by Subject|0|||
163273885|NCT00972179|589711508|FG006|Overall Study|Withdrawal by Subject|2|||
163273886|NCT00972179|589711502|FG000|Overall Study|Administrative Decision|0|||
163273887|NCT00972179|589711503|FG001|Overall Study|Administrative Decision|0|||
163273888|NCT00972179|589711504|FG002|Overall Study|Administrative Decision|0|||
163273889|NCT00972179|589711505|FG003|Overall Study|Administrative Decision|0|||
163273890|NCT00972179|589711506|FG004|Overall Study|Administrative Decision|1|||
163273891|NCT00972179|589711507|FG005|Overall Study|Administrative Decision|0|||
163273892|NCT00972179|589711508|FG006|Overall Study|Administrative Decision|0|||
163273893|NCT00972179|589711502|FG000|Overall Study|Lost to Follow-up|0|||
163273894|NCT00972179|589711503|FG001|Overall Study|Lost to Follow-up|0|||
163273895|NCT00972179|589711504|FG002|Overall Study|Lost to Follow-up|1|||
163273896|NCT00972179|589711505|FG003|Overall Study|Lost to Follow-up|0|||
163273897|NCT00972179|589711506|FG004|Overall Study|Lost to Follow-up|0|||
163273898|NCT00972179|589711507|FG005|Overall Study|Lost to Follow-up|3|||
163273899|NCT00972179|589711508|FG006|Overall Study|Lost to Follow-up|1|||
163273900|NCT03055832|589711509|FG000|Week 2|Withdrawal by Subject|1|||
163273901|NCT03055832|589711510|FG001|Week 2|Withdrawal by Subject|0|||
163273902|NCT00136916|589711511|FG000|Overall Study|Never received study treatment|3|||
163273903|NCT00136916|589711512|FG001|Overall Study|Never received study treatment|5|||
163273904|NCT00136916|589711511|FG000|Overall Study|Death|1|||
163273905|NCT00136916|589711512|FG001|Overall Study|Death|3|||
163273906|NCT00136916|589711511|FG000|Overall Study|Adverse Event|27|||
163273907|NCT00136916|589711512|FG001|Overall Study|Adverse Event|8|||
163273908|NCT00136916|589711511|FG000|Overall Study|Laboratory abnormality|0|||
163273909|NCT00136916|589711512|FG001|Overall Study|Laboratory abnormality|1|||
163273910|NCT00136916|589711511|FG000|Overall Study|Lack of Efficacy|13|||
163273911|NCT00136916|589711512|FG001|Overall Study|Lack of Efficacy|3|||
163161067|NCT02405442|589304066|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
163161068|NCT02405442|589304067|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
163161069|NCT02405442|589304064|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
163161070|NCT02405442|589304065|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
163161071|NCT02405442|589304066|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
163161072|NCT02405442|589304067|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
163161073|NCT00337675|589304070|FG000|Overall Study|Adverse Event|10|||
163161074|NCT00337675|589304071|FG001|Overall Study|Adverse Event|9|||
163161075|NCT00337675|589304072|FG002|Overall Study|Adverse Event|19|||
163161076|NCT00337675|589304070|FG000|Overall Study|Lack of Efficacy|10|||
163161077|NCT00337675|589304071|FG001|Overall Study|Lack of Efficacy|7|||
163161078|NCT00337675|589304072|FG002|Overall Study|Lack of Efficacy|9|||
163161079|NCT00337675|589304070|FG000|Overall Study|Lost to Follow-up|22|||
163161080|NCT00337675|589304071|FG001|Overall Study|Lost to Follow-up|19|||
163161081|NCT00337675|589304072|FG002|Overall Study|Lost to Follow-up|17|||
163161082|NCT00337675|589304070|FG000|Overall Study|Physician Decision|9|||
163161083|NCT00337675|589304071|FG001|Overall Study|Physician Decision|17|||
163161084|NCT00337675|589304072|FG002|Overall Study|Physician Decision|14|||
163161085|NCT00337675|589304070|FG000|Overall Study|Protocol Violation|21|||
163161086|NCT00337675|589304071|FG001|Overall Study|Protocol Violation|24|||
163161087|NCT00337675|589304072|FG002|Overall Study|Protocol Violation|19|||
163161088|NCT00337675|589304070|FG000|Overall Study|Withdrawal by Subject|25|||
163161089|NCT00337675|589304071|FG001|Overall Study|Withdrawal by Subject|25|||
163161090|NCT00337675|589304072|FG002|Overall Study|Withdrawal by Subject|19|||
163273912|NCT00136916|589711511|FG000|Overall Study|Lost to Follow-up|12|||
163273913|NCT00136916|589711512|FG001|Overall Study|Lost to Follow-up|14|||
163273914|NCT00136916|589711511|FG000|Overall Study|Withdrawal by Subject|44|||
163273915|NCT00136916|589711512|FG001|Overall Study|Withdrawal by Subject|46|||
163273916|NCT00136916|589711511|FG000|Overall Study|Other|22|||
163273917|NCT00136916|589711512|FG001|Overall Study|Other|24|||
163273918|NCT00136916|589711511|FG000|Overall Study|Discontinued in follow up period|3|||
163273919|NCT00136916|589711512|FG001|Overall Study|Discontinued in follow up period|0|||
163273920|NCT01991197|589711513|FG000|Overall Study|Lost to Follow-up|1|||
163273921|NCT01991197|589711514|FG001|Overall Study|Lost to Follow-up|1|||
163273922|NCT01991197|589711513|FG000|Overall Study|Physician Decision|0|||
163273923|NCT01991197|589711514|FG001|Overall Study|Physician Decision|2|||
163273924|NCT01991197|589711513|FG000|Overall Study|Withdrawal by Subject|2|||
163273925|NCT01991197|589711514|FG001|Overall Study|Withdrawal by Subject|0|||
163273926|NCT01012973|589711515|FG000|Overall Study|Adverse Event|5|||
163273927|NCT01012973|589711516|FG001|Overall Study|Adverse Event|5|||
163273928|NCT01012973|589711515|FG000|Overall Study|Lack of Efficacy|0|||
163273929|NCT01012973|589711516|FG001|Overall Study|Lack of Efficacy|5|||
163273930|NCT01012973|589711515|FG000|Overall Study|Lost to Follow-up|1|||
163273931|NCT01012973|589711516|FG001|Overall Study|Lost to Follow-up|0|||
163273932|NCT01012973|589711515|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
163273933|NCT01012973|589711516|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
163273934|NCT01012973|589711515|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
163273935|NCT01012973|589711516|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
163273936|NCT01012973|589711515|FG000|Overall Study|Protocol Violation|5|||
163273937|NCT01012973|589711516|FG001|Overall Study|Protocol Violation|2|||
163273938|NCT01012973|589711515|FG000|Overall Study|Withdrawal by Subject|4|||
163273939|NCT01012973|589711516|FG001|Overall Study|Withdrawal by Subject|6|||
163273940|NCT01932996|589711517|FG000|Overall Study|Protocol Violation|2|||
163273941|NCT01932996|589711518|FG001|Overall Study|Protocol Violation|0|||
163273942|NCT00846742|589711521|FG000|Overall Study|Withdrawal by Subject|1|||
163273943|NCT01435798|589711526|FG000|Overall Study|Withdrawal by Subject|1|||
163273944|NCT03257995|589711530|FG000|Overall Study|Adverse Event|0|||
163273945|NCT03257995|589711531|FG001|Overall Study|Adverse Event|1|||
163273946|NCT03257995|589711532|FG002|Overall Study|Adverse Event|0|||
163273947|NCT03257995|589711533|FG003|Overall Study|Adverse Event|0|||
163273948|NCT03257995|589711534|FG004|Overall Study|Adverse Event|0|||
163273949|NCT03257995|589711535|FG005|Overall Study|Adverse Event|0|||
163273950|NCT03257995|589711530|FG000|Overall Study|Protocol deviation|0|||
163273951|NCT03257995|589711531|FG001|Overall Study|Protocol deviation|0|||
163273952|NCT03257995|589711532|FG002|Overall Study|Protocol deviation|0|||
163273953|NCT03257995|589711533|FG003|Overall Study|Protocol deviation|0|||
163273954|NCT03257995|589711534|FG004|Overall Study|Protocol deviation|0|||
163273955|NCT03257995|589711535|FG005|Overall Study|Protocol deviation|2|||
163273956|NCT04170296|589711540|FG000|Overall Study|Adverse Event|1|||
163273957|NCT04170296|589711541|FG001|Overall Study|Adverse Event|0|||
163273958|NCT04170296|589711540|FG000|Overall Study|Withdrawal by Subject|3|||
163273959|NCT04170296|589711541|FG001|Overall Study|Withdrawal by Subject|2|||
163273960|NCT04170296|589711540|FG000|Overall Study|Lost to Follow-up|4|||
163273961|NCT04170296|589711541|FG001|Overall Study|Lost to Follow-up|2|||
163273962|NCT03567993|589711542|FG000|Overall Study|Lost to Follow-up|4|||
163273963|NCT03567993|589711543|FG001|Overall Study|Lost to Follow-up|2|||
163273964|NCT03567993|589711542|FG000|Overall Study|Death|1|||
163273965|NCT03567993|589711543|FG001|Overall Study|Death|1|||
163273966|NCT03567993|589711542|FG000|Overall Study|Withdrawal by Subject|1|||
163273967|NCT03567993|589711543|FG001|Overall Study|Withdrawal by Subject|0|||
163273968|NCT00903786|589711547|FG000|Overall Study|Physician Decision|6|||
163273969|NCT00903786|589711547|FG000|Overall Study|Lack of Efficacy|5|||
163273970|NCT00903786|589711547|FG000|Overall Study|Reason other than lack of efficacy|4|||
163273971|NCT02285595|589711548|FG000|Overall Study|Lost to Follow-up|14|||
163273972|NCT02285595|589711548|FG000|Overall Study|Withdrawal by Subject|1|||
163273973|NCT01960790|589711549|FG000|Overall Study|Survey forms could not be recovered|3|||
163273974|NCT01960790|589711549|FG000|Overall Study|Treat with Humira outside survey period|3|||
163273975|NCT01960790|589711549|FG000|Overall Study|Transferred to another hospital|4|||
163273976|NCT01960790|589711549|FG000|Overall Study|Unevaluable for safety|1|||
163273977|NCT04318093|589711551|FG000|Overall Study|Adverse Event|2|||
163273978|NCT04318093|589711552|FG001|Overall Study|Adverse Event|2|||
163273979|NCT04318093|589711551|FG000|Overall Study|Participant withdrew consent|1|||
163273980|NCT04318093|589711552|FG001|Overall Study|Participant withdrew consent|0|||
163273981|NCT04318093|589711551|FG000|Overall Study|Other reasons|0|||
163273982|NCT04318093|589711552|FG001|Overall Study|Other reasons|1|||
162924204|NCT02426125|588423830|FG001|Overall Study|Death|200|||
163273983|NCT01370603|589711553|FG000|Period 1|Adverse Event|5|||
163273984|NCT01370603|589711554|FG001|Period 1|Adverse Event|3|||
163273985|NCT01370603|589711553|FG000|Period 1|Lost to Follow-up|2|||
163273986|NCT01370603|589711554|FG001|Period 1|Lost to Follow-up|0|||
163273987|NCT01370603|589711553|FG000|Period 1|Protocol Violation|2|||
163273988|NCT01370603|589711554|FG001|Period 1|Protocol Violation|2|||
163273989|NCT01370603|589711553|FG000|Period 1|Withdrawal by Subject|5|||
163273990|NCT01370603|589711554|FG001|Period 1|Withdrawal by Subject|5|||
163273991|NCT01370603|589711553|FG000|Crossover Washout|Adverse Event|2|||
163273992|NCT01370603|589711554|FG001|Crossover Washout|Adverse Event|1|||
163273993|NCT01370603|589711553|FG000|Crossover Washout|Lost to Follow-up|2|||
163273994|NCT01370603|589711554|FG001|Crossover Washout|Lost to Follow-up|0|||
163273995|NCT01370603|589711553|FG000|Crossover Washout|Protocol Violation|1|||
163273996|NCT01370603|589711554|FG001|Crossover Washout|Protocol Violation|0|||
163273997|NCT01370603|589711553|FG000|Crossover Washout|Withdrawal by Subject|4|||
163273998|NCT01370603|589711554|FG001|Crossover Washout|Withdrawal by Subject|1|||
163273999|NCT01370603|589711553|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
163274000|NCT01370603|589711554|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
163274001|NCT01370603|589711553|FG000|Period 2|Adverse Event|1|||
163274002|NCT01370603|589711554|FG001|Period 2|Adverse Event|4|||
163274003|NCT01370603|589711553|FG000|Period 2|Lost to Follow-up|1|||
163274004|NCT01370603|589711554|FG001|Period 2|Lost to Follow-up|0|||
163274005|NCT01370603|589711553|FG000|Period 2|Withdrawal by Subject|1|||
163274006|NCT01370603|589711554|FG001|Period 2|Withdrawal by Subject|0|||
163274007|NCT02924389|589711562|FG000|Overall Study|Lost to Follow-up|1|||
163274008|NCT02924389|589711563|FG001|Overall Study|Lost to Follow-up|0|||
163274009|NCT02924389|589711562|FG000|Overall Study|Physician Decision|2|||
163274010|NCT02924389|589711563|FG001|Overall Study|Physician Decision|0|||
163274011|NCT02924389|589711562|FG000|Overall Study|Withdrawal by Subject|3|||
163274012|NCT02924389|589711563|FG001|Overall Study|Withdrawal by Subject|0|||
163274013|NCT02924389|589711562|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
163274014|NCT02924389|589711563|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
163274015|NCT05220501|589712767|FG000|Overall Study|Withdrawal by Subject|11|||
163274016|NCT05220501|589712768|FG001|Overall Study|Withdrawal by Subject|21|||
163274017|NCT05220501|589712769|FG002|Overall Study|Withdrawal by Subject|32|||
163274018|NCT05220501|589712767|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
163274019|NCT05220501|589712768|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
163274020|NCT05220501|589712769|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
163274021|NCT02692235|589712770|FG000|Overall Study|Withdrawal by Subject|2|||
163274022|NCT02692235|589712771|FG001|Overall Study|Withdrawal by Subject|1|||
163274023|NCT02692235|589712770|FG000|Overall Study|Adverse Event|1|||
163274024|NCT02692235|589712771|FG001|Overall Study|Adverse Event|2|||
163274025|NCT00802841|589712772|FG000|Overall Study|Administrative problems|1|||
163274026|NCT00802841|589712773|FG001|Overall Study|Administrative problems|0|||
163274027|NCT00802841|589712772|FG000|Overall Study|Lost to Follow-up|2|||
163274028|NCT00802841|589712773|FG001|Overall Study|Lost to Follow-up|1|||
163274029|NCT00802841|589712772|FG000|Overall Study|Death|1|||
163274030|NCT00802841|589712773|FG001|Overall Study|Death|2|||
163274031|NCT00802841|589712772|FG000|Overall Study|Adverse Event|8|||
163274032|NCT00802841|589712773|FG001|Overall Study|Adverse Event|2|||
163274033|NCT00802841|589712772|FG000|Overall Study|Disease progression|7|||
163274034|NCT00802841|589712773|FG001|Overall Study|Disease progression|3|||
163274035|NCT00802841|589712772|FG000|Overall Study|Withdrawal by Subject|9|||
163274036|NCT00802841|589712773|FG001|Overall Study|Withdrawal by Subject|5|||
163274037|NCT00802841|589712772|FG000|Overall Study|Protocol deviation|2|||
163274038|NCT00802841|589712773|FG001|Overall Study|Protocol deviation|6|||
163274039|NCT00802841|589712772|FG000|Overall Study|Treatment duration completed|66|||
163274040|NCT00802841|589712773|FG001|Overall Study|Treatment duration completed|76|||
163274041|NCT01268059|589712774|FG000|Overall Study|Lost to Follow-up|0|||
163274042|NCT01268059|589712775|FG001|Overall Study|Lost to Follow-up|1|||
163274043|NCT01268059|589712776|FG002|Overall Study|Lost to Follow-up|0|||
163274044|NCT01268059|589712777|FG003|Overall Study|Lost to Follow-up|0|||
163274045|NCT01268059|589712774|FG000|Overall Study|Withdrawal by Subject|7|||
163274046|NCT01268059|589712775|FG001|Overall Study|Withdrawal by Subject|4|||
163274047|NCT01268059|589712776|FG002|Overall Study|Withdrawal by Subject|0|||
163274048|NCT01268059|589712777|FG003|Overall Study|Withdrawal by Subject|0|||
163274049|NCT01268059|589712774|FG000|Overall Study|Death|20|||
163274050|NCT01268059|589712775|FG001|Overall Study|Death|30|||
163274051|NCT01268059|589712776|FG002|Overall Study|Death|3|||
163274052|NCT01268059|589712777|FG003|Overall Study|Death|5|||
163274053|NCT01268059|589712774|FG000|Overall Study|Progression of disease|1|||
163274054|NCT01268059|589712775|FG001|Overall Study|Progression of disease|0|||
163274055|NCT01268059|589712776|FG002|Overall Study|Progression of disease|0|||
163274056|NCT01268059|589712777|FG003|Overall Study|Progression of disease|0|||
163274057|NCT03660943|589712778|FG000|Overall Study|Adverse Event|5|||
163274058|NCT03660943|589712779|FG001|Overall Study|Adverse Event|3|||
163274059|NCT03660943|589712778|FG000|Overall Study|Death|0|||
163274060|NCT03660943|589712779|FG001|Overall Study|Death|2|||
163274061|NCT03660943|589712778|FG000|Overall Study|Lost to Follow-up|7|||
163274062|NCT03660943|589712779|FG001|Overall Study|Lost to Follow-up|3|||
163274063|NCT03660943|589712778|FG000|Overall Study|Protocol Violation|3|||
163274064|NCT03660943|589712779|FG001|Overall Study|Protocol Violation|5|||
163274065|NCT03660943|589712778|FG000|Overall Study|Withdrawal by Subject|8|||
163274066|NCT03660943|589712779|FG001|Overall Study|Withdrawal by Subject|15|||
163274067|NCT03660943|589712778|FG000|Overall Study|Lack of Efficacy|9|||
163274068|NCT03660943|589712779|FG001|Overall Study|Lack of Efficacy|12|||
163274069|NCT03660943|589712778|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
163274070|NCT03660943|589712779|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
163274071|NCT03699124|589712780|FG000|Overall Study|Adverse Event|6|||
163274072|NCT03699124|589712781|FG001|Overall Study|Adverse Event|5|||
163274073|NCT03699124|589712782|FG002|Overall Study|Adverse Event|2|||
163274074|NCT03699124|589712780|FG000|Overall Study|Death|0|||
163274075|NCT03699124|589712781|FG001|Overall Study|Death|2|||
163274076|NCT03699124|589712782|FG002|Overall Study|Death|0|||
163274077|NCT03699124|589712780|FG000|Overall Study|Lost to Follow-up|20|||
163274078|NCT03699124|589712781|FG001|Overall Study|Lost to Follow-up|16|||
163274079|NCT03699124|589712782|FG002|Overall Study|Lost to Follow-up|15|||
163274080|NCT03699124|589712780|FG000|Overall Study|Protocol Violation|1|||
163274081|NCT03699124|589712781|FG001|Overall Study|Protocol Violation|0|||
163274082|NCT03699124|589712782|FG002|Overall Study|Protocol Violation|0|||
163274083|NCT03699124|589712780|FG000|Overall Study|Withdrawal by Subject|13|||
163274084|NCT03699124|589712781|FG001|Overall Study|Withdrawal by Subject|14|||
163274085|NCT03699124|589712782|FG002|Overall Study|Withdrawal by Subject|13|||
163274086|NCT03699124|589712780|FG000|Overall Study|Other reasons|5|||
163274087|NCT03699124|589712781|FG001|Overall Study|Other reasons|3|||
163274088|NCT03699124|589712782|FG002|Overall Study|Other reasons|10|||
163274089|NCT00472186|589712786|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
163274090|NCT00472186|589712787|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
163274091|NCT00724061|589712790|FG000|Dose Escalation Phase|Adverse Event|2|||
163274092|NCT00724061|589712790|FG000|Dose Escalation Phase|Disease Progression|3|||
163274093|NCT01536145|589712793|FG000|Overall Study|Progressive disease|3|||
163274094|NCT01536145|589712794|FG001|Overall Study|Progressive disease|4|||
163274095|NCT01536145|589712795|FG002|Overall Study|Progressive disease|1|||
163274096|NCT01536145|589712796|FG003|Overall Study|Progressive disease|2|||
163274097|NCT01536145|589712797|FG004|Overall Study|Progressive disease|1|||
163274098|NCT01536145|589712798|FG005|Overall Study|Progressive disease|2|||
163274099|NCT01536145|589712799|FG006|Overall Study|Progressive disease|1|||
163274100|NCT01536145|589712800|FG007|Overall Study|Progressive disease|2|||
163274101|NCT01536145|589712801|FG008|Overall Study|Progressive disease|1|||
163274102|NCT01536145|589712802|FG009|Overall Study|Progressive disease|3|||
163274103|NCT01536145|589712803|FG010|Overall Study|Progressive disease|3|||
163274104|NCT01536145|589712793|FG000|Overall Study|Withdrawal by Subject|0|||
163274105|NCT01536145|589712794|FG001|Overall Study|Withdrawal by Subject|0|||
163274106|NCT01536145|589712795|FG002|Overall Study|Withdrawal by Subject|1|||
163274107|NCT01536145|589712796|FG003|Overall Study|Withdrawal by Subject|0|||
163274108|NCT01536145|589712797|FG004|Overall Study|Withdrawal by Subject|0|||
163274109|NCT01536145|589712798|FG005|Overall Study|Withdrawal by Subject|1|||
163274110|NCT01536145|589712799|FG006|Overall Study|Withdrawal by Subject|0|||
163274111|NCT01536145|589712800|FG007|Overall Study|Withdrawal by Subject|0|||
163274112|NCT01536145|589712801|FG008|Overall Study|Withdrawal by Subject|2|||
163274113|NCT01536145|589712802|FG009|Overall Study|Withdrawal by Subject|0|||
163274114|NCT01536145|589712803|FG010|Overall Study|Withdrawal by Subject|2|||
163274115|NCT01536145|589712793|FG000|Overall Study|Other|0|||
163274116|NCT01536145|589712794|FG001|Overall Study|Other|0|||
163274117|NCT01536145|589712795|FG002|Overall Study|Other|0|||
163274118|NCT01536145|589712796|FG003|Overall Study|Other|0|||
163274119|NCT01536145|589712797|FG004|Overall Study|Other|1|||
163274120|NCT01536145|589712798|FG005|Overall Study|Other|0|||
163274121|NCT01536145|589712799|FG006|Overall Study|Other|0|||
163274122|NCT01536145|589712800|FG007|Overall Study|Other|0|||
163274123|NCT01536145|589712801|FG008|Overall Study|Other|0|||
163274124|NCT01536145|589712802|FG009|Overall Study|Other|3|||
163274125|NCT01536145|589712803|FG010|Overall Study|Other|2|||
163274126|NCT01536145|589712793|FG000|Overall Study|Death|0|||
163274127|NCT01536145|589712794|FG001|Overall Study|Death|0|||
163274128|NCT01536145|589712795|FG002|Overall Study|Death|0|||
163274129|NCT01536145|589712796|FG003|Overall Study|Death|0|||
163274130|NCT01536145|589712797|FG004|Overall Study|Death|0|||
163274131|NCT01536145|589712798|FG005|Overall Study|Death|0|||
163274132|NCT01536145|589712799|FG006|Overall Study|Death|1|||
163274133|NCT01536145|589712800|FG007|Overall Study|Death|0|||
163274134|NCT01536145|589712801|FG008|Overall Study|Death|0|||
163274135|NCT01536145|589712802|FG009|Overall Study|Death|0|||
163274136|NCT01536145|589712803|FG010|Overall Study|Death|0|||
163274137|NCT01536145|589712793|FG000|Overall Study|Adverse Event|0|||
163274138|NCT01536145|589712794|FG001|Overall Study|Adverse Event|0|||
163274139|NCT01536145|589712795|FG002|Overall Study|Adverse Event|0|||
163274140|NCT01536145|589712796|FG003|Overall Study|Adverse Event|0|||
163274141|NCT01536145|589712797|FG004|Overall Study|Adverse Event|0|||
163274142|NCT01536145|589712798|FG005|Overall Study|Adverse Event|0|||
163274143|NCT01536145|589712799|FG006|Overall Study|Adverse Event|0|||
163274144|NCT01536145|589712800|FG007|Overall Study|Adverse Event|2|||
163274145|NCT01536145|589712801|FG008|Overall Study|Adverse Event|0|||
163274146|NCT01536145|589712802|FG009|Overall Study|Adverse Event|0|||
163274147|NCT01536145|589712803|FG010|Overall Study|Adverse Event|3|||
163274148|NCT00688259|589712806|FG000|Overall Study|Lost to Follow-up|2|||
163274149|NCT00688259|589712807|FG001|Overall Study|Lost to Follow-up|4|||
163274150|NCT00688259|589712806|FG000|Overall Study|Physician Decision|1|||
163274151|NCT00688259|589712807|FG001|Overall Study|Physician Decision|0|||
163274152|NCT00688259|589712806|FG000|Overall Study|Withdrawal by Subject|2|||
163274153|NCT00688259|589712807|FG001|Overall Study|Withdrawal by Subject|0|||
163274154|NCT00688259|589712806|FG000|Overall Study|Declined Interview|2|||
163274155|NCT00688259|589712807|FG001|Overall Study|Declined Interview|3|||
163274156|NCT00688259|589712806|FG000|Overall Study|Hospitalized at Follow-up|0|||
163274157|NCT00688259|589712807|FG001|Overall Study|Hospitalized at Follow-up|1|||
163274158|NCT03824938|589712808|FG000|Overall Study|Withdrawal by Subject|2|||
163274159|NCT03824938|589712809|FG001|Overall Study|Withdrawal by Subject|1|||
163274160|NCT03824938|589712810|FG002|Overall Study|Withdrawal by Subject|0|||
163274161|NCT03824938|589712811|FG003|Overall Study|Withdrawal by Subject|2|||
163274162|NCT03824938|589712812|FG004|Overall Study|Withdrawal by Subject|0|||
163274163|NCT03824938|589712813|FG005|Overall Study|Withdrawal by Subject|1|||
163274164|NCT03824938|589712808|FG000|Overall Study|Lost to Follow-up|0|||
163274165|NCT03824938|589712809|FG001|Overall Study|Lost to Follow-up|1|||
163274166|NCT03824938|589712810|FG002|Overall Study|Lost to Follow-up|0|||
163274167|NCT03824938|589712811|FG003|Overall Study|Lost to Follow-up|0|||
163274168|NCT03824938|589712812|FG004|Overall Study|Lost to Follow-up|1|||
163274169|NCT03824938|589712813|FG005|Overall Study|Lost to Follow-up|0|||
163274170|NCT00287469|589712814|FG000|Overall Study|serious adverse event|1|||
163274171|NCT00287469|589712815|FG001|Overall Study|serious adverse event|6|||
163274172|NCT00287469|589712814|FG000|Overall Study|Adverse Event|1|||
163274173|NCT00287469|589712815|FG001|Overall Study|Adverse Event|1|||
163274174|NCT00287469|589712814|FG000|Overall Study|moved from area|144|||
163274175|NCT00287469|589712815|FG001|Overall Study|moved from area|138|||
163274176|NCT00287469|589712814|FG000|Overall Study|Lost to Follow-up|74|||
163274177|NCT00287469|589712815|FG001|Overall Study|Lost to Follow-up|69|||
163274178|NCT01058863|589712816|FG000|Overall Study|Lost to Follow-up|1|||
163274179|NCT01058863|589712816|FG000|Overall Study|Withdrawal by Subject|1|||
163274180|NCT01058863|589712816|FG000|Overall Study|Sponsor requested withdrawal|1|||
163274181|NCT01058863|589712816|FG000|Overall Study|Randomized in error|1|||
163274182|NCT03653416|589712817|FG000|Overall Study|Protocol Violation|6|||
163274183|NCT03653416|589712818|FG001|Overall Study|Protocol Violation|1|||
163274184|NCT00776100|589712821|FG000|Overall Study|Disease Progression|1|||
163274185|NCT00776100|589712822|FG001|Overall Study|Disease Progression|0|||
163274186|NCT04759885|589712827|FG000|Overall Study|Other|1|||
163274187|NCT04759885|589712828|FG001|Overall Study|Other|0|||
163274188|NCT04759885|589712829|FG002|Overall Study|Other|2|||
163274189|NCT04759885|589712830|FG003|Overall Study|Other|0|||
163274190|NCT04759885|589712831|FG004|Overall Study|Other|0|||
163274191|NCT04759885|589712827|FG000|Overall Study|Withdrawal by Subject|0|||
163274192|NCT04759885|589712828|FG001|Overall Study|Withdrawal by Subject|0|||
163274193|NCT04759885|589712829|FG002|Overall Study|Withdrawal by Subject|1|||
163274194|NCT04759885|589712830|FG003|Overall Study|Withdrawal by Subject|9|||
163274195|NCT04759885|589712831|FG004|Overall Study|Withdrawal by Subject|6|||
163274196|NCT04759885|589712827|FG000|Overall Study|Adverse Event|0|||
163274197|NCT04759885|589712828|FG001|Overall Study|Adverse Event|0|||
163274198|NCT04759885|589712829|FG002|Overall Study|Adverse Event|0|||
163274199|NCT04759885|589712830|FG003|Overall Study|Adverse Event|3|||
163274200|NCT04759885|589712831|FG004|Overall Study|Adverse Event|0|||
163274201|NCT04759885|589712827|FG000|Overall Study|Physician Decision|0|||
163274202|NCT04759885|589712828|FG001|Overall Study|Physician Decision|0|||
163274203|NCT04759885|589712829|FG002|Overall Study|Physician Decision|0|||
163274204|NCT04759885|589712830|FG003|Overall Study|Physician Decision|2|||
163274205|NCT04759885|589712831|FG004|Overall Study|Physician Decision|0|||
163274206|NCT00195715|589712832|FG000|Overall Study|Adverse Event|122|||
163274207|NCT00195715|589712832|FG000|Overall Study|Withdrawal by Subject|58|||
163274208|NCT00195715|589712832|FG000|Overall Study|Lost to Follow-up|27|||
163274209|NCT00195715|589712832|FG000|Overall Study|Protocol Violation|13|||
163274210|NCT00195715|589712832|FG000|Overall Study|Lack of Efficacy|93|||
163274211|NCT00195715|589712832|FG000|Overall Study|Pregnancy|14|||
163274212|NCT00195715|589712832|FG000|Overall Study|Investigative site closure|8|||
163274213|NCT00195715|589712832|FG000|Overall Study|Subject moved/relocated|7|||
163274214|NCT00195715|589712832|FG000|Overall Study|Subject non-compliance|6|||
163274215|NCT00195715|589712832|FG000|Overall Study|Subject started commercial Humira|5|||
163274216|NCT00195715|589712832|FG000|Overall Study|Subject choice|3|||
163274217|NCT00195715|589712832|FG000|Overall Study|Loss of response/no improvement|3|||
163274218|NCT00195715|589712832|FG000|Overall Study|Sponsor stopped study|1|||
163274219|NCT00195715|589712832|FG000|Overall Study|Administrative reasons|2|||
163274220|NCT00195715|589712832|FG000|Overall Study|Investigator's decision|2|||
163274221|NCT00195715|589712832|FG000|Overall Study|Subject wants to get pregnant|4|||
163274222|NCT00195715|589712832|FG000|Overall Study|Use of prohibited medication|2|||
163274223|NCT00195715|589712832|FG000|Overall Study|Planned surgery|2|||
163274224|NCT00195715|589712832|FG000|Overall Study|Increased infection rate|1|||
163274225|NCT00195715|589712832|FG000|Overall Study|Ineligible|1|||
163274226|NCT00195715|589712832|FG000|Overall Study|Colonic stricture|1|||
163274227|NCT00195715|589712832|FG000|Overall Study|Sponsor discontinued trial|1|||
163274228|NCT00195715|589712832|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
163274229|NCT05822921|589712837|FG000|Overall Study|Lost to Follow-up|1|||
163274230|NCT05822921|589712838|FG001|Overall Study|Lost to Follow-up|1|||
163274231|NCT01267253|589712841|FG000|Overall Study|Ineligible - required test not done|1|||
163274232|NCT01267253|589712841|FG000|Overall Study|Inevaluable-never received study treatme|2|||
163274233|NCT00996580|589712842|FG000|Overall Study|Adverse Event|466|||
163274234|NCT00996580|589712842|FG000|Overall Study|Lost to Follow-up|480|||
163274235|NCT00996580|589712842|FG000|Overall Study|Noncompliance with the protocol|137|||
163274236|NCT00996580|589712842|FG000|Overall Study|Physician Decision|5|||
163274237|NCT00996580|589712842|FG000|Overall Study|Pregnancy|68|||
163274238|NCT00996580|589712842|FG000|Overall Study|Protocol Violation|16|||
163274239|NCT00996580|589712842|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
163274240|NCT00996580|589712842|FG000|Overall Study|Withdrawal by Subject|217|||
163274241|NCT00996580|589712842|FG000|Overall Study|Other|29|||
163274242|NCT00064025|589712843|FG000|Overall Study|Ineligible|4|||
163274243|NCT00064025|589712843|FG000|Overall Study|Inevaluable|3|||
163274244|NCT02468934|589712844|FG000|Overall Study|Withdrawal by Subject|4|||
163274245|NCT02468934|589712844|FG000|Overall Study|Screen Failure|3|||
163274246|NCT02036515|589712849|FG000|Overall Study|Adverse Event|1|||
163274247|NCT02036515|589712850|FG001|Overall Study|Adverse Event|1|||
163274248|NCT02036515|589712851|FG002|Overall Study|Adverse Event|2|||
163274249|NCT02036515|589712849|FG000|Overall Study|Lost to Follow-up|0|||
163274250|NCT02036515|589712850|FG001|Overall Study|Lost to Follow-up|2|||
163274251|NCT02036515|589712851|FG002|Overall Study|Lost to Follow-up|0|||
163274252|NCT02036515|589712849|FG000|Overall Study|Non-compliance with study drug|0|||
163274253|NCT02036515|589712850|FG001|Overall Study|Non-compliance with study drug|0|||
163274254|NCT02036515|589712851|FG002|Overall Study|Non-compliance with study drug|2|||
163274255|NCT02036515|589712849|FG000|Overall Study|Screen failure|0|||
163274256|NCT02036515|589712850|FG001|Overall Study|Screen failure|2|||
163274257|NCT02036515|589712851|FG002|Overall Study|Screen failure|0|||
163274258|NCT02036515|589712849|FG000|Overall Study|Withdrawal by Subject|4|||
163274259|NCT02036515|589712850|FG001|Overall Study|Withdrawal by Subject|7|||
163274260|NCT02036515|589712851|FG002|Overall Study|Withdrawal by Subject|9|||
163274261|NCT02036515|589712849|FG000|Overall Study|Hyperglycemia|0|||
163274262|NCT02036515|589712850|FG001|Overall Study|Hyperglycemia|0|||
163274263|NCT02036515|589712851|FG002|Overall Study|Hyperglycemia|1|||
163274264|NCT02218489|589712858|FG000|Overall Study|Withdrawal by Subject|4|||
163274265|NCT02218489|589712859|FG001|Overall Study|Withdrawal by Subject|3|||
163274266|NCT02218489|589712858|FG000|Overall Study|Lost to Follow-up|1|||
163274267|NCT02218489|589712859|FG001|Overall Study|Lost to Follow-up|0|||
163274268|NCT00547911|589712860|FG000|Overall Study|Adverse Event|0|||
163274269|NCT00547911|589712861|FG001|Overall Study|Adverse Event|0|||
163274270|NCT00547911|589712862|FG002|Overall Study|Adverse Event|0|||
163274271|NCT00547911|589712863|FG003|Overall Study|Adverse Event|1|||
163274272|NCT00547911|589712864|FG004|Overall Study|Adverse Event|0|||
163274273|NCT00547911|589712865|FG005|Overall Study|Adverse Event|0|||
163274274|NCT02133924|589712866|FG000|Overall Study|Death|38|||
163274275|NCT02133924|589712866|FG000|Overall Study|Physician Decision|1|||
163274276|NCT02133924|589712866|FG000|Overall Study|Withdrawal by Subject|3|||
163274277|NCT01644474|589712868|FG000|Overall Study|Poor compliance to protocol|1|||
163274278|NCT01644474|589712869|FG001|Overall Study|Poor compliance to protocol|0|||
163274279|NCT01644474|589712868|FG000|Overall Study|Consent withdrawn by participant|0|||
163274280|NCT01644474|589712869|FG001|Overall Study|Consent withdrawn by participant|1|||
163274281|NCT01644474|589712868|FG000|Overall Study|Participant moved|0|||
163274282|NCT01644474|589712869|FG001|Overall Study|Participant moved|1|||
163274283|NCT01644474|589712868|FG000|Overall Study|Adverse Event|4|||
163274284|NCT01644474|589712869|FG001|Overall Study|Adverse Event|5|||
163274285|NCT01644474|589712868|FG000|Overall Study|Site scheduling error|1|||
163274286|NCT01644474|589712869|FG001|Overall Study|Site scheduling error|1|||
163274287|NCT01644474|589712868|FG000|Overall Study|Protocol Violation|1|||
163274288|NCT01644474|589712869|FG001|Overall Study|Protocol Violation|0|||
163274289|NCT04039503|589712875|FG000|Overall Study|Adverse Event|3|||
163274290|NCT04039503|589712876|FG001|Overall Study|Adverse Event|0|||
163274291|NCT04039503|589712877|FG002|Overall Study|Adverse Event|2|||
163274292|NCT04039503|589712878|FG003|Overall Study|Adverse Event|0|||
163274293|NCT04039503|589712875|FG000|Overall Study|Lost to Follow-up|0|||
163274294|NCT04039503|589712876|FG001|Overall Study|Lost to Follow-up|0|||
163274295|NCT04039503|589712877|FG002|Overall Study|Lost to Follow-up|1|||
163274296|NCT04039503|589712878|FG003|Overall Study|Lost to Follow-up|0|||
163274297|NCT04039503|589712875|FG000|Overall Study|Protocol Violation|0|||
163274298|NCT04039503|589712876|FG001|Overall Study|Protocol Violation|1|||
163274299|NCT04039503|589712877|FG002|Overall Study|Protocol Violation|2|||
163274300|NCT04039503|589712878|FG003|Overall Study|Protocol Violation|1|||
163274301|NCT04039503|589712875|FG000|Overall Study|Withdrawal by Subject|4|||
163274302|NCT04039503|589712876|FG001|Overall Study|Withdrawal by Subject|3|||
163274303|NCT04039503|589712877|FG002|Overall Study|Withdrawal by Subject|5|||
163274304|NCT04039503|589712878|FG003|Overall Study|Withdrawal by Subject|2|||
163274305|NCT01163747|589712879|FG000|Overall Study|Adverse Event|0|||
163274306|NCT01163747|589712880|FG001|Overall Study|Adverse Event|5|||
163274307|NCT01163747|589712879|FG000|Overall Study|Insufficient Therapeutic Response|0|||
163274308|NCT01163747|589712880|FG001|Overall Study|Insufficient Therapeutic Response|1|||
163274309|NCT01163747|589712879|FG000|Overall Study|Protocol Violation|0|||
163274310|NCT01163747|589712880|FG001|Overall Study|Protocol Violation|1|||
163274311|NCT01163747|589712879|FG000|Overall Study|Refused Treatment|6|||
163274312|NCT01163747|589712880|FG001|Overall Study|Refused Treatment|4|||
163274313|NCT02044458|589712881|FG000|Overall Study|Protocol Violation|3|||
163274314|NCT02044458|589712882|FG001|Overall Study|Protocol Violation|8|||
163274315|NCT02601937|589712884|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
163274316|NCT02601937|589712885|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
163274317|NCT02601937|589712886|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
163274318|NCT02601937|589712887|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
163274319|NCT02601937|589712888|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
163274320|NCT02601937|589712889|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
163274321|NCT02601937|589712890|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
163274322|NCT02601937|589712891|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
163274323|NCT02601937|589712892|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
163274324|NCT02601937|589712893|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
163274325|NCT02601937|589712894|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
163274326|NCT02601937|589712884|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
163274327|NCT02601937|589712885|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163274328|NCT02601937|589712886|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163274329|NCT02601937|589712887|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163274330|NCT02601937|589712888|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163274331|NCT02601937|589712889|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163274332|NCT02601937|589712890|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
163274333|NCT02601937|589712891|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163274334|NCT02601937|589712892|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163274335|NCT02601937|589712893|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163274336|NCT02601937|589712894|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163274337|NCT02601937|589712884|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163274338|NCT02601937|589712885|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163274339|NCT02601937|589712886|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
163274340|NCT02601937|589712887|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163274341|NCT02601937|589712888|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163274342|NCT02601937|589712889|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163274343|NCT02601937|589712890|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163274344|NCT02601937|589712891|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163274345|NCT02601937|589712892|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163274346|NCT02601937|589712893|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163274347|NCT02601937|589712894|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163274348|NCT02601937|589712884|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
163274349|NCT02601937|589712885|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
163274350|NCT02601937|589712886|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
163274351|NCT02601937|589712887|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
163274352|NCT02601937|589712888|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
163274353|NCT02601937|589712889|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
163274354|NCT02601937|589712890|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
163274355|NCT02601937|589712891|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
163274356|NCT02601937|589712892|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
163274357|NCT02601937|589712893|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
163274358|NCT02601937|589712894|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
163274359|NCT02601937|589712884|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163274360|NCT02601937|589712885|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163274361|NCT02601937|589712886|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163274362|NCT02601937|589712887|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163274363|NCT02601937|589712888|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163274364|NCT02601937|589712889|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163274365|NCT02601937|589712890|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163274366|NCT02601937|589712891|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163274367|NCT02601937|589712892|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163385770|NCT00146328|590123239|FG000|Overall Study|Trial ended/site closed|8|||
163385771|NCT00146328|590123240|FG001|Overall Study|Trial ended/site closed|2|||
163274368|NCT02601937|589712893|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
163274369|NCT02601937|589712894|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163274370|NCT02601937|589712884|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163274371|NCT02601937|589712885|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163274372|NCT02601937|589712886|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163274373|NCT02601937|589712887|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163274374|NCT02601937|589712888|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163274375|NCT02601937|589712889|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163274376|NCT02601937|589712890|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163274377|NCT02601937|589712891|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
163274378|NCT02601937|589712892|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163274379|NCT02601937|589712893|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163274380|NCT02601937|589712894|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163274381|NCT02601937|589712884|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163274382|NCT02601937|589712885|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163274383|NCT02601937|589712886|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163274384|NCT02601937|589712887|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163274385|NCT02601937|589712888|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163274386|NCT02601937|589712889|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163274387|NCT02601937|589712890|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163274388|NCT02601937|589712891|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163274389|NCT02601937|589712892|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163274390|NCT02601937|589712893|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
163274391|NCT02601937|589712894|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
163274392|NCT02601937|589712884|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
163274393|NCT02601937|589712885|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
163274394|NCT02601937|589712886|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
163274395|NCT02601937|589712887|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
163274396|NCT02601937|589712888|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
163274397|NCT02601937|589712889|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
163274398|NCT02601937|589712890|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
163274399|NCT02601937|589712891|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
163274400|NCT02601937|589712892|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
163274401|NCT02601937|589712893|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
163274402|NCT02601937|589712894|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
163274403|NCT02601937|589712884|FG000|Period 2: Dose Expansion Cohort|Other|0|||
163274404|NCT02601937|589712885|FG001|Period 2: Dose Expansion Cohort|Other|0|||
163274405|NCT02601937|589712886|FG002|Period 2: Dose Expansion Cohort|Other|0|||
163274406|NCT02601937|589712887|FG003|Period 2: Dose Expansion Cohort|Other|0|||
163274407|NCT02601937|589712888|FG004|Period 2: Dose Expansion Cohort|Other|0|||
163274408|NCT02601937|589712889|FG005|Period 2: Dose Expansion Cohort|Other|0|||
163274409|NCT02601937|589712890|FG006|Period 2: Dose Expansion Cohort|Other|0|||
163274410|NCT02601937|589712891|FG007|Period 2: Dose Expansion Cohort|Other|0|||
163274411|NCT02601937|589712892|FG008|Period 2: Dose Expansion Cohort|Other|2|||
163274412|NCT02601937|589712893|FG009|Period 2: Dose Expansion Cohort|Other|2|||
163274413|NCT02601937|589712894|FG010|Period 2: Dose Expansion Cohort|Other|0|||
163274414|NCT02601937|589712884|FG000|Period 2: Dose Expansion Cohort|Death|0|||
163274415|NCT02601937|589712885|FG001|Period 2: Dose Expansion Cohort|Death|0|||
163274416|NCT02601937|589712886|FG002|Period 2: Dose Expansion Cohort|Death|0|||
163274417|NCT02601937|589712887|FG003|Period 2: Dose Expansion Cohort|Death|0|||
163274418|NCT02601937|589712888|FG004|Period 2: Dose Expansion Cohort|Death|0|||
163274419|NCT02601937|589712889|FG005|Period 2: Dose Expansion Cohort|Death|0|||
163274420|NCT02601937|589712890|FG006|Period 2: Dose Expansion Cohort|Death|0|||
163274421|NCT02601937|589712891|FG007|Period 2: Dose Expansion Cohort|Death|0|||
163274422|NCT02601937|589712892|FG008|Period 2: Dose Expansion Cohort|Death|1|||
163274423|NCT02601937|589712893|FG009|Period 2: Dose Expansion Cohort|Death|0|||
163274424|NCT02601937|589712894|FG010|Period 2: Dose Expansion Cohort|Death|0|||
163274425|NCT04145349|589714678|FG000|Overall Study|Withdrawal by Subject|3|||
163274426|NCT04145349|589714679|FG001|Overall Study|Withdrawal by Subject|0|||
163274427|NCT04145349|589714678|FG000|Overall Study|Lost to Follow-up|0|||
163274428|NCT04145349|589714679|FG001|Overall Study|Lost to Follow-up|1|||
163274429|NCT04145349|589714678|FG000|Overall Study|On study treatment (Ongoing)|0|||
163274430|NCT04145349|589714679|FG001|Overall Study|On study treatment (Ongoing)|1|||
163274431|NCT05567952|589714680|FG000|Overall Study|Lost to Follow-up|3|||
163274432|NCT05567952|589714681|FG001|Overall Study|Lost to Follow-up|2|||
163274433|NCT05567952|589714680|FG000|Overall Study|Withdrawal by Subject|6|||
163274434|NCT05567952|589714681|FG001|Overall Study|Withdrawal by Subject|3|||
163274435|NCT05567952|589714680|FG000|Overall Study|Other|3|||
163274436|NCT05567952|589714681|FG001|Overall Study|Other|1|||
163274437|NCT03280563|589714683|FG000|Stage 1|Death|2|||
163274438|NCT03280563|589714684|FG001|Stage 1|Death|1|||
163274439|NCT03280563|589714685|FG002|Stage 1|Death|0|||
163274440|NCT03280563|589714686|FG003|Stage 1|Death|0|||
163274441|NCT03280563|589714687|FG004|Stage 1|Death|0|||
163274442|NCT03280563|589714688|FG005|Stage 1|Death|3|||
163274443|NCT03280563|589714689|FG006|Stage 1|Death|0|||
163274444|NCT03280563|589714690|FG007|Stage 1|Death|0|||
163274445|NCT03280563|589714691|FG008|Stage 1|Death|0|||
163274446|NCT03280563|589714683|FG000|Stage 1|Study Ended by Sponsor|0|||
163274447|NCT03280563|589714684|FG001|Stage 1|Study Ended by Sponsor|0|||
163274448|NCT03280563|589714685|FG002|Stage 1|Study Ended by Sponsor|1|||
163274449|NCT03280563|589714686|FG003|Stage 1|Study Ended by Sponsor|0|||
163274450|NCT03280563|589714687|FG004|Stage 1|Study Ended by Sponsor|0|||
163274451|NCT03280563|589714688|FG005|Stage 1|Study Ended by Sponsor|1|||
163274452|NCT03280563|589714689|FG006|Stage 1|Study Ended by Sponsor|0|||
163274453|NCT03280563|589714690|FG007|Stage 1|Study Ended by Sponsor|0|||
163274454|NCT03280563|589714691|FG008|Stage 1|Study Ended by Sponsor|0|||
163274455|NCT03280563|589714683|FG000|Stage 1|Withdrawal by Subject|5|||
163274456|NCT03280563|589714684|FG001|Stage 1|Withdrawal by Subject|1|||
163274457|NCT03280563|589714685|FG002|Stage 1|Withdrawal by Subject|2|||
163274458|NCT03280563|589714686|FG003|Stage 1|Withdrawal by Subject|0|||
163274459|NCT03280563|589714687|FG004|Stage 1|Withdrawal by Subject|0|||
163274460|NCT03280563|589714688|FG005|Stage 1|Withdrawal by Subject|2|||
163274461|NCT03280563|589714689|FG006|Stage 1|Withdrawal by Subject|0|||
163274462|NCT03280563|589714690|FG007|Stage 1|Withdrawal by Subject|0|||
163274463|NCT03280563|589714691|FG008|Stage 1|Withdrawal by Subject|0|||
163274464|NCT03280563|589714683|FG000|Stage 1|Reason Not Specified|0|||
163274465|NCT03280563|589714684|FG001|Stage 1|Reason Not Specified|0|||
163274466|NCT03280563|589714685|FG002|Stage 1|Reason Not Specified|0|||
163274467|NCT03280563|589714686|FG003|Stage 1|Reason Not Specified|0|||
163274468|NCT03280563|589714687|FG004|Stage 1|Reason Not Specified|0|||
163274469|NCT03280563|589714688|FG005|Stage 1|Reason Not Specified|1|||
163274470|NCT03280563|589714689|FG006|Stage 1|Reason Not Specified|0|||
163274471|NCT03280563|589714690|FG007|Stage 1|Reason Not Specified|0|||
163274472|NCT03280563|589714691|FG008|Stage 1|Reason Not Specified|0|||
163274473|NCT03280563|589714683|FG000|Stage 1|Physician Decision|0|||
163274474|NCT03280563|589714684|FG001|Stage 1|Physician Decision|1|||
163274475|NCT03280563|589714685|FG002|Stage 1|Physician Decision|0|||
163274476|NCT03280563|589714686|FG003|Stage 1|Physician Decision|0|||
163274477|NCT03280563|589714687|FG004|Stage 1|Physician Decision|0|||
163274478|NCT03280563|589714688|FG005|Stage 1|Physician Decision|0|||
163274479|NCT03280563|589714689|FG006|Stage 1|Physician Decision|0|||
163274480|NCT03280563|589714690|FG007|Stage 1|Physician Decision|0|||
163274481|NCT03280563|589714691|FG008|Stage 1|Physician Decision|0|||
163274482|NCT03280563|589714683|FG000|Stage 2|Death|0|||
163274483|NCT03280563|589714684|FG001|Stage 2|Death|0|||
163274484|NCT03280563|589714685|FG002|Stage 2|Death|0|||
163274485|NCT03280563|589714686|FG003|Stage 2|Death|0|||
163274486|NCT03280563|589714687|FG004|Stage 2|Death|0|||
163274487|NCT03280563|589714688|FG005|Stage 2|Death|0|||
163274488|NCT03280563|589714689|FG006|Stage 2|Death|0|||
163274489|NCT03280563|589714690|FG007|Stage 2|Death|1|||
163274490|NCT03280563|589714691|FG008|Stage 2|Death|0|||
163274491|NCT03280563|589714683|FG000|Stage 2|Progressive Disease|0|||
163274492|NCT03280563|589714684|FG001|Stage 2|Progressive Disease|0|||
163274493|NCT03280563|589714685|FG002|Stage 2|Progressive Disease|0|||
163274494|NCT03280563|589714686|FG003|Stage 2|Progressive Disease|0|||
163274495|NCT03280563|589714687|FG004|Stage 2|Progressive Disease|0|||
163274496|NCT03280563|589714688|FG005|Stage 2|Progressive Disease|0|||
163274497|NCT03280563|589714689|FG006|Stage 2|Progressive Disease|2|||
163274498|NCT03280563|589714690|FG007|Stage 2|Progressive Disease|0|||
163274499|NCT03280563|589714691|FG008|Stage 2|Progressive Disease|0|||
163274500|NCT03280563|589714683|FG000|Long-term Survival Follow-up|Death|10|||
163274501|NCT03280563|589714684|FG001|Long-term Survival Follow-up|Death|14|||
163274502|NCT03280563|589714685|FG002|Long-term Survival Follow-up|Death|15|||
163274503|NCT03280563|589714686|FG003|Long-term Survival Follow-up|Death|3|||
163274504|NCT03280563|589714687|FG004|Long-term Survival Follow-up|Death|6|||
163274505|NCT03280563|589714688|FG005|Long-term Survival Follow-up|Death|18|||
163274506|NCT03280563|589714689|FG006|Long-term Survival Follow-up|Death|11|||
163274507|NCT03280563|589714690|FG007|Long-term Survival Follow-up|Death|1|||
163274508|NCT03280563|589714691|FG008|Long-term Survival Follow-up|Death|3|||
163274509|NCT03280563|589714683|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
163274510|NCT03280563|589714684|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
163274511|NCT03280563|589714685|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
163274512|NCT03280563|589714686|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
163274513|NCT03280563|589714687|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
163274514|NCT03280563|589714688|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
163274515|NCT03280563|589714689|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
163274516|NCT03280563|589714690|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
163274517|NCT03280563|589714691|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
163274518|NCT03280563|589714683|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
163274519|NCT03280563|589714684|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
163274520|NCT03280563|589714685|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
163274521|NCT03280563|589714686|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
163274522|NCT03280563|589714687|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
163274523|NCT03280563|589714688|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
163274524|NCT03280563|589714689|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
163274525|NCT03280563|589714690|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
163274526|NCT03280563|589714691|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
163274527|NCT03280563|589714683|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
163274528|NCT03280563|589714684|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
163274529|NCT03280563|589714685|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
163274530|NCT03280563|589714686|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
163274531|NCT03280563|589714687|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
163274532|NCT03280563|589714688|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
163274533|NCT03280563|589714689|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
163274534|NCT03280563|589714690|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
163274535|NCT03280563|589714691|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
163274536|NCT03038672|589714692|FG000|Initial Treatment|Unacceptable chemistry|0|||
163274537|NCT03038672|589714693|FG001|Initial Treatment|Unacceptable chemistry|1|||
163274538|NCT03038672|589714692|FG000|Initial Treatment|Progression prior to treatment|1|||
163274539|NCT03038672|589714693|FG001|Initial Treatment|Progression prior to treatment|0|||
163274540|NCT03038672|589714692|FG000|Initial Treatment|No treatment per protocol|1|||
163274541|NCT03038672|589714693|FG001|Initial Treatment|No treatment per protocol|0|||
163274542|NCT04423393|589714694|FG000|Overall Study|Withdrawal by Subject|0|||
163274543|NCT04423393|589714695|FG001|Overall Study|Withdrawal by Subject|0|||
163274544|NCT04423393|589714696|FG002|Overall Study|Withdrawal by Subject|0|||
163274545|NCT04423393|589714697|FG003|Overall Study|Withdrawal by Subject|0|||
163274546|NCT04423393|589714698|FG004|Overall Study|Withdrawal by Subject|0|||
163274547|NCT04423393|589714699|FG005|Overall Study|Withdrawal by Subject|1|||
163274548|NCT04423393|589714700|FG006|Overall Study|Withdrawal by Subject|0|||
163274549|NCT04423393|589714701|FG007|Overall Study|Withdrawal by Subject|0|||
163274550|NCT04423393|589714702|FG008|Overall Study|Withdrawal by Subject|0|||
163274551|NCT04423393|589714703|FG009|Overall Study|Withdrawal by Subject|0|||
163274552|NCT04423393|589714704|FG010|Overall Study|Withdrawal by Subject|0|||
163274553|NCT04423393|589714705|FG011|Overall Study|Withdrawal by Subject|0|||
163274554|NCT04423393|589714706|FG012|Overall Study|Withdrawal by Subject|0|||
163274555|NCT04423393|589714707|FG013|Overall Study|Withdrawal by Subject|1|||
163274556|NCT04423393|589714708|FG014|Overall Study|Withdrawal by Subject|0|||
163274557|NCT04423393|589714709|FG015|Overall Study|Withdrawal by Subject|0|||
163274558|NCT04423393|589714710|FG016|Overall Study|Withdrawal by Subject|0|||
163274559|NCT04423393|589714711|FG017|Overall Study|Withdrawal by Subject|0|||
163274560|NCT04423393|589714694|FG000|Overall Study|Sponsor Decision|0|||
163274561|NCT04423393|589714695|FG001|Overall Study|Sponsor Decision|0|||
163274562|NCT04423393|589714696|FG002|Overall Study|Sponsor Decision|0|||
163274563|NCT04423393|589714697|FG003|Overall Study|Sponsor Decision|0|||
163274564|NCT04423393|589714698|FG004|Overall Study|Sponsor Decision|0|||
163274565|NCT04423393|589714699|FG005|Overall Study|Sponsor Decision|0|||
163274566|NCT04423393|589714700|FG006|Overall Study|Sponsor Decision|0|||
163274567|NCT04423393|589714701|FG007|Overall Study|Sponsor Decision|0|||
163274568|NCT04423393|589714702|FG008|Overall Study|Sponsor Decision|0|||
163274569|NCT04423393|589714703|FG009|Overall Study|Sponsor Decision|0|||
163274570|NCT04423393|589714704|FG010|Overall Study|Sponsor Decision|0|||
163274571|NCT04423393|589714705|FG011|Overall Study|Sponsor Decision|0|||
163274572|NCT04423393|589714706|FG012|Overall Study|Sponsor Decision|0|||
163274573|NCT04423393|589714707|FG013|Overall Study|Sponsor Decision|1|||
163274574|NCT04423393|589714708|FG014|Overall Study|Sponsor Decision|0|||
163274575|NCT04423393|589714709|FG015|Overall Study|Sponsor Decision|0|||
163274576|NCT04423393|589714710|FG016|Overall Study|Sponsor Decision|0|||
163274577|NCT04423393|589714711|FG017|Overall Study|Sponsor Decision|0|||
163274578|NCT00432159|589714712|FG000|Overall Study|Death|0|||
163274579|NCT00432159|589714713|FG001|Overall Study|Death|1|||
163274580|NCT00432159|589714714|FG002|Overall Study|Death|0|||
163274581|NCT00432159|589714715|FG003|Overall Study|Death|0|||
163274582|NCT00432159|589714716|FG004|Overall Study|Death|0|||
163274583|NCT00432159|589714712|FG000|Overall Study|Failure|9|||
163274584|NCT00432159|589714713|FG001|Overall Study|Failure|5|||
163274585|NCT00432159|589714714|FG002|Overall Study|Failure|3|||
163274586|NCT00432159|589714715|FG003|Overall Study|Failure|2|||
163274587|NCT00432159|589714716|FG004|Overall Study|Failure|3|||
163274588|NCT00432159|589714712|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
163274589|NCT00432159|589714713|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
163274590|NCT00432159|589714714|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
163274591|NCT00432159|589714715|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
163274592|NCT00432159|589714716|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
163274593|NCT01929993|589714718|FG000|Overall Study|Protocol Violation|4|||
163042784|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
163042785|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
163042786|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
163042787|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
163042788|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
163042789|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
163042790|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
163042791|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
163042792|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
163042793|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
163042794|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
163042795|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
163042796|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
163042797|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
163042798|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
163042799|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
163042800|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
163042801|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
163042802|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
163042803|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
163042804|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
163042805|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
163042806|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
163042807|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
163042808|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
163042809|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
163042810|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
163042811|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
163042812|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
163042813|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
163058555|NCT00042289|588924242|FG007|Overall Study|Site closed|0|||
163058556|NCT00042289|588924243|FG008|Overall Study|Site closed|0|||
163058557|NCT00042289|588924244|FG009|Overall Study|Site closed|0|||
163058558|NCT00042289|588924245|FG010|Overall Study|Site closed|0|||
163058559|NCT00042289|588924246|FG011|Overall Study|Site closed|0|||
163058560|NCT00042289|588924247|FG012|Overall Study|Site closed|0|||
163058561|NCT00042289|588924248|FG013|Overall Study|Site closed|0|||
163058562|NCT00042289|588924249|FG014|Overall Study|Site closed|0|||
163058563|NCT00042289|588924250|FG015|Overall Study|Site closed|0|||
163058564|NCT00042289|588924251|FG016|Overall Study|Site closed|0|||
163058565|NCT00042289|588924252|FG017|Overall Study|Site closed|0|||
163058566|NCT00042289|588924253|FG018|Overall Study|Site closed|0|||
163058567|NCT00042289|588924254|FG019|Overall Study|Site closed|0|||
163058568|NCT00042289|588924255|FG020|Overall Study|Site closed|0|||
163058569|NCT00042289|588924256|FG021|Overall Study|Site closed|0|||
163058570|NCT00042289|588924257|FG022|Overall Study|Site closed|0|||
163058571|NCT00042289|588924258|FG023|Overall Study|Site closed|0|||
163058572|NCT00042289|588924259|FG024|Overall Study|Site closed|0|||
163058573|NCT00042289|588924260|FG025|Overall Study|Site closed|0|||
163058574|NCT00042289|588924261|FG026|Overall Study|Site closed|0|||
163058575|NCT00042289|588924262|FG027|Overall Study|Site closed|0|||
163058576|NCT00042289|588924263|FG028|Overall Study|Site closed|0|||
163058577|NCT00042289|588924264|FG029|Overall Study|Site closed|0|||
163058578|NCT00042289|588924265|FG030|Overall Study|Site closed|0|||
163058579|NCT00042289|588924266|FG031|Overall Study|Site closed|3|||
163058580|NCT00042289|588924267|FG032|Overall Study|Site closed|0|||
163058581|NCT00042289|588924268|FG033|Overall Study|Site closed|0|||
163058582|NCT00042289|588924269|FG034|Overall Study|Site closed|0|||
163058583|NCT00042289|588924270|FG035|Overall Study|Site closed|0|||
163058584|NCT00042289|588924271|FG036|Overall Study|Site closed|1|||
163058585|NCT00042289|588924272|FG037|Overall Study|Site closed|0|||
163058586|NCT00042289|588924273|FG038|Overall Study|Site closed|0|||
163058587|NCT00042289|588924274|FG039|Overall Study|Site closed|0|||
163058588|NCT00042289|588924275|FG040|Overall Study|Site closed|0|||
163058589|NCT00042289|588924276|FG041|Overall Study|Site closed|0|||
163058590|NCT00042289|588924277|FG042|Overall Study|Site closed|1|||
163058591|NCT00042289|588924278|FG043|Overall Study|Site closed|0|||
163058592|NCT00042289|588924279|FG044|Overall Study|Site closed|0|||
163058593|NCT00042289|588924280|FG045|Overall Study|Site closed|0|||
163058594|NCT00042289|588924281|FG046|Overall Study|Site closed|0|||
163058595|NCT00042289|588924235|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
163058596|NCT00042289|588924236|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
163274594|NCT01929993|589714719|FG001|Overall Study|Protocol Violation|6|||
163161091|NCT00337675|589304070|FG000|Overall Study|Progressive Disease|0|||
163161092|NCT00337675|589304071|FG001|Overall Study|Progressive Disease|2|||
163161093|NCT00337675|589304072|FG002|Overall Study|Progressive Disease|0|||
163161094|NCT00337675|589304070|FG000|Overall Study|Trial Terminated|0|||
163161095|NCT00337675|589304071|FG001|Overall Study|Trial Terminated|0|||
163161096|NCT00337675|589304072|FG002|Overall Study|Trial Terminated|2|||
163161097|NCT02015637|589304073|FG000|Overall Study|Lost to Follow-up|3|||
163161098|NCT02015637|589304074|FG001|Overall Study|Lost to Follow-up|5|||
163161099|NCT02015637|589304073|FG000|Overall Study|Adverse Event|3|||
163161100|NCT02015637|589304074|FG001|Overall Study|Adverse Event|0|||
163161101|NCT02015637|589304073|FG000|Overall Study|Did not take study drug|2|||
163161102|NCT02015637|589304074|FG001|Overall Study|Did not take study drug|0|||
163161103|NCT01317277|589304079|FG000|Overall Study|Lost to Follow-up|3|||
163274595|NCT01929993|589714718|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
163274596|NCT01929993|589714719|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
163274597|NCT00107380|589714720|FG000|Overall Study|Adverse Event|7|||
163274598|NCT00107380|589714720|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
163274599|NCT00107380|589714720|FG000|Overall Study|Progression/relapse|4|||
163274600|NCT00107380|589714720|FG000|Overall Study|Death|3|||
163274601|NCT00107380|589714720|FG000|Overall Study|Other - not protocol specified|7|||
163274602|NCT00107380|589714720|FG000|Overall Study|Ineligible|2|||
163274603|NCT03673098|589714721|FG000|Overall Study|Lost to Follow-up|2|||
163274604|NCT03673098|589714722|FG001|Overall Study|Lost to Follow-up|3|||
163274605|NCT03673098|589714721|FG000|Overall Study|Withdrawal by Subject|6|||
163274606|NCT03673098|589714722|FG001|Overall Study|Withdrawal by Subject|1|||
163274607|NCT03673098|589714721|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
163274608|NCT03673098|589714722|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
163274609|NCT03850444|589714723|FG000|Overall Study|Adverse Event|16|||
163274610|NCT03850444|589714724|FG001|Overall Study|Adverse Event|10|||
163274611|NCT03850444|589714723|FG000|Overall Study|Death|87|||
163274612|NCT03850444|589714724|FG001|Overall Study|Death|107|||
163274613|NCT03850444|589714723|FG000|Overall Study|Lost to Follow-up|1|||
163274614|NCT03850444|589714724|FG001|Overall Study|Lost to Follow-up|1|||
163274615|NCT03850444|589714723|FG000|Overall Study|Withdrawal by Subject|1|||
163274616|NCT03850444|589714724|FG001|Overall Study|Withdrawal by Subject|5|||
163274617|NCT03850444|589714723|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
163274618|NCT03850444|589714724|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
163274619|NCT03595683|589714725|FG000|Overall Study|Adverse Event|1|||
163274620|NCT03595683|589714726|FG001|Overall Study|Adverse Event|0|||
163274621|NCT03595683|589714725|FG000|Overall Study|Pursue alternative therapy|1|||
163274622|NCT03595683|589714726|FG001|Overall Study|Pursue alternative therapy|1|||
163274623|NCT03595683|589714725|FG000|Overall Study|Progressive disease|1|||
163274624|NCT03595683|589714726|FG001|Overall Study|Progressive disease|3|||
163274625|NCT01021878|589714727|FG000|Overall Study|Lost to Follow-up|4|||
163274626|NCT01021878|589714728|FG001|Overall Study|Lost to Follow-up|3|||
163274627|NCT01021878|589714727|FG000|Overall Study|Death|0|||
163274628|NCT01021878|589714728|FG001|Overall Study|Death|1|||
163274629|NCT01021878|589714727|FG000|Overall Study|Adverse Event|6|||
163274630|NCT01021878|589714728|FG001|Overall Study|Adverse Event|5|||
163274631|NCT01021878|589714727|FG000|Overall Study|Transplantation|6|||
163274632|NCT01021878|589714728|FG001|Overall Study|Transplantation|1|||
163274633|NCT03158948|589714730|FG000|Overall Study|Death|1|||
163274634|NCT03158948|589714731|FG001|Overall Study|Death|1|||
163274635|NCT03158948|589714732|FG002|Overall Study|Death|3|||
163274636|NCT03158948|589714733|FG003|Overall Study|Death|2|||
163274637|NCT03158948|589714730|FG000|Overall Study|Physician Decision|0|||
163274638|NCT03158948|589714731|FG001|Overall Study|Physician Decision|0|||
163274639|NCT03158948|589714732|FG002|Overall Study|Physician Decision|0|||
163274640|NCT03158948|589714733|FG003|Overall Study|Physician Decision|1|||
163274641|NCT05876351|589714734|FG000|Overall Study|Other than specified|2|||
163274642|NCT05876351|589714734|FG000|Overall Study|Study specific discontinuation criteria|1|||
163274643|NCT00997243|589714735|FG000|Overall Study|Early termination of study by sponsor|7|||
163274644|NCT03415022|589714738|FG000|Overall Study|Withdrawal by Subject|1|||
163274645|NCT03415022|589714739|FG001|Overall Study|Withdrawal by Subject|2|||
163274646|NCT03415022|589714738|FG000|Overall Study|COVID-19 Suspension|2|||
163274647|NCT03415022|589714739|FG001|Overall Study|COVID-19 Suspension|3|||
163274648|NCT03415022|589714738|FG000|Overall Study|Lost to Follow-up|2|||
163274649|NCT03415022|589714739|FG001|Overall Study|Lost to Follow-up|0|||
163274650|NCT02086552|589714742|FG000|Overall Study|Withdrawal by Subject|1|||
163274651|NCT02206152|589714743|FG000|Pre-Randomization|Withdrawal by Subject|2|||
163274652|NCT00478608|589714744|FG000|Overall Study|Adverse Event|1|||
163274653|NCT00478608|589714744|FG000|Overall Study|Serious Adverse Event|14|||
163274654|NCT00478608|589714744|FG000|Overall Study|Withdrawal by Subject|2|||
163274655|NCT00478608|589714744|FG000|Overall Study|Protocol Violation|3|||
163274656|NCT01349907|589714745|FG000|Overall Study|Adverse Event|37|||
163274657|NCT01349907|589714746|FG001|Overall Study|Adverse Event|11|||
163274658|NCT01349907|589714745|FG000|Overall Study|Treatment failure|13|||
163274659|NCT01349907|589714746|FG001|Overall Study|Treatment failure|4|||
163274660|NCT01349907|589714745|FG000|Overall Study|Lost to Follow-up|25|||
163274661|NCT01349907|589714746|FG001|Overall Study|Lost to Follow-up|6|||
163274662|NCT01349907|589714745|FG000|Overall Study|Withdrawal by Subject|30|||
163274663|NCT01349907|589714746|FG001|Overall Study|Withdrawal by Subject|8|||
163274664|NCT01349907|589714745|FG000|Overall Study|Protocol Violation|33|||
163274665|NCT01349907|589714746|FG001|Overall Study|Protocol Violation|13|||
163274666|NCT01349907|589714745|FG000|Overall Study|Administrative|1|||
163274667|NCT01349907|589714746|FG001|Overall Study|Administrative|1|||
163274668|NCT03583541|589714754|FG000|Overall Study|Lost to Follow-up|31|||
163274669|NCT03583541|589714755|FG001|Overall Study|Lost to Follow-up|65|||
163274670|NCT00884286|589714756|FG000|Overall Study|Progressive disease|21|||
163274671|NCT00884286|589714757|FG001|Overall Study|Progressive disease|28|||
163274672|NCT00884286|589714756|FG000|Overall Study|Toxicity|4|||
163274673|NCT00884286|589714757|FG001|Overall Study|Toxicity|1|||
163274674|NCT00884286|589714756|FG000|Overall Study|Death|2|||
163274675|NCT00884286|589714757|FG001|Overall Study|Death|2|||
163274676|NCT00884286|589714756|FG000|Overall Study|Physician Decision|1|||
163274677|NCT00884286|589714757|FG001|Overall Study|Physician Decision|0|||
163274678|NCT00884286|589714756|FG000|Overall Study|Septic shock|1|||
163274679|NCT00884286|589714757|FG001|Overall Study|Septic shock|0|||
163274680|NCT00884286|589714756|FG000|Overall Study|Thrombus in right auricle|1|||
163274681|NCT00884286|589714757|FG001|Overall Study|Thrombus in right auricle|0|||
163274682|NCT00884286|589714756|FG000|Overall Study|Not treated|2|||
163274683|NCT00884286|589714757|FG001|Overall Study|Not treated|1|||
163274684|NCT00884286|589714756|FG000|Overall Study|Comprised lung carcinoma|0|||
163274685|NCT00884286|589714757|FG001|Overall Study|Comprised lung carcinoma|1|||
163274686|NCT00594932|589714759|FG000|First 3 Months|Withdrawal by Subject|1|||
163274687|NCT00594932|589714760|FG001|First 3 Months|Withdrawal by Subject|3|||
163274688|NCT00594932|589714759|FG000|Final 3 Months|Withdrawal by Subject|4|||
163274689|NCT00594932|589714760|FG001|Final 3 Months|Withdrawal by Subject|3|||
163274690|NCT00088205|589714761|FG000|Overall Study|Adverse Event|4|||
163274691|NCT00088205|589714761|FG000|Overall Study|Progressive Disease|51|||
163274692|NCT00088205|589714761|FG000|Overall Study|Physician Decision|1|||
163274693|NCT00088205|589714761|FG000|Overall Study|Death Due to Study Disease|4|||
163274694|NCT05199233|589714762|FG000|Overall Study|Lack of Efficacy|1|||
163274695|NCT02491892|589714769|FG000|Overall Study|Adverse Event|1|||
163274696|NCT02491892|589714770|FG001|Overall Study|Adverse Event|1|||
163274697|NCT02491892|589714769|FG000|Overall Study|Death|1|||
163274698|NCT02491892|589714770|FG001|Overall Study|Death|1|||
163274699|NCT02491892|589714769|FG000|Overall Study|Lack of Efficacy|37|||
163274700|NCT02491892|589714770|FG001|Overall Study|Lack of Efficacy|36|||
163274701|NCT02491892|589714769|FG000|Overall Study|Refused Treatment|1|||
163274702|NCT02491892|589714770|FG001|Overall Study|Refused Treatment|0|||
163274703|NCT02491892|589714769|FG000|Overall Study|Lost to Follow-up|1|||
163274704|NCT02491892|589714770|FG001|Overall Study|Lost to Follow-up|0|||
163274705|NCT02982720|589714771|FG000|Overall Study|Adverse Event|3|||
163274706|NCT02982720|589714771|FG000|Overall Study|Death|1|||
163274707|NCT01734850|589714776|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
163274708|NCT01734850|589714777|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
163274709|NCT01734850|589714778|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
163274710|NCT01734850|589714776|FG000|Overall Study|Not infused due to manufacturing failure|0|||
163274711|NCT01734850|589714777|FG001|Overall Study|Not infused due to manufacturing failure|0|||
163274712|NCT01734850|589714778|FG002|Overall Study|Not infused due to manufacturing failure|1|||
163274713|NCT00681187|589714782|FG000|Overall Study|Withdrawal by Subject|1|||
163274714|NCT00681187|589714783|FG001|Overall Study|Withdrawal by Subject|0|||
163274715|NCT00681187|589714782|FG000|Overall Study|Death|0|||
163274716|NCT00681187|589714783|FG001|Overall Study|Death|1|||
163274717|NCT00681187|589714782|FG000|Overall Study|Adverse Event|0|||
163274718|NCT00681187|589714783|FG001|Overall Study|Adverse Event|1|||
163274719|NCT03619174|589714784|FG000|Overall Study|Lost to Follow-up|3|||
163274720|NCT03619174|589714785|FG001|Overall Study|Lost to Follow-up|0|||
163274721|NCT03619174|589714784|FG000|Overall Study|Withdrawal by Subject|4|||
163274722|NCT03619174|589714785|FG001|Overall Study|Withdrawal by Subject|3|||
163274723|NCT03619174|589714784|FG000|Overall Study|Pregnancy|1|||
163274724|NCT03619174|589714785|FG001|Overall Study|Pregnancy|1|||
163274725|NCT03619174|589714784|FG000|Overall Study|Discomfort during treatment|1|||
163274726|NCT03619174|589714785|FG001|Overall Study|Discomfort during treatment|0|||
163274727|NCT02448719|589714792|FG000|Overall Study|Withdrawal by Subject|0|||
163274728|NCT02448719|589714793|FG001|Overall Study|Withdrawal by Subject|0|||
163274729|NCT02448719|589714794|FG002|Overall Study|Withdrawal by Subject|0|||
163161104|NCT01317277|589304080|FG001|Overall Study|Lost to Follow-up|1|||
163274730|NCT02448719|589714795|FG003|Overall Study|Withdrawal by Subject|0|||
163274731|NCT02448719|589714796|FG004|Overall Study|Withdrawal by Subject|1|||
163274732|NCT02448719|589714797|FG005|Overall Study|Withdrawal by Subject|0|||
163274733|NCT02448719|589714798|FG006|Overall Study|Withdrawal by Subject|0|||
163274734|NCT02448719|589714799|FG007|Overall Study|Withdrawal by Subject|0|||
163274735|NCT02448719|589714800|FG008|Overall Study|Withdrawal by Subject|0|||
163274736|NCT02448719|589714801|FG009|Overall Study|Withdrawal by Subject|0|||
163274737|NCT02448719|589714802|FG010|Overall Study|Withdrawal by Subject|0|||
163274738|NCT04707391|589714805|FG000|Overall Study|Adverse Event|5|||
163274739|NCT04707391|589714806|FG001|Overall Study|Adverse Event|8|||
163274740|NCT04707391|589714805|FG000|Overall Study|Lost to Follow-up|44|||
163274741|NCT04707391|589714806|FG001|Overall Study|Lost to Follow-up|31|||
163274742|NCT04707391|589714805|FG000|Overall Study|Protocol Violation|1|||
163274743|NCT04707391|589714806|FG001|Overall Study|Protocol Violation|5|||
163274744|NCT04707391|589714805|FG000|Overall Study|Withdrawal by Subject|27|||
163274745|NCT04707391|589714806|FG001|Overall Study|Withdrawal by Subject|25|||
163274746|NCT04707391|589714805|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
163274747|NCT04707391|589714806|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
163274748|NCT04707391|589714805|FG000|Overall Study|Other|0|||
163274749|NCT04707391|589714806|FG001|Overall Study|Other|2|||
163274750|NCT01406717|589714809|FG000|Overall Study|Subject non-compliance|4|||
163274751|NCT01406717|589714810|FG001|Overall Study|Subject non-compliance|3|||
163274752|NCT01406717|589714809|FG000|Overall Study|Protocol Violation|5|||
163274753|NCT01406717|589714810|FG001|Overall Study|Protocol Violation|1|||
163274754|NCT01406717|589714809|FG000|Overall Study|Lost to Follow-up|14|||
163274755|NCT01406717|589714810|FG001|Overall Study|Lost to Follow-up|8|||
163274756|NCT01406717|589714809|FG000|Overall Study|Withdrawal by Subject|19|||
163274757|NCT01406717|589714810|FG001|Overall Study|Withdrawal by Subject|15|||
163274758|NCT01406717|589714809|FG000|Overall Study|Adverse Event|1|||
163274759|NCT01406717|589714810|FG001|Overall Study|Adverse Event|2|||
163274760|NCT01406717|589714809|FG000|Overall Study|Lack of Efficacy|0|||
163274761|NCT01406717|589714810|FG001|Overall Study|Lack of Efficacy|1|||
163274762|NCT01406717|589714809|FG000|Overall Study|Non-completion of visit activity|0|||
163274763|NCT01406717|589714810|FG001|Overall Study|Non-completion of visit activity|1|||
163274764|NCT02040090|589714811|FG000|Overall Study|Adverse Event|2|||
163274765|NCT02040090|589714812|FG001|Overall Study|Adverse Event|0|||
163274766|NCT02040090|589714811|FG000|Overall Study|Physician Decision|1|||
163274767|NCT02040090|589714812|FG001|Overall Study|Physician Decision|0|||
163274768|NCT02040090|589714811|FG000|Overall Study|Withdrawal by Subject|0|||
163274769|NCT02040090|589714812|FG001|Overall Study|Withdrawal by Subject|1|||
163274770|NCT02040090|589714811|FG000|Overall Study|Lost to Follow-up|0|||
163274771|NCT02040090|589714812|FG001|Overall Study|Lost to Follow-up|1|||
163274772|NCT02275533|589714815|FG000|Overall Study|Protocol Violation|2|||
163274773|NCT02275533|589714816|FG001|Overall Study|Protocol Violation|0|||
163274774|NCT02275533|589714815|FG000|Overall Study|Never received study treatment|1|||
163274775|NCT02275533|589714816|FG001|Overall Study|Never received study treatment|0|||
163274776|NCT01570868|589714817|FG000|Overall Study|Adverse Event|8|||
163274777|NCT01570868|589714818|FG001|Overall Study|Adverse Event|1|||
163274778|NCT01570868|589714817|FG000|Overall Study|FDA Recommendation|23|||
163274779|NCT01570868|589714818|FG001|Overall Study|FDA Recommendation|3|||
163274780|NCT01570868|589714817|FG000|Overall Study|Physician Decision|10|||
163274781|NCT01570868|589714818|FG001|Overall Study|Physician Decision|4|||
163274782|NCT01570868|589714817|FG000|Overall Study|Lost to Follow-up|1|||
163274783|NCT01570868|589714818|FG001|Overall Study|Lost to Follow-up|0|||
163274784|NCT01570868|589714817|FG000|Overall Study|Withdrawal by Subject|1|||
163274785|NCT01570868|589714818|FG001|Overall Study|Withdrawal by Subject|0|||
163274786|NCT03370276|589714819|FG000|Overall Study|Death|0|||
163274787|NCT03370276|589714820|FG001|Overall Study|Death|2|||
163274788|NCT03370276|589714821|FG002|Overall Study|Death|5|||
163274789|NCT01556763|589714827|FG000|Overall Study|Withdrawal by Subject|0|||
163274790|NCT01556763|589714828|FG001|Overall Study|Withdrawal by Subject|1|||
163274791|NCT01556763|589714829|FG002|Overall Study|Withdrawal by Subject|0|||
163274792|NCT02258464|589714830|FG000|Overall Study|Progressive disease (PD)|9|||
163274793|NCT02258464|589714831|FG001|Overall Study|Progressive disease (PD)|17|||
163274794|NCT02258464|589714830|FG000|Overall Study|Study drug never administered|1|||
163274795|NCT02258464|589714831|FG001|Overall Study|Study drug never administered|1|||
163274796|NCT02258464|589714830|FG000|Overall Study|AE not related to clinical PD|1|||
163274797|NCT02258464|589714831|FG001|Overall Study|AE not related to clinical PD|3|||
163161105|NCT01317277|589304079|FG000|Overall Study|Lost MEMS|1|||
163161106|NCT01317277|589304080|FG001|Overall Study|Lost MEMS|1|||
163274798|NCT02258464|589714830|FG000|Overall Study|Withdrawal by Subject|5|||
163161107|NCT01317277|589304079|FG000|Overall Study|Unable to comply with intervention|1|||
163274799|NCT02258464|589714831|FG001|Overall Study|Withdrawal by Subject|4|||
163274800|NCT02258464|589714830|FG000|Overall Study|AE related to clinical PD|1|||
163274801|NCT02258464|589714831|FG001|Overall Study|AE related to clinical PD|0|||
163274802|NCT00932646|589714832|FG000|Overall Study|Adverse Event|2|||
163274803|NCT00932646|589714833|FG001|Overall Study|Adverse Event|1|||
163161108|NCT01317277|589304080|FG001|Overall Study|Unable to comply with intervention|0|||
163161109|NCT01317277|589304079|FG000|Overall Study|Withdrawal by Subject|1|||
163274804|NCT00932646|589714834|FG002|Overall Study|Adverse Event|1|||
163274805|NCT00932646|589714835|FG003|Overall Study|Adverse Event|1|||
163274806|NCT00932646|589714832|FG000|Overall Study|Lost to Follow-up|2|||
163274807|NCT00932646|589714833|FG001|Overall Study|Lost to Follow-up|1|||
163274808|NCT00932646|589714834|FG002|Overall Study|Lost to Follow-up|0|||
163161110|NCT01317277|589304080|FG001|Overall Study|Withdrawal by Subject|0|||
163274809|NCT00932646|589714835|FG003|Overall Study|Lost to Follow-up|0|||
163274810|NCT00932646|589714832|FG000|Overall Study|Withdrawal by Subject|1|||
163274811|NCT00932646|589714833|FG001|Overall Study|Withdrawal by Subject|1|||
163274812|NCT00932646|589714834|FG002|Overall Study|Withdrawal by Subject|3|||
163274813|NCT00932646|589714835|FG003|Overall Study|Withdrawal by Subject|0|||
163274814|NCT00653263|589714836|FG000|Overall Study|Withdrawal by Subject|1|||
163274815|NCT00653263|589714836|FG000|Overall Study|Physician Decision|1|||
163274816|NCT00895843|589714837|FG000|Overall Study|Protocol Violation|12|||
163274817|NCT00895843|589714838|FG001|Overall Study|Protocol Violation|12|||
163274818|NCT04963062|589714841|FG000|Overall Study|withdrew by the study team|4|||
163274819|NCT04963062|589714842|FG001|Overall Study|withdrew by the study team|2|||
163274820|NCT01518257|589716362|FG000|Overall Study|Lost to Follow-up|1|||
163274821|NCT01518257|589716363|FG001|Overall Study|Lost to Follow-up|0|||
163274822|NCT01518257|589716362|FG000|Overall Study|Other Miscellaneous Reason|1|||
163274823|NCT01518257|589716363|FG001|Overall Study|Other Miscellaneous Reason|0|||
163274824|NCT01155726|589716365|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
163274825|NCT01155726|589716366|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
163274826|NCT01155726|589716367|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
163274827|NCT01155726|589716368|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
163274828|NCT05257837|589716372|FG000|Overall Study|Excluded (did not find the guns)|4|||
163274829|NCT05257837|589716373|FG001|Overall Study|Excluded (did not find the guns)|2|||
163274830|NCT05257837|589716374|FG002|Overall Study|Excluded (did not find the guns)|4|||
163274831|NCT05257837|589716375|FG003|Overall Study|Excluded (did not find the guns)|0|||
163274832|NCT05675709|589716378|FG000|Overall Study|incomplete outcome data|2|||
163274833|NCT05675709|589716379|FG001|Overall Study|incomplete outcome data|8|||
163274834|NCT01254565|589716383|FG000|Overall Study|Non-compliance to Study Procedures|0|||
163274835|NCT01254565|589716384|FG001|Overall Study|Non-compliance to Study Procedures|0|||
163274836|NCT01254565|589716385|FG002|Overall Study|Non-compliance to Study Procedures|0|||
163274837|NCT01254565|589716386|FG003|Overall Study|Non-compliance to Study Procedures|0|||
163274838|NCT01254565|589716387|FG004|Overall Study|Non-compliance to Study Procedures|1|||
163274839|NCT01254565|589716388|FG005|Overall Study|Non-compliance to Study Procedures|0|||
163274840|NCT01254565|589716383|FG000|Overall Study|Did not Receive Treatment|1|||
163274841|NCT01254565|589716384|FG001|Overall Study|Did not Receive Treatment|1|||
163274842|NCT01254565|589716385|FG002|Overall Study|Did not Receive Treatment|0|||
163274843|NCT01254565|589716386|FG003|Overall Study|Did not Receive Treatment|0|||
163274844|NCT01254565|589716387|FG004|Overall Study|Did not Receive Treatment|3|||
163274845|NCT01254565|589716388|FG005|Overall Study|Did not Receive Treatment|4|||
163274846|NCT01254565|589716383|FG000|Overall Study|Other|0|||
163274847|NCT01254565|589716384|FG001|Overall Study|Other|0|||
163274848|NCT01254565|589716385|FG002|Overall Study|Other|0|||
163274849|NCT01254565|589716386|FG003|Overall Study|Other|1|||
163274850|NCT01254565|589716387|FG004|Overall Study|Other|0|||
163274851|NCT01254565|589716388|FG005|Overall Study|Other|0|||
163274852|NCT02726399|589716395|FG000|Overall Study|Participant Non-Compliance|1|||
163274853|NCT02726399|589716395|FG000|Overall Study|Adverse Event|2|||
163274854|NCT02726399|589716395|FG000|Overall Study|Progression of disease|4|||
163274855|NCT03468426|589716398|FG000|Overall Study|Progressive disease|3|||
163274856|NCT03468426|589716399|FG001|Overall Study|Progressive disease|0|||
163274857|NCT03468426|589716400|FG002|Overall Study|Progressive disease|4|||
163274858|NCT03468426|589716401|FG003|Overall Study|Progressive disease|20|||
163274859|NCT03468426|589716402|FG004|Overall Study|Progressive disease|23|||
163274860|NCT03468426|589716403|FG005|Overall Study|Progressive disease|15|||
163274861|NCT03468426|589716404|FG006|Overall Study|Progressive disease|24|||
163274862|NCT03468426|589716405|FG007|Overall Study|Progressive disease|27|||
163274863|NCT03468426|589716406|FG008|Overall Study|Progressive disease|13|||
163161111|NCT01317277|589304079|FG000|Overall Study|Adverse Event|1|||
163161112|NCT01317277|589304080|FG001|Overall Study|Adverse Event|0|||
163161113|NCT02454517|589304087|FG000|Overall Study|Withdrawal by Subject|3|||
163161114|NCT02454517|589304088|FG001|Overall Study|Withdrawal by Subject|0|||
163161115|NCT02454517|589304087|FG000|Overall Study|Lost to Follow-up|4|||
163161116|NCT02454517|589304088|FG001|Overall Study|Lost to Follow-up|7|||
163161117|NCT02454517|589304087|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
163161118|NCT02454517|589304088|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
163161119|NCT00473382|589304089|FG000|Core Study|Adverse Event|3|||
163161120|NCT00473382|589304090|FG001|Core Study|Adverse Event|1|||
163161121|NCT00473382|589304091|FG002|Core Study|Adverse Event|1|||
163161122|NCT00473382|589304089|FG000|Core Study|Death|3|||
163161123|NCT00473382|589304090|FG001|Core Study|Death|5|||
163161124|NCT00473382|589304091|FG002|Core Study|Death|10|||
163161125|NCT00473382|589304089|FG000|Core Study|Lost to Follow-up|3|||
163161126|NCT00473382|589304090|FG001|Core Study|Lost to Follow-up|3|||
163161127|NCT00473382|589304091|FG002|Core Study|Lost to Follow-up|3|||
163161128|NCT00473382|589304089|FG000|Core Study|Physician Decision|1|||
163161129|NCT00473382|589304090|FG001|Core Study|Physician Decision|2|||
163161130|NCT00473382|589304091|FG002|Core Study|Physician Decision|2|||
163161131|NCT00473382|589304089|FG000|Core Study|Subject non-compliance|5|||
163161132|NCT00473382|589304090|FG001|Core Study|Subject non-compliance|2|||
163274864|NCT03468426|589716407|FG009|Overall Study|Progressive disease|13|||
163274865|NCT03468426|589716408|FG010|Overall Study|Progressive disease|0|||
163274866|NCT03468426|589716398|FG000|Overall Study|Other adverse event or clinical progression|0|||
163274867|NCT03468426|589716399|FG001|Overall Study|Other adverse event or clinical progression|1|||
163274868|NCT03468426|589716400|FG002|Overall Study|Other adverse event or clinical progression|3|||
163274869|NCT03468426|589716401|FG003|Overall Study|Other adverse event or clinical progression|14|||
163274870|NCT03468426|589716402|FG004|Overall Study|Other adverse event or clinical progression|10|||
163274871|NCT03468426|589716403|FG005|Overall Study|Other adverse event or clinical progression|8|||
163274872|NCT03468426|589716404|FG006|Overall Study|Other adverse event or clinical progression|5|||
163274873|NCT03468426|589716405|FG007|Overall Study|Other adverse event or clinical progression|4|||
163274874|NCT03468426|589716406|FG008|Overall Study|Other adverse event or clinical progression|6|||
163161133|NCT00473382|589304091|FG002|Core Study|Subject non-compliance|1|||
163274875|NCT03468426|589716407|FG009|Overall Study|Other adverse event or clinical progression|11|||
163274876|NCT03468426|589716408|FG010|Overall Study|Other adverse event or clinical progression|0|||
163274877|NCT03468426|589716398|FG000|Overall Study|Refused to continue taking trial medication|0|||
163274878|NCT03468426|589716399|FG001|Overall Study|Refused to continue taking trial medication|0|||
163274879|NCT03468426|589716400|FG002|Overall Study|Refused to continue taking trial medication|0|||
163274880|NCT03468426|589716401|FG003|Overall Study|Refused to continue taking trial medication|2|||
163274881|NCT03468426|589716402|FG004|Overall Study|Refused to continue taking trial medication|0|||
163274882|NCT03468426|589716403|FG005|Overall Study|Refused to continue taking trial medication|3|||
163274883|NCT03468426|589716404|FG006|Overall Study|Refused to continue taking trial medication|0|||
163274884|NCT03468426|589716405|FG007|Overall Study|Refused to continue taking trial medication|0|||
163274885|NCT03468426|589716406|FG008|Overall Study|Refused to continue taking trial medication|1|||
163274886|NCT03468426|589716407|FG009|Overall Study|Refused to continue taking trial medication|0|||
163274887|NCT03468426|589716408|FG010|Overall Study|Refused to continue taking trial medication|0|||
163274888|NCT03468426|589716398|FG000|Overall Study|Other than listed|0|||
163274889|NCT03468426|589716399|FG001|Overall Study|Other than listed|1|||
163274890|NCT03468426|589716400|FG002|Overall Study|Other than listed|0|||
163274891|NCT03468426|589716401|FG003|Overall Study|Other than listed|0|||
163274892|NCT03468426|589716402|FG004|Overall Study|Other than listed|2|||
163274893|NCT03468426|589716403|FG005|Overall Study|Other than listed|2|||
163274894|NCT03468426|589716404|FG006|Overall Study|Other than listed|0|||
163274895|NCT03468426|589716405|FG007|Overall Study|Other than listed|0|||
163274896|NCT03468426|589716406|FG008|Overall Study|Other than listed|4|||
163274897|NCT03468426|589716407|FG009|Overall Study|Other than listed|4|||
163274898|NCT03468426|589716408|FG010|Overall Study|Other than listed|1|||
163274899|NCT03468426|589716398|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163274900|NCT03468426|589716399|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163274901|NCT03468426|589716400|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
163274902|NCT03468426|589716401|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163274903|NCT03468426|589716402|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163274904|NCT03468426|589716403|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163274905|NCT03468426|589716404|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163274906|NCT03468426|589716405|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163274907|NCT03468426|589716406|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163274908|NCT03468426|589716407|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163274909|NCT03468426|589716408|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163274910|NCT03468426|589716398|FG000|Overall Study|missing reason|0|||
163274911|NCT03468426|589716399|FG001|Overall Study|missing reason|0|||
163274912|NCT03468426|589716400|FG002|Overall Study|missing reason|0|||
163274913|NCT03468426|589716401|FG003|Overall Study|missing reason|0|||
163274914|NCT03468426|589716402|FG004|Overall Study|missing reason|0|||
163274915|NCT03468426|589716403|FG005|Overall Study|missing reason|0|||
163274916|NCT03468426|589716404|FG006|Overall Study|missing reason|0|||
163274917|NCT03468426|589716405|FG007|Overall Study|missing reason|0|||
163274918|NCT03468426|589716406|FG008|Overall Study|missing reason|0|||
163274919|NCT03468426|589716407|FG009|Overall Study|missing reason|1|||
163161134|NCT00473382|589304089|FG000|Core Study|Subject needed other treatment|1|||
163161135|NCT00473382|589304090|FG001|Core Study|Subject needed other treatment|3|||
163161136|NCT00473382|589304091|FG002|Core Study|Subject needed other treatment|2|||
163161137|NCT00473382|589304089|FG000|Core Study|Subject's decision|12|||
163274920|NCT03468426|589716408|FG010|Overall Study|missing reason|0|||
163274921|NCT01440049|589716410|FG000|Overall Study|Adverse Event|5|||
163274922|NCT02268552|589716411|FG000|Part 1|Death|1|||
163274923|NCT02268552|589716412|FG001|Part 1|Death|1|||
163274924|NCT02268552|589716413|FG002|Part 1|Death|1|||
163274925|NCT02268552|589716414|FG003|Part 1|Death|2|||
163274926|NCT02268552|589716415|FG004|Part 1|Death|0|||
163274927|NCT02268552|589716416|FG005|Part 1|Death|0|||
163161138|NCT00473382|589304090|FG001|Core Study|Subject's decision|11|||
163161139|NCT00473382|589304091|FG002|Core Study|Subject's decision|10|||
163161140|NCT00473382|589304089|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
163274928|NCT02268552|589716417|FG006|Part 1|Death|0|||
163274929|NCT02268552|589716411|FG000|Part 1|Subject/guardian decision|0|||
163274930|NCT02268552|589716412|FG001|Part 1|Subject/guardian decision|0|||
163274931|NCT02268552|589716413|FG002|Part 1|Subject/guardian decision|0|||
163274932|NCT02268552|589716414|FG003|Part 1|Subject/guardian decision|1|||
163274933|NCT02268552|589716415|FG004|Part 1|Subject/guardian decision|0|||
163274934|NCT02268552|589716416|FG005|Part 1|Subject/guardian decision|0|||
163274935|NCT02268552|589716417|FG006|Part 1|Subject/guardian decision|0|||
163274936|NCT02268552|589716411|FG000|Part 2|Death|0|||
163274937|NCT02268552|589716412|FG001|Part 2|Death|0|||
163274938|NCT02268552|589716413|FG002|Part 2|Death|0|||
163274939|NCT02268552|589716414|FG003|Part 2|Death|0|||
163274940|NCT02268552|589716415|FG004|Part 2|Death|0|||
163274941|NCT02268552|589716416|FG005|Part 2|Death|0|||
163274942|NCT02268552|589716417|FG006|Part 2|Death|2|||
163274943|NCT02268552|589716411|FG000|Part 2|Subject/guardian decision|0|||
163274944|NCT02268552|589716412|FG001|Part 2|Subject/guardian decision|0|||
163274945|NCT02268552|589716413|FG002|Part 2|Subject/guardian decision|0|||
163274946|NCT02268552|589716414|FG003|Part 2|Subject/guardian decision|0|||
163274947|NCT02268552|589716415|FG004|Part 2|Subject/guardian decision|0|||
163274948|NCT02268552|589716416|FG005|Part 2|Subject/guardian decision|0|||
163274949|NCT02268552|589716417|FG006|Part 2|Subject/guardian decision|1|||
163274950|NCT02268552|589716411|FG000|Part 3 Extension|Death|0|||
163274951|NCT02268552|589716412|FG001|Part 3 Extension|Death|1|||
163274952|NCT02268552|589716413|FG002|Part 3 Extension|Death|1|||
163274953|NCT02268552|589716414|FG003|Part 3 Extension|Death|1|||
163274954|NCT02268552|589716415|FG004|Part 3 Extension|Death|1|||
163274955|NCT02268552|589716416|FG005|Part 3 Extension|Death|1|||
163274956|NCT02268552|589716417|FG006|Part 3 Extension|Death|0|||
163274957|NCT02268552|589716411|FG000|Part 3 Extension|Early termination of trial|1|||
163274958|NCT02268552|589716412|FG001|Part 3 Extension|Early termination of trial|0|||
163274959|NCT02268552|589716413|FG002|Part 3 Extension|Early termination of trial|0|||
163274960|NCT02268552|589716414|FG003|Part 3 Extension|Early termination of trial|0|||
163274961|NCT02268552|589716415|FG004|Part 3 Extension|Early termination of trial|2|||
163274962|NCT02268552|589716416|FG005|Part 3 Extension|Early termination of trial|9|||
163274963|NCT02268552|589716417|FG006|Part 3 Extension|Early termination of trial|11|||
163274964|NCT02268552|589716411|FG000|Part 3 Extension|Subject/guardian decision|0|||
163274965|NCT02268552|589716412|FG001|Part 3 Extension|Subject/guardian decision|0|||
163274966|NCT02268552|589716413|FG002|Part 3 Extension|Subject/guardian decision|0|||
163274967|NCT02268552|589716414|FG003|Part 3 Extension|Subject/guardian decision|0|||
163274968|NCT02268552|589716415|FG004|Part 3 Extension|Subject/guardian decision|0|||
163274969|NCT02268552|589716416|FG005|Part 3 Extension|Subject/guardian decision|0|||
163274970|NCT02268552|589716417|FG006|Part 3 Extension|Subject/guardian decision|1|||
163274971|NCT04168385|589716419|FG000|Overall Study|Withdrawal by Subject|1|||
163274972|NCT04168385|589716420|FG001|Overall Study|Withdrawal by Subject|0|||
163274973|NCT04168385|589716419|FG000|Overall Study|Adverse Event|2|||
163274974|NCT04168385|589716420|FG001|Overall Study|Adverse Event|1|||
163274975|NCT04168385|589716419|FG000|Overall Study|Liver transplant|3|||
163274976|NCT04168385|589716420|FG001|Overall Study|Liver transplant|1|||
163274977|NCT04168385|589716419|FG000|Overall Study|Listed for liver transplant|1|||
163274978|NCT04168385|589716420|FG001|Overall Study|Listed for liver transplant|0|||
163274979|NCT02139982|589716421|FG000|Overall Study|Lack of Efficacy|0|||
163274980|NCT02139982|589716422|FG001|Overall Study|Lack of Efficacy|1|||
163274981|NCT02139982|589716423|FG002|Overall Study|Lack of Efficacy|0|||
163274982|NCT02139982|589716424|FG003|Overall Study|Lack of Efficacy|1|||
163274983|NCT02139982|589716425|FG004|Overall Study|Lack of Efficacy|0|||
163274984|NCT02139982|589716426|FG005|Overall Study|Lack of Efficacy|0|||
163274985|NCT02139982|589716427|FG006|Overall Study|Lack of Efficacy|0|||
163274986|NCT02139982|589716428|FG007|Overall Study|Lack of Efficacy|0|||
163274987|NCT02139982|589716429|FG008|Overall Study|Lack of Efficacy|0|||
163274988|NCT02139982|589716430|FG009|Overall Study|Lack of Efficacy|0|||
163274989|NCT02748512|589716433|FG000|Overall Study|Lost to Follow-up|1|||
163274990|NCT02748512|589716434|FG001|Overall Study|Lost to Follow-up|1|||
163274991|NCT01196104|589716448|FG000|Overall Study|Lost to Follow-up|1|||
163274992|NCT01196104|589716449|FG001|Overall Study|Lost to Follow-up|0|||
163274993|NCT01196104|589716448|FG000|Overall Study|Physician Decision|0|||
163274994|NCT01196104|589716449|FG001|Overall Study|Physician Decision|1|||
163274995|NCT01196104|589716448|FG000|Overall Study|Withdrawal by Subject|3|||
163274996|NCT01196104|589716449|FG001|Overall Study|Withdrawal by Subject|3|||
163274997|NCT01196104|589716448|FG000|Overall Study|Various|0|||
163274998|NCT01196104|589716449|FG001|Overall Study|Various|1|||
163274999|NCT01094171|589716456|FG000|Overall Study|Lost to Follow-up|2|||
163275000|NCT01094171|589716456|FG000|Overall Study|Informed consent withdrawal|4|||
163275001|NCT01094171|589716456|FG000|Overall Study|Migration from the study area|3|||
163275002|NCT01094171|589716456|FG000|Overall Study|Other|1|||
163275003|NCT01310868|589716457|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
163275004|NCT00065468|589716458|FG000|Overall Study|Death|172|||
163275005|NCT00065468|589716459|FG001|Overall Study|Death|169|||
163275006|NCT00065468|589716460|FG002|Overall Study|Death|171|||
163275007|NCT00065468|589716458|FG000|Overall Study|Withdrawal by Subject|3|||
163275008|NCT00065468|589716459|FG001|Overall Study|Withdrawal by Subject|4|||
163275009|NCT00065468|589716460|FG002|Overall Study|Withdrawal by Subject|5|||
163275010|NCT00065468|589716458|FG000|Overall Study|Lost to Follow-up|5|||
163275011|NCT00065468|589716459|FG001|Overall Study|Lost to Follow-up|3|||
163275012|NCT00065468|589716460|FG002|Overall Study|Lost to Follow-up|2|||
163275013|NCT00065468|589716458|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
163275014|NCT00065468|589716459|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
163275015|NCT00065468|589716460|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
163275016|NCT00065468|589716458|FG000|Overall Study|Disease progression|0|||
163275017|NCT00065468|589716459|FG001|Overall Study|Disease progression|0|||
163275018|NCT00065468|589716460|FG002|Overall Study|Disease progression|1|||
163275019|NCT00065468|589716458|FG000|Overall Study|Other|14|||
163275020|NCT00065468|589716459|FG001|Overall Study|Other|24|||
163275021|NCT00065468|589716460|FG002|Overall Study|Other|18|||
163275022|NCT04496167|589716461|FG000|Overall Study|Adverse Event|6|||
163275023|NCT04496167|589716462|FG001|Overall Study|Adverse Event|2|||
163275024|NCT04496167|589716461|FG000|Overall Study|Withdrawal by Subject|7|||
163275025|NCT04496167|589716462|FG001|Overall Study|Withdrawal by Subject|6|||
163275026|NCT04496167|589716461|FG000|Overall Study|Lost to Follow-up|3|||
163275027|NCT04496167|589716462|FG001|Overall Study|Lost to Follow-up|5|||
163275028|NCT04496167|589716461|FG000|Overall Study|Not Treated|1|||
163275029|NCT04496167|589716462|FG001|Overall Study|Not Treated|2|||
163275030|NCT04496167|589716461|FG000|Overall Study|Other Than Specified|1|||
163275031|NCT04496167|589716462|FG001|Overall Study|Other Than Specified|1|||
163275032|NCT00598481|589716463|FG000|Treatment|Physician Decision|1|||
163275033|NCT01708187|589716466|FG000|Overall Study|Lost to Follow-up|0|||
163275034|NCT01708187|589716467|FG001|Overall Study|Lost to Follow-up|1|||
163275035|NCT02117544|589716468|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
163275036|NCT02117544|589716469|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
163275037|NCT02408549|589716471|FG000|Overall Study|Adverse Event|15|||
163275038|NCT02408549|589716471|FG000|Overall Study|Death|4|||
163275039|NCT02408549|589716471|FG000|Overall Study|Lack of Efficacy|17|||
163275040|NCT02408549|589716471|FG000|Overall Study|Protocol Violation|4|||
163275041|NCT02408549|589716471|FG000|Overall Study|Lost to Follow-up|6|||
163275042|NCT02408549|589716471|FG000|Overall Study|Consent withdrawn|30|||
163275043|NCT02408549|589716471|FG000|Overall Study|Neurology research program closing at site|1|||
163275044|NCT02408549|589716471|FG000|Overall Study|Site closure|1|||
163275045|NCT02408549|589716471|FG000|Overall Study|Pregnancy|1|||
163275046|NCT02408549|589716471|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
163275047|NCT02408549|589716471|FG000|Overall Study|Subject moved to another place, far from site|1|||
163275048|NCT02408549|589716471|FG000|Overall Study|Study terminated at site|1|||
163275049|NCT00231894|589716472|FG000|Overall Study|Withdrawal by Subject|1|||
163275050|NCT00231894|589716473|FG001|Overall Study|Withdrawal by Subject|1|||
163275051|NCT02025205|589716474|FG000|Overall Study|Withdrawal by Subject|1|||
163275052|NCT02025205|589716475|FG001|Overall Study|Withdrawal by Subject|1|||
163275053|NCT02025205|589716474|FG000|Overall Study|Protocol Violation|2|||
163275054|NCT02025205|589716475|FG001|Overall Study|Protocol Violation|1|||
163275055|NCT02025205|589716474|FG000|Overall Study|Death|0|||
163275056|NCT02025205|589716475|FG001|Overall Study|Death|1|||
163275057|NCT01232556|589716478|FG000|Overall Study|Withdrawal by Subject|21|||
163275058|NCT01232556|589716479|FG001|Overall Study|Withdrawal by Subject|17|||
163275059|NCT01232556|589716478|FG000|Overall Study|Death|97|||
163275060|NCT01232556|589716479|FG001|Overall Study|Death|97|||
163275061|NCT01232556|589716478|FG000|Overall Study|Lost to Follow-up|0|||
163275062|NCT01232556|589716479|FG001|Overall Study|Lost to Follow-up|2|||
163275063|NCT01232556|589716478|FG000|Overall Study|Terminated by Sponsor|35|||
163275064|NCT01232556|589716479|FG001|Overall Study|Terminated by Sponsor|51|||
163275065|NCT01232556|589716478|FG000|Overall Study|Other|6|||
163275066|NCT01232556|589716479|FG001|Overall Study|Other|4|||
163275067|NCT04172987|589716480|FG000|Lead In Period|Adverse Event|1|||
163275068|NCT04172987|589716480|FG000|Lead In Period|Protocol Violation|1|||
163275069|NCT04172987|589716480|FG000|Period 1|Physician Decision|1|||
163275070|NCT04172987|589716480|FG000|Period 2|Adverse Event|5|||
163275071|NCT04172987|589716480|FG000|Period 2|Dosing Termination by Sponsor|4|||
163275072|NCT03785340|589716482|FG000|Overall Study|Lost to Follow-up|2|||
163275073|NCT03785340|589716483|FG001|Overall Study|Lost to Follow-up|0|||
163275074|NCT03785340|589716482|FG000|Overall Study|Adverse Event|1|||
163275075|NCT03785340|589716483|FG001|Overall Study|Adverse Event|0|||
163275076|NCT02500316|589716484|FG000|Overall Study|Adverse Event|3|||
163275077|NCT02500316|589716484|FG000|Overall Study|Lost to Follow-up|2|||
163275078|NCT02500316|589716484|FG000|Overall Study|Protocol Violation|1|||
163275079|NCT02500316|589716484|FG000|Overall Study|Withdrawal by Subject|15|||
163275080|NCT02500316|589716484|FG000|Overall Study|Final height achieved|5|||
163275081|NCT02500316|589716484|FG000|Overall Study|Due to war activity|1|||
163275082|NCT01848834|589716485|FG000|Overall Study|Adverse Event|3|||
163275083|NCT01848834|589716486|FG001|Overall Study|Adverse Event|11|||
163275084|NCT01848834|589716487|FG002|Overall Study|Adverse Event|3|||
163275085|NCT01848834|589716488|FG003|Overall Study|Adverse Event|5|||
163275086|NCT01848834|589716489|FG004|Overall Study|Adverse Event|9|||
163275087|NCT01848834|589716485|FG000|Overall Study|Death|2|||
163275088|NCT01848834|589716486|FG001|Overall Study|Death|11|||
163275089|NCT01848834|589716487|FG002|Overall Study|Death|1|||
163275090|NCT01848834|589716488|FG003|Overall Study|Death|8|||
163275091|NCT01848834|589716489|FG004|Overall Study|Death|27|||
163275092|NCT01848834|589716485|FG000|Overall Study|Excluded Medication|5|||
163161141|NCT00473382|589304090|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
163161142|NCT00473382|589304091|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
163161143|NCT00473382|589304089|FG000|Open-label Extension Through Month 48|Death|1|||
163161144|NCT00473382|589304090|FG001|Open-label Extension Through Month 48|Death|3|||
163161145|NCT00473382|589304091|FG002|Open-label Extension Through Month 48|Death|3|||
163161146|NCT00473382|589304089|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
163161147|NCT00473382|589304090|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
163161148|NCT00473382|589304091|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
163161149|NCT00473382|589304089|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
163161150|NCT00473382|589304090|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
163161151|NCT00473382|589304091|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
163161152|NCT00473382|589304089|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
163161153|NCT00473382|589304090|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
163161154|NCT00473382|589304091|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
163161155|NCT00473382|589304089|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
163161156|NCT00473382|589304090|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
163161157|NCT00473382|589304091|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
163161158|NCT00473382|589304089|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
163161159|NCT00473382|589304090|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
163161160|NCT00473382|589304091|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
163161161|NCT00473382|589304089|FG000|Open-label Extension Through Month 60|Death|1|||
163161162|NCT00473382|589304090|FG001|Open-label Extension Through Month 60|Death|7|||
163161163|NCT00473382|589304091|FG002|Open-label Extension Through Month 60|Death|4|||
163161164|NCT00473382|589304089|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
163161165|NCT00473382|589304090|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
163161166|NCT00473382|589304091|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
163161167|NCT00473382|589304089|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
163161168|NCT00473382|589304090|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
163161169|NCT00473382|589304091|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
163161170|NCT00473382|589304089|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
163161171|NCT00473382|589304090|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
163161172|NCT00473382|589304091|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
163161173|NCT00473382|589304089|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
163161174|NCT00473382|589304090|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
163161175|NCT00473382|589304091|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
163161176|NCT03565497|589304092|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
163161177|NCT03565497|589304093|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
163161178|NCT03565497|589304094|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
163161179|NCT03565497|589304092|FG000|Overall Study|Lost to Follow-up|1|||
163161180|NCT03565497|589304093|FG001|Overall Study|Lost to Follow-up|1|||
163161181|NCT03565497|589304094|FG002|Overall Study|Lost to Follow-up|2|||
163161182|NCT03565497|589304092|FG000|Overall Study|Withdrawal by Subject|1|||
163161183|NCT03565497|589304093|FG001|Overall Study|Withdrawal by Subject|1|||
163161184|NCT03565497|589304094|FG002|Overall Study|Withdrawal by Subject|1|||
163161185|NCT02999672|589304095|FG000|Overall Study|Death|0|||
163161186|NCT02999672|589304096|FG001|Overall Study|Death|1|||
163161187|NCT02999672|589304095|FG000|Overall Study|Study Terminated by Sponsor|0|||
163161188|NCT02999672|589304096|FG001|Overall Study|Study Terminated by Sponsor|1|||
163161189|NCT02999672|589304095|FG000|Overall Study|Progressive Disease|9|||
163161190|NCT02999672|589304096|FG001|Overall Study|Progressive Disease|5|||
163161191|NCT02999672|589304095|FG000|Overall Study|Adverse Event|4|||
163161192|NCT02999672|589304096|FG001|Overall Study|Adverse Event|0|||
163161193|NCT01166282|589304097|FG000|Open-label Period|Adverse Event|0|||
163161194|NCT01166282|589304098|FG001|Open-label Period|Adverse Event|0|||
163161195|NCT01166282|589304099|FG002|Open-label Period|Adverse Event|6|||
163161196|NCT01166282|589304097|FG000|Open-label Period|Withdrawal by Subject|0|||
163161197|NCT01166282|589304098|FG001|Open-label Period|Withdrawal by Subject|0|||
163275093|NCT01848834|589716486|FG001|Overall Study|Excluded Medication|4|||
163275094|NCT01848834|589716487|FG002|Overall Study|Excluded Medication|3|||
163161198|NCT01166282|589304099|FG002|Open-label Period|Withdrawal by Subject|4|||
163275095|NCT01848834|589716488|FG003|Overall Study|Excluded Medication|6|||
163161199|NCT01166282|589304097|FG000|Open-label Period|Lack of Efficacy|0|||
163161200|NCT01166282|589304098|FG001|Open-label Period|Lack of Efficacy|0|||
163161201|NCT01166282|589304099|FG002|Open-label Period|Lack of Efficacy|2|||
163161202|NCT01166282|589304097|FG000|Open-label Period|Remission|0|||
163275096|NCT01848834|589716489|FG004|Overall Study|Excluded Medication|6|||
163275097|NCT01848834|589716485|FG000|Overall Study|Lost to Follow-up|5|||
163275098|NCT01848834|589716486|FG001|Overall Study|Lost to Follow-up|5|||
163275099|NCT01848834|589716487|FG002|Overall Study|Lost to Follow-up|3|||
163275100|NCT01848834|589716488|FG003|Overall Study|Lost to Follow-up|0|||
163275101|NCT01848834|589716489|FG004|Overall Study|Lost to Follow-up|3|||
163275102|NCT01848834|589716485|FG000|Overall Study|Physician Decision|1|||
163275103|NCT01848834|589716486|FG001|Overall Study|Physician Decision|3|||
163275104|NCT01848834|589716487|FG002|Overall Study|Physician Decision|4|||
163275105|NCT01848834|589716488|FG003|Overall Study|Physician Decision|0|||
163275106|NCT01848834|589716489|FG004|Overall Study|Physician Decision|11|||
163275107|NCT01848834|589716485|FG000|Overall Study|Protocol Violation|0|||
163275108|NCT01848834|589716486|FG001|Overall Study|Protocol Violation|0|||
163275109|NCT01848834|589716487|FG002|Overall Study|Protocol Violation|0|||
163275110|NCT01848834|589716488|FG003|Overall Study|Protocol Violation|0|||
163275111|NCT01848834|589716489|FG004|Overall Study|Protocol Violation|1|||
163275112|NCT01848834|589716485|FG000|Overall Study|Sponsor Decision|1|||
163275113|NCT01848834|589716486|FG001|Overall Study|Sponsor Decision|1|||
163275114|NCT01848834|589716487|FG002|Overall Study|Sponsor Decision|0|||
163275115|NCT01848834|589716488|FG003|Overall Study|Sponsor Decision|1|||
163275116|NCT01848834|589716489|FG004|Overall Study|Sponsor Decision|1|||
163275117|NCT01848834|589716485|FG000|Overall Study|Withdrawal by Subject|2|||
163275118|NCT01848834|589716486|FG001|Overall Study|Withdrawal by Subject|13|||
163275119|NCT01848834|589716487|FG002|Overall Study|Withdrawal by Subject|10|||
163275120|NCT01848834|589716488|FG003|Overall Study|Withdrawal by Subject|6|||
163275121|NCT01848834|589716489|FG004|Overall Study|Withdrawal by Subject|36|||
163275122|NCT02584855|589716490|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
163275123|NCT02584855|589716491|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
163275124|NCT02584855|589716492|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
163275125|NCT02584855|589716493|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
163275126|NCT02584855|589716494|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
163275127|NCT02584855|589716495|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
163275128|NCT02584855|589716490|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
163275129|NCT02584855|589716491|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
163275130|NCT02584855|589716492|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
163275131|NCT02584855|589716493|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
163275132|NCT02584855|589716494|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
163275133|NCT02584855|589716495|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
163275134|NCT02584855|589716490|FG000|Open-Label Treatment Period|Adverse Event|14|||
163275135|NCT02584855|589716491|FG001|Open-Label Treatment Period|Adverse Event|0|||
163275136|NCT02584855|589716492|FG002|Open-Label Treatment Period|Adverse Event|0|||
163275137|NCT02584855|589716493|FG003|Open-Label Treatment Period|Adverse Event|0|||
163275138|NCT02584855|589716494|FG004|Open-Label Treatment Period|Adverse Event|0|||
163275139|NCT02584855|589716495|FG005|Open-Label Treatment Period|Adverse Event|0|||
163275140|NCT02584855|589716490|FG000|Open-Label Treatment Period|Death|2|||
163275141|NCT02584855|589716491|FG001|Open-Label Treatment Period|Death|0|||
163275142|NCT02584855|589716492|FG002|Open-Label Treatment Period|Death|0|||
163275143|NCT02584855|589716493|FG003|Open-Label Treatment Period|Death|0|||
163275144|NCT02584855|589716494|FG004|Open-Label Treatment Period|Death|0|||
163275145|NCT02584855|589716495|FG005|Open-Label Treatment Period|Death|0|||
163275146|NCT02584855|589716490|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
163275147|NCT02584855|589716491|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
163275148|NCT02584855|589716492|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
163275149|NCT02584855|589716493|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
163275150|NCT02584855|589716494|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
163275151|NCT02584855|589716495|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
163275152|NCT02584855|589716490|FG000|Open-Label Treatment Period|Protocol Violation|1|||
163275153|NCT02584855|589716491|FG001|Open-Label Treatment Period|Protocol Violation|0|||
163275154|NCT02584855|589716492|FG002|Open-Label Treatment Period|Protocol Violation|0|||
163275155|NCT02584855|589716493|FG003|Open-Label Treatment Period|Protocol Violation|0|||
163275156|NCT02584855|589716494|FG004|Open-Label Treatment Period|Protocol Violation|0|||
163275157|NCT02584855|589716495|FG005|Open-Label Treatment Period|Protocol Violation|0|||
163275158|NCT02584855|589716490|FG000|Open-Label Treatment Period|No PI Available|2|||
163275159|NCT02584855|589716491|FG001|Open-Label Treatment Period|No PI Available|0|||
163275160|NCT02584855|589716492|FG002|Open-Label Treatment Period|No PI Available|0|||
163275161|NCT02584855|589716493|FG003|Open-Label Treatment Period|No PI Available|0|||
163275162|NCT02584855|589716494|FG004|Open-Label Treatment Period|No PI Available|0|||
163275163|NCT02584855|589716495|FG005|Open-Label Treatment Period|No PI Available|0|||
163275164|NCT02584855|589716490|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
163275165|NCT02584855|589716491|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
163275166|NCT02584855|589716492|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
163275167|NCT02584855|589716493|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
163275168|NCT02584855|589716494|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
163275169|NCT02584855|589716495|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
163275170|NCT02584855|589716490|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
163275171|NCT02584855|589716491|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
163275172|NCT02584855|589716492|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
163275173|NCT02584855|589716493|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
163275174|NCT02584855|589716494|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
163275175|NCT02584855|589716495|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
163275176|NCT02584855|589716490|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
163275177|NCT02584855|589716491|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
163275178|NCT02584855|589716492|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
163275179|NCT02584855|589716493|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
163275180|NCT02584855|589716494|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
163275181|NCT02584855|589716495|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
163275182|NCT02584855|589716490|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
163275183|NCT02584855|589716491|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
163275184|NCT02584855|589716492|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
163275185|NCT02584855|589716493|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
163275186|NCT02584855|589716494|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
163275187|NCT02584855|589716495|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
163275188|NCT02584855|589716490|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
163275189|NCT02584855|589716491|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
163275190|NCT02584855|589716492|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
163275191|NCT02584855|589716493|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
163275192|NCT02584855|589716494|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
163275193|NCT02584855|589716495|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
163275194|NCT02584855|589716490|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163275195|NCT02584855|589716491|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163275196|NCT02584855|589716492|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163275197|NCT02584855|589716493|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163275198|NCT02584855|589716494|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
163275199|NCT02584855|589716495|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163275200|NCT02584855|589716490|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
163275201|NCT02584855|589716491|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
163275202|NCT02584855|589716492|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
163275203|NCT02584855|589716493|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
163275204|NCT02584855|589716494|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
163275205|NCT02584855|589716495|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
163275206|NCT02337478|589716496|FG000|Overall Study|Lack of Efficacy|5|||
163275207|NCT02611830|589716497|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
163275208|NCT02611830|589716498|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
163275209|NCT02611830|589716499|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
163275210|NCT02611830|589716500|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
163275211|NCT02611830|589716497|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
163275212|NCT02611830|589716498|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
163275213|NCT02611830|589716499|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
163275214|NCT02611830|589716500|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
163275215|NCT02611830|589716497|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
163275216|NCT02611830|589716498|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
163275217|NCT02611830|589716499|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
163275218|NCT02611830|589716500|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
163385772|NCT00146328|590123241|FG002|Overall Study|Trial ended/site closed|19|||
163385773|NCT00146328|590123239|FG000|Overall Study|Patient decision to end|0|||
163385774|NCT00146328|590123240|FG001|Overall Study|Patient decision to end|1|||
163385775|NCT00146328|590123241|FG002|Overall Study|Patient decision to end|6|||
163385776|NCT00146328|590123239|FG000|Overall Study|Enroll into other trial|2|||
163385777|NCT00146328|590123240|FG001|Overall Study|Enroll into other trial|4|||
163385778|NCT00146328|590123241|FG002|Overall Study|Enroll into other trial|2|||
163385779|NCT00146328|590123239|FG000|Overall Study|Death|0|||
163385780|NCT00146328|590123240|FG001|Overall Study|Death|1|||
163385781|NCT00146328|590123241|FG002|Overall Study|Death|1|||
163385782|NCT00146328|590123239|FG000|Overall Study|Moved|2|||
163385783|NCT00146328|590123240|FG001|Overall Study|Moved|0|||
163385784|NCT00146328|590123241|FG002|Overall Study|Moved|0|||
163385785|NCT00146328|590123239|FG000|Overall Study|Interaction with other medication|2|||
163385786|NCT00146328|590123240|FG001|Overall Study|Interaction with other medication|0|||
163385787|NCT00146328|590123241|FG002|Overall Study|Interaction with other medication|1|||
163385788|NCT01717989|590123242|FG000|Overall Study|Ineligibility determined|6|||
163385789|NCT01717989|590123242|FG000|Overall Study|Protocol deviation|6|||
163385790|NCT01717989|590123242|FG000|Overall Study|Withdrawal by Subject|11|||
163385791|NCT01717989|590123242|FG000|Overall Study|Physician Decision|2|||
163385792|NCT01717989|590123242|FG000|Overall Study|Lost to Follow-up|11|||
163385793|NCT01717989|590123242|FG000|Overall Study|Death|439|||
163385794|NCT01717989|590123242|FG000|Overall Study|Protocol-specified criteria|551|||
163161203|NCT01166282|589304098|FG001|Open-label Period|Remission|0|||
163385795|NCT01717989|590123242|FG000|Overall Study|Other|40|||
163275219|NCT02611830|589716497|FG000|OL Induction Phase|Lack of Efficacy|9|||
163275220|NCT02611830|589716498|FG001|OL Induction Phase|Lack of Efficacy|0|||
163275221|NCT02611830|589716499|FG002|OL Induction Phase|Lack of Efficacy|0|||
163275222|NCT02611830|589716500|FG003|OL Induction Phase|Lack of Efficacy|0|||
163275223|NCT02611830|589716497|FG000|OL Induction Phase|Reason not specified|3|||
163275224|NCT02611830|589716498|FG001|OL Induction Phase|Reason not specified|0|||
163275225|NCT02611830|589716499|FG002|OL Induction Phase|Reason not specified|0|||
163275226|NCT02611830|589716500|FG003|OL Induction Phase|Reason not specified|0|||
163275227|NCT02611830|589716497|FG000|Maintenance Phase|Lack of Efficacy|0|||
163275228|NCT02611830|589716498|FG001|Maintenance Phase|Lack of Efficacy|29|||
163275229|NCT02611830|589716499|FG002|Maintenance Phase|Lack of Efficacy|18|||
163275230|NCT02611830|589716500|FG003|Maintenance Phase|Lack of Efficacy|6|||
163275231|NCT02611830|589716497|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
163275232|NCT02611830|589716498|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
163275233|NCT02611830|589716499|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
163275234|NCT02611830|589716500|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
163275235|NCT02611830|589716497|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
163275236|NCT02611830|589716498|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
163275237|NCT02611830|589716499|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
163275238|NCT02611830|589716500|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
163275239|NCT02611830|589716497|FG000|Maintenance Phase|Lost to Follow-up|0|||
163275240|NCT02611830|589716498|FG001|Maintenance Phase|Lost to Follow-up|0|||
163275241|NCT02611830|589716499|FG002|Maintenance Phase|Lost to Follow-up|0|||
163275242|NCT02611830|589716500|FG003|Maintenance Phase|Lost to Follow-up|1|||
163275243|NCT02611830|589716497|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
163275244|NCT02611830|589716498|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
163275245|NCT02611830|589716499|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
163275246|NCT02611830|589716500|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
163275247|NCT02611830|589716497|FG000|Maintenance Phase|Pregnancy|0|||
163275248|NCT02611830|589716498|FG001|Maintenance Phase|Pregnancy|0|||
163275249|NCT02611830|589716499|FG002|Maintenance Phase|Pregnancy|1|||
163275250|NCT02611830|589716500|FG003|Maintenance Phase|Pregnancy|0|||
163275251|NCT02611830|589716497|FG000|Maintenance Phase|Reason not specified|0|||
163275252|NCT02611830|589716498|FG001|Maintenance Phase|Reason not specified|1|||
163275253|NCT02611830|589716499|FG002|Maintenance Phase|Reason not specified|4|||
163275254|NCT02611830|589716500|FG003|Maintenance Phase|Reason not specified|0|||
163275255|NCT01513967|589716511|FG000|Overall Study|Pregnancy|0|||
163275256|NCT01513967|589716512|FG001|Overall Study|Pregnancy|0|||
163275257|NCT01513967|589716513|FG002|Overall Study|Pregnancy|0|||
163161204|NCT01166282|589304099|FG002|Open-label Period|Remission|4|||
163161205|NCT01166282|589304097|FG000|Open-label Period|Irregular Compliance|0|||
163161206|NCT01166282|589304098|FG001|Open-label Period|Irregular Compliance|0|||
163161207|NCT01166282|589304099|FG002|Open-label Period|Irregular Compliance|1|||
163161208|NCT02892448|589304108|FG000|Overall Study|Screening failure|2|||
163161209|NCT02892448|589304109|FG001|Overall Study|Screening failure|2|||
163161210|NCT02892448|589304110|FG002|Overall Study|Screening failure|1|||
163161211|NCT01262989|589304111|FG000|Period 1|Lost to Follow-up|1|||
163161212|NCT01262989|589304112|FG001|Period 1|Lost to Follow-up|1|||
163161213|NCT01262989|589304111|FG000|Period 1|Intercurrent disease|0|||
163161214|NCT01262989|589304112|FG001|Period 1|Intercurrent disease|1|||
163161215|NCT01262989|589304111|FG000|Period 1|Positive answer for exclusion criteria|0|||
163161216|NCT01262989|589304112|FG001|Period 1|Positive answer for exclusion criteria|1|||
163161217|NCT01262989|589304111|FG000|Period 2|Intercurrent disease|0|||
163161218|NCT01262989|589304112|FG001|Period 2|Intercurrent disease|1|||
163161219|NCT03599089|589304113|FG000|Overall Study|Lost to Follow-up|1|||
163161220|NCT03599089|589304114|FG001|Overall Study|Lost to Follow-up|0|||
163161221|NCT03599089|589304115|FG002|Overall Study|Lost to Follow-up|0|||
163161222|NCT03599089|589304116|FG003|Overall Study|Lost to Follow-up|0|||
163161223|NCT03599089|589304113|FG000|Overall Study|Withdrawal by Subject|2|||
163161224|NCT03599089|589304114|FG001|Overall Study|Withdrawal by Subject|1|||
163161225|NCT03599089|589304115|FG002|Overall Study|Withdrawal by Subject|0|||
163161226|NCT03599089|589304116|FG003|Overall Study|Withdrawal by Subject|0|||
163161227|NCT03599089|589304113|FG000|Overall Study|Lack of Efficacy|0|||
163275258|NCT01513967|589716514|FG003|Overall Study|Pregnancy|0|||
163275259|NCT01513967|589716515|FG004|Overall Study|Pregnancy|0|||
163275260|NCT01513967|589716516|FG005|Overall Study|Pregnancy|0|||
163275261|NCT01513967|589716517|FG006|Overall Study|Pregnancy|1|||
163275262|NCT01513967|589716518|FG007|Overall Study|Pregnancy|0|||
163275263|NCT01513967|589716511|FG000|Overall Study|missed a study visit|0|||
163275264|NCT01513967|589716512|FG001|Overall Study|missed a study visit|0|||
163161228|NCT03599089|589304114|FG001|Overall Study|Lack of Efficacy|0|||
163161229|NCT03599089|589304115|FG002|Overall Study|Lack of Efficacy|1|||
163161230|NCT03599089|589304116|FG003|Overall Study|Lack of Efficacy|2|||
163161231|NCT03214666|589304117|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
163275265|NCT01513967|589716513|FG002|Overall Study|missed a study visit|0|||
163275266|NCT01513967|589716514|FG003|Overall Study|missed a study visit|0|||
163275267|NCT01513967|589716515|FG004|Overall Study|missed a study visit|0|||
163275268|NCT01513967|589716516|FG005|Overall Study|missed a study visit|0|||
163275269|NCT01513967|589716517|FG006|Overall Study|missed a study visit|1|||
163275270|NCT01513967|589716518|FG007|Overall Study|missed a study visit|0|||
163275271|NCT01513967|589716511|FG000|Overall Study|excluded due to positive drug screen|0|||
163275272|NCT01513967|589716512|FG001|Overall Study|excluded due to positive drug screen|0|||
163275273|NCT01513967|589716513|FG002|Overall Study|excluded due to positive drug screen|0|||
163275274|NCT01513967|589716514|FG003|Overall Study|excluded due to positive drug screen|0|||
163275275|NCT01513967|589716515|FG004|Overall Study|excluded due to positive drug screen|0|||
163275276|NCT01513967|589716516|FG005|Overall Study|excluded due to positive drug screen|0|||
163275277|NCT01513967|589716517|FG006|Overall Study|excluded due to positive drug screen|0|||
163275278|NCT01513967|589716518|FG007|Overall Study|excluded due to positive drug screen|2|||
163275279|NCT01513967|589716511|FG000|Overall Study|Physician Decision|0|||
163275280|NCT01513967|589716512|FG001|Overall Study|Physician Decision|0|||
163275281|NCT01513967|589716513|FG002|Overall Study|Physician Decision|0|||
163275282|NCT01513967|589716514|FG003|Overall Study|Physician Decision|0|||
163275283|NCT01513967|589716515|FG004|Overall Study|Physician Decision|0|||
163275284|NCT01513967|589716516|FG005|Overall Study|Physician Decision|1|||
163275285|NCT01513967|589716517|FG006|Overall Study|Physician Decision|0|||
163275286|NCT01513967|589716518|FG007|Overall Study|Physician Decision|0|||
163275287|NCT01987830|589716519|FG000|Overall Study|Never received baseline scan|1|||
163275288|NCT00544544|589716520|FG000|Overall Study|Withdrawal by Subject|1|||
163275289|NCT00544544|589716520|FG000|Overall Study|Adverse Event|1|||
163275290|NCT00544544|589716520|FG000|Overall Study|Lost to Follow-up|1|||
163275291|NCT02107274|589718035|FG000|Treatment vs. Placebo|Adverse Event|3|||
163275292|NCT02107274|589718036|FG001|Treatment vs. Placebo|Adverse Event|0|||
163275293|NCT02107274|589718035|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
163275294|NCT02107274|589718036|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
163275295|NCT02107274|589718035|FG000|Control Phase|Lost to Follow-up|1|||
163275296|NCT02107274|589718036|FG001|Control Phase|Lost to Follow-up|1|||
163275297|NCT02107274|589718035|FG000|Control Phase|Death|2|||
163275298|NCT02107274|589718036|FG001|Control Phase|Death|0|||
163275299|NCT02107274|589718035|FG000|Control Phase|Adverse Event|0|||
163275300|NCT02107274|589718036|FG001|Control Phase|Adverse Event|1|||
163275301|NCT05305040|589718039|FG000|Overall Study|Not Dosed|37|||
163275302|NCT05305040|589718040|FG001|Overall Study|Not Dosed|37|||
163275303|NCT05305040|589718039|FG000|Overall Study|Study Closure|34|||
163275304|NCT05305040|589718040|FG001|Overall Study|Study Closure|46|||
163275305|NCT05305040|589718039|FG000|Overall Study|Death|14|||
163275306|NCT05305040|589718040|FG001|Overall Study|Death|13|||
163275307|NCT05305040|589718039|FG000|Overall Study|Withdrawal by Subject|15|||
163275308|NCT05305040|589718040|FG001|Overall Study|Withdrawal by Subject|10|||
163275309|NCT05305040|589718039|FG000|Overall Study|Other|13|||
163275310|NCT05305040|589718040|FG001|Overall Study|Other|10|||
163275311|NCT05305040|589718039|FG000|Overall Study|Primary Malignancy Relapse|3|||
163275312|NCT05305040|589718040|FG001|Overall Study|Primary Malignancy Relapse|4|||
163275313|NCT05305040|589718039|FG000|Overall Study|Adverse Event|3|||
163275314|NCT05305040|589718040|FG001|Overall Study|Adverse Event|3|||
163275315|NCT05305040|589718039|FG000|Overall Study|Lost to Follow-up|2|||
163275316|NCT05305040|589718040|FG001|Overall Study|Lost to Follow-up|1|||
163275317|NCT05305040|589718039|FG000|Overall Study|Graft versus host disease|2|||
163275318|NCT05305040|589718040|FG001|Overall Study|Graft versus host disease|0|||
163275319|NCT05305040|589718039|FG000|Overall Study|Investigator's Decision|1|||
163275320|NCT05305040|589718040|FG001|Overall Study|Investigator's Decision|1|||
163275321|NCT05305040|589718039|FG000|Overall Study|COVID-19 Reasons|1|||
163275322|NCT05305040|589718040|FG001|Overall Study|COVID-19 Reasons|0|||
163275323|NCT02206685|589718041|FG000|Overall Study|Surgery cancelled/changed|2|||
163275324|NCT02206685|589718042|FG001|Overall Study|Surgery cancelled/changed|3|||
163275325|NCT02206685|589718041|FG000|Overall Study|Withdrawal by Subject|1|||
163275326|NCT02206685|589718042|FG001|Overall Study|Withdrawal by Subject|2|||
163275327|NCT02206685|589718041|FG000|Overall Study|Protocol Violation|2|||
163275328|NCT02206685|589718042|FG001|Overall Study|Protocol Violation|2|||
163275329|NCT01195675|589718043|FG000|Overall Study|Adverse Event|1|||
163275330|NCT01195675|589718043|FG000|Overall Study|Withdrawal by Subject|2|||
163275331|NCT02424344|589718044|FG000|Overall Study|Lack of Efficacy|0|||
163275332|NCT02424344|589718045|FG001|Overall Study|Lack of Efficacy|1|||
163275333|NCT02424344|589718044|FG000|Overall Study|Withdrawal by Subject|2|||
163275334|NCT02424344|589718045|FG001|Overall Study|Withdrawal by Subject|1|||
163161232|NCT03214666|589304118|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
163275335|NCT02424344|589718044|FG000|Overall Study|Lost to Follow-up|1|||
163275336|NCT02424344|589718045|FG001|Overall Study|Lost to Follow-up|0|||
163275337|NCT02424344|589718044|FG000|Overall Study|Adverse Event|4|||
163275338|NCT02424344|589718045|FG001|Overall Study|Adverse Event|8|||
163275339|NCT04730947|589718046|FG000|Overall Study|Withdrawal by Subject|0|||
163275340|NCT04730947|589718047|FG001|Overall Study|Withdrawal by Subject|1|||
163275341|NCT01174550|589718048|FG000|Overall Study|Death|75|||
163275342|NCT01174550|589718049|FG001|Overall Study|Death|74|||
163275343|NCT01174550|589718048|FG000|Overall Study|Lost to Follow-up|652|||
163275344|NCT01174550|589718049|FG001|Overall Study|Lost to Follow-up|510|||
163275345|NCT01174550|589718048|FG000|Overall Study|Withdrawal by Subject|543|||
163275346|NCT01174550|589718049|FG001|Overall Study|Withdrawal by Subject|289|||
163275347|NCT02123966|589718050|FG000|Overall Study|Intercurrent Illness|1|||
163275348|NCT01536262|589718051|FG000|Overall Study|Adverse Event|6|||
163275349|NCT01536262|589718052|FG001|Overall Study|Adverse Event|1|||
163275350|NCT01536262|589718053|FG002|Overall Study|Adverse Event|2|||
163275351|NCT01536262|589718051|FG000|Overall Study|Withdrawal by Subject|1|||
163275352|NCT01536262|589718052|FG001|Overall Study|Withdrawal by Subject|1|||
163275353|NCT01536262|589718053|FG002|Overall Study|Withdrawal by Subject|0|||
163275354|NCT01536262|589718051|FG000|Overall Study|Other than stated above|1|||
163275355|NCT01536262|589718052|FG001|Overall Study|Other than stated above|0|||
163275356|NCT01536262|589718053|FG002|Overall Study|Other than stated above|0|||
163275357|NCT01460381|589718057|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
163275358|NCT01460381|589718058|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
163275359|NCT01097655|589718059|FG000|Overall Study|Withdrawal by Subject|1|||
163275360|NCT01097655|589718059|FG000|Overall Study|Subject Documented Twice|1|||
163275361|NCT01097655|589718059|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
163275362|NCT02561455|589718060|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
163275363|NCT02561455|589718061|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
163275364|NCT02561455|589718062|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
163275365|NCT02561455|589718063|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
163275366|NCT02561455|589718060|FG000|Overall Study|Withdrawal by Subject|1|||
163275367|NCT02561455|589718061|FG001|Overall Study|Withdrawal by Subject|0|||
163275368|NCT02561455|589718062|FG002|Overall Study|Withdrawal by Subject|1|||
163275369|NCT02561455|589718063|FG003|Overall Study|Withdrawal by Subject|0|||
163275370|NCT02561455|589718060|FG000|Overall Study|Disease Progression|0|||
163275371|NCT02561455|589718061|FG001|Overall Study|Disease Progression|1|||
163275372|NCT02561455|589718062|FG002|Overall Study|Disease Progression|0|||
163275373|NCT02561455|589718063|FG003|Overall Study|Disease Progression|0|||
163275374|NCT03639675|589718064|FG000|Overall Study|Withdrawal by Subject|1|||
163275375|NCT01021332|589718065|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
163275376|NCT01021332|589718065|FG000|Overall Study|Adverse Event|43|||
163275377|NCT01021332|589718065|FG000|Overall Study|Lack of Efficacy|19|||
163275378|NCT01021332|589718065|FG000|Overall Study|Withdrawal of Consent|23|||
163275379|NCT01021332|589718065|FG000|Overall Study|Lost to Follow-up|4|||
163275380|NCT01021332|589718065|FG000|Overall Study|Protocol Violation|9|||
163275381|NCT01021332|589718065|FG000|Overall Study|Miscellaneous|3|||
163275382|NCT00826280|589718066|FG000|Overall Study|Randomized but drug not received|1|||
163275383|NCT00826280|589718067|FG001|Overall Study|Randomized but drug not received|0|||
163275384|NCT00826280|589718068|FG002|Overall Study|Randomized but drug not received|1|||
163275385|NCT00826280|589718066|FG000|Overall Study|Adverse Event|1|||
163275386|NCT00826280|589718067|FG001|Overall Study|Adverse Event|3|||
163275387|NCT00826280|589718068|FG002|Overall Study|Adverse Event|0|||
163275388|NCT00826280|589718066|FG000|Overall Study|Lost to Follow-up|0|||
163275389|NCT00826280|589718067|FG001|Overall Study|Lost to Follow-up|1|||
163275390|NCT00826280|589718068|FG002|Overall Study|Lost to Follow-up|0|||
163275391|NCT00826280|589718066|FG000|Overall Study|Sponsor discontinued subject or study|1|||
163275392|NCT00826280|589718067|FG001|Overall Study|Sponsor discontinued subject or study|0|||
163275393|NCT00826280|589718068|FG002|Overall Study|Sponsor discontinued subject or study|0|||
163275394|NCT00826280|589718066|FG000|Overall Study|Reversible ischemic defect not present|43|||
163275395|NCT00826280|589718067|FG001|Overall Study|Reversible ischemic defect not present|40|||
163275396|NCT00826280|589718068|FG002|Overall Study|Reversible ischemic defect not present|44|||
163275397|NCT00826280|589718066|FG000|Overall Study|Interpretation Failure|1|||
163275398|NCT00826280|589718067|FG001|Overall Study|Interpretation Failure|0|||
163275399|NCT00826280|589718068|FG002|Overall Study|Interpretation Failure|0|||
163275400|NCT00826280|589718066|FG000|Overall Study|Machine Failure|1|||
163275401|NCT00826280|589718067|FG001|Overall Study|Machine Failure|1|||
163275402|NCT00826280|589718068|FG002|Overall Study|Machine Failure|0|||
163275403|NCT00826280|589718066|FG000|Overall Study|One or more non-interpretable scan|0|||
163275404|NCT00826280|589718067|FG001|Overall Study|One or more non-interpretable scan|1|||
163275405|NCT00826280|589718068|FG002|Overall Study|One or more non-interpretable scan|1|||
163275406|NCT05343455|589718071|FG000|Overall Study|Withdrawal by Subject|4|||
163275407|NCT05343455|589718072|FG001|Overall Study|Withdrawal by Subject|9|||
163275408|NCT05343455|589718073|FG002|Overall Study|Withdrawal by Subject|7|||
163275409|NCT05343455|589718071|FG000|Overall Study|Adverse Event|2|||
163275410|NCT05343455|589718072|FG001|Overall Study|Adverse Event|1|||
163275411|NCT05343455|589718073|FG002|Overall Study|Adverse Event|2|||
163275412|NCT05343455|589718071|FG000|Overall Study|Lost to Follow-up|1|||
163275413|NCT05343455|589718072|FG001|Overall Study|Lost to Follow-up|1|||
163275414|NCT05343455|589718073|FG002|Overall Study|Lost to Follow-up|3|||
163275415|NCT05343455|589718071|FG000|Overall Study|Pregnancy|1|||
163275416|NCT05343455|589718072|FG001|Overall Study|Pregnancy|0|||
163275417|NCT05343455|589718073|FG002|Overall Study|Pregnancy|0|||
163275418|NCT05343455|589718071|FG000|Overall Study|Physician Decision|0|||
163275419|NCT05343455|589718072|FG001|Overall Study|Physician Decision|0|||
163275420|NCT05343455|589718073|FG002|Overall Study|Physician Decision|1|||
163275421|NCT05343455|589718071|FG000|Overall Study|Protocol Violation|0|||
163275422|NCT05343455|589718072|FG001|Overall Study|Protocol Violation|1|||
163275423|NCT05343455|589718073|FG002|Overall Study|Protocol Violation|1|||
163275424|NCT03354637|589718076|FG000|Double-blind Period|Protocol Violation|2|||
163275425|NCT03354637|589718077|FG001|Double-blind Period|Protocol Violation|0|||
163275426|NCT03354637|589718078|FG002|Double-blind Period|Protocol Violation|0|||
163275427|NCT03354637|589718076|FG000|Double-blind Period|Adverse Event|1|||
163275428|NCT03354637|589718077|FG001|Double-blind Period|Adverse Event|2|||
163275429|NCT03354637|589718078|FG002|Double-blind Period|Adverse Event|0|||
163275430|NCT03354637|589718076|FG000|Double-blind Period|Lost to Follow-up|3|||
163275431|NCT03354637|589718077|FG001|Double-blind Period|Lost to Follow-up|4|||
163275432|NCT03354637|589718078|FG002|Double-blind Period|Lost to Follow-up|3|||
163275433|NCT03354637|589718076|FG000|Double-blind Period|Withdrawal by Subject|10|||
163275434|NCT03354637|589718077|FG001|Double-blind Period|Withdrawal by Subject|6|||
163275435|NCT03354637|589718078|FG002|Double-blind Period|Withdrawal by Subject|4|||
163275436|NCT03354637|589718076|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
163275437|NCT03354637|589718077|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
163275438|NCT03354637|589718078|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
163275439|NCT03354637|589718076|FG000|Open Label Extension|Adverse Event|0|||
163275440|NCT03354637|589718077|FG001|Open Label Extension|Adverse Event|0|||
163275441|NCT03354637|589718078|FG002|Open Label Extension|Adverse Event|1|||
163275442|NCT03354637|589718076|FG000|Open Label Extension|Lost to Follow-up|0|||
163275443|NCT03354637|589718077|FG001|Open Label Extension|Lost to Follow-up|0|||
163275444|NCT03354637|589718078|FG002|Open Label Extension|Lost to Follow-up|2|||
163275445|NCT03354637|589718076|FG000|Open Label Extension|Withdrawal by Subject|0|||
163275446|NCT03354637|589718077|FG001|Open Label Extension|Withdrawal by Subject|0|||
163275447|NCT03354637|589718078|FG002|Open Label Extension|Withdrawal by Subject|5|||
163275448|NCT03354637|589718076|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
163275449|NCT03354637|589718077|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
163275450|NCT03354637|589718078|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
163275451|NCT03354637|589718076|FG000|Open Label Extension|Subject Noncompliance|0|||
163275452|NCT03354637|589718077|FG001|Open Label Extension|Subject Noncompliance|0|||
163275453|NCT03354637|589718078|FG002|Open Label Extension|Subject Noncompliance|1|||
163275454|NCT03354637|589718076|FG000|Open Label Extension|Lack of Efficacy|0|||
163275455|NCT03354637|589718077|FG001|Open Label Extension|Lack of Efficacy|0|||
163275456|NCT03354637|589718078|FG002|Open Label Extension|Lack of Efficacy|1|||
163275457|NCT03354637|589718076|FG000|Open Label Extension|Physician Decision|0|||
163275458|NCT03354637|589718077|FG001|Open Label Extension|Physician Decision|0|||
163275459|NCT03354637|589718078|FG002|Open Label Extension|Physician Decision|1|||
163275460|NCT04006366|589718079|FG000|Overall Study|Withdrawal by Subject|1|||
163275461|NCT01603121|589718082|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
163275462|NCT01603121|589718083|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
163275463|NCT00738530|589718084|FG000|Overall Study|Death|220|||
163275464|NCT00738530|589718085|FG001|Overall Study|Death|224|||
163275465|NCT00738530|589718084|FG000|Overall Study|Lost to Follow-up|8|||
163275466|NCT00738530|589718085|FG001|Overall Study|Lost to Follow-up|6|||
163275467|NCT00738530|589718084|FG000|Overall Study|Withdrawal by Subject|6|||
163275468|NCT00738530|589718085|FG001|Overall Study|Withdrawal by Subject|8|||
163275469|NCT01628510|589718086|FG000|Overall Study|Withdrawal by Subject|0|||
163275470|NCT01628510|589718087|FG001|Overall Study|Withdrawal by Subject|4|||
163275471|NCT01628510|589718086|FG000|Overall Study|Death|3|||
163275472|NCT01628510|589718087|FG001|Overall Study|Death|1|||
163275473|NCT01656759|589718088|FG000|Overall Study|Protocol Violation|2|||
163275474|NCT01656759|589718089|FG001|Overall Study|Protocol Violation|3|||
163275475|NCT04179461|589718090|FG000|Overall Study|Lost to Follow-up|4|||
163275476|NCT03160079|589718098|FG000|Overall Study|Adverse Event|2|||
163275477|NCT03160079|589718099|FG001|Overall Study|Adverse Event|0|||
163275478|NCT03160079|589718098|FG000|Overall Study|Disease Progression|1|||
163275479|NCT03160079|589718099|FG001|Overall Study|Disease Progression|0|||
163275480|NCT03160079|589718098|FG000|Overall Study|Physician Decision|1|||
163275481|NCT03160079|589718099|FG001|Overall Study|Physician Decision|0|||
163275482|NCT03259373|589718111|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
163275483|NCT03259373|589718112|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
163275484|NCT03259373|589718111|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
163275485|NCT03259373|589718112|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
163275486|NCT03259373|589718111|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
163275487|NCT03259373|589718112|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
163275488|NCT03259373|589718111|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
163275489|NCT03259373|589718112|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
163275490|NCT03259373|589718111|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
163275491|NCT03259373|589718112|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
163275492|NCT03259373|589718111|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
163275493|NCT03259373|589718112|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
163275494|NCT05764239|589718118|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
163275495|NCT05764239|589718118|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
163275496|NCT05764239|589718118|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
163275497|NCT05764239|589718118|FG000|DEP (Part 1)|Adverse Event|1|||
163275498|NCT05764239|589718118|FG000|DEP (Part 1)|Lost to Follow-up|1|||
163275499|NCT05764239|589718118|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
163275500|NCT05764239|589718118|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
163275501|NCT05764239|589718118|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
163275502|NCT05764239|589718118|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
163275503|NCT00057811|589718122|FG000|Overall Study|Lack of Efficacy|1|||
163275504|NCT00057811|589718123|FG001|Overall Study|Lack of Efficacy|4|||
163275505|NCT00057811|589718122|FG000|Overall Study|Physician Decision|1|||
163385796|NCT03224325|590123243|FG000|Overall Study|Adverse Event|1|||
163385797|NCT03224325|590123244|FG001|Overall Study|Adverse Event|0|||
163385798|NCT03224325|590123245|FG002|Overall Study|Adverse Event|0|||
163385799|NCT03224325|590123246|FG003|Overall Study|Adverse Event|0|||
163385800|NCT03224325|590123247|FG004|Overall Study|Adverse Event|0|||
163385801|NCT03224325|590123248|FG005|Overall Study|Adverse Event|0|||
163385802|NCT03224325|590123249|FG006|Overall Study|Adverse Event|1|||
163385803|NCT03224325|590123243|FG000|Overall Study|Withdrawal by Subject|0|||
163385804|NCT03224325|590123244|FG001|Overall Study|Withdrawal by Subject|0|||
163385805|NCT03224325|590123245|FG002|Overall Study|Withdrawal by Subject|0|||
163385806|NCT03224325|590123246|FG003|Overall Study|Withdrawal by Subject|1|||
163385807|NCT03224325|590123247|FG004|Overall Study|Withdrawal by Subject|0|||
163385808|NCT03224325|590123248|FG005|Overall Study|Withdrawal by Subject|0|||
163385809|NCT03224325|590123249|FG006|Overall Study|Withdrawal by Subject|0|||
163385810|NCT02072434|590123253|FG000|Overall Study|Protocol Violation|10|||
163385811|NCT02072434|590123254|FG001|Overall Study|Protocol Violation|9|||
163385812|NCT02072434|590123253|FG000|Overall Study|Physician Decision|5|||
163385813|NCT02072434|590123254|FG001|Overall Study|Physician Decision|10|||
163385814|NCT02072434|590123253|FG000|Overall Study|Adverse event, serious fatal|1|||
163385815|NCT02072434|590123254|FG001|Overall Study|Adverse event, serious fatal|6|||
163385816|NCT02072434|590123253|FG000|Overall Study|Adverse Event|7|||
163385817|NCT02072434|590123254|FG001|Overall Study|Adverse Event|6|||
163385818|NCT02072434|590123253|FG000|Overall Study|Withdrawal by Subject|17|||
163385819|NCT02072434|590123254|FG001|Overall Study|Withdrawal by Subject|29|||
163385820|NCT02072434|590123253|FG000|Overall Study|Other|14|||
163385821|NCT02072434|590123254|FG001|Overall Study|Other|29|||
163385822|NCT02072434|590123253|FG000|Overall Study|Lost to Follow-up|0|||
163385823|NCT02072434|590123254|FG001|Overall Study|Lost to Follow-up|1|||
163385824|NCT01117454|590123257|FG000|Overall Study|Pregnancy|0|||
163385825|NCT01117454|590123258|FG001|Overall Study|Pregnancy|1|||
163385826|NCT00888433|590123261|FG000|Overall Study|Withdrawal by Subject|1|||
163385827|NCT00888433|590123262|FG001|Overall Study|Withdrawal by Subject|2|||
163385828|NCT00888433|590123261|FG000|Overall Study|Missed Visit|2|||
163385829|NCT00888433|590123262|FG001|Overall Study|Missed Visit|1|||
163385830|NCT02276872|590123263|FG000|Overall Study|Adverse Event|1|||
163385831|NCT02276872|590123264|FG001|Overall Study|Adverse Event|0|||
163385832|NCT02276872|590123265|FG002|Overall Study|Adverse Event|0|||
163385833|NCT04175808|590123266|FG000|Part A|Miscellaneous|2|||
163385834|NCT04175808|590123267|FG001|Part A|Miscellaneous|0|||
163385835|NCT04175808|590123268|FG002|Part A|Miscellaneous|0|||
163385836|NCT04175808|590123269|FG003|Part A|Miscellaneous|0|||
163385837|NCT04175808|590123270|FG004|Part A|Miscellaneous|0|||
163385838|NCT04175808|590123271|FG005|Part A|Miscellaneous|0|||
163385839|NCT04175808|590123272|FG006|Part A|Miscellaneous|0|||
163385840|NCT02544217|590123274|FG000|Overall Study|Withdrawal by Subject|1|||
163385841|NCT02544217|590123275|FG001|Overall Study|Withdrawal by Subject|1|||
163385842|NCT02544217|590123276|FG002|Overall Study|Withdrawal by Subject|0|||
163385843|NCT02544217|590123277|FG003|Overall Study|Withdrawal by Subject|0|||
163385844|NCT02544217|590123278|FG004|Overall Study|Withdrawal by Subject|0|||
163385845|NCT02544217|590123279|FG005|Overall Study|Withdrawal by Subject|0|||
163385846|NCT03278106|590123280|FG000|Overall Study|No protocol treatment|1|||
163385847|NCT03952806|590123285|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
163385848|NCT03952806|590123286|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
163385849|NCT03952806|590123285|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
163385850|NCT03952806|590123286|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
163275506|NCT00057811|589718123|FG001|Overall Study|Physician Decision|0|||
163385851|NCT03952806|590123285|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
163385852|NCT03952806|590123286|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
163385853|NCT03952806|590123285|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
163385854|NCT03952806|590123286|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
163385855|NCT03952806|590123285|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
163385856|NCT03952806|590123286|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
163385857|NCT03952806|590123285|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
163385858|NCT03952806|590123286|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
163385859|NCT03952806|590123285|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
163275507|NCT00057811|589718122|FG000|Overall Study|Withdrawal by Subject|3|||
163275508|NCT00057811|589718123|FG001|Overall Study|Withdrawal by Subject|4|||
163275509|NCT00057811|589718122|FG000|Overall Study|Ineligible|4|||
163275510|NCT00057811|589718123|FG001|Overall Study|Ineligible|2|||
163275511|NCT00057811|589718122|FG000|Overall Study|Inevaluable|1|||
163275512|NCT00057811|589718123|FG001|Overall Study|Inevaluable|2|||
163275513|NCT00556374|589718124|FG000|Overall Study|Withdrawal by Subject|235|||
163275514|NCT00556374|589718125|FG001|Overall Study|Withdrawal by Subject|205|||
163275515|NCT00556374|589718124|FG000|Overall Study|Death|158|||
163275516|NCT00556374|589718125|FG001|Overall Study|Death|127|||
163275517|NCT00556374|589718124|FG000|Overall Study|Lost to Follow-up|24|||
163275518|NCT00556374|589718125|FG001|Overall Study|Lost to Follow-up|17|||
163275519|NCT00556374|589718124|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
163275520|NCT00556374|589718125|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
163275521|NCT04131907|589718126|FG000|Overall Study|Adverse Event|2|||
163275522|NCT04131907|589718127|FG001|Overall Study|Adverse Event|0|||
163275523|NCT04131907|589718128|FG002|Overall Study|Adverse Event|0|||
163275524|NCT04131907|589718126|FG000|Overall Study|Physician Decision|4|||
163275525|NCT04131907|589718127|FG001|Overall Study|Physician Decision|22|||
163275526|NCT04131907|589718128|FG002|Overall Study|Physician Decision|0|||
163275527|NCT04131907|589718126|FG000|Overall Study|Withdrawal by Subject|2|||
163275528|NCT04131907|589718127|FG001|Overall Study|Withdrawal by Subject|0|||
163275529|NCT04131907|589718128|FG002|Overall Study|Withdrawal by Subject|1|||
163275530|NCT04131907|589718126|FG000|Overall Study|Treatment failure|2|||
163275531|NCT04131907|589718127|FG001|Overall Study|Treatment failure|0|||
163275532|NCT04131907|589718128|FG002|Overall Study|Treatment failure|1|||
163275533|NCT05294419|589718129|FG000|Overall Study|Protocol Violation|4|||
163275534|NCT05294419|589718130|FG001|Overall Study|Protocol Violation|0|||
163275535|NCT05294419|589718131|FG002|Overall Study|Protocol Violation|0|||
163275536|NCT05294419|589718129|FG000|Overall Study|Lost to Follow-up|6|||
163275537|NCT05294419|589718130|FG001|Overall Study|Lost to Follow-up|0|||
163275538|NCT05294419|589718131|FG002|Overall Study|Lost to Follow-up|0|||
163275539|NCT05294419|589718129|FG000|Overall Study|Results voided after publishing|2|||
163275540|NCT05294419|589718130|FG001|Overall Study|Results voided after publishing|0|||
163275541|NCT05294419|589718131|FG002|Overall Study|Results voided after publishing|0|||
163275542|NCT00847301|589718132|FG000|Overall Study|Adverse Event|35|||
163275543|NCT00847301|589718132|FG000|Overall Study|Switch to other anticoagulants|16|||
163275544|NCT00847301|589718132|FG000|Overall Study|Lost to Follow-up|1|||
163275545|NCT00847301|589718132|FG000|Overall Study|No prescription after hospital discharge|1|||
163275546|NCT00847301|589718132|FG000|Overall Study|Other reason not defined above|1|||
163275547|NCT00442286|589718133|FG000|Overall Study|Death|2|||
163275548|NCT00442286|589718134|FG001|Overall Study|Death|2|||
163275549|NCT00442286|589718133|FG000|Overall Study|Lost to Follow-up|1|||
163275550|NCT00442286|589718134|FG001|Overall Study|Lost to Follow-up|0|||
163275551|NCT00442286|589718133|FG000|Overall Study|Withdrawal by Subject|2|||
163275552|NCT00442286|589718134|FG001|Overall Study|Withdrawal by Subject|0|||
163275553|NCT00442286|589718133|FG000|Overall Study|System explanted|1|||
163275554|NCT00442286|589718134|FG001|Overall Study|System explanted|0|||
163275555|NCT00442286|589718133|FG000|Overall Study|Patient Injury|1|||
163275556|NCT00442286|589718134|FG001|Overall Study|Patient Injury|0|||
163275557|NCT00641186|589718135|FG000|Overall Study|Adverse Event|3|||
163275558|NCT05221749|589718138|FG000|Overall Study|Lost to Follow-up|2|||
163275559|NCT05221749|589718139|FG001|Overall Study|Lost to Follow-up|3|||
163275560|NCT03428815|589718140|FG000|Overall Study|Lost to Follow-up|2|||
163275561|NCT03428815|589718141|FG001|Overall Study|Lost to Follow-up|2|||
163275562|NCT03428815|589718140|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
163275563|NCT03428815|589718141|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
163275564|NCT03428815|589718140|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
163275565|NCT03428815|589718141|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
163275566|NCT04140890|589718144|FG000|Overall Study|Withdrawal by Subject|0|||
163275567|NCT04140890|589718145|FG001|Overall Study|Withdrawal by Subject|1|||
163161233|NCT03214666|589304119|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
163275568|NCT01700348|589718146|FG000|Overall Study|Withdrawal by Subject|22|||
163275569|NCT01700348|589718146|FG000|Overall Study|Lost to Follow-up|1|||
163161234|NCT03214666|589304120|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
163161235|NCT03214666|589304121|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
163161236|NCT03214666|589304122|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
163275570|NCT02404493|589718147|FG000|Overall Study|Adverse Event|1|||
163275571|NCT02404493|589718148|FG001|Overall Study|Adverse Event|1|||
163275572|NCT02102464|589718149|FG000|Randomized Study|Withdrawal by Subject|0|||
163275573|NCT02102464|589718150|FG001|Randomized Study|Withdrawal by Subject|1|||
163275574|NCT02102464|589718151|FG002|Randomized Study|Withdrawal by Subject|0|||
163275575|NCT02388074|589718152|FG000|Overall Study|Lost in Transit|2|||
163275576|NCT02388074|589718152|FG000|Overall Study|Sample Not Returned|1|||
163275577|NCT01778062|589718155|FG000|Overall Study|Adverse Event|1|||
163275578|NCT01778062|589718156|FG001|Overall Study|Adverse Event|3|||
163275579|NCT01778062|589718155|FG000|Overall Study|Consent Withdrawal|1|||
163275580|NCT01778062|589718156|FG001|Overall Study|Consent Withdrawal|5|||
163275581|NCT01778062|589718155|FG000|Overall Study|major protocol deviation|4|||
163275582|NCT01778062|589718156|FG001|Overall Study|major protocol deviation|3|||
163275583|NCT03958630|589718157|FG000|Overall Study|Withdrawal by Subject|0|||
163275584|NCT03958630|589718158|FG001|Overall Study|Withdrawal by Subject|0|||
163275585|NCT03958630|589718159|FG002|Overall Study|Withdrawal by Subject|1|||
163275586|NCT03958630|589718157|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
163275587|NCT03958630|589718158|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
163275588|NCT03958630|589718159|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
163275589|NCT03317379|589718169|FG000|Overall Study|Lost to Follow-up|0|||
163275590|NCT03317379|589718170|FG001|Overall Study|Lost to Follow-up|3|||
163275591|NCT03317379|589718171|FG002|Overall Study|Lost to Follow-up|2|||
163275592|NCT04445155|589718172|FG000|Overall Study|Lost to Follow-up|11|||
163275593|NCT04445155|589718173|FG001|Overall Study|Lost to Follow-up|2|||
163275594|NCT04445155|589718174|FG002|Overall Study|Lost to Follow-up|3|||
163275595|NCT04445155|589718175|FG003|Overall Study|Lost to Follow-up|0|||
163275596|NCT04445155|589718172|FG000|Overall Study|Withdrawal by Subject|8|||
163275597|NCT04445155|589718173|FG001|Overall Study|Withdrawal by Subject|0|||
163275598|NCT04445155|589718174|FG002|Overall Study|Withdrawal by Subject|0|||
163275599|NCT04445155|589718175|FG003|Overall Study|Withdrawal by Subject|0|||
163275600|NCT04445155|589718172|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
163385860|NCT03952806|590123286|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
163385861|NCT03952806|590123285|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
163385862|NCT03952806|590123286|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
163385863|NCT03952806|590123285|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
163385864|NCT03952806|590123286|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
163385865|NCT03952806|590123285|FG000|OLE Phase (48 Weeks)|Other|16|||
163385866|NCT03952806|590123286|FG001|OLE Phase (48 Weeks)|Other|13|||
163385867|NCT00068588|590123287|FG000|Overall Study|Adverse Event|0|||
163275601|NCT04445155|589718173|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
163275602|NCT04445155|589718174|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
163275603|NCT04445155|589718175|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
163275604|NCT04445155|589718172|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
163275605|NCT04445155|589718173|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
163275606|NCT04445155|589718174|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
163275607|NCT04445155|589718175|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
163275608|NCT04157686|589718176|FG000|Overall Study|Adverse Event|1|||
163275609|NCT04157686|589718177|FG001|Overall Study|Adverse Event|0|||
163275610|NCT04157686|589718178|FG002|Overall Study|Adverse Event|1|||
163275611|NCT04157686|589718179|FG003|Overall Study|Adverse Event|0|||
163275612|NCT04157686|589718180|FG004|Overall Study|Adverse Event|1|||
163275613|NCT04157686|589718181|FG005|Overall Study|Adverse Event|0|||
163275614|NCT04157686|589718182|FG006|Overall Study|Adverse Event|0|||
163275615|NCT04157686|589718183|FG007|Overall Study|Adverse Event|0|||
163275616|NCT04157686|589718176|FG000|Overall Study|Pregnancy|0|||
163275617|NCT04157686|589718177|FG001|Overall Study|Pregnancy|1|||
163275618|NCT04157686|589718178|FG002|Overall Study|Pregnancy|3|||
163275619|NCT04157686|589718179|FG003|Overall Study|Pregnancy|0|||
163275620|NCT04157686|589718180|FG004|Overall Study|Pregnancy|0|||
163275621|NCT04157686|589718181|FG005|Overall Study|Pregnancy|0|||
163275622|NCT04157686|589718182|FG006|Overall Study|Pregnancy|3|||
163275623|NCT04157686|589718183|FG007|Overall Study|Pregnancy|0|||
163275624|NCT04157686|589718176|FG000|Overall Study|Lost to Follow-up|1|||
163275625|NCT04157686|589718177|FG001|Overall Study|Lost to Follow-up|2|||
163275626|NCT04157686|589718178|FG002|Overall Study|Lost to Follow-up|8|||
163275627|NCT04157686|589718179|FG003|Overall Study|Lost to Follow-up|6|||
163275628|NCT04157686|589718180|FG004|Overall Study|Lost to Follow-up|6|||
163275629|NCT04157686|589718181|FG005|Overall Study|Lost to Follow-up|3|||
163275630|NCT04157686|589718182|FG006|Overall Study|Lost to Follow-up|7|||
163275631|NCT04157686|589718183|FG007|Overall Study|Lost to Follow-up|9|||
163275632|NCT04157686|589718176|FG000|Overall Study|Lack of Efficacy|0|||
163275633|NCT04157686|589718177|FG001|Overall Study|Lack of Efficacy|0|||
163275634|NCT04157686|589718178|FG002|Overall Study|Lack of Efficacy|0|||
163275635|NCT04157686|589718179|FG003|Overall Study|Lack of Efficacy|0|||
163275636|NCT04157686|589718180|FG004|Overall Study|Lack of Efficacy|0|||
163275637|NCT04157686|589718181|FG005|Overall Study|Lack of Efficacy|2|||
163275638|NCT04157686|589718182|FG006|Overall Study|Lack of Efficacy|0|||
163275639|NCT04157686|589718183|FG007|Overall Study|Lack of Efficacy|1|||
163275640|NCT04157686|589718176|FG000|Overall Study|Withdrawal by Subject|10|||
163275641|NCT04157686|589718177|FG001|Overall Study|Withdrawal by Subject|10|||
163275642|NCT04157686|589718178|FG002|Overall Study|Withdrawal by Subject|12|||
163275643|NCT04157686|589718179|FG003|Overall Study|Withdrawal by Subject|20|||
163275644|NCT04157686|589718180|FG004|Overall Study|Withdrawal by Subject|12|||
163275645|NCT04157686|589718181|FG005|Overall Study|Withdrawal by Subject|11|||
163275646|NCT04157686|589718182|FG006|Overall Study|Withdrawal by Subject|18|||
163275647|NCT04157686|589718183|FG007|Overall Study|Withdrawal by Subject|24|||
163275648|NCT04157686|589718176|FG000|Overall Study|Physician Decision|0|||
163275649|NCT04157686|589718177|FG001|Overall Study|Physician Decision|0|||
163275650|NCT04157686|589718178|FG002|Overall Study|Physician Decision|1|||
163275651|NCT04157686|589718179|FG003|Overall Study|Physician Decision|0|||
163275652|NCT04157686|589718180|FG004|Overall Study|Physician Decision|1|||
163275653|NCT04157686|589718181|FG005|Overall Study|Physician Decision|0|||
163275654|NCT04157686|589718182|FG006|Overall Study|Physician Decision|3|||
163275655|NCT04157686|589718183|FG007|Overall Study|Physician Decision|0|||
163275656|NCT04157686|589718176|FG000|Overall Study|Death|0|||
163275657|NCT04157686|589718177|FG001|Overall Study|Death|0|||
163275658|NCT04157686|589718178|FG002|Overall Study|Death|0|||
163275659|NCT04157686|589718179|FG003|Overall Study|Death|2|||
163275660|NCT04157686|589718180|FG004|Overall Study|Death|0|||
163275661|NCT04157686|589718181|FG005|Overall Study|Death|0|||
163275662|NCT04157686|589718182|FG006|Overall Study|Death|0|||
163275663|NCT04157686|589718183|FG007|Overall Study|Death|0|||
163275664|NCT04157686|589718176|FG000|Overall Study|Protocol Violation|0|||
163275665|NCT04157686|589718177|FG001|Overall Study|Protocol Violation|0|||
163275666|NCT04157686|589718178|FG002|Overall Study|Protocol Violation|0|||
163275667|NCT04157686|589718179|FG003|Overall Study|Protocol Violation|0|||
163275668|NCT04157686|589718180|FG004|Overall Study|Protocol Violation|1|||
163275669|NCT04157686|589718181|FG005|Overall Study|Protocol Violation|0|||
163275670|NCT04157686|589718182|FG006|Overall Study|Protocol Violation|0|||
163275671|NCT04157686|589718183|FG007|Overall Study|Protocol Violation|0|||
163275672|NCT04157686|589718176|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
163275673|NCT04157686|589718177|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
163275674|NCT04157686|589718178|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
163275675|NCT04157686|589718179|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
163275676|NCT04157686|589718180|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
163275677|NCT04157686|589718181|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
163275678|NCT04157686|589718182|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
163275679|NCT04157686|589718183|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
163275680|NCT01388543|589718185|FG000|Day 14|Adverse Event|1|||
163275681|NCT01388543|589718186|FG001|Day 14|Adverse Event|4|||
163275682|NCT03363659|589718187|FG000|Overall Study|Adverse Event|1|||
163275683|NCT03363659|589718187|FG000|Overall Study|Screen fail|1|||
163275684|NCT03363659|589718187|FG000|Overall Study|Withdrawal by Subject|1|||
163275685|NCT00904150|589718188|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
163275686|NCT00904150|589718189|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
163275687|NCT00904150|589718188|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
163275688|NCT00904150|589718189|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
163275689|NCT01671748|589718190|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
163275690|NCT01671748|589718191|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
163275691|NCT01671748|589718190|FG000|4 Week run-in Phase|Adverse Event|1|||
163275692|NCT01671748|589718191|FG001|4 Week run-in Phase|Adverse Event|0|||
163275693|NCT01671748|589718190|FG000|4 Week run-in Phase|Not eligible|9|||
163275694|NCT01671748|589718191|FG001|4 Week run-in Phase|Not eligible|0|||
163275695|NCT03872388|589718192|FG000|Overall Study|Disease Progression|0|||
163275696|NCT03872388|589718193|FG001|Overall Study|Disease Progression|0|||
163275697|NCT03872388|589718194|FG002|Overall Study|Disease Progression|0|||
163275698|NCT03872388|589718195|FG003|Overall Study|Disease Progression|0|||
163275699|NCT03872388|589718196|FG004|Overall Study|Disease Progression|0|||
163275700|NCT03872388|589718197|FG005|Overall Study|Disease Progression|0|||
163275701|NCT03872388|589718198|FG006|Overall Study|Disease Progression|1|||
163275702|NCT03872388|589718199|FG007|Overall Study|Disease Progression|1|||
163275703|NCT04191135|589718200|FG000|Induction Treatment|Not Treated|2|||
163275704|NCT04191135|589718201|FG001|Induction Treatment|Not Treated|0|||
163275705|NCT04191135|589718202|FG002|Induction Treatment|Not Treated|0|||
163275706|NCT04191135|589718200|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
163275707|NCT04191135|589718201|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
163275708|NCT04191135|589718202|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
163275709|NCT04191135|589718200|FG000|Induction Treatment|Adverse Event|25|||
163275710|NCT04191135|589718201|FG001|Induction Treatment|Adverse Event|0|||
163275711|NCT04191135|589718202|FG002|Induction Treatment|Adverse Event|0|||
163275712|NCT04191135|589718200|FG000|Induction Treatment|Clinical Progression|8|||
163275713|NCT04191135|589718201|FG001|Induction Treatment|Clinical Progression|0|||
163275714|NCT04191135|589718202|FG002|Induction Treatment|Clinical Progression|0|||
163275715|NCT04191135|589718200|FG000|Induction Treatment|Excluded Medication|1|||
163275716|NCT04191135|589718201|FG001|Induction Treatment|Excluded Medication|0|||
163275717|NCT04191135|589718202|FG002|Induction Treatment|Excluded Medication|0|||
163275718|NCT04191135|589718200|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
163275719|NCT04191135|589718201|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
163275720|NCT04191135|589718202|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
163275721|NCT04191135|589718200|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
163275722|NCT04191135|589718201|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
163275723|NCT04191135|589718202|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
163275724|NCT04191135|589718200|FG000|Induction Treatment|Physician Decision|2|||
163275725|NCT04191135|589718201|FG001|Induction Treatment|Physician Decision|0|||
163275726|NCT04191135|589718202|FG002|Induction Treatment|Physician Decision|0|||
163275727|NCT04191135|589718200|FG000|Induction Treatment|Progressive Disease|135|||
163275728|NCT04191135|589718201|FG001|Induction Treatment|Progressive Disease|0|||
163275729|NCT04191135|589718202|FG002|Induction Treatment|Progressive Disease|0|||
163275730|NCT04191135|589718200|FG000|Induction Treatment|Protocol Violation|10|||
163275731|NCT04191135|589718201|FG001|Induction Treatment|Protocol Violation|0|||
163275732|NCT04191135|589718202|FG002|Induction Treatment|Protocol Violation|0|||
163275733|NCT04191135|589718200|FG000|Induction Treatment|Withdrawal by Subject|4|||
163275734|NCT04191135|589718201|FG001|Induction Treatment|Withdrawal by Subject|0|||
163275735|NCT04191135|589718202|FG002|Induction Treatment|Withdrawal by Subject|0|||
163275736|NCT04191135|589718200|FG000|Randomized Treatment|Death|0|||
163275737|NCT04191135|589718201|FG001|Randomized Treatment|Death|50|||
163275738|NCT04191135|589718202|FG002|Randomized Treatment|Death|54|||
163275739|NCT04191135|589718200|FG000|Randomized Treatment|Lost to Follow-up|0|||
163275740|NCT04191135|589718201|FG001|Randomized Treatment|Lost to Follow-up|0|||
163275741|NCT04191135|589718202|FG002|Randomized Treatment|Lost to Follow-up|1|||
163385868|NCT00068588|590123288|FG001|Overall Study|Adverse Event|0|||
163385869|NCT00068588|590123289|FG002|Overall Study|Adverse Event|2|||
163385870|NCT00068588|590123287|FG000|Overall Study|Withdrawal by Subject|0|||
163385871|NCT00068588|590123288|FG001|Overall Study|Withdrawal by Subject|0|||
163385872|NCT00068588|590123289|FG002|Overall Study|Withdrawal by Subject|1|||
163385873|NCT00068588|590123287|FG000|Overall Study|Poor KPS|0|||
163385874|NCT00068588|590123288|FG001|Overall Study|Poor KPS|0|||
163385875|NCT00068588|590123289|FG002|Overall Study|Poor KPS|1|||
163385876|NCT02027701|590123293|FG000|Overall Study|Adverse Event|3|||
163385877|NCT02027701|590123293|FG000|Overall Study|Lack of Efficacy|8|||
163385878|NCT02027701|590123293|FG000|Overall Study|Physician Decision|2|||
163385879|NCT02027701|590123293|FG000|Overall Study|Withdrawal by Subject|3|||
163385880|NCT02875977|590123294|FG000|Overall Study|Lost to Follow-up|42|||
163385881|NCT02875977|590123295|FG001|Overall Study|Lost to Follow-up|29|||
163385882|NCT00820027|590123296|FG000|Overall Study|Adverse Event|15|||
163385883|NCT00820027|590123297|FG001|Overall Study|Adverse Event|8|||
163385884|NCT00820027|590123298|FG002|Overall Study|Adverse Event|10|||
163275742|NCT04191135|589718200|FG000|Randomized Treatment|Withdrawal by Subject|0|||
163275743|NCT04191135|589718201|FG001|Randomized Treatment|Withdrawal by Subject|2|||
163275744|NCT04191135|589718202|FG002|Randomized Treatment|Withdrawal by Subject|0|||
163275745|NCT04191135|589718200|FG000|Randomized Treatment|Ongoing in Trial|0|||
163275746|NCT04191135|589718201|FG001|Randomized Treatment|Ongoing in Trial|83|||
163275747|NCT04191135|589718202|FG002|Randomized Treatment|Ongoing in Trial|81|||
163275748|NCT01781611|589719929|FG000|Overall Study|Adverse Event|4|||
163275749|NCT01781611|589719930|FG001|Overall Study|Adverse Event|0|||
163275750|NCT00354029|589719931|FG000|Overall Study|Protocol Violation|4|||
163275751|NCT00354029|589719932|FG001|Overall Study|Protocol Violation|2|||
163275752|NCT01123161|589719937|FG000|Overall Study|Lost to Follow-up|1|||
163275753|NCT01123161|589719938|FG001|Overall Study|Lost to Follow-up|0|||
163275754|NCT01123161|589719937|FG000|Overall Study|Withdrawal by Subject|1|||
163275755|NCT01123161|589719938|FG001|Overall Study|Withdrawal by Subject|0|||
163275756|NCT04466618|589719943|FG000|Overall Study|Withdrawal by Subject|0|||
163275757|NCT04466618|589719944|FG001|Overall Study|Withdrawal by Subject|1|||
163275758|NCT02800928|589719945|FG000|Overall Study|Withdrawal by Subject|1|||
163275759|NCT02800928|589719946|FG001|Overall Study|Withdrawal by Subject|1|||
163275760|NCT02800928|589719945|FG000|Overall Study|Protocol Violation|1|||
163275761|NCT02800928|589719946|FG001|Overall Study|Protocol Violation|1|||
163275762|NCT02886728|589719954|FG000|Overall Study|Withdrew Consent|31|||
163275763|NCT02886728|589719955|FG001|Overall Study|Withdrew Consent|13|||
163275764|NCT02886728|589719956|FG002|Overall Study|Withdrew Consent|11|||
163385885|NCT00820027|590123299|FG003|Overall Study|Adverse Event|5|||
163385886|NCT00820027|590123296|FG000|Overall Study|Lack of Efficacy|2|||
163385887|NCT00820027|590123297|FG001|Overall Study|Lack of Efficacy|1|||
163385888|NCT00820027|590123298|FG002|Overall Study|Lack of Efficacy|2|||
163385889|NCT00820027|590123299|FG003|Overall Study|Lack of Efficacy|2|||
163385890|NCT00820027|590123296|FG000|Overall Study|Physician Decision|0|||
163385891|NCT00820027|590123297|FG001|Overall Study|Physician Decision|1|||
163385892|NCT00820027|590123298|FG002|Overall Study|Physician Decision|1|||
163385893|NCT00820027|590123299|FG003|Overall Study|Physician Decision|0|||
163385894|NCT00820027|590123296|FG000|Overall Study|Protocol Violation|3|||
163275765|NCT02886728|589719957|FG003|Overall Study|Withdrew Consent|47|||
163275766|NCT02886728|589719954|FG000|Overall Study|Lost to Follow-up|12|||
163275767|NCT02886728|589719955|FG001|Overall Study|Lost to Follow-up|6|||
163385895|NCT00820027|590123297|FG001|Overall Study|Protocol Violation|0|||
163385896|NCT00820027|590123298|FG002|Overall Study|Protocol Violation|4|||
163385897|NCT00820027|590123299|FG003|Overall Study|Protocol Violation|0|||
163385898|NCT00820027|590123296|FG000|Overall Study|Withdrawal by Subject|6|||
163385899|NCT00820027|590123297|FG001|Overall Study|Withdrawal by Subject|4|||
163385900|NCT00820027|590123298|FG002|Overall Study|Withdrawal by Subject|4|||
163385901|NCT00820027|590123299|FG003|Overall Study|Withdrawal by Subject|6|||
163385902|NCT02604433|590123300|FG000|Overall Study|Withdrawal by Subject|37|||
163385903|NCT02604433|590123301|FG001|Overall Study|Withdrawal by Subject|16|||
163385904|NCT02604433|590123300|FG000|Overall Study|Adverse Event|4|||
163385905|NCT02604433|590123301|FG001|Overall Study|Adverse Event|0|||
163385906|NCT02604433|590123300|FG000|Overall Study|Other reasons|3|||
163385907|NCT02604433|590123301|FG001|Overall Study|Other reasons|5|||
163385908|NCT02604433|590123300|FG000|Overall Study|Death|4|||
163385909|NCT02604433|590123301|FG001|Overall Study|Death|1|||
163385910|NCT02604433|590123300|FG000|Overall Study|Transition to Rollover Protocol|169|||
163385911|NCT02604433|590123301|FG001|Overall Study|Transition to Rollover Protocol|82|||
163385912|NCT02604433|590123300|FG000|Overall Study|Physician Decision|1|||
163385913|NCT02604433|590123301|FG001|Overall Study|Physician Decision|1|||
163385914|NCT02604433|590123300|FG000|Overall Study|Lack of Efficacy|0|||
163385915|NCT02604433|590123301|FG001|Overall Study|Lack of Efficacy|1|||
163385916|NCT03285178|590123302|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
163385917|NCT03285178|590123303|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
163385918|NCT03285178|590123304|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
163385919|NCT03285178|590123305|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
163385920|NCT03285178|590123306|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
163385921|NCT03285178|590123307|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
163385922|NCT03285178|590123308|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
163385923|NCT03285178|590123302|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
163385924|NCT03285178|590123303|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
163385925|NCT03285178|590123304|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
163385926|NCT03285178|590123305|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
163385927|NCT03285178|590123306|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
163385928|NCT03285178|590123307|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
163385929|NCT03285178|590123308|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
163385930|NCT03285178|590123302|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
163385931|NCT03285178|590123303|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
163385932|NCT03285178|590123304|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
163385933|NCT03285178|590123305|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
163385934|NCT03285178|590123306|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
163385935|NCT03285178|590123307|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
163385936|NCT03285178|590123308|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
163385937|NCT03285178|590123302|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
163385938|NCT03285178|590123303|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
163385939|NCT03285178|590123304|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
163385940|NCT03285178|590123305|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
163385941|NCT03285178|590123306|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
163385942|NCT03285178|590123307|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
163385943|NCT03285178|590123308|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
163385944|NCT03285178|590123302|FG000|Single-Blind Run-In Period|Physician Decision|2|||
163385945|NCT03285178|590123303|FG001|Single-Blind Run-In Period|Physician Decision|0|||
163385946|NCT03285178|590123304|FG002|Single-Blind Run-In Period|Physician Decision|0|||
163385947|NCT03285178|590123305|FG003|Single-Blind Run-In Period|Physician Decision|0|||
163385948|NCT03285178|590123306|FG004|Single-Blind Run-In Period|Physician Decision|0|||
163385949|NCT03285178|590123307|FG005|Single-Blind Run-In Period|Physician Decision|0|||
163385950|NCT03285178|590123308|FG006|Single-Blind Run-In Period|Physician Decision|0|||
163385951|NCT03285178|590123302|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
163385952|NCT03285178|590123303|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
163385953|NCT03285178|590123304|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
163385954|NCT03285178|590123305|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
163385955|NCT03285178|590123306|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
163385956|NCT03285178|590123307|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
163385957|NCT03285178|590123308|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
162924205|NCT02426125|588423829|FG000|Overall Study|Randomized, But Never Treated|5|||
163275768|NCT02886728|589719956|FG002|Overall Study|Lost to Follow-up|13|||
163385958|NCT03285178|590123302|FG000|Double-Blind Treatment Period|Adverse Event|0|||
163385959|NCT03285178|590123303|FG001|Double-Blind Treatment Period|Adverse Event|0|||
163385960|NCT03285178|590123304|FG002|Double-Blind Treatment Period|Adverse Event|0|||
163385961|NCT03285178|590123305|FG003|Double-Blind Treatment Period|Adverse Event|0|||
163385962|NCT03285178|590123306|FG004|Double-Blind Treatment Period|Adverse Event|0|||
163385963|NCT03285178|590123307|FG005|Double-Blind Treatment Period|Adverse Event|0|||
163385964|NCT03285178|590123308|FG006|Double-Blind Treatment Period|Adverse Event|2|||
163385965|NCT03285178|590123302|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163385966|NCT03285178|590123303|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
163385967|NCT03285178|590123304|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
163385968|NCT03285178|590123305|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
163385969|NCT03285178|590123306|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
163385970|NCT03285178|590123307|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
163385971|NCT03285178|590123308|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
163385972|NCT03285178|590123302|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163385973|NCT03285178|590123303|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163385974|NCT03285178|590123304|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
163385975|NCT03285178|590123305|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
163385976|NCT03285178|590123306|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163385977|NCT03285178|590123307|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
163385978|NCT03285178|590123308|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
163385979|NCT03285178|590123302|FG000|Double-Blind Treatment Period|COVID-19|0|||
163385980|NCT03285178|590123303|FG001|Double-Blind Treatment Period|COVID-19|0|||
163385981|NCT03285178|590123304|FG002|Double-Blind Treatment Period|COVID-19|1|||
163385982|NCT03285178|590123305|FG003|Double-Blind Treatment Period|COVID-19|0|||
163385983|NCT03285178|590123306|FG004|Double-Blind Treatment Period|COVID-19|0|||
163385984|NCT03285178|590123307|FG005|Double-Blind Treatment Period|COVID-19|0|||
163385985|NCT03285178|590123308|FG006|Double-Blind Treatment Period|COVID-19|0|||
163385986|NCT01128894|590123309|FG000|Overall Study|Adverse Event|31|||
163385987|NCT01128894|590123310|FG001|Overall Study|Adverse Event|41|||
163385988|NCT01128894|590123309|FG000|Overall Study|Protocol Violation|2|||
163385989|NCT01128894|590123310|FG001|Overall Study|Protocol Violation|1|||
163385990|NCT01128894|590123309|FG000|Overall Study|Noncompliance|4|||
163385991|NCT01128894|590123310|FG001|Overall Study|Noncompliance|5|||
163385992|NCT01128894|590123309|FG000|Overall Study|Lost to Follow-up|8|||
163385993|NCT01128894|590123310|FG001|Overall Study|Lost to Follow-up|8|||
163385994|NCT01128894|590123309|FG000|Overall Study|Withdrawal by Subject|10|||
163385995|NCT01128894|590123310|FG001|Overall Study|Withdrawal by Subject|12|||
163385996|NCT01128894|590123309|FG000|Overall Study|Physician Decision|2|||
163385997|NCT01128894|590123310|FG001|Overall Study|Physician Decision|1|||
163385998|NCT01128894|590123309|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
163385999|NCT01128894|590123310|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
163386000|NCT01128738|590123311|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
163386001|NCT01128738|590123312|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
163386002|NCT01128738|590123311|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
163161237|NCT03048578|589304123|FG000|Overall Study|Withdrawal by Subject|5|||
163161238|NCT03048578|589304124|FG001|Overall Study|Withdrawal by Subject|6|||
163161239|NCT03048578|589304123|FG000|Overall Study|Lost to Follow-up|22|||
163161240|NCT03048578|589304124|FG001|Overall Study|Lost to Follow-up|10|||
163161241|NCT03048578|589304123|FG000|Overall Study|Adverse Event|1|||
163161242|NCT03048578|589304124|FG001|Overall Study|Adverse Event|2|||
163161243|NCT03048578|589304123|FG000|Overall Study|Terminated|3|||
163161244|NCT03048578|589304124|FG001|Overall Study|Terminated|2|||
163161245|NCT00459186|589304130|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
163161246|NCT00459186|589304130|FG000|PET Imaging and Assessment|Adverse Event|3|||
163161247|NCT02500797|589304131|FG000|Overall Study|Cancel (rapid disease progression)|0|||
163161248|NCT02500797|589304132|FG001|Overall Study|Cancel (rapid disease progression)|0|||
163161249|NCT02500797|589304133|FG002|Overall Study|Cancel (rapid disease progression)|0|||
163161250|NCT02500797|589304134|FG003|Overall Study|Cancel (rapid disease progression)|0|||
163161251|NCT02500797|589304135|FG004|Overall Study|Cancel (rapid disease progression)|1|||
163161252|NCT02500797|589304136|FG005|Overall Study|Cancel (rapid disease progression)|1|||
163161253|NCT02500797|589304137|FG006|Overall Study|Cancel (rapid disease progression)|0|||
163161254|NCT02500797|589304138|FG007|Overall Study|Cancel (rapid disease progression)|0|||
163386003|NCT01128738|590123312|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
163161255|NCT02500797|589304131|FG000|Overall Study|Withdrawal by Subject|1|||
163161256|NCT02500797|589304132|FG001|Overall Study|Withdrawal by Subject|0|||
163161257|NCT02500797|589304133|FG002|Overall Study|Withdrawal by Subject|0|||
163386004|NCT01128738|590123311|FG000|Second TP|Lost to Follow-up|0|||
163386005|NCT01128738|590123312|FG001|Second TP|Lost to Follow-up|1|||
163386006|NCT01128738|590123311|FG000|Second TP|Withdrawal by Subject|0|||
163386007|NCT01128738|590123312|FG001|Second TP|Withdrawal by Subject|2|||
163386008|NCT00973362|590123313|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
163386009|NCT00973362|590123314|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
163386010|NCT00973362|590123313|FG000|Baseline Evaluation|No colposcopy visit|62|||
163386011|NCT00973362|590123314|FG001|Baseline Evaluation|No colposcopy visit|0|||
163386012|NCT00973362|590123313|FG000|Baseline Evaluation|Inevaluable|686|||
163386013|NCT00973362|590123314|FG001|Baseline Evaluation|Inevaluable|223|||
163386014|NCT00973362|590123313|FG000|3-Year Follow-up|Lost to Follow-up|17|||
163386015|NCT00973362|590123314|FG001|3-Year Follow-up|Lost to Follow-up|0|||
163386016|NCT00887679|590123317|FG000|Overall Study|Withdrawal by Subject|1|||
163386017|NCT00887679|590123317|FG000|Overall Study|Lost to Follow-up|4|||
163386018|NCT00887679|590123317|FG000|Overall Study|Physician Decision|5|||
163386019|NCT02683941|590123318|FG000|Double-blind Phase|Adverse Event|0|||
163386020|NCT02683941|590123319|FG001|Double-blind Phase|Adverse Event|1|||
163386021|NCT02683941|590123318|FG000|Double-blind Phase|Withdrawal by Subject|4|||
163386022|NCT02683941|590123319|FG001|Double-blind Phase|Withdrawal by Subject|2|||
163386023|NCT02683941|590123318|FG000|Double-blind Phase|Lost to Follow-up|1|||
163386024|NCT02683941|590123319|FG001|Double-blind Phase|Lost to Follow-up|0|||
163386025|NCT02683941|590123318|FG000|Double-blind Phase|Disease Progression|5|||
163386026|NCT02683941|590123319|FG001|Double-blind Phase|Disease Progression|2|||
163386027|NCT02683941|590123318|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
163386028|NCT02683941|590123319|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
163386029|NCT02683941|590123318|FG000|Open-label Treatment Phase|Disease Progression|1|||
163386030|NCT02683941|590123319|FG001|Open-label Treatment Phase|Disease Progression|2|||
163386031|NCT02683941|590123318|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
163386032|NCT02683941|590123319|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
163386033|NCT02683941|590123318|FG000|Open-label Treatment Phase|Other|1|||
163386034|NCT02683941|590123319|FG001|Open-label Treatment Phase|Other|0|||
163386035|NCT02683941|590123318|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
163386036|NCT02683941|590123319|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
163386037|NCT02683941|590123318|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
163386038|NCT02683941|590123319|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
163386039|NCT02683941|590123318|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
163386040|NCT02683941|590123319|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
163386041|NCT02683941|590123318|FG000|Open-label Follow-up Phase|Other|8|||
163386042|NCT02683941|590123319|FG001|Open-label Follow-up Phase|Other|1|||
163386043|NCT00146757|590123320|FG000|Overall Study|Death|1|||
163386044|NCT00146757|590123321|FG001|Overall Study|Death|0|||
163386045|NCT00146757|590123320|FG000|Overall Study|Adverse Event|1|||
163386046|NCT00146757|590123321|FG001|Overall Study|Adverse Event|0|||
163386047|NCT02571049|590123327|FG000|Screening|Did not meet entry criteria|2|||
163386048|NCT02571049|590123328|FG001|Screening|Did not meet entry criteria|2|||
163386049|NCT02571049|590123327|FG000|Randomization|No migraine attack|0|||
163386050|NCT02571049|590123328|FG001|Randomization|No migraine attack|1|||
163386051|NCT02571049|590123327|FG000|Randomization|Adverse Event|0|||
163386052|NCT02571049|590123328|FG001|Randomization|Adverse Event|1|||
163386053|NCT01201265|590123331|FG000|Overall Study|Death|14|||
163386054|NCT01201265|590123331|FG000|Overall Study|Insufficient Therapeutic Response|3|||
163386055|NCT01201265|590123331|FG000|Overall Study|Lost to Follow-up|10|||
163386056|NCT01201265|590123331|FG000|Overall Study|Withdrawal by Subject|7|||
163386057|NCT01201265|590123331|FG000|Overall Study|Disease Progression|4|||
163386058|NCT00723021|590123332|FG000|Intervention Period 4|Adverse Event|0|||
163386059|NCT00723021|590123333|FG001|Intervention Period 4|Adverse Event|0|||
163386060|NCT00723021|590123334|FG002|Intervention Period 4|Adverse Event|0|||
163386061|NCT00723021|590123335|FG003|Intervention Period 4|Adverse Event|0|||
163386062|NCT00723021|590123336|FG004|Intervention Period 4|Adverse Event|1|||
163386063|NCT02254278|590123340|FG000|Overall Study|Protocol Violation|1|||
163386064|NCT02254278|590123341|FG001|Overall Study|Protocol Violation|1|||
163386065|NCT02903368|590123345|FG000|Part 1|Adverse Event|3|||
163386066|NCT02903368|590123346|FG001|Part 1|Adverse Event|0|||
163386067|NCT02903368|590123347|FG002|Part 1|Adverse Event|0|||
163386068|NCT02903368|590123348|FG003|Part 1|Adverse Event|0|||
163386069|NCT02903368|590123345|FG000|Part 1|Withdrawal by Subject|1|||
163386070|NCT02903368|590123346|FG001|Part 1|Withdrawal by Subject|0|||
163386071|NCT02903368|590123347|FG002|Part 1|Withdrawal by Subject|0|||
163386072|NCT02903368|590123348|FG003|Part 1|Withdrawal by Subject|0|||
163386073|NCT02903368|590123345|FG000|Part 2|Adverse Event|0|||
163386074|NCT02903368|590123346|FG001|Part 2|Adverse Event|0|||
163386075|NCT02903368|590123347|FG002|Part 2|Adverse Event|5|||
163386076|NCT02903368|590123348|FG003|Part 2|Adverse Event|0|||
163386077|NCT02903368|590123345|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
163386078|NCT02903368|590123346|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
163386079|NCT02903368|590123347|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
163386080|NCT02903368|590123348|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
163386081|NCT02903368|590123345|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
163386082|NCT02903368|590123346|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
163386083|NCT02903368|590123347|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
163386084|NCT02903368|590123348|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
163161258|NCT02500797|589304134|FG003|Overall Study|Withdrawal by Subject|0|||
163161259|NCT02500797|589304135|FG004|Overall Study|Withdrawal by Subject|0|||
163161260|NCT02500797|589304136|FG005|Overall Study|Withdrawal by Subject|0|||
163161261|NCT02500797|589304137|FG006|Overall Study|Withdrawal by Subject|0|||
163161262|NCT02500797|589304138|FG007|Overall Study|Withdrawal by Subject|0|||
163161263|NCT00357006|589304145|FG000|Overall Study|Lost to Follow-up|1|||
163161264|NCT00357006|589304146|FG001|Overall Study|Lost to Follow-up|2|||
163161265|NCT00357006|589304147|FG002|Overall Study|Lost to Follow-up|1|||
163161266|NCT00357006|589304145|FG000|Overall Study|Withdrawal by Subject|1|||
163161267|NCT00357006|589304146|FG001|Overall Study|Withdrawal by Subject|3|||
163161268|NCT00357006|589304147|FG002|Overall Study|Withdrawal by Subject|2|||
163161269|NCT03710161|589304148|FG000|Overall Study|Study halted due to COVID pandemic|3|||
163161270|NCT03710161|589304149|FG001|Overall Study|Study halted due to COVID pandemic|2|||
163161271|NCT02023697|589304154|FG000|Treatment Period|Radiological progression|13|||
163161272|NCT02023697|589304155|FG001|Treatment Period|Radiological progression|17|||
163161273|NCT02023697|589304156|FG002|Treatment Period|Radiological progression|26|||
163161274|NCT02023697|589304154|FG000|Treatment Period|Never Treated|5|||
163161275|NCT02023697|589304155|FG001|Treatment Period|Never Treated|6|||
163161276|NCT02023697|589304156|FG002|Treatment Period|Never Treated|10|||
163161277|NCT02023697|589304154|FG000|Treatment Period|Adverse Event|13|||
163161278|NCT02023697|589304155|FG001|Treatment Period|Adverse Event|25|||
163161279|NCT02023697|589304156|FG002|Treatment Period|Adverse Event|23|||
163161280|NCT02023697|589304154|FG000|Treatment Period|Logistical difficulties|1|||
163161281|NCT02023697|589304155|FG001|Treatment Period|Logistical difficulties|1|||
163161282|NCT02023697|589304156|FG002|Treatment Period|Logistical difficulties|1|||
163161283|NCT02023697|589304154|FG000|Treatment Period|Clinical progression|10|||
163161284|NCT02023697|589304155|FG001|Treatment Period|Clinical progression|8|||
163161285|NCT02023697|589304156|FG002|Treatment Period|Clinical progression|28|||
163161286|NCT02023697|589304154|FG000|Treatment Period|Withdrawal by Subject|4|||
163161287|NCT02023697|589304155|FG001|Treatment Period|Withdrawal by Subject|5|||
163161288|NCT02023697|589304156|FG002|Treatment Period|Withdrawal by Subject|13|||
163161289|NCT02023697|589304154|FG000|Treatment Period|Safety outcome reached|0|||
163161290|NCT02023697|589304155|FG001|Treatment Period|Safety outcome reached|1|||
163161291|NCT02023697|589304156|FG002|Treatment Period|Safety outcome reached|0|||
163161292|NCT02023697|589304154|FG000|Treatment Period|Physician Decision|0|||
163161293|NCT02023697|589304155|FG001|Treatment Period|Physician Decision|0|||
163161294|NCT02023697|589304156|FG002|Treatment Period|Physician Decision|1|||
163161295|NCT02023697|589304154|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
163161296|NCT02023697|589304155|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
163161297|NCT02023697|589304156|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
163161298|NCT02023697|589304154|FG000|Active Follow-up Period|Lost to Follow-up|1|||
163161299|NCT02023697|589304155|FG001|Active Follow-up Period|Lost to Follow-up|1|||
163161300|NCT02023697|589304156|FG002|Active Follow-up Period|Lost to Follow-up|1|||
163161301|NCT02023697|589304154|FG000|Active Follow-up Period|Deterioration of general condition|1|||
163161302|NCT02023697|589304155|FG001|Active Follow-up Period|Deterioration of general condition|1|||
163161303|NCT02023697|589304156|FG002|Active Follow-up Period|Deterioration of general condition|1|||
163161304|NCT02023697|589304154|FG000|Active Follow-up Period|Other unspecified|2|||
163161305|NCT02023697|589304155|FG001|Active Follow-up Period|Other unspecified|0|||
163161306|NCT02023697|589304156|FG002|Active Follow-up Period|Other unspecified|1|||
163161307|NCT02023697|589304154|FG000|Active Follow-up Period|Clinical progression|0|||
163161308|NCT02023697|589304155|FG001|Active Follow-up Period|Clinical progression|2|||
163161309|NCT02023697|589304156|FG002|Active Follow-up Period|Clinical progression|1|||
163161310|NCT02023697|589304154|FG000|Active Follow-up Period|Radiological progression|0|||
163161311|NCT02023697|589304155|FG001|Active Follow-up Period|Radiological progression|0|||
163161312|NCT02023697|589304156|FG002|Active Follow-up Period|Radiological progression|1|||
163161313|NCT02023697|589304154|FG000|Active Follow-up Period|Death|83|||
163161314|NCT02023697|589304155|FG001|Active Follow-up Period|Death|82|||
163161315|NCT02023697|589304156|FG002|Active Follow-up Period|Death|87|||
163161316|NCT02023697|589304154|FG000|Long-term Follow-up Period|Death|9|||
163161317|NCT02023697|589304155|FG001|Long-term Follow-up Period|Death|6|||
163161318|NCT02023697|589304156|FG002|Long-term Follow-up Period|Death|4|||
163161319|NCT02023697|589304154|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
163161320|NCT02023697|589304155|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
163161321|NCT02023697|589304156|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
163275769|NCT02886728|589719957|FG003|Overall Study|Lost to Follow-up|12|||
163161322|NCT02023697|589304154|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
163161323|NCT02023697|589304155|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
163161324|NCT02023697|589304156|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
163275770|NCT02886728|589719954|FG000|Overall Study|Adverse Event|13|||
163161325|NCT02023697|589304154|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
163161326|NCT02023697|589304155|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
163161327|NCT02023697|589304156|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
163275771|NCT02886728|589719955|FG001|Overall Study|Adverse Event|5|||
163161328|NCT02023697|589304154|FG000|Long-term Follow-up Period|Technical problems|0|||
163161329|NCT02023697|589304155|FG001|Long-term Follow-up Period|Technical problems|0|||
163161330|NCT02023697|589304156|FG002|Long-term Follow-up Period|Technical problems|1|||
163161331|NCT02023697|589304154|FG000|Long-term Follow-up Period|Other unspecified|6|||
163161332|NCT02023697|589304155|FG001|Long-term Follow-up Period|Other unspecified|3|||
163161333|NCT02023697|589304156|FG002|Long-term Follow-up Period|Other unspecified|5|||
163161334|NCT00541385|589304157|FG000|Overall Study|Adverse Event|6|||
163161335|NCT00541385|589304158|FG001|Overall Study|Adverse Event|3|||
163161336|NCT00541385|589304157|FG000|Overall Study|Withdrawal by Subject|2|||
163161337|NCT00541385|589304158|FG001|Overall Study|Withdrawal by Subject|2|||
163161338|NCT00541385|589304157|FG000|Overall Study|Lost to Follow-up|6|||
163161339|NCT00541385|589304158|FG001|Overall Study|Lost to Follow-up|1|||
163161340|NCT00541385|589304157|FG000|Overall Study|Parasite reappearance/malaria|67|||
163161341|NCT00541385|589304158|FG001|Overall Study|Parasite reappearance/malaria|32|||
163161342|NCT01469377|589304159|FG000|Overall Study|Protocol Deviation|7|||
163161343|NCT01469377|589304160|FG001|Overall Study|Protocol Deviation|10|||
163161344|NCT01469377|589304161|FG002|Overall Study|Protocol Deviation|10|||
163161345|NCT01469377|589304159|FG000|Overall Study|Lost to Follow-up|3|||
163161346|NCT01469377|589304160|FG001|Overall Study|Lost to Follow-up|2|||
163161347|NCT01469377|589304161|FG002|Overall Study|Lost to Follow-up|5|||
163161348|NCT01469377|589304159|FG000|Overall Study|Withdrawal of Consent|12|||
163161349|NCT01469377|589304160|FG001|Overall Study|Withdrawal of Consent|14|||
163161350|NCT01469377|589304161|FG002|Overall Study|Withdrawal of Consent|15|||
163161351|NCT01469377|589304159|FG000|Overall Study|Adverse Event|8|||
163161352|NCT01469377|589304160|FG001|Overall Study|Adverse Event|18|||
163161353|NCT01469377|589304161|FG002|Overall Study|Adverse Event|36|||
163161354|NCT01469377|589304159|FG000|Overall Study|Insufficient Therapeutic Response|3|||
163161355|NCT01469377|589304160|FG001|Overall Study|Insufficient Therapeutic Response|4|||
163161356|NCT01469377|589304161|FG002|Overall Study|Insufficient Therapeutic Response|0|||
163161357|NCT01469377|589304159|FG000|Overall Study|Other Miscellaneous Reasons|2|||
163161358|NCT01469377|589304160|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163161359|NCT01469377|589304161|FG002|Overall Study|Other Miscellaneous Reasons|0|||
163161360|NCT01733680|589304162|FG000|Overall Study|Withdrawal by Subject|0|||
163161361|NCT01733680|589304163|FG001|Overall Study|Withdrawal by Subject|1|||
163161362|NCT04139798|589304166|FG000|Overall Study|Withdrawal by Subject|6|||
163161363|NCT04139798|589304167|FG001|Overall Study|Withdrawal by Subject|5|||
163161364|NCT04139798|589304166|FG000|Overall Study|Lost to Follow-up|2|||
163161365|NCT04139798|589304167|FG001|Overall Study|Lost to Follow-up|5|||
163161366|NCT04139798|589304166|FG000|Overall Study|Discontinued|4|||
163161367|NCT04139798|589304167|FG001|Overall Study|Discontinued|2|||
163161368|NCT04139798|589304166|FG000|Overall Study|Adverse Event|1|||
163161369|NCT04139798|589304167|FG001|Overall Study|Adverse Event|3|||
163161370|NCT04139798|589304166|FG000|Overall Study|Protocol Violation|1|||
163161371|NCT04139798|589304167|FG001|Overall Study|Protocol Violation|0|||
163161372|NCT01526733|589304168|FG000|Phase 1|Protocol Violation|1|||
163161373|NCT01526733|589304169|FG001|Phase 1|Protocol Violation|0|||
163161374|NCT01526733|589304168|FG000|Phase 1|Withdrawal by Subject|1|||
163161375|NCT01526733|589304169|FG001|Phase 1|Withdrawal by Subject|1|||
163161376|NCT02952820|589304172|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
163161377|NCT02952820|589304173|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
163161378|NCT02952820|589304174|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
163161379|NCT02952820|589304172|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
163161380|NCT02952820|589304173|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
163161381|NCT02952820|589304174|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
163161382|NCT02952820|589304172|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
163161383|NCT02952820|589304173|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
163161384|NCT02952820|589304174|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
163161385|NCT02952820|589304172|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
163161386|NCT02952820|589304173|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
163161387|NCT02952820|589304174|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
163161388|NCT02952820|589304172|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
163161389|NCT02952820|589304173|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
163161390|NCT02952820|589304174|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
163161391|NCT02952820|589304172|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
163161392|NCT02952820|589304173|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
163161393|NCT02952820|589304174|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
163161394|NCT02952820|589304172|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
163275772|NCT02886728|589719956|FG002|Overall Study|Adverse Event|5|||
163161395|NCT02952820|589304173|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
163161396|NCT02952820|589304174|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
163275773|NCT02886728|589719957|FG003|Overall Study|Adverse Event|11|||
163161397|NCT02952820|589304172|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
163161398|NCT02952820|589304173|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
163161399|NCT02952820|589304174|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
163161400|NCT02952820|589304172|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
163161401|NCT02952820|589304173|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
163161402|NCT02952820|589304174|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
163161403|NCT02952820|589304172|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
163161404|NCT02952820|589304173|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
163161405|NCT02952820|589304174|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
163161406|NCT02952820|589304172|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
163161407|NCT02952820|589304173|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
163161408|NCT02952820|589304174|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
163161409|NCT02952820|589304172|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
163161410|NCT02952820|589304173|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
163161411|NCT02952820|589304174|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
163161412|NCT02952820|589304172|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
163161413|NCT02952820|589304173|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
163161414|NCT02952820|589304174|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
163161415|NCT02952820|589304172|FG000|Active Treatment Period (6 Months)|Not treated|0|||
163161416|NCT02952820|589304173|FG001|Active Treatment Period (6 Months)|Not treated|0|||
163161417|NCT02952820|589304174|FG002|Active Treatment Period (6 Months)|Not treated|1|||
163161418|NCT03857867|589304175|FG000|Overall Study|Physician Decision|1|||
163161419|NCT03070964|589304176|FG000|Overall Study|Progressive disease|8|||
163161420|NCT03070964|589304176|FG000|Overall Study|Treatment-unrelated adverse event|2|||
163161421|NCT03070964|589304176|FG000|Overall Study|Never treated|1|||
163161422|NCT03070964|589304176|FG000|Overall Study|Physician Decision|1|||
163161423|NCT03070964|589304176|FG000|Overall Study|Withdrawal by Subject|1|||
163161424|NCT03070964|589304176|FG000|Overall Study|Adverse Event|1|||
163161425|NCT02506244|589304180|FG000|Overall Study|Did not undergo active monitoring|458|||
163161426|NCT02506244|589304181|FG001|Overall Study|Did not undergo active monitoring|459|||
163161427|NCT02506244|589304182|FG002|Overall Study|Did not undergo active monitoring|0|||
163161428|NCT02170077|589304187|FG000|Overall Study|Withdrawal by Subject|3|||
163161429|NCT02170077|589304188|FG001|Overall Study|Withdrawal by Subject|4|||
163161430|NCT02170077|589304189|FG002|Overall Study|Withdrawal by Subject|2|||
163161431|NCT02170077|589304187|FG000|Overall Study|Adverse Event|4|||
163161432|NCT02170077|589304188|FG001|Overall Study|Adverse Event|4|||
163161433|NCT02170077|589304189|FG002|Overall Study|Adverse Event|4|||
163161434|NCT02170077|589304187|FG000|Overall Study|Lost to Follow-up|0|||
163161435|NCT02170077|589304188|FG001|Overall Study|Lost to Follow-up|1|||
163161436|NCT02170077|589304189|FG002|Overall Study|Lost to Follow-up|0|||
163161437|NCT02170077|589304187|FG000|Overall Study|Exclusion criteria|2|||
163161438|NCT02170077|589304188|FG001|Overall Study|Exclusion criteria|2|||
163161439|NCT02170077|589304189|FG002|Overall Study|Exclusion criteria|5|||
163161440|NCT02170077|589304187|FG000|Overall Study|Exacerbation of seizures|0|||
163161441|NCT02170077|589304188|FG001|Overall Study|Exacerbation of seizures|2|||
163161442|NCT02170077|589304189|FG002|Overall Study|Exacerbation of seizures|1|||
163161443|NCT01780974|589304190|FG000|Overall Study|Death|1|||
163161444|NCT01780974|589304191|FG001|Overall Study|Death|0|||
163161445|NCT01780974|589304190|FG000|Overall Study|Adverse Event|1|||
163161446|NCT01780974|589304191|FG001|Overall Study|Adverse Event|3|||
163161447|NCT02447003|589304194|FG000|Overall Study|Other|0|||
163161448|NCT02447003|589304195|FG001|Overall Study|Other|4|||
163161449|NCT02447003|589304194|FG000|Overall Study|Site discontinued|0|||
163161450|NCT02447003|589304195|FG001|Overall Study|Site discontinued|2|||
163161451|NCT02447003|589304194|FG000|Overall Study|Physician Decision|0|||
163161452|NCT02447003|589304195|FG001|Overall Study|Physician Decision|1|||
163161453|NCT02447003|589304194|FG000|Overall Study|Withdrawal by Subject|4|||
163161454|NCT02447003|589304195|FG001|Overall Study|Withdrawal by Subject|3|||
163161455|NCT02447003|589304194|FG000|Overall Study|Sponsor Decision|6|||
163161456|NCT02447003|589304195|FG001|Overall Study|Sponsor Decision|11|||
163161457|NCT02447003|589304194|FG000|Overall Study|Progressive Disease|1|||
163161458|NCT02447003|589304195|FG001|Overall Study|Progressive Disease|0|||
163161459|NCT02447003|589304194|FG000|Overall Study|Lost to Follow-up|5|||
163161460|NCT02447003|589304195|FG001|Overall Study|Lost to Follow-up|0|||
163386085|NCT02903368|590123345|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
163161461|NCT02447003|589304194|FG000|Overall Study|Death|154|||
163161462|NCT02447003|589304195|FG001|Overall Study|Death|63|||
163161463|NCT00750438|589304196|FG000|Overall Study|Protocol Violation|4|||
163161464|NCT00750438|589304197|FG001|Overall Study|Protocol Violation|1|||
163161465|NCT00750438|589304196|FG000|Overall Study|Physician Decision|2|||
163161466|NCT00750438|589304197|FG001|Overall Study|Physician Decision|2|||
163161467|NCT00750438|589304196|FG000|Overall Study|Withdrawal by Subject|1|||
163161468|NCT00750438|589304197|FG001|Overall Study|Withdrawal by Subject|1|||
163161469|NCT03848728|589304198|FG000|Overall Study|Death|16|||
163161470|NCT03848728|589304199|FG001|Overall Study|Death|13|||
163161471|NCT03848728|589304198|FG000|Overall Study|Outmigrated to non-study community|98|||
163161472|NCT03848728|589304199|FG001|Overall Study|Outmigrated to non-study community|106|||
163161473|NCT03848728|589304198|FG000|Overall Study|Transfered to non-study clinic|32|||
163161474|NCT03848728|589304199|FG001|Overall Study|Transfered to non-study clinic|48|||
163161475|NCT03848728|589304198|FG000|Overall Study|Withdrawal by Subject|1|||
163161476|NCT03848728|589304199|FG001|Overall Study|Withdrawal by Subject|0|||
163161477|NCT01185080|589304200|FG000|Overall Study|Adverse Event|1|||
163161478|NCT01185080|589304201|FG001|Overall Study|Adverse Event|1|||
163161479|NCT01185080|589304202|FG002|Overall Study|Adverse Event|0|||
163161480|NCT01185080|589304200|FG000|Overall Study|Personal reasons|0|||
163161481|NCT01185080|589304201|FG001|Overall Study|Personal reasons|0|||
163161482|NCT01185080|589304202|FG002|Overall Study|Personal reasons|1|||
163161483|NCT06083506|589304203|FG000|Overall Study|Physician Decision|2|||
163161484|NCT06083506|589304203|FG000|Overall Study|Lack of Efficacy|1|||
163161485|NCT04500158|589304204|FG000|Overall Study|Physician Decision|17|||
163161486|NCT04500158|589304205|FG001|Overall Study|Physician Decision|11|||
163161487|NCT03830892|589305772|FG000|Overall Study|Physician Decision|2|||
163161488|NCT03830892|589305773|FG001|Overall Study|Physician Decision|3|||
163161489|NCT03830892|589305772|FG000|Overall Study|Study terminated due to COVID|4|||
163161490|NCT03830892|589305773|FG001|Overall Study|Study terminated due to COVID|0|||
163161491|NCT03830892|589305772|FG000|Overall Study|Protocol Violation|0|||
163161492|NCT03830892|589305773|FG001|Overall Study|Protocol Violation|1|||
163161493|NCT03830892|589305772|FG000|Overall Study|Withdrawal by Subject|0|||
163161494|NCT03830892|589305773|FG001|Overall Study|Withdrawal by Subject|2|||
163161495|NCT01499277|589305774|FG000|Overall Study|Adverse Event|3|||
163161496|NCT01499277|589305775|FG001|Overall Study|Adverse Event|6|||
163161497|NCT01499277|589305774|FG000|Overall Study|Death|3|||
163161498|NCT01499277|589305775|FG001|Overall Study|Death|2|||
163161499|NCT01499277|589305774|FG000|Overall Study|Lost to Follow-up|15|||
163161500|NCT01499277|589305775|FG001|Overall Study|Lost to Follow-up|8|||
163161501|NCT01499277|589305774|FG000|Overall Study|Protocol Violation|2|||
163161502|NCT01499277|589305775|FG001|Overall Study|Protocol Violation|3|||
163161503|NCT01499277|589305774|FG000|Overall Study|Withdrawal by Subject|16|||
163161504|NCT01499277|589305775|FG001|Overall Study|Withdrawal by Subject|6|||
163161505|NCT01499277|589305774|FG000|Overall Study|Lack of therapeutic response and other|8|||
163161506|NCT01499277|589305775|FG001|Overall Study|Lack of therapeutic response and other|7|||
163161507|NCT00975689|589305776|FG000|Overall Study|Adverse Event|0|||
163161508|NCT00975689|589305777|FG001|Overall Study|Adverse Event|3|||
163161509|NCT00975689|589305776|FG000|Overall Study|Withdrawal by Subject|1|||
163161510|NCT00975689|589305777|FG001|Overall Study|Withdrawal by Subject|0|||
163161511|NCT00975689|589305776|FG000|Overall Study|Physician Decision|1|||
163161512|NCT00975689|589305777|FG001|Overall Study|Physician Decision|0|||
163161513|NCT00372593|589305780|FG000|Overall Study|Adverse Event|43|||
163161514|NCT00372593|589305781|FG001|Overall Study|Adverse Event|45|||
163161515|NCT00372593|589305782|FG002|Overall Study|Adverse Event|0|||
163161516|NCT00372593|589305780|FG000|Overall Study|Death|16|||
163161517|NCT00372593|589305781|FG001|Overall Study|Death|20|||
163161518|NCT00372593|589305782|FG002|Overall Study|Death|1|||
163161519|NCT00372593|589305780|FG000|Overall Study|Lack of Efficacy|82|||
163161520|NCT00372593|589305781|FG001|Overall Study|Lack of Efficacy|71|||
163161521|NCT00372593|589305782|FG002|Overall Study|Lack of Efficacy|2|||
163386086|NCT02903368|590123346|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
163386087|NCT02903368|590123347|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
163386088|NCT02903368|590123348|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
163386089|NCT05437510|590123349|FG000|Overall Study|Adverse Event|2|||
163386090|NCT05437510|590123350|FG001|Overall Study|Adverse Event|1|||
163386091|NCT05437510|590123349|FG000|Overall Study|Protocol Deviation|1|||
163386092|NCT05437510|590123350|FG001|Overall Study|Protocol Deviation|6|||
163386093|NCT05437510|590123349|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
163161522|NCT00372593|589305780|FG000|Overall Study|Lost to Follow-up|1|||
163161523|NCT00372593|589305781|FG001|Overall Study|Lost to Follow-up|0|||
163161524|NCT00372593|589305782|FG002|Overall Study|Lost to Follow-up|0|||
163161525|NCT00372593|589305780|FG000|Overall Study|Physician Decision|42|||
163161526|NCT00372593|589305781|FG001|Overall Study|Physician Decision|41|||
163161527|NCT00372593|589305782|FG002|Overall Study|Physician Decision|0|||
163161528|NCT00372593|589305780|FG000|Overall Study|Ineligible|20|||
163161529|NCT00372593|589305781|FG001|Overall Study|Ineligible|21|||
163161530|NCT00372593|589305782|FG002|Overall Study|Ineligible|1|||
163161531|NCT02974543|589305783|FG000|Overall Study|Withdrawal by Subject|1|||
163161532|NCT02974543|589305784|FG001|Overall Study|Withdrawal by Subject|0|||
163386094|NCT05437510|590123350|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
163386095|NCT05437510|590123349|FG000|Overall Study|Lost to Follow-up|265|||
163161533|NCT03534180|589305785|FG000|Overall Study|Withdrawal by Subject|1|||
163161534|NCT00220636|589305786|FG000|Overall Study|Withdrawal by Subject|4|||
163275774|NCT02886728|589719954|FG000|Overall Study|Investigator's Discretion|11|||
163161535|NCT00330967|589305787|FG000|Overall Study|Withdrawal by Subject|0|||
163161536|NCT00330967|589305788|FG001|Overall Study|Withdrawal by Subject|5|||
163161537|NCT00330967|589305787|FG000|Overall Study|Physician Decision|0|||
163161538|NCT00330967|589305788|FG001|Overall Study|Physician Decision|9|||
163161539|NCT01237899|589305789|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
163161540|NCT01237899|589305790|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
163161541|NCT01237899|589305791|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
163161542|NCT01237899|589305792|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
163161543|NCT01237899|589305793|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
163161544|NCT01237899|589305794|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
163161545|NCT01237899|589305795|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
163161546|NCT01237899|589305796|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
163161547|NCT01237899|589305797|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
163161548|NCT01237899|589305798|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
163161549|NCT01237899|589305799|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
163161550|NCT00790088|589305800|FG000|Overall Study|Protocol Violation|11|||
163161551|NCT00790088|589305800|FG000|Overall Study|Withdrawal by Subject|17|||
163161552|NCT00790088|589305800|FG000|Overall Study|Lost to Follow-up|7|||
163161553|NCT00790088|589305800|FG000|Overall Study|Physician Decision|4|||
163161554|NCT02910986|589305801|FG000|Overall Study|non-Latina|14|||
163161555|NCT02910986|589305802|FG001|Overall Study|non-Latina|13|||
163161556|NCT02910986|589305803|FG002|Overall Study|non-Latina|12|||
163161557|NCT02910986|589305801|FG000|Overall Study|Failure to return T! survey|72|||
163161558|NCT02910986|589305802|FG001|Overall Study|Failure to return T! survey|84|||
163161559|NCT02910986|589305803|FG002|Overall Study|Failure to return T! survey|72|||
163161560|NCT02910986|589305801|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
163161561|NCT02910986|589305802|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
163161562|NCT02910986|589305803|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
163161563|NCT02910986|589305801|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
163161564|NCT02910986|589305802|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
163161565|NCT02910986|589305803|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
163161566|NCT03682770|589305814|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
163161567|NCT03682770|589305815|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
163161568|NCT03682770|589305816|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
163161569|NCT03682770|589305817|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
163161570|NCT03682770|589305818|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
163161571|NCT03682770|589305819|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
163161572|NCT03682770|589305820|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
163161573|NCT03682770|589305814|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
163161574|NCT03682770|589305815|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
163161575|NCT03682770|589305816|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
163161576|NCT03682770|589305817|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
163161577|NCT03682770|589305818|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
163161578|NCT03682770|589305819|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
163161579|NCT03682770|589305820|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
163161580|NCT03682770|589305814|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
163161581|NCT03682770|589305815|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
163161582|NCT03682770|589305816|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
163161583|NCT03682770|589305817|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
163161584|NCT03682770|589305818|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
163161585|NCT03682770|589305819|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
163161586|NCT03682770|589305820|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
163161587|NCT03682770|589305814|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
163161588|NCT03682770|589305815|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
163161589|NCT03682770|589305816|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
163161590|NCT03682770|589305817|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
163161591|NCT03682770|589305818|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
163161592|NCT03682770|589305819|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
163161593|NCT03682770|589305820|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
163161594|NCT03682770|589305814|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
163161595|NCT03682770|589305815|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
163161596|NCT03682770|589305816|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
163161597|NCT03682770|589305817|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
163161598|NCT03682770|589305818|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
163161599|NCT03682770|589305819|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
163161600|NCT03682770|589305820|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
163161601|NCT03682770|589305814|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
163161602|NCT03682770|589305815|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
163161603|NCT03682770|589305816|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
163161604|NCT03682770|589305817|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
163161605|NCT03682770|589305818|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
163386096|NCT05437510|590123350|FG001|Overall Study|Lost to Follow-up|358|||
163386097|NCT00147823|590123353|FG000|Overall Study|Lost to Follow-up|6|||
163386098|NCT00147823|590123354|FG001|Overall Study|Lost to Follow-up|12|||
163386099|NCT00147823|590123353|FG000|Overall Study|Physician Decision|1|||
163386100|NCT00147823|590123354|FG001|Overall Study|Physician Decision|0|||
163386101|NCT00147823|590123353|FG000|Overall Study|Withdrawal by Subject|0|||
163386102|NCT00147823|590123354|FG001|Overall Study|Withdrawal by Subject|1|||
163386103|NCT00147823|590123353|FG000|Overall Study|Did not receive vitoss due to infection|6|||
163386104|NCT00147823|590123354|FG001|Overall Study|Did not receive vitoss due to infection|2|||
163386105|NCT05199571|590125521|FG000|Treatment period|Participant decision|3|||
163386106|NCT05199571|590125521|FG000|Treatment period|Physician Decision|1|||
163386107|NCT05199571|590125521|FG000|Post-treatment follow up period|Participant decision|3|||
163386108|NCT02892344|590125522|FG000|Overall Study|Protocol deviation|3|||
163386109|NCT02892344|590125523|FG001|Overall Study|Protocol deviation|4|||
163386110|NCT02892344|590125522|FG000|Overall Study|Adverse Event|1|||
163386111|NCT02892344|590125523|FG001|Overall Study|Adverse Event|8|||
163386112|NCT02892344|590125522|FG000|Overall Study|Lost to Follow-up|0|||
163386113|NCT02892344|590125523|FG001|Overall Study|Lost to Follow-up|1|||
163386114|NCT02892344|590125522|FG000|Overall Study|Non-compliance with study treatment|0|||
163386115|NCT02892344|590125523|FG001|Overall Study|Non-compliance with study treatment|1|||
163386116|NCT02892344|590125522|FG000|Overall Study|Physician Decision|0|||
163386117|NCT02892344|590125523|FG001|Overall Study|Physician Decision|2|||
163386118|NCT02892344|590125522|FG000|Overall Study|Subject/guardian decision|0|||
163386119|NCT02892344|590125523|FG001|Overall Study|Subject/guardian decision|4|||
163386120|NCT02892344|590125522|FG000|Overall Study|Technical problems|0|||
163386121|NCT02892344|590125523|FG001|Overall Study|Technical problems|1|||
163386122|NCT03938454|590125524|FG000|Overall Study|Protocol Violation|1|||
163386123|NCT03938454|590125524|FG000|Overall Study|Withdrawal by Subject|2|||
163386124|NCT03938454|590125524|FG000|Overall Study|Lost to Follow-up|3|||
163386125|NCT04441905|590125525|FG000|Overall Study|Lost to Follow-up|1|||
163386126|NCT04441905|590125526|FG001|Overall Study|Lost to Follow-up|0|||
163386127|NCT04441905|590125527|FG002|Overall Study|Lost to Follow-up|0|||
163386128|NCT04441905|590125528|FG003|Overall Study|Lost to Follow-up|0|||
163386129|NCT04441905|590125529|FG004|Overall Study|Lost to Follow-up|0|||
163386130|NCT04441905|590125530|FG005|Overall Study|Lost to Follow-up|0|||
163386131|NCT04441905|590125525|FG000|Overall Study|Enrolled but treatment not administered|0|||
163386132|NCT04441905|590125526|FG001|Overall Study|Enrolled but treatment not administered|1|||
163386133|NCT04441905|590125527|FG002|Overall Study|Enrolled but treatment not administered|0|||
163386134|NCT04441905|590125528|FG003|Overall Study|Enrolled but treatment not administered|0|||
163386135|NCT04441905|590125529|FG004|Overall Study|Enrolled but treatment not administered|0|||
163386136|NCT04441905|590125530|FG005|Overall Study|Enrolled but treatment not administered|0|||
163386137|NCT04441905|590125525|FG000|Overall Study|Became ineligible after enrollment|0|||
163386138|NCT04441905|590125526|FG001|Overall Study|Became ineligible after enrollment|0|||
163386139|NCT04441905|590125527|FG002|Overall Study|Became ineligible after enrollment|0|||
163386140|NCT04441905|590125528|FG003|Overall Study|Became ineligible after enrollment|0|||
163386141|NCT04441905|590125529|FG004|Overall Study|Became ineligible after enrollment|1|||
163386142|NCT04441905|590125530|FG005|Overall Study|Became ineligible after enrollment|0|||
163386143|NCT03922802|590125531|FG000|Overall Study|Withdrawal by Subject|4|||
163386144|NCT04486716|590125532|FG000|Core Phase|Subject decision|6|||
163386145|NCT04486716|590125532|FG000|Core Phase|Adverse Event|5|||
163386146|NCT04486716|590125532|FG000|Core Phase|Lost to Follow-up|1|||
163386147|NCT04486716|590125532|FG000|Core Phase|Physician Decision|1|||
163386148|NCT04486716|590125532|FG000|Core Phase|Enrolled subjects not treated|9|||
163386149|NCT05888103|590125533|FG000|Overall Study|Participant decision|3|||
163386150|NCT05888103|590125534|FG001|Overall Study|Participant decision|3|||
163386151|NCT04987307|590125535|FG000|Overall Study|Protocol-specified criteria|2|||
163386152|NCT04987307|590125536|FG001|Overall Study|Protocol-specified criteria|0|||
163386153|NCT04987307|590125537|FG002|Overall Study|Protocol-specified criteria|0|||
163161606|NCT03682770|589305819|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
163161607|NCT03682770|589305820|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
163161608|NCT03682770|589305814|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
163161609|NCT03682770|589305815|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
163161610|NCT03682770|589305816|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
163161611|NCT03682770|589305817|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
163386154|NCT04987307|590125538|FG003|Overall Study|Protocol-specified criteria|3|||
163386155|NCT04987307|590125535|FG000|Overall Study|Withdrawal by Subject|34|||
163386156|NCT04987307|590125536|FG001|Overall Study|Withdrawal by Subject|30|||
163386157|NCT04987307|590125537|FG002|Overall Study|Withdrawal by Subject|29|||
163386158|NCT04987307|590125538|FG003|Overall Study|Withdrawal by Subject|35|||
163386159|NCT04987307|590125535|FG000|Overall Study|Decision by sponsor|10|||
163161612|NCT03682770|589305818|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
163386160|NCT04987307|590125536|FG001|Overall Study|Decision by sponsor|13|||
163386161|NCT04987307|590125537|FG002|Overall Study|Decision by sponsor|11|||
163386162|NCT04987307|590125538|FG003|Overall Study|Decision by sponsor|9|||
163386163|NCT04987307|590125535|FG000|Overall Study|Lost to Follow-up|1|||
163386164|NCT04987307|590125536|FG001|Overall Study|Lost to Follow-up|0|||
163386165|NCT04987307|590125537|FG002|Overall Study|Lost to Follow-up|0|||
163386166|NCT04987307|590125538|FG003|Overall Study|Lost to Follow-up|0|||
163386167|NCT03650400|590125539|FG000|Overall Study|Study terminated by sponsor|0|||
163386168|NCT03650400|590125540|FG001|Overall Study|Study terminated by sponsor|5|||
163386169|NCT00792805|590125542|FG000|Overall Study|Adverse Event|12|||
163386170|NCT00792805|590125543|FG001|Overall Study|Adverse Event|10|||
163386171|NCT00792805|590125544|FG002|Overall Study|Adverse Event|10|||
163386172|NCT00792805|590125542|FG000|Overall Study|Subject withdrew consent|5|||
163386173|NCT00792805|590125543|FG001|Overall Study|Subject withdrew consent|6|||
163386174|NCT00792805|590125544|FG002|Overall Study|Subject withdrew consent|5|||
163386175|NCT00792805|590125542|FG000|Overall Study|Administrative problems|2|||
163386176|NCT00792805|590125543|FG001|Overall Study|Administrative problems|0|||
163386177|NCT00792805|590125544|FG002|Overall Study|Administrative problems|4|||
163386178|NCT00792805|590125542|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163386179|NCT00792805|590125543|FG001|Overall Study|Abnormal test procedure result(s)|2|||
163386180|NCT00792805|590125544|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163386181|NCT00792805|590125542|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163386182|NCT00792805|590125543|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
163386183|NCT00792805|590125544|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
163386184|NCT00792805|590125542|FG000|Overall Study|Lost to Follow-up|1|||
163386185|NCT00792805|590125543|FG001|Overall Study|Lost to Follow-up|1|||
163386186|NCT00792805|590125544|FG002|Overall Study|Lost to Follow-up|6|||
163386187|NCT00792805|590125542|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163386188|NCT00792805|590125543|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163386189|NCT00792805|590125544|FG002|Overall Study|Abnormal laboratory value(s)|1|||
163386190|NCT00792805|590125542|FG000|Overall Study|Protocol deviation|0|||
163386191|NCT00792805|590125543|FG001|Overall Study|Protocol deviation|1|||
163386192|NCT00792805|590125544|FG002|Overall Study|Protocol deviation|1|||
163386193|NCT05541861|590125545|FG000|Overall Study|Withdrawal by Subject|0|||
163386194|NCT05541861|590125546|FG001|Overall Study|Withdrawal by Subject|0|||
163386195|NCT05541861|590125547|FG002|Overall Study|Withdrawal by Subject|0|||
163386196|NCT05541861|590125548|FG003|Overall Study|Withdrawal by Subject|0|||
163386197|NCT05541861|590125549|FG004|Overall Study|Withdrawal by Subject|0|||
163386198|NCT05541861|590125550|FG005|Overall Study|Withdrawal by Subject|0|||
163386199|NCT05541861|590125551|FG006|Overall Study|Withdrawal by Subject|2|||
163386200|NCT05541861|590125552|FG007|Overall Study|Withdrawal by Subject|0|||
163386201|NCT05541861|590125553|FG008|Overall Study|Withdrawal by Subject|0|||
163386202|NCT05541861|590125545|FG000|Overall Study|Randomized but not dosed|0|||
163386203|NCT05541861|590125546|FG001|Overall Study|Randomized but not dosed|1|||
163386204|NCT05541861|590125547|FG002|Overall Study|Randomized but not dosed|1|||
163386205|NCT05541861|590125548|FG003|Overall Study|Randomized but not dosed|0|||
163386206|NCT05541861|590125549|FG004|Overall Study|Randomized but not dosed|0|||
163386207|NCT05541861|590125550|FG005|Overall Study|Randomized but not dosed|0|||
163386208|NCT05541861|590125551|FG006|Overall Study|Randomized but not dosed|1|||
163386209|NCT05541861|590125552|FG007|Overall Study|Randomized but not dosed|0|||
163386210|NCT05541861|590125553|FG008|Overall Study|Randomized but not dosed|1|||
163386211|NCT04452877|590125560|FG000|Overall Study|Adverse Event|5|||
163386212|NCT04452877|590125560|FG000|Overall Study|Lost to Follow-up|1|||
163386213|NCT04452877|590125560|FG000|Overall Study|Physician Decision|4|||
163386214|NCT04452877|590125560|FG000|Overall Study|Progressive Disease|18|||
163386215|NCT04452877|590125560|FG000|Overall Study|Withdrawal by Subject|3|||
163386216|NCT05678959|590125561|FG000|Overall Study|Study Terminated by Sponsor|76|||
163386217|NCT05678959|590125562|FG001|Overall Study|Study Terminated by Sponsor|76|||
163386218|NCT05678959|590125561|FG000|Overall Study|Physician Decision|2|||
163386219|NCT05678959|590125562|FG001|Overall Study|Physician Decision|3|||
163386220|NCT05678959|590125561|FG000|Overall Study|Adverse Event|1|||
163386221|NCT05678959|590125562|FG001|Overall Study|Adverse Event|1|||
163386222|NCT05678959|590125561|FG000|Overall Study|Guardian Decision|1|||
163386223|NCT05678959|590125562|FG001|Overall Study|Guardian Decision|0|||
163386224|NCT05678959|590125561|FG000|Overall Study|Protocol Deviation|0|||
163386225|NCT05678959|590125562|FG001|Overall Study|Protocol Deviation|1|||
163386226|NCT05678959|590125561|FG000|Overall Study|Subject Decision|1|||
163386227|NCT05678959|590125562|FG001|Overall Study|Subject Decision|0|||
163386228|NCT05678959|590125561|FG000|Overall Study|Technical Problem|0|||
163386229|NCT05678959|590125562|FG001|Overall Study|Technical Problem|1|||
163386230|NCT02065336|590125563|FG000|Extension Phase|Study Terminated by Sponsor|0|||
163386231|NCT02065336|590125564|FG001|Extension Phase|Study Terminated by Sponsor|0|||
163386232|NCT02065336|590125565|FG002|Extension Phase|Study Terminated by Sponsor|0|||
163386233|NCT02065336|590125566|FG003|Extension Phase|Study Terminated by Sponsor|0|||
163386234|NCT02065336|590125567|FG004|Extension Phase|Study Terminated by Sponsor|0|||
163386235|NCT02065336|590125568|FG005|Extension Phase|Study Terminated by Sponsor|0|||
163386236|NCT02065336|590125569|FG006|Extension Phase|Study Terminated by Sponsor|0|||
163386237|NCT02065336|590125570|FG007|Extension Phase|Study Terminated by Sponsor|0|||
163386238|NCT02065336|590125571|FG008|Extension Phase|Study Terminated by Sponsor|2|||
163386239|NCT02065336|590125572|FG009|Extension Phase|Study Terminated by Sponsor|8|||
163386240|NCT03226392|590125573|FG000|Overall Study|Protocol Deviation|1|||
163386241|NCT03226392|590125574|FG001|Overall Study|Protocol Deviation|0|||
163386242|NCT03226392|590125573|FG000|Overall Study|Physician Decision|1|||
163386243|NCT03226392|590125574|FG001|Overall Study|Physician Decision|0|||
163386244|NCT03226392|590125573|FG000|Overall Study|Lost to Follow-up|1|||
163386245|NCT03226392|590125574|FG001|Overall Study|Lost to Follow-up|0|||
163386246|NCT03226392|590125573|FG000|Overall Study|Adverse Event|1|||
163386247|NCT03226392|590125574|FG001|Overall Study|Adverse Event|0|||
163386248|NCT03226392|590125573|FG000|Overall Study|Technical Problems|0|||
163386249|NCT03226392|590125574|FG001|Overall Study|Technical Problems|2|||
163386250|NCT03226392|590125573|FG000|Overall Study|Subject/Guardian Decision|7|||
163386251|NCT03226392|590125574|FG001|Overall Study|Subject/Guardian Decision|6|||
163386252|NCT03056755|590125575|FG000|Core Phase|Progressive disease|89|||
163386253|NCT03056755|590125576|FG001|Core Phase|Progressive disease|88|||
163386254|NCT03056755|590125577|FG002|Core Phase|Progressive disease|90|||
163386255|NCT03056755|590125575|FG000|Core Phase|Adverse Event|20|||
163386256|NCT03056755|590125576|FG001|Core Phase|Adverse Event|14|||
163386257|NCT03056755|590125577|FG002|Core Phase|Adverse Event|13|||
163386258|NCT03056755|590125575|FG000|Core Phase|Physician Decision|7|||
163386259|NCT03056755|590125576|FG001|Core Phase|Physician Decision|13|||
163386260|NCT03056755|590125577|FG002|Core Phase|Physician Decision|5|||
163386261|NCT03056755|590125575|FG000|Core Phase|Subject/guardian decision|5|||
163386262|NCT03056755|590125576|FG001|Core Phase|Subject/guardian decision|8|||
163386263|NCT03056755|590125577|FG002|Core Phase|Subject/guardian decision|4|||
163386264|NCT03056755|590125575|FG000|Core Phase|Death|3|||
163386265|NCT03056755|590125576|FG001|Core Phase|Death|2|||
163386266|NCT03056755|590125577|FG002|Core Phase|Death|4|||
163386267|NCT03056755|590125575|FG000|Core Phase|Protocol deviation|1|||
163386268|NCT03056755|590125576|FG001|Core Phase|Protocol deviation|1|||
163386269|NCT03056755|590125577|FG002|Core Phase|Protocol deviation|0|||
163386270|NCT03056755|590125575|FG000|Core Phase|Technical problems|1|||
163386271|NCT03056755|590125576|FG001|Core Phase|Technical problems|0|||
163386272|NCT03056755|590125577|FG002|Core Phase|Technical problems|0|||
163386273|NCT03056755|590125575|FG000|Extension Phase|Physician Decision|1|||
163386274|NCT03056755|590125576|FG001|Extension Phase|Physician Decision|0|||
163386275|NCT03056755|590125577|FG002|Extension Phase|Physician Decision|3|||
163386276|NCT03056755|590125575|FG000|Extension Phase|Adverse Event|0|||
163386277|NCT03056755|590125576|FG001|Extension Phase|Adverse Event|0|||
163386278|NCT03056755|590125577|FG002|Extension Phase|Adverse Event|1|||
163386279|NCT03056755|590125575|FG000|Extension Phase|Subject/guardian decision|0|||
163386280|NCT03056755|590125576|FG001|Extension Phase|Subject/guardian decision|0|||
163386281|NCT03056755|590125577|FG002|Extension Phase|Subject/guardian decision|1|||
163386282|NCT00402363|590125578|FG000|Overall Study|Adverse Event|9|||
163386283|NCT00402363|590125579|FG001|Overall Study|Adverse Event|14|||
163386284|NCT00402363|590125580|FG002|Overall Study|Adverse Event|2|||
163386285|NCT00402363|590125581|FG003|Overall Study|Adverse Event|2|||
163386286|NCT00402363|590125578|FG000|Overall Study|Withdrew Consent|10|||
163386287|NCT00402363|590125579|FG001|Overall Study|Withdrew Consent|5|||
163386288|NCT00402363|590125580|FG002|Overall Study|Withdrew Consent|2|||
163386289|NCT00402363|590125581|FG003|Overall Study|Withdrew Consent|1|||
163386290|NCT00402363|590125578|FG000|Overall Study|Protocol Violation|3|||
163386291|NCT00402363|590125579|FG001|Overall Study|Protocol Violation|5|||
163386292|NCT00402363|590125580|FG002|Overall Study|Protocol Violation|0|||
163386293|NCT00402363|590125581|FG003|Overall Study|Protocol Violation|3|||
163386294|NCT00402363|590125578|FG000|Overall Study|Lost to Follow-up|5|||
163161613|NCT03682770|589305819|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
163161614|NCT03682770|589305820|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
163161615|NCT03682770|589305814|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
163161616|NCT03682770|589305815|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
163386295|NCT00402363|590125579|FG001|Overall Study|Lost to Follow-up|4|||
163386296|NCT00402363|590125580|FG002|Overall Study|Lost to Follow-up|0|||
163386297|NCT00402363|590125581|FG003|Overall Study|Lost to Follow-up|2|||
163386298|NCT00402363|590125578|FG000|Overall Study|"Captured as Other"|6|||
163386299|NCT00402363|590125579|FG001|Overall Study|"Captured as Other"|2|||
163386300|NCT00402363|590125580|FG002|Overall Study|"Captured as Other"|2|||
163386301|NCT00402363|590125581|FG003|Overall Study|"Captured as Other"|2|||
163386302|NCT04667949|590125597|FG000|Overall Study|Adverse Event|0|||
163386303|NCT04667949|590125598|FG001|Overall Study|Adverse Event|2|||
163386304|NCT04667949|590125597|FG000|Overall Study|Lost to Follow-up|0|||
163386305|NCT04667949|590125598|FG001|Overall Study|Lost to Follow-up|1|||
163386306|NCT04667949|590125597|FG000|Overall Study|Physician Decision|0|||
163386307|NCT04667949|590125598|FG001|Overall Study|Physician Decision|2|||
163386308|NCT04667949|590125597|FG000|Overall Study|Subject decision|1|||
163386309|NCT04667949|590125598|FG001|Overall Study|Subject decision|7|||
163386310|NCT04504630|590125599|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
163386311|NCT04504630|590125600|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
163386312|NCT04504630|590125599|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
163386313|NCT04504630|590125600|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
163386314|NCT00568321|590125601|FG000|Overall Study|Adverse Event|1|||
163386315|NCT00568321|590125602|FG001|Overall Study|Adverse Event|0|||
163386316|NCT00568321|590125603|FG002|Overall Study|Adverse Event|0|||
163386317|NCT00568321|590125601|FG000|Overall Study|Lack of Efficacy|8|||
163386318|NCT00568321|590125602|FG001|Overall Study|Lack of Efficacy|5|||
163386319|NCT00568321|590125603|FG002|Overall Study|Lack of Efficacy|6|||
163386320|NCT00568321|590125601|FG000|Overall Study|Lost to Follow-up|0|||
163386321|NCT00568321|590125602|FG001|Overall Study|Lost to Follow-up|0|||
163386322|NCT00568321|590125603|FG002|Overall Study|Lost to Follow-up|1|||
163386323|NCT00568321|590125601|FG000|Overall Study|Withdrawal by Subject|2|||
163386324|NCT00568321|590125602|FG001|Overall Study|Withdrawal by Subject|0|||
163386325|NCT00568321|590125603|FG002|Overall Study|Withdrawal by Subject|0|||
163386326|NCT00568321|590125601|FG000|Overall Study|Protocol Violation|0|||
163386327|NCT00568321|590125602|FG001|Overall Study|Protocol Violation|0|||
163386328|NCT00568321|590125603|FG002|Overall Study|Protocol Violation|1|||
163386329|NCT00568321|590125601|FG000|Overall Study|Randomized, not treated|2|||
163386330|NCT00568321|590125602|FG001|Overall Study|Randomized, not treated|0|||
163386331|NCT00568321|590125603|FG002|Overall Study|Randomized, not treated|1|||
163386332|NCT00937833|590125605|FG000|Overall Study|Protocol Violation|1|||
163386333|NCT00937833|590125606|FG001|Overall Study|Protocol Violation|2|||
163386334|NCT00937833|590125605|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
163386335|NCT00937833|590125606|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
163386336|NCT00937833|590125605|FG000|Overall Study|Lost to Follow-up|10|||
163386337|NCT00937833|590125606|FG001|Overall Study|Lost to Follow-up|8|||
163386338|NCT00937833|590125605|FG000|Overall Study|Withdrawal by Subject|4|||
163386339|NCT00937833|590125606|FG001|Overall Study|Withdrawal by Subject|6|||
163386340|NCT04266301|590125607|FG000|Overall Study|Progressive Disease|111|||
163386341|NCT04266301|590125608|FG001|Overall Study|Progressive Disease|92|||
163386342|NCT04266301|590125607|FG000|Overall Study|Adverse Event|41|||
163386343|NCT04266301|590125608|FG001|Overall Study|Adverse Event|43|||
163386344|NCT04266301|590125607|FG000|Overall Study|Death|26|||
163386345|NCT04266301|590125608|FG001|Overall Study|Death|35|||
163386346|NCT04266301|590125607|FG000|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
163386347|NCT04266301|590125608|FG001|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
163386348|NCT04266301|590125607|FG000|Overall Study|Study Terminated by Sponsor|22|||
163386349|NCT04266301|590125608|FG001|Overall Study|Study Terminated by Sponsor|27|||
163386350|NCT04266301|590125607|FG000|Overall Study|Participant Decision|22|||
163386351|NCT04266301|590125608|FG001|Overall Study|Participant Decision|28|||
163386352|NCT04266301|590125607|FG000|Overall Study|Physician Decision|14|||
163386353|NCT04266301|590125608|FG001|Overall Study|Physician Decision|9|||
163386354|NCT04266301|590125607|FG000|Overall Study|New Therapy for Study Indication|2|||
163386355|NCT04266301|590125608|FG001|Overall Study|New Therapy for Study Indication|4|||
163386356|NCT04266301|590125607|FG000|Overall Study|Protocol Deviation|2|||
163386357|NCT04266301|590125608|FG001|Overall Study|Protocol Deviation|4|||
163386358|NCT04266301|590125607|FG000|Overall Study|Guardian Decision|1|||
163386359|NCT04266301|590125608|FG001|Overall Study|Guardian Decision|0|||
163386360|NCT04266301|590125607|FG000|Overall Study|Lost to Follow-up|1|||
163386361|NCT04266301|590125608|FG001|Overall Study|Lost to Follow-up|0|||
163386362|NCT04266301|590125607|FG000|Overall Study|Participants Not Treated|1|||
163386363|NCT04266301|590125608|FG001|Overall Study|Participants Not Treated|1|||
163386364|NCT03215758|590125609|FG000|Overall Study|Technical Problems|1|||
163386365|NCT03215758|590125610|FG001|Overall Study|Technical Problems|0|||
163386366|NCT03215758|590125609|FG000|Overall Study|Protocol deviation|0|||
163386367|NCT03215758|590125610|FG001|Overall Study|Protocol deviation|1|||
163386368|NCT03215758|590125609|FG000|Overall Study|Physician Decision|0|||
163386369|NCT03215758|590125610|FG001|Overall Study|Physician Decision|1|||
163386370|NCT03215758|590125609|FG000|Overall Study|Death|0|||
163386371|NCT03215758|590125610|FG001|Overall Study|Death|1|||
163386372|NCT03215758|590125609|FG000|Overall Study|Adverse Event|1|||
163386373|NCT03215758|590125610|FG001|Overall Study|Adverse Event|2|||
162924206|NCT02426125|588423830|FG001|Overall Study|Randomized, But Never Treated|2|||
162924207|NCT00077766|588423833|FG000|Overall Study|Adverse Event|1|||
162924208|NCT00077766|588423834|FG001|Overall Study|Adverse Event|1|||
162924209|NCT00077766|588423833|FG000|Overall Study|Withdrawal by Subject|4|||
162924210|NCT00077766|588423834|FG001|Overall Study|Withdrawal by Subject|3|||
162924211|NCT00077766|588423833|FG000|Overall Study|Death|12|||
162924212|NCT00077766|588423834|FG001|Overall Study|Death|10|||
162924213|NCT00077766|588423833|FG000|Overall Study|Lost to Follow-up|2|||
162924214|NCT00077766|588423834|FG001|Overall Study|Lost to Follow-up|0|||
162924215|NCT00077766|588423833|FG000|Overall Study|Protocol Violation|1|||
162924216|NCT00077766|588423834|FG001|Overall Study|Protocol Violation|0|||
162924217|NCT00077766|588423833|FG000|Overall Study|Kidney Transplantation|9|||
162924218|NCT00077766|588423834|FG001|Overall Study|Kidney Transplantation|5|||
162924219|NCT00077766|588423833|FG000|Overall Study|Transplantation|5|||
163386374|NCT03215758|590125609|FG000|Overall Study|Subject/Guardian Decision|3|||
163386375|NCT03215758|590125610|FG001|Overall Study|Subject/Guardian Decision|3|||
163386376|NCT02175004|590125614|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
163386377|NCT02175004|590125615|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
163386378|NCT02175004|590125614|FG000|Overall Study|Investigator Judgment|1|||
163386379|NCT02175004|590125615|FG001|Overall Study|Investigator Judgment|4|||
163386380|NCT02175004|590125614|FG000|Overall Study|Voluntary Withdrawal|6|||
163386381|NCT02175004|590125615|FG001|Overall Study|Voluntary Withdrawal|19|||
163386382|NCT02175004|590125614|FG000|Overall Study|Liver Transplant|1|||
163386383|NCT02175004|590125615|FG001|Overall Study|Liver Transplant|0|||
163386384|NCT02175004|590125614|FG000|Overall Study|Disease Progression|1|||
163386385|NCT02175004|590125615|FG001|Overall Study|Disease Progression|0|||
163386386|NCT02175004|590125614|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
163386387|NCT02175004|590125615|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
163386388|NCT00162032|590125616|FG000|Overall Study|Lost to Follow-up|4|||
163386389|NCT00162032|590125617|FG001|Overall Study|Lost to Follow-up|2|||
163386390|NCT00162032|590125616|FG000|Overall Study|Reason not specified|1|||
163386391|NCT00162032|590125617|FG001|Overall Study|Reason not specified|0|||
163386392|NCT01137955|590125618|FG000|Overall Study|Withdrawal by Subject|5|||
163386393|NCT01137955|590125619|FG001|Overall Study|Withdrawal by Subject|4|||
163386394|NCT02977988|590125621|FG000|Overall Study|Lost to Follow-up|13|||
163386395|NCT02977988|590125622|FG001|Overall Study|Lost to Follow-up|7|||
163386396|NCT05341115|590125623|FG000|Overall Study|Adverse Event|1|||
163386397|NCT05341115|590125623|FG000|Overall Study|Lost to Follow-up|1|||
163386398|NCT04263909|590125629|FG000|Overall Study|Physician Decision|1|||
163386399|NCT04263909|590125630|FG001|Overall Study|Physician Decision|0|||
163386400|NCT04263909|590125631|FG002|Overall Study|Physician Decision|0|||
163386401|NCT04263909|590125629|FG000|Overall Study|Adverse Event|3|||
163386402|NCT04263909|590125630|FG001|Overall Study|Adverse Event|0|||
163386403|NCT04263909|590125631|FG002|Overall Study|Adverse Event|0|||
163386404|NCT04263909|590125629|FG000|Overall Study|Protocol Violation|5|||
163386405|NCT04263909|590125630|FG001|Overall Study|Protocol Violation|0|||
163386406|NCT04263909|590125631|FG002|Overall Study|Protocol Violation|0|||
163386407|NCT05630001|590125632|FG000|Overall Study|Adverse Event|1|||
163386408|NCT05386680|590125633|FG000|Overall Study|Guardian decision|2|||
163386409|NCT03946670|590125634|FG000|Overall Study|Progressive Disease|34|||
163386410|NCT03946670|590125635|FG001|Overall Study|Progressive Disease|27|||
163386411|NCT03946670|590125634|FG000|Overall Study|Adverse Event|7|||
163386412|NCT03946670|590125635|FG001|Overall Study|Adverse Event|10|||
163386413|NCT03946670|590125634|FG000|Overall Study|Physician Decision|6|||
163386414|NCT03946670|590125635|FG001|Overall Study|Physician Decision|5|||
163386415|NCT03946670|590125634|FG000|Overall Study|Death|5|||
163386416|NCT03946670|590125635|FG001|Overall Study|Death|8|||
163386417|NCT03946670|590125634|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
163386418|NCT03946670|590125635|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
163386419|NCT03946670|590125634|FG000|Overall Study|Subject Decision|4|||
163386420|NCT03946670|590125635|FG001|Overall Study|Subject Decision|5|||
163386421|NCT03946670|590125634|FG000|Overall Study|Study Terminated By Sponsor|2|||
163386422|NCT03946670|590125635|FG001|Overall Study|Study Terminated By Sponsor|0|||
163386423|NCT03946670|590125634|FG000|Overall Study|New Therapy For Study Indication|1|||
163386424|NCT03946670|590125635|FG001|Overall Study|New Therapy For Study Indication|0|||
163386425|NCT03946670|590125634|FG000|Overall Study|Not Treated|1|||
163386426|NCT03946670|590125635|FG001|Overall Study|Not Treated|1|||
163386427|NCT03840486|590125636|FG000|Overall Study|Withdrawal by Subject|0|||
163386428|NCT03840486|590125637|FG001|Overall Study|Withdrawal by Subject|1|||
163386429|NCT03840486|590125638|FG002|Overall Study|Withdrawal by Subject|0|||
163386430|NCT03840486|590125639|FG003|Overall Study|Withdrawal by Subject|0|||
163386431|NCT03840486|590125640|FG004|Overall Study|Withdrawal by Subject|0|||
163386432|NCT03840486|590125641|FG005|Overall Study|Withdrawal by Subject|0|||
163386433|NCT03840486|590125642|FG006|Overall Study|Withdrawal by Subject|0|||
163386434|NCT03840486|590125643|FG007|Overall Study|Withdrawal by Subject|0|||
163386435|NCT03840486|590125644|FG008|Overall Study|Withdrawal by Subject|0|||
163386436|NCT03840486|590125645|FG009|Overall Study|Withdrawal by Subject|0|||
163386437|NCT03840486|590125646|FG010|Overall Study|Withdrawal by Subject|0|||
163386438|NCT03840486|590125647|FG011|Overall Study|Withdrawal by Subject|0|||
163386439|NCT03437278|590125648|FG000|Overall Study|Adverse Event|0|||
163386440|NCT03437278|590125649|FG001|Overall Study|Adverse Event|0|||
163161617|NCT03682770|589305816|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
163386441|NCT03437278|590125650|FG002|Overall Study|Adverse Event|1|||
163386442|NCT03437278|590125648|FG000|Overall Study|Progressive disease|1|||
163386443|NCT03437278|590125649|FG001|Overall Study|Progressive disease|0|||
163386444|NCT03437278|590125650|FG002|Overall Study|Progressive disease|0|||
163386445|NCT03437278|590125648|FG000|Overall Study|Physician Decision|1|||
163386446|NCT03437278|590125649|FG001|Overall Study|Physician Decision|0|||
163386447|NCT03437278|590125650|FG002|Overall Study|Physician Decision|1|||
163386448|NCT05116046|590125651|FG000|Overall Study|Withdrawal by parent/guardian|2|||
163386449|NCT05116046|590125652|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163386450|NCT05116046|590125653|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163386451|NCT05116046|590125651|FG000|Overall Study|Study terminated by sponsor|14|||
163386452|NCT05116046|590125652|FG001|Overall Study|Study terminated by sponsor|16|||
163386453|NCT05116046|590125653|FG002|Overall Study|Study terminated by sponsor|1|||
163386454|NCT04328727|590125655|FG000|Overall Study|Guardian Decision|1|||
163386455|NCT04328727|590125655|FG000|Overall Study|Participant decision|4|||
163386456|NCT04328727|590125655|FG000|Overall Study|Death|3|||
163386457|NCT02604199|590125663|FG000|Overall Study|Pregnancy|0|||
163386458|NCT02604199|590125664|FG001|Overall Study|Pregnancy|0|||
163386459|NCT02604199|590125665|FG002|Overall Study|Pregnancy|0|||
163386460|NCT02604199|590125666|FG003|Overall Study|Pregnancy|1|||
163386461|NCT02604199|590125663|FG000|Overall Study|Study terminated by sponsor|0|||
163386462|NCT02604199|590125664|FG001|Overall Study|Study terminated by sponsor|2|||
163386463|NCT02604199|590125665|FG002|Overall Study|Study terminated by sponsor|0|||
163386464|NCT02604199|590125666|FG003|Overall Study|Study terminated by sponsor|2|||
163386465|NCT02604199|590125663|FG000|Overall Study|Withdrawal by Subject|0|||
163386466|NCT02604199|590125664|FG001|Overall Study|Withdrawal by Subject|1|||
163386467|NCT02604199|590125665|FG002|Overall Study|Withdrawal by Subject|0|||
163386468|NCT02604199|590125666|FG003|Overall Study|Withdrawal by Subject|0|||
163386469|NCT02604212|590125667|FG000|Overall Study|Study Terminated by Sponsor|2|||
163386470|NCT02604212|590125668|FG001|Overall Study|Study Terminated by Sponsor|1|||
163386471|NCT02604212|590125669|FG002|Overall Study|Study Terminated by Sponsor|3|||
163386472|NCT02604212|590125670|FG003|Overall Study|Study Terminated by Sponsor|3|||
163386473|NCT02604212|590125667|FG000|Overall Study|Withdrawal by Subject|0|||
163386474|NCT02604212|590125668|FG001|Overall Study|Withdrawal by Subject|0|||
163386475|NCT02604212|590125669|FG002|Overall Study|Withdrawal by Subject|1|||
163386476|NCT02604212|590125670|FG003|Overall Study|Withdrawal by Subject|0|||
163386477|NCT00343252|590125677|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
163386478|NCT00343252|590125678|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
163386479|NCT00343252|590125677|FG000|6 Months (All Treated Participants)|Death|0|||
163386480|NCT00343252|590125678|FG001|6 Months (All Treated Participants)|Death|2|||
163386481|NCT00343252|590125677|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
163386482|NCT00343252|590125678|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
163386483|NCT00343252|590125677|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
163386484|NCT00343252|590125678|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
163386485|NCT00343252|590125677|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
163386486|NCT00343252|590125678|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
163386487|NCT00343252|590125677|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
163386488|NCT00343252|590125678|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
163386489|NCT00343252|590125677|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
163386490|NCT00343252|590125678|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
163386491|NCT00343252|590125677|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
163386492|NCT00343252|590125678|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
163386493|NCT00343252|590125677|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
163386494|NCT00343252|590125678|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
163386495|NCT00343252|590125677|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
163386496|NCT00343252|590125678|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
163386497|NCT00343252|590125677|FG000|12 Months (All Treated Participants)|Death|3|||
163386498|NCT00343252|590125678|FG001|12 Months (All Treated Participants)|Death|3|||
163386499|NCT00343252|590125677|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
163386500|NCT00343252|590125678|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
163386501|NCT00343252|590125677|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
163386502|NCT00343252|590125678|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
163386503|NCT00343252|590125677|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
163386504|NCT00343252|590125678|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
163386505|NCT00343252|590125677|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
163386506|NCT00343252|590125678|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
163386507|NCT00343252|590125677|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
163386508|NCT00343252|590125678|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
163386509|NCT00343252|590125677|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
163386510|NCT00343252|590125678|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
163386511|NCT00343252|590125677|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
163386512|NCT00343252|590125678|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
163386513|NCT00343252|590125677|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
163386514|NCT00343252|590125678|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
163386515|NCT00343252|590125677|FG000|18 Months (All Treated Participants)|Death|4|||
163386516|NCT00343252|590125678|FG001|18 Months (All Treated Participants)|Death|5|||
163386517|NCT00343252|590125677|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
163386518|NCT00343252|590125678|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
163386519|NCT00343252|590125677|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
163386520|NCT00343252|590125678|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
163386521|NCT00343252|590125677|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
163386522|NCT00343252|590125678|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
163161618|NCT03682770|589305817|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
163161619|NCT03682770|589305818|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
163161620|NCT03682770|589305819|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
163161621|NCT03682770|589305820|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
163161622|NCT03682770|589305814|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
163161623|NCT03682770|589305815|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
163161624|NCT03682770|589305816|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
163161625|NCT03682770|589305817|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
163386523|NCT00343252|590125677|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
163386524|NCT00343252|590125678|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
163386525|NCT00343252|590125677|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
163386526|NCT00343252|590125678|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
163386527|NCT00343252|590125677|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
163386528|NCT00343252|590125678|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
163386529|NCT00343252|590125677|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
163386530|NCT00343252|590125678|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
163386531|NCT01026454|590125679|FG000|Second Intervention|Pregnancy|1|||
163161626|NCT03682770|589305818|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
163161627|NCT03682770|589305819|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
163161628|NCT03682770|589305820|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
163161629|NCT03682770|589305814|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
163386532|NCT01026454|590125680|FG001|Second Intervention|Pregnancy|1|||
163386533|NCT01592864|590125683|FG000|Overall Study|Withdrawal by Subject|0|||
163386534|NCT01592864|590125684|FG001|Overall Study|Withdrawal by Subject|1|||
163386535|NCT01971203|590125687|FG000|Overall Study|Protocol Violation|3|||
163386536|NCT01971203|590125688|FG001|Overall Study|Protocol Violation|2|||
163386537|NCT01971203|590125687|FG000|Overall Study|Withdrawal by Subject|5|||
163386538|NCT01971203|590125688|FG001|Overall Study|Withdrawal by Subject|6|||
163386539|NCT01971203|590125687|FG000|Overall Study|Adverse Event|1|||
163386540|NCT01971203|590125688|FG001|Overall Study|Adverse Event|0|||
163386541|NCT03037619|590125689|FG000|Overall Study|Lost to Follow-up|0|||
163386542|NCT03037619|590125690|FG001|Overall Study|Lost to Follow-up|1|||
163386543|NCT00307125|590125695|FG000|Screening Phase|Adverse Event|1|||
163386544|NCT00307125|590125696|FG001|Screening Phase|Adverse Event|0|||
163386545|NCT00307125|590125697|FG002|Screening Phase|Adverse Event|0|||
163386546|NCT00307125|590125695|FG000|Screening Phase|Protocol Violation|27|||
163386547|NCT00307125|590125696|FG001|Screening Phase|Protocol Violation|0|||
163386548|NCT00307125|590125697|FG002|Screening Phase|Protocol Violation|0|||
163386549|NCT00307125|590125695|FG000|Screening Phase|Lost to Follow-up|87|||
163386550|NCT00307125|590125696|FG001|Screening Phase|Lost to Follow-up|0|||
163386551|NCT00307125|590125697|FG002|Screening Phase|Lost to Follow-up|0|||
163386552|NCT00307125|590125695|FG000|Screening Phase|Death|10|||
163386553|NCT00307125|590125696|FG001|Screening Phase|Death|0|||
163386554|NCT00307125|590125697|FG002|Screening Phase|Death|0|||
163386555|NCT00307125|590125695|FG000|Screening Phase|Withdrawal by Subject|77|||
163386556|NCT00307125|590125696|FG001|Screening Phase|Withdrawal by Subject|0|||
163386557|NCT00307125|590125697|FG002|Screening Phase|Withdrawal by Subject|0|||
163386558|NCT00307125|590125695|FG000|Screening Phase|Physician Decision|26|||
163386559|NCT00307125|590125696|FG001|Screening Phase|Physician Decision|0|||
163386560|NCT00307125|590125697|FG002|Screening Phase|Physician Decision|0|||
163386561|NCT00307125|590125695|FG000|Screening Phase|Sponsor Decision|4|||
163161630|NCT03682770|589305815|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
163161631|NCT03682770|589305816|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
163161632|NCT03682770|589305817|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
163161633|NCT03682770|589305818|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
163386562|NCT00307125|590125696|FG001|Screening Phase|Sponsor Decision|0|||
163386563|NCT00307125|590125697|FG002|Screening Phase|Sponsor Decision|0|||
163386564|NCT00307125|590125695|FG000|Screening Phase|Study Terminated|17|||
163386565|NCT00307125|590125696|FG001|Screening Phase|Study Terminated|0|||
163386566|NCT00307125|590125697|FG002|Screening Phase|Study Terminated|0|||
163386567|NCT00307125|590125695|FG000|Screening Phase|Graft Loss|3|||
163386568|NCT00307125|590125696|FG001|Screening Phase|Graft Loss|0|||
163386569|NCT00307125|590125697|FG002|Screening Phase|Graft Loss|0|||
163386570|NCT00307125|590125695|FG000|Screening Phase|Graft Failure|8|||
163386571|NCT00307125|590125696|FG001|Screening Phase|Graft Failure|0|||
163386572|NCT00307125|590125697|FG002|Screening Phase|Graft Failure|0|||
163386573|NCT00307125|590125695|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
163386574|NCT00307125|590125696|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
163386575|NCT00307125|590125697|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
163386576|NCT00307125|590125695|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
163386577|NCT00307125|590125696|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
163386578|NCT00307125|590125697|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
163386579|NCT00307125|590125695|FG000|Screening Phase|Moved or transferred facilities|34|||
163386580|NCT00307125|590125696|FG001|Screening Phase|Moved or transferred facilities|0|||
163386581|NCT00307125|590125697|FG002|Screening Phase|Moved or transferred facilities|0|||
163386582|NCT00307125|590125695|FG000|Screening Phase|Received Pancreas Transplant|8|||
163386583|NCT00307125|590125696|FG001|Screening Phase|Received Pancreas Transplant|0|||
163386584|NCT00307125|590125697|FG002|Screening Phase|Received Pancreas Transplant|0|||
163386585|NCT00307125|590125695|FG000|Screening Phase|Ineligible for pilot|4|||
163386586|NCT00307125|590125696|FG001|Screening Phase|Ineligible for pilot|0|||
163386587|NCT00307125|590125697|FG002|Screening Phase|Ineligible for pilot|0|||
163386588|NCT00307125|590125695|FG000|Screening Phase|Try to get pregnant|1|||
163386589|NCT00307125|590125696|FG001|Screening Phase|Try to get pregnant|0|||
163386590|NCT00307125|590125697|FG002|Screening Phase|Try to get pregnant|0|||
163386591|NCT00307125|590125695|FG000|Screening Phase|Developed acute leukemia|1|||
163386592|NCT00307125|590125696|FG001|Screening Phase|Developed acute leukemia|0|||
163386593|NCT00307125|590125697|FG002|Screening Phase|Developed acute leukemia|0|||
163386594|NCT00307125|590125695|FG000|Screening Phase|Metastatic colon cancer|1|||
163386595|NCT00307125|590125696|FG001|Screening Phase|Metastatic colon cancer|0|||
163386596|NCT00307125|590125697|FG002|Screening Phase|Metastatic colon cancer|0|||
163386597|NCT00307125|590125695|FG000|Screening Phase|Malignancy|1|||
163386598|NCT00307125|590125696|FG001|Screening Phase|Malignancy|0|||
163386599|NCT00307125|590125697|FG002|Screening Phase|Malignancy|0|||
163386600|NCT00307125|590125695|FG000|Screening Phase|PAK|1|||
163386601|NCT00307125|590125696|FG001|Screening Phase|PAK|0|||
163386602|NCT00307125|590125697|FG002|Screening Phase|PAK|0|||
163386603|NCT00307125|590125695|FG000|Screening Phase|Ineligible|1|||
163386604|NCT00307125|590125696|FG001|Screening Phase|Ineligible|0|||
163386605|NCT00307125|590125697|FG002|Screening Phase|Ineligible|0|||
163386606|NCT00307125|590125695|FG000|Screening Phase|Screen Error|1|||
163386607|NCT00307125|590125696|FG001|Screening Phase|Screen Error|0|||
163386608|NCT00307125|590125697|FG002|Screening Phase|Screen Error|0|||
163386609|NCT00307125|590125695|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
163386610|NCT00307125|590125696|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
163386611|NCT00307125|590125697|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
163386612|NCT00307125|590125695|FG000|Screening Phase|AMR and treated with rituximab|1|||
163386613|NCT00307125|590125696|FG001|Screening Phase|AMR and treated with rituximab|0|||
163386614|NCT00307125|590125697|FG002|Screening Phase|AMR and treated with rituximab|0|||
163386615|NCT00307125|590125695|FG000|Screening Phase|Coronary artery bypass|1|||
163386616|NCT00307125|590125696|FG001|Screening Phase|Coronary artery bypass|0|||
163386617|NCT00307125|590125697|FG002|Screening Phase|Coronary artery bypass|0|||
163386618|NCT00307125|590125695|FG000|Pilot Phase|Lost to Follow-up|0|||
163386619|NCT00307125|590125696|FG001|Pilot Phase|Lost to Follow-up|1|||
163386620|NCT00307125|590125697|FG002|Pilot Phase|Lost to Follow-up|0|||
163386621|NCT00307125|590125695|FG000|Pilot Phase|Withdrawal by Subject|0|||
163386622|NCT00307125|590125696|FG001|Pilot Phase|Withdrawal by Subject|1|||
163386623|NCT00307125|590125697|FG002|Pilot Phase|Withdrawal by Subject|1|||
163386624|NCT01055262|590125698|FG000|Overall Study|Adverse Event|5|||
163386625|NCT01055262|590125698|FG000|Overall Study|Protocol Violation|3|||
163386626|NCT01055262|590125698|FG000|Overall Study|Uncooperativeness|1|||
163386627|NCT00561951|590125700|FG000|Overall Study|Adverse Event|11|||
163386628|NCT00561951|590125701|FG001|Overall Study|Adverse Event|14|||
163386629|NCT00561951|590125702|FG002|Overall Study|Adverse Event|14|||
163386630|NCT00561951|590125700|FG000|Overall Study|Lack of Efficacy|5|||
163386631|NCT00561951|590125701|FG001|Overall Study|Lack of Efficacy|3|||
163386632|NCT00561951|590125702|FG002|Overall Study|Lack of Efficacy|2|||
163386633|NCT00561951|590125700|FG000|Overall Study|Lost to Follow-up|1|||
163386634|NCT00561951|590125701|FG001|Overall Study|Lost to Follow-up|1|||
163386635|NCT00561951|590125702|FG002|Overall Study|Lost to Follow-up|0|||
163161634|NCT03682770|589305819|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
163161635|NCT03682770|589305820|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
163386636|NCT00561951|590125700|FG000|Overall Study|Withdrawal by Subject|10|||
163386637|NCT00561951|590125701|FG001|Overall Study|Withdrawal by Subject|9|||
163386638|NCT00561951|590125702|FG002|Overall Study|Withdrawal by Subject|10|||
163386639|NCT00561951|590125700|FG000|Overall Study|Protocol Violation|4|||
163386640|NCT00561951|590125701|FG001|Overall Study|Protocol Violation|3|||
163386641|NCT00561951|590125702|FG002|Overall Study|Protocol Violation|4|||
163161636|NCT03682770|589305814|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
163386642|NCT00561951|590125700|FG000|Overall Study|Physician Decision|1|||
163386643|NCT00561951|590125701|FG001|Overall Study|Physician Decision|0|||
163386644|NCT00561951|590125702|FG002|Overall Study|Physician Decision|0|||
163386645|NCT00561951|590125700|FG000|Overall Study|Pregnancy|0|||
163386646|NCT00561951|590125701|FG001|Overall Study|Pregnancy|1|||
163386647|NCT00561951|590125702|FG002|Overall Study|Pregnancy|0|||
163386648|NCT00561951|590125700|FG000|Overall Study|Meet Withdrawal Criterion|0|||
163386649|NCT00561951|590125701|FG001|Overall Study|Meet Withdrawal Criterion|1|||
163386650|NCT00561951|590125702|FG002|Overall Study|Meet Withdrawal Criterion|1|||
163386651|NCT00561951|590125700|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
163386652|NCT00561951|590125701|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
163386653|NCT00561951|590125702|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
163386654|NCT01596621|590125703|FG000|Overall Study|Death|4|||
163386655|NCT01596621|590125703|FG000|Overall Study|Withdrawal by Subject|9|||
163386656|NCT01596621|590125703|FG000|Overall Study|Disease Progression|49|||
163386657|NCT01596621|590125703|FG000|Overall Study|Lost to Follow-up|3|||
163386658|NCT01596621|590125703|FG000|Overall Study|Other than specified|13|||
163386659|NCT00421707|590125704|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
163386660|NCT00421707|590125705|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
163386661|NCT00421707|590125704|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
163386662|NCT00421707|590125705|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
163386663|NCT00421707|590125704|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
163386664|NCT00421707|590125705|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
163386665|NCT00421707|590125704|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
163386666|NCT00421707|590125705|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
163386667|NCT00421707|590125704|FG000|Period 2: Washout|Adverse Event|1|||
163386668|NCT00421707|590125705|FG001|Period 2: Washout|Adverse Event|1|||
163386669|NCT00421707|590125704|FG000|Period 2: Washout|Withdrawal by Subject|0|||
163386670|NCT00421707|590125705|FG001|Period 2: Washout|Withdrawal by Subject|1|||
163386671|NCT00421707|590125704|FG000|Period 2: Washout|Lost to Follow-up|0|||
163386672|NCT00421707|590125705|FG001|Period 2: Washout|Lost to Follow-up|1|||
163386673|NCT00421707|590125704|FG000|Period 2: Washout|Other: Pregnancy|0|||
163386674|NCT00421707|590125705|FG001|Period 2: Washout|Other: Pregnancy|1|||
163386675|NCT00421707|590125704|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
163386676|NCT00421707|590125705|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
163386677|NCT00421707|590125704|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
163386678|NCT00421707|590125705|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
163386679|NCT00421707|590125704|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
163386680|NCT00421707|590125705|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
163386681|NCT01898923|590125708|FG000|Overall Study|Lack of Efficacy|5|||
163386682|NCT01898923|590125709|FG001|Overall Study|Lack of Efficacy|6|||
163386683|NCT01898923|590125708|FG000|Overall Study|Adverse Event|3|||
163386684|NCT01898923|590125709|FG001|Overall Study|Adverse Event|1|||
163386685|NCT01898923|590125708|FG000|Overall Study|Lost to Follow-up|0|||
163386686|NCT01898923|590125709|FG001|Overall Study|Lost to Follow-up|1|||
163386687|NCT01898923|590125708|FG000|Overall Study|Withdrawal by Subject|4|||
163386688|NCT01898923|590125709|FG001|Overall Study|Withdrawal by Subject|7|||
163386689|NCT01898923|590125708|FG000|Overall Study|Physician Decision|3|||
163386690|NCT01898923|590125709|FG001|Overall Study|Physician Decision|4|||
163386691|NCT01898923|590125708|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
163386692|NCT01898923|590125709|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
163386693|NCT02975700|590125711|FG000|Overall Study|Adverse Event|1|||
163386694|NCT02975700|590125711|FG000|Overall Study|Progressive disease|3|||
163386695|NCT02975700|590125711|FG000|Overall Study|Failed screening criteria|2|||
163386696|NCT02441686|590125712|FG000|Induction|Adverse Event|4|||
163386697|NCT02441686|590125712|FG000|Induction|Complicating disease|1|||
163386698|NCT02441686|590125712|FG000|Induction|Physician Decision|1|||
163386699|NCT02441686|590125712|FG000|Induction|Withdrawal by Subject|1|||
163386700|NCT02441686|590125712|FG000|Induction|Did not receive treatment|1|||
163386701|NCT02441686|590125712|FG000|Maintenance|Remaining on Treatment|23|||
163386702|NCT02441686|590125712|FG000|Maintenance|Physician Decision|1|||
163386703|NCT02441686|590125712|FG000|Maintenance|Adverse Event|3|||
163386704|NCT02441686|590125712|FG000|Maintenance|Progressive Disease|10|||
163386705|NCT02441686|590125712|FG000|Maintenance|Withdrawal by Subject|1|||
163386706|NCT04150029|590125713|FG000|Overall Study|Disease Relapse|0|||
163386707|NCT04150029|590125714|FG001|Overall Study|Disease Relapse|18|||
163386708|NCT04150029|590125713|FG000|Overall Study|Progressive Disease|2|||
163386709|NCT04150029|590125714|FG001|Overall Study|Progressive Disease|16|||
163386710|NCT04150029|590125713|FG000|Overall Study|Adverse Event|1|||
163386711|NCT04150029|590125714|FG001|Overall Study|Adverse Event|11|||
163161637|NCT03682770|589305815|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
163161638|NCT03682770|589305816|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
163161639|NCT03682770|589305817|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
163386712|NCT04150029|590125713|FG000|Overall Study|Physician Decision|0|||
163386713|NCT04150029|590125714|FG001|Overall Study|Physician Decision|10|||
163386714|NCT04150029|590125713|FG000|Overall Study|Study Terminated by Sponsor|1|||
163386715|NCT04150029|590125714|FG001|Overall Study|Study Terminated by Sponsor|10|||
163386716|NCT04150029|590125713|FG000|Overall Study|Death|0|||
163386717|NCT04150029|590125714|FG001|Overall Study|Death|8|||
163386718|NCT04150029|590125713|FG000|Overall Study|Participant Decision|0|||
163386719|NCT04150029|590125714|FG001|Overall Study|Participant Decision|7|||
163386720|NCT04150029|590125713|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
163386721|NCT04150029|590125714|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
163386722|NCT05497284|590125715|FG000|Overall Study|Adverse Event|1|||
163386723|NCT05497284|590125716|FG001|Overall Study|Adverse Event|0|||
163386724|NCT05497284|590125715|FG000|Overall Study|Physician Decision|0|||
163386725|NCT05497284|590125716|FG001|Overall Study|Physician Decision|1|||
163386726|NCT05497284|590125715|FG000|Overall Study|Study terminated by sponsor|7|||
163386727|NCT05497284|590125716|FG001|Overall Study|Study terminated by sponsor|4|||
163386728|NCT05497284|590125715|FG000|Overall Study|Subject Decision|0|||
163386729|NCT05497284|590125716|FG001|Overall Study|Subject Decision|1|||
163386730|NCT04652726|590127153|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
163386731|NCT04652726|590127154|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
163386732|NCT04652726|590127155|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
163386733|NCT04652726|590127153|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
163386734|NCT04652726|590127154|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
163386735|NCT04652726|590127155|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
163386736|NCT03780725|590127156|FG000|Overall Study|Progression of disease|3|||
163386737|NCT03780725|590127157|FG001|Overall Study|Progression of disease|4|||
163386738|NCT03780725|590127156|FG000|Overall Study|Adverse Event|0|||
163386739|NCT03780725|590127157|FG001|Overall Study|Adverse Event|1|||
163386740|NCT02738008|590127158|FG000|Overall Study|Study Terminated by Sponsor|1|||
163386741|NCT02738008|590127159|FG001|Overall Study|Study Terminated by Sponsor|5|||
163386742|NCT02738008|590127160|FG002|Overall Study|Study Terminated by Sponsor|3|||
163386743|NCT02738008|590127158|FG000|Overall Study|Adverse Event|0|||
163386744|NCT02738008|590127159|FG001|Overall Study|Adverse Event|1|||
163386745|NCT02738008|590127160|FG002|Overall Study|Adverse Event|2|||
163386746|NCT05192382|590127161|FG000|RC Phase (Up to Week 24)|Adverse Event|1|||
163386747|NCT05192382|590127162|FG001|RC Phase (Up to Week 24)|Adverse Event|1|||
163386748|NCT05192382|590127163|FG002|RC Phase (Up to Week 24)|Adverse Event|0|||
163386749|NCT05192382|590127161|FG000|RC Phase (Up to Week 24)|Withdrawal by Subject|1|||
163386750|NCT05192382|590127162|FG001|RC Phase (Up to Week 24)|Withdrawal by Subject|2|||
163386751|NCT05192382|590127163|FG002|RC Phase (Up to Week 24)|Withdrawal by Subject|0|||
163386752|NCT05192382|590127161|FG000|OLE Phase (Up to Week 200)|Discontinued|1|||
163386753|NCT05192382|590127162|FG001|OLE Phase (Up to Week 200)|Discontinued|4|||
163386754|NCT05192382|590127163|FG002|OLE Phase (Up to Week 200)|Discontinued|1|||
163386755|NCT05192382|590127161|FG000|OLE Phase (Up to Week 200)|Ongoing|49|||
163386756|NCT05192382|590127162|FG001|OLE Phase (Up to Week 200)|Ongoing|48|||
163386757|NCT05192382|590127163|FG002|OLE Phase (Up to Week 200)|Ongoing|10|||
163386758|NCT04702776|590127166|FG000|Overall Study|Adverse Event|1|||
163386759|NCT04702776|590127167|FG001|Overall Study|Adverse Event|2|||
163386760|NCT04702776|590127168|FG002|Overall Study|Adverse Event|1|||
163386761|NCT04702776|590127166|FG000|Overall Study|Lost to Follow-up|2|||
163386762|NCT04702776|590127167|FG001|Overall Study|Lost to Follow-up|1|||
163386763|NCT04702776|590127168|FG002|Overall Study|Lost to Follow-up|4|||
163386764|NCT04702776|590127166|FG000|Overall Study|Protocol Violation|2|||
163386765|NCT04702776|590127167|FG001|Overall Study|Protocol Violation|2|||
163386766|NCT04702776|590127168|FG002|Overall Study|Protocol Violation|3|||
163386767|NCT02076178|590127171|FG000|Oral Phase|Adverse Event|0|||
163386768|NCT02076178|590127172|FG001|Oral Phase|Adverse Event|7|||
163386769|NCT02076178|590127171|FG000|Oral Phase|Withdrawal by Subject|0|||
163386770|NCT02076178|590127172|FG001|Oral Phase|Withdrawal by Subject|4|||
163386771|NCT02076178|590127171|FG000|Oral Phase|Physician Decision|0|||
163386772|NCT02076178|590127172|FG001|Oral Phase|Physician Decision|1|||
163386773|NCT02076178|590127171|FG000|Injection Phase|Protocol defined stopping criteria|1|||
163386774|NCT02076178|590127172|FG001|Injection Phase|Protocol defined stopping criteria|0|||
163386775|NCT02076178|590127171|FG000|Injection Phase|Withdrawal by Subject|0|||
163386776|NCT02076178|590127172|FG001|Injection Phase|Withdrawal by Subject|3|||
163386777|NCT02076178|590127171|FG000|Injection Phase|Physician Decision|0|||
163386778|NCT02076178|590127172|FG001|Injection Phase|Physician Decision|3|||
163386779|NCT02076178|590127171|FG000|Injection Phase|Lost to Follow-up|0|||
163386780|NCT02076178|590127172|FG001|Injection Phase|Lost to Follow-up|1|||
163386781|NCT02893930|590127173|FG000|Overall Study|Adverse Event|3|||
163386782|NCT02893930|590127173|FG000|Overall Study|Death|1|||
163386783|NCT02893930|590127173|FG000|Overall Study|Disease progression|5|||
163386784|NCT02893930|590127173|FG000|Overall Study|Withdrawal by Subject|2|||
163161640|NCT03682770|589305818|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
163161641|NCT03682770|589305819|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
163386785|NCT02893930|590127173|FG000|Overall Study|Physician Decision|1|||
163386786|NCT02893930|590127173|FG000|Overall Study|Ineligible|1|||
163386787|NCT03370471|590127176|FG000|Overall Study|Withdrawal by Subject|6|||
163386788|NCT03370471|590127177|FG001|Overall Study|Withdrawal by Subject|1|||
163386789|NCT03370471|590127176|FG000|Overall Study|Unable to access veins for blood draw|0|||
163386790|NCT03370471|590127177|FG001|Overall Study|Unable to access veins for blood draw|1|||
163386791|NCT03370471|590127176|FG000|Overall Study|Screen fail|1|||
163386792|NCT03370471|590127177|FG001|Overall Study|Screen fail|0|||
163386793|NCT01765179|590127179|FG000|Overall Study|Adverse Event|3|||
163386794|NCT01765179|590127179|FG000|Overall Study|Lost to Follow-up|5|||
163386795|NCT01765179|590127179|FG000|Overall Study|Non-compliance with study drug|2|||
163386796|NCT01765179|590127179|FG000|Overall Study|Protocol Violation|1|||
163386797|NCT01765179|590127179|FG000|Overall Study|Withdrawal by Subject|8|||
163161642|NCT03682770|589305820|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
163386798|NCT01765179|590127179|FG000|Overall Study|Hematocrit >54%|3|||
163386799|NCT01765179|590127179|FG000|Overall Study|prohibited med|1|||
163386800|NCT01765179|590127179|FG000|Overall Study|Out of country unable to finish study|1|||
163386801|NCT01765179|590127179|FG000|Overall Study|lack of venous access|1|||
163386802|NCT01765179|590127179|FG000|Overall Study|work conflict|1|||
163386803|NCT01765179|590127179|FG000|Overall Study|Ca elevated 10.6|1|||
163386804|NCT05358717|590127180|FG000|Overall Study|Adverse Event|0|||
163386805|NCT05358717|590127181|FG001|Overall Study|Adverse Event|1|||
163386806|NCT05358717|590127182|FG002|Overall Study|Adverse Event|1|||
163386807|NCT05358717|590127180|FG000|Overall Study|Death|1|||
163386808|NCT05358717|590127181|FG001|Overall Study|Death|1|||
163386809|NCT05358717|590127182|FG002|Overall Study|Death|0|||
163386810|NCT05358717|590127180|FG000|Overall Study|Withdrawal by Subject|1|||
163386811|NCT05358717|590127181|FG001|Overall Study|Withdrawal by Subject|1|||
163386812|NCT05358717|590127182|FG002|Overall Study|Withdrawal by Subject|2|||
163386813|NCT05358717|590127180|FG000|Overall Study|Study Paused by Sponsor in United States|0|||
163386814|NCT05358717|590127181|FG001|Overall Study|Study Paused by Sponsor in United States|2|||
163386815|NCT05358717|590127182|FG002|Overall Study|Study Paused by Sponsor in United States|0|||
163386816|NCT02640157|590127183|FG000|Overall Study|Adverse Event|2|||
163386817|NCT02640157|590127184|FG001|Overall Study|Adverse Event|2|||
163386818|NCT02640157|590127185|FG002|Overall Study|Adverse Event|1|||
163386819|NCT02640157|590127183|FG000|Overall Study|Withdrew consent|2|||
163386820|NCT02640157|590127184|FG001|Overall Study|Withdrew consent|0|||
163386821|NCT02640157|590127185|FG002|Overall Study|Withdrew consent|2|||
163386822|NCT02640157|590127183|FG000|Overall Study|Lost to Follow-up|9|||
163386823|NCT02640157|590127184|FG001|Overall Study|Lost to Follow-up|2|||
163386824|NCT02640157|590127185|FG002|Overall Study|Lost to Follow-up|7|||
163386825|NCT02640157|590127183|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
163386826|NCT02640157|590127184|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
163386827|NCT02640157|590127185|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
163386828|NCT00710021|590127186|FG000|Overall Study|Lost to Follow-up|1|||
163386829|NCT00710021|590127187|FG001|Overall Study|Lost to Follow-up|0|||
163386830|NCT00710021|590127188|FG002|Overall Study|Lost to Follow-up|0|||
163386831|NCT00710021|590127186|FG000|Overall Study|Subject's Decision|0|||
163386832|NCT00710021|590127187|FG001|Overall Study|Subject's Decision|1|||
163386833|NCT00710021|590127188|FG002|Overall Study|Subject's Decision|0|||
163386834|NCT00710021|590127186|FG000|Overall Study|Subject misrandomized|0|||
163386835|NCT00710021|590127187|FG001|Overall Study|Subject misrandomized|1|||
163386836|NCT00710021|590127188|FG002|Overall Study|Subject misrandomized|1|||
163386837|NCT00710021|590127186|FG000|Overall Study|Physician Decision|0|||
163386838|NCT00710021|590127187|FG001|Overall Study|Physician Decision|1|||
163386839|NCT00710021|590127188|FG002|Overall Study|Physician Decision|0|||
163386840|NCT04837040|590127192|FG000|RC Phase (Up to Week 36)|Withdrawal by Subject|0|||
163386841|NCT04837040|590127193|FG001|RC Phase (Up to Week 36)|Withdrawal by Subject|1|||
163386842|NCT02961218|590127194|FG000|Overall Study|Lost to Follow-up|0|||
163386843|NCT02961218|590127195|FG001|Overall Study|Lost to Follow-up|2|||
163386844|NCT02961218|590127194|FG000|Overall Study|Physician Decision|0|||
163386845|NCT02961218|590127195|FG001|Overall Study|Physician Decision|2|||
163386846|NCT02961218|590127194|FG000|Overall Study|Subject/Guardian Decision|3|||
163386847|NCT02961218|590127195|FG001|Overall Study|Subject/Guardian Decision|1|||
163386848|NCT00602667|590127196|FG000|Overall Study|Still on Therapy|0|||
163386849|NCT00602667|590127197|FG001|Overall Study|Still on Therapy|2|||
163386850|NCT00602667|590127198|FG002|Overall Study|Still on Therapy|2|||
163386851|NCT00602667|590127196|FG000|Overall Study|Death|0|||
163386852|NCT00602667|590127197|FG001|Overall Study|Death|1|||
163386853|NCT00602667|590127198|FG002|Overall Study|Death|1|||
163386854|NCT00602667|590127196|FG000|Overall Study|Family request|3|||
163386855|NCT00602667|590127197|FG001|Overall Study|Family request|25|||
163161643|NCT03682770|589305814|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
163386856|NCT00602667|590127198|FG002|Overall Study|Family request|6|||
163386857|NCT00602667|590127196|FG000|Overall Study|Excessive toxicity|1|||
163386858|NCT00602667|590127197|FG001|Overall Study|Excessive toxicity|1|||
163386859|NCT00602667|590127198|FG002|Overall Study|Excessive toxicity|0|||
163386860|NCT00602667|590127196|FG000|Overall Study|Second malignancy|0|||
163386861|NCT00602667|590127197|FG001|Overall Study|Second malignancy|1|||
163386862|NCT00602667|590127198|FG002|Overall Study|Second malignancy|0|||
163386863|NCT00602667|590127196|FG000|Overall Study|Physician Decision|2|||
163386864|NCT00602667|590127197|FG001|Overall Study|Physician Decision|3|||
163386865|NCT00602667|590127198|FG002|Overall Study|Physician Decision|8|||
163386866|NCT00602667|590127196|FG000|Overall Study|Progressive disease|13|||
163386867|NCT00602667|590127197|FG001|Overall Study|Progressive disease|48|||
163386868|NCT00602667|590127198|FG002|Overall Study|Progressive disease|45|||
163386869|NCT00602667|590127196|FG000|Overall Study|Progressive disease prior to therapy|0|||
163386870|NCT00602667|590127197|FG001|Overall Study|Progressive disease prior to therapy|0|||
163386871|NCT00602667|590127198|FG002|Overall Study|Progressive disease prior to therapy|1|||
163386872|NCT04765059|590127201|FG000|Overall Study|Failure to meet randomization criteria|1|||
163386873|NCT04765059|590127202|FG001|Overall Study|Failure to meet randomization criteria|0|||
163386874|NCT04765059|590127201|FG000|Overall Study|Withdrawal by Subject|1|||
163386875|NCT04765059|590127202|FG001|Overall Study|Withdrawal by Subject|4|||
163386876|NCT04765059|590127201|FG000|Overall Study|Lost to Follow-up|1|||
163386877|NCT04765059|590127202|FG001|Overall Study|Lost to Follow-up|1|||
163386878|NCT04765059|590127201|FG000|Overall Study|Death|25|||
163386879|NCT04765059|590127202|FG001|Overall Study|Death|28|||
163386880|NCT04765059|590127201|FG000|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|21|||
163386881|NCT04765059|590127202|FG001|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|16|||
163386882|NCT04300309|590127203|FG000|Overall Study|Lost to Follow-up|1|||
163386883|NCT04300309|590127204|FG001|Overall Study|Lost to Follow-up|0|||
163386884|NCT04647526|590127205|FG000|Overall Study|Death|13|||
163386885|NCT04647526|590127206|FG001|Overall Study|Death|76|||
163386886|NCT04647526|590127207|FG002|Overall Study|Death|32|||
163386887|NCT04647526|590127208|FG003|Overall Study|Death|0|||
163386888|NCT04647526|590127205|FG000|Overall Study|Lost to Follow-up|1|||
163386889|NCT04647526|590127206|FG001|Overall Study|Lost to Follow-up|0|||
163386890|NCT04647526|590127207|FG002|Overall Study|Lost to Follow-up|1|||
163386891|NCT04647526|590127208|FG003|Overall Study|Lost to Follow-up|0|||
163386892|NCT04647526|590127205|FG000|Overall Study|Withdrawal by Subject|4|||
163386893|NCT04647526|590127206|FG001|Overall Study|Withdrawal by Subject|15|||
163386894|NCT04647526|590127207|FG002|Overall Study|Withdrawal by Subject|8|||
163386895|NCT04647526|590127208|FG003|Overall Study|Withdrawal by Subject|1|||
163386896|NCT04647526|590127205|FG000|Overall Study|Incorrect enrollment|0|||
163386897|NCT04647526|590127206|FG001|Overall Study|Incorrect enrollment|1|||
163386898|NCT04647526|590127207|FG002|Overall Study|Incorrect enrollment|1|||
163386899|NCT04647526|590127208|FG003|Overall Study|Incorrect enrollment|0|||
163386900|NCT04647526|590127205|FG000|Overall Study|Physician Decision|0|||
163386901|NCT04647526|590127206|FG001|Overall Study|Physician Decision|1|||
163386902|NCT04647526|590127207|FG002|Overall Study|Physician Decision|1|||
163386903|NCT04647526|590127208|FG003|Overall Study|Physician Decision|0|||
163386904|NCT04647526|590127205|FG000|Overall Study|Ongoing|9|||
163386905|NCT04647526|590127206|FG001|Overall Study|Ongoing|183|||
163386906|NCT04647526|590127207|FG002|Overall Study|Ongoing|93|||
163386907|NCT04647526|590127208|FG003|Overall Study|Ongoing|15|||
163386908|NCT03816891|590127209|FG000|Double-Blind Period|Withdrawal by Subject|1|||
163386909|NCT03816891|590127210|FG001|Double-Blind Period|Withdrawal by Subject|2|||
163386910|NCT03816891|590127211|FG002|Double-Blind Period|Withdrawal by Subject|0|||
163386911|NCT03816891|590127212|FG003|Double-Blind Period|Withdrawal by Subject|2|||
163386912|NCT03816891|590127213|FG004|Double-Blind Period|Withdrawal by Subject|0|||
163386913|NCT03816891|590127214|FG005|Double-Blind Period|Withdrawal by Subject|0|||
163386914|NCT03816891|590127209|FG000|Double-Blind Period|Adverse Event|0|||
163386915|NCT03816891|590127210|FG001|Double-Blind Period|Adverse Event|0|||
163386916|NCT03816891|590127211|FG002|Double-Blind Period|Adverse Event|2|||
163386917|NCT03816891|590127212|FG003|Double-Blind Period|Adverse Event|0|||
163386918|NCT03816891|590127213|FG004|Double-Blind Period|Adverse Event|0|||
163386919|NCT03816891|590127214|FG005|Double-Blind Period|Adverse Event|0|||
163386920|NCT03816891|590127209|FG000|Double-Blind Period|Lost to Follow-up|2|||
163386921|NCT03816891|590127210|FG001|Double-Blind Period|Lost to Follow-up|0|||
163386922|NCT03816891|590127211|FG002|Double-Blind Period|Lost to Follow-up|0|||
163386923|NCT03816891|590127212|FG003|Double-Blind Period|Lost to Follow-up|0|||
163386924|NCT03816891|590127213|FG004|Double-Blind Period|Lost to Follow-up|0|||
163386925|NCT03816891|590127214|FG005|Double-Blind Period|Lost to Follow-up|1|||
163386926|NCT03816891|590127209|FG000|Double-Blind Period|Physician Decision|0|||
163386927|NCT03816891|590127210|FG001|Double-Blind Period|Physician Decision|0|||
163386928|NCT03816891|590127211|FG002|Double-Blind Period|Physician Decision|0|||
163386929|NCT03816891|590127212|FG003|Double-Blind Period|Physician Decision|1|||
163386930|NCT03816891|590127213|FG004|Double-Blind Period|Physician Decision|0|||
163386931|NCT03816891|590127214|FG005|Double-Blind Period|Physician Decision|0|||
163386932|NCT03816891|590127209|FG000|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
163386933|NCT03816891|590127210|FG001|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
163386934|NCT03816891|590127211|FG002|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
163386935|NCT03816891|590127212|FG003|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
163386936|NCT03816891|590127213|FG004|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
163386937|NCT03816891|590127214|FG005|Double-Blind Period|Coronavirus Disease (COVID-19)|1|||
163386938|NCT03816891|590127209|FG000|Double-Blind Period|Other|1|||
163386939|NCT03816891|590127210|FG001|Double-Blind Period|Other|0|||
163386940|NCT03816891|590127211|FG002|Double-Blind Period|Other|0|||
163386941|NCT03816891|590127212|FG003|Double-Blind Period|Other|0|||
163386942|NCT03816891|590127213|FG004|Double-Blind Period|Other|0|||
163386943|NCT03816891|590127214|FG005|Double-Blind Period|Other|0|||
163386944|NCT03816891|590127209|FG000|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
163386945|NCT03816891|590127210|FG001|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
163386946|NCT03816891|590127211|FG002|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|4|||
163386947|NCT03816891|590127212|FG003|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|3|||
163386948|NCT03816891|590127213|FG004|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|2|||
163386949|NCT03816891|590127214|FG005|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
163386950|NCT03816891|590127209|FG000|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
163386951|NCT03816891|590127210|FG001|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
163386952|NCT03816891|590127211|FG002|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
163386953|NCT03816891|590127212|FG003|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
163386954|NCT03816891|590127213|FG004|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
163386955|NCT03816891|590127214|FG005|Open-Label Period (Phase 2b Only)|Adverse Event|1|||
163386956|NCT03816891|590127209|FG000|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
163386957|NCT03816891|590127210|FG001|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
163386958|NCT03816891|590127211|FG002|Open-Label Period (Phase 2b Only)|Lack of Efficacy|1|||
163386959|NCT03816891|590127212|FG003|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
163386960|NCT03816891|590127213|FG004|Open-Label Period (Phase 2b Only)|Lack of Efficacy|3|||
163386961|NCT03816891|590127214|FG005|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
163386962|NCT03816891|590127209|FG000|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
163386963|NCT03816891|590127210|FG001|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
163386964|NCT03816891|590127211|FG002|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
163386965|NCT03816891|590127212|FG003|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
163386966|NCT03816891|590127213|FG004|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
163386967|NCT03816891|590127214|FG005|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
163386968|NCT03816891|590127209|FG000|Open-Label Period (Phase 2b Only)|Other|0|||
163386969|NCT03816891|590127210|FG001|Open-Label Period (Phase 2b Only)|Other|0|||
163386970|NCT03816891|590127211|FG002|Open-Label Period (Phase 2b Only)|Other|0|||
163386971|NCT03816891|590127212|FG003|Open-Label Period (Phase 2b Only)|Other|0|||
163386972|NCT03816891|590127213|FG004|Open-Label Period (Phase 2b Only)|Other|0|||
163386973|NCT03816891|590127214|FG005|Open-Label Period (Phase 2b Only)|Other|1|||
163386974|NCT02577029|590127215|FG000|Overall Study|Adverse Event|1|||
163386975|NCT02577029|590127216|FG001|Overall Study|Adverse Event|0|||
163386976|NCT02577029|590127217|FG002|Overall Study|Adverse Event|2|||
163386977|NCT02577029|590127218|FG003|Overall Study|Adverse Event|0|||
163386978|NCT02577029|590127219|FG004|Overall Study|Adverse Event|1|||
163386979|NCT02577029|590127220|FG005|Overall Study|Adverse Event|0|||
163386980|NCT02577029|590127221|FG006|Overall Study|Adverse Event|0|||
163386981|NCT02577029|590127222|FG007|Overall Study|Adverse Event|0|||
163386982|NCT02577029|590127215|FG000|Overall Study|Withdrawal by Subject|0|||
163386983|NCT02577029|590127216|FG001|Overall Study|Withdrawal by Subject|0|||
163386984|NCT02577029|590127217|FG002|Overall Study|Withdrawal by Subject|0|||
163386985|NCT02577029|590127218|FG003|Overall Study|Withdrawal by Subject|0|||
163386986|NCT02577029|590127219|FG004|Overall Study|Withdrawal by Subject|0|||
163386987|NCT02577029|590127220|FG005|Overall Study|Withdrawal by Subject|1|||
163386988|NCT02577029|590127221|FG006|Overall Study|Withdrawal by Subject|0|||
163386989|NCT02577029|590127222|FG007|Overall Study|Withdrawal by Subject|0|||
163386990|NCT02577029|590127215|FG000|Overall Study|Sponsor Termination of the Study|9|||
163386991|NCT02577029|590127216|FG001|Overall Study|Sponsor Termination of the Study|2|||
163386992|NCT02577029|590127217|FG002|Overall Study|Sponsor Termination of the Study|5|||
163386993|NCT02577029|590127218|FG003|Overall Study|Sponsor Termination of the Study|12|||
163386994|NCT02577029|590127219|FG004|Overall Study|Sponsor Termination of the Study|10|||
163386995|NCT02577029|590127220|FG005|Overall Study|Sponsor Termination of the Study|12|||
163386996|NCT02577029|590127221|FG006|Overall Study|Sponsor Termination of the Study|12|||
163386997|NCT02577029|590127222|FG007|Overall Study|Sponsor Termination of the Study|12|||
163386998|NCT04379518|590127223|FG000|Overall Study|Physician Decision|2|||
163386999|NCT04379518|590127224|FG001|Overall Study|Physician Decision|0|||
163387000|NCT04379518|590127225|FG002|Overall Study|Physician Decision|0|||
163387001|NCT04379518|590127226|FG003|Overall Study|Physician Decision|0|||
163387002|NCT04379518|590127227|FG004|Overall Study|Physician Decision|0|||
163387003|NCT04379518|590127223|FG000|Overall Study|Withdrawal by Subject|1|||
163387004|NCT04379518|590127224|FG001|Overall Study|Withdrawal by Subject|0|||
163387005|NCT04379518|590127225|FG002|Overall Study|Withdrawal by Subject|0|||
163387006|NCT04379518|590127226|FG003|Overall Study|Withdrawal by Subject|0|||
163387007|NCT04379518|590127227|FG004|Overall Study|Withdrawal by Subject|0|||
163387008|NCT05666505|590127228|FG000|Overall Study|Withdrawn due to caregiver consent obtained from non-legal guardian|1|||
163387009|NCT05135000|590127229|FG000|Overall Study|Adverse Event|2|||
163387010|NCT05135000|590127230|FG001|Overall Study|Adverse Event|0|||
163387011|NCT05135000|590127229|FG000|Overall Study|Lost to Follow-up|1|||
163387012|NCT05135000|590127230|FG001|Overall Study|Lost to Follow-up|0|||
163387013|NCT05135000|590127229|FG000|Overall Study|Study Terminated by Sponsor|6|||
163387014|NCT05135000|590127230|FG001|Overall Study|Study Terminated by Sponsor|3|||
163387015|NCT04751656|590128340|FG000|Overall Study|Lost to Follow-up|1|||
163387016|NCT01485354|590128346|FG000|Overall Study|Withdrawal by Subject|5|||
163387017|NCT03566810|590128347|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
163387018|NCT03566810|590128348|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
163387019|NCT03566810|590128349|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
163387020|NCT03566810|590128350|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
163387021|NCT01444651|590128353|FG000|Overall Study|Adverse Event|3|||
163387022|NCT01444651|590128354|FG001|Overall Study|Adverse Event|2|||
163387023|NCT01444651|590128353|FG000|Overall Study|Lost to Follow-up|5|||
163387024|NCT01444651|590128354|FG001|Overall Study|Lost to Follow-up|5|||
163387025|NCT01444651|590128353|FG000|Overall Study|Non-fasting|2|||
163387026|NCT01444651|590128354|FG001|Overall Study|Non-fasting|1|||
163387027|NCT01444651|590128353|FG000|Overall Study|Missing data|1|||
163387028|NCT01444651|590128354|FG001|Overall Study|Missing data|1|||
163387029|NCT03338192|590128355|FG000|Year One to Year Two|High Blood Pressure|7|||
163387030|NCT03338192|590128356|FG001|Year One to Year Two|High Blood Pressure|1|||
163387031|NCT03338192|590128355|FG000|Year One to Year Two|HIV +|1|||
163387032|NCT03338192|590128356|FG001|Year One to Year Two|HIV +|0|||
163387033|NCT03338192|590128355|FG000|Year Two to Year Four|High Blood Pressure|1|||
163387034|NCT03338192|590128356|FG001|Year Two to Year Four|High Blood Pressure|0|||
163387035|NCT03338192|590128355|FG000|Year Two to Year Four|HIV +|2|||
163387036|NCT03338192|590128356|FG001|Year Two to Year Four|HIV +|0|||
163387037|NCT03338192|590128355|FG000|Year Four to Year Six|High Blood Pressure|2|||
163387038|NCT03338192|590128356|FG001|Year Four to Year Six|High Blood Pressure|1|||
163387039|NCT03236246|590128361|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
163387040|NCT03236246|590128362|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
163387041|NCT03236246|590128361|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
163387042|NCT03236246|590128362|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
163387043|NCT03236246|590128361|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
163387044|NCT03236246|590128362|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
163387045|NCT03236246|590128361|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
163387046|NCT03236246|590128362|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
163387047|NCT03236246|590128361|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
163387048|NCT03236246|590128362|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
163387049|NCT03236246|590128361|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
163387050|NCT03236246|590128362|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
163387051|NCT03236246|590128361|FG000|24-Week Dose Titration Period|Death|3|||
163387052|NCT03236246|590128362|FG001|24-Week Dose Titration Period|Death|1|||
163387053|NCT03236246|590128361|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
163387054|NCT03236246|590128362|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
163387055|NCT03236246|590128361|FG000|24-Week Dose Titration Period|Adverse Event|7|||
163387056|NCT03236246|590128362|FG001|24-Week Dose Titration Period|Adverse Event|8|||
163387057|NCT03236246|590128361|FG000|24-Week Dose Titration Period|Captured as Other|1|||
163387058|NCT03236246|590128362|FG001|24-Week Dose Titration Period|Captured as Other|2|||
163387059|NCT03236246|590128361|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
163387060|NCT03236246|590128362|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
163387061|NCT03236246|590128361|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
163387062|NCT03236246|590128362|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
163387063|NCT03236246|590128361|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
163387064|NCT03236246|590128362|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
163387065|NCT03236246|590128361|FG000|24-Week Dose Maintenance Period|Death|0|||
163387066|NCT03236246|590128362|FG001|24-Week Dose Maintenance Period|Death|1|||
163161644|NCT03682770|589305815|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
163161645|NCT03682770|589305816|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
163161646|NCT03682770|589305817|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
163161647|NCT03682770|589305818|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
163161648|NCT03682770|589305819|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
163161649|NCT03682770|589305820|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
163161650|NCT00774566|589305821|FG000|Overall Study|Protocol Violation|18|||
163161651|NCT00774566|589305822|FG001|Overall Study|Protocol Violation|15|||
163161652|NCT04896073|589305823|FG000|Overall Study|Screen failure|0|||
163161653|NCT04896073|589305824|FG001|Overall Study|Screen failure|2|||
163161654|NCT04896073|589305823|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
163161655|NCT04896073|589305824|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
163161656|NCT02304367|589305825|FG000|Overall Study|Lack of Response to Bruosumab|1|||
163161657|NCT02304367|589305825|FG000|Overall Study|Sponsor Decision|3|||
163161658|NCT02304367|589305825|FG000|Overall Study|Death|2|||
163161659|NCT02304367|589305825|FG000|Overall Study|Physician Decision|1|||
163161660|NCT02304367|589305825|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
163161661|NCT00573144|589305826|FG000|Overall Study|Withdrawal by Subject|2|||
163161662|NCT00573144|589305827|FG001|Overall Study|Withdrawal by Subject|3|||
163161663|NCT02637037|589305830|FG000|Overall Study|Positive drug screen at admission|1|||
163161664|NCT02637037|589305831|FG001|Overall Study|Positive drug screen at admission|0|||
163161665|NCT02637037|589305830|FG000|Overall Study|Withdrawal by Subject|2|||
163161666|NCT02637037|589305831|FG001|Overall Study|Withdrawal by Subject|1|||
163161667|NCT02637037|589305830|FG000|Overall Study|Adverse Event|1|||
163161668|NCT02637037|589305831|FG001|Overall Study|Adverse Event|0|||
163161669|NCT00074490|589305837|FG000|Overall Study|Progressive malignancy|0|||
163161670|NCT00074490|589305838|FG001|Overall Study|Progressive malignancy|7|||
163161671|NCT00074490|589305839|FG002|Overall Study|Progressive malignancy|0|||
163161672|NCT00074490|589305840|FG003|Overall Study|Progressive malignancy|0|||
163161673|NCT00074490|589305841|FG004|Overall Study|Progressive malignancy|3|||
163161674|NCT00074490|589305842|FG005|Overall Study|Progressive malignancy|0|||
163161675|NCT04411667|589305847|FG000|Overall Study|Physician Decision|1|||
163161676|NCT04411667|589305848|FG001|Overall Study|Physician Decision|0|||
163161677|NCT01147874|589305853|FG000|Overall Study|Adverse Event|5|||
163161678|NCT01147874|589305853|FG000|Overall Study|Investigator's Request|1|||
163161679|NCT01147874|589305853|FG000|Overall Study|Lost to Follow-up|25|||
163161680|NCT01147874|589305853|FG000|Overall Study|Other|5|||
163161681|NCT01147874|589305853|FG000|Overall Study|Protocol Violation|5|||
163161682|NCT01147874|589305853|FG000|Overall Study|Sponsor's Decision|2|||
163161683|NCT01147874|589305853|FG000|Overall Study|Withdrawal by Subject|24|||
163161684|NCT02991040|589305854|FG000|Overall Study|Withdrawal by Subject|2|||
163161685|NCT02991040|589305854|FG000|Overall Study|Lost to Follow-up|2|||
163161686|NCT04287517|589305855|FG000|Overall Study|Withdrawal by Subject|1|||
163161687|NCT04287517|589305856|FG001|Overall Study|Withdrawal by Subject|1|||
163161688|NCT01869764|589305863|FG000|Overall Study|Withdrawal by Subject|0|||
163161689|NCT01869764|589305864|FG001|Overall Study|Withdrawal by Subject|2|||
163161690|NCT02175030|589305865|FG000|Overall Study|Failed screen after consent|7|||
163161691|NCT02175030|589305866|FG001|Overall Study|Failed screen after consent|6|||
163161692|NCT02175030|589305865|FG000|Overall Study|Failed IUD Insertion|20|||
163161693|NCT02175030|589305866|FG001|Overall Study|Failed IUD Insertion|21|||
163161694|NCT02175030|589305865|FG000|Overall Study|Physician Decision|1|||
163161695|NCT02175030|589305866|FG001|Overall Study|Physician Decision|1|||
163161696|NCT02175030|589305865|FG000|Overall Study|Lost to Follow-up|6|||
163161697|NCT02175030|589305866|FG001|Overall Study|Lost to Follow-up|6|||
163161698|NCT02175030|589305865|FG000|Overall Study|Withdrawal by Subject|1|||
163161699|NCT02175030|589305866|FG001|Overall Study|Withdrawal by Subject|4|||
163161700|NCT00068419|589305871|FG000|Overall Study|Adverse Event|3|||
163275775|NCT02886728|589719955|FG001|Overall Study|Investigator's Discretion|7|||
163275776|NCT02886728|589719956|FG002|Overall Study|Investigator's Discretion|5|||
163042814|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
163161701|NCT00068419|589305871|FG000|Overall Study|Lack of Efficacy|24|||
163161702|NCT00068419|589305871|FG000|Overall Study|Lost to Follow-up|1|||
163161703|NCT00068419|589305871|FG000|Overall Study|Physician Decision|7|||
163161704|NCT00068419|589305871|FG000|Overall Study|Withdrawal by Subject|14|||
163161705|NCT00068419|589305871|FG000|Overall Study|Ineligible|11|||
163161706|NCT04717336|589305876|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
163161707|NCT04717336|589305877|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
163161708|NCT04717336|589305876|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
163161709|NCT04717336|589305877|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
163161710|NCT02039843|589305878|FG000|Randomization and Observation Period|Adverse Event|2|||
163161711|NCT02039843|589305879|FG001|Randomization and Observation Period|Adverse Event|0|||
163161712|NCT02039843|589305878|FG000|Randomization and Observation Period|Death|1|||
163161713|NCT02039843|589305879|FG001|Randomization and Observation Period|Death|0|||
163161714|NCT02039843|589305878|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
163161715|NCT02039843|589305879|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
163161716|NCT02039843|589305878|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
163161717|NCT02039843|589305879|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
163161718|NCT02039843|589305878|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
163161719|NCT02039843|589305879|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
163161720|NCT02039843|589305878|FG000|Pairing With a Study Dog|Death|1|||
163161721|NCT02039843|589305879|FG001|Pairing With a Study Dog|Death|0|||
163161722|NCT02039843|589305878|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
163161723|NCT02039843|589305879|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
163161724|NCT02039843|589305878|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
163161725|NCT02039843|589305879|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
163275777|NCT02886728|589719957|FG003|Overall Study|Investigator's Discretion|11|||
163275778|NCT02886728|589719954|FG000|Overall Study|Death|3|||
163275779|NCT02886728|589719955|FG001|Overall Study|Death|1|||
163275780|NCT02886728|589719956|FG002|Overall Study|Death|0|||
163275781|NCT02886728|589719957|FG003|Overall Study|Death|0|||
163275782|NCT02886728|589719954|FG000|Overall Study|Protocol Violation|0|||
163275783|NCT02886728|589719955|FG001|Overall Study|Protocol Violation|0|||
163275784|NCT02886728|589719956|FG002|Overall Study|Protocol Violation|0|||
163275785|NCT02886728|589719957|FG003|Overall Study|Protocol Violation|4|||
163275786|NCT02886728|589719954|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163275787|NCT02886728|589719955|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163275788|NCT02886728|589719956|FG002|Overall Study|Non-Compliance with Study Drug|1|||
163275789|NCT02886728|589719957|FG003|Overall Study|Non-Compliance with Study Drug|0|||
163275790|NCT02886728|589719954|FG000|Overall Study|Pregnancy|0|||
163275791|NCT02886728|589719955|FG001|Overall Study|Pregnancy|0|||
163275792|NCT02886728|589719956|FG002|Overall Study|Pregnancy|1|||
163275793|NCT02886728|589719957|FG003|Overall Study|Pregnancy|0|||
163275794|NCT02886728|589719954|FG000|Overall Study|Randomized but Not Dosed|1|||
163275795|NCT02886728|589719955|FG001|Overall Study|Randomized but Not Dosed|0|||
163275796|NCT02886728|589719956|FG002|Overall Study|Randomized but Not Dosed|0|||
163275797|NCT02886728|589719957|FG003|Overall Study|Randomized but Not Dosed|2|||
163275798|NCT00109928|589719958|FG000|Overall Study|Adverse Event|2|||
163275799|NCT00109928|589719958|FG000|Overall Study|Progression|6|||
163275800|NCT00109928|589719958|FG000|Overall Study|Death|2|||
163275801|NCT00109928|589719958|FG000|Overall Study|not protocol specified|2|||
163275802|NCT00109928|589719958|FG000|Overall Study|not eligible|1|||
163275803|NCT01364727|589719962|FG000|Overall Study|Not Eligible|2|||
163275804|NCT01676220|589719963|FG000|Overall Study|Randomized But Not Treated|4|||
163275805|NCT01676220|589719964|FG001|Overall Study|Randomized But Not Treated|1|||
163275806|NCT01676220|589719963|FG000|Overall Study|Adverse Event|10|||
163275807|NCT01676220|589719964|FG001|Overall Study|Adverse Event|8|||
163275808|NCT01676220|589719963|FG000|Overall Study|Lack of Efficacy|2|||
163275809|NCT01676220|589719964|FG001|Overall Study|Lack of Efficacy|5|||
163275810|NCT01676220|589719963|FG000|Overall Study|Protocol Violation|11|||
163275811|NCT01676220|589719964|FG001|Overall Study|Protocol Violation|12|||
163275812|NCT01676220|589719963|FG000|Overall Study|Received Rescue Therapy|14|||
163275813|NCT01676220|589719964|FG001|Overall Study|Received Rescue Therapy|22|||
163275814|NCT01676220|589719963|FG000|Overall Study|Personal Reason|34|||
163275815|NCT01676220|589719964|FG001|Overall Study|Personal Reason|45|||
163275816|NCT01676220|589719963|FG000|Overall Study|Lost to Follow-up|11|||
163275817|NCT01676220|589719964|FG001|Overall Study|Lost to Follow-up|18|||
163161726|NCT02039843|589305878|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
163161727|NCT02039843|589305879|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
163161728|NCT01958164|589305883|FG000|Overall Study|Adverse Event|0|||
163275818|NCT01676220|589719963|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
163275819|NCT01676220|589719964|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
163275820|NCT01676220|589719963|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
163275821|NCT01676220|589719964|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
163275822|NCT01676220|589719963|FG000|Overall Study|Perceived Lack of Efficacy|3|||
163161729|NCT01958164|589305884|FG001|Overall Study|Adverse Event|2|||
163161730|NCT01958164|589305883|FG000|Overall Study|Lost to Follow-up|2|||
163161731|NCT01958164|589305884|FG001|Overall Study|Lost to Follow-up|3|||
163161732|NCT00740857|589305885|FG000|Overall Study|Withdrawal by Subject|1|||
163161733|NCT00740857|589305886|FG001|Overall Study|Withdrawal by Subject|0|||
163161734|NCT00740857|589305887|FG002|Overall Study|Withdrawal by Subject|0|||
163161735|NCT02963506|589305888|FG000|Double-Blind Period|Adverse Event|0|||
163275823|NCT01676220|589719964|FG001|Overall Study|Perceived Lack of Efficacy|1|||
163275824|NCT01676220|589719963|FG000|Overall Study|Non Serious Hypoglycemia|2|||
163275825|NCT01676220|589719964|FG001|Overall Study|Non Serious Hypoglycemia|0|||
163275826|NCT01676220|589719963|FG000|Overall Study|No More Need of Insulin|1|||
163275827|NCT01676220|589719964|FG001|Overall Study|No More Need of Insulin|0|||
163275828|NCT02411591|589719965|FG000|Overall Study|Adverse Event|0|||
163275829|NCT02411591|589719966|FG001|Overall Study|Adverse Event|4|||
163275830|NCT02411591|589719967|FG002|Overall Study|Adverse Event|2|||
163275831|NCT02411591|589719965|FG000|Overall Study|Withdrawal by Subject|0|||
163275832|NCT02411591|589719966|FG001|Overall Study|Withdrawal by Subject|3|||
163275833|NCT02411591|589719967|FG002|Overall Study|Withdrawal by Subject|0|||
163275834|NCT02411591|589719965|FG000|Overall Study|Physician Decision|0|||
163275835|NCT02411591|589719966|FG001|Overall Study|Physician Decision|3|||
163275836|NCT02411591|589719967|FG002|Overall Study|Physician Decision|1|||
163275837|NCT00750893|589719970|FG000|Overall Study|Adverse Event|5|||
163275838|NCT00750893|589719970|FG000|Overall Study|Withdrawal by Subject|10|||
163275839|NCT00750893|589719970|FG000|Overall Study|Lost to Follow-up|510|||
163275840|NCT00750893|589719970|FG000|Overall Study|Other|17|||
163275841|NCT00661258|589719978|FG000|Overall Study|Death|1|||
163275842|NCT00661258|589719979|FG001|Overall Study|Death|0|||
163275843|NCT00661258|589719978|FG000|Overall Study|caught by police and in detox center|2|||
163275844|NCT00661258|589719979|FG001|Overall Study|caught by police and in detox center|1|||
163275845|NCT01628874|589719980|FG000|Overall Study|Physician Decision|1|||
163275846|NCT01628874|589719981|FG001|Overall Study|Physician Decision|1|||
163275847|NCT01628874|589719980|FG000|Overall Study|Age >4 months|4|||
163275848|NCT01628874|589719981|FG001|Overall Study|Age >4 months|2|||
163275849|NCT00873093|589719982|FG000|Overall Study|Adverse Event|0|||
163275850|NCT00873093|589719983|FG001|Overall Study|Adverse Event|2|||
163275851|NCT00873093|589719984|FG002|Overall Study|Adverse Event|0|||
163275852|NCT00873093|589719985|FG003|Overall Study|Adverse Event|0|||
163275853|NCT00873093|589719986|FG004|Overall Study|Adverse Event|0|||
163275854|NCT00873093|589719982|FG000|Overall Study|Death|0|||
163275855|NCT00873093|589719983|FG001|Overall Study|Death|3|||
163275856|NCT00873093|589719984|FG002|Overall Study|Death|2|||
163275857|NCT00873093|589719985|FG003|Overall Study|Death|0|||
163275858|NCT00873093|589719986|FG004|Overall Study|Death|0|||
163275859|NCT00873093|589719982|FG000|Overall Study|Physician Decision|0|||
163275860|NCT00873093|589719983|FG001|Overall Study|Physician Decision|17|||
163275861|NCT00873093|589719984|FG002|Overall Study|Physician Decision|10|||
163275862|NCT00873093|589719985|FG003|Overall Study|Physician Decision|10|||
163275863|NCT00873093|589719986|FG004|Overall Study|Physician Decision|2|||
163275864|NCT00873093|589719982|FG000|Overall Study|Withdrawal by Subject|1|||
163275865|NCT00873093|589719983|FG001|Overall Study|Withdrawal by Subject|4|||
163275866|NCT00873093|589719984|FG002|Overall Study|Withdrawal by Subject|4|||
163275867|NCT00873093|589719985|FG003|Overall Study|Withdrawal by Subject|0|||
163275868|NCT00873093|589719986|FG004|Overall Study|Withdrawal by Subject|0|||
163275869|NCT00873093|589719982|FG000|Overall Study|Ineligible|0|||
163275870|NCT00873093|589719983|FG001|Overall Study|Ineligible|1|||
163275871|NCT00873093|589719984|FG002|Overall Study|Ineligible|0|||
163275872|NCT00873093|589719985|FG003|Overall Study|Ineligible|1|||
163275873|NCT00873093|589719986|FG004|Overall Study|Ineligible|0|||
163275874|NCT01152554|589719988|FG000|Overall Study|Withdrawal by Subject|73|||
163275875|NCT01152554|589719989|FG001|Overall Study|Withdrawal by Subject|28|||
163275876|NCT01152554|589719988|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
163275877|NCT01152554|589719989|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
163275878|NCT01152554|589719988|FG000|Overall Study|Adverse Event|67|||
163275879|NCT01152554|589719989|FG001|Overall Study|Adverse Event|14|||
163275880|NCT01152554|589719988|FG000|Overall Study|Severe non-compliance to protocol|36|||
163275881|NCT01152554|589719989|FG001|Overall Study|Severe non-compliance to protocol|14|||
163275882|NCT01152554|589719988|FG000|Overall Study|Condition under investigation worsened|5|||
163275883|NCT01152554|589719989|FG001|Overall Study|Condition under investigation worsened|2|||
163275884|NCT01152554|589719988|FG000|Overall Study|Lack of Efficacy|20|||
163275885|NCT01152554|589719989|FG001|Overall Study|Lack of Efficacy|3|||
163275886|NCT01152554|589719988|FG000|Overall Study|Study-specific withdrawal criteria|17|||
163275887|NCT01152554|589719989|FG001|Overall Study|Study-specific withdrawal criteria|8|||
163275888|NCT01152554|589719988|FG000|Overall Study|Lost to Follow-up|87|||
163275889|NCT01152554|589719989|FG001|Overall Study|Lost to Follow-up|32|||
163275890|NCT01152554|589719988|FG000|Overall Study|Other|28|||
163275891|NCT01152554|589719989|FG001|Overall Study|Other|8|||
163275892|NCT01152554|589719988|FG000|Overall Study|Death|1|||
163161736|NCT02963506|589305889|FG001|Double-Blind Period|Adverse Event|0|||
163275893|NCT01152554|589719989|FG001|Overall Study|Death|1|||
163161737|NCT02963506|589305890|FG002|Double-Blind Period|Adverse Event|1|||
163161738|NCT02963506|589305891|FG003|Double-Blind Period|Adverse Event|0|||
163161739|NCT02963506|589305892|FG004|Double-Blind Period|Adverse Event|0|||
163161740|NCT02963506|589305893|FG005|Double-Blind Period|Adverse Event|0|||
163161741|NCT02963506|589305894|FG006|Double-Blind Period|Adverse Event|0|||
163161742|NCT02963506|589305895|FG007|Double-Blind Period|Adverse Event|0|||
163161743|NCT02963506|589305896|FG008|Double-Blind Period|Adverse Event|0|||
163161744|NCT02963506|589305897|FG009|Double-Blind Period|Adverse Event|0|||
163161745|NCT02963506|589305898|FG010|Double-Blind Period|Adverse Event|0|||
163161746|NCT02963506|589305899|FG011|Double-Blind Period|Adverse Event|0|||
163161747|NCT02963506|589305900|FG012|Double-Blind Period|Adverse Event|0|||
163161748|NCT02963506|589305888|FG000|Double-Blind Period|Death|0|||
163161749|NCT02963506|589305889|FG001|Double-Blind Period|Death|0|||
163161750|NCT02963506|589305890|FG002|Double-Blind Period|Death|0|||
163161751|NCT02963506|589305891|FG003|Double-Blind Period|Death|1|||
163161752|NCT02963506|589305892|FG004|Double-Blind Period|Death|0|||
163161753|NCT02963506|589305893|FG005|Double-Blind Period|Death|0|||
163161754|NCT02963506|589305894|FG006|Double-Blind Period|Death|0|||
163161755|NCT02963506|589305895|FG007|Double-Blind Period|Death|0|||
163161756|NCT02963506|589305896|FG008|Double-Blind Period|Death|0|||
163161757|NCT02963506|589305897|FG009|Double-Blind Period|Death|0|||
163161758|NCT02963506|589305898|FG010|Double-Blind Period|Death|0|||
163161759|NCT02963506|589305899|FG011|Double-Blind Period|Death|0|||
163387067|NCT03236246|590128361|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
163387068|NCT03236246|590128362|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
163387069|NCT02952001|590128363|FG000|Overall Study|Adverse Event|3|||
163387070|NCT02952001|590128364|FG001|Overall Study|Adverse Event|0|||
163387071|NCT02952001|590128363|FG000|Overall Study|Prohibited therapy|10|||
163387072|NCT02952001|590128364|FG001|Overall Study|Prohibited therapy|3|||
163387073|NCT02952001|590128363|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
163387074|NCT02952001|590128364|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
163387075|NCT01681628|590128367|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
163387076|NCT01681628|590128368|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
163387077|NCT01681628|590128367|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
163387078|NCT01681628|590128368|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
163387079|NCT01681628|590128367|FG000|19 Months Follow-up|Death|1|||
163387080|NCT01681628|590128368|FG001|19 Months Follow-up|Death|0|||
163387081|NCT01681628|590128367|FG000|19 Months Follow-up|Lost to Follow-up|61|||
163387082|NCT01681628|590128368|FG001|19 Months Follow-up|Lost to Follow-up|43|||
163387083|NCT01794520|590128369|FG000|Overall Study|Adverse events- related to progression|0|||
163387084|NCT01794520|590128370|FG001|Overall Study|Adverse events- related to progression|0|||
163387085|NCT01794520|590128371|FG002|Overall Study|Adverse events- related to progression|1|||
163387086|NCT01794520|590128372|FG003|Overall Study|Adverse events- related to progression|2|||
163387087|NCT01794520|590128373|FG004|Overall Study|Adverse events- related to progression|0|||
163387088|NCT01794520|590128374|FG005|Overall Study|Adverse events- related to progression|1|||
163387089|NCT01794520|590128375|FG006|Overall Study|Adverse events- related to progression|0|||
163387090|NCT01794520|590128369|FG000|Overall Study|Adverse event- not related to progression|1|||
163387091|NCT01794520|590128370|FG001|Overall Study|Adverse event- not related to progression|1|||
163042815|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
163161760|NCT02963506|589305900|FG012|Double-Blind Period|Death|0|||
163161761|NCT02963506|589305888|FG000|Double-Blind Period|Lost to Follow-up|0|||
163161762|NCT02963506|589305889|FG001|Double-Blind Period|Lost to Follow-up|1|||
163161763|NCT02963506|589305890|FG002|Double-Blind Period|Lost to Follow-up|0|||
163161764|NCT02963506|589305891|FG003|Double-Blind Period|Lost to Follow-up|0|||
163161765|NCT02963506|589305892|FG004|Double-Blind Period|Lost to Follow-up|0|||
163161766|NCT02963506|589305893|FG005|Double-Blind Period|Lost to Follow-up|0|||
163161767|NCT02963506|589305894|FG006|Double-Blind Period|Lost to Follow-up|0|||
163161768|NCT02963506|589305895|FG007|Double-Blind Period|Lost to Follow-up|0|||
163161769|NCT02963506|589305896|FG008|Double-Blind Period|Lost to Follow-up|0|||
163161770|NCT02963506|589305897|FG009|Double-Blind Period|Lost to Follow-up|0|||
163161771|NCT02963506|589305898|FG010|Double-Blind Period|Lost to Follow-up|0|||
163387092|NCT01794520|590128371|FG002|Overall Study|Adverse event- not related to progression|0|||
163387093|NCT01794520|590128372|FG003|Overall Study|Adverse event- not related to progression|0|||
163387094|NCT01794520|590128373|FG004|Overall Study|Adverse event- not related to progression|2|||
163387095|NCT01794520|590128374|FG005|Overall Study|Adverse event- not related to progression|0|||
163387096|NCT01794520|590128375|FG006|Overall Study|Adverse event- not related to progression|0|||
163387097|NCT01794520|590128369|FG000|Overall Study|Progressive disease|5|||
163387098|NCT01794520|590128370|FG001|Overall Study|Progressive disease|6|||
163387099|NCT01794520|590128371|FG002|Overall Study|Progressive disease|2|||
163387100|NCT01794520|590128372|FG003|Overall Study|Progressive disease|5|||
163161772|NCT02963506|589305899|FG011|Double-Blind Period|Lost to Follow-up|0|||
163161773|NCT02963506|589305900|FG012|Double-Blind Period|Lost to Follow-up|0|||
163387101|NCT01794520|590128373|FG004|Overall Study|Progressive disease|27|||
163161774|NCT02963506|589305888|FG000|Double-Blind Period|Withdrawal by Subject|0|||
163161775|NCT02963506|589305889|FG001|Double-Blind Period|Withdrawal by Subject|0|||
163387102|NCT01794520|590128374|FG005|Overall Study|Progressive disease|18|||
163387103|NCT01794520|590128375|FG006|Overall Study|Progressive disease|0|||
163387104|NCT01794520|590128369|FG000|Overall Study|Withdrew consent|0|||
163387105|NCT01794520|590128370|FG001|Overall Study|Withdrew consent|0|||
163387106|NCT01794520|590128371|FG002|Overall Study|Withdrew consent|1|||
163387107|NCT01794520|590128372|FG003|Overall Study|Withdrew consent|1|||
163387108|NCT01794520|590128373|FG004|Overall Study|Withdrew consent|0|||
163387109|NCT01794520|590128374|FG005|Overall Study|Withdrew consent|0|||
163387110|NCT01794520|590128375|FG006|Overall Study|Withdrew consent|0|||
163387111|NCT01794520|590128369|FG000|Overall Study|Lost to Follow-up|0|||
163387112|NCT01794520|590128370|FG001|Overall Study|Lost to Follow-up|0|||
163387113|NCT01794520|590128371|FG002|Overall Study|Lost to Follow-up|0|||
163387114|NCT01794520|590128372|FG003|Overall Study|Lost to Follow-up|0|||
163387115|NCT01794520|590128373|FG004|Overall Study|Lost to Follow-up|1|||
163387116|NCT01794520|590128374|FG005|Overall Study|Lost to Follow-up|0|||
163387117|NCT01794520|590128375|FG006|Overall Study|Lost to Follow-up|0|||
163161776|NCT02963506|589305890|FG002|Double-Blind Period|Withdrawal by Subject|1|||
163161777|NCT02963506|589305891|FG003|Double-Blind Period|Withdrawal by Subject|1|||
163161778|NCT02963506|589305892|FG004|Double-Blind Period|Withdrawal by Subject|0|||
163161779|NCT02963506|589305893|FG005|Double-Blind Period|Withdrawal by Subject|0|||
163387118|NCT01794520|590128369|FG000|Overall Study|Toxicity|0|||
163387119|NCT01794520|590128370|FG001|Overall Study|Toxicity|2|||
163387120|NCT01794520|590128371|FG002|Overall Study|Toxicity|0|||
163387121|NCT01794520|590128372|FG003|Overall Study|Toxicity|0|||
163387122|NCT01794520|590128373|FG004|Overall Study|Toxicity|0|||
163387123|NCT01794520|590128374|FG005|Overall Study|Toxicity|0|||
163161780|NCT02963506|589305894|FG006|Double-Blind Period|Withdrawal by Subject|0|||
163161781|NCT02963506|589305895|FG007|Double-Blind Period|Withdrawal by Subject|0|||
163161782|NCT02963506|589305896|FG008|Double-Blind Period|Withdrawal by Subject|0|||
163161783|NCT02963506|589305897|FG009|Double-Blind Period|Withdrawal by Subject|0|||
163161784|NCT02963506|589305898|FG010|Double-Blind Period|Withdrawal by Subject|0|||
163161785|NCT02963506|589305899|FG011|Double-Blind Period|Withdrawal by Subject|0|||
163161786|NCT02963506|589305900|FG012|Double-Blind Period|Withdrawal by Subject|0|||
163387124|NCT01794520|590128375|FG006|Overall Study|Toxicity|0|||
163387125|NCT01794520|590128369|FG000|Overall Study|Study terminated by sponsor|0|||
163387126|NCT01794520|590128370|FG001|Overall Study|Study terminated by sponsor|0|||
163387127|NCT01794520|590128371|FG002|Overall Study|Study terminated by sponsor|1|||
163387128|NCT01794520|590128372|FG003|Overall Study|Study terminated by sponsor|0|||
163387129|NCT01794520|590128373|FG004|Overall Study|Study terminated by sponsor|1|||
163387130|NCT01794520|590128374|FG005|Overall Study|Study terminated by sponsor|0|||
163161787|NCT02963506|589305888|FG000|Double-Blind Period|No compliance|0|||
163161788|NCT02963506|589305889|FG001|Double-Blind Period|No compliance|1|||
163161789|NCT02963506|589305890|FG002|Double-Blind Period|No compliance|0|||
162924220|NCT00077766|588423834|FG001|Overall Study|Transplantation|1|||
163161790|NCT02963506|589305891|FG003|Double-Blind Period|No compliance|0|||
163387131|NCT01794520|590128375|FG006|Overall Study|Study terminated by sponsor|7|||
163387132|NCT01794520|590128369|FG000|Overall Study|Death|0|||
163387133|NCT01794520|590128370|FG001|Overall Study|Death|0|||
163387134|NCT01794520|590128371|FG002|Overall Study|Death|0|||
163387135|NCT01794520|590128372|FG003|Overall Study|Death|0|||
163387136|NCT01794520|590128373|FG004|Overall Study|Death|1|||
163387137|NCT01794520|590128374|FG005|Overall Study|Death|0|||
163387138|NCT01794520|590128375|FG006|Overall Study|Death|22|||
163387139|NCT01794520|590128369|FG000|Overall Study|Other, not specified|0|||
163387140|NCT01794520|590128370|FG001|Overall Study|Other, not specified|0|||
163387141|NCT01794520|590128371|FG002|Overall Study|Other, not specified|1|||
163387142|NCT01794520|590128372|FG003|Overall Study|Other, not specified|1|||
163387143|NCT01794520|590128373|FG004|Overall Study|Other, not specified|4|||
163387144|NCT01794520|590128374|FG005|Overall Study|Other, not specified|1|||
163387145|NCT01794520|590128375|FG006|Overall Study|Other, not specified|2|||
163387146|NCT04796896|590128376|FG000|Overall Study|Adverse Event|1|||
163387147|NCT04796896|590128377|FG001|Overall Study|Adverse Event|0|||
163387148|NCT04796896|590128378|FG002|Overall Study|Adverse Event|0|||
163387149|NCT04796896|590128379|FG003|Overall Study|Adverse Event|0|||
163387150|NCT04796896|590128380|FG004|Overall Study|Adverse Event|0|||
163387151|NCT04796896|590128381|FG005|Overall Study|Adverse Event|1|||
163387152|NCT04796896|590128382|FG006|Overall Study|Adverse Event|1|||
163387153|NCT04796896|590128383|FG007|Overall Study|Adverse Event|0|||
163387154|NCT04796896|590128384|FG008|Overall Study|Adverse Event|1|||
163387155|NCT04796896|590128385|FG009|Overall Study|Adverse Event|1|||
163387156|NCT04796896|590128386|FG010|Overall Study|Adverse Event|1|||
163387157|NCT04796896|590128387|FG011|Overall Study|Adverse Event|0|||
163387158|NCT04796896|590128376|FG000|Overall Study|Lost to Follow-up|24|||
163387159|NCT04796896|590128377|FG001|Overall Study|Lost to Follow-up|15|||
163387160|NCT04796896|590128378|FG002|Overall Study|Lost to Follow-up|6|||
163387161|NCT04796896|590128379|FG003|Overall Study|Lost to Follow-up|4|||
163387162|NCT04796896|590128380|FG004|Overall Study|Lost to Follow-up|21|||
163387163|NCT04796896|590128381|FG005|Overall Study|Lost to Follow-up|55|||
163387164|NCT04796896|590128382|FG006|Overall Study|Lost to Follow-up|237|||
163387165|NCT04796896|590128383|FG007|Overall Study|Lost to Follow-up|52|||
163387166|NCT04796896|590128384|FG008|Overall Study|Lost to Follow-up|221|||
163387167|NCT04796896|590128385|FG009|Overall Study|Lost to Follow-up|43|||
163387168|NCT04796896|590128386|FG010|Overall Study|Lost to Follow-up|142|||
163387169|NCT04796896|590128387|FG011|Overall Study|Lost to Follow-up|18|||
163387170|NCT04796896|590128376|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
163387171|NCT04796896|590128377|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
163387172|NCT04796896|590128378|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
163387173|NCT04796896|590128379|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
163387174|NCT04796896|590128380|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
163387175|NCT04796896|590128381|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
163387176|NCT04796896|590128382|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
163387177|NCT04796896|590128383|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
163387178|NCT04796896|590128384|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
163387179|NCT04796896|590128385|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
163387180|NCT04796896|590128386|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
163387181|NCT04796896|590128387|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
163387182|NCT04796896|590128376|FG000|Overall Study|Physician Decision|1|||
163387183|NCT04796896|590128377|FG001|Overall Study|Physician Decision|0|||
163387184|NCT04796896|590128378|FG002|Overall Study|Physician Decision|0|||
163387185|NCT04796896|590128379|FG003|Overall Study|Physician Decision|0|||
163387186|NCT04796896|590128380|FG004|Overall Study|Physician Decision|0|||
163387187|NCT04796896|590128381|FG005|Overall Study|Physician Decision|3|||
163387188|NCT04796896|590128382|FG006|Overall Study|Physician Decision|18|||
163387189|NCT04796896|590128383|FG007|Overall Study|Physician Decision|1|||
163387190|NCT04796896|590128384|FG008|Overall Study|Physician Decision|7|||
163387191|NCT04796896|590128385|FG009|Overall Study|Physician Decision|0|||
163387192|NCT04796896|590128386|FG010|Overall Study|Physician Decision|5|||
163387193|NCT04796896|590128387|FG011|Overall Study|Physician Decision|0|||
163387194|NCT04796896|590128376|FG000|Overall Study|Withdrawal by Subject|36|||
163387195|NCT04796896|590128377|FG001|Overall Study|Withdrawal by Subject|31|||
163387196|NCT04796896|590128378|FG002|Overall Study|Withdrawal by Subject|11|||
163387197|NCT04796896|590128379|FG003|Overall Study|Withdrawal by Subject|8|||
163387198|NCT04796896|590128380|FG004|Overall Study|Withdrawal by Subject|16|||
163387199|NCT04796896|590128381|FG005|Overall Study|Withdrawal by Subject|162|||
163387200|NCT04796896|590128382|FG006|Overall Study|Withdrawal by Subject|299|||
163387201|NCT04796896|590128383|FG007|Overall Study|Withdrawal by Subject|149|||
163387202|NCT04796896|590128384|FG008|Overall Study|Withdrawal by Subject|303|||
163387203|NCT04796896|590128385|FG009|Overall Study|Withdrawal by Subject|94|||
163387204|NCT04796896|590128386|FG010|Overall Study|Withdrawal by Subject|192|||
163387205|NCT04796896|590128387|FG011|Overall Study|Withdrawal by Subject|16|||
163387206|NCT04796896|590128376|FG000|Overall Study|Other Than Specified|6|||
163387207|NCT04796896|590128377|FG001|Overall Study|Other Than Specified|5|||
163387208|NCT04796896|590128378|FG002|Overall Study|Other Than Specified|3|||
163387209|NCT04796896|590128379|FG003|Overall Study|Other Than Specified|2|||
163387210|NCT04796896|590128380|FG004|Overall Study|Other Than Specified|6|||
163387211|NCT04796896|590128381|FG005|Overall Study|Other Than Specified|31|||
163387212|NCT04796896|590128382|FG006|Overall Study|Other Than Specified|86|||
163387213|NCT04796896|590128383|FG007|Overall Study|Other Than Specified|66|||
163387214|NCT04796896|590128384|FG008|Overall Study|Other Than Specified|388|||
163387215|NCT04796896|590128385|FG009|Overall Study|Other Than Specified|48|||
163387216|NCT04796896|590128386|FG010|Overall Study|Other Than Specified|258|||
163387217|NCT04796896|590128387|FG011|Overall Study|Other Than Specified|4|||
163387218|NCT04796896|590128376|FG000|Overall Study|Protocol Deviation|0|||
163387219|NCT04796896|590128377|FG001|Overall Study|Protocol Deviation|0|||
163387220|NCT04796896|590128378|FG002|Overall Study|Protocol Deviation|0|||
163387221|NCT04796896|590128379|FG003|Overall Study|Protocol Deviation|1|||
163387222|NCT04796896|590128380|FG004|Overall Study|Protocol Deviation|1|||
163387223|NCT04796896|590128381|FG005|Overall Study|Protocol Deviation|2|||
163387224|NCT04796896|590128382|FG006|Overall Study|Protocol Deviation|2|||
163387225|NCT04796896|590128383|FG007|Overall Study|Protocol Deviation|2|||
163387226|NCT04796896|590128384|FG008|Overall Study|Protocol Deviation|2|||
163387227|NCT04796896|590128385|FG009|Overall Study|Protocol Deviation|1|||
163387228|NCT04796896|590128386|FG010|Overall Study|Protocol Deviation|0|||
163387229|NCT04796896|590128387|FG011|Overall Study|Protocol Deviation|0|||
163387230|NCT04796896|590128376|FG000|Overall Study|Missing|0|||
163387231|NCT04796896|590128377|FG001|Overall Study|Missing|0|||
163387232|NCT04796896|590128378|FG002|Overall Study|Missing|0|||
163387233|NCT04796896|590128379|FG003|Overall Study|Missing|0|||
163387234|NCT04796896|590128380|FG004|Overall Study|Missing|0|||
163387235|NCT04796896|590128381|FG005|Overall Study|Missing|0|||
163387236|NCT04796896|590128382|FG006|Overall Study|Missing|2|||
163387237|NCT04796896|590128383|FG007|Overall Study|Missing|1|||
163387238|NCT04796896|590128384|FG008|Overall Study|Missing|2|||
163387239|NCT04796896|590128385|FG009|Overall Study|Missing|1|||
163387240|NCT04796896|590128386|FG010|Overall Study|Missing|1|||
163387241|NCT04796896|590128387|FG011|Overall Study|Missing|0|||
163387242|NCT04796896|590128376|FG000|Overall Study|Death|0|||
163387243|NCT04796896|590128377|FG001|Overall Study|Death|0|||
163387244|NCT04796896|590128378|FG002|Overall Study|Death|0|||
163387245|NCT04796896|590128379|FG003|Overall Study|Death|0|||
163387246|NCT04796896|590128380|FG004|Overall Study|Death|0|||
163387247|NCT04796896|590128381|FG005|Overall Study|Death|0|||
163387248|NCT04796896|590128382|FG006|Overall Study|Death|0|||
163387249|NCT04796896|590128383|FG007|Overall Study|Death|0|||
163387250|NCT04796896|590128384|FG008|Overall Study|Death|1|||
163387251|NCT04796896|590128385|FG009|Overall Study|Death|0|||
163387252|NCT04796896|590128386|FG010|Overall Study|Death|0|||
163387253|NCT04796896|590128387|FG011|Overall Study|Death|0|||
163387254|NCT02021292|590128388|FG000|Overall Study|Physician Decision|0|||
163387255|NCT02021292|590128389|FG001|Overall Study|Physician Decision|1|||
163387256|NCT02021292|590128388|FG000|Overall Study|Lost to Follow-up|0|||
163387257|NCT02021292|590128389|FG001|Overall Study|Lost to Follow-up|1|||
163387258|NCT02021292|590128388|FG000|Overall Study|Death|0|||
163387259|NCT02021292|590128389|FG001|Overall Study|Death|1|||
163387260|NCT04356183|590128390|FG000|Overall Study|Lost to Follow-up|1|||
163387261|NCT04356183|590128391|FG001|Overall Study|Lost to Follow-up|0|||
163387262|NCT04356183|590128390|FG000|Overall Study|Withdrawal by Subject|1|||
163387263|NCT04356183|590128391|FG001|Overall Study|Withdrawal by Subject|1|||
163387264|NCT01637623|590128392|FG000|Overall Study|Lost to Follow-up|0|||
163387265|NCT01637623|590128393|FG001|Overall Study|Lost to Follow-up|0|||
163387266|NCT01637623|590128394|FG002|Overall Study|Lost to Follow-up|2|||
163387267|NCT01637623|590128392|FG000|Overall Study|Physician Decision|1|||
163387268|NCT01637623|590128393|FG001|Overall Study|Physician Decision|0|||
163387269|NCT01637623|590128394|FG002|Overall Study|Physician Decision|1|||
163387270|NCT02824263|590128397|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
163387271|NCT02824263|590128398|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
163387272|NCT02824263|590128397|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
163387273|NCT02824263|590128398|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
163387274|NCT01676909|590128399|FG000|Overall Study|Withdrawal by Subject|3|||
163387275|NCT01676909|590128400|FG001|Overall Study|Withdrawal by Subject|5|||
163387276|NCT01676909|590128399|FG000|Overall Study|Lost to Follow-up|15|||
163387277|NCT01676909|590128400|FG001|Overall Study|Lost to Follow-up|9|||
163387278|NCT04615247|590128401|FG000|Overall Study|Adverse Event|0|||
163387279|NCT04615247|590128402|FG001|Overall Study|Adverse Event|2|||
163387280|NCT04615247|590128401|FG000|Overall Study|Withdrawal by Subject|1|||
163387281|NCT04615247|590128402|FG001|Overall Study|Withdrawal by Subject|1|||
163387282|NCT00823901|590128405|FG000|Overall Study|Adverse Event|1|||
163387283|NCT00823901|590128406|FG001|Overall Study|Adverse Event|1|||
163387284|NCT00823901|590128405|FG000|Overall Study|Lack of Efficacy|1|||
163387285|NCT00823901|590128406|FG001|Overall Study|Lack of Efficacy|0|||
163387286|NCT00823901|590128405|FG000|Overall Study|Lost to Follow-up|2|||
163387287|NCT00823901|590128406|FG001|Overall Study|Lost to Follow-up|1|||
163387288|NCT01369511|590128407|FG000|Overall Study|Adverse Event|1|||
163387289|NCT01369511|590128408|FG001|Overall Study|Adverse Event|1|||
163387290|NCT01369511|590128409|FG002|Overall Study|Adverse Event|5|||
163387291|NCT01369511|590128410|FG003|Overall Study|Adverse Event|0|||
163387292|NCT01369511|590128407|FG000|Overall Study|Entry criteria not met|2|||
163387293|NCT01369511|590128408|FG001|Overall Study|Entry criteria not met|0|||
163387294|NCT01369511|590128409|FG002|Overall Study|Entry criteria not met|0|||
163387295|NCT01369511|590128410|FG003|Overall Study|Entry criteria not met|1|||
163387296|NCT01369511|590128407|FG000|Overall Study|Lost to Follow-up|0|||
163387297|NCT01369511|590128408|FG001|Overall Study|Lost to Follow-up|1|||
163387298|NCT01369511|590128409|FG002|Overall Study|Lost to Follow-up|1|||
163387299|NCT01369511|590128410|FG003|Overall Study|Lost to Follow-up|2|||
163387300|NCT01369511|590128407|FG000|Overall Study|Protocol Violation|0|||
163387301|NCT01369511|590128408|FG001|Overall Study|Protocol Violation|1|||
163387302|NCT01369511|590128409|FG002|Overall Study|Protocol Violation|0|||
163387303|NCT01369511|590128410|FG003|Overall Study|Protocol Violation|2|||
163387304|NCT01369511|590128407|FG000|Overall Study|Physician Decision|3|||
163387305|NCT01369511|590128408|FG001|Overall Study|Physician Decision|4|||
163387306|NCT01369511|590128409|FG002|Overall Study|Physician Decision|0|||
163387307|NCT01369511|590128410|FG003|Overall Study|Physician Decision|0|||
163387308|NCT01369511|590128407|FG000|Overall Study|Sponsor decision|2|||
163387309|NCT01369511|590128408|FG001|Overall Study|Sponsor decision|0|||
163387310|NCT01369511|590128409|FG002|Overall Study|Sponsor decision|1|||
163387311|NCT01369511|590128410|FG003|Overall Study|Sponsor decision|0|||
163387312|NCT01369511|590128407|FG000|Overall Study|Withdrawal by Subject|5|||
163387313|NCT01369511|590128408|FG001|Overall Study|Withdrawal by Subject|6|||
163387314|NCT01369511|590128409|FG002|Overall Study|Withdrawal by Subject|4|||
163387315|NCT01369511|590128410|FG003|Overall Study|Withdrawal by Subject|6|||
163387316|NCT01376349|590128411|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
163387317|NCT01376349|590128412|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
163387318|NCT01376349|590128413|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
163387319|NCT01376349|590128411|FG000|Raondomized Treatment|Adverse Event|13|||
163387320|NCT01376349|590128412|FG001|Raondomized Treatment|Adverse Event|17|||
163387321|NCT01376349|590128413|FG002|Raondomized Treatment|Adverse Event|14|||
163387322|NCT01376349|590128411|FG000|Raondomized Treatment|Unkown|1|||
163387323|NCT01376349|590128412|FG001|Raondomized Treatment|Unkown|2|||
163387324|NCT01376349|590128413|FG002|Raondomized Treatment|Unkown|1|||
163387325|NCT01376349|590128411|FG000|Raondomized Treatment|Alternative Treatment|0|||
163387326|NCT01376349|590128412|FG001|Raondomized Treatment|Alternative Treatment|0|||
163387327|NCT01376349|590128413|FG002|Raondomized Treatment|Alternative Treatment|1|||
163387328|NCT00718640|590128414|FG000|Overall Study|Adverse Event|4|||
163387329|NCT00718640|590128414|FG000|Overall Study|Death|1|||
163387330|NCT00718640|590128414|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
163387331|NCT01294683|590128417|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
163387332|NCT01294683|590128418|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
163387333|NCT01294683|590128417|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
163387334|NCT01294683|590128418|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
163387335|NCT01294683|590128417|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
163387336|NCT01294683|590128418|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
163387337|NCT01294683|590128417|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
163387338|NCT01294683|590128418|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
163387339|NCT01294683|590128417|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
163387340|NCT01294683|590128418|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
163387341|NCT01294683|590128417|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
163387342|NCT01294683|590128418|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
163387343|NCT01294683|590128417|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
163387344|NCT01294683|590128418|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
163387345|NCT01294683|590128417|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
163387346|NCT01294683|590128418|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
163387347|NCT01294683|590128417|FG000|Post Crossover (Period III)|Adverse Event|6|||
163387348|NCT01294683|590128418|FG001|Post Crossover (Period III)|Adverse Event|6|||
163387349|NCT01294683|590128417|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
163387350|NCT01294683|590128418|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
163387351|NCT01294683|590128417|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
163387352|NCT01294683|590128418|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
163387353|NCT01294683|590128417|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
163387354|NCT01294683|590128418|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
163387355|NCT00051363|590128419|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
163387356|NCT00051363|590128420|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
163387357|NCT00051363|590128419|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
163161791|NCT02963506|589305892|FG004|Double-Blind Period|No compliance|0|||
163387358|NCT00051363|590128420|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
163387359|NCT00051363|590128419|FG000|Overall Study|Death|2|||
163387360|NCT00051363|590128420|FG001|Overall Study|Death|2|||
163161792|NCT02963506|589305893|FG005|Double-Blind Period|No compliance|0|||
163387361|NCT00051363|590128419|FG000|Overall Study|Excluded Pre-Randomization|2|||
163387362|NCT00051363|590128420|FG001|Overall Study|Excluded Pre-Randomization|5|||
163387363|NCT00026208|590128421|FG000|Overall Study|Complications of auto accident|1|||
163387364|NCT00026208|590128422|FG001|Overall Study|Complications of auto accident|0|||
163387365|NCT03282240|590128423|FG000|Overall Study|Adverse Event|2|||
163387366|NCT03282240|590128424|FG001|Overall Study|Adverse Event|2|||
163387367|NCT03282240|590128425|FG002|Overall Study|Adverse Event|0|||
163387368|NCT03282240|590128423|FG000|Overall Study|Lost to Follow-up|3|||
163387369|NCT03282240|590128424|FG001|Overall Study|Lost to Follow-up|0|||
163387370|NCT03282240|590128425|FG002|Overall Study|Lost to Follow-up|0|||
163387371|NCT03282240|590128423|FG000|Overall Study|Protocol Deviation|4|||
163387372|NCT03282240|590128424|FG001|Overall Study|Protocol Deviation|1|||
163387373|NCT03282240|590128425|FG002|Overall Study|Protocol Deviation|2|||
163387374|NCT03282240|590128423|FG000|Overall Study|Withdrawal by Subject|1|||
163387375|NCT03282240|590128424|FG001|Overall Study|Withdrawal by Subject|0|||
163387376|NCT03282240|590128425|FG002|Overall Study|Withdrawal by Subject|1|||
163387377|NCT01675479|590128426|FG000|Overall Study|Lost to Follow-up|11|||
163387378|NCT02910739|590128427|FG000|Overall Study|Adverse Event|1|||
163387379|NCT02910739|590128428|FG001|Overall Study|Adverse Event|0|||
163387380|NCT02910739|590128429|FG002|Overall Study|Adverse Event|0|||
163387381|NCT02910739|590128430|FG003|Overall Study|Adverse Event|0|||
163387382|NCT01103245|590129872|FG000|Overall Study|Withdrawal by Subject|1|||
163387383|NCT01103245|590129873|FG001|Overall Study|Withdrawal by Subject|0|||
163387384|NCT01103245|590129874|FG002|Overall Study|Withdrawal by Subject|3|||
163387385|NCT01103245|590129875|FG003|Overall Study|Withdrawal by Subject|0|||
163387386|NCT01103245|590129872|FG000|Overall Study|Inadequate IV access|1|||
163387387|NCT01103245|590129873|FG001|Overall Study|Inadequate IV access|0|||
163387388|NCT01103245|590129874|FG002|Overall Study|Inadequate IV access|0|||
163387389|NCT01103245|590129875|FG003|Overall Study|Inadequate IV access|0|||
163387390|NCT01103245|590129872|FG000|Overall Study|Adverse Event|0|||
163387391|NCT01103245|590129873|FG001|Overall Study|Adverse Event|2|||
163387392|NCT01103245|590129874|FG002|Overall Study|Adverse Event|1|||
163387393|NCT01103245|590129875|FG003|Overall Study|Adverse Event|0|||
163387394|NCT01103245|590129872|FG000|Overall Study|Physician Decision|1|||
163387395|NCT01103245|590129873|FG001|Overall Study|Physician Decision|0|||
163387396|NCT01103245|590129874|FG002|Overall Study|Physician Decision|0|||
163387397|NCT01103245|590129875|FG003|Overall Study|Physician Decision|0|||
163387398|NCT03078907|590129880|FG000|Overall Study|Adverse Event|2|||
163387399|NCT03078907|590129881|FG001|Overall Study|Adverse Event|0|||
163387400|NCT03078907|590129880|FG000|Overall Study|Other|1|||
163387401|NCT03078907|590129881|FG001|Overall Study|Other|0|||
163387402|NCT03078907|590129880|FG000|Overall Study|Protocol Violation|0|||
163387403|NCT03078907|590129881|FG001|Overall Study|Protocol Violation|1|||
163387404|NCT01955122|590129882|FG000|Overall Study|Physician Decision|5|||
163387405|NCT01955122|590129883|FG001|Overall Study|Physician Decision|5|||
163387406|NCT01672788|590129884|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
163387407|NCT01672788|590129885|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
163387408|NCT01672788|590129886|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
163387409|NCT01672788|590129887|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
163387410|NCT01128361|590129897|FG000|Overall Study|Lost to Follow-up|0|||
163387411|NCT01128361|590129898|FG001|Overall Study|Lost to Follow-up|1|||
163387412|NCT01128361|590129897|FG000|Overall Study|Withdrawal by Subject|5|||
163387413|NCT01128361|590129898|FG001|Overall Study|Withdrawal by Subject|2|||
163387414|NCT02464228|590129899|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
163387415|NCT02464228|590129900|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
163387416|NCT02464228|590129901|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
163387417|NCT02464228|590129902|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
163387418|NCT02464228|590129899|FG000|Overall Study|Physician Decision|2|||
163387419|NCT02464228|590129900|FG001|Overall Study|Physician Decision|0|||
163387420|NCT02464228|590129901|FG002|Overall Study|Physician Decision|1|||
163387421|NCT02464228|590129902|FG003|Overall Study|Physician Decision|0|||
163387422|NCT02464228|590129899|FG000|Overall Study|Miscellaneous|1|||
163387423|NCT02464228|590129900|FG001|Overall Study|Miscellaneous|0|||
163387424|NCT02464228|590129901|FG002|Overall Study|Miscellaneous|1|||
163387425|NCT02464228|590129902|FG003|Overall Study|Miscellaneous|0|||
163387426|NCT02464228|590129899|FG000|Overall Study|Adverse Event|9|||
163387427|NCT02464228|590129900|FG001|Overall Study|Adverse Event|0|||
163275894|NCT00146640|589719990|FG000|Overall Study|Adverse Event|12|||
163387428|NCT02464228|590129901|FG002|Overall Study|Adverse Event|3|||
163387429|NCT02464228|590129902|FG003|Overall Study|Adverse Event|0|||
163387430|NCT02464228|590129899|FG000|Overall Study|Withdrawal by Subject|1|||
163387431|NCT02464228|590129900|FG001|Overall Study|Withdrawal by Subject|1|||
163387432|NCT02464228|590129901|FG002|Overall Study|Withdrawal by Subject|1|||
163387433|NCT02464228|590129902|FG003|Overall Study|Withdrawal by Subject|0|||
163387434|NCT02464228|590129899|FG000|Overall Study|Disease Progression|22|||
163387435|NCT02464228|590129900|FG001|Overall Study|Disease Progression|12|||
163387436|NCT02464228|590129901|FG002|Overall Study|Disease Progression|5|||
163387437|NCT02464228|590129902|FG003|Overall Study|Disease Progression|2|||
163387438|NCT05972733|590129913|FG000|Overall Study|Lost to Follow-up|2|||
163387439|NCT05972733|590129913|FG000|Overall Study|Withdrawal by Subject|1|||
163387440|NCT01177787|590129914|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
163387441|NCT01177787|590129914|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
163387442|NCT01177787|590129914|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
163387443|NCT00818389|590129917|FG000|Overall Study|Death|1|||
163387444|NCT00818389|590129918|FG001|Overall Study|Death|3|||
163161793|NCT02963506|589305894|FG006|Double-Blind Period|No compliance|0|||
163161794|NCT02963506|589305895|FG007|Double-Blind Period|No compliance|0|||
163161795|NCT02963506|589305896|FG008|Double-Blind Period|No compliance|0|||
163161796|NCT02963506|589305897|FG009|Double-Blind Period|No compliance|0|||
163161797|NCT02963506|589305898|FG010|Double-Blind Period|No compliance|0|||
163161798|NCT02963506|589305899|FG011|Double-Blind Period|No compliance|0|||
163161799|NCT02963506|589305900|FG012|Double-Blind Period|No compliance|0|||
163161800|NCT02963506|589305888|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161801|NCT02963506|589305889|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
163161802|NCT02963506|589305890|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161803|NCT02963506|589305891|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161804|NCT02963506|589305892|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161805|NCT02963506|589305893|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161806|NCT02963506|589305894|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161807|NCT02963506|589305895|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161808|NCT02963506|589305896|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161809|NCT02963506|589305897|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161810|NCT02963506|589305898|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161811|NCT02963506|589305899|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161812|NCT02963506|589305900|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161813|NCT02963506|589305888|FG000|Dose-Blind Period|Adverse Event|0|||
163161814|NCT02963506|589305889|FG001|Dose-Blind Period|Adverse Event|0|||
163161815|NCT02963506|589305890|FG002|Dose-Blind Period|Adverse Event|0|||
163161816|NCT02963506|589305891|FG003|Dose-Blind Period|Adverse Event|0|||
163161817|NCT02963506|589305892|FG004|Dose-Blind Period|Adverse Event|0|||
163161818|NCT02963506|589305893|FG005|Dose-Blind Period|Adverse Event|1|||
163161819|NCT02963506|589305894|FG006|Dose-Blind Period|Adverse Event|3|||
163161820|NCT02963506|589305895|FG007|Dose-Blind Period|Adverse Event|2|||
163161821|NCT02963506|589305896|FG008|Dose-Blind Period|Adverse Event|2|||
163161822|NCT02963506|589305897|FG009|Dose-Blind Period|Adverse Event|2|||
163161823|NCT02963506|589305898|FG010|Dose-Blind Period|Adverse Event|1|||
163275895|NCT00146640|589719991|FG001|Overall Study|Adverse Event|10|||
163275896|NCT00146640|589719990|FG000|Overall Study|Medical Reasons|3|||
163275897|NCT00146640|589719991|FG001|Overall Study|Medical Reasons|0|||
163275898|NCT00146640|589719990|FG000|Overall Study|Non-Medical Reasons|8|||
163275899|NCT00146640|589719991|FG001|Overall Study|Non-Medical Reasons|4|||
163275900|NCT03486899|589719992|FG000|Overall Study|Lost to Follow-up|4|||
163275901|NCT03486899|589719993|FG001|Overall Study|Lost to Follow-up|1|||
163275902|NCT03486899|589719994|FG002|Overall Study|Lost to Follow-up|4|||
163275903|NCT03486899|589719995|FG003|Overall Study|Lost to Follow-up|3|||
163275904|NCT03486899|589719992|FG000|Overall Study|Death|1|||
163275905|NCT03486899|589719993|FG001|Overall Study|Death|0|||
163275906|NCT03486899|589719994|FG002|Overall Study|Death|0|||
163275907|NCT03486899|589719995|FG003|Overall Study|Death|1|||
163275908|NCT03486899|589719992|FG000|Overall Study|Adverse Event|0|||
163275909|NCT03486899|589719993|FG001|Overall Study|Adverse Event|2|||
163275910|NCT03486899|589719994|FG002|Overall Study|Adverse Event|0|||
163275911|NCT03486899|589719995|FG003|Overall Study|Adverse Event|2|||
163275912|NCT03486899|589719992|FG000|Overall Study|Withdrawal by Subject|3|||
163275913|NCT03486899|589719993|FG001|Overall Study|Withdrawal by Subject|7|||
163275914|NCT03486899|589719994|FG002|Overall Study|Withdrawal by Subject|4|||
163275915|NCT03486899|589719995|FG003|Overall Study|Withdrawal by Subject|3|||
163275916|NCT03486899|589719992|FG000|Overall Study|Other Reasons|0|||
163275917|NCT03486899|589719993|FG001|Overall Study|Other Reasons|1|||
163275918|NCT03486899|589719994|FG002|Overall Study|Other Reasons|0|||
163275919|NCT03486899|589719995|FG003|Overall Study|Other Reasons|1|||
163275920|NCT01439711|589719996|FG000|Overall Study|Ineligible|13|||
163275921|NCT01439711|589719996|FG000|Overall Study|Cancel|3|||
163275922|NCT01439711|589719996|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
163275923|NCT01439711|589719996|FG000|Overall Study|Adverse Event|5|||
163275924|NCT01439711|589719996|FG000|Overall Study|Withdrawal by Subject|3|||
163275925|NCT01439711|589719996|FG000|Overall Study|Progression During Active Tx|3|||
163275926|NCT01439711|589719996|FG000|Overall Study|Noncompliance|3|||
163275927|NCT01439711|589719996|FG000|Overall Study|No MRI|9|||
163275928|NCT04242875|589719997|FG000|Overall Study|Adverse Event|2|||
163275929|NCT02397460|589719998|FG000|Treatment Period 2|Adverse Event|0|||
163275930|NCT02397460|589719999|FG001|Treatment Period 2|Adverse Event|0|||
163275931|NCT02397460|589720000|FG002|Treatment Period 2|Adverse Event|0|||
163275932|NCT02397460|589720001|FG003|Treatment Period 2|Adverse Event|0|||
163275933|NCT02397460|589720002|FG004|Treatment Period 2|Adverse Event|0|||
163161824|NCT02963506|589305899|FG011|Dose-Blind Period|Adverse Event|1|||
163161825|NCT02963506|589305900|FG012|Dose-Blind Period|Adverse Event|6|||
163161826|NCT02963506|589305888|FG000|Dose-Blind Period|Lack of Efficacy|0|||
163275934|NCT02397460|589720003|FG005|Treatment Period 2|Adverse Event|0|||
163275935|NCT02397460|589720004|FG006|Treatment Period 2|Adverse Event|0|||
163275936|NCT02397460|589720005|FG007|Treatment Period 2|Adverse Event|1|||
163275937|NCT02397460|589719998|FG000|Treatment Period 4|Adverse Event|0|||
163387445|NCT00818389|590129917|FG000|Overall Study|ALS Disease Progression|1|||
163387446|NCT00818389|590129918|FG001|Overall Study|ALS Disease Progression|0|||
163387447|NCT00818389|590129917|FG000|Overall Study|Withdrawal by Subject|2|||
163387448|NCT00818389|590129918|FG001|Overall Study|Withdrawal by Subject|2|||
163387449|NCT00818389|590129917|FG000|Overall Study|Adverse Event|0|||
163387450|NCT00818389|590129918|FG001|Overall Study|Adverse Event|1|||
163387451|NCT05193500|590129921|FG000|Overall Study|Withdrawal by Subject|7|||
163387452|NCT05193500|590129922|FG001|Overall Study|Withdrawal by Subject|4|||
163387453|NCT05193500|590129923|FG002|Overall Study|Withdrawal by Subject|3|||
163387454|NCT05193500|590129924|FG003|Overall Study|Withdrawal by Subject|5|||
163387455|NCT03871829|590129925|FG000|Overall Study|Lost to Follow-up|0|||
163387456|NCT03871829|590129926|FG001|Overall Study|Lost to Follow-up|1|||
163387457|NCT03871829|590129925|FG000|Overall Study|Withdrawal by Subject|1|||
163387458|NCT03871829|590129926|FG001|Overall Study|Withdrawal by Subject|1|||
163387459|NCT03871829|590129925|FG000|Overall Study|Death|12|||
163387460|NCT03871829|590129926|FG001|Overall Study|Death|8|||
163387461|NCT03871829|590129925|FG000|Overall Study|Study terminated by sponsor|31|||
163387462|NCT03871829|590129926|FG001|Overall Study|Study terminated by sponsor|34|||
163387463|NCT02993523|590129927|FG000|Overall Study|Withdrew Consent|0|||
163387464|NCT02993523|590129928|FG001|Overall Study|Withdrew Consent|0|||
163387465|NCT02993523|590129929|FG002|Overall Study|Withdrew Consent|2|||
163387466|NCT02993523|590129930|FG003|Overall Study|Withdrew Consent|9|||
163387467|NCT02993523|590129931|FG004|Overall Study|Withdrew Consent|0|||
163161827|NCT02963506|589305889|FG001|Dose-Blind Period|Lack of Efficacy|0|||
163161828|NCT02963506|589305890|FG002|Dose-Blind Period|Lack of Efficacy|0|||
163161829|NCT02963506|589305891|FG003|Dose-Blind Period|Lack of Efficacy|0|||
163161830|NCT02963506|589305892|FG004|Dose-Blind Period|Lack of Efficacy|0|||
163161831|NCT02963506|589305893|FG005|Dose-Blind Period|Lack of Efficacy|0|||
163161832|NCT02963506|589305894|FG006|Dose-Blind Period|Lack of Efficacy|0|||
163161833|NCT02963506|589305895|FG007|Dose-Blind Period|Lack of Efficacy|1|||
163275938|NCT02397460|589719999|FG001|Treatment Period 4|Adverse Event|1|||
163275939|NCT02397460|589720000|FG002|Treatment Period 4|Adverse Event|0|||
163275940|NCT02397460|589720001|FG003|Treatment Period 4|Adverse Event|0|||
163275941|NCT02397460|589720002|FG004|Treatment Period 4|Adverse Event|0|||
163275942|NCT02397460|589720003|FG005|Treatment Period 4|Adverse Event|0|||
163275943|NCT02397460|589720004|FG006|Treatment Period 4|Adverse Event|0|||
163275944|NCT02397460|589720005|FG007|Treatment Period 4|Adverse Event|0|||
163275945|NCT02397460|589719998|FG000|Treatment Period 4|Physician Decision|0|||
163275946|NCT02397460|589719999|FG001|Treatment Period 4|Physician Decision|0|||
163275947|NCT02397460|589720000|FG002|Treatment Period 4|Physician Decision|0|||
163275948|NCT02397460|589720001|FG003|Treatment Period 4|Physician Decision|0|||
163275949|NCT02397460|589720002|FG004|Treatment Period 4|Physician Decision|1|||
163275950|NCT02397460|589720003|FG005|Treatment Period 4|Physician Decision|0|||
163275951|NCT02397460|589720004|FG006|Treatment Period 4|Physician Decision|0|||
163275952|NCT02397460|589720005|FG007|Treatment Period 4|Physician Decision|0|||
163275953|NCT01723826|589720009|FG000|Overall Study|Adverse Event|4|||
163275954|NCT01723826|589720010|FG001|Overall Study|Adverse Event|1|||
163275955|NCT01723826|589720011|FG002|Overall Study|Adverse Event|4|||
163275956|NCT01723826|589720012|FG003|Overall Study|Adverse Event|5|||
163275957|NCT01723826|589720009|FG000|Overall Study|Death according to AE eCRF|2|||
163275958|NCT01723826|589720010|FG001|Overall Study|Death according to AE eCRF|3|||
163275959|NCT01723826|589720011|FG002|Overall Study|Death according to AE eCRF|3|||
163275960|NCT01723826|589720012|FG003|Overall Study|Death according to AE eCRF|7|||
163275961|NCT01723826|589720009|FG000|Overall Study|Lost to Follow-up|1|||
163275962|NCT01723826|589720010|FG001|Overall Study|Lost to Follow-up|3|||
163275963|NCT01723826|589720011|FG002|Overall Study|Lost to Follow-up|1|||
163275964|NCT01723826|589720012|FG003|Overall Study|Lost to Follow-up|1|||
163275965|NCT01723826|589720009|FG000|Overall Study|Non-compliance|0|||
163275966|NCT01723826|589720010|FG001|Overall Study|Non-compliance|1|||
163275967|NCT01723826|589720011|FG002|Overall Study|Non-compliance|3|||
163275968|NCT01723826|589720012|FG003|Overall Study|Non-compliance|3|||
163275969|NCT01723826|589720009|FG000|Overall Study|Non-compliance With Study Drug|0|||
163275970|NCT01723826|589720010|FG001|Overall Study|Non-compliance With Study Drug|1|||
163275971|NCT01723826|589720011|FG002|Overall Study|Non-compliance With Study Drug|0|||
163275972|NCT01723826|589720012|FG003|Overall Study|Non-compliance With Study Drug|0|||
163275973|NCT01723826|589720009|FG000|Overall Study|Other Reason|8|||
163275974|NCT01723826|589720010|FG001|Overall Study|Other Reason|6|||
163275975|NCT01723826|589720011|FG002|Overall Study|Other Reason|12|||
163275976|NCT01723826|589720012|FG003|Overall Study|Other Reason|14|||
163275977|NCT01723826|589720009|FG000|Overall Study|Physician Decision|1|||
163275978|NCT01723826|589720010|FG001|Overall Study|Physician Decision|3|||
163275979|NCT01723826|589720011|FG002|Overall Study|Physician Decision|4|||
163275980|NCT01723826|589720012|FG003|Overall Study|Physician Decision|11|||
163275981|NCT01723826|589720009|FG000|Overall Study|Protocol Violation|1|||
163275982|NCT01723826|589720010|FG001|Overall Study|Protocol Violation|1|||
163275983|NCT01723826|589720011|FG002|Overall Study|Protocol Violation|3|||
163275984|NCT01723826|589720012|FG003|Overall Study|Protocol Violation|1|||
163275985|NCT01723826|589720009|FG000|Overall Study|Withdrawal by Subject|10|||
163275986|NCT01723826|589720010|FG001|Overall Study|Withdrawal by Subject|17|||
163275987|NCT01723826|589720011|FG002|Overall Study|Withdrawal by Subject|27|||
163275988|NCT01723826|589720012|FG003|Overall Study|Withdrawal by Subject|48|||
163275989|NCT01767129|589720013|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
163275990|NCT01767129|589720014|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
163275991|NCT01473420|589720018|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
163275992|NCT01473420|589720019|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
163275993|NCT01473420|589720018|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
163275994|NCT01473420|589720019|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
163275995|NCT01473420|589720018|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
163275996|NCT01473420|589720019|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
163275997|NCT01473420|589720018|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
163275998|NCT01473420|589720019|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
163275999|NCT01473420|589720018|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
163276000|NCT01473420|589720019|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
163276001|NCT01473420|589720018|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
163276002|NCT01473420|589720019|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
163276003|NCT01473420|589720018|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
163276004|NCT01473420|589720019|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
163276005|NCT01473420|589720018|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
163276006|NCT01473420|589720019|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
163276007|NCT01473420|589720018|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
163276008|NCT01473420|589720019|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
163276009|NCT01473420|589720018|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
163276010|NCT01473420|589720019|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
163276011|NCT01473420|589720018|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
163276012|NCT01473420|589720019|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
163161834|NCT02963506|589305896|FG008|Dose-Blind Period|Lack of Efficacy|0|||
163161835|NCT02963506|589305897|FG009|Dose-Blind Period|Lack of Efficacy|1|||
163161836|NCT02963506|589305898|FG010|Dose-Blind Period|Lack of Efficacy|0|||
163161837|NCT02963506|589305899|FG011|Dose-Blind Period|Lack of Efficacy|0|||
163161838|NCT02963506|589305900|FG012|Dose-Blind Period|Lack of Efficacy|0|||
163161839|NCT02963506|589305888|FG000|Dose-Blind Period|Lost to Follow-up|0|||
163161840|NCT02963506|589305889|FG001|Dose-Blind Period|Lost to Follow-up|0|||
163161841|NCT02963506|589305890|FG002|Dose-Blind Period|Lost to Follow-up|0|||
163161842|NCT02963506|589305891|FG003|Dose-Blind Period|Lost to Follow-up|0|||
163161843|NCT02963506|589305892|FG004|Dose-Blind Period|Lost to Follow-up|0|||
163161844|NCT02963506|589305893|FG005|Dose-Blind Period|Lost to Follow-up|1|||
163161845|NCT02963506|589305894|FG006|Dose-Blind Period|Lost to Follow-up|0|||
163161846|NCT02963506|589305895|FG007|Dose-Blind Period|Lost to Follow-up|0|||
163161847|NCT02963506|589305896|FG008|Dose-Blind Period|Lost to Follow-up|1|||
163161848|NCT02963506|589305897|FG009|Dose-Blind Period|Lost to Follow-up|0|||
163161849|NCT02963506|589305898|FG010|Dose-Blind Period|Lost to Follow-up|0|||
163161850|NCT02963506|589305899|FG011|Dose-Blind Period|Lost to Follow-up|1|||
163161851|NCT02963506|589305900|FG012|Dose-Blind Period|Lost to Follow-up|0|||
163161852|NCT02963506|589305888|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
163276013|NCT01473420|589720018|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
163276014|NCT01473420|589720019|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
163276015|NCT01473420|589720018|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
163276016|NCT01473420|589720019|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
163276017|NCT02906202|589720026|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
163276018|NCT03990363|589720028|FG000|Overall Study|Withdrawal by Subject|10|||
163276019|NCT03990363|589720029|FG001|Overall Study|Withdrawal by Subject|9|||
163276020|NCT03990363|589720030|FG002|Overall Study|Withdrawal by Subject|18|||
163276021|NCT03990363|589720031|FG003|Overall Study|Withdrawal by Subject|11|||
163276022|NCT03990363|589720032|FG004|Overall Study|Withdrawal by Subject|9|||
163276023|NCT03990363|589720028|FG000|Overall Study|Physician Decision|1|||
163276024|NCT03990363|589720029|FG001|Overall Study|Physician Decision|0|||
163276025|NCT03990363|589720030|FG002|Overall Study|Physician Decision|0|||
163276026|NCT03990363|589720031|FG003|Overall Study|Physician Decision|0|||
163276027|NCT03990363|589720032|FG004|Overall Study|Physician Decision|0|||
163276028|NCT03990363|589720028|FG000|Overall Study|Adverse Event|1|||
163276029|NCT03990363|589720029|FG001|Overall Study|Adverse Event|3|||
163276030|NCT03990363|589720030|FG002|Overall Study|Adverse Event|2|||
163276031|NCT03990363|589720031|FG003|Overall Study|Adverse Event|2|||
163276032|NCT03990363|589720032|FG004|Overall Study|Adverse Event|0|||
163276033|NCT03990363|589720028|FG000|Overall Study|Death|14|||
163276034|NCT03990363|589720029|FG001|Overall Study|Death|8|||
163276035|NCT03990363|589720030|FG002|Overall Study|Death|14|||
163276036|NCT03990363|589720031|FG003|Overall Study|Death|10|||
163276037|NCT03990363|589720032|FG004|Overall Study|Death|11|||
163276038|NCT03990363|589720028|FG000|Overall Study|Failure to meet randomization criteria|0|||
163276039|NCT03990363|589720029|FG001|Overall Study|Failure to meet randomization criteria|1|||
163276040|NCT03990363|589720030|FG002|Overall Study|Failure to meet randomization criteria|1|||
163276041|NCT03990363|589720031|FG003|Overall Study|Failure to meet randomization criteria|0|||
163276042|NCT03990363|589720032|FG004|Overall Study|Failure to meet randomization criteria|0|||
163276043|NCT03990363|589720028|FG000|Overall Study|Lost to Follow-up|0|||
163276044|NCT03990363|589720029|FG001|Overall Study|Lost to Follow-up|0|||
163276045|NCT03990363|589720030|FG002|Overall Study|Lost to Follow-up|0|||
163276046|NCT03990363|589720031|FG003|Overall Study|Lost to Follow-up|1|||
163276047|NCT03990363|589720032|FG004|Overall Study|Lost to Follow-up|2|||
163276048|NCT03990363|589720028|FG000|Overall Study|Non-compliance with study drug|2|||
163276049|NCT03990363|589720029|FG001|Overall Study|Non-compliance with study drug|1|||
163276050|NCT03990363|589720030|FG002|Overall Study|Non-compliance with study drug|2|||
163276051|NCT03990363|589720031|FG003|Overall Study|Non-compliance with study drug|0|||
163276052|NCT03990363|589720032|FG004|Overall Study|Non-compliance with study drug|0|||
163276053|NCT03990363|589720028|FG000|Overall Study|Study terminated by sponsor|0|||
163276054|NCT03990363|589720029|FG001|Overall Study|Study terminated by sponsor|1|||
163276055|NCT03990363|589720030|FG002|Overall Study|Study terminated by sponsor|0|||
163276056|NCT03990363|589720031|FG003|Overall Study|Study terminated by sponsor|0|||
163276057|NCT03990363|589720032|FG004|Overall Study|Study terminated by sponsor|0|||
163276058|NCT03990363|589720028|FG000|Overall Study|Site terminated by sponsor|2|||
163276059|NCT03990363|589720029|FG001|Overall Study|Site terminated by sponsor|1|||
163276060|NCT03990363|589720030|FG002|Overall Study|Site terminated by sponsor|2|||
163276061|NCT03990363|589720031|FG003|Overall Study|Site terminated by sponsor|0|||
163276062|NCT03990363|589720032|FG004|Overall Study|Site terminated by sponsor|2|||
163276063|NCT03990363|589720028|FG000|Overall Study|Not categorized|5|||
163276064|NCT03990363|589720029|FG001|Overall Study|Not categorized|5|||
163276065|NCT03990363|589720030|FG002|Overall Study|Not categorized|3|||
163276066|NCT03990363|589720031|FG003|Overall Study|Not categorized|2|||
163276067|NCT03990363|589720032|FG004|Overall Study|Not categorized|2|||
163276068|NCT01563978|589720038|FG000|Overall Study|Physician Decision|1|||
163276069|NCT01563978|589720039|FG001|Overall Study|Physician Decision|0|||
163276070|NCT01563978|589720038|FG000|Overall Study|Lost to Follow-up|1|||
163276071|NCT01563978|589720039|FG001|Overall Study|Lost to Follow-up|0|||
163276072|NCT01563978|589720038|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
163276073|NCT01563978|589720039|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
163276074|NCT01563978|589720038|FG000|Overall Study|Adverse Event|1|||
163276075|NCT01563978|589720039|FG001|Overall Study|Adverse Event|2|||
163276076|NCT04630756|589720040|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
163276077|NCT04630756|589720041|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
163276078|NCT04630756|589720042|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
163276079|NCT01824472|589720046|FG000|Overall Study|Lost to Follow-up|0|||
163276080|NCT01824472|589720047|FG001|Overall Study|Lost to Follow-up|0|||
163276081|NCT01824472|589720048|FG002|Overall Study|Lost to Follow-up|1|||
163276082|NCT01824472|589720046|FG000|Overall Study|Withdrawal by Subject|1|||
163276083|NCT01824472|589720047|FG001|Overall Study|Withdrawal by Subject|5|||
163276084|NCT01824472|589720048|FG002|Overall Study|Withdrawal by Subject|3|||
163276085|NCT01824472|589720046|FG000|Overall Study|Ineligible post randomization&screening|0|||
163276086|NCT01824472|589720047|FG001|Overall Study|Ineligible post randomization&screening|2|||
163276087|NCT01824472|589720048|FG002|Overall Study|Ineligible post randomization&screening|0|||
163161853|NCT02963506|589305889|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
163161854|NCT02963506|589305890|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
163161855|NCT02963506|589305891|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
163161856|NCT02963506|589305892|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
163161857|NCT02963506|589305893|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
163161858|NCT02963506|589305894|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
163161859|NCT02963506|589305895|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
163161860|NCT02963506|589305896|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
163161861|NCT02963506|589305897|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
163161862|NCT02963506|589305898|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
163161863|NCT02963506|589305899|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
163161864|NCT02963506|589305900|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
163161865|NCT02963506|589305888|FG000|Dose-Blind Period|Sponsor decision|0|||
163161866|NCT02963506|589305889|FG001|Dose-Blind Period|Sponsor decision|0|||
163161867|NCT02963506|589305890|FG002|Dose-Blind Period|Sponsor decision|0|||
163161868|NCT02963506|589305891|FG003|Dose-Blind Period|Sponsor decision|0|||
163161869|NCT02963506|589305892|FG004|Dose-Blind Period|Sponsor decision|0|||
163161870|NCT02963506|589305893|FG005|Dose-Blind Period|Sponsor decision|1|||
163161871|NCT02963506|589305894|FG006|Dose-Blind Period|Sponsor decision|0|||
163161872|NCT02963506|589305895|FG007|Dose-Blind Period|Sponsor decision|0|||
163161873|NCT02963506|589305896|FG008|Dose-Blind Period|Sponsor decision|0|||
163161874|NCT02963506|589305897|FG009|Dose-Blind Period|Sponsor decision|0|||
163161875|NCT02963506|589305898|FG010|Dose-Blind Period|Sponsor decision|0|||
163161876|NCT02963506|589305899|FG011|Dose-Blind Period|Sponsor decision|0|||
163161877|NCT02963506|589305900|FG012|Dose-Blind Period|Sponsor decision|0|||
163161878|NCT02963506|589305888|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161879|NCT02963506|589305889|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161880|NCT02963506|589305890|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161881|NCT02963506|589305891|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161882|NCT02963506|589305892|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161883|NCT02963506|589305893|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161884|NCT02963506|589305894|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161885|NCT02963506|589305895|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161886|NCT02963506|589305896|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163276088|NCT01815736|589720049|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
163276089|NCT01815736|589720050|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
163276090|NCT01815736|589720049|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
163276091|NCT01815736|589720050|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
163276092|NCT01815736|589720049|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
163276093|NCT01815736|589720050|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
163276094|NCT01815736|589720049|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
163276095|NCT01815736|589720050|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
163276096|NCT01815736|589720049|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
163276097|NCT01815736|589720050|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
163276098|NCT01815736|589720049|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
163276099|NCT01815736|589720050|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
163276100|NCT01815736|589720049|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
163276101|NCT01815736|589720050|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
163276102|NCT01815736|589720049|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
163276103|NCT01815736|589720050|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
163276104|NCT01815736|589720049|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
163276105|NCT01815736|589720050|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
163276106|NCT01815736|589720049|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
163276107|NCT01815736|589720050|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
163276108|NCT01815736|589720049|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
163276109|NCT01815736|589720050|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
163276110|NCT01815736|589720049|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
163276111|NCT01815736|589720050|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
163276112|NCT01815736|589720049|FG000|Extension Treatment Phase- After Week 96|Death|1|||
163276113|NCT01815736|589720050|FG001|Extension Treatment Phase- After Week 96|Death|0|||
163276114|NCT03387514|589720053|FG000|Overall Study|Withdrawal by Subject|2|||
163276115|NCT03387514|589720053|FG000|Overall Study|Physician Decision|1|||
163276116|NCT03387514|589720053|FG000|Overall Study|Lost to Follow-up|2|||
163276117|NCT03040687|589720054|FG000|Overall Study|Withdrawal by Subject|1|||
163276118|NCT03040687|589720055|FG001|Overall Study|Withdrawal by Subject|0|||
163276119|NCT03040687|589720056|FG002|Overall Study|Withdrawal by Subject|0|||
163276120|NCT02846558|589720057|FG000|Overall Study|Adverse Event|1|||
163276121|NCT02846558|589720058|FG001|Overall Study|Adverse Event|0|||
163276122|NCT02846558|589720059|FG002|Overall Study|Adverse Event|0|||
163276123|NCT02846558|589720060|FG003|Overall Study|Adverse Event|0|||
163161887|NCT02963506|589305897|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161888|NCT02963506|589305898|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161889|NCT02963506|589305899|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161890|NCT02963506|589305900|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
163161891|NCT01724346|589305901|FG000|Overall Study|Death|42|||
163161892|NCT01724346|589305902|FG001|Overall Study|Death|42|||
163161893|NCT01724346|589305901|FG000|Overall Study|Lost to Follow-up|5|||
163161894|NCT01724346|589305902|FG001|Overall Study|Lost to Follow-up|1|||
163161895|NCT01724346|589305901|FG000|Overall Study|Withdrawal by Subject|27|||
163161896|NCT01724346|589305902|FG001|Overall Study|Withdrawal by Subject|19|||
163161897|NCT01724346|589305901|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
163161898|NCT01724346|589305902|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
163161899|NCT00536744|589305905|FG000|Overall Study|Adverse Event|13|||
163161900|NCT00536744|589305906|FG001|Overall Study|Adverse Event|10|||
163161901|NCT00536744|589305905|FG000|Overall Study|Death|2|||
163161902|NCT00536744|589305906|FG001|Overall Study|Death|1|||
163161903|NCT00536744|589305905|FG000|Overall Study|Physician Decision|3|||
163161904|NCT00536744|589305906|FG001|Overall Study|Physician Decision|1|||
163161905|NCT00536744|589305905|FG000|Overall Study|Lost to Follow-up|3|||
163161906|NCT00536744|589305906|FG001|Overall Study|Lost to Follow-up|5|||
163161907|NCT00536744|589305905|FG000|Overall Study|Withdrawal by Subject|7|||
163161908|NCT00536744|589305906|FG001|Overall Study|Withdrawal by Subject|8|||
163161909|NCT00536744|589305905|FG000|Overall Study|PI tried alternative treatment|1|||
163161910|NCT00536744|589305906|FG001|Overall Study|PI tried alternative treatment|3|||
163161911|NCT00787644|589305907|FG000|Overall Study|Lost to Follow-up|1|||
163161912|NCT00787644|589305908|FG001|Overall Study|Lost to Follow-up|1|||
163161913|NCT00787644|589305907|FG000|Overall Study|Withdrawal by Subject|1|||
163161914|NCT00787644|589305908|FG001|Overall Study|Withdrawal by Subject|1|||
163161915|NCT01642589|589305912|FG000|Overall Study|Withdrawal by Subject|1|||
163276124|NCT02846558|589720057|FG000|Overall Study|Withdrawal by Subject|5|||
163161916|NCT01642589|589305913|FG001|Overall Study|Withdrawal by Subject|1|||
163161917|NCT01108185|589305914|FG000|Overall Study|Non-compliance|15|||
163161918|NCT01108185|589305914|FG000|Overall Study|Lost to Follow-up|12|||
163276125|NCT02846558|589720058|FG001|Overall Study|Withdrawal by Subject|4|||
163161919|NCT02581410|589305919|FG000|Vaccination Phase|Adverse Event|2|||
163161920|NCT02581410|589305920|FG001|Vaccination Phase|Adverse Event|1|||
163161921|NCT02581410|589305919|FG000|Vaccination Phase|Withdrawal by Subject|0|||
163161922|NCT02581410|589305920|FG001|Vaccination Phase|Withdrawal by Subject|1|||
163161923|NCT02581410|589305919|FG000|Vaccination Phase|Migrated/moved from study area|0|||
163276126|NCT02846558|589720059|FG002|Overall Study|Withdrawal by Subject|2|||
163276127|NCT02846558|589720060|FG003|Overall Study|Withdrawal by Subject|2|||
163276128|NCT02846558|589720057|FG000|Overall Study|Lost to Follow-up|2|||
163276129|NCT02846558|589720058|FG001|Overall Study|Lost to Follow-up|0|||
163276130|NCT02846558|589720059|FG002|Overall Study|Lost to Follow-up|0|||
163276131|NCT02846558|589720060|FG003|Overall Study|Lost to Follow-up|0|||
163276132|NCT01556243|589720064|FG000|Overall Study|Ineligible|34|||
163276133|NCT01556243|589720064|FG000|Overall Study|Converted to mastectomy|14|||
163276134|NCT01556243|589720064|FG000|Overall Study|Unable to achieve negative margins|2|||
163276135|NCT01556243|589720064|FG000|Overall Study|Withdrawal by Subject|16|||
163276136|NCT04684914|589720065|FG000|Overall Study|Withdrawal by Subject|1|||
163276137|NCT04684914|589720066|FG001|Overall Study|Withdrawal by Subject|0|||
163276138|NCT04684914|589720065|FG000|Overall Study|Discontinued before receiving study treatment|1|||
163276139|NCT04684914|589720066|FG001|Overall Study|Discontinued before receiving study treatment|2|||
163276140|NCT02353832|589720067|FG000|Overall Study|Ineligible after enrollment|1|||
163276141|NCT02353832|589720067|FG000|Overall Study|Lost to Follow-up|1|||
163276142|NCT00394095|589721572|FG000|Screening|Withdrawal by Subject|1|||
163276143|NCT00394095|589721573|FG001|Screening|Withdrawal by Subject|0|||
163276144|NCT00394095|589721572|FG000|Randomized|Withdrawal by Subject|5|||
163276145|NCT00394095|589721573|FG001|Randomized|Withdrawal by Subject|1|||
163276146|NCT00394095|589721572|FG000|Randomized|Adverse Event|1|||
163276147|NCT00394095|589721573|FG001|Randomized|Adverse Event|1|||
163276148|NCT00394095|589721572|FG000|Randomized|Overdose|1|||
163276149|NCT00394095|589721573|FG001|Randomized|Overdose|0|||
163276150|NCT00394095|589721572|FG000|Randomized|Lost to Follow-up|1|||
163276151|NCT00394095|589721573|FG001|Randomized|Lost to Follow-up|2|||
163276152|NCT04213846|589721574|FG000|Overall Study|Withdrawal by Subject|7|||
163276153|NCT04213846|589721575|FG001|Overall Study|Withdrawal by Subject|6|||
163276154|NCT04213846|589721574|FG000|Overall Study|Lost to Follow-up|15|||
163276155|NCT04213846|589721575|FG001|Overall Study|Lost to Follow-up|21|||
163276156|NCT04096365|589721594|FG000|Overall Study|Adverse Event|1|||
163276157|NCT02401529|589721597|FG000|Overall Study|Lost to Follow-up|2|||
163276158|NCT02401529|589721598|FG001|Overall Study|Lost to Follow-up|1|||
163276159|NCT02401529|589721597|FG000|Overall Study|Physician Decision|2|||
163276160|NCT02401529|589721598|FG001|Overall Study|Physician Decision|6|||
163276161|NCT02401529|589721597|FG000|Overall Study|Protocol Violation|5|||
163276162|NCT02401529|589721598|FG001|Overall Study|Protocol Violation|0|||
163276163|NCT01939158|589721601|FG000|Overall Study|Adverse Event|1|||
163276164|NCT01939158|589721602|FG001|Overall Study|Adverse Event|0|||
163276165|NCT01939158|589721603|FG002|Overall Study|Adverse Event|0|||
163276166|NCT01939158|589721604|FG003|Overall Study|Adverse Event|0|||
163276167|NCT01939158|589721601|FG000|Overall Study|Withdrawal by Subject|22|||
163276168|NCT01939158|589721602|FG001|Overall Study|Withdrawal by Subject|25|||
163276169|NCT01939158|589721603|FG002|Overall Study|Withdrawal by Subject|15|||
163276170|NCT01939158|589721604|FG003|Overall Study|Withdrawal by Subject|17|||
163276171|NCT01939158|589721601|FG000|Overall Study|Migrated/moved from study area|5|||
163276172|NCT01939158|589721602|FG001|Overall Study|Migrated/moved from study area|7|||
163276173|NCT01939158|589721603|FG002|Overall Study|Migrated/moved from study area|3|||
163276174|NCT01939158|589721604|FG003|Overall Study|Migrated/moved from study area|6|||
163276175|NCT01939158|589721601|FG000|Overall Study|Lost to Follow-up|18|||
163276176|NCT01939158|589721602|FG001|Overall Study|Lost to Follow-up|17|||
163276177|NCT01939158|589721603|FG002|Overall Study|Lost to Follow-up|17|||
163276178|NCT01939158|589721604|FG003|Overall Study|Lost to Follow-up|17|||
163276179|NCT01939158|589721601|FG000|Overall Study|Death|0|||
163276180|NCT01939158|589721602|FG001|Overall Study|Death|0|||
163276181|NCT01939158|589721603|FG002|Overall Study|Death|1|||
163276182|NCT01939158|589721604|FG003|Overall Study|Death|1|||
163276183|NCT01939158|589721601|FG000|Overall Study|No longer meets eligibility criteria|0|||
163276184|NCT01939158|589721602|FG001|Overall Study|No longer meets eligibility criteria|0|||
163276185|NCT01939158|589721603|FG002|Overall Study|No longer meets eligibility criteria|1|||
163161924|NCT02581410|589305920|FG001|Vaccination Phase|Migrated/moved from study area|1|||
163161925|NCT02581410|589305919|FG000|End of Study Phase|Adverse Event|4|||
163161926|NCT02581410|589305920|FG001|End of Study Phase|Adverse Event|3|||
163161927|NCT02581410|589305919|FG000|End of Study Phase|Withdrawal by Subject|1|||
163161928|NCT02581410|589305920|FG001|End of Study Phase|Withdrawal by Subject|2|||
163161929|NCT02581410|589305919|FG000|End of Study Phase|Migrated/moved from study area|0|||
163161930|NCT02581410|589305920|FG001|End of Study Phase|Migrated/moved from study area|3|||
163161931|NCT02581410|589305919|FG000|End of Study Phase|Lost to Follow-up|0|||
163161932|NCT02581410|589305920|FG001|End of Study Phase|Lost to Follow-up|2|||
163161933|NCT02581410|589305919|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
163161934|NCT02581410|589305920|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
163161935|NCT00670748|589305924|FG000|Overall Study|Death during treatment|1|||
163161936|NCT00670748|589305925|FG001|Overall Study|Death during treatment|1|||
163161937|NCT00670748|589305926|FG002|Overall Study|Death during treatment|1|||
163161938|NCT00670748|589305927|FG003|Overall Study|Death during treatment|0|||
163161939|NCT00670748|589305924|FG000|Overall Study|Not off study|2|||
163161940|NCT00670748|589305925|FG001|Overall Study|Not off study|1|||
163161941|NCT00670748|589305926|FG002|Overall Study|Not off study|1|||
163161942|NCT00670748|589305927|FG003|Overall Study|Not off study|1|||
163161943|NCT02736578|589305930|FG000|Overall Study|Adverse Event|1|||
163161944|NCT02736578|589305931|FG001|Overall Study|Adverse Event|0|||
163161945|NCT05615922|589305934|FG000|Overall Study|Lost to Follow-up|1|||
163161946|NCT04774094|589305940|FG000|Overall Study|Other|2|||
163161947|NCT04774094|589305940|FG000|Overall Study|Withdrawal by Subject|9|||
163161948|NCT04774094|589305940|FG000|Overall Study|Lost to Follow-up|7|||
163161949|NCT04774094|589305940|FG000|Overall Study|Lack of Efficacy|5|||
163161950|NCT04774094|589305940|FG000|Overall Study|Death|17|||
163161951|NCT04774094|589305940|FG000|Overall Study|Adverse Event|4|||
163161952|NCT02374450|589305941|FG000|Overall Study|Protocol Violation|0|||
163161953|NCT02374450|589305942|FG001|Overall Study|Protocol Violation|1|||
163161954|NCT02374450|589305943|FG002|Overall Study|Protocol Violation|0|||
163161955|NCT02374450|589305941|FG000|Overall Study|Withdrawal by Subject|91|||
163161956|NCT02374450|589305942|FG001|Overall Study|Withdrawal by Subject|110|||
163161957|NCT02374450|589305943|FG002|Overall Study|Withdrawal by Subject|4|||
163161958|NCT02374450|589305941|FG000|Overall Study|Lost to Follow-up|168|||
163161959|NCT02374450|589305942|FG001|Overall Study|Lost to Follow-up|194|||
163161960|NCT02374450|589305943|FG002|Overall Study|Lost to Follow-up|138|||
163161961|NCT02374450|589305941|FG000|Overall Study|Death|173|||
163161962|NCT02374450|589305942|FG001|Overall Study|Death|185|||
163161963|NCT02374450|589305943|FG002|Overall Study|Death|81|||
163161964|NCT02374450|589305941|FG000|Overall Study|Migrated from the study area|538|||
163161965|NCT02374450|589305942|FG001|Overall Study|Migrated from the study area|648|||
163161966|NCT02374450|589305943|FG002|Overall Study|Migrated from the study area|181|||
163161967|NCT02374450|589305941|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
163161968|NCT02374450|589305942|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
163161969|NCT02374450|589305943|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
163161970|NCT02374450|589305941|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
163161971|NCT02374450|589305942|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
163161972|NCT02374450|589305943|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
163161973|NCT02374450|589305941|FG000|Overall Study|Other|0|||
163161974|NCT02374450|589305942|FG001|Overall Study|Other|21|||
163161975|NCT02374450|589305943|FG002|Overall Study|Other|79|||
163161976|NCT01006291|589307420|FG000|Overall Study|Adverse Event|2|||
163161977|NCT01006291|589307421|FG001|Overall Study|Adverse Event|1|||
163161978|NCT01006291|589307422|FG002|Overall Study|Adverse Event|2|||
163161979|NCT01006291|589307420|FG000|Overall Study|Lack of Efficacy|2|||
163161980|NCT01006291|589307421|FG001|Overall Study|Lack of Efficacy|2|||
163161981|NCT01006291|589307422|FG002|Overall Study|Lack of Efficacy|1|||
163161982|NCT01006291|589307420|FG000|Overall Study|Protocol Violation|3|||
163161983|NCT01006291|589307421|FG001|Overall Study|Protocol Violation|3|||
163161984|NCT01006291|589307422|FG002|Overall Study|Protocol Violation|3|||
163161985|NCT01006291|589307420|FG000|Overall Study|Withdrawal criteria|5|||
163161986|NCT01006291|589307421|FG001|Overall Study|Withdrawal criteria|4|||
163276186|NCT01939158|589721604|FG003|Overall Study|No longer meets eligibility criteria|0|||
163276187|NCT01939158|589721601|FG000|Overall Study|Other|1|||
163276188|NCT01939158|589721602|FG001|Overall Study|Other|3|||
163276189|NCT01939158|589721603|FG002|Overall Study|Other|4|||
163276190|NCT01939158|589721604|FG003|Overall Study|Other|3|||
163161987|NCT01006291|589307422|FG002|Overall Study|Withdrawal criteria|4|||
163161988|NCT01006291|589307420|FG000|Overall Study|Other|14|||
163161989|NCT01006291|589307421|FG001|Overall Study|Other|14|||
163161990|NCT01006291|589307422|FG002|Overall Study|Other|17|||
163161991|NCT01677377|589307423|FG000|Overall Study|Protocol Violation|1|||
163161992|NCT01677377|589307424|FG001|Overall Study|Protocol Violation|0|||
163161993|NCT01677377|589307425|FG002|Overall Study|Protocol Violation|0|||
163161994|NCT01677377|589307423|FG000|Overall Study|Lost to Follow-up|0|||
163161995|NCT01677377|589307424|FG001|Overall Study|Lost to Follow-up|1|||
163276191|NCT05310084|589721605|FG000|Overall Study|Withdrawal by Subject|2|||
163161996|NCT01677377|589307425|FG002|Overall Study|Lost to Follow-up|1|||
163161997|NCT01677377|589307423|FG000|Overall Study|Withdrawal by Subject|0|||
163161998|NCT01677377|589307424|FG001|Overall Study|Withdrawal by Subject|0|||
163161999|NCT01677377|589307425|FG002|Overall Study|Withdrawal by Subject|3|||
163162000|NCT01677377|589307423|FG000|Overall Study|Lack of Efficacy|0|||
163162001|NCT01677377|589307424|FG001|Overall Study|Lack of Efficacy|0|||
163162002|NCT01677377|589307425|FG002|Overall Study|Lack of Efficacy|1|||
163162003|NCT01677377|589307423|FG000|Overall Study|Pregnancy|0|||
163162004|NCT01677377|589307424|FG001|Overall Study|Pregnancy|0|||
163162005|NCT01677377|589307425|FG002|Overall Study|Pregnancy|1|||
163162006|NCT02260180|589307426|FG000|Overall Study|Adverse Event|2|||
163162007|NCT02260180|589307427|FG001|Overall Study|Adverse Event|0|||
163162008|NCT02260180|589307428|FG002|Overall Study|Adverse Event|1|||
163162009|NCT00943072|589307431|FG000|Overall Study|Adverse Event|0|||
163162010|NCT00943072|589307432|FG001|Overall Study|Adverse Event|3|||
163162011|NCT00943072|589307431|FG000|Overall Study|Death|0|||
163162012|NCT00943072|589307432|FG001|Overall Study|Death|2|||
163162013|NCT00943072|589307431|FG000|Overall Study|Withdrawal by Subject|3|||
163162014|NCT00943072|589307432|FG001|Overall Study|Withdrawal by Subject|1|||
163162015|NCT00943072|589307431|FG000|Overall Study|Protocol Violation|0|||
163162016|NCT00943072|589307432|FG001|Overall Study|Protocol Violation|1|||
163162017|NCT00943072|589307431|FG000|Overall Study|Lost to Follow-up|1|||
163162018|NCT00943072|589307432|FG001|Overall Study|Lost to Follow-up|2|||
163162019|NCT00943072|589307431|FG000|Overall Study|Lack of Efficacy|0|||
163162020|NCT00943072|589307432|FG001|Overall Study|Lack of Efficacy|4|||
163162021|NCT00943072|589307431|FG000|Overall Study|Other|1|||
163162022|NCT00943072|589307432|FG001|Overall Study|Other|1|||
163162023|NCT01193257|589307433|FG000|Overall Study|Death|202|||
163162024|NCT01193257|589307434|FG001|Overall Study|Death|391|||
163162025|NCT01193257|589307433|FG000|Overall Study|Study termination by sponsor|0|||
163162026|NCT01193257|589307434|FG001|Overall Study|Study termination by sponsor|3|||
163162027|NCT01193257|589307433|FG000|Overall Study|Withdrawal by Subject|26|||
163162028|NCT01193257|589307434|FG001|Overall Study|Withdrawal by Subject|86|||
163162029|NCT01193257|589307433|FG000|Overall Study|Lost to Follow-up|2|||
163162030|NCT01193257|589307434|FG001|Overall Study|Lost to Follow-up|3|||
163162031|NCT01193257|589307433|FG000|Overall Study|Unblinded due to futility|135|||
163162032|NCT01193257|589307434|FG001|Overall Study|Unblinded due to futility|251|||
163162033|NCT01330108|589307443|FG000|Overall Study|Withdrawal by Subject|4|||
163162034|NCT00423917|589307446|FG000|Overall Study|Cancel|2|||
163162035|NCT00423917|589307446|FG000|Overall Study|Ineligible|1|||
163162036|NCT00555061|589307447|FG000|Overall Study|Adverse Event|3|||
163162037|NCT00555061|589307447|FG000|Overall Study|Protocol Violation|1|||
163162038|NCT00555061|589307447|FG000|Overall Study|Lost to Follow-up|2|||
163162039|NCT00555061|589307447|FG000|Overall Study|Withdrawal by Subject|2|||
163162040|NCT00555061|589307447|FG000|Overall Study|Participant enrolled, but never treated|1|||
163162041|NCT01175083|589307448|FG000|Primary Epoch|Withdrawal by Subject|0|||
163162042|NCT01175083|589307449|FG001|Primary Epoch|Withdrawal by Subject|0|||
163162043|NCT01175083|589307450|FG002|Primary Epoch|Withdrawal by Subject|0|||
163162044|NCT01175083|589307451|FG003|Primary Epoch|Withdrawal by Subject|0|||
163162045|NCT01175083|589307452|FG004|Primary Epoch|Withdrawal by Subject|0|||
163162046|NCT01175083|589307453|FG005|Primary Epoch|Withdrawal by Subject|2|||
163162047|NCT01175083|589307448|FG000|Primary Epoch|Lost to Follow-up|0|||
163162048|NCT01175083|589307449|FG001|Primary Epoch|Lost to Follow-up|0|||
163162049|NCT01175083|589307450|FG002|Primary Epoch|Lost to Follow-up|0|||
163162050|NCT01175083|589307451|FG003|Primary Epoch|Lost to Follow-up|0|||
163162051|NCT01175083|589307452|FG004|Primary Epoch|Lost to Follow-up|0|||
163162052|NCT01175083|589307453|FG005|Primary Epoch|Lost to Follow-up|1|||
163162053|NCT01175083|589307448|FG000|Booster Epoch|Death|0|||
163162054|NCT01175083|589307449|FG001|Booster Epoch|Death|0|||
163162055|NCT01175083|589307450|FG002|Booster Epoch|Death|1|||
163162056|NCT01175083|589307451|FG003|Booster Epoch|Death|0|||
163162057|NCT01175083|589307452|FG004|Booster Epoch|Death|0|||
163162058|NCT01175083|589307453|FG005|Booster Epoch|Death|0|||
163162059|NCT01175083|589307448|FG000|Booster Epoch|Withdrawal by Subject|0|||
163162060|NCT01175083|589307449|FG001|Booster Epoch|Withdrawal by Subject|0|||
163162061|NCT01175083|589307450|FG002|Booster Epoch|Withdrawal by Subject|0|||
163162062|NCT01175083|589307451|FG003|Booster Epoch|Withdrawal by Subject|1|||
163162063|NCT01175083|589307452|FG004|Booster Epoch|Withdrawal by Subject|0|||
163162064|NCT01175083|589307453|FG005|Booster Epoch|Withdrawal by Subject|0|||
163162065|NCT02881567|589307454|FG000|Overall Study|Adverse Event|1|||
163162066|NCT02881567|589307454|FG000|Overall Study|Lost to Follow-up|3|||
163162067|NCT02881567|589307454|FG000|Overall Study|Consent withdrawn|1|||
163162068|NCT02881567|589307454|FG000|Overall Study|Investigator decision|1|||
163276192|NCT05310084|589721606|FG001|Overall Study|Withdrawal by Subject|3|||
163276193|NCT05310084|589721605|FG000|Overall Study|Participant availability|0|||
163276194|NCT05310084|589721606|FG001|Overall Study|Participant availability|4|||
163276195|NCT05310084|589721605|FG000|Overall Study|Lost to Follow-up|1|||
163276196|NCT05310084|589721606|FG001|Overall Study|Lost to Follow-up|1|||
163276197|NCT05310084|589721605|FG000|Overall Study|Adverse Event|1|||
163276198|NCT05310084|589721606|FG001|Overall Study|Adverse Event|1|||
163276199|NCT05310084|589721605|FG000|Overall Study|Randomized but not vaccinated|4|||
163276200|NCT05310084|589721606|FG001|Overall Study|Randomized but not vaccinated|2|||
163276201|NCT02065245|589721608|FG000|Infusion 1|Lost to Follow-up|0|||
163276202|NCT02065245|589721609|FG001|Infusion 1|Lost to Follow-up|0|||
163276203|NCT02065245|589721610|FG002|Infusion 1|Lost to Follow-up|0|||
163276204|NCT02065245|589721611|FG003|Infusion 1|Lost to Follow-up|0|||
163276205|NCT02065245|589721612|FG004|Infusion 1|Lost to Follow-up|0|||
163276206|NCT02065245|589721613|FG005|Infusion 1|Lost to Follow-up|0|||
163276207|NCT02065245|589721614|FG006|Infusion 1|Lost to Follow-up|1|||
163276208|NCT02065245|589721608|FG000|Infusion 1|Death|0|||
163276209|NCT02065245|589721609|FG001|Infusion 1|Death|0|||
163276210|NCT02065245|589721610|FG002|Infusion 1|Death|1|||
163276211|NCT02065245|589721611|FG003|Infusion 1|Death|0|||
163276212|NCT02065245|589721612|FG004|Infusion 1|Death|1|||
163276213|NCT02065245|589721613|FG005|Infusion 1|Death|0|||
163276214|NCT02065245|589721614|FG006|Infusion 1|Death|0|||
163276215|NCT02065245|589721608|FG000|Infusion 2|Death|0|||
163276216|NCT02065245|589721609|FG001|Infusion 2|Death|0|||
163276217|NCT02065245|589721610|FG002|Infusion 2|Death|0|||
163276218|NCT02065245|589721611|FG003|Infusion 2|Death|0|||
163276219|NCT02065245|589721612|FG004|Infusion 2|Death|0|||
163276220|NCT02065245|589721613|FG005|Infusion 2|Death|0|||
163276221|NCT02065245|589721614|FG006|Infusion 2|Death|1|||
163276222|NCT02065245|589721608|FG000|Infusion 3|Lost to Follow-up|1|||
163276223|NCT02065245|589721609|FG001|Infusion 3|Lost to Follow-up|1|||
163276224|NCT02065245|589721610|FG002|Infusion 3|Lost to Follow-up|0|||
163276225|NCT02065245|589721611|FG003|Infusion 3|Lost to Follow-up|0|||
163276226|NCT02065245|589721612|FG004|Infusion 3|Lost to Follow-up|0|||
163276227|NCT02065245|589721613|FG005|Infusion 3|Lost to Follow-up|0|||
163276228|NCT02065245|589721614|FG006|Infusion 3|Lost to Follow-up|0|||
163162069|NCT02881567|589307454|FG000|Overall Study|Study terminated by sponsor|9|||
163162070|NCT02881567|589307454|FG000|Overall Study|Reason not Specified|3|||
163162071|NCT00373113|589307456|FG000|Overall Study|Death|1|||
163162072|NCT00373113|589307457|FG001|Overall Study|Death|7|||
163162073|NCT00373113|589307456|FG000|Overall Study|Adverse Event|38|||
163162074|NCT00373113|589307457|FG001|Overall Study|Adverse Event|24|||
163162075|NCT00373113|589307456|FG000|Overall Study|Study terminated by sponsor|9|||
163162076|NCT00373113|589307457|FG001|Overall Study|Study terminated by sponsor|1|||
163162077|NCT00373113|589307456|FG000|Overall Study|Global deterioration of health status|10|||
163162078|NCT00373113|589307457|FG001|Overall Study|Global deterioration of health status|7|||
163162079|NCT00373113|589307456|FG000|Overall Study|Lost to Follow-up|1|||
163162080|NCT00373113|589307457|FG001|Overall Study|Lost to Follow-up|3|||
163162081|NCT00373113|589307456|FG000|Overall Study|Objective progression or relapse|150|||
163162082|NCT00373113|589307457|FG001|Overall Study|Objective progression or relapse|169|||
163162083|NCT00373113|589307456|FG000|Overall Study|Other|14|||
163162084|NCT00373113|589307457|FG001|Overall Study|Other|17|||
163162085|NCT00373113|589307456|FG000|Overall Study|Protocol Violation|5|||
163162086|NCT00373113|589307457|FG001|Overall Study|Protocol Violation|1|||
163162087|NCT00373113|589307456|FG000|Overall Study|Withdrawal by Subject|10|||
163162088|NCT00373113|589307457|FG001|Overall Study|Withdrawal by Subject|15|||
163162089|NCT03275350|589307458|FG000|Overall Study|Lost to Follow-up|4|||
163162090|NCT03275350|589307459|FG001|Overall Study|Lost to Follow-up|6|||
163162091|NCT03275350|589307458|FG000|Overall Study|Death|2|||
163162092|NCT03275350|589307459|FG001|Overall Study|Death|1|||
163162093|NCT03275350|589307458|FG000|Overall Study|Physician Decision|1|||
163162094|NCT03275350|589307459|FG001|Overall Study|Physician Decision|0|||
163162095|NCT03275350|589307458|FG000|Overall Study|Incarcerated|1|||
163162096|NCT03275350|589307459|FG001|Overall Study|Incarcerated|1|||
163162097|NCT00905645|589307462|FG000|Overall Study|Death (not device related)|10|||
163162098|NCT00905645|589307463|FG001|Overall Study|Death (not device related)|4|||
163162099|NCT00905645|589307464|FG002|Overall Study|Death (not device related)|15|||
163162100|NCT00905645|589307465|FG003|Overall Study|Death (not device related)|8|||
163162101|NCT00905645|589307462|FG000|Overall Study|Explantation of study device(s)|78|||
163162102|NCT00905645|589307463|FG001|Overall Study|Explantation of study device(s)|47|||
163162103|NCT00905645|589307464|FG002|Overall Study|Explantation of study device(s)|28|||
163162104|NCT00905645|589307465|FG003|Overall Study|Explantation of study device(s)|21|||
163162105|NCT00905645|589307462|FG000|Overall Study|Subject Request|41|||
163162106|NCT00905645|589307463|FG001|Overall Study|Subject Request|17|||
163162107|NCT00905645|589307464|FG002|Overall Study|Subject Request|13|||
163162108|NCT00905645|589307465|FG003|Overall Study|Subject Request|11|||
163162109|NCT00905645|589307462|FG000|Overall Study|Lost to Follow-up|299|||
163162110|NCT00905645|589307463|FG001|Overall Study|Lost to Follow-up|103|||
163162111|NCT00905645|589307464|FG002|Overall Study|Lost to Follow-up|51|||
163162112|NCT00905645|589307465|FG003|Overall Study|Lost to Follow-up|12|||
163162113|NCT01386970|589307466|FG000|Overall Study|Withdrawal by Subject|0|||
163162114|NCT01386970|589307467|FG001|Overall Study|Withdrawal by Subject|1|||
163162115|NCT01386970|589307466|FG000|Overall Study|Adverse Event|4|||
163162116|NCT01386970|589307467|FG001|Overall Study|Adverse Event|1|||
163162117|NCT04439136|589307468|FG000|Overall Study|Ineligible|1|||
163162118|NCT04439136|589307468|FG000|Overall Study|Never Started Treatment|2|||
163162119|NCT04439136|589307468|FG000|Overall Study|Adverse Event|4|||
163162120|NCT04439136|589307468|FG000|Overall Study|Death|3|||
163162121|NCT04439136|589307468|FG000|Overall Study|Disease Progression|27|||
163162122|NCT04439136|589307468|FG000|Overall Study|Alternative Therapy|1|||
163162123|NCT04439136|589307468|FG000|Overall Study|Increased Tumor Burden|1|||
163162124|NCT04439136|589307468|FG000|Overall Study|Symptomatic Detrioration|1|||
163162125|NCT00578292|589307469|FG000|Overall Study|Death|1|||
163162126|NCT00578292|589307469|FG000|Overall Study|Graft failure|2|||
163162127|NCT04849559|589307470|FG000|Overall Study|Withdrawal by Subject|2|||
163162128|NCT04849559|589307471|FG001|Overall Study|Withdrawal by Subject|1|||
163162129|NCT03901469|589307472|FG000|Overall Study|Radiographic Progression|4|||
163162130|NCT03901469|589307473|FG001|Overall Study|Radiographic Progression|6|||
163162131|NCT03901469|589307474|FG002|Overall Study|Radiographic Progression|3|||
163162132|NCT03901469|589307475|FG003|Overall Study|Radiographic Progression|30|||
163162133|NCT03901469|589307476|FG004|Overall Study|Radiographic Progression|7|||
163162134|NCT03901469|589307477|FG005|Overall Study|Radiographic Progression|2|||
163162135|NCT03901469|589307478|FG006|Overall Study|Radiographic Progression|11|||
163162136|NCT03901469|589307472|FG000|Overall Study|Clinical Progression|0|||
163162137|NCT03901469|589307473|FG001|Overall Study|Clinical Progression|2|||
163162138|NCT03901469|589307474|FG002|Overall Study|Clinical Progression|0|||
163162139|NCT03901469|589307475|FG003|Overall Study|Clinical Progression|7|||
163162140|NCT03901469|589307476|FG004|Overall Study|Clinical Progression|6|||
163162141|NCT03901469|589307477|FG005|Overall Study|Clinical Progression|0|||
163162142|NCT03901469|589307478|FG006|Overall Study|Clinical Progression|2|||
163162143|NCT03901469|589307472|FG000|Overall Study|Adverse Event|1|||
163162144|NCT03901469|589307473|FG001|Overall Study|Adverse Event|0|||
163162145|NCT03901469|589307474|FG002|Overall Study|Adverse Event|0|||
163162146|NCT03901469|589307475|FG003|Overall Study|Adverse Event|0|||
163162147|NCT03901469|589307476|FG004|Overall Study|Adverse Event|0|||
163162148|NCT03901469|589307477|FG005|Overall Study|Adverse Event|0|||
163162149|NCT03901469|589307478|FG006|Overall Study|Adverse Event|9|||
163162150|NCT03901469|589307472|FG000|Overall Study|Physician Decision|0|||
163162151|NCT03901469|589307473|FG001|Overall Study|Physician Decision|0|||
163162152|NCT03901469|589307474|FG002|Overall Study|Physician Decision|0|||
163162153|NCT03901469|589307475|FG003|Overall Study|Physician Decision|1|||
163162154|NCT03901469|589307476|FG004|Overall Study|Physician Decision|0|||
163162155|NCT03901469|589307477|FG005|Overall Study|Physician Decision|0|||
163162156|NCT03901469|589307478|FG006|Overall Study|Physician Decision|0|||
163162157|NCT03901469|589307472|FG000|Overall Study|Withdrawal by Subject|0|||
163162158|NCT03901469|589307473|FG001|Overall Study|Withdrawal by Subject|0|||
163162159|NCT03901469|589307474|FG002|Overall Study|Withdrawal by Subject|0|||
163162160|NCT03901469|589307475|FG003|Overall Study|Withdrawal by Subject|0|||
163162161|NCT03901469|589307476|FG004|Overall Study|Withdrawal by Subject|2|||
163162162|NCT03901469|589307477|FG005|Overall Study|Withdrawal by Subject|0|||
163162163|NCT03901469|589307478|FG006|Overall Study|Withdrawal by Subject|8|||
163162164|NCT03901469|589307472|FG000|Overall Study|Death|0|||
163162165|NCT03901469|589307473|FG001|Overall Study|Death|0|||
163162166|NCT03901469|589307474|FG002|Overall Study|Death|0|||
163162167|NCT03901469|589307475|FG003|Overall Study|Death|3|||
163162168|NCT03901469|589307476|FG004|Overall Study|Death|5|||
163162169|NCT03901469|589307477|FG005|Overall Study|Death|0|||
163162170|NCT03901469|589307478|FG006|Overall Study|Death|1|||
163162171|NCT03901469|589307472|FG000|Overall Study|Termination of study by sponsor|0|||
163162172|NCT03901469|589307473|FG001|Overall Study|Termination of study by sponsor|0|||
163162173|NCT03901469|589307474|FG002|Overall Study|Termination of study by sponsor|0|||
163162174|NCT03901469|589307475|FG003|Overall Study|Termination of study by sponsor|0|||
163162175|NCT03901469|589307476|FG004|Overall Study|Termination of study by sponsor|1|||
163162176|NCT03901469|589307477|FG005|Overall Study|Termination of study by sponsor|1|||
163162177|NCT03901469|589307478|FG006|Overall Study|Termination of study by sponsor|0|||
163162178|NCT03901469|589307472|FG000|Overall Study|Not Reported|1|||
163162179|NCT03901469|589307473|FG001|Overall Study|Not Reported|0|||
163162180|NCT03901469|589307474|FG002|Overall Study|Not Reported|0|||
163162181|NCT03901469|589307475|FG003|Overall Study|Not Reported|1|||
163162182|NCT03901469|589307476|FG004|Overall Study|Not Reported|0|||
163162183|NCT03901469|589307477|FG005|Overall Study|Not Reported|0|||
163162184|NCT03901469|589307478|FG006|Overall Study|Not Reported|1|||
163162185|NCT01662102|589307479|FG000|Overall Study|Sponsor's decision|1|||
163162186|NCT01662102|589307480|FG001|Overall Study|Sponsor's decision|0|||
163162187|NCT02586207|589307481|FG000|Overall Study|Physician Decision|1|||
163162188|NCT02586207|589307481|FG000|Overall Study|Withdrawal by Subject|1|||
163162189|NCT02362282|589307482|FG000|Overall Study|Withdrawal by Subject|1|||
163162190|NCT02362282|589307483|FG001|Overall Study|Withdrawal by Subject|0|||
163162191|NCT02004093|589307484|FG000|Overall Study|Death|2|||
163162192|NCT02004093|589307485|FG001|Overall Study|Death|1|||
163162193|NCT02004093|589307484|FG000|Overall Study|Lack of Efficacy|66|||
163162194|NCT02004093|589307485|FG001|Overall Study|Lack of Efficacy|62|||
163162195|NCT02004093|589307484|FG000|Overall Study|Protocol Violation|0|||
163162196|NCT02004093|589307485|FG001|Overall Study|Protocol Violation|1|||
163162197|NCT02004093|589307484|FG000|Overall Study|Lost to Follow-up|0|||
163162198|NCT02004093|589307485|FG001|Overall Study|Lost to Follow-up|1|||
163162199|NCT02004093|589307484|FG000|Overall Study|Withdrawal by Subject|3|||
163162200|NCT02004093|589307485|FG001|Overall Study|Withdrawal by Subject|7|||
163162201|NCT02004093|589307484|FG000|Overall Study|Other|3|||
163162202|NCT02004093|589307485|FG001|Overall Study|Other|1|||
163162203|NCT04085289|589307486|FG000|Overall Study|Withdrawal by Subject|0|||
163162204|NCT04085289|589307487|FG001|Overall Study|Withdrawal by Subject|0|||
163162205|NCT04085289|589307488|FG002|Overall Study|Withdrawal by Subject|1|||
163162206|NCT00439517|589307489|FG000|Overall Study|Subject on treatment|1|||
163162207|NCT00439517|589307490|FG001|Overall Study|Subject on treatment|0|||
163276229|NCT00924664|589721615|FG000|Overall Study|Adverse Event|23|||
163162208|NCT00439517|589307489|FG000|Overall Study|Subject in survival follow-up|1|||
163162209|NCT00439517|589307490|FG001|Overall Study|Subject in survival follow-up|0|||
163162210|NCT03527732|589307493|FG000|Overall Study|Lost to Follow-up|21|||
163162211|NCT03527732|589307494|FG001|Overall Study|Lost to Follow-up|23|||
163162212|NCT03527732|589307495|FG002|Overall Study|Lost to Follow-up|80|||
163162213|NCT03527732|589307496|FG003|Overall Study|Lost to Follow-up|62|||
163162214|NCT03527732|589307497|FG004|Overall Study|Lost to Follow-up|12|||
163162215|NCT03527732|589307498|FG005|Overall Study|Lost to Follow-up|20|||
163162216|NCT00470275|589307499|FG000|Overall Study|Death|1|||
163162217|NCT00470275|589307499|FG000|Overall Study|Lack of Efficacy|7|||
163162218|NCT00470275|589307499|FG000|Overall Study|Withdrawal by Subject|2|||
163162219|NCT02207088|589307500|FG000|Overall Study|Adverse Event|2|||
163162220|NCT03306173|589307502|FG000|Overall Study|Lost to Follow-up|16|||
163276230|NCT00924664|589721616|FG001|Overall Study|Adverse Event|39|||
163162221|NCT03306173|589307503|FG001|Overall Study|Lost to Follow-up|23|||
163162222|NCT03306173|589307502|FG000|Overall Study|Withdrawal by Subject|4|||
163162223|NCT03306173|589307503|FG001|Overall Study|Withdrawal by Subject|3|||
163162224|NCT03306173|589307502|FG000|Overall Study|Discontinued|4|||
163162225|NCT03306173|589307503|FG001|Overall Study|Discontinued|4|||
163162226|NCT01077076|589307504|FG000|First Intervention|Withdrawal by Subject|1|||
163162227|NCT01077076|589307505|FG001|First Intervention|Withdrawal by Subject|0|||
163162228|NCT01077076|589307506|FG002|First Intervention|Withdrawal by Subject|0|||
163162229|NCT01077076|589307507|FG003|First Intervention|Withdrawal by Subject|0|||
163162230|NCT01077076|589307508|FG004|First Intervention|Withdrawal by Subject|0|||
163162231|NCT01077076|589307509|FG005|First Intervention|Withdrawal by Subject|0|||
163162232|NCT01077076|589307504|FG000|Third Intervention|Death in the participant's family|0|||
163162233|NCT01077076|589307505|FG001|Third Intervention|Death in the participant's family|0|||
163162234|NCT01077076|589307506|FG002|Third Intervention|Death in the participant's family|0|||
163162235|NCT01077076|589307507|FG003|Third Intervention|Death in the participant's family|0|||
163162236|NCT01077076|589307508|FG004|Third Intervention|Death in the participant's family|0|||
163162237|NCT01077076|589307509|FG005|Third Intervention|Death in the participant's family|1|||
163162238|NCT00060840|589307512|FG000|Overall Study|Change in surgical plan|2|||
163162239|NCT00060840|589307513|FG001|Overall Study|Change in surgical plan|6|||
163162240|NCT00060840|589307512|FG000|Overall Study|Death|0|||
163162241|NCT00060840|589307513|FG001|Overall Study|Death|1|||
163162242|NCT00060840|589307512|FG000|Overall Study|Withdrawal by Subject|0|||
163162243|NCT00060840|589307513|FG001|Overall Study|Withdrawal by Subject|1|||
163162244|NCT00060840|589307512|FG000|Overall Study|Subinvestigator unavailable|0|||
163162245|NCT00060840|589307513|FG001|Overall Study|Subinvestigator unavailable|1|||
163162246|NCT00060840|589307512|FG000|Overall Study|Physician Decision|1|||
163162247|NCT00060840|589307513|FG001|Overall Study|Physician Decision|0|||
163162248|NCT00060840|589307512|FG000|Overall Study|Other|1|||
163162249|NCT00060840|589307513|FG001|Overall Study|Other|0|||
163162250|NCT01388335|589307514|FG000|Period 1|Progressive Disease|1|||
163162251|NCT01388335|589307514|FG000|Period 2|Progressive Disease|2|||
163162252|NCT01388335|589307514|FG000|Period 2|Sponsor Decision|1|||
163162253|NCT01388335|589307514|FG000|Safety Extension|Progressive Disease|7|||
163162254|NCT01415882|589307515|FG000|Overall Study|Ineligible|1|||
163162255|NCT01415882|589307516|FG001|Overall Study|Ineligible|0|||
163162256|NCT01415882|589307517|FG002|Overall Study|Ineligible|0|||
163162257|NCT01415882|589307518|FG003|Overall Study|Ineligible|3|||
163162258|NCT01415882|589307519|FG004|Overall Study|Ineligible|0|||
163162259|NCT01415882|589307515|FG000|Overall Study|Withdrawal by Subject|0|||
163162260|NCT01415882|589307516|FG001|Overall Study|Withdrawal by Subject|1|||
163162261|NCT01415882|589307517|FG002|Overall Study|Withdrawal by Subject|0|||
163162262|NCT01415882|589307518|FG003|Overall Study|Withdrawal by Subject|1|||
163162263|NCT01415882|589307519|FG004|Overall Study|Withdrawal by Subject|0|||
163162264|NCT00976560|589307520|FG000|Overall Study|Adverse Event|5|||
163162265|NCT00976560|589307521|FG001|Overall Study|Adverse Event|5|||
163162266|NCT00976560|589307520|FG000|Overall Study|Lack of Efficacy|3|||
163162267|NCT00976560|589307521|FG001|Overall Study|Lack of Efficacy|5|||
163162268|NCT00976560|589307520|FG000|Overall Study|Protocol Violation|1|||
163162269|NCT00976560|589307521|FG001|Overall Study|Protocol Violation|0|||
163162270|NCT00976560|589307520|FG000|Overall Study|Lost to Follow-up|1|||
163162271|NCT00976560|589307521|FG001|Overall Study|Lost to Follow-up|0|||
163162272|NCT00976560|589307520|FG000|Overall Study|Physician Decision|2|||
163162273|NCT00976560|589307521|FG001|Overall Study|Physician Decision|0|||
163162274|NCT00976560|589307520|FG000|Overall Study|Withdrawal by Subject|2|||
163162275|NCT00976560|589307521|FG001|Overall Study|Withdrawal by Subject|3|||
163162276|NCT00125164|589307524|FG000|Overall Study|Adverse Event|0|||
163162277|NCT00125164|589307525|FG001|Overall Study|Adverse Event|0|||
163162278|NCT00125164|589307526|FG002|Overall Study|Adverse Event|2|||
163162279|NCT00125164|589307527|FG003|Overall Study|Adverse Event|4|||
163162280|NCT00125164|589307524|FG000|Overall Study|Lost to Follow-up|0|||
163162281|NCT00125164|589307525|FG001|Overall Study|Lost to Follow-up|0|||
163162282|NCT00125164|589307526|FG002|Overall Study|Lost to Follow-up|1|||
163162283|NCT00125164|589307527|FG003|Overall Study|Lost to Follow-up|1|||
163162284|NCT00125164|589307524|FG000|Overall Study|Withdrawal by Subject|2|||
163162285|NCT00125164|589307525|FG001|Overall Study|Withdrawal by Subject|0|||
163162286|NCT00125164|589307526|FG002|Overall Study|Withdrawal by Subject|1|||
163162287|NCT00125164|589307527|FG003|Overall Study|Withdrawal by Subject|1|||
163162288|NCT01339052|589307528|FG000|Overall Study|Disease progression|13|||
163162289|NCT01339052|589307529|FG001|Overall Study|Disease progression|46|||
163162290|NCT01339052|589307528|FG000|Overall Study|Adverse Event|1|||
163162291|NCT01339052|589307529|FG001|Overall Study|Adverse Event|1|||
163162292|NCT01339052|589307528|FG000|Overall Study|Withdrawal by Subject|0|||
163162293|NCT01339052|589307529|FG001|Overall Study|Withdrawal by Subject|3|||
163162294|NCT01339052|589307528|FG000|Overall Study|Physician Decision|1|||
163162295|NCT01339052|589307529|FG001|Overall Study|Physician Decision|0|||
163162296|NCT03339219|589307533|FG000|Overall Study|Death|12|||
163042816|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
163162297|NCT03339219|589307533|FG000|Overall Study|Site Terminated by Sponsor|22|||
163162298|NCT03339219|589307533|FG000|Overall Study|Withdrawal by Subject|1|||
163162299|NCT01301027|589307537|FG000|Overall Study|Physician Decision|2|||
163162300|NCT01301027|589307538|FG001|Overall Study|Physician Decision|0|||
163162301|NCT01301027|589307537|FG000|Overall Study|Withdrawal by Subject|2|||
163162302|NCT01301027|589307538|FG001|Overall Study|Withdrawal by Subject|3|||
163162303|NCT01301027|589307537|FG000|Overall Study|Adverse Event|0|||
163162304|NCT01301027|589307538|FG001|Overall Study|Adverse Event|2|||
163162305|NCT01301027|589307537|FG000|Overall Study|Fracture|1|||
163162306|NCT01301027|589307538|FG001|Overall Study|Fracture|3|||
163162307|NCT01301027|589307537|FG000|Overall Study|Transplant|0|||
163162308|NCT01301027|589307538|FG001|Overall Study|Transplant|2|||
163162309|NCT01301027|589307537|FG000|Overall Study|Volume Overload|3|||
163162310|NCT01301027|589307538|FG001|Overall Study|Volume Overload|0|||
163162311|NCT03155841|589307540|FG000|Overall Study|Protocol Violation|3|||
163162312|NCT03155841|589307541|FG001|Overall Study|Protocol Violation|4|||
163162313|NCT04308291|589307542|FG000|Run-In Phase|Withdrawal by Subject|4|||
163162314|NCT04308291|589307542|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
163162315|NCT04308291|589307542|FG000|Study Phase 6-M|Physician Decision|2|||
163162316|NCT04308291|589307542|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
163162317|NCT04308291|589307542|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
163162318|NCT04308291|589307542|FG000|Study Phase 12-M|Physician Decision|2|||
163162319|NCT04308291|589307542|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
163162320|NCT00714870|589307545|FG000|Overall Study|Lost to Follow-up|22|||
163162321|NCT00714870|589307546|FG001|Overall Study|Lost to Follow-up|5|||
163162322|NCT00714870|589307545|FG000|Overall Study|patient unable to come b/c back pain|1|||
163162323|NCT00714870|589307546|FG001|Overall Study|patient unable to come b/c back pain|0|||
163162324|NCT00714870|589307545|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
163162325|NCT00714870|589307546|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
163162326|NCT03399552|589307547|FG000|Overall Study|No evidence of disease|1|||
163162327|NCT03399552|589307547|FG000|Overall Study|Unevaluable|1|||
163162328|NCT02357368|589307548|FG000|Overall Study|Lost to Follow-up|0|||
163162329|NCT02357368|589307549|FG001|Overall Study|Lost to Follow-up|0|||
163162330|NCT02357368|589307550|FG002|Overall Study|Lost to Follow-up|0|||
163162331|NCT02357368|589307551|FG003|Overall Study|Lost to Follow-up|1|||
163162332|NCT02357368|589307548|FG000|Overall Study|Pregnancy|3|||
163162333|NCT02357368|589307549|FG001|Overall Study|Pregnancy|2|||
163162334|NCT02357368|589307550|FG002|Overall Study|Pregnancy|0|||
163162335|NCT02357368|589307551|FG003|Overall Study|Pregnancy|0|||
163162336|NCT02357368|589307548|FG000|Overall Study|Withdrawal by Subject|3|||
163162337|NCT02357368|589307549|FG001|Overall Study|Withdrawal by Subject|1|||
163162338|NCT02357368|589307550|FG002|Overall Study|Withdrawal by Subject|1|||
163162339|NCT02357368|589307551|FG003|Overall Study|Withdrawal by Subject|2|||
163162340|NCT01931566|589307552|FG000|Overall Study|Randomized But Not Treated|6|||
163162341|NCT01931566|589307553|FG001|Overall Study|Randomized But Not Treated|9|||
163162342|NCT01931566|589307554|FG002|Overall Study|Randomized But Not Treated|14|||
163162343|NCT01931566|589307552|FG000|Overall Study|Adverse Event|37|||
163162344|NCT01931566|589307553|FG001|Overall Study|Adverse Event|167|||
163162345|NCT01931566|589307554|FG002|Overall Study|Adverse Event|132|||
163162346|NCT01931566|589307552|FG000|Overall Study|Major Protocol Deviation|5|||
163162347|NCT01931566|589307553|FG001|Overall Study|Major Protocol Deviation|14|||
163162348|NCT01931566|589307554|FG002|Overall Study|Major Protocol Deviation|21|||
163162349|NCT01931566|589307552|FG000|Overall Study|Lost to Follow-up|3|||
163162350|NCT01931566|589307553|FG001|Overall Study|Lost to Follow-up|26|||
163162351|NCT01931566|589307554|FG002|Overall Study|Lost to Follow-up|23|||
163162352|NCT01931566|589307552|FG000|Overall Study|Voluntary Withdrawal|78|||
163162353|NCT01931566|589307553|FG001|Overall Study|Voluntary Withdrawal|245|||
163162354|NCT01931566|589307554|FG002|Overall Study|Voluntary Withdrawal|225|||
163162355|NCT01931566|589307552|FG000|Overall Study|Study Termination|289|||
163162356|NCT01931566|589307553|FG001|Overall Study|Study Termination|968|||
163162357|NCT01931566|589307554|FG002|Overall Study|Study Termination|1037|||
163162358|NCT01931566|589307552|FG000|Overall Study|Reason Not Specified|11|||
163162359|NCT01931566|589307553|FG001|Overall Study|Reason Not Specified|47|||
163162360|NCT01931566|589307554|FG002|Overall Study|Reason Not Specified|53|||
163162361|NCT01931566|589307552|FG000|Overall Study|Missing|0|||
163162362|NCT01931566|589307553|FG001|Overall Study|Missing|0|||
163162363|NCT01931566|589307554|FG002|Overall Study|Missing|1|||
163162364|NCT04625101|589307556|FG000|Overall Study|Withdrawal by Subject|0|||
163162365|NCT04625101|589307557|FG001|Overall Study|Withdrawal by Subject|1|||
163162366|NCT04625101|589307556|FG000|Overall Study|Protocol Deviation|1|||
163162367|NCT04625101|589307557|FG001|Overall Study|Protocol Deviation|0|||
163162368|NCT00467753|589307559|FG000|Overall Study|Lost to Follow-up|1|||
163162369|NCT00467753|589307560|FG001|Overall Study|Lost to Follow-up|2|||
163162370|NCT00467753|589307559|FG000|Overall Study|Adverse Event|2|||
163162371|NCT00467753|589307560|FG001|Overall Study|Adverse Event|0|||
163162372|NCT02533453|589307561|FG000|Overall Study|Adverse Event|6|||
163162373|NCT02533453|589307561|FG000|Overall Study|Protocol Violation|1|||
163162374|NCT02533453|589307561|FG000|Overall Study|Withdrawal by Subject|2|||
163162375|NCT01273519|589307562|FG000|Overall Study|Adverse Event|3|||
163162376|NCT01273519|589307563|FG001|Overall Study|Adverse Event|0|||
163162377|NCT01273519|589307564|FG002|Overall Study|Adverse Event|0|||
163162378|NCT01273519|589307562|FG000|Overall Study|Lost to Follow-up|2|||
163162379|NCT01273519|589307563|FG001|Overall Study|Lost to Follow-up|1|||
163162380|NCT01273519|589307564|FG002|Overall Study|Lost to Follow-up|3|||
163162381|NCT01273519|589307562|FG000|Overall Study|Lack of Efficacy|8|||
163162382|NCT01273519|589307563|FG001|Overall Study|Lack of Efficacy|3|||
163162383|NCT01273519|589307564|FG002|Overall Study|Lack of Efficacy|4|||
163162384|NCT01273519|589307562|FG000|Overall Study|Other|6|||
163162385|NCT01273519|589307563|FG001|Overall Study|Other|1|||
163162386|NCT01273519|589307564|FG002|Overall Study|Other|1|||
163162387|NCT03695367|589307565|FG000|Overall Study|Missed the Day 28 visit.|1|||
163162388|NCT03695367|589307566|FG001|Overall Study|Missed the Day 28 visit.|0|||
163162389|NCT03695367|589307565|FG000|Overall Study|Lost to Follow-up|0|||
163162390|NCT03695367|589307566|FG001|Overall Study|Lost to Follow-up|1|||
163162391|NCT03695367|589307565|FG000|Overall Study|Withdrawal by Subject|0|||
163162392|NCT03695367|589307566|FG001|Overall Study|Withdrawal by Subject|1|||
163162393|NCT03695367|589307565|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
163162394|NCT03695367|589307566|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
163162395|NCT00396253|589307569|FG000|Overall Study|Protocol Violation|1|||
163162396|NCT00396253|589307569|FG000|Overall Study|Withdrawal by Subject|7|||
163162397|NCT00396253|589307569|FG000|Overall Study|Death|3|||
163162398|NCT00396253|589307569|FG000|Overall Study|Physician Decision|1|||
163162399|NCT00396253|589307569|FG000|Overall Study|Change in eligibility status|1|||
163162400|NCT00092443|589307570|FG000|Overall Study|Adverse Event|9|||
163162401|NCT00092443|589307571|FG001|Overall Study|Adverse Event|13|||
163162402|NCT00092443|589307570|FG000|Overall Study|Lost to Follow-up|7|||
163162403|NCT00092443|589307571|FG001|Overall Study|Lost to Follow-up|3|||
163162404|NCT00092443|589307570|FG000|Overall Study|Protocol Violation|11|||
163162405|NCT00092443|589307571|FG001|Overall Study|Protocol Violation|9|||
163162406|NCT00092443|589307570|FG000|Overall Study|Withdrawal by Subject|9|||
163162407|NCT00092443|589307571|FG001|Overall Study|Withdrawal by Subject|11|||
163162408|NCT00092443|589307570|FG000|Overall Study|Moved|5|||
163162409|NCT00092443|589307571|FG001|Overall Study|Moved|5|||
163162410|NCT00092443|589307570|FG000|Overall Study|Other|17|||
163162411|NCT00092443|589307571|FG001|Overall Study|Other|13|||
163162412|NCT01865552|589309630|FG000|Period 1|Adverse Event|1|||
163162413|NCT01865552|589309631|FG001|Period 1|Adverse Event|0|||
163162414|NCT01865552|589309632|FG002|Period 1|Adverse Event|0|||
163162415|NCT01865552|589309633|FG003|Period 1|Adverse Event|1|||
163162416|NCT01865552|589309634|FG004|Period 1|Adverse Event|1|||
163162417|NCT01865552|589309635|FG005|Period 1|Adverse Event|1|||
163162418|NCT01865552|589309630|FG000|Period 1|Pathological lab|0|||
163162419|NCT01865552|589309631|FG001|Period 1|Pathological lab|0|||
163162420|NCT01865552|589309632|FG002|Period 1|Pathological lab|0|||
163162421|NCT01865552|589309633|FG003|Period 1|Pathological lab|0|||
163162422|NCT01865552|589309634|FG004|Period 1|Pathological lab|1|||
163162423|NCT01865552|589309635|FG005|Period 1|Pathological lab|0|||
163162424|NCT01865552|589309630|FG000|Period 1|Other|0|||
163162425|NCT01865552|589309631|FG001|Period 1|Other|0|||
163162426|NCT01865552|589309632|FG002|Period 1|Other|0|||
163162427|NCT01865552|589309633|FG003|Period 1|Other|0|||
163162428|NCT01865552|589309634|FG004|Period 1|Other|1|||
163162429|NCT01865552|589309635|FG005|Period 1|Other|0|||
163162430|NCT03079102|589309638|FG000|Overall Study|Physician Decision|0|||
163162431|NCT03079102|589309639|FG001|Overall Study|Physician Decision|1|||
163162432|NCT02923921|589309640|FG000|Overall Study|Sponsor Decision|39|||
163162433|NCT02923921|589309641|FG001|Overall Study|Sponsor Decision|38|||
163162434|NCT02923921|589309640|FG000|Overall Study|Lost to Follow-up|1|||
163162435|NCT02923921|589309641|FG001|Overall Study|Lost to Follow-up|0|||
163162436|NCT02923921|589309640|FG000|Overall Study|Withdrawal by Subject|6|||
163162437|NCT02923921|589309641|FG001|Overall Study|Withdrawal by Subject|13|||
163162438|NCT02923921|589309640|FG000|Overall Study|Unknown, Not Collected|7|||
163162439|NCT02923921|589309641|FG001|Overall Study|Unknown, Not Collected|6|||
163162440|NCT03083873|589309642|FG000|Overall Study|Death|6|||
163162441|NCT03083873|589309643|FG001|Overall Study|Death|15|||
163162442|NCT03083873|589309644|FG002|Overall Study|Death|13|||
163162443|NCT03083873|589309645|FG003|Overall Study|Death|9|||
163162444|NCT03083873|589309646|FG004|Overall Study|Death|0|||
163162445|NCT03083873|589309642|FG000|Overall Study|Sponsor Terminated Study|0|||
163162446|NCT03083873|589309643|FG001|Overall Study|Sponsor Terminated Study|1|||
163162447|NCT03083873|589309644|FG002|Overall Study|Sponsor Terminated Study|2|||
163162448|NCT03083873|589309645|FG003|Overall Study|Sponsor Terminated Study|3|||
163162449|NCT03083873|589309646|FG004|Overall Study|Sponsor Terminated Study|0|||
163162450|NCT03083873|589309642|FG000|Overall Study|Lost to Follow-up|0|||
163162451|NCT03083873|589309643|FG001|Overall Study|Lost to Follow-up|1|||
163162452|NCT03083873|589309644|FG002|Overall Study|Lost to Follow-up|1|||
163162453|NCT03083873|589309645|FG003|Overall Study|Lost to Follow-up|0|||
163162454|NCT03083873|589309646|FG004|Overall Study|Lost to Follow-up|0|||
163162455|NCT03083873|589309642|FG000|Overall Study|Withdrawal by Subject|2|||
163162456|NCT03083873|589309643|FG001|Overall Study|Withdrawal by Subject|0|||
163162457|NCT03083873|589309644|FG002|Overall Study|Withdrawal by Subject|0|||
163162458|NCT03083873|589309645|FG003|Overall Study|Withdrawal by Subject|0|||
163162459|NCT03083873|589309646|FG004|Overall Study|Withdrawal by Subject|0|||
163162460|NCT03083873|589309642|FG000|Overall Study|Did Not Receive TIL|2|||
163162461|NCT03083873|589309643|FG001|Overall Study|Did Not Receive TIL|5|||
163162462|NCT03083873|589309644|FG002|Overall Study|Did Not Receive TIL|3|||
163162463|NCT03083873|589309645|FG003|Overall Study|Did Not Receive TIL|1|||
163162464|NCT03083873|589309646|FG004|Overall Study|Did Not Receive TIL|0|||
163162465|NCT00854113|589309647|FG000|Overall Study|Adverse Event|0|||
163162466|NCT00854113|589309648|FG001|Overall Study|Adverse Event|0|||
163162467|NCT00854113|589309649|FG002|Overall Study|Adverse Event|0|||
163162468|NCT00854113|589309650|FG003|Overall Study|Adverse Event|0|||
163162469|NCT00854113|589309651|FG004|Overall Study|Adverse Event|0|||
163162470|NCT00854113|589309652|FG005|Overall Study|Adverse Event|0|||
163162471|NCT00854113|589309653|FG006|Overall Study|Adverse Event|0|||
163162472|NCT00854113|589309654|FG007|Overall Study|Adverse Event|2|||
163162473|NCT00854113|589309655|FG008|Overall Study|Adverse Event|0|||
163162474|NCT00854113|589309656|FG009|Overall Study|Adverse Event|0|||
163162475|NCT00854113|589309657|FG010|Overall Study|Adverse Event|0|||
163162476|NCT00854113|589309647|FG000|Overall Study|Withdrawal by Subject|0|||
163162477|NCT00854113|589309648|FG001|Overall Study|Withdrawal by Subject|0|||
163162478|NCT00854113|589309649|FG002|Overall Study|Withdrawal by Subject|0|||
163162479|NCT00854113|589309650|FG003|Overall Study|Withdrawal by Subject|0|||
163162480|NCT00854113|589309651|FG004|Overall Study|Withdrawal by Subject|0|||
163162481|NCT00854113|589309652|FG005|Overall Study|Withdrawal by Subject|0|||
163162482|NCT00854113|589309653|FG006|Overall Study|Withdrawal by Subject|0|||
163162483|NCT00854113|589309654|FG007|Overall Study|Withdrawal by Subject|1|||
163162484|NCT00854113|589309655|FG008|Overall Study|Withdrawal by Subject|1|||
163162485|NCT00854113|589309656|FG009|Overall Study|Withdrawal by Subject|0|||
163162486|NCT00854113|589309657|FG010|Overall Study|Withdrawal by Subject|0|||
163162487|NCT00539864|589309658|FG000|Overall Study|Lost to Follow-up|0|||
163162488|NCT00539864|589309659|FG001|Overall Study|Lost to Follow-up|1|||
163162489|NCT00539864|589309658|FG000|Overall Study|Withdrawal by Subject|1|||
163162490|NCT00539864|589309659|FG001|Overall Study|Withdrawal by Subject|1|||
163162491|NCT01250145|589309660|FG000|Overall Study|Adverse Event|2|||
163162492|NCT01250145|589309661|FG001|Overall Study|Adverse Event|1|||
163162493|NCT01250145|589309660|FG000|Overall Study|Withdrawal by Subject|0|||
163162494|NCT01250145|589309661|FG001|Overall Study|Withdrawal by Subject|4|||
163162495|NCT04661579|589309666|FG000|Overall Study|Lost to Follow-up|19|||
163162496|NCT04661579|589309667|FG001|Overall Study|Lost to Follow-up|10|||
163162497|NCT04661579|589309668|FG002|Overall Study|Lost to Follow-up|2|||
163162498|NCT04661579|589309669|FG003|Overall Study|Lost to Follow-up|7|||
163162499|NCT04661579|589309670|FG004|Overall Study|Lost to Follow-up|11|||
163162500|NCT04661579|589309666|FG000|Overall Study|Physician Decision|2|||
163162501|NCT04661579|589309667|FG001|Overall Study|Physician Decision|0|||
163162502|NCT04661579|589309668|FG002|Overall Study|Physician Decision|0|||
163162503|NCT04661579|589309669|FG003|Overall Study|Physician Decision|1|||
163162504|NCT04661579|589309670|FG004|Overall Study|Physician Decision|0|||
163162505|NCT04661579|589309666|FG000|Overall Study|Withdrawal by Subject|1|||
163162506|NCT04661579|589309667|FG001|Overall Study|Withdrawal by Subject|4|||
163162507|NCT04661579|589309668|FG002|Overall Study|Withdrawal by Subject|0|||
163162508|NCT04661579|589309669|FG003|Overall Study|Withdrawal by Subject|2|||
163162509|NCT04661579|589309670|FG004|Overall Study|Withdrawal by Subject|0|||
163162510|NCT04661579|589309666|FG000|Overall Study|Death|1|||
163162511|NCT04661579|589309667|FG001|Overall Study|Death|0|||
163162512|NCT04661579|589309668|FG002|Overall Study|Death|0|||
163162513|NCT04661579|589309669|FG003|Overall Study|Death|0|||
163162514|NCT04661579|589309670|FG004|Overall Study|Death|0|||
163162515|NCT04661579|589309666|FG000|Overall Study|Other|1|||
163162516|NCT04661579|589309667|FG001|Overall Study|Other|2|||
163162517|NCT04661579|589309668|FG002|Overall Study|Other|1|||
163162518|NCT04661579|589309669|FG003|Overall Study|Other|1|||
163162519|NCT04661579|589309670|FG004|Overall Study|Other|1|||
163162520|NCT04661579|589309666|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
163162521|NCT04661579|589309667|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
163162522|NCT04661579|589309668|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
163162523|NCT04661579|589309669|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
163162524|NCT04661579|589309670|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
163162525|NCT03656562|589309671|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
163162526|NCT03656562|589309672|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
163162527|NCT03656562|589309673|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
163162528|NCT03656562|589309674|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
163162529|NCT03656562|589309671|FG000|Overall Study|Physician Decision|1|||
163162530|NCT03656562|589309672|FG001|Overall Study|Physician Decision|2|||
163162531|NCT03656562|589309673|FG002|Overall Study|Physician Decision|0|||
163162532|NCT03656562|589309674|FG003|Overall Study|Physician Decision|0|||
163162533|NCT03656562|589309671|FG000|Overall Study|Subject Decision|3|||
163162534|NCT03656562|589309672|FG001|Overall Study|Subject Decision|5|||
163162535|NCT03656562|589309673|FG002|Overall Study|Subject Decision|0|||
163162536|NCT03656562|589309674|FG003|Overall Study|Subject Decision|2|||
163162537|NCT04335136|589309675|FG000|Overall Study|Death|8|||
163162538|NCT04335136|589309676|FG001|Overall Study|Death|4|||
163162539|NCT04335136|589309675|FG000|Overall Study|Lost to Follow-up|2|||
163162540|NCT04335136|589309676|FG001|Overall Study|Lost to Follow-up|0|||
163162541|NCT04335136|589309675|FG000|Overall Study|Protocol Violation|1|||
163162542|NCT04335136|589309676|FG001|Overall Study|Protocol Violation|0|||
163162543|NCT04335136|589309675|FG000|Overall Study|Withdrawal by Subject|1|||
163162544|NCT04335136|589309676|FG001|Overall Study|Withdrawal by Subject|1|||
163162545|NCT04335136|589309675|FG000|Overall Study|Health-threatening condition|0|||
163162546|NCT04335136|589309676|FG001|Overall Study|Health-threatening condition|1|||
163162547|NCT04335136|589309675|FG000|Overall Study|Adverse Event|0|||
163162548|NCT04335136|589309676|FG001|Overall Study|Adverse Event|1|||
163162549|NCT04335136|589309675|FG000|Overall Study|Erroneously randomized|2|||
163162550|NCT04335136|589309676|FG001|Overall Study|Erroneously randomized|0|||
163162551|NCT01396447|589309677|FG000|Overall Study|Did Not Receive Treatment|3|||
163162552|NCT01396447|589309678|FG001|Overall Study|Did Not Receive Treatment|2|||
163162553|NCT01396447|589309679|FG002|Overall Study|Did Not Receive Treatment|1|||
163162554|NCT01396447|589309680|FG003|Overall Study|Did Not Receive Treatment|0|||
163162555|NCT01396447|589309677|FG000|Overall Study|Adverse Event|15|||
163162556|NCT01396447|589309678|FG001|Overall Study|Adverse Event|12|||
163162557|NCT01396447|589309679|FG002|Overall Study|Adverse Event|12|||
163162558|NCT01396447|589309680|FG003|Overall Study|Adverse Event|17|||
163162559|NCT01396447|589309677|FG000|Overall Study|Insufficient Therapeutic Response|5|||
163162560|NCT01396447|589309678|FG001|Overall Study|Insufficient Therapeutic Response|5|||
163162561|NCT01396447|589309679|FG002|Overall Study|Insufficient Therapeutic Response|2|||
163162562|NCT01396447|589309680|FG003|Overall Study|Insufficient Therapeutic Response|4|||
163162563|NCT01396447|589309677|FG000|Overall Study|Protocol Violation|5|||
163162564|NCT01396447|589309678|FG001|Overall Study|Protocol Violation|2|||
163162565|NCT01396447|589309679|FG002|Overall Study|Protocol Violation|3|||
163162566|NCT01396447|589309680|FG003|Overall Study|Protocol Violation|7|||
163162567|NCT01396447|589309677|FG000|Overall Study|Withdrawal of Consent|11|||
163162568|NCT01396447|589309678|FG001|Overall Study|Withdrawal of Consent|9|||
163162569|NCT01396447|589309679|FG002|Overall Study|Withdrawal of Consent|4|||
163162570|NCT01396447|589309680|FG003|Overall Study|Withdrawal of Consent|15|||
163162571|NCT01396447|589309677|FG000|Overall Study|Lost to Follow-up|4|||
163162572|NCT01396447|589309678|FG001|Overall Study|Lost to Follow-up|8|||
163162573|NCT01396447|589309679|FG002|Overall Study|Lost to Follow-up|7|||
163162574|NCT01396447|589309680|FG003|Overall Study|Lost to Follow-up|9|||
163162575|NCT01396447|589309677|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163162576|NCT01396447|589309678|FG001|Overall Study|Other Miscellaneous Reasons|2|||
163162577|NCT01396447|589309679|FG002|Overall Study|Other Miscellaneous Reasons|1|||
163162578|NCT01396447|589309680|FG003|Overall Study|Other Miscellaneous Reasons|0|||
163162579|NCT01402102|589309681|FG000|Overall Study|Protocol Violation|1|||
163162580|NCT01402102|589309682|FG001|Overall Study|Protocol Violation|0|||
163162581|NCT01402102|589309681|FG000|Overall Study|Insufficiency of compliance|1|||
163162582|NCT01402102|589309682|FG001|Overall Study|Insufficiency of compliance|1|||
163276231|NCT00924664|589721615|FG000|Overall Study|Lack of Efficacy|10|||
163276232|NCT00924664|589721616|FG001|Overall Study|Lack of Efficacy|15|||
163276233|NCT00924664|589721615|FG000|Overall Study|Lost to Follow-up|10|||
163276234|NCT00924664|589721616|FG001|Overall Study|Lost to Follow-up|12|||
163276235|NCT00924664|589721615|FG000|Overall Study|Withdrawal by Subject|47|||
163276236|NCT00924664|589721616|FG001|Overall Study|Withdrawal by Subject|71|||
163276237|NCT00924664|589721615|FG000|Overall Study|Protocol Violation|2|||
163276238|NCT00924664|589721616|FG001|Overall Study|Protocol Violation|5|||
163276239|NCT00924664|589721615|FG000|Overall Study|Pregnancy|1|||
163276240|NCT00924664|589721616|FG001|Overall Study|Pregnancy|1|||
163276241|NCT00924664|589721615|FG000|Overall Study|Death|0|||
163276242|NCT00924664|589721616|FG001|Overall Study|Death|2|||
163276243|NCT00924664|589721615|FG000|Overall Study|Study terminated by sponsor|199|||
163276244|NCT00924664|589721616|FG001|Overall Study|Study terminated by sponsor|330|||
163276245|NCT00924664|589721615|FG000|Overall Study|Other|29|||
163276246|NCT00924664|589721616|FG001|Overall Study|Other|52|||
163276247|NCT00924664|589721615|FG000|Overall Study|Randomized but not Treated|1|||
163276248|NCT00924664|589721616|FG001|Overall Study|Randomized but not Treated|0|||
163276249|NCT01598987|589721617|FG000|Baseline to Month 12|Administrative problems|2|||
163276250|NCT01598987|589721617|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
163162583|NCT01402102|589309681|FG000|Overall Study|Withdrawal by Subject|0|||
163162584|NCT01402102|589309682|FG001|Overall Study|Withdrawal by Subject|2|||
163162585|NCT04269265|589309683|FG000|Overall Study|Physician Decision|1|||
163162586|NCT04269265|589309683|FG000|Overall Study|Withdrawal by Subject|1|||
163162587|NCT04269265|589309683|FG000|Overall Study|Overenrolled (sample size reached)|4|||
163162588|NCT04693234|589309684|FG000|Overall Study|Death|79|||
163162589|NCT04693234|589309685|FG001|Overall Study|Death|19|||
163276251|NCT01598987|589721617|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
163276252|NCT01598987|589721617|FG000|Baseline to 24 Month|Administrative problems|2|||
163162590|NCT04693234|589309684|FG000|Overall Study|Sponsor Ended Study|47|||
163162591|NCT04693234|589309685|FG001|Overall Study|Sponsor Ended Study|18|||
163162592|NCT04693234|589309684|FG000|Overall Study|Withdrawal by Subject|10|||
163162593|NCT04693234|589309685|FG001|Overall Study|Withdrawal by Subject|2|||
163162594|NCT04693234|589309684|FG000|Overall Study|Lost to Follow-up|2|||
163162595|NCT04693234|589309685|FG001|Overall Study|Lost to Follow-up|1|||
163162596|NCT04838626|589309688|FG000|Overall Study|Adverse Event|2|||
163162597|NCT04838626|589309688|FG000|Overall Study|Physician Decision|6|||
163162598|NCT04838626|589309688|FG000|Overall Study|Protocol Violation|3|||
163162599|NCT04838626|589309688|FG000|Overall Study|Withdrawal by Subject|9|||
163162600|NCT04838626|589309688|FG000|Overall Study|Technical Problems|2|||
163162601|NCT02578706|589309689|FG000|Overall Study|Withdrawal by Subject|1|||
163162602|NCT02578706|589309690|FG001|Overall Study|Withdrawal by Subject|0|||
163162603|NCT02578706|589309691|FG002|Overall Study|Withdrawal by Subject|0|||
163162604|NCT02578706|589309689|FG000|Overall Study|Lost to Follow-up|0|||
163162605|NCT02578706|589309690|FG001|Overall Study|Lost to Follow-up|4|||
163162606|NCT02578706|589309691|FG002|Overall Study|Lost to Follow-up|0|||
163162607|NCT02578706|589309689|FG000|Overall Study|Physician Decision|0|||
163162608|NCT02578706|589309690|FG001|Overall Study|Physician Decision|1|||
163162609|NCT02578706|589309691|FG002|Overall Study|Physician Decision|0|||
163162610|NCT00670306|589309700|FG000|Overall Study|Adverse Event|8|||
163162611|NCT00670306|589309700|FG000|Overall Study|Lack of Efficacy|10|||
163162612|NCT00670306|589309700|FG000|Overall Study|Withdrawal by Subject|9|||
163162613|NCT00670306|589309700|FG000|Overall Study|Physician Decision|1|||
163162614|NCT00670306|589309700|FG000|Overall Study|Lost to Follow-up|8|||
163162615|NCT00670306|589309700|FG000|Overall Study|incl/excl criterias did not meet|19|||
163162616|NCT04939415|589309703|FG000|Overall Study|Withdrawal by Subject|1|||
163162617|NCT04939415|589309704|FG001|Overall Study|Withdrawal by Subject|3|||
163162618|NCT04939415|589309703|FG000|Overall Study|Lost to Follow-up|0|||
163162619|NCT04939415|589309704|FG001|Overall Study|Lost to Follow-up|2|||
163162620|NCT00067002|589309708|FG000|Overall Study|Early Death|1|||
163162621|NCT00067002|589309709|FG001|Overall Study|Early Death|2|||
163162622|NCT00067002|589309708|FG000|Overall Study|Delayed|1|||
163162623|NCT00067002|589309709|FG001|Overall Study|Delayed|1|||
163162624|NCT00067002|589309708|FG000|Overall Study|Graft Failure|5|||
163162625|NCT00067002|589309709|FG001|Overall Study|Graft Failure|6|||
163162626|NCT03350672|589309710|FG000|Overall Study|Withdrawal by Subject|7|||
163162627|NCT03350672|589309711|FG001|Overall Study|Withdrawal by Subject|0|||
163162628|NCT03350672|589309712|FG002|Overall Study|Withdrawal by Subject|0|||
163162629|NCT00478023|589309713|FG000|Overall Study|Adverse Event|11|||
163162630|NCT00478023|589309714|FG001|Overall Study|Adverse Event|7|||
163162631|NCT00478023|589309715|FG002|Overall Study|Adverse Event|8|||
163162632|NCT00478023|589309716|FG003|Overall Study|Adverse Event|14|||
163162633|NCT00478023|589309717|FG004|Overall Study|Adverse Event|6|||
163162634|NCT00478023|589309713|FG000|Overall Study|Death|1|||
163162635|NCT00478023|589309714|FG001|Overall Study|Death|0|||
163162636|NCT00478023|589309715|FG002|Overall Study|Death|0|||
163162637|NCT00478023|589309716|FG003|Overall Study|Death|0|||
163162638|NCT00478023|589309717|FG004|Overall Study|Death|0|||
163162639|NCT00478023|589309713|FG000|Overall Study|Lack of Efficacy|11|||
163162640|NCT00478023|589309714|FG001|Overall Study|Lack of Efficacy|10|||
163162641|NCT00478023|589309715|FG002|Overall Study|Lack of Efficacy|4|||
163162642|NCT00478023|589309716|FG003|Overall Study|Lack of Efficacy|5|||
163162643|NCT00478023|589309717|FG004|Overall Study|Lack of Efficacy|41|||
163162644|NCT00478023|589309713|FG000|Overall Study|Lost to Follow-up|3|||
163162645|NCT00478023|589309714|FG001|Overall Study|Lost to Follow-up|1|||
163162646|NCT00478023|589309715|FG002|Overall Study|Lost to Follow-up|1|||
163162647|NCT00478023|589309716|FG003|Overall Study|Lost to Follow-up|1|||
163162648|NCT00478023|589309717|FG004|Overall Study|Lost to Follow-up|0|||
163162649|NCT00478023|589309713|FG000|Overall Study|Withdrawal by Subject|2|||
163162650|NCT00478023|589309714|FG001|Overall Study|Withdrawal by Subject|3|||
163162651|NCT00478023|589309715|FG002|Overall Study|Withdrawal by Subject|2|||
163162652|NCT00478023|589309716|FG003|Overall Study|Withdrawal by Subject|4|||
163162653|NCT00478023|589309717|FG004|Overall Study|Withdrawal by Subject|5|||
163162654|NCT00478023|589309713|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
163162655|NCT00478023|589309714|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
163162656|NCT00478023|589309715|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
163162657|NCT00478023|589309716|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
163162658|NCT00478023|589309717|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
163162659|NCT03895840|589309719|FG000|Overall Study|Withdrawal by Subject|21|||
163162660|NCT01599637|589309722|FG000|Overall Study|administrative problems|0|||
163162661|NCT01599637|589309723|FG001|Overall Study|administrative problems|2|||
163162662|NCT01599637|589309724|FG002|Overall Study|administrative problems|0|||
163162663|NCT01599637|589309722|FG000|Overall Study|Adverse Event|1|||
163162664|NCT01599637|589309723|FG001|Overall Study|Adverse Event|0|||
163162665|NCT01599637|589309724|FG002|Overall Study|Adverse Event|0|||
163162666|NCT00611026|589309725|FG000|Randomized to Double-blind Treatment|Not treated|2|||
163162667|NCT00611026|589309726|FG001|Randomized to Double-blind Treatment|Not treated|1|||
163387468|NCT02993523|590129927|FG000|Overall Study|Lost to Follow-up|0|||
163162668|NCT00611026|589309727|FG002|Randomized to Double-blind Treatment|Not treated|3|||
163162669|NCT00611026|589309725|FG000|Double-blind Treatment Period|Death|1|||
163162670|NCT00611026|589309726|FG001|Double-blind Treatment Period|Death|0|||
163162671|NCT00611026|589309727|FG002|Double-blind Treatment Period|Death|0|||
163162672|NCT00611026|589309725|FG000|Double-blind Treatment Period|Adverse Event|9|||
163162673|NCT00611026|589309726|FG001|Double-blind Treatment Period|Adverse Event|28|||
163162674|NCT00611026|589309727|FG002|Double-blind Treatment Period|Adverse Event|46|||
163162675|NCT00611026|589309725|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
163162676|NCT00611026|589309726|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
163162677|NCT00611026|589309727|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
163162678|NCT00611026|589309725|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
163162679|NCT00611026|589309726|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
163162680|NCT00611026|589309727|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
163162681|NCT00611026|589309725|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
163162682|NCT00611026|589309726|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
163162683|NCT00611026|589309727|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
163162684|NCT00611026|589309725|FG000|Double-blind Treatment Period|Other|13|||
163162685|NCT00611026|589309726|FG001|Double-blind Treatment Period|Other|20|||
163162686|NCT00611026|589309727|FG002|Double-blind Treatment Period|Other|18|||
163162687|NCT00760617|589309728|FG000|Overall Study|Adverse Event|5|||
163162688|NCT00760617|589309729|FG001|Overall Study|Adverse Event|2|||
163162689|NCT00760617|589309730|FG002|Overall Study|Adverse Event|0|||
163162690|NCT00760617|589309728|FG000|Overall Study|Lost to Follow-up|0|||
163162691|NCT00760617|589309729|FG001|Overall Study|Lost to Follow-up|0|||
163162692|NCT00760617|589309730|FG002|Overall Study|Lost to Follow-up|5|||
163162693|NCT01192191|589309731|FG000|Overall Study|Adverse Event|7|||
163162694|NCT01192191|589309732|FG001|Overall Study|Adverse Event|12|||
163162695|NCT01192191|589309731|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
163162696|NCT01192191|589309732|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
163162697|NCT01192191|589309731|FG000|Overall Study|Lost to Follow-up|0|||
163162698|NCT01192191|589309732|FG001|Overall Study|Lost to Follow-up|1|||
163162699|NCT01192191|589309731|FG000|Overall Study|Withdrawal by Subject|1|||
163162700|NCT01192191|589309732|FG001|Overall Study|Withdrawal by Subject|6|||
163162701|NCT01047553|589309733|FG000|Overall Study|Adverse Event|10|||
163162702|NCT01047553|589309734|FG001|Overall Study|Adverse Event|5|||
163162703|NCT01047553|589309733|FG000|Overall Study|Withdrawal by Subject|4|||
163162704|NCT01047553|589309734|FG001|Overall Study|Withdrawal by Subject|2|||
163162705|NCT01047553|589309733|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
163162706|NCT01047553|589309734|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
163162707|NCT01047553|589309733|FG000|Overall Study|Lost to Follow-up|1|||
163162708|NCT01047553|589309734|FG001|Overall Study|Lost to Follow-up|0|||
163162709|NCT01047553|589309733|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
163162710|NCT01047553|589309734|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
163162711|NCT01047553|589309733|FG000|Overall Study|PI's decision|0|||
163162712|NCT01047553|589309734|FG001|Overall Study|PI's decision|1|||
163162713|NCT02817464|589309736|FG000|Overall Study|Lost to Follow-up|1|||
163162714|NCT02817464|589309737|FG001|Overall Study|Lost to Follow-up|0|||
163162715|NCT02817464|589309736|FG000|Overall Study|Discontinued early due to personal decision|1|||
163162716|NCT02817464|589309737|FG001|Overall Study|Discontinued early due to personal decision|1|||
163162717|NCT04292899|589309739|FG000|Overall Study|Death|21|||
163162718|NCT04292899|589309740|FG001|Overall Study|Death|28|||
163162719|NCT04292899|589309741|FG002|Overall Study|Death|188|||
163162720|NCT04292899|589309742|FG003|Overall Study|Death|371|||
163162721|NCT04292899|589309739|FG000|Overall Study|Lost to Follow-up|8|||
163162722|NCT04292899|589309740|FG001|Overall Study|Lost to Follow-up|4|||
163162723|NCT04292899|589309741|FG002|Overall Study|Lost to Follow-up|22|||
163162724|NCT04292899|589309742|FG003|Overall Study|Lost to Follow-up|235|||
163162725|NCT04292899|589309739|FG000|Overall Study|Withdrew consent|1|||
163162726|NCT04292899|589309740|FG001|Overall Study|Withdrew consent|0|||
163162727|NCT04292899|589309741|FG002|Overall Study|Withdrew consent|11|||
163162728|NCT04292899|589309742|FG003|Overall Study|Withdrew consent|32|||
163162729|NCT04292899|589309739|FG000|Overall Study|Adverse Event|2|||
163162730|NCT04292899|589309740|FG001|Overall Study|Adverse Event|1|||
163162731|NCT04292899|589309741|FG002|Overall Study|Adverse Event|2|||
163162732|NCT04292899|589309742|FG003|Overall Study|Adverse Event|2|||
163162733|NCT04292899|589309739|FG000|Overall Study|Investigator's Discretion|0|||
163162734|NCT04292899|589309740|FG001|Overall Study|Investigator's Discretion|0|||
163162735|NCT04292899|589309741|FG002|Overall Study|Investigator's Discretion|0|||
163162736|NCT04292899|589309742|FG003|Overall Study|Investigator's Discretion|3|||
163162737|NCT04292899|589309739|FG000|Overall Study|Non-compliance With Study Drug|0|||
163162738|NCT04292899|589309740|FG001|Overall Study|Non-compliance With Study Drug|0|||
163162739|NCT04292899|589309741|FG002|Overall Study|Non-compliance With Study Drug|0|||
163162740|NCT04292899|589309742|FG003|Overall Study|Non-compliance With Study Drug|1|||
163162741|NCT04292899|589309739|FG000|Overall Study|Protocol Violation|0|||
163162742|NCT04292899|589309740|FG001|Overall Study|Protocol Violation|0|||
163162743|NCT04292899|589309741|FG002|Overall Study|Protocol Violation|0|||
163162744|NCT04292899|589309742|FG003|Overall Study|Protocol Violation|1|||
163162745|NCT00948441|589309743|FG000|Overall Study|no longer meet inclusion criteria|1|||
163162746|NCT00948441|589309744|FG001|Overall Study|no longer meet inclusion criteria|4|||
163162747|NCT01026324|589309745|FG000|Follow up/Survival|Withdrawal by Subject|1|||
163162748|NCT01026324|589309746|FG001|Follow up/Survival|Withdrawal by Subject|0|||
163162749|NCT01026324|589309747|FG002|Follow up/Survival|Withdrawal by Subject|0|||
163162750|NCT05340478|589309754|FG000|Overall Study|Scheduling Issues|10|||
163162751|NCT05340478|589309755|FG001|Overall Study|Scheduling Issues|4|||
163162752|NCT05340478|589309754|FG000|Overall Study|Neither member of dyad started treatment|2|||
163162753|NCT05340478|589309755|FG001|Overall Study|Neither member of dyad started treatment|2|||
163162754|NCT05340478|589309754|FG000|Overall Study|Withdrawn from study|2|||
163162755|NCT05340478|589309755|FG001|Overall Study|Withdrawn from study|2|||
163162756|NCT05340478|589309754|FG000|Overall Study|Lost to Follow-up|1|||
163162757|NCT05340478|589309755|FG001|Overall Study|Lost to Follow-up|4|||
163162758|NCT01032889|589309758|FG000|Overall Study|Adverse Event|2|||
163162759|NCT01032889|589309759|FG001|Overall Study|Adverse Event|2|||
163162760|NCT01032889|589309760|FG002|Overall Study|Adverse Event|0|||
163162761|NCT01032889|589309758|FG000|Overall Study|Withdrawal of Consent|1|||
163162762|NCT01032889|589309759|FG001|Overall Study|Withdrawal of Consent|2|||
163162763|NCT01032889|589309760|FG002|Overall Study|Withdrawal of Consent|1|||
163162764|NCT01032889|589309758|FG000|Overall Study|Patient Request|0|||
163162765|NCT01032889|589309759|FG001|Overall Study|Patient Request|1|||
163162766|NCT01032889|589309760|FG002|Overall Study|Patient Request|0|||
163162767|NCT01032889|589309758|FG000|Overall Study|Lost to Follow-up|1|||
163162768|NCT01032889|589309759|FG001|Overall Study|Lost to Follow-up|1|||
163162769|NCT01032889|589309760|FG002|Overall Study|Lost to Follow-up|0|||
163162770|NCT01032889|589309758|FG000|Overall Study|Lack of Submental Fat|2|||
163162771|NCT01032889|589309759|FG001|Overall Study|Lack of Submental Fat|8|||
163162772|NCT01032889|589309760|FG002|Overall Study|Lack of Submental Fat|1|||
163162773|NCT01032889|589309758|FG000|Overall Study|Miscellaneous Reasons|2|||
163162774|NCT01032889|589309759|FG001|Overall Study|Miscellaneous Reasons|1|||
163162775|NCT01032889|589309760|FG002|Overall Study|Miscellaneous Reasons|1|||
163162776|NCT01500720|589309761|FG000|Overall Study|Randomized But Not Treated|1|||
163162777|NCT01500720|589309762|FG001|Overall Study|Randomized But Not Treated|1|||
163162778|NCT01500720|589309761|FG000|Overall Study|Other|4|||
163162779|NCT01500720|589309762|FG001|Overall Study|Other|8|||
163162780|NCT02624986|589309763|FG000|Overall Study|Death|0|||
163162781|NCT02624986|589309764|FG001|Overall Study|Death|1|||
163162782|NCT02624986|589309765|FG002|Overall Study|Death|2|||
163162783|NCT02624986|589309766|FG003|Overall Study|Death|2|||
163162784|NCT02624986|589309767|FG004|Overall Study|Death|2|||
163162785|NCT02624986|589309768|FG005|Overall Study|Death|0|||
163162786|NCT02624986|589309769|FG006|Overall Study|Death|0|||
163162787|NCT02624986|589309770|FG007|Overall Study|Death|1|||
163162788|NCT02624986|589309763|FG000|Overall Study|Study Terminated by Sponsor|1|||
163162789|NCT02624986|589309764|FG001|Overall Study|Study Terminated by Sponsor|1|||
163162790|NCT02624986|589309765|FG002|Overall Study|Study Terminated by Sponsor|0|||
163162791|NCT02624986|589309766|FG003|Overall Study|Study Terminated by Sponsor|1|||
163162792|NCT02624986|589309767|FG004|Overall Study|Study Terminated by Sponsor|2|||
163162793|NCT02624986|589309768|FG005|Overall Study|Study Terminated by Sponsor|2|||
163162794|NCT02624986|589309769|FG006|Overall Study|Study Terminated by Sponsor|4|||
163162795|NCT02624986|589309770|FG007|Overall Study|Study Terminated by Sponsor|3|||
163162796|NCT02624986|589309763|FG000|Overall Study|Progressive Disease|0|||
163162797|NCT02624986|589309764|FG001|Overall Study|Progressive Disease|1|||
163162798|NCT02624986|589309765|FG002|Overall Study|Progressive Disease|0|||
163162799|NCT02624986|589309766|FG003|Overall Study|Progressive Disease|0|||
163162800|NCT02624986|589309767|FG004|Overall Study|Progressive Disease|0|||
163162801|NCT02624986|589309768|FG005|Overall Study|Progressive Disease|0|||
163162802|NCT02624986|589309769|FG006|Overall Study|Progressive Disease|0|||
163162803|NCT02624986|589309770|FG007|Overall Study|Progressive Disease|0|||
163162804|NCT02624986|589309763|FG000|Overall Study|Protocol Violation|1|||
163162805|NCT02624986|589309764|FG001|Overall Study|Protocol Violation|0|||
163162806|NCT02624986|589309765|FG002|Overall Study|Protocol Violation|0|||
163162807|NCT02624986|589309766|FG003|Overall Study|Protocol Violation|0|||
163162808|NCT02624986|589309767|FG004|Overall Study|Protocol Violation|0|||
163162809|NCT02624986|589309768|FG005|Overall Study|Protocol Violation|0|||
163162810|NCT02624986|589309769|FG006|Overall Study|Protocol Violation|0|||
163162811|NCT02624986|589309770|FG007|Overall Study|Protocol Violation|0|||
163162812|NCT02624986|589309763|FG000|Overall Study|Withdrawal by Subject|0|||
163162813|NCT02624986|589309764|FG001|Overall Study|Withdrawal by Subject|0|||
163162814|NCT02624986|589309765|FG002|Overall Study|Withdrawal by Subject|0|||
163162815|NCT02624986|589309766|FG003|Overall Study|Withdrawal by Subject|0|||
163162816|NCT02624986|589309767|FG004|Overall Study|Withdrawal by Subject|0|||
163162817|NCT02624986|589309768|FG005|Overall Study|Withdrawal by Subject|0|||
163162818|NCT02624986|589309769|FG006|Overall Study|Withdrawal by Subject|0|||
163162819|NCT02624986|589309770|FG007|Overall Study|Withdrawal by Subject|1|||
163162820|NCT03532451|589309772|FG000|Overall Study|Withdrawal by Subject|0|||
163162821|NCT03532451|589309773|FG001|Overall Study|Withdrawal by Subject|1|||
163162822|NCT03532451|589309772|FG000|Overall Study|Did not undergo surgery|1|||
163162823|NCT03532451|589309773|FG001|Overall Study|Did not undergo surgery|1|||
163162824|NCT02116205|589309774|FG000|Overall Study|Withdrawal by Subject|2|||
163162825|NCT02116205|589309775|FG001|Overall Study|Withdrawal by Subject|4|||
163162826|NCT02116205|589309776|FG002|Overall Study|Withdrawal by Subject|1|||
163162827|NCT02116205|589309777|FG003|Overall Study|Withdrawal by Subject|3|||
163162828|NCT02116205|589309774|FG000|Overall Study|Lost to Follow-up|0|||
163162829|NCT02116205|589309775|FG001|Overall Study|Lost to Follow-up|2|||
163162830|NCT02116205|589309776|FG002|Overall Study|Lost to Follow-up|1|||
163162831|NCT02116205|589309777|FG003|Overall Study|Lost to Follow-up|2|||
163162832|NCT02116205|589309774|FG000|Overall Study|Physician Decision|0|||
163162833|NCT02116205|589309775|FG001|Overall Study|Physician Decision|1|||
163162834|NCT02116205|589309776|FG002|Overall Study|Physician Decision|1|||
163162835|NCT02116205|589309777|FG003|Overall Study|Physician Decision|1|||
163162836|NCT02116205|589309774|FG000|Overall Study|Exclusion criteria|0|||
163162837|NCT02116205|589309775|FG001|Overall Study|Exclusion criteria|0|||
163162838|NCT02116205|589309776|FG002|Overall Study|Exclusion criteria|1|||
163162839|NCT02116205|589309777|FG003|Overall Study|Exclusion criteria|0|||
163162840|NCT00525161|589309780|FG000|Overall Study|Adverse Event|1|||
163162841|NCT01076361|589309781|FG000|Overall Study|22 leads were excluded from analysis|21|||
163162842|NCT00630838|589309791|FG000|Overall Study|Death|0|||
163162843|NCT00630838|589309792|FG001|Overall Study|Death|1|||
163162844|NCT00630838|589309791|FG000|Overall Study|Lost to Follow-up|0|||
163162845|NCT00630838|589309792|FG001|Overall Study|Lost to Follow-up|1|||
163162846|NCT00928408|589309793|FG000|Overall Study|Other|2|||
163162847|NCT00928408|589309793|FG000|Overall Study|Withdrawal by Subject|4|||
163162848|NCT00928408|589309793|FG000|Overall Study|Death|5|||
163162849|NCT00928408|589309793|FG000|Overall Study|Lost to Follow-up|12|||
163162850|NCT00256997|589309798|FG000|Overall Study|Protocol Violation|1|||
163162851|NCT00256997|589309799|FG001|Overall Study|Protocol Violation|4|||
163162852|NCT00256997|589309798|FG000|Overall Study|Lack of Efficacy|1|||
163162853|NCT00256997|589309799|FG001|Overall Study|Lack of Efficacy|4|||
163162854|NCT00256997|589309798|FG000|Overall Study|Death|2|||
163162855|NCT00256997|589309799|FG001|Overall Study|Death|0|||
163162856|NCT00256997|589309798|FG000|Overall Study|Adverse Event|4|||
163162857|NCT00256997|589309799|FG001|Overall Study|Adverse Event|0|||
163162858|NCT00256997|589309798|FG000|Overall Study|Lost to Follow-up|3|||
163162859|NCT00256997|589309799|FG001|Overall Study|Lost to Follow-up|5|||
163162860|NCT00256997|589309798|FG000|Overall Study|Withdrawal by Subject|13|||
163162861|NCT00256997|589309799|FG001|Overall Study|Withdrawal by Subject|3|||
163162862|NCT00256997|589309798|FG000|Overall Study|Started but not treated|2|||
163162863|NCT00256997|589309799|FG001|Overall Study|Started but not treated|0|||
163162864|NCT00256997|589309798|FG000|Overall Study|Other|5|||
163162865|NCT00256997|589309799|FG001|Overall Study|Other|8|||
163162866|NCT00256997|589309798|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
163162867|NCT00256997|589309799|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
163162868|NCT00256997|589309798|FG000|Overall Study|Participant Non-compliant|3|||
163162869|NCT00256997|589309799|FG001|Overall Study|Participant Non-compliant|6|||
163162870|NCT00256997|589309798|FG000|Overall Study|Investigator Withdrew Participant|2|||
163162871|NCT00256997|589309799|FG001|Overall Study|Investigator Withdrew Participant|1|||
163162872|NCT04672655|589309804|FG000|Overall Study|Lost to Follow-up|12|||
163162873|NCT04672655|589309805|FG001|Overall Study|Lost to Follow-up|17|||
163162874|NCT04672655|589309804|FG000|Overall Study|Withdrawal by Subject|1|||
163162875|NCT04672655|589309805|FG001|Overall Study|Withdrawal by Subject|0|||
163162876|NCT04672655|589309804|FG000|Overall Study|Withdrawal by Study|1|||
163162877|NCT04672655|589309805|FG001|Overall Study|Withdrawal by Study|0|||
163162878|NCT01326104|589309806|FG000|Overall Study|progressed prior to vaccine|0|||
163162879|NCT01326104|589309807|FG001|Overall Study|progressed prior to vaccine|2|||
163162880|NCT01326104|589309806|FG000|Overall Study|unable to make vaccine|0|||
163162881|NCT01326104|589309807|FG001|Overall Study|unable to make vaccine|2|||
163162882|NCT01287741|589309808|FG000|Overall Study|Withdrawal by Subject|35|||
163162883|NCT01287741|589309809|FG001|Overall Study|Withdrawal by Subject|38|||
163162884|NCT01287741|589309808|FG000|Overall Study|Protocol Violation|2|||
163162885|NCT01287741|589309809|FG001|Overall Study|Protocol Violation|0|||
163162886|NCT01287741|589309808|FG000|Overall Study|Physician Decision|15|||
163162887|NCT01287741|589309809|FG001|Overall Study|Physician Decision|23|||
163162888|NCT01287741|589309808|FG000|Overall Study|Non-compliance|8|||
163162889|NCT01287741|589309809|FG001|Overall Study|Non-compliance|6|||
163162890|NCT01287741|589309808|FG000|Overall Study|Lost to Follow-up|10|||
163162891|NCT01287741|589309809|FG001|Overall Study|Lost to Follow-up|8|||
163162892|NCT01287741|589309808|FG000|Overall Study|Death|32|||
163162893|NCT01287741|589309809|FG001|Overall Study|Death|44|||
163162894|NCT01287741|589309808|FG000|Overall Study|Adverse Event|4|||
163162895|NCT01287741|589309809|FG001|Overall Study|Adverse Event|6|||
163162896|NCT01287741|589309808|FG000|Overall Study|Study terminated by Sponsor|307|||
163162897|NCT01287741|589309809|FG001|Overall Study|Study terminated by Sponsor|315|||
163162898|NCT01287741|589309808|FG000|Overall Study|Progressive disease|190|||
163162899|NCT01287741|589309809|FG001|Overall Study|Progressive disease|166|||
163162900|NCT01287741|589309808|FG000|Overall Study|Reason not specified|23|||
163162901|NCT01287741|589309809|FG001|Overall Study|Reason not specified|9|||
163162902|NCT03843541|589309810|FG000|Overall Study|Adverse Event|4|||
163162903|NCT03843541|589309811|FG001|Overall Study|Adverse Event|2|||
163162904|NCT03843541|589309812|FG002|Overall Study|Adverse Event|3|||
163162905|NCT03843541|589309810|FG000|Overall Study|Death|1|||
163162906|NCT03843541|589309811|FG001|Overall Study|Death|0|||
163162907|NCT03843541|589309812|FG002|Overall Study|Death|0|||
163162908|NCT03843541|589309810|FG000|Overall Study|Lack of adherence to study medication|0|||
163162909|NCT03843541|589309811|FG001|Overall Study|Lack of adherence to study medication|0|||
163162910|NCT03843541|589309812|FG002|Overall Study|Lack of adherence to study medication|1|||
163162911|NCT03843541|589309810|FG000|Overall Study|Physician Decision|1|||
163162912|NCT03843541|589309811|FG001|Overall Study|Physician Decision|2|||
163162913|NCT03843541|589309812|FG002|Overall Study|Physician Decision|2|||
163162914|NCT03843541|589309810|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
163162915|NCT03843541|589309811|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
163162916|NCT03843541|589309812|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
163162917|NCT03843541|589309810|FG000|Overall Study|Withdrawal by Subject|6|||
163162918|NCT03843541|589309811|FG001|Overall Study|Withdrawal by Subject|9|||
163162919|NCT03843541|589309812|FG002|Overall Study|Withdrawal by Subject|7|||
163162920|NCT03843541|589309810|FG000|Overall Study|Administration of rescue mucolytic|0|||
163162921|NCT03843541|589309811|FG001|Overall Study|Administration of rescue mucolytic|0|||
163162922|NCT03843541|589309812|FG002|Overall Study|Administration of rescue mucolytic|1|||
163162923|NCT03843541|589309810|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
163162924|NCT03843541|589309811|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
163162925|NCT03843541|589309812|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
163162926|NCT02930018|589309814|FG000|Overall Study|Lost to Follow-up|1|||
163162927|NCT02930018|589309815|FG001|Overall Study|Lost to Follow-up|1|||
163162928|NCT02930018|589309814|FG000|Overall Study|Withdrawal by Subject|5|||
163162929|NCT02930018|589309815|FG001|Overall Study|Withdrawal by Subject|2|||
163162930|NCT02807402|589309816|FG000|Overall Study|Failure to Return|1|||
163162931|NCT02807402|589309816|FG000|Overall Study|Death|3|||
163162932|NCT02807402|589309816|FG000|Overall Study|Other|2|||
163162933|NCT00479687|589311245|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
163162934|NCT00479687|589311246|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
163162935|NCT00479687|589311247|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
163162936|NCT00479687|589311245|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
163162937|NCT00479687|589311246|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
163162938|NCT00479687|589311247|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
163162939|NCT00479687|589311245|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
163276253|NCT01598987|589721617|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
163162940|NCT00479687|589311246|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
163162941|NCT00479687|589311247|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
163162942|NCT00479687|589311245|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
163162943|NCT00479687|589311246|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
163162944|NCT00479687|589311247|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
163162945|NCT00479687|589311245|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
163162946|NCT00479687|589311246|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
163162947|NCT00479687|589311247|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
163162948|NCT00479687|589311245|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
163162949|NCT00479687|589311246|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
163162950|NCT00479687|589311247|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
163162951|NCT00479687|589311245|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
163162952|NCT00479687|589311246|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
163162953|NCT00479687|589311247|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
163162954|NCT00479687|589311245|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
163162955|NCT00479687|589311246|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
163162956|NCT00479687|589311247|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
163162957|NCT00479687|589311245|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
163162958|NCT00479687|589311246|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
163162959|NCT00479687|589311247|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
163162960|NCT00796419|589311251|FG000|Overall Study|Death|0|||
163162961|NCT00796419|589311252|FG001|Overall Study|Death|1|||
163162962|NCT02840799|589311255|FG000|Phase 1|Physician Decision|1|||
163162963|NCT02840799|589311256|FG001|Phase 1|Physician Decision|3|||
163162964|NCT02840799|589311255|FG000|Phase 1|Withdrawal by Subject|4|||
163162965|NCT02840799|589311256|FG001|Phase 1|Withdrawal by Subject|0|||
163162966|NCT02840799|589311255|FG000|Phase 2 (Crossover)|Adverse Event|0|||
163162967|NCT02840799|589311256|FG001|Phase 2 (Crossover)|Adverse Event|1|||
163162968|NCT02840799|589311255|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
163162969|NCT02840799|589311256|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
163162970|NCT02687191|589311263|FG000|Overall Study|Death|0|||
163162971|NCT02687191|589311264|FG001|Overall Study|Death|1|||
163162972|NCT02687191|589311265|FG002|Overall Study|Death|1|||
163162973|NCT02687191|589311266|FG003|Overall Study|Death|0|||
163162974|NCT02687191|589311267|FG004|Overall Study|Death|1|||
163162975|NCT02687191|589311268|FG005|Overall Study|Death|1|||
163162976|NCT02687191|589311263|FG000|Overall Study|Withdrawal by Subject|0|||
163162977|NCT02687191|589311264|FG001|Overall Study|Withdrawal by Subject|0|||
163162978|NCT02687191|589311265|FG002|Overall Study|Withdrawal by Subject|0|||
163162979|NCT02687191|589311266|FG003|Overall Study|Withdrawal by Subject|1|||
163162980|NCT02687191|589311267|FG004|Overall Study|Withdrawal by Subject|0|||
163162981|NCT02687191|589311268|FG005|Overall Study|Withdrawal by Subject|0|||
163162982|NCT01349049|589311269|FG000|Overall Study|Disease progression|3|||
163162983|NCT01349049|589311270|FG001|Overall Study|Disease progression|5|||
163162984|NCT01349049|589311271|FG002|Overall Study|Disease progression|3|||
163162985|NCT01349049|589311272|FG003|Overall Study|Disease progression|2|||
163162986|NCT01349049|589311273|FG004|Overall Study|Disease progression|2|||
163162987|NCT01349049|589311274|FG005|Overall Study|Disease progression|2|||
163162988|NCT01349049|589311275|FG006|Overall Study|Disease progression|3|||
163162989|NCT01349049|589311276|FG007|Overall Study|Disease progression|2|||
163162990|NCT01349049|589311277|FG008|Overall Study|Disease progression|33|||
163162991|NCT01349049|589311269|FG000|Overall Study|Adverse Event|0|||
163162992|NCT01349049|589311270|FG001|Overall Study|Adverse Event|1|||
163162993|NCT01349049|589311271|FG002|Overall Study|Adverse Event|0|||
163162994|NCT01349049|589311272|FG003|Overall Study|Adverse Event|0|||
163162995|NCT01349049|589311273|FG004|Overall Study|Adverse Event|0|||
163162996|NCT01349049|589311274|FG005|Overall Study|Adverse Event|3|||
163162997|NCT01349049|589311275|FG006|Overall Study|Adverse Event|1|||
163162998|NCT01349049|589311276|FG007|Overall Study|Adverse Event|0|||
163162999|NCT01349049|589311277|FG008|Overall Study|Adverse Event|4|||
163163000|NCT01349049|589311269|FG000|Overall Study|Physician Decision|0|||
163163001|NCT01349049|589311270|FG001|Overall Study|Physician Decision|1|||
163163002|NCT01349049|589311271|FG002|Overall Study|Physician Decision|0|||
163163003|NCT01349049|589311272|FG003|Overall Study|Physician Decision|0|||
163163004|NCT01349049|589311273|FG004|Overall Study|Physician Decision|0|||
163163005|NCT01349049|589311274|FG005|Overall Study|Physician Decision|0|||
163163006|NCT01349049|589311275|FG006|Overall Study|Physician Decision|0|||
163163007|NCT01349049|589311276|FG007|Overall Study|Physician Decision|0|||
163163008|NCT01349049|589311277|FG008|Overall Study|Physician Decision|2|||
163163009|NCT01349049|589311269|FG000|Overall Study|Protocol Violation|0|||
163163010|NCT01349049|589311270|FG001|Overall Study|Protocol Violation|0|||
163163011|NCT01349049|589311271|FG002|Overall Study|Protocol Violation|0|||
163163012|NCT01349049|589311272|FG003|Overall Study|Protocol Violation|0|||
163163013|NCT01349049|589311273|FG004|Overall Study|Protocol Violation|0|||
163163014|NCT01349049|589311274|FG005|Overall Study|Protocol Violation|0|||
163163015|NCT01349049|589311275|FG006|Overall Study|Protocol Violation|0|||
163163016|NCT01349049|589311276|FG007|Overall Study|Protocol Violation|0|||
163163017|NCT01349049|589311277|FG008|Overall Study|Protocol Violation|1|||
163163018|NCT01349049|589311269|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
163163019|NCT01349049|589311270|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
163163020|NCT01349049|589311271|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
163163021|NCT01349049|589311272|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
163163022|NCT01349049|589311273|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
163163023|NCT01349049|589311274|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
163163024|NCT01349049|589311275|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
163163025|NCT01349049|589311276|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
163163026|NCT01349049|589311277|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
163163027|NCT01349049|589311269|FG000|Overall Study|Other|0|||
163163028|NCT01349049|589311270|FG001|Overall Study|Other|0|||
163163029|NCT01349049|589311271|FG002|Overall Study|Other|0|||
163163030|NCT01349049|589311272|FG003|Overall Study|Other|0|||
163163031|NCT01349049|589311273|FG004|Overall Study|Other|0|||
163163032|NCT01349049|589311274|FG005|Overall Study|Other|1|||
163163033|NCT01349049|589311275|FG006|Overall Study|Other|0|||
163163034|NCT01349049|589311276|FG007|Overall Study|Other|0|||
163163035|NCT01349049|589311277|FG008|Overall Study|Other|4|||
163163036|NCT01349049|589311269|FG000|Overall Study|Death|0|||
163163037|NCT01349049|589311270|FG001|Overall Study|Death|0|||
163163038|NCT01349049|589311271|FG002|Overall Study|Death|0|||
163163039|NCT01349049|589311272|FG003|Overall Study|Death|0|||
163163040|NCT01349049|589311273|FG004|Overall Study|Death|0|||
163163041|NCT01349049|589311274|FG005|Overall Study|Death|0|||
163163042|NCT01349049|589311275|FG006|Overall Study|Death|0|||
163163043|NCT01349049|589311276|FG007|Overall Study|Death|1|||
163163044|NCT01349049|589311277|FG008|Overall Study|Death|5|||
163163045|NCT01349049|589311269|FG000|Overall Study|Non-compliance|0|||
163163046|NCT01349049|589311270|FG001|Overall Study|Non-compliance|0|||
163163047|NCT01349049|589311271|FG002|Overall Study|Non-compliance|0|||
163163048|NCT01349049|589311272|FG003|Overall Study|Non-compliance|1|||
163163049|NCT01349049|589311273|FG004|Overall Study|Non-compliance|0|||
163163050|NCT01349049|589311274|FG005|Overall Study|Non-compliance|0|||
163163051|NCT01349049|589311275|FG006|Overall Study|Non-compliance|0|||
163163052|NCT01349049|589311276|FG007|Overall Study|Non-compliance|0|||
163163053|NCT01349049|589311277|FG008|Overall Study|Non-compliance|0|||
163163054|NCT01349049|589311269|FG000|Overall Study|Withdrawal by Subject|0|||
163163055|NCT01349049|589311270|FG001|Overall Study|Withdrawal by Subject|0|||
163163056|NCT01349049|589311271|FG002|Overall Study|Withdrawal by Subject|0|||
163163057|NCT01349049|589311272|FG003|Overall Study|Withdrawal by Subject|0|||
163163058|NCT01349049|589311273|FG004|Overall Study|Withdrawal by Subject|0|||
163163059|NCT01349049|589311274|FG005|Overall Study|Withdrawal by Subject|0|||
163163060|NCT01349049|589311275|FG006|Overall Study|Withdrawal by Subject|0|||
163163061|NCT01349049|589311276|FG007|Overall Study|Withdrawal by Subject|0|||
163163062|NCT01349049|589311277|FG008|Overall Study|Withdrawal by Subject|6|||
163163063|NCT03887702|589311278|FG000|Overall Study|Study terminated|0|||
163163064|NCT03887702|589311279|FG001|Overall Study|Study terminated|0|||
163163065|NCT03887702|589311280|FG002|Overall Study|Study terminated|2|||
163163066|NCT03887702|589311281|FG003|Overall Study|Study terminated|2|||
163163067|NCT01643772|589311282|FG000|Overall Study|Protocol Violation|0|||
163163068|NCT01643772|589311283|FG001|Overall Study|Protocol Violation|0|||
163163069|NCT01643772|589311284|FG002|Overall Study|Protocol Violation|0|||
163163070|NCT01643772|589311285|FG003|Overall Study|Protocol Violation|1|||
163163071|NCT01643772|589311282|FG000|Overall Study|Adverse Event|0|||
163163072|NCT01643772|589311283|FG001|Overall Study|Adverse Event|0|||
163163073|NCT01643772|589311284|FG002|Overall Study|Adverse Event|0|||
163163074|NCT01643772|589311285|FG003|Overall Study|Adverse Event|1|||
163163075|NCT03860818|589311286|FG000|Overall Study|Death|144|||
163163076|NCT03860818|589311287|FG001|Overall Study|Death|195|||
163163077|NCT03860818|589311286|FG000|Overall Study|Graft Loss|32|||
163163078|NCT03860818|589311287|FG001|Overall Study|Graft Loss|45|||
163163079|NCT00505778|589311288|FG000|Overall Study|Adverse Event|2|||
163163080|NCT00505778|589311289|FG001|Overall Study|Adverse Event|7|||
163163081|NCT00505778|589311288|FG000|Overall Study|Physician Decision|8|||
163163082|NCT00505778|589311289|FG001|Overall Study|Physician Decision|14|||
163163083|NCT00505778|589311288|FG000|Overall Study|Lost to Follow-up|17|||
163163084|NCT00505778|589311289|FG001|Overall Study|Lost to Follow-up|23|||
163163085|NCT00505778|589311288|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
163163086|NCT00505778|589311289|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
163163087|NCT00505778|589311288|FG000|Overall Study|Protocol Violation|7|||
163163088|NCT00505778|589311289|FG001|Overall Study|Protocol Violation|9|||
163163089|NCT00505778|589311288|FG000|Overall Study|Withdrawal by Subject|29|||
163163090|NCT00505778|589311289|FG001|Overall Study|Withdrawal by Subject|14|||
163163091|NCT00505778|589311288|FG000|Overall Study|Relapse|65|||
163163092|NCT00505778|589311289|FG001|Overall Study|Relapse|65|||
163163093|NCT00505778|589311288|FG000|Overall Study|Took No Study Drug|2|||
163163094|NCT00505778|589311289|FG001|Overall Study|Took No Study Drug|2|||
163163095|NCT03436082|589311290|FG000|Overall Study|Did not undergo procedure|1|||
163163096|NCT03436082|589311291|FG001|Overall Study|Did not undergo procedure|0|||
163163097|NCT01864603|589311294|FG000|Stage 2|DSMB design modification|86056|||
163163098|NCT01864603|589311295|FG001|Stage 2|DSMB design modification|92558|||
163163099|NCT02423902|589311296|FG000|Overall Study|Disease progression|1|||
163163100|NCT02423902|589311297|FG001|Overall Study|Disease progression|4|||
163163101|NCT02136069|589311298|FG000|Overall Study|UC flare-up|1|||
163163102|NCT02136069|589311299|FG001|Overall Study|UC flare-up|0|||
163163103|NCT02136069|589311298|FG000|Overall Study|Adverse Event|6|||
163163104|NCT02136069|589311299|FG001|Overall Study|Adverse Event|8|||
163163105|NCT02136069|589311298|FG000|Overall Study|Death|0|||
163163106|NCT02136069|589311299|FG001|Overall Study|Death|1|||
163163107|NCT02136069|589311298|FG000|Overall Study|Lack of Efficacy|10|||
163163108|NCT02136069|589311299|FG001|Overall Study|Lack of Efficacy|4|||
163163109|NCT02136069|589311298|FG000|Overall Study|Lost to Follow-up|1|||
163163110|NCT02136069|589311299|FG001|Overall Study|Lost to Follow-up|0|||
163163111|NCT02136069|589311298|FG000|Overall Study|Non-Compliance|1|||
163163112|NCT02136069|589311299|FG001|Overall Study|Non-Compliance|0|||
163163113|NCT02136069|589311298|FG000|Overall Study|Physician Decision|5|||
163163114|NCT02136069|589311299|FG001|Overall Study|Physician Decision|4|||
163163115|NCT02136069|589311298|FG000|Overall Study|Withdrawal by Subject|10|||
163163116|NCT02136069|589311299|FG001|Overall Study|Withdrawal by Subject|11|||
163163117|NCT00811018|589311301|FG000|Overall Study|Additional Chronic Treatment|31|||
163163118|NCT00811018|589311301|FG000|Overall Study|Adverse Event|79|||
163163119|NCT00811018|589311301|FG000|Overall Study|Death|147|||
163163120|NCT00811018|589311301|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
163163121|NCT00811018|589311301|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
163163122|NCT00811018|589311301|FG000|Overall Study|Investigator Decision|57|||
163163123|NCT00811018|589311301|FG000|Overall Study|Lost to Follow-up|19|||
163163124|NCT00811018|589311301|FG000|Overall Study|Pregnancy|6|||
163163125|NCT00811018|589311301|FG000|Overall Study|Sponsor Decision|450|||
163163126|NCT00811018|589311301|FG000|Overall Study|Withdrawal by Subject|70|||
163163127|NCT00811018|589311301|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
163163128|NCT00811018|589311301|FG000|Overall Study|Other|26|||
163163129|NCT00392769|589311302|FG000|Overall Study|Clinical Deterioration|9|||
163163130|NCT00392769|589311302|FG000|Overall Study|Adverse Event|1|||
163163131|NCT04154189|589311303|FG000|Overall Study|Withdrawal by Subject|4|||
163163132|NCT04154189|589311304|FG001|Overall Study|Withdrawal by Subject|6|||
163163133|NCT04154189|589311303|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
163163134|NCT04154189|589311304|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
163163135|NCT04154189|589311303|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
163163136|NCT04154189|589311304|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
163163137|NCT04154189|589311303|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
163163138|NCT04154189|589311304|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
163163139|NCT04154189|589311303|FG000|Overall Study|Death|25|||
163163140|NCT04154189|589311304|FG001|Overall Study|Death|25|||
163163141|NCT00845897|589311307|FG000|Overall Study|Lost to Follow-up|1|||
163163142|NCT00845897|589311308|FG001|Overall Study|Lost to Follow-up|1|||
163163143|NCT00845897|589311309|FG002|Overall Study|Lost to Follow-up|0|||
163163144|NCT00845897|589311307|FG000|Overall Study|Withdrawal by Subject|0|||
163163145|NCT00845897|589311308|FG001|Overall Study|Withdrawal by Subject|3|||
163163146|NCT00845897|589311309|FG002|Overall Study|Withdrawal by Subject|2|||
163163147|NCT00845897|589311307|FG000|Overall Study|Ulcer did not heal|1|||
163163148|NCT00845897|589311308|FG001|Overall Study|Ulcer did not heal|0|||
163163149|NCT00845897|589311309|FG002|Overall Study|Ulcer did not heal|1|||
163163150|NCT00845897|589311307|FG000|Overall Study|Too ill to participate|0|||
163163151|NCT00845897|589311308|FG001|Overall Study|Too ill to participate|1|||
163163152|NCT00845897|589311309|FG002|Overall Study|Too ill to participate|0|||
163163153|NCT02722499|589311311|FG000|Overall Study|Lost to Follow-up|2|||
163163154|NCT02722499|589311312|FG001|Overall Study|Lost to Follow-up|0|||
163163155|NCT02722499|589311313|FG002|Overall Study|Lost to Follow-up|1|||
163163156|NCT04999852|589311314|FG000|Overall Study|Withdrawal by Subject|11|||
163163157|NCT04999852|589311315|FG001|Overall Study|Withdrawal by Subject|1|||
163163158|NCT04999852|589311314|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
163163159|NCT04999852|589311315|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
163163160|NCT05626322|589311316|FG000|Overall Study|Death|2|||
163163161|NCT05626322|589311317|FG001|Overall Study|Death|0|||
163163162|NCT05626322|589311318|FG002|Overall Study|Death|0|||
163163163|NCT05626322|589311316|FG000|Overall Study|Physician Decision|1|||
163163164|NCT05626322|589311317|FG001|Overall Study|Physician Decision|0|||
163163165|NCT05626322|589311318|FG002|Overall Study|Physician Decision|0|||
163163166|NCT05626322|589311316|FG000|Overall Study|Progressive Disease|0|||
163163167|NCT05626322|589311317|FG001|Overall Study|Progressive Disease|1|||
163163168|NCT05626322|589311318|FG002|Overall Study|Progressive Disease|1|||
163163169|NCT05626322|589311316|FG000|Overall Study|Study terminated by sponsor|0|||
163163170|NCT05626322|589311317|FG001|Overall Study|Study terminated by sponsor|1|||
163163171|NCT05626322|589311318|FG002|Overall Study|Study terminated by sponsor|0|||
163163172|NCT04758637|589311319|FG000|Overall Study|Lost to Follow-up|0|||
163163173|NCT04758637|589311320|FG001|Overall Study|Lost to Follow-up|1|||
163163174|NCT04758637|589311321|FG002|Overall Study|Lost to Follow-up|0|||
163163175|NCT04758637|589311322|FG003|Overall Study|Lost to Follow-up|0|||
163163176|NCT03610269|589311323|FG000|Overall Study|Physician Decision|10|||
163163177|NCT03610269|589311323|FG000|Overall Study|Protocol Violation|1|||
163163178|NCT03610269|589311323|FG000|Overall Study|Unable to draw blood|1|||
163163179|NCT03610269|589311323|FG000|Overall Study|Screen fail|4|||
163163180|NCT01354314|589311324|FG000|Overall Study|Lost to Follow-up|1|||
163163181|NCT01354314|589311325|FG001|Overall Study|Lost to Follow-up|0|||
163163182|NCT01354314|589311326|FG002|Overall Study|Lost to Follow-up|1|||
163163183|NCT01354314|589311327|FG003|Overall Study|Lost to Follow-up|1|||
163163184|NCT01354314|589311324|FG000|Overall Study|Withdrawal by Subject|0|||
163163185|NCT01354314|589311325|FG001|Overall Study|Withdrawal by Subject|0|||
163163186|NCT01354314|589311326|FG002|Overall Study|Withdrawal by Subject|1|||
163163187|NCT01354314|589311327|FG003|Overall Study|Withdrawal by Subject|0|||
163163188|NCT01354314|589311324|FG000|Overall Study|Adverse Event|0|||
163163189|NCT01354314|589311325|FG001|Overall Study|Adverse Event|0|||
163163190|NCT01354314|589311326|FG002|Overall Study|Adverse Event|0|||
163163191|NCT01354314|589311327|FG003|Overall Study|Adverse Event|1|||
163163192|NCT01354314|589311324|FG000|Overall Study|Protocol Violation|1|||
163163193|NCT01354314|589311325|FG001|Overall Study|Protocol Violation|1|||
163163194|NCT01354314|589311326|FG002|Overall Study|Protocol Violation|0|||
163163195|NCT01354314|589311327|FG003|Overall Study|Protocol Violation|0|||
163163196|NCT01354314|589311324|FG000|Overall Study|Less than 90% Adherence|4|||
163163197|NCT01354314|589311325|FG001|Overall Study|Less than 90% Adherence|2|||
163163198|NCT01354314|589311326|FG002|Overall Study|Less than 90% Adherence|6|||
163163199|NCT01354314|589311327|FG003|Overall Study|Less than 90% Adherence|4|||
163163200|NCT00369265|589311328|FG000|Overall Study|Study terminated|4|||
163163201|NCT00369265|589311329|FG001|Overall Study|Study terminated|7|||
163163202|NCT05019521|589311330|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
163163203|NCT05019521|589311331|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
163163204|NCT05019521|589311332|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
163163205|NCT05019521|589311333|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
163163206|NCT05019521|589311334|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
163163207|NCT05019521|589311335|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
163163208|NCT05019521|589311336|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
163163209|NCT05019521|589311330|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
163163210|NCT05019521|589311331|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
163163211|NCT05019521|589311332|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
163163212|NCT05019521|589311333|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
163163213|NCT05019521|589311334|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
163163214|NCT05019521|589311335|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
163163215|NCT05019521|589311336|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
163163216|NCT05019521|589311330|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
163163217|NCT05019521|589311331|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
163163218|NCT05019521|589311332|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
163163219|NCT05019521|589311333|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
163163220|NCT05019521|589311334|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
163163221|NCT05019521|589311335|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
163163222|NCT05019521|589311336|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
163163223|NCT05019521|589311330|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
163163224|NCT05019521|589311331|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
163163225|NCT05019521|589311332|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
163163226|NCT05019521|589311333|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
163163227|NCT05019521|589311334|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
163163228|NCT05019521|589311335|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
163163229|NCT05019521|589311336|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
163163230|NCT05019521|589311330|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
163163231|NCT05019521|589311331|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
163163232|NCT05019521|589311332|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
163163233|NCT05019521|589311333|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
163163234|NCT05019521|589311334|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
163163235|NCT05019521|589311335|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
163163236|NCT05019521|589311336|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
163163237|NCT05019521|589311330|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
163163238|NCT05019521|589311331|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163239|NCT05019521|589311332|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163240|NCT05019521|589311333|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163241|NCT05019521|589311334|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163242|NCT05019521|589311335|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163243|NCT05019521|589311336|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163244|NCT05019521|589311330|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
163163245|NCT05019521|589311331|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
163163246|NCT05019521|589311332|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
163163247|NCT05019521|589311333|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
163163248|NCT05019521|589311334|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
163163249|NCT05019521|589311335|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
163163250|NCT05019521|589311336|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
163163251|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
163163252|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
163163253|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
163163254|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
163163255|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
163163256|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
163163257|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
163163258|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
163163259|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
163163260|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
163163261|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
163163262|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
163163263|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
163163264|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
163163265|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
163163266|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
163163267|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
163163268|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
163163269|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
163163270|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
163163271|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
163163272|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
163163273|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
163163274|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
163163275|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
163163276|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
163163277|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
163163278|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
163163279|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
163163280|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
163163281|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
163163282|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
163163283|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
163163284|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
163163285|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
163163286|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163287|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163288|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163289|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163290|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163291|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
163163292|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163293|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
163163294|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
163163295|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
163276254|NCT03531905|589721618|FG000|Overall Study|Withdrawal by Subject|3|||
163276255|NCT03531905|589721619|FG001|Overall Study|Withdrawal by Subject|3|||
163276256|NCT03531905|589721620|FG002|Overall Study|Withdrawal by Subject|2|||
163276257|NCT03531905|589721618|FG000|Overall Study|Lost to Follow-up|2|||
163163296|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
163163297|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
163163298|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
163163299|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
163163300|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
163163301|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
163163302|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
163163303|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
163163304|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
163163305|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
163163306|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
163163307|NCT02721966|589311337|FG000|Overall Study|Protocol Violation|1|||
163163308|NCT02721966|589311338|FG001|Overall Study|Protocol Violation|0|||
163163309|NCT02721966|589311339|FG002|Overall Study|Protocol Violation|0|||
163163310|NCT02721966|589311340|FG003|Overall Study|Protocol Violation|0|||
163163311|NCT02721966|589311341|FG004|Overall Study|Protocol Violation|0|||
163163312|NCT02721966|589311337|FG000|Overall Study|Withdrawal by Subject|9|||
163163313|NCT02721966|589311338|FG001|Overall Study|Withdrawal by Subject|2|||
163163314|NCT02721966|589311339|FG002|Overall Study|Withdrawal by Subject|3|||
163163315|NCT02721966|589311340|FG003|Overall Study|Withdrawal by Subject|7|||
163163316|NCT02721966|589311341|FG004|Overall Study|Withdrawal by Subject|0|||
163163317|NCT02721966|589311337|FG000|Overall Study|Adverse Event|4|||
163163318|NCT02721966|589311338|FG001|Overall Study|Adverse Event|4|||
163163319|NCT02721966|589311339|FG002|Overall Study|Adverse Event|3|||
163163320|NCT02721966|589311340|FG003|Overall Study|Adverse Event|0|||
163163321|NCT02721966|589311341|FG004|Overall Study|Adverse Event|0|||
163163322|NCT02721966|589311337|FG000|Overall Study|Death|1|||
163163323|NCT02721966|589311338|FG001|Overall Study|Death|0|||
163163324|NCT02721966|589311339|FG002|Overall Study|Death|0|||
163163325|NCT02721966|589311340|FG003|Overall Study|Death|0|||
163163326|NCT02721966|589311341|FG004|Overall Study|Death|0|||
163163327|NCT02721966|589311337|FG000|Overall Study|Lack of Efficacy|7|||
163163328|NCT02721966|589311338|FG001|Overall Study|Lack of Efficacy|4|||
163163329|NCT02721966|589311339|FG002|Overall Study|Lack of Efficacy|0|||
163163330|NCT02721966|589311340|FG003|Overall Study|Lack of Efficacy|0|||
163163331|NCT02721966|589311341|FG004|Overall Study|Lack of Efficacy|0|||
163163332|NCT02721966|589311337|FG000|Overall Study|Lost to Follow-up|0|||
163163333|NCT02721966|589311338|FG001|Overall Study|Lost to Follow-up|0|||
163163334|NCT02721966|589311339|FG002|Overall Study|Lost to Follow-up|3|||
163163335|NCT02721966|589311340|FG003|Overall Study|Lost to Follow-up|0|||
163163336|NCT02721966|589311341|FG004|Overall Study|Lost to Follow-up|0|||
163163337|NCT02721966|589311337|FG000|Overall Study|Physician Decision|1|||
163163338|NCT02721966|589311338|FG001|Overall Study|Physician Decision|1|||
163163339|NCT02721966|589311339|FG002|Overall Study|Physician Decision|0|||
163163340|NCT02721966|589311340|FG003|Overall Study|Physician Decision|0|||
163163341|NCT02721966|589311341|FG004|Overall Study|Physician Decision|0|||
163163342|NCT02721966|589311337|FG000|Overall Study|Pregnancy|1|||
163163343|NCT02721966|589311338|FG001|Overall Study|Pregnancy|0|||
163163344|NCT02721966|589311339|FG002|Overall Study|Pregnancy|0|||
163163345|NCT02721966|589311340|FG003|Overall Study|Pregnancy|0|||
163163346|NCT02721966|589311341|FG004|Overall Study|Pregnancy|0|||
163276258|NCT03531905|589721619|FG001|Overall Study|Lost to Follow-up|2|||
163163347|NCT02721966|589311337|FG000|Overall Study|Did not continue to period 2|5|||
163276259|NCT03531905|589721620|FG002|Overall Study|Lost to Follow-up|1|||
163276260|NCT03531905|589721618|FG000|Overall Study|Participant was out of town|1|||
163276261|NCT03531905|589721619|FG001|Overall Study|Participant was out of town|0|||
163163348|NCT02721966|589311338|FG001|Overall Study|Did not continue to period 2|12|||
163163349|NCT02721966|589311339|FG002|Overall Study|Did not continue to period 2|0|||
163163350|NCT02721966|589311340|FG003|Overall Study|Did not continue to period 2|0|||
163163351|NCT02721966|589311341|FG004|Overall Study|Did not continue to period 2|5|||
163163352|NCT00828204|589311342|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
163163353|NCT00828204|589311343|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
163163354|NCT00828204|589311342|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
163163355|NCT00828204|589311343|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
163163356|NCT00828204|589311342|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
163163357|NCT00828204|589311343|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
163163358|NCT00828204|589311342|FG000|Main Study: After Study Restart|Adverse Event|0|||
163163359|NCT00828204|589311343|FG001|Main Study: After Study Restart|Adverse Event|2|||
163163360|NCT00828204|589311342|FG000|Main Study: After Study Restart|Noncompliance|0|||
163163361|NCT00828204|589311343|FG001|Main Study: After Study Restart|Noncompliance|1|||
163163362|NCT00828204|589311342|FG000|Extension Study|Lost to Follow-up|0|||
163163363|NCT00828204|589311343|FG001|Extension Study|Lost to Follow-up|1|||
163163364|NCT00828204|589311342|FG000|Extension Study|Physician Decision|0|||
163163365|NCT00828204|589311343|FG001|Extension Study|Physician Decision|2|||
163163366|NCT02840461|589311344|FG000|Overall Study|Adverse Event|1|||
163163367|NCT02840461|589311345|FG001|Overall Study|Adverse Event|5|||
163163368|NCT02840461|589311346|FG002|Overall Study|Adverse Event|3|||
163163369|NCT02840461|589311344|FG000|Overall Study|Lost to Follow-up|10|||
163163370|NCT02840461|589311345|FG001|Overall Study|Lost to Follow-up|7|||
163163371|NCT02840461|589311346|FG002|Overall Study|Lost to Follow-up|6|||
163163372|NCT02840461|589311344|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
163163373|NCT02840461|589311345|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
163163374|NCT02840461|589311346|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
163163375|NCT02840461|589311344|FG000|Overall Study|Protocol Violation|2|||
163163376|NCT02840461|589311345|FG001|Overall Study|Protocol Violation|3|||
163163377|NCT02840461|589311346|FG002|Overall Study|Protocol Violation|1|||
163163378|NCT02840461|589311344|FG000|Overall Study|Withdrawal by Subject|10|||
163163379|NCT02840461|589311345|FG001|Overall Study|Withdrawal by Subject|6|||
163163380|NCT02840461|589311346|FG002|Overall Study|Withdrawal by Subject|2|||
163163381|NCT02840461|589311344|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
163163382|NCT02840461|589311345|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
163163383|NCT02840461|589311346|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
163163384|NCT04163016|589311349|FG000|Enrollment|Adverse Event|1|||
163163385|NCT04163016|589311350|FG001|Enrollment|Adverse Event|0|||
163163386|NCT04163016|589311351|FG002|Enrollment|Adverse Event|0|||
163163387|NCT04163016|589311352|FG003|Enrollment|Adverse Event|0|||
163163388|NCT04163016|589311349|FG000|Treatment|Adverse Event|0|||
163163389|NCT04163016|589311350|FG001|Treatment|Adverse Event|1|||
163163390|NCT04163016|589311351|FG002|Treatment|Adverse Event|0|||
163163391|NCT04163016|589311352|FG003|Treatment|Adverse Event|0|||
163163392|NCT04163016|589311349|FG000|Treatment|Withdrawal by Subject|0|||
163163393|NCT04163016|589311350|FG001|Treatment|Withdrawal by Subject|2|||
163163394|NCT04163016|589311351|FG002|Treatment|Withdrawal by Subject|0|||
163163395|NCT04163016|589311352|FG003|Treatment|Withdrawal by Subject|0|||
163163396|NCT04163016|589311349|FG000|Treatment|Indeterminate TB-test|0|||
163163397|NCT04163016|589311350|FG001|Treatment|Indeterminate TB-test|0|||
163163398|NCT04163016|589311351|FG002|Treatment|Indeterminate TB-test|0|||
163276262|NCT03531905|589721620|FG002|Overall Study|Participant was out of town|0|||
163163399|NCT04163016|589311352|FG003|Treatment|Indeterminate TB-test|1|||
163163400|NCT04163016|589311349|FG000|Treatment|Participant did not want to continue in study|0|||
163163401|NCT04163016|589311350|FG001|Treatment|Participant did not want to continue in study|0|||
163163402|NCT04163016|589311351|FG002|Treatment|Participant did not want to continue in study|0|||
163387469|NCT02993523|590129928|FG001|Overall Study|Lost to Follow-up|0|||
163387470|NCT02993523|590129929|FG002|Overall Study|Lost to Follow-up|3|||
163387471|NCT02993523|590129930|FG003|Overall Study|Lost to Follow-up|6|||
163387472|NCT02993523|590129931|FG004|Overall Study|Lost to Follow-up|0|||
163387473|NCT02993523|590129927|FG000|Overall Study|Death|1|||
163387474|NCT02993523|590129928|FG001|Overall Study|Death|1|||
163387475|NCT02993523|590129929|FG002|Overall Study|Death|138|||
163387476|NCT02993523|590129930|FG003|Overall Study|Death|222|||
163387477|NCT02993523|590129931|FG004|Overall Study|Death|6|||
163387478|NCT02993523|590129927|FG000|Overall Study|Reason not Specified|0|||
163387479|NCT02993523|590129928|FG001|Overall Study|Reason not Specified|0|||
163387480|NCT02993523|590129929|FG002|Overall Study|Reason not Specified|1|||
163387481|NCT02993523|590129930|FG003|Overall Study|Reason not Specified|1|||
163387482|NCT02993523|590129931|FG004|Overall Study|Reason not Specified|0|||
163387483|NCT03694418|590129932|FG000|Overall Study|Lost to Follow-up|115|||
163387484|NCT03694418|590129933|FG001|Overall Study|Lost to Follow-up|23|||
163387485|NCT03694418|590129934|FG002|Overall Study|Lost to Follow-up|12|||
163387486|NCT03694418|590129935|FG003|Overall Study|Lost to Follow-up|12|||
163387487|NCT03694418|590129936|FG004|Overall Study|Lost to Follow-up|13|||
163387488|NCT04288778|590129939|FG000|Overall Study|Withdrawal by Subject|2|||
163387489|NCT04288778|590129939|FG000|Overall Study|Adverse Event|5|||
163387490|NCT04288778|590129939|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163387491|NCT04288778|590129939|FG000|Overall Study|Other|1|||
163387492|NCT04288778|590129939|FG000|Overall Study|Started but not treated|2|||
163387493|NCT04442737|590129940|FG000|Overall Study|Lost to Follow-up|1|||
163163403|NCT04163016|589311352|FG003|Treatment|Participant did not want to continue in study|1|||
163163404|NCT01104311|589311355|FG000|Overall Study|Withdrawal by Subject|6|||
163163405|NCT01104311|589311356|FG001|Overall Study|Withdrawal by Subject|6|||
163163406|NCT01104311|589311355|FG000|Overall Study|Protocol Violation|0|||
163163407|NCT01104311|589311356|FG001|Overall Study|Protocol Violation|1|||
163163408|NCT01104311|589311355|FG000|Overall Study|Physician Decision|2|||
163163409|NCT01104311|589311356|FG001|Overall Study|Physician Decision|2|||
163163410|NCT01104311|589311355|FG000|Overall Study|low compliance|1|||
163163411|NCT01104311|589311356|FG001|Overall Study|low compliance|1|||
163163412|NCT01104311|589311355|FG000|Overall Study|Adverse Event|1|||
163163413|NCT01104311|589311356|FG001|Overall Study|Adverse Event|2|||
163163414|NCT04434937|589311358|FG000|Overall Study|Death|4|||
163163415|NCT04434937|589311358|FG000|Overall Study|Withdrawal by Subject|1|||
163163416|NCT04434937|589311358|FG000|Overall Study|Transitioned to Rollover Study|19|||
163163417|NCT04434937|589311358|FG000|Overall Study|Progressive Disease|18|||
163163418|NCT04193189|589311363|FG000|Overall Study|Lost to Follow-up|9|||
163163419|NCT04193189|589311364|FG001|Overall Study|Lost to Follow-up|7|||
163163420|NCT04193189|589311365|FG002|Overall Study|Lost to Follow-up|9|||
163163421|NCT04193189|589311366|FG003|Overall Study|Lost to Follow-up|0|||
163163422|NCT04193189|589311363|FG000|Overall Study|Withdrawal by Subject|1|||
163163423|NCT04193189|589311364|FG001|Overall Study|Withdrawal by Subject|2|||
163163424|NCT04193189|589311365|FG002|Overall Study|Withdrawal by Subject|2|||
163163425|NCT04193189|589311366|FG003|Overall Study|Withdrawal by Subject|0|||
163163426|NCT04193189|589311363|FG000|Overall Study|Death|1|||
163163427|NCT04193189|589311364|FG001|Overall Study|Death|1|||
163163428|NCT04193189|589311365|FG002|Overall Study|Death|0|||
163163429|NCT04193189|589311366|FG003|Overall Study|Death|0|||
163163430|NCT04193189|589311363|FG000|Overall Study|Protocol Violation|0|||
163163431|NCT04193189|589311364|FG001|Overall Study|Protocol Violation|0|||
163163432|NCT04193189|589311365|FG002|Overall Study|Protocol Violation|0|||
163163433|NCT04193189|589311366|FG003|Overall Study|Protocol Violation|1|||
163163434|NCT04549545|589312673|FG000|Initial Period|Withdrawal by Subject|4|||
163163435|NCT04549545|589312674|FG001|Initial Period|Withdrawal by Subject|0|||
163163436|NCT04549545|589312673|FG000|Initial Period|Additional ENT Procedure|3|||
163163437|NCT04549545|589312674|FG001|Initial Period|Additional ENT Procedure|0|||
163163438|NCT04549545|589312673|FG000|Initial Period|Lost to Follow-up|3|||
163163439|NCT04549545|589312674|FG001|Initial Period|Lost to Follow-up|1|||
163163440|NCT04549545|589312673|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
163163441|NCT04549545|589312674|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
163163442|NCT04549545|589312673|FG000|Crossover Period|Additional ENT Procedure|0|||
163163443|NCT04549545|589312674|FG001|Crossover Period|Additional ENT Procedure|6|||
163163444|NCT04549545|589312673|FG000|Crossover Period|Lost to Follow-up|0|||
163163445|NCT04549545|589312674|FG001|Crossover Period|Lost to Follow-up|1|||
163163446|NCT04549545|589312673|FG000|Crossover Period|Withdrawal by Subject|0|||
163163447|NCT04549545|589312674|FG001|Crossover Period|Withdrawal by Subject|4|||
163163448|NCT00295880|589312678|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
163163449|NCT00295880|589312678|FG000|Overall Study|Unit randomization did not occur|1|||
163163450|NCT01474239|589312679|FG000|Overall Study|Disease Progression|37|||
163163451|NCT01474239|589312680|FG001|Overall Study|Disease Progression|25|||
163163452|NCT01474239|589312679|FG000|Overall Study|Adverse Event|12|||
163163453|NCT01474239|589312680|FG001|Overall Study|Adverse Event|3|||
163163454|NCT01474239|589312679|FG000|Overall Study|Withdrawal by Subject|1|||
163163455|NCT01474239|589312680|FG001|Overall Study|Withdrawal by Subject|2|||
163163456|NCT01474239|589312679|FG000|Overall Study|Death|1|||
163163457|NCT01474239|589312680|FG001|Overall Study|Death|1|||
163163458|NCT01474239|589312679|FG000|Overall Study|Clinical Disease Progression|7|||
163163459|NCT01474239|589312680|FG001|Overall Study|Clinical Disease Progression|1|||
163163460|NCT01474239|589312679|FG000|Overall Study|Withdrawal for Economic Reason|1|||
163163461|NCT01474239|589312680|FG001|Overall Study|Withdrawal for Economic Reason|0|||
163163462|NCT01243242|589312681|FG000|Overall Study|Adverse Event|1|||
163163463|NCT01243242|589312682|FG001|Overall Study|Adverse Event|1|||
163163464|NCT01243242|589312681|FG000|Overall Study|Withdrawal by Subject|1|||
163163465|NCT01243242|589312682|FG001|Overall Study|Withdrawal by Subject|1|||
163163466|NCT01243242|589312681|FG000|Overall Study|Physician Decision|0|||
163163467|NCT01243242|589312682|FG001|Overall Study|Physician Decision|1|||
163163468|NCT01243242|589312681|FG000|Overall Study|sponsor decision|0|||
163163469|NCT01243242|589312682|FG001|Overall Study|sponsor decision|1|||
163163470|NCT01243242|589312681|FG000|Overall Study|non compliance|1|||
163163471|NCT01243242|589312682|FG001|Overall Study|non compliance|0|||
163163472|NCT03983317|589312683|FG000|Overall Study|Physician Decision|5|||
163163473|NCT01256294|589312689|FG000|Overall Study|Adverse Event|1|||
163163474|NCT01256294|589312690|FG001|Overall Study|Adverse Event|0|||
163163475|NCT01256294|589312689|FG000|Overall Study|Withdrawal by Subject|1|||
163163476|NCT01256294|589312690|FG001|Overall Study|Withdrawal by Subject|1|||
163163477|NCT01256294|589312689|FG000|Overall Study|Protocol deviation|2|||
163163478|NCT01256294|589312690|FG001|Overall Study|Protocol deviation|1|||
163163479|NCT04681352|589312691|FG000|Overall Study|Lost to Follow-up|2|||
163163480|NCT04681352|589312691|FG000|Overall Study|Withdrawal by Subject|22|||
163163481|NCT01675544|589312694|FG000|Overall Study|Withdrawal by Subject|2|||
163163482|NCT00792571|589312695|FG000|Overall Study|Death|1|||
163163483|NCT00792571|589312695|FG000|Overall Study|Adverse Event|4|||
163163484|NCT00792571|589312695|FG000|Overall Study|Withdrawal by Subject|1|||
163163485|NCT00792571|589312695|FG000|Overall Study|Other|4|||
163163486|NCT02600819|589312696|FG000|GEN Phase|Adverse Event|2|||
163163487|NCT02600819|589312697|FG001|GEN Phase|Adverse Event|0|||
163163488|NCT02600819|589312696|FG000|GEN Phase|Death|2|||
163163489|NCT02600819|589312697|FG001|GEN Phase|Death|0|||
163163490|NCT02600819|589312696|FG000|GEN Phase|Investigator's Discretion|4|||
163163491|NCT02600819|589312697|FG001|GEN Phase|Investigator's Discretion|0|||
163163492|NCT02600819|589312696|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
163163493|NCT02600819|589312697|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
163163494|NCT02600819|589312696|FG000|GEN Phase|Withdrew Consent|5|||
163163495|NCT02600819|589312697|FG001|GEN Phase|Withdrew Consent|0|||
163163496|NCT02600819|589312696|FG000|GEN Phase|Lost to Follow-up|2|||
163163497|NCT02600819|589312697|FG001|GEN Phase|Lost to Follow-up|0|||
163163498|NCT01621802|589312699|FG000|Overall Study|Protocol Violation|0|||
163163499|NCT01621802|589312700|FG001|Overall Study|Protocol Violation|0|||
163163500|NCT01621802|589312701|FG002|Overall Study|Protocol Violation|0|||
163163501|NCT01621802|589312702|FG003|Overall Study|Protocol Violation|0|||
163163502|NCT01621802|589312703|FG004|Overall Study|Protocol Violation|0|||
163163503|NCT01621802|589312704|FG005|Overall Study|Protocol Violation|1|||
163163504|NCT01621802|589312699|FG000|Overall Study|Withdrawal by Subject|8|||
163163505|NCT01621802|589312700|FG001|Overall Study|Withdrawal by Subject|4|||
163163506|NCT01621802|589312701|FG002|Overall Study|Withdrawal by Subject|4|||
163163507|NCT01621802|589312702|FG003|Overall Study|Withdrawal by Subject|2|||
163163508|NCT01621802|589312703|FG004|Overall Study|Withdrawal by Subject|2|||
163163509|NCT01621802|589312704|FG005|Overall Study|Withdrawal by Subject|0|||
163163510|NCT01621802|589312699|FG000|Overall Study|Migrated/moved from study area|0|||
163163511|NCT01621802|589312700|FG001|Overall Study|Migrated/moved from study area|0|||
163163512|NCT01621802|589312701|FG002|Overall Study|Migrated/moved from study area|2|||
163163513|NCT01621802|589312702|FG003|Overall Study|Migrated/moved from study area|0|||
163163514|NCT01621802|589312703|FG004|Overall Study|Migrated/moved from study area|1|||
163163515|NCT01621802|589312704|FG005|Overall Study|Migrated/moved from study area|0|||
163163516|NCT01621802|589312699|FG000|Overall Study|Others|3|||
163163517|NCT01621802|589312700|FG001|Overall Study|Others|3|||
163163518|NCT01621802|589312701|FG002|Overall Study|Others|3|||
163163519|NCT01621802|589312702|FG003|Overall Study|Others|2|||
163163520|NCT01621802|589312703|FG004|Overall Study|Others|1|||
163163521|NCT01621802|589312704|FG005|Overall Study|Others|0|||
163163522|NCT01621802|589312699|FG000|Overall Study|Lost to Follow-up|36|||
163163523|NCT01621802|589312700|FG001|Overall Study|Lost to Follow-up|16|||
163163524|NCT01621802|589312701|FG002|Overall Study|Lost to Follow-up|24|||
163163525|NCT01621802|589312702|FG003|Overall Study|Lost to Follow-up|7|||
163163526|NCT01621802|589312703|FG004|Overall Study|Lost to Follow-up|31|||
163163527|NCT01621802|589312704|FG005|Overall Study|Lost to Follow-up|11|||
163163528|NCT03790696|589312706|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
163163529|NCT03790696|589312707|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
163163530|NCT01149148|589312708|FG000|Overall Study|Lost to Follow-up|1|||
163163531|NCT01149148|589312709|FG001|Overall Study|Lost to Follow-up|2|||
163163532|NCT01149148|589312708|FG000|Overall Study|Death|1|||
163163533|NCT01149148|589312709|FG001|Overall Study|Death|0|||
163163534|NCT04896086|589312710|FG000|Overall Study|Lost to Follow-up|0|||
163163535|NCT04896086|589312711|FG001|Overall Study|Lost to Follow-up|2|||
163163536|NCT04896086|589312712|FG002|Overall Study|Lost to Follow-up|1|||
163163537|NCT04896086|589312713|FG003|Overall Study|Lost to Follow-up|0|||
163163538|NCT04896086|589312714|FG004|Overall Study|Lost to Follow-up|0|||
163163539|NCT04896086|589312710|FG000|Overall Study|Physician Decision|0|||
163163540|NCT04896086|589312711|FG001|Overall Study|Physician Decision|1|||
163163541|NCT04896086|589312712|FG002|Overall Study|Physician Decision|0|||
163163542|NCT04896086|589312713|FG003|Overall Study|Physician Decision|0|||
163163543|NCT04896086|589312714|FG004|Overall Study|Physician Decision|0|||
163163544|NCT04896086|589312710|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
163163545|NCT04896086|589312711|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
163163546|NCT04896086|589312712|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
163163547|NCT04896086|589312713|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
163163548|NCT04896086|589312714|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
163163549|NCT04896086|589312710|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
163163550|NCT04896086|589312711|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
163163551|NCT04896086|589312712|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
163163552|NCT04896086|589312713|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
163163553|NCT04896086|589312714|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
163163554|NCT02249832|589312715|FG000|Overall Study|Withdrawal by Subject|3|||
163163555|NCT02249832|589312715|FG000|Overall Study|Lost to Follow-up|10|||
163163556|NCT00485134|589312721|FG000|Overall Study|Lost to Follow-up|1|||
163163557|NCT00485134|589312722|FG001|Overall Study|Lost to Follow-up|0|||
163163558|NCT00485134|589312723|FG002|Overall Study|Lost to Follow-up|0|||
163163559|NCT00485134|589312724|FG003|Overall Study|Lost to Follow-up|0|||
163163560|NCT00485134|589312725|FG004|Overall Study|Lost to Follow-up|0|||
163163561|NCT00485134|589312726|FG005|Overall Study|Lost to Follow-up|0|||
163163562|NCT00485134|589312727|FG006|Overall Study|Lost to Follow-up|0|||
163163563|NCT00485134|589312728|FG007|Overall Study|Lost to Follow-up|0|||
163163564|NCT00485134|589312721|FG000|Overall Study|Withdrawal by Subject|0|||
163163565|NCT00485134|589312722|FG001|Overall Study|Withdrawal by Subject|1|||
163163566|NCT00485134|589312723|FG002|Overall Study|Withdrawal by Subject|0|||
163163567|NCT00485134|589312724|FG003|Overall Study|Withdrawal by Subject|0|||
163163568|NCT00485134|589312725|FG004|Overall Study|Withdrawal by Subject|0|||
163163569|NCT00485134|589312726|FG005|Overall Study|Withdrawal by Subject|0|||
163163570|NCT00485134|589312727|FG006|Overall Study|Withdrawal by Subject|0|||
163163571|NCT00485134|589312728|FG007|Overall Study|Withdrawal by Subject|0|||
163163572|NCT00485134|589312721|FG000|Overall Study|Change in health status|0|||
163163573|NCT00485134|589312722|FG001|Overall Study|Change in health status|1|||
163163574|NCT00485134|589312723|FG002|Overall Study|Change in health status|2|||
163163575|NCT00485134|589312724|FG003|Overall Study|Change in health status|1|||
163163576|NCT00485134|589312725|FG004|Overall Study|Change in health status|0|||
163163577|NCT00485134|589312726|FG005|Overall Study|Change in health status|1|||
163163578|NCT00485134|589312727|FG006|Overall Study|Change in health status|0|||
163163579|NCT00485134|589312728|FG007|Overall Study|Change in health status|0|||
163163580|NCT00485134|589312721|FG000|Overall Study|Withdrew for adverse event|0|||
163163581|NCT00485134|589312722|FG001|Overall Study|Withdrew for adverse event|0|||
163163582|NCT00485134|589312723|FG002|Overall Study|Withdrew for adverse event|1|||
163163583|NCT00485134|589312724|FG003|Overall Study|Withdrew for adverse event|0|||
163163584|NCT00485134|589312725|FG004|Overall Study|Withdrew for adverse event|0|||
163163585|NCT00485134|589312726|FG005|Overall Study|Withdrew for adverse event|0|||
163163586|NCT00485134|589312727|FG006|Overall Study|Withdrew for adverse event|0|||
163163587|NCT00485134|589312728|FG007|Overall Study|Withdrew for adverse event|0|||
163163588|NCT00485134|589312721|FG000|Overall Study|Positive drug test|0|||
163163589|NCT00485134|589312722|FG001|Overall Study|Positive drug test|0|||
163163590|NCT00485134|589312723|FG002|Overall Study|Positive drug test|0|||
163163591|NCT00485134|589312724|FG003|Overall Study|Positive drug test|0|||
163163592|NCT00485134|589312725|FG004|Overall Study|Positive drug test|2|||
163163593|NCT00485134|589312726|FG005|Overall Study|Positive drug test|1|||
163163594|NCT00485134|589312727|FG006|Overall Study|Positive drug test|0|||
163163595|NCT00485134|589312728|FG007|Overall Study|Positive drug test|0|||
163163596|NCT00485134|589312721|FG000|Overall Study|Non-compliance|0|||
163163597|NCT00485134|589312722|FG001|Overall Study|Non-compliance|0|||
163163598|NCT00485134|589312723|FG002|Overall Study|Non-compliance|0|||
163163599|NCT00485134|589312724|FG003|Overall Study|Non-compliance|0|||
163163600|NCT00485134|589312725|FG004|Overall Study|Non-compliance|1|||
163163601|NCT00485134|589312726|FG005|Overall Study|Non-compliance|2|||
163163602|NCT00485134|589312727|FG006|Overall Study|Non-compliance|2|||
163163603|NCT00485134|589312728|FG007|Overall Study|Non-compliance|0|||
163163604|NCT00485134|589312721|FG000|Overall Study|Unable to comply with study schedule|0|||
163163605|NCT00485134|589312722|FG001|Overall Study|Unable to comply with study schedule|0|||
163163606|NCT00485134|589312723|FG002|Overall Study|Unable to comply with study schedule|0|||
163163607|NCT00485134|589312724|FG003|Overall Study|Unable to comply with study schedule|0|||
163163608|NCT00485134|589312725|FG004|Overall Study|Unable to comply with study schedule|0|||
163163609|NCT00485134|589312726|FG005|Overall Study|Unable to comply with study schedule|0|||
163163610|NCT00485134|589312727|FG006|Overall Study|Unable to comply with study schedule|0|||
163163611|NCT00485134|589312728|FG007|Overall Study|Unable to comply with study schedule|1|||
163163612|NCT00485134|589312721|FG000|Overall Study|Pregnancy|0|||
163163613|NCT00485134|589312722|FG001|Overall Study|Pregnancy|0|||
163163614|NCT00485134|589312723|FG002|Overall Study|Pregnancy|0|||
163163615|NCT00485134|589312724|FG003|Overall Study|Pregnancy|0|||
163163616|NCT00485134|589312725|FG004|Overall Study|Pregnancy|0|||
163163617|NCT00485134|589312726|FG005|Overall Study|Pregnancy|0|||
163163618|NCT00485134|589312727|FG006|Overall Study|Pregnancy|1|||
163163619|NCT00485134|589312728|FG007|Overall Study|Pregnancy|0|||
163163620|NCT00970684|589312729|FG000|Overall Study|Lack of Efficacy|5|||
163163621|NCT00970684|589312729|FG000|Overall Study|Adverse Event|4|||
163163622|NCT00970684|589312729|FG000|Overall Study|Withdrawal by Subject|1|||
163163623|NCT00481091|589312730|FG000|Overall Study|Withdrawal by Subject|0|||
163163624|NCT00481091|589312731|FG001|Overall Study|Withdrawal by Subject|1|||
163163625|NCT00481091|589312732|FG002|Overall Study|Withdrawal by Subject|1|||
163276263|NCT03531905|589721618|FG000|Overall Study|Could not speak with the participant|1|||
163163626|NCT00481091|589312733|FG003|Overall Study|Withdrawal by Subject|0|||
163163627|NCT00481091|589312734|FG004|Overall Study|Withdrawal by Subject|0|||
163163628|NCT00481091|589312735|FG005|Overall Study|Withdrawal by Subject|0|||
163163629|NCT00481091|589312736|FG006|Overall Study|Withdrawal by Subject|0|||
163163630|NCT00481091|589312737|FG007|Overall Study|Withdrawal by Subject|0|||
163163631|NCT00481091|589312738|FG008|Overall Study|Withdrawal by Subject|1|||
163163632|NCT00481091|589312739|FG009|Overall Study|Withdrawal by Subject|6|||
163163633|NCT00481091|589312730|FG000|Overall Study|Other, Not Specified|0|||
163163634|NCT00481091|589312731|FG001|Overall Study|Other, Not Specified|1|||
163163635|NCT00481091|589312732|FG002|Overall Study|Other, Not Specified|1|||
163163636|NCT00481091|589312733|FG003|Overall Study|Other, Not Specified|0|||
163163637|NCT00481091|589312734|FG004|Overall Study|Other, Not Specified|0|||
163163638|NCT00481091|589312735|FG005|Overall Study|Other, Not Specified|1|||
163163639|NCT00481091|589312736|FG006|Overall Study|Other, Not Specified|0|||
163163640|NCT00481091|589312737|FG007|Overall Study|Other, Not Specified|0|||
163163641|NCT00481091|589312738|FG008|Overall Study|Other, Not Specified|0|||
163163642|NCT00481091|589312739|FG009|Overall Study|Other, Not Specified|4|||
163163643|NCT00481091|589312730|FG000|Overall Study|Adverse Event|1|||
163163644|NCT00481091|589312731|FG001|Overall Study|Adverse Event|2|||
163163645|NCT00481091|589312732|FG002|Overall Study|Adverse Event|0|||
163163646|NCT00481091|589312733|FG003|Overall Study|Adverse Event|1|||
163163647|NCT00481091|589312734|FG004|Overall Study|Adverse Event|1|||
163163648|NCT00481091|589312735|FG005|Overall Study|Adverse Event|1|||
163163649|NCT00481091|589312736|FG006|Overall Study|Adverse Event|2|||
163163650|NCT00481091|589312737|FG007|Overall Study|Adverse Event|1|||
163163651|NCT00481091|589312738|FG008|Overall Study|Adverse Event|1|||
163163652|NCT00481091|589312739|FG009|Overall Study|Adverse Event|6|||
163163653|NCT00481091|589312730|FG000|Overall Study|Progressive disease clinical|0|||
163163654|NCT00481091|589312731|FG001|Overall Study|Progressive disease clinical|0|||
163163655|NCT00481091|589312732|FG002|Overall Study|Progressive disease clinical|0|||
163163656|NCT00481091|589312733|FG003|Overall Study|Progressive disease clinical|0|||
163163657|NCT00481091|589312734|FG004|Overall Study|Progressive disease clinical|0|||
163163658|NCT00481091|589312735|FG005|Overall Study|Progressive disease clinical|0|||
163163659|NCT00481091|589312736|FG006|Overall Study|Progressive disease clinical|0|||
163163660|NCT00481091|589312737|FG007|Overall Study|Progressive disease clinical|0|||
163163661|NCT00481091|589312738|FG008|Overall Study|Progressive disease clinical|1|||
163163662|NCT00481091|589312739|FG009|Overall Study|Progressive disease clinical|7|||
163163663|NCT00481091|589312730|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
163163664|NCT00481091|589312731|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
163163665|NCT00481091|589312732|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
163163666|NCT00481091|589312733|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
163163667|NCT00481091|589312734|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
163163668|NCT00481091|589312735|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
163163669|NCT00481091|589312736|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
163163670|NCT00481091|589312737|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
163163671|NCT00481091|589312738|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
163163672|NCT00481091|589312739|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
163163673|NCT00481091|589312730|FG000|Overall Study|Progressive disease other|1|||
163163674|NCT00481091|589312731|FG001|Overall Study|Progressive disease other|1|||
163163675|NCT00481091|589312732|FG002|Overall Study|Progressive disease other|0|||
163163676|NCT00481091|589312733|FG003|Overall Study|Progressive disease other|1|||
163163677|NCT00481091|589312734|FG004|Overall Study|Progressive disease other|1|||
163163678|NCT00481091|589312735|FG005|Overall Study|Progressive disease other|1|||
163163679|NCT00481091|589312736|FG006|Overall Study|Progressive disease other|0|||
163163680|NCT00481091|589312737|FG007|Overall Study|Progressive disease other|2|||
163163681|NCT00481091|589312738|FG008|Overall Study|Progressive disease other|0|||
163163682|NCT00481091|589312739|FG009|Overall Study|Progressive disease other|0|||
163163683|NCT00481091|589312730|FG000|Overall Study|No reason given|0|||
163163684|NCT00481091|589312731|FG001|Overall Study|No reason given|0|||
163163685|NCT00481091|589312732|FG002|Overall Study|No reason given|1|||
163163686|NCT00481091|589312733|FG003|Overall Study|No reason given|1|||
163163687|NCT00481091|589312734|FG004|Overall Study|No reason given|1|||
163163688|NCT00481091|589312735|FG005|Overall Study|No reason given|0|||
163163689|NCT00481091|589312736|FG006|Overall Study|No reason given|1|||
163163690|NCT00481091|589312737|FG007|Overall Study|No reason given|1|||
163163691|NCT00481091|589312738|FG008|Overall Study|No reason given|1|||
163163692|NCT00481091|589312739|FG009|Overall Study|No reason given|4|||
163163693|NCT04294680|589312740|FG000|Overall Study|Withdrawal by Subject|2|||
163163694|NCT04294680|589312741|FG001|Overall Study|Withdrawal by Subject|1|||
163163695|NCT04294680|589312740|FG000|Overall Study|Follow-up visits completed outside of window|1|||
163163696|NCT04294680|589312741|FG001|Overall Study|Follow-up visits completed outside of window|0|||
163163697|NCT02078960|589312744|FG000|Treatment Period|Other|0|||
163163698|NCT02078960|589312745|FG001|Treatment Period|Other|0|||
163163699|NCT02078960|589312746|FG002|Treatment Period|Other|1|||
163163700|NCT02078960|589312744|FG000|Treatment Period|Lack of Efficacy|0|||
163163701|NCT02078960|589312745|FG001|Treatment Period|Lack of Efficacy|1|||
163163702|NCT02078960|589312746|FG002|Treatment Period|Lack of Efficacy|0|||
163163703|NCT02078960|589312744|FG000|Treatment Period|Disease progression - accelerated phase|0|||
163163704|NCT02078960|589312745|FG001|Treatment Period|Disease progression - accelerated phase|1|||
163163705|NCT02078960|589312746|FG002|Treatment Period|Disease progression - accelerated phase|0|||
163163706|NCT02078960|589312744|FG000|Treatment Period|Disease progression - blast phase|1|||
163163707|NCT02078960|589312745|FG001|Treatment Period|Disease progression - blast phase|0|||
163163708|NCT02078960|589312746|FG002|Treatment Period|Disease progression - blast phase|0|||
163163709|NCT02078960|589312744|FG000|Treatment Period|Withdrawal by Subject|0|||
163163710|NCT02078960|589312745|FG001|Treatment Period|Withdrawal by Subject|1|||
163163711|NCT02078960|589312746|FG002|Treatment Period|Withdrawal by Subject|1|||
163163712|NCT02078960|589312744|FG000|Treatment Period|Adverse Event|1|||
163163713|NCT02078960|589312745|FG001|Treatment Period|Adverse Event|0|||
163163714|NCT02078960|589312746|FG002|Treatment Period|Adverse Event|0|||
163163715|NCT02078960|589312744|FG000|Treatment Period|Death|0|||
163163716|NCT02078960|589312745|FG001|Treatment Period|Death|0|||
163163717|NCT02078960|589312746|FG002|Treatment Period|Death|1|||
163163718|NCT02078960|589312744|FG000|Follow-up Period|Death|2|||
163163719|NCT02078960|589312745|FG001|Follow-up Period|Death|0|||
163163720|NCT02078960|589312746|FG002|Follow-up Period|Death|0|||
163163721|NCT02078960|589312744|FG000|Follow-up Period|Lost to Follow-up|0|||
163163722|NCT02078960|589312745|FG001|Follow-up Period|Lost to Follow-up|1|||
163163723|NCT02078960|589312746|FG002|Follow-up Period|Lost to Follow-up|0|||
163163724|NCT04605991|589312748|FG000|Overall Study|Adverse Event|5|||
163163725|NCT04605991|589312748|FG000|Overall Study|Lack of Efficacy|1|||
163163726|NCT04605991|589312748|FG000|Overall Study|Lost to Follow-up|8|||
163163727|NCT04605991|589312748|FG000|Overall Study|Physician Decision|4|||
163163728|NCT04605991|589312748|FG000|Overall Study|Withdrawal by Subject|14|||
163163729|NCT04605991|589312748|FG000|Overall Study|Non-compliance with study|1|||
163163730|NCT04881942|589312751|FG000|Overall Study|Adverse Event|0|||
163163731|NCT04881942|589312752|FG001|Overall Study|Adverse Event|0|||
163163732|NCT04881942|589312753|FG002|Overall Study|Adverse Event|0|||
163163733|NCT04881942|589312754|FG003|Overall Study|Adverse Event|0|||
163163734|NCT04881942|589312755|FG004|Overall Study|Adverse Event|1|||
163163735|NCT04881942|589312751|FG000|Overall Study|Alternates|0|||
163163736|NCT04881942|589312752|FG001|Overall Study|Alternates|0|||
163163737|NCT04881942|589312753|FG002|Overall Study|Alternates|0|||
163163738|NCT04881942|589312754|FG003|Overall Study|Alternates|0|||
163163739|NCT04881942|589312755|FG004|Overall Study|Alternates|2|||
163163740|NCT00859638|589312756|FG000|Overall Study|Lost to Follow-up|6|||
163163741|NCT00859638|589312757|FG001|Overall Study|Lost to Follow-up|1|||
163163742|NCT00859638|589312756|FG000|Overall Study|Withdrawal by Subject|3|||
163163743|NCT00859638|589312757|FG001|Overall Study|Withdrawal by Subject|2|||
163163744|NCT00859638|589312756|FG000|Overall Study|Ill health|1|||
163163745|NCT00859638|589312757|FG001|Overall Study|Ill health|1|||
163163746|NCT00771953|589312761|FG000|Overall Study|Adverse Event|5|||
163163747|NCT00771953|589312762|FG001|Overall Study|Adverse Event|3|||
163163748|NCT00771953|589312761|FG000|Overall Study|Death|2|||
163163749|NCT00771953|589312762|FG001|Overall Study|Death|2|||
163163750|NCT00771953|589312761|FG000|Overall Study|Progression before active Tx|1|||
163163751|NCT00771953|589312762|FG001|Overall Study|Progression before active Tx|2|||
163163752|NCT00771953|589312761|FG000|Overall Study|Sponsor decision|1|||
163163753|NCT00771953|589312762|FG001|Overall Study|Sponsor decision|0|||
163163754|NCT00771953|589312761|FG000|Overall Study|Other complicating disease|1|||
163163755|NCT00771953|589312762|FG001|Overall Study|Other complicating disease|0|||
163163756|NCT00771953|589312761|FG000|Overall Study|Withdrawal by Subject|0|||
163163757|NCT00771953|589312762|FG001|Overall Study|Withdrawal by Subject|3|||
163163758|NCT00947193|589312765|FG000|Overall Study|Lost to Follow-up|1|||
163163759|NCT00947193|589312766|FG001|Overall Study|Lost to Follow-up|0|||
163163760|NCT00947193|589312765|FG000|Overall Study|Withdrawal by Subject|1|||
163163761|NCT00947193|589312766|FG001|Overall Study|Withdrawal by Subject|0|||
163163762|NCT00947193|589312765|FG000|Overall Study|Factor VIII >1%|1|||
163163763|NCT00947193|589312766|FG001|Overall Study|Factor VIII >1%|0|||
163163764|NCT04364984|589312767|FG000|Overall Study|Death|2|||
163163765|NCT04364984|589312768|FG001|Overall Study|Death|2|||
163163766|NCT04364984|589312769|FG002|Overall Study|Death|0|||
163163767|NCT01349959|589312770|FG000|Overall Study|Adverse Event|7|||
163163768|NCT02675634|589312771|FG000|Test Period 1|Adverse Event|0|||
163163769|NCT02675634|589312772|FG001|Test Period 1|Adverse Event|1|||
163163770|NCT02675634|589312773|FG002|Test Period 1|Adverse Event|0|||
163163771|NCT02675634|589312774|FG003|Test Period 1|Adverse Event|1|||
163163772|NCT02675634|589312775|FG004|Test Period 1|Adverse Event|0|||
163163773|NCT02675634|589312776|FG005|Test Period 1|Adverse Event|0|||
163163774|NCT02675634|589312771|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
163163775|NCT02675634|589312772|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
163163776|NCT02675634|589312773|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
163163777|NCT02675634|589312774|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
163163778|NCT02675634|589312775|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
163163779|NCT02675634|589312776|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
163163780|NCT02675634|589312771|FG000|Test Period 2|Lack of Efficacy|1|||
163163781|NCT02675634|589312772|FG001|Test Period 2|Lack of Efficacy|0|||
163163782|NCT02675634|589312773|FG002|Test Period 2|Lack of Efficacy|0|||
163163783|NCT02675634|589312774|FG003|Test Period 2|Lack of Efficacy|0|||
163163784|NCT02675634|589312775|FG004|Test Period 2|Lack of Efficacy|0|||
163163785|NCT02675634|589312776|FG005|Test Period 2|Lack of Efficacy|0|||
163163786|NCT02675634|589312771|FG000|Test Period 2|Adverse Event|0|||
163163787|NCT02675634|589312772|FG001|Test Period 2|Adverse Event|0|||
163163788|NCT02675634|589312773|FG002|Test Period 2|Adverse Event|0|||
163163789|NCT02675634|589312774|FG003|Test Period 2|Adverse Event|0|||
163163790|NCT02675634|589312775|FG004|Test Period 2|Adverse Event|0|||
163163791|NCT02675634|589312776|FG005|Test Period 2|Adverse Event|1|||
163163792|NCT01652534|589312777|FG000|Overall Study|Lack of Efficacy|1|||
163163793|NCT01652534|589312778|FG001|Overall Study|Lack of Efficacy|0|||
163163794|NCT02722304|589312779|FG000|Overall Study|Study Terminated by Sponsor|1|||
163163795|NCT02722304|589312780|FG001|Overall Study|Study Terminated by Sponsor|0|||
163163796|NCT02722304|589312781|FG002|Overall Study|Study Terminated by Sponsor|2|||
163163797|NCT02722304|589312782|FG003|Overall Study|Study Terminated by Sponsor|1|||
163163798|NCT02722304|589312783|FG004|Overall Study|Study Terminated by Sponsor|1|||
163163799|NCT02722304|589312779|FG000|Overall Study|Other|0|||
163163800|NCT02722304|589312780|FG001|Overall Study|Other|0|||
163163801|NCT02722304|589312781|FG002|Overall Study|Other|0|||
163163802|NCT02722304|589312782|FG003|Overall Study|Other|1|||
163163803|NCT02722304|589312783|FG004|Overall Study|Other|1|||
163163804|NCT01727024|589312786|FG000|Period 1|Lost to Follow-up|1|||
163163805|NCT01727024|589312787|FG001|Period 1|Lost to Follow-up|1|||
163163806|NCT01727024|589312786|FG000|Period 1|Withdrawal by Subject|2|||
163163807|NCT01727024|589312787|FG001|Period 1|Withdrawal by Subject|3|||
163163808|NCT02920242|589312788|FG000|Overall Study|Withdrawal by Subject|1|||
163163809|NCT02920242|589312789|FG001|Overall Study|Withdrawal by Subject|0|||
163163810|NCT02920242|589312790|FG002|Overall Study|Withdrawal by Subject|1|||
163163811|NCT02920242|589312788|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
163163812|NCT02920242|589312789|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
163163813|NCT02920242|589312790|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
163163814|NCT04995419|589312796|FG000|Overall Study|Withdrawal by Subject|3|||
163163815|NCT04995419|589312796|FG000|Overall Study|Progressive Disease|19|||
163163816|NCT04995419|589312796|FG000|Overall Study|Adverse Event|2|||
163163817|NCT04995419|589312796|FG000|Overall Study|Ongoing|16|||
163163818|NCT02948088|589312797|FG000|Overall Study|Lost to Follow-up|8|||
163163819|NCT02948088|589312797|FG000|Overall Study|Death|1|||
163163820|NCT02948088|589312797|FG000|Overall Study|Withdrawal by Subject|4|||
163163821|NCT02948088|589312797|FG000|Overall Study|Other|2|||
163163822|NCT00634101|589312798|FG000|Overall Study|Study Terminated|3|||
163163823|NCT00634101|589312799|FG001|Overall Study|Study Terminated|3|||
163163824|NCT00634101|589312798|FG000|Overall Study|Lost to Follow-up|2|||
163163825|NCT00634101|589312799|FG001|Overall Study|Lost to Follow-up|0|||
163163826|NCT00139477|589312800|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
163163827|NCT00139477|589312801|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
163163828|NCT00139477|589312800|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
163163829|NCT00139477|589312801|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
163163830|NCT00139477|589312800|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
163163831|NCT00139477|589312801|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
163163832|NCT00139477|589312800|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
163163833|NCT00139477|589312801|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
163163834|NCT00139477|589312800|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
163163835|NCT00139477|589312801|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
163163836|NCT00139477|589312800|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
163163837|NCT00139477|589312801|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
163163838|NCT00139477|589312800|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
163163839|NCT00139477|589312801|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
163163840|NCT03776812|589312802|FG000|Overall Study|Death|53|||
163163841|NCT03776812|589312803|FG001|Overall Study|Death|49|||
163163842|NCT03776812|589312804|FG002|Overall Study|Death|56|||
163163843|NCT03776812|589312802|FG000|Overall Study|Withdrawal by Subject|1|||
163163844|NCT03776812|589312803|FG001|Overall Study|Withdrawal by Subject|7|||
163163845|NCT03776812|589312804|FG002|Overall Study|Withdrawal by Subject|2|||
163163846|NCT03776812|589312802|FG000|Overall Study|Lost to Follow-up|1|||
163163847|NCT03776812|589312803|FG001|Overall Study|Lost to Follow-up|1|||
163163848|NCT03776812|589312804|FG002|Overall Study|Lost to Follow-up|0|||
163163849|NCT03776812|589312802|FG000|Overall Study|Did not enter long-term follow-up|3|||
163163850|NCT03776812|589312803|FG001|Overall Study|Did not enter long-term follow-up|3|||
163163851|NCT03776812|589312804|FG002|Overall Study|Did not enter long-term follow-up|2|||
163163852|NCT00552188|589314180|FG000|Overall Study|Adverse Event|0|||
163163853|NCT00552188|589314181|FG001|Overall Study|Adverse Event|2|||
163163854|NCT00552188|589314180|FG000|Overall Study|Lost to Follow-up|2|||
163163855|NCT00552188|589314181|FG001|Overall Study|Lost to Follow-up|1|||
163163856|NCT00552188|589314180|FG000|Overall Study|Withdrawal of consent|0|||
163163857|NCT00552188|589314181|FG001|Overall Study|Withdrawal of consent|1|||
163163858|NCT00552188|589314180|FG000|Overall Study|Subject returned to home country|0|||
163163859|NCT00552188|589314181|FG001|Overall Study|Subject returned to home country|1|||
163163860|NCT01368562|589314182|FG000|Overall Study|Adverse Event|1|||
163163861|NCT01368562|589314182|FG000|Overall Study|Disease progression|1|||
163163862|NCT01368562|589314182|FG000|Overall Study|Lost to Follow-up|1|||
163163863|NCT01368562|589314182|FG000|Overall Study|Death|6|||
163163864|NCT01368562|589314182|FG000|Overall Study|Unresponsive to treatment|5|||
163163865|NCT01368562|589314182|FG000|Overall Study|Other|3|||
163163866|NCT01368562|589314182|FG000|Overall Study|Other than specified|2|||
163163867|NCT00243269|589314187|FG000|Overall Study|Protocol Violation|2|||
163163868|NCT00243269|589314188|FG001|Overall Study|Protocol Violation|1|||
163163869|NCT00243269|589314189|FG002|Overall Study|Protocol Violation|0|||
163163870|NCT00243269|589314190|FG003|Overall Study|Protocol Violation|1|||
163163871|NCT00243269|589314187|FG000|Overall Study|Lost to Follow-up|1|||
163163872|NCT00243269|589314188|FG001|Overall Study|Lost to Follow-up|0|||
163163873|NCT00243269|589314189|FG002|Overall Study|Lost to Follow-up|1|||
163163874|NCT00243269|589314190|FG003|Overall Study|Lost to Follow-up|3|||
163163875|NCT01296672|589314195|FG000|Overall Study|Lost to Follow-up|73|||
163163876|NCT01296672|589314196|FG001|Overall Study|Lost to Follow-up|18|||
163163877|NCT01311024|589314197|FG000|Overall Study|Protocol Violation|35|||
163163878|NCT01311024|589314198|FG001|Overall Study|Protocol Violation|22|||
163163879|NCT00856518|589314199|FG000|Overall Study|Lost to Follow-up|4|||
163163880|NCT00856518|589314200|FG001|Overall Study|Lost to Follow-up|2|||
163163881|NCT02867384|589314201|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
163163882|NCT02867384|589314202|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
163163883|NCT02867384|589314203|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
163163884|NCT02867384|589314201|FG000|Overall Study|Progression/ Relapse|15|||
163163885|NCT02867384|589314202|FG001|Overall Study|Progression/ Relapse|19|||
163163886|NCT02867384|589314203|FG002|Overall Study|Progression/ Relapse|0|||
163163887|NCT02867384|589314201|FG000|Overall Study|Adverse Event|13|||
163163888|NCT02867384|589314202|FG001|Overall Study|Adverse Event|1|||
163163889|NCT02867384|589314203|FG002|Overall Study|Adverse Event|0|||
163163890|NCT02867384|589314201|FG000|Overall Study|Withdrawal by Subject|6|||
163276264|NCT03531905|589721619|FG001|Overall Study|Could not speak with the participant|0|||
163276265|NCT03531905|589721620|FG002|Overall Study|Could not speak with the participant|0|||
163276266|NCT01036087|589721621|FG000|Overall Study|Adverse Event|2|||
163276267|NCT01036087|589721621|FG000|Overall Study|Lack of Efficacy|1|||
163163891|NCT02867384|589314202|FG001|Overall Study|Withdrawal by Subject|5|||
163163892|NCT02867384|589314203|FG002|Overall Study|Withdrawal by Subject|0|||
163163893|NCT02867384|589314201|FG000|Overall Study|Physician Decision|1|||
163163894|NCT02867384|589314202|FG001|Overall Study|Physician Decision|2|||
163163895|NCT02867384|589314203|FG002|Overall Study|Physician Decision|0|||
163163896|NCT02867384|589314201|FG000|Overall Study|Patient compliance|1|||
163163897|NCT02867384|589314202|FG001|Overall Study|Patient compliance|0|||
163163898|NCT02867384|589314203|FG002|Overall Study|Patient compliance|0|||
163163899|NCT02867384|589314201|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
163163900|NCT02867384|589314202|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
163163901|NCT02867384|589314203|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
163163902|NCT02867384|589314201|FG000|Overall Study|Never start treatment|3|||
163163903|NCT02867384|589314202|FG001|Overall Study|Never start treatment|0|||
163163904|NCT02867384|589314203|FG002|Overall Study|Never start treatment|0|||
163163905|NCT01941186|589314204|FG000|Follow-up|Lost to Follow-up|1|||
163163906|NCT01941186|589314205|FG001|Follow-up|Lost to Follow-up|0|||
163163907|NCT02105961|589314206|FG000|Overall Study|Adverse Event|18|||
163163908|NCT02105961|589314207|FG001|Overall Study|Adverse Event|7|||
163163909|NCT02105961|589314208|FG002|Overall Study|Adverse Event|13|||
163163910|NCT02105961|589314206|FG000|Overall Study|Lack of Efficacy|3|||
163163911|NCT02105961|589314207|FG001|Overall Study|Lack of Efficacy|0|||
163163912|NCT02105961|589314208|FG002|Overall Study|Lack of Efficacy|3|||
163163913|NCT02105961|589314206|FG000|Overall Study|Lost to Follow-up|2|||
163163914|NCT02105961|589314207|FG001|Overall Study|Lost to Follow-up|0|||
163163915|NCT02105961|589314208|FG002|Overall Study|Lost to Follow-up|1|||
163163916|NCT02105961|589314206|FG000|Overall Study|Physician Decision|3|||
163163917|NCT02105961|589314207|FG001|Overall Study|Physician Decision|3|||
163163918|NCT02105961|589314208|FG002|Overall Study|Physician Decision|2|||
163163919|NCT02105961|589314206|FG000|Overall Study|Withdrawal by Subject|15|||
163163920|NCT02105961|589314207|FG001|Overall Study|Withdrawal by Subject|7|||
163276268|NCT01616563|589721624|FG000|Overall Study|Lost to Follow-up|40|||
163163921|NCT02105961|589314208|FG002|Overall Study|Withdrawal by Subject|11|||
163163922|NCT00934362|589314212|FG000|Overall Study|Adverse Event|1|||
163276269|NCT00072475|589721625|FG000|Overall Study|Adverse Event|44|||
163163923|NCT00934362|589314213|FG001|Overall Study|Adverse Event|0|||
163163924|NCT01092117|589314216|FG000|Index Procedure to 1 Month|Death|1|||
163163925|NCT01092117|589314216|FG000|1 Month|Death|1|||
163163926|NCT01092117|589314216|FG000|1 Month|Withdrawal by Subject|1|||
163163927|NCT01092117|589314216|FG000|1 Month|Lost to Follow-up|1|||
163163928|NCT01092117|589314216|FG000|6 Months|Death|2|||
163163929|NCT01092117|589314216|FG000|6 Months|Withdrawal by Subject|3|||
163163930|NCT01092117|589314216|FG000|12 Month|Death|11|||
163163931|NCT01092117|589314216|FG000|12 Month|Withdrawal by Subject|2|||
163163932|NCT01092117|589314216|FG000|12 Month|Lost to Follow-up|1|||
163163933|NCT01092117|589314216|FG000|Year 2|Death|5|||
163163934|NCT01092117|589314216|FG000|Year 2|Withdrawal by Subject|4|||
163163935|NCT01092117|589314216|FG000|Year 2|Lost to Follow-up|1|||
163163936|NCT01092117|589314216|FG000|Year 3|Death|7|||
163163937|NCT01092117|589314216|FG000|Year 3|Withdrawal by Subject|9|||
163163938|NCT01092117|589314216|FG000|Year 3|Lost to Follow-up|3|||
163163939|NCT01092117|589314216|FG000|Year 4|Death|8|||
163163940|NCT01092117|589314216|FG000|Year 4|Withdrawal by Subject|4|||
163163941|NCT01092117|589314216|FG000|Year 4|Lost to Follow-up|4|||
163163942|NCT04380519|589314217|FG000|Overall Study|Withdrawal by Subject|4|||
163163943|NCT04380519|589314218|FG001|Overall Study|Withdrawal by Subject|0|||
163163944|NCT04380519|589314219|FG002|Overall Study|Withdrawal by Subject|1|||
163163945|NCT04380519|589314217|FG000|Overall Study|Death|14|||
163163946|NCT04380519|589314218|FG001|Overall Study|Death|9|||
163163947|NCT04380519|589314219|FG002|Overall Study|Death|6|||
163163948|NCT04380519|589314217|FG000|Overall Study|Adverse Event|0|||
163163949|NCT04380519|589314218|FG001|Overall Study|Adverse Event|1|||
163163950|NCT04380519|589314219|FG002|Overall Study|Adverse Event|0|||
163163951|NCT04380519|589314217|FG000|Overall Study|relatives' decision|0|||
163163952|NCT04380519|589314218|FG001|Overall Study|relatives' decision|1|||
163163953|NCT04380519|589314219|FG002|Overall Study|relatives' decision|0|||
163163954|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
163163955|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
163163956|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
163163957|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
163163958|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
163163959|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
163163960|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
163163961|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
163163962|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
163163963|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
163163964|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
163163965|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
163163966|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
163163967|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
163163968|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
163163969|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
163163970|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
163163971|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
163163972|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
163163973|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
163163974|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
163163975|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
163163976|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
163163977|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
163163978|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
163163979|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
163163980|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
163163981|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
163163982|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
163163983|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
163163984|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
163163985|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
163163986|NCT01623050|589314222|FG000|Overall Study|Lost to Follow-up|9|||
163163987|NCT00526071|589314225|FG000|Overall Study|Adverse Event|1|||
163163988|NCT00526071|589314225|FG000|Overall Study|Withdrawal by Subject|1|||
163276270|NCT00072475|589721625|FG000|Overall Study|Death|3|||
163276271|NCT00072475|589721625|FG000|Overall Study|Withdrawal by Subject|46|||
163276272|NCT00072475|589721625|FG000|Overall Study|Patient/Investigator Decision|4|||
163276273|NCT03303105|589721628|FG000|Overall Study|Adverse Event|0|||
163163989|NCT00526071|589314225|FG000|Overall Study|Lack of Response to Study Drug|4|||
163163990|NCT01191762|589314226|FG000|Overall Study|Adverse Event|1|||
163163991|NCT01191762|589314227|FG001|Overall Study|Adverse Event|0|||
163163992|NCT00393861|589314230|FG000|Overall Study|Adverse Event|2|||
163163993|NCT00393861|589314230|FG000|Overall Study|Disease Progression|24|||
163163994|NCT05300763|589314231|FG000|Overall Study|Adverse Event|0|||
163163995|NCT05300763|589314232|FG001|Overall Study|Adverse Event|1|||
163163996|NCT05300763|589314231|FG000|Overall Study|Major Protocol Deviation|1|||
163163997|NCT05300763|589314232|FG001|Overall Study|Major Protocol Deviation|0|||
163163998|NCT05300763|589314231|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
163163999|NCT05300763|589314232|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
163164000|NCT01485172|589314233|FG000|Overall Study|Adverse Event|2|||
163164001|NCT01485172|589314234|FG001|Overall Study|Adverse Event|1|||
163164002|NCT01485172|589314235|FG002|Overall Study|Adverse Event|2|||
163164003|NCT01485172|589314236|FG003|Overall Study|Adverse Event|2|||
163164004|NCT01485172|589314237|FG004|Overall Study|Adverse Event|1|||
163164005|NCT01485172|589314238|FG005|Overall Study|Adverse Event|2|||
163164006|NCT01485172|589314233|FG000|Overall Study|Lack of Efficacy|2|||
163164007|NCT01485172|589314234|FG001|Overall Study|Lack of Efficacy|0|||
163164008|NCT01485172|589314235|FG002|Overall Study|Lack of Efficacy|0|||
163164009|NCT01485172|589314236|FG003|Overall Study|Lack of Efficacy|0|||
163164010|NCT01485172|589314237|FG004|Overall Study|Lack of Efficacy|0|||
163164011|NCT01485172|589314238|FG005|Overall Study|Lack of Efficacy|0|||
163164012|NCT01485172|589314233|FG000|Overall Study|Protocol Violation|0|||
163164013|NCT01485172|589314234|FG001|Overall Study|Protocol Violation|0|||
163164014|NCT01485172|589314235|FG002|Overall Study|Protocol Violation|4|||
163164015|NCT01485172|589314236|FG003|Overall Study|Protocol Violation|5|||
163164016|NCT01485172|589314237|FG004|Overall Study|Protocol Violation|1|||
163164017|NCT01485172|589314238|FG005|Overall Study|Protocol Violation|0|||
163164018|NCT01485172|589314233|FG000|Overall Study|Protocol defined stopping criteria|1|||
163164019|NCT01485172|589314234|FG001|Overall Study|Protocol defined stopping criteria|0|||
163164020|NCT01485172|589314235|FG002|Overall Study|Protocol defined stopping criteria|0|||
163164021|NCT01485172|589314236|FG003|Overall Study|Protocol defined stopping criteria|0|||
163164022|NCT01485172|589314237|FG004|Overall Study|Protocol defined stopping criteria|1|||
163164023|NCT01485172|589314238|FG005|Overall Study|Protocol defined stopping criteria|0|||
163164024|NCT01485172|589314233|FG000|Overall Study|Lost to Follow-up|0|||
163164025|NCT01485172|589314234|FG001|Overall Study|Lost to Follow-up|0|||
163164026|NCT01485172|589314235|FG002|Overall Study|Lost to Follow-up|1|||
163164027|NCT01485172|589314236|FG003|Overall Study|Lost to Follow-up|0|||
163164028|NCT01485172|589314237|FG004|Overall Study|Lost to Follow-up|0|||
163164029|NCT01485172|589314238|FG005|Overall Study|Lost to Follow-up|1|||
163164030|NCT01485172|589314233|FG000|Overall Study|Physician Decision|0|||
163164031|NCT01485172|589314234|FG001|Overall Study|Physician Decision|0|||
163164032|NCT01485172|589314235|FG002|Overall Study|Physician Decision|0|||
163164033|NCT01485172|589314236|FG003|Overall Study|Physician Decision|0|||
163164034|NCT01485172|589314237|FG004|Overall Study|Physician Decision|1|||
163164035|NCT01485172|589314238|FG005|Overall Study|Physician Decision|0|||
163164036|NCT01485172|589314233|FG000|Overall Study|Withdrawal by Subject|2|||
163164037|NCT01485172|589314234|FG001|Overall Study|Withdrawal by Subject|0|||
163164038|NCT01485172|589314235|FG002|Overall Study|Withdrawal by Subject|0|||
163164039|NCT01485172|589314236|FG003|Overall Study|Withdrawal by Subject|1|||
163164040|NCT01485172|589314237|FG004|Overall Study|Withdrawal by Subject|1|||
163164041|NCT01485172|589314238|FG005|Overall Study|Withdrawal by Subject|1|||
163164042|NCT01587014|589314239|FG000|Overall Study|Death|2|||
163164043|NCT01409811|589314240|FG000|Overall Study|Insurance denial|1|||
163164044|NCT00441064|589314241|FG000|Overall Study|Adverse Event|1|||
163164045|NCT00441064|589314242|FG001|Overall Study|Adverse Event|0|||
163164046|NCT00441064|589314241|FG000|Overall Study|Abnormal laboratory values|0|||
163164047|NCT00441064|589314242|FG001|Overall Study|Abnormal laboratory values|2|||
163164048|NCT00441064|589314241|FG000|Overall Study|Abnormal test procedure results|0|||
163164049|NCT00441064|589314242|FG001|Overall Study|Abnormal test procedure results|1|||
163164050|NCT00441064|589314241|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163164051|NCT00441064|589314242|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163164052|NCT00441064|589314241|FG000|Overall Study|Protocol Deviation|3|||
163164053|NCT00441064|589314242|FG001|Overall Study|Protocol Deviation|2|||
163164054|NCT00441064|589314241|FG000|Overall Study|Patient withdrew consent|5|||
163164055|NCT00441064|589314242|FG001|Overall Study|Patient withdrew consent|2|||
163164056|NCT03051178|589314243|FG000|Overall Study|Withdrawal by Subject|5|||
163164057|NCT00953056|589314244|FG000|Overall Study|Withdrew Consent|0|||
163164058|NCT00953056|589314245|FG001|Overall Study|Withdrew Consent|0|||
163164059|NCT00953056|589314246|FG002|Overall Study|Withdrew Consent|0|||
163164060|NCT00953056|589314247|FG003|Overall Study|Withdrew Consent|0|||
163164061|NCT00953056|589314248|FG004|Overall Study|Withdrew Consent|2|||
163164062|NCT00953056|589314249|FG005|Overall Study|Withdrew Consent|3|||
163164063|NCT00953056|589314244|FG000|Overall Study|Serious Adverse Event|0|||
163164064|NCT00953056|589314245|FG001|Overall Study|Serious Adverse Event|0|||
163164065|NCT00953056|589314246|FG002|Overall Study|Serious Adverse Event|0|||
163164066|NCT00953056|589314247|FG003|Overall Study|Serious Adverse Event|0|||
163164067|NCT00953056|589314248|FG004|Overall Study|Serious Adverse Event|0|||
163164068|NCT00953056|589314249|FG005|Overall Study|Serious Adverse Event|1|||
163164069|NCT00048074|589314253|FG000|Overall Study|Adverse Event|46|||
163164070|NCT00048074|589314254|FG001|Overall Study|Adverse Event|41|||
163164071|NCT00048074|589314255|FG002|Overall Study|Adverse Event|53|||
163164072|NCT00048074|589314253|FG000|Overall Study|Death|3|||
163164073|NCT00048074|589314254|FG001|Overall Study|Death|3|||
163164074|NCT00048074|589314255|FG002|Overall Study|Death|2|||
163164075|NCT00048074|589314253|FG000|Overall Study|Lost to Follow-up|2|||
163164076|NCT00048074|589314254|FG001|Overall Study|Lost to Follow-up|6|||
163164077|NCT00048074|589314255|FG002|Overall Study|Lost to Follow-up|6|||
163164078|NCT00048074|589314253|FG000|Overall Study|Withdrawal by Subject|28|||
163164079|NCT00048074|589314254|FG001|Overall Study|Withdrawal by Subject|30|||
163164080|NCT00048074|589314255|FG002|Overall Study|Withdrawal by Subject|35|||
163164081|NCT00048074|589314253|FG000|Overall Study|Protocol Violation|1|||
163164082|NCT00048074|589314254|FG001|Overall Study|Protocol Violation|3|||
163164083|NCT00048074|589314255|FG002|Overall Study|Protocol Violation|0|||
163164084|NCT00048074|589314253|FG000|Overall Study|Study participation was terminated|0|||
163164085|NCT00048074|589314254|FG001|Overall Study|Study participation was terminated|1|||
163164086|NCT00048074|589314255|FG002|Overall Study|Study participation was terminated|0|||
163164087|NCT00048074|589314253|FG000|Overall Study|Husband ill|0|||
163164088|NCT00048074|589314254|FG001|Overall Study|Husband ill|1|||
163164089|NCT00048074|589314255|FG002|Overall Study|Husband ill|0|||
163164090|NCT00048074|589314253|FG000|Overall Study|Poor compliance|0|||
163164091|NCT00048074|589314254|FG001|Overall Study|Poor compliance|1|||
163164092|NCT00048074|589314255|FG002|Overall Study|Poor compliance|0|||
163164093|NCT00048074|589314253|FG000|Overall Study|Out of station|0|||
163164094|NCT00048074|589314254|FG001|Overall Study|Out of station|1|||
163164095|NCT00048074|589314255|FG002|Overall Study|Out of station|1|||
163164096|NCT00048074|589314253|FG000|Overall Study|Social reasons|1|||
163164097|NCT00048074|589314254|FG001|Overall Study|Social reasons|0|||
163164098|NCT00048074|589314255|FG002|Overall Study|Social reasons|0|||
163164099|NCT04476797|589314256|FG000|Overall Study|Withdrawal by Subject|1|||
163164100|NCT04476797|589314257|FG001|Overall Study|Withdrawal by Subject|0|||
163164101|NCT04476797|589314258|FG002|Overall Study|Withdrawal by Subject|0|||
163164102|NCT04476797|589314256|FG000|Overall Study|Death|0|||
163164103|NCT04476797|589314257|FG001|Overall Study|Death|1|||
163164104|NCT04476797|589314258|FG002|Overall Study|Death|2|||
163164105|NCT04476797|589314256|FG000|Overall Study|Sponsor Terminated Study|0|||
163164106|NCT04476797|589314257|FG001|Overall Study|Sponsor Terminated Study|18|||
163164107|NCT04476797|589314258|FG002|Overall Study|Sponsor Terminated Study|17|||
163164108|NCT02395081|589314259|FG000|Overall Study|Withdrawal by Subject|1|||
163164109|NCT02395081|589314260|FG001|Overall Study|Withdrawal by Subject|1|||
163164110|NCT02395081|589314261|FG002|Overall Study|Withdrawal by Subject|0|||
163164111|NCT02395081|589314259|FG000|Overall Study|Moved where blood couldn't be collected|4|||
163164112|NCT02395081|589314260|FG001|Overall Study|Moved where blood couldn't be collected|1|||
163164113|NCT02395081|589314261|FG002|Overall Study|Moved where blood couldn't be collected|3|||
163164114|NCT02395081|589314259|FG000|Overall Study|Fetal Loss|2|||
163164115|NCT02395081|589314260|FG001|Overall Study|Fetal Loss|3|||
163164116|NCT02395081|589314261|FG002|Overall Study|Fetal Loss|1|||
163164117|NCT01583296|589314262|FG000|Overall Study|Withdrawal by Subject|11|||
163164118|NCT01583296|589314263|FG001|Overall Study|Withdrawal by Subject|10|||
163164119|NCT01063283|589314264|FG000|Cycle 1|Adverse Event|2|||
163164120|NCT01063283|589314265|FG001|Cycle 1|Adverse Event|0|||
163164121|NCT01063283|589314266|FG002|Cycle 1|Adverse Event|0|||
163164122|NCT01063283|589314264|FG000|Cycle 1|Technical failure in data collection|1|||
163164123|NCT01063283|589314265|FG001|Cycle 1|Technical failure in data collection|0|||
163164124|NCT01063283|589314266|FG002|Cycle 1|Technical failure in data collection|0|||
163164125|NCT02504216|589314269|FG000|Overall Study|Lost to Follow-up|3|||
163164126|NCT02504216|589314270|FG001|Overall Study|Lost to Follow-up|3|||
163164127|NCT02504216|589314269|FG000|Overall Study|Withdrawal by Subject|8|||
163164128|NCT02504216|589314270|FG001|Overall Study|Withdrawal by Subject|12|||
163164129|NCT00223080|589314271|FG000|Overall Study|Withdrawal by Subject|253|||
163164130|NCT00223080|589314272|FG001|Overall Study|Withdrawal by Subject|232|||
163164131|NCT00223080|589314271|FG000|Overall Study|Required contraindicated med|0|||
163164132|NCT00223080|589314272|FG001|Overall Study|Required contraindicated med|1|||
163164133|NCT00223080|589314271|FG000|Overall Study|Non-compliant|7|||
163164134|NCT00223080|589314272|FG001|Overall Study|Non-compliant|7|||
163164135|NCT00223080|589314271|FG000|Overall Study|Moved from study area|37|||
163164136|NCT00223080|589314272|FG001|Overall Study|Moved from study area|47|||
163164137|NCT00223080|589314271|FG000|Overall Study|Lost to Follow-up|259|||
163164138|NCT00223080|589314272|FG001|Overall Study|Lost to Follow-up|284|||
163164139|NCT00223080|589314271|FG000|Overall Study|Death|85|||
163164140|NCT00223080|589314272|FG001|Overall Study|Death|74|||
163164141|NCT00223080|589314271|FG000|Overall Study|Other|14|||
163164142|NCT00223080|589314272|FG001|Overall Study|Other|11|||
163164143|NCT00223080|589314271|FG000|Overall Study|Reason not provided|141|||
163164144|NCT00223080|589314272|FG001|Overall Study|Reason not provided|140|||
163164145|NCT00223080|589314271|FG000|Overall Study|Adverse Event|0|||
163164146|NCT00223080|589314272|FG001|Overall Study|Adverse Event|1|||
163164147|NCT02598583|589314273|FG000|Extension Period|Withdrawal by Subject|1|||
163164148|NCT02598583|589314274|FG001|Extension Period|Withdrawal by Subject|0|||
163164149|NCT03237286|589314275|FG000|Overall Study|Withdrawal by Subject|1|||
163164150|NCT03237286|589314276|FG001|Overall Study|Withdrawal by Subject|0|||
163164151|NCT03237286|589314277|FG002|Overall Study|Withdrawal by Subject|2|||
163164152|NCT03237286|589314275|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
163164153|NCT03237286|589314276|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
163164154|NCT03237286|589314277|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
163164155|NCT02792829|589314285|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
163164156|NCT02792829|589314286|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
163164157|NCT02792829|589314287|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
163164158|NCT02792829|589314288|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
163164159|NCT02792829|589314289|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
163164160|NCT02792829|589314290|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
163164161|NCT02792829|589314291|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
163164162|NCT02792829|589314292|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
163164163|NCT02792829|589314285|FG000|Treatment Period 2|Adverse Event|0|||
163164164|NCT02792829|589314286|FG001|Treatment Period 2|Adverse Event|0|||
163164165|NCT02792829|589314287|FG002|Treatment Period 2|Adverse Event|0|||
163164166|NCT02792829|589314288|FG003|Treatment Period 2|Adverse Event|0|||
163164167|NCT02792829|589314289|FG004|Treatment Period 2|Adverse Event|1|||
163164168|NCT02792829|589314290|FG005|Treatment Period 2|Adverse Event|0|||
163164169|NCT02792829|589314291|FG006|Treatment Period 2|Adverse Event|1|||
163164170|NCT02792829|589314292|FG007|Treatment Period 2|Adverse Event|1|||
163164171|NCT02792829|589314285|FG000|Treatment Period 2|Use of proscribed medications|0|||
163164172|NCT02792829|589314286|FG001|Treatment Period 2|Use of proscribed medications|0|||
163164173|NCT02792829|589314287|FG002|Treatment Period 2|Use of proscribed medications|0|||
163164174|NCT02792829|589314288|FG003|Treatment Period 2|Use of proscribed medications|0|||
163164175|NCT02792829|589314289|FG004|Treatment Period 2|Use of proscribed medications|0|||
163164176|NCT02792829|589314290|FG005|Treatment Period 2|Use of proscribed medications|0|||
163164177|NCT02792829|589314291|FG006|Treatment Period 2|Use of proscribed medications|0|||
163164178|NCT02792829|589314292|FG007|Treatment Period 2|Use of proscribed medications|1|||
163164179|NCT01262820|589314293|FG000|Overall Study|Adverse Event|5|||
163164180|NCT01262820|589314293|FG000|Overall Study|Lack of Efficacy|9|||
163164181|NCT01262820|589314293|FG000|Overall Study|Drug held for 21+ days|1|||
163164182|NCT00104520|589314295|FG000|Overall Study|Unrelated adverse event|34|||
163164183|NCT00104520|589314296|FG001|Overall Study|Unrelated adverse event|47|||
163164184|NCT00104520|589314295|FG000|Overall Study|Study drug intolerance|0|||
163164185|NCT00104520|589314296|FG001|Overall Study|Study drug intolerance|1|||
163164186|NCT00104520|589314295|FG000|Overall Study|Related adverse event|13|||
163164187|NCT00104520|589314296|FG001|Overall Study|Related adverse event|15|||
163164188|NCT00104520|589314295|FG000|Overall Study|Lost to Follow-up|1|||
163164189|NCT00104520|589314296|FG001|Overall Study|Lost to Follow-up|0|||
163164190|NCT00104520|589314295|FG000|Overall Study|Noncompliance|0|||
163164191|NCT00104520|589314296|FG001|Overall Study|Noncompliance|2|||
163164192|NCT00104520|589314295|FG000|Overall Study|Personal/administrative|1|||
163164193|NCT00104520|589314296|FG001|Overall Study|Personal/administrative|1|||
163164194|NCT00104520|589314295|FG000|Overall Study|Other|1|||
163164195|NCT00104520|589314296|FG001|Overall Study|Other|5|||
163164196|NCT02442804|589314298|FG000|Overall Study|Withdrawal by Subject|0|||
163164197|NCT02442804|589314299|FG001|Overall Study|Withdrawal by Subject|1|||
163164198|NCT02442804|589314298|FG000|Overall Study|Adverse Event|1|||
163164199|NCT02442804|589314299|FG001|Overall Study|Adverse Event|0|||
163164200|NCT02527421|589314306|FG000|Overall Study|Withdrawal by Subject|1|||
163164201|NCT02527421|589314307|FG001|Overall Study|Withdrawal by Subject|0|||
163164202|NCT04200352|589314308|FG000|Overall Study|Death|1|||
163164203|NCT04200352|589314308|FG000|Overall Study|Adverse Event|6|||
163164204|NCT04200352|589314308|FG000|Overall Study|Withdrawal by parent/guardian|6|||
163164205|NCT04200352|589314308|FG000|Overall Study|Lack of Efficacy|1|||
163164206|NCT04200352|589314308|FG000|Overall Study|Other than specified|6|||
163164207|NCT02541604|589314309|FG000|Overall Study|Death|6|||
163164208|NCT02541604|589314310|FG001|Overall Study|Death|5|||
163164209|NCT02541604|589314311|FG002|Overall Study|Death|7|||
163164210|NCT02541604|589314312|FG003|Overall Study|Death|2|||
163164211|NCT02541604|589314313|FG004|Overall Study|Death|9|||
163276274|NCT03303105|589721629|FG001|Overall Study|Adverse Event|2|||
163042817|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
163164212|NCT02541604|589314314|FG005|Overall Study|Death|8|||
163164213|NCT02541604|589314315|FG006|Overall Study|Death|9|||
163164214|NCT02541604|589314316|FG007|Overall Study|Death|9|||
163164215|NCT02541604|589314317|FG008|Overall Study|Death|3|||
163164216|NCT02541604|589314318|FG009|Overall Study|Death|4|||
163164217|NCT02541604|589314319|FG010|Overall Study|Death|2|||
163164218|NCT02541604|589314320|FG011|Overall Study|Death|3|||
163164219|NCT02541604|589314309|FG000|Overall Study|Lost to Follow-up|2|||
163164220|NCT02541604|589314310|FG001|Overall Study|Lost to Follow-up|0|||
163164221|NCT02541604|589314311|FG002|Overall Study|Lost to Follow-up|1|||
163164222|NCT02541604|589314312|FG003|Overall Study|Lost to Follow-up|0|||
163164223|NCT02541604|589314313|FG004|Overall Study|Lost to Follow-up|0|||
163164224|NCT02541604|589314314|FG005|Overall Study|Lost to Follow-up|1|||
163164225|NCT02541604|589314315|FG006|Overall Study|Lost to Follow-up|1|||
163164226|NCT02541604|589314316|FG007|Overall Study|Lost to Follow-up|0|||
163164227|NCT02541604|589314317|FG008|Overall Study|Lost to Follow-up|0|||
163164228|NCT02541604|589314318|FG009|Overall Study|Lost to Follow-up|0|||
163164229|NCT02541604|589314319|FG010|Overall Study|Lost to Follow-up|0|||
163164230|NCT02541604|589314320|FG011|Overall Study|Lost to Follow-up|0|||
163164231|NCT02541604|589314309|FG000|Overall Study|Withdrawal by Subject|2|||
163164232|NCT02541604|589314310|FG001|Overall Study|Withdrawal by Subject|0|||
163164233|NCT02541604|589314311|FG002|Overall Study|Withdrawal by Subject|1|||
163164234|NCT02541604|589314312|FG003|Overall Study|Withdrawal by Subject|0|||
163164235|NCT02541604|589314313|FG004|Overall Study|Withdrawal by Subject|1|||
163164236|NCT02541604|589314314|FG005|Overall Study|Withdrawal by Subject|1|||
163164237|NCT02541604|589314315|FG006|Overall Study|Withdrawal by Subject|0|||
163164238|NCT02541604|589314316|FG007|Overall Study|Withdrawal by Subject|0|||
163164239|NCT02541604|589314317|FG008|Overall Study|Withdrawal by Subject|1|||
163164240|NCT02541604|589314318|FG009|Overall Study|Withdrawal by Subject|0|||
163164241|NCT02541604|589314319|FG010|Overall Study|Withdrawal by Subject|0|||
163164242|NCT02541604|589314320|FG011|Overall Study|Withdrawal by Subject|0|||
163164243|NCT02541604|589314309|FG000|Overall Study|Study Terminated by Sponsor|1|||
163164244|NCT02541604|589314310|FG001|Overall Study|Study Terminated by Sponsor|4|||
163164245|NCT02541604|589314311|FG002|Overall Study|Study Terminated by Sponsor|2|||
163164246|NCT02541604|589314312|FG003|Overall Study|Study Terminated by Sponsor|1|||
163164247|NCT02541604|589314313|FG004|Overall Study|Study Terminated by Sponsor|0|||
163164248|NCT02541604|589314314|FG005|Overall Study|Study Terminated by Sponsor|0|||
163164249|NCT02541604|589314315|FG006|Overall Study|Study Terminated by Sponsor|0|||
163164250|NCT02541604|589314316|FG007|Overall Study|Study Terminated by Sponsor|0|||
163164251|NCT02541604|589314317|FG008|Overall Study|Study Terminated by Sponsor|0|||
163164252|NCT02541604|589314318|FG009|Overall Study|Study Terminated by Sponsor|0|||
163164253|NCT02541604|589314319|FG010|Overall Study|Study Terminated by Sponsor|0|||
163164254|NCT02541604|589314320|FG011|Overall Study|Study Terminated by Sponsor|0|||
163164255|NCT02541604|589314309|FG000|Overall Study|Medical condition may jeopardize safety|0|||
163164256|NCT02541604|589314310|FG001|Overall Study|Medical condition may jeopardize safety|0|||
163164257|NCT02541604|589314311|FG002|Overall Study|Medical condition may jeopardize safety|0|||
163164258|NCT02541604|589314312|FG003|Overall Study|Medical condition may jeopardize safety|0|||
163164259|NCT02541604|589314313|FG004|Overall Study|Medical condition may jeopardize safety|0|||
163164260|NCT02541604|589314314|FG005|Overall Study|Medical condition may jeopardize safety|0|||
163164261|NCT02541604|589314315|FG006|Overall Study|Medical condition may jeopardize safety|0|||
163164262|NCT02541604|589314316|FG007|Overall Study|Medical condition may jeopardize safety|1|||
163164263|NCT02541604|589314317|FG008|Overall Study|Medical condition may jeopardize safety|0|||
163164264|NCT02541604|589314318|FG009|Overall Study|Medical condition may jeopardize safety|0|||
163164265|NCT02541604|589314319|FG010|Overall Study|Medical condition may jeopardize safety|0|||
163164266|NCT02541604|589314320|FG011|Overall Study|Medical condition may jeopardize safety|0|||
163164267|NCT00993148|589314321|FG000|Overall Study|Lost to Follow-up|2|||
163164268|NCT00993148|589314321|FG000|Overall Study|never initiated treatment|1|||
163164269|NCT00806819|589314322|FG000|Overall Study|progressive disease (modified RECIST )|217|||
163164270|NCT00806819|589314323|FG001|Overall Study|progressive disease (modified RECIST )|216|||
163164271|NCT00806819|589314322|FG000|Overall Study|Worsening or AE of underlying disease|18|||
163164272|NCT00806819|589314323|FG001|Overall Study|Worsening or AE of underlying disease|25|||
163164273|NCT00806819|589314322|FG000|Overall Study|Other AE|38|||
163164274|NCT00806819|589314323|FG001|Overall Study|Other AE|40|||
163164275|NCT00806819|589314322|FG000|Overall Study|Protocol Violation|9|||
163164276|NCT00806819|589314323|FG001|Overall Study|Protocol Violation|4|||
163164277|NCT00806819|589314322|FG000|Overall Study|Lost to Follow-up|1|||
163164278|NCT00806819|589314323|FG001|Overall Study|Lost to Follow-up|0|||
163164279|NCT00806819|589314322|FG000|Overall Study|Withdrawal by Subject|32|||
163164280|NCT00806819|589314323|FG001|Overall Study|Withdrawal by Subject|29|||
163276275|NCT03303105|589721628|FG000|Overall Study|Lack of Efficacy|1|||
163164281|NCT00806819|589314322|FG000|Overall Study|Not treated|6|||
163164282|NCT00806819|589314323|FG001|Overall Study|Not treated|3|||
163276276|NCT03303105|589721629|FG001|Overall Study|Lack of Efficacy|0|||
163164283|NCT00806819|589314322|FG000|Overall Study|Reasons other than stated above|25|||
163164284|NCT00806819|589314323|FG001|Overall Study|Reasons other than stated above|41|||
163164285|NCT01737502|589314327|FG000|Phase I|Disease progression|2|||
163276277|NCT03303105|589721628|FG000|Overall Study|Protocol Violation|1|||
163276278|NCT03303105|589721629|FG001|Overall Study|Protocol Violation|0|||
163164286|NCT01737502|589314328|FG001|Phase I|Disease progression|3|||
163164287|NCT01737502|589314327|FG000|Phase I|Complicating disease|1|||
163164288|NCT01737502|589314328|FG001|Phase I|Complicating disease|0|||
163164289|NCT01737502|589314327|FG000|Phase II|Adverse Event|0|||
163164290|NCT01737502|589314328|FG001|Phase II|Adverse Event|3|||
163164291|NCT01737502|589314327|FG000|Phase II|Disease progression|0|||
163164292|NCT01737502|589314328|FG001|Phase II|Disease progression|18|||
163164293|NCT01737502|589314327|FG000|Phase II|Death|0|||
163164294|NCT01737502|589314328|FG001|Phase II|Death|1|||
163164295|NCT01737502|589314327|FG000|Phase II|Transition to hospice care|0|||
163164296|NCT01737502|589314328|FG001|Phase II|Transition to hospice care|1|||
163164297|NCT00912197|589314334|FG000|Overall Study|Withdrawal by Subject|3|||
163164298|NCT00912197|589314335|FG001|Overall Study|Withdrawal by Subject|3|||
163164299|NCT03304249|589314338|FG000|Overall Study|Lost to Follow-up|8|||
163164300|NCT03304249|589314339|FG001|Overall Study|Lost to Follow-up|10|||
163164301|NCT03304249|589314338|FG000|Overall Study|Withdrawal by Subject|12|||
163164302|NCT03304249|589314339|FG001|Overall Study|Withdrawal by Subject|2|||
163164303|NCT03304249|589314338|FG000|Overall Study|Moved Out of District|4|||
163164304|NCT03304249|589314339|FG001|Overall Study|Moved Out of District|2|||
163164305|NCT01395524|589315971|FG000|Overall Study|Non-compliance with study schedule|1|||
163164306|NCT01395524|589315972|FG001|Overall Study|Non-compliance with study schedule|0|||
163164307|NCT01395524|589315973|FG002|Overall Study|Non-compliance with study schedule|1|||
163164308|NCT01395524|589315971|FG000|Overall Study|Lost to Follow-up|3|||
163164309|NCT01395524|589315972|FG001|Overall Study|Lost to Follow-up|1|||
163164310|NCT01395524|589315973|FG002|Overall Study|Lost to Follow-up|1|||
163164311|NCT01395524|589315971|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
163164312|NCT01395524|589315972|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
163164313|NCT01395524|589315973|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
163164314|NCT01395524|589315971|FG000|Overall Study|Severe noncompliance with protocol|1|||
163164315|NCT01395524|589315972|FG001|Overall Study|Severe noncompliance with protocol|0|||
163164316|NCT01395524|589315973|FG002|Overall Study|Severe noncompliance with protocol|0|||
163164317|NCT01395524|589315971|FG000|Overall Study|Adverse Event|4|||
163164318|NCT01395524|589315972|FG001|Overall Study|Adverse Event|4|||
163164319|NCT01395524|589315973|FG002|Overall Study|Adverse Event|3|||
163164320|NCT01395524|589315971|FG000|Overall Study|Death|1|||
163164321|NCT01395524|589315972|FG001|Overall Study|Death|0|||
163164322|NCT01395524|589315973|FG002|Overall Study|Death|0|||
163164323|NCT01395524|589315971|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
163164324|NCT01395524|589315972|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
163164325|NCT01395524|589315973|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
163164326|NCT01395524|589315971|FG000|Overall Study|Withdrawal by Subject|4|||
163164327|NCT01395524|589315972|FG001|Overall Study|Withdrawal by Subject|8|||
163164328|NCT01395524|589315973|FG002|Overall Study|Withdrawal by Subject|8|||
163164329|NCT01395524|589315971|FG000|Overall Study|Did not receive treatment|1|||
163164330|NCT01395524|589315972|FG001|Overall Study|Did not receive treatment|1|||
163164331|NCT01395524|589315973|FG002|Overall Study|Did not receive treatment|3|||
163164332|NCT01395524|589315971|FG000|Overall Study|Subject had spinal surgery|0|||
163164333|NCT01395524|589315972|FG001|Overall Study|Subject had spinal surgery|0|||
163164334|NCT01395524|589315973|FG002|Overall Study|Subject had spinal surgery|1|||
163164335|NCT02175199|589315984|FG000|Overall Study|Withdrawal by Subject|1|||
163164336|NCT02175199|589315985|FG001|Overall Study|Withdrawal by Subject|5|||
163164337|NCT02175199|589315984|FG000|Overall Study|Randomized in Error|1|||
163164338|NCT02175199|589315985|FG001|Overall Study|Randomized in Error|0|||
163164339|NCT02175199|589315984|FG000|Overall Study|Sponsor Decision|1|||
163164340|NCT02175199|589315985|FG001|Overall Study|Sponsor Decision|0|||
163164341|NCT00122980|589315986|FG000|Overall Study|Death|0|||
163164342|NCT00122980|589315987|FG001|Overall Study|Death|1|||
163164343|NCT00122980|589315986|FG000|Overall Study|Physician Decision|2|||
163164344|NCT00122980|589315987|FG001|Overall Study|Physician Decision|0|||
163164345|NCT00122980|589315986|FG000|Overall Study|Protocol Violation|5|||
163164346|NCT00122980|589315987|FG001|Overall Study|Protocol Violation|1|||
163164347|NCT00122980|589315986|FG000|Overall Study|Withdrawal by Subject|2|||
163164348|NCT00122980|589315987|FG001|Overall Study|Withdrawal by Subject|3|||
163164349|NCT00122980|589315986|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
163164350|NCT00122980|589315987|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
163164351|NCT00122980|589315986|FG000|Overall Study|Study termination|27|||
163164352|NCT00122980|589315987|FG001|Overall Study|Study termination|35|||
163164353|NCT01124864|589315990|FG000|Overall Study|Follow up phase competed as per protocol|18|||
163164354|NCT01124864|589315991|FG001|Overall Study|Follow up phase competed as per protocol|22|||
163164355|NCT01124864|589315992|FG002|Overall Study|Follow up phase competed as per protocol|24|||
163164356|NCT01124864|589315993|FG003|Overall Study|Follow up phase competed as per protocol|18|||
163164357|NCT01124864|589315994|FG004|Overall Study|Follow up phase competed as per protocol|26|||
163164358|NCT01124864|589315995|FG005|Overall Study|Follow up phase competed as per protocol|2|||
163042818|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
163164359|NCT01124864|589315990|FG000|Overall Study|Death|6|||
163164360|NCT01124864|589315991|FG001|Overall Study|Death|9|||
163164361|NCT01124864|589315992|FG002|Overall Study|Death|6|||
163164362|NCT01124864|589315993|FG003|Overall Study|Death|2|||
163164363|NCT01124864|589315994|FG004|Overall Study|Death|1|||
163164364|NCT01124864|589315995|FG005|Overall Study|Death|0|||
163164365|NCT01124864|589315990|FG000|Overall Study|Withdrawal by Subject|2|||
163164366|NCT01124864|589315991|FG001|Overall Study|Withdrawal by Subject|3|||
163164367|NCT01124864|589315992|FG002|Overall Study|Withdrawal by Subject|4|||
163164368|NCT01124864|589315993|FG003|Overall Study|Withdrawal by Subject|0|||
163164369|NCT01124864|589315994|FG004|Overall Study|Withdrawal by Subject|2|||
163164370|NCT01124864|589315995|FG005|Overall Study|Withdrawal by Subject|1|||
163164371|NCT01124864|589315990|FG000|Overall Study|Lost to Follow-up|1|||
163164372|NCT01124864|589315991|FG001|Overall Study|Lost to Follow-up|1|||
163164373|NCT01124864|589315992|FG002|Overall Study|Lost to Follow-up|0|||
163164374|NCT01124864|589315993|FG003|Overall Study|Lost to Follow-up|1|||
163164375|NCT01124864|589315994|FG004|Overall Study|Lost to Follow-up|0|||
163164376|NCT01124864|589315995|FG005|Overall Study|Lost to Follow-up|0|||
163164377|NCT01124864|589315990|FG000|Overall Study|Protocol Violation|1|||
163164378|NCT01124864|589315991|FG001|Overall Study|Protocol Violation|0|||
163164379|NCT01124864|589315992|FG002|Overall Study|Protocol Violation|0|||
163164380|NCT01124864|589315993|FG003|Overall Study|Protocol Violation|0|||
163164381|NCT01124864|589315994|FG004|Overall Study|Protocol Violation|1|||
163164382|NCT01124864|589315995|FG005|Overall Study|Protocol Violation|0|||
163164383|NCT00798759|589315998|FG000|Overall Study|Adverse Event|3|||
163164384|NCT00798759|589315999|FG001|Overall Study|Adverse Event|3|||
163164385|NCT00798759|589315998|FG000|Overall Study|Lost to Follow-up|1|||
163164386|NCT00798759|589315999|FG001|Overall Study|Lost to Follow-up|1|||
163164387|NCT00798759|589315998|FG000|Overall Study|Protocol Violation|4|||
163164388|NCT00798759|589315999|FG001|Overall Study|Protocol Violation|8|||
163164389|NCT00798759|589315998|FG000|Overall Study|Other|0|||
163164390|NCT00798759|589315999|FG001|Overall Study|Other|1|||
163164391|NCT00724711|589316000|FG000|Overall Study|Adverse Event|7|||
163164392|NCT00724711|589316001|FG001|Overall Study|Adverse Event|3|||
163164393|NCT00724711|589316000|FG000|Overall Study|Pregnancy|0|||
163164394|NCT00724711|589316001|FG001|Overall Study|Pregnancy|1|||
163164395|NCT00724711|589316000|FG000|Overall Study|Lack of Efficacy|0|||
163164396|NCT00724711|589316001|FG001|Overall Study|Lack of Efficacy|1|||
163164397|NCT00724711|589316000|FG000|Overall Study|Physician Decision|0|||
163164398|NCT00724711|589316001|FG001|Overall Study|Physician Decision|3|||
163164399|NCT00724711|589316000|FG000|Overall Study|Withdrawal by Subject|5|||
163164400|NCT00724711|589316001|FG001|Overall Study|Withdrawal by Subject|4|||
163164401|NCT00724711|589316000|FG000|Overall Study|Lost to Follow-up|4|||
163164402|NCT00724711|589316001|FG001|Overall Study|Lost to Follow-up|5|||
163164403|NCT00724711|589316000|FG000|Overall Study|Protocol Violation|1|||
163164404|NCT00724711|589316001|FG001|Overall Study|Protocol Violation|0|||
163164405|NCT03387111|589316002|FG000|Overall Study|Progressive Disease|3|||
163164406|NCT03387111|589316002|FG000|Overall Study|Other|1|||
163164407|NCT00727441|589316006|FG000|Overall Study|Disease Progression|11|||
163164408|NCT00727441|589316007|FG001|Overall Study|Disease Progression|14|||
163164409|NCT00727441|589316008|FG002|Overall Study|Disease Progression|17|||
163164410|NCT00727441|589316006|FG000|Overall Study|Eligibility|7|||
163164411|NCT00727441|589316007|FG001|Overall Study|Eligibility|5|||
163164412|NCT00727441|589316008|FG002|Overall Study|Eligibility|7|||
163164413|NCT00727441|589316006|FG000|Overall Study|Death|0|||
163164414|NCT00727441|589316007|FG001|Overall Study|Death|1|||
163164415|NCT00727441|589316008|FG002|Overall Study|Death|1|||
163164416|NCT00727441|589316006|FG000|Overall Study|Physician Decision|0|||
163164417|NCT00727441|589316007|FG001|Overall Study|Physician Decision|1|||
163164418|NCT00727441|589316008|FG002|Overall Study|Physician Decision|0|||
163164419|NCT00727441|589316006|FG000|Overall Study|Withdrawal by Subject|0|||
163164420|NCT00727441|589316007|FG001|Overall Study|Withdrawal by Subject|1|||
163164421|NCT00727441|589316008|FG002|Overall Study|Withdrawal by Subject|0|||
163164422|NCT01239992|589316009|FG000|Overall Study|Withdrawal by Subject|2|||
163164423|NCT00535288|589316010|FG000|Overall Study|Adverse Event|20|||
163164424|NCT00535288|589316011|FG001|Overall Study|Adverse Event|19|||
163164425|NCT00535288|589316012|FG002|Overall Study|Adverse Event|25|||
163276279|NCT03303105|589721628|FG000|Overall Study|Withdrawal by Subject|0|||
163164426|NCT00535288|589316013|FG003|Overall Study|Adverse Event|20|||
163164427|NCT00535288|589316014|FG004|Overall Study|Adverse Event|30|||
163164428|NCT00535288|589316010|FG000|Overall Study|Lost to Follow-up|0|||
163164429|NCT00535288|589316011|FG001|Overall Study|Lost to Follow-up|3|||
163276280|NCT03303105|589721629|FG001|Overall Study|Withdrawal by Subject|2|||
163164430|NCT00535288|589316012|FG002|Overall Study|Lost to Follow-up|0|||
163164431|NCT00535288|589316013|FG003|Overall Study|Lost to Follow-up|0|||
163164432|NCT00535288|589316014|FG004|Overall Study|Lost to Follow-up|0|||
163164433|NCT00535288|589316010|FG000|Overall Study|Lack of Efficacy|26|||
163164434|NCT00535288|589316011|FG001|Overall Study|Lack of Efficacy|3|||
163164435|NCT00535288|589316012|FG002|Overall Study|Lack of Efficacy|4|||
163164436|NCT00535288|589316013|FG003|Overall Study|Lack of Efficacy|4|||
163164437|NCT00535288|589316014|FG004|Overall Study|Lack of Efficacy|7|||
163164438|NCT00535288|589316010|FG000|Overall Study|Unwilling to cooperate|6|||
163164439|NCT00535288|589316011|FG001|Overall Study|Unwilling to cooperate|6|||
163164440|NCT00535288|589316012|FG002|Overall Study|Unwilling to cooperate|3|||
163164441|NCT00535288|589316013|FG003|Overall Study|Unwilling to cooperate|3|||
163164442|NCT00535288|589316014|FG004|Overall Study|Unwilling to cooperate|4|||
163164443|NCT00535288|589316010|FG000|Overall Study|Other|2|||
163164444|NCT00535288|589316011|FG001|Overall Study|Other|1|||
163164445|NCT00535288|589316012|FG002|Overall Study|Other|1|||
163164446|NCT00535288|589316013|FG003|Overall Study|Other|2|||
163164447|NCT00535288|589316014|FG004|Overall Study|Other|1|||
163164448|NCT02810444|589316015|FG000|Overall Study|Screen Failures|14|||
163164449|NCT02810444|589316015|FG000|Overall Study|Withdrawal by Subject|4|||
163164450|NCT02810444|589316015|FG000|Overall Study|Adverse Event|3|||
163164451|NCT04643158|589316016|FG000|Overall Study|Study terminated by sponsor|0|||
163164452|NCT04643158|589316017|FG001|Overall Study|Study terminated by sponsor|0|||
163164453|NCT04643158|589316018|FG002|Overall Study|Study terminated by sponsor|1|||
163164454|NCT04643158|589316019|FG003|Overall Study|Study terminated by sponsor|0|||
163164455|NCT04643158|589316020|FG004|Overall Study|Study terminated by sponsor|0|||
163164456|NCT04643158|589316021|FG005|Overall Study|Study terminated by sponsor|1|||
163164457|NCT04643158|589316022|FG006|Overall Study|Study terminated by sponsor|0|||
163164458|NCT04643158|589316016|FG000|Overall Study|Global/country situation|0|||
163164459|NCT04643158|589316017|FG001|Overall Study|Global/country situation|0|||
163164460|NCT04643158|589316018|FG002|Overall Study|Global/country situation|1|||
163164461|NCT04643158|589316019|FG003|Overall Study|Global/country situation|0|||
163164462|NCT04643158|589316020|FG004|Overall Study|Global/country situation|0|||
163164463|NCT04643158|589316021|FG005|Overall Study|Global/country situation|0|||
163164464|NCT04643158|589316022|FG006|Overall Study|Global/country situation|0|||
163164465|NCT04643158|589316016|FG000|Overall Study|Withdrawal by Subject|0|||
163164466|NCT04643158|589316017|FG001|Overall Study|Withdrawal by Subject|0|||
163164467|NCT04643158|589316018|FG002|Overall Study|Withdrawal by Subject|0|||
163164468|NCT04643158|589316019|FG003|Overall Study|Withdrawal by Subject|0|||
163164469|NCT04643158|589316020|FG004|Overall Study|Withdrawal by Subject|0|||
163164470|NCT04643158|589316021|FG005|Overall Study|Withdrawal by Subject|1|||
163164471|NCT04643158|589316022|FG006|Overall Study|Withdrawal by Subject|0|||
163164472|NCT04329806|589316023|FG000|Overall Study|Physician Decision|3|||
163164473|NCT04329806|589316024|FG001|Overall Study|Physician Decision|4|||
163164474|NCT00622440|589316037|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
163164475|NCT00622440|589316038|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
163164476|NCT00622440|589316037|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
163164477|NCT00622440|589316038|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
163164478|NCT00622440|589316037|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
163164479|NCT00622440|589316038|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
163164480|NCT00622440|589316037|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
163164481|NCT00622440|589316038|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
163164482|NCT02147561|589316044|FG000|Overall Study|Lost to Follow-up|3|||
163164483|NCT02147561|589316044|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
163164484|NCT03023813|589316047|FG000|Overall Study|Lost to Follow-up|1|||
163164485|NCT03023813|589316048|FG001|Overall Study|Lost to Follow-up|2|||
163164486|NCT03023813|589316049|FG002|Overall Study|Lost to Follow-up|0|||
163164487|NCT03710083|589316050|FG000|Overall Study|Withdrawal by Subject|2|||
163164488|NCT03710083|589316050|FG000|Overall Study|Unsuccessful Procedure|1|||
163164489|NCT02283762|589316054|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
163164490|NCT02283762|589316055|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
163164491|NCT02283762|589316054|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
163164492|NCT02283762|589316055|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
163164493|NCT02283762|589316054|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
163164494|NCT02283762|589316055|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
163164495|NCT02283762|589316054|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
163164496|NCT02283762|589316055|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
163164497|NCT02283762|589316054|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
163276281|NCT01033643|589721633|FG000|Overall Study|Withdrew Consent|0|||
163164498|NCT02283762|589316055|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
163164499|NCT02283762|589316054|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
163164500|NCT02283762|589316055|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
163164501|NCT02283762|589316054|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
163164502|NCT02283762|589316055|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
163164503|NCT02283762|589316054|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
163164504|NCT02283762|589316055|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
163164505|NCT02283762|589316054|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
163164506|NCT02283762|589316055|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
163164507|NCT02283762|589316054|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
163164508|NCT02283762|589316055|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
163276282|NCT01033643|589721634|FG001|Overall Study|Withdrew Consent|3|||
163164509|NCT02283762|589316054|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
163164510|NCT02283762|589316055|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
163164511|NCT02283762|589316054|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
163164512|NCT02283762|589316055|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
163164513|NCT00202878|589316056|FG000|Overall Study|Death|964|||
163164514|NCT00202878|589316057|FG001|Overall Study|Death|968|||
163164515|NCT00202878|589316056|FG000|Overall Study|Only Vital Status Known|357|||
163164516|NCT00202878|589316057|FG001|Overall Study|Only Vital Status Known|356|||
163164517|NCT00202878|589316056|FG000|Overall Study|Lost to Follow-up|44|||
163164518|NCT00202878|589316057|FG001|Overall Study|Lost to Follow-up|49|||
163164519|NCT00202878|589316056|FG000|Overall Study|Site Closure|39|||
163164520|NCT00202878|589316057|FG001|Overall Study|Site Closure|36|||
163164521|NCT00202878|589316056|FG000|Overall Study|Withdrawal by Subject|795|||
163164522|NCT00202878|589316057|FG001|Overall Study|Withdrawal by Subject|808|||
163164523|NCT00975780|589316066|FG000|Follow Up|Death|88|||
163164524|NCT00975780|589316067|FG001|Follow Up|Death|122|||
163164525|NCT00975780|589316066|FG000|Follow Up|Facility Withdrawal|7|||
163164526|NCT00975780|589316067|FG001|Follow Up|Facility Withdrawal|23|||
163164527|NCT00975780|589316066|FG000|Follow Up|Discharged from Facility|7|||
163164528|NCT00975780|589316067|FG001|Follow Up|Discharged from Facility|12|||
163164529|NCT02813577|589316068|FG000|Overall Study|Study terminated|4|||
163164530|NCT01976741|589316069|FG000|Overall Study|Withdrawal by Subject|1|||
163164531|NCT01976741|589316070|FG001|Overall Study|Withdrawal by Subject|0|||
163164532|NCT01976741|589316071|FG002|Overall Study|Withdrawal by Subject|1|||
163164533|NCT01976741|589316072|FG003|Overall Study|Withdrawal by Subject|1|||
163164534|NCT01976741|589316073|FG004|Overall Study|Withdrawal by Subject|0|||
163164535|NCT01976741|589316074|FG005|Overall Study|Withdrawal by Subject|0|||
163164536|NCT01976741|589316075|FG006|Overall Study|Withdrawal by Subject|1|||
163164537|NCT01976741|589316076|FG007|Overall Study|Withdrawal by Subject|4|||
163164538|NCT01976741|589316077|FG008|Overall Study|Withdrawal by Subject|0|||
163164539|NCT01976741|589316078|FG009|Overall Study|Withdrawal by Subject|0|||
163164540|NCT01976741|589316069|FG000|Overall Study|Adverse Event|0|||
163164541|NCT01976741|589316070|FG001|Overall Study|Adverse Event|0|||
163164542|NCT01976741|589316071|FG002|Overall Study|Adverse Event|2|||
163164543|NCT01976741|589316072|FG003|Overall Study|Adverse Event|0|||
163164544|NCT01976741|589316073|FG004|Overall Study|Adverse Event|0|||
163164545|NCT01976741|589316074|FG005|Overall Study|Adverse Event|0|||
163164546|NCT01976741|589316075|FG006|Overall Study|Adverse Event|3|||
163164547|NCT01976741|589316076|FG007|Overall Study|Adverse Event|8|||
163164548|NCT01976741|589316077|FG008|Overall Study|Adverse Event|1|||
163164549|NCT01976741|589316078|FG009|Overall Study|Adverse Event|4|||
163164550|NCT00889720|589316079|FG000|Overall Study|Withdrawal by Subject|4|||
163164551|NCT00889720|589316079|FG000|Overall Study|Other|4|||
163164552|NCT03865381|589316089|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
163164553|NCT03865381|589316089|FG000|Overall Study|Withdrawal by Subject|2|||
163164554|NCT02873377|589316093|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
163164555|NCT02873377|589316094|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
163164556|NCT02873377|589316093|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
163164557|NCT02873377|589316094|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
163164558|NCT00452361|589316095|FG000|Overall Study|Adverse Event|8|||
163164559|NCT00452361|589316096|FG001|Overall Study|Adverse Event|0|||
163164560|NCT00452361|589316095|FG000|Overall Study|Withdrawal by Subject|0|||
163164561|NCT00452361|589316096|FG001|Overall Study|Withdrawal by Subject|1|||
163164562|NCT00452361|589316095|FG000|Overall Study|Premature termination|13|||
163164563|NCT00452361|589316096|FG001|Overall Study|Premature termination|9|||
163164564|NCT04421027|589316097|FG000|Treatment Period|Adverse Event|5|||
163164565|NCT04421027|589316098|FG001|Treatment Period|Adverse Event|3|||
163164566|NCT04421027|589316099|FG002|Treatment Period|Adverse Event|0|||
163164567|NCT04421027|589316100|FG003|Treatment Period|Adverse Event|0|||
163164568|NCT04421027|589316097|FG000|Treatment Period|Death|98|||
163276283|NCT01033643|589721635|FG002|Overall Study|Withdrew Consent|0|||
163164569|NCT04421027|589316098|FG001|Treatment Period|Death|61|||
163164570|NCT04421027|589316099|FG002|Treatment Period|Death|0|||
163164571|NCT04421027|589316100|FG003|Treatment Period|Death|0|||
163164572|NCT04421027|589316097|FG000|Treatment Period|Lost to Follow-up|22|||
163164573|NCT04421027|589316098|FG001|Treatment Period|Lost to Follow-up|20|||
163164574|NCT04421027|589316099|FG002|Treatment Period|Lost to Follow-up|0|||
163164575|NCT04421027|589316100|FG003|Treatment Period|Lost to Follow-up|0|||
163164576|NCT04421027|589316097|FG000|Treatment Period|Other-Unknown|15|||
163164577|NCT04421027|589316098|FG001|Treatment Period|Other-Unknown|9|||
163276284|NCT01033643|589721636|FG003|Overall Study|Withdrew Consent|0|||
163276285|NCT01033643|589721637|FG004|Overall Study|Withdrew Consent|0|||
163276286|NCT01033643|589721638|FG005|Overall Study|Withdrew Consent|1|||
163276287|NCT03527277|589721639|FG000|Overall Study|Withdrawal by Subject|5|||
163276288|NCT03527277|589721640|FG001|Overall Study|Withdrawal by Subject|0|||
163164578|NCT04421027|589316099|FG002|Treatment Period|Other-Unknown|0|||
163164579|NCT04421027|589316100|FG003|Treatment Period|Other-Unknown|0|||
163164580|NCT04421027|589316097|FG000|Treatment Period|Physician Decision|1|||
163164581|NCT04421027|589316098|FG001|Treatment Period|Physician Decision|1|||
163164582|NCT04421027|589316099|FG002|Treatment Period|Physician Decision|0|||
163164583|NCT04421027|589316100|FG003|Treatment Period|Physician Decision|0|||
163164584|NCT04421027|589316097|FG000|Treatment Period|Withdrawal by Subject|7|||
163164585|NCT04421027|589316098|FG001|Treatment Period|Withdrawal by Subject|12|||
163164586|NCT04421027|589316099|FG002|Treatment Period|Withdrawal by Subject|0|||
163164587|NCT04421027|589316100|FG003|Treatment Period|Withdrawal by Subject|0|||
163164588|NCT04421027|589316097|FG000|Treatment Period|Randomized Not Dosed|9|||
163164589|NCT04421027|589316098|FG001|Treatment Period|Randomized Not Dosed|14|||
163164590|NCT04421027|589316099|FG002|Treatment Period|Randomized Not Dosed|0|||
163164591|NCT04421027|589316100|FG003|Treatment Period|Randomized Not Dosed|0|||
163164592|NCT04421027|589316097|FG000|Follow-Up Period|Adverse Event|0|||
163164593|NCT04421027|589316098|FG001|Follow-Up Period|Adverse Event|0|||
163164594|NCT04421027|589316099|FG002|Follow-Up Period|Adverse Event|0|||
163164595|NCT04421027|589316100|FG003|Follow-Up Period|Adverse Event|3|||
163164596|NCT04421027|589316097|FG000|Follow-Up Period|Death|0|||
163164597|NCT04421027|589316098|FG001|Follow-Up Period|Death|0|||
163164598|NCT04421027|589316099|FG002|Follow-Up Period|Death|16|||
163164599|NCT04421027|589316100|FG003|Follow-Up Period|Death|17|||
163164600|NCT04421027|589316097|FG000|Follow-Up Period|Lost to Follow-up|0|||
163164601|NCT04421027|589316098|FG001|Follow-Up Period|Lost to Follow-up|0|||
163164602|NCT04421027|589316099|FG002|Follow-Up Period|Lost to Follow-up|7|||
163164603|NCT04421027|589316100|FG003|Follow-Up Period|Lost to Follow-up|7|||
163164604|NCT04421027|589316097|FG000|Follow-Up Period|Protocol Deviation|0|||
163164605|NCT04421027|589316098|FG001|Follow-Up Period|Protocol Deviation|0|||
163164606|NCT04421027|589316099|FG002|Follow-Up Period|Protocol Deviation|1|||
163164607|NCT04421027|589316100|FG003|Follow-Up Period|Protocol Deviation|0|||
163164608|NCT04421027|589316097|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
163164609|NCT04421027|589316098|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
163164610|NCT04421027|589316099|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
163164611|NCT04421027|589316100|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
163164612|NCT04421027|589316097|FG000|Follow-Up Period|Left message, participant did not call back|0|||
163164613|NCT04421027|589316098|FG001|Follow-Up Period|Left message, participant did not call back|0|||
163164614|NCT04421027|589316099|FG002|Follow-Up Period|Left message, participant did not call back|0|||
163164615|NCT04421027|589316100|FG003|Follow-Up Period|Left message, participant did not call back|1|||
163164616|NCT04421027|589316097|FG000|Follow-Up Period|Participant died|0|||
163164617|NCT04421027|589316098|FG001|Follow-Up Period|Participant died|0|||
163164618|NCT04421027|589316099|FG002|Follow-Up Period|Participant died|0|||
163164619|NCT04421027|589316100|FG003|Follow-Up Period|Participant died|1|||
163164620|NCT04421027|589316097|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
163164621|NCT04421027|589316098|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
163164622|NCT04421027|589316099|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
163164623|NCT04421027|589316100|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
163164624|NCT00560352|589316105|FG000|Overall Study|Adverse event unrelated to study drug|2|||
163164625|NCT00560352|589316106|FG001|Overall Study|Adverse event unrelated to study drug|1|||
163164626|NCT00560352|589316107|FG002|Overall Study|Adverse event unrelated to study drug|1|||
163164627|NCT00560352|589316105|FG000|Overall Study|Study drug toxicity|3|||
163164628|NCT00560352|589316106|FG001|Overall Study|Study drug toxicity|0|||
163164629|NCT00560352|589316107|FG002|Overall Study|Study drug toxicity|1|||
163164630|NCT00560352|589316105|FG000|Overall Study|Disease progression|0|||
163164631|NCT00560352|589316106|FG001|Overall Study|Disease progression|1|||
163164632|NCT00560352|589316107|FG002|Overall Study|Disease progression|1|||
163164633|NCT00560352|589316105|FG000|Overall Study|Withdrawal by Subject|1|||
163164634|NCT00560352|589316106|FG001|Overall Study|Withdrawal by Subject|1|||
163164635|NCT00560352|589316107|FG002|Overall Study|Withdrawal by Subject|1|||
163164636|NCT00560352|589316105|FG000|Overall Study|Maximum clinical benefit|1|||
163164637|NCT00560352|589316106|FG001|Overall Study|Maximum clinical benefit|0|||
163164638|NCT00560352|589316107|FG002|Overall Study|Maximum clinical benefit|0|||
163164639|NCT03892967|589316111|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
163164640|NCT03892967|589316112|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
163276289|NCT03527277|589721639|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
163318862|NCT01208662|589878795|FG001|Induction and Consolidation|Disease Progression|13|||
163164641|NCT03892967|589316113|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
163164642|NCT03892967|589316114|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
163164643|NCT03892967|589316115|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
163164644|NCT03892967|589316111|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
163164645|NCT03892967|589316112|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
163164646|NCT03892967|589316113|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
163164647|NCT03892967|589316114|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
163164648|NCT03892967|589316115|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
163164649|NCT03892967|589316111|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
163164650|NCT03892967|589316112|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
163164651|NCT03892967|589316113|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
163164652|NCT03892967|589316114|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
163164653|NCT03892967|589316115|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
163164654|NCT03892967|589316111|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
163164655|NCT03892967|589316112|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
163164656|NCT03892967|589316113|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
163164657|NCT03892967|589316114|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
163164658|NCT03892967|589316115|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
163164659|NCT03892967|589316111|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
163164660|NCT03892967|589316112|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
163164661|NCT03892967|589316113|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
163164662|NCT03892967|589316114|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
163164663|NCT03892967|589316115|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
163164664|NCT03892967|589316111|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
163164665|NCT03892967|589316112|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
163164666|NCT03892967|589316113|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
163164667|NCT03892967|589316114|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
163164668|NCT03892967|589316115|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
163164669|NCT05767749|589316119|FG000|Overall Study|Withdrawal by Subject|0|||
163164670|NCT05767749|589316120|FG001|Overall Study|Withdrawal by Subject|0|||
163164671|NCT05767749|589316121|FG002|Overall Study|Withdrawal by Subject|2|||
163164672|NCT05767749|589316122|FG003|Overall Study|Withdrawal by Subject|2|||
163164673|NCT05767749|589316123|FG004|Overall Study|Withdrawal by Subject|2|||
163164674|NCT05767749|589316124|FG005|Overall Study|Withdrawal by Subject|2|||
163164675|NCT03568461|589316125|FG000|Overall Study|Death|7|||
163164676|NCT03568461|589316125|FG000|Overall Study|Physician Decision|5|||
163164677|NCT03568461|589316125|FG000|Overall Study|Subject decision|5|||
163164678|NCT03568461|589316125|FG000|Overall Study|Lost to Follow-up|1|||
163164679|NCT03387085|589316129|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
163164680|NCT02848729|589318208|FG000|Overall Study|Withdrawal by Subject|1|||
163164681|NCT02848729|589318209|FG001|Overall Study|Withdrawal by Subject|0|||
163164682|NCT02848729|589318208|FG000|Overall Study|Emesis|15|||
163164683|NCT02848729|589318209|FG001|Overall Study|Emesis|11|||
163164684|NCT03390101|589318210|FG000|Weeks 0-12|Withdrawal by Subject|0|||
163164685|NCT03390101|589318211|FG001|Weeks 0-12|Withdrawal by Subject|1|||
163164686|NCT03390101|589318212|FG002|Weeks 0-12|Withdrawal by Subject|1|||
163164687|NCT03390101|589318210|FG000|Weeks 0-12|Lost to Follow-up|0|||
163164688|NCT03390101|589318211|FG001|Weeks 0-12|Lost to Follow-up|1|||
163164689|NCT03390101|589318212|FG002|Weeks 0-12|Lost to Follow-up|0|||
163164690|NCT03390101|589318210|FG000|Weeks 12-54|Withdrawal by Subject|0|||
163164691|NCT03390101|589318211|FG001|Weeks 12-54|Withdrawal by Subject|3|||
163164692|NCT03390101|589318212|FG002|Weeks 12-54|Withdrawal by Subject|1|||
163164693|NCT03390101|589318210|FG000|Weeks 12-54|Pregnancy|1|||
163164694|NCT03390101|589318211|FG001|Weeks 12-54|Pregnancy|0|||
163164695|NCT03390101|589318212|FG002|Weeks 12-54|Pregnancy|0|||
163164696|NCT03390101|589318210|FG000|Weeks 12-54|Adverse Event|2|||
163164697|NCT03390101|589318211|FG001|Weeks 12-54|Adverse Event|1|||
163164698|NCT03390101|589318212|FG002|Weeks 12-54|Adverse Event|1|||
163164699|NCT04838977|589318213|FG000|Overall Study|Lost to Follow-up|2|||
163164700|NCT04838977|589318214|FG001|Overall Study|Lost to Follow-up|3|||
163164701|NCT04838977|589318213|FG000|Overall Study|Withdrawal by Subject|1|||
163164702|NCT04838977|589318214|FG001|Overall Study|Withdrawal by Subject|1|||
163164703|NCT00950859|589318218|FG000|Overall Study|Adverse Event|3|||
163164704|NCT00950859|589318219|FG001|Overall Study|Adverse Event|3|||
163164705|NCT00950859|589318218|FG000|Overall Study|Insufficient Viral Load Response|12|||
163164706|NCT00950859|589318219|FG001|Overall Study|Insufficient Viral Load Response|3|||
163164707|NCT00950859|589318218|FG000|Overall Study|Protocol Violation|1|||
163164708|NCT00950859|589318219|FG001|Overall Study|Protocol Violation|1|||
163164709|NCT00950859|589318218|FG000|Overall Study|Lost to Follow-up|0|||
163164710|NCT00950859|589318219|FG001|Overall Study|Lost to Follow-up|3|||
163164711|NCT03583385|589318220|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163164712|NCT03583385|589318221|FG001|Treatment Period 1|Withdrawal by Subject|1|||
163164713|NCT03583385|589318220|FG000|Treatment Period 2|Adverse Event|1|||
163164714|NCT03583385|589318221|FG001|Treatment Period 2|Adverse Event|0|||
163164715|NCT00545272|589318223|FG000|Overall Study|Protocol deviation|0|||
163164716|NCT00545272|589318224|FG001|Overall Study|Protocol deviation|1|||
163164717|NCT00545272|589318225|FG002|Overall Study|Protocol deviation|0|||
163164718|NCT00545272|589318226|FG003|Overall Study|Protocol deviation|1|||
163164719|NCT00545272|589318227|FG004|Overall Study|Protocol deviation|0|||
163164720|NCT00545272|589318228|FG005|Overall Study|Protocol deviation|1|||
163164721|NCT00545272|589318223|FG000|Overall Study|Adverse Event|0|||
163164722|NCT00545272|589318224|FG001|Overall Study|Adverse Event|0|||
163164723|NCT00545272|589318225|FG002|Overall Study|Adverse Event|1|||
163164724|NCT00545272|589318226|FG003|Overall Study|Adverse Event|0|||
163164725|NCT00545272|589318227|FG004|Overall Study|Adverse Event|0|||
163164726|NCT00545272|589318228|FG005|Overall Study|Adverse Event|1|||
163164727|NCT00545272|589318223|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163164728|NCT00545272|589318224|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163164729|NCT00545272|589318225|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163164730|NCT00545272|589318226|FG003|Overall Study|Abnormal laboratory value(s)|0|||
163164731|NCT00545272|589318227|FG004|Overall Study|Abnormal laboratory value(s)|0|||
163164732|NCT00545272|589318228|FG005|Overall Study|Abnormal laboratory value(s)|1|||
163164733|NCT00545272|589318223|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163164734|NCT00545272|589318224|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163164735|NCT00545272|589318225|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163164736|NCT00545272|589318226|FG003|Overall Study|Abnormal test procedure result(s)|0|||
163164737|NCT00545272|589318227|FG004|Overall Study|Abnormal test procedure result(s)|1|||
163164738|NCT00545272|589318228|FG005|Overall Study|Abnormal test procedure result(s)|0|||
163164739|NCT00545272|589318223|FG000|Overall Study|Lost to Follow-up|0|||
163164740|NCT00545272|589318224|FG001|Overall Study|Lost to Follow-up|0|||
163164741|NCT00545272|589318225|FG002|Overall Study|Lost to Follow-up|0|||
163164742|NCT00545272|589318226|FG003|Overall Study|Lost to Follow-up|0|||
163164743|NCT00545272|589318227|FG004|Overall Study|Lost to Follow-up|1|||
163164744|NCT00545272|589318228|FG005|Overall Study|Lost to Follow-up|0|||
163164745|NCT02934503|589318229|FG000|Overall Study|progression of disease|3|||
163164746|NCT02934503|589318229|FG000|Overall Study|Withdrawal by Subject|1|||
163164747|NCT00724867|589318230|FG000|Overall Study|Adverse Event|25|||
163164748|NCT00724867|589318230|FG000|Overall Study|Lack of Efficacy|14|||
163164749|NCT00724867|589318230|FG000|Overall Study|Lost to Follow-up|12|||
163164750|NCT00724867|589318230|FG000|Overall Study|Non-compliance with study drug|6|||
163164751|NCT00724867|589318230|FG000|Overall Study|Physician Decision|17|||
163164752|NCT00724867|589318230|FG000|Overall Study|Protocol Violation|1|||
163164753|NCT00724867|589318230|FG000|Overall Study|Withdrawal by Subject|31|||
163164754|NCT00724867|589318230|FG000|Overall Study|Sponsor decision to end study|14|||
163164755|NCT00724867|589318230|FG000|Overall Study|Subject incarcerated|1|||
163164756|NCT00724867|589318230|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
163164757|NCT00724867|589318230|FG000|Overall Study|Subject moved out of state|1|||
163164758|NCT00724867|589318230|FG000|Overall Study|Elected to exit due to site closure|2|||
163164759|NCT00436345|589318231|FG000|Overall Study|ICU resident beyond follow-up period|3|||
163164760|NCT00436345|589318232|FG001|Overall Study|ICU resident beyond follow-up period|0|||
163276290|NCT03527277|589721640|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
163276291|NCT03527277|589721639|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
163276292|NCT03527277|589721640|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
163276293|NCT01333943|589721644|FG000|Overall Study|Known neuropathy|1|||
163276294|NCT01333943|589721645|FG001|Overall Study|Known neuropathy|0|||
163276295|NCT02459587|589721652|FG000|3-Month Follow-up Assessment|Death|0|||
163276296|NCT02459587|589721653|FG001|3-Month Follow-up Assessment|Death|2|||
163276297|NCT02459587|589721652|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
163276298|NCT02459587|589721653|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
163276299|NCT02459587|589721652|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
163276300|NCT02459587|589721653|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
163276301|NCT02459587|589721652|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
163276302|NCT02459587|589721653|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
163276303|NCT02459587|589721652|FG000|6-month Follow-up Assessment|Death|2|||
163276304|NCT02459587|589721653|FG001|6-month Follow-up Assessment|Death|1|||
163276305|NCT02459587|589721652|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
163276306|NCT02459587|589721653|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
163164761|NCT04027608|589318233|FG000|Overall Study|Withdrawal by Subject|13|||
163164762|NCT04027608|589318234|FG001|Overall Study|Withdrawal by Subject|2|||
163164763|NCT04027608|589318233|FG000|Overall Study|Protocol Violation|2|||
163164764|NCT04027608|589318234|FG001|Overall Study|Protocol Violation|1|||
163164765|NCT04027608|589318233|FG000|Overall Study|Physician Decision|1|||
163164766|NCT04027608|589318234|FG001|Overall Study|Physician Decision|0|||
163164767|NCT04027608|589318233|FG000|Overall Study|Lost to Follow-up|20|||
163164768|NCT04027608|589318234|FG001|Overall Study|Lost to Follow-up|4|||
163164769|NCT04248491|589318238|FG000|Overall Study|Lost to Follow-up|1|||
163164770|NCT04248491|589318239|FG001|Overall Study|Lost to Follow-up|0|||
163164771|NCT02474069|589318249|FG000|Selection Phase (SP)|Adverse Event|8|||
163164772|NCT02474069|589318250|FG001|Selection Phase (SP)|Adverse Event|0|||
163164773|NCT02474069|589318251|FG002|Selection Phase (SP)|Adverse Event|0|||
163164774|NCT02474069|589318249|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
163164775|NCT02474069|589318250|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
163164776|NCT02474069|589318251|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
163164777|NCT02474069|589318249|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
163164778|NCT02474069|589318250|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
163164779|NCT02474069|589318251|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
163164780|NCT02474069|589318249|FG000|Selection Phase (SP)|Physician Decision|1|||
163164781|NCT02474069|589318250|FG001|Selection Phase (SP)|Physician Decision|0|||
163164782|NCT02474069|589318251|FG002|Selection Phase (SP)|Physician Decision|0|||
163164783|NCT02474069|589318249|FG000|Selection Phase (SP)|Protocol Violation|1|||
163164784|NCT02474069|589318250|FG001|Selection Phase (SP)|Protocol Violation|0|||
163164785|NCT02474069|589318251|FG002|Selection Phase (SP)|Protocol Violation|0|||
163164786|NCT02474069|589318249|FG000|Selection Phase (SP)|No longer requires treatment|1|||
163164787|NCT02474069|589318250|FG001|Selection Phase (SP)|No longer requires treatment|0|||
163164788|NCT02474069|589318251|FG002|Selection Phase (SP)|No longer requires treatment|0|||
163164789|NCT02474069|589318249|FG000|Selection Phase (SP)|Technical Problem|1|||
163164790|NCT02474069|589318250|FG001|Selection Phase (SP)|Technical Problem|0|||
163164791|NCT02474069|589318251|FG002|Selection Phase (SP)|Technical Problem|0|||
163164792|NCT02474069|589318249|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
163164793|NCT02474069|589318250|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
163164794|NCT02474069|589318251|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
163164795|NCT02474069|589318249|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
163164796|NCT02474069|589318250|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
163164797|NCT02474069|589318251|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
163164798|NCT02474069|589318249|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
163164799|NCT02474069|589318250|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
163164800|NCT02474069|589318251|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
163164801|NCT02474069|589318249|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
163164802|NCT02474069|589318250|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
163164803|NCT02474069|589318251|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
163164804|NCT02474069|589318249|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
163164805|NCT02474069|589318250|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
163164806|NCT02474069|589318251|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
163164807|NCT02474069|589318249|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
163164808|NCT02474069|589318250|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
163164809|NCT02474069|589318251|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
163164810|NCT02123472|589318252|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
163164811|NCT02123472|589318253|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
163164812|NCT00918736|589318254|FG000|Overall Study|Withdrawal by Subject|4|||
163164813|NCT01474018|589318255|FG000|Overall Study|Lost to Follow-up|0|||
163164814|NCT01474018|589318256|FG001|Overall Study|Lost to Follow-up|1|||
163164815|NCT01474018|589318255|FG000|Overall Study|Withdrawal by Subject|0|||
163164816|NCT01474018|589318256|FG001|Overall Study|Withdrawal by Subject|2|||
163164817|NCT03801031|589318257|FG000|Overall Study|Lost to Follow-up|1|||
163164818|NCT03801031|589318258|FG001|Overall Study|Lost to Follow-up|0|||
163164819|NCT03801031|589318257|FG000|Overall Study|Unable to comply|1|||
163164820|NCT03801031|589318258|FG001|Overall Study|Unable to comply|0|||
163164821|NCT03801031|589318257|FG000|Overall Study|Withdrawal by Subject|0|||
163164822|NCT03801031|589318258|FG001|Overall Study|Withdrawal by Subject|1|||
163164823|NCT01942733|589318259|FG000|Overall Study|Lost to Follow-up|1|||
163164824|NCT01942733|589318259|FG000|Overall Study|Non-compliance with IMP|1|||
163164825|NCT01942733|589318259|FG000|Overall Study|Administrative|1|||
163164826|NCT00838513|589318260|FG000|Screening Period|Screen Failure|3|||
163164827|NCT00838513|589318260|FG000|Extension Treatment Period|Death|1|||
163164828|NCT00838513|589318260|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
163164829|NCT00126490|589318261|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
163276307|NCT02459587|589721652|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
163164830|NCT02925416|589318263|FG000|Overall Study|Adverse Event|2|||
163164831|NCT02925416|589318264|FG001|Overall Study|Adverse Event|0|||
163164832|NCT01598506|589318265|FG000|Overall Study|Withdrawal by Subject|2|||
163164833|NCT03962504|589318266|FG000|Overall Study|Other|11|||
163276308|NCT02459587|589721653|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
163164834|NCT03962504|589318267|FG001|Overall Study|Other|32|||
163164835|NCT00035932|589318268|FG000|Overall Study|Adverse Event|10|||
163164836|NCT00035932|589318269|FG001|Overall Study|Adverse Event|9|||
163164837|NCT00035932|589318270|FG002|Overall Study|Adverse Event|9|||
163164838|NCT00035932|589318268|FG000|Overall Study|Death|0|||
163164839|NCT00035932|589318269|FG001|Overall Study|Death|0|||
163164840|NCT00035932|589318270|FG002|Overall Study|Death|1|||
163164841|NCT00035932|589318268|FG000|Overall Study|Disease Progression / Relapse|1|||
163164842|NCT00035932|589318269|FG001|Overall Study|Disease Progression / Relapse|1|||
163164843|NCT00035932|589318270|FG002|Overall Study|Disease Progression / Relapse|0|||
163164844|NCT00035932|589318268|FG000|Overall Study|Lost to Follow-up|4|||
163164845|NCT00035932|589318269|FG001|Overall Study|Lost to Follow-up|4|||
163164846|NCT00035932|589318270|FG002|Overall Study|Lost to Follow-up|3|||
163164847|NCT00035932|589318268|FG000|Overall Study|Noncompliance|6|||
163164848|NCT00035932|589318269|FG001|Overall Study|Noncompliance|7|||
163164849|NCT00035932|589318270|FG002|Overall Study|Noncompliance|6|||
163164850|NCT00035932|589318268|FG000|Overall Study|Protocol Violation While on Study|0|||
163164851|NCT00035932|589318269|FG001|Overall Study|Protocol Violation While on Study|1|||
163164852|NCT00035932|589318270|FG002|Overall Study|Protocol Violation While on Study|2|||
163164853|NCT00035932|589318268|FG000|Overall Study|Withdrawal by Subject|1|||
163164854|NCT00035932|589318269|FG001|Overall Study|Withdrawal by Subject|5|||
163164855|NCT00035932|589318270|FG002|Overall Study|Withdrawal by Subject|0|||
163164856|NCT00035932|589318268|FG000|Overall Study|Study Termination by Sponsor|1|||
163164857|NCT00035932|589318269|FG001|Overall Study|Study Termination by Sponsor|0|||
163164858|NCT00035932|589318270|FG002|Overall Study|Study Termination by Sponsor|0|||
163164859|NCT00035932|589318268|FG000|Overall Study|Lack of Efficacy|33|||
163164860|NCT00035932|589318269|FG001|Overall Study|Lack of Efficacy|33|||
163164861|NCT00035932|589318270|FG002|Overall Study|Lack of Efficacy|28|||
163164862|NCT04080167|589318273|FG000|Overall Study|Lost to Follow-up-Patients|7|||
163164863|NCT04080167|589318274|FG001|Overall Study|Lost to Follow-up-Patients|14|||
163164864|NCT04080167|589318275|FG002|Overall Study|Lost to Follow-up-Patients|0|||
163164865|NCT04080167|589318273|FG000|Overall Study|Lost to Follow-up-Providers|2|||
163164866|NCT04080167|589318274|FG001|Overall Study|Lost to Follow-up-Providers|2|||
163164867|NCT04080167|589318275|FG002|Overall Study|Lost to Follow-up-Providers|0|||
163164868|NCT04080167|589318273|FG000|Overall Study|Withdrawal by Subject|1|||
163164869|NCT04080167|589318274|FG001|Overall Study|Withdrawal by Subject|2|||
163164870|NCT04080167|589318275|FG002|Overall Study|Withdrawal by Subject|0|||
163164871|NCT04080167|589318273|FG000|Overall Study|Withdrawal by Provider|0|||
163164872|NCT04080167|589318274|FG001|Overall Study|Withdrawal by Provider|0|||
163164873|NCT04080167|589318275|FG002|Overall Study|Withdrawal by Provider|4|||
163164874|NCT04080167|589318273|FG000|Overall Study|Death-Patient|2|||
163164875|NCT04080167|589318274|FG001|Overall Study|Death-Patient|1|||
163164876|NCT04080167|589318275|FG002|Overall Study|Death-Patient|0|||
163164877|NCT04080167|589318273|FG000|Overall Study|Hydroxyurea New Starts|0|||
163164878|NCT04080167|589318274|FG001|Overall Study|Hydroxyurea New Starts|0|||
163164879|NCT04080167|589318275|FG002|Overall Study|Hydroxyurea New Starts|1|||
163164880|NCT04080167|589318273|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
163164881|NCT04080167|589318274|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
163164882|NCT04080167|589318275|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
163164883|NCT02100696|589318276|FG000|Induction Phase|Adverse Event|0|||
163164884|NCT02100696|589318277|FG001|Induction Phase|Adverse Event|0|||
163164885|NCT02100696|589318278|FG002|Induction Phase|Adverse Event|1|||
163164886|NCT02100696|589318279|FG003|Induction Phase|Adverse Event|0|||
163164887|NCT02100696|589318280|FG004|Induction Phase|Adverse Event|0|||
163164888|NCT02100696|589318281|FG005|Induction Phase|Adverse Event|0|||
163164889|NCT02100696|589318276|FG000|Induction Phase|Lost to Follow-up|1|||
163164890|NCT02100696|589318277|FG001|Induction Phase|Lost to Follow-up|0|||
163164891|NCT02100696|589318278|FG002|Induction Phase|Lost to Follow-up|1|||
163164892|NCT02100696|589318279|FG003|Induction Phase|Lost to Follow-up|0|||
163164893|NCT02100696|589318280|FG004|Induction Phase|Lost to Follow-up|0|||
163164894|NCT02100696|589318281|FG005|Induction Phase|Lost to Follow-up|0|||
163164895|NCT02100696|589318276|FG000|Induction Phase|Protocol Violation|0|||
163164896|NCT02100696|589318277|FG001|Induction Phase|Protocol Violation|1|||
163164897|NCT02100696|589318278|FG002|Induction Phase|Protocol Violation|1|||
163164898|NCT02100696|589318279|FG003|Induction Phase|Protocol Violation|0|||
163164899|NCT02100696|589318280|FG004|Induction Phase|Protocol Violation|0|||
163164900|NCT02100696|589318281|FG005|Induction Phase|Protocol Violation|0|||
163164901|NCT02100696|589318276|FG000|Induction Phase|Withdrawal by Subject|8|||
163164902|NCT02100696|589318277|FG001|Induction Phase|Withdrawal by Subject|2|||
163164903|NCT02100696|589318278|FG002|Induction Phase|Withdrawal by Subject|13|||
163164904|NCT02100696|589318279|FG003|Induction Phase|Withdrawal by Subject|0|||
163164905|NCT02100696|589318280|FG004|Induction Phase|Withdrawal by Subject|0|||
163164906|NCT02100696|589318281|FG005|Induction Phase|Withdrawal by Subject|0|||
163164907|NCT02100696|589318276|FG000|Induction Phase|Physician Decision|1|||
163164908|NCT02100696|589318277|FG001|Induction Phase|Physician Decision|0|||
163164909|NCT02100696|589318278|FG002|Induction Phase|Physician Decision|2|||
163164910|NCT02100696|589318279|FG003|Induction Phase|Physician Decision|0|||
163164911|NCT02100696|589318280|FG004|Induction Phase|Physician Decision|0|||
163164912|NCT02100696|589318281|FG005|Induction Phase|Physician Decision|0|||
163164913|NCT02100696|589318276|FG000|Induction Phase|Multiple Reasons|5|||
163164914|NCT02100696|589318277|FG001|Induction Phase|Multiple Reasons|2|||
163164915|NCT02100696|589318278|FG002|Induction Phase|Multiple Reasons|8|||
163164916|NCT02100696|589318279|FG003|Induction Phase|Multiple Reasons|0|||
163164917|NCT02100696|589318280|FG004|Induction Phase|Multiple Reasons|0|||
163164918|NCT02100696|589318281|FG005|Induction Phase|Multiple Reasons|0|||
163164919|NCT02100696|589318276|FG000|Maintenance Phase|Adverse Event|0|||
163164920|NCT02100696|589318277|FG001|Maintenance Phase|Adverse Event|0|||
163164921|NCT02100696|589318278|FG002|Maintenance Phase|Adverse Event|0|||
163164922|NCT02100696|589318279|FG003|Maintenance Phase|Adverse Event|0|||
163164923|NCT02100696|589318280|FG004|Maintenance Phase|Adverse Event|0|||
163164924|NCT02100696|589318281|FG005|Maintenance Phase|Adverse Event|2|||
163164925|NCT02100696|589318276|FG000|Maintenance Phase|Lost to Follow-up|0|||
163164926|NCT02100696|589318277|FG001|Maintenance Phase|Lost to Follow-up|0|||
163164927|NCT02100696|589318278|FG002|Maintenance Phase|Lost to Follow-up|0|||
163164928|NCT02100696|589318279|FG003|Maintenance Phase|Lost to Follow-up|0|||
163164929|NCT02100696|589318280|FG004|Maintenance Phase|Lost to Follow-up|1|||
163164930|NCT02100696|589318281|FG005|Maintenance Phase|Lost to Follow-up|0|||
163164931|NCT02100696|589318276|FG000|Maintenance Phase|Protocol Violation|0|||
163164932|NCT02100696|589318277|FG001|Maintenance Phase|Protocol Violation|0|||
163164933|NCT02100696|589318278|FG002|Maintenance Phase|Protocol Violation|0|||
163164934|NCT02100696|589318279|FG003|Maintenance Phase|Protocol Violation|0|||
163164935|NCT02100696|589318280|FG004|Maintenance Phase|Protocol Violation|1|||
163164936|NCT02100696|589318281|FG005|Maintenance Phase|Protocol Violation|0|||
163164937|NCT02100696|589318276|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163164938|NCT02100696|589318277|FG001|Maintenance Phase|Withdrawal by Subject|0|||
163164939|NCT02100696|589318278|FG002|Maintenance Phase|Withdrawal by Subject|0|||
163164940|NCT02100696|589318279|FG003|Maintenance Phase|Withdrawal by Subject|1|||
163164941|NCT02100696|589318280|FG004|Maintenance Phase|Withdrawal by Subject|4|||
163164942|NCT02100696|589318281|FG005|Maintenance Phase|Withdrawal by Subject|2|||
163164943|NCT02100696|589318276|FG000|Maintenance Phase|Physician Decision|0|||
163164944|NCT02100696|589318277|FG001|Maintenance Phase|Physician Decision|0|||
163164945|NCT02100696|589318278|FG002|Maintenance Phase|Physician Decision|0|||
163164946|NCT02100696|589318279|FG003|Maintenance Phase|Physician Decision|0|||
163164947|NCT02100696|589318280|FG004|Maintenance Phase|Physician Decision|1|||
163164948|NCT02100696|589318281|FG005|Maintenance Phase|Physician Decision|0|||
163164949|NCT02100696|589318276|FG000|Maintenance Phase|Multiple Reasons|0|||
163164950|NCT02100696|589318277|FG001|Maintenance Phase|Multiple Reasons|0|||
163164951|NCT02100696|589318278|FG002|Maintenance Phase|Multiple Reasons|0|||
163164952|NCT02100696|589318279|FG003|Maintenance Phase|Multiple Reasons|0|||
163164953|NCT02100696|589318280|FG004|Maintenance Phase|Multiple Reasons|2|||
163164954|NCT02100696|589318281|FG005|Maintenance Phase|Multiple Reasons|1|||
163164955|NCT03566485|589318285|FG000|Overall Study|Disease progression|5|||
163164956|NCT03566485|589318286|FG001|Overall Study|Disease progression|4|||
163164957|NCT03566485|589318285|FG000|Overall Study|Clinical progression|0|||
163164958|NCT03566485|589318286|FG001|Overall Study|Clinical progression|1|||
163164959|NCT03566485|589318285|FG000|Overall Study|Toxicity|0|||
163164960|NCT03566485|589318286|FG001|Overall Study|Toxicity|2|||
163164961|NCT01010867|589318297|FG000|Overall Study|< 50% adherence to probiotic|1|||
163164962|NCT01668589|589318298|FG000|Overall Study|Lost to Follow-up|29|||
163164963|NCT01668589|589318299|FG001|Overall Study|Lost to Follow-up|37|||
163164964|NCT01668589|589318300|FG002|Overall Study|Lost to Follow-up|15|||
163164965|NCT01668589|589318301|FG003|Overall Study|Lost to Follow-up|5|||
163164966|NCT01668589|589318298|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
163164967|NCT01668589|589318299|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
163164968|NCT01668589|589318300|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
163164969|NCT01668589|589318301|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
163164970|NCT01668589|589318298|FG000|Overall Study|Death|12|||
163164971|NCT01668589|589318299|FG001|Overall Study|Death|3|||
163164972|NCT01668589|589318300|FG002|Overall Study|Death|2|||
163164973|NCT01668589|589318301|FG003|Overall Study|Death|11|||
163164974|NCT01668589|589318298|FG000|Overall Study|Other|44|||
163164975|NCT01668589|589318299|FG001|Overall Study|Other|10|||
163164976|NCT01668589|589318300|FG002|Overall Study|Other|7|||
163164977|NCT01668589|589318301|FG003|Overall Study|Other|15|||
163164978|NCT02954172|589318302|FG000|Overall Study|Protocol Violation|3|||
163164979|NCT02954172|589318303|FG001|Overall Study|Protocol Violation|0|||
163164980|NCT02954172|589318302|FG000|Overall Study|allergic reaction|2|||
163164981|NCT02954172|589318303|FG001|Overall Study|allergic reaction|1|||
163164982|NCT02954172|589318302|FG000|Overall Study|non-measurable lesions at baseline|1|||
163164983|NCT02954172|589318303|FG001|Overall Study|non-measurable lesions at baseline|2|||
163164984|NCT00233064|589318304|FG000|Overall Study|Lost to Follow-up|7|||
163164985|NCT00233064|589318305|FG001|Overall Study|Lost to Follow-up|7|||
163164986|NCT00233064|589318304|FG000|Overall Study|Withdrawal by Subject|5|||
163164987|NCT00233064|589318305|FG001|Overall Study|Withdrawal by Subject|3|||
163164988|NCT00233064|589318304|FG000|Overall Study|Death|0|||
163164989|NCT00233064|589318305|FG001|Overall Study|Death|1|||
163164990|NCT00233064|589318304|FG000|Overall Study|Relocation|0|||
163164991|NCT00233064|589318305|FG001|Overall Study|Relocation|1|||
163164992|NCT00233064|589318304|FG000|Overall Study|Protocol Violation|1|||
163164993|NCT00233064|589318305|FG001|Overall Study|Protocol Violation|0|||
163164994|NCT00233064|589318304|FG000|Overall Study|Moved to Dom. Republic|1|||
163164995|NCT00233064|589318305|FG001|Overall Study|Moved to Dom. Republic|0|||
163164996|NCT02302339|589318306|FG000|Overall Study|Lost to Follow-up|1|||
163164997|NCT02302339|589318307|FG001|Overall Study|Lost to Follow-up|0|||
163164998|NCT02302339|589318308|FG002|Overall Study|Lost to Follow-up|0|||
163164999|NCT02302339|589318309|FG003|Overall Study|Lost to Follow-up|0|||
163165000|NCT02302339|589318306|FG000|Overall Study|Withdrawal by Subject|0|||
163165001|NCT02302339|589318307|FG001|Overall Study|Withdrawal by Subject|2|||
163165002|NCT02302339|589318308|FG002|Overall Study|Withdrawal by Subject|1|||
163165003|NCT02302339|589318309|FG003|Overall Study|Withdrawal by Subject|0|||
163165004|NCT01827956|589318312|FG000|Overall Study|Protocol Violation|3|||
163165005|NCT04393454|589318313|FG000|Overall Study|Death|1|||
163165006|NCT04393454|589318313|FG000|Overall Study|Lost to Follow-up|1|||
163165007|NCT02752165|589318314|FG000|Overall Study|Withdrawal by Subject|6|||
163165008|NCT02752165|589318315|FG001|Overall Study|Withdrawal by Subject|6|||
163165009|NCT02752165|589318314|FG000|Overall Study|Protocol Violation|6|||
163165010|NCT02752165|589318315|FG001|Overall Study|Protocol Violation|5|||
163165011|NCT02752165|589318314|FG000|Overall Study|Lost to Follow-up|33|||
163165012|NCT02752165|589318315|FG001|Overall Study|Lost to Follow-up|38|||
163165013|NCT01120964|589318316|FG000|Overall Study|Did not receive full treatment|1|||
163165014|NCT01120964|589318317|FG001|Overall Study|Did not receive full treatment|0|||
163165015|NCT01704599|589318321|FG000|Overall Study|Adverse Event|1|||
163165016|NCT05064358|589318322|FG000|Overall Study|Death|23|||
163165017|NCT05064358|589318323|FG001|Overall Study|Death|23|||
163165018|NCT05064358|589318324|FG002|Overall Study|Death|25|||
163165019|NCT05064358|589318325|FG003|Overall Study|Death|21|||
163165020|NCT05064358|589318326|FG004|Overall Study|Death|5|||
163165021|NCT05064358|589318322|FG000|Overall Study|Lost to Follow-up|1|||
163165022|NCT05064358|589318323|FG001|Overall Study|Lost to Follow-up|2|||
163165023|NCT05064358|589318324|FG002|Overall Study|Lost to Follow-up|0|||
163165024|NCT05064358|589318325|FG003|Overall Study|Lost to Follow-up|2|||
163165025|NCT05064358|589318326|FG004|Overall Study|Lost to Follow-up|0|||
163165026|NCT05064358|589318322|FG000|Overall Study|Physician Decision|1|||
163165027|NCT05064358|589318323|FG001|Overall Study|Physician Decision|1|||
163165028|NCT05064358|589318324|FG002|Overall Study|Physician Decision|2|||
163165029|NCT05064358|589318325|FG003|Overall Study|Physician Decision|0|||
163165030|NCT05064358|589318326|FG004|Overall Study|Physician Decision|0|||
163165031|NCT05064358|589318322|FG000|Overall Study|Withdrawal by Subject|4|||
163165032|NCT05064358|589318323|FG001|Overall Study|Withdrawal by Subject|5|||
163165033|NCT05064358|589318324|FG002|Overall Study|Withdrawal by Subject|3|||
163165034|NCT05064358|589318325|FG003|Overall Study|Withdrawal by Subject|6|||
163165035|NCT05064358|589318326|FG004|Overall Study|Withdrawal by Subject|3|||
163165036|NCT05064358|589318322|FG000|Overall Study|Ongoing at the time of analysis|1|||
163165037|NCT05064358|589318323|FG001|Overall Study|Ongoing at the time of analysis|2|||
163165038|NCT05064358|589318324|FG002|Overall Study|Ongoing at the time of analysis|2|||
163165039|NCT05064358|589318325|FG003|Overall Study|Ongoing at the time of analysis|2|||
163165040|NCT05064358|589318326|FG004|Overall Study|Ongoing at the time of analysis|2|||
163165041|NCT00494676|589318329|FG000|Allocation|Withdrawal by Subject|2|||
163165042|NCT00494676|589318330|FG001|Allocation|Withdrawal by Subject|4|||
163165043|NCT00494676|589318329|FG000|First Intervention|Withdrawal by Subject|1|||
163165044|NCT00494676|589318330|FG001|First Intervention|Withdrawal by Subject|3|||
163165045|NCT00494676|589318329|FG000|Second Intervention|Withdrawal by Subject|1|||
163165046|NCT00494676|589318330|FG001|Second Intervention|Withdrawal by Subject|1|||
163165047|NCT04976192|589318331|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165048|NCT04976192|589318332|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
163165049|NCT04976192|589318333|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165050|NCT04976192|589318334|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165051|NCT04976192|589318335|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165052|NCT04976192|589318336|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165053|NCT04976192|589318337|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165054|NCT04976192|589318338|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165055|NCT04976192|589318339|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165056|NCT04976192|589318340|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165057|NCT04976192|589318331|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
163165058|NCT04976192|589318332|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
163165059|NCT04976192|589318333|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
163165060|NCT04976192|589318334|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
163165061|NCT04976192|589318335|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165062|NCT04976192|589318336|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165063|NCT04976192|589318337|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165064|NCT04976192|589318338|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165065|NCT04976192|589318339|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165066|NCT04976192|589318340|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165067|NCT04976192|589318331|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
163165068|NCT04976192|589318332|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165069|NCT04976192|589318333|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
163165070|NCT04976192|589318334|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165071|NCT04976192|589318335|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165072|NCT04976192|589318336|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165073|NCT04976192|589318337|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165074|NCT04976192|589318338|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165075|NCT04976192|589318339|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165076|NCT04976192|589318340|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165077|NCT04976192|589318331|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165078|NCT04976192|589318332|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165079|NCT04976192|589318333|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165080|NCT04976192|589318334|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165081|NCT04976192|589318335|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
163165082|NCT04976192|589318336|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
163165083|NCT04976192|589318337|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
163165084|NCT04976192|589318338|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
163165085|NCT04976192|589318339|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
163165086|NCT04976192|589318340|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
163165087|NCT04976192|589318331|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165088|NCT04976192|589318332|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165089|NCT04976192|589318333|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165090|NCT04976192|589318334|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165091|NCT04976192|589318335|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
163165092|NCT04976192|589318336|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165093|NCT04976192|589318337|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165094|NCT04976192|589318338|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165095|NCT04976192|589318339|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165096|NCT04976192|589318340|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165097|NCT04976192|589318331|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165098|NCT04976192|589318332|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165099|NCT04976192|589318333|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165100|NCT04976192|589318334|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165101|NCT04976192|589318335|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165102|NCT04976192|589318336|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
163165103|NCT04976192|589318337|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165104|NCT04976192|589318338|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165105|NCT04976192|589318339|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165106|NCT04976192|589318340|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165107|NCT02621151|589318341|FG000|Overall Study|Not eligible for trial|6|||
163165108|NCT04073225|589318342|FG000|Overall Study|Lost to Follow-up|4|||
163165109|NCT04073225|589318343|FG001|Overall Study|Lost to Follow-up|3|||
163165110|NCT04238819|589318350|FG000|Overall Study|Ongoing Treatment|0|||
163165111|NCT04238819|589318351|FG001|Overall Study|Ongoing Treatment|0|||
163165112|NCT04238819|589318352|FG002|Overall Study|Ongoing Treatment|0|||
163165113|NCT04238819|589318353|FG003|Overall Study|Ongoing Treatment|0|||
163165114|NCT04238819|589318354|FG004|Overall Study|Ongoing Treatment|1|||
163165115|NCT04238819|589318355|FG005|Overall Study|Ongoing Treatment|4|||
163165116|NCT04238819|589318356|FG006|Overall Study|Ongoing Treatment|0|||
163165117|NCT04238819|589318350|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
163165118|NCT04238819|589318351|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
163165119|NCT04238819|589318352|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
163165120|NCT04238819|589318353|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
163165121|NCT04238819|589318354|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
163165122|NCT04238819|589318355|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
163165123|NCT04238819|589318356|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
163165124|NCT02529553|589318357|FG000|Overall Study|Progressive Disease|1|||
163165125|NCT02529553|589318358|FG001|Overall Study|Progressive Disease|0|||
163165126|NCT02529553|589318359|FG002|Overall Study|Progressive Disease|1|||
163165127|NCT02529553|589318360|FG003|Overall Study|Progressive Disease|3|||
163165128|NCT02529553|589318361|FG004|Overall Study|Progressive Disease|2|||
163165129|NCT02529553|589318362|FG005|Overall Study|Progressive Disease|3|||
163165130|NCT02529553|589318363|FG006|Overall Study|Progressive Disease|3|||
163165131|NCT02529553|589318364|FG007|Overall Study|Progressive Disease|5|||
163165132|NCT02529553|589318365|FG008|Overall Study|Progressive Disease|3|||
163165133|NCT02529553|589318357|FG000|Overall Study|Physician Decision|0|||
163165134|NCT02529553|589318358|FG001|Overall Study|Physician Decision|1|||
163165135|NCT02529553|589318359|FG002|Overall Study|Physician Decision|0|||
163165136|NCT02529553|589318360|FG003|Overall Study|Physician Decision|0|||
163165137|NCT02529553|589318361|FG004|Overall Study|Physician Decision|1|||
163165138|NCT02529553|589318362|FG005|Overall Study|Physician Decision|0|||
163165139|NCT02529553|589318363|FG006|Overall Study|Physician Decision|0|||
163165140|NCT02529553|589318364|FG007|Overall Study|Physician Decision|0|||
163165141|NCT02529553|589318365|FG008|Overall Study|Physician Decision|0|||
163165142|NCT02529553|589318357|FG000|Overall Study|Withdrawal by Subject|0|||
163165143|NCT02529553|589318358|FG001|Overall Study|Withdrawal by Subject|0|||
163165144|NCT02529553|589318359|FG002|Overall Study|Withdrawal by Subject|0|||
163165145|NCT02529553|589318360|FG003|Overall Study|Withdrawal by Subject|0|||
163165146|NCT02529553|589318361|FG004|Overall Study|Withdrawal by Subject|0|||
163165147|NCT02529553|589318362|FG005|Overall Study|Withdrawal by Subject|1|||
163165148|NCT02529553|589318363|FG006|Overall Study|Withdrawal by Subject|0|||
163165149|NCT02529553|589318364|FG007|Overall Study|Withdrawal by Subject|1|||
163165150|NCT02529553|589318365|FG008|Overall Study|Withdrawal by Subject|0|||
163165151|NCT00114517|589318366|FG000|Overall Study|Adverse Event|6|||
163165152|NCT00114517|589318367|FG001|Overall Study|Adverse Event|1|||
163165153|NCT00114517|589318368|FG002|Overall Study|Adverse Event|6|||
163165154|NCT00114517|589318369|FG003|Overall Study|Adverse Event|3|||
163165155|NCT00114517|589318366|FG000|Overall Study|Lost to Follow-up|2|||
163165156|NCT00114517|589318367|FG001|Overall Study|Lost to Follow-up|2|||
163165157|NCT00114517|589318368|FG002|Overall Study|Lost to Follow-up|2|||
163165158|NCT00114517|589318369|FG003|Overall Study|Lost to Follow-up|1|||
163165159|NCT00114517|589318366|FG000|Overall Study|Too busy|3|||
163165160|NCT00114517|589318367|FG001|Overall Study|Too busy|1|||
163165161|NCT00114517|589318368|FG002|Overall Study|Too busy|1|||
163165162|NCT00114517|589318369|FG003|Overall Study|Too busy|2|||
163165163|NCT00114517|589318366|FG000|Overall Study|Moved from area|0|||
163165164|NCT00114517|589318367|FG001|Overall Study|Moved from area|3|||
163165165|NCT00114517|589318368|FG002|Overall Study|Moved from area|2|||
163165166|NCT00114517|589318369|FG003|Overall Study|Moved from area|1|||
163165167|NCT00114517|589318366|FG000|Overall Study|Did not want estradiol|1|||
163165168|NCT00114517|589318367|FG001|Overall Study|Did not want estradiol|1|||
163165169|NCT00114517|589318368|FG002|Overall Study|Did not want estradiol|0|||
163165170|NCT00114517|589318369|FG003|Overall Study|Did not want estradiol|0|||
163165171|NCT00114517|589318366|FG000|Overall Study|Armed-services duty|0|||
163165172|NCT00114517|589318367|FG001|Overall Study|Armed-services duty|1|||
163165173|NCT00114517|589318368|FG002|Overall Study|Armed-services duty|0|||
163165174|NCT00114517|589318369|FG003|Overall Study|Armed-services duty|1|||
163165175|NCT00114517|589318366|FG000|Overall Study|Competing family issue|0|||
163165176|NCT00114517|589318367|FG001|Overall Study|Competing family issue|1|||
163165177|NCT00114517|589318368|FG002|Overall Study|Competing family issue|0|||
163165178|NCT00114517|589318369|FG003|Overall Study|Competing family issue|1|||
163165179|NCT00114517|589318366|FG000|Overall Study|Physician Decision|0|||
163165180|NCT00114517|589318367|FG001|Overall Study|Physician Decision|1|||
163165181|NCT00114517|589318368|FG002|Overall Study|Physician Decision|0|||
163165182|NCT00114517|589318369|FG003|Overall Study|Physician Decision|0|||
163165183|NCT00114517|589318366|FG000|Overall Study|Lost interest|0|||
163165184|NCT00114517|589318367|FG001|Overall Study|Lost interest|0|||
163165185|NCT00114517|589318368|FG002|Overall Study|Lost interest|1|||
163165186|NCT00114517|589318369|FG003|Overall Study|Lost interest|0|||
163165187|NCT00114517|589318366|FG000|Overall Study|Weight increase|0|||
163165188|NCT00114517|589318367|FG001|Overall Study|Weight increase|0|||
163165189|NCT00114517|589318368|FG002|Overall Study|Weight increase|1|||
163165190|NCT00114517|589318369|FG003|Overall Study|Weight increase|0|||
163165191|NCT00114517|589318366|FG000|Overall Study|Concern about blood clots|0|||
163165192|NCT00114517|589318367|FG001|Overall Study|Concern about blood clots|0|||
163165193|NCT00114517|589318368|FG002|Overall Study|Concern about blood clots|1|||
163165194|NCT00114517|589318369|FG003|Overall Study|Concern about blood clots|0|||
163165195|NCT00114517|589318366|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
163165196|NCT00114517|589318367|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
163165197|NCT00114517|589318368|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
163165198|NCT00114517|589318369|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
163165199|NCT00924027|589318374|FG000|Overall Study|Lost to Further Follow-Up|4|||
163165200|NCT00924027|589318375|FG001|Overall Study|Lost to Further Follow-Up|0|||
163165201|NCT00924027|589318376|FG002|Overall Study|Lost to Further Follow-Up|0|||
163165202|NCT00924027|589318377|FG003|Overall Study|Lost to Further Follow-Up|0|||
163165203|NCT00924027|589318374|FG000|Overall Study|Physician Decision|1|||
163165204|NCT00924027|589318375|FG001|Overall Study|Physician Decision|0|||
163165205|NCT00924027|589318376|FG002|Overall Study|Physician Decision|0|||
163165206|NCT00924027|589318377|FG003|Overall Study|Physician Decision|1|||
163165207|NCT00924027|589318374|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
163165208|NCT00924027|589318375|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
163165209|NCT00924027|589318376|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
163165210|NCT00924027|589318377|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
163165211|NCT00924027|589318374|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
163165212|NCT00924027|589318375|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
163165213|NCT00924027|589318376|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
163165214|NCT00924027|589318377|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
163165215|NCT00924027|589318374|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
163165216|NCT00924027|589318375|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
163165217|NCT00924027|589318376|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
163165218|NCT00924027|589318377|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
163165219|NCT04236141|589319855|FG000|Overall Study|Death|18|||
163165220|NCT04236141|589319856|FG001|Overall Study|Death|10|||
163165221|NCT04236141|589319855|FG000|Overall Study|Withdrawal by Participant|1|||
163165222|NCT04236141|589319856|FG001|Overall Study|Withdrawal by Participant|0|||
163165223|NCT04236141|589319855|FG000|Overall Study|Reason not Specified|1|||
163165224|NCT04236141|589319856|FG001|Overall Study|Reason not Specified|0|||
163165225|NCT04236141|589319855|FG000|Overall Study|Study terminated by Sponsor|8|||
163165226|NCT04236141|589319856|FG001|Overall Study|Study terminated by Sponsor|4|||
163165227|NCT01657461|589319857|FG000|Overall Study|Death|9|||
163165228|NCT01657461|589319858|FG001|Overall Study|Death|12|||
163165229|NCT01657461|589319857|FG000|Overall Study|Lost to Follow-up|0|||
163165230|NCT01657461|589319858|FG001|Overall Study|Lost to Follow-up|3|||
163165231|NCT01657461|589319857|FG000|Overall Study|Physician Decision|0|||
163165232|NCT01657461|589319858|FG001|Overall Study|Physician Decision|2|||
163165233|NCT01657461|589319857|FG000|Overall Study|Withdrawal by Subject|1|||
163165234|NCT01657461|589319858|FG001|Overall Study|Withdrawal by Subject|3|||
163165235|NCT01761162|589319863|FG000|Overall Study|Withdrawal by Subject|3|||
163165236|NCT02160899|589319868|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
163165237|NCT02160899|589319869|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
163165238|NCT02160899|589319870|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
163165239|NCT02160899|589319871|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
163165240|NCT02160899|589319872|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
163165241|NCT02160899|589319873|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
163165242|NCT04129151|589319874|FG000|Overall Study|Adverse Event|1|||
163165243|NCT04129151|589319874|FG000|Overall Study|Disease Progression|7|||
163165244|NCT04129151|589319874|FG000|Overall Study|Study closure|1|||
163165245|NCT04473235|589319875|FG000|Overall Study|Lost to Follow-up|6|||
163165246|NCT04473235|589319876|FG001|Overall Study|Lost to Follow-up|5|||
163165247|NCT04473235|589319875|FG000|Overall Study|Declined continuation|2|||
163165248|NCT04473235|589319876|FG001|Overall Study|Declined continuation|0|||
163165249|NCT04473235|589319875|FG000|Overall Study|Physician Decision|1|||
163165250|NCT04473235|589319876|FG001|Overall Study|Physician Decision|1|||
163165251|NCT04473235|589319875|FG000|Overall Study|Protocol Violation|10|||
163165252|NCT04473235|589319876|FG001|Overall Study|Protocol Violation|6|||
163165253|NCT01945710|589319879|FG000|Overall Study|Progressive Disease|5|||
163165254|NCT01945710|589319880|FG001|Overall Study|Progressive Disease|4|||
163165255|NCT01945710|589319881|FG002|Overall Study|Progressive Disease|3|||
163165256|NCT01945710|589319882|FG003|Overall Study|Progressive Disease|2|||
163165257|NCT01945710|589319883|FG004|Overall Study|Progressive Disease|7|||
163165258|NCT01945710|589319884|FG005|Overall Study|Progressive Disease|3|||
163165259|NCT01945710|589319885|FG006|Overall Study|Progressive Disease|19|||
163165260|NCT01945710|589319879|FG000|Overall Study|Adverse Event|0|||
163165261|NCT01945710|589319880|FG001|Overall Study|Adverse Event|1|||
163165262|NCT01945710|589319881|FG002|Overall Study|Adverse Event|0|||
163165263|NCT01945710|589319882|FG003|Overall Study|Adverse Event|0|||
163165264|NCT01945710|589319883|FG004|Overall Study|Adverse Event|0|||
163165265|NCT01945710|589319884|FG005|Overall Study|Adverse Event|0|||
163165266|NCT01945710|589319885|FG006|Overall Study|Adverse Event|0|||
163165267|NCT01945710|589319879|FG000|Overall Study|Other|2|||
163165268|NCT01945710|589319880|FG001|Overall Study|Other|0|||
163165269|NCT01945710|589319881|FG002|Overall Study|Other|3|||
163165270|NCT01945710|589319882|FG003|Overall Study|Other|1|||
163165271|NCT01945710|589319883|FG004|Overall Study|Other|1|||
163165272|NCT01945710|589319884|FG005|Overall Study|Other|0|||
163165273|NCT01945710|589319885|FG006|Overall Study|Other|4|||
163165274|NCT01945710|589319879|FG000|Overall Study|Withdrawal by Subject|0|||
163165275|NCT01945710|589319880|FG001|Overall Study|Withdrawal by Subject|1|||
163165276|NCT01945710|589319881|FG002|Overall Study|Withdrawal by Subject|1|||
163165277|NCT01945710|589319882|FG003|Overall Study|Withdrawal by Subject|0|||
163165278|NCT01945710|589319883|FG004|Overall Study|Withdrawal by Subject|1|||
163165279|NCT01945710|589319884|FG005|Overall Study|Withdrawal by Subject|0|||
163165280|NCT01945710|589319885|FG006|Overall Study|Withdrawal by Subject|0|||
163165281|NCT02730195|589319886|FG000|Overall Study|Withdrawal by Subject|1|||
163165282|NCT00745849|589319887|FG000|First Intervention|Withdrawal by Subject|0|||
163165283|NCT00745849|589319888|FG001|First Intervention|Withdrawal by Subject|1|||
163165284|NCT00745849|589319887|FG000|First Intervention|Lost to Follow-up|1|||
163165285|NCT00745849|589319888|FG001|First Intervention|Lost to Follow-up|1|||
163165286|NCT00745849|589319887|FG000|Second Intervention|Lost to Follow-up|2|||
163165287|NCT00745849|589319888|FG001|Second Intervention|Lost to Follow-up|1|||
163165288|NCT01139008|589319889|FG000|Overall Study|Withdrawal by Subject|5|||
163165289|NCT01139008|589319889|FG000|Overall Study|Non-compliant, lost product|1|||
163276309|NCT02459587|589721652|FG000|12-month Follow-up Assessment|Death|2|||
163165290|NCT01754727|589319892|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
163165291|NCT02785770|589319893|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
163165292|NCT02785770|589319894|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
163165293|NCT02785770|589319895|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
163165294|NCT02785770|589319896|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
163165295|NCT02785770|589319893|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
163165296|NCT02785770|589319894|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
163165297|NCT02785770|589319895|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
163165298|NCT02785770|589319896|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
163276310|NCT02459587|589721653|FG001|12-month Follow-up Assessment|Death|0|||
163165299|NCT02785770|589319893|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
163165300|NCT02785770|589319894|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
163165301|NCT02785770|589319895|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
163165302|NCT02785770|589319896|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
163165303|NCT00813943|589319900|FG000|Overall Study|Ongoing at cut-off date|5|||
163165304|NCT00813943|589319901|FG001|Overall Study|Ongoing at cut-off date|5|||
163165305|NCT00813943|589319902|FG002|Overall Study|Ongoing at cut-off date|3|||
163165306|NCT05367492|589319903|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
163165307|NCT05367492|589319904|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
163165308|NCT05367492|589319905|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
163165309|NCT05367492|589319903|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
163165310|NCT05367492|589319904|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
163165311|NCT05367492|589319905|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
163165312|NCT05367492|589319903|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
163165313|NCT05367492|589319904|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
163165314|NCT05367492|589319905|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
163165315|NCT05367492|589319903|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
163165316|NCT05367492|589319904|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
163165317|NCT05367492|589319905|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
163165318|NCT00265148|589319906|FG000|Overall Study|Adverse Event|2|||
163165319|NCT00265148|589319907|FG001|Overall Study|Adverse Event|2|||
163165320|NCT00265148|589319906|FG000|Overall Study|Lack of Efficacy|0|||
163165321|NCT00265148|589319907|FG001|Overall Study|Lack of Efficacy|2|||
163165322|NCT00265148|589319906|FG000|Overall Study|Protocol Violation|3|||
163165323|NCT00265148|589319907|FG001|Overall Study|Protocol Violation|2|||
163165324|NCT00265148|589319906|FG000|Overall Study|Lost to Follow-up|0|||
163165325|NCT00265148|589319907|FG001|Overall Study|Lost to Follow-up|1|||
163165326|NCT00265148|589319906|FG000|Overall Study|Withdrawal by Subject|2|||
163165327|NCT00265148|589319907|FG001|Overall Study|Withdrawal by Subject|1|||
163165328|NCT00265148|589319906|FG000|Overall Study|Physician Decision|1|||
163165329|NCT00265148|589319907|FG001|Overall Study|Physician Decision|0|||
163165330|NCT00265148|589319906|FG000|Overall Study|Increasing frailty|0|||
163165331|NCT00265148|589319907|FG001|Overall Study|Increasing frailty|1|||
163165332|NCT00265148|589319906|FG000|Overall Study|Subject chose to change of the dose|1|||
163165333|NCT00265148|589319907|FG001|Overall Study|Subject chose to change of the dose|0|||
163165334|NCT01463007|589319908|FG000|Overall Study|Physician Decision|1|||
163165335|NCT03539549|589319913|FG000|Overall Study|Adverse Event|12|||
163165336|NCT03539549|589319913|FG000|Overall Study|Lost to Follow-up|1|||
163165337|NCT03539549|589319913|FG000|Overall Study|Death|2|||
163165338|NCT03539549|589319913|FG000|Overall Study|Progressive Disease|1|||
163165339|NCT03539549|589319913|FG000|Overall Study|Reason not Specified|1|||
163165340|NCT01652469|589319917|FG000|Overall Study|Withdrawal by Subject|1|||
163165341|NCT01652469|589319918|FG001|Overall Study|Withdrawal by Subject|4|||
163165342|NCT01652469|589319917|FG000|Overall Study|Lost to Follow-up|0|||
163165343|NCT01652469|589319918|FG001|Overall Study|Lost to Follow-up|2|||
163165344|NCT01049009|589319919|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
163165345|NCT01049009|589319920|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
163165346|NCT01049009|589319919|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163165347|NCT01049009|589319920|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
163165348|NCT01049009|589319919|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
163165349|NCT01049009|589319920|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
163165350|NCT01049009|589319919|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
163165351|NCT01049009|589319920|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
163165352|NCT03760731|589319921|FG000|Pre-Treatment and Randomization|Withdrawal by Subject|1|||
163165353|NCT03760731|589319922|FG001|Pre-Treatment and Randomization|Withdrawal by Subject|0|||
163165354|NCT03760731|589319921|FG000|Treatment|Attended less than 70% of sessions|10|||
163165355|NCT03760731|589319922|FG001|Treatment|Attended less than 70% of sessions|15|||
163165356|NCT01092546|589319923|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
163165357|NCT01970358|589319924|FG000|Overall Study|Unable to make NeoVax or NeoVax not viable|3|||
163165358|NCT01970358|589319924|FG000|Overall Study|Ineligible at time of second consent|4|||
163165359|NCT02644109|589319925|FG000|Overall Study|Adverse Event|0|||
163165360|NCT02644109|589319926|FG001|Overall Study|Adverse Event|4|||
163165361|NCT04075734|589319927|FG000|Overall Study|Lost to Follow-up|1|||
163165362|NCT04075734|589319928|FG001|Overall Study|Lost to Follow-up|1|||
163165363|NCT04075734|589319929|FG002|Overall Study|Lost to Follow-up|0|||
163165364|NCT04075734|589319927|FG000|Overall Study|Withdrawal by Subject|3|||
163165365|NCT04075734|589319928|FG001|Overall Study|Withdrawal by Subject|0|||
163165366|NCT04075734|589319929|FG002|Overall Study|Withdrawal by Subject|0|||
163165367|NCT02433080|589319931|FG000|Overall Study|Lost to Follow-up|1|||
163165368|NCT02433080|589319932|FG001|Overall Study|Lost to Follow-up|2|||
163165369|NCT02433080|589319931|FG000|Overall Study|Withdrawal by Subject|0|||
163165370|NCT02433080|589319932|FG001|Overall Study|Withdrawal by Subject|2|||
163165371|NCT03462511|589319933|FG000|Overall Study|Withdrawal by Subject|2|||
163165372|NCT03462511|589319934|FG001|Overall Study|Withdrawal by Subject|3|||
163165373|NCT02625909|589319935|FG000|Overall Study|Death|2|||
163165374|NCT02625909|589319936|FG001|Overall Study|Death|0|||
163165375|NCT02625909|589319935|FG000|Overall Study|Lost to Follow-up|3|||
163165376|NCT02625909|589319936|FG001|Overall Study|Lost to Follow-up|5|||
163165377|NCT02625909|589319935|FG000|Overall Study|Lack of Efficacy|9|||
163165378|NCT02625909|589319936|FG001|Overall Study|Lack of Efficacy|2|||
163165379|NCT02625909|589319935|FG000|Overall Study|Reinfection|3|||
163165380|NCT02625909|589319936|FG001|Overall Study|Reinfection|2|||
163165381|NCT02367833|589319937|FG000|Overall Study|Withdrawal by Subject|1|||
163165382|NCT02367833|589319938|FG001|Overall Study|Withdrawal by Subject|1|||
163165383|NCT02367833|589319939|FG002|Overall Study|Withdrawal by Subject|0|||
163165384|NCT02167139|589319944|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
163165385|NCT02167139|589319945|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
163165386|NCT02167139|589319946|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
163165387|NCT02167139|589319947|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
163165388|NCT02167139|589319944|FG000|Randomised, Double-blind|Adverse Event|2|||
163165389|NCT02167139|589319945|FG001|Randomised, Double-blind|Adverse Event|9|||
163165390|NCT02167139|589319946|FG002|Randomised, Double-blind|Adverse Event|0|||
163165391|NCT02167139|589319947|FG003|Randomised, Double-blind|Adverse Event|0|||
163165392|NCT02167139|589319944|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
163165393|NCT02167139|589319945|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
163165394|NCT02167139|589319946|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
163165395|NCT02167139|589319947|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
163165396|NCT02167139|589319944|FG000|Randomised, Double-blind|Other|3|||
163165397|NCT02167139|589319945|FG001|Randomised, Double-blind|Other|0|||
163165398|NCT02167139|589319946|FG002|Randomised, Double-blind|Other|0|||
163165399|NCT02167139|589319947|FG003|Randomised, Double-blind|Other|0|||
163165400|NCT02167139|589319944|FG000|Transition-extension|Adverse Event|2|||
163165401|NCT02167139|589319945|FG001|Transition-extension|Adverse Event|0|||
163165402|NCT02167139|589319946|FG002|Transition-extension|Adverse Event|2|||
163165403|NCT02167139|589319947|FG003|Transition-extension|Adverse Event|3|||
163165404|NCT02167139|589319944|FG000|Transition-extension|Withdrawal by Subject|2|||
163165405|NCT02167139|589319945|FG001|Transition-extension|Withdrawal by Subject|0|||
163165406|NCT02167139|589319946|FG002|Transition-extension|Withdrawal by Subject|4|||
163165407|NCT02167139|589319947|FG003|Transition-extension|Withdrawal by Subject|1|||
163165408|NCT02167139|589319944|FG000|Transition-extension|Lack of Efficacy|0|||
163165409|NCT02167139|589319945|FG001|Transition-extension|Lack of Efficacy|0|||
163165410|NCT02167139|589319946|FG002|Transition-extension|Lack of Efficacy|1|||
163165411|NCT02167139|589319947|FG003|Transition-extension|Lack of Efficacy|1|||
163165412|NCT02167139|589319944|FG000|Transition-extension|Other|1|||
163165413|NCT02167139|589319945|FG001|Transition-extension|Other|0|||
163165414|NCT02167139|589319946|FG002|Transition-extension|Other|1|||
163165415|NCT02167139|589319947|FG003|Transition-extension|Other|0|||
163165416|NCT02167139|589319944|FG000|Transition-extension|Lost to Follow-up|1|||
163165417|NCT02167139|589319945|FG001|Transition-extension|Lost to Follow-up|0|||
163165418|NCT02167139|589319946|FG002|Transition-extension|Lost to Follow-up|0|||
163165419|NCT02167139|589319947|FG003|Transition-extension|Lost to Follow-up|0|||
163165420|NCT02067676|589319948|FG000|Overall Study|Withdrawal by Subject|1|||
163165421|NCT02067676|589319949|FG001|Overall Study|Withdrawal by Subject|0|||
163165422|NCT02067676|589319950|FG002|Overall Study|Withdrawal by Subject|0|||
163165423|NCT02067676|589319951|FG003|Overall Study|Withdrawal by Subject|0|||
163165424|NCT02067676|589319952|FG004|Overall Study|Withdrawal by Subject|0|||
163165425|NCT02067676|589319953|FG005|Overall Study|Withdrawal by Subject|0|||
163165426|NCT00996333|589319954|FG000|Overall Study|Screen failure|1|||
163165427|NCT00996333|589319954|FG000|Overall Study|Withdrawal by Subject|1|||
163165428|NCT00996333|589319954|FG000|Overall Study|Death|4|||
163165429|NCT00996333|589319954|FG000|Overall Study|Adverse Event|1|||
163165430|NCT00996333|589319954|FG000|Overall Study|Physician Decision|1|||
163165431|NCT00996333|589319954|FG000|Overall Study|Other|5|||
163165432|NCT00476229|589319955|FG000|Overall Study|Progressive shortness of breath|1|||
163165433|NCT01387542|589319961|FG000|Overall Study|Adverse Event|3|||
163165434|NCT01387542|589319961|FG000|Overall Study|Withdrawal by Subject|1|||
163165435|NCT01387542|589319961|FG000|Overall Study|Changed diagnosis|1|||
163165436|NCT01387542|589319961|FG000|Overall Study|Insufficient response|1|||
163165437|NCT01387542|589319961|FG000|Overall Study|Non-compliant|1|||
163165438|NCT01387542|589319961|FG000|Overall Study|Lost to Follow-up|1|||
163165439|NCT05422638|589319964|FG000|Overall Study|Withdrawal by Subject|8|||
163165440|NCT05422638|589319965|FG001|Overall Study|Withdrawal by Subject|2|||
163165441|NCT04695977|589319967|FG000|Overall Study|Sponsor Decision|9|||
163165442|NCT04695977|589319968|FG001|Overall Study|Sponsor Decision|4|||
163165443|NCT04695977|589319967|FG000|Overall Study|Death|2|||
163165444|NCT04695977|589319968|FG001|Overall Study|Death|5|||
163165445|NCT01868542|589321541|FG000|Overall Study|Protocol Violation|0|||
163165446|NCT01868542|589321542|FG001|Overall Study|Protocol Violation|1|||
163165447|NCT01868542|589321541|FG000|Overall Study|Unclassified|0|||
163165448|NCT01868542|589321542|FG001|Overall Study|Unclassified|1|||
163165449|NCT00130247|589321543|FG000|Overall Study|Pregnancy|1|||
163165450|NCT00130247|589321544|FG001|Overall Study|Pregnancy|0|||
163165451|NCT00130247|589321543|FG000|Overall Study|Post-randomization exclusion|1|||
163387494|NCT04442737|590129941|FG001|Overall Study|Lost to Follow-up|3|||
163165452|NCT00130247|589321544|FG001|Overall Study|Post-randomization exclusion|2|||
163165453|NCT00130247|589321543|FG000|Overall Study|Not compliant with DOT|0|||
163165454|NCT00130247|589321544|FG001|Overall Study|Not compliant with DOT|2|||
163165455|NCT03844945|589321545|FG000|Overall Study|Adverse Event|1|||
163165456|NCT03844945|589321546|FG001|Overall Study|Adverse Event|1|||
163165457|NCT03844945|589321547|FG002|Overall Study|Adverse Event|4|||
163165458|NCT03844945|589321548|FG003|Overall Study|Adverse Event|0|||
163276311|NCT02459587|589721652|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
163276312|NCT02459587|589721653|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
163276313|NCT02459587|589721652|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
163276314|NCT02459587|589721653|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
163276315|NCT02459587|589721652|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
163276316|NCT02459587|589721653|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
163276317|NCT02652130|589721656|FG000|Overall Study|Death|1|||
163276318|NCT02028884|589721657|FG000|Double-blind Period|Adverse Event|5|||
163276319|NCT02028884|589721658|FG001|Double-blind Period|Adverse Event|3|||
163276320|NCT02028884|589721659|FG002|Double-blind Period|Adverse Event|0|||
163276321|NCT02028884|589721657|FG000|Double-blind Period|Eligibility Violation|1|||
163276322|NCT02028884|589721658|FG001|Double-blind Period|Eligibility Violation|0|||
163276323|NCT02028884|589721659|FG002|Double-blind Period|Eligibility Violation|0|||
163276324|NCT02028884|589721657|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
163276325|NCT02028884|589721658|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
163276326|NCT02028884|589721659|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
163276327|NCT02028884|589721657|FG000|Double-blind Period|Withdrawal by Subject|2|||
163276328|NCT02028884|589721658|FG001|Double-blind Period|Withdrawal by Subject|0|||
163276329|NCT02028884|589721659|FG002|Double-blind Period|Withdrawal by Subject|0|||
163276330|NCT02028884|589721657|FG000|Open-label Extension Period|Adverse Event|3|||
163276331|NCT02028884|589721658|FG001|Open-label Extension Period|Adverse Event|1|||
163276332|NCT02028884|589721659|FG002|Open-label Extension Period|Adverse Event|0|||
163276333|NCT02028884|589721657|FG000|Open-label Extension Period|Lack of Efficacy|3|||
163276334|NCT02028884|589721658|FG001|Open-label Extension Period|Lack of Efficacy|0|||
163276335|NCT02028884|589721659|FG002|Open-label Extension Period|Lack of Efficacy|0|||
163276336|NCT02028884|589721657|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
163276337|NCT02028884|589721658|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
163276338|NCT02028884|589721659|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
163276339|NCT02028884|589721657|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
163276340|NCT02028884|589721658|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
163276341|NCT02028884|589721659|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
163276342|NCT02028884|589721657|FG000|Open-label Extension Period|Switched to another treatment option|3|||
163276343|NCT02028884|589721658|FG001|Open-label Extension Period|Switched to another treatment option|0|||
163276344|NCT02028884|589721659|FG002|Open-label Extension Period|Switched to another treatment option|0|||
163276345|NCT00839917|589721663|FG000|Overall Study|Lost to Follow-up|1|||
163276346|NCT00839917|589721664|FG001|Overall Study|Lost to Follow-up|0|||
163276347|NCT00839917|589721663|FG000|Overall Study|Did not receive vaccine|0|||
163276348|NCT00839917|589721664|FG001|Overall Study|Did not receive vaccine|1|||
163276349|NCT02297503|589721665|FG000|Overall Study|Withdrawal by Subject|1|||
163276350|NCT02297503|589721666|FG001|Overall Study|Withdrawal by Subject|1|||
163276351|NCT02297503|589721665|FG000|Overall Study|Protocol Violation|1|||
163276352|NCT02297503|589721666|FG001|Overall Study|Protocol Violation|0|||
163276353|NCT02297503|589721665|FG000|Overall Study|Pregnancy|0|||
163276354|NCT02297503|589721666|FG001|Overall Study|Pregnancy|1|||
163276355|NCT02297503|589721665|FG000|Overall Study|Lost to Follow-up|0|||
163276356|NCT02297503|589721666|FG001|Overall Study|Lost to Follow-up|1|||
163276357|NCT02297503|589721665|FG000|Overall Study|Medical reason|0|||
163276358|NCT02297503|589721666|FG001|Overall Study|Medical reason|1|||
163276359|NCT00765362|589721667|FG000|Overall Study|Death|9|||
163276360|NCT00765362|589721667|FG000|Overall Study|Adverse Event|2|||
163276361|NCT00765362|589721667|FG000|Overall Study|Protocol Violation|18|||
163276362|NCT00765362|589721667|FG000|Overall Study|Withdrawal by Subject|13|||
163276363|NCT00765362|589721667|FG000|Overall Study|Lost to Follow-up|95|||
163276364|NCT00519779|589721670|FG000|Overall Study|Withdrawal by Subject|0|||
163276365|NCT00519779|589721671|FG001|Overall Study|Withdrawal by Subject|1|||
163276366|NCT01349660|589721675|FG000|Overall Study|Still Receiving Study Treatment|0|||
163276367|NCT01349660|589721676|FG001|Overall Study|Still Receiving Study Treatment|0|||
163276368|NCT01349660|589721677|FG002|Overall Study|Still Receiving Study Treatment|1|||
163276369|NCT01349660|589721675|FG000|Overall Study|Disease Progression|2|||
163276370|NCT01349660|589721676|FG001|Overall Study|Disease Progression|4|||
163276371|NCT01349660|589721677|FG002|Overall Study|Disease Progression|50|||
163276372|NCT01349660|589721675|FG000|Overall Study|Adverse Event|1|||
163276373|NCT01349660|589721676|FG001|Overall Study|Adverse Event|1|||
163276374|NCT01349660|589721677|FG002|Overall Study|Adverse Event|12|||
163276375|NCT01349660|589721675|FG000|Overall Study|Withdrawal by Subject|2|||
163276376|NCT01349660|589721676|FG001|Overall Study|Withdrawal by Subject|0|||
163276377|NCT01349660|589721677|FG002|Overall Study|Withdrawal by Subject|9|||
163276378|NCT01349660|589721675|FG000|Overall Study|Death|1|||
163276379|NCT01349660|589721676|FG001|Overall Study|Death|1|||
163276380|NCT01349660|589721677|FG002|Overall Study|Death|0|||
163276381|NCT01349660|589721675|FG000|Overall Study|Non-Permitted Interventions|0|||
163276382|NCT01349660|589721676|FG001|Overall Study|Non-Permitted Interventions|0|||
163276383|NCT01349660|589721677|FG002|Overall Study|Non-Permitted Interventions|2|||
163276384|NCT01349660|589721675|FG000|Overall Study|Study Compliance|0|||
163276385|NCT01349660|589721676|FG001|Overall Study|Study Compliance|0|||
163165459|NCT03844945|589321545|FG000|Overall Study|Withdrawal by Subject|0|||
163165460|NCT03844945|589321546|FG001|Overall Study|Withdrawal by Subject|0|||
163165461|NCT03844945|589321547|FG002|Overall Study|Withdrawal by Subject|1|||
163165462|NCT03844945|589321548|FG003|Overall Study|Withdrawal by Subject|0|||
163165463|NCT03844945|589321545|FG000|Overall Study|Lack of Efficacy|0|||
163165464|NCT03844945|589321546|FG001|Overall Study|Lack of Efficacy|0|||
163165465|NCT03844945|589321547|FG002|Overall Study|Lack of Efficacy|0|||
163165466|NCT03844945|589321548|FG003|Overall Study|Lack of Efficacy|1|||
163165467|NCT04518995|589321549|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
163165468|NCT04518995|589321550|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
163165469|NCT04518995|589321551|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
163165470|NCT04518995|589321549|FG000|Overall Study|Lack of Efficacy|2|||
163165471|NCT04518995|589321550|FG001|Overall Study|Lack of Efficacy|1|||
163165472|NCT04518995|589321551|FG002|Overall Study|Lack of Efficacy|0|||
163165473|NCT04518995|589321549|FG000|Overall Study|Non-compliance With Study Drug|0|||
163165474|NCT04518995|589321550|FG001|Overall Study|Non-compliance With Study Drug|3|||
163165475|NCT04518995|589321551|FG002|Overall Study|Non-compliance With Study Drug|2|||
163165476|NCT04518995|589321549|FG000|Overall Study|Pregnancy|0|||
163165477|NCT04518995|589321550|FG001|Overall Study|Pregnancy|0|||
163165478|NCT04518995|589321551|FG002|Overall Study|Pregnancy|1|||
163165479|NCT04518995|589321549|FG000|Overall Study|Protocol Violation|2|||
163165480|NCT04518995|589321550|FG001|Overall Study|Protocol Violation|0|||
163165481|NCT04518995|589321551|FG002|Overall Study|Protocol Violation|1|||
163165482|NCT04518995|589321549|FG000|Overall Study|Reason not Specified|4|||
163165483|NCT04518995|589321550|FG001|Overall Study|Reason not Specified|11|||
163165484|NCT04518995|589321551|FG002|Overall Study|Reason not Specified|2|||
163165485|NCT04518995|589321549|FG000|Overall Study|Lost to Follow-up|1|||
163165486|NCT04518995|589321550|FG001|Overall Study|Lost to Follow-up|10|||
163165487|NCT04518995|589321551|FG002|Overall Study|Lost to Follow-up|6|||
163165488|NCT02052414|589321552|FG000|Overall Study|Adverse Event|12|||
163165489|NCT02052414|589321552|FG000|Overall Study|Lack of Efficacy|2|||
163165490|NCT02052414|589321552|FG000|Overall Study|Withdrawal by Subject|3|||
163165491|NCT01088048|589321558|FG000|Overall Study|Adverse Event|7|||
163165492|NCT01088048|589321559|FG001|Overall Study|Adverse Event|9|||
163165493|NCT01088048|589321560|FG002|Overall Study|Adverse Event|7|||
163165494|NCT01088048|589321561|FG003|Overall Study|Adverse Event|5|||
163165495|NCT01088048|589321562|FG004|Overall Study|Adverse Event|6|||
163165496|NCT01088048|589321563|FG005|Overall Study|Adverse Event|3|||
163165497|NCT01088048|589321564|FG006|Overall Study|Adverse Event|3|||
163165498|NCT01088048|589321565|FG007|Overall Study|Adverse Event|0|||
163165499|NCT01088048|589321566|FG008|Overall Study|Adverse Event|2|||
163165500|NCT01088048|589321567|FG009|Overall Study|Adverse Event|2|||
163165501|NCT01088048|589321558|FG000|Overall Study|Withdrew Consent|1|||
163165502|NCT01088048|589321559|FG001|Overall Study|Withdrew Consent|1|||
163165503|NCT01088048|589321560|FG002|Overall Study|Withdrew Consent|1|||
163165504|NCT01088048|589321561|FG003|Overall Study|Withdrew Consent|1|||
163165505|NCT01088048|589321562|FG004|Overall Study|Withdrew Consent|2|||
163165506|NCT01088048|589321563|FG005|Overall Study|Withdrew Consent|1|||
163165507|NCT01088048|589321564|FG006|Overall Study|Withdrew Consent|0|||
163165508|NCT01088048|589321565|FG007|Overall Study|Withdrew Consent|2|||
163165509|NCT01088048|589321566|FG008|Overall Study|Withdrew Consent|2|||
163165510|NCT01088048|589321567|FG009|Overall Study|Withdrew Consent|1|||
163165511|NCT01088048|589321558|FG000|Overall Study|Concomitant Medication Prohibited|1|||
163165512|NCT01088048|589321559|FG001|Overall Study|Concomitant Medication Prohibited|0|||
163165513|NCT01088048|589321560|FG002|Overall Study|Concomitant Medication Prohibited|0|||
163165514|NCT01088048|589321561|FG003|Overall Study|Concomitant Medication Prohibited|0|||
163165515|NCT01088048|589321562|FG004|Overall Study|Concomitant Medication Prohibited|0|||
163165516|NCT01088048|589321563|FG005|Overall Study|Concomitant Medication Prohibited|0|||
163165517|NCT01088048|589321564|FG006|Overall Study|Concomitant Medication Prohibited|0|||
163165518|NCT01088048|589321565|FG007|Overall Study|Concomitant Medication Prohibited|0|||
163165519|NCT01088048|589321566|FG008|Overall Study|Concomitant Medication Prohibited|0|||
163165520|NCT01088048|589321567|FG009|Overall Study|Concomitant Medication Prohibited|0|||
163165521|NCT01088048|589321558|FG000|Overall Study|Investigator Request|2|||
163165522|NCT01088048|589321559|FG001|Overall Study|Investigator Request|2|||
163165523|NCT01088048|589321560|FG002|Overall Study|Investigator Request|0|||
163165524|NCT01088048|589321561|FG003|Overall Study|Investigator Request|0|||
163165525|NCT01088048|589321562|FG004|Overall Study|Investigator Request|3|||
163165526|NCT01088048|589321563|FG005|Overall Study|Investigator Request|1|||
163165527|NCT01088048|589321564|FG006|Overall Study|Investigator Request|1|||
163165528|NCT01088048|589321565|FG007|Overall Study|Investigator Request|0|||
163165529|NCT01088048|589321566|FG008|Overall Study|Investigator Request|0|||
163165530|NCT01088048|589321567|FG009|Overall Study|Investigator Request|0|||
163165531|NCT01088048|589321558|FG000|Overall Study|Patient Non-compliance|0|||
163165532|NCT01088048|589321559|FG001|Overall Study|Patient Non-compliance|1|||
163165533|NCT01088048|589321560|FG002|Overall Study|Patient Non-compliance|0|||
163165534|NCT01088048|589321561|FG003|Overall Study|Patient Non-compliance|0|||
163165535|NCT01088048|589321562|FG004|Overall Study|Patient Non-compliance|0|||
163165536|NCT01088048|589321563|FG005|Overall Study|Patient Non-compliance|0|||
163165537|NCT01088048|589321564|FG006|Overall Study|Patient Non-compliance|0|||
163165538|NCT01088048|589321565|FG007|Overall Study|Patient Non-compliance|0|||
163165539|NCT01088048|589321566|FG008|Overall Study|Patient Non-compliance|0|||
163165540|NCT01088048|589321567|FG009|Overall Study|Patient Non-compliance|0|||
163165541|NCT01088048|589321558|FG000|Overall Study|Disease Progression|7|||
163165542|NCT01088048|589321559|FG001|Overall Study|Disease Progression|4|||
163165543|NCT01088048|589321560|FG002|Overall Study|Disease Progression|3|||
163165544|NCT01088048|589321561|FG003|Overall Study|Disease Progression|5|||
163165545|NCT01088048|589321562|FG004|Overall Study|Disease Progression|3|||
163165546|NCT01088048|589321563|FG005|Overall Study|Disease Progression|3|||
163165547|NCT01088048|589321564|FG006|Overall Study|Disease Progression|2|||
163165548|NCT01088048|589321565|FG007|Overall Study|Disease Progression|1|||
163165549|NCT01088048|589321566|FG008|Overall Study|Disease Progression|0|||
163165550|NCT01088048|589321567|FG009|Overall Study|Disease Progression|0|||
163165551|NCT01088048|589321558|FG000|Overall Study|Death|1|||
163165552|NCT01088048|589321559|FG001|Overall Study|Death|5|||
163165553|NCT01088048|589321560|FG002|Overall Study|Death|3|||
163165554|NCT01088048|589321561|FG003|Overall Study|Death|3|||
163165555|NCT01088048|589321562|FG004|Overall Study|Death|1|||
163165556|NCT01088048|589321563|FG005|Overall Study|Death|3|||
163165557|NCT01088048|589321564|FG006|Overall Study|Death|0|||
163165558|NCT01088048|589321565|FG007|Overall Study|Death|0|||
163165559|NCT01088048|589321566|FG008|Overall Study|Death|3|||
163165560|NCT01088048|589321567|FG009|Overall Study|Death|1|||
163165561|NCT01088048|589321558|FG000|Overall Study|Other|3|||
163165562|NCT01088048|589321559|FG001|Overall Study|Other|5|||
163165563|NCT01088048|589321560|FG002|Overall Study|Other|0|||
163165564|NCT01088048|589321561|FG003|Overall Study|Other|0|||
163165565|NCT01088048|589321562|FG004|Overall Study|Other|2|||
163165566|NCT01088048|589321563|FG005|Overall Study|Other|0|||
163165567|NCT01088048|589321564|FG006|Overall Study|Other|0|||
163165568|NCT01088048|589321565|FG007|Overall Study|Other|2|||
163165569|NCT01088048|589321566|FG008|Overall Study|Other|0|||
163165570|NCT01088048|589321567|FG009|Overall Study|Other|0|||
163165571|NCT01343693|589321573|FG000|Overall Study|Lost to Follow-up|9|||
163165572|NCT01235598|589321574|FG000|Overall Study|Adverse Event|0|||
163165573|NCT01235598|589321575|FG001|Overall Study|Adverse Event|3|||
163165574|NCT01235598|589321574|FG000|Overall Study|Lack of Efficacy|0|||
163165575|NCT01235598|589321575|FG001|Overall Study|Lack of Efficacy|1|||
163165576|NCT01235598|589321574|FG000|Overall Study|Withdrawal by Subject|1|||
163165577|NCT01235598|589321575|FG001|Overall Study|Withdrawal by Subject|0|||
163165578|NCT00395343|589321576|FG000|Overall Study|Adverse Event|13|||
163165579|NCT00395343|589321577|FG001|Overall Study|Adverse Event|5|||
163165580|NCT00395343|589321576|FG000|Overall Study|Lack of Efficacy|0|||
163165581|NCT00395343|589321577|FG001|Overall Study|Lack of Efficacy|1|||
163165582|NCT00395343|589321576|FG000|Overall Study|Lost to Follow-up|4|||
163165583|NCT00395343|589321577|FG001|Overall Study|Lost to Follow-up|4|||
163165584|NCT00395343|589321576|FG000|Overall Study|Physician Decision|2|||
163165585|NCT00395343|589321577|FG001|Overall Study|Physician Decision|4|||
163165586|NCT00395343|589321576|FG000|Overall Study|Protocol Violation|6|||
163165587|NCT00395343|589321577|FG001|Overall Study|Protocol Violation|8|||
163165588|NCT00395343|589321576|FG000|Overall Study|Withdrawal by Subject|11|||
163165589|NCT00395343|589321577|FG001|Overall Study|Withdrawal by Subject|12|||
163165590|NCT00395343|589321576|FG000|Overall Study|Other|5|||
163165591|NCT00395343|589321577|FG001|Overall Study|Other|2|||
163165592|NCT01667419|589321578|FG000|Overall Study|Reason Not Specified|1|||
163165593|NCT01667419|589321579|FG001|Overall Study|Reason Not Specified|0|||
163165594|NCT01667419|589321580|FG002|Overall Study|Reason Not Specified|0|||
163165595|NCT01667419|589321581|FG003|Overall Study|Reason Not Specified|0|||
163165596|NCT01667419|589321578|FG000|Overall Study|Withdrawal by Subject|16|||
163165597|NCT01667419|589321579|FG001|Overall Study|Withdrawal by Subject|8|||
163165598|NCT01667419|589321580|FG002|Overall Study|Withdrawal by Subject|9|||
163165599|NCT01667419|589321581|FG003|Overall Study|Withdrawal by Subject|8|||
163165600|NCT01667419|589321578|FG000|Overall Study|Non-compliance|0|||
163165601|NCT01667419|589321579|FG001|Overall Study|Non-compliance|0|||
163165602|NCT01667419|589321580|FG002|Overall Study|Non-compliance|0|||
163165603|NCT01667419|589321581|FG003|Overall Study|Non-compliance|1|||
163165604|NCT01667419|589321578|FG000|Overall Study|Protocol Violation|1|||
163165605|NCT01667419|589321579|FG001|Overall Study|Protocol Violation|0|||
163165606|NCT01667419|589321580|FG002|Overall Study|Protocol Violation|0|||
163165607|NCT01667419|589321581|FG003|Overall Study|Protocol Violation|0|||
163165608|NCT01667419|589321578|FG000|Overall Study|Lost to Follow-up|7|||
163165609|NCT01667419|589321579|FG001|Overall Study|Lost to Follow-up|6|||
163165610|NCT01667419|589321580|FG002|Overall Study|Lost to Follow-up|2|||
163165611|NCT01667419|589321581|FG003|Overall Study|Lost to Follow-up|4|||
163165612|NCT01667419|589321578|FG000|Overall Study|Death|18|||
163165613|NCT01667419|589321579|FG001|Overall Study|Death|33|||
163165614|NCT01667419|589321580|FG002|Overall Study|Death|25|||
163165615|NCT01667419|589321581|FG003|Overall Study|Death|26|||
163165616|NCT03869216|589321583|FG000|Overall Study|prostate removed during the study|1|||
163165617|NCT03869216|589321584|FG001|Overall Study|prostate removed during the study|1|||
163165618|NCT03869216|589321583|FG000|Overall Study|Withdrawal by Subject|0|||
163165619|NCT03869216|589321584|FG001|Overall Study|Withdrawal by Subject|1|||
163165620|NCT03869216|589321583|FG000|Overall Study|Lost to Follow-up|3|||
163165621|NCT03869216|589321584|FG001|Overall Study|Lost to Follow-up|12|||
163165622|NCT03869216|589321583|FG000|Overall Study|Changed clinical site or moved out of city|5|||
163165623|NCT03869216|589321584|FG001|Overall Study|Changed clinical site or moved out of city|9|||
163165624|NCT03869216|589321583|FG000|Overall Study|No primary care appointment scheduled|10|||
163165625|NCT03869216|589321584|FG001|Overall Study|No primary care appointment scheduled|4|||
163165626|NCT03869216|589321583|FG000|Overall Study|Death|1|||
163165627|NCT03869216|589321584|FG001|Overall Study|Death|1|||
163165628|NCT03646123|589321585|FG000|Overall Study|Withdrawal by Subject|2|||
163165629|NCT03646123|589321586|FG001|Overall Study|Withdrawal by Subject|2|||
163165630|NCT03646123|589321587|FG002|Overall Study|Withdrawal by Subject|3|||
163165631|NCT03646123|589321585|FG000|Overall Study|Study termination by sponsor|0|||
163165632|NCT03646123|589321586|FG001|Overall Study|Study termination by sponsor|45|||
163165633|NCT03646123|589321587|FG002|Overall Study|Study termination by sponsor|139|||
163165634|NCT03646123|589321585|FG000|Overall Study|Lost to Follow-up|4|||
163165635|NCT03646123|589321586|FG001|Overall Study|Lost to Follow-up|10|||
163165636|NCT03646123|589321587|FG002|Overall Study|Lost to Follow-up|10|||
163165637|NCT03646123|589321585|FG000|Overall Study|Death|2|||
163165638|NCT03646123|589321586|FG001|Overall Study|Death|1|||
163165639|NCT03646123|589321587|FG002|Overall Study|Death|1|||
163165640|NCT03646123|589321585|FG000|Overall Study|Other|2|||
163165641|NCT03646123|589321586|FG001|Overall Study|Other|0|||
163165642|NCT03646123|589321587|FG002|Overall Study|Other|2|||
163165643|NCT03860259|589321594|FG000|Overall Study|Lost to Follow-up|5|||
163165644|NCT03860259|589321595|FG001|Overall Study|Lost to Follow-up|5|||
163165645|NCT03860259|589321594|FG000|Overall Study|Protocol Violation|1|||
163165646|NCT03860259|589321595|FG001|Overall Study|Protocol Violation|0|||
163165647|NCT02280408|589321596|FG000|Overall Study|Lost to Follow-up|0|||
163165648|NCT02280408|589321597|FG001|Overall Study|Lost to Follow-up|2|||
163165649|NCT02280408|589321598|FG002|Overall Study|Lost to Follow-up|0|||
163165650|NCT02280408|589321599|FG003|Overall Study|Lost to Follow-up|0|||
163165651|NCT01068600|589321600|FG000|Overall Study|Withdrawal by Subject|5|||
163165652|NCT01068600|589321601|FG001|Overall Study|Withdrawal by Subject|6|||
163165653|NCT01068600|589321600|FG000|Overall Study|Adverse Event|3|||
163165654|NCT01068600|589321601|FG001|Overall Study|Adverse Event|3|||
163165655|NCT01068600|589321600|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163165656|NCT01068600|589321601|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163165657|NCT01068600|589321600|FG000|Overall Study|Lost to Follow-up|1|||
163165658|NCT01068600|589321601|FG001|Overall Study|Lost to Follow-up|2|||
163165659|NCT01068600|589321600|FG000|Overall Study|Protocol deviation|1|||
163165660|NCT01068600|589321601|FG001|Overall Study|Protocol deviation|1|||
163165661|NCT01068600|589321600|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163165662|NCT01068600|589321601|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
163165663|NCT01068600|589321600|FG000|Overall Study|Administrative problems|0|||
163165664|NCT01068600|589321601|FG001|Overall Study|Administrative problems|1|||
163165665|NCT01519869|589321604|FG000|Overall Study|Lost to Follow-up|1|||
163165666|NCT01015638|589321613|FG000|Overall Study|Withdrawal by Subject|1|||
163165667|NCT01015638|589321614|FG001|Overall Study|Withdrawal by Subject|0|||
163165668|NCT02164461|589321615|FG000|Overall Study|Adverse Event|0|||
163165669|NCT02164461|589321616|FG001|Overall Study|Adverse Event|0|||
163165670|NCT02164461|589321617|FG002|Overall Study|Adverse Event|1|||
163165671|NCT02164461|589321615|FG000|Overall Study|Disease Progression|1|||
163165672|NCT02164461|589321616|FG001|Overall Study|Disease Progression|3|||
163165673|NCT02164461|589321617|FG002|Overall Study|Disease Progression|4|||
163165674|NCT02164461|589321615|FG000|Overall Study|Withdrawal by Subject|0|||
163165675|NCT02164461|589321616|FG001|Overall Study|Withdrawal by Subject|3|||
163165676|NCT02164461|589321617|FG002|Overall Study|Withdrawal by Subject|0|||
163165677|NCT00324961|589321619|FG000|Overall Study|Adverse Event|5|||
163165678|NCT00324961|589321619|FG000|Overall Study|Consent Withdrawn|11|||
163165679|NCT00324961|589321619|FG000|Overall Study|Lost to Follow-up|22|||
163165680|NCT00324961|589321619|FG000|Overall Study|Protocol Violation|3|||
163165681|NCT00324961|589321619|FG000|Overall Study|Other|2|||
163276386|NCT01349660|589721677|FG002|Overall Study|Study Compliance|1|||
163165682|NCT00344487|589321620|FG000|Overall Study|immunologic failure|1|||
163165683|NCT04927364|589321623|FG000|Overall Study|Withdrawal by Subject|3|||
163165684|NCT04927364|589321623|FG000|Overall Study|Unable to complete preassessment MRI|1|||
163165685|NCT05188053|589321627|FG000|Overall Study|Lost to Follow-up|23|||
163165686|NCT05188053|589321628|FG001|Overall Study|Lost to Follow-up|30|||
163165687|NCT05188053|589321627|FG000|Overall Study|Protocol Violation|16|||
163165688|NCT05188053|589321628|FG001|Overall Study|Protocol Violation|16|||
163165689|NCT05188053|589321627|FG000|Overall Study|Physician Decision|3|||
163165690|NCT05188053|589321628|FG001|Overall Study|Physician Decision|0|||
163165691|NCT05188053|589321627|FG000|Overall Study|Withdrawal by Subject|0|||
163165692|NCT05188053|589321628|FG001|Overall Study|Withdrawal by Subject|1|||
163165693|NCT01761240|589321632|FG000|Overall Study|Progressive disease:radiology assessment|3|||
163165694|NCT01761240|589321633|FG001|Overall Study|Progressive disease:radiology assessment|3|||
163165695|NCT01761240|589321634|FG002|Overall Study|Progressive disease:radiology assessment|0|||
163165696|NCT01761240|589321635|FG003|Overall Study|Progressive disease:radiology assessment|0|||
163165697|NCT01761240|589321636|FG004|Overall Study|Progressive disease:radiology assessment|0|||
163165698|NCT01761240|589321632|FG000|Overall Study|Progressive disease:clinical assessment|0|||
163165699|NCT01761240|589321633|FG001|Overall Study|Progressive disease:clinical assessment|0|||
163165700|NCT01761240|589321634|FG002|Overall Study|Progressive disease:clinical assessment|3|||
163165701|NCT01761240|589321635|FG003|Overall Study|Progressive disease:clinical assessment|1|||
163165702|NCT01761240|589321636|FG004|Overall Study|Progressive disease:clinical assessment|0|||
163165703|NCT01761240|589321632|FG000|Overall Study|Withdrawal by Subject|0|||
163165704|NCT01761240|589321633|FG001|Overall Study|Withdrawal by Subject|0|||
163165705|NCT01761240|589321634|FG002|Overall Study|Withdrawal by Subject|0|||
163165706|NCT01761240|589321635|FG003|Overall Study|Withdrawal by Subject|3|||
163165707|NCT01761240|589321636|FG004|Overall Study|Withdrawal by Subject|1|||
163165708|NCT01761240|589321632|FG000|Overall Study|Adverse Event|0|||
163165709|NCT01761240|589321633|FG001|Overall Study|Adverse Event|0|||
163165710|NCT01761240|589321634|FG002|Overall Study|Adverse Event|0|||
163165711|NCT01761240|589321635|FG003|Overall Study|Adverse Event|1|||
163165712|NCT01761240|589321636|FG004|Overall Study|Adverse Event|6|||
163165713|NCT01761240|589321632|FG000|Overall Study|Death|0|||
163165714|NCT01761240|589321633|FG001|Overall Study|Death|1|||
163165715|NCT01761240|589321634|FG002|Overall Study|Death|1|||
163165716|NCT01761240|589321635|FG003|Overall Study|Death|2|||
163165717|NCT01761240|589321636|FG004|Overall Study|Death|1|||
163165718|NCT01761240|589321632|FG000|Overall Study|Non-compliance|0|||
163165719|NCT01761240|589321633|FG001|Overall Study|Non-compliance|0|||
163165720|NCT01761240|589321634|FG002|Overall Study|Non-compliance|1|||
163165721|NCT01761240|589321635|FG003|Overall Study|Non-compliance|0|||
163165722|NCT01761240|589321636|FG004|Overall Study|Non-compliance|0|||
163165723|NCT02355184|589321644|FG000|Overall Study|Lost to Follow-up|2|||
163165724|NCT02355184|589321644|FG000|Overall Study|Study Terminated|10|||
163165725|NCT06173063|589321645|FG000|Overall Study|Withdrawal by Subject|2|||
163165726|NCT03254459|589322719|FG000|Overall Study|Adverse Event|7|||
163165727|NCT03254459|589322720|FG001|Overall Study|Adverse Event|20|||
163165728|NCT03254459|589322719|FG000|Overall Study|Withdrawal by Subject Consent|3|||
163165729|NCT03254459|589322720|FG001|Overall Study|Withdrawal by Subject Consent|1|||
163165730|NCT03254459|589322719|FG000|Overall Study|Lost to Follow-up|0|||
163165731|NCT03254459|589322720|FG001|Overall Study|Lost to Follow-up|1|||
163165732|NCT03254459|589322719|FG000|Overall Study|Miscellaneous|0|||
163165733|NCT03254459|589322720|FG001|Overall Study|Miscellaneous|1|||
163165734|NCT01904773|589322721|FG000|Screen|Screen failure|3|||
163165735|NCT01904773|589322722|FG001|Screen|Screen failure|0|||
163165736|NCT01904773|589322723|FG002|Screen|Screen failure|0|||
163165737|NCT01904773|589322724|FG003|Screen|Screen failure|0|||
163165738|NCT01904773|589322725|FG004|Screen|Screen failure|0|||
163165739|NCT01904773|589322726|FG005|Screen|Screen failure|0|||
163165740|NCT01904773|589322727|FG006|Screen|Screen failure|0|||
163165741|NCT01904773|589322728|FG007|Screen|Screen failure|0|||
163165742|NCT01904773|589322729|FG008|Screen|Screen failure|0|||
163165743|NCT01904773|589322721|FG000|Screen|Withdrawal by Subject|1|||
163165744|NCT01904773|589322722|FG001|Screen|Withdrawal by Subject|0|||
163165745|NCT01904773|589322723|FG002|Screen|Withdrawal by Subject|0|||
163165746|NCT01904773|589322724|FG003|Screen|Withdrawal by Subject|0|||
163165747|NCT01904773|589322725|FG004|Screen|Withdrawal by Subject|0|||
163165748|NCT01904773|589322726|FG005|Screen|Withdrawal by Subject|0|||
163165749|NCT01904773|589322727|FG006|Screen|Withdrawal by Subject|0|||
163165750|NCT01904773|589322728|FG007|Screen|Withdrawal by Subject|0|||
163165751|NCT01904773|589322729|FG008|Screen|Withdrawal by Subject|0|||
163165752|NCT01904773|589322721|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
163165753|NCT01904773|589322722|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165754|NCT01904773|589322723|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165755|NCT01904773|589322724|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165756|NCT01904773|589322725|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165757|NCT01904773|589322726|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165758|NCT01904773|589322727|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165759|NCT01904773|589322728|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165760|NCT01904773|589322729|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165761|NCT01904773|589322721|FG000|First Intervention|Adverse Event|0|||
163165762|NCT01904773|589322722|FG001|First Intervention|Adverse Event|0|||
163165763|NCT01904773|589322723|FG002|First Intervention|Adverse Event|0|||
163165764|NCT01904773|589322724|FG003|First Intervention|Adverse Event|0|||
163165765|NCT01904773|589322725|FG004|First Intervention|Adverse Event|0|||
163165766|NCT01904773|589322726|FG005|First Intervention|Adverse Event|0|||
163165767|NCT01904773|589322727|FG006|First Intervention|Adverse Event|1|||
163165768|NCT01904773|589322728|FG007|First Intervention|Adverse Event|0|||
163165769|NCT01904773|589322729|FG008|First Intervention|Adverse Event|0|||
163165770|NCT01904773|589322721|FG000|Placebo Washout First Intervention|Condition worsened|0|||
163165771|NCT01904773|589322722|FG001|Placebo Washout First Intervention|Condition worsened|1|||
163165772|NCT01904773|589322723|FG002|Placebo Washout First Intervention|Condition worsened|0|||
163042819|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
163165773|NCT01904773|589322724|FG003|Placebo Washout First Intervention|Condition worsened|0|||
163165774|NCT01904773|589322725|FG004|Placebo Washout First Intervention|Condition worsened|0|||
163165775|NCT01904773|589322726|FG005|Placebo Washout First Intervention|Condition worsened|0|||
163165776|NCT01904773|589322727|FG006|Placebo Washout First Intervention|Condition worsened|0|||
163165777|NCT01904773|589322728|FG007|Placebo Washout First Intervention|Condition worsened|0|||
163165778|NCT01904773|589322729|FG008|Placebo Washout First Intervention|Condition worsened|0|||
163165779|NCT01904773|589322721|FG000|Fifth Intervention|Adverse Event|0|||
163165780|NCT01904773|589322722|FG001|Fifth Intervention|Adverse Event|0|||
163165781|NCT01904773|589322723|FG002|Fifth Intervention|Adverse Event|0|||
163165782|NCT01904773|589322724|FG003|Fifth Intervention|Adverse Event|0|||
163165783|NCT01904773|589322725|FG004|Fifth Intervention|Adverse Event|0|||
163165784|NCT01904773|589322726|FG005|Fifth Intervention|Adverse Event|0|||
163165785|NCT01904773|589322727|FG006|Fifth Intervention|Adverse Event|0|||
163165786|NCT01904773|589322728|FG007|Fifth Intervention|Adverse Event|1|||
163165787|NCT01904773|589322729|FG008|Fifth Intervention|Adverse Event|0|||
163165788|NCT01904773|589322721|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165789|NCT01904773|589322722|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
163165790|NCT01904773|589322723|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165791|NCT01904773|589322724|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165792|NCT01904773|589322725|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165793|NCT01904773|589322726|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165794|NCT01904773|589322727|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165795|NCT01904773|589322728|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165796|NCT01904773|589322729|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165797|NCT00220779|589322730|FG000|Overall Study|Adverse Event|1|||
163165798|NCT00220779|589322731|FG001|Overall Study|Adverse Event|0|||
163165799|NCT00220779|589322732|FG002|Overall Study|Adverse Event|0|||
163165800|NCT00220779|589322730|FG000|Overall Study|Withdrawal by Subject|1|||
163165801|NCT00220779|589322731|FG001|Overall Study|Withdrawal by Subject|4|||
163165802|NCT00220779|589322732|FG002|Overall Study|Withdrawal by Subject|1|||
163165803|NCT00220779|589322730|FG000|Overall Study|Non-compliance|1|||
163165804|NCT00220779|589322731|FG001|Overall Study|Non-compliance|0|||
163165805|NCT00220779|589322732|FG002|Overall Study|Non-compliance|0|||
163165806|NCT00220779|589322730|FG000|Overall Study|Too time consuming|1|||
163165807|NCT00220779|589322731|FG001|Overall Study|Too time consuming|0|||
163165808|NCT00220779|589322732|FG002|Overall Study|Too time consuming|0|||
163165809|NCT00220779|589322730|FG000|Overall Study|Pregnancy|0|||
163165810|NCT00220779|589322731|FG001|Overall Study|Pregnancy|0|||
163165811|NCT00220779|589322732|FG002|Overall Study|Pregnancy|2|||
163165812|NCT00220779|589322730|FG000|Overall Study|Lack of Efficacy|3|||
163165813|NCT00220779|589322731|FG001|Overall Study|Lack of Efficacy|0|||
163165814|NCT00220779|589322732|FG002|Overall Study|Lack of Efficacy|1|||
163165815|NCT01511055|589322735|FG000|Overall Study|Withdrawal by Subject|6|||
163165816|NCT04590248|589322740|FG000|Overall Study|Lost to Follow-up|1|||
163165817|NCT04590248|589322740|FG000|Overall Study|Withdrawal by Subject|16|||
163165818|NCT04590248|589322740|FG000|Overall Study|Other|2|||
163165819|NCT02891070|589322743|FG000|Overall Study|Adverse Event|1|||
163165820|NCT02891070|589322744|FG001|Overall Study|Adverse Event|0|||
163165821|NCT02891070|589322743|FG000|Overall Study|Physician Decision|0|||
163165822|NCT02891070|589322744|FG001|Overall Study|Physician Decision|1|||
163165823|NCT02891070|589322743|FG000|Overall Study|Lost to Follow-up|4|||
163165824|NCT02891070|589322744|FG001|Overall Study|Lost to Follow-up|4|||
163165825|NCT02891070|589322743|FG000|Overall Study|Other|1|||
163165826|NCT02891070|589322744|FG001|Overall Study|Other|0|||
163165827|NCT02891070|589322743|FG000|Overall Study|Protocol Violation|0|||
163165828|NCT02891070|589322744|FG001|Overall Study|Protocol Violation|1|||
163165829|NCT02891070|589322743|FG000|Overall Study|Withdrawal by Subject|1|||
163165830|NCT02891070|589322744|FG001|Overall Study|Withdrawal by Subject|2|||
163276387|NCT01349660|589721675|FG000|Overall Study|Declining Performance Status|0|||
163276388|NCT01349660|589721676|FG001|Overall Study|Declining Performance Status|0|||
163165831|NCT02891070|589322743|FG000|Overall Study|Death|3|||
163165832|NCT02891070|589322744|FG001|Overall Study|Death|0|||
163276389|NCT01349660|589721677|FG002|Overall Study|Declining Performance Status|1|||
163276390|NCT05593211|589721678|FG000|Overall Study|Withdrawal by Subject|1|||
163276391|NCT03225846|589721679|FG000|Overall Study|Adverse Event|0|||
163276392|NCT03225846|589721680|FG001|Overall Study|Adverse Event|0|||
163165833|NCT02704143|589322745|FG000|Overall Study|disease progression|10|||
163165834|NCT02551991|589322750|FG000|Overall Study|Death|5|||
163276393|NCT03225846|589721681|FG002|Overall Study|Adverse Event|0|||
163165835|NCT02551991|589322751|FG001|Overall Study|Death|7|||
163165836|NCT02551991|589322752|FG002|Overall Study|Death|8|||
163165837|NCT02551991|589322753|FG003|Overall Study|Death|7|||
163165838|NCT02551991|589322754|FG004|Overall Study|Death|17|||
163165839|NCT02551991|589322750|FG000|Overall Study|Withdrawal by Subject|1|||
163276394|NCT03225846|589721682|FG003|Overall Study|Adverse Event|0|||
163165840|NCT02551991|589322751|FG001|Overall Study|Withdrawal by Subject|0|||
163165841|NCT02551991|589322752|FG002|Overall Study|Withdrawal by Subject|0|||
163165842|NCT02551991|589322753|FG003|Overall Study|Withdrawal by Subject|0|||
163165843|NCT02551991|589322754|FG004|Overall Study|Withdrawal by Subject|2|||
163165844|NCT02551991|589322750|FG000|Overall Study|Lost to Follow-up|0|||
163165845|NCT02551991|589322751|FG001|Overall Study|Lost to Follow-up|0|||
163165846|NCT02551991|589322752|FG002|Overall Study|Lost to Follow-up|1|||
163165847|NCT02551991|589322753|FG003|Overall Study|Lost to Follow-up|0|||
163165848|NCT02551991|589322754|FG004|Overall Study|Lost to Follow-up|0|||
163165849|NCT02551991|589322750|FG000|Overall Study|Sponsor Decision|1|||
163165850|NCT02551991|589322751|FG001|Overall Study|Sponsor Decision|0|||
163165851|NCT02551991|589322752|FG002|Overall Study|Sponsor Decision|1|||
163165852|NCT02551991|589322753|FG003|Overall Study|Sponsor Decision|0|||
163165853|NCT02551991|589322754|FG004|Overall Study|Sponsor Decision|5|||
163165854|NCT02551991|589322750|FG000|Overall Study|Other|0|||
163165855|NCT02551991|589322751|FG001|Overall Study|Other|0|||
163165856|NCT02551991|589322752|FG002|Overall Study|Other|0|||
163165857|NCT02551991|589322753|FG003|Overall Study|Other|0|||
163165858|NCT02551991|589322754|FG004|Overall Study|Other|1|||
163165859|NCT00942994|589322758|FG000|Overall Study|Adverse Event|7|||
163165860|NCT00942994|589322759|FG001|Overall Study|Adverse Event|4|||
163165861|NCT00942994|589322758|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163165862|NCT00942994|589322759|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163165863|NCT00942994|589322758|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163165864|NCT00942994|589322759|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163165865|NCT00942994|589322758|FG000|Overall Study|Patient withdrew consent|5|||
163165866|NCT00942994|589322759|FG001|Overall Study|Patient withdrew consent|8|||
163165867|NCT00942994|589322758|FG000|Overall Study|Lost to Follow-up|1|||
163165868|NCT00942994|589322759|FG001|Overall Study|Lost to Follow-up|4|||
163165869|NCT00942994|589322758|FG000|Overall Study|Protocol deviation|1|||
163165870|NCT00942994|589322759|FG001|Overall Study|Protocol deviation|2|||
163165871|NCT00387790|589322760|FG000|Overall Study|Adverse Event|5|||
163165872|NCT00387790|589322760|FG000|Overall Study|Lack of Efficacy|2|||
163165873|NCT00387790|589322760|FG000|Overall Study|Physician Decision|2|||
163165874|NCT00387790|589322760|FG000|Overall Study|Withdrawal by Subject|3|||
163165875|NCT00387790|589322760|FG000|Overall Study|Ineligible for study|2|||
163165876|NCT04491604|589322761|FG000|Overall Study|Withdrawal by Subject|3|||
163165877|NCT01536067|589322765|FG000|Overall Study|Disease Progression|1|||
163165878|NCT00606905|589322766|FG000|Overall Study|No Pregnancy|9|||
163165879|NCT00606905|589322767|FG001|Overall Study|No Pregnancy|6|||
163165880|NCT00606905|589322766|FG000|Overall Study|Non-Index Pregnancy|1|||
163165881|NCT00606905|589322767|FG001|Overall Study|Non-Index Pregnancy|4|||
163165882|NCT00606905|589322766|FG000|Overall Study|Withdrew|5|||
163165883|NCT00606905|589322767|FG001|Overall Study|Withdrew|5|||
163165884|NCT04657666|589322768|FG000|Period 1|Withdrawal of participant consent|2|||
163165885|NCT04657666|589322769|FG001|Period 1|Withdrawal of participant consent|1|||
163165886|NCT04657666|589322768|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
163165887|NCT04657666|589322769|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
163165888|NCT04657666|589322768|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
163165889|NCT04657666|589322769|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
163165890|NCT04657666|589322768|FG000|Period 2|Other|2|||
163165891|NCT04657666|589322769|FG001|Period 2|Other|0|||
163165892|NCT04657666|589322768|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
163165893|NCT04657666|589322769|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
163165894|NCT02386189|589322771|FG000|Overall Study|Lost to Follow-up|2|||
163165895|NCT02386189|589322772|FG001|Overall Study|Lost to Follow-up|3|||
163165896|NCT02386189|589322771|FG000|Overall Study|Withdrawal by Subject|1|||
163165897|NCT02386189|589322772|FG001|Overall Study|Withdrawal by Subject|0|||
163165898|NCT02386189|589322771|FG000|Overall Study|Death|1|||
163165899|NCT02386189|589322772|FG001|Overall Study|Death|0|||
163165900|NCT03120351|589322773|FG000|Overall Study|Physician Decision|1|||
163165901|NCT03120351|589322774|FG001|Overall Study|Physician Decision|1|||
163165902|NCT04931888|589322776|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
163165903|NCT04931888|589322777|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
163165904|NCT04931888|589322778|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
163165905|NCT04931888|589322779|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
163165906|NCT01022398|589322780|FG000|Overall Study|Study terminated|2|||
163165907|NCT01022398|589322781|FG001|Overall Study|Study terminated|2|||
163165908|NCT02969408|589322783|FG000|Overall Study|Adverse Event|2|||
163165909|NCT02969408|589322783|FG000|Overall Study|Withdrawal by Subject|8|||
163165910|NCT02969408|589322783|FG000|Overall Study|Lost to Follow-up|4|||
163165911|NCT02969408|589322783|FG000|Overall Study|Protocol Violation|1|||
163165912|NCT02969408|589322783|FG000|Overall Study|Other than specified|1|||
163165913|NCT02350478|589322784|FG000|Overall Study|Lost to Follow-up|5|||
163165914|NCT02350478|589322785|FG001|Overall Study|Lost to Follow-up|1|||
163165915|NCT03330002|589322786|FG000|Overall Study|Lost to Follow-up|15|||
163165916|NCT03330002|589322786|FG000|Overall Study|Death|7|||
163165917|NCT00486291|589322789|FG000|Overall Study|Adverse Event|3|||
163165918|NCT00486291|589322790|FG001|Overall Study|Adverse Event|4|||
163165919|NCT00486291|589322789|FG000|Overall Study|Lost to Follow-up|3|||
163165920|NCT00486291|589322790|FG001|Overall Study|Lost to Follow-up|7|||
163165921|NCT00486291|589322789|FG000|Overall Study|protocol non-compliance|10|||
163165922|NCT00486291|589322790|FG001|Overall Study|protocol non-compliance|15|||
163165923|NCT00486291|589322789|FG000|Overall Study|requirement for restricted medication|0|||
163165924|NCT00486291|589322790|FG001|Overall Study|requirement for restricted medication|3|||
163165925|NCT02745145|589322791|FG000|Overall Study|Adverse Event|1|||
163165926|NCT02745145|589322792|FG001|Overall Study|Adverse Event|0|||
163165927|NCT02745145|589322793|FG002|Overall Study|Adverse Event|0|||
163165928|NCT02745145|589322791|FG000|Overall Study|Death|0|||
163165929|NCT02745145|589322792|FG001|Overall Study|Death|1|||
163165930|NCT02745145|589322793|FG002|Overall Study|Death|0|||
163165931|NCT02745145|589322791|FG000|Overall Study|Progressive disease|0|||
163165932|NCT02745145|589322792|FG001|Overall Study|Progressive disease|0|||
163165933|NCT02745145|589322793|FG002|Overall Study|Progressive disease|1|||
163165934|NCT02745145|589322791|FG000|Overall Study|Withdrew consent|1|||
163165935|NCT02745145|589322792|FG001|Overall Study|Withdrew consent|1|||
163165936|NCT02745145|589322793|FG002|Overall Study|Withdrew consent|1|||
163165937|NCT02745145|589322791|FG000|Overall Study|Study Termination|8|||
163165938|NCT02745145|589322792|FG001|Overall Study|Study Termination|3|||
163165939|NCT02745145|589322793|FG002|Overall Study|Study Termination|7|||
163165940|NCT04413617|589322799|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
163165941|NCT04413617|589322800|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
163165942|NCT04413617|589322801|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
163165943|NCT04413617|589322802|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
163165944|NCT04413617|589322803|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
163165945|NCT04413617|589322799|FG000|Overall Study|Protocol Violation|0|||
163165946|NCT04413617|589322800|FG001|Overall Study|Protocol Violation|1|||
163165947|NCT04413617|589322801|FG002|Overall Study|Protocol Violation|0|||
163165948|NCT04413617|589322802|FG003|Overall Study|Protocol Violation|0|||
163165949|NCT04413617|589322803|FG004|Overall Study|Protocol Violation|1|||
163165950|NCT04413617|589322799|FG000|Overall Study|Lack of Efficacy|2|||
163165951|NCT04413617|589322800|FG001|Overall Study|Lack of Efficacy|0|||
163165952|NCT04413617|589322801|FG002|Overall Study|Lack of Efficacy|2|||
163165953|NCT04413617|589322802|FG003|Overall Study|Lack of Efficacy|1|||
163165954|NCT04413617|589322803|FG004|Overall Study|Lack of Efficacy|0|||
163165955|NCT04413617|589322799|FG000|Overall Study|Withdrawal by Subject|3|||
163165956|NCT04413617|589322800|FG001|Overall Study|Withdrawal by Subject|4|||
163165957|NCT04413617|589322801|FG002|Overall Study|Withdrawal by Subject|2|||
163165958|NCT04413617|589322802|FG003|Overall Study|Withdrawal by Subject|5|||
163165959|NCT04413617|589322803|FG004|Overall Study|Withdrawal by Subject|3|||
163165960|NCT04413617|589322799|FG000|Overall Study|Death|1|||
163165961|NCT04413617|589322800|FG001|Overall Study|Death|0|||
163165962|NCT04413617|589322801|FG002|Overall Study|Death|0|||
163165963|NCT04413617|589322802|FG003|Overall Study|Death|0|||
163165964|NCT04413617|589322803|FG004|Overall Study|Death|0|||
163165965|NCT04413617|589322799|FG000|Overall Study|Adverse Event|1|||
163165966|NCT04413617|589322800|FG001|Overall Study|Adverse Event|0|||
163165967|NCT04413617|589322801|FG002|Overall Study|Adverse Event|0|||
163165968|NCT04413617|589322802|FG003|Overall Study|Adverse Event|1|||
163165969|NCT04413617|589322803|FG004|Overall Study|Adverse Event|1|||
163165970|NCT04413617|589322799|FG000|Overall Study|COVID-19|0|||
163165971|NCT04413617|589322800|FG001|Overall Study|COVID-19|1|||
163165972|NCT04413617|589322801|FG002|Overall Study|COVID-19|0|||
163165973|NCT04413617|589322802|FG003|Overall Study|COVID-19|0|||
163165974|NCT04413617|589322803|FG004|Overall Study|COVID-19|0|||
163165975|NCT00775593|589322804|FG000|Overall Study|Unmet eligibility criteria|6|||
163165976|NCT00775593|589322804|FG000|Overall Study|Death|1|||
163165977|NCT00984620|589322807|FG000|Overall Study|Adverse Event|5|||
163276395|NCT03225846|589721683|FG004|Overall Study|Adverse Event|0|||
163276396|NCT03225846|589721684|FG005|Overall Study|Adverse Event|0|||
163165978|NCT00984620|589322808|FG001|Overall Study|Adverse Event|5|||
163165979|NCT00984620|589322807|FG000|Overall Study|Lost to Follow-up|1|||
163165980|NCT00984620|589322808|FG001|Overall Study|Lost to Follow-up|1|||
163165981|NCT00984620|589322807|FG000|Overall Study|Withdrawal by Subject|0|||
163165982|NCT00984620|589322808|FG001|Overall Study|Withdrawal by Subject|2|||
163165983|NCT00984620|589322807|FG000|Overall Study|reason other than listed above|0|||
163165984|NCT00984620|589322808|FG001|Overall Study|reason other than listed above|4|||
163165985|NCT01703754|589322809|FG000|Overall Study|Clinically significant disease progression|2|||
163165986|NCT01703754|589322810|FG001|Overall Study|Clinically significant disease progression|2|||
163165987|NCT01703754|589322811|FG002|Overall Study|Clinically significant disease progression|1|||
163165988|NCT01703754|589322809|FG000|Overall Study|Adverse Event|1|||
163165989|NCT01703754|589322810|FG001|Overall Study|Adverse Event|1|||
163165990|NCT01703754|589322811|FG002|Overall Study|Adverse Event|0|||
163165991|NCT01703754|589322809|FG000|Overall Study|Withdrawal by Subject|2|||
163165992|NCT01703754|589322810|FG001|Overall Study|Withdrawal by Subject|0|||
163165993|NCT01703754|589322811|FG002|Overall Study|Withdrawal by Subject|0|||
163165994|NCT00947882|589322812|FG000|Overall Study|Adverse Event|0|||
163165995|NCT00947882|589322813|FG001|Overall Study|Adverse Event|1|||
163165996|NCT00947882|589322814|FG002|Overall Study|Adverse Event|4|||
163165997|NCT00947882|589322815|FG003|Overall Study|Adverse Event|4|||
163165998|NCT00947882|589322812|FG000|Overall Study|Withdrawal by Subject|2|||
163165999|NCT00947882|589322813|FG001|Overall Study|Withdrawal by Subject|0|||
163166000|NCT00947882|589322814|FG002|Overall Study|Withdrawal by Subject|8|||
163166001|NCT00947882|589322815|FG003|Overall Study|Withdrawal by Subject|2|||
163166002|NCT00947882|589322812|FG000|Overall Study|Protocol Violation|0|||
163166003|NCT00947882|589322813|FG001|Overall Study|Protocol Violation|0|||
163166004|NCT00947882|589322814|FG002|Overall Study|Protocol Violation|1|||
163166005|NCT00947882|589322815|FG003|Overall Study|Protocol Violation|0|||
163166006|NCT00947882|589322812|FG000|Overall Study|Lost to Follow-up|0|||
163166007|NCT00947882|589322813|FG001|Overall Study|Lost to Follow-up|2|||
163166008|NCT00947882|589322814|FG002|Overall Study|Lost to Follow-up|1|||
163166009|NCT00947882|589322815|FG003|Overall Study|Lost to Follow-up|0|||
163166010|NCT00947882|589322812|FG000|Overall Study|Other/Unknown|10|||
163166011|NCT00947882|589322813|FG001|Overall Study|Other/Unknown|13|||
163166012|NCT00947882|589322814|FG002|Overall Study|Other/Unknown|3|||
163166013|NCT00947882|589322815|FG003|Overall Study|Other/Unknown|6|||
163166014|NCT00947882|589322812|FG000|Overall Study|Trial Terminated by Sponsor|62|||
163166015|NCT00947882|589322813|FG001|Overall Study|Trial Terminated by Sponsor|61|||
163166016|NCT00947882|589322814|FG002|Overall Study|Trial Terminated by Sponsor|62|||
163166017|NCT00947882|589322815|FG003|Overall Study|Trial Terminated by Sponsor|70|||
163166018|NCT02379637|589322816|FG000|Overall Study|Protocol Violation|0|||
163166019|NCT02379637|589322817|FG001|Overall Study|Protocol Violation|1|||
163166020|NCT02379637|589322816|FG000|Overall Study|Adverse Event|1|||
163166021|NCT02379637|589322817|FG001|Overall Study|Adverse Event|0|||
163166022|NCT02379637|589322816|FG000|Overall Study|Withdrawal by Subject|1|||
163166023|NCT02379637|589322817|FG001|Overall Study|Withdrawal by Subject|0|||
163166024|NCT02447302|589322818|FG000|Overall Study|Physician Decision|1|||
163166025|NCT02447302|589322819|FG001|Overall Study|Physician Decision|0|||
163166026|NCT02447302|589322820|FG002|Overall Study|Physician Decision|0|||
163166027|NCT02447302|589322818|FG000|Overall Study|Adverse Event|4|||
163166028|NCT02447302|589322819|FG001|Overall Study|Adverse Event|3|||
163166029|NCT02447302|589322820|FG002|Overall Study|Adverse Event|0|||
163276397|NCT03225846|589721685|FG006|Overall Study|Adverse Event|6|||
163276398|NCT03225846|589721679|FG000|Overall Study|Withdrawal by Subject|0|||
163276399|NCT03225846|589721680|FG001|Overall Study|Withdrawal by Subject|1|||
163276400|NCT03225846|589721681|FG002|Overall Study|Withdrawal by Subject|0|||
163276401|NCT03225846|589721682|FG003|Overall Study|Withdrawal by Subject|0|||
163276402|NCT03225846|589721683|FG004|Overall Study|Withdrawal by Subject|0|||
163276403|NCT03225846|589721684|FG005|Overall Study|Withdrawal by Subject|0|||
163276404|NCT03225846|589721685|FG006|Overall Study|Withdrawal by Subject|0|||
163276405|NCT03225846|589721679|FG000|Overall Study|Death|0|||
163276406|NCT03225846|589721680|FG001|Overall Study|Death|1|||
163276407|NCT03225846|589721681|FG002|Overall Study|Death|0|||
163276408|NCT03225846|589721682|FG003|Overall Study|Death|0|||
163276409|NCT03225846|589721683|FG004|Overall Study|Death|0|||
163276410|NCT03225846|589721684|FG005|Overall Study|Death|0|||
163276411|NCT03225846|589721685|FG006|Overall Study|Death|0|||
163276412|NCT03225846|589721679|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
163276413|NCT03225846|589721680|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
163276414|NCT03225846|589721681|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
163166030|NCT02447302|589322818|FG000|Overall Study|Withdrawal by Subject|0|||
163166031|NCT02447302|589322819|FG001|Overall Study|Withdrawal by Subject|1|||
163166032|NCT02447302|589322820|FG002|Overall Study|Withdrawal by Subject|5|||
163276415|NCT03225846|589721682|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
163166033|NCT02447302|589322818|FG000|Overall Study|Sponsor Decision|0|||
163166034|NCT02447302|589322819|FG001|Overall Study|Sponsor Decision|0|||
163166035|NCT02447302|589322820|FG002|Overall Study|Sponsor Decision|1|||
163166036|NCT01561313|589322828|FG000|Overall Study|Withdrawal by Subject|1|||
163166037|NCT01561313|589322829|FG001|Overall Study|Withdrawal by Subject|0|||
163166038|NCT01561313|589322828|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
163166039|NCT01561313|589322829|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
163166040|NCT01742286|589322832|FG000|Escalation Phase|Administrative problems|1|||
163166041|NCT01742286|589322833|FG001|Escalation Phase|Administrative problems|1|||
163166042|NCT01742286|589322834|FG002|Escalation Phase|Administrative problems|0|||
163166043|NCT01742286|589322835|FG003|Escalation Phase|Administrative problems|0|||
163166044|NCT01742286|589322836|FG004|Escalation Phase|Administrative problems|0|||
163166045|NCT01742286|589322837|FG005|Escalation Phase|Administrative problems|0|||
163166046|NCT01742286|589322838|FG006|Escalation Phase|Administrative problems|2|||
163166047|NCT01742286|589322832|FG000|Escalation Phase|Adverse Event|0|||
163166048|NCT01742286|589322833|FG001|Escalation Phase|Adverse Event|1|||
163166049|NCT01742286|589322834|FG002|Escalation Phase|Adverse Event|2|||
163166050|NCT01742286|589322835|FG003|Escalation Phase|Adverse Event|0|||
163166051|NCT01742286|589322836|FG004|Escalation Phase|Adverse Event|0|||
163166052|NCT01742286|589322837|FG005|Escalation Phase|Adverse Event|1|||
163166053|NCT01742286|589322838|FG006|Escalation Phase|Adverse Event|0|||
163166054|NCT01742286|589322832|FG000|Escalation Phase|Disease progression|3|||
163166055|NCT01742286|589322833|FG001|Escalation Phase|Disease progression|7|||
163166056|NCT01742286|589322834|FG002|Escalation Phase|Disease progression|4|||
163166057|NCT01742286|589322835|FG003|Escalation Phase|Disease progression|1|||
163166058|NCT01742286|589322836|FG004|Escalation Phase|Disease progression|4|||
163166059|NCT01742286|589322837|FG005|Escalation Phase|Disease progression|3|||
163166060|NCT01742286|589322838|FG006|Escalation Phase|Disease progression|2|||
163166061|NCT01742286|589322832|FG000|Escalation Phase|Death|0|||
163166062|NCT01742286|589322833|FG001|Escalation Phase|Death|0|||
163166063|NCT01742286|589322834|FG002|Escalation Phase|Death|0|||
163166064|NCT01742286|589322835|FG003|Escalation Phase|Death|0|||
163166065|NCT01742286|589322836|FG004|Escalation Phase|Death|0|||
163166066|NCT01742286|589322837|FG005|Escalation Phase|Death|1|||
163166067|NCT01742286|589322838|FG006|Escalation Phase|Death|0|||
163166068|NCT01742286|589322832|FG000|Escalation Phase|Physician Decision|0|||
163166069|NCT01742286|589322833|FG001|Escalation Phase|Physician Decision|3|||
163166070|NCT01742286|589322834|FG002|Escalation Phase|Physician Decision|0|||
163166071|NCT01742286|589322835|FG003|Escalation Phase|Physician Decision|1|||
163166072|NCT01742286|589322836|FG004|Escalation Phase|Physician Decision|0|||
163166073|NCT01742286|589322837|FG005|Escalation Phase|Physician Decision|0|||
163166074|NCT01742286|589322838|FG006|Escalation Phase|Physician Decision|2|||
163166075|NCT01742286|589322832|FG000|Escalation Phase|Subject/guardian decision|1|||
163166076|NCT01742286|589322833|FG001|Escalation Phase|Subject/guardian decision|0|||
163166077|NCT01742286|589322834|FG002|Escalation Phase|Subject/guardian decision|0|||
163166078|NCT01742286|589322835|FG003|Escalation Phase|Subject/guardian decision|0|||
163166079|NCT01742286|589322836|FG004|Escalation Phase|Subject/guardian decision|0|||
163166080|NCT01742286|589322837|FG005|Escalation Phase|Subject/guardian decision|0|||
163166081|NCT01742286|589322838|FG006|Escalation Phase|Subject/guardian decision|0|||
163166082|NCT01742286|589322832|FG000|Expansion Phase|Administrative problems|0|||
163166083|NCT01742286|589322833|FG001|Expansion Phase|Administrative problems|0|||
163166084|NCT01742286|589322834|FG002|Expansion Phase|Administrative problems|0|||
163166085|NCT01742286|589322835|FG003|Expansion Phase|Administrative problems|0|||
163166086|NCT01742286|589322836|FG004|Expansion Phase|Administrative problems|0|||
163166087|NCT01742286|589322837|FG005|Expansion Phase|Administrative problems|0|||
163166088|NCT01742286|589322838|FG006|Expansion Phase|Administrative problems|5|||
163166089|NCT01742286|589322832|FG000|Expansion Phase|Physician Decision|0|||
163166090|NCT01742286|589322833|FG001|Expansion Phase|Physician Decision|0|||
163166091|NCT01742286|589322834|FG002|Expansion Phase|Physician Decision|4|||
163276416|NCT03225846|589721683|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
163276417|NCT03225846|589721684|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
163276418|NCT03225846|589721685|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
163276419|NCT03225846|589721679|FG000|Overall Study|Patient decision|0|||
163276420|NCT03225846|589721680|FG001|Overall Study|Patient decision|0|||
163276421|NCT03225846|589721681|FG002|Overall Study|Patient decision|0|||
163276422|NCT03225846|589721682|FG003|Overall Study|Patient decision|0|||
163276423|NCT03225846|589721683|FG004|Overall Study|Patient decision|0|||
163276424|NCT03225846|589721684|FG005|Overall Study|Patient decision|0|||
163276425|NCT03225846|589721685|FG006|Overall Study|Patient decision|1|||
163276426|NCT00810641|589721693|FG000|Overall Study|Withdrawal by Subject|0|||
163276427|NCT00810641|589721694|FG001|Overall Study|Withdrawal by Subject|1|||
163276428|NCT00810641|589721695|FG002|Overall Study|Withdrawal by Subject|2|||
163276429|NCT01213173|589721699|FG000|Overall Study|Protocol Violation|2|||
163276430|NCT01213173|589721700|FG001|Overall Study|Protocol Violation|0|||
163276431|NCT01213173|589721699|FG000|Overall Study|Adverse Event|4|||
163276432|NCT01213173|589721700|FG001|Overall Study|Adverse Event|8|||
163276433|NCT01213173|589721699|FG000|Overall Study|Withdrawal by Subject|5|||
163276434|NCT01213173|589721700|FG001|Overall Study|Withdrawal by Subject|5|||
163276435|NCT01213173|589721699|FG000|Overall Study|Incorrect Enrollment|1|||
163276436|NCT01213173|589721700|FG001|Overall Study|Incorrect Enrollment|3|||
163276437|NCT02253316|589721701|FG000|Consolidation|Progression|4|||
163276438|NCT02253316|589721702|FG001|Consolidation|Progression|0|||
163276439|NCT02253316|589721703|FG002|Consolidation|Progression|0|||
163276440|NCT02253316|589721701|FG000|Consolidation|Non-Compliance|1|||
163276441|NCT02253316|589721702|FG001|Consolidation|Non-Compliance|0|||
163276442|NCT02253316|589721703|FG002|Consolidation|Non-Compliance|0|||
163276443|NCT02253316|589721701|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
163276444|NCT02253316|589721702|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
163276445|NCT02253316|589721703|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
163276446|NCT02253316|589721701|FG000|Consolidation|Secondary Malignancy|2|||
163276447|NCT02253316|589721702|FG001|Consolidation|Secondary Malignancy|0|||
163276448|NCT02253316|589721703|FG002|Consolidation|Secondary Malignancy|0|||
163276449|NCT02253316|589721701|FG000|Consolidation|Adverse Event|7|||
163276450|NCT02253316|589721702|FG001|Consolidation|Adverse Event|0|||
163276451|NCT02253316|589721703|FG002|Consolidation|Adverse Event|0|||
163276452|NCT02253316|589721701|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
163276453|NCT02253316|589721702|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
163276454|NCT02253316|589721703|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
163276455|NCT02253316|589721701|FG000|Maintenance|Physician Decision|0|||
163276456|NCT02253316|589721702|FG001|Maintenance|Physician Decision|7|||
163276457|NCT02253316|589721703|FG002|Maintenance|Physician Decision|16|||
163276458|NCT02253316|589721701|FG000|Maintenance|Non-Compliance|0|||
163276459|NCT02253316|589721702|FG001|Maintenance|Non-Compliance|1|||
163276460|NCT02253316|589721703|FG002|Maintenance|Non-Compliance|1|||
163276461|NCT02253316|589721701|FG000|Maintenance|Secondary Malignancy|0|||
163276462|NCT02253316|589721702|FG001|Maintenance|Secondary Malignancy|2|||
163276463|NCT02253316|589721703|FG002|Maintenance|Secondary Malignancy|6|||
163276464|NCT02253316|589721701|FG000|Maintenance|Adverse Event|0|||
163276465|NCT02253316|589721702|FG001|Maintenance|Adverse Event|8|||
163276466|NCT02253316|589721703|FG002|Maintenance|Adverse Event|12|||
163276467|NCT02253316|589721701|FG000|Maintenance|Still receiving active treatment|0|||
163276468|NCT02253316|589721702|FG001|Maintenance|Still receiving active treatment|4|||
163276469|NCT02253316|589721703|FG002|Maintenance|Still receiving active treatment|0|||
163276470|NCT02684903|589721704|FG000|Overall Study|COVID-19 shutdown of lab|4|||
163276471|NCT02684903|589721705|FG001|Overall Study|COVID-19 shutdown of lab|6|||
163276472|NCT02684903|589721704|FG000|Overall Study|Lost to Follow-up|31|||
163276473|NCT02684903|589721705|FG001|Overall Study|Lost to Follow-up|41|||
163276474|NCT06403605|589721710|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
163276475|NCT06403605|589721711|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
163276476|NCT06403605|589721710|FG000|Follow-up|Adverse Event|4|||
163276477|NCT06403605|589721711|FG001|Follow-up|Adverse Event|2|||
163276478|NCT06403605|589721710|FG000|Follow-up|Withdrawal by Subject|2|||
163276479|NCT06403605|589721711|FG001|Follow-up|Withdrawal by Subject|3|||
163276480|NCT06403605|589721710|FG000|Follow-up|Lost to Follow-up|1|||
163276481|NCT06403605|589721711|FG001|Follow-up|Lost to Follow-up|0|||
163276482|NCT06403605|589721710|FG000|Follow-up|Death|1|||
163276483|NCT06403605|589721711|FG001|Follow-up|Death|0|||
163276484|NCT06403605|589721710|FG000|Follow-up|Other reasons|0|||
163276485|NCT06403605|589721711|FG001|Follow-up|Other reasons|4|||
163276486|NCT07083843|589721712|FG000|Intervention period.|Withdrawal by Subject|1|||
163166092|NCT01742286|589322835|FG003|Expansion Phase|Physician Decision|0|||
163276487|NCT07083843|589721713|FG001|Intervention period.|Withdrawal by Subject|0|||
163276488|NCT07083843|589721712|FG000|Intervention period.|Death|0|||
163276489|NCT07083843|589721713|FG001|Intervention period.|Death|1|||
163276490|NCT02153788|589723401|FG000|Overall Study|Physician Decision|2|||
163276491|NCT02153788|589723402|FG001|Overall Study|Physician Decision|1|||
163276492|NCT01106287|589723403|FG000|Overall Study|Adverse Event|1|||
163276493|NCT01106287|589723404|FG001|Overall Study|Adverse Event|0|||
163276494|NCT01106287|589723405|FG002|Overall Study|Adverse Event|0|||
163276495|NCT01106287|589723406|FG003|Overall Study|Adverse Event|0|||
163276496|NCT01450943|589723409|FG000|Overall Study|Screen failure, loss to follow-up|2|||
163276497|NCT01450943|589723410|FG001|Overall Study|Screen failure, loss to follow-up|7|||
163276498|NCT01450943|589723411|FG002|Overall Study|Screen failure, loss to follow-up|6|||
163276499|NCT02724020|589723424|FG000|Overall Study|Death|16|||
163276500|NCT02724020|589723425|FG001|Overall Study|Death|18|||
163276501|NCT02724020|589723426|FG002|Overall Study|Death|19|||
163276502|NCT02724020|589723424|FG000|Overall Study|Lost to Follow-up|0|||
163276503|NCT02724020|589723425|FG001|Overall Study|Lost to Follow-up|3|||
163276504|NCT02724020|589723426|FG002|Overall Study|Lost to Follow-up|0|||
163276505|NCT02724020|589723424|FG000|Overall Study|Site Terminated by Sponsor|15|||
163276506|NCT02724020|589723425|FG001|Overall Study|Site Terminated by Sponsor|8|||
163276507|NCT02724020|589723426|FG002|Overall Study|Site Terminated by Sponsor|8|||
163276508|NCT02724020|589723424|FG000|Overall Study|Withdrawal by Subject|1|||
163276509|NCT02724020|589723425|FG001|Overall Study|Withdrawal by Subject|3|||
163276510|NCT02724020|589723426|FG002|Overall Study|Withdrawal by Subject|5|||
163276511|NCT02179918|589723427|FG000|Overall Study|Death|0|||
163276512|NCT02179918|589723428|FG001|Overall Study|Death|0|||
163276513|NCT02179918|589723429|FG002|Overall Study|Death|0|||
163276514|NCT02179918|589723430|FG003|Overall Study|Death|1|||
163276515|NCT02179918|589723431|FG004|Overall Study|Death|0|||
163276516|NCT02179918|589723427|FG000|Overall Study|Lost to Follow-up|0|||
163276517|NCT02179918|589723428|FG001|Overall Study|Lost to Follow-up|0|||
163276518|NCT02179918|589723429|FG002|Overall Study|Lost to Follow-up|1|||
163276519|NCT02179918|589723430|FG003|Overall Study|Lost to Follow-up|0|||
163276520|NCT02179918|589723431|FG004|Overall Study|Lost to Follow-up|0|||
163276521|NCT02179918|589723427|FG000|Overall Study|Progressive Disease|4|||
163276522|NCT02179918|589723428|FG001|Overall Study|Progressive Disease|1|||
163276523|NCT02179918|589723429|FG002|Overall Study|Progressive Disease|1|||
163276524|NCT02179918|589723430|FG003|Overall Study|Progressive Disease|2|||
163276525|NCT02179918|589723431|FG004|Overall Study|Progressive Disease|6|||
163276526|NCT02179918|589723427|FG000|Overall Study|Other|0|||
163276527|NCT02179918|589723428|FG001|Overall Study|Other|1|||
163276528|NCT02179918|589723429|FG002|Overall Study|Other|0|||
163276529|NCT02179918|589723430|FG003|Overall Study|Other|0|||
163276530|NCT02179918|589723431|FG004|Overall Study|Other|1|||
163276531|NCT02179918|589723427|FG000|Overall Study|Subject refused further follow-up|0|||
163276532|NCT02179918|589723428|FG001|Overall Study|Subject refused further follow-up|1|||
163276533|NCT02179918|589723429|FG002|Overall Study|Subject refused further follow-up|0|||
163276534|NCT02179918|589723430|FG003|Overall Study|Subject refused further follow-up|0|||
163276535|NCT02179918|589723431|FG004|Overall Study|Subject refused further follow-up|1|||
163276536|NCT02954575|589723433|FG000|Overall Study|Withdrawal by Subject|2|||
163276537|NCT02954575|589723433|FG000|Overall Study|Adverse Event|1|||
163276538|NCT00570661|589723436|FG000|Overall Study|Disease worsening|5|||
163276539|NCT00570661|589723436|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
163276540|NCT00570661|589723436|FG000|Overall Study|Adverse Event|1|||
163166093|NCT01742286|589322836|FG004|Expansion Phase|Physician Decision|0|||
163166094|NCT01742286|589322837|FG005|Expansion Phase|Physician Decision|0|||
163166095|NCT01742286|589322838|FG006|Expansion Phase|Physician Decision|9|||
163166096|NCT01742286|589322832|FG000|Expansion Phase|Adverse Event|0|||
163166097|NCT01742286|589322833|FG001|Expansion Phase|Adverse Event|0|||
163276541|NCT01734382|589723440|FG000|Part 1|Adverse Event|2|||
163276542|NCT01734382|589723441|FG001|Part 1|Adverse Event|0|||
163276543|NCT01734382|589723442|FG002|Part 1|Adverse Event|0|||
163276544|NCT01734382|589723440|FG000|Part 2|Adverse Event|0|||
163276545|NCT01734382|589723441|FG001|Part 2|Adverse Event|0|||
163276546|NCT01734382|589723442|FG002|Part 2|Adverse Event|1|||
163276547|NCT01734382|589723440|FG000|Part 2|Lack of Efficacy|0|||
163276548|NCT01734382|589723441|FG001|Part 2|Lack of Efficacy|1|||
163276549|NCT01734382|589723442|FG002|Part 2|Lack of Efficacy|1|||
163276550|NCT01734382|589723440|FG000|Part 2|Other|0|||
163276551|NCT01734382|589723441|FG001|Part 2|Other|0|||
163276552|NCT01734382|589723442|FG002|Part 2|Other|1|||
163276553|NCT01734382|589723440|FG000|Part 2|Physician Decision|0|||
163276554|NCT01734382|589723441|FG001|Part 2|Physician Decision|0|||
163276555|NCT01734382|589723442|FG002|Part 2|Physician Decision|3|||
163276556|NCT01734382|589723440|FG000|Part 2|Protocol Violation|0|||
163276557|NCT01734382|589723441|FG001|Part 2|Protocol Violation|1|||
163276558|NCT01734382|589723442|FG002|Part 2|Protocol Violation|0|||
163276559|NCT01734382|589723440|FG000|Part 2|Withdrawal by Subject|0|||
163276560|NCT01734382|589723441|FG001|Part 2|Withdrawal by Subject|0|||
163276561|NCT01734382|589723442|FG002|Part 2|Withdrawal by Subject|1|||
163276562|NCT04537949|589723443|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
163276563|NCT04537949|589723444|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
163276564|NCT04537949|589723445|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
163276565|NCT04537949|589723446|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
163276566|NCT04537949|589723447|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
163276567|NCT04537949|589723448|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
163276568|NCT04537949|589723449|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
163276569|NCT04537949|589723450|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
163276570|NCT04537949|589723443|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
163276571|NCT04537949|589723444|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
163276572|NCT04537949|589723445|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
163276573|NCT04537949|589723446|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
163276574|NCT04537949|589723447|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
163276575|NCT04537949|589723448|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
163276576|NCT04537949|589723449|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
163276577|NCT04537949|589723450|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
163276578|NCT04537949|589723443|FG000|Follow-up Phase|Lost to Follow-up|0|||
163276579|NCT04537949|589723444|FG001|Follow-up Phase|Lost to Follow-up|3|||
163276580|NCT04537949|589723445|FG002|Follow-up Phase|Lost to Follow-up|0|||
163276581|NCT04537949|589723446|FG003|Follow-up Phase|Lost to Follow-up|0|||
163276582|NCT04537949|589723447|FG004|Follow-up Phase|Lost to Follow-up|0|||
163276583|NCT04537949|589723448|FG005|Follow-up Phase|Lost to Follow-up|0|||
163276584|NCT04537949|589723449|FG006|Follow-up Phase|Lost to Follow-up|0|||
163276585|NCT04537949|589723450|FG007|Follow-up Phase|Lost to Follow-up|0|||
163276586|NCT04537949|589723443|FG000|Follow-up Phase|personal reasons|0|||
163276587|NCT04537949|589723444|FG001|Follow-up Phase|personal reasons|0|||
163276588|NCT04537949|589723445|FG002|Follow-up Phase|personal reasons|0|||
163276589|NCT04537949|589723446|FG003|Follow-up Phase|personal reasons|1|||
163276590|NCT04537949|589723447|FG004|Follow-up Phase|personal reasons|1|||
163276591|NCT04537949|589723448|FG005|Follow-up Phase|personal reasons|0|||
163276592|NCT04537949|589723449|FG006|Follow-up Phase|personal reasons|0|||
163276593|NCT04537949|589723450|FG007|Follow-up Phase|personal reasons|0|||
163276594|NCT04537949|589723443|FG000|Follow-up Phase|Withdrawal by Subject|0|||
163276595|NCT04537949|589723444|FG001|Follow-up Phase|Withdrawal by Subject|0|||
163276596|NCT04537949|589723445|FG002|Follow-up Phase|Withdrawal by Subject|0|||
163276597|NCT04537949|589723446|FG003|Follow-up Phase|Withdrawal by Subject|0|||
163276598|NCT04537949|589723447|FG004|Follow-up Phase|Withdrawal by Subject|1|||
163276599|NCT04537949|589723448|FG005|Follow-up Phase|Withdrawal by Subject|0|||
163276600|NCT04537949|589723449|FG006|Follow-up Phase|Withdrawal by Subject|0|||
163276601|NCT04537949|589723450|FG007|Follow-up Phase|Withdrawal by Subject|0|||
163276602|NCT01347645|589723464|FG000|Overall Study|Death|1|||
163276603|NCT01347645|589723465|FG001|Overall Study|Death|5|||
163276604|NCT01347645|589723466|FG002|Overall Study|Death|2|||
163276605|NCT01347645|589723467|FG003|Overall Study|Death|7|||
163276606|NCT01347645|589723468|FG004|Overall Study|Death|7|||
163276607|NCT01347645|589723464|FG000|Overall Study|Lost to Follow-up|1|||
163276608|NCT01347645|589723465|FG001|Overall Study|Lost to Follow-up|1|||
163276609|NCT01347645|589723466|FG002|Overall Study|Lost to Follow-up|0|||
163276610|NCT01347645|589723467|FG003|Overall Study|Lost to Follow-up|1|||
163276611|NCT01347645|589723468|FG004|Overall Study|Lost to Follow-up|1|||
163276612|NCT01347645|589723464|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
163276613|NCT01347645|589723465|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
163276614|NCT01347645|589723466|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
163276615|NCT01347645|589723467|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
163318863|NCT01208662|589878796|FG002|Induction and Consolidation|Disease Progression|0|||
163166098|NCT01742286|589322834|FG002|Expansion Phase|Adverse Event|0|||
163166099|NCT01742286|589322835|FG003|Expansion Phase|Adverse Event|0|||
163166100|NCT01742286|589322836|FG004|Expansion Phase|Adverse Event|0|||
163166101|NCT01742286|589322837|FG005|Expansion Phase|Adverse Event|0|||
163166102|NCT01742286|589322838|FG006|Expansion Phase|Adverse Event|6|||
163276616|NCT01347645|589723468|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
163276617|NCT01347645|589723464|FG000|Overall Study|Other|1|||
163276618|NCT01347645|589723465|FG001|Overall Study|Other|0|||
163276619|NCT01347645|589723466|FG002|Overall Study|Other|0|||
163276620|NCT01347645|589723467|FG003|Overall Study|Other|0|||
163276621|NCT01347645|589723468|FG004|Overall Study|Other|1|||
163276622|NCT01347645|589723464|FG000|Overall Study|Withdrawal by Subject|0|||
163276623|NCT01347645|589723465|FG001|Overall Study|Withdrawal by Subject|0|||
163276624|NCT01347645|589723466|FG002|Overall Study|Withdrawal by Subject|0|||
163042820|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
163166103|NCT01742286|589322832|FG000|Expansion Phase|Disease progression|0|||
163166104|NCT01742286|589322833|FG001|Expansion Phase|Disease progression|0|||
163166105|NCT01742286|589322834|FG002|Expansion Phase|Disease progression|3|||
163166106|NCT01742286|589322835|FG003|Expansion Phase|Disease progression|0|||
163166107|NCT01742286|589322836|FG004|Expansion Phase|Disease progression|0|||
163276625|NCT01347645|589723467|FG003|Overall Study|Withdrawal by Subject|3|||
163276626|NCT01347645|589723468|FG004|Overall Study|Withdrawal by Subject|3|||
163276627|NCT01347645|589723464|FG000|Overall Study|Physician Decision|0|||
163276628|NCT01347645|589723465|FG001|Overall Study|Physician Decision|0|||
163276629|NCT01347645|589723466|FG002|Overall Study|Physician Decision|0|||
163276630|NCT01347645|589723467|FG003|Overall Study|Physician Decision|0|||
163276631|NCT01347645|589723468|FG004|Overall Study|Physician Decision|1|||
163166108|NCT01742286|589322837|FG005|Expansion Phase|Disease progression|0|||
163166109|NCT01742286|589322838|FG006|Expansion Phase|Disease progression|15|||
163166110|NCT01742286|589322832|FG000|Expansion Phase|Withdrawal by Subject|0|||
163166111|NCT01742286|589322833|FG001|Expansion Phase|Withdrawal by Subject|0|||
163166112|NCT01742286|589322834|FG002|Expansion Phase|Withdrawal by Subject|0|||
163166113|NCT01742286|589322835|FG003|Expansion Phase|Withdrawal by Subject|0|||
163166114|NCT01742286|589322836|FG004|Expansion Phase|Withdrawal by Subject|0|||
163166115|NCT01742286|589322837|FG005|Expansion Phase|Withdrawal by Subject|0|||
163166116|NCT01742286|589322838|FG006|Expansion Phase|Withdrawal by Subject|1|||
163166117|NCT01233232|589322839|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
163166118|NCT01233232|589322840|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
163166119|NCT01233232|589322841|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
163166120|NCT04198714|589322842|FG000|Overall Study|Physician Decision|0|||
163166121|NCT04198714|589322843|FG001|Overall Study|Physician Decision|1|||
163166122|NCT01925131|589325589|FG000|Overall Study|Death|0|||
163166123|NCT01925131|589325590|FG001|Overall Study|Death|0|||
163166124|NCT01925131|589325591|FG002|Overall Study|Death|1|||
163166125|NCT01925131|589325592|FG003|Overall Study|Death|0|||
163166126|NCT01925131|589325593|FG004|Overall Study|Death|0|||
163166127|NCT01925131|589325594|FG005|Overall Study|Death|0|||
163166128|NCT01925131|589325589|FG000|Overall Study|Progression/Relapse|1|||
163166129|NCT01925131|589325590|FG001|Overall Study|Progression/Relapse|1|||
163166130|NCT01925131|589325591|FG002|Overall Study|Progression/Relapse|4|||
163166131|NCT01925131|589325592|FG003|Overall Study|Progression/Relapse|0|||
163166132|NCT01925131|589325593|FG004|Overall Study|Progression/Relapse|0|||
163166133|NCT01925131|589325594|FG005|Overall Study|Progression/Relapse|1|||
163166134|NCT01925131|589325589|FG000|Overall Study|Patient Refusal|1|||
163166135|NCT01925131|589325590|FG001|Overall Study|Patient Refusal|0|||
163166136|NCT01925131|589325591|FG002|Overall Study|Patient Refusal|0|||
163166137|NCT01925131|589325592|FG003|Overall Study|Patient Refusal|0|||
163166138|NCT01925131|589325593|FG004|Overall Study|Patient Refusal|0|||
163166139|NCT01925131|589325594|FG005|Overall Study|Patient Refusal|0|||
163166140|NCT01925131|589325589|FG000|Overall Study|Adverse Event|0|||
163166141|NCT01925131|589325590|FG001|Overall Study|Adverse Event|0|||
163166142|NCT01925131|589325591|FG002|Overall Study|Adverse Event|2|||
163166143|NCT01925131|589325592|FG003|Overall Study|Adverse Event|0|||
163166144|NCT01925131|589325593|FG004|Overall Study|Adverse Event|1|||
163166145|NCT01925131|589325594|FG005|Overall Study|Adverse Event|3|||
163166146|NCT01925131|589325589|FG000|Overall Study|Other - Not Protocol Specified|3|||
163166147|NCT01925131|589325590|FG001|Overall Study|Other - Not Protocol Specified|1|||
163166148|NCT01925131|589325591|FG002|Overall Study|Other - Not Protocol Specified|2|||
163166149|NCT01925131|589325592|FG003|Overall Study|Other - Not Protocol Specified|5|||
163166150|NCT01925131|589325593|FG004|Overall Study|Other - Not Protocol Specified|10|||
163166151|NCT01925131|589325594|FG005|Overall Study|Other - Not Protocol Specified|6|||
163166152|NCT05091567|589325595|FG000|Enrollment Phase|Death|37|||
163166153|NCT05091567|589325596|FG001|Enrollment Phase|Death|0|||
163166154|NCT05091567|589325597|FG002|Enrollment Phase|Death|0|||
163166155|NCT05091567|589325595|FG000|Enrollment Phase|Adverse Event|21|||
163166156|NCT05091567|589325596|FG001|Enrollment Phase|Adverse Event|0|||
163166157|NCT05091567|589325597|FG002|Enrollment Phase|Adverse Event|0|||
163166158|NCT05091567|589325595|FG000|Enrollment Phase|Progressive Disease|10|||
163166159|NCT05091567|589325596|FG001|Enrollment Phase|Progressive Disease|0|||
163166160|NCT05091567|589325597|FG002|Enrollment Phase|Progressive Disease|0|||
163166161|NCT05091567|589325595|FG000|Enrollment Phase|Withdrawal by Subject|8|||
163166162|NCT05091567|589325596|FG001|Enrollment Phase|Withdrawal by Subject|0|||
163166163|NCT05091567|589325597|FG002|Enrollment Phase|Withdrawal by Subject|0|||
163166164|NCT05091567|589325595|FG000|Enrollment Phase|Symptomatic Deterioration|7|||
163166165|NCT05091567|589325596|FG001|Enrollment Phase|Symptomatic Deterioration|0|||
163166166|NCT05091567|589325597|FG002|Enrollment Phase|Symptomatic Deterioration|0|||
163166167|NCT05091567|589325595|FG000|Enrollment Phase|Physician Decision|3|||
163166168|NCT05091567|589325596|FG001|Enrollment Phase|Physician Decision|0|||
163166169|NCT05091567|589325597|FG002|Enrollment Phase|Physician Decision|0|||
163166170|NCT05091567|589325595|FG000|Enrollment Phase|Protocol Violation|2|||
163166171|NCT05091567|589325596|FG001|Enrollment Phase|Protocol Violation|0|||
163166172|NCT05091567|589325597|FG002|Enrollment Phase|Protocol Violation|0|||
163166173|NCT05091567|589325595|FG000|Enrollment Phase|Reason not Specified|1|||
163166174|NCT05091567|589325596|FG001|Enrollment Phase|Reason not Specified|0|||
163166175|NCT05091567|589325597|FG002|Enrollment Phase|Reason not Specified|0|||
163166176|NCT05091567|589325595|FG000|Randomized Phase|Death|0|||
163166177|NCT05091567|589325596|FG001|Randomized Phase|Death|135|||
163166178|NCT05091567|589325597|FG002|Randomized Phase|Death|112|||
163166179|NCT05091567|589325595|FG000|Randomized Phase|Progressive Disease|0|||
163166180|NCT05091567|589325596|FG001|Randomized Phase|Progressive Disease|2|||
163276632|NCT01347645|589723464|FG000|Overall Study|Adverse Event|0|||
163276633|NCT01347645|589723465|FG001|Overall Study|Adverse Event|0|||
163276634|NCT01347645|589723466|FG002|Overall Study|Adverse Event|0|||
163166181|NCT05091567|589325597|FG002|Randomized Phase|Progressive Disease|0|||
163166182|NCT05091567|589325595|FG000|Randomized Phase|Withdrawal by Subject|0|||
163166183|NCT05091567|589325596|FG001|Randomized Phase|Withdrawal by Subject|1|||
163166184|NCT05091567|589325597|FG002|Randomized Phase|Withdrawal by Subject|3|||
163166185|NCT05091567|589325595|FG000|Randomized Phase|Lost to Follow-up|0|||
163166186|NCT05091567|589325596|FG001|Randomized Phase|Lost to Follow-up|1|||
163166187|NCT05091567|589325597|FG002|Randomized Phase|Lost to Follow-up|1|||
163166188|NCT05091567|589325595|FG000|Randomized Phase|Ongoing in Study|0|||
163276635|NCT01347645|589723467|FG003|Overall Study|Adverse Event|1|||
163276636|NCT01347645|589723468|FG004|Overall Study|Adverse Event|1|||
163276637|NCT00388362|589723469|FG000|Enrolled|Ineligible|1|||
163276638|NCT00388362|589723469|FG000|Enrolled|Adverse Event|9|||
163166189|NCT05091567|589325596|FG001|Randomized Phase|Ongoing in Study|102|||
163166190|NCT05091567|589325597|FG002|Randomized Phase|Ongoing in Study|126|||
163276639|NCT00388362|589723469|FG000|Enrolled|Death|1|||
163276640|NCT00388362|589723469|FG000|Enrolled|Loss insurance|1|||
163276641|NCT00388362|589723469|FG000|Enrolled|Withdrawal by Subject|1|||
163276642|NCT00388362|589723469|FG000|Remained on Study Median of 514 Days|Death|2|||
163276643|NCT01141660|589723470|FG000|Overall Study|Physician Decision|0|||
163276644|NCT01141660|589723471|FG001|Overall Study|Physician Decision|12|||
163276645|NCT00209027|589723473|FG000|Overall Study|study terminated|10|||
163276646|NCT00209027|589723474|FG001|Overall Study|study terminated|0|||
163276647|NCT02335268|589723475|FG000|Overall Study|Physician Decision|5|||
163276648|NCT02335268|589723476|FG001|Overall Study|Physician Decision|1|||
163276649|NCT02335268|589723475|FG000|Overall Study|Lack of Efficacy|2|||
163276650|NCT02335268|589723476|FG001|Overall Study|Lack of Efficacy|1|||
163276651|NCT02335268|589723475|FG000|Overall Study|Adverse Event|5|||
163276652|NCT02335268|589723476|FG001|Overall Study|Adverse Event|2|||
163276653|NCT02335268|589723475|FG000|Overall Study|increase blasts|2|||
163276654|NCT02335268|589723476|FG001|Overall Study|increase blasts|0|||
163276655|NCT02335268|589723475|FG000|Overall Study|Withdrawal by Subject|3|||
163276656|NCT02335268|589723476|FG001|Overall Study|Withdrawal by Subject|2|||
163276657|NCT05893797|589723479|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
163276658|NCT05893797|589723479|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
163276659|NCT05893797|589723479|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
163276660|NCT05893797|589723479|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
163276661|NCT04770220|589723480|FG000|Overall Study|Adverse Event|2|||
163276662|NCT04770220|589723481|FG001|Overall Study|Adverse Event|11|||
163276663|NCT04770220|589723480|FG000|Overall Study|Withdrawal by Subject|5|||
163276664|NCT04770220|589723481|FG001|Overall Study|Withdrawal by Subject|11|||
163276665|NCT04770220|589723480|FG000|Overall Study|Lost to Follow-up|4|||
163276666|NCT04770220|589723481|FG001|Overall Study|Lost to Follow-up|3|||
163276667|NCT04770220|589723480|FG000|Overall Study|not otherwise specified|2|||
163276668|NCT04770220|589723481|FG001|Overall Study|not otherwise specified|3|||
163276669|NCT04770220|589723480|FG000|Overall Study|Physician Decision|1|||
163276670|NCT04770220|589723481|FG001|Overall Study|Physician Decision|3|||
163276671|NCT04894903|589723483|FG000|Overall Study|Death|1|||
163276672|NCT04894903|589723484|FG001|Overall Study|Death|0|||
163276673|NCT04894903|589723483|FG000|Overall Study|Pregnancy|1|||
163276674|NCT04894903|589723484|FG001|Overall Study|Pregnancy|0|||
163276675|NCT04894903|589723483|FG000|Overall Study|Withdrawal by Subject|1|||
163276676|NCT04894903|589723484|FG001|Overall Study|Withdrawal by Subject|1|||
163276677|NCT04894903|589723483|FG000|Overall Study|moved or exited health system|1|||
163276678|NCT04894903|589723484|FG001|Overall Study|moved or exited health system|3|||
163276679|NCT01923428|589723485|FG000|Overall Study|Adverse Event|8|||
163276680|NCT01923428|589723486|FG001|Overall Study|Adverse Event|6|||
163276681|NCT01923428|589723487|FG002|Overall Study|Adverse Event|3|||
163276682|NCT01923428|589723488|FG003|Overall Study|Adverse Event|3|||
163276683|NCT01923428|589723485|FG000|Overall Study|Withdrawal by Subject|5|||
163276684|NCT01923428|589723486|FG001|Overall Study|Withdrawal by Subject|3|||
163276685|NCT01923428|589723487|FG002|Overall Study|Withdrawal by Subject|0|||
163276686|NCT01923428|589723488|FG003|Overall Study|Withdrawal by Subject|4|||
163276687|NCT01923428|589723485|FG000|Overall Study|Lost to Follow-up|2|||
163276688|NCT01923428|589723486|FG001|Overall Study|Lost to Follow-up|1|||
163276689|NCT01923428|589723487|FG002|Overall Study|Lost to Follow-up|5|||
163276690|NCT01923428|589723488|FG003|Overall Study|Lost to Follow-up|0|||
163276691|NCT01923428|589723485|FG000|Overall Study|Protocol Violation|3|||
163276692|NCT01923428|589723486|FG001|Overall Study|Protocol Violation|0|||
163276693|NCT01923428|589723487|FG002|Overall Study|Protocol Violation|2|||
163276694|NCT01923428|589723488|FG003|Overall Study|Protocol Violation|1|||
163276695|NCT01923428|589723485|FG000|Overall Study|Non Compliance to treatment|1|||
163276696|NCT01923428|589723486|FG001|Overall Study|Non Compliance to treatment|2|||
163276697|NCT01923428|589723487|FG002|Overall Study|Non Compliance to treatment|0|||
163276698|NCT01923428|589723488|FG003|Overall Study|Non Compliance to treatment|1|||
163276699|NCT01923428|589723485|FG000|Overall Study|Lack of Efficacy|0|||
163276700|NCT01923428|589723486|FG001|Overall Study|Lack of Efficacy|0|||
163276701|NCT01923428|589723487|FG002|Overall Study|Lack of Efficacy|1|||
163276702|NCT01923428|589723488|FG003|Overall Study|Lack of Efficacy|1|||
163276703|NCT02550873|589723489|FG000|Randomized Double Blind|Adverse Event|3|||
163276704|NCT02550873|589723490|FG001|Randomized Double Blind|Adverse Event|1|||
163276705|NCT02550873|589723491|FG002|Randomized Double Blind|Adverse Event|0|||
163276706|NCT02550873|589723489|FG000|Randomized Double Blind|Disease progression|1|||
163276707|NCT02550873|589723490|FG001|Randomized Double Blind|Disease progression|1|||
163276708|NCT02550873|589723491|FG002|Randomized Double Blind|Disease progression|0|||
163276709|NCT02550873|589723489|FG000|Open Label Extension|Study ongoing|0|||
163276710|NCT02550873|589723490|FG001|Open Label Extension|Study ongoing|0|||
163276711|NCT02550873|589723491|FG002|Open Label Extension|Study ongoing|111|||
163276712|NCT01822353|589723492|FG000|Overall Study|Adverse Event|1|||
163276713|NCT01822353|589723493|FG001|Overall Study|Adverse Event|3|||
163276714|NCT01822353|589723494|FG002|Overall Study|Adverse Event|1|||
163276715|NCT01822353|589723492|FG000|Overall Study|Pregnancy|0|||
163276716|NCT01822353|589723493|FG001|Overall Study|Pregnancy|1|||
163276717|NCT01822353|589723494|FG002|Overall Study|Pregnancy|0|||
163166191|NCT01217307|589325598|FG000|Overall Study|Withdrawal by Subject|0|||
163166192|NCT01217307|589325599|FG001|Overall Study|Withdrawal by Subject|1|||
163166193|NCT00843284|589325602|FG000|Overall Study|Adverse Event|39|||
163166194|NCT00843284|589325602|FG000|Overall Study|Lack of Efficacy|5|||
163166195|NCT00843284|589325602|FG000|Overall Study|Lost to Follow-up|11|||
163166196|NCT00843284|589325602|FG000|Overall Study|Other|10|||
163166197|NCT00843284|589325602|FG000|Overall Study|Withdrawal by Subject|4|||
163166198|NCT00843284|589325602|FG000|Overall Study|Death|3|||
163166199|NCT01696929|589325603|FG000|Overall Study|Physician Decision|1|||
163166200|NCT03320824|589325605|FG000|Overall Study|Withdrawal by Subject|8|||
163166201|NCT03320824|589325606|FG001|Overall Study|Withdrawal by Subject|1|||
163166202|NCT03320824|589325605|FG000|Overall Study|Lost to Follow-up|10|||
163166203|NCT03320824|589325606|FG001|Overall Study|Lost to Follow-up|1|||
163166204|NCT03320824|589325605|FG000|Overall Study|moved out of state|0|||
163166205|NCT03320824|589325606|FG001|Overall Study|moved out of state|1|||
163166206|NCT03320824|589325605|FG000|Overall Study|could not complete final visit|0|||
163166207|NCT03320824|589325606|FG001|Overall Study|could not complete final visit|1|||
163166208|NCT00109590|589325607|FG000|Overall Study|Lost to Follow-up|1|||
163166209|NCT00109590|589325608|FG001|Overall Study|Lost to Follow-up|0|||
163166210|NCT00109590|589325609|FG002|Overall Study|Lost to Follow-up|1|||
163166211|NCT00109590|589325607|FG000|Overall Study|Never Started Treatment|1|||
163166212|NCT00109590|589325608|FG001|Overall Study|Never Started Treatment|2|||
163166213|NCT00109590|589325609|FG002|Overall Study|Never Started Treatment|3|||
163166214|NCT00588861|589325610|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
163166215|NCT00588861|589325611|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
163166216|NCT00588861|589325610|FG000|6 Months|Patients did not return for follow-up|98|||
163166217|NCT00588861|589325611|FG001|6 Months|Patients did not return for follow-up|73|||
163166218|NCT00588861|589325610|FG000|1 Year|Patients did not return for follow-up|89|||
163166219|NCT00588861|589325611|FG001|1 Year|Patients did not return for follow-up|82|||
163166220|NCT00588861|589325610|FG000|2 Years|Patients did not return for follow-up|92|||
163166221|NCT00588861|589325611|FG001|2 Years|Patients did not return for follow-up|87|||
163166222|NCT00588861|589325610|FG000|4 Years|Patients did not return for follow-up|91|||
163166223|NCT00588861|589325611|FG001|4 Years|Patients did not return for follow-up|103|||
163166224|NCT00588861|589325610|FG000|6 Years|Patients did not return for follow-up|104|||
163166225|NCT00588861|589325611|FG001|6 Years|Patients did not return for follow-up|109|||
163166226|NCT00588861|589325610|FG000|8 Years|Patients did not return for follow-up|105|||
163166227|NCT00588861|589325611|FG001|8 Years|Patients did not return for follow-up|114|||
163166228|NCT00588861|589325610|FG000|10 Years|Incomplete due to study termination|107|||
163166229|NCT00588861|589325611|FG001|10 Years|Incomplete due to study termination|114|||
163276718|NCT01822353|589723492|FG000|Overall Study|Withdrawal by Subject|3|||
163166230|NCT00490529|589325616|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
163166231|NCT00490529|589325616|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
163166232|NCT00490529|589325616|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
163166233|NCT00490529|589325616|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
163166234|NCT00490529|589325616|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
163166235|NCT00490529|589325616|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
163166236|NCT01129583|589325617|FG000|Overall Study|Death|1|||
163166237|NCT01129583|589325618|FG001|Overall Study|Death|0|||
163166238|NCT01129583|589325617|FG000|Overall Study|Lost to Follow-up|1|||
163166239|NCT01129583|589325618|FG001|Overall Study|Lost to Follow-up|1|||
163166240|NCT01129583|589325617|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
163166241|NCT01129583|589325618|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
163166242|NCT02617485|589325631|FG000|Treatment and Observation Period|Adverse Event|9|||
163166243|NCT02617485|589325632|FG001|Treatment and Observation Period|Adverse Event|1|||
163166244|NCT02617485|589325631|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
163166245|NCT02617485|589325632|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
163166246|NCT02617485|589325631|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
163166247|NCT02617485|589325632|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
163166248|NCT02617485|589325631|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
163166249|NCT02617485|589325632|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
163166250|NCT02617485|589325631|FG000|Treatment and Observation Period|Physician Decision|0|||
163166251|NCT02617485|589325632|FG001|Treatment and Observation Period|Physician Decision|1|||
163166252|NCT02617485|589325631|FG000|Follow-up Period|Adverse Event|1|||
163166253|NCT02617485|589325632|FG001|Follow-up Period|Adverse Event|0|||
163166254|NCT02617485|589325631|FG000|Follow-up Period|Withdrawal by Subject|1|||
163166255|NCT02617485|589325632|FG001|Follow-up Period|Withdrawal by Subject|0|||
163166256|NCT02617485|589325631|FG000|Follow-up Period|Disease progression|2|||
163166257|NCT02617485|589325632|FG001|Follow-up Period|Disease progression|1|||
163166258|NCT02617485|589325631|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
163166259|NCT02617485|589325632|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
163166260|NCT02617485|589325631|FG000|Follow-up Period|Patient needed radiotherapy|9|||
163166261|NCT02617485|589325632|FG001|Follow-up Period|Patient needed radiotherapy|5|||
163166262|NCT02617485|589325631|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
163166263|NCT02617485|589325632|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
163166264|NCT00791076|589325633|FG000|Overall Study|Study was terminated,PI left institution|8|||
163166265|NCT00669409|589325635|FG000|Part 2|Withdrawal by Subject|0|||
163166266|NCT00669409|589325636|FG001|Part 2|Withdrawal by Subject|0|||
163166267|NCT00669409|589325637|FG002|Part 2|Withdrawal by Subject|0|||
163166268|NCT00669409|589325638|FG003|Part 2|Withdrawal by Subject|0|||
163166269|NCT00669409|589325639|FG004|Part 2|Withdrawal by Subject|0|||
163166270|NCT00669409|589325640|FG005|Part 2|Withdrawal by Subject|0|||
163166271|NCT00669409|589325641|FG006|Part 2|Withdrawal by Subject|0|||
163166272|NCT00669409|589325642|FG007|Part 2|Withdrawal by Subject|0|||
163166273|NCT00669409|589325643|FG008|Part 2|Withdrawal by Subject|0|||
163166274|NCT00669409|589325644|FG009|Part 2|Withdrawal by Subject|1|||
163166275|NCT00669409|589325645|FG010|Part 2|Withdrawal by Subject|0|||
163166276|NCT00095940|589325648|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
163166277|NCT00095940|589325649|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
163166278|NCT00095940|589325650|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
163166279|NCT00095940|589325651|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
163166280|NCT00095940|589325652|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
163166281|NCT00095940|589325653|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
163166282|NCT00095940|589325654|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
163166283|NCT00095940|589325655|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
163166284|NCT00095940|589325656|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
163166285|NCT00095940|589325648|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
163166286|NCT00095940|589325649|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
163166287|NCT00095940|589325650|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
163166288|NCT00095940|589325651|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
163166289|NCT00095940|589325652|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
163276719|NCT01822353|589723493|FG001|Overall Study|Withdrawal by Subject|1|||
163276720|NCT01822353|589723494|FG002|Overall Study|Withdrawal by Subject|0|||
163276721|NCT04320615|589723495|FG000|Overall Study|Withdrawal by Subject|4|||
163276722|NCT04320615|589723496|FG001|Overall Study|Withdrawal by Subject|10|||
163276723|NCT04320615|589723495|FG000|Overall Study|Physician Decision|2|||
163276724|NCT04320615|589723496|FG001|Overall Study|Physician Decision|0|||
163166290|NCT00095940|589325653|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
163166291|NCT00095940|589325654|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
163166292|NCT00095940|589325655|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
163166293|NCT00095940|589325656|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
163166294|NCT00095940|589325648|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
163166295|NCT00095940|589325649|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
163166296|NCT00095940|589325650|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
163166297|NCT00095940|589325651|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
163166298|NCT00095940|589325652|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
163166299|NCT00095940|589325653|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
163166300|NCT00095940|589325654|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
163276725|NCT04320615|589723495|FG000|Overall Study|Other|2|||
163166301|NCT00095940|589325655|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
163166302|NCT00095940|589325656|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
163166303|NCT01874340|589325659|FG000|Overall Study|Study terminated by Sponsor|6|||
163166304|NCT01874340|589325660|FG001|Overall Study|Study terminated by Sponsor|8|||
163166305|NCT01874340|589325661|FG002|Overall Study|Study terminated by Sponsor|8|||
163166306|NCT01874340|589325662|FG003|Overall Study|Study terminated by Sponsor|4|||
163166307|NCT01874340|589325659|FG000|Overall Study|Withdrawal by Subject|0|||
163166308|NCT01874340|589325660|FG001|Overall Study|Withdrawal by Subject|0|||
163166309|NCT01874340|589325661|FG002|Overall Study|Withdrawal by Subject|0|||
163166310|NCT01874340|589325662|FG003|Overall Study|Withdrawal by Subject|1|||
163166311|NCT01716052|589325663|FG000|Overall Study|Withdrawal of funding|1|||
163166312|NCT01716052|589325664|FG001|Overall Study|Withdrawal of funding|1|||
163166313|NCT02864862|589325670|FG000|Overall Study|Lost to Follow-up|1|||
163166314|NCT02864862|589325671|FG001|Overall Study|Lost to Follow-up|0|||
163166315|NCT02864862|589325672|FG002|Overall Study|Lost to Follow-up|1|||
163166316|NCT02864862|589325670|FG000|Overall Study|Protocol Violation|0|||
163166317|NCT02864862|589325671|FG001|Overall Study|Protocol Violation|0|||
163166318|NCT02864862|589325672|FG002|Overall Study|Protocol Violation|1|||
163166319|NCT01523275|589325676|FG000|Overall Study|Lost to Follow-up|1|||
163166320|NCT01523275|589325677|FG001|Overall Study|Lost to Follow-up|2|||
163166321|NCT01523275|589325676|FG000|Overall Study|Withdrawal by Subject|1|||
163166322|NCT01523275|589325677|FG001|Overall Study|Withdrawal by Subject|0|||
163166323|NCT03263702|589325678|FG000|Overall Study|Lost to Follow-up|2|||
163166324|NCT03263702|589325679|FG001|Overall Study|Lost to Follow-up|2|||
163166325|NCT03263702|589325678|FG000|Overall Study|Withdrawal by Subject|1|||
163166326|NCT03263702|589325679|FG001|Overall Study|Withdrawal by Subject|2|||
163166327|NCT03598114|589325680|FG000|Overall Study|Staff turnover/left the program|3|||
163166328|NCT03598114|589325681|FG001|Overall Study|Staff turnover/left the program|39|||
163166329|NCT02527200|589325682|FG000|Overall Study|Withdrawal by Subject|3|||
163166330|NCT02527200|589325683|FG001|Overall Study|Withdrawal by Subject|2|||
163166331|NCT02527200|589325684|FG002|Overall Study|Withdrawal by Subject|1|||
163166332|NCT02527200|589325685|FG003|Overall Study|Withdrawal by Subject|0|||
163166333|NCT02527200|589325682|FG000|Overall Study|Unclassified|0|||
163166334|NCT02527200|589325683|FG001|Overall Study|Unclassified|1|||
163166335|NCT02527200|589325684|FG002|Overall Study|Unclassified|0|||
163166336|NCT02527200|589325685|FG003|Overall Study|Unclassified|0|||
163166337|NCT02527200|589325682|FG000|Overall Study|Lost to Follow-up|0|||
163166338|NCT02527200|589325683|FG001|Overall Study|Lost to Follow-up|0|||
163166339|NCT02527200|589325684|FG002|Overall Study|Lost to Follow-up|1|||
163166340|NCT02527200|589325685|FG003|Overall Study|Lost to Follow-up|0|||
163166341|NCT00966875|589325686|FG000|Part A|Adverse Event|2|||
163166342|NCT00966875|589325687|FG001|Part A|Adverse Event|1|||
163166343|NCT00966875|589325688|FG002|Part A|Adverse Event|0|||
163166344|NCT00966875|589325689|FG003|Part A|Adverse Event|1|||
163166345|NCT00966875|589325690|FG004|Part A|Adverse Event|0|||
163166346|NCT00966875|589325691|FG005|Part A|Adverse Event|1|||
163166347|NCT00966875|589325692|FG006|Part A|Adverse Event|0|||
163166348|NCT00966875|589325693|FG007|Part A|Adverse Event|3|||
163166349|NCT00966875|589325694|FG008|Part A|Adverse Event|3|||
163166350|NCT00966875|589325686|FG000|Part A|Entry Criteria|0|||
163166351|NCT00966875|589325687|FG001|Part A|Entry Criteria|0|||
163166352|NCT00966875|589325688|FG002|Part A|Entry Criteria|0|||
163166353|NCT00966875|589325689|FG003|Part A|Entry Criteria|0|||
163166354|NCT00966875|589325690|FG004|Part A|Entry Criteria|0|||
163166355|NCT00966875|589325691|FG005|Part A|Entry Criteria|2|||
163166356|NCT00966875|589325692|FG006|Part A|Entry Criteria|0|||
163166357|NCT00966875|589325693|FG007|Part A|Entry Criteria|0|||
163166358|NCT00966875|589325694|FG008|Part A|Entry Criteria|0|||
163166359|NCT00966875|589325686|FG000|Part A|Lack of Efficacy|0|||
163166360|NCT00966875|589325687|FG001|Part A|Lack of Efficacy|1|||
163166361|NCT00966875|589325688|FG002|Part A|Lack of Efficacy|0|||
163166362|NCT00966875|589325689|FG003|Part A|Lack of Efficacy|0|||
163166363|NCT00966875|589325690|FG004|Part A|Lack of Efficacy|0|||
163166364|NCT00966875|589325691|FG005|Part A|Lack of Efficacy|0|||
163166365|NCT00966875|589325692|FG006|Part A|Lack of Efficacy|4|||
163166366|NCT00966875|589325693|FG007|Part A|Lack of Efficacy|0|||
163166367|NCT00966875|589325694|FG008|Part A|Lack of Efficacy|0|||
163166368|NCT00966875|589325686|FG000|Part A|Lost to Follow-up|2|||
163166369|NCT00966875|589325687|FG001|Part A|Lost to Follow-up|0|||
163166370|NCT00966875|589325688|FG002|Part A|Lost to Follow-up|0|||
163166371|NCT00966875|589325689|FG003|Part A|Lost to Follow-up|0|||
163166372|NCT00966875|589325690|FG004|Part A|Lost to Follow-up|0|||
163166373|NCT00966875|589325691|FG005|Part A|Lost to Follow-up|1|||
163166374|NCT00966875|589325692|FG006|Part A|Lost to Follow-up|0|||
163166375|NCT00966875|589325693|FG007|Part A|Lost to Follow-up|0|||
163166376|NCT00966875|589325694|FG008|Part A|Lost to Follow-up|0|||
163166377|NCT00966875|589325686|FG000|Part A|Parent/Caregiver Decision|0|||
163166378|NCT00966875|589325687|FG001|Part A|Parent/Caregiver Decision|0|||
163166379|NCT00966875|589325688|FG002|Part A|Parent/Caregiver Decision|0|||
163166380|NCT00966875|589325689|FG003|Part A|Parent/Caregiver Decision|1|||
163166381|NCT00966875|589325690|FG004|Part A|Parent/Caregiver Decision|0|||
163166382|NCT00966875|589325691|FG005|Part A|Parent/Caregiver Decision|0|||
163166383|NCT00966875|589325692|FG006|Part A|Parent/Caregiver Decision|0|||
163166384|NCT00966875|589325693|FG007|Part A|Parent/Caregiver Decision|0|||
163166385|NCT00966875|589325694|FG008|Part A|Parent/Caregiver Decision|0|||
163166386|NCT00966875|589325686|FG000|Part A|Physician Decision|0|||
163166387|NCT00966875|589325687|FG001|Part A|Physician Decision|0|||
163166388|NCT00966875|589325688|FG002|Part A|Physician Decision|0|||
163166389|NCT00966875|589325689|FG003|Part A|Physician Decision|0|||
163166390|NCT00966875|589325690|FG004|Part A|Physician Decision|1|||
163166391|NCT00966875|589325691|FG005|Part A|Physician Decision|0|||
163166392|NCT00966875|589325692|FG006|Part A|Physician Decision|1|||
163166393|NCT00966875|589325693|FG007|Part A|Physician Decision|0|||
163166394|NCT00966875|589325694|FG008|Part A|Physician Decision|2|||
163166395|NCT00966875|589325686|FG000|Part A|Sponsor Decision|0|||
163166396|NCT00966875|589325687|FG001|Part A|Sponsor Decision|0|||
163166397|NCT00966875|589325688|FG002|Part A|Sponsor Decision|1|||
163166398|NCT00966875|589325689|FG003|Part A|Sponsor Decision|0|||
163166399|NCT00966875|589325690|FG004|Part A|Sponsor Decision|1|||
163166400|NCT00966875|589325691|FG005|Part A|Sponsor Decision|0|||
163166401|NCT00966875|589325692|FG006|Part A|Sponsor Decision|0|||
163166402|NCT00966875|589325693|FG007|Part A|Sponsor Decision|2|||
163166403|NCT00966875|589325694|FG008|Part A|Sponsor Decision|1|||
163166404|NCT00966875|589325686|FG000|Part A|Withdrawal by Subject|2|||
163166405|NCT00966875|589325687|FG001|Part A|Withdrawal by Subject|2|||
163166406|NCT00966875|589325688|FG002|Part A|Withdrawal by Subject|1|||
163166407|NCT00966875|589325689|FG003|Part A|Withdrawal by Subject|1|||
163166408|NCT00966875|589325690|FG004|Part A|Withdrawal by Subject|3|||
163166409|NCT00966875|589325691|FG005|Part A|Withdrawal by Subject|0|||
163166410|NCT00966875|589325692|FG006|Part A|Withdrawal by Subject|5|||
163166411|NCT00966875|589325693|FG007|Part A|Withdrawal by Subject|1|||
163166412|NCT00966875|589325694|FG008|Part A|Withdrawal by Subject|1|||
163166413|NCT00966875|589325686|FG000|Part A|Protocol Violation|0|||
163166414|NCT00966875|589325687|FG001|Part A|Protocol Violation|0|||
163166415|NCT00966875|589325688|FG002|Part A|Protocol Violation|0|||
163166416|NCT00966875|589325689|FG003|Part A|Protocol Violation|0|||
163166417|NCT00966875|589325690|FG004|Part A|Protocol Violation|0|||
163166418|NCT00966875|589325691|FG005|Part A|Protocol Violation|0|||
163166419|NCT00966875|589325692|FG006|Part A|Protocol Violation|2|||
163166420|NCT00966875|589325693|FG007|Part A|Protocol Violation|1|||
163166421|NCT00966875|589325694|FG008|Part A|Protocol Violation|1|||
163166422|NCT00966875|589325686|FG000|Part B|Adverse Event|0|||
163166423|NCT00966875|589325687|FG001|Part B|Adverse Event|1|||
163166424|NCT00966875|589325688|FG002|Part B|Adverse Event|1|||
163166425|NCT00966875|589325689|FG003|Part B|Adverse Event|0|||
163166426|NCT00966875|589325690|FG004|Part B|Adverse Event|1|||
163166427|NCT00966875|589325691|FG005|Part B|Adverse Event|0|||
163166428|NCT00966875|589325692|FG006|Part B|Adverse Event|5|||
163166429|NCT00966875|589325693|FG007|Part B|Adverse Event|2|||
163166430|NCT00966875|589325694|FG008|Part B|Adverse Event|2|||
163166431|NCT00966875|589325686|FG000|Part B|Death|0|||
163166432|NCT00966875|589325687|FG001|Part B|Death|0|||
163166433|NCT00966875|589325688|FG002|Part B|Death|1|||
163166434|NCT00966875|589325689|FG003|Part B|Death|0|||
163166435|NCT00966875|589325690|FG004|Part B|Death|0|||
163166436|NCT00966875|589325691|FG005|Part B|Death|0|||
163166437|NCT00966875|589325692|FG006|Part B|Death|0|||
163166438|NCT00966875|589325693|FG007|Part B|Death|1|||
163166439|NCT00966875|589325694|FG008|Part B|Death|0|||
163166440|NCT00966875|589325686|FG000|Part B|Lack of Efficacy|2|||
163166441|NCT00966875|589325687|FG001|Part B|Lack of Efficacy|1|||
163166442|NCT00966875|589325688|FG002|Part B|Lack of Efficacy|1|||
163166443|NCT00966875|589325689|FG003|Part B|Lack of Efficacy|1|||
163166444|NCT00966875|589325690|FG004|Part B|Lack of Efficacy|2|||
163166445|NCT00966875|589325691|FG005|Part B|Lack of Efficacy|3|||
163166446|NCT00966875|589325692|FG006|Part B|Lack of Efficacy|12|||
163166447|NCT00966875|589325693|FG007|Part B|Lack of Efficacy|9|||
163166448|NCT00966875|589325694|FG008|Part B|Lack of Efficacy|6|||
163166449|NCT00966875|589325686|FG000|Part B|Lost to Follow-up|0|||
163166450|NCT00966875|589325687|FG001|Part B|Lost to Follow-up|0|||
163166451|NCT00966875|589325688|FG002|Part B|Lost to Follow-up|0|||
163166452|NCT00966875|589325689|FG003|Part B|Lost to Follow-up|1|||
163166453|NCT00966875|589325690|FG004|Part B|Lost to Follow-up|0|||
163166454|NCT00966875|589325691|FG005|Part B|Lost to Follow-up|0|||
163166455|NCT00966875|589325692|FG006|Part B|Lost to Follow-up|0|||
163166456|NCT00966875|589325693|FG007|Part B|Lost to Follow-up|0|||
163166457|NCT00966875|589325694|FG008|Part B|Lost to Follow-up|1|||
163166458|NCT00966875|589325686|FG000|Part B|Physician Decision|0|||
163166459|NCT00966875|589325687|FG001|Part B|Physician Decision|0|||
163166460|NCT00966875|589325688|FG002|Part B|Physician Decision|1|||
163166461|NCT00966875|589325689|FG003|Part B|Physician Decision|0|||
163166462|NCT00966875|589325690|FG004|Part B|Physician Decision|2|||
163166463|NCT00966875|589325691|FG005|Part B|Physician Decision|1|||
163166464|NCT00966875|589325692|FG006|Part B|Physician Decision|0|||
163166465|NCT00966875|589325693|FG007|Part B|Physician Decision|0|||
163166466|NCT00966875|589325694|FG008|Part B|Physician Decision|2|||
163166467|NCT00966875|589325686|FG000|Part B|Sponsor Decision|1|||
163166468|NCT00966875|589325687|FG001|Part B|Sponsor Decision|0|||
163166469|NCT00966875|589325688|FG002|Part B|Sponsor Decision|0|||
163166470|NCT00966875|589325689|FG003|Part B|Sponsor Decision|0|||
163166471|NCT00966875|589325690|FG004|Part B|Sponsor Decision|0|||
163166472|NCT00966875|589325691|FG005|Part B|Sponsor Decision|1|||
163166473|NCT00966875|589325692|FG006|Part B|Sponsor Decision|0|||
163166474|NCT00966875|589325693|FG007|Part B|Sponsor Decision|2|||
163166475|NCT00966875|589325694|FG008|Part B|Sponsor Decision|1|||
163166476|NCT00966875|589325686|FG000|Part B|Withdrawal by Subject|2|||
163166477|NCT00966875|589325687|FG001|Part B|Withdrawal by Subject|1|||
163166478|NCT00966875|589325688|FG002|Part B|Withdrawal by Subject|2|||
163166479|NCT00966875|589325689|FG003|Part B|Withdrawal by Subject|1|||
163166480|NCT00966875|589325690|FG004|Part B|Withdrawal by Subject|2|||
163166481|NCT00966875|589325691|FG005|Part B|Withdrawal by Subject|1|||
163166482|NCT00966875|589325692|FG006|Part B|Withdrawal by Subject|4|||
163166483|NCT00966875|589325693|FG007|Part B|Withdrawal by Subject|5|||
163166484|NCT00966875|589325694|FG008|Part B|Withdrawal by Subject|5|||
163166485|NCT00966875|589325686|FG000|Part B|Entry Criteria|0|||
163166486|NCT00966875|589325687|FG001|Part B|Entry Criteria|0|||
163166487|NCT00966875|589325688|FG002|Part B|Entry Criteria|0|||
163166488|NCT00966875|589325689|FG003|Part B|Entry Criteria|0|||
163166489|NCT00966875|589325690|FG004|Part B|Entry Criteria|0|||
163166490|NCT00966875|589325691|FG005|Part B|Entry Criteria|0|||
163166491|NCT00966875|589325692|FG006|Part B|Entry Criteria|1|||
163166492|NCT00966875|589325693|FG007|Part B|Entry Criteria|0|||
163166493|NCT00966875|589325694|FG008|Part B|Entry Criteria|1|||
163166494|NCT00689117|589325695|FG000|Overall Study|Adverse Event|6|||
163166495|NCT00689117|589325696|FG001|Overall Study|Adverse Event|0|||
163166496|NCT00689117|589325697|FG002|Overall Study|Adverse Event|5|||
163166497|NCT00689117|589325698|FG003|Overall Study|Adverse Event|0|||
163166498|NCT00689117|589325695|FG000|Overall Study|Lost to Follow-up|26|||
163166499|NCT00689117|589325696|FG001|Overall Study|Lost to Follow-up|19|||
163166500|NCT00689117|589325697|FG002|Overall Study|Lost to Follow-up|17|||
163166501|NCT00689117|589325698|FG003|Overall Study|Lost to Follow-up|11|||
163166502|NCT00689117|589325695|FG000|Overall Study|Lack of Efficacy|1|||
163166503|NCT00689117|589325696|FG001|Overall Study|Lack of Efficacy|2|||
163166504|NCT00689117|589325697|FG002|Overall Study|Lack of Efficacy|2|||
163166505|NCT00689117|589325698|FG003|Overall Study|Lack of Efficacy|2|||
163166506|NCT00689117|589325695|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
163166507|NCT00689117|589325696|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
163166508|NCT00689117|589325697|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
163166509|NCT00689117|589325698|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
163166510|NCT00689117|589325695|FG000|Overall Study|Withdrawal by Subject|19|||
163166511|NCT00689117|589325696|FG001|Overall Study|Withdrawal by Subject|18|||
163166512|NCT00689117|589325697|FG002|Overall Study|Withdrawal by Subject|26|||
163166513|NCT00689117|589325698|FG003|Overall Study|Withdrawal by Subject|13|||
163166514|NCT00689117|589325695|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
163166515|NCT00689117|589325696|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
163166516|NCT00689117|589325697|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
163166517|NCT00689117|589325698|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
163166518|NCT00689117|589325695|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
163166519|NCT00689117|589325696|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
163166520|NCT00689117|589325697|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163166521|NCT00689117|589325698|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163166522|NCT00689117|589325695|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
163166523|NCT00689117|589325696|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
163166524|NCT00689117|589325697|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
163166525|NCT00689117|589325698|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
163166526|NCT00689117|589325695|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
163166527|NCT00689117|589325696|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
163166528|NCT00689117|589325697|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
163276726|NCT04320615|589723496|FG001|Overall Study|Other|0|||
163276727|NCT04320615|589723495|FG000|Overall Study|Lost to Follow-up|5|||
163166529|NCT00689117|589325698|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
163166530|NCT00689117|589325695|FG000|Overall Study|Use of Prohibitive Medication|2|||
163166531|NCT00689117|589325696|FG001|Overall Study|Use of Prohibitive Medication|1|||
163166532|NCT00689117|589325697|FG002|Overall Study|Use of Prohibitive Medication|3|||
163166533|NCT00689117|589325698|FG003|Overall Study|Use of Prohibitive Medication|0|||
163166534|NCT00689117|589325695|FG000|Overall Study|Pregnancy|0|||
163166535|NCT00689117|589325696|FG001|Overall Study|Pregnancy|2|||
163166536|NCT00689117|589325697|FG002|Overall Study|Pregnancy|0|||
163166537|NCT00689117|589325698|FG003|Overall Study|Pregnancy|2|||
163166538|NCT00689117|589325695|FG000|Overall Study|Incarceration|2|||
163166539|NCT00689117|589325696|FG001|Overall Study|Incarceration|0|||
163166540|NCT00689117|589325697|FG002|Overall Study|Incarceration|0|||
163276728|NCT04320615|589723496|FG001|Overall Study|Lost to Follow-up|23|||
163166541|NCT00689117|589325698|FG003|Overall Study|Incarceration|0|||
163166542|NCT00689117|589325695|FG000|Overall Study|Fear of Birth Defects|0|||
163166543|NCT00689117|589325696|FG001|Overall Study|Fear of Birth Defects|0|||
163166544|NCT00689117|589325697|FG002|Overall Study|Fear of Birth Defects|1|||
163166545|NCT00689117|589325698|FG003|Overall Study|Fear of Birth Defects|0|||
163166546|NCT00689117|589325695|FG000|Overall Study|Transportation|1|||
163166547|NCT00689117|589325696|FG001|Overall Study|Transportation|0|||
163166548|NCT00689117|589325697|FG002|Overall Study|Transportation|0|||
163166549|NCT00689117|589325698|FG003|Overall Study|Transportation|0|||
163166550|NCT00689117|589325695|FG000|Overall Study|Patient Withdrew from Study|0|||
163166551|NCT00689117|589325696|FG001|Overall Study|Patient Withdrew from Study|0|||
163166552|NCT00689117|589325697|FG002|Overall Study|Patient Withdrew from Study|0|||
163166553|NCT00689117|589325698|FG003|Overall Study|Patient Withdrew from Study|1|||
163166554|NCT00689117|589325695|FG000|Overall Study|Personal Reason|0|||
163166555|NCT00689117|589325696|FG001|Overall Study|Personal Reason|1|||
163166556|NCT00689117|589325697|FG002|Overall Study|Personal Reason|0|||
163166557|NCT00689117|589325698|FG003|Overall Study|Personal Reason|0|||
163166558|NCT00689117|589325695|FG000|Overall Study|Dispensing Error|0|||
163166559|NCT00689117|589325696|FG001|Overall Study|Dispensing Error|1|||
163166560|NCT00689117|589325697|FG002|Overall Study|Dispensing Error|0|||
163166561|NCT00689117|589325698|FG003|Overall Study|Dispensing Error|0|||
163166562|NCT00444678|589325701|FG000|Overall Study|Toxicity|11|||
163166563|NCT00444678|589325701|FG000|Overall Study|Disease Progression|12|||
163166564|NCT00444678|589325701|FG000|Overall Study|Death|3|||
163166565|NCT00444678|589325701|FG000|Overall Study|Physician Decision|3|||
163166566|NCT00444678|589325701|FG000|Overall Study|Withdrawal by Subject|2|||
163166567|NCT02597478|589325703|FG000|Overall Study|Withdrawal by Subject|2|||
163166568|NCT02597478|589325704|FG001|Overall Study|Withdrawal by Subject|0|||
163166569|NCT02597478|589325703|FG000|Overall Study|Change of opioid dose|1|||
163166570|NCT02597478|589325704|FG001|Overall Study|Change of opioid dose|0|||
163166571|NCT02597478|589325703|FG000|Overall Study|Insufficient exertional dyspnea|0|||
163166572|NCT02597478|589325704|FG001|Overall Study|Insufficient exertional dyspnea|1|||
163166573|NCT01305577|589325707|FG000|Overall Study|Adverse Event|2|||
163166574|NCT01305577|589325708|FG001|Overall Study|Adverse Event|2|||
163166575|NCT01305577|589325709|FG002|Overall Study|Adverse Event|1|||
163166576|NCT01305577|589325707|FG000|Overall Study|Withdrawal by Subject|7|||
163166577|NCT01305577|589325708|FG001|Overall Study|Withdrawal by Subject|5|||
163166578|NCT01305577|589325709|FG002|Overall Study|Withdrawal by Subject|6|||
163166579|NCT01305577|589325707|FG000|Overall Study|Lost to Follow-up|4|||
163166580|NCT01305577|589325708|FG001|Overall Study|Lost to Follow-up|3|||
163166581|NCT01305577|589325709|FG002|Overall Study|Lost to Follow-up|2|||
163166582|NCT01305577|589325707|FG000|Overall Study|Protocol Deviation|0|||
163166583|NCT01305577|589325708|FG001|Overall Study|Protocol Deviation|1|||
163166584|NCT01305577|589325709|FG002|Overall Study|Protocol Deviation|1|||
163166585|NCT00796978|589325710|FG000|Overall Study|Cardiac adverse event|5|||
163166586|NCT00796978|589325710|FG000|Overall Study|Adverse Event|4|||
163166587|NCT00796978|589325710|FG000|Overall Study|Withdrawal by Subject|3|||
163166588|NCT01256190|589325711|FG000|Overall Study|Lost to Follow-up|2|||
163166589|NCT01256190|589325712|FG001|Overall Study|Lost to Follow-up|0|||
163166590|NCT02834793|589325713|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
163166591|NCT02834793|589325714|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
163166592|NCT02834793|589325715|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
163166593|NCT02834793|589325716|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
163166594|NCT02834793|589325713|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
163166595|NCT02834793|589325714|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
163166596|NCT02834793|589325715|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
163166597|NCT02834793|589325716|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
163166598|NCT02834793|589325713|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
163166599|NCT02834793|589325714|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
163166600|NCT02834793|589325715|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
163166601|NCT02834793|589325716|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
163166602|NCT02834793|589325713|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
163276729|NCT04320615|589723495|FG000|Overall Study|Death|35|||
163166603|NCT02834793|589325714|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
163166604|NCT02834793|589325715|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
163166605|NCT02834793|589325716|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
163166606|NCT02834793|589325713|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
163166607|NCT02834793|589325714|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
163166608|NCT02834793|589325715|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
163166609|NCT02834793|589325716|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
163166610|NCT02834793|589325713|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
163166611|NCT02834793|589325714|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
163166612|NCT02834793|589325715|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
163166613|NCT02834793|589325716|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
163166614|NCT02834793|589325713|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
163166615|NCT02834793|589325714|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
163166616|NCT02834793|589325715|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
163166617|NCT02834793|589325716|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
163166618|NCT02834793|589325713|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
163166619|NCT02834793|589325714|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
163166620|NCT02834793|589325715|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
163166621|NCT02834793|589325716|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
163166622|NCT02834793|589325713|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
163166623|NCT02834793|589325714|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
163166624|NCT02834793|589325715|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
163166625|NCT02834793|589325716|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
163166626|NCT02834793|589325713|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
163166627|NCT02834793|589325714|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
163166628|NCT02834793|589325715|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
163166629|NCT02834793|589325716|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
163166630|NCT02834793|589325713|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
163166631|NCT02834793|589325714|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
163166632|NCT02834793|589325715|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
163166633|NCT02834793|589325716|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
163166634|NCT02834793|589325713|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
163166635|NCT02834793|589325714|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
163166636|NCT02834793|589325715|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
163166637|NCT02834793|589325716|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
163166638|NCT02834793|589325713|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
163166639|NCT02834793|589325714|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
163166640|NCT02834793|589325715|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
163166641|NCT02834793|589325716|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
163166642|NCT02834793|589325713|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
163166643|NCT02834793|589325714|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
163166644|NCT02834793|589325715|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
163166645|NCT02834793|589325716|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
163166646|NCT02834793|589325713|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
163166647|NCT02834793|589325714|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
163166648|NCT02834793|589325715|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
163166649|NCT02834793|589325716|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
163166650|NCT02364336|589325717|FG000|Overall Study|Adverse Event|0|||
163166651|NCT02364336|589325718|FG001|Overall Study|Adverse Event|1|||
163166652|NCT01731938|589325719|FG000|Preliminary Part I|Withdrawal by Subject|2|||
163166653|NCT01731938|589325720|FG001|Preliminary Part I|Withdrawal by Subject|2|||
163166654|NCT01731938|589325719|FG000|Preliminary Part I|Physician Decision|1|||
163166655|NCT01731938|589325720|FG001|Preliminary Part I|Physician Decision|0|||
163166656|NCT01731938|589325719|FG000|Preliminary Part I|Lost to Follow-up|0|||
163166657|NCT01731938|589325720|FG001|Preliminary Part I|Lost to Follow-up|3|||
163166658|NCT01731938|589325719|FG000|Preliminary Part I|Missed Week 6 visit|0|||
163166659|NCT01731938|589325720|FG001|Preliminary Part I|Missed Week 6 visit|3|||
163166660|NCT01731938|589325719|FG000|Primary Part II|Withdrawal by Subject|5|||
163276730|NCT04320615|589723496|FG001|Overall Study|Death|71|||
163276731|NCT03873246|589723498|FG000|Overall Study|Adverse Event|1|||
163276732|NCT03873246|589723499|FG001|Overall Study|Adverse Event|3|||
163166661|NCT01731938|589325720|FG001|Primary Part II|Withdrawal by Subject|4|||
163166662|NCT01731938|589325719|FG000|Primary Part II|Lost to Follow-up|4|||
163166663|NCT01731938|589325720|FG001|Primary Part II|Lost to Follow-up|5|||
163166664|NCT01731938|589325719|FG000|Primary Part II|Death|2|||
163166665|NCT01731938|589325720|FG001|Primary Part II|Death|1|||
163166666|NCT01731938|589325719|FG000|Primary Part II|Missed Week 6 visit|2|||
163166667|NCT01731938|589325720|FG001|Primary Part II|Missed Week 6 visit|3|||
163166668|NCT03319745|589325721|FG000|Overall Study|Death|1|||
163166669|NCT03319745|589325721|FG000|Overall Study|Toxicity Precluding Surgery|1|||
163166670|NCT00870103|589325722|FG000|Overall Study|Physician Decision|2|||
163166671|NCT00870103|589325722|FG000|Overall Study|Lost to Follow-up|2|||
163166672|NCT01317550|589325723|FG000|Overall Study|Withdrawal by Subject|1|||
163166673|NCT01317550|589325724|FG001|Overall Study|Withdrawal by Subject|0|||
163166674|NCT01317550|589325725|FG002|Overall Study|Withdrawal by Subject|0|||
163166675|NCT01317550|589325726|FG003|Overall Study|Withdrawal by Subject|0|||
163166676|NCT01317550|589325723|FG000|Overall Study|Lack of compliance study med|1|||
163166677|NCT01317550|589325724|FG001|Overall Study|Lack of compliance study med|0|||
163166678|NCT01317550|589325725|FG002|Overall Study|Lack of compliance study med|0|||
163166679|NCT01317550|589325726|FG003|Overall Study|Lack of compliance study med|0|||
163276733|NCT03873246|589723500|FG002|Overall Study|Adverse Event|3|||
163276734|NCT03873246|589723498|FG000|Overall Study|Lost to Follow-up|4|||
163166680|NCT03179202|589325727|FG000|Overall Study|Screen Failure|67|||
163166681|NCT03179202|589325727|FG000|Overall Study|Subject Lost to Follow Up|12|||
163166682|NCT03179202|589325727|FG000|Overall Study|Withdrawal by Subject|7|||
163166683|NCT03179202|589325727|FG000|Overall Study|Adverse Event|3|||
163166684|NCT03179202|589325727|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
163166685|NCT03179202|589325727|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
163166686|NCT03255629|589325728|FG000|Overall Study|Adverse Event|1|||
163166687|NCT03255629|589325729|FG001|Overall Study|Adverse Event|0|||
163166688|NCT03255629|589325728|FG000|Overall Study|did not experience hypoglycemia|2|||
163166689|NCT03255629|589325729|FG001|Overall Study|did not experience hypoglycemia|1|||
163166690|NCT04540198|589325730|FG000|Overall Study|Lost to Follow-up|25|||
163166691|NCT04540198|589325731|FG001|Overall Study|Lost to Follow-up|23|||
163166692|NCT04540198|589325730|FG000|Overall Study|Withdrawal by Subject|15|||
163166693|NCT04540198|589325731|FG001|Overall Study|Withdrawal by Subject|9|||
163166694|NCT04540198|589325730|FG000|Overall Study|Discontinued|1|||
163166695|NCT04540198|589325731|FG001|Overall Study|Discontinued|0|||
163166696|NCT02779556|589325732|FG000|Baseline|Partial baseline interview completed|1|||
163166697|NCT02779556|589325733|FG001|Baseline|Partial baseline interview completed|0|||
163166698|NCT02779556|589325732|FG000|3 Months|Lost to Follow-up|40|||
163166699|NCT02779556|589325733|FG001|3 Months|Lost to Follow-up|29|||
163166700|NCT02779556|589325732|FG000|3 Months|Missed 3 month clinic visit|27|||
163166701|NCT02779556|589325733|FG001|3 Months|Missed 3 month clinic visit|19|||
163166702|NCT02779556|589325732|FG000|6 Month|Lost to Follow-up|33|||
163166703|NCT02779556|589325733|FG001|6 Month|Lost to Follow-up|39|||
163166704|NCT02779556|589325732|FG000|6 Month HbA1c|No value collected during window|69|||
163166705|NCT02779556|589325733|FG001|6 Month HbA1c|No value collected during window|50|||
163166706|NCT02779556|589325732|FG000|12 Month HbA1c|No value collected during window|138|||
163166707|NCT02779556|589325733|FG001|12 Month HbA1c|No value collected during window|102|||
163166708|NCT03110770|589325735|FG000|Overall Study|Death|1|||
163166709|NCT03110770|589325736|FG001|Overall Study|Death|0|||
163166710|NCT03110770|589325737|FG002|Overall Study|Death|0|||
163166711|NCT03110770|589325738|FG003|Overall Study|Death|1|||
163166712|NCT03110770|589325739|FG004|Overall Study|Death|0|||
163166713|NCT03110770|589325735|FG000|Overall Study|Enrolled but did not receive product|0|||
163166714|NCT03110770|589325736|FG001|Overall Study|Enrolled but did not receive product|0|||
163166715|NCT03110770|589325737|FG002|Overall Study|Enrolled but did not receive product|0|||
163166716|NCT03110770|589325738|FG003|Overall Study|Enrolled but did not receive product|8|||
163166717|NCT03110770|589325739|FG004|Overall Study|Enrolled but did not receive product|7|||
163166718|NCT03110770|589325735|FG000|Overall Study|Lost to Follow-up|0|||
163166719|NCT03110770|589325736|FG001|Overall Study|Lost to Follow-up|0|||
163166720|NCT03110770|589325737|FG002|Overall Study|Lost to Follow-up|0|||
163166721|NCT03110770|589325738|FG003|Overall Study|Lost to Follow-up|53|||
163166722|NCT03110770|589325739|FG004|Overall Study|Lost to Follow-up|45|||
163166723|NCT03110770|589325735|FG000|Overall Study|Investigator Decision|0|||
163166724|NCT03110770|589325736|FG001|Overall Study|Investigator Decision|0|||
163166725|NCT03110770|589325737|FG002|Overall Study|Investigator Decision|0|||
163166726|NCT03110770|589325738|FG003|Overall Study|Investigator Decision|5|||
163166727|NCT03110770|589325739|FG004|Overall Study|Investigator Decision|3|||
163166728|NCT03110770|589325735|FG000|Overall Study|Withdrawal by Subject|0|||
163166729|NCT03110770|589325736|FG001|Overall Study|Withdrawal by Subject|0|||
163166730|NCT03110770|589325737|FG002|Overall Study|Withdrawal by Subject|0|||
163166731|NCT03110770|589325738|FG003|Overall Study|Withdrawal by Subject|24|||
163166732|NCT03110770|589325739|FG004|Overall Study|Withdrawal by Subject|24|||
163166733|NCT03110770|589325735|FG000|Overall Study|Moved from area|5|||
163166734|NCT03110770|589325736|FG001|Overall Study|Moved from area|0|||
163166735|NCT03110770|589325737|FG002|Overall Study|Moved from area|2|||
163166736|NCT03110770|589325738|FG003|Overall Study|Moved from area|42|||
163166737|NCT03110770|589325739|FG004|Overall Study|Moved from area|43|||
163166738|NCT03110770|589325735|FG000|Overall Study|Illness/Injury unrelated to product|0|||
163166739|NCT03110770|589325736|FG001|Overall Study|Illness/Injury unrelated to product|0|||
163166740|NCT03110770|589325737|FG002|Overall Study|Illness/Injury unrelated to product|0|||
163166741|NCT03110770|589325738|FG003|Overall Study|Illness/Injury unrelated to product|0|||
163166742|NCT03110770|589325739|FG004|Overall Study|Illness/Injury unrelated to product|1|||
163166743|NCT01086358|589325742|FG000|First Intervention|Lost to Follow-up|9|||
163166744|NCT01086358|589325743|FG001|First Intervention|Lost to Follow-up|4|||
163166745|NCT01086358|589325742|FG000|First Intervention|Withdrawal by Subject|0|||
163166746|NCT01086358|589325743|FG001|First Intervention|Withdrawal by Subject|1|||
163166747|NCT01086358|589325742|FG000|Second Intervention|Lost to Follow-up|4|||
163166748|NCT01086358|589325743|FG001|Second Intervention|Lost to Follow-up|4|||
163166749|NCT02888119|589325746|FG000|Overall Study|Lost to Follow-up|5|||
163166750|NCT02888119|589325747|FG001|Overall Study|Lost to Follow-up|4|||
163166751|NCT02888119|589325748|FG002|Overall Study|Lost to Follow-up|0|||
163166752|NCT05246514|589325752|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
163166753|NCT05246514|589325752|FG000|Overall Study|Withdrawal by Subject|1|||
163166754|NCT05246514|589325752|FG000|Overall Study|Death|13|||
163166755|NCT01802073|589325753|FG000|Overall Study|Lost to Follow-up|0|||
163166756|NCT01802073|589325754|FG001|Overall Study|Lost to Follow-up|1|||
163166757|NCT01802073|589325753|FG000|Overall Study|Non-compliant|4|||
163166758|NCT01802073|589325754|FG001|Overall Study|Non-compliant|2|||
163166759|NCT01802073|589325753|FG000|Overall Study|Withdrawal by Subject|1|||
163166760|NCT01802073|589325754|FG001|Overall Study|Withdrawal by Subject|1|||
163166761|NCT01802073|589325753|FG000|Overall Study|Physician Decision|0|||
163166762|NCT01802073|589325754|FG001|Overall Study|Physician Decision|7|||
163166763|NCT01297491|589325763|FG000|Overall Study|Adverse Event|11|||
163166764|NCT01297491|589325764|FG001|Overall Study|Adverse Event|6|||
163166765|NCT01297491|589325763|FG000|Overall Study|Physician Decision|3|||
163166766|NCT01297491|589325764|FG001|Overall Study|Physician Decision|2|||
163166767|NCT01297491|589325763|FG000|Overall Study|Progressive disease|11|||
163166768|NCT01297491|589325764|FG001|Overall Study|Progressive disease|20|||
163166769|NCT01297491|589325763|FG000|Overall Study|Patient/Guardian decision|3|||
163166770|NCT01297491|589325764|FG001|Overall Study|Patient/Guardian decision|4|||
163166771|NCT01297491|589325763|FG000|Overall Study|Death|2|||
163166772|NCT01297491|589325764|FG001|Overall Study|Death|1|||
163166773|NCT01327482|589325770|FG000|Overall Study|Adverse Event|1|||
163166774|NCT00312195|589325771|FG000|Overall Study|Adverse Event|4|||
163166775|NCT00312195|589325772|FG001|Overall Study|Adverse Event|6|||
163166776|NCT00312195|589325771|FG000|Overall Study|Lost to Follow-up|1|||
163166777|NCT00312195|589325772|FG001|Overall Study|Lost to Follow-up|0|||
163166778|NCT00312195|589325771|FG000|Overall Study|Protocol Violation|1|||
163166779|NCT00312195|589325772|FG001|Overall Study|Protocol Violation|0|||
163166780|NCT01018810|589325773|FG000|Overall Study|Withdrawal by Subject|0|||
163166781|NCT01018810|589325774|FG001|Overall Study|Withdrawal by Subject|1|||
163166782|NCT01018810|589325775|FG002|Overall Study|Withdrawal by Subject|0|||
163166783|NCT01018810|589325776|FG003|Overall Study|Withdrawal by Subject|0|||
163166784|NCT01018810|589325777|FG004|Overall Study|Withdrawal by Subject|0|||
163166785|NCT01018810|589325773|FG000|Overall Study|Sponsor Decision|2|||
163166786|NCT01018810|589325774|FG001|Overall Study|Sponsor Decision|0|||
163166787|NCT01018810|589325775|FG002|Overall Study|Sponsor Decision|1|||
163166788|NCT01018810|589325776|FG003|Overall Study|Sponsor Decision|1|||
163166789|NCT01018810|589325777|FG004|Overall Study|Sponsor Decision|1|||
163166790|NCT04145219|589325778|FG000|Overall Study|Adverse Event|18|||
163166791|NCT04145219|589325779|FG001|Overall Study|Adverse Event|6|||
163166792|NCT04145219|589325778|FG000|Overall Study|Lost to Follow-up|2|||
163166793|NCT04145219|589325779|FG001|Overall Study|Lost to Follow-up|3|||
163166794|NCT04145219|589325778|FG000|Overall Study|Physician Decision|0|||
163166795|NCT04145219|589325779|FG001|Overall Study|Physician Decision|2|||
163166796|NCT04145219|589325778|FG000|Overall Study|Withdrawal by Subject|12|||
163166797|NCT04145219|589325779|FG001|Overall Study|Withdrawal by Subject|8|||
163166798|NCT04145219|589325778|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
163166799|NCT04145219|589325779|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
163166800|NCT01031836|589327570|FG000|Stage I|Adverse Event|1|||
163166801|NCT01031836|589327571|FG001|Stage I|Adverse Event|1|||
163166802|NCT01031836|589327572|FG002|Stage I|Adverse Event|0|||
163166803|NCT01031836|589327573|FG003|Stage I|Adverse Event|0|||
163166804|NCT01031836|589327574|FG004|Stage I|Adverse Event|0|||
163166805|NCT01031836|589327575|FG005|Stage I|Adverse Event|0|||
163166806|NCT01031836|589327570|FG000|Stage I|Other|0|||
163166807|NCT01031836|589327571|FG001|Stage I|Other|1|||
163166808|NCT01031836|589327572|FG002|Stage I|Other|0|||
163166809|NCT01031836|589327573|FG003|Stage I|Other|0|||
163166810|NCT01031836|589327574|FG004|Stage I|Other|0|||
163166811|NCT01031836|589327575|FG005|Stage I|Other|1|||
163166812|NCT01031836|589327570|FG000|Stage II|Adverse Event|0|||
163166813|NCT01031836|589327571|FG001|Stage II|Adverse Event|0|||
163166814|NCT01031836|589327572|FG002|Stage II|Adverse Event|2|||
163166815|NCT01031836|589327573|FG003|Stage II|Adverse Event|2|||
163166816|NCT01031836|589327574|FG004|Stage II|Adverse Event|1|||
163166817|NCT01031836|589327575|FG005|Stage II|Adverse Event|1|||
163166818|NCT01031836|589327570|FG000|Stage II|Other|2|||
163166819|NCT01031836|589327571|FG001|Stage II|Other|0|||
163166820|NCT01031836|589327572|FG002|Stage II|Other|0|||
163166821|NCT01031836|589327573|FG003|Stage II|Other|1|||
163166822|NCT01031836|589327574|FG004|Stage II|Other|1|||
163166823|NCT01031836|589327575|FG005|Stage II|Other|0|||
163166824|NCT01888432|589327580|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
163166825|NCT01888432|589327581|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
163166826|NCT01888432|589327580|FG000|12-month Analysis (FAS)|Physician Decision|1|||
163166827|NCT01888432|589327581|FG001|12-month Analysis (FAS)|Physician Decision|1|||
163166828|NCT01888432|589327580|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
163166829|NCT01888432|589327581|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
163166830|NCT01888432|589327580|FG000|12-month Analysis (FAS)|Death|4|||
163166831|NCT01888432|589327581|FG001|12-month Analysis (FAS)|Death|3|||
163166832|NCT01888432|589327580|FG000|24-month Analysis (FAS)|Graft loss|0|||
163166833|NCT01888432|589327581|FG001|24-month Analysis (FAS)|Graft loss|1|||
163166834|NCT01888432|589327580|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
163166835|NCT01888432|589327581|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
163166836|NCT01888432|589327580|FG000|24-month Analysis (FAS)|Physician Decision|2|||
163166837|NCT01888432|589327581|FG001|24-month Analysis (FAS)|Physician Decision|4|||
163166838|NCT01888432|589327580|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
163166839|NCT01888432|589327581|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
163166840|NCT01888432|589327580|FG000|24-month Analysis (FAS)|Death|8|||
163166841|NCT01888432|589327581|FG001|24-month Analysis (FAS)|Death|4|||
163166842|NCT01888432|589327580|FG000|36-month Analysis (Extension)|Death|1|||
163166843|NCT01888432|589327581|FG001|36-month Analysis (Extension)|Death|0|||
163166844|NCT01794338|589327587|FG000|Overall Study|Death|2|||
163166845|NCT01794338|589327588|FG001|Overall Study|Death|0|||
163166846|NCT01794338|589327587|FG000|Overall Study|Lost to Follow-up|6|||
163166847|NCT01794338|589327588|FG001|Overall Study|Lost to Follow-up|9|||
163166848|NCT01754402|589327589|FG000|Overall Study|Death|0|||
163166849|NCT01754402|589327590|FG001|Overall Study|Death|0|||
163166850|NCT01754402|589327591|FG002|Overall Study|Death|1|||
163166851|NCT01754402|589327589|FG000|Overall Study|Adverse Event|2|||
163166852|NCT01754402|589327590|FG001|Overall Study|Adverse Event|2|||
163166853|NCT01754402|589327591|FG002|Overall Study|Adverse Event|1|||
163166854|NCT01754402|589327589|FG000|Overall Study|Withdrawal by Subject|0|||
163166855|NCT01754402|589327590|FG001|Overall Study|Withdrawal by Subject|0|||
163166856|NCT01754402|589327591|FG002|Overall Study|Withdrawal by Subject|1|||
163166857|NCT01754402|589327589|FG000|Overall Study|Lack of Efficacy|0|||
163166858|NCT01754402|589327590|FG001|Overall Study|Lack of Efficacy|0|||
163166859|NCT01754402|589327591|FG002|Overall Study|Lack of Efficacy|1|||
163166860|NCT01282463|589327592|FG000|Overall Study|Lost to Follow-up|1|||
163166861|NCT01282463|589327593|FG001|Overall Study|Lost to Follow-up|0|||
163166862|NCT01282463|589327594|FG002|Overall Study|Lost to Follow-up|0|||
163166863|NCT01282463|589327592|FG000|Overall Study|Withdrawal by Subject|6|||
163166864|NCT01282463|589327593|FG001|Overall Study|Withdrawal by Subject|2|||
163166865|NCT01282463|589327594|FG002|Overall Study|Withdrawal by Subject|3|||
163276735|NCT03873246|589723499|FG001|Overall Study|Lost to Follow-up|4|||
163166866|NCT01282463|589327592|FG000|Overall Study|"Never Treated Death"|0|||
163166867|NCT01282463|589327593|FG001|Overall Study|"Never Treated Death"|1|||
163166868|NCT01282463|589327594|FG002|Overall Study|"Never Treated Death"|0|||
163166869|NCT01282463|589327592|FG000|Overall Study|"Never Treated PD"|0|||
163166870|NCT01282463|589327593|FG001|Overall Study|"Never Treated PD"|1|||
163166871|NCT01282463|589327594|FG002|Overall Study|"Never Treated PD"|0|||
163166872|NCT01282463|589327592|FG000|Overall Study|Protocol Violation|0|||
163166873|NCT01282463|589327593|FG001|Overall Study|Protocol Violation|0|||
163166874|NCT01282463|589327594|FG002|Overall Study|Protocol Violation|1|||
163166875|NCT01282463|589327592|FG000|Overall Study|Physician Decision|1|||
163166876|NCT01282463|589327593|FG001|Overall Study|Physician Decision|0|||
163166877|NCT01282463|589327594|FG002|Overall Study|Physician Decision|0|||
163166878|NCT02051933|589327595|FG000|Overall Study|Physician Decision|0|||
163166879|NCT02051933|589327596|FG001|Overall Study|Physician Decision|1|||
163166880|NCT01954927|589327597|FG000|Overall Study|Withdrawal by Subject|3|||
163166881|NCT01954927|589327598|FG001|Overall Study|Withdrawal by Subject|1|||
163166882|NCT02156271|589327599|FG000|Overall Study|Physician Decision|4|||
163166883|NCT02156271|589327600|FG001|Overall Study|Physician Decision|3|||
163166884|NCT00955305|589327601|FG000|Overall Study|Disease progression|39|||
163166885|NCT00955305|589327602|FG001|Overall Study|Disease progression|41|||
163166886|NCT00955305|589327601|FG000|Overall Study|Adverse Event|22|||
163166887|NCT00955305|589327602|FG001|Overall Study|Adverse Event|22|||
163166888|NCT00955305|589327601|FG000|Overall Study|Death|2|||
163166889|NCT00955305|589327602|FG001|Overall Study|Death|1|||
163166890|NCT00955305|589327601|FG000|Overall Study|Withdrawal by Subject|5|||
163166891|NCT00955305|589327602|FG001|Overall Study|Withdrawal by Subject|4|||
163166892|NCT00955305|589327601|FG000|Overall Study|Alternative therapy|4|||
163166893|NCT00955305|589327602|FG001|Overall Study|Alternative therapy|0|||
163166894|NCT00955305|589327601|FG000|Overall Study|Other complicating disease|2|||
163166895|NCT00955305|589327602|FG001|Overall Study|Other complicating disease|4|||
163166896|NCT00955305|589327601|FG000|Overall Study|Physician Decision|1|||
163166897|NCT00955305|589327602|FG001|Overall Study|Physician Decision|0|||
163166898|NCT00955305|589327601|FG000|Overall Study|Continued presence of residual disease|0|||
163166899|NCT00955305|589327602|FG001|Overall Study|Continued presence of residual disease|1|||
163166900|NCT00955305|589327601|FG000|Overall Study|Functional decline|2|||
163166901|NCT00955305|589327602|FG001|Overall Study|Functional decline|0|||
163166902|NCT00955305|589327601|FG000|Overall Study|Maximum response achieved|0|||
163166903|NCT00955305|589327602|FG001|Overall Study|Maximum response achieved|1|||
163166904|NCT00955305|589327601|FG000|Overall Study|Lost to Follow-up|0|||
163166905|NCT00955305|589327602|FG001|Overall Study|Lost to Follow-up|1|||
163166906|NCT00955305|589327601|FG000|Overall Study|No off-treatment reason submitted|1|||
163166907|NCT00955305|589327602|FG001|Overall Study|No off-treatment reason submitted|0|||
163166908|NCT00955305|589327601|FG000|Overall Study|Never started protocol treatment|5|||
163166909|NCT00955305|589327602|FG001|Overall Study|Never started protocol treatment|5|||
163166910|NCT00955305|589327601|FG000|Overall Study|Ineligible|5|||
163166911|NCT00955305|589327602|FG001|Overall Study|Ineligible|7|||
163166912|NCT01221285|589327603|FG000|Overall Study|Withdrawal by Subject|1|||
163166913|NCT02123251|589327604|FG000|Overall Study|Death|1|||
163166914|NCT02123251|589327605|FG001|Overall Study|Death|1|||
163166915|NCT02123251|589327604|FG000|Overall Study|Withdrawal by Subject|0|||
163166916|NCT02123251|589327605|FG001|Overall Study|Withdrawal by Subject|3|||
163166917|NCT02123251|589327604|FG000|Overall Study|Lost Medicaid eligibility|29|||
163166918|NCT02123251|589327605|FG001|Overall Study|Lost Medicaid eligibility|22|||
163166919|NCT02123251|589327604|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
163166920|NCT02123251|589327605|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
163166921|NCT00375609|589327612|FG000|Overall Study|Did not receive treatment|1|||
163166922|NCT00375609|589327613|FG001|Overall Study|Did not receive treatment|0|||
163166923|NCT00375609|589327614|FG002|Overall Study|Did not receive treatment|0|||
163166924|NCT00375609|589327612|FG000|Overall Study|Adverse Event|0|||
163166925|NCT00375609|589327613|FG001|Overall Study|Adverse Event|3|||
163166926|NCT00375609|589327614|FG002|Overall Study|Adverse Event|0|||
163166927|NCT00375609|589327612|FG000|Overall Study|Lost to Follow-up|1|||
163166928|NCT00375609|589327613|FG001|Overall Study|Lost to Follow-up|0|||
163166929|NCT00375609|589327614|FG002|Overall Study|Lost to Follow-up|0|||
163166930|NCT00375609|589327612|FG000|Overall Study|Physician Decision|0|||
163166931|NCT00375609|589327613|FG001|Overall Study|Physician Decision|0|||
163166932|NCT00375609|589327614|FG002|Overall Study|Physician Decision|1|||
163166933|NCT00375609|589327612|FG000|Overall Study|Withdrawal by Subject|1|||
163166934|NCT00375609|589327613|FG001|Overall Study|Withdrawal by Subject|4|||
163166935|NCT00375609|589327614|FG002|Overall Study|Withdrawal by Subject|0|||
163166936|NCT00375609|589327612|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
163166937|NCT00375609|589327613|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
163166938|NCT00375609|589327614|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
163166939|NCT02338882|589327615|FG000|Overall Study|Death|1|||
163166940|NCT02338882|589327616|FG001|Overall Study|Death|0|||
163166941|NCT02338882|589327615|FG000|Overall Study|Lost to Follow-up|6|||
163166942|NCT02338882|589327616|FG001|Overall Study|Lost to Follow-up|3|||
163166943|NCT02184455|589327617|FG000|Overall Study|Lost to Follow-up|1|||
163166944|NCT00617669|589327624|FG000|Overall Study|Withdrawal by Subject|71|||
163166945|NCT00617669|589327625|FG001|Overall Study|Withdrawal by Subject|77|||
163166946|NCT00617669|589327624|FG000|Overall Study|Lost to Follow-up|3|||
163166947|NCT00617669|589327625|FG001|Overall Study|Lost to Follow-up|2|||
163166948|NCT00617669|589327624|FG000|Overall Study|Adverse Event|87|||
163166949|NCT00617669|589327625|FG001|Overall Study|Adverse Event|76|||
163166950|NCT00617669|589327624|FG000|Overall Study|Protocol Violation|2|||
163166951|NCT00617669|589327625|FG001|Overall Study|Protocol Violation|3|||
163166952|NCT00617669|589327624|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
163166953|NCT00617669|589327625|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
163166954|NCT00617669|589327624|FG000|Overall Study|Patients randomized but not treated|2|||
163166955|NCT00617669|589327625|FG001|Overall Study|Patients randomized but not treated|3|||
163166956|NCT00926029|589327626|FG000|Overall Study|Lost to Follow-up|2|||
163166957|NCT00926029|589327627|FG001|Overall Study|Lost to Follow-up|1|||
163166958|NCT00926029|589327628|FG002|Overall Study|Lost to Follow-up|1|||
163166959|NCT03206788|589327629|FG000|Overall Study|Withdrawal by Subject|0|||
163166960|NCT03206788|589327630|FG001|Overall Study|Withdrawal by Subject|1|||
163166961|NCT03206788|589327629|FG000|Overall Study|Adverse Event|0|||
163166962|NCT03206788|589327630|FG001|Overall Study|Adverse Event|1|||
163166963|NCT03206788|589327629|FG000|Overall Study|Physician Decision|0|||
163166964|NCT03206788|589327630|FG001|Overall Study|Physician Decision|1|||
163166965|NCT02082340|589327631|FG000|Overall Study|Lost to Follow-up|1|||
163166966|NCT02082340|589327632|FG001|Overall Study|Lost to Follow-up|1|||
163166967|NCT00833417|589327633|FG000|Overall Study|Adverse Event|5|||
163166968|NCT00833417|589327634|FG001|Overall Study|Adverse Event|16|||
163166969|NCT00833417|589327633|FG000|Overall Study|Death|1|||
163166970|NCT00833417|589327634|FG001|Overall Study|Death|3|||
163166971|NCT00833417|589327633|FG000|Overall Study|Lost to Follow-up|1|||
163166972|NCT00833417|589327634|FG001|Overall Study|Lost to Follow-up|2|||
163166973|NCT00833417|589327633|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
163166974|NCT00833417|589327634|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
163166975|NCT00833417|589327633|FG000|Overall Study|Patient Decision to Withdraw|4|||
163166976|NCT00833417|589327634|FG001|Overall Study|Patient Decision to Withdraw|23|||
163166977|NCT00833417|589327633|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
163166978|NCT00833417|589327634|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
163166979|NCT00833417|589327633|FG000|Overall Study|Disease Progression|18|||
163166980|NCT00833417|589327634|FG001|Overall Study|Disease Progression|17|||
163166981|NCT00833417|589327633|FG000|Overall Study|Reason Not Specified|0|||
163166982|NCT00833417|589327634|FG001|Overall Study|Reason Not Specified|1|||
163166983|NCT01625260|589327635|FG000|Overall Study|Adverse Event|3|||
163166984|NCT01625260|589327636|FG001|Overall Study|Adverse Event|0|||
163166985|NCT01625260|589327635|FG000|Overall Study|Study Terminated by Investigator|2|||
163166986|NCT01625260|589327636|FG001|Overall Study|Study Terminated by Investigator|0|||
163166987|NCT01625260|589327635|FG000|Overall Study|Disease Progression|2|||
163166988|NCT01625260|589327636|FG001|Overall Study|Disease Progression|0|||
163166989|NCT01625260|589327635|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
163166990|NCT01625260|589327636|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
163166991|NCT05573386|589327637|FG000|Overall Study|Withdrawal by Subject|3|||
163166992|NCT05573386|589327638|FG001|Overall Study|Withdrawal by Subject|2|||
163166993|NCT03899805|589327639|FG000|Overall Study|Physician Decision|3|||
163166994|NCT03899805|589327640|FG001|Overall Study|Physician Decision|0|||
163166995|NCT03899805|589327641|FG002|Overall Study|Physician Decision|2|||
163166996|NCT03899805|589327639|FG000|Overall Study|Withdrawal by Subject|1|||
163166997|NCT03899805|589327640|FG001|Overall Study|Withdrawal by Subject|0|||
163166998|NCT03899805|589327641|FG002|Overall Study|Withdrawal by Subject|2|||
163166999|NCT03899805|589327639|FG000|Overall Study|Progressive Disease|10|||
163167000|NCT03899805|589327640|FG001|Overall Study|Progressive Disease|18|||
163167001|NCT03899805|589327641|FG002|Overall Study|Progressive Disease|12|||
163167002|NCT03899805|589327639|FG000|Overall Study|Adverse Event|3|||
163167003|NCT03899805|589327640|FG001|Overall Study|Adverse Event|1|||
163167004|NCT03899805|589327641|FG002|Overall Study|Adverse Event|0|||
163167005|NCT03899805|589327639|FG000|Overall Study|Death|2|||
163167006|NCT03899805|589327640|FG001|Overall Study|Death|0|||
163167007|NCT03899805|589327641|FG002|Overall Study|Death|0|||
163167008|NCT03899805|589327639|FG000|Overall Study|Came off for surgery|0|||
163167009|NCT03899805|589327640|FG001|Overall Study|Came off for surgery|0|||
163167010|NCT03899805|589327641|FG002|Overall Study|Came off for surgery|1|||
163167011|NCT04195893|589327642|FG000|Second Intervention|Withdrawal by Subject|1|||
163167012|NCT04195893|589327643|FG001|Second Intervention|Withdrawal by Subject|0|||
163167013|NCT01137604|589327649|FG000|Overall Study|Adverse Event|3|||
163167014|NCT01137604|589327650|FG001|Overall Study|Adverse Event|6|||
163167015|NCT01137604|589327651|FG002|Overall Study|Adverse Event|9|||
163167016|NCT01137604|589327652|FG003|Overall Study|Adverse Event|9|||
163167017|NCT01137604|589327649|FG000|Overall Study|Participant Choice|0|||
163167018|NCT01137604|589327650|FG001|Overall Study|Participant Choice|2|||
163167019|NCT01137604|589327651|FG002|Overall Study|Participant Choice|2|||
163167020|NCT01137604|589327652|FG003|Overall Study|Participant Choice|0|||
163167021|NCT01137604|589327649|FG000|Overall Study|Withdrawal of consent|0|||
163167022|NCT01137604|589327650|FG001|Overall Study|Withdrawal of consent|0|||
163167023|NCT01137604|589327651|FG002|Overall Study|Withdrawal of consent|0|||
163167024|NCT01137604|589327652|FG003|Overall Study|Withdrawal of consent|2|||
163167025|NCT01137604|589327649|FG000|Overall Study|Clinical progression/deterioration|1|||
163167026|NCT01137604|589327650|FG001|Overall Study|Clinical progression/deterioration|2|||
163167027|NCT01137604|589327651|FG002|Overall Study|Clinical progression/deterioration|2|||
163167028|NCT01137604|589327652|FG003|Overall Study|Clinical progression/deterioration|0|||
163167029|NCT01776307|589327653|FG000|Overall Study|Not dosed|0|||
163167030|NCT01776307|589327654|FG001|Overall Study|Not dosed|0|||
163167031|NCT01776307|589327655|FG002|Overall Study|Not dosed|1|||
163167032|NCT00567255|589327656|FG000|Overall Study|Adverse Event|241|||
163167033|NCT00567255|589327657|FG001|Overall Study|Adverse Event|68|||
163167034|NCT00567255|589327656|FG000|Overall Study|Lost to Follow-up|77|||
163167035|NCT00567255|589327657|FG001|Overall Study|Lost to Follow-up|48|||
163167036|NCT00567255|589327656|FG000|Overall Study|Withdrawal by Subject|75|||
163167037|NCT00567255|589327657|FG001|Overall Study|Withdrawal by Subject|56|||
163167038|NCT00567255|589327656|FG000|Overall Study|Lack of Efficacy|19|||
163167039|NCT00567255|589327657|FG001|Overall Study|Lack of Efficacy|33|||
163167040|NCT00567255|589327656|FG000|Overall Study|Protocol Violation|20|||
163167041|NCT00567255|589327657|FG001|Overall Study|Protocol Violation|8|||
163167042|NCT00567255|589327656|FG000|Overall Study|Pregnancy|6|||
163167043|NCT00567255|589327657|FG001|Overall Study|Pregnancy|0|||
163167044|NCT00567255|589327656|FG000|Overall Study|Drug noncompliance,moved,other|25|||
163167045|NCT00567255|589327657|FG001|Overall Study|Drug noncompliance,moved,other|15|||
163167046|NCT03672097|589327660|FG000|Period 1|Withdrawal by Subject|2|||
163167047|NCT03672097|589327660|FG000|Period 1|Adverse Event|1|||
163167048|NCT03672097|589327660|FG000|Period 1|Did not receive treatment|1|||
163167049|NCT03672097|589327660|FG000|Period 2|Withdrawal by Subject|3|||
163167050|NCT03672097|589327660|FG000|Period 2|Other|1|||
163167051|NCT01459497|589327661|FG000|Overall Study|Inability to meet trial constraints.|1|||
163167052|NCT01459497|589327662|FG001|Overall Study|Inability to meet trial constraints.|0|||
163167053|NCT01459497|589327661|FG000|Overall Study|Physician Decision|1|||
163167054|NCT01459497|589327662|FG001|Overall Study|Physician Decision|1|||
163167055|NCT01459497|589327661|FG000|Overall Study|Hospitalization.|0|||
163167056|NCT01459497|589327662|FG001|Overall Study|Hospitalization.|3|||
163167057|NCT01459497|589327661|FG000|Overall Study|Disease progression.|0|||
163167058|NCT01459497|589327662|FG001|Overall Study|Disease progression.|1|||
163167059|NCT00080899|589327663|FG000|Overall Study|Adverse Event|1|||
163167060|NCT02872935|589327664|FG000|Overall Study|Other|0|||
163167061|NCT02872935|589327665|FG001|Overall Study|Other|1|||
163167062|NCT03530124|589327666|FG000|Overall Study|Withdrawal by Subject|0|||
163167063|NCT03530124|589327667|FG001|Overall Study|Withdrawal by Subject|1|||
163167064|NCT03530124|589327666|FG000|Overall Study|Protocol Violation|1|||
163167065|NCT03530124|589327667|FG001|Overall Study|Protocol Violation|0|||
163167066|NCT03530124|589327666|FG000|Overall Study|Discharged prior to study completion|1|||
163167067|NCT03530124|589327667|FG001|Overall Study|Discharged prior to study completion|0|||
163167068|NCT05343624|589327668|FG000|Overall Study|Chart review not completed|1|||
163167069|NCT00862082|589327669|FG000|Overall Study|Sponsor decision to terminate the study|5|||
163167070|NCT00862082|589327670|FG001|Overall Study|Sponsor decision to terminate the study|0|||
163167071|NCT00862082|589327669|FG000|Overall Study|Withdrawal by Subject|0|||
163167072|NCT00862082|589327670|FG001|Overall Study|Withdrawal by Subject|1|||
163167073|NCT02791763|589327674|FG000|Overall Study|Protocol Violation|0|||
163167074|NCT02791763|589327675|FG001|Overall Study|Protocol Violation|0|||
163167075|NCT02791763|589327676|FG002|Overall Study|Protocol Violation|1|||
163167076|NCT02791763|589327674|FG000|Overall Study|Withdrawal by Subject|5|||
163167077|NCT02791763|589327675|FG001|Overall Study|Withdrawal by Subject|1|||
163167078|NCT02791763|589327676|FG002|Overall Study|Withdrawal by Subject|0|||
163167079|NCT02791763|589327674|FG000|Overall Study|Physician Decision|0|||
163167080|NCT02791763|589327675|FG001|Overall Study|Physician Decision|1|||
163167081|NCT02791763|589327676|FG002|Overall Study|Physician Decision|0|||
163167082|NCT02791763|589327674|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
163167083|NCT02791763|589327675|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
163167084|NCT02791763|589327676|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
163167085|NCT02791763|589327674|FG000|Overall Study|Cancer event|1|||
163167086|NCT02791763|589327675|FG001|Overall Study|Cancer event|3|||
163167087|NCT02791763|589327676|FG002|Overall Study|Cancer event|0|||
163276736|NCT03873246|589723500|FG002|Overall Study|Lost to Follow-up|5|||
163167088|NCT02791763|589327674|FG000|Overall Study|Participant had renal transplant|3|||
163167089|NCT02791763|589327675|FG001|Overall Study|Participant had renal transplant|0|||
163167090|NCT02791763|589327676|FG002|Overall Study|Participant had renal transplant|0|||
163167091|NCT02791763|589327674|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
163167092|NCT02791763|589327675|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
163167093|NCT02791763|589327676|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
163167094|NCT02791763|589327674|FG000|Overall Study|Adverse Event|12|||
163167095|NCT02791763|589327675|FG001|Overall Study|Adverse Event|13|||
163167096|NCT02791763|589327676|FG002|Overall Study|Adverse Event|7|||
163167097|NCT05334212|589327677|FG000|Overall Study|Study terminated prematurely|7|||
163167098|NCT00910299|589327678|FG000|Overall Study|Withdrawal by Subject|16|||
163167099|NCT00910299|589327679|FG001|Overall Study|Withdrawal by Subject|13|||
163167100|NCT00910299|589327678|FG000|Overall Study|Sponsor Decision|58|||
163167101|NCT00910299|589327679|FG001|Overall Study|Sponsor Decision|60|||
163167102|NCT00910299|589327678|FG000|Overall Study|Didn't receive any study drug|2|||
163167103|NCT00910299|589327679|FG001|Overall Study|Didn't receive any study drug|1|||
163167104|NCT01456897|589327680|FG000|Overall Study|Adverse Event|19|||
163167105|NCT01456897|589327681|FG001|Overall Study|Adverse Event|22|||
163167106|NCT01456897|589327680|FG000|Overall Study|Protocol Violation|3|||
163167107|NCT01456897|589327681|FG001|Overall Study|Protocol Violation|4|||
163167108|NCT01456897|589327680|FG000|Overall Study|Physician Decision|5|||
163167109|NCT01456897|589327681|FG001|Overall Study|Physician Decision|3|||
163167110|NCT01456897|589327680|FG000|Overall Study|Withdrawal by Subject|44|||
163167111|NCT01456897|589327681|FG001|Overall Study|Withdrawal by Subject|17|||
163167112|NCT01456897|589327680|FG000|Overall Study|Lack of Efficacy|4|||
163167113|NCT01456897|589327681|FG001|Overall Study|Lack of Efficacy|11|||
163167114|NCT04535453|589327682|FG000|Overall Study|Death|0|||
163167115|NCT04535453|589327683|FG001|Overall Study|Death|1|||
163167116|NCT04535453|589327684|FG002|Overall Study|Death|0|||
163167117|NCT04535453|589327685|FG003|Overall Study|Death|0|||
163167118|NCT04535453|589327686|FG004|Overall Study|Death|0|||
163167119|NCT04535453|589327687|FG005|Overall Study|Death|0|||
163167120|NCT04535453|589327688|FG006|Overall Study|Death|0|||
163167121|NCT04535453|589327689|FG007|Overall Study|Death|0|||
163167122|NCT04535453|589327690|FG008|Overall Study|Death|0|||
163167123|NCT04535453|589327691|FG009|Overall Study|Death|0|||
163167124|NCT04535453|589327692|FG010|Overall Study|Death|0|||
163167125|NCT04535453|589327693|FG011|Overall Study|Death|0|||
163167126|NCT04535453|589327682|FG000|Overall Study|Lost to Follow-up|1|||
163167127|NCT04535453|589327683|FG001|Overall Study|Lost to Follow-up|1|||
163167128|NCT04535453|589327684|FG002|Overall Study|Lost to Follow-up|1|||
163167129|NCT04535453|589327685|FG003|Overall Study|Lost to Follow-up|0|||
163167130|NCT04535453|589327686|FG004|Overall Study|Lost to Follow-up|3|||
163167131|NCT04535453|589327687|FG005|Overall Study|Lost to Follow-up|1|||
163167132|NCT04535453|589327688|FG006|Overall Study|Lost to Follow-up|0|||
163167133|NCT04535453|589327689|FG007|Overall Study|Lost to Follow-up|0|||
163167134|NCT04535453|589327690|FG008|Overall Study|Lost to Follow-up|1|||
163167135|NCT04535453|589327691|FG009|Overall Study|Lost to Follow-up|1|||
163167136|NCT04535453|589327692|FG010|Overall Study|Lost to Follow-up|0|||
163167137|NCT04535453|589327693|FG011|Overall Study|Lost to Follow-up|0|||
163167138|NCT04535453|589327682|FG000|Overall Study|Physician Decision|0|||
163167139|NCT04535453|589327683|FG001|Overall Study|Physician Decision|0|||
163167140|NCT04535453|589327684|FG002|Overall Study|Physician Decision|0|||
163167141|NCT04535453|589327685|FG003|Overall Study|Physician Decision|1|||
163167142|NCT04535453|589327686|FG004|Overall Study|Physician Decision|0|||
163167143|NCT04535453|589327687|FG005|Overall Study|Physician Decision|0|||
163167144|NCT04535453|589327688|FG006|Overall Study|Physician Decision|0|||
163167145|NCT04535453|589327689|FG007|Overall Study|Physician Decision|0|||
163167146|NCT04535453|589327690|FG008|Overall Study|Physician Decision|0|||
163167147|NCT04535453|589327691|FG009|Overall Study|Physician Decision|0|||
163167148|NCT04535453|589327692|FG010|Overall Study|Physician Decision|0|||
163167149|NCT04535453|589327693|FG011|Overall Study|Physician Decision|0|||
163167150|NCT04535453|589327682|FG000|Overall Study|Withdrawal by Subject|3|||
163167151|NCT04535453|589327683|FG001|Overall Study|Withdrawal by Subject|6|||
163167152|NCT04535453|589327684|FG002|Overall Study|Withdrawal by Subject|3|||
163167153|NCT04535453|589327685|FG003|Overall Study|Withdrawal by Subject|3|||
163167154|NCT04535453|589327686|FG004|Overall Study|Withdrawal by Subject|2|||
163167155|NCT04535453|589327687|FG005|Overall Study|Withdrawal by Subject|1|||
163167156|NCT04535453|589327688|FG006|Overall Study|Withdrawal by Subject|1|||
163167157|NCT04535453|589327689|FG007|Overall Study|Withdrawal by Subject|1|||
163167158|NCT04535453|589327690|FG008|Overall Study|Withdrawal by Subject|1|||
163167159|NCT04535453|589327691|FG009|Overall Study|Withdrawal by Subject|1|||
163167160|NCT04535453|589327692|FG010|Overall Study|Withdrawal by Subject|0|||
163167161|NCT04535453|589327693|FG011|Overall Study|Withdrawal by Subject|1|||
163167162|NCT04535453|589327682|FG000|Overall Study|Other|0|||
163167163|NCT04535453|589327683|FG001|Overall Study|Other|0|||
163167164|NCT04535453|589327684|FG002|Overall Study|Other|1|||
163167165|NCT04535453|589327685|FG003|Overall Study|Other|0|||
163167166|NCT04535453|589327686|FG004|Overall Study|Other|1|||
163167167|NCT04535453|589327687|FG005|Overall Study|Other|0|||
163167168|NCT04535453|589327688|FG006|Overall Study|Other|1|||
163167169|NCT04535453|589327689|FG007|Overall Study|Other|1|||
163167170|NCT04535453|589327690|FG008|Overall Study|Other|1|||
163167171|NCT04535453|589327691|FG009|Overall Study|Other|0|||
163167172|NCT04535453|589327692|FG010|Overall Study|Other|0|||
163167173|NCT04535453|589327693|FG011|Overall Study|Other|0|||
163167174|NCT02878798|589327694|FG000|Overall Study|Withdrawal by Subject|5|||
163167175|NCT02878798|589327695|FG001|Overall Study|Withdrawal by Subject|4|||
163167176|NCT02878798|589327694|FG000|Overall Study|Lost to Follow-up|2|||
163167177|NCT02878798|589327695|FG001|Overall Study|Lost to Follow-up|2|||
163167178|NCT02878798|589327694|FG000|Overall Study|Protocol Violation|0|||
163167179|NCT02878798|589327695|FG001|Overall Study|Protocol Violation|1|||
163167180|NCT02762370|589327696|FG000|Overall Study|Protocol Violation|1|||
163167181|NCT02762370|589327697|FG001|Overall Study|Protocol Violation|0|||
163167182|NCT01708902|589327701|FG000|Overall Study|Adverse Event|3|||
163167183|NCT01708902|589327702|FG001|Overall Study|Adverse Event|4|||
163167184|NCT01708902|589327703|FG002|Overall Study|Adverse Event|9|||
163167185|NCT01708902|589327704|FG003|Overall Study|Adverse Event|2|||
163167186|NCT01708902|589327705|FG004|Overall Study|Adverse Event|7|||
163167187|NCT01708902|589327706|FG005|Overall Study|Adverse Event|3|||
163167188|NCT01708902|589327707|FG006|Overall Study|Adverse Event|5|||
163167189|NCT01708902|589327701|FG000|Overall Study|Lack of Efficacy|3|||
163167190|NCT01708902|589327702|FG001|Overall Study|Lack of Efficacy|1|||
163167191|NCT01708902|589327703|FG002|Overall Study|Lack of Efficacy|0|||
163167192|NCT01708902|589327704|FG003|Overall Study|Lack of Efficacy|0|||
163167193|NCT01708902|589327705|FG004|Overall Study|Lack of Efficacy|0|||
163167194|NCT01708902|589327706|FG005|Overall Study|Lack of Efficacy|1|||
163167195|NCT01708902|589327707|FG006|Overall Study|Lack of Efficacy|0|||
163167196|NCT01708902|589327701|FG000|Overall Study|Non compliance with protocol|0|||
163167197|NCT01708902|589327702|FG001|Overall Study|Non compliance with protocol|2|||
163167198|NCT01708902|589327703|FG002|Overall Study|Non compliance with protocol|1|||
163167199|NCT01708902|589327704|FG003|Overall Study|Non compliance with protocol|3|||
163167200|NCT01708902|589327705|FG004|Overall Study|Non compliance with protocol|0|||
163167201|NCT01708902|589327706|FG005|Overall Study|Non compliance with protocol|0|||
163167202|NCT01708902|589327707|FG006|Overall Study|Non compliance with protocol|0|||
163167203|NCT01708902|589327701|FG000|Overall Study|Lost to Follow-up|2|||
163167204|NCT01708902|589327702|FG001|Overall Study|Lost to Follow-up|1|||
163167205|NCT01708902|589327703|FG002|Overall Study|Lost to Follow-up|2|||
163167206|NCT01708902|589327704|FG003|Overall Study|Lost to Follow-up|2|||
163167207|NCT01708902|589327705|FG004|Overall Study|Lost to Follow-up|0|||
163167208|NCT01708902|589327706|FG005|Overall Study|Lost to Follow-up|0|||
163167209|NCT01708902|589327707|FG006|Overall Study|Lost to Follow-up|1|||
163167210|NCT01708902|589327701|FG000|Overall Study|Refused to continue trial medication|8|||
163167211|NCT01708902|589327702|FG001|Overall Study|Refused to continue trial medication|0|||
163167212|NCT01708902|589327703|FG002|Overall Study|Refused to continue trial medication|4|||
163167213|NCT01708902|589327704|FG003|Overall Study|Refused to continue trial medication|2|||
163167214|NCT01708902|589327705|FG004|Overall Study|Refused to continue trial medication|8|||
163167215|NCT01708902|589327706|FG005|Overall Study|Refused to continue trial medication|1|||
163167216|NCT01708902|589327707|FG006|Overall Study|Refused to continue trial medication|1|||
163167217|NCT01708902|589327701|FG000|Overall Study|Other Reason|1|||
163167218|NCT01708902|589327702|FG001|Overall Study|Other Reason|0|||
163167219|NCT01708902|589327703|FG002|Overall Study|Other Reason|1|||
163167220|NCT01708902|589327704|FG003|Overall Study|Other Reason|1|||
163167221|NCT01708902|589327705|FG004|Overall Study|Other Reason|1|||
163167222|NCT01708902|589327706|FG005|Overall Study|Other Reason|2|||
163167223|NCT01708902|589327707|FG006|Overall Study|Other Reason|0|||
163167224|NCT00530816|589327711|FG000|Overall Study|Progressive Disease|16|||
163167225|NCT00530816|589327712|FG001|Overall Study|Progressive Disease|24|||
163167226|NCT00530816|589327713|FG002|Overall Study|Progressive Disease|24|||
163167227|NCT00530816|589327711|FG000|Overall Study|Adverse Event|6|||
163167228|NCT00530816|589327712|FG001|Overall Study|Adverse Event|13|||
163167229|NCT00530816|589327713|FG002|Overall Study|Adverse Event|7|||
163167230|NCT00530816|589327711|FG000|Overall Study|Other|3|||
163167231|NCT00530816|589327712|FG001|Overall Study|Other|3|||
163167232|NCT00530816|589327713|FG002|Overall Study|Other|4|||
163167233|NCT00530816|589327711|FG000|Overall Study|Withdrawal by Subject|1|||
163167234|NCT00530816|589327712|FG001|Overall Study|Withdrawal by Subject|2|||
163167235|NCT00530816|589327713|FG002|Overall Study|Withdrawal by Subject|6|||
163167236|NCT02445794|589327714|FG000|Overall Study|Adverse Event|0|||
163167237|NCT02445794|589327715|FG001|Overall Study|Adverse Event|0|||
163167238|NCT02445794|589327716|FG002|Overall Study|Adverse Event|2|||
163167239|NCT02445794|589327717|FG003|Overall Study|Adverse Event|0|||
163167240|NCT01388985|589327718|FG000|Overall Study|Death|0|||
163167241|NCT01388985|589327719|FG001|Overall Study|Death|1|||
163167242|NCT01388985|589327718|FG000|Overall Study|Lost to Follow-up|30|||
163167243|NCT01388985|589327719|FG001|Overall Study|Lost to Follow-up|30|||
163167244|NCT01388985|589327718|FG000|Overall Study|Withdrawal by Subject|13|||
163167245|NCT01388985|589327719|FG001|Overall Study|Withdrawal by Subject|4|||
163167246|NCT01388985|589327718|FG000|Overall Study|Subject unavailable|1|||
163167247|NCT01388985|589327719|FG001|Overall Study|Subject unavailable|1|||
163167248|NCT01388985|589327718|FG000|Overall Study|Other (no reason)|0|||
163167249|NCT01388985|589327719|FG001|Overall Study|Other (no reason)|1|||
163167250|NCT01388985|589327718|FG000|Overall Study|Error of nurse|5|||
163167251|NCT01388985|589327719|FG001|Overall Study|Error of nurse|1|||
163167252|NCT01057589|589327720|FG000|Overall Study|Disease Progression|35|||
163167253|NCT01057589|589327720|FG000|Overall Study|Adverse Event|10|||
163167254|NCT01057589|589327720|FG000|Overall Study|Physician Decision|8|||
163167255|NCT01057589|589327720|FG000|Overall Study|Withdrawal by Subject|3|||
163167256|NCT01057589|589327720|FG000|Overall Study|Sponsor Decision|1|||
163167257|NCT01057589|589327720|FG000|Overall Study|Death|8|||
163167258|NCT01057589|589327720|FG000|Overall Study|Lost to Follow-up|1|||
163167259|NCT01519167|589327723|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
163167260|NCT01519167|589327724|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
163167261|NCT01519167|589327723|FG000|Overall Study|Adverse Event|0|||
163167262|NCT01519167|589327724|FG001|Overall Study|Adverse Event|1|||
163167263|NCT01519167|589327723|FG000|Overall Study|Lack of Efficacy|0|||
163167264|NCT01519167|589327724|FG001|Overall Study|Lack of Efficacy|1|||
163167265|NCT01519167|589327723|FG000|Overall Study|Medical condition changes&deep sedation|0|||
163167266|NCT01519167|589327724|FG001|Overall Study|Medical condition changes&deep sedation|2|||
163167267|NCT01519167|589327723|FG000|Overall Study|Physician Decision|0|||
163167268|NCT01519167|589327724|FG001|Overall Study|Physician Decision|1|||
163167269|NCT00870584|589327730|FG000|Overall Study|Adverse Event|3|||
163167270|NCT00870584|589327731|FG001|Overall Study|Adverse Event|3|||
163167271|NCT00870584|589327730|FG000|Overall Study|Withdrawal by Subject|6|||
163167272|NCT00870584|589327731|FG001|Overall Study|Withdrawal by Subject|7|||
163167273|NCT00870584|589327730|FG000|Overall Study|Lost to Follow-up|5|||
163167274|NCT00870584|589327731|FG001|Overall Study|Lost to Follow-up|1|||
163167275|NCT00870584|589327730|FG000|Overall Study|Protocol Deviation|2|||
163167276|NCT00870584|589327731|FG001|Overall Study|Protocol Deviation|2|||
163167277|NCT02560025|589327732|FG000|Overall Study|Ineligible after consent/ registration|3|||
163167278|NCT01497366|589327733|FG000|Overall Study|Virologic failure|2|||
163167279|NCT01497366|589327734|FG001|Overall Study|Virologic failure|50|||
163167280|NCT01497366|589327733|FG000|Overall Study|Lost to Follow-up|11|||
163167281|NCT01497366|589327734|FG001|Overall Study|Lost to Follow-up|10|||
163167282|NCT01497366|589327733|FG000|Overall Study|Withdrawal by Subject|6|||
163167283|NCT01497366|589327734|FG001|Overall Study|Withdrawal by Subject|6|||
163167284|NCT01497366|589327733|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
163167285|NCT01497366|589327734|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
163167286|NCT01497366|589327733|FG000|Overall Study|Other|5|||
163167287|NCT01497366|589327734|FG001|Overall Study|Other|0|||
163167288|NCT01497366|589327733|FG000|Overall Study|Death|1|||
163167289|NCT01497366|589327734|FG001|Overall Study|Death|1|||
163167290|NCT01497366|589327733|FG000|Overall Study|Randomized but not treated|7|||
163167291|NCT01497366|589327734|FG001|Overall Study|Randomized but not treated|21|||
163167292|NCT02745080|589327744|FG000|Overall Study|Adverse Event|13|||
163167293|NCT02745080|589327745|FG001|Overall Study|Adverse Event|21|||
163167294|NCT02745080|589327744|FG000|Overall Study|Lack of Efficacy|11|||
163167295|NCT02745080|589327745|FG001|Overall Study|Lack of Efficacy|23|||
163167296|NCT02745080|589327744|FG000|Overall Study|Lost to Follow-up|3|||
163167297|NCT02745080|589327745|FG001|Overall Study|Lost to Follow-up|3|||
163167298|NCT02745080|589327744|FG000|Overall Study|Physician Decision|3|||
163167299|NCT02745080|589327745|FG001|Overall Study|Physician Decision|0|||
163167300|NCT02745080|589327744|FG000|Overall Study|Protocol Violation|3|||
163167301|NCT02745080|589327745|FG001|Overall Study|Protocol Violation|1|||
163167302|NCT02745080|589327744|FG000|Overall Study|Withdrawal by Subject|22|||
163167303|NCT02745080|589327745|FG001|Overall Study|Withdrawal by Subject|41|||
163167304|NCT00472030|589327749|FG000|Overall Study|Physician Decision|1|||
163167305|NCT00472030|589327750|FG001|Overall Study|Physician Decision|0|||
163167306|NCT00829504|589327751|FG000|First Intervention|Adverse Event|1|||
163167307|NCT00829504|589327752|FG001|First Intervention|Adverse Event|0|||
163167308|NCT00829504|589327751|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
163276737|NCT03873246|589723498|FG000|Overall Study|Protocol Violation|0|||
163167309|NCT00829504|589327752|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
163167310|NCT00829504|589327751|FG000|Second Intervention|Physician Decision|1|||
163167311|NCT00829504|589327752|FG001|Second Intervention|Physician Decision|0|||
163167312|NCT02248675|589328962|FG000|Overall Study|Lost to Follow-up|3|||
163167313|NCT02248675|589328963|FG001|Overall Study|Lost to Follow-up|1|||
163167314|NCT03745820|589328966|FG000|Overall Study|Adverse Event|0|||
163167315|NCT03745820|589328967|FG001|Overall Study|Adverse Event|3|||
163167316|NCT03745820|589328968|FG002|Overall Study|Adverse Event|2|||
163167317|NCT03745820|589328966|FG000|Overall Study|Non-Compliance with Study Drug|4|||
163167318|NCT03745820|589328967|FG001|Overall Study|Non-Compliance with Study Drug|3|||
163167319|NCT03745820|589328968|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163167320|NCT03745820|589328966|FG000|Overall Study|Withdrawal by Subject|4|||
163167321|NCT03745820|589328967|FG001|Overall Study|Withdrawal by Subject|4|||
163167322|NCT03745820|589328968|FG002|Overall Study|Withdrawal by Subject|4|||
163167323|NCT03745820|589328966|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
163167324|NCT03745820|589328967|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
163167325|NCT03745820|589328968|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
163167326|NCT03745820|589328966|FG000|Overall Study|Lost to Follow-up|2|||
163167327|NCT03745820|589328967|FG001|Overall Study|Lost to Follow-up|0|||
163167328|NCT03745820|589328968|FG002|Overall Study|Lost to Follow-up|3|||
163167329|NCT03745820|589328966|FG000|Overall Study|Reason not Specified|2|||
163167330|NCT03745820|589328967|FG001|Overall Study|Reason not Specified|4|||
163167331|NCT03745820|589328968|FG002|Overall Study|Reason not Specified|1|||
163167332|NCT04250077|589328977|FG000|Overall Study|Withdrawal by Subject|0|||
163167333|NCT04250077|589328978|FG001|Overall Study|Withdrawal by Subject|1|||
163167334|NCT04250077|589328979|FG002|Overall Study|Withdrawal by Subject|0|||
163167335|NCT04250077|589328977|FG000|Overall Study|Lost to Follow-up|2|||
163167336|NCT04250077|589328978|FG001|Overall Study|Lost to Follow-up|3|||
163167337|NCT04250077|589328979|FG002|Overall Study|Lost to Follow-up|0|||
163167338|NCT02471612|589328980|FG000|Overall Study|Lost to Follow-up|2|||
163167339|NCT01598129|589328981|FG000|Overall Study|Disease progression|6|||
163167340|NCT01598129|589328981|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
163167341|NCT01598129|589328981|FG000|Overall Study|Withdrawal by Subject|1|||
163167342|NCT00591318|589328982|FG000|Overall Study|Lack of Efficacy|2|||
163167343|NCT00591318|589328983|FG001|Overall Study|Lack of Efficacy|0|||
163167344|NCT00591318|589328982|FG000|Overall Study|Adverse Event|2|||
163167345|NCT00591318|589328983|FG001|Overall Study|Adverse Event|0|||
163167346|NCT00647270|589328984|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
163167347|NCT00647270|589328985|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
163167348|NCT00647270|589328986|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
163167349|NCT00647270|589328984|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
163167350|NCT00647270|589328985|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
163167351|NCT00647270|589328986|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
163167352|NCT00647270|589328984|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
163167353|NCT00647270|589328985|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
163167354|NCT00647270|589328986|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
163167355|NCT00647270|589328984|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
163167356|NCT00647270|589328985|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
163167357|NCT00647270|589328986|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
163167358|NCT00647270|589328984|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
163167359|NCT00647270|589328985|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
163167360|NCT00647270|589328986|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
163167361|NCT00647270|589328984|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
163167362|NCT00647270|589328985|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
163167363|NCT00647270|589328986|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
163167364|NCT00647270|589328984|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
163167365|NCT00647270|589328985|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
163167366|NCT00647270|589328986|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
163167367|NCT03615040|589328987|FG000|Overall Study|Withdrawal by Subject|2|||
163167368|NCT03615040|589328988|FG001|Overall Study|Withdrawal by Subject|1|||
163167369|NCT03615040|589328987|FG000|Overall Study|Physician Decision|2|||
163167370|NCT03615040|589328988|FG001|Overall Study|Physician Decision|2|||
163167371|NCT03615040|589328987|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
163167372|NCT03615040|589328988|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
163167373|NCT03615040|589328987|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
163167374|NCT03615040|589328988|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
163167375|NCT03615040|589328987|FG000|Overall Study|Death|0|||
163167376|NCT03615040|589328988|FG001|Overall Study|Death|2|||
163167377|NCT01024309|589328991|FG000|Overall Study|Physician Decision|4|||
163167378|NCT01024309|589328992|FG001|Overall Study|Physician Decision|0|||
163167379|NCT01024309|589328991|FG000|Overall Study|Withdrawal by Subject|4|||
163167380|NCT01024309|589328992|FG001|Overall Study|Withdrawal by Subject|4|||
163167381|NCT01743001|589328993|FG000|Overall Study|Physician Decision|1|||
163167382|NCT01743001|589328994|FG001|Overall Study|Physician Decision|0|||
163167383|NCT01743001|589328993|FG000|Overall Study|Pregnancy|1|||
163167384|NCT01743001|589328994|FG001|Overall Study|Pregnancy|0|||
163167385|NCT01743001|589328993|FG000|Overall Study|Death|1|||
163167386|NCT01743001|589328994|FG001|Overall Study|Death|0|||
163167387|NCT02657408|589328997|FG000|Overall Study|Adverse Event|3|||
163167388|NCT02657408|589328998|FG001|Overall Study|Adverse Event|7|||
163167389|NCT01403948|589328999|FG000|Overall Study|Progressive disease|0|||
163167390|NCT01403948|589329000|FG001|Overall Study|Progressive disease|2|||
163167391|NCT01403948|589329001|FG002|Overall Study|Progressive disease|2|||
163167392|NCT01403948|589329002|FG003|Overall Study|Progressive disease|4|||
163167393|NCT01403948|589329003|FG004|Overall Study|Progressive disease|2|||
163167394|NCT01403948|589329004|FG005|Overall Study|Progressive disease|6|||
163167395|NCT01403948|589329005|FG006|Overall Study|Progressive disease|2|||
163167396|NCT01403948|589329006|FG007|Overall Study|Progressive disease|4|||
163167397|NCT01403948|589329007|FG008|Overall Study|Progressive disease|5|||
163167398|NCT01403948|589329008|FG009|Overall Study|Progressive disease|5|||
163167399|NCT01403948|589328999|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
163167400|NCT01403948|589329000|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
163167401|NCT01403948|589329001|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
163167402|NCT01403948|589329002|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
163167403|NCT01403948|589329003|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
163167404|NCT01403948|589329004|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
163167405|NCT01403948|589329005|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
163167406|NCT01403948|589329006|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
163167407|NCT01403948|589329007|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
163167408|NCT01403948|589329008|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
163167409|NCT01403948|589328999|FG000|Overall Study|Lost to Follow-up|0|||
163167410|NCT01403948|589329000|FG001|Overall Study|Lost to Follow-up|0|||
163167411|NCT01403948|589329001|FG002|Overall Study|Lost to Follow-up|0|||
163167412|NCT01403948|589329002|FG003|Overall Study|Lost to Follow-up|0|||
163167413|NCT01403948|589329003|FG004|Overall Study|Lost to Follow-up|0|||
163167414|NCT01403948|589329004|FG005|Overall Study|Lost to Follow-up|0|||
163167415|NCT01403948|589329005|FG006|Overall Study|Lost to Follow-up|0|||
163167416|NCT01403948|589329006|FG007|Overall Study|Lost to Follow-up|0|||
163167417|NCT01403948|589329007|FG008|Overall Study|Lost to Follow-up|0|||
163167418|NCT01403948|589329008|FG009|Overall Study|Lost to Follow-up|1|||
163167419|NCT01403948|589328999|FG000|Overall Study|Refused cont. medication|0|||
163167420|NCT01403948|589329000|FG001|Overall Study|Refused cont. medication|0|||
163167421|NCT01403948|589329001|FG002|Overall Study|Refused cont. medication|0|||
163167422|NCT01403948|589329002|FG003|Overall Study|Refused cont. medication|0|||
163167423|NCT01403948|589329003|FG004|Overall Study|Refused cont. medication|1|||
163167424|NCT01403948|589329004|FG005|Overall Study|Refused cont. medication|0|||
163167425|NCT01403948|589329005|FG006|Overall Study|Refused cont. medication|0|||
163167426|NCT01403948|589329006|FG007|Overall Study|Refused cont. medication|0|||
163167427|NCT01403948|589329007|FG008|Overall Study|Refused cont. medication|0|||
163167428|NCT01403948|589329008|FG009|Overall Study|Refused cont. medication|1|||
163167429|NCT01403948|589328999|FG000|Overall Study|other than above|1|||
163167430|NCT01403948|589329000|FG001|Overall Study|other than above|2|||
163167431|NCT01403948|589329001|FG002|Overall Study|other than above|1|||
163167432|NCT01403948|589329002|FG003|Overall Study|other than above|0|||
163167433|NCT01403948|589329003|FG004|Overall Study|other than above|1|||
163167434|NCT01403948|589329004|FG005|Overall Study|other than above|1|||
163167435|NCT01403948|589329005|FG006|Overall Study|other than above|2|||
163167436|NCT01403948|589329006|FG007|Overall Study|other than above|0|||
163167437|NCT01403948|589329007|FG008|Overall Study|other than above|0|||
163167438|NCT01403948|589329008|FG009|Overall Study|other than above|0|||
163167439|NCT01090323|589329009|FG000|Overall Study|Adverse Event|12|||
163167440|NCT01090323|589329010|FG001|Overall Study|Adverse Event|2|||
163167441|NCT01090323|589329009|FG000|Overall Study|Abnormal Lab Values|3|||
163167442|NCT01090323|589329010|FG001|Overall Study|Abnormal Lab Values|1|||
163167443|NCT01090323|589329009|FG000|Overall Study|Abnormal Test Procedure Results|2|||
163167444|NCT01090323|589329010|FG001|Overall Study|Abnormal Test Procedure Results|0|||
163167445|NCT01090323|589329009|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
163167446|NCT01090323|589329010|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163167447|NCT01090323|589329009|FG000|Overall Study|Condition no longer requires drug|5|||
163167448|NCT01090323|589329010|FG001|Overall Study|Condition no longer requires drug|4|||
163167449|NCT01090323|589329009|FG000|Overall Study|Protocol Violation|2|||
163167450|NCT01090323|589329010|FG001|Overall Study|Protocol Violation|1|||
163167451|NCT01090323|589329009|FG000|Overall Study|Withdrew consent|33|||
163167452|NCT01090323|589329010|FG001|Overall Study|Withdrew consent|11|||
163167453|NCT01090323|589329009|FG000|Overall Study|Lost to Follow-up|11|||
163167454|NCT01090323|589329010|FG001|Overall Study|Lost to Follow-up|6|||
163167455|NCT01090323|589329009|FG000|Overall Study|Administrative problems|6|||
163167456|NCT01090323|589329010|FG001|Overall Study|Administrative problems|4|||
163276738|NCT03873246|589723499|FG001|Overall Study|Protocol Violation|1|||
163276739|NCT03873246|589723500|FG002|Overall Study|Protocol Violation|0|||
163167457|NCT01090323|589329009|FG000|Overall Study|Death|1|||
163167458|NCT01090323|589329010|FG001|Overall Study|Death|2|||
163167459|NCT01090323|589329009|FG000|Overall Study|Stopped end of core|7|||
163167460|NCT01090323|589329010|FG001|Overall Study|Stopped end of core|0|||
163167461|NCT01090323|589329009|FG000|Overall Study|Stopped end of extension 1#|3|||
163167462|NCT01090323|589329010|FG001|Overall Study|Stopped end of extension 1#|1|||
163167463|NCT05498701|589329011|FG000|Period 3|Adverse Event|1|||
163167464|NCT05498701|589329012|FG001|Period 3|Adverse Event|0|||
163167465|NCT01864005|589329013|FG000|Overall Study|Protocol Violation|0|||
163167466|NCT01864005|589329014|FG001|Overall Study|Protocol Violation|1|||
163167467|NCT01864005|589329013|FG000|Overall Study|Withdrawal by Subject|0|||
163167468|NCT01864005|589329014|FG001|Overall Study|Withdrawal by Subject|1|||
163167469|NCT01864005|589329013|FG000|Overall Study|Incorrect enrolment|1|||
163167470|NCT01864005|589329014|FG001|Overall Study|Incorrect enrolment|0|||
163167471|NCT01864005|589329013|FG000|Overall Study|Disease need|1|||
163167472|NCT01864005|589329014|FG001|Overall Study|Disease need|1|||
163167473|NCT01864005|589329013|FG000|Overall Study|Need GP IIb/IIIa|1|||
163167474|NCT01864005|589329014|FG001|Overall Study|Need GP IIb/IIIa|3|||
163167475|NCT02424578|589329015|FG000|Overall Study|Withdrawal by Subject|0|||
163276740|NCT03873246|589723498|FG000|Overall Study|Withdrawal by Subject|0|||
163167476|NCT02424578|589329016|FG001|Overall Study|Withdrawal by Subject|1|||
163167477|NCT02184572|589329017|FG000|Overall Study|Lost to Follow-up|29|||
163167478|NCT02184572|589329018|FG001|Overall Study|Lost to Follow-up|21|||
163167479|NCT02184572|589329017|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
163167480|NCT02184572|589329018|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
163167481|NCT02184572|589329017|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
163167482|NCT02184572|589329018|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
163167483|NCT02184572|589329017|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
163167484|NCT02184572|589329018|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
163167485|NCT02184572|589329017|FG000|Overall Study|Traveling Outside The Country|1|||
163167486|NCT02184572|589329018|FG001|Overall Study|Traveling Outside The Country|0|||
163167487|NCT02184572|589329017|FG000|Overall Study|Withdrawal by Subject|14|||
163167488|NCT02184572|589329018|FG001|Overall Study|Withdrawal by Subject|9|||
163167489|NCT00763698|589329021|FG000|Overall Study|Unsuccessful Implant|5|||
163167490|NCT00763698|589329021|FG000|Overall Study|Death|4|||
163167491|NCT00763698|589329021|FG000|Overall Study|Withdrawal by Subject|1|||
163167492|NCT03679754|589329026|FG000|Overall Study|Investigator request|1|||
163167493|NCT00964171|589329027|FG000|Overall Study|Death|5|||
163167494|NCT03179319|589329031|FG000|Overall Study|Lost to Follow-up|6|||
163167495|NCT03179319|589329032|FG001|Overall Study|Lost to Follow-up|0|||
163167496|NCT01120717|589329033|FG000|Overall Study|Withdrawal by Subject|11|||
163167497|NCT01120717|589329034|FG001|Overall Study|Withdrawal by Subject|6|||
163167498|NCT01120717|589329033|FG000|Overall Study|Adverse Event|10|||
163167499|NCT01120717|589329034|FG001|Overall Study|Adverse Event|6|||
163167500|NCT01120717|589329033|FG000|Overall Study|Protocol Deviation|2|||
163167501|NCT01120717|589329034|FG001|Overall Study|Protocol Deviation|5|||
163167502|NCT01120717|589329033|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
163167503|NCT01120717|589329034|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
163167504|NCT01120717|589329033|FG000|Overall Study|Lost to Follow-up|2|||
163167505|NCT01120717|589329034|FG001|Overall Study|Lost to Follow-up|3|||
163167506|NCT01120717|589329033|FG000|Overall Study|Death|3|||
163167507|NCT01120717|589329034|FG001|Overall Study|Death|1|||
163167508|NCT01120717|589329033|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
163167509|NCT01120717|589329034|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
163167510|NCT02640508|589329039|FG000|Overall Study|Death|19|||
163167511|NCT02640508|589329039|FG000|Overall Study|Withdrawal by Subject|8|||
163167512|NCT02640508|589329039|FG000|Overall Study|Physician Decision|1|||
163167513|NCT02640508|589329039|FG000|Overall Study|Lost to Follow-up|1|||
163167514|NCT04534686|589329041|FG000|Baseline Measurement|Lost to Follow-up|4|||
163167515|NCT04534686|589329042|FG001|Baseline Measurement|Lost to Follow-up|6|||
163167516|NCT04534686|589329041|FG000|Baseline Measurement|Withdrawal by Subject|3|||
163167517|NCT04534686|589329042|FG001|Baseline Measurement|Withdrawal by Subject|1|||
163167518|NCT04534686|589329041|FG000|Intervention|Withdrawal by Subject|2|||
163167519|NCT04534686|589329042|FG001|Intervention|Withdrawal by Subject|2|||
163167520|NCT03179605|589329043|FG000|Overall Study|Withdrawal by Subject|1|||
163167521|NCT00635999|589329044|FG000|Overall Study|Withdrawal by Subject|4|||
163167522|NCT00635999|589329045|FG001|Overall Study|Withdrawal by Subject|2|||
163167523|NCT00635999|589329046|FG002|Overall Study|Withdrawal by Subject|1|||
163167524|NCT00711477|589329047|FG000|Overall Study|Adverse Event|3|||
163167525|NCT00711477|589329048|FG001|Overall Study|Adverse Event|1|||
163167526|NCT00711477|589329047|FG000|Overall Study|Lost to Follow-up|0|||
163167527|NCT00711477|589329048|FG001|Overall Study|Lost to Follow-up|1|||
163167528|NCT00711477|589329047|FG000|Overall Study|Noncompliance|0|||
163167529|NCT00711477|589329048|FG001|Overall Study|Noncompliance|1|||
163167530|NCT01396070|589329050|FG000|Overall Study|Withdrawal by Subject|2|||
163167531|NCT01396070|589329050|FG000|Overall Study|Death|2|||
163167532|NCT01396070|589329050|FG000|Overall Study|Adverse Event|8|||
163167533|NCT01396070|589329050|FG000|Overall Study|Physician Decision|3|||
163167534|NCT01396070|589329050|FG000|Overall Study|Lack of Efficacy|4|||
163167535|NCT02636361|589329051|FG000|Period 4|Physician Decision|0|||
163167536|NCT02636361|589329052|FG001|Period 4|Physician Decision|0|||
163167537|NCT02636361|589329053|FG002|Period 4|Physician Decision|0|||
163167538|NCT02636361|589329054|FG003|Period 4|Physician Decision|1|||
163167539|NCT02636361|589329055|FG004|Period 4|Physician Decision|0|||
163167540|NCT02695420|589329056|FG000|Overall Study|Death|0|||
163167541|NCT02695420|589329057|FG001|Overall Study|Death|1|||
163167542|NCT02695420|589329058|FG002|Overall Study|Death|0|||
163167543|NCT02695420|589329059|FG003|Overall Study|Death|0|||
163167544|NCT00916929|589329063|FG000|Overall Study|Lost to Follow-up|1|||
163167545|NCT00916929|589329064|FG001|Overall Study|Lost to Follow-up|3|||
163167546|NCT00916929|589329063|FG000|Overall Study|Death|5|||
163167547|NCT00916929|589329064|FG001|Overall Study|Death|10|||
163167548|NCT00916929|589329063|FG000|Overall Study|Withdrawal by Subject|1|||
163167549|NCT00916929|589329064|FG001|Overall Study|Withdrawal by Subject|5|||
163167550|NCT00916929|589329063|FG000|Overall Study|Left ventricular epicardial lead|1|||
163167551|NCT00916929|589329064|FG001|Overall Study|Left ventricular epicardial lead|2|||
163167552|NCT00916929|589329063|FG000|Overall Study|Transferred to hospice care|1|||
163167553|NCT00916929|589329064|FG001|Overall Study|Transferred to hospice care|1|||
163167554|NCT00916929|589329063|FG000|Overall Study|System explant|1|||
163167555|NCT00916929|589329064|FG001|Overall Study|System explant|0|||
163167556|NCT00916929|589329063|FG000|Overall Study|Moved to another state|0|||
163167557|NCT00916929|589329064|FG001|Overall Study|Moved to another state|1|||
163167558|NCT00916929|589329063|FG000|Overall Study|Device unable to process impedance data|0|||
163167559|NCT00916929|589329064|FG001|Overall Study|Device unable to process impedance data|7|||
163167560|NCT02929407|589329065|FG000|Overall Study|Adverse Event|1|||
163167561|NCT03037580|589329067|FG000|Overall Study|Withdrawal by Subject|3|||
163167562|NCT03037580|589329068|FG001|Overall Study|Withdrawal by Subject|0|||
163167563|NCT03037580|589329067|FG000|Overall Study|Adverse Event|1|||
163167564|NCT03037580|589329068|FG001|Overall Study|Adverse Event|0|||
163167565|NCT03037580|589329067|FG000|Overall Study|Study Terminated by Sponsor|12|||
163167566|NCT03037580|589329068|FG001|Overall Study|Study Terminated by Sponsor|15|||
163167567|NCT03037580|589329067|FG000|Overall Study|Death|0|||
163167568|NCT03037580|589329068|FG001|Overall Study|Death|1|||
163167569|NCT02036853|589329069|FG000|Overall Study|Adverse Event|0|||
163167570|NCT02036853|589329070|FG001|Overall Study|Adverse Event|2|||
163167571|NCT02036853|589329069|FG000|Overall Study|Lack of Efficacy|0|||
163167572|NCT02036853|589329070|FG001|Overall Study|Lack of Efficacy|2|||
163167573|NCT02036853|589329069|FG000|Overall Study|Physician Decision|0|||
163167574|NCT02036853|589329070|FG001|Overall Study|Physician Decision|1|||
163167575|NCT02036853|589329069|FG000|Overall Study|Withdrawal by Subject|0|||
163167576|NCT02036853|589329070|FG001|Overall Study|Withdrawal by Subject|1|||
163167577|NCT00228553|589329071|FG000|Overall Study|Adverse Event|112|||
163167578|NCT00228553|589329071|FG000|Overall Study|Lack of Efficacy|34|||
163167579|NCT00228553|589329071|FG000|Overall Study|Lost to Follow-up|67|||
163167580|NCT00228553|589329071|FG000|Overall Study|Physician Decision|48|||
163167581|NCT00228553|589329071|FG000|Overall Study|Protocol Violation|6|||
163167582|NCT00228553|589329071|FG000|Overall Study|Withdrawal by Subject|115|||
163167583|NCT00228553|589329071|FG000|Overall Study|Pregnancy|2|||
163167584|NCT00228553|589329071|FG000|Overall Study|Miscellaneous|46|||
163167585|NCT04530136|589329072|FG000|Overall Study|Lost to Follow-up|2|||
163167586|NCT04530136|589329073|FG001|Overall Study|Lost to Follow-up|3|||
163167587|NCT04530136|589329072|FG000|Overall Study|Withdrawal by Subject|1|||
163167588|NCT04530136|589329073|FG001|Overall Study|Withdrawal by Subject|0|||
163167589|NCT04530136|589329072|FG000|Overall Study|Death|0|||
163167590|NCT04530136|589329073|FG001|Overall Study|Death|1|||
163167591|NCT01309282|589329074|FG000|Overall Study|Lost to Follow-up|1|||
163167592|NCT01136785|589329079|FG000|Overall Study|Protocol Violation|2|||
163167593|NCT01136785|589329080|FG001|Overall Study|Protocol Violation|1|||
163167594|NCT02873429|589329081|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
163167595|NCT02873429|589329082|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
163167596|NCT02873429|589329081|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
163167597|NCT02873429|589329082|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
163167598|NCT02873429|589329081|FG000|16 Weeks|Lost to Follow-up|3|||
163167599|NCT02873429|589329082|FG001|16 Weeks|Lost to Follow-up|0|||
163167600|NCT00612807|589329083|FG000|Overall Study|Withdrawal by Subject|2|||
163167601|NCT00612807|589329084|FG001|Overall Study|Withdrawal by Subject|0|||
163167602|NCT01516034|589329085|FG000|Overall Study|Physician Decision|1|||
163167603|NCT01516034|589329085|FG000|Overall Study|Lack of Efficacy|7|||
163167604|NCT01033448|589329086|FG000|Overall Study|Withdrawal by Subject|4|||
163167605|NCT01033448|589329086|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
163167606|NCT01033448|589329086|FG000|Overall Study|Lost to Follow-up|3|||
163167607|NCT01033448|589329086|FG000|Overall Study|Withdrew due to other reasons|3|||
163167608|NCT01033448|589329086|FG000|Overall Study|Unknown disposition|1|||
163167609|NCT05564052|589329087|FG000|Overall Study|Withdrawal by Subject|0|||
163167610|NCT05564052|589329088|FG001|Overall Study|Withdrawal by Subject|0|||
163167611|NCT05564052|589329089|FG002|Overall Study|Withdrawal by Subject|0|||
163167612|NCT05564052|589329090|FG003|Overall Study|Withdrawal by Subject|1|||
163167613|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
163167614|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
163167615|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
163167616|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
163167617|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
163167618|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
163167619|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
163167620|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
163167621|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
163167622|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
163167623|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
163167624|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
163167625|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
163167626|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
163167627|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
163167628|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
163167629|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
163167630|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
163167631|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
163167632|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
163167633|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
163167634|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
163167635|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
163167636|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
163167637|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
163167638|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
163167639|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
163167640|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
163167641|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
163167642|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
163167643|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
163167644|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
163167645|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
163167646|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
163167647|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
163167648|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
163167649|NCT03818035|589329093|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
163167650|NCT03818035|589329094|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
163167651|NCT03818035|589329095|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
163167652|NCT03818035|589329096|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
163167653|NCT03818035|589329093|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
163167654|NCT03818035|589329094|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
163167655|NCT03818035|589329095|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
163167656|NCT03818035|589329096|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
163167657|NCT03818035|589329093|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
163167658|NCT03818035|589329094|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
163167659|NCT03818035|589329095|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
163167660|NCT03818035|589329096|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
163167661|NCT03818035|589329093|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
163167662|NCT03818035|589329094|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
163167663|NCT03818035|589329095|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
163167664|NCT03818035|589329096|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
163167665|NCT03818035|589329093|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
163167666|NCT03818035|589329094|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
163167667|NCT03818035|589329095|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
163167668|NCT03818035|589329096|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
163167669|NCT03818035|589329093|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
163167670|NCT03818035|589329094|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
163167671|NCT03818035|589329095|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
163167672|NCT03818035|589329096|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
163167673|NCT03338959|589330610|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
163167674|NCT03338959|589330610|FG000|Overall Study|Physician Decision|1|||
163167675|NCT00409331|589330612|FG000|Overall Study|Physician Decision|1|||
163167676|NCT00281658|589330613|FG000|Randomized Phase|Adverse Event|0|||
163167677|NCT00281658|589330614|FG001|Randomized Phase|Adverse Event|2|||
163167678|NCT00281658|589330615|FG002|Randomized Phase|Adverse Event|0|||
163167679|NCT00281658|589330616|FG003|Randomized Phase|Adverse Event|0|||
163167680|NCT00281658|589330613|FG000|Randomized Phase|Lost to Follow-up|34|||
163167681|NCT00281658|589330614|FG001|Randomized Phase|Lost to Follow-up|27|||
163167682|NCT00281658|589330615|FG002|Randomized Phase|Lost to Follow-up|0|||
163167683|NCT00281658|589330616|FG003|Randomized Phase|Lost to Follow-up|0|||
163167684|NCT00281658|589330613|FG000|Randomized Phase|Withdrawal by Subject|8|||
163167685|NCT00281658|589330614|FG001|Randomized Phase|Withdrawal by Subject|7|||
163167686|NCT00281658|589330615|FG002|Randomized Phase|Withdrawal by Subject|0|||
163167687|NCT00281658|589330616|FG003|Randomized Phase|Withdrawal by Subject|0|||
163167688|NCT00281658|589330613|FG000|Randomized Phase|Study closed/terminated|1|||
163167689|NCT00281658|589330614|FG001|Randomized Phase|Study closed/terminated|1|||
163167690|NCT00281658|589330615|FG002|Randomized Phase|Study closed/terminated|0|||
163167691|NCT00281658|589330616|FG003|Randomized Phase|Study closed/terminated|0|||
163167692|NCT00281658|589330613|FG000|Randomized Phase|Disease progression|36|||
163167693|NCT00281658|589330614|FG001|Randomized Phase|Disease progression|27|||
163167694|NCT00281658|589330615|FG002|Randomized Phase|Disease progression|0|||
163167695|NCT00281658|589330616|FG003|Randomized Phase|Disease progression|0|||
163167696|NCT00281658|589330613|FG000|Randomized Phase|Physician Decision|1|||
163167697|NCT00281658|589330614|FG001|Randomized Phase|Physician Decision|1|||
163167698|NCT00281658|589330615|FG002|Randomized Phase|Physician Decision|0|||
163167699|NCT00281658|589330616|FG003|Randomized Phase|Physician Decision|0|||
163167700|NCT00281658|589330613|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
163167701|NCT00281658|589330614|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
163167702|NCT00281658|589330615|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
163167703|NCT00281658|589330616|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
163167704|NCT00281658|589330613|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
163167705|NCT00281658|589330614|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
163167706|NCT00281658|589330615|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
163167707|NCT00281658|589330616|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
163167708|NCT00281658|589330613|FG000|Randomized Phase|Treatment ongoing|1|||
163167709|NCT00281658|589330614|FG001|Randomized Phase|Treatment ongoing|0|||
163167710|NCT00281658|589330615|FG002|Randomized Phase|Treatment ongoing|0|||
163167711|NCT00281658|589330616|FG003|Randomized Phase|Treatment ongoing|0|||
163167712|NCT00281658|589330613|FG000|Open Label Phase|Adverse Event|0|||
163167713|NCT00281658|589330614|FG001|Open Label Phase|Adverse Event|0|||
163167714|NCT00281658|589330615|FG002|Open Label Phase|Adverse Event|1|||
163167715|NCT00281658|589330616|FG003|Open Label Phase|Adverse Event|0|||
163167716|NCT00281658|589330613|FG000|Open Label Phase|Lost to Follow-up|0|||
163167717|NCT00281658|589330614|FG001|Open Label Phase|Lost to Follow-up|0|||
163167718|NCT00281658|589330615|FG002|Open Label Phase|Lost to Follow-up|16|||
163167719|NCT00281658|589330616|FG003|Open Label Phase|Lost to Follow-up|2|||
163167720|NCT00281658|589330613|FG000|Open Label Phase|Withdrawal by Subject|0|||
163167721|NCT00281658|589330614|FG001|Open Label Phase|Withdrawal by Subject|0|||
163167722|NCT00281658|589330615|FG002|Open Label Phase|Withdrawal by Subject|3|||
163167723|NCT00281658|589330616|FG003|Open Label Phase|Withdrawal by Subject|2|||
163167724|NCT00281658|589330613|FG000|Open Label Phase|Disease progression|0|||
163167725|NCT00281658|589330614|FG001|Open Label Phase|Disease progression|0|||
163167726|NCT00281658|589330615|FG002|Open Label Phase|Disease progression|18|||
163167727|NCT00281658|589330616|FG003|Open Label Phase|Disease progression|0|||
163167728|NCT00281658|589330613|FG000|Open Label Phase|Physician Decision|0|||
163167729|NCT00281658|589330614|FG001|Open Label Phase|Physician Decision|0|||
163167730|NCT00281658|589330615|FG002|Open Label Phase|Physician Decision|1|||
163167731|NCT00281658|589330616|FG003|Open Label Phase|Physician Decision|0|||
163167732|NCT00281658|589330613|FG000|Open Label Phase|Relocation of patient|0|||
163167733|NCT00281658|589330614|FG001|Open Label Phase|Relocation of patient|0|||
163167734|NCT00281658|589330615|FG002|Open Label Phase|Relocation of patient|1|||
163167735|NCT00281658|589330616|FG003|Open Label Phase|Relocation of patient|0|||
163167736|NCT00281658|589330613|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
163167737|NCT00281658|589330614|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
163167738|NCT00281658|589330615|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
163167739|NCT00281658|589330616|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
163167740|NCT02151773|589330617|FG000|Overall Study|Protocol Deviation|64|||
163167741|NCT03680742|589330618|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
163167742|NCT02894502|589330621|FG000|Baseline|Withdrawal by Subject|24|||
163167743|NCT02894502|589330622|FG001|Baseline|Withdrawal by Subject|31|||
163167744|NCT02894502|589330623|FG002|Baseline|Withdrawal by Subject|36|||
163167745|NCT02894502|589330621|FG000|Baseline|Death|3|||
163167746|NCT02894502|589330622|FG001|Baseline|Death|1|||
163167747|NCT02894502|589330623|FG002|Baseline|Death|9|||
163167748|NCT02894502|589330621|FG000|First Follow up|Withdrawal by Subject|32|||
163167749|NCT02894502|589330622|FG001|First Follow up|Withdrawal by Subject|29|||
163167750|NCT02894502|589330623|FG002|First Follow up|Withdrawal by Subject|37|||
163167751|NCT02894502|589330621|FG000|First Follow up|Death|2|||
163167752|NCT02894502|589330622|FG001|First Follow up|Death|2|||
163167753|NCT02894502|589330623|FG002|First Follow up|Death|3|||
163167754|NCT02894502|589330621|FG000|Second Follow up|Withdrawal by Subject|13|||
163167755|NCT02894502|589330622|FG001|Second Follow up|Withdrawal by Subject|15|||
163167756|NCT02894502|589330623|FG002|Second Follow up|Withdrawal by Subject|13|||
163167757|NCT02894502|589330621|FG000|Second Follow up|Death|2|||
163167758|NCT02894502|589330622|FG001|Second Follow up|Death|3|||
163167759|NCT02894502|589330623|FG002|Second Follow up|Death|1|||
163167760|NCT02894502|589330621|FG000|Third Follow up|Withdrawal by Subject|5|||
163167761|NCT02894502|589330622|FG001|Third Follow up|Withdrawal by Subject|6|||
163167762|NCT02894502|589330623|FG002|Third Follow up|Withdrawal by Subject|3|||
163167763|NCT02894502|589330621|FG000|Third Follow up|Death|1|||
163167764|NCT02894502|589330622|FG001|Third Follow up|Death|1|||
163167765|NCT02894502|589330623|FG002|Third Follow up|Death|0|||
163167766|NCT01410357|589330624|FG000|Overall Study|Death|2|||
163167767|NCT01410357|589330625|FG001|Overall Study|Death|1|||
163167768|NCT01410357|589330624|FG000|Overall Study|Withdrawal by Subject|1|||
163167769|NCT01410357|589330625|FG001|Overall Study|Withdrawal by Subject|2|||
163167770|NCT01410357|589330624|FG000|Overall Study|Lost to Follow-up|23|||
163167771|NCT01410357|589330625|FG001|Overall Study|Lost to Follow-up|21|||
163167772|NCT01206322|589330629|FG000|Overall Study|Adverse Event|0|||
163167773|NCT01206322|589330630|FG001|Overall Study|Adverse Event|0|||
163167774|NCT01206322|589330631|FG002|Overall Study|Adverse Event|0|||
163167775|NCT01206322|589330632|FG003|Overall Study|Adverse Event|1|||
163167776|NCT00003590|589330636|FG000|Overall Study|Ineligible Patient|1|||
163167777|NCT00003590|589330636|FG000|Overall Study|Adverse Event|7|||
163167778|NCT00003590|589330636|FG000|Overall Study|Withdrawal by Subject|1|||
163167779|NCT00003590|589330636|FG000|Overall Study|Lack of Efficacy|11|||
163167780|NCT00003590|589330636|FG000|Overall Study|Death|1|||
163167781|NCT00003590|589330636|FG000|Overall Study|Physician Decision|1|||
163167782|NCT01589653|589330637|FG000|Overall Study|Protocol Violation|3|||
163167783|NCT01589653|589330638|FG001|Overall Study|Protocol Violation|1|||
163167784|NCT01589653|589330637|FG000|Overall Study|Withdrawal criteria|4|||
163167785|NCT01589653|589330638|FG001|Overall Study|Withdrawal criteria|7|||
163167786|NCT01589653|589330637|FG000|Overall Study|Unclassified|0|||
163167787|NCT01589653|589330638|FG001|Overall Study|Unclassified|3|||
163167788|NCT03700684|589330641|FG000|Overall Study|COVID-19|0|||
163167789|NCT03700684|589330642|FG001|Overall Study|COVID-19|0|||
163167790|NCT03700684|589330643|FG002|Overall Study|COVID-19|2|||
163167791|NCT01767142|589330645|FG000|Overall Study|Lost to Follow-up|3|||
163167792|NCT03317405|589330646|FG000|Overall Study|Withdrawal by Subject|1|||
163167793|NCT03317405|589330647|FG001|Overall Study|Withdrawal by Subject|0|||
163167794|NCT03317405|589330648|FG002|Overall Study|Withdrawal by Subject|0|||
163167795|NCT03317405|589330646|FG000|Overall Study|Physician Decision|0|||
163167796|NCT03317405|589330647|FG001|Overall Study|Physician Decision|0|||
163167797|NCT03317405|589330648|FG002|Overall Study|Physician Decision|1|||
163167798|NCT03317405|589330646|FG000|Overall Study|Surgery Rescheduled|0|||
163167799|NCT03317405|589330647|FG001|Overall Study|Surgery Rescheduled|1|||
163167800|NCT03317405|589330648|FG002|Overall Study|Surgery Rescheduled|0|||
163167801|NCT00635219|589330649|FG000|Overall Study|Adverse Event|12|||
163167802|NCT00635219|589330650|FG001|Overall Study|Adverse Event|10|||
163167803|NCT00635219|589330651|FG002|Overall Study|Adverse Event|18|||
163167804|NCT00635219|589330652|FG003|Overall Study|Adverse Event|15|||
163167805|NCT00635219|589330653|FG004|Overall Study|Adverse Event|19|||
163167806|NCT00635219|589330649|FG000|Overall Study|Lack of Efficacy|5|||
163167807|NCT00635219|589330650|FG001|Overall Study|Lack of Efficacy|6|||
163167808|NCT00635219|589330651|FG002|Overall Study|Lack of Efficacy|3|||
163167809|NCT00635219|589330652|FG003|Overall Study|Lack of Efficacy|4|||
163167810|NCT00635219|589330653|FG004|Overall Study|Lack of Efficacy|6|||
163167811|NCT00635219|589330649|FG000|Overall Study|Non-compliance With Study Product|0|||
163167812|NCT00635219|589330650|FG001|Overall Study|Non-compliance With Study Product|0|||
163167813|NCT00635219|589330651|FG002|Overall Study|Non-compliance With Study Product|0|||
163167814|NCT00635219|589330652|FG003|Overall Study|Non-compliance With Study Product|2|||
163167815|NCT00635219|589330653|FG004|Overall Study|Non-compliance With Study Product|1|||
163167816|NCT00635219|589330649|FG000|Overall Study|Protocol Violation|0|||
163167817|NCT00635219|589330650|FG001|Overall Study|Protocol Violation|2|||
163167818|NCT00635219|589330651|FG002|Overall Study|Protocol Violation|3|||
163167819|NCT00635219|589330652|FG003|Overall Study|Protocol Violation|2|||
163167820|NCT00635219|589330653|FG004|Overall Study|Protocol Violation|4|||
163167821|NCT00635219|589330649|FG000|Overall Study|Withdrawal of Consent|8|||
163167822|NCT00635219|589330650|FG001|Overall Study|Withdrawal of Consent|6|||
163167823|NCT00635219|589330651|FG002|Overall Study|Withdrawal of Consent|8|||
163167824|NCT00635219|589330652|FG003|Overall Study|Withdrawal of Consent|11|||
163276741|NCT03873246|589723499|FG001|Overall Study|Withdrawal by Subject|4|||
163276742|NCT03873246|589723500|FG002|Overall Study|Withdrawal by Subject|1|||
163167825|NCT00635219|589330653|FG004|Overall Study|Withdrawal of Consent|8|||
163167826|NCT00635219|589330649|FG000|Overall Study|Lost to Follow-up|0|||
163167827|NCT00635219|589330650|FG001|Overall Study|Lost to Follow-up|0|||
163167828|NCT00635219|589330651|FG002|Overall Study|Lost to Follow-up|2|||
163167829|NCT00635219|589330652|FG003|Overall Study|Lost to Follow-up|0|||
163167830|NCT00635219|589330653|FG004|Overall Study|Lost to Follow-up|3|||
163167831|NCT00635219|589330649|FG000|Overall Study|Administrative or Other Reasons|0|||
163167832|NCT00635219|589330650|FG001|Overall Study|Administrative or Other Reasons|1|||
163167833|NCT00635219|589330651|FG002|Overall Study|Administrative or Other Reasons|1|||
163167834|NCT00635219|589330652|FG003|Overall Study|Administrative or Other Reasons|0|||
163167835|NCT00635219|589330653|FG004|Overall Study|Administrative or Other Reasons|1|||
163167836|NCT04093024|589330656|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
163167837|NCT04093024|589330657|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
163167838|NCT04093024|589330656|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
163167839|NCT04093024|589330657|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
163167840|NCT04093024|589330656|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
163167841|NCT04093024|589330657|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
163167842|NCT04093024|589330656|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
163167843|NCT04093024|589330657|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
163276743|NCT00885495|589723501|FG000|Overall Study|Adverse Event|1|||
163276744|NCT00885495|589723502|FG001|Overall Study|Adverse Event|2|||
163167844|NCT00435045|589330664|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
163167845|NCT00435045|589330665|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
163167846|NCT00435045|589330664|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
163167847|NCT00435045|589330665|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
163167848|NCT00435045|589330664|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
163167849|NCT00435045|589330665|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
163167850|NCT00435045|589330664|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
163167851|NCT00435045|589330665|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
163167852|NCT00435045|589330664|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
163167853|NCT00435045|589330665|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
163167854|NCT00435045|589330664|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
163167855|NCT00435045|589330665|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
163167856|NCT00435045|589330664|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
163167857|NCT00435045|589330665|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
163167858|NCT00435045|589330664|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
163167859|NCT00435045|589330665|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
163167860|NCT00435045|589330664|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
163167861|NCT00435045|589330665|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
163167862|NCT00435045|589330664|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
163167863|NCT00435045|589330665|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
163167864|NCT00435045|589330664|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
163167865|NCT00435045|589330665|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
163167866|NCT03052426|589330666|FG000|Overall Study|Withdrawal by Subject|0|||
163167867|NCT03052426|589330667|FG001|Overall Study|Withdrawal by Subject|1|||
163167868|NCT03052426|589330668|FG002|Overall Study|Withdrawal by Subject|0|||
163167869|NCT03052426|589330666|FG000|Overall Study|Lost to Follow-up|2|||
163167870|NCT03052426|589330667|FG001|Overall Study|Lost to Follow-up|0|||
163167871|NCT03052426|589330668|FG002|Overall Study|Lost to Follow-up|1|||
163167872|NCT01290796|589330675|FG000|Overall Study|Lost to Follow-up|21|||
163167873|NCT01290796|589330675|FG000|Overall Study|Withdrawal by Subject|4|||
163167874|NCT01290796|589330675|FG000|Overall Study|Physician Decision|2|||
163167875|NCT01290796|589330675|FG000|Overall Study|Secondary Surgical Intervention|2|||
163167876|NCT01290796|589330675|FG000|Overall Study|Withdrawal by Sponsor|1|||
163167877|NCT00865280|589330676|FG000|Overall Study|Withdrawal by Subject|4|||
163167878|NCT00865280|589330677|FG001|Overall Study|Withdrawal by Subject|1|||
163167879|NCT00865280|589330676|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
163167880|NCT00865280|589330677|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
163167881|NCT00865280|589330676|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
163167882|NCT00865280|589330677|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
163167883|NCT00865280|589330676|FG000|Overall Study|Exclusion Condition|1|||
163167884|NCT00865280|589330677|FG001|Overall Study|Exclusion Condition|0|||
163167885|NCT00865280|589330676|FG000|Overall Study|Adverse Event|0|||
163167886|NCT00865280|589330677|FG001|Overall Study|Adverse Event|1|||
163167887|NCT00329797|589330678|FG000|Overall Study|Protocol Violation|1|||
163167888|NCT00329797|589330679|FG001|Overall Study|Protocol Violation|0|||
163167889|NCT00329797|589330678|FG000|Overall Study|Withdrawal by Subject|6|||
163167890|NCT00329797|589330679|FG001|Overall Study|Withdrawal by Subject|6|||
163167891|NCT03091348|589330687|FG000|Overall Study|Lost to Follow-up|2|||
163167892|NCT03091348|589330688|FG001|Overall Study|Lost to Follow-up|1|||
163167893|NCT02087423|589330690|FG000|Overall Study|Withdrawal by Subject|20|||
163167894|NCT02087423|589330691|FG001|Overall Study|Withdrawal by Subject|20|||
163167895|NCT02087423|589330692|FG002|Overall Study|Withdrawal by Subject|3|||
163167896|NCT02087423|589330690|FG000|Overall Study|Death|68|||
163167897|NCT02087423|589330691|FG001|Overall Study|Death|207|||
163167898|NCT02087423|589330692|FG002|Overall Study|Death|40|||
163167899|NCT02087423|589330690|FG000|Overall Study|Lost to Follow-up|0|||
163167900|NCT02087423|589330691|FG001|Overall Study|Lost to Follow-up|2|||
163167901|NCT02087423|589330692|FG002|Overall Study|Lost to Follow-up|0|||
163167902|NCT02087423|589330690|FG000|Overall Study|Terminated from study at final DCO|23|||
163167903|NCT02087423|589330691|FG001|Overall Study|Terminated from study at final DCO|36|||
163167904|NCT02087423|589330692|FG002|Overall Study|Terminated from study at final DCO|25|||
163167905|NCT00499590|589330694|FG000|Overall Study|Study Terminated|112|||
163167906|NCT00499590|589330695|FG001|Overall Study|Study Terminated|112|||
163167907|NCT00499590|589330696|FG002|Overall Study|Study Terminated|112|||
163167908|NCT00499590|589330694|FG000|Overall Study|Not treated|1|||
163167909|NCT00499590|589330695|FG001|Overall Study|Not treated|0|||
163167910|NCT00499590|589330696|FG002|Overall Study|Not treated|1|||
163167911|NCT02633020|589330700|FG000|Overall Study|Adverse Event|1|||
163167912|NCT02633020|589330701|FG001|Overall Study|Adverse Event|0|||
163167913|NCT00934440|589330702|FG000|Overall Study|Lost to Follow-up|1|||
163167914|NCT05661851|589330703|FG000|Overall Study|Protocol Violation|1|||
163167915|NCT05661851|589330704|FG001|Overall Study|Protocol Violation|1|||
163167916|NCT05661851|589330703|FG000|Overall Study|Covid-19 Related|3|||
163167917|NCT05661851|589330704|FG001|Overall Study|Covid-19 Related|4|||
163167918|NCT05661851|589330703|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
163167919|NCT05661851|589330704|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
163167920|NCT05661851|589330703|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
163167921|NCT05661851|589330704|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
163167922|NCT02152956|589330705|FG000|Overall Study|Adverse Event|0|||
163167923|NCT02152956|589330706|FG001|Overall Study|Adverse Event|0|||
163167924|NCT02152956|589330707|FG002|Overall Study|Adverse Event|0|||
163167925|NCT02152956|589330708|FG003|Overall Study|Adverse Event|0|||
163167926|NCT02152956|589330709|FG004|Overall Study|Adverse Event|0|||
163167927|NCT02152956|589330710|FG005|Overall Study|Adverse Event|0|||
163167928|NCT02152956|589330711|FG006|Overall Study|Adverse Event|0|||
163167929|NCT02152956|589330712|FG007|Overall Study|Adverse Event|0|||
163167930|NCT02152956|589330713|FG008|Overall Study|Adverse Event|0|||
163167931|NCT02152956|589330714|FG009|Overall Study|Adverse Event|0|||
163167932|NCT02152956|589330715|FG010|Overall Study|Adverse Event|0|||
163167933|NCT02152956|589330716|FG011|Overall Study|Adverse Event|4|||
163167934|NCT02152956|589330717|FG012|Overall Study|Adverse Event|0|||
163167935|NCT02152956|589330705|FG000|Overall Study|Death|0|||
163167936|NCT02152956|589330706|FG001|Overall Study|Death|3|||
163167937|NCT02152956|589330707|FG002|Overall Study|Death|3|||
163167938|NCT02152956|589330708|FG003|Overall Study|Death|4|||
163167939|NCT02152956|589330709|FG004|Overall Study|Death|1|||
163167940|NCT02152956|589330710|FG005|Overall Study|Death|2|||
163167941|NCT02152956|589330711|FG006|Overall Study|Death|6|||
163167942|NCT02152956|589330712|FG007|Overall Study|Death|6|||
163167943|NCT02152956|589330713|FG008|Overall Study|Death|4|||
163167944|NCT02152956|589330714|FG009|Overall Study|Death|5|||
163167945|NCT02152956|589330715|FG010|Overall Study|Death|3|||
163167946|NCT02152956|589330716|FG011|Overall Study|Death|143|||
163167947|NCT02152956|589330717|FG012|Overall Study|Death|12|||
163167948|NCT02152956|589330705|FG000|Overall Study|Lost to Follow-up|0|||
163167949|NCT02152956|589330706|FG001|Overall Study|Lost to Follow-up|1|||
163167950|NCT02152956|589330707|FG002|Overall Study|Lost to Follow-up|0|||
163167951|NCT02152956|589330708|FG003|Overall Study|Lost to Follow-up|0|||
163167952|NCT02152956|589330709|FG004|Overall Study|Lost to Follow-up|0|||
163167953|NCT02152956|589330710|FG005|Overall Study|Lost to Follow-up|0|||
163167954|NCT02152956|589330711|FG006|Overall Study|Lost to Follow-up|0|||
163167955|NCT02152956|589330712|FG007|Overall Study|Lost to Follow-up|0|||
163167956|NCT02152956|589330713|FG008|Overall Study|Lost to Follow-up|0|||
163167957|NCT02152956|589330714|FG009|Overall Study|Lost to Follow-up|0|||
163167958|NCT02152956|589330715|FG010|Overall Study|Lost to Follow-up|0|||
163167959|NCT02152956|589330716|FG011|Overall Study|Lost to Follow-up|3|||
163167960|NCT02152956|589330717|FG012|Overall Study|Lost to Follow-up|0|||
163167961|NCT02152956|589330705|FG000|Overall Study|Withdrawal by Subject|1|||
163167962|NCT02152956|589330706|FG001|Overall Study|Withdrawal by Subject|0|||
163167963|NCT02152956|589330707|FG002|Overall Study|Withdrawal by Subject|1|||
163167964|NCT02152956|589330708|FG003|Overall Study|Withdrawal by Subject|0|||
163167965|NCT02152956|589330709|FG004|Overall Study|Withdrawal by Subject|2|||
163167966|NCT02152956|589330710|FG005|Overall Study|Withdrawal by Subject|2|||
163167967|NCT02152956|589330711|FG006|Overall Study|Withdrawal by Subject|0|||
163167968|NCT02152956|589330712|FG007|Overall Study|Withdrawal by Subject|0|||
163167969|NCT02152956|589330713|FG008|Overall Study|Withdrawal by Subject|1|||
163167970|NCT02152956|589330714|FG009|Overall Study|Withdrawal by Subject|0|||
163167971|NCT02152956|589330715|FG010|Overall Study|Withdrawal by Subject|0|||
163167972|NCT02152956|589330716|FG011|Overall Study|Withdrawal by Subject|4|||
163167973|NCT02152956|589330717|FG012|Overall Study|Withdrawal by Subject|0|||
163167974|NCT02152956|589330705|FG000|Overall Study|Physician Decision|0|||
163167975|NCT02152956|589330706|FG001|Overall Study|Physician Decision|0|||
163167976|NCT02152956|589330707|FG002|Overall Study|Physician Decision|0|||
163167977|NCT02152956|589330708|FG003|Overall Study|Physician Decision|0|||
163167978|NCT02152956|589330709|FG004|Overall Study|Physician Decision|0|||
163167979|NCT02152956|589330710|FG005|Overall Study|Physician Decision|0|||
163167980|NCT02152956|589330711|FG006|Overall Study|Physician Decision|0|||
163167981|NCT02152956|589330712|FG007|Overall Study|Physician Decision|0|||
163167982|NCT02152956|589330713|FG008|Overall Study|Physician Decision|0|||
163167983|NCT02152956|589330714|FG009|Overall Study|Physician Decision|0|||
163167984|NCT02152956|589330715|FG010|Overall Study|Physician Decision|0|||
163167985|NCT02152956|589330716|FG011|Overall Study|Physician Decision|1|||
163167986|NCT02152956|589330717|FG012|Overall Study|Physician Decision|0|||
163167987|NCT02152956|589330705|FG000|Overall Study|Study terminated by sponsor|0|||
163167988|NCT02152956|589330706|FG001|Overall Study|Study terminated by sponsor|0|||
163167989|NCT02152956|589330707|FG002|Overall Study|Study terminated by sponsor|0|||
163167990|NCT02152956|589330708|FG003|Overall Study|Study terminated by sponsor|0|||
163167991|NCT02152956|589330709|FG004|Overall Study|Study terminated by sponsor|0|||
163167992|NCT02152956|589330710|FG005|Overall Study|Study terminated by sponsor|0|||
163167993|NCT02152956|589330711|FG006|Overall Study|Study terminated by sponsor|0|||
163167994|NCT02152956|589330712|FG007|Overall Study|Study terminated by sponsor|0|||
163167995|NCT02152956|589330713|FG008|Overall Study|Study terminated by sponsor|0|||
163167996|NCT02152956|589330714|FG009|Overall Study|Study terminated by sponsor|0|||
163167997|NCT02152956|589330715|FG010|Overall Study|Study terminated by sponsor|0|||
163167998|NCT02152956|589330716|FG011|Overall Study|Study terminated by sponsor|29|||
163167999|NCT02152956|589330717|FG012|Overall Study|Study terminated by sponsor|0|||
163168000|NCT02152956|589330705|FG000|Overall Study|progressive disease|0|||
163168001|NCT02152956|589330706|FG001|Overall Study|progressive disease|0|||
163168002|NCT02152956|589330707|FG002|Overall Study|progressive disease|0|||
163168003|NCT02152956|589330708|FG003|Overall Study|progressive disease|0|||
163168004|NCT02152956|589330709|FG004|Overall Study|progressive disease|0|||
163168005|NCT02152956|589330710|FG005|Overall Study|progressive disease|0|||
163168006|NCT02152956|589330711|FG006|Overall Study|progressive disease|0|||
163168007|NCT02152956|589330712|FG007|Overall Study|progressive disease|0|||
163168008|NCT02152956|589330713|FG008|Overall Study|progressive disease|1|||
163168009|NCT02152956|589330714|FG009|Overall Study|progressive disease|0|||
163168010|NCT02152956|589330715|FG010|Overall Study|progressive disease|0|||
163168011|NCT02152956|589330716|FG011|Overall Study|progressive disease|1|||
163168012|NCT02152956|589330717|FG012|Overall Study|progressive disease|0|||
163168013|NCT01014910|589330718|FG000|Overall Study|Withdrawal by Subject|0|||
163168014|NCT01014910|589330719|FG001|Overall Study|Withdrawal by Subject|2|||
163168015|NCT03753789|589330720|FG000|Overall Study|Withdrawal by Subject|2|||
163168016|NCT00744042|589330724|FG000|Overall Study|Withdrawal by Subject|1|||
163168017|NCT00853567|589330725|FG000|Overall Study|Study prematurely terminated|71|||
163168018|NCT00782834|589330729|FG000|Treatment Phase|fibrous tumor not GIST|1|||
163168019|NCT02055118|589330730|FG000|Overall Study|Withdrawal by Subject|0|||
163168020|NCT02055118|589330731|FG001|Overall Study|Withdrawal by Subject|2|||
163168021|NCT02055118|589330732|FG002|Overall Study|Withdrawal by Subject|0|||
163168022|NCT02281383|589330734|FG000|Overall Study|Progressive Disease|1|||
163168023|NCT02281383|589330734|FG000|Overall Study|Withdrawal by Subject|6|||
163168024|NCT02281383|589330734|FG000|Overall Study|Protocol Violation|2|||
163168025|NCT02281383|589330734|FG000|Overall Study|Death|1|||
163168026|NCT02281383|589330734|FG000|Overall Study|Adverse Event|2|||
163168027|NCT02252939|589330735|FG000|Overall Study|Lost to Follow-up|3|||
163168028|NCT04270370|589330736|FG000|Overall Study|Lost to Follow-up|1|||
163168029|NCT04270370|589330737|FG001|Overall Study|Lost to Follow-up|0|||
163168030|NCT04270370|589330738|FG002|Overall Study|Lost to Follow-up|0|||
163168031|NCT04270370|589330739|FG003|Overall Study|Lost to Follow-up|0|||
163168032|NCT04270370|589330740|FG004|Overall Study|Lost to Follow-up|0|||
163168033|NCT04270370|589330741|FG005|Overall Study|Lost to Follow-up|0|||
163168034|NCT04270370|589330742|FG006|Overall Study|Lost to Follow-up|0|||
163168035|NCT04270370|589330743|FG007|Overall Study|Lost to Follow-up|0|||
163168036|NCT04270370|589330744|FG008|Overall Study|Lost to Follow-up|1|||
163168037|NCT04270370|589330745|FG009|Overall Study|Lost to Follow-up|0|||
163168038|NCT04270370|589330746|FG010|Overall Study|Lost to Follow-up|0|||
163168039|NCT04270370|589330747|FG011|Overall Study|Lost to Follow-up|0|||
163168040|NCT01324141|589330748|FG000|Overall Study|Declined to participate before treatment started|1|||
163168041|NCT01324141|589330748|FG000|Overall Study|Disease progression on study|1|||
163168042|NCT00599339|589330751|FG000|Overall Study|Adverse Event|79|||
163168043|NCT00599339|589330751|FG000|Overall Study|Withdrawal by Subject|137|||
163168044|NCT00599339|589330751|FG000|Overall Study|Other Reason|179|||
163168045|NCT00599339|589330751|FG000|Overall Study|Lost to Follow-up|221|||
163168046|NCT00599339|589330751|FG000|Overall Study|No valid data consent|36|||
163168047|NCT00599339|589330751|FG000|Overall Study|Study Termination Status Unknown|12|||
163168048|NCT04189224|589330752|FG000|Period 2|Adverse Event|0|||
163168049|NCT04189224|589330753|FG001|Period 2|Adverse Event|1|||
163168050|NCT00336856|589332263|FG000|Overall Study|Withdrawal by Subject|3|||
163168051|NCT00336856|589332263|FG000|Overall Study|Found ineligible at time of analysis|1|||
163168052|NCT00843778|589332276|FG000|Overall Study|Adverse Event|15|||
163168053|NCT00843778|589332276|FG000|Overall Study|Lack of Efficacy|14|||
163168054|NCT00843778|589332276|FG000|Overall Study|Loss of efficacy|2|||
163168055|NCT00843778|589332276|FG000|Overall Study|Withdrawal by Subject|4|||
163168056|NCT00830869|589332279|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
163168057|NCT00830869|589332280|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
163168058|NCT00830869|589332281|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
163168059|NCT00830869|589332282|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
163168060|NCT00830869|589332283|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
163168061|NCT00830869|589332284|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
163168062|NCT00830869|589332285|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
163168063|NCT00830869|589332286|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
163168064|NCT00830869|589332287|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
163168065|NCT00830869|589332288|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
163168066|NCT00830869|589332289|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
163168067|NCT00830869|589332290|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
163168068|NCT00830869|589332279|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
163168069|NCT00830869|589332280|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
163168070|NCT00830869|589332281|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
163168071|NCT00830869|589332282|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
163168072|NCT00830869|589332283|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
163168073|NCT00830869|589332284|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
163168074|NCT00830869|589332285|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
163168075|NCT00830869|589332286|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
163168076|NCT00830869|589332287|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
163168077|NCT00830869|589332288|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
163168078|NCT00830869|589332289|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
163168079|NCT00830869|589332290|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
163168080|NCT00830869|589332279|FG000|Period 1: Part 1|Adverse Event|0|||
163168081|NCT00830869|589332280|FG001|Period 1: Part 1|Adverse Event|0|||
163168082|NCT00830869|589332281|FG002|Period 1: Part 1|Adverse Event|0|||
163168083|NCT00830869|589332282|FG003|Period 1: Part 1|Adverse Event|0|||
163168084|NCT00830869|589332283|FG004|Period 1: Part 1|Adverse Event|0|||
163168085|NCT00830869|589332284|FG005|Period 1: Part 1|Adverse Event|1|||
163168086|NCT00830869|589332285|FG006|Period 1: Part 1|Adverse Event|1|||
163168087|NCT00830869|589332286|FG007|Period 1: Part 1|Adverse Event|0|||
163168088|NCT00830869|589332287|FG008|Period 1: Part 1|Adverse Event|0|||
163168089|NCT00830869|589332288|FG009|Period 1: Part 1|Adverse Event|0|||
163168090|NCT00830869|589332289|FG010|Period 1: Part 1|Adverse Event|0|||
163168091|NCT00830869|589332290|FG011|Period 1: Part 1|Adverse Event|0|||
163168092|NCT00830869|589332279|FG000|Period 1: Part 1|Progressive disease|1|||
163168093|NCT00830869|589332280|FG001|Period 1: Part 1|Progressive disease|0|||
163168094|NCT00830869|589332281|FG002|Period 1: Part 1|Progressive disease|1|||
163168095|NCT00830869|589332282|FG003|Period 1: Part 1|Progressive disease|6|||
163168096|NCT00830869|589332283|FG004|Period 1: Part 1|Progressive disease|4|||
163168097|NCT00830869|589332284|FG005|Period 1: Part 1|Progressive disease|4|||
163168098|NCT00830869|589332285|FG006|Period 1: Part 1|Progressive disease|1|||
163168099|NCT00830869|589332286|FG007|Period 1: Part 1|Progressive disease|0|||
163168100|NCT00830869|589332287|FG008|Period 1: Part 1|Progressive disease|0|||
163168101|NCT00830869|589332288|FG009|Period 1: Part 1|Progressive disease|0|||
163168102|NCT00830869|589332289|FG010|Period 1: Part 1|Progressive disease|0|||
163168103|NCT00830869|589332290|FG011|Period 1: Part 1|Progressive disease|0|||
163168104|NCT00830869|589332279|FG000|Period 2: Part 2|Protocol Violation|0|||
163168105|NCT00830869|589332280|FG001|Period 2: Part 2|Protocol Violation|0|||
163168106|NCT00830869|589332281|FG002|Period 2: Part 2|Protocol Violation|0|||
163168107|NCT00830869|589332282|FG003|Period 2: Part 2|Protocol Violation|0|||
163168108|NCT00830869|589332283|FG004|Period 2: Part 2|Protocol Violation|0|||
163168109|NCT00830869|589332284|FG005|Period 2: Part 2|Protocol Violation|0|||
163168110|NCT00830869|589332285|FG006|Period 2: Part 2|Protocol Violation|0|||
163168111|NCT00830869|589332286|FG007|Period 2: Part 2|Protocol Violation|1|||
163168112|NCT00830869|589332287|FG008|Period 2: Part 2|Protocol Violation|0|||
163168113|NCT00830869|589332288|FG009|Period 2: Part 2|Protocol Violation|1|||
163168114|NCT00830869|589332289|FG010|Period 2: Part 2|Protocol Violation|0|||
163168115|NCT00830869|589332290|FG011|Period 2: Part 2|Protocol Violation|0|||
163168116|NCT00830869|589332279|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
163168117|NCT00830869|589332280|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
163168118|NCT00830869|589332281|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
163168119|NCT00830869|589332282|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
163168120|NCT00830869|589332283|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
163168121|NCT00830869|589332284|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
163168122|NCT00830869|589332285|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
163168123|NCT00830869|589332286|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
163168124|NCT00830869|589332287|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
163168125|NCT00830869|589332288|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
163168126|NCT00830869|589332289|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
163168127|NCT00830869|589332290|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
163168128|NCT00830869|589332279|FG000|Period 2: Part 2|Adverse Event|0|||
163168129|NCT00830869|589332280|FG001|Period 2: Part 2|Adverse Event|0|||
163168130|NCT00830869|589332281|FG002|Period 2: Part 2|Adverse Event|0|||
163168131|NCT00830869|589332282|FG003|Period 2: Part 2|Adverse Event|0|||
163168132|NCT00830869|589332283|FG004|Period 2: Part 2|Adverse Event|0|||
163168133|NCT00830869|589332284|FG005|Period 2: Part 2|Adverse Event|0|||
163168134|NCT00830869|589332285|FG006|Period 2: Part 2|Adverse Event|0|||
163168135|NCT00830869|589332286|FG007|Period 2: Part 2|Adverse Event|4|||
163168136|NCT00830869|589332287|FG008|Period 2: Part 2|Adverse Event|3|||
163168137|NCT00830869|589332288|FG009|Period 2: Part 2|Adverse Event|2|||
163168138|NCT00830869|589332289|FG010|Period 2: Part 2|Adverse Event|2|||
163168139|NCT00830869|589332290|FG011|Period 2: Part 2|Adverse Event|0|||
163168140|NCT00830869|589332279|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
163168141|NCT00830869|589332280|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
163168142|NCT00830869|589332281|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
163168143|NCT00830869|589332282|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
163168144|NCT00830869|589332283|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
163168145|NCT00830869|589332284|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
163168146|NCT00830869|589332285|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
163168147|NCT00830869|589332286|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
163168148|NCT00830869|589332287|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
163168149|NCT00830869|589332288|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
163168150|NCT00830869|589332289|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
163168151|NCT00830869|589332290|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
163168152|NCT00830869|589332279|FG000|Period 2: Part 2|Progressive disease|0|||
163168153|NCT00830869|589332280|FG001|Period 2: Part 2|Progressive disease|0|||
163168154|NCT00830869|589332281|FG002|Period 2: Part 2|Progressive disease|0|||
163168155|NCT00830869|589332282|FG003|Period 2: Part 2|Progressive disease|0|||
163168156|NCT00830869|589332283|FG004|Period 2: Part 2|Progressive disease|0|||
163168157|NCT00830869|589332284|FG005|Period 2: Part 2|Progressive disease|0|||
163168158|NCT00830869|589332285|FG006|Period 2: Part 2|Progressive disease|0|||
163168159|NCT00830869|589332286|FG007|Period 2: Part 2|Progressive disease|14|||
163168160|NCT00830869|589332287|FG008|Period 2: Part 2|Progressive disease|11|||
163168161|NCT00830869|589332288|FG009|Period 2: Part 2|Progressive disease|12|||
163168162|NCT00830869|589332289|FG010|Period 2: Part 2|Progressive disease|8|||
163168163|NCT00830869|589332290|FG011|Period 2: Part 2|Progressive disease|15|||
163168164|NCT00830869|589332279|FG000|Period 2: Part 2|Other|0|||
163168165|NCT00830869|589332280|FG001|Period 2: Part 2|Other|0|||
163168166|NCT00830869|589332281|FG002|Period 2: Part 2|Other|0|||
163168167|NCT00830869|589332282|FG003|Period 2: Part 2|Other|0|||
163168168|NCT00830869|589332283|FG004|Period 2: Part 2|Other|0|||
163168169|NCT00830869|589332284|FG005|Period 2: Part 2|Other|0|||
163168170|NCT00830869|589332285|FG006|Period 2: Part 2|Other|0|||
163168171|NCT00830869|589332286|FG007|Period 2: Part 2|Other|0|||
163168172|NCT00830869|589332287|FG008|Period 2: Part 2|Other|0|||
163168173|NCT00830869|589332288|FG009|Period 2: Part 2|Other|1|||
163168174|NCT00830869|589332289|FG010|Period 2: Part 2|Other|0|||
163168175|NCT00830869|589332290|FG011|Period 2: Part 2|Other|0|||
163168176|NCT00507728|589332291|FG000|Randomization to Month 3|Lost to Follow-up|15|||
163168177|NCT00507728|589332292|FG001|Randomization to Month 3|Lost to Follow-up|14|||
163168178|NCT00507728|589332293|FG002|Randomization to Month 3|Lost to Follow-up|20|||
163168179|NCT00507728|589332291|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
163168180|NCT00507728|589332292|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
163168181|NCT00507728|589332293|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
163168182|NCT00730028|589332295|FG000|Overall Study|Adverse Event|23|||
163168183|NCT00730028|589332296|FG001|Overall Study|Adverse Event|26|||
163168184|NCT00730028|589332297|FG002|Overall Study|Adverse Event|16|||
163168185|NCT00730028|589332298|FG003|Overall Study|Adverse Event|20|||
163168186|NCT00730028|589332299|FG004|Overall Study|Adverse Event|43|||
163168187|NCT00730028|589332295|FG000|Overall Study|Lost to Follow-up|13|||
163168188|NCT00730028|589332296|FG001|Overall Study|Lost to Follow-up|26|||
163168189|NCT00730028|589332297|FG002|Overall Study|Lost to Follow-up|22|||
163168190|NCT00730028|589332298|FG003|Overall Study|Lost to Follow-up|26|||
163168191|NCT00730028|589332299|FG004|Overall Study|Lost to Follow-up|25|||
163168192|NCT00730028|589332295|FG000|Overall Study|Protocol Violation|6|||
163168193|NCT00730028|589332296|FG001|Overall Study|Protocol Violation|1|||
163168194|NCT00730028|589332297|FG002|Overall Study|Protocol Violation|1|||
163168195|NCT00730028|589332298|FG003|Overall Study|Protocol Violation|2|||
163168196|NCT00730028|589332299|FG004|Overall Study|Protocol Violation|0|||
163168197|NCT00730028|589332295|FG000|Overall Study|Withdrawal by Subject|9|||
163168198|NCT00730028|589332296|FG001|Overall Study|Withdrawal by Subject|5|||
163168199|NCT00730028|589332297|FG002|Overall Study|Withdrawal by Subject|4|||
163168200|NCT00730028|589332298|FG003|Overall Study|Withdrawal by Subject|5|||
163168201|NCT00730028|589332299|FG004|Overall Study|Withdrawal by Subject|9|||
163168202|NCT00730028|589332295|FG000|Overall Study|Physician Decision|3|||
163168203|NCT00730028|589332296|FG001|Overall Study|Physician Decision|3|||
163168204|NCT00730028|589332297|FG002|Overall Study|Physician Decision|2|||
163168205|NCT00730028|589332298|FG003|Overall Study|Physician Decision|3|||
163168206|NCT00730028|589332299|FG004|Overall Study|Physician Decision|2|||
163168207|NCT00730028|589332295|FG000|Overall Study|Treatment Failure|5|||
163168208|NCT00730028|589332296|FG001|Overall Study|Treatment Failure|5|||
163168209|NCT00730028|589332297|FG002|Overall Study|Treatment Failure|0|||
163168210|NCT00730028|589332298|FG003|Overall Study|Treatment Failure|0|||
163276745|NCT00885495|589723501|FG000|Overall Study|Protocol Violation|0|||
163276746|NCT00885495|589723502|FG001|Overall Study|Protocol Violation|1|||
163168211|NCT00730028|589332299|FG004|Overall Study|Treatment Failure|1|||
163168212|NCT00730028|589332295|FG000|Overall Study|Randomization Error|1|||
163168213|NCT00730028|589332296|FG001|Overall Study|Randomization Error|0|||
163168214|NCT00730028|589332297|FG002|Overall Study|Randomization Error|0|||
163168215|NCT00730028|589332298|FG003|Overall Study|Randomization Error|0|||
163276747|NCT00885495|589723501|FG000|Overall Study|Withdrawal by Subject|1|||
163276748|NCT00885495|589723502|FG001|Overall Study|Withdrawal by Subject|0|||
163168216|NCT00730028|589332299|FG004|Overall Study|Randomization Error|2|||
163276749|NCT02107443|589723503|FG000|Overall Study|Death|42|||
163168217|NCT00615901|589332300|FG000|Overall Study|Withdrawal by Subject|2|||
163168218|NCT00615901|589332300|FG000|Overall Study|Adverse Event|7|||
163168219|NCT01250496|589332301|FG000|Overall Study|Study terminated|124|||
163168220|NCT01250496|589332302|FG001|Overall Study|Study terminated|124|||
163168221|NCT01425463|589332310|FG000|Overall Study|Adverse Event|5|||
163168222|NCT01425463|589332311|FG001|Overall Study|Adverse Event|7|||
163168223|NCT01425463|589332310|FG000|Overall Study|Lack of Efficacy|1|||
163168224|NCT01425463|589332311|FG001|Overall Study|Lack of Efficacy|1|||
163168225|NCT01425463|589332310|FG000|Overall Study|Protocol Violation|2|||
163168226|NCT01425463|589332311|FG001|Overall Study|Protocol Violation|2|||
163168227|NCT01425463|589332310|FG000|Overall Study|Lost to Follow-up|5|||
163168228|NCT01425463|589332311|FG001|Overall Study|Lost to Follow-up|2|||
163168229|NCT01425463|589332310|FG000|Overall Study|Withdrawal by Subject|7|||
163168230|NCT01425463|589332311|FG001|Overall Study|Withdrawal by Subject|5|||
163168231|NCT01425463|589332310|FG000|Overall Study|Unknown Reason|4|||
163168232|NCT01425463|589332311|FG001|Overall Study|Unknown Reason|7|||
163168233|NCT01332799|589332312|FG000|Overall Study|Insufficient funding|10|||
163168234|NCT01332799|589332313|FG001|Overall Study|Insufficient funding|10|||
163168235|NCT03467152|589332314|FG000|Overall Study|Adverse Event|4|||
163168236|NCT03467152|589332315|FG001|Overall Study|Adverse Event|5|||
163168237|NCT03467152|589332316|FG002|Overall Study|Adverse Event|0|||
163168238|NCT03467152|589332314|FG000|Overall Study|Subject Choice|1|||
163168239|NCT03467152|589332315|FG001|Overall Study|Subject Choice|3|||
163168240|NCT03467152|589332316|FG002|Overall Study|Subject Choice|0|||
163168241|NCT03467152|589332314|FG000|Overall Study|Lost to Follow-up|1|||
163168242|NCT03467152|589332315|FG001|Overall Study|Lost to Follow-up|0|||
163168243|NCT03467152|589332316|FG002|Overall Study|Lost to Follow-up|0|||
163168244|NCT03467152|589332314|FG000|Overall Study|Withdrawal by Subject|4|||
163168245|NCT03467152|589332315|FG001|Overall Study|Withdrawal by Subject|2|||
163168246|NCT03467152|589332316|FG002|Overall Study|Withdrawal by Subject|0|||
163168247|NCT03467152|589332314|FG000|Overall Study|Others|3|||
163168248|NCT03467152|589332315|FG001|Overall Study|Others|0|||
163168249|NCT03467152|589332316|FG002|Overall Study|Others|0|||
163168250|NCT03467152|589332314|FG000|Overall Study|Not treated|3|||
163168251|NCT03467152|589332315|FG001|Overall Study|Not treated|1|||
163168252|NCT03467152|589332316|FG002|Overall Study|Not treated|6|||
163168253|NCT00945906|589332317|FG000|Overall Study|Withdrawal by Subject|1|||
163168254|NCT00945906|589332317|FG000|Overall Study|Did not want to return for last visit|2|||
163168255|NCT00945906|589332317|FG000|Overall Study|Unable to return for last visit|2|||
163168256|NCT00945906|589332317|FG000|Overall Study|Moved to another country|2|||
163168257|NCT01236547|589332319|FG000|Overall Study|Protocol Violation|0|||
163168258|NCT01236547|589332320|FG001|Overall Study|Protocol Violation|1|||
163168259|NCT01236547|589332321|FG002|Overall Study|Protocol Violation|1|||
163168260|NCT01236547|589332322|FG003|Overall Study|Protocol Violation|6|||
163168261|NCT01236547|589332323|FG004|Overall Study|Protocol Violation|12|||
163168262|NCT01120782|589332324|FG000|Overall Study|Test article shipping error|11|||
163168263|NCT04140227|589332325|FG000|Overall Study|Withdrawal by Subject|26|||
163168264|NCT04140227|589332325|FG000|Overall Study|Lost to Follow-up|8|||
163168265|NCT04140227|589332325|FG000|Overall Study|Adverse Event|8|||
163168266|NCT04140227|589332325|FG000|Overall Study|Death|1|||
163168267|NCT04140227|589332325|FG000|Overall Study|Other|3|||
163168268|NCT04140227|589332325|FG000|Overall Study|Protocol Violation|2|||
163168269|NCT00538785|589332326|FG000|Overall Study|Death|9|||
163168270|NCT00538785|589332327|FG001|Overall Study|Death|10|||
163168271|NCT00538785|589332326|FG000|Overall Study|Withdrawal of consent|9|||
163168272|NCT00538785|589332327|FG001|Overall Study|Withdrawal of consent|7|||
163168273|NCT00538785|589332326|FG000|Overall Study|Lost to Follow-up|1|||
163168274|NCT00538785|589332327|FG001|Overall Study|Lost to Follow-up|0|||
163168275|NCT04022733|589332328|FG000|Overall Study|conversion to open surgery|3|||
163168276|NCT04022733|589332329|FG001|Overall Study|conversion to open surgery|2|||
163168277|NCT04022733|589332328|FG000|Overall Study|bradycardia|0|||
163168278|NCT04022733|589332329|FG001|Overall Study|bradycardia|1|||
163168279|NCT01541397|589332330|FG000|Overall Study|Study ended prior to data collection|4|||
163168280|NCT01541397|589332331|FG001|Overall Study|Study ended prior to data collection|2|||
163168281|NCT00233454|589332332|FG000|Overall Study|Death|6|||
163168282|NCT04224688|589332333|FG000|Overall Study|Withdrawal by Subject|1|||
163168283|NCT04224688|589332334|FG001|Overall Study|Withdrawal by Subject|3|||
163168284|NCT04224688|589332333|FG000|Overall Study|Lack of Efficacy|1|||
163168285|NCT04224688|589332334|FG001|Overall Study|Lack of Efficacy|1|||
163168286|NCT04224688|589332333|FG000|Overall Study|Adverse event, not fatal|0|||
163168287|NCT04224688|589332334|FG001|Overall Study|Adverse event, not fatal|2|||
163168288|NCT04224688|589332333|FG000|Overall Study|COVID-19|0|||
163168289|NCT04224688|589332334|FG001|Overall Study|COVID-19|1|||
163168290|NCT03083990|589332335|FG000|Overall Study|Adverse Event|1|||
163168291|NCT03083990|589332336|FG001|Overall Study|Adverse Event|0|||
163168292|NCT01853839|589332337|FG000|Overall Study|Violated inclusion criteria|2|||
163168293|NCT01853839|589332337|FG000|Overall Study|Not meet ITT population definition|58|||
163168294|NCT01853839|589332337|FG000|Overall Study|End of treatment visit too early|33|||
163168295|NCT01853839|589332337|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
163168296|NCT01640314|589332338|FG000|Overall Study|Protocol Violation|0|||
163168297|NCT01640314|589332339|FG001|Overall Study|Protocol Violation|1|||
163168298|NCT02709538|589332341|FG000|Overall Study|Adverse Event|13|||
163168299|NCT02709538|589332342|FG001|Overall Study|Adverse Event|2|||
163168300|NCT02709538|589332343|FG002|Overall Study|Adverse Event|3|||
163168301|NCT02709538|589332341|FG000|Overall Study|Lack of Efficacy|1|||
163168302|NCT02709538|589332342|FG001|Overall Study|Lack of Efficacy|0|||
163168303|NCT02709538|589332343|FG002|Overall Study|Lack of Efficacy|0|||
163168304|NCT02709538|589332341|FG000|Overall Study|Lost to Follow-up|24|||
163168305|NCT02709538|589332342|FG001|Overall Study|Lost to Follow-up|8|||
163168306|NCT02709538|589332343|FG002|Overall Study|Lost to Follow-up|4|||
163168307|NCT02709538|589332341|FG000|Overall Study|Physician Decision|1|||
163168308|NCT02709538|589332342|FG001|Overall Study|Physician Decision|0|||
163168309|NCT02709538|589332343|FG002|Overall Study|Physician Decision|0|||
163168310|NCT02709538|589332341|FG000|Overall Study|Withdrawal by Subject|40|||
163168311|NCT02709538|589332342|FG001|Overall Study|Withdrawal by Subject|7|||
163168312|NCT02709538|589332343|FG002|Overall Study|Withdrawal by Subject|4|||
163168313|NCT02709538|589332341|FG000|Overall Study|Non-compliance with study procedures|5|||
163168314|NCT02709538|589332342|FG001|Overall Study|Non-compliance with study procedures|0|||
163168315|NCT02709538|589332343|FG002|Overall Study|Non-compliance with study procedures|0|||
163168316|NCT02709538|589332341|FG000|Overall Study|Non-compliance with study drug|2|||
163168317|NCT02709538|589332342|FG001|Overall Study|Non-compliance with study drug|0|||
163168318|NCT02709538|589332343|FG002|Overall Study|Non-compliance with study drug|0|||
163168319|NCT02709538|589332341|FG000|Overall Study|Protocol deviation|10|||
163168320|NCT02709538|589332342|FG001|Overall Study|Protocol deviation|4|||
163168321|NCT02709538|589332343|FG002|Overall Study|Protocol deviation|4|||
163168322|NCT02709538|589332341|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
163168323|NCT02709538|589332342|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
163168324|NCT02709538|589332343|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
163168325|NCT02709538|589332341|FG000|Overall Study|Other|16|||
163168326|NCT02709538|589332342|FG001|Overall Study|Other|7|||
163168327|NCT02709538|589332343|FG002|Overall Study|Other|5|||
163168328|NCT00835211|589332345|FG000|First Intervention|Withdrawal by Subject|0|||
163168329|NCT00835211|589332346|FG001|First Intervention|Withdrawal by Subject|1|||
163168330|NCT00835211|589332345|FG000|Washout: 7 Days|Adverse Event|2|||
163168331|NCT00835211|589332346|FG001|Washout: 7 Days|Adverse Event|1|||
163168332|NCT00835211|589332345|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
163168333|NCT00835211|589332346|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
163168334|NCT02343549|589332347|FG000|Overall Study|Death|11|||
163168335|NCT02343549|589332347|FG000|Overall Study|Withdrawal by Subject|2|||
163168336|NCT03087617|589332348|FG000|Overall Study|Lost to Follow-up|32|||
163168337|NCT03087617|589332349|FG001|Overall Study|Lost to Follow-up|30|||
163168338|NCT03087617|589332350|FG002|Overall Study|Lost to Follow-up|30|||
163168339|NCT03087617|589332351|FG003|Overall Study|Lost to Follow-up|39|||
163168340|NCT02160041|589332353|FG000|Overall Study|Adverse Event|11|||
163168341|NCT02160041|589332353|FG000|Overall Study|Death|2|||
163168342|NCT02160041|589332353|FG000|Overall Study|disease progression|57|||
163168343|NCT02160041|589332353|FG000|Overall Study|Protocol Violation|1|||
163168344|NCT02160041|589332353|FG000|Overall Study|non-compliance with study|1|||
163168345|NCT02160041|589332353|FG000|Overall Study|Physician Decision|3|||
163168346|NCT02160041|589332353|FG000|Overall Study|Withdrawal by Subject|8|||
163168347|NCT02160041|589332353|FG000|Overall Study|study terminated by by sponsor|1|||
163168348|NCT04450381|589332354|FG000|Overall Study|Protocol Violation|4|||
163168349|NCT04450381|589332354|FG000|Overall Study|Wrong device setting|2|||
163168350|NCT00006409|589332357|FG000|Baseline|Protocol Violation|48|||
163168351|NCT00006409|589332358|FG001|Baseline|Protocol Violation|70|||
163168352|NCT00006409|589332359|FG002|Baseline|Protocol Violation|0|||
163168353|NCT00006409|589332360|FG003|Baseline|Protocol Violation|0|||
163168354|NCT00006409|589332361|FG004|Baseline|Protocol Violation|0|||
163168355|NCT00006409|589332362|FG005|Baseline|Protocol Violation|0|||
163168356|NCT00006409|589332357|FG000|Post-2 Year Intervention|Protocol Violation|0|||
163168357|NCT00006409|589332358|FG001|Post-2 Year Intervention|Protocol Violation|0|||
163168358|NCT00006409|589332359|FG002|Post-2 Year Intervention|Protocol Violation|251|||
163168359|NCT00006409|589332360|FG003|Post-2 Year Intervention|Protocol Violation|168|||
163168360|NCT00006409|589332361|FG004|Post-2 Year Intervention|Protocol Violation|0|||
163168361|NCT00006409|589332362|FG005|Post-2 Year Intervention|Protocol Violation|0|||
163168362|NCT00006409|589332357|FG000|Post-3 Year Intervention|Protocol Violation|0|||
163168363|NCT00006409|589332358|FG001|Post-3 Year Intervention|Protocol Violation|0|||
163168364|NCT00006409|589332359|FG002|Post-3 Year Intervention|Protocol Violation|0|||
163168365|NCT00006409|589332360|FG003|Post-3 Year Intervention|Protocol Violation|0|||
163168366|NCT00006409|589332361|FG004|Post-3 Year Intervention|Protocol Violation|62|||
163168367|NCT00006409|589332362|FG005|Post-3 Year Intervention|Protocol Violation|62|||
163168368|NCT04343235|589332365|FG000|Overall Study|Lost to Follow-up|3|||
163168369|NCT04343235|589332366|FG001|Overall Study|Lost to Follow-up|2|||
163168370|NCT00787267|589332367|FG000|Overall Study|Screen failure/Ineligible|10|||
163168371|NCT00787267|589332367|FG000|Overall Study|No Reason Provided|1|||
163168372|NCT00787267|589332367|FG000|Overall Study|Withdrawal by Subject|1|||
163276750|NCT02107443|589723504|FG001|Overall Study|Death|30|||
163276751|NCT02107443|589723503|FG000|Overall Study|Study Protocol Violation|3|||
163168373|NCT01763996|589332368|FG000|Treatment Period 2|Adverse Event|0|||
163168374|NCT01763996|589332369|FG001|Treatment Period 2|Adverse Event|1|||
163168375|NCT00776919|589332370|FG000|Overall Study|Withdrawal by Subject|16|||
163168376|NCT00776919|589332371|FG001|Overall Study|Withdrawal by Subject|14|||
163168377|NCT00776919|589332372|FG002|Overall Study|Withdrawal by Subject|15|||
163168378|NCT00776919|589332373|FG003|Overall Study|Withdrawal by Subject|26|||
163168379|NCT00776919|589332370|FG000|Overall Study|Lost to Follow-up|8|||
163168380|NCT00776919|589332371|FG001|Overall Study|Lost to Follow-up|12|||
163168381|NCT00776919|589332372|FG002|Overall Study|Lost to Follow-up|11|||
163168382|NCT00776919|589332373|FG003|Overall Study|Lost to Follow-up|8|||
163276752|NCT02107443|589723504|FG001|Overall Study|Study Protocol Violation|1|||
163276753|NCT02107443|589723503|FG000|Overall Study|Registered but Not Eligible|0|||
163276754|NCT02107443|589723504|FG001|Overall Study|Registered but Not Eligible|1|||
163276755|NCT02107443|589723503|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
163276756|NCT02107443|589723504|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
163276757|NCT02107443|589723503|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
163276758|NCT02107443|589723504|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
163276759|NCT02107443|589723503|FG000|Overall Study|Withdrawal: Changed Mind|2|||
163276760|NCT02107443|589723504|FG001|Overall Study|Withdrawal: Changed Mind|0|||
163276761|NCT02107443|589723503|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
163276762|NCT02107443|589723504|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
163276763|NCT02107443|589723503|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
163276764|NCT02107443|589723504|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
163276765|NCT02107443|589723503|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
163276766|NCT02107443|589723504|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
163276767|NCT02107443|589723503|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
163276768|NCT02107443|589723504|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
163276769|NCT02107443|589723503|FG000|Overall Study|Withdrawal: Other Medical|9|||
163276770|NCT02107443|589723504|FG001|Overall Study|Withdrawal: Other Medical|5|||
163276771|NCT02107443|589723503|FG000|Overall Study|Withdrawal: Disease Progression|4|||
163276772|NCT02107443|589723504|FG001|Overall Study|Withdrawal: Disease Progression|2|||
163276773|NCT02107443|589723503|FG000|Overall Study|Withdrawal: Personal Issues|0|||
163276774|NCT02107443|589723504|FG001|Overall Study|Withdrawal: Personal Issues|3|||
163276775|NCT00946647|589723505|FG000|Phase 1 Part|Adverse Event|2|||
163276776|NCT00946647|589723506|FG001|Phase 1 Part|Adverse Event|5|||
163276777|NCT00946647|589723507|FG002|Phase 1 Part|Adverse Event|3|||
163276778|NCT00946647|589723508|FG003|Phase 1 Part|Adverse Event|0|||
163276779|NCT00946647|589723509|FG004|Phase 1 Part|Adverse Event|0|||
163276780|NCT00946647|589723505|FG000|Phase 1 Part|Disease progression|3|||
163276781|NCT00946647|589723506|FG001|Phase 1 Part|Disease progression|6|||
163276782|NCT00946647|589723507|FG002|Phase 1 Part|Disease progression|1|||
163276783|NCT00946647|589723508|FG003|Phase 1 Part|Disease progression|0|||
163276784|NCT00946647|589723509|FG004|Phase 1 Part|Disease progression|0|||
163276785|NCT00946647|589723505|FG000|Phase 1 Part|Withdrawal by Subject|1|||
163276786|NCT00946647|589723506|FG001|Phase 1 Part|Withdrawal by Subject|4|||
163276787|NCT00946647|589723507|FG002|Phase 1 Part|Withdrawal by Subject|3|||
163276788|NCT00946647|589723508|FG003|Phase 1 Part|Withdrawal by Subject|0|||
163276789|NCT00946647|589723509|FG004|Phase 1 Part|Withdrawal by Subject|0|||
163276790|NCT00946647|589723505|FG000|Phase 1 Part|Abnormal values|0|||
163276791|NCT00946647|589723506|FG001|Phase 1 Part|Abnormal values|2|||
163276792|NCT00946647|589723507|FG002|Phase 1 Part|Abnormal values|0|||
163276793|NCT00946647|589723508|FG003|Phase 1 Part|Abnormal values|0|||
163276794|NCT00946647|589723509|FG004|Phase 1 Part|Abnormal values|0|||
163276795|NCT00946647|589723505|FG000|Phase 1 Part|Reason missing|0|||
163276796|NCT00946647|589723506|FG001|Phase 1 Part|Reason missing|1|||
163276797|NCT00946647|589723507|FG002|Phase 1 Part|Reason missing|0|||
163276798|NCT00946647|589723508|FG003|Phase 1 Part|Reason missing|0|||
163276799|NCT00946647|589723509|FG004|Phase 1 Part|Reason missing|0|||
163276800|NCT00946647|589723505|FG000|Phase ll Part|Untreated|0|||
163276801|NCT00946647|589723506|FG001|Phase ll Part|Untreated|0|||
163276802|NCT00946647|589723507|FG002|Phase ll Part|Untreated|0|||
163276803|NCT00946647|589723508|FG003|Phase ll Part|Untreated|0|||
163276804|NCT00946647|589723509|FG004|Phase ll Part|Untreated|2|||
163276805|NCT00946647|589723505|FG000|Phase ll Part|Adverse Event|0|||
163276806|NCT00946647|589723506|FG001|Phase ll Part|Adverse Event|0|||
163168383|NCT00776919|589332370|FG000|Overall Study|Adverse Event|1|||
163168384|NCT00776919|589332371|FG001|Overall Study|Adverse Event|0|||
163168385|NCT00776919|589332372|FG002|Overall Study|Adverse Event|2|||
163276807|NCT00946647|589723507|FG002|Phase ll Part|Adverse Event|0|||
163276808|NCT00946647|589723508|FG003|Phase ll Part|Adverse Event|10|||
163276809|NCT00946647|589723509|FG004|Phase ll Part|Adverse Event|6|||
163276810|NCT00946647|589723505|FG000|Phase ll Part|Withdrawal by Subject|0|||
163276811|NCT00946647|589723506|FG001|Phase ll Part|Withdrawal by Subject|0|||
163276812|NCT00946647|589723507|FG002|Phase ll Part|Withdrawal by Subject|0|||
163276813|NCT00946647|589723508|FG003|Phase ll Part|Withdrawal by Subject|8|||
163276814|NCT00946647|589723509|FG004|Phase ll Part|Withdrawal by Subject|6|||
163276815|NCT00946647|589723505|FG000|Phase ll Part|Administrative problems|0|||
163276816|NCT00946647|589723506|FG001|Phase ll Part|Administrative problems|0|||
163276817|NCT00946647|589723507|FG002|Phase ll Part|Administrative problems|0|||
163168386|NCT00776919|589332373|FG003|Overall Study|Adverse Event|2|||
163168387|NCT00776919|589332370|FG000|Overall Study|Protocol Violation|1|||
163168388|NCT00776919|589332371|FG001|Overall Study|Protocol Violation|2|||
163168389|NCT00776919|589332372|FG002|Overall Study|Protocol Violation|0|||
163168390|NCT00776919|589332373|FG003|Overall Study|Protocol Violation|1|||
163168391|NCT00776919|589332370|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
163168392|NCT00776919|589332371|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
163168393|NCT00776919|589332372|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
163168394|NCT00776919|589332373|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
163168395|NCT01396057|589332382|FG000|Overall Study|Adverse Event|2|||
163168396|NCT01396057|589332383|FG001|Overall Study|Adverse Event|6|||
163168397|NCT01396057|589332382|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163168398|NCT01396057|589332383|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
163168399|NCT01396057|589332382|FG000|Overall Study|Protocol deviation|4|||
163168400|NCT01396057|589332383|FG001|Overall Study|Protocol deviation|4|||
163168401|NCT01396057|589332382|FG000|Overall Study|Consent withdrawn|3|||
163168402|NCT01396057|589332383|FG001|Overall Study|Consent withdrawn|2|||
163168403|NCT00884741|589332386|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
163168404|NCT00884741|589332387|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
163168405|NCT00884741|589332388|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
163168406|NCT00884741|589332389|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
163168407|NCT00884741|589332386|FG000|Step 1 Registration: Tissue Screening|Death|3|||
163168408|NCT00884741|589332387|FG001|Step 1 Registration: Tissue Screening|Death|0|||
163168409|NCT00884741|589332388|FG002|Step 1 Registration: Tissue Screening|Death|0|||
163168410|NCT00884741|589332389|FG003|Step 1 Registration: Tissue Screening|Death|0|||
163168411|NCT00884741|589332386|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
163168412|NCT00884741|589332387|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
163168413|NCT00884741|589332388|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
163168414|NCT00884741|589332389|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
163168415|NCT00884741|589332386|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
163168416|NCT00884741|589332387|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
163168417|NCT00884741|589332388|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
163168418|NCT00884741|589332389|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
163168419|NCT00884741|589332386|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
163168420|NCT00884741|589332387|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
163168421|NCT00884741|589332388|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
163168422|NCT00884741|589332389|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
163168423|NCT00884741|589332386|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
163168424|NCT00884741|589332387|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
163168425|NCT00884741|589332388|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
163168426|NCT00884741|589332389|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
163168427|NCT00884741|589332386|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
163168428|NCT00884741|589332387|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
163168429|NCT00884741|589332388|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
163168430|NCT00884741|589332389|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
163168431|NCT00884741|589332386|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
163168432|NCT00884741|589332387|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
163168433|NCT00884741|589332388|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
163168434|NCT00884741|589332389|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
163168435|NCT00884741|589332386|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
163168436|NCT00884741|589332387|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
163168437|NCT00884741|589332388|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
163168438|NCT00884741|589332389|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
163168439|NCT00884741|589332386|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
163168440|NCT00884741|589332387|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
163168441|NCT00884741|589332388|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
163168442|NCT00884741|589332389|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
163168443|NCT00884741|589332386|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
163168444|NCT00884741|589332387|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
163168445|NCT00884741|589332388|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
163168446|NCT00884741|589332389|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
163168447|NCT00884741|589332386|FG000|Randomization|Protocol Violation|0|||
163168448|NCT00884741|589332387|FG001|Randomization|Protocol Violation|0|||
163168449|NCT00884741|589332388|FG002|Randomization|Protocol Violation|8|||
163168450|NCT00884741|589332389|FG003|Randomization|Protocol Violation|8|||
163168451|NCT01324401|589332390|FG000|Overall Study|Withdrawn before any treatment|0|||
163168452|NCT01324401|589332391|FG001|Overall Study|Withdrawn before any treatment|3|||
163168453|NCT01324401|589332390|FG000|Overall Study|Adverse Event|1|||
163168454|NCT01324401|589332391|FG001|Overall Study|Adverse Event|3|||
163168455|NCT02969655|589332392|FG000|Overall Study|Withdrawal by Subject|3|||
163168456|NCT02969655|589332393|FG001|Overall Study|Withdrawal by Subject|2|||
163168457|NCT02969655|589332392|FG000|Overall Study|Physician Decision|4|||
163168458|NCT02969655|589332393|FG001|Overall Study|Physician Decision|3|||
163168459|NCT02969655|589332392|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
163168460|NCT02969655|589332393|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
163168461|NCT02969655|589332392|FG000|Overall Study|Adverse Event|10|||
163168462|NCT02969655|589332393|FG001|Overall Study|Adverse Event|8|||
163168463|NCT01578850|589332395|FG000|Period 1|Insufficient Clinical Response|1|||
163168464|NCT01578850|589332396|FG001|Period 1|Insufficient Clinical Response|0|||
163168465|NCT01578850|589332397|FG002|Period 1|Insufficient Clinical Response|0|||
163168466|NCT01578850|589332395|FG000|Period 1|Adverse Event|11|||
163168467|NCT01578850|589332396|FG001|Period 1|Adverse Event|0|||
163168468|NCT01578850|589332397|FG002|Period 1|Adverse Event|0|||
163168469|NCT01578850|589332395|FG000|Period 1|Death|1|||
163168470|NCT01578850|589332396|FG001|Period 1|Death|0|||
163168471|NCT01578850|589332397|FG002|Period 1|Death|0|||
163168472|NCT01578850|589332395|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
163168473|NCT01578850|589332396|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
163168474|NCT01578850|589332397|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
163168475|NCT01578850|589332395|FG000|Period 1|Withdrawal by Subject|9|||
163168476|NCT01578850|589332396|FG001|Period 1|Withdrawal by Subject|0|||
163168477|NCT01578850|589332397|FG002|Period 1|Withdrawal by Subject|0|||
163168478|NCT01578850|589332395|FG000|Period 1|Study Terminated by Sponsor|3|||
163168479|NCT01578850|589332396|FG001|Period 1|Study Terminated by Sponsor|0|||
163168480|NCT01578850|589332397|FG002|Period 1|Study Terminated by Sponsor|0|||
163168481|NCT01578850|589332395|FG000|Period 2|Insufficient Clinical Response|0|||
163168482|NCT01578850|589332396|FG001|Period 2|Insufficient Clinical Response|1|||
163168483|NCT01578850|589332397|FG002|Period 2|Insufficient Clinical Response|0|||
163168484|NCT01578850|589332395|FG000|Period 2|Adverse Event|0|||
163168485|NCT01578850|589332396|FG001|Period 2|Adverse Event|3|||
163168486|NCT01578850|589332397|FG002|Period 2|Adverse Event|6|||
163168487|NCT01578850|589332395|FG000|Period 2|Lost to Follow-up|0|||
163168488|NCT01578850|589332396|FG001|Period 2|Lost to Follow-up|1|||
163276818|NCT00946647|589723508|FG003|Phase ll Part|Administrative problems|3|||
163276819|NCT00946647|589723509|FG004|Phase ll Part|Administrative problems|8|||
163276820|NCT00946647|589723505|FG000|Phase ll Part|Death|0|||
163276821|NCT00946647|589723506|FG001|Phase ll Part|Death|0|||
163276822|NCT00946647|589723507|FG002|Phase ll Part|Death|0|||
163276823|NCT00946647|589723508|FG003|Phase ll Part|Death|7|||
163276824|NCT00946647|589723509|FG004|Phase ll Part|Death|4|||
163276825|NCT00946647|589723505|FG000|Phase ll Part|Disease progression|0|||
163276826|NCT00946647|589723506|FG001|Phase ll Part|Disease progression|0|||
163276827|NCT00946647|589723507|FG002|Phase ll Part|Disease progression|0|||
163276828|NCT00946647|589723508|FG003|Phase ll Part|Disease progression|6|||
163276829|NCT00946647|589723509|FG004|Phase ll Part|Disease progression|14|||
163276830|NCT00946647|589723505|FG000|Phase ll Part|Protocol Violation|0|||
163276831|NCT00946647|589723506|FG001|Phase ll Part|Protocol Violation|0|||
163276832|NCT00946647|589723507|FG002|Phase ll Part|Protocol Violation|0|||
163276833|NCT00946647|589723508|FG003|Phase ll Part|Protocol Violation|4|||
163276834|NCT00946647|589723509|FG004|Phase ll Part|Protocol Violation|2|||
163276835|NCT00946647|589723505|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
163276836|NCT00946647|589723506|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
163276837|NCT00946647|589723507|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
163276838|NCT00946647|589723508|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
163276839|NCT00946647|589723509|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
163276840|NCT01368211|589723510|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
163276841|NCT01368211|589723511|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
163276842|NCT04248465|589723515|FG000|Randomized-Controlled Period|Death|12|||
163276843|NCT04248465|589723516|FG001|Randomized-Controlled Period|Death|5|||
163276844|NCT04248465|589723515|FG000|Randomized-Controlled Period|Adverse Event|2|||
163276845|NCT04248465|589723516|FG001|Randomized-Controlled Period|Adverse Event|0|||
163168489|NCT01578850|589332397|FG002|Period 2|Lost to Follow-up|2|||
163168490|NCT01578850|589332395|FG000|Period 2|Withdrawal by Subject|0|||
163168491|NCT01578850|589332396|FG001|Period 2|Withdrawal by Subject|2|||
163168492|NCT01578850|589332397|FG002|Period 2|Withdrawal by Subject|2|||
163276846|NCT04248465|589723515|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
163168493|NCT01578850|589332395|FG000|Period 2|Study Terminated by Sponsor|0|||
163168494|NCT01578850|589332396|FG001|Period 2|Study Terminated by Sponsor|5|||
163168495|NCT01578850|589332397|FG002|Period 2|Study Terminated by Sponsor|4|||
163168496|NCT01578850|589332395|FG000|Period 2|Unspecified Reasons|0|||
163276847|NCT04248465|589723516|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
163276848|NCT04248465|589723515|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
163276849|NCT04248465|589723516|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
163276850|NCT04248465|589723515|FG000|Randomized-Controlled Period|Physician Decision|1|||
163276851|NCT04248465|589723516|FG001|Randomized-Controlled Period|Physician Decision|1|||
163168497|NCT01578850|589332396|FG001|Period 2|Unspecified Reasons|1|||
163168498|NCT01578850|589332397|FG002|Period 2|Unspecified Reasons|0|||
163168499|NCT02703337|589332401|FG000|Period One (Part A)|Withdrawal by Subject|0|||
163168500|NCT02703337|589332402|FG001|Period One (Part A)|Withdrawal by Subject|0|||
163168501|NCT02703337|589332403|FG002|Period One (Part A)|Withdrawal by Subject|0|||
163168502|NCT02703337|589332404|FG003|Period One (Part A)|Withdrawal by Subject|0|||
163168503|NCT02703337|589332405|FG004|Period One (Part A)|Withdrawal by Subject|1|||
163168504|NCT02703337|589332406|FG005|Period One (Part A)|Withdrawal by Subject|0|||
163168505|NCT02703337|589332407|FG006|Period One (Part A)|Withdrawal by Subject|0|||
163168506|NCT02703337|589332408|FG007|Period One (Part A)|Withdrawal by Subject|0|||
163168507|NCT01001325|589332414|FG000|Overall Study|Lost to Follow-up|16|||
163168508|NCT01001325|589332415|FG001|Overall Study|Lost to Follow-up|10|||
163168509|NCT01001325|589332414|FG000|Overall Study|Protocol Violation|2|||
163168510|NCT01001325|589332415|FG001|Overall Study|Protocol Violation|0|||
163168511|NCT01584440|589332418|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
163168512|NCT01584440|589332419|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
163168513|NCT01584440|589332420|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
163168514|NCT01584440|589332421|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
163168515|NCT01584440|589332422|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
163168516|NCT01584440|589332418|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
163168517|NCT01584440|589332419|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
163168518|NCT01584440|589332420|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
163168519|NCT01584440|589332421|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
163168520|NCT01584440|589332422|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
163168521|NCT01584440|589332418|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
163168522|NCT01584440|589332419|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
163168523|NCT01584440|589332420|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
163168524|NCT01584440|589332421|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
163168525|NCT01584440|589332422|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
163168526|NCT01584440|589332418|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
163168527|NCT01584440|589332419|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
163168528|NCT01584440|589332420|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
163168529|NCT01584440|589332421|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
163168530|NCT01584440|589332422|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
163168531|NCT01584440|589332418|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
163168532|NCT01584440|589332419|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
163168533|NCT01584440|589332420|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
163168534|NCT01584440|589332421|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
163168535|NCT01584440|589332422|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
163168536|NCT01584440|589332418|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
163168537|NCT01584440|589332419|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
163168538|NCT01584440|589332420|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
163168539|NCT01584440|589332421|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
163168540|NCT01584440|589332422|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
163168541|NCT01584440|589332418|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
163168542|NCT01584440|589332419|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
163168543|NCT01584440|589332420|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
163168544|NCT01584440|589332421|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
163168545|NCT01584440|589332422|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
163168546|NCT01584440|589332418|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
163168547|NCT01584440|589332419|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
163168548|NCT01584440|589332420|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
163168549|NCT01584440|589332421|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
163168550|NCT01584440|589332422|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
163168551|NCT01584440|589332418|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
163168552|NCT01584440|589332419|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
163168553|NCT01584440|589332420|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
163168554|NCT01584440|589332421|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
163168555|NCT01584440|589332422|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
163168556|NCT04237116|589332423|FG000|Overall Study|Adverse Event|0|||
163168557|NCT04237116|589332424|FG001|Overall Study|Adverse Event|1|||
163168558|NCT04237116|589332423|FG000|Overall Study|Study terminated by Sponsor|4|||
163168559|NCT04237116|589332424|FG001|Overall Study|Study terminated by Sponsor|1|||
163168560|NCT03212144|589332425|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
163168561|NCT03212144|589332426|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
163168562|NCT03212144|589332425|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
163168563|NCT03212144|589332426|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
163168564|NCT00899431|589332427|FG000|Overall Study|Physician Decision|1|||
163168565|NCT00899431|589332428|FG001|Overall Study|Physician Decision|0|||
163168566|NCT00899431|589332429|FG002|Overall Study|Physician Decision|0|||
163168567|NCT00661427|589332432|FG000|Overall Study|Adverse Event|5|||
163168568|NCT00661427|589332433|FG001|Overall Study|Adverse Event|5|||
163168569|NCT00661427|589332432|FG000|Overall Study|Patient not treated|0|||
163168570|NCT00661427|589332433|FG001|Overall Study|Patient not treated|2|||
163168571|NCT01821560|589332434|FG000|Overall Study|Lost to Follow-up|5|||
163168572|NCT01821560|589332435|FG001|Overall Study|Lost to Follow-up|5|||
163168573|NCT01821560|589332434|FG000|Overall Study|Withdrawal by Subject|1|||
163168574|NCT01821560|589332435|FG001|Overall Study|Withdrawal by Subject|1|||
163168575|NCT01821560|589332434|FG000|Overall Study|Protocol Violation|0|||
163168576|NCT01821560|589332435|FG001|Overall Study|Protocol Violation|1|||
163168577|NCT01338298|589332436|FG000|Overall Study|Withdrawal by Subject|1|||
163168578|NCT01338298|589332437|FG001|Overall Study|Withdrawal by Subject|1|||
163168579|NCT01338298|589332436|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
163168580|NCT01338298|589332437|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
163168581|NCT01338298|589332436|FG000|Overall Study|Administrative error|0|||
163168582|NCT01338298|589332437|FG001|Overall Study|Administrative error|1|||
163168583|NCT01338298|589332436|FG000|Overall Study|Positive symptom worsening|1|||
163168584|NCT01338298|589332437|FG001|Overall Study|Positive symptom worsening|0|||
163168585|NCT01338298|589332436|FG000|Overall Study|Depressive symptoms and nausea|1|||
163168586|NCT01338298|589332437|FG001|Overall Study|Depressive symptoms and nausea|0|||
163168587|NCT01338298|589332436|FG000|Overall Study|Non-adherence|1|||
163168588|NCT01338298|589332437|FG001|Overall Study|Non-adherence|0|||
163168589|NCT00531427|589332438|FG000|Overall Study|Withdrawal by Subject|7|||
163168590|NCT00531427|589332439|FG001|Overall Study|Withdrawal by Subject|13|||
163168591|NCT00531427|589332438|FG000|Overall Study|Adverse Event|44|||
163168592|NCT00531427|589332439|FG001|Overall Study|Adverse Event|30|||
163168593|NCT00531427|589332438|FG000|Overall Study|Lost to Follow-up|4|||
163168594|NCT00531427|589332439|FG001|Overall Study|Lost to Follow-up|3|||
163168595|NCT00531427|589332438|FG000|Overall Study|Lack of Efficacy|14|||
163168596|NCT00531427|589332439|FG001|Overall Study|Lack of Efficacy|39|||
163168597|NCT00531427|589332438|FG000|Overall Study|Administrative|4|||
163168598|NCT00531427|589332439|FG001|Overall Study|Administrative|9|||
163168599|NCT05477108|589332440|FG000|Overall Study|Participants randomized, not treated|1|||
163168600|NCT05477108|589332441|FG001|Overall Study|Participants randomized, not treated|1|||
163168601|NCT05477108|589332442|FG002|Overall Study|Participants randomized, not treated|1|||
163168602|NCT05477108|589332440|FG000|Overall Study|Physician Decision|0|||
163168603|NCT05477108|589332441|FG001|Overall Study|Physician Decision|0|||
163168604|NCT05477108|589332442|FG002|Overall Study|Physician Decision|1|||
163168605|NCT05477108|589332440|FG000|Overall Study|withdrawn from study|0|||
163168606|NCT05477108|589332441|FG001|Overall Study|withdrawn from study|0|||
163168607|NCT05477108|589332442|FG002|Overall Study|withdrawn from study|1|||
163168608|NCT01253577|589332443|FG000|Overall Study|Lost to Follow-up|3|||
163168609|NCT05688670|589332444|FG000|Overall Study|Change in surgery plan|1|||
163168610|NCT05688670|589332445|FG001|Overall Study|Change in surgery plan|4|||
163168611|NCT05688670|589332444|FG000|Overall Study|Inability to extubate|1|||
163168612|NCT05688670|589332445|FG001|Overall Study|Inability to extubate|2|||
163168613|NCT05688670|589332444|FG000|Overall Study|Day of surgery cancellation|0|||
163168614|NCT05688670|589332445|FG001|Overall Study|Day of surgery cancellation|1|||
163168615|NCT05688670|589332444|FG000|Overall Study|Reintubated on PCICU arrival|0|||
163168616|NCT05688670|589332445|FG001|Overall Study|Reintubated on PCICU arrival|1|||
163168617|NCT00488683|589332446|FG000|Overall Study|Withdrawal by Subject|1|||
163168618|NCT00488683|589332447|FG001|Overall Study|Withdrawal by Subject|2|||
163168619|NCT00488683|589332448|FG002|Overall Study|Withdrawal by Subject|2|||
163168620|NCT00488683|589332446|FG000|Overall Study|Lost to Follow-up|5|||
163168621|NCT00488683|589332447|FG001|Overall Study|Lost to Follow-up|3|||
163168622|NCT00488683|589332448|FG002|Overall Study|Lost to Follow-up|0|||
163168623|NCT00488683|589332446|FG000|Overall Study|Protocol Violation|5|||
163168624|NCT00488683|589332447|FG001|Overall Study|Protocol Violation|1|||
163168625|NCT00488683|589332448|FG002|Overall Study|Protocol Violation|0|||
163168626|NCT00488683|589332446|FG000|Overall Study|Unable to Classify|1|||
163168627|NCT00488683|589332447|FG001|Overall Study|Unable to Classify|0|||
163168628|NCT00488683|589332448|FG002|Overall Study|Unable to Classify|0|||
163168629|NCT00361634|589334467|FG000|Overall Study|Lost to Follow-up|1|||
163168630|NCT00361634|589334467|FG000|Overall Study|Withdrawal by Subject|1|||
163168631|NCT05315908|589334468|FG000|Overall Study|Lost to Follow-up|4477|||
163168632|NCT05315908|589334469|FG001|Overall Study|Lost to Follow-up|4606|||
163168633|NCT00505076|589334478|FG000|Overall Study|Adverse Event|1|||
163168634|NCT00505076|589334479|FG001|Overall Study|Adverse Event|0|||
163168635|NCT00505076|589334480|FG002|Overall Study|Adverse Event|1|||
163168636|NCT00505076|589334478|FG000|Overall Study|Protocol Violation|2|||
163168637|NCT00505076|589334479|FG001|Overall Study|Protocol Violation|1|||
163168638|NCT00505076|589334480|FG002|Overall Study|Protocol Violation|2|||
163168639|NCT00505076|589334478|FG000|Overall Study|Withdrawal by Subject|0|||
163168640|NCT00505076|589334479|FG001|Overall Study|Withdrawal by Subject|1|||
163168641|NCT00505076|589334480|FG002|Overall Study|Withdrawal by Subject|2|||
163168642|NCT01128621|589334481|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
163168643|NCT01128621|589334482|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
163168644|NCT04074161|589334485|FG000|Overall Study|Withdrawal by Subject|2|||
163168645|NCT04074161|589334486|FG001|Overall Study|Withdrawal by Subject|4|||
163168646|NCT04074161|589334487|FG002|Overall Study|Withdrawal by Subject|1|||
163168647|NCT04074161|589334485|FG000|Overall Study|Lost to Follow-up|4|||
163168648|NCT04074161|589334486|FG001|Overall Study|Lost to Follow-up|5|||
163168649|NCT04074161|589334487|FG002|Overall Study|Lost to Follow-up|3|||
163168650|NCT03595228|589334490|FG000|Overall Study|Death|2|||
163168651|NCT03595228|589334490|FG000|Overall Study|Lack of Efficacy|13|||
163168652|NCT03595228|589334490|FG000|Overall Study|Withdrawal by Subject|3|||
163168653|NCT03595228|589334490|FG000|Overall Study|Withdrawal by Sponsor|1|||
163168654|NCT01639729|589334491|FG000|Overall Study|Withdrawal by Subject|1|||
163168655|NCT01639729|589334492|FG001|Overall Study|Withdrawal by Subject|0|||
163168656|NCT01639729|589334493|FG002|Overall Study|Withdrawal by Subject|1|||
163168657|NCT01639729|589334494|FG003|Overall Study|Withdrawal by Subject|1|||
163168658|NCT01639729|589334495|FG004|Overall Study|Withdrawal by Subject|0|||
163168659|NCT01639729|589334496|FG005|Overall Study|Withdrawal by Subject|0|||
163168660|NCT03232333|589334497|FG000|Overall Study|Infection or Osteomyelitis|9|||
163168661|NCT03232333|589334497|FG000|Overall Study|Lost to Follow-up|4|||
163168662|NCT03232333|589334497|FG000|Overall Study|Withdrawal by Subject|2|||
163168663|NCT01155011|589334498|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
163168664|NCT01155011|589334499|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
163168665|NCT01155011|589334498|FG000|Baseline to 6 Months|investigator decision, moved|4|||
163168666|NCT01155011|589334499|FG001|Baseline to 6 Months|investigator decision, moved|5|||
163168667|NCT01155011|589334498|FG000|Baseline to 6 Months|Death|0|||
163168668|NCT01155011|589334499|FG001|Baseline to 6 Months|Death|1|||
163168669|NCT01155011|589334498|FG000|6 to 12 Months|Withdrawal by Subject|8|||
163168670|NCT01155011|589334499|FG001|6 to 12 Months|Withdrawal by Subject|5|||
163168671|NCT01155011|589334498|FG000|6 to 12 Months|Death|1|||
163168672|NCT01155011|589334499|FG001|6 to 12 Months|Death|5|||
163168673|NCT01087736|589334500|FG000|Overall Study|Lost to Follow-up|1|||
163168674|NCT01087736|589334501|FG001|Overall Study|Lost to Follow-up|0|||
163168675|NCT01087736|589334500|FG000|Overall Study|Death|0|||
163168676|NCT01087736|589334501|FG001|Overall Study|Death|1|||
163168677|NCT01087736|589334500|FG000|Overall Study|Withdrawal by Subject|0|||
163168678|NCT01087736|589334501|FG001|Overall Study|Withdrawal by Subject|1|||
163168679|NCT01253811|589334502|FG000|Overall Study|Withdrawal criteria|1|||
163168680|NCT00759564|589334503|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
163168681|NCT00759564|589334504|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
163168682|NCT00759564|589334505|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
163168683|NCT00759564|589334506|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
163168684|NCT00759564|589334507|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
163168685|NCT01565343|589334510|FG000|Overall Study|Administrative decision/technical issues|1|||
163168686|NCT01565343|589334511|FG001|Overall Study|Administrative decision/technical issues|0|||
163168687|NCT01565343|589334512|FG002|Overall Study|Administrative decision/technical issues|0|||
163168688|NCT02059291|589334517|FG000|Epoch 2|Lack of Efficacy|0|||
163168689|NCT02059291|589334518|FG001|Epoch 2|Lack of Efficacy|0|||
163168690|NCT02059291|589334519|FG002|Epoch 2|Lack of Efficacy|0|||
163168691|NCT02059291|589334520|FG003|Epoch 2|Lack of Efficacy|1|||
163168692|NCT02059291|589334521|FG004|Epoch 2|Lack of Efficacy|0|||
163168693|NCT02059291|589334522|FG005|Epoch 2|Lack of Efficacy|1|||
163168694|NCT02059291|589334523|FG006|Epoch 2|Lack of Efficacy|0|||
163168695|NCT02059291|589334524|FG007|Epoch 2|Lack of Efficacy|0|||
163168696|NCT02059291|589334525|FG008|Epoch 2|Lack of Efficacy|0|||
163168697|NCT02059291|589334526|FG009|Epoch 2|Lack of Efficacy|0|||
163168698|NCT02059291|589334527|FG010|Epoch 2|Lack of Efficacy|0|||
163168699|NCT02059291|589334528|FG011|Epoch 2|Lack of Efficacy|0|||
163168700|NCT02059291|589334529|FG012|Epoch 2|Lack of Efficacy|0|||
163168701|NCT02059291|589334530|FG013|Epoch 2|Lack of Efficacy|0|||
163168702|NCT02059291|589334531|FG014|Epoch 2|Lack of Efficacy|0|||
163168703|NCT02059291|589334532|FG015|Epoch 2|Lack of Efficacy|0|||
163168704|NCT02059291|589334533|FG016|Epoch 2|Lack of Efficacy|0|||
163168705|NCT02059291|589334534|FG017|Epoch 2|Lack of Efficacy|0|||
163168706|NCT02059291|589334535|FG018|Epoch 2|Lack of Efficacy|0|||
163168707|NCT02059291|589334536|FG019|Epoch 2|Lack of Efficacy|0|||
163168708|NCT02059291|589334537|FG020|Epoch 2|Lack of Efficacy|0|||
163168709|NCT02059291|589334538|FG021|Epoch 2|Lack of Efficacy|0|||
163168710|NCT02059291|589334539|FG022|Epoch 2|Lack of Efficacy|0|||
163168711|NCT02059291|589334540|FG023|Epoch 2|Lack of Efficacy|0|||
163168712|NCT02059291|589334541|FG024|Epoch 2|Lack of Efficacy|0|||
163168713|NCT02059291|589334517|FG000|Epoch 2|Adverse Event|0|||
163168714|NCT02059291|589334518|FG001|Epoch 2|Adverse Event|0|||
163168715|NCT02059291|589334519|FG002|Epoch 2|Adverse Event|1|||
163168716|NCT02059291|589334520|FG003|Epoch 2|Adverse Event|1|||
163168717|NCT02059291|589334521|FG004|Epoch 2|Adverse Event|0|||
163168718|NCT02059291|589334522|FG005|Epoch 2|Adverse Event|0|||
163168719|NCT02059291|589334523|FG006|Epoch 2|Adverse Event|0|||
163168720|NCT02059291|589334524|FG007|Epoch 2|Adverse Event|1|||
163168721|NCT02059291|589334525|FG008|Epoch 2|Adverse Event|1|||
163168722|NCT02059291|589334526|FG009|Epoch 2|Adverse Event|0|||
163168723|NCT02059291|589334527|FG010|Epoch 2|Adverse Event|0|||
163168724|NCT02059291|589334528|FG011|Epoch 2|Adverse Event|0|||
163168725|NCT02059291|589334529|FG012|Epoch 2|Adverse Event|0|||
163168726|NCT02059291|589334530|FG013|Epoch 2|Adverse Event|0|||
163168727|NCT02059291|589334531|FG014|Epoch 2|Adverse Event|0|||
163168728|NCT02059291|589334532|FG015|Epoch 2|Adverse Event|0|||
163168729|NCT02059291|589334533|FG016|Epoch 2|Adverse Event|0|||
163168730|NCT02059291|589334534|FG017|Epoch 2|Adverse Event|0|||
163168731|NCT02059291|589334535|FG018|Epoch 2|Adverse Event|0|||
163168732|NCT02059291|589334536|FG019|Epoch 2|Adverse Event|0|||
163168733|NCT02059291|589334537|FG020|Epoch 2|Adverse Event|0|||
163168734|NCT02059291|589334538|FG021|Epoch 2|Adverse Event|0|||
163168735|NCT02059291|589334539|FG022|Epoch 2|Adverse Event|0|||
163168736|NCT02059291|589334540|FG023|Epoch 2|Adverse Event|0|||
163168737|NCT02059291|589334541|FG024|Epoch 2|Adverse Event|0|||
163168738|NCT02059291|589334517|FG000|Epoch 2|Withdrawal by Subject|0|||
163168739|NCT02059291|589334518|FG001|Epoch 2|Withdrawal by Subject|1|||
163168740|NCT02059291|589334519|FG002|Epoch 2|Withdrawal by Subject|0|||
163168741|NCT02059291|589334520|FG003|Epoch 2|Withdrawal by Subject|0|||
163168742|NCT02059291|589334521|FG004|Epoch 2|Withdrawal by Subject|0|||
163168743|NCT02059291|589334522|FG005|Epoch 2|Withdrawal by Subject|1|||
163168744|NCT02059291|589334523|FG006|Epoch 2|Withdrawal by Subject|0|||
163168745|NCT02059291|589334524|FG007|Epoch 2|Withdrawal by Subject|0|||
163168746|NCT02059291|589334525|FG008|Epoch 2|Withdrawal by Subject|1|||
163168747|NCT02059291|589334526|FG009|Epoch 2|Withdrawal by Subject|0|||
163168748|NCT02059291|589334527|FG010|Epoch 2|Withdrawal by Subject|0|||
163168749|NCT02059291|589334528|FG011|Epoch 2|Withdrawal by Subject|0|||
163168750|NCT02059291|589334529|FG012|Epoch 2|Withdrawal by Subject|0|||
163168751|NCT02059291|589334530|FG013|Epoch 2|Withdrawal by Subject|0|||
163168752|NCT02059291|589334531|FG014|Epoch 2|Withdrawal by Subject|0|||
163168753|NCT02059291|589334532|FG015|Epoch 2|Withdrawal by Subject|0|||
163168754|NCT02059291|589334533|FG016|Epoch 2|Withdrawal by Subject|0|||
163168755|NCT02059291|589334534|FG017|Epoch 2|Withdrawal by Subject|0|||
163168756|NCT02059291|589334535|FG018|Epoch 2|Withdrawal by Subject|0|||
163168757|NCT02059291|589334536|FG019|Epoch 2|Withdrawal by Subject|0|||
163168758|NCT02059291|589334537|FG020|Epoch 2|Withdrawal by Subject|0|||
163168759|NCT02059291|589334538|FG021|Epoch 2|Withdrawal by Subject|0|||
163168760|NCT02059291|589334539|FG022|Epoch 2|Withdrawal by Subject|0|||
163168761|NCT02059291|589334540|FG023|Epoch 2|Withdrawal by Subject|0|||
163168762|NCT02059291|589334541|FG024|Epoch 2|Withdrawal by Subject|0|||
163168763|NCT02059291|589334517|FG000|Epoch 3|Physician Decision|0|||
163168764|NCT02059291|589334518|FG001|Epoch 3|Physician Decision|0|||
163168765|NCT02059291|589334519|FG002|Epoch 3|Physician Decision|0|||
163168766|NCT02059291|589334520|FG003|Epoch 3|Physician Decision|0|||
163168767|NCT02059291|589334521|FG004|Epoch 3|Physician Decision|0|||
163168768|NCT02059291|589334522|FG005|Epoch 3|Physician Decision|0|||
163168769|NCT02059291|589334523|FG006|Epoch 3|Physician Decision|0|||
163168770|NCT02059291|589334524|FG007|Epoch 3|Physician Decision|0|||
163168771|NCT02059291|589334525|FG008|Epoch 3|Physician Decision|0|||
163168772|NCT02059291|589334526|FG009|Epoch 3|Physician Decision|0|||
163168773|NCT02059291|589334527|FG010|Epoch 3|Physician Decision|0|||
163168774|NCT02059291|589334528|FG011|Epoch 3|Physician Decision|0|||
163168775|NCT02059291|589334529|FG012|Epoch 3|Physician Decision|0|||
163168776|NCT02059291|589334530|FG013|Epoch 3|Physician Decision|1|||
163168777|NCT02059291|589334531|FG014|Epoch 3|Physician Decision|0|||
163168778|NCT02059291|589334532|FG015|Epoch 3|Physician Decision|1|||
163168779|NCT02059291|589334533|FG016|Epoch 3|Physician Decision|0|||
163168780|NCT02059291|589334534|FG017|Epoch 3|Physician Decision|0|||
163168781|NCT02059291|589334535|FG018|Epoch 3|Physician Decision|0|||
163168782|NCT02059291|589334536|FG019|Epoch 3|Physician Decision|0|||
163168783|NCT02059291|589334537|FG020|Epoch 3|Physician Decision|0|||
163168784|NCT02059291|589334538|FG021|Epoch 3|Physician Decision|0|||
163168785|NCT02059291|589334539|FG022|Epoch 3|Physician Decision|0|||
163168786|NCT02059291|589334540|FG023|Epoch 3|Physician Decision|0|||
163168787|NCT02059291|589334541|FG024|Epoch 3|Physician Decision|0|||
163168788|NCT02059291|589334517|FG000|Epoch 3|Adverse Event|0|||
163168789|NCT02059291|589334518|FG001|Epoch 3|Adverse Event|0|||
163168790|NCT02059291|589334519|FG002|Epoch 3|Adverse Event|0|||
163168791|NCT02059291|589334520|FG003|Epoch 3|Adverse Event|0|||
163168792|NCT02059291|589334521|FG004|Epoch 3|Adverse Event|0|||
163168793|NCT02059291|589334522|FG005|Epoch 3|Adverse Event|0|||
163168794|NCT02059291|589334523|FG006|Epoch 3|Adverse Event|0|||
163168795|NCT02059291|589334524|FG007|Epoch 3|Adverse Event|0|||
163168796|NCT02059291|589334525|FG008|Epoch 3|Adverse Event|0|||
163168797|NCT02059291|589334526|FG009|Epoch 3|Adverse Event|0|||
163168798|NCT02059291|589334527|FG010|Epoch 3|Adverse Event|0|||
163168799|NCT02059291|589334528|FG011|Epoch 3|Adverse Event|0|||
163168800|NCT02059291|589334529|FG012|Epoch 3|Adverse Event|0|||
163168801|NCT02059291|589334530|FG013|Epoch 3|Adverse Event|0|||
163168802|NCT02059291|589334531|FG014|Epoch 3|Adverse Event|0|||
163168803|NCT02059291|589334532|FG015|Epoch 3|Adverse Event|1|||
163168804|NCT02059291|589334533|FG016|Epoch 3|Adverse Event|0|||
163168805|NCT02059291|589334534|FG017|Epoch 3|Adverse Event|0|||
163168806|NCT02059291|589334535|FG018|Epoch 3|Adverse Event|0|||
163168807|NCT02059291|589334536|FG019|Epoch 3|Adverse Event|0|||
163168808|NCT02059291|589334537|FG020|Epoch 3|Adverse Event|0|||
163168809|NCT02059291|589334538|FG021|Epoch 3|Adverse Event|0|||
163168810|NCT02059291|589334539|FG022|Epoch 3|Adverse Event|0|||
163168811|NCT02059291|589334540|FG023|Epoch 3|Adverse Event|0|||
163168812|NCT02059291|589334541|FG024|Epoch 3|Adverse Event|0|||
163168813|NCT02059291|589334517|FG000|Epoch 3|Lack of Efficacy|0|||
163168814|NCT02059291|589334518|FG001|Epoch 3|Lack of Efficacy|0|||
163168815|NCT02059291|589334519|FG002|Epoch 3|Lack of Efficacy|0|||
163168816|NCT02059291|589334520|FG003|Epoch 3|Lack of Efficacy|0|||
163168817|NCT02059291|589334521|FG004|Epoch 3|Lack of Efficacy|0|||
163168818|NCT02059291|589334522|FG005|Epoch 3|Lack of Efficacy|0|||
163168819|NCT02059291|589334523|FG006|Epoch 3|Lack of Efficacy|0|||
163168820|NCT02059291|589334524|FG007|Epoch 3|Lack of Efficacy|0|||
163168821|NCT02059291|589334525|FG008|Epoch 3|Lack of Efficacy|0|||
163276852|NCT04248465|589723515|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
163168822|NCT02059291|589334526|FG009|Epoch 3|Lack of Efficacy|0|||
163168823|NCT02059291|589334527|FG010|Epoch 3|Lack of Efficacy|0|||
163168824|NCT02059291|589334528|FG011|Epoch 3|Lack of Efficacy|0|||
163168825|NCT02059291|589334529|FG012|Epoch 3|Lack of Efficacy|0|||
163168826|NCT02059291|589334530|FG013|Epoch 3|Lack of Efficacy|0|||
163168827|NCT02059291|589334531|FG014|Epoch 3|Lack of Efficacy|0|||
163168828|NCT02059291|589334532|FG015|Epoch 3|Lack of Efficacy|3|||
163168829|NCT02059291|589334533|FG016|Epoch 3|Lack of Efficacy|0|||
163168830|NCT02059291|589334534|FG017|Epoch 3|Lack of Efficacy|0|||
163168831|NCT02059291|589334535|FG018|Epoch 3|Lack of Efficacy|0|||
163168832|NCT02059291|589334536|FG019|Epoch 3|Lack of Efficacy|0|||
163168833|NCT02059291|589334537|FG020|Epoch 3|Lack of Efficacy|0|||
163168834|NCT02059291|589334538|FG021|Epoch 3|Lack of Efficacy|0|||
163168835|NCT02059291|589334539|FG022|Epoch 3|Lack of Efficacy|0|||
163168836|NCT02059291|589334540|FG023|Epoch 3|Lack of Efficacy|0|||
163168837|NCT02059291|589334541|FG024|Epoch 3|Lack of Efficacy|0|||
163168838|NCT02059291|589334517|FG000|Epoch 3|Withdrawal by Subject|0|||
163276853|NCT04248465|589723516|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
163168839|NCT02059291|589334518|FG001|Epoch 3|Withdrawal by Subject|0|||
163168840|NCT02059291|589334519|FG002|Epoch 3|Withdrawal by Subject|0|||
163168841|NCT02059291|589334520|FG003|Epoch 3|Withdrawal by Subject|0|||
163168842|NCT02059291|589334521|FG004|Epoch 3|Withdrawal by Subject|0|||
163168843|NCT02059291|589334522|FG005|Epoch 3|Withdrawal by Subject|0|||
163168844|NCT02059291|589334523|FG006|Epoch 3|Withdrawal by Subject|0|||
163168845|NCT02059291|589334524|FG007|Epoch 3|Withdrawal by Subject|0|||
163168846|NCT02059291|589334525|FG008|Epoch 3|Withdrawal by Subject|0|||
163168847|NCT02059291|589334526|FG009|Epoch 3|Withdrawal by Subject|0|||
163168848|NCT02059291|589334527|FG010|Epoch 3|Withdrawal by Subject|0|||
163168849|NCT02059291|589334528|FG011|Epoch 3|Withdrawal by Subject|0|||
163168850|NCT02059291|589334529|FG012|Epoch 3|Withdrawal by Subject|0|||
163168851|NCT02059291|589334530|FG013|Epoch 3|Withdrawal by Subject|0|||
163168852|NCT02059291|589334531|FG014|Epoch 3|Withdrawal by Subject|0|||
163168853|NCT02059291|589334532|FG015|Epoch 3|Withdrawal by Subject|1|||
163168854|NCT02059291|589334533|FG016|Epoch 3|Withdrawal by Subject|0|||
163168855|NCT02059291|589334534|FG017|Epoch 3|Withdrawal by Subject|0|||
163168856|NCT02059291|589334535|FG018|Epoch 3|Withdrawal by Subject|0|||
163168857|NCT02059291|589334536|FG019|Epoch 3|Withdrawal by Subject|0|||
163168858|NCT02059291|589334537|FG020|Epoch 3|Withdrawal by Subject|0|||
163168859|NCT02059291|589334538|FG021|Epoch 3|Withdrawal by Subject|0|||
163168860|NCT02059291|589334539|FG022|Epoch 3|Withdrawal by Subject|0|||
163168861|NCT02059291|589334540|FG023|Epoch 3|Withdrawal by Subject|0|||
163168862|NCT02059291|589334541|FG024|Epoch 3|Withdrawal by Subject|0|||
163168863|NCT02059291|589334517|FG000|Epoch 4|Adverse Event|0|||
163168864|NCT02059291|589334518|FG001|Epoch 4|Adverse Event|0|||
163168865|NCT02059291|589334519|FG002|Epoch 4|Adverse Event|0|||
163168866|NCT02059291|589334520|FG003|Epoch 4|Adverse Event|0|||
163168867|NCT02059291|589334521|FG004|Epoch 4|Adverse Event|0|||
163168868|NCT02059291|589334522|FG005|Epoch 4|Adverse Event|0|||
163168869|NCT02059291|589334523|FG006|Epoch 4|Adverse Event|0|||
163168870|NCT02059291|589334524|FG007|Epoch 4|Adverse Event|0|||
163168871|NCT02059291|589334525|FG008|Epoch 4|Adverse Event|0|||
163168872|NCT02059291|589334526|FG009|Epoch 4|Adverse Event|0|||
163168873|NCT02059291|589334527|FG010|Epoch 4|Adverse Event|0|||
163168874|NCT02059291|589334528|FG011|Epoch 4|Adverse Event|0|||
163168875|NCT02059291|589334529|FG012|Epoch 4|Adverse Event|0|||
163168876|NCT02059291|589334530|FG013|Epoch 4|Adverse Event|0|||
163168877|NCT02059291|589334531|FG014|Epoch 4|Adverse Event|0|||
163168878|NCT02059291|589334532|FG015|Epoch 4|Adverse Event|0|||
163168879|NCT02059291|589334533|FG016|Epoch 4|Adverse Event|1|||
163168880|NCT02059291|589334534|FG017|Epoch 4|Adverse Event|0|||
163168881|NCT02059291|589334535|FG018|Epoch 4|Adverse Event|0|||
163168882|NCT02059291|589334536|FG019|Epoch 4|Adverse Event|0|||
163168883|NCT02059291|589334537|FG020|Epoch 4|Adverse Event|0|||
163168884|NCT02059291|589334538|FG021|Epoch 4|Adverse Event|0|||
163168885|NCT02059291|589334539|FG022|Epoch 4|Adverse Event|1|||
163168886|NCT02059291|589334540|FG023|Epoch 4|Adverse Event|0|||
163168887|NCT02059291|589334541|FG024|Epoch 4|Adverse Event|0|||
163168888|NCT02059291|589334517|FG000|Epoch 4|Pregnancy|0|||
163168889|NCT02059291|589334518|FG001|Epoch 4|Pregnancy|0|||
163168890|NCT02059291|589334519|FG002|Epoch 4|Pregnancy|0|||
163168891|NCT02059291|589334520|FG003|Epoch 4|Pregnancy|0|||
163168892|NCT02059291|589334521|FG004|Epoch 4|Pregnancy|0|||
163168893|NCT02059291|589334522|FG005|Epoch 4|Pregnancy|0|||
163168894|NCT02059291|589334523|FG006|Epoch 4|Pregnancy|0|||
163168895|NCT02059291|589334524|FG007|Epoch 4|Pregnancy|0|||
163276854|NCT04248465|589723515|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
163276855|NCT04248465|589723516|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
163276856|NCT04248465|589723515|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
163168896|NCT02059291|589334525|FG008|Epoch 4|Pregnancy|0|||
163168897|NCT02059291|589334526|FG009|Epoch 4|Pregnancy|0|||
163168898|NCT02059291|589334527|FG010|Epoch 4|Pregnancy|0|||
163168899|NCT02059291|589334528|FG011|Epoch 4|Pregnancy|0|||
163168900|NCT02059291|589334529|FG012|Epoch 4|Pregnancy|0|||
163168901|NCT02059291|589334530|FG013|Epoch 4|Pregnancy|0|||
163168902|NCT02059291|589334531|FG014|Epoch 4|Pregnancy|0|||
163168903|NCT02059291|589334532|FG015|Epoch 4|Pregnancy|0|||
163168904|NCT02059291|589334533|FG016|Epoch 4|Pregnancy|1|||
163168905|NCT02059291|589334534|FG017|Epoch 4|Pregnancy|0|||
163168906|NCT02059291|589334535|FG018|Epoch 4|Pregnancy|0|||
163168907|NCT02059291|589334536|FG019|Epoch 4|Pregnancy|0|||
163168908|NCT02059291|589334537|FG020|Epoch 4|Pregnancy|0|||
163168909|NCT02059291|589334538|FG021|Epoch 4|Pregnancy|0|||
163168910|NCT02059291|589334539|FG022|Epoch 4|Pregnancy|0|||
163168911|NCT02059291|589334540|FG023|Epoch 4|Pregnancy|0|||
163168912|NCT02059291|589334541|FG024|Epoch 4|Pregnancy|0|||
163168913|NCT02059291|589334517|FG000|Epoch 4|Withdrawal by Subject|0|||
163168914|NCT02059291|589334518|FG001|Epoch 4|Withdrawal by Subject|0|||
163168915|NCT02059291|589334519|FG002|Epoch 4|Withdrawal by Subject|0|||
163168916|NCT02059291|589334520|FG003|Epoch 4|Withdrawal by Subject|0|||
163168917|NCT02059291|589334521|FG004|Epoch 4|Withdrawal by Subject|0|||
163168918|NCT02059291|589334522|FG005|Epoch 4|Withdrawal by Subject|0|||
163168919|NCT02059291|589334523|FG006|Epoch 4|Withdrawal by Subject|0|||
163168920|NCT02059291|589334524|FG007|Epoch 4|Withdrawal by Subject|0|||
163168921|NCT02059291|589334525|FG008|Epoch 4|Withdrawal by Subject|0|||
163168922|NCT02059291|589334526|FG009|Epoch 4|Withdrawal by Subject|0|||
163168923|NCT02059291|589334527|FG010|Epoch 4|Withdrawal by Subject|0|||
163168924|NCT02059291|589334528|FG011|Epoch 4|Withdrawal by Subject|0|||
163168925|NCT02059291|589334529|FG012|Epoch 4|Withdrawal by Subject|0|||
163168926|NCT02059291|589334530|FG013|Epoch 4|Withdrawal by Subject|0|||
163168927|NCT02059291|589334531|FG014|Epoch 4|Withdrawal by Subject|0|||
163168928|NCT02059291|589334532|FG015|Epoch 4|Withdrawal by Subject|0|||
163168929|NCT02059291|589334533|FG016|Epoch 4|Withdrawal by Subject|0|||
163168930|NCT02059291|589334534|FG017|Epoch 4|Withdrawal by Subject|0|||
163168931|NCT02059291|589334535|FG018|Epoch 4|Withdrawal by Subject|0|||
163168932|NCT02059291|589334536|FG019|Epoch 4|Withdrawal by Subject|0|||
163168933|NCT02059291|589334537|FG020|Epoch 4|Withdrawal by Subject|1|||
163168934|NCT02059291|589334538|FG021|Epoch 4|Withdrawal by Subject|0|||
163168935|NCT02059291|589334539|FG022|Epoch 4|Withdrawal by Subject|0|||
163168936|NCT02059291|589334540|FG023|Epoch 4|Withdrawal by Subject|0|||
163168937|NCT02059291|589334541|FG024|Epoch 4|Withdrawal by Subject|0|||
163168938|NCT02059291|589334517|FG000|Epoch 4|Lack of Efficacy|0|||
163168939|NCT02059291|589334518|FG001|Epoch 4|Lack of Efficacy|0|||
163168940|NCT02059291|589334519|FG002|Epoch 4|Lack of Efficacy|0|||
163168941|NCT02059291|589334520|FG003|Epoch 4|Lack of Efficacy|0|||
163168942|NCT02059291|589334521|FG004|Epoch 4|Lack of Efficacy|0|||
163168943|NCT02059291|589334522|FG005|Epoch 4|Lack of Efficacy|0|||
163168944|NCT02059291|589334523|FG006|Epoch 4|Lack of Efficacy|0|||
163168945|NCT02059291|589334524|FG007|Epoch 4|Lack of Efficacy|0|||
163168946|NCT02059291|589334525|FG008|Epoch 4|Lack of Efficacy|0|||
163168947|NCT02059291|589334526|FG009|Epoch 4|Lack of Efficacy|0|||
163168948|NCT02059291|589334527|FG010|Epoch 4|Lack of Efficacy|0|||
163168949|NCT02059291|589334528|FG011|Epoch 4|Lack of Efficacy|0|||
163276857|NCT04248465|589723516|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
163276858|NCT05708846|589723517|FG000|Overall Study|Death|5|||
163276859|NCT05708846|589723517|FG000|Overall Study|Withdrawal by Subject|20|||
163276860|NCT03621982|589723518|FG000|Overall Study|Withdrawal by Subject|1|||
163168950|NCT02059291|589334529|FG012|Epoch 4|Lack of Efficacy|0|||
163168951|NCT02059291|589334530|FG013|Epoch 4|Lack of Efficacy|0|||
163168952|NCT02059291|589334531|FG014|Epoch 4|Lack of Efficacy|0|||
163168953|NCT02059291|589334532|FG015|Epoch 4|Lack of Efficacy|0|||
163168954|NCT02059291|589334533|FG016|Epoch 4|Lack of Efficacy|0|||
163168955|NCT02059291|589334534|FG017|Epoch 4|Lack of Efficacy|0|||
163168956|NCT02059291|589334535|FG018|Epoch 4|Lack of Efficacy|0|||
163168957|NCT02059291|589334536|FG019|Epoch 4|Lack of Efficacy|0|||
163168958|NCT02059291|589334537|FG020|Epoch 4|Lack of Efficacy|0|||
163168959|NCT02059291|589334538|FG021|Epoch 4|Lack of Efficacy|0|||
163168960|NCT02059291|589334539|FG022|Epoch 4|Lack of Efficacy|0|||
163168961|NCT02059291|589334540|FG023|Epoch 4|Lack of Efficacy|1|||
163168962|NCT02059291|589334541|FG024|Epoch 4|Lack of Efficacy|0|||
163168963|NCT04975438|589334545|FG000|Overall Study|Lost to Follow-up|1|||
163168964|NCT04975438|589334546|FG001|Overall Study|Lost to Follow-up|0|||
163168965|NCT04975438|589334547|FG002|Overall Study|Lost to Follow-up|1|||
163168966|NCT04975438|589334548|FG003|Overall Study|Lost to Follow-up|0|||
163168967|NCT04975438|589334545|FG000|Overall Study|Withdrawal by Subject|1|||
163168968|NCT04975438|589334546|FG001|Overall Study|Withdrawal by Subject|0|||
163168969|NCT04975438|589334547|FG002|Overall Study|Withdrawal by Subject|0|||
163168970|NCT04975438|589334548|FG003|Overall Study|Withdrawal by Subject|0|||
163168971|NCT01276054|589334552|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
163168972|NCT01276054|589334553|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
163168973|NCT05405257|589334557|FG000|Overall Study|Withdrawal by Subject|1|||
163168974|NCT01788215|589334560|FG000|Overall Study|Withdrawal by Subject|0|||
163168975|NCT01788215|589334561|FG001|Overall Study|Withdrawal by Subject|1|||
163168976|NCT01788215|589334560|FG000|Overall Study|Lost to Follow-up|2|||
163168977|NCT01788215|589334561|FG001|Overall Study|Lost to Follow-up|0|||
163168978|NCT03116152|589334562|FG000|Overall Study|Disease Progression|49|||
163168979|NCT03116152|589334563|FG001|Overall Study|Disease Progression|47|||
163168980|NCT03116152|589334562|FG000|Overall Study|Death|5|||
163168981|NCT03116152|589334563|FG001|Overall Study|Death|2|||
163168982|NCT03116152|589334562|FG000|Overall Study|Adverse Event|21|||
163168983|NCT03116152|589334563|FG001|Overall Study|Adverse Event|7|||
163168984|NCT03116152|589334562|FG000|Overall Study|Protocol Violation|2|||
163168985|NCT03116152|589334563|FG001|Overall Study|Protocol Violation|2|||
163168986|NCT03116152|589334562|FG000|Overall Study|Withdrawal by Subject|0|||
163168987|NCT03116152|589334563|FG001|Overall Study|Withdrawal by Subject|1|||
163168988|NCT03116152|589334562|FG000|Overall Study|Physician Decision|3|||
163168989|NCT03116152|589334563|FG001|Overall Study|Physician Decision|2|||
163168990|NCT03116152|589334562|FG000|Overall Study|other|11|||
163168991|NCT03116152|589334563|FG001|Overall Study|other|34|||
163168992|NCT03500224|589334568|FG000|Overall Study|Withdrawal by Subject|2|||
163168993|NCT00335764|589334569|FG000|Overall Study|wrong histology|1|||
163168994|NCT00335764|589334570|FG001|Overall Study|wrong histology|0|||
163168995|NCT00335764|589334571|FG002|Overall Study|wrong histology|0|||
163168996|NCT00335764|589334572|FG003|Overall Study|wrong histology|0|||
163168997|NCT00335764|589334573|FG004|Overall Study|wrong histology|1|||
163168998|NCT00929643|589334574|FG000|Overall Study|Protocol Violation|2|||
163276861|NCT03621982|589723519|FG001|Overall Study|Withdrawal by Subject|0|||
163276862|NCT03621982|589723520|FG002|Overall Study|Withdrawal by Subject|0|||
163168999|NCT00145977|589334575|FG000|Overall Study|Lack of Efficacy|0|||
163169000|NCT00145977|589334576|FG001|Overall Study|Lack of Efficacy|4|||
163169001|NCT00145977|589334575|FG000|Overall Study|Lost to Follow-up|1|||
163276863|NCT03621982|589723521|FG003|Overall Study|Withdrawal by Subject|1|||
163169002|NCT00145977|589334576|FG001|Overall Study|Lost to Follow-up|0|||
163169003|NCT00145977|589334575|FG000|Overall Study|Withdrawal by Subject|1|||
163169004|NCT00145977|589334576|FG001|Overall Study|Withdrawal by Subject|0|||
163169005|NCT02717832|589334587|FG000|Overall Study|Inability to place IV|3|||
163169006|NCT01215097|589334588|FG000|Overall Study|Adverse Event|1|||
163276864|NCT03621982|589723522|FG004|Overall Study|Withdrawal by Subject|0|||
163169007|NCT01215097|589334589|FG001|Overall Study|Adverse Event|3|||
163169008|NCT01215097|589334588|FG000|Overall Study|Protocol Violation|0|||
163169009|NCT01215097|589334589|FG001|Overall Study|Protocol Violation|2|||
163169010|NCT01215097|589334588|FG000|Overall Study|Lost to Follow-up|2|||
163169011|NCT01215097|589334589|FG001|Overall Study|Lost to Follow-up|0|||
163169012|NCT01215097|589334588|FG000|Overall Study|Withdrawal by Subject|6|||
163169013|NCT01215097|589334589|FG001|Overall Study|Withdrawal by Subject|3|||
163169014|NCT01215097|589334588|FG000|Overall Study|Lack of Efficacy|0|||
163169015|NCT01215097|589334589|FG001|Overall Study|Lack of Efficacy|3|||
163169016|NCT01215097|589334588|FG000|Overall Study|patient's refusal to come|2|||
163169017|NCT01215097|589334589|FG001|Overall Study|patient's refusal to come|2|||
163169018|NCT01215097|589334588|FG000|Overall Study|patient's private reason|1|||
163169019|NCT01215097|589334589|FG001|Overall Study|patient's private reason|1|||
163169020|NCT01818752|589334590|FG000|Overall Study|Adverse Event|64|||
163169021|NCT01818752|589334591|FG001|Overall Study|Adverse Event|74|||
163169022|NCT01818752|589334590|FG000|Overall Study|Death|14|||
163169023|NCT01818752|589334591|FG001|Overall Study|Death|18|||
163169024|NCT01818752|589334590|FG000|Overall Study|Non-compliance|16|||
163169025|NCT01818752|589334591|FG001|Overall Study|Non-compliance|20|||
163169026|NCT01818752|589334590|FG000|Overall Study|Withdrawal by Subject|15|||
163169027|NCT01818752|589334591|FG001|Overall Study|Withdrawal by Subject|14|||
163169028|NCT01818752|589334590|FG000|Overall Study|Physician Decision|9|||
163169029|NCT01818752|589334591|FG001|Overall Study|Physician Decision|8|||
163169030|NCT01818752|589334590|FG000|Overall Study|Disease Progression|54|||
163169031|NCT01818752|589334591|FG001|Overall Study|Disease Progression|48|||
163169032|NCT01818752|589334590|FG000|Overall Study|Other|7|||
163169033|NCT01818752|589334591|FG001|Overall Study|Other|8|||
163169034|NCT01818752|589334590|FG000|Overall Study|Continuing Treatment|1|||
163169035|NCT01818752|589334591|FG001|Overall Study|Continuing Treatment|4|||
163169036|NCT01818752|589334590|FG000|Overall Study|Randomized but not Dosed|7|||
163169037|NCT01818752|589334591|FG001|Overall Study|Randomized but not Dosed|4|||
163169038|NCT04629066|589334592|FG000|Overall Study|Lost to Follow-up|3|||
163169039|NCT04629066|589334593|FG001|Overall Study|Lost to Follow-up|2|||
163169040|NCT00282308|589334598|FG000|Treatment Period|Lost to Follow-up|1|||
163169041|NCT00282308|589334599|FG001|Treatment Period|Lost to Follow-up|0|||
163169042|NCT00282308|589334600|FG002|Treatment Period|Lost to Follow-up|0|||
163169043|NCT00282308|589334598|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
163169044|NCT00282308|589334599|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
163169045|NCT00282308|589334600|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
163169046|NCT00282308|589334598|FG000|Treatment Period|Adverse Event|0|||
163169047|NCT00282308|589334599|FG001|Treatment Period|Adverse Event|2|||
163169048|NCT00282308|589334600|FG002|Treatment Period|Adverse Event|0|||
163169049|NCT00282308|589334598|FG000|Treatment Period|Not Treated with Study Drug|1|||
163169050|NCT00282308|589334599|FG001|Treatment Period|Not Treated with Study Drug|0|||
163169051|NCT00282308|589334600|FG002|Treatment Period|Not Treated with Study Drug|0|||
163169052|NCT00282308|589334598|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
163169053|NCT00282308|589334599|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
163169054|NCT00282308|589334600|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
163169055|NCT00282308|589334598|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
163169056|NCT00282308|589334599|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
163169057|NCT00282308|589334600|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
163169058|NCT00282308|589334598|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
163169059|NCT00282308|589334599|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
163169060|NCT00282308|589334600|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
163169061|NCT00282308|589334598|FG000|Safety Follow-up Period|Adverse Event|0|||
163169062|NCT00282308|589334599|FG001|Safety Follow-up Period|Adverse Event|0|||
163169063|NCT00282308|589334600|FG002|Safety Follow-up Period|Adverse Event|1|||
163169064|NCT00282308|589334598|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
163169065|NCT00282308|589334599|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
163169066|NCT00282308|589334600|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
163169067|NCT00282308|589334598|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
163169068|NCT00282308|589334599|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
163169069|NCT00282308|589334600|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
163169070|NCT00282308|589334598|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
163169071|NCT00282308|589334599|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
163169072|NCT00282308|589334600|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
163169073|NCT02872285|589334602|FG000|Overall Study|Withdrawal by Subject|2|||
163169074|NCT02872285|589334603|FG001|Overall Study|Withdrawal by Subject|0|||
163169075|NCT02872285|589334602|FG000|Overall Study|Lost to Follow-up|2|||
163169076|NCT02872285|589334603|FG001|Overall Study|Lost to Follow-up|2|||
163169077|NCT02872285|589334602|FG000|Overall Study|Discontinued due to back surgery|1|||
163169078|NCT02872285|589334603|FG001|Overall Study|Discontinued due to back surgery|0|||
163169079|NCT02970942|589334604|FG000|Overall Study|Death|0|||
163169080|NCT02970942|589334605|FG001|Overall Study|Death|1|||
163169081|NCT02970942|589334606|FG002|Overall Study|Death|0|||
163169082|NCT02970942|589334607|FG003|Overall Study|Death|0|||
163169083|NCT02970942|589334604|FG000|Overall Study|Lost to Follow-up|1|||
163169084|NCT02970942|589334605|FG001|Overall Study|Lost to Follow-up|0|||
163169085|NCT02970942|589334606|FG002|Overall Study|Lost to Follow-up|2|||
163169086|NCT02970942|589334607|FG003|Overall Study|Lost to Follow-up|1|||
163169087|NCT02970942|589334604|FG000|Overall Study|Withdrawal by Subject|3|||
163169088|NCT02970942|589334605|FG001|Overall Study|Withdrawal by Subject|5|||
163169089|NCT02970942|589334606|FG002|Overall Study|Withdrawal by Subject|3|||
163169090|NCT02970942|589334607|FG003|Overall Study|Withdrawal by Subject|2|||
163169091|NCT01065454|589334610|FG000|Treatment|Adverse Event|7|||
163169092|NCT01065454|589334611|FG001|Treatment|Adverse Event|4|||
163169093|NCT01065454|589334612|FG002|Treatment|Adverse Event|3|||
163169094|NCT01065454|589334613|FG003|Treatment|Adverse Event|6|||
163169095|NCT01065454|589334610|FG000|Treatment|Death|1|||
163169096|NCT01065454|589334611|FG001|Treatment|Death|0|||
163169097|NCT01065454|589334612|FG002|Treatment|Death|0|||
163169098|NCT01065454|589334613|FG003|Treatment|Death|0|||
163169099|NCT01065454|589334610|FG000|Treatment|Non-compliance|1|||
163169100|NCT01065454|589334611|FG001|Treatment|Non-compliance|0|||
163169101|NCT01065454|589334612|FG002|Treatment|Non-compliance|0|||
163169102|NCT01065454|589334613|FG003|Treatment|Non-compliance|1|||
163169103|NCT01065454|589334610|FG000|Treatment|Protocol Decision|0|||
163169104|NCT01065454|589334611|FG001|Treatment|Protocol Decision|0|||
163169105|NCT01065454|589334612|FG002|Treatment|Protocol Decision|3|||
163169106|NCT01065454|589334613|FG003|Treatment|Protocol Decision|2|||
163169107|NCT01065454|589334610|FG000|Treatment|Protocol Violation|1|||
163169108|NCT01065454|589334611|FG001|Treatment|Protocol Violation|0|||
163169109|NCT01065454|589334612|FG002|Treatment|Protocol Violation|1|||
163169110|NCT01065454|589334613|FG003|Treatment|Protocol Violation|0|||
163169111|NCT01065454|589334610|FG000|Treatment|Withdrawal by Subject|3|||
163169112|NCT01065454|589334611|FG001|Treatment|Withdrawal by Subject|1|||
163169113|NCT01065454|589334612|FG002|Treatment|Withdrawal by Subject|2|||
163169114|NCT01065454|589334613|FG003|Treatment|Withdrawal by Subject|3|||
163169115|NCT01065454|589334610|FG000|Follow up|Adverse Event|1|||
163169116|NCT01065454|589334611|FG001|Follow up|Adverse Event|0|||
163169117|NCT01065454|589334612|FG002|Follow up|Adverse Event|0|||
163169118|NCT01065454|589334613|FG003|Follow up|Adverse Event|1|||
163169119|NCT01065454|589334610|FG000|Follow up|Death|0|||
163169120|NCT01065454|589334611|FG001|Follow up|Death|1|||
163169121|NCT01065454|589334612|FG002|Follow up|Death|1|||
163169122|NCT01065454|589334613|FG003|Follow up|Death|0|||
163169123|NCT01065454|589334610|FG000|Follow up|Lost to Follow-up|0|||
163169124|NCT01065454|589334611|FG001|Follow up|Lost to Follow-up|0|||
163169125|NCT01065454|589334612|FG002|Follow up|Lost to Follow-up|0|||
163169126|NCT01065454|589334613|FG003|Follow up|Lost to Follow-up|1|||
163169127|NCT01065454|589334610|FG000|Follow up|Progressive disease|0|||
163169128|NCT01065454|589334611|FG001|Follow up|Progressive disease|0|||
163169129|NCT01065454|589334612|FG002|Follow up|Progressive disease|0|||
163169130|NCT01065454|589334613|FG003|Follow up|Progressive disease|1|||
163169131|NCT01065454|589334610|FG000|Follow up|Withdrawal by Subject|1|||
163169132|NCT01065454|589334611|FG001|Follow up|Withdrawal by Subject|1|||
163169133|NCT01065454|589334612|FG002|Follow up|Withdrawal by Subject|1|||
163169134|NCT01065454|589334613|FG003|Follow up|Withdrawal by Subject|0|||
163169135|NCT01065454|589334610|FG000|Follow up|study ongoing|37|||
163169136|NCT01065454|589334611|FG001|Follow up|study ongoing|22|||
163169137|NCT01065454|589334612|FG002|Follow up|study ongoing|15|||
163169138|NCT01065454|589334613|FG003|Follow up|study ongoing|41|||
163169139|NCT03374202|589334614|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
163169140|NCT03374202|589334615|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
163169141|NCT03374202|589334616|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
163169142|NCT03374202|589334614|FG000|Five Year Long Term Follow Up|Death|0|||
163169143|NCT03374202|589334615|FG001|Five Year Long Term Follow Up|Death|1|||
163169144|NCT03374202|589334616|FG002|Five Year Long Term Follow Up|Death|0|||
163169145|NCT01325337|589336411|FG000|Overall Study|Adverse Event|0|||
163169146|NCT01325337|589336412|FG001|Overall Study|Adverse Event|2|||
163169147|NCT01325337|589336413|FG002|Overall Study|Adverse Event|2|||
163169148|NCT01325337|589336414|FG003|Overall Study|Adverse Event|1|||
163169149|NCT01325337|589336415|FG004|Overall Study|Adverse Event|2|||
163169150|NCT01325337|589336411|FG000|Overall Study|Lost to Follow-up|2|||
163169151|NCT01325337|589336412|FG001|Overall Study|Lost to Follow-up|2|||
163169152|NCT01325337|589336413|FG002|Overall Study|Lost to Follow-up|2|||
163169153|NCT01325337|589336414|FG003|Overall Study|Lost to Follow-up|1|||
163169154|NCT01325337|589336415|FG004|Overall Study|Lost to Follow-up|2|||
163169155|NCT01325337|589336411|FG000|Overall Study|Personal Reasons|2|||
163169156|NCT01325337|589336412|FG001|Overall Study|Personal Reasons|5|||
163169157|NCT01325337|589336413|FG002|Overall Study|Personal Reasons|4|||
163169158|NCT01325337|589336414|FG003|Overall Study|Personal Reasons|8|||
163169159|NCT01325337|589336415|FG004|Overall Study|Personal Reasons|3|||
163169160|NCT01325337|589336411|FG000|Overall Study|Withdrawal by Subject|1|||
163169161|NCT01325337|589336412|FG001|Overall Study|Withdrawal by Subject|0|||
163169162|NCT01325337|589336413|FG002|Overall Study|Withdrawal by Subject|1|||
163169163|NCT01325337|589336414|FG003|Overall Study|Withdrawal by Subject|0|||
163169164|NCT01325337|589336415|FG004|Overall Study|Withdrawal by Subject|1|||
163169165|NCT01604278|589336416|FG000|Overall Study|Lack of Efficacy|0|||
163169166|NCT01604278|589336417|FG001|Overall Study|Lack of Efficacy|1|||
163169167|NCT01604278|589336416|FG000|Overall Study|Lost to Follow-up|1|||
163169168|NCT01604278|589336417|FG001|Overall Study|Lost to Follow-up|0|||
163169169|NCT01604278|589336416|FG000|Overall Study|Administrative problems|2|||
163169170|NCT01604278|589336417|FG001|Overall Study|Administrative problems|1|||
163169171|NCT01604278|589336416|FG000|Overall Study|Withdrawal by Subject|3|||
163169172|NCT01604278|589336417|FG001|Overall Study|Withdrawal by Subject|3|||
163169173|NCT01604278|589336416|FG000|Overall Study|Adverse Event|3|||
163169174|NCT01604278|589336417|FG001|Overall Study|Adverse Event|5|||
163169175|NCT01604278|589336416|FG000|Overall Study|Protocol Deviation|5|||
163169176|NCT01604278|589336417|FG001|Overall Study|Protocol Deviation|3|||
163169177|NCT02500056|589336439|FG000|Overall Study|Lost to Follow-up|3|||
163169178|NCT02500056|589336440|FG001|Overall Study|Lost to Follow-up|7|||
163169179|NCT02500056|589336439|FG000|Overall Study|Recurrence|1|||
163169180|NCT02500056|589336440|FG001|Overall Study|Recurrence|0|||
163169181|NCT02500056|589336439|FG000|Overall Study|Death|3|||
163169182|NCT02500056|589336440|FG001|Overall Study|Death|1|||
163169183|NCT04973436|589336449|FG000|Overall Study|Lost to Follow-up|3|||
163169184|NCT04973436|589336449|FG000|Overall Study|Withdrawal by Subject|1|||
163169185|NCT04973436|589336449|FG000|Overall Study|Death|2|||
163169186|NCT00275340|589336450|FG000|Overall Study|Lost to Follow-up|2|||
163169187|NCT00275340|589336451|FG001|Overall Study|Lost to Follow-up|4|||
163169188|NCT00862641|589336454|FG000|Overall Study|Randomized, but drug not received|1|||
163169189|NCT00862641|589336455|FG001|Overall Study|Randomized, but drug not received|4|||
163169190|NCT00862641|589336456|FG002|Overall Study|Randomized, but drug not received|1|||
163169191|NCT00862641|589336457|FG003|Overall Study|Randomized, but drug not received|4|||
163169192|NCT02365480|589336458|FG000|Overall Study|Withdrawal by Subject|2|||
163169193|NCT02365480|589336459|FG001|Overall Study|Withdrawal by Subject|0|||
163169194|NCT01419197|589336464|FG000|Overall Study|Death|247|||
163169195|NCT01419197|589336465|FG001|Overall Study|Death|122|||
163169196|NCT01419197|589336464|FG000|Overall Study|Physician Decision|4|||
163169197|NCT01419197|589336465|FG001|Overall Study|Physician Decision|4|||
163169198|NCT01419197|589336464|FG000|Overall Study|Non-compliance|3|||
163169199|NCT01419197|589336465|FG001|Overall Study|Non-compliance|1|||
163169200|NCT01419197|589336464|FG000|Overall Study|Withdrawal by Subject|33|||
163169201|NCT01419197|589336465|FG001|Overall Study|Withdrawal by Subject|32|||
163169202|NCT01419197|589336464|FG000|Overall Study|Study Completed by Sponsor|103|||
163169203|NCT01419197|589336465|FG001|Overall Study|Study Completed by Sponsor|34|||
163169204|NCT01419197|589336464|FG000|Overall Study|Reason Not Specified|0|||
163169205|NCT01419197|589336465|FG001|Overall Study|Reason Not Specified|1|||
163169206|NCT01419197|589336464|FG000|Overall Study|Lost to Follow-up|14|||
163169207|NCT01419197|589336465|FG001|Overall Study|Lost to Follow-up|4|||
163169208|NCT01781299|589336466|FG000|Overall Study|Withdrawal by Subject|0|||
163169209|NCT01781299|589336467|FG001|Overall Study|Withdrawal by Subject|1|||
163169210|NCT00146848|589336471|FG000|Pre-randomization|Death|19|||
163169211|NCT00146848|589336472|FG001|Pre-randomization|Death|0|||
163169212|NCT00146848|589336473|FG002|Pre-randomization|Death|0|||
163169213|NCT00146848|589336471|FG000|Pre-randomization|Lost to Follow-up|70|||
163169214|NCT00146848|589336472|FG001|Pre-randomization|Lost to Follow-up|0|||
163169215|NCT00146848|589336473|FG002|Pre-randomization|Lost to Follow-up|0|||
163169216|NCT00146848|589336471|FG000|Pre-randomization|Physician Decision|8|||
163169217|NCT00146848|589336472|FG001|Pre-randomization|Physician Decision|0|||
163169218|NCT00146848|589336473|FG002|Pre-randomization|Physician Decision|0|||
163169219|NCT00146848|589336471|FG000|Pre-randomization|Protocol Violation|172|||
163169220|NCT00146848|589336472|FG001|Pre-randomization|Protocol Violation|0|||
163169221|NCT00146848|589336473|FG002|Pre-randomization|Protocol Violation|0|||
163169222|NCT00146848|589336471|FG000|Pre-randomization|Withdrawal by Subject|40|||
163169223|NCT00146848|589336472|FG001|Pre-randomization|Withdrawal by Subject|0|||
163169224|NCT00146848|589336473|FG002|Pre-randomization|Withdrawal by Subject|0|||
163169225|NCT00146848|589336471|FG000|Post-randomization|Lost to Follow-up|12|||
163169226|NCT00146848|589336472|FG001|Post-randomization|Lost to Follow-up|15|||
163169227|NCT00146848|589336473|FG002|Post-randomization|Lost to Follow-up|12|||
163169228|NCT00146848|589336471|FG000|Post-randomization|Withdrawn|26|||
163169229|NCT00146848|589336472|FG001|Post-randomization|Withdrawn|32|||
163169230|NCT00146848|589336473|FG002|Post-randomization|Withdrawn|27|||
163169231|NCT01798849|589336474|FG000|Overall Study|Physician Decision|0|||
163169232|NCT01798849|589336475|FG001|Overall Study|Physician Decision|0|||
163169233|NCT01798849|589336476|FG002|Overall Study|Physician Decision|1|||
163169234|NCT02395172|589336477|FG000|Overall Study|Participants randomized but not treated|3|||
163169235|NCT02395172|589336478|FG001|Overall Study|Participants randomized but not treated|31|||
163169236|NCT02032238|589336479|FG000|Overall Study|Lost to Follow-up|2|||
163169237|NCT02032238|589336480|FG001|Overall Study|Lost to Follow-up|0|||
163169238|NCT00653939|589336481|FG000|Overall Study|Adverse Event|1|||
163169239|NCT00653939|589336482|FG001|Overall Study|Adverse Event|3|||
163169240|NCT00653939|589336481|FG000|Overall Study|Withdrawal by Subject|3|||
163169241|NCT00653939|589336482|FG001|Overall Study|Withdrawal by Subject|3|||
163169242|NCT00653939|589336481|FG000|Overall Study|Physician Decision|4|||
163276865|NCT03621982|589723523|FG005|Overall Study|Withdrawal by Subject|1|||
163169243|NCT00653939|589336482|FG001|Overall Study|Physician Decision|0|||
163169244|NCT00653939|589336481|FG000|Overall Study|Disease Progression|2|||
163169245|NCT00653939|589336482|FG001|Overall Study|Disease Progression|3|||
163169246|NCT00653939|589336481|FG000|Overall Study|Other|2|||
163169247|NCT00653939|589336482|FG001|Overall Study|Other|6|||
163169248|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
163169249|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
163169250|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
163169251|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
163169252|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
163169253|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
163169254|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
163169255|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
163169256|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
163169257|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
163169258|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
163169259|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
163169260|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
163169261|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
163169262|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
163169263|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
163169264|NCT00612105|589336483|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
163169265|NCT00612105|589336484|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
163169266|NCT00612105|589336483|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
163169267|NCT00612105|589336484|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
163169268|NCT00612105|589336483|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
163169269|NCT00612105|589336484|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
163169270|NCT00612105|589336483|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
163169271|NCT00612105|589336484|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
163169272|NCT00717236|589336485|FG000|Double-Blind Period|Adverse Event|33|||
163169273|NCT00717236|589336486|FG001|Double-Blind Period|Adverse Event|6|||
163169274|NCT00717236|589336485|FG000|Double-Blind Period|Lack of Efficacy|6|||
163169275|NCT00717236|589336486|FG001|Double-Blind Period|Lack of Efficacy|6|||
163169276|NCT00717236|589336485|FG000|Double-Blind Period|Lost to Follow-up|3|||
163169277|NCT00717236|589336486|FG001|Double-Blind Period|Lost to Follow-up|5|||
163169278|NCT00717236|589336485|FG000|Double-Blind Period|Withdrawal by Subject|10|||
163169279|NCT00717236|589336486|FG001|Double-Blind Period|Withdrawal by Subject|2|||
163169280|NCT00717236|589336485|FG000|Double-Blind Period|Loss of efficacy|3|||
163169281|NCT00717236|589336486|FG001|Double-Blind Period|Loss of efficacy|0|||
163169282|NCT00717236|589336485|FG000|Double-Blind Period|Other: Death|1|||
163169283|NCT00717236|589336486|FG001|Double-Blind Period|Other: Death|0|||
163169284|NCT00717236|589336485|FG000|Double-Blind Period|Other: Pregnancy|1|||
163169285|NCT00717236|589336486|FG001|Double-Blind Period|Other: Pregnancy|0|||
163169286|NCT00717236|589336485|FG000|Double-Blind Period|Other: Protocol Violation|2|||
163169287|NCT00717236|589336486|FG001|Double-Blind Period|Other: Protocol Violation|0|||
163169288|NCT00717236|589336485|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
163169289|NCT00717236|589336486|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
163169290|NCT00717236|589336485|FG000|Double-Blind Period|Other: Site withdrew|2|||
163169291|NCT00717236|589336486|FG001|Double-Blind Period|Other: Site withdrew|0|||
163169292|NCT00717236|589336485|FG000|Double-Blind Period|Other: Screening failure|1|||
163169293|NCT00717236|589336486|FG001|Double-Blind Period|Other: Screening failure|0|||
163169294|NCT00717236|589336485|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
163169295|NCT00717236|589336486|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
163169296|NCT00717236|589336485|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
163169297|NCT00717236|589336486|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
163169298|NCT00717236|589336485|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
163169299|NCT00717236|589336486|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
163169300|NCT00717236|589336485|FG000|Double-Blind Period|Other: History of cancer|1|||
163169301|NCT00717236|589336486|FG001|Double-Blind Period|Other: History of cancer|0|||
163169302|NCT00717236|589336485|FG000|Double-Blind Period|Other: Sponsor request|1|||
163169303|NCT00717236|589336486|FG001|Double-Blind Period|Other: Sponsor request|0|||
163169304|NCT00717236|589336485|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
163169305|NCT00717236|589336486|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
163276866|NCT03621982|589723524|FG006|Overall Study|Withdrawal by Subject|1|||
163276867|NCT03621982|589723525|FG007|Overall Study|Withdrawal by Subject|0|||
163169306|NCT00717236|589336485|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
163169307|NCT00717236|589336486|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
163169308|NCT00717236|589336485|FG000|Double-Blind Period|Other: Subject moved|1|||
163169309|NCT00717236|589336486|FG001|Double-Blind Period|Other: Subject moved|1|||
163169310|NCT00717236|589336485|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
163169311|NCT00717236|589336486|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
163169312|NCT00717236|589336485|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
163169313|NCT00717236|589336486|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
163169314|NCT00717236|589336485|FG000|Double-Blind Period|Other: Transportation problems|0|||
163169315|NCT00717236|589336486|FG001|Double-Blind Period|Other: Transportation problems|1|||
163169316|NCT00717236|589336485|FG000|Double-Blind Period|Other: Investigator Decision|0|||
163169317|NCT00717236|589336486|FG001|Double-Blind Period|Other: Investigator Decision|1|||
163169318|NCT00717236|589336485|FG000|Open-Label Period|Adverse Event|29|||
163169319|NCT00717236|589336486|FG001|Open-Label Period|Adverse Event|4|||
163169320|NCT00717236|589336485|FG000|Open-Label Period|Lack of Efficacy|30|||
163169321|NCT00717236|589336486|FG001|Open-Label Period|Lack of Efficacy|8|||
163169322|NCT00717236|589336485|FG000|Open-Label Period|Lost to Follow-up|28|||
163169323|NCT00717236|589336486|FG001|Open-Label Period|Lost to Follow-up|4|||
163169324|NCT00717236|589336485|FG000|Open-Label Period|Withdrawal by Subject|20|||
163169325|NCT00717236|589336486|FG001|Open-Label Period|Withdrawal by Subject|2|||
163169326|NCT00717236|589336485|FG000|Open-Label Period|Loss of Efficacy|6|||
163169327|NCT00717236|589336486|FG001|Open-Label Period|Loss of Efficacy|1|||
163169328|NCT00717236|589336485|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
163169329|NCT00717236|589336486|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
163169330|NCT00717236|589336485|FG000|Open-Label Period|Other: Lack of Compliance|1|||
163169331|NCT00717236|589336486|FG001|Open-Label Period|Other: Lack of Compliance|1|||
163169332|NCT00717236|589336485|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
163169333|NCT00717236|589336486|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
163169334|NCT00717236|589336485|FG000|Open-Label Period|Other: Moved|1|||
163169335|NCT00717236|589336486|FG001|Open-Label Period|Other: Moved|0|||
163169336|NCT00717236|589336485|FG000|Open-Label Period|Other: Investigator Decision|1|||
163169337|NCT00717236|589336486|FG001|Open-Label Period|Other: Investigator Decision|0|||
163169338|NCT00717236|589336485|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
163169339|NCT00717236|589336486|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
163169340|NCT00717236|589336485|FG000|Open-Label Period|Other: Sponsor Request|3|||
163169341|NCT00717236|589336486|FG001|Open-Label Period|Other: Sponsor Request|0|||
163169342|NCT00717236|589336485|FG000|Open-Label Period|Other: Cataract Surgery|1|||
163169343|NCT00717236|589336486|FG001|Open-Label Period|Other: Cataract Surgery|0|||
163169344|NCT00717236|589336485|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
163169345|NCT00717236|589336486|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
163169346|NCT00717236|589336485|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
163169347|NCT00717236|589336486|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
163169348|NCT00717236|589336485|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
163169349|NCT00717236|589336486|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
163169350|NCT00475982|589336487|FG000|Overall Study|surgery rescheduled|7|||
163169351|NCT00475982|589336488|FG001|Overall Study|surgery rescheduled|3|||
163169352|NCT01105767|589336489|FG000|Overall Study|Lost to Follow-up|1160|||
163169353|NCT01105767|589336490|FG001|Overall Study|Lost to Follow-up|1614|||
163169354|NCT01105767|589336491|FG002|Overall Study|Lost to Follow-up|1184|||
163169355|NCT00743106|589336492|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
163169356|NCT00743106|589336493|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
163169357|NCT02410343|589336498|FG000|Core Period (24 Weeks)|Adverse Event|1|||
163169358|NCT02410343|589336499|FG001|Core Period (24 Weeks)|Adverse Event|0|||
163169359|NCT02410343|589336498|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
163169360|NCT02410343|589336499|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
163169361|NCT02410343|589336498|FG000|Extension Period (12 Months)|Adverse Event|1|||
163169362|NCT02410343|589336499|FG001|Extension Period (12 Months)|Adverse Event|0|||
163169363|NCT02410343|589336498|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
163169364|NCT02410343|589336499|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
163169365|NCT00029146|589336500|FG000|Overall Study|Lost to Follow-up|2|||
163169366|NCT00029146|589336501|FG001|Overall Study|Lost to Follow-up|1|||
163169367|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
163169368|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
163169369|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
163169370|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
163169371|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
163169372|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
163169373|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
163169374|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
163169375|NCT00946985|589336504|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
163169376|NCT00271505|589336505|FG000|Overall Study|Screen Failure|3|||
163169377|NCT00271505|589336505|FG000|Overall Study|Adverse Event|1|||
163169378|NCT00271505|589336505|FG000|Overall Study|Death|1|||
163169379|NCT04556383|589336506|FG000|PCP|Lack of Efficacy|28|||
163169380|NCT04556383|589336507|FG001|PCP|Lack of Efficacy|23|||
163169381|NCT04556383|589336508|FG002|PCP|Lack of Efficacy|23|||
163169382|NCT04556383|589336509|FG003|PCP|Lack of Efficacy|0|||
163169383|NCT04556383|589336506|FG000|PCP|Study terminated by sponsor|15|||
163169384|NCT04556383|589336507|FG001|PCP|Study terminated by sponsor|13|||
163169385|NCT04556383|589336508|FG002|PCP|Study terminated by sponsor|16|||
163169386|NCT04556383|589336509|FG003|PCP|Study terminated by sponsor|0|||
163169387|NCT04556383|589336506|FG000|PCP|Withdrawal by Subject|8|||
163169388|NCT04556383|589336507|FG001|PCP|Withdrawal by Subject|6|||
163169389|NCT04556383|589336508|FG002|PCP|Withdrawal by Subject|6|||
163169390|NCT04556383|589336509|FG003|PCP|Withdrawal by Subject|0|||
163169391|NCT04556383|589336506|FG000|PCP|Adverse Event|1|||
163169392|NCT04556383|589336507|FG001|PCP|Adverse Event|7|||
163169393|NCT04556383|589336508|FG002|PCP|Adverse Event|7|||
163169394|NCT04556383|589336509|FG003|PCP|Adverse Event|0|||
163169395|NCT04556383|589336506|FG000|PCP|Other, Not Specified|1|||
163169396|NCT04556383|589336507|FG001|PCP|Other, Not Specified|2|||
163169397|NCT04556383|589336508|FG002|PCP|Other, Not Specified|1|||
163169398|NCT04556383|589336509|FG003|PCP|Other, Not Specified|0|||
163169399|NCT04556383|589336506|FG000|PCP|Protocol Violation|1|||
163169400|NCT04556383|589336507|FG001|PCP|Protocol Violation|0|||
163169401|NCT04556383|589336508|FG002|PCP|Protocol Violation|1|||
163169402|NCT04556383|589336509|FG003|PCP|Protocol Violation|0|||
163169403|NCT04556383|589336506|FG000|PCP|Lost to Follow-up|1|||
163169404|NCT04556383|589336507|FG001|PCP|Lost to Follow-up|0|||
163169405|NCT04556383|589336508|FG002|PCP|Lost to Follow-up|0|||
163169406|NCT04556383|589336509|FG003|PCP|Lost to Follow-up|0|||
163169407|NCT04556383|589336506|FG000|PCP|Physician Decision|0|||
163169408|NCT04556383|589336507|FG001|PCP|Physician Decision|1|||
163169409|NCT04556383|589336508|FG002|PCP|Physician Decision|0|||
163169410|NCT04556383|589336509|FG003|PCP|Physician Decision|0|||
163169411|NCT04556383|589336506|FG000|PCP|Site terminated by sponsor|0|||
163169412|NCT04556383|589336507|FG001|PCP|Site terminated by sponsor|1|||
163169413|NCT04556383|589336508|FG002|PCP|Site terminated by sponsor|0|||
163169414|NCT04556383|589336509|FG003|PCP|Site terminated by sponsor|0|||
163169415|NCT04556383|589336506|FG000|OLE|Study terminated by sponsor|0|||
163169416|NCT04556383|589336507|FG001|OLE|Study terminated by sponsor|0|||
163169417|NCT04556383|589336508|FG002|OLE|Study terminated by sponsor|0|||
163169418|NCT04556383|589336509|FG003|OLE|Study terminated by sponsor|68|||
163169419|NCT04556383|589336506|FG000|OLE|Withdrawal by Subject|0|||
163169420|NCT04556383|589336507|FG001|OLE|Withdrawal by Subject|0|||
163169421|NCT04556383|589336508|FG002|OLE|Withdrawal by Subject|0|||
163169422|NCT04556383|589336509|FG003|OLE|Withdrawal by Subject|10|||
163169423|NCT04556383|589336506|FG000|OLE|Lack of Efficacy|0|||
163169424|NCT04556383|589336507|FG001|OLE|Lack of Efficacy|0|||
163169425|NCT04556383|589336508|FG002|OLE|Lack of Efficacy|0|||
163169426|NCT04556383|589336509|FG003|OLE|Lack of Efficacy|7|||
163169427|NCT04556383|589336506|FG000|OLE|Adverse Event|0|||
163169428|NCT04556383|589336507|FG001|OLE|Adverse Event|0|||
163169429|NCT04556383|589336508|FG002|OLE|Adverse Event|0|||
163169430|NCT04556383|589336509|FG003|OLE|Adverse Event|2|||
163169431|NCT04556383|589336506|FG000|OLE|Other, Not Specified|0|||
163169432|NCT04556383|589336507|FG001|OLE|Other, Not Specified|0|||
163169433|NCT04556383|589336508|FG002|OLE|Other, Not Specified|0|||
163169434|NCT04556383|589336509|FG003|OLE|Other, Not Specified|2|||
163169435|NCT04556383|589336506|FG000|OLE|Death|0|||
163169436|NCT04556383|589336507|FG001|OLE|Death|0|||
163169437|NCT04556383|589336508|FG002|OLE|Death|0|||
163169438|NCT04556383|589336509|FG003|OLE|Death|1|||
163169439|NCT04556383|589336506|FG000|OLE|Lost to Follow-up|0|||
163169440|NCT04556383|589336507|FG001|OLE|Lost to Follow-up|0|||
163169441|NCT04556383|589336508|FG002|OLE|Lost to Follow-up|0|||
163169442|NCT04556383|589336509|FG003|OLE|Lost to Follow-up|1|||
163169443|NCT02720042|589336515|FG000|Overall Study|Death|3|||
163169444|NCT02720042|589336515|FG000|Overall Study|Lost to Follow-up|4|||
163169445|NCT02720042|589336515|FG000|Overall Study|Withdrawal by Subject|1|||
163169446|NCT02720042|589336515|FG000|Overall Study|Physician Decision|3|||
163169447|NCT02720042|589336515|FG000|Overall Study|Phasix Mesh explanted|1|||
163169448|NCT02720042|589336515|FG000|Overall Study|unable due to non-study-related illness|3|||
163169449|NCT03704636|589336516|FG000|Overall Study|Inadequate Venous Flow|3|||
163169450|NCT00539188|589336517|FG000|Overall Study|Withdrawal by Subject|1|||
163169451|NCT00539188|589336518|FG001|Overall Study|Withdrawal by Subject|0|||
163169452|NCT00539188|589336517|FG000|Overall Study|Lost to Follow-up|2|||
163169453|NCT00539188|589336518|FG001|Overall Study|Lost to Follow-up|1|||
163169454|NCT04784442|589336519|FG000|Overall Study|Adverse Event|1|||
163169455|NCT04784442|589336520|FG001|Overall Study|Adverse Event|0|||
163169456|NCT04784442|589336521|FG002|Overall Study|Adverse Event|2|||
163169457|NCT04784442|589336522|FG003|Overall Study|Adverse Event|1|||
163169458|NCT04784442|589336519|FG000|Overall Study|Protocol Violation|1|||
163169459|NCT04784442|589336520|FG001|Overall Study|Protocol Violation|0|||
163169460|NCT04784442|589336521|FG002|Overall Study|Protocol Violation|0|||
163169461|NCT04784442|589336522|FG003|Overall Study|Protocol Violation|0|||
163169462|NCT04784442|589336519|FG000|Overall Study|Non-compliance with study drug|1|||
163169463|NCT04784442|589336520|FG001|Overall Study|Non-compliance with study drug|0|||
163169464|NCT04784442|589336521|FG002|Overall Study|Non-compliance with study drug|0|||
163169465|NCT04784442|589336522|FG003|Overall Study|Non-compliance with study drug|0|||
163169466|NCT00509145|589336523|FG000|Overall Study|Death|0|||
163169467|NCT00509145|589336524|FG001|Overall Study|Death|2|||
163169468|NCT00509145|589336523|FG000|Overall Study|Adverse Event|42|||
163169469|NCT00509145|589336524|FG001|Overall Study|Adverse Event|28|||
163169470|NCT00509145|589336523|FG000|Overall Study|Withdrawal by Subject|32|||
163169471|NCT00509145|589336524|FG001|Overall Study|Withdrawal by Subject|38|||
163169472|NCT00509145|589336523|FG000|Overall Study|Physician Decision|11|||
163169473|NCT00509145|589336524|FG001|Overall Study|Physician Decision|14|||
163169474|NCT00509145|589336523|FG000|Overall Study|Protocol Violation|1|||
163169475|NCT00509145|589336524|FG001|Overall Study|Protocol Violation|6|||
163169476|NCT00509145|589336523|FG000|Overall Study|Pregnancy|3|||
163169477|NCT00509145|589336524|FG001|Overall Study|Pregnancy|8|||
163169478|NCT00509145|589336523|FG000|Overall Study|Lost to Follow-up|6|||
163169479|NCT00509145|589336524|FG001|Overall Study|Lost to Follow-up|5|||
163169480|NCT00509145|589336523|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
163169481|NCT00509145|589336524|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
163169482|NCT00509145|589336523|FG000|Overall Study|Other|6|||
163169483|NCT00509145|589336524|FG001|Overall Study|Other|6|||
163169484|NCT01994889|589336527|FG000|Overall Study|Adverse Event|5|||
163169485|NCT01994889|589336528|FG001|Overall Study|Adverse Event|12|||
163169486|NCT01994889|589336529|FG002|Overall Study|Adverse Event|11|||
163169487|NCT01994889|589336527|FG000|Overall Study|Cardiac Device Implantation|0|||
163169488|NCT01994889|589336528|FG001|Overall Study|Cardiac Device Implantation|2|||
163169489|NCT01994889|589336529|FG002|Overall Study|Cardiac Device Implantation|0|||
163169490|NCT01994889|589336527|FG000|Overall Study|Organ Transplantation|1|||
163169491|NCT01994889|589336528|FG001|Overall Study|Organ Transplantation|5|||
163169492|NCT01994889|589336529|FG002|Overall Study|Organ Transplantation|5|||
163169493|NCT01994889|589336527|FG000|Overall Study|No longer willing to participate|8|||
163169494|NCT01994889|589336528|FG001|Overall Study|No longer willing to participate|17|||
163169495|NCT01994889|589336529|FG002|Overall Study|No longer willing to participate|37|||
163169496|NCT01994889|589336527|FG000|Overall Study|Lost to Follow-up|0|||
163169497|NCT01994889|589336528|FG001|Overall Study|Lost to Follow-up|1|||
163169498|NCT01994889|589336529|FG002|Overall Study|Lost to Follow-up|0|||
163169499|NCT01994889|589336527|FG000|Overall Study|Protocol Violation|0|||
163169500|NCT01994889|589336528|FG001|Overall Study|Protocol Violation|1|||
163169501|NCT01994889|589336529|FG002|Overall Study|Protocol Violation|1|||
163169502|NCT01994889|589336527|FG000|Overall Study|Death|14|||
163169503|NCT01994889|589336528|FG001|Overall Study|Death|25|||
163169504|NCT01994889|589336529|FG002|Overall Study|Death|38|||
163169505|NCT01711216|589336533|FG000|Overall Study|Adverse Event|4|||
163169506|NCT01711216|589336533|FG000|Overall Study|Pregnancy|56|||
163169507|NCT01711216|589336533|FG000|Overall Study|Withdrawal by Subject|6|||
163169508|NCT01711216|589336533|FG000|Overall Study|Lost to Follow-up|46|||
163169509|NCT01711216|589336533|FG000|Overall Study|variety of other minor reasons|83|||
163169510|NCT01711216|589336533|FG000|Overall Study|no reason specified|22|||
163169511|NCT02259088|589336534|FG000|Overall Study|Adverse Event|6|||
163169512|NCT02259088|589336535|FG001|Overall Study|Adverse Event|4|||
163169513|NCT02259088|589336534|FG000|Overall Study|Lost to Follow-up|2|||
163169514|NCT02259088|589336535|FG001|Overall Study|Lost to Follow-up|0|||
163169515|NCT02259088|589336534|FG000|Overall Study|Death|2|||
163169516|NCT02259088|589336535|FG001|Overall Study|Death|0|||
163169517|NCT02259088|589336534|FG000|Overall Study|Physician Decision|5|||
163169518|NCT02259088|589336535|FG001|Overall Study|Physician Decision|2|||
163169519|NCT02259088|589336534|FG000|Overall Study|Protocol deviation|5|||
163169520|NCT02259088|589336535|FG001|Overall Study|Protocol deviation|0|||
163169521|NCT02259088|589336534|FG000|Overall Study|Subject/guardian decision|8|||
163169522|NCT02259088|589336535|FG001|Overall Study|Subject/guardian decision|8|||
163169523|NCT03060551|589336537|FG000|Overall Study|Withdrawal by Subject|1|||
163169524|NCT03060551|589336537|FG000|Overall Study|Adverse Event|1|||
163169525|NCT01214395|589336545|FG000|Overall Study|All patients had infection|5|||
163169526|NCT03698591|589336549|FG000|Overall Study|Withdrawal by Subject|2|||
163169527|NCT03698591|589336550|FG001|Overall Study|Withdrawal by Subject|2|||
163169528|NCT03698591|589336549|FG000|Overall Study|Failed drug screen|1|||
163169529|NCT03698591|589336550|FG001|Overall Study|Failed drug screen|1|||
163169530|NCT03698591|589336549|FG000|Overall Study|Failed health screen|0|||
163169531|NCT03698591|589336550|FG001|Overall Study|Failed health screen|1|||
163169532|NCT03698591|589336549|FG000|Overall Study|Ineligible for financial compensation|1|||
163169533|NCT03698591|589336550|FG001|Overall Study|Ineligible for financial compensation|0|||
163169534|NCT03698591|589336549|FG000|Overall Study|Equipment Error|1|||
163169535|NCT03698591|589336550|FG001|Overall Study|Equipment Error|0|||
163169536|NCT03698591|589336549|FG000|Overall Study|Could not establish TMS dosage|0|||
163169537|NCT03698591|589336550|FG001|Overall Study|Could not establish TMS dosage|1|||
163169538|NCT02660983|589336559|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
163169539|NCT02660983|589336560|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
163169540|NCT02660983|589336559|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
163169541|NCT02660983|589336560|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
163169542|NCT02660983|589336559|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
163169543|NCT02660983|589336560|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
163169544|NCT02660983|589336559|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
163169545|NCT02660983|589336560|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
163169546|NCT02660983|589336559|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
163169547|NCT02660983|589336560|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
163169548|NCT02660983|589336559|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
163169549|NCT02660983|589336560|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
163169550|NCT02660983|589336559|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
163169551|NCT02660983|589336560|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
163169552|NCT00721968|589336569|FG000|Overall Study|Lost to Follow-up|2|||
163169553|NCT00721968|589336570|FG001|Overall Study|Lost to Follow-up|0|||
163169554|NCT01064947|589336571|FG000|Overall Study|negative culture|41|||
163169555|NCT06457204|589336574|FG000|Washout|Adverse Event|0|||
163169556|NCT06457204|589336575|FG001|Washout|Adverse Event|2|||
163169557|NCT01457352|589336576|FG000|Period 1|Adverse Event|2|||
163169558|NCT01457352|589336577|FG001|Period 1|Adverse Event|0|||
163169559|NCT01457352|589336576|FG000|Period 1|Withdrawal by Subject|2|||
163169560|NCT01457352|589336577|FG001|Period 1|Withdrawal by Subject|0|||
163169561|NCT01457352|589336576|FG000|Period 1|Physician Decision|2|||
163169562|NCT01457352|589336577|FG001|Period 1|Physician Decision|0|||
163169563|NCT01457352|589336576|FG000|Period 1|MS related disease progression|1|||
163169564|NCT01457352|589336577|FG001|Period 1|MS related disease progression|0|||
163169565|NCT01457352|589336576|FG000|Period 1|Withdrawn|1|||
163169566|NCT01457352|589336577|FG001|Period 1|Withdrawn|0|||
163169567|NCT01457352|589336576|FG000|Period 1|withdrew per sponsor|1|||
163169568|NCT01457352|589336577|FG001|Period 1|withdrew per sponsor|0|||
163169569|NCT01457352|589336576|FG000|Period 1|Protocol Violation|4|||
163169570|NCT01457352|589336577|FG001|Period 1|Protocol Violation|0|||
163169571|NCT01457352|589336576|FG000|Period 1|Did not meet eligibility criteria|3|||
163169572|NCT01457352|589336577|FG001|Period 1|Did not meet eligibility criteria|0|||
163169573|NCT01457352|589336576|FG000|Period 2|Withdrawal by Subject|23|||
163169574|NCT01457352|589336577|FG001|Period 2|Withdrawal by Subject|0|||
163169575|NCT01457352|589336576|FG000|Period 2|Adverse Event|22|||
163169576|NCT01457352|589336577|FG001|Period 2|Adverse Event|0|||
163169577|NCT01457352|589336576|FG000|Period 2|no analysis|10|||
163169578|NCT01457352|589336577|FG001|Period 2|no analysis|0|||
163169579|NCT01457352|589336576|FG000|Period 2|Lack of Efficacy|8|||
163169580|NCT01457352|589336577|FG001|Period 2|Lack of Efficacy|0|||
163169581|NCT01457352|589336576|FG000|Period 2|Protocol Violation|4|||
163169582|NCT01457352|589336577|FG001|Period 2|Protocol Violation|0|||
163169583|NCT01457352|589336576|FG000|Period 2|Sponsor's withdrawal|7|||
163169584|NCT01457352|589336577|FG001|Period 2|Sponsor's withdrawal|0|||
163169585|NCT01457352|589336576|FG000|Period 2|Lost to Follow-up|1|||
163169586|NCT01457352|589336577|FG001|Period 2|Lost to Follow-up|0|||
163169587|NCT01457352|589336576|FG000|Period 2|dose change|1|||
163169588|NCT01457352|589336577|FG001|Period 2|dose change|0|||
163169589|NCT01457352|589336576|FG000|Period 2|Physician Decision|1|||
163169590|NCT01457352|589336577|FG001|Period 2|Physician Decision|0|||
163169591|NCT01457352|589336576|FG000|Period 2|Did not meet eligibility criteria|3|||
163169592|NCT01457352|589336577|FG001|Period 2|Did not meet eligibility criteria|0|||
163169593|NCT01457352|589336576|FG000|Period 3|Adverse Event|1|||
163169594|NCT01457352|589336577|FG001|Period 3|Adverse Event|1|||
163169595|NCT01457352|589336576|FG000|Period 3|Withdrawal by Subject|0|||
163169596|NCT01457352|589336577|FG001|Period 3|Withdrawal by Subject|2|||
163169597|NCT01457352|589336576|FG000|Period 3|incorrect treatment|0|||
163169598|NCT01457352|589336577|FG001|Period 3|incorrect treatment|1|||
163169599|NCT01457352|589336576|FG000|Period 3|Sponsor's withdrawal|0|||
163169600|NCT01457352|589336577|FG001|Period 3|Sponsor's withdrawal|1|||
163169601|NCT03865316|589338440|FG000|Overall Study|Procedure Cancelled|4|||
163169602|NCT03865316|589338440|FG000|Overall Study|Equipment failure|4|||
163169603|NCT01948193|589338441|FG000|Overall Study|Serious event|2|||
163169604|NCT01948193|589338441|FG000|Overall Study|Lost to Follow-up|7|||
163169605|NCT00668733|589338449|FG000|Overall Study|Lost to Follow-up|2|||
163169606|NCT00668733|589338450|FG001|Overall Study|Lost to Follow-up|3|||
163169607|NCT00668733|589338449|FG000|Overall Study|Withdrawal by Subject|0|||
163169608|NCT00668733|589338450|FG001|Overall Study|Withdrawal by Subject|4|||
163169609|NCT01122264|589338456|FG000|Overall Study|Adverse Event|6|||
163169610|NCT01122264|589338457|FG001|Overall Study|Adverse Event|5|||
163169611|NCT01122264|589338458|FG002|Overall Study|Adverse Event|7|||
163169612|NCT01122264|589338456|FG000|Overall Study|Death|1|||
163169613|NCT01122264|589338457|FG001|Overall Study|Death|0|||
163169614|NCT01122264|589338458|FG002|Overall Study|Death|0|||
163169615|NCT01122264|589338456|FG000|Overall Study|Lost to Follow-up|5|||
163169616|NCT01122264|589338457|FG001|Overall Study|Lost to Follow-up|9|||
163169617|NCT01122264|589338458|FG002|Overall Study|Lost to Follow-up|13|||
163169618|NCT01122264|589338456|FG000|Overall Study|Entry Criteria Not Met|1|||
163169619|NCT01122264|589338457|FG001|Overall Study|Entry Criteria Not Met|0|||
163169620|NCT01122264|589338458|FG002|Overall Study|Entry Criteria Not Met|0|||
163169621|NCT01122264|589338456|FG000|Overall Study|Protocol Violation|7|||
163169622|NCT01122264|589338457|FG001|Overall Study|Protocol Violation|7|||
163169623|NCT01122264|589338458|FG002|Overall Study|Protocol Violation|9|||
163169624|NCT01122264|589338456|FG000|Overall Study|Withdrawal by Subject|6|||
163169625|NCT01122264|589338457|FG001|Overall Study|Withdrawal by Subject|6|||
163169626|NCT01122264|589338458|FG002|Overall Study|Withdrawal by Subject|16|||
163169627|NCT01122264|589338456|FG000|Overall Study|Physician Decision|3|||
163169628|NCT01122264|589338457|FG001|Overall Study|Physician Decision|1|||
163169629|NCT01122264|589338458|FG002|Overall Study|Physician Decision|1|||
163169630|NCT01122264|589338456|FG000|Overall Study|Lack of Efficacy|3|||
163169631|NCT01122264|589338457|FG001|Overall Study|Lack of Efficacy|1|||
163169632|NCT01122264|589338458|FG002|Overall Study|Lack of Efficacy|1|||
163169633|NCT00097981|589338459|FG000|Overall Study|Adverse Event|31|||
163169634|NCT00097981|589338460|FG001|Overall Study|Adverse Event|44|||
163169635|NCT00097981|589338459|FG000|Overall Study|Withdrawal by Subject|10|||
163169636|NCT00097981|589338460|FG001|Overall Study|Withdrawal by Subject|8|||
163169637|NCT00097981|589338459|FG000|Overall Study|Protocol Violation|1|||
163169638|NCT00097981|589338460|FG001|Overall Study|Protocol Violation|1|||
163169639|NCT00097981|589338459|FG000|Overall Study|Death|2|||
163169640|NCT00097981|589338460|FG001|Overall Study|Death|4|||
163169641|NCT00097981|589338459|FG000|Overall Study|Physician Decision|7|||
163169642|NCT00097981|589338460|FG001|Overall Study|Physician Decision|1|||
163169643|NCT00097981|589338459|FG000|Overall Study|Disease Progression|8|||
163169644|NCT00097981|589338460|FG001|Overall Study|Disease Progression|2|||
163169645|NCT00097981|589338459|FG000|Overall Study|Transplant planned|28|||
163169646|NCT00097981|589338460|FG001|Overall Study|Transplant planned|27|||
163169647|NCT00097981|589338459|FG000|Overall Study|Other|19|||
163169648|NCT00097981|589338460|FG001|Overall Study|Other|13|||
163169649|NCT01836276|589338462|FG000|Overall Study|Lost to Follow-up|28|||
163169650|NCT01836276|589338463|FG001|Overall Study|Lost to Follow-up|51|||
163169651|NCT02208063|589338472|FG000|Overall Study|Death|3|||
163169652|NCT02208063|589338473|FG001|Overall Study|Death|5|||
163169653|NCT02208063|589338472|FG000|Overall Study|Not Specified in report|3|||
163169654|NCT02208063|589338473|FG001|Overall Study|Not Specified in report|4|||
163169655|NCT02208063|589338472|FG000|Overall Study|Withdrawal by Subject|5|||
163169656|NCT02208063|589338473|FG001|Overall Study|Withdrawal by Subject|2|||
163169657|NCT02208063|589338472|FG000|Overall Study|Lost to Follow-up|1|||
163169658|NCT02208063|589338473|FG001|Overall Study|Lost to Follow-up|0|||
163169659|NCT00388583|589338474|FG000|Overall Study|Protocol Violation|1|||
163169660|NCT00388583|589338475|FG001|Overall Study|Protocol Violation|0|||
163169661|NCT00388583|589338474|FG000|Overall Study|Withdrawal by Subject|3|||
163169662|NCT00388583|589338475|FG001|Overall Study|Withdrawal by Subject|3|||
163169663|NCT00388583|589338474|FG000|Overall Study|Serious Adverse Event|2|||
163169664|NCT00388583|589338475|FG001|Overall Study|Serious Adverse Event|0|||
163169665|NCT00388583|589338474|FG000|Overall Study|Did not receive vaccine|0|||
163169666|NCT00388583|589338475|FG001|Overall Study|Did not receive vaccine|1|||
163169667|NCT00913458|589338476|FG000|Phase 1|Non-Responder|54|||
163169668|NCT00913458|589338477|FG001|Phase 1|Non-Responder|0|||
163169669|NCT00913458|589338478|FG002|Phase 1|Non-Responder|0|||
163169670|NCT00913458|589338479|FG003|Phase 1|Non-Responder|0|||
163169671|NCT00913458|589338480|FG004|Phase 1|Non-Responder|0|||
163169672|NCT00913458|589338481|FG005|Phase 1|Non-Responder|0|||
163169673|NCT00913458|589338482|FG006|Phase 1|Non-Responder|0|||
163169674|NCT00913458|589338476|FG000|Phase 1|Subject Request|17|||
163169675|NCT00913458|589338477|FG001|Phase 1|Subject Request|0|||
163169676|NCT00913458|589338478|FG002|Phase 1|Subject Request|0|||
163169677|NCT00913458|589338479|FG003|Phase 1|Subject Request|0|||
163169678|NCT00913458|589338480|FG004|Phase 1|Subject Request|0|||
163169679|NCT00913458|589338481|FG005|Phase 1|Subject Request|0|||
163169680|NCT00913458|589338482|FG006|Phase 1|Subject Request|0|||
163169681|NCT00913458|589338476|FG000|Phase 1|Adverse Event|20|||
163169682|NCT00913458|589338477|FG001|Phase 1|Adverse Event|0|||
163169683|NCT00913458|589338478|FG002|Phase 1|Adverse Event|0|||
163169684|NCT00913458|589338479|FG003|Phase 1|Adverse Event|0|||
163169685|NCT00913458|589338480|FG004|Phase 1|Adverse Event|0|||
163169686|NCT00913458|589338481|FG005|Phase 1|Adverse Event|0|||
163169687|NCT00913458|589338482|FG006|Phase 1|Adverse Event|0|||
163169688|NCT00913458|589338476|FG000|Phase 1|Lost to Follow-up|2|||
163169689|NCT00913458|589338477|FG001|Phase 1|Lost to Follow-up|0|||
163169690|NCT00913458|589338478|FG002|Phase 1|Lost to Follow-up|0|||
163169691|NCT00913458|589338479|FG003|Phase 1|Lost to Follow-up|0|||
163169692|NCT00913458|589338480|FG004|Phase 1|Lost to Follow-up|0|||
163169693|NCT00913458|589338481|FG005|Phase 1|Lost to Follow-up|0|||
163169694|NCT00913458|589338482|FG006|Phase 1|Lost to Follow-up|0|||
163169695|NCT00913458|589338476|FG000|Phase 1|Protocol Violation|10|||
163169696|NCT00913458|589338477|FG001|Phase 1|Protocol Violation|0|||
163169697|NCT00913458|589338478|FG002|Phase 1|Protocol Violation|0|||
163169698|NCT00913458|589338479|FG003|Phase 1|Protocol Violation|0|||
163169699|NCT00913458|589338480|FG004|Phase 1|Protocol Violation|0|||
163169700|NCT00913458|589338481|FG005|Phase 1|Protocol Violation|0|||
163169701|NCT00913458|589338482|FG006|Phase 1|Protocol Violation|0|||
163169702|NCT00913458|589338476|FG000|Phase 1|Sponsor|2|||
163169703|NCT00913458|589338477|FG001|Phase 1|Sponsor|0|||
163169704|NCT00913458|589338478|FG002|Phase 1|Sponsor|0|||
163169705|NCT00913458|589338479|FG003|Phase 1|Sponsor|0|||
163169706|NCT00913458|589338480|FG004|Phase 1|Sponsor|0|||
163169707|NCT00913458|589338481|FG005|Phase 1|Sponsor|0|||
163169708|NCT00913458|589338482|FG006|Phase 1|Sponsor|0|||
163169709|NCT00913458|589338476|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
163169710|NCT00913458|589338477|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
163169711|NCT00913458|589338478|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
163169712|NCT00913458|589338479|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
163169713|NCT00913458|589338480|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
163169714|NCT00913458|589338481|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
163169715|NCT00913458|589338482|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
163169716|NCT00913458|589338476|FG000|Phase 2|Non-Responder|0|||
163169717|NCT00913458|589338477|FG001|Phase 2|Non-Responder|5|||
163169718|NCT00913458|589338478|FG002|Phase 2|Non-Responder|7|||
163169719|NCT00913458|589338479|FG003|Phase 2|Non-Responder|12|||
163169720|NCT00913458|589338480|FG004|Phase 2|Non-Responder|0|||
163169721|NCT00913458|589338481|FG005|Phase 2|Non-Responder|0|||
163169722|NCT00913458|589338482|FG006|Phase 2|Non-Responder|0|||
163169723|NCT00913458|589338476|FG000|Phase 2|Subject Request|0|||
163169724|NCT00913458|589338477|FG001|Phase 2|Subject Request|0|||
163169725|NCT00913458|589338478|FG002|Phase 2|Subject Request|1|||
163169726|NCT00913458|589338479|FG003|Phase 2|Subject Request|2|||
163169727|NCT00913458|589338480|FG004|Phase 2|Subject Request|0|||
163169728|NCT00913458|589338481|FG005|Phase 2|Subject Request|0|||
163169729|NCT00913458|589338482|FG006|Phase 2|Subject Request|0|||
163169730|NCT00913458|589338476|FG000|Phase 2|Adverse Event|0|||
163169731|NCT00913458|589338477|FG001|Phase 2|Adverse Event|3|||
163169732|NCT00913458|589338478|FG002|Phase 2|Adverse Event|0|||
163169733|NCT00913458|589338479|FG003|Phase 2|Adverse Event|1|||
163169734|NCT00913458|589338480|FG004|Phase 2|Adverse Event|0|||
163169735|NCT00913458|589338481|FG005|Phase 2|Adverse Event|0|||
163169736|NCT00913458|589338482|FG006|Phase 2|Adverse Event|0|||
163169737|NCT00913458|589338476|FG000|Phase 2|Lost to Follow-up|0|||
163169738|NCT00913458|589338477|FG001|Phase 2|Lost to Follow-up|0|||
163169739|NCT00913458|589338478|FG002|Phase 2|Lost to Follow-up|0|||
163169740|NCT00913458|589338479|FG003|Phase 2|Lost to Follow-up|1|||
163169741|NCT00913458|589338480|FG004|Phase 2|Lost to Follow-up|0|||
163169742|NCT00913458|589338481|FG005|Phase 2|Lost to Follow-up|0|||
163169743|NCT00913458|589338482|FG006|Phase 2|Lost to Follow-up|0|||
163169744|NCT00913458|589338476|FG000|Phase 2|Protocol Violation|0|||
163169745|NCT00913458|589338477|FG001|Phase 2|Protocol Violation|2|||
163169746|NCT00913458|589338478|FG002|Phase 2|Protocol Violation|0|||
163169747|NCT00913458|589338479|FG003|Phase 2|Protocol Violation|0|||
163169748|NCT00913458|589338480|FG004|Phase 2|Protocol Violation|0|||
163169749|NCT00913458|589338481|FG005|Phase 2|Protocol Violation|0|||
163169750|NCT00913458|589338482|FG006|Phase 2|Protocol Violation|0|||
163169751|NCT00913458|589338476|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
163169752|NCT00913458|589338477|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
163169753|NCT00913458|589338478|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
163169754|NCT00913458|589338479|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
163169755|NCT00913458|589338480|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
163169756|NCT00913458|589338481|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
163169757|NCT00913458|589338482|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
163169758|NCT00913458|589338476|FG000|Phase 3|Adverse Event|0|||
163169759|NCT00913458|589338477|FG001|Phase 3|Adverse Event|0|||
163169760|NCT00913458|589338478|FG002|Phase 3|Adverse Event|0|||
163169761|NCT00913458|589338479|FG003|Phase 3|Adverse Event|0|||
163169762|NCT00913458|589338480|FG004|Phase 3|Adverse Event|5|||
163169763|NCT00913458|589338481|FG005|Phase 3|Adverse Event|4|||
163169764|NCT00913458|589338482|FG006|Phase 3|Adverse Event|1|||
163169765|NCT00913458|589338476|FG000|Phase 3|Lost to Follow-up|0|||
163169766|NCT00913458|589338477|FG001|Phase 3|Lost to Follow-up|0|||
163169767|NCT00913458|589338478|FG002|Phase 3|Lost to Follow-up|0|||
163169768|NCT00913458|589338479|FG003|Phase 3|Lost to Follow-up|0|||
163169769|NCT00913458|589338480|FG004|Phase 3|Lost to Follow-up|2|||
163169770|NCT00913458|589338481|FG005|Phase 3|Lost to Follow-up|0|||
163169771|NCT00913458|589338482|FG006|Phase 3|Lost to Follow-up|0|||
163169772|NCT00913458|589338476|FG000|Phase 3|Non-Responder|0|||
163169773|NCT00913458|589338477|FG001|Phase 3|Non-Responder|0|||
163169774|NCT00913458|589338478|FG002|Phase 3|Non-Responder|0|||
163169775|NCT00913458|589338479|FG003|Phase 3|Non-Responder|0|||
163169776|NCT00913458|589338480|FG004|Phase 3|Non-Responder|0|||
163169777|NCT00913458|589338481|FG005|Phase 3|Non-Responder|1|||
163169778|NCT00913458|589338482|FG006|Phase 3|Non-Responder|3|||
163169779|NCT00913458|589338476|FG000|Phase 3|Withdrawal by Subject|0|||
163169780|NCT00913458|589338477|FG001|Phase 3|Withdrawal by Subject|0|||
163169781|NCT00913458|589338478|FG002|Phase 3|Withdrawal by Subject|0|||
163169782|NCT00913458|589338479|FG003|Phase 3|Withdrawal by Subject|0|||
163169783|NCT00913458|589338480|FG004|Phase 3|Withdrawal by Subject|1|||
163169784|NCT00913458|589338481|FG005|Phase 3|Withdrawal by Subject|2|||
163169785|NCT00913458|589338482|FG006|Phase 3|Withdrawal by Subject|0|||
163169786|NCT00913458|589338476|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
163169787|NCT00913458|589338477|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
163169788|NCT00913458|589338478|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
163169789|NCT00913458|589338479|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
163169790|NCT00913458|589338480|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
163169791|NCT00913458|589338481|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
163169792|NCT00913458|589338482|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
163169793|NCT02366091|589338483|FG000|Overall Study|Withdrawal by Subject|3|||
163169794|NCT02366091|589338484|FG001|Overall Study|Withdrawal by Subject|7|||
163169795|NCT02366091|589338485|FG002|Overall Study|Withdrawal by Subject|3|||
163169796|NCT02366091|589338486|FG003|Overall Study|Withdrawal by Subject|1|||
163169797|NCT05194579|589338487|FG000|Overall Study|Lost to Follow-up|2|||
163169798|NCT05194579|589338488|FG001|Overall Study|Lost to Follow-up|3|||
163169799|NCT05194579|589338487|FG000|Overall Study|Withdrawal by Subject|3|||
163169800|NCT05194579|589338488|FG001|Overall Study|Withdrawal by Subject|4|||
163169801|NCT05194579|589338487|FG000|Overall Study|Refused further study procedures|0|||
163169802|NCT05194579|589338488|FG001|Overall Study|Refused further study procedures|1|||
163169803|NCT05194579|589338487|FG000|Overall Study|Protocol deviation|1|||
163169804|NCT05194579|589338488|FG001|Overall Study|Protocol deviation|0|||
163169805|NCT02338232|589338489|FG000|Overall Study|Screen Failure|3|||
163169806|NCT02338232|589338489|FG000|Overall Study|Withdrawal by Subject|6|||
163169807|NCT02338232|589338489|FG000|Overall Study|Adverse Event|2|||
163169808|NCT03890666|589338490|FG000|Overall Study|Withdrawal by Subject|0|||
163169809|NCT03890666|589338491|FG001|Overall Study|Withdrawal by Subject|1|||
163169810|NCT03890666|589338490|FG000|Overall Study|Protocol deviation|1|||
163169811|NCT03890666|589338491|FG001|Overall Study|Protocol deviation|4|||
163169812|NCT03890666|589338490|FG000|Overall Study|Lost to Follow-up|2|||
163169813|NCT03890666|589338491|FG001|Overall Study|Lost to Follow-up|5|||
163169814|NCT03890666|589338490|FG000|Overall Study|Other than specified|1|||
163169815|NCT03890666|589338491|FG001|Overall Study|Other than specified|8|||
163169816|NCT01105065|589338492|FG000|Overall Study|Adverse Event|5|||
163169817|NCT01105065|589338492|FG000|Overall Study|Technical Problems|1|||
163169818|NCT02122783|589338496|FG000|Overall Study|Adverse Event|0|||
163169819|NCT02122783|589338497|FG001|Overall Study|Adverse Event|1|||
163276868|NCT03621982|589723526|FG008|Overall Study|Withdrawal by Subject|1|||
163276869|NCT03621982|589723527|FG009|Overall Study|Withdrawal by Subject|0|||
163276870|NCT03621982|589723528|FG010|Overall Study|Withdrawal by Subject|2|||
163276871|NCT03621982|589723529|FG011|Overall Study|Withdrawal by Subject|1|||
163276872|NCT03621982|589723530|FG012|Overall Study|Withdrawal by Subject|2|||
163276873|NCT03621982|589723531|FG013|Overall Study|Withdrawal by Subject|2|||
163276874|NCT03621982|589723518|FG000|Overall Study|Investigator/Sponsor decision|0|||
163276875|NCT03621982|589723519|FG001|Overall Study|Investigator/Sponsor decision|0|||
163276876|NCT03621982|589723520|FG002|Overall Study|Investigator/Sponsor decision|0|||
163276877|NCT03621982|589723521|FG003|Overall Study|Investigator/Sponsor decision|0|||
163276878|NCT03621982|589723522|FG004|Overall Study|Investigator/Sponsor decision|0|||
163276879|NCT03621982|589723523|FG005|Overall Study|Investigator/Sponsor decision|0|||
163276880|NCT03621982|589723524|FG006|Overall Study|Investigator/Sponsor decision|0|||
163276881|NCT03621982|589723525|FG007|Overall Study|Investigator/Sponsor decision|0|||
163276882|NCT03621982|589723526|FG008|Overall Study|Investigator/Sponsor decision|0|||
163276883|NCT03621982|589723527|FG009|Overall Study|Investigator/Sponsor decision|0|||
163276884|NCT03621982|589723528|FG010|Overall Study|Investigator/Sponsor decision|0|||
163276885|NCT03621982|589723529|FG011|Overall Study|Investigator/Sponsor decision|4|||
163276886|NCT03621982|589723530|FG012|Overall Study|Investigator/Sponsor decision|0|||
163276887|NCT03621982|589723531|FG013|Overall Study|Investigator/Sponsor decision|2|||
163276888|NCT03621982|589723518|FG000|Overall Study|Death|2|||
163276889|NCT03621982|589723519|FG001|Overall Study|Death|4|||
163276890|NCT03621982|589723520|FG002|Overall Study|Death|4|||
163276891|NCT03621982|589723521|FG003|Overall Study|Death|3|||
163276892|NCT03621982|589723522|FG004|Overall Study|Death|8|||
163276893|NCT03621982|589723523|FG005|Overall Study|Death|4|||
163169820|NCT00322621|589338498|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
163169821|NCT00322621|589338499|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
163169822|NCT00322621|589338500|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
163169823|NCT00322621|589338498|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
163276894|NCT03621982|589723524|FG006|Overall Study|Death|6|||
163276895|NCT03621982|589723525|FG007|Overall Study|Death|3|||
163169824|NCT00322621|589338499|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
163169825|NCT00322621|589338500|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
163276896|NCT03621982|589723526|FG008|Overall Study|Death|0|||
163276897|NCT03621982|589723527|FG009|Overall Study|Death|3|||
163276898|NCT03621982|589723528|FG010|Overall Study|Death|8|||
163276899|NCT03621982|589723529|FG011|Overall Study|Death|4|||
163169826|NCT00322621|589338498|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
163169827|NCT00322621|589338499|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
163276900|NCT03621982|589723530|FG012|Overall Study|Death|2|||
163276901|NCT03621982|589723531|FG013|Overall Study|Death|2|||
163169828|NCT00322621|589338500|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
163169829|NCT00322621|589338498|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
163169830|NCT00322621|589338499|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
163169831|NCT00322621|589338500|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
163169832|NCT00322621|589338498|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
163169833|NCT00322621|589338499|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
163169834|NCT00322621|589338500|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
163169835|NCT00322621|589338498|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
163169836|NCT00322621|589338499|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
163169837|NCT00322621|589338500|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
163169838|NCT00322621|589338498|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
163169839|NCT00322621|589338499|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
163169840|NCT00322621|589338500|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
163169841|NCT00322621|589338498|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
163169842|NCT00322621|589338499|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
163169843|NCT00322621|589338500|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
163169844|NCT00322621|589338498|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
163169845|NCT00322621|589338499|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
163169846|NCT00322621|589338500|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
163169847|NCT00322621|589338498|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
163169848|NCT00322621|589338499|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
163169849|NCT00322621|589338500|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
163169850|NCT00322621|589338498|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
163169851|NCT00322621|589338499|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
163169852|NCT00322621|589338500|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
163169853|NCT02213133|589338505|FG000|Overall Study|Participant discontinued study therapy|2|||
163169854|NCT02213133|589338506|FG001|Overall Study|Participant discontinued study therapy|0|||
163169855|NCT02213133|589338507|FG002|Overall Study|Participant discontinued study therapy|0|||
163169856|NCT02213133|589338505|FG000|Overall Study|Participant withdrew informed consent|2|||
163169857|NCT02213133|589338506|FG001|Overall Study|Participant withdrew informed consent|1|||
163169858|NCT02213133|589338507|FG002|Overall Study|Participant withdrew informed consent|2|||
163169859|NCT02213133|589338505|FG000|Overall Study|Disease progression|11|||
163169860|NCT02213133|589338506|FG001|Overall Study|Disease progression|2|||
163169861|NCT02213133|589338507|FG002|Overall Study|Disease progression|0|||
163169862|NCT02213133|589338505|FG000|Overall Study|Adverse Event (AE)|1|||
163169863|NCT02213133|589338506|FG001|Overall Study|Adverse Event (AE)|0|||
163169864|NCT02213133|589338507|FG002|Overall Study|Adverse Event (AE)|0|||
163169865|NCT02213133|589338505|FG000|Overall Study|Death|16|||
163169866|NCT02213133|589338506|FG001|Overall Study|Death|2|||
163169867|NCT02213133|589338507|FG002|Overall Study|Death|1|||
163169868|NCT02213133|589338505|FG000|Overall Study|Other|5|||
163169869|NCT02213133|589338506|FG001|Overall Study|Other|0|||
163169870|NCT02213133|589338507|FG002|Overall Study|Other|0|||
163169871|NCT00638183|589338508|FG000|Overall Study|Adverse Event|23|||
163169872|NCT00638183|589338508|FG000|Overall Study|Lack of Efficacy|14|||
163169873|NCT00638183|589338508|FG000|Overall Study|Physician Decision|9|||
163169874|NCT00638183|589338508|FG000|Overall Study|Lost to Follow-up|46|||
163169875|NCT00638183|589338508|FG000|Overall Study|Other reason not defined above|27|||
163169876|NCT03180619|589338509|FG000|Overall Study|Withdrew Consent|5|||
163169877|NCT03180619|589338510|FG001|Overall Study|Withdrew Consent|0|||
163169878|NCT03180619|589338511|FG002|Overall Study|Withdrew Consent|2|||
163169879|NCT03180619|589338509|FG000|Overall Study|Death|2|||
163169880|NCT03180619|589338510|FG001|Overall Study|Death|1|||
163169881|NCT03180619|589338511|FG002|Overall Study|Death|2|||
163169882|NCT03180619|589338509|FG000|Overall Study|Adverse Event|2|||
163169883|NCT03180619|589338510|FG001|Overall Study|Adverse Event|0|||
163169884|NCT03180619|589338511|FG002|Overall Study|Adverse Event|1|||
163169885|NCT03180619|589338509|FG000|Overall Study|Investigator's discretion|2|||
163169886|NCT03180619|589338510|FG001|Overall Study|Investigator's discretion|0|||
163169887|NCT03180619|589338511|FG002|Overall Study|Investigator's discretion|1|||
163169888|NCT02743611|589338512|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
163169889|NCT02743611|589338513|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
163169890|NCT02743611|589338514|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
163169891|NCT02743611|589338515|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
163169892|NCT00729469|589338516|FG000|Overall Study|Adverse Event|14|||
163169893|NCT00729469|589338517|FG001|Overall Study|Adverse Event|25|||
163169894|NCT00729469|589338516|FG000|Overall Study|Lost to Follow-up|9|||
163169895|NCT00729469|589338517|FG001|Overall Study|Lost to Follow-up|9|||
163169896|NCT00729469|589338516|FG000|Overall Study|Protocol Violation|2|||
163169897|NCT00729469|589338517|FG001|Overall Study|Protocol Violation|1|||
163169898|NCT00729469|589338516|FG000|Overall Study|Withdrawal by Subject|19|||
163169899|NCT00729469|589338517|FG001|Overall Study|Withdrawal by Subject|8|||
163169900|NCT00729469|589338516|FG000|Overall Study|Other-Not mentioned|9|||
163169901|NCT00729469|589338517|FG001|Overall Study|Other-Not mentioned|4|||
163169902|NCT01989208|589338518|FG000|200 mg (7 Days)|Protocol Violation|0|||
163169903|NCT01989208|589338519|FG001|200 mg (7 Days)|Protocol Violation|1|||
163169904|NCT00566696|589338520|FG000|Overall Study|Met Exclusion Criteria|2|||
163169905|NCT00566696|589338520|FG000|Overall Study|Muromonab not available|1|||
163169906|NCT00566696|589338520|FG000|Overall Study|Health Status Change|1|||
163169907|NCT00566696|589338520|FG000|Overall Study|Physician Decision|1|||
163169908|NCT00566696|589338520|FG000|Overall Study|Non-Patient Donors|37|||
163169909|NCT00706342|589338521|FG000|Overall Study|Adverse Event|3|||
163169910|NCT00706342|589338521|FG000|Overall Study|Not responding to treatment|2|||
163169911|NCT00706342|589338521|FG000|Overall Study|Withdrawn due to failure to respond|1|||
163169912|NCT00706342|589338521|FG000|Overall Study|Death|1|||
163169913|NCT00706342|589338521|FG000|Overall Study|Withdrew from the study on his own.|1|||
163169914|NCT00706342|589338521|FG000|Overall Study|Investigator discretion|2|||
163169915|NCT00706342|589338521|FG000|Overall Study|Non-responder Week 12|1|||
163169916|NCT00706342|589338521|FG000|Overall Study|Ongoing|6|||
163169917|NCT00706342|589338521|FG000|Overall Study|WIthdrawal of consent|1|||
163169918|NCT00119678|589338522|FG000|Double-blind Treatment Period|Death|1|||
163169919|NCT00119678|589338523|FG001|Double-blind Treatment Period|Death|0|||
163169920|NCT00119678|589338522|FG000|Double-blind Treatment Period|Adverse Event|7|||
163169921|NCT00119678|589338523|FG001|Double-blind Treatment Period|Adverse Event|1|||
163169922|NCT00119678|589338522|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
163169923|NCT00119678|589338523|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
163169924|NCT00119678|589338522|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
163169925|NCT00119678|589338523|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
163169926|NCT00119678|589338522|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
163169927|NCT00119678|589338523|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
163169928|NCT00119678|589338522|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
163169929|NCT00119678|589338523|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
163169930|NCT00119678|589338522|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
163169931|NCT00119678|589338523|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
163169932|NCT00119678|589338522|FG000|Double-blind Treatment Period|Pregnancy|0|||
163169933|NCT00119678|589338523|FG001|Double-blind Treatment Period|Pregnancy|2|||
163169934|NCT00119678|589338522|FG000|Double-blind Treatment Period|Not treated|1|||
163169935|NCT00119678|589338523|FG001|Double-blind Treatment Period|Not treated|2|||
163169936|NCT00119678|589338522|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
163169937|NCT00119678|589338523|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
163169938|NCT00119678|589338522|FG000|Open-label Treatment Period|Death|1|||
163169939|NCT00119678|589338523|FG001|Open-label Treatment Period|Death|0|||
163169940|NCT00119678|589338522|FG000|Open-label Treatment Period|Adverse Event|3|||
163169941|NCT00119678|589338523|FG001|Open-label Treatment Period|Adverse Event|0|||
163169942|NCT00119678|589338522|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
163169943|NCT00119678|589338523|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
163169944|NCT00119678|589338522|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
163169945|NCT00119678|589338523|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
163169946|NCT00119678|589338522|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
163169947|NCT00119678|589338523|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
163169948|NCT00119678|589338522|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
163169949|NCT00119678|589338523|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
163169950|NCT00119678|589338522|FG000|Open-label Treatment Period|Pregnancy|1|||
163169951|NCT00119678|589338523|FG001|Open-label Treatment Period|Pregnancy|0|||
163169952|NCT00119678|589338522|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
163169953|NCT00119678|589338523|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
163169954|NCT03567343|589338524|FG000|Overall Study|Lost to Follow-up|2|||
163169955|NCT03567343|589338525|FG001|Overall Study|Lost to Follow-up|1|||
163169956|NCT03567343|589338524|FG000|Overall Study|No longer eligible|2|||
163169957|NCT03567343|589338525|FG001|Overall Study|No longer eligible|1|||
163169958|NCT03567343|589338524|FG000|Overall Study|Adverse Event|1|||
163169959|NCT03567343|589338525|FG001|Overall Study|Adverse Event|0|||
163169960|NCT03567343|589338524|FG000|Overall Study|Protocol Violation|1|||
163169961|NCT03567343|589338525|FG001|Overall Study|Protocol Violation|1|||
163169962|NCT00852371|589338527|FG000|Overall Study|Lost to Follow-up|2|||
163169963|NCT00852371|589338528|FG001|Overall Study|Lost to Follow-up|3|||
163169964|NCT00852371|589338529|FG002|Overall Study|Lost to Follow-up|4|||
163169965|NCT00852371|589338530|FG003|Overall Study|Lost to Follow-up|2|||
163169966|NCT02744040|589338531|FG000|Overall Study|Withdrawal by Subject|3|||
163169967|NCT02744040|589338532|FG001|Overall Study|Withdrawal by Subject|2|||
163169968|NCT02744040|589338533|FG002|Overall Study|Withdrawal by Subject|2|||
163169969|NCT02744040|589338531|FG000|Overall Study|Physician Decision|0|||
163169970|NCT02744040|589338532|FG001|Overall Study|Physician Decision|8|||
163169971|NCT02744040|589338533|FG002|Overall Study|Physician Decision|13|||
163169972|NCT02744040|589338531|FG000|Overall Study|Lost to Follow-up|3|||
163169973|NCT02744040|589338532|FG001|Overall Study|Lost to Follow-up|1|||
163169974|NCT02744040|589338533|FG002|Overall Study|Lost to Follow-up|7|||
163169975|NCT01185353|589338534|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
163169976|NCT01185353|589338535|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
163169977|NCT01185353|589338536|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
163169978|NCT01185353|589338537|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
163169979|NCT01185353|589338538|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
163169980|NCT01185353|589338539|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
163169981|NCT01185353|589338540|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
163169982|NCT01185353|589338541|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
163169983|NCT01185353|589338542|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
163169984|NCT01185353|589338543|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
163169985|NCT01185353|589338534|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169986|NCT01185353|589338535|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169987|NCT01185353|589338536|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169988|NCT01185353|589338537|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169989|NCT01185353|589338538|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
163169990|NCT01185353|589338539|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169991|NCT01185353|589338540|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169992|NCT01185353|589338541|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169993|NCT01185353|589338542|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169994|NCT01185353|589338543|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169995|NCT01185353|589338534|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
163169996|NCT01185353|589338535|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163169997|NCT01185353|589338536|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163169998|NCT01185353|589338537|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163169999|NCT01185353|589338538|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
163170000|NCT01185353|589338539|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163170001|NCT01185353|589338540|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163170002|NCT01185353|589338541|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163170003|NCT01185353|589338542|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163170004|NCT01185353|589338543|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163170005|NCT01185353|589338534|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170006|NCT01185353|589338535|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170007|NCT01185353|589338536|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
163170008|NCT01185353|589338537|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170009|NCT01185353|589338538|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
163170010|NCT01185353|589338539|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170011|NCT01185353|589338540|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170012|NCT01185353|589338541|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170013|NCT01185353|589338542|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170014|NCT01185353|589338543|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170015|NCT01185353|589338534|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170016|NCT01185353|589338535|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170017|NCT01185353|589338536|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170018|NCT01185353|589338537|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170019|NCT01185353|589338538|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
163170020|NCT01185353|589338539|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170021|NCT01185353|589338540|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170022|NCT01185353|589338541|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170023|NCT01185353|589338542|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170024|NCT01185353|589338543|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170025|NCT01185353|589338534|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
163170026|NCT01185353|589338535|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
163170027|NCT01185353|589338536|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
163170028|NCT01185353|589338537|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
163170029|NCT01185353|589338538|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
163170030|NCT01185353|589338539|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
163170031|NCT01185353|589338540|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
163170032|NCT01185353|589338541|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
163170033|NCT01185353|589338542|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
163170034|NCT01185353|589338543|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
163170035|NCT01185353|589338534|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163170036|NCT01185353|589338535|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163276902|NCT03621982|589723518|FG000|Overall Study|Lost to Follow-up|0|||
163170037|NCT01185353|589338536|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
163170038|NCT01185353|589338537|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163170039|NCT01185353|589338538|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163170040|NCT01185353|589338539|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
163170041|NCT01185353|589338540|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163170042|NCT01185353|589338541|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163170043|NCT01185353|589338542|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163170044|NCT01185353|589338543|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163170045|NCT01185353|589338534|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170046|NCT01185353|589338535|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
163170047|NCT01185353|589338536|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170048|NCT01185353|589338537|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
163170049|NCT01185353|589338538|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170050|NCT01185353|589338539|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170051|NCT01185353|589338540|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170052|NCT01185353|589338541|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170053|NCT01185353|589338542|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170054|NCT01185353|589338543|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170055|NCT01185353|589338534|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170056|NCT01185353|589338535|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170057|NCT01185353|589338536|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170058|NCT01185353|589338537|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
163170059|NCT01185353|589338538|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170060|NCT01185353|589338539|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170061|NCT01185353|589338540|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
163170062|NCT01185353|589338541|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170063|NCT01185353|589338542|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170064|NCT01185353|589338543|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170065|NCT01185353|589338534|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
163170066|NCT01185353|589338535|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
163170067|NCT01185353|589338536|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
163170068|NCT01185353|589338537|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
163170069|NCT01185353|589338538|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
163170070|NCT01185353|589338539|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
163170071|NCT01185353|589338540|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
163170072|NCT01185353|589338541|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
163170073|NCT01185353|589338542|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
163170074|NCT01185353|589338543|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
163170075|NCT01185353|589338534|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170076|NCT01185353|589338535|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170077|NCT01185353|589338536|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170078|NCT01185353|589338537|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170079|NCT01185353|589338538|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170080|NCT01185353|589338539|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170081|NCT01185353|589338540|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
163170082|NCT01185353|589338541|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170083|NCT01185353|589338542|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170084|NCT01185353|589338543|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170085|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
163170086|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
163170087|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
163170088|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
163170089|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
163170090|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
163170091|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
163170092|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
163170093|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
163170094|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
163170095|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
163276903|NCT03621982|589723519|FG001|Overall Study|Lost to Follow-up|0|||
163170096|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
163170097|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
163170098|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
163170099|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
163170100|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
163170101|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
163170102|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
163276904|NCT03621982|589723520|FG002|Overall Study|Lost to Follow-up|1|||
163170103|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
163170104|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
163170105|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
163170106|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
163170107|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
163170108|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
163170109|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
163170110|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
163170111|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
163170112|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
163170113|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
163170114|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
163170115|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170116|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170117|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170118|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170119|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170120|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170121|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170122|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170123|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
163170124|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170125|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Death|0|||
163170126|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Death|0|||
163170127|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Death|0|||
163170128|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Death|0|||
163170129|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Death|0|||
163170130|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Death|0|||
163170131|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Death|0|||
163170132|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Death|0|||
163170133|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Death|0|||
163170134|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Death|1|||
163170135|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170136|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170137|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170138|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170139|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170140|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170141|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170142|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170143|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170144|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
163170145|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170146|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170147|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170148|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170149|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170150|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170151|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170152|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170153|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170154|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
163170155|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170156|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170157|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170158|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170159|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170160|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170161|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170162|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170163|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
163170164|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170165|NCT01185353|589338534|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
163170166|NCT01185353|589338535|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
163170167|NCT01185353|589338536|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
163170168|NCT01185353|589338537|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
163170169|NCT01185353|589338538|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
163170170|NCT01185353|589338539|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
163170171|NCT01185353|589338540|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
163170172|NCT01185353|589338541|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
163170173|NCT01185353|589338542|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
163170174|NCT01185353|589338543|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
163276905|NCT03621982|589723521|FG003|Overall Study|Lost to Follow-up|0|||
163170175|NCT01185353|589338534|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
163170176|NCT01185353|589338535|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
163170177|NCT01185353|589338536|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
163170178|NCT01185353|589338537|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
163170179|NCT01185353|589338538|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
163170180|NCT01185353|589338539|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
163170181|NCT01185353|589338540|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
163170182|NCT01185353|589338541|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
163170183|NCT01185353|589338542|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
163170184|NCT01185353|589338543|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
163170185|NCT01185353|589338534|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170186|NCT01185353|589338535|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170187|NCT01185353|589338536|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170188|NCT01185353|589338537|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170189|NCT01185353|589338538|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170190|NCT01185353|589338539|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170191|NCT01185353|589338540|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170192|NCT01185353|589338541|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
163170193|NCT01185353|589338542|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
163170194|NCT01185353|589338543|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170195|NCT00334113|589338546|FG000|Overall Study|Lost to Follow-up|2|||
163170196|NCT00334113|589338547|FG001|Overall Study|Lost to Follow-up|2|||
163170197|NCT00334113|589338546|FG000|Overall Study|Withdrawal by Subject|0|||
163170198|NCT00334113|589338547|FG001|Overall Study|Withdrawal by Subject|1|||
163170199|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
163170200|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
163170201|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
163170202|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
163170203|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Other|2|||
163170204|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
163170205|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
163170206|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
163170207|NCT02509026|589338550|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
163170208|NCT02509026|589338550|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
163170209|NCT02509026|589338550|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
163170210|NCT02509026|589338550|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
163170211|NCT02509026|589338550|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
163170212|NCT01165216|589338551|FG000|Overall Study|Adverse Event|6|||
163170213|NCT01165216|589338552|FG001|Overall Study|Adverse Event|3|||
163170214|NCT01165216|589338551|FG000|Overall Study|Withdrawal by Subject|1|||
163170215|NCT01165216|589338552|FG001|Overall Study|Withdrawal by Subject|1|||
163170216|NCT01165216|589338551|FG000|Overall Study|Disease progression|1|||
163170217|NCT01165216|589338552|FG001|Overall Study|Disease progression|3|||
163170218|NCT00243841|589338556|FG000|Overall Study|Physician Decision|0|||
163170219|NCT00243841|589338557|FG001|Overall Study|Physician Decision|0|||
163170220|NCT00243841|589338558|FG002|Overall Study|Physician Decision|1|||
163170221|NCT00243841|589338559|FG003|Overall Study|Physician Decision|0|||
163170222|NCT00243841|589338560|FG004|Overall Study|Physician Decision|0|||
163170223|NCT00243841|589338561|FG005|Overall Study|Physician Decision|2|||
163170224|NCT00363545|589338562|FG000|Overall Study|Serious Adverse Event|0|||
163170225|NCT00363545|589338563|FG001|Overall Study|Serious Adverse Event|1|||
163170226|NCT00363545|589338562|FG000|Overall Study|Withdrawal by Subject|12|||
163170227|NCT00363545|589338563|FG001|Overall Study|Withdrawal by Subject|15|||
163170228|NCT00363545|589338562|FG000|Overall Study|Migrated/moved from study area|3|||
163170229|NCT00363545|589338563|FG001|Overall Study|Migrated/moved from study area|6|||
163170230|NCT00363545|589338562|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
163170231|NCT00363545|589338563|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
163170232|NCT00363545|589338562|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
163170233|NCT00363545|589338563|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
163170234|NCT00363545|589338562|FG000|Overall Study|Others|1|||
163170235|NCT00363545|589338563|FG001|Overall Study|Others|0|||
163170236|NCT04303195|589338564|FG000|Overall Study|Adverse Event|1|||
163170237|NCT04303195|589338565|FG001|Overall Study|Adverse Event|3|||
163170238|NCT04303195|589338566|FG002|Overall Study|Adverse Event|7|||
163170239|NCT04303195|589338567|FG003|Overall Study|Adverse Event|0|||
163170240|NCT04303195|589338564|FG000|Overall Study|Lost to Follow-up|1|||
163170241|NCT04303195|589338565|FG001|Overall Study|Lost to Follow-up|0|||
163170242|NCT04303195|589338566|FG002|Overall Study|Lost to Follow-up|1|||
163170243|NCT04303195|589338567|FG003|Overall Study|Lost to Follow-up|4|||
163170244|NCT04303195|589338564|FG000|Overall Study|Withdrawal by Subject|3|||
163170245|NCT04303195|589338565|FG001|Overall Study|Withdrawal by Subject|1|||
163170246|NCT04303195|589338566|FG002|Overall Study|Withdrawal by Subject|1|||
163170247|NCT04303195|589338567|FG003|Overall Study|Withdrawal by Subject|1|||
163170248|NCT04303195|589338564|FG000|Overall Study|No study drug administered or protocol deviation|0|||
163170249|NCT04303195|589338565|FG001|Overall Study|No study drug administered or protocol deviation|2|||
163170250|NCT04303195|589338566|FG002|Overall Study|No study drug administered or protocol deviation|0|||
163170251|NCT04303195|589338567|FG003|Overall Study|No study drug administered or protocol deviation|2|||
163170252|NCT01601652|589338571|FG000|Overall Study|Death|1|||
163170253|NCT01808092|589338572|FG000|Overall Study|Death|39|||
163170254|NCT01808092|589338573|FG001|Overall Study|Death|29|||
163170255|NCT01808092|589338572|FG000|Overall Study|Lost to Follow-up|3|||
163170256|NCT01808092|589338573|FG001|Overall Study|Lost to Follow-up|7|||
163170257|NCT01808092|589338572|FG000|Overall Study|Withdrawal by Subject|9|||
163170258|NCT01808092|589338573|FG001|Overall Study|Withdrawal by Subject|4|||
163170259|NCT01808092|589338572|FG000|Overall Study|Other Eligibility criteria|3|||
163170260|NCT01808092|589338573|FG001|Overall Study|Other Eligibility criteria|5|||
163170261|NCT01097005|589338579|FG000|Overall Study|Case Report Form not collected|18|||
163170262|NCT01097005|589338579|FG000|Overall Study|Subjects cannot visit the hospital|1|||
163170263|NCT01097005|589338579|FG000|Overall Study|Poor medication compliance|1|||
163170264|NCT01097005|589338579|FG000|Overall Study|No examination data available|244|||
163276906|NCT03621982|589723522|FG004|Overall Study|Lost to Follow-up|0|||
163170265|NCT01097005|589338579|FG000|Overall Study|Deviation from exclusion criteria|37|||
163170266|NCT01097005|589338579|FG000|Overall Study|Adverse Event|14|||
163170267|NCT01097005|589338579|FG000|Overall Study|Discontinuance by complication|50|||
163170268|NCT03425253|589338585|FG000|Overall Study|Adverse Event|2|||
163170269|NCT03425253|589338585|FG000|Overall Study|Lost to Follow-up|3|||
163170270|NCT03425253|589338585|FG000|Overall Study|Withdrew Consent|6|||
163170271|NCT03425253|589338585|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
163170272|NCT04614324|589338588|FG000|Overall Study|Lost to Follow-up|3|||
163170273|NCT04614324|589338588|FG000|Overall Study|Physician Decision|1|||
163170274|NCT04614324|589338588|FG000|Overall Study|Withdrawal by Subject|2|||
163170275|NCT04614324|589338588|FG000|Overall Study|Remaining in Follow up|123|||
163170276|NCT04174365|589338591|FG000|Overall Study|Lost to Follow-up|1|||
163170277|NCT04174365|589338592|FG001|Overall Study|Lost to Follow-up|2|||
163170278|NCT04174365|589338591|FG000|Overall Study|Adverse Event|2|||
163170279|NCT04174365|589338592|FG001|Overall Study|Adverse Event|1|||
163170280|NCT04174365|589338591|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
163170281|NCT04174365|589338592|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
163170282|NCT04174365|589338591|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
163170283|NCT04174365|589338592|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
163170284|NCT04174365|589338591|FG000|Overall Study|Protocol Deviation|1|||
163170285|NCT04174365|589338592|FG001|Overall Study|Protocol Deviation|0|||
163276907|NCT03621982|589723523|FG005|Overall Study|Lost to Follow-up|0|||
163170286|NCT04174365|589338591|FG000|Overall Study|Lack of Efficacy|0|||
163170287|NCT04174365|589338592|FG001|Overall Study|Lack of Efficacy|2|||
163276908|NCT03621982|589723524|FG006|Overall Study|Lost to Follow-up|1|||
163276909|NCT03621982|589723525|FG007|Overall Study|Lost to Follow-up|0|||
163276910|NCT03621982|589723526|FG008|Overall Study|Lost to Follow-up|0|||
163276911|NCT03621982|589723527|FG009|Overall Study|Lost to Follow-up|1|||
163276912|NCT03621982|589723528|FG010|Overall Study|Lost to Follow-up|0|||
163276913|NCT03621982|589723529|FG011|Overall Study|Lost to Follow-up|0|||
163276914|NCT03621982|589723530|FG012|Overall Study|Lost to Follow-up|0|||
163276915|NCT03621982|589723531|FG013|Overall Study|Lost to Follow-up|0|||
163276916|NCT00238420|589723532|FG000|Overall Study|Protocol Violation|1|||
163276917|NCT00238420|589723533|FG001|Overall Study|Protocol Violation|1|||
163276918|NCT01254890|589723534|FG000|Overall Study|Ineligible|0|||
163276919|NCT01254890|589723535|FG001|Overall Study|Ineligible|3|||
163276920|NCT01254890|589723534|FG000|Overall Study|Withdrawal by Subject|1|||
163276921|NCT01254890|589723535|FG001|Overall Study|Withdrawal by Subject|2|||
163276922|NCT01254890|589723534|FG000|Overall Study|Disease Progression|0|||
163276923|NCT01254890|589723535|FG001|Overall Study|Disease Progression|5|||
163276924|NCT02419755|589723543|FG000|Overall Study|Death|1|||
163276925|NCT02419755|589723544|FG001|Overall Study|Death|3|||
163276926|NCT02419755|589723543|FG000|Overall Study|Relapse|0|||
163276927|NCT02419755|589723544|FG001|Overall Study|Relapse|1|||
163276928|NCT02419755|589723543|FG000|Overall Study|Ineligible|1|||
163276929|NCT02419755|589723544|FG001|Overall Study|Ineligible|0|||
163276930|NCT02419755|589723543|FG000|Overall Study|Withdrawal by Subject|1|||
163276931|NCT02419755|589723544|FG001|Overall Study|Withdrawal by Subject|0|||
163276932|NCT02325713|589723545|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163276933|NCT02325713|589723546|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163276934|NCT02325713|589723547|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163276935|NCT02325713|589723548|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163276936|NCT02325713|589723549|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163276937|NCT02325713|589723550|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163276938|NCT02325713|589723551|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163276939|NCT02325713|589723552|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163276940|NCT02325713|589723553|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163276941|NCT02325713|589723554|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163276942|NCT02325713|589723555|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
163276943|NCT02325713|589723556|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163276944|NCT02325713|589723557|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163276945|NCT02325713|589723558|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163276946|NCT02325713|589723559|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163276947|NCT02325713|589723560|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163276948|NCT02325713|589723545|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
163276949|NCT02325713|589723546|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163276950|NCT02325713|589723547|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163276951|NCT02325713|589723548|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163276952|NCT02325713|589723549|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163276953|NCT02325713|589723550|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163276954|NCT02325713|589723551|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163276955|NCT02325713|589723552|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163276956|NCT02325713|589723553|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163276957|NCT02325713|589723554|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163170288|NCT04174365|589338591|FG000|Overall Study|Disease Relapse|1|||
163170289|NCT04174365|589338592|FG001|Overall Study|Disease Relapse|0|||
163170290|NCT04174365|589338591|FG000|Overall Study|Reason Not Specified|0|||
163170291|NCT04174365|589338592|FG001|Overall Study|Reason Not Specified|1|||
163170292|NCT03472547|589338593|FG000|Overall Study|Withdrawal by Subject|30|||
163170293|NCT05141448|589338594|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
163170294|NCT05141448|589338595|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
163170295|NCT05141448|589338596|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
163170296|NCT05141448|589338597|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
163170297|NCT05141448|589338598|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
163170298|NCT05141448|589338599|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
163170299|NCT05141448|589338594|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
163170300|NCT05141448|589338595|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
163170301|NCT05141448|589338596|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
163170302|NCT05141448|589338597|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
163170303|NCT05141448|589338598|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
163170304|NCT05141448|589338599|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
163170305|NCT05141448|589338594|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
163170306|NCT05141448|589338595|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
163170307|NCT05141448|589338596|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
163170308|NCT05141448|589338597|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
163170309|NCT05141448|589338598|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
163170310|NCT05141448|589338599|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
163170311|NCT05141448|589338594|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
163170312|NCT05141448|589338595|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
163170313|NCT05141448|589338596|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
163276958|NCT02325713|589723555|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163276959|NCT02325713|589723556|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163276960|NCT02325713|589723557|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163170314|NCT05141448|589338597|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
163170315|NCT05141448|589338598|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
163170316|NCT05141448|589338599|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
163170317|NCT05141448|589338594|FG000|Period 2|COVID-19 Related|0|||
163170318|NCT05141448|589338595|FG001|Period 2|COVID-19 Related|0|||
163170319|NCT05141448|589338596|FG002|Period 2|COVID-19 Related|0|||
163170320|NCT05141448|589338597|FG003|Period 2|COVID-19 Related|1|||
163170321|NCT05141448|589338598|FG004|Period 2|COVID-19 Related|0|||
163170322|NCT05141448|589338599|FG005|Period 2|COVID-19 Related|1|||
163170323|NCT05141448|589338594|FG000|3|Covid-19 related|2|||
163170324|NCT05141448|589338595|FG001|3|Covid-19 related|0|||
163276961|NCT02325713|589723558|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163276962|NCT02325713|589723559|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163276963|NCT02325713|589723560|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163276964|NCT02325713|589723545|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163170325|NCT05141448|589338596|FG002|3|Covid-19 related|0|||
163170326|NCT05141448|589338597|FG003|3|Covid-19 related|0|||
163170327|NCT05141448|589338598|FG004|3|Covid-19 related|0|||
163170328|NCT05141448|589338599|FG005|3|Covid-19 related|1|||
163170329|NCT05141448|589338594|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
163170330|NCT05141448|589338595|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
163170331|NCT05141448|589338596|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
163170332|NCT05141448|589338597|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
163170333|NCT05141448|589338598|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
163170334|NCT05141448|589338599|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
163170335|NCT04627285|589338600|FG000|Overall Study|Adverse Event|0|||
163170336|NCT04627285|589338601|FG001|Overall Study|Adverse Event|2|||
163170337|NCT04627285|589338600|FG000|Overall Study|Lost to Follow-up|1|||
163170338|NCT04627285|589338601|FG001|Overall Study|Lost to Follow-up|0|||
163170339|NCT04627285|589338600|FG000|Overall Study|Withdrawal by Subject|1|||
163170340|NCT04627285|589338601|FG001|Overall Study|Withdrawal by Subject|1|||
163170341|NCT04627285|589338600|FG000|Overall Study|Sponsor decision|5|||
163170342|NCT04627285|589338601|FG001|Overall Study|Sponsor decision|0|||
163170343|NCT04627285|589338600|FG000|Overall Study|Participant left country; aunt informed the site|0|||
163170344|NCT04627285|589338601|FG001|Overall Study|Participant left country; aunt informed the site|1|||
163170345|NCT03658876|589340917|FG000|Overall Study|Protocol Violation|3|||
163170346|NCT03658876|589340918|FG001|Overall Study|Protocol Violation|2|||
163170347|NCT03658876|589340917|FG000|Overall Study|Withdrawal by Subject|2|||
163170348|NCT03658876|589340918|FG001|Overall Study|Withdrawal by Subject|0|||
163276965|NCT02325713|589723546|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163276966|NCT02325713|589723547|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163276967|NCT02325713|589723548|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163276968|NCT02325713|589723549|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163276969|NCT02325713|589723550|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163276970|NCT02325713|589723551|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163276971|NCT02325713|589723552|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163276972|NCT02325713|589723553|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163170349|NCT03658876|589340917|FG000|Overall Study|Death|0|||
163170350|NCT03658876|589340918|FG001|Overall Study|Death|1|||
163170351|NCT03658876|589340917|FG000|Overall Study|Intercurrent illness|6|||
163170352|NCT03658876|589340918|FG001|Overall Study|Intercurrent illness|4|||
163170353|NCT03658876|589340917|FG000|Overall Study|Transplantation/other operation|1|||
163170354|NCT03658876|589340918|FG001|Overall Study|Transplantation/other operation|5|||
163170355|NCT01330017|589340919|FG000|Overall Study|Adverse Event|0|||
163170356|NCT01330017|589340920|FG001|Overall Study|Adverse Event|1|||
163170357|NCT01330017|589340921|FG002|Overall Study|Adverse Event|1|||
163170358|NCT01330017|589340922|FG003|Overall Study|Adverse Event|4|||
163170359|NCT01330017|589340923|FG004|Overall Study|Adverse Event|0|||
163170360|NCT01330017|589340919|FG000|Overall Study|Withdrawal by Subject|0|||
163170361|NCT01330017|589340920|FG001|Overall Study|Withdrawal by Subject|0|||
163170362|NCT01330017|589340921|FG002|Overall Study|Withdrawal by Subject|1|||
163170363|NCT01330017|589340922|FG003|Overall Study|Withdrawal by Subject|0|||
163170364|NCT01330017|589340923|FG004|Overall Study|Withdrawal by Subject|1|||
163170365|NCT01330017|589340919|FG000|Overall Study|Lost to Follow-up|0|||
163170366|NCT01330017|589340920|FG001|Overall Study|Lost to Follow-up|0|||
163170367|NCT01330017|589340921|FG002|Overall Study|Lost to Follow-up|1|||
163170368|NCT01330017|589340922|FG003|Overall Study|Lost to Follow-up|0|||
163170369|NCT01330017|589340923|FG004|Overall Study|Lost to Follow-up|0|||
163170370|NCT01330017|589340919|FG000|Overall Study|Protocol Violation|0|||
163170371|NCT01330017|589340920|FG001|Overall Study|Protocol Violation|0|||
163170372|NCT01330017|589340921|FG002|Overall Study|Protocol Violation|0|||
163170373|NCT01330017|589340922|FG003|Overall Study|Protocol Violation|1|||
163170374|NCT01330017|589340923|FG004|Overall Study|Protocol Violation|0|||
163170375|NCT01330017|589340919|FG000|Overall Study|Unknown Reason|5|||
163170376|NCT01330017|589340920|FG001|Overall Study|Unknown Reason|3|||
163276973|NCT02325713|589723554|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
163276974|NCT02325713|589723555|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163276975|NCT02325713|589723556|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163276976|NCT02325713|589723557|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163276977|NCT02325713|589723558|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163276978|NCT02325713|589723559|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163276979|NCT02325713|589723560|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163276980|NCT04988477|589723563|FG000|Overall Study|Death|1|||
163276981|NCT04988477|589723564|FG001|Overall Study|Death|0|||
163276982|NCT04988477|589723565|FG002|Overall Study|Death|0|||
163276983|NCT04988477|589723563|FG000|Overall Study|Lost to Follow-up|5|||
163276984|NCT04988477|589723564|FG001|Overall Study|Lost to Follow-up|2|||
163276985|NCT04988477|589723565|FG002|Overall Study|Lost to Follow-up|0|||
163276986|NCT04988477|589723563|FG000|Overall Study|Withdrawal by Subject|2|||
163276987|NCT04988477|589723564|FG001|Overall Study|Withdrawal by Subject|0|||
163276988|NCT04988477|589723565|FG002|Overall Study|Withdrawal by Subject|0|||
163276989|NCT04034238|589725095|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
163276990|NCT04034238|589725096|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
163276991|NCT04034238|589725097|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
163276992|NCT04034238|589725098|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
163276993|NCT04034238|589725095|FG000|Dose Escalation Phase|Screen failures|0|||
163276994|NCT04034238|589725096|FG001|Dose Escalation Phase|Screen failures|0|||
163276995|NCT04034238|589725097|FG002|Dose Escalation Phase|Screen failures|0|||
163276996|NCT04034238|589725098|FG003|Dose Escalation Phase|Screen failures|2|||
163276997|NCT04034238|589725095|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
163276998|NCT04034238|589725096|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
163276999|NCT04034238|589725097|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
163277000|NCT04034238|589725098|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
163277001|NCT04034238|589725095|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
163277002|NCT04034238|589725096|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
163277003|NCT04034238|589725097|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
163277004|NCT04034238|589725098|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
163277005|NCT04822298|589725099|FG000|Overall Study|Death|3|||
163277006|NCT00465361|589725100|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
163277007|NCT01625338|589725101|FG000|Overall Study|Enrolled but not Treated|0|||
163277008|NCT01625338|589725102|FG001|Overall Study|Enrolled but not Treated|0|||
163277009|NCT01625338|589725103|FG002|Overall Study|Enrolled but not Treated|1|||
163277010|NCT01625338|589725101|FG000|Overall Study|Efficacy Failure|27|||
163277011|NCT01625338|589725102|FG001|Overall Study|Efficacy Failure|39|||
163277012|NCT01625338|589725103|FG002|Overall Study|Efficacy Failure|31|||
163277013|NCT01625338|589725101|FG000|Overall Study|Lost to Follow-up|3|||
163277014|NCT01625338|589725102|FG001|Overall Study|Lost to Follow-up|3|||
163277015|NCT01625338|589725103|FG002|Overall Study|Lost to Follow-up|2|||
163277016|NCT01625338|589725101|FG000|Overall Study|Investigator Decision|0|||
163277017|NCT01625338|589725102|FG001|Overall Study|Investigator Decision|2|||
163277018|NCT01625338|589725103|FG002|Overall Study|Investigator Decision|1|||
163277019|NCT01625338|589725101|FG000|Overall Study|Subject Withdrew Consent|1|||
163277020|NCT01625338|589725102|FG001|Overall Study|Subject Withdrew Consent|0|||
163277021|NCT01625338|589725103|FG002|Overall Study|Subject Withdrew Consent|2|||
163277022|NCT01625338|589725101|FG000|Overall Study|Adverse Event|1|||
163277023|NCT01625338|589725102|FG001|Overall Study|Adverse Event|0|||
163277024|NCT01625338|589725103|FG002|Overall Study|Adverse Event|1|||
163277025|NCT01625338|589725101|FG000|Overall Study|Study Discontinued by Sponsor|0|||
163277026|NCT01625338|589725102|FG001|Overall Study|Study Discontinued by Sponsor|0|||
163277027|NCT01625338|589725103|FG002|Overall Study|Study Discontinued by Sponsor|1|||
163277028|NCT00515086|589725110|FG000|Overall Study|Adverse Event|1|||
163277029|NCT00515086|589725111|FG001|Overall Study|Adverse Event|1|||
163277030|NCT00515086|589725112|FG002|Overall Study|Adverse Event|2|||
163277031|NCT00515086|589725113|FG003|Overall Study|Adverse Event|3|||
163277032|NCT00515086|589725110|FG000|Overall Study|Administrative|1|||
163277033|NCT00515086|589725111|FG001|Overall Study|Administrative|1|||
162924221|NCT00077766|588423833|FG000|Overall Study|Investigators Discretion|1|||
163170377|NCT01330017|589340921|FG002|Overall Study|Unknown Reason|5|||
163170378|NCT01330017|589340922|FG003|Overall Study|Unknown Reason|7|||
163170379|NCT01330017|589340923|FG004|Overall Study|Unknown Reason|2|||
163170380|NCT03137069|589340926|FG000|Overall Study|Withdrawal by Subject|1|||
163170381|NCT03137069|589340927|FG001|Overall Study|Withdrawal by Subject|2|||
163170382|NCT03137069|589340928|FG002|Overall Study|Withdrawal by Subject|2|||
163170383|NCT03137069|589340929|FG003|Overall Study|Withdrawal by Subject|2|||
163170384|NCT03137069|589340930|FG004|Overall Study|Withdrawal by Subject|0|||
163170385|NCT03137069|589340931|FG005|Overall Study|Withdrawal by Subject|0|||
163277034|NCT00515086|589725112|FG002|Overall Study|Administrative|0|||
163277035|NCT00515086|589725113|FG003|Overall Study|Administrative|0|||
163277036|NCT00515086|589725110|FG000|Overall Study|Withdrawal by Subject|1|||
163277037|NCT00515086|589725111|FG001|Overall Study|Withdrawal by Subject|0|||
163277038|NCT00515086|589725112|FG002|Overall Study|Withdrawal by Subject|0|||
163277039|NCT00515086|589725113|FG003|Overall Study|Withdrawal by Subject|1|||
163277040|NCT00515086|589725110|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
163277041|NCT00515086|589725111|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
163277042|NCT00515086|589725112|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
163277043|NCT00515086|589725113|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
163277044|NCT00515086|589725110|FG000|Overall Study|Lost to Follow-up|1|||
163277045|NCT00515086|589725111|FG001|Overall Study|Lost to Follow-up|0|||
163277046|NCT00515086|589725112|FG002|Overall Study|Lost to Follow-up|0|||
163277047|NCT00515086|589725113|FG003|Overall Study|Lost to Follow-up|0|||
163277048|NCT00515086|589725110|FG000|Overall Study|Study drug no longer required|0|||
163277049|NCT00515086|589725111|FG001|Overall Study|Study drug no longer required|1|||
163277050|NCT00515086|589725112|FG002|Overall Study|Study drug no longer required|0|||
163277051|NCT00515086|589725113|FG003|Overall Study|Study drug no longer required|0|||
163277052|NCT00515086|589725110|FG000|Overall Study|Death|2|||
163277053|NCT00515086|589725111|FG001|Overall Study|Death|0|||
163277054|NCT00515086|589725112|FG002|Overall Study|Death|0|||
163277055|NCT00515086|589725113|FG003|Overall Study|Death|0|||
163277056|NCT03487666|589725118|FG000|Overall Study|Disease progression|4|||
163277057|NCT03487666|589725119|FG001|Overall Study|Disease progression|2|||
163277058|NCT03487666|589725120|FG002|Overall Study|Disease progression|0|||
163277059|NCT03487666|589725118|FG000|Overall Study|Adverse Event|0|||
163277060|NCT03487666|589725119|FG001|Overall Study|Adverse Event|0|||
163277061|NCT03487666|589725120|FG002|Overall Study|Adverse Event|1|||
163277062|NCT03201757|589725121|FG000|Overall Study|Withdrawal by Subject|133|||
163277063|NCT03201757|589725121|FG000|Overall Study|Adverse Event|44|||
163277064|NCT03201757|589725121|FG000|Overall Study|Lost to Follow-up|37|||
163277065|NCT03201757|589725121|FG000|Overall Study|Pregnancy|2|||
163277066|NCT03201757|589725121|FG000|Overall Study|Lack of Efficacy|1|||
163277067|NCT03201757|589725121|FG000|Overall Study|Protocol Violation|20|||
163277068|NCT03201757|589725121|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
163277069|NCT03201757|589725121|FG000|Overall Study|Not Yet Determined|5|||
163277070|NCT03201757|589725121|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
163277071|NCT03201757|589725121|FG000|Overall Study|Other|20|||
163277072|NCT03930186|589725125|FG000|Weeks 0 to 16|Adverse Event|6|||
163277073|NCT03930186|589725125|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
163277074|NCT03930186|589725125|FG000|Weeks 16 to 32|Adverse Event|1|||
163277075|NCT03930186|589725125|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
163277076|NCT00557505|589725128|FG000|Overall Study|Death|0|||
163277077|NCT00557505|589725129|FG001|Overall Study|Death|0|||
163277078|NCT00557505|589725130|FG002|Overall Study|Death|0|||
163277079|NCT00557505|589725131|FG003|Overall Study|Death|0|||
163277080|NCT00557505|589725132|FG004|Overall Study|Death|0|||
163277081|NCT00557505|589725133|FG005|Overall Study|Death|0|||
163277082|NCT00557505|589725134|FG006|Overall Study|Death|0|||
163277083|NCT00557505|589725135|FG007|Overall Study|Death|0|||
163277084|NCT00557505|589725136|FG008|Overall Study|Death|1|||
162929556|NCT04682639|588447389|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
163277085|NCT00557505|589725128|FG000|Overall Study|Adverse Event|0|||
163277086|NCT00557505|589725129|FG001|Overall Study|Adverse Event|0|||
163277087|NCT00557505|589725130|FG002|Overall Study|Adverse Event|1|||
163277088|NCT00557505|589725131|FG003|Overall Study|Adverse Event|0|||
163277089|NCT00557505|589725132|FG004|Overall Study|Adverse Event|0|||
163277090|NCT00557505|589725133|FG005|Overall Study|Adverse Event|0|||
163277091|NCT00557505|589725134|FG006|Overall Study|Adverse Event|1|||
163277092|NCT00557505|589725135|FG007|Overall Study|Adverse Event|0|||
163277093|NCT00557505|589725136|FG008|Overall Study|Adverse Event|0|||
163277094|NCT00557505|589725128|FG000|Overall Study|Global deterioration of health|1|||
163277095|NCT00557505|589725129|FG001|Overall Study|Global deterioration of health|0|||
163277096|NCT00557505|589725130|FG002|Overall Study|Global deterioration of health|0|||
163277097|NCT00557505|589725131|FG003|Overall Study|Global deterioration of health|0|||
163277098|NCT00557505|589725132|FG004|Overall Study|Global deterioration of health|0|||
163277099|NCT00557505|589725133|FG005|Overall Study|Global deterioration of health|0|||
163277100|NCT00557505|589725134|FG006|Overall Study|Global deterioration of health|0|||
163277101|NCT00557505|589725135|FG007|Overall Study|Global deterioration of health|0|||
163277102|NCT00557505|589725136|FG008|Overall Study|Global deterioration of health|0|||
163277103|NCT00557505|589725128|FG000|Overall Study|Objective progression or relapse|2|||
163277104|NCT00557505|589725129|FG001|Overall Study|Objective progression or relapse|3|||
163277105|NCT00557505|589725130|FG002|Overall Study|Objective progression or relapse|3|||
163277106|NCT00557505|589725131|FG003|Overall Study|Objective progression or relapse|2|||
163277107|NCT00557505|589725132|FG004|Overall Study|Objective progression or relapse|2|||
163277108|NCT00557505|589725133|FG005|Overall Study|Objective progression or relapse|3|||
163277109|NCT00557505|589725134|FG006|Overall Study|Objective progression or relapse|2|||
163277110|NCT00557505|589725135|FG007|Overall Study|Objective progression or relapse|5|||
163277111|NCT00557505|589725136|FG008|Overall Study|Objective progression or relapse|15|||
163277112|NCT00557505|589725128|FG000|Overall Study|Withdrawal by Subject|0|||
163277113|NCT00557505|589725129|FG001|Overall Study|Withdrawal by Subject|0|||
163277114|NCT00557505|589725130|FG002|Overall Study|Withdrawal by Subject|0|||
163277115|NCT00557505|589725131|FG003|Overall Study|Withdrawal by Subject|1|||
163277116|NCT00557505|589725132|FG004|Overall Study|Withdrawal by Subject|0|||
163277117|NCT00557505|589725133|FG005|Overall Study|Withdrawal by Subject|0|||
163277118|NCT00557505|589725134|FG006|Overall Study|Withdrawal by Subject|0|||
163277119|NCT00557505|589725135|FG007|Overall Study|Withdrawal by Subject|0|||
163277120|NCT00557505|589725136|FG008|Overall Study|Withdrawal by Subject|1|||
163277121|NCT01244763|589725137|FG000|Overall Study|Adverse Event|1|||
163277122|NCT01244763|589725138|FG001|Overall Study|Adverse Event|0|||
163277123|NCT01244763|589725139|FG002|Overall Study|Adverse Event|0|||
163277124|NCT01244763|589725140|FG003|Overall Study|Adverse Event|0|||
163277125|NCT01244763|589725141|FG004|Overall Study|Adverse Event|0|||
163277126|NCT01244763|589725142|FG005|Overall Study|Adverse Event|1|||
163277127|NCT01244763|589725137|FG000|Overall Study|Death|1|||
163277128|NCT01244763|589725138|FG001|Overall Study|Death|0|||
163277129|NCT01244763|589725139|FG002|Overall Study|Death|1|||
163277130|NCT01244763|589725140|FG003|Overall Study|Death|0|||
163277131|NCT01244763|589725141|FG004|Overall Study|Death|2|||
163277132|NCT01244763|589725142|FG005|Overall Study|Death|0|||
163277133|NCT01244763|589725137|FG000|Overall Study|Physician Decision|0|||
163277134|NCT01244763|589725138|FG001|Overall Study|Physician Decision|0|||
163277135|NCT01244763|589725139|FG002|Overall Study|Physician Decision|1|||
163277136|NCT01244763|589725140|FG003|Overall Study|Physician Decision|0|||
163277137|NCT01244763|589725141|FG004|Overall Study|Physician Decision|0|||
163277138|NCT01244763|589725142|FG005|Overall Study|Physician Decision|0|||
163277139|NCT01244763|589725137|FG000|Overall Study|Withdrawal by Subject|1|||
163277140|NCT01244763|589725138|FG001|Overall Study|Withdrawal by Subject|2|||
163277141|NCT01244763|589725139|FG002|Overall Study|Withdrawal by Subject|0|||
163277142|NCT01244763|589725140|FG003|Overall Study|Withdrawal by Subject|1|||
163277143|NCT01244763|589725141|FG004|Overall Study|Withdrawal by Subject|1|||
163277144|NCT01244763|589725142|FG005|Overall Study|Withdrawal by Subject|2|||
163277145|NCT01244763|589725137|FG000|Overall Study|Lost to Follow-up|0|||
163277146|NCT01244763|589725138|FG001|Overall Study|Lost to Follow-up|1|||
163277147|NCT01244763|589725139|FG002|Overall Study|Lost to Follow-up|0|||
163277148|NCT01244763|589725140|FG003|Overall Study|Lost to Follow-up|0|||
163277149|NCT01244763|589725141|FG004|Overall Study|Lost to Follow-up|0|||
163277150|NCT01244763|589725142|FG005|Overall Study|Lost to Follow-up|0|||
163277151|NCT01244763|589725137|FG000|Overall Study|Enrolled into the Extension Study|0|||
163277152|NCT01244763|589725138|FG001|Overall Study|Enrolled into the Extension Study|0|||
163277153|NCT01244763|589725139|FG002|Overall Study|Enrolled into the Extension Study|0|||
163277154|NCT01244763|589725140|FG003|Overall Study|Enrolled into the Extension Study|0|||
163277155|NCT01244763|589725141|FG004|Overall Study|Enrolled into the Extension Study|0|||
163277156|NCT01244763|589725142|FG005|Overall Study|Enrolled into the Extension Study|1|||
163277157|NCT03330119|589725143|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
163277158|NCT03330119|589725144|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
163277159|NCT00550732|589725149|FG000|Overall Study|Death|4|||
163277160|NCT00550732|589725149|FG000|Overall Study|Withdrawal by Subject|2|||
162929557|NCT04682639|588447390|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
163277161|NCT00550732|589725149|FG000|Overall Study|Physician Decision|2|||
163277162|NCT00550732|589725149|FG000|Overall Study|Lost to Follow-up|1|||
163277163|NCT00550732|589725149|FG000|Overall Study|Palliative care|1|||
163277164|NCT00550732|589725149|FG000|Overall Study|Adverse Event|1|||
163277165|NCT01323660|589725150|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
163277166|NCT01323660|589725151|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
163277167|NCT01323660|589725152|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
163277168|NCT01323660|589725153|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
163277169|NCT01323660|589725154|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
163277170|NCT01323660|589725155|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
163277171|NCT01323660|589725150|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
163277172|NCT01323660|589725151|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
163277173|NCT01323660|589725152|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
163277174|NCT01323660|589725153|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
163277175|NCT01323660|589725154|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
163277176|NCT01323660|589725155|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
163277177|NCT01323660|589725150|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
163277178|NCT01323660|589725151|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
163277179|NCT01323660|589725152|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
163277180|NCT01323660|589725153|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
163277181|NCT01323660|589725154|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
163277182|NCT01323660|589725155|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
163277183|NCT01323660|589725150|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
163277184|NCT01323660|589725151|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
163277185|NCT01323660|589725152|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
163277186|NCT01323660|589725153|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
163277187|NCT01323660|589725154|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
163277188|NCT01323660|589725155|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
163277189|NCT01323660|589725150|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163277190|NCT01323660|589725151|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163277191|NCT01323660|589725152|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163277192|NCT01323660|589725153|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163277193|NCT01323660|589725154|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
163277194|NCT01323660|589725155|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163277195|NCT01323660|589725150|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
163277196|NCT01323660|589725151|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
163277197|NCT01323660|589725152|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
163277198|NCT01323660|589725153|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
163277199|NCT01323660|589725154|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
163277200|NCT01323660|589725155|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
163277201|NCT01323660|589725150|FG000|Washout Period (14 Days)|Adverse Event|0|||
163277202|NCT01323660|589725151|FG001|Washout Period (14 Days)|Adverse Event|0|||
163277203|NCT01323660|589725152|FG002|Washout Period (14 Days)|Adverse Event|0|||
163277204|NCT01323660|589725153|FG003|Washout Period (14 Days)|Adverse Event|0|||
163277205|NCT01323660|589725154|FG004|Washout Period (14 Days)|Adverse Event|1|||
163277206|NCT01323660|589725155|FG005|Washout Period (14 Days)|Adverse Event|0|||
163277207|NCT01323660|589725150|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
163277208|NCT01323660|589725151|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
163277209|NCT01323660|589725152|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
163277210|NCT01323660|589725153|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
163277211|NCT01323660|589725154|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
163277212|NCT01323660|589725155|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
163277213|NCT01323660|589725150|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
163277214|NCT01323660|589725151|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
163277215|NCT01323660|589725152|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
163277216|NCT01323660|589725153|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
163277217|NCT01323660|589725154|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
163277218|NCT01323660|589725155|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
163277219|NCT01323660|589725150|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
163277220|NCT01323660|589725151|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
163277221|NCT01323660|589725152|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
163277222|NCT01323660|589725153|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
163277223|NCT01323660|589725154|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
163277224|NCT01323660|589725155|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
163277225|NCT01323660|589725150|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
163277226|NCT01323660|589725151|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
163277227|NCT01323660|589725152|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
163277228|NCT01323660|589725153|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
163277229|NCT01323660|589725154|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
163277230|NCT01323660|589725155|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
163277231|NCT01323660|589725150|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
163277232|NCT01323660|589725151|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
163277233|NCT01323660|589725152|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
163277234|NCT01323660|589725153|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
163277235|NCT01323660|589725154|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
163277236|NCT01323660|589725155|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
163277237|NCT01323660|589725150|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
163277238|NCT01323660|589725151|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
163277239|NCT01323660|589725152|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
163277240|NCT01323660|589725153|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163277241|NCT01323660|589725154|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
163277242|NCT01323660|589725155|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163277243|NCT01403987|589725159|FG000|Overall Study|Residents forgot their secret PIN|18|||
163277244|NCT01403987|589725160|FG001|Overall Study|Residents forgot their secret PIN|17|||
163277245|NCT01403987|589725161|FG002|Overall Study|Residents forgot their secret PIN|18|||
163277246|NCT03566680|589725164|FG000|Overall Study|Pregnancy|1|||
163277247|NCT03566680|589725164|FG000|Overall Study|Lost to Follow-up|13|||
163277248|NCT03566680|589725164|FG000|Overall Study|Withdrawal by Subject|3|||
163277249|NCT04227340|589725166|FG000|Overall Study|Withdrawal by Subject|3|||
163277250|NCT01066156|589725167|FG000|Overall Study|ineligible|2|||
163277251|NCT01066156|589725167|FG000|Overall Study|Lost to Follow-up|7|||
163277252|NCT01066156|589725167|FG000|Overall Study|Withdrawal by Subject|1|||
163277253|NCT04003974|589725168|FG000|Overall Study|Missing|1|||
163277254|NCT04003974|589725169|FG001|Overall Study|Missing|0|||
163277255|NCT04003974|589725168|FG000|Overall Study|Withdrawal by Subject|0|||
163277256|NCT04003974|589725169|FG001|Overall Study|Withdrawal by Subject|2|||
163277257|NCT02400307|589725170|FG000|Overall Study|Enrolled and Never Dosed|1|||
163277258|NCT02400307|589725171|FG001|Overall Study|Enrolled and Never Dosed|0|||
163277259|NCT02015663|589725174|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
163277260|NCT02015663|589725175|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
163277261|NCT02015663|589725174|FG000|Overall Study|Withdrawal by Subject|1|||
163277262|NCT02015663|589725175|FG001|Overall Study|Withdrawal by Subject|0|||
163277263|NCT02015663|589725174|FG000|Overall Study|Protocol Violation|0|||
163277264|NCT02015663|589725175|FG001|Overall Study|Protocol Violation|1|||
163277265|NCT02015663|589725174|FG000|Overall Study|Adverse Event|3|||
163277266|NCT02015663|589725175|FG001|Overall Study|Adverse Event|0|||
163277267|NCT02015663|589725174|FG000|Overall Study|Administrative problems|10|||
163277268|NCT02015663|589725175|FG001|Overall Study|Administrative problems|11|||
163277269|NCT02059161|589725177|FG000|Overall Study|Pregnancy|0|||
163277270|NCT02059161|589725178|FG001|Overall Study|Pregnancy|2|||
163277271|NCT02059161|589725177|FG000|Overall Study|Adverse Event|2|||
163277272|NCT02059161|589725178|FG001|Overall Study|Adverse Event|6|||
163277273|NCT02059161|589725177|FG000|Overall Study|Lost to Follow-up|20|||
163277274|NCT02059161|589725178|FG001|Overall Study|Lost to Follow-up|12|||
163277275|NCT02059161|589725177|FG000|Overall Study|Physician Decision|4|||
163277276|NCT02059161|589725178|FG001|Overall Study|Physician Decision|4|||
163277277|NCT02059161|589725177|FG000|Overall Study|Protocol Violation|1|||
163277278|NCT02059161|589725178|FG001|Overall Study|Protocol Violation|1|||
163277279|NCT02059161|589725177|FG000|Overall Study|Withdrawal by Subject|16|||
163277280|NCT02059161|589725178|FG001|Overall Study|Withdrawal by Subject|13|||
163277281|NCT02059161|589725177|FG000|Overall Study|Randomized in error, no study drug|0|||
163277282|NCT02059161|589725178|FG001|Overall Study|Randomized in error, no study drug|1|||
163277283|NCT02059161|589725177|FG000|Overall Study|Non-compliance with study drug|6|||
163277284|NCT02059161|589725178|FG001|Overall Study|Non-compliance with study drug|2|||
163277285|NCT03389893|589725181|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
163277286|NCT03389893|589725182|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
163277287|NCT03389893|589725183|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
163277288|NCT03389893|589725184|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
163277289|NCT03389893|589725181|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
163277290|NCT03389893|589725182|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
163277291|NCT03389893|589725183|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
163277292|NCT03389893|589725184|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
163277293|NCT03389893|589725181|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
163277294|NCT03389893|589725182|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
163277295|NCT03389893|589725183|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
163277296|NCT03389893|589725184|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
163277297|NCT03389893|589725181|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
163277298|NCT03389893|589725182|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
163277299|NCT03389893|589725183|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
163277300|NCT03389893|589725184|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
163277301|NCT01719861|589725186|FG000|Cycle 1|Death|4|||
163277302|NCT01719861|589725186|FG000|Cycle 2|Death|1|||
163277303|NCT00958009|589725187|FG000|Overall Study|Adverse Event|1|||
163277304|NCT00958009|589725187|FG000|Overall Study|Subject found device difficult to use|1|||
163277305|NCT00087490|589725191|FG000|Overall Study|Death|6|||
163277306|NCT00087490|589725192|FG001|Overall Study|Death|4|||
163277307|NCT00087490|589725191|FG000|Overall Study|Adverse Event|3|||
163277308|NCT00087490|589725192|FG001|Overall Study|Adverse Event|8|||
163277309|NCT00087490|589725191|FG000|Overall Study|Lack of Efficacy|0|||
163277310|NCT00087490|589725192|FG001|Overall Study|Lack of Efficacy|2|||
163277311|NCT00087490|589725191|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
163277312|NCT00087490|589725192|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
163277313|NCT00087490|589725191|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
163277314|NCT00087490|589725192|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
163277315|NCT00087490|589725191|FG000|Overall Study|Randomized but not treated|7|||
163277316|NCT00087490|589725192|FG001|Overall Study|Randomized but not treated|18|||
163277317|NCT01925170|589725193|FG000|Overall Study|Unverified cancer status|53|||
163277318|NCT01077024|589725196|FG000|Overall Study|Lost to Follow-up|20|||
163277319|NCT01077024|589725197|FG001|Overall Study|Lost to Follow-up|14|||
163277320|NCT01077024|589725196|FG000|Overall Study|Withdrawal by Subject|0|||
163277321|NCT01077024|589725197|FG001|Overall Study|Withdrawal by Subject|2|||
163277322|NCT01077024|589725196|FG000|Overall Study|Incarcerated|7|||
163277323|NCT01077024|589725197|FG001|Overall Study|Incarcerated|8|||
163277324|NCT01077024|589725196|FG000|Overall Study|Other|4|||
163277325|NCT01077024|589725197|FG001|Overall Study|Other|4|||
163277326|NCT02034435|589725198|FG000|Overall Study|Withdrawal by Subject|1|||
163277327|NCT02034435|589725199|FG001|Overall Study|Withdrawal by Subject|0|||
163277328|NCT02034435|589725200|FG002|Overall Study|Withdrawal by Subject|0|||
163277329|NCT02034435|589725201|FG003|Overall Study|Withdrawal by Subject|0|||
163277330|NCT02034435|589725198|FG000|Overall Study|Illness|0|||
163277331|NCT02034435|589725199|FG001|Overall Study|Illness|2|||
163277332|NCT02034435|589725200|FG002|Overall Study|Illness|0|||
163277333|NCT02034435|589725201|FG003|Overall Study|Illness|0|||
163277334|NCT02034435|589725198|FG000|Overall Study|Inadequate IV access|1|||
163277335|NCT02034435|589725199|FG001|Overall Study|Inadequate IV access|0|||
163277336|NCT02034435|589725200|FG002|Overall Study|Inadequate IV access|0|||
163277337|NCT02034435|589725201|FG003|Overall Study|Inadequate IV access|1|||
163277338|NCT02300311|589725207|FG000|Overall Study|Other than the reason specified|1|||
163277339|NCT02300311|589725208|FG001|Overall Study|Other than the reason specified|0|||
163277340|NCT02300311|589725207|FG000|Overall Study|Refused to continue taking medication|18|||
163277341|NCT02300311|589725208|FG001|Overall Study|Refused to continue taking medication|0|||
163277342|NCT02839681|589725209|FG000|Overall Study|Death|2|||
163277343|NCT00848211|589725210|FG000|Overall Study|Protocol Violation|0|||
163277344|NCT00848211|589725211|FG001|Overall Study|Protocol Violation|1|||
163277345|NCT00848211|589725212|FG002|Overall Study|Protocol Violation|1|||
163277346|NCT00848211|589725213|FG003|Overall Study|Protocol Violation|0|||
163277347|NCT00848211|589725210|FG000|Overall Study|Adverse Event|0|||
163277348|NCT00848211|589725211|FG001|Overall Study|Adverse Event|0|||
163277349|NCT00848211|589725212|FG002|Overall Study|Adverse Event|0|||
163277350|NCT00848211|589725213|FG003|Overall Study|Adverse Event|0|||
163277351|NCT00772928|589725214|FG000|Overall Study|Lost to Follow-up|9|||
163277352|NCT00772928|589725215|FG001|Overall Study|Lost to Follow-up|6|||
163277353|NCT00772928|589725214|FG000|Overall Study|Protocol Violation|10|||
163277354|NCT00772928|589725215|FG001|Overall Study|Protocol Violation|12|||
163277355|NCT00772928|589725214|FG000|Overall Study|Withdrawal by Subject|25|||
163277356|NCT00772928|589725215|FG001|Overall Study|Withdrawal by Subject|22|||
163277357|NCT00772928|589725214|FG000|Overall Study|Did not receive vaccine|0|||
163277358|NCT00772928|589725215|FG001|Overall Study|Did not receive vaccine|1|||
163277359|NCT03100838|589725217|FG000|Overall Study|Adverse Event|1|||
163277360|NCT03100838|589725218|FG001|Overall Study|Adverse Event|0|||
163277361|NCT03100838|589725219|FG002|Overall Study|Adverse Event|0|||
163277362|NCT03100838|589725220|FG003|Overall Study|Adverse Event|0|||
163277363|NCT03100838|589725217|FG000|Overall Study|Physician Decision|1|||
163277364|NCT03100838|589725218|FG001|Overall Study|Physician Decision|1|||
163277365|NCT03100838|589725219|FG002|Overall Study|Physician Decision|1|||
163277366|NCT03100838|589725220|FG003|Overall Study|Physician Decision|1|||
163277367|NCT03100838|589725217|FG000|Overall Study|Pregnancy|0|||
163277368|NCT03100838|589725218|FG001|Overall Study|Pregnancy|1|||
163277369|NCT03100838|589725219|FG002|Overall Study|Pregnancy|0|||
163277370|NCT03100838|589725220|FG003|Overall Study|Pregnancy|0|||
163277371|NCT03100838|589725217|FG000|Overall Study|Lost to Follow-up|0|||
163277372|NCT03100838|589725218|FG001|Overall Study|Lost to Follow-up|0|||
163277373|NCT03100838|589725219|FG002|Overall Study|Lost to Follow-up|1|||
163277374|NCT03100838|589725220|FG003|Overall Study|Lost to Follow-up|0|||
163277375|NCT00801242|589725221|FG000|Overall Study|Adverse Event|10|||
163277376|NCT00801242|589725221|FG000|Overall Study|Withdrawal by Subject|13|||
163277377|NCT00801242|589725221|FG000|Overall Study|Protocol Violation|5|||
163277378|NCT00801242|589725221|FG000|Overall Study|Physician Decision|3|||
163277379|NCT00801242|589725221|FG000|Overall Study|Lost to Follow-up|1|||
163277380|NCT00801242|589725221|FG000|Overall Study|Miscellaneous reasons|20|||
163277381|NCT00184028|589725222|FG000|Overall Study|Death|1|||
163277382|NCT00184028|589725222|FG000|Overall Study|Lack of Efficacy|4|||
163277383|NCT00184028|589725222|FG000|Overall Study|Adverse Event|2|||
163277384|NCT00184028|589725222|FG000|Overall Study|Withdrawal by Subject|1|||
163277385|NCT00184028|589725222|FG000|Overall Study|Non-compliance|2|||
163277386|NCT00994279|589725223|FG000|Overall Study|Withdrawal by Subject|2|||
163277387|NCT00994279|589725224|FG001|Overall Study|Withdrawal by Subject|2|||
163277388|NCT00994279|589725223|FG000|Overall Study|Toxicity|1|||
163277389|NCT00994279|589725224|FG001|Overall Study|Toxicity|0|||
163277390|NCT00994279|589725223|FG000|Overall Study|Multiple reasons|1|||
163277391|NCT00994279|589725224|FG001|Overall Study|Multiple reasons|3|||
163277392|NCT01606189|589725225|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
163277393|NCT01606189|589725226|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
163277394|NCT01606189|589725227|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
163277395|NCT01606189|589725228|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
163277396|NCT01606189|589725229|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
163277397|NCT01606189|589725230|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
163277398|NCT01606189|589725225|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
163277399|NCT01606189|589725226|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
163277400|NCT01606189|589725227|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
163277401|NCT01606189|589725228|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
163277402|NCT01606189|589725229|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
163277403|NCT01606189|589725230|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
163277404|NCT01857323|589725231|FG000|Overall Study|Adverse Event|1|||
163277405|NCT01857323|589725231|FG000|Overall Study|Withdrawal by Subject|3|||
163277406|NCT01857323|589725231|FG000|Overall Study|Non-compliance|1|||
163277407|NCT01857323|589725231|FG000|Overall Study|Protocol Violation|6|||
163277408|NCT01857323|589725231|FG000|Overall Study|Lost to Follow-up|1|||
163277409|NCT01857323|589725231|FG000|Overall Study|Other|4|||
163277410|NCT01857323|589725231|FG000|Overall Study|Did not complete 180 doses|48|||
163277411|NCT01400893|589725232|FG000|Overall Study|Death|27|||
163277412|NCT01400893|589725233|FG001|Overall Study|Death|21|||
163277413|NCT01400893|589725232|FG000|Overall Study|Lost to Follow-up|0|||
163277414|NCT01400893|589725233|FG001|Overall Study|Lost to Follow-up|6|||
163277415|NCT00519636|589725234|FG000|Treatment Period 1|Adverse Event|1|||
163277416|NCT00519636|589725235|FG001|Treatment Period 1|Adverse Event|0|||
163277417|NCT00519636|589725236|FG002|Treatment Period 1|Adverse Event|1|||
163277418|NCT00519636|589725237|FG003|Treatment Period 1|Adverse Event|0|||
163277419|NCT00519636|589725234|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
163277420|NCT00519636|589725235|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
163277421|NCT00519636|589725236|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
163277422|NCT00519636|589725237|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
163277423|NCT00519636|589725234|FG000|Washout Period|Adverse Event|2|||
163277424|NCT00519636|589725235|FG001|Washout Period|Adverse Event|1|||
163277425|NCT00519636|589725236|FG002|Washout Period|Adverse Event|1|||
163277426|NCT00519636|589725237|FG003|Washout Period|Adverse Event|0|||
163277427|NCT00519636|589725234|FG000|Washout Period|Lost to Follow-up|1|||
163277428|NCT00519636|589725235|FG001|Washout Period|Lost to Follow-up|0|||
163277429|NCT00519636|589725236|FG002|Washout Period|Lost to Follow-up|0|||
163277430|NCT00519636|589725237|FG003|Washout Period|Lost to Follow-up|0|||
163277431|NCT00519636|589725234|FG000|Washout Period|Protocol Violation|0|||
163277432|NCT00519636|589725235|FG001|Washout Period|Protocol Violation|0|||
163277433|NCT00519636|589725236|FG002|Washout Period|Protocol Violation|1|||
163277434|NCT00519636|589725237|FG003|Washout Period|Protocol Violation|2|||
163277435|NCT00519636|589725234|FG000|Washout Period|Withdrawal by Subject|1|||
163277436|NCT00519636|589725235|FG001|Washout Period|Withdrawal by Subject|0|||
163277437|NCT00519636|589725236|FG002|Washout Period|Withdrawal by Subject|1|||
163277438|NCT00519636|589725237|FG003|Washout Period|Withdrawal by Subject|0|||
163277439|NCT00519636|589725234|FG000|Washout Period|Failed to meet continuation criteria|14|||
163277440|NCT00519636|589725235|FG001|Washout Period|Failed to meet continuation criteria|11|||
163277441|NCT00519636|589725236|FG002|Washout Period|Failed to meet continuation criteria|9|||
163277442|NCT00519636|589725237|FG003|Washout Period|Failed to meet continuation criteria|3|||
163277443|NCT00519636|589725234|FG000|Washout Period|Out of pollen area > 48 hours|1|||
163277444|NCT00519636|589725235|FG001|Washout Period|Out of pollen area > 48 hours|0|||
163277445|NCT00519636|589725236|FG002|Washout Period|Out of pollen area > 48 hours|0|||
163277446|NCT00519636|589725237|FG003|Washout Period|Out of pollen area > 48 hours|0|||
163277447|NCT00519636|589725234|FG000|Washout Period|Participating in study at another site|1|||
163277448|NCT00519636|589725235|FG001|Washout Period|Participating in study at another site|0|||
163277449|NCT00519636|589725236|FG002|Washout Period|Participating in study at another site|0|||
163277450|NCT00519636|589725237|FG003|Washout Period|Participating in study at another site|0|||
163277451|NCT00519636|589725234|FG000|Washout Period|Non-compliant|0|||
163277452|NCT00519636|589725235|FG001|Washout Period|Non-compliant|1|||
163277453|NCT00519636|589725236|FG002|Washout Period|Non-compliant|0|||
163277454|NCT00519636|589725237|FG003|Washout Period|Non-compliant|0|||
163277455|NCT00519636|589725234|FG000|Washout Period|Per doctors request|0|||
163277456|NCT00519636|589725235|FG001|Washout Period|Per doctors request|1|||
163277457|NCT00519636|589725236|FG002|Washout Period|Per doctors request|0|||
163277458|NCT00519636|589725237|FG003|Washout Period|Per doctors request|0|||
163277459|NCT00519636|589725234|FG000|Washout Period|Subject randomized in error|0|||
163277460|NCT00519636|589725235|FG001|Washout Period|Subject randomized in error|0|||
163277461|NCT00519636|589725236|FG002|Washout Period|Subject randomized in error|1|||
163277462|NCT00519636|589725237|FG003|Washout Period|Subject randomized in error|0|||
163277463|NCT00519636|589725234|FG000|Washout Period|Prohibited medications|0|||
163277464|NCT00519636|589725235|FG001|Washout Period|Prohibited medications|0|||
163277465|NCT00519636|589725236|FG002|Washout Period|Prohibited medications|1|||
163277466|NCT00519636|589725237|FG003|Washout Period|Prohibited medications|0|||
163277467|NCT00519636|589725234|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
163277468|NCT00519636|589725235|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
163277469|NCT00519636|589725236|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
163277470|NCT00519636|589725237|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
163277471|NCT00519636|589725234|FG000|Treatment Period 2|Subject randomized in error|0|||
163277472|NCT00519636|589725235|FG001|Treatment Period 2|Subject randomized in error|1|||
163277473|NCT00519636|589725236|FG002|Treatment Period 2|Subject randomized in error|0|||
163277474|NCT00519636|589725237|FG003|Treatment Period 2|Subject randomized in error|0|||
163277475|NCT00519636|589725234|FG000|Treatment Period 2|Per doctors request|0|||
163277476|NCT00519636|589725235|FG001|Treatment Period 2|Per doctors request|0|||
163277477|NCT00519636|589725236|FG002|Treatment Period 2|Per doctors request|1|||
163277478|NCT00519636|589725237|FG003|Treatment Period 2|Per doctors request|0|||
163277479|NCT00519636|589725234|FG000|Treatment Period 2|Subject misrandomized|0|||
163277480|NCT00519636|589725235|FG001|Treatment Period 2|Subject misrandomized|0|||
163277481|NCT00519636|589725236|FG002|Treatment Period 2|Subject misrandomized|0|||
163277482|NCT00519636|589725237|FG003|Treatment Period 2|Subject misrandomized|1|||
163277483|NCT00519636|589725234|FG000|Post Study Period|Subject randomized in error|0|||
163277484|NCT00519636|589725235|FG001|Post Study Period|Subject randomized in error|0|||
163277485|NCT00519636|589725236|FG002|Post Study Period|Subject randomized in error|0|||
163277486|NCT00519636|589725237|FG003|Post Study Period|Subject randomized in error|1|||
163277487|NCT04504916|589725238|FG000|Overall Study|Study terminated|7|||
163277488|NCT04504916|589725239|FG001|Overall Study|Study terminated|8|||
163277489|NCT04504916|589725238|FG000|Overall Study|Death|54|||
163277490|NCT04504916|589725239|FG001|Overall Study|Death|18|||
163277491|NCT04504916|589725238|FG000|Overall Study|Lost to Follow-up|1|||
163277492|NCT04504916|589725239|FG001|Overall Study|Lost to Follow-up|1|||
163277493|NCT04504916|589725238|FG000|Overall Study|Withdrawal by Subject|8|||
163277494|NCT04504916|589725239|FG001|Overall Study|Withdrawal by Subject|4|||
163277495|NCT04504916|589725238|FG000|Overall Study|Did not agree to follow-up|0|||
163277496|NCT04504916|589725239|FG001|Overall Study|Did not agree to follow-up|1|||
163277497|NCT03057834|589725240|FG000|Overall Study|Withdrawal by Subject|25|||
163277498|NCT03057834|589725241|FG001|Overall Study|Withdrawal by Subject|29|||
163277499|NCT00003509|589725243|FG000|Overall Study|Not evaluable|5|||
163277500|NCT03803774|589725244|FG000|Dose Escalation|Withdrawal by Subject|0|||
163277501|NCT03803774|589725245|FG001|Dose Escalation|Withdrawal by Subject|0|||
163277502|NCT03803774|589725246|FG002|Dose Escalation|Withdrawal by Subject|0|||
163277503|NCT03803774|589725247|FG003|Dose Escalation|Withdrawal by Subject|1|||
163277504|NCT03803774|589725248|FG004|Dose Escalation|Withdrawal by Subject|0|||
163277505|NCT03077620|589725253|FG000|Overall Study|Unable to place lumbar catheter|1|||
162924222|NCT00077766|588423834|FG001|Overall Study|Investigators Discretion|0|||
163277506|NCT03077620|589725254|FG001|Overall Study|Unable to place lumbar catheter|0|||
163277507|NCT03077620|589725255|FG002|Overall Study|Unable to place lumbar catheter|1|||
163277508|NCT03077620|589725256|FG003|Overall Study|Unable to place lumbar catheter|0|||
163277509|NCT03077620|589725253|FG000|Overall Study|Withdrawal by Subject|0|||
163277510|NCT03077620|589725254|FG001|Overall Study|Withdrawal by Subject|1|||
163277511|NCT03077620|589725255|FG002|Overall Study|Withdrawal by Subject|0|||
163277512|NCT03077620|589725256|FG003|Overall Study|Withdrawal by Subject|0|||
163277513|NCT03077620|589725253|FG000|Overall Study|Physician Decision|0|||
163277514|NCT03077620|589725254|FG001|Overall Study|Physician Decision|0|||
163277515|NCT03077620|589725255|FG002|Overall Study|Physician Decision|1|||
163277516|NCT03077620|589725256|FG003|Overall Study|Physician Decision|0|||
163170386|NCT03137069|589340926|FG000|Overall Study|Adverse Event|0|||
163170387|NCT03137069|589340927|FG001|Overall Study|Adverse Event|3|||
163170388|NCT03137069|589340928|FG002|Overall Study|Adverse Event|1|||
163170389|NCT03137069|589340929|FG003|Overall Study|Adverse Event|1|||
163170390|NCT03137069|589340930|FG004|Overall Study|Adverse Event|0|||
163170391|NCT03137069|589340931|FG005|Overall Study|Adverse Event|1|||
163170392|NCT03137069|589340926|FG000|Overall Study|Protocol Violation|0|||
163170393|NCT03137069|589340927|FG001|Overall Study|Protocol Violation|1|||
163170394|NCT03137069|589340928|FG002|Overall Study|Protocol Violation|0|||
163170395|NCT03137069|589340929|FG003|Overall Study|Protocol Violation|1|||
163170396|NCT03137069|589340930|FG004|Overall Study|Protocol Violation|1|||
163170397|NCT03137069|589340931|FG005|Overall Study|Protocol Violation|1|||
163170398|NCT03137069|589340926|FG000|Overall Study|Physician Decision|0|||
163170399|NCT03137069|589340927|FG001|Overall Study|Physician Decision|0|||
163170400|NCT03137069|589340928|FG002|Overall Study|Physician Decision|0|||
163170401|NCT03137069|589340929|FG003|Overall Study|Physician Decision|1|||
163170402|NCT03137069|589340930|FG004|Overall Study|Physician Decision|0|||
163170403|NCT03137069|589340931|FG005|Overall Study|Physician Decision|0|||
163170404|NCT03137069|589340926|FG000|Overall Study|Study Terminated by Sponsor|0|||
163170405|NCT03137069|589340927|FG001|Overall Study|Study Terminated by Sponsor|0|||
163170406|NCT03137069|589340928|FG002|Overall Study|Study Terminated by Sponsor|0|||
163170407|NCT03137069|589340929|FG003|Overall Study|Study Terminated by Sponsor|0|||
163170408|NCT03137069|589340930|FG004|Overall Study|Study Terminated by Sponsor|1|||
163170409|NCT03137069|589340931|FG005|Overall Study|Study Terminated by Sponsor|0|||
163170410|NCT03137069|589340926|FG000|Overall Study|Data Entry Error|0|||
163170411|NCT03137069|589340927|FG001|Overall Study|Data Entry Error|0|||
163170412|NCT03137069|589340928|FG002|Overall Study|Data Entry Error|0|||
163170413|NCT03137069|589340929|FG003|Overall Study|Data Entry Error|1|||
163170414|NCT03137069|589340930|FG004|Overall Study|Data Entry Error|0|||
163170415|NCT03137069|589340931|FG005|Overall Study|Data Entry Error|0|||
163170416|NCT01106092|589340933|FG000|Overall Study|Withdrawal by Subject|0|||
163170417|NCT01106092|589340934|FG001|Overall Study|Withdrawal by Subject|0|||
163170418|NCT01106092|589340935|FG002|Overall Study|Withdrawal by Subject|0|||
163170419|NCT01106092|589340936|FG003|Overall Study|Withdrawal by Subject|1|||
163170420|NCT02434471|589340937|FG000|Overall Study|Physician Decision|9|||
163170421|NCT00369629|589340942|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
163170422|NCT00369629|589340943|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
163170423|NCT00369629|589340944|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
163170424|NCT00369629|589340945|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
163170425|NCT00369629|589340942|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
163170426|NCT00369629|589340943|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
163170427|NCT00369629|589340944|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
163170428|NCT00369629|589340945|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
163170429|NCT00369629|589340942|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
163170430|NCT00369629|589340943|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
163170431|NCT00369629|589340944|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
163170432|NCT00369629|589340945|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
163170433|NCT00369629|589340942|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
163170434|NCT00369629|589340943|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
163170435|NCT00369629|589340944|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
163170436|NCT00369629|589340945|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
163170437|NCT00369629|589340942|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
163170438|NCT00369629|589340943|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
163170439|NCT00369629|589340944|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
163170440|NCT00369629|589340945|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
163170441|NCT00369629|589340942|FG000|Completed 4 More Cycles|Progressive disease|2|||
163170442|NCT00369629|589340943|FG001|Completed 4 More Cycles|Progressive disease|1|||
163170443|NCT00369629|589340944|FG002|Completed 4 More Cycles|Progressive disease|2|||
163170444|NCT00369629|589340945|FG003|Completed 4 More Cycles|Progressive disease|0|||
163170445|NCT00369629|589340942|FG000|Follow up for 1 Year|Death|2|||
163170446|NCT00369629|589340943|FG001|Follow up for 1 Year|Death|1|||
163170447|NCT00369629|589340944|FG002|Follow up for 1 Year|Death|1|||
163170448|NCT00369629|589340945|FG003|Follow up for 1 Year|Death|0|||
163170449|NCT00369629|589340942|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
163170450|NCT00369629|589340943|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
163170451|NCT00369629|589340944|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
163170452|NCT00369629|589340945|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
163170453|NCT00369629|589340942|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
163277517|NCT00245011|589725258|FG000|Overall Study|Lack of Efficacy|1|||
163277518|NCT00550173|589725259|FG000|Overall Study|Death|45|||
163277519|NCT00550173|589725260|FG001|Overall Study|Death|38|||
163277520|NCT00550173|589725261|FG002|Overall Study|Death|50|||
163277521|NCT00550173|589725259|FG000|Overall Study|Physician Decision|1|||
163277522|NCT00550173|589725260|FG001|Overall Study|Physician Decision|2|||
163277523|NCT00550173|589725261|FG002|Overall Study|Physician Decision|2|||
163277524|NCT00550173|589725259|FG000|Overall Study|Withdrawal by Subject|9|||
163277525|NCT00550173|589725260|FG001|Overall Study|Withdrawal by Subject|12|||
163277526|NCT00550173|589725261|FG002|Overall Study|Withdrawal by Subject|17|||
163277527|NCT00550173|589725259|FG000|Overall Study|Sponsor Decision|13|||
163277528|NCT00550173|589725260|FG001|Overall Study|Sponsor Decision|7|||
163277529|NCT00550173|589725261|FG002|Overall Study|Sponsor Decision|1|||
163277530|NCT00550173|589725259|FG000|Overall Study|Lost to Follow-up|4|||
163277531|NCT00550173|589725260|FG001|Overall Study|Lost to Follow-up|4|||
163277532|NCT00550173|589725261|FG002|Overall Study|Lost to Follow-up|3|||
163277533|NCT01345292|589726651|FG000|Overall Study|Withdrawal by Subject|2|||
163277534|NCT01345292|589726652|FG001|Overall Study|Withdrawal by Subject|0|||
163277535|NCT01345292|589726653|FG002|Overall Study|Withdrawal by Subject|1|||
163277536|NCT05406791|589726659|FG000|Overall Study|Lost to Follow-up|13|||
163277537|NCT05406791|589726660|FG001|Overall Study|Lost to Follow-up|10|||
163277538|NCT01789203|589726661|FG000|Overall Study|Adverse Event|2|||
163277539|NCT01789203|589726662|FG001|Overall Study|Adverse Event|2|||
163277540|NCT01789203|589726661|FG000|Overall Study|Withdrawal by Subject|1|||
163277541|NCT01789203|589726662|FG001|Overall Study|Withdrawal by Subject|0|||
163277542|NCT01789203|589726661|FG000|Overall Study|Death|1|||
163277543|NCT01789203|589726662|FG001|Overall Study|Death|0|||
163277544|NCT01789203|589726661|FG000|Overall Study|Protocol Violation|2|||
163277545|NCT01789203|589726662|FG001|Overall Study|Protocol Violation|1|||
163277546|NCT01789203|589726661|FG000|Overall Study|Other|1|||
163277547|NCT01789203|589726662|FG001|Overall Study|Other|1|||
163277548|NCT01789203|589726661|FG000|Overall Study|patient non-adherent|2|||
163277549|NCT01789203|589726662|FG001|Overall Study|patient non-adherent|0|||
163277550|NCT02403674|589726663|FG000|Base Study|Death|1|||
163277551|NCT02403674|589726664|FG001|Base Study|Death|4|||
163277552|NCT02403674|589726663|FG000|Base Study|Adverse Event|11|||
163277553|NCT02403674|589726664|FG001|Base Study|Adverse Event|26|||
163277554|NCT02403674|589726663|FG000|Base Study|Lack of Efficacy|31|||
163277555|NCT02403674|589726664|FG001|Base Study|Lack of Efficacy|23|||
163277556|NCT02403674|589726663|FG000|Base Study|Lost to Follow-up|6|||
163277557|NCT02403674|589726664|FG001|Base Study|Lost to Follow-up|8|||
163277558|NCT02403674|589726663|FG000|Base Study|Withdrawal by Subject|10|||
163277559|NCT02403674|589726664|FG001|Base Study|Withdrawal by Subject|17|||
163277560|NCT02403674|589726663|FG000|Base Study|Physician Decision|2|||
163277561|NCT02403674|589726664|FG001|Base Study|Physician Decision|2|||
163277562|NCT02403674|589726663|FG000|Base Study|Pregnancy|2|||
163277563|NCT02403674|589726664|FG001|Base Study|Pregnancy|2|||
163277564|NCT02403674|589726663|FG000|Base Study|Protocol Violation|8|||
163277565|NCT02403674|589726664|FG001|Base Study|Protocol Violation|4|||
163277566|NCT02403674|589726663|FG000|Base Study|Non-Compliance with study drug|1|||
163277567|NCT02403674|589726664|FG001|Base Study|Non-Compliance with study drug|4|||
163277568|NCT02403674|589726663|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
163277569|NCT02403674|589726664|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
163277570|NCT02403674|589726663|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
163277571|NCT02403674|589726664|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
163277572|NCT02403674|589726663|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
163277573|NCT02403674|589726664|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
163277574|NCT02403674|589726663|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
163277575|NCT02403674|589726664|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
163277576|NCT02403674|589726663|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
163277577|NCT02403674|589726664|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
163277578|NCT02403674|589726663|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
163277579|NCT02403674|589726664|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
163277580|NCT02403674|589726663|FG000|Study Extension 1 (Open-Label)|Death|1|||
163277581|NCT02403674|589726664|FG001|Study Extension 1 (Open-Label)|Death|0|||
163277582|NCT02403674|589726663|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
163277583|NCT02403674|589726664|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
163277584|NCT02403674|589726663|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
163277585|NCT02403674|589726664|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
163277586|NCT02403674|589726663|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
163277587|NCT02403674|589726664|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
163277588|NCT02403674|589726663|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
163277589|NCT02403674|589726664|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
163277590|NCT02403674|589726663|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
163277591|NCT02403674|589726664|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
163277592|NCT02403674|589726663|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
163277593|NCT02403674|589726664|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
163277594|NCT02403674|589726663|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
163277595|NCT02403674|589726664|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
163277596|NCT02403674|589726663|FG000|Study Extension 2 (Open-Label)|Death|2|||
163277597|NCT02403674|589726664|FG001|Study Extension 2 (Open-Label)|Death|2|||
163277598|NCT02403674|589726663|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
163277599|NCT02403674|589726664|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
163277600|NCT02403674|589726663|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
163277601|NCT02403674|589726664|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
163277602|NCT02403674|589726663|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
163277603|NCT02403674|589726664|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
163277604|NCT02403674|589726663|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
163277605|NCT02403674|589726664|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
163277606|NCT02403674|589726663|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
163277607|NCT02403674|589726664|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
163277608|NCT02403674|589726663|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
163277609|NCT02403674|589726664|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
163277610|NCT02403674|589726663|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
163277611|NCT02403674|589726664|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
163277612|NCT01254305|589726665|FG000|Overall Study|Adverse Event|6|||
163277613|NCT01254305|589726666|FG001|Overall Study|Adverse Event|3|||
163277614|NCT01254305|589726667|FG002|Overall Study|Adverse Event|2|||
163277615|NCT01254305|589726665|FG000|Overall Study|Lack of Efficacy|1|||
163277616|NCT01254305|589726666|FG001|Overall Study|Lack of Efficacy|0|||
163277617|NCT01254305|589726667|FG002|Overall Study|Lack of Efficacy|1|||
163277618|NCT01254305|589726665|FG000|Overall Study|Protocol Violation|1|||
163277619|NCT01254305|589726666|FG001|Overall Study|Protocol Violation|7|||
163277620|NCT01254305|589726667|FG002|Overall Study|Protocol Violation|3|||
163277621|NCT01254305|589726665|FG000|Overall Study|Withdrawal by Subject|4|||
163277622|NCT01254305|589726666|FG001|Overall Study|Withdrawal by Subject|2|||
163277623|NCT01254305|589726667|FG002|Overall Study|Withdrawal by Subject|4|||
163277624|NCT01254305|589726665|FG000|Overall Study|Lost to Follow-up|10|||
163277625|NCT01254305|589726666|FG001|Overall Study|Lost to Follow-up|6|||
163277626|NCT01254305|589726667|FG002|Overall Study|Lost to Follow-up|5|||
163277627|NCT01254305|589726665|FG000|Overall Study|Other Reasons|0|||
163277628|NCT01254305|589726666|FG001|Overall Study|Other Reasons|0|||
163277629|NCT01254305|589726667|FG002|Overall Study|Other Reasons|2|||
163277630|NCT03019458|589726668|FG000|Overall Study|Death|0|||
163277631|NCT03019458|589726669|FG001|Overall Study|Death|1|||
163277632|NCT00031447|589726670|FG000|Overall Study|Lost to Follow-up|0|||
163277633|NCT00031447|589726671|FG001|Overall Study|Lost to Follow-up|1|||
163277634|NCT00031447|589726670|FG000|Overall Study|Non-compliant|1|||
163277635|NCT00031447|589726671|FG001|Overall Study|Non-compliant|1|||
163277636|NCT00031447|589726670|FG000|Overall Study|Re-activation of Disease|2|||
163277637|NCT00031447|589726671|FG001|Overall Study|Re-activation of Disease|1|||
163277638|NCT00031447|589726670|FG000|Overall Study|Disruption of blinded study drug supply|7|||
163277639|NCT00031447|589726671|FG001|Overall Study|Disruption of blinded study drug supply|4|||
163277640|NCT01636362|589726675|FG000|Overall Study|Physician Decision|6|||
163277641|NCT01636362|589726675|FG000|Overall Study|Subject healed, not returning|1|||
163277642|NCT01636362|589726675|FG000|Overall Study|Withdrawal by Subject|1|||
163277643|NCT02271594|589726676|FG000|Overall Study|Study closed; recruiting failure|19|||
163277644|NCT02271594|589726677|FG001|Overall Study|Study closed; recruiting failure|12|||
163277645|NCT01561079|589726680|FG000|Overall Study|Physician Decision|17|||
163277646|NCT01561079|589726680|FG000|Overall Study|Withdrawal by Subject|59|||
163277647|NCT01561079|589726680|FG000|Overall Study|Protocol Violation|2|||
163277648|NCT00926393|589726688|FG000|Overall Study|Withdrawal by Subject|1|||
163277649|NCT00926393|589726689|FG001|Overall Study|Withdrawal by Subject|2|||
163277650|NCT00926393|589726688|FG000|Overall Study|Adverse Event|1|||
163277651|NCT00926393|589726689|FG001|Overall Study|Adverse Event|1|||
163277652|NCT00751790|589726695|FG000|Overall Study|Lost to Follow-up|1|||
163277653|NCT00751790|589726695|FG000|Overall Study|Death|3|||
163277654|NCT00751790|589726695|FG000|Overall Study|Withdrawal by Subject|1|||
163277655|NCT00180674|589726696|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
163277656|NCT00180674|589726696|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
163277657|NCT03302910|589726697|FG000|Overall Study|Protocol Violation|1|||
163277658|NCT03302910|589726698|FG001|Overall Study|Protocol Violation|0|||
163277659|NCT01106976|589726701|FG000|Overall Study|Lost to Follow-up|8|||
163277660|NCT01477749|589726704|FG000|Overall Study|Physician Decision|4|||
163170454|NCT00369629|589340943|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
163170455|NCT00369629|589340944|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
163170456|NCT00369629|589340945|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
163170457|NCT04839562|589340946|FG000|Overall Study|Withdrawal by Subject|0|||
163170458|NCT04839562|589340947|FG001|Overall Study|Withdrawal by Subject|1|||
163170459|NCT04839562|589340946|FG000|Overall Study|Physician Decision|0|||
163170460|NCT04839562|589340947|FG001|Overall Study|Physician Decision|1|||
163170461|NCT00877773|589340948|FG000|Overall Study|Disease Progression|44|||
163170462|NCT02907892|589340951|FG000|Overall Study|Lost to Follow-up|27|||
163170463|NCT02907892|589340952|FG001|Overall Study|Lost to Follow-up|40|||
163170464|NCT01347580|589340953|FG000|Overall Study|Withdrawal by Subject|13|||
163170465|NCT01347580|589340954|FG001|Overall Study|Withdrawal by Subject|23|||
163170466|NCT01347580|589340953|FG000|Overall Study|Death|30|||
163170467|NCT01347580|589340954|FG001|Overall Study|Death|19|||
163170468|NCT01347580|589340953|FG000|Overall Study|Protocol Violation|10|||
163170469|NCT01347580|589340954|FG001|Overall Study|Protocol Violation|7|||
163170470|NCT01347580|589340953|FG000|Overall Study|Lost to Follow-up|3|||
163170471|NCT01347580|589340954|FG001|Overall Study|Lost to Follow-up|1|||
163170472|NCT01347580|589340953|FG000|Overall Study|Had other reason|9|||
163170473|NCT01347580|589340954|FG001|Overall Study|Had other reason|6|||
163170474|NCT01964755|589340955|FG000|Overall Study|Death|2|||
163170475|NCT00412373|589340956|FG000|Overall Study|Adverse Event|8|||
163170476|NCT00412373|589340957|FG001|Overall Study|Adverse Event|13|||
163170477|NCT00412373|589340956|FG000|Overall Study|Lack of Efficacy|16|||
163170478|NCT00412373|589340957|FG001|Overall Study|Lack of Efficacy|22|||
163170479|NCT00412373|589340956|FG000|Overall Study|Lost to Follow-up|7|||
163170480|NCT00412373|589340957|FG001|Overall Study|Lost to Follow-up|13|||
163170481|NCT00412373|589340956|FG000|Overall Study|Withdrawal by Subject|8|||
163170482|NCT00412373|589340957|FG001|Overall Study|Withdrawal by Subject|27|||
163170483|NCT00412373|589340956|FG000|Overall Study|Other|2|||
163170484|NCT00412373|589340957|FG001|Overall Study|Other|2|||
163170485|NCT00422513|589340958|FG000|Overall Study|Lack of Efficacy|4|||
163170486|NCT00422513|589340959|FG001|Overall Study|Lack of Efficacy|5|||
163170487|NCT00422513|589340958|FG000|Overall Study|Protocol Violation|23|||
163170488|NCT00422513|589340959|FG001|Overall Study|Protocol Violation|7|||
163170489|NCT00422513|589340958|FG000|Overall Study|Refused Treatment|4|||
163170490|NCT00422513|589340959|FG001|Overall Study|Refused Treatment|2|||
163170491|NCT00422513|589340958|FG000|Overall Study|Withdrawal by Subject|2|||
163170492|NCT00422513|589340959|FG001|Overall Study|Withdrawal by Subject|1|||
163170493|NCT00422513|589340958|FG000|Overall Study|early termination of the study|67|||
163170494|NCT00422513|589340959|FG001|Overall Study|early termination of the study|80|||
163170495|NCT00422513|589340958|FG000|Overall Study|Adverse Event|4|||
163170496|NCT00422513|589340959|FG001|Overall Study|Adverse Event|4|||
163170497|NCT00422513|589340958|FG000|Overall Study|Death|3|||
163170498|NCT00422513|589340959|FG001|Overall Study|Death|7|||
163170499|NCT03135119|589340960|FG000|Overall Study|Lost to Follow-up|2|||
163170500|NCT03135119|589340961|FG001|Overall Study|Lost to Follow-up|0|||
163170501|NCT03135119|589340960|FG000|Overall Study|Physician Decision|1|||
163170502|NCT03135119|589340961|FG001|Overall Study|Physician Decision|1|||
163170503|NCT03135119|589340960|FG000|Overall Study|COVID-19 Shutdown|2|||
163170504|NCT03135119|589340961|FG001|Overall Study|COVID-19 Shutdown|2|||
163170505|NCT01478048|589340962|FG000|Overall Study|Disease Progression|52|||
163170506|NCT01478048|589340963|FG001|Overall Study|Disease Progression|35|||
163170507|NCT01478048|589340962|FG000|Overall Study|study drug toxicity|11|||
163170508|NCT01478048|589340963|FG001|Overall Study|study drug toxicity|14|||
163170509|NCT01478048|589340962|FG000|Overall Study|Adverse Event|2|||
163170510|NCT01478048|589340963|FG001|Overall Study|Adverse Event|11|||
163170511|NCT01478048|589340962|FG000|Overall Study|subject request to discontinue treatment|3|||
163170512|NCT01478048|589340963|FG001|Overall Study|subject request to discontinue treatment|5|||
163170513|NCT01478048|589340962|FG000|Overall Study|Withdrawal by Subject|2|||
163170514|NCT01478048|589340963|FG001|Overall Study|Withdrawal by Subject|5|||
163170515|NCT01478048|589340962|FG000|Overall Study|non-specified|6|||
163170516|NCT01478048|589340963|FG001|Overall Study|non-specified|4|||
163170517|NCT01478048|589340962|FG000|Overall Study|poor/non-compliance|0|||
163170518|NCT01478048|589340963|FG001|Overall Study|poor/non-compliance|1|||
163170519|NCT01478048|589340962|FG000|Overall Study|no longer meets study criteria|1|||
163170520|NCT01478048|589340963|FG001|Overall Study|no longer meets study criteria|0|||
163170521|NCT01369329|589340965|FG000|Overall Study|Withdrawal by Subject|8|||
163170522|NCT01369329|589340966|FG001|Overall Study|Withdrawal by Subject|6|||
163170523|NCT01369329|589340967|FG002|Overall Study|Withdrawal by Subject|10|||
163170524|NCT01369329|589340965|FG000|Overall Study|Lost to Follow-up|2|||
163170525|NCT01369329|589340966|FG001|Overall Study|Lost to Follow-up|2|||
163170526|NCT01369329|589340967|FG002|Overall Study|Lost to Follow-up|2|||
163170527|NCT01369329|589340965|FG000|Overall Study|Other|2|||
163170528|NCT01369329|589340966|FG001|Overall Study|Other|3|||
163170529|NCT01369329|589340967|FG002|Overall Study|Other|2|||
163170530|NCT03032380|589340968|FG000|Overall Study|Adverse Event|0|||
163170531|NCT03032380|589340969|FG001|Overall Study|Adverse Event|1|||
163170532|NCT03032380|589340968|FG000|Overall Study|Lack of Efficacy|1|||
163170533|NCT03032380|589340969|FG001|Overall Study|Lack of Efficacy|0|||
163170534|NCT03032380|589340968|FG000|Overall Study|Withdrawal by Subject|2|||
163170535|NCT03032380|589340969|FG001|Overall Study|Withdrawal by Subject|3|||
163170536|NCT03032380|589340968|FG000|Overall Study|Recovery|0|||
163170537|NCT03032380|589340969|FG001|Overall Study|Recovery|1|||
163170538|NCT03032380|589340968|FG000|Overall Study|Death|39|||
163170539|NCT03032380|589340969|FG001|Overall Study|Death|34|||
163170540|NCT03032380|589340968|FG000|Overall Study|Other - Miscellaneous|0|||
163170541|NCT03032380|589340969|FG001|Overall Study|Other - Miscellaneous|1|||
163170542|NCT02937584|589340970|FG000|Period 1|Adverse Event|1|||
163170543|NCT02937584|589340971|FG001|Period 1|Adverse Event|2|||
163170544|NCT02937584|589340970|FG000|Washout|Adverse Event|0|||
163170545|NCT02937584|589340971|FG001|Washout|Adverse Event|1|||
163170546|NCT01883453|589340972|FG000|Overall Study|No episode of common cold|25|||
163170547|NCT01883453|589340973|FG001|Overall Study|No episode of common cold|23|||
163170548|NCT02238080|589340974|FG000|Overall Study|Death|13|||
163170549|NCT02238080|589340974|FG000|Overall Study|Treatment interrupted|6|||
163170550|NCT02238080|589340974|FG000|Overall Study|Withdrawal by Subject|2|||
163170551|NCT02238080|589340974|FG000|Overall Study|Other|4|||
163170552|NCT00796445|589340975|FG000|Overall Study|Protocol Violation|5|||
163170553|NCT00796445|589340976|FG001|Overall Study|Protocol Violation|3|||
163170554|NCT00796445|589340975|FG000|Overall Study|Adverse event, serious fatal|10|||
163170555|NCT00796445|589340976|FG001|Overall Study|Adverse event, serious fatal|5|||
163170556|NCT00796445|589340975|FG000|Overall Study|Adverse event, non-fatal|4|||
163170557|NCT00796445|589340976|FG001|Overall Study|Adverse event, non-fatal|0|||
163170558|NCT00796445|589340975|FG000|Overall Study|Disease progression/recurrence|537|||
163170559|NCT00796445|589340976|FG001|Overall Study|Disease progression/recurrence|268|||
163170560|NCT00796445|589340975|FG000|Overall Study|Other|10|||
163170561|NCT00796445|589340976|FG001|Overall Study|Other|7|||
163170562|NCT00796445|589340975|FG000|Overall Study|Withdrawal by Subject|18|||
163170563|NCT00796445|589340976|FG001|Overall Study|Withdrawal by Subject|9|||
163170564|NCT00796445|589340975|FG000|Overall Study|Invalid Informed Consent Form|1|||
163170565|NCT00796445|589340976|FG001|Overall Study|Invalid Informed Consent Form|0|||
163170566|NCT01038869|589340977|FG000|Overall Study|Withdrawal by Subject|1|||
163170567|NCT01038869|589340977|FG000|Overall Study|Lost to Follow-up|6|||
163170568|NCT04136444|589340978|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
163170569|NCT04136444|589340979|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
163170570|NCT02238067|589340980|FG000|Overall Study|Not completed survey at Month 6|45|||
163170571|NCT02350764|589340982|FG000|Overall Study|Adverse Event|4|||
163170572|NCT02350764|589340982|FG000|Overall Study|Death|3|||
163170573|NCT02350764|589340982|FG000|Overall Study|Physician Decision|2|||
163170574|NCT02350764|589340982|FG000|Overall Study|Withdrawal by Subject|2|||
163170575|NCT01433289|589340983|FG000|Overall Study|Pregnancy|0|||
163170576|NCT01433289|589340984|FG001|Overall Study|Pregnancy|1|||
163170577|NCT01433289|589340985|FG002|Overall Study|Pregnancy|0|||
163170578|NCT01433289|589340986|FG003|Overall Study|Pregnancy|0|||
163170579|NCT00783198|589340991|FG000|Overall Study|Adverse Event|15|||
163170580|NCT00783198|589340992|FG001|Overall Study|Adverse Event|19|||
163170581|NCT00783198|589340993|FG002|Overall Study|Adverse Event|3|||
163170582|NCT00783198|589340991|FG000|Overall Study|Lost to Follow-up|11|||
163170583|NCT00783198|589340992|FG001|Overall Study|Lost to Follow-up|1|||
163170584|NCT00783198|589340993|FG002|Overall Study|Lost to Follow-up|7|||
163170585|NCT00783198|589340991|FG000|Overall Study|Withdrawal by Subject|22|||
163170586|NCT00783198|589340992|FG001|Overall Study|Withdrawal by Subject|14|||
163170587|NCT00783198|589340993|FG002|Overall Study|Withdrawal by Subject|20|||
163170588|NCT00783198|589340991|FG000|Overall Study|Noncompliance with protocol|7|||
163170589|NCT00783198|589340992|FG001|Overall Study|Noncompliance with protocol|7|||
163170590|NCT00783198|589340993|FG002|Overall Study|Noncompliance with protocol|10|||
163170591|NCT00783198|589340991|FG000|Overall Study|Did not meet protocol eligibility|0|||
163170592|NCT00783198|589340992|FG001|Overall Study|Did not meet protocol eligibility|1|||
163170593|NCT00783198|589340993|FG002|Overall Study|Did not meet protocol eligibility|0|||
163170594|NCT00783198|589340991|FG000|Overall Study|Administrative|2|||
163170595|NCT00783198|589340992|FG001|Overall Study|Administrative|1|||
163170596|NCT00783198|589340993|FG002|Overall Study|Administrative|2|||
163170597|NCT01546623|589340994|FG000|Overall Study|Adverse Event|2|||
163170598|NCT01546623|589340995|FG001|Overall Study|Adverse Event|3|||
163170599|NCT01546623|589340994|FG000|Overall Study|Major Protocol Deviation|1|||
163170600|NCT01546623|589340995|FG001|Overall Study|Major Protocol Deviation|1|||
163170601|NCT01546623|589340994|FG000|Overall Study|High Prostate specific antigen|2|||
163277661|NCT01094743|589726711|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
163170602|NCT01546623|589340995|FG001|Overall Study|High Prostate specific antigen|1|||
163170603|NCT01546623|589340994|FG000|Overall Study|Did Not Receive Study Drug|1|||
163170604|NCT01546623|589340995|FG001|Overall Study|Did Not Receive Study Drug|1|||
163170605|NCT01134705|589340996|FG000|Overall Study|Adverse Event|1|||
163277662|NCT02851511|589726712|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
163277663|NCT02851511|589726713|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
163170606|NCT01134705|589340997|FG001|Overall Study|Adverse Event|7|||
163170607|NCT01134705|589340996|FG000|Overall Study|Withdrawal by Subject|6|||
163170608|NCT01134705|589340997|FG001|Overall Study|Withdrawal by Subject|6|||
163277664|NCT02851511|589726714|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
163277665|NCT02851511|589726715|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
163277666|NCT02851511|589726712|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
163277667|NCT02851511|589726713|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
163277668|NCT02851511|589726714|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
163277669|NCT02851511|589726715|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
163277670|NCT02851511|589726712|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
163277671|NCT02851511|589726713|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
163277672|NCT02851511|589726714|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
163277673|NCT02851511|589726715|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
163277674|NCT02851511|589726712|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
163277675|NCT02851511|589726713|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
163277676|NCT02851511|589726714|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
163277677|NCT02851511|589726715|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
163277678|NCT02851511|589726712|FG000|Phase I|Physician Decision|0|||
163277679|NCT02851511|589726713|FG001|Phase I|Physician Decision|0|||
163277680|NCT02851511|589726714|FG002|Phase I|Physician Decision|0|||
163277681|NCT02851511|589726715|FG003|Phase I|Physician Decision|1|||
163277682|NCT02851511|589726712|FG000|Phase I|Withdrawal by Subject|2|||
163277683|NCT02851511|589726713|FG001|Phase I|Withdrawal by Subject|1|||
163277684|NCT02851511|589726714|FG002|Phase I|Withdrawal by Subject|0|||
163277685|NCT02851511|589726715|FG003|Phase I|Withdrawal by Subject|3|||
163277686|NCT02851511|589726712|FG000|Phase II|Physician Decision|18|||
163277687|NCT02851511|589726713|FG001|Phase II|Physician Decision|16|||
163277688|NCT02851511|589726714|FG002|Phase II|Physician Decision|0|||
163277689|NCT02851511|589726715|FG003|Phase II|Physician Decision|0|||
163277690|NCT02851511|589726712|FG000|Phase II|Withdrawal by Subject|18|||
163277691|NCT02851511|589726713|FG001|Phase II|Withdrawal by Subject|16|||
163277692|NCT02851511|589726714|FG002|Phase II|Withdrawal by Subject|0|||
163277693|NCT02851511|589726715|FG003|Phase II|Withdrawal by Subject|0|||
163277694|NCT02851511|589726712|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
163277695|NCT02851511|589726713|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
163277696|NCT02851511|589726714|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
163277697|NCT02851511|589726715|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
163277698|NCT02851511|589726712|FG000|Phase II|Lost to Follow-up|0|||
163277699|NCT02851511|589726713|FG001|Phase II|Lost to Follow-up|1|||
163277700|NCT02851511|589726714|FG002|Phase II|Lost to Follow-up|0|||
163277701|NCT02851511|589726715|FG003|Phase II|Lost to Follow-up|0|||
163277702|NCT04004208|589726718|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163277703|NCT04004208|589726719|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163170609|NCT01134705|589340996|FG000|Overall Study|Pregnancy|1|||
163170610|NCT01134705|589340997|FG001|Overall Study|Pregnancy|0|||
163170611|NCT01134705|589340996|FG000|Overall Study|Lost to Follow-up|5|||
163170612|NCT01134705|589340997|FG001|Overall Study|Lost to Follow-up|2|||
163170613|NCT01134705|589340996|FG000|Overall Study|Protocol Violation|1|||
163170614|NCT01134705|589340997|FG001|Overall Study|Protocol Violation|1|||
163170615|NCT01134705|589340996|FG000|Overall Study|Other|1|||
163170616|NCT01134705|589340997|FG001|Overall Study|Other|6|||
163170617|NCT00246740|589340998|FG000|Initial Enrollment|Death|1|||
163170618|NCT00246740|589340999|FG001|Initial Enrollment|Death|0|||
163277704|NCT04004208|589726718|FG000|Overall Study|Death|3|||
163170619|NCT00246740|589340998|FG000|Initial Enrollment|Additional surgery scheduled|0|||
163170620|NCT00246740|589340999|FG001|Initial Enrollment|Additional surgery scheduled|2|||
163170621|NCT00246740|589340998|FG000|Initial Enrollment|Surgery schedule change|4|||
163170622|NCT00246740|589340999|FG001|Initial Enrollment|Surgery schedule change|4|||
163170623|NCT00246740|589340998|FG000|Initial Enrollment|Other|1|||
163170624|NCT00246740|589340999|FG001|Initial Enrollment|Other|2|||
163170625|NCT00101452|589341000|FG000|Overall Study|Adverse Event|2|||
163170626|NCT00101452|589341001|FG001|Overall Study|Adverse Event|0|||
163170627|NCT00101452|589341002|FG002|Overall Study|Adverse Event|1|||
163170628|NCT00101452|589341000|FG000|Overall Study|Lost to Follow-up|13|||
163170629|NCT00101452|589341001|FG001|Overall Study|Lost to Follow-up|8|||
163170630|NCT00101452|589341002|FG002|Overall Study|Lost to Follow-up|14|||
163170631|NCT00101452|589341000|FG000|Overall Study|Withdrawal by Subject|10|||
163170632|NCT00101452|589341001|FG001|Overall Study|Withdrawal by Subject|14|||
163170633|NCT00101452|589341002|FG002|Overall Study|Withdrawal by Subject|9|||
163170634|NCT00101452|589341000|FG000|Overall Study|Baseline Fail|2|||
163170635|NCT00101452|589341001|FG001|Overall Study|Baseline Fail|1|||
163170636|NCT00101452|589341002|FG002|Overall Study|Baseline Fail|2|||
163170637|NCT00101452|589341000|FG000|Overall Study|Physician Decision|0|||
163170638|NCT00101452|589341001|FG001|Overall Study|Physician Decision|3|||
163170639|NCT00101452|589341002|FG002|Overall Study|Physician Decision|2|||
163170640|NCT00101452|589341000|FG000|Overall Study|Protocol Violation|2|||
163170641|NCT00101452|589341001|FG001|Overall Study|Protocol Violation|1|||
163170642|NCT00101452|589341002|FG002|Overall Study|Protocol Violation|3|||
163170643|NCT00101452|589341000|FG000|Overall Study|Other|15|||
163170644|NCT00101452|589341001|FG001|Overall Study|Other|16|||
163170645|NCT00101452|589341002|FG002|Overall Study|Other|12|||
163170646|NCT01510769|589341003|FG000|Overall Study|Adverse Event|7|||
163170647|NCT01510769|589341004|FG001|Overall Study|Adverse Event|6|||
163170648|NCT01510769|589341005|FG002|Overall Study|Adverse Event|4|||
163170649|NCT01510769|589341003|FG000|Overall Study|Gout Flare|0|||
163170650|NCT01510769|589341004|FG001|Overall Study|Gout Flare|3|||
163170651|NCT01510769|589341005|FG002|Overall Study|Gout Flare|1|||
163170652|NCT01510769|589341003|FG000|Overall Study|Protocol Violation|11|||
163170653|NCT01510769|589341004|FG001|Overall Study|Protocol Violation|10|||
163170654|NCT01510769|589341005|FG002|Overall Study|Protocol Violation|9|||
163170655|NCT01510769|589341003|FG000|Overall Study|Lost to Follow-up|5|||
163170656|NCT01510769|589341004|FG001|Overall Study|Lost to Follow-up|1|||
163170657|NCT01510769|589341005|FG002|Overall Study|Lost to Follow-up|5|||
163170658|NCT01510769|589341003|FG000|Overall Study|Withdrawal by Subject|3|||
163170659|NCT01510769|589341004|FG001|Overall Study|Withdrawal by Subject|4|||
163170660|NCT01510769|589341005|FG002|Overall Study|Withdrawal by Subject|3|||
163170661|NCT01510769|589341003|FG000|Overall Study|Death|1|||
163170662|NCT01510769|589341004|FG001|Overall Study|Death|1|||
163170663|NCT01510769|589341005|FG002|Overall Study|Death|0|||
163170664|NCT02674204|589341006|FG000|Overall Study|Adverse Event|1|||
163170665|NCT02674204|589341007|FG001|Overall Study|Adverse Event|0|||
163170666|NCT02466659|589341010|FG000|Overall Study|Lost to Follow-up|5|||
163170667|NCT02466659|589341011|FG001|Overall Study|Lost to Follow-up|2|||
163170668|NCT01536392|589341012|FG000|Overall Study|Adverse Event|2|||
163170669|NCT01536392|589341013|FG001|Overall Study|Adverse Event|2|||
163170670|NCT01536392|589341012|FG000|Overall Study|Physician Decision|2|||
163170671|NCT01536392|589341013|FG001|Overall Study|Physician Decision|3|||
163170672|NCT01536392|589341012|FG000|Overall Study|Withdrawal by Subject|3|||
163170673|NCT01536392|589341013|FG001|Overall Study|Withdrawal by Subject|6|||
163170674|NCT01536392|589341012|FG000|Overall Study|Non Compliance|3|||
163170675|NCT01536392|589341013|FG001|Overall Study|Non Compliance|4|||
163170676|NCT01536392|589341012|FG000|Overall Study|Completed therapy early|3|||
163170677|NCT01536392|589341013|FG001|Overall Study|Completed therapy early|0|||
163170678|NCT02874144|589341014|FG000|Overall Study|Lost to Follow-up|3|||
163170679|NCT02874144|589341015|FG001|Overall Study|Lost to Follow-up|5|||
163170680|NCT00486811|589341018|FG000|Overall Study|Adverse Event|28|||
163170681|NCT00486811|589341019|FG001|Overall Study|Adverse Event|60|||
163170682|NCT00486811|589341020|FG002|Overall Study|Adverse Event|135|||
163170683|NCT00486811|589341018|FG000|Overall Study|Lack of Efficacy|34|||
163170684|NCT00486811|589341019|FG001|Overall Study|Lack of Efficacy|14|||
163170685|NCT00486811|589341020|FG002|Overall Study|Lack of Efficacy|7|||
163170686|NCT00486811|589341018|FG000|Overall Study|Lost to Follow-up|4|||
163170687|NCT00486811|589341019|FG001|Overall Study|Lost to Follow-up|6|||
163170688|NCT00486811|589341020|FG002|Overall Study|Lost to Follow-up|4|||
163170689|NCT00486811|589341018|FG000|Overall Study|Withdrawal by Subject|33|||
163170690|NCT00486811|589341019|FG001|Overall Study|Withdrawal by Subject|44|||
163170691|NCT00486811|589341020|FG002|Overall Study|Withdrawal by Subject|58|||
163170692|NCT00486811|589341018|FG000|Overall Study|Study drug non-compliant|5|||
163170693|NCT00486811|589341019|FG001|Overall Study|Study drug non-compliant|6|||
163170694|NCT00486811|589341020|FG002|Overall Study|Study drug non-compliant|3|||
163170695|NCT00486811|589341018|FG000|Overall Study|All other|18|||
163170696|NCT00486811|589341019|FG001|Overall Study|All other|11|||
163170697|NCT00486811|589341020|FG002|Overall Study|All other|7|||
163170698|NCT04525885|589341024|FG000|Overall Study|Screen Failure|1|||
163170699|NCT04525885|589341025|FG001|Overall Study|Screen Failure|0|||
163170700|NCT04525885|589341026|FG002|Overall Study|Screen Failure|0|||
163170701|NCT04525885|589341024|FG000|Overall Study|Withdrawal by Subject|14|||
163170702|NCT04525885|589341025|FG001|Overall Study|Withdrawal by Subject|6|||
163170703|NCT04525885|589341026|FG002|Overall Study|Withdrawal by Subject|20|||
163170704|NCT04525885|589341024|FG000|Overall Study|Physician Decision|1|||
163170705|NCT04525885|589341025|FG001|Overall Study|Physician Decision|0|||
163170706|NCT04525885|589341026|FG002|Overall Study|Physician Decision|1|||
163170707|NCT02756806|589341027|FG000|Overall Study|Study terminated early|5|||
163170708|NCT03158285|589341028|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
163170709|NCT03158285|589341029|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
163170710|NCT03158285|589341030|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
163170711|NCT03158285|589341028|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
163170712|NCT03158285|589341029|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
163170713|NCT03158285|589341030|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
163170714|NCT03158285|589341028|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
163170715|NCT03158285|589341029|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
163170716|NCT03158285|589341030|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
163170717|NCT03158285|589341028|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
163170718|NCT03158285|589341029|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
163170719|NCT03158285|589341030|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
163170720|NCT03158285|589341028|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
163170721|NCT03158285|589341029|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
163170722|NCT03158285|589341030|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
163170723|NCT03158285|589341028|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
163170724|NCT03158285|589341029|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
163170725|NCT03158285|589341030|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
163170726|NCT03158285|589341028|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
163170727|NCT03158285|589341029|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
163170728|NCT03158285|589341030|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
163170729|NCT03158285|589341028|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
163170730|NCT03158285|589341029|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
163170731|NCT03158285|589341030|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
163170732|NCT03158285|589341028|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
163170733|NCT03158285|589341029|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
163170734|NCT03158285|589341030|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
163170735|NCT03158285|589341028|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
163170736|NCT03158285|589341029|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
163170737|NCT03158285|589341030|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
163170738|NCT03158285|589341028|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
163170739|NCT03158285|589341029|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
163170740|NCT03158285|589341030|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
163170741|NCT03158285|589341028|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
163170742|NCT03158285|589341029|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
163170743|NCT03158285|589341030|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
163170744|NCT03158285|589341028|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
163170745|NCT03158285|589341029|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
163170746|NCT03158285|589341030|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
163170747|NCT03158285|589341028|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
163170748|NCT03158285|589341029|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
163170749|NCT03158285|589341030|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
163170750|NCT03158285|589341028|FG000|Active Treatment Period: Week 52-100|Death|1|||
163170751|NCT03158285|589341029|FG001|Active Treatment Period: Week 52-100|Death|0|||
163170752|NCT03158285|589341030|FG002|Active Treatment Period: Week 52-100|Death|0|||
163170753|NCT03158285|589341028|FG000|Active Treatment Period: Week 52-100|Other|4|||
163170754|NCT03158285|589341029|FG001|Active Treatment Period: Week 52-100|Other|1|||
163170755|NCT03158285|589341030|FG002|Active Treatment Period: Week 52-100|Other|0|||
163170756|NCT02228980|589341033|FG000|Overall Study|Adverse Event|14|||
163170757|NCT02228980|589341034|FG001|Overall Study|Adverse Event|0|||
163170758|NCT02228980|589341035|FG002|Overall Study|Adverse Event|0|||
163170759|NCT02228980|589341036|FG003|Overall Study|Adverse Event|0|||
163170760|NCT02228980|589341033|FG000|Overall Study|Protocol Violation|7|||
163170761|NCT02228980|589341034|FG001|Overall Study|Protocol Violation|0|||
163170762|NCT02228980|589341035|FG002|Overall Study|Protocol Violation|0|||
163170763|NCT02228980|589341036|FG003|Overall Study|Protocol Violation|0|||
163170764|NCT02228980|589341033|FG000|Overall Study|Withdrawal by Subject|3|||
163170765|NCT02228980|589341034|FG001|Overall Study|Withdrawal by Subject|3|||
163170766|NCT02228980|589341035|FG002|Overall Study|Withdrawal by Subject|2|||
163170767|NCT02228980|589341036|FG003|Overall Study|Withdrawal by Subject|3|||
163170768|NCT00750152|589341037|FG000|Overall Study|Adverse Event|2|||
163170769|NCT00750152|589341038|FG001|Overall Study|Adverse Event|1|||
163170770|NCT00750152|589341037|FG000|Overall Study|Lost to Follow-up|8|||
163170771|NCT00750152|589341038|FG001|Overall Study|Lost to Follow-up|13|||
163170772|NCT00750152|589341037|FG000|Overall Study|Withdrawal by Subject|3|||
163170773|NCT00750152|589341038|FG001|Overall Study|Withdrawal by Subject|3|||
163170774|NCT00750152|589341037|FG000|Overall Study|Physician Decision|1|||
163170775|NCT00750152|589341038|FG001|Overall Study|Physician Decision|1|||
163170776|NCT00750152|589341037|FG000|Overall Study|Non-compliance|0|||
163170777|NCT00750152|589341038|FG001|Overall Study|Non-compliance|1|||
163170778|NCT00750152|589341037|FG000|Overall Study|Termination by sponsor|1|||
163170779|NCT00750152|589341038|FG001|Overall Study|Termination by sponsor|0|||
163170780|NCT00750152|589341037|FG000|Overall Study|Other|7|||
163170781|NCT00750152|589341038|FG001|Overall Study|Other|8|||
163277705|NCT04004208|589726719|FG001|Overall Study|Death|0|||
163277706|NCT04004208|589726718|FG000|Overall Study|COVID-19 pandemic|1|||
163277707|NCT04004208|589726719|FG001|Overall Study|COVID-19 pandemic|0|||
163277708|NCT04004208|589726718|FG000|Overall Study|Physician Decision|1|||
163277709|NCT04004208|589726719|FG001|Overall Study|Physician Decision|0|||
163277710|NCT04004208|589726718|FG000|Overall Study|Adverse Event|1|||
163277711|NCT04004208|589726719|FG001|Overall Study|Adverse Event|1|||
163277712|NCT02118714|589726733|FG000|Overall Study|Lost to Follow-up|2|||
163277713|NCT02118714|589726733|FG000|Overall Study|Protocol Violation|1|||
163277714|NCT03023332|589726737|FG000|Overall Study|Withdrawal by Subject|10|||
163277715|NCT03023332|589726738|FG001|Overall Study|Withdrawal by Subject|5|||
163277716|NCT03023332|589726739|FG002|Overall Study|Withdrawal by Subject|4|||
163170782|NCT01642615|589341039|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
163170783|NCT01642615|589341040|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
163170784|NCT01642615|589341041|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
163170785|NCT01642615|589341039|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
163277717|NCT03023332|589726740|FG003|Overall Study|Withdrawal by Subject|7|||
163277718|NCT03023332|589726737|FG000|Overall Study|Lost to Follow-up|13|||
163277719|NCT03023332|589726738|FG001|Overall Study|Lost to Follow-up|16|||
163277720|NCT03023332|589726739|FG002|Overall Study|Lost to Follow-up|8|||
163277721|NCT03023332|589726740|FG003|Overall Study|Lost to Follow-up|13|||
163170786|NCT01642615|589341040|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
163170787|NCT01642615|589341041|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
163170788|NCT01642615|589341039|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
163170789|NCT01642615|589341040|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
163170790|NCT01642615|589341041|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
163170791|NCT01642615|589341039|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
163170792|NCT01642615|589341040|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
163170793|NCT01642615|589341041|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
163170794|NCT01642615|589341039|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
163170795|NCT01642615|589341040|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
163170796|NCT01642615|589341041|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
163170797|NCT01642615|589341039|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
163170798|NCT01642615|589341040|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
163170799|NCT01642615|589341041|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
163170800|NCT01642615|589341039|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
163170801|NCT01642615|589341040|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
163170802|NCT01642615|589341041|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
163170803|NCT01642615|589341039|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
163170804|NCT01642615|589341040|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
163170805|NCT01642615|589341041|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
163170806|NCT01642615|589341039|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
163170807|NCT01642615|589341040|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
163170808|NCT01642615|589341041|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
163170809|NCT00978757|589341046|FG000|Overall Study|Physician Decision|1|||
163170810|NCT00978757|589341047|FG001|Overall Study|Physician Decision|3|||
163170811|NCT00402740|589341048|FG000|Overall Study|Withdrawal by Subject|18|||
163170812|NCT00402740|589341048|FG000|Overall Study|Death|50|||
163170813|NCT00402740|589341048|FG000|Overall Study|Lost to Follow-up|6|||
163170814|NCT00402740|589341048|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
163170815|NCT00402740|589341048|FG000|Overall Study|Subject disposition unknown.|1|||
163170816|NCT01028300|589341049|FG000|Overall Study|Study Terminated|4|||
163170817|NCT00715910|589341052|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
163170818|NCT00715910|589341053|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
163170819|NCT00715910|589341054|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
163277722|NCT03023332|589726737|FG000|Overall Study|Death|1|||
163277723|NCT03023332|589726738|FG001|Overall Study|Death|0|||
163277724|NCT03023332|589726739|FG002|Overall Study|Death|0|||
163277725|NCT03023332|589726740|FG003|Overall Study|Death|0|||
163277726|NCT02412761|589726741|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163277727|NCT02412761|589726742|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
163277728|NCT02412761|589726743|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
163277729|NCT02412761|589726744|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163277730|NCT02412761|589726745|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163277731|NCT02412761|589726746|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
163277732|NCT01627340|589726747|FG000|Overall Study|Adverse Event|1|||
163277733|NCT01627340|589726748|FG001|Overall Study|Adverse Event|0|||
163277734|NCT01627340|589726747|FG000|Overall Study|Lost to Follow-up|8|||
163277735|NCT01627340|589726748|FG001|Overall Study|Lost to Follow-up|4|||
163277736|NCT01627340|589726747|FG000|Overall Study|Pregnancy|1|||
163277737|NCT01627340|589726748|FG001|Overall Study|Pregnancy|0|||
163277738|NCT01627340|589726747|FG000|Overall Study|Withdrawal by Subject|2|||
163277739|NCT01627340|589726748|FG001|Overall Study|Withdrawal by Subject|0|||
163277740|NCT02013687|589726749|FG000|Overall Study|Lost to Follow-up|0|||
163277741|NCT02013687|589726750|FG001|Overall Study|Lost to Follow-up|0|||
163277742|NCT02013687|589726751|FG002|Overall Study|Lost to Follow-up|1|||
163277743|NCT02013687|589726752|FG003|Overall Study|Lost to Follow-up|0|||
163277744|NCT02013687|589726749|FG000|Overall Study|Protocol Violation|0|||
163277745|NCT02013687|589726750|FG001|Overall Study|Protocol Violation|0|||
163277746|NCT02013687|589726751|FG002|Overall Study|Protocol Violation|0|||
163277747|NCT02013687|589726752|FG003|Overall Study|Protocol Violation|1|||
163277748|NCT02013687|589726749|FG000|Overall Study|Withdrawal by Subject|0|||
163170820|NCT00715910|589341055|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
163170821|NCT00715910|589341056|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
163170822|NCT00715910|589341057|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
163277749|NCT02013687|589726750|FG001|Overall Study|Withdrawal by Subject|0|||
163277750|NCT02013687|589726751|FG002|Overall Study|Withdrawal by Subject|0|||
163170823|NCT00715910|589341052|FG000|Booster and ESFU Phase|Other|0|||
163170824|NCT00715910|589341053|FG001|Booster and ESFU Phase|Other|0|||
163277751|NCT02013687|589726752|FG003|Overall Study|Withdrawal by Subject|1|||
163277752|NCT02013687|589726749|FG000|Overall Study|Missed visits due to patient travel|0|||
163277753|NCT02013687|589726750|FG001|Overall Study|Missed visits due to patient travel|0|||
163277754|NCT02013687|589726751|FG002|Overall Study|Missed visits due to patient travel|1|||
163277755|NCT02013687|589726752|FG003|Overall Study|Missed visits due to patient travel|0|||
163277756|NCT01272011|589726753|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
163277757|NCT01272011|589726754|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
163277758|NCT01272011|589726755|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
163277759|NCT02240680|589726758|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
163277760|NCT02240680|589726759|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
163277761|NCT02240680|589726760|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
163277762|NCT02240680|589726761|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
163277763|NCT02240680|589726758|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
163277764|NCT02240680|589726759|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
163277765|NCT02240680|589726760|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
163277766|NCT02240680|589726761|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
163277767|NCT02240680|589726758|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
163277768|NCT02240680|589726759|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
163277769|NCT02240680|589726760|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
163277770|NCT02240680|589726761|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
163277771|NCT02240680|589726758|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
163277772|NCT02240680|589726759|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
163277773|NCT02240680|589726760|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
163277774|NCT02240680|589726761|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
163277775|NCT02240680|589726758|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
163277776|NCT02240680|589726759|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
163277777|NCT02240680|589726760|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
163277778|NCT02240680|589726761|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
163277779|NCT02240680|589726758|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
163277780|NCT02240680|589726759|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
163277781|NCT02240680|589726760|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
163277782|NCT02240680|589726761|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
163277783|NCT02240680|589726758|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
163277784|NCT02240680|589726759|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
163277785|NCT02240680|589726760|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
163277786|NCT02240680|589726761|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
163277787|NCT02240680|589726758|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
163277788|NCT02240680|589726759|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
163277789|NCT02240680|589726760|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
163277790|NCT02240680|589726761|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
163277791|NCT01657032|589726762|FG000|Overall Study|Lost to Follow-up|0|||
163277792|NCT01657032|589726763|FG001|Overall Study|Lost to Follow-up|7|||
163277793|NCT01782326|589726764|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
163277794|NCT01782326|589726765|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
163277795|NCT01782326|589726764|FG000|Planned Treatment Epoch|Death|29|||
163277796|NCT01782326|589726765|FG001|Planned Treatment Epoch|Death|30|||
163277797|NCT01782326|589726764|FG000|Planned Treatment Epoch|Physician Decision|18|||
163277798|NCT01782326|589726765|FG001|Planned Treatment Epoch|Physician Decision|16|||
163277799|NCT01782326|589726764|FG000|Planned Treatment Epoch|Protocol deviation|2|||
163277800|NCT01782326|589726765|FG001|Planned Treatment Epoch|Protocol deviation|3|||
163277801|NCT01782326|589726764|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
163277802|NCT01782326|589726765|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
163277803|NCT01782326|589726764|FG000|Planned Treatment Epoch|Technical problems|0|||
163277804|NCT01782326|589726765|FG001|Planned Treatment Epoch|Technical problems|4|||
163277805|NCT01782326|589726764|FG000|Double-blind Treatment|Adverse Event|129|||
163277806|NCT01782326|589726765|FG001|Double-blind Treatment|Adverse Event|145|||
163277807|NCT01782326|589726764|FG000|Double-blind Treatment|Subject/guardian decision|111|||
163277808|NCT01782326|589726765|FG001|Double-blind Treatment|Subject/guardian decision|125|||
163277809|NCT01782326|589726764|FG000|Double-blind Treatment|Lack of Efficacy|17|||
163277810|NCT01782326|589726765|FG001|Double-blind Treatment|Lack of Efficacy|22|||
163277811|NCT01782326|589726764|FG000|Double-blind Treatment|Physician Decision|13|||
163277812|NCT01782326|589726765|FG001|Double-blind Treatment|Physician Decision|16|||
163277813|NCT01782326|589726764|FG000|Double-blind Treatment|Protocol deviation|8|||
163277814|NCT01782326|589726765|FG001|Double-blind Treatment|Protocol deviation|7|||
163277815|NCT01782326|589726764|FG000|Double-blind Treatment|Technical problems|0|||
163277816|NCT01782326|589726765|FG001|Double-blind Treatment|Technical problems|5|||
163277817|NCT05968482|589726766|FG000|First Crossover Period|Withdrawal by Subject|0|||
163277818|NCT05968482|589726767|FG001|First Crossover Period|Withdrawal by Subject|0|||
163277819|NCT05968482|589726768|FG002|First Crossover Period|Withdrawal by Subject|1|||
163277820|NCT05968482|589726769|FG003|First Crossover Period|Withdrawal by Subject|0|||
163277821|NCT05968482|589726770|FG004|First Crossover Period|Withdrawal by Subject|0|||
163277822|NCT05968482|589726771|FG005|First Crossover Period|Withdrawal by Subject|0|||
163277823|NCT05968482|589726766|FG000|First Crossover Period|Adverse Event|0|||
163277824|NCT05968482|589726767|FG001|First Crossover Period|Adverse Event|0|||
163277825|NCT05968482|589726768|FG002|First Crossover Period|Adverse Event|0|||
163277826|NCT05968482|589726769|FG003|First Crossover Period|Adverse Event|0|||
163277827|NCT05968482|589726770|FG004|First Crossover Period|Adverse Event|0|||
163277828|NCT05968482|589726771|FG005|First Crossover Period|Adverse Event|1|||
163277829|NCT05968482|589726766|FG000|Second Crossover Period|Withdrawal by Subject|0|||
163277830|NCT05968482|589726767|FG001|Second Crossover Period|Withdrawal by Subject|0|||
163277831|NCT05968482|589726768|FG002|Second Crossover Period|Withdrawal by Subject|0|||
163277832|NCT05968482|589726769|FG003|Second Crossover Period|Withdrawal by Subject|0|||
163277833|NCT05968482|589726770|FG004|Second Crossover Period|Withdrawal by Subject|1|||
163277834|NCT05968482|589726771|FG005|Second Crossover Period|Withdrawal by Subject|0|||
163277835|NCT05968482|589726766|FG000|Third Crossover Period|Adverse Event|0|||
163277836|NCT05968482|589726767|FG001|Third Crossover Period|Adverse Event|0|||
163277837|NCT05968482|589726768|FG002|Third Crossover Period|Adverse Event|0|||
163277838|NCT05968482|589726769|FG003|Third Crossover Period|Adverse Event|0|||
163277839|NCT05968482|589726770|FG004|Third Crossover Period|Adverse Event|1|||
163277840|NCT05968482|589726771|FG005|Third Crossover Period|Adverse Event|0|||
163277841|NCT05968482|589726766|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
163277842|NCT05968482|589726767|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
163277843|NCT05968482|589726768|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
163277844|NCT05968482|589726769|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
163277845|NCT05968482|589726770|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
163277846|NCT05968482|589726771|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
163277847|NCT02559817|589726772|FG000|Treatment Period|Adverse Event|1|||
163277848|NCT02559817|589726773|FG001|Treatment Period|Adverse Event|0|||
163277849|NCT02559817|589726774|FG002|Treatment Period|Adverse Event|1|||
163277850|NCT02559817|589726775|FG003|Treatment Period|Adverse Event|0|||
163277851|NCT02559817|589726776|FG004|Treatment Period|Adverse Event|0|||
163277852|NCT02559817|589726772|FG000|Treatment Period|Lack of Efficacy|0|||
163277853|NCT02559817|589726773|FG001|Treatment Period|Lack of Efficacy|1|||
163277854|NCT02559817|589726774|FG002|Treatment Period|Lack of Efficacy|0|||
163277855|NCT02559817|589726775|FG003|Treatment Period|Lack of Efficacy|0|||
163277856|NCT02559817|589726776|FG004|Treatment Period|Lack of Efficacy|0|||
163277857|NCT02559817|589726772|FG000|Treatment Period|Lost to Follow-up|0|||
163277858|NCT02559817|589726773|FG001|Treatment Period|Lost to Follow-up|1|||
163277859|NCT02559817|589726774|FG002|Treatment Period|Lost to Follow-up|0|||
163277860|NCT02559817|589726775|FG003|Treatment Period|Lost to Follow-up|1|||
163277861|NCT02559817|589726776|FG004|Treatment Period|Lost to Follow-up|0|||
163277862|NCT02559817|589726772|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
163277863|NCT02559817|589726773|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
163277864|NCT02559817|589726774|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
163277865|NCT02559817|589726775|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
163277866|NCT02559817|589726776|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
163277867|NCT02559817|589726772|FG000|Treatment Period|Protocol Violation|0|||
163277868|NCT02559817|589726773|FG001|Treatment Period|Protocol Violation|0|||
163277869|NCT02559817|589726774|FG002|Treatment Period|Protocol Violation|0|||
163277870|NCT02559817|589726775|FG003|Treatment Period|Protocol Violation|1|||
163277871|NCT02559817|589726776|FG004|Treatment Period|Protocol Violation|0|||
163277872|NCT02687919|589726777|FG000|Overall Study|Withdrawal by Subject|6|||
163277873|NCT02687919|589726778|FG001|Overall Study|Withdrawal by Subject|6|||
163277874|NCT02687919|589726777|FG000|Overall Study|Protocol Violation|2|||
163277875|NCT02687919|589726778|FG001|Overall Study|Protocol Violation|0|||
163277876|NCT00419003|589726779|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
163277877|NCT00419003|589726780|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
163277878|NCT00419003|589726779|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
163277879|NCT00419003|589726780|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
163277880|NCT01653847|589726781|FG000|Overall Study|Withdrawal by Subject|1|||
163277881|NCT01653847|589726782|FG001|Overall Study|Withdrawal by Subject|0|||
163277882|NCT02554513|589726783|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
163277883|NCT02554513|589726784|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
163277884|NCT02303574|589726785|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163277885|NCT02303574|589726786|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163277886|NCT02303574|589726787|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
163277887|NCT02303574|589726788|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163277888|NCT02303574|589726789|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163277889|NCT02303574|589726790|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163277890|NCT02303574|589726791|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163277891|NCT02303574|589726792|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163277892|NCT02303574|589726793|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163277893|NCT02303574|589726794|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163277894|NCT02303574|589726785|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163277895|NCT02303574|589726786|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163170825|NCT00715910|589341054|FG002|Booster and ESFU Phase|Other|0|||
163170826|NCT00715910|589341055|FG003|Booster and ESFU Phase|Other|5|||
163170827|NCT00715910|589341056|FG004|Booster and ESFU Phase|Other|1|||
163170828|NCT00715910|589341057|FG005|Booster and ESFU Phase|Other|0|||
163170829|NCT00946153|589341058|FG000|Phase 2|Adverse Event|0|||
163170830|NCT00946153|589341059|FG001|Phase 2|Adverse Event|0|||
163170831|NCT00946153|589341060|FG002|Phase 2|Adverse Event|0|||
163170832|NCT00946153|589341061|FG003|Phase 2|Adverse Event|0|||
163170833|NCT00946153|589341062|FG004|Phase 2|Adverse Event|6|||
163170834|NCT00946153|589341058|FG000|Phase 2|Need more reduction of dose|0|||
163170835|NCT00946153|589341059|FG001|Phase 2|Need more reduction of dose|0|||
163170836|NCT00946153|589341060|FG002|Phase 2|Need more reduction of dose|0|||
163170837|NCT00946153|589341061|FG003|Phase 2|Need more reduction of dose|0|||
163170838|NCT00946153|589341062|FG004|Phase 2|Need more reduction of dose|2|||
163170839|NCT00946153|589341058|FG000|Phase 2|Physician Decision|0|||
163170840|NCT00946153|589341059|FG001|Phase 2|Physician Decision|0|||
163170841|NCT00946153|589341060|FG002|Phase 2|Physician Decision|0|||
163170842|NCT00946153|589341061|FG003|Phase 2|Physician Decision|0|||
163170843|NCT00946153|589341062|FG004|Phase 2|Physician Decision|1|||
163170844|NCT00946153|589341058|FG000|Phase 2|14 days washout for recovery due to AE|0|||
163170845|NCT00946153|589341059|FG001|Phase 2|14 days washout for recovery due to AE|0|||
163170846|NCT00946153|589341060|FG002|Phase 2|14 days washout for recovery due to AE|0|||
163170847|NCT00946153|589341061|FG003|Phase 2|14 days washout for recovery due to AE|0|||
163170848|NCT00946153|589341062|FG004|Phase 2|14 days washout for recovery due to AE|4|||
163170849|NCT01030666|589341063|FG000|Overall Study|Lost to Follow-up|3|||
163170850|NCT01030666|589341064|FG001|Overall Study|Lost to Follow-up|2|||
163170851|NCT01144299|589341065|FG000|Overall Study|Lost to Follow-up|1|||
163170852|NCT01144299|589341066|FG001|Overall Study|Lost to Follow-up|0|||
163170853|NCT01144299|589341065|FG000|Overall Study|Withdrawal by Subject|1|||
163170854|NCT01144299|589341066|FG001|Overall Study|Withdrawal by Subject|0|||
163170855|NCT04002908|589341075|FG000|Overall Study|Death|41|||
163170856|NCT04002908|589341076|FG001|Overall Study|Death|0|||
163170857|NCT04002908|589341077|FG002|Overall Study|Death|0|||
163170858|NCT04002908|589341078|FG003|Overall Study|Death|0|||
163277896|NCT02303574|589726787|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163277897|NCT02303574|589726788|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163277898|NCT02303574|589726789|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163277899|NCT02303574|589726790|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163277900|NCT02303574|589726791|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163277901|NCT02303574|589726792|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
163277902|NCT02303574|589726793|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163277903|NCT02303574|589726794|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163170859|NCT04002908|589341075|FG000|Overall Study|Withdrawal by Subject|112|||
163170860|NCT04002908|589341076|FG001|Overall Study|Withdrawal by Subject|0|||
163170861|NCT04002908|589341077|FG002|Overall Study|Withdrawal by Subject|0|||
163170862|NCT04002908|589341078|FG003|Overall Study|Withdrawal by Subject|0|||
163170863|NCT04002908|589341075|FG000|Overall Study|Lost to Follow-up|72|||
163170864|NCT04002908|589341076|FG001|Overall Study|Lost to Follow-up|0|||
163170865|NCT04002908|589341077|FG002|Overall Study|Lost to Follow-up|0|||
163170866|NCT04002908|589341078|FG003|Overall Study|Lost to Follow-up|0|||
163170867|NCT04002908|589341075|FG000|Overall Study|Infant died, so mother withdrawn|34|||
163170868|NCT04002908|589341076|FG001|Overall Study|Infant died, so mother withdrawn|0|||
163170869|NCT04002908|589341077|FG002|Overall Study|Infant died, so mother withdrawn|0|||
163277904|NCT00859014|589726799|FG000|Overall Study|Death|4|||
163170870|NCT04002908|589341078|FG003|Overall Study|Infant died, so mother withdrawn|0|||
163170871|NCT04359901|589341083|FG000|Overall Study|Withdrawal by Subject|0|||
163170872|NCT04359901|589341084|FG001|Overall Study|Withdrawal by Subject|1|||
163170873|NCT04359901|589341083|FG000|Overall Study|Death|6|||
163170874|NCT04359901|589341084|FG001|Overall Study|Death|2|||
163170875|NCT00557856|589341085|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
163170876|NCT00557856|589341086|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
163170877|NCT00557856|589341087|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
163170878|NCT00557856|589341088|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
163170879|NCT00557856|589341089|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
163170880|NCT00557856|589341090|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
163170881|NCT00557856|589341091|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
163170882|NCT00557856|589341092|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
163170883|NCT00557856|589341093|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
163170884|NCT00557856|589341085|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
163170885|NCT00557856|589341086|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
163170886|NCT00557856|589341087|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
163170887|NCT00557856|589341088|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
163170888|NCT00557856|589341089|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
163170889|NCT00557856|589341090|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
163170890|NCT00557856|589341091|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
163170891|NCT00557856|589341092|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
163170892|NCT00557856|589341093|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
163170893|NCT00557856|589341085|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
163170894|NCT00557856|589341086|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
163170895|NCT00557856|589341087|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
163170896|NCT00557856|589341088|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
163170897|NCT00557856|589341089|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
163170898|NCT00557856|589341090|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
163170899|NCT00557856|589341091|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
163170900|NCT00557856|589341092|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
163170901|NCT00557856|589341093|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
163170902|NCT00557856|589341085|FG000|Part 1: Dose Escalation Phase|Other|0|||
163170903|NCT00557856|589341086|FG001|Part 1: Dose Escalation Phase|Other|0|||
163170904|NCT00557856|589341087|FG002|Part 1: Dose Escalation Phase|Other|1|||
163170905|NCT00557856|589341088|FG003|Part 1: Dose Escalation Phase|Other|1|||
163170906|NCT00557856|589341089|FG004|Part 1: Dose Escalation Phase|Other|0|||
163170907|NCT00557856|589341090|FG005|Part 1: Dose Escalation Phase|Other|0|||
163170908|NCT00557856|589341091|FG006|Part 1: Dose Escalation Phase|Other|0|||
163170909|NCT00557856|589341092|FG007|Part 1: Dose Escalation Phase|Other|1|||
163170910|NCT00557856|589341093|FG008|Part 1: Dose Escalation Phase|Other|0|||
163170911|NCT00557856|589341085|FG000|Part 1: Dose Escalation Phase|Death|0|||
163277905|NCT00859014|589726799|FG000|Overall Study|Lost to Follow-up|1|||
163170912|NCT00557856|589341086|FG001|Part 1: Dose Escalation Phase|Death|0|||
163170913|NCT00557856|589341087|FG002|Part 1: Dose Escalation Phase|Death|0|||
163170914|NCT00557856|589341088|FG003|Part 1: Dose Escalation Phase|Death|0|||
163170915|NCT00557856|589341089|FG004|Part 1: Dose Escalation Phase|Death|0|||
163170916|NCT00557856|589341090|FG005|Part 1: Dose Escalation Phase|Death|1|||
163170917|NCT00557856|589341091|FG006|Part 1: Dose Escalation Phase|Death|0|||
163170918|NCT00557856|589341092|FG007|Part 1: Dose Escalation Phase|Death|0|||
163170919|NCT00557856|589341093|FG008|Part 1: Dose Escalation Phase|Death|0|||
163170920|NCT00557856|589341085|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
163170921|NCT00557856|589341086|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
163170922|NCT00557856|589341087|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
163170923|NCT00557856|589341088|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
163170924|NCT00557856|589341089|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
163170925|NCT00557856|589341090|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
163170926|NCT00557856|589341091|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
163170927|NCT00557856|589341092|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
163170928|NCT00557856|589341093|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
163170929|NCT00557856|589341085|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
163170930|NCT00557856|589341086|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170931|NCT00557856|589341087|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170932|NCT00557856|589341088|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170933|NCT00557856|589341089|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170934|NCT00557856|589341090|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170935|NCT00557856|589341091|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170936|NCT00557856|589341092|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170937|NCT00557856|589341093|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170938|NCT00557856|589341085|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170939|NCT00557856|589341086|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170940|NCT00557856|589341087|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170941|NCT00557856|589341088|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170942|NCT00557856|589341089|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170943|NCT00557856|589341090|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170944|NCT00557856|589341091|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170945|NCT00557856|589341092|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170946|NCT00557856|589341093|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
163170947|NCT00557856|589341085|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170948|NCT00557856|589341086|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170949|NCT00557856|589341087|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170950|NCT00557856|589341088|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170951|NCT00557856|589341089|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170952|NCT00557856|589341090|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170953|NCT00557856|589341091|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170954|NCT00557856|589341092|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170955|NCT00557856|589341093|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
163170956|NCT00557856|589341085|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
163170957|NCT00557856|589341086|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
163170958|NCT00557856|589341087|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
163170959|NCT00557856|589341088|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
163170960|NCT00557856|589341089|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
163170961|NCT00557856|589341090|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
163170962|NCT00557856|589341091|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
163170963|NCT00557856|589341092|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
163170964|NCT00557856|589341093|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
163170965|NCT00557856|589341085|FG000|Part 2: Exploratory Phase|Other|0|||
163170966|NCT00557856|589341086|FG001|Part 2: Exploratory Phase|Other|0|||
163170967|NCT00557856|589341087|FG002|Part 2: Exploratory Phase|Other|0|||
163170968|NCT00557856|589341088|FG003|Part 2: Exploratory Phase|Other|0|||
163170969|NCT00557856|589341089|FG004|Part 2: Exploratory Phase|Other|0|||
163170970|NCT00557856|589341090|FG005|Part 2: Exploratory Phase|Other|0|||
163170971|NCT00557856|589341091|FG006|Part 2: Exploratory Phase|Other|0|||
163170972|NCT00557856|589341092|FG007|Part 2: Exploratory Phase|Other|0|||
163170973|NCT00557856|589341093|FG008|Part 2: Exploratory Phase|Other|1|||
163170974|NCT00557856|589341085|FG000|Part 2: Exploratory Phase|Death|0|||
163170975|NCT00557856|589341086|FG001|Part 2: Exploratory Phase|Death|0|||
163170976|NCT00557856|589341087|FG002|Part 2: Exploratory Phase|Death|0|||
163170977|NCT00557856|589341088|FG003|Part 2: Exploratory Phase|Death|0|||
163170978|NCT00557856|589341089|FG004|Part 2: Exploratory Phase|Death|0|||
163170979|NCT00557856|589341090|FG005|Part 2: Exploratory Phase|Death|0|||
163170980|NCT00557856|589341091|FG006|Part 2: Exploratory Phase|Death|0|||
163170981|NCT00557856|589341092|FG007|Part 2: Exploratory Phase|Death|0|||
163170982|NCT00557856|589341093|FG008|Part 2: Exploratory Phase|Death|2|||
163170983|NCT00557856|589341085|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170984|NCT00557856|589341086|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170985|NCT00557856|589341087|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170986|NCT00557856|589341088|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170987|NCT00557856|589341089|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170988|NCT00557856|589341090|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170989|NCT00557856|589341091|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170990|NCT00557856|589341092|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170991|NCT00557856|589341093|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
163170992|NCT05601544|589341094|FG000|Phase 2 Period 1|Adverse Event|0|||
163170993|NCT05601544|589341095|FG001|Phase 2 Period 1|Adverse Event|1|||
163170994|NCT05601544|589341096|FG002|Phase 2 Period 1|Adverse Event|0|||
163170995|NCT05601544|589341097|FG003|Phase 2 Period 1|Adverse Event|0|||
163170996|NCT05601544|589341098|FG004|Phase 2 Period 1|Adverse Event|0|||
163170997|NCT05601544|589341099|FG005|Phase 2 Period 1|Adverse Event|0|||
163170998|NCT02537015|589341106|FG000|Overall Study|Adverse Event|3|||
163170999|NCT02537015|589341106|FG000|Overall Study|Withdrawal by Subject|2|||
163171000|NCT02537015|589341106|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163171001|NCT02626624|589341114|FG000|Overall Study|Adverse Event|1|||
163171002|NCT02626624|589341114|FG000|Overall Study|Lost to Follow-up|3|||
163171003|NCT02626624|589341114|FG000|Overall Study|Protocol Violation|4|||
163171004|NCT02626624|589341114|FG000|Overall Study|Death|2|||
163171005|NCT02043899|589342271|FG000|Overall Study|Adverse Event|3|||
163171006|NCT02043899|589342271|FG000|Overall Study|Physician Decision|1|||
163171007|NCT02043899|589342271|FG000|Overall Study|Withdrawal by Subject|2|||
163171008|NCT02043899|589342271|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
163171009|NCT02043899|589342271|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
163171010|NCT02043899|589342271|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
163171011|NCT02043899|589342271|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
163171012|NCT02043899|589342271|FG000|Overall Study|Treatment delayed|1|||
163171013|NCT01659554|589342275|FG000|Overall Study|Study Termination|4|||
163171014|NCT03699475|589342276|FG000|Overall Study|Death|1|||
163171015|NCT00701662|589342279|FG000|Overall Study|Lack of Efficacy|1|||
163171016|NCT02267317|589342282|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
163171017|NCT02267317|589342283|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
163171018|NCT02267317|589342284|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
163171019|NCT02267317|589342285|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
163171020|NCT02267317|589342286|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
163171021|NCT02267317|589342287|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
163277906|NCT04796935|589726800|FG000|Overall Study|Withdrawal by Subject|0|||
163277907|NCT04796935|589726801|FG001|Overall Study|Withdrawal by Subject|1|||
163277908|NCT04796935|589726800|FG000|Overall Study|Physician Decision|0|||
163277909|NCT04796935|589726801|FG001|Overall Study|Physician Decision|1|||
163277910|NCT04796935|589726800|FG000|Overall Study|Device not available|1|||
163277911|NCT04796935|589726801|FG001|Overall Study|Device not available|0|||
163277912|NCT04796935|589726800|FG000|Overall Study|Trained provider not available|1|||
163277913|NCT04796935|589726801|FG001|Overall Study|Trained provider not available|0|||
163277914|NCT00052962|589726802|FG000|Overall Study|Not evaluable|0|||
163277915|NCT00052962|589726803|FG001|Overall Study|Not evaluable|2|||
163277916|NCT00052962|589726802|FG000|Overall Study|Not randomized/not evaluable|1|||
163277917|NCT00052962|589726803|FG001|Overall Study|Not randomized/not evaluable|0|||
163277918|NCT03782727|589726804|FG000|Overall Study|Lost to Follow-up|32|||
163277919|NCT00495469|589728413|FG000|Overall Study|Adverse Event|0|||
163277920|NCT00495469|589728414|FG001|Overall Study|Adverse Event|1|||
163277921|NCT00495469|589728415|FG002|Overall Study|Adverse Event|3|||
163277922|NCT00495469|589728416|FG003|Overall Study|Adverse Event|0|||
163277923|NCT00495469|589728417|FG004|Overall Study|Adverse Event|1|||
163277924|NCT00495469|589728418|FG005|Overall Study|Adverse Event|1|||
163277925|NCT00495469|589728419|FG006|Overall Study|Adverse Event|1|||
163277926|NCT00495469|589728413|FG000|Overall Study|Lost to Follow-up|1|||
163277927|NCT00495469|589728414|FG001|Overall Study|Lost to Follow-up|1|||
163277928|NCT00495469|589728415|FG002|Overall Study|Lost to Follow-up|3|||
163277929|NCT00495469|589728416|FG003|Overall Study|Lost to Follow-up|1|||
163277930|NCT00495469|589728417|FG004|Overall Study|Lost to Follow-up|0|||
163277931|NCT00495469|589728418|FG005|Overall Study|Lost to Follow-up|0|||
163277932|NCT00495469|589728419|FG006|Overall Study|Lost to Follow-up|0|||
163277933|NCT00495469|589728413|FG000|Overall Study|Protocol Violation|0|||
163277934|NCT00495469|589728414|FG001|Overall Study|Protocol Violation|0|||
163277935|NCT00495469|589728415|FG002|Overall Study|Protocol Violation|0|||
163277936|NCT00495469|589728416|FG003|Overall Study|Protocol Violation|0|||
163277937|NCT00495469|589728417|FG004|Overall Study|Protocol Violation|1|||
163277938|NCT00495469|589728418|FG005|Overall Study|Protocol Violation|2|||
163277939|NCT00495469|589728419|FG006|Overall Study|Protocol Violation|0|||
163277940|NCT00495469|589728413|FG000|Overall Study|Withdrawal by Subject|5|||
163277941|NCT00495469|589728414|FG001|Overall Study|Withdrawal by Subject|3|||
163277942|NCT00495469|589728415|FG002|Overall Study|Withdrawal by Subject|1|||
163277943|NCT00495469|589728416|FG003|Overall Study|Withdrawal by Subject|3|||
163277944|NCT00495469|589728417|FG004|Overall Study|Withdrawal by Subject|3|||
163277945|NCT00495469|589728418|FG005|Overall Study|Withdrawal by Subject|2|||
163277946|NCT00495469|589728419|FG006|Overall Study|Withdrawal by Subject|3|||
163277947|NCT00495469|589728413|FG000|Overall Study|Lack of Efficacy|0|||
163277948|NCT00495469|589728414|FG001|Overall Study|Lack of Efficacy|0|||
163277949|NCT00495469|589728415|FG002|Overall Study|Lack of Efficacy|0|||
163277950|NCT00495469|589728416|FG003|Overall Study|Lack of Efficacy|0|||
163277951|NCT00495469|589728417|FG004|Overall Study|Lack of Efficacy|0|||
163277952|NCT00495469|589728418|FG005|Overall Study|Lack of Efficacy|0|||
163277953|NCT00495469|589728419|FG006|Overall Study|Lack of Efficacy|1|||
163277954|NCT00495469|589728413|FG000|Overall Study|Liver function test abnormality|0|||
163277955|NCT00495469|589728414|FG001|Overall Study|Liver function test abnormality|1|||
163277956|NCT00495469|589728415|FG002|Overall Study|Liver function test abnormality|0|||
163277957|NCT00495469|589728416|FG003|Overall Study|Liver function test abnormality|0|||
163277958|NCT00495469|589728417|FG004|Overall Study|Liver function test abnormality|0|||
163277959|NCT00495469|589728418|FG005|Overall Study|Liver function test abnormality|0|||
163277960|NCT00495469|589728419|FG006|Overall Study|Liver function test abnormality|0|||
163277961|NCT00495469|589728413|FG000|Overall Study|ST depression at randomisation in ECG|0|||
163277962|NCT00495469|589728414|FG001|Overall Study|ST depression at randomisation in ECG|1|||
163277963|NCT00495469|589728415|FG002|Overall Study|ST depression at randomisation in ECG|0|||
163277964|NCT00495469|589728416|FG003|Overall Study|ST depression at randomisation in ECG|0|||
163277965|NCT00495469|589728417|FG004|Overall Study|ST depression at randomisation in ECG|0|||
163277966|NCT00495469|589728418|FG005|Overall Study|ST depression at randomisation in ECG|0|||
163277967|NCT00495469|589728419|FG006|Overall Study|ST depression at randomisation in ECG|0|||
163277968|NCT00051311|589728420|FG000|Overall Study|Starting new study|0|||
163277969|NCT00051311|589728421|FG001|Overall Study|Starting new study|1|||
163277970|NCT00051311|589728420|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
163277971|NCT00051311|589728421|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
162929558|NCT04682639|588447391|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
163277972|NCT00051311|589728420|FG000|Overall Study|Death of recipient|8|||
163277973|NCT00051311|589728421|FG001|Overall Study|Death of recipient|8|||
163277974|NCT00051311|589728420|FG000|Overall Study|Recipient taken off study|4|||
163277975|NCT00051311|589728421|FG001|Overall Study|Recipient taken off study|4|||
163277976|NCT04170023|589728422|FG000|LTE Period|Withdrawal by Subject|1|||
163277977|NCT04170023|589728423|FG001|LTE Period|Withdrawal by Subject|0|||
163277978|NCT04170023|589728424|FG002|LTE Period|Withdrawal by Subject|0|||
163277979|NCT04170023|589728422|FG000|LTE Period|Study Termination|11|||
163277980|NCT04170023|589728423|FG001|LTE Period|Study Termination|11|||
163277981|NCT04170023|589728424|FG002|LTE Period|Study Termination|5|||
163277982|NCT04990440|589728425|FG000|Overall Study|Sponsor's Decision|0|||
163277983|NCT04990440|589728426|FG001|Overall Study|Sponsor's Decision|0|||
163277984|NCT04990440|589728427|FG002|Overall Study|Sponsor's Decision|1|||
163277985|NCT03712098|589728428|FG000|Overall Study|Lost to Follow-up|3|||
163277986|NCT03712098|589728429|FG001|Overall Study|Lost to Follow-up|7|||
163277987|NCT03712098|589728428|FG000|Overall Study|Withdrawal by Subject|9|||
163277988|NCT03712098|589728429|FG001|Overall Study|Withdrawal by Subject|4|||
163277989|NCT03712098|589728428|FG000|Overall Study|Protocol Violation|2|||
163277990|NCT03712098|589728429|FG001|Overall Study|Protocol Violation|1|||
163277991|NCT02256969|589728430|FG000|Overall Study|Screenfailed or withdrew|2|||
163277992|NCT02256969|589728431|FG001|Overall Study|Screenfailed or withdrew|1|||
163277993|NCT02256969|589728432|FG002|Overall Study|Screenfailed or withdrew|1|||
163277994|NCT00372567|589728433|FG000|Phase 3 Study|Adverse Event|5|||
163277995|NCT00372567|589728434|FG001|Phase 3 Study|Adverse Event|1|||
163277996|NCT00372567|589728435|FG002|Phase 3 Study|Adverse Event|1|||
163277997|NCT00372567|589728433|FG000|Phase 3 Study|Death|1|||
163277998|NCT00372567|589728434|FG001|Phase 3 Study|Death|1|||
163277999|NCT00372567|589728435|FG002|Phase 3 Study|Death|0|||
163278000|NCT00372567|589728433|FG000|Phase 3 Study|Protocol Violation|0|||
163278001|NCT00372567|589728434|FG001|Phase 3 Study|Protocol Violation|0|||
163278002|NCT00372567|589728435|FG002|Phase 3 Study|Protocol Violation|1|||
163278003|NCT00372567|589728433|FG000|Phase 3 Study|Objective progression or relapse|10|||
163278004|NCT00372567|589728434|FG001|Phase 3 Study|Objective progression or relapse|13|||
163278005|NCT00372567|589728435|FG002|Phase 3 Study|Objective progression or relapse|4|||
163278006|NCT00372567|589728433|FG000|Phase 3 Study|Global deterioration of health status|0|||
163278007|NCT00372567|589728434|FG001|Phase 3 Study|Global deterioration of health status|1|||
163278008|NCT00372567|589728435|FG002|Phase 3 Study|Global deterioration of health status|0|||
163278009|NCT00372567|589728433|FG000|Phase 3 Study|Other|2|||
163278010|NCT00372567|589728434|FG001|Phase 3 Study|Other|2|||
163171022|NCT02267317|589342282|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
163171023|NCT02267317|589342283|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
163171024|NCT02267317|589342284|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
163171025|NCT02267317|589342285|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
163171026|NCT02267317|589342286|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
163171027|NCT02267317|589342287|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
163171028|NCT03595618|589342288|FG000|Overall Study|Adverse Event|16|||
163171029|NCT03595618|589342289|FG001|Overall Study|Adverse Event|17|||
163171030|NCT03595618|589342290|FG002|Overall Study|Adverse Event|20|||
163171031|NCT03595618|589342291|FG003|Overall Study|Adverse Event|8|||
163171032|NCT03595618|589342288|FG000|Overall Study|Withdrawal by Subject|12|||
163171033|NCT03595618|589342289|FG001|Overall Study|Withdrawal by Subject|14|||
163171034|NCT03595618|589342290|FG002|Overall Study|Withdrawal by Subject|14|||
163171035|NCT03595618|589342291|FG003|Overall Study|Withdrawal by Subject|10|||
163171036|NCT03595618|589342288|FG000|Overall Study|Lost to Follow-up|6|||
163171037|NCT03595618|589342289|FG001|Overall Study|Lost to Follow-up|4|||
163171038|NCT03595618|589342290|FG002|Overall Study|Lost to Follow-up|5|||
163171039|NCT03595618|589342291|FG003|Overall Study|Lost to Follow-up|6|||
163171040|NCT03595618|589342288|FG000|Overall Study|Protocol Violation|2|||
163171041|NCT03595618|589342289|FG001|Overall Study|Protocol Violation|0|||
163171042|NCT03595618|589342290|FG002|Overall Study|Protocol Violation|6|||
163171043|NCT03595618|589342291|FG003|Overall Study|Protocol Violation|2|||
163171044|NCT03595618|589342288|FG000|Overall Study|Physician Decision|0|||
163171045|NCT03595618|589342289|FG001|Overall Study|Physician Decision|0|||
163171046|NCT03595618|589342290|FG002|Overall Study|Physician Decision|1|||
163171047|NCT03595618|589342291|FG003|Overall Study|Physician Decision|2|||
163171048|NCT03595618|589342288|FG000|Overall Study|Miscellaneous|7|||
163171049|NCT03595618|589342289|FG001|Overall Study|Miscellaneous|5|||
163171050|NCT03595618|589342290|FG002|Overall Study|Miscellaneous|10|||
163171051|NCT03595618|589342291|FG003|Overall Study|Miscellaneous|6|||
163171052|NCT02279407|589342292|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
163278011|NCT00372567|589728435|FG002|Phase 3 Study|Other|1|||
163278012|NCT00372567|589728433|FG000|Phase 3 Study|study terminated by sponsor|13|||
163278013|NCT00372567|589728434|FG001|Phase 3 Study|study terminated by sponsor|8|||
163278014|NCT00372567|589728435|FG002|Phase 3 Study|study terminated by sponsor|5|||
163278015|NCT00953160|589728436|FG000|Overall Study|Lost to Follow-up|23|||
163278016|NCT00953160|589728436|FG000|Overall Study|Withdrawal by Subject|4|||
163171053|NCT02279407|589342293|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
163171054|NCT02279407|589342294|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
163171055|NCT02279407|589342295|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
163278017|NCT03836664|589728439|FG000|Overall Study|Didn't complete forms and lost drug|3|||
163278018|NCT03836664|589728440|FG001|Overall Study|Didn't complete forms and lost drug|3|||
163278019|NCT01427907|589728441|FG000|Overall Study|Withdrawal by Subject|3|||
163278020|NCT01427907|589728442|FG001|Overall Study|Withdrawal by Subject|4|||
163278021|NCT00425503|589728445|FG000|Overall Study|Adverse Event|2|||
163278022|NCT00425503|589728445|FG000|Overall Study|Protocol Violation|1|||
163278023|NCT03278028|589728447|FG000|Overall Study|Lost to Follow-up|1|||
163171056|NCT02279407|589342292|FG000|Overall Study|Withdrawal by Subject|1|||
163171057|NCT02279407|589342293|FG001|Overall Study|Withdrawal by Subject|0|||
163171058|NCT02279407|589342294|FG002|Overall Study|Withdrawal by Subject|1|||
163171059|NCT02279407|589342295|FG003|Overall Study|Withdrawal by Subject|1|||
163171060|NCT02279407|589342292|FG000|Overall Study|Adverse Event|1|||
163171061|NCT02279407|589342293|FG001|Overall Study|Adverse Event|1|||
163171062|NCT02279407|589342294|FG002|Overall Study|Adverse Event|2|||
163171063|NCT02279407|589342295|FG003|Overall Study|Adverse Event|0|||
163171064|NCT00422084|589342296|FG000|Overall Study|Adverse Event|21|||
163171065|NCT00422084|589342297|FG001|Overall Study|Adverse Event|7|||
163171066|NCT00422084|589342296|FG000|Overall Study|Withdrawal by Subject|12|||
163171067|NCT00422084|589342297|FG001|Overall Study|Withdrawal by Subject|9|||
163171068|NCT00422084|589342296|FG000|Overall Study|Lost to Follow-up|14|||
163171069|NCT00422084|589342297|FG001|Overall Study|Lost to Follow-up|9|||
163171070|NCT00422084|589342296|FG000|Overall Study|Protocol Violation|4|||
163171071|NCT00422084|589342297|FG001|Overall Study|Protocol Violation|1|||
163171072|NCT00422084|589342296|FG000|Overall Study|Lack of Efficacy|40|||
163171073|NCT00422084|589342297|FG001|Overall Study|Lack of Efficacy|42|||
163171074|NCT00422084|589342296|FG000|Overall Study|P. vivax infection|3|||
163171075|NCT00422084|589342297|FG001|Overall Study|P. vivax infection|6|||
163171076|NCT00422084|589342296|FG000|Overall Study|Cyesis|1|||
163171077|NCT00422084|589342297|FG001|Overall Study|Cyesis|0|||
163171078|NCT00422084|589342296|FG000|Overall Study|Withdrawn from study accidentally|1|||
163171079|NCT00422084|589342297|FG001|Overall Study|Withdrawn from study accidentally|0|||
163171080|NCT00422084|589342296|FG000|Overall Study|Non-compliance|1|||
163171081|NCT00422084|589342297|FG001|Overall Study|Non-compliance|0|||
163171082|NCT00422084|589342296|FG000|Overall Study|Re-location|0|||
163171083|NCT00422084|589342297|FG001|Overall Study|Re-location|1|||
163171084|NCT00422084|589342296|FG000|Overall Study|Not defined|1|||
163171085|NCT00422084|589342297|FG001|Overall Study|Not defined|1|||
163171086|NCT03996369|589342304|FG000|Overall Study|Protocol deviation|1|||
163171087|NCT03996369|589342305|FG001|Overall Study|Protocol deviation|1|||
163171088|NCT03996369|589342304|FG000|Overall Study|Physician Decision|4|||
163171089|NCT03996369|589342305|FG001|Overall Study|Physician Decision|2|||
163171090|NCT03996369|589342304|FG000|Overall Study|Participant decision|0|||
163171091|NCT03996369|589342305|FG001|Overall Study|Participant decision|1|||
163171092|NCT03996369|589342304|FG000|Overall Study|Lack of Efficacy|4|||
163171093|NCT03996369|589342305|FG001|Overall Study|Lack of Efficacy|0|||
163171094|NCT03996369|589342304|FG000|Overall Study|Adverse Event|9|||
163171095|NCT03996369|589342305|FG001|Overall Study|Adverse Event|0|||
163171096|NCT03996369|589342304|FG000|Overall Study|Withdrawal by Subject|6|||
163171097|NCT03996369|589342305|FG001|Overall Study|Withdrawal by Subject|8|||
163171098|NCT03996369|589342304|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
163171099|NCT03996369|589342305|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
163171100|NCT03996369|589342304|FG000|Overall Study|Lost to Follow-up|0|||
163171101|NCT03996369|589342305|FG001|Overall Study|Lost to Follow-up|1|||
163171102|NCT01579812|589342306|FG000|Overall Study|Ineligible after treatment start|40|||
163171103|NCT01579812|589342306|FG000|Overall Study|Patient choice|3|||
163171104|NCT01579812|589342306|FG000|Overall Study|Noncompliance|3|||
163171105|NCT01579812|589342306|FG000|Overall Study|Withdrawal by Subject|6|||
163171106|NCT00653432|589342307|FG000|Overall Study|Adverse Event|4|||
163171107|NCT00653432|589342308|FG001|Overall Study|Adverse Event|1|||
163171108|NCT00653432|589342307|FG000|Overall Study|Withdrawal by Subject|4|||
163171109|NCT00653432|589342308|FG001|Overall Study|Withdrawal by Subject|5|||
163171110|NCT00653432|589342307|FG000|Overall Study|Lost to Follow-up|7|||
163171111|NCT00653432|589342308|FG001|Overall Study|Lost to Follow-up|6|||
163171112|NCT00653432|589342307|FG000|Overall Study|Use/Need of Con Therapy|2|||
163171113|NCT00653432|589342308|FG001|Overall Study|Use/Need of Con Therapy|1|||
163171114|NCT00653432|589342307|FG000|Overall Study|Other - Reason Not Provided|5|||
163171115|NCT00653432|589342308|FG001|Overall Study|Other - Reason Not Provided|3|||
163171116|NCT01782469|589342309|FG000|Overall Study|Lost to Follow-up|1|||
163171117|NCT00357760|589342310|FG000|Overall Study|Disease progression|44|||
163171118|NCT00357760|589342311|FG001|Overall Study|Disease progression|17|||
163171119|NCT00357760|589342310|FG000|Overall Study|Adverse Event|10|||
163171120|NCT00357760|589342311|FG001|Overall Study|Adverse Event|7|||
163171121|NCT00357760|589342310|FG000|Overall Study|Death|0|||
163171122|NCT00357760|589342311|FG001|Overall Study|Death|3|||
163171123|NCT00357760|589342310|FG000|Overall Study|Alternative therapy|1|||
163171124|NCT00357760|589342311|FG001|Overall Study|Alternative therapy|0|||
163171125|NCT00357760|589342310|FG000|Overall Study|Withdrawal by Subject|0|||
163171126|NCT00357760|589342311|FG001|Overall Study|Withdrawal by Subject|2|||
163171127|NCT00357760|589342310|FG000|Overall Study|Never started treatment|2|||
163171128|NCT00357760|589342311|FG001|Overall Study|Never started treatment|1|||
163171129|NCT00357760|589342310|FG000|Overall Study|Ineligible|0|||
163171130|NCT00357760|589342311|FG001|Overall Study|Ineligible|2|||
163171131|NCT00357760|589342310|FG000|Overall Study|Physician Decision|2|||
163171132|NCT00357760|589342311|FG001|Overall Study|Physician Decision|1|||
163171133|NCT00357760|589342310|FG000|Overall Study|Protocol Violation|0|||
163171134|NCT00357760|589342311|FG001|Overall Study|Protocol Violation|1|||
163278024|NCT03278028|589728448|FG001|Overall Study|Lost to Follow-up|0|||
163278025|NCT03278028|589728447|FG000|Overall Study|Withdrawal by Subject|3|||
163278026|NCT03278028|589728448|FG001|Overall Study|Withdrawal by Subject|1|||
163278027|NCT03278028|589728447|FG000|Overall Study|Pregnancy|0|||
163278028|NCT03278028|589728448|FG001|Overall Study|Pregnancy|1|||
163278029|NCT03890120|589728450|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
163278030|NCT03890120|589728451|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
163278031|NCT03890120|589728452|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
163278032|NCT03890120|589728453|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
163278033|NCT03890120|589728450|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
163278034|NCT03890120|589728451|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
163278035|NCT03890120|589728452|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
163278036|NCT03890120|589728453|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
163278037|NCT03890120|589728450|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
163278038|NCT03890120|589728451|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
163278039|NCT03890120|589728452|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
163278040|NCT03890120|589728453|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
163278041|NCT03890120|589728450|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
163278042|NCT03890120|589728451|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
163278043|NCT03890120|589728452|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
163278044|NCT03890120|589728453|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
163278045|NCT03890120|589728450|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
163278046|NCT03890120|589728451|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
163278047|NCT03890120|589728452|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
163278048|NCT03890120|589728453|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
163278049|NCT03890120|589728450|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
163278050|NCT03890120|589728451|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
163278051|NCT03890120|589728452|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
163278052|NCT03890120|589728453|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
163278053|NCT03890120|589728450|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
163278054|NCT03890120|589728451|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
163278055|NCT03890120|589728452|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
163278056|NCT03890120|589728453|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
163278057|NCT03890120|589728450|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
163278058|NCT03890120|589728451|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
163278059|NCT03890120|589728452|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
163278060|NCT03890120|589728453|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
163171135|NCT00357760|589342310|FG000|Overall Study|To receive hospice care|0|||
163171136|NCT00357760|589342311|FG001|Overall Study|To receive hospice care|1|||
163171137|NCT02353143|589342312|FG000|Overall Study|Withdrawal by Subject|1|||
163171138|NCT02353143|589342313|FG001|Overall Study|Withdrawal by Subject|0|||
163171139|NCT02353143|589342314|FG002|Overall Study|Withdrawal by Subject|0|||
163171140|NCT02353143|589342315|FG003|Overall Study|Withdrawal by Subject|0|||
163171141|NCT02353143|589342316|FG004|Overall Study|Withdrawal by Subject|1|||
163171142|NCT02353143|589342317|FG005|Overall Study|Withdrawal by Subject|0|||
163171143|NCT02353143|589342318|FG006|Overall Study|Withdrawal by Subject|0|||
163171144|NCT02353143|589342319|FG007|Overall Study|Withdrawal by Subject|1|||
163171145|NCT02353143|589342320|FG008|Overall Study|Withdrawal by Subject|1|||
163171146|NCT02353143|589342312|FG000|Overall Study|Lack of Efficacy|2|||
163171147|NCT02353143|589342313|FG001|Overall Study|Lack of Efficacy|1|||
163171148|NCT02353143|589342314|FG002|Overall Study|Lack of Efficacy|2|||
163171149|NCT02353143|589342315|FG003|Overall Study|Lack of Efficacy|4|||
163171150|NCT02353143|589342316|FG004|Overall Study|Lack of Efficacy|13|||
163171151|NCT02353143|589342317|FG005|Overall Study|Lack of Efficacy|2|||
163171152|NCT02353143|589342318|FG006|Overall Study|Lack of Efficacy|2|||
163171153|NCT02353143|589342319|FG007|Overall Study|Lack of Efficacy|2|||
163171154|NCT02353143|589342320|FG008|Overall Study|Lack of Efficacy|1|||
163171155|NCT02353143|589342312|FG000|Overall Study|reason not specified|1|||
163171156|NCT02353143|589342313|FG001|Overall Study|reason not specified|2|||
163171157|NCT02353143|589342314|FG002|Overall Study|reason not specified|0|||
163171158|NCT02353143|589342315|FG003|Overall Study|reason not specified|0|||
163171159|NCT02353143|589342316|FG004|Overall Study|reason not specified|6|||
163278061|NCT03890120|589728450|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
163278062|NCT03890120|589728451|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
163171160|NCT02353143|589342317|FG005|Overall Study|reason not specified|1|||
163171161|NCT02353143|589342318|FG006|Overall Study|reason not specified|0|||
163171162|NCT02353143|589342319|FG007|Overall Study|reason not specified|3|||
163171163|NCT02353143|589342320|FG008|Overall Study|reason not specified|1|||
163171164|NCT02353143|589342312|FG000|Overall Study|Physician Decision|0|||
163171165|NCT02353143|589342313|FG001|Overall Study|Physician Decision|4|||
163171166|NCT02353143|589342314|FG002|Overall Study|Physician Decision|2|||
163171167|NCT02353143|589342315|FG003|Overall Study|Physician Decision|3|||
163171168|NCT02353143|589342316|FG004|Overall Study|Physician Decision|4|||
163171169|NCT02353143|589342317|FG005|Overall Study|Physician Decision|0|||
163278063|NCT03890120|589728452|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
163278064|NCT03890120|589728453|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
163278065|NCT03890120|589728450|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
163171170|NCT02353143|589342318|FG006|Overall Study|Physician Decision|1|||
163171171|NCT02353143|589342319|FG007|Overall Study|Physician Decision|2|||
163171172|NCT02353143|589342320|FG008|Overall Study|Physician Decision|0|||
163171173|NCT02353143|589342312|FG000|Overall Study|Adverse Event|0|||
163171174|NCT02353143|589342313|FG001|Overall Study|Adverse Event|0|||
163171175|NCT02353143|589342314|FG002|Overall Study|Adverse Event|1|||
163171176|NCT02353143|589342315|FG003|Overall Study|Adverse Event|0|||
163171177|NCT02353143|589342316|FG004|Overall Study|Adverse Event|1|||
163171178|NCT02353143|589342317|FG005|Overall Study|Adverse Event|1|||
163171179|NCT02353143|589342318|FG006|Overall Study|Adverse Event|0|||
163171180|NCT02353143|589342319|FG007|Overall Study|Adverse Event|0|||
163171181|NCT02353143|589342320|FG008|Overall Study|Adverse Event|0|||
163171182|NCT02353143|589342312|FG000|Overall Study|patient receiving other treatment for AML|0|||
163171183|NCT02353143|589342313|FG001|Overall Study|patient receiving other treatment for AML|0|||
163171184|NCT02353143|589342314|FG002|Overall Study|patient receiving other treatment for AML|1|||
163171185|NCT02353143|589342315|FG003|Overall Study|patient receiving other treatment for AML|0|||
163171186|NCT02353143|589342316|FG004|Overall Study|patient receiving other treatment for AML|0|||
163171187|NCT02353143|589342317|FG005|Overall Study|patient receiving other treatment for AML|0|||
163171188|NCT02353143|589342318|FG006|Overall Study|patient receiving other treatment for AML|0|||
163171189|NCT02353143|589342319|FG007|Overall Study|patient receiving other treatment for AML|0|||
163171190|NCT02353143|589342320|FG008|Overall Study|patient receiving other treatment for AML|0|||
163171191|NCT02353143|589342312|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
163171192|NCT02353143|589342313|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
163171193|NCT02353143|589342314|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
163171194|NCT02353143|589342315|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
163171195|NCT02353143|589342316|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
163171196|NCT02353143|589342317|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
163171197|NCT02353143|589342318|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
163171198|NCT02353143|589342319|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
163171199|NCT02353143|589342320|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
163171200|NCT00600119|589342321|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
163171201|NCT00600119|589342322|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
163278066|NCT03890120|589728451|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
163171202|NCT00600119|589342323|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
163171203|NCT00600119|589342324|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
163171204|NCT00600119|589342325|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
163171205|NCT00600119|589342326|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
163171206|NCT00600119|589342321|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163171207|NCT00600119|589342322|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
163171208|NCT00600119|589342323|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
163171209|NCT00600119|589342324|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163171210|NCT00600119|589342325|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163171211|NCT00600119|589342326|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163171212|NCT00600119|589342321|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
163171213|NCT00600119|589342322|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
163171214|NCT00600119|589342323|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
163171215|NCT00600119|589342324|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
163171216|NCT00600119|589342325|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
163171217|NCT00600119|589342326|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
163171218|NCT00600119|589342321|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
163171219|NCT00600119|589342322|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
163171220|NCT00600119|589342323|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
163171221|NCT00600119|589342324|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
163171222|NCT00600119|589342325|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
163171223|NCT00600119|589342326|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
163171224|NCT00600119|589342321|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
163171225|NCT00600119|589342322|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
163171226|NCT00600119|589342323|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
163171227|NCT00600119|589342324|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
163171228|NCT00600119|589342325|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
163171229|NCT00600119|589342326|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
163171230|NCT00600119|589342321|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
163171231|NCT00600119|589342322|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
163171232|NCT00600119|589342323|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
163171233|NCT00600119|589342324|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
163171234|NCT00600119|589342325|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
163171235|NCT00600119|589342326|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
163171236|NCT00600119|589342321|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
163171237|NCT00600119|589342322|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
163171238|NCT00600119|589342323|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
163171239|NCT00600119|589342324|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
163171240|NCT00600119|589342325|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
163171241|NCT00600119|589342326|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
163171242|NCT00600119|589342321|FG000|Double-blind Treatment Period|Other|0|||
163171243|NCT00600119|589342322|FG001|Double-blind Treatment Period|Other|0|||
163171244|NCT00600119|589342323|FG002|Double-blind Treatment Period|Other|0|||
163171245|NCT00600119|589342324|FG003|Double-blind Treatment Period|Other|0|||
163171246|NCT00600119|589342325|FG004|Double-blind Treatment Period|Other|2|||
163171247|NCT00600119|589342326|FG005|Double-blind Treatment Period|Other|1|||
163171248|NCT00600119|589342321|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
163171249|NCT00600119|589342322|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
163171250|NCT00600119|589342323|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
163171251|NCT00600119|589342324|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
163171252|NCT00600119|589342325|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
163171253|NCT00600119|589342326|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
163171254|NCT00600119|589342321|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
163171255|NCT00600119|589342322|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
163171256|NCT00600119|589342323|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
163171257|NCT00600119|589342324|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
163171258|NCT00600119|589342325|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
163171259|NCT00600119|589342326|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
163171260|NCT00600119|589342321|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
163171261|NCT00600119|589342322|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
163171262|NCT00600119|589342323|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
163171263|NCT00600119|589342324|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
163171264|NCT00600119|589342325|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
163171265|NCT00600119|589342326|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
163171266|NCT00600119|589342321|FG000|Double-blind Treatment Period|Physician Decision|2|||
163171267|NCT00600119|589342322|FG001|Double-blind Treatment Period|Physician Decision|0|||
163171268|NCT00600119|589342323|FG002|Double-blind Treatment Period|Physician Decision|0|||
163171269|NCT00600119|589342324|FG003|Double-blind Treatment Period|Physician Decision|0|||
163171270|NCT00600119|589342325|FG004|Double-blind Treatment Period|Physician Decision|0|||
163171271|NCT00600119|589342326|FG005|Double-blind Treatment Period|Physician Decision|0|||
163171272|NCT00600119|589342321|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
162929559|NCT04682639|588447392|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
163171273|NCT00600119|589342322|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
163171274|NCT00600119|589342323|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
163171275|NCT00600119|589342324|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
163171276|NCT00600119|589342325|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
163171277|NCT00600119|589342326|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
163171278|NCT00600119|589342321|FG000|Double-blind Treatment Period|Adverse Event|1|||
163171279|NCT00600119|589342322|FG001|Double-blind Treatment Period|Adverse Event|1|||
163171280|NCT00600119|589342323|FG002|Double-blind Treatment Period|Adverse Event|0|||
163171281|NCT00600119|589342324|FG003|Double-blind Treatment Period|Adverse Event|1|||
163171282|NCT00600119|589342325|FG004|Double-blind Treatment Period|Adverse Event|2|||
163171283|NCT00600119|589342326|FG005|Double-blind Treatment Period|Adverse Event|10|||
163171284|NCT00600119|589342321|FG000|Follow-up Period|Adverse Event|0|||
163171285|NCT00600119|589342322|FG001|Follow-up Period|Adverse Event|0|||
163171286|NCT00600119|589342323|FG002|Follow-up Period|Adverse Event|0|||
163171287|NCT00600119|589342324|FG003|Follow-up Period|Adverse Event|0|||
163171288|NCT00600119|589342325|FG004|Follow-up Period|Adverse Event|0|||
163171289|NCT00600119|589342326|FG005|Follow-up Period|Adverse Event|1|||
163171290|NCT00600119|589342321|FG000|Follow-up Period|Other|1|||
163171291|NCT00600119|589342322|FG001|Follow-up Period|Other|0|||
163171292|NCT00600119|589342323|FG002|Follow-up Period|Other|0|||
163171293|NCT00600119|589342324|FG003|Follow-up Period|Other|0|||
163171294|NCT00600119|589342325|FG004|Follow-up Period|Other|0|||
163171295|NCT00600119|589342326|FG005|Follow-up Period|Other|0|||
163171296|NCT04740905|589342327|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
163171297|NCT04740905|589342328|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
163171298|NCT04740905|589342327|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
163171299|NCT04740905|589342328|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
163171300|NCT04740905|589342327|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
163171301|NCT04740905|589342328|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
163171302|NCT04740905|589342327|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
163171303|NCT04740905|589342328|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
163171304|NCT04740905|589342327|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
163171305|NCT04740905|589342328|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
163171306|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
163171307|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
163171308|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
163171309|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
163171310|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
163171311|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
163171312|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
163171313|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
163171314|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
163171315|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
163171316|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
163171317|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
163171318|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
163171319|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
163171320|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
163171321|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
163171322|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
163171323|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
163171324|NCT00561977|589342329|FG000|Overall Study|Withdrawal by Subject|0|||
163171325|NCT00561977|589342330|FG001|Overall Study|Withdrawal by Subject|2|||
163171326|NCT00561977|589342331|FG002|Overall Study|Withdrawal by Subject|1|||
163171327|NCT00561977|589342329|FG000|Overall Study|Pregnancy|0|||
163171328|NCT00561977|589342330|FG001|Overall Study|Pregnancy|1|||
163171329|NCT00561977|589342331|FG002|Overall Study|Pregnancy|1|||
163171330|NCT03077087|589342332|FG000|Overall Study|Physician Decision|2|||
163171331|NCT01989468|589342333|FG000|Overall Study|Adverse Event|10|||
163171332|NCT01989468|589342334|FG001|Overall Study|Adverse Event|15|||
163171333|NCT01989468|589342335|FG002|Overall Study|Adverse Event|4|||
163171334|NCT01989468|589342336|FG003|Overall Study|Adverse Event|5|||
163171335|NCT01989468|589342337|FG004|Overall Study|Adverse Event|4|||
163171336|NCT01989468|589342333|FG000|Overall Study|Lack of Efficacy|11|||
163171337|NCT01989468|589342334|FG001|Overall Study|Lack of Efficacy|11|||
163171338|NCT01989468|589342335|FG002|Overall Study|Lack of Efficacy|7|||
163171339|NCT01989468|589342336|FG003|Overall Study|Lack of Efficacy|4|||
163171340|NCT01989468|589342337|FG004|Overall Study|Lack of Efficacy|2|||
163171341|NCT01989468|589342333|FG000|Overall Study|Lost to Follow-up|5|||
163171342|NCT01989468|589342334|FG001|Overall Study|Lost to Follow-up|2|||
163171343|NCT01989468|589342335|FG002|Overall Study|Lost to Follow-up|0|||
163171344|NCT01989468|589342336|FG003|Overall Study|Lost to Follow-up|1|||
163171345|NCT01989468|589342337|FG004|Overall Study|Lost to Follow-up|1|||
163171346|NCT01989468|589342333|FG000|Overall Study|Physician Decision|4|||
163171347|NCT01989468|589342334|FG001|Overall Study|Physician Decision|1|||
163171348|NCT01989468|589342335|FG002|Overall Study|Physician Decision|0|||
163171349|NCT01989468|589342336|FG003|Overall Study|Physician Decision|1|||
163171350|NCT01989468|589342337|FG004|Overall Study|Physician Decision|0|||
163171351|NCT01989468|589342333|FG000|Overall Study|Pregnancy|0|||
163171352|NCT01989468|589342334|FG001|Overall Study|Pregnancy|1|||
163171353|NCT01989468|589342335|FG002|Overall Study|Pregnancy|0|||
163171354|NCT01989468|589342336|FG003|Overall Study|Pregnancy|0|||
163171355|NCT01989468|589342337|FG004|Overall Study|Pregnancy|0|||
163171356|NCT01989468|589342333|FG000|Overall Study|Technical Problems|3|||
163171357|NCT01989468|589342334|FG001|Overall Study|Technical Problems|1|||
163171358|NCT01989468|589342335|FG002|Overall Study|Technical Problems|3|||
163171359|NCT01989468|589342336|FG003|Overall Study|Technical Problems|1|||
163171360|NCT01989468|589342337|FG004|Overall Study|Technical Problems|0|||
163171361|NCT01989468|589342333|FG000|Overall Study|Subject Guardian Decision|11|||
163171362|NCT01989468|589342334|FG001|Overall Study|Subject Guardian Decision|6|||
163171363|NCT01989468|589342335|FG002|Overall Study|Subject Guardian Decision|4|||
163171364|NCT01989468|589342336|FG003|Overall Study|Subject Guardian Decision|4|||
163171365|NCT01989468|589342337|FG004|Overall Study|Subject Guardian Decision|1|||
163171366|NCT01989468|589342333|FG000|Overall Study|Death|3|||
163171367|NCT01989468|589342334|FG001|Overall Study|Death|0|||
163171368|NCT01989468|589342335|FG002|Overall Study|Death|1|||
163171369|NCT01989468|589342336|FG003|Overall Study|Death|0|||
163171370|NCT01989468|589342337|FG004|Overall Study|Death|0|||
163171371|NCT01224782|589342338|FG000|Overall Study|Lost to Follow-up|177|||
163171372|NCT01224782|589342338|FG000|Overall Study|Withdrawal by Subject|16|||
163171373|NCT01224782|589342338|FG000|Overall Study|Death|14|||
163171374|NCT01224782|589342338|FG000|Overall Study|Improvement|13|||
163171375|NCT01224782|589342338|FG000|Overall Study|Adverse Event|12|||
163171376|NCT01224782|589342338|FG000|Overall Study|Adverse Reaction|11|||
163171377|NCT01224782|589342338|FG000|Overall Study|Noncompliance|10|||
163171378|NCT01224782|589342338|FG000|Overall Study|Other|4|||
163171379|NCT01224782|589342338|FG000|Overall Study|Start of Dialysis|3|||
163171380|NCT01224782|589342338|FG000|Overall Study|Change of Treatment|1|||
163171381|NCT01224782|589342338|FG000|Overall Study|Financial Reasons|1|||
163171382|NCT01224782|589342338|FG000|Overall Study|Deterioration|1|||
163171383|NCT01224782|589342338|FG000|Overall Study|Transplantation|1|||
163171384|NCT01960907|589342339|FG000|Overall Study|Death|4|||
163171385|NCT01960907|589342340|FG001|Overall Study|Death|3|||
163171386|NCT01960907|589342339|FG000|Overall Study|Withdrawal by Subject|32|||
163171387|NCT01960907|589342340|FG001|Overall Study|Withdrawal by Subject|42|||
163171388|NCT01950013|589342343|FG000|Overall Study|Withdrawal by Subject|0|||
163171389|NCT01950013|589342344|FG001|Overall Study|Withdrawal by Subject|2|||
163171390|NCT01950013|589342345|FG002|Overall Study|Withdrawal by Subject|0|||
163171391|NCT01765218|589342350|FG000|Overall Study|Protocol Violation|1|||
163171392|NCT01765218|589342351|FG001|Overall Study|Protocol Violation|2|||
163171393|NCT01590758|589342354|FG000|Overall Study|Withdrawal by Subject|0|||
163171394|NCT01590758|589342355|FG001|Overall Study|Withdrawal by Subject|3|||
163171395|NCT01590758|589342354|FG000|Overall Study|Physician Decision|1|||
163171396|NCT01590758|589342355|FG001|Overall Study|Physician Decision|2|||
163171397|NCT01590758|589342354|FG000|Overall Study|Lost to Follow-up|4|||
163171398|NCT01590758|589342355|FG001|Overall Study|Lost to Follow-up|2|||
163171399|NCT02929498|589342356|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
163171400|NCT02929498|589342357|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
163171401|NCT02929498|589342358|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
163171402|NCT02929498|589342356|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
163171403|NCT02929498|589342357|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
163171404|NCT02929498|589342358|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
163171405|NCT01011309|589342363|FG000|Overall Study|Adverse Event|2|||
163171406|NCT01011309|589342364|FG001|Overall Study|Adverse Event|1|||
163171407|NCT01011309|589342365|FG002|Overall Study|Adverse Event|2|||
163171408|NCT01011309|589342363|FG000|Overall Study|Lack of Efficacy|0|||
163171409|NCT01011309|589342364|FG001|Overall Study|Lack of Efficacy|1|||
163171410|NCT01011309|589342365|FG002|Overall Study|Lack of Efficacy|0|||
163171411|NCT01011309|589342363|FG000|Overall Study|Protocol Violation|0|||
163171412|NCT01011309|589342364|FG001|Overall Study|Protocol Violation|1|||
163171413|NCT01011309|589342365|FG002|Overall Study|Protocol Violation|3|||
163171414|NCT00530504|589342368|FG000|Overall Study|Death|54|||
163171415|NCT00530504|589342368|FG000|Overall Study|Lost to Follow-up|26|||
163171416|NCT00530504|589342368|FG000|Overall Study|Withdrawal by Subject|39|||
163171417|NCT00530504|589342368|FG000|Overall Study|Exited study due to other reasons|33|||
163171418|NCT00006289|589342369|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
163171419|NCT00006289|589342370|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
163171420|NCT00006289|589342369|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
163171421|NCT00006289|589342370|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
163171422|NCT03255083|589342376|FG000|Overall Study|Clinical progression|1|||
163171423|NCT03255083|589342377|FG001|Overall Study|Clinical progression|0|||
163171424|NCT03255083|589342378|FG002|Overall Study|Clinical progression|0|||
163171425|NCT03255083|589342379|FG003|Overall Study|Clinical progression|0|||
163171426|NCT03255083|589342376|FG000|Overall Study|Adverse Event|0|||
163171427|NCT03255083|589342377|FG001|Overall Study|Adverse Event|1|||
163171428|NCT03255083|589342378|FG002|Overall Study|Adverse Event|0|||
163171429|NCT03255083|589342379|FG003|Overall Study|Adverse Event|0|||
163171430|NCT03255083|589342376|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
163171431|NCT03255083|589342377|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
163171432|NCT03255083|589342378|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
163171433|NCT03255083|589342379|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
163171434|NCT03255083|589342376|FG000|Overall Study|Withdrawal by Subject|1|||
163171435|NCT03255083|589342377|FG001|Overall Study|Withdrawal by Subject|1|||
163171436|NCT03255083|589342378|FG002|Overall Study|Withdrawal by Subject|1|||
163171437|NCT03255083|589342379|FG003|Overall Study|Withdrawal by Subject|0|||
163171438|NCT05009979|589342380|FG000|Overall Study|Withdrawal by Subject|1|||
163171439|NCT00576420|589343836|FG000|Overall Study|Death|0|||
163171440|NCT00576420|589343837|FG001|Overall Study|Death|0|||
163171441|NCT00576420|589343838|FG002|Overall Study|Death|1|||
163171442|NCT02616146|589343839|FG000|Overall Study|Adverse Event|64|||
163171443|NCT02616146|589343840|FG001|Overall Study|Adverse Event|24|||
163171444|NCT02616146|589343839|FG000|Overall Study|Lost to Follow-up|23|||
163171445|NCT02616146|589343840|FG001|Overall Study|Lost to Follow-up|13|||
163171446|NCT02616146|589343839|FG000|Overall Study|Non-compliance with study protocol|2|||
163171447|NCT02616146|589343840|FG001|Overall Study|Non-compliance with study protocol|0|||
163171448|NCT02616146|589343839|FG000|Overall Study|Non-compliance with study drug|4|||
163171449|NCT02616146|589343840|FG001|Overall Study|Non-compliance with study drug|2|||
163171450|NCT02616146|589343839|FG000|Overall Study|Pregnancy|2|||
163171451|NCT02616146|589343840|FG001|Overall Study|Pregnancy|2|||
163171452|NCT02616146|589343839|FG000|Overall Study|Pregnancy wish|3|||
163171453|NCT02616146|589343840|FG001|Overall Study|Pregnancy wish|0|||
163171454|NCT02616146|589343839|FG000|Overall Study|Protocol Violation|6|||
163171455|NCT02616146|589343840|FG001|Overall Study|Protocol Violation|3|||
163171456|NCT02616146|589343839|FG000|Overall Study|Study terminated by sponsor|1372|||
163171457|NCT02616146|589343840|FG001|Overall Study|Study terminated by sponsor|432|||
163171458|NCT02616146|589343839|FG000|Overall Study|Participant moved|4|||
163171459|NCT02616146|589343840|FG001|Overall Study|Participant moved|3|||
163171460|NCT02616146|589343839|FG000|Overall Study|Withdrawal by Subject|30|||
163171461|NCT02616146|589343840|FG001|Overall Study|Withdrawal by Subject|24|||
163171462|NCT02616146|589343839|FG000|Overall Study|Physician Decision|2|||
163171463|NCT02616146|589343840|FG001|Overall Study|Physician Decision|1|||
163171464|NCT01221272|589343841|FG000|Period 1|Adverse Event|2|||
163171465|NCT01221272|589343842|FG001|Period 1|Adverse Event|0|||
163171466|NCT01221272|589343841|FG000|Period 1|Consent Withdrawal|0|||
163171467|NCT01221272|589343842|FG001|Period 1|Consent Withdrawal|1|||
163171468|NCT01221272|589343841|FG000|Period 1|Significant Dosing Noncompliance|0|||
163171469|NCT01221272|589343842|FG001|Period 1|Significant Dosing Noncompliance|1|||
163171470|NCT01221272|589343841|FG000|Period 2|Adverse Event|0|||
163171471|NCT01221272|589343842|FG001|Period 2|Adverse Event|2|||
163171472|NCT01340872|589343843|FG000|Double-blind Phase|Adverse Event|6|||
163171473|NCT01340872|589343844|FG001|Double-blind Phase|Adverse Event|4|||
163171474|NCT01340872|589343845|FG002|Double-blind Phase|Adverse Event|0|||
163171475|NCT01340872|589343846|FG003|Double-blind Phase|Adverse Event|0|||
163171476|NCT01340872|589343843|FG000|Double-blind Phase|Withdrawal by Subject|3|||
163171477|NCT01340872|589343844|FG001|Double-blind Phase|Withdrawal by Subject|5|||
163171478|NCT01340872|589343845|FG002|Double-blind Phase|Withdrawal by Subject|0|||
163171479|NCT01340872|589343846|FG003|Double-blind Phase|Withdrawal by Subject|0|||
163171480|NCT01340872|589343843|FG000|Double-blind Phase|Lost to Follow-up|0|||
163171481|NCT01340872|589343844|FG001|Double-blind Phase|Lost to Follow-up|1|||
163171482|NCT01340872|589343845|FG002|Double-blind Phase|Lost to Follow-up|0|||
163171483|NCT01340872|589343846|FG003|Double-blind Phase|Lost to Follow-up|0|||
163171484|NCT01340872|589343843|FG000|Double-blind Phase|Protocol Violation|0|||
163171485|NCT01340872|589343844|FG001|Double-blind Phase|Protocol Violation|1|||
163171486|NCT01340872|589343845|FG002|Double-blind Phase|Protocol Violation|0|||
163171487|NCT01340872|589343846|FG003|Double-blind Phase|Protocol Violation|0|||
163171488|NCT01340872|589343843|FG000|Open-label Phase|Physician Decision|0|||
163171489|NCT01340872|589343844|FG001|Open-label Phase|Physician Decision|0|||
163171490|NCT01340872|589343845|FG002|Open-label Phase|Physician Decision|2|||
163171491|NCT01340872|589343846|FG003|Open-label Phase|Physician Decision|1|||
163171492|NCT01340872|589343843|FG000|Open-label Phase|Pregnancy|0|||
163171493|NCT01340872|589343844|FG001|Open-label Phase|Pregnancy|0|||
163171494|NCT01340872|589343845|FG002|Open-label Phase|Pregnancy|1|||
163171495|NCT01340872|589343846|FG003|Open-label Phase|Pregnancy|0|||
163171496|NCT01340872|589343843|FG000|Open-label Phase|Adverse Event|0|||
163171497|NCT01340872|589343844|FG001|Open-label Phase|Adverse Event|0|||
163171498|NCT01340872|589343845|FG002|Open-label Phase|Adverse Event|8|||
163171499|NCT01340872|589343846|FG003|Open-label Phase|Adverse Event|4|||
163171500|NCT01340872|589343843|FG000|Open-label Phase|Withdrawal by Subject|0|||
163171501|NCT01340872|589343844|FG001|Open-label Phase|Withdrawal by Subject|0|||
163171502|NCT01340872|589343845|FG002|Open-label Phase|Withdrawal by Subject|1|||
163171503|NCT01340872|589343846|FG003|Open-label Phase|Withdrawal by Subject|6|||
163171504|NCT01340872|589343843|FG000|Open-label Phase|Worsening of IBD|0|||
163171505|NCT01340872|589343844|FG001|Open-label Phase|Worsening of IBD|0|||
163171506|NCT01340872|589343845|FG002|Open-label Phase|Worsening of IBD|1|||
163171507|NCT01340872|589343846|FG003|Open-label Phase|Worsening of IBD|0|||
163278067|NCT03890120|589728452|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
163278068|NCT03890120|589728453|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
163171508|NCT03039621|589343851|FG000|Overall Study|Violation of inclusion criteria|3|||
163171509|NCT03039621|589343852|FG001|Overall Study|Violation of inclusion criteria|2|||
163171510|NCT03039621|589343851|FG000|Overall Study|Non-compliance with protocol requirement|4|||
163171511|NCT03039621|589343852|FG001|Overall Study|Non-compliance with protocol requirement|5|||
163171512|NCT03039621|589343851|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
163278069|NCT03890120|589728450|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
163278070|NCT03890120|589728451|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
163278071|NCT03890120|589728452|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
163278072|NCT03890120|589728453|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
163278073|NCT03890120|589728450|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
163278074|NCT03890120|589728451|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
163278075|NCT03890120|589728452|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
163278076|NCT03890120|589728453|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
163278077|NCT03890120|589728450|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
163278078|NCT03890120|589728451|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
163278079|NCT03890120|589728452|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
163278080|NCT03890120|589728453|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
163278081|NCT01052662|589728454|FG000|Overall Study|Lost to Follow-up|15|||
163278082|NCT01052662|589728455|FG001|Overall Study|Lost to Follow-up|13|||
163278083|NCT01052662|589728456|FG002|Overall Study|Lost to Follow-up|18|||
163278084|NCT01052662|589728454|FG000|Overall Study|Withdrawal by Subject|3|||
163278085|NCT01052662|589728455|FG001|Overall Study|Withdrawal by Subject|2|||
163278086|NCT01052662|589728456|FG002|Overall Study|Withdrawal by Subject|1|||
163278087|NCT01052662|589728454|FG000|Overall Study|Pharmacy issue|1|||
163278088|NCT01052662|589728455|FG001|Overall Study|Pharmacy issue|3|||
163278089|NCT01052662|589728456|FG002|Overall Study|Pharmacy issue|3|||
163278090|NCT01052662|589728454|FG000|Overall Study|Adverse Event|1|||
163278091|NCT01052662|589728455|FG001|Overall Study|Adverse Event|1|||
163278092|NCT01052662|589728456|FG002|Overall Study|Adverse Event|0|||
163278093|NCT01052662|589728454|FG000|Overall Study|Legal Problem|2|||
163278094|NCT01052662|589728455|FG001|Overall Study|Legal Problem|0|||
163278095|NCT01052662|589728456|FG002|Overall Study|Legal Problem|0|||
163278096|NCT01052662|589728454|FG000|Overall Study|Administrative|0|||
163278097|NCT01052662|589728455|FG001|Overall Study|Administrative|3|||
163278098|NCT01052662|589728456|FG002|Overall Study|Administrative|0|||
163278099|NCT00479674|589728457|FG000|Overall Study|Adverse Event|18|||
163278100|NCT00479674|589728457|FG000|Overall Study|Withdrawal by Subject|6|||
163278101|NCT00479674|589728457|FG000|Overall Study|Physician Decision|14|||
163278102|NCT00479674|589728457|FG000|Overall Study|none provided|3|||
163278103|NCT02478359|589728459|FG000|Overall Study|Disenrolled from health plan|106|||
163278104|NCT02478359|589728460|FG001|Overall Study|Disenrolled from health plan|65|||
163278105|NCT03293485|589728462|FG000|Overall Study|Death|1|||
163278106|NCT03293485|589728462|FG000|Overall Study|Screen Failure|2|||
163278107|NCT03293485|589728462|FG000|Overall Study|Withdrawal by Subject|2|||
163278108|NCT01818700|589728463|FG000|Overall Study|Adverse Event|67|||
163278109|NCT01818700|589728463|FG000|Overall Study|Lack of Efficacy|2|||
163278110|NCT01818700|589728463|FG000|Overall Study|Lost to Follow-up|5|||
163278111|NCT01818700|589728463|FG000|Overall Study|Withdrawal by Subject|27|||
163278112|NCT01818700|589728463|FG000|Overall Study|Protocol Violation|2|||
163278113|NCT01818700|589728463|FG000|Overall Study|Other|1|||
163278114|NCT03633903|589728466|FG000|Overall Study|Withdrawal by Subject|1|||
163278115|NCT03633903|589728467|FG001|Overall Study|Withdrawal by Subject|2|||
163278116|NCT03633903|589728466|FG000|Overall Study|Lost to Follow-up|5|||
163278117|NCT03633903|589728467|FG001|Overall Study|Lost to Follow-up|5|||
163278118|NCT03379233|589728474|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
163278119|NCT03379233|589728475|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
163278120|NCT00965484|589728476|FG000|Overall Study|Protocol Violation|1|||
163278121|NCT00965484|589728476|FG000|Overall Study|Withdrawal by Subject|1|||
163278122|NCT02531438|589728477|FG000|Overall Study|Adverse Event|7|||
163278123|NCT02531438|589728478|FG001|Overall Study|Adverse Event|9|||
163278124|NCT02531438|589728477|FG000|Overall Study|Lost to Follow-up|0|||
163278125|NCT02531438|589728478|FG001|Overall Study|Lost to Follow-up|3|||
163278126|NCT02531438|589728477|FG000|Overall Study|Withdrawal by Subject|7|||
163278127|NCT02531438|589728478|FG001|Overall Study|Withdrawal by Subject|8|||
163278128|NCT02531438|589728477|FG000|Overall Study|Physician Decision|0|||
163278129|NCT02531438|589728478|FG001|Overall Study|Physician Decision|1|||
163278130|NCT02531438|589728477|FG000|Overall Study|Death|6|||
163278131|NCT02531438|589728478|FG001|Overall Study|Death|3|||
163278132|NCT02531438|589728477|FG000|Overall Study|Randomized, but Not Treated|4|||
163278133|NCT02531438|589728478|FG001|Overall Study|Randomized, but Not Treated|0|||
163278134|NCT02531438|589728477|FG000|Overall Study|Missed EOT/PTE Visit|5|||
163278135|NCT02531438|589728478|FG001|Overall Study|Missed EOT/PTE Visit|2|||
163278136|NCT02531438|589728477|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
163278137|NCT02531438|589728478|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
163278138|NCT01813422|589728479|FG000|Overall Study|Withdrawal by Subject|14|||
163278139|NCT01813422|589728480|FG001|Overall Study|Withdrawal by Subject|8|||
163278140|NCT01813422|589728479|FG000|Overall Study|Death|2|||
163278141|NCT01813422|589728480|FG001|Overall Study|Death|3|||
163278142|NCT01813422|589728479|FG000|Overall Study|Sponsor Decision|2|||
163278143|NCT01813422|589728480|FG001|Overall Study|Sponsor Decision|1|||
163278144|NCT01813422|589728479|FG000|Overall Study|Lost to Follow-up|2|||
163278145|NCT01813422|589728480|FG001|Overall Study|Lost to Follow-up|4|||
163171513|NCT03039621|589343852|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
163171514|NCT03039621|589343851|FG000|Overall Study|Violation of non-inclusion criteria|1|||
163171515|NCT03039621|589343852|FG001|Overall Study|Violation of non-inclusion criteria|2|||
163171516|NCT02522624|589343853|FG000|Overall Study|Technical failure|1|||
163171517|NCT02522624|589343854|FG001|Overall Study|Technical failure|0|||
163171518|NCT03254108|589343855|FG000|Overall Study|Adverse Event|0|||
163171519|NCT03254108|589343856|FG001|Overall Study|Adverse Event|2|||
163171520|NCT03254108|589343857|FG002|Overall Study|Adverse Event|0|||
163171521|NCT03254108|589343858|FG003|Overall Study|Adverse Event|1|||
163171522|NCT03254108|589343859|FG004|Overall Study|Adverse Event|1|||
163171523|NCT03254108|589343855|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
163171524|NCT03254108|589343856|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
163171525|NCT03254108|589343857|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
163171526|NCT03254108|589343858|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
163171527|NCT03254108|589343859|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
163171528|NCT01771809|589343860|FG000|Overall Study|Adverse Event|4|||
163171529|NCT01771809|589343861|FG001|Overall Study|Adverse Event|12|||
163171530|NCT01771809|589343860|FG000|Overall Study|Protocol Violation|0|||
163171531|NCT01771809|589343861|FG001|Overall Study|Protocol Violation|1|||
163171532|NCT01771809|589343860|FG000|Overall Study|Withdrawal by Subject|34|||
163171533|NCT01771809|589343861|FG001|Overall Study|Withdrawal by Subject|42|||
163171534|NCT01771809|589343860|FG000|Overall Study|Lost to Follow-up|1|||
163171535|NCT01771809|589343861|FG001|Overall Study|Lost to Follow-up|3|||
163171536|NCT01771809|589343860|FG000|Overall Study|Other (Insufficient clinical response)|22|||
163171537|NCT01771809|589343861|FG001|Overall Study|Other (Insufficient clinical response)|20|||
163171538|NCT01771809|589343860|FG000|Overall Study|Death|1|||
163171539|NCT01771809|589343861|FG001|Overall Study|Death|0|||
163171540|NCT01771809|589343860|FG000|Overall Study|Other (other)|9|||
163171541|NCT01771809|589343861|FG001|Overall Study|Other (other)|5|||
163171542|NCT00362180|589343862|FG000|Treated Period|Withdrawal by Subject|1|||
163171543|NCT00362180|589343863|FG001|Treated Period|Withdrawal by Subject|0|||
163171544|NCT00362180|589343864|FG002|Treated Period|Withdrawal by Subject|0|||
163171545|NCT00362180|589343865|FG003|Treated Period|Withdrawal by Subject|0|||
163171546|NCT00362180|589343866|FG004|Treated Period|Withdrawal by Subject|0|||
163171547|NCT00362180|589343867|FG005|Treated Period|Withdrawal by Subject|0|||
163171548|NCT00362180|589343868|FG006|Treated Period|Withdrawal by Subject|0|||
163171549|NCT00362180|589343869|FG007|Treated Period|Withdrawal by Subject|0|||
163171550|NCT00362180|589343870|FG008|Treated Period|Withdrawal by Subject|0|||
163171551|NCT00362180|589343862|FG000|Treated Period|Adverse Event|0|||
163171552|NCT00362180|589343863|FG001|Treated Period|Adverse Event|0|||
163171553|NCT00362180|589343864|FG002|Treated Period|Adverse Event|0|||
163171554|NCT00362180|589343865|FG003|Treated Period|Adverse Event|0|||
163171555|NCT00362180|589343866|FG004|Treated Period|Adverse Event|0|||
163171556|NCT00362180|589343867|FG005|Treated Period|Adverse Event|1|||
163171557|NCT00362180|589343868|FG006|Treated Period|Adverse Event|0|||
163171558|NCT00362180|589343869|FG007|Treated Period|Adverse Event|1|||
163171559|NCT00362180|589343870|FG008|Treated Period|Adverse Event|0|||
163171560|NCT02600871|589343873|FG000|Overall Study|Lost to Follow-up|13|||
163171561|NCT02600871|589343874|FG001|Overall Study|Lost to Follow-up|10|||
163171562|NCT01246466|589343878|FG000|Overall Study|Death|1|||
163171563|NCT01246466|589343878|FG000|Overall Study|Withdrawal by Subject|1|||
163171564|NCT01142089|589343884|FG000|Overall Study|Physician Decision|1|||
163171565|NCT01142089|589343885|FG001|Overall Study|Physician Decision|0|||
163171566|NCT01142089|589343884|FG000|Overall Study|Withdrawal by Subject|1|||
163171567|NCT01142089|589343885|FG001|Overall Study|Withdrawal by Subject|2|||
163171568|NCT01142089|589343884|FG000|Overall Study|Use of prohibited medications|0|||
163171569|NCT01142089|589343885|FG001|Overall Study|Use of prohibited medications|1|||
163171570|NCT01142089|589343884|FG000|Overall Study|Noncompliance with study procedures|2|||
163171571|NCT01142089|589343885|FG001|Overall Study|Noncompliance with study procedures|1|||
163171572|NCT01142089|589343884|FG000|Overall Study|Patient required rescue medication|8|||
163171573|NCT01142089|589343885|FG001|Overall Study|Patient required rescue medication|17|||
163171574|NCT01974765|589343888|FG000|Overall Study|Withdrawal by Subject|1|||
163171575|NCT01974765|589343888|FG000|Overall Study|Death|1|||
163171576|NCT01974765|589343888|FG000|Overall Study|Adverse Event|2|||
163171577|NCT00348933|589343889|FG000|Overall Study|Withdrawal by Subject|10|||
163171578|NCT00348933|589343889|FG000|Overall Study|Lost to Follow-up|6|||
163171579|NCT00348933|589343889|FG000|Overall Study|Protocol Violation|2|||
163171580|NCT00348933|589343889|FG000|Overall Study|Adverse Event|7|||
163171581|NCT01489111|589343890|FG000|Overall Study|Withdrawal criterion|1|||
163171582|NCT00003472|589343895|FG000|Overall Study|Not evaluable|3|||
163171583|NCT00874939|589343896|FG000|Overall Study|Study terminated|4|||
163171584|NCT02870933|589343897|FG000|Overall Study|Death|2|||
163171585|NCT02870933|589343898|FG001|Overall Study|Death|1|||
163171586|NCT02870933|589343897|FG000|Overall Study|Withdrawal by Subject|0|||
163171587|NCT02870933|589343898|FG001|Overall Study|Withdrawal by Subject|1|||
163171588|NCT02168387|589343899|FG000|Overall Study|Planned exubation|6|||
163278146|NCT01653743|589728483|FG000|Overall Study|Withdrawal by Subject|1|||
163278147|NCT01653743|589728484|FG001|Overall Study|Withdrawal by Subject|0|||
163278148|NCT01653743|589728483|FG000|Overall Study|Investigator discretion|3|||
163278149|NCT01653743|589728484|FG001|Overall Study|Investigator discretion|0|||
163278150|NCT02015195|589728486|FG000|Overall Study|Adverse Event|0|||
163278151|NCT02015195|589728487|FG001|Overall Study|Adverse Event|0|||
163278152|NCT02015195|589728488|FG002|Overall Study|Adverse Event|0|||
163278153|NCT02015195|589728489|FG003|Overall Study|Adverse Event|1|||
163278154|NCT02015195|589728490|FG004|Overall Study|Adverse Event|0|||
163278155|NCT02015195|589728491|FG005|Overall Study|Adverse Event|0|||
163278156|NCT02015195|589728492|FG006|Overall Study|Adverse Event|0|||
163278157|NCT00162942|589728499|FG000|Overall Study|Adverse Event|10|||
163278158|NCT00162942|589728500|FG001|Overall Study|Adverse Event|6|||
163278159|NCT00162942|589728499|FG000|Overall Study|Death|1|||
163278160|NCT00162942|589728500|FG001|Overall Study|Death|0|||
163278161|NCT00162942|589728499|FG000|Overall Study|Withdrawal by Subject|3|||
163278162|NCT00162942|589728500|FG001|Overall Study|Withdrawal by Subject|6|||
163278163|NCT00162942|589728499|FG000|Overall Study|Physician Decision|1|||
163278164|NCT00162942|589728500|FG001|Overall Study|Physician Decision|0|||
163278165|NCT00162942|589728499|FG000|Overall Study|Enter Open-Label Study|76|||
163278166|NCT00162942|589728500|FG001|Overall Study|Enter Open-Label Study|35|||
163278167|NCT00162942|589728499|FG000|Overall Study|Alternate Therapy|6|||
163278168|NCT00162942|589728500|FG001|Overall Study|Alternate Therapy|2|||
163278169|NCT00162942|589728499|FG000|Overall Study|Lack of Efficacy|1|||
163278170|NCT00162942|589728500|FG001|Overall Study|Lack of Efficacy|0|||
163278171|NCT00162942|589728499|FG000|Overall Study|Flare During Active Treatment|7|||
163278172|NCT00162942|589728500|FG001|Overall Study|Flare During Active Treatment|3|||
163278173|NCT00162942|589728499|FG000|Overall Study|2 or more consecutive treatments missed|1|||
163278174|NCT00162942|589728500|FG001|Overall Study|2 or more consecutive treatments missed|0|||
163278175|NCT00410384|589728501|FG000|Overall Study|Withdrawal by Subject|28|||
163278176|NCT00410384|589728502|FG001|Overall Study|Withdrawal by Subject|17|||
163278177|NCT00410384|589728503|FG002|Overall Study|Withdrawal by Subject|20|||
163278178|NCT00410384|589728501|FG000|Overall Study|Adverse Event|23|||
163278179|NCT00410384|589728502|FG001|Overall Study|Adverse Event|18|||
163278180|NCT00410384|589728503|FG002|Overall Study|Adverse Event|23|||
163278181|NCT00410384|589728501|FG000|Overall Study|Lack of Efficacy|20|||
163278182|NCT00410384|589728502|FG001|Overall Study|Lack of Efficacy|12|||
163278183|NCT00410384|589728503|FG002|Overall Study|Lack of Efficacy|17|||
163278184|NCT00410384|589728501|FG000|Overall Study|Lack of Compliance|2|||
163278185|NCT00410384|589728502|FG001|Overall Study|Lack of Compliance|2|||
163278186|NCT00410384|589728503|FG002|Overall Study|Lack of Compliance|2|||
163278187|NCT00410384|589728501|FG000|Overall Study|Lost to Follow-up|4|||
163278188|NCT00410384|589728502|FG001|Overall Study|Lost to Follow-up|6|||
163278189|NCT00410384|589728503|FG002|Overall Study|Lost to Follow-up|6|||
163278190|NCT00410384|589728501|FG000|Overall Study|Protocol Violation|6|||
163278191|NCT00410384|589728502|FG001|Overall Study|Protocol Violation|6|||
163171589|NCT02168387|589343900|FG001|Overall Study|Planned exubation|3|||
163171590|NCT02168387|589343899|FG000|Overall Study|Death|1|||
163171591|NCT02168387|589343900|FG001|Overall Study|Death|0|||
163171592|NCT01350544|589343902|FG000|Overall Study|Administrative Withdrawal|0|||
163171593|NCT01350544|589343903|FG001|Overall Study|Administrative Withdrawal|1|||
163171594|NCT01350544|589343902|FG000|Overall Study|Death|1|||
163171595|NCT01350544|589343903|FG001|Overall Study|Death|2|||
163171596|NCT01350544|589343902|FG000|Overall Study|Moved out of LA County|2|||
163171597|NCT01350544|589343903|FG001|Overall Study|Moved out of LA County|2|||
163171598|NCT01350544|589343902|FG000|Overall Study|Medical Issues|1|||
163171599|NCT01350544|589343903|FG001|Overall Study|Medical Issues|1|||
163171600|NCT01350544|589343902|FG000|Overall Study|Withdrawal by Subject|0|||
163171601|NCT01350544|589343903|FG001|Overall Study|Withdrawal by Subject|1|||
163278192|NCT00410384|589728503|FG002|Overall Study|Protocol Violation|6|||
163278193|NCT00410384|589728501|FG000|Overall Study|Physician Decision|3|||
163278194|NCT00410384|589728502|FG001|Overall Study|Physician Decision|3|||
163278195|NCT00410384|589728503|FG002|Overall Study|Physician Decision|4|||
163278196|NCT00410384|589728501|FG000|Overall Study|Other|3|||
163278197|NCT00410384|589728502|FG001|Overall Study|Other|8|||
163278198|NCT00410384|589728503|FG002|Overall Study|Other|4|||
163278199|NCT00783718|589728506|FG000|Induction Phase|Adverse Event|4|||
163278200|NCT00783718|589728507|FG001|Induction Phase|Adverse Event|0|||
163278201|NCT00783718|589728508|FG002|Induction Phase|Adverse Event|7|||
163278202|NCT00783718|589728509|FG003|Induction Phase|Adverse Event|0|||
163278203|NCT00783718|589728510|FG004|Induction Phase|Adverse Event|0|||
163278204|NCT00783718|589728511|FG005|Induction Phase|Adverse Event|0|||
163171602|NCT01350544|589343902|FG000|Overall Study|Incarceration|1|||
163171603|NCT01350544|589343903|FG001|Overall Study|Incarceration|0|||
163171604|NCT01350544|589343902|FG000|Overall Study|Lost to Follow-up|18|||
163171605|NCT01350544|589343903|FG001|Overall Study|Lost to Follow-up|15|||
163278205|NCT00783718|589728512|FG006|Induction Phase|Adverse Event|0|||
163278206|NCT00783718|589728506|FG000|Induction Phase|Protocol Violation|1|||
163171606|NCT01444092|589343904|FG000|Overall Study|Adverse Event|8|||
163171607|NCT01444092|589343904|FG000|Overall Study|Protocol Violation|1|||
163171608|NCT01444092|589343904|FG000|Overall Study|Withdrawal by Subject|1|||
163171609|NCT01444092|589343904|FG000|Overall Study|Other Eligibility criteria|7|||
163171610|NCT00603590|589343905|FG000|Overall Study|Did not attend study clinic|39|||
163171611|NCT00603590|589343906|FG001|Overall Study|Did not attend study clinic|30|||
163171612|NCT00603590|589343905|FG000|Overall Study|Refused blood test|5|||
163171613|NCT00603590|589343906|FG001|Overall Study|Refused blood test|1|||
163171614|NCT00603590|589343905|FG000|Overall Study|Patient discontinued study drug|22|||
163171615|NCT00603590|589343906|FG001|Overall Study|Patient discontinued study drug|15|||
163171616|NCT00603590|589343905|FG000|Overall Study|Adverse Event|2|||
163171617|NCT00603590|589343906|FG001|Overall Study|Adverse Event|0|||
163171618|NCT00603590|589343905|FG000|Overall Study|Lost to Follow-up|8|||
163171619|NCT00603590|589343906|FG001|Overall Study|Lost to Follow-up|4|||
163171620|NCT00603590|589343905|FG000|Overall Study|Cardiovascular event|0|||
163171621|NCT00603590|589343906|FG001|Overall Study|Cardiovascular event|1|||
163171622|NCT00910624|589343910|FG000|Treatment Phase|Adverse Event|2|||
163171623|NCT00910624|589343911|FG001|Treatment Phase|Adverse Event|6|||
163171624|NCT00910624|589343912|FG002|Treatment Phase|Adverse Event|6|||
163171625|NCT00910624|589343913|FG003|Treatment Phase|Adverse Event|0|||
163171626|NCT00910624|589343910|FG000|Treatment Phase|Treatment Failure|23|||
163171627|NCT00910624|589343911|FG001|Treatment Phase|Treatment Failure|10|||
163278207|NCT00783718|589728507|FG001|Induction Phase|Protocol Violation|1|||
163278208|NCT00783718|589728508|FG002|Induction Phase|Protocol Violation|6|||
163278209|NCT00783718|589728509|FG003|Induction Phase|Protocol Violation|0|||
163278210|NCT00783718|589728510|FG004|Induction Phase|Protocol Violation|0|||
163278211|NCT00783718|589728511|FG005|Induction Phase|Protocol Violation|0|||
163278212|NCT00783718|589728512|FG006|Induction Phase|Protocol Violation|0|||
163278213|NCT00783718|589728506|FG000|Induction Phase|Lack of Efficacy|5|||
163278214|NCT00783718|589728507|FG001|Induction Phase|Lack of Efficacy|2|||
163278215|NCT00783718|589728508|FG002|Induction Phase|Lack of Efficacy|14|||
163278216|NCT00783718|589728509|FG003|Induction Phase|Lack of Efficacy|0|||
163278217|NCT00783718|589728510|FG004|Induction Phase|Lack of Efficacy|0|||
163278218|NCT00783718|589728511|FG005|Induction Phase|Lack of Efficacy|0|||
163278219|NCT00783718|589728512|FG006|Induction Phase|Lack of Efficacy|0|||
163278220|NCT00783718|589728506|FG000|Induction Phase|Withdrawal by Subject|3|||
163278221|NCT00783718|589728507|FG001|Induction Phase|Withdrawal by Subject|4|||
163278222|NCT00783718|589728508|FG002|Induction Phase|Withdrawal by Subject|8|||
163278223|NCT00783718|589728509|FG003|Induction Phase|Withdrawal by Subject|0|||
163278224|NCT00783718|589728510|FG004|Induction Phase|Withdrawal by Subject|0|||
163171628|NCT00910624|589343912|FG002|Treatment Phase|Treatment Failure|0|||
163171629|NCT00910624|589343913|FG003|Treatment Phase|Treatment Failure|0|||
163171630|NCT00910624|589343910|FG000|Treatment Phase|Lost to Follow-up|0|||
163171631|NCT00910624|589343911|FG001|Treatment Phase|Lost to Follow-up|0|||
163278225|NCT00783718|589728511|FG005|Induction Phase|Withdrawal by Subject|0|||
163278226|NCT00783718|589728512|FG006|Induction Phase|Withdrawal by Subject|0|||
163278227|NCT00783718|589728506|FG000|Induction Phase|Lost to Follow-up|1|||
163278228|NCT00783718|589728507|FG001|Induction Phase|Lost to Follow-up|0|||
163278229|NCT00783718|589728508|FG002|Induction Phase|Lost to Follow-up|1|||
163278230|NCT00783718|589728509|FG003|Induction Phase|Lost to Follow-up|0|||
163278231|NCT00783718|589728510|FG004|Induction Phase|Lost to Follow-up|0|||
163278232|NCT00783718|589728511|FG005|Induction Phase|Lost to Follow-up|0|||
163171632|NCT00910624|589343912|FG002|Treatment Phase|Lost to Follow-up|1|||
163278233|NCT00783718|589728512|FG006|Induction Phase|Lost to Follow-up|0|||
163171633|NCT00910624|589343913|FG003|Treatment Phase|Lost to Follow-up|0|||
163171634|NCT00910624|589343910|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
163171635|NCT00910624|589343911|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
163278234|NCT00783718|589728506|FG000|Maintenance Phase|Adverse Event|12|||
163171636|NCT00910624|589343912|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
163171637|NCT00910624|589343913|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
163171638|NCT00910624|589343910|FG000|Treatment Phase|Withdrawal by Subject|2|||
163278235|NCT00783718|589728507|FG001|Maintenance Phase|Adverse Event|0|||
163278236|NCT00783718|589728508|FG002|Maintenance Phase|Adverse Event|0|||
163278237|NCT00783718|589728509|FG003|Maintenance Phase|Adverse Event|15|||
163278238|NCT00783718|589728510|FG004|Maintenance Phase|Adverse Event|7|||
163278239|NCT00783718|589728511|FG005|Maintenance Phase|Adverse Event|6|||
163278240|NCT00783718|589728512|FG006|Maintenance Phase|Adverse Event|16|||
163278241|NCT00783718|589728506|FG000|Maintenance Phase|Protocol Violation|1|||
163278242|NCT00783718|589728507|FG001|Maintenance Phase|Protocol Violation|0|||
163278243|NCT00783718|589728508|FG002|Maintenance Phase|Protocol Violation|0|||
163278244|NCT00783718|589728509|FG003|Maintenance Phase|Protocol Violation|0|||
163278245|NCT00783718|589728510|FG004|Maintenance Phase|Protocol Violation|0|||
163278246|NCT00783718|589728511|FG005|Maintenance Phase|Protocol Violation|0|||
163278247|NCT00783718|589728512|FG006|Maintenance Phase|Protocol Violation|2|||
163278248|NCT00783718|589728506|FG000|Maintenance Phase|Lack of Efficacy|83|||
163278249|NCT00783718|589728507|FG001|Maintenance Phase|Lack of Efficacy|0|||
163278250|NCT00783718|589728508|FG002|Maintenance Phase|Lack of Efficacy|0|||
163278251|NCT00783718|589728509|FG003|Maintenance Phase|Lack of Efficacy|61|||
163278252|NCT00783718|589728510|FG004|Maintenance Phase|Lack of Efficacy|31|||
163278253|NCT00783718|589728511|FG005|Maintenance Phase|Lack of Efficacy|33|||
163278254|NCT00783718|589728512|FG006|Maintenance Phase|Lack of Efficacy|155|||
163278255|NCT00783718|589728506|FG000|Maintenance Phase|Withdrawal by Subject|6|||
163278256|NCT00783718|589728507|FG001|Maintenance Phase|Withdrawal by Subject|0|||
163278257|NCT00783718|589728508|FG002|Maintenance Phase|Withdrawal by Subject|0|||
163278258|NCT00783718|589728509|FG003|Maintenance Phase|Withdrawal by Subject|2|||
163278259|NCT00783718|589728510|FG004|Maintenance Phase|Withdrawal by Subject|5|||
163278260|NCT00783718|589728511|FG005|Maintenance Phase|Withdrawal by Subject|2|||
163278261|NCT00783718|589728512|FG006|Maintenance Phase|Withdrawal by Subject|20|||
163278262|NCT00783718|589728506|FG000|Maintenance Phase|Lost to Follow-up|3|||
163278263|NCT00783718|589728507|FG001|Maintenance Phase|Lost to Follow-up|0|||
163278264|NCT00783718|589728508|FG002|Maintenance Phase|Lost to Follow-up|0|||
163278265|NCT00783718|589728509|FG003|Maintenance Phase|Lost to Follow-up|0|||
163278266|NCT00783718|589728510|FG004|Maintenance Phase|Lost to Follow-up|2|||
163278267|NCT00783718|589728511|FG005|Maintenance Phase|Lost to Follow-up|0|||
163278268|NCT00783718|589728512|FG006|Maintenance Phase|Lost to Follow-up|2|||
163278269|NCT01192295|589728513|FG000|Overall Study|Adverse Event|3|||
163278270|NCT01192295|589728514|FG001|Overall Study|Adverse Event|7|||
163278271|NCT01192295|589728513|FG000|Overall Study|Withdrawal by Subject|3|||
163278272|NCT01192295|589728514|FG001|Overall Study|Withdrawal by Subject|4|||
163278273|NCT01192295|589728513|FG000|Overall Study|Lost to Follow-up|0|||
163278274|NCT01192295|589728514|FG001|Overall Study|Lost to Follow-up|1|||
163278275|NCT01192295|589728513|FG000|Overall Study|Lack of Efficacy|0|||
163278276|NCT01192295|589728514|FG001|Overall Study|Lack of Efficacy|5|||
163278277|NCT01192295|589728513|FG000|Overall Study|Administrative|4|||
163278278|NCT01192295|589728514|FG001|Overall Study|Administrative|6|||
163278279|NCT00630539|589728515|FG000|Overall Study|Adverse Event|1|||
163278280|NCT00630539|589728516|FG001|Overall Study|Adverse Event|3|||
163278281|NCT00630539|589728517|FG002|Overall Study|Adverse Event|1|||
163278282|NCT00630539|589728518|FG003|Overall Study|Adverse Event|2|||
163278283|NCT00630539|589728515|FG000|Overall Study|Withdrawal by Subject|0|||
163278284|NCT00630539|589728516|FG001|Overall Study|Withdrawal by Subject|1|||
163278285|NCT00630539|589728517|FG002|Overall Study|Withdrawal by Subject|0|||
163278286|NCT00630539|589728518|FG003|Overall Study|Withdrawal by Subject|1|||
163278287|NCT00577629|589728530|FG000|Treatment Period|Death|1|||
163278288|NCT00577629|589728530|FG000|Long Term Follow-Up|Death|15|||
163278289|NCT00577629|589728530|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
163278290|NCT00577629|589728530|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
163278291|NCT00577629|589728530|FG000|Long Term Follow-Up|Physician Decision|1|||
163278292|NCT02929108|589728533|FG000|Overall Study|Hospice patient death|100|||
163278293|NCT02929108|589728534|FG001|Overall Study|Hospice patient death|64|||
163278294|NCT02929108|589728535|FG002|Overall Study|Hospice patient death|28|||
163278295|NCT02929108|589728536|FG003|Overall Study|Hospice patient death|46|||
163278296|NCT02929108|589728537|FG004|Overall Study|Hospice patient death|55|||
163278297|NCT02929108|589728538|FG005|Overall Study|Hospice patient death|28|||
163278298|NCT02929108|589728539|FG006|Overall Study|Hospice patient death|78|||
163278299|NCT01027871|589728540|FG000|Overall Study|Physician Decision|1|||
163278300|NCT01027871|589728541|FG001|Overall Study|Physician Decision|5|||
163278301|NCT01027871|589728542|FG002|Overall Study|Physician Decision|0|||
163278302|NCT01027871|589728540|FG000|Overall Study|Protocol Violation|0|||
163278303|NCT01027871|589728541|FG001|Overall Study|Protocol Violation|2|||
163278304|NCT01027871|589728542|FG002|Overall Study|Protocol Violation|2|||
163278305|NCT01027871|589728540|FG000|Overall Study|Withdrawal by Subject|1|||
163278306|NCT01027871|589728541|FG001|Overall Study|Withdrawal by Subject|2|||
163278307|NCT01027871|589728542|FG002|Overall Study|Withdrawal by Subject|2|||
163278308|NCT01027871|589728540|FG000|Overall Study|Adverse Event|0|||
163278309|NCT01027871|589728541|FG001|Overall Study|Adverse Event|2|||
163171639|NCT00910624|589343911|FG001|Treatment Phase|Withdrawal by Subject|1|||
163171640|NCT00910624|589343912|FG002|Treatment Phase|Withdrawal by Subject|0|||
163171641|NCT00910624|589343913|FG003|Treatment Phase|Withdrawal by Subject|0|||
163171642|NCT00910624|589343910|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
163171643|NCT00910624|589343911|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
163171644|NCT00910624|589343912|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
163171645|NCT00910624|589343913|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
163171646|NCT00910624|589343910|FG000|Follow-Up Phase|Adverse Event|0|||
163171647|NCT00910624|589343911|FG001|Follow-Up Phase|Adverse Event|0|||
163171648|NCT00910624|589343912|FG002|Follow-Up Phase|Adverse Event|1|||
163171649|NCT00910624|589343913|FG003|Follow-Up Phase|Adverse Event|0|||
163171650|NCT00910624|589343910|FG000|Follow-Up Phase|Lost to Follow-up|3|||
163171651|NCT00910624|589343911|FG001|Follow-Up Phase|Lost to Follow-up|1|||
163171652|NCT00910624|589343912|FG002|Follow-Up Phase|Lost to Follow-up|2|||
163171653|NCT00910624|589343913|FG003|Follow-Up Phase|Lost to Follow-up|0|||
163171654|NCT00910624|589343910|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
163171655|NCT00910624|589343911|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
163171656|NCT00910624|589343912|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
163171657|NCT00910624|589343913|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
163171658|NCT00910624|589343910|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
163171659|NCT00910624|589343911|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
163171660|NCT00910624|589343912|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
163171661|NCT00910624|589343913|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
163171662|NCT00910624|589343910|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
163171663|NCT00910624|589343911|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
163171664|NCT00910624|589343912|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
163171665|NCT00910624|589343913|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
163171666|NCT00910624|589343910|FG000|Follow-Up Phase|Administrative|0|||
163171667|NCT00910624|589343911|FG001|Follow-Up Phase|Administrative|1|||
163171668|NCT00910624|589343912|FG002|Follow-Up Phase|Administrative|1|||
163171669|NCT00910624|589343913|FG003|Follow-Up Phase|Administrative|0|||
163171670|NCT03005873|589343914|FG000|Overall Study|Prohibited medication use post radnomization|1|||
163171671|NCT03005873|589343915|FG001|Overall Study|Prohibited medication use post radnomization|1|||
163171672|NCT03005873|589343916|FG002|Overall Study|Prohibited medication use post radnomization|1|||
163171673|NCT03005873|589343914|FG000|Overall Study|Withdrew consent|0|||
163171674|NCT03005873|589343915|FG001|Overall Study|Withdrew consent|1|||
163171675|NCT03005873|589343916|FG002|Overall Study|Withdrew consent|2|||
163171676|NCT03005873|589343914|FG000|Overall Study|Lost to Follow-up|0|||
163171677|NCT03005873|589343915|FG001|Overall Study|Lost to Follow-up|1|||
163171678|NCT03005873|589343916|FG002|Overall Study|Lost to Follow-up|0|||
163171679|NCT03005873|589343914|FG000|Overall Study|Ineligible post randomization|0|||
163171680|NCT03005873|589343915|FG001|Overall Study|Ineligible post randomization|0|||
163171681|NCT03005873|589343916|FG002|Overall Study|Ineligible post randomization|1|||
163171682|NCT04585009|589343917|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
163171683|NCT04585009|589343918|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171684|NCT04585009|589343919|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171685|NCT04585009|589343920|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171686|NCT04585009|589343921|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171687|NCT04585009|589343922|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171688|NCT04585009|589343923|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171689|NCT04585009|589343924|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171690|NCT04585009|589343925|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171691|NCT04585009|589343926|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171692|NCT04585009|589343927|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171693|NCT04585009|589343928|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171694|NCT04585009|589343917|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
163171695|NCT04585009|589343918|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171696|NCT04585009|589343919|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171697|NCT04585009|589343920|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171698|NCT04585009|589343921|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171699|NCT04585009|589343922|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171700|NCT04585009|589343923|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171701|NCT04585009|589343924|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171702|NCT04585009|589343925|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171703|NCT04585009|589343926|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171704|NCT04585009|589343927|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171705|NCT04585009|589343928|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171706|NCT04585009|589343917|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163278310|NCT01027871|589728542|FG002|Overall Study|Adverse Event|2|||
163278311|NCT01027871|589728540|FG000|Overall Study|Sponsor Decision|0|||
163278312|NCT01027871|589728541|FG001|Overall Study|Sponsor Decision|2|||
163278313|NCT01027871|589728542|FG002|Overall Study|Sponsor Decision|0|||
163278314|NCT01027871|589728540|FG000|Overall Study|Discontinued Prior to Treatment|0|||
163278315|NCT01027871|589728541|FG001|Overall Study|Discontinued Prior to Treatment|0|||
163278316|NCT01027871|589728542|FG002|Overall Study|Discontinued Prior to Treatment|1|||
163278317|NCT01414166|589728543|FG000|Overall Study|Adverse Event|10|||
163278318|NCT01414166|589728544|FG001|Overall Study|Adverse Event|2|||
163278319|NCT01414166|589728543|FG000|Overall Study|Lost to Follow-up|4|||
163278320|NCT01414166|589728544|FG001|Overall Study|Lost to Follow-up|1|||
163278321|NCT01414166|589728543|FG000|Overall Study|Non-compliance with study drug|2|||
163278322|NCT01414166|589728544|FG001|Overall Study|Non-compliance with study drug|0|||
163278323|NCT01414166|589728543|FG000|Overall Study|Physician Decision|2|||
163278324|NCT01414166|589728544|FG001|Overall Study|Physician Decision|0|||
163278325|NCT01414166|589728543|FG000|Overall Study|Protocol Violation|2|||
163278326|NCT01414166|589728544|FG001|Overall Study|Protocol Violation|0|||
163278327|NCT01414166|589728543|FG000|Overall Study|Study terminated by Sponsor|68|||
163278328|NCT01414166|589728544|FG001|Overall Study|Study terminated by Sponsor|75|||
163278329|NCT01414166|589728543|FG000|Overall Study|Withdrawal by Subject|3|||
163278330|NCT01414166|589728544|FG001|Overall Study|Withdrawal by Subject|5|||
163278331|NCT05489224|589728545|FG000|Treatment Period I|Withdrawal by Subject|6|||
163278332|NCT05489224|589728546|FG001|Treatment Period I|Withdrawal by Subject|5|||
163278333|NCT05489224|589728547|FG002|Treatment Period I|Withdrawal by Subject|0|||
163278334|NCT05489224|589728545|FG000|Treatment Period I|Adverse Event|3|||
163278335|NCT05489224|589728546|FG001|Treatment Period I|Adverse Event|11|||
163278336|NCT05489224|589728547|FG002|Treatment Period I|Adverse Event|0|||
163278337|NCT05489224|589728545|FG000|Treatment Period I|Lost to Follow-up|0|||
163278338|NCT05489224|589728546|FG001|Treatment Period I|Lost to Follow-up|1|||
163278339|NCT05489224|589728547|FG002|Treatment Period I|Lost to Follow-up|0|||
163278340|NCT05489224|589728545|FG000|Treatment Period I|Physician Decision|0|||
163278341|NCT05489224|589728546|FG001|Treatment Period I|Physician Decision|1|||
163278342|NCT05489224|589728547|FG002|Treatment Period I|Physician Decision|0|||
163278343|NCT05489224|589728545|FG000|Treatment Period II up to Week 32|Ongoing|222|||
163278344|NCT05489224|589728546|FG001|Treatment Period II up to Week 32|Ongoing|107|||
163278345|NCT05489224|589728547|FG002|Treatment Period II up to Week 32|Ongoing|107|||
163278346|NCT05489224|589728545|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
163278347|NCT05489224|589728546|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
163278348|NCT05489224|589728547|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
163278349|NCT05489224|589728545|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
163278350|NCT05489224|589728546|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
163278351|NCT05489224|589728547|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
163278352|NCT04887285|589728548|FG000|Overall Study|Lost to Follow-up|0|||
163278353|NCT04887285|589728549|FG001|Overall Study|Lost to Follow-up|2|||
163278354|NCT04887285|589728550|FG002|Overall Study|Lost to Follow-up|3|||
163278355|NCT04640571|589728551|FG000|Overall Study|Withdrawal by Subject|0|||
163278356|NCT04640571|589728552|FG001|Overall Study|Withdrawal by Subject|0|||
163278357|NCT04640571|589728553|FG002|Overall Study|Withdrawal by Subject|0|||
163278358|NCT04640571|589728554|FG003|Overall Study|Withdrawal by Subject|0|||
163278359|NCT04640571|589728555|FG004|Overall Study|Withdrawal by Subject|0|||
163278360|NCT04640571|589728556|FG005|Overall Study|Withdrawal by Subject|2|||
163278361|NCT00832780|589728561|FG000|Overall Study|Death|16|||
163278362|NCT00832780|589728561|FG000|Overall Study|Lost to Follow-up|4|||
163278363|NCT00832780|589728561|FG000|Overall Study|no reason given|2|||
163278364|NCT00832780|589728561|FG000|Overall Study|other complicating condition|2|||
163278365|NCT00832780|589728561|FG000|Overall Study|Physician Decision|1|||
163278366|NCT05705167|589728562|FG000|Overall Study|Randomised but not Treated|0|||
163278367|NCT05705167|589728563|FG001|Overall Study|Randomised but not Treated|2|||
163278368|NCT05705167|589728564|FG002|Overall Study|Randomised but not Treated|0|||
163278369|NCT05705167|589728565|FG003|Overall Study|Randomised but not Treated|7|||
163278370|NCT05705167|589728566|FG004|Overall Study|Randomised but not Treated|0|||
163278371|NCT05705167|589728567|FG005|Overall Study|Randomised but not Treated|0|||
163278372|NCT05705167|589728568|FG006|Overall Study|Randomised but not Treated|0|||
163278373|NCT05705167|589728562|FG000|Overall Study|Death|0|||
163278374|NCT05705167|589728563|FG001|Overall Study|Death|0|||
163278375|NCT05705167|589728564|FG002|Overall Study|Death|3|||
163278376|NCT05705167|589728565|FG003|Overall Study|Death|0|||
163278377|NCT05705167|589728566|FG004|Overall Study|Death|1|||
163278378|NCT05705167|589728567|FG005|Overall Study|Death|1|||
163278379|NCT05705167|589728568|FG006|Overall Study|Death|1|||
163278380|NCT05705167|589728562|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
163278381|NCT05705167|589728563|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
163278382|NCT05705167|589728564|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
163278383|NCT05705167|589728565|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
163278384|NCT05705167|589728566|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
163278385|NCT05705167|589728567|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
163278386|NCT05705167|589728568|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
163278387|NCT03658811|589728571|FG000|Overall Study|Lost to Follow-up|3|||
163171707|NCT04585009|589343918|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171708|NCT04585009|589343919|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171709|NCT04585009|589343920|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171710|NCT04585009|589343921|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171711|NCT04585009|589343922|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171712|NCT04585009|589343923|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171713|NCT04585009|589343924|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
163171714|NCT04585009|589343925|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171715|NCT04585009|589343926|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171716|NCT04585009|589343927|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171717|NCT04585009|589343928|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163278388|NCT04209790|589728572|FG000|Overall Study|Physician Decision|1|||
163278389|NCT04060680|589728573|FG000|Overall Study|Unsuccessful implant|17|||
163278390|NCT04060680|589728574|FG001|Overall Study|Unsuccessful implant|2|||
163278391|NCT04060680|589728573|FG000|Overall Study|Adverse Event|3|||
163278392|NCT04060680|589728574|FG001|Overall Study|Adverse Event|0|||
163278393|NCT04060680|589728573|FG000|Overall Study|Death|2|||
163278394|NCT04060680|589728574|FG001|Overall Study|Death|0|||
163278395|NCT04060680|589728573|FG000|Overall Study|Study product no longer in use|1|||
163278396|NCT04060680|589728574|FG001|Overall Study|Study product no longer in use|0|||
163278397|NCT04060680|589728573|FG000|Overall Study|Withdrawal by Subject|1|||
163278398|NCT04060680|589728574|FG001|Overall Study|Withdrawal by Subject|0|||
163278399|NCT04482855|589728575|FG000|Overall Study|Lost to Follow-up|1|||
163278400|NCT04482855|589728576|FG001|Overall Study|Lost to Follow-up|0|||
163278401|NCT04482855|589728575|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
163278402|NCT04482855|589728576|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
163278403|NCT04482855|589728575|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
163278404|NCT04482855|589728576|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
163278405|NCT02320721|589728580|FG000|Overall Study|Adverse Event|6|||
163278406|NCT02320721|589728581|FG001|Overall Study|Adverse Event|6|||
163278407|NCT02320721|589728580|FG000|Overall Study|Lack of Efficacy|2|||
163278408|NCT02320721|589728581|FG001|Overall Study|Lack of Efficacy|0|||
163278409|NCT02320721|589728580|FG000|Overall Study|Poor compliance to protocol|3|||
163278410|NCT02320721|589728581|FG001|Overall Study|Poor compliance to protocol|7|||
163278411|NCT02320721|589728580|FG000|Overall Study|Randomized but not treated|0|||
163278412|NCT02320721|589728581|FG001|Overall Study|Randomized but not treated|1|||
163278413|NCT02320721|589728580|FG000|Overall Study|Hypoglycemia|1|||
163278414|NCT02320721|589728581|FG001|Overall Study|Hypoglycemia|0|||
163278415|NCT02320721|589728580|FG000|Overall Study|Other than specified above|15|||
163278416|NCT02320721|589728581|FG001|Overall Study|Other than specified above|20|||
163278417|NCT03173248|589728582|FG000|Overall Study|Death|28|||
163278418|NCT03173248|589728583|FG001|Overall Study|Death|46|||
163278419|NCT03173248|589728582|FG000|Overall Study|Lost to Follow-up|0|||
163278420|NCT03173248|589728583|FG001|Overall Study|Lost to Follow-up|1|||
163278421|NCT03173248|589728582|FG000|Overall Study|Withdrawal by Subject|6|||
163278422|NCT03173248|589728583|FG001|Overall Study|Withdrawal by Subject|4|||
163278423|NCT03173248|589728582|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
163278424|NCT03173248|589728583|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
163278425|NCT01544582|589728584|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
163278426|NCT01544582|589728585|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
163171718|NCT04585009|589343917|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171719|NCT04585009|589343918|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171720|NCT04585009|589343919|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171721|NCT04585009|589343920|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171722|NCT04585009|589343921|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
163171723|NCT04585009|589343922|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171724|NCT04585009|589343923|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171725|NCT04585009|589343924|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171726|NCT04585009|589343925|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171727|NCT04585009|589343926|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171728|NCT04585009|589343927|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171729|NCT04585009|589343928|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171730|NCT04585009|589343917|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171731|NCT04585009|589343918|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171732|NCT04585009|589343919|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171733|NCT04585009|589343920|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171734|NCT04585009|589343921|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171735|NCT04585009|589343922|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171736|NCT04585009|589343923|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171737|NCT04585009|589343924|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171738|NCT04585009|589343925|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171739|NCT04585009|589343926|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
163171740|NCT04585009|589343927|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171741|NCT04585009|589343928|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171742|NCT04585009|589343917|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171743|NCT04585009|589343918|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171744|NCT04585009|589343919|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171745|NCT04585009|589343920|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171746|NCT04585009|589343921|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171747|NCT04585009|589343922|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171748|NCT04585009|589343923|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171749|NCT04585009|589343924|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171750|NCT04585009|589343925|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171751|NCT04585009|589343926|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171752|NCT04585009|589343927|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171753|NCT04585009|589343928|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
163171754|NCT04618770|589343937|FG000|Overall Study|Censored from Analysis|12|||
163171755|NCT04618770|589343937|FG000|Overall Study|Early Termination|25|||
163171756|NCT00640224|589343940|FG000|Overall Study|Lost to Follow-up|5|||
163171757|NCT00640224|589343941|FG001|Overall Study|Lost to Follow-up|2|||
163171758|NCT00640224|589343942|FG002|Overall Study|Lost to Follow-up|0|||
163171759|NCT00640224|589343943|FG003|Overall Study|Lost to Follow-up|0|||
163171760|NCT00640224|589343940|FG000|Overall Study|Withdrawal by Subject|1|||
163171761|NCT00640224|589343941|FG001|Overall Study|Withdrawal by Subject|0|||
163171762|NCT00640224|589343942|FG002|Overall Study|Withdrawal by Subject|0|||
163171763|NCT00640224|589343943|FG003|Overall Study|Withdrawal by Subject|0|||
163171764|NCT00640224|589343940|FG000|Overall Study|Headaches|0|||
163171765|NCT00640224|589343941|FG001|Overall Study|Headaches|1|||
163171766|NCT00640224|589343942|FG002|Overall Study|Headaches|0|||
163171767|NCT00640224|589343943|FG003|Overall Study|Headaches|0|||
163171768|NCT01252667|589343944|FG000|Overall Study|Transplant aborted post-conditioning|0|||
163171769|NCT01252667|589343945|FG001|Overall Study|Transplant aborted post-conditioning|0|||
163171770|NCT01252667|589343946|FG002|Overall Study|Transplant aborted post-conditioning|0|||
163171771|NCT01252667|589343947|FG003|Overall Study|Transplant aborted post-conditioning|0|||
163171772|NCT01252667|589343948|FG004|Overall Study|Transplant aborted post-conditioning|0|||
163171773|NCT01252667|589343949|FG005|Overall Study|Transplant aborted post-conditioning|1|||
163171774|NCT04644315|589343950|FG000|Overall Study|Subject withdrawal of consent|1|||
163171775|NCT00294762|589343951|FG000|Overall Study|Did not receive study treatment|3|||
163171776|NCT00294762|589343952|FG001|Overall Study|Did not receive study treatment|3|||
163171777|NCT01738646|589343953|FG000|Overall Study|Still Receiving Treatment|2|||
163171778|NCT04493892|589343960|FG000|Overall Study|Withdrawal by Subject|15|||
163171779|NCT02577887|589343961|FG000|Overall Study|Death|93|||
163171780|NCT02577887|589343961|FG000|Overall Study|Protocol Violation|125|||
163278427|NCT01544582|589728586|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
163278428|NCT01544582|589728587|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
163278429|NCT01544582|589728584|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
163278430|NCT01544582|589728585|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
163278431|NCT01544582|589728586|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
163278432|NCT01544582|589728587|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
163278433|NCT01544582|589728584|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
163278434|NCT01544582|589728585|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
163278435|NCT01544582|589728586|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
163278436|NCT01544582|589728587|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
163278437|NCT01544582|589728584|FG000|Analysis Population|Physician Decision|0|||
163278438|NCT01544582|589728585|FG001|Analysis Population|Physician Decision|13|||
163278439|NCT01544582|589728586|FG002|Analysis Population|Physician Decision|10|||
163278440|NCT01544582|589728587|FG003|Analysis Population|Physician Decision|9|||
163278441|NCT01544582|589728584|FG000|Analysis Population|Safety Reason|0|||
163278442|NCT01544582|589728585|FG001|Analysis Population|Safety Reason|33|||
163278443|NCT01544582|589728586|FG002|Analysis Population|Safety Reason|31|||
163278444|NCT01544582|589728587|FG003|Analysis Population|Safety Reason|8|||
163278445|NCT01544582|589728584|FG000|Analysis Population|Effectiveness Reason|0|||
163278446|NCT01544582|589728585|FG001|Analysis Population|Effectiveness Reason|48|||
163278447|NCT01544582|589728586|FG002|Analysis Population|Effectiveness Reason|29|||
163278448|NCT01544582|589728587|FG003|Analysis Population|Effectiveness Reason|12|||
163278449|NCT01544582|589728584|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
163278450|NCT01544582|589728585|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
163278451|NCT01544582|589728586|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
163278452|NCT01544582|589728587|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
163278453|NCT01544582|589728584|FG000|Analysis Population|Lost to Follow-up|0|||
163278454|NCT01544582|589728585|FG001|Analysis Population|Lost to Follow-up|6|||
163278455|NCT01544582|589728586|FG002|Analysis Population|Lost to Follow-up|6|||
163278456|NCT01544582|589728587|FG003|Analysis Population|Lost to Follow-up|5|||
163278457|NCT01544582|589728584|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
163278458|NCT01544582|589728585|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
163278459|NCT01544582|589728586|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
163278460|NCT01544582|589728587|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
163278461|NCT01544582|589728584|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
163278462|NCT01544582|589728585|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
163278463|NCT01544582|589728586|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
163278464|NCT01544582|589728587|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
163278465|NCT01544582|589728584|FG000|Analysis Population|Intolerance|0|||
163278466|NCT01544582|589728585|FG001|Analysis Population|Intolerance|1|||
163278467|NCT01544582|589728586|FG002|Analysis Population|Intolerance|0|||
163278468|NCT01544582|589728587|FG003|Analysis Population|Intolerance|0|||
163278469|NCT01544582|589728584|FG000|Analysis Population|Liver Transplantation|0|||
163278470|NCT01544582|589728585|FG001|Analysis Population|Liver Transplantation|0|||
163278471|NCT01544582|589728586|FG002|Analysis Population|Liver Transplantation|1|||
163278472|NCT01544582|589728587|FG003|Analysis Population|Liver Transplantation|0|||
163278473|NCT01544582|589728584|FG000|Analysis Population|No Social Insurance|0|||
163278474|NCT01544582|589728585|FG001|Analysis Population|No Social Insurance|0|||
163278475|NCT01544582|589728586|FG002|Analysis Population|No Social Insurance|1|||
163278476|NCT01544582|589728587|FG003|Analysis Population|No Social Insurance|0|||
163278477|NCT01544582|589728584|FG000|Analysis Population|Poor Adherence|0|||
163278478|NCT01544582|589728585|FG001|Analysis Population|Poor Adherence|0|||
163278479|NCT01544582|589728586|FG002|Analysis Population|Poor Adherence|1|||
163278480|NCT01544582|589728587|FG003|Analysis Population|Poor Adherence|0|||
163278481|NCT01544582|589728584|FG000|Analysis Population|Poor Participant Compliance|0|||
163278482|NCT01544582|589728585|FG001|Analysis Population|Poor Participant Compliance|1|||
163278483|NCT01544582|589728586|FG002|Analysis Population|Poor Participant Compliance|0|||
163278484|NCT01544582|589728587|FG003|Analysis Population|Poor Participant Compliance|0|||
163278485|NCT01544582|589728584|FG000|Analysis Population|Programmed Surgery|0|||
163278486|NCT01544582|589728585|FG001|Analysis Population|Programmed Surgery|1|||
163278487|NCT01544582|589728586|FG002|Analysis Population|Programmed Surgery|0|||
163278488|NCT01544582|589728587|FG003|Analysis Population|Programmed Surgery|0|||
163278489|NCT01544582|589728584|FG000|Analysis Population|Participant in Jail|0|||
163278490|NCT01544582|589728585|FG001|Analysis Population|Participant in Jail|0|||
163278491|NCT01544582|589728586|FG002|Analysis Population|Participant in Jail|1|||
163278492|NCT01544582|589728587|FG003|Analysis Population|Participant in Jail|0|||
163278493|NCT03015740|589728590|FG000|Overall Study|Adverse Event|1|||
163278494|NCT03015740|589728591|FG001|Overall Study|Adverse Event|0|||
163278495|NCT03015740|589728592|FG002|Overall Study|Adverse Event|0|||
163278496|NCT03015740|589728590|FG000|Overall Study|Death|3|||
163278497|NCT03015740|589728591|FG001|Overall Study|Death|5|||
163278498|NCT03015740|589728592|FG002|Overall Study|Death|0|||
163278499|NCT03015740|589728590|FG000|Overall Study|Withdrawal by Subject|2|||
163278500|NCT03015740|589728591|FG001|Overall Study|Withdrawal by Subject|0|||
163171781|NCT02577887|589343961|FG000|Overall Study|Withdrawal by Subject|80|||
163171782|NCT00864916|589343966|FG000|Overall Study|Lost to Follow-up|4|||
163171783|NCT00864916|589343967|FG001|Overall Study|Lost to Follow-up|4|||
163171784|NCT00864916|589343966|FG000|Overall Study|Protocol Violation|1|||
163171785|NCT00864916|589343967|FG001|Overall Study|Protocol Violation|0|||
163171786|NCT00864916|589343966|FG000|Overall Study|Withdrawal by Subject|1|||
163171787|NCT00864916|589343967|FG001|Overall Study|Withdrawal by Subject|0|||
163171788|NCT03774823|589343971|FG000|Overall Study|Withdrawal by Subject|1|||
163171789|NCT03774823|589343972|FG001|Overall Study|Withdrawal by Subject|1|||
163171790|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
163171791|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
163171792|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Adverse Event|7|||
163171793|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Adverse Event|6|||
163171794|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
163171795|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
163171796|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Physician Decision|4|||
163171797|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Physician Decision|4|||
163171798|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
163171799|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
163171800|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
163171801|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
163171802|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
163171803|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
163171804|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Non-compliance|1|||
163171805|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Non-compliance|0|||
163171806|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
163171807|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
163171808|NCT00470834|589343973|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
163171809|NCT00470834|589343974|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
163171810|NCT00470834|589343973|FG000|Extension Period (24 Months)|Adverse Event|3|||
163171811|NCT00470834|589343974|FG001|Extension Period (24 Months)|Adverse Event|4|||
163171812|NCT00470834|589343973|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
163171813|NCT00470834|589343974|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
163171814|NCT00470834|589343973|FG000|Extension Period (24 Months)|Physician Decision|4|||
163171815|NCT00470834|589343974|FG001|Extension Period (24 Months)|Physician Decision|3|||
163171816|NCT00470834|589343973|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
163171817|NCT00470834|589343974|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
163171818|NCT00470834|589343973|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
163171819|NCT00470834|589343974|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
163171820|NCT00470834|589343973|FG000|Extension Period (24 Months)|Non-compliance|0|||
163171821|NCT00470834|589343974|FG001|Extension Period (24 Months)|Non-compliance|1|||
163171822|NCT00470834|589343973|FG000|Extension Period (24 Months)|Disease Progression|0|||
163171823|NCT00470834|589343974|FG001|Extension Period (24 Months)|Disease Progression|1|||
163171824|NCT00065429|589343977|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
163171825|NCT00065429|589343978|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
163171826|NCT00065429|589343979|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
163171827|NCT00065429|589343980|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
163171828|NCT00065429|589343981|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
163171829|NCT00065429|589343982|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
163171830|NCT00065429|589343983|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
163171831|NCT00065429|589343977|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
163171832|NCT00065429|589343978|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
163171833|NCT00065429|589343979|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
163171834|NCT00065429|589343980|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
163171835|NCT00065429|589343981|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
163171836|NCT00065429|589343982|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
163171837|NCT00065429|589343983|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
163171838|NCT00065429|589343977|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
163171839|NCT00065429|589343978|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
163171840|NCT00065429|589343979|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
163171841|NCT00065429|589343980|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
163171842|NCT00065429|589343981|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
163171843|NCT00065429|589343982|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
163171844|NCT00065429|589343983|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
163171845|NCT00065429|589343977|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
163171846|NCT00065429|589343978|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
163171847|NCT00065429|589343979|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
163171848|NCT00065429|589343980|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
163171849|NCT00065429|589343981|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
163171850|NCT00065429|589343982|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
163171851|NCT00065429|589343983|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
163171852|NCT00065429|589343977|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
163171853|NCT00065429|589343978|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
163171854|NCT00065429|589343979|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
163171855|NCT00065429|589343980|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
163171856|NCT00065429|589343981|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
163171857|NCT00065429|589343982|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
163171858|NCT00065429|589343983|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
163171859|NCT00065429|589343977|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
163171860|NCT00065429|589343978|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
163171861|NCT00065429|589343979|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
163171862|NCT00065429|589343980|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
163171863|NCT00065429|589343981|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
163171864|NCT00065429|589343982|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
163171865|NCT00065429|589343983|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
163171866|NCT00065429|589343977|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
163171867|NCT00065429|589343978|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
163171868|NCT00065429|589343979|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
163171869|NCT00065429|589343980|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
163171870|NCT00065429|589343981|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
163171871|NCT00065429|589343982|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
163171872|NCT00065429|589343983|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
163171873|NCT00977080|589343984|FG000|Overall Study|Adverse Event|2|||
163171874|NCT00977080|589343985|FG001|Overall Study|Adverse Event|7|||
163171875|NCT00977080|589343986|FG002|Overall Study|Adverse Event|7|||
163171876|NCT00977080|589343987|FG003|Overall Study|Adverse Event|7|||
163171877|NCT00977080|589343984|FG000|Overall Study|Withdrawal by Subject|1|||
163171878|NCT00977080|589343985|FG001|Overall Study|Withdrawal by Subject|5|||
163171879|NCT00977080|589343986|FG002|Overall Study|Withdrawal by Subject|1|||
163278501|NCT03015740|589728592|FG002|Overall Study|Withdrawal by Subject|0|||
163171880|NCT00977080|589343987|FG003|Overall Study|Withdrawal by Subject|5|||
163171881|NCT00977080|589343984|FG000|Overall Study|Protocol Violation|7|||
163171882|NCT00977080|589343985|FG001|Overall Study|Protocol Violation|3|||
163171883|NCT00977080|589343986|FG002|Overall Study|Protocol Violation|4|||
163171884|NCT00977080|589343987|FG003|Overall Study|Protocol Violation|3|||
163171885|NCT00977080|589343984|FG000|Overall Study|Noncompliance|0|||
163171886|NCT00977080|589343985|FG001|Overall Study|Noncompliance|2|||
163171887|NCT00977080|589343986|FG002|Overall Study|Noncompliance|1|||
163171888|NCT00977080|589343987|FG003|Overall Study|Noncompliance|0|||
163278502|NCT05194735|589731308|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
163171889|NCT00977080|589343984|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
163171890|NCT00977080|589343985|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
163171891|NCT00977080|589343986|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
163171892|NCT00977080|589343987|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
163171893|NCT00977080|589343984|FG000|Overall Study|Required kidney transplantation|1|||
163171894|NCT00977080|589343985|FG001|Overall Study|Required kidney transplantation|3|||
163171895|NCT00977080|589343986|FG002|Overall Study|Required kidney transplantation|3|||
163171896|NCT00977080|589343987|FG003|Overall Study|Required kidney transplantation|1|||
163171897|NCT00977080|589343984|FG000|Overall Study|Travel for family reasons|1|||
163171898|NCT00977080|589343985|FG001|Overall Study|Travel for family reasons|0|||
163171899|NCT00977080|589343986|FG002|Overall Study|Travel for family reasons|0|||
163171900|NCT00977080|589343987|FG003|Overall Study|Travel for family reasons|0|||
163171901|NCT00636363|589343991|FG000|Overall Study|Conjunctivitis|0|||
163171902|NCT00636363|589343992|FG001|Overall Study|Conjunctivitis|0|||
163171903|NCT00636363|589343993|FG002|Overall Study|Conjunctivitis|1|||
163171904|NCT00636363|589343991|FG000|Overall Study|Adverse Event|0|||
163171905|NCT00636363|589343992|FG001|Overall Study|Adverse Event|0|||
163171906|NCT00636363|589343993|FG002|Overall Study|Adverse Event|1|||
163171907|NCT00636363|589343991|FG000|Overall Study|Positive slit lamp finding|0|||
163171908|NCT00636363|589343992|FG001|Overall Study|Positive slit lamp finding|2|||
163171909|NCT00636363|589343993|FG002|Overall Study|Positive slit lamp finding|1|||
163171910|NCT00636363|589343991|FG000|Overall Study|Study related symptoms/complaints|8|||
163171911|NCT00636363|589343992|FG001|Overall Study|Study related symptoms/complaints|7|||
163171912|NCT00636363|589343993|FG002|Overall Study|Study related symptoms/complaints|4|||
163171913|NCT00636363|589343991|FG000|Overall Study|Met ineligibility criteria|0|||
163171914|NCT00636363|589343992|FG001|Overall Study|Met ineligibility criteria|0|||
163171915|NCT00636363|589343993|FG002|Overall Study|Met ineligibility criteria|3|||
163171916|NCT00636363|589343991|FG000|Overall Study|Missed > 1 visit|0|||
163171917|NCT00636363|589343992|FG001|Overall Study|Missed > 1 visit|1|||
163171918|NCT00636363|589343993|FG002|Overall Study|Missed > 1 visit|3|||
163171919|NCT00636363|589343991|FG000|Overall Study|Lack of motivation|1|||
163171920|NCT00636363|589343992|FG001|Overall Study|Lack of motivation|0|||
163171921|NCT00636363|589343993|FG002|Overall Study|Lack of motivation|1|||
163171922|NCT00636363|589343991|FG000|Overall Study|Protocol Violation|0|||
163171923|NCT00636363|589343992|FG001|Overall Study|Protocol Violation|3|||
163171924|NCT00636363|589343993|FG002|Overall Study|Protocol Violation|0|||
163171925|NCT00636363|589343991|FG000|Overall Study|Lost to Follow-up|3|||
163171926|NCT00636363|589343992|FG001|Overall Study|Lost to Follow-up|4|||
163171927|NCT00636363|589343993|FG002|Overall Study|Lost to Follow-up|2|||
163171928|NCT00636363|589343991|FG000|Overall Study|Withdrawal by Subject|1|||
163171929|NCT00636363|589343992|FG001|Overall Study|Withdrawal by Subject|3|||
163171930|NCT00636363|589343993|FG002|Overall Study|Withdrawal by Subject|2|||
163171931|NCT00313781|589343994|FG000|Before Crossover|Death|22|||
163171932|NCT00313781|589343995|FG001|Before Crossover|Death|8|||
163278503|NCT05194735|589731309|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
163171933|NCT00313781|589343996|FG002|Before Crossover|Death|0|||
163171934|NCT00313781|589343994|FG000|Before Crossover|Lost to Follow-up|0|||
163171935|NCT00313781|589343995|FG001|Before Crossover|Lost to Follow-up|3|||
163171936|NCT00313781|589343996|FG002|Before Crossover|Lost to Follow-up|0|||
163171937|NCT00313781|589343994|FG000|Before Crossover|Withdrawal by Subject|3|||
163171938|NCT00313781|589343995|FG001|Before Crossover|Withdrawal by Subject|1|||
163171939|NCT00313781|589343996|FG002|Before Crossover|Withdrawal by Subject|0|||
163171940|NCT00313781|589343994|FG000|Before Crossover|Other|45|||
163171941|NCT00313781|589343995|FG001|Before Crossover|Other|30|||
163171942|NCT00313781|589343996|FG002|Before Crossover|Other|0|||
163171943|NCT00313781|589343994|FG000|Before Crossover|Crossover|0|||
163171944|NCT00313781|589343995|FG001|Before Crossover|Crossover|37|||
163171945|NCT00313781|589343996|FG002|Before Crossover|Crossover|0|||
163171946|NCT00313781|589343994|FG000|Before Crossover|Randomized, not treated|5|||
163171947|NCT00313781|589343995|FG001|Before Crossover|Randomized, not treated|0|||
163171948|NCT00313781|589343996|FG002|Before Crossover|Randomized, not treated|0|||
163171949|NCT00313781|589343994|FG000|After Crossover|Death|0|||
163171950|NCT00313781|589343995|FG001|After Crossover|Death|0|||
163171951|NCT00313781|589343996|FG002|After Crossover|Death|6|||
163171952|NCT00313781|589343994|FG000|After Crossover|Withdrawal by Subject|0|||
163171953|NCT00313781|589343995|FG001|After Crossover|Withdrawal by Subject|0|||
163171954|NCT00313781|589343996|FG002|After Crossover|Withdrawal by Subject|3|||
163171955|NCT00313781|589343994|FG000|After Crossover|Other|0|||
163171956|NCT00313781|589343995|FG001|After Crossover|Other|0|||
163171957|NCT00313781|589343996|FG002|After Crossover|Other|18|||
163171958|NCT03148691|589343997|FG000|Overall Study|Protocol Violation|1|||
163278504|NCT05194735|589731310|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
163171959|NCT03148691|589343998|FG001|Overall Study|Protocol Violation|2|||
163171960|NCT03148691|589343999|FG002|Overall Study|Protocol Violation|7|||
163171961|NCT03148691|589343997|FG000|Overall Study|Lost to Follow-up|0|||
163171962|NCT03148691|589343998|FG001|Overall Study|Lost to Follow-up|0|||
163171963|NCT03148691|589343999|FG002|Overall Study|Lost to Follow-up|1|||
163171964|NCT03148691|589343997|FG000|Overall Study|Other|1|||
163171965|NCT03148691|589343998|FG001|Overall Study|Other|0|||
163171966|NCT03148691|589343999|FG002|Overall Study|Other|0|||
163171967|NCT03148691|589343997|FG000|Overall Study|Withdrawal by Subject|1|||
163171968|NCT03148691|589343998|FG001|Overall Study|Withdrawal by Subject|0|||
163171969|NCT03148691|589343999|FG002|Overall Study|Withdrawal by Subject|0|||
163171970|NCT00096356|589344000|FG000|Overall Study|Adverse Event|11|||
163171971|NCT00096356|589344001|FG001|Overall Study|Adverse Event|9|||
163171972|NCT00096356|589344000|FG000|Overall Study|Physician Decision|5|||
163171973|NCT00096356|589344001|FG001|Overall Study|Physician Decision|3|||
163171974|NCT00096356|589344000|FG000|Overall Study|Withdrawal by Subject|17|||
163171975|NCT00096356|589344001|FG001|Overall Study|Withdrawal by Subject|23|||
163171976|NCT00096356|589344000|FG000|Overall Study|Lack of Efficacy|1|||
163171977|NCT00096356|589344001|FG001|Overall Study|Lack of Efficacy|0|||
163171978|NCT00096356|589344000|FG000|Overall Study|multiple reasons|10|||
163171979|NCT00096356|589344001|FG001|Overall Study|multiple reasons|18|||
163171980|NCT01181986|589344002|FG000|Phase 1|Lost to Follow-up|0|||
163171981|NCT01181986|589344003|FG001|Phase 1|Lost to Follow-up|1|||
163278505|NCT05194735|589731308|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
163278506|NCT05194735|589731309|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
163278507|NCT05194735|589731310|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
163278508|NCT05194735|589731308|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
163278509|NCT05194735|589731309|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
163278510|NCT05194735|589731310|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
163278511|NCT05194735|589731308|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
163278512|NCT05194735|589731309|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
163278513|NCT05194735|589731310|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
163278514|NCT00731042|589731311|FG000|Second Intervention|Did not meet inclusion criteria|0|||
163278515|NCT00731042|589731312|FG001|Second Intervention|Did not meet inclusion criteria|2|||
163278516|NCT02624778|589731313|FG000|Overall Study|Lost to Follow-up|0|||
163278517|NCT02624778|589731314|FG001|Overall Study|Lost to Follow-up|0|||
163278518|NCT02624778|589731315|FG002|Overall Study|Lost to Follow-up|1|||
163278519|NCT02624778|589731316|FG003|Overall Study|Lost to Follow-up|0|||
163278520|NCT02624778|589731317|FG004|Overall Study|Lost to Follow-up|0|||
163278521|NCT02624778|589731318|FG005|Overall Study|Lost to Follow-up|0|||
163278522|NCT02624778|589731319|FG006|Overall Study|Lost to Follow-up|0|||
163278523|NCT02624778|589731320|FG007|Overall Study|Lost to Follow-up|0|||
163278524|NCT02624778|589731321|FG008|Overall Study|Lost to Follow-up|0|||
163278525|NCT02624778|589731313|FG000|Overall Study|Withdrawal by Subject|0|||
163278526|NCT02624778|589731314|FG001|Overall Study|Withdrawal by Subject|1|||
163278527|NCT02624778|589731315|FG002|Overall Study|Withdrawal by Subject|0|||
163278528|NCT02624778|589731316|FG003|Overall Study|Withdrawal by Subject|0|||
163278529|NCT02624778|589731317|FG004|Overall Study|Withdrawal by Subject|0|||
163278530|NCT02624778|589731318|FG005|Overall Study|Withdrawal by Subject|1|||
163278531|NCT02624778|589731319|FG006|Overall Study|Withdrawal by Subject|1|||
163278532|NCT02624778|589731320|FG007|Overall Study|Withdrawal by Subject|1|||
163278533|NCT02624778|589731321|FG008|Overall Study|Withdrawal by Subject|1|||
163278534|NCT02624778|589731313|FG000|Overall Study|Adverse Event|0|||
163278535|NCT02624778|589731314|FG001|Overall Study|Adverse Event|0|||
163278536|NCT02624778|589731315|FG002|Overall Study|Adverse Event|0|||
163278537|NCT02624778|589731316|FG003|Overall Study|Adverse Event|0|||
163278538|NCT02624778|589731317|FG004|Overall Study|Adverse Event|0|||
163171982|NCT01181986|589344004|FG002|Phase 1|Lost to Follow-up|1|||
163171983|NCT01181986|589344002|FG000|Phase 1|Adverse Event|0|||
163171984|NCT01181986|589344003|FG001|Phase 1|Adverse Event|0|||
163171985|NCT01181986|589344004|FG002|Phase 1|Adverse Event|1|||
163171986|NCT01181986|589344002|FG000|Phase 1|Protocol Violation|1|||
163171987|NCT01181986|589344003|FG001|Phase 1|Protocol Violation|0|||
163171988|NCT01181986|589344004|FG002|Phase 1|Protocol Violation|0|||
163171989|NCT01181986|589344002|FG000|Phase 2|Adverse Event|0|||
163171990|NCT01181986|589344003|FG001|Phase 2|Adverse Event|3|||
163171991|NCT01181986|589344004|FG002|Phase 2|Adverse Event|0|||
163171992|NCT01181986|589344002|FG000|Phase 2|Medical condition|0|||
163171993|NCT01181986|589344003|FG001|Phase 2|Medical condition|1|||
163171994|NCT01181986|589344004|FG002|Phase 2|Medical condition|0|||
163171995|NCT05092360|589344005|FG000|Overall Study|Withdrawal by Subject|21|||
163171996|NCT05092360|589344006|FG001|Overall Study|Withdrawal by Subject|4|||
163171997|NCT05092360|589344007|FG002|Overall Study|Withdrawal by Subject|9|||
163171998|NCT05092360|589344008|FG003|Overall Study|Withdrawal by Subject|26|||
163171999|NCT05092360|589344005|FG000|Overall Study|Death|97|||
163172000|NCT05092360|589344006|FG001|Overall Study|Death|14|||
163172001|NCT05092360|589344007|FG002|Overall Study|Death|31|||
163172002|NCT05092360|589344008|FG003|Overall Study|Death|101|||
163172003|NCT05092360|589344005|FG000|Overall Study|Lost to Follow-up|1|||
163172004|NCT05092360|589344006|FG001|Overall Study|Lost to Follow-up|2|||
163172005|NCT05092360|589344007|FG002|Overall Study|Lost to Follow-up|2|||
163172006|NCT05092360|589344008|FG003|Overall Study|Lost to Follow-up|2|||
163172007|NCT05092360|589344005|FG000|Overall Study|Study terminated by sponsor|65|||
163278539|NCT02624778|589731318|FG005|Overall Study|Adverse Event|0|||
163172008|NCT05092360|589344006|FG001|Overall Study|Study terminated by sponsor|7|||
163172009|NCT05092360|589344007|FG002|Overall Study|Study terminated by sponsor|13|||
163172010|NCT05092360|589344008|FG003|Overall Study|Study terminated by sponsor|61|||
163172011|NCT01675167|589344009|FG000|Open-label Titration Phase|Adverse Event|81|||
163172012|NCT01675167|589344010|FG001|Open-label Titration Phase|Adverse Event|0|||
163278540|NCT02624778|589731319|FG006|Overall Study|Adverse Event|0|||
163172013|NCT01675167|589344011|FG002|Open-label Titration Phase|Adverse Event|0|||
163172014|NCT01675167|589344009|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
163172015|NCT01675167|589344010|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
163172016|NCT01675167|589344011|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
163172017|NCT01675167|589344009|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
163278541|NCT02624778|589731320|FG007|Overall Study|Adverse Event|0|||
163172018|NCT01675167|589344010|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
163172019|NCT01675167|589344011|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
163172020|NCT01675167|589344009|FG000|Open-label Titration Phase|Protocol Violation|43|||
163172021|NCT01675167|589344010|FG001|Open-label Titration Phase|Protocol Violation|0|||
163172022|NCT01675167|589344011|FG002|Open-label Titration Phase|Protocol Violation|0|||
163172023|NCT01675167|589344009|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
163172024|NCT01675167|589344010|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
163172025|NCT01675167|589344011|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
163172026|NCT01675167|589344009|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
163172027|NCT01675167|589344010|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
163172028|NCT01675167|589344011|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
163172029|NCT01675167|589344009|FG000|Open-label Titration Phase|Other|55|||
163172030|NCT01675167|589344010|FG001|Open-label Titration Phase|Other|0|||
163172031|NCT01675167|589344011|FG002|Open-label Titration Phase|Other|0|||
163172032|NCT01675167|589344009|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
163172033|NCT01675167|589344010|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
163172034|NCT01675167|589344011|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
163172035|NCT01675167|589344009|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
163172036|NCT01675167|589344010|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
163172037|NCT01675167|589344011|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
163172038|NCT01675167|589344009|FG000|Double-blind Treatment Phase|Adverse Event|0|||
163172039|NCT01675167|589344010|FG001|Double-blind Treatment Phase|Adverse Event|5|||
163172040|NCT01675167|589344011|FG002|Double-blind Treatment Phase|Adverse Event|13|||
163172041|NCT01675167|589344009|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
163172042|NCT01675167|589344010|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
163172043|NCT01675167|589344011|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
163172044|NCT01675167|589344009|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
163172045|NCT01675167|589344010|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
163172046|NCT01675167|589344011|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
163172047|NCT01675167|589344009|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
163172048|NCT01675167|589344010|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
163172049|NCT01675167|589344011|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
163172050|NCT01675167|589344009|FG000|Double-blind Treatment Phase|Other|0|||
163172051|NCT01675167|589344010|FG001|Double-blind Treatment Phase|Other|7|||
163172052|NCT01675167|589344011|FG002|Double-blind Treatment Phase|Other|5|||
163172053|NCT04531462|589345161|FG000|Overall Study|Withdrawal by Subject|3|||
163172054|NCT04531462|589345162|FG001|Overall Study|Withdrawal by Subject|1|||
163172055|NCT04531462|589345161|FG000|Overall Study|Adverse Event|3|||
163172056|NCT04531462|589345162|FG001|Overall Study|Adverse Event|3|||
163172057|NCT05338671|589345163|FG000|Overall Study|Lost to Follow-up|2|||
163172058|NCT05338671|589345164|FG001|Overall Study|Lost to Follow-up|2|||
163172059|NCT05338671|589345163|FG000|Overall Study|Root canal completed in a single visit|1|||
163172060|NCT05338671|589345164|FG001|Overall Study|Root canal completed in a single visit|0|||
163172061|NCT03859973|589345165|FG000|Overall Study|Other reason than listed|3|||
163172062|NCT03859973|589345166|FG001|Overall Study|Other reason than listed|2|||
163278542|NCT02624778|589731321|FG008|Overall Study|Adverse Event|2|||
163172063|NCT03859973|589345165|FG000|Overall Study|COVID-19 related, not due to AE|3|||
163172064|NCT03859973|589345166|FG001|Overall Study|COVID-19 related, not due to AE|4|||
163172065|NCT03859973|589345165|FG000|Overall Study|Withdrawal by Subject|8|||
163172066|NCT03859973|589345166|FG001|Overall Study|Withdrawal by Subject|9|||
163172067|NCT03859973|589345165|FG000|Overall Study|Lost to Follow-up|2|||
163172068|NCT03859973|589345166|FG001|Overall Study|Lost to Follow-up|3|||
163172069|NCT03859973|589345165|FG000|Overall Study|Protocol Violation|1|||
163172070|NCT03859973|589345166|FG001|Overall Study|Protocol Violation|3|||
163172071|NCT03859973|589345165|FG000|Overall Study|Adverse Event|3|||
163172072|NCT03859973|589345166|FG001|Overall Study|Adverse Event|5|||
163172073|NCT03085914|589345167|FG000|Overall Study|Death|6|||
163172074|NCT03085914|589345168|FG001|Overall Study|Death|6|||
163172075|NCT03085914|589345169|FG002|Overall Study|Death|4|||
163172076|NCT03085914|589345170|FG003|Overall Study|Death|1|||
163172077|NCT03085914|589345171|FG004|Overall Study|Death|5|||
163172078|NCT03085914|589345172|FG005|Overall Study|Death|2|||
163172079|NCT03085914|589345173|FG006|Overall Study|Death|2|||
163172080|NCT03085914|589345167|FG000|Overall Study|Withdrawal by Subject|1|||
163172081|NCT03085914|589345168|FG001|Overall Study|Withdrawal by Subject|1|||
163172082|NCT03085914|589345169|FG002|Overall Study|Withdrawal by Subject|2|||
163172083|NCT03085914|589345170|FG003|Overall Study|Withdrawal by Subject|2|||
163172084|NCT03085914|589345171|FG004|Overall Study|Withdrawal by Subject|2|||
163172085|NCT03085914|589345172|FG005|Overall Study|Withdrawal by Subject|0|||
163172086|NCT03085914|589345173|FG006|Overall Study|Withdrawal by Subject|1|||
163172087|NCT03085914|589345167|FG000|Overall Study|Lost to Follow-up|0|||
163172088|NCT03085914|589345168|FG001|Overall Study|Lost to Follow-up|0|||
163172089|NCT03085914|589345169|FG002|Overall Study|Lost to Follow-up|1|||
163172090|NCT03085914|589345170|FG003|Overall Study|Lost to Follow-up|0|||
163172091|NCT03085914|589345171|FG004|Overall Study|Lost to Follow-up|0|||
163172092|NCT03085914|589345172|FG005|Overall Study|Lost to Follow-up|1|||
163172093|NCT03085914|589345173|FG006|Overall Study|Lost to Follow-up|1|||
163172094|NCT03085914|589345167|FG000|Overall Study|Reason was not specified,|2|||
163172095|NCT03085914|589345168|FG001|Overall Study|Reason was not specified,|2|||
163172096|NCT03085914|589345169|FG002|Overall Study|Reason was not specified,|2|||
163172097|NCT03085914|589345170|FG003|Overall Study|Reason was not specified,|3|||
163172098|NCT03085914|589345171|FG004|Overall Study|Reason was not specified,|3|||
163172099|NCT03085914|589345172|FG005|Overall Study|Reason was not specified,|3|||
163172100|NCT03085914|589345173|FG006|Overall Study|Reason was not specified,|6|||
163172101|NCT03085914|589345167|FG000|Overall Study|Progressive Disease|0|||
163172102|NCT03085914|589345168|FG001|Overall Study|Progressive Disease|0|||
163172103|NCT03085914|589345169|FG002|Overall Study|Progressive Disease|2|||
163172104|NCT03085914|589345170|FG003|Overall Study|Progressive Disease|2|||
163172105|NCT03085914|589345171|FG004|Overall Study|Progressive Disease|1|||
163172106|NCT03085914|589345172|FG005|Overall Study|Progressive Disease|1|||
163172107|NCT03085914|589345173|FG006|Overall Study|Progressive Disease|1|||
163172108|NCT03085914|589345167|FG000|Overall Study|Study Terminated by the Sponsor|0|||
163172109|NCT03085914|589345168|FG001|Overall Study|Study Terminated by the Sponsor|0|||
163172110|NCT03085914|589345169|FG002|Overall Study|Study Terminated by the Sponsor|0|||
163172111|NCT03085914|589345170|FG003|Overall Study|Study Terminated by the Sponsor|1|||
163172112|NCT03085914|589345171|FG004|Overall Study|Study Terminated by the Sponsor|2|||
163172113|NCT03085914|589345172|FG005|Overall Study|Study Terminated by the Sponsor|1|||
163172114|NCT03085914|589345173|FG006|Overall Study|Study Terminated by the Sponsor|0|||
163172115|NCT03874429|589345177|FG000|Overall Study|Adverse Event|2|||
163172116|NCT03874429|589345178|FG001|Overall Study|Adverse Event|2|||
163172117|NCT03874429|589345177|FG000|Overall Study|Lack of Efficacy|0|||
163172118|NCT03874429|589345178|FG001|Overall Study|Lack of Efficacy|1|||
163172119|NCT03874429|589345177|FG000|Overall Study|Covid-19 pandemic|4|||
163172120|NCT03874429|589345178|FG001|Overall Study|Covid-19 pandemic|2|||
163172121|NCT00331552|589345179|FG000|Period 3: Phase II|Neurological Symptoms|1|||
163172122|NCT00331552|589345180|FG001|Period 3: Phase II|Neurological Symptoms|0|||
163172123|NCT00331552|589345179|FG000|Period 3: Phase II|Severe Nausea|1|||
163172124|NCT00331552|589345180|FG001|Period 3: Phase II|Severe Nausea|0|||
163172125|NCT03642132|589345181|FG000|Chemotherapy Period|Adverse Event|1|||
163172126|NCT03642132|589345182|FG001|Chemotherapy Period|Adverse Event|1|||
163172127|NCT03642132|589345183|FG002|Chemotherapy Period|Adverse Event|0|||
163172128|NCT03642132|589345181|FG000|Chemotherapy Period|Physician's decision|4|||
163172129|NCT03642132|589345182|FG001|Chemotherapy Period|Physician's decision|1|||
163172130|NCT03642132|589345183|FG002|Chemotherapy Period|Physician's decision|0|||
163172131|NCT03642132|589345181|FG000|Chemotherapy Period|Progressive disease|0|||
163278543|NCT02624778|589731313|FG000|Overall Study|Death|0|||
163278544|NCT02624778|589731314|FG001|Overall Study|Death|0|||
163278545|NCT02624778|589731315|FG002|Overall Study|Death|0|||
163278546|NCT02624778|589731316|FG003|Overall Study|Death|0|||
163172132|NCT03642132|589345182|FG001|Chemotherapy Period|Progressive disease|0|||
163172133|NCT03642132|589345183|FG002|Chemotherapy Period|Progressive disease|1|||
163278547|NCT02624778|589731317|FG004|Overall Study|Death|0|||
163278548|NCT02624778|589731318|FG005|Overall Study|Death|0|||
163278549|NCT02624778|589731319|FG006|Overall Study|Death|1|||
163278550|NCT02624778|589731320|FG007|Overall Study|Death|0|||
163278551|NCT02624778|589731321|FG008|Overall Study|Death|0|||
163278552|NCT02624778|589731313|FG000|Overall Study|Physician Decision|0|||
163278553|NCT02624778|589731314|FG001|Overall Study|Physician Decision|0|||
163278554|NCT02624778|589731315|FG002|Overall Study|Physician Decision|0|||
163278555|NCT02624778|589731316|FG003|Overall Study|Physician Decision|0|||
163278556|NCT02624778|589731317|FG004|Overall Study|Physician Decision|0|||
163278557|NCT02624778|589731318|FG005|Overall Study|Physician Decision|0|||
163278558|NCT02624778|589731319|FG006|Overall Study|Physician Decision|0|||
163278559|NCT02624778|589731320|FG007|Overall Study|Physician Decision|3|||
163278560|NCT02624778|589731321|FG008|Overall Study|Physician Decision|3|||
163278561|NCT04091672|589731324|FG000|Overall Study|Death|6|||
163278562|NCT04091672|589731325|FG001|Overall Study|Death|6|||
163278563|NCT04091672|589731324|FG000|Overall Study|Lost to Follow-up|7|||
163278564|NCT04091672|589731325|FG001|Overall Study|Lost to Follow-up|7|||
163278565|NCT04091672|589731324|FG000|Overall Study|Withdrawal by Subject|3|||
163278566|NCT04091672|589731325|FG001|Overall Study|Withdrawal by Subject|3|||
163278567|NCT04091672|589731324|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
163278568|NCT04091672|589731325|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
163278569|NCT01256476|589731326|FG000|Overall Study|Adverse Event|2|||
163278570|NCT01256476|589731327|FG001|Overall Study|Adverse Event|1|||
163278571|NCT01256476|589731326|FG000|Overall Study|Withdrawal by Subject|2|||
163278572|NCT01256476|589731327|FG001|Overall Study|Withdrawal by Subject|1|||
163278573|NCT01256476|589731326|FG000|Overall Study|Lost to Follow-up|1|||
163278574|NCT01256476|589731327|FG001|Overall Study|Lost to Follow-up|2|||
163278575|NCT01256476|589731326|FG000|Overall Study|Persistent ALT or AST elevation|1|||
163278576|NCT01256476|589731327|FG001|Overall Study|Persistent ALT or AST elevation|0|||
163278577|NCT01256476|589731326|FG000|Overall Study|Physician Decision|0|||
163278578|NCT01256476|589731327|FG001|Overall Study|Physician Decision|1|||
163278579|NCT01256476|589731326|FG000|Overall Study|Subject non-compliance|0|||
163278580|NCT01256476|589731327|FG001|Overall Study|Subject non-compliance|1|||
163278581|NCT01256476|589731326|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
163278582|NCT01256476|589731327|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
163278583|NCT05296629|589731328|FG000|Overall Study|Withdrawal by Subject|3|||
163278584|NCT05296629|589731329|FG001|Overall Study|Withdrawal by Subject|10|||
163278585|NCT05296629|589731330|FG002|Overall Study|Withdrawal by Subject|4|||
163278586|NCT05296629|589731328|FG000|Overall Study|Lost to Follow-up|2|||
163278587|NCT05296629|589731329|FG001|Overall Study|Lost to Follow-up|7|||
163278588|NCT05296629|589731330|FG002|Overall Study|Lost to Follow-up|1|||
163278589|NCT05296629|589731328|FG000|Overall Study|Adverse Event|0|||
163278590|NCT05296629|589731329|FG001|Overall Study|Adverse Event|4|||
163278591|NCT05296629|589731330|FG002|Overall Study|Adverse Event|2|||
163278592|NCT05296629|589731328|FG000|Overall Study|Protocol Violation|0|||
163278593|NCT05296629|589731329|FG001|Overall Study|Protocol Violation|2|||
163278594|NCT05296629|589731330|FG002|Overall Study|Protocol Violation|0|||
163278595|NCT00231179|589731336|FG000|Overall Study|Lost to Follow-up|21|||
163172134|NCT03642132|589345181|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
163172135|NCT03642132|589345182|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
163172136|NCT03642132|589345183|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
163172137|NCT03642132|589345181|FG000|Chemotherapy Period|Other|1|||
163172138|NCT03642132|589345182|FG001|Chemotherapy Period|Other|0|||
163172139|NCT03642132|589345183|FG002|Chemotherapy Period|Other|2|||
163172140|NCT03642132|589345181|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
163172141|NCT03642132|589345182|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
163172142|NCT03642132|589345183|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
163172143|NCT03642132|589345181|FG000|Maintenance Period|Adverse Event|1|||
163278596|NCT00231179|589731337|FG001|Overall Study|Lost to Follow-up|21|||
163278597|NCT00231179|589731336|FG000|Overall Study|Withdrawal by Subject|3|||
163278598|NCT00231179|589731337|FG001|Overall Study|Withdrawal by Subject|3|||
163278599|NCT02491411|589731338|FG000|Overall Study|Physician Decision|4|||
163278600|NCT04610684|589731341|FG000|Study Treatment|Withdrawal by Subject|1|||
163278601|NCT04610684|589731341|FG000|Study Treatment|Disease Progression|2|||
163278602|NCT04610684|589731341|FG000|Follow up|Death|2|||
163278603|NCT04610684|589731341|FG000|Follow up|Withdrawal by Subject|1|||
163278604|NCT00359619|589731343|FG000|Overall Study|Adverse Event|0|||
163278605|NCT00359619|589731344|FG001|Overall Study|Adverse Event|0|||
163172144|NCT03642132|589345182|FG001|Maintenance Period|Adverse Event|2|||
163172145|NCT03642132|589345183|FG002|Maintenance Period|Adverse Event|0|||
163172146|NCT03642132|589345181|FG000|Maintenance Period|Non-compliance with study drug|0|||
163278606|NCT00359619|589731345|FG002|Overall Study|Adverse Event|1|||
163278607|NCT00359619|589731346|FG003|Overall Study|Adverse Event|0|||
163278608|NCT00359619|589731347|FG004|Overall Study|Adverse Event|0|||
163172147|NCT03642132|589345182|FG001|Maintenance Period|Non-compliance with study drug|0|||
163172148|NCT03642132|589345183|FG002|Maintenance Period|Non-compliance with study drug|1|||
163172149|NCT03642132|589345181|FG000|Maintenance Period|Physician's decision|2|||
163172150|NCT03642132|589345182|FG001|Maintenance Period|Physician's decision|2|||
163172151|NCT03642132|589345183|FG002|Maintenance Period|Physician's decision|2|||
163172152|NCT03642132|589345181|FG000|Maintenance Period|Progressive disease|9|||
163172153|NCT03642132|589345182|FG001|Maintenance Period|Progressive disease|3|||
163172154|NCT03642132|589345183|FG002|Maintenance Period|Progressive disease|6|||
163172155|NCT03642132|589345181|FG000|Maintenance Period|Other|0|||
163172156|NCT03642132|589345182|FG001|Maintenance Period|Other|0|||
163172157|NCT03642132|589345183|FG002|Maintenance Period|Other|3|||
163172158|NCT03642132|589345181|FG000|Maintenance Period|Withdrawal by Subject|1|||
163172159|NCT03642132|589345182|FG001|Maintenance Period|Withdrawal by Subject|1|||
163172160|NCT03642132|589345183|FG002|Maintenance Period|Withdrawal by Subject|2|||
163172161|NCT03642132|589345181|FG000|Follow-up Period|Other|0|||
163172162|NCT03642132|589345182|FG001|Follow-up Period|Other|0|||
163172163|NCT03642132|589345183|FG002|Follow-up Period|Other|1|||
163172164|NCT03642132|589345181|FG000|Follow-up Period|Withdrawal by Subject|1|||
163172165|NCT03642132|589345182|FG001|Follow-up Period|Withdrawal by Subject|2|||
163172166|NCT03642132|589345183|FG002|Follow-up Period|Withdrawal by Subject|0|||
163172167|NCT03642132|589345181|FG000|Follow-up Period|Study terminated by sponsor|1|||
163172168|NCT03642132|589345182|FG001|Follow-up Period|Study terminated by sponsor|0|||
163172169|NCT03642132|589345183|FG002|Follow-up Period|Study terminated by sponsor|1|||
163172170|NCT03642132|589345181|FG000|Follow-up Period|Lack of Efficacy|1|||
163172171|NCT03642132|589345182|FG001|Follow-up Period|Lack of Efficacy|0|||
163172172|NCT03642132|589345183|FG002|Follow-up Period|Lack of Efficacy|0|||
163172173|NCT03642132|589345181|FG000|Follow-up Period|Death|1|||
163172174|NCT03642132|589345182|FG001|Follow-up Period|Death|0|||
163172175|NCT03642132|589345183|FG002|Follow-up Period|Death|2|||
163172176|NCT03642132|589345181|FG000|Follow-up Period|Adverse Event|1|||
163172177|NCT03642132|589345182|FG001|Follow-up Period|Adverse Event|0|||
163172178|NCT03642132|589345183|FG002|Follow-up Period|Adverse Event|0|||
163172179|NCT03560518|589345184|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
163172180|NCT03560518|589345185|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
163172181|NCT03560518|589345186|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
163172182|NCT03560518|589345184|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
163278609|NCT00359619|589731348|FG005|Overall Study|Adverse Event|0|||
163278610|NCT00359619|589731349|FG006|Overall Study|Adverse Event|1|||
163172183|NCT03560518|589345185|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
163172184|NCT03560518|589345186|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
163172185|NCT03560518|589345184|FG000|Double Blind Treatment Period|Protocol Violation|1|||
163172186|NCT03560518|589345185|FG001|Double Blind Treatment Period|Protocol Violation|2|||
163172187|NCT03560518|589345186|FG002|Double Blind Treatment Period|Protocol Violation|0|||
163172188|NCT03560518|589345184|FG000|Double Blind Treatment Period|Pregnancy|0|||
163172189|NCT03560518|589345185|FG001|Double Blind Treatment Period|Pregnancy|2|||
163172190|NCT03560518|589345186|FG002|Double Blind Treatment Period|Pregnancy|0|||
163278611|NCT00359619|589731343|FG000|Overall Study|Withdrawal by Subject|3|||
163278612|NCT00359619|589731344|FG001|Overall Study|Withdrawal by Subject|1|||
163172191|NCT03560518|589345184|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
163172192|NCT03560518|589345185|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
163172193|NCT03560518|589345186|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
163172194|NCT03560518|589345184|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
163172195|NCT03560518|589345185|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
163172196|NCT03560518|589345186|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
163172197|NCT03560518|589345184|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
163172198|NCT03560518|589345185|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
163172199|NCT03560518|589345186|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
163172200|NCT03560518|589345184|FG000|Double Blind Treatment Period|Adverse Event|0|||
163172201|NCT03560518|589345185|FG001|Double Blind Treatment Period|Adverse Event|3|||
163172202|NCT03560518|589345186|FG002|Double Blind Treatment Period|Adverse Event|1|||
163172203|NCT00159822|589345187|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
163172204|NCT00159822|589345187|FG000|Voriconazole Treatment Period|Adverse Event|9|||
163172205|NCT00159822|589345187|FG000|Voriconazole Treatment Period|Death|4|||
163172206|NCT00159822|589345187|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
163172207|NCT00159822|589345187|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
163172208|NCT00159822|589345187|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
163172209|NCT00159822|589345187|FG000|Post-treatment Follow-up Period|Death|1|||
163172210|NCT00159822|589345187|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
163172211|NCT00159822|589345187|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
163172212|NCT00958438|589345189|FG000|Overall Study|Protocol Violation|3|||
163172213|NCT00958438|589345190|FG001|Overall Study|Protocol Violation|2|||
163172214|NCT00958438|589345191|FG002|Overall Study|Protocol Violation|2|||
163172215|NCT00958438|589345189|FG000|Overall Study|Withdrawal by Subject|4|||
163172216|NCT00958438|589345190|FG001|Overall Study|Withdrawal by Subject|2|||
163172217|NCT00958438|589345191|FG002|Overall Study|Withdrawal by Subject|1|||
163172218|NCT00958438|589345189|FG000|Overall Study|Adverse Event|0|||
163172219|NCT00958438|589345190|FG001|Overall Study|Adverse Event|3|||
163172220|NCT00958438|589345191|FG002|Overall Study|Adverse Event|0|||
163172221|NCT00958438|589345189|FG000|Overall Study|Physician Decision|1|||
163172222|NCT00958438|589345190|FG001|Overall Study|Physician Decision|0|||
163172223|NCT00958438|589345191|FG002|Overall Study|Physician Decision|1|||
163172224|NCT00958438|589345189|FG000|Overall Study|Other than specified above|2|||
163172225|NCT00958438|589345190|FG001|Overall Study|Other than specified above|3|||
163172226|NCT00958438|589345191|FG002|Overall Study|Other than specified above|2|||
163172227|NCT02946931|589345196|FG000|Overall Study|Did not require collection of CRFs|588|||
163172228|NCT02946931|589345196|FG000|Overall Study|Other than listed|37|||
163172229|NCT02946931|589345196|FG000|Overall Study|Discharge from hospital|118|||
163172230|NCT02946931|589345196|FG000|Overall Study|Adverse Event|81|||
163172231|NCT02946931|589345196|FG000|Overall Study|CRFs not valid|1|||
163172232|NCT02946931|589345196|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
163172233|NCT00869778|589345200|FG000|Overall Study|Adverse Event|2|||
163172234|NCT00869778|589345201|FG001|Overall Study|Adverse Event|0|||
163172235|NCT00869778|589345202|FG002|Overall Study|Adverse Event|0|||
163172236|NCT00869778|589345200|FG000|Overall Study|Withdrawal by Subject|3|||
163172237|NCT00869778|589345201|FG001|Overall Study|Withdrawal by Subject|4|||
163172238|NCT00869778|589345202|FG002|Overall Study|Withdrawal by Subject|5|||
163172239|NCT00869778|589345200|FG000|Overall Study|Pregnancy|1|||
163172240|NCT00869778|589345201|FG001|Overall Study|Pregnancy|0|||
163172241|NCT00869778|589345202|FG002|Overall Study|Pregnancy|0|||
163172242|NCT00869778|589345200|FG000|Overall Study|Protocol Violation|5|||
163172243|NCT00869778|589345201|FG001|Overall Study|Protocol Violation|3|||
163172244|NCT00869778|589345202|FG002|Overall Study|Protocol Violation|5|||
163172245|NCT00869778|589345200|FG000|Overall Study|Unblinding|1|||
163172246|NCT00869778|589345201|FG001|Overall Study|Unblinding|0|||
163172247|NCT00869778|589345202|FG002|Overall Study|Unblinding|0|||
163172248|NCT03531632|589345207|FG000|Overall Study|Adverse Event|0|||
163172249|NCT03531632|589345208|FG001|Overall Study|Adverse Event|0|||
163172250|NCT03531632|589345209|FG002|Overall Study|Adverse Event|1|||
163172251|NCT03531632|589345207|FG000|Overall Study|Death|4|||
163172252|NCT03531632|589345208|FG001|Overall Study|Death|0|||
163172253|NCT03531632|589345209|FG002|Overall Study|Death|14|||
163172254|NCT03531632|589345207|FG000|Overall Study|Study Terminated|1|||
163172255|NCT03531632|589345208|FG001|Overall Study|Study Terminated|3|||
163278613|NCT00359619|589731345|FG002|Overall Study|Withdrawal by Subject|4|||
163278614|NCT00359619|589731346|FG003|Overall Study|Withdrawal by Subject|2|||
163278615|NCT00359619|589731347|FG004|Overall Study|Withdrawal by Subject|2|||
163278616|NCT00359619|589731348|FG005|Overall Study|Withdrawal by Subject|0|||
163278617|NCT00359619|589731349|FG006|Overall Study|Withdrawal by Subject|3|||
163278618|NCT00359619|589731343|FG000|Overall Study|Other|1|||
163278619|NCT00359619|589731344|FG001|Overall Study|Other|0|||
163278620|NCT00359619|589731345|FG002|Overall Study|Other|0|||
163278621|NCT00359619|589731346|FG003|Overall Study|Other|0|||
163278622|NCT00359619|589731347|FG004|Overall Study|Other|0|||
163278623|NCT00359619|589731348|FG005|Overall Study|Other|0|||
163278624|NCT00359619|589731349|FG006|Overall Study|Other|0|||
163278625|NCT00359619|589731343|FG000|Overall Study|Lost to Follow-up|4|||
163278626|NCT00359619|589731344|FG001|Overall Study|Lost to Follow-up|4|||
163278627|NCT00359619|589731345|FG002|Overall Study|Lost to Follow-up|2|||
163278628|NCT00359619|589731346|FG003|Overall Study|Lost to Follow-up|1|||
163278629|NCT00359619|589731347|FG004|Overall Study|Lost to Follow-up|1|||
163278630|NCT00359619|589731348|FG005|Overall Study|Lost to Follow-up|5|||
163278631|NCT00359619|589731349|FG006|Overall Study|Lost to Follow-up|0|||
163278632|NCT04672460|589731350|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
163278633|NCT04672460|589731351|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
163278634|NCT04672460|589731350|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
163278635|NCT04672460|589731351|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
163278636|NCT04672460|589731350|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
163278637|NCT04672460|589731351|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
163278638|NCT04672460|589731350|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
163278639|NCT04672460|589731351|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
163278640|NCT04672460|589731350|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
163278641|NCT04672460|589731351|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
163278642|NCT04672460|589731350|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
163278643|NCT04672460|589731351|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
163278644|NCT04672460|589731350|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
163278645|NCT04672460|589731351|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
163278646|NCT04672460|589731350|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
163278647|NCT04672460|589731351|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
163278648|NCT04672460|589731350|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
163172256|NCT03531632|589345209|FG002|Overall Study|Study Terminated|11|||
163172257|NCT03051620|589345210|FG000|Overall Study|Lost to Follow-up|6|||
163172258|NCT03051620|589345210|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
163172259|NCT00393510|589345211|FG000|Overall Study|Physician Decision|3|||
163172260|NCT00393510|589345212|FG001|Overall Study|Physician Decision|9|||
163172261|NCT01534182|589345213|FG000|Overall Study|Administrative problems|1|||
163172262|NCT01534182|589345214|FG001|Overall Study|Administrative problems|0|||
163172263|NCT01534182|589345213|FG000|Overall Study|Withdrawal by Subject|4|||
163172264|NCT01534182|589345214|FG001|Overall Study|Withdrawal by Subject|7|||
163172265|NCT01534182|589345213|FG000|Overall Study|Adverse Event|7|||
163172266|NCT01534182|589345214|FG001|Overall Study|Adverse Event|3|||
163172267|NCT02412488|589345215|FG000|Overall Study|Lost to Follow-up|10|||
163172268|NCT02412488|589345215|FG000|Overall Study|Withdrawal by Subject|5|||
163172269|NCT02412488|589345215|FG000|Overall Study|Physician Decision|1|||
163172270|NCT02412488|589345215|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
163172271|NCT02412488|589345215|FG000|Overall Study|Reveal LINQ explant|1|||
163172272|NCT00674154|589345216|FG000|Overall Study|Withdrawal by Subject|3|||
163172273|NCT00674154|589345217|FG001|Overall Study|Withdrawal by Subject|1|||
163172274|NCT00674154|589345216|FG000|Overall Study|Did not want parathyroidectomy|0|||
163172275|NCT00674154|589345217|FG001|Overall Study|Did not want parathyroidectomy|2|||
163172276|NCT00816023|589345218|FG000|Overall Study|Lost to Follow-up|1|||
163172277|NCT00816023|589345219|FG001|Overall Study|Lost to Follow-up|1|||
163172278|NCT00816023|589345220|FG002|Overall Study|Lost to Follow-up|0|||
163172279|NCT00816023|589345221|FG003|Overall Study|Lost to Follow-up|0|||
163172280|NCT00816023|589345218|FG000|Overall Study|Withdrawal by Subject|1|||
163172281|NCT00816023|589345219|FG001|Overall Study|Withdrawal by Subject|0|||
163172282|NCT00816023|589345220|FG002|Overall Study|Withdrawal by Subject|0|||
163172283|NCT00816023|589345221|FG003|Overall Study|Withdrawal by Subject|0|||
163172284|NCT00816023|589345218|FG000|Overall Study|Physician Decision|0|||
163172285|NCT00816023|589345219|FG001|Overall Study|Physician Decision|0|||
163172286|NCT00816023|589345220|FG002|Overall Study|Physician Decision|1|||
163172287|NCT00816023|589345221|FG003|Overall Study|Physician Decision|0|||
163172288|NCT00816023|589345218|FG000|Overall Study|assessments complete prior to window|1|||
163172289|NCT00816023|589345219|FG001|Overall Study|assessments complete prior to window|1|||
163172290|NCT00816023|589345220|FG002|Overall Study|assessments complete prior to window|2|||
163172291|NCT00816023|589345221|FG003|Overall Study|assessments complete prior to window|1|||
163172292|NCT00816023|589345218|FG000|Overall Study|Randomized Not Treated|6|||
163172293|NCT00816023|589345219|FG001|Overall Study|Randomized Not Treated|4|||
163172294|NCT00816023|589345220|FG002|Overall Study|Randomized Not Treated|6|||
163172295|NCT00816023|589345221|FG003|Overall Study|Randomized Not Treated|11|||
163172296|NCT01616693|589345226|FG000|Evaluated for Safety|Physician Decision|1|||
163172297|NCT01616693|589345227|FG001|Evaluated for Safety|Physician Decision|0|||
163172298|NCT01616693|589345228|FG002|Evaluated for Safety|Physician Decision|1|||
163172299|NCT01616693|589345229|FG003|Evaluated for Safety|Physician Decision|0|||
163172300|NCT01616693|589345226|FG000|Received Both Vaccines|Adverse Event|2|||
163172301|NCT01616693|589345227|FG001|Received Both Vaccines|Adverse Event|0|||
163172302|NCT01616693|589345228|FG002|Received Both Vaccines|Adverse Event|0|||
163172303|NCT01616693|589345229|FG003|Received Both Vaccines|Adverse Event|0|||
163172304|NCT01616693|589345226|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
163172305|NCT01616693|589345227|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
163172306|NCT01616693|589345228|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
163172307|NCT01616693|589345229|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
163172308|NCT01616693|589345226|FG000|Received Both Vaccines|Lost to Follow-up|4|||
163172309|NCT01616693|589345227|FG001|Received Both Vaccines|Lost to Follow-up|3|||
163172310|NCT01616693|589345228|FG002|Received Both Vaccines|Lost to Follow-up|4|||
163172311|NCT01616693|589345229|FG003|Received Both Vaccines|Lost to Follow-up|4|||
163172312|NCT01616693|589345226|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
163172313|NCT01616693|589345227|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
163172314|NCT01616693|589345228|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
163172315|NCT01616693|589345229|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
163172316|NCT00441116|589345230|FG000|Overall Study|Adverse Event|1|||
163172317|NCT00441116|589345231|FG001|Overall Study|Adverse Event|1|||
163172318|NCT00441116|589345230|FG000|Overall Study|Withdrawal by Subject|1|||
163172319|NCT00441116|589345231|FG001|Overall Study|Withdrawal by Subject|0|||
163278649|NCT04672460|589731351|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
163278650|NCT04672460|589731350|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
163278651|NCT04672460|589731351|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
163278652|NCT04672460|589731350|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
163278653|NCT04672460|589731351|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
163278654|NCT04672460|589731350|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
163278655|NCT04672460|589731351|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
163278656|NCT04672460|589731350|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
163387495|NCT04442737|590129940|FG000|Overall Study|Withdrawal by Subject|3|||
163387496|NCT04442737|590129941|FG001|Overall Study|Withdrawal by Subject|2|||
163387497|NCT04442737|590129940|FG000|Overall Study|Adverse Event|3|||
163387498|NCT04442737|590129941|FG001|Overall Study|Adverse Event|2|||
163387499|NCT04442737|590129940|FG000|Overall Study|Death|0|||
163387500|NCT04442737|590129941|FG001|Overall Study|Death|1|||
163387501|NCT04442737|590129940|FG000|Overall Study|Protocol Violation|0|||
163387502|NCT04442737|590129941|FG001|Overall Study|Protocol Violation|2|||
163387503|NCT04442737|590129940|FG000|Overall Study|Other|1|||
163387504|NCT04442737|590129941|FG001|Overall Study|Other|1|||
163387505|NCT01139021|590129942|FG000|Overall Study|Adverse Event|0|||
163387506|NCT01139021|590129943|FG001|Overall Study|Adverse Event|0|||
163387507|NCT01139021|590129944|FG002|Overall Study|Adverse Event|0|||
163387508|NCT01139021|590129945|FG003|Overall Study|Adverse Event|0|||
163387509|NCT01139021|590129946|FG004|Overall Study|Adverse Event|1|||
163387510|NCT01139021|590129947|FG005|Overall Study|Adverse Event|0|||
163387511|NCT01139021|590129942|FG000|Overall Study|Lost to Follow-up|0|||
163387512|NCT01139021|590129943|FG001|Overall Study|Lost to Follow-up|0|||
163387513|NCT01139021|590129944|FG002|Overall Study|Lost to Follow-up|0|||
163387514|NCT01139021|590129945|FG003|Overall Study|Lost to Follow-up|0|||
163387515|NCT01139021|590129946|FG004|Overall Study|Lost to Follow-up|2|||
163387516|NCT01139021|590129947|FG005|Overall Study|Lost to Follow-up|0|||
163387517|NCT01139021|590129942|FG000|Overall Study|Protocol Violation|1|||
163387518|NCT01139021|590129943|FG001|Overall Study|Protocol Violation|0|||
163387519|NCT01139021|590129944|FG002|Overall Study|Protocol Violation|0|||
163387520|NCT01139021|590129945|FG003|Overall Study|Protocol Violation|0|||
163387521|NCT01139021|590129946|FG004|Overall Study|Protocol Violation|2|||
163387522|NCT01139021|590129947|FG005|Overall Study|Protocol Violation|0|||
163387523|NCT01139021|590129942|FG000|Overall Study|Withdrawal by Subject|0|||
163387524|NCT01139021|590129943|FG001|Overall Study|Withdrawal by Subject|0|||
163387525|NCT01139021|590129944|FG002|Overall Study|Withdrawal by Subject|0|||
163387526|NCT01139021|590129945|FG003|Overall Study|Withdrawal by Subject|1|||
163387527|NCT01139021|590129946|FG004|Overall Study|Withdrawal by Subject|4|||
163278657|NCT04672460|589731351|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
163278658|NCT04672460|589731350|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
163278659|NCT04672460|589731351|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
163278660|NCT04672460|589731350|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
163278661|NCT04672460|589731351|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
163278662|NCT04672460|589731350|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
163278663|NCT04672460|589731351|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
163278664|NCT04672460|589731350|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
163278665|NCT04672460|589731351|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
163172320|NCT00441116|589345230|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
163172321|NCT00441116|589345231|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
163172322|NCT02925338|589345232|FG000|Overall Study|Death|0|||
163172323|NCT02925338|589345233|FG001|Overall Study|Death|2|||
163172324|NCT02925338|589345234|FG002|Overall Study|Death|1|||
163172325|NCT02925338|589345235|FG003|Overall Study|Death|0|||
163172326|NCT02925338|589345236|FG004|Overall Study|Death|0|||
163172327|NCT02925338|589345232|FG000|Overall Study|Lost to Follow-up|30|||
163172328|NCT02925338|589345233|FG001|Overall Study|Lost to Follow-up|10|||
163172329|NCT02925338|589345234|FG002|Overall Study|Lost to Follow-up|1|||
163172330|NCT02925338|589345235|FG003|Overall Study|Lost to Follow-up|16|||
163172331|NCT02925338|589345236|FG004|Overall Study|Lost to Follow-up|3|||
163172332|NCT02925338|589345232|FG000|Overall Study|Withdrawal by Subject|3|||
163172333|NCT02925338|589345233|FG001|Overall Study|Withdrawal by Subject|0|||
163172334|NCT02925338|589345234|FG002|Overall Study|Withdrawal by Subject|3|||
163172335|NCT02925338|589345235|FG003|Overall Study|Withdrawal by Subject|2|||
163172336|NCT02925338|589345236|FG004|Overall Study|Withdrawal by Subject|2|||
163172337|NCT02925338|589345232|FG000|Overall Study|Missing|38|||
163172338|NCT02925338|589345233|FG001|Overall Study|Missing|27|||
163172339|NCT02925338|589345234|FG002|Overall Study|Missing|0|||
163172340|NCT02925338|589345235|FG003|Overall Study|Missing|3|||
163172341|NCT02925338|589345236|FG004|Overall Study|Missing|2|||
163278666|NCT00049517|589731354|FG000|Induction|Disease progression|0|||
163172342|NCT02925338|589345232|FG000|Overall Study|Participant's Decision|11|||
163278667|NCT00049517|589731355|FG001|Induction|Disease progression|0|||
163172343|NCT02925338|589345233|FG001|Overall Study|Participant's Decision|7|||
163172344|NCT02925338|589345234|FG002|Overall Study|Participant's Decision|3|||
163172345|NCT02925338|589345235|FG003|Overall Study|Participant's Decision|8|||
163172346|NCT02925338|589345236|FG004|Overall Study|Participant's Decision|1|||
163172347|NCT02925338|589345232|FG000|Overall Study|Treatment Discontinuation|144|||
163172348|NCT02925338|589345233|FG001|Overall Study|Treatment Discontinuation|65|||
163172349|NCT02925338|589345234|FG002|Overall Study|Treatment Discontinuation|56|||
163172350|NCT02925338|589345235|FG003|Overall Study|Treatment Discontinuation|131|||
163172351|NCT02925338|589345236|FG004|Overall Study|Treatment Discontinuation|22|||
163172352|NCT01008423|589345241|FG000|Overall Study|Adverse Event|13|||
163172353|NCT01008423|589345242|FG001|Overall Study|Adverse Event|6|||
163172354|NCT01008423|589345241|FG000|Overall Study|Withdrawal by Subject|4|||
163172355|NCT01008423|589345242|FG001|Overall Study|Withdrawal by Subject|7|||
163172356|NCT01008423|589345241|FG000|Overall Study|Lost to Follow-up|0|||
163172357|NCT01008423|589345242|FG001|Overall Study|Lost to Follow-up|2|||
163172358|NCT01008423|589345241|FG000|Overall Study|Low Cortisol|0|||
163172359|NCT01008423|589345242|FG001|Overall Study|Low Cortisol|1|||
163172360|NCT01008423|589345241|FG000|Overall Study|Lack of Efficacy|0|||
163172361|NCT01008423|589345242|FG001|Overall Study|Lack of Efficacy|5|||
163172362|NCT01008423|589345241|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
163172363|NCT01008423|589345242|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
163172364|NCT01008423|589345241|FG000|Overall Study|Personal Conflict|1|||
163172365|NCT01008423|589345242|FG001|Overall Study|Personal Conflict|0|||
162929560|NCT04682639|588447388|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
163172366|NCT01008423|589345241|FG000|Overall Study|Other|0|||
163172367|NCT01008423|589345242|FG001|Overall Study|Other|1|||
163172368|NCT02034409|589345244|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
163172369|NCT02034409|589345245|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
163172370|NCT02034409|589345244|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
163172371|NCT02034409|589345245|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
163172372|NCT02034409|589345244|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
163172373|NCT02034409|589345245|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
163172374|NCT02034409|589345244|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
163172375|NCT02034409|589345245|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
163172376|NCT02034409|589345244|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
163172377|NCT02034409|589345245|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
163172378|NCT02034409|589345244|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
163172379|NCT02034409|589345245|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
163172380|NCT02342418|589345246|FG000|Overall Study|Adverse Event|0|||
163172381|NCT02342418|589345247|FG001|Overall Study|Adverse Event|1|||
163172382|NCT01699867|589345248|FG000|Overall Study|Screening Failure|3|||
163172383|NCT04255394|589345249|FG000|Overall Study|Death|35|||
163172384|NCT04255394|589345250|FG001|Overall Study|Death|25|||
163172385|NCT04255394|589345249|FG000|Overall Study|Device removed|2|||
163172386|NCT04255394|589345250|FG001|Overall Study|Device removed|10|||
163172387|NCT04255394|589345249|FG000|Overall Study|Withdrawal by Subject|9|||
163172388|NCT04255394|589345250|FG001|Overall Study|Withdrawal by Subject|8|||
163172389|NCT04255394|589345249|FG000|Overall Study|Screen Failure/Not treated|12|||
163172390|NCT04255394|589345250|FG001|Overall Study|Screen Failure/Not treated|8|||
163172391|NCT04255394|589345249|FG000|Overall Study|Lost to Follow-up|123|||
163172392|NCT04255394|589345250|FG001|Overall Study|Lost to Follow-up|265|||
163172393|NCT04255394|589345249|FG000|Overall Study|Adverse Event|1|||
163172394|NCT04255394|589345250|FG001|Overall Study|Adverse Event|3|||
163172395|NCT00831493|589345255|FG000|Overall Study|Intractable nausea and vomiting|1|||
163172396|NCT00835731|589345258|FG000|Overall Study|Withdrawal by Subject|1|||
163172397|NCT00835731|589345259|FG001|Overall Study|Withdrawal by Subject|0|||
163172398|NCT00835731|589345258|FG000|Overall Study|Physician Decision|1|||
163172399|NCT00835731|589345259|FG001|Overall Study|Physician Decision|1|||
163172400|NCT00348881|589345260|FG000|Overall Study|Lost to Follow-up|12|||
163172401|NCT00348881|589345261|FG001|Overall Study|Lost to Follow-up|6|||
163172402|NCT00348881|589345260|FG000|Overall Study|Withdrawal by Subject|3|||
163172403|NCT00348881|589345261|FG001|Overall Study|Withdrawal by Subject|4|||
163172404|NCT00348881|589345260|FG000|Overall Study|Adverse Event|2|||
163172405|NCT00348881|589345261|FG001|Overall Study|Adverse Event|0|||
163172406|NCT00348881|589345260|FG000|Overall Study|Serious Adverse Event|0|||
163172407|NCT00348881|589345261|FG001|Overall Study|Serious Adverse Event|2|||
163172408|NCT01525225|589345271|FG000|Enrollment|No longer met study criteria|1|||
163172409|NCT01525225|589345271|FG000|Enrollment|Other|1|||
163172410|NCT01182844|589345272|FG000|Overall Study|Withdrawal by Subject|0|||
163172411|NCT01182844|589345273|FG001|Overall Study|Withdrawal by Subject|2|||
163172412|NCT01379508|589345274|FG000|Treatment to Week 104|Adverse Event|2|||
163172413|NCT01379508|589345275|FG001|Treatment to Week 104|Adverse Event|0|||
163172414|NCT01379508|589345276|FG002|Treatment to Week 104|Adverse Event|5|||
163172415|NCT01379508|589345277|FG003|Treatment to Week 104|Adverse Event|0|||
163172416|NCT01379508|589345274|FG000|Treatment to Week 104|Abnormal lab value|1|||
163172417|NCT01379508|589345275|FG001|Treatment to Week 104|Abnormal lab value|0|||
163172418|NCT01379508|589345276|FG002|Treatment to Week 104|Abnormal lab value|0|||
163172419|NCT01379508|589345277|FG003|Treatment to Week 104|Abnormal lab value|0|||
163172420|NCT01379508|589345274|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
163172421|NCT01379508|589345275|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
163172422|NCT01379508|589345276|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
163172423|NCT01379508|589345277|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
163172424|NCT01379508|589345274|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
163172425|NCT01379508|589345275|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
163278668|NCT00049517|589731356|FG002|Induction|Disease progression|0|||
163172426|NCT01379508|589345276|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
163172427|NCT01379508|589345277|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
163172428|NCT01379508|589345274|FG000|Treatment to Week 104|Lost to Follow-up|5|||
163172429|NCT01379508|589345275|FG001|Treatment to Week 104|Lost to Follow-up|0|||
163172430|NCT01379508|589345276|FG002|Treatment to Week 104|Lost to Follow-up|3|||
163172431|NCT01379508|589345277|FG003|Treatment to Week 104|Lost to Follow-up|0|||
163278669|NCT00049517|589731357|FG003|Induction|Disease progression|0|||
163172432|NCT01379508|589345274|FG000|Treatment to Week 104|Administrative problems|3|||
163172433|NCT01379508|589345275|FG001|Treatment to Week 104|Administrative problems|1|||
163172434|NCT01379508|589345276|FG002|Treatment to Week 104|Administrative problems|0|||
163172435|NCT01379508|589345277|FG003|Treatment to Week 104|Administrative problems|0|||
163172436|NCT01379508|589345274|FG000|Treatment to Week 104|Protocol Violation|1|||
163172437|NCT01379508|589345275|FG001|Treatment to Week 104|Protocol Violation|1|||
163172438|NCT01379508|589345276|FG002|Treatment to Week 104|Protocol Violation|1|||
163172439|NCT01379508|589345277|FG003|Treatment to Week 104|Protocol Violation|0|||
163172440|NCT01379508|589345274|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
163172441|NCT01379508|589345275|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
163172442|NCT01379508|589345276|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
163172443|NCT01379508|589345277|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
163172444|NCT01379508|589345274|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
163172445|NCT01379508|589345275|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
163172446|NCT01379508|589345276|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
163172447|NCT01379508|589345277|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
163172448|NCT01379508|589345274|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
163172449|NCT01379508|589345275|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
163172450|NCT01379508|589345276|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
163278670|NCT00049517|589731358|FG004|Induction|Disease progression|18|||
163172451|NCT01379508|589345277|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
163172452|NCT01379508|589345274|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
163172453|NCT01379508|589345275|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
163172454|NCT01379508|589345276|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
163172455|NCT01379508|589345277|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
163172456|NCT03952039|589345280|FG000|Overall Study|Adverse Event|22|||
163172457|NCT03952039|589345281|FG001|Overall Study|Adverse Event|8|||
163172458|NCT03952039|589345280|FG000|Overall Study|Withdrawal by Participant|17|||
163172459|NCT03952039|589345281|FG001|Overall Study|Withdrawal by Participant|12|||
163172460|NCT03952039|589345280|FG000|Overall Study|Death|13|||
163172461|NCT03952039|589345281|FG001|Overall Study|Death|6|||
163172462|NCT03952039|589345280|FG000|Overall Study|Lack of Efficacy|12|||
163172463|NCT03952039|589345281|FG001|Overall Study|Lack of Efficacy|2|||
163172464|NCT03952039|589345280|FG000|Overall Study|Physician Decision|9|||
163172465|NCT03952039|589345281|FG001|Overall Study|Physician Decision|3|||
163172466|NCT03952039|589345280|FG000|Overall Study|Progressive Disease|6|||
163172467|NCT03952039|589345281|FG001|Overall Study|Progressive Disease|4|||
163278671|NCT00049517|589731359|FG005|Induction|Disease progression|11|||
163172468|NCT03952039|589345280|FG000|Overall Study|Other Reasons|12|||
163172469|NCT03952039|589345281|FG001|Overall Study|Other Reasons|4|||
163172470|NCT02055365|589347194|FG000|Overall Study|Prematurely Withdrawn|1|||
163172471|NCT02656680|589347196|FG000|Overall Study|Lost to Follow-up|0|||
163278672|NCT00049517|589731354|FG000|Induction|Adverse Event|0|||
163278673|NCT00049517|589731355|FG001|Induction|Adverse Event|0|||
163278674|NCT00049517|589731356|FG002|Induction|Adverse Event|0|||
163278675|NCT00049517|589731357|FG003|Induction|Adverse Event|0|||
163278676|NCT00049517|589731358|FG004|Induction|Adverse Event|5|||
163278677|NCT00049517|589731359|FG005|Induction|Adverse Event|7|||
163278678|NCT00049517|589731354|FG000|Induction|Death|0|||
163278679|NCT00049517|589731355|FG001|Induction|Death|0|||
163278680|NCT00049517|589731356|FG002|Induction|Death|0|||
163278681|NCT00049517|589731357|FG003|Induction|Death|0|||
163278682|NCT00049517|589731358|FG004|Induction|Death|9|||
163278683|NCT00049517|589731359|FG005|Induction|Death|6|||
163278684|NCT00049517|589731354|FG000|Induction|Withdrawal by Subject|0|||
163278685|NCT00049517|589731355|FG001|Induction|Withdrawal by Subject|0|||
163278686|NCT00049517|589731356|FG002|Induction|Withdrawal by Subject|0|||
163278687|NCT00049517|589731357|FG003|Induction|Withdrawal by Subject|0|||
163278688|NCT00049517|589731358|FG004|Induction|Withdrawal by Subject|1|||
163278689|NCT00049517|589731359|FG005|Induction|Withdrawal by Subject|3|||
163278690|NCT00049517|589731354|FG000|Induction|Alternative therapy|0|||
163278691|NCT00049517|589731355|FG001|Induction|Alternative therapy|0|||
163278692|NCT00049517|589731356|FG002|Induction|Alternative therapy|0|||
163278693|NCT00049517|589731357|FG003|Induction|Alternative therapy|0|||
163278694|NCT00049517|589731358|FG004|Induction|Alternative therapy|2|||
163278695|NCT00049517|589731359|FG005|Induction|Alternative therapy|2|||
163278696|NCT00049517|589731354|FG000|Induction|Other complicating disease|0|||
163278697|NCT00049517|589731355|FG001|Induction|Other complicating disease|0|||
163278698|NCT00049517|589731356|FG002|Induction|Other complicating disease|0|||
163278699|NCT00049517|589731357|FG003|Induction|Other complicating disease|0|||
163278700|NCT00049517|589731358|FG004|Induction|Other complicating disease|3|||
163278701|NCT00049517|589731359|FG005|Induction|Other complicating disease|0|||
163278702|NCT00049517|589731354|FG000|Induction|Reasons not reported|0|||
163278703|NCT00049517|589731355|FG001|Induction|Reasons not reported|0|||
163278704|NCT00049517|589731356|FG002|Induction|Reasons not reported|0|||
163278705|NCT00049517|589731357|FG003|Induction|Reasons not reported|0|||
163278706|NCT00049517|589731358|FG004|Induction|Reasons not reported|22|||
163278707|NCT00049517|589731359|FG005|Induction|Reasons not reported|25|||
163278708|NCT00049517|589731354|FG000|Conditioning/Transplant|Disease progression|14|||
163278709|NCT00049517|589731355|FG001|Conditioning/Transplant|Disease progression|6|||
163278710|NCT00049517|589731356|FG002|Conditioning/Transplant|Disease progression|10|||
163278711|NCT00049517|589731357|FG003|Conditioning/Transplant|Disease progression|6|||
163278712|NCT00049517|589731358|FG004|Conditioning/Transplant|Disease progression|0|||
163278713|NCT00049517|589731359|FG005|Conditioning/Transplant|Disease progression|0|||
163278714|NCT00049517|589731354|FG000|Conditioning/Transplant|Adverse Event|2|||
163278715|NCT00049517|589731355|FG001|Conditioning/Transplant|Adverse Event|1|||
163278716|NCT00049517|589731356|FG002|Conditioning/Transplant|Adverse Event|4|||
163278717|NCT00049517|589731357|FG003|Conditioning/Transplant|Adverse Event|8|||
163278718|NCT00049517|589731358|FG004|Conditioning/Transplant|Adverse Event|0|||
163278719|NCT00049517|589731359|FG005|Conditioning/Transplant|Adverse Event|0|||
163278720|NCT00049517|589731354|FG000|Conditioning/Transplant|Death|1|||
163278721|NCT00049517|589731355|FG001|Conditioning/Transplant|Death|0|||
163278722|NCT00049517|589731356|FG002|Conditioning/Transplant|Death|0|||
163278723|NCT00049517|589731357|FG003|Conditioning/Transplant|Death|2|||
163278724|NCT00049517|589731358|FG004|Conditioning/Transplant|Death|0|||
163172472|NCT02656680|589347197|FG001|Overall Study|Lost to Follow-up|1|||
163172473|NCT02656680|589347198|FG002|Overall Study|Lost to Follow-up|7|||
163172474|NCT01258998|589347199|FG000|Overall Study|Ineligible|1|||
163172475|NCT01143389|589347200|FG000|Overall Study|Lost to Follow-up|26|||
163172476|NCT01143389|589347201|FG001|Overall Study|Lost to Follow-up|25|||
163172477|NCT04966910|589347202|FG000|Baseline|Participant did not complete measure|0|||
163172478|NCT04966910|589347203|FG001|Baseline|Participant did not complete measure|0|||
163172479|NCT04966910|589347204|FG002|Baseline|Participant did not complete measure|1|||
163172480|NCT04966910|589347205|FG003|Baseline|Participant did not complete measure|0|||
163172481|NCT04966910|589347202|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
163172482|NCT04966910|589347203|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
163172483|NCT04966910|589347204|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
163172484|NCT04966910|589347205|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
163172485|NCT04966910|589347202|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
163172486|NCT04966910|589347203|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
163172487|NCT04966910|589347204|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
163172488|NCT04966910|589347205|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
163172489|NCT04966910|589347202|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
163172490|NCT04966910|589347203|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
163172491|NCT04966910|589347204|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
163172492|NCT04966910|589347205|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
163172493|NCT01757691|589347214|FG000|Overall Study|Administrative problems|2|||
163172494|NCT01757691|589347215|FG001|Overall Study|Administrative problems|0|||
163172495|NCT02054481|589347217|FG000|Overall Study|Adverse Event|1|||
163172496|NCT02054481|589347218|FG001|Overall Study|Adverse Event|1|||
163278725|NCT00049517|589731359|FG005|Conditioning/Transplant|Death|0|||
163278726|NCT00049517|589731354|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
163278727|NCT00049517|589731355|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
163278728|NCT00049517|589731356|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
163278729|NCT00049517|589731357|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
163278730|NCT00049517|589731358|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
163278731|NCT00049517|589731359|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
163278732|NCT00049517|589731354|FG000|Conditioning/Transplant|Alternative therapy|4|||
163278733|NCT00049517|589731355|FG001|Conditioning/Transplant|Alternative therapy|4|||
163278734|NCT00049517|589731356|FG002|Conditioning/Transplant|Alternative therapy|2|||
163278735|NCT00049517|589731357|FG003|Conditioning/Transplant|Alternative therapy|1|||
163278736|NCT00049517|589731358|FG004|Conditioning/Transplant|Alternative therapy|1|||
163278737|NCT00049517|589731359|FG005|Conditioning/Transplant|Alternative therapy|0|||
163278738|NCT00049517|589731354|FG000|Conditioning/Transplant|Other complicating disease|2|||
163278739|NCT00049517|589731355|FG001|Conditioning/Transplant|Other complicating disease|0|||
163278740|NCT00049517|589731356|FG002|Conditioning/Transplant|Other complicating disease|0|||
163387528|NCT01139021|590129947|FG005|Overall Study|Withdrawal by Subject|0|||
163387529|NCT05458479|590129952|FG000|Overall Study|Lost to Follow-up|1|||
163387530|NCT00784693|590129953|FG000|Overall Study|Lost to Follow-up|0|||
163387531|NCT00784693|590129954|FG001|Overall Study|Lost to Follow-up|1|||
163387532|NCT00784693|590129953|FG000|Overall Study|Lack of Efficacy|1|||
163387533|NCT00784693|590129954|FG001|Overall Study|Lack of Efficacy|1|||
163387534|NCT00784693|590129953|FG000|Overall Study|Withdrawal by Subject|0|||
163387535|NCT00784693|590129954|FG001|Overall Study|Withdrawal by Subject|4|||
163387536|NCT00784693|590129953|FG000|Overall Study|Randomized but not Treated|1|||
163387537|NCT00784693|590129954|FG001|Overall Study|Randomized but not Treated|0|||
163387538|NCT00784693|590129953|FG000|Overall Study|Other|1|||
163387539|NCT00784693|590129954|FG001|Overall Study|Other|0|||
163387540|NCT02982187|590129955|FG000|Overall Study|Withdrawal by Subject|0|||
163387541|NCT02982187|590129956|FG001|Overall Study|Withdrawal by Subject|0|||
163387542|NCT02982187|590129957|FG002|Overall Study|Withdrawal by Subject|0|||
163387543|NCT02982187|590129958|FG003|Overall Study|Withdrawal by Subject|0|||
163387544|NCT02982187|590129959|FG004|Overall Study|Withdrawal by Subject|0|||
163387545|NCT02982187|590129960|FG005|Overall Study|Withdrawal by Subject|0|||
163387546|NCT02982187|590129961|FG006|Overall Study|Withdrawal by Subject|1|||
163387547|NCT02982187|590129962|FG007|Overall Study|Withdrawal by Subject|0|||
163387548|NCT01978262|590129963|FG000|Overall Study|Withdrawal by Subject|9|||
163387549|NCT01978262|590129963|FG000|Overall Study|Lost to Follow-up|2|||
163387550|NCT02202551|590129964|FG000|Overall Study|Adverse Event|8|||
163387551|NCT02202551|590129965|FG001|Overall Study|Adverse Event|19|||
163387552|NCT02202551|590129966|FG002|Overall Study|Adverse Event|5|||
163387553|NCT02202551|590129967|FG003|Overall Study|Adverse Event|9|||
163387554|NCT02202551|590129964|FG000|Overall Study|Death|3|||
163387555|NCT02202551|590129965|FG001|Overall Study|Death|2|||
163387556|NCT02202551|590129966|FG002|Overall Study|Death|1|||
163387557|NCT02202551|590129967|FG003|Overall Study|Death|1|||
163387558|NCT02202551|590129964|FG000|Overall Study|Lost to Follow-up|0|||
163387559|NCT02202551|590129965|FG001|Overall Study|Lost to Follow-up|1|||
163387560|NCT02202551|590129966|FG002|Overall Study|Lost to Follow-up|0|||
163387561|NCT02202551|590129967|FG003|Overall Study|Lost to Follow-up|1|||
163387562|NCT02202551|590129964|FG000|Overall Study|Needed to take excluded medication|0|||
163387563|NCT02202551|590129965|FG001|Overall Study|Needed to take excluded medication|2|||
163387564|NCT02202551|590129966|FG002|Overall Study|Needed to take excluded medication|0|||
163387565|NCT02202551|590129967|FG003|Overall Study|Needed to take excluded medication|1|||
163387566|NCT02202551|590129964|FG000|Overall Study|Subject moved away|0|||
163387567|NCT02202551|590129965|FG001|Overall Study|Subject moved away|1|||
163387568|NCT02202551|590129966|FG002|Overall Study|Subject moved away|0|||
163387569|NCT02202551|590129967|FG003|Overall Study|Subject moved away|0|||
163387570|NCT02202551|590129964|FG000|Overall Study|DBS surgery|3|||
163387571|NCT02202551|590129965|FG001|Overall Study|DBS surgery|0|||
163387572|NCT02202551|590129966|FG002|Overall Study|DBS surgery|0|||
163387573|NCT02202551|590129967|FG003|Overall Study|DBS surgery|0|||
163387574|NCT02202551|590129964|FG000|Overall Study|Dyskinesia upon taper|1|||
163387575|NCT02202551|590129965|FG001|Overall Study|Dyskinesia upon taper|0|||
163387576|NCT02202551|590129966|FG002|Overall Study|Dyskinesia upon taper|0|||
163387577|NCT02202551|590129967|FG003|Overall Study|Dyskinesia upon taper|0|||
163387578|NCT02202551|590129964|FG000|Overall Study|Lack of Efficacy|0|||
163387579|NCT02202551|590129965|FG001|Overall Study|Lack of Efficacy|1|||
163387580|NCT02202551|590129966|FG002|Overall Study|Lack of Efficacy|0|||
163387581|NCT02202551|590129967|FG003|Overall Study|Lack of Efficacy|0|||
163387582|NCT02202551|590129964|FG000|Overall Study|Physician Decision|1|||
163387583|NCT02202551|590129965|FG001|Overall Study|Physician Decision|0|||
163387584|NCT02202551|590129966|FG002|Overall Study|Physician Decision|0|||
163387585|NCT02202551|590129967|FG003|Overall Study|Physician Decision|0|||
163387586|NCT02202551|590129964|FG000|Overall Study|Site closure|3|||
163387587|NCT02202551|590129965|FG001|Overall Study|Site closure|0|||
163387588|NCT02202551|590129966|FG002|Overall Study|Site closure|0|||
163278741|NCT00049517|589731357|FG003|Conditioning/Transplant|Other complicating disease|4|||
163278742|NCT00049517|589731358|FG004|Conditioning/Transplant|Other complicating disease|0|||
163278743|NCT00049517|589731359|FG005|Conditioning/Transplant|Other complicating disease|1|||
163278744|NCT00049517|589731354|FG000|Conditioning/Transplant|Reasons not reported|25|||
163278745|NCT00049517|589731355|FG001|Conditioning/Transplant|Reasons not reported|31|||
163278746|NCT00049517|589731356|FG002|Conditioning/Transplant|Reasons not reported|18|||
163278747|NCT00049517|589731357|FG003|Conditioning/Transplant|Reasons not reported|15|||
163278748|NCT00049517|589731358|FG004|Conditioning/Transplant|Reasons not reported|5|||
163278749|NCT00049517|589731359|FG005|Conditioning/Transplant|Reasons not reported|5|||
163278750|NCT00940017|589731360|FG000|Overall Study|did not meet entrance criteria|3|||
163278751|NCT00940017|589731360|FG000|Overall Study|Adverse Event|1|||
163278752|NCT00569946|589731361|FG000|Overall Study|Adverse Event|16|||
163278753|NCT00569946|589731361|FG000|Overall Study|Objective Progression or Relapse|42|||
163278754|NCT00569946|589731361|FG000|Overall Study|Global Deterioration of Health Status|1|||
163278755|NCT02949271|589731364|FG000|Overall Study|Lack of Efficacy|5|||
163278756|NCT02949271|589731365|FG001|Overall Study|Lack of Efficacy|4|||
163278757|NCT02949271|589731364|FG000|Overall Study|Lost to Follow-up|3|||
163278758|NCT02949271|589731365|FG001|Overall Study|Lost to Follow-up|6|||
163278759|NCT02949271|589731364|FG000|Overall Study|Physician Decision|5|||
163278760|NCT02949271|589731365|FG001|Overall Study|Physician Decision|5|||
163278761|NCT02949271|589731364|FG000|Overall Study|Protocol Violation|6|||
163278762|NCT02949271|589731365|FG001|Overall Study|Protocol Violation|3|||
163278763|NCT02949271|589731364|FG000|Overall Study|Withdrawal by Subject|1|||
163278764|NCT02949271|589731365|FG001|Overall Study|Withdrawal by Subject|0|||
163278765|NCT02949271|589731364|FG000|Overall Study|Delivered prior to intervention|7|||
163278766|NCT02949271|589731365|FG001|Overall Study|Delivered prior to intervention|9|||
163278767|NCT02949271|589731364|FG000|Overall Study|Outside the window for cervical dilation|2|||
163278768|NCT02949271|589731365|FG001|Overall Study|Outside the window for cervical dilation|3|||
163172497|NCT02054481|589347219|FG002|Overall Study|Adverse Event|0|||
163172498|NCT02054481|589347220|FG003|Overall Study|Adverse Event|1|||
163172499|NCT02054481|589347217|FG000|Overall Study|Lost to Follow-up|1|||
163172500|NCT02054481|589347218|FG001|Overall Study|Lost to Follow-up|0|||
163172501|NCT02054481|589347219|FG002|Overall Study|Lost to Follow-up|0|||
163172502|NCT02054481|589347220|FG003|Overall Study|Lost to Follow-up|0|||
163172503|NCT02054481|589347217|FG000|Overall Study|Other reason|2|||
163172504|NCT02054481|589347218|FG001|Overall Study|Other reason|1|||
163172505|NCT02054481|589347219|FG002|Overall Study|Other reason|2|||
163172506|NCT02054481|589347220|FG003|Overall Study|Other reason|0|||
163172507|NCT01713933|589347221|FG000|Overall Study|Lost to Follow-up|2|||
163172508|NCT01713933|589347221|FG000|Overall Study|Withdrawal by Subject|3|||
163172509|NCT01713933|589347221|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
163172510|NCT00528970|589347222|FG000|Overall Study|Adverse Event|6|||
163172511|NCT00528970|589347223|FG001|Overall Study|Adverse Event|8|||
163172512|NCT00528970|589347224|FG002|Overall Study|Adverse Event|5|||
163172513|NCT00528970|589347222|FG000|Overall Study|Lost to Follow-up|0|||
163172514|NCT00528970|589347223|FG001|Overall Study|Lost to Follow-up|0|||
163172515|NCT00528970|589347224|FG002|Overall Study|Lost to Follow-up|1|||
163172516|NCT00528970|589347222|FG000|Overall Study|Other than specified|2|||
163172517|NCT00528970|589347223|FG001|Overall Study|Other than specified|3|||
163172518|NCT00528970|589347224|FG002|Overall Study|Other than specified|3|||
163172519|NCT00528970|589347222|FG000|Overall Study|Protocol Violation|2|||
163172520|NCT00528970|589347223|FG001|Overall Study|Protocol Violation|1|||
163172521|NCT00528970|589347224|FG002|Overall Study|Protocol Violation|4|||
163172522|NCT00528970|589347222|FG000|Overall Study|Lack of Efficacy|0|||
163172523|NCT00528970|589347223|FG001|Overall Study|Lack of Efficacy|0|||
163172524|NCT00528970|589347224|FG002|Overall Study|Lack of Efficacy|1|||
163172525|NCT00528970|589347222|FG000|Overall Study|Withdrawal by Subject|4|||
163172526|NCT00528970|589347223|FG001|Overall Study|Withdrawal by Subject|3|||
163172527|NCT00528970|589347224|FG002|Overall Study|Withdrawal by Subject|5|||
163172528|NCT00528970|589347222|FG000|Overall Study|Randomized but not treated|0|||
163172529|NCT00528970|589347223|FG001|Overall Study|Randomized but not treated|0|||
163172530|NCT00528970|589347224|FG002|Overall Study|Randomized but not treated|1|||
163172531|NCT02882152|589347225|FG000|Overall Study|Lost to Follow-up|1|||
163172532|NCT02882152|589347226|FG001|Overall Study|Lost to Follow-up|0|||
163172533|NCT01673347|589347229|FG000|Overall Study|failure of allograft|7|||
163172534|NCT01430754|589347230|FG000|Run-In Phase|Circadian Period Ineligible|24|||
163172535|NCT01430754|589347231|FG001|Run-In Phase|Circadian Period Ineligible|0|||
163172536|NCT01430754|589347230|FG000|Run-In Phase|Protocol Violation|6|||
163172537|NCT01430754|589347231|FG001|Run-In Phase|Protocol Violation|0|||
163278769|NCT05458102|589731366|FG000|Overall Study|Withdrew consent|2|||
163278770|NCT05458102|589731367|FG001|Overall Study|Withdrew consent|0|||
163278771|NCT05458102|589731366|FG000|Overall Study|Adverse Event|1|||
163278772|NCT05458102|589731367|FG001|Overall Study|Adverse Event|0|||
163278773|NCT05458102|589731366|FG000|Overall Study|Enrolled but never treated|1|||
163278774|NCT05458102|589731367|FG001|Overall Study|Enrolled but never treated|0|||
163278775|NCT05458102|589731366|FG000|Overall Study|Protocol Violation|1|||
163278776|NCT05458102|589731367|FG001|Overall Study|Protocol Violation|0|||
163278777|NCT00852475|589731373|FG000|Overall Study|Lost to Follow-up|3|||
163278778|NCT00852475|589731374|FG001|Overall Study|Lost to Follow-up|4|||
163278779|NCT02373813|589731375|FG000|Run-In Period|Other, Not Specified|5|||
163278780|NCT02373813|589731376|FG001|Run-In Period|Other, Not Specified|0|||
163278781|NCT02373813|589731377|FG002|Run-In Period|Other, Not Specified|0|||
163172538|NCT01430754|589347230|FG000|Run-In Phase|Adverse Event|2|||
163172539|NCT01430754|589347231|FG001|Run-In Phase|Adverse Event|0|||
163172540|NCT01430754|589347230|FG000|Run-In Phase|Other|2|||
163172541|NCT01430754|589347231|FG001|Run-In Phase|Other|0|||
163172542|NCT01430754|589347230|FG000|Run-In Phase|Withdrawal by Subject|2|||
163172543|NCT01430754|589347231|FG001|Run-In Phase|Withdrawal by Subject|0|||
163172544|NCT01430754|589347230|FG000|Run-In Phase|Lost to Follow-up|1|||
163172545|NCT01430754|589347231|FG001|Run-In Phase|Lost to Follow-up|0|||
163172546|NCT00895011|589347232|FG000|Overall Study|Withdrawal by Subject|14|||
163172547|NCT00895011|589347233|FG001|Overall Study|Withdrawal by Subject|7|||
163172548|NCT00895011|589347234|FG002|Overall Study|Withdrawal by Subject|2|||
163172549|NCT00895011|589347232|FG000|Overall Study|Lost to Follow-up|5|||
163172550|NCT00895011|589347233|FG001|Overall Study|Lost to Follow-up|4|||
163172551|NCT00895011|589347234|FG002|Overall Study|Lost to Follow-up|1|||
163172552|NCT00895011|589347232|FG000|Overall Study|Protocol Violation|3|||
163172553|NCT00895011|589347233|FG001|Overall Study|Protocol Violation|1|||
163172554|NCT00895011|589347234|FG002|Overall Study|Protocol Violation|3|||
163172555|NCT00895011|589347232|FG000|Overall Study|Adverse Event|1|||
163172556|NCT00895011|589347233|FG001|Overall Study|Adverse Event|2|||
163172557|NCT00895011|589347234|FG002|Overall Study|Adverse Event|2|||
163172558|NCT00895011|589347232|FG000|Overall Study|schedule conflict|1|||
163172559|NCT00895011|589347233|FG001|Overall Study|schedule conflict|0|||
163172560|NCT00895011|589347234|FG002|Overall Study|schedule conflict|0|||
163172561|NCT02661178|589347242|FG000|Part 1|Protocol Violation|1|||
163172562|NCT02661178|589347243|FG001|Part 1|Protocol Violation|0|||
163172563|NCT02661178|589347244|FG002|Part 1|Protocol Violation|0|||
163172564|NCT02661178|589347245|FG003|Part 1|Protocol Violation|0|||
163172565|NCT02661178|589347246|FG004|Part 1|Protocol Violation|0|||
163172566|NCT02661178|589347247|FG005|Part 1|Protocol Violation|0|||
163172567|NCT02661178|589347248|FG006|Part 1|Protocol Violation|0|||
163172568|NCT02661178|589347249|FG007|Part 1|Protocol Violation|0|||
163172569|NCT02661178|589347250|FG008|Part 1|Protocol Violation|0|||
163172570|NCT02661178|589347251|FG009|Part 1|Protocol Violation|0|||
163172571|NCT02661178|589347252|FG010|Part 1|Protocol Violation|0|||
163172572|NCT02661178|589347253|FG011|Part 1|Protocol Violation|0|||
163172573|NCT02661178|589347254|FG012|Part 1|Protocol Violation|0|||
163172574|NCT02661178|589347255|FG013|Part 1|Protocol Violation|0|||
163172575|NCT02661178|589347256|FG014|Part 1|Protocol Violation|0|||
163172576|NCT02278471|589347257|FG000|Overall Study|Lost to Follow-up|6|||
163172577|NCT02278471|589347258|FG001|Overall Study|Lost to Follow-up|15|||
163172578|NCT02278471|589347257|FG000|Overall Study|Death|2|||
163172579|NCT02278471|589347258|FG001|Overall Study|Death|2|||
163172580|NCT02278471|589347257|FG000|Overall Study|Withdrawal by Subject|0|||
163172581|NCT02278471|589347258|FG001|Overall Study|Withdrawal by Subject|3|||
163172582|NCT04391049|589347259|FG000|Overall Study|Protocol Violation|1|||
163172583|NCT02855541|589347260|FG000|Overall Study|Change in health status|2|||
163172584|NCT02855541|589347260|FG000|Overall Study|Withdrawal by Subject|2|||
163172585|NCT01242813|589347261|FG000|Overall Study|Lost to Follow-up|2|||
163172586|NCT01561898|589347262|FG000|Overall Study|Withdrawal by Subject|0|||
163172587|NCT01561898|589347263|FG001|Overall Study|Withdrawal by Subject|8|||
163172588|NCT01561898|589347264|FG002|Overall Study|Withdrawal by Subject|12|||
163172589|NCT01561898|589347265|FG003|Overall Study|Withdrawal by Subject|5|||
163172590|NCT01561898|589347262|FG000|Overall Study|Lack of Efficacy|0|||
163172591|NCT01561898|589347263|FG001|Overall Study|Lack of Efficacy|8|||
163172592|NCT01561898|589347264|FG002|Overall Study|Lack of Efficacy|10|||
163172593|NCT01561898|589347265|FG003|Overall Study|Lack of Efficacy|5|||
163172594|NCT01561898|589347262|FG000|Overall Study|Worsening of complications|0|||
163172595|NCT01561898|589347263|FG001|Overall Study|Worsening of complications|1|||
163172596|NCT01561898|589347264|FG002|Overall Study|Worsening of complications|0|||
163172597|NCT01561898|589347265|FG003|Overall Study|Worsening of complications|0|||
163172598|NCT01561898|589347262|FG000|Overall Study|Lost to Follow-up|0|||
163172599|NCT01561898|589347263|FG001|Overall Study|Lost to Follow-up|0|||
163172600|NCT01561898|589347264|FG002|Overall Study|Lost to Follow-up|1|||
163172601|NCT01561898|589347265|FG003|Overall Study|Lost to Follow-up|0|||
163172602|NCT01561898|589347262|FG000|Overall Study|Adverse Event|1|||
163172603|NCT01561898|589347263|FG001|Overall Study|Adverse Event|19|||
163172604|NCT01561898|589347264|FG002|Overall Study|Adverse Event|14|||
163172605|NCT01561898|589347265|FG003|Overall Study|Adverse Event|9|||
163172606|NCT01561898|589347262|FG000|Overall Study|Physician Decision|1|||
163172607|NCT01561898|589347263|FG001|Overall Study|Physician Decision|5|||
163278782|NCT02373813|589731378|FG003|Run-In Period|Other, Not Specified|0|||
163278783|NCT02373813|589731375|FG000|Run-In Period|Withdrawal by Subject|16|||
163278784|NCT02373813|589731376|FG001|Run-In Period|Withdrawal by Subject|0|||
163172608|NCT01561898|589347264|FG002|Overall Study|Physician Decision|7|||
163172609|NCT01561898|589347265|FG003|Overall Study|Physician Decision|1|||
163172610|NCT01445548|589347266|FG000|Overall Study|Adverse Event|1|||
163172611|NCT00275821|589347268|FG000|Overall Study|Adverse Event|4|||
163172612|NCT00275821|589347269|FG001|Overall Study|Adverse Event|12|||
163172613|NCT00275821|589347270|FG002|Overall Study|Adverse Event|5|||
163172614|NCT00275821|589347268|FG000|Overall Study|Administrative problems|3|||
163172615|NCT00275821|589347269|FG001|Overall Study|Administrative problems|4|||
163172616|NCT00275821|589347270|FG002|Overall Study|Administrative problems|4|||
163172617|NCT00275821|589347268|FG000|Overall Study|Withdrawal by Subject|0|||
163172618|NCT00275821|589347269|FG001|Overall Study|Withdrawal by Subject|2|||
163172619|NCT00275821|589347270|FG002|Overall Study|Withdrawal by Subject|1|||
163172620|NCT00275821|589347268|FG000|Overall Study|Lost to Follow-up|0|||
163172621|NCT00275821|589347269|FG001|Overall Study|Lost to Follow-up|1|||
163172622|NCT00275821|589347270|FG002|Overall Study|Lost to Follow-up|1|||
163172623|NCT00275821|589347268|FG000|Overall Study|Death|0|||
163172624|NCT00275821|589347269|FG001|Overall Study|Death|2|||
163172625|NCT00275821|589347270|FG002|Overall Study|Death|1|||
163172626|NCT00275821|589347268|FG000|Overall Study|Lack of Efficacy|2|||
163172627|NCT00275821|589347269|FG001|Overall Study|Lack of Efficacy|1|||
163172628|NCT00275821|589347270|FG002|Overall Study|Lack of Efficacy|0|||
163172629|NCT00275821|589347268|FG000|Overall Study|Protocol Violation|5|||
163172630|NCT00275821|589347269|FG001|Overall Study|Protocol Violation|1|||
163172631|NCT00275821|589347270|FG002|Overall Study|Protocol Violation|0|||
163172632|NCT01215916|589347271|FG000|Overall Study|Progressive Disease|0|||
163172633|NCT01215916|589347272|FG001|Overall Study|Progressive Disease|2|||
163172634|NCT01215916|589347273|FG002|Overall Study|Progressive Disease|1|||
163172635|NCT01215916|589347274|FG003|Overall Study|Progressive Disease|2|||
163172636|NCT01215916|589347275|FG004|Overall Study|Progressive Disease|5|||
163172637|NCT01215916|589347276|FG005|Overall Study|Progressive Disease|4|||
163172638|NCT01215916|589347277|FG006|Overall Study|Progressive Disease|5|||
163172639|NCT01215916|589347278|FG007|Overall Study|Progressive Disease|3|||
163172640|NCT01215916|589347279|FG008|Overall Study|Progressive Disease|1|||
163172641|NCT01215916|589347271|FG000|Overall Study|Adverse Event|1|||
163172642|NCT01215916|589347272|FG001|Overall Study|Adverse Event|1|||
163172643|NCT01215916|589347273|FG002|Overall Study|Adverse Event|0|||
163172644|NCT01215916|589347274|FG003|Overall Study|Adverse Event|1|||
163278785|NCT02373813|589731377|FG002|Run-In Period|Withdrawal by Subject|0|||
163278786|NCT02373813|589731378|FG003|Run-In Period|Withdrawal by Subject|0|||
163278787|NCT02373813|589731375|FG000|Run-In Period|Decision by Sponsor|11|||
163278788|NCT02373813|589731376|FG001|Run-In Period|Decision by Sponsor|0|||
163278789|NCT02373813|589731377|FG002|Run-In Period|Decision by Sponsor|0|||
163278790|NCT02373813|589731378|FG003|Run-In Period|Decision by Sponsor|0|||
163278791|NCT02373813|589731375|FG000|Run-In Period|Protocol Violation|75|||
163278792|NCT02373813|589731376|FG001|Run-In Period|Protocol Violation|0|||
163278793|NCT02373813|589731377|FG002|Run-In Period|Protocol Violation|0|||
163278794|NCT02373813|589731378|FG003|Run-In Period|Protocol Violation|0|||
163278795|NCT02373813|589731375|FG000|Run-In Period|Lost to Follow-up|2|||
163278796|NCT02373813|589731376|FG001|Run-In Period|Lost to Follow-up|0|||
163278797|NCT02373813|589731377|FG002|Run-In Period|Lost to Follow-up|0|||
163278798|NCT02373813|589731378|FG003|Run-In Period|Lost to Follow-up|0|||
163278799|NCT02373813|589731375|FG000|Run-In Period|Adverse Event|3|||
163278800|NCT02373813|589731376|FG001|Run-In Period|Adverse Event|0|||
163278801|NCT02373813|589731377|FG002|Run-In Period|Adverse Event|0|||
163278802|NCT02373813|589731378|FG003|Run-In Period|Adverse Event|0|||
163278803|NCT02373813|589731375|FG000|Run-In Period|Noncompliance|1|||
163278804|NCT02373813|589731376|FG001|Run-In Period|Noncompliance|0|||
163278805|NCT02373813|589731377|FG002|Run-In Period|Noncompliance|0|||
163278806|NCT02373813|589731378|FG003|Run-In Period|Noncompliance|0|||
163278807|NCT02373813|589731375|FG000|Run-In Period|Ineligibility Determined|3|||
163278808|NCT02373813|589731376|FG001|Run-In Period|Ineligibility Determined|0|||
163278809|NCT02373813|589731377|FG002|Run-In Period|Ineligibility Determined|0|||
163278810|NCT02373813|589731378|FG003|Run-In Period|Ineligibility Determined|0|||
163278811|NCT02373813|589731375|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
163278812|NCT02373813|589731376|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
163278813|NCT02373813|589731377|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
163278814|NCT02373813|589731378|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
163278815|NCT02373813|589731375|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
163278816|NCT02373813|589731376|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
163278817|NCT02373813|589731377|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
163278818|NCT02373813|589731378|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
163278819|NCT02373813|589731375|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163278820|NCT02373813|589731376|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
163278821|NCT02373813|589731377|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
163278822|NCT02373813|589731378|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
163278823|NCT02373813|589731375|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163278824|NCT02373813|589731376|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
163172645|NCT01215916|589347275|FG004|Overall Study|Adverse Event|0|||
163172646|NCT01215916|589347276|FG005|Overall Study|Adverse Event|0|||
163172647|NCT01215916|589347277|FG006|Overall Study|Adverse Event|3|||
163172648|NCT01215916|589347278|FG007|Overall Study|Adverse Event|0|||
163172649|NCT01215916|589347279|FG008|Overall Study|Adverse Event|0|||
163172650|NCT01215916|589347271|FG000|Overall Study|Withdrawal by Subject|0|||
163172651|NCT01215916|589347272|FG001|Overall Study|Withdrawal by Subject|1|||
163172652|NCT01215916|589347273|FG002|Overall Study|Withdrawal by Subject|1|||
163172653|NCT01215916|589347274|FG003|Overall Study|Withdrawal by Subject|2|||
163172654|NCT01215916|589347275|FG004|Overall Study|Withdrawal by Subject|0|||
163172655|NCT01215916|589347276|FG005|Overall Study|Withdrawal by Subject|0|||
163172656|NCT01215916|589347277|FG006|Overall Study|Withdrawal by Subject|1|||
163172657|NCT01215916|589347278|FG007|Overall Study|Withdrawal by Subject|0|||
163278825|NCT02373813|589731377|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
163278826|NCT02373813|589731378|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
163278827|NCT01511536|589731379|FG000|Phase 1|Other|0|||
163278828|NCT01511536|589731380|FG001|Phase 1|Other|1|||
163278829|NCT01511536|589731381|FG002|Phase 1|Other|0|||
163278830|NCT01511536|589731379|FG000|Phase 2|Other|0|||
163278831|NCT01511536|589731380|FG001|Phase 2|Other|0|||
163278832|NCT01511536|589731381|FG002|Phase 2|Other|9|||
163172658|NCT01215916|589347279|FG008|Overall Study|Withdrawal by Subject|0|||
163172659|NCT01215916|589347271|FG000|Overall Study|Death|0|||
163172660|NCT01215916|589347272|FG001|Overall Study|Death|1|||
163172661|NCT01215916|589347273|FG002|Overall Study|Death|0|||
163172662|NCT01215916|589347274|FG003|Overall Study|Death|0|||
163172663|NCT01215916|589347275|FG004|Overall Study|Death|1|||
163172664|NCT01215916|589347276|FG005|Overall Study|Death|0|||
163172665|NCT01215916|589347277|FG006|Overall Study|Death|0|||
163172666|NCT01215916|589347278|FG007|Overall Study|Death|0|||
163172667|NCT01215916|589347279|FG008|Overall Study|Death|1|||
163172668|NCT01215916|589347271|FG000|Overall Study|Physician Decision|0|||
163172669|NCT01215916|589347272|FG001|Overall Study|Physician Decision|0|||
163172670|NCT01215916|589347273|FG002|Overall Study|Physician Decision|1|||
163172671|NCT01215916|589347274|FG003|Overall Study|Physician Decision|1|||
163172672|NCT01215916|589347275|FG004|Overall Study|Physician Decision|0|||
163172673|NCT01215916|589347276|FG005|Overall Study|Physician Decision|0|||
163172674|NCT01215916|589347277|FG006|Overall Study|Physician Decision|0|||
163172675|NCT01215916|589347278|FG007|Overall Study|Physician Decision|0|||
163172676|NCT01215916|589347279|FG008|Overall Study|Physician Decision|0|||
163172677|NCT02788279|589347280|FG000|Overall Study|Death|62|||
163172678|NCT02788279|589347281|FG001|Overall Study|Death|136|||
163172679|NCT02788279|589347282|FG002|Overall Study|Death|72|||
163172680|NCT02788279|589347280|FG000|Overall Study|Withdrawal by Subject|10|||
163172681|NCT02788279|589347281|FG001|Overall Study|Withdrawal by Subject|15|||
163172682|NCT02788279|589347282|FG002|Overall Study|Withdrawal by Subject|5|||
163172683|NCT02788279|589347280|FG000|Overall Study|Lost to Follow-up|0|||
163172684|NCT02788279|589347281|FG001|Overall Study|Lost to Follow-up|3|||
163172685|NCT02788279|589347282|FG002|Overall Study|Lost to Follow-up|2|||
163172686|NCT02788279|589347280|FG000|Overall Study|Sponsor decision|18|||
163172687|NCT02788279|589347281|FG001|Overall Study|Sponsor decision|29|||
163172688|NCT02788279|589347282|FG002|Overall Study|Sponsor decision|11|||
163172689|NCT00329849|589347284|FG000|Overall Study|Withdrawal by Subject|6|||
163172690|NCT00329849|589347285|FG001|Overall Study|Withdrawal by Subject|4|||
163172691|NCT01133990|589347290|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
163172692|NCT01133990|589347291|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163172693|NCT01133990|589347292|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163172694|NCT01133990|589347293|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163172695|NCT01133990|589347294|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163172696|NCT01133990|589347295|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163172697|NCT01133990|589347290|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
163172698|NCT01133990|589347291|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
163172699|NCT01133990|589347292|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
163172700|NCT01133990|589347293|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
163172701|NCT01133990|589347294|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
163172702|NCT01133990|589347295|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
163172703|NCT01133990|589347290|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
163387589|NCT02202551|590129967|FG003|Overall Study|Site closure|1|||
163172704|NCT01133990|589347291|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163172705|NCT01133990|589347292|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163172706|NCT01133990|589347293|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163172707|NCT01133990|589347294|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163172708|NCT01133990|589347295|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163172709|NCT01133990|589347290|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
163172710|NCT01133990|589347291|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
163172711|NCT01133990|589347292|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
163172712|NCT01133990|589347293|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
163172713|NCT01133990|589347294|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
163172714|NCT01133990|589347295|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
163172715|NCT05277337|589347296|FG000|Overall Study|Lost to Follow-up|2|||
163278833|NCT01764386|589731385|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
163278834|NCT01764386|589731386|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
163278835|NCT01764386|589731385|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
163278836|NCT01764386|589731386|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
163278837|NCT01764386|589731385|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
163278838|NCT01764386|589731386|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
163278839|NCT01764386|589731385|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
163278840|NCT01764386|589731386|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
163278841|NCT01764386|589731385|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
163278842|NCT01764386|589731386|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
163278843|NCT01764386|589731385|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
163278844|NCT01764386|589731386|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
163278845|NCT01764386|589731385|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
163278846|NCT01764386|589731386|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
163278847|NCT01764386|589731385|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
163278848|NCT01764386|589731386|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
163278849|NCT02703532|589731388|FG000|Overall Study|Withdrawal by Subject|0|||
163278850|NCT02703532|589731389|FG001|Overall Study|Withdrawal by Subject|1|||
163278851|NCT02703532|589731390|FG002|Overall Study|Withdrawal by Subject|0|||
163278852|NCT02703532|589731391|FG003|Overall Study|Withdrawal by Subject|1|||
163278853|NCT02703532|589731388|FG000|Overall Study|Lost to Follow-up|2|||
163278854|NCT02703532|589731389|FG001|Overall Study|Lost to Follow-up|0|||
163278855|NCT02703532|589731390|FG002|Overall Study|Lost to Follow-up|2|||
163278856|NCT02703532|589731391|FG003|Overall Study|Lost to Follow-up|0|||
163278857|NCT03738241|589731392|FG000|Overall Study|Withdrawal by Subject|0|||
163278858|NCT03738241|589731393|FG001|Overall Study|Withdrawal by Subject|0|||
163278859|NCT03738241|589731394|FG002|Overall Study|Withdrawal by Subject|0|||
163278860|NCT03738241|589731395|FG003|Overall Study|Withdrawal by Subject|0|||
163278861|NCT03738241|589731396|FG004|Overall Study|Withdrawal by Subject|0|||
163278862|NCT03738241|589731397|FG005|Overall Study|Withdrawal by Subject|0|||
163278863|NCT03738241|589731398|FG006|Overall Study|Withdrawal by Subject|0|||
163278864|NCT03738241|589731399|FG007|Overall Study|Withdrawal by Subject|0|||
163278865|NCT03738241|589731400|FG008|Overall Study|Withdrawal by Subject|0|||
163278866|NCT03738241|589731401|FG009|Overall Study|Withdrawal by Subject|1|||
163278867|NCT03738241|589731392|FG000|Overall Study|Physician Decision|0|||
163278868|NCT03738241|589731393|FG001|Overall Study|Physician Decision|0|||
163278869|NCT03738241|589731394|FG002|Overall Study|Physician Decision|0|||
163278870|NCT03738241|589731395|FG003|Overall Study|Physician Decision|0|||
163278871|NCT03738241|589731396|FG004|Overall Study|Physician Decision|0|||
163172716|NCT05277337|589347297|FG001|Overall Study|Lost to Follow-up|0|||
163278872|NCT03738241|589731397|FG005|Overall Study|Physician Decision|0|||
163278873|NCT03738241|589731398|FG006|Overall Study|Physician Decision|0|||
163278874|NCT03738241|589731399|FG007|Overall Study|Physician Decision|0|||
163278875|NCT03738241|589731400|FG008|Overall Study|Physician Decision|1|||
163278876|NCT03738241|589731401|FG009|Overall Study|Physician Decision|0|||
163278877|NCT03738241|589731392|FG000|Overall Study|Adverse Event|1|||
163278878|NCT03738241|589731393|FG001|Overall Study|Adverse Event|0|||
163278879|NCT03738241|589731394|FG002|Overall Study|Adverse Event|0|||
163278880|NCT03738241|589731395|FG003|Overall Study|Adverse Event|0|||
163278881|NCT03738241|589731396|FG004|Overall Study|Adverse Event|0|||
163278882|NCT03738241|589731397|FG005|Overall Study|Adverse Event|0|||
163278883|NCT03738241|589731398|FG006|Overall Study|Adverse Event|0|||
163278884|NCT03738241|589731399|FG007|Overall Study|Adverse Event|0|||
163278885|NCT03738241|589731400|FG008|Overall Study|Adverse Event|0|||
163278886|NCT03738241|589731401|FG009|Overall Study|Adverse Event|0|||
163278887|NCT03169361|589731402|FG000|Overall Study|Protocol Violation|32|||
163278888|NCT02263885|589731403|FG000|Overall Study|Withdrawal by Subject|7|||
163278889|NCT02263885|589731403|FG000|Overall Study|Alternative Treatment|3|||
163278890|NCT00278564|589731409|FG000|Overall Study|Lack of Efficacy|4|||
163278891|NCT00480441|589731414|FG000|Screening|Not Eligible|37|||
163278892|NCT00480441|589731415|FG001|Screening|Not Eligible|0|||
163278893|NCT00480441|589731416|FG002|Screening|Not Eligible|0|||
163278894|NCT00480441|589731414|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
163278895|NCT00480441|589731415|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
163278896|NCT00480441|589731416|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
163278897|NCT00480441|589731414|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
163278898|NCT00480441|589731415|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
163278899|NCT00480441|589731416|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
163278900|NCT00480441|589731414|FG000|Baseline Functional MRI|physical contraindication|4|||
163172717|NCT05277337|589347296|FG000|Overall Study|Withdrawal by Subject|1|||
163172718|NCT05277337|589347297|FG001|Overall Study|Withdrawal by Subject|0|||
163172719|NCT01185301|589347298|FG000|Overall Study|Adverse Event|3|||
163172720|NCT01185301|589347299|FG001|Overall Study|Adverse Event|0|||
163172721|NCT01185301|589347300|FG002|Overall Study|Adverse Event|2|||
163172722|NCT01185301|589347301|FG003|Overall Study|Adverse Event|3|||
163172723|NCT01185301|589347298|FG000|Overall Study|Withdrawal by Subject|7|||
163172724|NCT01185301|589347299|FG001|Overall Study|Withdrawal by Subject|5|||
163172725|NCT01185301|589347300|FG002|Overall Study|Withdrawal by Subject|2|||
163172726|NCT01185301|589347301|FG003|Overall Study|Withdrawal by Subject|3|||
163172727|NCT01185301|589347298|FG000|Overall Study|Lost to Follow-up|2|||
163172728|NCT01185301|589347299|FG001|Overall Study|Lost to Follow-up|0|||
163172729|NCT01185301|589347300|FG002|Overall Study|Lost to Follow-up|0|||
163172730|NCT01185301|589347301|FG003|Overall Study|Lost to Follow-up|1|||
163172731|NCT01185301|589347298|FG000|Overall Study|Other Reason|3|||
163172732|NCT01185301|589347299|FG001|Overall Study|Other Reason|2|||
163172733|NCT01185301|589347300|FG002|Overall Study|Other Reason|2|||
163172734|NCT01185301|589347301|FG003|Overall Study|Other Reason|2|||
163172735|NCT02683746|589347302|FG000|Overall Study|Adverse Event|3|||
163172736|NCT02683746|589347303|FG001|Overall Study|Adverse Event|2|||
163172737|NCT02683746|589347302|FG000|Overall Study|Lost to Follow-up|5|||
163172738|NCT02683746|589347303|FG001|Overall Study|Lost to Follow-up|6|||
163172739|NCT02683746|589347302|FG000|Overall Study|Withdrawal by Subject|6|||
163172740|NCT02683746|589347303|FG001|Overall Study|Withdrawal by Subject|5|||
163172741|NCT02683746|589347302|FG000|Overall Study|Physician Decision|2|||
163172742|NCT02683746|589347303|FG001|Overall Study|Physician Decision|1|||
163172743|NCT04987944|589347308|FG000|Overall Study|Adverse Event|0|||
163172744|NCT04987944|589347309|FG001|Overall Study|Adverse Event|1|||
163172745|NCT04987944|589347308|FG000|Overall Study|Withdrawal by Subject|0|||
163172746|NCT04987944|589347309|FG001|Overall Study|Withdrawal by Subject|1|||
163172747|NCT00409175|589347315|FG000|Overall Study|Adverse Event|4|||
163172748|NCT00409175|589347316|FG001|Overall Study|Adverse Event|3|||
163172749|NCT00409175|589347315|FG000|Overall Study|Withdrawal by Subject|1|||
163172750|NCT00409175|589347316|FG001|Overall Study|Withdrawal by Subject|2|||
163172751|NCT00409175|589347315|FG000|Overall Study|Negative genotype|0|||
163172752|NCT00409175|589347316|FG001|Overall Study|Negative genotype|1|||
163172753|NCT00409175|589347315|FG000|Overall Study|Liver transplantation|13|||
163172754|NCT00409175|589347316|FG001|Overall Study|Liver transplantation|13|||
163172755|NCT03339297|589347317|FG000|Overall Study|Relapse of Hematologic Disease|1|||
163172756|NCT03339297|589347318|FG001|Overall Study|Relapse of Hematologic Disease|0|||
163278901|NCT00480441|589731415|FG001|Baseline Functional MRI|physical contraindication|0|||
163278902|NCT00480441|589731416|FG002|Baseline Functional MRI|physical contraindication|0|||
163278903|NCT00480441|589731414|FG000|Randomization|Lost to Follow-up|0|||
163278904|NCT00480441|589731415|FG001|Randomization|Lost to Follow-up|7|||
163278905|NCT00480441|589731416|FG002|Randomization|Lost to Follow-up|2|||
163278906|NCT01417000|589731417|FG000|Overall Study|Death|59|||
163278907|NCT01417000|589731418|FG001|Overall Study|Death|28|||
163278908|NCT01417000|589731417|FG000|Overall Study|Lost to Follow-up|1|||
163278909|NCT01417000|589731418|FG001|Overall Study|Lost to Follow-up|0|||
163172757|NCT03339297|589347317|FG000|Overall Study|Death|10|||
163172758|NCT03339297|589347318|FG001|Overall Study|Death|7|||
163172759|NCT03339297|589347317|FG000|Overall Study|Hepatic Candidosis|1|||
163172760|NCT03339297|589347318|FG001|Overall Study|Hepatic Candidosis|0|||
163172761|NCT03339297|589347317|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
163172762|NCT03339297|589347318|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
163172763|NCT03339297|589347317|FG000|Overall Study|Consent Withdrawn by Participant|3|||
163172764|NCT03339297|589347318|FG001|Overall Study|Consent Withdrawn by Participant|3|||
163172765|NCT03339297|589347317|FG000|Overall Study|Disease Relapse|2|||
163172766|NCT03339297|589347318|FG001|Overall Study|Disease Relapse|0|||
163172767|NCT03339297|589347317|FG000|Overall Study|Physician Decision|1|||
163172768|NCT03339297|589347318|FG001|Overall Study|Physician Decision|1|||
163172769|NCT03339297|589347317|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
163172770|NCT03339297|589347318|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
163172771|NCT03339297|589347317|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
163172772|NCT03339297|589347318|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
163172773|NCT03339297|589347317|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
163172774|NCT03339297|589347318|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
163172775|NCT03339297|589347317|FG000|Overall Study|Adverse Event, Non-fatal|1|||
163172776|NCT03339297|589347318|FG001|Overall Study|Adverse Event, Non-fatal|0|||
163172777|NCT03339297|589347317|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
163172778|NCT03339297|589347318|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
163172779|NCT03339297|589347317|FG000|Overall Study|Patient Was Not Eligible|1|||
163172780|NCT03339297|589347318|FG001|Overall Study|Patient Was Not Eligible|0|||
163172781|NCT03726996|589347321|FG000|Overall Study|Parent's decision|2|||
163172782|NCT03726996|589347321|FG000|Overall Study|Study early termination|2|||
163172783|NCT01328444|589347324|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
163172784|NCT01328444|589347325|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
163172785|NCT01328444|589347326|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
163172786|NCT01328444|589347327|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
163172787|NCT01328444|589347328|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
163172788|NCT01328444|589347329|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
163172789|NCT01328444|589347324|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
163172790|NCT01328444|589347325|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
163172791|NCT01328444|589347326|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
163172792|NCT01328444|589347327|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
163172793|NCT01328444|589347328|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
163172794|NCT01328444|589347329|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
163172795|NCT01328444|589347324|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
163172796|NCT01328444|589347325|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
163172797|NCT01328444|589347326|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
163172798|NCT01328444|589347327|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
163172799|NCT01328444|589347328|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
163172800|NCT01328444|589347329|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
163172801|NCT01328444|589347324|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
163172802|NCT01328444|589347325|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
163172803|NCT01328444|589347326|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
163172804|NCT01328444|589347327|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
163172805|NCT01328444|589347328|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
163172806|NCT01328444|589347329|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
163172807|NCT01328444|589347324|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
163172808|NCT01328444|589347325|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163172809|NCT01328444|589347326|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163172810|NCT01328444|589347327|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
163172811|NCT01328444|589347328|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163172812|NCT01328444|589347329|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
163172813|NCT01328444|589347324|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
163172814|NCT01328444|589347325|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
163172815|NCT01328444|589347326|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
163172816|NCT01328444|589347327|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
163172817|NCT01328444|589347328|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
163172818|NCT01328444|589347329|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
163172819|NCT01328444|589347324|FG000|Washout Period (14 Days)|Adverse Event|1|||
163172820|NCT01328444|589347325|FG001|Washout Period (14 Days)|Adverse Event|1|||
163172821|NCT01328444|589347326|FG002|Washout Period (14 Days)|Adverse Event|0|||
163172822|NCT01328444|589347327|FG003|Washout Period (14 Days)|Adverse Event|1|||
163172823|NCT01328444|589347328|FG004|Washout Period (14 Days)|Adverse Event|1|||
163172824|NCT01328444|589347329|FG005|Washout Period (14 Days)|Adverse Event|2|||
163278910|NCT01417000|589731417|FG000|Overall Study|Study Terminated by Sponsor|1|||
163278911|NCT01417000|589731418|FG001|Overall Study|Study Terminated by Sponsor|1|||
163278912|NCT01657682|589731419|FG000|Overall Study|Lost to Follow-up|1|||
163278913|NCT01657682|589731420|FG001|Overall Study|Lost to Follow-up|0|||
163278914|NCT01657682|589731421|FG002|Overall Study|Lost to Follow-up|0|||
163278915|NCT01657682|589731419|FG000|Overall Study|Withdrawal by Subject|0|||
163278916|NCT01657682|589731420|FG001|Overall Study|Withdrawal by Subject|1|||
163278917|NCT01657682|589731421|FG002|Overall Study|Withdrawal by Subject|1|||
163278918|NCT01657682|589731419|FG000|Overall Study|Adverse Event|0|||
162929561|NCT04682639|588447389|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
162929562|NCT04682639|588447390|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
162929563|NCT04682639|588447391|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
162929564|NCT04682639|588447392|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
162929565|NCT04682639|588447388|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
162929566|NCT04682639|588447389|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
162929567|NCT04682639|588447390|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
162929568|NCT04682639|588447391|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
163278919|NCT01657682|589731420|FG001|Overall Study|Adverse Event|1|||
163278920|NCT01657682|589731421|FG002|Overall Study|Adverse Event|0|||
163278921|NCT01318811|589731430|FG000|Overall Study|Physician Decision|1|||
163278922|NCT01318811|589731431|FG001|Overall Study|Physician Decision|1|||
163278923|NCT01318811|589731430|FG000|Overall Study|CRRT stopped for head CT|0|||
163278924|NCT01318811|589731431|FG001|Overall Study|CRRT stopped for head CT|1|||
163278925|NCT01318811|589731430|FG000|Overall Study|Death|0|||
163278926|NCT01318811|589731431|FG001|Overall Study|Death|1|||
163278927|NCT01318811|589731430|FG000|Overall Study|CRRT stopped for head MRI|0|||
163278928|NCT01318811|589731431|FG001|Overall Study|CRRT stopped for head MRI|1|||
163278929|NCT00811187|589731432|FG000|Overall Study|Unable to place device / procedure abort|3|||
163278930|NCT00811187|589731433|FG001|Overall Study|Unable to place device / procedure abort|3|||
163278931|NCT02825043|589731434|FG000|Overall Study|Lost to Follow-up|4|||
163278932|NCT00131911|589731435|FG000|Overall Study|Withdrawal by Subject|1|||
163278933|NCT00131911|589731436|FG001|Overall Study|Withdrawal by Subject|0|||
163278934|NCT00329303|589731440|FG000|Overall Study|Lack of Efficacy|1|||
163278935|NCT00329303|589731441|FG001|Overall Study|Lack of Efficacy|0|||
163278936|NCT00329303|589731440|FG000|Overall Study|Decision of the sponsor|0|||
163278937|NCT00329303|589731441|FG001|Overall Study|Decision of the sponsor|1|||
163278938|NCT00329303|589731440|FG000|Overall Study|Patient no longer available|1|||
163278939|NCT00329303|589731441|FG001|Overall Study|Patient no longer available|0|||
163278940|NCT00329303|589731440|FG000|Overall Study|Patient relocated|0|||
163278941|NCT00329303|589731441|FG001|Overall Study|Patient relocated|1|||
163278942|NCT03582137|589731444|FG000|Overall Study|Adverse Event|1|||
163278943|NCT03582137|589731445|FG001|Overall Study|Adverse Event|0|||
163278944|NCT03704298|589731450|FG000|Overall Study|Death|3|||
163278945|NCT03704298|589731451|FG001|Overall Study|Death|1|||
163278946|NCT03704298|589731452|FG002|Overall Study|Death|1|||
163278947|NCT03704298|589731453|FG003|Overall Study|Death|0|||
163278948|NCT03704298|589731450|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
163278949|NCT03704298|589731451|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
163278950|NCT03704298|589731452|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
163278951|NCT03704298|589731453|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
163278952|NCT03704298|589731450|FG000|Overall Study|Withdrawal by Subject|1|||
163278953|NCT03704298|589731451|FG001|Overall Study|Withdrawal by Subject|0|||
163278954|NCT03704298|589731452|FG002|Overall Study|Withdrawal by Subject|0|||
163278955|NCT03704298|589731453|FG003|Overall Study|Withdrawal by Subject|0|||
163278956|NCT03704298|589731450|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
163278957|NCT03704298|589731451|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
163278958|NCT03704298|589731452|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
163278959|NCT03704298|589731453|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
163278960|NCT00558753|589731454|FG000|Overall Study|Lost to Follow-up|5|||
163278961|NCT00558753|589731455|FG001|Overall Study|Lost to Follow-up|7|||
163278962|NCT01167023|589731456|FG000|Overall Study|Lost to Follow-up|0|||
163278963|NCT01167023|589731457|FG001|Overall Study|Lost to Follow-up|1|||
163278964|NCT01167023|589731458|FG002|Overall Study|Lost to Follow-up|1|||
163278965|NCT01167023|589731456|FG000|Overall Study|Screen Failure|0|||
162929569|NCT04682639|588447392|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
162929570|NCT04682639|588447388|FG000|OLE Period (28 Weeks)|Other|1|||
162929571|NCT04682639|588447389|FG001|OLE Period (28 Weeks)|Other|2|||
162929572|NCT04682639|588447390|FG002|OLE Period (28 Weeks)|Other|0|||
162929573|NCT04682639|588447391|FG003|OLE Period (28 Weeks)|Other|0|||
162929574|NCT04682639|588447392|FG004|OLE Period (28 Weeks)|Other|1|||
162929575|NCT04682639|588447388|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
162929576|NCT04682639|588447389|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
162929577|NCT04682639|588447390|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
162929578|NCT04682639|588447391|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
162929579|NCT04682639|588447392|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
163278966|NCT01167023|589731457|FG001|Overall Study|Screen Failure|1|||
163278967|NCT01167023|589731458|FG002|Overall Study|Screen Failure|0|||
163278968|NCT01167023|589731456|FG000|Overall Study|Sponsor Decision|0|||
163278969|NCT01167023|589731457|FG001|Overall Study|Sponsor Decision|1|||
163278970|NCT01167023|589731458|FG002|Overall Study|Sponsor Decision|0|||
163278971|NCT01167023|589731456|FG000|Overall Study|Withdrawal by Subject|0|||
163278972|NCT01167023|589731457|FG001|Overall Study|Withdrawal by Subject|0|||
163278973|NCT01167023|589731458|FG002|Overall Study|Withdrawal by Subject|1|||
163278974|NCT02820051|589731463|FG000|Overall Study|Lost to Follow-up|7|||
163278975|NCT02820051|589731464|FG001|Overall Study|Lost to Follow-up|4|||
163278976|NCT01670500|589731467|FG000|Overall Study|Withdrawal by Subject|1|||
163278977|NCT01670500|589731468|FG001|Overall Study|Withdrawal by Subject|0|||
163278978|NCT04955626|589731469|FG000|Blinded Period|Lost to Follow-up|28|||
163278979|NCT04955626|589731470|FG001|Blinded Period|Lost to Follow-up|28|||
163278980|NCT04955626|589731471|FG002|Blinded Period|Lost to Follow-up|7|||
163278981|NCT04955626|589731472|FG003|Blinded Period|Lost to Follow-up|14|||
163278982|NCT04955626|589731473|FG004|Blinded Period|Lost to Follow-up|3|||
163278983|NCT04955626|589731474|FG005|Blinded Period|Lost to Follow-up|2|||
163278984|NCT04955626|589731475|FG006|Blinded Period|Lost to Follow-up|6|||
162929580|NCT04682639|588447388|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
162929581|NCT04682639|588447389|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
162929582|NCT04682639|588447390|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162929583|NCT04682639|588447391|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162929584|NCT04682639|588447392|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162929585|NCT04682639|588447388|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
162929586|NCT04682639|588447389|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
162929587|NCT04682639|588447390|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
162929588|NCT04682639|588447391|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
162929589|NCT04682639|588447392|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
162929590|NCT04682639|588447388|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
162929591|NCT04682639|588447389|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
162929592|NCT04682639|588447390|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
162929593|NCT04682639|588447391|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
163278985|NCT04955626|589731476|FG007|Blinded Period|Lost to Follow-up|4|||
163278986|NCT04955626|589731477|FG008|Blinded Period|Lost to Follow-up|5|||
163278987|NCT04955626|589731478|FG009|Blinded Period|Lost to Follow-up|8|||
163278988|NCT04955626|589731479|FG010|Blinded Period|Lost to Follow-up|10|||
163278989|NCT04955626|589731480|FG011|Blinded Period|Lost to Follow-up|32|||
163278990|NCT04955626|589731481|FG012|Blinded Period|Lost to Follow-up|0|||
163278991|NCT04955626|589731482|FG013|Blinded Period|Lost to Follow-up|0|||
163278992|NCT04955626|589731483|FG014|Blinded Period|Lost to Follow-up|0|||
163278993|NCT04955626|589731484|FG015|Blinded Period|Lost to Follow-up|12|||
162929594|NCT04682639|588447392|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
162929595|NCT04388527|588447393|FG000|Overall Study|Death|14|||
162929596|NCT04388527|588447393|FG000|Overall Study|Withdrawal by Subject|2|||
162929597|NCT04388527|588447393|FG000|Overall Study|Lost to Follow-up|1|||
162929598|NCT00331773|588447394|FG000|Overall Study|Withdrawal by Subject|6|||
162929599|NCT00331773|588447395|FG001|Overall Study|Withdrawal by Subject|4|||
162929600|NCT00331773|588447394|FG000|Overall Study|Protocol Violation|10|||
162929601|NCT00331773|588447395|FG001|Overall Study|Protocol Violation|3|||
162929602|NCT02773446|588447396|FG000|First Admission|Withdrawal by Subject|0|||
162929603|NCT02773446|588447397|FG001|First Admission|Withdrawal by Subject|0|||
163278994|NCT04955626|589731485|FG016|Blinded Period|Lost to Follow-up|2|||
163278995|NCT04955626|589731486|FG017|Blinded Period|Lost to Follow-up|5|||
163278996|NCT04955626|589731487|FG018|Blinded Period|Lost to Follow-up|0|||
163278997|NCT04955626|589731488|FG019|Blinded Period|Lost to Follow-up|0|||
163278998|NCT04955626|589731489|FG020|Blinded Period|Lost to Follow-up|0|||
163278999|NCT04955626|589731490|FG021|Blinded Period|Lost to Follow-up|0|||
163279000|NCT04955626|589731491|FG022|Blinded Period|Lost to Follow-up|0|||
163279001|NCT04955626|589731492|FG023|Blinded Period|Lost to Follow-up|0|||
163279002|NCT04955626|589731493|FG024|Blinded Period|Lost to Follow-up|3|||
163279003|NCT04955626|589731494|FG025|Blinded Period|Lost to Follow-up|1|||
163279004|NCT04955626|589731495|FG026|Blinded Period|Lost to Follow-up|2|||
163172825|NCT01328444|589347324|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
163172826|NCT01328444|589347325|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
163172827|NCT01328444|589347326|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
163172828|NCT01328444|589347327|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
163172829|NCT01328444|589347328|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
163172830|NCT01328444|589347329|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
163172831|NCT01328444|589347324|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
163172832|NCT01328444|589347325|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
163172833|NCT01328444|589347326|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
163172834|NCT01328444|589347327|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
163172835|NCT01328444|589347328|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
163172836|NCT01328444|589347329|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
163172837|NCT01328444|589347324|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
163172838|NCT01328444|589347325|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
163172839|NCT01328444|589347326|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
163172840|NCT01328444|589347327|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
163172841|NCT01328444|589347328|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
163172842|NCT01328444|589347329|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
163172843|NCT01328444|589347324|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
163172844|NCT01328444|589347325|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
163279005|NCT04955626|589731496|FG027|Blinded Period|Lost to Follow-up|2|||
163279006|NCT04955626|589731497|FG028|Blinded Period|Lost to Follow-up|2|||
163279007|NCT04955626|589731498|FG029|Blinded Period|Lost to Follow-up|0|||
163279008|NCT04955626|589731499|FG030|Blinded Period|Lost to Follow-up|0|||
163279009|NCT04955626|589731500|FG031|Blinded Period|Lost to Follow-up|0|||
163279010|NCT04955626|589731501|FG032|Blinded Period|Lost to Follow-up|0|||
163279011|NCT04955626|589731502|FG033|Blinded Period|Lost to Follow-up|0|||
163279012|NCT04955626|589731503|FG034|Blinded Period|Lost to Follow-up|0|||
163172845|NCT01328444|589347326|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
163172846|NCT01328444|589347327|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
163279013|NCT04955626|589731504|FG035|Blinded Period|Lost to Follow-up|0|||
163279014|NCT04955626|589731469|FG000|Blinded Period|Protocol Violation|5|||
163279015|NCT04955626|589731470|FG001|Blinded Period|Protocol Violation|14|||
163279016|NCT04955626|589731471|FG002|Blinded Period|Protocol Violation|0|||
163279017|NCT04955626|589731472|FG003|Blinded Period|Protocol Violation|1|||
163279018|NCT04955626|589731473|FG004|Blinded Period|Protocol Violation|2|||
163279019|NCT04955626|589731474|FG005|Blinded Period|Protocol Violation|2|||
163279020|NCT04955626|589731475|FG006|Blinded Period|Protocol Violation|0|||
163279021|NCT04955626|589731476|FG007|Blinded Period|Protocol Violation|0|||
163279022|NCT04955626|589731477|FG008|Blinded Period|Protocol Violation|0|||
163279023|NCT04955626|589731478|FG009|Blinded Period|Protocol Violation|4|||
163279024|NCT04955626|589731479|FG010|Blinded Period|Protocol Violation|6|||
163279025|NCT04955626|589731480|FG011|Blinded Period|Protocol Violation|1|||
163279026|NCT04955626|589731481|FG012|Blinded Period|Protocol Violation|0|||
163279027|NCT04955626|589731482|FG013|Blinded Period|Protocol Violation|0|||
163279028|NCT04955626|589731483|FG014|Blinded Period|Protocol Violation|2|||
163279029|NCT04955626|589731484|FG015|Blinded Period|Protocol Violation|6|||
163279030|NCT04955626|589731485|FG016|Blinded Period|Protocol Violation|4|||
163279031|NCT04955626|589731486|FG017|Blinded Period|Protocol Violation|6|||
163279032|NCT04955626|589731487|FG018|Blinded Period|Protocol Violation|0|||
163279033|NCT04955626|589731488|FG019|Blinded Period|Protocol Violation|1|||
163279034|NCT04955626|589731489|FG020|Blinded Period|Protocol Violation|0|||
163279035|NCT04955626|589731490|FG021|Blinded Period|Protocol Violation|1|||
163279036|NCT04955626|589731491|FG022|Blinded Period|Protocol Violation|0|||
163279037|NCT04955626|589731492|FG023|Blinded Period|Protocol Violation|0|||
163279038|NCT04955626|589731493|FG024|Blinded Period|Protocol Violation|4|||
163279039|NCT04955626|589731494|FG025|Blinded Period|Protocol Violation|6|||
163279040|NCT04955626|589731495|FG026|Blinded Period|Protocol Violation|5|||
163279041|NCT04955626|589731496|FG027|Blinded Period|Protocol Violation|3|||
163279042|NCT04955626|589731497|FG028|Blinded Period|Protocol Violation|4|||
162929604|NCT02773446|588447398|FG002|First Admission|Withdrawal by Subject|0|||
162929605|NCT02773446|588447399|FG003|First Admission|Withdrawal by Subject|1|||
163279043|NCT04955626|589731498|FG029|Blinded Period|Protocol Violation|3|||
163279044|NCT04955626|589731499|FG030|Blinded Period|Protocol Violation|0|||
163279045|NCT04955626|589731500|FG031|Blinded Period|Protocol Violation|0|||
163279046|NCT04955626|589731501|FG032|Blinded Period|Protocol Violation|0|||
163279047|NCT04955626|589731502|FG033|Blinded Period|Protocol Violation|0|||
163279048|NCT04955626|589731503|FG034|Blinded Period|Protocol Violation|0|||
163279049|NCT04955626|589731504|FG035|Blinded Period|Protocol Violation|0|||
163279050|NCT04955626|589731469|FG000|Blinded Period|Death|0|||
163279051|NCT04955626|589731470|FG001|Blinded Period|Death|2|||
163279052|NCT04955626|589731471|FG002|Blinded Period|Death|0|||
163279053|NCT04955626|589731472|FG003|Blinded Period|Death|0|||
163279054|NCT04955626|589731473|FG004|Blinded Period|Death|0|||
163279055|NCT04955626|589731474|FG005|Blinded Period|Death|0|||
163279056|NCT04955626|589731475|FG006|Blinded Period|Death|0|||
163279057|NCT04955626|589731476|FG007|Blinded Period|Death|2|||
163279058|NCT04955626|589731477|FG008|Blinded Period|Death|1|||
163279059|NCT04955626|589731478|FG009|Blinded Period|Death|1|||
163279060|NCT04955626|589731479|FG010|Blinded Period|Death|0|||
163279061|NCT04955626|589731480|FG011|Blinded Period|Death|2|||
163279062|NCT04955626|589731481|FG012|Blinded Period|Death|0|||
163279063|NCT04955626|589731482|FG013|Blinded Period|Death|0|||
163279064|NCT04955626|589731483|FG014|Blinded Period|Death|0|||
163279065|NCT04955626|589731484|FG015|Blinded Period|Death|0|||
163279066|NCT04955626|589731485|FG016|Blinded Period|Death|0|||
163279067|NCT04955626|589731486|FG017|Blinded Period|Death|0|||
163279068|NCT04955626|589731487|FG018|Blinded Period|Death|0|||
163279069|NCT04955626|589731488|FG019|Blinded Period|Death|0|||
163279070|NCT04955626|589731489|FG020|Blinded Period|Death|0|||
163279071|NCT04955626|589731490|FG021|Blinded Period|Death|0|||
163279072|NCT04955626|589731491|FG022|Blinded Period|Death|0|||
163279073|NCT04955626|589731492|FG023|Blinded Period|Death|1|||
163279074|NCT04955626|589731493|FG024|Blinded Period|Death|0|||
163279075|NCT04955626|589731494|FG025|Blinded Period|Death|0|||
163279076|NCT04955626|589731495|FG026|Blinded Period|Death|1|||
163279077|NCT04955626|589731496|FG027|Blinded Period|Death|1|||
163279078|NCT04955626|589731497|FG028|Blinded Period|Death|0|||
163279079|NCT04955626|589731498|FG029|Blinded Period|Death|1|||
163279080|NCT04955626|589731499|FG030|Blinded Period|Death|0|||
163279081|NCT04955626|589731500|FG031|Blinded Period|Death|0|||
163279082|NCT04955626|589731501|FG032|Blinded Period|Death|0|||
163279083|NCT04955626|589731502|FG033|Blinded Period|Death|0|||
163279084|NCT04955626|589731503|FG034|Blinded Period|Death|0|||
163279085|NCT04955626|589731504|FG035|Blinded Period|Death|0|||
163279086|NCT04955626|589731469|FG000|Blinded Period|Adverse Event|0|||
163279087|NCT04955626|589731470|FG001|Blinded Period|Adverse Event|1|||
163279088|NCT04955626|589731471|FG002|Blinded Period|Adverse Event|1|||
163279089|NCT04955626|589731472|FG003|Blinded Period|Adverse Event|1|||
163279090|NCT04955626|589731473|FG004|Blinded Period|Adverse Event|0|||
163279091|NCT04955626|589731474|FG005|Blinded Period|Adverse Event|0|||
163279092|NCT04955626|589731475|FG006|Blinded Period|Adverse Event|0|||
163279093|NCT04955626|589731476|FG007|Blinded Period|Adverse Event|0|||
163279094|NCT04955626|589731477|FG008|Blinded Period|Adverse Event|0|||
163279095|NCT04955626|589731478|FG009|Blinded Period|Adverse Event|1|||
163279096|NCT04955626|589731479|FG010|Blinded Period|Adverse Event|1|||
163172847|NCT01328444|589347328|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
163172848|NCT01328444|589347329|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
163172849|NCT01328444|589347324|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
163172850|NCT01328444|589347325|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
163172851|NCT01328444|589347326|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
163172852|NCT01328444|589347327|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
163172853|NCT01328444|589347328|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
163172854|NCT01328444|589347329|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
163172855|NCT01328444|589347324|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
163172856|NCT01328444|589347325|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
163172857|NCT01328444|589347326|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
163172858|NCT01328444|589347327|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
163172859|NCT01328444|589347328|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
163172860|NCT01328444|589347329|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
163172861|NCT01328444|589347324|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
163172862|NCT01328444|589347325|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
163172863|NCT01328444|589347326|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
163172864|NCT01328444|589347327|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
163172865|NCT01328444|589347328|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
163172866|NCT01328444|589347329|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
163172867|NCT01328444|589347324|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163172868|NCT01328444|589347325|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163172869|NCT01328444|589347326|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163172870|NCT01328444|589347327|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163172871|NCT01328444|589347328|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
163172872|NCT01328444|589347329|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
163172873|NCT03241368|589347334|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
163172874|NCT03241368|589347334|FG000|Overall Study|Lost to Follow-up|1|||
163172875|NCT03241368|589347334|FG000|Overall Study|Physician Decision|6|||
163172876|NCT03241368|589347334|FG000|Overall Study|Withdrawal by Subject|6|||
163172877|NCT03241368|589347334|FG000|Overall Study|Protocol Violation|1|||
163172878|NCT01119937|589347335|FG000|Overall Study|Adverse Event|11|||
163172879|NCT01119937|589347336|FG001|Overall Study|Adverse Event|5|||
163172880|NCT01119937|589347335|FG000|Overall Study|Protocol deviation|3|||
163172881|NCT01119937|589347336|FG001|Overall Study|Protocol deviation|1|||
163172882|NCT01119937|589347335|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
163172883|NCT01119937|589347336|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163172884|NCT01119937|589347335|FG000|Overall Study|Withdrawal by Subject|2|||
163172885|NCT01119937|589347336|FG001|Overall Study|Withdrawal by Subject|1|||
163172886|NCT03316911|589347337|FG000|Overall Study|Lost to Follow-up|33|||
163172887|NCT03316911|589347338|FG001|Overall Study|Lost to Follow-up|29|||
163172888|NCT01270802|589347339|FG000|Overall Study|Withdrawal by Subject|1|||
163172889|NCT01270802|589347340|FG001|Overall Study|Withdrawal by Subject|0|||
163172890|NCT01270802|589347339|FG000|Overall Study|Adverse Event|1|||
163172891|NCT01270802|589347340|FG001|Overall Study|Adverse Event|0|||
163172892|NCT01270802|589347339|FG000|Overall Study|Lost to Follow-up|0|||
163172893|NCT01270802|589347340|FG001|Overall Study|Lost to Follow-up|1|||
163172894|NCT01566214|589347341|FG000|Overall Study|Lost to Follow-up|3|||
163172895|NCT01566214|589347342|FG001|Overall Study|Lost to Follow-up|0|||
163172896|NCT04620798|589347343|FG000|Overall Study|Lost to Follow-up|126|||
163172897|NCT04620798|589347344|FG001|Overall Study|Lost to Follow-up|138|||
163172898|NCT03222492|589347352|FG000|Overall Study|Withdrawal by Subject|0|||
163172899|NCT03222492|589347353|FG001|Overall Study|Withdrawal by Subject|0|||
163172900|NCT03222492|589347354|FG002|Overall Study|Withdrawal by Subject|1|||
163172901|NCT03222492|589347355|FG003|Overall Study|Withdrawal by Subject|0|||
163172902|NCT03222492|589347352|FG000|Overall Study|COVID-19 related|0|||
163172903|NCT03222492|589347353|FG001|Overall Study|COVID-19 related|0|||
163172904|NCT03222492|589347354|FG002|Overall Study|COVID-19 related|1|||
163172905|NCT03222492|589347355|FG003|Overall Study|COVID-19 related|0|||
163172906|NCT02486627|589347358|FG000|Overall Study|Death|1|||
163172907|NCT02486627|589347359|FG001|Overall Study|Death|0|||
163172908|NCT02486627|589347358|FG000|Overall Study|Other Unspecified|0|||
163172909|NCT02486627|589347359|FG001|Overall Study|Other Unspecified|2|||
163172910|NCT02486627|589347358|FG000|Overall Study|Consent Withdrawn by Participant|4|||
163172911|NCT02486627|589347359|FG001|Overall Study|Consent Withdrawn by Participant|3|||
163172912|NCT02486627|589347358|FG000|Overall Study|Significant Participant Noncompliance|1|||
163172913|NCT02486627|589347359|FG001|Overall Study|Significant Participant Noncompliance|1|||
163172914|NCT02486627|589347358|FG000|Overall Study|Lost to Follow-up|1|||
163279097|NCT04955626|589731480|FG011|Blinded Period|Adverse Event|0|||
163279098|NCT04955626|589731481|FG012|Blinded Period|Adverse Event|0|||
163279099|NCT04955626|589731482|FG013|Blinded Period|Adverse Event|0|||
163172915|NCT02486627|589347359|FG001|Overall Study|Lost to Follow-up|3|||
163172916|NCT02112045|589347363|FG000|Overall Study|Withdrawal by Subject|1|||
163279100|NCT04955626|589731483|FG014|Blinded Period|Adverse Event|0|||
163279101|NCT04955626|589731484|FG015|Blinded Period|Adverse Event|0|||
163279102|NCT04955626|589731485|FG016|Blinded Period|Adverse Event|0|||
163279103|NCT04955626|589731486|FG017|Blinded Period|Adverse Event|0|||
163279104|NCT04955626|589731487|FG018|Blinded Period|Adverse Event|1|||
163279105|NCT04955626|589731488|FG019|Blinded Period|Adverse Event|0|||
163279106|NCT04955626|589731489|FG020|Blinded Period|Adverse Event|0|||
163279107|NCT04955626|589731490|FG021|Blinded Period|Adverse Event|0|||
163279108|NCT04955626|589731491|FG022|Blinded Period|Adverse Event|0|||
163279109|NCT04955626|589731492|FG023|Blinded Period|Adverse Event|0|||
163279110|NCT04955626|589731493|FG024|Blinded Period|Adverse Event|0|||
163279111|NCT04955626|589731494|FG025|Blinded Period|Adverse Event|0|||
163279112|NCT04955626|589731495|FG026|Blinded Period|Adverse Event|1|||
163279113|NCT04955626|589731496|FG027|Blinded Period|Adverse Event|0|||
163279114|NCT04955626|589731497|FG028|Blinded Period|Adverse Event|0|||
163279115|NCT04955626|589731498|FG029|Blinded Period|Adverse Event|0|||
163279116|NCT04955626|589731499|FG030|Blinded Period|Adverse Event|0|||
163279117|NCT04955626|589731500|FG031|Blinded Period|Adverse Event|0|||
163279118|NCT04955626|589731501|FG032|Blinded Period|Adverse Event|0|||
163279119|NCT04955626|589731502|FG033|Blinded Period|Adverse Event|0|||
163279120|NCT04955626|589731503|FG034|Blinded Period|Adverse Event|0|||
163279121|NCT04955626|589731504|FG035|Blinded Period|Adverse Event|0|||
163279122|NCT04955626|589731469|FG000|Blinded Period|No longer meets eligibility criteria|1|||
163279123|NCT04955626|589731470|FG001|Blinded Period|No longer meets eligibility criteria|2|||
163279124|NCT04955626|589731471|FG002|Blinded Period|No longer meets eligibility criteria|0|||
163279125|NCT04955626|589731472|FG003|Blinded Period|No longer meets eligibility criteria|1|||
163279126|NCT04955626|589731473|FG004|Blinded Period|No longer meets eligibility criteria|0|||
163279127|NCT04955626|589731474|FG005|Blinded Period|No longer meets eligibility criteria|0|||
163279128|NCT04955626|589731475|FG006|Blinded Period|No longer meets eligibility criteria|0|||
163279129|NCT04955626|589731476|FG007|Blinded Period|No longer meets eligibility criteria|0|||
163279130|NCT04955626|589731477|FG008|Blinded Period|No longer meets eligibility criteria|1|||
163279131|NCT04955626|589731478|FG009|Blinded Period|No longer meets eligibility criteria|0|||
163279132|NCT04955626|589731479|FG010|Blinded Period|No longer meets eligibility criteria|1|||
163279133|NCT04955626|589731480|FG011|Blinded Period|No longer meets eligibility criteria|1|||
163279134|NCT04955626|589731481|FG012|Blinded Period|No longer meets eligibility criteria|0|||
163279135|NCT04955626|589731482|FG013|Blinded Period|No longer meets eligibility criteria|0|||
163279136|NCT04955626|589731483|FG014|Blinded Period|No longer meets eligibility criteria|0|||
163279137|NCT04955626|589731484|FG015|Blinded Period|No longer meets eligibility criteria|3|||
163279138|NCT04955626|589731485|FG016|Blinded Period|No longer meets eligibility criteria|0|||
163279139|NCT04955626|589731486|FG017|Blinded Period|No longer meets eligibility criteria|2|||
162929606|NCT02773446|588447400|FG004|First Admission|Withdrawal by Subject|0|||
162929607|NCT02773446|588447401|FG005|First Admission|Withdrawal by Subject|0|||
162929608|NCT02773446|588447396|FG000|First Admission|Lost to Follow-up|1|||
162929609|NCT02773446|588447397|FG001|First Admission|Lost to Follow-up|0|||
162929610|NCT02773446|588447398|FG002|First Admission|Lost to Follow-up|0|||
162929611|NCT02773446|588447399|FG003|First Admission|Lost to Follow-up|0|||
162929612|NCT02773446|588447400|FG004|First Admission|Lost to Follow-up|0|||
162929613|NCT02773446|588447401|FG005|First Admission|Lost to Follow-up|0|||
162929614|NCT02513459|588447402|FG000|Overall Study|Adverse Event|7|||
162929615|NCT02513459|588447402|FG000|Overall Study|Withdrew consent|5|||
163279140|NCT04955626|589731487|FG018|Blinded Period|No longer meets eligibility criteria|0|||
163279141|NCT04955626|589731488|FG019|Blinded Period|No longer meets eligibility criteria|0|||
162929616|NCT02513459|588447402|FG000|Overall Study|Loss of efficacy|2|||
162929617|NCT02513459|588447402|FG000|Overall Study|Pregnancy|2|||
162929618|NCT02513459|588447402|FG000|Overall Study|Subject decision|2|||
162929619|NCT02513459|588447402|FG000|Overall Study|Lack of response|1|||
162929620|NCT02513459|588447402|FG000|Overall Study|Reproductive plans|1|||
162929621|NCT02513459|588447402|FG000|Overall Study|Surgery planned-- not done|1|||
162929622|NCT00923195|588447403|FG000|Overall Study|Death|0|||
162929623|NCT00923195|588447404|FG001|Overall Study|Death|1|||
162929624|NCT00525031|588447405|FG000|Overall Study|Disease Progression|1|||
162929625|NCT00525031|588447406|FG001|Overall Study|Disease Progression|1|||
162929626|NCT01613131|588447407|FG000|Overall Study|Withdrawal by Subject|3|||
162929627|NCT01613131|588447408|FG001|Overall Study|Withdrawal by Subject|5|||
162929628|NCT02454972|588447411|FG000|Overall Study|Progressive disease|17|||
162929629|NCT02454972|588447412|FG001|Overall Study|Progressive disease|16|||
162929630|NCT02454972|588447413|FG002|Overall Study|Progressive disease|59|||
162929631|NCT02454972|588447414|FG003|Overall Study|Progressive disease|23|||
162929632|NCT02454972|588447415|FG004|Overall Study|Progressive disease|16|||
162929633|NCT02454972|588447416|FG005|Overall Study|Progressive disease|12|||
162929634|NCT02454972|588447417|FG006|Overall Study|Progressive disease|19|||
162929635|NCT02454972|588447418|FG007|Overall Study|Progressive disease|27|||
162929636|NCT02454972|588447419|FG008|Overall Study|Progressive disease|0|||
162929637|NCT02454972|588447411|FG000|Overall Study|Death|0|||
162929638|NCT02454972|588447412|FG001|Overall Study|Death|0|||
162929639|NCT02454972|588447413|FG002|Overall Study|Death|5|||
163279142|NCT04955626|589731489|FG020|Blinded Period|No longer meets eligibility criteria|0|||
163279143|NCT04955626|589731490|FG021|Blinded Period|No longer meets eligibility criteria|0|||
163279144|NCT04955626|589731491|FG022|Blinded Period|No longer meets eligibility criteria|0|||
163279145|NCT04955626|589731492|FG023|Blinded Period|No longer meets eligibility criteria|0|||
163279146|NCT04955626|589731493|FG024|Blinded Period|No longer meets eligibility criteria|1|||
163279147|NCT04955626|589731494|FG025|Blinded Period|No longer meets eligibility criteria|0|||
163279148|NCT04955626|589731495|FG026|Blinded Period|No longer meets eligibility criteria|0|||
163279149|NCT04955626|589731496|FG027|Blinded Period|No longer meets eligibility criteria|1|||
163279150|NCT04955626|589731497|FG028|Blinded Period|No longer meets eligibility criteria|0|||
163279151|NCT04955626|589731498|FG029|Blinded Period|No longer meets eligibility criteria|0|||
163279152|NCT04955626|589731499|FG030|Blinded Period|No longer meets eligibility criteria|0|||
163279153|NCT04955626|589731500|FG031|Blinded Period|No longer meets eligibility criteria|0|||
162929640|NCT02454972|588447414|FG003|Overall Study|Death|1|||
162929641|NCT02454972|588447415|FG004|Overall Study|Death|0|||
162929642|NCT02454972|588447416|FG005|Overall Study|Death|0|||
162929643|NCT02454972|588447417|FG006|Overall Study|Death|0|||
162929644|NCT02454972|588447418|FG007|Overall Study|Death|0|||
162929645|NCT02454972|588447419|FG008|Overall Study|Death|95|||
162929646|NCT02454972|588447411|FG000|Overall Study|Physician Decision|0|||
162929647|NCT02454972|588447412|FG001|Overall Study|Physician Decision|1|||
162929648|NCT02454972|588447413|FG002|Overall Study|Physician Decision|2|||
162929649|NCT02454972|588447414|FG003|Overall Study|Physician Decision|1|||
162929650|NCT02454972|588447415|FG004|Overall Study|Physician Decision|2|||
162929651|NCT02454972|588447416|FG005|Overall Study|Physician Decision|0|||
162929652|NCT02454972|588447417|FG006|Overall Study|Physician Decision|0|||
162929653|NCT02454972|588447418|FG007|Overall Study|Physician Decision|1|||
162929654|NCT02454972|588447419|FG008|Overall Study|Physician Decision|0|||
162929655|NCT02454972|588447411|FG000|Overall Study|Non treatment-related adverse event|2|||
163279154|NCT04955626|589731501|FG032|Blinded Period|No longer meets eligibility criteria|0|||
163279155|NCT04955626|589731502|FG033|Blinded Period|No longer meets eligibility criteria|0|||
163279156|NCT04955626|589731503|FG034|Blinded Period|No longer meets eligibility criteria|0|||
163279157|NCT04955626|589731504|FG035|Blinded Period|No longer meets eligibility criteria|0|||
163279158|NCT04955626|589731469|FG000|Blinded Period|Other|54|||
163279159|NCT04955626|589731470|FG001|Blinded Period|Other|3|||
163279160|NCT04955626|589731471|FG002|Blinded Period|Other|4|||
163279161|NCT04955626|589731472|FG003|Blinded Period|Other|2|||
163279162|NCT04955626|589731473|FG004|Blinded Period|Other|0|||
163279163|NCT04955626|589731474|FG005|Blinded Period|Other|0|||
163279164|NCT04955626|589731475|FG006|Blinded Period|Other|2|||
163279165|NCT04955626|589731476|FG007|Blinded Period|Other|2|||
163279166|NCT04955626|589731477|FG008|Blinded Period|Other|1|||
163279167|NCT04955626|589731478|FG009|Blinded Period|Other|0|||
163279168|NCT04955626|589731479|FG010|Blinded Period|Other|1|||
163279169|NCT04955626|589731480|FG011|Blinded Period|Other|1|||
163279170|NCT04955626|589731481|FG012|Blinded Period|Other|0|||
163279171|NCT04955626|589731482|FG013|Blinded Period|Other|0|||
163279172|NCT04955626|589731483|FG014|Blinded Period|Other|0|||
163279173|NCT04955626|589731484|FG015|Blinded Period|Other|0|||
163279174|NCT04955626|589731485|FG016|Blinded Period|Other|0|||
163279175|NCT04955626|589731486|FG017|Blinded Period|Other|1|||
163279176|NCT04955626|589731487|FG018|Blinded Period|Other|0|||
163279177|NCT04955626|589731488|FG019|Blinded Period|Other|0|||
163279178|NCT04955626|589731489|FG020|Blinded Period|Other|0|||
163279179|NCT04955626|589731490|FG021|Blinded Period|Other|0|||
163279180|NCT04955626|589731491|FG022|Blinded Period|Other|0|||
163279181|NCT04955626|589731492|FG023|Blinded Period|Other|0|||
163279182|NCT04955626|589731493|FG024|Blinded Period|Other|0|||
163279183|NCT04955626|589731494|FG025|Blinded Period|Other|0|||
163279184|NCT04955626|589731495|FG026|Blinded Period|Other|2|||
163279185|NCT04955626|589731496|FG027|Blinded Period|Other|0|||
163279186|NCT04955626|589731497|FG028|Blinded Period|Other|0|||
163279187|NCT04955626|589731498|FG029|Blinded Period|Other|0|||
163279188|NCT04955626|589731499|FG030|Blinded Period|Other|0|||
163279189|NCT04955626|589731500|FG031|Blinded Period|Other|0|||
162929656|NCT02454972|588447412|FG001|Overall Study|Non treatment-related adverse event|0|||
162929657|NCT02454972|588447413|FG002|Overall Study|Non treatment-related adverse event|1|||
162929658|NCT02454972|588447414|FG003|Overall Study|Non treatment-related adverse event|0|||
163279190|NCT04955626|589731501|FG032|Blinded Period|Other|0|||
163279191|NCT04955626|589731502|FG033|Blinded Period|Other|0|||
163279192|NCT04955626|589731503|FG034|Blinded Period|Other|0|||
163279193|NCT04955626|589731504|FG035|Blinded Period|Other|0|||
163279194|NCT04955626|589731469|FG000|Blinded Period|Physician Decision|1|||
163279195|NCT04955626|589731470|FG001|Blinded Period|Physician Decision|1|||
163279196|NCT04955626|589731471|FG002|Blinded Period|Physician Decision|0|||
163279197|NCT04955626|589731472|FG003|Blinded Period|Physician Decision|3|||
163279198|NCT04955626|589731473|FG004|Blinded Period|Physician Decision|0|||
163279199|NCT04955626|589731474|FG005|Blinded Period|Physician Decision|0|||
163279200|NCT04955626|589731475|FG006|Blinded Period|Physician Decision|1|||
163279201|NCT04955626|589731476|FG007|Blinded Period|Physician Decision|1|||
163279202|NCT04955626|589731477|FG008|Blinded Period|Physician Decision|0|||
163172917|NCT02112045|589347364|FG001|Overall Study|Withdrawal by Subject|0|||
163172918|NCT00627445|589347365|FG000|Overall Study|Adverse Event|3|||
163172919|NCT00627445|589347366|FG001|Overall Study|Adverse Event|3|||
163172920|NCT00627445|589347365|FG000|Overall Study|Lack of Efficacy|0|||
163172921|NCT00627445|589347366|FG001|Overall Study|Lack of Efficacy|1|||
163172922|NCT00627445|589347365|FG000|Overall Study|Other|6|||
163172923|NCT00627445|589347366|FG001|Overall Study|Other|8|||
163172924|NCT03554486|589347367|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
163172925|NCT03554486|589347368|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
163172926|NCT03554486|589347369|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
163172927|NCT03554486|589347367|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
163172928|NCT03554486|589347368|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
163172929|NCT03554486|589347369|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
163172930|NCT03554486|589347367|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
163172931|NCT03554486|589347368|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
163172932|NCT03554486|589347369|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
163172933|NCT02431260|589347374|FG000|Overall Study|Subject Decision|0|||
163172934|NCT02431260|589347375|FG001|Overall Study|Subject Decision|1|||
163172935|NCT02431260|589347376|FG002|Overall Study|Subject Decision|1|||
163172936|NCT02431260|589347377|FG003|Overall Study|Subject Decision|0|||
163172937|NCT02431260|589347378|FG004|Overall Study|Subject Decision|0|||
163172938|NCT02431260|589347379|FG005|Overall Study|Subject Decision|0|||
163172939|NCT02431260|589347380|FG006|Overall Study|Subject Decision|0|||
163172940|NCT02431260|589347381|FG007|Overall Study|Subject Decision|0|||
163172941|NCT02431260|589347382|FG008|Overall Study|Subject Decision|1|||
163172942|NCT02431260|589347383|FG009|Overall Study|Subject Decision|1|||
163172943|NCT02431260|589347384|FG010|Overall Study|Subject Decision|0|||
163172944|NCT02431260|589347385|FG011|Overall Study|Subject Decision|1|||
163172945|NCT02431260|589347386|FG012|Overall Study|Subject Decision|0|||
163172946|NCT02431260|589347387|FG013|Overall Study|Subject Decision|0|||
163172947|NCT02431260|589347374|FG000|Overall Study|Death|4|||
163172948|NCT02431260|589347375|FG001|Overall Study|Death|4|||
163172949|NCT02431260|589347376|FG002|Overall Study|Death|3|||
163172950|NCT02431260|589347377|FG003|Overall Study|Death|4|||
163172951|NCT02431260|589347378|FG004|Overall Study|Death|2|||
163172952|NCT02431260|589347379|FG005|Overall Study|Death|2|||
163172953|NCT02431260|589347380|FG006|Overall Study|Death|3|||
163172954|NCT02431260|589347381|FG007|Overall Study|Death|1|||
163172955|NCT02431260|589347382|FG008|Overall Study|Death|6|||
163172956|NCT02431260|589347383|FG009|Overall Study|Death|6|||
163172957|NCT02431260|589347384|FG010|Overall Study|Death|3|||
163172958|NCT02431260|589347385|FG011|Overall Study|Death|2|||
163172959|NCT02431260|589347386|FG012|Overall Study|Death|5|||
163172960|NCT02431260|589347387|FG013|Overall Study|Death|1|||
163172961|NCT02431260|589347374|FG000|Overall Study|Lost to Follow-up|0|||
163172962|NCT02431260|589347375|FG001|Overall Study|Lost to Follow-up|0|||
163172963|NCT02431260|589347376|FG002|Overall Study|Lost to Follow-up|0|||
163172964|NCT02431260|589347377|FG003|Overall Study|Lost to Follow-up|0|||
163172965|NCT02431260|589347378|FG004|Overall Study|Lost to Follow-up|0|||
163172966|NCT02431260|589347379|FG005|Overall Study|Lost to Follow-up|1|||
163172967|NCT02431260|589347380|FG006|Overall Study|Lost to Follow-up|0|||
163172968|NCT02431260|589347381|FG007|Overall Study|Lost to Follow-up|0|||
163172969|NCT02431260|589347382|FG008|Overall Study|Lost to Follow-up|0|||
163172970|NCT02431260|589347383|FG009|Overall Study|Lost to Follow-up|0|||
163172971|NCT02431260|589347384|FG010|Overall Study|Lost to Follow-up|0|||
163172972|NCT02431260|589347385|FG011|Overall Study|Lost to Follow-up|0|||
163172973|NCT02431260|589347386|FG012|Overall Study|Lost to Follow-up|0|||
163279203|NCT04955626|589731478|FG009|Blinded Period|Physician Decision|0|||
163279204|NCT04955626|589731479|FG010|Blinded Period|Physician Decision|0|||
163279205|NCT04955626|589731480|FG011|Blinded Period|Physician Decision|5|||
163279206|NCT04955626|589731481|FG012|Blinded Period|Physician Decision|0|||
163172974|NCT02431260|589347387|FG013|Overall Study|Lost to Follow-up|0|||
163172975|NCT02431260|589347374|FG000|Overall Study|Study Terminated by the Sponsor|0|||
163172976|NCT02431260|589347375|FG001|Overall Study|Study Terminated by the Sponsor|0|||
163172977|NCT02431260|589347376|FG002|Overall Study|Study Terminated by the Sponsor|2|||
163172978|NCT02431260|589347377|FG003|Overall Study|Study Terminated by the Sponsor|1|||
163172979|NCT02431260|589347378|FG004|Overall Study|Study Terminated by the Sponsor|1|||
163172980|NCT02431260|589347379|FG005|Overall Study|Study Terminated by the Sponsor|0|||
163172981|NCT02431260|589347380|FG006|Overall Study|Study Terminated by the Sponsor|1|||
163172982|NCT02431260|589347381|FG007|Overall Study|Study Terminated by the Sponsor|2|||
163172983|NCT02431260|589347382|FG008|Overall Study|Study Terminated by the Sponsor|1|||
163172984|NCT02431260|589347383|FG009|Overall Study|Study Terminated by the Sponsor|1|||
163172985|NCT02431260|589347384|FG010|Overall Study|Study Terminated by the Sponsor|1|||
163172986|NCT02431260|589347385|FG011|Overall Study|Study Terminated by the Sponsor|0|||
163172987|NCT02431260|589347386|FG012|Overall Study|Study Terminated by the Sponsor|4|||
163172988|NCT02431260|589347387|FG013|Overall Study|Study Terminated by the Sponsor|0|||
163172989|NCT02431260|589347374|FG000|Overall Study|Physician Decision|0|||
163172990|NCT02431260|589347375|FG001|Overall Study|Physician Decision|0|||
162929659|NCT02454972|588447415|FG004|Overall Study|Non treatment-related adverse event|0|||
162929660|NCT02454972|588447416|FG005|Overall Study|Non treatment-related adverse event|1|||
162929661|NCT02454972|588447417|FG006|Overall Study|Non treatment-related adverse event|0|||
162929662|NCT02454972|588447418|FG007|Overall Study|Non treatment-related adverse event|1|||
162929663|NCT02454972|588447419|FG008|Overall Study|Non treatment-related adverse event|0|||
162929664|NCT02454972|588447411|FG000|Overall Study|Treatment-related adverse events|0|||
162929665|NCT02454972|588447412|FG001|Overall Study|Treatment-related adverse events|1|||
162929666|NCT02454972|588447413|FG002|Overall Study|Treatment-related adverse events|1|||
162929667|NCT02454972|588447414|FG003|Overall Study|Treatment-related adverse events|0|||
162929668|NCT02454972|588447415|FG004|Overall Study|Treatment-related adverse events|2|||
162929669|NCT02454972|588447416|FG005|Overall Study|Treatment-related adverse events|0|||
162929670|NCT02454972|588447417|FG006|Overall Study|Treatment-related adverse events|0|||
162929671|NCT02454972|588447418|FG007|Overall Study|Treatment-related adverse events|2|||
162929672|NCT02454972|588447419|FG008|Overall Study|Treatment-related adverse events|0|||
162929673|NCT02454972|588447411|FG000|Overall Study|Patient moves to compassionate use|0|||
162929674|NCT02454972|588447412|FG001|Overall Study|Patient moves to compassionate use|0|||
162929675|NCT02454972|588447413|FG002|Overall Study|Patient moves to compassionate use|0|||
162929676|NCT02454972|588447414|FG003|Overall Study|Patient moves to compassionate use|0|||
162929677|NCT02454972|588447415|FG004|Overall Study|Patient moves to compassionate use|0|||
162929678|NCT02454972|588447416|FG005|Overall Study|Patient moves to compassionate use|0|||
162929679|NCT02454972|588447417|FG006|Overall Study|Patient moves to compassionate use|2|||
162929680|NCT02454972|588447418|FG007|Overall Study|Patient moves to compassionate use|0|||
162929681|NCT02454972|588447419|FG008|Overall Study|Patient moves to compassionate use|0|||
162929682|NCT02454972|588447411|FG000|Overall Study|Withdrawal by Subject|0|||
162929683|NCT02454972|588447412|FG001|Overall Study|Withdrawal by Subject|1|||
162929684|NCT02454972|588447413|FG002|Overall Study|Withdrawal by Subject|5|||
162929685|NCT02454972|588447414|FG003|Overall Study|Withdrawal by Subject|2|||
162929686|NCT02454972|588447415|FG004|Overall Study|Withdrawal by Subject|3|||
162929687|NCT02454972|588447416|FG005|Overall Study|Withdrawal by Subject|2|||
162929688|NCT02454972|588447417|FG006|Overall Study|Withdrawal by Subject|0|||
162929689|NCT02454972|588447418|FG007|Overall Study|Withdrawal by Subject|1|||
162929690|NCT02454972|588447419|FG008|Overall Study|Withdrawal by Subject|2|||
162929691|NCT02454972|588447411|FG000|Overall Study|Multiple delay/holds on treatment|0|||
162929692|NCT02454972|588447412|FG001|Overall Study|Multiple delay/holds on treatment|0|||
162929693|NCT02454972|588447413|FG002|Overall Study|Multiple delay/holds on treatment|0|||
162929694|NCT02454972|588447414|FG003|Overall Study|Multiple delay/holds on treatment|1|||
162929695|NCT02454972|588447415|FG004|Overall Study|Multiple delay/holds on treatment|0|||
162929696|NCT02454972|588447416|FG005|Overall Study|Multiple delay/holds on treatment|0|||
162929697|NCT02454972|588447417|FG006|Overall Study|Multiple delay/holds on treatment|0|||
162929698|NCT02454972|588447418|FG007|Overall Study|Multiple delay/holds on treatment|0|||
162929699|NCT02454972|588447419|FG008|Overall Study|Multiple delay/holds on treatment|0|||
162929700|NCT02454972|588447411|FG000|Overall Study|Never treated|0|||
162929701|NCT02454972|588447412|FG001|Overall Study|Never treated|0|||
162929702|NCT02454972|588447413|FG002|Overall Study|Never treated|3|||
162929703|NCT02454972|588447414|FG003|Overall Study|Never treated|1|||
162929704|NCT02454972|588447415|FG004|Overall Study|Never treated|1|||
162929705|NCT02454972|588447416|FG005|Overall Study|Never treated|0|||
162929706|NCT02454972|588447417|FG006|Overall Study|Never treated|0|||
162929707|NCT02454972|588447418|FG007|Overall Study|Never treated|0|||
162929708|NCT02454972|588447419|FG008|Overall Study|Never treated|5|||
162929709|NCT02454972|588447411|FG000|Overall Study|Lost to Follow-up|0|||
162929710|NCT02454972|588447412|FG001|Overall Study|Lost to Follow-up|0|||
162929711|NCT02454972|588447413|FG002|Overall Study|Lost to Follow-up|0|||
162929712|NCT02454972|588447414|FG003|Overall Study|Lost to Follow-up|0|||
162929713|NCT02454972|588447415|FG004|Overall Study|Lost to Follow-up|0|||
162929714|NCT02454972|588447416|FG005|Overall Study|Lost to Follow-up|0|||
162929715|NCT02454972|588447417|FG006|Overall Study|Lost to Follow-up|0|||
162929716|NCT02454972|588447418|FG007|Overall Study|Lost to Follow-up|0|||
162929717|NCT02454972|588447419|FG008|Overall Study|Lost to Follow-up|2|||
162929718|NCT02454972|588447411|FG000|Overall Study|Study termination|0|||
162929719|NCT02454972|588447412|FG001|Overall Study|Study termination|0|||
162929720|NCT02454972|588447413|FG002|Overall Study|Study termination|0|||
162929721|NCT02454972|588447414|FG003|Overall Study|Study termination|0|||
162929722|NCT02454972|588447415|FG004|Overall Study|Study termination|0|||
162929723|NCT02454972|588447416|FG005|Overall Study|Study termination|0|||
162929724|NCT02454972|588447417|FG006|Overall Study|Study termination|0|||
162929725|NCT02454972|588447418|FG007|Overall Study|Study termination|0|||
162929726|NCT02454972|588447419|FG008|Overall Study|Study termination|6|||
162929727|NCT00787566|588447420|FG000|Overall Study|AE related to chemotherapy|0|||
162929728|NCT00787566|588447421|FG001|Overall Study|AE related to chemotherapy|1|||
162929729|NCT00787566|588447422|FG002|Overall Study|AE related to chemotherapy|0|||
163279207|NCT04955626|589731482|FG013|Blinded Period|Physician Decision|0|||
163279208|NCT04955626|589731483|FG014|Blinded Period|Physician Decision|0|||
162929730|NCT02140164|588447423|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
162929731|NCT01814761|588447428|FG000|Overall Study|Other Reasons|1|||
163172991|NCT02431260|589347376|FG002|Overall Study|Physician Decision|0|||
163172992|NCT02431260|589347377|FG003|Overall Study|Physician Decision|0|||
163172993|NCT02431260|589347378|FG004|Overall Study|Physician Decision|0|||
163172994|NCT02431260|589347379|FG005|Overall Study|Physician Decision|1|||
163172995|NCT02431260|589347380|FG006|Overall Study|Physician Decision|0|||
163172996|NCT02431260|589347381|FG007|Overall Study|Physician Decision|0|||
163172997|NCT02431260|589347382|FG008|Overall Study|Physician Decision|0|||
163172998|NCT02431260|589347383|FG009|Overall Study|Physician Decision|0|||
163172999|NCT02431260|589347384|FG010|Overall Study|Physician Decision|0|||
163173000|NCT02431260|589347385|FG011|Overall Study|Physician Decision|0|||
163173001|NCT02431260|589347386|FG012|Overall Study|Physician Decision|0|||
163173002|NCT02431260|589347387|FG013|Overall Study|Physician Decision|0|||
163173003|NCT02431260|589347374|FG000|Overall Study|Other Unspecified|0|||
163173004|NCT02431260|589347375|FG001|Overall Study|Other Unspecified|0|||
163173005|NCT02431260|589347376|FG002|Overall Study|Other Unspecified|0|||
163173006|NCT02431260|589347377|FG003|Overall Study|Other Unspecified|0|||
163173007|NCT02431260|589347378|FG004|Overall Study|Other Unspecified|0|||
163173008|NCT02431260|589347379|FG005|Overall Study|Other Unspecified|0|||
163173009|NCT02431260|589347380|FG006|Overall Study|Other Unspecified|0|||
163173010|NCT02431260|589347381|FG007|Overall Study|Other Unspecified|0|||
163173011|NCT02431260|589347382|FG008|Overall Study|Other Unspecified|0|||
163173012|NCT02431260|589347383|FG009|Overall Study|Other Unspecified|0|||
163173013|NCT02431260|589347384|FG010|Overall Study|Other Unspecified|0|||
163173014|NCT02431260|589347385|FG011|Overall Study|Other Unspecified|1|||
163173015|NCT02431260|589347386|FG012|Overall Study|Other Unspecified|1|||
163173016|NCT02431260|589347387|FG013|Overall Study|Other Unspecified|0|||
163173017|NCT00321646|589347388|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
163173018|NCT00321646|589347388|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
163173019|NCT00321646|589347388|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
163173020|NCT02270944|589347389|FG000|Overall Study|Lost to Follow-up|9|||
163173021|NCT02270944|589347390|FG001|Overall Study|Lost to Follow-up|4|||
163173022|NCT02270944|589347389|FG000|Overall Study|Withdrawal by Subject|2|||
163173023|NCT02270944|589347390|FG001|Overall Study|Withdrawal by Subject|1|||
163173024|NCT01375075|589347395|FG000|Overall Study|Adverse Event|0|||
163173025|NCT01375075|589347396|FG001|Overall Study|Adverse Event|0|||
163173026|NCT01375075|589347397|FG002|Overall Study|Adverse Event|3|||
163173027|NCT01375075|589347398|FG003|Overall Study|Adverse Event|1|||
163173028|NCT01375075|589347399|FG004|Overall Study|Adverse Event|0|||
163173029|NCT01375075|589347400|FG005|Overall Study|Adverse Event|1|||
163173030|NCT01375075|589347395|FG000|Overall Study|Entry Criterion Not Met|1|||
163173031|NCT01375075|589347396|FG001|Overall Study|Entry Criterion Not Met|0|||
163173032|NCT01375075|589347397|FG002|Overall Study|Entry Criterion Not Met|0|||
163173033|NCT01375075|589347398|FG003|Overall Study|Entry Criterion Not Met|0|||
163173034|NCT01375075|589347399|FG004|Overall Study|Entry Criterion Not Met|0|||
163173035|NCT01375075|589347400|FG005|Overall Study|Entry Criterion Not Met|1|||
163173036|NCT01375075|589347395|FG000|Overall Study|Withdrawal by Subject|0|||
163173037|NCT01375075|589347396|FG001|Overall Study|Withdrawal by Subject|1|||
163173038|NCT01375075|589347397|FG002|Overall Study|Withdrawal by Subject|0|||
163173039|NCT01375075|589347398|FG003|Overall Study|Withdrawal by Subject|0|||
163173040|NCT01375075|589347399|FG004|Overall Study|Withdrawal by Subject|0|||
163173041|NCT01375075|589347400|FG005|Overall Study|Withdrawal by Subject|1|||
163173042|NCT00129311|589347408|FG000|Overall Study|Withdrawal by Subject|12|||
163173043|NCT00129311|589347409|FG001|Overall Study|Withdrawal by Subject|19|||
163173044|NCT03603509|589349773|FG000|Overall Study|Lost to Follow-up|3|||
163173045|NCT03603509|589349774|FG001|Overall Study|Lost to Follow-up|4|||
163173046|NCT00002931|589349777|FG000|Overall Study|rapidly progressing disease during|2|||
163173047|NCT00504582|589349778|FG000|Overall Study|Lost to Follow-up|1|||
163173048|NCT00504582|589349779|FG001|Overall Study|Lost to Follow-up|0|||
163173049|NCT00504582|589349780|FG002|Overall Study|Lost to Follow-up|0|||
162929732|NCT01814761|588447429|FG001|Overall Study|Other Reasons|10|||
163279209|NCT04955626|589731484|FG015|Blinded Period|Physician Decision|0|||
163279210|NCT04955626|589731485|FG016|Blinded Period|Physician Decision|0|||
163279211|NCT04955626|589731486|FG017|Blinded Period|Physician Decision|0|||
163279212|NCT04955626|589731487|FG018|Blinded Period|Physician Decision|0|||
163279213|NCT04955626|589731488|FG019|Blinded Period|Physician Decision|0|||
163279214|NCT04955626|589731489|FG020|Blinded Period|Physician Decision|0|||
163279215|NCT04955626|589731490|FG021|Blinded Period|Physician Decision|0|||
163279216|NCT04955626|589731491|FG022|Blinded Period|Physician Decision|0|||
163279217|NCT04955626|589731492|FG023|Blinded Period|Physician Decision|0|||
163279218|NCT04955626|589731493|FG024|Blinded Period|Physician Decision|0|||
163279219|NCT04955626|589731494|FG025|Blinded Period|Physician Decision|0|||
163279220|NCT04955626|589731495|FG026|Blinded Period|Physician Decision|0|||
163279221|NCT04955626|589731496|FG027|Blinded Period|Physician Decision|0|||
163279222|NCT04955626|589731497|FG028|Blinded Period|Physician Decision|0|||
163279223|NCT04955626|589731498|FG029|Blinded Period|Physician Decision|0|||
163279224|NCT04955626|589731499|FG030|Blinded Period|Physician Decision|0|||
162929733|NCT01814761|588447428|FG000|Overall Study|Ocular Adverse Event|6|||
162929734|NCT01814761|588447429|FG001|Overall Study|Ocular Adverse Event|15|||
162929735|NCT01814761|588447428|FG000|Overall Study|Lost to Follow-up|1|||
162929736|NCT01814761|588447429|FG001|Overall Study|Lost to Follow-up|5|||
162929737|NCT00775983|588447430|FG000|Overall Study|Protocol Violation|1|||
162929738|NCT00775983|588447431|FG001|Overall Study|Protocol Violation|2|||
162929739|NCT01020305|588447434|FG000|Overall Study|Adverse Event|2|||
162929740|NCT01070966|588447437|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
162929741|NCT01070966|588447437|FG000|Participants for Safety Evaluation|Off-label use|9|||
162929742|NCT01070966|588447437|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
162929743|NCT01070966|588447437|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
162929744|NCT01070966|588447437|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
162929745|NCT01070966|588447437|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
162929746|NCT01070966|588447437|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
162929747|NCT01070966|588447437|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
162929748|NCT01725113|588447438|FG000|Overall Study|Kidney Transplant|1|||
162929749|NCT01725113|588447439|FG001|Overall Study|Kidney Transplant|1|||
162929750|NCT01725113|588447438|FG000|Overall Study|Withdrawal by Subject|0|||
162929751|NCT01725113|588447439|FG001|Overall Study|Withdrawal by Subject|1|||
162929752|NCT02753400|588447441|FG000|Overall Study|Adverse Event|3|||
162929753|NCT02753400|588447442|FG001|Overall Study|Adverse Event|0|||
162929754|NCT02753400|588447441|FG000|Overall Study|Withdrawal by Subject|2|||
162929755|NCT02753400|588447442|FG001|Overall Study|Withdrawal by Subject|1|||
163279225|NCT04955626|589731500|FG031|Blinded Period|Physician Decision|0|||
163279226|NCT04955626|589731501|FG032|Blinded Period|Physician Decision|0|||
163279227|NCT04955626|589731502|FG033|Blinded Period|Physician Decision|0|||
163279228|NCT04955626|589731503|FG034|Blinded Period|Physician Decision|0|||
163279229|NCT04955626|589731504|FG035|Blinded Period|Physician Decision|0|||
163279230|NCT04955626|589731469|FG000|Blinded Period|Withdrawal by Subject|26|||
163279231|NCT04955626|589731470|FG001|Blinded Period|Withdrawal by Subject|62|||
163279232|NCT04955626|589731471|FG002|Blinded Period|Withdrawal by Subject|14|||
163279233|NCT04955626|589731472|FG003|Blinded Period|Withdrawal by Subject|16|||
163279234|NCT04955626|589731473|FG004|Blinded Period|Withdrawal by Subject|1|||
163279235|NCT04955626|589731474|FG005|Blinded Period|Withdrawal by Subject|2|||
163279236|NCT04955626|589731475|FG006|Blinded Period|Withdrawal by Subject|9|||
163279237|NCT04955626|589731476|FG007|Blinded Period|Withdrawal by Subject|5|||
163279238|NCT04955626|589731477|FG008|Blinded Period|Withdrawal by Subject|3|||
163279239|NCT04955626|589731478|FG009|Blinded Period|Withdrawal by Subject|15|||
163279240|NCT04955626|589731479|FG010|Blinded Period|Withdrawal by Subject|11|||
163279241|NCT04955626|589731480|FG011|Blinded Period|Withdrawal by Subject|7|||
163279242|NCT04955626|589731481|FG012|Blinded Period|Withdrawal by Subject|2|||
163279243|NCT04955626|589731482|FG013|Blinded Period|Withdrawal by Subject|0|||
163279244|NCT04955626|589731483|FG014|Blinded Period|Withdrawal by Subject|1|||
163279245|NCT04955626|589731484|FG015|Blinded Period|Withdrawal by Subject|11|||
163279246|NCT04955626|589731485|FG016|Blinded Period|Withdrawal by Subject|2|||
163279247|NCT04955626|589731486|FG017|Blinded Period|Withdrawal by Subject|5|||
163279248|NCT04955626|589731487|FG018|Blinded Period|Withdrawal by Subject|0|||
163279249|NCT04955626|589731488|FG019|Blinded Period|Withdrawal by Subject|0|||
163279250|NCT04955626|589731489|FG020|Blinded Period|Withdrawal by Subject|1|||
163279251|NCT04955626|589731490|FG021|Blinded Period|Withdrawal by Subject|0|||
163279252|NCT04955626|589731491|FG022|Blinded Period|Withdrawal by Subject|0|||
163279253|NCT04955626|589731492|FG023|Blinded Period|Withdrawal by Subject|0|||
163279254|NCT04955626|589731493|FG024|Blinded Period|Withdrawal by Subject|5|||
163279255|NCT04955626|589731494|FG025|Blinded Period|Withdrawal by Subject|1|||
163279256|NCT04955626|589731495|FG026|Blinded Period|Withdrawal by Subject|5|||
163279257|NCT04955626|589731496|FG027|Blinded Period|Withdrawal by Subject|1|||
163279258|NCT04955626|589731497|FG028|Blinded Period|Withdrawal by Subject|4|||
163279259|NCT04955626|589731498|FG029|Blinded Period|Withdrawal by Subject|2|||
163279260|NCT04955626|589731499|FG030|Blinded Period|Withdrawal by Subject|0|||
163279261|NCT04955626|589731500|FG031|Blinded Period|Withdrawal by Subject|0|||
163279262|NCT04955626|589731501|FG032|Blinded Period|Withdrawal by Subject|0|||
163279263|NCT04955626|589731502|FG033|Blinded Period|Withdrawal by Subject|0|||
163279264|NCT04955626|589731503|FG034|Blinded Period|Withdrawal by Subject|0|||
163279265|NCT04955626|589731504|FG035|Blinded Period|Withdrawal by Subject|0|||
163279266|NCT04955626|589731469|FG000|Blinded Period|Refused further study procedures|0|||
163279267|NCT04955626|589731470|FG001|Blinded Period|Refused further study procedures|0|||
163279268|NCT04955626|589731471|FG002|Blinded Period|Refused further study procedures|0|||
163279269|NCT04955626|589731472|FG003|Blinded Period|Refused further study procedures|0|||
163279270|NCT04955626|589731473|FG004|Blinded Period|Refused further study procedures|0|||
163279271|NCT04955626|589731474|FG005|Blinded Period|Refused further study procedures|0|||
163279272|NCT04955626|589731475|FG006|Blinded Period|Refused further study procedures|1|||
163279273|NCT04955626|589731476|FG007|Blinded Period|Refused further study procedures|0|||
163279274|NCT04955626|589731477|FG008|Blinded Period|Refused further study procedures|0|||
163279275|NCT04955626|589731478|FG009|Blinded Period|Refused further study procedures|0|||
163279276|NCT04955626|589731479|FG010|Blinded Period|Refused further study procedures|0|||
163279277|NCT04955626|589731480|FG011|Blinded Period|Refused further study procedures|2|||
163279278|NCT04955626|589731481|FG012|Blinded Period|Refused further study procedures|0|||
163279279|NCT04955626|589731482|FG013|Blinded Period|Refused further study procedures|0|||
163279280|NCT04955626|589731483|FG014|Blinded Period|Refused further study procedures|0|||
163279281|NCT04955626|589731484|FG015|Blinded Period|Refused further study procedures|0|||
163279282|NCT04955626|589731485|FG016|Blinded Period|Refused further study procedures|0|||
163279283|NCT04955626|589731486|FG017|Blinded Period|Refused further study procedures|0|||
163279284|NCT04955626|589731487|FG018|Blinded Period|Refused further study procedures|0|||
163279285|NCT04955626|589731488|FG019|Blinded Period|Refused further study procedures|0|||
163279286|NCT04955626|589731489|FG020|Blinded Period|Refused further study procedures|0|||
163279287|NCT04955626|589731490|FG021|Blinded Period|Refused further study procedures|0|||
163279288|NCT04955626|589731491|FG022|Blinded Period|Refused further study procedures|0|||
163279289|NCT04955626|589731492|FG023|Blinded Period|Refused further study procedures|0|||
163279290|NCT04955626|589731493|FG024|Blinded Period|Refused further study procedures|0|||
163279291|NCT04955626|589731494|FG025|Blinded Period|Refused further study procedures|0|||
163279292|NCT04955626|589731495|FG026|Blinded Period|Refused further study procedures|0|||
163279293|NCT04955626|589731496|FG027|Blinded Period|Refused further study procedures|0|||
162929756|NCT03989115|588447443|FG000|Overall Study|Withdrawal by Subject|2|||
162929757|NCT03989115|588447444|FG001|Overall Study|Withdrawal by Subject|1|||
162929758|NCT03989115|588447445|FG002|Overall Study|Withdrawal by Subject|3|||
162929759|NCT03989115|588447446|FG003|Overall Study|Withdrawal by Subject|0|||
162929760|NCT03989115|588447447|FG004|Overall Study|Withdrawal by Subject|17|||
162929761|NCT03989115|588447448|FG005|Overall Study|Withdrawal by Subject|1|||
162929762|NCT03989115|588447449|FG006|Overall Study|Withdrawal by Subject|0|||
162929763|NCT03989115|588447450|FG007|Overall Study|Withdrawal by Subject|0|||
162929764|NCT03989115|588447443|FG000|Overall Study|Sponsor decision to terminate the study|1|||
162929765|NCT03989115|588447444|FG001|Overall Study|Sponsor decision to terminate the study|1|||
162929766|NCT03989115|588447445|FG002|Overall Study|Sponsor decision to terminate the study|0|||
162929767|NCT03989115|588447446|FG003|Overall Study|Sponsor decision to terminate the study|1|||
162929768|NCT03989115|588447447|FG004|Overall Study|Sponsor decision to terminate the study|11|||
162929769|NCT03989115|588447448|FG005|Overall Study|Sponsor decision to terminate the study|0|||
162929770|NCT03989115|588447449|FG006|Overall Study|Sponsor decision to terminate the study|2|||
163279294|NCT04955626|589731497|FG028|Blinded Period|Refused further study procedures|0|||
163279295|NCT04955626|589731498|FG029|Blinded Period|Refused further study procedures|0|||
163279296|NCT04955626|589731499|FG030|Blinded Period|Refused further study procedures|0|||
163279297|NCT04955626|589731500|FG031|Blinded Period|Refused further study procedures|0|||
163279298|NCT04955626|589731501|FG032|Blinded Period|Refused further study procedures|0|||
163279299|NCT04955626|589731502|FG033|Blinded Period|Refused further study procedures|0|||
163279300|NCT04955626|589731503|FG034|Blinded Period|Refused further study procedures|0|||
163279301|NCT04955626|589731504|FG035|Blinded Period|Refused further study procedures|0|||
163279302|NCT04955626|589731469|FG000|Blinded Period|Participants entered open label period|4544|||
163279303|NCT04955626|589731470|FG001|Blinded Period|Participants entered open label period|4906|||
163279304|NCT04955626|589731471|FG002|Blinded Period|Participants entered open label period|0|||
163279305|NCT04955626|589731472|FG003|Blinded Period|Participants entered open label period|0|||
163279306|NCT04955626|589731473|FG004|Blinded Period|Participants entered open label period|0|||
163279307|NCT04955626|589731474|FG005|Blinded Period|Participants entered open label period|0|||
163279308|NCT04955626|589731475|FG006|Blinded Period|Participants entered open label period|0|||
163279309|NCT04955626|589731476|FG007|Blinded Period|Participants entered open label period|0|||
163279310|NCT04955626|589731477|FG008|Blinded Period|Participants entered open label period|0|||
163279311|NCT04955626|589731478|FG009|Blinded Period|Participants entered open label period|0|||
163279312|NCT04955626|589731479|FG010|Blinded Period|Participants entered open label period|0|||
163279313|NCT04955626|589731480|FG011|Blinded Period|Participants entered open label period|0|||
163279314|NCT04955626|589731481|FG012|Blinded Period|Participants entered open label period|0|||
163279315|NCT04955626|589731482|FG013|Blinded Period|Participants entered open label period|0|||
163279316|NCT04955626|589731483|FG014|Blinded Period|Participants entered open label period|0|||
163279317|NCT04955626|589731484|FG015|Blinded Period|Participants entered open label period|0|||
163279318|NCT04955626|589731485|FG016|Blinded Period|Participants entered open label period|0|||
163279319|NCT04955626|589731486|FG017|Blinded Period|Participants entered open label period|0|||
163279320|NCT04955626|589731487|FG018|Blinded Period|Participants entered open label period|0|||
163279321|NCT04955626|589731488|FG019|Blinded Period|Participants entered open label period|0|||
163279322|NCT04955626|589731489|FG020|Blinded Period|Participants entered open label period|0|||
163279323|NCT04955626|589731490|FG021|Blinded Period|Participants entered open label period|0|||
163279324|NCT04955626|589731491|FG022|Blinded Period|Participants entered open label period|0|||
163279325|NCT04955626|589731492|FG023|Blinded Period|Participants entered open label period|0|||
163279326|NCT04955626|589731493|FG024|Blinded Period|Participants entered open label period|0|||
163279327|NCT04955626|589731494|FG025|Blinded Period|Participants entered open label period|0|||
163279328|NCT04955626|589731495|FG026|Blinded Period|Participants entered open label period|0|||
163279329|NCT04955626|589731496|FG027|Blinded Period|Participants entered open label period|0|||
163279330|NCT04955626|589731497|FG028|Blinded Period|Participants entered open label period|0|||
163279331|NCT04955626|589731498|FG029|Blinded Period|Participants entered open label period|0|||
163279332|NCT04955626|589731499|FG030|Blinded Period|Participants entered open label period|0|||
163279333|NCT04955626|589731500|FG031|Blinded Period|Participants entered open label period|0|||
163279334|NCT04955626|589731501|FG032|Blinded Period|Participants entered open label period|0|||
163279335|NCT04955626|589731502|FG033|Blinded Period|Participants entered open label period|0|||
163279336|NCT04955626|589731503|FG034|Blinded Period|Participants entered open label period|0|||
163279337|NCT04955626|589731504|FG035|Blinded Period|Participants entered open label period|0|||
163279338|NCT04955626|589731469|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
163279339|NCT04955626|589731470|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
163279340|NCT04955626|589731471|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
163279341|NCT04955626|589731472|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
163279342|NCT04955626|589731473|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
163279343|NCT04955626|589731474|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
163279344|NCT04955626|589731475|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
163279345|NCT04955626|589731476|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
163279346|NCT04955626|589731477|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
163279347|NCT04955626|589731478|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
163279348|NCT04955626|589731479|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
163279349|NCT04955626|589731480|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
163173050|NCT02716896|589349781|FG000|Overall Study|Physician Decision|0|||
163173051|NCT02716896|589349782|FG001|Overall Study|Physician Decision|1|||
163173052|NCT01727700|589349783|FG000|Overall Study|Adverse Event|0|||
163173053|NCT01727700|589349784|FG001|Overall Study|Adverse Event|7|||
163173054|NCT01727700|589349785|FG002|Overall Study|Adverse Event|1|||
163173055|NCT01727700|589349783|FG000|Overall Study|Particpant withdrew consent|0|||
163173056|NCT01727700|589349784|FG001|Overall Study|Particpant withdrew consent|3|||
163173057|NCT01727700|589349785|FG002|Overall Study|Particpant withdrew consent|1|||
163173058|NCT01727700|589349783|FG000|Overall Study|Protocol Violation|2|||
163173059|NCT01727700|589349784|FG001|Overall Study|Protocol Violation|0|||
163173060|NCT01727700|589349785|FG002|Overall Study|Protocol Violation|0|||
163173061|NCT01909791|589349803|FG000|Overall Study|Death|9|||
163173062|NCT01909791|589349804|FG001|Overall Study|Death|8|||
163173063|NCT01909791|589349805|FG002|Overall Study|Death|4|||
163173064|NCT01909791|589349803|FG000|Overall Study|Withdrawal by Subject|5|||
163173065|NCT01909791|589349804|FG001|Overall Study|Withdrawal by Subject|9|||
163173066|NCT01909791|589349805|FG002|Overall Study|Withdrawal by Subject|13|||
163173067|NCT01909791|589349803|FG000|Overall Study|Lost to Follow-up|5|||
163173068|NCT01909791|589349804|FG001|Overall Study|Lost to Follow-up|11|||
163173069|NCT01909791|589349805|FG002|Overall Study|Lost to Follow-up|10|||
163173070|NCT01909791|589349803|FG000|Overall Study|Missed Visit|2|||
163173071|NCT01909791|589349804|FG001|Overall Study|Missed Visit|0|||
163173072|NCT01909791|589349805|FG002|Overall Study|Missed Visit|1|||
163173073|NCT01104376|589349810|FG000|Overall Study|Withdrawal by Subject|15|||
163173074|NCT01104376|589349810|FG000|Overall Study|Consented but excluded after labs|13|||
163173075|NCT00797966|589349811|FG000|Phase A|Lost to Follow-up|0|||
163173076|NCT00797966|589349812|FG001|Phase A|Lost to Follow-up|0|||
163173077|NCT00797966|589349813|FG002|Phase A|Lost to Follow-up|0|||
163173078|NCT00797966|589349814|FG003|Phase A|Lost to Follow-up|0|||
163173079|NCT00797966|589349815|FG004|Phase A|Lost to Follow-up|33|||
163279350|NCT04955626|589731481|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
163173080|NCT00797966|589349816|FG005|Phase A|Lost to Follow-up|0|||
163173081|NCT00797966|589349811|FG000|Phase A|Adverse Event|0|||
163173082|NCT00797966|589349812|FG001|Phase A|Adverse Event|0|||
163173083|NCT00797966|589349813|FG002|Phase A|Adverse Event|0|||
163173084|NCT00797966|589349814|FG003|Phase A|Adverse Event|0|||
163173085|NCT00797966|589349815|FG004|Phase A|Adverse Event|46|||
163173086|NCT00797966|589349816|FG005|Phase A|Adverse Event|0|||
163173087|NCT00797966|589349811|FG000|Phase A|Met withdrawal criteria|0|||
163279351|NCT04955626|589731482|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
163279352|NCT04955626|589731483|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
163279353|NCT04955626|589731484|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
163279354|NCT04955626|589731485|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
163279355|NCT04955626|589731486|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
163279356|NCT04955626|589731487|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
163279357|NCT04955626|589731488|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
163279358|NCT04955626|589731489|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
163279359|NCT04955626|589731490|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
163279360|NCT04955626|589731491|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
163279361|NCT04955626|589731492|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
163279362|NCT04955626|589731493|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
163279363|NCT04955626|589731494|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
163279364|NCT04955626|589731495|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
163279365|NCT04955626|589731496|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
163279366|NCT04955626|589731497|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
163279367|NCT04955626|589731498|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
163279368|NCT04955626|589731499|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
163279369|NCT04955626|589731500|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
163279370|NCT04955626|589731501|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
163279371|NCT04955626|589731502|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
163279372|NCT04955626|589731503|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
163279373|NCT04955626|589731504|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
163279374|NCT04955626|589731469|FG000|Blinded Period|Medication error|0|||
162929771|NCT03989115|588447450|FG007|Overall Study|Sponsor decision to terminate the study|1|||
162929772|NCT03989115|588447443|FG000|Overall Study|Lost to Follow-up|2|||
162929773|NCT03989115|588447444|FG001|Overall Study|Lost to Follow-up|0|||
162929774|NCT03989115|588447445|FG002|Overall Study|Lost to Follow-up|0|||
162929775|NCT03989115|588447446|FG003|Overall Study|Lost to Follow-up|0|||
162929776|NCT03989115|588447447|FG004|Overall Study|Lost to Follow-up|1|||
162929777|NCT03989115|588447448|FG005|Overall Study|Lost to Follow-up|0|||
162929778|NCT03989115|588447449|FG006|Overall Study|Lost to Follow-up|0|||
162929779|NCT03989115|588447450|FG007|Overall Study|Lost to Follow-up|0|||
162929780|NCT03989115|588447443|FG000|Overall Study|Death|2|||
162929781|NCT03989115|588447444|FG001|Overall Study|Death|2|||
162929782|NCT03989115|588447445|FG002|Overall Study|Death|9|||
162929783|NCT03989115|588447446|FG003|Overall Study|Death|6|||
162929784|NCT03989115|588447447|FG004|Overall Study|Death|31|||
162929785|NCT03989115|588447448|FG005|Overall Study|Death|6|||
162929786|NCT03989115|588447449|FG006|Overall Study|Death|2|||
162929787|NCT03989115|588447450|FG007|Overall Study|Death|3|||
163279375|NCT04955626|589731470|FG001|Blinded Period|Medication error|0|||
163279376|NCT04955626|589731471|FG002|Blinded Period|Medication error|0|||
163279377|NCT04955626|589731472|FG003|Blinded Period|Medication error|0|||
163279378|NCT04955626|589731473|FG004|Blinded Period|Medication error|0|||
162929788|NCT03989115|588447443|FG000|Overall Study|Other|1|||
162929789|NCT03989115|588447444|FG001|Overall Study|Other|2|||
162929790|NCT03989115|588447445|FG002|Overall Study|Other|0|||
162929791|NCT03989115|588447446|FG003|Overall Study|Other|0|||
162929792|NCT03989115|588447447|FG004|Overall Study|Other|5|||
162929793|NCT03989115|588447448|FG005|Overall Study|Other|0|||
162929794|NCT03989115|588447449|FG006|Overall Study|Other|0|||
162929795|NCT03989115|588447450|FG007|Overall Study|Other|0|||
162929796|NCT01415921|588447451|FG000|Overall Study|Adverse Event|0|||
162929797|NCT01415921|588447452|FG001|Overall Study|Adverse Event|1|||
162929798|NCT01415921|588447451|FG000|Overall Study|Physician Decision|1|||
162929799|NCT01415921|588447452|FG001|Overall Study|Physician Decision|1|||
162929800|NCT01415921|588447451|FG000|Overall Study|Withdrawal by Subject|0|||
162929801|NCT01415921|588447452|FG001|Overall Study|Withdrawal by Subject|1|||
162929802|NCT01415921|588447451|FG000|Overall Study|Other|2|||
162929803|NCT01415921|588447452|FG001|Overall Study|Other|0|||
162929804|NCT02143947|588447453|FG000|Overall Study|Lost to Follow-up|4|||
162929805|NCT02143947|588447454|FG001|Overall Study|Lost to Follow-up|2|||
162929806|NCT00697112|588447459|FG000|Overall Study|Adverse Event|8|||
162929807|NCT00697112|588447459|FG000|Overall Study|Lost to Follow-up|1|||
162929808|NCT00697112|588447459|FG000|Overall Study|Did not meet inclusion criteria|1|||
162929809|NCT04736576|588447462|FG000|Overall Study|Progressive disease|3|||
162929810|NCT04736576|588447463|FG001|Overall Study|Progressive disease|1|||
162929811|NCT04736576|588447462|FG000|Overall Study|Death|1|||
162929812|NCT04736576|588447463|FG001|Overall Study|Death|0|||
162929813|NCT00720304|588447464|FG000|Overall Study|Withdrawal by Subject|14|||
162929814|NCT00720304|588447465|FG001|Overall Study|Withdrawal by Subject|1|||
162929815|NCT00720304|588447464|FG000|Overall Study|Death|1|||
162929816|NCT00720304|588447465|FG001|Overall Study|Death|0|||
162929817|NCT00720304|588447464|FG000|Overall Study|Physician Decision|5|||
162929818|NCT00720304|588447465|FG001|Overall Study|Physician Decision|2|||
162929819|NCT00720304|588447464|FG000|Overall Study|Adverse Event|3|||
162929820|NCT00720304|588447465|FG001|Overall Study|Adverse Event|1|||
162929821|NCT00720304|588447464|FG000|Overall Study|Disease progression|6|||
162929822|NCT00720304|588447465|FG001|Overall Study|Disease progression|1|||
162929823|NCT04330482|588447468|FG000|Overall Study|Lost to Follow-up|2|||
162929824|NCT04330482|588447469|FG001|Overall Study|Lost to Follow-up|1|||
162929825|NCT04330482|588447468|FG000|Overall Study|Withdrawal by Subject|0|||
162929826|NCT04330482|588447469|FG001|Overall Study|Withdrawal by Subject|3|||
162929827|NCT05180630|588447470|FG000|First Intervention|Physician Decision|0|||
162929828|NCT05180630|588447471|FG001|First Intervention|Physician Decision|0|||
162929829|NCT05180630|588447472|FG002|First Intervention|Physician Decision|3|||
162929830|NCT00709735|588447475|FG000|Overall Study|Lost to Follow-up|1|||
162929831|NCT00709735|588447476|FG001|Overall Study|Lost to Follow-up|1|||
162929832|NCT00709735|588447475|FG000|Overall Study|Relapse into Opioid Abuse|0|||
162929833|NCT00709735|588447476|FG001|Overall Study|Relapse into Opioid Abuse|1|||
162929834|NCT00709735|588447475|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
162929835|NCT00709735|588447476|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
162929836|NCT02725671|588447478|FG000|Overall Study|Lost to Follow-up|1|||
162929837|NCT00963599|588447479|FG000|Overall Study|Adverse Event|2|||
162929838|NCT00963599|588447480|FG001|Overall Study|Adverse Event|0|||
162929839|NCT00963599|588447481|FG002|Overall Study|Adverse Event|1|||
162929840|NCT00963599|588447482|FG003|Overall Study|Adverse Event|2|||
162929841|NCT00963599|588447479|FG000|Overall Study|Lack of Efficacy|0|||
162929842|NCT00963599|588447480|FG001|Overall Study|Lack of Efficacy|2|||
162929843|NCT00963599|588447481|FG002|Overall Study|Lack of Efficacy|1|||
162929844|NCT00963599|588447482|FG003|Overall Study|Lack of Efficacy|4|||
162929845|NCT00963599|588447479|FG000|Overall Study|Lost to Follow-up|0|||
162929846|NCT00963599|588447480|FG001|Overall Study|Lost to Follow-up|1|||
162929847|NCT00963599|588447481|FG002|Overall Study|Lost to Follow-up|1|||
162929848|NCT00963599|588447482|FG003|Overall Study|Lost to Follow-up|1|||
162929849|NCT00963599|588447479|FG000|Overall Study|Protocol Violation|2|||
162929850|NCT00963599|588447480|FG001|Overall Study|Protocol Violation|2|||
162929851|NCT00963599|588447481|FG002|Overall Study|Protocol Violation|3|||
162929852|NCT00963599|588447482|FG003|Overall Study|Protocol Violation|4|||
162929853|NCT00963599|588447479|FG000|Overall Study|Withdrawal by Subject|2|||
162929854|NCT00963599|588447480|FG001|Overall Study|Withdrawal by Subject|1|||
162929855|NCT00963599|588447481|FG002|Overall Study|Withdrawal by Subject|3|||
162929856|NCT00963599|588447482|FG003|Overall Study|Withdrawal by Subject|3|||
162929857|NCT00190684|588447487|FG000|Overall Study|Adverse Event|86|||
162929858|NCT00190684|588447487|FG000|Overall Study|Satisfactory response|80|||
162929859|NCT00190684|588447487|FG000|Overall Study|Lack of efficacy|204|||
162929860|NCT00190684|588447487|FG000|Overall Study|Lost to Follow-up|232|||
162929861|NCT00190684|588447487|FG000|Overall Study|Patient moved|60|||
162929862|NCT00190684|588447487|FG000|Overall Study|Patient Decision|432|||
162929863|NCT00190684|588447487|FG000|Overall Study|Clinical relapse|67|||
162929864|NCT00190684|588447487|FG000|Overall Study|Sponsor's decision|17|||
162929865|NCT00190684|588447487|FG000|Overall Study|Physician Decision|84|||
162929866|NCT00190684|588447487|FG000|Overall Study|Protocol Violation|123|||
162929867|NCT00190684|588447487|FG000|Overall Study|Study Period III Completed|103|||
162929868|NCT00190684|588447487|FG000|Overall Study|Study Period V Completed|1|||
163173088|NCT00797966|589349812|FG001|Phase A|Met withdrawal criteria|0|||
163173089|NCT00797966|589349813|FG002|Phase A|Met withdrawal criteria|0|||
163173090|NCT00797966|589349814|FG003|Phase A|Met withdrawal criteria|0|||
163173091|NCT00797966|589349815|FG004|Phase A|Met withdrawal criteria|4|||
163173092|NCT00797966|589349816|FG005|Phase A|Met withdrawal criteria|0|||
163173093|NCT00797966|589349811|FG000|Phase A|Physician Decision|0|||
163173094|NCT00797966|589349812|FG001|Phase A|Physician Decision|0|||
162929869|NCT02354976|588447491|FG000|Overall Study|Other - reason not specified|1|||
162929870|NCT02354976|588447492|FG001|Overall Study|Other - reason not specified|0|||
162929871|NCT02354976|588447493|FG002|Overall Study|Other - reason not specified|1|||
163173095|NCT00797966|589349813|FG002|Phase A|Physician Decision|0|||
163173096|NCT00797966|589349814|FG003|Phase A|Physician Decision|0|||
162929872|NCT02354976|588447491|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
162929873|NCT02354976|588447492|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
162929874|NCT02354976|588447493|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
162929875|NCT02354976|588447491|FG000|Overall Study|Adverse Event|1|||
162929876|NCT02354976|588447492|FG001|Overall Study|Adverse Event|0|||
162929877|NCT02354976|588447493|FG002|Overall Study|Adverse Event|2|||
162929878|NCT01706770|588447494|FG000|Overall Study|Lost to Follow-up|1|||
162929879|NCT01706770|588447495|FG001|Overall Study|Lost to Follow-up|0|||
162929880|NCT01706770|588447494|FG000|Overall Study|Physician Decision|1|||
162929881|NCT01706770|588447495|FG001|Overall Study|Physician Decision|0|||
162929882|NCT00068445|588447496|FG000|Randomization|Cancel|1|||
162929883|NCT00068445|588447497|FG001|Randomization|Cancel|3|||
162929884|NCT00068445|588447496|FG000|Randomization|Ineligible|1|||
162929885|NCT00068445|588447497|FG001|Randomization|Ineligible|1|||
162929886|NCT00068445|588447496|FG000|Treatment|Refused Further Treatment|13|||
162929887|NCT00068445|588447497|FG001|Treatment|Refused Further Treatment|10|||
162929888|NCT00068445|588447496|FG000|Treatment|Adverse Event|7|||
162929889|NCT00068445|588447497|FG001|Treatment|Adverse Event|1|||
162929890|NCT00068445|588447496|FG000|Treatment|Other (Specifics not available)|9|||
162929891|NCT00068445|588447497|FG001|Treatment|Other (Specifics not available)|5|||
162929892|NCT01155284|588447498|FG000|Overall Study|Withdrawal by Subject|4|||
162929893|NCT01155284|588447499|FG001|Overall Study|Withdrawal by Subject|3|||
162929894|NCT01155284|588447498|FG000|Overall Study|Lost to Follow-up|1|||
162929895|NCT01155284|588447499|FG001|Overall Study|Lost to Follow-up|2|||
162929896|NCT01155284|588447498|FG000|Overall Study|Physician Decision|1|||
162929897|NCT01155284|588447499|FG001|Overall Study|Physician Decision|0|||
162929898|NCT01155284|588447498|FG000|Overall Study|Adverse Event|1|||
162929899|NCT01155284|588447499|FG001|Overall Study|Adverse Event|0|||
162929900|NCT01896700|588447500|FG000|Overall Study|Adverse Event|4|||
162929901|NCT01896700|588447501|FG001|Overall Study|Adverse Event|5|||
162929902|NCT01896700|588447500|FG000|Overall Study|Withdrawal by Subject|0|||
162929903|NCT01896700|588447501|FG001|Overall Study|Withdrawal by Subject|1|||
162929904|NCT00123487|588447502|FG000|Randomized|Death prior to starting treatment|0|||
162929905|NCT00123487|588447503|FG001|Randomized|Death prior to starting treatment|1|||
162929906|NCT00123487|588447502|FG000|Randomized|SAE prior to starting treatment|1|||
162929907|NCT00123487|588447503|FG001|Randomized|SAE prior to starting treatment|0|||
162929908|NCT00123487|588447502|FG000|Treated With Study Drug|Adverse Event|23|||
162929909|NCT00123487|588447503|FG001|Treated With Study Drug|Adverse Event|22|||
162929910|NCT00123487|588447502|FG000|Treated With Study Drug|Disease Progression|141|||
162929911|NCT00123487|588447503|FG001|Treated With Study Drug|Disease Progression|122|||
162929912|NCT00123487|588447502|FG000|Treated With Study Drug|Physician Decision|8|||
162929913|NCT00123487|588447503|FG001|Treated With Study Drug|Physician Decision|9|||
162929914|NCT00123487|588447502|FG000|Treated With Study Drug|Other|59|||
162929915|NCT00123487|588447503|FG001|Treated With Study Drug|Other|58|||
162929916|NCT00123487|588447502|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
162929917|NCT00123487|588447503|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
162929918|NCT00123487|588447502|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
162929919|NCT00123487|588447503|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
162929920|NCT00123487|588447502|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
162929921|NCT00123487|588447503|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
162929922|NCT01656967|588447510|FG000|Overall Study|faulty monitor|1|||
162929923|NCT01656967|588447511|FG001|Overall Study|faulty monitor|0|||
162929924|NCT01656967|588447510|FG000|Overall Study|unsuccessful ETT insertion|3|||
162929925|NCT01656967|588447511|FG001|Overall Study|unsuccessful ETT insertion|2|||
162929926|NCT05788237|588447517|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
162929927|NCT05788237|588447518|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
162929928|NCT05788237|588447519|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
162929929|NCT05788237|588447520|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
162929930|NCT05788237|588447517|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
162929931|NCT05788237|588447518|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
162929932|NCT05788237|588447519|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
162929933|NCT05788237|588447520|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
162929934|NCT05788237|588447517|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
162929935|NCT05788237|588447518|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
162929936|NCT05788237|588447519|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
162929937|NCT05788237|588447520|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
162929938|NCT05788237|588447517|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
162929939|NCT05788237|588447518|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
162929940|NCT05788237|588447519|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
162929941|NCT05788237|588447520|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
162929942|NCT05788237|588447517|FG000|SSA (Approximately 2 Months)|Death|0|||
163279379|NCT04955626|589731474|FG005|Blinded Period|Medication error|0|||
162929943|NCT05788237|588447518|FG001|SSA (Approximately 2 Months)|Death|1|||
162929944|NCT05788237|588447519|FG002|SSA (Approximately 2 Months)|Death|0|||
163173097|NCT00797966|589349815|FG004|Phase A|Physician Decision|13|||
163173098|NCT00797966|589349816|FG005|Phase A|Physician Decision|0|||
163173099|NCT00797966|589349811|FG000|Phase A|Withdrawal by Subject|0|||
163173100|NCT00797966|589349812|FG001|Phase A|Withdrawal by Subject|0|||
162929945|NCT05788237|588447520|FG003|SSA (Approximately 2 Months)|Death|0|||
162929946|NCT05788237|588447517|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
162929947|NCT05788237|588447518|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
162929948|NCT05788237|588447519|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
162929949|NCT05788237|588447520|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
162929950|NCT05788237|588447517|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
162929951|NCT05788237|588447518|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
162929952|NCT05788237|588447519|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
162929953|NCT05788237|588447520|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
162929954|NCT05788237|588447517|FG000|SSB (Approximately 1 Month)|Other|0|||
162929955|NCT05788237|588447518|FG001|SSB (Approximately 1 Month)|Other|0|||
162929956|NCT05788237|588447519|FG002|SSB (Approximately 1 Month)|Other|0|||
162929957|NCT05788237|588447520|FG003|SSB (Approximately 1 Month)|Other|1|||
162929958|NCT00681824|588448779|FG000|Overall Study|withdrawn by investigator|0|||
162929959|NCT00681824|588448780|FG001|Overall Study|withdrawn by investigator|0|||
162929960|NCT00681824|588448781|FG002|Overall Study|withdrawn by investigator|1|||
162929961|NCT00681824|588448779|FG000|Overall Study|scheduling conflict|1|||
162929962|NCT00681824|588448780|FG001|Overall Study|scheduling conflict|0|||
162929963|NCT00681824|588448781|FG002|Overall Study|scheduling conflict|0|||
162929964|NCT00681824|588448779|FG000|Overall Study|Death|0|||
162929965|NCT00681824|588448780|FG001|Overall Study|Death|1|||
162929966|NCT00681824|588448781|FG002|Overall Study|Death|0|||
162929967|NCT03724916|588448782|FG000|Overall Study|Withdrawal by Subject|0|||
162929968|NCT03724916|588448783|FG001|Overall Study|Withdrawal by Subject|1|||
162929969|NCT03724916|588448784|FG002|Overall Study|Withdrawal by Subject|1|||
162929970|NCT03724916|588448785|FG003|Overall Study|Withdrawal by Subject|2|||
162929971|NCT03724916|588448782|FG000|Overall Study|Randomized but not Treated|1|||
162929972|NCT03724916|588448783|FG001|Overall Study|Randomized but not Treated|0|||
162929973|NCT03724916|588448784|FG002|Overall Study|Randomized but not Treated|0|||
162929974|NCT03724916|588448785|FG003|Overall Study|Randomized but not Treated|0|||
162929975|NCT04575038|588448786|FG000|Overall Study|Withdrawal by Subject|1|||
162929976|NCT04575038|588448787|FG001|Overall Study|Withdrawal by Subject|1|||
162929977|NCT04335110|588448794|FG000|Overall Study|Withdrawal by Subject|1|||
162929978|NCT04335110|588448795|FG001|Overall Study|Withdrawal by Subject|1|||
162929979|NCT04335110|588448794|FG000|Overall Study|Death|0|||
162929980|NCT04335110|588448795|FG001|Overall Study|Death|1|||
162929981|NCT03101293|588448798|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
162929982|NCT03101293|588448799|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
162929983|NCT03333382|588448808|FG000|Overall Study|Lost to Follow-up|1|||
162929984|NCT03333382|588448809|FG001|Overall Study|Lost to Follow-up|0|||
162929985|NCT03471182|588448810|FG000|Overall Study|Withdrawal by Subject|1|||
162929986|NCT03471182|588448811|FG001|Overall Study|Withdrawal by Subject|1|||
162929987|NCT03471182|588448812|FG002|Overall Study|Withdrawal by Subject|0|||
162929988|NCT03471182|588448810|FG000|Overall Study|Technical failure|2|||
162929989|NCT03471182|588448811|FG001|Overall Study|Technical failure|0|||
163173101|NCT00797966|589349813|FG002|Phase A|Withdrawal by Subject|0|||
163173102|NCT00797966|589349814|FG003|Phase A|Withdrawal by Subject|0|||
163173103|NCT00797966|589349815|FG004|Phase A|Withdrawal by Subject|33|||
162929990|NCT03471182|588448812|FG002|Overall Study|Technical failure|0|||
162929991|NCT03451331|588448816|FG000|Overall Study|Withdrawal by Subject|1|||
162929992|NCT03451331|588448817|FG001|Overall Study|Withdrawal by Subject|0|||
162929993|NCT03451331|588448816|FG000|Overall Study|Unable to start treatment.|1|||
162929994|NCT03451331|588448817|FG001|Overall Study|Unable to start treatment.|1|||
162929995|NCT00289731|588448818|FG000|Overall Study|Adverse Event|1|||
162929996|NCT00289731|588448819|FG001|Overall Study|Adverse Event|2|||
163173104|NCT00797966|589349816|FG005|Phase A|Withdrawal by Subject|0|||
162929997|NCT00289731|588448820|FG002|Overall Study|Adverse Event|2|||
162929998|NCT00289731|588448818|FG000|Overall Study|Other|1|||
162929999|NCT00289731|588448819|FG001|Overall Study|Other|0|||
162930000|NCT00289731|588448820|FG002|Overall Study|Other|0|||
162930001|NCT00660790|588448829|FG000|Baseline to 3 Months|Death|1|||
162930002|NCT00660790|588448829|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
162930003|NCT00660790|588448829|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
162930004|NCT00686374|588448835|FG000|Overall Study|Lack of Efficacy|10|||
162930005|NCT00686374|588448835|FG000|Overall Study|Adverse Event|8|||
162930006|NCT00686374|588448835|FG000|Overall Study|Withdrew consent|5|||
162930007|NCT00686374|588448835|FG000|Overall Study|Lost to Follow-up|1|||
162930008|NCT00686374|588448835|FG000|Overall Study|Missing reason|33|||
162930009|NCT00686374|588448835|FG000|Overall Study|Other, not specified|4|||
162930010|NCT00618774|588448836|FG000|Overall Study|Adverse Event|5|||
162930011|NCT00618774|588448837|FG001|Overall Study|Adverse Event|3|||
162930012|NCT00618774|588448836|FG000|Overall Study|Withdrawal by Subject|1|||
162930013|NCT00618774|588448837|FG001|Overall Study|Withdrawal by Subject|0|||
162930014|NCT02424565|588448839|FG000|Period 1 (D0)|Protocol Violation|0|||
162930015|NCT02424565|588448840|FG001|Period 1 (D0)|Protocol Violation|1|||
162930016|NCT01808209|588448841|FG000|Overall Study|Lost to Follow-up|0|||
162930017|NCT01808209|588448842|FG001|Overall Study|Lost to Follow-up|1|||
162930018|NCT04228302|588448849|FG000|Overall Study|Adverse Event|0|||
162930019|NCT04228302|588448850|FG001|Overall Study|Adverse Event|0|||
162930020|NCT04228302|588448851|FG002|Overall Study|Adverse Event|0|||
162930021|NCT04228302|588448852|FG003|Overall Study|Adverse Event|0|||
162930022|NCT04228302|588448853|FG004|Overall Study|Adverse Event|1|||
162930023|NCT04228302|588448854|FG005|Overall Study|Adverse Event|0|||
162930024|NCT00685919|588448855|FG000|Overall Study|Withdrawal by Subject|0|||
162930025|NCT00685919|588448856|FG001|Overall Study|Withdrawal by Subject|0|||
162930026|NCT00685919|588448857|FG002|Overall Study|Withdrawal by Subject|1|||
162930027|NCT00685919|588448858|FG003|Overall Study|Withdrawal by Subject|0|||
162930028|NCT00685919|588448855|FG000|Overall Study|Physician Decision|1|||
162930029|NCT00685919|588448856|FG001|Overall Study|Physician Decision|0|||
162930030|NCT00685919|588448857|FG002|Overall Study|Physician Decision|0|||
162930031|NCT00685919|588448858|FG003|Overall Study|Physician Decision|0|||
162930032|NCT00423488|588448859|FG000|Overall Study|No evidence of study drug intake|2|||
162930033|NCT00423488|588448860|FG001|Overall Study|No evidence of study drug intake|1|||
162930034|NCT00423488|588448859|FG000|Overall Study|No post baseline data|3|||
162930035|NCT00423488|588448860|FG001|Overall Study|No post baseline data|0|||
162930036|NCT03118765|588448861|FG000|Overall Study|Withdrawal by Subject|0|||
162930037|NCT03118765|588448862|FG001|Overall Study|Withdrawal by Subject|0|||
162930038|NCT03118765|588448863|FG002|Overall Study|Withdrawal by Subject|1|||
162930039|NCT03118765|588448864|FG003|Overall Study|Withdrawal by Subject|0|||
162930040|NCT03118765|588448865|FG004|Overall Study|Withdrawal by Subject|0|||
162930041|NCT03118765|588448861|FG000|Overall Study|Adverse Event|1|||
162930042|NCT03118765|588448862|FG001|Overall Study|Adverse Event|1|||
162930043|NCT03118765|588448863|FG002|Overall Study|Adverse Event|1|||
162930044|NCT03118765|588448864|FG003|Overall Study|Adverse Event|1|||
162930045|NCT03118765|588448865|FG004|Overall Study|Adverse Event|1|||
162930046|NCT03118765|588448861|FG000|Overall Study|Non compliance with Study Procedures|0|||
162930047|NCT03118765|588448862|FG001|Overall Study|Non compliance with Study Procedures|0|||
162930048|NCT03118765|588448863|FG002|Overall Study|Non compliance with Study Procedures|0|||
162930049|NCT03118765|588448864|FG003|Overall Study|Non compliance with Study Procedures|1|||
162930050|NCT03118765|588448865|FG004|Overall Study|Non compliance with Study Procedures|0|||
162930051|NCT03118765|588448861|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
163173105|NCT00797966|589349811|FG000|Phase A|Protocol deviation|0|||
163173106|NCT00797966|589349812|FG001|Phase A|Protocol deviation|0|||
163173107|NCT00797966|589349813|FG002|Phase A|Protocol deviation|0|||
163173108|NCT00797966|589349814|FG003|Phase A|Protocol deviation|0|||
163173109|NCT00797966|589349815|FG004|Phase A|Protocol deviation|56|||
163173110|NCT00797966|589349816|FG005|Phase A|Protocol deviation|0|||
163173111|NCT00797966|589349811|FG000|Phase B|Lost to Follow-up|0|||
163173112|NCT00797966|589349812|FG001|Phase B|Lost to Follow-up|1|||
163173113|NCT00797966|589349813|FG002|Phase B|Lost to Follow-up|3|||
163173114|NCT00797966|589349814|FG003|Phase B|Lost to Follow-up|0|||
163173115|NCT00797966|589349815|FG004|Phase B|Lost to Follow-up|0|||
163173116|NCT00797966|589349816|FG005|Phase B|Lost to Follow-up|0|||
163173117|NCT00797966|589349811|FG000|Phase B|Adverse Event|2|||
163173118|NCT00797966|589349812|FG001|Phase B|Adverse Event|1|||
163173119|NCT00797966|589349813|FG002|Phase B|Adverse Event|3|||
163173120|NCT00797966|589349814|FG003|Phase B|Adverse Event|1|||
163173121|NCT00797966|589349815|FG004|Phase B|Adverse Event|0|||
163173122|NCT00797966|589349816|FG005|Phase B|Adverse Event|0|||
163173123|NCT00797966|589349811|FG000|Phase B|Met Withdrawal Criteria|3|||
163173124|NCT00797966|589349812|FG001|Phase B|Met Withdrawal Criteria|3|||
163173125|NCT00797966|589349813|FG002|Phase B|Met Withdrawal Criteria|6|||
162930052|NCT03118765|588448862|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
162930053|NCT03118765|588448863|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
162930054|NCT03118765|588448864|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
162930055|NCT03118765|588448865|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
163173126|NCT00797966|589349814|FG003|Phase B|Met Withdrawal Criteria|1|||
163173127|NCT00797966|589349815|FG004|Phase B|Met Withdrawal Criteria|0|||
163173128|NCT00797966|589349816|FG005|Phase B|Met Withdrawal Criteria|0|||
163173129|NCT00797966|589349811|FG000|Phase B|Physician Decision|1|||
163173130|NCT00797966|589349812|FG001|Phase B|Physician Decision|0|||
163173131|NCT00797966|589349813|FG002|Phase B|Physician Decision|3|||
163173132|NCT00797966|589349814|FG003|Phase B|Physician Decision|1|||
163173133|NCT00797966|589349815|FG004|Phase B|Physician Decision|0|||
163173134|NCT00797966|589349816|FG005|Phase B|Physician Decision|0|||
163173135|NCT00797966|589349811|FG000|Phase B|Withdrawal by Subject|1|||
163173136|NCT00797966|589349812|FG001|Phase B|Withdrawal by Subject|4|||
163173137|NCT00797966|589349813|FG002|Phase B|Withdrawal by Subject|3|||
163173138|NCT00797966|589349814|FG003|Phase B|Withdrawal by Subject|3|||
163173139|NCT00797966|589349815|FG004|Phase B|Withdrawal by Subject|0|||
163173140|NCT00797966|589349816|FG005|Phase B|Withdrawal by Subject|0|||
163173141|NCT00797966|589349811|FG000|Phase B|Protocol Deviation|4|||
163173142|NCT00797966|589349812|FG001|Phase B|Protocol Deviation|8|||
163173143|NCT00797966|589349813|FG002|Phase B|Protocol Deviation|2|||
163173144|NCT00797966|589349814|FG003|Phase B|Protocol Deviation|6|||
163173145|NCT00797966|589349815|FG004|Phase B|Protocol Deviation|0|||
163173146|NCT00797966|589349816|FG005|Phase B|Protocol Deviation|0|||
163173147|NCT00797966|589349811|FG000|Phase B|Lack of Efficacy|0|||
163173148|NCT00797966|589349812|FG001|Phase B|Lack of Efficacy|1|||
163173149|NCT00797966|589349813|FG002|Phase B|Lack of Efficacy|1|||
163173150|NCT00797966|589349814|FG003|Phase B|Lack of Efficacy|4|||
163173151|NCT00797966|589349815|FG004|Phase B|Lack of Efficacy|0|||
163173152|NCT00797966|589349816|FG005|Phase B|Lack of Efficacy|0|||
163173153|NCT00797966|589349811|FG000|Phase A+|Lost to Follow-up|0|||
163173154|NCT00797966|589349812|FG001|Phase A+|Lost to Follow-up|0|||
163173155|NCT00797966|589349813|FG002|Phase A+|Lost to Follow-up|0|||
163173156|NCT00797966|589349814|FG003|Phase A+|Lost to Follow-up|0|||
163173157|NCT00797966|589349815|FG004|Phase A+|Lost to Follow-up|0|||
163173158|NCT00797966|589349816|FG005|Phase A+|Lost to Follow-up|9|||
163173159|NCT00797966|589349811|FG000|Phase A+|Met withdrawal criteria|0|||
163173160|NCT00797966|589349812|FG001|Phase A+|Met withdrawal criteria|0|||
163173161|NCT00797966|589349813|FG002|Phase A+|Met withdrawal criteria|0|||
163173162|NCT00797966|589349814|FG003|Phase A+|Met withdrawal criteria|0|||
163173163|NCT00797966|589349815|FG004|Phase A+|Met withdrawal criteria|0|||
163173164|NCT00797966|589349816|FG005|Phase A+|Met withdrawal criteria|5|||
163173165|NCT00797966|589349811|FG000|Phase A+|Withdrawal by Subject|0|||
163173166|NCT00797966|589349812|FG001|Phase A+|Withdrawal by Subject|0|||
163173167|NCT00797966|589349813|FG002|Phase A+|Withdrawal by Subject|0|||
163173168|NCT00797966|589349814|FG003|Phase A+|Withdrawal by Subject|0|||
163173169|NCT00797966|589349815|FG004|Phase A+|Withdrawal by Subject|0|||
163173170|NCT00797966|589349816|FG005|Phase A+|Withdrawal by Subject|6|||
163173171|NCT00797966|589349811|FG000|Phase A+|Adverse Event|0|||
163173172|NCT00797966|589349812|FG001|Phase A+|Adverse Event|0|||
163279380|NCT04955626|589731475|FG006|Blinded Period|Medication error|0|||
163173173|NCT00797966|589349813|FG002|Phase A+|Adverse Event|0|||
163279381|NCT04955626|589731476|FG007|Blinded Period|Medication error|0|||
163173174|NCT00797966|589349814|FG003|Phase A+|Adverse Event|0|||
163173175|NCT00797966|589349815|FG004|Phase A+|Adverse Event|0|||
163173176|NCT00797966|589349816|FG005|Phase A+|Adverse Event|4|||
163173177|NCT00797966|589349811|FG000|Phase A+|Protocol deviation|0|||
163173178|NCT00797966|589349812|FG001|Phase A+|Protocol deviation|0|||
163173179|NCT00797966|589349813|FG002|Phase A+|Protocol deviation|0|||
163173180|NCT00797966|589349814|FG003|Phase A+|Protocol deviation|0|||
163173181|NCT00797966|589349815|FG004|Phase A+|Protocol deviation|0|||
163279382|NCT04955626|589731477|FG008|Blinded Period|Medication error|0|||
163173182|NCT00797966|589349816|FG005|Phase A+|Protocol deviation|4|||
163173183|NCT01002820|589349818|FG000|Overall Study|Adverse Event|1|||
162930056|NCT03118765|588448861|FG000|Overall Study|COPD Exacerbation|1|||
162930057|NCT03118765|588448862|FG001|Overall Study|COPD Exacerbation|0|||
162930058|NCT03118765|588448863|FG002|Overall Study|COPD Exacerbation|0|||
162930059|NCT03118765|588448864|FG003|Overall Study|COPD Exacerbation|1|||
162930060|NCT03118765|588448865|FG004|Overall Study|COPD Exacerbation|0|||
162930061|NCT03118765|588448861|FG000|Overall Study|Lost to Follow-up|1|||
162930062|NCT03118765|588448862|FG001|Overall Study|Lost to Follow-up|0|||
162930063|NCT03118765|588448863|FG002|Overall Study|Lost to Follow-up|1|||
162930064|NCT03118765|588448864|FG003|Overall Study|Lost to Follow-up|0|||
162930065|NCT03118765|588448865|FG004|Overall Study|Lost to Follow-up|0|||
162930066|NCT03118765|588448861|FG000|Overall Study|Sponsor Decision|1|||
162930067|NCT03118765|588448862|FG001|Overall Study|Sponsor Decision|0|||
162930068|NCT03118765|588448863|FG002|Overall Study|Sponsor Decision|1|||
162930069|NCT03118765|588448864|FG003|Overall Study|Sponsor Decision|0|||
162930070|NCT03118765|588448865|FG004|Overall Study|Sponsor Decision|1|||
162930071|NCT02643966|588448866|FG000|First Screening Round|ineligible|1|||
162930072|NCT02643966|588448866|FG000|First Screening Round|excluded from analysis|2|||
162930073|NCT02643966|588448866|FG000|First Screening Round|Lost to Follow-up|56|||
162930074|NCT02643966|588448866|FG000|First Screening Round|Withdrawal by Subject|28|||
162930075|NCT02643966|588448866|FG000|First Screening Round|Death|1|||
162930076|NCT02643966|588448866|FG000|Between First and Second Screening|Lost to Follow-up|65|||
162930077|NCT02643966|588448866|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
162930078|NCT02643966|588448866|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
162930079|NCT02643966|588448866|FG000|Second Screening Round|Withdrawal by Subject|20|||
162930080|NCT02643966|588448866|FG000|Second Screening Round|Lost to Follow-up|57|||
162930081|NCT02643966|588448866|FG000|Second Screening Round|Physician Decision|2|||
162930082|NCT02643966|588448866|FG000|Second Screening Round|Death|4|||
162930083|NCT02643966|588448866|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
162930084|NCT02643966|588448866|FG000|Between Second and Third Screening|Death|1|||
162930085|NCT02643966|588448866|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
162930086|NCT02643966|588448866|FG000|Third Screening Round|PI excluded|2|||
162930087|NCT02643966|588448866|FG000|Third Screening Round|Lost to Follow-up|241|||
162930088|NCT01493531|588448867|FG000|Overall Study|Adverse Event|4|||
162930089|NCT01493531|588448868|FG001|Overall Study|Adverse Event|12|||
162930090|NCT01493531|588448869|FG002|Overall Study|Adverse Event|9|||
162930091|NCT01493531|588448867|FG000|Overall Study|Gout flare|3|||
162930092|NCT01493531|588448868|FG001|Overall Study|Gout flare|0|||
162930093|NCT01493531|588448869|FG002|Overall Study|Gout flare|2|||
162930094|NCT01493531|588448867|FG000|Overall Study|Protocol Violation|8|||
162930095|NCT01493531|588448868|FG001|Overall Study|Protocol Violation|15|||
162930096|NCT01493531|588448869|FG002|Overall Study|Protocol Violation|12|||
162930097|NCT01493531|588448867|FG000|Overall Study|Sponsor terminated study|5|||
162930098|NCT01493531|588448868|FG001|Overall Study|Sponsor terminated study|2|||
162930099|NCT01493531|588448869|FG002|Overall Study|Sponsor terminated study|3|||
162930100|NCT01493531|588448867|FG000|Overall Study|Lost to Follow-up|5|||
162930101|NCT01493531|588448868|FG001|Overall Study|Lost to Follow-up|7|||
162930102|NCT01493531|588448869|FG002|Overall Study|Lost to Follow-up|11|||
162930103|NCT01493531|588448867|FG000|Overall Study|Withdrawal by Subject|16|||
162930104|NCT01493531|588448868|FG001|Overall Study|Withdrawal by Subject|13|||
162930105|NCT01493531|588448869|FG002|Overall Study|Withdrawal by Subject|11|||
162930106|NCT01493531|588448867|FG000|Overall Study|Death|0|||
162930107|NCT01493531|588448868|FG001|Overall Study|Death|1|||
162930108|NCT01493531|588448869|FG002|Overall Study|Death|0|||
162930109|NCT03835975|588448872|FG000|Overall Study|Lost to Follow-up|1|||
162930110|NCT03835975|588448873|FG001|Overall Study|Lost to Follow-up|1|||
162930111|NCT03835975|588448874|FG002|Overall Study|Lost to Follow-up|0|||
162930112|NCT03835975|588448875|FG003|Overall Study|Lost to Follow-up|0|||
162930113|NCT03835975|588448876|FG004|Overall Study|Lost to Follow-up|0|||
162930114|NCT03835975|588448872|FG000|Overall Study|No longer met eligibility criteria|0|||
162930115|NCT03835975|588448873|FG001|Overall Study|No longer met eligibility criteria|1|||
162930116|NCT03835975|588448874|FG002|Overall Study|No longer met eligibility criteria|0|||
162930117|NCT03835975|588448875|FG003|Overall Study|No longer met eligibility criteria|0|||
162930118|NCT03835975|588448876|FG004|Overall Study|No longer met eligibility criteria|0|||
162930119|NCT03835975|588448872|FG000|Overall Study|Protocol Violation|1|||
162930120|NCT03835975|588448873|FG001|Overall Study|Protocol Violation|1|||
162930121|NCT03835975|588448874|FG002|Overall Study|Protocol Violation|2|||
162930122|NCT03835975|588448875|FG003|Overall Study|Protocol Violation|0|||
162930123|NCT03835975|588448876|FG004|Overall Study|Protocol Violation|0|||
162930124|NCT03835975|588448872|FG000|Overall Study|Withdrawal by Subject|1|||
162930125|NCT03835975|588448873|FG001|Overall Study|Withdrawal by Subject|0|||
162930126|NCT03835975|588448874|FG002|Overall Study|Withdrawal by Subject|1|||
162930127|NCT03835975|588448875|FG003|Overall Study|Withdrawal by Subject|1|||
162930128|NCT03835975|588448876|FG004|Overall Study|Withdrawal by Subject|0|||
162930129|NCT01612702|588448879|FG000|Overall Study|Protocol Violation|11|||
162930130|NCT01612702|588448880|FG001|Overall Study|Protocol Violation|11|||
163279383|NCT04955626|589731478|FG009|Blinded Period|Medication error|0|||
162930131|NCT03070431|588448881|FG000|Overall Study|Withdrawal by Subject|2|||
162930132|NCT03070431|588448881|FG000|Overall Study|Lost to Follow-up|2|||
162930133|NCT00370396|588448882|FG000|Overall Study|Withdrawal by Subject|0|||
162930134|NCT00370396|588448883|FG001|Overall Study|Withdrawal by Subject|0|||
162930135|NCT00370396|588448884|FG002|Overall Study|Withdrawal by Subject|1|||
162930136|NCT00370396|588448882|FG000|Overall Study|Lost to Follow-up|11|||
162930137|NCT00370396|588448883|FG001|Overall Study|Lost to Follow-up|1|||
162930138|NCT00370396|588448884|FG002|Overall Study|Lost to Follow-up|0|||
162930139|NCT00995488|588448886|FG000|Overall Study|Withdrawal by Subject|1|||
162930140|NCT00051636|588448887|FG000|Period 1 - Core|Adverse Event|2|||
162930141|NCT00051636|588448888|FG001|Period 1 - Core|Adverse Event|2|||
162930142|NCT00051636|588448887|FG000|Period 1 - Core|Protocol Violation|1|||
162930143|NCT00051636|588448888|FG001|Period 1 - Core|Protocol Violation|0|||
162930144|NCT00051636|588448887|FG000|Period 1 - Core|Withdrawal by Subject|1|||
162930145|NCT00051636|588448888|FG001|Period 1 - Core|Withdrawal by Subject|2|||
162930146|NCT00051636|588448887|FG000|Period 1 - Core|Lost to Follow-up|0|||
162930147|NCT00051636|588448888|FG001|Period 1 - Core|Lost to Follow-up|2|||
162930148|NCT00051636|588448887|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
162930149|NCT00051636|588448888|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
162930150|NCT00051636|588448887|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
162930151|NCT00051636|588448888|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
162930152|NCT00051636|588448887|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
162930153|NCT00051636|588448888|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
162930154|NCT00051636|588448887|FG000|Period 2- Extended Observation Period|Death|4|||
162930155|NCT00051636|588448888|FG001|Period 2- Extended Observation Period|Death|5|||
162930156|NCT00051636|588448887|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
162930157|NCT00051636|588448888|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
162930158|NCT02340078|588448889|FG000|Overall Study|Protocol Violation|1|||
162930159|NCT00944125|588448892|FG000|3 to 6 Months|Withdrawal by Subject|0|||
162930160|NCT00944125|588448893|FG001|3 to 6 Months|Withdrawal by Subject|2|||
162930161|NCT00944125|588448892|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
162930162|NCT00944125|588448893|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
162930163|NCT03338673|588448896|FG000|Overall Study|Lost to Follow-up|1|||
162930164|NCT03338673|588448897|FG001|Overall Study|Lost to Follow-up|1|||
162930165|NCT01170364|588450347|FG000|Overall Study|Protocol Violation|4|||
162930166|NCT01170364|588450348|FG001|Overall Study|Protocol Violation|1|||
162930167|NCT00368537|588450350|FG000|Randomization|No study drug dosed|13|||
162930168|NCT00368537|588450351|FG001|Randomization|No study drug dosed|6|||
162930169|NCT00368537|588450350|FG000|Baseline Participants|Lost to Follow-up|16|||
162930170|NCT00368537|588450351|FG001|Baseline Participants|Lost to Follow-up|17|||
162930171|NCT00368537|588450350|FG000|Baseline Participants|Withdrawal by Subject|6|||
162930172|NCT00368537|588450351|FG001|Baseline Participants|Withdrawal by Subject|4|||
162930173|NCT00368537|588450350|FG000|Baseline Participants|Death|1|||
162930174|NCT00368537|588450351|FG001|Baseline Participants|Death|2|||
162930175|NCT00368537|588450350|FG000|Baseline Participants|No susceptibility|1|||
162930176|NCT00368537|588450351|FG001|Baseline Participants|No susceptibility|0|||
162930177|NCT00368537|588450350|FG000|Baseline Participants|Patient uncompliant|0|||
162930178|NCT00368537|588450351|FG001|Baseline Participants|Patient uncompliant|1|||
162930179|NCT01368276|588450361|FG000|Overall Study|Death|1|||
162930180|NCT01368276|588450362|FG001|Overall Study|Death|10|||
162930181|NCT01427920|588450365|FG000|Overall Study|Adverse Event|1|||
162930182|NCT01427920|588450366|FG001|Overall Study|Adverse Event|2|||
162930183|NCT01427920|588450365|FG000|Overall Study|Lack of Efficacy|1|||
162930184|NCT01427920|588450366|FG001|Overall Study|Lack of Efficacy|0|||
162930185|NCT01427920|588450365|FG000|Overall Study|Protocol Violation|1|||
162930186|NCT01427920|588450366|FG001|Overall Study|Protocol Violation|3|||
162930187|NCT01427920|588450365|FG000|Overall Study|Withdrawal Criteria|4|||
162930188|NCT01427920|588450366|FG001|Overall Study|Withdrawal Criteria|4|||
162930189|NCT01427920|588450365|FG000|Overall Study|Unclassified|2|||
162930190|NCT01427920|588450366|FG001|Overall Study|Unclassified|8|||
162930191|NCT03341273|588450367|FG000|Overall Study|Lost to Follow-up|7|||
162930192|NCT03341273|588450368|FG001|Overall Study|Lost to Follow-up|7|||
162930193|NCT03341273|588450367|FG000|Overall Study|Withdrawal by Subject|4|||
162930194|NCT03341273|588450368|FG001|Overall Study|Withdrawal by Subject|2|||
162930195|NCT03341273|588450367|FG000|Overall Study|Physician Decision|1|||
162930196|NCT03341273|588450368|FG001|Overall Study|Physician Decision|0|||
162930197|NCT03341273|588450367|FG000|Overall Study|Protocol Violation|0|||
162930198|NCT03341273|588450368|FG001|Overall Study|Protocol Violation|1|||
162930199|NCT03341273|588450367|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
162930200|NCT03341273|588450368|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
162930201|NCT03341273|588450367|FG000|Overall Study|Became ineligible after enrollment|1|||
162930202|NCT03341273|588450368|FG001|Overall Study|Became ineligible after enrollment|0|||
162930203|NCT03341273|588450367|FG000|Overall Study|Not Eligible at Enrollment|0|||
162930204|NCT03341273|588450368|FG001|Overall Study|Not Eligible at Enrollment|1|||
162930205|NCT03341273|588450367|FG000|Overall Study|Participant incarcerated|1|||
162930206|NCT03341273|588450368|FG001|Overall Study|Participant incarcerated|0|||
162930207|NCT01717456|588450375|FG000|End of Treatment|Physician Decision|0|||
162930208|NCT01717456|588450376|FG001|End of Treatment|Physician Decision|1|||
162930209|NCT01717456|588450375|FG000|End of Treatment|Lost to Follow-up|0|||
162930210|NCT01717456|588450376|FG001|End of Treatment|Lost to Follow-up|1|||
162930211|NCT01717456|588450375|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
162930212|NCT01717456|588450376|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
162930213|NCT02732561|588450377|FG000|Overall Study|Lost to Follow-up|1|||
162930214|NCT02732561|588450378|FG001|Overall Study|Lost to Follow-up|1|||
162930215|NCT02732561|588450377|FG000|Overall Study|Withdrawal by Subject|1|||
162930216|NCT02732561|588450378|FG001|Overall Study|Withdrawal by Subject|0|||
162930217|NCT03066440|588450381|FG000|Overall Study|Physician Decision|1|||
162930218|NCT03066440|588450382|FG001|Overall Study|Physician Decision|1|||
162930219|NCT03066440|588450381|FG000|Overall Study|Protocol Violation|0|||
162930220|NCT03066440|588450382|FG001|Overall Study|Protocol Violation|2|||
162930221|NCT00736333|588450383|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
162930222|NCT00736333|588450383|FG000|Overall Study|Data Missing|2|||
162930223|NCT00736333|588450383|FG000|Overall Study|Tumor Progression|75|||
162930224|NCT00736333|588450383|FG000|Overall Study|Toxicity|6|||
162930225|NCT00736333|588450383|FG000|Overall Study|Withdrawal by Subject|10|||
162930226|NCT00736333|588450383|FG000|Overall Study|Death|7|||
162930227|NCT00736333|588450383|FG000|Overall Study|Other|4|||
162930228|NCT04991311|588450385|FG000|Overall Study|Adverse Event|1|||
162930229|NCT00054275|588450387|FG000|Overall Study|Withdrawal by Subject|4|||
162930230|NCT00054275|588450387|FG000|Overall Study|Adverse Event|5|||
162930231|NCT00054275|588450387|FG000|Overall Study|Progressive disease in cycle 1|1|||
162930232|NCT00054275|588450387|FG000|Overall Study|Physician Decision|1|||
162930233|NCT01106352|588450388|FG000|Overall Study|Subjects untreated|0|||
162930234|NCT01106352|588450389|FG001|Overall Study|Subjects untreated|0|||
162930235|NCT01106352|588450390|FG002|Overall Study|Subjects untreated|0|||
162930236|NCT01106352|588450391|FG003|Overall Study|Subjects untreated|3|||
162930237|NCT01106352|588450392|FG004|Overall Study|Subjects untreated|4|||
162930238|NCT01106352|588450388|FG000|Overall Study|Sponsor Decision|1|||
162930239|NCT01106352|588450389|FG001|Overall Study|Sponsor Decision|0|||
162930240|NCT01106352|588450390|FG002|Overall Study|Sponsor Decision|0|||
162930241|NCT01106352|588450391|FG003|Overall Study|Sponsor Decision|0|||
162930242|NCT01106352|588450392|FG004|Overall Study|Sponsor Decision|0|||
162930243|NCT01106352|588450388|FG000|Overall Study|Too ill to come in for the visit|0|||
162930244|NCT01106352|588450389|FG001|Overall Study|Too ill to come in for the visit|0|||
162930245|NCT01106352|588450390|FG002|Overall Study|Too ill to come in for the visit|1|||
162930246|NCT01106352|588450391|FG003|Overall Study|Too ill to come in for the visit|0|||
162930247|NCT01106352|588450392|FG004|Overall Study|Too ill to come in for the visit|0|||
162930248|NCT01106352|588450388|FG000|Overall Study|Lost to Follow-up|0|||
162930249|NCT01106352|588450389|FG001|Overall Study|Lost to Follow-up|0|||
162930250|NCT01106352|588450390|FG002|Overall Study|Lost to Follow-up|0|||
162930251|NCT01106352|588450391|FG003|Overall Study|Lost to Follow-up|0|||
162930252|NCT01106352|588450392|FG004|Overall Study|Lost to Follow-up|1|||
162930253|NCT01106352|588450388|FG000|Overall Study|Death|0|||
162930254|NCT01106352|588450389|FG001|Overall Study|Death|0|||
162930255|NCT01106352|588450390|FG002|Overall Study|Death|1|||
162930256|NCT01106352|588450391|FG003|Overall Study|Death|3|||
162930257|NCT01106352|588450392|FG004|Overall Study|Death|1|||
162930258|NCT01106352|588450388|FG000|Overall Study|Disease progression|0|||
162930259|NCT01106352|588450389|FG001|Overall Study|Disease progression|0|||
162930260|NCT01106352|588450390|FG002|Overall Study|Disease progression|0|||
162930261|NCT01106352|588450391|FG003|Overall Study|Disease progression|1|||
162930262|NCT01106352|588450392|FG004|Overall Study|Disease progression|0|||
162930263|NCT01106352|588450388|FG000|Overall Study|Withdrawal by Subject|0|||
162930264|NCT01106352|588450389|FG001|Overall Study|Withdrawal by Subject|0|||
162930265|NCT01106352|588450390|FG002|Overall Study|Withdrawal by Subject|0|||
162930266|NCT01106352|588450391|FG003|Overall Study|Withdrawal by Subject|3|||
162930267|NCT01106352|588450392|FG004|Overall Study|Withdrawal by Subject|2|||
162930268|NCT01106352|588450388|FG000|Overall Study|Went on hospice|0|||
162930269|NCT01106352|588450389|FG001|Overall Study|Went on hospice|0|||
162930270|NCT01106352|588450390|FG002|Overall Study|Went on hospice|0|||
162930271|NCT01106352|588450391|FG003|Overall Study|Went on hospice|1|||
162930272|NCT01106352|588450392|FG004|Overall Study|Went on hospice|0|||
162930273|NCT01106352|588450388|FG000|Overall Study|Subject entered hospice|0|||
162930274|NCT01106352|588450389|FG001|Overall Study|Subject entered hospice|0|||
162930275|NCT01106352|588450390|FG002|Overall Study|Subject entered hospice|0|||
162930276|NCT01106352|588450391|FG003|Overall Study|Subject entered hospice|1|||
162930277|NCT01106352|588450392|FG004|Overall Study|Subject entered hospice|0|||
162930278|NCT01106352|588450388|FG000|Overall Study|Home hospice since July 2013|0|||
162930279|NCT01106352|588450389|FG001|Overall Study|Home hospice since July 2013|0|||
162930280|NCT01106352|588450390|FG002|Overall Study|Home hospice since July 2013|0|||
162930281|NCT01106352|588450391|FG003|Overall Study|Home hospice since July 2013|1|||
162930282|NCT01106352|588450392|FG004|Overall Study|Home hospice since July 2013|0|||
162930283|NCT03944707|588450393|FG000|Overall Study|Adverse Event|0|||
162930284|NCT03944707|588450394|FG001|Overall Study|Adverse Event|2|||
162930285|NCT03944707|588450393|FG000|Overall Study|Study terminated by sponsor|12|||
162930286|NCT03944707|588450394|FG001|Overall Study|Study terminated by sponsor|7|||
162930287|NCT03944707|588450393|FG000|Overall Study|Subject decision|0|||
162930288|NCT03944707|588450394|FG001|Overall Study|Subject decision|1|||
162930289|NCT02444182|588450396|FG000|Overall Study|non-compliance|2|||
162930290|NCT02444182|588450397|FG001|Overall Study|non-compliance|1|||
162930291|NCT02444182|588450396|FG000|Overall Study|Lost to Follow-up|0|||
162930292|NCT02444182|588450397|FG001|Overall Study|Lost to Follow-up|4|||
162930293|NCT01959230|588450398|FG000|Overall Study|Failure to follow study procedures|0|||
162930294|NCT01959230|588450399|FG001|Overall Study|Failure to follow study procedures|1|||
162930295|NCT01959230|588450398|FG000|Overall Study|Administrative reasons|2|||
162930296|NCT01959230|588450399|FG001|Overall Study|Administrative reasons|0|||
162930297|NCT01959230|588450398|FG000|Overall Study|Withdrawal by Subject|2|||
162930298|NCT01959230|588450399|FG001|Overall Study|Withdrawal by Subject|0|||
162930299|NCT01453374|588450400|FG000|Overall Study|Adverse Event|7|||
162930300|NCT01453374|588450400|FG000|Overall Study|Lack of Efficacy|1|||
162930301|NCT01453374|588450400|FG000|Overall Study|Lost to Follow-up|3|||
162930302|NCT01453374|588450400|FG000|Overall Study|Withdrawal by Subject|5|||
162930303|NCT01453374|588450400|FG000|Overall Study|Incarcerated|2|||
162930304|NCT00751998|588450401|FG000|Overall Study|Lost to Follow-up|7|||
162930305|NCT00751998|588450401|FG000|Overall Study|Death|11|||
162930306|NCT00751998|588450401|FG000|Overall Study|Withdrawal by Subject|2|||
162930307|NCT00996918|588450405|FG000|Overall Study|Lack of Efficacy|1|||
162930308|NCT00996918|588450406|FG001|Overall Study|Lack of Efficacy|1|||
162930309|NCT00996918|588450407|FG002|Overall Study|Lack of Efficacy|2|||
162930310|NCT00996918|588450408|FG003|Overall Study|Lack of Efficacy|2|||
162930311|NCT00996918|588450409|FG004|Overall Study|Lack of Efficacy|0|||
162930312|NCT00996918|588450405|FG000|Overall Study|Adverse Event|2|||
162930313|NCT00996918|588450406|FG001|Overall Study|Adverse Event|5|||
162930314|NCT00996918|588450407|FG002|Overall Study|Adverse Event|2|||
162930315|NCT00996918|588450408|FG003|Overall Study|Adverse Event|6|||
162930316|NCT00996918|588450409|FG004|Overall Study|Adverse Event|0|||
162930317|NCT00996918|588450405|FG000|Overall Study|Withdrawal by Subject|1|||
162930318|NCT00996918|588450406|FG001|Overall Study|Withdrawal by Subject|4|||
162930319|NCT00996918|588450407|FG002|Overall Study|Withdrawal by Subject|3|||
162930320|NCT00996918|588450408|FG003|Overall Study|Withdrawal by Subject|3|||
162930321|NCT00996918|588450409|FG004|Overall Study|Withdrawal by Subject|2|||
162930322|NCT00996918|588450405|FG000|Overall Study|Physician Decision|1|||
162930323|NCT00996918|588450406|FG001|Overall Study|Physician Decision|0|||
162930324|NCT00996918|588450407|FG002|Overall Study|Physician Decision|0|||
162930325|NCT00996918|588450408|FG003|Overall Study|Physician Decision|0|||
162930326|NCT00996918|588450409|FG004|Overall Study|Physician Decision|0|||
162930327|NCT00996918|588450405|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
162930328|NCT00996918|588450406|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
162930329|NCT00996918|588450407|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
162930330|NCT00996918|588450408|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
162930331|NCT00996918|588450409|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
162930332|NCT00996918|588450405|FG000|Overall Study|Loss of Caregiver|0|||
162930333|NCT00996918|588450406|FG001|Overall Study|Loss of Caregiver|1|||
162930334|NCT00996918|588450407|FG002|Overall Study|Loss of Caregiver|0|||
162930335|NCT00996918|588450408|FG003|Overall Study|Loss of Caregiver|0|||
162930336|NCT00996918|588450409|FG004|Overall Study|Loss of Caregiver|0|||
162930337|NCT00996918|588450405|FG000|Overall Study|Other|3|||
162930338|NCT00996918|588450406|FG001|Overall Study|Other|1|||
162930339|NCT00996918|588450407|FG002|Overall Study|Other|0|||
162930340|NCT00996918|588450408|FG003|Overall Study|Other|0|||
162930341|NCT00996918|588450409|FG004|Overall Study|Other|0|||
162930342|NCT01965535|588450412|FG000|Overall Study|Lack of Efficacy|2|||
162930343|NCT01965535|588450413|FG001|Overall Study|Lack of Efficacy|1|||
162930344|NCT00829439|588450415|FG000|Overall Study|Adverse Event|0|||
162930345|NCT00829439|588450416|FG001|Overall Study|Adverse Event|0|||
163279384|NCT04955626|589731479|FG010|Blinded Period|Medication error|2|||
163279385|NCT04955626|589731480|FG011|Blinded Period|Medication error|0|||
163279386|NCT04955626|589731481|FG012|Blinded Period|Medication error|0|||
163279387|NCT04955626|589731482|FG013|Blinded Period|Medication error|0|||
163279388|NCT04955626|589731483|FG014|Blinded Period|Medication error|0|||
162930346|NCT00829439|588450417|FG002|Overall Study|Adverse Event|1|||
162930347|NCT00829439|588450418|FG003|Overall Study|Adverse Event|0|||
162930348|NCT02525562|588450419|FG000|Overall Study|Death|9|||
162930349|NCT02525562|588450420|FG001|Overall Study|Death|0|||
162930350|NCT02525562|588450421|FG002|Overall Study|Death|0|||
162930351|NCT02525562|588450419|FG000|Overall Study|Lost to Follow-up|19|||
162930352|NCT02525562|588450420|FG001|Overall Study|Lost to Follow-up|0|||
162930353|NCT02525562|588450421|FG002|Overall Study|Lost to Follow-up|0|||
162930354|NCT02525562|588450419|FG000|Overall Study|Withdrawal by Subject|37|||
162930355|NCT02525562|588450420|FG001|Overall Study|Withdrawal by Subject|0|||
163279389|NCT04955626|589731484|FG015|Blinded Period|Medication error|0|||
163279390|NCT04955626|589731485|FG016|Blinded Period|Medication error|0|||
162930356|NCT02525562|588450421|FG002|Overall Study|Withdrawal by Subject|0|||
162930357|NCT02525562|588450419|FG000|Overall Study|Revision/Removal of Study Device|4|||
162930358|NCT02525562|588450420|FG001|Overall Study|Revision/Removal of Study Device|0|||
162930359|NCT02525562|588450421|FG002|Overall Study|Revision/Removal of Study Device|0|||
162930360|NCT02525562|588450419|FG000|Overall Study|Study Closed by Sponsor|154|||
162930361|NCT02525562|588450420|FG001|Overall Study|Study Closed by Sponsor|0|||
162930362|NCT02525562|588450421|FG002|Overall Study|Study Closed by Sponsor|0|||
162930363|NCT00886782|588450422|FG000|Overall Study|Disease progression|3|||
162930364|NCT00886782|588450423|FG001|Overall Study|Disease progression|3|||
162930365|NCT00886782|588450424|FG002|Overall Study|Disease progression|3|||
162930366|NCT00886782|588450422|FG000|Overall Study|Study drug toxicity|0|||
162930367|NCT00886782|588450423|FG001|Overall Study|Study drug toxicity|0|||
162930368|NCT00886782|588450424|FG002|Overall Study|Study drug toxicity|1|||
162930369|NCT00886782|588450422|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
162930370|NCT00886782|588450423|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
162930371|NCT00886782|588450424|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
162930372|NCT01946282|588450425|FG000|Year 1|Did not return FIT kit|4186|||
162930373|NCT01946282|588450426|FG001|Year 1|Did not return FIT kit|608|||
162930374|NCT01946282|588450427|FG002|Year 1|Did not return FIT kit|654|||
162930375|NCT01946282|588450425|FG000|Year 2|Did not return FIT kit|803|||
162930376|NCT01946282|588450426|FG001|Year 2|Did not return FIT kit|131|||
162930377|NCT01946282|588450427|FG002|Year 2|Did not return FIT kit|115|||
162930378|NCT01946282|588450425|FG000|Year 3|Did not return FIT kit|288|||
162930379|NCT01946282|588450426|FG001|Year 3|Did not return FIT kit|43|||
162930380|NCT01946282|588450427|FG002|Year 3|Did not return FIT kit|30|||
162930381|NCT03031431|588450428|FG000|Overall Study|Infant removed by maternal request|1|||
162930382|NCT00078819|588450429|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
162930383|NCT00078819|588450430|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
162930384|NCT00078819|588450431|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
162930385|NCT00078819|588450432|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
162930386|NCT00078819|588450429|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
162930387|NCT00078819|588450430|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
162930388|NCT00078819|588450431|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
162930389|NCT00078819|588450432|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
162930390|NCT00078819|588450429|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
162930391|NCT00078819|588450430|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
162930392|NCT00078819|588450431|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
162930393|NCT00078819|588450432|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
162930394|NCT00078819|588450429|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
162930395|NCT00078819|588450430|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
162930396|NCT00078819|588450431|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
162930397|NCT00078819|588450432|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
162930398|NCT00078819|588450429|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
162930399|NCT00078819|588450430|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
162930400|NCT00078819|588450431|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
162930401|NCT00078819|588450432|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
162930402|NCT00078819|588450429|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
162930403|NCT00078819|588450430|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
162930404|NCT00078819|588450431|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
162930405|NCT00078819|588450432|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
162930406|NCT00078819|588450429|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
162930407|NCT00078819|588450430|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
162930408|NCT00078819|588450431|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
162930409|NCT00078819|588450432|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
162930410|NCT00078819|588450429|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
162930411|NCT00078819|588450430|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
162930412|NCT00078819|588450431|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
162930413|NCT00078819|588450432|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
162930414|NCT04130919|588450433|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
162930415|NCT04130919|588450434|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
162930416|NCT04130919|588450435|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
162930417|NCT04130919|588450436|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
162930418|NCT04130919|588450437|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
162930419|NCT04130919|588450438|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
162930420|NCT04130919|588450433|FG000|Blinded Treatment Phase|Adverse Event|0|||
162930421|NCT04130919|588450434|FG001|Blinded Treatment Phase|Adverse Event|0|||
162930422|NCT04130919|588450435|FG002|Blinded Treatment Phase|Adverse Event|1|||
162930423|NCT04130919|588450436|FG003|Blinded Treatment Phase|Adverse Event|0|||
162930424|NCT04130919|588450437|FG004|Blinded Treatment Phase|Adverse Event|0|||
162930425|NCT04130919|588450438|FG005|Blinded Treatment Phase|Adverse Event|0|||
162930426|NCT04130919|588450433|FG000|Blinded Treatment Phase|Disease worsening|0|||
162930427|NCT04130919|588450434|FG001|Blinded Treatment Phase|Disease worsening|0|||
162930428|NCT04130919|588450435|FG002|Blinded Treatment Phase|Disease worsening|1|||
162930429|NCT04130919|588450436|FG003|Blinded Treatment Phase|Disease worsening|0|||
162930430|NCT04130919|588450437|FG004|Blinded Treatment Phase|Disease worsening|0|||
162930431|NCT04130919|588450438|FG005|Blinded Treatment Phase|Disease worsening|0|||
162930432|NCT04130919|588450433|FG000|Blinded Treatment Phase|Investigator's decision|0|||
162930433|NCT04130919|588450434|FG001|Blinded Treatment Phase|Investigator's decision|1|||
162930434|NCT04130919|588450435|FG002|Blinded Treatment Phase|Investigator's decision|0|||
162930435|NCT04130919|588450436|FG003|Blinded Treatment Phase|Investigator's decision|0|||
162930436|NCT04130919|588450437|FG004|Blinded Treatment Phase|Investigator's decision|0|||
162930437|NCT04130919|588450438|FG005|Blinded Treatment Phase|Investigator's decision|0|||
162930438|NCT04130919|588450433|FG000|Blinded Treatment Phase|Withdrew consent|1|||
162930439|NCT04130919|588450434|FG001|Blinded Treatment Phase|Withdrew consent|0|||
162930440|NCT04130919|588450435|FG002|Blinded Treatment Phase|Withdrew consent|0|||
162930441|NCT04130919|588450436|FG003|Blinded Treatment Phase|Withdrew consent|0|||
162930442|NCT04130919|588450437|FG004|Blinded Treatment Phase|Withdrew consent|0|||
162930443|NCT04130919|588450438|FG005|Blinded Treatment Phase|Withdrew consent|0|||
162930444|NCT04130919|588450433|FG000|Open-label Treatment Phase|Withdrew consent|0|||
162930445|NCT04130919|588450434|FG001|Open-label Treatment Phase|Withdrew consent|0|||
162930446|NCT04130919|588450435|FG002|Open-label Treatment Phase|Withdrew consent|0|||
162930447|NCT04130919|588450436|FG003|Open-label Treatment Phase|Withdrew consent|1|||
162930448|NCT04130919|588450437|FG004|Open-label Treatment Phase|Withdrew consent|1|||
162930449|NCT04130919|588450438|FG005|Open-label Treatment Phase|Withdrew consent|1|||
162930450|NCT04130919|588450433|FG000|Open-label Treatment Phase|Disease worsening|0|||
162930451|NCT04130919|588450434|FG001|Open-label Treatment Phase|Disease worsening|0|||
162930452|NCT04130919|588450435|FG002|Open-label Treatment Phase|Disease worsening|0|||
162930453|NCT04130919|588450436|FG003|Open-label Treatment Phase|Disease worsening|1|||
162930454|NCT04130919|588450437|FG004|Open-label Treatment Phase|Disease worsening|0|||
162930455|NCT04130919|588450438|FG005|Open-label Treatment Phase|Disease worsening|1|||
162930456|NCT04130919|588450433|FG000|Open-label Treatment Phase|Investigator's decision|0|||
162930457|NCT04130919|588450434|FG001|Open-label Treatment Phase|Investigator's decision|0|||
162930458|NCT04130919|588450435|FG002|Open-label Treatment Phase|Investigator's decision|0|||
162930459|NCT04130919|588450436|FG003|Open-label Treatment Phase|Investigator's decision|1|||
162930460|NCT04130919|588450437|FG004|Open-label Treatment Phase|Investigator's decision|0|||
162930461|NCT04130919|588450438|FG005|Open-label Treatment Phase|Investigator's decision|0|||
162930462|NCT04130919|588450433|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
162930463|NCT04130919|588450434|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
162930464|NCT04130919|588450435|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
162930465|NCT04130919|588450436|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
162930466|NCT04130919|588450437|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
162930467|NCT04130919|588450438|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
162930468|NCT04130919|588450433|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
162930469|NCT04130919|588450434|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
162930470|NCT04130919|588450435|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
162930471|NCT04130919|588450436|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
162930472|NCT04130919|588450437|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
162930473|NCT04130919|588450438|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
162930474|NCT03012815|588450439|FG000|Overall Study|Lost to Follow-up|1|||
162930475|NCT03012815|588450440|FG001|Overall Study|Lost to Follow-up|0|||
162930476|NCT03012815|588450439|FG000|Overall Study|Physician Decision|3|||
162930477|NCT03012815|588450440|FG001|Overall Study|Physician Decision|2|||
162930478|NCT03012815|588450439|FG000|Overall Study|Adverse Event|1|||
162930479|NCT03012815|588450440|FG001|Overall Study|Adverse Event|0|||
162930480|NCT01462695|588450442|FG000|Overall Study|Adverse Event|1|||
162930481|NCT01462695|588450443|FG001|Overall Study|Adverse Event|1|||
162930482|NCT01462695|588450442|FG000|Overall Study|Death|2|||
162930483|NCT01462695|588450443|FG001|Overall Study|Death|0|||
162930484|NCT01462695|588450442|FG000|Overall Study|Lack of Efficacy|6|||
162930485|NCT01462695|588450443|FG001|Overall Study|Lack of Efficacy|12|||
162930486|NCT01462695|588450442|FG000|Overall Study|Physician Decision|5|||
162930487|NCT01462695|588450443|FG001|Overall Study|Physician Decision|0|||
162930488|NCT01462695|588450442|FG000|Overall Study|Withdrawal by Subject|2|||
163279391|NCT04955626|589731486|FG017|Blinded Period|Medication error|0|||
163279392|NCT04955626|589731487|FG018|Blinded Period|Medication error|0|||
162930489|NCT01462695|588450443|FG001|Overall Study|Withdrawal by Subject|0|||
162930490|NCT01462695|588450442|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
162930491|NCT01462695|588450443|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
162930492|NCT02400905|588450444|FG000|Overall Study|Death|24|||
162930493|NCT02400905|588450444|FG000|Overall Study|Lost to Follow-up|18|||
162930494|NCT02400905|588450444|FG000|Overall Study|Withdrawal by Subject|16|||
162930495|NCT02400905|588450444|FG000|Overall Study|Physician Decision|4|||
162930496|NCT02400905|588450444|FG000|Overall Study|Other|1|||
162930497|NCT03196791|588450447|FG000|Overall Study|Protocol Violation|7|||
162930498|NCT03196791|588450448|FG001|Overall Study|Protocol Violation|3|||
162930499|NCT03196791|588450447|FG000|Overall Study|Withdrawal by Subject|3|||
162930500|NCT03196791|588450448|FG001|Overall Study|Withdrawal by Subject|2|||
162930501|NCT00879970|588450449|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
162930502|NCT00879970|588450450|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
162930503|NCT00879970|588450451|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
162930504|NCT00879970|588450452|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
162930505|NCT00879970|588450453|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
162930506|NCT00879970|588450449|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
162930507|NCT00879970|588450450|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
162930508|NCT00879970|588450451|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
162930509|NCT00879970|588450452|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
162930510|NCT00879970|588450453|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
162930511|NCT00879970|588450449|FG000|Period 1 TZD Randomization|Death|2|||
162930512|NCT00879970|588450450|FG001|Period 1 TZD Randomization|Death|1|||
162930513|NCT00879970|588450451|FG002|Period 1 TZD Randomization|Death|0|||
162930514|NCT00879970|588450452|FG003|Period 1 TZD Randomization|Death|0|||
162930515|NCT00879970|588450453|FG004|Period 1 TZD Randomization|Death|0|||
162930516|NCT00879970|588450449|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
162930517|NCT00879970|588450450|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
162930518|NCT00879970|588450451|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
162930519|NCT00879970|588450452|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
162930520|NCT00879970|588450453|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
162930521|NCT00879970|588450449|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
162930522|NCT00879970|588450450|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
162930523|NCT00879970|588450451|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
162930524|NCT00879970|588450452|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
162930525|NCT00879970|588450453|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
162930526|NCT00879970|588450449|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
162930527|NCT00879970|588450450|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
162930528|NCT00879970|588450451|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
162930529|NCT00879970|588450452|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
162930530|NCT00879970|588450453|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
162930531|NCT00879970|588450449|FG000|Period 2 Vitamin D Randomization|Death|0|||
162930532|NCT00879970|588450450|FG001|Period 2 Vitamin D Randomization|Death|0|||
162930533|NCT00879970|588450451|FG002|Period 2 Vitamin D Randomization|Death|0|||
162930534|NCT00879970|588450452|FG003|Period 2 Vitamin D Randomization|Death|2|||
162930535|NCT00879970|588450453|FG004|Period 2 Vitamin D Randomization|Death|0|||
162930536|NCT01749033|588450457|FG000|Overall Study|Did not receive allocated intervention|3|||
162930537|NCT01749033|588450458|FG001|Overall Study|Did not receive allocated intervention|3|||
162930538|NCT01749033|588450459|FG002|Overall Study|Did not receive allocated intervention|0|||
162930539|NCT01749033|588450457|FG000|Overall Study|Lost to Follow-up|0|||
162930540|NCT01749033|588450458|FG001|Overall Study|Lost to Follow-up|2|||
162930541|NCT01749033|588450459|FG002|Overall Study|Lost to Follow-up|1|||
162930542|NCT01256398|588450461|FG000|Overall Study|Withdrawal by Subject|1|||
162930543|NCT01039584|588450462|FG000|Overall Study|Withdrawal by Subject|4|||
162930544|NCT01039584|588450463|FG001|Overall Study|Withdrawal by Subject|2|||
162930545|NCT01039584|588450464|FG002|Overall Study|Withdrawal by Subject|1|||
162930546|NCT01039584|588450462|FG000|Overall Study|Protocol Violation|10|||
162930547|NCT01039584|588450463|FG001|Overall Study|Protocol Violation|4|||
162930548|NCT01039584|588450464|FG002|Overall Study|Protocol Violation|6|||
162930549|NCT01039584|588450462|FG000|Overall Study|Lost to Follow-up|5|||
162930550|NCT01039584|588450463|FG001|Overall Study|Lost to Follow-up|3|||
162930551|NCT01039584|588450464|FG002|Overall Study|Lost to Follow-up|4|||
162930552|NCT01039584|588450462|FG000|Overall Study|Negative Baseline culture for Candida|59|||
162930553|NCT01039584|588450463|FG001|Overall Study|Negative Baseline culture for Candida|59|||
162930554|NCT01039584|588450464|FG002|Overall Study|Negative Baseline culture for Candida|24|||
162930555|NCT01039584|588450462|FG000|Overall Study|Lack of Efficacy|7|||
162930556|NCT01039584|588450463|FG001|Overall Study|Lack of Efficacy|6|||
162930557|NCT01039584|588450464|FG002|Overall Study|Lack of Efficacy|10|||
162930558|NCT01039584|588450462|FG000|Overall Study|other|1|||
163279393|NCT04955626|589731488|FG019|Blinded Period|Medication error|0|||
163279394|NCT04955626|589731489|FG020|Blinded Period|Medication error|0|||
162930559|NCT01039584|588450463|FG001|Overall Study|other|3|||
162930560|NCT01039584|588450464|FG002|Overall Study|other|1|||
162930561|NCT01039584|588450462|FG000|Overall Study|Pap smear with significant pathology|10|||
162930562|NCT01039584|588450463|FG001|Overall Study|Pap smear with significant pathology|10|||
162930563|NCT01039584|588450464|FG002|Overall Study|Pap smear with significant pathology|3|||
162930564|NCT01039584|588450462|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
162930565|NCT01039584|588450463|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
162930566|NCT01039584|588450464|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
162930567|NCT01174368|588450467|FG000|Overall Study|Withdrawal by Subject|1|||
162930568|NCT00479765|588450468|FG000|Overall Study|study terminated|4|||
162930569|NCT03550794|588450471|FG000|Overall Study|No longer met inclusion criteria|1|||
162930570|NCT03550794|588450472|FG001|Overall Study|No longer met inclusion criteria|2|||
162930571|NCT03550794|588450471|FG000|Overall Study|Goals of care changed|1|||
162930572|NCT03550794|588450472|FG001|Overall Study|Goals of care changed|0|||
162930573|NCT03550794|588450471|FG000|Overall Study|Withdrawal by Subject|2|||
162930574|NCT03550794|588450472|FG001|Overall Study|Withdrawal by Subject|0|||
162930575|NCT03550794|588450471|FG000|Overall Study|Death|0|||
162930576|NCT03550794|588450472|FG001|Overall Study|Death|1|||
162930577|NCT01864525|588450473|FG000|Overall Study|Adverse Event|1|||
162930578|NCT01864525|588450474|FG001|Overall Study|Adverse Event|0|||
162930579|NCT01890785|588450475|FG000|Third Intervention|Withdrawal by Subject|0|||
162930580|NCT01890785|588450476|FG001|Third Intervention|Withdrawal by Subject|1|||
162930581|NCT01890785|588450477|FG002|Third Intervention|Withdrawal by Subject|0|||
162930582|NCT01890785|588450478|FG003|Third Intervention|Withdrawal by Subject|0|||
162930583|NCT01890785|588450479|FG004|Third Intervention|Withdrawal by Subject|0|||
162930584|NCT01890785|588450480|FG005|Third Intervention|Withdrawal by Subject|0|||
162930585|NCT03296553|588450481|FG000|Overall Study|Withdrawal by Subject|1|||
162930586|NCT03296553|588450482|FG001|Overall Study|Withdrawal by Subject|1|||
162930587|NCT03296553|588450481|FG000|Overall Study|Death|1|||
162930588|NCT03296553|588450482|FG001|Overall Study|Death|0|||
162930589|NCT00558519|588450483|FG000|Overall Study|Ph+|20|||
162930590|NCT00558519|588450483|FG000|Overall Study|Ineligible|1|||
162930591|NCT00558519|588450483|FG000|Overall Study|Insufficient data|1|||
162930592|NCT00558519|588450483|FG000|Overall Study|Never received treatment|1|||
162930593|NCT03001011|588450484|FG000|Overall Study|Adverse Event|9|||
162930594|NCT03001011|588450485|FG001|Overall Study|Adverse Event|3|||
162930595|NCT03001011|588450484|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
162930596|NCT03001011|588450485|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
162930597|NCT03001011|588450484|FG000|Overall Study|Other than specified above|3|||
162930598|NCT03001011|588450485|FG001|Overall Study|Other than specified above|8|||
162930599|NCT03077828|588450487|FG000|Treatment Cycles|Death|1|||
162930600|NCT03077828|588450487|FG000|Treatment Cycles|Withdrawal by Subject|1|||
162930601|NCT03077828|588450487|FG000|Treatment Cycles|Screen Fail|2|||
162930602|NCT03077828|588450487|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
162930603|NCT03077828|588450487|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
162930604|NCT03077828|588450487|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
162930605|NCT03077828|588450487|FG000|Follow-up|Patients still in follow-up|15|||
162930606|NCT02392559|588450488|FG000|Overall Study|Withdrawal by Subject|0|||
162930607|NCT02392559|588450489|FG001|Overall Study|Withdrawal by Subject|1|||
162930608|NCT03125915|588450495|FG000|1 Month Follow up|Lost to Follow-up|3|||
162930609|NCT03125915|588450496|FG001|1 Month Follow up|Lost to Follow-up|3|||
162930610|NCT03125915|588450497|FG002|1 Month Follow up|Lost to Follow-up|2|||
162930611|NCT03125915|588450498|FG003|1 Month Follow up|Lost to Follow-up|3|||
162930612|NCT03125915|588450495|FG000|3 Month Follow-up|Lost to Follow-up|6|||
162930613|NCT03125915|588450496|FG001|3 Month Follow-up|Lost to Follow-up|4|||
162930614|NCT03125915|588450497|FG002|3 Month Follow-up|Lost to Follow-up|4|||
162930615|NCT03125915|588450498|FG003|3 Month Follow-up|Lost to Follow-up|2|||
162930616|NCT03125915|588450495|FG000|6 Month Follow-up|Lost to Follow-up|7|||
162930617|NCT03125915|588450496|FG001|6 Month Follow-up|Lost to Follow-up|3|||
162930618|NCT03125915|588450497|FG002|6 Month Follow-up|Lost to Follow-up|6|||
162930619|NCT03125915|588450498|FG003|6 Month Follow-up|Lost to Follow-up|3|||
162930620|NCT04816877|588450499|FG000|Overall Study|Withdrawal by Subject|1|||
162930621|NCT04816877|588450500|FG001|Overall Study|Withdrawal by Subject|0|||
162930622|NCT02176642|588450502|FG000|Overall Study|Withdrawal by Subject|0|||
162930623|NCT02176642|588450503|FG001|Overall Study|Withdrawal by Subject|1|||
162930624|NCT01309828|588450504|FG000|Overall Study|Adverse Event|10|||
162930625|NCT01309828|588450505|FG001|Overall Study|Adverse Event|11|||
162930626|NCT01309828|588450504|FG000|Overall Study|Voluntary Withdrawal|5|||
162930627|NCT01309828|588450505|FG001|Overall Study|Voluntary Withdrawal|4|||
162930628|NCT01309828|588450504|FG000|Overall Study|Major Protocol Deviation|0|||
162930629|NCT01309828|588450505|FG001|Overall Study|Major Protocol Deviation|1|||
162930630|NCT01309828|588450504|FG000|Overall Study|Other|1|||
162930631|NCT01309828|588450505|FG001|Overall Study|Other|0|||
162930632|NCT00295620|588450506|FG000|Overall Study|Lost to Follow-up|9|||
162930633|NCT00295620|588450507|FG001|Overall Study|Lost to Follow-up|5|||
162930634|NCT00295620|588450506|FG000|Overall Study|Withdrawal by Subject|37|||
162930635|NCT00295620|588450507|FG001|Overall Study|Withdrawal by Subject|50|||
162930636|NCT00295620|588450506|FG000|Overall Study|Death|206|||
162930637|NCT00295620|588450507|FG001|Overall Study|Death|207|||
162930638|NCT00295620|588450506|FG000|Overall Study|Other reasons|10|||
162930639|NCT00295620|588450507|FG001|Overall Study|Other reasons|9|||
162930640|NCT00295620|588450506|FG000|Overall Study|Discontinuation by sponsor|580|||
162930641|NCT00295620|588450507|FG001|Overall Study|Discontinuation by sponsor|593|||
162930642|NCT00295620|588450506|FG000|Overall Study|Protocol Violation|30|||
162930643|NCT00295620|588450507|FG001|Overall Study|Protocol Violation|32|||
162930644|NCT00217971|588450508|FG000|Overall Study|Adverse Event|1|||
162930645|NCT00217971|588450509|FG001|Overall Study|Adverse Event|1|||
162930646|NCT00217971|588450508|FG000|Overall Study|Lost to Follow-up|15|||
162930647|NCT00217971|588450509|FG001|Overall Study|Lost to Follow-up|19|||
162930648|NCT00217971|588450508|FG000|Overall Study|Physician Decision|0|||
162930649|NCT00217971|588450509|FG001|Overall Study|Physician Decision|1|||
162930650|NCT00217971|588450508|FG000|Overall Study|Withdrawal by Subject|7|||
162930651|NCT00217971|588450509|FG001|Overall Study|Withdrawal by Subject|12|||
162930652|NCT00217971|588450508|FG000|Overall Study|non compliant|1|||
162930653|NCT00217971|588450509|FG001|Overall Study|non compliant|0|||
162930654|NCT00808015|588450510|FG000|Overall Study|Death|1|||
162930655|NCT00808015|588450510|FG000|Overall Study|Lack of Efficacy|58|||
163173184|NCT01002820|589349818|FG000|Overall Study|Withdrawal by Subject|2|||
163173185|NCT01002820|589349818|FG000|Overall Study|Lack of Efficacy|1|||
163173186|NCT02478398|589349819|FG000|Overall Study|Adverse Event|20|||
162930656|NCT00808015|588450510|FG000|Overall Study|Lost to Follow-up|76|||
162930657|NCT00808015|588450510|FG000|Overall Study|Participants not willing to participate|158|||
162930658|NCT00808015|588450510|FG000|Overall Study|Adverse Event|22|||
162930659|NCT00808015|588450510|FG000|Overall Study|Other|25|||
162930660|NCT00808015|588450510|FG000|Overall Study|Enrolled but not treated|4|||
162930661|NCT00084617|588450513|FG000|Overall Study|Withdrawal by Subject|7|||
162930662|NCT00084617|588450513|FG000|Overall Study|Lack of Efficacy|1|||
162930663|NCT00084617|588450513|FG000|Overall Study|Protocol Violation|1|||
162930664|NCT01625286|588450514|FG000|Overall Study|Adverse Event|0|||
162930665|NCT01625286|588450515|FG001|Overall Study|Adverse Event|0|||
162930666|NCT01625286|588450516|FG002|Overall Study|Adverse Event|0|||
162930667|NCT01625286|588450517|FG003|Overall Study|Adverse Event|0|||
162930668|NCT01625286|588450518|FG004|Overall Study|Adverse Event|1|||
162930669|NCT01625286|588450519|FG005|Overall Study|Adverse Event|2|||
162930670|NCT01625286|588450520|FG006|Overall Study|Adverse Event|1|||
162930671|NCT01625286|588450514|FG000|Overall Study|Death|0|||
162930672|NCT01625286|588450515|FG001|Overall Study|Death|0|||
163279395|NCT04955626|589731490|FG021|Blinded Period|Medication error|0|||
163279396|NCT04955626|589731491|FG022|Blinded Period|Medication error|0|||
163279397|NCT04955626|589731492|FG023|Blinded Period|Medication error|0|||
163279398|NCT04955626|589731493|FG024|Blinded Period|Medication error|0|||
163279399|NCT04955626|589731494|FG025|Blinded Period|Medication error|0|||
163279400|NCT04955626|589731495|FG026|Blinded Period|Medication error|0|||
162930673|NCT01625286|588450516|FG002|Overall Study|Death|1|||
162930674|NCT01625286|588450517|FG003|Overall Study|Death|1|||
162930675|NCT01625286|588450518|FG004|Overall Study|Death|0|||
162930676|NCT01625286|588450519|FG005|Overall Study|Death|11|||
162930677|NCT01625286|588450520|FG006|Overall Study|Death|16|||
162930678|NCT01625286|588450514|FG000|Overall Study|Withdrawal by Subject|0|||
162930679|NCT01625286|588450515|FG001|Overall Study|Withdrawal by Subject|1|||
162930680|NCT01625286|588450516|FG002|Overall Study|Withdrawal by Subject|0|||
162930681|NCT01625286|588450517|FG003|Overall Study|Withdrawal by Subject|1|||
162930682|NCT01625286|588450518|FG004|Overall Study|Withdrawal by Subject|0|||
162930683|NCT01625286|588450519|FG005|Overall Study|Withdrawal by Subject|0|||
162930684|NCT01625286|588450520|FG006|Overall Study|Withdrawal by Subject|1|||
162930685|NCT01625286|588450514|FG000|Overall Study|Any reason not specifically recorded|0|||
162930686|NCT01625286|588450515|FG001|Overall Study|Any reason not specifically recorded|0|||
162930687|NCT01625286|588450516|FG002|Overall Study|Any reason not specifically recorded|0|||
162930688|NCT01625286|588450517|FG003|Overall Study|Any reason not specifically recorded|0|||
162930689|NCT01625286|588450518|FG004|Overall Study|Any reason not specifically recorded|0|||
162930690|NCT01625286|588450519|FG005|Overall Study|Any reason not specifically recorded|1|||
162930691|NCT01625286|588450520|FG006|Overall Study|Any reason not specifically recorded|0|||
162930692|NCT01625286|588450514|FG000|Overall Study|Progressive disease|6|||
162930693|NCT01625286|588450515|FG001|Overall Study|Progressive disease|3|||
162930694|NCT01625286|588450516|FG002|Overall Study|Progressive disease|4|||
162930695|NCT01625286|588450517|FG003|Overall Study|Progressive disease|5|||
162930696|NCT01625286|588450518|FG004|Overall Study|Progressive disease|5|||
162930697|NCT01625286|588450519|FG005|Overall Study|Progressive disease|0|||
162930698|NCT01625286|588450520|FG006|Overall Study|Progressive disease|0|||
162930699|NCT01625286|588450514|FG000|Overall Study|Lost to Follow-up|0|||
162930700|NCT01625286|588450515|FG001|Overall Study|Lost to Follow-up|0|||
162930701|NCT01625286|588450516|FG002|Overall Study|Lost to Follow-up|0|||
162930702|NCT01625286|588450517|FG003|Overall Study|Lost to Follow-up|0|||
162930703|NCT01625286|588450518|FG004|Overall Study|Lost to Follow-up|0|||
162930704|NCT01625286|588450519|FG005|Overall Study|Lost to Follow-up|0|||
162930705|NCT01625286|588450520|FG006|Overall Study|Lost to Follow-up|1|||
162930706|NCT04523831|588450523|FG000|Overall Study|Lost to Follow-up|15|||
162930707|NCT04523831|588450524|FG001|Overall Study|Lost to Follow-up|17|||
162930708|NCT04523831|588450523|FG000|Overall Study|Death|0|||
162930709|NCT04523831|588450524|FG001|Overall Study|Death|3|||
162930710|NCT04523831|588450523|FG000|Overall Study|Adverse Event|2|||
162930711|NCT04523831|588450524|FG001|Overall Study|Adverse Event|0|||
162930712|NCT00995930|588450525|FG000|Overall Study|Protocol deviation|2|||
162930713|NCT00995930|588450526|FG001|Overall Study|Protocol deviation|5|||
162930714|NCT00995930|588450525|FG000|Overall Study|Death|0|||
162930715|NCT00995930|588450526|FG001|Overall Study|Death|1|||
162930716|NCT00995930|588450525|FG000|Overall Study|Administrative problems|4|||
162930717|NCT00995930|588450526|FG001|Overall Study|Administrative problems|2|||
162930718|NCT00995930|588450525|FG000|Overall Study|Lost to Follow-up|1|||
162930719|NCT00995930|588450526|FG001|Overall Study|Lost to Follow-up|2|||
163279401|NCT04955626|589731496|FG027|Blinded Period|Medication error|0|||
163279402|NCT04955626|589731497|FG028|Blinded Period|Medication error|4|||
162930720|NCT00995930|588450525|FG000|Overall Study|Withdrawal by Subject|3|||
162930721|NCT00995930|588450526|FG001|Overall Study|Withdrawal by Subject|4|||
162930722|NCT00995930|588450525|FG000|Overall Study|Adverse Event|11|||
162930723|NCT00995930|588450526|FG001|Overall Study|Adverse Event|14|||
162930724|NCT01963676|588452173|FG000|Overall Study|Withdrawal by Subject|1|||
162930725|NCT01963676|588452174|FG001|Overall Study|Withdrawal by Subject|0|||
162930726|NCT03627195|588452175|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
162930727|NCT03627195|588452176|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
162930728|NCT03627195|588452177|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
162930729|NCT03627195|588452178|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
162930730|NCT03627195|588452179|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
163279403|NCT04955626|589731498|FG029|Blinded Period|Medication error|0|||
162930731|NCT03627195|588452180|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
162930732|NCT00096382|588452183|FG000|Overall Study|Not treated|1|||
162930733|NCT00096382|588452184|FG001|Overall Study|Not treated|0|||
162930734|NCT00096382|588452183|FG000|Overall Study|Death during treatment|1|||
162930735|NCT00096382|588452184|FG001|Overall Study|Death during treatment|0|||
162930736|NCT01977352|588452185|FG000|Overall Study|Lost to Follow-up|1|||
162930737|NCT01977352|588452186|FG001|Overall Study|Lost to Follow-up|2|||
162930738|NCT00409188|588452192|FG000|Overall Study|Ongoing at data cut-off|383|||
162930739|NCT00409188|588452193|FG001|Overall Study|Ongoing at data cut-off|175|||
162930740|NCT01835132|588452194|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
162930741|NCT00856778|588452195|FG000|Overall Study|Adverse Event|7|||
162930742|NCT00856778|588452195|FG000|Overall Study|Withdrawal by Subject|10|||
162930743|NCT00856778|588452195|FG000|Overall Study|Study deviation|2|||
162930744|NCT00856778|588452195|FG000|Overall Study|Lost to Follow-up|5|||
162930745|NCT01681771|588452196|FG000|Overall Study|Lost to Follow-up|4|||
162930746|NCT01681771|588452197|FG001|Overall Study|Lost to Follow-up|2|||
162930747|NCT00265083|588452198|FG000|Overall Study|Adverse Event|5|||
162930748|NCT00265083|588452199|FG001|Overall Study|Adverse Event|13|||
162930749|NCT00265083|588452200|FG002|Overall Study|Adverse Event|15|||
162930750|NCT00265083|588452198|FG000|Overall Study|Lost to Follow-up|3|||
162930751|NCT00265083|588452199|FG001|Overall Study|Lost to Follow-up|4|||
162930752|NCT00265083|588452200|FG002|Overall Study|Lost to Follow-up|4|||
162930753|NCT00265083|588452198|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
162930754|NCT00265083|588452199|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
162930755|NCT00265083|588452200|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
162930756|NCT00265083|588452198|FG000|Overall Study|Other|1|||
162930757|NCT00265083|588452199|FG001|Overall Study|Other|12|||
162930758|NCT00265083|588452200|FG002|Overall Study|Other|9|||
162930759|NCT03208933|588452204|FG000|Overall Study|Death|3|||
162930760|NCT03208933|588452204|FG000|Overall Study|Withdrawal by Subject|3|||
162930761|NCT03208933|588452204|FG000|Overall Study|Adverse Event|1|||
162930762|NCT03208933|588452204|FG000|Overall Study|Lost to Follow-up|2|||
162930763|NCT03208933|588452204|FG000|Overall Study|Physician Decision|3|||
162930764|NCT03208933|588452204|FG000|Overall Study|Protocol Violation|1|||
162930765|NCT00854620|588452207|FG000|Overall Study|Adverse Event|1|||
162930766|NCT04242186|588452213|FG000|Overall Study|Death|5|||
162930767|NCT00550420|588452215|FG000|Overall Study|Adverse Event|28|||
162930768|NCT00550420|588452215|FG000|Overall Study|Lost to Follow-up|8|||
162930769|NCT00550420|588452215|FG000|Overall Study|Protocol Violation|11|||
162930770|NCT00550420|588452215|FG000|Overall Study|Withdrawal by Subject|30|||
162930771|NCT00550420|588452215|FG000|Overall Study|Still in study at termination|206|||
162930772|NCT00550420|588452215|FG000|Overall Study|Missing|2|||
162930773|NCT00550420|588452215|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
162930774|NCT00550420|588452215|FG000|Overall Study|Investigators opinion|1|||
162930775|NCT00550420|588452215|FG000|Overall Study|Lack of curative effect|1|||
163173187|NCT02478398|589349820|FG001|Overall Study|Adverse Event|5|||
163173188|NCT02478398|589349819|FG000|Overall Study|Lost to Follow-up|5|||
163173189|NCT02478398|589349820|FG001|Overall Study|Lost to Follow-up|4|||
163173190|NCT02478398|589349819|FG000|Overall Study|Non-Compliance With Study Drug|5|||
163173191|NCT02478398|589349820|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163173192|NCT02478398|589349819|FG000|Overall Study|Protocol Violation|3|||
163173193|NCT02478398|589349820|FG001|Overall Study|Protocol Violation|1|||
163173194|NCT02478398|589349819|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
163279404|NCT04955626|589731499|FG030|Blinded Period|Medication error|0|||
163279405|NCT04955626|589731500|FG031|Blinded Period|Medication error|0|||
163279406|NCT04955626|589731501|FG032|Blinded Period|Medication error|0|||
163279407|NCT04955626|589731502|FG033|Blinded Period|Medication error|0|||
163279408|NCT04955626|589731503|FG034|Blinded Period|Medication error|0|||
163279409|NCT04955626|589731504|FG035|Blinded Period|Medication error|0|||
163279410|NCT04955626|589731469|FG000|Open-Label Period|Lost to Follow-up|109|||
162930776|NCT00550420|588452215|FG000|Overall Study|Unethical stop of enrollment|2|||
162930777|NCT00550420|588452215|FG000|Overall Study|Caregiver's decision to withdraw|1|||
162930778|NCT00550420|588452215|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
162930779|NCT00550420|588452215|FG000|Overall Study|Exclusion criteria|1|||
162930780|NCT00550420|588452215|FG000|Overall Study|Prohibited medicine|1|||
163279411|NCT04955626|589731470|FG001|Open-Label Period|Lost to Follow-up|41|||
162930781|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
162930782|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
162930783|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
162930784|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
162930785|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
162930786|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
162930787|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
162930788|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
162930789|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
162930790|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
162930791|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
162930792|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
162930793|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
162930794|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
162930795|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
163173195|NCT02478398|589349820|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
163173196|NCT02478398|589349819|FG000|Overall Study|Withdrawal By Participant|10|||
162930796|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
162930797|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
163279412|NCT04955626|589731471|FG002|Open-Label Period|Lost to Follow-up|0|||
163279413|NCT04955626|589731472|FG003|Open-Label Period|Lost to Follow-up|0|||
163279414|NCT04955626|589731473|FG004|Open-Label Period|Lost to Follow-up|0|||
163279415|NCT04955626|589731474|FG005|Open-Label Period|Lost to Follow-up|0|||
163279416|NCT04955626|589731475|FG006|Open-Label Period|Lost to Follow-up|0|||
162930798|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
162930799|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
162930800|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
162930801|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
162930802|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
162930803|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
162930804|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
162930805|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
162930806|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
162930807|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
162930808|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
162930809|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
162930810|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
162930811|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
162930812|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
162930813|NCT01872689|588452221|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
162930814|NCT01872689|588452222|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
162930815|NCT01872689|588452223|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
162930816|NCT01872689|588452224|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
162930817|NCT01872689|588452221|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
162930818|NCT01872689|588452222|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
162930819|NCT01872689|588452223|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
162930820|NCT01872689|588452224|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
162930821|NCT01872689|588452221|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
162930822|NCT01872689|588452222|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
162930823|NCT01872689|588452223|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
162930824|NCT01872689|588452224|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
162930825|NCT01872689|588452221|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
162930826|NCT01872689|588452222|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
162930827|NCT01872689|588452223|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
162930828|NCT01872689|588452224|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
162930829|NCT01872689|588452221|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
162930830|NCT01872689|588452222|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
162930831|NCT01872689|588452223|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
162930832|NCT01872689|588452224|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
162930833|NCT01872689|588452221|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
162930834|NCT01872689|588452222|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
162930835|NCT01872689|588452223|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
162930836|NCT01872689|588452224|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
162930837|NCT01456052|588452225|FG000|Overall Study|Adverse Event|1|||
162930838|NCT01456052|588452226|FG001|Overall Study|Adverse Event|1|||
162930839|NCT01456052|588452227|FG002|Overall Study|Adverse Event|2|||
162930840|NCT01456052|588452225|FG000|Overall Study|Consent withdrawn|0|||
162930841|NCT01456052|588452226|FG001|Overall Study|Consent withdrawn|2|||
162930842|NCT01456052|588452227|FG002|Overall Study|Consent withdrawn|1|||
162930843|NCT01456052|588452225|FG000|Overall Study|Protocol Violation|0|||
162930844|NCT01456052|588452226|FG001|Overall Study|Protocol Violation|1|||
162930845|NCT01456052|588452227|FG002|Overall Study|Protocol Violation|0|||
162930846|NCT01456052|588452225|FG000|Overall Study|Physician Decision|1|||
162930847|NCT01456052|588452226|FG001|Overall Study|Physician Decision|0|||
162930848|NCT01456052|588452227|FG002|Overall Study|Physician Decision|1|||
162930849|NCT01456052|588452225|FG000|Overall Study|Treatment Failure|0|||
162930850|NCT01456052|588452226|FG001|Overall Study|Treatment Failure|1|||
162930851|NCT01456052|588452227|FG002|Overall Study|Treatment Failure|1|||
162930852|NCT02762565|588452230|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
162930853|NCT01113710|588452231|FG000|Overall Study|Adverse Event|64|||
162930854|NCT01113710|588452231|FG000|Overall Study|Lack of Efficacy|41|||
162930855|NCT01113710|588452231|FG000|Overall Study|No Information Available|40|||
162930856|NCT01113710|588452231|FG000|Overall Study|Withdrawal by Subject|28|||
162930857|NCT01113710|588452231|FG000|Overall Study|Lost to Follow-up|20|||
162930858|NCT01113710|588452231|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
162930859|NCT01113710|588452231|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
162930860|NCT01113710|588452231|FG000|Overall Study|Lack of Patient's Compliance|8|||
162930861|NCT01113710|588452231|FG000|Overall Study|Other|7|||
162930862|NCT01113710|588452231|FG000|Overall Study|Adverse Event/Other|5|||
162930863|NCT01113710|588452231|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
162930864|NCT01113710|588452231|FG000|Overall Study|Lack of Efficacy/Other|4|||
162930865|NCT01113710|588452231|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
162930866|NCT01113710|588452231|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
162930867|NCT01113710|588452231|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
162930868|NCT01113710|588452231|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
162930869|NCT01113710|588452231|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
162930870|NCT01113710|588452231|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
162930871|NCT01113710|588452231|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
162930872|NCT01113710|588452231|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
162930873|NCT01113710|588452231|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
162930874|NCT01113710|588452231|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
162930875|NCT01113710|588452231|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
162930876|NCT01113710|588452231|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
162930877|NCT01113710|588452231|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
162930878|NCT02770716|588452233|FG000|Overall Study|Death|101|||
162930879|NCT02770716|588452234|FG001|Overall Study|Death|45|||
162930880|NCT02770716|588452233|FG000|Overall Study|Withdrawal by Subject|4|||
162930881|NCT02770716|588452234|FG001|Overall Study|Withdrawal by Subject|2|||
162930882|NCT02770716|588452233|FG000|Overall Study|Lost to Follow-up|1|||
162930883|NCT02770716|588452234|FG001|Overall Study|Lost to Follow-up|0|||
162930884|NCT02770716|588452233|FG000|Overall Study|Various reasons|6|||
162930885|NCT02770716|588452234|FG001|Overall Study|Various reasons|2|||
162930886|NCT01042977|588452235|FG000|Overall Study|Adverse Event|4|||
162930887|NCT01042977|588452236|FG001|Overall Study|Adverse Event|12|||
162930888|NCT01042977|588452235|FG000|Overall Study|Death|2|||
162930889|NCT01042977|588452236|FG001|Overall Study|Death|1|||
162930890|NCT01042977|588452235|FG000|Overall Study|Withdrawal by Subject|8|||
162930891|NCT01042977|588452236|FG001|Overall Study|Withdrawal by Subject|16|||
162930892|NCT01042977|588452235|FG000|Overall Study|Lost to Follow-up|0|||
163173197|NCT02478398|589349820|FG001|Overall Study|Withdrawal By Participant|4|||
163173198|NCT01475071|589349827|FG000|Overall Study|Physician Decision|1|||
162930893|NCT01042977|588452236|FG001|Overall Study|Lost to Follow-up|2|||
162930894|NCT01042977|588452235|FG000|Overall Study|Poor/non-compliance|3|||
162930895|NCT01042977|588452236|FG001|Overall Study|Poor/non-compliance|4|||
162930896|NCT01042977|588452235|FG000|Overall Study|Subject no longer meets study criteria|15|||
162930897|NCT01042977|588452236|FG001|Overall Study|Subject no longer meets study criteria|13|||
162930898|NCT01042977|588452235|FG000|Overall Study|Incorrect enrollment|6|||
162930899|NCT01042977|588452236|FG001|Overall Study|Incorrect enrollment|4|||
162930900|NCT01042977|588452235|FG000|Overall Study|Safety|0|||
162930901|NCT01042977|588452236|FG001|Overall Study|Safety|2|||
162930902|NCT01042977|588452235|FG000|Overall Study|Administrative reason by sponsor|0|||
162930903|NCT01042977|588452236|FG001|Overall Study|Administrative reason by sponsor|1|||
162930904|NCT01042977|588452235|FG000|Overall Study|Various|3|||
162930905|NCT01042977|588452236|FG001|Overall Study|Various|0|||
162930906|NCT02499354|588452237|FG000|Overall Study|Withdrawal by Subject|1|||
162930907|NCT02499354|588452238|FG001|Overall Study|Withdrawal by Subject|0|||
162930908|NCT01677910|588452240|FG000|Double-Blind Treatment Period|Adverse Event|6|||
162930909|NCT01677910|588452241|FG001|Double-Blind Treatment Period|Adverse Event|2|||
162930910|NCT01677910|588452242|FG002|Double-Blind Treatment Period|Adverse Event|3|||
162930911|NCT01677910|588452243|FG003|Double-Blind Treatment Period|Adverse Event|0|||
162930912|NCT01677910|588452240|FG000|Double-Blind Treatment Period|Physician Decision|0|||
162930913|NCT01677910|588452241|FG001|Double-Blind Treatment Period|Physician Decision|0|||
162930914|NCT01677910|588452242|FG002|Double-Blind Treatment Period|Physician Decision|1|||
162930915|NCT01677910|588452243|FG003|Double-Blind Treatment Period|Physician Decision|0|||
162930916|NCT01677910|588452240|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
162930917|NCT01677910|588452241|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
162930918|NCT01677910|588452242|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
162930919|NCT01677910|588452243|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
162930920|NCT01677910|588452240|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
162930921|NCT01677910|588452241|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
162930922|NCT01677910|588452242|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
162930923|NCT01677910|588452243|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
162930924|NCT01677910|588452240|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
162930925|NCT01677910|588452241|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
162930926|NCT01677910|588452242|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
162930927|NCT01677910|588452243|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
162930928|NCT01677910|588452240|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
162930929|NCT01677910|588452241|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
162930930|NCT01677910|588452242|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
162930931|NCT01677910|588452243|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
162930932|NCT01677910|588452240|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
162930933|NCT01677910|588452241|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
162930934|NCT01677910|588452242|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
162930935|NCT01677910|588452243|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
162930936|NCT01677910|588452240|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
162930937|NCT01677910|588452241|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
162930938|NCT01677910|588452242|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
162930939|NCT01677910|588452243|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
162930940|NCT01677910|588452240|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
162930941|NCT01677910|588452241|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
162930942|NCT01677910|588452242|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
162930943|NCT01677910|588452243|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
162930944|NCT01677910|588452240|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
162930945|NCT01677910|588452241|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
162930946|NCT01677910|588452242|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
162930947|NCT01677910|588452243|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
162930948|NCT01703741|588452245|FG000|Overall Study|Withdrawal by Subject|6|||
162930949|NCT01703741|588452245|FG000|Overall Study|Adverse Event|2|||
162930950|NCT01703741|588452245|FG000|Overall Study|Physician Decision|2|||
162930951|NCT01703741|588452245|FG000|Overall Study|Protocol Violation|1|||
162930952|NCT01703741|588452245|FG000|Overall Study|Lost to Follow-up|3|||
162930953|NCT01703741|588452245|FG000|Overall Study|Subject did not want to continue|2|||
162930954|NCT01703741|588452245|FG000|Overall Study|Subject cannot comply with study visits|1|||
162930955|NCT01703741|588452245|FG000|Overall Study|Subject started testosterone injections|1|||
162930956|NCT04132232|588452246|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
162930957|NCT04132232|588452247|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
162930958|NCT04132232|588452246|FG000|Overall Study|Lost to Follow-up|6|||
162930959|NCT04132232|588452247|FG001|Overall Study|Lost to Follow-up|7|||
162930960|NCT00755937|588452248|FG000|Recruitment|Unknown if infliximab received|164|||
162930961|NCT00755937|588452248|FG000|Observational Follow-up|Lost to Follow-up|148|||
162930962|NCT03876873|588452249|FG000|Overall Study|Physician Decision|0|||
162930963|NCT03876873|588452250|FG001|Overall Study|Physician Decision|1|||
162930964|NCT03547531|588452251|FG000|Overall Study|not coming in data collection : sick|2|||
162930965|NCT03547531|588452252|FG001|Overall Study|not coming in data collection : sick|2|||
162930966|NCT03547531|588452251|FG000|Overall Study|having family occasion|0|||
162930967|NCT03547531|588452252|FG001|Overall Study|having family occasion|2|||
162930968|NCT02117479|588452262|FG000|Overall Study|Death|13|||
162930969|NCT02117479|588452263|FG001|Overall Study|Death|8|||
162930970|NCT02117479|588452262|FG000|Overall Study|Adverse Event|8|||
162930971|NCT02117479|588452263|FG001|Overall Study|Adverse Event|16|||
162930972|NCT02117479|588452262|FG000|Overall Study|Subject decision|8|||
162930973|NCT02117479|588452263|FG001|Overall Study|Subject decision|9|||
162930974|NCT02117479|588452262|FG000|Overall Study|Disease progression|104|||
162930975|NCT02117479|588452263|FG001|Overall Study|Disease progression|108|||
162930976|NCT02117479|588452262|FG000|Overall Study|Noncompliance with study treatment|1|||
162930977|NCT02117479|588452263|FG001|Overall Study|Noncompliance with study treatment|0|||
162930978|NCT02117479|588452262|FG000|Overall Study|Study terminated by the sponsor|4|||
162930979|NCT02117479|588452263|FG001|Overall Study|Study terminated by the sponsor|6|||
162930980|NCT02117479|588452262|FG000|Overall Study|Physician Decision|7|||
162930981|NCT02117479|588452263|FG001|Overall Study|Physician Decision|2|||
162930982|NCT02117479|588452262|FG000|Overall Study|Other unspecified|11|||
162930983|NCT02117479|588452263|FG001|Overall Study|Other unspecified|7|||
162930984|NCT01223196|588452269|FG000|Overall Study|Lost to Follow-up|2|||
162930985|NCT01223196|588452270|FG001|Overall Study|Lost to Follow-up|0|||
162930986|NCT01223196|588452269|FG000|Overall Study|Physician Decision|1|||
162930987|NCT01223196|588452270|FG001|Overall Study|Physician Decision|0|||
162930988|NCT01223196|588452269|FG000|Overall Study|Withdrawal by Subject|1|||
162930989|NCT01223196|588452270|FG001|Overall Study|Withdrawal by Subject|0|||
162930990|NCT02629133|588452271|FG000|Overall Study|Lost to Follow-up|3|||
162930991|NCT02629133|588452272|FG001|Overall Study|Lost to Follow-up|1|||
162930992|NCT02629133|588452271|FG000|Overall Study|Withdrawal by Subject|1|||
162930993|NCT02629133|588452272|FG001|Overall Study|Withdrawal by Subject|1|||
162930994|NCT01238822|588452273|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
162930995|NCT02598193|588452274|FG000|Overall Study|Adverse Event|13|||
162930996|NCT02598193|588452274|FG000|Overall Study|Withdrawal by Subject|1|||
162930997|NCT02598193|588452274|FG000|Overall Study|Listed in active lung transplant list|1|||
162930998|NCT02598193|588452274|FG000|Overall Study|Does not want to take Nintedanib|1|||
162930999|NCT00447694|588452277|FG000|Overall Study|Adverse Event|2|||
162931000|NCT00447694|588452277|FG000|Overall Study|Abnormal laboratory value|1|||
162931001|NCT00447694|588452277|FG000|Overall Study|Abnormal test procedure result|1|||
162931002|NCT00447694|588452277|FG000|Overall Study|Withdrawal by Subject|2|||
162931003|NCT01169987|588452278|FG000|Overall Study|Withdrawal by Subject|3|||
162931004|NCT01169987|588452278|FG000|Overall Study|Lost to Follow-up|24|||
162931005|NCT01169987|588452278|FG000|Overall Study|Other|4|||
162931006|NCT00386100|588452280|FG000|Overall Study|Did not receive study medication|6|||
162931007|NCT00386100|588452281|FG001|Overall Study|Did not receive study medication|4|||
162931008|NCT00386100|588452280|FG000|Overall Study|Adverse Event|15|||
162931009|NCT00386100|588452281|FG001|Overall Study|Adverse Event|25|||
162931010|NCT00386100|588452280|FG000|Overall Study|Death|0|||
162931011|NCT00386100|588452281|FG001|Overall Study|Death|1|||
162931012|NCT00386100|588452280|FG000|Overall Study|Insufficient therapeutic effect|30|||
162931013|NCT00386100|588452281|FG001|Overall Study|Insufficient therapeutic effect|6|||
162931014|NCT00386100|588452280|FG000|Overall Study|Lost to Follow-up|29|||
162931015|NCT00386100|588452281|FG001|Overall Study|Lost to Follow-up|29|||
162931016|NCT00386100|588452280|FG000|Overall Study|Non-compliance|18|||
162931017|NCT00386100|588452281|FG001|Overall Study|Non-compliance|19|||
162931018|NCT00386100|588452280|FG000|Overall Study|Protocol Violation|5|||
162931019|NCT00386100|588452281|FG001|Overall Study|Protocol Violation|3|||
162931020|NCT00386100|588452280|FG000|Overall Study|Withdrawal by Subject|32|||
162931021|NCT00386100|588452281|FG001|Overall Study|Withdrawal by Subject|31|||
162931022|NCT00386100|588452280|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
162931023|NCT00386100|588452281|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
162931024|NCT00386100|588452280|FG000|Overall Study|BMD <2.5|1|||
162931025|NCT00386100|588452281|FG001|Overall Study|BMD <2.5|0|||
162931026|NCT00386100|588452280|FG000|Overall Study|Consecutive elevated Hba1C|1|||
162931027|NCT00386100|588452281|FG001|Overall Study|Consecutive elevated Hba1C|0|||
162931028|NCT00386100|588452280|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
162931029|NCT00386100|588452281|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
162931030|NCT00386100|588452280|FG000|Overall Study|Laboratory findings|1|||
162931031|NCT00386100|588452281|FG001|Overall Study|Laboratory findings|0|||
162931032|NCT00386100|588452280|FG000|Overall Study|Participant's concern due to CPK levels|1|||
162931033|NCT00386100|588452281|FG001|Overall Study|Participant's concern due to CPK levels|0|||
162931034|NCT00386100|588452280|FG000|Overall Study|Participant moving out of state|2|||
162931035|NCT00386100|588452281|FG001|Overall Study|Participant moving out of state|0|||
162931036|NCT00386100|588452280|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
162931037|NCT00386100|588452281|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
162931038|NCT00386100|588452280|FG000|Overall Study|Didn't meet entry criteria|1|||
162931039|NCT00386100|588452281|FG001|Overall Study|Didn't meet entry criteria|1|||
162931040|NCT00386100|588452280|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
162931041|NCT00386100|588452281|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
163173199|NCT01475071|589349827|FG000|Overall Study|Withdrawal by Subject|6|||
163173200|NCT01475071|589349827|FG000|Overall Study|Lost to Follow-up|1|||
163173201|NCT01205581|589349831|FG000|Overall Study|Withdrawal by Subject|1|||
163173202|NCT01205581|589349832|FG001|Overall Study|Withdrawal by Subject|0|||
163173203|NCT01205581|589349833|FG002|Overall Study|Withdrawal by Subject|0|||
163173204|NCT01205581|589349834|FG003|Overall Study|Withdrawal by Subject|0|||
162931042|NCT00386100|588452280|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
162931043|NCT00386100|588452281|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
162931044|NCT00386100|588452280|FG000|Overall Study|Bad metabolic control & patient security|1|||
162931045|NCT00386100|588452281|FG001|Overall Study|Bad metabolic control & patient security|0|||
162931046|NCT00386100|588452280|FG000|Overall Study|Bone loss by DXA bone scan|1|||
162931047|NCT00386100|588452281|FG001|Overall Study|Bone loss by DXA bone scan|0|||
162931048|NCT00386100|588452280|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
162931049|NCT00386100|588452281|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
162931050|NCT00386100|588452280|FG000|Overall Study|7.6% bone loss|1|||
162931051|NCT00386100|588452281|FG001|Overall Study|7.6% bone loss|0|||
162931052|NCT00386100|588452280|FG000|Overall Study|Osteoporosis|0|||
162931053|NCT00386100|588452281|FG001|Overall Study|Osteoporosis|1|||
162931054|NCT00386100|588452280|FG000|Overall Study|Positive pregnancy test|1|||
162931055|NCT00386100|588452281|FG001|Overall Study|Positive pregnancy test|3|||
162931056|NCT00386100|588452280|FG000|Overall Study|Out of country for 5 months|1|||
162931057|NCT00386100|588452281|FG001|Overall Study|Out of country for 5 months|0|||
162931058|NCT00386100|588452280|FG000|Overall Study|Hb1Ac >8%|0|||
162931059|NCT00386100|588452281|FG001|Overall Study|Hb1Ac >8%|1|||
162931060|NCT00386100|588452280|FG000|Overall Study|Participant randomized in error|1|||
162931061|NCT00386100|588452281|FG001|Overall Study|Participant randomized in error|0|||
162931062|NCT03672396|588452283|FG000|Overall Study|Withdrawal by Subject|4|||
162931063|NCT03672396|588452283|FG000|Overall Study|Physician Decision|1|||
162931064|NCT03672396|588452283|FG000|Overall Study|Adverse Event|1|||
162931065|NCT04380701|588452288|FG000|Overall Study|Pregnancy|0|||
162931066|NCT04380701|588452289|FG001|Overall Study|Pregnancy|0|||
162931067|NCT04380701|588452290|FG002|Overall Study|Pregnancy|0|||
162931068|NCT04380701|588452291|FG003|Overall Study|Pregnancy|0|||
162931069|NCT04380701|588452292|FG004|Overall Study|Pregnancy|0|||
162931070|NCT04380701|588452293|FG005|Overall Study|Pregnancy|0|||
162931071|NCT04380701|588452294|FG006|Overall Study|Pregnancy|0|||
162931072|NCT04380701|588452295|FG007|Overall Study|Pregnancy|0|||
162931073|NCT04380701|588452296|FG008|Overall Study|Pregnancy|0|||
162931074|NCT04380701|588452297|FG009|Overall Study|Pregnancy|0|||
162931075|NCT04380701|588452298|FG010|Overall Study|Pregnancy|0|||
162931076|NCT04380701|588452299|FG011|Overall Study|Pregnancy|0|||
162931077|NCT04380701|588452300|FG012|Overall Study|Pregnancy|0|||
162931078|NCT04380701|588452301|FG013|Overall Study|Pregnancy|0|||
162931079|NCT04380701|588452302|FG014|Overall Study|Pregnancy|0|||
162931080|NCT04380701|588452303|FG015|Overall Study|Pregnancy|0|||
162931081|NCT04380701|588452304|FG016|Overall Study|Pregnancy|0|||
162931082|NCT04380701|588452305|FG017|Overall Study|Pregnancy|0|||
162931083|NCT04380701|588452306|FG018|Overall Study|Pregnancy|0|||
162931084|NCT04380701|588452307|FG019|Overall Study|Pregnancy|0|||
162931085|NCT04380701|588452308|FG020|Overall Study|Pregnancy|0|||
162931086|NCT04380701|588452309|FG021|Overall Study|Pregnancy|0|||
162931087|NCT04380701|588452310|FG022|Overall Study|Pregnancy|0|||
162931088|NCT04380701|588452311|FG023|Overall Study|Pregnancy|0|||
162931089|NCT04380701|588452312|FG024|Overall Study|Pregnancy|0|||
162931090|NCT04380701|588452313|FG025|Overall Study|Pregnancy|0|||
162931091|NCT04380701|588452314|FG026|Overall Study|Pregnancy|0|||
162931092|NCT04380701|588452315|FG027|Overall Study|Pregnancy|0|||
162931093|NCT04380701|588452316|FG028|Overall Study|Pregnancy|0|||
162931094|NCT04380701|588452317|FG029|Overall Study|Pregnancy|0|||
162931095|NCT04380701|588452318|FG030|Overall Study|Pregnancy|0|||
162931096|NCT04380701|588452319|FG031|Overall Study|Pregnancy|0|||
162931097|NCT04380701|588452320|FG032|Overall Study|Pregnancy|1|||
162931098|NCT04380701|588452321|FG033|Overall Study|Pregnancy|0|||
162931099|NCT04380701|588452288|FG000|Overall Study|Lost to Follow-up|0|||
162931100|NCT04380701|588452289|FG001|Overall Study|Lost to Follow-up|0|||
162931101|NCT04380701|588452290|FG002|Overall Study|Lost to Follow-up|0|||
162931102|NCT04380701|588452291|FG003|Overall Study|Lost to Follow-up|0|||
162931103|NCT04380701|588452292|FG004|Overall Study|Lost to Follow-up|0|||
162931104|NCT04380701|588452293|FG005|Overall Study|Lost to Follow-up|0|||
162931105|NCT04380701|588452294|FG006|Overall Study|Lost to Follow-up|0|||
162931106|NCT04380701|588452295|FG007|Overall Study|Lost to Follow-up|0|||
162931107|NCT04380701|588452296|FG008|Overall Study|Lost to Follow-up|0|||
162931108|NCT04380701|588452297|FG009|Overall Study|Lost to Follow-up|0|||
162931109|NCT04380701|588452298|FG010|Overall Study|Lost to Follow-up|0|||
162931110|NCT04380701|588452299|FG011|Overall Study|Lost to Follow-up|0|||
163173205|NCT01205581|589349835|FG004|Overall Study|Withdrawal by Subject|0|||
162931111|NCT04380701|588452300|FG012|Overall Study|Lost to Follow-up|0|||
162931112|NCT04380701|588452301|FG013|Overall Study|Lost to Follow-up|0|||
162931113|NCT04380701|588452302|FG014|Overall Study|Lost to Follow-up|0|||
162931114|NCT04380701|588452303|FG015|Overall Study|Lost to Follow-up|0|||
162931115|NCT04380701|588452304|FG016|Overall Study|Lost to Follow-up|0|||
162931116|NCT04380701|588452305|FG017|Overall Study|Lost to Follow-up|0|||
162931117|NCT04380701|588452306|FG018|Overall Study|Lost to Follow-up|0|||
163173206|NCT01205581|589349836|FG005|Overall Study|Withdrawal by Subject|0|||
162931118|NCT04380701|588452307|FG019|Overall Study|Lost to Follow-up|0|||
162931119|NCT04380701|588452308|FG020|Overall Study|Lost to Follow-up|1|||
162931120|NCT04380701|588452309|FG021|Overall Study|Lost to Follow-up|0|||
162931121|NCT04380701|588452310|FG022|Overall Study|Lost to Follow-up|0|||
162931122|NCT04380701|588452311|FG023|Overall Study|Lost to Follow-up|1|||
162931123|NCT04380701|588452312|FG024|Overall Study|Lost to Follow-up|0|||
162931124|NCT04380701|588452313|FG025|Overall Study|Lost to Follow-up|0|||
162931125|NCT04380701|588452314|FG026|Overall Study|Lost to Follow-up|0|||
162931126|NCT04380701|588452315|FG027|Overall Study|Lost to Follow-up|0|||
162931127|NCT04380701|588452316|FG028|Overall Study|Lost to Follow-up|0|||
162931128|NCT04380701|588452317|FG029|Overall Study|Lost to Follow-up|1|||
162931129|NCT04380701|588452318|FG030|Overall Study|Lost to Follow-up|0|||
162931130|NCT04380701|588452319|FG031|Overall Study|Lost to Follow-up|0|||
162931131|NCT04380701|588452320|FG032|Overall Study|Lost to Follow-up|0|||
162931132|NCT04380701|588452321|FG033|Overall Study|Lost to Follow-up|1|||
162931133|NCT04380701|588452288|FG000|Overall Study|Private reason(s)|0|||
162931134|NCT04380701|588452289|FG001|Overall Study|Private reason(s)|0|||
162931135|NCT04380701|588452290|FG002|Overall Study|Private reason(s)|0|||
162931136|NCT04380701|588452291|FG003|Overall Study|Private reason(s)|0|||
162931137|NCT04380701|588452292|FG004|Overall Study|Private reason(s)|0|||
162931138|NCT04380701|588452293|FG005|Overall Study|Private reason(s)|0|||
162931139|NCT04380701|588452294|FG006|Overall Study|Private reason(s)|1|||
162931140|NCT04380701|588452295|FG007|Overall Study|Private reason(s)|0|||
162931141|NCT04380701|588452296|FG008|Overall Study|Private reason(s)|1|||
162931142|NCT04380701|588452297|FG009|Overall Study|Private reason(s)|1|||
162931143|NCT04380701|588452298|FG010|Overall Study|Private reason(s)|0|||
162931144|NCT04380701|588452299|FG011|Overall Study|Private reason(s)|0|||
162931145|NCT04380701|588452300|FG012|Overall Study|Private reason(s)|0|||
162931146|NCT04380701|588452301|FG013|Overall Study|Private reason(s)|0|||
162931147|NCT04380701|588452302|FG014|Overall Study|Private reason(s)|0|||
162931148|NCT04380701|588452303|FG015|Overall Study|Private reason(s)|0|||
162931149|NCT04380701|588452304|FG016|Overall Study|Private reason(s)|0|||
162931150|NCT04380701|588452305|FG017|Overall Study|Private reason(s)|0|||
162931151|NCT04380701|588452306|FG018|Overall Study|Private reason(s)|0|||
162931152|NCT04380701|588452307|FG019|Overall Study|Private reason(s)|0|||
162931153|NCT04380701|588452308|FG020|Overall Study|Private reason(s)|0|||
162931154|NCT04380701|588452309|FG021|Overall Study|Private reason(s)|0|||
162931155|NCT04380701|588452310|FG022|Overall Study|Private reason(s)|0|||
162931156|NCT04380701|588452311|FG023|Overall Study|Private reason(s)|1|||
162931157|NCT04380701|588452312|FG024|Overall Study|Private reason(s)|0|||
162931158|NCT04380701|588452313|FG025|Overall Study|Private reason(s)|0|||
162931159|NCT04380701|588452314|FG026|Overall Study|Private reason(s)|0|||
162931160|NCT04380701|588452315|FG027|Overall Study|Private reason(s)|0|||
162931161|NCT04380701|588452316|FG028|Overall Study|Private reason(s)|0|||
162931162|NCT04380701|588452317|FG029|Overall Study|Private reason(s)|1|||
162931163|NCT04380701|588452318|FG030|Overall Study|Private reason(s)|0|||
162931164|NCT04380701|588452319|FG031|Overall Study|Private reason(s)|0|||
162931165|NCT04380701|588452320|FG032|Overall Study|Private reason(s)|0|||
162931166|NCT04380701|588452321|FG033|Overall Study|Private reason(s)|0|||
162931167|NCT04380701|588452288|FG000|Overall Study|Withdrawal by Subject|0|||
162931168|NCT04380701|588452289|FG001|Overall Study|Withdrawal by Subject|0|||
162931169|NCT04380701|588452290|FG002|Overall Study|Withdrawal by Subject|0|||
162931170|NCT04380701|588452291|FG003|Overall Study|Withdrawal by Subject|0|||
162931171|NCT04380701|588452292|FG004|Overall Study|Withdrawal by Subject|0|||
162931172|NCT04380701|588452293|FG005|Overall Study|Withdrawal by Subject|0|||
162931173|NCT04380701|588452294|FG006|Overall Study|Withdrawal by Subject|1|||
162931174|NCT04380701|588452295|FG007|Overall Study|Withdrawal by Subject|1|||
162931175|NCT04380701|588452296|FG008|Overall Study|Withdrawal by Subject|0|||
162931176|NCT04380701|588452297|FG009|Overall Study|Withdrawal by Subject|0|||
162931177|NCT04380701|588452298|FG010|Overall Study|Withdrawal by Subject|0|||
162931178|NCT04380701|588452299|FG011|Overall Study|Withdrawal by Subject|1|||
162931179|NCT04380701|588452300|FG012|Overall Study|Withdrawal by Subject|0|||
162931180|NCT04380701|588452301|FG013|Overall Study|Withdrawal by Subject|1|||
162931181|NCT04380701|588452302|FG014|Overall Study|Withdrawal by Subject|0|||
162931182|NCT04380701|588452303|FG015|Overall Study|Withdrawal by Subject|0|||
162931183|NCT04380701|588452304|FG016|Overall Study|Withdrawal by Subject|1|||
162931184|NCT04380701|588452305|FG017|Overall Study|Withdrawal by Subject|0|||
162931185|NCT04380701|588452306|FG018|Overall Study|Withdrawal by Subject|0|||
162931186|NCT04380701|588452307|FG019|Overall Study|Withdrawal by Subject|0|||
162931187|NCT04380701|588452308|FG020|Overall Study|Withdrawal by Subject|0|||
162931188|NCT04380701|588452309|FG021|Overall Study|Withdrawal by Subject|0|||
162931189|NCT04380701|588452310|FG022|Overall Study|Withdrawal by Subject|2|||
162931190|NCT04380701|588452311|FG023|Overall Study|Withdrawal by Subject|2|||
162931191|NCT04380701|588452312|FG024|Overall Study|Withdrawal by Subject|1|||
162931192|NCT04380701|588452313|FG025|Overall Study|Withdrawal by Subject|1|||
162931193|NCT04380701|588452314|FG026|Overall Study|Withdrawal by Subject|0|||
162931194|NCT04380701|588452315|FG027|Overall Study|Withdrawal by Subject|0|||
162931195|NCT04380701|588452316|FG028|Overall Study|Withdrawal by Subject|0|||
162931196|NCT04380701|588452317|FG029|Overall Study|Withdrawal by Subject|0|||
162931197|NCT04380701|588452318|FG030|Overall Study|Withdrawal by Subject|0|||
162931198|NCT04380701|588452319|FG031|Overall Study|Withdrawal by Subject|0|||
162931199|NCT04380701|588452320|FG032|Overall Study|Withdrawal by Subject|0|||
162931200|NCT04380701|588452321|FG033|Overall Study|Withdrawal by Subject|0|||
162931201|NCT04380701|588452288|FG000|Overall Study|Adverse Event|0|||
162931202|NCT04380701|588452289|FG001|Overall Study|Adverse Event|0|||
162931203|NCT04380701|588452290|FG002|Overall Study|Adverse Event|0|||
162931204|NCT04380701|588452291|FG003|Overall Study|Adverse Event|0|||
162931205|NCT04380701|588452292|FG004|Overall Study|Adverse Event|0|||
162931206|NCT04380701|588452293|FG005|Overall Study|Adverse Event|1|||
162931207|NCT04380701|588452294|FG006|Overall Study|Adverse Event|0|||
162931208|NCT04380701|588452295|FG007|Overall Study|Adverse Event|0|||
162931209|NCT04380701|588452296|FG008|Overall Study|Adverse Event|0|||
162931210|NCT04380701|588452297|FG009|Overall Study|Adverse Event|0|||
162931211|NCT04380701|588452298|FG010|Overall Study|Adverse Event|0|||
162931212|NCT04380701|588452299|FG011|Overall Study|Adverse Event|0|||
162931213|NCT04380701|588452300|FG012|Overall Study|Adverse Event|0|||
162931214|NCT04380701|588452301|FG013|Overall Study|Adverse Event|0|||
162931215|NCT04380701|588452302|FG014|Overall Study|Adverse Event|0|||
162931216|NCT04380701|588452303|FG015|Overall Study|Adverse Event|1|||
162931217|NCT04380701|588452304|FG016|Overall Study|Adverse Event|0|||
162931218|NCT04380701|588452305|FG017|Overall Study|Adverse Event|0|||
162931219|NCT04380701|588452306|FG018|Overall Study|Adverse Event|0|||
162931220|NCT04380701|588452307|FG019|Overall Study|Adverse Event|1|||
162931221|NCT04380701|588452308|FG020|Overall Study|Adverse Event|0|||
162931222|NCT04380701|588452309|FG021|Overall Study|Adverse Event|0|||
162931223|NCT04380701|588452310|FG022|Overall Study|Adverse Event|0|||
162931224|NCT04380701|588452311|FG023|Overall Study|Adverse Event|0|||
162931225|NCT04380701|588452312|FG024|Overall Study|Adverse Event|0|||
162931226|NCT04380701|588452313|FG025|Overall Study|Adverse Event|0|||
162931227|NCT04380701|588452314|FG026|Overall Study|Adverse Event|0|||
162931228|NCT04380701|588452315|FG027|Overall Study|Adverse Event|0|||
162931229|NCT04380701|588452316|FG028|Overall Study|Adverse Event|0|||
162931230|NCT04380701|588452317|FG029|Overall Study|Adverse Event|0|||
162931231|NCT04380701|588452318|FG030|Overall Study|Adverse Event|0|||
162931232|NCT04380701|588452319|FG031|Overall Study|Adverse Event|0|||
162931233|NCT04380701|588452320|FG032|Overall Study|Adverse Event|0|||
162931234|NCT04380701|588452321|FG033|Overall Study|Adverse Event|0|||
162931235|NCT04380701|588452288|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
162931236|NCT04380701|588452289|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
162931237|NCT04380701|588452290|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
162931238|NCT04380701|588452291|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
162931239|NCT04380701|588452292|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
162931240|NCT04380701|588452293|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
162931241|NCT04380701|588452294|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
162931242|NCT04380701|588452295|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
162931243|NCT04380701|588452296|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
162931244|NCT04380701|588452297|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
162931245|NCT04380701|588452298|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
162931246|NCT04380701|588452299|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
162931247|NCT04380701|588452300|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
162931248|NCT04380701|588452301|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
162931249|NCT04380701|588452302|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
162931250|NCT04380701|588452303|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
162931251|NCT04380701|588452304|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
162931252|NCT04380701|588452305|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
162931253|NCT04380701|588452306|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
162931254|NCT04380701|588452307|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
162931255|NCT04380701|588452308|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
162931256|NCT04380701|588452309|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
163279417|NCT04955626|589731476|FG007|Open-Label Period|Lost to Follow-up|0|||
163279418|NCT04955626|589731477|FG008|Open-Label Period|Lost to Follow-up|0|||
162931257|NCT04380701|588452310|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
162931258|NCT04380701|588452311|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
162931259|NCT04380701|588452312|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
162931260|NCT04380701|588452313|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
162931261|NCT04380701|588452314|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
162931262|NCT04380701|588452315|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
162931263|NCT04380701|588452316|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
162931264|NCT04380701|588452317|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
162931265|NCT04380701|588452318|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
162931266|NCT04380701|588452319|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
162931267|NCT04380701|588452320|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
162931268|NCT04380701|588452321|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
162931269|NCT04380701|588452288|FG000|Overall Study|Physician Decision|0|||
162931270|NCT04380701|588452289|FG001|Overall Study|Physician Decision|0|||
162931271|NCT04380701|588452290|FG002|Overall Study|Physician Decision|0|||
162931272|NCT04380701|588452291|FG003|Overall Study|Physician Decision|0|||
163173207|NCT01238588|589349852|FG000|Overall Study|Withdrawal by Subject|1|||
163173208|NCT01238588|589349852|FG000|Overall Study|Physician Decision|2|||
163279419|NCT04955626|589731478|FG009|Open-Label Period|Lost to Follow-up|0|||
163279420|NCT04955626|589731479|FG010|Open-Label Period|Lost to Follow-up|0|||
163279421|NCT04955626|589731480|FG011|Open-Label Period|Lost to Follow-up|0|||
163279422|NCT04955626|589731481|FG012|Open-Label Period|Lost to Follow-up|0|||
163279423|NCT04955626|589731482|FG013|Open-Label Period|Lost to Follow-up|0|||
163279424|NCT04955626|589731483|FG014|Open-Label Period|Lost to Follow-up|0|||
163279425|NCT04955626|589731484|FG015|Open-Label Period|Lost to Follow-up|0|||
163279426|NCT04955626|589731485|FG016|Open-Label Period|Lost to Follow-up|0|||
163279427|NCT04955626|589731486|FG017|Open-Label Period|Lost to Follow-up|0|||
163279428|NCT04955626|589731487|FG018|Open-Label Period|Lost to Follow-up|0|||
163279429|NCT04955626|589731488|FG019|Open-Label Period|Lost to Follow-up|0|||
163279430|NCT04955626|589731489|FG020|Open-Label Period|Lost to Follow-up|0|||
163279431|NCT04955626|589731490|FG021|Open-Label Period|Lost to Follow-up|0|||
163279432|NCT04955626|589731491|FG022|Open-Label Period|Lost to Follow-up|0|||
163279433|NCT04955626|589731492|FG023|Open-Label Period|Lost to Follow-up|0|||
163279434|NCT04955626|589731493|FG024|Open-Label Period|Lost to Follow-up|0|||
163279435|NCT04955626|589731494|FG025|Open-Label Period|Lost to Follow-up|0|||
163279436|NCT04955626|589731495|FG026|Open-Label Period|Lost to Follow-up|0|||
163279437|NCT04955626|589731496|FG027|Open-Label Period|Lost to Follow-up|0|||
163279438|NCT04955626|589731497|FG028|Open-Label Period|Lost to Follow-up|0|||
163279439|NCT04955626|589731498|FG029|Open-Label Period|Lost to Follow-up|0|||
163279440|NCT04955626|589731499|FG030|Open-Label Period|Lost to Follow-up|0|||
163279441|NCT04955626|589731500|FG031|Open-Label Period|Lost to Follow-up|0|||
163279442|NCT04955626|589731501|FG032|Open-Label Period|Lost to Follow-up|0|||
163279443|NCT04955626|589731502|FG033|Open-Label Period|Lost to Follow-up|0|||
163279444|NCT04955626|589731503|FG034|Open-Label Period|Lost to Follow-up|0|||
163279445|NCT04955626|589731504|FG035|Open-Label Period|Lost to Follow-up|0|||
163279446|NCT04955626|589731469|FG000|Open-Label Period|Protocol Violation|377|||
163279447|NCT04955626|589731470|FG001|Open-Label Period|Protocol Violation|48|||
163279448|NCT04955626|589731471|FG002|Open-Label Period|Protocol Violation|0|||
163279449|NCT04955626|589731472|FG003|Open-Label Period|Protocol Violation|0|||
163279450|NCT04955626|589731473|FG004|Open-Label Period|Protocol Violation|0|||
163279451|NCT04955626|589731474|FG005|Open-Label Period|Protocol Violation|0|||
163279452|NCT04955626|589731475|FG006|Open-Label Period|Protocol Violation|0|||
163279453|NCT04955626|589731476|FG007|Open-Label Period|Protocol Violation|0|||
163279454|NCT04955626|589731477|FG008|Open-Label Period|Protocol Violation|0|||
163279455|NCT04955626|589731478|FG009|Open-Label Period|Protocol Violation|0|||
163279456|NCT04955626|589731479|FG010|Open-Label Period|Protocol Violation|0|||
163279457|NCT04955626|589731480|FG011|Open-Label Period|Protocol Violation|0|||
163279458|NCT04955626|589731481|FG012|Open-Label Period|Protocol Violation|0|||
163279459|NCT04955626|589731482|FG013|Open-Label Period|Protocol Violation|0|||
163279460|NCT04955626|589731483|FG014|Open-Label Period|Protocol Violation|0|||
163279461|NCT04955626|589731484|FG015|Open-Label Period|Protocol Violation|0|||
163279462|NCT04955626|589731485|FG016|Open-Label Period|Protocol Violation|0|||
163279463|NCT04955626|589731486|FG017|Open-Label Period|Protocol Violation|0|||
163279464|NCT04955626|589731487|FG018|Open-Label Period|Protocol Violation|0|||
163279465|NCT04955626|589731488|FG019|Open-Label Period|Protocol Violation|0|||
163279466|NCT04955626|589731489|FG020|Open-Label Period|Protocol Violation|0|||
163279467|NCT04955626|589731490|FG021|Open-Label Period|Protocol Violation|0|||
163279468|NCT04955626|589731491|FG022|Open-Label Period|Protocol Violation|0|||
163279469|NCT04955626|589731492|FG023|Open-Label Period|Protocol Violation|0|||
163279470|NCT04955626|589731493|FG024|Open-Label Period|Protocol Violation|0|||
163279471|NCT04955626|589731494|FG025|Open-Label Period|Protocol Violation|0|||
163279472|NCT04955626|589731495|FG026|Open-Label Period|Protocol Violation|0|||
163279473|NCT04955626|589731496|FG027|Open-Label Period|Protocol Violation|0|||
163279474|NCT04955626|589731497|FG028|Open-Label Period|Protocol Violation|0|||
163279475|NCT04955626|589731498|FG029|Open-Label Period|Protocol Violation|0|||
163279476|NCT04955626|589731499|FG030|Open-Label Period|Protocol Violation|0|||
163279477|NCT04955626|589731500|FG031|Open-Label Period|Protocol Violation|0|||
163279478|NCT04955626|589731501|FG032|Open-Label Period|Protocol Violation|0|||
163279479|NCT04955626|589731502|FG033|Open-Label Period|Protocol Violation|0|||
163279480|NCT04955626|589731503|FG034|Open-Label Period|Protocol Violation|0|||
163279481|NCT04955626|589731504|FG035|Open-Label Period|Protocol Violation|0|||
163279482|NCT04955626|589731469|FG000|Open-Label Period|Death|5|||
163279483|NCT04955626|589731470|FG001|Open-Label Period|Death|5|||
163279484|NCT04955626|589731471|FG002|Open-Label Period|Death|0|||
163279485|NCT04955626|589731472|FG003|Open-Label Period|Death|0|||
163279486|NCT04955626|589731473|FG004|Open-Label Period|Death|0|||
163279487|NCT04955626|589731474|FG005|Open-Label Period|Death|0|||
163279488|NCT04955626|589731475|FG006|Open-Label Period|Death|0|||
163279489|NCT04955626|589731476|FG007|Open-Label Period|Death|0|||
163279490|NCT04955626|589731477|FG008|Open-Label Period|Death|0|||
163279491|NCT04955626|589731478|FG009|Open-Label Period|Death|0|||
163279492|NCT04955626|589731479|FG010|Open-Label Period|Death|0|||
163279493|NCT04955626|589731480|FG011|Open-Label Period|Death|0|||
163279494|NCT04955626|589731481|FG012|Open-Label Period|Death|0|||
163279495|NCT04955626|589731482|FG013|Open-Label Period|Death|0|||
162931273|NCT04380701|588452292|FG004|Overall Study|Physician Decision|0|||
163279496|NCT04955626|589731483|FG014|Open-Label Period|Death|0|||
163279497|NCT04955626|589731484|FG015|Open-Label Period|Death|0|||
163279498|NCT04955626|589731485|FG016|Open-Label Period|Death|0|||
163279499|NCT04955626|589731486|FG017|Open-Label Period|Death|0|||
163279500|NCT04955626|589731487|FG018|Open-Label Period|Death|0|||
163279501|NCT04955626|589731488|FG019|Open-Label Period|Death|0|||
163279502|NCT04955626|589731489|FG020|Open-Label Period|Death|0|||
163279503|NCT04955626|589731490|FG021|Open-Label Period|Death|0|||
163279504|NCT04955626|589731491|FG022|Open-Label Period|Death|0|||
163279505|NCT04955626|589731492|FG023|Open-Label Period|Death|0|||
163279506|NCT04955626|589731493|FG024|Open-Label Period|Death|0|||
162931274|NCT04380701|588452293|FG005|Overall Study|Physician Decision|0|||
163279507|NCT04955626|589731494|FG025|Open-Label Period|Death|0|||
162931275|NCT04380701|588452294|FG006|Overall Study|Physician Decision|0|||
162931276|NCT04380701|588452295|FG007|Overall Study|Physician Decision|0|||
162931277|NCT04380701|588452296|FG008|Overall Study|Physician Decision|0|||
163173209|NCT05395091|589349853|FG000|Baseline to Month 12|Adverse Event|7|||
163173210|NCT05395091|589349854|FG001|Baseline to Month 12|Adverse Event|2|||
163173211|NCT05395091|589349855|FG002|Baseline to Month 12|Adverse Event|0|||
163173212|NCT05395091|589349853|FG000|Baseline to Month 12|Death|3|||
163173213|NCT05395091|589349854|FG001|Baseline to Month 12|Death|1|||
162931278|NCT04380701|588452297|FG009|Overall Study|Physician Decision|0|||
162931279|NCT04380701|588452298|FG010|Overall Study|Physician Decision|0|||
162931280|NCT04380701|588452299|FG011|Overall Study|Physician Decision|0|||
162931281|NCT04380701|588452300|FG012|Overall Study|Physician Decision|0|||
162931282|NCT04380701|588452301|FG013|Overall Study|Physician Decision|0|||
162931283|NCT04380701|588452302|FG014|Overall Study|Physician Decision|0|||
162931284|NCT04380701|588452303|FG015|Overall Study|Physician Decision|0|||
162931285|NCT04380701|588452304|FG016|Overall Study|Physician Decision|0|||
162931286|NCT04380701|588452305|FG017|Overall Study|Physician Decision|0|||
162931287|NCT04380701|588452306|FG018|Overall Study|Physician Decision|0|||
162931288|NCT04380701|588452307|FG019|Overall Study|Physician Decision|0|||
162931289|NCT04380701|588452308|FG020|Overall Study|Physician Decision|0|||
163279508|NCT04955626|589731495|FG026|Open-Label Period|Death|0|||
162931290|NCT04380701|588452309|FG021|Overall Study|Physician Decision|0|||
163279509|NCT04955626|589731496|FG027|Open-Label Period|Death|0|||
163279510|NCT04955626|589731497|FG028|Open-Label Period|Death|0|||
162931291|NCT04380701|588452310|FG022|Overall Study|Physician Decision|0|||
162931292|NCT04380701|588452311|FG023|Overall Study|Physician Decision|0|||
162931293|NCT04380701|588452312|FG024|Overall Study|Physician Decision|2|||
162931294|NCT04380701|588452313|FG025|Overall Study|Physician Decision|0|||
162931295|NCT04380701|588452314|FG026|Overall Study|Physician Decision|0|||
162931296|NCT04380701|588452315|FG027|Overall Study|Physician Decision|0|||
162931297|NCT04380701|588452316|FG028|Overall Study|Physician Decision|0|||
162931298|NCT04380701|588452317|FG029|Overall Study|Physician Decision|0|||
162931299|NCT04380701|588452318|FG030|Overall Study|Physician Decision|0|||
162931300|NCT04380701|588452319|FG031|Overall Study|Physician Decision|0|||
162931301|NCT04380701|588452320|FG032|Overall Study|Physician Decision|0|||
162931302|NCT04380701|588452321|FG033|Overall Study|Physician Decision|0|||
162931303|NCT04380701|588452288|FG000|Overall Study|Death|0|||
162931304|NCT04380701|588452289|FG001|Overall Study|Death|0|||
162931305|NCT04380701|588452290|FG002|Overall Study|Death|0|||
162931306|NCT04380701|588452291|FG003|Overall Study|Death|0|||
162931307|NCT04380701|588452292|FG004|Overall Study|Death|0|||
162931308|NCT04380701|588452293|FG005|Overall Study|Death|0|||
162931309|NCT04380701|588452294|FG006|Overall Study|Death|0|||
162931310|NCT04380701|588452295|FG007|Overall Study|Death|0|||
162931311|NCT04380701|588452296|FG008|Overall Study|Death|0|||
162931312|NCT04380701|588452297|FG009|Overall Study|Death|0|||
162931313|NCT04380701|588452298|FG010|Overall Study|Death|0|||
162931314|NCT04380701|588452299|FG011|Overall Study|Death|0|||
162931315|NCT04380701|588452300|FG012|Overall Study|Death|0|||
162931316|NCT04380701|588452301|FG013|Overall Study|Death|0|||
162931317|NCT04380701|588452302|FG014|Overall Study|Death|0|||
162931318|NCT04380701|588452303|FG015|Overall Study|Death|0|||
162931319|NCT04380701|588452304|FG016|Overall Study|Death|0|||
162931320|NCT04380701|588452305|FG017|Overall Study|Death|0|||
162931321|NCT04380701|588452306|FG018|Overall Study|Death|0|||
162931322|NCT04380701|588452307|FG019|Overall Study|Death|0|||
162931323|NCT04380701|588452308|FG020|Overall Study|Death|0|||
162931324|NCT04380701|588452309|FG021|Overall Study|Death|0|||
162931325|NCT04380701|588452310|FG022|Overall Study|Death|0|||
162931326|NCT04380701|588452311|FG023|Overall Study|Death|0|||
162931327|NCT04380701|588452312|FG024|Overall Study|Death|1|||
162931328|NCT04380701|588452313|FG025|Overall Study|Death|0|||
162931329|NCT04380701|588452314|FG026|Overall Study|Death|0|||
162931330|NCT04380701|588452315|FG027|Overall Study|Death|0|||
162931331|NCT04380701|588452316|FG028|Overall Study|Death|0|||
162931332|NCT04380701|588452317|FG029|Overall Study|Death|0|||
162931333|NCT04380701|588452318|FG030|Overall Study|Death|0|||
162931334|NCT04380701|588452319|FG031|Overall Study|Death|0|||
162931335|NCT04380701|588452320|FG032|Overall Study|Death|0|||
162931336|NCT04380701|588452321|FG033|Overall Study|Death|0|||
162931337|NCT04380701|588452288|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931338|NCT04380701|588452289|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931339|NCT04380701|588452290|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931340|NCT04380701|588452291|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931341|NCT04380701|588452292|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931342|NCT04380701|588452293|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931343|NCT04380701|588452294|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931344|NCT04380701|588452295|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931345|NCT04380701|588452296|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931346|NCT04380701|588452297|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931347|NCT04380701|588452298|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931348|NCT04380701|588452299|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931349|NCT04380701|588452300|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931350|NCT04380701|588452301|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931351|NCT04380701|588452302|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
163042821|NCT01990768|588863968|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
163042822|NCT01990768|588863969|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
163279511|NCT04955626|589731498|FG029|Open-Label Period|Death|0|||
162931352|NCT04380701|588452303|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931353|NCT04380701|588452304|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931354|NCT04380701|588452305|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931355|NCT04380701|588452306|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931356|NCT04380701|588452307|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931357|NCT04380701|588452308|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931358|NCT04380701|588452309|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
162931359|NCT04380701|588452310|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
162931360|NCT04380701|588452311|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
162931361|NCT04380701|588452312|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
162931362|NCT04380701|588452313|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931363|NCT04380701|588452314|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931364|NCT04380701|588452315|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931365|NCT04380701|588452316|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931366|NCT04380701|588452317|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931367|NCT04380701|588452318|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931368|NCT04380701|588452319|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931369|NCT04380701|588452320|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931370|NCT04380701|588452321|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931371|NCT00065065|588452322|FG000|Overall Study|Adverse Event|3|||
162931372|NCT00065065|588452323|FG001|Overall Study|Adverse Event|2|||
162931373|NCT00065065|588452322|FG000|Overall Study|Withdrawal by Subject|1|||
162931374|NCT00065065|588452323|FG001|Overall Study|Withdrawal by Subject|5|||
162931375|NCT00065065|588452322|FG000|Overall Study|Lack of Efficacy|4|||
162931376|NCT00065065|588452323|FG001|Overall Study|Lack of Efficacy|11|||
162931377|NCT00065065|588452322|FG000|Overall Study|Other|2|||
162931378|NCT00065065|588452323|FG001|Overall Study|Other|2|||
162931379|NCT01050673|588452324|FG000|Overall Study|Physician Decision|4|||
162931380|NCT01050673|588452325|FG001|Overall Study|Physician Decision|5|||
162931381|NCT04363736|588452326|FG000|Overall Study|Withdrawal by Subject|1|||
162931382|NCT04363736|588452327|FG001|Overall Study|Withdrawal by Subject|0|||
162931383|NCT04363736|588452326|FG000|Overall Study|Lost to Follow-up|10|||
162931384|NCT04363736|588452327|FG001|Overall Study|Lost to Follow-up|7|||
162931385|NCT04363736|588452326|FG000|Overall Study|Death|8|||
162931386|NCT04363736|588452327|FG001|Overall Study|Death|6|||
162931387|NCT03797222|588452328|FG000|Overall Study|Withdrawal by Subject|1|||
162931388|NCT02556632|588452335|FG000|Overall Study|Lost to Follow-up|1|||
162931389|NCT02556632|588452336|FG001|Overall Study|Lost to Follow-up|0|||
163173214|NCT05395091|589349855|FG002|Baseline to Month 12|Death|0|||
163173215|NCT05395091|589349853|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
163173216|NCT05395091|589349854|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
163173217|NCT05395091|589349855|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
163173218|NCT05395091|589349853|FG000|Baseline to Month 12|Protocol Violation|2|||
163173219|NCT05395091|589349854|FG001|Baseline to Month 12|Protocol Violation|3|||
163173220|NCT05395091|589349855|FG002|Baseline to Month 12|Protocol Violation|0|||
163173221|NCT05395091|589349853|FG000|Baseline to Month 12|Physician Decision|1|||
163279512|NCT04955626|589731499|FG030|Open-Label Period|Death|0|||
162931390|NCT02556632|588452337|FG002|Overall Study|Lost to Follow-up|0|||
162931391|NCT02556632|588452335|FG000|Overall Study|Disliked Intervention|1|||
162931392|NCT02556632|588452336|FG001|Overall Study|Disliked Intervention|1|||
162931393|NCT02556632|588452337|FG002|Overall Study|Disliked Intervention|1|||
163279513|NCT04955626|589731500|FG031|Open-Label Period|Death|0|||
162931394|NCT02556632|588452335|FG000|Overall Study|No Reason|1|||
163173222|NCT05395091|589349854|FG001|Baseline to Month 12|Physician Decision|0|||
162931395|NCT02556632|588452336|FG001|Overall Study|No Reason|0|||
162931396|NCT02556632|588452337|FG002|Overall Study|No Reason|1|||
162931397|NCT02556632|588452335|FG000|Overall Study|Personal Issues|0|||
162931398|NCT02556632|588452336|FG001|Overall Study|Personal Issues|1|||
162931399|NCT02556632|588452337|FG002|Overall Study|Personal Issues|1|||
162931400|NCT02556632|588452335|FG000|Overall Study|Changed Mind|0|||
162931401|NCT02556632|588452336|FG001|Overall Study|Changed Mind|1|||
162931402|NCT02556632|588452337|FG002|Overall Study|Changed Mind|0|||
162931403|NCT02556632|588452335|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
162931404|NCT02556632|588452336|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
162931405|NCT02556632|588452337|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
162931406|NCT02556632|588452335|FG000|Overall Study|Unrelated Adverse Event|1|||
162931407|NCT02556632|588452336|FG001|Overall Study|Unrelated Adverse Event|0|||
162931408|NCT02556632|588452337|FG002|Overall Study|Unrelated Adverse Event|3|||
162931409|NCT02556632|588452335|FG000|Overall Study|Related Adverse Event|0|||
162931410|NCT02556632|588452336|FG001|Overall Study|Related Adverse Event|1|||
162931411|NCT02556632|588452337|FG002|Overall Study|Related Adverse Event|0|||
162931412|NCT02556632|588452335|FG000|Overall Study|Possibly Related Adverse Event|0|||
162931413|NCT02556632|588452336|FG001|Overall Study|Possibly Related Adverse Event|0|||
162931414|NCT02556632|588452337|FG002|Overall Study|Possibly Related Adverse Event|1|||
162931415|NCT02556632|588452335|FG000|Overall Study|Did Not Start RT|0|||
162931416|NCT02556632|588452336|FG001|Overall Study|Did Not Start RT|1|||
162931417|NCT02556632|588452337|FG002|Overall Study|Did Not Start RT|0|||
162931418|NCT02556632|588452335|FG000|Overall Study|Ineligible|0|||
162931419|NCT02556632|588452336|FG001|Overall Study|Ineligible|1|||
162931420|NCT02556632|588452337|FG002|Overall Study|Ineligible|0|||
162931421|NCT02556632|588452335|FG000|Overall Study|Disliked Study Procedures|0|||
162931422|NCT02556632|588452336|FG001|Overall Study|Disliked Study Procedures|0|||
162931423|NCT02556632|588452337|FG002|Overall Study|Disliked Study Procedures|1|||
162931424|NCT02556632|588452335|FG000|Overall Study|Treatment or Change Delay|0|||
162931425|NCT02556632|588452336|FG001|Overall Study|Treatment or Change Delay|0|||
162931426|NCT02556632|588452337|FG002|Overall Study|Treatment or Change Delay|1|||
162931427|NCT00928135|588452347|FG000|Overall Study|Withdrawal by Subject|1|||
162931428|NCT00928135|588452348|FG001|Overall Study|Withdrawal by Subject|0|||
162931429|NCT04355767|588452349|FG000|Overall Study|Withdrawal by Subject|2|||
162931430|NCT04355767|588452350|FG001|Overall Study|Withdrawal by Subject|2|||
162931431|NCT04355767|588452349|FG000|Overall Study|Death|5|||
162931432|NCT04355767|588452350|FG001|Overall Study|Death|1|||
162931433|NCT01999322|588452351|FG000|Overall Study|Adverse Event|1|||
162931434|NCT01999322|588452352|FG001|Overall Study|Adverse Event|0|||
162931435|NCT00766506|588454220|FG000|Overall Study|Use rescue medication after 3 hours|3|||
162931436|NCT00766506|588454221|FG001|Overall Study|Use rescue medication after 3 hours|0|||
162931437|NCT00766506|588454220|FG000|Overall Study|Other|2|||
162931438|NCT00766506|588454221|FG001|Overall Study|Other|2|||
162931439|NCT03053622|588454222|FG000|Overall Study|Lost to Follow-up|0|||
162931440|NCT03053622|588454223|FG001|Overall Study|Lost to Follow-up|0|||
162931441|NCT03053622|588454224|FG002|Overall Study|Lost to Follow-up|0|||
162931442|NCT03053622|588454225|FG003|Overall Study|Lost to Follow-up|1|||
162931443|NCT01246986|588454226|FG000|Overall Study|Lost to Follow-up|0|||
162931444|NCT01246986|588454227|FG001|Overall Study|Lost to Follow-up|1|||
162931445|NCT01246986|588454228|FG002|Overall Study|Lost to Follow-up|3|||
162931446|NCT01246986|588454229|FG003|Overall Study|Lost to Follow-up|0|||
162931447|NCT01246986|588454230|FG004|Overall Study|Lost to Follow-up|0|||
162931448|NCT01246986|588454231|FG005|Overall Study|Lost to Follow-up|1|||
162931449|NCT01246986|588454232|FG006|Overall Study|Lost to Follow-up|0|||
162931450|NCT01246986|588454226|FG000|Overall Study|Withdrawal by Subject|3|||
162931451|NCT01246986|588454227|FG001|Overall Study|Withdrawal by Subject|4|||
162931452|NCT01246986|588454228|FG002|Overall Study|Withdrawal by Subject|3|||
162931453|NCT01246986|588454229|FG003|Overall Study|Withdrawal by Subject|0|||
162931454|NCT01246986|588454230|FG004|Overall Study|Withdrawal by Subject|4|||
162931455|NCT01246986|588454231|FG005|Overall Study|Withdrawal by Subject|0|||
162931456|NCT01246986|588454232|FG006|Overall Study|Withdrawal by Subject|0|||
162931457|NCT01440647|588454237|FG000|Overall Study|Death|2|||
162931458|NCT01440647|588454238|FG001|Overall Study|Death|3|||
162931459|NCT01406873|588454252|FG000|Overall Study|Withdrawal by Subject|1|||
162931460|NCT01406873|588454253|FG001|Overall Study|Withdrawal by Subject|1|||
162931461|NCT03990389|588454254|FG000|Overall Study|Lost to Follow-up|3|||
162931462|NCT03990389|588454255|FG001|Overall Study|Lost to Follow-up|0|||
162931463|NCT00207714|588454256|FG000|Overall Study|Adverse Event|6|||
162931464|NCT00207714|588454257|FG001|Overall Study|Adverse Event|2|||
162931465|NCT00207714|588454258|FG002|Overall Study|Adverse Event|4|||
162931466|NCT00207714|588454259|FG003|Overall Study|Adverse Event|3|||
162931467|NCT00207714|588454260|FG004|Overall Study|Adverse Event|1|||
162931468|NCT00207714|588454256|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
162931469|NCT00207714|588454257|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
162931470|NCT00207714|588454258|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
162931471|NCT00207714|588454259|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
162931472|NCT00207714|588454260|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
162931473|NCT00207714|588454256|FG000|Overall Study|Other|3|||
162931474|NCT00207714|588454257|FG001|Overall Study|Other|2|||
162931475|NCT00207714|588454258|FG002|Overall Study|Other|5|||
162931476|NCT00207714|588454259|FG003|Overall Study|Other|1|||
162931477|NCT00207714|588454260|FG004|Overall Study|Other|0|||
162931478|NCT02595528|588454261|FG000|Overall Study|Withdrawal by Subject|1|||
162931479|NCT02595528|588454262|FG001|Overall Study|Withdrawal by Subject|2|||
162931480|NCT02595528|588454263|FG002|Overall Study|Withdrawal by Subject|1|||
162931481|NCT02595528|588454264|FG003|Overall Study|Withdrawal by Subject|3|||
162931482|NCT02595528|588454261|FG000|Overall Study|Lost to Follow-up|1|||
162931483|NCT02595528|588454262|FG001|Overall Study|Lost to Follow-up|1|||
162931484|NCT02595528|588454263|FG002|Overall Study|Lost to Follow-up|0|||
162931485|NCT02595528|588454264|FG003|Overall Study|Lost to Follow-up|1|||
162931486|NCT03202511|588454265|FG000|Overall Study|Withdrawal by Subject|1|||
162931487|NCT03202511|588454266|FG001|Overall Study|Withdrawal by Subject|0|||
162931488|NCT00686790|588454267|FG000|Overall Study|Adverse Event|2|||
162931489|NCT00686790|588454267|FG000|Overall Study|Withdrawal by Subject|1|||
162931490|NCT00686790|588454267|FG000|Overall Study|Death|1|||
162931491|NCT00686790|588454267|FG000|Overall Study|Lost to Follow-up|12|||
162931492|NCT03862625|588454270|FG000|Overall Study|Lost to Follow-up|0|||
162931493|NCT03862625|588454271|FG001|Overall Study|Lost to Follow-up|1|||
162931494|NCT02082912|588454272|FG000|Overall Study|Physician Decision|0|||
162931495|NCT02082912|588454273|FG001|Overall Study|Physician Decision|1|||
162931496|NCT02614703|588454274|FG000|Overall Study|Withdrawal by Subject|7|||
162931497|NCT02614703|588454275|FG001|Overall Study|Withdrawal by Subject|1|||
162931498|NCT00782275|588454285|FG000|Overall Study|Adverse Event|11|||
162931499|NCT00782275|588454285|FG000|Overall Study|Withdrawal by Subject|1|||
162931500|NCT00782275|588454285|FG000|Overall Study|Progressive Disease|21|||
162931501|NCT00782275|588454285|FG000|Overall Study|Physician Decision|4|||
162931502|NCT00782275|588454285|FG000|Overall Study|Not started treatment|1|||
162931503|NCT00782275|588454285|FG000|Overall Study|Other|3|||
162931504|NCT04378010|588454286|FG000|Overall Study|Adverse Event|8|||
162931505|NCT04378010|588454287|FG001|Overall Study|Adverse Event|14|||
162931506|NCT04378010|588454288|FG002|Overall Study|Adverse Event|4|||
162931507|NCT04378010|588454286|FG000|Overall Study|Withdrawal by Subject|0|||
162931508|NCT04378010|588454287|FG001|Overall Study|Withdrawal by Subject|2|||
162931509|NCT04378010|588454288|FG002|Overall Study|Withdrawal by Subject|1|||
162931510|NCT04378010|588454286|FG000|Overall Study|Protocol Violation|2|||
162931511|NCT04378010|588454287|FG001|Overall Study|Protocol Violation|1|||
162931512|NCT04378010|588454288|FG002|Overall Study|Protocol Violation|4|||
162931513|NCT04378010|588454286|FG000|Overall Study|Study terminated by Sponsor|22|||
162931514|NCT04378010|588454287|FG001|Overall Study|Study terminated by Sponsor|16|||
162931515|NCT04378010|588454288|FG002|Overall Study|Study terminated by Sponsor|22|||
162931516|NCT04378010|588454286|FG000|Overall Study|Subject inability to complete study visit|0|||
162931517|NCT04378010|588454287|FG001|Overall Study|Subject inability to complete study visit|0|||
162931518|NCT04378010|588454288|FG002|Overall Study|Subject inability to complete study visit|1|||
162931519|NCT04378010|588454286|FG000|Overall Study|Subject never dosed|0|||
162931520|NCT04378010|588454287|FG001|Overall Study|Subject never dosed|1|||
162931521|NCT04378010|588454288|FG002|Overall Study|Subject never dosed|0|||
162931522|NCT01792284|588454289|FG000|Lead-in Period|Adverse Event|15|||
162931523|NCT01792284|588454290|FG001|Lead-in Period|Adverse Event|0|||
162931524|NCT01792284|588454291|FG002|Lead-in Period|Adverse Event|0|||
162931525|NCT01792284|588454289|FG000|Lead-in Period|Lost to Follow-up|2|||
162931526|NCT01792284|588454290|FG001|Lead-in Period|Lost to Follow-up|0|||
162931527|NCT01792284|588454291|FG002|Lead-in Period|Lost to Follow-up|0|||
162931528|NCT01792284|588454289|FG000|Lead-in Period|Protocol Violation|1|||
162931529|NCT01792284|588454290|FG001|Lead-in Period|Protocol Violation|0|||
162931530|NCT01792284|588454291|FG002|Lead-in Period|Protocol Violation|0|||
162931531|NCT01792284|588454289|FG000|Lead-in Period|Withdrawal by Subject|10|||
162931532|NCT01792284|588454290|FG001|Lead-in Period|Withdrawal by Subject|0|||
162931533|NCT01792284|588454291|FG002|Lead-in Period|Withdrawal by Subject|0|||
163279514|NCT04955626|589731501|FG032|Open-Label Period|Death|0|||
162931534|NCT01792284|588454289|FG000|Lead-in Period|Physician Decision|1|||
162931535|NCT01792284|588454290|FG001|Lead-in Period|Physician Decision|0|||
162931536|NCT01792284|588454291|FG002|Lead-in Period|Physician Decision|0|||
162931537|NCT01792284|588454289|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
162931538|NCT01792284|588454290|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
162931539|NCT01792284|588454291|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
162931540|NCT01792284|588454289|FG000|Randomization Period 1|Withdrawal by Subject|0|||
162931541|NCT01792284|588454290|FG001|Randomization Period 1|Withdrawal by Subject|1|||
162931542|NCT01792284|588454291|FG002|Randomization Period 1|Withdrawal by Subject|1|||
162931543|NCT01792284|588454289|FG000|Randomization Period 1|Physician Decision|0|||
162931544|NCT01792284|588454290|FG001|Randomization Period 1|Physician Decision|1|||
162931545|NCT01792284|588454291|FG002|Randomization Period 1|Physician Decision|1|||
162931546|NCT01792284|588454289|FG000|Randomization Period 1|Adverse Event|0|||
162931547|NCT01792284|588454290|FG001|Randomization Period 1|Adverse Event|0|||
162931548|NCT01792284|588454291|FG002|Randomization Period 1|Adverse Event|2|||
162931549|NCT01792284|588454289|FG000|Randomization Period 1|Lost to Follow-up|0|||
163173223|NCT05395091|589349855|FG002|Baseline to Month 12|Physician Decision|0|||
163173224|NCT05395091|589349853|FG000|Month 12 to Month 18|Death|1|||
163173225|NCT05395091|589349854|FG001|Month 12 to Month 18|Death|0|||
163173226|NCT05395091|589349855|FG002|Month 12 to Month 18|Death|0|||
163173227|NCT05395091|589349853|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
163173228|NCT05395091|589349854|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
163173229|NCT05395091|589349855|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
163173230|NCT05395091|589349853|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
163173231|NCT05395091|589349854|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
163173232|NCT05395091|589349855|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
163173233|NCT05395091|589349853|FG000|Month 12 to Month 18|Other reasons|0|||
163173234|NCT05395091|589349854|FG001|Month 12 to Month 18|Other reasons|0|||
163173235|NCT05395091|589349855|FG002|Month 12 to Month 18|Other reasons|1|||
163173236|NCT01915303|589349862|FG000|Core Phase|Adverse Event|7|||
163173237|NCT01915303|589349862|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
163173238|NCT01915303|589349862|FG000|Core Phase|Death|2|||
163173239|NCT01915303|589349862|FG000|Core Phase|Protocol Violation|2|||
163173240|NCT01915303|589349862|FG000|Core Phase|Abnormal lab value|1|||
163173241|NCT01915303|589349862|FG000|Core Phase|Withdrawal by Subject|1|||
163173242|NCT01915303|589349862|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
163173243|NCT01915303|589349862|FG000|Extension Phase|Withdrawal by Subject|4|||
163173244|NCT01915303|589349862|FG000|Extension Phase|Adverse Event|3|||
163173245|NCT01915303|589349862|FG000|Extension Phase|Death|1|||
163173246|NCT01915303|589349862|FG000|Extension Phase|Protocol Violation|1|||
163173247|NCT02509117|589349864|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173248|NCT02509117|589349865|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
163173249|NCT02509117|589349866|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173250|NCT02509117|589349867|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173251|NCT02509117|589349868|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173252|NCT02509117|589349869|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173253|NCT02509117|589349870|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173254|NCT02509117|589349871|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173255|NCT02509117|589349872|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173256|NCT02509117|589349873|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173257|NCT02509117|589349864|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
162931550|NCT01792284|588454290|FG001|Randomization Period 1|Lost to Follow-up|0|||
162931551|NCT01792284|588454291|FG002|Randomization Period 1|Lost to Follow-up|1|||
162931552|NCT01792284|588454289|FG000|Randomization Period 2|Protocol Violation|0|||
162931553|NCT01792284|588454290|FG001|Randomization Period 2|Protocol Violation|1|||
162931554|NCT01792284|588454291|FG002|Randomization Period 2|Protocol Violation|0|||
162931555|NCT01792284|588454289|FG000|Randomization Period 2|Withdrawal by Subject|0|||
162931556|NCT01792284|588454290|FG001|Randomization Period 2|Withdrawal by Subject|2|||
162931557|NCT01792284|588454291|FG002|Randomization Period 2|Withdrawal by Subject|0|||
162931558|NCT02019979|588454292|FG000|Overall Study|study terminated|14|||
162931559|NCT00379587|588454294|FG000|Overall Study|Lost to Follow-up|2|||
162931560|NCT03237611|588454295|FG000|Overall Study|Withdrawal by Subject|1|||
162931561|NCT03237611|588454295|FG000|Overall Study|Ineligible|1|||
162931562|NCT01169649|588454300|FG000|Overall Study|Patient Not Treated|3|||
162931563|NCT00534092|588454301|FG000|Overall Study|Lost to Follow-up|1|||
162931564|NCT00534092|588454302|FG001|Overall Study|Lost to Follow-up|0|||
162931565|NCT00534092|588454301|FG000|Overall Study|personal reasons/family concerns|1|||
162931566|NCT00534092|588454302|FG001|Overall Study|personal reasons/family concerns|0|||
162931567|NCT02919475|588454303|FG000|Overall Study|Adverse Event|3|||
162931568|NCT02919475|588454304|FG001|Overall Study|Adverse Event|3|||
162931569|NCT02919475|588454305|FG002|Overall Study|Adverse Event|3|||
162931570|NCT02919475|588454306|FG003|Overall Study|Adverse Event|9|||
162931571|NCT02919475|588454307|FG004|Overall Study|Adverse Event|2|||
162931572|NCT02919475|588454303|FG000|Overall Study|Death|0|||
162931573|NCT02919475|588454304|FG001|Overall Study|Death|1|||
162931574|NCT02919475|588454305|FG002|Overall Study|Death|0|||
162931575|NCT02919475|588454306|FG003|Overall Study|Death|0|||
162931576|NCT02919475|588454307|FG004|Overall Study|Death|0|||
162931577|NCT02919475|588454303|FG000|Overall Study|Lost to Follow-up|0|||
162931578|NCT02919475|588454304|FG001|Overall Study|Lost to Follow-up|0|||
162931579|NCT02919475|588454305|FG002|Overall Study|Lost to Follow-up|0|||
162931580|NCT02919475|588454306|FG003|Overall Study|Lost to Follow-up|1|||
162931581|NCT02919475|588454307|FG004|Overall Study|Lost to Follow-up|0|||
162931582|NCT02919475|588454303|FG000|Overall Study|Withdrawal by Subject|2|||
162931583|NCT02919475|588454304|FG001|Overall Study|Withdrawal by Subject|3|||
162931584|NCT02919475|588454305|FG002|Overall Study|Withdrawal by Subject|1|||
162931585|NCT02919475|588454306|FG003|Overall Study|Withdrawal by Subject|2|||
162931586|NCT02919475|588454307|FG004|Overall Study|Withdrawal by Subject|2|||
162931587|NCT02919475|588454303|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
162931588|NCT02919475|588454304|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
162931589|NCT02919475|588454305|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
162931590|NCT02919475|588454306|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
162931591|NCT02919475|588454307|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162931592|NCT00275028|588454310|FG000|Overall Study|Withdrew consent before treatment began|1|||
162931593|NCT00275028|588454310|FG000|Overall Study|Withdrawal by Subject|5|||
162931594|NCT00275028|588454310|FG000|Overall Study|Adverse Event|9|||
162931595|NCT00275028|588454310|FG000|Overall Study|Progressive Disease|30|||
162931596|NCT00275028|588454310|FG000|Overall Study|Physician Decision|2|||
162931597|NCT02323295|588454316|FG000|Overall Study|Adverse Event|0|||
162931598|NCT02323295|588454317|FG001|Overall Study|Adverse Event|1|||
162931599|NCT02323295|588454316|FG000|Overall Study|Withdrawal by Subject|0|||
162931600|NCT02323295|588454317|FG001|Overall Study|Withdrawal by Subject|1|||
162931601|NCT02323295|588454316|FG000|Overall Study|Patient did not have surgery as planned.|0|||
162931602|NCT02323295|588454317|FG001|Overall Study|Patient did not have surgery as planned.|1|||
162931603|NCT02370784|588454320|FG000|Overall Study|Patient started prohibited medication|0|||
162931604|NCT02370784|588454321|FG001|Overall Study|Patient started prohibited medication|1|||
162931605|NCT04356573|588454325|FG000|Overall Study|Didn't Qualify|1|||
162931606|NCT04356573|588454326|FG001|Overall Study|Didn't Qualify|0|||
162931607|NCT01244815|588454329|FG000|Overall Study|Not Treated|0|||
162931608|NCT01244815|588454330|FG001|Overall Study|Not Treated|1|||
163279515|NCT04955626|589731502|FG033|Open-Label Period|Death|0|||
162931609|NCT01244815|588454331|FG002|Overall Study|Not Treated|0|||
162931610|NCT01244815|588454332|FG003|Overall Study|Not Treated|0|||
162931611|NCT01244815|588454329|FG000|Overall Study|Adverse Event|4|||
162931612|NCT01244815|588454330|FG001|Overall Study|Adverse Event|7|||
162931613|NCT01244815|588454331|FG002|Overall Study|Adverse Event|5|||
162931614|NCT01244815|588454332|FG003|Overall Study|Adverse Event|5|||
162931615|NCT01244815|588454329|FG000|Overall Study|Treatment Failure|0|||
162931616|NCT01244815|588454330|FG001|Overall Study|Treatment Failure|0|||
162931617|NCT01244815|588454331|FG002|Overall Study|Treatment Failure|0|||
162931618|NCT01244815|588454332|FG003|Overall Study|Treatment Failure|1|||
162931619|NCT01244815|588454329|FG000|Overall Study|Lost to Follow-up|3|||
162931620|NCT01244815|588454330|FG001|Overall Study|Lost to Follow-up|2|||
162931621|NCT01244815|588454331|FG002|Overall Study|Lost to Follow-up|3|||
162931622|NCT01244815|588454332|FG003|Overall Study|Lost to Follow-up|2|||
162931623|NCT01244815|588454329|FG000|Overall Study|Withdrawal by Subject|0|||
162931624|NCT01244815|588454330|FG001|Overall Study|Withdrawal by Subject|2|||
162931625|NCT01244815|588454331|FG002|Overall Study|Withdrawal by Subject|0|||
163279516|NCT04955626|589731503|FG034|Open-Label Period|Death|0|||
162931626|NCT01244815|588454332|FG003|Overall Study|Withdrawal by Subject|3|||
162931627|NCT01244815|588454329|FG000|Overall Study|Protocol Violation|7|||
162931628|NCT01244815|588454330|FG001|Overall Study|Protocol Violation|4|||
162931629|NCT01244815|588454331|FG002|Overall Study|Protocol Violation|3|||
162931630|NCT01244815|588454332|FG003|Overall Study|Protocol Violation|1|||
162931631|NCT01244815|588454329|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
162931632|NCT01244815|588454330|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
162931633|NCT01244815|588454331|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
162931634|NCT01244815|588454332|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
162931635|NCT02041494|588454334|FG000|Overall Study|Death|1|||
162931636|NCT02041494|588454335|FG001|Overall Study|Death|3|||
162931637|NCT02041494|588454334|FG000|Overall Study|Lost to Follow-up|2|||
162931638|NCT02041494|588454335|FG001|Overall Study|Lost to Follow-up|6|||
162931639|NCT02041494|588454334|FG000|Overall Study|study terminated|16|||
162931640|NCT02041494|588454335|FG001|Overall Study|study terminated|11|||
162931641|NCT02487979|588454340|FG000|Overall Study|Physician Decision|2|||
162931642|NCT02487979|588454340|FG000|Overall Study|Withdrawal by Subject|2|||
162931643|NCT02487979|588454340|FG000|Overall Study|Progressive Disease|17|||
162931644|NCT02410837|588454341|FG000|Overall Study|Death|387|||
162931645|NCT02410837|588454341|FG000|Overall Study|Lost to Follow-up|50|||
162931646|NCT02410837|588454341|FG000|Overall Study|Withdrawal by Subject|44|||
162931647|NCT02410837|588454341|FG000|Overall Study|Physician Decision|6|||
162931648|NCT02410837|588454341|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
162931649|NCT00849524|588454348|FG000|Overall Study|Lack of Efficacy|3|||
162931650|NCT01825876|588454351|FG000|Period 2|Withdrawal by Subject|0|||
162931651|NCT01825876|588454352|FG001|Period 2|Withdrawal by Subject|1|||
162931652|NCT01027884|588454356|FG000|Overall Study|Adverse Event|2|||
162931653|NCT01027884|588454357|FG001|Overall Study|Adverse Event|1|||
162931654|NCT01027884|588454356|FG000|Overall Study|Protocol Violation|1|||
162931655|NCT01027884|588454357|FG001|Overall Study|Protocol Violation|0|||
162931656|NCT01027884|588454356|FG000|Overall Study|Non-compliance|1|||
162931657|NCT01027884|588454357|FG001|Overall Study|Non-compliance|1|||
162931658|NCT01027884|588454356|FG000|Overall Study|Withdrawal by Subject|0|||
162931659|NCT01027884|588454357|FG001|Overall Study|Withdrawal by Subject|1|||
162931660|NCT01027884|588454356|FG000|Overall Study|Lost to Follow-up|0|||
162931661|NCT01027884|588454357|FG001|Overall Study|Lost to Follow-up|1|||
162931662|NCT01027884|588454356|FG000|Overall Study|Spinal fixation surgery|0|||
162931663|NCT01027884|588454357|FG001|Overall Study|Spinal fixation surgery|3|||
162931664|NCT03670537|588454359|FG000|Overall Study|Protocol Violation|1|||
162931665|NCT03636542|588454360|FG000|Overall Study|Lost to Follow-up|1|||
162931666|NCT03636542|588454361|FG001|Overall Study|Lost to Follow-up|1|||
162931667|NCT03636542|588454360|FG000|Overall Study|Physician Decision|0|||
162931668|NCT03636542|588454361|FG001|Overall Study|Physician Decision|1|||
163279517|NCT04955626|589731504|FG035|Open-Label Period|Death|0|||
163279518|NCT04955626|589731469|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
163279519|NCT04955626|589731470|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
163279520|NCT04955626|589731471|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
163279521|NCT04955626|589731472|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
163279522|NCT04955626|589731473|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
163279523|NCT04955626|589731474|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
163279524|NCT04955626|589731475|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
163279525|NCT04955626|589731476|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
163279526|NCT04955626|589731477|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
163279527|NCT04955626|589731478|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
163279528|NCT04955626|589731479|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
163279529|NCT04955626|589731480|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
163279530|NCT04955626|589731481|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
163279531|NCT04955626|589731482|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
163279532|NCT04955626|589731483|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
163279533|NCT04955626|589731484|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
163279534|NCT04955626|589731485|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
163279535|NCT04955626|589731486|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
162931669|NCT03636542|588454360|FG000|Overall Study|Withdrawal by Subject|1|||
162931670|NCT03636542|588454361|FG001|Overall Study|Withdrawal by Subject|0|||
163279536|NCT04955626|589731487|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
162931671|NCT02059187|588454364|FG000|Overall Study|Adverse Event|0|||
162931672|NCT02059187|588454365|FG001|Overall Study|Adverse Event|3|||
162931673|NCT02059187|588454364|FG000|Overall Study|Death|1|||
162931674|NCT02059187|588454365|FG001|Overall Study|Death|1|||
162931675|NCT02059187|588454364|FG000|Overall Study|Lost to Follow-up|9|||
162931676|NCT02059187|588454365|FG001|Overall Study|Lost to Follow-up|8|||
162931677|NCT02059187|588454364|FG000|Overall Study|Non-compliance with study drug|1|||
162931678|NCT02059187|588454365|FG001|Overall Study|Non-compliance with study drug|0|||
162931679|NCT02059187|588454364|FG000|Overall Study|Physician Decision|1|||
162931680|NCT02059187|588454365|FG001|Overall Study|Physician Decision|2|||
162931681|NCT02059187|588454364|FG000|Overall Study|Protocol Violation|1|||
162931682|NCT02059187|588454365|FG001|Overall Study|Protocol Violation|0|||
162931683|NCT02059187|588454364|FG000|Overall Study|Withdrawal by Subject|12|||
162931684|NCT02059187|588454365|FG001|Overall Study|Withdrawal by Subject|8|||
162931685|NCT03751020|588454366|FG000|Overall Study|Withdrawal by Subject|2|||
162931686|NCT03751020|588454367|FG001|Overall Study|Withdrawal by Subject|0|||
162931687|NCT03751020|588454368|FG002|Overall Study|Withdrawal by Subject|0|||
162931688|NCT03751020|588454366|FG000|Overall Study|Lost to Follow-up|7|||
162931689|NCT03751020|588454367|FG001|Overall Study|Lost to Follow-up|4|||
162931690|NCT03751020|588454368|FG002|Overall Study|Lost to Follow-up|10|||
162931691|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
162931692|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
162931693|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
162931694|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
162931695|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
162931696|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
162931697|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
162931698|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
162931699|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
162931700|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
162931701|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
162931702|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
162931703|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
162931704|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
162931705|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
162931706|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
162931707|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
162931708|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
162931709|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
162931710|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
162931711|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
162931712|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
162931713|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
162931714|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
162931715|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
162931716|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
162931717|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
162931718|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
162931719|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
162931720|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
162931721|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
162931722|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
162931723|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
162931724|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
162931725|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
162931726|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
162931727|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
162931728|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
162931729|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
162931730|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
162931731|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
162931732|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
162931733|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
162931734|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
162931735|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
163173258|NCT02509117|589349865|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173259|NCT02509117|589349866|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173260|NCT02509117|589349867|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173261|NCT02509117|589349868|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173262|NCT02509117|589349869|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173263|NCT02509117|589349870|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173264|NCT02509117|589349871|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173265|NCT02509117|589349872|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173266|NCT02509117|589349873|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
163173267|NCT02509117|589349864|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173268|NCT02509117|589349865|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173269|NCT02509117|589349866|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173270|NCT02509117|589349867|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173271|NCT02509117|589349868|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173272|NCT02509117|589349869|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173273|NCT02509117|589349870|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173274|NCT02509117|589349871|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173275|NCT02509117|589349872|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173276|NCT02509117|589349873|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
163173277|NCT00832624|589349874|FG000|Overall Study|Study Terminated|10|||
163173278|NCT00548184|589349877|FG000|Overall Study|Adverse Event|3|||
163173279|NCT00548184|589349877|FG000|Overall Study|took other drug|1|||
163173280|NCT00548184|589349877|FG000|Overall Study|Found Her2 negative|1|||
163173281|NCT00280748|589349884|FG000|Overall Study|Decline in performance|3|||
163173282|NCT00280748|589349884|FG000|Overall Study|Extra-cranial disease progression|1|||
163173283|NCT01433250|589349885|FG000|Overall Study|Protocol Violation|0|||
163173284|NCT01433250|589349886|FG001|Overall Study|Protocol Violation|1|||
163173285|NCT01433250|589349885|FG000|Overall Study|Withdrawal by Subject|3|||
163173286|NCT01433250|589349886|FG001|Overall Study|Withdrawal by Subject|2|||
163173287|NCT00796523|589349889|FG000|Overall Study|Lost to Follow-up|9|||
163173288|NCT00796523|589349890|FG001|Overall Study|Lost to Follow-up|7|||
163173289|NCT03288142|589349893|FG000|Overall Study|Lost to Follow-up|22|||
163173290|NCT03288142|589349894|FG001|Overall Study|Lost to Follow-up|15|||
163173291|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
163173292|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
163173293|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
163173294|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
163173295|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
163173296|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
163173297|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
163173298|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
163173299|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
163173300|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
163279537|NCT04955626|589731488|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
162931736|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
162931737|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
163173301|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
162931738|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
162931739|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
162931740|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
162931741|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
162931742|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
162931743|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
162931744|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
162931745|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
162931746|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
162931747|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
162931748|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
162931749|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
162931750|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
163173302|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
163173303|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
163173304|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
163173305|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
163173306|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
163173307|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
163173308|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
163173309|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
163173310|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
163173311|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
163173312|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
163173313|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
163173314|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
163173315|NCT01227824|589349895|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
163173316|NCT01227824|589349896|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
163173317|NCT01227824|589349897|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
163173318|NCT01227824|589349895|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
163173319|NCT01227824|589349896|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
163173320|NCT01227824|589349897|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
163173321|NCT01227824|589349895|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
163173322|NCT01227824|589349896|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
163173323|NCT01227824|589349897|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
163173324|NCT01227824|589349895|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
163173325|NCT01227824|589349896|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
163173326|NCT01227824|589349897|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
163173327|NCT01227824|589349895|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
163173328|NCT01227824|589349896|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
163173329|NCT01227824|589349897|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
163173330|NCT01227824|589349895|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
163173331|NCT01227824|589349896|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
163173332|NCT01227824|589349897|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
163173333|NCT01227824|589349895|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
163173334|NCT01227824|589349896|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
163173335|NCT01227824|589349897|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
163173336|NCT02576145|589349898|FG000|Overall Study|Adverse Event|1|||
163173337|NCT02576145|589349899|FG001|Overall Study|Adverse Event|0|||
163173338|NCT02576145|589349898|FG000|Overall Study|Withdrawal by Subject|1|||
163173339|NCT02576145|589349899|FG001|Overall Study|Withdrawal by Subject|0|||
163173340|NCT02576145|589349898|FG000|Overall Study|Acute rejection|1|||
163173341|NCT02576145|589349899|FG001|Overall Study|Acute rejection|0|||
163173342|NCT02576145|589349898|FG000|Overall Study|Tetanus Titers Decreased|0|||
163173343|NCT02576145|589349899|FG001|Overall Study|Tetanus Titers Decreased|1|||
163173344|NCT00384111|589349905|FG000|Overall Study|Disease Progression|3|||
163173345|NCT00384111|589349905|FG000|Overall Study|Adverse Event|1|||
163173346|NCT00384111|589349905|FG000|Overall Study|Investigator Decision|3|||
163173347|NCT00384111|589349905|FG000|Overall Study|Study Terminated by the Sponsor|19|||
163173348|NCT00821509|589349906|FG000|Overall Study|Withdrawal by Subject|12|||
162931751|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
162931752|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
162931753|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
163173349|NCT00821509|589349907|FG001|Overall Study|Withdrawal by Subject|11|||
163173350|NCT00821509|589349908|FG002|Overall Study|Withdrawal by Subject|34|||
163279538|NCT04955626|589731489|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
163279539|NCT04955626|589731490|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
162931754|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
162931755|NCT01159769|588454373|FG000|Overall Study|Adverse Event|1|||
162931756|NCT02555618|588454374|FG000|Overall Study|Sponsor's Circumstances|1|||
162931757|NCT02555618|588454375|FG001|Overall Study|Sponsor's Circumstances|0|||
162931758|NCT02217345|588454376|FG000|Overall Study|Lost to Follow-up|2|||
162931759|NCT02217345|588454377|FG001|Overall Study|Lost to Follow-up|1|||
162931760|NCT02217345|588454376|FG000|Overall Study|Withdrawal by Subject|3|||
162931761|NCT02217345|588454377|FG001|Overall Study|Withdrawal by Subject|2|||
162931762|NCT02217345|588454376|FG000|Overall Study|Adverse Event|2|||
162931763|NCT02217345|588454377|FG001|Overall Study|Adverse Event|1|||
162931764|NCT02217345|588454376|FG000|Overall Study|Physician Decision|0|||
162931765|NCT02217345|588454377|FG001|Overall Study|Physician Decision|1|||
162931766|NCT00845026|588454378|FG000|Study Period III|Adverse Event|23|||
162931767|NCT00845026|588454379|FG001|Study Period III|Adverse Event|19|||
162931768|NCT00845026|588454378|FG000|Study Period III|Perceived lack of efficacy|27|||
162931769|NCT00845026|588454379|FG001|Study Period III|Perceived lack of efficacy|15|||
162931770|NCT00845026|588454378|FG000|Study Period III|Withdrawal by Subject|19|||
162931771|NCT00845026|588454379|FG001|Study Period III|Withdrawal by Subject|15|||
162931772|NCT00845026|588454378|FG000|Study Period III|Entry Criteria not met|8|||
162931773|NCT00845026|588454379|FG001|Study Period III|Entry Criteria not met|11|||
162931774|NCT00845026|588454378|FG000|Study Period III|Lost to Follow-up|4|||
162931775|NCT00845026|588454379|FG001|Study Period III|Lost to Follow-up|5|||
162931776|NCT00845026|588454378|FG000|Study Period III|Protocol Violation|8|||
162931777|NCT00845026|588454379|FG001|Study Period III|Protocol Violation|1|||
162931778|NCT00845026|588454378|FG000|Study Period III|Scheduled conflict|3|||
162931779|NCT00845026|588454379|FG001|Study Period III|Scheduled conflict|1|||
162931780|NCT00845026|588454378|FG000|Study Period III|Subject is moving or has moved|2|||
162931781|NCT00845026|588454379|FG001|Study Period III|Subject is moving or has moved|4|||
162931782|NCT00845026|588454378|FG000|Study Period III|Transportation issues|1|||
162931783|NCT00845026|588454379|FG001|Study Period III|Transportation issues|1|||
162931784|NCT00845026|588454378|FG000|Study Period IV|Adverse Event|4|||
162931785|NCT00845026|588454379|FG001|Study Period IV|Adverse Event|0|||
162931786|NCT00845026|588454378|FG000|Study Period IV|Perceived lack of efficacy|2|||
162931787|NCT00845026|588454379|FG001|Study Period IV|Perceived lack of efficacy|1|||
162931788|NCT00845026|588454378|FG000|Study Period IV|Protocol Violation|3|||
162931789|NCT00845026|588454379|FG001|Study Period IV|Protocol Violation|1|||
162931790|NCT00845026|588454378|FG000|Study Period IV|Lost to Follow-up|1|||
162931791|NCT00845026|588454379|FG001|Study Period IV|Lost to Follow-up|0|||
162931792|NCT00845026|588454378|FG000|Study Period IV|Withdrawal by Subject|4|||
162931793|NCT00845026|588454379|FG001|Study Period IV|Withdrawal by Subject|1|||
162931794|NCT00845026|588454378|FG000|Study Period IV|Entry Criteria Not Met|1|||
162931795|NCT00845026|588454379|FG001|Study Period IV|Entry Criteria Not Met|0|||
162931796|NCT00845026|588454378|FG000|Study Period IV|Subject is moving or has moved|0|||
162931797|NCT00845026|588454379|FG001|Study Period IV|Subject is moving or has moved|1|||
162931798|NCT00845026|588454378|FG000|Study Period IV|Scheduling conflict|1|||
162931799|NCT00845026|588454379|FG001|Study Period IV|Scheduling conflict|0|||
162931800|NCT01325532|588454380|FG000|Overall Study|Withdrawal by Subject|2|||
162931801|NCT01325532|588454381|FG001|Overall Study|Withdrawal by Subject|0|||
162931802|NCT00061945|588454388|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
162931803|NCT00061945|588454389|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
162931804|NCT00061945|588454388|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
162931805|NCT00061945|588454389|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
162931806|NCT00061945|588454388|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
162931807|NCT00061945|588454389|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
162931808|NCT00061945|588454388|FG000|Course IV: Alemtuzumab|Early exits|6|||
162931809|NCT00061945|588454389|FG001|Course IV: Alemtuzumab|Early exits|15|||
162931810|NCT03712228|588454390|FG000|Treatment Period 1|Lack of Efficacy|0|||
162931811|NCT03712228|588454391|FG001|Treatment Period 1|Lack of Efficacy|0|||
162931812|NCT03712228|588454392|FG002|Treatment Period 1|Lack of Efficacy|0|||
163279540|NCT04955626|589731491|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
163279541|NCT04955626|589731492|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
162931813|NCT03712228|588454393|FG003|Treatment Period 1|Lack of Efficacy|0|||
162931814|NCT03712228|588454394|FG004|Treatment Period 1|Lack of Efficacy|0|||
162931815|NCT03712228|588454395|FG005|Treatment Period 1|Lack of Efficacy|1|||
162931816|NCT03712228|588454390|FG000|Treatment Period 2|Pregnancy|0|||
162931817|NCT03712228|588454391|FG001|Treatment Period 2|Pregnancy|0|||
163279542|NCT04955626|589731493|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
162931818|NCT03712228|588454392|FG002|Treatment Period 2|Pregnancy|0|||
162931819|NCT03712228|588454393|FG003|Treatment Period 2|Pregnancy|1|||
162931820|NCT03712228|588454394|FG004|Treatment Period 2|Pregnancy|0|||
162931821|NCT03712228|588454395|FG005|Treatment Period 2|Pregnancy|0|||
162931822|NCT03712228|588454390|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163279543|NCT04955626|589731494|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
162931823|NCT03712228|588454391|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162931824|NCT03712228|588454392|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162931825|NCT03712228|588454393|FG003|Treatment Period 2|Withdrawal by Subject|1|||
162931826|NCT03712228|588454394|FG004|Treatment Period 2|Withdrawal by Subject|0|||
162931827|NCT03712228|588454395|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162931828|NCT01964105|588454396|FG000|Overall Study|Lost to Follow-up|2|||
162931829|NCT01964105|588454397|FG001|Overall Study|Lost to Follow-up|13|||
162931830|NCT01964105|588454398|FG002|Overall Study|Lost to Follow-up|0|||
162931831|NCT01254045|588454401|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
162931832|NCT01254045|588454402|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
162931833|NCT01254045|588454403|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
162931834|NCT01254045|588454404|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
162931835|NCT01254045|588454405|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
162931836|NCT01254045|588454406|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
162931837|NCT00597207|588454407|FG000|Overall Study|Lost to Follow-up|5|||
162931838|NCT00597207|588454408|FG001|Overall Study|Lost to Follow-up|7|||
162931839|NCT00520351|588454409|FG000|First Intervention|Withdrawal by Subject|1|||
162931840|NCT00520351|588454410|FG001|First Intervention|Withdrawal by Subject|1|||
162931841|NCT01021137|588454413|FG000|Overall Study|Lost to Follow-up|9|||
162931842|NCT01021137|588454414|FG001|Overall Study|Lost to Follow-up|4|||
162931843|NCT01021137|588454415|FG002|Overall Study|Lost to Follow-up|2|||
162931844|NCT01021137|588454416|FG003|Overall Study|Lost to Follow-up|6|||
162931845|NCT01021137|588454413|FG000|Overall Study|Withdrawal by Subject|1|||
162931846|NCT01021137|588454414|FG001|Overall Study|Withdrawal by Subject|0|||
162931847|NCT01021137|588454415|FG002|Overall Study|Withdrawal by Subject|0|||
162931848|NCT01021137|588454416|FG003|Overall Study|Withdrawal by Subject|3|||
162931849|NCT00725725|588454417|FG000|Overall Study|Adverse Event|1|||
162931850|NCT00725725|588454418|FG001|Overall Study|Adverse Event|3|||
162931851|NCT00725725|588454419|FG002|Overall Study|Adverse Event|2|||
162931852|NCT00725725|588454417|FG000|Overall Study|Lost to Follow-up|2|||
162931853|NCT00725725|588454418|FG001|Overall Study|Lost to Follow-up|0|||
162931854|NCT00725725|588454419|FG002|Overall Study|Lost to Follow-up|2|||
162931855|NCT00725725|588454417|FG000|Overall Study|Withdrawal by Subject|1|||
162931856|NCT00725725|588454418|FG001|Overall Study|Withdrawal by Subject|0|||
162931857|NCT00725725|588454419|FG002|Overall Study|Withdrawal by Subject|1|||
162931858|NCT00725725|588454417|FG000|Overall Study|Protocol Violation|0|||
162931859|NCT00725725|588454418|FG001|Overall Study|Protocol Violation|1|||
162931860|NCT00725725|588454419|FG002|Overall Study|Protocol Violation|0|||
162931861|NCT04288115|588454421|FG000|Overall Study|Withdrawal by Subject|0|||
162931862|NCT04288115|588454422|FG001|Overall Study|Withdrawal by Subject|1|||
162931863|NCT04288115|588454421|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
162931864|NCT04288115|588454422|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
162931865|NCT00729365|588454423|FG000|Overall Study|Physician Decision|33|||
162931866|NCT00729365|588454424|FG001|Overall Study|Physician Decision|6|||
162931867|NCT00729365|588454425|FG002|Overall Study|Physician Decision|7|||
162931868|NCT04556838|588454426|FG000|Overall Study|Withdrawal by Subject|3|||
162931869|NCT04556838|588454427|FG001|Overall Study|Withdrawal by Subject|1|||
162931870|NCT04556838|588454428|FG002|Overall Study|Withdrawal by Subject|2|||
162931871|NCT04556838|588454426|FG000|Overall Study|Adverse Event|0|||
162931872|NCT04556838|588454427|FG001|Overall Study|Adverse Event|1|||
162931873|NCT04556838|588454428|FG002|Overall Study|Adverse Event|1|||
162931874|NCT04556838|588454426|FG000|Overall Study|Lost to Follow-up|0|||
162931875|NCT04556838|588454427|FG001|Overall Study|Lost to Follow-up|0|||
162931876|NCT04556838|588454428|FG002|Overall Study|Lost to Follow-up|2|||
162931877|NCT04556838|588454426|FG000|Overall Study|Subject travel|0|||
162931878|NCT04556838|588454427|FG001|Overall Study|Subject travel|1|||
162931879|NCT04556838|588454428|FG002|Overall Study|Subject travel|0|||
162931880|NCT04556838|588454426|FG000|Overall Study|Physician Decision|1|||
162931881|NCT04556838|588454427|FG001|Overall Study|Physician Decision|0|||
162931882|NCT04556838|588454428|FG002|Overall Study|Physician Decision|0|||
162931883|NCT00382291|588456426|FG000|Overall Study|Adverse Event|1|||
162931884|NCT00382291|588456427|FG001|Overall Study|Adverse Event|2|||
162931885|NCT00382291|588456428|FG002|Overall Study|Adverse Event|2|||
162931886|NCT00382291|588456426|FG000|Overall Study|Protocol Violation|1|||
163173351|NCT01551420|589349909|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
163173352|NCT01551420|589349910|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
162931887|NCT00382291|588456427|FG001|Overall Study|Protocol Violation|0|||
162931888|NCT00382291|588456428|FG002|Overall Study|Protocol Violation|0|||
162931889|NCT00382291|588456426|FG000|Overall Study|Temporary study suspension|2|||
162931890|NCT00382291|588456427|FG001|Overall Study|Temporary study suspension|2|||
162931891|NCT00382291|588456428|FG002|Overall Study|Temporary study suspension|5|||
162931892|NCT00382291|588456426|FG000|Overall Study|Withdrawal by Subject|0|||
163279544|NCT04955626|589731495|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
162931893|NCT00382291|588456427|FG001|Overall Study|Withdrawal by Subject|2|||
162931894|NCT00382291|588456428|FG002|Overall Study|Withdrawal by Subject|0|||
162931895|NCT00382291|588456426|FG000|Overall Study|Physician Decision|0|||
162931896|NCT00382291|588456427|FG001|Overall Study|Physician Decision|1|||
163279545|NCT04955626|589731496|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
163279546|NCT04955626|589731497|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
163279547|NCT04955626|589731498|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
163279548|NCT04955626|589731499|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
163279549|NCT04955626|589731500|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
163279550|NCT04955626|589731501|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
163279551|NCT04955626|589731502|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
163279552|NCT04955626|589731503|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
163279553|NCT04955626|589731504|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
163173353|NCT01551420|589349909|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
163173354|NCT01551420|589349910|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
163173355|NCT01551420|589349909|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
163173356|NCT01551420|589349910|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
163173357|NCT01551420|589349909|FG000|Screened for Part B Eligibility|Declined participation|8|||
163173358|NCT01551420|589349910|FG001|Screened for Part B Eligibility|Declined participation|1|||
163173359|NCT01551420|589349909|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
163173360|NCT01551420|589349910|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
163173361|NCT01551420|589349909|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
163173362|NCT01551420|589349910|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
163173363|NCT01551420|589349909|FG000|Home Use (Part B)|Withdrawal by staff|0|||
163173364|NCT01551420|589349910|FG001|Home Use (Part B)|Withdrawal by staff|1|||
163173365|NCT03612856|589349911|FG000|Pre-dose Period|Physician Decision|0|||
163173366|NCT03612856|589349912|FG001|Pre-dose Period|Physician Decision|1|||
163173367|NCT03612856|589349913|FG002|Pre-dose Period|Physician Decision|1|||
163173368|NCT03612856|589349911|FG000|Pre-dose Period|Withdrawal by Subject|0|||
163173369|NCT03612856|589349912|FG001|Pre-dose Period|Withdrawal by Subject|1|||
163173370|NCT03612856|589349913|FG002|Pre-dose Period|Withdrawal by Subject|0|||
163173371|NCT01576159|589349914|FG000|Overall Study|Withdrawal by Subject|0|||
163173372|NCT01576159|589349915|FG001|Overall Study|Withdrawal by Subject|1|||
163173373|NCT01576159|589349916|FG002|Overall Study|Withdrawal by Subject|0|||
163173374|NCT01576159|589349917|FG003|Overall Study|Withdrawal by Subject|0|||
163173375|NCT01576159|589349914|FG000|Overall Study|Physician Decision|0|||
163173376|NCT01576159|589349915|FG001|Overall Study|Physician Decision|0|||
163173377|NCT01576159|589349916|FG002|Overall Study|Physician Decision|1|||
163173378|NCT01576159|589349917|FG003|Overall Study|Physician Decision|0|||
163279554|NCT04955626|589731469|FG000|Open-Label Period|Other|621|||
163279555|NCT04955626|589731470|FG001|Open-Label Period|Other|429|||
163173379|NCT01576159|589349914|FG000|Overall Study|Lost to Follow-up|0|||
163173380|NCT01576159|589349915|FG001|Overall Study|Lost to Follow-up|0|||
163173381|NCT01576159|589349916|FG002|Overall Study|Lost to Follow-up|0|||
163279556|NCT04955626|589731471|FG002|Open-Label Period|Other|0|||
163279557|NCT04955626|589731472|FG003|Open-Label Period|Other|0|||
163279558|NCT04955626|589731473|FG004|Open-Label Period|Other|0|||
163279559|NCT04955626|589731474|FG005|Open-Label Period|Other|0|||
163279560|NCT04955626|589731475|FG006|Open-Label Period|Other|0|||
162931897|NCT00382291|588456428|FG002|Overall Study|Physician Decision|0|||
162931898|NCT00382291|588456426|FG000|Overall Study|Lack of Efficacy|0|||
162931899|NCT00382291|588456427|FG001|Overall Study|Lack of Efficacy|0|||
163279561|NCT04955626|589731476|FG007|Open-Label Period|Other|0|||
162931900|NCT00382291|588456428|FG002|Overall Study|Lack of Efficacy|1|||
163279562|NCT04955626|589731477|FG008|Open-Label Period|Other|0|||
162931901|NCT01326702|588456429|FG000|Overall Study|Other|1|||
163279563|NCT04955626|589731478|FG009|Open-Label Period|Other|0|||
163279564|NCT04955626|589731479|FG010|Open-Label Period|Other|0|||
163279565|NCT04955626|589731480|FG011|Open-Label Period|Other|0|||
163279566|NCT04955626|589731481|FG012|Open-Label Period|Other|0|||
163279567|NCT04955626|589731482|FG013|Open-Label Period|Other|0|||
163279568|NCT04955626|589731483|FG014|Open-Label Period|Other|0|||
163279569|NCT04955626|589731484|FG015|Open-Label Period|Other|0|||
163173382|NCT01576159|589349917|FG003|Overall Study|Lost to Follow-up|1|||
163173383|NCT01576159|589349914|FG000|Overall Study|Protocol Violation|1|||
163173384|NCT01576159|589349915|FG001|Overall Study|Protocol Violation|0|||
163173385|NCT01576159|589349916|FG002|Overall Study|Protocol Violation|0|||
163173386|NCT01576159|589349917|FG003|Overall Study|Protocol Violation|0|||
163173387|NCT04463069|589349918|FG000|Overall Study|Withdrawal by Subject|2|||
163173388|NCT04463069|589349919|FG001|Overall Study|Withdrawal by Subject|10|||
163173389|NCT04463069|589349918|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
163173390|NCT04463069|589349919|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
163173391|NCT00311584|589349920|FG000|Overall Study|Death|1|||
163173392|NCT00311584|589349921|FG001|Overall Study|Death|0|||
163173393|NCT00311584|589349920|FG000|Overall Study|Lack of Efficacy|12|||
163173394|NCT00311584|589349921|FG001|Overall Study|Lack of Efficacy|15|||
163173395|NCT00311584|589349920|FG000|Overall Study|Physician Decision|4|||
163173396|NCT00311584|589349921|FG001|Overall Study|Physician Decision|5|||
163173397|NCT00311584|589349920|FG000|Overall Study|Withdrawal by Subject|1|||
163279570|NCT04955626|589731485|FG016|Open-Label Period|Other|0|||
163173398|NCT00311584|589349921|FG001|Overall Study|Withdrawal by Subject|1|||
163173399|NCT00311584|589349920|FG000|Overall Study|ineligible|2|||
163173400|NCT00311584|589349921|FG001|Overall Study|ineligible|2|||
163173401|NCT03073733|589349922|FG000|Overall Study|Lost to Follow-up|1|||
163279571|NCT04955626|589731486|FG017|Open-Label Period|Other|0|||
162931902|NCT01326702|588456430|FG001|Overall Study|Other|0|||
162931903|NCT01326702|588456431|FG002|Overall Study|Other|0|||
162931904|NCT01326702|588456432|FG003|Overall Study|Other|0|||
162931905|NCT01326702|588456433|FG004|Overall Study|Other|0|||
162931906|NCT01326702|588456434|FG005|Overall Study|Other|1|||
162931907|NCT01326702|588456435|FG006|Overall Study|Other|0|||
162931908|NCT01326702|588456429|FG000|Overall Study|progressive disease|1|||
162931909|NCT01326702|588456430|FG001|Overall Study|progressive disease|1|||
162931910|NCT01326702|588456431|FG002|Overall Study|progressive disease|3|||
162931911|NCT01326702|588456432|FG003|Overall Study|progressive disease|1|||
162931912|NCT01326702|588456433|FG004|Overall Study|progressive disease|3|||
162931913|NCT01326702|588456434|FG005|Overall Study|progressive disease|2|||
162931914|NCT01326702|588456435|FG006|Overall Study|progressive disease|3|||
162931915|NCT01326702|588456429|FG000|Overall Study|Death|0|||
162931916|NCT01326702|588456430|FG001|Overall Study|Death|1|||
162931917|NCT01326702|588456431|FG002|Overall Study|Death|0|||
162931918|NCT01326702|588456432|FG003|Overall Study|Death|0|||
162931919|NCT01326702|588456433|FG004|Overall Study|Death|0|||
162931920|NCT01326702|588456434|FG005|Overall Study|Death|0|||
162931921|NCT01326702|588456435|FG006|Overall Study|Death|0|||
162931922|NCT01326702|588456429|FG000|Overall Study|Adverse Event|0|||
162931923|NCT01326702|588456430|FG001|Overall Study|Adverse Event|0|||
162931924|NCT01326702|588456431|FG002|Overall Study|Adverse Event|1|||
162931925|NCT01326702|588456432|FG003|Overall Study|Adverse Event|1|||
162931926|NCT01326702|588456433|FG004|Overall Study|Adverse Event|0|||
162931927|NCT01326702|588456434|FG005|Overall Study|Adverse Event|3|||
162931928|NCT01326702|588456435|FG006|Overall Study|Adverse Event|1|||
162931929|NCT01326702|588456429|FG000|Overall Study|Withdrawal by Subject|0|||
162931930|NCT01326702|588456430|FG001|Overall Study|Withdrawal by Subject|0|||
163173402|NCT03073733|589349923|FG001|Overall Study|Lost to Follow-up|0|||
163173403|NCT03073733|589349924|FG002|Overall Study|Lost to Follow-up|0|||
163173404|NCT03073733|589349922|FG000|Overall Study|Physician Decision|0|||
163173405|NCT03073733|589349923|FG001|Overall Study|Physician Decision|1|||
163173406|NCT03073733|589349924|FG002|Overall Study|Physician Decision|0|||
163173407|NCT03073733|589349922|FG000|Overall Study|Withdrawal by Subject|0|||
163173408|NCT03073733|589349923|FG001|Overall Study|Withdrawal by Subject|0|||
163173409|NCT03073733|589349924|FG002|Overall Study|Withdrawal by Subject|1|||
163173410|NCT01454778|589349925|FG000|Overall Study|Lost to Follow-up|2|||
163173411|NCT01454778|589349925|FG000|Overall Study|Death|1|||
163173412|NCT01227629|589349926|FG000|Overall Study|Adverse Event|2|||
163173413|NCT01227629|589349927|FG001|Overall Study|Adverse Event|2|||
163173414|NCT01227629|589349928|FG002|Overall Study|Adverse Event|1|||
163173415|NCT01227629|589349929|FG003|Overall Study|Adverse Event|6|||
163173416|NCT01227629|589349930|FG004|Overall Study|Adverse Event|1|||
163173417|NCT01227629|589349931|FG005|Overall Study|Adverse Event|1|||
163173418|NCT01227629|589349932|FG006|Overall Study|Adverse Event|6|||
163173419|NCT01227629|589349933|FG007|Overall Study|Adverse Event|6|||
163173420|NCT01227629|589349934|FG008|Overall Study|Adverse Event|4|||
163173421|NCT01227629|589349935|FG009|Overall Study|Adverse Event|0|||
163173422|NCT01227629|589349926|FG000|Overall Study|Protocol Violation|0|||
163173423|NCT01227629|589349927|FG001|Overall Study|Protocol Violation|0|||
163173424|NCT01227629|589349928|FG002|Overall Study|Protocol Violation|0|||
163173425|NCT01227629|589349929|FG003|Overall Study|Protocol Violation|1|||
163173426|NCT01227629|589349930|FG004|Overall Study|Protocol Violation|0|||
163173427|NCT01227629|589349931|FG005|Overall Study|Protocol Violation|0|||
163173428|NCT01227629|589349932|FG006|Overall Study|Protocol Violation|0|||
163173429|NCT01227629|589349933|FG007|Overall Study|Protocol Violation|0|||
163173430|NCT01227629|589349934|FG008|Overall Study|Protocol Violation|0|||
163173431|NCT01227629|589349935|FG009|Overall Study|Protocol Violation|0|||
163173432|NCT01227629|589349926|FG000|Overall Study|Lost to Follow-up|0|||
163279572|NCT04955626|589731487|FG018|Open-Label Period|Other|0|||
162931931|NCT01326702|588456431|FG002|Overall Study|Withdrawal by Subject|1|||
162931932|NCT01326702|588456432|FG003|Overall Study|Withdrawal by Subject|0|||
162931933|NCT01326702|588456433|FG004|Overall Study|Withdrawal by Subject|1|||
162931934|NCT01326702|588456434|FG005|Overall Study|Withdrawal by Subject|1|||
162931935|NCT01326702|588456435|FG006|Overall Study|Withdrawal by Subject|3|||
162931936|NCT01326702|588456429|FG000|Overall Study|Not Treated|0|||
162931937|NCT01326702|588456430|FG001|Overall Study|Not Treated|0|||
162931938|NCT01326702|588456431|FG002|Overall Study|Not Treated|0|||
162931939|NCT01326702|588456432|FG003|Overall Study|Not Treated|1|||
162931940|NCT01326702|588456433|FG004|Overall Study|Not Treated|0|||
163173433|NCT01227629|589349927|FG001|Overall Study|Lost to Follow-up|0|||
163173434|NCT01227629|589349928|FG002|Overall Study|Lost to Follow-up|0|||
163173435|NCT01227629|589349929|FG003|Overall Study|Lost to Follow-up|0|||
163173436|NCT01227629|589349930|FG004|Overall Study|Lost to Follow-up|1|||
162931941|NCT01326702|588456434|FG005|Overall Study|Not Treated|1|||
163173437|NCT01227629|589349931|FG005|Overall Study|Lost to Follow-up|0|||
163173438|NCT01227629|589349932|FG006|Overall Study|Lost to Follow-up|0|||
163173439|NCT01227629|589349933|FG007|Overall Study|Lost to Follow-up|0|||
163173440|NCT01227629|589349934|FG008|Overall Study|Lost to Follow-up|0|||
163173441|NCT01227629|589349935|FG009|Overall Study|Lost to Follow-up|0|||
163173442|NCT01227629|589349926|FG000|Overall Study|Withdrawal by Subject|0|||
162931942|NCT01326702|588456435|FG006|Overall Study|Not Treated|0|||
162931943|NCT02266706|588456436|FG000|Overall Study|Withdrawal by Subject|0|||
162931944|NCT02266706|588456437|FG001|Overall Study|Withdrawal by Subject|1|||
162931945|NCT02266706|588456438|FG002|Overall Study|Withdrawal by Subject|1|||
162931946|NCT02266706|588456439|FG003|Overall Study|Withdrawal by Subject|0|||
162931947|NCT02266706|588456440|FG004|Overall Study|Withdrawal by Subject|0|||
162931948|NCT02266706|588456441|FG005|Overall Study|Withdrawal by Subject|1|||
162931949|NCT02266706|588456442|FG006|Overall Study|Withdrawal by Subject|0|||
162931950|NCT02266706|588456443|FG007|Overall Study|Withdrawal by Subject|0|||
162931951|NCT02266706|588456444|FG008|Overall Study|Withdrawal by Subject|0|||
162931952|NCT02266706|588456436|FG000|Overall Study|Screen failure|0|||
162931953|NCT02266706|588456437|FG001|Overall Study|Screen failure|0|||
162931954|NCT02266706|588456438|FG002|Overall Study|Screen failure|0|||
162931955|NCT02266706|588456439|FG003|Overall Study|Screen failure|0|||
162931956|NCT02266706|588456440|FG004|Overall Study|Screen failure|0|||
162931957|NCT02266706|588456441|FG005|Overall Study|Screen failure|1|||
162931958|NCT02266706|588456442|FG006|Overall Study|Screen failure|1|||
162931959|NCT02266706|588456443|FG007|Overall Study|Screen failure|0|||
162931960|NCT02266706|588456444|FG008|Overall Study|Screen failure|0|||
162931961|NCT02266706|588456436|FG000|Overall Study|Enrollment in another study|0|||
162931962|NCT02266706|588456437|FG001|Overall Study|Enrollment in another study|0|||
162931963|NCT02266706|588456438|FG002|Overall Study|Enrollment in another study|0|||
162931964|NCT02266706|588456439|FG003|Overall Study|Enrollment in another study|1|||
162931965|NCT02266706|588456440|FG004|Overall Study|Enrollment in another study|0|||
162931966|NCT02266706|588456441|FG005|Overall Study|Enrollment in another study|0|||
162931967|NCT02266706|588456442|FG006|Overall Study|Enrollment in another study|0|||
162931968|NCT02266706|588456443|FG007|Overall Study|Enrollment in another study|0|||
162931969|NCT02266706|588456444|FG008|Overall Study|Enrollment in another study|0|||
162931970|NCT02270983|588456446|FG000|Overall Study|Adverse Event|3|||
162931971|NCT02270983|588456447|FG001|Overall Study|Adverse Event|2|||
162931972|NCT02270983|588456448|FG002|Overall Study|Adverse Event|6|||
162931973|NCT02270983|588456446|FG000|Overall Study|Lack of Efficacy|2|||
162931974|NCT02270983|588456447|FG001|Overall Study|Lack of Efficacy|1|||
162931975|NCT02270983|588456448|FG002|Overall Study|Lack of Efficacy|1|||
162931976|NCT02270983|588456446|FG000|Overall Study|Withdrawal by Subject|1|||
162931977|NCT02270983|588456447|FG001|Overall Study|Withdrawal by Subject|0|||
162931978|NCT02270983|588456448|FG002|Overall Study|Withdrawal by Subject|2|||
162931979|NCT02270983|588456446|FG000|Overall Study|Lost to Follow-up|1|||
162931980|NCT02270983|588456447|FG001|Overall Study|Lost to Follow-up|1|||
162931981|NCT02270983|588456448|FG002|Overall Study|Lost to Follow-up|2|||
162931982|NCT02270983|588456446|FG000|Overall Study|Protocol Violation|1|||
162931983|NCT02270983|588456447|FG001|Overall Study|Protocol Violation|1|||
162931984|NCT02270983|588456448|FG002|Overall Study|Protocol Violation|1|||
162931985|NCT02270983|588456446|FG000|Overall Study|family emergency|0|||
162931986|NCT02270983|588456447|FG001|Overall Study|family emergency|1|||
162931987|NCT02270983|588456448|FG002|Overall Study|family emergency|0|||
162931988|NCT02270983|588456446|FG000|Overall Study|study procedure non-compliance|1|||
162931989|NCT02270983|588456447|FG001|Overall Study|study procedure non-compliance|0|||
162931990|NCT02270983|588456448|FG002|Overall Study|study procedure non-compliance|0|||
162931991|NCT02270983|588456446|FG000|Overall Study|moved away from study site|0|||
162931992|NCT02270983|588456447|FG001|Overall Study|moved away from study site|1|||
162931993|NCT02270983|588456448|FG002|Overall Study|moved away from study site|0|||
162931994|NCT01059071|588456450|FG000|Overall Study|Lack of Efficacy|1|||
162931995|NCT01059071|588456451|FG001|Overall Study|Lack of Efficacy|4|||
162931996|NCT01059071|588456452|FG002|Overall Study|Lack of Efficacy|2|||
162931997|NCT01059071|588456453|FG003|Overall Study|Lack of Efficacy|3|||
162931998|NCT01059071|588456450|FG000|Overall Study|Withdrawal by Subject|1|||
162931999|NCT01059071|588456451|FG001|Overall Study|Withdrawal by Subject|0|||
162932000|NCT01059071|588456452|FG002|Overall Study|Withdrawal by Subject|0|||
162932001|NCT01059071|588456453|FG003|Overall Study|Withdrawal by Subject|2|||
162932002|NCT01059071|588456450|FG000|Overall Study|Physician Decision|0|||
162932003|NCT01059071|588456451|FG001|Overall Study|Physician Decision|0|||
162932004|NCT01059071|588456452|FG002|Overall Study|Physician Decision|0|||
162932005|NCT01059071|588456453|FG003|Overall Study|Physician Decision|1|||
162932006|NCT02962882|588456454|FG000|Overall Study|Adverse Event|2|||
162932007|NCT02962882|588456454|FG000|Overall Study|Withdrawal by Subject|2|||
162932008|NCT02962882|588456454|FG000|Overall Study|Transfer from ICU|32|||
162932009|NCT04741503|588456455|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
162932010|NCT04741503|588456456|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
162932011|NCT04741503|588456457|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
162932012|NCT04741503|588456455|FG000|Initial Enrollment|Overquotas removed|0|||
162932013|NCT04741503|588456456|FG001|Initial Enrollment|Overquotas removed|0|||
162932014|NCT04741503|588456457|FG002|Initial Enrollment|Overquotas removed|186|||
162932015|NCT04741503|588456455|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
163279573|NCT04955626|589731488|FG019|Open-Label Period|Other|0|||
163279574|NCT04955626|589731489|FG020|Open-Label Period|Other|0|||
163279575|NCT04955626|589731490|FG021|Open-Label Period|Other|0|||
162932016|NCT04741503|588456456|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
162932017|NCT04741503|588456457|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
162932018|NCT02791659|588456465|FG000|Overall Study|Protocol Violation|0|||
162932019|NCT02791659|588456466|FG001|Overall Study|Protocol Violation|1|||
162932020|NCT00881959|588456467|FG000|Overall Study|Lost to Follow-up|2|||
162932021|NCT00881959|588456468|FG001|Overall Study|Lost to Follow-up|4|||
162932022|NCT03840811|588456469|FG000|Overall Study|Lost to Follow-up|0|||
162932023|NCT03840811|588456470|FG001|Overall Study|Lost to Follow-up|0|||
163173443|NCT01227629|589349927|FG001|Overall Study|Withdrawal by Subject|0|||
163173444|NCT01227629|589349928|FG002|Overall Study|Withdrawal by Subject|0|||
163173445|NCT01227629|589349929|FG003|Overall Study|Withdrawal by Subject|0|||
163173446|NCT01227629|589349930|FG004|Overall Study|Withdrawal by Subject|0|||
163173447|NCT01227629|589349931|FG005|Overall Study|Withdrawal by Subject|0|||
163173448|NCT01227629|589349932|FG006|Overall Study|Withdrawal by Subject|2|||
163173449|NCT01227629|589349933|FG007|Overall Study|Withdrawal by Subject|0|||
163173450|NCT01227629|589349934|FG008|Overall Study|Withdrawal by Subject|0|||
163173451|NCT01227629|589349935|FG009|Overall Study|Withdrawal by Subject|1|||
163173452|NCT01227629|589349926|FG000|Overall Study|Other|0|||
163173453|NCT01227629|589349927|FG001|Overall Study|Other|0|||
163173454|NCT01227629|589349928|FG002|Overall Study|Other|0|||
163173455|NCT01227629|589349929|FG003|Overall Study|Other|1|||
163173456|NCT01227629|589349930|FG004|Overall Study|Other|0|||
163173457|NCT01227629|589349931|FG005|Overall Study|Other|0|||
163173458|NCT01227629|589349932|FG006|Overall Study|Other|0|||
163173459|NCT01227629|589349933|FG007|Overall Study|Other|0|||
163173460|NCT01227629|589349934|FG008|Overall Study|Other|2|||
163173461|NCT01227629|589349935|FG009|Overall Study|Other|1|||
163173462|NCT02276027|589351549|FG000|Overall Study|Death|1|||
163173463|NCT02276027|589351550|FG001|Overall Study|Death|0|||
163173464|NCT02276027|589351551|FG002|Overall Study|Death|0|||
163173465|NCT02276027|589351552|FG003|Overall Study|Death|2|||
163173466|NCT02276027|589351549|FG000|Overall Study|Physician Decision|0|||
163173467|NCT02276027|589351550|FG001|Overall Study|Physician Decision|0|||
163173468|NCT02276027|589351551|FG002|Overall Study|Physician Decision|0|||
163173469|NCT02276027|589351552|FG003|Overall Study|Physician Decision|1|||
163173470|NCT02276027|589351549|FG000|Overall Study|Progressive disease|1|||
163173471|NCT02276027|589351550|FG001|Overall Study|Progressive disease|13|||
163173472|NCT02276027|589351551|FG002|Overall Study|Progressive disease|12|||
163173473|NCT02276027|589351552|FG003|Overall Study|Progressive disease|14|||
163173474|NCT02276027|589351549|FG000|Overall Study|Subject/guardian decision|0|||
163173475|NCT02276027|589351550|FG001|Overall Study|Subject/guardian decision|1|||
163173476|NCT02276027|589351551|FG002|Overall Study|Subject/guardian decision|0|||
163173477|NCT02276027|589351552|FG003|Overall Study|Subject/guardian decision|3|||
163173478|NCT02276027|589351549|FG000|Overall Study|Adverse Event|0|||
163173479|NCT02276027|589351550|FG001|Overall Study|Adverse Event|2|||
163173480|NCT02276027|589351551|FG002|Overall Study|Adverse Event|8|||
163173481|NCT02276027|589351552|FG003|Overall Study|Adverse Event|2|||
163173482|NCT02446171|589351553|FG000|Overall Study|Withdrawal by Subject|0|||
163173483|NCT02446171|589351554|FG001|Overall Study|Withdrawal by Subject|0|||
163173484|NCT02446171|589351555|FG002|Overall Study|Withdrawal by Subject|2|||
163173485|NCT02446171|589351556|FG003|Overall Study|Withdrawal by Subject|0|||
163173486|NCT01264081|589351557|FG000|Participants Screened|Screening failures|30|||
163173487|NCT01264081|589351557|FG000|Started Treatment|Withdrawal by Subject|1|||
163173488|NCT01264081|589351557|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
163173489|NCT02320903|589351560|FG000|Overall Study|Withdrawal by Subject|0|||
163173490|NCT02320903|589351561|FG001|Overall Study|Withdrawal by Subject|9|||
163173491|NCT02320903|589351562|FG002|Overall Study|Withdrawal by Subject|9|||
163173492|NCT02320903|589351560|FG000|Overall Study|Exited therapy; no longer eligible|8|||
163173493|NCT02320903|589351561|FG001|Overall Study|Exited therapy; no longer eligible|2|||
163173494|NCT02320903|589351562|FG002|Overall Study|Exited therapy; no longer eligible|2|||
163173495|NCT02320903|589351560|FG000|Overall Study|Lost to Follow-up|0|||
163173496|NCT02320903|589351561|FG001|Overall Study|Lost to Follow-up|5|||
163173497|NCT02320903|589351562|FG002|Overall Study|Lost to Follow-up|5|||
163173498|NCT00773383|589351563|FG000|Overall Study|Adverse Event|4|||
163173499|NCT00773383|589351563|FG000|Overall Study|Death|1|||
163173500|NCT00773383|589351563|FG000|Overall Study|Progression of Disease|23|||
163173501|NCT00773383|589351563|FG000|Overall Study|Other|2|||
163173502|NCT00773383|589351563|FG000|Overall Study|No study dose received|1|||
163173503|NCT01012219|589351566|FG000|Period 1|Withdrawal by Subject|1|||
163173504|NCT01012219|589351566|FG000|Period 2|Withdrawal by Subject|1|||
163173505|NCT03811093|589351569|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
163173506|NCT03811093|589351570|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
163173507|NCT03811093|589351569|FG000|Overall Study|Unable to measure body fat percentage|2|||
163173508|NCT03811093|589351570|FG001|Overall Study|Unable to measure body fat percentage|0|||
163173509|NCT00464490|589351574|FG000|Overall Study|Physician Decision|11|||
163173510|NCT00464490|589351575|FG001|Overall Study|Physician Decision|11|||
163173511|NCT03188042|589351578|FG000|Overall Study|Withdrawal by Subject|1|||
163173512|NCT03188042|589351579|FG001|Overall Study|Withdrawal by Subject|1|||
163173513|NCT01328366|589351583|FG000|Overall Study|Death|1|||
163173514|NCT01328366|589351583|FG000|Overall Study|Withdrawal by Subject|2|||
163173515|NCT01328366|589351583|FG000|Overall Study|Lost to Follow-up|7|||
162932024|NCT03840811|588456471|FG002|Overall Study|Lost to Follow-up|1|||
162932025|NCT01904383|588456472|FG000|Overall Study|CRF not collected|117|||
162932026|NCT01904383|588456472|FG000|Overall Study|Reason not listed|147|||
162932027|NCT01904383|588456472|FG000|Overall Study|Lost to Follow-up|674|||
162932028|NCT01904383|588456472|FG000|Overall Study|Lack of Efficacy|370|||
162932029|NCT01904383|588456472|FG000|Overall Study|Improvement|141|||
162932030|NCT01904383|588456472|FG000|Overall Study|Adverse Event|271|||
162932031|NCT01904383|588456472|FG000|Overall Study|No patient visit after entry|54|||
162932032|NCT04313283|588456475|FG000|Overall Study|did not complete intervention|4|||
162932033|NCT00472446|588456476|FG000|Overall Study|Protocol Violation|0|||
162932034|NCT00472446|588456477|FG001|Overall Study|Protocol Violation|0|||
162932035|NCT00472446|588456478|FG002|Overall Study|Protocol Violation|0|||
162932036|NCT00472446|588456479|FG003|Overall Study|Protocol Violation|1|||
162932037|NCT00472446|588456476|FG000|Overall Study|Reintervention|0|||
162932038|NCT00472446|588456477|FG001|Overall Study|Reintervention|0|||
162932039|NCT00472446|588456478|FG002|Overall Study|Reintervention|1|||
162932040|NCT00472446|588456479|FG003|Overall Study|Reintervention|1|||
162932041|NCT00472446|588456476|FG000|Overall Study|Questionnaires not returned|5|||
162932042|NCT00472446|588456477|FG001|Overall Study|Questionnaires not returned|6|||
162932043|NCT00472446|588456478|FG002|Overall Study|Questionnaires not returned|6|||
162932044|NCT00472446|588456479|FG003|Overall Study|Questionnaires not returned|4|||
162932045|NCT03211156|588456480|FG000|Overall Study|Withdrawal by Subject|0|||
162932046|NCT03211156|588456481|FG001|Overall Study|Withdrawal by Subject|2|||
162932047|NCT03211156|588456480|FG000|Overall Study|Lost to Follow-up|1|||
162932048|NCT03211156|588456481|FG001|Overall Study|Lost to Follow-up|1|||
162932049|NCT03211156|588456480|FG000|Overall Study|Adverse Event|1|||
162932050|NCT03211156|588456481|FG001|Overall Study|Adverse Event|0|||
162932051|NCT04126733|588456495|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
162932052|NCT04126733|588456495|FG000|Treatment Period|Adverse Event|8|||
162932053|NCT04126733|588456495|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
162932054|NCT04126733|588456495|FG000|Treatment Period|Physician Decision|5|||
162932055|NCT04126733|588456495|FG000|Treatment Period|Death|1|||
162932056|NCT04126733|588456495|FG000|Treatment Period|Other Reasons|2|||
162932057|NCT04126733|588456495|FG000|Active Follow-up Period|Death|13|||
162932058|NCT04126733|588456495|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
162932059|NCT04126733|588456495|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
162932060|NCT04126733|588456495|FG000|Active Follow-up Period|Other Reasons|1|||
162932061|NCT04126733|588456495|FG000|Long-term Follow-up Period|Death|22|||
162932062|NCT04126733|588456495|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
162932063|NCT04126733|588456495|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
162932064|NCT00837577|588456496|FG000|Double-blind Period|Clinical Adverse Event|1|||
162932065|NCT00837577|588456497|FG001|Double-blind Period|Clinical Adverse Event|0|||
162932066|NCT00837577|588456496|FG000|Double-blind Period|Withdrawal by Subject|1|||
162932067|NCT00837577|588456497|FG001|Double-blind Period|Withdrawal by Subject|0|||
162932068|NCT00837577|588456496|FG000|Open-label Period|Clinical Adverse Event|2|||
163173516|NCT01009840|589351584|FG000|Overall Study|Lost to Follow-up|1|||
163173517|NCT01009840|589351584|FG000|Overall Study|Adverse Event|4|||
163173518|NCT01009840|589351584|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
163173519|NCT01009840|589351584|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
163173520|NCT01009840|589351584|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
163173521|NCT03739242|589351589|FG000|Overall Study|Withdrawal by Subject|1|||
163173522|NCT03739242|589351590|FG001|Overall Study|Withdrawal by Subject|1|||
163173523|NCT03739242|589351589|FG000|Overall Study|Protocol Violation|0|||
163173524|NCT03739242|589351590|FG001|Overall Study|Protocol Violation|1|||
163173525|NCT01122394|589351591|FG000|Overall Study|Withdrawal by Subject|1|||
163173526|NCT01122394|589351592|FG001|Overall Study|Withdrawal by Subject|1|||
163173527|NCT01122394|589351591|FG000|Overall Study|Lost to Follow-up|2|||
163173528|NCT01122394|589351592|FG001|Overall Study|Lost to Follow-up|2|||
163173529|NCT01122394|589351591|FG000|Overall Study|Adverse Event|0|||
163173530|NCT01122394|589351592|FG001|Overall Study|Adverse Event|1|||
163173531|NCT00039871|589351593|FG000|Overall Study|Adverse Event|165|||
163173532|NCT00039871|589351593|FG000|Overall Study|Lost to Follow-up|18|||
163173533|NCT00039871|589351593|FG000|Overall Study|Protocol Violation|24|||
163173534|NCT00039871|589351593|FG000|Overall Study|Withdrawal by Subject|97|||
163173535|NCT00039871|589351593|FG000|Overall Study|Did not meet eligibility criteria|11|||
163173536|NCT00039871|589351593|FG000|Overall Study|Administrative|1|||
163173537|NCT00039871|589351593|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
163173538|NCT00039871|589351593|FG000|Overall Study|Never entered follow-up|7|||
163173539|NCT02446743|589351594|FG000|Overall Study|Withdrawal by Subject|1|||
163173540|NCT02446743|589351595|FG001|Overall Study|Withdrawal by Subject|1|||
163173541|NCT02446743|589351594|FG000|Overall Study|Lost to Follow-up|1|||
163173542|NCT02446743|589351595|FG001|Overall Study|Lost to Follow-up|0|||
163173543|NCT02446743|589351594|FG000|Overall Study|Adverse Event|1|||
163173544|NCT02446743|589351595|FG001|Overall Study|Adverse Event|1|||
163173545|NCT02446743|589351594|FG000|Overall Study|Other|2|||
163173546|NCT02446743|589351595|FG001|Overall Study|Other|3|||
163173547|NCT03086967|589351596|FG000|Overall Study|Screen Failure|2|||
163173548|NCT03086967|589351597|FG001|Overall Study|Screen Failure|2|||
163173549|NCT02230527|589351601|FG000|Overall Study|Withdrawal by Subject|1|||
163173550|NCT02230527|589351602|FG001|Overall Study|Withdrawal by Subject|1|||
163173551|NCT02230527|589351601|FG000|Overall Study|Death|1|||
163173552|NCT02230527|589351602|FG001|Overall Study|Death|0|||
163279576|NCT04955626|589731491|FG022|Open-Label Period|Other|0|||
163279577|NCT04955626|589731492|FG023|Open-Label Period|Other|0|||
163279578|NCT04955626|589731493|FG024|Open-Label Period|Other|0|||
163279579|NCT04955626|589731494|FG025|Open-Label Period|Other|0|||
162932069|NCT00837577|588456497|FG001|Open-label Period|Clinical Adverse Event|2|||
162932070|NCT00837577|588456496|FG000|Open-label Period|Laboratory Adverse Event|0|||
162932071|NCT00837577|588456497|FG001|Open-label Period|Laboratory Adverse Event|1|||
162932072|NCT00837577|588456496|FG000|Open-label Period|Lack of Efficacy|4|||
162932073|NCT00837577|588456497|FG001|Open-label Period|Lack of Efficacy|3|||
162932074|NCT00837577|588456496|FG000|Open-label Period|Withdrawal by Subject|1|||
162932075|NCT00837577|588456497|FG001|Open-label Period|Withdrawal by Subject|2|||
162932076|NCT00837577|588456496|FG000|Open-label Period|Other Reason|1|||
162932077|NCT00837577|588456497|FG001|Open-label Period|Other Reason|1|||
162932078|NCT00971204|588456498|FG000|Overall Study|Did not meet all criteria-not treated|14|||
162932079|NCT00971204|588456498|FG000|Overall Study|Lost to Follow-up|10|||
162932080|NCT02624518|588456499|FG000|Overall Study|Physician Decision|1|||
162932081|NCT02729194|588456500|FG000|Overall Study|Withdrawal by Subject|3|||
162932082|NCT00272961|588456501|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
162932083|NCT00272961|588456502|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
162932084|NCT00272961|588456503|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
162932085|NCT00272961|588456504|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
162932086|NCT00272961|588456505|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
162932087|NCT00272961|588456501|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
162932088|NCT00272961|588456502|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
162932089|NCT00272961|588456503|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
162932090|NCT00272961|588456504|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
162932091|NCT00272961|588456505|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
162932092|NCT00272961|588456501|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
162932093|NCT00272961|588456502|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
162932094|NCT00272961|588456503|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
162932095|NCT00272961|588456504|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
162932096|NCT00272961|588456505|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
162932097|NCT00272961|588456501|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
162932098|NCT00272961|588456502|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
162932099|NCT00272961|588456503|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
162932100|NCT00272961|588456504|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
162932101|NCT00272961|588456505|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
162932102|NCT00272961|588456501|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
162932103|NCT00272961|588456502|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
162932104|NCT00272961|588456503|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
162932105|NCT00272961|588456504|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
162932106|NCT00272961|588456505|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
162932107|NCT00272961|588456501|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
162932108|NCT00272961|588456502|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
162932109|NCT00272961|588456503|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
162932110|NCT00272961|588456504|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
163173553|NCT02230527|589351601|FG000|Overall Study|Lost to Follow-up|2|||
163173554|NCT02230527|589351602|FG001|Overall Study|Lost to Follow-up|1|||
163173555|NCT02230527|589351601|FG000|Overall Study|Other|1|||
163173556|NCT02230527|589351602|FG001|Overall Study|Other|0|||
163173557|NCT01752036|589351603|FG000|Overall Study|Death|2|||
163173558|NCT01011478|589351604|FG000|Overall Study|No follow up data|12|||
163173559|NCT01011478|589351605|FG001|Overall Study|No follow up data|7|||
163173560|NCT04418661|589351608|FG000|Overall Study|Adverse Event|0|||
163173561|NCT04418661|589351609|FG001|Overall Study|Adverse Event|1|||
163173562|NCT04418661|589351610|FG002|Overall Study|Adverse Event|5|||
163173563|NCT04418661|589351611|FG003|Overall Study|Adverse Event|3|||
163173564|NCT04418661|589351612|FG004|Overall Study|Adverse Event|0|||
163173565|NCT04418661|589351613|FG005|Overall Study|Adverse Event|2|||
163279580|NCT04955626|589731495|FG026|Open-Label Period|Other|0|||
163279581|NCT04955626|589731496|FG027|Open-Label Period|Other|0|||
163173566|NCT04418661|589351608|FG000|Overall Study|Progressive disease|4|||
163173567|NCT04418661|589351609|FG001|Overall Study|Progressive disease|11|||
163279582|NCT04955626|589731497|FG028|Open-Label Period|Other|0|||
163279583|NCT04955626|589731498|FG029|Open-Label Period|Other|0|||
163279584|NCT04955626|589731499|FG030|Open-Label Period|Other|0|||
163279585|NCT04955626|589731500|FG031|Open-Label Period|Other|0|||
163173568|NCT04418661|589351610|FG002|Overall Study|Progressive disease|6|||
163173569|NCT04418661|589351611|FG003|Overall Study|Progressive disease|11|||
163173570|NCT04418661|589351612|FG004|Overall Study|Progressive disease|1|||
163173571|NCT04418661|589351613|FG005|Overall Study|Progressive disease|12|||
163173572|NCT04418661|589351608|FG000|Overall Study|Withdrawal by Subject|0|||
163173573|NCT04418661|589351609|FG001|Overall Study|Withdrawal by Subject|1|||
163173574|NCT04418661|589351610|FG002|Overall Study|Withdrawal by Subject|0|||
163173575|NCT04418661|589351611|FG003|Overall Study|Withdrawal by Subject|1|||
163173576|NCT04418661|589351612|FG004|Overall Study|Withdrawal by Subject|0|||
163173577|NCT04418661|589351613|FG005|Overall Study|Withdrawal by Subject|0|||
163173578|NCT04418661|589351608|FG000|Overall Study|Other|0|||
163173579|NCT04418661|589351609|FG001|Overall Study|Other|0|||
163173580|NCT04418661|589351610|FG002|Overall Study|Other|1|||
163173581|NCT04418661|589351611|FG003|Overall Study|Other|3|||
163173582|NCT04418661|589351612|FG004|Overall Study|Other|0|||
163173583|NCT04418661|589351613|FG005|Overall Study|Other|1|||
163173584|NCT03337490|589351614|FG000|Overall Study|Withdrawal by Subject|1|||
163173585|NCT03337490|589351615|FG001|Overall Study|Withdrawal by Subject|0|||
163173586|NCT03337490|589351616|FG002|Overall Study|Withdrawal by Subject|0|||
163173587|NCT03337490|589351614|FG000|Overall Study|Lack of Efficacy|10|||
163173588|NCT03337490|589351615|FG001|Overall Study|Lack of Efficacy|12|||
163173589|NCT03337490|589351616|FG002|Overall Study|Lack of Efficacy|35|||
163173590|NCT03337490|589351614|FG000|Overall Study|Physician Decision|0|||
163173591|NCT03337490|589351615|FG001|Overall Study|Physician Decision|1|||
163173592|NCT03337490|589351616|FG002|Overall Study|Physician Decision|0|||
163173593|NCT03337490|589351614|FG000|Overall Study|Lost to Follow-up|0|||
163173594|NCT03337490|589351615|FG001|Overall Study|Lost to Follow-up|1|||
163173595|NCT03337490|589351616|FG002|Overall Study|Lost to Follow-up|0|||
163173596|NCT00917644|589351617|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
163173597|NCT00917644|589351618|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
163173598|NCT00917644|589351617|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
163173599|NCT00917644|589351618|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
163173600|NCT00917644|589351617|FG000|Period 2: Second Intervention|family emergency|1|||
163173601|NCT00917644|589351618|FG001|Period 2: Second Intervention|family emergency|0|||
163173602|NCT02108262|589351629|FG000|Overall Study|Non-compliance|0|||
163173603|NCT02108262|589351630|FG001|Overall Study|Non-compliance|2|||
163173604|NCT02108262|589351631|FG002|Overall Study|Non-compliance|1|||
163173605|NCT02108262|589351632|FG003|Overall Study|Non-compliance|1|||
163173606|NCT02108262|589351629|FG000|Overall Study|Randomized by error/screen failure|0|||
163173607|NCT02108262|589351630|FG001|Overall Study|Randomized by error/screen failure|0|||
163173608|NCT02108262|589351631|FG002|Overall Study|Randomized by error/screen failure|1|||
163173609|NCT02108262|589351632|FG003|Overall Study|Randomized by error/screen failure|0|||
163173610|NCT02108262|589351629|FG000|Overall Study|Distance to center|0|||
163173611|NCT02108262|589351630|FG001|Overall Study|Distance to center|1|||
163173612|NCT02108262|589351631|FG002|Overall Study|Distance to center|1|||
163173613|NCT02108262|589351632|FG003|Overall Study|Distance to center|0|||
163173614|NCT02108262|589351629|FG000|Overall Study|Adverse Event|0|||
163173615|NCT02108262|589351630|FG001|Overall Study|Adverse Event|11|||
163173616|NCT02108262|589351631|FG002|Overall Study|Adverse Event|6|||
163173617|NCT02108262|589351632|FG003|Overall Study|Adverse Event|12|||
163173618|NCT02108262|589351629|FG000|Overall Study|Death|0|||
163173619|NCT02108262|589351630|FG001|Overall Study|Death|2|||
163173620|NCT02108262|589351631|FG002|Overall Study|Death|2|||
163173621|NCT02108262|589351632|FG003|Overall Study|Death|1|||
163173622|NCT02108262|589351629|FG000|Overall Study|Lost to Follow-up|0|||
163173623|NCT02108262|589351630|FG001|Overall Study|Lost to Follow-up|0|||
163173624|NCT02108262|589351631|FG002|Overall Study|Lost to Follow-up|1|||
163173625|NCT02108262|589351632|FG003|Overall Study|Lost to Follow-up|0|||
163279586|NCT04955626|589731501|FG032|Open-Label Period|Other|0|||
163173626|NCT02108262|589351629|FG000|Overall Study|Physician Decision|0|||
163173627|NCT02108262|589351630|FG001|Overall Study|Physician Decision|0|||
163173628|NCT02108262|589351631|FG002|Overall Study|Physician Decision|2|||
163173629|NCT02108262|589351632|FG003|Overall Study|Physician Decision|0|||
163173630|NCT02108262|589351629|FG000|Overall Study|Withdrawal by Subject|0|||
163173631|NCT02108262|589351630|FG001|Overall Study|Withdrawal by Subject|7|||
163173632|NCT02108262|589351631|FG002|Overall Study|Withdrawal by Subject|3|||
163173633|NCT02108262|589351632|FG003|Overall Study|Withdrawal by Subject|4|||
163173634|NCT02108262|589351629|FG000|Overall Study|Due to key hepatic values|0|||
163173635|NCT02108262|589351630|FG001|Overall Study|Due to key hepatic values|1|||
163173636|NCT02108262|589351631|FG002|Overall Study|Due to key hepatic values|0|||
163173637|NCT02108262|589351632|FG003|Overall Study|Due to key hepatic values|0|||
163173638|NCT02108262|589351629|FG000|Overall Study|Unable to contact patient|0|||
163173639|NCT02108262|589351630|FG001|Overall Study|Unable to contact patient|3|||
163173640|NCT02108262|589351631|FG002|Overall Study|Unable to contact patient|1|||
163173641|NCT02108262|589351632|FG003|Overall Study|Unable to contact patient|2|||
163173642|NCT02108262|589351629|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
163173643|NCT02108262|589351630|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
163279587|NCT04955626|589731502|FG033|Open-Label Period|Other|0|||
162932111|NCT00272961|588456505|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
162932112|NCT00272961|588456501|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
162932113|NCT00272961|588456502|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
162932114|NCT00272961|588456503|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
162932115|NCT00272961|588456504|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
162932116|NCT00272961|588456505|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
162932117|NCT00272961|588456501|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
162932118|NCT00272961|588456502|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
162932119|NCT00272961|588456503|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
162932120|NCT00272961|588456504|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
162932121|NCT00272961|588456505|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
162932122|NCT01507831|588456506|FG000|Overall Study|Randomized but not treated|0|||
162932123|NCT01507831|588456507|FG001|Overall Study|Randomized but not treated|3|||
162932124|NCT01507831|588456506|FG000|Overall Study|Adverse Event|48|||
162932125|NCT01507831|588456507|FG001|Overall Study|Adverse Event|113|||
162932126|NCT01507831|588456506|FG000|Overall Study|Death|6|||
162932127|NCT01507831|588456507|FG001|Overall Study|Death|2|||
162932128|NCT01507831|588456506|FG000|Overall Study|Poor compliance to protocol|38|||
162932129|NCT01507831|588456507|FG001|Overall Study|Poor compliance to protocol|60|||
162932130|NCT01507831|588456506|FG000|Overall Study|Physician Decision|0|||
162932131|NCT01507831|588456507|FG001|Overall Study|Physician Decision|4|||
162932132|NCT01507831|588456506|FG000|Overall Study|Participant moved|5|||
162932133|NCT01507831|588456507|FG001|Overall Study|Participant moved|19|||
162932134|NCT01507831|588456506|FG000|Overall Study|Consent withdrawn by participant|34|||
162932135|NCT01507831|588456507|FG001|Overall Study|Consent withdrawn by participant|72|||
162932136|NCT01507831|588456506|FG000|Overall Study|Related to study drug administration|5|||
162932137|NCT01507831|588456507|FG001|Overall Study|Related to study drug administration|14|||
162932138|NCT01507831|588456506|FG000|Overall Study|Last visit outside protocol visit window|51|||
162932139|NCT01507831|588456507|FG001|Overall Study|Last visit outside protocol visit window|143|||
162932140|NCT01507831|588456506|FG000|Overall Study|Selection criteria finally not met|0|||
162932141|NCT01507831|588456507|FG001|Overall Study|Selection criteria finally not met|1|||
162932142|NCT01507831|588456506|FG000|Overall Study|Site closure|0|||
162932143|NCT01507831|588456507|FG001|Overall Study|Site closure|3|||
162932144|NCT01507831|588456506|FG000|Overall Study|Potential lost to follow-up|3|||
162932145|NCT01507831|588456507|FG001|Overall Study|Potential lost to follow-up|0|||
162932146|NCT01507831|588456506|FG000|Overall Study|Other|3|||
162932147|NCT01507831|588456507|FG001|Overall Study|Other|6|||
162932148|NCT03652961|588456508|FG000|Overall Study|Lost to Follow-up|3|||
162932149|NCT03652961|588456508|FG000|Overall Study|Screen Failure|1|||
162932150|NCT01280981|588456511|FG000|Overall Study|Withdrawal by Subject|11|||
162932151|NCT01280981|588456511|FG000|Overall Study|Protocol Violation|2|||
162932152|NCT01280981|588456511|FG000|Overall Study|Lack of Efficacy|13|||
162932153|NCT01280981|588456511|FG000|Overall Study|Lost to Follow-up|3|||
162932154|NCT01280981|588456511|FG000|Overall Study|Adverse Event|6|||
162932155|NCT01280981|588456511|FG000|Overall Study|Irregular or discontinued menses|3|||
162932156|NCT01280981|588456511|FG000|Overall Study|Failed to return|45|||
162932157|NCT01280981|588456511|FG000|Overall Study|Non-compliance with protocol|3|||
162932158|NCT01280981|588456511|FG000|Overall Study|Withdrawal of consent|3|||
162932159|NCT01280981|588456511|FG000|Overall Study|Elective surgery|2|||
162932160|NCT01280981|588456511|FG000|Overall Study|Study site closure|1|||
162932161|NCT01610167|588456514|FG000|Overall Study|Scheduling conflict.|0|||
162932162|NCT01610167|588456515|FG001|Overall Study|Scheduling conflict.|0|||
162932163|NCT01610167|588456516|FG002|Overall Study|Scheduling conflict.|2|||
162932164|NCT03276962|588456521|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
162932165|NCT03276962|588456522|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
162932166|NCT03276962|588456523|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
162932167|NCT03276962|588456524|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
162932168|NCT03276962|588456525|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
162932169|NCT03276962|588456521|FG000|Overall Study|Protocol Deviation|2|||
162932170|NCT03276962|588456522|FG001|Overall Study|Protocol Deviation|0|||
162932171|NCT03276962|588456523|FG002|Overall Study|Protocol Deviation|1|||
162932172|NCT03276962|588456524|FG003|Overall Study|Protocol Deviation|2|||
162932173|NCT03276962|588456525|FG004|Overall Study|Protocol Deviation|1|||
162932174|NCT03276962|588456521|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
162932175|NCT03276962|588456522|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
162932176|NCT03276962|588456523|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
162932177|NCT03276962|588456524|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
162932178|NCT03276962|588456525|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
162932179|NCT03276962|588456521|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
162932180|NCT03276962|588456522|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
162932181|NCT03276962|588456523|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
162932182|NCT03276962|588456524|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
162932183|NCT03276962|588456525|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
162932184|NCT03276962|588456521|FG000|Overall Study|Lost to Follow-up|10|||
162932185|NCT03276962|588456522|FG001|Overall Study|Lost to Follow-up|10|||
162932186|NCT03276962|588456523|FG002|Overall Study|Lost to Follow-up|4|||
162932187|NCT03276962|588456524|FG003|Overall Study|Lost to Follow-up|6|||
162932188|NCT03276962|588456525|FG004|Overall Study|Lost to Follow-up|10|||
162932189|NCT03276962|588456521|FG000|Overall Study|Other|0|||
162932190|NCT03276962|588456522|FG001|Overall Study|Other|2|||
162932191|NCT03276962|588456523|FG002|Overall Study|Other|0|||
162932192|NCT03276962|588456524|FG003|Overall Study|Other|2|||
162932193|NCT03276962|588456525|FG004|Overall Study|Other|1|||
162932194|NCT01358708|588456526|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
162932195|NCT01358708|588456527|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
162932196|NCT01358708|588456526|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
162932197|NCT01358708|588456527|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
162932198|NCT03056001|588456531|FG000|Overall Study|Death|24|||
162932199|NCT01364298|588456532|FG000|Overall Study|Adverse Event|3|||
162932200|NCT01364298|588456533|FG001|Overall Study|Adverse Event|4|||
162932201|NCT01364298|588456532|FG000|Overall Study|Lack of adherence to treatment|1|||
162932202|NCT01364298|588456533|FG001|Overall Study|Lack of adherence to treatment|3|||
162932203|NCT01364298|588456532|FG000|Overall Study|Lack of Efficacy|1|||
162932204|NCT01364298|588456533|FG001|Overall Study|Lack of Efficacy|0|||
162932205|NCT01364298|588456532|FG000|Overall Study|Lost to Follow-up|5|||
162932206|NCT01364298|588456533|FG001|Overall Study|Lost to Follow-up|10|||
162932207|NCT01364298|588456532|FG000|Overall Study|Withdrawal by Subject|3|||
162932208|NCT01364298|588456533|FG001|Overall Study|Withdrawal by Subject|3|||
162932209|NCT01364298|588456532|FG000|Overall Study|Other|1|||
162932210|NCT01364298|588456533|FG001|Overall Study|Other|3|||
162932211|NCT02766400|588456549|FG000|Overall Study|Death|1|||
162932212|NCT02766400|588456550|FG001|Overall Study|Death|2|||
162932213|NCT02766400|588456549|FG000|Overall Study|Withdrawal by Subject|1|||
162932214|NCT02766400|588456550|FG001|Overall Study|Withdrawal by Subject|0|||
162932215|NCT03499249|588456556|FG000|Overall Study|Physician Decision|1|||
162932216|NCT01374906|588456557|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162932217|NCT01374906|588456558|FG001|Overall Study|Abnormal laboratory value(s)|3|||
162932218|NCT01374906|588456557|FG000|Overall Study|Administrative problems|2|||
162932219|NCT01374906|588456558|FG001|Overall Study|Administrative problems|2|||
162932220|NCT01374906|588456557|FG000|Overall Study|Adverse Event|10|||
162932221|NCT01374906|588456558|FG001|Overall Study|Adverse Event|11|||
162932222|NCT01374906|588456557|FG000|Overall Study|Death|0|||
162932223|NCT01374906|588456558|FG001|Overall Study|Death|2|||
162932224|NCT01374906|588456557|FG000|Overall Study|Protocol Violation|2|||
162932225|NCT01374906|588456558|FG001|Overall Study|Protocol Violation|2|||
162932226|NCT01374906|588456557|FG000|Overall Study|Withdrawal by Subject|15|||
162932227|NCT01374906|588456558|FG001|Overall Study|Withdrawal by Subject|9|||
162932228|NCT01374906|588456557|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
162932229|NCT01374906|588456558|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
162932230|NCT02475980|588456563|FG000|Overall Study|Lost to Follow-up|4|||
162932231|NCT02475980|588456563|FG000|Overall Study|Withdrawal by Subject|1|||
162932232|NCT01458119|588456571|FG000|Overall Study|Physician Decision|4|||
162932233|NCT01458119|588456571|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
162932234|NCT01458119|588456571|FG000|Overall Study|Pregnancy|1|||
162932235|NCT01458119|588456571|FG000|Overall Study|Death|2|||
162932236|NCT01458119|588456571|FG000|Overall Study|Adverse Event|1|||
162932237|NCT01458119|588456571|FG000|Overall Study|Consent Withdrawn by Participant|8|||
162932238|NCT01458119|588456571|FG000|Overall Study|Non-compliance With Study Drug|3|||
162932239|NCT03033069|588456572|FG000|Overall Study|Adverse Event|6|||
162932240|NCT03033069|588456573|FG001|Overall Study|Adverse Event|7|||
162932241|NCT03033069|588456574|FG002|Overall Study|Adverse Event|4|||
162932242|NCT03033069|588456575|FG003|Overall Study|Adverse Event|6|||
162932243|NCT03033069|588456572|FG000|Overall Study|Lack of Efficacy|0|||
162932244|NCT03033069|588456573|FG001|Overall Study|Lack of Efficacy|0|||
162932245|NCT03033069|588456574|FG002|Overall Study|Lack of Efficacy|1|||
162932246|NCT03033069|588456575|FG003|Overall Study|Lack of Efficacy|0|||
162932247|NCT03033069|588456572|FG000|Overall Study|Lost to Follow-up|6|||
162932248|NCT03033069|588456573|FG001|Overall Study|Lost to Follow-up|5|||
162932249|NCT03033069|588456574|FG002|Overall Study|Lost to Follow-up|5|||
162932250|NCT03033069|588456575|FG003|Overall Study|Lost to Follow-up|6|||
162932251|NCT03033069|588456572|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162932252|NCT03033069|588456573|FG001|Overall Study|Non-Compliance With Study Drug|1|||
162932253|NCT03033069|588456574|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163173644|NCT02108262|589351631|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
163173645|NCT02108262|589351632|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
162932254|NCT03033069|588456575|FG003|Overall Study|Non-Compliance With Study Drug|0|||
162932255|NCT03033069|588456572|FG000|Overall Study|Protocol Deviation|0|||
162932256|NCT03033069|588456573|FG001|Overall Study|Protocol Deviation|1|||
162932257|NCT03033069|588456574|FG002|Overall Study|Protocol Deviation|0|||
162932258|NCT03033069|588456575|FG003|Overall Study|Protocol Deviation|0|||
163173646|NCT02108262|589351629|FG000|Overall Study|Patient did not want another infusion|0|||
162932259|NCT03033069|588456572|FG000|Overall Study|Withdrawal by Subject|10|||
162932260|NCT03033069|588456573|FG001|Overall Study|Withdrawal by Subject|10|||
163279588|NCT04955626|589731503|FG034|Open-Label Period|Other|0|||
163279589|NCT04955626|589731504|FG035|Open-Label Period|Other|0|||
163279590|NCT04955626|589731469|FG000|Open-Label Period|Physician Decision|2|||
163279591|NCT04955626|589731470|FG001|Open-Label Period|Physician Decision|0|||
163279592|NCT04955626|589731471|FG002|Open-Label Period|Physician Decision|0|||
163279593|NCT04955626|589731472|FG003|Open-Label Period|Physician Decision|0|||
163279594|NCT04955626|589731473|FG004|Open-Label Period|Physician Decision|0|||
163279595|NCT04955626|589731474|FG005|Open-Label Period|Physician Decision|0|||
163279596|NCT04955626|589731475|FG006|Open-Label Period|Physician Decision|0|||
163279597|NCT04955626|589731476|FG007|Open-Label Period|Physician Decision|0|||
163279598|NCT04955626|589731477|FG008|Open-Label Period|Physician Decision|0|||
163279599|NCT04955626|589731478|FG009|Open-Label Period|Physician Decision|0|||
163279600|NCT04955626|589731479|FG010|Open-Label Period|Physician Decision|0|||
163279601|NCT04955626|589731480|FG011|Open-Label Period|Physician Decision|0|||
163279602|NCT04955626|589731481|FG012|Open-Label Period|Physician Decision|0|||
163279603|NCT04955626|589731482|FG013|Open-Label Period|Physician Decision|0|||
163279604|NCT04955626|589731483|FG014|Open-Label Period|Physician Decision|0|||
163279605|NCT04955626|589731484|FG015|Open-Label Period|Physician Decision|0|||
163279606|NCT04955626|589731485|FG016|Open-Label Period|Physician Decision|0|||
163279607|NCT04955626|589731486|FG017|Open-Label Period|Physician Decision|0|||
163279608|NCT04955626|589731487|FG018|Open-Label Period|Physician Decision|0|||
163279609|NCT04955626|589731488|FG019|Open-Label Period|Physician Decision|0|||
163279610|NCT04955626|589731489|FG020|Open-Label Period|Physician Decision|0|||
163279611|NCT04955626|589731490|FG021|Open-Label Period|Physician Decision|0|||
163279612|NCT04955626|589731491|FG022|Open-Label Period|Physician Decision|0|||
163279613|NCT04955626|589731492|FG023|Open-Label Period|Physician Decision|0|||
163279614|NCT04955626|589731493|FG024|Open-Label Period|Physician Decision|0|||
163279615|NCT04955626|589731494|FG025|Open-Label Period|Physician Decision|0|||
163279616|NCT04955626|589731495|FG026|Open-Label Period|Physician Decision|0|||
163279617|NCT04955626|589731496|FG027|Open-Label Period|Physician Decision|0|||
163279618|NCT04955626|589731497|FG028|Open-Label Period|Physician Decision|0|||
163173647|NCT02108262|589351630|FG001|Overall Study|Patient did not want another infusion|3|||
163173648|NCT02108262|589351631|FG002|Overall Study|Patient did not want another infusion|3|||
163279619|NCT04955626|589731498|FG029|Open-Label Period|Physician Decision|0|||
163279620|NCT04955626|589731499|FG030|Open-Label Period|Physician Decision|0|||
163279621|NCT04955626|589731500|FG031|Open-Label Period|Physician Decision|0|||
163279622|NCT04955626|589731501|FG032|Open-Label Period|Physician Decision|0|||
163279623|NCT04955626|589731502|FG033|Open-Label Period|Physician Decision|0|||
163279624|NCT04955626|589731503|FG034|Open-Label Period|Physician Decision|0|||
163279625|NCT04955626|589731504|FG035|Open-Label Period|Physician Decision|0|||
163279626|NCT04955626|589731469|FG000|Open-Label Period|Withdrawal by Subject|135|||
163279627|NCT04955626|589731470|FG001|Open-Label Period|Withdrawal by Subject|25|||
163279628|NCT04955626|589731471|FG002|Open-Label Period|Withdrawal by Subject|0|||
163279629|NCT04955626|589731472|FG003|Open-Label Period|Withdrawal by Subject|0|||
163279630|NCT04955626|589731473|FG004|Open-Label Period|Withdrawal by Subject|0|||
163279631|NCT04955626|589731474|FG005|Open-Label Period|Withdrawal by Subject|0|||
163279632|NCT04955626|589731475|FG006|Open-Label Period|Withdrawal by Subject|0|||
163279633|NCT04955626|589731476|FG007|Open-Label Period|Withdrawal by Subject|0|||
163279634|NCT04955626|589731477|FG008|Open-Label Period|Withdrawal by Subject|0|||
163279635|NCT04955626|589731478|FG009|Open-Label Period|Withdrawal by Subject|0|||
163279636|NCT04955626|589731479|FG010|Open-Label Period|Withdrawal by Subject|0|||
163279637|NCT04955626|589731480|FG011|Open-Label Period|Withdrawal by Subject|0|||
163279638|NCT04955626|589731481|FG012|Open-Label Period|Withdrawal by Subject|0|||
163279639|NCT04955626|589731482|FG013|Open-Label Period|Withdrawal by Subject|0|||
163279640|NCT04955626|589731483|FG014|Open-Label Period|Withdrawal by Subject|0|||
163173649|NCT02108262|589351632|FG003|Overall Study|Patient did not want another infusion|2|||
163173650|NCT02108262|589351629|FG000|Overall Study|Vacation|0|||
163173651|NCT02108262|589351630|FG001|Overall Study|Vacation|1|||
163173652|NCT02108262|589351631|FG002|Overall Study|Vacation|0|||
163173653|NCT02108262|589351632|FG003|Overall Study|Vacation|0|||
163173654|NCT02108262|589351629|FG000|Overall Study|Patient decision|0|||
163173655|NCT02108262|589351630|FG001|Overall Study|Patient decision|7|||
163173656|NCT02108262|589351631|FG002|Overall Study|Patient decision|9|||
163173657|NCT02108262|589351632|FG003|Overall Study|Patient decision|14|||
163173658|NCT02108262|589351629|FG000|Overall Study|Missed IV due to pharmacy error|0|||
163173659|NCT02108262|589351630|FG001|Overall Study|Missed IV due to pharmacy error|0|||
163173660|NCT02108262|589351631|FG002|Overall Study|Missed IV due to pharmacy error|1|||
163173661|NCT02108262|589351632|FG003|Overall Study|Missed IV due to pharmacy error|0|||
163173662|NCT04449029|589351637|FG000|Overall Study|Adverse Event|0|||
163173663|NCT04449029|589351638|FG001|Overall Study|Adverse Event|1|||
163173664|NCT04449029|589351639|FG002|Overall Study|Adverse Event|1|||
163173665|NCT04449029|589351640|FG003|Overall Study|Adverse Event|0|||
163173666|NCT04449029|589351641|FG004|Overall Study|Adverse Event|1|||
163279641|NCT04955626|589731484|FG015|Open-Label Period|Withdrawal by Subject|0|||
163279642|NCT04955626|589731485|FG016|Open-Label Period|Withdrawal by Subject|0|||
163279643|NCT04955626|589731486|FG017|Open-Label Period|Withdrawal by Subject|0|||
163279644|NCT04955626|589731487|FG018|Open-Label Period|Withdrawal by Subject|0|||
163279645|NCT04955626|589731488|FG019|Open-Label Period|Withdrawal by Subject|0|||
163279646|NCT04955626|589731489|FG020|Open-Label Period|Withdrawal by Subject|0|||
163279647|NCT04955626|589731490|FG021|Open-Label Period|Withdrawal by Subject|0|||
163279648|NCT04955626|589731491|FG022|Open-Label Period|Withdrawal by Subject|0|||
163279649|NCT04955626|589731492|FG023|Open-Label Period|Withdrawal by Subject|0|||
163279650|NCT04955626|589731493|FG024|Open-Label Period|Withdrawal by Subject|0|||
163173667|NCT04449029|589351642|FG005|Overall Study|Adverse Event|0|||
163279651|NCT04955626|589731494|FG025|Open-Label Period|Withdrawal by Subject|0|||
163279652|NCT04955626|589731495|FG026|Open-Label Period|Withdrawal by Subject|0|||
163279653|NCT04955626|589731496|FG027|Open-Label Period|Withdrawal by Subject|0|||
163279654|NCT04955626|589731497|FG028|Open-Label Period|Withdrawal by Subject|0|||
163279655|NCT04955626|589731498|FG029|Open-Label Period|Withdrawal by Subject|0|||
163279656|NCT04955626|589731499|FG030|Open-Label Period|Withdrawal by Subject|0|||
163279657|NCT04955626|589731500|FG031|Open-Label Period|Withdrawal by Subject|0|||
163279658|NCT04955626|589731501|FG032|Open-Label Period|Withdrawal by Subject|0|||
163279659|NCT04955626|589731502|FG033|Open-Label Period|Withdrawal by Subject|0|||
163279660|NCT04955626|589731503|FG034|Open-Label Period|Withdrawal by Subject|0|||
163279661|NCT04955626|589731504|FG035|Open-Label Period|Withdrawal by Subject|0|||
163279662|NCT04955626|589731469|FG000|Open-Label Period|Refused further study procedures|1|||
163279663|NCT04955626|589731470|FG001|Open-Label Period|Refused further study procedures|0|||
163279664|NCT04955626|589731471|FG002|Open-Label Period|Refused further study procedures|0|||
163279665|NCT04955626|589731472|FG003|Open-Label Period|Refused further study procedures|0|||
163279666|NCT04955626|589731473|FG004|Open-Label Period|Refused further study procedures|0|||
163279667|NCT04955626|589731474|FG005|Open-Label Period|Refused further study procedures|0|||
163279668|NCT04955626|589731475|FG006|Open-Label Period|Refused further study procedures|0|||
163279669|NCT04955626|589731476|FG007|Open-Label Period|Refused further study procedures|0|||
163279670|NCT04955626|589731477|FG008|Open-Label Period|Refused further study procedures|0|||
163279671|NCT04955626|589731478|FG009|Open-Label Period|Refused further study procedures|0|||
163279672|NCT04955626|589731479|FG010|Open-Label Period|Refused further study procedures|0|||
163279673|NCT04955626|589731480|FG011|Open-Label Period|Refused further study procedures|0|||
163279674|NCT04955626|589731481|FG012|Open-Label Period|Refused further study procedures|0|||
163279675|NCT04955626|589731482|FG013|Open-Label Period|Refused further study procedures|0|||
163279676|NCT04955626|589731483|FG014|Open-Label Period|Refused further study procedures|0|||
163279677|NCT04955626|589731484|FG015|Open-Label Period|Refused further study procedures|0|||
163279678|NCT04955626|589731485|FG016|Open-Label Period|Refused further study procedures|0|||
163279679|NCT04955626|589731486|FG017|Open-Label Period|Refused further study procedures|0|||
163279680|NCT04955626|589731487|FG018|Open-Label Period|Refused further study procedures|0|||
163279681|NCT04955626|589731488|FG019|Open-Label Period|Refused further study procedures|0|||
163279682|NCT04955626|589731489|FG020|Open-Label Period|Refused further study procedures|0|||
163279683|NCT04955626|589731490|FG021|Open-Label Period|Refused further study procedures|0|||
163279684|NCT04955626|589731491|FG022|Open-Label Period|Refused further study procedures|0|||
163279685|NCT04955626|589731492|FG023|Open-Label Period|Refused further study procedures|0|||
163279686|NCT04955626|589731493|FG024|Open-Label Period|Refused further study procedures|0|||
163279687|NCT04955626|589731494|FG025|Open-Label Period|Refused further study procedures|0|||
163279688|NCT04955626|589731495|FG026|Open-Label Period|Refused further study procedures|0|||
163279689|NCT04955626|589731496|FG027|Open-Label Period|Refused further study procedures|0|||
163279690|NCT04955626|589731497|FG028|Open-Label Period|Refused further study procedures|0|||
163279691|NCT04955626|589731498|FG029|Open-Label Period|Refused further study procedures|0|||
163279692|NCT04955626|589731499|FG030|Open-Label Period|Refused further study procedures|0|||
163279693|NCT04955626|589731500|FG031|Open-Label Period|Refused further study procedures|0|||
163279694|NCT04955626|589731501|FG032|Open-Label Period|Refused further study procedures|0|||
163279695|NCT04955626|589731502|FG033|Open-Label Period|Refused further study procedures|0|||
163279696|NCT04955626|589731503|FG034|Open-Label Period|Refused further study procedures|0|||
163279697|NCT04955626|589731504|FG035|Open-Label Period|Refused further study procedures|0|||
163279698|NCT04955626|589731469|FG000|Open-Label Period|Adverse Event|1|||
163279699|NCT04955626|589731470|FG001|Open-Label Period|Adverse Event|0|||
163279700|NCT04955626|589731471|FG002|Open-Label Period|Adverse Event|0|||
163279701|NCT04955626|589731472|FG003|Open-Label Period|Adverse Event|0|||
163279702|NCT04955626|589731473|FG004|Open-Label Period|Adverse Event|0|||
163279703|NCT04955626|589731474|FG005|Open-Label Period|Adverse Event|0|||
163279704|NCT04955626|589731475|FG006|Open-Label Period|Adverse Event|0|||
163279705|NCT04955626|589731476|FG007|Open-Label Period|Adverse Event|0|||
163279706|NCT04955626|589731477|FG008|Open-Label Period|Adverse Event|0|||
163279707|NCT04955626|589731478|FG009|Open-Label Period|Adverse Event|0|||
163279708|NCT04955626|589731479|FG010|Open-Label Period|Adverse Event|0|||
163279709|NCT04955626|589731480|FG011|Open-Label Period|Adverse Event|0|||
163279710|NCT04955626|589731481|FG012|Open-Label Period|Adverse Event|0|||
163279711|NCT04955626|589731482|FG013|Open-Label Period|Adverse Event|0|||
163279712|NCT04955626|589731483|FG014|Open-Label Period|Adverse Event|0|||
162932261|NCT03033069|588456574|FG002|Overall Study|Withdrawal by Subject|11|||
163279713|NCT04955626|589731484|FG015|Open-Label Period|Adverse Event|0|||
163279714|NCT04955626|589731485|FG016|Open-Label Period|Adverse Event|0|||
163279715|NCT04955626|589731486|FG017|Open-Label Period|Adverse Event|0|||
163279716|NCT04955626|589731487|FG018|Open-Label Period|Adverse Event|0|||
163279717|NCT04955626|589731488|FG019|Open-Label Period|Adverse Event|0|||
163279718|NCT04955626|589731489|FG020|Open-Label Period|Adverse Event|0|||
163279719|NCT04955626|589731490|FG021|Open-Label Period|Adverse Event|0|||
163279720|NCT04955626|589731491|FG022|Open-Label Period|Adverse Event|0|||
163279721|NCT04955626|589731492|FG023|Open-Label Period|Adverse Event|0|||
163173668|NCT04449029|589351643|FG006|Overall Study|Adverse Event|1|||
163173669|NCT04449029|589351644|FG007|Overall Study|Adverse Event|0|||
163173670|NCT04449029|589351637|FG000|Overall Study|Lost to Follow-up|0|||
163173671|NCT04449029|589351638|FG001|Overall Study|Lost to Follow-up|1|||
163173672|NCT04449029|589351639|FG002|Overall Study|Lost to Follow-up|0|||
163173673|NCT04449029|589351640|FG003|Overall Study|Lost to Follow-up|0|||
163173674|NCT04449029|589351641|FG004|Overall Study|Lost to Follow-up|0|||
163173675|NCT04449029|589351642|FG005|Overall Study|Lost to Follow-up|0|||
163173676|NCT04449029|589351643|FG006|Overall Study|Lost to Follow-up|0|||
163173677|NCT04449029|589351644|FG007|Overall Study|Lost to Follow-up|0|||
163173678|NCT04449029|589351637|FG000|Overall Study|Protocol Violation|0|||
163173679|NCT04449029|589351638|FG001|Overall Study|Protocol Violation|1|||
163173680|NCT04449029|589351639|FG002|Overall Study|Protocol Violation|0|||
163173681|NCT04449029|589351640|FG003|Overall Study|Protocol Violation|0|||
163173682|NCT04449029|589351641|FG004|Overall Study|Protocol Violation|0|||
163173683|NCT04449029|589351642|FG005|Overall Study|Protocol Violation|0|||
163173684|NCT04449029|589351643|FG006|Overall Study|Protocol Violation|0|||
163173685|NCT04449029|589351644|FG007|Overall Study|Protocol Violation|0|||
163173686|NCT04449029|589351637|FG000|Overall Study|Physician Decision|0|||
163173687|NCT04449029|589351638|FG001|Overall Study|Physician Decision|0|||
163173688|NCT04449029|589351639|FG002|Overall Study|Physician Decision|0|||
163173689|NCT04449029|589351640|FG003|Overall Study|Physician Decision|0|||
163173690|NCT04449029|589351641|FG004|Overall Study|Physician Decision|0|||
163173691|NCT04449029|589351642|FG005|Overall Study|Physician Decision|1|||
163173692|NCT04449029|589351643|FG006|Overall Study|Physician Decision|0|||
163173693|NCT04449029|589351644|FG007|Overall Study|Physician Decision|0|||
163173694|NCT04449029|589351637|FG000|Overall Study|Withdrawal by Subject|3|||
163173695|NCT04449029|589351638|FG001|Overall Study|Withdrawal by Subject|0|||
163173696|NCT04449029|589351639|FG002|Overall Study|Withdrawal by Subject|1|||
163173697|NCT04449029|589351640|FG003|Overall Study|Withdrawal by Subject|1|||
163173698|NCT04449029|589351641|FG004|Overall Study|Withdrawal by Subject|5|||
163173699|NCT04449029|589351642|FG005|Overall Study|Withdrawal by Subject|1|||
163173700|NCT04449029|589351643|FG006|Overall Study|Withdrawal by Subject|4|||
163173701|NCT04449029|589351644|FG007|Overall Study|Withdrawal by Subject|0|||
163173702|NCT01073462|589351645|FG000|Overall Study|Death|14|||
163173703|NCT01073462|589351645|FG000|Overall Study|Kidney transplant|10|||
163173704|NCT01073462|589351645|FG000|Overall Study|Low parathyroid hormone levels|8|||
163173705|NCT01073462|589351645|FG000|Overall Study|Serious adverse event|2|||
163173706|NCT01073462|589351645|FG000|Overall Study|Lost to Follow-up|7|||
163173707|NCT00247611|589351648|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
163173708|NCT00247611|589351649|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
163173709|NCT00247611|589351648|FG000|Baselined|Completed baseline only|9|||
163173710|NCT00247611|589351649|FG001|Baselined|Completed baseline only|8|||
163173711|NCT00392379|589351653|FG000|Overall Study|Withdrawal by Subject|17|||
163173712|NCT00392379|589351654|FG001|Overall Study|Withdrawal by Subject|28|||
163173713|NCT00392379|589351653|FG000|Overall Study|Lost to Follow-up|4|||
163173714|NCT00392379|589351654|FG001|Overall Study|Lost to Follow-up|9|||
163173715|NCT00392379|589351653|FG000|Overall Study|Adverse Event|1|||
163173716|NCT00392379|589351654|FG001|Overall Study|Adverse Event|1|||
163173717|NCT01700387|589351660|FG000|Overall Study|Withdrawal by Subject|1|||
163173718|NCT01700387|589351661|FG001|Overall Study|Withdrawal by Subject|2|||
163173719|NCT01700387|589351660|FG000|Overall Study|Adverse Event|1|||
163173720|NCT01700387|589351661|FG001|Overall Study|Adverse Event|1|||
163173721|NCT01700387|589351660|FG000|Overall Study|Lost to Follow-up|2|||
163173722|NCT01700387|589351661|FG001|Overall Study|Lost to Follow-up|1|||
163173723|NCT02730793|589351664|FG000|Overall Study|Physician Decision|0|||
163173724|NCT02730793|589351665|FG001|Overall Study|Physician Decision|1|||
163173725|NCT02730793|589351664|FG000|Overall Study|Withdrawal by Subject|0|||
163173726|NCT02730793|589351665|FG001|Overall Study|Withdrawal by Subject|1|||
163173727|NCT02365233|589351666|FG000|Overall Study|IRB withheld the data|1|||
163173728|NCT02365233|589351667|FG001|Overall Study|IRB withheld the data|2|||
163173729|NCT02365233|589351668|FG002|Overall Study|IRB withheld the data|2|||
163173730|NCT00934843|589351669|FG000|Overall Study|Protocol Violation|0|||
163173731|NCT00934843|589351670|FG001|Overall Study|Protocol Violation|1|||
163173732|NCT00160667|589351671|FG000|Overall Study|Adverse Event|3|||
163173733|NCT00160667|589351672|FG001|Overall Study|Adverse Event|1|||
163173734|NCT00160667|589351673|FG002|Overall Study|Adverse Event|4|||
163173735|NCT00160667|589351671|FG000|Overall Study|Withdrawal by Subject|2|||
163173736|NCT00160667|589351672|FG001|Overall Study|Withdrawal by Subject|0|||
163173737|NCT00160667|589351673|FG002|Overall Study|Withdrawal by Subject|1|||
163173738|NCT00160667|589351671|FG000|Overall Study|Lack of Efficacy|0|||
163279722|NCT04955626|589731493|FG024|Open-Label Period|Adverse Event|0|||
163173739|NCT00160667|589351672|FG001|Overall Study|Lack of Efficacy|1|||
163173740|NCT00160667|589351673|FG002|Overall Study|Lack of Efficacy|0|||
163173741|NCT00160667|589351671|FG000|Overall Study|Protocol Violation|0|||
163173742|NCT00160667|589351672|FG001|Overall Study|Protocol Violation|1|||
163173743|NCT00160667|589351673|FG002|Overall Study|Protocol Violation|0|||
163173744|NCT00160667|589351671|FG000|Overall Study|Patient decision|0|||
163173745|NCT00160667|589351672|FG001|Overall Study|Patient decision|0|||
163279723|NCT04955626|589731494|FG025|Open-Label Period|Adverse Event|0|||
163279724|NCT04955626|589731495|FG026|Open-Label Period|Adverse Event|0|||
163279725|NCT04955626|589731496|FG027|Open-Label Period|Adverse Event|0|||
163279726|NCT04955626|589731497|FG028|Open-Label Period|Adverse Event|0|||
163279727|NCT04955626|589731498|FG029|Open-Label Period|Adverse Event|0|||
163279728|NCT04955626|589731499|FG030|Open-Label Period|Adverse Event|0|||
163279729|NCT04955626|589731500|FG031|Open-Label Period|Adverse Event|0|||
163279730|NCT04955626|589731501|FG032|Open-Label Period|Adverse Event|0|||
163279731|NCT04955626|589731502|FG033|Open-Label Period|Adverse Event|0|||
163279732|NCT04955626|589731503|FG034|Open-Label Period|Adverse Event|0|||
163279733|NCT04955626|589731504|FG035|Open-Label Period|Adverse Event|0|||
163279734|NCT04955626|589731469|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
163279735|NCT04955626|589731470|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
163279736|NCT04955626|589731471|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
163279737|NCT04955626|589731472|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
163279738|NCT04955626|589731473|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
163279739|NCT04955626|589731474|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
163279740|NCT04955626|589731475|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
163279741|NCT04955626|589731476|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
163279742|NCT04955626|589731477|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
163279743|NCT04955626|589731478|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
163279744|NCT04955626|589731479|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
163279745|NCT04955626|589731480|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
163279746|NCT04955626|589731481|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
163279747|NCT04955626|589731482|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
163279748|NCT04955626|589731483|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
163279749|NCT04955626|589731484|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
163279750|NCT04955626|589731485|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
163279751|NCT04955626|589731486|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
163279752|NCT04955626|589731487|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
163279753|NCT04955626|589731488|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
163279754|NCT04955626|589731489|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
163279755|NCT04955626|589731490|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
163279756|NCT04955626|589731491|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
163279757|NCT04955626|589731492|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
163279758|NCT04955626|589731493|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
163279759|NCT04955626|589731494|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
163279760|NCT04955626|589731495|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
163279761|NCT04955626|589731496|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
163279762|NCT04955626|589731497|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
163279763|NCT04955626|589731498|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
163279764|NCT04955626|589731499|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
163279765|NCT04955626|589731500|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
163279766|NCT04955626|589731501|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
163279767|NCT04955626|589731502|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
163279768|NCT04955626|589731503|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
163279769|NCT04955626|589731504|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
163279770|NCT04955626|589731469|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279771|NCT04955626|589731470|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
163279772|NCT04955626|589731471|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279773|NCT04955626|589731472|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279774|NCT04955626|589731473|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279775|NCT04955626|589731474|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279776|NCT04955626|589731475|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279777|NCT04955626|589731476|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279778|NCT04955626|589731477|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279779|NCT04955626|589731478|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279780|NCT04955626|589731479|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279781|NCT04955626|589731480|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279782|NCT04955626|589731481|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279783|NCT04955626|589731482|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279784|NCT04955626|589731483|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279785|NCT04955626|589731484|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279786|NCT04955626|589731485|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279787|NCT04955626|589731486|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279788|NCT04955626|589731487|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279789|NCT04955626|589731488|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279790|NCT04955626|589731489|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279791|NCT04955626|589731490|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279792|NCT04955626|589731491|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279793|NCT04955626|589731492|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279794|NCT04955626|589731493|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279795|NCT04955626|589731494|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279796|NCT04955626|589731495|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279797|NCT04955626|589731496|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279798|NCT04955626|589731497|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279799|NCT04955626|589731498|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279800|NCT04955626|589731499|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279801|NCT04955626|589731500|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279802|NCT04955626|589731501|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279803|NCT04955626|589731502|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279804|NCT04955626|589731503|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279805|NCT04955626|589731504|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163279806|NCT03473756|589731505|FG000|Overall Study|Withdrawal by Subject|1|||
163279807|NCT03473756|589731506|FG001|Overall Study|Withdrawal by Subject|4|||
163279808|NCT03473756|589731505|FG000|Overall Study|Adverse Event|6|||
163279809|NCT03473756|589731506|FG001|Overall Study|Adverse Event|7|||
163279810|NCT03473756|589731505|FG000|Overall Study|Lack of Efficacy|3|||
163279811|NCT03473756|589731506|FG001|Overall Study|Lack of Efficacy|10|||
163279812|NCT03473756|589731505|FG000|Overall Study|Physician Decision|0|||
163279813|NCT03473756|589731506|FG001|Overall Study|Physician Decision|2|||
163279814|NCT03473756|589731505|FG000|Overall Study|End of study treatment|0|||
163279815|NCT03473756|589731506|FG001|Overall Study|End of study treatment|2|||
163279816|NCT03473756|589731505|FG000|Overall Study|Lost to Follow-up|0|||
163279817|NCT03473756|589731506|FG001|Overall Study|Lost to Follow-up|1|||
163279818|NCT03714022|589731507|FG000|Overall Study|Adverse Event|1|||
163279819|NCT03714022|589731508|FG001|Overall Study|Adverse Event|0|||
163279820|NCT03714022|589731507|FG000|Overall Study|Consent withdrawal|0|||
163279821|NCT03714022|589731508|FG001|Overall Study|Consent withdrawal|1|||
163279822|NCT03714022|589731507|FG000|Overall Study|Lost to Follow-up|3|||
163279823|NCT03714022|589731508|FG001|Overall Study|Lost to Follow-up|2|||
163279824|NCT02487446|589731514|FG000|Period 1|Physician Decision|0|||
163279825|NCT02487446|589731515|FG001|Period 1|Physician Decision|1|||
163279826|NCT02487446|589731514|FG000|Period 1|Lack of Efficacy|1|||
163279827|NCT02487446|589731515|FG001|Period 1|Lack of Efficacy|0|||
163279828|NCT02487446|589731514|FG000|Period 1|Protocol deviation|3|||
163279829|NCT02487446|589731515|FG001|Period 1|Protocol deviation|2|||
163279830|NCT02487446|589731514|FG000|Period 1|Lost to Follow-up|2|||
163279831|NCT02487446|589731515|FG001|Period 1|Lost to Follow-up|0|||
163279832|NCT02487446|589731514|FG000|Period 1|Withdrawal by Subject|2|||
163279833|NCT02487446|589731515|FG001|Period 1|Withdrawal by Subject|0|||
163279834|NCT02487446|589731514|FG000|Period 1|Adverse Event|5|||
163279835|NCT02487446|589731515|FG001|Period 1|Adverse Event|5|||
163279836|NCT02487446|589731514|FG000|Washout|Lost to Follow-up|0|||
163279837|NCT02487446|589731515|FG001|Washout|Lost to Follow-up|2|||
163279838|NCT02487446|589731514|FG000|Washout|Withdrawal by Subject|1|||
163279839|NCT02487446|589731515|FG001|Washout|Withdrawal by Subject|4|||
163279840|NCT02487446|589731514|FG000|Washout|Adverse Event|2|||
163279841|NCT02487446|589731515|FG001|Washout|Adverse Event|2|||
163279842|NCT02487446|589731514|FG000|Period 2|Protocol deviation|0|||
163279843|NCT02487446|589731515|FG001|Period 2|Protocol deviation|1|||
163279844|NCT02487446|589731514|FG000|Period 2|Lost to Follow-up|1|||
163279845|NCT02487446|589731515|FG001|Period 2|Lost to Follow-up|1|||
163279846|NCT02487446|589731514|FG000|Period 2|Withdrawal by Subject|1|||
163279847|NCT02487446|589731515|FG001|Period 2|Withdrawal by Subject|1|||
163279848|NCT02487446|589731514|FG000|Period 2|Adverse Event|6|||
163279849|NCT02487446|589731515|FG001|Period 2|Adverse Event|2|||
162932262|NCT03033069|588456575|FG003|Overall Study|Withdrawal by Subject|6|||
163279850|NCT02234310|589731516|FG000|Overall Study|Physician Decision|1|||
163279851|NCT02234310|589731516|FG000|Overall Study|Adverse Event|1|||
163279852|NCT02234310|589731516|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
163279853|NCT02234310|589731516|FG000|Overall Study|Withdrawal by Subject|2|||
163279854|NCT03289455|589731517|FG000|Overall Study|Death|1|||
163279855|NCT03289455|589731518|FG001|Overall Study|Death|0|||
163279856|NCT03289455|589731519|FG002|Overall Study|Death|0|||
163279857|NCT03289455|589731517|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
163279858|NCT03289455|589731518|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
163279859|NCT03289455|589731519|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
163279860|NCT03289455|589731517|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
163279861|NCT03289455|589731518|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
163279862|NCT03289455|589731519|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
163279863|NCT03289455|589731517|FG000|Overall Study|Progressive disease|3|||
163279864|NCT03289455|589731518|FG001|Overall Study|Progressive disease|4|||
163279865|NCT03289455|589731519|FG002|Overall Study|Progressive disease|5|||
163279866|NCT04951479|589731520|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
163279867|NCT03706690|589731521|FG000|Overall Study|Withdrawal by Subject|8|||
163279868|NCT03706690|589731522|FG001|Overall Study|Withdrawal by Subject|8|||
163279869|NCT03706690|589731521|FG000|Overall Study|Death|143|||
163279870|NCT03706690|589731522|FG001|Overall Study|Death|75|||
163279871|NCT03706690|589731521|FG000|Overall Study|Ongoing at DCO|121|||
163173746|NCT00160667|589351673|FG002|Overall Study|Patient decision|1|||
163173747|NCT00995566|589351681|FG000|Overall Study|Adverse Event|2|||
163173748|NCT00995566|589351681|FG000|Overall Study|Early study termination|52|||
163173749|NCT00336583|589352910|FG000|Overall Study|Lost to Follow-up|1|||
163173750|NCT00336583|589352910|FG000|Overall Study|Death|1|||
163173751|NCT03224598|589352913|FG000|Overall Study|Lost to Follow-up|0|||
163173752|NCT03224598|589352914|FG001|Overall Study|Lost to Follow-up|2|||
163173753|NCT03224598|589352915|FG002|Overall Study|Lost to Follow-up|0|||
163173754|NCT03224598|589352913|FG000|Overall Study|Other|0|||
163173755|NCT03224598|589352914|FG001|Overall Study|Other|1|||
163173756|NCT03224598|589352915|FG002|Overall Study|Other|0|||
163173757|NCT03328182|589352918|FG000|Overall Study|Withdrawal by Subject|1|||
163173758|NCT03328182|589352918|FG000|Overall Study|Protocol Violation|2|||
163173759|NCT03328182|589352918|FG000|Overall Study|No Product Evaluated|1|||
163173760|NCT01095094|589352919|FG000|Overall Study|Withdrawal by Subject|1|||
163173761|NCT01095094|589352919|FG000|Overall Study|Death|1|||
163173762|NCT01095094|589352919|FG000|Overall Study|Physician Decision|1|||
163173763|NCT00137839|589352923|FG000|Overall Study|Adverse Event|7|||
163173764|NCT00137839|589352923|FG000|Overall Study|Physician Decision|7|||
163173765|NCT00137839|589352923|FG000|Overall Study|Death|8|||
163173766|NCT00137839|589352923|FG000|Overall Study|Disease Progression|60|||
163173767|NCT00137839|589352923|FG000|Overall Study|Not Start Treatment|1|||
163173768|NCT00137839|589352923|FG000|Overall Study|Prolonged Treatment Delay|1|||
163173769|NCT03860935|589352928|FG000|Overall Study|Withdrawal of Consent|15|||
163173770|NCT03860935|589352929|FG001|Overall Study|Withdrawal of Consent|6|||
163173771|NCT03860935|589352928|FG000|Overall Study|Death|75|||
163173772|NCT03860935|589352929|FG001|Overall Study|Death|51|||
163173773|NCT03361176|589352933|FG000|Overall Study|Lost to Follow-up|1|||
163173774|NCT03361176|589352934|FG001|Overall Study|Lost to Follow-up|2|||
163173775|NCT03361176|589352933|FG000|Overall Study|Adverse Event|0|||
163173776|NCT03361176|589352934|FG001|Overall Study|Adverse Event|2|||
163173777|NCT03361176|589352933|FG000|Overall Study|Withdrawal by Subject|0|||
163173778|NCT03361176|589352934|FG001|Overall Study|Withdrawal by Subject|1|||
163173779|NCT04461600|589352935|FG000|Overall Study|Death|6|||
163173780|NCT04461600|589352936|FG001|Overall Study|Death|5|||
163173781|NCT04461600|589352935|FG000|Overall Study|Withdrawal by Subject|0|||
163173782|NCT04461600|589352936|FG001|Overall Study|Withdrawal by Subject|1|||
163173783|NCT01437995|589352938|FG000|Overall Study|Lost to Follow-up|11|||
163173784|NCT01437995|589352939|FG001|Overall Study|Lost to Follow-up|18|||
163173785|NCT01437995|589352940|FG002|Overall Study|Lost to Follow-up|20|||
163173786|NCT04456673|589352941|FG000|Overall Study|Adverse Event|7|||
163173787|NCT04456673|589352942|FG001|Overall Study|Adverse Event|14|||
163173788|NCT04456673|589352941|FG000|Overall Study|Poor compliance to protocol|1|||
163173789|NCT04456673|589352942|FG001|Overall Study|Poor compliance to protocol|0|||
163173790|NCT04456673|589352941|FG000|Overall Study|Withdrawal by Subject|31|||
163173791|NCT04456673|589352942|FG001|Overall Study|Withdrawal by Subject|23|||
163173792|NCT04456673|589352941|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
163173793|NCT04456673|589352942|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
163173794|NCT02160002|589352943|FG000|Overall Study|Withdrawal by Subject|2|||
163173795|NCT02160002|589352944|FG001|Overall Study|Withdrawal by Subject|1|||
163173796|NCT04395001|589352946|FG000|Overall Study|Lost to Follow-up|8|||
163173797|NCT04395001|589352947|FG001|Overall Study|Lost to Follow-up|9|||
163173798|NCT04395001|589352948|FG002|Overall Study|Lost to Follow-up|5|||
163173799|NCT04395001|589352946|FG000|Overall Study|Withdrawal by Subject|3|||
163173800|NCT04395001|589352947|FG001|Overall Study|Withdrawal by Subject|1|||
163173801|NCT04395001|589352948|FG002|Overall Study|Withdrawal by Subject|3|||
163173802|NCT04395001|589352946|FG000|Overall Study|missed appointment|7|||
163173803|NCT04395001|589352947|FG001|Overall Study|missed appointment|4|||
163173804|NCT04395001|589352948|FG002|Overall Study|missed appointment|1|||
163173805|NCT01689532|589352949|FG000|Overall Study|Adverse Event|9|||
163173806|NCT01689532|589352950|FG001|Overall Study|Adverse Event|5|||
163173807|NCT01689532|589352949|FG000|Overall Study|Lack of Efficacy|2|||
163173808|NCT01689532|589352950|FG001|Overall Study|Lack of Efficacy|2|||
163173809|NCT01689532|589352949|FG000|Overall Study|Withdrawal by Subject|1|||
163173810|NCT01689532|589352950|FG001|Overall Study|Withdrawal by Subject|2|||
163173811|NCT01689532|589352949|FG000|Overall Study|Physician Decision|2|||
162932263|NCT03033069|588456572|FG000|Overall Study|Withdrawal By Caregiver|1|||
162932264|NCT03033069|588456573|FG001|Overall Study|Withdrawal By Caregiver|0|||
162932265|NCT03033069|588456574|FG002|Overall Study|Withdrawal By Caregiver|0|||
162932266|NCT03033069|588456575|FG003|Overall Study|Withdrawal By Caregiver|0|||
163173812|NCT01689532|589352950|FG001|Overall Study|Physician Decision|0|||
163173813|NCT01363349|589352951|FG000|Overall Study|Adverse Event|6|||
163173814|NCT01363349|589352952|FG001|Overall Study|Adverse Event|7|||
163173815|NCT01363349|589352951|FG000|Overall Study|Lack of Efficacy|3|||
163173816|NCT01363349|589352952|FG001|Overall Study|Lack of Efficacy|10|||
163173817|NCT01363349|589352951|FG000|Overall Study|Non compliance/Protocol deviations|2|||
163173818|NCT01363349|589352952|FG001|Overall Study|Non compliance/Protocol deviations|2|||
163173819|NCT01363349|589352951|FG000|Overall Study|Withdrawal by Subject|14|||
163173820|NCT01363349|589352952|FG001|Overall Study|Withdrawal by Subject|6|||
163173821|NCT01363349|589352951|FG000|Overall Study|Lost to Follow-up|5|||
163173822|NCT01363349|589352952|FG001|Overall Study|Lost to Follow-up|6|||
163173823|NCT01363349|589352951|FG000|Overall Study|Not reported|36|||
163173824|NCT01363349|589352952|FG001|Overall Study|Not reported|37|||
163173825|NCT01363349|589352951|FG000|Overall Study|missing|1|||
163173826|NCT01363349|589352952|FG001|Overall Study|missing|2|||
163173827|NCT05508074|589352953|FG000|Overall Study|Death|2|||
163173828|NCT05508074|589352954|FG001|Overall Study|Death|5|||
163173829|NCT05508074|589352953|FG000|Overall Study|Withdrawal by Subject|1|||
163173830|NCT05508074|589352954|FG001|Overall Study|Withdrawal by Subject|2|||
163173831|NCT05508074|589352953|FG000|Overall Study|Adverse Event|0|||
163173832|NCT05508074|589352954|FG001|Overall Study|Adverse Event|1|||
163173833|NCT05508074|589352953|FG000|Overall Study|Physician Decision|0|||
163173834|NCT05508074|589352954|FG001|Overall Study|Physician Decision|1|||
163173835|NCT05508074|589352953|FG000|Overall Study|wrongly randomized|0|||
163173836|NCT05508074|589352954|FG001|Overall Study|wrongly randomized|1|||
163173837|NCT05508074|589352953|FG000|Overall Study|non-compliance|0|||
163173838|NCT05508074|589352954|FG001|Overall Study|non-compliance|1|||
163173839|NCT02142387|589352955|FG000|Overall Study|<19 years old|49|||
163173840|NCT02142387|589352956|FG001|Overall Study|<19 years old|326|||
163173841|NCT02142387|589352955|FG000|Overall Study|non-cardiac etiology|504|||
163173842|NCT02142387|589352956|FG001|Overall Study|non-cardiac etiology|3431|||
163173843|NCT02142387|589352955|FG000|Overall Study|CPR not performed|74|||
163173844|NCT02142387|589352956|FG001|Overall Study|CPR not performed|473|||
163173845|NCT02142387|589352955|FG000|Overall Study|witnessed by paramedic|139|||
163173846|NCT02142387|589352956|FG001|Overall Study|witnessed by paramedic|917|||
163173847|NCT02142387|589352955|FG000|Overall Study|incomplete data|1|||
163173848|NCT02142387|589352956|FG001|Overall Study|incomplete data|9|||
163173849|NCT02142387|589352955|FG000|Overall Study|occurred not at home|298|||
163173850|NCT02142387|589352956|FG001|Overall Study|occurred not at home|2474|||
163173851|NCT01101308|589352957|FG000|Period 1|Adverse Event|2|||
163173852|NCT01101308|589352958|FG001|Period 1|Adverse Event|1|||
163173853|NCT01101308|589352957|FG000|Period 1|Positive for cotinine|1|||
163173854|NCT01101308|589352958|FG001|Period 1|Positive for cotinine|0|||
163173855|NCT02984943|589352959|FG000|Overall Study|Withdrawal by Subject|3|||
163173856|NCT02984943|589352959|FG000|Overall Study|Physician Decision|1|||
163173857|NCT02282345|589352962|FG000|Overall Study|Progression|0|||
163173858|NCT02282345|589352963|FG001|Overall Study|Progression|1|||
163173859|NCT02296138|589352964|FG000|Overall Study|Adverse Event|348|||
163173860|NCT02296138|589352965|FG001|Overall Study|Adverse Event|259|||
163173861|NCT02296138|589352964|FG000|Overall Study|Lack of Efficacy|59|||
163173862|NCT02296138|589352965|FG001|Overall Study|Lack of Efficacy|37|||
163173863|NCT02296138|589352964|FG000|Overall Study|Protocol Violation|35|||
163173864|NCT02296138|589352965|FG001|Overall Study|Protocol Violation|36|||
163173865|NCT02296138|589352964|FG000|Overall Study|Lost to Follow-up|9|||
163173866|NCT02296138|589352965|FG001|Overall Study|Lost to Follow-up|12|||
163173867|NCT02296138|589352964|FG000|Overall Study|Withdrawal by Subject|184|||
163173868|NCT02296138|589352965|FG001|Overall Study|Withdrawal by Subject|131|||
162932267|NCT03033069|588456572|FG000|Overall Study|Reason not Specified|0|||
163173869|NCT02296138|589352964|FG000|Overall Study|Not Treated|1|||
162932268|NCT03033069|588456573|FG001|Overall Study|Reason not Specified|1|||
162932269|NCT03033069|588456574|FG002|Overall Study|Reason not Specified|0|||
163173870|NCT02296138|589352965|FG001|Overall Study|Not Treated|1|||
163173871|NCT02296138|589352964|FG000|Overall Study|Patients with data irregularities|10|||
163173872|NCT02296138|589352965|FG001|Overall Study|Patients with data irregularities|11|||
163173873|NCT02296138|589352964|FG000|Overall Study|Other than specified|15|||
163173874|NCT02296138|589352965|FG001|Overall Study|Other than specified|13|||
163173875|NCT00711516|589352966|FG000|Overall Study|Adverse Event|1|||
163173876|NCT00711516|589352967|FG001|Overall Study|Adverse Event|1|||
163173877|NCT00711516|589352966|FG000|Overall Study|Withdrawal by Subject|0|||
163173878|NCT00711516|589352967|FG001|Overall Study|Withdrawal by Subject|1|||
163173879|NCT00711516|589352966|FG000|Overall Study|Protocol Violation|0|||
163173880|NCT00711516|589352967|FG001|Overall Study|Protocol Violation|1|||
163173881|NCT02692651|589352968|FG000|Study Treatment|Death|7|||
163173882|NCT02692651|589352969|FG001|Study Treatment|Death|3|||
163173883|NCT02692651|589352968|FG000|Study Treatment|comfort care|1|||
163173884|NCT02692651|589352969|FG001|Study Treatment|comfort care|1|||
163173885|NCT02692651|589352968|FG000|Study Treatment|Protocol violation per treating team preference|8|||
163173886|NCT02692651|589352969|FG001|Study Treatment|Protocol violation per treating team preference|6|||
163173887|NCT02692651|589352968|FG000|Post Study Treatment Follow-up|Death|4|||
163173888|NCT02692651|589352969|FG001|Post Study Treatment Follow-up|Death|4|||
163173889|NCT03490981|589352970|FG000|Overall Study|Lost to Follow-up|1|||
163173890|NCT03490981|589352971|FG001|Overall Study|Lost to Follow-up|2|||
163173891|NCT02480712|589352972|FG000|Overall Study|Enrolled but Never Treated|1|||
163173892|NCT02480712|589352972|FG000|Overall Study|Lost to Follow-up|5|||
163173893|NCT02480712|589352972|FG000|Overall Study|Withdrew Consent|3|||
163173894|NCT02480712|589352972|FG000|Overall Study|Death|1|||
163173895|NCT02480712|589352972|FG000|Overall Study|Lack of Efficacy|1|||
163173896|NCT01860846|589352979|FG000|Overall Study|Lost to Follow-up|33|||
163173897|NCT00466687|589352980|FG000|Overall Study|Adverse Event|1|||
163173898|NCT00466687|589352980|FG000|Overall Study|Other complicating illness|3|||
163173899|NCT00466687|589352980|FG000|Overall Study|Withdrawal by Subject|1|||
163173900|NCT00466687|589352980|FG000|Overall Study|Disease progression|29|||
163173901|NCT02586506|589352981|FG000|Overall Study|Protocol Violation|6|||
163173902|NCT02586506|589352981|FG000|Overall Study|Lost to Follow-up|1|||
163173903|NCT02586506|589352981|FG000|Overall Study|Other Reason|2|||
163173904|NCT00770146|589352982|FG000|Treatment Period|Withdrawal by Subject|6|||
163173905|NCT00770146|589352983|FG001|Treatment Period|Withdrawal by Subject|13|||
163173906|NCT00770146|589352982|FG000|Treatment Period|Adverse Event|2|||
163173907|NCT00770146|589352983|FG001|Treatment Period|Adverse Event|26|||
163173908|NCT00770146|589352982|FG000|Treatment Period|Other|1|||
163173909|NCT00770146|589352983|FG001|Treatment Period|Other|5|||
163173910|NCT00770146|589352982|FG000|Treatment Period|Protocol non-compliance|0|||
163173911|NCT00770146|589352983|FG001|Treatment Period|Protocol non-compliance|1|||
163173912|NCT00770146|589352982|FG000|Follow-up Period|Withdrawal by Subject|7|||
163173913|NCT00770146|589352983|FG001|Follow-up Period|Withdrawal by Subject|13|||
163173914|NCT00770146|589352982|FG000|Follow-up Period|Adverse Event|0|||
163173915|NCT00770146|589352983|FG001|Follow-up Period|Adverse Event|2|||
163173916|NCT00770146|589352982|FG000|Follow-up Period|Other|4|||
163173917|NCT00770146|589352983|FG001|Follow-up Period|Other|5|||
163173918|NCT01525901|589352984|FG000|Period 2: 12 Weeks|Adverse Event|0|||
163173919|NCT01525901|589352985|FG001|Period 2: 12 Weeks|Adverse Event|1|||
163173920|NCT01525901|589352986|FG002|Period 2: 12 Weeks|Adverse Event|0|||
163173921|NCT01525901|589352987|FG003|Period 2: 12 Weeks|Adverse Event|0|||
163173922|NCT01509053|589352988|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
163173923|NCT01509053|589352988|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
163173924|NCT01509053|589352988|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
163173925|NCT01509053|589352988|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
163173926|NCT01509053|589352988|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
163173927|NCT01509053|589352988|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
163173928|NCT00834080|589352989|FG000|Overall Study|Adverse Event|7|||
163173929|NCT00834080|589352989|FG000|Overall Study|Lost to Follow-up|7|||
163173930|NCT00834080|589352989|FG000|Overall Study|Withdrawal by Subject|5|||
163173931|NCT00834080|589352989|FG000|Overall Study|Other - Pregnancy|1|||
163173932|NCT00834080|589352989|FG000|Overall Study|Other - False positive tests of the UDS|1|||
163173933|NCT00834080|589352989|FG000|Overall Study|Physician Decision|1|||
163173934|NCT00834080|589352989|FG000|Overall Study|Subject Relocated|1|||
163173935|NCT04345367|589352991|FG000|Overall Study|Other|3|||
163173936|NCT04345367|589352992|FG001|Overall Study|Other|4|||
163173937|NCT04345367|589352991|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
163173938|NCT04345367|589352992|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
163173939|NCT04345367|589352991|FG000|Overall Study|Withdrawal by Subject|11|||
163173940|NCT04345367|589352992|FG001|Overall Study|Withdrawal by Subject|11|||
163173941|NCT04345367|589352991|FG000|Overall Study|Protocol Violation|4|||
163173942|NCT04345367|589352992|FG001|Overall Study|Protocol Violation|3|||
163173943|NCT04345367|589352991|FG000|Overall Study|Lost to Follow-up|2|||
163173944|NCT04345367|589352992|FG001|Overall Study|Lost to Follow-up|4|||
163173945|NCT04345367|589352991|FG000|Overall Study|Lack of Efficacy|2|||
163173946|NCT04345367|589352992|FG001|Overall Study|Lack of Efficacy|0|||
163173947|NCT04345367|589352991|FG000|Overall Study|Death|2|||
163173948|NCT04345367|589352992|FG001|Overall Study|Death|0|||
163173949|NCT04345367|589352991|FG000|Overall Study|Adverse Event|10|||
163173950|NCT04345367|589352992|FG001|Overall Study|Adverse Event|9|||
163173951|NCT00439738|589352996|FG000|Overall Study|Withdrawal by Subject|16|||
163173952|NCT00439738|589352997|FG001|Overall Study|Withdrawal by Subject|13|||
163173953|NCT00439738|589352996|FG000|Overall Study|Adverse Event|6|||
163173954|NCT00439738|589352997|FG001|Overall Study|Adverse Event|4|||
163173955|NCT00439738|589352996|FG000|Overall Study|Lost to Follow-up|5|||
163173956|NCT00439738|589352997|FG001|Overall Study|Lost to Follow-up|6|||
163173957|NCT00439738|589352996|FG000|Overall Study|Protocol Violation|6|||
163173958|NCT00439738|589352997|FG001|Overall Study|Protocol Violation|3|||
163173959|NCT00439738|589352996|FG000|Overall Study|Lack of Efficacy|2|||
163173960|NCT00439738|589352997|FG001|Overall Study|Lack of Efficacy|2|||
163173961|NCT00439738|589352996|FG000|Overall Study|Abnormal Lab Values|1|||
163173962|NCT00439738|589352997|FG001|Overall Study|Abnormal Lab Values|0|||
163173963|NCT00781885|589353000|FG000|Overall Study|Physician Decision|1|||
163173964|NCT01755026|589353001|FG000|Overall Study|Adverse Event|1|||
163173965|NCT01755026|589353002|FG001|Overall Study|Adverse Event|0|||
163173966|NCT01755026|589353001|FG000|Overall Study|Withdrawal by Subject|1|||
163173967|NCT01755026|589353002|FG001|Overall Study|Withdrawal by Subject|1|||
163173968|NCT03836001|589353003|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
163173969|NCT03836001|589353004|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
163173970|NCT03836001|589353005|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
163173971|NCT03836001|589353003|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
163173972|NCT03836001|589353004|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
163173973|NCT03836001|589353005|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
163173974|NCT03836001|589353003|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
163173975|NCT03836001|589353004|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
163173976|NCT03836001|589353005|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
163173977|NCT03836001|589353003|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
163173978|NCT03836001|589353004|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
163173979|NCT03836001|589353005|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
163173980|NCT01284491|589353006|FG000|Overall Study|Study termination|13|||
163173981|NCT01978938|589353007|FG000|Overall Study|Lost to Follow-up|12|||
163173982|NCT01978938|589353008|FG001|Overall Study|Lost to Follow-up|6|||
163173983|NCT01978938|589353007|FG000|Overall Study|Withdrawal by Subject|8|||
163173984|NCT01978938|589353008|FG001|Overall Study|Withdrawal by Subject|4|||
163173985|NCT01978938|589353007|FG000|Overall Study|Adverse Event, non-fatal|2|||
163173986|NCT01978938|589353008|FG001|Overall Study|Adverse Event, non-fatal|1|||
163173987|NCT01978938|589353007|FG000|Overall Study|Participant noncompliance|1|||
163173988|NCT01978938|589353008|FG001|Overall Study|Participant noncompliance|1|||
163173989|NCT01978938|589353007|FG000|Overall Study|Did not meet inclusion criteria|0|||
163173990|NCT01978938|589353008|FG001|Overall Study|Did not meet inclusion criteria|1|||
163173991|NCT01978938|589353007|FG000|Overall Study|Previously scheduled procedure|0|||
163173992|NCT01978938|589353008|FG001|Overall Study|Previously scheduled procedure|1|||
163173993|NCT02694757|589353009|FG000|Overall Study|Lack of Efficacy|3|||
163173994|NCT02650921|589353010|FG000|Overall Study|Withdrawal by Subject|4|||
163173995|NCT02650921|589353010|FG000|Overall Study|Lost to Follow-up|2|||
163173996|NCT02650921|589353010|FG000|Overall Study|Adverse Event|1|||
163173997|NCT02650921|589353010|FG000|Overall Study|Due to Medical Condition|1|||
163173998|NCT01087788|589353011|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
163173999|NCT01087788|589353012|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
163174000|NCT01087788|589353013|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
163174001|NCT01087788|589353011|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
163174002|NCT01087788|589353012|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
163174003|NCT01087788|589353013|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
163174004|NCT01087788|589353011|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
163174005|NCT01087788|589353012|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
163174006|NCT01087788|589353013|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
163174007|NCT01087788|589353011|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
163174008|NCT01087788|589353012|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
163174009|NCT01087788|589353013|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
163174010|NCT01087788|589353011|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
163174011|NCT01087788|589353012|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
163174012|NCT01087788|589353013|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
163174013|NCT01087788|589353011|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
163174014|NCT01087788|589353012|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
163174015|NCT01087788|589353013|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
163174016|NCT01087788|589353011|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
163174017|NCT01087788|589353012|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
163174018|NCT01087788|589353013|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
163174019|NCT01087788|589353011|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
163174020|NCT01087788|589353012|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
163174021|NCT01087788|589353013|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
163174022|NCT01087788|589353011|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
163174023|NCT01087788|589353012|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
163174024|NCT01087788|589353013|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
163174025|NCT01087788|589353011|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
163174026|NCT01087788|589353012|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
163174027|NCT01087788|589353013|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
163174028|NCT01087788|589353011|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
163174029|NCT01087788|589353012|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
163174030|NCT01087788|589353013|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
163279872|NCT03706690|589731522|FG001|Overall Study|Ongoing at DCO|52|||
163279873|NCT05617040|589731523|FG000|Overall Study|Adverse Event|0|||
163174031|NCT01087788|589353011|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
163174032|NCT01087788|589353012|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
163174033|NCT01087788|589353013|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
163174034|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
163174035|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
163174036|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
163174037|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
163174038|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
163174039|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
163174040|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
163174041|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
163174042|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
163174043|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
163174044|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
163174045|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
163174046|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
163174047|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
163174048|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
163174049|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
163174050|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
163174051|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
163174052|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
163174053|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
163174054|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
163174055|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|Patient moved|0|||
163174056|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|Patient moved|0|||
163174057|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|Patient moved|1|||
163174058|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
163174059|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
163174060|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
163174061|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
163174062|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
163174063|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
163174064|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
163174065|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
163174066|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
163174067|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
163174068|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
163174069|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
163174070|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
163174071|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
163174072|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
163174073|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
163174074|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
163174075|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
163174076|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
163174077|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
163174078|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
163174079|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
163174080|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
163174081|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
163174082|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
163174083|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
163174084|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
163174085|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
163174086|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
163279874|NCT05617040|589731524|FG001|Overall Study|Adverse Event|1|||
163279875|NCT05617040|589731525|FG002|Overall Study|Adverse Event|0|||
163279876|NCT05617040|589731523|FG000|Overall Study|Death|0|||
163279877|NCT05617040|589731524|FG001|Overall Study|Death|0|||
163279878|NCT05617040|589731525|FG002|Overall Study|Death|1|||
163279879|NCT02711826|589731526|FG000|Overall Study|Physician Decision|0|||
163279880|NCT02711826|589731527|FG001|Overall Study|Physician Decision|0|||
163174087|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
163174088|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
163174089|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
163279881|NCT02711826|589731528|FG002|Overall Study|Physician Decision|0|||
163279882|NCT02711826|589731529|FG003|Overall Study|Physician Decision|1|||
163174090|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
163174091|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
163174092|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
163174093|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
163174094|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
163174095|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
163174096|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
163174097|NCT00783302|589353014|FG000|Overall Study|Lost to Follow-up|17|||
163174098|NCT00783302|589353014|FG000|Overall Study|Technical Problems|11|||
163174099|NCT00783302|589353014|FG000|Overall Study|Protocol Violation|3|||
163174100|NCT00783302|589353014|FG000|Overall Study|Physician Decision|1|||
163174101|NCT00783302|589353014|FG000|Overall Study|Withdrawal by Subject|3|||
163174102|NCT01806662|589353015|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
163174103|NCT01806662|589353016|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
163174104|NCT01806662|589353015|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
163174105|NCT01806662|589353016|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
163174106|NCT01806662|589353015|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
163174107|NCT01806662|589353016|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
163174108|NCT01806662|589353015|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
163174109|NCT01806662|589353016|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
163174110|NCT00043550|589353017|FG000|Overall Study|Withdrawal by Subject|22|||
163174111|NCT00043550|589353018|FG001|Overall Study|Withdrawal by Subject|12|||
163174112|NCT00043550|589353019|FG002|Overall Study|Withdrawal by Subject|20|||
163174113|NCT01917656|589353020|FG000|Overall Study|Adverse Event|11|||
163174114|NCT01917656|589353021|FG001|Overall Study|Adverse Event|0|||
163174115|NCT01917656|589353020|FG000|Overall Study|Withdrawal criteria|8|||
163174116|NCT01917656|589353021|FG001|Overall Study|Withdrawal criteria|14|||
163174117|NCT01917656|589353020|FG000|Overall Study|Unclassified|0|||
163174118|NCT01917656|589353021|FG001|Overall Study|Unclassified|3|||
163174119|NCT01917656|589353020|FG000|Overall Study|Withdrawal by Subject|4|||
163174120|NCT01917656|589353021|FG001|Overall Study|Withdrawal by Subject|3|||
163174121|NCT01917656|589353020|FG000|Overall Study|Lost to Follow-up|3|||
163174122|NCT01917656|589353021|FG001|Overall Study|Lost to Follow-up|4|||
163174123|NCT02285062|589353022|FG000|Pre-Treatment Period|Protocol Violation|0|||
163174124|NCT02285062|589353023|FG001|Pre-Treatment Period|Protocol Violation|2|||
163174125|NCT02285062|589353022|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
163174126|NCT02285062|589353023|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
163174127|NCT00545129|589353024|FG000|Overall Study|Lack of Efficacy|2|||
163174128|NCT00545129|589353025|FG001|Overall Study|Lack of Efficacy|5|||
163174129|NCT00545129|589353024|FG000|Overall Study|Death|2|||
163174130|NCT00545129|589353025|FG001|Overall Study|Death|1|||
163174131|NCT00545129|589353024|FG000|Overall Study|Adverse Event|1|||
163174132|NCT00545129|589353025|FG001|Overall Study|Adverse Event|1|||
163174133|NCT00545129|589353024|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
163174134|NCT00545129|589353025|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
163174135|NCT00545129|589353024|FG000|Overall Study|Other|3|||
163174136|NCT00545129|589353025|FG001|Overall Study|Other|3|||
163174137|NCT03678870|589353026|FG000|Overall Study|prescribed non- protocol medications|10|||
163174138|NCT03678870|589353027|FG001|Overall Study|prescribed non- protocol medications|6|||
163174139|NCT03678870|589353026|FG000|Overall Study|Lost to Follow-up|3|||
163174140|NCT03678870|589353027|FG001|Overall Study|Lost to Follow-up|2|||
163174141|NCT03104816|589353029|FG000|Overall Study|Lack of Efficacy|0|||
163174142|NCT03104816|589353030|FG001|Overall Study|Lack of Efficacy|2|||
163174143|NCT03104816|589353031|FG002|Overall Study|Lack of Efficacy|0|||
163174144|NCT03104816|589353029|FG000|Overall Study|Protocol Violation|2|||
163174145|NCT03104816|589353030|FG001|Overall Study|Protocol Violation|0|||
163174146|NCT03104816|589353031|FG002|Overall Study|Protocol Violation|2|||
163174147|NCT01426789|589353032|FG000|Part 1|Protocol deviation|0|||
163174148|NCT01426789|589353033|FG001|Part 1|Protocol deviation|1|||
163174149|NCT01426789|589353034|FG002|Part 1|Protocol deviation|0|||
163174150|NCT01426789|589353035|FG003|Part 1|Protocol deviation|0|||
163174151|NCT01426789|589353036|FG004|Part 1|Protocol deviation|0|||
163174152|NCT01426789|589353037|FG005|Part 1|Protocol deviation|0|||
163174153|NCT01426789|589353032|FG000|Part 1|Lost to Follow-up|1|||
163174154|NCT01426789|589353033|FG001|Part 1|Lost to Follow-up|2|||
163174155|NCT01426789|589353034|FG002|Part 1|Lost to Follow-up|0|||
163174156|NCT01426789|589353035|FG003|Part 1|Lost to Follow-up|0|||
163174157|NCT01426789|589353036|FG004|Part 1|Lost to Follow-up|0|||
163174158|NCT01426789|589353037|FG005|Part 1|Lost to Follow-up|0|||
163174159|NCT01426789|589353032|FG000|Part 1|Lack of Efficacy|2|||
163174160|NCT01426789|589353033|FG001|Part 1|Lack of Efficacy|1|||
163174161|NCT01426789|589353034|FG002|Part 1|Lack of Efficacy|0|||
163174162|NCT01426789|589353035|FG003|Part 1|Lack of Efficacy|0|||
163174163|NCT01426789|589353036|FG004|Part 1|Lack of Efficacy|0|||
163174164|NCT01426789|589353037|FG005|Part 1|Lack of Efficacy|0|||
163174165|NCT01426789|589353032|FG000|Part 1|Adverse Event|3|||
163174166|NCT01426789|589353033|FG001|Part 1|Adverse Event|0|||
163174167|NCT01426789|589353034|FG002|Part 1|Adverse Event|0|||
162932270|NCT03033069|588456575|FG003|Overall Study|Reason not Specified|1|||
162932271|NCT00430638|588456576|FG000|Overall Study|Adverse Event|15|||
162932272|NCT00430638|588456577|FG001|Overall Study|Adverse Event|15|||
162932273|NCT00430638|588456576|FG000|Overall Study|Uncontrolled blood pressure|48|||
162932274|NCT00430638|588456577|FG001|Overall Study|Uncontrolled blood pressure|13|||
162932275|NCT00430638|588456576|FG000|Overall Study|Lost to Follow-up|1|||
162932276|NCT00430638|588456577|FG001|Overall Study|Lost to Follow-up|7|||
162932277|NCT00430638|588456576|FG000|Overall Study|Protocol Violation|6|||
162932278|NCT00430638|588456577|FG001|Overall Study|Protocol Violation|4|||
162932279|NCT00430638|588456576|FG000|Overall Study|Withdrawal by Subject|4|||
162932280|NCT00430638|588456577|FG001|Overall Study|Withdrawal by Subject|6|||
163174168|NCT01426789|589353035|FG003|Part 1|Adverse Event|0|||
163174169|NCT01426789|589353036|FG004|Part 1|Adverse Event|0|||
163174170|NCT01426789|589353037|FG005|Part 1|Adverse Event|0|||
163174171|NCT01426789|589353032|FG000|Part 2|Protocol deviation|0|||
163174172|NCT01426789|589353033|FG001|Part 2|Protocol deviation|0|||
163174173|NCT01426789|589353034|FG002|Part 2|Protocol deviation|1|||
163174174|NCT01426789|589353035|FG003|Part 2|Protocol deviation|0|||
163174175|NCT01426789|589353036|FG004|Part 2|Protocol deviation|0|||
163174176|NCT01426789|589353037|FG005|Part 2|Protocol deviation|0|||
163174177|NCT01426789|589353032|FG000|Part 2|Death|0|||
163174178|NCT01426789|589353033|FG001|Part 2|Death|0|||
163174179|NCT01426789|589353034|FG002|Part 2|Death|1|||
163174180|NCT01426789|589353035|FG003|Part 2|Death|0|||
163174181|NCT01426789|589353036|FG004|Part 2|Death|1|||
163174182|NCT01426789|589353037|FG005|Part 2|Death|0|||
163174183|NCT01426789|589353032|FG000|Part 2|Administrative problems|0|||
163174184|NCT01426789|589353033|FG001|Part 2|Administrative problems|0|||
163174185|NCT01426789|589353034|FG002|Part 2|Administrative problems|2|||
163174186|NCT01426789|589353035|FG003|Part 2|Administrative problems|0|||
163174187|NCT01426789|589353036|FG004|Part 2|Administrative problems|1|||
163174188|NCT01426789|589353037|FG005|Part 2|Administrative problems|0|||
163174189|NCT01426789|589353032|FG000|Part 2|Lost to Follow-up|0|||
163174190|NCT01426789|589353033|FG001|Part 2|Lost to Follow-up|0|||
163174191|NCT01426789|589353034|FG002|Part 2|Lost to Follow-up|4|||
163174192|NCT01426789|589353035|FG003|Part 2|Lost to Follow-up|0|||
163174193|NCT01426789|589353036|FG004|Part 2|Lost to Follow-up|1|||
163174194|NCT01426789|589353037|FG005|Part 2|Lost to Follow-up|0|||
163174195|NCT01426789|589353032|FG000|Part 2|Withdrawal by Subject|0|||
163174196|NCT01426789|589353033|FG001|Part 2|Withdrawal by Subject|0|||
163174197|NCT01426789|589353034|FG002|Part 2|Withdrawal by Subject|0|||
163174198|NCT01426789|589353035|FG003|Part 2|Withdrawal by Subject|1|||
163174199|NCT01426789|589353036|FG004|Part 2|Withdrawal by Subject|2|||
163174200|NCT01426789|589353037|FG005|Part 2|Withdrawal by Subject|0|||
163174201|NCT01426789|589353032|FG000|Part 2|Lack of Efficacy|0|||
163174202|NCT01426789|589353033|FG001|Part 2|Lack of Efficacy|0|||
163174203|NCT01426789|589353034|FG002|Part 2|Lack of Efficacy|5|||
163174204|NCT01426789|589353035|FG003|Part 2|Lack of Efficacy|0|||
163174205|NCT01426789|589353036|FG004|Part 2|Lack of Efficacy|2|||
163174206|NCT01426789|589353037|FG005|Part 2|Lack of Efficacy|0|||
163174207|NCT01426789|589353032|FG000|Part 2|Adverse Event|0|||
163174208|NCT01426789|589353033|FG001|Part 2|Adverse Event|0|||
163174209|NCT01426789|589353034|FG002|Part 2|Adverse Event|2|||
163174210|NCT01426789|589353035|FG003|Part 2|Adverse Event|0|||
163174211|NCT01426789|589353036|FG004|Part 2|Adverse Event|1|||
163174212|NCT01426789|589353037|FG005|Part 2|Adverse Event|0|||
163174213|NCT00003830|589354835|FG000|Overall Study|No follow up data|3|||
163174214|NCT00003830|589354836|FG001|Overall Study|No follow up data|0|||
163174215|NCT00003830|589354835|FG000|Overall Study|Sentinel node positive patients|829|||
163174216|NCT00003830|589354836|FG001|Overall Study|Sentinel node positive patients|793|||
163174217|NCT00883688|589354837|FG000|Overall Study|Ineligible|2|||
163174218|NCT00704522|589354838|FG000|Overall Study|Lack of Efficacy|65|||
163174219|NCT00704522|589354839|FG001|Overall Study|Lack of Efficacy|17|||
162932281|NCT00430638|588456576|FG000|Overall Study|Non-compliant|2|||
162932282|NCT00430638|588456577|FG001|Overall Study|Non-compliant|1|||
163174220|NCT00704522|589354838|FG000|Overall Study|Failure to appear again at hospital|56|||
163174221|NCT00704522|589354839|FG001|Overall Study|Failure to appear again at hospital|10|||
163174222|NCT00704522|589354838|FG000|Overall Study|Withdrawal by Subject|17|||
163174223|NCT00704522|589354839|FG001|Overall Study|Withdrawal by Subject|8|||
163174224|NCT00704522|589354838|FG000|Overall Study|Adverse Event|9|||
163174225|NCT00704522|589354839|FG001|Overall Study|Adverse Event|1|||
163174226|NCT00704522|589354838|FG000|Overall Study|Undefined causes|9|||
163279883|NCT02711826|589731530|FG004|Overall Study|Physician Decision|0|||
162932283|NCT00430638|588456576|FG000|Overall Study|Other|2|||
163174227|NCT00704522|589354839|FG001|Overall Study|Undefined causes|7|||
163174228|NCT00704522|589354838|FG000|Overall Study|No information on therapy end|27|||
163174229|NCT00704522|589354839|FG001|Overall Study|No information on therapy end|2|||
163174230|NCT04896229|589354840|FG000|Overall Study|Lost to Follow-up|113|||
163174231|NCT04896229|589354841|FG001|Overall Study|Lost to Follow-up|113|||
163174232|NCT00635024|589354842|FG000|Overall Study|Adverse Event|1|||
163174233|NCT01958489|589354843|FG000|Period 2|Adverse Event|0|||
163174234|NCT01958489|589354844|FG001|Period 2|Adverse Event|1|||
163174235|NCT00992589|589354845|FG000|Open-Label Phase|Adverse Event|4|||
163174236|NCT00992589|589354846|FG001|Open-Label Phase|Adverse Event|0|||
163174237|NCT00992589|589354847|FG002|Open-Label Phase|Adverse Event|0|||
163174238|NCT00992589|589354848|FG003|Open-Label Phase|Adverse Event|0|||
163174239|NCT00992589|589354845|FG000|Open-Label Phase|Withdrawal by Subject|20|||
163174240|NCT00992589|589354846|FG001|Open-Label Phase|Withdrawal by Subject|0|||
163174241|NCT00992589|589354847|FG002|Open-Label Phase|Withdrawal by Subject|0|||
163174242|NCT00992589|589354848|FG003|Open-Label Phase|Withdrawal by Subject|0|||
163174243|NCT00992589|589354845|FG000|Open-Label Phase|Lost to Follow-up|1|||
163174244|NCT00992589|589354846|FG001|Open-Label Phase|Lost to Follow-up|0|||
163174245|NCT00992589|589354847|FG002|Open-Label Phase|Lost to Follow-up|0|||
163174246|NCT00992589|589354848|FG003|Open-Label Phase|Lost to Follow-up|0|||
163174247|NCT00992589|589354845|FG000|Open-Label Phase|Protocol Violation|3|||
163174248|NCT00992589|589354846|FG001|Open-Label Phase|Protocol Violation|0|||
163174249|NCT00992589|589354847|FG002|Open-Label Phase|Protocol Violation|0|||
163174250|NCT00992589|589354848|FG003|Open-Label Phase|Protocol Violation|0|||
163174251|NCT00992589|589354845|FG000|Open-Label Phase|Physician Decision|4|||
163174252|NCT00992589|589354846|FG001|Open-Label Phase|Physician Decision|0|||
163174253|NCT00992589|589354847|FG002|Open-Label Phase|Physician Decision|0|||
163174254|NCT00992589|589354848|FG003|Open-Label Phase|Physician Decision|0|||
163174255|NCT00992589|589354845|FG000|Open-Label Phase|Other|45|||
163174256|NCT00992589|589354846|FG001|Open-Label Phase|Other|0|||
163174257|NCT00992589|589354847|FG002|Open-Label Phase|Other|0|||
163174258|NCT00992589|589354848|FG003|Open-Label Phase|Other|0|||
163174259|NCT00992589|589354845|FG000|Double-Blind Phase|Adverse Event|0|||
163174260|NCT00992589|589354846|FG001|Double-Blind Phase|Adverse Event|6|||
163174261|NCT00992589|589354847|FG002|Double-Blind Phase|Adverse Event|2|||
163174262|NCT00992589|589354848|FG003|Double-Blind Phase|Adverse Event|3|||
163174263|NCT00992589|589354845|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
163174264|NCT00992589|589354846|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
163174265|NCT00992589|589354847|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
163174266|NCT00992589|589354848|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
163174267|NCT00992589|589354845|FG000|Double-Blind Phase|Lost to Follow-up|0|||
163174268|NCT00992589|589354846|FG001|Double-Blind Phase|Lost to Follow-up|0|||
163174269|NCT00992589|589354847|FG002|Double-Blind Phase|Lost to Follow-up|0|||
163174270|NCT00992589|589354848|FG003|Double-Blind Phase|Lost to Follow-up|2|||
163174271|NCT00992589|589354845|FG000|Double-Blind Phase|Other|0|||
163174272|NCT00992589|589354846|FG001|Double-Blind Phase|Other|1|||
163174273|NCT00992589|589354847|FG002|Double-Blind Phase|Other|6|||
163174274|NCT00992589|589354848|FG003|Double-Blind Phase|Other|3|||
163174275|NCT00045942|589354849|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
163174276|NCT00045942|589354850|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174277|NCT00045942|589354851|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174278|NCT00045942|589354852|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174279|NCT00045942|589354853|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174280|NCT00045942|589354854|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174281|NCT00045942|589354855|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174282|NCT00045942|589354856|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174283|NCT00045942|589354857|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174284|NCT00045942|589354849|FG000|PKC412A2104 (Core)|Adverse Event|5|||
163174285|NCT00045942|589354850|FG001|PKC412A2104 (Core)|Adverse Event|0|||
163174286|NCT00045942|589354851|FG002|PKC412A2104 (Core)|Adverse Event|0|||
163174287|NCT00045942|589354852|FG003|PKC412A2104 (Core)|Adverse Event|0|||
163174288|NCT00045942|589354853|FG004|PKC412A2104 (Core)|Adverse Event|0|||
163174289|NCT00045942|589354854|FG005|PKC412A2104 (Core)|Adverse Event|0|||
163174290|NCT00045942|589354855|FG006|PKC412A2104 (Core)|Adverse Event|0|||
163174291|NCT00045942|589354856|FG007|PKC412A2104 (Core)|Adverse Event|0|||
163174292|NCT00045942|589354857|FG008|PKC412A2104 (Core)|Adverse Event|0|||
163174293|NCT00045942|589354849|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
163174294|NCT00045942|589354850|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
163174295|NCT00045942|589354851|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
163174296|NCT00045942|589354852|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
163174297|NCT00045942|589354853|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
163174298|NCT00045942|589354854|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
163174299|NCT00045942|589354855|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
163174300|NCT00045942|589354856|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
163174301|NCT00045942|589354857|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
163174302|NCT00045942|589354849|FG000|PKC412A2104 (Core)|Death|1|||
163174303|NCT00045942|589354850|FG001|PKC412A2104 (Core)|Death|0|||
163174304|NCT00045942|589354851|FG002|PKC412A2104 (Core)|Death|0|||
163174305|NCT00045942|589354852|FG003|PKC412A2104 (Core)|Death|0|||
163174306|NCT00045942|589354853|FG004|PKC412A2104 (Core)|Death|0|||
163174307|NCT00045942|589354854|FG005|PKC412A2104 (Core)|Death|0|||
163174308|NCT00045942|589354855|FG006|PKC412A2104 (Core)|Death|0|||
163174309|NCT00045942|589354856|FG007|PKC412A2104 (Core)|Death|0|||
163174310|NCT00045942|589354857|FG008|PKC412A2104 (Core)|Death|0|||
163174311|NCT00045942|589354849|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
163174312|NCT00045942|589354850|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
162932284|NCT00430638|588456577|FG001|Overall Study|Other|2|||
162932285|NCT01529749|588456578|FG000|Overall Study|Lost to Follow-up|0|||
162932286|NCT01529749|588456579|FG001|Overall Study|Lost to Follow-up|1|||
162932287|NCT01529749|588456580|FG002|Overall Study|Lost to Follow-up|1|||
162932288|NCT01529749|588456581|FG003|Overall Study|Lost to Follow-up|0|||
162932289|NCT01529749|588456578|FG000|Overall Study|Physician Decision|0|||
162932290|NCT01529749|588456579|FG001|Overall Study|Physician Decision|0|||
162932291|NCT01529749|588456580|FG002|Overall Study|Physician Decision|0|||
162932292|NCT01529749|588456581|FG003|Overall Study|Physician Decision|1|||
162932293|NCT01529749|588456578|FG000|Overall Study|Withdrawal by Subject|0|||
162932294|NCT01529749|588456579|FG001|Overall Study|Withdrawal by Subject|1|||
162932295|NCT01529749|588456580|FG002|Overall Study|Withdrawal by Subject|1|||
163174313|NCT00045942|589354851|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
163174314|NCT00045942|589354852|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
163174315|NCT00045942|589354853|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
163174316|NCT00045942|589354854|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
163174317|NCT00045942|589354855|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
163174318|NCT00045942|589354856|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
163174319|NCT00045942|589354857|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
163174320|NCT00045942|589354849|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
163174321|NCT00045942|589354850|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
163174322|NCT00045942|589354851|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
163174323|NCT00045942|589354852|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
163174324|NCT00045942|589354853|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
163174325|NCT00045942|589354854|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
163174326|NCT00045942|589354855|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
163174327|NCT00045942|589354856|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
163174328|NCT00045942|589354857|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
163174329|NCT00045942|589354849|FG000|PKC412A2104E1|Lack of Efficacy|0|||
163174330|NCT00045942|589354850|FG001|PKC412A2104E1|Lack of Efficacy|11|||
163174331|NCT00045942|589354851|FG002|PKC412A2104E1|Lack of Efficacy|11|||
163174332|NCT00045942|589354852|FG003|PKC412A2104E1|Lack of Efficacy|23|||
163174333|NCT00045942|589354853|FG004|PKC412A2104E1|Lack of Efficacy|17|||
163174334|NCT00045942|589354854|FG005|PKC412A2104E1|Lack of Efficacy|0|||
163174335|NCT00045942|589354855|FG006|PKC412A2104E1|Lack of Efficacy|0|||
163174336|NCT00045942|589354856|FG007|PKC412A2104E1|Lack of Efficacy|0|||
163174337|NCT00045942|589354857|FG008|PKC412A2104E1|Lack of Efficacy|0|||
163174338|NCT00045942|589354849|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
163174339|NCT00045942|589354850|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
163174340|NCT00045942|589354851|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
163174341|NCT00045942|589354852|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
163174342|NCT00045942|589354853|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
163174343|NCT00045942|589354854|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
163174344|NCT00045942|589354855|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
163174345|NCT00045942|589354856|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
163174346|NCT00045942|589354857|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
163174347|NCT00045942|589354849|FG000|PKC412A2104E1|Adverse Event|0|||
163174348|NCT00045942|589354850|FG001|PKC412A2104E1|Adverse Event|1|||
163174349|NCT00045942|589354851|FG002|PKC412A2104E1|Adverse Event|1|||
163174350|NCT00045942|589354852|FG003|PKC412A2104E1|Adverse Event|3|||
163174351|NCT00045942|589354853|FG004|PKC412A2104E1|Adverse Event|6|||
163174352|NCT00045942|589354854|FG005|PKC412A2104E1|Adverse Event|0|||
163174353|NCT00045942|589354855|FG006|PKC412A2104E1|Adverse Event|0|||
163174354|NCT00045942|589354856|FG007|PKC412A2104E1|Adverse Event|0|||
163174355|NCT00045942|589354857|FG008|PKC412A2104E1|Adverse Event|0|||
163174356|NCT00045942|589354849|FG000|PKC412A2104E1|Death|0|||
163174357|NCT00045942|589354850|FG001|PKC412A2104E1|Death|4|||
163174358|NCT00045942|589354851|FG002|PKC412A2104E1|Death|1|||
163174359|NCT00045942|589354852|FG003|PKC412A2104E1|Death|1|||
162932296|NCT01529749|588456581|FG003|Overall Study|Withdrawal by Subject|0|||
162932297|NCT01529749|588456578|FG000|Overall Study|Protocol Violation|0|||
162932298|NCT01529749|588456579|FG001|Overall Study|Protocol Violation|0|||
162932299|NCT01529749|588456580|FG002|Overall Study|Protocol Violation|0|||
163174360|NCT00045942|589354853|FG004|PKC412A2104E1|Death|1|||
163174361|NCT00045942|589354854|FG005|PKC412A2104E1|Death|0|||
163174362|NCT00045942|589354855|FG006|PKC412A2104E1|Death|0|||
163174363|NCT00045942|589354856|FG007|PKC412A2104E1|Death|0|||
163174364|NCT00045942|589354857|FG008|PKC412A2104E1|Death|0|||
163174365|NCT00045942|589354849|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
163174366|NCT00045942|589354850|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
163174367|NCT00045942|589354851|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
163174368|NCT00045942|589354852|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
162932300|NCT01529749|588456581|FG003|Overall Study|Protocol Violation|1|||
163174369|NCT00045942|589354853|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
163174370|NCT00045942|589354854|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
162932301|NCT00789828|588456582|FG000|Core Period (48 Weeks)|Administrative problems|0|||
163174371|NCT00045942|589354855|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
163279884|NCT02711826|589731526|FG000|Overall Study|Withdrawal by Subject|0|||
163279885|NCT02711826|589731527|FG001|Overall Study|Withdrawal by Subject|1|||
163279886|NCT02711826|589731528|FG002|Overall Study|Withdrawal by Subject|0|||
163279887|NCT02711826|589731529|FG003|Overall Study|Withdrawal by Subject|4|||
163279888|NCT02711826|589731530|FG004|Overall Study|Withdrawal by Subject|0|||
163279889|NCT02711826|589731526|FG000|Overall Study|Failure to manufacture cellular product|0|||
163279890|NCT02711826|589731527|FG001|Overall Study|Failure to manufacture cellular product|0|||
163279891|NCT02711826|589731528|FG002|Overall Study|Failure to manufacture cellular product|5|||
163279892|NCT02711826|589731529|FG003|Overall Study|Failure to manufacture cellular product|0|||
163279893|NCT02711826|589731530|FG004|Overall Study|Failure to manufacture cellular product|0|||
163279894|NCT02711826|589731526|FG000|Overall Study|Infusion canceled for active infection|0|||
163279895|NCT02711826|589731527|FG001|Overall Study|Infusion canceled for active infection|1|||
163279896|NCT02711826|589731528|FG002|Overall Study|Infusion canceled for active infection|0|||
163279897|NCT02711826|589731529|FG003|Overall Study|Infusion canceled for active infection|0|||
163279898|NCT02711826|589731530|FG004|Overall Study|Infusion canceled for active infection|0|||
163279899|NCT02711826|589731526|FG000|Overall Study|Screen failures|0|||
163279900|NCT02711826|589731527|FG001|Overall Study|Screen failures|0|||
163279901|NCT02711826|589731528|FG002|Overall Study|Screen failures|0|||
163279902|NCT02711826|589731529|FG003|Overall Study|Screen failures|4|||
163279903|NCT02711826|589731530|FG004|Overall Study|Screen failures|0|||
163279904|NCT00729690|589731531|FG000|Overall Study|IT Catheter Malfunction|0|||
163279905|NCT00729690|589731532|FG001|Overall Study|IT Catheter Malfunction|2|||
163279906|NCT00729690|589731533|FG002|Overall Study|IT Catheter Malfunction|2|||
163279907|NCT02169219|589731534|FG000|Overall Study|Lack of Efficacy|6|||
163279908|NCT02886936|589731535|FG000|Overall Study|Lost to Follow-up|4|||
163279909|NCT02886936|589731536|FG001|Overall Study|Lost to Follow-up|3|||
163279910|NCT02886936|589731537|FG002|Overall Study|Lost to Follow-up|0|||
163279911|NCT02507219|589731538|FG000|Overall Study|Physician Decision|1|||
163279912|NCT02507219|589731539|FG001|Overall Study|Physician Decision|0|||
163279913|NCT02507219|589731540|FG002|Overall Study|Physician Decision|0|||
163279914|NCT02507219|589731541|FG003|Overall Study|Physician Decision|0|||
163279915|NCT02507219|589731542|FG004|Overall Study|Physician Decision|0|||
163279916|NCT02507219|589731543|FG005|Overall Study|Physician Decision|0|||
163279917|NCT02507219|589731538|FG000|Overall Study|Withdrawal by Subject|0|||
163279918|NCT02507219|589731539|FG001|Overall Study|Withdrawal by Subject|0|||
163279919|NCT02507219|589731540|FG002|Overall Study|Withdrawal by Subject|0|||
163279920|NCT02507219|589731541|FG003|Overall Study|Withdrawal by Subject|0|||
163279921|NCT02507219|589731542|FG004|Overall Study|Withdrawal by Subject|1|||
163279922|NCT02507219|589731543|FG005|Overall Study|Withdrawal by Subject|0|||
163279923|NCT04562779|589731544|FG000|Overall Study|Lost to Follow-up|7|||
163279924|NCT04562779|589731545|FG001|Overall Study|Lost to Follow-up|5|||
163279925|NCT04562779|589731546|FG002|Overall Study|Lost to Follow-up|10|||
163279926|NCT04562779|589731544|FG000|Overall Study|Protocol Violation|2|||
163279927|NCT04562779|589731545|FG001|Overall Study|Protocol Violation|2|||
163279928|NCT04562779|589731546|FG002|Overall Study|Protocol Violation|0|||
163279929|NCT02788656|589732957|FG000|Overall Study|Withdrawal by Subject|1|||
163279930|NCT02788656|589732958|FG001|Overall Study|Withdrawal by Subject|0|||
163279931|NCT03929302|589732963|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
163279932|NCT03929302|589732964|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
163279933|NCT03929302|589732965|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
163279934|NCT03929302|589732963|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
163279935|NCT03929302|589732964|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
163279936|NCT03929302|589732965|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
163279937|NCT03929302|589732963|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
163279938|NCT03929302|589732964|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
163279939|NCT03929302|589732965|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
163279940|NCT04454567|589732967|FG000|Overall Study|Study Terminated by Sponsor|1|||
163279941|NCT04454567|589732968|FG001|Overall Study|Study Terminated by Sponsor|1|||
163279942|NCT02757885|589732972|FG000|Overall Study|Screen Failures|4|||
163279943|NCT00664521|589732973|FG000|Overall Study|Adverse Event|4|||
163279944|NCT00664521|589732974|FG001|Overall Study|Adverse Event|1|||
163279945|NCT00664521|589732973|FG000|Overall Study|Lost to Follow-up|1|||
163279946|NCT00664521|589732974|FG001|Overall Study|Lost to Follow-up|0|||
163279947|NCT00664521|589732973|FG000|Overall Study|Other|1|||
163279948|NCT00664521|589732974|FG001|Overall Study|Other|0|||
163279949|NCT02459964|589732975|FG000|Overall Study|Withdrawal by Subject|0|||
163279950|NCT02459964|589732976|FG001|Overall Study|Withdrawal by Subject|0|||
163279951|NCT02459964|589732977|FG002|Overall Study|Withdrawal by Subject|1|||
163279952|NCT02459964|589732975|FG000|Overall Study|Abnormal EKG changes|0|||
163279953|NCT02459964|589732976|FG001|Overall Study|Abnormal EKG changes|0|||
163279954|NCT02459964|589732977|FG002|Overall Study|Abnormal EKG changes|1|||
163279955|NCT01175707|589732978|FG000|Overall Study|Adverse Event|4|||
163279956|NCT01175707|589732979|FG001|Overall Study|Adverse Event|6|||
163279957|NCT01456780|589732980|FG000|Overall Study|Lost to Follow-up|3|||
163279958|NCT01456780|589732981|FG001|Overall Study|Lost to Follow-up|3|||
163279959|NCT01456780|589732982|FG002|Overall Study|Lost to Follow-up|0|||
163279960|NCT04531540|589732991|FG000|Overall Study|Adverse Event|1|||
163279961|NCT04531540|589732991|FG000|Overall Study|Protocol Violation|3|||
163279962|NCT04531540|589732991|FG000|Overall Study|Withdrawal by Subject|4|||
163279963|NCT04531540|589732991|FG000|Overall Study|Found to be Ineligible|1|||
163279964|NCT02688621|589732992|FG000|Overall Study|Pregnancy|1|||
163279965|NCT02688621|589732993|FG001|Overall Study|Pregnancy|3|||
163279966|NCT02688621|589732992|FG000|Overall Study|Lost to Follow-up|38|||
163279967|NCT02688621|589732993|FG001|Overall Study|Lost to Follow-up|15|||
163279968|NCT02688621|589732992|FG000|Overall Study|Withdrawal by Subject|1|||
163279969|NCT02688621|589732993|FG001|Overall Study|Withdrawal by Subject|0|||
163279970|NCT03239210|589732998|FG000|Overall Study|Lost to Follow-up|2|||
163279971|NCT03239210|589732999|FG001|Overall Study|Lost to Follow-up|2|||
163279972|NCT03239210|589732998|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
163279973|NCT03239210|589732999|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
163279974|NCT03239210|589732998|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
163279975|NCT03239210|589732999|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
163279976|NCT01575860|589733000|FG000|Overall Study|Withdrawal by Subject|1|||
163279977|NCT01575860|589733000|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
163279978|NCT05349864|589733005|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
163279979|NCT05349864|589733006|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
163279980|NCT00984282|589733007|FG000|Double Blind Treatment|Adverse Event|40|||
163279981|NCT00984282|589733008|FG001|Double Blind Treatment|Adverse Event|6|||
163279982|NCT00984282|589733007|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
163279983|NCT00984282|589733008|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
163279984|NCT00984282|589733007|FG000|Double Blind Treatment|Physician Decision|1|||
163279985|NCT00984282|589733008|FG001|Double Blind Treatment|Physician Decision|2|||
163279986|NCT00984282|589733007|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
163279987|NCT00984282|589733008|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
163279988|NCT00984282|589733007|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
163279989|NCT00984282|589733008|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
162932302|NCT00789828|588456583|FG001|Core Period (48 Weeks)|Administrative problems|1|||
162932303|NCT00789828|588456582|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
163174372|NCT00045942|589354856|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
163174373|NCT00045942|589354857|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
163174374|NCT00045942|589354849|FG000|PKC412A2104E2|Lost to Follow-up|0|||
163174375|NCT00045942|589354850|FG001|PKC412A2104E2|Lost to Follow-up|0|||
163174376|NCT00045942|589354851|FG002|PKC412A2104E2|Lost to Follow-up|0|||
163174377|NCT00045942|589354852|FG003|PKC412A2104E2|Lost to Follow-up|0|||
163174378|NCT00045942|589354853|FG004|PKC412A2104E2|Lost to Follow-up|0|||
163174379|NCT00045942|589354854|FG005|PKC412A2104E2|Lost to Follow-up|0|||
163174380|NCT00045942|589354855|FG006|PKC412A2104E2|Lost to Follow-up|0|||
163174381|NCT00045942|589354856|FG007|PKC412A2104E2|Lost to Follow-up|3|||
163174382|NCT00045942|589354857|FG008|PKC412A2104E2|Lost to Follow-up|0|||
163174383|NCT00045942|589354849|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
163174384|NCT00045942|589354850|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
163174385|NCT00045942|589354851|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
163174386|NCT00045942|589354852|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
163174387|NCT00045942|589354853|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
163174388|NCT00045942|589354854|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
163174389|NCT00045942|589354855|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
163174390|NCT00045942|589354856|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
163174391|NCT00045942|589354857|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
163174392|NCT00045942|589354849|FG000|PKC412A2104E2|Lack of Efficacy|0|||
163174393|NCT00045942|589354850|FG001|PKC412A2104E2|Lack of Efficacy|0|||
163174394|NCT00045942|589354851|FG002|PKC412A2104E2|Lack of Efficacy|0|||
163174395|NCT00045942|589354852|FG003|PKC412A2104E2|Lack of Efficacy|0|||
163174396|NCT00045942|589354853|FG004|PKC412A2104E2|Lack of Efficacy|0|||
163174397|NCT00045942|589354854|FG005|PKC412A2104E2|Lack of Efficacy|3|||
163174398|NCT00045942|589354855|FG006|PKC412A2104E2|Lack of Efficacy|2|||
163174399|NCT00045942|589354856|FG007|PKC412A2104E2|Lack of Efficacy|2|||
163174400|NCT00045942|589354857|FG008|PKC412A2104E2|Lack of Efficacy|6|||
163174401|NCT00045942|589354849|FG000|PKC412A2104E2|Adverse Event|0|||
163174402|NCT00045942|589354850|FG001|PKC412A2104E2|Adverse Event|0|||
163174403|NCT00045942|589354851|FG002|PKC412A2104E2|Adverse Event|0|||
163174404|NCT00045942|589354852|FG003|PKC412A2104E2|Adverse Event|0|||
163174405|NCT00045942|589354853|FG004|PKC412A2104E2|Adverse Event|0|||
163174406|NCT00045942|589354854|FG005|PKC412A2104E2|Adverse Event|4|||
163279990|NCT00984282|589733007|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
163279991|NCT00984282|589733008|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
163279992|NCT00984282|589733007|FG000|Double Blind Treatment|Lost to Follow-up|3|||
163279993|NCT00984282|589733008|FG001|Double Blind Treatment|Lost to Follow-up|0|||
163174407|NCT00045942|589354855|FG006|PKC412A2104E2|Adverse Event|3|||
163174408|NCT00045942|589354856|FG007|PKC412A2104E2|Adverse Event|1|||
163174409|NCT00045942|589354857|FG008|PKC412A2104E2|Adverse Event|0|||
163174410|NCT00045942|589354849|FG000|PKC412A2104E2|Death|0|||
163174411|NCT00045942|589354850|FG001|PKC412A2104E2|Death|0|||
163174412|NCT00045942|589354851|FG002|PKC412A2104E2|Death|0|||
163174413|NCT00045942|589354852|FG003|PKC412A2104E2|Death|0|||
163174414|NCT00045942|589354853|FG004|PKC412A2104E2|Death|0|||
163174415|NCT00045942|589354854|FG005|PKC412A2104E2|Death|1|||
163174416|NCT00045942|589354855|FG006|PKC412A2104E2|Death|2|||
163174417|NCT00045942|589354856|FG007|PKC412A2104E2|Death|0|||
163174418|NCT00045942|589354857|FG008|PKC412A2104E2|Death|0|||
163174419|NCT04575597|589354858|FG000|Overall Study|Death|0|||
163174420|NCT04575597|589354859|FG001|Overall Study|Death|0|||
163174421|NCT04575597|589354860|FG002|Overall Study|Death|0|||
163174422|NCT04575597|589354861|FG003|Overall Study|Death|1|||
163174423|NCT04575597|589354862|FG004|Overall Study|Death|3|||
163174424|NCT04575597|589354863|FG005|Overall Study|Death|14|||
163174425|NCT04575597|589354858|FG000|Overall Study|Lost to Follow-up|2|||
163174426|NCT04575597|589354859|FG001|Overall Study|Lost to Follow-up|1|||
163174427|NCT04575597|589354860|FG002|Overall Study|Lost to Follow-up|1|||
163174428|NCT04575597|589354861|FG003|Overall Study|Lost to Follow-up|2|||
163174429|NCT04575597|589354862|FG004|Overall Study|Lost to Follow-up|10|||
163174430|NCT04575597|589354863|FG005|Overall Study|Lost to Follow-up|8|||
163174431|NCT04575597|589354858|FG000|Overall Study|Withdrawal by Subject|2|||
163174432|NCT04575597|589354859|FG001|Overall Study|Withdrawal by Subject|2|||
163174433|NCT04575597|589354860|FG002|Overall Study|Withdrawal by Subject|4|||
163174434|NCT04575597|589354861|FG003|Overall Study|Withdrawal by Subject|2|||
163174435|NCT04575597|589354862|FG004|Overall Study|Withdrawal by Subject|25|||
163174436|NCT04575597|589354863|FG005|Overall Study|Withdrawal by Subject|28|||
163174437|NCT04575597|589354858|FG000|Overall Study|Not Recorded|0|||
163174438|NCT04575597|589354859|FG001|Overall Study|Not Recorded|0|||
163174439|NCT04575597|589354860|FG002|Overall Study|Not Recorded|0|||
163174440|NCT04575597|589354861|FG003|Overall Study|Not Recorded|0|||
163174441|NCT04575597|589354862|FG004|Overall Study|Not Recorded|0|||
163174442|NCT04575597|589354863|FG005|Overall Study|Not Recorded|2|||
163174443|NCT04575597|589354858|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163174444|NCT04575597|589354859|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163174445|NCT04575597|589354860|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163174446|NCT04575597|589354861|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163174447|NCT04575597|589354862|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
163174448|NCT04575597|589354863|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
163174449|NCT02095132|589354865|FG000|Overall Study|Adverse Event|0|||
163174450|NCT02095132|589354866|FG001|Overall Study|Adverse Event|0|||
163174451|NCT02095132|589354867|FG002|Overall Study|Adverse Event|0|||
163174452|NCT02095132|589354868|FG003|Overall Study|Adverse Event|0|||
163174453|NCT02095132|589354869|FG004|Overall Study|Adverse Event|1|||
163174454|NCT02095132|589354870|FG005|Overall Study|Adverse Event|0|||
163174455|NCT02095132|589354871|FG006|Overall Study|Adverse Event|1|||
163174456|NCT02095132|589354872|FG007|Overall Study|Adverse Event|0|||
163174457|NCT02095132|589354873|FG008|Overall Study|Adverse Event|0|||
163174458|NCT02095132|589354865|FG000|Overall Study|Death|0|||
163174459|NCT02095132|589354866|FG001|Overall Study|Death|0|||
163174460|NCT02095132|589354867|FG002|Overall Study|Death|0|||
163174461|NCT02095132|589354868|FG003|Overall Study|Death|0|||
163174462|NCT02095132|589354869|FG004|Overall Study|Death|0|||
163174463|NCT02095132|589354870|FG005|Overall Study|Death|0|||
163174464|NCT02095132|589354871|FG006|Overall Study|Death|1|||
163174465|NCT02095132|589354872|FG007|Overall Study|Death|0|||
163174466|NCT02095132|589354873|FG008|Overall Study|Death|0|||
163174467|NCT02095132|589354865|FG000|Overall Study|Lack of Efficacy|3|||
163174468|NCT02095132|589354866|FG001|Overall Study|Lack of Efficacy|5|||
163174469|NCT02095132|589354867|FG002|Overall Study|Lack of Efficacy|2|||
163174470|NCT02095132|589354868|FG003|Overall Study|Lack of Efficacy|8|||
163174471|NCT02095132|589354869|FG004|Overall Study|Lack of Efficacy|3|||
163174472|NCT02095132|589354870|FG005|Overall Study|Lack of Efficacy|6|||
163174473|NCT02095132|589354871|FG006|Overall Study|Lack of Efficacy|10|||
163174474|NCT02095132|589354872|FG007|Overall Study|Lack of Efficacy|9|||
163174475|NCT02095132|589354873|FG008|Overall Study|Lack of Efficacy|8|||
163174476|NCT02095132|589354865|FG000|Overall Study|Physician Decision|1|||
163174477|NCT02095132|589354866|FG001|Overall Study|Physician Decision|0|||
163174478|NCT02095132|589354867|FG002|Overall Study|Physician Decision|0|||
163174479|NCT02095132|589354868|FG003|Overall Study|Physician Decision|0|||
163174480|NCT02095132|589354869|FG004|Overall Study|Physician Decision|0|||
163174481|NCT02095132|589354870|FG005|Overall Study|Physician Decision|0|||
163174482|NCT02095132|589354871|FG006|Overall Study|Physician Decision|1|||
163174483|NCT02095132|589354872|FG007|Overall Study|Physician Decision|0|||
163174484|NCT02095132|589354873|FG008|Overall Study|Physician Decision|2|||
163174485|NCT02095132|589354865|FG000|Overall Study|Withdrawal by Subject|0|||
163174486|NCT02095132|589354866|FG001|Overall Study|Withdrawal by Subject|0|||
163174487|NCT02095132|589354867|FG002|Overall Study|Withdrawal by Subject|2|||
163174488|NCT02095132|589354868|FG003|Overall Study|Withdrawal by Subject|2|||
163174489|NCT02095132|589354869|FG004|Overall Study|Withdrawal by Subject|3|||
163174490|NCT02095132|589354870|FG005|Overall Study|Withdrawal by Subject|0|||
163174491|NCT02095132|589354871|FG006|Overall Study|Withdrawal by Subject|5|||
163174492|NCT02095132|589354872|FG007|Overall Study|Withdrawal by Subject|0|||
163174493|NCT02095132|589354873|FG008|Overall Study|Withdrawal by Subject|0|||
163174494|NCT04905498|589354876|FG000|Overall Study|Lost to Follow-up|0|||
163174495|NCT04905498|589354877|FG001|Overall Study|Lost to Follow-up|2|||
163174496|NCT04905498|589354876|FG000|Overall Study|COVID lockdown|1|||
163174497|NCT04905498|589354877|FG001|Overall Study|COVID lockdown|0|||
163174498|NCT01029405|589354878|FG000|Overall Study|Withdrawal by Subject|0|||
163174499|NCT01029405|589354879|FG001|Overall Study|Withdrawal by Subject|1|||
163174500|NCT01029405|589354880|FG002|Overall Study|Withdrawal by Subject|2|||
163174501|NCT01029405|589354881|FG003|Overall Study|Withdrawal by Subject|0|||
163174502|NCT01029405|589354878|FG000|Overall Study|Protocol Violation|0|||
163174503|NCT01029405|589354879|FG001|Overall Study|Protocol Violation|0|||
163174504|NCT01029405|589354880|FG002|Overall Study|Protocol Violation|0|||
163174505|NCT01029405|589354881|FG003|Overall Study|Protocol Violation|1|||
163174506|NCT01029405|589354878|FG000|Overall Study|Adverse Event|0|||
163174507|NCT01029405|589354879|FG001|Overall Study|Adverse Event|0|||
163174508|NCT01029405|589354880|FG002|Overall Study|Adverse Event|1|||
163174509|NCT01029405|589354881|FG003|Overall Study|Adverse Event|1|||
163174510|NCT01029405|589354878|FG000|Overall Study|Lost to Follow-up|2|||
163174511|NCT01029405|589354879|FG001|Overall Study|Lost to Follow-up|1|||
163174512|NCT01029405|589354880|FG002|Overall Study|Lost to Follow-up|1|||
163174513|NCT01029405|589354881|FG003|Overall Study|Lost to Follow-up|2|||
163174514|NCT01029405|589354878|FG000|Overall Study|Other|0|||
163174515|NCT01029405|589354879|FG001|Overall Study|Other|1|||
163174516|NCT01029405|589354880|FG002|Overall Study|Other|0|||
163174517|NCT01029405|589354881|FG003|Overall Study|Other|1|||
163174518|NCT01268579|589354882|FG000|Overall Study|Adverse Event|1|||
163174519|NCT01268579|589354882|FG000|Overall Study|Withdrawal by Subject|2|||
163174520|NCT03312751|589354883|FG000|Overall Study|Death|7|||
163174521|NCT03312751|589354884|FG001|Overall Study|Death|9|||
163174522|NCT03312751|589354883|FG000|Overall Study|Study discontinuation due to other reason|0|||
163174523|NCT03312751|589354884|FG001|Overall Study|Study discontinuation due to other reason|1|||
163174524|NCT05463198|589354885|FG000|Overall Study|Withdrawal by Subject|19|||
163174525|NCT05463198|589354885|FG000|Overall Study|Procedure Notes Missing|18|||
163174526|NCT00420641|589354888|FG000|Overall Study|Adverse Event|3|||
163174527|NCT00420641|589354889|FG001|Overall Study|Adverse Event|25|||
163174528|NCT00420641|589354890|FG002|Overall Study|Adverse Event|10|||
163174529|NCT00420641|589354888|FG000|Overall Study|Lost to Follow-up|2|||
163174530|NCT00420641|589354889|FG001|Overall Study|Lost to Follow-up|4|||
163174531|NCT00420641|589354890|FG002|Overall Study|Lost to Follow-up|2|||
163174532|NCT00420641|589354888|FG000|Overall Study|Protocol Violation|8|||
163174533|NCT00420641|589354889|FG001|Overall Study|Protocol Violation|8|||
163174534|NCT00420641|589354890|FG002|Overall Study|Protocol Violation|7|||
163174535|NCT00420641|589354888|FG000|Overall Study|Withdrawal by Subject|15|||
163174536|NCT00420641|589354889|FG001|Overall Study|Withdrawal by Subject|21|||
163174537|NCT00420641|589354890|FG002|Overall Study|Withdrawal by Subject|14|||
163174538|NCT00420641|589354888|FG000|Overall Study|Lack of Efficacy|6|||
163174539|NCT00420641|589354889|FG001|Overall Study|Lack of Efficacy|5|||
163174540|NCT00420641|589354890|FG002|Overall Study|Lack of Efficacy|4|||
163174541|NCT00420641|589354888|FG000|Overall Study|Non-compliance|7|||
163174542|NCT00420641|589354889|FG001|Overall Study|Non-compliance|5|||
163174543|NCT00420641|589354890|FG002|Overall Study|Non-compliance|4|||
162932304|NCT00789828|588456583|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
162932305|NCT00789828|588456582|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
162932306|NCT00789828|588456583|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
162932307|NCT00789828|588456582|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
162932308|NCT00789828|588456583|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
162932309|NCT00789828|588456582|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
162932310|NCT00789828|588456583|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
162932311|NCT00789828|588456582|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
162932312|NCT00789828|588456583|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
162932313|NCT00789828|588456582|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
162932314|NCT00789828|588456583|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
162932315|NCT00789828|588456582|FG000|Open-label Extension Period (4 Years)|Death|1|||
162932316|NCT00789828|588456583|FG001|Open-label Extension Period (4 Years)|Death|0|||
162932317|NCT00789828|588456582|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
162932318|NCT00789828|588456583|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
162932319|NCT00789828|588456582|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
162932320|NCT00789828|588456583|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
162932321|NCT02623426|588456584|FG000|Overall Study|Lost to Follow-up|0|||
162932322|NCT02623426|588456585|FG001|Overall Study|Lost to Follow-up|0|||
162932323|NCT02623426|588456586|FG002|Overall Study|Lost to Follow-up|1|||
162932324|NCT02623426|588456584|FG000|Overall Study|Withdrawal by Subject|1|||
162932325|NCT02623426|588456585|FG001|Overall Study|Withdrawal by Subject|2|||
162932326|NCT02623426|588456586|FG002|Overall Study|Withdrawal by Subject|2|||
162932327|NCT02094937|588456587|FG000|8 Weeks in Period 1|Adverse Event|9|||
162932328|NCT02094937|588456588|FG001|8 Weeks in Period 1|Adverse Event|0|||
162932329|NCT02094937|588456589|FG002|8 Weeks in Period 1|Adverse Event|0|||
162932330|NCT02094937|588456590|FG003|8 Weeks in Period 1|Adverse Event|0|||
162932331|NCT02094937|588456587|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
162932332|NCT02094937|588456588|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
162932333|NCT02094937|588456589|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
162932334|NCT02094937|588456590|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
162932335|NCT02094937|588456587|FG000|8 Weeks in Period 1|Protocol Violation|2|||
162932336|NCT02094937|588456588|FG001|8 Weeks in Period 1|Protocol Violation|0|||
162932337|NCT02094937|588456589|FG002|8 Weeks in Period 1|Protocol Violation|0|||
162932338|NCT02094937|588456590|FG003|8 Weeks in Period 1|Protocol Violation|0|||
162932339|NCT02094937|588456587|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
162932340|NCT02094937|588456588|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
162932341|NCT02094937|588456589|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
162932342|NCT02094937|588456590|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
162932343|NCT02094937|588456587|FG000|8 Weeks in Period 1|Physician Decision|1|||
162932344|NCT02094937|588456588|FG001|8 Weeks in Period 1|Physician Decision|0|||
162932345|NCT02094937|588456589|FG002|8 Weeks in Period 1|Physician Decision|0|||
162932346|NCT02094937|588456590|FG003|8 Weeks in Period 1|Physician Decision|0|||
162932347|NCT02094937|588456587|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
162932348|NCT02094937|588456588|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
162932349|NCT02094937|588456589|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
162932350|NCT02094937|588456590|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
162932351|NCT02094937|588456587|FG000|12 Weeks in Period 2|Adverse Event|0|||
162932352|NCT02094937|588456588|FG001|12 Weeks in Period 2|Adverse Event|2|||
162932353|NCT02094937|588456589|FG002|12 Weeks in Period 2|Adverse Event|4|||
162932354|NCT02094937|588456590|FG003|12 Weeks in Period 2|Adverse Event|1|||
162932355|NCT02094937|588456587|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
162932356|NCT02094937|588456588|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
162932357|NCT02094937|588456589|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
162932358|NCT02094937|588456590|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
162932359|NCT02094937|588456587|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
162932360|NCT02094937|588456588|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
162932361|NCT02094937|588456589|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
162932362|NCT02094937|588456590|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
163174544|NCT00420641|589354888|FG000|Overall Study|Other|4|||
163174545|NCT00420641|589354889|FG001|Overall Study|Other|4|||
163174546|NCT00420641|589354890|FG002|Overall Study|Other|3|||
163174547|NCT02815280|589354898|FG000|Double-Blind Phase|Adverse Event|1|||
162932363|NCT02094937|588456587|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
162932364|NCT02094937|588456588|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
162932365|NCT02094937|588456589|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
162932366|NCT02094937|588456590|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
162932367|NCT02094937|588456587|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
163174548|NCT02815280|589354899|FG001|Double-Blind Phase|Adverse Event|1|||
162932368|NCT02094937|588456588|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
162932369|NCT02094937|588456589|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
163174549|NCT02815280|589354898|FG000|Double-Blind Phase|Lost to Follow-up|10|||
163279994|NCT00984282|589733007|FG000|Double Blind Treatment|Death|8|||
163279995|NCT00984282|589733008|FG001|Double Blind Treatment|Death|4|||
163279996|NCT00984282|589733007|FG000|Double Blind Treatment|Not treated|0|||
163279997|NCT00984282|589733008|FG001|Double Blind Treatment|Not treated|1|||
163279998|NCT00984282|589733007|FG000|Double Blind Treatment|Switched to commercial drug|6|||
163279999|NCT00984282|589733008|FG001|Double Blind Treatment|Switched to commercial drug|1|||
163280000|NCT00984282|589733007|FG000|Double Blind Treatment|protocol driven decision point|1|||
163280001|NCT00984282|589733008|FG001|Double Blind Treatment|protocol driven decision point|1|||
163280002|NCT00984282|589733007|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
163280003|NCT00984282|589733008|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
163280004|NCT00984282|589733007|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
163280005|NCT00984282|589733008|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
163280006|NCT00984282|589733007|FG000|Open-label Treatment|Adverse Event|20|||
163280007|NCT00984282|589733008|FG001|Open-label Treatment|Adverse Event|30|||
163280008|NCT00984282|589733007|FG000|Open-label Treatment|Withdrawal by Subject|6|||
163280009|NCT00984282|589733008|FG001|Open-label Treatment|Withdrawal by Subject|21|||
163280010|NCT00984282|589733007|FG000|Open-label Treatment|Death|7|||
163174550|NCT02815280|589354899|FG001|Double-Blind Phase|Lost to Follow-up|9|||
163174551|NCT02815280|589354898|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
163174552|NCT02815280|589354899|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
163174553|NCT02815280|589354898|FG000|Double-Blind Phase|Protocol Violation|2|||
163174554|NCT02815280|589354899|FG001|Double-Blind Phase|Protocol Violation|2|||
163174555|NCT02815280|589354898|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
163174556|NCT02815280|589354899|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
163174557|NCT02815280|589354898|FG000|Open-Label Phase|Adverse Event|2|||
163174558|NCT02815280|589354899|FG001|Open-Label Phase|Adverse Event|3|||
163174559|NCT02815280|589354898|FG000|Open-Label Phase|Lost to Follow-up|18|||
163174560|NCT02815280|589354899|FG001|Open-Label Phase|Lost to Follow-up|9|||
163174561|NCT02815280|589354898|FG000|Open-Label Phase|Withdrawal by Subject|33|||
163174562|NCT02815280|589354899|FG001|Open-Label Phase|Withdrawal by Subject|18|||
163174563|NCT02815280|589354898|FG000|Open-Label Phase|Protocol Violation|3|||
163174564|NCT02815280|589354899|FG001|Open-Label Phase|Protocol Violation|0|||
163174565|NCT02815280|589354898|FG000|Open-Label Phase|Administrative|26|||
163174566|NCT02815280|589354899|FG001|Open-Label Phase|Administrative|12|||
163174567|NCT02815280|589354898|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
163174568|NCT02815280|589354899|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
163174569|NCT01944839|589354902|FG000|Overall Study|Physician Decision|2|||
163174570|NCT01944839|589354903|FG001|Overall Study|Physician Decision|2|||
163174571|NCT01944839|589354902|FG000|Overall Study|Protocol Violation|0|||
163174572|NCT01944839|589354903|FG001|Overall Study|Protocol Violation|1|||
163174573|NCT01944839|589354902|FG000|Overall Study|Adverse Event|10|||
163174574|NCT01944839|589354903|FG001|Overall Study|Adverse Event|5|||
163174575|NCT01944839|589354902|FG000|Overall Study|Withdrawal by Subject|9|||
163174576|NCT01944839|589354903|FG001|Overall Study|Withdrawal by Subject|17|||
163174577|NCT01944839|589354902|FG000|Overall Study|Lost to Follow-up|1|||
163174578|NCT01944839|589354903|FG001|Overall Study|Lost to Follow-up|0|||
163174579|NCT01944839|589354902|FG000|Overall Study|Subject non-compliance|0|||
163174580|NCT01944839|589354903|FG001|Overall Study|Subject non-compliance|3|||
163174581|NCT00609362|589354904|FG000|Overall Study|Withdrawal by Subject|2|||
163174582|NCT00609362|589354905|FG001|Overall Study|Withdrawal by Subject|1|||
163174583|NCT00609362|589354904|FG000|Overall Study|Adverse Event|1|||
163174584|NCT00609362|589354905|FG001|Overall Study|Adverse Event|0|||
163174585|NCT05093790|589354906|FG000|Overall Study|Failure to meet continuation criteria|0|||
163174586|NCT05093790|589354907|FG001|Overall Study|Failure to meet continuation criteria|0|||
163174587|NCT05093790|589354908|FG002|Overall Study|Failure to meet continuation criteria|1|||
163174588|NCT05093790|589354909|FG003|Overall Study|Failure to meet continuation criteria|0|||
163174589|NCT05093790|589354906|FG000|Overall Study|Adverse Event|1|||
163174590|NCT05093790|589354907|FG001|Overall Study|Adverse Event|0|||
163174591|NCT05093790|589354908|FG002|Overall Study|Adverse Event|0|||
163174592|NCT05093790|589354909|FG003|Overall Study|Adverse Event|0|||
163174593|NCT05027971|589354919|FG000|Overall Study|Physician Decision|7|||
163174594|NCT05027971|589354920|FG001|Overall Study|Physician Decision|3|||
163174595|NCT05027971|589354919|FG000|Overall Study|Lost to Follow-up|1|||
163174596|NCT05027971|589354920|FG001|Overall Study|Lost to Follow-up|1|||
163174597|NCT05027971|589354919|FG000|Overall Study|Withdrawal by Subject|0|||
163174598|NCT05027971|589354920|FG001|Overall Study|Withdrawal by Subject|2|||
163280011|NCT00984282|589733008|FG001|Open-label Treatment|Death|15|||
163280012|NCT00984282|589733007|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
163280013|NCT00984282|589733008|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
163280014|NCT00984282|589733007|FG000|Open-label Treatment|Lost to Follow-up|1|||
163280015|NCT00984282|589733008|FG001|Open-label Treatment|Lost to Follow-up|1|||
163280016|NCT00984282|589733007|FG000|Open-label Treatment|Patient convenience|1|||
162932370|NCT02094937|588456590|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
162932371|NCT05458895|588456591|FG000|Overall Study|Withdrawal by Subject|8|||
163174599|NCT05027971|589354919|FG000|Overall Study|Non-study fiber used.|0|||
163174600|NCT05027971|589354920|FG001|Overall Study|Non-study fiber used.|1|||
163174601|NCT05027971|589354919|FG000|Overall Study|Protocol Violation|0|||
163174602|NCT05027971|589354920|FG001|Overall Study|Protocol Violation|2|||
163174603|NCT02025556|589354921|FG000|Overall Study|Adverse Event|0|||
163174604|NCT02025556|589354922|FG001|Overall Study|Adverse Event|4|||
163174605|NCT02025556|589354923|FG002|Overall Study|Adverse Event|2|||
163174606|NCT02025556|589354921|FG000|Overall Study|Lack of Efficacy|2|||
163174607|NCT02025556|589354922|FG001|Overall Study|Lack of Efficacy|1|||
163174608|NCT02025556|589354923|FG002|Overall Study|Lack of Efficacy|0|||
163174609|NCT02025556|589354921|FG000|Overall Study|Protocol Violation|2|||
163174610|NCT02025556|589354922|FG001|Overall Study|Protocol Violation|1|||
163174611|NCT02025556|589354923|FG002|Overall Study|Protocol Violation|0|||
163174612|NCT02025556|589354921|FG000|Overall Study|Withdrawal by Subject|0|||
163174613|NCT02025556|589354922|FG001|Overall Study|Withdrawal by Subject|3|||
163174614|NCT02025556|589354923|FG002|Overall Study|Withdrawal by Subject|6|||
163174615|NCT02025556|589354921|FG000|Overall Study|Lost to Follow-up|2|||
163174616|NCT02025556|589354922|FG001|Overall Study|Lost to Follow-up|4|||
163174617|NCT02025556|589354923|FG002|Overall Study|Lost to Follow-up|0|||
163174618|NCT02025556|589354921|FG000|Overall Study|Reason not reported|0|||
163174619|NCT02025556|589354922|FG001|Overall Study|Reason not reported|0|||
163174620|NCT02025556|589354923|FG002|Overall Study|Reason not reported|1|||
163174621|NCT02582684|589354925|FG000|Overall Study|Unable to contact subject/parent|4|||
163174622|NCT02582684|589354925|FG000|Overall Study|Subject not able to get to clinic|10|||
163174623|NCT02582684|589354925|FG000|Overall Study|Subject withdrew consent|1|||
163174624|NCT02582684|589354925|FG000|Overall Study|Found to be ineligible after enrollment|2|||
163174625|NCT01587898|589354926|FG000|Overall Study|Adverse Event|1|||
163174626|NCT01587898|589354927|FG001|Overall Study|Adverse Event|1|||
163174627|NCT01587898|589354928|FG002|Overall Study|Adverse Event|0|||
163174628|NCT01587898|589354929|FG003|Overall Study|Adverse Event|0|||
163174629|NCT01587898|589354926|FG000|Overall Study|Protocol Violation|0|||
163174630|NCT01587898|589354927|FG001|Overall Study|Protocol Violation|2|||
163174631|NCT01587898|589354928|FG002|Overall Study|Protocol Violation|1|||
163174632|NCT01587898|589354929|FG003|Overall Study|Protocol Violation|1|||
163174633|NCT01587898|589354926|FG000|Overall Study|Lost to Follow-up|0|||
163174634|NCT01587898|589354927|FG001|Overall Study|Lost to Follow-up|0|||
163174635|NCT01587898|589354928|FG002|Overall Study|Lost to Follow-up|0|||
163174636|NCT01587898|589354929|FG003|Overall Study|Lost to Follow-up|1|||
163174637|NCT01587898|589354926|FG000|Overall Study|Withdrawal by Subject|2|||
163174638|NCT01587898|589354927|FG001|Overall Study|Withdrawal by Subject|1|||
163174639|NCT01587898|589354928|FG002|Overall Study|Withdrawal by Subject|0|||
163174640|NCT01587898|589354929|FG003|Overall Study|Withdrawal by Subject|0|||
163174641|NCT01587898|589354926|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
163174642|NCT01587898|589354927|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
163174643|NCT01587898|589354928|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
163174644|NCT01587898|589354929|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
163174645|NCT00796991|589354931|FG000|Overall Study|Adverse Event|0|||
162932372|NCT05458895|588456591|FG000|Overall Study|Lost to Follow-up|17|||
162932373|NCT05458895|588456591|FG000|Overall Study|Pregnancy|2|||
162932374|NCT05458895|588456591|FG000|Overall Study|Withdrawal by Study Team|1|||
163174646|NCT00796991|589354932|FG001|Overall Study|Adverse Event|0|||
163174647|NCT00796991|589354933|FG002|Overall Study|Adverse Event|1|||
163174648|NCT00796991|589354931|FG000|Overall Study|Death|2|||
163174649|NCT00796991|589354932|FG001|Overall Study|Death|0|||
163174650|NCT00796991|589354933|FG002|Overall Study|Death|0|||
163174651|NCT00796991|589354931|FG000|Overall Study|Disease Progression|10|||
163174652|NCT00796991|589354932|FG001|Overall Study|Disease Progression|9|||
163174653|NCT00796991|589354933|FG002|Overall Study|Disease Progression|7|||
163174654|NCT00796991|589354931|FG000|Overall Study|Study Drug Toxicity|3|||
163174655|NCT00796991|589354932|FG001|Overall Study|Study Drug Toxicity|3|||
163174656|NCT00796991|589354933|FG002|Overall Study|Study Drug Toxicity|5|||
163174657|NCT00796991|589354931|FG000|Overall Study|Withdrawal by Subject|0|||
163174658|NCT00796991|589354932|FG001|Overall Study|Withdrawal by Subject|0|||
163174659|NCT00796991|589354933|FG002|Overall Study|Withdrawal by Subject|1|||
162932375|NCT04639310|588456592|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
162932376|NCT04639310|588456593|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
162932377|NCT05166421|588456594|FG000|Overall Study|Other|3|||
162932378|NCT05166421|588456595|FG001|Overall Study|Other|1|||
162932379|NCT05166421|588456596|FG002|Overall Study|Other|1|||
162932380|NCT05166421|588456594|FG000|Overall Study|Withdrawal by Subject|5|||
162932381|NCT05166421|588456595|FG001|Overall Study|Withdrawal by Subject|3|||
162932382|NCT05166421|588456596|FG002|Overall Study|Withdrawal by Subject|6|||
162932383|NCT05166421|588456594|FG000|Overall Study|Lost to Follow-up|4|||
162932384|NCT05166421|588456595|FG001|Overall Study|Lost to Follow-up|1|||
162932385|NCT05166421|588456596|FG002|Overall Study|Lost to Follow-up|7|||
162932386|NCT03262233|588458471|FG000|Overall Study|Withdrawal by Subject|12|||
162932387|NCT03262233|588458472|FG001|Overall Study|Withdrawal by Subject|8|||
163174660|NCT02437110|589354935|FG000|Screening|Lost to Follow-up|3|||
163174661|NCT02437110|589354935|FG000|Screening|Physician Decision|1|||
163174662|NCT02437110|589354935|FG000|ART|Adverse Event|3|||
163174663|NCT02437110|589354935|FG000|ART|Protocol Violation|3|||
163174664|NCT02437110|589354935|FG000|ART|Withdrawal by Subject|4|||
163174665|NCT02437110|589354935|FG000|ART|Lost to follow-up prior to start of intervention|1|||
163174666|NCT02437110|589354935|FG000|ART|Physician decision prior to start of intervention|2|||
163174667|NCT02437110|589354935|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
163174668|NCT02437110|589354935|FG000|Post-ART|Lost to Follow-up|3|||
163174669|NCT02437110|589354935|FG000|Post-ART|Protocol Violation|4|||
163174670|NCT02437110|589354935|FG000|Post-ART|Withdrawal by Subject|3|||
163174671|NCT00171834|589354936|FG000|Overall Study|Adverse Event|2|||
163174672|NCT00171834|589354937|FG001|Overall Study|Adverse Event|1|||
163174673|NCT00171834|589354938|FG002|Overall Study|Adverse Event|3|||
163174674|NCT00171834|589354939|FG003|Overall Study|Adverse Event|2|||
163174675|NCT00171834|589354940|FG004|Overall Study|Adverse Event|2|||
163174676|NCT00171834|589354941|FG005|Overall Study|Adverse Event|15|||
163174677|NCT00171834|589354942|FG006|Overall Study|Adverse Event|1|||
163174678|NCT00171834|589354936|FG000|Overall Study|Withdrawal by Subject|0|||
163174679|NCT00171834|589354937|FG001|Overall Study|Withdrawal by Subject|2|||
163174680|NCT00171834|589354938|FG002|Overall Study|Withdrawal by Subject|0|||
163174681|NCT00171834|589354939|FG003|Overall Study|Withdrawal by Subject|1|||
163174682|NCT00171834|589354940|FG004|Overall Study|Withdrawal by Subject|1|||
163174683|NCT00171834|589354941|FG005|Overall Study|Withdrawal by Subject|1|||
163174684|NCT00171834|589354942|FG006|Overall Study|Withdrawal by Subject|0|||
163174685|NCT00171834|589354936|FG000|Overall Study|Death from study indication|0|||
163174686|NCT00171834|589354937|FG001|Overall Study|Death from study indication|1|||
163174687|NCT00171834|589354938|FG002|Overall Study|Death from study indication|0|||
163174688|NCT00171834|589354939|FG003|Overall Study|Death from study indication|0|||
163174689|NCT00171834|589354940|FG004|Overall Study|Death from study indication|1|||
163174690|NCT00171834|589354941|FG005|Overall Study|Death from study indication|0|||
163174691|NCT00171834|589354942|FG006|Overall Study|Death from study indication|0|||
163174692|NCT00171834|589354936|FG000|Overall Study|Disease Progression|4|||
163174693|NCT00171834|589354937|FG001|Overall Study|Disease Progression|8|||
163174694|NCT00171834|589354938|FG002|Overall Study|Disease Progression|8|||
163174695|NCT00171834|589354939|FG003|Overall Study|Disease Progression|9|||
163174696|NCT00171834|589354940|FG004|Overall Study|Disease Progression|2|||
163174697|NCT00171834|589354941|FG005|Overall Study|Disease Progression|18|||
163174698|NCT00171834|589354942|FG006|Overall Study|Disease Progression|3|||
163174699|NCT00171834|589354936|FG000|Overall Study|Treatment Duration Completed|0|||
163174700|NCT00171834|589354937|FG001|Overall Study|Treatment Duration Completed|0|||
163174701|NCT00171834|589354938|FG002|Overall Study|Treatment Duration Completed|1|||
163174702|NCT00171834|589354939|FG003|Overall Study|Treatment Duration Completed|0|||
163174703|NCT00171834|589354940|FG004|Overall Study|Treatment Duration Completed|2|||
163174704|NCT00171834|589354941|FG005|Overall Study|Treatment Duration Completed|1|||
163174705|NCT00171834|589354942|FG006|Overall Study|Treatment Duration Completed|0|||
163174706|NCT01261780|589354943|FG000|Overall Study|Withdrawal by Subject|1|||
163174707|NCT01261780|589354944|FG001|Overall Study|Withdrawal by Subject|0|||
163174708|NCT01261780|589354943|FG000|Overall Study|Event not related to subject|1|||
163174709|NCT01261780|589354944|FG001|Overall Study|Event not related to subject|2|||
163174710|NCT01239732|589354945|FG000|Overall Study|Termination of study per protocol|667|||
163174711|NCT01239732|589354945|FG000|Overall Study|Death|226|||
163174712|NCT01239732|589354945|FG000|Overall Study|Withdrawal by Subject|87|||
163174713|NCT01239732|589354945|FG000|Overall Study|Adverse Event|6|||
163174714|NCT01239732|589354945|FG000|Overall Study|Protocol Violation|3|||
163174715|NCT01239732|589354945|FG000|Overall Study|Participant non compliance|5|||
163174716|NCT01239732|589354945|FG000|Overall Study|Study termination by sponsor|2|||
163174717|NCT01239732|589354945|FG000|Overall Study|Investigator's decision|4|||
163174718|NCT01239732|589354945|FG000|Overall Study|Treatment failure|2|||
163174719|NCT01239732|589354945|FG000|Overall Study|Other|19|||
162932388|NCT03262233|588458473|FG002|Overall Study|Withdrawal by Subject|21|||
162932389|NCT03262233|588458474|FG003|Overall Study|Withdrawal by Subject|13|||
163174720|NCT02015221|589354948|FG000|Overall Study|Withdrawal by Subject|8|||
162932390|NCT03262233|588458471|FG000|Overall Study|Declined due to shock|1|||
162932391|NCT03262233|588458472|FG001|Overall Study|Declined due to shock|2|||
162932392|NCT03262233|588458473|FG002|Overall Study|Declined due to shock|2|||
162932393|NCT03262233|588458474|FG003|Overall Study|Declined due to shock|3|||
162932394|NCT03262233|588458471|FG000|Overall Study|Protocol Violation|5|||
162932395|NCT03262233|588458472|FG001|Overall Study|Protocol Violation|10|||
162932396|NCT03262233|588458473|FG002|Overall Study|Protocol Violation|2|||
162932397|NCT03262233|588458474|FG003|Overall Study|Protocol Violation|13|||
163174721|NCT02015221|589354949|FG001|Overall Study|Withdrawal by Subject|6|||
163174722|NCT02015221|589354948|FG000|Overall Study|Lost to Follow-up|1|||
163174723|NCT02015221|589354949|FG001|Overall Study|Lost to Follow-up|0|||
163174724|NCT01306929|589354950|FG000|Overall Study|Withdrawal by Subject|23|||
163174725|NCT01306929|589354950|FG000|Overall Study|Adverse Event|21|||
163174726|NCT01306929|589354950|FG000|Overall Study|Physician Decision|13|||
163174727|NCT01306929|589354950|FG000|Overall Study|Death|8|||
163174728|NCT01306929|589354950|FG000|Overall Study|Withdrawal by parent/guardian|5|||
163174729|NCT01306929|589354950|FG000|Overall Study|Protocol Violation|3|||
163174730|NCT01306929|589354950|FG000|Overall Study|Non-compliance with study drug|2|||
163174731|NCT01306929|589354950|FG000|Overall Study|Lost to Follow-up|2|||
163174732|NCT01306929|589354950|FG000|Overall Study|Various|17|||
163174733|NCT01870076|589354951|FG000|Overall Study|Withdrawal by Subject|1|||
163174734|NCT01870076|589354952|FG001|Overall Study|Withdrawal by Subject|0|||
163174735|NCT01870076|589354953|FG002|Overall Study|Withdrawal by Subject|1|||
163174736|NCT01870076|589354954|FG003|Overall Study|Withdrawal by Subject|0|||
163174737|NCT03041129|589354955|FG000|Overall Study|Withdrawal by Subject|2|||
163174738|NCT03041129|589354956|FG001|Overall Study|Withdrawal by Subject|0|||
163174739|NCT03041129|589354957|FG002|Overall Study|Withdrawal by Subject|0|||
163174740|NCT03041129|589354958|FG003|Overall Study|Withdrawal by Subject|0|||
163174741|NCT00436501|589354963|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
163174742|NCT00436501|589354964|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
163174743|NCT00436501|589354963|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
163174744|NCT00436501|589354964|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
163174745|NCT00608569|589354977|FG000|Overall Study|Death|4|||
163174746|NCT00608569|589354978|FG001|Overall Study|Death|3|||
163174747|NCT00608569|589354977|FG000|Overall Study|Lost to Follow-up|4|||
163174748|NCT00608569|589354978|FG001|Overall Study|Lost to Follow-up|5|||
163174749|NCT00608569|589354977|FG000|Overall Study|Withdrawal by Subject|1|||
163174750|NCT00608569|589354978|FG001|Overall Study|Withdrawal by Subject|0|||
163174751|NCT00608569|589354977|FG000|Overall Study|Adverse Event|1|||
163174752|NCT00608569|589354978|FG001|Overall Study|Adverse Event|0|||
163174753|NCT00608569|589354977|FG000|Overall Study|Unable to adhere with study requirements|0|||
163174754|NCT00608569|589354978|FG001|Overall Study|Unable to adhere with study requirements|1|||
163174755|NCT03011892|589354979|FG000|Double Blind (DB) Period|Adverse Event|0|||
163174756|NCT03011892|589354980|FG001|Double Blind (DB) Period|Adverse Event|1|||
163174757|NCT03011892|589354981|FG002|Double Blind (DB) Period|Adverse Event|1|||
163174758|NCT03011892|589354982|FG003|Double Blind (DB) Period|Adverse Event|0|||
163174759|NCT03011892|589354983|FG004|Double Blind (DB) Period|Adverse Event|0|||
163174760|NCT03011892|589354984|FG005|Double Blind (DB) Period|Adverse Event|0|||
163174761|NCT03011892|589354985|FG006|Double Blind (DB) Period|Adverse Event|0|||
163174762|NCT03011892|589354986|FG007|Double Blind (DB) Period|Adverse Event|0|||
163174763|NCT03011892|589354987|FG008|Double Blind (DB) Period|Adverse Event|0|||
163174764|NCT03011892|589354988|FG009|Double Blind (DB) Period|Adverse Event|0|||
163174765|NCT03011892|589354989|FG010|Double Blind (DB) Period|Adverse Event|0|||
163174766|NCT03011892|589354990|FG011|Double Blind (DB) Period|Adverse Event|0|||
163174767|NCT03011892|589354979|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
163174768|NCT03011892|589354980|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
163174769|NCT03011892|589354981|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
163174770|NCT03011892|589354982|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
163174771|NCT03011892|589354983|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
163174772|NCT03011892|589354984|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
163174773|NCT03011892|589354985|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
163174774|NCT03011892|589354986|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
163174775|NCT03011892|589354987|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
163174776|NCT03011892|589354988|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
163174777|NCT03011892|589354989|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
163174778|NCT03011892|589354990|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
163174779|NCT03011892|589354979|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
163174780|NCT03011892|589354980|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
163174781|NCT03011892|589354981|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
163174782|NCT03011892|589354982|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
163174783|NCT03011892|589354983|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
163174784|NCT03011892|589354984|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
163174785|NCT03011892|589354985|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
163174786|NCT03011892|589354986|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
162932398|NCT03262233|588458471|FG000|Overall Study|data collection artifact|0|||
163280017|NCT00984282|589733008|FG001|Open-label Treatment|Patient convenience|0|||
163280018|NCT00984282|589733007|FG000|Open-label Treatment|Non-compliant with study medication|1|||
163280019|NCT00984282|589733008|FG001|Open-label Treatment|Non-compliant with study medication|0|||
163280020|NCT00984282|589733007|FG000|Open-label Treatment|Target lesion removed|0|||
163280021|NCT00984282|589733008|FG001|Open-label Treatment|Target lesion removed|1|||
163280022|NCT00984282|589733007|FG000|Open-label Treatment|Protocol driven decision point|1|||
163280023|NCT00984282|589733008|FG001|Open-label Treatment|Protocol driven decision point|1|||
163280024|NCT00984282|589733007|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
163280025|NCT00984282|589733008|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
163280026|NCT00984282|589733007|FG000|Open-label Treatment|Switched to commercial drug|6|||
163280027|NCT00984282|589733008|FG001|Open-label Treatment|Switched to commercial drug|7|||
163280028|NCT00984282|589733007|FG000|Open-label Treatment|Physician Decision|1|||
163280029|NCT00984282|589733008|FG001|Open-label Treatment|Physician Decision|0|||
163280030|NCT00984282|589733007|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
163280031|NCT00984282|589733008|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
163280032|NCT00984282|589733007|FG000|Long Term Follow-up|Death|27|||
163280033|NCT00984282|589733008|FG001|Long Term Follow-up|Death|68|||
163280034|NCT00984282|589733007|FG000|Long Term Follow-up|Lost to Follow-up|3|||
163280035|NCT00984282|589733008|FG001|Long Term Follow-up|Lost to Follow-up|6|||
163280036|NCT00984282|589733007|FG000|Long Term Follow-up|Protocol driven decision point|25|||
163280037|NCT00984282|589733008|FG001|Long Term Follow-up|Protocol driven decision point|26|||
163280038|NCT00984282|589733007|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
163280039|NCT00984282|589733008|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
163280040|NCT00984282|589733007|FG000|Long Term Follow-up|Switched to commercial drug|4|||
163280041|NCT00984282|589733008|FG001|Long Term Follow-up|Switched to commercial drug|2|||
163280042|NCT00984282|589733007|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
163280043|NCT00984282|589733008|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
163280044|NCT02223793|589733009|FG000|Overall Study|Lost to Follow-up|10|||
163280045|NCT02223793|589733010|FG001|Overall Study|Lost to Follow-up|1|||
163280046|NCT02223793|589733011|FG002|Overall Study|Lost to Follow-up|2|||
163280047|NCT02223793|589733009|FG000|Overall Study|Withdrawal by Subject|3|||
163280048|NCT02223793|589733010|FG001|Overall Study|Withdrawal by Subject|2|||
163280049|NCT02223793|589733011|FG002|Overall Study|Withdrawal by Subject|3|||
163280050|NCT02223793|589733009|FG000|Overall Study|Moved/studycenter unable to participate|4|||
163280051|NCT02223793|589733010|FG001|Overall Study|Moved/studycenter unable to participate|6|||
163280052|NCT02223793|589733011|FG002|Overall Study|Moved/studycenter unable to participate|8|||
163280053|NCT02321540|589733014|FG000|Overall Study|Death|0|||
163280054|NCT02321540|589733015|FG001|Overall Study|Death|1|||
163280055|NCT02321540|589733014|FG000|Overall Study|Progression|3|||
163280056|NCT02321540|589733015|FG001|Overall Study|Progression|9|||
163280057|NCT03606460|589733016|FG000|Overall Study|Lost to Follow-up|1|||
163280058|NCT03606460|589733017|FG001|Overall Study|Lost to Follow-up|8|||
163280059|NCT00003377|589733018|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
163280060|NCT00003377|589733019|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
163280061|NCT00003377|589733020|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
163280062|NCT00003377|589733021|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
163280063|NCT00003377|589733022|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
163280064|NCT00003377|589733018|FG000|Period II|Ureteral stent complications|0|||
163280065|NCT00003377|589733019|FG001|Period II|Ureteral stent complications|0|||
163280066|NCT00003377|589733020|FG002|Period II|Ureteral stent complications|0|||
163280067|NCT00003377|589733021|FG003|Period II|Ureteral stent complications|0|||
163280068|NCT00003377|589733022|FG004|Period II|Ureteral stent complications|1|||
163280069|NCT04541186|589733026|FG000|Main Study|Adverse Event|0|||
163280070|NCT04541186|589733027|FG001|Main Study|Adverse Event|0|||
163280071|NCT04541186|589733028|FG002|Main Study|Adverse Event|4|||
163280072|NCT04541186|589733029|FG003|Main Study|Adverse Event|0|||
163280073|NCT04541186|589733030|FG004|Main Study|Adverse Event|0|||
163280074|NCT04541186|589733026|FG000|Main Study|Investigator Decision|0|||
163280075|NCT04541186|589733027|FG001|Main Study|Investigator Decision|0|||
163280076|NCT04541186|589733028|FG002|Main Study|Investigator Decision|1|||
163280077|NCT04541186|589733029|FG003|Main Study|Investigator Decision|1|||
163280078|NCT04541186|589733030|FG004|Main Study|Investigator Decision|0|||
163280079|NCT04541186|589733026|FG000|Main Study|Withdrawal by Subject|1|||
163280080|NCT04541186|589733027|FG001|Main Study|Withdrawal by Subject|1|||
163280081|NCT04541186|589733028|FG002|Main Study|Withdrawal by Subject|0|||
163280082|NCT04541186|589733029|FG003|Main Study|Withdrawal by Subject|0|||
163280083|NCT04541186|589733030|FG004|Main Study|Withdrawal by Subject|0|||
163280084|NCT04541186|589733026|FG000|Main Study|COVID-19-related Dose Interruption|0|||
163280085|NCT04541186|589733027|FG001|Main Study|COVID-19-related Dose Interruption|0|||
163280086|NCT04541186|589733028|FG002|Main Study|COVID-19-related Dose Interruption|0|||
163280087|NCT04541186|589733029|FG003|Main Study|COVID-19-related Dose Interruption|0|||
163280088|NCT04541186|589733030|FG004|Main Study|COVID-19-related Dose Interruption|1|||
163280089|NCT04541186|589733026|FG000|Main Study|Randomized in Error Not Treated|0|||
163280090|NCT04541186|589733027|FG001|Main Study|Randomized in Error Not Treated|0|||
163174787|NCT03011892|589354987|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
163174788|NCT03011892|589354988|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
163174789|NCT03011892|589354989|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
163174790|NCT03011892|589354990|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
163174791|NCT03011892|589354979|FG000|Double Blind (DB) Period|Other|1|||
163174792|NCT03011892|589354980|FG001|Double Blind (DB) Period|Other|1|||
163174793|NCT03011892|589354981|FG002|Double Blind (DB) Period|Other|1|||
163174794|NCT03011892|589354982|FG003|Double Blind (DB) Period|Other|0|||
163174795|NCT03011892|589354983|FG004|Double Blind (DB) Period|Other|1|||
163174796|NCT03011892|589354984|FG005|Double Blind (DB) Period|Other|0|||
163174797|NCT03011892|589354985|FG006|Double Blind (DB) Period|Other|0|||
163174798|NCT03011892|589354986|FG007|Double Blind (DB) Period|Other|0|||
163174799|NCT03011892|589354987|FG008|Double Blind (DB) Period|Other|0|||
163174800|NCT03011892|589354988|FG009|Double Blind (DB) Period|Other|0|||
163174801|NCT03011892|589354989|FG010|Double Blind (DB) Period|Other|0|||
163174802|NCT03011892|589354990|FG011|Double Blind (DB) Period|Other|0|||
163174803|NCT03011892|589354979|FG000|Double Blind (DB) Period|Physician Decision|1|||
163174804|NCT03011892|589354980|FG001|Double Blind (DB) Period|Physician Decision|0|||
163174805|NCT03011892|589354981|FG002|Double Blind (DB) Period|Physician Decision|1|||
163174806|NCT03011892|589354982|FG003|Double Blind (DB) Period|Physician Decision|0|||
163174807|NCT03011892|589354983|FG004|Double Blind (DB) Period|Physician Decision|0|||
163174808|NCT03011892|589354984|FG005|Double Blind (DB) Period|Physician Decision|0|||
163174809|NCT03011892|589354985|FG006|Double Blind (DB) Period|Physician Decision|0|||
163174810|NCT03011892|589354986|FG007|Double Blind (DB) Period|Physician Decision|0|||
163174811|NCT03011892|589354987|FG008|Double Blind (DB) Period|Physician Decision|0|||
163174812|NCT03011892|589354988|FG009|Double Blind (DB) Period|Physician Decision|0|||
163174813|NCT03011892|589354989|FG010|Double Blind (DB) Period|Physician Decision|0|||
163174814|NCT03011892|589354990|FG011|Double Blind (DB) Period|Physician Decision|0|||
163174815|NCT03011892|589354979|FG000|Double Blind (DB) Period|Pregnancy|0|||
163174816|NCT03011892|589354980|FG001|Double Blind (DB) Period|Pregnancy|0|||
163174817|NCT03011892|589354981|FG002|Double Blind (DB) Period|Pregnancy|0|||
163174818|NCT03011892|589354982|FG003|Double Blind (DB) Period|Pregnancy|0|||
163174819|NCT03011892|589354983|FG004|Double Blind (DB) Period|Pregnancy|1|||
163174820|NCT03011892|589354984|FG005|Double Blind (DB) Period|Pregnancy|0|||
163174821|NCT03011892|589354985|FG006|Double Blind (DB) Period|Pregnancy|0|||
163174822|NCT03011892|589354986|FG007|Double Blind (DB) Period|Pregnancy|0|||
163174823|NCT03011892|589354987|FG008|Double Blind (DB) Period|Pregnancy|0|||
163174824|NCT03011892|589354988|FG009|Double Blind (DB) Period|Pregnancy|0|||
163174825|NCT03011892|589354989|FG010|Double Blind (DB) Period|Pregnancy|0|||
163174826|NCT03011892|589354990|FG011|Double Blind (DB) Period|Pregnancy|0|||
163174827|NCT03011892|589354979|FG000|Double Blind (DB) Period|Protocol Violation|1|||
163174828|NCT03011892|589354980|FG001|Double Blind (DB) Period|Protocol Violation|0|||
163174829|NCT03011892|589354981|FG002|Double Blind (DB) Period|Protocol Violation|0|||
163174830|NCT03011892|589354982|FG003|Double Blind (DB) Period|Protocol Violation|0|||
163174831|NCT03011892|589354983|FG004|Double Blind (DB) Period|Protocol Violation|0|||
163174832|NCT03011892|589354984|FG005|Double Blind (DB) Period|Protocol Violation|0|||
163174833|NCT03011892|589354985|FG006|Double Blind (DB) Period|Protocol Violation|0|||
163174834|NCT03011892|589354986|FG007|Double Blind (DB) Period|Protocol Violation|0|||
163174835|NCT03011892|589354987|FG008|Double Blind (DB) Period|Protocol Violation|0|||
163174836|NCT03011892|589354988|FG009|Double Blind (DB) Period|Protocol Violation|0|||
163174837|NCT03011892|589354989|FG010|Double Blind (DB) Period|Protocol Violation|0|||
163174838|NCT03011892|589354990|FG011|Double Blind (DB) Period|Protocol Violation|0|||
163280091|NCT04541186|589733028|FG002|Main Study|Randomized in Error Not Treated|1|||
163280092|NCT04541186|589733029|FG003|Main Study|Randomized in Error Not Treated|0|||
163280093|NCT04541186|589733030|FG004|Main Study|Randomized in Error Not Treated|0|||
163280094|NCT04541186|589733026|FG000|Fibrate Expansion Study|Other than Specified|0|||
163280095|NCT04541186|589733027|FG001|Fibrate Expansion Study|Other than Specified|0|||
163280096|NCT04541186|589733028|FG002|Fibrate Expansion Study|Other than Specified|0|||
163280097|NCT04541186|589733029|FG003|Fibrate Expansion Study|Other than Specified|0|||
163280098|NCT04541186|589733030|FG004|Fibrate Expansion Study|Other than Specified|1|||
163280099|NCT00303303|589733033|FG000|Overall Study|Withdrawal by Subject|0|||
163280100|NCT00303303|589733034|FG001|Overall Study|Withdrawal by Subject|0|||
163280101|NCT00303303|589733035|FG002|Overall Study|Withdrawal by Subject|1|||
163280102|NCT00058058|589733036|FG000|Overall Study|Withdrawal by Subject|4|||
163280103|NCT00058058|589733036|FG000|Overall Study|Ineligible|20|||
163280104|NCT00058058|589733036|FG000|Overall Study|Claustrophobic|5|||
163280105|NCT00058058|589733036|FG000|Overall Study|technical issues|6|||
163280106|NCT00058058|589733036|FG000|Overall Study|Poor positioning, illness,pain|3|||
163280107|NCT03085017|589733037|FG000|Overall Study|Death|0|||
163280108|NCT03085017|589733038|FG001|Overall Study|Death|3|||
163280109|NCT00582790|589733039|FG000|Overall Study|Rapid progression of disease|1|||
163280110|NCT02680756|589733044|FG000|Overall Study|Adverse Event|10|||
163280111|NCT02680756|589733045|FG001|Overall Study|Adverse Event|2|||
163280112|NCT02680756|589733044|FG000|Overall Study|Lost to Follow-up|7|||
163280113|NCT02680756|589733045|FG001|Overall Study|Lost to Follow-up|6|||
163280114|NCT02680756|589733044|FG000|Overall Study|Withdrawal by Subject|5|||
163280115|NCT02680756|589733045|FG001|Overall Study|Withdrawal by Subject|5|||
163280116|NCT02680756|589733044|FG000|Overall Study|Physician Decision|4|||
163280117|NCT02680756|589733045|FG001|Overall Study|Physician Decision|1|||
163280118|NCT02680756|589733044|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
163280119|NCT02680756|589733045|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
163280120|NCT02680756|589733044|FG000|Overall Study|Blood transfusion for any reason|0|||
163280121|NCT02680756|589733045|FG001|Overall Study|Blood transfusion for any reason|1|||
163280122|NCT02680756|589733044|FG000|Overall Study|Death|1|||
163280123|NCT02680756|589733045|FG001|Overall Study|Death|0|||
163280124|NCT02680756|589733044|FG000|Overall Study|Protocol Violation|1|||
163280125|NCT02680756|589733045|FG001|Overall Study|Protocol Violation|0|||
163280126|NCT02680756|589733044|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
163280127|NCT02680756|589733045|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
163280128|NCT02680756|589733044|FG000|Overall Study|None of above or not recorded|3|||
163280129|NCT02680756|589733045|FG001|Overall Study|None of above or not recorded|2|||
163280130|NCT02374957|589733046|FG000|Overall Study|Patient did not complete forms correctly|1|||
163280131|NCT02374957|589733047|FG001|Overall Study|Patient did not complete forms correctly|0|||
163280132|NCT00748969|589733048|FG000|Overall Study|Withdrawal by Subject|1|||
163280133|NCT00748969|589733049|FG001|Overall Study|Withdrawal by Subject|0|||
163174839|NCT03011892|589354979|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
163174840|NCT03011892|589354980|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
163174841|NCT03011892|589354981|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
163174842|NCT03011892|589354982|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
163174843|NCT03011892|589354983|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
163174844|NCT03011892|589354984|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
163174845|NCT03011892|589354985|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
163174846|NCT03011892|589354986|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
163174847|NCT03011892|589354987|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
163174848|NCT03011892|589354988|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
163174849|NCT03011892|589354989|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
163174850|NCT03011892|589354990|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
163174851|NCT03011892|589354979|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
163174852|NCT03011892|589354980|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
163174853|NCT03011892|589354981|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
163174854|NCT03011892|589354982|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
163174855|NCT03011892|589354983|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
163174856|NCT03011892|589354984|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
163174857|NCT03011892|589354985|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
163174858|NCT03011892|589354986|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
163174859|NCT03011892|589354987|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
163174860|NCT03011892|589354988|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
163174861|NCT03011892|589354989|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
163174862|NCT03011892|589354990|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
163174863|NCT03011892|589354979|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
163174864|NCT03011892|589354980|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
163174865|NCT03011892|589354981|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
163174866|NCT03011892|589354982|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
163174867|NCT03011892|589354983|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
163174868|NCT03011892|589354984|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
163174869|NCT03011892|589354985|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
163174870|NCT03011892|589354986|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
163174871|NCT03011892|589354987|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
163174872|NCT03011892|589354988|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
163174873|NCT03011892|589354989|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
163174874|NCT03011892|589354990|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
163174875|NCT03011892|589354979|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
163174876|NCT03011892|589354980|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
163174877|NCT03011892|589354981|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
163174878|NCT03011892|589354982|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
163174879|NCT03011892|589354983|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
163174880|NCT03011892|589354984|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
163174881|NCT03011892|589354985|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
163174882|NCT03011892|589354986|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
163174883|NCT03011892|589354987|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
163174884|NCT03011892|589354988|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
163174885|NCT03011892|589354989|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
163174886|NCT03011892|589354990|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
163174887|NCT03011892|589354979|FG000|Open Label (OL) Period|Reason not specified|0|||
163174888|NCT03011892|589354980|FG001|Open Label (OL) Period|Reason not specified|0|||
163174889|NCT03011892|589354981|FG002|Open Label (OL) Period|Reason not specified|0|||
163174890|NCT03011892|589354982|FG003|Open Label (OL) Period|Reason not specified|0|||
163174891|NCT03011892|589354983|FG004|Open Label (OL) Period|Reason not specified|0|||
163174892|NCT03011892|589354984|FG005|Open Label (OL) Period|Reason not specified|0|||
163174893|NCT03011892|589354985|FG006|Open Label (OL) Period|Reason not specified|0|||
163174894|NCT03011892|589354986|FG007|Open Label (OL) Period|Reason not specified|1|||
163174895|NCT03011892|589354987|FG008|Open Label (OL) Period|Reason not specified|0|||
163174896|NCT03011892|589354988|FG009|Open Label (OL) Period|Reason not specified|0|||
163174897|NCT03011892|589354989|FG010|Open Label (OL) Period|Reason not specified|0|||
163174898|NCT03011892|589354990|FG011|Open Label (OL) Period|Reason not specified|0|||
163174899|NCT02312687|589355004|FG000|Overall Study|Other, Not Specified|1|||
163174900|NCT00906971|589355007|FG000|Overall Study|Withdrawal by Subject|8|||
163174901|NCT00906971|589355008|FG001|Overall Study|Withdrawal by Subject|2|||
163174902|NCT00906971|589355007|FG000|Overall Study|Lost to Follow-up|0|||
163174903|NCT00906971|589355008|FG001|Overall Study|Lost to Follow-up|1|||
163174904|NCT01007253|589355015|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
163174905|NCT01007253|589355016|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
163174906|NCT01007253|589355017|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
163174907|NCT01007253|589355018|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
163174908|NCT01159431|589355021|FG000|Overall Study|Adverse Event|1|||
163174909|NCT01159431|589355022|FG001|Overall Study|Adverse Event|2|||
163174910|NCT01159431|589355021|FG000|Overall Study|non-compliance|1|||
163174911|NCT01159431|589355022|FG001|Overall Study|non-compliance|1|||
163174912|NCT01159431|589355021|FG000|Overall Study|Lack of Efficacy|0|||
163174913|NCT01159431|589355022|FG001|Overall Study|Lack of Efficacy|3|||
163174914|NCT00884377|589357290|FG000|Overall Study|Withdrawal by Subject|1|||
163174915|NCT00884377|589357291|FG001|Overall Study|Withdrawal by Subject|0|||
163174916|NCT00884377|589357290|FG000|Overall Study|Could not confirm diagnosis|1|||
163174917|NCT00884377|589357291|FG001|Overall Study|Could not confirm diagnosis|0|||
163174918|NCT00884377|589357290|FG000|Overall Study|Physician Decision|0|||
163174919|NCT00884377|589357291|FG001|Overall Study|Physician Decision|1|||
163174920|NCT05347147|589357292|FG000|Overall Study|Lost to Follow-up|0|||
163174921|NCT05347147|589357293|FG001|Overall Study|Lost to Follow-up|1|||
163174922|NCT05347147|589357292|FG000|Overall Study|Sponsor request|3|||
163174923|NCT05347147|589357293|FG001|Overall Study|Sponsor request|3|||
163174924|NCT05347147|589357292|FG000|Overall Study|Study termination|2|||
163174925|NCT05347147|589357293|FG001|Overall Study|Study termination|1|||
163174926|NCT02677324|589357299|FG000|Overall Study|Disease Progression|6|||
163174927|NCT02677324|589357299|FG000|Overall Study|Inability to Swallow pills|1|||
163174928|NCT02677324|589357299|FG000|Overall Study|Non-compliance|1|||
163174929|NCT02677324|589357299|FG000|Overall Study|Lack of Efficacy|1|||
163174930|NCT02677324|589357299|FG000|Overall Study|Medical insurance coverage|1|||
163174931|NCT02677324|589357299|FG000|Overall Study|Adverse Event|1|||
163174932|NCT02677324|589357299|FG000|Overall Study|IgM Myeloma diagnosis|1|||
163174933|NCT01895361|589357300|FG000|Overall Study|Adverse Event|1|||
163174934|NCT01895361|589357301|FG001|Overall Study|Adverse Event|1|||
163174935|NCT01895361|589357302|FG002|Overall Study|Adverse Event|3|||
163174936|NCT01895361|589357300|FG000|Overall Study|Death|2|||
163174937|NCT01895361|589357301|FG001|Overall Study|Death|1|||
163174938|NCT01895361|589357302|FG002|Overall Study|Death|2|||
163174939|NCT01895361|589357300|FG000|Overall Study|Lost to Follow-up|4|||
163174940|NCT01895361|589357301|FG001|Overall Study|Lost to Follow-up|4|||
163174941|NCT01895361|589357302|FG002|Overall Study|Lost to Follow-up|6|||
163174942|NCT01895361|589357300|FG000|Overall Study|Non-compliance with study|1|||
163174943|NCT01895361|589357301|FG001|Overall Study|Non-compliance with study|3|||
163174944|NCT01895361|589357302|FG002|Overall Study|Non-compliance with study|1|||
163174945|NCT01895361|589357300|FG000|Overall Study|Physician Decision|2|||
163174946|NCT01895361|589357301|FG001|Overall Study|Physician Decision|2|||
163174947|NCT01895361|589357302|FG002|Overall Study|Physician Decision|2|||
163174948|NCT01895361|589357300|FG000|Overall Study|Withdrawal by Subject|7|||
163174949|NCT01895361|589357301|FG001|Overall Study|Withdrawal by Subject|6|||
163174950|NCT01895361|589357302|FG002|Overall Study|Withdrawal by Subject|6|||
163174951|NCT01895361|589357300|FG000|Overall Study|Lack of Efficacy|0|||
163174952|NCT01895361|589357301|FG001|Overall Study|Lack of Efficacy|1|||
163174953|NCT01895361|589357302|FG002|Overall Study|Lack of Efficacy|0|||
163174954|NCT01895361|589357300|FG000|Overall Study|Reasons different from categories above|7|||
163174955|NCT01895361|589357301|FG001|Overall Study|Reasons different from categories above|3|||
163174956|NCT01895361|589357302|FG002|Overall Study|Reasons different from categories above|4|||
163174957|NCT00282464|589357303|FG000|Overall Study|Adverse Event|26|||
163174958|NCT00282464|589357304|FG001|Overall Study|Adverse Event|20|||
163174959|NCT00282464|589357303|FG000|Overall Study|Lack of Efficacy|8|||
163174960|NCT00282464|589357304|FG001|Overall Study|Lack of Efficacy|8|||
163174961|NCT00282464|589357303|FG000|Overall Study|Lost to Follow-up|10|||
163174962|NCT00282464|589357304|FG001|Overall Study|Lost to Follow-up|10|||
163174963|NCT00282464|589357303|FG000|Overall Study|Withdrawal by Subject|24|||
163174964|NCT00282464|589357304|FG001|Overall Study|Withdrawal by Subject|10|||
163174965|NCT00282464|589357303|FG000|Overall Study|laboratory abnormality|1|||
163174966|NCT00282464|589357304|FG001|Overall Study|laboratory abnormality|2|||
163174967|NCT00282464|589357303|FG000|Overall Study|Protocol Violation|0|||
163174968|NCT00282464|589357304|FG001|Overall Study|Protocol Violation|7|||
163174969|NCT00282464|589357303|FG000|Overall Study|Patient moved|1|||
163174970|NCT00282464|589357304|FG001|Overall Study|Patient moved|0|||
163174971|NCT00282464|589357303|FG000|Overall Study|patient non-compliant|3|||
163174972|NCT00282464|589357304|FG001|Overall Study|patient non-compliant|0|||
163174973|NCT00282464|589357303|FG000|Overall Study|patient no show|0|||
163174974|NCT00282464|589357304|FG001|Overall Study|patient no show|1|||
163174975|NCT00282464|589357303|FG000|Overall Study|patient incarcerated|0|||
163174976|NCT00282464|589357304|FG001|Overall Study|patient incarcerated|1|||
163174977|NCT00282464|589357303|FG000|Overall Study|family crisis|0|||
163174978|NCT00282464|589357304|FG001|Overall Study|family crisis|1|||
163174979|NCT00282464|589357303|FG000|Overall Study|dispensed wrong kit|0|||
163174980|NCT00282464|589357304|FG001|Overall Study|dispensed wrong kit|1|||
163174981|NCT00282464|589357303|FG000|Overall Study|dropped due to missed visits|0|||
163280134|NCT00748969|589733048|FG000|Overall Study|Withdrawal by Subject|0|||
163280135|NCT00748969|589733049|FG001|Overall Study|Withdrawal by Subject|1|||
163280136|NCT03532178|589733050|FG000|First Period|Withdrawal by Subject|1|||
163280137|NCT03532178|589733051|FG001|First Period|Withdrawal by Subject|3|||
163280138|NCT03532178|589733050|FG000|First Period|technical issues in data collection Technical issues|0|||
163280139|NCT03532178|589733051|FG001|First Period|technical issues in data collection Technical issues|1|||
163280140|NCT03532178|589733050|FG000|Second Period|Withdrawal by Subject|1|||
163280141|NCT03532178|589733051|FG001|Second Period|Withdrawal by Subject|1|||
163280142|NCT03532178|589733050|FG000|Second Period|Technical issues|0|||
163280143|NCT03532178|589733051|FG001|Second Period|Technical issues|1|||
163280144|NCT01113463|589733055|FG000|Overall Study|Physician Decision|5|||
163280145|NCT00372528|589733056|FG000|Overall Study|Lack of Efficacy|1|||
163280146|NCT00372528|589733056|FG000|Overall Study|Adverse Event|1|||
163280147|NCT00372528|589733056|FG000|Overall Study|Study Terminated by Sponsor|18|||
163280148|NCT00372528|589733056|FG000|Overall Study|Other|1|||
163280149|NCT00562965|589733057|FG000|Overall Study|Withdrawal by Subject|0|||
163280150|NCT00562965|589733058|FG001|Overall Study|Withdrawal by Subject|1|||
162932399|NCT03262233|588458472|FG001|Overall Study|data collection artifact|1|||
162932400|NCT03262233|588458473|FG002|Overall Study|data collection artifact|0|||
162932401|NCT03262233|588458474|FG003|Overall Study|data collection artifact|0|||
162932402|NCT03770000|588458475|FG000|Overall Study|Premature discontinuation due to PD|0|||
162932403|NCT03770000|588458476|FG001|Overall Study|Premature discontinuation due to PD|0|||
162932404|NCT03770000|588458477|FG002|Overall Study|Premature discontinuation due to PD|1|||
162932405|NCT03770000|588458478|FG003|Overall Study|Premature discontinuation due to PD|3|||
162932406|NCT03770000|588458479|FG004|Overall Study|Premature discontinuation due to PD|2|||
162932407|NCT03877237|588458480|FG000|Overall Study|Adverse Event|1|||
162932408|NCT03877237|588458481|FG001|Overall Study|Adverse Event|2|||
162932409|NCT03877237|588458480|FG000|Overall Study|Death|3|||
162932410|NCT03877237|588458481|FG001|Overall Study|Death|2|||
162932411|NCT03877237|588458480|FG000|Overall Study|Physician Decision|1|||
162932412|NCT03877237|588458481|FG001|Overall Study|Physician Decision|0|||
162932413|NCT03877237|588458480|FG000|Overall Study|Withdrawal by Subject|0|||
162932414|NCT03877237|588458481|FG001|Overall Study|Withdrawal by Subject|2|||
162932415|NCT02290028|588458483|FG000|Overall Study|Death|217|||
162932416|NCT02290028|588458483|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
162932417|NCT02290028|588458483|FG000|Overall Study|No longer under care of study physician|76|||
162932418|NCT02290028|588458483|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
162932419|NCT02290028|588458483|FG000|Overall Study|Withdrawal by Subject|52|||
162932420|NCT02290028|588458483|FG000|Overall Study|Study site closure|44|||
162932421|NCT02290028|588458483|FG000|Overall Study|Lost to Follow-up|34|||
162932422|NCT02290028|588458483|FG000|Overall Study|Miscellaneous|10|||
163280151|NCT00562965|589733057|FG000|Overall Study|Death|2|||
163280152|NCT00562965|589733058|FG001|Overall Study|Death|4|||
163280153|NCT00562965|589733057|FG000|Overall Study|Lost to Follow-up|1|||
163280154|NCT00562965|589733058|FG001|Overall Study|Lost to Follow-up|0|||
162932423|NCT02290028|588458483|FG000|Overall Study|Transition to EP PASSION|1295|||
163280155|NCT00562965|589733057|FG000|Overall Study|Other|0|||
163280156|NCT00562965|589733058|FG001|Overall Study|Other|1|||
163280157|NCT00761774|589733059|FG000|Overall Study|Adverse Event|17|||
162932424|NCT02290028|588458483|FG000|Overall Study|Planned study completion at 12 months|257|||
162932425|NCT00833547|588458484|FG000|Overall Study|Withdrawal by Subject|2|||
162932426|NCT00833547|588458485|FG001|Overall Study|Withdrawal by Subject|2|||
163280158|NCT00761774|589733059|FG000|Overall Study|Lack of Efficacy|37|||
163280159|NCT00761774|589733059|FG000|Overall Study|Lost to Follow-up|2|||
163174982|NCT00282464|589357304|FG001|Overall Study|dropped due to missed visits|1|||
163174983|NCT00475423|589357305|FG000|Overall Study|Protocol Violation|5|||
163174984|NCT00475423|589357305|FG000|Overall Study|Adverse Event|4|||
163174985|NCT00475423|589357305|FG000|Overall Study|Withdrawal by Subject|6|||
163174986|NCT00475423|589357305|FG000|Overall Study|Lack of Efficacy|8|||
163174987|NCT00475423|589357305|FG000|Overall Study|Death|1|||
163174988|NCT00475423|589357305|FG000|Overall Study|Reason not specified|1|||
163174989|NCT00475423|589357305|FG000|Overall Study|Lost to Follow-up|7|||
163174990|NCT01214174|589357306|FG000|Overall Study|Withdrawal by Subject|0|||
163174991|NCT01214174|589357307|FG001|Overall Study|Withdrawal by Subject|0|||
163174992|NCT01214174|589357308|FG002|Overall Study|Withdrawal by Subject|1|||
163174993|NCT02239120|589357309|FG000|Overall Study|Death|56|||
163174994|NCT02239120|589357310|FG001|Overall Study|Death|58|||
163174995|NCT02239120|589357309|FG000|Overall Study|Lost to Follow-up|19|||
163174996|NCT02239120|589357310|FG001|Overall Study|Lost to Follow-up|14|||
163174997|NCT00548405|589357331|FG000|Overall Study|Adverse Event|6|||
163174998|NCT00548405|589357332|FG001|Overall Study|Adverse Event|2|||
163174999|NCT00548405|589357333|FG002|Overall Study|Adverse Event|0|||
163175000|NCT00548405|589357331|FG000|Overall Study|Lack of Efficacy|6|||
163175001|NCT00548405|589357332|FG001|Overall Study|Lack of Efficacy|0|||
163175002|NCT00548405|589357333|FG002|Overall Study|Lack of Efficacy|0|||
163175003|NCT00548405|589357331|FG000|Overall Study|Physician Decision|3|||
163175004|NCT00548405|589357332|FG001|Overall Study|Physician Decision|4|||
163175005|NCT00548405|589357333|FG002|Overall Study|Physician Decision|1|||
163175006|NCT00548405|589357331|FG000|Overall Study|Pregnancy|1|||
163175007|NCT00548405|589357332|FG001|Overall Study|Pregnancy|0|||
163175008|NCT00548405|589357333|FG002|Overall Study|Pregnancy|0|||
163175009|NCT00548405|589357331|FG000|Overall Study|Protocol Violation|1|||
163175010|NCT00548405|589357332|FG001|Overall Study|Protocol Violation|0|||
163175011|NCT00548405|589357333|FG002|Overall Study|Protocol Violation|0|||
163175012|NCT00548405|589357331|FG000|Overall Study|Withdrawal by Subject|36|||
163175013|NCT00548405|589357332|FG001|Overall Study|Withdrawal by Subject|12|||
163175014|NCT00548405|589357333|FG002|Overall Study|Withdrawal by Subject|5|||
163175015|NCT00548405|589357331|FG000|Overall Study|Lost to Follow-up|1|||
163175016|NCT00548405|589357332|FG001|Overall Study|Lost to Follow-up|1|||
163175017|NCT00548405|589357333|FG002|Overall Study|Lost to Follow-up|2|||
163175018|NCT00548405|589357331|FG000|Overall Study|Death|0|||
163175019|NCT00548405|589357332|FG001|Overall Study|Death|1|||
163175020|NCT00548405|589357333|FG002|Overall Study|Death|1|||
163175021|NCT00548405|589357331|FG000|Overall Study|Sponsor decision|1|||
163175022|NCT00548405|589357332|FG001|Overall Study|Sponsor decision|0|||
163175023|NCT00548405|589357333|FG002|Overall Study|Sponsor decision|0|||
163175024|NCT00548405|589357331|FG000|Overall Study|Randomized but not treated|1|||
163175025|NCT00548405|589357332|FG001|Overall Study|Randomized but not treated|0|||
163175026|NCT00548405|589357333|FG002|Overall Study|Randomized but not treated|0|||
163175027|NCT01624870|589357334|FG000|Overall Study|Death|19|||
163175028|NCT01624870|589357334|FG000|Overall Study|Withdrawal by Subject|1|||
163175029|NCT01624870|589357334|FG000|Overall Study|CoreValve not implanted|6|||
163175030|NCT01624870|589357334|FG000|Overall Study|Lost to follow up|1|||
163175031|NCT01878149|589357335|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
163175032|NCT01878149|589357336|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
163175033|NCT04672252|589357339|FG000|Overall Study|Protocol Violation|1|||
163175034|NCT04672252|589357340|FG001|Overall Study|Protocol Violation|0|||
163175035|NCT03735238|589357344|FG000|Overall Study|Did not want to participate in research|3|||
163175036|NCT03735238|589357344|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
163175037|NCT02660138|589357345|FG000|Overall Study|Adverse Event|0|||
163175038|NCT02660138|589357346|FG001|Overall Study|Adverse Event|3|||
163175039|NCT02660138|589357347|FG002|Overall Study|Adverse Event|2|||
163175040|NCT02660138|589357345|FG000|Overall Study|Lack of Efficacy|1|||
163175041|NCT02660138|589357346|FG001|Overall Study|Lack of Efficacy|2|||
163175042|NCT02660138|589357347|FG002|Overall Study|Lack of Efficacy|1|||
163175043|NCT02660138|589357345|FG000|Overall Study|Withdrawal by Subject|7|||
163175044|NCT02660138|589357346|FG001|Overall Study|Withdrawal by Subject|6|||
163280160|NCT00761774|589733059|FG000|Overall Study|Withdrawal by Subject|9|||
163175045|NCT02660138|589357347|FG002|Overall Study|Withdrawal by Subject|6|||
163175046|NCT02660138|589357345|FG000|Overall Study|Lost to Follow-up|4|||
163280161|NCT00761774|589733059|FG000|Overall Study|Non-compliance|4|||
163175047|NCT02660138|589357346|FG001|Overall Study|Lost to Follow-up|4|||
163175048|NCT02660138|589357347|FG002|Overall Study|Lost to Follow-up|1|||
163175049|NCT02660138|589357345|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
163175050|NCT02660138|589357346|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
163175051|NCT02660138|589357347|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
163175052|NCT02660138|589357345|FG000|Overall Study|Other|1|||
163175053|NCT02660138|589357346|FG001|Overall Study|Other|1|||
163175054|NCT02660138|589357347|FG002|Overall Study|Other|0|||
163175055|NCT02660138|589357345|FG000|Overall Study|Not treated|0|||
163175056|NCT02660138|589357346|FG001|Overall Study|Not treated|1|||
163175057|NCT02660138|589357347|FG002|Overall Study|Not treated|0|||
163175058|NCT00308581|589357348|FG000|Induction Phase|Adverse Event|0|||
163280162|NCT00761774|589733059|FG000|Overall Study|End of study|2|||
163280163|NCT00761774|589733059|FG000|Overall Study|Reclassification of seizures|1|||
163280164|NCT00761774|589733059|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
163280165|NCT00761774|589733059|FG000|Overall Study|Sponsor decision|1|||
163280166|NCT00761774|589733059|FG000|Overall Study|Investigator clinical judgement|1|||
163280167|NCT00761774|589733059|FG000|Overall Study|Patient moved out of study area|1|||
163280168|NCT00761774|589733059|FG000|Overall Study|Coordinator leaving site|1|||
163280169|NCT00761774|589733059|FG000|Overall Study|Subject IP non-compliance|1|||
163280170|NCT00761774|589733059|FG000|Overall Study|IP stopped by hospital physician|1|||
163280171|NCT01648283|589733060|FG000|Overall Study|Withdrawal by Subject|14|||
163280172|NCT01124617|589733061|FG000|Overall Study|Adverse Event|5|||
163280173|NCT01124617|589733062|FG001|Overall Study|Adverse Event|2|||
163280174|NCT01124617|589733061|FG000|Overall Study|Lack of Efficacy|2|||
163280175|NCT01124617|589733062|FG001|Overall Study|Lack of Efficacy|1|||
163280176|NCT01124617|589733061|FG000|Overall Study|Protocol Violation|1|||
163280177|NCT01124617|589733062|FG001|Overall Study|Protocol Violation|1|||
163280178|NCT01124617|589733061|FG000|Overall Study|Withdrawal by Subject|9|||
163280179|NCT01124617|589733062|FG001|Overall Study|Withdrawal by Subject|1|||
163280180|NCT01124617|589733061|FG000|Overall Study|Other|2|||
163280181|NCT01124617|589733062|FG001|Overall Study|Other|1|||
163280182|NCT01354938|589733066|FG000|Overall Study|Lost to Follow-up|1|||
163280183|NCT01253200|589733067|FG000|Overall Study|Death|1|||
163280184|NCT01253200|589733068|FG001|Overall Study|Death|0|||
163280185|NCT01253200|589733069|FG002|Overall Study|Death|0|||
163280186|NCT01253200|589733070|FG003|Overall Study|Death|0|||
163280187|NCT01253200|589733071|FG004|Overall Study|Death|0|||
163280188|NCT01253200|589733067|FG000|Overall Study|Lost to Follow-up|1|||
163280189|NCT01253200|589733068|FG001|Overall Study|Lost to Follow-up|1|||
163280190|NCT01253200|589733069|FG002|Overall Study|Lost to Follow-up|0|||
163280191|NCT01253200|589733070|FG003|Overall Study|Lost to Follow-up|0|||
163280192|NCT01253200|589733071|FG004|Overall Study|Lost to Follow-up|0|||
163280193|NCT01253200|589733067|FG000|Overall Study|Withdrawal by Subject|2|||
163280194|NCT01253200|589733068|FG001|Overall Study|Withdrawal by Subject|0|||
163280195|NCT01253200|589733069|FG002|Overall Study|Withdrawal by Subject|0|||
163280196|NCT01253200|589733070|FG003|Overall Study|Withdrawal by Subject|0|||
163280197|NCT01253200|589733071|FG004|Overall Study|Withdrawal by Subject|0|||
163280198|NCT01253200|589733067|FG000|Overall Study|Protocol Violation|1|||
163280199|NCT01253200|589733068|FG001|Overall Study|Protocol Violation|4|||
163280200|NCT01253200|589733069|FG002|Overall Study|Protocol Violation|0|||
163280201|NCT01253200|589733070|FG003|Overall Study|Protocol Violation|0|||
163280202|NCT01253200|589733071|FG004|Overall Study|Protocol Violation|5|||
163280203|NCT01253200|589733067|FG000|Overall Study|intents|10|||
163280204|NCT01253200|589733068|FG001|Overall Study|intents|10|||
163280205|NCT01253200|589733069|FG002|Overall Study|intents|1|||
163280206|NCT01253200|589733070|FG003|Overall Study|intents|3|||
163280207|NCT01253200|589733071|FG004|Overall Study|intents|0|||
163280208|NCT01253200|589733067|FG000|Overall Study|Attempts|6|||
163280209|NCT01253200|589733068|FG001|Overall Study|Attempts|4|||
163280210|NCT01253200|589733069|FG002|Overall Study|Attempts|1|||
163280211|NCT01253200|589733070|FG003|Overall Study|Attempts|2|||
163280212|NCT01253200|589733071|FG004|Overall Study|Attempts|0|||
163280213|NCT02049437|589733072|FG000|Period 1|Adverse Event|1|||
163280214|NCT02049437|589733073|FG001|Period 1|Adverse Event|1|||
163280215|NCT02049437|589733072|FG000|Period 1|Adverse Event|1|||
163280216|NCT02049437|589733073|FG001|Period 1|Adverse Event|0|||
163280217|NCT01163149|589733079|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
163280218|NCT01163149|589733080|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
163280219|NCT01163149|589733081|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
163280220|NCT01163149|589733079|FG000|Extension Treatment Period|Adverse Event|0|||
163280221|NCT01163149|589733080|FG001|Extension Treatment Period|Adverse Event|1|||
163280222|NCT01163149|589733081|FG002|Extension Treatment Period|Adverse Event|0|||
163280223|NCT01163149|589733079|FG000|Extension Treatment Period|Noncompliance|0|||
163280224|NCT01163149|589733080|FG001|Extension Treatment Period|Noncompliance|0|||
163280225|NCT01163149|589733081|FG002|Extension Treatment Period|Noncompliance|1|||
163280226|NCT01700530|589733083|FG000|Overall Study|Withdrawal by Subject|0|||
163280227|NCT01700530|589733084|FG001|Overall Study|Withdrawal by Subject|3|||
163280228|NCT01700530|589733085|FG002|Overall Study|Withdrawal by Subject|1|||
163280229|NCT00578227|589733086|FG000|Overall Study|Lost to Follow-up|0|||
163280230|NCT00578227|589733087|FG001|Overall Study|Lost to Follow-up|1|||
163280231|NCT00578227|589733088|FG002|Overall Study|Lost to Follow-up|1|||
163280232|NCT00578227|589733086|FG000|Overall Study|Withdrawal by Subject|5|||
163280233|NCT00578227|589733087|FG001|Overall Study|Withdrawal by Subject|1|||
163280234|NCT00578227|589733088|FG002|Overall Study|Withdrawal by Subject|3|||
163280235|NCT04956692|589733096|FG000|Overall Study|Death|115|||
163280236|NCT04956692|589733097|FG001|Overall Study|Death|47|||
163280237|NCT04956692|589733096|FG000|Overall Study|Lost to Follow-up|0|||
163280238|NCT04956692|589733097|FG001|Overall Study|Lost to Follow-up|1|||
163280239|NCT04956692|589733096|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
163280240|NCT04956692|589733097|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163280241|NCT04956692|589733096|FG000|Overall Study|Withdrawal by Subject|5|||
163280242|NCT04956692|589733097|FG001|Overall Study|Withdrawal by Subject|2|||
163280243|NCT04956692|589733096|FG000|Overall Study|Ongoing in Study|236|||
163280244|NCT04956692|589733097|FG001|Overall Study|Ongoing in Study|123|||
163280245|NCT02099539|589733100|FG000|Overall Study|Progressive Disease|3|||
163280246|NCT02099539|589733101|FG001|Overall Study|Progressive Disease|2|||
163280247|NCT02099539|589733102|FG002|Overall Study|Progressive Disease|2|||
163280248|NCT02099539|589733103|FG003|Overall Study|Progressive Disease|1|||
163280249|NCT02099539|589733104|FG004|Overall Study|Progressive Disease|4|||
163280250|NCT02099539|589733105|FG005|Overall Study|Progressive Disease|2|||
163280251|NCT02099539|589733106|FG006|Overall Study|Progressive Disease|0|||
163280252|NCT02099539|589733100|FG000|Overall Study|Adverse Event|0|||
163280253|NCT02099539|589733101|FG001|Overall Study|Adverse Event|0|||
163175059|NCT00308581|589357349|FG001|Induction Phase|Adverse Event|0|||
163175060|NCT00308581|589357350|FG002|Induction Phase|Adverse Event|37|||
163175061|NCT00308581|589357348|FG000|Induction Phase|Lack of Efficacy|0|||
163175062|NCT00308581|589357349|FG001|Induction Phase|Lack of Efficacy|0|||
163175063|NCT00308581|589357350|FG002|Induction Phase|Lack of Efficacy|121|||
163175064|NCT00308581|589357348|FG000|Induction Phase|Withdrawal by Subject|0|||
163175065|NCT00308581|589357349|FG001|Induction Phase|Withdrawal by Subject|0|||
163175066|NCT00308581|589357350|FG002|Induction Phase|Withdrawal by Subject|5|||
163175067|NCT00308581|589357348|FG000|Induction Phase|Unknown reason|0|||
163175068|NCT00308581|589357349|FG001|Induction Phase|Unknown reason|0|||
163175069|NCT00308581|589357350|FG002|Induction Phase|Unknown reason|3|||
163175070|NCT00308581|589357348|FG000|Randomized Maintenance Phase|Adverse Event|10|||
163175071|NCT00308581|589357349|FG001|Randomized Maintenance Phase|Adverse Event|17|||
163175072|NCT00308581|589357350|FG002|Randomized Maintenance Phase|Adverse Event|0|||
163175073|NCT00308581|589357348|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
163175074|NCT00308581|589357349|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
163175075|NCT00308581|589357350|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
163175076|NCT00308581|589357348|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
163175077|NCT00308581|589357349|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
163175078|NCT00308581|589357350|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
163175079|NCT00308581|589357348|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
163175080|NCT00308581|589357349|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
163175081|NCT00308581|589357350|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
163280254|NCT02099539|589733102|FG002|Overall Study|Adverse Event|1|||
163280255|NCT02099539|589733103|FG003|Overall Study|Adverse Event|1|||
163280256|NCT02099539|589733104|FG004|Overall Study|Adverse Event|0|||
163280257|NCT02099539|589733105|FG005|Overall Study|Adverse Event|0|||
163280258|NCT02099539|589733106|FG006|Overall Study|Adverse Event|0|||
163280259|NCT02099539|589733100|FG000|Overall Study|Physician Decision|0|||
162932427|NCT00566098|588458488|FG000|Collection of MILs|Withdrawal by Subject|1|||
163280260|NCT02099539|589733101|FG001|Overall Study|Physician Decision|0|||
163280261|NCT02099539|589733102|FG002|Overall Study|Physician Decision|0|||
163280262|NCT02099539|589733103|FG003|Overall Study|Physician Decision|0|||
163280263|NCT02099539|589733104|FG004|Overall Study|Physician Decision|0|||
163280264|NCT02099539|589733105|FG005|Overall Study|Physician Decision|1|||
163280265|NCT02099539|589733106|FG006|Overall Study|Physician Decision|0|||
163280266|NCT01449721|589733108|FG000|Overall Study|Physician Decision|0|||
163280267|NCT01449721|589733109|FG001|Overall Study|Physician Decision|1|||
163280268|NCT01449721|589733108|FG000|Overall Study|Physician Decision|0|||
163280269|NCT01449721|589733109|FG001|Overall Study|Physician Decision|1|||
163280270|NCT02148718|589733110|FG000|Overall Study|Protocol Violation|26|||
163280271|NCT02148718|589733110|FG000|Overall Study|Discontinued Study Prematurely|5|||
163280272|NCT00333788|589733117|FG000|Overall Study|Adverse Event|44|||
163280273|NCT00333788|589733117|FG000|Overall Study|Lack of Efficacy|80|||
163280274|NCT00333788|589733117|FG000|Overall Study|Lost to Follow-up|2|||
163280275|NCT00333788|589733117|FG000|Overall Study|Withdrawal by Subject|24|||
163280276|NCT00333788|589733117|FG000|Overall Study|Other: Non-compliance|2|||
163280277|NCT00333788|589733117|FG000|Overall Study|Other: Moved|2|||
163280278|NCT00333788|589733117|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
163280279|NCT00333788|589733117|FG000|Overall Study|Other: Investigator decision|1|||
163280280|NCT00333788|589733117|FG000|Overall Study|Other: Quality of life concern|1|||
163280281|NCT00333788|589733117|FG000|Overall Study|Other: Sponsor decision|1|||
163280282|NCT00333788|589733117|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
163280283|NCT00333788|589733117|FG000|Overall Study|Other: Medical monitor decision|1|||
163280284|NCT00333788|589733117|FG000|Overall Study|Other: Physician decision|1|||
163280285|NCT00333788|589733117|FG000|Overall Study|Other: Signed consent for another study|1|||
163280286|NCT00114959|589733118|FG000|Overall Study|Lack of Efficacy|6|||
163280287|NCT00114959|589733118|FG000|Overall Study|Physician Decision|1|||
163280288|NCT00114959|589733118|FG000|Overall Study|Death|1|||
163280289|NCT04978363|589735490|FG000|Overall Study|Other medical issues unrelated to the study|0|||
163280290|NCT04978363|589735491|FG001|Overall Study|Other medical issues unrelated to the study|0|||
163280291|NCT04978363|589735492|FG002|Overall Study|Other medical issues unrelated to the study|0|||
163280292|NCT04978363|589735493|FG003|Overall Study|Other medical issues unrelated to the study|0|||
163280293|NCT04978363|589735494|FG004|Overall Study|Other medical issues unrelated to the study|1|||
163280294|NCT04978363|589735495|FG005|Overall Study|Other medical issues unrelated to the study|0|||
163280295|NCT04978363|589735496|FG006|Overall Study|Other medical issues unrelated to the study|0|||
163280296|NCT04978363|589735497|FG007|Overall Study|Other medical issues unrelated to the study|0|||
163280297|NCT04978363|589735498|FG008|Overall Study|Other medical issues unrelated to the study|0|||
163280298|NCT04978363|589735499|FG009|Overall Study|Other medical issues unrelated to the study|0|||
163280299|NCT04978363|589735500|FG010|Overall Study|Other medical issues unrelated to the study|0|||
163280300|NCT04978363|589735490|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
163280301|NCT04978363|589735491|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
163280302|NCT04978363|589735492|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
163280303|NCT04978363|589735493|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
163280304|NCT04978363|589735494|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
163280305|NCT04978363|589735495|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
163280306|NCT04978363|589735496|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
163280307|NCT04978363|589735497|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
163280308|NCT04978363|589735498|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
163280309|NCT04978363|589735499|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
163280310|NCT04978363|589735500|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
163280311|NCT04978363|589735490|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163280312|NCT04978363|589735491|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
163280313|NCT04978363|589735492|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163280314|NCT04978363|589735493|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163280315|NCT04978363|589735494|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163280316|NCT04978363|589735495|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163280317|NCT04978363|589735496|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163280318|NCT04978363|589735497|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163280319|NCT04978363|589735498|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163280320|NCT04978363|589735499|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162932428|NCT00566098|588458488|FG000|Collection of MILs|Relapsed|1|||
162932429|NCT00566098|588458488|FG000|Generation of MILs Product|Relapsed|1|||
163280321|NCT04978363|589735500|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163280322|NCT01251614|589735501|FG000|Overall Study|Adverse Event|1|||
163280323|NCT01251614|589735502|FG001|Overall Study|Adverse Event|0|||
163280324|NCT01251614|589735503|FG002|Overall Study|Adverse Event|1|||
163280325|NCT01251614|589735501|FG000|Overall Study|Lack of Efficacy|1|||
163280326|NCT01251614|589735502|FG001|Overall Study|Lack of Efficacy|9|||
163280327|NCT01251614|589735503|FG002|Overall Study|Lack of Efficacy|4|||
163280328|NCT01251614|589735501|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
163280329|NCT01251614|589735502|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
163280330|NCT01251614|589735503|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
163280331|NCT01251614|589735501|FG000|Overall Study|Pregnancy|0|||
163280332|NCT01251614|589735502|FG001|Overall Study|Pregnancy|0|||
163280333|NCT01251614|589735503|FG002|Overall Study|Pregnancy|2|||
163280334|NCT01251614|589735501|FG000|Overall Study|Loss of Disease Control|0|||
163280335|NCT01251614|589735502|FG001|Overall Study|Loss of Disease Control|1|||
163280336|NCT01251614|589735503|FG002|Overall Study|Loss of Disease Control|0|||
163280337|NCT01251614|589735501|FG000|Overall Study|Withdrawal by Subject|0|||
163280338|NCT01251614|589735502|FG001|Overall Study|Withdrawal by Subject|2|||
163280339|NCT01251614|589735503|FG002|Overall Study|Withdrawal by Subject|1|||
163280340|NCT01251614|589735501|FG000|Overall Study|Lost to Follow-up|0|||
163280341|NCT01251614|589735502|FG001|Overall Study|Lost to Follow-up|1|||
163280342|NCT01251614|589735503|FG002|Overall Study|Lost to Follow-up|0|||
163280343|NCT01876043|589735504|FG000|Overall Study|Death|1|||
163280344|NCT01876043|589735504|FG000|Overall Study|Withdrawal by Subject|1|||
163280345|NCT01211665|589735506|FG000|Overall Study|Withdrawal by Subject|1|||
163280346|NCT01211665|589735507|FG001|Overall Study|Withdrawal by Subject|0|||
163280347|NCT01211665|589735506|FG000|Overall Study|Death|1|||
163280348|NCT01211665|589735507|FG001|Overall Study|Death|0|||
163280349|NCT00498186|589735510|FG000|Overall Study|Protocol Violation|10|||
163280350|NCT00498186|589735510|FG000|Overall Study|Lack of Efficacy|31|||
163280351|NCT00498186|589735510|FG000|Overall Study|Adverse Event|89|||
163280352|NCT00498186|589735510|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
163280353|NCT00498186|589735510|FG000|Overall Study|Withdrawal by Subject|18|||
163280354|NCT00498186|589735510|FG000|Overall Study|Lost to Follow-up|3|||
163280355|NCT00498186|589735510|FG000|Overall Study|Other|10|||
163280356|NCT03302156|589735511|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
163280357|NCT03302156|589735512|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
163280358|NCT03302156|589735513|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
163280359|NCT03635112|589735515|FG000|Overall Study|Adverse Event|5|||
163280360|NCT03635112|589735516|FG001|Overall Study|Adverse Event|9|||
163280361|NCT03635112|589735517|FG002|Overall Study|Adverse Event|14|||
163280362|NCT03635112|589735515|FG000|Overall Study|Lost to Follow-up|1|||
163280363|NCT03635112|589735516|FG001|Overall Study|Lost to Follow-up|0|||
163280364|NCT03635112|589735517|FG002|Overall Study|Lost to Follow-up|1|||
163280365|NCT03635112|589735515|FG000|Overall Study|Physician Decision|5|||
163280366|NCT03635112|589735516|FG001|Overall Study|Physician Decision|7|||
163280367|NCT03635112|589735517|FG002|Overall Study|Physician Decision|5|||
163280368|NCT03635112|589735515|FG000|Overall Study|Protocol Violation|0|||
163280369|NCT03635112|589735516|FG001|Overall Study|Protocol Violation|0|||
163280370|NCT03635112|589735517|FG002|Overall Study|Protocol Violation|1|||
163280371|NCT03635112|589735515|FG000|Overall Study|Study Terminated by Sponsor|11|||
163280372|NCT03635112|589735516|FG001|Overall Study|Study Terminated by Sponsor|17|||
163280373|NCT03635112|589735517|FG002|Overall Study|Study Terminated by Sponsor|21|||
163280374|NCT03635112|589735515|FG000|Overall Study|Withdrawal by Subject|4|||
163280375|NCT03635112|589735516|FG001|Overall Study|Withdrawal by Subject|9|||
163280376|NCT03635112|589735517|FG002|Overall Study|Withdrawal by Subject|7|||
163280377|NCT03635112|589735515|FG000|Overall Study|Miscellaneous|0|||
163280378|NCT03635112|589735516|FG001|Overall Study|Miscellaneous|0|||
163280379|NCT03635112|589735517|FG002|Overall Study|Miscellaneous|1|||
163280380|NCT03283553|589735522|FG000|Patient Participant Flow|Death|5|||
163280381|NCT03283553|589735523|FG001|Patient Participant Flow|Death|10|||
163280382|NCT03283553|589735522|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
163280383|NCT03283553|589735523|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
163280384|NCT03283553|589735522|FG000|Patient Participant Flow|Lost to Follow-up|1|||
163280385|NCT03283553|589735523|FG001|Patient Participant Flow|Lost to Follow-up|1|||
163280386|NCT03283553|589735522|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
163280387|NCT03283553|589735523|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
163280388|NCT03283553|589735522|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
163280389|NCT03283553|589735523|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
163280390|NCT03283553|589735522|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
163280391|NCT03283553|589735523|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
163280392|NCT03686683|589735524|FG000|Overall Study|Withdrawal by Subject|52|||
162932430|NCT00566098|588458488|FG000|Administration of ASCT+MILs|Death|10|||
162932431|NCT00566098|588458488|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
162932432|NCT02236754|588458489|FG000|Overall Study|Withdrawal by Subject|1|||
162932433|NCT02236754|588458490|FG001|Overall Study|Withdrawal by Subject|0|||
162932434|NCT01270841|588458491|FG000|Overall Study|Adverse Event|0|||
162932435|NCT01270841|588458492|FG001|Overall Study|Adverse Event|1|||
162932436|NCT01270841|588458493|FG002|Overall Study|Adverse Event|0|||
162932437|NCT01270841|588458494|FG003|Overall Study|Adverse Event|3|||
162932438|NCT01270841|588458491|FG000|Overall Study|Withdrawal by Subject|3|||
163280393|NCT03686683|589735525|FG001|Overall Study|Withdrawal by Subject|32|||
163280394|NCT03686683|589735524|FG000|Overall Study|Lost to Follow-up|23|||
163280395|NCT03686683|589735525|FG001|Overall Study|Lost to Follow-up|19|||
163280396|NCT03686683|589735524|FG000|Overall Study|Adverse Event|1|||
163280397|NCT03686683|589735525|FG001|Overall Study|Adverse Event|0|||
163280398|NCT03686683|589735524|FG000|Overall Study|Death|10|||
163280399|NCT03686683|589735525|FG001|Overall Study|Death|5|||
163280400|NCT03686683|589735524|FG000|Overall Study|Progressive Disease|1|||
163280401|NCT03686683|589735525|FG001|Overall Study|Progressive Disease|1|||
163280402|NCT03686683|589735524|FG000|Overall Study|Noncompliance|1|||
163280403|NCT03686683|589735525|FG001|Overall Study|Noncompliance|0|||
163280404|NCT03686683|589735524|FG000|Overall Study|Physician Decision|1|||
163280405|NCT03686683|589735525|FG001|Overall Study|Physician Decision|1|||
163280406|NCT03686683|589735524|FG000|Overall Study|Screen fail post-randomization|1|||
162932439|NCT01270841|588458492|FG001|Overall Study|Withdrawal by Subject|2|||
163175082|NCT00308581|589357348|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
163175083|NCT00308581|589357349|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
163175084|NCT00308581|589357350|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
163175085|NCT00308581|589357348|FG000|Randomized Maintenance Phase|Unknown reason|3|||
163175086|NCT00308581|589357349|FG001|Randomized Maintenance Phase|Unknown reason|0|||
163175087|NCT00308581|589357350|FG002|Randomized Maintenance Phase|Unknown reason|0|||
163175088|NCT00899353|589357351|FG000|Overall Study|Adverse Event|2|||
163175089|NCT00899353|589357351|FG000|Overall Study|Lost to Follow-up|1|||
163175090|NCT00899353|589357351|FG000|Overall Study|Withdrawal by Subject|2|||
163175091|NCT00095147|589357362|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
163175092|NCT00095147|589357363|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
163175093|NCT00095147|589357364|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
163175094|NCT00095147|589357365|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
163175095|NCT00095147|589357366|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
163175096|NCT00095147|589357362|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
163175097|NCT00095147|589357363|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
163175098|NCT00095147|589357364|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
163175099|NCT00095147|589357365|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
163175100|NCT00095147|589357366|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
163175101|NCT00095147|589357362|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
163175102|NCT00095147|589357363|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
163175103|NCT00095147|589357364|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
163175104|NCT00095147|589357365|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
163175105|NCT00095147|589357366|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
163175106|NCT00095147|589357362|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
163175107|NCT00095147|589357363|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
163175108|NCT00095147|589357364|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
163175109|NCT00095147|589357365|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
163175110|NCT00095147|589357366|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
163175111|NCT00095147|589357362|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
163175112|NCT00095147|589357363|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
163175113|NCT00095147|589357364|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
163175114|NCT00095147|589357365|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
163175115|NCT00095147|589357366|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
163175116|NCT00095147|589357362|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
163175117|NCT00095147|589357363|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
163175118|NCT00095147|589357364|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
163280407|NCT03686683|589735525|FG001|Overall Study|Screen fail post-randomization|0|||
163280408|NCT03686683|589735524|FG000|Overall Study|Protocol Violation|3|||
162932440|NCT01270841|588458493|FG002|Overall Study|Withdrawal by Subject|3|||
163175119|NCT00095147|589357365|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
163175120|NCT00095147|589357366|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
163175121|NCT00095147|589357362|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
163280409|NCT03686683|589735525|FG001|Overall Study|Protocol Violation|0|||
163280410|NCT03686683|589735524|FG000|Overall Study|No data available|1|||
163280411|NCT03686683|589735525|FG001|Overall Study|No data available|0|||
163280412|NCT01770860|589735526|FG000|Overall Study|Withdrawal by Subject|4|||
162932441|NCT01270841|588458494|FG003|Overall Study|Withdrawal by Subject|3|||
162932442|NCT01270841|588458491|FG000|Overall Study|Lost to Follow-up|3|||
163280413|NCT01770860|589735526|FG000|Overall Study|Lost to Follow-up|1|||
163280414|NCT01770860|589735526|FG000|Overall Study|Administrative decision made by the PI|1|||
163280415|NCT05124899|589735527|FG000|Overall Study|Lost to Follow-up|3|||
163280416|NCT03432533|589735532|FG000|Overall Study|Lost to Follow-up|1|||
163280417|NCT03432533|589735533|FG001|Overall Study|Lost to Follow-up|2|||
163280418|NCT03432533|589735532|FG000|Overall Study|Withdrawal by Subject|14|||
163280419|NCT03432533|589735533|FG001|Overall Study|Withdrawal by Subject|9|||
163280420|NCT00797225|589735538|FG000|Weeks 1 to 12|Adverse Event|0|||
163280421|NCT00797225|589735539|FG001|Weeks 1 to 12|Adverse Event|0|||
163280422|NCT00797225|589735540|FG002|Weeks 1 to 12|Adverse Event|1|||
163280423|NCT00797225|589735541|FG003|Weeks 1 to 12|Adverse Event|0|||
163280424|NCT00797225|589735542|FG004|Weeks 1 to 12|Adverse Event|0|||
163280425|NCT00797225|589735543|FG005|Weeks 1 to 12|Adverse Event|0|||
163280426|NCT00797225|589735544|FG006|Weeks 1 to 12|Adverse Event|0|||
163280427|NCT00797225|589735545|FG007|Weeks 1 to 12|Adverse Event|0|||
163280428|NCT00797225|589735538|FG000|Weeks 1 to 12|Non-compliance|0|||
163280429|NCT00797225|589735539|FG001|Weeks 1 to 12|Non-compliance|1|||
163280430|NCT00797225|589735540|FG002|Weeks 1 to 12|Non-compliance|0|||
163280431|NCT00797225|589735541|FG003|Weeks 1 to 12|Non-compliance|0|||
163280432|NCT00797225|589735542|FG004|Weeks 1 to 12|Non-compliance|0|||
163280433|NCT00797225|589735543|FG005|Weeks 1 to 12|Non-compliance|0|||
163280434|NCT00797225|589735544|FG006|Weeks 1 to 12|Non-compliance|0|||
163280435|NCT00797225|589735545|FG007|Weeks 1 to 12|Non-compliance|0|||
163280436|NCT00797225|589735538|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
163280437|NCT00797225|589735539|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
163280438|NCT00797225|589735540|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
163280439|NCT00797225|589735541|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
163280440|NCT00797225|589735542|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
163280441|NCT00797225|589735543|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
163280442|NCT00797225|589735544|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
163280443|NCT00797225|589735545|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
163280444|NCT00797225|589735538|FG000|Weeks 1 to 12|Sponsor Decision|1|||
163280445|NCT00797225|589735539|FG001|Weeks 1 to 12|Sponsor Decision|0|||
163280446|NCT00797225|589735540|FG002|Weeks 1 to 12|Sponsor Decision|0|||
163280447|NCT00797225|589735541|FG003|Weeks 1 to 12|Sponsor Decision|0|||
163280448|NCT00797225|589735542|FG004|Weeks 1 to 12|Sponsor Decision|0|||
163280449|NCT00797225|589735543|FG005|Weeks 1 to 12|Sponsor Decision|0|||
163280450|NCT00797225|589735544|FG006|Weeks 1 to 12|Sponsor Decision|0|||
163280451|NCT00797225|589735545|FG007|Weeks 1 to 12|Sponsor Decision|0|||
163280452|NCT00797225|589735538|FG000|Weeks 13 to 24|Non-compliance|0|||
163280453|NCT00797225|589735539|FG001|Weeks 13 to 24|Non-compliance|2|||
163280454|NCT00797225|589735540|FG002|Weeks 13 to 24|Non-compliance|0|||
163280455|NCT00797225|589735541|FG003|Weeks 13 to 24|Non-compliance|0|||
163280456|NCT00797225|589735542|FG004|Weeks 13 to 24|Non-compliance|0|||
163280457|NCT00797225|589735543|FG005|Weeks 13 to 24|Non-compliance|0|||
163280458|NCT00797225|589735544|FG006|Weeks 13 to 24|Non-compliance|0|||
163280459|NCT00797225|589735545|FG007|Weeks 13 to 24|Non-compliance|0|||
163280460|NCT00797225|589735538|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
163280461|NCT00797225|589735539|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
163280462|NCT00797225|589735540|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
163280463|NCT00797225|589735541|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
163280464|NCT00797225|589735542|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
163280465|NCT00797225|589735543|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
163280466|NCT00797225|589735544|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
163280467|NCT00797225|589735545|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
163280468|NCT00797225|589735538|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
163280469|NCT00797225|589735539|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
163280470|NCT00797225|589735540|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
163280471|NCT00797225|589735541|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
163280472|NCT00797225|589735542|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
163280473|NCT00797225|589735543|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
163280474|NCT00797225|589735544|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
163280475|NCT00797225|589735545|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
163280476|NCT00797225|589735538|FG000|Weeks 13 to 24|Adverse Event|0|||
163280477|NCT00797225|589735539|FG001|Weeks 13 to 24|Adverse Event|1|||
163280478|NCT00797225|589735540|FG002|Weeks 13 to 24|Adverse Event|0|||
163280479|NCT00797225|589735541|FG003|Weeks 13 to 24|Adverse Event|0|||
163280480|NCT00797225|589735542|FG004|Weeks 13 to 24|Adverse Event|0|||
163280481|NCT00797225|589735543|FG005|Weeks 13 to 24|Adverse Event|0|||
163280482|NCT00797225|589735544|FG006|Weeks 13 to 24|Adverse Event|1|||
163280483|NCT00797225|589735545|FG007|Weeks 13 to 24|Adverse Event|0|||
163280484|NCT00797225|589735538|FG000|Weeks 13 to 24|Sponsor Decision|0|||
163280485|NCT00797225|589735539|FG001|Weeks 13 to 24|Sponsor Decision|0|||
163280486|NCT00797225|589735540|FG002|Weeks 13 to 24|Sponsor Decision|0|||
163280487|NCT00797225|589735541|FG003|Weeks 13 to 24|Sponsor Decision|0|||
163280488|NCT00797225|589735542|FG004|Weeks 13 to 24|Sponsor Decision|0|||
163280489|NCT00797225|589735543|FG005|Weeks 13 to 24|Sponsor Decision|0|||
163280490|NCT00797225|589735544|FG006|Weeks 13 to 24|Sponsor Decision|1|||
163280491|NCT00797225|589735545|FG007|Weeks 13 to 24|Sponsor Decision|0|||
163280492|NCT00916006|589735550|FG000|Overall Study|Adverse Event|1|||
163280493|NCT00916006|589735551|FG001|Overall Study|Adverse Event|1|||
163280494|NCT00916006|589735550|FG000|Overall Study|Withdrawal by Subject|2|||
163280495|NCT00916006|589735551|FG001|Overall Study|Withdrawal by Subject|5|||
163280496|NCT00916006|589735550|FG000|Overall Study|Protocol Violation|0|||
163280497|NCT00916006|589735551|FG001|Overall Study|Protocol Violation|1|||
163280498|NCT01605136|589735554|FG000|Study Period|Withdrawal by Subject|2|||
163280499|NCT01605136|589735555|FG001|Study Period|Withdrawal by Subject|0|||
163280500|NCT01605136|589735554|FG000|Study Period|Physician Decision|1|||
163280501|NCT01605136|589735555|FG001|Study Period|Physician Decision|1|||
163280502|NCT01605136|589735554|FG000|Study Period|Lost to Follow-up|0|||
163280503|NCT01605136|589735555|FG001|Study Period|Lost to Follow-up|2|||
163280504|NCT01605136|589735554|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
163280505|NCT01605136|589735555|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
163280506|NCT01072929|589735556|FG000|Overall Study|Adverse Event|8|||
163280507|NCT01072929|589735557|FG001|Overall Study|Adverse Event|11|||
163280508|NCT01072929|589735558|FG002|Overall Study|Adverse Event|2|||
163280509|NCT01072929|589735556|FG000|Overall Study|Lack of Efficacy|7|||
163280510|NCT01072929|589735557|FG001|Overall Study|Lack of Efficacy|4|||
163280511|NCT01072929|589735558|FG002|Overall Study|Lack of Efficacy|0|||
163280512|NCT01072929|589735556|FG000|Overall Study|Withdrawal by Subject|7|||
163280513|NCT01072929|589735557|FG001|Overall Study|Withdrawal by Subject|15|||
163280514|NCT01072929|589735558|FG002|Overall Study|Withdrawal by Subject|3|||
163280515|NCT01072929|589735556|FG000|Overall Study|Protocol Violation|13|||
163280516|NCT01072929|589735557|FG001|Overall Study|Protocol Violation|11|||
163280517|NCT01072929|589735558|FG002|Overall Study|Protocol Violation|2|||
163280518|NCT01072929|589735556|FG000|Overall Study|Lost to Follow-up|8|||
163280519|NCT01072929|589735557|FG001|Overall Study|Lost to Follow-up|4|||
163280520|NCT01072929|589735558|FG002|Overall Study|Lost to Follow-up|1|||
163280521|NCT01072929|589735556|FG000|Overall Study|Noncompliance with study medication|0|||
163280522|NCT01072929|589735557|FG001|Overall Study|Noncompliance with study medication|3|||
163280523|NCT01072929|589735558|FG002|Overall Study|Noncompliance with study medication|0|||
163280524|NCT01072929|589735556|FG000|Overall Study|Noncompliance with study procedures|1|||
163280525|NCT01072929|589735557|FG001|Overall Study|Noncompliance with study procedures|0|||
163280526|NCT01072929|589735558|FG002|Overall Study|Noncompliance with study procedures|1|||
163280527|NCT01072929|589735556|FG000|Overall Study|Other|0|||
163280528|NCT01072929|589735557|FG001|Overall Study|Other|3|||
163280529|NCT01072929|589735558|FG002|Overall Study|Other|0|||
163280530|NCT04833855|589735559|FG000|Overall Study|Decision by sponsor|0|||
163280531|NCT04833855|589735560|FG001|Overall Study|Decision by sponsor|1|||
163280532|NCT04833855|589735561|FG002|Overall Study|Decision by sponsor|0|||
163280533|NCT04833855|589735562|FG003|Overall Study|Decision by sponsor|0|||
163175122|NCT00095147|589357363|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
163175123|NCT00095147|589357364|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
163175124|NCT00095147|589357365|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
163175125|NCT00095147|589357366|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
163175126|NCT00095147|589357362|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
163175127|NCT00095147|589357363|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
163175128|NCT00095147|589357364|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
163175129|NCT00095147|589357365|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
163175130|NCT00095147|589357366|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
163175131|NCT00095147|589357362|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
163175132|NCT00095147|589357363|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
163280534|NCT04833855|589735559|FG000|Overall Study|Withdrawal by Subject|4|||
163280535|NCT04833855|589735560|FG001|Overall Study|Withdrawal by Subject|1|||
163280536|NCT04833855|589735561|FG002|Overall Study|Withdrawal by Subject|3|||
163280537|NCT04833855|589735562|FG003|Overall Study|Withdrawal by Subject|1|||
163280538|NCT04833855|589735559|FG000|Overall Study|Lost to Follow-up|1|||
163175133|NCT00095147|589357364|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
163175134|NCT00095147|589357365|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
163175135|NCT00095147|589357366|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
163280539|NCT04833855|589735560|FG001|Overall Study|Lost to Follow-up|0|||
163280540|NCT04833855|589735561|FG002|Overall Study|Lost to Follow-up|2|||
163280541|NCT04833855|589735562|FG003|Overall Study|Lost to Follow-up|2|||
163280542|NCT04833855|589735559|FG000|Overall Study|Protocol specified criteria|0|||
163280543|NCT04833855|589735560|FG001|Overall Study|Protocol specified criteria|0|||
163280544|NCT04833855|589735561|FG002|Overall Study|Protocol specified criteria|2|||
163280545|NCT04833855|589735562|FG003|Overall Study|Protocol specified criteria|1|||
163280546|NCT02806336|589735563|FG000|Overall Study|Physician Decision|1|||
163280547|NCT02806336|589735564|FG001|Overall Study|Physician Decision|0|||
163280548|NCT02806336|589735563|FG000|Overall Study|Withdrawal by Subject|2|||
163280549|NCT02806336|589735564|FG001|Overall Study|Withdrawal by Subject|4|||
163280550|NCT02806336|589735563|FG000|Overall Study|COVID-19 research shut down|3|||
163280551|NCT02806336|589735564|FG001|Overall Study|COVID-19 research shut down|4|||
163280552|NCT02806336|589735563|FG000|Overall Study|Lack of Efficacy|0|||
163280553|NCT02806336|589735564|FG001|Overall Study|Lack of Efficacy|1|||
163280554|NCT03682536|589735565|FG000|Randomization|Withdrawal by Subject|0|||
163280555|NCT03682536|589735566|FG001|Randomization|Withdrawal by Subject|2|||
163280556|NCT03682536|589735565|FG000|Treatment|Other Reasons|8|||
163280557|NCT03682536|589735566|FG001|Treatment|Other Reasons|7|||
163280558|NCT03682536|589735565|FG000|Treatment|Physician Decision|5|||
163280559|NCT03682536|589735566|FG001|Treatment|Physician Decision|5|||
163280560|NCT03682536|589735565|FG000|Treatment|Protocol Violation|1|||
163280561|NCT03682536|589735566|FG001|Treatment|Protocol Violation|0|||
163280562|NCT03682536|589735565|FG000|Treatment|Study Terminated by Sponsor|1|||
163280563|NCT03682536|589735566|FG001|Treatment|Study Terminated by Sponsor|2|||
163280564|NCT03682536|589735565|FG000|Treatment|Lost to Follow-up|0|||
163280565|NCT03682536|589735566|FG001|Treatment|Lost to Follow-up|1|||
163280566|NCT03682536|589735565|FG000|Treatment|Withdrawal by Subject|16|||
163280567|NCT03682536|589735566|FG001|Treatment|Withdrawal by Subject|18|||
163280568|NCT03682536|589735565|FG000|Treatment|Lack of Efficacy|41|||
163280569|NCT03682536|589735566|FG001|Treatment|Lack of Efficacy|68|||
163280570|NCT03682536|589735565|FG000|Treatment|Disease Progression|9|||
163280571|NCT03682536|589735566|FG001|Treatment|Disease Progression|7|||
163280572|NCT03682536|589735565|FG000|Treatment|Adverse Event|9|||
163280573|NCT03682536|589735566|FG001|Treatment|Adverse Event|5|||
163280574|NCT03682536|589735565|FG000|Treatment|Death|14|||
163280575|NCT03682536|589735566|FG001|Treatment|Death|13|||
163280576|NCT04824131|589735567|FG000|CAB LA Oral Phase|Adverse Event|1|||
163280577|NCT04824131|589735567|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
163280578|NCT04824131|589735567|FG000|Step 3|Withdrawal by Subject|2|||
163280579|NCT03008122|589735573|FG000|Overall Study|Physician Decision|3|||
163280580|NCT03008122|589735574|FG001|Overall Study|Physician Decision|2|||
163280581|NCT03008122|589735575|FG002|Overall Study|Physician Decision|0|||
163280582|NCT03008122|589735573|FG000|Overall Study|Withdrawal by Subject|1|||
163280583|NCT03008122|589735574|FG001|Overall Study|Withdrawal by Subject|3|||
163280584|NCT03008122|589735575|FG002|Overall Study|Withdrawal by Subject|0|||
163280585|NCT03008122|589735573|FG000|Overall Study|Lost to Follow-up|4|||
163280586|NCT03008122|589735574|FG001|Overall Study|Lost to Follow-up|8|||
163280587|NCT03008122|589735575|FG002|Overall Study|Lost to Follow-up|3|||
163280588|NCT03008122|589735573|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
163280589|NCT03008122|589735574|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
163280590|NCT03008122|589735575|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
163280591|NCT03008122|589735573|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
163280592|NCT03008122|589735574|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
163280593|NCT03008122|589735575|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
163280594|NCT03008122|589735573|FG000|Overall Study|Death|0|||
163280595|NCT03008122|589735574|FG001|Overall Study|Death|0|||
163280596|NCT03008122|589735575|FG002|Overall Study|Death|1|||
163280597|NCT04159896|589735576|FG000|Overall Study|Lack of Efficacy|7|||
163280598|NCT04159896|589735576|FG000|Overall Study|Withdrawal by Subject|1|||
163280599|NCT04159896|589735576|FG000|Overall Study|Adverse Event|1|||
163280600|NCT04159896|589735576|FG000|Overall Study|A transient ischaemic attack|1|||
163280601|NCT01222247|589735578|FG000|Overall Study|Lost to Follow-up|2|||
163280602|NCT01222247|589735579|FG001|Overall Study|Lost to Follow-up|2|||
163280603|NCT02338609|589735580|FG000|Overall Study|Physician Decision|1|||
163280604|NCT02338609|589735580|FG000|Overall Study|Death|1|||
163280605|NCT02084082|589735581|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
163280606|NCT02084082|589735582|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
163280607|NCT02084082|589735583|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
163280608|NCT02084082|589735584|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
163280609|NCT02084082|589735581|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
163280610|NCT02084082|589735582|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
163280611|NCT02084082|589735583|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
163280612|NCT02084082|589735584|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
163280613|NCT04736056|589735589|FG000|Overall Study|Death|0|||
163280614|NCT04736056|589735590|FG001|Overall Study|Death|0|||
163280615|NCT04736056|589735591|FG002|Overall Study|Death|0|||
163280616|NCT04736056|589735592|FG003|Overall Study|Death|1|||
163280617|NCT04736056|589735589|FG000|Overall Study|Lost to Follow-up|1|||
163280618|NCT04736056|589735590|FG001|Overall Study|Lost to Follow-up|0|||
163280619|NCT04736056|589735591|FG002|Overall Study|Lost to Follow-up|1|||
163280620|NCT04736056|589735592|FG003|Overall Study|Lost to Follow-up|1|||
163042823|NCT01990768|588863970|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
163175136|NCT00095147|589357362|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
163175137|NCT00095147|589357363|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
163175138|NCT00095147|589357364|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
163175139|NCT00095147|589357365|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
163175140|NCT00095147|589357366|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
163175141|NCT00095147|589357362|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
163175142|NCT00095147|589357363|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
163175143|NCT00095147|589357364|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
163175144|NCT00095147|589357365|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
163175145|NCT00095147|589357366|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
163175146|NCT00095147|589357362|FG000|Long-term Extension Period|Death|0|||
163175147|NCT00095147|589357363|FG001|Long-term Extension Period|Death|0|||
163175148|NCT00095147|589357364|FG002|Long-term Extension Period|Death|0|||
163175149|NCT00095147|589357365|FG003|Long-term Extension Period|Death|0|||
163175150|NCT00095147|589357366|FG004|Long-term Extension Period|Death|3|||
163175151|NCT00095147|589357362|FG000|Long-term Extension Period|Adverse Event|0|||
163175152|NCT00095147|589357363|FG001|Long-term Extension Period|Adverse Event|0|||
163175153|NCT00095147|589357364|FG002|Long-term Extension Period|Adverse Event|0|||
163175154|NCT00095147|589357365|FG003|Long-term Extension Period|Adverse Event|0|||
163175155|NCT00095147|589357366|FG004|Long-term Extension Period|Adverse Event|11|||
163175156|NCT00095147|589357362|FG000|Long-term Extension Period|Lack of Efficacy|0|||
163175157|NCT00095147|589357363|FG001|Long-term Extension Period|Lack of Efficacy|0|||
163175158|NCT00095147|589357364|FG002|Long-term Extension Period|Lack of Efficacy|0|||
163175159|NCT00095147|589357365|FG003|Long-term Extension Period|Lack of Efficacy|0|||
163175160|NCT00095147|589357366|FG004|Long-term Extension Period|Lack of Efficacy|9|||
163175161|NCT00095147|589357362|FG000|Long-term Extension Period|Lost to Follow-up|0|||
163175162|NCT00095147|589357363|FG001|Long-term Extension Period|Lost to Follow-up|0|||
163175163|NCT00095147|589357364|FG002|Long-term Extension Period|Lost to Follow-up|0|||
163175164|NCT00095147|589357365|FG003|Long-term Extension Period|Lost to Follow-up|0|||
163175165|NCT00095147|589357366|FG004|Long-term Extension Period|Lost to Follow-up|6|||
163175166|NCT00095147|589357362|FG000|Long-term Extension Period|Withdrawal of consent|0|||
163175167|NCT00095147|589357363|FG001|Long-term Extension Period|Withdrawal of consent|0|||
163175168|NCT00095147|589357364|FG002|Long-term Extension Period|Withdrawal of consent|0|||
163175169|NCT00095147|589357365|FG003|Long-term Extension Period|Withdrawal of consent|0|||
163175170|NCT00095147|589357366|FG004|Long-term Extension Period|Withdrawal of consent|12|||
163175171|NCT00095147|589357362|FG000|Long-term Extension Period|Pregnancy|0|||
163175172|NCT00095147|589357363|FG001|Long-term Extension Period|Pregnancy|0|||
163175173|NCT00095147|589357364|FG002|Long-term Extension Period|Pregnancy|0|||
163175174|NCT00095147|589357365|FG003|Long-term Extension Period|Pregnancy|0|||
163175175|NCT00095147|589357366|FG004|Long-term Extension Period|Pregnancy|1|||
163175176|NCT00095147|589357362|FG000|Long-term Extension Period|No longer meets study criteria|0|||
163175177|NCT00095147|589357363|FG001|Long-term Extension Period|No longer meets study criteria|0|||
163175178|NCT00095147|589357364|FG002|Long-term Extension Period|No longer meets study criteria|0|||
163175179|NCT00095147|589357365|FG003|Long-term Extension Period|No longer meets study criteria|0|||
163175180|NCT00095147|589357366|FG004|Long-term Extension Period|No longer meets study criteria|1|||
163175181|NCT00095147|589357362|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
163175182|NCT00095147|589357363|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
163175183|NCT00095147|589357364|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
163175184|NCT00095147|589357365|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
163175185|NCT00095147|589357366|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
163175186|NCT00095147|589357362|FG000|Long-term Extension Period|Leaving country|0|||
163175187|NCT00095147|589357363|FG001|Long-term Extension Period|Leaving country|0|||
163175188|NCT00095147|589357364|FG002|Long-term Extension Period|Leaving country|0|||
163175189|NCT00095147|589357365|FG003|Long-term Extension Period|Leaving country|0|||
163175190|NCT00095147|589357366|FG004|Long-term Extension Period|Leaving country|1|||
163175191|NCT02395302|589357367|FG000|Overall Study|Screen Failure|3|||
163175192|NCT02395302|589357367|FG000|Overall Study|Run In Failure|7|||
163175193|NCT02395302|589357367|FG000|Overall Study|Withdrawal by Subject|2|||
163175194|NCT02395302|589357367|FG000|Overall Study|Physician Decision|2|||
163175195|NCT04604132|589357368|FG000|Overall Study|Adverse Event|2|||
163175196|NCT04604132|589357369|FG001|Overall Study|Adverse Event|0|||
163175197|NCT04604132|589357370|FG002|Overall Study|Adverse Event|0|||
163280621|NCT04736056|589735589|FG000|Overall Study|Withdrawal by Subject|2|||
163280622|NCT04736056|589735590|FG001|Overall Study|Withdrawal by Subject|0|||
163175198|NCT04604132|589357371|FG003|Overall Study|Adverse Event|1|||
163175199|NCT04604132|589357372|FG004|Overall Study|Adverse Event|2|||
163175200|NCT04604132|589357368|FG000|Overall Study|Study terminated by sponsor|0|||
163175201|NCT04604132|589357369|FG001|Overall Study|Study terminated by sponsor|0|||
163280623|NCT04736056|589735591|FG002|Overall Study|Withdrawal by Subject|0|||
163280624|NCT04736056|589735592|FG003|Overall Study|Withdrawal by Subject|0|||
163175202|NCT04604132|589357370|FG002|Overall Study|Study terminated by sponsor|0|||
163175203|NCT04604132|589357371|FG003|Overall Study|Study terminated by sponsor|0|||
163175204|NCT04604132|589357372|FG004|Overall Study|Study terminated by sponsor|1|||
163175205|NCT04604132|589357368|FG000|Overall Study|Progressive disease: Clinical progression|0|||
163175206|NCT04604132|589357369|FG001|Overall Study|Progressive disease: Clinical progression|0|||
163175207|NCT04604132|589357370|FG002|Overall Study|Progressive disease: Clinical progression|1|||
163175208|NCT04604132|589357371|FG003|Overall Study|Progressive disease: Clinical progression|0|||
163175209|NCT04604132|589357372|FG004|Overall Study|Progressive disease: Clinical progression|0|||
163175210|NCT04604132|589357368|FG000|Overall Study|Progressive disease: Radiological progression|8|||
163175211|NCT04604132|589357369|FG001|Overall Study|Progressive disease: Radiological progression|7|||
163175212|NCT04604132|589357370|FG002|Overall Study|Progressive disease: Radiological progression|10|||
163175213|NCT04604132|589357371|FG003|Overall Study|Progressive disease: Radiological progression|4|||
163175214|NCT04604132|589357372|FG004|Overall Study|Progressive disease: Radiological progression|3|||
163175215|NCT04604132|589357368|FG000|Overall Study|Death|3|||
163175216|NCT04604132|589357369|FG001|Overall Study|Death|1|||
163175217|NCT04604132|589357370|FG002|Overall Study|Death|2|||
163175218|NCT04604132|589357371|FG003|Overall Study|Death|1|||
163175219|NCT04604132|589357372|FG004|Overall Study|Death|0|||
163175220|NCT00952380|589357373|FG000|Overall Study|Other|0|||
163175221|NCT00952380|589357374|FG001|Overall Study|Other|0|||
163175222|NCT00952380|589357375|FG002|Overall Study|Other|0|||
163175223|NCT00952380|589357376|FG003|Overall Study|Other|0|||
163175224|NCT00952380|589357377|FG004|Overall Study|Other|1|||
163175225|NCT00952380|589357373|FG000|Overall Study|Withdrawal by Subject|0|||
163175226|NCT00952380|589357374|FG001|Overall Study|Withdrawal by Subject|0|||
163175227|NCT00952380|589357375|FG002|Overall Study|Withdrawal by Subject|1|||
163175228|NCT00952380|589357376|FG003|Overall Study|Withdrawal by Subject|0|||
163175229|NCT00952380|589357377|FG004|Overall Study|Withdrawal by Subject|2|||
163175230|NCT00952380|589357373|FG000|Overall Study|Adverse Event|0|||
163175231|NCT00952380|589357374|FG001|Overall Study|Adverse Event|1|||
163175232|NCT00952380|589357375|FG002|Overall Study|Adverse Event|0|||
163175233|NCT00952380|589357376|FG003|Overall Study|Adverse Event|0|||
163175234|NCT00952380|589357377|FG004|Overall Study|Adverse Event|3|||
163175235|NCT00952380|589357373|FG000|Overall Study|Physician Decision|0|||
163175236|NCT00952380|589357374|FG001|Overall Study|Physician Decision|0|||
163175237|NCT00952380|589357375|FG002|Overall Study|Physician Decision|1|||
163175238|NCT00952380|589357376|FG003|Overall Study|Physician Decision|2|||
163175239|NCT00952380|589357377|FG004|Overall Study|Physician Decision|0|||
163175240|NCT00952380|589357373|FG000|Overall Study|Non-compliant to protocol|0|||
163175241|NCT00952380|589357374|FG001|Overall Study|Non-compliant to protocol|0|||
163175242|NCT00952380|589357375|FG002|Overall Study|Non-compliant to protocol|0|||
163175243|NCT00952380|589357376|FG003|Overall Study|Non-compliant to protocol|1|||
163175244|NCT00952380|589357377|FG004|Overall Study|Non-compliant to protocol|0|||
163175245|NCT02048241|589357379|FG000|Overall Study|Withdrawal by Subject|0|||
163175246|NCT02048241|589357380|FG001|Overall Study|Withdrawal by Subject|1|||
163175247|NCT00534313|589357381|FG000|Short-term Period|Adverse Event|1|||
163175248|NCT00534313|589357382|FG001|Short-term Period|Adverse Event|2|||
163175249|NCT00534313|589357383|FG002|Short-term Period|Adverse Event|1|||
163175250|NCT00534313|589357384|FG003|Short-term Period|Adverse Event|3|||
163175251|NCT00534313|589357381|FG000|Short-term Period|Lack of Efficacy|3|||
163175252|NCT00534313|589357382|FG001|Short-term Period|Lack of Efficacy|4|||
163175253|NCT00534313|589357383|FG002|Short-term Period|Lack of Efficacy|0|||
163175254|NCT00534313|589357384|FG003|Short-term Period|Lack of Efficacy|3|||
163175255|NCT00534313|589357381|FG000|Short-term Period|Participant not meeting study criteria|0|||
163175256|NCT00534313|589357382|FG001|Short-term Period|Participant not meeting study criteria|0|||
163175257|NCT00534313|589357383|FG002|Short-term Period|Participant not meeting study criteria|0|||
163175258|NCT00534313|589357384|FG003|Short-term Period|Participant not meeting study criteria|1|||
163175259|NCT00534313|589357381|FG000|Short-term Period|Participant withdrew consent|2|||
163175260|NCT00534313|589357382|FG001|Short-term Period|Participant withdrew consent|0|||
163175261|NCT00534313|589357383|FG002|Short-term Period|Participant withdrew consent|0|||
163175262|NCT00534313|589357384|FG003|Short-term Period|Participant withdrew consent|2|||
162932443|NCT01270841|588458492|FG001|Overall Study|Lost to Follow-up|1|||
163175263|NCT00534313|589357381|FG000|Short-term Period|Pregnancy|0|||
163175264|NCT00534313|589357382|FG001|Short-term Period|Pregnancy|0|||
163175265|NCT00534313|589357383|FG002|Short-term Period|Pregnancy|1|||
163175266|NCT00534313|589357384|FG003|Short-term Period|Pregnancy|0|||
163175267|NCT00534313|589357381|FG000|Long-term Period|Adverse Event|2|||
163175268|NCT00534313|589357382|FG001|Long-term Period|Adverse Event|1|||
163175269|NCT00534313|589357383|FG002|Long-term Period|Adverse Event|0|||
163175270|NCT00534313|589357384|FG003|Long-term Period|Adverse Event|1|||
163175271|NCT00534313|589357381|FG000|Long-term Period|Lack of Efficacy|14|||
163175272|NCT00534313|589357382|FG001|Long-term Period|Lack of Efficacy|10|||
163175273|NCT00534313|589357383|FG002|Long-term Period|Lack of Efficacy|14|||
163175274|NCT00534313|589357384|FG003|Long-term Period|Lack of Efficacy|12|||
163175275|NCT00534313|589357381|FG000|Long-term Period|Lost to Follow-up|1|||
163175276|NCT00534313|589357382|FG001|Long-term Period|Lost to Follow-up|2|||
163175277|NCT00534313|589357383|FG002|Long-term Period|Lost to Follow-up|0|||
163175278|NCT00534313|589357384|FG003|Long-term Period|Lost to Follow-up|0|||
163175279|NCT00534313|589357381|FG000|Long-term Period|Withdrawal by Subject|2|||
163175280|NCT00534313|589357382|FG001|Long-term Period|Withdrawal by Subject|2|||
163175281|NCT00534313|589357383|FG002|Long-term Period|Withdrawal by Subject|0|||
163175282|NCT00534313|589357384|FG003|Long-term Period|Withdrawal by Subject|0|||
163175283|NCT00534313|589357381|FG000|Long-term Period|No longer meets study criteria|0|||
163175284|NCT00534313|589357382|FG001|Long-term Period|No longer meets study criteria|1|||
163175285|NCT00534313|589357383|FG002|Long-term Period|No longer meets study criteria|0|||
163175286|NCT00534313|589357384|FG003|Long-term Period|No longer meets study criteria|0|||
163175287|NCT00534313|589357381|FG000|Long-term Period|Poor compliance/noncompliance|0|||
163175288|NCT00534313|589357382|FG001|Long-term Period|Poor compliance/noncompliance|1|||
163175289|NCT00534313|589357383|FG002|Long-term Period|Poor compliance/noncompliance|1|||
163175290|NCT00534313|589357384|FG003|Long-term Period|Poor compliance/noncompliance|0|||
163175291|NCT00534313|589357381|FG000|Long-term Period|Administrative reason by sponsor|17|||
163175292|NCT00534313|589357382|FG001|Long-term Period|Administrative reason by sponsor|15|||
163175293|NCT00534313|589357383|FG002|Long-term Period|Administrative reason by sponsor|26|||
163175294|NCT00534313|589357384|FG003|Long-term Period|Administrative reason by sponsor|18|||
163175295|NCT00534313|589357381|FG000|Long-term Period|Other|1|||
163175296|NCT00534313|589357382|FG001|Long-term Period|Other|2|||
163175297|NCT00534313|589357383|FG002|Long-term Period|Other|2|||
163175298|NCT00534313|589357384|FG003|Long-term Period|Other|2|||
163175299|NCT00402233|589357385|FG000|Overall Study|Adverse Event|1|||
163175300|NCT00402233|589357386|FG001|Overall Study|Adverse Event|7|||
163175301|NCT00402233|589357387|FG002|Overall Study|Adverse Event|9|||
163175302|NCT00402233|589357388|FG003|Overall Study|Adverse Event|9|||
163175303|NCT00402233|589357385|FG000|Overall Study|Protocol Violation|0|||
163175304|NCT00402233|589357386|FG001|Overall Study|Protocol Violation|1|||
163175305|NCT00402233|589357387|FG002|Overall Study|Protocol Violation|0|||
163175306|NCT00402233|589357388|FG003|Overall Study|Protocol Violation|0|||
163175307|NCT00402233|589357385|FG000|Overall Study|Withdrawal by Subject|2|||
163175308|NCT00402233|589357386|FG001|Overall Study|Withdrawal by Subject|1|||
163175309|NCT00402233|589357387|FG002|Overall Study|Withdrawal by Subject|2|||
163175310|NCT00402233|589357388|FG003|Overall Study|Withdrawal by Subject|2|||
163175311|NCT00402233|589357385|FG000|Overall Study|Worsening of disease under study|2|||
163175312|NCT00402233|589357386|FG001|Overall Study|Worsening of disease under study|0|||
163175313|NCT00402233|589357387|FG002|Overall Study|Worsening of disease under study|0|||
163175314|NCT00402233|589357388|FG003|Overall Study|Worsening of disease under study|0|||
163175315|NCT00402233|589357385|FG000|Overall Study|Worsening of other pre-existing disease|0|||
163175316|NCT00402233|589357386|FG001|Overall Study|Worsening of other pre-existing disease|1|||
163175317|NCT00402233|589357387|FG002|Overall Study|Worsening of other pre-existing disease|0|||
163175318|NCT00402233|589357388|FG003|Overall Study|Worsening of other pre-existing disease|0|||
163175319|NCT03007888|589357389|FG000|First Intervention (14 Days)|Adverse Event|1|||
163175320|NCT03007888|589357390|FG001|First Intervention (14 Days)|Adverse Event|0|||
163175321|NCT00927940|589357392|FG000|Overall Study|Death|1|||
163175322|NCT04658940|589357393|FG000|Overall Study|Withdrawal by Subject|1|||
163175323|NCT00827931|589357395|FG000|Overall Study|Death|3|||
163175324|NCT00827931|589357396|FG001|Overall Study|Death|5|||
163175325|NCT00827931|589357395|FG000|Overall Study|Adverse Event|1|||
163175326|NCT00827931|589357396|FG001|Overall Study|Adverse Event|0|||
163175327|NCT00827931|589357395|FG000|Overall Study|Lost to Follow-up|1|||
163175328|NCT00827931|589357396|FG001|Overall Study|Lost to Follow-up|0|||
163175329|NCT00827931|589357395|FG000|Overall Study|Withdrawal by Subject|0|||
163175330|NCT00827931|589357396|FG001|Overall Study|Withdrawal by Subject|1|||
163175331|NCT00827931|589357395|FG000|Overall Study|Other|1|||
163175332|NCT00827931|589357396|FG001|Overall Study|Other|0|||
163175333|NCT03579602|589357400|FG000|Overall Study|Subject unable to receive study drug|0|||
163175334|NCT03579602|589357401|FG001|Overall Study|Subject unable to receive study drug|2|||
163175335|NCT03579602|589357400|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
163175336|NCT03579602|589357401|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
163175337|NCT00483756|589357402|FG000|Overall Study|Death|2|||
163175338|NCT00483756|589357403|FG001|Overall Study|Death|0|||
163175339|NCT00483756|589357404|FG002|Overall Study|Death|1|||
163175340|NCT00483756|589357402|FG000|Overall Study|Adverse Event|19|||
163175341|NCT00483756|589357403|FG001|Overall Study|Adverse Event|38|||
163175342|NCT00483756|589357404|FG002|Overall Study|Adverse Event|40|||
163175343|NCT00483756|589357402|FG000|Overall Study|Lack of Efficacy|1|||
163175344|NCT00483756|589357403|FG001|Overall Study|Lack of Efficacy|0|||
163175345|NCT00483756|589357404|FG002|Overall Study|Lack of Efficacy|0|||
163175346|NCT00483756|589357402|FG000|Overall Study|Lost to Follow-up|3|||
163280625|NCT04736056|589735589|FG000|Overall Study|Physician Decision|1|||
163175347|NCT00483756|589357403|FG001|Overall Study|Lost to Follow-up|1|||
163175348|NCT00483756|589357404|FG002|Overall Study|Lost to Follow-up|0|||
163175349|NCT00483756|589357402|FG000|Overall Study|Withdrawal by Subject|5|||
163175350|NCT00483756|589357403|FG001|Overall Study|Withdrawal by Subject|3|||
163175351|NCT00483756|589357404|FG002|Overall Study|Withdrawal by Subject|4|||
163280626|NCT04736056|589735590|FG001|Overall Study|Physician Decision|0|||
163280627|NCT04736056|589735591|FG002|Overall Study|Physician Decision|1|||
163280628|NCT04736056|589735592|FG003|Overall Study|Physician Decision|0|||
163280629|NCT04529538|589735593|FG000|Overall Study|Lost to Follow-up|3|||
163280630|NCT04529538|589735594|FG001|Overall Study|Lost to Follow-up|2|||
163280631|NCT04529538|589735595|FG002|Overall Study|Lost to Follow-up|1|||
163280632|NCT04529538|589735596|FG003|Overall Study|Lost to Follow-up|0|||
163280633|NCT04529538|589735597|FG004|Overall Study|Lost to Follow-up|1|||
163280634|NCT04529538|589735598|FG005|Overall Study|Lost to Follow-up|1|||
163280635|NCT04529538|589735599|FG006|Overall Study|Lost to Follow-up|2|||
163280636|NCT04529538|589735600|FG007|Overall Study|Lost to Follow-up|0|||
163280637|NCT04529538|589735593|FG000|Overall Study|Not eligible at enrollment|0|||
163280638|NCT04529538|589735594|FG001|Overall Study|Not eligible at enrollment|1|||
163280639|NCT04529538|589735595|FG002|Overall Study|Not eligible at enrollment|2|||
163280640|NCT04529538|589735596|FG003|Overall Study|Not eligible at enrollment|1|||
163280641|NCT04529538|589735597|FG004|Overall Study|Not eligible at enrollment|0|||
163280642|NCT04529538|589735598|FG005|Overall Study|Not eligible at enrollment|0|||
163280643|NCT04529538|589735599|FG006|Overall Study|Not eligible at enrollment|0|||
163280644|NCT04529538|589735600|FG007|Overall Study|Not eligible at enrollment|1|||
163280645|NCT04529538|589735593|FG000|Overall Study|Withdrawal by Subject|0|||
163280646|NCT04529538|589735594|FG001|Overall Study|Withdrawal by Subject|1|||
163280647|NCT04529538|589735595|FG002|Overall Study|Withdrawal by Subject|1|||
163280648|NCT04529538|589735596|FG003|Overall Study|Withdrawal by Subject|2|||
163280649|NCT04529538|589735597|FG004|Overall Study|Withdrawal by Subject|0|||
163280650|NCT04529538|589735598|FG005|Overall Study|Withdrawal by Subject|2|||
163280651|NCT04529538|589735599|FG006|Overall Study|Withdrawal by Subject|3|||
163280652|NCT04529538|589735600|FG007|Overall Study|Withdrawal by Subject|0|||
163280653|NCT04529538|589735593|FG000|Overall Study|Other|0|||
163280654|NCT04529538|589735594|FG001|Overall Study|Other|1|||
163280655|NCT04529538|589735595|FG002|Overall Study|Other|0|||
163280656|NCT04529538|589735596|FG003|Overall Study|Other|0|||
163280657|NCT04529538|589735597|FG004|Overall Study|Other|0|||
163280658|NCT04529538|589735598|FG005|Overall Study|Other|0|||
163280659|NCT04529538|589735599|FG006|Overall Study|Other|0|||
163280660|NCT04529538|589735600|FG007|Overall Study|Other|0|||
163280661|NCT04529538|589735593|FG000|Overall Study|Adverse Event|0|||
163280662|NCT04529538|589735594|FG001|Overall Study|Adverse Event|0|||
163280663|NCT04529538|589735595|FG002|Overall Study|Adverse Event|0|||
163280664|NCT04529538|589735596|FG003|Overall Study|Adverse Event|1|||
163280665|NCT04529538|589735597|FG004|Overall Study|Adverse Event|0|||
163280666|NCT04529538|589735598|FG005|Overall Study|Adverse Event|0|||
163280667|NCT04529538|589735599|FG006|Overall Study|Adverse Event|0|||
163280668|NCT04529538|589735600|FG007|Overall Study|Adverse Event|0|||
163280669|NCT04529538|589735593|FG000|Overall Study|Protocol Deviation|0|||
163280670|NCT04529538|589735594|FG001|Overall Study|Protocol Deviation|0|||
163280671|NCT04529538|589735595|FG002|Overall Study|Protocol Deviation|0|||
163280672|NCT04529538|589735596|FG003|Overall Study|Protocol Deviation|1|||
163280673|NCT04529538|589735597|FG004|Overall Study|Protocol Deviation|0|||
163280674|NCT04529538|589735598|FG005|Overall Study|Protocol Deviation|0|||
163280675|NCT04529538|589735599|FG006|Overall Study|Protocol Deviation|0|||
163280676|NCT04529538|589735600|FG007|Overall Study|Protocol Deviation|0|||
163280677|NCT04529538|589735593|FG000|Overall Study|Physician Decision|0|||
163280678|NCT04529538|589735594|FG001|Overall Study|Physician Decision|0|||
163280679|NCT04529538|589735595|FG002|Overall Study|Physician Decision|0|||
163280680|NCT04529538|589735596|FG003|Overall Study|Physician Decision|0|||
163280681|NCT04529538|589735597|FG004|Overall Study|Physician Decision|0|||
163280682|NCT04529538|589735598|FG005|Overall Study|Physician Decision|1|||
163280683|NCT04529538|589735599|FG006|Overall Study|Physician Decision|0|||
163280684|NCT04529538|589735600|FG007|Overall Study|Physician Decision|1|||
163280685|NCT02223182|589735602|FG000|Double-Blind Period|Adverse Event|0|||
163280686|NCT02223182|589735603|FG001|Double-Blind Period|Adverse Event|2|||
163280687|NCT02223182|589735604|FG002|Double-Blind Period|Adverse Event|1|||
163280688|NCT02223182|589735605|FG003|Double-Blind Period|Adverse Event|0|||
163280689|NCT02223182|589735602|FG000|Double-Blind Period|Withdrawal by Subject|1|||
163280690|NCT02223182|589735603|FG001|Double-Blind Period|Withdrawal by Subject|1|||
163280691|NCT02223182|589735604|FG002|Double-Blind Period|Withdrawal by Subject|1|||
163280692|NCT02223182|589735605|FG003|Double-Blind Period|Withdrawal by Subject|0|||
163280693|NCT02223182|589735602|FG000|Double-Blind Period|Lost to Follow-up|0|||
163280694|NCT02223182|589735603|FG001|Double-Blind Period|Lost to Follow-up|1|||
163280695|NCT02223182|589735604|FG002|Double-Blind Period|Lost to Follow-up|0|||
163280696|NCT02223182|589735605|FG003|Double-Blind Period|Lost to Follow-up|0|||
163280697|NCT02223182|589735602|FG000|Double-Blind Period|Non Compliance|0|||
163280698|NCT02223182|589735603|FG001|Double-Blind Period|Non Compliance|0|||
163280699|NCT02223182|589735604|FG002|Double-Blind Period|Non Compliance|0|||
163280700|NCT02223182|589735605|FG003|Double-Blind Period|Non Compliance|1|||
163280701|NCT02223182|589735602|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
163280702|NCT02223182|589735603|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
163280703|NCT02223182|589735604|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
163280704|NCT02223182|589735605|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
163175352|NCT00483756|589357402|FG000|Overall Study|Other|2|||
163175353|NCT00483756|589357403|FG001|Overall Study|Other|4|||
163175354|NCT00483756|589357404|FG002|Overall Study|Other|3|||
163175355|NCT00483756|589357402|FG000|Overall Study|Randomized, Not Treated|1|||
163175356|NCT00483756|589357403|FG001|Overall Study|Randomized, Not Treated|4|||
163175357|NCT00483756|589357404|FG002|Overall Study|Randomized, Not Treated|4|||
163175358|NCT00495040|589357405|FG000|Overall Study|Withdrawal by Subject|3|||
163175359|NCT01829243|589357406|FG000|First Intervention|Screen Failure|4|||
163175360|NCT01829243|589357407|FG001|First Intervention|Screen Failure|2|||
163175361|NCT02282293|589357410|FG000|Overall Study|Lost to Follow-up|2|||
163175362|NCT02282293|589357411|FG001|Overall Study|Lost to Follow-up|2|||
163175363|NCT02282293|589357410|FG000|Overall Study|Unable to comply with study procedures|1|||
163175364|NCT02282293|589357411|FG001|Overall Study|Unable to comply with study procedures|0|||
163175365|NCT02282293|589357410|FG000|Overall Study|Moved out of study area|0|||
163175366|NCT02282293|589357411|FG001|Overall Study|Moved out of study area|1|||
163175367|NCT01894568|589357414|FG000|Overall Study|Adverse Event|2|||
163175368|NCT01894568|589357415|FG001|Overall Study|Adverse Event|3|||
163175369|NCT01894568|589357414|FG000|Overall Study|Protocol required discontinuation|2|||
163175370|NCT01894568|589357415|FG001|Overall Study|Protocol required discontinuation|1|||
163175371|NCT01894568|589357414|FG000|Overall Study|Withdrawal by Subject|5|||
163175372|NCT01894568|589357415|FG001|Overall Study|Withdrawal by Subject|5|||
163175373|NCT01894568|589357414|FG000|Overall Study|Physician Decision|1|||
163175374|NCT01894568|589357415|FG001|Overall Study|Physician Decision|0|||
163175375|NCT01894568|589357414|FG000|Overall Study|Lost to Follow-up|0|||
163175376|NCT01894568|589357415|FG001|Overall Study|Lost to Follow-up|1|||
163175377|NCT00807573|589357416|FG000|Overall Study|Withdrawal by Subject|1|||
163175378|NCT00807573|589357416|FG000|Overall Study|Adverse Event|1|||
163175379|NCT01514370|589357419|FG000|Overall Study|Protocol Violation|2|||
163175380|NCT01514370|589357420|FG001|Overall Study|Protocol Violation|3|||
163175381|NCT01514370|589357419|FG000|Overall Study|Lost to Follow-up|0|||
163175382|NCT01514370|589357420|FG001|Overall Study|Lost to Follow-up|2|||
163175383|NCT01514370|589357419|FG000|Overall Study|Withdrawal by Subject|2|||
163175384|NCT01514370|589357420|FG001|Overall Study|Withdrawal by Subject|1|||
163175385|NCT01514370|589357419|FG000|Overall Study|Adverse Event|1|||
163175386|NCT01514370|589357420|FG001|Overall Study|Adverse Event|3|||
163175387|NCT01514370|589357419|FG000|Overall Study|Other|6|||
163175388|NCT01514370|589357420|FG001|Overall Study|Other|7|||
163175389|NCT01089361|589357421|FG000|Overall Study|Death|1|||
163175390|NCT01089361|589357422|FG001|Overall Study|Death|0|||
163175391|NCT00169442|589357423|FG000|Overall Study|Withdrawal by Subject|0|||
163175392|NCT00169442|589357424|FG001|Overall Study|Withdrawal by Subject|0|||
163175393|NCT00169442|589357425|FG002|Overall Study|Withdrawal by Subject|1|||
163175394|NCT00169442|589357426|FG003|Overall Study|Withdrawal by Subject|0|||
163175395|NCT00169442|589357427|FG004|Overall Study|Withdrawal by Subject|0|||
163175396|NCT00169442|589357428|FG005|Overall Study|Withdrawal by Subject|0|||
163175397|NCT00169442|589357423|FG000|Overall Study|Migrated/moved from study area|0|||
163175398|NCT00169442|589357424|FG001|Overall Study|Migrated/moved from study area|0|||
163175399|NCT00169442|589357425|FG002|Overall Study|Migrated/moved from study area|0|||
163175400|NCT00169442|589357426|FG003|Overall Study|Migrated/moved from study area|0|||
163280705|NCT02223182|589735602|FG000|Open-Label 500 Period|Adverse Event|1|||
163280706|NCT02223182|589735603|FG001|Open-Label 500 Period|Adverse Event|0|||
163280707|NCT02223182|589735604|FG002|Open-Label 500 Period|Adverse Event|2|||
163280708|NCT02223182|589735605|FG003|Open-Label 500 Period|Adverse Event|1|||
163280709|NCT02223182|589735602|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
163280710|NCT02223182|589735603|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
163280711|NCT02223182|589735604|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
163280712|NCT02223182|589735605|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
163280713|NCT02223182|589735602|FG000|Open-Label 500 Period|Physician Decision|0|||
163280714|NCT02223182|589735603|FG001|Open-Label 500 Period|Physician Decision|0|||
163280715|NCT02223182|589735604|FG002|Open-Label 500 Period|Physician Decision|0|||
163280716|NCT02223182|589735605|FG003|Open-Label 500 Period|Physician Decision|1|||
163280717|NCT02223182|589735602|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
163280718|NCT02223182|589735603|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
163280719|NCT02223182|589735604|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
163280720|NCT02223182|589735605|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
163280721|NCT02223182|589735602|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
163280722|NCT02223182|589735603|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
163280723|NCT02223182|589735604|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
163280724|NCT02223182|589735605|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
163280725|NCT02223182|589735602|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
163280726|NCT02223182|589735603|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
163280727|NCT02223182|589735604|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
163280728|NCT02223182|589735605|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
163280729|NCT02223182|589735602|FG000|Open-Label 300 Period|Non Compliance|0|||
163280730|NCT02223182|589735603|FG001|Open-Label 300 Period|Non Compliance|2|||
163280731|NCT02223182|589735604|FG002|Open-Label 300 Period|Non Compliance|1|||
163280732|NCT02223182|589735605|FG003|Open-Label 300 Period|Non Compliance|0|||
163280733|NCT04739423|589735616|FG000|Overall Study|Protocol Violation|0|||
163280734|NCT04739423|589735617|FG001|Overall Study|Protocol Violation|1|||
163280735|NCT04739423|589735618|FG002|Overall Study|Protocol Violation|0|||
163280736|NCT04739423|589735619|FG003|Overall Study|Protocol Violation|0|||
163280737|NCT04739423|589735620|FG004|Overall Study|Protocol Violation|0|||
163280738|NCT04739423|589735621|FG005|Overall Study|Protocol Violation|0|||
163280739|NCT04739423|589735616|FG000|Overall Study|Adverse Event|0|||
163280740|NCT04739423|589735617|FG001|Overall Study|Adverse Event|0|||
163280741|NCT04739423|589735618|FG002|Overall Study|Adverse Event|1|||
163280742|NCT04739423|589735619|FG003|Overall Study|Adverse Event|0|||
163280743|NCT04739423|589735620|FG004|Overall Study|Adverse Event|1|||
163280744|NCT04739423|589735621|FG005|Overall Study|Adverse Event|0|||
163280745|NCT04739423|589735616|FG000|Overall Study|Withdrawal by Subject|0|||
163280746|NCT04739423|589735617|FG001|Overall Study|Withdrawal by Subject|0|||
163280747|NCT04739423|589735618|FG002|Overall Study|Withdrawal by Subject|0|||
163280748|NCT04739423|589735619|FG003|Overall Study|Withdrawal by Subject|0|||
163280749|NCT04739423|589735620|FG004|Overall Study|Withdrawal by Subject|0|||
163280750|NCT04739423|589735621|FG005|Overall Study|Withdrawal by Subject|1|||
163280751|NCT01007552|589735625|FG000|Overall Study|Withdrawal by Subject|1|||
163280752|NCT03212365|589735641|FG000|Overall Study|Discharged prior to Xa level|12|||
163280753|NCT03212365|589735642|FG001|Overall Study|Discharged prior to Xa level|8|||
163280754|NCT03212365|589735641|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
163280755|NCT03212365|589735642|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
163280756|NCT03212365|589735641|FG000|Overall Study|Refused study medication|3|||
163280757|NCT03212365|589735642|FG001|Overall Study|Refused study medication|0|||
163280758|NCT03212365|589735641|FG000|Overall Study|Initiated heparin infusion on floor|1|||
163280759|NCT03212365|589735642|FG001|Overall Study|Initiated heparin infusion on floor|1|||
163280760|NCT03212365|589735641|FG000|Overall Study|Unexpected return to OR|1|||
163280761|NCT03212365|589735642|FG001|Overall Study|Unexpected return to OR|1|||
163280762|NCT03212365|589735641|FG000|Overall Study|Medication distribution error|1|||
163280763|NCT03212365|589735642|FG001|Overall Study|Medication distribution error|0|||
163280764|NCT03212365|589735641|FG000|Overall Study|Required epidural placement|1|||
163280765|NCT03212365|589735642|FG001|Overall Study|Required epidural placement|0|||
163280766|NCT03212365|589735641|FG000|Overall Study|Withdrawal by Subject|0|||
163280767|NCT03212365|589735642|FG001|Overall Study|Withdrawal by Subject|1|||
163280768|NCT03212365|589735641|FG000|Overall Study|developed acute renal failure|0|||
163280769|NCT03212365|589735642|FG001|Overall Study|developed acute renal failure|1|||
163280770|NCT00333138|589735643|FG000|Core Study (6 Months)|Adverse Event|4|||
163280771|NCT00333138|589735644|FG001|Core Study (6 Months)|Adverse Event|5|||
162932444|NCT01270841|588458493|FG002|Overall Study|Lost to Follow-up|4|||
163280772|NCT00333138|589735645|FG002|Core Study (6 Months)|Adverse Event|8|||
163280773|NCT00333138|589735643|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
163280774|NCT00333138|589735644|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
163280775|NCT00333138|589735645|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
163280776|NCT00333138|589735643|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
163280777|NCT00333138|589735644|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
163280778|NCT00333138|589735645|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
163280779|NCT00333138|589735643|FG000|Core Study (6 Months)|Protocol Violation|1|||
163280780|NCT00333138|589735644|FG001|Core Study (6 Months)|Protocol Violation|0|||
163280781|NCT00333138|589735645|FG002|Core Study (6 Months)|Protocol Violation|1|||
163280782|NCT00333138|589735643|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
163280783|NCT00333138|589735644|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
163280784|NCT00333138|589735645|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
163280785|NCT00333138|589735643|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
163280786|NCT00333138|589735644|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
163280787|NCT00333138|589735645|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
163280788|NCT00333138|589735643|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
163280789|NCT00333138|589735644|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
163280790|NCT00333138|589735645|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
163280791|NCT00333138|589735643|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
163280792|NCT00333138|589735644|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
163280793|NCT00333138|589735645|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
163280794|NCT00333138|589735643|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
163280795|NCT00333138|589735644|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
163280796|NCT00333138|589735645|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
163280797|NCT00333138|589735643|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
163280798|NCT00333138|589735644|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
163280799|NCT00333138|589735645|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
163280800|NCT00333138|589735643|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
163280801|NCT00333138|589735644|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
163280802|NCT00333138|589735645|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
163280803|NCT00333138|589735643|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
163280804|NCT00333138|589735644|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
163280805|NCT00333138|589735645|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
163280806|NCT00333138|589735643|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
163280807|NCT00333138|589735644|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
163280808|NCT00333138|589735645|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
163280809|NCT00333138|589735643|FG000|Extension Study (Month6 to End of Study)|Death|0|||
163280810|NCT00333138|589735644|FG001|Extension Study (Month6 to End of Study)|Death|1|||
163280811|NCT00333138|589735645|FG002|Extension Study (Month6 to End of Study)|Death|0|||
163280812|NCT03005288|589735646|FG000|Overall Study|Withdrawal by Subject|7|||
163280813|NCT03005288|589735647|FG001|Overall Study|Withdrawal by Subject|5|||
163280814|NCT03005288|589735646|FG000|Overall Study|Lost to Follow-up|0|||
163280815|NCT03005288|589735647|FG001|Overall Study|Lost to Follow-up|1|||
163280816|NCT03005288|589735646|FG000|Overall Study|Adverse Event|5|||
163280817|NCT03005288|589735647|FG001|Overall Study|Adverse Event|0|||
163280818|NCT03005288|589735646|FG000|Overall Study|Protocol deviation|0|||
163280819|NCT03005288|589735647|FG001|Overall Study|Protocol deviation|1|||
163280820|NCT03005288|589735646|FG000|Overall Study|Physician Decision|0|||
163280821|NCT03005288|589735647|FG001|Overall Study|Physician Decision|1|||
163280822|NCT04011033|589735648|FG000|Overall Study|Physician Decision|2|||
163280823|NCT04011033|589735649|FG001|Overall Study|Physician Decision|3|||
163280824|NCT04011033|589735648|FG000|Overall Study|Withdrawal by Subject|1|||
163280825|NCT04011033|589735649|FG001|Overall Study|Withdrawal by Subject|0|||
163280826|NCT01823341|589735650|FG000|Overall Study|Failed run-in|7|||
163280827|NCT01823341|589735650|FG000|Overall Study|Withdrawal by Subject|7|||
163280828|NCT01823341|589735650|FG000|Overall Study|Adverse Event|1|||
163280829|NCT01342887|589735651|FG000|Overall Study|Death|2|||
163280830|NCT00663962|589735652|FG000|Overall Study|somnolence|1|||
163280831|NCT00663962|589735653|FG001|Overall Study|somnolence|0|||
163280832|NCT01449929|589735669|FG000|Randomization Phase 96 Week|Adverse Event|5|||
163280833|NCT01449929|589735670|FG001|Randomization Phase 96 Week|Adverse Event|13|||
163280834|NCT01449929|589735671|FG002|Randomization Phase 96 Week|Adverse Event|0|||
163280835|NCT01449929|589735669|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
163280836|NCT01449929|589735670|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
163280837|NCT01449929|589735671|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
163280838|NCT01449929|589735669|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
163280839|NCT01449929|589735670|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
163280840|NCT01449929|589735671|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
163280841|NCT01449929|589735669|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
163280842|NCT01449929|589735670|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
163280843|NCT01449929|589735671|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
163280844|NCT01449929|589735669|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
163280845|NCT01449929|589735670|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
163280846|NCT01449929|589735671|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
163280847|NCT01449929|589735669|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
163280848|NCT01449929|589735670|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
163280849|NCT01449929|589735671|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
163280850|NCT01449929|589735669|FG000|Randomization Phase 96 Week|Physician Decision|2|||
163280851|NCT01449929|589735670|FG001|Randomization Phase 96 Week|Physician Decision|3|||
163280852|NCT01449929|589735671|FG002|Randomization Phase 96 Week|Physician Decision|0|||
163280853|NCT01449929|589735669|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
163280854|NCT01449929|589735670|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
163280855|NCT01449929|589735671|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
163280856|NCT01449929|589735669|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
163280857|NCT01449929|589735670|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
163280858|NCT01449929|589735671|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
163280859|NCT01449929|589735669|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
163280860|NCT01449929|589735670|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
163280861|NCT01449929|589735671|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
163280862|NCT01449929|589735669|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
163280863|NCT01449929|589735670|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
163280864|NCT01449929|589735671|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
163280865|NCT03253653|589735672|FG000|Overall Study|Withdrawal by Subject|4|||
163280866|NCT03253653|589735673|FG001|Overall Study|Withdrawal by Subject|1|||
163280867|NCT03253653|589735672|FG000|Overall Study|Protocol Violation|0|||
163280868|NCT03253653|589735673|FG001|Overall Study|Protocol Violation|5|||
163280869|NCT00079937|589737428|FG000|Overall Study|Adverse Event|2|||
163280870|NCT00079937|589737429|FG001|Overall Study|Adverse Event|1|||
163280871|NCT00079937|589737428|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163280872|NCT00079937|589737429|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163280873|NCT00079937|589737428|FG000|Overall Study|Subject no longer requires study drug|3|||
163280874|NCT00079937|589737429|FG001|Overall Study|Subject no longer requires study drug|0|||
163280875|NCT00079937|589737428|FG000|Overall Study|Protocol Violation|8|||
163280876|NCT00079937|589737429|FG001|Overall Study|Protocol Violation|6|||
163280877|NCT00079937|589737428|FG000|Overall Study|Withdrawal by Subject|21|||
163280878|NCT00079937|589737429|FG001|Overall Study|Withdrawal by Subject|7|||
163280879|NCT00079937|589737428|FG000|Overall Study|Lost to Follow-up|12|||
163280880|NCT00079937|589737429|FG001|Overall Study|Lost to Follow-up|5|||
163280881|NCT00079937|589737428|FG000|Overall Study|Administrative problems|22|||
163280882|NCT00079937|589737429|FG001|Overall Study|Administrative problems|11|||
162932445|NCT01270841|588458494|FG003|Overall Study|Lost to Follow-up|2|||
163175401|NCT00169442|589357427|FG004|Overall Study|Migrated/moved from study area|0|||
163175402|NCT00169442|589357428|FG005|Overall Study|Migrated/moved from study area|2|||
163175403|NCT00169442|589357423|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
163175404|NCT00169442|589357424|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
163175405|NCT00169442|589357425|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
163175406|NCT00169442|589357426|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
163175407|NCT00169442|589357427|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
163175408|NCT00169442|589357428|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
163175409|NCT00169442|589357423|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
163175410|NCT00169442|589357424|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
163175411|NCT00169442|589357425|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
163175412|NCT00169442|589357426|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
163175413|NCT00169442|589357427|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
163175414|NCT00169442|589357428|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
163175415|NCT03353740|589357431|FG000|Overall Study|Images for these participants not viable|52|||
163175416|NCT02232880|589357433|FG000|Overall Study|study stopped prior to randomization|1|||
163175417|NCT03976648|589357436|FG000|Overall Study|Adverse Event|0|||
163175418|NCT03976648|589357437|FG001|Overall Study|Adverse Event|2|||
163175419|NCT03976648|589357436|FG000|Overall Study|Study terminated by sponsor|21|||
163175420|NCT03976648|589357437|FG001|Overall Study|Study terminated by sponsor|8|||
163175421|NCT03645434|589357438|FG000|Period 1|Adverse Event|0|||
163175422|NCT03645434|589357439|FG001|Period 1|Adverse Event|0|||
163175423|NCT03645434|589357440|FG002|Period 1|Adverse Event|0|||
163175424|NCT03645434|589357441|FG003|Period 1|Adverse Event|1|||
163175425|NCT03645434|589357442|FG004|Period 1|Adverse Event|0|||
163175426|NCT03645434|589357443|FG005|Period 1|Adverse Event|0|||
163175427|NCT03645434|589357438|FG000|Period 1|COPD exacerbation|0|||
163175428|NCT03645434|589357439|FG001|Period 1|COPD exacerbation|0|||
163175429|NCT03645434|589357440|FG002|Period 1|COPD exacerbation|0|||
163175430|NCT03645434|589357441|FG003|Period 1|COPD exacerbation|0|||
163175431|NCT03645434|589357442|FG004|Period 1|COPD exacerbation|1|||
163175432|NCT03645434|589357443|FG005|Period 1|COPD exacerbation|0|||
163175433|NCT00881868|589357444|FG000|Overall Study|Adverse Event|0|||
163175434|NCT00881868|589357445|FG001|Overall Study|Adverse Event|1|||
163175435|NCT00881868|589357444|FG000|Overall Study|Lost to Follow-up|2|||
163175436|NCT00881868|589357445|FG001|Overall Study|Lost to Follow-up|1|||
163175437|NCT00881868|589357444|FG000|Overall Study|Physician Decision|4|||
163175438|NCT00881868|589357445|FG001|Overall Study|Physician Decision|0|||
163175439|NCT00881868|589357444|FG000|Overall Study|Protocol Violation|2|||
163175440|NCT00881868|589357445|FG001|Overall Study|Protocol Violation|0|||
163175441|NCT02880956|589357448|FG000|Overall Study|Adverse Event|3|||
163175442|NCT02880956|589357449|FG001|Overall Study|Adverse Event|6|||
163175443|NCT02880956|589357450|FG002|Overall Study|Adverse Event|5|||
163175444|NCT02880956|589357451|FG003|Overall Study|Adverse Event|4|||
163175445|NCT02880956|589357448|FG000|Overall Study|Withdrawal by Subject|9|||
163175446|NCT02880956|589357449|FG001|Overall Study|Withdrawal by Subject|4|||
163175447|NCT02880956|589357450|FG002|Overall Study|Withdrawal by Subject|6|||
163175448|NCT02880956|589357451|FG003|Overall Study|Withdrawal by Subject|11|||
163175449|NCT02880956|589357448|FG000|Overall Study|Lost to Follow-up|0|||
163175450|NCT02880956|589357449|FG001|Overall Study|Lost to Follow-up|1|||
163175451|NCT02880956|589357450|FG002|Overall Study|Lost to Follow-up|0|||
163175452|NCT02880956|589357451|FG003|Overall Study|Lost to Follow-up|0|||
163175453|NCT02880956|589357448|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
163175454|NCT02880956|589357449|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
163175455|NCT02880956|589357450|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
163175456|NCT02880956|589357451|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
163175457|NCT02880956|589357448|FG000|Overall Study|Other, Not Specified|4|||
163175458|NCT02880956|589357449|FG001|Overall Study|Other, Not Specified|2|||
163175459|NCT02880956|589357450|FG002|Overall Study|Other, Not Specified|0|||
163175460|NCT02880956|589357451|FG003|Overall Study|Other, Not Specified|3|||
163175461|NCT02081859|589357452|FG000|Overall Study|No fertilization|2|||
163175462|NCT02081859|589357453|FG001|Overall Study|No fertilization|2|||
163175463|NCT02081859|589357452|FG000|Overall Study|No sperm|1|||
163175464|NCT02081859|589357453|FG001|Overall Study|No sperm|0|||
163175465|NCT02081859|589357452|FG000|Overall Study|Unanticipated freeze all cycle|2|||
163175466|NCT02081859|589357453|FG001|Overall Study|Unanticipated freeze all cycle|6|||
163175467|NCT02081859|589357452|FG000|Overall Study|< 4 embryos|27|||
163175468|NCT02081859|589357453|FG001|Overall Study|< 4 embryos|23|||
163175469|NCT02081859|589357452|FG000|Overall Study|Other reasons|2|||
163175470|NCT02081859|589357453|FG001|Overall Study|Other reasons|0|||
163175471|NCT03718299|589358760|FG000|Overall Study|Adverse Event|1|||
163175472|NCT03718299|589358760|FG000|Overall Study|Withdrawal by Subject|6|||
163175473|NCT03718299|589358760|FG000|Overall Study|Physician Decision|2|||
163175474|NCT03718299|589358760|FG000|Overall Study|Lost to Follow-up|1|||
163175475|NCT04389970|589358762|FG000|Overall Study|Lost to Follow-up|1|||
163175476|NCT03123185|589358763|FG000|Overall Study|Withdrawal by Subject|0|||
163175477|NCT03123185|589358764|FG001|Overall Study|Withdrawal by Subject|0|||
163175478|NCT03123185|589358765|FG002|Overall Study|Withdrawal by Subject|0|||
163175479|NCT03123185|589358766|FG003|Overall Study|Withdrawal by Subject|0|||
163175480|NCT03123185|589358767|FG004|Overall Study|Withdrawal by Subject|0|||
163175481|NCT03123185|589358768|FG005|Overall Study|Withdrawal by Subject|0|||
163175482|NCT03123185|589358769|FG006|Overall Study|Withdrawal by Subject|0|||
163175483|NCT03123185|589358770|FG007|Overall Study|Withdrawal by Subject|0|||
163175484|NCT03123185|589358771|FG008|Overall Study|Withdrawal by Subject|0|||
163175485|NCT03123185|589358772|FG009|Overall Study|Withdrawal by Subject|0|||
163175486|NCT03123185|589358773|FG010|Overall Study|Withdrawal by Subject|0|||
163175487|NCT03123185|589358774|FG011|Overall Study|Withdrawal by Subject|0|||
163175488|NCT03123185|589358775|FG012|Overall Study|Withdrawal by Subject|1|||
163175489|NCT03123185|589358776|FG013|Overall Study|Withdrawal by Subject|0|||
163175490|NCT00686634|589358781|FG000|Overall Study|Protocol Violation|6|||
163175491|NCT04369924|589358783|FG000|Overall Study|Lost to Follow-up|302|||
163175492|NCT04369924|589358784|FG001|Overall Study|Lost to Follow-up|339|||
163175493|NCT01653132|589358787|FG000|First Intervention|Protocol Violation|1|||
163175494|NCT01653132|589358788|FG001|First Intervention|Protocol Violation|0|||
163175495|NCT03828370|589358789|FG000|3 Month Follow-up|Lost to Follow-up|4|||
163175496|NCT03828370|589358790|FG001|3 Month Follow-up|Lost to Follow-up|12|||
163175497|NCT03828370|589358789|FG000|9 Month Follow up|Lost to Follow-up|12|||
163175498|NCT03828370|589358790|FG001|9 Month Follow up|Lost to Follow-up|20|||
163175499|NCT01209832|589358791|FG000|Period 1|Sponsor Decision and was not dosed|1|||
163175500|NCT01209832|589358791|FG000|Period 2|Sponsor Decision|1|||
163175501|NCT00761150|589358792|FG000|Open-label Period|Adverse Event|36|||
163175502|NCT00761150|589358793|FG001|Open-label Period|Adverse Event|0|||
163175503|NCT00761150|589358794|FG002|Open-label Period|Adverse Event|0|||
163175504|NCT00761150|589358792|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
163175505|NCT00761150|589358793|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
163175506|NCT00761150|589358794|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
163175507|NCT00761150|589358792|FG000|Open-label Period|Lost to Follow-up|7|||
163175508|NCT00761150|589358793|FG001|Open-label Period|Lost to Follow-up|0|||
163175509|NCT00761150|589358794|FG002|Open-label Period|Lost to Follow-up|0|||
163175510|NCT00761150|589358792|FG000|Open-label Period|Lack of Efficacy|4|||
163175511|NCT00761150|589358793|FG001|Open-label Period|Lack of Efficacy|0|||
163175512|NCT00761150|589358794|FG002|Open-label Period|Lack of Efficacy|0|||
163280883|NCT02857283|589737430|FG000|First Exposure|Withdrawal by Subject|1|||
163280884|NCT02857283|589737431|FG001|First Exposure|Withdrawal by Subject|0|||
163280885|NCT00093795|589737432|FG000|Overall Study|No follow up data|20|||
163280886|NCT00093795|589737433|FG001|Overall Study|No follow up data|16|||
163280887|NCT00093795|589737434|FG002|Overall Study|No follow up data|17|||
163280888|NCT00613301|589737435|FG000|Overall Study|Adverse Event|49|||
163280889|NCT00613301|589737435|FG000|Overall Study|Lost to Follow-up|88|||
163280890|NCT00613301|589737435|FG000|Overall Study|Withdrawal by Subject|5|||
163280891|NCT00613301|589737435|FG000|Overall Study|Death|6|||
163280892|NCT00613301|589737435|FG000|Overall Study|Lack of Efficacy|13|||
163280893|NCT00613301|589737435|FG000|Overall Study|Physician Decision|2|||
163280894|NCT00613301|589737435|FG000|Overall Study|No data was collected|53|||
163280895|NCT00613301|589737435|FG000|Overall Study|Irregularly enrolled patients|12|||
163280896|NCT01684046|589737438|FG000|Period 1, First 30 Days|Adverse Event|0|||
163280897|NCT01684046|589737439|FG001|Period 1, First 30 Days|Adverse Event|2|||
163280898|NCT00587288|589737440|FG000|Overall Study|Adverse Event|0|||
163280899|NCT00587288|589737441|FG001|Overall Study|Adverse Event|1|||
163280900|NCT00587288|589737440|FG000|Overall Study|Lack of Efficacy|2|||
163280901|NCT00587288|589737441|FG001|Overall Study|Lack of Efficacy|8|||
163280902|NCT00587288|589737440|FG000|Overall Study|Protocol Violation|1|||
163280903|NCT00587288|589737441|FG001|Overall Study|Protocol Violation|0|||
163280904|NCT00762463|589737442|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
163280905|NCT00762463|589737443|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
163280906|NCT00762463|589737444|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
163175513|NCT00761150|589358792|FG000|Open-label Period|Withdrawal by Subject|5|||
163175514|NCT00761150|589358793|FG001|Open-label Period|Withdrawal by Subject|0|||
163175515|NCT00761150|589358794|FG002|Open-label Period|Withdrawal by Subject|0|||
163175516|NCT00761150|589358792|FG000|Open-label Period|Noncompliance|2|||
163175517|NCT00761150|589358793|FG001|Open-label Period|Noncompliance|0|||
163175518|NCT00761150|589358794|FG002|Open-label Period|Noncompliance|0|||
163175519|NCT00761150|589358792|FG000|Open-label Period|Other|5|||
163175520|NCT00761150|589358793|FG001|Open-label Period|Other|0|||
163175521|NCT00761150|589358794|FG002|Open-label Period|Other|0|||
163175522|NCT00761150|589358792|FG000|Double-blind Period|Lack of Efficacy|0|||
163175523|NCT00761150|589358793|FG001|Double-blind Period|Lack of Efficacy|2|||
163175524|NCT00761150|589358794|FG002|Double-blind Period|Lack of Efficacy|19|||
163175525|NCT00761150|589358792|FG000|Double-blind Period|Adverse Event|0|||
163175526|NCT00761150|589358793|FG001|Double-blind Period|Adverse Event|3|||
163175527|NCT00761150|589358794|FG002|Double-blind Period|Adverse Event|3|||
163175528|NCT00761150|589358792|FG000|Double-blind Period|Withdrawal by Subject|0|||
163175529|NCT00761150|589358793|FG001|Double-blind Period|Withdrawal by Subject|3|||
163175530|NCT00761150|589358794|FG002|Double-blind Period|Withdrawal by Subject|2|||
163175531|NCT00761150|589358792|FG000|Double-blind Period|Lost to Follow-up|0|||
163175532|NCT00761150|589358793|FG001|Double-blind Period|Lost to Follow-up|2|||
163175533|NCT00761150|589358794|FG002|Double-blind Period|Lost to Follow-up|1|||
163175534|NCT00761150|589358792|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
163175535|NCT00761150|589358793|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
163175536|NCT00761150|589358794|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
163175537|NCT00761150|589358792|FG000|Double-blind Period|Noncompliance|0|||
163175538|NCT00761150|589358793|FG001|Double-blind Period|Noncompliance|1|||
163175539|NCT00761150|589358794|FG002|Double-blind Period|Noncompliance|0|||
163175540|NCT00761150|589358792|FG000|Double-blind Period|Other|0|||
163175541|NCT00761150|589358793|FG001|Double-blind Period|Other|3|||
163175542|NCT00761150|589358794|FG002|Double-blind Period|Other|3|||
163175543|NCT00046891|589358797|FG000|Overall Study|Cancels|5|||
163175544|NCT00046891|589358798|FG001|Overall Study|Cancels|9|||
163175545|NCT00046891|589358797|FG000|Overall Study|Ineligible|1|||
163175546|NCT00046891|589358798|FG001|Overall Study|Ineligible|1|||
163175547|NCT00046891|589358797|FG000|Overall Study|Withdrawal by Subject|18|||
163175548|NCT00046891|589358798|FG001|Overall Study|Withdrawal by Subject|15|||
163175549|NCT00046891|589358797|FG000|Overall Study|Adverse Event|5|||
163175550|NCT00046891|589358798|FG001|Overall Study|Adverse Event|5|||
163175551|NCT06400251|589358802|FG000|Overall Study|Never Start Protocol Therapy|1|||
163280907|NCT00762463|589737445|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
163280908|NCT00762463|589737442|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
163280909|NCT00762463|589737443|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
163280910|NCT00762463|589737444|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
162932446|NCT01270841|588458491|FG000|Overall Study|Physician Decision|0|||
163175552|NCT06400251|589358802|FG000|Overall Study|Ineligible|2|||
163175553|NCT06400251|589358802|FG000|Overall Study|Mutation Status Not Confirmed|3|||
163175554|NCT06400251|589358802|FG000|Overall Study|Disease Progression|25|||
163175555|NCT06400251|589358802|FG000|Overall Study|Adverse Event|1|||
163175556|NCT06400251|589358802|FG000|Overall Study|Complicating Disease|1|||
163175557|NCT06400251|589358802|FG000|Overall Study|Physician Decision|2|||
162932447|NCT01270841|588458492|FG001|Overall Study|Physician Decision|1|||
163175558|NCT02217527|589358803|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
163280911|NCT00762463|589737445|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
163280912|NCT00762463|589737442|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
163280913|NCT00762463|589737443|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
163280914|NCT00762463|589737444|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
163280915|NCT00762463|589737445|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
163280916|NCT00762463|589737442|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
163280917|NCT00762463|589737443|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
163280918|NCT00762463|589737444|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
163280919|NCT00762463|589737445|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
163280920|NCT00762463|589737442|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
163280921|NCT00762463|589737443|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
163280922|NCT00762463|589737444|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
163280923|NCT00762463|589737445|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
163280924|NCT00762463|589737442|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
163280925|NCT00762463|589737443|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
163280926|NCT00762463|589737444|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
163280927|NCT00762463|589737445|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
163280928|NCT00762463|589737442|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
163280929|NCT00762463|589737443|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
163280930|NCT00762463|589737444|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
163280931|NCT00762463|589737445|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
163280932|NCT00762463|589737442|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
163280933|NCT00762463|589737443|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
163280934|NCT00762463|589737444|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
163280935|NCT00762463|589737445|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
163280936|NCT00797862|589737446|FG000|Overall Study|Adverse Event|86|||
163280937|NCT00797862|589737447|FG001|Overall Study|Adverse Event|44|||
163280938|NCT00797862|589737448|FG002|Overall Study|Adverse Event|58|||
163280939|NCT00797862|589737446|FG000|Overall Study|Abnormal Test Procedure Result|0|||
163280940|NCT00797862|589737447|FG001|Overall Study|Abnormal Test Procedure Result|1|||
163280941|NCT00797862|589737448|FG002|Overall Study|Abnormal Test Procedure Result|1|||
163280942|NCT00797862|589737446|FG000|Overall Study|Lack of Efficacy|1|||
163280943|NCT00797862|589737447|FG001|Overall Study|Lack of Efficacy|7|||
163280944|NCT00797862|589737448|FG002|Overall Study|Lack of Efficacy|6|||
163280945|NCT00797862|589737446|FG000|Overall Study|No longer required study medication|1|||
163280946|NCT00797862|589737447|FG001|Overall Study|No longer required study medication|0|||
163280947|NCT00797862|589737448|FG002|Overall Study|No longer required study medication|0|||
163280948|NCT00797862|589737446|FG000|Overall Study|Withdrawal by Subject|14|||
163280949|NCT00797862|589737447|FG001|Overall Study|Withdrawal by Subject|7|||
163280950|NCT00797862|589737448|FG002|Overall Study|Withdrawal by Subject|7|||
163280951|NCT00797862|589737446|FG000|Overall Study|Lost to Follow-up|11|||
163280952|NCT00797862|589737447|FG001|Overall Study|Lost to Follow-up|0|||
163280953|NCT00797862|589737448|FG002|Overall Study|Lost to Follow-up|5|||
163280954|NCT00797862|589737446|FG000|Overall Study|Administrative Problem|4|||
163280955|NCT00797862|589737447|FG001|Overall Study|Administrative Problem|0|||
163280956|NCT00797862|589737448|FG002|Overall Study|Administrative Problem|0|||
163280957|NCT00797862|589737446|FG000|Overall Study|Protocol Violation|4|||
163280958|NCT00797862|589737447|FG001|Overall Study|Protocol Violation|6|||
163280959|NCT00797862|589737448|FG002|Overall Study|Protocol Violation|8|||
163280960|NCT00797862|589737446|FG000|Overall Study|Mis-randomized|3|||
163280961|NCT00797862|589737447|FG001|Overall Study|Mis-randomized|3|||
163280962|NCT00797862|589737448|FG002|Overall Study|Mis-randomized|1|||
163280963|NCT00531479|589737449|FG000|Overall Study|Death|68|||
163280964|NCT00531479|589737450|FG001|Overall Study|Death|71|||
163280965|NCT00531479|589737449|FG000|Overall Study|Lost to Follow-up|0|||
163280966|NCT00531479|589737450|FG001|Overall Study|Lost to Follow-up|2|||
163280967|NCT00531479|589737449|FG000|Overall Study|Other|0|||
163280968|NCT00531479|589737450|FG001|Overall Study|Other|1|||
163280969|NCT00531479|589737449|FG000|Overall Study|Withdrawal by Subject|6|||
163280970|NCT00531479|589737450|FG001|Overall Study|Withdrawal by Subject|6|||
163280971|NCT00531479|589737449|FG000|Overall Study|Did not receive treatment|2|||
163280972|NCT00531479|589737450|FG001|Overall Study|Did not receive treatment|3|||
163280973|NCT05074498|589737455|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
163280974|NCT05074498|589737456|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
163280975|NCT05074498|589737457|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
163280976|NCT05074498|589737458|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
163280977|NCT05074498|589737459|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
163280978|NCT05074498|589737460|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
163280979|NCT05074498|589737455|FG000|Part 1 (Upto Day 104)|Other|1|||
163280980|NCT05074498|589737456|FG001|Part 1 (Upto Day 104)|Other|0|||
163280981|NCT05074498|589737457|FG002|Part 1 (Upto Day 104)|Other|0|||
163280982|NCT05074498|589737458|FG003|Part 1 (Upto Day 104)|Other|0|||
163280983|NCT05074498|589737459|FG004|Part 1 (Upto Day 104)|Other|0|||
163280984|NCT05074498|589737460|FG005|Part 1 (Upto Day 104)|Other|0|||
163280985|NCT05074498|589737455|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
163280986|NCT05074498|589737456|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
163280987|NCT05074498|589737457|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
163280988|NCT05074498|589737458|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
163280989|NCT05074498|589737459|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
163280990|NCT05074498|589737460|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
163280991|NCT05074498|589737455|FG000|Part 2 (Upto Day 104)|Death|0|||
163280992|NCT05074498|589737456|FG001|Part 2 (Upto Day 104)|Death|0|||
163280993|NCT05074498|589737457|FG002|Part 2 (Upto Day 104)|Death|0|||
163280994|NCT05074498|589737458|FG003|Part 2 (Upto Day 104)|Death|0|||
163280995|NCT05074498|589737459|FG004|Part 2 (Upto Day 104)|Death|1|||
163280996|NCT05074498|589737460|FG005|Part 2 (Upto Day 104)|Death|0|||
163280997|NCT05074498|589737455|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
163280998|NCT05074498|589737456|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
163280999|NCT05074498|589737457|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
163281000|NCT05074498|589737458|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
163281001|NCT05074498|589737459|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
163281002|NCT05074498|589737460|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
163281003|NCT05074498|589737455|FG000|Part 2 (Upto Day 104)|Other|0|||
163281004|NCT05074498|589737456|FG001|Part 2 (Upto Day 104)|Other|0|||
163281005|NCT05074498|589737457|FG002|Part 2 (Upto Day 104)|Other|0|||
163281006|NCT05074498|589737458|FG003|Part 2 (Upto Day 104)|Other|0|||
163281007|NCT05074498|589737459|FG004|Part 2 (Upto Day 104)|Other|1|||
163281008|NCT05074498|589737460|FG005|Part 2 (Upto Day 104)|Other|0|||
163281009|NCT01306331|589737462|FG000|Overall Study|Adverse Event|28|||
163281010|NCT01306331|589737463|FG001|Overall Study|Adverse Event|25|||
163281011|NCT01306331|589737462|FG000|Overall Study|Lost to Follow-up|321|||
163281012|NCT01306331|589737463|FG001|Overall Study|Lost to Follow-up|323|||
163281013|NCT01306331|589737462|FG000|Overall Study|Physician Decision|26|||
163281014|NCT01306331|589737463|FG001|Overall Study|Physician Decision|22|||
163281015|NCT01306331|589737462|FG000|Overall Study|Pregnancy|136|||
163281016|NCT01306331|589737463|FG001|Overall Study|Pregnancy|151|||
163281017|NCT01306331|589737462|FG000|Overall Study|Protocol Violation|154|||
163281018|NCT01306331|589737463|FG001|Overall Study|Protocol Violation|124|||
163281019|NCT01306331|589737462|FG000|Overall Study|Withdrawal by Subject|163|||
163281020|NCT01306331|589737463|FG001|Overall Study|Withdrawal by Subject|152|||
163281021|NCT01306331|589737462|FG000|Overall Study|Not sexually active|29|||
163281022|NCT01306331|589737463|FG001|Overall Study|Not sexually active|28|||
163281023|NCT01306331|589737462|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
163281024|NCT01306331|589737463|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
163281025|NCT01306331|589737462|FG000|Overall Study|Other|34|||
163281026|NCT01306331|589737463|FG001|Overall Study|Other|32|||
163281027|NCT00172185|589737470|FG000|Overall Study|Adverse Event|0|||
163281028|NCT00172185|589737471|FG001|Overall Study|Adverse Event|1|||
163281029|NCT00172185|589737472|FG002|Overall Study|Adverse Event|3|||
163281030|NCT00172185|589737473|FG003|Overall Study|Adverse Event|4|||
163281031|NCT00172185|589737470|FG000|Overall Study|Physician Decision|0|||
163281032|NCT00172185|589737471|FG001|Overall Study|Physician Decision|0|||
163281033|NCT00172185|589737472|FG002|Overall Study|Physician Decision|1|||
163281034|NCT00172185|589737473|FG003|Overall Study|Physician Decision|0|||
163281035|NCT00172185|589737470|FG000|Overall Study|SPONSOR Decision|0|||
163281036|NCT00172185|589737471|FG001|Overall Study|SPONSOR Decision|1|||
163281037|NCT00172185|589737472|FG002|Overall Study|SPONSOR Decision|0|||
163281038|NCT00172185|589737473|FG003|Overall Study|SPONSOR Decision|0|||
163281039|NCT00172185|589737470|FG000|Overall Study|Withdrawal by Subject|0|||
163281040|NCT00172185|589737471|FG001|Overall Study|Withdrawal by Subject|0|||
163281041|NCT00172185|589737472|FG002|Overall Study|Withdrawal by Subject|1|||
163281042|NCT00172185|589737473|FG003|Overall Study|Withdrawal by Subject|0|||
163281043|NCT01677936|589737474|FG000|Overall Study|Lost to Follow-up|4|||
163281044|NCT01677936|589737475|FG001|Overall Study|Lost to Follow-up|1|||
163281045|NCT01677936|589737474|FG000|Overall Study|Protocol Violation|3|||
163281046|NCT01677936|589737475|FG001|Overall Study|Protocol Violation|0|||
163281047|NCT01677936|589737474|FG000|Overall Study|Adverse Event|1|||
163281048|NCT01677936|589737475|FG001|Overall Study|Adverse Event|0|||
163281049|NCT01677936|589737474|FG000|Overall Study|Lost to Follow-up|1|||
163281050|NCT01677936|589737475|FG001|Overall Study|Lost to Follow-up|0|||
163281051|NCT01677936|589737474|FG000|Overall Study|Protocol Violation|0|||
163281052|NCT01677936|589737475|FG001|Overall Study|Protocol Violation|4|||
163281053|NCT02790606|589737478|FG000|Overall Study|Death|27|||
163281054|NCT02790606|589737478|FG000|Overall Study|Lost to Follow-up|4|||
163281055|NCT02790606|589737478|FG000|Overall Study|Physician Decision|3|||
163281056|NCT02790606|589737478|FG000|Overall Study|Withdrawal by Subject|1|||
163281057|NCT02735915|589737479|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
163281058|NCT02735915|589737479|FG000|Overall Study|Withdrawal following SAE|2|||
163281059|NCT02735915|589737479|FG000|Overall Study|Withdrawal by Subject|1|||
163281060|NCT05328973|589737480|FG000|Overall Study|Withdrawal by Subject|0|||
163281061|NCT05328973|589737481|FG001|Overall Study|Withdrawal by Subject|1|||
163281062|NCT00409708|589737487|FG000|Treatment|Abnormal test procedure result(s)|1|||
163281063|NCT00409708|589737488|FG001|Treatment|Abnormal test procedure result(s)|0|||
163281064|NCT00409708|589737487|FG000|Treatment|Lack of Efficacy|0|||
163281065|NCT00409708|589737488|FG001|Treatment|Lack of Efficacy|1|||
163281066|NCT00409708|589737487|FG000|Treatment|Protocol Violation|6|||
163281067|NCT00409708|589737488|FG001|Treatment|Protocol Violation|2|||
163281068|NCT00409708|589737487|FG000|Treatment|Withdrawal by Subject|3|||
163281069|NCT00409708|589737488|FG001|Treatment|Withdrawal by Subject|8|||
163281070|NCT00409708|589737487|FG000|Treatment|Lost to Follow-up|0|||
163281071|NCT00409708|589737488|FG001|Treatment|Lost to Follow-up|6|||
163281072|NCT00409708|589737487|FG000|Treatment|Administrative problems|5|||
163281073|NCT00409708|589737488|FG001|Treatment|Administrative problems|0|||
163175559|NCT02217527|589358804|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
163175560|NCT02217527|589358803|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
163175561|NCT02217527|589358804|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
163175562|NCT06390839|589358810|FG000|Overall Study|Ineligible|2|||
163175563|NCT06390839|589358810|FG000|Overall Study|Never start protocol therapy|3|||
163175564|NCT06390839|589358810|FG000|Overall Study|Adverse Event|1|||
163175565|NCT06390839|589358810|FG000|Overall Study|Alternative therapy|2|||
163175566|NCT06390839|589358810|FG000|Overall Study|Death|3|||
163175567|NCT06390839|589358810|FG000|Overall Study|Disease progression|28|||
163175568|NCT06390839|589358810|FG000|Overall Study|Withdrawal by Subject|2|||
163281074|NCT00409708|589737487|FG000|Washout|Lack of Efficacy|9|||
163281075|NCT00409708|589737488|FG001|Washout|Lack of Efficacy|1|||
163281076|NCT00409708|589737487|FG000|Washout|Protocol Violation|0|||
163281077|NCT00409708|589737488|FG001|Washout|Protocol Violation|1|||
163281078|NCT00409708|589737487|FG000|Washout|Withdrawal by Subject|11|||
163281079|NCT00409708|589737488|FG001|Washout|Withdrawal by Subject|5|||
163281080|NCT00409708|589737487|FG000|Washout|Lost to Follow-up|1|||
163281081|NCT00409708|589737488|FG001|Washout|Lost to Follow-up|3|||
163175569|NCT06390839|589358810|FG000|Overall Study|Complicating disease|1|||
163281082|NCT00946114|589737489|FG000|Overall Study|Death|5|||
163281083|NCT00946114|589737490|FG001|Overall Study|Death|2|||
163281084|NCT00946114|589737489|FG000|Overall Study|Other|1|||
163281085|NCT00946114|589737490|FG001|Overall Study|Other|0|||
163281086|NCT00946114|589737489|FG000|Overall Study|Withdrawal by Subject|2|||
163175570|NCT06390839|589358810|FG000|Overall Study|Noncompliance|1|||
163281087|NCT00946114|589737490|FG001|Overall Study|Withdrawal by Subject|0|||
163281088|NCT00723294|589737491|FG000|Overall Study|Lobular histology|2|||
163281089|NCT00723294|589737491|FG000|Overall Study|>25% intraductal component|1|||
163281090|NCT00723294|589737491|FG000|Overall Study|No MRI tumor enhancement|1|||
163281091|NCT00723294|589737491|FG000|Overall Study|1.0-Tesla MRI|1|||
163281092|NCT00723294|589737491|FG000|Overall Study|No cryoabalation|2|||
163281093|NCT00723294|589737491|FG000|Overall Study|Did not undergo surgery|1|||
163281094|NCT00723294|589737491|FG000|Overall Study|Treated prior to registration|1|||
163281095|NCT00723294|589737491|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
163281096|NCT00723294|589737491|FG000|Overall Study|Benign lesion|1|||
163281097|NCT00723294|589737491|FG000|Overall Study|Withdrawal by Subject|1|||
163281098|NCT00723294|589737491|FG000|Overall Study|No treatment due to probe failure|1|||
163281099|NCT00088465|589737492|FG000|Overall Study|Withdrawal by Subject|290|||
163281100|NCT00088465|589737492|FG000|Overall Study|Adverse Event|77|||
163281101|NCT00088465|589737492|FG000|Overall Study|Lost to Follow-up|57|||
163281102|NCT00088465|589737492|FG000|Overall Study|Physician Decision|45|||
163281103|NCT00088465|589737492|FG000|Overall Study|Sponsor Decision|37|||
163281104|NCT00088465|589737492|FG000|Overall Study|Lack of Efficacy|27|||
163281105|NCT00088465|589737492|FG000|Overall Study|Protocol Violation|17|||
163281106|NCT00088465|589737492|FG000|Overall Study|Death|11|||
163281107|NCT04565249|589737493|FG000|Overall Study|Death|0|||
163281108|NCT04565249|589737494|FG001|Overall Study|Death|0|||
163281109|NCT04565249|589737495|FG002|Overall Study|Death|0|||
163281110|NCT04565249|589737496|FG003|Overall Study|Death|1|||
163281111|NCT03613129|589737499|FG000|Pre-treatment Assessment|Protocol Violation|2|||
163281112|NCT03613129|589737500|FG001|Pre-treatment Assessment|Protocol Violation|0|||
162932448|NCT01270841|588458493|FG002|Overall Study|Physician Decision|0|||
162932449|NCT01270841|588458494|FG003|Overall Study|Physician Decision|0|||
162932450|NCT01270841|588458491|FG000|Overall Study|Did not qualify|6|||
162932451|NCT01270841|588458492|FG001|Overall Study|Did not qualify|3|||
162932452|NCT01270841|588458493|FG002|Overall Study|Did not qualify|4|||
162932453|NCT01270841|588458494|FG003|Overall Study|Did not qualify|5|||
162932454|NCT01270841|588458491|FG000|Overall Study|Protocol Violation|1|||
162932455|NCT01270841|588458492|FG001|Overall Study|Protocol Violation|5|||
162932456|NCT01270841|588458493|FG002|Overall Study|Protocol Violation|0|||
162932457|NCT01270841|588458494|FG003|Overall Study|Protocol Violation|0|||
162932458|NCT01270841|588458491|FG000|Overall Study|Enrolled in error|0|||
162932459|NCT01270841|588458492|FG001|Overall Study|Enrolled in error|1|||
163281113|NCT03613129|589737501|FG002|Pre-treatment Assessment|Protocol Violation|0|||
163281114|NCT03613129|589737502|FG003|Pre-treatment Assessment|Protocol Violation|0|||
163281115|NCT03613129|589737503|FG004|Pre-treatment Assessment|Protocol Violation|0|||
163281116|NCT03613129|589737499|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
163281117|NCT03613129|589737500|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
163281118|NCT03613129|589737501|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
162932460|NCT01270841|588458493|FG002|Overall Study|Enrolled in error|0|||
162932461|NCT01270841|588458494|FG003|Overall Study|Enrolled in error|0|||
162932462|NCT01375010|588458495|FG000|Overall Study|Lost to Follow-up|8|||
163175571|NCT01738477|589358815|FG000|Overall Study|Lost to Follow-up|1|||
163175572|NCT01738477|589358816|FG001|Overall Study|Lost to Follow-up|4|||
163175573|NCT00502203|589358817|FG000|Overall Study|Inevaluable|1|||
163175574|NCT02720094|589358818|FG000|Overall Study|Ongoing|2210|||
163175575|NCT02720094|589358819|FG001|Overall Study|Ongoing|2203|||
163175576|NCT02720094|589358818|FG000|Overall Study|Scheduled exit visit/end of study|2|||
163175577|NCT02720094|589358819|FG001|Overall Study|Scheduled exit visit/end of study|1|||
163175578|NCT02720094|589358818|FG000|Overall Study|Death|4|||
163175579|NCT02720094|589358819|FG001|Overall Study|Death|7|||
163175580|NCT02720094|589358818|FG000|Overall Study|Withdrawal by Subject|55|||
163175581|NCT02720094|589358819|FG001|Overall Study|Withdrawal by Subject|56|||
163175582|NCT02720094|589358818|FG000|Overall Study|Lost to Follow-up|2|||
163175583|NCT02720094|589358819|FG001|Overall Study|Lost to Follow-up|7|||
163175584|NCT02720094|589358818|FG000|Overall Study|Physician Decision|1|||
163175585|NCT02720094|589358819|FG001|Overall Study|Physician Decision|3|||
163175586|NCT02720094|589358818|FG000|Overall Study|Inappropriate enrollment|1|||
163175587|NCT02720094|589358819|FG001|Overall Study|Inappropriate enrollment|3|||
163175588|NCT02720094|589358818|FG000|Overall Study|Relocation|1|||
163175589|NCT02720094|589358819|FG001|Overall Study|Relocation|1|||
163281119|NCT03613129|589737502|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
162932463|NCT01375010|588458496|FG001|Overall Study|Lost to Follow-up|2|||
162932464|NCT01375010|588458495|FG000|Overall Study|Withdrawal by Subject|4|||
163281120|NCT03613129|589737503|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
163281121|NCT02334306|589737504|FG000|Double-blind Period|Adverse Event|0|||
163281122|NCT02334306|589737505|FG001|Double-blind Period|Adverse Event|1|||
162932465|NCT01375010|588458496|FG001|Overall Study|Withdrawal by Subject|2|||
162932466|NCT02402933|588458497|FG000|Overall Study|Withdrawal by Subject|4|||
162932467|NCT02402933|588458497|FG000|Overall Study|Discontinued; Site Termination|10|||
163175590|NCT01431638|589358822|FG000|Overall Study|Adverse Event|1|||
163175591|NCT01431638|589358823|FG001|Overall Study|Adverse Event|3|||
163175592|NCT01431638|589358824|FG002|Overall Study|Adverse Event|1|||
163175593|NCT01431638|589358822|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163281123|NCT02334306|589737504|FG000|Double-blind Period|Withdrawal by Subject|1|||
163281124|NCT02334306|589737505|FG001|Double-blind Period|Withdrawal by Subject|1|||
163281125|NCT01687270|589737506|FG000|Overall Study|Lack of Efficacy|11|||
163281126|NCT01687270|589737506|FG000|Overall Study|Lost to Follow-up|1|||
163281127|NCT02390557|589737507|FG000|Wave 2|Survey non-respondent|72|||
163281128|NCT02390557|589737508|FG001|Wave 2|Survey non-respondent|41|||
163281129|NCT02390557|589737509|FG002|Wave 2|Survey non-respondent|23|||
163281130|NCT00920686|589737515|FG000|Overall Study|Lost to Follow-up|2|||
162932468|NCT00830063|588458500|FG000|Overall Study|Adverse Event|7|||
163281131|NCT00920686|589737516|FG001|Overall Study|Lost to Follow-up|3|||
163281132|NCT00920686|589737517|FG002|Overall Study|Lost to Follow-up|1|||
163281133|NCT00920686|589737515|FG000|Overall Study|Study drug dosing criteria not met|17|||
163281134|NCT00920686|589737516|FG001|Overall Study|Study drug dosing criteria not met|19|||
163281135|NCT00920686|589737517|FG002|Overall Study|Study drug dosing criteria not met|12|||
163281136|NCT03006341|589737518|FG000|Overall Study|Not linked in the EMR|25069|||
163281137|NCT03006341|589737519|FG001|Overall Study|Not linked in the EMR|67505|||
163281138|NCT03006341|589737520|FG002|Overall Study|Not linked in the EMR|30993|||
163281139|NCT03006341|589737521|FG003|Overall Study|Not linked in the EMR|10685|||
163281140|NCT04337489|589737522|FG000|Overall Study|Withdrawal by Subject|1|||
163281141|NCT02950545|589737523|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
163281142|NCT02950545|589737524|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
163281143|NCT02950545|589737525|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
163281144|NCT02950545|589737526|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
163281145|NCT02950545|589737527|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
163281146|NCT02950545|589737528|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
163281147|NCT02950545|589737523|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
163281148|NCT02950545|589737524|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
163281149|NCT02950545|589737525|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
163281150|NCT02950545|589737526|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
163281151|NCT02950545|589737527|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
163281152|NCT02950545|589737528|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
163281153|NCT02950545|589737523|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
163281154|NCT02950545|589737524|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
163281155|NCT02950545|589737525|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
163281156|NCT02950545|589737526|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
163281157|NCT02950545|589737527|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
163281158|NCT02950545|589737528|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
163281159|NCT02950545|589737523|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
163281160|NCT02950545|589737524|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
163281161|NCT02950545|589737525|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
163281162|NCT02950545|589737526|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
163281163|NCT02950545|589737527|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
163281164|NCT02950545|589737528|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
163281165|NCT02950545|589737523|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
163281166|NCT02950545|589737524|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
163281167|NCT02950545|589737525|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
163281168|NCT02950545|589737526|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
163281169|NCT02950545|589737527|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
163281170|NCT02950545|589737528|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
163281171|NCT04296942|589737529|FG000|Overall Study|Study closure by sponsor|1|||
163281172|NCT04296942|589737530|FG001|Overall Study|Study closure by sponsor|0|||
162932469|NCT00830063|588458501|FG001|Overall Study|Adverse Event|13|||
162932470|NCT00830063|588458502|FG002|Overall Study|Adverse Event|16|||
162932471|NCT00830063|588458503|FG003|Overall Study|Adverse Event|13|||
162932472|NCT00830063|588458500|FG000|Overall Study|Death|1|||
162932473|NCT00830063|588458501|FG001|Overall Study|Death|0|||
162932474|NCT00830063|588458502|FG002|Overall Study|Death|0|||
162932475|NCT00830063|588458503|FG003|Overall Study|Death|0|||
162932476|NCT00830063|588458500|FG000|Overall Study|Lost to Follow-up|0|||
162932477|NCT00830063|588458501|FG001|Overall Study|Lost to Follow-up|0|||
162932478|NCT00830063|588458502|FG002|Overall Study|Lost to Follow-up|3|||
162932479|NCT00830063|588458503|FG003|Overall Study|Lost to Follow-up|1|||
163281173|NCT04296942|589737531|FG002|Overall Study|Study closure by sponsor|0|||
163281174|NCT03255941|589737532|FG000|Overall Study|Not eligible or refused injection|37|||
163281175|NCT03255941|589737533|FG001|Overall Study|Not eligible or refused injection|44|||
162932480|NCT00830063|588458500|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
162932481|NCT00830063|588458501|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
162932482|NCT00830063|588458502|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
163281176|NCT03255941|589737534|FG002|Overall Study|Not eligible or refused injection|5|||
163281177|NCT03255941|589737535|FG003|Overall Study|Not eligible or refused injection|6|||
163281178|NCT03255941|589737532|FG000|Overall Study|Did not complete exit interview|1|||
163281179|NCT03255941|589737533|FG001|Overall Study|Did not complete exit interview|2|||
163281180|NCT03255941|589737534|FG002|Overall Study|Did not complete exit interview|0|||
162932483|NCT00830063|588458503|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
163281181|NCT03255941|589737535|FG003|Overall Study|Did not complete exit interview|0|||
163281182|NCT00335153|589737547|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
163281183|NCT00335153|589737547|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
163281184|NCT00335153|589737547|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
163281185|NCT00335153|589737547|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
163281186|NCT00335153|589737547|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
163281187|NCT00335153|589737547|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
163281188|NCT00335153|589737547|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
163281189|NCT00335153|589737547|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
163281190|NCT00335153|589737547|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
163281191|NCT00335153|589737547|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
163281192|NCT01528709|589737548|FG000|Overall Study|Death|2|||
163281193|NCT01528709|589737549|FG001|Overall Study|Death|0|||
163281194|NCT01528709|589737548|FG000|Overall Study|Withdrawal by Subject|10|||
163281195|NCT01528709|589737549|FG001|Overall Study|Withdrawal by Subject|15|||
163281196|NCT01528709|589737548|FG000|Overall Study|allergy|1|||
163281197|NCT01528709|589737549|FG001|Overall Study|allergy|0|||
163281198|NCT00945477|589737550|FG000|Overall Study|Adverse Event|3|||
163281199|NCT00945477|589737550|FG000|Overall Study|Lack of Efficacy|2|||
163281200|NCT00945477|589737550|FG000|Overall Study|Withdrawal by Subject|1|||
163281201|NCT01008748|589737552|FG000|Overall Study|Lost to Follow-up|80|||
163281202|NCT01008748|589737552|FG000|Overall Study|Other|1|||
163281203|NCT01822821|589737553|FG000|Overall Study|Eligible surgery cancelled|1|||
163281204|NCT01822821|589737554|FG001|Overall Study|Eligible surgery cancelled|1|||
163281205|NCT01822821|589737553|FG000|Overall Study|Other reasons|1|||
163281206|NCT01822821|589737554|FG001|Overall Study|Other reasons|0|||
163281207|NCT03251378|589737555|FG000|Overall Study|Death|3|||
163281208|NCT03251378|589737556|FG001|Overall Study|Death|2|||
163281209|NCT03251378|589737557|FG002|Overall Study|Death|3|||
163281210|NCT03251378|589737558|FG003|Overall Study|Death|30|||
163281211|NCT03251378|589737559|FG004|Overall Study|Death|24|||
163281212|NCT03251378|589737560|FG005|Overall Study|Death|12|||
163281213|NCT03251378|589737561|FG006|Overall Study|Death|12|||
163281214|NCT03251378|589737555|FG000|Overall Study|Lost to Follow-up|0|||
163281215|NCT03251378|589737556|FG001|Overall Study|Lost to Follow-up|0|||
163281216|NCT03251378|589737557|FG002|Overall Study|Lost to Follow-up|1|||
163281217|NCT03251378|589737558|FG003|Overall Study|Lost to Follow-up|3|||
163281218|NCT03251378|589737559|FG004|Overall Study|Lost to Follow-up|0|||
163281219|NCT03251378|589737560|FG005|Overall Study|Lost to Follow-up|0|||
163281220|NCT03251378|589737561|FG006|Overall Study|Lost to Follow-up|0|||
163281221|NCT03251378|589737555|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
163281222|NCT03251378|589737556|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
163281223|NCT03251378|589737557|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
163281224|NCT03251378|589737558|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
163281225|NCT03251378|589737559|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
163281226|NCT03251378|589737560|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
163281227|NCT03251378|589737561|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
163281228|NCT03251378|589737555|FG000|Overall Study|Progressive disease|2|||
163281229|NCT03251378|589737556|FG001|Overall Study|Progressive disease|0|||
163281230|NCT03251378|589737557|FG002|Overall Study|Progressive disease|0|||
163281231|NCT03251378|589737558|FG003|Overall Study|Progressive disease|1|||
163281232|NCT03251378|589737559|FG004|Overall Study|Progressive disease|0|||
163281233|NCT03251378|589737560|FG005|Overall Study|Progressive disease|0|||
163281234|NCT03251378|589737561|FG006|Overall Study|Progressive disease|0|||
163281235|NCT03251378|589737555|FG000|Overall Study|Physician Decision|0|||
163281236|NCT03251378|589737556|FG001|Overall Study|Physician Decision|2|||
163281237|NCT03251378|589737557|FG002|Overall Study|Physician Decision|0|||
163281238|NCT03251378|589737558|FG003|Overall Study|Physician Decision|0|||
163281239|NCT03251378|589737559|FG004|Overall Study|Physician Decision|0|||
163281240|NCT03251378|589737560|FG005|Overall Study|Physician Decision|0|||
163281241|NCT03251378|589737561|FG006|Overall Study|Physician Decision|0|||
163281242|NCT03251378|589737555|FG000|Overall Study|Other|2|||
163281243|NCT03251378|589737556|FG001|Overall Study|Other|3|||
163281244|NCT03251378|589737557|FG002|Overall Study|Other|2|||
163281245|NCT03251378|589737558|FG003|Overall Study|Other|0|||
163281246|NCT03251378|589737559|FG004|Overall Study|Other|1|||
163281247|NCT03251378|589737560|FG005|Overall Study|Other|1|||
163281248|NCT03251378|589737561|FG006|Overall Study|Other|1|||
163281249|NCT03251378|589737555|FG000|Overall Study|Other|0|||
163281250|NCT03251378|589737556|FG001|Overall Study|Other|0|||
163281251|NCT03251378|589737557|FG002|Overall Study|Other|0|||
163281252|NCT03251378|589737558|FG003|Overall Study|Other|4|||
163281253|NCT03251378|589737559|FG004|Overall Study|Other|13|||
163281254|NCT03251378|589737560|FG005|Overall Study|Other|0|||
163281255|NCT03251378|589737561|FG006|Overall Study|Other|0|||
163281256|NCT02322775|589737562|FG000|Overall Study|Adverse Event|1|||
163281257|NCT02322775|589737563|FG001|Overall Study|Adverse Event|0|||
163281258|NCT02322775|589737562|FG000|Overall Study|Lost to Follow-up|0|||
163281259|NCT02322775|589737563|FG001|Overall Study|Lost to Follow-up|1|||
163281260|NCT02322775|589737562|FG000|Overall Study|Protocol Violation|1|||
163281261|NCT02322775|589737563|FG001|Overall Study|Protocol Violation|0|||
163281262|NCT02322775|589737562|FG000|Overall Study|Withdrawal by Subject|3|||
163281263|NCT02322775|589737563|FG001|Overall Study|Withdrawal by Subject|4|||
163281264|NCT02322775|589737562|FG000|Overall Study|Not willing to perform all FU visits|0|||
163281265|NCT02322775|589737563|FG001|Overall Study|Not willing to perform all FU visits|1|||
163281266|NCT05780047|589737564|FG000|Overall Study|Did not submit baseline urine test kit|226|||
163281267|NCT05780047|589737564|FG000|Overall Study|Lost to Follow-up|34|||
163281268|NCT05780047|589737564|FG000|Overall Study|Did not submit second urine test kit|124|||
163281269|NCT00764868|589737570|FG000|Overall Study|Adverse Event|18|||
163281270|NCT00764868|589737570|FG000|Overall Study|Withdrawal by Subject|31|||
163281271|NCT00764868|589737570|FG000|Overall Study|Non-compliance|16|||
163281272|NCT00764868|589737570|FG000|Overall Study|Lost to Follow-up|25|||
163281273|NCT00764868|589737570|FG000|Overall Study|Lack of Efficacy|5|||
163281274|NCT00764868|589737570|FG000|Overall Study|Subject moved|7|||
163281275|NCT00764868|589737570|FG000|Overall Study|Pregnancy|3|||
163281276|NCT00764868|589737570|FG000|Overall Study|Prohibited medication|1|||
163281277|NCT00764868|589737570|FG000|Overall Study|Out of town|1|||
163281278|NCT00764868|589737570|FG000|Overall Study|Misuse and compliance of study drug|1|||
163281279|NCT00764868|589737570|FG000|Overall Study|Subject sent to boarding school|1|||
163281280|NCT00764868|589737570|FG000|Overall Study|Met an exclusion criteria|1|||
163281281|NCT00764868|589737570|FG000|Overall Study|Positive drug screen|2|||
163281282|NCT00764868|589737570|FG000|Overall Study|Sponsor requested withdrawal|1|||
163281283|NCT02698436|589737571|FG000|Overall Study|Adverse Event|1|||
163281284|NCT02698436|589737572|FG001|Overall Study|Adverse Event|0|||
163281285|NCT02698436|589737571|FG000|Overall Study|Withdrawal by Subject|3|||
163281286|NCT02698436|589737572|FG001|Overall Study|Withdrawal by Subject|3|||
163281287|NCT02698436|589737571|FG000|Overall Study|Lost to Follow-up|2|||
163281288|NCT02698436|589737572|FG001|Overall Study|Lost to Follow-up|4|||
163281289|NCT02698436|589737571|FG000|Overall Study|Non-compliance with study regimen|1|||
163281290|NCT02698436|589737572|FG001|Overall Study|Non-compliance with study regimen|0|||
163281291|NCT00665561|589737573|FG000|Overall Study|Death recorded on subject summary pages|75|||
163281292|NCT00665561|589737574|FG001|Overall Study|Death recorded on subject summary pages|75|||
163281293|NCT00665561|589737573|FG000|Overall Study|Does not meet entrance criteria|19|||
163281294|NCT00665561|589737574|FG001|Overall Study|Does not meet entrance criteria|21|||
163281295|NCT00665561|589737573|FG000|Overall Study|Lost to Follow-up|203|||
163281296|NCT00665561|589737574|FG001|Overall Study|Lost to Follow-up|264|||
163281297|NCT00665561|589737573|FG000|Overall Study|Withdrawal by Subject|74|||
163281298|NCT00665561|589737574|FG001|Overall Study|Withdrawal by Subject|65|||
163281299|NCT00665561|589737573|FG000|Overall Study|Other|123|||
163281300|NCT00665561|589737574|FG001|Overall Study|Other|108|||
163281301|NCT00665561|589737573|FG000|Overall Study|Site closed|8|||
163281302|NCT00665561|589737574|FG001|Overall Study|Site closed|0|||
163281303|NCT00665561|589737573|FG000|Overall Study|Withdrawn due to pregnancy|0|||
163281304|NCT00665561|589737574|FG001|Overall Study|Withdrawn due to pregnancy|1|||
163281305|NCT04949399|589737575|FG000|Overall Study|Lost to Follow-up|11|||
163281306|NCT04949399|589737576|FG001|Overall Study|Lost to Follow-up|6|||
163281307|NCT04949399|589737575|FG000|Overall Study|Withdrawal by Subject|2|||
163281308|NCT04949399|589737576|FG001|Overall Study|Withdrawal by Subject|3|||
163281309|NCT01515319|589737577|FG000|Overall Study|Withdrawal by Subject|0|||
163281310|NCT01515319|589737578|FG001|Overall Study|Withdrawal by Subject|0|||
163281311|NCT01515319|589737579|FG002|Overall Study|Withdrawal by Subject|0|||
163281312|NCT01515319|589737580|FG003|Overall Study|Withdrawal by Subject|0|||
163281313|NCT01515319|589737581|FG004|Overall Study|Withdrawal by Subject|0|||
163281314|NCT01515319|589737582|FG005|Overall Study|Withdrawal by Subject|0|||
163281315|NCT01515319|589737583|FG006|Overall Study|Withdrawal by Subject|1|||
163281316|NCT01515319|589737584|FG007|Overall Study|Withdrawal by Subject|0|||
163281317|NCT01515319|589737585|FG008|Overall Study|Withdrawal by Subject|0|||
163281318|NCT01515319|589737586|FG009|Overall Study|Withdrawal by Subject|0|||
163281319|NCT01515319|589737577|FG000|Overall Study|Adverse Event|0|||
163281320|NCT01515319|589737578|FG001|Overall Study|Adverse Event|0|||
163281321|NCT01515319|589737579|FG002|Overall Study|Adverse Event|0|||
163281322|NCT01515319|589737580|FG003|Overall Study|Adverse Event|0|||
163281323|NCT01515319|589737581|FG004|Overall Study|Adverse Event|0|||
163281324|NCT01515319|589737582|FG005|Overall Study|Adverse Event|0|||
163281325|NCT01515319|589737583|FG006|Overall Study|Adverse Event|0|||
163281326|NCT01515319|589737584|FG007|Overall Study|Adverse Event|0|||
163281327|NCT01515319|589737585|FG008|Overall Study|Adverse Event|3|||
163281328|NCT01515319|589737586|FG009|Overall Study|Adverse Event|0|||
163281329|NCT01515319|589737577|FG000|Overall Study|Protocol Violation|0|||
163281330|NCT01515319|589737578|FG001|Overall Study|Protocol Violation|0|||
163281331|NCT01515319|589737579|FG002|Overall Study|Protocol Violation|0|||
163281332|NCT01515319|589737580|FG003|Overall Study|Protocol Violation|0|||
163281333|NCT01515319|589737581|FG004|Overall Study|Protocol Violation|0|||
163281334|NCT01515319|589737582|FG005|Overall Study|Protocol Violation|0|||
163281335|NCT01515319|589737583|FG006|Overall Study|Protocol Violation|0|||
163281336|NCT01515319|589737584|FG007|Overall Study|Protocol Violation|0|||
163281337|NCT01515319|589737585|FG008|Overall Study|Protocol Violation|2|||
163281338|NCT01515319|589737586|FG009|Overall Study|Protocol Violation|0|||
163281339|NCT01354106|589737587|FG000|Overall Study|Withdrawal by Subject|2|||
163281340|NCT01871285|589737588|FG000|First Intervention (1 Day)|Adverse Event|1|||
163281341|NCT01871285|589737589|FG001|First Intervention (1 Day)|Adverse Event|0|||
163281342|NCT01871285|589737590|FG002|First Intervention (1 Day)|Adverse Event|0|||
163281343|NCT01871285|589737591|FG003|First Intervention (1 Day)|Adverse Event|0|||
163281344|NCT01871285|589737588|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
163281345|NCT01871285|589737589|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
163281346|NCT01871285|589737590|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
163281347|NCT01871285|589737591|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
163281348|NCT05397470|589737592|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
163281349|NCT05397470|589737593|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
163281350|NCT05397470|589737594|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
163281351|NCT05397470|589737592|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
163281352|NCT05397470|589737593|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
163281353|NCT05397470|589737594|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
163281354|NCT05397470|589737592|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
163281355|NCT05397470|589737593|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
163281356|NCT05397470|589737594|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
163281357|NCT05397470|589737592|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
163281358|NCT05397470|589737593|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
163281359|NCT05397470|589737594|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
163281360|NCT05397470|589737592|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
163281361|NCT05397470|589737593|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
163281362|NCT05397470|589737594|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
163281363|NCT05397470|589737592|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
163281364|NCT05397470|589737593|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
163281365|NCT05397470|589737594|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
163281366|NCT05397470|589737592|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
163281367|NCT05397470|589737593|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
163281368|NCT05397470|589737594|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
163281369|NCT01919619|589737595|FG000|Overall Study|Physician Decision|1|||
163281370|NCT01919619|589737596|FG001|Overall Study|Physician Decision|1|||
163281371|NCT02738840|589739399|FG000|Overall Study|MRI Scan not Performed|5|||
163281372|NCT02738840|589739399|FG000|Overall Study|Lost to Follow-up|1|||
163281373|NCT02738840|589739399|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
163281374|NCT02738840|589739399|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
163281375|NCT02268396|589739402|FG000|Overall Study|Adverse Event|3|||
163281376|NCT02268396|589739402|FG000|Overall Study|Administrative|2|||
163281377|NCT02268396|589739402|FG000|Overall Study|Withdrawal by Subject|1|||
163281378|NCT02268396|589739402|FG000|Overall Study|Lost to Follow-up|2|||
163281379|NCT02268396|589739402|FG000|Overall Study|Protocol-Specified Criteria|2|||
163281380|NCT02268396|589739402|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
163281381|NCT01311648|589739403|FG000|Main Study|Protocol Violation|0|||
163281382|NCT01311648|589739404|FG001|Main Study|Protocol Violation|1|||
163281383|NCT01311648|589739403|FG000|Main Study|Adverse Event|0|||
163281384|NCT01311648|589739404|FG001|Main Study|Adverse Event|1|||
163281385|NCT01311648|589739403|FG000|Main Study|Inhibitor management|0|||
163281386|NCT01311648|589739404|FG001|Main Study|Inhibitor management|17|||
163281387|NCT01311648|589739403|FG000|Main Study|Withdrawal by Subject|0|||
163281388|NCT01311648|589739404|FG001|Main Study|Withdrawal by Subject|2|||
163281389|NCT01311648|589739403|FG000|Extension Study|Physician Decision|0|||
163281390|NCT01311648|589739404|FG001|Extension Study|Physician Decision|1|||
162932484|NCT00830063|588458500|FG000|Overall Study|Lack of Efficacy|51|||
162932485|NCT00830063|588458501|FG001|Overall Study|Lack of Efficacy|23|||
162932486|NCT00830063|588458502|FG002|Overall Study|Lack of Efficacy|25|||
163281391|NCT01311648|589739403|FG000|Extension Study|ITI therapy with marketed product|0|||
163281392|NCT01311648|589739404|FG001|Extension Study|ITI therapy with marketed product|1|||
163281393|NCT01311648|589739403|FG000|Extension Study|Incorrect visit planning|0|||
163281394|NCT01311648|589739404|FG001|Extension Study|Incorrect visit planning|1|||
163281395|NCT01311648|589739403|FG000|Extension Study|Family's decision|0|||
163281396|NCT01311648|589739404|FG001|Extension Study|Family's decision|1|||
163281397|NCT01311648|589739403|FG000|Extension Study|Failure of ITI therapy|0|||
163281398|NCT01311648|589739404|FG001|Extension Study|Failure of ITI therapy|3|||
163281399|NCT01311648|589739403|FG000|Extension Study|Long travel|0|||
163281400|NCT01311648|589739404|FG001|Extension Study|Long travel|1|||
163281401|NCT01311648|589739403|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
163281402|NCT01311648|589739404|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
163281403|NCT01311648|589739403|FG000|Extension Study|Withdrawal by Subject|0|||
163281404|NCT01311648|589739404|FG001|Extension Study|Withdrawal by Subject|1|||
163281405|NCT01311648|589739403|FG000|Extension Study|Inhibitor management|0|||
163281406|NCT01311648|589739404|FG001|Extension Study|Inhibitor management|2|||
163281407|NCT01645111|589739405|FG000|Overall Study|Did not require Clevidipine|15|||
163281408|NCT01304706|589739411|FG000|Overall Study|Adverse Event|2|||
163281409|NCT01304706|589739411|FG000|Overall Study|Lack of Efficacy|1|||
163281410|NCT01304706|589739411|FG000|Overall Study|Death|3|||
163281411|NCT01304706|589739411|FG000|Overall Study|Withdrawal by Subject|3|||
163281412|NCT01304706|589739411|FG000|Overall Study|Lost to Follow-up|7|||
163281413|NCT01304706|589739411|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
163281414|NCT05526911|589739414|FG000|Overall Study|Adverse Event|2|||
163281415|NCT05025449|589739415|FG000|Overall Study|Withdrawal by Subject|1|||
163281416|NCT05025449|589739415|FG000|Overall Study|Patient emergently taken to operating room|1|||
163281417|NCT01257503|589739419|FG000|Overall Study|Lost to Follow-up|7|||
163281418|NCT01257503|589739420|FG001|Overall Study|Lost to Follow-up|10|||
163281419|NCT01257503|589739419|FG000|Overall Study|Over 5 years old at enrollment|0|||
163281420|NCT01257503|589739420|FG001|Overall Study|Over 5 years old at enrollment|1|||
163281421|NCT01257503|589739419|FG000|Overall Study|strep culture positive at enrollment|1|||
163281422|NCT01257503|589739420|FG001|Overall Study|strep culture positive at enrollment|0|||
163281423|NCT02333630|589739421|FG000|Overall Study|Lost to Follow-up|5|||
163281424|NCT02333630|589739422|FG001|Overall Study|Lost to Follow-up|2|||
163281425|NCT00315055|589739423|FG000|Overall Study|Protocol Violation|2|||
163281426|NCT00315055|589739424|FG001|Overall Study|Protocol Violation|4|||
163281427|NCT00315055|589739423|FG000|Overall Study|Lost to Follow-up|1|||
163281428|NCT00315055|589739424|FG001|Overall Study|Lost to Follow-up|1|||
163281429|NCT02359435|589739425|FG000|Overall Study|Lost to Follow-up|4|||
163281430|NCT02359435|589739426|FG001|Overall Study|Lost to Follow-up|4|||
163281431|NCT02347943|589739427|FG000|Overall Study|Study was cancelled|140|||
163281432|NCT02347943|589739428|FG001|Overall Study|Study was cancelled|67|||
163281433|NCT02347943|589739429|FG002|Overall Study|Study was cancelled|45|||
163281434|NCT00711646|589739435|FG000|Overall Study|Adverse Event|6|||
163281435|NCT00711646|589739436|FG001|Overall Study|Adverse Event|1|||
163281436|NCT00711646|589739435|FG000|Overall Study|Withdrawal by Subject|4|||
163281437|NCT00711646|589739436|FG001|Overall Study|Withdrawal by Subject|0|||
163281438|NCT00711646|589739435|FG000|Overall Study|Protocol Violation|0|||
163281439|NCT00711646|589739436|FG001|Overall Study|Protocol Violation|1|||
163281440|NCT00711646|589739435|FG000|Overall Study|Lost to Follow-up|1|||
163281441|NCT00711646|589739436|FG001|Overall Study|Lost to Follow-up|0|||
163281442|NCT00711646|589739435|FG000|Overall Study|administrative decision|0|||
163281443|NCT00711646|589739436|FG001|Overall Study|administrative decision|1|||
163281444|NCT00711646|589739435|FG000|Overall Study|patient non-compliance|1|||
163281445|NCT00711646|589739436|FG001|Overall Study|patient non-compliance|0|||
163281446|NCT03441360|589739437|FG000|Overall Study|Radiological disease progression|5|||
163281447|NCT03441360|589739438|FG001|Overall Study|Radiological disease progression|6|||
163281448|NCT03441360|589739439|FG002|Overall Study|Radiological disease progression|4|||
163281449|NCT03441360|589739437|FG000|Overall Study|Clinical disease progression|2|||
163281450|NCT03441360|589739438|FG001|Overall Study|Clinical disease progression|2|||
163281451|NCT03441360|589739439|FG002|Overall Study|Clinical disease progression|0|||
163281452|NCT03441360|589739437|FG000|Overall Study|Adverse Event|1|||
163281453|NCT03441360|589739438|FG001|Overall Study|Adverse Event|0|||
163281454|NCT03441360|589739439|FG002|Overall Study|Adverse Event|1|||
163281455|NCT01360840|589739440|FG000|Overall Study|Ongoing at data cut-off|10|||
163281456|NCT01360840|589739441|FG001|Overall Study|Ongoing at data cut-off|10|||
163281457|NCT01360840|589739442|FG002|Overall Study|Ongoing at data cut-off|9|||
163281458|NCT00688688|589739443|FG000|Overall Study|Eligibility criterion not met|7|||
163281459|NCT00688688|589739444|FG001|Overall Study|Eligibility criterion not met|7|||
163281460|NCT00688688|589739445|FG002|Overall Study|Eligibility criterion not met|10|||
163281461|NCT00688688|589739443|FG000|Overall Study|Adverse Event|52|||
163281462|NCT00688688|589739444|FG001|Overall Study|Adverse Event|51|||
163281463|NCT00688688|589739445|FG002|Overall Study|Adverse Event|50|||
163281464|NCT00688688|589739443|FG000|Overall Study|Lack of Efficacy|34|||
163281465|NCT00688688|589739444|FG001|Overall Study|Lack of Efficacy|25|||
163281466|NCT00688688|589739445|FG002|Overall Study|Lack of Efficacy|45|||
163281467|NCT00688688|589739443|FG000|Overall Study|Withdrawal by Subject|66|||
163281468|NCT00688688|589739444|FG001|Overall Study|Withdrawal by Subject|75|||
163281469|NCT00688688|589739445|FG002|Overall Study|Withdrawal by Subject|65|||
163281470|NCT00688688|589739443|FG000|Overall Study|Lost to Follow-up|14|||
163281471|NCT00688688|589739444|FG001|Overall Study|Lost to Follow-up|7|||
163281472|NCT00688688|589739445|FG002|Overall Study|Lost to Follow-up|7|||
163281473|NCT00688688|589739443|FG000|Overall Study|Protocol Violation|6|||
163281474|NCT00688688|589739444|FG001|Overall Study|Protocol Violation|9|||
163281475|NCT00688688|589739445|FG002|Overall Study|Protocol Violation|11|||
163281476|NCT00688688|589739443|FG000|Overall Study|Randomized but never received study drug|1|||
162932487|NCT00830063|588458503|FG003|Overall Study|Lack of Efficacy|32|||
162932488|NCT00830063|588458500|FG000|Overall Study|Other|5|||
162932489|NCT00830063|588458501|FG001|Overall Study|Other|5|||
162932490|NCT00830063|588458502|FG002|Overall Study|Other|8|||
162932491|NCT00830063|588458503|FG003|Overall Study|Other|6|||
162932492|NCT00830063|588458500|FG000|Overall Study|Withdrawal by Subject|16|||
162932493|NCT00830063|588458501|FG001|Overall Study|Withdrawal by Subject|10|||
162932494|NCT00830063|588458502|FG002|Overall Study|Withdrawal by Subject|16|||
162932495|NCT00830063|588458503|FG003|Overall Study|Withdrawal by Subject|13|||
162932496|NCT00830063|588458500|FG000|Overall Study|Protocol Violation|1|||
162932497|NCT00830063|588458501|FG001|Overall Study|Protocol Violation|0|||
162932498|NCT00830063|588458502|FG002|Overall Study|Protocol Violation|3|||
162932499|NCT00830063|588458503|FG003|Overall Study|Protocol Violation|2|||
162932500|NCT00830063|588458500|FG000|Overall Study|Randomized But Not Treated|0|||
162932501|NCT00830063|588458501|FG001|Overall Study|Randomized But Not Treated|2|||
162932502|NCT00830063|588458502|FG002|Overall Study|Randomized But Not Treated|0|||
162932503|NCT00830063|588458503|FG003|Overall Study|Randomized But Not Treated|2|||
162932504|NCT01847313|588458504|FG000|Overall Study|Death|0|||
162932505|NCT01847313|588458505|FG001|Overall Study|Death|1|||
162932506|NCT01847313|588458504|FG000|Overall Study|Withdrawal by Subject|0|||
162932507|NCT01847313|588458505|FG001|Overall Study|Withdrawal by Subject|1|||
162932508|NCT00598559|588458506|FG000|Overall Study|Adverse Event|11|||
162932509|NCT00598559|588458507|FG001|Overall Study|Adverse Event|7|||
162932510|NCT00598559|588458508|FG002|Overall Study|Adverse Event|0|||
162932511|NCT00598559|588458506|FG000|Overall Study|Withdrawal by Subject|2|||
162932512|NCT00598559|588458507|FG001|Overall Study|Withdrawal by Subject|2|||
162932513|NCT00598559|588458508|FG002|Overall Study|Withdrawal by Subject|0|||
162932514|NCT00598559|588458506|FG000|Overall Study|Protocol Non-compliance|1|||
162932515|NCT00598559|588458507|FG001|Overall Study|Protocol Non-compliance|0|||
162932516|NCT00598559|588458508|FG002|Overall Study|Protocol Non-compliance|0|||
162932517|NCT00598559|588458506|FG000|Overall Study|Early discharge from hospital|9|||
162932518|NCT00598559|588458507|FG001|Overall Study|Early discharge from hospital|12|||
162932519|NCT00598559|588458508|FG002|Overall Study|Early discharge from hospital|3|||
162932520|NCT00598559|588458506|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
162932521|NCT00598559|588458507|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
162932522|NCT00598559|588458508|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
162932523|NCT03763331|588458513|FG000|Overall Study|Lost to Follow-up|1|||
162932524|NCT03763331|588458514|FG001|Overall Study|Lost to Follow-up|0|||
162932525|NCT03763331|588458513|FG000|Overall Study|Withdrawal by Subject|1|||
162932526|NCT03763331|588458514|FG001|Overall Study|Withdrawal by Subject|0|||
162932527|NCT03763331|588458513|FG000|Overall Study|Non-compliance|0|||
162932528|NCT03763331|588458514|FG001|Overall Study|Non-compliance|3|||
162932529|NCT01155063|588458515|FG000|Overall Study|Adverse Event|1|||
162932530|NCT01155063|588458515|FG000|Overall Study|Withdrawal by Subject|1|||
162932531|NCT01155063|588458515|FG000|Overall Study|Study terminated by sponsor|87|||
162932532|NCT00936884|588458516|FG000|Double-blind|Withdrawal by Subject|6|||
162932533|NCT00936884|588458517|FG001|Double-blind|Withdrawal by Subject|4|||
162932534|NCT00936884|588458518|FG002|Double-blind|Withdrawal by Subject|0|||
162932535|NCT00936884|588458516|FG000|Double-blind|Death|2|||
162932536|NCT00936884|588458517|FG001|Double-blind|Death|1|||
162932537|NCT00936884|588458518|FG002|Double-blind|Death|0|||
163281477|NCT00688688|589739444|FG001|Overall Study|Randomized but never received study drug|0|||
163281478|NCT00688688|589739445|FG002|Overall Study|Randomized but never received study drug|0|||
163281479|NCT00688688|589739443|FG000|Overall Study|Non-compliance with study procedures|5|||
162932538|NCT00936884|588458516|FG000|Double-blind|Lack of Efficacy|1|||
162932539|NCT00936884|588458517|FG001|Double-blind|Lack of Efficacy|1|||
162932540|NCT00936884|588458518|FG002|Double-blind|Lack of Efficacy|0|||
162932541|NCT00936884|588458516|FG000|Double-blind|Adverse Event|1|||
162932542|NCT00936884|588458517|FG001|Double-blind|Adverse Event|0|||
162932543|NCT00936884|588458518|FG002|Double-blind|Adverse Event|0|||
162932544|NCT00936884|588458516|FG000|Double-blind|Physician Decision|1|||
162932545|NCT00936884|588458517|FG001|Double-blind|Physician Decision|0|||
162932546|NCT00936884|588458518|FG002|Double-blind|Physician Decision|0|||
162932547|NCT00936884|588458516|FG000|Double-blind|No post baseline diary entry|1|||
162932548|NCT00936884|588458517|FG001|Double-blind|No post baseline diary entry|0|||
162932549|NCT00936884|588458518|FG002|Double-blind|No post baseline diary entry|0|||
162932550|NCT00936884|588458516|FG000|Double-blind|Did not receive study drug|0|||
162932551|NCT00936884|588458517|FG001|Double-blind|Did not receive study drug|1|||
162932552|NCT00936884|588458518|FG002|Double-blind|Did not receive study drug|0|||
162932553|NCT01663714|588458519|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
162932554|NCT01663714|588458519|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
162932555|NCT01663714|588458519|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
162932556|NCT01663714|588458519|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
162932557|NCT01663714|588458519|FG000|Long-Term Follow-Up|Death|4|||
162932558|NCT01663714|588458519|FG000|Long-Term Follow-Up|Non-compliance|1|||
162932559|NCT00597584|588458520|FG000|Overall Study|Adverse Event|4|||
163175594|NCT01431638|589358823|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163175595|NCT01431638|589358824|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
163175596|NCT01431638|589358822|FG000|Overall Study|Participants condition no longer requires study drug|0|||
163175597|NCT01431638|589358823|FG001|Overall Study|Participants condition no longer requires study drug|1|||
163175598|NCT01431638|589358824|FG002|Overall Study|Participants condition no longer requires study drug|0|||
163175599|NCT01431638|589358822|FG000|Overall Study|Participant withdrew consent|14|||
163175600|NCT01431638|589358823|FG001|Overall Study|Participant withdrew consent|5|||
163175601|NCT01431638|589358824|FG002|Overall Study|Participant withdrew consent|8|||
163175602|NCT01431638|589358822|FG000|Overall Study|Lost to Follow-up|7|||
163175603|NCT01431638|589358823|FG001|Overall Study|Lost to Follow-up|9|||
163175604|NCT01431638|589358824|FG002|Overall Study|Lost to Follow-up|7|||
163175605|NCT01431638|589358822|FG000|Overall Study|Administrative problems|1|||
163175606|NCT01431638|589358823|FG001|Overall Study|Administrative problems|4|||
163175607|NCT01431638|589358824|FG002|Overall Study|Administrative problems|6|||
163175608|NCT01431638|589358822|FG000|Overall Study|Death|1|||
163175609|NCT01431638|589358823|FG001|Overall Study|Death|0|||
163175610|NCT01431638|589358824|FG002|Overall Study|Death|0|||
163175611|NCT01431638|589358822|FG000|Overall Study|Protocol deviation|1|||
163175612|NCT01431638|589358823|FG001|Overall Study|Protocol deviation|1|||
163175613|NCT01431638|589358824|FG002|Overall Study|Protocol deviation|4|||
163175614|NCT01431638|589358822|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
163175615|NCT01431638|589358823|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
163175616|NCT01431638|589358824|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
163175617|NCT01381562|589358825|FG000|Overall Study|Adverse Event|0|||
163175618|NCT01381562|589358826|FG001|Overall Study|Adverse Event|1|||
163175619|NCT01381562|589358827|FG002|Overall Study|Adverse Event|0|||
163175620|NCT03400956|589358832|FG000|Treatment Period 1|Adverse Event|0|||
163175621|NCT03400956|589358833|FG001|Treatment Period 1|Adverse Event|1|||
163175622|NCT03400956|589358834|FG002|Treatment Period 1|Adverse Event|0|||
163175623|NCT03400956|589358832|FG000|Treatment Period 1|Lost to Follow-up|0|||
163175624|NCT03400956|589358833|FG001|Treatment Period 1|Lost to Follow-up|0|||
163175625|NCT03400956|589358834|FG002|Treatment Period 1|Lost to Follow-up|1|||
163175626|NCT03400956|589358832|FG000|Treatment Period 1|Protocol Violation|0|||
163175627|NCT03400956|589358833|FG001|Treatment Period 1|Protocol Violation|2|||
163175628|NCT03400956|589358834|FG002|Treatment Period 1|Protocol Violation|0|||
163175629|NCT03400956|589358832|FG000|Treatment Period 1|Study terminated by sponsor|3|||
163175630|NCT03400956|589358833|FG001|Treatment Period 1|Study terminated by sponsor|1|||
163175631|NCT03400956|589358834|FG002|Treatment Period 1|Study terminated by sponsor|1|||
163175632|NCT03400956|589358832|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163175633|NCT03400956|589358833|FG001|Treatment Period 1|Withdrawal by Subject|2|||
163175634|NCT03400956|589358834|FG002|Treatment Period 1|Withdrawal by Subject|4|||
163175635|NCT03400956|589358832|FG000|Treatment Period 1|Other|1|||
163175636|NCT03400956|589358833|FG001|Treatment Period 1|Other|2|||
163175637|NCT03400956|589358834|FG002|Treatment Period 1|Other|3|||
163175638|NCT03400956|589358832|FG000|Post-treatment Period 1|Adverse Event|0|||
163175639|NCT03400956|589358833|FG001|Post-treatment Period 1|Adverse Event|0|||
163175640|NCT03400956|589358834|FG002|Post-treatment Period 1|Adverse Event|1|||
163175641|NCT03400956|589358832|FG000|Post-treatment Period 1|Physician Decision|2|||
163175642|NCT03400956|589358833|FG001|Post-treatment Period 1|Physician Decision|3|||
163175643|NCT03400956|589358834|FG002|Post-treatment Period 1|Physician Decision|0|||
163175644|NCT03400956|589358832|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
163175645|NCT03400956|589358833|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
163175646|NCT03400956|589358834|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
163175647|NCT03400956|589358832|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
163175648|NCT03400956|589358833|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
163175649|NCT03400956|589358834|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
163175650|NCT03400956|589358832|FG000|Post-treatment Period 1|Other|4|||
163175651|NCT03400956|589358833|FG001|Post-treatment Period 1|Other|3|||
163175652|NCT03400956|589358834|FG002|Post-treatment Period 1|Other|4|||
163175653|NCT03400956|589358832|FG000|Treatment Period 2|Adverse Event|2|||
163175654|NCT03400956|589358833|FG001|Treatment Period 2|Adverse Event|1|||
163175655|NCT03400956|589358834|FG002|Treatment Period 2|Adverse Event|1|||
163281480|NCT00688688|589739444|FG001|Overall Study|Non-compliance with study procedures|3|||
162932560|NCT00597584|588458521|FG001|Overall Study|Adverse Event|2|||
163175656|NCT03400956|589358832|FG000|Treatment Period 2|Lost to Follow-up|1|||
163175657|NCT03400956|589358833|FG001|Treatment Period 2|Lost to Follow-up|1|||
163175658|NCT03400956|589358834|FG002|Treatment Period 2|Lost to Follow-up|0|||
163175659|NCT03400956|589358832|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163175660|NCT03400956|589358833|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163175661|NCT03400956|589358834|FG002|Treatment Period 2|Withdrawal by Subject|3|||
163175662|NCT03400956|589358832|FG000|Treatment Period 2|Other|1|||
163175663|NCT03400956|589358833|FG001|Treatment Period 2|Other|1|||
163175664|NCT03400956|589358834|FG002|Treatment Period 2|Other|0|||
163175665|NCT03400956|589358832|FG000|Follow-up Period|Withdrawal by Subject|0|||
163175666|NCT03400956|589358833|FG001|Follow-up Period|Withdrawal by Subject|0|||
163175667|NCT03400956|589358834|FG002|Follow-up Period|Withdrawal by Subject|1|||
163175668|NCT03400956|589358832|FG000|Follow-up Period|Other|0|||
163175669|NCT03400956|589358833|FG001|Follow-up Period|Other|0|||
163175670|NCT03400956|589358834|FG002|Follow-up Period|Other|1|||
163175671|NCT00492063|589358835|FG000|Overall Study|Death|0|||
163175672|NCT00492063|589358836|FG001|Overall Study|Death|0|||
163175673|NCT00492063|589358837|FG002|Overall Study|Death|1|||
163175674|NCT00492063|589358838|FG003|Overall Study|Death|2|||
163175675|NCT00492063|589358835|FG000|Overall Study|Withdrawal by Subject|4|||
163175676|NCT00492063|589358836|FG001|Overall Study|Withdrawal by Subject|3|||
163175677|NCT00492063|589358837|FG002|Overall Study|Withdrawal by Subject|5|||
163175678|NCT00492063|589358838|FG003|Overall Study|Withdrawal by Subject|4|||
163175679|NCT00492063|589358835|FG000|Overall Study|Lost to Follow-up|6|||
163175680|NCT00492063|589358836|FG001|Overall Study|Lost to Follow-up|11|||
163175681|NCT00492063|589358837|FG002|Overall Study|Lost to Follow-up|5|||
163175682|NCT00492063|589358838|FG003|Overall Study|Lost to Follow-up|3|||
163175683|NCT00492063|589358835|FG000|Overall Study|Protocol Violation|0|||
163175684|NCT00492063|589358836|FG001|Overall Study|Protocol Violation|0|||
163175685|NCT00492063|589358837|FG002|Overall Study|Protocol Violation|0|||
163175686|NCT00492063|589358838|FG003|Overall Study|Protocol Violation|1|||
163175687|NCT01947855|589358844|FG000|Overall Study|Withdrawal by Subject|1|||
163175688|NCT01947855|589358845|FG001|Overall Study|Withdrawal by Subject|0|||
163175689|NCT01947855|589358846|FG002|Overall Study|Withdrawal by Subject|0|||
163175690|NCT00710762|589358847|FG000|Overall Study|Progressive disease|27|||
163175691|NCT00710762|589358848|FG001|Overall Study|Progressive disease|30|||
163175692|NCT00710762|589358847|FG000|Overall Study|Adverse Event other disease worsening|2|||
163175693|NCT00710762|589358848|FG001|Overall Study|Adverse Event other disease worsening|1|||
163175694|NCT00710762|589358847|FG000|Overall Study|Other Adverse Event|7|||
163175695|NCT00710762|589358848|FG001|Overall Study|Other Adverse Event|7|||
163175696|NCT00710762|589358847|FG000|Overall Study|Lost to Follow-up|1|||
163175697|NCT00710762|589358848|FG001|Overall Study|Lost to Follow-up|0|||
163175698|NCT00710762|589358847|FG000|Overall Study|Reason other than listed above|2|||
163175699|NCT00710762|589358848|FG001|Overall Study|Reason other than listed above|2|||
163175700|NCT01700439|589358852|FG000|Overall Study|Lost to Follow-up|47|||
163175701|NCT01700439|589358852|FG000|Overall Study|Withdrawal by Subject|183|||
163175702|NCT01700439|589358852|FG000|Overall Study|Death|186|||
163175703|NCT00592774|589358853|FG000|Overall Study|Adverse Event|5|||
163175704|NCT00592774|589358854|FG001|Overall Study|Adverse Event|19|||
163175705|NCT00592774|589358855|FG002|Overall Study|Adverse Event|2|||
163175706|NCT00592774|589358856|FG003|Overall Study|Adverse Event|14|||
163175707|NCT00592774|589358857|FG004|Overall Study|Adverse Event|8|||
163175708|NCT00592774|589358853|FG000|Overall Study|Protocol Violation|0|||
163175709|NCT00592774|589358854|FG001|Overall Study|Protocol Violation|1|||
163175710|NCT00592774|589358855|FG002|Overall Study|Protocol Violation|0|||
163175711|NCT00592774|589358856|FG003|Overall Study|Protocol Violation|0|||
163175712|NCT00592774|589358857|FG004|Overall Study|Protocol Violation|1|||
163175713|NCT00592774|589358853|FG000|Overall Study|Withdrawal by Subject|3|||
163175714|NCT00592774|589358854|FG001|Overall Study|Withdrawal by Subject|7|||
163175715|NCT00592774|589358855|FG002|Overall Study|Withdrawal by Subject|0|||
163175716|NCT00592774|589358856|FG003|Overall Study|Withdrawal by Subject|0|||
163175717|NCT00592774|589358857|FG004|Overall Study|Withdrawal by Subject|0|||
163175718|NCT00592774|589358853|FG000|Overall Study|Lack of Efficacy|3|||
163175719|NCT00592774|589358854|FG001|Overall Study|Lack of Efficacy|3|||
163175720|NCT00592774|589358855|FG002|Overall Study|Lack of Efficacy|0|||
163175721|NCT00592774|589358856|FG003|Overall Study|Lack of Efficacy|0|||
163042824|NCT01990768|588863968|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
163175722|NCT00592774|589358857|FG004|Overall Study|Lack of Efficacy|2|||
163175723|NCT00592774|589358853|FG000|Overall Study|Physician Decision|0|||
163175724|NCT00592774|589358854|FG001|Overall Study|Physician Decision|1|||
163175725|NCT00592774|589358855|FG002|Overall Study|Physician Decision|1|||
163175726|NCT00592774|589358856|FG003|Overall Study|Physician Decision|0|||
163175727|NCT00592774|589358857|FG004|Overall Study|Physician Decision|1|||
163175728|NCT00592774|589358853|FG000|Overall Study|Other|0|||
163175729|NCT00592774|589358854|FG001|Overall Study|Other|1|||
163175730|NCT00592774|589358855|FG002|Overall Study|Other|1|||
163281481|NCT00688688|589739445|FG002|Overall Study|Non-compliance with study procedures|4|||
163281482|NCT00688688|589739443|FG000|Overall Study|Taking exclusionary medications|1|||
163281483|NCT00688688|589739444|FG001|Overall Study|Taking exclusionary medications|0|||
163281484|NCT00688688|589739445|FG002|Overall Study|Taking exclusionary medications|0|||
163281485|NCT00688688|589739443|FG000|Overall Study|Site closure|0|||
163281486|NCT00688688|589739444|FG001|Overall Study|Site closure|1|||
163281487|NCT00688688|589739445|FG002|Overall Study|Site closure|0|||
163281488|NCT00688688|589739443|FG000|Overall Study|Violation of exclusion criterion|0|||
163281489|NCT00688688|589739444|FG001|Overall Study|Violation of exclusion criterion|1|||
163281490|NCT00688688|589739445|FG002|Overall Study|Violation of exclusion criterion|0|||
163281491|NCT01237678|589739448|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
163281492|NCT01237678|589739449|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
163281493|NCT01237678|589739450|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
163281494|NCT01237678|589739448|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
163281495|NCT01237678|589739449|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
163281496|NCT01237678|589739450|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
163281497|NCT01237678|589739448|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
163281498|NCT01237678|589739449|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
163281499|NCT01237678|589739450|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
163281500|NCT01237678|589739448|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
163281501|NCT01237678|589739449|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
163281502|NCT01237678|589739450|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
163281503|NCT01237678|589739448|FG000|Phase II|Adverse Event|0|||
163281504|NCT01237678|589739449|FG001|Phase II|Adverse Event|39|||
163281505|NCT01237678|589739450|FG002|Phase II|Adverse Event|9|||
163281506|NCT01237678|589739448|FG000|Phase II|Death|0|||
163281507|NCT01237678|589739449|FG001|Phase II|Death|0|||
163281508|NCT01237678|589739450|FG002|Phase II|Death|2|||
163281509|NCT01237678|589739448|FG000|Phase II|Lack of Efficacy|0|||
163281510|NCT01237678|589739449|FG001|Phase II|Lack of Efficacy|25|||
163281511|NCT01237678|589739450|FG002|Phase II|Lack of Efficacy|3|||
163281512|NCT01237678|589739448|FG000|Phase II|Withdrawal by Subject|0|||
163281513|NCT01237678|589739449|FG001|Phase II|Withdrawal by Subject|1|||
163281514|NCT01237678|589739450|FG002|Phase II|Withdrawal by Subject|5|||
163281515|NCT01237678|589739448|FG000|Phase II|Completed Cycles 4-6|0|||
163281516|NCT01237678|589739449|FG001|Phase II|Completed Cycles 4-6|11|||
163281517|NCT01237678|589739450|FG002|Phase II|Completed Cycles 4-6|21|||
163281518|NCT01237678|589739448|FG000|Phase II|Sponsor Decision/Study Closed|0|||
163281519|NCT01237678|589739449|FG001|Phase II|Sponsor Decision/Study Closed|18|||
163281520|NCT01237678|589739450|FG002|Phase II|Sponsor Decision/Study Closed|7|||
163281521|NCT01237678|589739448|FG000|Phase II|Randomized but were not treated|0|||
163281522|NCT01237678|589739449|FG001|Phase II|Randomized but were not treated|4|||
163281523|NCT01237678|589739450|FG002|Phase II|Randomized but were not treated|3|||
163281524|NCT01982760|589739453|FG000|Overall Study|Physician Decision|1|||
163281525|NCT01982760|589739454|FG001|Overall Study|Physician Decision|0|||
163281526|NCT00530777|589739455|FG000|Overall Study|Lost to Follow-up|0|||
163281527|NCT00530777|589739456|FG001|Overall Study|Lost to Follow-up|1|||
163281528|NCT00530777|589739455|FG000|Overall Study|Death|1|||
163281529|NCT00530777|589739456|FG001|Overall Study|Death|2|||
163281530|NCT00530777|589739455|FG000|Overall Study|Physician Decision|1|||
163281531|NCT00530777|589739456|FG001|Overall Study|Physician Decision|0|||
163281532|NCT00530777|589739455|FG000|Overall Study|Withdrawal by Subject|0|||
163281533|NCT00530777|589739456|FG001|Overall Study|Withdrawal by Subject|1|||
163281534|NCT00530777|589739455|FG000|Overall Study|Unable to adhere to visit schedule|5|||
163281535|NCT00530777|589739456|FG001|Overall Study|Unable to adhere to visit schedule|1|||
163281536|NCT02954055|589739458|FG000|Overall Study|Did not initiate therapy|6|||
163281537|NCT02954055|589739459|FG001|Overall Study|Did not initiate therapy|1|||
163281538|NCT00783692|589739464|FG000|Induction Phase|Adverse Event|7|||
163281539|NCT00783692|589739465|FG001|Induction Phase|Adverse Event|9|||
163281540|NCT00783692|589739466|FG002|Induction Phase|Adverse Event|24|||
163281541|NCT00783692|589739467|FG003|Induction Phase|Adverse Event|0|||
163281542|NCT00783692|589739468|FG004|Induction Phase|Adverse Event|0|||
163281543|NCT00783692|589739469|FG005|Induction Phase|Adverse Event|0|||
163281544|NCT00783692|589739470|FG006|Induction Phase|Adverse Event|0|||
163281545|NCT00783692|589739464|FG000|Induction Phase|Protocol Violation|0|||
163281546|NCT00783692|589739465|FG001|Induction Phase|Protocol Violation|0|||
163281547|NCT00783692|589739466|FG002|Induction Phase|Protocol Violation|1|||
163281548|NCT00783692|589739467|FG003|Induction Phase|Protocol Violation|0|||
162932561|NCT00597584|588458520|FG000|Overall Study|Death|53|||
163281549|NCT00783692|589739468|FG004|Induction Phase|Protocol Violation|0|||
163281550|NCT00783692|589739469|FG005|Induction Phase|Protocol Violation|0|||
163281551|NCT00783692|589739470|FG006|Induction Phase|Protocol Violation|0|||
163281552|NCT00783692|589739464|FG000|Induction Phase|Lack of Efficacy|1|||
163281553|NCT00783692|589739465|FG001|Induction Phase|Lack of Efficacy|3|||
163281554|NCT00783692|589739466|FG002|Induction Phase|Lack of Efficacy|28|||
162932562|NCT00597584|588458521|FG001|Overall Study|Death|30|||
163175731|NCT00592774|589358856|FG003|Overall Study|Other|0|||
163175732|NCT00592774|589358857|FG004|Overall Study|Other|2|||
163175733|NCT01892384|589358858|FG000|Overall Study|Withdrawal by Subject|1|||
163175734|NCT01892384|589358859|FG001|Overall Study|Withdrawal by Subject|1|||
163175735|NCT01892384|589358860|FG002|Overall Study|Withdrawal by Subject|0|||
163175736|NCT01892384|589358861|FG003|Overall Study|Withdrawal by Subject|0|||
163175737|NCT00621621|589358862|FG000|Overall Study|Subjects were exited at EP study|30|||
163175738|NCT00621621|589358863|FG001|Overall Study|Subjects were exited at EP study|0|||
163175739|NCT00053898|589358867|FG000|Overall Study|No follow-up data from any source|9|||
163175740|NCT00053898|589358868|FG001|Overall Study|No follow-up data from any source|12|||
163175741|NCT00053898|589358867|FG000|Overall Study|Follow-up from telephone contact only|5|||
163175742|NCT00053898|589358868|FG001|Overall Study|Follow-up from telephone contact only|1|||
163175743|NCT03985878|589358872|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
163175744|NCT03985878|589358872|FG000|Overall Study|Study Terminated by Sponsor|12|||
163175745|NCT03985878|589358872|FG000|Overall Study|Withdrawal by Subject|1|||
163175746|NCT02889562|589358873|FG000|Overall Study|Physician Decision|0|||
163175747|NCT02889562|589358874|FG001|Overall Study|Physician Decision|1|||
163175748|NCT02889562|589358873|FG000|Overall Study|Withdrawal by Subject|0|||
163175749|NCT02889562|589358874|FG001|Overall Study|Withdrawal by Subject|1|||
163175750|NCT04054947|589358878|FG000|Overall Study|Withdrawal by Subject|1|||
163175751|NCT04054947|589358879|FG001|Overall Study|Withdrawal by Subject|0|||
163175752|NCT04054947|589358878|FG000|Overall Study|Lost to Follow-up|2|||
163175753|NCT04054947|589358879|FG001|Overall Study|Lost to Follow-up|5|||
163175754|NCT01606878|589358880|FG000|Overall Study|Adverse Event|1|||
163175755|NCT01606878|589358881|FG001|Overall Study|Adverse Event|1|||
163175756|NCT01606878|589358882|FG002|Overall Study|Adverse Event|0|||
163175757|NCT01606878|589358883|FG003|Overall Study|Adverse Event|0|||
163175758|NCT01606878|589358884|FG004|Overall Study|Adverse Event|0|||
163175759|NCT01606878|589358885|FG005|Overall Study|Adverse Event|0|||
163175760|NCT01606878|589358886|FG006|Overall Study|Adverse Event|1|||
163175761|NCT01606878|589358887|FG007|Overall Study|Adverse Event|0|||
163175762|NCT01606878|589358888|FG008|Overall Study|Adverse Event|1|||
163175763|NCT01606878|589358889|FG009|Overall Study|Adverse Event|3|||
163175764|NCT01606878|589358890|FG010|Overall Study|Adverse Event|0|||
163175765|NCT01606878|589358880|FG000|Overall Study|Lack of Efficacy|1|||
163175766|NCT01606878|589358881|FG001|Overall Study|Lack of Efficacy|1|||
163175767|NCT01606878|589358882|FG002|Overall Study|Lack of Efficacy|1|||
163175768|NCT01606878|589358883|FG003|Overall Study|Lack of Efficacy|2|||
163175769|NCT01606878|589358884|FG004|Overall Study|Lack of Efficacy|1|||
163175770|NCT01606878|589358885|FG005|Overall Study|Lack of Efficacy|2|||
163175771|NCT01606878|589358886|FG006|Overall Study|Lack of Efficacy|1|||
163175772|NCT01606878|589358887|FG007|Overall Study|Lack of Efficacy|2|||
163175773|NCT01606878|589358888|FG008|Overall Study|Lack of Efficacy|2|||
163175774|NCT01606878|589358889|FG009|Overall Study|Lack of Efficacy|0|||
163175775|NCT01606878|589358890|FG010|Overall Study|Lack of Efficacy|1|||
163175776|NCT01606878|589358880|FG000|Overall Study|Physician Decision|1|||
163175777|NCT01606878|589358881|FG001|Overall Study|Physician Decision|0|||
163175778|NCT01606878|589358882|FG002|Overall Study|Physician Decision|2|||
163175779|NCT01606878|589358883|FG003|Overall Study|Physician Decision|1|||
163175780|NCT01606878|589358884|FG004|Overall Study|Physician Decision|1|||
163175781|NCT01606878|589358885|FG005|Overall Study|Physician Decision|1|||
163175782|NCT01606878|589358886|FG006|Overall Study|Physician Decision|2|||
163175783|NCT01606878|589358887|FG007|Overall Study|Physician Decision|0|||
163175784|NCT01606878|589358888|FG008|Overall Study|Physician Decision|1|||
163175785|NCT01606878|589358889|FG009|Overall Study|Physician Decision|0|||
163175786|NCT01606878|589358890|FG010|Overall Study|Physician Decision|0|||
163175787|NCT01606878|589358880|FG000|Overall Study|Withdrawal by Subject|3|||
163175788|NCT01606878|589358881|FG001|Overall Study|Withdrawal by Subject|2|||
163175789|NCT01606878|589358882|FG002|Overall Study|Withdrawal by Subject|2|||
163175790|NCT01606878|589358883|FG003|Overall Study|Withdrawal by Subject|0|||
163175791|NCT01606878|589358884|FG004|Overall Study|Withdrawal by Subject|1|||
163175792|NCT01606878|589358885|FG005|Overall Study|Withdrawal by Subject|1|||
163175793|NCT01606878|589358886|FG006|Overall Study|Withdrawal by Subject|2|||
163175794|NCT01606878|589358887|FG007|Overall Study|Withdrawal by Subject|1|||
163175795|NCT01606878|589358888|FG008|Overall Study|Withdrawal by Subject|2|||
163175796|NCT01606878|589358889|FG009|Overall Study|Withdrawal by Subject|0|||
163175797|NCT01606878|589358890|FG010|Overall Study|Withdrawal by Subject|2|||
163175798|NCT03720652|589358891|FG000|Overall Study|Withdrawal by Subject|2|||
163175799|NCT03720652|589358892|FG001|Overall Study|Withdrawal by Subject|7|||
163175800|NCT03720652|589358891|FG000|Overall Study|Lost to Follow-up|0|||
163175801|NCT03720652|589358892|FG001|Overall Study|Lost to Follow-up|4|||
163175802|NCT01155167|589358896|FG000|Overall Study|Insufficient ultrasound data|2|||
163175803|NCT01155167|589358897|FG001|Overall Study|Insufficient ultrasound data|0|||
163175804|NCT01155167|589358896|FG000|Overall Study|Access site changed to femoral artery|1|||
163175805|NCT01155167|589358897|FG001|Overall Study|Access site changed to femoral artery|0|||
163175806|NCT00167778|589358898|FG000|Overall Study|Withdrawal by Subject|1|||
163175807|NCT02654717|589358899|FG000|Overall Study|Adverse Event|2|||
163281555|NCT00783692|589739467|FG003|Induction Phase|Lack of Efficacy|0|||
163281556|NCT00783692|589739468|FG004|Induction Phase|Lack of Efficacy|0|||
163281557|NCT00783692|589739469|FG005|Induction Phase|Lack of Efficacy|0|||
163281558|NCT00783692|589739470|FG006|Induction Phase|Lack of Efficacy|0|||
163281559|NCT00783692|589739464|FG000|Induction Phase|Withdrawal by Subject|3|||
163281560|NCT00783692|589739465|FG001|Induction Phase|Withdrawal by Subject|9|||
163281561|NCT00783692|589739466|FG002|Induction Phase|Withdrawal by Subject|16|||
163281562|NCT00783692|589739467|FG003|Induction Phase|Withdrawal by Subject|0|||
163281563|NCT00783692|589739468|FG004|Induction Phase|Withdrawal by Subject|0|||
163281564|NCT00783692|589739469|FG005|Induction Phase|Withdrawal by Subject|0|||
163281565|NCT00783692|589739470|FG006|Induction Phase|Withdrawal by Subject|0|||
163281566|NCT00783692|589739464|FG000|Induction Phase|Lost to Follow-up|0|||
163281567|NCT00783692|589739465|FG001|Induction Phase|Lost to Follow-up|0|||
163281568|NCT00783692|589739466|FG002|Induction Phase|Lost to Follow-up|3|||
163281569|NCT00783692|589739467|FG003|Induction Phase|Lost to Follow-up|0|||
163281570|NCT00783692|589739468|FG004|Induction Phase|Lost to Follow-up|0|||
163281571|NCT00783692|589739469|FG005|Induction Phase|Lost to Follow-up|0|||
163281572|NCT00783692|589739470|FG006|Induction Phase|Lost to Follow-up|0|||
163281573|NCT00783692|589739464|FG000|Induction Phase|Other|0|||
163281574|NCT00783692|589739465|FG001|Induction Phase|Other|0|||
163281575|NCT00783692|589739466|FG002|Induction Phase|Other|2|||
163281576|NCT00783692|589739467|FG003|Induction Phase|Other|0|||
163281577|NCT00783692|589739468|FG004|Induction Phase|Other|0|||
163281578|NCT00783692|589739469|FG005|Induction Phase|Other|0|||
163281579|NCT00783692|589739470|FG006|Induction Phase|Other|0|||
163281580|NCT00783692|589739464|FG000|Maintenance Phase|Adverse Event|7|||
163281581|NCT00783692|589739465|FG001|Maintenance Phase|Adverse Event|0|||
163281582|NCT00783692|589739466|FG002|Maintenance Phase|Adverse Event|0|||
163281583|NCT00783692|589739467|FG003|Maintenance Phase|Adverse Event|15|||
163281584|NCT00783692|589739468|FG004|Maintenance Phase|Adverse Event|12|||
163281585|NCT00783692|589739469|FG005|Maintenance Phase|Adverse Event|9|||
163281586|NCT00783692|589739470|FG006|Maintenance Phase|Adverse Event|38|||
163281587|NCT00783692|589739464|FG000|Maintenance Phase|Protocol Violation|0|||
163281588|NCT00783692|589739465|FG001|Maintenance Phase|Protocol Violation|0|||
163281589|NCT00783692|589739466|FG002|Maintenance Phase|Protocol Violation|0|||
163281590|NCT00783692|589739467|FG003|Maintenance Phase|Protocol Violation|1|||
163281591|NCT00783692|589739468|FG004|Maintenance Phase|Protocol Violation|2|||
163281592|NCT00783692|589739469|FG005|Maintenance Phase|Protocol Violation|3|||
163281593|NCT00783692|589739470|FG006|Maintenance Phase|Protocol Violation|4|||
163281594|NCT00783692|589739464|FG000|Maintenance Phase|Lack of Efficacy|79|||
163281595|NCT00783692|589739465|FG001|Maintenance Phase|Lack of Efficacy|0|||
163281596|NCT00783692|589739466|FG002|Maintenance Phase|Lack of Efficacy|0|||
163281597|NCT00783692|589739467|FG003|Maintenance Phase|Lack of Efficacy|64|||
163281598|NCT00783692|589739468|FG004|Maintenance Phase|Lack of Efficacy|58|||
163281599|NCT00783692|589739469|FG005|Maintenance Phase|Lack of Efficacy|48|||
163281600|NCT00783692|589739470|FG006|Maintenance Phase|Lack of Efficacy|177|||
163281601|NCT00783692|589739464|FG000|Maintenance Phase|Withdrawal by Subject|7|||
163281602|NCT00783692|589739465|FG001|Maintenance Phase|Withdrawal by Subject|0|||
163281603|NCT00783692|589739466|FG002|Maintenance Phase|Withdrawal by Subject|0|||
163281604|NCT00783692|589739467|FG003|Maintenance Phase|Withdrawal by Subject|7|||
163281605|NCT00783692|589739468|FG004|Maintenance Phase|Withdrawal by Subject|6|||
163281606|NCT00783692|589739469|FG005|Maintenance Phase|Withdrawal by Subject|9|||
163281607|NCT00783692|589739470|FG006|Maintenance Phase|Withdrawal by Subject|24|||
163281608|NCT00783692|589739464|FG000|Maintenance Phase|Lost to Follow-up|2|||
163281609|NCT00783692|589739465|FG001|Maintenance Phase|Lost to Follow-up|0|||
163281610|NCT00783692|589739466|FG002|Maintenance Phase|Lost to Follow-up|0|||
163281611|NCT00783692|589739467|FG003|Maintenance Phase|Lost to Follow-up|1|||
163281612|NCT00783692|589739468|FG004|Maintenance Phase|Lost to Follow-up|3|||
163281613|NCT00783692|589739469|FG005|Maintenance Phase|Lost to Follow-up|2|||
163281614|NCT00783692|589739470|FG006|Maintenance Phase|Lost to Follow-up|5|||
163281615|NCT00783692|589739464|FG000|Maintenance Phase|Other|0|||
163281616|NCT00783692|589739465|FG001|Maintenance Phase|Other|0|||
163281617|NCT00783692|589739466|FG002|Maintenance Phase|Other|0|||
163281618|NCT00783692|589739467|FG003|Maintenance Phase|Other|1|||
163281619|NCT00783692|589739468|FG004|Maintenance Phase|Other|0|||
163281620|NCT00783692|589739469|FG005|Maintenance Phase|Other|1|||
163281621|NCT00783692|589739470|FG006|Maintenance Phase|Other|1|||
163281622|NCT04438785|589739478|FG000|Overall Study|change of weight, give up intervention|2|||
163281623|NCT04438785|589739479|FG001|Overall Study|change of weight, give up intervention|10|||
163281624|NCT04831775|589739480|FG000|Overall Study|Lost to Follow-up|11|||
163281625|NCT04831775|589739481|FG001|Overall Study|Lost to Follow-up|13|||
163281626|NCT02027935|589739482|FG000|Overall Study|Death|1|||
163281627|NCT02027935|589739482|FG000|Overall Study|Lack of Efficacy|5|||
163281628|NCT02027935|589739482|FG000|Overall Study|Study Closure|1|||
163281629|NCT03115346|589739483|FG000|Overall Study|Did not have AAA surgery|28|||
163281630|NCT03115346|589739484|FG001|Overall Study|Did not have AAA surgery|15|||
163281631|NCT03115346|589739483|FG000|Overall Study|Death|3|||
163281632|NCT03115346|589739484|FG001|Overall Study|Death|1|||
163281633|NCT03115346|589739483|FG000|Overall Study|Withdrawal by Subject|0|||
163175808|NCT02654717|589358900|FG001|Overall Study|Adverse Event|2|||
163175809|NCT02654717|589358899|FG000|Overall Study|Protocol Violation|1|||
163175810|NCT02654717|589358900|FG001|Overall Study|Protocol Violation|2|||
163175811|NCT02654717|589358899|FG000|Overall Study|Withdrawal by Subject|0|||
163175812|NCT02654717|589358900|FG001|Overall Study|Withdrawal by Subject|1|||
163175813|NCT02654717|589358899|FG000|Overall Study|Non-permitted medication|3|||
163175814|NCT02654717|589358900|FG001|Overall Study|Non-permitted medication|0|||
163175815|NCT00960570|589358901|FG000|21 Day Washout Period|Adverse Event|1|||
163175816|NCT00960570|589358901|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
163175817|NCT00960570|589358901|FG000|1 Day Period Between Dosing|Adverse Event|2|||
163175818|NCT00960570|589358901|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
163175819|NCT00853970|589358905|FG000|Overall Study|Withdrawal by Subject|2|||
163175820|NCT00853970|589358906|FG001|Overall Study|Withdrawal by Subject|1|||
163175821|NCT00853970|589358905|FG000|Overall Study|Cancelled surgery|4|||
163175822|NCT00853970|589358906|FG001|Overall Study|Cancelled surgery|2|||
163175823|NCT02519855|589360126|FG000|Overall Study|Adverse Event|0|||
163175824|NCT02519855|589360127|FG001|Overall Study|Adverse Event|1|||
163175825|NCT02519855|589360126|FG000|Overall Study|Lost to Follow-up|3|||
163175826|NCT02519855|589360127|FG001|Overall Study|Lost to Follow-up|3|||
163175827|NCT01842633|589360128|FG000|Overall Study|Screen Failure|1|||
163175828|NCT01842633|589360129|FG001|Overall Study|Screen Failure|0|||
163175829|NCT01842633|589360130|FG002|Overall Study|Screen Failure|0|||
163175830|NCT01842633|589360128|FG000|Overall Study|Adverse Event|1|||
163175831|NCT01842633|589360129|FG001|Overall Study|Adverse Event|1|||
163175832|NCT01842633|589360130|FG002|Overall Study|Adverse Event|0|||
163175833|NCT01842633|589360128|FG000|Overall Study|Withdrawal by Subject|0|||
163175834|NCT01842633|589360129|FG001|Overall Study|Withdrawal by Subject|1|||
163175835|NCT01842633|589360130|FG002|Overall Study|Withdrawal by Subject|0|||
163175836|NCT01842633|589360128|FG000|Overall Study|Technical issues|1|||
163175837|NCT01842633|589360129|FG001|Overall Study|Technical issues|0|||
163175838|NCT01842633|589360130|FG002|Overall Study|Technical issues|0|||
163175839|NCT02093351|589360131|FG000|Part A|Adverse Event|0|||
163175840|NCT02093351|589360132|FG001|Part A|Adverse Event|1|||
163175841|NCT02093351|589360133|FG002|Part A|Adverse Event|1|||
163175842|NCT02093351|589360134|FG003|Part A|Adverse Event|0|||
163175843|NCT02093351|589360131|FG000|Part A|Condition under investigation worsened|2|||
163175844|NCT02093351|589360132|FG001|Part A|Condition under investigation worsened|0|||
163175845|NCT02093351|589360133|FG002|Part A|Condition under investigation worsened|2|||
163175846|NCT02093351|589360134|FG003|Part A|Condition under investigation worsened|0|||
163175847|NCT02093351|589360131|FG000|Part A|Death|0|||
163175848|NCT02093351|589360132|FG001|Part A|Death|1|||
163175849|NCT02093351|589360133|FG002|Part A|Death|0|||
163175850|NCT02093351|589360134|FG003|Part A|Death|0|||
163175851|NCT02093351|589360131|FG000|Part B|Patient decision|0|||
163175852|NCT02093351|589360132|FG001|Part B|Patient decision|0|||
163175853|NCT02093351|589360133|FG002|Part B|Patient decision|0|||
163175854|NCT02093351|589360134|FG003|Part B|Patient decision|3|||
163175855|NCT02093351|589360131|FG000|Part B|Disease progression|0|||
163175856|NCT02093351|589360132|FG001|Part B|Disease progression|0|||
163175857|NCT02093351|589360133|FG002|Part B|Disease progression|0|||
163175858|NCT02093351|589360134|FG003|Part B|Disease progression|4|||
163175859|NCT02093351|589360131|FG000|Part B|Complete response|0|||
163175860|NCT02093351|589360132|FG001|Part B|Complete response|0|||
163175861|NCT02093351|589360133|FG002|Part B|Complete response|0|||
163175862|NCT02093351|589360134|FG003|Part B|Complete response|1|||
163175863|NCT02093351|589360131|FG000|Part B|Adverse event + disease progression|0|||
163175864|NCT02093351|589360132|FG001|Part B|Adverse event + disease progression|0|||
163175865|NCT02093351|589360133|FG002|Part B|Adverse event + disease progression|0|||
163175866|NCT02093351|589360134|FG003|Part B|Adverse event + disease progression|1|||
163175867|NCT02093351|589360131|FG000|Part B|Lack of therapeutic response|0|||
163281634|NCT03115346|589739484|FG001|Overall Study|Withdrawal by Subject|3|||
163281635|NCT03115346|589739483|FG000|Overall Study|Lost to Follow-up|0|||
163175868|NCT02093351|589360132|FG001|Part B|Lack of therapeutic response|0|||
163175869|NCT02093351|589360133|FG002|Part B|Lack of therapeutic response|0|||
163175870|NCT02093351|589360134|FG003|Part B|Lack of therapeutic response|12|||
163175871|NCT02093351|589360131|FG000|Part B|Condition under investigation worsened|0|||
163175872|NCT02093351|589360132|FG001|Part B|Condition under investigation worsened|0|||
163175873|NCT02093351|589360133|FG002|Part B|Condition under investigation worsened|0|||
163281636|NCT03115346|589739484|FG001|Overall Study|Lost to Follow-up|3|||
162932563|NCT00597584|588458520|FG000|Overall Study|Lack of Efficacy|1|||
162932564|NCT00597584|588458521|FG001|Overall Study|Lack of Efficacy|0|||
162932565|NCT00597584|588458520|FG000|Overall Study|Lost to Follow-up|2|||
162932566|NCT00597584|588458521|FG001|Overall Study|Lost to Follow-up|4|||
162932567|NCT00597584|588458520|FG000|Overall Study|Physician Decision|3|||
162932568|NCT00597584|588458521|FG001|Overall Study|Physician Decision|0|||
162932569|NCT00597584|588458520|FG000|Overall Study|Pregnancy|2|||
163175874|NCT02093351|589360134|FG003|Part B|Condition under investigation worsened|39|||
163175875|NCT02093351|589360131|FG000|Part B|Adverse Event|0|||
163175876|NCT02093351|589360132|FG001|Part B|Adverse Event|0|||
163175877|NCT02093351|589360133|FG002|Part B|Adverse Event|0|||
163175878|NCT02093351|589360134|FG003|Part B|Adverse Event|2|||
163175879|NCT02093351|589360131|FG000|Part B|Death|0|||
163175880|NCT02093351|589360132|FG001|Part B|Death|0|||
163175881|NCT02093351|589360133|FG002|Part B|Death|0|||
163175882|NCT02093351|589360134|FG003|Part B|Death|1|||
163175883|NCT03565367|589360135|FG000|Overall Study|No scan due to technical issues|4|||
163175884|NCT03565367|589360136|FG001|Overall Study|No scan due to technical issues|0|||
163175885|NCT01099709|589360137|FG000|Period 1|Withdrawal by Subject|0|||
163175886|NCT01099709|589360138|FG001|Period 1|Withdrawal by Subject|1|||
163175887|NCT01099709|589360137|FG000|Period 1|Positive cotinine test|0|||
163175888|NCT01099709|589360138|FG001|Period 1|Positive cotinine test|1|||
163175889|NCT01099709|589360137|FG000|Period 1|Adverse Event|1|||
163175890|NCT01099709|589360138|FG001|Period 1|Adverse Event|0|||
163175891|NCT00706849|589360139|FG000|Treatment Period|Adverse Event|0|||
163175892|NCT00706849|589360140|FG001|Treatment Period|Adverse Event|9|||
163175893|NCT00706849|589360139|FG000|Treatment Period|Other|0|||
163175894|NCT00706849|589360140|FG001|Treatment Period|Other|1|||
163175895|NCT00706849|589360139|FG000|Follow-up Period|Withdrawal by Subject|0|||
163175896|NCT00706849|589360140|FG001|Follow-up Period|Withdrawal by Subject|2|||
163175897|NCT00706849|589360139|FG000|Follow-up Period|Protocol non-compliance|0|||
163175898|NCT00706849|589360140|FG001|Follow-up Period|Protocol non-compliance|1|||
163175899|NCT01611454|589360142|FG000|Overall Study|Lack of Efficacy|18|||
163175900|NCT01611454|589360143|FG001|Overall Study|Lack of Efficacy|10|||
163175901|NCT01275339|589360144|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
163175902|NCT01275339|589360145|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
163175903|NCT01275339|589360146|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
163175904|NCT01275339|589360147|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
163175905|NCT01275339|589360144|FG000|Overall Study|Withdrawal by Subject|0|||
163175906|NCT01275339|589360145|FG001|Overall Study|Withdrawal by Subject|0|||
163175907|NCT01275339|589360146|FG002|Overall Study|Withdrawal by Subject|1|||
163175908|NCT01275339|589360147|FG003|Overall Study|Withdrawal by Subject|0|||
163175909|NCT03023046|589360152|FG000|Overall Study|Withdrawal by Subject|1|||
163175910|NCT00640835|589360158|FG000|Overall Study|Adverse Event|5|||
163175911|NCT00640835|589360159|FG001|Overall Study|Adverse Event|3|||
163175912|NCT00640835|589360158|FG000|Overall Study|Withdrawal by Subject|12|||
163175913|NCT00640835|589360159|FG001|Overall Study|Withdrawal by Subject|14|||
163175914|NCT00640835|589360158|FG000|Overall Study|Physician Decision|10|||
163175915|NCT00640835|589360159|FG001|Overall Study|Physician Decision|14|||
163281637|NCT00689104|589739485|FG000|Overall Study|Eligibility criterion not met|5|||
163281638|NCT00689104|589739486|FG001|Overall Study|Eligibility criterion not met|8|||
163281639|NCT00689104|589739487|FG002|Overall Study|Eligibility criterion not met|0|||
162932570|NCT00597584|588458521|FG001|Overall Study|Pregnancy|0|||
162932571|NCT00597584|588458520|FG000|Overall Study|Withdrawal by Subject|44|||
162932572|NCT00597584|588458521|FG001|Overall Study|Withdrawal by Subject|12|||
162932573|NCT00597584|588458520|FG000|Overall Study|Discontinued Dialysis|0|||
162932574|NCT00597584|588458521|FG001|Overall Study|Discontinued Dialysis|1|||
162932575|NCT00597584|588458520|FG000|Overall Study|Lost ability to consent|1|||
162932576|NCT00597584|588458521|FG001|Overall Study|Lost ability to consent|1|||
162932577|NCT00597584|588458520|FG000|Overall Study|Never dosed|1|||
162932578|NCT00597584|588458521|FG001|Overall Study|Never dosed|0|||
162932579|NCT00597584|588458520|FG000|Overall Study|Relocation|8|||
162932580|NCT00597584|588458521|FG001|Overall Study|Relocation|6|||
162932581|NCT00597584|588458520|FG000|Overall Study|Renal transplant|9|||
163175916|NCT00640835|589360158|FG000|Overall Study|Sponsor's Decision|11|||
163175917|NCT00640835|589360159|FG001|Overall Study|Sponsor's Decision|7|||
163175918|NCT00640835|589360158|FG000|Overall Study|Protocol Violation|2|||
163175919|NCT00640835|589360159|FG001|Overall Study|Protocol Violation|2|||
163175920|NCT00640835|589360158|FG000|Overall Study|Lost to Follow-up|17|||
163175921|NCT00640835|589360159|FG001|Overall Study|Lost to Follow-up|13|||
163175922|NCT00640835|589360158|FG000|Overall Study|Other Reason|19|||
162932582|NCT00597584|588458521|FG001|Overall Study|Renal transplant|7|||
162932583|NCT02280421|588458522|FG000|Washout (2 Weeks)|Adverse Event|0|||
162932584|NCT02280421|588458523|FG001|Washout (2 Weeks)|Adverse Event|1|||
162932585|NCT02280421|588458522|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
162932586|NCT02280421|588458523|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
163175923|NCT00640835|589360159|FG001|Overall Study|Other Reason|4|||
163175924|NCT05954143|589360164|FG000|Overall Study|Progressive Disease|1|||
163175925|NCT05954143|589360165|FG001|Overall Study|Progressive Disease|0|||
163175926|NCT05954143|589360164|FG000|Overall Study|Physician Decision|1|||
163175927|NCT05954143|589360165|FG001|Overall Study|Physician Decision|0|||
163175928|NCT05954143|589360164|FG000|Overall Study|Study Terminated by Sponsor|2|||
163175929|NCT05954143|589360165|FG001|Overall Study|Study Terminated by Sponsor|4|||
163175930|NCT05954143|589360164|FG000|Overall Study|Death|1|||
163175931|NCT05954143|589360165|FG001|Overall Study|Death|0|||
163175932|NCT05954143|589360164|FG000|Overall Study|Withdrawal by Subject|0|||
163175933|NCT05954143|589360165|FG001|Overall Study|Withdrawal by Subject|1|||
163175934|NCT05954143|589360164|FG000|Overall Study|Other|1|||
163175935|NCT05954143|589360165|FG001|Overall Study|Other|0|||
163175936|NCT00713310|589360166|FG000|Overall Study|Adverse Event|5|||
163175937|NCT00713310|589360167|FG001|Overall Study|Adverse Event|2|||
163175938|NCT00713310|589360166|FG000|Overall Study|Lack of Efficacy|0|||
163175939|NCT00713310|589360167|FG001|Overall Study|Lack of Efficacy|2|||
163175940|NCT00713310|589360166|FG000|Overall Study|Withdrawal by Subject|0|||
163175941|NCT00713310|589360167|FG001|Overall Study|Withdrawal by Subject|2|||
163175942|NCT05028361|589360168|FG000|Overall Study|Withdrawal by Subject|1|||
163175943|NCT05028361|589360169|FG001|Overall Study|Withdrawal by Subject|0|||
163175944|NCT01993836|589360170|FG000|Overall Study|Surgery Cancelled|3|||
163175945|NCT01993836|589360171|FG001|Overall Study|Surgery Cancelled|0|||
163175946|NCT01993836|589360172|FG002|Overall Study|Surgery Cancelled|0|||
163175947|NCT01993836|589360170|FG000|Overall Study|Physician Decision|2|||
163175948|NCT01993836|589360171|FG001|Overall Study|Physician Decision|1|||
163175949|NCT01993836|589360172|FG002|Overall Study|Physician Decision|0|||
163175950|NCT01993836|589360170|FG000|Overall Study|Death|0|||
163175951|NCT01993836|589360171|FG001|Overall Study|Death|2|||
163175952|NCT01993836|589360172|FG002|Overall Study|Death|0|||
163175953|NCT01993836|589360170|FG000|Overall Study|Withdrawal by Subject|12|||
163175954|NCT01993836|589360171|FG001|Overall Study|Withdrawal by Subject|10|||
163175955|NCT01993836|589360172|FG002|Overall Study|Withdrawal by Subject|5|||
163175956|NCT02195687|589360173|FG000|Overall Study|Personal Reasons|1|||
163175957|NCT02195687|589360174|FG001|Overall Study|Personal Reasons|1|||
163175958|NCT02195687|589360173|FG000|Overall Study|Lost to Follow-up|4|||
163175959|NCT02195687|589360174|FG001|Overall Study|Lost to Follow-up|1|||
163175960|NCT00779259|589360175|FG000|Quinine Alone|Adverse Event|2|||
163175961|NCT01925989|589360181|FG000|Period 1|Sponsor Decision|1|||
163175962|NCT01925989|589360182|FG001|Period 1|Sponsor Decision|1|||
163175963|NCT01925989|589360183|FG002|Period 1|Sponsor Decision|0|||
163175964|NCT01925989|589360181|FG000|Period 1|Withdrawal by Subject|0|||
163175965|NCT01925989|589360182|FG001|Period 1|Withdrawal by Subject|1|||
163175966|NCT01925989|589360183|FG002|Period 1|Withdrawal by Subject|0|||
163175967|NCT02496676|589360185|FG000|Phase 1 - Period 1|Adverse Event|0|||
163175968|NCT02496676|589360186|FG001|Phase 1 - Period 1|Adverse Event|1|||
163175969|NCT02496676|589360185|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
163175970|NCT02496676|589360186|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
163175971|NCT03459690|589360187|FG000|Overall Study|Lost to Follow-up|0|||
163175972|NCT03459690|589360188|FG001|Overall Study|Lost to Follow-up|1|||
163175973|NCT03459690|589360187|FG000|Overall Study|Withdrawal by Subject|1|||
163175974|NCT03459690|589360188|FG001|Overall Study|Withdrawal by Subject|1|||
163175975|NCT02963831|589360189|FG000|Overall Study|Progressive Disease|3|||
163175976|NCT02963831|589360190|FG001|Overall Study|Progressive Disease|3|||
163175977|NCT02963831|589360191|FG002|Overall Study|Progressive Disease|16|||
163175978|NCT02963831|589360192|FG003|Overall Study|Progressive Disease|27|||
163175979|NCT02963831|589360189|FG000|Overall Study|Withdrawal by Subject|1|||
163175980|NCT02963831|589360190|FG001|Overall Study|Withdrawal by Subject|0|||
163175981|NCT02963831|589360191|FG002|Overall Study|Withdrawal by Subject|2|||
163175982|NCT02963831|589360192|FG003|Overall Study|Withdrawal by Subject|4|||
163175983|NCT02963831|589360189|FG000|Overall Study|Adverse Event|0|||
163175984|NCT02963831|589360190|FG001|Overall Study|Adverse Event|1|||
163175985|NCT02963831|589360191|FG002|Overall Study|Adverse Event|1|||
163175986|NCT02963831|589360192|FG003|Overall Study|Adverse Event|2|||
163175987|NCT02963831|589360189|FG000|Overall Study|Death|0|||
163175988|NCT02963831|589360190|FG001|Overall Study|Death|0|||
163175989|NCT02963831|589360191|FG002|Overall Study|Death|0|||
163175990|NCT02963831|589360192|FG003|Overall Study|Death|2|||
163175991|NCT02536404|589360196|FG000|Overall Study|Adverse Event|5|||
163175992|NCT02536404|589360197|FG001|Overall Study|Adverse Event|0|||
163175993|NCT02536404|589360196|FG000|Overall Study|Withdrawal by Subject|4|||
163175994|NCT02536404|589360197|FG001|Overall Study|Withdrawal by Subject|1|||
163175995|NCT02536404|589360196|FG000|Overall Study|Physician Decision|10|||
163175996|NCT02536404|589360197|FG001|Overall Study|Physician Decision|0|||
163175997|NCT02536404|589360196|FG000|Overall Study|Sponsor decision|1|||
163175998|NCT02536404|589360197|FG001|Overall Study|Sponsor decision|0|||
163175999|NCT02514473|589360198|FG000|Overall Study|Adverse Event|0|||
163176000|NCT02514473|589360199|FG001|Overall Study|Adverse Event|2|||
163176001|NCT02514473|589360198|FG000|Overall Study|Withdrawal by Subject|2|||
163176002|NCT02514473|589360199|FG001|Overall Study|Withdrawal by Subject|1|||
163176003|NCT02514473|589360198|FG000|Overall Study|Lost to Follow-up|0|||
163176004|NCT02514473|589360199|FG001|Overall Study|Lost to Follow-up|1|||
163176005|NCT02514473|589360198|FG000|Overall Study|Other|1|||
163176006|NCT02514473|589360199|FG001|Overall Study|Other|1|||
163176007|NCT04381988|589360200|FG000|Overall Study|The study was terminated|4|||
163176008|NCT04381988|589360201|FG001|Overall Study|The study was terminated|0|||
163176009|NCT02106923|589360202|FG000|Overall Study|Protocol Violation|0|||
163176010|NCT02106923|589360203|FG001|Overall Study|Protocol Violation|0|||
163176011|NCT02106923|589360204|FG002|Overall Study|Protocol Violation|0|||
163176012|NCT02106923|589360205|FG003|Overall Study|Protocol Violation|0|||
163176013|NCT02106923|589360206|FG004|Overall Study|Protocol Violation|0|||
163281640|NCT00689104|589739488|FG003|Overall Study|Eligibility criterion not met|4|||
163281641|NCT00689104|589739485|FG000|Overall Study|Adverse Event|13|||
163281642|NCT00689104|589739486|FG001|Overall Study|Adverse Event|25|||
163281643|NCT00689104|589739487|FG002|Overall Study|Adverse Event|16|||
163281644|NCT00689104|589739488|FG003|Overall Study|Adverse Event|24|||
163281645|NCT00689104|589739485|FG000|Overall Study|Lack of Efficacy|5|||
163281646|NCT00689104|589739486|FG001|Overall Study|Lack of Efficacy|6|||
163281647|NCT00689104|589739487|FG002|Overall Study|Lack of Efficacy|2|||
163281648|NCT00689104|589739488|FG003|Overall Study|Lack of Efficacy|3|||
163281649|NCT00689104|589739485|FG000|Overall Study|Withdrawal by Subject|12|||
163281650|NCT00689104|589739486|FG001|Overall Study|Withdrawal by Subject|11|||
163281651|NCT00689104|589739487|FG002|Overall Study|Withdrawal by Subject|18|||
163281652|NCT00689104|589739488|FG003|Overall Study|Withdrawal by Subject|11|||
163281653|NCT00689104|589739485|FG000|Overall Study|Lost to Follow-up|4|||
163281654|NCT00689104|589739486|FG001|Overall Study|Lost to Follow-up|3|||
163281655|NCT00689104|589739487|FG002|Overall Study|Lost to Follow-up|2|||
163281656|NCT00689104|589739488|FG003|Overall Study|Lost to Follow-up|5|||
163281657|NCT00689104|589739485|FG000|Overall Study|Protocol Violation|2|||
163042825|NCT01990768|588863969|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
163176014|NCT02106923|589360207|FG005|Overall Study|Protocol Violation|1|||
163176015|NCT03485495|589360208|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
163176016|NCT03485495|589360209|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
163176017|NCT03915860|589360210|FG000|Overall Study|Adverse Event|3|||
163281658|NCT00689104|589739486|FG001|Overall Study|Protocol Violation|3|||
163281659|NCT00689104|589739487|FG002|Overall Study|Protocol Violation|5|||
163281660|NCT00689104|589739488|FG003|Overall Study|Protocol Violation|3|||
163176018|NCT03915860|589360210|FG000|Overall Study|Withdrawal by Subject|6|||
163176019|NCT03915860|589360210|FG000|Overall Study|Lost to Follow-up|2|||
163176020|NCT03915860|589360210|FG000|Overall Study|Other than specified|3|||
163176021|NCT01107379|589360214|FG000|Overall Study|Withdrawal by Subject|18|||
163176022|NCT01107379|589360214|FG000|Overall Study|Lost to Follow-up|3|||
163176023|NCT04559529|589360215|FG000|First Intervention (1 Day)|Adverse Event|0|||
163176024|NCT04559529|589360216|FG001|First Intervention (1 Day)|Adverse Event|0|||
163176025|NCT04559529|589360217|FG002|First Intervention (1 Day)|Adverse Event|0|||
163176026|NCT04559529|589360218|FG003|First Intervention (1 Day)|Adverse Event|1|||
163176027|NCT04559529|589360215|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
163176028|NCT04559529|589360216|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
163176029|NCT04559529|589360217|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
163176030|NCT04559529|589360218|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
163176031|NCT04559529|589360215|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
163176032|NCT04559529|589360216|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
163176033|NCT04559529|589360217|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
163176034|NCT04559529|589360218|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
163176035|NCT01009281|589360219|FG000|Overall Study|Administrative problems|7|||
163176036|NCT00924170|589360220|FG000|Overall Study|Refused further treatment|0|||
163176037|NCT00924170|589360221|FG001|Overall Study|Refused further treatment|1|||
163176038|NCT00924170|589360220|FG000|Overall Study|Physician Decision|0|||
163176039|NCT00924170|589360221|FG001|Overall Study|Physician Decision|1|||
163176040|NCT00924170|589360220|FG000|Overall Study|Progressive disease|3|||
163176041|NCT00924170|589360221|FG001|Overall Study|Progressive disease|6|||
163176042|NCT00924170|589360220|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
163176043|NCT00924170|589360221|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
163176044|NCT00924170|589360220|FG000|Overall Study|Death|1|||
163176045|NCT00924170|589360221|FG001|Overall Study|Death|0|||
163176046|NCT03901456|589360224|FG000|Overall Study|Withdrawal by Subject|0|||
163176047|NCT03901456|589360225|FG001|Overall Study|Withdrawal by Subject|0|||
163176048|NCT03901456|589360226|FG002|Overall Study|Withdrawal by Subject|1|||
163176049|NCT03901456|589360224|FG000|Overall Study|Lost to Follow-up|0|||
163176050|NCT03901456|589360225|FG001|Overall Study|Lost to Follow-up|1|||
163176051|NCT03901456|589360226|FG002|Overall Study|Lost to Follow-up|0|||
163176052|NCT05318183|589360227|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
163176053|NCT05318183|589360228|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
163176054|NCT05318183|589360227|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
163176055|NCT05318183|589360228|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
163176056|NCT05318183|589360227|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
163176057|NCT05318183|589360228|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
163176058|NCT05318183|589360227|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
163176059|NCT05318183|589360228|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
163176060|NCT04098224|589360229|FG000|Overall Study|Adverse Event|1|||
163176061|NCT04098224|589360230|FG001|Overall Study|Adverse Event|0|||
163176062|NCT04098224|589360229|FG000|Overall Study|Physician Decision|1|||
163176063|NCT04098224|589360230|FG001|Overall Study|Physician Decision|0|||
163176064|NCT04098224|589360229|FG000|Overall Study|Patient not required enteral feeding|1|||
163176065|NCT04098224|589360230|FG001|Overall Study|Patient not required enteral feeding|0|||
163176066|NCT04098224|589360229|FG000|Overall Study|Patient failure nasogastric tube|1|||
163176067|NCT04098224|589360230|FG001|Overall Study|Patient failure nasogastric tube|0|||
163176068|NCT04098224|589360229|FG000|Overall Study|Patient early extubation|1|||
163176069|NCT04098224|589360230|FG001|Overall Study|Patient early extubation|3|||
163176070|NCT01203852|589360234|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
163176071|NCT01203852|589360234|FG000|Washout 2 Weeks|Physician Decision|46|||
163176072|NCT00899392|589360235|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
163176073|NCT00899392|589360236|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
163176074|NCT03709576|589360239|FG000|Overall Study|progression prior to enrollment|1|||
163176075|NCT00890045|589360249|FG000|Overall Study|Death|0|||
163176076|NCT00890045|589360250|FG001|Overall Study|Death|1|||
163176077|NCT00890045|589360249|FG000|Overall Study|Did not receive HeRO Graft|0|||
163176078|NCT00890045|589360250|FG001|Overall Study|Did not receive HeRO Graft|2|||
163176079|NCT00890045|589360249|FG000|Overall Study|Lost to Follow-up|5|||
163176080|NCT00890045|589360250|FG001|Overall Study|Lost to Follow-up|7|||
163176081|NCT00510653|589360251|FG000|Overall Study|Withdrawal by Subject|8|||
163176082|NCT00510653|589360251|FG000|Overall Study|Monetary|3|||
163176083|NCT02520089|589360254|FG000|Overall Study|Lost to Follow-up|3|||
163176084|NCT02520089|589360255|FG001|Overall Study|Lost to Follow-up|4|||
163281661|NCT00689104|589739485|FG000|Overall Study|Randomized but never received study drug|2|||
163281662|NCT00689104|589739486|FG001|Overall Study|Randomized but never received study drug|1|||
163176085|NCT01981551|589360258|FG000|Overall Study|Refused further treatment|8|||
163176086|NCT01981551|589360258|FG000|Overall Study|Adverse Event|1|||
163176087|NCT01451437|589360261|FG000|Overall Study|Adverse Event|0|||
163176088|NCT01451437|589360262|FG001|Overall Study|Adverse Event|0|||
163281663|NCT00689104|589739487|FG002|Overall Study|Randomized but never received study drug|1|||
163281664|NCT00689104|589739488|FG003|Overall Study|Randomized but never received study drug|0|||
163281665|NCT00689104|589739485|FG000|Overall Study|Physician Decision|1|||
163281666|NCT00689104|589739486|FG001|Overall Study|Physician Decision|0|||
163281667|NCT00689104|589739487|FG002|Overall Study|Physician Decision|0|||
163281668|NCT00689104|589739488|FG003|Overall Study|Physician Decision|0|||
163281669|NCT00689104|589739485|FG000|Overall Study|Non-compliance with study procedures|0|||
163281670|NCT00689104|589739486|FG001|Overall Study|Non-compliance with study procedures|0|||
163281671|NCT00689104|589739487|FG002|Overall Study|Non-compliance with study procedures|1|||
163281672|NCT00689104|589739488|FG003|Overall Study|Non-compliance with study procedures|0|||
163281673|NCT01737268|589739489|FG000|Overall Study|Adverse Event|6|||
163281674|NCT01737268|589739489|FG000|Overall Study|Worsening of Target Disease|2|||
163281675|NCT01737268|589739489|FG000|Overall Study|In consideration of the patient's safety|1|||
163281676|NCT04873817|589739490|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
163281677|NCT04873817|589739490|FG000|Overall Study|Lost to Follow-up|4|||
163281678|NCT04873817|589739490|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
163281679|NCT04873817|589739490|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
163281680|NCT04873817|589739490|FG000|Overall Study|Other Reasons|3|||
163281681|NCT02696226|589739498|FG000|Overall Study|Study terminated - lack of enrollment|1|||
163281682|NCT02696226|589739499|FG001|Overall Study|Study terminated - lack of enrollment|0|||
163281683|NCT02696226|589739500|FG002|Overall Study|Study terminated - lack of enrollment|2|||
163281684|NCT02696226|589739501|FG003|Overall Study|Study terminated - lack of enrollment|0|||
163281685|NCT01394991|589739504|FG000|Overall Study|Adverse Event|0|||
163281686|NCT01394991|589739505|FG001|Overall Study|Adverse Event|4|||
163281687|NCT01394991|589739504|FG000|Overall Study|Lack of Efficacy|5|||
163281688|NCT01394991|589739505|FG001|Overall Study|Lack of Efficacy|7|||
163281689|NCT01394991|589739504|FG000|Overall Study|Lost to Follow-up|6|||
163281690|NCT01394991|589739505|FG001|Overall Study|Lost to Follow-up|8|||
163281691|NCT01394991|589739504|FG000|Overall Study|Physician Decision|1|||
163281692|NCT01394991|589739505|FG001|Overall Study|Physician Decision|3|||
163281693|NCT01394991|589739504|FG000|Overall Study|Protocol Violation|1|||
163281694|NCT01394991|589739505|FG001|Overall Study|Protocol Violation|1|||
163281695|NCT01394991|589739504|FG000|Overall Study|Withdrawal by Subject|20|||
163281696|NCT01394991|589739505|FG001|Overall Study|Withdrawal by Subject|17|||
163281697|NCT01394991|589739504|FG000|Overall Study|Chemotherapy Termination|10|||
163281698|NCT01394991|589739505|FG001|Overall Study|Chemotherapy Termination|15|||
163281699|NCT01394991|589739504|FG000|Overall Study|Disease Progression|7|||
163281700|NCT01394991|589739505|FG001|Overall Study|Disease Progression|7|||
163281701|NCT01394991|589739504|FG000|Overall Study|Prematurely Termination of Trial|9|||
163281702|NCT01394991|589739505|FG001|Overall Study|Prematurely Termination of Trial|10|||
163281703|NCT00097370|589739506|FG000|Stage 1|Adverse Event|3|||
163281704|NCT00097370|589739506|FG000|Stage 1|Withdrawal by Subject|1|||
163281705|NCT00097370|589739506|FG000|Stage 1|Lack of Efficacy|2|||
163281706|NCT00097370|589739506|FG000|Stage 2|Adverse Event|5|||
163281707|NCT00097370|589739506|FG000|Stage 2|Withdrawal by Subject|1|||
163281708|NCT00097370|589739506|FG000|Stage 2|Lack of Efficacy|3|||
163281709|NCT00097370|589739506|FG000|Stage 2|Pregnancy|1|||
163281710|NCT00097370|589739506|FG000|Stage 2|Sponsor Terminated Study|2|||
163281711|NCT00097370|589739506|FG000|Stage 2|Lost to Follow-up|1|||
163281712|NCT00097370|589739506|FG000|Stage 3|Adverse Event|2|||
163281713|NCT00097370|589739506|FG000|Stage 3|Withdrawal by Subject|3|||
163281714|NCT00097370|589739506|FG000|Stage 3|Lack of Efficacy|1|||
163281715|NCT00097370|589739506|FG000|Stage 3|Sponsor Terminated Study|52|||
163281716|NCT00097370|589739506|FG000|Stage 3|Lost to Follow-up|1|||
163281717|NCT02337361|589739507|FG000|3-month Follow-up|Lost to Follow-up|19|||
163281718|NCT02337361|589739508|FG001|3-month Follow-up|Lost to Follow-up|14|||
163281719|NCT02337361|589739507|FG000|6-month Follow-up|Lost to Follow-up|2|||
163281720|NCT02337361|589739508|FG001|6-month Follow-up|Lost to Follow-up|4|||
163281721|NCT03073005|589739510|FG000|Overall Study|Death|6|||
163281722|NCT03073005|589739511|FG001|Overall Study|Death|0|||
163281723|NCT03073005|589739512|FG002|Overall Study|Death|7|||
163281724|NCT03073005|589739513|FG003|Overall Study|Death|0|||
163281725|NCT03073005|589739510|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
163281726|NCT03073005|589739511|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
163281727|NCT03073005|589739512|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
163281728|NCT03073005|589739513|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
163281729|NCT03073005|589739510|FG000|Overall Study|Lost to Follow-up|2|||
163281730|NCT03073005|589739511|FG001|Overall Study|Lost to Follow-up|2|||
163281731|NCT03073005|589739512|FG002|Overall Study|Lost to Follow-up|1|||
163281732|NCT03073005|589739513|FG003|Overall Study|Lost to Follow-up|2|||
163281733|NCT03073005|589739510|FG000|Overall Study|Withdrawal by Subject|0|||
163281734|NCT03073005|589739511|FG001|Overall Study|Withdrawal by Subject|4|||
163281735|NCT03073005|589739512|FG002|Overall Study|Withdrawal by Subject|4|||
163281736|NCT03073005|589739513|FG003|Overall Study|Withdrawal by Subject|4|||
163281737|NCT01734811|589739521|FG000|Overall Study|Lost to Follow-up|2|||
163281738|NCT01734811|589739522|FG001|Overall Study|Lost to Follow-up|3|||
163281739|NCT01734811|589739521|FG000|Overall Study|Withdrawal by Subject|2|||
162932587|NCT03870997|588458530|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
162932588|NCT03870997|588458531|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
162932589|NCT03870997|588458532|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
162932590|NCT03870997|588458533|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
162932591|NCT03870997|588458534|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
162932592|NCT03870997|588458535|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
162932593|NCT03726437|588458536|FG000|Overall Study|Lost to Follow-up|85|||
162932594|NCT03726437|588458537|FG001|Overall Study|Lost to Follow-up|76|||
162932595|NCT01889862|588458546|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
162932596|NCT01889862|588458547|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
162932597|NCT01889862|588458548|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
162932598|NCT01889862|588458549|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
162932599|NCT01889862|588458550|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
162932600|NCT01889862|588458546|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
162932601|NCT01889862|588458547|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
162932602|NCT01889862|588458548|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
162932603|NCT01889862|588458549|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
162932604|NCT01889862|588458550|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
163176089|NCT01451437|589360263|FG002|Overall Study|Adverse Event|0|||
163176090|NCT01451437|589360264|FG003|Overall Study|Adverse Event|0|||
163176091|NCT01451437|589360265|FG004|Overall Study|Adverse Event|0|||
163176092|NCT01451437|589360266|FG005|Overall Study|Adverse Event|1|||
163176093|NCT01451437|589360267|FG006|Overall Study|Adverse Event|1|||
163176094|NCT01451437|589360268|FG007|Overall Study|Adverse Event|2|||
163176095|NCT01451437|589360269|FG008|Overall Study|Adverse Event|1|||
163176096|NCT01451437|589360261|FG000|Overall Study|Physician Decision|1|||
163176097|NCT01451437|589360262|FG001|Overall Study|Physician Decision|1|||
163176098|NCT01451437|589360263|FG002|Overall Study|Physician Decision|2|||
163176099|NCT01451437|589360264|FG003|Overall Study|Physician Decision|0|||
163176100|NCT01451437|589360265|FG004|Overall Study|Physician Decision|0|||
163176101|NCT01451437|589360266|FG005|Overall Study|Physician Decision|0|||
163176102|NCT01451437|589360267|FG006|Overall Study|Physician Decision|0|||
163176103|NCT01451437|589360268|FG007|Overall Study|Physician Decision|0|||
163176104|NCT01451437|589360269|FG008|Overall Study|Physician Decision|0|||
163176105|NCT01451437|589360261|FG000|Overall Study|Disease Progression|0|||
163176106|NCT01451437|589360262|FG001|Overall Study|Disease Progression|0|||
163176107|NCT01451437|589360263|FG002|Overall Study|Disease Progression|1|||
163176108|NCT01451437|589360264|FG003|Overall Study|Disease Progression|1|||
163176109|NCT01451437|589360265|FG004|Overall Study|Disease Progression|3|||
163176110|NCT01451437|589360266|FG005|Overall Study|Disease Progression|2|||
163176111|NCT01451437|589360267|FG006|Overall Study|Disease Progression|3|||
163176112|NCT01451437|589360268|FG007|Overall Study|Disease Progression|1|||
163176113|NCT01451437|589360269|FG008|Overall Study|Disease Progression|3|||
163176114|NCT01451437|589360261|FG000|Overall Study|Protocol Violation|0|||
163176115|NCT01451437|589360262|FG001|Overall Study|Protocol Violation|0|||
163176116|NCT01451437|589360263|FG002|Overall Study|Protocol Violation|0|||
163176117|NCT01451437|589360264|FG003|Overall Study|Protocol Violation|0|||
163176118|NCT01451437|589360265|FG004|Overall Study|Protocol Violation|0|||
163176119|NCT01451437|589360266|FG005|Overall Study|Protocol Violation|0|||
163176120|NCT01451437|589360267|FG006|Overall Study|Protocol Violation|1|||
163176121|NCT01451437|589360268|FG007|Overall Study|Protocol Violation|0|||
163176122|NCT01451437|589360269|FG008|Overall Study|Protocol Violation|0|||
163176123|NCT01451437|589360261|FG000|Overall Study|Withdrawal by Subject|0|||
163176124|NCT01451437|589360262|FG001|Overall Study|Withdrawal by Subject|0|||
163176125|NCT01451437|589360263|FG002|Overall Study|Withdrawal by Subject|0|||
163176126|NCT01451437|589360264|FG003|Overall Study|Withdrawal by Subject|0|||
163176127|NCT01451437|589360265|FG004|Overall Study|Withdrawal by Subject|1|||
163176128|NCT01451437|589360266|FG005|Overall Study|Withdrawal by Subject|0|||
163176129|NCT01451437|589360267|FG006|Overall Study|Withdrawal by Subject|1|||
163176130|NCT01451437|589360268|FG007|Overall Study|Withdrawal by Subject|0|||
163176131|NCT01451437|589360269|FG008|Overall Study|Withdrawal by Subject|0|||
163176132|NCT04085367|589362055|FG000|Overall Study|Adverse Event|1|||
163176133|NCT04085367|589362056|FG001|Overall Study|Adverse Event|1|||
163176134|NCT04085367|589362055|FG000|Overall Study|Withdrawal by Subject|13|||
163176135|NCT04085367|589362056|FG001|Overall Study|Withdrawal by Subject|4|||
163176136|NCT04085367|589362055|FG000|Overall Study|Lost to Follow-up|3|||
163176137|NCT04085367|589362056|FG001|Overall Study|Lost to Follow-up|1|||
163176138|NCT04085367|589362055|FG000|Overall Study|Other unspecified|2|||
163176139|NCT04085367|589362056|FG001|Overall Study|Other unspecified|1|||
163176140|NCT04085367|589362055|FG000|Overall Study|Status Unknown|1|||
163176141|NCT04085367|589362056|FG001|Overall Study|Status Unknown|1|||
162932605|NCT01889862|588458546|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
163176142|NCT00130442|589362060|FG000|Overall Study|Withdrawal by Subject|0|||
163176143|NCT00130442|589362061|FG001|Overall Study|Withdrawal by Subject|1|||
163176144|NCT00130442|589362060|FG000|Overall Study|did not meet criteria|1|||
163176145|NCT00130442|589362061|FG001|Overall Study|did not meet criteria|1|||
163281740|NCT01734811|589739522|FG001|Overall Study|Withdrawal by Subject|0|||
163176146|NCT00814333|589362062|FG000|Enrollment|Lost to Follow-up|1|||
163176147|NCT00814333|589362063|FG001|Enrollment|Lost to Follow-up|0|||
163176148|NCT01527357|589362064|FG000|Overall Study|Death|8|||
163176149|NCT01527357|589362065|FG001|Overall Study|Death|2|||
163176150|NCT01527357|589362064|FG000|Overall Study|Lost to Follow-up|6|||
163176151|NCT01527357|589362065|FG001|Overall Study|Lost to Follow-up|4|||
163176152|NCT01527357|589362064|FG000|Overall Study|Withdrew Consent|1|||
163176153|NCT01527357|589362065|FG001|Overall Study|Withdrew Consent|1|||
163176154|NCT01527357|589362064|FG000|Overall Study|Non-compliance|0|||
163176155|NCT01527357|589362065|FG001|Overall Study|Non-compliance|1|||
163176156|NCT01527357|589362064|FG000|Overall Study|No Day 29 Visit|0|||
163176157|NCT01527357|589362065|FG001|Overall Study|No Day 29 Visit|1|||
163176158|NCT01527357|589362064|FG000|Overall Study|Did Not Receive Treatment|2|||
163176159|NCT01527357|589362065|FG001|Overall Study|Did Not Receive Treatment|0|||
163176160|NCT02233946|589362066|FG000|Baseline|Withdrawal by Subject|2|||
163176161|NCT02233946|589362067|FG001|Baseline|Withdrawal by Subject|0|||
163176162|NCT02233946|589362066|FG000|3-months Follow-up|Lost to Follow-up|53|||
163176163|NCT02233946|589362067|FG001|3-months Follow-up|Lost to Follow-up|29|||
163176164|NCT02233946|589362066|FG000|6-months Follow-up|Lost to Follow-up|21|||
163176165|NCT02233946|589362067|FG001|6-months Follow-up|Lost to Follow-up|2|||
163176166|NCT02233946|589362066|FG000|9-month Follow-up|Lost to Follow-up|20|||
163176167|NCT02233946|589362067|FG001|9-month Follow-up|Lost to Follow-up|11|||
163176168|NCT02233946|589362066|FG000|12-month Follow-up|Lost to Follow-up|28|||
163176169|NCT02233946|589362067|FG001|12-month Follow-up|Lost to Follow-up|11|||
163176170|NCT00910247|589362068|FG000|Overall Study|Adverse Event|15|||
163281741|NCT00062868|589739523|FG000|Dose Level 1|Death|2|||
163281742|NCT00062868|589739524|FG001|Dose Level 1|Death|0|||
163281743|NCT00062868|589739525|FG002|Dose Level 1|Death|0|||
163281744|NCT00062868|589739526|FG003|Dose Level 1|Death|2|||
163281745|NCT00062868|589739527|FG004|Dose Level 1|Death|0|||
163281746|NCT00062868|589739528|FG005|Dose Level 1|Death|0|||
163281747|NCT00062868|589739529|FG006|Dose Level 1|Death|3|||
163281748|NCT00062868|589739530|FG007|Dose Level 1|Death|0|||
163281749|NCT00062868|589739531|FG008|Dose Level 1|Death|0|||
163281750|NCT00062868|589739532|FG009|Dose Level 1|Death|0|||
163281751|NCT00062868|589739533|FG010|Dose Level 1|Death|0|||
163281752|NCT00062868|589739534|FG011|Dose Level 1|Death|0|||
163281753|NCT00062868|589739535|FG012|Dose Level 1|Death|0|||
163281754|NCT00062868|589739536|FG013|Dose Level 1|Death|0|||
163281755|NCT00062868|589739537|FG014|Dose Level 1|Death|0|||
163281756|NCT00062868|589739538|FG015|Dose Level 1|Death|0|||
163281757|NCT00062868|589739539|FG016|Dose Level 1|Death|0|||
163281758|NCT00062868|589739540|FG017|Dose Level 1|Death|0|||
163281759|NCT00062868|589739541|FG018|Dose Level 1|Death|7|||
163281760|NCT00062868|589739542|FG019|Dose Level 1|Death|0|||
163281761|NCT00062868|589739543|FG020|Dose Level 1|Death|1|||
163281762|NCT00062868|589739523|FG000|Dose Level 1|Lost to Follow-up|0|||
163281763|NCT00062868|589739524|FG001|Dose Level 1|Lost to Follow-up|0|||
163281764|NCT00062868|589739525|FG002|Dose Level 1|Lost to Follow-up|0|||
163281765|NCT00062868|589739526|FG003|Dose Level 1|Lost to Follow-up|0|||
163281766|NCT00062868|589739527|FG004|Dose Level 1|Lost to Follow-up|0|||
163281767|NCT00062868|589739528|FG005|Dose Level 1|Lost to Follow-up|0|||
163281768|NCT00062868|589739529|FG006|Dose Level 1|Lost to Follow-up|0|||
163281769|NCT00062868|589739530|FG007|Dose Level 1|Lost to Follow-up|0|||
163281770|NCT00062868|589739531|FG008|Dose Level 1|Lost to Follow-up|0|||
163281771|NCT00062868|589739532|FG009|Dose Level 1|Lost to Follow-up|0|||
163281772|NCT00062868|589739533|FG010|Dose Level 1|Lost to Follow-up|0|||
163281773|NCT00062868|589739534|FG011|Dose Level 1|Lost to Follow-up|0|||
163281774|NCT00062868|589739535|FG012|Dose Level 1|Lost to Follow-up|1|||
163281775|NCT00062868|589739536|FG013|Dose Level 1|Lost to Follow-up|0|||
163281776|NCT00062868|589739537|FG014|Dose Level 1|Lost to Follow-up|0|||
163281777|NCT00062868|589739538|FG015|Dose Level 1|Lost to Follow-up|0|||
163281778|NCT00062868|589739539|FG016|Dose Level 1|Lost to Follow-up|0|||
163281779|NCT00062868|589739540|FG017|Dose Level 1|Lost to Follow-up|0|||
163281780|NCT00062868|589739541|FG018|Dose Level 1|Lost to Follow-up|2|||
163281781|NCT00062868|589739542|FG019|Dose Level 1|Lost to Follow-up|0|||
163281782|NCT00062868|589739543|FG020|Dose Level 1|Lost to Follow-up|1|||
163281783|NCT00062868|589739523|FG000|Dose Level 2|Death|0|||
163281784|NCT00062868|589739524|FG001|Dose Level 2|Death|3|||
163281785|NCT00062868|589739525|FG002|Dose Level 2|Death|0|||
163281786|NCT00062868|589739526|FG003|Dose Level 2|Death|0|||
163281787|NCT00062868|589739527|FG004|Dose Level 2|Death|2|||
163281788|NCT00062868|589739528|FG005|Dose Level 2|Death|0|||
163281789|NCT00062868|589739529|FG006|Dose Level 2|Death|0|||
163281790|NCT00062868|589739530|FG007|Dose Level 2|Death|0|||
163281791|NCT00062868|589739531|FG008|Dose Level 2|Death|0|||
163281792|NCT00062868|589739532|FG009|Dose Level 2|Death|0|||
163281793|NCT00062868|589739533|FG010|Dose Level 2|Death|1|||
163281794|NCT00062868|589739534|FG011|Dose Level 2|Death|0|||
163281795|NCT00062868|589739535|FG012|Dose Level 2|Death|0|||
163281796|NCT00062868|589739536|FG013|Dose Level 2|Death|0|||
163281797|NCT00062868|589739537|FG014|Dose Level 2|Death|0|||
163281798|NCT00062868|589739538|FG015|Dose Level 2|Death|0|||
163281799|NCT00062868|589739539|FG016|Dose Level 2|Death|2|||
163281800|NCT00062868|589739540|FG017|Dose Level 2|Death|0|||
163281801|NCT00062868|589739541|FG018|Dose Level 2|Death|0|||
162932606|NCT01889862|588458547|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
163281802|NCT00062868|589739542|FG019|Dose Level 2|Death|0|||
163281803|NCT00062868|589739543|FG020|Dose Level 2|Death|0|||
163281804|NCT00062868|589739523|FG000|Dose Level 2|Lost to Follow-up|0|||
163281805|NCT00062868|589739524|FG001|Dose Level 2|Lost to Follow-up|0|||
163281806|NCT00062868|589739525|FG002|Dose Level 2|Lost to Follow-up|0|||
163281807|NCT00062868|589739526|FG003|Dose Level 2|Lost to Follow-up|0|||
163281808|NCT00062868|589739527|FG004|Dose Level 2|Lost to Follow-up|0|||
163281809|NCT00062868|589739528|FG005|Dose Level 2|Lost to Follow-up|0|||
163281810|NCT00062868|589739529|FG006|Dose Level 2|Lost to Follow-up|0|||
163281811|NCT00062868|589739530|FG007|Dose Level 2|Lost to Follow-up|0|||
163281812|NCT00062868|589739531|FG008|Dose Level 2|Lost to Follow-up|0|||
163281813|NCT00062868|589739532|FG009|Dose Level 2|Lost to Follow-up|0|||
163281814|NCT00062868|589739533|FG010|Dose Level 2|Lost to Follow-up|0|||
163281815|NCT00062868|589739534|FG011|Dose Level 2|Lost to Follow-up|0|||
162932607|NCT01889862|588458548|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
162932608|NCT01889862|588458549|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
162932609|NCT01889862|588458550|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
162932610|NCT01889862|588458546|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
162932611|NCT01889862|588458547|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
162932612|NCT01889862|588458548|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
162932613|NCT01889862|588458549|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
162932614|NCT01889862|588458550|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
162932615|NCT01889862|588458546|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
162932616|NCT01889862|588458547|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
162932617|NCT01889862|588458548|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
162932618|NCT01889862|588458549|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
162932619|NCT01889862|588458550|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
162932620|NCT01889862|588458546|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
162932621|NCT01889862|588458547|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
162932622|NCT01889862|588458548|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
163176171|NCT00910247|589362068|FG000|Overall Study|Death|2|||
163176172|NCT00910247|589362068|FG000|Overall Study|Lost to Follow-up|10|||
163176173|NCT00910247|589362068|FG000|Overall Study|Physician Decision|3|||
163176174|NCT00910247|589362068|FG000|Overall Study|Protocol Violation|10|||
163176175|NCT00910247|589362068|FG000|Overall Study|Withdrawal by Subject|25|||
163176176|NCT00910247|589362068|FG000|Overall Study|Not collected|4|||
163176177|NCT02927067|589362069|FG000|Overall Study|Withdrawn Consent|20|||
163176178|NCT02927067|589362070|FG001|Overall Study|Withdrawn Consent|12|||
163176179|NCT02927067|589362069|FG000|Overall Study|Death|18|||
163176180|NCT02927067|589362070|FG001|Overall Study|Death|31|||
163176181|NCT02927067|589362069|FG000|Overall Study|Adverse Event|13|||
163176182|NCT02927067|589362070|FG001|Overall Study|Adverse Event|10|||
163176183|NCT02927067|589362069|FG000|Overall Study|Noncompliance|5|||
163176184|NCT02927067|589362070|FG001|Overall Study|Noncompliance|2|||
163176185|NCT02927067|589362069|FG000|Overall Study|Reason not Specified|4|||
163176186|NCT02927067|589362070|FG001|Overall Study|Reason not Specified|6|||
163176187|NCT02292784|589362071|FG000|Overall Study|Lost to Follow-up|1|||
163176188|NCT02292784|589362072|FG001|Overall Study|Lost to Follow-up|17|||
163176189|NCT02292784|589362073|FG002|Overall Study|Lost to Follow-up|18|||
163176190|NCT02292784|589362071|FG000|Overall Study|Withdrawal by Subject|0|||
163176191|NCT02292784|589362072|FG001|Overall Study|Withdrawal by Subject|3|||
163176192|NCT02292784|589362073|FG002|Overall Study|Withdrawal by Subject|3|||
163176193|NCT00622739|589362074|FG000|Overall Study|Physician Decision|1|||
163176194|NCT00622739|589362075|FG001|Overall Study|Physician Decision|0|||
163176195|NCT00622739|589362074|FG000|Overall Study|Adverse Event|1|||
163176196|NCT00622739|589362075|FG001|Overall Study|Adverse Event|2|||
163176197|NCT00622739|589362074|FG000|Overall Study|Lack of Efficacy|0|||
163176198|NCT00622739|589362075|FG001|Overall Study|Lack of Efficacy|2|||
163176199|NCT00622739|589362074|FG000|Overall Study|Withdrawal by Subject|0|||
163176200|NCT00622739|589362075|FG001|Overall Study|Withdrawal by Subject|1|||
163176201|NCT00622739|589362074|FG000|Overall Study|Lost to Follow-up|0|||
163176202|NCT00622739|589362075|FG001|Overall Study|Lost to Follow-up|1|||
163176203|NCT00134784|589362076|FG000|Overall Study|Withdrawal by Subject|2|||
163176204|NCT00134784|589362077|FG001|Overall Study|Withdrawal by Subject|2|||
163176205|NCT00134784|589362078|FG002|Overall Study|Withdrawal by Subject|2|||
163176206|NCT00134784|589362079|FG003|Overall Study|Withdrawal by Subject|1|||
163176207|NCT00625742|589362080|FG000|Overall Study|Disease Progression|2|||
163176208|NCT00625742|589362080|FG000|Overall Study|Withdrawal by Subject|1|||
163176209|NCT00625742|589362080|FG000|Overall Study|Adverse Event|4|||
163176210|NCT00625742|589362080|FG000|Overall Study|Lost to Follow-up|4|||
163176211|NCT00625742|589362080|FG000|Overall Study|Ineligible|1|||
163176212|NCT03384693|589362081|FG000|Overall Study|Adverse Event|3|||
163176213|NCT03387150|589362082|FG000|Overall Study|Withdrawal by Subject|3|||
163176214|NCT03387150|589362083|FG001|Overall Study|Withdrawal by Subject|0|||
163176215|NCT03387150|589362084|FG002|Overall Study|Withdrawal by Subject|3|||
163176216|NCT03387150|589362085|FG003|Overall Study|Withdrawal by Subject|4|||
163176217|NCT03387150|589362086|FG004|Overall Study|Withdrawal by Subject|1|||
162932623|NCT01889862|588458549|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
163176218|NCT03387150|589362087|FG005|Overall Study|Withdrawal by Subject|2|||
163176219|NCT03387150|589362088|FG006|Overall Study|Withdrawal by Subject|0|||
162932624|NCT01889862|588458550|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
163176220|NCT03387150|589362082|FG000|Overall Study|Lost to Follow-up|3|||
163176221|NCT03387150|589362083|FG001|Overall Study|Lost to Follow-up|2|||
162932625|NCT01889862|588458546|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
163176222|NCT03387150|589362084|FG002|Overall Study|Lost to Follow-up|2|||
163176223|NCT03387150|589362085|FG003|Overall Study|Lost to Follow-up|3|||
163176224|NCT03387150|589362086|FG004|Overall Study|Lost to Follow-up|3|||
163176225|NCT03387150|589362087|FG005|Overall Study|Lost to Follow-up|3|||
162932626|NCT01889862|588458547|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
162932627|NCT01889862|588458548|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
163176226|NCT03387150|589362088|FG006|Overall Study|Lost to Follow-up|0|||
163281816|NCT00062868|589739535|FG012|Dose Level 2|Lost to Follow-up|0|||
163281817|NCT00062868|589739536|FG013|Dose Level 2|Lost to Follow-up|1|||
163281818|NCT00062868|589739537|FG014|Dose Level 2|Lost to Follow-up|0|||
163281819|NCT00062868|589739538|FG015|Dose Level 2|Lost to Follow-up|0|||
163281820|NCT00062868|589739539|FG016|Dose Level 2|Lost to Follow-up|1|||
163281821|NCT00062868|589739540|FG017|Dose Level 2|Lost to Follow-up|0|||
163281822|NCT00062868|589739541|FG018|Dose Level 2|Lost to Follow-up|0|||
163281823|NCT00062868|589739542|FG019|Dose Level 2|Lost to Follow-up|0|||
163281824|NCT00062868|589739543|FG020|Dose Level 2|Lost to Follow-up|0|||
163281825|NCT00062868|589739523|FG000|Dose Level 3|Death|0|||
163281826|NCT00062868|589739524|FG001|Dose Level 3|Death|0|||
163281827|NCT00062868|589739525|FG002|Dose Level 3|Death|0|||
163281828|NCT00062868|589739526|FG003|Dose Level 3|Death|0|||
163281829|NCT00062868|589739527|FG004|Dose Level 3|Death|0|||
163281830|NCT00062868|589739528|FG005|Dose Level 3|Death|0|||
163281831|NCT00062868|589739529|FG006|Dose Level 3|Death|0|||
163281832|NCT00062868|589739530|FG007|Dose Level 3|Death|0|||
163281833|NCT00062868|589739531|FG008|Dose Level 3|Death|0|||
163281834|NCT00062868|589739532|FG009|Dose Level 3|Death|0|||
163281835|NCT00062868|589739533|FG010|Dose Level 3|Death|0|||
163281836|NCT00062868|589739534|FG011|Dose Level 3|Death|1|||
163281837|NCT00062868|589739535|FG012|Dose Level 3|Death|0|||
163281838|NCT00062868|589739536|FG013|Dose Level 3|Death|0|||
163281839|NCT00062868|589739537|FG014|Dose Level 3|Death|0|||
163281840|NCT00062868|589739538|FG015|Dose Level 3|Death|0|||
163281841|NCT00062868|589739539|FG016|Dose Level 3|Death|0|||
163281842|NCT00062868|589739540|FG017|Dose Level 3|Death|1|||
163281843|NCT00062868|589739541|FG018|Dose Level 3|Death|0|||
163281844|NCT00062868|589739542|FG019|Dose Level 3|Death|0|||
163281845|NCT00062868|589739543|FG020|Dose Level 3|Death|0|||
163281846|NCT00062868|589739523|FG000|Dose Level 3|Lost to Follow-up|0|||
163281847|NCT00062868|589739524|FG001|Dose Level 3|Lost to Follow-up|0|||
163281848|NCT00062868|589739525|FG002|Dose Level 3|Lost to Follow-up|0|||
163281849|NCT00062868|589739526|FG003|Dose Level 3|Lost to Follow-up|0|||
163281850|NCT00062868|589739527|FG004|Dose Level 3|Lost to Follow-up|0|||
163281851|NCT00062868|589739528|FG005|Dose Level 3|Lost to Follow-up|0|||
163281852|NCT00062868|589739529|FG006|Dose Level 3|Lost to Follow-up|0|||
163281853|NCT00062868|589739530|FG007|Dose Level 3|Lost to Follow-up|0|||
163281854|NCT00062868|589739531|FG008|Dose Level 3|Lost to Follow-up|0|||
163281855|NCT00062868|589739532|FG009|Dose Level 3|Lost to Follow-up|0|||
163281856|NCT00062868|589739533|FG010|Dose Level 3|Lost to Follow-up|0|||
163281857|NCT00062868|589739534|FG011|Dose Level 3|Lost to Follow-up|0|||
163281858|NCT00062868|589739535|FG012|Dose Level 3|Lost to Follow-up|0|||
163281859|NCT00062868|589739536|FG013|Dose Level 3|Lost to Follow-up|0|||
163281860|NCT00062868|589739537|FG014|Dose Level 3|Lost to Follow-up|1|||
163281861|NCT00062868|589739538|FG015|Dose Level 3|Lost to Follow-up|0|||
163281862|NCT00062868|589739539|FG016|Dose Level 3|Lost to Follow-up|0|||
163176227|NCT03387150|589362082|FG000|Overall Study|Participant unable to adhere to visit|0|||
163176228|NCT03387150|589362083|FG001|Overall Study|Participant unable to adhere to visit|1|||
163176229|NCT03387150|589362084|FG002|Overall Study|Participant unable to adhere to visit|0|||
163176230|NCT03387150|589362085|FG003|Overall Study|Participant unable to adhere to visit|0|||
163176231|NCT03387150|589362086|FG004|Overall Study|Participant unable to adhere to visit|2|||
163176232|NCT03387150|589362087|FG005|Overall Study|Participant unable to adhere to visit|2|||
163176233|NCT03387150|589362088|FG006|Overall Study|Participant unable to adhere to visit|0|||
163176234|NCT04006119|589362089|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
163176235|NCT04006119|589362089|FG000|End of Treatment Veledimex|Adverse Event|2|||
163176236|NCT04006119|589362089|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
163176237|NCT04006119|589362089|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
163176238|NCT04006119|589362089|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
163176239|NCT04006119|589362089|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
163176240|NCT02919969|589362090|FG000|Overall Study|Lack of Efficacy|22|||
163176241|NCT02919969|589362090|FG000|Overall Study|Death|4|||
163176242|NCT02919969|589362090|FG000|Overall Study|Physician Decision|3|||
163176243|NCT02919969|589362090|FG000|Overall Study|Withdrawal by Subject|2|||
163176244|NCT03621475|589362091|FG000|Overall Study|No longer required restraints at initiation|0|||
163176245|NCT03621475|589362092|FG001|Overall Study|No longer required restraints at initiation|1|||
163176246|NCT00920907|589362098|FG000|Induction Period|Adverse Event|0|||
163176247|NCT00920907|589362099|FG001|Induction Period|Adverse Event|2|||
163176248|NCT00920907|589362098|FG000|Induction Period|Death|1|||
163176249|NCT00920907|589362099|FG001|Induction Period|Death|1|||
163176250|NCT00920907|589362098|FG000|Induction Period|Disease Progression|12|||
163176251|NCT00920907|589362099|FG001|Induction Period|Disease Progression|11|||
163176252|NCT00920907|589362098|FG000|Induction Period|Study Drug Toxicity|8|||
163176253|NCT00920907|589362099|FG001|Induction Period|Study Drug Toxicity|6|||
163176254|NCT00920907|589362098|FG000|Induction Period|No longer meets study criteria|0|||
163176255|NCT00920907|589362099|FG001|Induction Period|No longer meets study criteria|1|||
163176256|NCT00920907|589362098|FG000|Induction Period|Withdrawal by Subject|1|||
163176257|NCT00920907|589362099|FG001|Induction Period|Withdrawal by Subject|1|||
163176258|NCT00920907|589362098|FG000|Maintenance Period|Disease Progression|3|||
163176259|NCT00920907|589362099|FG001|Maintenance Period|Disease Progression|7|||
163176260|NCT00920907|589362098|FG000|Maintenance Period|Administrative (study closure)|7|||
163176261|NCT00920907|589362099|FG001|Maintenance Period|Administrative (study closure)|2|||
163176262|NCT00920907|589362098|FG000|Maintenance Period|Study Drug Toxicity|0|||
163176263|NCT00920907|589362099|FG001|Maintenance Period|Study Drug Toxicity|2|||
163176264|NCT00920907|589362098|FG000|Maintenance Period|Death|1|||
163176265|NCT00920907|589362099|FG001|Maintenance Period|Death|1|||
163176266|NCT00920907|589362098|FG000|Maintenance Period|Withdrawal by Subject|1|||
163176267|NCT00920907|589362099|FG001|Maintenance Period|Withdrawal by Subject|0|||
163176268|NCT00920907|589362098|FG000|Maintenance Period|Adverse Event|0|||
163176269|NCT00920907|589362099|FG001|Maintenance Period|Adverse Event|1|||
163176270|NCT02616601|589362100|FG000|Overall Study|Withdrawal by Subject|4|||
163176271|NCT02616601|589362101|FG001|Overall Study|Withdrawal by Subject|4|||
163176272|NCT02616601|589362102|FG002|Overall Study|Withdrawal by Subject|3|||
163176273|NCT02616601|589362100|FG000|Overall Study|Adverse Event|2|||
163176274|NCT02616601|589362101|FG001|Overall Study|Adverse Event|0|||
163176275|NCT02616601|589362102|FG002|Overall Study|Adverse Event|2|||
163176276|NCT02616601|589362100|FG000|Overall Study|Death|1|||
163176277|NCT02616601|589362101|FG001|Overall Study|Death|0|||
163176278|NCT02616601|589362102|FG002|Overall Study|Death|0|||
163176279|NCT02616601|589362100|FG000|Overall Study|Lost to Follow-up|1|||
163176280|NCT02616601|589362101|FG001|Overall Study|Lost to Follow-up|0|||
163176281|NCT02616601|589362102|FG002|Overall Study|Lost to Follow-up|1|||
163281863|NCT00062868|589739540|FG017|Dose Level 3|Lost to Follow-up|0|||
163281864|NCT00062868|589739541|FG018|Dose Level 3|Lost to Follow-up|0|||
163281865|NCT00062868|589739542|FG019|Dose Level 3|Lost to Follow-up|0|||
163281866|NCT00062868|589739543|FG020|Dose Level 3|Lost to Follow-up|0|||
163281867|NCT00062868|589739523|FG000|Dose Level 3|Withdrew|0|||
163281868|NCT00062868|589739524|FG001|Dose Level 3|Withdrew|0|||
163281869|NCT00062868|589739525|FG002|Dose Level 3|Withdrew|2|||
163281870|NCT00062868|589739526|FG003|Dose Level 3|Withdrew|0|||
163281871|NCT00062868|589739527|FG004|Dose Level 3|Withdrew|0|||
163281872|NCT00062868|589739528|FG005|Dose Level 3|Withdrew|0|||
163281873|NCT00062868|589739529|FG006|Dose Level 3|Withdrew|0|||
163281874|NCT00062868|589739530|FG007|Dose Level 3|Withdrew|0|||
163281875|NCT00062868|589739531|FG008|Dose Level 3|Withdrew|0|||
163281876|NCT00062868|589739532|FG009|Dose Level 3|Withdrew|0|||
163281877|NCT00062868|589739533|FG010|Dose Level 3|Withdrew|0|||
163281878|NCT00062868|589739534|FG011|Dose Level 3|Withdrew|0|||
163281879|NCT00062868|589739535|FG012|Dose Level 3|Withdrew|0|||
163281880|NCT00062868|589739536|FG013|Dose Level 3|Withdrew|0|||
163281881|NCT00062868|589739537|FG014|Dose Level 3|Withdrew|0|||
163281882|NCT00062868|589739538|FG015|Dose Level 3|Withdrew|0|||
163281883|NCT00062868|589739539|FG016|Dose Level 3|Withdrew|0|||
163281884|NCT00062868|589739540|FG017|Dose Level 3|Withdrew|0|||
163281885|NCT00062868|589739541|FG018|Dose Level 3|Withdrew|0|||
163281886|NCT00062868|589739542|FG019|Dose Level 3|Withdrew|0|||
163281887|NCT00062868|589739543|FG020|Dose Level 3|Withdrew|0|||
163281888|NCT02427646|589739544|FG000|Overall Study|Lack of Efficacy|2|||
163281889|NCT02427646|589739545|FG001|Overall Study|Lack of Efficacy|3|||
163281890|NCT02427646|589739544|FG000|Overall Study|Physician Decision|1|||
163281891|NCT02427646|589739545|FG001|Overall Study|Physician Decision|4|||
163281892|NCT02427646|589739544|FG000|Overall Study|Protocol Violation|3|||
163281893|NCT02427646|589739545|FG001|Overall Study|Protocol Violation|3|||
163281894|NCT02427646|589739544|FG000|Overall Study|Bothersome hand weakness|2|||
163281895|NCT02427646|589739545|FG001|Overall Study|Bothersome hand weakness|4|||
163281896|NCT03824236|589739546|FG000|Overall Study|Lost to Follow-up|0|||
163281897|NCT03824236|589739547|FG001|Overall Study|Lost to Follow-up|0|||
163281898|NCT03824236|589739548|FG002|Overall Study|Lost to Follow-up|1|||
163281899|NCT01641861|589739549|FG000|Overall Study|Lost to Follow-up|21|||
163281900|NCT01641861|589739550|FG001|Overall Study|Lost to Follow-up|16|||
163281901|NCT01641861|589739549|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
163281902|NCT01641861|589739550|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
163281903|NCT01641861|589739549|FG000|Overall Study|Died due to drowning|0|||
163281904|NCT01641861|589739550|FG001|Overall Study|Died due to drowning|1|||
163281905|NCT01101542|589739553|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
163281906|NCT01101542|589739553|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
163281907|NCT01101542|589739553|FG000|Year 4 Surveillance Period|Other|287|||
163281908|NCT01101542|589739553|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
163281909|NCT01101542|589739553|FG000|Year 5 Surveillance Period|Pregnancy|1|||
163281910|NCT01101542|589739553|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
163281911|NCT01101542|589739553|FG000|Year 6 Surveillance Period|Pregnancy|1|||
163281912|NCT01101542|589739553|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
163281913|NCT00701311|589739554|FG000|Overall Study|Lack of Efficacy|3|||
163281914|NCT00701311|589739554|FG000|Overall Study|Adverse Event|3|||
163281915|NCT00701311|589739554|FG000|Overall Study|Withdrawal by Subject|2|||
163281916|NCT04580407|589739555|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
163281917|NCT00814489|589739583|FG000|Overall Study|Other|2|||
163176282|NCT02616601|589362100|FG000|Overall Study|Non-Compliance with Test Article|1|||
163176283|NCT02616601|589362101|FG001|Overall Study|Non-Compliance with Test Article|0|||
163176284|NCT02616601|589362102|FG002|Overall Study|Non-Compliance with Test Article|1|||
163176285|NCT00371761|589362103|FG000|Overall Study|Adverse Event|1|||
163176286|NCT00371761|589362104|FG001|Overall Study|Adverse Event|1|||
163176287|NCT00371761|589362103|FG000|Overall Study|Withdrawal by Subject|1|||
163176288|NCT00371761|589362104|FG001|Overall Study|Withdrawal by Subject|3|||
163176289|NCT00371761|589362103|FG000|Overall Study|Investigator Judgment|2|||
163176290|NCT00371761|589362104|FG001|Overall Study|Investigator Judgment|3|||
163176291|NCT00371761|589362103|FG000|Overall Study|Study termination|4|||
163176292|NCT00371761|589362104|FG001|Overall Study|Study termination|3|||
163176293|NCT00718081|589362106|FG000|Overall Study|Adverse Event|0|||
163176294|NCT00718081|589362107|FG001|Overall Study|Adverse Event|1|||
163176295|NCT00718081|589362108|FG002|Overall Study|Adverse Event|0|||
163176296|NCT00718081|589362106|FG000|Overall Study|Lack of Efficacy|7|||
163176297|NCT00718081|589362107|FG001|Overall Study|Lack of Efficacy|3|||
163176298|NCT00718081|589362108|FG002|Overall Study|Lack of Efficacy|21|||
163176299|NCT00923364|589362109|FG000|Overall Study|Death|3|||
163176300|NCT00923364|589362110|FG001|Overall Study|Death|0|||
163176301|NCT00923364|589362109|FG000|Overall Study|Did not go to transplant|1|||
163176302|NCT00923364|589362110|FG001|Overall Study|Did not go to transplant|0|||
163176303|NCT01397825|589362111|FG000|Overall Study|Progressive Disease|10|||
163176304|NCT01397825|589362112|FG001|Overall Study|Progressive Disease|3|||
163176305|NCT01397825|589362113|FG002|Overall Study|Progressive Disease|11|||
163176306|NCT01397825|589362114|FG003|Overall Study|Progressive Disease|1|||
163176307|NCT01397825|589362115|FG004|Overall Study|Progressive Disease|0|||
163176308|NCT01397825|589362111|FG000|Overall Study|Symptomatic Deterioration|2|||
163176309|NCT01397825|589362112|FG001|Overall Study|Symptomatic Deterioration|0|||
163176310|NCT01397825|589362113|FG002|Overall Study|Symptomatic Deterioration|4|||
163176311|NCT01397825|589362114|FG003|Overall Study|Symptomatic Deterioration|0|||
163176312|NCT01397825|589362115|FG004|Overall Study|Symptomatic Deterioration|0|||
163176313|NCT01397825|589362111|FG000|Overall Study|Adverse Event|0|||
163176314|NCT01397825|589362112|FG001|Overall Study|Adverse Event|1|||
163176315|NCT01397825|589362113|FG002|Overall Study|Adverse Event|5|||
163176316|NCT01397825|589362114|FG003|Overall Study|Adverse Event|1|||
163176317|NCT01397825|589362115|FG004|Overall Study|Adverse Event|0|||
163176318|NCT01397825|589362111|FG000|Overall Study|Withdrawal by Subject|1|||
163176319|NCT01397825|589362112|FG001|Overall Study|Withdrawal by Subject|0|||
163176320|NCT01397825|589362113|FG002|Overall Study|Withdrawal by Subject|5|||
163176321|NCT01397825|589362114|FG003|Overall Study|Withdrawal by Subject|1|||
163176322|NCT01397825|589362115|FG004|Overall Study|Withdrawal by Subject|0|||
163176323|NCT01931670|589362117|FG000|Treatment Period|Exclusionary Medication Received|1|||
163176324|NCT01931670|589362118|FG001|Treatment Period|Exclusionary Medication Received|1|||
163176325|NCT01931670|589362119|FG002|Treatment Period|Exclusionary Medication Received|1|||
163176326|NCT01931670|589362117|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
163176327|NCT01931670|589362118|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
163176328|NCT01931670|589362119|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
163176329|NCT01931670|589362117|FG000|Treatment Period|Subject Noncompliant|4|||
163176330|NCT01931670|589362118|FG001|Treatment Period|Subject Noncompliant|9|||
163176331|NCT01931670|589362119|FG002|Treatment Period|Subject Noncompliant|5|||
163176332|NCT01931670|589362117|FG000|Treatment Period|Adverse Event|19|||
163176333|NCT01931670|589362118|FG001|Treatment Period|Adverse Event|8|||
163176334|NCT01931670|589362119|FG002|Treatment Period|Adverse Event|21|||
163176335|NCT01931670|589362117|FG000|Treatment Period|Lack of Efficacy|11|||
163176336|NCT01931670|589362118|FG001|Treatment Period|Lack of Efficacy|2|||
163176337|NCT01931670|589362119|FG002|Treatment Period|Lack of Efficacy|2|||
163176338|NCT01931670|589362117|FG000|Treatment Period|Pregnancy|7|||
163176339|NCT01931670|589362118|FG001|Treatment Period|Pregnancy|2|||
163281918|NCT00814489|589739584|FG001|Overall Study|Other|0|||
163281919|NCT00814489|589739585|FG002|Overall Study|Other|1|||
163281920|NCT01712685|589739586|FG000|Overall Study|pt declined to participate before trmt|1|||
163281921|NCT04880161|589739587|FG000|Overall Study|Withdrawal by Subject|1|||
163281922|NCT04880161|589739588|FG001|Overall Study|Withdrawal by Subject|0|||
163281923|NCT04880161|589739587|FG000|Overall Study|Lack of Compliance|1|||
163281924|NCT04880161|589739588|FG001|Overall Study|Lack of Compliance|1|||
163281925|NCT04880161|589739587|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
163281926|NCT04880161|589739588|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
163281927|NCT04880161|589739587|FG000|Overall Study|Screen Failure|0|||
163281928|NCT04880161|589739588|FG001|Overall Study|Screen Failure|1|||
163281929|NCT00901485|589739589|FG000|Overall Study|Lack of Efficacy|0|||
163281930|NCT00901485|589739590|FG001|Overall Study|Lack of Efficacy|2|||
163281931|NCT00901485|589739589|FG000|Overall Study|Withdrawal by Subject|1|||
163281932|NCT00901485|589739590|FG001|Overall Study|Withdrawal by Subject|2|||
163281933|NCT00256308|589741183|FG000|Overall Study|Death|2|||
163281934|NCT01419717|589741184|FG000|Overall Study|Protocol-specified Criteria|62|||
163281935|NCT01419717|589741184|FG000|Overall Study|Adverse Event|19|||
163281936|NCT01419717|589741184|FG000|Overall Study|Death|17|||
163281937|NCT01419717|589741184|FG000|Overall Study|Withdrawal by Subject|10|||
163281938|NCT01419717|589741184|FG000|Overall Study|Disease Progression|9|||
163281939|NCT01419717|589741184|FG000|Overall Study|Other|4|||
163281940|NCT01419717|589741184|FG000|Overall Study|Lost to Follow-up|2|||
163281941|NCT01419717|589741184|FG000|Overall Study|Administrative Decision|1|||
163281942|NCT01419717|589741184|FG000|Overall Study|Noncompliance|1|||
163281943|NCT01240356|589741186|FG000|Overall Study|Withdrawal by Subject|2|||
163281944|NCT01240356|589741187|FG001|Overall Study|Withdrawal by Subject|0|||
163281945|NCT01240356|589741186|FG000|Overall Study|MRI contraindication|1|||
163281946|NCT01240356|589741187|FG001|Overall Study|MRI contraindication|0|||
163281947|NCT04048135|589741190|FG000|Overall Study|Withdrawal by Subject|1|||
163281948|NCT04048135|589741191|FG001|Overall Study|Withdrawal by Subject|1|||
163281949|NCT04048135|589741192|FG002|Overall Study|Withdrawal by Subject|1|||
163281950|NCT04048135|589741193|FG003|Overall Study|Withdrawal by Subject|2|||
163281951|NCT04048135|589741194|FG004|Overall Study|Withdrawal by Subject|0|||
163281952|NCT04048135|589741195|FG005|Overall Study|Withdrawal by Subject|0|||
163281953|NCT04048135|589741196|FG006|Overall Study|Withdrawal by Subject|1|||
163281954|NCT04048135|589741197|FG007|Overall Study|Withdrawal by Subject|1|||
163281955|NCT04048135|589741190|FG000|Overall Study|Adverse Event|0|||
163281956|NCT04048135|589741191|FG001|Overall Study|Adverse Event|0|||
163281957|NCT04048135|589741192|FG002|Overall Study|Adverse Event|0|||
163281958|NCT04048135|589741193|FG003|Overall Study|Adverse Event|1|||
163281959|NCT04048135|589741194|FG004|Overall Study|Adverse Event|1|||
163281960|NCT04048135|589741195|FG005|Overall Study|Adverse Event|0|||
163281961|NCT04048135|589741196|FG006|Overall Study|Adverse Event|0|||
163281962|NCT04048135|589741197|FG007|Overall Study|Adverse Event|0|||
163281963|NCT04048135|589741190|FG000|Overall Study|Protocol Violation|0|||
163281964|NCT04048135|589741191|FG001|Overall Study|Protocol Violation|0|||
163281965|NCT04048135|589741192|FG002|Overall Study|Protocol Violation|0|||
163281966|NCT04048135|589741193|FG003|Overall Study|Protocol Violation|0|||
163281967|NCT04048135|589741194|FG004|Overall Study|Protocol Violation|0|||
163281968|NCT04048135|589741195|FG005|Overall Study|Protocol Violation|1|||
163281969|NCT04048135|589741196|FG006|Overall Study|Protocol Violation|0|||
163281970|NCT04048135|589741197|FG007|Overall Study|Protocol Violation|0|||
163281971|NCT00448864|589741198|FG000|Overall Study|Death|1|||
163281972|NCT00448864|589741199|FG001|Overall Study|Death|0|||
163281973|NCT00448864|589741200|FG002|Overall Study|Death|0|||
163281974|NCT00448864|589741198|FG000|Overall Study|Lost to Follow-up|3|||
163281975|NCT00448864|589741199|FG001|Overall Study|Lost to Follow-up|1|||
163281976|NCT00448864|589741200|FG002|Overall Study|Lost to Follow-up|0|||
163281977|NCT00448864|589741198|FG000|Overall Study|Physician Decision|1|||
163281978|NCT00448864|589741199|FG001|Overall Study|Physician Decision|0|||
163281979|NCT00448864|589741200|FG002|Overall Study|Physician Decision|1|||
163281980|NCT00448864|589741198|FG000|Overall Study|Withdrawal by Subject|0|||
163281981|NCT00448864|589741199|FG001|Overall Study|Withdrawal by Subject|2|||
163281982|NCT00448864|589741200|FG002|Overall Study|Withdrawal by Subject|0|||
163281983|NCT00448864|589741198|FG000|Overall Study|Protocol Violation|0|||
163281984|NCT00448864|589741199|FG001|Overall Study|Protocol Violation|2|||
163281985|NCT00448864|589741200|FG002|Overall Study|Protocol Violation|0|||
163281986|NCT01474538|589741202|FG000|Treatment Period 1|Death|1|||
163281987|NCT01474538|589741203|FG001|Treatment Period 1|Death|0|||
163281988|NCT01474538|589741202|FG000|Treatment Period 1|Physician Decision|1|||
163281989|NCT01474538|589741203|FG001|Treatment Period 1|Physician Decision|0|||
163281990|NCT01474538|589741202|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163281991|NCT01474538|589741203|FG001|Treatment Period 1|Withdrawal by Subject|3|||
163281992|NCT01474538|589741202|FG000|Treatment Period 1|Protocol Violation|0|||
163281993|NCT01474538|589741203|FG001|Treatment Period 1|Protocol Violation|1|||
163281994|NCT01474538|589741202|FG000|Treatment Period 2|Death|1|||
163281995|NCT01474538|589741203|FG001|Treatment Period 2|Death|0|||
163281996|NCT01474538|589741202|FG000|Treatment Period 2|Adverse Event|1|||
163281997|NCT01474538|589741203|FG001|Treatment Period 2|Adverse Event|1|||
163281998|NCT01474538|589741202|FG000|Treatment Period 2|Withdrawal by Subject|2|||
163281999|NCT01474538|589741203|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163282000|NCT01474538|589741202|FG000|Treatment Period 2|Sponsor decision|1|||
163282001|NCT01474538|589741203|FG001|Treatment Period 2|Sponsor decision|0|||
163282002|NCT01474538|589741202|FG000|Treatment Period 2|Physician Decision|0|||
163282003|NCT01474538|589741203|FG001|Treatment Period 2|Physician Decision|1|||
163282004|NCT01474538|589741202|FG000|Treatment Period 2|Protocol Violation|1|||
163282005|NCT01474538|589741203|FG001|Treatment Period 2|Protocol Violation|0|||
163282006|NCT00367237|589741204|FG000|Overall Study|Adverse Event|7|||
163282007|NCT00367237|589741205|FG001|Overall Study|Adverse Event|2|||
163282008|NCT00367237|589741204|FG000|Overall Study|Lost to Follow-up|1|||
163282009|NCT00367237|589741205|FG001|Overall Study|Lost to Follow-up|0|||
163282010|NCT00367237|589741204|FG000|Overall Study|Withdrawal by Subject|0|||
163282011|NCT00367237|589741205|FG001|Overall Study|Withdrawal by Subject|4|||
163282012|NCT00367237|589741204|FG000|Overall Study|Protocol Violation|2|||
163282013|NCT00367237|589741205|FG001|Overall Study|Protocol Violation|5|||
163282014|NCT02501629|589741206|FG000|Overall Study|Death|0|||
163282015|NCT02501629|589741207|FG001|Overall Study|Death|1|||
163282016|NCT02501629|589741206|FG000|Overall Study|Withdrawn from study by sponsor|1|||
163282017|NCT02501629|589741207|FG001|Overall Study|Withdrawn from study by sponsor|0|||
163282018|NCT02501629|589741206|FG000|Overall Study|Early termination by sponsor|1|||
163282019|NCT02501629|589741207|FG001|Overall Study|Early termination by sponsor|0|||
163282020|NCT02501629|589741206|FG000|Overall Study|Withdrawal by Subject|3|||
163282021|NCT02501629|589741207|FG001|Overall Study|Withdrawal by Subject|5|||
163282022|NCT02501629|589741206|FG000|Overall Study|Subject did not return to site|0|||
163282023|NCT02501629|589741207|FG001|Overall Study|Subject did not return to site|1|||
163282024|NCT00868231|589741208|FG000|Treatment Period 1|Adverse Event|0|||
163282025|NCT00868231|589741209|FG001|Treatment Period 1|Adverse Event|0|||
163282026|NCT00868231|589741210|FG002|Treatment Period 1|Adverse Event|0|||
163282027|NCT00868231|589741211|FG003|Treatment Period 1|Adverse Event|0|||
163282028|NCT00868231|589741212|FG004|Treatment Period 1|Adverse Event|1|||
163282029|NCT00868231|589741213|FG005|Treatment Period 1|Adverse Event|0|||
163282030|NCT00868231|589741208|FG000|Treatment Period 2|Adverse Event|1|||
163282031|NCT00868231|589741209|FG001|Treatment Period 2|Adverse Event|0|||
163282032|NCT00868231|589741210|FG002|Treatment Period 2|Adverse Event|0|||
163282033|NCT00868231|589741211|FG003|Treatment Period 2|Adverse Event|0|||
163282034|NCT00868231|589741212|FG004|Treatment Period 2|Adverse Event|0|||
163282035|NCT00868231|589741213|FG005|Treatment Period 2|Adverse Event|0|||
163282036|NCT00868231|589741208|FG000|Treatment Period 3|Adverse Event|0|||
163282037|NCT00868231|589741209|FG001|Treatment Period 3|Adverse Event|0|||
163282038|NCT00868231|589741210|FG002|Treatment Period 3|Adverse Event|1|||
163282039|NCT00868231|589741211|FG003|Treatment Period 3|Adverse Event|0|||
163282040|NCT00868231|589741212|FG004|Treatment Period 3|Adverse Event|0|||
163282041|NCT00868231|589741213|FG005|Treatment Period 3|Adverse Event|0|||
163282042|NCT03120676|589741214|FG000|Overall Study|Not treated|1|||
163282043|NCT00886613|589741219|FG000|Overall Study|Protocol deviation (Part B)|1|||
163282044|NCT00886613|589741220|FG001|Overall Study|Protocol deviation (Part B)|0|||
163282045|NCT00886613|589741221|FG002|Overall Study|Protocol deviation (Part B)|0|||
163282046|NCT00886613|589741219|FG000|Overall Study|Lost to follow-up (Part B)|1|||
163282047|NCT00886613|589741220|FG001|Overall Study|Lost to follow-up (Part B)|0|||
163282048|NCT00886613|589741221|FG002|Overall Study|Lost to follow-up (Part B)|1|||
163282049|NCT00886613|589741219|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
163282050|NCT00886613|589741220|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
163282051|NCT00886613|589741221|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
163282052|NCT00672256|589741226|FG000|Overall Study|PI dropped, bad data|44|||
163282053|NCT01124162|589741227|FG000|First Intervention|Adverse Event|2|||
163282054|NCT01124162|589741228|FG001|First Intervention|Adverse Event|0|||
163282055|NCT01124162|589741227|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
163282056|NCT01124162|589741228|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
163282057|NCT03681691|589741229|FG000|Overall Study|COVID|1|||
163282058|NCT03681691|589741230|FG001|Overall Study|COVID|0|||
163282059|NCT03681691|589741229|FG000|Overall Study|prolonged bleeding|1|||
163282060|NCT03681691|589741230|FG001|Overall Study|prolonged bleeding|0|||
163282061|NCT03681691|589741229|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
163282062|NCT03681691|589741230|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
163282063|NCT02534896|589741231|FG000|Overall Study|Adverse Event|2|||
163282064|NCT02534896|589741232|FG001|Overall Study|Adverse Event|1|||
163282065|NCT02534896|589741233|FG002|Overall Study|Adverse Event|1|||
163282066|NCT02534896|589741231|FG000|Overall Study|Insufficient therapeutic response|2|||
163282067|NCT02534896|589741232|FG001|Overall Study|Insufficient therapeutic response|0|||
163282068|NCT02534896|589741233|FG002|Overall Study|Insufficient therapeutic response|0|||
163282069|NCT00465985|589741234|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
162932628|NCT01889862|588458549|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
162932629|NCT01889862|588458550|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
162932630|NCT01889862|588458546|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
162932631|NCT01889862|588458547|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
162932632|NCT01889862|588458548|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
162932633|NCT01889862|588458549|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
162932634|NCT01889862|588458550|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
162932635|NCT01889862|588458546|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
162932636|NCT01889862|588458547|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
162932637|NCT01889862|588458548|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
162932638|NCT01889862|588458549|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
162932639|NCT01889862|588458550|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
162932640|NCT01889862|588458546|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
162932641|NCT01889862|588458547|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
162932642|NCT01889862|588458548|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
162932643|NCT01889862|588458549|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
162932644|NCT01889862|588458550|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
162932645|NCT00033631|588458551|FG000|Overall Study|Protocol Violation|14|||
162932646|NCT00033631|588458552|FG001|Overall Study|Protocol Violation|11|||
162932647|NCT00033631|588458551|FG000|Overall Study|Withdrawal by Subject|4|||
162932648|NCT00033631|588458552|FG001|Overall Study|Withdrawal by Subject|4|||
162932649|NCT00667719|588458553|FG000|Overall Study|Adverse Event|39|||
162932650|NCT00667719|588458553|FG000|Overall Study|Abnormal Test Procedure|1|||
162932651|NCT00667719|588458553|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
162932652|NCT00667719|588458553|FG000|Overall Study|Protocol Violation|3|||
162932653|NCT00667719|588458553|FG000|Overall Study|Withdrawal by Subject|17|||
162932654|NCT00667719|588458553|FG000|Overall Study|Lost to Follow-up|8|||
162932655|NCT01827371|588458554|FG000|Overall Study|Adverse Event|0|||
162932656|NCT01827371|588458555|FG001|Overall Study|Adverse Event|0|||
162932657|NCT01827371|588458556|FG002|Overall Study|Adverse Event|4|||
162932658|NCT01827371|588458557|FG003|Overall Study|Adverse Event|2|||
162932659|NCT01827371|588458554|FG000|Overall Study|Lost to Follow-up|0|||
162932660|NCT01827371|588458555|FG001|Overall Study|Lost to Follow-up|2|||
162932661|NCT01827371|588458556|FG002|Overall Study|Lost to Follow-up|0|||
162932662|NCT01827371|588458557|FG003|Overall Study|Lost to Follow-up|4|||
162932663|NCT01827371|588458554|FG000|Overall Study|Protocol Violation|1|||
163176340|NCT01931670|589362119|FG002|Treatment Period|Pregnancy|0|||
163176341|NCT01931670|589362117|FG000|Treatment Period|Other|8|||
163176342|NCT01931670|589362118|FG001|Treatment Period|Other|7|||
163176343|NCT01931670|589362119|FG002|Treatment Period|Other|2|||
163176344|NCT01931670|589362117|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
163176345|NCT01931670|589362118|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
163176346|NCT01931670|589362119|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
163176347|NCT01931670|589362117|FG000|Treatment Period|Lost to Follow-up|19|||
163176348|NCT01931670|589362118|FG001|Treatment Period|Lost to Follow-up|5|||
163176349|NCT01931670|589362119|FG002|Treatment Period|Lost to Follow-up|7|||
163176350|NCT01931670|589362117|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
163176351|NCT01931670|589362118|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
163176352|NCT01931670|589362119|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
163176353|NCT01931670|589362117|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
163176354|NCT01931670|589362118|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
163176355|NCT01931670|589362119|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
163176356|NCT01931670|589362117|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
163176357|NCT01931670|589362118|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
163176358|NCT01931670|589362119|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
163176359|NCT01931670|589362117|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
163176360|NCT01931670|589362118|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
163176361|NCT01931670|589362119|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
163176362|NCT01931670|589362117|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
163176363|NCT01931670|589362118|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
163176364|NCT01931670|589362119|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
162932664|NCT01827371|588458555|FG001|Overall Study|Protocol Violation|0|||
162932665|NCT01827371|588458556|FG002|Overall Study|Protocol Violation|0|||
162932666|NCT01827371|588458557|FG003|Overall Study|Protocol Violation|0|||
163176365|NCT01931670|589362117|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
163176366|NCT01931670|589362118|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
163176367|NCT01931670|589362119|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
163176368|NCT00976508|589362122|FG000|Overall Study|Death|7|||
162932667|NCT01827371|588458554|FG000|Overall Study|Withdrawal by Subject|1|||
162932668|NCT01827371|588458555|FG001|Overall Study|Withdrawal by Subject|2|||
162932669|NCT01827371|588458556|FG002|Overall Study|Withdrawal by Subject|2|||
162932670|NCT01827371|588458557|FG003|Overall Study|Withdrawal by Subject|3|||
163282070|NCT00465985|589741235|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
163282071|NCT00465985|589741234|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
163282072|NCT00465985|589741235|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
163282073|NCT00465985|589741234|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
163282074|NCT00465985|589741235|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
163282075|NCT00465985|589741234|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
163282076|NCT00465985|589741235|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
163282077|NCT00269399|589741236|FG000|Overall Study|Lack of Efficacy|27|||
163282078|NCT00269399|589741237|FG001|Overall Study|Lack of Efficacy|10|||
163282079|NCT00269399|589741236|FG000|Overall Study|Adverse Event|10|||
163282080|NCT00269399|589741237|FG001|Overall Study|Adverse Event|4|||
163282081|NCT00269399|589741236|FG000|Overall Study|Withdrawal by Subject|2|||
163282082|NCT00269399|589741237|FG001|Overall Study|Withdrawal by Subject|5|||
163282083|NCT00269399|589741236|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
163282084|NCT00269399|589741237|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
163282085|NCT00269399|589741236|FG000|Overall Study|Other|0|||
163282086|NCT00269399|589741237|FG001|Overall Study|Other|4|||
163282087|NCT00269399|589741236|FG000|Overall Study|Development of exclusion criteria|0|||
163282088|NCT00269399|589741237|FG001|Overall Study|Development of exclusion criteria|1|||
163282089|NCT03439124|589741238|FG000|Overall Study|Adverse Event|2|||
163282090|NCT03439124|589741239|FG001|Overall Study|Adverse Event|0|||
163282091|NCT03439124|589741238|FG000|Overall Study|Lost to Follow-up|1|||
163282092|NCT03439124|589741239|FG001|Overall Study|Lost to Follow-up|0|||
163282093|NCT03439124|589741238|FG000|Overall Study|Other reasons|1|||
163282094|NCT03439124|589741239|FG001|Overall Study|Other reasons|0|||
163282095|NCT04353037|589741240|FG000|Overall Study|Lost to Follow-up|0|||
163282096|NCT04353037|589741241|FG001|Overall Study|Lost to Follow-up|1|||
163282097|NCT04353037|589741242|FG002|Overall Study|Lost to Follow-up|2|||
163282098|NCT04353037|589741243|FG003|Overall Study|Lost to Follow-up|3|||
163282099|NCT04353037|589741240|FG000|Overall Study|Withdrawal by Subject|0|||
163282100|NCT04353037|589741241|FG001|Overall Study|Withdrawal by Subject|2|||
163282101|NCT04353037|589741242|FG002|Overall Study|Withdrawal by Subject|3|||
163282102|NCT04353037|589741243|FG003|Overall Study|Withdrawal by Subject|5|||
163282103|NCT04353037|589741240|FG000|Overall Study|Adverse Event|0|||
163282104|NCT04353037|589741241|FG001|Overall Study|Adverse Event|0|||
163282105|NCT04353037|589741242|FG002|Overall Study|Adverse Event|2|||
163282106|NCT04353037|589741243|FG003|Overall Study|Adverse Event|0|||
163282107|NCT04353037|589741240|FG000|Overall Study|Exposure Change|0|||
163282108|NCT04353037|589741241|FG001|Overall Study|Exposure Change|0|||
163282109|NCT04353037|589741242|FG002|Overall Study|Exposure Change|0|||
163282110|NCT04353037|589741243|FG003|Overall Study|Exposure Change|2|||
163282111|NCT00463151|589741245|FG000|Overall Study|Adverse Event|0|||
163282112|NCT00463151|589741246|FG001|Overall Study|Adverse Event|0|||
163282113|NCT00463151|589741247|FG002|Overall Study|Adverse Event|1|||
163282114|NCT00463151|589741248|FG003|Overall Study|Adverse Event|0|||
163282115|NCT00463151|589741245|FG000|Overall Study|Lack of Efficacy|2|||
163282116|NCT00463151|589741246|FG001|Overall Study|Lack of Efficacy|5|||
163282117|NCT00463151|589741247|FG002|Overall Study|Lack of Efficacy|2|||
163282118|NCT00463151|589741248|FG003|Overall Study|Lack of Efficacy|5|||
163282119|NCT00463151|589741245|FG000|Overall Study|Protocol Violation|0|||
163282120|NCT00463151|589741246|FG001|Overall Study|Protocol Violation|0|||
163282121|NCT00463151|589741247|FG002|Overall Study|Protocol Violation|0|||
163282122|NCT00463151|589741248|FG003|Overall Study|Protocol Violation|1|||
163282123|NCT00463151|589741245|FG000|Overall Study|Withdrawal by Subject|0|||
163282124|NCT00463151|589741246|FG001|Overall Study|Withdrawal by Subject|0|||
163282125|NCT00463151|589741247|FG002|Overall Study|Withdrawal by Subject|0|||
163282126|NCT00463151|589741248|FG003|Overall Study|Withdrawal by Subject|1|||
163282127|NCT05349084|589741249|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
163282128|NCT01579578|589741250|FG000|Overall Study|Death|4|||
163282129|NCT01579578|589741251|FG001|Overall Study|Death|1|||
163282130|NCT01579578|589741250|FG000|Overall Study|Lost to Follow-up|1|||
163282131|NCT01579578|589741251|FG001|Overall Study|Lost to Follow-up|1|||
163282132|NCT01579578|589741250|FG000|Overall Study|Withdrawal by Subject|2|||
163282133|NCT01579578|589741251|FG001|Overall Study|Withdrawal by Subject|1|||
163282134|NCT01579578|589741250|FG000|Overall Study|Eligibility criteria|3|||
163282135|NCT01579578|589741251|FG001|Overall Study|Eligibility criteria|9|||
163282136|NCT01579578|589741250|FG000|Overall Study|Ongoing|3|||
163282137|NCT01579578|589741251|FG001|Overall Study|Ongoing|0|||
163282138|NCT01004263|589741254|FG000|Overall Study|Adverse Event|15|||
163282139|NCT01004263|589741254|FG000|Overall Study|Withdrawal by Subject|58|||
163282140|NCT01004263|589741254|FG000|Overall Study|Protocol Violation|10|||
163282141|NCT01004263|589741254|FG000|Overall Study|Lost to Follow-up|64|||
163282142|NCT01004263|589741254|FG000|Overall Study|Lack of Efficacy|13|||
162932671|NCT01827371|588458554|FG000|Overall Study|Physician Decision|0|||
162932672|NCT01827371|588458555|FG001|Overall Study|Physician Decision|1|||
162932673|NCT01827371|588458556|FG002|Overall Study|Physician Decision|0|||
162932674|NCT01827371|588458557|FG003|Overall Study|Physician Decision|1|||
162932675|NCT01827371|588458554|FG000|Overall Study|Temporary study halt to vaccinations|11|||
162932676|NCT01827371|588458555|FG001|Overall Study|Temporary study halt to vaccinations|2|||
162932677|NCT01827371|588458556|FG002|Overall Study|Temporary study halt to vaccinations|5|||
162932678|NCT01827371|588458557|FG003|Overall Study|Temporary study halt to vaccinations|13|||
162932679|NCT00950599|588458558|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932680|NCT00950599|588458559|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932681|NCT00950599|588458560|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932682|NCT00950599|588458561|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
162932683|NCT00950599|588458562|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932684|NCT00950599|588458563|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932685|NCT00950599|588458564|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932686|NCT00950599|588458565|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932687|NCT00950599|588458566|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932688|NCT00950599|588458567|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932689|NCT00950599|588458558|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162932690|NCT00950599|588458559|FG001|Double-Blind Treatment Period|Adverse Event|1|||
162932691|NCT00950599|588458560|FG002|Double-Blind Treatment Period|Adverse Event|1|||
162932692|NCT00950599|588458561|FG003|Double-Blind Treatment Period|Adverse Event|1|||
162932693|NCT00950599|588458562|FG004|Double-Blind Treatment Period|Adverse Event|1|||
162932694|NCT00950599|588458563|FG005|Double-Blind Treatment Period|Adverse Event|1|||
162932695|NCT00950599|588458564|FG006|Double-Blind Treatment Period|Adverse Event|0|||
162932696|NCT00950599|588458565|FG007|Double-Blind Treatment Period|Adverse Event|0|||
162932697|NCT00950599|588458566|FG008|Double-Blind Treatment Period|Adverse Event|0|||
162932698|NCT00950599|588458567|FG009|Double-Blind Treatment Period|Adverse Event|0|||
162932699|NCT00950599|588458558|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
162932700|NCT00950599|588458559|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
163176369|NCT00976508|589362123|FG001|Overall Study|Death|1|||
163176370|NCT00976508|589362122|FG000|Overall Study|Lost to Follow-up|1|||
163176371|NCT00976508|589362123|FG001|Overall Study|Lost to Follow-up|0|||
163176372|NCT00976508|589362122|FG000|Overall Study|Withdrawal by Subject|1|||
163176373|NCT00976508|589362123|FG001|Overall Study|Withdrawal by Subject|0|||
163176374|NCT00976508|589362122|FG000|Overall Study|Disease Progression|4|||
163176375|NCT00976508|589362123|FG001|Overall Study|Disease Progression|4|||
163176376|NCT00976508|589362122|FG000|Overall Study|Subject Enrolled in Hospice|1|||
163176377|NCT00976508|589362123|FG001|Overall Study|Subject Enrolled in Hospice|0|||
163176378|NCT00976508|589362122|FG000|Overall Study|Terminated by the Sponsor|0|||
163176379|NCT00976508|589362123|FG001|Overall Study|Terminated by the Sponsor|1|||
163176380|NCT04352127|589362124|FG000|Overall Study|Unable to obtain readings|4|||
163176381|NCT04352127|589362125|FG001|Overall Study|Unable to obtain readings|1|||
163176382|NCT00470158|589362126|FG000|Overall Study|Death|0|||
163176383|NCT00470158|589362127|FG001|Overall Study|Death|0|||
163176384|NCT00470158|589362128|FG002|Overall Study|Death|0|||
163176385|NCT00470158|589362129|FG003|Overall Study|Death|0|||
163176386|NCT00470158|589362130|FG004|Overall Study|Death|2|||
163176387|NCT00470158|589362126|FG000|Overall Study|Lost to Follow-up|7|||
163176388|NCT00470158|589362127|FG001|Overall Study|Lost to Follow-up|8|||
163176389|NCT00470158|589362128|FG002|Overall Study|Lost to Follow-up|8|||
163176390|NCT00470158|589362129|FG003|Overall Study|Lost to Follow-up|5|||
163176391|NCT00470158|589362130|FG004|Overall Study|Lost to Follow-up|4|||
163176392|NCT00470158|589362126|FG000|Overall Study|Protocol Violation|1|||
163176393|NCT00470158|589362127|FG001|Overall Study|Protocol Violation|0|||
163176394|NCT00470158|589362128|FG002|Overall Study|Protocol Violation|0|||
163176395|NCT00470158|589362129|FG003|Overall Study|Protocol Violation|0|||
163176396|NCT00470158|589362130|FG004|Overall Study|Protocol Violation|0|||
163176397|NCT01249118|589362131|FG000|First Washout Period|Physician Decision|0|||
163176398|NCT01249118|589362132|FG001|First Washout Period|Physician Decision|1|||
163176399|NCT01249118|589362133|FG002|First Washout Period|Physician Decision|0|||
163176400|NCT00880685|589362134|FG000|Memantine 10mg|Lost to Follow-up|2|||
163176401|NCT00880685|589362134|FG000|Memantine 20mg|Withdrawal by Subject|1|||
163176402|NCT04179890|589362135|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
163176403|NCT04179890|589362136|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
163176404|NCT04179890|589362135|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
163176405|NCT04179890|589362136|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
163176406|NCT04179890|589362135|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
163282143|NCT01004263|589741254|FG000|Overall Study|Pregnancy|2|||
163176407|NCT04179890|589362136|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
163282144|NCT01004263|589741254|FG000|Overall Study|Physician Decision|15|||
162932701|NCT00950599|588458560|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
162932702|NCT00950599|588458561|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
162932703|NCT00950599|588458562|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
162932704|NCT00950599|588458563|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
162932705|NCT00950599|588458564|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
162932706|NCT00950599|588458565|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
162932707|NCT00950599|588458566|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
162932708|NCT00950599|588458567|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
162932709|NCT00950599|588458558|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162932710|NCT00950599|588458559|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
162932711|NCT00950599|588458560|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
162932712|NCT00950599|588458561|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
162932713|NCT00950599|588458562|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
162932714|NCT00950599|588458563|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
162932715|NCT00950599|588458564|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
162932716|NCT00950599|588458565|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
162932717|NCT00950599|588458566|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
162932718|NCT00950599|588458567|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
162932719|NCT00950599|588458558|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
162932720|NCT00950599|588458559|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
162932721|NCT00950599|588458560|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
162932722|NCT00950599|588458561|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
162932723|NCT00950599|588458562|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
162932724|NCT00950599|588458563|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
162932725|NCT00950599|588458564|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
162932726|NCT00950599|588458565|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
162932727|NCT00950599|588458566|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
162932728|NCT00950599|588458567|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
162932729|NCT00950599|588458558|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932730|NCT00950599|588458559|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932731|NCT00950599|588458560|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932732|NCT00950599|588458561|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932733|NCT00950599|588458562|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
162932734|NCT00950599|588458563|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
162932735|NCT00950599|588458564|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932736|NCT00950599|588458565|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932737|NCT00950599|588458566|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932738|NCT00950599|588458567|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932739|NCT00950599|588458558|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
162932740|NCT00950599|588458559|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
162932741|NCT00950599|588458560|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
162932742|NCT00950599|588458561|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
162932743|NCT00950599|588458562|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
162932744|NCT00950599|588458563|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
162932745|NCT00950599|588458564|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
162932746|NCT00950599|588458565|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
162932747|NCT00950599|588458566|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
162932748|NCT00950599|588458567|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
162932749|NCT00950599|588458558|FG000|Follow-Up Period|Adverse Event|0|||
162932750|NCT00950599|588458559|FG001|Follow-Up Period|Adverse Event|0|||
162932751|NCT00950599|588458560|FG002|Follow-Up Period|Adverse Event|0|||
162932752|NCT00950599|588458561|FG003|Follow-Up Period|Adverse Event|0|||
162932753|NCT00950599|588458562|FG004|Follow-Up Period|Adverse Event|0|||
162932754|NCT00950599|588458563|FG005|Follow-Up Period|Adverse Event|0|||
162932755|NCT00950599|588458564|FG006|Follow-Up Period|Adverse Event|0|||
162932756|NCT00950599|588458565|FG007|Follow-Up Period|Adverse Event|0|||
162932757|NCT00950599|588458566|FG008|Follow-Up Period|Adverse Event|1|||
162932758|NCT00950599|588458567|FG009|Follow-Up Period|Adverse Event|0|||
162932759|NCT00950599|588458558|FG000|Follow-Up Period|Lack of Efficacy|0|||
162932760|NCT00950599|588458559|FG001|Follow-Up Period|Lack of Efficacy|0|||
162932761|NCT00950599|588458560|FG002|Follow-Up Period|Lack of Efficacy|0|||
162932762|NCT00950599|588458561|FG003|Follow-Up Period|Lack of Efficacy|0|||
162932763|NCT00950599|588458562|FG004|Follow-Up Period|Lack of Efficacy|0|||
162932764|NCT00950599|588458563|FG005|Follow-Up Period|Lack of Efficacy|0|||
162932765|NCT00950599|588458564|FG006|Follow-Up Period|Lack of Efficacy|0|||
162932766|NCT00950599|588458565|FG007|Follow-Up Period|Lack of Efficacy|0|||
162932767|NCT00950599|588458566|FG008|Follow-Up Period|Lack of Efficacy|3|||
162932768|NCT00950599|588458567|FG009|Follow-Up Period|Lack of Efficacy|0|||
162932769|NCT00950599|588458558|FG000|Follow-Up Period|Lost to Follow-up|0|||
162932770|NCT00950599|588458559|FG001|Follow-Up Period|Lost to Follow-up|0|||
163282145|NCT01004263|589741254|FG000|Overall Study|Lack of Qualifying Event|2|||
163282146|NCT03398356|589741258|FG000|Before Treatment|Lost to Follow-up|1|||
163282147|NCT03398356|589741259|FG001|Before Treatment|Lost to Follow-up|2|||
163282148|NCT03398356|589741260|FG002|Before Treatment|Lost to Follow-up|0|||
163282149|NCT03398356|589741258|FG000|Before Treatment|drug intolerance|2|||
163282150|NCT03398356|589741259|FG001|Before Treatment|drug intolerance|1|||
163282151|NCT03398356|589741260|FG002|Before Treatment|drug intolerance|0|||
163282152|NCT03398356|589741258|FG000|Before Treatment|Withdrawal by Subject|0|||
163282153|NCT03398356|589741259|FG001|Before Treatment|Withdrawal by Subject|5|||
163282154|NCT03398356|589741260|FG002|Before Treatment|Withdrawal by Subject|0|||
163282155|NCT03398356|589741258|FG000|Before Treatment|Physician Decision|0|||
163282156|NCT03398356|589741259|FG001|Before Treatment|Physician Decision|0|||
163282157|NCT03398356|589741260|FG002|Before Treatment|Physician Decision|11|||
163282158|NCT03398356|589741258|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
163282159|NCT03398356|589741259|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
163282160|NCT03398356|589741260|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
163282161|NCT00821236|589741263|FG000|Overall Study|Lost to Follow-up|3|||
163282162|NCT01582243|589741264|FG000|Overall Study|Withdrawal by Subject|1|||
163282163|NCT01582243|589741264|FG000|Overall Study|Adverse Event|1|||
163282164|NCT01582243|589741264|FG000|Overall Study|Lost to Follow-up|1|||
163282165|NCT02096003|589741266|FG000|Overall Study|Protocol Violation|0|||
163282166|NCT02096003|589741267|FG001|Overall Study|Protocol Violation|2|||
163282167|NCT02096003|589741266|FG000|Overall Study|additional surgery|2|||
163282168|NCT02096003|589741267|FG001|Overall Study|additional surgery|1|||
163282169|NCT01763047|589741268|FG000|Period 1|Test Article Not Available|4|||
163282170|NCT01763047|589741269|FG001|Period 1|Test Article Not Available|1|||
163282171|NCT01763047|589741268|FG000|Period 1|Protocol Violation|4|||
163282172|NCT01763047|589741269|FG001|Period 1|Protocol Violation|4|||
163282173|NCT01763047|589741268|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
163282174|NCT01763047|589741269|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
162932771|NCT00950599|588458560|FG002|Follow-Up Period|Lost to Follow-up|0|||
162932772|NCT00950599|588458561|FG003|Follow-Up Period|Lost to Follow-up|0|||
162932773|NCT00950599|588458562|FG004|Follow-Up Period|Lost to Follow-up|0|||
162932774|NCT00950599|588458563|FG005|Follow-Up Period|Lost to Follow-up|0|||
162932775|NCT00950599|588458564|FG006|Follow-Up Period|Lost to Follow-up|0|||
162932776|NCT00950599|588458565|FG007|Follow-Up Period|Lost to Follow-up|0|||
162932777|NCT00950599|588458566|FG008|Follow-Up Period|Lost to Follow-up|5|||
162932778|NCT00950599|588458567|FG009|Follow-Up Period|Lost to Follow-up|1|||
162932779|NCT00950599|588458558|FG000|Follow-Up Period|Physician Decision|0|||
162932780|NCT00950599|588458559|FG001|Follow-Up Period|Physician Decision|0|||
162932781|NCT00950599|588458560|FG002|Follow-Up Period|Physician Decision|0|||
162932782|NCT00950599|588458561|FG003|Follow-Up Period|Physician Decision|0|||
162932783|NCT00950599|588458562|FG004|Follow-Up Period|Physician Decision|0|||
162932784|NCT00950599|588458563|FG005|Follow-Up Period|Physician Decision|0|||
162932785|NCT00950599|588458564|FG006|Follow-Up Period|Physician Decision|0|||
162932786|NCT00950599|588458565|FG007|Follow-Up Period|Physician Decision|0|||
162932787|NCT00950599|588458566|FG008|Follow-Up Period|Physician Decision|1|||
162932788|NCT00950599|588458567|FG009|Follow-Up Period|Physician Decision|0|||
162932789|NCT00950599|588458558|FG000|Follow-Up Period|Poor/Noncompliance|0|||
162932790|NCT00950599|588458559|FG001|Follow-Up Period|Poor/Noncompliance|0|||
162932791|NCT00950599|588458560|FG002|Follow-Up Period|Poor/Noncompliance|0|||
162932792|NCT00950599|588458561|FG003|Follow-Up Period|Poor/Noncompliance|0|||
162932793|NCT00950599|588458562|FG004|Follow-Up Period|Poor/Noncompliance|0|||
162932794|NCT00950599|588458563|FG005|Follow-Up Period|Poor/Noncompliance|0|||
162932795|NCT00950599|588458564|FG006|Follow-Up Period|Poor/Noncompliance|0|||
162932796|NCT00950599|588458565|FG007|Follow-Up Period|Poor/Noncompliance|0|||
162932797|NCT00950599|588458566|FG008|Follow-Up Period|Poor/Noncompliance|1|||
162932798|NCT00950599|588458567|FG009|Follow-Up Period|Poor/Noncompliance|0|||
162932799|NCT00950599|588458558|FG000|Follow-Up Period|Subject withdrew Consent|0|||
162932800|NCT00950599|588458559|FG001|Follow-Up Period|Subject withdrew Consent|0|||
162932801|NCT00950599|588458560|FG002|Follow-Up Period|Subject withdrew Consent|0|||
162932802|NCT00950599|588458561|FG003|Follow-Up Period|Subject withdrew Consent|0|||
162932803|NCT00950599|588458562|FG004|Follow-Up Period|Subject withdrew Consent|0|||
162932804|NCT00950599|588458563|FG005|Follow-Up Period|Subject withdrew Consent|0|||
162932805|NCT00950599|588458564|FG006|Follow-Up Period|Subject withdrew Consent|0|||
162932806|NCT00950599|588458565|FG007|Follow-Up Period|Subject withdrew Consent|0|||
163282175|NCT01763047|589741268|FG000|Period 1|Adverse Event|0|||
163282176|NCT01763047|589741269|FG001|Period 1|Adverse Event|1|||
163282177|NCT01763047|589741268|FG000|Period 1|Unsatisfactory Visual Response|0|||
163282178|NCT01763047|589741269|FG001|Period 1|Unsatisfactory Visual Response|3|||
163282179|NCT01763047|589741268|FG000|Period 1|Lens Power Not Available|0|||
163282180|NCT01763047|589741269|FG001|Period 1|Lens Power Not Available|1|||
163282181|NCT01763047|589741268|FG000|Period 1|Study Site office Closed|0|||
162932807|NCT00950599|588458566|FG008|Follow-Up Period|Subject withdrew Consent|2|||
163282182|NCT01763047|589741269|FG001|Period 1|Study Site office Closed|1|||
163282183|NCT01763047|589741268|FG000|Period 2|Lens Discomfort|1|||
163282184|NCT01763047|589741269|FG001|Period 2|Lens Discomfort|0|||
163176408|NCT04179890|589362135|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
163176409|NCT04179890|589362136|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
163176410|NCT04179890|589362135|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
163176411|NCT04179890|589362136|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
163176412|NCT04179890|589362135|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
163176413|NCT04179890|589362136|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
163176414|NCT04179890|589362135|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
163176415|NCT04179890|589362136|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
163176416|NCT04179890|589362135|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
163176417|NCT04179890|589362136|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
163176418|NCT04179890|589362135|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
163176419|NCT04179890|589362136|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
163176420|NCT00997438|589362138|FG000|Overall Study|Blood draw difficulty|2|||
163176421|NCT00997438|589362139|FG001|Overall Study|Blood draw difficulty|0|||
163176422|NCT00997438|589362140|FG002|Overall Study|Blood draw difficulty|1|||
163176423|NCT00997438|589362138|FG000|Overall Study|Withdrawal by Subject|1|||
163176424|NCT00997438|589362139|FG001|Overall Study|Withdrawal by Subject|1|||
163176425|NCT00997438|589362140|FG002|Overall Study|Withdrawal by Subject|0|||
163176426|NCT00997438|589362138|FG000|Overall Study|Exclusion criteria at visit 1|2|||
163176427|NCT00997438|589362139|FG001|Overall Study|Exclusion criteria at visit 1|2|||
163176428|NCT00997438|589362140|FG002|Overall Study|Exclusion criteria at visit 1|3|||
163176429|NCT01236118|589362141|FG000|Overall Study|Adverse Event|2|||
163176430|NCT01236118|589362142|FG001|Overall Study|Adverse Event|0|||
163176431|NCT01236118|589362143|FG002|Overall Study|Adverse Event|2|||
163176432|NCT01236118|589362141|FG000|Overall Study|Physician Decision|0|||
163176433|NCT01236118|589362142|FG001|Overall Study|Physician Decision|1|||
163176434|NCT01236118|589362143|FG002|Overall Study|Physician Decision|0|||
163176435|NCT01236118|589362141|FG000|Overall Study|Withdrawal by Subject|0|||
163176436|NCT01236118|589362142|FG001|Overall Study|Withdrawal by Subject|0|||
163176437|NCT01236118|589362143|FG002|Overall Study|Withdrawal by Subject|1|||
163176438|NCT04535167|589362144|FG000|Treatment|Adverse Event|0|||
163176439|NCT04535167|589362145|FG001|Treatment|Adverse Event|0|||
163176440|NCT04535167|589362146|FG002|Treatment|Adverse Event|0|||
163176441|NCT04535167|589362147|FG003|Treatment|Adverse Event|0|||
163176442|NCT04535167|589362148|FG004|Treatment|Adverse Event|0|||
163176443|NCT04535167|589362149|FG005|Treatment|Adverse Event|0|||
163176444|NCT04535167|589362150|FG006|Treatment|Adverse Event|1|||
163176445|NCT04535167|589362144|FG000|Follow-Up|Death|0|||
163176446|NCT04535167|589362145|FG001|Follow-Up|Death|0|||
163176447|NCT04535167|589362146|FG002|Follow-Up|Death|0|||
163176448|NCT04535167|589362147|FG003|Follow-Up|Death|0|||
163176449|NCT04535167|589362148|FG004|Follow-Up|Death|0|||
163176450|NCT04535167|589362149|FG005|Follow-Up|Death|0|||
163176451|NCT04535167|589362150|FG006|Follow-Up|Death|1|||
163176452|NCT04535167|589362144|FG000|Follow-Up|Lost to Follow-up|0|||
163176453|NCT04535167|589362145|FG001|Follow-Up|Lost to Follow-up|0|||
163176454|NCT04535167|589362146|FG002|Follow-Up|Lost to Follow-up|0|||
163176455|NCT04535167|589362147|FG003|Follow-Up|Lost to Follow-up|1|||
163176456|NCT04535167|589362148|FG004|Follow-Up|Lost to Follow-up|0|||
163176457|NCT04535167|589362149|FG005|Follow-Up|Lost to Follow-up|0|||
163176458|NCT04535167|589362150|FG006|Follow-Up|Lost to Follow-up|0|||
163176459|NCT00978432|589362151|FG000|Overall Study|Withdrawal by Subject|0|||
163176460|NCT00978432|589362152|FG001|Overall Study|Withdrawal by Subject|0|||
163176461|NCT00978432|589362153|FG002|Overall Study|Withdrawal by Subject|1|||
163176462|NCT00978432|589362151|FG000|Overall Study|Lack of Efficacy|1|||
163176463|NCT00978432|589362152|FG001|Overall Study|Lack of Efficacy|1|||
163176464|NCT00978432|589362153|FG002|Overall Study|Lack of Efficacy|3|||
163176465|NCT00978432|589362151|FG000|Overall Study|Adverse Event|2|||
163176466|NCT00978432|589362152|FG001|Overall Study|Adverse Event|0|||
163176467|NCT00978432|589362153|FG002|Overall Study|Adverse Event|1|||
163176468|NCT02579928|589362154|FG000|Overall Study|Withdrawal by Subject|1|||
163176469|NCT02579928|589362155|FG001|Overall Study|Withdrawal by Subject|0|||
163176470|NCT04300751|589362158|FG000|Overall Study|Withdrawal by Subject|1|||
163176471|NCT04656275|589362164|FG000|Overall Study|Study terminated by sponsor|2|||
163176472|NCT04656275|589362165|FG001|Overall Study|Study terminated by sponsor|4|||
163282185|NCT01763047|589741268|FG000|Period 2|No longer meets Eligibility Criteria|1|||
163282186|NCT01763047|589741269|FG001|Period 2|No longer meets Eligibility Criteria|0|||
163282187|NCT01763047|589741268|FG000|Period 2|Study Site office Closed|1|||
163282188|NCT01763047|589741269|FG001|Period 2|Study Site office Closed|1|||
163176473|NCT00329901|589362167|FG000|Overall Study|Withdrawal by Subject|4|||
163282189|NCT01763047|589741268|FG000|Period 2|Unsatisfactory Visual Response|1|||
163282190|NCT01763047|589741269|FG001|Period 2|Unsatisfactory Visual Response|1|||
163282191|NCT01763047|589741268|FG000|Period 2|Protocol Violation|0|||
163282192|NCT01763047|589741269|FG001|Period 2|Protocol Violation|2|||
163282193|NCT01763047|589741268|FG000|Period 2|Unsatisfactory lens Fitting|0|||
163282194|NCT01763047|589741269|FG001|Period 2|Unsatisfactory lens Fitting|1|||
163282195|NCT01941316|589741277|FG000|Overall Study|Adverse Event|0|||
163282196|NCT01941316|589741278|FG001|Overall Study|Adverse Event|1|||
163282197|NCT01941316|589741279|FG002|Overall Study|Adverse Event|0|||
163282198|NCT01941316|589741280|FG003|Overall Study|Adverse Event|7|||
163282199|NCT01941316|589741277|FG000|Overall Study|Progressive Disease|3|||
163282200|NCT01941316|589741278|FG001|Overall Study|Progressive Disease|6|||
163282201|NCT01941316|589741279|FG002|Overall Study|Progressive Disease|2|||
163282202|NCT01941316|589741280|FG003|Overall Study|Progressive Disease|29|||
163282203|NCT01941316|589741277|FG000|Overall Study|Withdrawal by Subject|0|||
163282204|NCT01941316|589741278|FG001|Overall Study|Withdrawal by Subject|2|||
163282205|NCT01941316|589741279|FG002|Overall Study|Withdrawal by Subject|1|||
163282206|NCT01941316|589741280|FG003|Overall Study|Withdrawal by Subject|8|||
163282207|NCT01941316|589741277|FG000|Overall Study|Death|0|||
163282208|NCT01941316|589741278|FG001|Overall Study|Death|0|||
163282209|NCT01941316|589741279|FG002|Overall Study|Death|0|||
163282210|NCT01941316|589741280|FG003|Overall Study|Death|3|||
163282211|NCT01941316|589741277|FG000|Overall Study|Physician Decision|0|||
163282212|NCT01941316|589741278|FG001|Overall Study|Physician Decision|0|||
163282213|NCT01941316|589741279|FG002|Overall Study|Physician Decision|0|||
163282214|NCT01941316|589741280|FG003|Overall Study|Physician Decision|3|||
163282215|NCT01941316|589741277|FG000|Overall Study|Protocol Violation|0|||
163282216|NCT01941316|589741278|FG001|Overall Study|Protocol Violation|0|||
163282217|NCT01941316|589741279|FG002|Overall Study|Protocol Violation|0|||
163282218|NCT01941316|589741280|FG003|Overall Study|Protocol Violation|3|||
163282219|NCT01941316|589741277|FG000|Overall Study|Intercurrent illness|0|||
163282220|NCT01941316|589741278|FG001|Overall Study|Intercurrent illness|0|||
163282221|NCT01941316|589741279|FG002|Overall Study|Intercurrent illness|0|||
163282222|NCT01941316|589741280|FG003|Overall Study|Intercurrent illness|1|||
163282223|NCT01941316|589741277|FG000|Overall Study|Other, not specified|0|||
163282224|NCT01941316|589741278|FG001|Overall Study|Other, not specified|0|||
162932808|NCT00950599|588458567|FG009|Follow-Up Period|Subject withdrew Consent|1|||
162932809|NCT01361607|588458568|FG000|Overall Study|Adverse Event|38|||
162932810|NCT01361607|588458569|FG001|Overall Study|Adverse Event|29|||
162932811|NCT01361607|588458568|FG000|Overall Study|Withdrawal by Subject|19|||
162932812|NCT01361607|588458569|FG001|Overall Study|Withdrawal by Subject|8|||
162932813|NCT01361607|588458568|FG000|Overall Study|Withdrawal by Investigator|5|||
162932814|NCT01361607|588458569|FG001|Overall Study|Withdrawal by Investigator|3|||
162932815|NCT01361607|588458568|FG000|Overall Study|Lost to Follow-up|1|||
162932816|NCT01361607|588458569|FG001|Overall Study|Lost to Follow-up|0|||
162932817|NCT01361607|588458568|FG000|Overall Study|Met Withdrawal Criteria|1|||
162932818|NCT01361607|588458569|FG001|Overall Study|Met Withdrawal Criteria|1|||
162932819|NCT02741271|588458580|FG000|Overall Study|Lost to Follow-up|2|||
162932820|NCT02741271|588458581|FG001|Overall Study|Lost to Follow-up|0|||
162932821|NCT02741271|588458580|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162932822|NCT02741271|588458581|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
162932823|NCT00373685|588458582|FG000|Overall Study|Death|2|||
162932824|NCT00373685|588458583|FG001|Overall Study|Death|1|||
163176474|NCT00329901|589362168|FG001|Overall Study|Withdrawal by Subject|3|||
163176475|NCT00329901|589362169|FG002|Overall Study|Withdrawal by Subject|2|||
163176476|NCT00329901|589362167|FG000|Overall Study|Lost to Follow-up|2|||
163176477|NCT00329901|589362168|FG001|Overall Study|Lost to Follow-up|0|||
163176478|NCT00329901|589362169|FG002|Overall Study|Lost to Follow-up|1|||
163176479|NCT00329901|589362167|FG000|Overall Study|Protocol Violation|1|||
163176480|NCT00329901|589362168|FG001|Overall Study|Protocol Violation|0|||
163176481|NCT00329901|589362169|FG002|Overall Study|Protocol Violation|1|||
163176482|NCT00329901|589362167|FG000|Overall Study|Unable to classify|2|||
163176483|NCT00329901|589362168|FG001|Overall Study|Unable to classify|2|||
163176484|NCT00329901|589362169|FG002|Overall Study|Unable to classify|0|||
163176485|NCT00924781|589362170|FG000|Overall Study|Study terminated by sponsor|12|||
163176486|NCT00924781|589362171|FG001|Overall Study|Study terminated by sponsor|10|||
163176487|NCT00868517|589362182|FG000|Overall Study|Withdrawal by Subject|3|||
163176488|NCT00868517|589362183|FG001|Overall Study|Withdrawal by Subject|3|||
163176489|NCT00868517|589362184|FG002|Overall Study|Withdrawal by Subject|2|||
163176490|NCT00868517|589362182|FG000|Overall Study|Protocol Violation|1|||
163176491|NCT00868517|589362183|FG001|Overall Study|Protocol Violation|1|||
163176492|NCT00868517|589362184|FG002|Overall Study|Protocol Violation|0|||
163176493|NCT01721577|589362185|FG000|Overall Study|Lack of Efficacy|1|||
163176494|NCT01721577|589362186|FG001|Overall Study|Lack of Efficacy|0|||
163176495|NCT01721577|589362185|FG000|Overall Study|Death|1|||
163176496|NCT01721577|589362186|FG001|Overall Study|Death|0|||
163176497|NCT01721577|589362185|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
163176498|NCT01721577|589362186|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
163176499|NCT01721577|589362185|FG000|Overall Study|Adverse Event|0|||
163176500|NCT01721577|589362186|FG001|Overall Study|Adverse Event|2|||
163176501|NCT01055496|589362188|FG000|Overall Study|Withdrawal by Subject|2|||
163176502|NCT01055496|589362189|FG001|Overall Study|Withdrawal by Subject|4|||
163176503|NCT01055496|589362188|FG000|Overall Study|Death|13|||
163176504|NCT01055496|589362189|FG001|Overall Study|Death|23|||
163176505|NCT01055496|589362188|FG000|Overall Study|Lost to Follow-up|0|||
163176506|NCT01055496|589362189|FG001|Overall Study|Lost to Follow-up|2|||
163176507|NCT01055496|589362188|FG000|Overall Study|Other - Unspecified|0|||
163176508|NCT01055496|589362189|FG001|Overall Study|Other - Unspecified|1|||
163176509|NCT00584740|589362190|FG000|Overall Study|Adverse Event|1|||
163176510|NCT00584740|589362191|FG001|Overall Study|Adverse Event|1|||
163176511|NCT00584740|589362190|FG000|Overall Study|Lack of Efficacy|8|||
163176512|NCT00584740|589362191|FG001|Overall Study|Lack of Efficacy|2|||
163176513|NCT00584740|589362190|FG000|Overall Study|Withdrawal by Subject|3|||
163176514|NCT00584740|589362191|FG001|Overall Study|Withdrawal by Subject|2|||
163176515|NCT00584740|589362190|FG000|Overall Study|Lost to Follow-up|0|||
163176516|NCT00584740|589362191|FG001|Overall Study|Lost to Follow-up|1|||
163176517|NCT02158364|589362193|FG000|Overall Study|Case report forms uncollected|10|||
163176518|NCT02158364|589362193|FG000|Overall Study|Protocol Deviation|50|||
163176519|NCT00732940|589362197|FG000|Overall Study|Withdrawal by Subject|1|||
163176520|NCT00732940|589362198|FG001|Overall Study|Withdrawal by Subject|2|||
163176521|NCT00732940|589362197|FG000|Overall Study|Adverse Event|0|||
163176522|NCT00732940|589362198|FG001|Overall Study|Adverse Event|1|||
163176523|NCT00732940|589362197|FG000|Overall Study|Lost to Follow-up|1|||
163176524|NCT00732940|589362198|FG001|Overall Study|Lost to Follow-up|0|||
163176525|NCT01642732|589362199|FG000|Overall Study|Withdrawal by Subject|1|||
163176526|NCT01589770|589362204|FG000|Overall Study|EGFR <60ml/min|6|||
163176527|NCT01589770|589362205|FG001|Overall Study|EGFR <60ml/min|4|||
163176528|NCT01589770|589362204|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
162932825|NCT00373685|588458582|FG000|Overall Study|Adverse Event|278|||
163176529|NCT01589770|589362205|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
163176530|NCT01077375|589362209|FG000|Overall Study|Adverse Event|2|||
163176531|NCT01077375|589362210|FG001|Overall Study|Adverse Event|15|||
163176532|NCT01077375|589362209|FG000|Overall Study|Lack of Efficacy|6|||
163176533|NCT01077375|589362210|FG001|Overall Study|Lack of Efficacy|8|||
163282225|NCT01941316|589741279|FG002|Overall Study|Other, not specified|0|||
163282226|NCT01941316|589741280|FG003|Overall Study|Other, not specified|1|||
163282227|NCT02775435|589741281|FG000|Overall Study|Adverse Event|32|||
163282228|NCT02775435|589741282|FG001|Overall Study|Adverse Event|27|||
163282229|NCT02775435|589741281|FG000|Overall Study|Lost to Follow-up|2|||
163282230|NCT02775435|589741282|FG001|Overall Study|Lost to Follow-up|2|||
163282231|NCT02775435|589741281|FG000|Overall Study|Sponsor decision|44|||
163282232|NCT02775435|589741282|FG001|Overall Study|Sponsor decision|19|||
163282233|NCT02775435|589741281|FG000|Overall Study|Withdrawal by Subject|4|||
163282234|NCT02775435|589741282|FG001|Overall Study|Withdrawal by Subject|9|||
163282235|NCT02775435|589741281|FG000|Overall Study|Death|196|||
163282236|NCT02775435|589741282|FG001|Overall Study|Death|224|||
163282237|NCT00320489|589741283|FG000|Overall Study|Adverse Event|26|||
163282238|NCT00320489|589741284|FG001|Overall Study|Adverse Event|25|||
163282239|NCT00320489|589741283|FG000|Overall Study|Clinical Relapse|26|||
163282240|NCT00320489|589741284|FG001|Overall Study|Clinical Relapse|20|||
163282241|NCT00320489|589741283|FG000|Overall Study|Death|0|||
163282242|NCT00320489|589741284|FG001|Overall Study|Death|2|||
163282243|NCT00320489|589741283|FG000|Overall Study|Entry Criteria Exclusion|2|||
163282244|NCT00320489|589741284|FG001|Overall Study|Entry Criteria Exclusion|4|||
163282245|NCT00320489|589741283|FG000|Overall Study|Lack of Efficacy|16|||
163282246|NCT00320489|589741284|FG001|Overall Study|Lack of Efficacy|7|||
163282247|NCT00320489|589741283|FG000|Overall Study|Lost to Follow-up|21|||
163282248|NCT00320489|589741284|FG001|Overall Study|Lost to Follow-up|22|||
163282249|NCT00320489|589741283|FG000|Overall Study|Physician Decision|8|||
163282250|NCT00320489|589741284|FG001|Overall Study|Physician Decision|8|||
163282251|NCT00320489|589741283|FG000|Overall Study|Protocol Violation|4|||
163282252|NCT00320489|589741284|FG001|Overall Study|Protocol Violation|4|||
163282253|NCT00320489|589741283|FG000|Overall Study|Sponsor Decision|3|||
163282254|NCT00320489|589741284|FG001|Overall Study|Sponsor Decision|3|||
163282255|NCT00320489|589741283|FG000|Overall Study|Withdrawal by Subject|39|||
163282256|NCT00320489|589741284|FG001|Overall Study|Withdrawal by Subject|41|||
163282257|NCT02282527|589741285|FG000|Overall Study|Lost to Follow-up|0|||
163282258|NCT02282527|589741286|FG001|Overall Study|Lost to Follow-up|1|||
163282259|NCT02282527|589741285|FG000|Overall Study|Lack of home health aid|1|||
163282260|NCT02282527|589741286|FG001|Overall Study|Lack of home health aid|0|||
163282261|NCT00941031|589741287|FG000|Induction Period|Lack of Efficacy|2|||
163282262|NCT00941031|589741288|FG001|Induction Period|Lack of Efficacy|1|||
163282263|NCT00941031|589741289|FG002|Induction Period|Lack of Efficacy|0|||
163282264|NCT00941031|589741290|FG003|Induction Period|Lack of Efficacy|5|||
163282265|NCT00941031|589741291|FG004|Induction Period|Lack of Efficacy|0|||
162932826|NCT00373685|588458583|FG001|Overall Study|Adverse Event|253|||
162932827|NCT00373685|588458582|FG000|Overall Study|Insufficient clinical response|169|||
162932828|NCT00373685|588458583|FG001|Overall Study|Insufficient clinical response|119|||
162932829|NCT00373685|588458582|FG000|Overall Study|Did not meet entrance criteria|167|||
162932830|NCT00373685|588458583|FG001|Overall Study|Did not meet entrance criteria|184|||
162932831|NCT00373685|588458582|FG000|Overall Study|Lost to follow up|83|||
162932832|NCT00373685|588458583|FG001|Overall Study|Lost to follow up|103|||
162932833|NCT00373685|588458582|FG000|Overall Study|No longer willing to participate|337|||
162932834|NCT00373685|588458583|FG001|Overall Study|No longer willing to participate|352|||
162932835|NCT00373685|588458582|FG000|Overall Study|Other|149|||
162932836|NCT00373685|588458583|FG001|Overall Study|Other|146|||
162932837|NCT00373685|588458582|FG000|Overall Study|Protocol Violation|191|||
162932838|NCT00373685|588458583|FG001|Overall Study|Protocol Violation|182|||
162932839|NCT00373685|588458582|FG000|Overall Study|Final Status Unknown|12|||
162932840|NCT00373685|588458583|FG001|Overall Study|Final Status Unknown|4|||
162932841|NCT00373685|588458582|FG000|Overall Study|Randomized, not treated|51|||
162932842|NCT00373685|588458583|FG001|Overall Study|Randomized, not treated|77|||
162932843|NCT02570165|588458584|FG000|Overall Study|Adverse Event|1|||
162932844|NCT02570165|588458585|FG001|Overall Study|Adverse Event|0|||
162932845|NCT02570165|588458586|FG002|Overall Study|Adverse Event|2|||
162932846|NCT02570165|588458587|FG003|Overall Study|Adverse Event|0|||
162932847|NCT02570165|588458588|FG004|Overall Study|Adverse Event|0|||
162932848|NCT02570165|588458589|FG005|Overall Study|Adverse Event|0|||
162932849|NCT02570165|588458590|FG006|Overall Study|Adverse Event|0|||
162932850|NCT02570165|588458584|FG000|Overall Study|Lack of Efficacy|0|||
162932851|NCT02570165|588458585|FG001|Overall Study|Lack of Efficacy|1|||
162932852|NCT02570165|588458586|FG002|Overall Study|Lack of Efficacy|0|||
162932853|NCT02570165|588458587|FG003|Overall Study|Lack of Efficacy|0|||
162932854|NCT02570165|588458588|FG004|Overall Study|Lack of Efficacy|4|||
162932855|NCT02570165|588458589|FG005|Overall Study|Lack of Efficacy|0|||
162932856|NCT02570165|588458590|FG006|Overall Study|Lack of Efficacy|0|||
162932857|NCT02570165|588458584|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
162932858|NCT02570165|588458585|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
162932859|NCT02570165|588458586|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
162932860|NCT02570165|588458587|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
162932861|NCT02570165|588458588|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
162932862|NCT02570165|588458589|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
162932863|NCT02570165|588458590|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
163176534|NCT01077375|589362209|FG000|Overall Study|Withdrawal by Subject|0|||
163176535|NCT01077375|589362210|FG001|Overall Study|Withdrawal by Subject|6|||
163176536|NCT01077375|589362209|FG000|Overall Study|Lost to Follow-up|2|||
163176537|NCT01077375|589362210|FG001|Overall Study|Lost to Follow-up|5|||
163176538|NCT01077375|589362209|FG000|Overall Study|Other Reason|0|||
163176539|NCT01077375|589362210|FG001|Overall Study|Other Reason|1|||
163176540|NCT03021564|589362214|FG000|Overall Study|Death|84|||
163176541|NCT03021564|589362215|FG001|Overall Study|Death|466|||
163176542|NCT03021564|589362214|FG000|Overall Study|Lost to Follow-up|0|||
163176543|NCT03021564|589362215|FG001|Overall Study|Lost to Follow-up|2|||
163176544|NCT00969280|589362216|FG000|Overall Study|Protocol Violation|2|||
163176545|NCT00969280|589362217|FG001|Overall Study|Protocol Violation|1|||
163176546|NCT00969280|589362216|FG000|Overall Study|Withdrawal by Subject|0|||
163176547|NCT00969280|589362217|FG001|Overall Study|Withdrawal by Subject|1|||
163176548|NCT00969280|589362216|FG000|Overall Study|infection of influenza A(H1N1)|0|||
163176549|NCT00969280|589362217|FG001|Overall Study|infection of influenza A(H1N1)|1|||
163176550|NCT00821327|589362218|FG000|Overall Study|Adverse Event|13|||
163176551|NCT00821327|589362218|FG000|Overall Study|Patient Request|1|||
163176552|NCT00821327|589362218|FG000|Overall Study|Investigator Request|2|||
163176553|NCT00821327|589362218|FG000|Overall Study|Sponsor Request|1|||
162932864|NCT02570165|588458584|FG000|Overall Study|Lost to Follow-up|0|||
162932865|NCT02570165|588458585|FG001|Overall Study|Lost to Follow-up|0|||
162932866|NCT02570165|588458586|FG002|Overall Study|Lost to Follow-up|1|||
162932867|NCT02570165|588458587|FG003|Overall Study|Lost to Follow-up|1|||
162932868|NCT02570165|588458588|FG004|Overall Study|Lost to Follow-up|0|||
162932869|NCT02570165|588458589|FG005|Overall Study|Lost to Follow-up|0|||
162932870|NCT02570165|588458590|FG006|Overall Study|Lost to Follow-up|0|||
162932871|NCT02570165|588458584|FG000|Overall Study|Physician Decision|0|||
162932872|NCT02570165|588458585|FG001|Overall Study|Physician Decision|1|||
163176554|NCT00821327|589362218|FG000|Overall Study|Disease Progression|13|||
163176555|NCT00821327|589362218|FG000|Overall Study|Other/Unknown|5|||
163176556|NCT00217464|589362219|FG000|Overall Study|Progression|15|||
163176557|NCT00217464|589362219|FG000|Overall Study|Other|2|||
162932873|NCT02570165|588458586|FG002|Overall Study|Physician Decision|0|||
162932874|NCT02570165|588458587|FG003|Overall Study|Physician Decision|0|||
162932875|NCT02570165|588458588|FG004|Overall Study|Physician Decision|0|||
162932876|NCT02570165|588458589|FG005|Overall Study|Physician Decision|0|||
162932877|NCT02570165|588458590|FG006|Overall Study|Physician Decision|0|||
162932878|NCT02570165|588458584|FG000|Overall Study|Withdrawal by Subject|0|||
163176558|NCT00459979|589362220|FG000|Overall Study|Withdrawal by Subject|1|||
162932879|NCT02570165|588458585|FG001|Overall Study|Withdrawal by Subject|0|||
162932880|NCT02570165|588458586|FG002|Overall Study|Withdrawal by Subject|0|||
162932881|NCT02570165|588458587|FG003|Overall Study|Withdrawal by Subject|2|||
162932882|NCT02570165|588458588|FG004|Overall Study|Withdrawal by Subject|1|||
162932883|NCT02570165|588458589|FG005|Overall Study|Withdrawal by Subject|0|||
162932884|NCT02570165|588458590|FG006|Overall Study|Withdrawal by Subject|0|||
162932885|NCT02570165|588458584|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
162932886|NCT02570165|588458585|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
162932887|NCT02570165|588458586|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
162932888|NCT02570165|588458587|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
162932889|NCT02570165|588458588|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
162932890|NCT02570165|588458589|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
162932891|NCT02570165|588458590|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
162932892|NCT02570165|588458584|FG000|Overall Study|Withdrawal Request by GSK|0|||
162932893|NCT02570165|588458585|FG001|Overall Study|Withdrawal Request by GSK|0|||
162932894|NCT02570165|588458586|FG002|Overall Study|Withdrawal Request by GSK|2|||
162932895|NCT02570165|588458587|FG003|Overall Study|Withdrawal Request by GSK|0|||
162932896|NCT02570165|588458588|FG004|Overall Study|Withdrawal Request by GSK|0|||
162932897|NCT02570165|588458589|FG005|Overall Study|Withdrawal Request by GSK|0|||
162932898|NCT02570165|588458590|FG006|Overall Study|Withdrawal Request by GSK|0|||
162932899|NCT01953783|588458591|FG000|Overall Study|Progressive disease|2|||
162932900|NCT01789281|588458592|FG000|Overall Study|Disease progression|15|||
162932901|NCT01789281|588458593|FG001|Overall Study|Disease progression|4|||
162932902|NCT01789281|588458592|FG000|Overall Study|Adverse Event|5|||
162932903|NCT01789281|588458593|FG001|Overall Study|Adverse Event|5|||
162932904|NCT01789281|588458592|FG000|Overall Study|Withdrawal by Subject|1|||
162932905|NCT01789281|588458593|FG001|Overall Study|Withdrawal by Subject|0|||
162932906|NCT01789281|588458592|FG000|Overall Study|Lost to Follow-up|1|||
162932907|NCT01789281|588458593|FG001|Overall Study|Lost to Follow-up|0|||
162932908|NCT01789281|588458592|FG000|Overall Study|Administrative problems|0|||
162932909|NCT01789281|588458593|FG001|Overall Study|Administrative problems|1|||
162932910|NCT01252238|588458594|FG000|Overall Study|Sponsor terminated study|4|||
162932911|NCT01252238|588458595|FG001|Overall Study|Sponsor terminated study|4|||
162932912|NCT01252238|588458596|FG002|Overall Study|Sponsor terminated study|4|||
162932913|NCT00411762|588458598|FG000|Overall Study|Withdrawal by Subject|5|||
162932914|NCT04428502|588458599|FG000|Overall Study|Did not meet entrance criteria|14|||
162932915|NCT02295280|588458601|FG000|Overall Study|Adverse Event|0|||
162932916|NCT02295280|588458602|FG001|Overall Study|Adverse Event|1|||
162932917|NCT02875067|588458603|FG000|Overall Study|Withdrawal by Subject|1|||
162932918|NCT02875067|588458603|FG000|Overall Study|Withdrawal by Termination of Study|5|||
162932919|NCT01430104|588458604|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
162932920|NCT02713243|588458606|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
162932921|NCT02713243|588458607|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
162932922|NCT02713243|588458606|FG000|Overall Study|Administrative problems|0|||
162932923|NCT02713243|588458607|FG001|Overall Study|Administrative problems|1|||
162932924|NCT02713243|588458606|FG000|Overall Study|Protocol deviation|0|||
162932925|NCT02713243|588458607|FG001|Overall Study|Protocol deviation|1|||
162932926|NCT01133392|588458608|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
162932927|NCT01133392|588458609|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
162932928|NCT01133392|588458608|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
162932929|NCT01133392|588458609|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
163176559|NCT00459979|589362220|FG000|Overall Study|Protocol Violation|1|||
163176560|NCT00278915|589362221|FG000|Overall Study|Disease progression|1|||
163176561|NCT05214573|589362222|FG000|Overall Study|Physician Decision|5924|||
163176562|NCT05214573|589362223|FG001|Overall Study|Physician Decision|0|||
163176563|NCT00814801|589362224|FG000|Overall Study|Adverse Event|15|||
163176564|NCT00814801|589362225|FG001|Overall Study|Adverse Event|16|||
163176565|NCT00814801|589362226|FG002|Overall Study|Adverse Event|19|||
163176566|NCT00814801|589362224|FG000|Overall Study|Withdrawal by Subject|9|||
163176567|NCT00814801|589362225|FG001|Overall Study|Withdrawal by Subject|11|||
163176568|NCT00814801|589362226|FG002|Overall Study|Withdrawal by Subject|14|||
163176569|NCT00814801|589362224|FG000|Overall Study|Inappropriate as a subject|1|||
163176570|NCT00814801|589362225|FG001|Overall Study|Inappropriate as a subject|1|||
163176571|NCT00814801|589362226|FG002|Overall Study|Inappropriate as a subject|1|||
163282266|NCT00941031|589741292|FG005|Induction Period|Lack of Efficacy|0|||
162932930|NCT03751124|588458610|FG000|Overall Study|Adverse Event|4|||
162932931|NCT03751124|588458611|FG001|Overall Study|Adverse Event|3|||
162932932|NCT03751124|588458610|FG000|Overall Study|Protocol Deviation|0|||
162932933|NCT03751124|588458611|FG001|Overall Study|Protocol Deviation|1|||
162932934|NCT03751124|588458610|FG000|Overall Study|Lost to Follow-up|6|||
162932935|NCT03751124|588458611|FG001|Overall Study|Lost to Follow-up|4|||
163176572|NCT00814801|589362224|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
163176573|NCT00814801|589362225|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
163176574|NCT00814801|589362226|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
163282267|NCT00941031|589741293|FG006|Induction Period|Lack of Efficacy|0|||
163176575|NCT00814801|589362224|FG000|Overall Study|Missing or change of caregiver|6|||
163176576|NCT00814801|589362225|FG001|Overall Study|Missing or change of caregiver|2|||
163176577|NCT00814801|589362226|FG002|Overall Study|Missing or change of caregiver|4|||
163176578|NCT00814801|589362224|FG000|Overall Study|Non-compliance|0|||
163176579|NCT00814801|589362225|FG001|Overall Study|Non-compliance|1|||
163176580|NCT00814801|589362226|FG002|Overall Study|Non-compliance|1|||
163176581|NCT00814801|589362224|FG000|Overall Study|Other|2|||
163176582|NCT00814801|589362225|FG001|Overall Study|Other|6|||
163176583|NCT00814801|589362226|FG002|Overall Study|Other|4|||
163176584|NCT01037088|589362232|FG000|Overall Study|Withdrawal by Subject|3|||
163176585|NCT00604214|589362233|FG000|Baseline to Day 28|Death|223|||
163176586|NCT00604214|589362234|FG001|Baseline to Day 28|Death|202|||
163176587|NCT00604214|589362233|FG000|Baseline to Day 28|Lost to Follow-up|2|||
163176588|NCT00604214|589362234|FG001|Baseline to Day 28|Lost to Follow-up|4|||
163176589|NCT00604214|589362233|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
163176590|NCT00604214|589362234|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
163176591|NCT00604214|589362233|FG000|Day 29 to Day 90|Death|64|||
163176592|NCT00604214|589362234|FG001|Day 29 to Day 90|Death|67|||
163176593|NCT00604214|589362233|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
163176594|NCT00604214|589362234|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
163176595|NCT00604214|589362233|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
163176596|NCT00604214|589362234|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
163176597|NCT00604214|589362233|FG000|Day 91 to Day 180|Death|19|||
163176598|NCT00604214|589362234|FG001|Day 91 to Day 180|Death|23|||
163176599|NCT00604214|589362233|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
163176600|NCT00604214|589362234|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
163176601|NCT00604214|589362233|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
163176602|NCT00604214|589362234|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
163176603|NCT00534599|589362235|FG000|Overall Study|Adverse Event|25|||
163176604|NCT00534599|589362236|FG001|Overall Study|Adverse Event|4|||
163176605|NCT00534599|589362235|FG000|Overall Study|Incorrect enrollment|2|||
163176606|NCT00534599|589362236|FG001|Overall Study|Incorrect enrollment|1|||
163176607|NCT00534599|589362235|FG000|Overall Study|Mis-randomization|2|||
163176608|NCT00534599|589362236|FG001|Overall Study|Mis-randomization|2|||
163176609|NCT00534599|589362235|FG000|Overall Study|Developed study-specific d/c criteria|5|||
163176610|NCT00534599|589362236|FG001|Overall Study|Developed study-specific d/c criteria|0|||
163176611|NCT00534599|589362235|FG000|Overall Study|Lack of Efficacy|0|||
163176612|NCT00534599|589362236|FG001|Overall Study|Lack of Efficacy|1|||
163176613|NCT00534599|589362235|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
163176614|NCT00534599|589362236|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
163176615|NCT00534599|589362235|FG000|Overall Study|Protocol Violation|1|||
163176616|NCT00534599|589362236|FG001|Overall Study|Protocol Violation|3|||
163176617|NCT00534599|589362235|FG000|Overall Study|Lost to Follow-up|11|||
163176618|NCT00534599|589362236|FG001|Overall Study|Lost to Follow-up|14|||
163176619|NCT00534599|589362235|FG000|Overall Study|Withdrawal by Subject|4|||
163176620|NCT00534599|589362236|FG001|Overall Study|Withdrawal by Subject|6|||
163176621|NCT00534599|589362235|FG000|Overall Study|Other|7|||
163176622|NCT00534599|589362236|FG001|Overall Study|Other|0|||
163176623|NCT01879579|589363654|FG000|Overall Study|Phone incompatible with texting platform|3|||
163176624|NCT01879579|589363655|FG001|Overall Study|Phone incompatible with texting platform|0|||
163176625|NCT01879579|589363654|FG000|Overall Study|Did not enroll in texting platform|1|||
163176626|NCT01879579|589363655|FG001|Overall Study|Did not enroll in texting platform|0|||
163176627|NCT01879579|589363654|FG000|Overall Study|Did not initiate insulin treatment|1|||
163176628|NCT01879579|589363655|FG001|Overall Study|Did not initiate insulin treatment|0|||
163176629|NCT01879579|589363654|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
163176630|NCT01879579|589363655|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
163176631|NCT01879579|589363654|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
163176632|NCT01879579|589363655|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
163176633|NCT00815516|589363662|FG000|Overall Study|Death|3|||
163176634|NCT00815516|589363663|FG001|Overall Study|Death|1|||
163176635|NCT00815516|589363662|FG000|Overall Study|Physician Decision|1|||
163176636|NCT00815516|589363663|FG001|Overall Study|Physician Decision|0|||
163176637|NCT01992159|589363669|FG000|Overall Study|Withdrawal by Subject|4|||
163176638|NCT01992159|589363670|FG001|Overall Study|Withdrawal by Subject|7|||
163176639|NCT01992159|589363671|FG002|Overall Study|Withdrawal by Subject|0|||
163176640|NCT01992159|589363672|FG003|Overall Study|Withdrawal by Subject|3|||
163176641|NCT01992159|589363669|FG000|Overall Study|Adverse Event|0|||
163176642|NCT01992159|589363670|FG001|Overall Study|Adverse Event|1|||
163176643|NCT01992159|589363671|FG002|Overall Study|Adverse Event|0|||
163176644|NCT01992159|589363672|FG003|Overall Study|Adverse Event|1|||
163176645|NCT01992159|589363669|FG000|Overall Study|Death|0|||
163176646|NCT01992159|589363670|FG001|Overall Study|Death|0|||
163176647|NCT01992159|589363671|FG002|Overall Study|Death|1|||
163176648|NCT01992159|589363672|FG003|Overall Study|Death|0|||
163176649|NCT00095238|589363673|FG000|Overall Study|Lack of Efficacy|9|||
163176650|NCT00095238|589363674|FG001|Overall Study|Lack of Efficacy|9|||
163176651|NCT00095238|589363673|FG000|Overall Study|Adverse Event|331|||
163176652|NCT00095238|589363674|FG001|Overall Study|Adverse Event|287|||
163282268|NCT00941031|589741287|FG000|Induction Period|Withdrawal by Subject|1|||
163282269|NCT00941031|589741288|FG001|Induction Period|Withdrawal by Subject|2|||
163282270|NCT00941031|589741289|FG002|Induction Period|Withdrawal by Subject|2|||
163282271|NCT00941031|589741290|FG003|Induction Period|Withdrawal by Subject|2|||
163282272|NCT00941031|589741291|FG004|Induction Period|Withdrawal by Subject|0|||
163282273|NCT00941031|589741292|FG005|Induction Period|Withdrawal by Subject|0|||
163282274|NCT00941031|589741293|FG006|Induction Period|Withdrawal by Subject|0|||
163282275|NCT00941031|589741287|FG000|Induction Period|Adminstative Problems|1|||
163282276|NCT00941031|589741288|FG001|Induction Period|Adminstative Problems|1|||
163282277|NCT00941031|589741289|FG002|Induction Period|Adminstative Problems|1|||
163282278|NCT00941031|589741290|FG003|Induction Period|Adminstative Problems|0|||
163282279|NCT00941031|589741291|FG004|Induction Period|Adminstative Problems|0|||
163282280|NCT00941031|589741292|FG005|Induction Period|Adminstative Problems|0|||
163282281|NCT00941031|589741293|FG006|Induction Period|Adminstative Problems|0|||
163282282|NCT00941031|589741287|FG000|Induction Period|Adverse Event|1|||
163282283|NCT00941031|589741288|FG001|Induction Period|Adverse Event|0|||
163282284|NCT00941031|589741289|FG002|Induction Period|Adverse Event|3|||
163282285|NCT00941031|589741290|FG003|Induction Period|Adverse Event|2|||
163282286|NCT00941031|589741291|FG004|Induction Period|Adverse Event|0|||
163282287|NCT00941031|589741292|FG005|Induction Period|Adverse Event|0|||
163282288|NCT00941031|589741293|FG006|Induction Period|Adverse Event|0|||
163282289|NCT00941031|589741287|FG000|Maintenance Period|Withdrawal by Subject|0|||
163282290|NCT00941031|589741288|FG001|Maintenance Period|Withdrawal by Subject|0|||
163282291|NCT00941031|589741289|FG002|Maintenance Period|Withdrawal by Subject|0|||
163282292|NCT00941031|589741290|FG003|Maintenance Period|Withdrawal by Subject|0|||
162932936|NCT03751124|588458610|FG000|Overall Study|Withdrawal by Subject|6|||
162932937|NCT03751124|588458611|FG001|Overall Study|Withdrawal by Subject|8|||
162932938|NCT03751124|588458610|FG000|Overall Study|Lack of Efficacy|1|||
162932939|NCT03751124|588458611|FG001|Overall Study|Lack of Efficacy|1|||
162932940|NCT03751124|588458610|FG000|Overall Study|Pregnancy|0|||
163176653|NCT00095238|589363673|FG000|Overall Study|Subject Withdrew Consent|208|||
163176654|NCT00095238|589363674|FG001|Overall Study|Subject Withdrew Consent|223|||
163176655|NCT00095238|589363673|FG000|Overall Study|Death|154|||
163176656|NCT00095238|589363674|FG001|Overall Study|Death|170|||
163176657|NCT00095238|589363673|FG000|Overall Study|Lost to Follow-up|19|||
163176658|NCT00095238|589363674|FG001|Overall Study|Lost to Follow-up|24|||
163176659|NCT00095238|589363673|FG000|Overall Study|Noncompliance|44|||
163176660|NCT00095238|589363674|FG001|Overall Study|Noncompliance|45|||
163176661|NCT00095238|589363673|FG000|Overall Study|No longer met study criteria|4|||
163176662|NCT00095238|589363674|FG001|Overall Study|No longer met study criteria|5|||
163176663|NCT00095238|589363673|FG000|Overall Study|Study terminated by sponsor|0|||
163176664|NCT00095238|589363674|FG001|Overall Study|Study terminated by sponsor|1|||
163176665|NCT00095238|589363673|FG000|Overall Study|Missing|1|||
163176666|NCT00095238|589363674|FG001|Overall Study|Missing|0|||
163176667|NCT00095238|589363673|FG000|Overall Study|Other Reasons|87|||
163176668|NCT00095238|589363674|FG001|Overall Study|Other Reasons|88|||
163176669|NCT03754972|589363675|FG000|Overall Study|Protocol Violation|25|||
163176670|NCT02311582|589363676|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
163176671|NCT02311582|589363677|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
163176672|NCT02311582|589363678|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
163176673|NCT02311582|589363679|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
163176674|NCT02311582|589363680|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
163176675|NCT03404960|589363682|FG000|Overall Study|Adverse Event|0|||
163176676|NCT03404960|589363683|FG001|Overall Study|Adverse Event|2|||
163176677|NCT03404960|589363682|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
163176678|NCT03404960|589363683|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
163176679|NCT03404960|589363682|FG000|Overall Study|Bowel obstruction|0|||
163176680|NCT03404960|589363683|FG001|Overall Study|Bowel obstruction|1|||
163176681|NCT03404960|589363682|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
163176682|NCT03404960|589363683|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
163176683|NCT06460493|589363686|FG000|Overall Study|Withdrawal by Subject|2|||
163176684|NCT00075270|589363691|FG000|Overall Study|Withdrawal by Subject|28|||
163176685|NCT00075270|589363692|FG001|Overall Study|Withdrawal by Subject|21|||
163176686|NCT00075270|589363691|FG000|Overall Study|Lost to Follow-up|25|||
163176687|NCT00075270|589363692|FG001|Overall Study|Lost to Follow-up|28|||
162932941|NCT03751124|588458611|FG001|Overall Study|Pregnancy|1|||
162932942|NCT03751124|588458610|FG000|Overall Study|Other|9|||
163176688|NCT00075270|589363691|FG000|Overall Study|Protocol Violation|0|||
163176689|NCT00075270|589363692|FG001|Overall Study|Protocol Violation|2|||
163176690|NCT00075270|589363691|FG000|Overall Study|Death|198|||
163282293|NCT00941031|589741291|FG004|Maintenance Period|Withdrawal by Subject|6|||
163282294|NCT00941031|589741292|FG005|Maintenance Period|Withdrawal by Subject|2|||
163282295|NCT00941031|589741293|FG006|Maintenance Period|Withdrawal by Subject|13|||
163282296|NCT00941031|589741287|FG000|Maintenance Period|Administrative Problems|0|||
163176691|NCT00075270|589363692|FG001|Overall Study|Death|215|||
163176692|NCT00075270|589363691|FG000|Overall Study|Other/Unknown|9|||
163176693|NCT00075270|589363692|FG001|Overall Study|Other/Unknown|5|||
163176694|NCT00075270|589363691|FG000|Overall Study|Missing|26|||
163176695|NCT00075270|589363692|FG001|Overall Study|Missing|13|||
163176696|NCT00246571|589363693|FG000|Overall Study|Adverse Event|7|||
163176697|NCT00246571|589363694|FG001|Overall Study|Adverse Event|0|||
163176698|NCT00246571|589363693|FG000|Overall Study|Protocol Violation|0|||
163176699|NCT00246571|589363694|FG001|Overall Study|Protocol Violation|1|||
163176700|NCT00246571|589363693|FG000|Overall Study|Withdrawal by Subject|2|||
163176701|NCT00246571|589363694|FG001|Overall Study|Withdrawal by Subject|3|||
163176702|NCT00246571|589363693|FG000|Overall Study|Lack of Efficacy|84|||
163176703|NCT00246571|589363694|FG001|Overall Study|Lack of Efficacy|21|||
163176704|NCT00246571|589363693|FG000|Overall Study|Death|17|||
163176705|NCT00246571|589363694|FG001|Overall Study|Death|3|||
163176706|NCT00246571|589363693|FG000|Overall Study|Sponsor|0|||
163176707|NCT00246571|589363694|FG001|Overall Study|Sponsor|1|||
163176708|NCT00246571|589363693|FG000|Overall Study|Did not meet entrance criteria|2|||
163176709|NCT00246571|589363694|FG001|Overall Study|Did not meet entrance criteria|1|||
163176710|NCT00246571|589363693|FG000|Overall Study|Laboratory abnormalities|1|||
163176711|NCT00246571|589363694|FG001|Overall Study|Laboratory abnormalities|0|||
163176712|NCT00246571|589363693|FG000|Overall Study|Crossover participants|0|||
163176713|NCT00246571|589363694|FG001|Overall Study|Crossover participants|74|||
163176714|NCT00775203|589363695|FG000|Overall Study|Adverse Event|25|||
163176715|NCT00775203|589363696|FG001|Overall Study|Adverse Event|6|||
163176716|NCT00775203|589363695|FG000|Overall Study|Lack of Efficacy|8|||
163176717|NCT00775203|589363696|FG001|Overall Study|Lack of Efficacy|9|||
163176718|NCT00775203|589363695|FG000|Overall Study|Withdrawal by Subject|11|||
163176719|NCT00775203|589363696|FG001|Overall Study|Withdrawal by Subject|9|||
163176720|NCT00775203|589363695|FG000|Overall Study|Lost to Follow-up|11|||
163176721|NCT00775203|589363696|FG001|Overall Study|Lost to Follow-up|15|||
163176722|NCT00775203|589363695|FG000|Overall Study|Administrative reason|2|||
163176723|NCT00775203|589363696|FG001|Overall Study|Administrative reason|0|||
163176724|NCT00775203|589363695|FG000|Overall Study|Noncompliance|4|||
163176725|NCT00775203|589363696|FG001|Overall Study|Noncompliance|2|||
163176726|NCT00775203|589363695|FG000|Overall Study|Protocol Violation|0|||
163176727|NCT00775203|589363696|FG001|Overall Study|Protocol Violation|1|||
163176728|NCT00775203|589363695|FG000|Overall Study|Entered other study|1|||
163176729|NCT00775203|589363696|FG001|Overall Study|Entered other study|0|||
163176730|NCT00775203|589363695|FG000|Overall Study|Physician Decision|0|||
163176731|NCT00775203|589363696|FG001|Overall Study|Physician Decision|1|||
163176732|NCT02987660|589363697|FG000|Overall Study|Study terminated by sponsor|10|||
163176733|NCT02987660|589363698|FG001|Overall Study|Study terminated by sponsor|10|||
163176734|NCT05247398|589363699|FG000|Overall Study|Withdrawal by Subject|1|||
163176735|NCT05171816|589363700|FG000|Overall Study|Death|18|||
163176736|NCT05171816|589363701|FG001|Overall Study|Death|16|||
163176737|NCT02937571|589363702|FG000|Overall Study|Adverse Event|0|||
163176738|NCT02937571|589363703|FG001|Overall Study|Adverse Event|0|||
163176739|NCT02937571|589363704|FG002|Overall Study|Adverse Event|4|||
163176740|NCT02937571|589363702|FG000|Overall Study|Withdrawal by Subject|0|||
163176741|NCT02937571|589363703|FG001|Overall Study|Withdrawal by Subject|0|||
162932943|NCT03751124|588458611|FG001|Overall Study|Other|9|||
163176742|NCT02937571|589363704|FG002|Overall Study|Withdrawal by Subject|3|||
163176743|NCT04902326|589363705|FG000|Overall Study|Withdrawal by Subject|1|||
163176744|NCT04902326|589363706|FG001|Overall Study|Withdrawal by Subject|3|||
163176745|NCT04902326|589363707|FG002|Overall Study|Withdrawal by Subject|0|||
163176746|NCT04902326|589363708|FG003|Overall Study|Withdrawal by Subject|1|||
163176747|NCT04902326|589363705|FG000|Overall Study|Lost to Follow-up|14|||
163176748|NCT04902326|589363706|FG001|Overall Study|Lost to Follow-up|14|||
163176749|NCT04902326|589363707|FG002|Overall Study|Lost to Follow-up|14|||
163176750|NCT04902326|589363708|FG003|Overall Study|Lost to Follow-up|6|||
163176751|NCT01155479|589363713|FG000|Part I|Adverse Event|13|||
163176752|NCT01155479|589363714|FG001|Part I|Adverse Event|8|||
163176753|NCT01155479|589363715|FG002|Part I|Adverse Event|18|||
163176754|NCT01155479|589363716|FG003|Part I|Adverse Event|7|||
163282297|NCT00941031|589741288|FG001|Maintenance Period|Administrative Problems|0|||
163282298|NCT00941031|589741289|FG002|Maintenance Period|Administrative Problems|0|||
163282299|NCT00941031|589741290|FG003|Maintenance Period|Administrative Problems|0|||
163282300|NCT00941031|589741291|FG004|Maintenance Period|Administrative Problems|1|||
163282301|NCT00941031|589741292|FG005|Maintenance Period|Administrative Problems|0|||
163282302|NCT00941031|589741293|FG006|Maintenance Period|Administrative Problems|1|||
163282303|NCT00941031|589741287|FG000|Maintenance Period|Protocol Violation|0|||
163282304|NCT00941031|589741288|FG001|Maintenance Period|Protocol Violation|0|||
163282305|NCT00941031|589741289|FG002|Maintenance Period|Protocol Violation|0|||
163282306|NCT00941031|589741290|FG003|Maintenance Period|Protocol Violation|0|||
163282307|NCT00941031|589741291|FG004|Maintenance Period|Protocol Violation|0|||
163282308|NCT00941031|589741292|FG005|Maintenance Period|Protocol Violation|0|||
163282309|NCT00941031|589741293|FG006|Maintenance Period|Protocol Violation|1|||
163282310|NCT00941031|589741287|FG000|Maintenance Period|Adverse Event|0|||
163282311|NCT00941031|589741288|FG001|Maintenance Period|Adverse Event|0|||
163282312|NCT00941031|589741289|FG002|Maintenance Period|Adverse Event|0|||
163282313|NCT00941031|589741290|FG003|Maintenance Period|Adverse Event|0|||
163282314|NCT00941031|589741291|FG004|Maintenance Period|Adverse Event|0|||
163282315|NCT00941031|589741292|FG005|Maintenance Period|Adverse Event|2|||
163282316|NCT00941031|589741293|FG006|Maintenance Period|Adverse Event|8|||
163282317|NCT00941031|589741287|FG000|Maintenance Period|Lost to Follow-up|0|||
163282318|NCT00941031|589741288|FG001|Maintenance Period|Lost to Follow-up|0|||
163282319|NCT00941031|589741289|FG002|Maintenance Period|Lost to Follow-up|0|||
163282320|NCT00941031|589741290|FG003|Maintenance Period|Lost to Follow-up|0|||
163282321|NCT00941031|589741291|FG004|Maintenance Period|Lost to Follow-up|2|||
163282322|NCT00941031|589741292|FG005|Maintenance Period|Lost to Follow-up|2|||
163282323|NCT00941031|589741293|FG006|Maintenance Period|Lost to Follow-up|7|||
163282324|NCT00941031|589741287|FG000|Maintenance Period|Lack of Efficacy|0|||
163282325|NCT00941031|589741288|FG001|Maintenance Period|Lack of Efficacy|0|||
163282326|NCT00941031|589741289|FG002|Maintenance Period|Lack of Efficacy|0|||
163282327|NCT00941031|589741290|FG003|Maintenance Period|Lack of Efficacy|0|||
163282328|NCT00941031|589741291|FG004|Maintenance Period|Lack of Efficacy|0|||
163282329|NCT00941031|589741292|FG005|Maintenance Period|Lack of Efficacy|0|||
163282330|NCT00941031|589741293|FG006|Maintenance Period|Lack of Efficacy|13|||
163282331|NCT01872611|589741294|FG000|Overall Study|Adverse Event|3|||
163282332|NCT01872611|589741295|FG001|Overall Study|Adverse Event|1|||
163282333|NCT01872611|589741294|FG000|Overall Study|Adverse Event, prior to treatment|0|||
163282334|NCT01872611|589741295|FG001|Overall Study|Adverse Event, prior to treatment|1|||
163282335|NCT01872611|589741294|FG000|Overall Study|Death|0|||
163282336|NCT01872611|589741295|FG001|Overall Study|Death|1|||
163282337|NCT01872611|589741294|FG000|Overall Study|Death, prior to treatment|0|||
163282338|NCT01872611|589741295|FG001|Overall Study|Death, prior to treatment|1|||
163282339|NCT01872611|589741294|FG000|Overall Study|Lost to Follow-up|8|||
163282340|NCT01872611|589741295|FG001|Overall Study|Lost to Follow-up|1|||
163282341|NCT01872611|589741294|FG000|Overall Study|Physician Decision|1|||
163282342|NCT01872611|589741295|FG001|Overall Study|Physician Decision|0|||
163282343|NCT01872611|589741294|FG000|Overall Study|Withdrawal by Subject|6|||
163282344|NCT01872611|589741295|FG001|Overall Study|Withdrawal by Subject|1|||
163282345|NCT01872611|589741294|FG000|Overall Study|Reason not provided|6|||
163282346|NCT01872611|589741295|FG001|Overall Study|Reason not provided|6|||
163282347|NCT04555044|589741298|FG000|Overall Study|Adverse Event|0|||
163282348|NCT04555044|589741299|FG001|Overall Study|Adverse Event|1|||
163282349|NCT04088188|589741302|FG000|Overall Study|Withdrawal by Subject|2|||
163282350|NCT04088188|589741303|FG001|Overall Study|Withdrawal by Subject|0|||
163282351|NCT04088188|589741302|FG000|Overall Study|Adverse Event|2|||
163282352|NCT04088188|589741303|FG001|Overall Study|Adverse Event|0|||
163282353|NCT03686384|589741304|FG000|Overall Study|Lack of Efficacy|4|||
163282354|NCT03686384|589741305|FG001|Overall Study|Lack of Efficacy|13|||
163282355|NCT03686384|589741304|FG000|Overall Study|Lost to Follow-up|3|||
163282356|NCT03686384|589741305|FG001|Overall Study|Lost to Follow-up|0|||
163282357|NCT03686384|589741304|FG000|Overall Study|Physician Decision|0|||
163282358|NCT03686384|589741305|FG001|Overall Study|Physician Decision|1|||
163282359|NCT03686384|589741304|FG000|Overall Study|Took prohibited medication|0|||
163282360|NCT03686384|589741305|FG001|Overall Study|Took prohibited medication|1|||
163282361|NCT01767909|589741308|FG000|Overall Study|Withdrawal by Subject|4|||
163282362|NCT01767909|589741309|FG001|Overall Study|Withdrawal by Subject|7|||
163282363|NCT01767909|589741308|FG000|Overall Study|Adverse Event|3|||
163282364|NCT01767909|589741309|FG001|Overall Study|Adverse Event|1|||
163282365|NCT01767909|589741308|FG000|Overall Study|Withdrawal by Study Partner|3|||
162932944|NCT03751124|588458610|FG000|Overall Study|Participants who did not receive any study drug|0|||
162932945|NCT03751124|588458611|FG001|Overall Study|Participants who did not receive any study drug|1|||
162932946|NCT00555399|588458614|FG000|Overall Study|Withdrawal by Subject|0|||
162932947|NCT00555399|588458615|FG001|Overall Study|Withdrawal by Subject|0|||
162932948|NCT00555399|588458616|FG002|Overall Study|Withdrawal by Subject|1|||
162932949|NCT00555399|588458617|FG003|Overall Study|Withdrawal by Subject|0|||
163176755|NCT01155479|589363717|FG004|Part I|Adverse Event|6|||
163176756|NCT01155479|589363713|FG000|Part I|Administrative|2|||
163176757|NCT01155479|589363714|FG001|Part I|Administrative|2|||
163176758|NCT01155479|589363715|FG002|Part I|Administrative|2|||
163176759|NCT01155479|589363716|FG003|Part I|Administrative|0|||
163176760|NCT01155479|589363717|FG004|Part I|Administrative|0|||
163176761|NCT01155479|589363713|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
163176762|NCT01155479|589363714|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
163176763|NCT01155479|589363715|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
163176764|NCT01155479|589363716|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
163176765|NCT01155479|589363717|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
163176766|NCT01155479|589363713|FG000|Part I|Withdrawal by Subject|11|||
163176767|NCT01155479|589363714|FG001|Part I|Withdrawal by Subject|13|||
163176768|NCT01155479|589363715|FG002|Part I|Withdrawal by Subject|8|||
163176769|NCT01155479|589363716|FG003|Part I|Withdrawal by Subject|8|||
163176770|NCT01155479|589363717|FG004|Part I|Withdrawal by Subject|9|||
163176771|NCT01155479|589363713|FG000|Part I|Lost to Follow-up|0|||
163176772|NCT01155479|589363714|FG001|Part I|Lost to Follow-up|0|||
163176773|NCT01155479|589363715|FG002|Part I|Lost to Follow-up|1|||
163176774|NCT01155479|589363716|FG003|Part I|Lost to Follow-up|1|||
163176775|NCT01155479|589363717|FG004|Part I|Lost to Follow-up|0|||
163176776|NCT01155479|589363713|FG000|Part I|Treatment Failure|3|||
163176777|NCT01155479|589363714|FG001|Part I|Treatment Failure|0|||
163176778|NCT01155479|589363715|FG002|Part I|Treatment Failure|3|||
163176779|NCT01155479|589363716|FG003|Part I|Treatment Failure|1|||
163176780|NCT01155479|589363717|FG004|Part I|Treatment Failure|2|||
163176781|NCT01155479|589363713|FG000|Part I|Did Not Receive Treatment|4|||
163176782|NCT01155479|589363714|FG001|Part I|Did Not Receive Treatment|2|||
163176783|NCT01155479|589363715|FG002|Part I|Did Not Receive Treatment|2|||
163176784|NCT01155479|589363716|FG003|Part I|Did Not Receive Treatment|6|||
163176785|NCT01155479|589363717|FG004|Part I|Did Not Receive Treatment|1|||
163176786|NCT01155479|589363713|FG000|Part I|Non-Compliance with Protocol|2|||
163176787|NCT01155479|589363714|FG001|Part I|Non-Compliance with Protocol|1|||
163176788|NCT01155479|589363715|FG002|Part I|Non-Compliance with Protocol|3|||
163176789|NCT01155479|589363716|FG003|Part I|Non-Compliance with Protocol|3|||
163176790|NCT01155479|589363717|FG004|Part I|Non-Compliance with Protocol|2|||
163176791|NCT01155479|589363713|FG000|Part II|Adverse Event|7|||
163176792|NCT01155479|589363714|FG001|Part II|Adverse Event|6|||
163176793|NCT01155479|589363715|FG002|Part II|Adverse Event|8|||
163176794|NCT01155479|589363716|FG003|Part II|Adverse Event|3|||
163176795|NCT01155479|589363717|FG004|Part II|Adverse Event|4|||
163176796|NCT01155479|589363713|FG000|Part II|Administrative|43|||
163176797|NCT01155479|589363714|FG001|Part II|Administrative|49|||
163176798|NCT01155479|589363715|FG002|Part II|Administrative|36|||
163176799|NCT01155479|589363716|FG003|Part II|Administrative|38|||
163176800|NCT01155479|589363717|FG004|Part II|Administrative|46|||
163176801|NCT01155479|589363713|FG000|Part II|Withdrawal by Subject|8|||
163176802|NCT01155479|589363714|FG001|Part II|Withdrawal by Subject|4|||
163176803|NCT01155479|589363715|FG002|Part II|Withdrawal by Subject|12|||
163176804|NCT01155479|589363716|FG003|Part II|Withdrawal by Subject|7|||
163176805|NCT01155479|589363717|FG004|Part II|Withdrawal by Subject|3|||
163176806|NCT01155479|589363713|FG000|Part II|Lost to Follow-up|1|||
163176807|NCT01155479|589363714|FG001|Part II|Lost to Follow-up|0|||
163176808|NCT01155479|589363715|FG002|Part II|Lost to Follow-up|0|||
163176809|NCT01155479|589363716|FG003|Part II|Lost to Follow-up|0|||
163282366|NCT01767909|589741309|FG001|Overall Study|Withdrawal by Study Partner|1|||
162932950|NCT00555399|588458618|FG004|Overall Study|Withdrawal by Subject|0|||
162932951|NCT00555399|588458619|FG005|Overall Study|Withdrawal by Subject|0|||
162932952|NCT00555399|588458620|FG006|Overall Study|Withdrawal by Subject|0|||
163176810|NCT01155479|589363717|FG004|Part II|Lost to Follow-up|1|||
163176811|NCT01155479|589363713|FG000|Part II|Treatment Failure|0|||
163176812|NCT01155479|589363714|FG001|Part II|Treatment Failure|1|||
163176813|NCT01155479|589363715|FG002|Part II|Treatment Failure|2|||
163176814|NCT01155479|589363716|FG003|Part II|Treatment Failure|0|||
163176815|NCT01155479|589363717|FG004|Part II|Treatment Failure|1|||
163176816|NCT01155479|589363713|FG000|Part II|Non-Compliance with Protocol|0|||
163176817|NCT01155479|589363714|FG001|Part II|Non-Compliance with Protocol|1|||
163176818|NCT01155479|589363715|FG002|Part II|Non-Compliance with Protocol|0|||
163176819|NCT01155479|589363716|FG003|Part II|Non-Compliance with Protocol|2|||
163176820|NCT01155479|589363717|FG004|Part II|Non-Compliance with Protocol|0|||
163176821|NCT01857310|589363718|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
163176822|NCT01857310|589363719|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
163176823|NCT02360605|589363720|FG000|Overall Study|Withdrawal by Subject|4|||
163176824|NCT02360605|589363721|FG001|Overall Study|Withdrawal by Subject|9|||
163176825|NCT02360605|589363720|FG000|Overall Study|Lost to Follow-up|7|||
163282367|NCT01767909|589741308|FG000|Overall Study|Non-Compliance|2|||
163282368|NCT01767909|589741309|FG001|Overall Study|Non-Compliance|0|||
163282369|NCT01767909|589741308|FG000|Overall Study|Perceived Lack of Efficacy|1|||
163282370|NCT01767909|589741309|FG001|Overall Study|Perceived Lack of Efficacy|0|||
163282371|NCT01767909|589741308|FG000|Overall Study|Investigator Recommendation|0|||
163282372|NCT01767909|589741309|FG001|Overall Study|Investigator Recommendation|1|||
163282373|NCT01767909|589741308|FG000|Overall Study|Lost to Follow-up|0|||
163282374|NCT01767909|589741309|FG001|Overall Study|Lost to Follow-up|1|||
163282375|NCT01767909|589741308|FG000|Overall Study|LP uncessessful|0|||
163282376|NCT01767909|589741309|FG001|Overall Study|LP uncessessful|1|||
163282377|NCT01740557|589741314|FG000|Overall Study|Ineligible|1|||
163282378|NCT01740557|589741314|FG000|Overall Study|Screen failure|1|||
163282379|NCT02320253|589741315|FG000|Overall Study|Withdrawal by Subject|3|||
163282380|NCT02320253|589741316|FG001|Overall Study|Withdrawal by Subject|0|||
163282381|NCT02320253|589741317|FG002|Overall Study|Withdrawal by Subject|0|||
163282382|NCT02320253|589741315|FG000|Overall Study|Lost to Follow-up|2|||
163282383|NCT02320253|589741316|FG001|Overall Study|Lost to Follow-up|2|||
163282384|NCT02320253|589741317|FG002|Overall Study|Lost to Follow-up|1|||
163282385|NCT02320253|589741315|FG000|Overall Study|Death|1|||
163282386|NCT02320253|589741316|FG001|Overall Study|Death|0|||
163282387|NCT02320253|589741317|FG002|Overall Study|Death|1|||
163282388|NCT05174065|589741318|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
163282389|NCT05174065|589741319|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
163282390|NCT05174065|589741320|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
163282391|NCT05174065|589741318|FG000|Placebo-controlled Period|Other|0|||
163282392|NCT05174065|589741319|FG001|Placebo-controlled Period|Other|1|||
163282393|NCT05174065|589741320|FG002|Placebo-controlled Period|Other|0|||
163282394|NCT05174065|589741318|FG000|Placebo-controlled Period|Adverse Event|1|||
163282395|NCT05174065|589741319|FG001|Placebo-controlled Period|Adverse Event|1|||
163282396|NCT05174065|589741320|FG002|Placebo-controlled Period|Adverse Event|0|||
163282397|NCT05174065|589741318|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
163282398|NCT05174065|589741319|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
163282399|NCT05174065|589741320|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
163282400|NCT05174065|589741318|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
163282401|NCT05174065|589741319|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
163282402|NCT05174065|589741320|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
163282403|NCT05174065|589741318|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
163282404|NCT05174065|589741319|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
163282405|NCT05174065|589741320|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
163282406|NCT00209274|589741322|FG000|Overall Study|Missed visit|3|||
163282407|NCT00209274|589741323|FG001|Overall Study|Missed visit|2|||
163282408|NCT00209274|589741322|FG000|Overall Study|Death|32|||
163282409|NCT00209274|589741323|FG001|Overall Study|Death|15|||
163282410|NCT00209274|589741322|FG000|Overall Study|Withdrawal by Subject|30|||
163282411|NCT00209274|589741323|FG001|Overall Study|Withdrawal by Subject|15|||
163282412|NCT00209274|589741322|FG000|Overall Study|Randomized not treated (RNT)|6|||
163282413|NCT00209274|589741323|FG001|Overall Study|Randomized not treated (RNT)|15|||
163282414|NCT01190176|589741324|FG000|Overall Study|Withdrawal by Subject|1|||
163282415|NCT01190176|589741324|FG000|Overall Study|Lost to Follow-up|1|||
163282416|NCT02909101|589741325|FG000|Overall Study|Lost to Follow-up|1|||
163282417|NCT02909101|589741326|FG001|Overall Study|Lost to Follow-up|1|||
163282418|NCT01221181|589741327|FG000|Overall Study|Lost to Follow-up|1|||
163282419|NCT02466516|589743528|FG000|Overall Study|Adverse Event|1|||
163282420|NCT02466516|589743529|FG001|Overall Study|Adverse Event|1|||
163282421|NCT02466516|589743530|FG002|Overall Study|Adverse Event|0|||
163282422|NCT02466516|589743531|FG003|Overall Study|Adverse Event|0|||
163282423|NCT02466516|589743532|FG004|Overall Study|Adverse Event|0|||
163282424|NCT02466516|589743528|FG000|Overall Study|Withdrew Consent|1|||
163282425|NCT02466516|589743529|FG001|Overall Study|Withdrew Consent|0|||
163282426|NCT02466516|589743530|FG002|Overall Study|Withdrew Consent|0|||
163282427|NCT02466516|589743531|FG003|Overall Study|Withdrew Consent|0|||
163282428|NCT02466516|589743532|FG004|Overall Study|Withdrew Consent|0|||
163282429|NCT02466516|589743528|FG000|Overall Study|Lost to Follow-up|2|||
163282430|NCT02466516|589743529|FG001|Overall Study|Lost to Follow-up|0|||
163282431|NCT02466516|589743530|FG002|Overall Study|Lost to Follow-up|1|||
163282432|NCT02466516|589743531|FG003|Overall Study|Lost to Follow-up|0|||
163282433|NCT02466516|589743532|FG004|Overall Study|Lost to Follow-up|0|||
163282434|NCT04358549|589743533|FG000|Overall Study|Adverse Event|0|||
163282435|NCT04358549|589743534|FG001|Overall Study|Adverse Event|1|||
163282436|NCT04358549|589743533|FG000|Overall Study|Death|1|||
163282437|NCT04358549|589743534|FG001|Overall Study|Death|0|||
163282438|NCT04358549|589743533|FG000|Overall Study|Lost to Follow-up|2|||
163282439|NCT04358549|589743534|FG001|Overall Study|Lost to Follow-up|1|||
163282440|NCT04358549|589743533|FG000|Overall Study|Withdrawal by Subject|6|||
163282441|NCT04358549|589743534|FG001|Overall Study|Withdrawal by Subject|6|||
163282442|NCT04358549|589743533|FG000|Overall Study|Start remdesivir|1|||
163282443|NCT04358549|589743534|FG001|Overall Study|Start remdesivir|0|||
163282444|NCT03712930|589743535|FG000|Overall Study|Death|7|||
162932953|NCT00555399|588458621|FG007|Overall Study|Withdrawal by Subject|0|||
162932954|NCT00555399|588458622|FG008|Overall Study|Withdrawal by Subject|0|||
162932955|NCT00555399|588458623|FG009|Overall Study|Withdrawal by Subject|0|||
162932956|NCT00555399|588458624|FG010|Overall Study|Withdrawal by Subject|0|||
163282445|NCT03712930|589743535|FG000|Overall Study|Physician Decision|1|||
163282446|NCT03712930|589743535|FG000|Overall Study|Study Terminated by Sponsor|3|||
163282447|NCT03712930|589743535|FG000|Overall Study|Progressive Disease|2|||
163282448|NCT01062126|589743539|FG000|Overall Study|Death|209|||
163282449|NCT01062126|589743539|FG000|Overall Study|All Withdrawals|324|||
163282450|NCT03837028|589743540|FG000|Overall Study|Lost to Follow-up|4|||
163282451|NCT03837028|589743541|FG001|Overall Study|Lost to Follow-up|0|||
163282452|NCT03837028|589743542|FG002|Overall Study|Lost to Follow-up|2|||
163282453|NCT03837028|589743543|FG003|Overall Study|Lost to Follow-up|0|||
163282454|NCT03837028|589743540|FG000|Overall Study|Withdrawal by Subject|12|||
163282455|NCT03837028|589743541|FG001|Overall Study|Withdrawal by Subject|11|||
163282456|NCT03837028|589743542|FG002|Overall Study|Withdrawal by Subject|11|||
163282457|NCT03837028|589743543|FG003|Overall Study|Withdrawal by Subject|7|||
163282458|NCT00646451|589743544|FG000|Overall Study|Adverse Event|3|||
163282459|NCT00646451|589743545|FG001|Overall Study|Adverse Event|0|||
163282460|NCT00646451|589743544|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
163282461|NCT00646451|589743545|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
163282462|NCT03784963|589743546|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
163282463|NCT03784963|589743547|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
163282464|NCT03784963|589743548|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
163282465|NCT03784963|589743549|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
163282466|NCT00157014|589743550|FG000|Overall Study|Death|4|||
163282467|NCT00157014|589743551|FG001|Overall Study|Death|2|||
163282468|NCT00157014|589743552|FG002|Overall Study|Death|1|||
163282469|NCT00157014|589743553|FG003|Overall Study|Death|1|||
163282470|NCT00157014|589743550|FG000|Overall Study|Physician Decision|0|||
163282471|NCT00157014|589743551|FG001|Overall Study|Physician Decision|1|||
163282472|NCT00157014|589743552|FG002|Overall Study|Physician Decision|0|||
163282473|NCT00157014|589743553|FG003|Overall Study|Physician Decision|0|||
163282474|NCT00157014|589743550|FG000|Overall Study|Medications withdrawn on family request|0|||
163282475|NCT00157014|589743551|FG001|Overall Study|Medications withdrawn on family request|1|||
163282476|NCT00157014|589743552|FG002|Overall Study|Medications withdrawn on family request|0|||
163282477|NCT00157014|589743553|FG003|Overall Study|Medications withdrawn on family request|0|||
163282478|NCT00157014|589743550|FG000|Overall Study|Patient withdrawn by investigator|1|||
163282479|NCT00157014|589743551|FG001|Overall Study|Patient withdrawn by investigator|0|||
163282480|NCT00157014|589743552|FG002|Overall Study|Patient withdrawn by investigator|0|||
163282481|NCT00157014|589743553|FG003|Overall Study|Patient withdrawn by investigator|0|||
163282482|NCT00157014|589743550|FG000|Overall Study|Patient unable to return in nursing home|1|||
163282483|NCT00157014|589743551|FG001|Overall Study|Patient unable to return in nursing home|0|||
163282484|NCT00157014|589743552|FG002|Overall Study|Patient unable to return in nursing home|0|||
163282485|NCT00157014|589743553|FG003|Overall Study|Patient unable to return in nursing home|0|||
163282486|NCT00157014|589743550|FG000|Overall Study|Patient would not receive transplant|0|||
163282487|NCT00157014|589743551|FG001|Overall Study|Patient would not receive transplant|1|||
163282488|NCT00157014|589743552|FG002|Overall Study|Patient would not receive transplant|0|||
163282489|NCT00157014|589743553|FG003|Overall Study|Patient would not receive transplant|0|||
163282490|NCT00157014|589743550|FG000|Overall Study|Withdrawal by Subject|1|||
163282491|NCT00157014|589743551|FG001|Overall Study|Withdrawal by Subject|0|||
163282492|NCT00157014|589743552|FG002|Overall Study|Withdrawal by Subject|0|||
163282493|NCT00157014|589743553|FG003|Overall Study|Withdrawal by Subject|0|||
163282494|NCT01362491|589743554|FG000|Overall Study|Ineligible|1|||
163282495|NCT01362491|589743555|FG001|Overall Study|Ineligible|0|||
163282496|NCT01362491|589743556|FG002|Overall Study|Ineligible|0|||
163282497|NCT04867902|589743557|FG000|Overall Study|Lost to Follow-up|1|||
163282498|NCT04867902|589743557|FG000|Overall Study|Withdrawal by Subject|2|||
163282499|NCT04867902|589743557|FG000|Overall Study|Protocol Violation|1|||
162932957|NCT00555399|588458625|FG011|Overall Study|Withdrawal by Subject|1|||
163282500|NCT05355116|589743558|FG000|Overall Study|Withdrawal by Subject|2|||
162932958|NCT00555399|588458614|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
163282501|NCT01390857|589743561|FG000|Overall Study|Protocol Violation|2|||
162932959|NCT00555399|588458615|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
162932960|NCT00555399|588458616|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
162932961|NCT00555399|588458617|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
162932962|NCT00555399|588458618|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
162932963|NCT00555399|588458619|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
162932964|NCT00555399|588458620|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
163282502|NCT01390857|589743561|FG000|Overall Study|Lost to Follow-up|1|||
163282503|NCT01390857|589743561|FG000|Overall Study|No Visit after the First Visit|7|||
163282504|NCT03255018|589743566|FG000|Overall Study|Death on study|0|||
163282505|NCT03255018|589743567|FG001|Overall Study|Death on study|5|||
163282506|NCT03255018|589743566|FG000|Overall Study|Withdrawal by Subject|0|||
163282507|NCT03255018|589743567|FG001|Overall Study|Withdrawal by Subject|2|||
163282508|NCT01688973|589743568|FG000|Overall Study|Ineligible|2|||
163282509|NCT01688973|589743569|FG001|Overall Study|Ineligible|3|||
163282510|NCT03710564|589743573|FG000|Overall Study|Study Terminated by Sponsor|104|||
163282511|NCT03710564|589743574|FG001|Overall Study|Study Terminated by Sponsor|55|||
163282512|NCT03710564|589743573|FG000|Overall Study|Withdrawal by Subject|57|||
163282513|NCT03710564|589743574|FG001|Overall Study|Withdrawal by Subject|25|||
163282514|NCT03710564|589743573|FG000|Overall Study|Death|10|||
163282515|NCT03710564|589743574|FG001|Overall Study|Death|4|||
163282516|NCT03710564|589743573|FG000|Overall Study|Lost to Follow-up|5|||
163282517|NCT03710564|589743574|FG001|Overall Study|Lost to Follow-up|4|||
163282518|NCT03710564|589743573|FG000|Overall Study|Protocol Violation|3|||
163282519|NCT03710564|589743574|FG001|Overall Study|Protocol Violation|2|||
163282520|NCT03710564|589743573|FG000|Overall Study|Adverse Event|3|||
163282521|NCT03710564|589743574|FG001|Overall Study|Adverse Event|0|||
163282522|NCT03710564|589743573|FG000|Overall Study|Physician Decision|2|||
163282523|NCT03710564|589743574|FG001|Overall Study|Physician Decision|3|||
163282524|NCT00293462|589743575|FG000|Overall Study|Withdrawal by Subject|4|||
163282525|NCT00293462|589743576|FG001|Overall Study|Withdrawal by Subject|3|||
163282526|NCT00293462|589743577|FG002|Overall Study|Withdrawal by Subject|8|||
163282527|NCT00293462|589743575|FG000|Overall Study|Death|1|||
163282528|NCT00293462|589743576|FG001|Overall Study|Death|0|||
163282529|NCT00293462|589743577|FG002|Overall Study|Death|0|||
163282530|NCT00293462|589743575|FG000|Overall Study|Lost to Follow-up|0|||
163282531|NCT00293462|589743576|FG001|Overall Study|Lost to Follow-up|1|||
163282532|NCT00293462|589743577|FG002|Overall Study|Lost to Follow-up|0|||
163282533|NCT00293462|589743575|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
163282534|NCT00293462|589743576|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
163282535|NCT00293462|589743577|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
163282536|NCT00293462|589743575|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
163282537|NCT00293462|589743576|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
163282538|NCT00293462|589743577|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
163282539|NCT00293462|589743575|FG000|Overall Study|Refuse Radiation Treatment|1|||
163282540|NCT00293462|589743576|FG001|Overall Study|Refuse Radiation Treatment|0|||
163282541|NCT00293462|589743577|FG002|Overall Study|Refuse Radiation Treatment|0|||
163282542|NCT00293462|589743575|FG000|Overall Study|No Show|0|||
163282543|NCT00293462|589743576|FG001|Overall Study|No Show|0|||
163282544|NCT00293462|589743577|FG002|Overall Study|No Show|1|||
163282545|NCT00293462|589743575|FG000|Overall Study|Went back to his home country|0|||
163282546|NCT00293462|589743576|FG001|Overall Study|Went back to his home country|0|||
163282547|NCT00293462|589743577|FG002|Overall Study|Went back to his home country|1|||
163282548|NCT00293462|589743575|FG000|Overall Study|Blood clot after chemotherapy|0|||
163282549|NCT00293462|589743576|FG001|Overall Study|Blood clot after chemotherapy|0|||
163282550|NCT00293462|589743577|FG002|Overall Study|Blood clot after chemotherapy|1|||
163282551|NCT00293462|589743575|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
163282552|NCT00293462|589743576|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
163282553|NCT00293462|589743577|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
163282554|NCT00293462|589743575|FG000|Overall Study|Possible Tracheostomy leakage|0|||
163282555|NCT00293462|589743576|FG001|Overall Study|Possible Tracheostomy leakage|1|||
163282556|NCT00293462|589743577|FG002|Overall Study|Possible Tracheostomy leakage|0|||
163282557|NCT00293462|589743575|FG000|Overall Study|Low radiation dose in oral cavity|0|||
163282558|NCT00293462|589743576|FG001|Overall Study|Low radiation dose in oral cavity|1|||
163282559|NCT00293462|589743577|FG002|Overall Study|Low radiation dose in oral cavity|0|||
163282560|NCT00293462|589743575|FG000|Overall Study|Physician Decision|0|||
163282561|NCT00293462|589743576|FG001|Overall Study|Physician Decision|1|||
163282562|NCT00293462|589743577|FG002|Overall Study|Physician Decision|0|||
163282563|NCT00372060|589743578|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
163282564|NCT00372060|589743579|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
163282565|NCT00372060|589743578|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
163282566|NCT00372060|589743579|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
163282567|NCT00372060|589743578|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
163282568|NCT00372060|589743579|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
163282569|NCT00372060|589743578|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
163282570|NCT00372060|589743579|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
163282571|NCT00372060|589743578|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
163282572|NCT00372060|589743579|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
163282573|NCT00372060|589743578|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
163282574|NCT00372060|589743579|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
163282575|NCT00647348|589743580|FG000|Overall Study|Lost to Follow-up|3|||
163282576|NCT00647348|589743581|FG001|Overall Study|Lost to Follow-up|6|||
163282577|NCT03382821|589743585|FG000|Overall Study|Did not receive allocated intervention.|0|||
162932965|NCT00555399|588458621|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
162932966|NCT00555399|588458622|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
163176826|NCT02360605|589363721|FG001|Overall Study|Lost to Follow-up|8|||
163176827|NCT02360605|589363720|FG000|Overall Study|Death|0|||
163176828|NCT02360605|589363721|FG001|Overall Study|Death|1|||
163176829|NCT00290407|589363722|FG000|Overall Study|Physician Decision|2|||
163176830|NCT05442775|589363725|FG000|Overall Study|Trial terminated|61|||
163176831|NCT05442775|589363725|FG000|Overall Study|Lack of Efficacy|4|||
163176832|NCT05442775|589363725|FG000|Overall Study|Withdrawal by Subject|4|||
163176833|NCT05442775|589363725|FG000|Overall Study|Death|1|||
163176834|NCT05442775|589363725|FG000|Overall Study|Participant removed at Sponsor request|1|||
163176835|NCT01966432|589363727|FG000|Overall Study|Lost to Follow-up|3|||
163176836|NCT01966432|589363728|FG001|Overall Study|Lost to Follow-up|2|||
163176837|NCT01966432|589363729|FG002|Overall Study|Lost to Follow-up|5|||
163176838|NCT01966432|589363727|FG000|Overall Study|Withdrawal by Subject|1|||
163176839|NCT01966432|589363728|FG001|Overall Study|Withdrawal by Subject|3|||
163176840|NCT01966432|589363729|FG002|Overall Study|Withdrawal by Subject|0|||
163176841|NCT01966432|589363727|FG000|Overall Study|Subject Incarcerated|0|||
163176842|NCT01966432|589363728|FG001|Overall Study|Subject Incarcerated|0|||
163176843|NCT01966432|589363729|FG002|Overall Study|Subject Incarcerated|1|||
163176844|NCT01966432|589363727|FG000|Overall Study|SBIRT program ended|1|||
163176845|NCT01966432|589363728|FG001|Overall Study|SBIRT program ended|8|||
163176846|NCT01966432|589363729|FG002|Overall Study|SBIRT program ended|20|||
163176847|NCT01120067|589363731|FG000|Overall Study|Lost to Follow-up|3|||
163176848|NCT01120067|589363732|FG001|Overall Study|Lost to Follow-up|1|||
163176849|NCT01120067|589363731|FG000|Overall Study|fail to engage >3 sessions|2|||
163176850|NCT01120067|589363732|FG001|Overall Study|fail to engage >3 sessions|0|||
163176851|NCT02216812|589363735|FG000|Overall Study|Lost to Follow-up|10|||
163176852|NCT02216812|589363736|FG001|Overall Study|Lost to Follow-up|5|||
163176853|NCT00527488|589363737|FG000|Overall Study|Withdrawn prior to dosing|0|||
163176854|NCT00527488|589363738|FG001|Overall Study|Withdrawn prior to dosing|1|||
163176855|NCT00527488|589363739|FG002|Overall Study|Withdrawn prior to dosing|1|||
163176856|NCT00527488|589363740|FG003|Overall Study|Withdrawn prior to dosing|0|||
163176857|NCT03036800|589363741|FG000|Overall Study|Protocol Violation|1|||
163176858|NCT03036800|589363742|FG001|Overall Study|Protocol Violation|0|||
163176859|NCT03036800|589363741|FG000|Overall Study|Non-compliance|1|||
163176860|NCT03036800|589363742|FG001|Overall Study|Non-compliance|0|||
163176861|NCT03036800|589363741|FG000|Overall Study|Lost to Follow-up|1|||
163176862|NCT03036800|589363742|FG001|Overall Study|Lost to Follow-up|0|||
163176863|NCT03036800|589363741|FG000|Overall Study|Death|1|||
163176864|NCT03036800|589363742|FG001|Overall Study|Death|0|||
163176865|NCT03036800|589363741|FG000|Overall Study|Tolerance|5|||
163176866|NCT03036800|589363742|FG001|Overall Study|Tolerance|0|||
163176867|NCT03036800|589363741|FG000|Overall Study|Unknown/no reason given|50|||
163176868|NCT03036800|589363742|FG001|Overall Study|Unknown/no reason given|39|||
163176869|NCT01986933|589363743|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
163176870|NCT01986933|589363744|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
163176871|NCT01986933|589363745|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
163176872|NCT01986933|589363746|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
163176873|NCT01986933|589363747|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
163176874|NCT01986933|589363743|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
163176875|NCT01986933|589363744|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
163176876|NCT01986933|589363745|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
163176877|NCT01986933|589363746|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
163176878|NCT01986933|589363747|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
163176879|NCT01986933|589363743|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
163176880|NCT01986933|589363744|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
163176881|NCT01986933|589363745|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
163176882|NCT01986933|589363746|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
163176883|NCT01986933|589363747|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
163282578|NCT03382821|589743586|FG001|Overall Study|Did not receive allocated intervention.|3|||
163176884|NCT01986933|589363743|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
163176885|NCT01986933|589363744|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
163176886|NCT01986933|589363745|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
163176887|NCT01986933|589363746|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
163176888|NCT01986933|589363747|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
163176889|NCT01986933|589363743|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
163176890|NCT01986933|589363744|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
163282579|NCT00282438|589743587|FG000|Overall Study|Lack of Efficacy|1|||
163176891|NCT01986933|589363745|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
163176892|NCT01986933|589363746|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
163176893|NCT01986933|589363747|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
163176894|NCT01986933|589363743|FG000|Active-to-active (Part B)|Adverse Event|0|||
163176895|NCT01986933|589363744|FG001|Active-to-active (Part B)|Adverse Event|2|||
163176896|NCT01986933|589363745|FG002|Active-to-active (Part B)|Adverse Event|0|||
163282580|NCT00282438|589743588|FG001|Overall Study|Lack of Efficacy|0|||
163282581|NCT00282438|589743587|FG000|Overall Study|Death|0|||
163282582|NCT00282438|589743588|FG001|Overall Study|Death|1|||
163282583|NCT01119703|589743597|FG000|Overall Study|Adverse Event|0|||
163282584|NCT01119703|589743598|FG001|Overall Study|Adverse Event|1|||
163282585|NCT01511250|589743599|FG000|Overall Study|Withdrawal of Consent|1|||
163282586|NCT01511250|589743600|FG001|Overall Study|Withdrawal of Consent|0|||
163282587|NCT01511250|589743601|FG002|Overall Study|Withdrawal of Consent|0|||
163282588|NCT01511250|589743602|FG003|Overall Study|Withdrawal of Consent|0|||
163282589|NCT01511250|589743603|FG004|Overall Study|Withdrawal of Consent|0|||
163282590|NCT01511250|589743604|FG005|Overall Study|Withdrawal of Consent|0|||
163282591|NCT01511250|589743605|FG006|Overall Study|Withdrawal of Consent|0|||
163282592|NCT01511250|589743606|FG007|Overall Study|Withdrawal of Consent|1|||
163282593|NCT01511250|589743607|FG008|Overall Study|Withdrawal of Consent|1|||
163282594|NCT01511250|589743608|FG009|Overall Study|Withdrawal of Consent|0|||
163282595|NCT01511250|589743599|FG000|Overall Study|Sponsor/Investigator Decision|1|||
163282596|NCT01511250|589743600|FG001|Overall Study|Sponsor/Investigator Decision|0|||
163282597|NCT01511250|589743601|FG002|Overall Study|Sponsor/Investigator Decision|0|||
163282598|NCT01511250|589743602|FG003|Overall Study|Sponsor/Investigator Decision|0|||
163282599|NCT01511250|589743603|FG004|Overall Study|Sponsor/Investigator Decision|0|||
163282600|NCT01511250|589743604|FG005|Overall Study|Sponsor/Investigator Decision|0|||
163282601|NCT01511250|589743605|FG006|Overall Study|Sponsor/Investigator Decision|0|||
163282602|NCT01511250|589743606|FG007|Overall Study|Sponsor/Investigator Decision|0|||
163282603|NCT01511250|589743607|FG008|Overall Study|Sponsor/Investigator Decision|0|||
163282604|NCT01511250|589743608|FG009|Overall Study|Sponsor/Investigator Decision|0|||
163282605|NCT01511250|589743599|FG000|Overall Study|Lost to Follow-up|7|||
163282606|NCT01511250|589743600|FG001|Overall Study|Lost to Follow-up|3|||
163282607|NCT01511250|589743601|FG002|Overall Study|Lost to Follow-up|3|||
163282608|NCT01511250|589743602|FG003|Overall Study|Lost to Follow-up|3|||
163282609|NCT01511250|589743603|FG004|Overall Study|Lost to Follow-up|0|||
163282610|NCT01511250|589743604|FG005|Overall Study|Lost to Follow-up|0|||
163282611|NCT01511250|589743605|FG006|Overall Study|Lost to Follow-up|2|||
163282612|NCT01511250|589743606|FG007|Overall Study|Lost to Follow-up|3|||
163282613|NCT01511250|589743607|FG008|Overall Study|Lost to Follow-up|13|||
163282614|NCT01511250|589743608|FG009|Overall Study|Lost to Follow-up|5|||
163282615|NCT01511250|589743599|FG000|Overall Study|Protocol Violation|0|||
163282616|NCT01511250|589743600|FG001|Overall Study|Protocol Violation|2|||
163282617|NCT01511250|589743601|FG002|Overall Study|Protocol Violation|1|||
163282618|NCT01511250|589743602|FG003|Overall Study|Protocol Violation|0|||
163282619|NCT01511250|589743603|FG004|Overall Study|Protocol Violation|0|||
163282620|NCT01511250|589743604|FG005|Overall Study|Protocol Violation|0|||
163282621|NCT01511250|589743605|FG006|Overall Study|Protocol Violation|0|||
163282622|NCT01511250|589743606|FG007|Overall Study|Protocol Violation|0|||
163282623|NCT01511250|589743607|FG008|Overall Study|Protocol Violation|0|||
163282624|NCT01511250|589743608|FG009|Overall Study|Protocol Violation|0|||
163282625|NCT04668144|589743609|FG000|Overall Study|Protocol Violation|0|||
163282626|NCT04668144|589743610|FG001|Overall Study|Protocol Violation|1|||
163282627|NCT04668144|589743611|FG002|Overall Study|Protocol Violation|2|||
163282628|NCT02095158|589743612|FG000|Overall Study|Adverse Event|14|||
163282629|NCT02095158|589743612|FG000|Overall Study|Lack of Efficacy|3|||
163282630|NCT02095158|589743612|FG000|Overall Study|Pregnancy|1|||
163282631|NCT02095158|589743612|FG000|Overall Study|Lost to Follow-up|20|||
163282632|NCT02095158|589743612|FG000|Overall Study|Personal Reasons|35|||
163282633|NCT02095158|589743612|FG000|Overall Study|Protocol Violation|1|||
163282634|NCT02095158|589743612|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163282635|NCT03441984|589743613|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163176897|NCT01986933|589363746|FG003|Active-to-active (Part B)|Adverse Event|1|||
163176898|NCT01986933|589363747|FG004|Active-to-active (Part B)|Adverse Event|3|||
163176899|NCT01986933|589363743|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
163176900|NCT01986933|589363744|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
163176901|NCT01986933|589363745|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
163176902|NCT01986933|589363746|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
163176903|NCT01986933|589363747|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
163176904|NCT01986933|589363743|FG000|Active-to-active (Part B)|Pregnancy|0|||
163176905|NCT01986933|589363744|FG001|Active-to-active (Part B)|Pregnancy|0|||
163176906|NCT01986933|589363745|FG002|Active-to-active (Part B)|Pregnancy|0|||
163176907|NCT01986933|589363746|FG003|Active-to-active (Part B)|Pregnancy|0|||
163176908|NCT01986933|589363747|FG004|Active-to-active (Part B)|Pregnancy|1|||
163176909|NCT01986933|589363743|FG000|Active-to-active (Part B)|Physician Decision|0|||
163176910|NCT01986933|589363744|FG001|Active-to-active (Part B)|Physician Decision|0|||
163176911|NCT01986933|589363745|FG002|Active-to-active (Part B)|Physician Decision|1|||
163282636|NCT03441984|589743614|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163282637|NCT03441984|589743615|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
163282638|NCT03441984|589743616|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163282639|NCT03441984|589743617|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162932967|NCT00555399|588458623|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
162932968|NCT00555399|588458624|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
162932969|NCT00555399|588458625|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
162932970|NCT00343642|588460059|FG000|Overall Study|Lost to Follow-up|0|||
162932971|NCT00343642|588460060|FG001|Overall Study|Lost to Follow-up|1|||
162932972|NCT00343642|588460061|FG002|Overall Study|Lost to Follow-up|0|||
162932973|NCT00343642|588460059|FG000|Overall Study|Pregnancy|1|||
162932974|NCT00343642|588460060|FG001|Overall Study|Pregnancy|0|||
162932975|NCT00343642|588460061|FG002|Overall Study|Pregnancy|2|||
162932976|NCT00343642|588460059|FG000|Overall Study|Withdrawal by Subject|2|||
162932977|NCT00343642|588460060|FG001|Overall Study|Withdrawal by Subject|3|||
162932978|NCT00343642|588460061|FG002|Overall Study|Withdrawal by Subject|4|||
162932979|NCT00343642|588460059|FG000|Overall Study|Adverse Event|0|||
162932980|NCT00343642|588460060|FG001|Overall Study|Adverse Event|0|||
162932981|NCT00343642|588460061|FG002|Overall Study|Adverse Event|1|||
162932982|NCT00343642|588460059|FG000|Overall Study|Flare up|6|||
162932983|NCT00343642|588460060|FG001|Overall Study|Flare up|4|||
162932984|NCT00343642|588460061|FG002|Overall Study|Flare up|0|||
162932985|NCT00860574|588460064|FG000|Overall Study|Death|2|||
162932986|NCT00860574|588460064|FG000|Overall Study|Relapse|1|||
162932987|NCT02496221|588460065|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
162932988|NCT02496221|588460066|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
162932989|NCT02496221|588460065|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
162932990|NCT02496221|588460066|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
162932991|NCT02496221|588460065|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
162932992|NCT02496221|588460066|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
162932993|NCT01335399|588460067|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
162932994|NCT01335399|588460068|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
162932995|NCT01335399|588460067|FG000|Pre-treatment Period|Participant request to discontinue|0|||
162932996|NCT01335399|588460068|FG001|Pre-treatment Period|Participant request to discontinue|1|||
162932997|NCT01335399|588460067|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
162932998|NCT01335399|588460068|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
162932999|NCT01335399|588460067|FG000|Pre-treatment Period|Consent withdrawal|3|||
162933000|NCT01335399|588460068|FG001|Pre-treatment Period|Consent withdrawal|0|||
162933001|NCT01335399|588460067|FG000|Treatment Period|Disease progression|117|||
162933002|NCT01335399|588460068|FG001|Treatment Period|Disease progression|145|||
162933003|NCT01335399|588460067|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
162933004|NCT01335399|588460068|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
163176912|NCT01986933|589363746|FG003|Active-to-active (Part B)|Physician Decision|1|||
163176913|NCT01986933|589363747|FG004|Active-to-active (Part B)|Physician Decision|0|||
163176914|NCT01986933|589363743|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
163176915|NCT01986933|589363744|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
163176916|NCT01986933|589363745|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
163176917|NCT01986933|589363746|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
163176918|NCT01986933|589363747|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
163176919|NCT01986933|589363743|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
163176920|NCT01986933|589363744|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
163176921|NCT01986933|589363745|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
163176922|NCT01986933|589363746|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
163176923|NCT01986933|589363747|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
163176924|NCT01986933|589363743|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
163176925|NCT01986933|589363744|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
163176926|NCT01986933|589363745|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
163176927|NCT01986933|589363746|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
163176928|NCT01986933|589363747|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
163176929|NCT01986933|589363743|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
163176930|NCT01986933|589363744|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
163176931|NCT01986933|589363745|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
163176932|NCT01986933|589363746|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
163176933|NCT01986933|589363747|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
163176934|NCT01986933|589363743|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
163176935|NCT01986933|589363744|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
163176936|NCT01986933|589363745|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
163176937|NCT01986933|589363746|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
163176938|NCT01986933|589363747|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
163176939|NCT01986933|589363743|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
163176940|NCT01986933|589363744|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
163176941|NCT01986933|589363745|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
163176942|NCT01986933|589363746|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
163176943|NCT01986933|589363747|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
163176944|NCT01986933|589363743|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
163176945|NCT01986933|589363744|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
163176946|NCT01986933|589363745|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
163176947|NCT01986933|589363746|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
163176948|NCT01986933|589363747|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
163176949|NCT01986933|589363743|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
163176950|NCT01986933|589363744|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
163176951|NCT01986933|589363745|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
163176952|NCT01986933|589363746|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
163176953|NCT01986933|589363747|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
163176954|NCT01077154|589363748|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
163176955|NCT01077154|589363749|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
163176956|NCT01077154|589363748|FG000|Overall Study|Withdrawal by Subject|369|||
163176957|NCT01077154|589363749|FG001|Overall Study|Withdrawal by Subject|385|||
163176958|NCT01077154|589363748|FG000|Overall Study|Death|215|||
163176959|NCT01077154|589363749|FG001|Overall Study|Death|214|||
163176960|NCT01077154|589363748|FG000|Overall Study|Lost to Follow-up|43|||
163176961|NCT01077154|589363749|FG001|Overall Study|Lost to Follow-up|35|||
163176962|NCT01077154|589363748|FG000|Overall Study|Noncompliance|22|||
163176963|NCT01077154|589363749|FG001|Overall Study|Noncompliance|20|||
163176964|NCT01077154|589363748|FG000|Overall Study|Disease Progression|18|||
163176965|NCT01077154|589363749|FG001|Overall Study|Disease Progression|20|||
163176966|NCT01077154|589363748|FG000|Overall Study|Ineligibility Determined|10|||
163176967|NCT01077154|589363749|FG001|Overall Study|Ineligibility Determined|14|||
163176968|NCT01077154|589363748|FG000|Overall Study|Other|14|||
163176969|NCT01077154|589363749|FG001|Overall Study|Other|11|||
163176970|NCT01077154|589363748|FG000|Overall Study|Adverse Event|9|||
162933005|NCT01335399|588460067|FG000|Treatment Period|Study drug toxicity|52|||
162933006|NCT01335399|588460068|FG001|Treatment Period|Study drug toxicity|64|||
162933007|NCT01335399|588460067|FG000|Treatment Period|Participant request to discontinue|30|||
163176971|NCT01077154|589363749|FG001|Overall Study|Adverse Event|9|||
162933008|NCT01335399|588460068|FG001|Treatment Period|Participant request to discontinue|22|||
163176972|NCT01077154|589363748|FG000|Overall Study|Administrative Decision|1|||
163176973|NCT01077154|589363749|FG001|Overall Study|Administrative Decision|6|||
163176974|NCT01077154|589363748|FG000|Overall Study|Protocol Deviation|1|||
163176975|NCT01077154|589363749|FG001|Overall Study|Protocol Deviation|0|||
163176976|NCT04030026|589363750|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
163176977|NCT04030026|589363751|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
163282640|NCT03441984|589743618|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163282641|NCT03441984|589743619|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163282642|NCT03441984|589743620|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163282643|NCT03441984|589743621|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163282644|NCT03441984|589743622|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163282645|NCT03441984|589743623|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163282646|NCT03441984|589743624|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163282647|NCT00631917|589743625|FG000|Overall Study|Adverse Event|34|||
163282648|NCT00631917|589743626|FG001|Overall Study|Adverse Event|45|||
163282649|NCT00631917|589743625|FG000|Overall Study|Abnormal laboratory value(s)|2|||
163282650|NCT00631917|589743626|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163282651|NCT00631917|589743625|FG000|Overall Study|Abnormal test procedure result(s)|3|||
163282652|NCT00631917|589743626|FG001|Overall Study|Abnormal test procedure result(s)|2|||
163282653|NCT00631917|589743625|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
163282654|NCT00631917|589743626|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
163282655|NCT00631917|589743625|FG000|Overall Study|No longer required study drug|0|||
163282656|NCT00631917|589743626|FG001|Overall Study|No longer required study drug|1|||
163282657|NCT00631917|589743625|FG000|Overall Study|Protocol deviation|6|||
163282658|NCT00631917|589743626|FG001|Overall Study|Protocol deviation|5|||
163282659|NCT00631917|589743625|FG000|Overall Study|Subject withdrew consent|25|||
163282660|NCT00631917|589743626|FG001|Overall Study|Subject withdrew consent|33|||
163282661|NCT00631917|589743625|FG000|Overall Study|Lost to Follow-up|7|||
163282662|NCT00631917|589743626|FG001|Overall Study|Lost to Follow-up|7|||
163282663|NCT00631917|589743625|FG000|Overall Study|Administrative problems|2|||
163282664|NCT00631917|589743626|FG001|Overall Study|Administrative problems|0|||
163282665|NCT00631917|589743625|FG000|Overall Study|Death|1|||
163282666|NCT00631917|589743626|FG001|Overall Study|Death|0|||
163282667|NCT02696785|589743630|FG000|Blinded Treatment Period|Adverse Event|0|||
163282668|NCT02696785|589743631|FG001|Blinded Treatment Period|Adverse Event|1|||
163282669|NCT02696785|589743632|FG002|Blinded Treatment Period|Adverse Event|3|||
163282670|NCT02696785|589743633|FG003|Blinded Treatment Period|Adverse Event|0|||
163282671|NCT02696785|589743630|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
163282672|NCT02696785|589743631|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
163282673|NCT02696785|589743632|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
163282674|NCT02696785|589743633|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
163282675|NCT02696785|589743630|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
163282676|NCT02696785|589743631|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
163282677|NCT02696785|589743632|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
163282678|NCT02696785|589743633|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
163282679|NCT02696785|589743630|FG000|Blinded Treatment Period|Screen Failure|1|||
163282680|NCT02696785|589743631|FG001|Blinded Treatment Period|Screen Failure|0|||
163282681|NCT02696785|589743632|FG002|Blinded Treatment Period|Screen Failure|0|||
163282682|NCT02696785|589743633|FG003|Blinded Treatment Period|Screen Failure|0|||
163282683|NCT02696785|589743630|FG000|Washout Period|Withdrawal by Subject|0|||
163282684|NCT02696785|589743631|FG001|Washout Period|Withdrawal by Subject|1|||
163282685|NCT02696785|589743632|FG002|Washout Period|Withdrawal by Subject|0|||
163282686|NCT02696785|589743633|FG003|Washout Period|Withdrawal by Subject|0|||
163282687|NCT02696785|589743630|FG000|Washout Period|Lack of Efficacy|0|||
163282688|NCT02696785|589743631|FG001|Washout Period|Lack of Efficacy|1|||
163282689|NCT02696785|589743632|FG002|Washout Period|Lack of Efficacy|0|||
163282690|NCT02696785|589743633|FG003|Washout Period|Lack of Efficacy|0|||
163282691|NCT02696785|589743630|FG000|Extended Treatment Period|Adverse Event|2|||
163282692|NCT02696785|589743631|FG001|Extended Treatment Period|Adverse Event|3|||
163282693|NCT02696785|589743632|FG002|Extended Treatment Period|Adverse Event|2|||
163282694|NCT02696785|589743633|FG003|Extended Treatment Period|Adverse Event|1|||
163282695|NCT02696785|589743630|FG000|Extended Treatment Period|Lack of Efficacy|0|||
163282696|NCT02696785|589743631|FG001|Extended Treatment Period|Lack of Efficacy|1|||
163282697|NCT02696785|589743632|FG002|Extended Treatment Period|Lack of Efficacy|0|||
163282698|NCT02696785|589743633|FG003|Extended Treatment Period|Lack of Efficacy|0|||
163282699|NCT02696785|589743630|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
163282700|NCT02696785|589743631|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
163282701|NCT02696785|589743632|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
163282702|NCT02696785|589743633|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
163282703|NCT02696785|589743630|FG000|Follow-up Period|Adverse Event|0|||
163282704|NCT02696785|589743631|FG001|Follow-up Period|Adverse Event|0|||
163282705|NCT02696785|589743632|FG002|Follow-up Period|Adverse Event|8|||
163282706|NCT02696785|589743633|FG003|Follow-up Period|Adverse Event|2|||
163282707|NCT02696785|589743630|FG000|Follow-up Period|Lost to Follow-up|0|||
163282708|NCT02696785|589743631|FG001|Follow-up Period|Lost to Follow-up|0|||
163282709|NCT02696785|589743632|FG002|Follow-up Period|Lost to Follow-up|0|||
163282710|NCT02696785|589743633|FG003|Follow-up Period|Lost to Follow-up|1|||
163282711|NCT02696785|589743630|FG000|Follow-up Period|Lack of Efficacy|0|||
163282712|NCT02696785|589743631|FG001|Follow-up Period|Lack of Efficacy|0|||
163282713|NCT02696785|589743632|FG002|Follow-up Period|Lack of Efficacy|0|||
163282714|NCT02696785|589743633|FG003|Follow-up Period|Lack of Efficacy|1|||
163282715|NCT02696785|589743630|FG000|Follow-up Period|Withdrawal by Subject|1|||
163282716|NCT02696785|589743631|FG001|Follow-up Period|Withdrawal by Subject|0|||
163282717|NCT02696785|589743632|FG002|Follow-up Period|Withdrawal by Subject|5|||
163282718|NCT02696785|589743633|FG003|Follow-up Period|Withdrawal by Subject|4|||
163282719|NCT04863898|589743637|FG000|Overall Study|Away from study clinic during intervention training period|2|||
163282720|NCT04863898|589743637|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
163282721|NCT04863898|589743637|FG000|Overall Study|Lost to Follow-up|3|||
163282722|NCT04863898|589743637|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
163282723|NCT04863898|589743637|FG000|Overall Study|No longer employed at clinic|3|||
163282724|NCT00614744|589743638|FG000|Overall Study|Lost to Follow-up|5|||
163282725|NCT00614744|589743639|FG001|Overall Study|Lost to Follow-up|4|||
163282726|NCT00614744|589743638|FG000|Overall Study|Incomplete for Behavior Issues|0|||
163282727|NCT00614744|589743639|FG001|Overall Study|Incomplete for Behavior Issues|2|||
163282728|NCT00877851|589743640|FG000|Overall Study|Lost to Follow-up|5|||
163282729|NCT00877851|589743641|FG001|Overall Study|Lost to Follow-up|5|||
163282730|NCT00877851|589743640|FG000|Overall Study|computer problem|3|||
163282731|NCT00877851|589743641|FG001|Overall Study|computer problem|0|||
163282732|NCT00877851|589743640|FG000|Overall Study|no longer interested in participating|1|||
163282733|NCT00877851|589743641|FG001|Overall Study|no longer interested in participating|0|||
163282734|NCT03285711|589743642|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
163282735|NCT03285711|589743643|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
163282736|NCT03285711|589743644|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
163282737|NCT03285711|589743645|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
163282738|NCT03285711|589743642|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
163282739|NCT03285711|589743643|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
163282740|NCT03285711|589743644|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
163282741|NCT03285711|589743645|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
163282742|NCT03285711|589743642|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
163282743|NCT03285711|589743643|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
163282744|NCT03285711|589743644|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
162933009|NCT01335399|588460067|FG000|Treatment Period|Other reasons|30|||
162933010|NCT01335399|588460068|FG001|Treatment Period|Other reasons|30|||
162933011|NCT01335399|588460067|FG000|Treatment Period|Consent withdrawal|10|||
162933012|NCT01335399|588460068|FG001|Treatment Period|Consent withdrawal|7|||
162933013|NCT01335399|588460067|FG000|Treatment Period|Death|7|||
162933014|NCT01335399|588460068|FG001|Treatment Period|Death|6|||
162933015|NCT01335399|588460067|FG000|Treatment Period|Poor/Non-compliance|3|||
162933016|NCT01335399|588460068|FG001|Treatment Period|Poor/Non-compliance|4|||
162933017|NCT01335399|588460067|FG000|Treatment Period|Lost to Follow-up|2|||
162933018|NCT01335399|588460068|FG001|Treatment Period|Lost to Follow-up|2|||
162933019|NCT01335399|588460067|FG000|Treatment Period|Maximum clinical benefit|1|||
162933020|NCT01335399|588460068|FG001|Treatment Period|Maximum clinical benefit|1|||
162933021|NCT01335399|588460067|FG000|Treatment Period|No longer meet study criteria|1|||
162933022|NCT01335399|588460068|FG001|Treatment Period|No longer meet study criteria|1|||
162933023|NCT01335399|588460067|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
162933024|NCT01335399|588460068|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
162933025|NCT01120600|588460071|FG000|Overall Study|Adverse Event|7|||
162933026|NCT01120600|588460072|FG001|Overall Study|Adverse Event|7|||
162933027|NCT01120600|588460071|FG000|Overall Study|Excessive Bone Loss|0|||
162933028|NCT01120600|588460072|FG001|Overall Study|Excessive Bone Loss|4|||
162933029|NCT01120600|588460071|FG000|Overall Study|Lost to Follow-up|1|||
162933030|NCT01120600|588460072|FG001|Overall Study|Lost to Follow-up|3|||
162933031|NCT01120600|588460071|FG000|Overall Study|Physician Decision|1|||
162933032|NCT01120600|588460072|FG001|Overall Study|Physician Decision|3|||
162933033|NCT01120600|588460071|FG000|Overall Study|Protocol Violation|0|||
162933034|NCT01120600|588460072|FG001|Overall Study|Protocol Violation|4|||
162933035|NCT01120600|588460071|FG000|Overall Study|Withdrawal by Subject|10|||
163282745|NCT03285711|589743645|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
163282746|NCT03285711|589743642|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
162933036|NCT01120600|588460072|FG001|Overall Study|Withdrawal by Subject|11|||
162933037|NCT01165242|588460075|FG000|Overall Study|Unreachable Subjects|1|||
162933038|NCT01165242|588460076|FG001|Overall Study|Unreachable Subjects|0|||
162933039|NCT01165242|588460077|FG002|Overall Study|Unreachable Subjects|0|||
162933040|NCT01165242|588460075|FG000|Overall Study|Incarcerated Subjects|0|||
162933041|NCT01165242|588460076|FG001|Overall Study|Incarcerated Subjects|1|||
162933042|NCT01165242|588460077|FG002|Overall Study|Incarcerated Subjects|0|||
162933043|NCT01165242|588460075|FG000|Overall Study|Visit 2 Declined by Subject|0|||
162933044|NCT01165242|588460076|FG001|Overall Study|Visit 2 Declined by Subject|0|||
162933045|NCT01165242|588460077|FG002|Overall Study|Visit 2 Declined by Subject|1|||
162933046|NCT01165242|588460075|FG000|Overall Study|Withdrawal by Subject|0|||
162933047|NCT01165242|588460076|FG001|Overall Study|Withdrawal by Subject|2|||
163176978|NCT04030026|589363750|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
163176979|NCT04030026|589363751|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
163176980|NCT04030026|589363750|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
163176981|NCT04030026|589363751|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
163176982|NCT04030026|589363750|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
163176983|NCT04030026|589363751|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
163176984|NCT04030026|589363750|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
163176985|NCT04030026|589363751|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
163176986|NCT04030026|589363750|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
163176987|NCT04030026|589363751|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
163176988|NCT04030026|589363750|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
163176989|NCT04030026|589363751|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
163176990|NCT02545543|589363752|FG000|Overall Study|Lost to Follow-up|67|||
163176991|NCT02545543|589363753|FG001|Overall Study|Lost to Follow-up|25|||
163176992|NCT02545543|589363752|FG000|Overall Study|Physician Decision|3|||
163176993|NCT02545543|589363753|FG001|Overall Study|Physician Decision|0|||
163176994|NCT02545543|589363752|FG000|Overall Study|Withdrawal by Subject|9|||
163176995|NCT02545543|589363753|FG001|Overall Study|Withdrawal by Subject|8|||
163176996|NCT02545543|589363752|FG000|Overall Study|Noncomplaince|1|||
163176997|NCT02545543|589363753|FG001|Overall Study|Noncomplaince|0|||
163176998|NCT02545543|589363752|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
163176999|NCT02545543|589363753|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
163177000|NCT00811642|589363754|FG000|Overall Study|Adverse Event|3|||
163177001|NCT00811642|589363754|FG000|Overall Study|Protocol Violation|1|||
163177002|NCT00811642|589363754|FG000|Overall Study|Death|2|||
163177003|NCT00811642|589363754|FG000|Overall Study|Withdrawal by Subject|7|||
163177004|NCT00811642|589363754|FG000|Overall Study|Cumulative use of antifungal agent|2|||
163177005|NCT04285580|589365104|FG000|Overall Study|Protocol Violation|0|||
163177006|NCT04285580|589365105|FG001|Overall Study|Protocol Violation|1|||
163177007|NCT00562627|589365106|FG000|Overall Study|Protocol Violation|1|||
163177008|NCT00562627|589365107|FG001|Overall Study|Protocol Violation|1|||
163177009|NCT00562627|589365108|FG002|Overall Study|Protocol Violation|1|||
163177010|NCT02316548|589365112|FG000|Overall Study|Protocol Violation|0|||
163177011|NCT02316548|589365113|FG001|Overall Study|Protocol Violation|1|||
163177012|NCT03422627|589365118|FG000|Overall Study|Protocol-specified Criteria|1|||
163177013|NCT03422627|589365119|FG001|Overall Study|Protocol-specified Criteria|1|||
163177014|NCT03422627|589365120|FG002|Overall Study|Protocol-specified Criteria|0|||
163177015|NCT03422627|589365121|FG003|Overall Study|Protocol-specified Criteria|0|||
163177016|NCT03422627|589365122|FG004|Overall Study|Protocol-specified Criteria|2|||
163177017|NCT03422627|589365118|FG000|Overall Study|Requirement for Alternative Therapy|1|||
163177018|NCT03422627|589365119|FG001|Overall Study|Requirement for Alternative Therapy|1|||
163177019|NCT03422627|589365120|FG002|Overall Study|Requirement for Alternative Therapy|2|||
163177020|NCT03422627|589365121|FG003|Overall Study|Requirement for Alternative Therapy|0|||
163177021|NCT03422627|589365122|FG004|Overall Study|Requirement for Alternative Therapy|0|||
163177022|NCT03422627|589365118|FG000|Overall Study|Disease Progression|1|||
163177023|NCT03422627|589365119|FG001|Overall Study|Disease Progression|0|||
163177024|NCT03422627|589365120|FG002|Overall Study|Disease Progression|1|||
163177025|NCT03422627|589365121|FG003|Overall Study|Disease Progression|2|||
163177026|NCT03422627|589365122|FG004|Overall Study|Disease Progression|0|||
163177027|NCT03422627|589365118|FG000|Overall Study|Adverse Event|2|||
163177028|NCT03422627|589365119|FG001|Overall Study|Adverse Event|1|||
163177029|NCT03422627|589365120|FG002|Overall Study|Adverse Event|0|||
163177030|NCT03422627|589365121|FG003|Overall Study|Adverse Event|0|||
163177031|NCT03422627|589365122|FG004|Overall Study|Adverse Event|2|||
163177032|NCT03422627|589365118|FG000|Overall Study|Ineligibility Determined|0|||
163177033|NCT03422627|589365119|FG001|Overall Study|Ineligibility Determined|1|||
163177034|NCT03422627|589365120|FG002|Overall Study|Ineligibility Determined|0|||
163177035|NCT03422627|589365121|FG003|Overall Study|Ineligibility Determined|0|||
163177036|NCT03422627|589365122|FG004|Overall Study|Ineligibility Determined|0|||
163177037|NCT03422627|589365118|FG000|Overall Study|Death|0|||
163177038|NCT03422627|589365119|FG001|Overall Study|Death|1|||
163177039|NCT03422627|589365120|FG002|Overall Study|Death|1|||
162933048|NCT01165242|588460077|FG002|Overall Study|Withdrawal by Subject|2|||
162933049|NCT01165242|588460075|FG000|Overall Study|Extended Holiday|0|||
162933050|NCT01165242|588460076|FG001|Overall Study|Extended Holiday|0|||
162933051|NCT01165242|588460077|FG002|Overall Study|Extended Holiday|1|||
162933052|NCT01165242|588460075|FG000|Overall Study|Lost to Follow-up|9|||
162933053|NCT01165242|588460076|FG001|Overall Study|Lost to Follow-up|7|||
162933054|NCT01165242|588460077|FG002|Overall Study|Lost to Follow-up|10|||
162933055|NCT03372083|588460078|FG000|Overall Study|Adverse Event|3|||
162933056|NCT03372083|588460078|FG000|Overall Study|Physician Decision|1|||
162933057|NCT03372083|588460078|FG000|Overall Study|Withdrawal by Subject|1|||
162933058|NCT01690520|588460079|FG000|Overall Study|Death|25|||
162933059|NCT01690520|588460080|FG001|Overall Study|Death|21|||
162933060|NCT01690520|588460079|FG000|Overall Study|Lost to Follow-up|2|||
162933061|NCT01690520|588460080|FG001|Overall Study|Lost to Follow-up|3|||
162933062|NCT01690520|588460079|FG000|Overall Study|Withdrawal by Subject|2|||
162933063|NCT01690520|588460080|FG001|Overall Study|Withdrawal by Subject|0|||
162933064|NCT01690520|588460079|FG000|Overall Study|Relapse|0|||
162933065|NCT01690520|588460080|FG001|Overall Study|Relapse|1|||
162933066|NCT01690520|588460079|FG000|Overall Study|Other|0|||
162933067|NCT01690520|588460080|FG001|Overall Study|Other|1|||
162933068|NCT01690520|588460079|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
162933069|NCT01690520|588460080|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
162933070|NCT02544633|588460083|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
162933071|NCT02544633|588460084|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
162933072|NCT02544633|588460085|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
162933073|NCT02544633|588460086|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
162933074|NCT02544633|588460083|FG000|Treatment Period|Adverse Event|7|||
162933075|NCT02544633|588460084|FG001|Treatment Period|Adverse Event|4|||
162933076|NCT02544633|588460085|FG002|Treatment Period|Adverse Event|0|||
162933077|NCT02544633|588460086|FG003|Treatment Period|Adverse Event|5|||
162933078|NCT02544633|588460083|FG000|Treatment Period|Lack of Efficacy|17|||
162933079|NCT02544633|588460084|FG001|Treatment Period|Lack of Efficacy|11|||
162933080|NCT02544633|588460085|FG002|Treatment Period|Lack of Efficacy|5|||
162933081|NCT02544633|588460086|FG003|Treatment Period|Lack of Efficacy|5|||
162933082|NCT02544633|588460083|FG000|Treatment Period|Global Deterioration of Health|3|||
163177040|NCT03422627|589365121|FG003|Overall Study|Death|0|||
163177041|NCT03422627|589365122|FG004|Overall Study|Death|0|||
163177042|NCT03422627|589365118|FG000|Overall Study|Withdrawal by Subject|0|||
163177043|NCT03422627|589365119|FG001|Overall Study|Withdrawal by Subject|0|||
163177044|NCT03422627|589365120|FG002|Overall Study|Withdrawal by Subject|0|||
163177045|NCT03422627|589365121|FG003|Overall Study|Withdrawal by Subject|1|||
163177046|NCT03422627|589365122|FG004|Overall Study|Withdrawal by Subject|0|||
163177047|NCT04251156|589365123|FG000|Overall Study|Lost to Follow-up|1|||
163177048|NCT04251156|589365124|FG001|Overall Study|Lost to Follow-up|1|||
163177049|NCT04251156|589365123|FG000|Overall Study|Withdrawal by Subject|4|||
163177050|NCT04251156|589365124|FG001|Overall Study|Withdrawal by Subject|4|||
163177051|NCT03675321|589365125|FG000|Overall Study|Lack of Efficacy|2|||
163177052|NCT03675321|589365126|FG001|Overall Study|Lack of Efficacy|2|||
163177053|NCT03675321|589365125|FG000|Overall Study|Withdrawal by Subject|1|||
163177054|NCT03675321|589365126|FG001|Overall Study|Withdrawal by Subject|3|||
163177055|NCT00934648|589365132|FG000|Overall Study|Failure to return|8|||
163177056|NCT00934648|589365132|FG000|Overall Study|Withdrawal by Subject|1|||
163177057|NCT01479985|589365135|FG000|Overall Study|Tablet malfunction, no data saved|1|||
163177058|NCT01479985|589365136|FG001|Overall Study|Tablet malfunction, no data saved|1|||
163177059|NCT01479985|589365135|FG000|Overall Study|No decisional conflict scale responses|0|||
163177060|NCT01479985|589365136|FG001|Overall Study|No decisional conflict scale responses|2|||
163177061|NCT01479985|589365135|FG000|Overall Study|No post-visit survey|5|||
163177062|NCT01479985|589365136|FG001|Overall Study|No post-visit survey|3|||
163177063|NCT00708201|589365137|FG000|Overall Study|Adverse Event|4|||
163177064|NCT00708201|589365138|FG001|Overall Study|Adverse Event|4|||
163177065|NCT00708201|589365137|FG000|Overall Study|Withdrawal by Subject|1|||
163177066|NCT00708201|589365138|FG001|Overall Study|Withdrawal by Subject|1|||
163177067|NCT00708201|589365137|FG000|Overall Study|Lost to Follow-up|2|||
163177068|NCT00708201|589365138|FG001|Overall Study|Lost to Follow-up|0|||
163177069|NCT00708201|589365137|FG000|Overall Study|Protocol Violation|0|||
163177070|NCT00708201|589365138|FG001|Overall Study|Protocol Violation|1|||
163177071|NCT01933789|589365141|FG000|Overall Study|Death|0|||
163177072|NCT01933789|589365142|FG001|Overall Study|Death|0|||
163177073|NCT01933789|589365143|FG002|Overall Study|Death|0|||
162933083|NCT02544633|588460084|FG001|Treatment Period|Global Deterioration of Health|3|||
162933084|NCT02544633|588460085|FG002|Treatment Period|Global Deterioration of Health|0|||
162933085|NCT02544633|588460086|FG003|Treatment Period|Global Deterioration of Health|1|||
162933086|NCT02544633|588460083|FG000|Treatment Period|Withdrawal by Subject|1|||
163177074|NCT01933789|589365144|FG003|Overall Study|Death|0|||
163177075|NCT01933789|589365145|FG004|Overall Study|Death|21|||
163177076|NCT01933789|589365146|FG005|Overall Study|Death|32|||
163177077|NCT01933789|589365147|FG006|Overall Study|Death|0|||
162933087|NCT02544633|588460084|FG001|Treatment Period|Withdrawal by Subject|0|||
163282747|NCT03285711|589743643|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
163282748|NCT03285711|589743644|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
163282749|NCT03285711|589743645|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
163282750|NCT02431533|589743646|FG000|Overall Study|Withdrawal by Subject|1|||
163282751|NCT02431533|589743647|FG001|Overall Study|Withdrawal by Subject|3|||
163282752|NCT02431533|589743646|FG000|Overall Study|Developed Exclusionary criteria|1|||
163282753|NCT02431533|589743647|FG001|Overall Study|Developed Exclusionary criteria|0|||
163282754|NCT00770211|589743650|FG000|Overall Study|Lost to Follow-up|1|||
163282755|NCT00770211|589743651|FG001|Overall Study|Lost to Follow-up|0|||
163282756|NCT00770211|589743650|FG000|Overall Study|Withdrawal by Subject|0|||
163282757|NCT00770211|589743651|FG001|Overall Study|Withdrawal by Subject|2|||
163282758|NCT01446003|589743653|FG000|Period 1|Protocol Violation|2|||
163282759|NCT01446003|589743654|FG001|Period 1|Protocol Violation|0|||
163282760|NCT01446003|589743653|FG000|Period 2|Adverse Event|1|||
163282761|NCT01446003|589743654|FG001|Period 2|Adverse Event|0|||
163282762|NCT00318656|589743655|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
163282763|NCT00318656|589743656|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
163282764|NCT00318656|589743655|FG000|Overall Study|Did not receive any treatment|0|||
163282765|NCT00318656|589743656|FG001|Overall Study|Did not receive any treatment|1|||
163282766|NCT00490555|589743657|FG000|Overall Study|noncompliant with drug administration|0|||
163282767|NCT00490555|589743658|FG001|Overall Study|noncompliant with drug administration|0|||
163282768|NCT00490555|589743659|FG002|Overall Study|noncompliant with drug administration|2|||
163282769|NCT00490555|589743660|FG003|Overall Study|noncompliant with drug administration|0|||
163282770|NCT01007149|589743661|FG000|Overall Study|Administrative problems|0|||
163282771|NCT01007149|589743662|FG001|Overall Study|Administrative problems|1|||
163282772|NCT01516892|589743664|FG000|Overall Study|Adverse Event|25|||
163282773|NCT01516892|589743664|FG000|Overall Study|Lack of Efficacy|35|||
163282774|NCT01516892|589743664|FG000|Overall Study|Pregnancy|5|||
163282775|NCT01516892|589743664|FG000|Overall Study|Lost to Follow-up|82|||
163282776|NCT01516892|589743664|FG000|Overall Study|Subject Withdrew Consent|92|||
163282777|NCT01516892|589743664|FG000|Overall Study|Protocol Violation|60|||
163282778|NCT01516892|589743664|FG000|Overall Study|Other Miscellaneous Reasons|43|||
163282779|NCT01516892|589743664|FG000|Overall Study|Missing|1|||
163282780|NCT02956967|589743665|FG000|Overall Study|Adverse Event|3|||
163282781|NCT02956967|589743665|FG000|Overall Study|Reason non-related to neutropenia|10|||
163282782|NCT02956967|589743665|FG000|Overall Study|Lost to Follow-up|5|||
163282783|NCT02956967|589743665|FG000|Overall Study|Missing|1|||
163282784|NCT02956967|589743665|FG000|Overall Study|Termination of Nivestim administration|29|||
163282785|NCT00819234|589743668|FG000|Overall Study|Withdrawal by Subject|8|||
163282786|NCT00819234|589743669|FG001|Overall Study|Withdrawal by Subject|13|||
163282787|NCT00819234|589743670|FG002|Overall Study|Withdrawal by Subject|6|||
163282788|NCT00819234|589743671|FG003|Overall Study|Withdrawal by Subject|3|||
163282789|NCT00819234|589743672|FG004|Overall Study|Withdrawal by Subject|0|||
163282790|NCT00819234|589743673|FG005|Overall Study|Withdrawal by Subject|4|||
163282791|NCT00819234|589743674|FG006|Overall Study|Withdrawal by Subject|4|||
163282792|NCT00819234|589743675|FG007|Overall Study|Withdrawal by Subject|8|||
163282793|NCT00819234|589743676|FG008|Overall Study|Withdrawal by Subject|5|||
163282794|NCT00819234|589743677|FG009|Overall Study|Withdrawal by Subject|3|||
163282795|NCT00819234|589743668|FG000|Overall Study|Adverse Event|0|||
163282796|NCT00819234|589743669|FG001|Overall Study|Adverse Event|0|||
163282797|NCT00819234|589743670|FG002|Overall Study|Adverse Event|1|||
163282798|NCT00819234|589743671|FG003|Overall Study|Adverse Event|0|||
163282799|NCT00819234|589743672|FG004|Overall Study|Adverse Event|0|||
163282800|NCT00819234|589743673|FG005|Overall Study|Adverse Event|2|||
163282801|NCT00819234|589743674|FG006|Overall Study|Adverse Event|0|||
163282802|NCT00819234|589743675|FG007|Overall Study|Adverse Event|0|||
163282803|NCT00819234|589743676|FG008|Overall Study|Adverse Event|0|||
163282804|NCT00819234|589743677|FG009|Overall Study|Adverse Event|0|||
163282805|NCT00819234|589743668|FG000|Overall Study|Physician Decision|0|||
163282806|NCT00819234|589743669|FG001|Overall Study|Physician Decision|0|||
163282807|NCT00819234|589743670|FG002|Overall Study|Physician Decision|0|||
163282808|NCT00819234|589743671|FG003|Overall Study|Physician Decision|1|||
163282809|NCT00819234|589743672|FG004|Overall Study|Physician Decision|0|||
163282810|NCT00819234|589743673|FG005|Overall Study|Physician Decision|0|||
163282811|NCT00819234|589743674|FG006|Overall Study|Physician Decision|0|||
163282812|NCT00819234|589743675|FG007|Overall Study|Physician Decision|0|||
163282813|NCT00819234|589743676|FG008|Overall Study|Physician Decision|0|||
163282814|NCT00819234|589743677|FG009|Overall Study|Physician Decision|2|||
163282815|NCT00819234|589743668|FG000|Overall Study|Protocol Violation|0|||
163282816|NCT00819234|589743669|FG001|Overall Study|Protocol Violation|0|||
163282817|NCT00819234|589743670|FG002|Overall Study|Protocol Violation|1|||
163282818|NCT00819234|589743671|FG003|Overall Study|Protocol Violation|0|||
163282819|NCT00819234|589743672|FG004|Overall Study|Protocol Violation|0|||
163282820|NCT00819234|589743673|FG005|Overall Study|Protocol Violation|0|||
163282821|NCT00819234|589743674|FG006|Overall Study|Protocol Violation|0|||
163282822|NCT00819234|589743675|FG007|Overall Study|Protocol Violation|0|||
163282823|NCT00819234|589743676|FG008|Overall Study|Protocol Violation|0|||
163282824|NCT00819234|589743677|FG009|Overall Study|Protocol Violation|0|||
163282825|NCT00819234|589743668|FG000|Overall Study|Lost to Follow-up|2|||
163282826|NCT00819234|589743669|FG001|Overall Study|Lost to Follow-up|2|||
163282827|NCT00819234|589743670|FG002|Overall Study|Lost to Follow-up|0|||
163282828|NCT00819234|589743671|FG003|Overall Study|Lost to Follow-up|2|||
163282829|NCT00819234|589743672|FG004|Overall Study|Lost to Follow-up|1|||
163282830|NCT00819234|589743673|FG005|Overall Study|Lost to Follow-up|1|||
163282831|NCT00819234|589743674|FG006|Overall Study|Lost to Follow-up|1|||
163282832|NCT00819234|589743675|FG007|Overall Study|Lost to Follow-up|1|||
163282833|NCT00819234|589743676|FG008|Overall Study|Lost to Follow-up|1|||
163282834|NCT00819234|589743677|FG009|Overall Study|Lost to Follow-up|2|||
163282835|NCT01096056|589743678|FG000|Overall Study|Lost to Follow-up|0|||
163282836|NCT01096056|589743679|FG001|Overall Study|Lost to Follow-up|1|||
163282837|NCT03568162|589743680|FG000|Overall Study|Adverse Event|0|||
163282838|NCT03568162|589743681|FG001|Overall Study|Adverse Event|1|||
163282839|NCT03568162|589743682|FG002|Overall Study|Adverse Event|2|||
163282840|NCT03568162|589743683|FG003|Overall Study|Adverse Event|0|||
163282841|NCT03568162|589743684|FG004|Overall Study|Adverse Event|0|||
163282842|NCT03568162|589743685|FG005|Overall Study|Adverse Event|1|||
163282843|NCT03568162|589743680|FG000|Overall Study|Death|0|||
163282844|NCT03568162|589743681|FG001|Overall Study|Death|0|||
163282845|NCT03568162|589743682|FG002|Overall Study|Death|0|||
163282846|NCT03568162|589743683|FG003|Overall Study|Death|0|||
163282847|NCT03568162|589743684|FG004|Overall Study|Death|1|||
163282848|NCT03568162|589743685|FG005|Overall Study|Death|0|||
163282849|NCT03568162|589743680|FG000|Overall Study|Lost to Follow-up|3|||
163282850|NCT03568162|589743681|FG001|Overall Study|Lost to Follow-up|2|||
163282851|NCT03568162|589743682|FG002|Overall Study|Lost to Follow-up|4|||
163282852|NCT03568162|589743683|FG003|Overall Study|Lost to Follow-up|2|||
163282853|NCT03568162|589743684|FG004|Overall Study|Lost to Follow-up|3|||
163282854|NCT03568162|589743685|FG005|Overall Study|Lost to Follow-up|2|||
163282855|NCT03568162|589743680|FG000|Overall Study|Physician Decision|0|||
163282856|NCT03568162|589743681|FG001|Overall Study|Physician Decision|1|||
163282857|NCT03568162|589743682|FG002|Overall Study|Physician Decision|1|||
163282858|NCT03568162|589743683|FG003|Overall Study|Physician Decision|0|||
163282859|NCT03568162|589743684|FG004|Overall Study|Physician Decision|1|||
163282860|NCT03568162|589743685|FG005|Overall Study|Physician Decision|0|||
163282861|NCT03568162|589743680|FG000|Overall Study|Pregnancy|0|||
163282862|NCT03568162|589743681|FG001|Overall Study|Pregnancy|0|||
163282863|NCT03568162|589743682|FG002|Overall Study|Pregnancy|0|||
163282864|NCT03568162|589743683|FG003|Overall Study|Pregnancy|1|||
163282865|NCT03568162|589743684|FG004|Overall Study|Pregnancy|0|||
163282866|NCT03568162|589743685|FG005|Overall Study|Pregnancy|0|||
163282867|NCT03568162|589743680|FG000|Overall Study|Protocol Violation|1|||
163282868|NCT03568162|589743681|FG001|Overall Study|Protocol Violation|0|||
163282869|NCT03568162|589743682|FG002|Overall Study|Protocol Violation|1|||
163282870|NCT03568162|589743683|FG003|Overall Study|Protocol Violation|1|||
163282871|NCT03568162|589743684|FG004|Overall Study|Protocol Violation|1|||
163282872|NCT03568162|589743685|FG005|Overall Study|Protocol Violation|1|||
163282873|NCT03568162|589743680|FG000|Overall Study|Withdrawal by Subject|15|||
163282874|NCT03568162|589743681|FG001|Overall Study|Withdrawal by Subject|15|||
163282875|NCT03568162|589743682|FG002|Overall Study|Withdrawal by Subject|26|||
163282876|NCT03568162|589743683|FG003|Overall Study|Withdrawal by Subject|22|||
163282877|NCT03568162|589743684|FG004|Overall Study|Withdrawal by Subject|6|||
163282878|NCT03568162|589743685|FG005|Overall Study|Withdrawal by Subject|9|||
163282879|NCT03568162|589743680|FG000|Overall Study|Others|3|||
163282880|NCT03568162|589743681|FG001|Overall Study|Others|4|||
162933088|NCT02544633|588460085|FG002|Treatment Period|Withdrawal by Subject|0|||
162933089|NCT02544633|588460086|FG003|Treatment Period|Withdrawal by Subject|0|||
162933090|NCT02544633|588460083|FG000|Treatment Period|Lost to Follow-up|0|||
162933091|NCT02544633|588460084|FG001|Treatment Period|Lost to Follow-up|1|||
162933092|NCT02544633|588460085|FG002|Treatment Period|Lost to Follow-up|0|||
162933093|NCT02544633|588460086|FG003|Treatment Period|Lost to Follow-up|0|||
163177078|NCT01933789|589365148|FG007|Overall Study|Death|0|||
163177079|NCT01933789|589365149|FG008|Overall Study|Death|0|||
163177080|NCT01933789|589365141|FG000|Overall Study|Lost to Follow-up|0|||
163177081|NCT01933789|589365142|FG001|Overall Study|Lost to Follow-up|0|||
163177082|NCT01933789|589365143|FG002|Overall Study|Lost to Follow-up|0|||
163177083|NCT01933789|589365144|FG003|Overall Study|Lost to Follow-up|1|||
163177084|NCT01933789|589365145|FG004|Overall Study|Lost to Follow-up|8|||
163177085|NCT01933789|589365146|FG005|Overall Study|Lost to Follow-up|9|||
163177086|NCT01933789|589365147|FG006|Overall Study|Lost to Follow-up|1|||
163177087|NCT01933789|589365148|FG007|Overall Study|Lost to Follow-up|4|||
163177088|NCT01933789|589365149|FG008|Overall Study|Lost to Follow-up|0|||
163177089|NCT01933789|589365141|FG000|Overall Study|Withdrawal by Subject|2|||
163177090|NCT01933789|589365142|FG001|Overall Study|Withdrawal by Subject|1|||
163177091|NCT01933789|589365143|FG002|Overall Study|Withdrawal by Subject|0|||
163177092|NCT01933789|589365144|FG003|Overall Study|Withdrawal by Subject|0|||
163177093|NCT01933789|589365145|FG004|Overall Study|Withdrawal by Subject|17|||
163177094|NCT01933789|589365146|FG005|Overall Study|Withdrawal by Subject|16|||
163177095|NCT01933789|589365147|FG006|Overall Study|Withdrawal by Subject|1|||
163177096|NCT01933789|589365148|FG007|Overall Study|Withdrawal by Subject|4|||
163177097|NCT01933789|589365149|FG008|Overall Study|Withdrawal by Subject|0|||
163177098|NCT01933789|589365141|FG000|Overall Study|Became Ineligible|4|||
163177099|NCT01933789|589365142|FG001|Overall Study|Became Ineligible|0|||
163177100|NCT01933789|589365143|FG002|Overall Study|Became Ineligible|0|||
163177101|NCT01933789|589365144|FG003|Overall Study|Became Ineligible|0|||
163177102|NCT01933789|589365145|FG004|Overall Study|Became Ineligible|13|||
163177103|NCT01933789|589365146|FG005|Overall Study|Became Ineligible|10|||
163177104|NCT01933789|589365147|FG006|Overall Study|Became Ineligible|13|||
163177105|NCT01933789|589365148|FG007|Overall Study|Became Ineligible|6|||
163177106|NCT01933789|589365149|FG008|Overall Study|Became Ineligible|0|||
163177107|NCT03562767|589365154|FG000|Overall Study|Physician Decision|2|||
163177108|NCT03562767|589365155|FG001|Overall Study|Physician Decision|0|||
163177109|NCT03562767|589365156|FG002|Overall Study|Physician Decision|0|||
163177110|NCT03562767|589365154|FG000|Overall Study|Logistic Reason|1|||
163177111|NCT03562767|589365155|FG001|Overall Study|Logistic Reason|3|||
163177112|NCT03562767|589365156|FG002|Overall Study|Logistic Reason|0|||
163177113|NCT02518464|589365159|FG000|Overall Study|Adverse Event|2|||
163177114|NCT03761797|589365160|FG000|Overall Study|Changing hospital|11|||
163177115|NCT03761797|589365160|FG000|Overall Study|Improvement/remission|6|||
163177116|NCT03761797|589365160|FG000|Overall Study|Withdrawal by Subject|19|||
163177117|NCT03761797|589365160|FG000|Overall Study|Lost to Follow-up|33|||
163177118|NCT03761797|589365160|FG000|Overall Study|Adverse Event|37|||
163177119|NCT03761797|589365160|FG000|Overall Study|Case report form (CRF) not collected|5|||
163177120|NCT03761797|589365160|FG000|Overall Study|No patient visit after entry|13|||
163177121|NCT03761797|589365160|FG000|Overall Study|Switch to other diabetes medication|10|||
163177122|NCT03761797|589365160|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
163177123|NCT03761797|589365160|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
163177124|NCT03761797|589365160|FG000|Overall Study|Insufficient effectives|2|||
163177125|NCT03761797|589365160|FG000|Overall Study|Excessive alcohol intake|1|||
163177126|NCT00266877|589365161|FG000|Overall Study|Death|1|||
163177127|NCT00266877|589365162|FG001|Overall Study|Death|1|||
163177128|NCT00266877|589365163|FG002|Overall Study|Death|1|||
163177129|NCT00266877|589365161|FG000|Overall Study|Adverse Event|6|||
163177130|NCT00266877|589365162|FG001|Overall Study|Adverse Event|4|||
163177131|NCT00266877|589365163|FG002|Overall Study|Adverse Event|1|||
163177132|NCT00266877|589365161|FG000|Overall Study|Physician Decision|2|||
163177133|NCT00266877|589365162|FG001|Overall Study|Physician Decision|1|||
163177134|NCT00266877|589365163|FG002|Overall Study|Physician Decision|1|||
163177135|NCT00266877|589365161|FG000|Overall Study|Withdrawal by Subject|3|||
163177136|NCT00266877|589365162|FG001|Overall Study|Withdrawal by Subject|1|||
163177137|NCT00266877|589365163|FG002|Overall Study|Withdrawal by Subject|1|||
163177138|NCT00266877|589365161|FG000|Overall Study|Disease Progression|72|||
163177139|NCT00266877|589365162|FG001|Overall Study|Disease Progression|37|||
163177140|NCT00266877|589365163|FG002|Overall Study|Disease Progression|23|||
163177141|NCT00266877|589365161|FG000|Overall Study|Symptomatic Deterioration|6|||
163177142|NCT00266877|589365162|FG001|Overall Study|Symptomatic Deterioration|3|||
163177143|NCT00266877|589365163|FG002|Overall Study|Symptomatic Deterioration|1|||
162933094|NCT02544633|588460083|FG000|Treatment Period|Death|0|||
162933095|NCT02544633|588460084|FG001|Treatment Period|Death|0|||
163177144|NCT00266877|589365161|FG000|Overall Study|Hospitalization|1|||
162933096|NCT02544633|588460085|FG002|Treatment Period|Death|1|||
163177145|NCT00266877|589365162|FG001|Overall Study|Hospitalization|0|||
163177146|NCT00266877|589365163|FG002|Overall Study|Hospitalization|0|||
163177147|NCT00266877|589365161|FG000|Overall Study|Concomitant Radiotherapy|0|||
163177148|NCT00266877|589365162|FG001|Overall Study|Concomitant Radiotherapy|1|||
163177149|NCT00266877|589365163|FG002|Overall Study|Concomitant Radiotherapy|0|||
163177150|NCT01150474|589365167|FG000|Overall Study|Withdrawal by Subject|5|||
163177151|NCT01150474|589365168|FG001|Overall Study|Withdrawal by Subject|2|||
163177152|NCT01150474|589365167|FG000|Overall Study|Cancer found|1|||
163177153|NCT01150474|589365168|FG001|Overall Study|Cancer found|0|||
163177154|NCT01150474|589365167|FG000|Overall Study|Multiple Studies|0|||
163177155|NCT01150474|589365168|FG001|Overall Study|Multiple Studies|1|||
163177156|NCT01150474|589365167|FG000|Overall Study|Rectotomy|1|||
163177157|NCT01150474|589365168|FG001|Overall Study|Rectotomy|0|||
163177158|NCT01150474|589365167|FG000|Overall Study|Drug did not arrive in time|1|||
163177159|NCT01150474|589365168|FG001|Overall Study|Drug did not arrive in time|0|||
163177160|NCT01150474|589365167|FG000|Overall Study|Drug not administered|1|||
163177161|NCT01150474|589365168|FG001|Overall Study|Drug not administered|0|||
163177162|NCT01150474|589365167|FG000|Overall Study|Surgery Changed|1|||
163177163|NCT01150474|589365168|FG001|Overall Study|Surgery Changed|0|||
163177164|NCT04231981|589365169|FG000|Overall Study|Adverse Event|1|||
163177165|NCT04231981|589365169|FG000|Overall Study|Death|16|||
163177166|NCT04231981|589365169|FG000|Overall Study|Lost to Follow-up|1|||
163177167|NCT02581943|589365170|FG000|Overall Study|Death|5|||
163177168|NCT02581943|589365171|FG001|Overall Study|Death|2|||
163177169|NCT02581943|589365170|FG000|Overall Study|Disease Progression|12|||
163177170|NCT02581943|589365171|FG001|Overall Study|Disease Progression|15|||
163177171|NCT02581943|589365170|FG000|Overall Study|Withdrawal by Subject|1|||
163177172|NCT02581943|589365171|FG001|Overall Study|Withdrawal by Subject|2|||
163177173|NCT01470989|589365172|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
163177174|NCT01470989|589365173|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
163177175|NCT01470989|589365172|FG000|Overall Study|Adverse Event|2|||
163177176|NCT01470989|589365173|FG001|Overall Study|Adverse Event|5|||
163177177|NCT01470989|589365172|FG000|Overall Study|Abnormal laboratory value|1|||
163177178|NCT01470989|589365173|FG001|Overall Study|Abnormal laboratory value|1|||
163177179|NCT01470989|589365172|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163177180|NCT01470989|589365173|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
163177181|NCT01470989|589365172|FG000|Overall Study|Withdrawal by Subject|19|||
163177182|NCT01470989|589365173|FG001|Overall Study|Withdrawal by Subject|17|||
163177183|NCT01470989|589365172|FG000|Overall Study|Lost to Follow-up|18|||
163177184|NCT01470989|589365173|FG001|Overall Study|Lost to Follow-up|13|||
163177185|NCT01470989|589365172|FG000|Overall Study|Administrative problems|2|||
163177186|NCT01470989|589365173|FG001|Overall Study|Administrative problems|4|||
163177187|NCT01470989|589365172|FG000|Overall Study|Death|2|||
163177188|NCT01470989|589365173|FG001|Overall Study|Death|2|||
163177189|NCT01470989|589365172|FG000|Overall Study|Protocol deviation|1|||
163177190|NCT01470989|589365173|FG001|Overall Study|Protocol deviation|2|||
163177191|NCT01233687|589365174|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
163177192|NCT01233687|589365174|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
163177193|NCT01233687|589365174|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
163177194|NCT02197234|589365177|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
163177195|NCT02197234|589365177|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
163177196|NCT02197234|589365177|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
163177197|NCT02197234|589365177|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
163177198|NCT02197234|589365177|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
163177199|NCT02197234|589365177|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
163177200|NCT03783702|589365178|FG000|Overall Study|Lost to Follow-up|6|||
163177201|NCT03783702|589365179|FG001|Overall Study|Lost to Follow-up|8|||
163177202|NCT03783702|589365178|FG000|Overall Study|Protocol Violation|1|||
163177203|NCT03783702|589365179|FG001|Overall Study|Protocol Violation|3|||
163177204|NCT02119676|589365180|FG000|Overall Study|Adverse Event|9|||
163177205|NCT02119676|589365181|FG001|Overall Study|Adverse Event|17|||
163177206|NCT02119676|589365182|FG002|Overall Study|Adverse Event|10|||
163177207|NCT02119676|589365183|FG003|Overall Study|Adverse Event|10|||
163177208|NCT02119676|589365180|FG000|Overall Study|Disease progression|53|||
163177209|NCT02119676|589365181|FG001|Overall Study|Disease progression|55|||
163177210|NCT02119676|589365182|FG002|Overall Study|Disease progression|68|||
163177211|NCT02119676|589365183|FG003|Overall Study|Disease progression|73|||
163177212|NCT02119676|589365180|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
163177213|NCT02119676|589365181|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
163177214|NCT02119676|589365182|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
163177215|NCT02119676|589365183|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
163282881|NCT03568162|589743682|FG002|Overall Study|Others|1|||
163282882|NCT03568162|589743683|FG003|Overall Study|Others|4|||
163177216|NCT02119676|589365180|FG000|Overall Study|Physician Decision|4|||
163177217|NCT02119676|589365181|FG001|Overall Study|Physician Decision|2|||
163177218|NCT02119676|589365182|FG002|Overall Study|Physician Decision|3|||
163177219|NCT02119676|589365183|FG003|Overall Study|Physician Decision|2|||
163177220|NCT02119676|589365180|FG000|Overall Study|Death|9|||
163177221|NCT02119676|589365181|FG001|Overall Study|Death|3|||
163282883|NCT03568162|589743684|FG004|Overall Study|Others|2|||
163282884|NCT03568162|589743685|FG005|Overall Study|Others|1|||
163282885|NCT00337818|589743686|FG000|Overall Study|Lost to Follow-up|289|||
163282886|NCT00337818|589743687|FG001|Overall Study|Lost to Follow-up|91|||
163282887|NCT00337818|589743688|FG002|Overall Study|Lost to Follow-up|107|||
163282888|NCT00938340|589743690|FG000|Overall Study|Withdrawal by Subject|3|||
163282889|NCT00938340|589743690|FG000|Overall Study|Protocol Violation|1|||
163282890|NCT00938340|589743690|FG000|Overall Study|Adverse Event|1|||
163282891|NCT00924560|589743693|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
163282892|NCT00924560|589743694|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
163282893|NCT00924560|589743695|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
163282894|NCT00924560|589743693|FG000|Overall Study|Non Compliance with the Protocol|20|||
163282895|NCT00924560|589743694|FG001|Overall Study|Non Compliance with the Protocol|15|||
163282896|NCT00924560|589743695|FG002|Overall Study|Non Compliance with the Protocol|4|||
163282897|NCT00924560|589743693|FG000|Overall Study|Physician Decision|2|||
163282898|NCT00924560|589743694|FG001|Overall Study|Physician Decision|3|||
163282899|NCT00924560|589743695|FG002|Overall Study|Physician Decision|4|||
163282900|NCT00924560|589743693|FG000|Overall Study|Withdrawal by Subject|50|||
163282901|NCT00924560|589743694|FG001|Overall Study|Withdrawal by Subject|44|||
163282902|NCT00924560|589743695|FG002|Overall Study|Withdrawal by Subject|18|||
163282903|NCT00924560|589743693|FG000|Overall Study|Adverse Event|39|||
163282904|NCT00924560|589743694|FG001|Overall Study|Adverse Event|33|||
163282905|NCT00924560|589743695|FG002|Overall Study|Adverse Event|0|||
163282906|NCT00924560|589743693|FG000|Overall Study|Pregnancy|5|||
163282907|NCT00924560|589743694|FG001|Overall Study|Pregnancy|7|||
163282908|NCT00924560|589743695|FG002|Overall Study|Pregnancy|1|||
163282909|NCT00924560|589743693|FG000|Overall Study|Lost to Follow-up|78|||
163282910|NCT00924560|589743694|FG001|Overall Study|Lost to Follow-up|94|||
163282911|NCT00924560|589743695|FG002|Overall Study|Lost to Follow-up|45|||
163282912|NCT00924560|589743693|FG000|Overall Study|Miscellaneous Reasons|13|||
163282913|NCT00924560|589743694|FG001|Overall Study|Miscellaneous Reasons|10|||
163282914|NCT00924560|589743695|FG002|Overall Study|Miscellaneous Reasons|10|||
163282915|NCT02753530|589743698|FG000|Overall Study|Adverse Event|7|||
163282916|NCT02753530|589743699|FG001|Overall Study|Adverse Event|1|||
163282917|NCT02753530|589743698|FG000|Overall Study|Death|0|||
163282918|NCT02753530|589743699|FG001|Overall Study|Death|1|||
163282919|NCT02753530|589743698|FG000|Overall Study|Physician Decision|0|||
163282920|NCT02753530|589743699|FG001|Overall Study|Physician Decision|1|||
163282921|NCT02753530|589743698|FG000|Overall Study|Protocol Violation|1|||
163282922|NCT02753530|589743699|FG001|Overall Study|Protocol Violation|0|||
163282923|NCT02753530|589743698|FG000|Overall Study|Withdrawal by Subject|4|||
163282924|NCT02753530|589743699|FG001|Overall Study|Withdrawal by Subject|3|||
163282925|NCT03590743|589743701|FG000|Overall Study|Withdrawal by Subject|0|||
162933097|NCT02544633|588460086|FG003|Treatment Period|Death|0|||
162933098|NCT02544633|588460083|FG000|Treatment Period|Non-compliance|0|||
162933099|NCT02544633|588460084|FG001|Treatment Period|Non-compliance|0|||
162933100|NCT02544633|588460085|FG002|Treatment Period|Non-compliance|1|||
162933101|NCT02544633|588460086|FG003|Treatment Period|Non-compliance|0|||
162933102|NCT02544633|588460083|FG000|Treatment Period|Clinical Disease Progression|0|||
162933103|NCT02544633|588460084|FG001|Treatment Period|Clinical Disease Progression|0|||
162933104|NCT02544633|588460085|FG002|Treatment Period|Clinical Disease Progression|0|||
162933105|NCT02544633|588460086|FG003|Treatment Period|Clinical Disease Progression|1|||
162933106|NCT02544633|588460083|FG000|Survival Follow-up Period|Death|12|||
162933107|NCT02544633|588460084|FG001|Survival Follow-up Period|Death|14|||
162933108|NCT02544633|588460085|FG002|Survival Follow-up Period|Death|3|||
162933109|NCT02544633|588460086|FG003|Survival Follow-up Period|Death|9|||
162933110|NCT02544633|588460083|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
162933111|NCT02544633|588460084|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
162933112|NCT02544633|588460085|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
162933113|NCT02544633|588460086|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
162933114|NCT02544633|588460083|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
162933115|NCT02544633|588460084|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
162933116|NCT02544633|588460085|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
162933117|NCT02544633|588460086|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
162933118|NCT02544633|588460083|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
162933119|NCT02544633|588460084|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
163282926|NCT03590743|589743702|FG001|Overall Study|Withdrawal by Subject|1|||
163282927|NCT01290094|589743703|FG000|Overall Study|Withdrawal by Subject|1|||
163282928|NCT01290094|589743703|FG000|Overall Study|Lost to Follow-up|5|||
163282929|NCT01959880|589743704|FG000|Overall Study|Withdrawal by Subject|11|||
163282930|NCT01959880|589743705|FG001|Overall Study|Withdrawal by Subject|13|||
163282931|NCT01959880|589743706|FG002|Overall Study|Withdrawal by Subject|8|||
163282932|NCT01959880|589743707|FG003|Overall Study|Withdrawal by Subject|7|||
162933120|NCT02544633|588460085|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
162933121|NCT02544633|588460086|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
162933122|NCT02092961|588460087|FG000|Overall Study|Not reported|1|||
163282933|NCT01959880|589743704|FG000|Overall Study|Death|1|||
162933123|NCT02092961|588460088|FG001|Overall Study|Not reported|0|||
162933124|NCT02092961|588460089|FG002|Overall Study|Not reported|1|||
162933125|NCT02092961|588460087|FG000|Overall Study|Study stopped|13|||
162933126|NCT02092961|588460088|FG001|Overall Study|Study stopped|9|||
162933127|NCT02092961|588460089|FG002|Overall Study|Study stopped|12|||
163282934|NCT01959880|589743705|FG001|Overall Study|Death|10|||
162933128|NCT02092961|588460087|FG000|Overall Study|Lack of therapeutic response|2|||
163177222|NCT02119676|589365182|FG002|Overall Study|Death|2|||
163177223|NCT02119676|589365183|FG003|Overall Study|Death|1|||
163177224|NCT02119676|589365180|FG000|Overall Study|Noncompliance|0|||
163177225|NCT02119676|589365181|FG001|Overall Study|Noncompliance|1|||
163177226|NCT02119676|589365182|FG002|Overall Study|Noncompliance|0|||
163177227|NCT02119676|589365183|FG003|Overall Study|Noncompliance|0|||
163177228|NCT02119676|589365180|FG000|Overall Study|Lost to Follow-up|0|||
163177229|NCT02119676|589365181|FG001|Overall Study|Lost to Follow-up|0|||
163177230|NCT02119676|589365182|FG002|Overall Study|Lost to Follow-up|1|||
163177231|NCT02119676|589365183|FG003|Overall Study|Lost to Follow-up|0|||
163177232|NCT02119676|589365180|FG000|Overall Study|Protocol deviation|0|||
163177233|NCT02119676|589365181|FG001|Overall Study|Protocol deviation|0|||
163177234|NCT02119676|589365182|FG002|Overall Study|Protocol deviation|1|||
163177235|NCT02119676|589365183|FG003|Overall Study|Protocol deviation|0|||
163177236|NCT02119676|589365180|FG000|Overall Study|Other, unspecified|2|||
163177237|NCT02119676|589365181|FG001|Overall Study|Other, unspecified|1|||
163177238|NCT02119676|589365182|FG002|Overall Study|Other, unspecified|3|||
163177239|NCT02119676|589365183|FG003|Overall Study|Other, unspecified|4|||
163177240|NCT02119676|589365180|FG000|Overall Study|Did not receive study med|2|||
163177241|NCT02119676|589365181|FG001|Overall Study|Did not receive study med|2|||
163177242|NCT02119676|589365182|FG002|Overall Study|Did not receive study med|4|||
163177243|NCT02119676|589365183|FG003|Overall Study|Did not receive study med|5|||
163177244|NCT00219544|589365184|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
163177245|NCT00219544|589365185|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
163177246|NCT00219544|589365184|FG000|Single Blind Treatment Period|Adverse Event|9|||
163177247|NCT00219544|589365185|FG001|Single Blind Treatment Period|Adverse Event|0|||
163177248|NCT00219544|589365184|FG000|Single Blind Treatment Period|Protocol Violation|4|||
163177249|NCT00219544|589365185|FG001|Single Blind Treatment Period|Protocol Violation|0|||
163177250|NCT00219544|589365184|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
163177251|NCT00219544|589365185|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
163177252|NCT00219544|589365184|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
163177253|NCT00219544|589365185|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
163177254|NCT00219544|589365184|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
163177255|NCT00219544|589365185|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
163177256|NCT00989573|589365186|FG000|Overall Study|Adverse Event|8|||
163177257|NCT00989573|589365187|FG001|Overall Study|Adverse Event|12|||
163177258|NCT00989573|589365188|FG002|Overall Study|Adverse Event|4|||
163177259|NCT00989573|589365186|FG000|Overall Study|Physician Decision|0|||
163177260|NCT00989573|589365187|FG001|Overall Study|Physician Decision|2|||
163177261|NCT00989573|589365188|FG002|Overall Study|Physician Decision|0|||
163177262|NCT00989573|589365186|FG000|Overall Study|Protocol Violation|1|||
163177263|NCT00989573|589365187|FG001|Overall Study|Protocol Violation|1|||
163177264|NCT00989573|589365188|FG002|Overall Study|Protocol Violation|1|||
163177265|NCT00989573|589365186|FG000|Overall Study|Withdrawal by Subject|4|||
163177266|NCT00989573|589365187|FG001|Overall Study|Withdrawal by Subject|7|||
163177267|NCT00989573|589365188|FG002|Overall Study|Withdrawal by Subject|3|||
163177268|NCT03473548|589365190|FG000|Overall Study|Did not attempt HST testing|3|||
163177269|NCT03473548|589365191|FG001|Overall Study|Did not attempt HST testing|0|||
163177270|NCT02207946|589365198|FG000|Overall Study|Lost to Follow-up|1|||
163177271|NCT02207946|589365199|FG001|Overall Study|Lost to Follow-up|0|||
163177272|NCT02207946|589365198|FG000|Overall Study|Adverse Event|0|||
163177273|NCT02207946|589365199|FG001|Overall Study|Adverse Event|1|||
163177274|NCT02829944|589365200|FG000|Overall Study|Physician Decision|0|||
163177275|NCT02829944|589365201|FG001|Overall Study|Physician Decision|1|||
163177276|NCT02829944|589365200|FG000|Overall Study|Screen Failure|2|||
163177277|NCT02829944|589365201|FG001|Overall Study|Screen Failure|2|||
163177278|NCT02829944|589365200|FG000|Overall Study|Inadequate Neuraxial Block|1|||
163177279|NCT02829944|589365201|FG001|Overall Study|Inadequate Neuraxial Block|1|||
163177280|NCT02829944|589365200|FG000|Overall Study|Withdrawal by Subject|2|||
163177281|NCT02829944|589365201|FG001|Overall Study|Withdrawal by Subject|1|||
163177282|NCT02829944|589365200|FG000|Overall Study|Catheter Displacement|1|||
163177283|NCT02829944|589365201|FG001|Overall Study|Catheter Displacement|0|||
163177284|NCT02829944|589365200|FG000|Overall Study|Catheter broke|0|||
163177285|NCT02829944|589365201|FG001|Overall Study|Catheter broke|1|||
163177286|NCT02829944|589365200|FG000|Overall Study|Staff unavailable|0|||
163177287|NCT02829944|589365201|FG001|Overall Study|Staff unavailable|1|||
163177288|NCT05856760|589365202|FG000|Overall Study|Adverse Event|2|||
163177289|NCT05856760|589365202|FG000|Overall Study|Physician Decision|1|||
163177290|NCT05856760|589365202|FG000|Overall Study|Protocol Violation|1|||
163177291|NCT05856760|589365202|FG000|Overall Study|Withdrawal by Subject|3|||
163177292|NCT04675151|589365203|FG000|Overall Study|Protocol Violation|1|||
163177293|NCT04675151|589365204|FG001|Overall Study|Protocol Violation|0|||
163177294|NCT04675151|589365205|FG002|Overall Study|Protocol Violation|0|||
163177295|NCT04675151|589365206|FG003|Overall Study|Protocol Violation|1|||
163177296|NCT04035486|589365207|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
163177297|NCT04035486|589365208|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
163177298|NCT04035486|589365209|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
163177299|NCT04035486|589365210|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
163177300|NCT04035486|589365207|FG000|Overall Study|Death|6|||
163177301|NCT04035486|589365208|FG001|Overall Study|Death|3|||
163177302|NCT04035486|589365209|FG002|Overall Study|Death|70|||
163177303|NCT04035486|589365210|FG003|Overall Study|Death|77|||
163177304|NCT04035486|589365207|FG000|Overall Study|Screen Failure|0|||
163177305|NCT04035486|589365208|FG001|Overall Study|Screen Failure|0|||
163177306|NCT04035486|589365209|FG002|Overall Study|Screen Failure|1|||
163177307|NCT04035486|589365210|FG003|Overall Study|Screen Failure|1|||
163177308|NCT04035486|589365207|FG000|Overall Study|Withdrawal by Subject|1|||
163177309|NCT04035486|589365208|FG001|Overall Study|Withdrawal by Subject|1|||
163177310|NCT04035486|589365209|FG002|Overall Study|Withdrawal by Subject|11|||
163177311|NCT04035486|589365210|FG003|Overall Study|Withdrawal by Subject|9|||
163177312|NCT01730937|589365211|FG000|Overall Study|Protocol Violation|5|||
163177313|NCT01730937|589365212|FG001|Overall Study|Protocol Violation|11|||
163177314|NCT03947684|589365213|FG000|Overall Study|Lost to Follow-up|13|||
163177315|NCT03947684|589365214|FG001|Overall Study|Lost to Follow-up|5|||
163177316|NCT03947684|589365215|FG002|Overall Study|Lost to Follow-up|1|||
163177317|NCT03947684|589365213|FG000|Overall Study|Withdrawal by Subject|11|||
163177318|NCT03947684|589365214|FG001|Overall Study|Withdrawal by Subject|4|||
163177319|NCT03947684|589365215|FG002|Overall Study|Withdrawal by Subject|0|||
163177320|NCT03947684|589365213|FG000|Overall Study|Physician Decision|1|||
163177321|NCT03947684|589365214|FG001|Overall Study|Physician Decision|0|||
163177322|NCT03947684|589365215|FG002|Overall Study|Physician Decision|0|||
163177323|NCT03947684|589365213|FG000|Overall Study|Lack of adherence to study protocol|2|||
163177324|NCT03947684|589365214|FG001|Overall Study|Lack of adherence to study protocol|0|||
163177325|NCT03947684|589365215|FG002|Overall Study|Lack of adherence to study protocol|0|||
163177326|NCT01395784|589365217|FG000|Overall Study|Lost to Follow-up|7|||
163177327|NCT01395784|589365217|FG000|Overall Study|Withdrawal by Subject|3|||
163177328|NCT01395784|589365217|FG000|Overall Study|Physician Decision|5|||
163177329|NCT05772702|589365218|FG000|Overall Study|Adverse Event|1|||
163177330|NCT01107418|589366539|FG000|Overall Study|Disease Progression|45|||
163177331|NCT01107418|589366539|FG000|Overall Study|Adverse Event|3|||
163177332|NCT01107418|589366539|FG000|Overall Study|Withdrawal by Subject|1|||
163177333|NCT01107418|589366539|FG000|Overall Study|Study Closing|1|||
163177334|NCT01107418|589366539|FG000|Overall Study|Started Other Therapy|1|||
163177335|NCT01107418|589366539|FG000|Overall Study|Entered Extension Study|1|||
163177336|NCT05710185|589366540|FG000|Overall Study|Adverse Event|1|||
163177337|NCT05710185|589366540|FG000|Overall Study|Lack of Efficacy|1|||
163177338|NCT03269552|589366541|FG000|Overall Study|Adverse Event|2|||
163177339|NCT01343823|589366542|FG000|Overall Study|Study Terminated|1|||
163177340|NCT01343823|589366543|FG001|Overall Study|Study Terminated|0|||
163177341|NCT01343823|589366544|FG002|Overall Study|Study Terminated|0|||
163177342|NCT01343823|589366545|FG003|Overall Study|Study Terminated|1|||
163177343|NCT01343823|589366542|FG000|Overall Study|Withdrawal by Subject|1|||
163177344|NCT01343823|589366543|FG001|Overall Study|Withdrawal by Subject|0|||
163177345|NCT01343823|589366544|FG002|Overall Study|Withdrawal by Subject|0|||
163177346|NCT01343823|589366545|FG003|Overall Study|Withdrawal by Subject|0|||
163177347|NCT03468543|589366548|FG000|Overall Study|Protocol stopping rules met|3|||
163177348|NCT04972630|589366549|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
163177349|NCT04972630|589366550|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
163177350|NCT04972630|589366551|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
163177351|NCT04214288|589366554|FG000|Overall Study|Ongoing in the study|41|||
163177352|NCT04214288|589366555|FG001|Overall Study|Ongoing in the study|51|||
163177353|NCT04214288|589366556|FG002|Overall Study|Ongoing in the study|12|||
163177354|NCT04214288|589366557|FG003|Overall Study|Ongoing in the study|39|||
163177355|NCT04214288|589366554|FG000|Overall Study|Adverse Event|1|||
163177356|NCT04214288|589366555|FG001|Overall Study|Adverse Event|0|||
163177357|NCT04214288|589366556|FG002|Overall Study|Adverse Event|0|||
163177358|NCT04214288|589366557|FG003|Overall Study|Adverse Event|0|||
163177359|NCT04214288|589366554|FG000|Overall Study|Death|22|||
163177360|NCT04214288|589366555|FG001|Overall Study|Death|13|||
163177361|NCT04214288|589366556|FG002|Overall Study|Death|7|||
163177362|NCT04214288|589366557|FG003|Overall Study|Death|19|||
163282935|NCT01959880|589743706|FG002|Overall Study|Death|1|||
163177363|NCT04214288|589366554|FG000|Overall Study|Lost to Follow-up|1|||
163177364|NCT04214288|589366555|FG001|Overall Study|Lost to Follow-up|2|||
162933129|NCT02092961|588460088|FG001|Overall Study|Lack of therapeutic response|1|||
162933130|NCT02092961|588460089|FG002|Overall Study|Lack of therapeutic response|3|||
162933131|NCT02092961|588460087|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
162933132|NCT02092961|588460088|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
162933133|NCT02092961|588460089|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
162933134|NCT02092961|588460087|FG000|Overall Study|Adverse Event|2|||
162933135|NCT02092961|588460088|FG001|Overall Study|Adverse Event|4|||
163177365|NCT04214288|589366556|FG002|Overall Study|Lost to Follow-up|1|||
163177366|NCT04214288|589366557|FG003|Overall Study|Lost to Follow-up|0|||
163177367|NCT04214288|589366554|FG000|Overall Study|Other|1|||
163177368|NCT04214288|589366555|FG001|Overall Study|Other|2|||
163177369|NCT04214288|589366556|FG002|Overall Study|Other|0|||
163177370|NCT04214288|589366557|FG003|Overall Study|Other|6|||
163177371|NCT04214288|589366554|FG000|Overall Study|Protocol Violation|0|||
163177372|NCT04214288|589366555|FG001|Overall Study|Protocol Violation|1|||
163177373|NCT04214288|589366556|FG002|Overall Study|Protocol Violation|0|||
163177374|NCT04214288|589366557|FG003|Overall Study|Protocol Violation|0|||
163177375|NCT04214288|589366554|FG000|Overall Study|Withdrawal by Subject|8|||
163177376|NCT04214288|589366555|FG001|Overall Study|Withdrawal by Subject|4|||
163177377|NCT04214288|589366556|FG002|Overall Study|Withdrawal by Subject|0|||
163177378|NCT04214288|589366557|FG003|Overall Study|Withdrawal by Subject|9|||
163177379|NCT02455557|589366559|FG000|Overall Study|Withdrawal by Subject|2|||
163177380|NCT02278341|589366560|FG000|Overall Study|Randomized but never received study drug|1|||
163177381|NCT02278341|589366561|FG001|Overall Study|Randomized but never received study drug|1|||
163177382|NCT02278341|589366560|FG000|Overall Study|Adverse Event|3|||
163177383|NCT02278341|589366561|FG001|Overall Study|Adverse Event|0|||
163177384|NCT02278341|589366560|FG000|Overall Study|Death|68|||
163177385|NCT02278341|589366561|FG001|Overall Study|Death|56|||
163177386|NCT02278341|589366560|FG000|Overall Study|Withdrawal by Subject|30|||
163177387|NCT02278341|589366561|FG001|Overall Study|Withdrawal by Subject|19|||
163177388|NCT02278341|589366560|FG000|Overall Study|Lost to Follow-up|0|||
163177389|NCT02278341|589366561|FG001|Overall Study|Lost to Follow-up|1|||
163177390|NCT02278341|589366560|FG000|Overall Study|Physician Decision|1|||
163177391|NCT02278341|589366561|FG001|Overall Study|Physician Decision|1|||
163177392|NCT02278341|589366560|FG000|Overall Study|Miscellaneous|15|||
163177393|NCT02278341|589366561|FG001|Overall Study|Miscellaneous|14|||
163177394|NCT01129024|589366562|FG000|Overall Study|Physician Decision|5|||
163177395|NCT01129024|589366562|FG000|Overall Study|Study Terminated by Sponsor|8|||
163177396|NCT01129024|589366562|FG000|Overall Study|Withdrawal by Subject|2|||
163177397|NCT01129024|589366562|FG000|Overall Study|Lack of Efficacy|3|||
163177398|NCT01129024|589366562|FG000|Overall Study|Needed a Platelet Transfusion|1|||
163177399|NCT02361580|589366564|FG000|Overall Study|Lost to Follow-up|6|||
163177400|NCT02361580|589366565|FG001|Overall Study|Lost to Follow-up|3|||
163177401|NCT02047318|589366566|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
163177402|NCT02047318|589366566|FG000|Core Study Period|Adverse Event|1|||
163177403|NCT02047318|589366566|FG000|Core Study Period|Withdrawal by caregiver|3|||
163177404|NCT02047318|589366566|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
163177405|NCT01487577|589366567|FG000|Overall Study|Became ineligible after signing consent|1|||
163177406|NCT00761748|589366568|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
163177407|NCT00761748|589366569|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
163177408|NCT00761748|589366568|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
163177409|NCT00761748|589366569|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
163177410|NCT02554279|589366570|FG000|Overall Study|Adverse Event|2|||
163177411|NCT02554279|589366571|FG001|Overall Study|Adverse Event|5|||
163177412|NCT02554279|589366570|FG000|Overall Study|Lost to Follow-up|3|||
163177413|NCT02554279|589366571|FG001|Overall Study|Lost to Follow-up|2|||
163177414|NCT02554279|589366570|FG000|Overall Study|Withdrawal by Subject|6|||
163177415|NCT02554279|589366571|FG001|Overall Study|Withdrawal by Subject|4|||
163177416|NCT02554279|589366570|FG000|Overall Study|Protocol Violation|2|||
163177417|NCT02554279|589366571|FG001|Overall Study|Protocol Violation|1|||
163177418|NCT02554279|589366570|FG000|Overall Study|Other reason|19|||
163177419|NCT02554279|589366571|FG001|Overall Study|Other reason|6|||
163177420|NCT00812487|589366572|FG000|Overall Study|Lost to Follow-up|2|||
163177421|NCT00812487|589366573|FG001|Overall Study|Lost to Follow-up|0|||
163177422|NCT00812487|589366572|FG000|Overall Study|Withdrawal by Subject|3|||
163177423|NCT00812487|589366573|FG001|Overall Study|Withdrawal by Subject|2|||
163177424|NCT00812487|589366572|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
163177425|NCT00812487|589366573|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
163177426|NCT00812487|589366572|FG000|Overall Study|Protocol Violation|0|||
163177427|NCT00812487|589366573|FG001|Overall Study|Protocol Violation|1|||
163177428|NCT00998764|589366574|FG000|Overall Study|Lack of Efficacy|3|||
163177429|NCT00998764|589366575|FG001|Overall Study|Lack of Efficacy|6|||
163177430|NCT00998764|589366574|FG000|Overall Study|Adverse Event|17|||
163177431|NCT00998764|589366575|FG001|Overall Study|Adverse Event|12|||
162933136|NCT02092961|588460089|FG002|Overall Study|Adverse Event|0|||
163177432|NCT00998764|589366574|FG000|Overall Study|Withdrawal by Subject|19|||
163177433|NCT00998764|589366575|FG001|Overall Study|Withdrawal by Subject|25|||
163282936|NCT01959880|589743707|FG003|Overall Study|Death|2|||
163282937|NCT01959880|589743704|FG000|Overall Study|Lost to Follow-up|95|||
163282938|NCT01959880|589743705|FG001|Overall Study|Lost to Follow-up|18|||
163282939|NCT01959880|589743706|FG002|Overall Study|Lost to Follow-up|15|||
163282940|NCT01959880|589743707|FG003|Overall Study|Lost to Follow-up|8|||
163282941|NCT01959880|589743704|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
163282942|NCT01959880|589743705|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
163282943|NCT01959880|589743706|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
163282944|NCT01959880|589743707|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
163282945|NCT01959880|589743704|FG000|Overall Study|Study completed early-FDA approved|1003|||
163282946|NCT01959880|589743705|FG001|Overall Study|Study completed early-FDA approved|311|||
163282947|NCT01959880|589743706|FG002|Overall Study|Study completed early-FDA approved|179|||
163282948|NCT01959880|589743707|FG003|Overall Study|Study completed early-FDA approved|152|||
163177434|NCT00998764|589366574|FG000|Overall Study|Physician Decision|3|||
163177435|NCT00998764|589366575|FG001|Overall Study|Physician Decision|3|||
163177436|NCT00998764|589366574|FG000|Overall Study|Death|3|||
163177437|NCT00998764|589366575|FG001|Overall Study|Death|1|||
163177438|NCT00998764|589366574|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
163177439|NCT00998764|589366575|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
163177440|NCT00998764|589366574|FG000|Overall Study|Protocol Violation|0|||
163177441|NCT00998764|589366575|FG001|Overall Study|Protocol Violation|1|||
163177442|NCT00998764|589366574|FG000|Overall Study|Failed to Return|1|||
163177443|NCT00998764|589366575|FG001|Overall Study|Failed to Return|1|||
163177444|NCT00998764|589366574|FG000|Overall Study|Lost to Follow-up|1|||
163177445|NCT00998764|589366575|FG001|Overall Study|Lost to Follow-up|1|||
163177446|NCT00998764|589366574|FG000|Overall Study|Loss of Caregiver|0|||
163177447|NCT00998764|589366575|FG001|Overall Study|Loss of Caregiver|3|||
163177448|NCT00998764|589366574|FG000|Overall Study|Other|4|||
163177449|NCT00998764|589366575|FG001|Overall Study|Other|4|||
163177450|NCT00998764|589366574|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
163177451|NCT00998764|589366575|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
163177452|NCT04761627|589366578|FG000|Run-in Period|Death|1|||
163177453|NCT04761627|589366579|FG001|Run-in Period|Death|0|||
163177454|NCT04761627|589366580|FG002|Run-in Period|Death|0|||
163177455|NCT04761627|589366578|FG000|Run-in Period|Required alternative therapy|2|||
163177456|NCT04761627|589366579|FG001|Run-in Period|Required alternative therapy|0|||
163177457|NCT04761627|589366580|FG002|Run-in Period|Required alternative therapy|0|||
163177458|NCT04761627|589366578|FG000|Run-in Period|Lost to Follow-up|2|||
163177459|NCT04761627|589366579|FG001|Run-in Period|Lost to Follow-up|0|||
163177460|NCT04761627|589366580|FG002|Run-in Period|Lost to Follow-up|0|||
163177461|NCT04761627|589366578|FG000|Run-in Period|Protocol Violation|3|||
163177462|NCT04761627|589366579|FG001|Run-in Period|Protocol Violation|0|||
163177463|NCT04761627|589366580|FG002|Run-in Period|Protocol Violation|0|||
163177464|NCT04761627|589366578|FG000|Run-in Period|Abnormal liver function|1|||
163177465|NCT04761627|589366579|FG001|Run-in Period|Abnormal liver function|0|||
163177466|NCT04761627|589366580|FG002|Run-in Period|Abnormal liver function|0|||
163177467|NCT04761627|589366578|FG000|Run-in Period|Adverse Event|6|||
163177468|NCT04761627|589366579|FG001|Run-in Period|Adverse Event|0|||
163177469|NCT04761627|589366580|FG002|Run-in Period|Adverse Event|0|||
163177470|NCT04761627|589366578|FG000|Run-in Period|Withdrawal by Subject|7|||
163177471|NCT04761627|589366579|FG001|Run-in Period|Withdrawal by Subject|0|||
163177472|NCT04761627|589366580|FG002|Run-in Period|Withdrawal by Subject|0|||
163177473|NCT04761627|589366578|FG000|Run-in Period|Did not meet PASI 50|15|||
163177474|NCT04761627|589366579|FG001|Run-in Period|Did not meet PASI 50|0|||
163177475|NCT04761627|589366580|FG002|Run-in Period|Did not meet PASI 50|0|||
163177476|NCT04761627|589366578|FG000|Run-in Period|Study site closure|2|||
163177477|NCT04761627|589366579|FG001|Run-in Period|Study site closure|0|||
163177478|NCT04761627|589366580|FG002|Run-in Period|Study site closure|0|||
163177479|NCT04761627|589366578|FG000|Run-in Period|Pregnancy|2|||
163177480|NCT04761627|589366579|FG001|Run-in Period|Pregnancy|0|||
163177481|NCT04761627|589366580|FG002|Run-in Period|Pregnancy|0|||
163177482|NCT04761627|589366578|FG000|Post-randomization Period|Military service|0|||
163177483|NCT04761627|589366579|FG001|Post-randomization Period|Military service|1|||
163177484|NCT04761627|589366580|FG002|Post-randomization Period|Military service|0|||
163177485|NCT04761627|589366578|FG000|Post-randomization Period|Adverse Event|0|||
163177486|NCT04761627|589366579|FG001|Post-randomization Period|Adverse Event|4|||
163177487|NCT04761627|589366580|FG002|Post-randomization Period|Adverse Event|2|||
163177488|NCT04761627|589366578|FG000|Post-randomization Period|Lost to Follow-up|0|||
163177489|NCT04761627|589366579|FG001|Post-randomization Period|Lost to Follow-up|6|||
163177490|NCT04761627|589366580|FG002|Post-randomization Period|Lost to Follow-up|6|||
163177491|NCT04761627|589366578|FG000|Post-randomization Period|Withdrawal by Subject|0|||
163282949|NCT01537133|589745601|FG000|Overall Study|Withdrawal by Subject|2|||
163282950|NCT01537133|589745602|FG001|Overall Study|Withdrawal by Subject|0|||
163282951|NCT01537133|589745603|FG002|Overall Study|Withdrawal by Subject|0|||
163177492|NCT04761627|589366579|FG001|Post-randomization Period|Withdrawal by Subject|7|||
163177493|NCT04761627|589366580|FG002|Post-randomization Period|Withdrawal by Subject|6|||
162933137|NCT01623830|588460092|FG000|Overall Study|Withdrawal by Subject|6|||
162933138|NCT01623830|588460093|FG001|Overall Study|Withdrawal by Subject|7|||
162933139|NCT01623830|588460092|FG000|Overall Study|Exclusion from Study|1|||
162933140|NCT01623830|588460093|FG001|Overall Study|Exclusion from Study|2|||
163177494|NCT04761627|589366578|FG000|Post-randomization Period|Pregnancy|0|||
163177495|NCT04761627|589366579|FG001|Post-randomization Period|Pregnancy|0|||
163177496|NCT04761627|589366580|FG002|Post-randomization Period|Pregnancy|1|||
163177497|NCT04761627|589366578|FG000|Post-randomization Period|Study site closure|0|||
163177498|NCT04761627|589366579|FG001|Post-randomization Period|Study site closure|0|||
163177499|NCT04761627|589366580|FG002|Post-randomization Period|Study site closure|1|||
163177500|NCT04761627|589366578|FG000|Post-randomization Period|Family planning|0|||
163177501|NCT04761627|589366579|FG001|Post-randomization Period|Family planning|1|||
163177502|NCT04761627|589366580|FG002|Post-randomization Period|Family planning|0|||
163177503|NCT01634178|589366581|FG000|Treatment Period 1|Adverse Event|0|||
163177504|NCT01634178|589366582|FG001|Treatment Period 1|Adverse Event|1|||
163177505|NCT01634178|589366581|FG000|Treatment Period 2|Adverse Event|1|||
163177506|NCT01634178|589366582|FG001|Treatment Period 2|Adverse Event|0|||
163177507|NCT01117792|589366583|FG000|Overall Study|Death|1|||
163177508|NCT01117792|589366583|FG000|Overall Study|Adverse Event|3|||
163177509|NCT05867342|589366584|FG000|Overall Study|Investigator Decision|3|||
163177510|NCT05867342|589366585|FG001|Overall Study|Investigator Decision|3|||
163177511|NCT00723203|589366586|FG000|Overall Study|Withdrawal by Subject|3|||
163177512|NCT00274924|589366587|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
163177513|NCT00274924|589366588|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
163177514|NCT00274924|589366589|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
163177515|NCT00274924|589366587|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
163177516|NCT00274924|589366588|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
163177517|NCT00274924|589366589|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
163177518|NCT00274924|589366587|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
163177519|NCT00274924|589366588|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
163177520|NCT00274924|589366589|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
163177521|NCT00274924|589366587|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
163177522|NCT00274924|589366588|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
163177523|NCT00274924|589366589|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
163177524|NCT00274924|589366587|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
163177525|NCT00274924|589366588|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
163177526|NCT00274924|589366589|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
163177527|NCT00274924|589366587|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
163177528|NCT00274924|589366588|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
163177529|NCT00274924|589366589|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
163177530|NCT00274924|589366587|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
163177531|NCT00274924|589366588|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
163177532|NCT00274924|589366589|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
163177533|NCT00274924|589366587|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
163177534|NCT00274924|589366588|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
163177535|NCT00274924|589366589|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
163177536|NCT00274924|589366587|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
163177537|NCT00274924|589366588|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
163177538|NCT00274924|589366589|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
163177539|NCT00274924|589366587|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
163177540|NCT00274924|589366588|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
163177541|NCT00274924|589366589|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
163177542|NCT00274924|589366587|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
163177543|NCT00274924|589366588|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
163177544|NCT00274924|589366589|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
163177545|NCT00274924|589366587|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
163177546|NCT00274924|589366588|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
163177547|NCT00274924|589366589|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
163177548|NCT00274924|589366587|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
163177549|NCT00274924|589366588|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
163177550|NCT00274924|589366589|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
163177551|NCT01903525|589366592|FG000|Overall Study|Lost to Follow-up|5|||
163177552|NCT01903525|589366593|FG001|Overall Study|Lost to Follow-up|9|||
163177553|NCT01903525|589366592|FG000|Overall Study|Adverse Event|0|||
163177554|NCT01903525|589366593|FG001|Overall Study|Adverse Event|1|||
163177555|NCT04365257|589366594|FG000|Overall Study|Physician Decision|1|||
163177556|NCT04365257|589366595|FG001|Overall Study|Physician Decision|0|||
163177557|NCT04365257|589366594|FG000|Overall Study|Patient Noncompliance|1|||
162933141|NCT02468557|588460094|FG000|Overall Study|Adverse Event|1|||
163177558|NCT04365257|589366595|FG001|Overall Study|Patient Noncompliance|0|||
163177559|NCT04365257|589366594|FG000|Overall Study|Withdrawal by Subject|0|||
162933142|NCT02468557|588460094|FG000|Overall Study|Death|1|||
162933143|NCT02468557|588460094|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
162933144|NCT02468557|588460094|FG000|Overall Study|All Enrolled but Never Dosed|4|||
162933145|NCT01605461|588460095|FG000|Overall Study|Lost to Follow-up|3|||
162933146|NCT01605461|588460095|FG000|Overall Study|Withdrawal by Subject|1|||
162933147|NCT02024698|588460096|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
162933148|NCT02024698|588460097|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
162933149|NCT03322462|588460098|FG000|Overall Study|Technical difficulties|2|||
162933150|NCT03322462|588460098|FG000|Overall Study|Other|1|||
162933151|NCT00515073|588460099|FG000|Overall Study|Withdrawal by Subject|1|||
162933152|NCT00515073|588460099|FG000|Overall Study|Physician Decision|1|||
162933153|NCT02764489|588460100|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
162933154|NCT02764489|588460101|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
162933155|NCT02764489|588460100|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
162933156|NCT02764489|588460101|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
162933157|NCT02764489|588460100|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
162933158|NCT02764489|588460101|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
162933159|NCT02764489|588460100|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
162933160|NCT02764489|588460101|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
163177560|NCT04365257|589366595|FG001|Overall Study|Withdrawal by Subject|1|||
163177561|NCT02129777|589366600|FG000|Double-Blind Period|Adverse Event|0|||
163177562|NCT02129777|589366601|FG001|Double-Blind Period|Adverse Event|0|||
163177563|NCT02129777|589366602|FG002|Double-Blind Period|Adverse Event|0|||
163177564|NCT02129777|589366603|FG003|Double-Blind Period|Adverse Event|0|||
163177565|NCT02129777|589366604|FG004|Double-Blind Period|Adverse Event|1|||
163177566|NCT02129777|589366605|FG005|Double-Blind Period|Adverse Event|0|||
163177567|NCT02129777|589366606|FG006|Double-Blind Period|Adverse Event|0|||
163177568|NCT02129777|589366600|FG000|Double-Blind Period|Lost to Follow-up|1|||
163177569|NCT02129777|589366601|FG001|Double-Blind Period|Lost to Follow-up|1|||
163177570|NCT02129777|589366602|FG002|Double-Blind Period|Lost to Follow-up|1|||
163177571|NCT02129777|589366603|FG003|Double-Blind Period|Lost to Follow-up|2|||
163177572|NCT02129777|589366604|FG004|Double-Blind Period|Lost to Follow-up|0|||
163177573|NCT02129777|589366605|FG005|Double-Blind Period|Lost to Follow-up|0|||
163177574|NCT02129777|589366606|FG006|Double-Blind Period|Lost to Follow-up|0|||
163177575|NCT02129777|589366600|FG000|Double-Blind Period|Withdrawal by Subject|2|||
163177576|NCT02129777|589366601|FG001|Double-Blind Period|Withdrawal by Subject|4|||
163177577|NCT02129777|589366602|FG002|Double-Blind Period|Withdrawal by Subject|3|||
163177578|NCT02129777|589366603|FG003|Double-Blind Period|Withdrawal by Subject|2|||
163177579|NCT02129777|589366604|FG004|Double-Blind Period|Withdrawal by Subject|3|||
163177580|NCT02129777|589366605|FG005|Double-Blind Period|Withdrawal by Subject|0|||
163177581|NCT02129777|589366606|FG006|Double-Blind Period|Withdrawal by Subject|0|||
163177582|NCT02129777|589366600|FG000|Double-Blind Period|Pregnancy|0|||
163177583|NCT02129777|589366601|FG001|Double-Blind Period|Pregnancy|0|||
163177584|NCT02129777|589366602|FG002|Double-Blind Period|Pregnancy|0|||
163177585|NCT02129777|589366603|FG003|Double-Blind Period|Pregnancy|0|||
163177586|NCT02129777|589366604|FG004|Double-Blind Period|Pregnancy|1|||
163177587|NCT02129777|589366605|FG005|Double-Blind Period|Pregnancy|0|||
163177588|NCT02129777|589366606|FG006|Double-Blind Period|Pregnancy|0|||
163177589|NCT02129777|589366600|FG000|Double-Blind Period|Lack of Efficacy|3|||
163177590|NCT02129777|589366601|FG001|Double-Blind Period|Lack of Efficacy|1|||
163177591|NCT02129777|589366602|FG002|Double-Blind Period|Lack of Efficacy|0|||
163177592|NCT02129777|589366603|FG003|Double-Blind Period|Lack of Efficacy|3|||
163177593|NCT02129777|589366604|FG004|Double-Blind Period|Lack of Efficacy|2|||
163177594|NCT02129777|589366605|FG005|Double-Blind Period|Lack of Efficacy|0|||
163177595|NCT02129777|589366606|FG006|Double-Blind Period|Lack of Efficacy|0|||
163177596|NCT02129777|589366600|FG000|Double-Blind Period|Other|1|||
163177597|NCT02129777|589366601|FG001|Double-Blind Period|Other|2|||
163177598|NCT02129777|589366602|FG002|Double-Blind Period|Other|0|||
163177599|NCT02129777|589366603|FG003|Double-Blind Period|Other|0|||
163177600|NCT02129777|589366604|FG004|Double-Blind Period|Other|0|||
163177601|NCT02129777|589366605|FG005|Double-Blind Period|Other|0|||
163177602|NCT02129777|589366606|FG006|Double-Blind Period|Other|0|||
163177603|NCT02129777|589366600|FG000|Open-Label Period|Lack of Efficacy|0|||
163177604|NCT02129777|589366601|FG001|Open-Label Period|Lack of Efficacy|0|||
163177605|NCT02129777|589366602|FG002|Open-Label Period|Lack of Efficacy|0|||
163177606|NCT02129777|589366603|FG003|Open-Label Period|Lack of Efficacy|0|||
162933161|NCT01625845|588460102|FG000|Overall Study|Adverse Event|1|||
162933162|NCT01625845|588460103|FG001|Overall Study|Adverse Event|2|||
162933163|NCT01625845|588460102|FG000|Overall Study|Lost to Follow-up|2|||
163177607|NCT02129777|589366604|FG004|Open-Label Period|Lack of Efficacy|0|||
163177608|NCT02129777|589366605|FG005|Open-Label Period|Lack of Efficacy|0|||
163177609|NCT02129777|589366606|FG006|Open-Label Period|Lack of Efficacy|5|||
163177610|NCT02129777|589366600|FG000|Open-Label Period|Lost to Follow-up|0|||
163177611|NCT02129777|589366601|FG001|Open-Label Period|Lost to Follow-up|0|||
163177612|NCT02129777|589366602|FG002|Open-Label Period|Lost to Follow-up|0|||
163177613|NCT02129777|589366603|FG003|Open-Label Period|Lost to Follow-up|0|||
163177614|NCT02129777|589366604|FG004|Open-Label Period|Lost to Follow-up|0|||
163177615|NCT02129777|589366605|FG005|Open-Label Period|Lost to Follow-up|1|||
163177616|NCT02129777|589366606|FG006|Open-Label Period|Lost to Follow-up|1|||
163177617|NCT02129777|589366600|FG000|Open-Label Period|Withdrawal by Subject|0|||
163177618|NCT02129777|589366601|FG001|Open-Label Period|Withdrawal by Subject|0|||
163177619|NCT02129777|589366602|FG002|Open-Label Period|Withdrawal by Subject|0|||
163177620|NCT02129777|589366603|FG003|Open-Label Period|Withdrawal by Subject|0|||
163177621|NCT02129777|589366604|FG004|Open-Label Period|Withdrawal by Subject|0|||
163177622|NCT02129777|589366605|FG005|Open-Label Period|Withdrawal by Subject|1|||
163177623|NCT02129777|589366606|FG006|Open-Label Period|Withdrawal by Subject|3|||
163177624|NCT02129777|589366600|FG000|Open-Label Period|Study Termination|0|||
163177625|NCT02129777|589366601|FG001|Open-Label Period|Study Termination|0|||
163177626|NCT02129777|589366602|FG002|Open-Label Period|Study Termination|0|||
163177627|NCT02129777|589366603|FG003|Open-Label Period|Study Termination|0|||
163177628|NCT02129777|589366604|FG004|Open-Label Period|Study Termination|0|||
163177629|NCT02129777|589366605|FG005|Open-Label Period|Study Termination|10|||
163177630|NCT02129777|589366606|FG006|Open-Label Period|Study Termination|39|||
163177631|NCT02915874|589366607|FG000|Overall Study|Lost to Follow-up|5|||
163177632|NCT02915874|589366608|FG001|Overall Study|Lost to Follow-up|4|||
163177633|NCT02915874|589366607|FG000|Overall Study|Withdrawal by Subject|1|||
163177634|NCT02915874|589366608|FG001|Overall Study|Withdrawal by Subject|1|||
163177635|NCT02915874|589366607|FG000|Overall Study|Started New Anxiety Medication|0|||
163177636|NCT02915874|589366608|FG001|Overall Study|Started New Anxiety Medication|1|||
163177637|NCT01609478|589366616|FG000|Overall Study|Adverse Event|3|||
163177638|NCT01609478|589366617|FG001|Overall Study|Adverse Event|1|||
163177639|NCT01609478|589366618|FG002|Overall Study|Adverse Event|5|||
163177640|NCT01609478|589366616|FG000|Overall Study|Protocol Deviation|0|||
163177641|NCT01609478|589366617|FG001|Overall Study|Protocol Deviation|1|||
163177642|NCT01609478|589366618|FG002|Overall Study|Protocol Deviation|1|||
163177643|NCT01609478|589366616|FG000|Overall Study|Non-Compliance with study treatment|1|||
163177644|NCT01609478|589366617|FG001|Overall Study|Non-Compliance with study treatment|0|||
163177645|NCT01609478|589366618|FG002|Overall Study|Non-Compliance with study treatment|0|||
163177646|NCT01609478|589366616|FG000|Overall Study|Physician Decision|1|||
163177647|NCT01609478|589366617|FG001|Overall Study|Physician Decision|0|||
163177648|NCT01609478|589366618|FG002|Overall Study|Physician Decision|1|||
163177649|NCT01609478|589366616|FG000|Overall Study|Withdrawal by Subject|2|||
163177650|NCT01609478|589366617|FG001|Overall Study|Withdrawal by Subject|0|||
163177651|NCT01609478|589366618|FG002|Overall Study|Withdrawal by Subject|2|||
163177652|NCT04973137|589366619|FG000|Double Blind Phase|Adverse Event|4|||
163177653|NCT04973137|589366620|FG001|Double Blind Phase|Adverse Event|0|||
163177654|NCT04973137|589366619|FG000|Double Blind Phase|Death|25|||
163177655|NCT04973137|589366620|FG001|Double Blind Phase|Death|15|||
163177656|NCT04973137|589366619|FG000|Double Blind Phase|Physician Decision|5|||
163177657|NCT04973137|589366620|FG001|Double Blind Phase|Physician Decision|1|||
163177658|NCT04973137|589366619|FG000|Double Blind Phase|Withdrawal by Subject|6|||
163177659|NCT04973137|589366620|FG001|Double Blind Phase|Withdrawal by Subject|1|||
163177660|NCT04973137|589366619|FG000|Double Blind Phase|Other|2|||
163177661|NCT04973137|589366620|FG001|Double Blind Phase|Other|2|||
163177662|NCT04973137|589366619|FG000|Open Label Extension Phase|Death|3|||
163177663|NCT04973137|589366620|FG001|Open Label Extension Phase|Death|0|||
163177664|NCT04973137|589366619|FG000|Open Label Extension Phase|Physician Decision|0|||
163177665|NCT04973137|589366620|FG001|Open Label Extension Phase|Physician Decision|1|||
163177666|NCT04973137|589366619|FG000|Open Label Extension Phase|Withdrawal by Subject|1|||
163177667|NCT04973137|589366620|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
163177668|NCT04973137|589366619|FG000|Open Label Extension Phase|Study Terminated by Sponsor|83|||
163177669|NCT04973137|589366620|FG001|Open Label Extension Phase|Study Terminated by Sponsor|43|||
163177670|NCT04973137|589366619|FG000|Open Label Extension Phase|Site Terminated by Sponsor|5|||
163177671|NCT04973137|589366620|FG001|Open Label Extension Phase|Site Terminated by Sponsor|0|||
163177672|NCT04391569|589366623|FG000|Overall Study|Death|15|||
163177673|NCT04391569|589366624|FG001|Overall Study|Death|10|||
163177674|NCT04391569|589366623|FG000|Overall Study|Withdrawal by Subject|1|||
163177675|NCT04391569|589366624|FG001|Overall Study|Withdrawal by Subject|0|||
163177676|NCT04391569|589366623|FG000|Overall Study|Lost to Follow-up|3|||
163177677|NCT04391569|589366624|FG001|Overall Study|Lost to Follow-up|2|||
163177678|NCT04391569|589366623|FG000|Overall Study|Lack of Efficacy|0|||
163177679|NCT04391569|589366624|FG001|Overall Study|Lack of Efficacy|1|||
163177680|NCT04391569|589366623|FG000|Overall Study|Participant discharged to hospice facility|0|||
163177681|NCT04391569|589366624|FG001|Overall Study|Participant discharged to hospice facility|1|||
163177682|NCT04391569|589366623|FG000|Overall Study|Participant family decision|1|||
163282952|NCT01537133|589745604|FG003|Overall Study|Withdrawal by Subject|0|||
163177683|NCT04391569|589366624|FG001|Overall Study|Participant family decision|0|||
163177684|NCT04391569|589366623|FG000|Overall Study|Participant discharged prematurely|1|||
163177685|NCT04391569|589366624|FG001|Overall Study|Participant discharged prematurely|0|||
163177686|NCT01903252|589366641|FG000|Double-Blind Induction|Adverse Event|20|||
163177687|NCT01903252|589366642|FG001|Double-Blind Induction|Adverse Event|18|||
163177688|NCT01903252|589366643|FG002|Double-Blind Induction|Adverse Event|0|||
163282953|NCT01537133|589745601|FG000|Overall Study|Lost to Follow-up|1|||
162933164|NCT01625845|588460103|FG001|Overall Study|Lost to Follow-up|1|||
162933165|NCT01625845|588460102|FG000|Overall Study|Withdrawal by Subject|2|||
162933166|NCT01625845|588460103|FG001|Overall Study|Withdrawal by Subject|0|||
162933167|NCT01294592|588460104|FG000|Overall Study|Adverse Event|28|||
162933168|NCT01294592|588460105|FG001|Overall Study|Adverse Event|13|||
162933169|NCT01294592|588460104|FG000|Overall Study|Lack of Efficacy|7|||
162933170|NCT01294592|588460105|FG001|Overall Study|Lack of Efficacy|5|||
162933171|NCT01294592|588460104|FG000|Overall Study|Protocol Violation|1|||
162933172|NCT01294592|588460105|FG001|Overall Study|Protocol Violation|7|||
162933173|NCT01294592|588460104|FG000|Overall Study|Lost to Follow-up|7|||
162933174|NCT01294592|588460105|FG001|Overall Study|Lost to Follow-up|9|||
162933175|NCT01294592|588460104|FG000|Overall Study|Physician Decision|6|||
162933176|NCT01294592|588460105|FG001|Overall Study|Physician Decision|11|||
162933177|NCT01294592|588460104|FG000|Overall Study|Withdrawal by Subject|28|||
162933178|NCT01294592|588460105|FG001|Overall Study|Withdrawal by Subject|28|||
162933179|NCT02853929|588460106|FG000|Overall Study|Lost to Follow-up|3|||
162933180|NCT02853929|588460107|FG001|Overall Study|Lost to Follow-up|0|||
162933181|NCT02853929|588460106|FG000|Overall Study|Withdrawal by Subject|1|||
162933182|NCT02853929|588460107|FG001|Overall Study|Withdrawal by Subject|0|||
162933183|NCT02853929|588460106|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
162933184|NCT02853929|588460107|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
162933185|NCT00623623|588460108|FG000|Overall Study|Previous enrolment into this study|1|||
162933186|NCT00623623|588460109|FG001|Overall Study|Previous enrolment into this study|1|||
162933187|NCT00693784|588460110|FG000|Overall Study|Lost to Follow-up|2|||
162933188|NCT00693784|588460110|FG000|Overall Study|Withdrawal by Subject|2|||
162933189|NCT02265952|588460111|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
162933190|NCT02265952|588460112|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
162933191|NCT02265952|588460111|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
162933192|NCT02265952|588460112|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
162933193|NCT00326885|588460115|FG000|Overall Study|Adverse Event|1|||
162933194|NCT00326885|588460115|FG000|Overall Study|Withdrawal by Subject|3|||
162933195|NCT00326885|588460115|FG000|Overall Study|Physician Decision|1|||
162933196|NCT00326885|588460115|FG000|Overall Study|Hospice withdrew consent|2|||
162933197|NCT00738673|588460127|FG000|Overall Study|Adverse Event|1|||
162933198|NCT00738673|588460128|FG001|Overall Study|Adverse Event|0|||
162933199|NCT00738673|588460127|FG000|Overall Study|Lack of Efficacy|19|||
162933200|NCT00738673|588460128|FG001|Overall Study|Lack of Efficacy|8|||
162933201|NCT00738673|588460127|FG000|Overall Study|Protocol Violation|1|||
162933202|NCT00738673|588460128|FG001|Overall Study|Protocol Violation|2|||
162933203|NCT00738673|588460127|FG000|Overall Study|Withdrawal by Subject|3|||
163177689|NCT01903252|589366644|FG003|Double-Blind Induction|Adverse Event|0|||
163177690|NCT01903252|589366645|FG004|Double-Blind Induction|Adverse Event|0|||
163177691|NCT01903252|589366646|FG005|Double-Blind Induction|Adverse Event|0|||
163177692|NCT01903252|589366641|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
163177693|NCT01903252|589366642|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
163177694|NCT01903252|589366643|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
163177695|NCT01903252|589366644|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
163177696|NCT01903252|589366645|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
163177697|NCT01903252|589366646|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
163177698|NCT01903252|589366641|FG000|Double-Blind Induction|Physician Decision|2|||
163177699|NCT01903252|589366642|FG001|Double-Blind Induction|Physician Decision|3|||
163177700|NCT01903252|589366643|FG002|Double-Blind Induction|Physician Decision|0|||
163177701|NCT01903252|589366644|FG003|Double-Blind Induction|Physician Decision|0|||
163177702|NCT01903252|589366645|FG004|Double-Blind Induction|Physician Decision|0|||
163177703|NCT01903252|589366646|FG005|Double-Blind Induction|Physician Decision|0|||
163177704|NCT01903252|589366641|FG000|Double-Blind Induction|non-compliance,|7|||
163177705|NCT01903252|589366642|FG001|Double-Blind Induction|non-compliance,|7|||
163177706|NCT01903252|589366643|FG002|Double-Blind Induction|non-compliance,|0|||
163177707|NCT01903252|589366644|FG003|Double-Blind Induction|non-compliance,|0|||
163282954|NCT01537133|589745602|FG001|Overall Study|Lost to Follow-up|0|||
162933204|NCT00738673|588460128|FG001|Overall Study|Withdrawal by Subject|1|||
162933205|NCT02736227|588460129|FG000|Overall Study|Withdrawal by Subject|0|||
162933206|NCT02736227|588460130|FG001|Overall Study|Withdrawal by Subject|0|||
162933207|NCT02736227|588460131|FG002|Overall Study|Withdrawal by Subject|1|||
162933208|NCT02736227|588460129|FG000|Overall Study|Physician Decision|0|||
162933209|NCT02736227|588460130|FG001|Overall Study|Physician Decision|0|||
162933210|NCT02736227|588460131|FG002|Overall Study|Physician Decision|5|||
162933211|NCT02736227|588460129|FG000|Overall Study|Non Compliant|0|||
162933212|NCT02736227|588460130|FG001|Overall Study|Non Compliant|0|||
162933213|NCT02736227|588460131|FG002|Overall Study|Non Compliant|2|||
162933214|NCT01205529|588460132|FG000|Overall Study|Procedure Cancelled|4|||
162933215|NCT01205529|588460132|FG000|Overall Study|Withdrawal by Subject|2|||
162933216|NCT01205529|588460132|FG000|Overall Study|Physician Decision|4|||
162933217|NCT01205529|588460132|FG000|Overall Study|Unstable post op|15|||
163177708|NCT01903252|589366645|FG004|Double-Blind Induction|non-compliance,|0|||
163177709|NCT01903252|589366646|FG005|Double-Blind Induction|non-compliance,|0|||
163177710|NCT01903252|589366641|FG000|Extended Induction, Open-Label|Adverse Event|0|||
163177711|NCT01903252|589366642|FG001|Extended Induction, Open-Label|Adverse Event|0|||
163177712|NCT01903252|589366643|FG002|Extended Induction, Open-Label|Adverse Event|17|||
163177713|NCT01903252|589366644|FG003|Extended Induction, Open-Label|Adverse Event|0|||
163177714|NCT01903252|589366645|FG004|Extended Induction, Open-Label|Adverse Event|0|||
163177715|NCT01903252|589366646|FG005|Extended Induction, Open-Label|Adverse Event|0|||
163177716|NCT01903252|589366641|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
163177717|NCT01903252|589366642|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
163177718|NCT01903252|589366643|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
163177719|NCT01903252|589366644|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
163177720|NCT01903252|589366645|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
163177721|NCT01903252|589366646|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
163177722|NCT01903252|589366641|FG000|Extended Induction, Open-Label|Physician Decision|0|||
163177723|NCT01903252|589366642|FG001|Extended Induction, Open-Label|Physician Decision|0|||
163177724|NCT01903252|589366643|FG002|Extended Induction, Open-Label|Physician Decision|1|||
163177725|NCT01903252|589366644|FG003|Extended Induction, Open-Label|Physician Decision|0|||
163177726|NCT01903252|589366645|FG004|Extended Induction, Open-Label|Physician Decision|0|||
163177727|NCT01903252|589366646|FG005|Extended Induction, Open-Label|Physician Decision|0|||
163177728|NCT01903252|589366641|FG000|Maintenance, Open-Label|Adverse Event|0|||
163177729|NCT01903252|589366642|FG001|Maintenance, Open-Label|Adverse Event|0|||
163177730|NCT01903252|589366643|FG002|Maintenance, Open-Label|Adverse Event|0|||
163177731|NCT01903252|589366644|FG003|Maintenance, Open-Label|Adverse Event|3|||
163177732|NCT01903252|589366645|FG004|Maintenance, Open-Label|Adverse Event|9|||
163177733|NCT01903252|589366646|FG005|Maintenance, Open-Label|Adverse Event|14|||
163177734|NCT01903252|589366641|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
163177735|NCT01903252|589366642|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
163177736|NCT01903252|589366643|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
163177737|NCT01903252|589366644|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
163177738|NCT01903252|589366645|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
163177739|NCT01903252|589366646|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
163177740|NCT01903252|589366641|FG000|Maintenance, Open-Label|Other|0|||
163177741|NCT01903252|589366642|FG001|Maintenance, Open-Label|Other|0|||
163177742|NCT01903252|589366643|FG002|Maintenance, Open-Label|Other|0|||
163177743|NCT01903252|589366644|FG003|Maintenance, Open-Label|Other|2|||
163177744|NCT01903252|589366645|FG004|Maintenance, Open-Label|Other|6|||
163177745|NCT01903252|589366646|FG005|Maintenance, Open-Label|Other|2|||
163177746|NCT00645788|589366658|FG000|Overall Study|Did not receive study drug|1|||
163177747|NCT00645788|589366659|FG001|Overall Study|Did not receive study drug|1|||
163177748|NCT00645788|589366660|FG002|Overall Study|Did not receive study drug|0|||
163177749|NCT00645788|589366661|FG003|Overall Study|Did not receive study drug|0|||
163177750|NCT00645788|589366658|FG000|Overall Study|Adverse Event|4|||
163177751|NCT00645788|589366659|FG001|Overall Study|Adverse Event|9|||
163177752|NCT00645788|589366660|FG002|Overall Study|Adverse Event|5|||
163177753|NCT00645788|589366661|FG003|Overall Study|Adverse Event|3|||
163177754|NCT00645788|589366658|FG000|Overall Study|Lost to Follow-up|1|||
163177755|NCT00645788|589366659|FG001|Overall Study|Lost to Follow-up|0|||
163177756|NCT00645788|589366660|FG002|Overall Study|Lost to Follow-up|0|||
163177757|NCT00645788|589366661|FG003|Overall Study|Lost to Follow-up|0|||
163177758|NCT00645788|589366658|FG000|Overall Study|Protocol Violation|1|||
163177759|NCT00645788|589366659|FG001|Overall Study|Protocol Violation|0|||
163177760|NCT00645788|589366660|FG002|Overall Study|Protocol Violation|2|||
163177761|NCT00645788|589366661|FG003|Overall Study|Protocol Violation|0|||
163177762|NCT00645788|589366658|FG000|Overall Study|Withdrawal by Subject|0|||
163177763|NCT00645788|589366659|FG001|Overall Study|Withdrawal by Subject|1|||
163177764|NCT00645788|589366660|FG002|Overall Study|Withdrawal by Subject|0|||
163177765|NCT00645788|589366661|FG003|Overall Study|Withdrawal by Subject|2|||
163177766|NCT00645788|589366658|FG000|Overall Study|Pulmonary exacerbation|13|||
163282955|NCT01537133|589745603|FG002|Overall Study|Lost to Follow-up|0|||
163282956|NCT01537133|589745604|FG003|Overall Study|Lost to Follow-up|0|||
163282957|NCT00349908|589745605|FG000|Overall Study|Withdrawal by Subject|0|||
163282958|NCT00349908|589745606|FG001|Overall Study|Withdrawal by Subject|4|||
163282959|NCT01289119|589745610|FG000|Overall Study|Adverse Event|2|||
163282960|NCT01289119|589745611|FG001|Overall Study|Adverse Event|1|||
163282961|NCT01289119|589745612|FG002|Overall Study|Adverse Event|0|||
163282962|NCT01289119|589745613|FG003|Overall Study|Adverse Event|2|||
163282963|NCT01289119|589745614|FG004|Overall Study|Adverse Event|1|||
163282964|NCT01289119|589745615|FG005|Overall Study|Adverse Event|0|||
163282965|NCT01289119|589745610|FG000|Overall Study|Major Protocol Deviation|2|||
163282966|NCT01289119|589745611|FG001|Overall Study|Major Protocol Deviation|1|||
163282967|NCT01289119|589745612|FG002|Overall Study|Major Protocol Deviation|3|||
163282968|NCT01289119|589745613|FG003|Overall Study|Major Protocol Deviation|0|||
163282969|NCT01289119|589745614|FG004|Overall Study|Major Protocol Deviation|2|||
163282970|NCT01289119|589745615|FG005|Overall Study|Major Protocol Deviation|1|||
163282971|NCT01289119|589745610|FG000|Overall Study|Lost to Follow-up|0|||
163282972|NCT01289119|589745611|FG001|Overall Study|Lost to Follow-up|3|||
163282973|NCT01289119|589745612|FG002|Overall Study|Lost to Follow-up|0|||
163282974|NCT01289119|589745613|FG003|Overall Study|Lost to Follow-up|0|||
163282975|NCT01289119|589745614|FG004|Overall Study|Lost to Follow-up|0|||
163282976|NCT01289119|589745615|FG005|Overall Study|Lost to Follow-up|1|||
163282977|NCT01289119|589745610|FG000|Overall Study|Withdrawal by Subject|4|||
163282978|NCT01289119|589745611|FG001|Overall Study|Withdrawal by Subject|2|||
163282979|NCT01289119|589745612|FG002|Overall Study|Withdrawal by Subject|4|||
163282980|NCT01289119|589745613|FG003|Overall Study|Withdrawal by Subject|3|||
163282981|NCT01289119|589745614|FG004|Overall Study|Withdrawal by Subject|1|||
163282982|NCT01289119|589745615|FG005|Overall Study|Withdrawal by Subject|1|||
163282983|NCT01289119|589745610|FG000|Overall Study|Pregnancy|0|||
163282984|NCT01289119|589745611|FG001|Overall Study|Pregnancy|1|||
163282985|NCT01289119|589745612|FG002|Overall Study|Pregnancy|0|||
163282986|NCT01289119|589745613|FG003|Overall Study|Pregnancy|0|||
163282987|NCT01289119|589745614|FG004|Overall Study|Pregnancy|0|||
163282988|NCT01289119|589745615|FG005|Overall Study|Pregnancy|0|||
163282989|NCT01289119|589745610|FG000|Overall Study|Lack of Efficacy|0|||
163282990|NCT01289119|589745611|FG001|Overall Study|Lack of Efficacy|1|||
163282991|NCT01289119|589745612|FG002|Overall Study|Lack of Efficacy|1|||
163282992|NCT01289119|589745613|FG003|Overall Study|Lack of Efficacy|1|||
163282993|NCT01289119|589745614|FG004|Overall Study|Lack of Efficacy|1|||
163282994|NCT01289119|589745615|FG005|Overall Study|Lack of Efficacy|1|||
163282995|NCT01289119|589745610|FG000|Overall Study|Other|1|||
163282996|NCT01289119|589745611|FG001|Overall Study|Other|0|||
163282997|NCT01289119|589745612|FG002|Overall Study|Other|1|||
163282998|NCT01289119|589745613|FG003|Overall Study|Other|0|||
163282999|NCT01289119|589745614|FG004|Overall Study|Other|0|||
163283000|NCT01289119|589745615|FG005|Overall Study|Other|0|||
163283001|NCT01704846|589745616|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163283002|NCT01704846|589745617|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163283003|NCT00530335|589745620|FG000|Overall Study|Adverse Event|3|||
163283004|NCT00530335|589745620|FG000|Overall Study|Protocol Violation|1|||
163283005|NCT00530335|589745620|FG000|Overall Study|Withdrawal by Subject|1|||
163283006|NCT00530335|589745620|FG000|Overall Study|Physician Decision|1|||
163283007|NCT01244984|589745621|FG000|Overall Study|Adverse Event|2|||
163283008|NCT01244984|589745622|FG001|Overall Study|Adverse Event|11|||
163283009|NCT01244984|589745623|FG002|Overall Study|Adverse Event|2|||
163283010|NCT01244984|589745621|FG000|Overall Study|Protocol Violation|1|||
162933218|NCT01205529|588460132|FG000|Overall Study|No longer met criteria|30|||
162933219|NCT03840135|588460135|FG000|Overall Study|Protocol Violation|6|||
162933220|NCT03840135|588460136|FG001|Overall Study|Protocol Violation|1|||
162933221|NCT03840135|588460135|FG000|Overall Study|Withdrawal by Subject|1|||
162933222|NCT03840135|588460136|FG001|Overall Study|Withdrawal by Subject|0|||
162933223|NCT04133519|588460137|FG000|Overall Study|Withdrawal by Subject|5|||
162933224|NCT04133519|588460138|FG001|Overall Study|Withdrawal by Subject|4|||
163283011|NCT01244984|589745622|FG001|Overall Study|Protocol Violation|0|||
163283012|NCT01244984|589745623|FG002|Overall Study|Protocol Violation|0|||
163283013|NCT01244984|589745621|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
163283014|NCT01244984|589745622|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
163283015|NCT01244984|589745623|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
163283016|NCT01244984|589745621|FG000|Overall Study|Withdrawal by Subject|1|||
163283017|NCT01244984|589745622|FG001|Overall Study|Withdrawal by Subject|2|||
163283018|NCT01244984|589745623|FG002|Overall Study|Withdrawal by Subject|2|||
163283019|NCT04577183|589745625|FG000|Overall Study|Death|1|||
163283020|NCT04577183|589745625|FG000|Overall Study|Withdrawal by Subject|3|||
163283021|NCT04577183|589745625|FG000|Overall Study|Early termination|2|||
163283022|NCT01168401|589745627|FG000|Overall Study|Lost to Follow-up|1|||
163283023|NCT01168401|589745628|FG001|Overall Study|Lost to Follow-up|1|||
163283024|NCT01168401|589745629|FG002|Overall Study|Lost to Follow-up|2|||
163283025|NCT01168401|589745630|FG003|Overall Study|Lost to Follow-up|1|||
163283026|NCT01168401|589745631|FG004|Overall Study|Lost to Follow-up|0|||
163283027|NCT01168401|589745632|FG005|Overall Study|Lost to Follow-up|0|||
163283028|NCT01168401|589745633|FG006|Overall Study|Lost to Follow-up|0|||
163283029|NCT01168401|589745634|FG007|Overall Study|Lost to Follow-up|0|||
163283030|NCT01168401|589745635|FG008|Overall Study|Lost to Follow-up|0|||
163177767|NCT00645788|589366659|FG001|Overall Study|Pulmonary exacerbation|16|||
163177768|NCT00645788|589366660|FG002|Overall Study|Pulmonary exacerbation|11|||
163177769|NCT00645788|589366661|FG003|Overall Study|Pulmonary exacerbation|9|||
163177770|NCT01924429|589366662|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
163177771|NCT01924429|589366663|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
163177772|NCT01445886|589366666|FG000|Overall Study|Lost to Follow-up|2|||
163177773|NCT01445886|589366666|FG000|Overall Study|Protocol Violation|3|||
163177774|NCT04268823|589366672|FG000|Overall Study|Adverse Event|1|||
163177775|NCT04268823|589366673|FG001|Overall Study|Adverse Event|0|||
163177776|NCT04268823|589366672|FG000|Overall Study|Participant Decision|1|||
163177777|NCT04268823|589366673|FG001|Overall Study|Participant Decision|0|||
163177778|NCT05313009|589368051|FG000|Overall Study|Death|1|||
163177779|NCT05313009|589368052|FG001|Overall Study|Death|0|||
163177780|NCT02186301|589368053|FG000|Overall Study|Progressive Disease|7|||
163177781|NCT02186301|589368054|FG001|Overall Study|Progressive Disease|22|||
163177782|NCT02186301|589368055|FG002|Overall Study|Progressive Disease|27|||
163177783|NCT02186301|589368053|FG000|Overall Study|Adverse Event|5|||
163177784|NCT02186301|589368054|FG001|Overall Study|Adverse Event|5|||
163177785|NCT02186301|589368055|FG002|Overall Study|Adverse Event|5|||
163177786|NCT02186301|589368053|FG000|Overall Study|Death|1|||
163177787|NCT02186301|589368054|FG001|Overall Study|Death|0|||
163177788|NCT02186301|589368055|FG002|Overall Study|Death|0|||
163177789|NCT02186301|589368053|FG000|Overall Study|Withdrawal by Subject|5|||
163177790|NCT02186301|589368054|FG001|Overall Study|Withdrawal by Subject|1|||
163177791|NCT02186301|589368055|FG002|Overall Study|Withdrawal by Subject|3|||
163177792|NCT02186301|589368053|FG000|Overall Study|Physician Decision|1|||
163177793|NCT02186301|589368054|FG001|Overall Study|Physician Decision|0|||
163177794|NCT02186301|589368055|FG002|Overall Study|Physician Decision|1|||
163177795|NCT02186301|589368053|FG000|Overall Study|Study Terminated by Sponsor|1|||
163177796|NCT02186301|589368054|FG001|Overall Study|Study Terminated by Sponsor|0|||
163177797|NCT02186301|589368055|FG002|Overall Study|Study Terminated by Sponsor|11|||
163177798|NCT02186301|589368053|FG000|Overall Study|Protocol Deviation|0|||
163177799|NCT02186301|589368054|FG001|Overall Study|Protocol Deviation|2|||
163177800|NCT02186301|589368055|FG002|Overall Study|Protocol Deviation|0|||
163177801|NCT02186301|589368053|FG000|Overall Study|Missing|0|||
163177802|NCT02186301|589368054|FG001|Overall Study|Missing|0|||
163177803|NCT02186301|589368055|FG002|Overall Study|Missing|2|||
163177804|NCT02186301|589368053|FG000|Overall Study|Other|0|||
163177805|NCT02186301|589368054|FG001|Overall Study|Other|0|||
163177806|NCT02186301|589368055|FG002|Overall Study|Other|1|||
163177807|NCT00749580|589368056|FG000|Overall Study|Lost to Follow-up|4|||
163177808|NCT00749580|589368057|FG001|Overall Study|Lost to Follow-up|8|||
163177809|NCT00749580|589368056|FG000|Overall Study|Adverse Event|0|||
163177810|NCT00749580|589368057|FG001|Overall Study|Adverse Event|1|||
163177811|NCT05128929|589368058|FG000|Overall Study|Adverse Event|0|||
163177812|NCT05128929|589368059|FG001|Overall Study|Adverse Event|1|||
163177813|NCT03553836|589368060|FG000|Overall Study|Ongoing in Study|460|||
163177814|NCT03553836|589368061|FG001|Overall Study|Ongoing in Study|459|||
163177815|NCT03553836|589368060|FG000|Overall Study|Withdrawal by Subject|9|||
163177816|NCT03553836|589368061|FG001|Overall Study|Withdrawal by Subject|10|||
163177817|NCT03553836|589368060|FG000|Overall Study|Lost to Follow-up|1|||
163177818|NCT03553836|589368061|FG001|Overall Study|Lost to Follow-up|3|||
163177819|NCT03553836|589368060|FG000|Overall Study|Death|17|||
163177820|NCT03553836|589368061|FG001|Overall Study|Death|17|||
163177821|NCT00807027|589368062|FG000|Overall Study|Withdrawal by Subject|13|||
163177822|NCT00807027|589368063|FG001|Overall Study|Withdrawal by Subject|14|||
163177823|NCT00807027|589368062|FG000|Overall Study|Protocol Violation|1|||
163177824|NCT00807027|589368063|FG001|Overall Study|Protocol Violation|1|||
163177825|NCT00807027|589368062|FG000|Overall Study|Adverse Event|2|||
163177826|NCT00807027|589368063|FG001|Overall Study|Adverse Event|2|||
163177827|NCT05660850|589368064|FG000|Treatment Period 2|Study Terminated by Sponsor|1|||
163177828|NCT05660850|589368065|FG001|Treatment Period 2|Study Terminated by Sponsor|0|||
163177829|NCT05660850|589368066|FG002|Treatment Period 2|Study Terminated by Sponsor|0|||
163177830|NCT05660850|589368067|FG003|Treatment Period 2|Study Terminated by Sponsor|0|||
163177831|NCT02604017|589368068|FG000|Overall Study|Withdrew Consent|0|||
163177832|NCT02604017|589368069|FG001|Overall Study|Withdrew Consent|2|||
163177833|NCT02604017|589368068|FG000|Overall Study|Lost to Follow-up|5|||
163177834|NCT02604017|589368069|FG001|Overall Study|Lost to Follow-up|6|||
163177835|NCT02604017|589368068|FG000|Overall Study|Other|1|||
163177836|NCT02604017|589368069|FG001|Overall Study|Other|0|||
163177837|NCT01653782|589368075|FG000|Overall Study|Withdrawal by Subject|9|||
163177838|NCT01653782|589368076|FG001|Overall Study|Withdrawal by Subject|15|||
163177839|NCT01653782|589368077|FG002|Overall Study|Withdrawal by Subject|4|||
163283031|NCT01168401|589745636|FG009|Overall Study|Lost to Follow-up|0|||
162933225|NCT04133519|588460137|FG000|Overall Study|Protocol Violation|0|||
162933226|NCT04133519|588460138|FG001|Overall Study|Protocol Violation|1|||
162933227|NCT04133519|588460137|FG000|Overall Study|Never started treatment|1|||
162933228|NCT04133519|588460138|FG001|Overall Study|Never started treatment|1|||
162933229|NCT00323609|588460139|FG000|Overall Study|Death|16|||
162933230|NCT00323609|588460140|FG001|Overall Study|Death|21|||
162933231|NCT00323609|588460141|FG002|Overall Study|Death|0|||
162933232|NCT00323609|588460142|FG003|Overall Study|Death|0|||
162933233|NCT00323609|588460139|FG000|Overall Study|Lost to Follow-up|9|||
162933234|NCT00323609|588460140|FG001|Overall Study|Lost to Follow-up|10|||
162933235|NCT00323609|588460141|FG002|Overall Study|Lost to Follow-up|0|||
162933236|NCT00323609|588460142|FG003|Overall Study|Lost to Follow-up|0|||
162933237|NCT00323609|588460139|FG000|Overall Study|Physician Decision|2|||
162933238|NCT00323609|588460140|FG001|Overall Study|Physician Decision|0|||
162933239|NCT00323609|588460141|FG002|Overall Study|Physician Decision|0|||
162933240|NCT00323609|588460142|FG003|Overall Study|Physician Decision|1|||
162933241|NCT00323609|588460139|FG000|Overall Study|Withdrawal by Subject|11|||
162933242|NCT00323609|588460140|FG001|Overall Study|Withdrawal by Subject|23|||
162933243|NCT00323609|588460141|FG002|Overall Study|Withdrawal by Subject|4|||
162933244|NCT00323609|588460142|FG003|Overall Study|Withdrawal by Subject|4|||
162933245|NCT00323609|588460139|FG000|Overall Study|Other non-VCF-related medical condition|3|||
162933246|NCT00323609|588460140|FG001|Overall Study|Other non-VCF-related medical condition|2|||
163177840|NCT01653782|589368075|FG000|Overall Study|Lost to Follow-up|7|||
163177841|NCT01653782|589368076|FG001|Overall Study|Lost to Follow-up|3|||
163177842|NCT01653782|589368077|FG002|Overall Study|Lost to Follow-up|2|||
163177843|NCT02497976|589368083|FG000|Overall Study|Withdrawal by Subject|2|||
163177844|NCT02497976|589368084|FG001|Overall Study|Withdrawal by Subject|0|||
163177845|NCT02497976|589368083|FG000|Overall Study|Moved out of area|0|||
163177846|NCT02497976|589368084|FG001|Overall Study|Moved out of area|1|||
163177847|NCT00058539|589368088|FG000|Overall Study|Disease progression|24|||
163177848|NCT00058539|589368088|FG000|Overall Study|Adverse Event|3|||
163177849|NCT00058539|589368088|FG000|Overall Study|Withdrawal by Subject|5|||
163177850|NCT00058539|589368088|FG000|Overall Study|Physician Decision|9|||
163177851|NCT00058539|589368088|FG000|Overall Study|Death|1|||
163177852|NCT01673282|589368089|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
163177853|NCT01673282|589368090|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
163177854|NCT01673282|589368089|FG000|Overall Study|Lack of Efficacy|9|||
163177855|NCT01673282|589368090|FG001|Overall Study|Lack of Efficacy|2|||
163177856|NCT01673282|589368089|FG000|Overall Study|Lost to Follow-up|11|||
163177857|NCT01673282|589368090|FG001|Overall Study|Lost to Follow-up|10|||
163177858|NCT01673282|589368089|FG000|Overall Study|Withdrawal by Subject|3|||
163177859|NCT01673282|589368090|FG001|Overall Study|Withdrawal by Subject|3|||
163177860|NCT01673282|589368089|FG000|Overall Study|Other|1|||
163177861|NCT01673282|589368090|FG001|Overall Study|Other|6|||
163177862|NCT02483533|589368091|FG000|Overall Study|Lack of Efficacy|50|||
162933247|NCT00323609|588460141|FG002|Overall Study|Other non-VCF-related medical condition|0|||
163177863|NCT02483533|589368092|FG001|Overall Study|Lack of Efficacy|50|||
163177864|NCT01323920|589368093|FG000|Overall Study|Death|5|||
163177865|NCT01323920|589368093|FG000|Overall Study|Withdrawal by Subject|1|||
163177866|NCT00768469|589368094|FG000|Overall Study|Adverse Event|0|||
163177867|NCT00768469|589368095|FG001|Overall Study|Adverse Event|2|||
163177868|NCT00768469|589368094|FG000|Overall Study|Disease Progression|3|||
163177869|NCT00768469|589368095|FG001|Overall Study|Disease Progression|4|||
163177870|NCT00768469|589368094|FG000|Overall Study|Withdrawal by Subject|0|||
163177871|NCT00768469|589368095|FG001|Overall Study|Withdrawal by Subject|1|||
163177872|NCT05040971|589368096|FG000|Overall Study|Withdrawal by Subject|0|||
163177873|NCT05040971|589368097|FG001|Overall Study|Withdrawal by Subject|2|||
163177874|NCT05040971|589368096|FG000|Overall Study|Lost to Follow-up|8|||
163177875|NCT05040971|589368097|FG001|Overall Study|Lost to Follow-up|3|||
163177876|NCT05040971|589368096|FG000|Overall Study|Death|2|||
163177877|NCT05040971|589368097|FG001|Overall Study|Death|0|||
163177878|NCT01293799|589368101|FG000|Overall Study|Kidney transplantation|109|||
163177879|NCT01293799|589368102|FG001|Overall Study|Kidney transplantation|96|||
163177880|NCT01293799|589368101|FG000|Overall Study|Transfer to hemodialysis|70|||
163177881|NCT01293799|589368102|FG001|Overall Study|Transfer to hemodialysis|90|||
163177882|NCT01293799|589368101|FG000|Overall Study|Death|27|||
163177883|NCT01293799|589368102|FG001|Overall Study|Death|29|||
163177884|NCT01293799|589368101|FG000|Overall Study|Transfer to assisted PD|24|||
163177885|NCT01293799|589368102|FG001|Overall Study|Transfer to assisted PD|18|||
163177886|NCT01293799|589368101|FG000|Overall Study|Withdrawal by Subject|26|||
163177887|NCT01293799|589368102|FG001|Overall Study|Withdrawal by Subject|0|||
163177888|NCT01293799|589368101|FG000|Overall Study|Investigator decision|5|||
163177889|NCT01293799|589368102|FG001|Overall Study|Investigator decision|2|||
162933248|NCT00323609|588460142|FG003|Overall Study|Other non-VCF-related medical condition|0|||
162933249|NCT00323609|588460139|FG000|Overall Study|Sponsor discontinued trial|29|||
162933250|NCT00323609|588460140|FG001|Overall Study|Sponsor discontinued trial|29|||
162933251|NCT00323609|588460141|FG002|Overall Study|Sponsor discontinued trial|0|||
162933252|NCT00323609|588460142|FG003|Overall Study|Sponsor discontinued trial|0|||
163177890|NCT01293799|589368101|FG000|Overall Study|Kidney function improved|6|||
163177891|NCT01293799|589368102|FG001|Overall Study|Kidney function improved|7|||
163177892|NCT01293799|589368101|FG000|Overall Study|Other causes|6|||
163177893|NCT01293799|589368102|FG001|Overall Study|Other causes|3|||
163177894|NCT00938886|589368108|FG000|Overall Study|Death|0|||
163177895|NCT00938886|589368109|FG001|Overall Study|Death|1|||
163177896|NCT00938886|589368108|FG000|Overall Study|Withdrawal by Subject|4|||
163177897|NCT00938886|589368109|FG001|Overall Study|Withdrawal by Subject|7|||
163177898|NCT00938886|589368108|FG000|Overall Study|Lost to Follow-up|3|||
163177899|NCT00938886|589368109|FG001|Overall Study|Lost to Follow-up|2|||
163177900|NCT02283177|589368110|FG000|Overall Study|Withdrawal by Subject|1|||
163177901|NCT02283177|589368111|FG001|Overall Study|Withdrawal by Subject|1|||
163177902|NCT03044574|589368112|FG000|Overall Study|Lost to Follow-up|37|||
163177903|NCT03044574|589368113|FG001|Overall Study|Lost to Follow-up|45|||
163177904|NCT02635646|589368115|FG000|Overall Study|Lost to Follow-up|24|||
163177905|NCT02635646|589368116|FG001|Overall Study|Lost to Follow-up|25|||
163177906|NCT02635646|589368115|FG000|Overall Study|Pregnancy|1|||
163177907|NCT02635646|589368116|FG001|Overall Study|Pregnancy|1|||
163177908|NCT00327470|589368125|FG000|Overall Study|Randomized, but not treated|0|||
163177909|NCT00327470|589368126|FG001|Overall Study|Randomized, but not treated|2|||
163177910|NCT00327470|589368125|FG000|Overall Study|Adverse Event|9|||
163177911|NCT00327470|589368126|FG001|Overall Study|Adverse Event|14|||
163177912|NCT00327470|589368125|FG000|Overall Study|Lack of Efficacy|7|||
163177913|NCT00327470|589368126|FG001|Overall Study|Lack of Efficacy|19|||
163177914|NCT00327470|589368125|FG000|Overall Study|Other|5|||
163177915|NCT00327470|589368126|FG001|Overall Study|Other|9|||
163177916|NCT00327470|589368125|FG000|Overall Study|Lost to Follow-up|1|||
163177917|NCT00327470|589368126|FG001|Overall Study|Lost to Follow-up|3|||
163177918|NCT00327470|589368125|FG000|Overall Study|Withdrawal by Subject|6|||
163177919|NCT00327470|589368126|FG001|Overall Study|Withdrawal by Subject|12|||
163177920|NCT00327470|589368125|FG000|Overall Study|Death|1|||
163177921|NCT00327470|589368126|FG001|Overall Study|Death|4|||
163177922|NCT01163032|589368136|FG000|Randomization Phase|Withdrawal by Subject|2|||
163177923|NCT01163032|589368137|FG001|Randomization Phase|Withdrawal by Subject|3|||
163177924|NCT01163032|589368138|FG002|Randomization Phase|Withdrawal by Subject|0|||
163177925|NCT01163032|589368136|FG000|Randomization Phase|Adverse Event|3|||
163177926|NCT01163032|589368137|FG001|Randomization Phase|Adverse Event|3|||
163177927|NCT01163032|589368138|FG002|Randomization Phase|Adverse Event|0|||
163177928|NCT01163032|589368136|FG000|Randomization Phase|Protocol Violation|0|||
163177929|NCT01163032|589368137|FG001|Randomization Phase|Protocol Violation|1|||
163177930|NCT01163032|589368138|FG002|Randomization Phase|Protocol Violation|0|||
163177931|NCT01163032|589368136|FG000|Randomization Phase|Various*|5|||
163177932|NCT01163032|589368137|FG001|Randomization Phase|Various*|4|||
163177933|NCT01163032|589368138|FG002|Randomization Phase|Various*|0|||
163177934|NCT01163032|589368136|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
163177935|NCT01163032|589368137|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
163177936|NCT01163032|589368138|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
163177937|NCT01163032|589368136|FG000|Open Label Extension Phase|Adverse Event|0|||
163177938|NCT01163032|589368137|FG001|Open Label Extension Phase|Adverse Event|0|||
163177939|NCT01163032|589368138|FG002|Open Label Extension Phase|Adverse Event|3|||
163177940|NCT01163032|589368136|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
163177941|NCT01163032|589368137|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
163177942|NCT01163032|589368138|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
163177943|NCT01163032|589368136|FG000|Open Label Extension Phase|Protocol Violation|0|||
163177944|NCT01163032|589368137|FG001|Open Label Extension Phase|Protocol Violation|0|||
163177945|NCT01163032|589368138|FG002|Open Label Extension Phase|Protocol Violation|1|||
163177946|NCT01163032|589368136|FG000|Open Label Extension Phase|Study Termination|0|||
163177947|NCT01163032|589368137|FG001|Open Label Extension Phase|Study Termination|0|||
163177948|NCT01163032|589368138|FG002|Open Label Extension Phase|Study Termination|7|||
163177949|NCT01163032|589368136|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
163177950|NCT01163032|589368137|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
163177951|NCT01163032|589368138|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
163177952|NCT02751931|589368140|FG000|Overall Study|Adverse Event|3|||
163177953|NCT02751931|589368141|FG001|Overall Study|Adverse Event|0|||
163177954|NCT02751931|589368140|FG000|Overall Study|Other: Miscelleneous|10|||
163283032|NCT01168401|589745637|FG010|Overall Study|Lost to Follow-up|0|||
163177955|NCT02751931|589368141|FG001|Overall Study|Other: Miscelleneous|8|||
163177956|NCT04090411|589368142|FG000|Induction Period|Adverse Event|3|||
163177957|NCT04090411|589368143|FG001|Induction Period|Adverse Event|1|||
163177958|NCT04090411|589368144|FG002|Induction Period|Adverse Event|1|||
163177959|NCT04090411|589368145|FG003|Induction Period|Adverse Event|1|||
163177960|NCT04090411|589368146|FG004|Induction Period|Adverse Event|0|||
163177961|NCT04090411|589368147|FG005|Induction Period|Adverse Event|0|||
163177962|NCT04090411|589368148|FG006|Induction Period|Adverse Event|0|||
163177963|NCT04090411|589368149|FG007|Induction Period|Adverse Event|0|||
163283033|NCT01168401|589745627|FG000|Overall Study|Withdrawal by Subject|0|||
163283034|NCT01168401|589745628|FG001|Overall Study|Withdrawal by Subject|0|||
163283035|NCT01168401|589745629|FG002|Overall Study|Withdrawal by Subject|0|||
163283036|NCT01168401|589745630|FG003|Overall Study|Withdrawal by Subject|1|||
163283037|NCT01168401|589745631|FG004|Overall Study|Withdrawal by Subject|0|||
163283038|NCT01168401|589745632|FG005|Overall Study|Withdrawal by Subject|0|||
163283039|NCT01168401|589745633|FG006|Overall Study|Withdrawal by Subject|0|||
163283040|NCT01168401|589745634|FG007|Overall Study|Withdrawal by Subject|0|||
163283041|NCT01168401|589745635|FG008|Overall Study|Withdrawal by Subject|0|||
163283042|NCT01168401|589745636|FG009|Overall Study|Withdrawal by Subject|0|||
163283043|NCT01168401|589745637|FG010|Overall Study|Withdrawal by Subject|0|||
163283044|NCT01801930|589745643|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
163283045|NCT01801930|589745644|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
163283046|NCT01801930|589745645|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
163283047|NCT01801930|589745646|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
163283048|NCT01801930|589745643|FG000|Overall Study|DLT occurs|0|||
163283049|NCT01801930|589745644|FG001|Overall Study|DLT occurs|1|||
163283050|NCT01801930|589745645|FG002|Overall Study|DLT occurs|0|||
163283051|NCT01801930|589745646|FG003|Overall Study|DLT occurs|0|||
163283052|NCT02072226|589745653|FG000|Overall Study|Lost to Follow-up|11|||
163283053|NCT02072226|589745654|FG001|Overall Study|Lost to Follow-up|7|||
163283054|NCT02072226|589745653|FG000|Overall Study|Patient Non-compliance|2|||
163283055|NCT02072226|589745654|FG001|Overall Study|Patient Non-compliance|3|||
163283056|NCT02072226|589745653|FG000|Overall Study|Death|1|||
163283057|NCT02072226|589745654|FG001|Overall Study|Death|0|||
163283058|NCT02072226|589745653|FG000|Overall Study|Patient Withdrawal of Consent|1|||
163283059|NCT02072226|589745654|FG001|Overall Study|Patient Withdrawal of Consent|0|||
163283060|NCT01720043|589745657|FG000|Overall Study|Withdrawal by Subject|1|||
163283061|NCT00972543|589745664|FG000|Overall Study|Adverse Event|1|||
163283062|NCT00972543|589745665|FG001|Overall Study|Adverse Event|0|||
163283063|NCT00972543|589745664|FG000|Overall Study|Early study termination by sponsor|4|||
163283064|NCT00972543|589745665|FG001|Overall Study|Early study termination by sponsor|1|||
163283065|NCT03101592|589745666|FG000|Overall Study|participant files could not be located|111|||
163283066|NCT03101592|589745667|FG001|Overall Study|participant files could not be located|170|||
163283067|NCT03101592|589745668|FG002|Overall Study|participant files could not be located|118|||
163283068|NCT02397889|589745671|FG000|Overall Study|Physician Decision|1|||
163283069|NCT02397889|589745672|FG001|Overall Study|Physician Decision|0|||
163283070|NCT01352507|589745673|FG000|Treatment Period 1|Adverse Event|3|||
163283071|NCT01352507|589745674|FG001|Treatment Period 1|Adverse Event|0|||
163283072|NCT01352507|589745673|FG000|Treatment Period 1|Lost to Follow-up|3|||
163283073|NCT01352507|589745674|FG001|Treatment Period 1|Lost to Follow-up|4|||
163283074|NCT01352507|589745673|FG000|Treatment Period 1|Withdrawal by Subject|7|||
163283075|NCT01352507|589745674|FG001|Treatment Period 1|Withdrawal by Subject|5|||
163283076|NCT01352507|589745673|FG000|Treatment Period 1|Physician Decision|1|||
163283077|NCT01352507|589745674|FG001|Treatment Period 1|Physician Decision|0|||
163283078|NCT01352507|589745673|FG000|Washout Period|Withdrawal by Subject|0|||
163283079|NCT01352507|589745674|FG001|Washout Period|Withdrawal by Subject|1|||
163283080|NCT01352507|589745673|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
163283081|NCT01352507|589745674|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
163283082|NCT01352507|589745673|FG000|Treatment Period 2|Withdrawal by Subject|4|||
163283083|NCT01352507|589745674|FG001|Treatment Period 2|Withdrawal by Subject|3|||
163283084|NCT01352507|589745673|FG000|Treatment Period 2|Lack of Efficacy|1|||
163283085|NCT01352507|589745674|FG001|Treatment Period 2|Lack of Efficacy|0|||
163283086|NCT03178201|589745675|FG000|Overall Study|Off study|5|||
163283087|NCT04639947|589745680|FG000|Overall Study|Screen fail|1|||
163283088|NCT01018511|589745681|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
163283089|NCT01018511|589745682|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
163283090|NCT01018511|589745683|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
163283091|NCT01018511|589745684|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
163283092|NCT01018511|589745681|FG000|Overall Study|Adverse Event|5|||
163283093|NCT01018511|589745682|FG001|Overall Study|Adverse Event|9|||
163283094|NCT01018511|589745683|FG002|Overall Study|Adverse Event|13|||
163283095|NCT01018511|589745684|FG003|Overall Study|Adverse Event|10|||
163283096|NCT01018511|589745681|FG000|Overall Study|Lack of Efficacy|4|||
163283097|NCT01018511|589745682|FG001|Overall Study|Lack of Efficacy|1|||
163283098|NCT01018511|589745683|FG002|Overall Study|Lack of Efficacy|1|||
163283099|NCT01018511|589745684|FG003|Overall Study|Lack of Efficacy|2|||
163283100|NCT01018511|589745681|FG000|Overall Study|Withdrawal by Subject|6|||
163283101|NCT01018511|589745682|FG001|Overall Study|Withdrawal by Subject|5|||
163283102|NCT01018511|589745683|FG002|Overall Study|Withdrawal by Subject|11|||
163283103|NCT01018511|589745684|FG003|Overall Study|Withdrawal by Subject|9|||
163283104|NCT01018511|589745681|FG000|Overall Study|Lost to Follow-up|0|||
163283105|NCT01018511|589745682|FG001|Overall Study|Lost to Follow-up|0|||
163283106|NCT01018511|589745683|FG002|Overall Study|Lost to Follow-up|1|||
163283107|NCT01018511|589745684|FG003|Overall Study|Lost to Follow-up|0|||
163283108|NCT01018511|589745681|FG000|Overall Study|Protocol Violation|5|||
162933253|NCT00323609|588460139|FG000|Overall Study|Unrelenting or severe back pain|1|||
162933254|NCT00323609|588460140|FG001|Overall Study|Unrelenting or severe back pain|1|||
162933255|NCT00323609|588460141|FG002|Overall Study|Unrelenting or severe back pain|0|||
162933256|NCT00323609|588460142|FG003|Overall Study|Unrelenting or severe back pain|0|||
162933257|NCT00323609|588460139|FG000|Overall Study|Logistical withdrawal|9|||
162933258|NCT00323609|588460140|FG001|Overall Study|Logistical withdrawal|5|||
162933259|NCT00323609|588460141|FG002|Overall Study|Logistical withdrawal|0|||
162933260|NCT00323609|588460142|FG003|Overall Study|Logistical withdrawal|1|||
162933261|NCT00323609|588460139|FG000|Overall Study|Other reason|11|||
162933262|NCT00323609|588460140|FG001|Overall Study|Other reason|8|||
162933263|NCT00323609|588460141|FG002|Overall Study|Other reason|4|||
162933264|NCT00323609|588460142|FG003|Overall Study|Other reason|9|||
162933265|NCT00068237|588460145|FG000|Overall Study|Ineligible|3|||
162933266|NCT00068237|588460145|FG000|Overall Study|No protocol treatment received|2|||
162933267|NCT05288673|588460146|FG000|Overall Study|Consent withdrawn by subject|0|||
162933268|NCT05288673|588460147|FG001|Overall Study|Consent withdrawn by subject|0|||
162933269|NCT05288673|588460148|FG002|Overall Study|Consent withdrawn by subject|1|||
162933270|NCT03056352|588460149|FG000|Overall Study|Lost to Follow-up|1|||
162933271|NCT00571922|588460150|FG000|Overall Study|Completion unknown|36|||
162933272|NCT00571922|588460151|FG001|Overall Study|Completion unknown|36|||
162933273|NCT02971605|588460152|FG000|Overall Study|Withdrawal by Subject|1|||
162933274|NCT01154153|588460155|FG000|Overall Study|Poor compliance to protocol|2|||
162933275|NCT01154153|588460156|FG001|Overall Study|Poor compliance to protocol|0|||
162933276|NCT01154153|588460155|FG000|Overall Study|Unable to use labs|2|||
162933277|NCT01154153|588460156|FG001|Overall Study|Unable to use labs|3|||
163177964|NCT04090411|589368150|FG008|Induction Period|Adverse Event|0|||
163177965|NCT04090411|589368151|FG009|Induction Period|Adverse Event|0|||
163177966|NCT04090411|589368152|FG010|Induction Period|Adverse Event|0|||
163177967|NCT04090411|589368153|FG011|Induction Period|Adverse Event|0|||
163177968|NCT04090411|589368154|FG012|Induction Period|Adverse Event|0|||
163177969|NCT04090411|589368142|FG000|Induction Period|Lack of Efficacy|0|||
163177970|NCT04090411|589368143|FG001|Induction Period|Lack of Efficacy|0|||
163177971|NCT04090411|589368144|FG002|Induction Period|Lack of Efficacy|1|||
163177972|NCT04090411|589368145|FG003|Induction Period|Lack of Efficacy|1|||
163177973|NCT04090411|589368146|FG004|Induction Period|Lack of Efficacy|0|||
163177974|NCT04090411|589368147|FG005|Induction Period|Lack of Efficacy|0|||
163177975|NCT04090411|589368148|FG006|Induction Period|Lack of Efficacy|0|||
163177976|NCT04090411|589368149|FG007|Induction Period|Lack of Efficacy|0|||
163283109|NCT01018511|589745682|FG001|Overall Study|Protocol Violation|8|||
163283110|NCT01018511|589745683|FG002|Overall Study|Protocol Violation|7|||
163283111|NCT01018511|589745684|FG003|Overall Study|Protocol Violation|9|||
162933278|NCT01154153|588460155|FG000|Overall Study|Withdrew consent|1|||
162933279|NCT01154153|588460156|FG001|Overall Study|Withdrew consent|0|||
162933280|NCT00964223|588460157|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
162933281|NCT03439293|588460158|FG000|Overall Study|Death|22|||
162933282|NCT03439293|588460158|FG000|Overall Study|Withdrawal by Subject|8|||
163177977|NCT04090411|589368150|FG008|Induction Period|Lack of Efficacy|0|||
163177978|NCT04090411|589368151|FG009|Induction Period|Lack of Efficacy|0|||
163177979|NCT04090411|589368152|FG010|Induction Period|Lack of Efficacy|0|||
163177980|NCT04090411|589368153|FG011|Induction Period|Lack of Efficacy|0|||
163177981|NCT04090411|589368154|FG012|Induction Period|Lack of Efficacy|0|||
163283112|NCT01018511|589745681|FG000|Overall Study|Miscellaneous|0|||
163042826|NCT01990768|588863970|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
163177982|NCT04090411|589368142|FG000|Induction Period|Physician Decision|0|||
163283113|NCT01018511|589745682|FG001|Overall Study|Miscellaneous|2|||
163283114|NCT01018511|589745683|FG002|Overall Study|Miscellaneous|0|||
163283115|NCT01018511|589745684|FG003|Overall Study|Miscellaneous|0|||
163177983|NCT04090411|589368143|FG001|Induction Period|Physician Decision|0|||
163177984|NCT04090411|589368144|FG002|Induction Period|Physician Decision|1|||
163177985|NCT04090411|589368145|FG003|Induction Period|Physician Decision|0|||
163177986|NCT04090411|589368146|FG004|Induction Period|Physician Decision|0|||
163177987|NCT04090411|589368147|FG005|Induction Period|Physician Decision|0|||
163177988|NCT04090411|589368148|FG006|Induction Period|Physician Decision|0|||
163177989|NCT04090411|589368149|FG007|Induction Period|Physician Decision|0|||
163177990|NCT04090411|589368150|FG008|Induction Period|Physician Decision|0|||
163177991|NCT04090411|589368151|FG009|Induction Period|Physician Decision|0|||
163177992|NCT04090411|589368152|FG010|Induction Period|Physician Decision|0|||
163177993|NCT04090411|589368153|FG011|Induction Period|Physician Decision|0|||
163177994|NCT04090411|589368154|FG012|Induction Period|Physician Decision|0|||
163177995|NCT04090411|589368142|FG000|Induction Period|Protocol Violation|0|||
163177996|NCT04090411|589368143|FG001|Induction Period|Protocol Violation|0|||
163177997|NCT04090411|589368144|FG002|Induction Period|Protocol Violation|0|||
163177998|NCT04090411|589368145|FG003|Induction Period|Protocol Violation|1|||
163177999|NCT04090411|589368146|FG004|Induction Period|Protocol Violation|0|||
163178000|NCT04090411|589368147|FG005|Induction Period|Protocol Violation|0|||
163178001|NCT04090411|589368148|FG006|Induction Period|Protocol Violation|0|||
163178002|NCT04090411|589368149|FG007|Induction Period|Protocol Violation|0|||
163178003|NCT04090411|589368150|FG008|Induction Period|Protocol Violation|0|||
163178004|NCT04090411|589368151|FG009|Induction Period|Protocol Violation|0|||
163178005|NCT04090411|589368152|FG010|Induction Period|Protocol Violation|0|||
163178006|NCT04090411|589368153|FG011|Induction Period|Protocol Violation|0|||
163178007|NCT04090411|589368154|FG012|Induction Period|Protocol Violation|0|||
163178008|NCT04090411|589368142|FG000|Induction Period|Withdrawal by Subject|2|||
163178009|NCT04090411|589368143|FG001|Induction Period|Withdrawal by Subject|0|||
163178010|NCT04090411|589368144|FG002|Induction Period|Withdrawal by Subject|1|||
163178011|NCT04090411|589368145|FG003|Induction Period|Withdrawal by Subject|5|||
163178012|NCT04090411|589368146|FG004|Induction Period|Withdrawal by Subject|0|||
163178013|NCT04090411|589368147|FG005|Induction Period|Withdrawal by Subject|0|||
163178014|NCT04090411|589368148|FG006|Induction Period|Withdrawal by Subject|0|||
163178015|NCT04090411|589368149|FG007|Induction Period|Withdrawal by Subject|0|||
163178016|NCT04090411|589368150|FG008|Induction Period|Withdrawal by Subject|0|||
163178017|NCT04090411|589368151|FG009|Induction Period|Withdrawal by Subject|0|||
163178018|NCT04090411|589368152|FG010|Induction Period|Withdrawal by Subject|0|||
163178019|NCT04090411|589368153|FG011|Induction Period|Withdrawal by Subject|0|||
163178020|NCT04090411|589368154|FG012|Induction Period|Withdrawal by Subject|0|||
163178021|NCT04090411|589368142|FG000|Chronic Period|Adverse Event|0|||
163178022|NCT04090411|589368143|FG001|Chronic Period|Adverse Event|0|||
163178023|NCT04090411|589368144|FG002|Chronic Period|Adverse Event|0|||
163178024|NCT04090411|589368145|FG003|Chronic Period|Adverse Event|0|||
163178025|NCT04090411|589368146|FG004|Chronic Period|Adverse Event|0|||
163178026|NCT04090411|589368147|FG005|Chronic Period|Adverse Event|1|||
163178027|NCT04090411|589368148|FG006|Chronic Period|Adverse Event|0|||
163178028|NCT04090411|589368149|FG007|Chronic Period|Adverse Event|3|||
163178029|NCT04090411|589368150|FG008|Chronic Period|Adverse Event|0|||
163178030|NCT04090411|589368151|FG009|Chronic Period|Adverse Event|0|||
163178031|NCT04090411|589368152|FG010|Chronic Period|Adverse Event|5|||
163178032|NCT04090411|589368153|FG011|Chronic Period|Adverse Event|1|||
163178033|NCT04090411|589368154|FG012|Chronic Period|Adverse Event|1|||
163178034|NCT04090411|589368142|FG000|Chronic Period|Lack of Efficacy|0|||
163178035|NCT04090411|589368143|FG001|Chronic Period|Lack of Efficacy|0|||
163178036|NCT04090411|589368144|FG002|Chronic Period|Lack of Efficacy|0|||
163178037|NCT04090411|589368145|FG003|Chronic Period|Lack of Efficacy|0|||
163178038|NCT04090411|589368146|FG004|Chronic Period|Lack of Efficacy|0|||
163178039|NCT04090411|589368147|FG005|Chronic Period|Lack of Efficacy|0|||
163178040|NCT04090411|589368148|FG006|Chronic Period|Lack of Efficacy|1|||
163178041|NCT04090411|589368149|FG007|Chronic Period|Lack of Efficacy|4|||
163178042|NCT04090411|589368150|FG008|Chronic Period|Lack of Efficacy|2|||
163178043|NCT04090411|589368151|FG009|Chronic Period|Lack of Efficacy|2|||
163178044|NCT04090411|589368152|FG010|Chronic Period|Lack of Efficacy|2|||
163178045|NCT04090411|589368153|FG011|Chronic Period|Lack of Efficacy|1|||
163178046|NCT04090411|589368154|FG012|Chronic Period|Lack of Efficacy|2|||
163178047|NCT04090411|589368142|FG000|Chronic Period|Relocation|0|||
163178048|NCT04090411|589368143|FG001|Chronic Period|Relocation|0|||
163178049|NCT04090411|589368144|FG002|Chronic Period|Relocation|0|||
163178050|NCT04090411|589368145|FG003|Chronic Period|Relocation|0|||
163178051|NCT04090411|589368146|FG004|Chronic Period|Relocation|0|||
163178052|NCT04090411|589368147|FG005|Chronic Period|Relocation|0|||
163178053|NCT04090411|589368148|FG006|Chronic Period|Relocation|0|||
163178054|NCT04090411|589368149|FG007|Chronic Period|Relocation|1|||
163178055|NCT04090411|589368150|FG008|Chronic Period|Relocation|0|||
163178056|NCT04090411|589368151|FG009|Chronic Period|Relocation|0|||
163178057|NCT04090411|589368152|FG010|Chronic Period|Relocation|0|||
163178058|NCT04090411|589368153|FG011|Chronic Period|Relocation|0|||
163178059|NCT04090411|589368154|FG012|Chronic Period|Relocation|0|||
163178060|NCT04090411|589368142|FG000|Chronic Period|Physician Decision|0|||
163178061|NCT04090411|589368143|FG001|Chronic Period|Physician Decision|0|||
163178062|NCT04090411|589368144|FG002|Chronic Period|Physician Decision|0|||
163178063|NCT04090411|589368145|FG003|Chronic Period|Physician Decision|0|||
163178064|NCT04090411|589368146|FG004|Chronic Period|Physician Decision|1|||
163178065|NCT04090411|589368147|FG005|Chronic Period|Physician Decision|0|||
163178066|NCT04090411|589368148|FG006|Chronic Period|Physician Decision|0|||
163178067|NCT04090411|589368149|FG007|Chronic Period|Physician Decision|1|||
163178068|NCT04090411|589368150|FG008|Chronic Period|Physician Decision|0|||
163178069|NCT04090411|589368151|FG009|Chronic Period|Physician Decision|0|||
163178070|NCT04090411|589368152|FG010|Chronic Period|Physician Decision|0|||
163178071|NCT04090411|589368153|FG011|Chronic Period|Physician Decision|1|||
163178072|NCT04090411|589368154|FG012|Chronic Period|Physician Decision|1|||
163178073|NCT04090411|589368142|FG000|Chronic Period|Protocol Violation|0|||
163178074|NCT04090411|589368143|FG001|Chronic Period|Protocol Violation|0|||
163178075|NCT04090411|589368144|FG002|Chronic Period|Protocol Violation|0|||
163178076|NCT04090411|589368145|FG003|Chronic Period|Protocol Violation|0|||
163178077|NCT04090411|589368146|FG004|Chronic Period|Protocol Violation|0|||
163178078|NCT04090411|589368147|FG005|Chronic Period|Protocol Violation|0|||
163178079|NCT04090411|589368148|FG006|Chronic Period|Protocol Violation|0|||
163178080|NCT04090411|589368149|FG007|Chronic Period|Protocol Violation|0|||
163178081|NCT04090411|589368150|FG008|Chronic Period|Protocol Violation|0|||
163178082|NCT04090411|589368151|FG009|Chronic Period|Protocol Violation|0|||
163178083|NCT04090411|589368152|FG010|Chronic Period|Protocol Violation|0|||
163178084|NCT04090411|589368153|FG011|Chronic Period|Protocol Violation|0|||
163178085|NCT04090411|589368154|FG012|Chronic Period|Protocol Violation|1|||
163178086|NCT04090411|589368142|FG000|Chronic Period|Withdrawal by Subject|0|||
163178087|NCT04090411|589368143|FG001|Chronic Period|Withdrawal by Subject|0|||
163178088|NCT04090411|589368144|FG002|Chronic Period|Withdrawal by Subject|0|||
163178089|NCT04090411|589368145|FG003|Chronic Period|Withdrawal by Subject|0|||
163178090|NCT04090411|589368146|FG004|Chronic Period|Withdrawal by Subject|0|||
163178091|NCT04090411|589368147|FG005|Chronic Period|Withdrawal by Subject|1|||
163178092|NCT04090411|589368148|FG006|Chronic Period|Withdrawal by Subject|1|||
163178093|NCT04090411|589368149|FG007|Chronic Period|Withdrawal by Subject|3|||
163178094|NCT04090411|589368150|FG008|Chronic Period|Withdrawal by Subject|3|||
163178095|NCT04090411|589368151|FG009|Chronic Period|Withdrawal by Subject|3|||
163178096|NCT04090411|589368152|FG010|Chronic Period|Withdrawal by Subject|1|||
163178097|NCT04090411|589368153|FG011|Chronic Period|Withdrawal by Subject|3|||
163178098|NCT04090411|589368154|FG012|Chronic Period|Withdrawal by Subject|0|||
163178099|NCT03764033|589368165|FG000|Treatment Phase|Withdrawal by Subject|8|||
163178100|NCT03764033|589368166|FG001|Treatment Phase|Withdrawal by Subject|3|||
163178101|NCT03764033|589368165|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
163178102|NCT03764033|589368166|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
162933283|NCT03439293|588460158|FG000|Overall Study|Lost to Follow-up|2|||
162933284|NCT03439293|588460158|FG000|Overall Study|Reason Not Specified|28|||
162933285|NCT03439293|588460158|FG000|Overall Study|Missing|1|||
162933286|NCT03404206|588460161|FG000|Overall Study|Withdrawal by Subject|1|||
162933287|NCT03404206|588460162|FG001|Overall Study|Withdrawal by Subject|1|||
162933288|NCT03404206|588460163|FG002|Overall Study|Withdrawal by Subject|0|||
162933289|NCT03404206|588460161|FG000|Overall Study|Lost to Follow-up|3|||
163178103|NCT03764033|589368165|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
163178104|NCT03764033|589368166|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
163178105|NCT04594369|589368167|FG000|Overall Study|Adverse Event|10|||
163178106|NCT04594369|589368168|FG001|Overall Study|Adverse Event|10|||
163178107|NCT04594369|589368169|FG002|Overall Study|Adverse Event|9|||
163178108|NCT04594369|589368167|FG000|Overall Study|Death|2|||
163178109|NCT04594369|589368168|FG001|Overall Study|Death|4|||
163178110|NCT04594369|589368169|FG002|Overall Study|Death|8|||
163178111|NCT04594369|589368167|FG000|Overall Study|Lost to Follow-up|10|||
163178112|NCT04594369|589368168|FG001|Overall Study|Lost to Follow-up|2|||
163178113|NCT04594369|589368169|FG002|Overall Study|Lost to Follow-up|4|||
163178114|NCT04594369|589368167|FG000|Overall Study|Physician Decision|2|||
163178115|NCT04594369|589368168|FG001|Overall Study|Physician Decision|2|||
163178116|NCT04594369|589368169|FG002|Overall Study|Physician Decision|3|||
163178117|NCT04594369|589368167|FG000|Overall Study|Protocol deviation|1|||
163178118|NCT04594369|589368168|FG001|Overall Study|Protocol deviation|3|||
163178119|NCT04594369|589368169|FG002|Overall Study|Protocol deviation|2|||
163178120|NCT04594369|589368167|FG000|Overall Study|Withdrawal by Subject|40|||
163178121|NCT04594369|589368168|FG001|Overall Study|Withdrawal by Subject|32|||
163178122|NCT04594369|589368169|FG002|Overall Study|Withdrawal by Subject|37|||
163178123|NCT04594369|589368167|FG000|Overall Study|Reason not specified|60|||
163178124|NCT04594369|589368168|FG001|Overall Study|Reason not specified|56|||
163178125|NCT04594369|589368169|FG002|Overall Study|Reason not specified|43|||
163178126|NCT01006603|589368170|FG000|Overall Study|Withdrawal by Subject|17|||
163178127|NCT01006603|589368171|FG001|Overall Study|Withdrawal by Subject|19|||
163178128|NCT01006603|589368170|FG000|Overall Study|Lost to Follow-up|0|||
163178129|NCT01006603|589368171|FG001|Overall Study|Lost to Follow-up|1|||
163178130|NCT01006603|589368170|FG000|Overall Study|Safety reason|1|||
163178131|NCT01006603|589368171|FG001|Overall Study|Safety reason|1|||
163178132|NCT01006603|589368170|FG000|Overall Study|Protocol Violation|1|||
163178133|NCT01006603|589368171|FG001|Overall Study|Protocol Violation|3|||
163178134|NCT01006603|589368170|FG000|Overall Study|Incorrect enrolment|0|||
163178135|NCT01006603|589368171|FG001|Overall Study|Incorrect enrolment|2|||
163178136|NCT01006603|589368170|FG000|Overall Study|Adverse Event|15|||
163178137|NCT01006603|589368171|FG001|Overall Study|Adverse Event|7|||
163178138|NCT01006603|589368170|FG000|Overall Study|Death|1|||
163178139|NCT01006603|589368171|FG001|Overall Study|Death|1|||
163178140|NCT01006603|589368170|FG000|Overall Study|Study specific discontinuation criteria|33|||
163178141|NCT01006603|589368171|FG001|Overall Study|Study specific discontinuation criteria|34|||
163178142|NCT01006603|589368170|FG000|Overall Study|Other|3|||
163178143|NCT01006603|589368171|FG001|Overall Study|Other|7|||
163178144|NCT03875235|589368172|FG000|Overall Study|Ongoing study treatment|63|||
163178145|NCT03875235|589368173|FG001|Overall Study|Ongoing study treatment|20|||
163178146|NCT03875235|589368172|FG000|Overall Study|Off treatment|77|||
163178147|NCT03875235|589368173|FG001|Overall Study|Off treatment|91|||
163178148|NCT03875235|589368172|FG000|Overall Study|Withdrawal by Subject|3|||
163178149|NCT03875235|589368173|FG001|Overall Study|Withdrawal by Subject|10|||
163178150|NCT03875235|589368172|FG000|Overall Study|Death|198|||
163178151|NCT03875235|589368173|FG001|Overall Study|Death|223|||
163178152|NCT02477696|589368178|FG000|Overall Study|Death|89|||
163178153|NCT02477696|589368179|FG001|Overall Study|Death|106|||
163178154|NCT02477696|589368178|FG000|Overall Study|Lost to Follow-up|7|||
162933290|NCT03404206|588460162|FG001|Overall Study|Lost to Follow-up|1|||
162933291|NCT03404206|588460163|FG002|Overall Study|Lost to Follow-up|0|||
162933292|NCT05478603|588460164|FG000|Overall Study|Withdrawal by Subject|0|||
162933293|NCT05478603|588460165|FG001|Overall Study|Withdrawal by Subject|1|||
162933294|NCT05478603|588460166|FG002|Overall Study|Withdrawal by Subject|0|||
162933295|NCT05478603|588460167|FG003|Overall Study|Withdrawal by Subject|0|||
163178155|NCT02477696|589368179|FG001|Overall Study|Lost to Follow-up|5|||
163178156|NCT02477696|589368178|FG000|Overall Study|Withdrawal by Subject|37|||
163178157|NCT02477696|589368179|FG001|Overall Study|Withdrawal by Subject|34|||
163178158|NCT02477696|589368178|FG000|Overall Study|Physician Decision|7|||
163178159|NCT02477696|589368179|FG001|Overall Study|Physician Decision|9|||
163178160|NCT02477696|589368178|FG000|Overall Study|Study terminated by sponsor|103|||
163178161|NCT02477696|589368179|FG001|Overall Study|Study terminated by sponsor|99|||
163178162|NCT02477696|589368178|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
163178163|NCT02477696|589368179|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
163178164|NCT02477696|589368178|FG000|Overall Study|Missing/Unknown|2|||
163178165|NCT02477696|589368179|FG001|Overall Study|Missing/Unknown|0|||
163178166|NCT02003365|589369158|FG000|Overall Study|Lost to Follow-up|0|||
163178167|NCT02003365|589369159|FG001|Overall Study|Lost to Follow-up|0|||
163178168|NCT02003365|589369160|FG002|Overall Study|Lost to Follow-up|1|||
163178169|NCT02582255|589369165|FG000|Overall Study|Protocol Violation|0|||
163178170|NCT02582255|589369166|FG001|Overall Study|Protocol Violation|3|||
163178171|NCT01709578|589369167|FG000|Overall Study|Rescued and entered in long term safety|63|||
163178172|NCT01709578|589369168|FG001|Overall Study|Rescued and entered in long term safety|25|||
163178173|NCT01709578|589369169|FG002|Overall Study|Rescued and entered in long term safety|26|||
163178174|NCT01709578|589369167|FG000|Overall Study|Adverse Event|9|||
163178175|NCT01709578|589369168|FG001|Overall Study|Adverse Event|18|||
163178176|NCT01709578|589369169|FG002|Overall Study|Adverse Event|17|||
163178177|NCT01709578|589369167|FG000|Overall Study|Lack of Efficacy|5|||
163178178|NCT01709578|589369168|FG001|Overall Study|Lack of Efficacy|4|||
163178179|NCT01709578|589369169|FG002|Overall Study|Lack of Efficacy|2|||
163178180|NCT01709578|589369167|FG000|Overall Study|Poor compliance to protocol|1|||
163178181|NCT01709578|589369168|FG001|Overall Study|Poor compliance to protocol|2|||
163178182|NCT01709578|589369169|FG002|Overall Study|Poor compliance to protocol|1|||
163178183|NCT01709578|589369167|FG000|Overall Study|Other, not related to safety or efficacy|2|||
163178184|NCT01709578|589369168|FG001|Overall Study|Other, not related to safety or efficacy|7|||
163178185|NCT01709578|589369169|FG002|Overall Study|Other, not related to safety or efficacy|5|||
163178186|NCT04050371|589369170|FG000|Overall Study|Withdrawal by Subject|1|||
163178187|NCT04050371|589369171|FG001|Overall Study|Withdrawal by Subject|0|||
163178188|NCT00597701|589369172|FG000|Overall Study|Withdrawal by Subject|5|||
163178189|NCT00597701|589369173|FG001|Overall Study|Withdrawal by Subject|5|||
163178190|NCT00597701|589369172|FG000|Overall Study|Death|0|||
163178191|NCT00597701|589369173|FG001|Overall Study|Death|1|||
163178192|NCT00597701|589369172|FG000|Overall Study|Physician Decision|2|||
163283116|NCT03424239|589745692|FG000|Overall Study|Withdrawal by Subject|2|||
163283117|NCT00604786|589745693|FG000|Overall Study|Lost to Follow-up|2|||
162933296|NCT03634488|588460170|FG000|Overall Study|Death|1|||
163178193|NCT00597701|589369173|FG001|Overall Study|Physician Decision|0|||
163178194|NCT00597701|589369172|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
163178195|NCT00597701|589369173|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
163283118|NCT00604786|589745694|FG001|Overall Study|Lost to Follow-up|0|||
163283119|NCT03697460|589745695|FG000|Overall Study|Withdrawal by Subject|3|||
163283120|NCT03369951|589745696|FG000|Overall Study|Withdrawal by Subject|3|||
163283121|NCT03369951|589745696|FG000|Overall Study|Death|1|||
163283122|NCT03369951|589745696|FG000|Overall Study|Lost to Follow-up|1|||
163283123|NCT03369951|589745696|FG000|Overall Study|Protocol Violation|1|||
163283124|NCT03677375|589745697|FG000|Overall Study|Incomplete procedure|8|||
163283125|NCT03677375|589745697|FG000|Overall Study|Adverse Event|3|||
163283126|NCT03677375|589745697|FG000|Overall Study|Physician Decision|1|||
163283127|NCT00725010|589745703|FG000|Overall Study|Toxicity|9|||
163283128|NCT00725010|589745703|FG000|Overall Study|Tumor Progression|7|||
163283129|NCT00725010|589745703|FG000|Overall Study|Withdrawal by Subject|2|||
163283130|NCT00725010|589745703|FG000|Overall Study|Death|1|||
163283131|NCT00725010|589745703|FG000|Overall Study|Lost to Follow-up|1|||
163283132|NCT00725010|589745703|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
163283133|NCT00725010|589745703|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
163283134|NCT00725010|589745703|FG000|Overall Study|No further documentation|1|||
163283135|NCT00725010|589745703|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
163283136|NCT02414828|589745704|FG000|Overall Study|Lost to Follow-up|0|||
163283137|NCT02414828|589745705|FG001|Overall Study|Lost to Follow-up|1|||
163283138|NCT02414828|589745706|FG002|Overall Study|Lost to Follow-up|1|||
163283139|NCT02414828|589745707|FG003|Overall Study|Lost to Follow-up|2|||
163283140|NCT00630864|589745709|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
163283141|NCT00630864|589745709|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
163283142|NCT00430677|589745710|FG000|Short-term Period|Death|1|||
163283143|NCT00430677|589745711|FG001|Short-term Period|Death|1|||
163283144|NCT00430677|589745712|FG002|Short-term Period|Death|5|||
163283145|NCT00430677|589745710|FG000|Short-term Period|Adverse Event|15|||
163283146|NCT00430677|589745711|FG001|Short-term Period|Adverse Event|13|||
163283147|NCT00430677|589745712|FG002|Short-term Period|Adverse Event|9|||
163283148|NCT00430677|589745710|FG000|Short-term Period|Lack of Efficacy|5|||
163283149|NCT00430677|589745711|FG001|Short-term Period|Lack of Efficacy|6|||
163283150|NCT00430677|589745712|FG002|Short-term Period|Lack of Efficacy|4|||
163283151|NCT00430677|589745710|FG000|Short-term Period|Withdrawal by Subject|1|||
163283152|NCT00430677|589745711|FG001|Short-term Period|Withdrawal by Subject|1|||
163283153|NCT00430677|589745712|FG002|Short-term Period|Withdrawal by Subject|2|||
163283154|NCT00430677|589745710|FG000|Short-term Period|Participant no longer met study criteria|1|||
163283155|NCT00430677|589745711|FG001|Short-term Period|Participant no longer met study criteria|1|||
163283156|NCT00430677|589745712|FG002|Short-term Period|Participant no longer met study criteria|2|||
163283157|NCT00430677|589745710|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
163283158|NCT00430677|589745711|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
163283159|NCT00430677|589745712|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
163283160|NCT00430677|589745710|FG000|Short-term Period|Pregnancy|0|||
163283161|NCT00430677|589745711|FG001|Short-term Period|Pregnancy|2|||
163283162|NCT00430677|589745712|FG002|Short-term Period|Pregnancy|0|||
163283163|NCT00430677|589745710|FG000|Long-term Extension Period|Death|1|||
163283164|NCT00430677|589745711|FG001|Long-term Extension Period|Death|0|||
163283165|NCT00430677|589745712|FG002|Long-term Extension Period|Death|0|||
163283166|NCT00430677|589745710|FG000|Long-term Extension Period|Adverse Event|3|||
163283167|NCT00430677|589745711|FG001|Long-term Extension Period|Adverse Event|2|||
163283168|NCT00430677|589745712|FG002|Long-term Extension Period|Adverse Event|5|||
163283169|NCT00430677|589745710|FG000|Long-term Extension Period|Lack of Efficacy|5|||
163283170|NCT00430677|589745711|FG001|Long-term Extension Period|Lack of Efficacy|3|||
163283171|NCT00430677|589745712|FG002|Long-term Extension Period|Lack of Efficacy|8|||
163283172|NCT00430677|589745710|FG000|Long-term Extension Period|Lost to Follow-up|1|||
163283173|NCT00430677|589745711|FG001|Long-term Extension Period|Lost to Follow-up|1|||
163283174|NCT00430677|589745712|FG002|Long-term Extension Period|Lost to Follow-up|1|||
163283175|NCT00430677|589745710|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
163283176|NCT00430677|589745711|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
163283177|NCT00430677|589745712|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
163283178|NCT00430677|589745710|FG000|Long-term Extension Period|Pregnancy|1|||
163283179|NCT00430677|589745711|FG001|Long-term Extension Period|Pregnancy|1|||
163283180|NCT00430677|589745712|FG002|Long-term Extension Period|Pregnancy|0|||
163283181|NCT00430677|589745710|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
163283182|NCT00430677|589745711|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
163283183|NCT00430677|589745712|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
163283184|NCT00430677|589745710|FG000|Long-term Extension Period|Other|2|||
163283185|NCT00430677|589745711|FG001|Long-term Extension Period|Other|1|||
163283186|NCT00430677|589745712|FG002|Long-term Extension Period|Other|1|||
162933297|NCT03634488|588460171|FG001|Overall Study|Death|0|||
162933298|NCT03634488|588460172|FG002|Overall Study|Death|0|||
162933299|NCT03634488|588460170|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
162933300|NCT03634488|588460171|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
162933301|NCT03634488|588460172|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
162933302|NCT00869089|588460173|FG000|Overall Study|Lost to Follow-up|1|||
162933303|NCT00869089|588460173|FG000|Overall Study|Withdrawal by Subject|1|||
162933304|NCT00869089|588460173|FG000|Overall Study|Screen Fail|1|||
162933305|NCT01169844|588460181|FG000|Overall Study|Adverse Event|0|||
162933306|NCT01169844|588460182|FG001|Overall Study|Adverse Event|1|||
162933307|NCT01169844|588460181|FG000|Overall Study|Patient withdrew consent|4|||
162933308|NCT01169844|588460182|FG001|Overall Study|Patient withdrew consent|0|||
162933309|NCT01169844|588460181|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162933310|NCT01169844|588460182|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162933311|NCT00435825|588460186|FG000|Overall Study|Abnormality of Laboratory Test|0|||
162933312|NCT00435825|588460187|FG001|Overall Study|Abnormality of Laboratory Test|1|||
162933313|NCT00435825|588460188|FG002|Overall Study|Abnormality of Laboratory Test|0|||
162933314|NCT00435825|588460189|FG003|Overall Study|Abnormality of Laboratory Test|0|||
162933315|NCT00435825|588460186|FG000|Overall Study|Insufficient Therapeutic Response|3|||
162933316|NCT00435825|588460187|FG001|Overall Study|Insufficient Therapeutic Response|1|||
162933317|NCT00435825|588460188|FG002|Overall Study|Insufficient Therapeutic Response|0|||
162933318|NCT00435825|588460189|FG003|Overall Study|Insufficient Therapeutic Response|3|||
162933319|NCT00435825|588460186|FG000|Overall Study|Other Protocol Violation|1|||
162933320|NCT00435825|588460187|FG001|Overall Study|Other Protocol Violation|0|||
162933321|NCT00435825|588460188|FG002|Overall Study|Other Protocol Violation|0|||
162933322|NCT00435825|588460189|FG003|Overall Study|Other Protocol Violation|0|||
162933323|NCT00435825|588460186|FG000|Overall Study|Refused treatment|2|||
162933324|NCT00435825|588460187|FG001|Overall Study|Refused treatment|0|||
162933325|NCT00435825|588460188|FG002|Overall Study|Refused treatment|0|||
162933326|NCT00435825|588460189|FG003|Overall Study|Refused treatment|5|||
162933327|NCT00435825|588460186|FG000|Overall Study|Failure to return|5|||
162933328|NCT00435825|588460187|FG001|Overall Study|Failure to return|0|||
162933329|NCT00435825|588460188|FG002|Overall Study|Failure to return|4|||
162933330|NCT00435825|588460189|FG003|Overall Study|Failure to return|0|||
162933331|NCT00435825|588460186|FG000|Overall Study|Did not receive study drug|1|||
162933332|NCT00435825|588460187|FG001|Overall Study|Did not receive study drug|0|||
162933333|NCT00435825|588460188|FG002|Overall Study|Did not receive study drug|2|||
162933334|NCT00435825|588460189|FG003|Overall Study|Did not receive study drug|0|||
162933335|NCT00435825|588460186|FG000|Overall Study|Did not enter follow-up|0|||
162933336|NCT00435825|588460187|FG001|Overall Study|Did not enter follow-up|4|||
162933337|NCT00435825|588460188|FG002|Overall Study|Did not enter follow-up|1|||
162933338|NCT00435825|588460189|FG003|Overall Study|Did not enter follow-up|3|||
162933339|NCT00435825|588460186|FG000|Overall Study|Did not complete full follow-up period|6|||
162933340|NCT00435825|588460187|FG001|Overall Study|Did not complete full follow-up period|6|||
162933341|NCT00435825|588460188|FG002|Overall Study|Did not complete full follow-up period|4|||
162933342|NCT00435825|588460189|FG003|Overall Study|Did not complete full follow-up period|5|||
162933343|NCT05003167|588460190|FG000|Overall Study|Withdrawal by Subject|1|||
162933344|NCT01010230|588460191|FG000|Overall Study|Withdrawal by Subject|6|||
162933345|NCT01010230|588460192|FG001|Overall Study|Withdrawal by Subject|5|||
162933346|NCT01010230|588460191|FG000|Overall Study|Lost to Follow-up|4|||
162933347|NCT01010230|588460192|FG001|Overall Study|Lost to Follow-up|2|||
162933348|NCT00530439|588460193|FG000|Overall Study|GDM|9|||
162933349|NCT00530439|588460194|FG001|Overall Study|GDM|3|||
163178196|NCT04078178|589369178|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
163178197|NCT04078178|589369179|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
163178198|NCT04078178|589369178|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
163178199|NCT04078178|589369179|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
163178200|NCT04078178|589369178|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
163178201|NCT04078178|589369179|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
163178202|NCT04078178|589369178|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
163283187|NCT00430677|589745710|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
163283188|NCT00430677|589745711|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
163283189|NCT00430677|589745712|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
163283190|NCT01555762|589745713|FG000|Overall Study|No information on Bevacizumab intake|11|||
162933350|NCT00530439|588460193|FG000|Overall Study|Withdraw|18|||
162933351|NCT00530439|588460194|FG001|Overall Study|Withdraw|14|||
162933352|NCT00530439|588460193|FG000|Overall Study|Missed abortion|1|||
162933353|NCT00530439|588460194|FG001|Overall Study|Missed abortion|4|||
162933354|NCT00530439|588460193|FG000|Overall Study|Misclassification|2|||
162933355|NCT00530439|588460194|FG001|Overall Study|Misclassification|0|||
162933356|NCT00530439|588460193|FG000|Overall Study|Twin pregnancy|0|||
162933357|NCT00530439|588460194|FG001|Overall Study|Twin pregnancy|2|||
162933358|NCT00530439|588460193|FG000|Overall Study|Severe malformation/abortion|0|||
163283191|NCT01555762|589745713|FG000|Overall Study|Missing start date of infusion|8|||
163283192|NCT01555762|589745713|FG000|Overall Study|75 years old or more ticked No|1|||
163283193|NCT01555762|589745713|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
163283194|NCT01555762|589745713|FG000|Overall Study|Death linked to progression of disease|165|||
163283195|NCT01555762|589745713|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
163283196|NCT01555762|589745713|FG000|Overall Study|Investigator's decision|10|||
163283197|NCT01555762|589745713|FG000|Overall Study|Participant not wishing to continue|5|||
163283198|NCT01555762|589745713|FG000|Overall Study|Missing data|1|||
162933359|NCT00530439|588460194|FG001|Overall Study|Severe malformation/abortion|3|||
162933360|NCT02367781|588460197|FG000|Overall Study|Withdrawal by Subject|20|||
162933361|NCT02367781|588460198|FG001|Overall Study|Withdrawal by Subject|13|||
163283199|NCT01555762|589745713|FG000|Overall Study|Death linked to an adverse event|14|||
163283200|NCT00299702|589745722|FG000|Overall Study|Death|1|||
163283201|NCT00299702|589745723|FG001|Overall Study|Death|0|||
163283202|NCT00299702|589745722|FG000|Overall Study|Adverse Event|0|||
163283203|NCT00299702|589745723|FG001|Overall Study|Adverse Event|4|||
163283204|NCT00299702|589745722|FG000|Overall Study|Lost to Follow-up|18|||
163283205|NCT00299702|589745723|FG001|Overall Study|Lost to Follow-up|10|||
163283206|NCT00299702|589745722|FG000|Overall Study|Withdrawal by Subject|25|||
163283207|NCT00299702|589745723|FG001|Overall Study|Withdrawal by Subject|23|||
163283208|NCT00299702|589745722|FG000|Overall Study|Pregnancy|0|||
163283209|NCT00299702|589745723|FG001|Overall Study|Pregnancy|1|||
163283210|NCT00299702|589745722|FG000|Overall Study|Insufficient Response|4|||
163283211|NCT00299702|589745723|FG001|Overall Study|Insufficient Response|3|||
163283212|NCT00299702|589745722|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
162933362|NCT02367781|588460197|FG000|Overall Study|Protocol Violation|0|||
162933363|NCT02367781|588460198|FG001|Overall Study|Protocol Violation|1|||
162933364|NCT02367781|588460197|FG000|Overall Study|Physician Decision|7|||
162933365|NCT02367781|588460198|FG001|Overall Study|Physician Decision|0|||
162933366|NCT02367781|588460197|FG000|Overall Study|Randomized in Error|5|||
162933367|NCT02367781|588460198|FG001|Overall Study|Randomized in Error|4|||
162933368|NCT02367781|588460197|FG000|Overall Study|Non-Compliance|1|||
162933369|NCT02367781|588460198|FG001|Overall Study|Non-Compliance|0|||
162933370|NCT02367781|588460197|FG000|Overall Study|Lost to Follow-up|1|||
162933371|NCT02367781|588460198|FG001|Overall Study|Lost to Follow-up|2|||
162933372|NCT02367781|588460197|FG000|Overall Study|Death|330|||
162933373|NCT02367781|588460198|FG001|Overall Study|Death|176|||
162933374|NCT02367781|588460197|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
162933375|NCT02367781|588460198|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
162933376|NCT02367781|588460197|FG000|Overall Study|Prolonged Hospitalization|1|||
162933377|NCT02367781|588460198|FG001|Overall Study|Prolonged Hospitalization|0|||
162933378|NCT02367781|588460197|FG000|Overall Study|Death Prior First Dose|1|||
162933379|NCT02367781|588460198|FG001|Overall Study|Death Prior First Dose|0|||
162933380|NCT02367781|588460197|FG000|Overall Study|Administrative-Change Facility|1|||
162933381|NCT02367781|588460198|FG001|Overall Study|Administrative-Change Facility|0|||
162933382|NCT02367781|588460197|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
162933383|NCT02367781|588460198|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
162933384|NCT02367781|588460197|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
162933385|NCT02367781|588460198|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
162933386|NCT02367781|588460197|FG000|Overall Study|Study Terminated by Sponsor|3|||
162933387|NCT02367781|588460198|FG001|Overall Study|Study Terminated by Sponsor|1|||
162933388|NCT02367781|588460197|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
162933389|NCT02367781|588460198|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
162933390|NCT02367781|588460197|FG000|Overall Study|Sponsor Decision|2|||
162933391|NCT02367781|588460198|FG001|Overall Study|Sponsor Decision|0|||
162933392|NCT02367781|588460197|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
162933393|NCT02367781|588460198|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
162933394|NCT01393990|588462186|FG000|Overall Study|Adverse Event|0|||
162933395|NCT01393990|588462187|FG001|Overall Study|Adverse Event|0|||
162933396|NCT01393990|588462188|FG002|Overall Study|Adverse Event|0|||
162933397|NCT01393990|588462189|FG003|Overall Study|Adverse Event|0|||
162933398|NCT01393990|588462190|FG004|Overall Study|Adverse Event|0|||
162933399|NCT01393990|588462191|FG005|Overall Study|Adverse Event|0|||
163283213|NCT00299702|589745723|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
163283214|NCT02931396|589745724|FG000|Overall Study|Lost to Follow-up|3|||
163283215|NCT02931396|589745725|FG001|Overall Study|Lost to Follow-up|0|||
163283216|NCT02931396|589745724|FG000|Overall Study|Withdrawal by Subject|2|||
163283217|NCT02931396|589745725|FG001|Overall Study|Withdrawal by Subject|0|||
163283218|NCT00670540|589745726|FG000|Overall Study|ineligible|17|||
162933400|NCT01393990|588462192|FG006|Overall Study|Adverse Event|0|||
162933401|NCT01393990|588462193|FG007|Overall Study|Adverse Event|0|||
162933402|NCT01393990|588462194|FG008|Overall Study|Adverse Event|0|||
162933403|NCT01393990|588462195|FG009|Overall Study|Adverse Event|0|||
162933404|NCT01393990|588462196|FG010|Overall Study|Adverse Event|0|||
162933405|NCT01393990|588462197|FG011|Overall Study|Adverse Event|0|||
162933406|NCT01393990|588462198|FG012|Overall Study|Adverse Event|0|||
162933407|NCT01393990|588462199|FG013|Overall Study|Adverse Event|0|||
162933408|NCT01393990|588462200|FG014|Overall Study|Adverse Event|1|||
162933409|NCT01393990|588462201|FG015|Overall Study|Adverse Event|1|||
162933410|NCT01393990|588462202|FG016|Overall Study|Adverse Event|0|||
162933411|NCT01393990|588462203|FG017|Overall Study|Adverse Event|0|||
162933412|NCT01393990|588462186|FG000|Overall Study|Progressive Disease|1|||
162933413|NCT01393990|588462187|FG001|Overall Study|Progressive Disease|0|||
162933414|NCT01393990|588462188|FG002|Overall Study|Progressive Disease|0|||
162933415|NCT01393990|588462189|FG003|Overall Study|Progressive Disease|1|||
162933416|NCT01393990|588462190|FG004|Overall Study|Progressive Disease|1|||
162933417|NCT01393990|588462191|FG005|Overall Study|Progressive Disease|1|||
162933418|NCT01393990|588462192|FG006|Overall Study|Progressive Disease|1|||
162933419|NCT01393990|588462193|FG007|Overall Study|Progressive Disease|1|||
162933420|NCT01393990|588462194|FG008|Overall Study|Progressive Disease|3|||
162933421|NCT01393990|588462195|FG009|Overall Study|Progressive Disease|1|||
162933422|NCT01393990|588462196|FG010|Overall Study|Progressive Disease|0|||
162933423|NCT01393990|588462197|FG011|Overall Study|Progressive Disease|0|||
162933424|NCT01393990|588462198|FG012|Overall Study|Progressive Disease|0|||
162933425|NCT01393990|588462199|FG013|Overall Study|Progressive Disease|1|||
162933426|NCT01393990|588462200|FG014|Overall Study|Progressive Disease|6|||
162933427|NCT01393990|588462201|FG015|Overall Study|Progressive Disease|1|||
162933428|NCT01393990|588462202|FG016|Overall Study|Progressive Disease|0|||
162933429|NCT01393990|588462203|FG017|Overall Study|Progressive Disease|0|||
162933430|NCT01393990|588462186|FG000|Overall Study|Death|0|||
162933431|NCT01393990|588462187|FG001|Overall Study|Death|0|||
162933432|NCT01393990|588462188|FG002|Overall Study|Death|0|||
162933433|NCT01393990|588462189|FG003|Overall Study|Death|0|||
162933434|NCT01393990|588462190|FG004|Overall Study|Death|1|||
162933435|NCT01393990|588462191|FG005|Overall Study|Death|0|||
162933436|NCT01393990|588462192|FG006|Overall Study|Death|0|||
162933437|NCT01393990|588462193|FG007|Overall Study|Death|0|||
162933438|NCT01393990|588462194|FG008|Overall Study|Death|0|||
162933439|NCT01393990|588462195|FG009|Overall Study|Death|0|||
162933440|NCT01393990|588462196|FG010|Overall Study|Death|0|||
162933441|NCT01393990|588462197|FG011|Overall Study|Death|0|||
162933442|NCT01393990|588462198|FG012|Overall Study|Death|0|||
162933443|NCT01393990|588462199|FG013|Overall Study|Death|1|||
162933444|NCT01393990|588462200|FG014|Overall Study|Death|1|||
162933445|NCT01393990|588462201|FG015|Overall Study|Death|0|||
162933446|NCT01393990|588462202|FG016|Overall Study|Death|0|||
162933447|NCT01393990|588462203|FG017|Overall Study|Death|0|||
162933448|NCT01393990|588462186|FG000|Overall Study|Withdrawal by Subject|0|||
162933449|NCT01393990|588462187|FG001|Overall Study|Withdrawal by Subject|0|||
162933450|NCT01393990|588462188|FG002|Overall Study|Withdrawal by Subject|0|||
162933451|NCT01393990|588462189|FG003|Overall Study|Withdrawal by Subject|0|||
162933452|NCT01393990|588462190|FG004|Overall Study|Withdrawal by Subject|0|||
162933453|NCT01393990|588462191|FG005|Overall Study|Withdrawal by Subject|0|||
162933454|NCT01393990|588462192|FG006|Overall Study|Withdrawal by Subject|0|||
162933455|NCT01393990|588462193|FG007|Overall Study|Withdrawal by Subject|0|||
162933456|NCT01393990|588462194|FG008|Overall Study|Withdrawal by Subject|0|||
162933457|NCT01393990|588462195|FG009|Overall Study|Withdrawal by Subject|0|||
162933458|NCT01393990|588462196|FG010|Overall Study|Withdrawal by Subject|0|||
162933459|NCT01393990|588462197|FG011|Overall Study|Withdrawal by Subject|0|||
162933460|NCT01393990|588462198|FG012|Overall Study|Withdrawal by Subject|0|||
163283219|NCT00670540|589745726|FG000|Overall Study|not living in France|348|||
163283220|NCT00670540|589745726|FG000|Overall Study|refused to participate|189|||
163283221|NCT00670540|589745726|FG000|Overall Study|controls randomised for no follow up|2770|||
163283222|NCT00670540|589745726|FG000|Overall Study|missing information inclusion criteria|1|||
163283223|NCT01866917|589745727|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
163283224|NCT01866917|589745728|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
163283225|NCT01562743|589745733|FG000|Overall Study|Adverse Event|29|||
163283226|NCT01562743|589745733|FG000|Overall Study|Lack of Efficacy|3|||
163283227|NCT01562743|589745733|FG000|Overall Study|Withdrawal by Subject|13|||
162933461|NCT01393990|588462199|FG013|Overall Study|Withdrawal by Subject|0|||
162933462|NCT01393990|588462200|FG014|Overall Study|Withdrawal by Subject|1|||
162933463|NCT01393990|588462201|FG015|Overall Study|Withdrawal by Subject|1|||
162933464|NCT01393990|588462202|FG016|Overall Study|Withdrawal by Subject|0|||
163283228|NCT01562743|589745733|FG000|Overall Study|Protocol Violation|1|||
163283229|NCT01562743|589745733|FG000|Overall Study|Discontinuation criteria|2|||
162933465|NCT01393990|588462203|FG017|Overall Study|Withdrawal by Subject|0|||
162933466|NCT00331630|588462213|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
162933467|NCT00331630|588462213|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
162933468|NCT00331630|588462213|FG000|Follow up for 5 Years|Death|5|||
162933469|NCT00331630|588462213|FG000|Follow up for 5 Years|Data collection was stopped|24|||
162933470|NCT01859390|588462217|FG000|Overall Study|Insufficient Sputum Collected|1|||
162933471|NCT01859390|588462218|FG001|Overall Study|Insufficient Sputum Collected|3|||
162933472|NCT01859390|588462217|FG000|Overall Study|Sample Missing Collection Date|0|||
163283230|NCT01562743|589745733|FG000|Overall Study|Lost to Follow-up|2|||
163283231|NCT01562743|589745733|FG000|Overall Study|Physician Decision|2|||
163283232|NCT00662909|589745735|FG000|Overall Study|Adverse Event|17|||
163283233|NCT00662909|589745736|FG001|Overall Study|Adverse Event|18|||
163283234|NCT00662909|589745737|FG002|Overall Study|Adverse Event|19|||
163283235|NCT00662909|589745735|FG000|Overall Study|Lack of Efficacy|9|||
163283236|NCT00662909|589745736|FG001|Overall Study|Lack of Efficacy|1|||
163283237|NCT00662909|589745737|FG002|Overall Study|Lack of Efficacy|5|||
163283238|NCT00662909|589745735|FG000|Overall Study|Withdrawal by Subject|29|||
163283239|NCT00662909|589745736|FG001|Overall Study|Withdrawal by Subject|22|||
163283240|NCT00662909|589745737|FG002|Overall Study|Withdrawal by Subject|16|||
163283241|NCT00662909|589745735|FG000|Overall Study|Lost to Follow-up|2|||
163283242|NCT00662909|589745736|FG001|Overall Study|Lost to Follow-up|9|||
163283243|NCT00662909|589745737|FG002|Overall Study|Lost to Follow-up|3|||
163283244|NCT00662909|589745735|FG000|Overall Study|Protocol Violation|7|||
163283245|NCT00662909|589745736|FG001|Overall Study|Protocol Violation|4|||
163283246|NCT00662909|589745737|FG002|Overall Study|Protocol Violation|5|||
163283247|NCT00662909|589745735|FG000|Overall Study|Randomized- never received study drug|1|||
163283248|NCT00662909|589745736|FG001|Overall Study|Randomized- never received study drug|0|||
163283249|NCT00662909|589745737|FG002|Overall Study|Randomized- never received study drug|0|||
163283250|NCT00662909|589745735|FG000|Overall Study|Non-compliance with study procedures|3|||
163283251|NCT00662909|589745736|FG001|Overall Study|Non-compliance with study procedures|3|||
163283252|NCT00662909|589745737|FG002|Overall Study|Non-compliance with study procedures|2|||
163283253|NCT00662909|589745735|FG000|Overall Study|Physician Decision|1|||
163283254|NCT00662909|589745736|FG001|Overall Study|Physician Decision|1|||
163283255|NCT00662909|589745737|FG002|Overall Study|Physician Decision|2|||
163283256|NCT00662909|589745735|FG000|Overall Study|Eligibility criterion not met|0|||
163283257|NCT00662909|589745736|FG001|Overall Study|Eligibility criterion not met|1|||
163283258|NCT00662909|589745737|FG002|Overall Study|Eligibility criterion not met|1|||
163283259|NCT03396835|589747459|FG000|Overall Study|Withdrawn prior to completion|1|||
163283260|NCT03396835|589747459|FG000|Overall Study|Did not meet criteria for data analysis|1|||
163283261|NCT03467724|589747460|FG000|Overall Study|Lost to Follow-up|5|||
163283262|NCT03467724|589747460|FG000|Overall Study|Withdrawal by Subject|1|||
163283263|NCT03467724|589747460|FG000|Overall Study|Protocol Violation|1|||
163283264|NCT03467724|589747460|FG000|Overall Study|Adverse Event|1|||
163283265|NCT01451814|589747461|FG000|Overall Study|Withdrawal by Subject|1|||
163283266|NCT01451814|589747462|FG001|Overall Study|Withdrawal by Subject|1|||
163283267|NCT01451814|589747461|FG000|Overall Study|Lost to Follow-up|5|||
163283268|NCT01451814|589747462|FG001|Overall Study|Lost to Follow-up|4|||
163283269|NCT02049866|589747463|FG000|Overall Study|Withdrawal by Subject|1|||
163283270|NCT02145182|589747465|FG000|Overall Study|Adverse Event|4|||
163283271|NCT02145182|589747466|FG001|Overall Study|Adverse Event|1|||
163283272|NCT02145182|589747465|FG000|Overall Study|Death|7|||
163283273|NCT02145182|589747466|FG001|Overall Study|Death|7|||
163283274|NCT02145182|589747465|FG000|Overall Study|Lost to Follow-up|2|||
163283275|NCT02145182|589747466|FG001|Overall Study|Lost to Follow-up|2|||
163283276|NCT02145182|589747465|FG000|Overall Study|Pre-transplant Withdrawal|0|||
163283277|NCT02145182|589747466|FG001|Overall Study|Pre-transplant Withdrawal|2|||
163283278|NCT02145182|589747465|FG000|Overall Study|Withdrawal by Subject|5|||
163283279|NCT02145182|589747466|FG001|Overall Study|Withdrawal by Subject|4|||
163283280|NCT01466881|589747467|FG000|Overall Study|Ineligible|5|||
163283281|NCT01466881|589747467|FG000|Overall Study|Adverse Event|6|||
163283282|NCT01466881|589747467|FG000|Overall Study|Progression/relapse|20|||
163283283|NCT01466881|589747467|FG000|Overall Study|Death|4|||
163283284|NCT01466881|589747467|FG000|Overall Study|Other reason not protocol specified|5|||
163283285|NCT02219490|589747471|FG000|Overall Study|Adverse Event|24|||
163283286|NCT02219490|589747471|FG000|Overall Study|Withdrew consent|96|||
163283287|NCT02219490|589747471|FG000|Overall Study|Lost to Follow-up|126|||
163283288|NCT02219490|589747471|FG000|Overall Study|COVID-19 infection|2|||
163283289|NCT02219490|589747471|FG000|Overall Study|COVID-19 logistical restrictions|33|||
163283290|NCT02219490|589747471|FG000|Overall Study|Other, not specified|57|||
163283291|NCT01928940|589747475|FG000|Overall Study|Adverse Event|0|||
163283292|NCT01928940|589747476|FG001|Overall Study|Adverse Event|1|||
163283293|NCT00197236|589747479|FG000|Overall Study|Adverse Event|1|||
163283294|NCT00197236|589747480|FG001|Overall Study|Adverse Event|0|||
163283295|NCT00197236|589747481|FG002|Overall Study|Adverse Event|1|||
163283296|NCT00197236|589747479|FG000|Overall Study|Lost to Follow-up|5|||
163283297|NCT00197236|589747480|FG001|Overall Study|Lost to Follow-up|14|||
163283298|NCT00197236|589747481|FG002|Overall Study|Lost to Follow-up|6|||
163283299|NCT00197236|589747479|FG000|Overall Study|Protocol Violation|0|||
163283300|NCT00197236|589747480|FG001|Overall Study|Protocol Violation|0|||
163283301|NCT00197236|589747481|FG002|Overall Study|Protocol Violation|1|||
163283302|NCT00197236|589747479|FG000|Overall Study|Withdrawal by Subject|7|||
163283303|NCT00197236|589747480|FG001|Overall Study|Withdrawal by Subject|3|||
163283304|NCT00197236|589747481|FG002|Overall Study|Withdrawal by Subject|11|||
162933473|NCT01859390|588462218|FG001|Overall Study|Sample Missing Collection Date|1|||
162933474|NCT01859390|588462217|FG000|Overall Study|Tube Cracked|0|||
162933475|NCT01859390|588462218|FG001|Overall Study|Tube Cracked|2|||
162933476|NCT01859390|588462217|FG000|Overall Study|Shipment Error|0|||
163283305|NCT00197236|589747479|FG000|Overall Study|Study drug/medication expiration|1|||
163283306|NCT00197236|589747480|FG001|Overall Study|Study drug/medication expiration|0|||
163283307|NCT00197236|589747481|FG002|Overall Study|Study drug/medication expiration|3|||
163283308|NCT00197236|589747479|FG000|Overall Study|Returned out of specified time window|0|||
163283309|NCT00197236|589747480|FG001|Overall Study|Returned out of specified time window|0|||
163283310|NCT00197236|589747481|FG002|Overall Study|Returned out of specified time window|1|||
163283311|NCT02524288|589747482|FG000|Overall Study|Adverse Event|115|||
163283312|NCT02524288|589747482|FG000|Overall Study|Lost to Follow-up|216|||
163283313|NCT02524288|589747482|FG000|Overall Study|Non-Compliance With Protocol|32|||
163283314|NCT02524288|589747482|FG000|Overall Study|Non-Compliance With Study Drug|14|||
163283315|NCT02524288|589747482|FG000|Overall Study|Pregnancy Wish|6|||
163283316|NCT02524288|589747482|FG000|Overall Study|Protocol Violation|6|||
163283317|NCT02524288|589747482|FG000|Overall Study|Screen Failure|2|||
163283318|NCT02524288|589747482|FG000|Overall Study|Site Discontinued Study Participation|1|||
163283319|NCT02524288|589747482|FG000|Overall Study|Study Terminated By Sponsor|1417|||
163283320|NCT02524288|589747482|FG000|Overall Study|Subject Moved|32|||
163283321|NCT02524288|589747482|FG000|Overall Study|Withdrawal by Subject|76|||
163283322|NCT02524288|589747482|FG000|Overall Study|Pregnancy|22|||
163283323|NCT02524288|589747482|FG000|Overall Study|Physician Decision|2|||
163283324|NCT01835899|589747484|FG000|Overall Study|Adverse Event|0|||
163283325|NCT01835899|589747485|FG001|Overall Study|Adverse Event|0|||
163283326|NCT01835899|589747486|FG002|Overall Study|Adverse Event|1|||
163283327|NCT01835899|589747484|FG000|Overall Study|Other than stated above|0|||
163283328|NCT01835899|589747485|FG001|Overall Study|Other than stated above|1|||
163283329|NCT01835899|589747486|FG002|Overall Study|Other than stated above|0|||
163283330|NCT02616263|589747487|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
163283331|NCT02616263|589747488|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
163283332|NCT02616263|589747487|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
163283333|NCT02616263|589747488|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
163283334|NCT02616263|589747487|FG000|6 Month to 1.5 Year|Death|1|||
163283335|NCT02616263|589747488|FG001|6 Month to 1.5 Year|Death|0|||
163283336|NCT02616263|589747487|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
163283337|NCT02616263|589747488|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
163283338|NCT02616263|589747487|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
163283339|NCT02616263|589747488|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
163283340|NCT02616263|589747487|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
163283341|NCT02616263|589747488|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
163283342|NCT02939183|589747494|FG000|Overall Study|Death|0|||
163283343|NCT02939183|589747495|FG001|Overall Study|Death|0|||
163283344|NCT02939183|589747496|FG002|Overall Study|Death|1|||
163283345|NCT02939183|589747497|FG003|Overall Study|Death|0|||
163283346|NCT02939183|589747498|FG004|Overall Study|Death|0|||
163283347|NCT02939183|589747499|FG005|Overall Study|Death|2|||
163283348|NCT02939183|589747500|FG006|Overall Study|Death|1|||
163283349|NCT02939183|589747501|FG007|Overall Study|Death|0|||
163283350|NCT02939183|589747502|FG008|Overall Study|Death|0|||
163283351|NCT02939183|589747494|FG000|Overall Study|Sponsor decision|0|||
163283352|NCT02939183|589747495|FG001|Overall Study|Sponsor decision|1|||
163283353|NCT02939183|589747496|FG002|Overall Study|Sponsor decision|0|||
163283354|NCT02939183|589747497|FG003|Overall Study|Sponsor decision|1|||
163283355|NCT02939183|589747498|FG004|Overall Study|Sponsor decision|2|||
163283356|NCT02939183|589747499|FG005|Overall Study|Sponsor decision|0|||
163283357|NCT02939183|589747500|FG006|Overall Study|Sponsor decision|3|||
163283358|NCT02939183|589747501|FG007|Overall Study|Sponsor decision|1|||
163283359|NCT02939183|589747502|FG008|Overall Study|Sponsor decision|4|||
162933477|NCT01859390|588462218|FG001|Overall Study|Shipment Error|1|||
163283360|NCT02939183|589747494|FG000|Overall Study|Withdrawal by Subject|0|||
163283361|NCT02939183|589747495|FG001|Overall Study|Withdrawal by Subject|2|||
163283362|NCT02939183|589747496|FG002|Overall Study|Withdrawal by Subject|0|||
163283363|NCT02939183|589747497|FG003|Overall Study|Withdrawal by Subject|1|||
163283364|NCT02939183|589747498|FG004|Overall Study|Withdrawal by Subject|0|||
163283365|NCT02939183|589747499|FG005|Overall Study|Withdrawal by Subject|0|||
163283366|NCT02939183|589747500|FG006|Overall Study|Withdrawal by Subject|2|||
163283367|NCT02939183|589747501|FG007|Overall Study|Withdrawal by Subject|2|||
163283368|NCT02939183|589747502|FG008|Overall Study|Withdrawal by Subject|2|||
163283369|NCT02939183|589747494|FG000|Overall Study|Not treated due to adverse event|0|||
163283370|NCT02939183|589747495|FG001|Overall Study|Not treated due to adverse event|0|||
163283371|NCT02939183|589747496|FG002|Overall Study|Not treated due to adverse event|0|||
163283372|NCT02939183|589747497|FG003|Overall Study|Not treated due to adverse event|1|||
162933478|NCT02451670|588462219|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
163283373|NCT02939183|589747498|FG004|Overall Study|Not treated due to adverse event|0|||
163283374|NCT02939183|589747499|FG005|Overall Study|Not treated due to adverse event|0|||
163283375|NCT02939183|589747500|FG006|Overall Study|Not treated due to adverse event|1|||
163283376|NCT02939183|589747501|FG007|Overall Study|Not treated due to adverse event|0|||
163283377|NCT02939183|589747502|FG008|Overall Study|Not treated due to adverse event|0|||
163283378|NCT05015478|589747503|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
163283379|NCT05015478|589747504|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
163283380|NCT05015478|589747505|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
163283381|NCT05015478|589747506|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
163283382|NCT04939428|589747507|FG000|Overall Study|Death|0|||
163283383|NCT04939428|589747508|FG001|Overall Study|Death|1|||
163283384|NCT04939428|589747509|FG002|Overall Study|Death|0|||
163283385|NCT04939428|589747507|FG000|Overall Study|Lost to Follow-up|0|||
163283386|NCT04939428|589747508|FG001|Overall Study|Lost to Follow-up|5|||
163283387|NCT04939428|589747509|FG002|Overall Study|Lost to Follow-up|0|||
163283388|NCT04939428|589747507|FG000|Overall Study|Physician Decision|1|||
163283389|NCT04939428|589747508|FG001|Overall Study|Physician Decision|0|||
163283390|NCT04939428|589747509|FG002|Overall Study|Physician Decision|0|||
163283391|NCT04939428|589747507|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
163283392|NCT04939428|589747508|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163283393|NCT04939428|589747509|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163283394|NCT04939428|589747507|FG000|Overall Study|Withdrawal by Subject|10|||
163283395|NCT04939428|589747508|FG001|Overall Study|Withdrawal by Subject|11|||
163283396|NCT04939428|589747509|FG002|Overall Study|Withdrawal by Subject|0|||
163283397|NCT04939428|589747507|FG000|Overall Study|Unkown|6|||
163283398|NCT04939428|589747508|FG001|Overall Study|Unkown|3|||
163283399|NCT04939428|589747509|FG002|Overall Study|Unkown|0|||
163283400|NCT04939428|589747507|FG000|Overall Study|Discotinued per protocol|0|||
163283401|NCT04939428|589747508|FG001|Overall Study|Discotinued per protocol|0|||
163283402|NCT04939428|589747509|FG002|Overall Study|Discotinued per protocol|902|||
163283403|NCT04319094|589747512|FG000|Baseline|Lost to Follow-up|4|||
163283404|NCT04319094|589747513|FG001|Baseline|Lost to Follow-up|5|||
163283405|NCT04319094|589747512|FG000|Baseline|Protocol Violation|0|||
163283406|NCT04319094|589747513|FG001|Baseline|Protocol Violation|3|||
163283407|NCT04319094|589747512|FG000|Baseline|Withdrawal by Subject|2|||
163283408|NCT04319094|589747513|FG001|Baseline|Withdrawal by Subject|1|||
163283409|NCT04319094|589747512|FG000|Post-Intervention|Death|0|||
163283410|NCT04319094|589747513|FG001|Post-Intervention|Death|1|||
163283411|NCT04319094|589747512|FG000|Post-Intervention|Lost to Follow-up|4|||
163283412|NCT04319094|589747513|FG001|Post-Intervention|Lost to Follow-up|4|||
163283413|NCT04319094|589747512|FG000|Post-Intervention|Withdrawal by Subject|8|||
163283414|NCT04319094|589747513|FG001|Post-Intervention|Withdrawal by Subject|5|||
163283415|NCT04319094|589747512|FG000|Post-Intervention|Incomplete Data Collection|1|||
163283416|NCT04319094|589747513|FG001|Post-Intervention|Incomplete Data Collection|3|||
163283417|NCT04319094|589747512|FG000|3-month|Death|1|||
163283418|NCT04319094|589747513|FG001|3-month|Death|0|||
163283419|NCT04319094|589747512|FG000|3-month|Lost to Follow-up|2|||
163283420|NCT04319094|589747513|FG001|3-month|Lost to Follow-up|2|||
163283421|NCT04319094|589747512|FG000|3-month|Withdrawal by Subject|0|||
163283422|NCT04319094|589747513|FG001|3-month|Withdrawal by Subject|3|||
163283423|NCT04319094|589747512|FG000|3-month|Incomplete data collection|9|||
163283424|NCT04319094|589747513|FG001|3-month|Incomplete data collection|7|||
163283425|NCT04319094|589747512|FG000|6-month|Lost to Follow-up|1|||
163283426|NCT04319094|589747513|FG001|6-month|Lost to Follow-up|1|||
163283427|NCT04319094|589747512|FG000|6-month|Withdrawal by Subject|0|||
163283428|NCT04319094|589747513|FG001|6-month|Withdrawal by Subject|3|||
163283429|NCT04319094|589747512|FG000|6-month|Incomplete data collection|14|||
163283430|NCT04319094|589747513|FG001|6-month|Incomplete data collection|9|||
163283431|NCT04319094|589747512|FG000|9-month|Lost to Follow-up|8|||
163283432|NCT04319094|589747513|FG001|9-month|Lost to Follow-up|4|||
163283433|NCT04319094|589747512|FG000|9-month|Withdrawal by Subject|0|||
162933479|NCT02451670|588462220|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
162933480|NCT00463866|588462224|FG000|Overall Study|Adverse Event|70|||
162933481|NCT00463866|588462225|FG001|Overall Study|Adverse Event|93|||
162933482|NCT00463866|588462224|FG000|Overall Study|Withdrawal by Subject|81|||
163283434|NCT04319094|589747513|FG001|9-month|Withdrawal by Subject|1|||
163283435|NCT04319094|589747512|FG000|9-month|Incomplete data collection|8|||
163283436|NCT04319094|589747513|FG001|9-month|Incomplete data collection|5|||
163283437|NCT04319094|589747512|FG000|12-month|Lost to Follow-up|11|||
163283438|NCT04319094|589747513|FG001|12-month|Lost to Follow-up|8|||
163283439|NCT00654238|589747517|FG000|Overall Study|Screen Failures|4|||
163283440|NCT03905135|589747519|FG000|Dose Escalation|Adverse Event|1|||
163283441|NCT03905135|589747520|FG001|Dose Escalation|Adverse Event|1|||
163283442|NCT03905135|589747519|FG000|Dose Escalation|Progressive disease|3|||
163283443|NCT03905135|589747520|FG001|Dose Escalation|Progressive disease|1|||
163283444|NCT03905135|589747519|FG000|Dose Escalation|Intercurrent illness|1|||
163283445|NCT03905135|589747520|FG001|Dose Escalation|Intercurrent illness|0|||
163283446|NCT04523181|589747523|FG000|Overall Study|Withdrawal by Subject|4|||
162933483|NCT00463866|588462225|FG001|Overall Study|Withdrawal by Subject|79|||
162933484|NCT00463866|588462224|FG000|Overall Study|Lost to Follow-up|46|||
162933485|NCT00463866|588462225|FG001|Overall Study|Lost to Follow-up|55|||
162933486|NCT00463866|588462224|FG000|Overall Study|Incorrect Enrolment|64|||
162933487|NCT00463866|588462225|FG001|Overall Study|Incorrect Enrolment|66|||
162933488|NCT00463866|588462224|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
162933489|NCT00463866|588462225|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
162933490|NCT00463866|588462224|FG000|Overall Study|Safety Reason|1|||
162933491|NCT00463866|588462225|FG001|Overall Study|Safety Reason|3|||
162933492|NCT00463866|588462224|FG000|Overall Study|Mis-Randomization of subject|0|||
162933493|NCT00463866|588462225|FG001|Overall Study|Mis-Randomization of subject|1|||
162933494|NCT00463866|588462224|FG000|Overall Study|Other|22|||
162933495|NCT00463866|588462225|FG001|Overall Study|Other|22|||
162933496|NCT01084005|588462226|FG000|Overall Study|Adverse Event|1|||
162933497|NCT01084005|588462227|FG001|Overall Study|Adverse Event|8|||
162933498|NCT01084005|588462226|FG000|Overall Study|Protocol Violation|3|||
162933499|NCT01084005|588462227|FG001|Overall Study|Protocol Violation|7|||
162933500|NCT01084005|588462226|FG000|Overall Study|Withdrawal by Subject|1|||
162933501|NCT01084005|588462227|FG001|Overall Study|Withdrawal by Subject|1|||
162933502|NCT02480010|588462232|FG000|Overall Study|Adverse Event|3|||
162933503|NCT02480010|588462233|FG001|Overall Study|Adverse Event|1|||
162933504|NCT02480010|588462232|FG000|Overall Study|Death|1|||
162933505|NCT02480010|588462233|FG001|Overall Study|Death|0|||
162933506|NCT02480010|588462232|FG000|Overall Study|Insufficient therapeutic response|31|||
162933507|NCT02480010|588462233|FG001|Overall Study|Insufficient therapeutic response|29|||
162933508|NCT02480010|588462232|FG000|Overall Study|Refused Treatment|0|||
162933509|NCT02480010|588462233|FG001|Overall Study|Refused Treatment|3|||
162933510|NCT00606684|588462234|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
162933511|NCT00606684|588462235|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
162933512|NCT00606684|588462236|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
162933513|NCT00606684|588462237|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
162933514|NCT00606684|588462238|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
162933515|NCT00606684|588462239|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
162933516|NCT00606684|588462240|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
162933517|NCT00606684|588462234|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
162933518|NCT00606684|588462235|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
162933519|NCT00606684|588462236|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
162933520|NCT00606684|588462237|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
162933521|NCT00606684|588462238|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
162933522|NCT00606684|588462239|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
162933523|NCT00606684|588462240|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
162933524|NCT00606684|588462234|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
162933525|NCT00606684|588462235|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
162933526|NCT00606684|588462236|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
162933527|NCT00606684|588462237|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
162933528|NCT00606684|588462238|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
162933529|NCT00606684|588462239|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
162933530|NCT00606684|588462240|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
163283447|NCT04523181|589747524|FG001|Overall Study|Withdrawal by Subject|5|||
163283448|NCT04523181|589747523|FG000|Overall Study|Lost to Follow-up|2|||
163283449|NCT04523181|589747524|FG001|Overall Study|Lost to Follow-up|3|||
163283450|NCT04523181|589747523|FG000|Overall Study|Physician Decision|1|||
163283451|NCT04523181|589747524|FG001|Overall Study|Physician Decision|0|||
163283452|NCT04523181|589747523|FG000|Overall Study|Transferred to external facility.|1|||
163283453|NCT04523181|589747524|FG001|Overall Study|Transferred to external facility.|1|||
163283454|NCT02042443|589747525|FG000|Overall Study|Adverse Event|2|||
163283455|NCT02042443|589747526|FG001|Overall Study|Adverse Event|1|||
163283456|NCT02042443|589747525|FG000|Overall Study|Withdrawal by Subject|0|||
163283457|NCT02042443|589747526|FG001|Overall Study|Withdrawal by Subject|1|||
163283458|NCT02042443|589747525|FG000|Overall Study|Progression|21|||
163283459|NCT02042443|589747526|FG001|Overall Study|Progression|17|||
163283460|NCT02042443|589747525|FG000|Overall Study|not protocol specified|1|||
163283461|NCT02042443|589747526|FG001|Overall Study|not protocol specified|1|||
163283462|NCT02042443|589747525|FG000|Overall Study|Not eligible/not analyzable|3|||
162933531|NCT00606684|588462234|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
162933532|NCT00606684|588462235|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
163283463|NCT02042443|589747526|FG001|Overall Study|Not eligible/not analyzable|6|||
163283464|NCT01649427|589747527|FG000|Overall Study|Adverse Event|1|||
163283465|NCT01649427|589747528|FG001|Overall Study|Adverse Event|1|||
163283466|NCT01649427|589747527|FG000|Overall Study|Withdrawal by Subject|8|||
163283467|NCT01649427|589747528|FG001|Overall Study|Withdrawal by Subject|7|||
163283468|NCT01649427|589747527|FG000|Overall Study|Lost to Follow-up|0|||
163283469|NCT01649427|589747528|FG001|Overall Study|Lost to Follow-up|1|||
163283470|NCT01649427|589747527|FG000|Overall Study|Graft loss|0|||
163283471|NCT01649427|589747528|FG001|Overall Study|Graft loss|1|||
162933533|NCT00606684|588462236|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
162933534|NCT00606684|588462237|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
162933535|NCT00606684|588462238|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
162933536|NCT00606684|588462239|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
162933537|NCT00606684|588462240|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
162933538|NCT00606684|588462234|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
162933539|NCT00606684|588462235|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
162933540|NCT00606684|588462236|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
162933541|NCT00606684|588462237|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
162933542|NCT00606684|588462238|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
162933543|NCT00606684|588462239|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
162933544|NCT00606684|588462240|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
162933545|NCT00606684|588462234|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
162933546|NCT00606684|588462235|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
162933547|NCT00606684|588462236|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
162933548|NCT00606684|588462237|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
162933549|NCT00606684|588462238|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
162933550|NCT00606684|588462239|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
162933551|NCT00606684|588462240|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
162933552|NCT00606684|588462234|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
162933553|NCT00606684|588462235|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
162933554|NCT00606684|588462236|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
162933555|NCT00606684|588462237|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
162933556|NCT00606684|588462238|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
162933557|NCT00606684|588462239|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
162933558|NCT00606684|588462240|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
162933559|NCT00606684|588462234|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162933560|NCT00606684|588462235|FG001|Double-Blind Treatment Period|Adverse Event|3|||
162933561|NCT00606684|588462236|FG002|Double-Blind Treatment Period|Adverse Event|2|||
163178203|NCT04078178|589369179|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
163178204|NCT04078178|589369178|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
163178205|NCT04078178|589369179|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
163178206|NCT04617795|589369180|FG000|Main Study|Lost to Follow-up|1|||
163178207|NCT04617795|589369181|FG001|Main Study|Lost to Follow-up|0|||
163178208|NCT04850313|589369182|FG000|Overall Study|Withdrawal by Subject|0|||
163178209|NCT04850313|589369183|FG001|Overall Study|Withdrawal by Subject|1|||
163178210|NCT03505671|589369188|FG000|Overall Study|Withdrawal by Subject|2|||
163178211|NCT03505671|589369189|FG001|Overall Study|Withdrawal by Subject|1|||
163178212|NCT03505671|589369188|FG000|Overall Study|Lost to Follow-up|1|||
163178213|NCT03505671|589369189|FG001|Overall Study|Lost to Follow-up|0|||
163178214|NCT02038829|589369190|FG000|Washout Period 1|Death|0|||
163178215|NCT02038829|589369191|FG001|Washout Period 1|Death|0|||
163178216|NCT02038829|589369192|FG002|Washout Period 1|Death|0|||
163178217|NCT02038829|589369193|FG003|Washout Period 1|Death|0|||
163178218|NCT02038829|589369194|FG004|Washout Period 1|Death|1|||
163178219|NCT02038829|589369195|FG005|Washout Period 1|Death|0|||
163178220|NCT02038829|589369196|FG006|Washout Period 1|Death|0|||
163178221|NCT02038829|589369197|FG007|Washout Period 1|Death|0|||
163178222|NCT02038829|589369198|FG008|Washout Period 1|Death|0|||
163178223|NCT02038829|589369199|FG009|Washout Period 1|Death|0|||
163178224|NCT02038829|589369200|FG010|Washout Period 1|Death|0|||
163178225|NCT02038829|589369201|FG011|Washout Period 1|Death|0|||
163178226|NCT02038829|589369190|FG000|Treatment Period 2|Adverse Event|0|||
163178227|NCT02038829|589369191|FG001|Treatment Period 2|Adverse Event|0|||
163178228|NCT02038829|589369192|FG002|Treatment Period 2|Adverse Event|0|||
163178229|NCT02038829|589369193|FG003|Treatment Period 2|Adverse Event|0|||
163178230|NCT02038829|589369194|FG004|Treatment Period 2|Adverse Event|0|||
163178231|NCT02038829|589369195|FG005|Treatment Period 2|Adverse Event|0|||
163178232|NCT02038829|589369196|FG006|Treatment Period 2|Adverse Event|0|||
163178233|NCT02038829|589369197|FG007|Treatment Period 2|Adverse Event|0|||
163178234|NCT02038829|589369198|FG008|Treatment Period 2|Adverse Event|0|||
163178235|NCT02038829|589369199|FG009|Treatment Period 2|Adverse Event|0|||
163178236|NCT02038829|589369200|FG010|Treatment Period 2|Adverse Event|1|||
163178237|NCT02038829|589369201|FG011|Treatment Period 2|Adverse Event|0|||
163178238|NCT02038829|589369190|FG000|Treatment Period 2|Withdrawal by Subject|1|||
163178239|NCT02038829|589369191|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163178240|NCT02038829|589369192|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163178241|NCT02038829|589369193|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163178242|NCT02038829|589369194|FG004|Treatment Period 2|Withdrawal by Subject|0|||
163178243|NCT02038829|589369195|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163178244|NCT02038829|589369196|FG006|Treatment Period 2|Withdrawal by Subject|0|||
163178245|NCT02038829|589369197|FG007|Treatment Period 2|Withdrawal by Subject|0|||
163178246|NCT02038829|589369198|FG008|Treatment Period 2|Withdrawal by Subject|0|||
162933562|NCT00606684|588462237|FG003|Double-Blind Treatment Period|Adverse Event|4|||
163283472|NCT01649427|589747527|FG000|Overall Study|Surgical problems during nephrectomy|2|||
163283473|NCT01649427|589747528|FG001|Overall Study|Surgical problems during nephrectomy|2|||
163283474|NCT02138916|589747531|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
163283475|NCT02138916|589747532|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
162933563|NCT00606684|588462238|FG004|Double-Blind Treatment Period|Adverse Event|2|||
162933564|NCT00606684|588462239|FG005|Double-Blind Treatment Period|Adverse Event|0|||
162933565|NCT00606684|588462240|FG006|Double-Blind Treatment Period|Adverse Event|1|||
162933566|NCT00606684|588462234|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
162933567|NCT00606684|588462235|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
162933568|NCT00606684|588462236|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
162933569|NCT00606684|588462237|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
162933570|NCT00606684|588462238|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
162933571|NCT00606684|588462239|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
162933572|NCT00606684|588462240|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
162933573|NCT00606684|588462234|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
162933574|NCT00606684|588462235|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
162933575|NCT00606684|588462236|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
162933576|NCT00606684|588462237|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
162933577|NCT00606684|588462238|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
162933578|NCT00606684|588462239|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
162933579|NCT00606684|588462240|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
162933580|NCT00606684|588462234|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
162933581|NCT00606684|588462235|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
162933582|NCT00606684|588462236|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
162933583|NCT00606684|588462237|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
162933584|NCT00606684|588462238|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
162933585|NCT00606684|588462239|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
162933586|NCT00606684|588462240|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
162933587|NCT00606684|588462234|FG000|Double-Blind Treatment Period|Physician Decision|0|||
162933588|NCT00606684|588462235|FG001|Double-Blind Treatment Period|Physician Decision|5|||
163283476|NCT02138916|589747533|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
163283477|NCT02138916|589747531|FG000|Overall Study|Death|14|||
163283478|NCT02138916|589747532|FG001|Overall Study|Death|11|||
163283479|NCT02138916|589747533|FG002|Overall Study|Death|12|||
163283480|NCT02138916|589747531|FG000|Overall Study|Withdrawal by Subject|27|||
163283481|NCT02138916|589747532|FG001|Overall Study|Withdrawal by Subject|31|||
163283482|NCT02138916|589747533|FG002|Overall Study|Withdrawal by Subject|32|||
163283483|NCT02138916|589747531|FG000|Overall Study|Study specific withdrawal criteria|0|||
163283484|NCT02138916|589747532|FG001|Overall Study|Study specific withdrawal criteria|0|||
163283485|NCT02138916|589747533|FG002|Overall Study|Study specific withdrawal criteria|1|||
163283486|NCT02138916|589747531|FG000|Overall Study|incorrect enrolment|1|||
163283487|NCT02138916|589747532|FG001|Overall Study|incorrect enrolment|1|||
163283488|NCT02138916|589747533|FG002|Overall Study|incorrect enrolment|0|||
163283489|NCT02138916|589747531|FG000|Overall Study|Severe non-compliance|1|||
163283490|NCT02138916|589747532|FG001|Overall Study|Severe non-compliance|2|||
163283491|NCT02138916|589747533|FG002|Overall Study|Severe non-compliance|1|||
163283492|NCT02138916|589747531|FG000|Overall Study|Lost to Follow-up|4|||
163283493|NCT02138916|589747532|FG001|Overall Study|Lost to Follow-up|2|||
163283494|NCT02138916|589747533|FG002|Overall Study|Lost to Follow-up|3|||
163283495|NCT02138916|589747531|FG000|Overall Study|Adverse Event|4|||
163283496|NCT02138916|589747532|FG001|Overall Study|Adverse Event|4|||
163283497|NCT02138916|589747533|FG002|Overall Study|Adverse Event|3|||
163283498|NCT01913340|589747534|FG000|Overall Study|Death|2|||
163283499|NCT01913340|589747535|FG001|Overall Study|Death|5|||
163283500|NCT01913340|589747534|FG000|Overall Study|Lost to Follow-up|1|||
162933589|NCT00606684|588462236|FG002|Double-Blind Treatment Period|Physician Decision|1|||
162933590|NCT00606684|588462237|FG003|Double-Blind Treatment Period|Physician Decision|0|||
162933591|NCT00606684|588462238|FG004|Double-Blind Treatment Period|Physician Decision|3|||
162933592|NCT00606684|588462239|FG005|Double-Blind Treatment Period|Physician Decision|1|||
162933593|NCT00606684|588462240|FG006|Double-Blind Treatment Period|Physician Decision|2|||
162933594|NCT00606684|588462234|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162933595|NCT00606684|588462235|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162933596|NCT00606684|588462236|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
163283501|NCT01913340|589747535|FG001|Overall Study|Lost to Follow-up|1|||
163283502|NCT05750745|589747537|FG000|Overall Study|Adverse Event|1|||
163283503|NCT05750745|589747538|FG001|Overall Study|Adverse Event|0|||
163283504|NCT05750745|589747539|FG002|Overall Study|Adverse Event|0|||
163283505|NCT05750745|589747537|FG000|Overall Study|Protocol Violation|1|||
163283506|NCT05750745|589747538|FG001|Overall Study|Protocol Violation|0|||
163283507|NCT05750745|589747539|FG002|Overall Study|Protocol Violation|0|||
163283508|NCT05750745|589747537|FG000|Overall Study|Withdrawal by Subject|0|||
163283509|NCT05750745|589747538|FG001|Overall Study|Withdrawal by Subject|1|||
163283510|NCT05750745|589747539|FG002|Overall Study|Withdrawal by Subject|0|||
163283511|NCT05096884|589747541|FG000|Overall Study|Excluded based on negative tilt table test|4|||
163283512|NCT02482233|589747542|FG000|Overall Study|Lost to Follow-up|1|||
163283513|NCT02482233|589747543|FG001|Overall Study|Lost to Follow-up|1|||
163283514|NCT04888585|589747544|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
163283515|NCT04888585|589747545|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
163283516|NCT04888585|589747546|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
163283517|NCT04888585|589747547|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
163283518|NCT04888585|589747548|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
163283519|NCT04888585|589747549|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
162933597|NCT00606684|588462237|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
162933598|NCT00606684|588462238|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162933599|NCT00606684|588462239|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
162933600|NCT00606684|588462240|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162933601|NCT03568500|588462241|FG000|Overall Study|Lost to Follow-up|1|||
162933602|NCT03568500|588462242|FG001|Overall Study|Lost to Follow-up|1|||
162933603|NCT03568500|588462243|FG002|Overall Study|Lost to Follow-up|2|||
162933604|NCT03568500|588462241|FG000|Overall Study|Adverse Event|1|||
162933605|NCT03568500|588462242|FG001|Overall Study|Adverse Event|1|||
162933606|NCT03568500|588462243|FG002|Overall Study|Adverse Event|2|||
162933607|NCT03568500|588462241|FG000|Overall Study|Physician Decision|1|||
162933608|NCT03568500|588462242|FG001|Overall Study|Physician Decision|0|||
162933609|NCT03568500|588462243|FG002|Overall Study|Physician Decision|0|||
162933610|NCT03568500|588462241|FG000|Overall Study|Withdrawal by Subject|4|||
162933611|NCT03568500|588462242|FG001|Overall Study|Withdrawal by Subject|2|||
162933612|NCT03568500|588462243|FG002|Overall Study|Withdrawal by Subject|0|||
162933613|NCT03568500|588462241|FG000|Overall Study|Technical Problems|2|||
162933614|NCT03568500|588462242|FG001|Overall Study|Technical Problems|1|||
162933615|NCT03568500|588462243|FG002|Overall Study|Technical Problems|0|||
163283520|NCT04888585|589747550|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
163283521|NCT04888585|589747551|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
163283522|NCT04888585|589747552|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
163283523|NCT04888585|589747553|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
163283524|NCT04888585|589747554|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
163283525|NCT04888585|589747544|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
163283526|NCT04888585|589747545|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
163283527|NCT04888585|589747546|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
163283528|NCT04888585|589747547|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
163283529|NCT04888585|589747548|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
163283530|NCT04888585|589747549|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
163283531|NCT04888585|589747550|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
163283532|NCT04888585|589747551|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
163283533|NCT04888585|589747552|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
163283534|NCT04888585|589747553|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
163283535|NCT04888585|589747554|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
163283536|NCT04888585|589747544|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163283537|NCT04888585|589747545|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163283538|NCT04888585|589747546|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
163283539|NCT04888585|589747547|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163283540|NCT04888585|589747548|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
163283541|NCT04888585|589747549|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163283542|NCT04888585|589747550|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163283543|NCT04888585|589747551|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163283544|NCT04888585|589747552|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163283545|NCT04888585|589747553|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163283546|NCT04888585|589747554|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163283547|NCT04888585|589747544|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
163283548|NCT04888585|589747545|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
162933616|NCT03568500|588462241|FG000|Overall Study|Participant Noncompliance|1|||
162933617|NCT03568500|588462242|FG001|Overall Study|Participant Noncompliance|1|||
162933618|NCT03568500|588462243|FG002|Overall Study|Participant Noncompliance|0|||
162933619|NCT01759381|588462252|FG000|Overall Study|Death|1|||
162933620|NCT01759381|588462253|FG001|Overall Study|Death|0|||
162933621|NCT03377556|588462258|FG000|Overall Study|Adverse Event|5|||
163283549|NCT04888585|589747546|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
163283550|NCT04888585|589747547|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
163283551|NCT04888585|589747548|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
162933622|NCT03377556|588462258|FG000|Overall Study|Refusal unrelated to adverse events|1|||
162933623|NCT03377556|588462258|FG000|Overall Study|Progression/relapse|38|||
162933624|NCT03377556|588462258|FG000|Overall Study|Death|3|||
162933625|NCT00910858|588462259|FG000|Pharmacokinetic Phase|Adverse Event|1|||
162933626|NCT00910858|588462260|FG001|Pharmacokinetic Phase|Adverse Event|0|||
162933627|NCT00910858|588462261|FG002|Pharmacokinetic Phase|Adverse Event|0|||
162933628|NCT00910858|588462259|FG000|Monotherapy Phase|Adverse Event|3|||
162933629|NCT00910858|588462260|FG001|Monotherapy Phase|Adverse Event|2|||
163283552|NCT04888585|589747549|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
163283553|NCT04888585|589747550|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
162933630|NCT00910858|588462261|FG002|Monotherapy Phase|Adverse Event|0|||
162933631|NCT00910858|588462259|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
162933632|NCT00910858|588462260|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
162933633|NCT00910858|588462261|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
162933634|NCT00910858|588462259|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
163283554|NCT04888585|589747551|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
163283555|NCT04888585|589747552|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
163283556|NCT04888585|589747553|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
163283557|NCT04888585|589747554|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
163283558|NCT04888585|589747544|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
163283559|NCT04888585|589747545|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
163283560|NCT04888585|589747546|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
163283561|NCT04888585|589747547|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
163283562|NCT04888585|589747548|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
163283563|NCT04888585|589747549|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
163283564|NCT04888585|589747550|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
163283565|NCT04888585|589747551|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
163283566|NCT04888585|589747552|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
163283567|NCT04888585|589747553|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
163283568|NCT04888585|589747554|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
163283569|NCT04888585|589747544|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
163283570|NCT04888585|589747545|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
163283571|NCT04888585|589747546|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
163283572|NCT04888585|589747547|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
163283573|NCT04888585|589747548|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
163283574|NCT04888585|589747549|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
163283575|NCT04888585|589747550|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
163283576|NCT04888585|589747551|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
163283577|NCT04888585|589747552|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
163283578|NCT04888585|589747553|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
163283579|NCT04888585|589747554|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
163283580|NCT04888585|589747544|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
163283581|NCT04888585|589747545|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
163283582|NCT04888585|589747546|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
163283583|NCT04888585|589747547|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
163283584|NCT04888585|589747548|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
163283585|NCT04888585|589747549|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
163283586|NCT04888585|589747550|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
162933635|NCT00910858|588462260|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
162933636|NCT00910858|588462261|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
162933637|NCT00910858|588462259|FG000|Monotherapy Phase|Protocol Violation|1|||
162933638|NCT00910858|588462260|FG001|Monotherapy Phase|Protocol Violation|0|||
162933639|NCT00910858|588462261|FG002|Monotherapy Phase|Protocol Violation|0|||
162933640|NCT00910858|588462259|FG000|Monotherapy Phase|Other|3|||
162933641|NCT00910858|588462260|FG001|Monotherapy Phase|Other|4|||
162933642|NCT00910858|588462261|FG002|Monotherapy Phase|Other|2|||
162933643|NCT00910858|588462259|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
162933644|NCT00910858|588462260|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
162933645|NCT00910858|588462261|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
162933646|NCT00910858|588462259|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
163283587|NCT04888585|589747551|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
163283588|NCT04888585|589747552|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
163283589|NCT04888585|589747553|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
163283590|NCT04888585|589747554|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
163283591|NCT04888585|589747544|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162933647|NCT00910858|588462260|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
162933648|NCT00910858|588462261|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
162933649|NCT00910858|588462259|FG000|Combined Treatment Phase|Protocol Violation|1|||
162933650|NCT00910858|588462260|FG001|Combined Treatment Phase|Protocol Violation|0|||
163178247|NCT02038829|589369199|FG009|Treatment Period 2|Withdrawal by Subject|0|||
163178248|NCT02038829|589369200|FG010|Treatment Period 2|Withdrawal by Subject|0|||
163178249|NCT02038829|589369201|FG011|Treatment Period 2|Withdrawal by Subject|0|||
163178250|NCT02038829|589369190|FG000|Washout Period 2|Adverse Event|0|||
163178251|NCT02038829|589369191|FG001|Washout Period 2|Adverse Event|0|||
163178252|NCT02038829|589369192|FG002|Washout Period 2|Adverse Event|0|||
163178253|NCT02038829|589369193|FG003|Washout Period 2|Adverse Event|0|||
163178254|NCT02038829|589369194|FG004|Washout Period 2|Adverse Event|0|||
163178255|NCT02038829|589369195|FG005|Washout Period 2|Adverse Event|0|||
163178256|NCT02038829|589369196|FG006|Washout Period 2|Adverse Event|0|||
163178257|NCT02038829|589369197|FG007|Washout Period 2|Adverse Event|0|||
163178258|NCT02038829|589369198|FG008|Washout Period 2|Adverse Event|1|||
163178259|NCT02038829|589369199|FG009|Washout Period 2|Adverse Event|0|||
163178260|NCT02038829|589369200|FG010|Washout Period 2|Adverse Event|0|||
163178261|NCT02038829|589369201|FG011|Washout Period 2|Adverse Event|0|||
163178262|NCT02038829|589369190|FG000|Washout Period 2|Withdrawal by Subject|0|||
163178263|NCT02038829|589369191|FG001|Washout Period 2|Withdrawal by Subject|0|||
163178264|NCT02038829|589369192|FG002|Washout Period 2|Withdrawal by Subject|0|||
163178265|NCT02038829|589369193|FG003|Washout Period 2|Withdrawal by Subject|0|||
163178266|NCT02038829|589369194|FG004|Washout Period 2|Withdrawal by Subject|0|||
163178267|NCT02038829|589369195|FG005|Washout Period 2|Withdrawal by Subject|1|||
163178268|NCT02038829|589369196|FG006|Washout Period 2|Withdrawal by Subject|0|||
163178269|NCT02038829|589369197|FG007|Washout Period 2|Withdrawal by Subject|0|||
163178270|NCT02038829|589369198|FG008|Washout Period 2|Withdrawal by Subject|0|||
163178271|NCT02038829|589369199|FG009|Washout Period 2|Withdrawal by Subject|0|||
163178272|NCT02038829|589369200|FG010|Washout Period 2|Withdrawal by Subject|0|||
163178273|NCT02038829|589369201|FG011|Washout Period 2|Withdrawal by Subject|0|||
163178274|NCT02038829|589369190|FG000|Treatment Period 4|Adverse Event|0|||
163178275|NCT02038829|589369191|FG001|Treatment Period 4|Adverse Event|1|||
163178276|NCT02038829|589369192|FG002|Treatment Period 4|Adverse Event|0|||
163178277|NCT02038829|589369193|FG003|Treatment Period 4|Adverse Event|0|||
163178278|NCT02038829|589369194|FG004|Treatment Period 4|Adverse Event|0|||
163178279|NCT02038829|589369195|FG005|Treatment Period 4|Adverse Event|0|||
163178280|NCT02038829|589369196|FG006|Treatment Period 4|Adverse Event|0|||
163178281|NCT02038829|589369197|FG007|Treatment Period 4|Adverse Event|0|||
163178282|NCT02038829|589369198|FG008|Treatment Period 4|Adverse Event|0|||
163178283|NCT02038829|589369199|FG009|Treatment Period 4|Adverse Event|0|||
163178284|NCT02038829|589369200|FG010|Treatment Period 4|Adverse Event|0|||
163178285|NCT02038829|589369201|FG011|Treatment Period 4|Adverse Event|0|||
163178286|NCT02038829|589369190|FG000|Washout Period 4|Adverse Event|0|||
163178287|NCT02038829|589369191|FG001|Washout Period 4|Adverse Event|0|||
163178288|NCT02038829|589369192|FG002|Washout Period 4|Adverse Event|0|||
163178289|NCT02038829|589369193|FG003|Washout Period 4|Adverse Event|0|||
163178290|NCT02038829|589369194|FG004|Washout Period 4|Adverse Event|0|||
163178291|NCT02038829|589369195|FG005|Washout Period 4|Adverse Event|0|||
163178292|NCT02038829|589369196|FG006|Washout Period 4|Adverse Event|1|||
163178293|NCT02038829|589369197|FG007|Washout Period 4|Adverse Event|0|||
163178294|NCT02038829|589369198|FG008|Washout Period 4|Adverse Event|0|||
163178295|NCT02038829|589369199|FG009|Washout Period 4|Adverse Event|0|||
163178296|NCT02038829|589369200|FG010|Washout Period 4|Adverse Event|0|||
163178297|NCT02038829|589369201|FG011|Washout Period 4|Adverse Event|0|||
163178298|NCT02038829|589369190|FG000|Treatment Period 6|Adverse Event|0|||
163178299|NCT02038829|589369191|FG001|Treatment Period 6|Adverse Event|0|||
163178300|NCT02038829|589369192|FG002|Treatment Period 6|Adverse Event|1|||
163178301|NCT02038829|589369193|FG003|Treatment Period 6|Adverse Event|0|||
163178302|NCT02038829|589369194|FG004|Treatment Period 6|Adverse Event|0|||
163178303|NCT02038829|589369195|FG005|Treatment Period 6|Adverse Event|0|||
163178304|NCT02038829|589369196|FG006|Treatment Period 6|Adverse Event|0|||
163178305|NCT02038829|589369197|FG007|Treatment Period 6|Adverse Event|0|||
163178306|NCT02038829|589369198|FG008|Treatment Period 6|Adverse Event|0|||
163178307|NCT02038829|589369199|FG009|Treatment Period 6|Adverse Event|0|||
163178308|NCT02038829|589369200|FG010|Treatment Period 6|Adverse Event|0|||
163178309|NCT02038829|589369201|FG011|Treatment Period 6|Adverse Event|0|||
163178310|NCT04393298|589369202|FG000|Overall Study|Adverse Event|0|||
163178311|NCT04393298|589369203|FG001|Overall Study|Adverse Event|0|||
163283592|NCT04888585|589747545|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
163178312|NCT04393298|589369204|FG002|Overall Study|Adverse Event|0|||
163283593|NCT04888585|589747546|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
163178313|NCT04393298|589369205|FG003|Overall Study|Adverse Event|0|||
163178314|NCT04393298|589369206|FG004|Overall Study|Adverse Event|1|||
163178315|NCT04393298|589369207|FG005|Overall Study|Adverse Event|0|||
163178316|NCT04393298|589369208|FG006|Overall Study|Adverse Event|0|||
163178317|NCT04393298|589369209|FG007|Overall Study|Adverse Event|0|||
163178318|NCT04393298|589369210|FG008|Overall Study|Adverse Event|2|||
163178319|NCT04393298|589369211|FG009|Overall Study|Adverse Event|0|||
163178320|NCT04393298|589369212|FG010|Overall Study|Adverse Event|0|||
163178321|NCT04393298|589369213|FG011|Overall Study|Adverse Event|0|||
163178322|NCT04393298|589369214|FG012|Overall Study|Adverse Event|1|||
163178323|NCT04393298|589369215|FG013|Overall Study|Adverse Event|1|||
162933651|NCT00910858|588462261|FG002|Combined Treatment Phase|Protocol Violation|0|||
162933652|NCT00910858|588462259|FG000|Combined Treatment Phase|Other|0|||
162933653|NCT00910858|588462260|FG001|Combined Treatment Phase|Other|2|||
163178324|NCT04393298|589369216|FG014|Overall Study|Adverse Event|0|||
163178325|NCT04393298|589369202|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178326|NCT04393298|589369203|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178327|NCT04393298|589369204|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
163178328|NCT04393298|589369205|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178329|NCT04393298|589369206|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178330|NCT04393298|589369207|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178331|NCT04393298|589369208|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178332|NCT04393298|589369209|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178333|NCT04393298|589369210|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178334|NCT04393298|589369211|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178335|NCT04393298|589369212|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178336|NCT04393298|589369213|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178337|NCT04393298|589369214|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178338|NCT04393298|589369215|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178339|NCT04393298|589369216|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
163178340|NCT04393298|589369202|FG000|Overall Study|Lack of Efficacy|0|||
163178341|NCT04393298|589369203|FG001|Overall Study|Lack of Efficacy|0|||
163178342|NCT04393298|589369204|FG002|Overall Study|Lack of Efficacy|0|||
163178343|NCT04393298|589369205|FG003|Overall Study|Lack of Efficacy|0|||
163178344|NCT04393298|589369206|FG004|Overall Study|Lack of Efficacy|0|||
163178345|NCT04393298|589369207|FG005|Overall Study|Lack of Efficacy|0|||
163178346|NCT04393298|589369208|FG006|Overall Study|Lack of Efficacy|0|||
163178347|NCT04393298|589369209|FG007|Overall Study|Lack of Efficacy|0|||
163178348|NCT04393298|589369210|FG008|Overall Study|Lack of Efficacy|0|||
163178349|NCT04393298|589369211|FG009|Overall Study|Lack of Efficacy|0|||
163178350|NCT04393298|589369212|FG010|Overall Study|Lack of Efficacy|0|||
163178351|NCT04393298|589369213|FG011|Overall Study|Lack of Efficacy|0|||
163178352|NCT04393298|589369214|FG012|Overall Study|Lack of Efficacy|0|||
163178353|NCT04393298|589369215|FG013|Overall Study|Lack of Efficacy|0|||
163178354|NCT04393298|589369216|FG014|Overall Study|Lack of Efficacy|1|||
163178355|NCT04393298|589369202|FG000|Overall Study|Progression|1|||
163178356|NCT04393298|589369203|FG001|Overall Study|Progression|0|||
163178357|NCT04393298|589369204|FG002|Overall Study|Progression|0|||
163178358|NCT04393298|589369205|FG003|Overall Study|Progression|0|||
163178359|NCT04393298|589369206|FG004|Overall Study|Progression|0|||
163178360|NCT04393298|589369207|FG005|Overall Study|Progression|0|||
163178361|NCT04393298|589369208|FG006|Overall Study|Progression|0|||
163178362|NCT04393298|589369209|FG007|Overall Study|Progression|0|||
163178363|NCT04393298|589369210|FG008|Overall Study|Progression|0|||
163178364|NCT04393298|589369211|FG009|Overall Study|Progression|0|||
163178365|NCT04393298|589369212|FG010|Overall Study|Progression|1|||
163178366|NCT04393298|589369213|FG011|Overall Study|Progression|1|||
163178367|NCT04393298|589369214|FG012|Overall Study|Progression|0|||
163178368|NCT04393298|589369215|FG013|Overall Study|Progression|0|||
163178369|NCT04393298|589369216|FG014|Overall Study|Progression|0|||
163178370|NCT04393298|589369202|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
163178371|NCT04393298|589369203|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178372|NCT04393298|589369204|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178373|NCT04393298|589369205|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178374|NCT04393298|589369206|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178375|NCT04393298|589369207|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178376|NCT04393298|589369208|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178377|NCT04393298|589369209|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178378|NCT04393298|589369210|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178379|NCT04393298|589369211|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178380|NCT04393298|589369212|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
162933654|NCT00910858|588462261|FG002|Combined Treatment Phase|Other|1|||
162933655|NCT00827827|588462262|FG000|Overall Study|Lost to Follow-up|3|||
163178381|NCT04393298|589369213|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178382|NCT04393298|589369214|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178383|NCT04393298|589369215|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178384|NCT04393298|589369216|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178385|NCT04393298|589369202|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178386|NCT04393298|589369203|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
163178387|NCT04393298|589369204|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162933656|NCT00827827|588462263|FG001|Overall Study|Lost to Follow-up|0|||
163178388|NCT04393298|589369205|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163283594|NCT04888585|589747547|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162933657|NCT00827827|588462262|FG000|Overall Study|Fall at home- hospitalization|1|||
162933658|NCT00827827|588462263|FG001|Overall Study|Fall at home- hospitalization|0|||
162933659|NCT00827827|588462262|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
163178389|NCT04393298|589369206|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178390|NCT04393298|589369207|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178391|NCT04393298|589369208|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178392|NCT04393298|589369209|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178393|NCT04393298|589369210|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178394|NCT04393298|589369211|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178395|NCT04393298|589369212|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178396|NCT04393298|589369213|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178397|NCT04393298|589369214|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178398|NCT04393298|589369215|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178399|NCT04393298|589369216|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178400|NCT04393298|589369202|FG000|Overall Study|Clinical Progression|0|||
163178401|NCT04393298|589369203|FG001|Overall Study|Clinical Progression|2|||
163178402|NCT04393298|589369204|FG002|Overall Study|Clinical Progression|0|||
163178403|NCT04393298|589369205|FG003|Overall Study|Clinical Progression|0|||
163178404|NCT04393298|589369206|FG004|Overall Study|Clinical Progression|0|||
163178405|NCT04393298|589369207|FG005|Overall Study|Clinical Progression|0|||
163178406|NCT04393298|589369208|FG006|Overall Study|Clinical Progression|0|||
163178407|NCT04393298|589369209|FG007|Overall Study|Clinical Progression|0|||
163178408|NCT04393298|589369210|FG008|Overall Study|Clinical Progression|0|||
163178409|NCT04393298|589369211|FG009|Overall Study|Clinical Progression|0|||
163178410|NCT04393298|589369212|FG010|Overall Study|Clinical Progression|0|||
163178411|NCT04393298|589369213|FG011|Overall Study|Clinical Progression|0|||
163178412|NCT04393298|589369214|FG012|Overall Study|Clinical Progression|0|||
163178413|NCT04393298|589369215|FG013|Overall Study|Clinical Progression|0|||
163178414|NCT04393298|589369216|FG014|Overall Study|Clinical Progression|0|||
163178415|NCT04393298|589369202|FG000|Overall Study|Disease Progression|0|||
163178416|NCT04393298|589369203|FG001|Overall Study|Disease Progression|1|||
163178417|NCT04393298|589369204|FG002|Overall Study|Disease Progression|0|||
163178418|NCT04393298|589369205|FG003|Overall Study|Disease Progression|0|||
163178419|NCT04393298|589369206|FG004|Overall Study|Disease Progression|0|||
163178420|NCT04393298|589369207|FG005|Overall Study|Disease Progression|3|||
163178421|NCT04393298|589369208|FG006|Overall Study|Disease Progression|2|||
163178422|NCT04393298|589369209|FG007|Overall Study|Disease Progression|1|||
163178423|NCT04393298|589369210|FG008|Overall Study|Disease Progression|2|||
163178424|NCT04393298|589369211|FG009|Overall Study|Disease Progression|1|||
163178425|NCT04393298|589369212|FG010|Overall Study|Disease Progression|0|||
163178426|NCT04393298|589369213|FG011|Overall Study|Disease Progression|3|||
163178427|NCT04393298|589369214|FG012|Overall Study|Disease Progression|0|||
163178428|NCT04393298|589369215|FG013|Overall Study|Disease Progression|0|||
163178429|NCT04393298|589369216|FG014|Overall Study|Disease Progression|1|||
163178430|NCT04393298|589369202|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178431|NCT04393298|589369203|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178432|NCT04393298|589369204|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
163178433|NCT04393298|589369205|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178434|NCT04393298|589369206|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178435|NCT04393298|589369207|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178436|NCT04393298|589369208|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178437|NCT04393298|589369209|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178438|NCT04393298|589369210|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178439|NCT04393298|589369211|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178440|NCT04393298|589369212|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178441|NCT04393298|589369213|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178442|NCT04393298|589369214|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178443|NCT04393298|589369215|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178444|NCT04393298|589369216|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178445|NCT04393298|589369202|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178446|NCT04393298|589369203|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178447|NCT04393298|589369204|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
163178448|NCT04393298|589369205|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178449|NCT04393298|589369206|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178450|NCT04393298|589369207|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178451|NCT04393298|589369208|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178452|NCT04393298|589369209|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178453|NCT04393298|589369210|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178454|NCT04393298|589369211|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
162933660|NCT00827827|588462263|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
162933661|NCT00827827|588462262|FG000|Overall Study|Gout|1|||
162933662|NCT00827827|588462263|FG001|Overall Study|Gout|0|||
162933663|NCT00827827|588462262|FG000|Overall Study|Transportation issues|1|||
162933664|NCT00827827|588462263|FG001|Overall Study|Transportation issues|0|||
162933665|NCT00827827|588462262|FG000|Overall Study|Burned with water at home|1|||
163283595|NCT04888585|589747548|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
163283596|NCT04888585|589747549|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
163283597|NCT04888585|589747550|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
163283598|NCT04888585|589747551|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
163283599|NCT04888585|589747552|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
163283600|NCT04888585|589747553|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
163283601|NCT04888585|589747554|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
163283602|NCT04927975|589747555|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
163283603|NCT04927975|589747556|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
163283604|NCT04927975|589747557|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
163283605|NCT04927975|589747558|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
163283606|NCT04927975|589747559|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
163283607|NCT04927975|589747560|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
163283608|NCT04927975|589747555|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
163283609|NCT04927975|589747556|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
163283610|NCT04927975|589747557|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
163283611|NCT04927975|589747558|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
163283612|NCT04927975|589747559|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
163283613|NCT04927975|589747560|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
163283614|NCT04927975|589747555|FG000|Period 1 (Baseline-Week 24)|Death|0|||
163283615|NCT04927975|589747556|FG001|Period 1 (Baseline-Week 24)|Death|0|||
163283616|NCT04927975|589747557|FG002|Period 1 (Baseline-Week 24)|Death|0|||
163283617|NCT04927975|589747558|FG003|Period 1 (Baseline-Week 24)|Death|0|||
163283618|NCT04927975|589747559|FG004|Period 1 (Baseline-Week 24)|Death|0|||
163283619|NCT04927975|589747560|FG005|Period 1 (Baseline-Week 24)|Death|1|||
163283620|NCT04927975|589747555|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
163283621|NCT04927975|589747556|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
163283622|NCT04927975|589747557|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
163283623|NCT04927975|589747558|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
163283624|NCT04927975|589747559|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
163283625|NCT04927975|589747560|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
163283626|NCT04927975|589747555|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
163283627|NCT04927975|589747556|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
163283628|NCT04927975|589747557|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
163283629|NCT04927975|589747558|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
163283630|NCT04927975|589747559|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
163283631|NCT04927975|589747560|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
163283632|NCT03822351|589747561|FG000|Overall Study|Death|27|||
163283633|NCT03822351|589747562|FG001|Overall Study|Death|23|||
163283634|NCT03822351|589747563|FG002|Overall Study|Death|24|||
163283635|NCT03822351|589747561|FG000|Overall Study|Lost to Follow-up|6|||
163283636|NCT03822351|589747562|FG001|Overall Study|Lost to Follow-up|2|||
163283637|NCT03822351|589747563|FG002|Overall Study|Lost to Follow-up|1|||
163283638|NCT03822351|589747561|FG000|Overall Study|Withdrawal by Subject|10|||
163283639|NCT03822351|589747562|FG001|Overall Study|Withdrawal by Subject|4|||
163283640|NCT03822351|589747563|FG002|Overall Study|Withdrawal by Subject|6|||
163283641|NCT03822351|589747561|FG000|Overall Study|Progressive Disease|2|||
163283642|NCT03822351|589747562|FG001|Overall Study|Progressive Disease|1|||
163283643|NCT03822351|589747563|FG002|Overall Study|Progressive Disease|0|||
163283644|NCT03822351|589747561|FG000|Overall Study|Not Treated|1|||
163283645|NCT03822351|589747562|FG001|Overall Study|Not Treated|1|||
163283646|NCT03822351|589747563|FG002|Overall Study|Not Treated|1|||
163283647|NCT00768066|589747566|FG000|Overall Study|Did not receive study product injection.|3|||
163283648|NCT00768066|589747567|FG001|Overall Study|Did not receive study product injection.|3|||
163283649|NCT00768066|589747568|FG002|Overall Study|Did not receive study product injection.|0|||
163283650|NCT05550337|589747569|FG000|Overall Study|Lack of Efficacy|0|||
163283651|NCT05550337|589747570|FG001|Overall Study|Lack of Efficacy|0|||
162933666|NCT00827827|588462263|FG001|Overall Study|Burned with water at home|0|||
163283652|NCT05550337|589747571|FG002|Overall Study|Lack of Efficacy|1|||
163283653|NCT05550337|589747569|FG000|Overall Study|Adverse Event|1|||
163283654|NCT05550337|589747570|FG001|Overall Study|Adverse Event|5|||
163283655|NCT05550337|589747571|FG002|Overall Study|Adverse Event|0|||
163283656|NCT05550337|589747569|FG000|Overall Study|Withdrawal by Subject|8|||
163283657|NCT05550337|589747570|FG001|Overall Study|Withdrawal by Subject|14|||
163283658|NCT05550337|589747571|FG002|Overall Study|Withdrawal by Subject|10|||
163283659|NCT05550337|589747569|FG000|Overall Study|Pregnancy|0|||
163283660|NCT05550337|589747570|FG001|Overall Study|Pregnancy|0|||
163283661|NCT05550337|589747571|FG002|Overall Study|Pregnancy|1|||
163283662|NCT05550337|589747569|FG000|Overall Study|Protocol Violation|1|||
162933667|NCT01907737|588462275|FG000|Overall Study|Withdrawal by Subject|1|||
162933668|NCT01165684|588462276|FG000|Overall Study|Adverse Event|1|||
162933669|NCT01165684|588462277|FG001|Overall Study|Adverse Event|1|||
162933670|NCT01165684|588462276|FG000|Overall Study|Lack of Efficacy|2|||
162933671|NCT01165684|588462277|FG001|Overall Study|Lack of Efficacy|1|||
162933672|NCT01165684|588462276|FG000|Overall Study|Protocol Violation|7|||
162933673|NCT01165684|588462277|FG001|Overall Study|Protocol Violation|15|||
162933674|NCT01165684|588462276|FG000|Overall Study|Withdrawal Criteria|2|||
162933675|NCT01165684|588462277|FG001|Overall Study|Withdrawal Criteria|13|||
162933676|NCT01165684|588462276|FG000|Overall Study|Unclassified|16|||
162933677|NCT01165684|588462277|FG001|Overall Study|Unclassified|22|||
162933678|NCT01886300|588462298|FG000|Overall Study|Trial terminated by sponsor|16|||
162933679|NCT00901628|588462299|FG000|Overall Study|disconnection of catheter|4|||
162933680|NCT00901628|588462300|FG001|Overall Study|disconnection of catheter|8|||
162933681|NCT00901628|588462299|FG000|Overall Study|disconnection of drain|0|||
162933682|NCT00901628|588462300|FG001|Overall Study|disconnection of drain|1|||
162933683|NCT00901628|588462299|FG000|Overall Study|peroneal nerve palsy|0|||
162933684|NCT00901628|588462300|FG001|Overall Study|peroneal nerve palsy|1|||
162933685|NCT00608205|588462301|FG000|Overall Study|Adverse Event|3|||
162933686|NCT00608205|588462302|FG001|Overall Study|Adverse Event|2|||
162933687|NCT00608205|588462301|FG000|Overall Study|Patient non-compliant|0|||
162933688|NCT00608205|588462302|FG001|Overall Study|Patient non-compliant|1|||
162933689|NCT02008721|588462305|FG000|Overall Study|Withdrawal by Subject|5|||
162933690|NCT02008721|588462306|FG001|Overall Study|Withdrawal by Subject|1|||
162933691|NCT02008721|588462305|FG000|Overall Study|Death|4|||
162933692|NCT02008721|588462306|FG001|Overall Study|Death|2|||
162933693|NCT02008721|588462305|FG000|Overall Study|Adverse Event|3|||
162933694|NCT02008721|588462306|FG001|Overall Study|Adverse Event|5|||
162933695|NCT02008721|588462305|FG000|Overall Study|Protocol Violation|3|||
162933696|NCT02008721|588462306|FG001|Overall Study|Protocol Violation|2|||
162933697|NCT00295854|588462307|FG000|Overall Study|Adverse Event|7|||
162933698|NCT00295854|588462308|FG001|Overall Study|Adverse Event|7|||
162933699|NCT00295854|588462309|FG002|Overall Study|Adverse Event|6|||
162933700|NCT00295854|588462307|FG000|Overall Study|Protocol Violation|1|||
162933701|NCT00295854|588462308|FG001|Overall Study|Protocol Violation|1|||
162933702|NCT00295854|588462309|FG002|Overall Study|Protocol Violation|1|||
162933703|NCT00295854|588462307|FG000|Overall Study|Lost to Follow-up|2|||
162933704|NCT00295854|588462308|FG001|Overall Study|Lost to Follow-up|0|||
162933705|NCT00295854|588462309|FG002|Overall Study|Lost to Follow-up|1|||
162933706|NCT00295854|588462307|FG000|Overall Study|Withdrawal by Subject|3|||
162933707|NCT00295854|588462308|FG001|Overall Study|Withdrawal by Subject|7|||
162933708|NCT00295854|588462309|FG002|Overall Study|Withdrawal by Subject|4|||
162933709|NCT00295854|588462307|FG000|Overall Study|did not continue to meet criteria|1|||
162933710|NCT00295854|588462308|FG001|Overall Study|did not continue to meet criteria|1|||
162933711|NCT00295854|588462309|FG002|Overall Study|did not continue to meet criteria|2|||
162933712|NCT00295854|588462307|FG000|Overall Study|required a prohibited medication|1|||
162933713|NCT00295854|588462308|FG001|Overall Study|required a prohibited medication|0|||
162933714|NCT00295854|588462309|FG002|Overall Study|required a prohibited medication|0|||
162933715|NCT00295854|588462307|FG000|Overall Study|Other|3|||
162933716|NCT00295854|588462308|FG001|Overall Study|Other|5|||
162933717|NCT00295854|588462309|FG002|Overall Study|Other|1|||
162933718|NCT01967888|588462311|FG000|Overall Study|Lost to Follow-up|6|||
162933719|NCT01967888|588462312|FG001|Overall Study|Lost to Follow-up|4|||
163178455|NCT04393298|589369212|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178456|NCT04393298|589369213|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178457|NCT04393298|589369214|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178458|NCT04393298|589369215|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178459|NCT04393298|589369216|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178460|NCT04393298|589369202|FG000|Overall Study|Progressive Disease (PD)|0|||
163178461|NCT04393298|589369203|FG001|Overall Study|Progressive Disease (PD)|0|||
163178462|NCT04393298|589369204|FG002|Overall Study|Progressive Disease (PD)|0|||
163178463|NCT04393298|589369205|FG003|Overall Study|Progressive Disease (PD)|3|||
163178464|NCT04393298|589369206|FG004|Overall Study|Progressive Disease (PD)|0|||
163178465|NCT04393298|589369207|FG005|Overall Study|Progressive Disease (PD)|0|||
163178466|NCT04393298|589369208|FG006|Overall Study|Progressive Disease (PD)|0|||
163178467|NCT04393298|589369209|FG007|Overall Study|Progressive Disease (PD)|0|||
163178468|NCT04393298|589369210|FG008|Overall Study|Progressive Disease (PD)|0|||
163178469|NCT04393298|589369211|FG009|Overall Study|Progressive Disease (PD)|0|||
163178470|NCT04393298|589369212|FG010|Overall Study|Progressive Disease (PD)|0|||
163178471|NCT04393298|589369213|FG011|Overall Study|Progressive Disease (PD)|0|||
163178472|NCT04393298|589369214|FG012|Overall Study|Progressive Disease (PD)|0|||
163283663|NCT05550337|589747570|FG001|Overall Study|Protocol Violation|3|||
162933720|NCT01967888|588462311|FG000|Overall Study|Withdrawal by Subject|1|||
162933721|NCT01967888|588462312|FG001|Overall Study|Withdrawal by Subject|1|||
162933722|NCT01967888|588462311|FG000|Overall Study|Did Not Have Transplant|1|||
162933723|NCT01967888|588462312|FG001|Overall Study|Did Not Have Transplant|0|||
163283664|NCT05550337|589747571|FG002|Overall Study|Protocol Violation|4|||
163283665|NCT05550337|589747569|FG000|Overall Study|Physician Decision|2|||
163283666|NCT05550337|589747570|FG001|Overall Study|Physician Decision|1|||
163283667|NCT05550337|589747571|FG002|Overall Study|Physician Decision|1|||
163283668|NCT05550337|589747569|FG000|Overall Study|Lost to Follow-up|16|||
163283669|NCT05550337|589747570|FG001|Overall Study|Lost to Follow-up|11|||
163283670|NCT05550337|589747571|FG002|Overall Study|Lost to Follow-up|11|||
163283671|NCT02189863|589747572|FG000|First 2 Weeks|Motion Sickness|4|||
163283672|NCT02189863|589747573|FG001|First 2 Weeks|Motion Sickness|2|||
163283673|NCT00813488|589747579|FG000|Titration Period 1|Adverse Event|6|||
163283674|NCT00813488|589747580|FG001|Titration Period 1|Adverse Event|1|||
163283675|NCT00813488|589747579|FG000|Titration Period 1|Lack of Efficacy|9|||
163283676|NCT00813488|589747580|FG001|Titration Period 1|Lack of Efficacy|7|||
163283677|NCT00813488|589747579|FG000|Titration Period 1|Withdrawal by Subject|2|||
163283678|NCT00813488|589747580|FG001|Titration Period 1|Withdrawal by Subject|2|||
163283679|NCT00813488|589747579|FG000|Titration Period 1|Protocol Violation|4|||
163283680|NCT00813488|589747580|FG001|Titration Period 1|Protocol Violation|3|||
163283681|NCT00813488|589747579|FG000|Titration Period 1|Non-compliance to study medication|4|||
163283682|NCT00813488|589747580|FG001|Titration Period 1|Non-compliance to study medication|1|||
163283683|NCT00813488|589747579|FG000|Titration Period 1|Non-compliance to study procedures|2|||
163283684|NCT00813488|589747580|FG001|Titration Period 1|Non-compliance to study procedures|2|||
163283685|NCT00813488|589747579|FG000|Titration Period 1|Technical Difficulties|0|||
163283686|NCT00813488|589747580|FG001|Titration Period 1|Technical Difficulties|1|||
163283687|NCT00813488|589747579|FG000|Titration Period 2|Adverse Event|2|||
163283688|NCT00813488|589747580|FG001|Titration Period 2|Adverse Event|3|||
163283689|NCT00813488|589747579|FG000|Titration Period 2|Lack of Efficacy|8|||
163283690|NCT00813488|589747580|FG001|Titration Period 2|Lack of Efficacy|4|||
163283691|NCT00813488|589747579|FG000|Titration Period 2|Protocol Violation|3|||
163283692|NCT00813488|589747580|FG001|Titration Period 2|Protocol Violation|2|||
163283693|NCT00813488|589747579|FG000|Titration Period 2|Lost to Follow-up|1|||
163283694|NCT00813488|589747580|FG001|Titration Period 2|Lost to Follow-up|0|||
163283695|NCT00813488|589747579|FG000|Titration Period 2|Non-compliance with study procedures|2|||
163283696|NCT00813488|589747580|FG001|Titration Period 2|Non-compliance with study procedures|1|||
163283697|NCT00813488|589747579|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
163283698|NCT00813488|589747580|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
163283699|NCT00813488|589747579|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
163283700|NCT00813488|589747580|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
163283701|NCT00813488|589747579|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
163283702|NCT00813488|589747580|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
163283703|NCT00813488|589747579|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
163283704|NCT00813488|589747580|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
163283705|NCT00813488|589747579|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
163283706|NCT00813488|589747580|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
163283707|NCT00813488|589747579|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
163283708|NCT00813488|589747580|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
163283709|NCT00813488|589747579|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
163283710|NCT00813488|589747580|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
163283711|NCT00813488|589747579|FG000|Double-blind Treatment Period 2|Other|1|||
163283712|NCT00813488|589747580|FG001|Double-blind Treatment Period 2|Other|0|||
163283713|NCT00813488|589747579|FG000|Open-label Extension|Adverse Event|1|||
163283714|NCT00813488|589747580|FG001|Open-label Extension|Adverse Event|2|||
163283715|NCT00813488|589747579|FG000|Open-label Extension|Lack of Efficacy|3|||
163283716|NCT00813488|589747580|FG001|Open-label Extension|Lack of Efficacy|0|||
163283717|NCT00813488|589747579|FG000|Open-label Extension|Withdrawal by Subject|0|||
163283718|NCT00813488|589747580|FG001|Open-label Extension|Withdrawal by Subject|2|||
163283719|NCT00813488|589747579|FG000|Open-label Extension|Protocol Violation|1|||
163283720|NCT00813488|589747580|FG001|Open-label Extension|Protocol Violation|2|||
163283721|NCT00813488|589747579|FG000|Open-label Extension|Non-compliance study medication|4|||
163283722|NCT00813488|589747580|FG001|Open-label Extension|Non-compliance study medication|0|||
163283723|NCT00813488|589747579|FG000|Open-label Extension|Non-compliance study procedures|2|||
163283724|NCT00813488|589747580|FG001|Open-label Extension|Non-compliance study procedures|1|||
163283725|NCT00813488|589747579|FG000|Open-label Extension|Other|1|||
163283726|NCT00813488|589747580|FG001|Open-label Extension|Other|0|||
163283727|NCT02926937|589747582|FG000|Overall Study|Adverse Event|0|||
163283728|NCT02926937|589747583|FG001|Overall Study|Adverse Event|1|||
163283729|NCT02926937|589747584|FG002|Overall Study|Adverse Event|1|||
163283730|NCT02926937|589747582|FG000|Overall Study|Poor Compliance to Protocol|1|||
163283731|NCT02926937|589747583|FG001|Overall Study|Poor Compliance to Protocol|0|||
163283732|NCT02926937|589747584|FG002|Overall Study|Poor Compliance to Protocol|0|||
163283733|NCT02926937|589747582|FG000|Overall Study|Lost to Follow-up|4|||
163283734|NCT02926937|589747583|FG001|Overall Study|Lost to Follow-up|5|||
163283735|NCT02926937|589747584|FG002|Overall Study|Lost to Follow-up|0|||
163283736|NCT02926937|589747582|FG000|Overall Study|At the Participant's own Request|11|||
162933724|NCT01967888|588462311|FG000|Overall Study|Research visit not done, data recorded|1|||
162933725|NCT01967888|588462312|FG001|Overall Study|Research visit not done, data recorded|0|||
162933726|NCT01967888|588462311|FG000|Overall Study|Subject excluded after randomization|1|||
162933727|NCT01967888|588462312|FG001|Overall Study|Subject excluded after randomization|0|||
162933728|NCT01967888|588462311|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
162933729|NCT01967888|588462312|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
162933730|NCT01967888|588462311|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
162933731|NCT01967888|588462312|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
162933732|NCT03175120|588462316|FG000|Overall Study|Adverse Event|2|||
162933733|NCT03175120|588462317|FG001|Overall Study|Adverse Event|2|||
162933734|NCT03175120|588462316|FG000|Overall Study|Protocol Violation|5|||
162933735|NCT03175120|588462317|FG001|Overall Study|Protocol Violation|2|||
162933736|NCT03175120|588462316|FG000|Overall Study|Lost to Follow-up|1|||
162933737|NCT03175120|588462317|FG001|Overall Study|Lost to Follow-up|0|||
162933738|NCT03175120|588462316|FG000|Overall Study|Withdrawal by Subject|2|||
162933739|NCT03175120|588462317|FG001|Overall Study|Withdrawal by Subject|5|||
162933740|NCT03175120|588462316|FG000|Overall Study|Other|2|||
162933741|NCT03175120|588462317|FG001|Overall Study|Other|3|||
162933742|NCT04120194|588462318|FG000|Overall Study|Lost to Follow-up|11|||
162933743|NCT04120194|588462319|FG001|Overall Study|Lost to Follow-up|8|||
162933744|NCT04120194|588462318|FG000|Overall Study|Adverse Event|4|||
162933745|NCT04120194|588462319|FG001|Overall Study|Adverse Event|5|||
162933746|NCT04120194|588462318|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
162933747|NCT04120194|588462319|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
162933748|NCT04120194|588462318|FG000|Overall Study|Miscellaneous|4|||
162933749|NCT04120194|588462319|FG001|Overall Study|Miscellaneous|5|||
162933750|NCT02622074|588462320|FG000|Overall Study|Death|4|||
162933751|NCT02622074|588462321|FG001|Overall Study|Death|0|||
162933752|NCT02622074|588462322|FG002|Overall Study|Death|0|||
162933753|NCT02622074|588462323|FG003|Overall Study|Death|1|||
162933754|NCT02622074|588462324|FG004|Overall Study|Death|1|||
162933755|NCT02622074|588462325|FG005|Overall Study|Death|0|||
162933756|NCT02622074|588462320|FG000|Overall Study|Withdrawal by Subject|0|||
162933757|NCT02622074|588462321|FG001|Overall Study|Withdrawal by Subject|1|||
162933758|NCT02622074|588462322|FG002|Overall Study|Withdrawal by Subject|0|||
162933759|NCT02622074|588462323|FG003|Overall Study|Withdrawal by Subject|0|||
162933760|NCT02622074|588462324|FG004|Overall Study|Withdrawal by Subject|0|||
162933761|NCT02622074|588462325|FG005|Overall Study|Withdrawal by Subject|0|||
162933762|NCT02114931|588462326|FG000|Overall Study|Withdrawal by Subject|15|||
162933763|NCT02114931|588462327|FG001|Overall Study|Withdrawal by Subject|18|||
162933764|NCT02114931|588462326|FG000|Overall Study|Adverse Event|4|||
162933765|NCT02114931|588462327|FG001|Overall Study|Adverse Event|6|||
162933766|NCT02114931|588462326|FG000|Overall Study|Lost to Follow-up|3|||
162933767|NCT02114931|588462327|FG001|Overall Study|Lost to Follow-up|3|||
162933768|NCT02114931|588462326|FG000|Overall Study|Physician Decision|1|||
162933769|NCT02114931|588462327|FG001|Overall Study|Physician Decision|2|||
162933770|NCT02114931|588462326|FG000|Overall Study|Other|2|||
162933771|NCT02114931|588462327|FG001|Overall Study|Other|1|||
162933772|NCT03565211|588462331|FG000|Overall Study|Withdrawal by Subject|2|||
162933773|NCT03565211|588462331|FG000|Overall Study|Lost to Follow-up|1|||
162933774|NCT03565211|588462331|FG000|Overall Study|Adverse Event|44|||
162933775|NCT03565211|588462331|FG000|Overall Study|Personal issues|1|||
162933776|NCT00986154|588462332|FG000|Overall Study|Death|136|||
162933777|NCT00986154|588462333|FG001|Overall Study|Death|127|||
162933778|NCT00986154|588462332|FG000|Overall Study|Lost to Follow-up|7|||
162933779|NCT00986154|588462333|FG001|Overall Study|Lost to Follow-up|4|||
162933780|NCT00986154|588462332|FG000|Overall Study|Withdrawal by Subject|32|||
162933781|NCT00986154|588462333|FG001|Overall Study|Withdrawal by Subject|33|||
162933782|NCT00986154|588462332|FG000|Overall Study|investigator/subject decide not continue|6|||
162933783|NCT00986154|588462333|FG001|Overall Study|investigator/subject decide not continue|3|||
162933784|NCT00986154|588462332|FG000|Overall Study|never received study drug|25|||
162933785|NCT00986154|588462333|FG001|Overall Study|never received study drug|27|||
162933786|NCT00267007|588462334|FG000|Overall Study|Withdrawal by Subject|6|||
162933787|NCT00267007|588462335|FG001|Overall Study|Withdrawal by Subject|0|||
162933788|NCT00267007|588462334|FG000|Overall Study|Lost to Follow-up|1|||
162933789|NCT00267007|588462335|FG001|Overall Study|Lost to Follow-up|0|||
162933790|NCT00267007|588462334|FG000|Overall Study|Non-compliance|0|||
162933791|NCT00267007|588462335|FG001|Overall Study|Non-compliance|1|||
162933792|NCT00267007|588462334|FG000|Overall Study|Adverse Event|1|||
162933793|NCT00267007|588462335|FG001|Overall Study|Adverse Event|0|||
162933794|NCT01684722|588462342|FG000|Overall Study|Lost to Follow-up|78|||
162933795|NCT01684722|588462343|FG001|Overall Study|Lost to Follow-up|56|||
162933796|NCT01684722|588462344|FG002|Overall Study|Lost to Follow-up|75|||
162933797|NCT01684722|588462345|FG003|Overall Study|Lost to Follow-up|89|||
162933798|NCT01684722|588462342|FG000|Overall Study|Death|19|||
162933799|NCT01684722|588462343|FG001|Overall Study|Death|21|||
162933800|NCT01684722|588462344|FG002|Overall Study|Death|19|||
162933801|NCT01684722|588462345|FG003|Overall Study|Death|21|||
162933802|NCT01664494|588462346|FG000|Overall Study|Withdrawal by Subject|27|||
162933803|NCT01664494|588462346|FG000|Overall Study|Death|18|||
162933804|NCT01664494|588462346|FG000|Overall Study|Other|49|||
162933805|NCT01664494|588462346|FG000|Overall Study|Lost to Follow-up|99|||
162933806|NCT00219557|588462347|FG000|Phase 1|Lack of Efficacy|3|||
162933807|NCT00219557|588462348|FG001|Phase 1|Lack of Efficacy|0|||
162933808|NCT00219557|588462349|FG002|Phase 1|Lack of Efficacy|0|||
162933809|NCT00219557|588462347|FG000|Phase 1|Adverse Event|2|||
162933810|NCT00219557|588462348|FG001|Phase 1|Adverse Event|0|||
162933811|NCT00219557|588462349|FG002|Phase 1|Adverse Event|0|||
162933812|NCT00219557|588462347|FG000|Phase 1|Withdrawal by Subject|1|||
162933813|NCT00219557|588462348|FG001|Phase 1|Withdrawal by Subject|0|||
162933814|NCT00219557|588462349|FG002|Phase 1|Withdrawal by Subject|0|||
162933815|NCT00219557|588462347|FG000|Phase 1|Started chemotherapy at other institute|1|||
162933816|NCT00219557|588462348|FG001|Phase 1|Started chemotherapy at other institute|0|||
162933817|NCT00219557|588462349|FG002|Phase 1|Started chemotherapy at other institute|0|||
162933818|NCT00219557|588462347|FG000|Phase 2|Lack of Efficacy|0|||
162933819|NCT00219557|588462348|FG001|Phase 2|Lack of Efficacy|21|||
162933820|NCT00219557|588462349|FG002|Phase 2|Lack of Efficacy|15|||
162933821|NCT00219557|588462347|FG000|Phase 2|Adverse Event|0|||
162933822|NCT00219557|588462348|FG001|Phase 2|Adverse Event|22|||
162933823|NCT00219557|588462349|FG002|Phase 2|Adverse Event|2|||
162933824|NCT00219557|588462347|FG000|Phase 2|Death|0|||
162933825|NCT00219557|588462348|FG001|Phase 2|Death|8|||
162933826|NCT00219557|588462349|FG002|Phase 2|Death|2|||
162933827|NCT00219557|588462347|FG000|Phase 2|Other|0|||
162933828|NCT00219557|588462348|FG001|Phase 2|Other|8|||
162933829|NCT00219557|588462349|FG002|Phase 2|Other|6|||
162933830|NCT00219557|588462347|FG000|Phase 2|Withdrawal by Subject|0|||
162933831|NCT00219557|588462348|FG001|Phase 2|Withdrawal by Subject|9|||
162933832|NCT00219557|588462349|FG002|Phase 2|Withdrawal by Subject|5|||
162933833|NCT00219557|588462347|FG000|Phase 2|Treatment not received|0|||
162933834|NCT00219557|588462348|FG001|Phase 2|Treatment not received|1|||
162933835|NCT00219557|588462349|FG002|Phase 2|Treatment not received|3|||
162933836|NCT03063632|588462350|FG000|Overall Study|Death|4|||
162933837|NCT03063632|588462351|FG001|Overall Study|Death|6|||
162933838|NCT03063632|588462350|FG000|Overall Study|Lost to Follow-up|0|||
162933839|NCT03063632|588462351|FG001|Overall Study|Lost to Follow-up|1|||
162933840|NCT03063632|588462350|FG000|Overall Study|Withdrawal by Subject|0|||
162933841|NCT03063632|588462351|FG001|Overall Study|Withdrawal by Subject|2|||
162933842|NCT03063632|588462350|FG000|Overall Study|Physician Decision|2|||
162933843|NCT03063632|588462351|FG001|Overall Study|Physician Decision|0|||
162933844|NCT03063632|588462350|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
162933845|NCT03063632|588462351|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
162933846|NCT01612156|588462352|FG000|Overall Study|Protocol Violation|2|||
162933847|NCT01612156|588462353|FG001|Overall Study|Protocol Violation|0|||
162933848|NCT00410410|588462354|FG000|Induction Period (IP)|Death|1|||
162933849|NCT00410410|588462355|FG001|Induction Period (IP)|Death|0|||
162933850|NCT00410410|588462356|FG002|Induction Period (IP)|Death|0|||
162933851|NCT00410410|588462357|FG003|Induction Period (IP)|Death|0|||
162933852|NCT00410410|588462358|FG004|Induction Period (IP)|Death|0|||
162933853|NCT00410410|588462359|FG005|Induction Period (IP)|Death|0|||
163178473|NCT04393298|589369215|FG013|Overall Study|Progressive Disease (PD)|0|||
163178474|NCT04393298|589369216|FG014|Overall Study|Progressive Disease (PD)|0|||
163178475|NCT04393298|589369202|FG000|Overall Study|Started a New Cancer Treatment|0|||
163178476|NCT04393298|589369203|FG001|Overall Study|Started a New Cancer Treatment|0|||
163178477|NCT04393298|589369204|FG002|Overall Study|Started a New Cancer Treatment|0|||
163178478|NCT04393298|589369205|FG003|Overall Study|Started a New Cancer Treatment|0|||
163178479|NCT04393298|589369206|FG004|Overall Study|Started a New Cancer Treatment|1|||
163178480|NCT04393298|589369207|FG005|Overall Study|Started a New Cancer Treatment|0|||
163178481|NCT04393298|589369208|FG006|Overall Study|Started a New Cancer Treatment|0|||
163178482|NCT04393298|589369209|FG007|Overall Study|Started a New Cancer Treatment|0|||
162933854|NCT00410410|588462360|FG006|Induction Period (IP)|Death|0|||
163178483|NCT04393298|589369210|FG008|Overall Study|Started a New Cancer Treatment|0|||
162933855|NCT00410410|588462361|FG007|Induction Period (IP)|Death|0|||
162933856|NCT00410410|588462362|FG008|Induction Period (IP)|Death|0|||
162933857|NCT00410410|588462354|FG000|Induction Period (IP)|Adverse Event|3|||
162933858|NCT00410410|588462355|FG001|Induction Period (IP)|Adverse Event|4|||
162933859|NCT00410410|588462356|FG002|Induction Period (IP)|Adverse Event|2|||
162933860|NCT00410410|588462357|FG003|Induction Period (IP)|Adverse Event|4|||
162933861|NCT00410410|588462358|FG004|Induction Period (IP)|Adverse Event|1|||
162933862|NCT00410410|588462359|FG005|Induction Period (IP)|Adverse Event|0|||
162933863|NCT00410410|588462360|FG006|Induction Period (IP)|Adverse Event|0|||
162933864|NCT00410410|588462361|FG007|Induction Period (IP)|Adverse Event|0|||
162933865|NCT00410410|588462362|FG008|Induction Period (IP)|Adverse Event|0|||
162933866|NCT00410410|588462354|FG000|Induction Period (IP)|Lack of Efficacy|26|||
162933867|NCT00410410|588462355|FG001|Induction Period (IP)|Lack of Efficacy|24|||
162933868|NCT00410410|588462356|FG002|Induction Period (IP)|Lack of Efficacy|8|||
162933869|NCT00410410|588462357|FG003|Induction Period (IP)|Lack of Efficacy|8|||
162933870|NCT00410410|588462358|FG004|Induction Period (IP)|Lack of Efficacy|7|||
162933871|NCT00410410|588462359|FG005|Induction Period (IP)|Lack of Efficacy|7|||
162933872|NCT00410410|588462360|FG006|Induction Period (IP)|Lack of Efficacy|0|||
162933873|NCT00410410|588462361|FG007|Induction Period (IP)|Lack of Efficacy|0|||
162933874|NCT00410410|588462362|FG008|Induction Period (IP)|Lack of Efficacy|0|||
162933875|NCT00410410|588462354|FG000|Induction Period (IP)|Lost to Follow-up|2|||
162933876|NCT00410410|588462355|FG001|Induction Period (IP)|Lost to Follow-up|2|||
162933877|NCT00410410|588462356|FG002|Induction Period (IP)|Lost to Follow-up|2|||
162933878|NCT00410410|588462357|FG003|Induction Period (IP)|Lost to Follow-up|3|||
162933879|NCT00410410|588462358|FG004|Induction Period (IP)|Lost to Follow-up|0|||
162933880|NCT00410410|588462359|FG005|Induction Period (IP)|Lost to Follow-up|1|||
162933881|NCT00410410|588462360|FG006|Induction Period (IP)|Lost to Follow-up|0|||
162933882|NCT00410410|588462361|FG007|Induction Period (IP)|Lost to Follow-up|0|||
162933883|NCT00410410|588462362|FG008|Induction Period (IP)|Lost to Follow-up|0|||
162933884|NCT00410410|588462354|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
162933885|NCT00410410|588462355|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
162933886|NCT00410410|588462356|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
162933887|NCT00410410|588462357|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
162933888|NCT00410410|588462358|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
162933889|NCT00410410|588462359|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
162933890|NCT00410410|588462360|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
162933891|NCT00410410|588462361|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
162933892|NCT00410410|588462362|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
162933893|NCT00410410|588462354|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933894|NCT00410410|588462355|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933895|NCT00410410|588462356|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
162933896|NCT00410410|588462357|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933897|NCT00410410|588462358|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933898|NCT00410410|588462359|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933899|NCT00410410|588462360|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933900|NCT00410410|588462361|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933901|NCT00410410|588462362|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933902|NCT00410410|588462354|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
162933903|NCT00410410|588462355|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
162933904|NCT00410410|588462356|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
162933905|NCT00410410|588462357|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
162933906|NCT00410410|588462358|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
162933907|NCT00410410|588462359|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
162933908|NCT00410410|588462360|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
162933909|NCT00410410|588462361|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
162933910|NCT00410410|588462362|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
162933911|NCT00410410|588462354|FG000|Induction Period (IP)|Other|0|||
162933912|NCT00410410|588462355|FG001|Induction Period (IP)|Other|0|||
162933913|NCT00410410|588462356|FG002|Induction Period (IP)|Other|1|||
162933914|NCT00410410|588462357|FG003|Induction Period (IP)|Other|0|||
162933915|NCT00410410|588462358|FG004|Induction Period (IP)|Other|0|||
162933916|NCT00410410|588462359|FG005|Induction Period (IP)|Other|0|||
162933917|NCT00410410|588462360|FG006|Induction Period (IP)|Other|0|||
162933918|NCT00410410|588462361|FG007|Induction Period (IP)|Other|0|||
162933919|NCT00410410|588462362|FG008|Induction Period (IP)|Other|0|||
162933920|NCT00410410|588462354|FG000|Maintenance Period (MP)|Death|0|||
162933921|NCT00410410|588462355|FG001|Maintenance Period (MP)|Death|0|||
162933922|NCT00410410|588462356|FG002|Maintenance Period (MP)|Death|0|||
162933923|NCT00410410|588462357|FG003|Maintenance Period (MP)|Death|0|||
162933924|NCT00410410|588462358|FG004|Maintenance Period (MP)|Death|0|||
162933925|NCT00410410|588462359|FG005|Maintenance Period (MP)|Death|0|||
162933926|NCT00410410|588462360|FG006|Maintenance Period (MP)|Death|1|||
162933927|NCT00410410|588462361|FG007|Maintenance Period (MP)|Death|0|||
162933928|NCT00410410|588462362|FG008|Maintenance Period (MP)|Death|0|||
162933929|NCT00410410|588462354|FG000|Maintenance Period (MP)|Adverse Event|0|||
162933930|NCT00410410|588462355|FG001|Maintenance Period (MP)|Adverse Event|0|||
163178484|NCT04393298|589369211|FG009|Overall Study|Started a New Cancer Treatment|0|||
162933931|NCT00410410|588462356|FG002|Maintenance Period (MP)|Adverse Event|0|||
162933932|NCT00410410|588462357|FG003|Maintenance Period (MP)|Adverse Event|0|||
162933933|NCT00410410|588462358|FG004|Maintenance Period (MP)|Adverse Event|0|||
163178485|NCT04393298|589369212|FG010|Overall Study|Started a New Cancer Treatment|0|||
163178486|NCT04393298|589369213|FG011|Overall Study|Started a New Cancer Treatment|0|||
162933934|NCT00410410|588462359|FG005|Maintenance Period (MP)|Adverse Event|0|||
162933935|NCT00410410|588462360|FG006|Maintenance Period (MP)|Adverse Event|1|||
162933936|NCT00410410|588462361|FG007|Maintenance Period (MP)|Adverse Event|3|||
162933937|NCT00410410|588462362|FG008|Maintenance Period (MP)|Adverse Event|0|||
162933938|NCT00410410|588462354|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
162933939|NCT00410410|588462355|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
162933940|NCT00410410|588462356|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
162933941|NCT00410410|588462357|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
162933942|NCT00410410|588462358|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
162933943|NCT00410410|588462359|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
162933944|NCT00410410|588462360|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
162933945|NCT00410410|588462361|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
162933946|NCT00410410|588462362|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
162933947|NCT00410410|588462354|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
162933948|NCT00410410|588462355|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
162933949|NCT00410410|588462356|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
162933950|NCT00410410|588462357|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
162933951|NCT00410410|588462358|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
162933952|NCT00410410|588462359|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
162933953|NCT00410410|588462360|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
162933954|NCT00410410|588462361|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
162933955|NCT00410410|588462362|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
162933956|NCT00410410|588462354|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
162933957|NCT00410410|588462355|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
162933958|NCT00410410|588462356|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
162933959|NCT00410410|588462357|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
162933960|NCT00410410|588462358|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
162933961|NCT00410410|588462359|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
162933962|NCT00410410|588462360|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
162933963|NCT00410410|588462361|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
162933964|NCT00410410|588462362|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
162933965|NCT00410410|588462354|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
162933966|NCT00410410|588462355|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
162933967|NCT00410410|588462356|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
162933968|NCT00410410|588462357|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
162933969|NCT00410410|588462358|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
162933970|NCT00410410|588462359|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
162933971|NCT00410410|588462360|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
162933972|NCT00410410|588462361|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
162933973|NCT00410410|588462362|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
162933974|NCT00410410|588462354|FG000|Open-Label Period (OL)|Death|0|||
162933975|NCT00410410|588462355|FG001|Open-Label Period (OL)|Death|0|||
162933976|NCT00410410|588462356|FG002|Open-Label Period (OL)|Death|0|||
162933977|NCT00410410|588462357|FG003|Open-Label Period (OL)|Death|0|||
162933978|NCT00410410|588462358|FG004|Open-Label Period (OL)|Death|0|||
162933979|NCT00410410|588462359|FG005|Open-Label Period (OL)|Death|0|||
162933980|NCT00410410|588462360|FG006|Open-Label Period (OL)|Death|0|||
162933981|NCT00410410|588462361|FG007|Open-Label Period (OL)|Death|0|||
162933982|NCT00410410|588462362|FG008|Open-Label Period (OL)|Death|1|||
162933983|NCT00410410|588462354|FG000|Open-Label Period (OL)|Adverse Event|0|||
162933984|NCT00410410|588462355|FG001|Open-Label Period (OL)|Adverse Event|0|||
162933985|NCT00410410|588462356|FG002|Open-Label Period (OL)|Adverse Event|0|||
162933986|NCT00410410|588462357|FG003|Open-Label Period (OL)|Adverse Event|0|||
162933987|NCT00410410|588462358|FG004|Open-Label Period (OL)|Adverse Event|0|||
162933988|NCT00410410|588462359|FG005|Open-Label Period (OL)|Adverse Event|0|||
162933989|NCT00410410|588462360|FG006|Open-Label Period (OL)|Adverse Event|0|||
162933990|NCT00410410|588462361|FG007|Open-Label Period (OL)|Adverse Event|0|||
162933991|NCT00410410|588462362|FG008|Open-Label Period (OL)|Adverse Event|10|||
162933992|NCT00410410|588462354|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
162933993|NCT00410410|588462355|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
162933994|NCT00410410|588462356|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
162933995|NCT00410410|588462357|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
162933996|NCT00410410|588462358|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
162933997|NCT00410410|588462359|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
162933998|NCT00410410|588462360|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
162933999|NCT00410410|588462361|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
162934000|NCT00410410|588462362|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
162934001|NCT00410410|588462354|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
162934002|NCT00410410|588462355|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
162934003|NCT00410410|588462356|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
162934004|NCT00410410|588462357|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
162934005|NCT00410410|588462358|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
162934006|NCT00410410|588462359|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
162934007|NCT00410410|588462360|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
162934008|NCT00410410|588462361|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
162934009|NCT00410410|588462362|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
162934010|NCT00410410|588462354|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934011|NCT00410410|588462355|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934012|NCT00410410|588462356|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934013|NCT00410410|588462357|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934014|NCT00410410|588462358|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934015|NCT00410410|588462359|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934016|NCT00410410|588462360|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934017|NCT00410410|588462361|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934018|NCT00410410|588462362|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
162934019|NCT00410410|588462354|FG000|Open-Label Period (OL)|Pregnancy|0|||
162934020|NCT00410410|588462355|FG001|Open-Label Period (OL)|Pregnancy|0|||
162934021|NCT00410410|588462356|FG002|Open-Label Period (OL)|Pregnancy|0|||
162934022|NCT00410410|588462357|FG003|Open-Label Period (OL)|Pregnancy|0|||
162934023|NCT00410410|588462358|FG004|Open-Label Period (OL)|Pregnancy|0|||
162934024|NCT00410410|588462359|FG005|Open-Label Period (OL)|Pregnancy|0|||
162934025|NCT00410410|588462360|FG006|Open-Label Period (OL)|Pregnancy|0|||
162934026|NCT00410410|588462361|FG007|Open-Label Period (OL)|Pregnancy|0|||
162934027|NCT00410410|588462362|FG008|Open-Label Period (OL)|Pregnancy|1|||
162934028|NCT00410410|588462354|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934029|NCT00410410|588462355|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934030|NCT00410410|588462356|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934031|NCT00410410|588462357|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934032|NCT00410410|588462358|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934033|NCT00410410|588462359|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934034|NCT00410410|588462360|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934035|NCT00410410|588462361|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934036|NCT00410410|588462362|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
162934037|NCT00410410|588462354|FG000|Open-Label Period (OL)|Other|0|||
162934038|NCT00410410|588462355|FG001|Open-Label Period (OL)|Other|0|||
162934039|NCT00410410|588462356|FG002|Open-Label Period (OL)|Other|0|||
162934040|NCT00410410|588462357|FG003|Open-Label Period (OL)|Other|0|||
162934041|NCT00410410|588462358|FG004|Open-Label Period (OL)|Other|0|||
162934042|NCT00410410|588462359|FG005|Open-Label Period (OL)|Other|0|||
162934043|NCT00410410|588462360|FG006|Open-Label Period (OL)|Other|0|||
162934044|NCT00410410|588462361|FG007|Open-Label Period (OL)|Other|0|||
162934045|NCT00410410|588462362|FG008|Open-Label Period (OL)|Other|7|||
162934046|NCT01783496|588462363|FG000|Overall Study|Lost to Follow-up|0|||
162934047|NCT01783496|588462364|FG001|Overall Study|Lost to Follow-up|0|||
162934048|NCT01783496|588462365|FG002|Overall Study|Lost to Follow-up|0|||
162934049|NCT01783496|588462366|FG003|Overall Study|Lost to Follow-up|2|||
162934050|NCT01783496|588462367|FG004|Overall Study|Lost to Follow-up|0|||
162934051|NCT01783496|588462368|FG005|Overall Study|Lost to Follow-up|1|||
162934052|NCT01783496|588462363|FG000|Overall Study|Withdrawal by Subject|1|||
162934053|NCT01783496|588462364|FG001|Overall Study|Withdrawal by Subject|0|||
162934054|NCT01783496|588462365|FG002|Overall Study|Withdrawal by Subject|0|||
162934055|NCT01783496|588462366|FG003|Overall Study|Withdrawal by Subject|0|||
162934056|NCT01783496|588462367|FG004|Overall Study|Withdrawal by Subject|0|||
162934057|NCT01783496|588462368|FG005|Overall Study|Withdrawal by Subject|0|||
162934058|NCT01023269|588462369|FG000|Overall Study|early termination of the study|2|||
162934059|NCT01023269|588462370|FG001|Overall Study|early termination of the study|0|||
162934060|NCT00106028|588462371|FG000|Overall Study|Adverse Event|3|||
162934061|NCT00106028|588462372|FG001|Overall Study|Adverse Event|2|||
162934062|NCT00106028|588462371|FG000|Overall Study|Protocol Violation|1|||
162934063|NCT00106028|588462372|FG001|Overall Study|Protocol Violation|1|||
162934064|NCT00106028|588462371|FG000|Overall Study|Withdrawal by Subject|2|||
162934065|NCT00106028|588462372|FG001|Overall Study|Withdrawal by Subject|8|||
162934066|NCT00106028|588462371|FG000|Overall Study|Lost to Follow-up|0|||
162934067|NCT00106028|588462372|FG001|Overall Study|Lost to Follow-up|1|||
162934068|NCT00947011|588462373|FG000|Overall Study|Study was terminated,PI left institution|12|||
162934069|NCT05266456|588462376|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
162934070|NCT05266456|588462377|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
162934071|NCT05266456|588462378|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
162934072|NCT05266456|588462379|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
162934073|NCT05266456|588462376|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
162934074|NCT05266456|588462377|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
162934075|NCT05266456|588462378|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
162934076|NCT05266456|588462379|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
162934077|NCT05266456|588462376|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
162934078|NCT05266456|588462377|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
162934079|NCT05266456|588462378|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
162934080|NCT05266456|588462379|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
162934081|NCT05266456|588462376|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
162934082|NCT05266456|588462377|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
162934083|NCT05266456|588462378|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
162934084|NCT05266456|588462379|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
162934085|NCT05266456|588462376|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
163178487|NCT04393298|589369214|FG012|Overall Study|Started a New Cancer Treatment|0|||
163178488|NCT04393298|589369215|FG013|Overall Study|Started a New Cancer Treatment|0|||
163178489|NCT04393298|589369216|FG014|Overall Study|Started a New Cancer Treatment|0|||
163178490|NCT04393298|589369202|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178491|NCT04393298|589369203|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178492|NCT04393298|589369204|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178493|NCT04393298|589369205|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178494|NCT04393298|589369206|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
163178495|NCT04393298|589369207|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163283737|NCT02926937|589747583|FG001|Overall Study|At the Participant's own Request|5|||
163283738|NCT02926937|589747584|FG002|Overall Study|At the Participant's own Request|8|||
163283739|NCT02926937|589747582|FG000|Overall Study|Reason not Specified|3|||
163283740|NCT02926937|589747583|FG001|Overall Study|Reason not Specified|4|||
163283741|NCT02926937|589747584|FG002|Overall Study|Reason not Specified|2|||
163283742|NCT01559090|589747585|FG000|Stage I|Withdrawal by Subject|2|||
163283743|NCT01559090|589747586|FG001|Stage I|Withdrawal by Subject|2|||
163283744|NCT01559090|589747587|FG002|Stage I|Withdrawal by Subject|3|||
163283745|NCT01559090|589747585|FG000|Stage II|Withdrawal by Subject|1|||
163283746|NCT01559090|589747586|FG001|Stage II|Withdrawal by Subject|0|||
163283747|NCT01559090|589747587|FG002|Stage II|Withdrawal by Subject|0|||
163283748|NCT03499600|589747591|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
163283749|NCT03499600|589747592|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
163283750|NCT00561574|589747593|FG000|Overall Study|Adverse Event|21|||
163283751|NCT00561574|589747594|FG001|Overall Study|Adverse Event|24|||
163283752|NCT00561574|589747593|FG000|Overall Study|Lack of Efficacy|11|||
162934086|NCT05266456|588462377|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
162934087|NCT05266456|588462378|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
162934088|NCT05266456|588462379|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
162934089|NCT02746705|588462386|FG000|Overall Study|Physician Decision|1|||
162934090|NCT02746705|588462387|FG001|Overall Study|Physician Decision|1|||
162934091|NCT02746705|588462386|FG000|Overall Study|Lost to Follow-up|1|||
162934092|NCT02746705|588462387|FG001|Overall Study|Lost to Follow-up|0|||
162934093|NCT02746705|588462386|FG000|Overall Study|outlier scores deemed not valid|0|||
162934094|NCT02746705|588462387|FG001|Overall Study|outlier scores deemed not valid|1|||
162934095|NCT00479401|588462388|FG000|Overall Study|Adverse Event|24|||
162934096|NCT00479401|588462389|FG001|Overall Study|Adverse Event|20|||
162934097|NCT00479401|588462390|FG002|Overall Study|Adverse Event|4|||
162934098|NCT00479401|588462388|FG000|Overall Study|Lack of Efficacy|2|||
162934099|NCT00479401|588462389|FG001|Overall Study|Lack of Efficacy|2|||
162934100|NCT00479401|588462390|FG002|Overall Study|Lack of Efficacy|4|||
162934101|NCT00479401|588462388|FG000|Overall Study|Protocol Violation|2|||
162934102|NCT00479401|588462389|FG001|Overall Study|Protocol Violation|1|||
162934103|NCT00479401|588462390|FG002|Overall Study|Protocol Violation|1|||
162934104|NCT00479401|588462388|FG000|Overall Study|Lost to Follow-up|1|||
162934105|NCT00479401|588462389|FG001|Overall Study|Lost to Follow-up|1|||
162934106|NCT00479401|588462390|FG002|Overall Study|Lost to Follow-up|1|||
162934107|NCT00479401|588462388|FG000|Overall Study|Withdrawal by Subject|16|||
162934108|NCT00479401|588462389|FG001|Overall Study|Withdrawal by Subject|10|||
162934109|NCT00479401|588462390|FG002|Overall Study|Withdrawal by Subject|2|||
162934110|NCT00479401|588462388|FG000|Overall Study|Exclusion criteria, relocation|4|||
162934111|NCT00479401|588462389|FG001|Overall Study|Exclusion criteria, relocation|3|||
162934112|NCT00479401|588462390|FG002|Overall Study|Exclusion criteria, relocation|0|||
162934113|NCT01504867|588462391|FG000|Overall Study|Inclusion criteria not met|2|||
162934114|NCT01504867|588462392|FG001|Overall Study|Inclusion criteria not met|2|||
162934115|NCT01504867|588462391|FG000|Overall Study|Consent revoked|5|||
162934116|NCT01504867|588462392|FG001|Overall Study|Consent revoked|1|||
162934117|NCT00378482|588462399|FG000|Overall Study|Lost to Follow-up|1|||
162934118|NCT00378482|588462399|FG000|Overall Study|Lack of Efficacy|8|||
162934119|NCT00378482|588462399|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
162934120|NCT00378482|588462399|FG000|Overall Study|Withdrawal by Subject|4|||
162934121|NCT00378482|588462399|FG000|Overall Study|Adverse Event|9|||
162934122|NCT00928252|588464275|FG000|Overall Study|Physician Decision|3|||
162934123|NCT02257632|588464276|FG000|Overall Study|Withdrawal by Subject|0|||
162934124|NCT02257632|588464277|FG001|Overall Study|Withdrawal by Subject|1|||
162934125|NCT02257632|588464276|FG000|Overall Study|Adverse Event|1|||
162934126|NCT02257632|588464277|FG001|Overall Study|Adverse Event|2|||
162934127|NCT00720798|588464281|FG000|Overall Study|Adverse Event|304|||
162934128|NCT00720798|588464281|FG000|Overall Study|Death|39|||
162934129|NCT00720798|588464281|FG000|Overall Study|Insufficient Therapeutic Response|129|||
162934130|NCT00720798|588464281|FG000|Overall Study|Protocol Violation|4|||
163178496|NCT04393298|589369208|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178497|NCT04393298|589369209|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178498|NCT04393298|589369210|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178499|NCT04393298|589369211|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178500|NCT04393298|589369212|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178501|NCT04393298|589369213|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178502|NCT04393298|589369214|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178503|NCT04393298|589369215|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178504|NCT04393298|589369216|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178505|NCT04393298|589369202|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178506|NCT04393298|589369203|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178507|NCT04393298|589369204|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178508|NCT04393298|589369205|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178509|NCT04393298|589369206|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178510|NCT04393298|589369207|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
163178511|NCT04393298|589369208|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178512|NCT04393298|589369209|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178513|NCT04393298|589369210|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
162934131|NCT00720798|588464281|FG000|Overall Study|Refused Treatment|151|||
163178514|NCT04393298|589369211|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
162934132|NCT00720798|588464281|FG000|Overall Study|Failure to Return|46|||
162934133|NCT00720798|588464281|FG000|Overall Study|Reason not Specified|83|||
162934134|NCT02806232|588464284|FG000|Overall Study|Lost to Follow-up|1|||
162934135|NCT02806232|588464285|FG001|Overall Study|Lost to Follow-up|2|||
162934136|NCT02806232|588464286|FG002|Overall Study|Lost to Follow-up|1|||
162934137|NCT02806232|588464287|FG003|Overall Study|Lost to Follow-up|0|||
162934138|NCT02806232|588464288|FG004|Overall Study|Lost to Follow-up|0|||
162934139|NCT02806232|588464289|FG005|Overall Study|Lost to Follow-up|1|||
163283753|NCT00561574|589747594|FG001|Overall Study|Lack of Efficacy|21|||
163283754|NCT00561574|589747593|FG000|Overall Study|Withdrawal by Subject|4|||
163283755|NCT00561574|589747594|FG001|Overall Study|Withdrawal by Subject|4|||
163283756|NCT00561574|589747593|FG000|Overall Study|Reason Unrelated to Trial|6|||
163283757|NCT00561574|589747594|FG001|Overall Study|Reason Unrelated to Trial|2|||
163283758|NCT00561574|589747593|FG000|Overall Study|Lost to Follow-up|1|||
163283759|NCT00561574|589747594|FG001|Overall Study|Lost to Follow-up|0|||
163283760|NCT00561574|589747593|FG000|Overall Study|Other|5|||
163283761|NCT00561574|589747594|FG001|Overall Study|Other|7|||
163283762|NCT00445692|589747595|FG000|Overall Study|Adverse Event|11|||
163283763|NCT00445692|589747595|FG000|Overall Study|Lack of Efficacy|5|||
163283764|NCT01729871|589747596|FG000|Overall Study|Adverse Event|7|||
163283765|NCT01729871|589747597|FG001|Overall Study|Adverse Event|7|||
163283766|NCT01729871|589747596|FG000|Overall Study|Death|0|||
162934140|NCT02806232|588464290|FG006|Overall Study|Lost to Follow-up|0|||
162934141|NCT02806232|588464291|FG007|Overall Study|Lost to Follow-up|0|||
162934142|NCT02806232|588464292|FG008|Overall Study|Lost to Follow-up|0|||
162934143|NCT02806232|588464284|FG000|Overall Study|Withdrawal by Subject|0|||
162934144|NCT02806232|588464285|FG001|Overall Study|Withdrawal by Subject|2|||
162934145|NCT02806232|588464286|FG002|Overall Study|Withdrawal by Subject|0|||
162934146|NCT02806232|588464287|FG003|Overall Study|Withdrawal by Subject|0|||
162934147|NCT02806232|588464288|FG004|Overall Study|Withdrawal by Subject|2|||
162934148|NCT02806232|588464289|FG005|Overall Study|Withdrawal by Subject|1|||
162934149|NCT02806232|588464290|FG006|Overall Study|Withdrawal by Subject|0|||
162934150|NCT02806232|588464291|FG007|Overall Study|Withdrawal by Subject|0|||
162934151|NCT02806232|588464292|FG008|Overall Study|Withdrawal by Subject|0|||
162934152|NCT01133821|588464293|FG000|Overall Study|Lost to Follow-up|8|||
162934153|NCT01133821|588464294|FG001|Overall Study|Lost to Follow-up|11|||
162934154|NCT01133821|588464293|FG000|Overall Study|Withdrawal by Subject|8|||
162934155|NCT01133821|588464294|FG001|Overall Study|Withdrawal by Subject|3|||
162934156|NCT01133821|588464293|FG000|Overall Study|preferred other treatment|1|||
162934157|NCT01133821|588464294|FG001|Overall Study|preferred other treatment|1|||
162934158|NCT01133821|588464293|FG000|Overall Study|Protocol Violation|0|||
162934159|NCT01133821|588464294|FG001|Overall Study|Protocol Violation|1|||
162934160|NCT01133821|588464293|FG000|Overall Study|Refused participation|1|||
162934161|NCT01133821|588464294|FG001|Overall Study|Refused participation|3|||
162934162|NCT00434161|588464295|FG000|Overall Study|Adverse Event|5|||
162934163|NCT00434161|588464296|FG001|Overall Study|Adverse Event|1|||
162934164|NCT00434161|588464297|FG002|Overall Study|Adverse Event|4|||
162934165|NCT00434161|588464295|FG000|Overall Study|Lost to Follow-up|0|||
162934166|NCT00434161|588464296|FG001|Overall Study|Lost to Follow-up|1|||
162934167|NCT00434161|588464297|FG002|Overall Study|Lost to Follow-up|0|||
162934168|NCT00434161|588464295|FG000|Overall Study|Death|1|||
162934169|NCT00434161|588464296|FG001|Overall Study|Death|0|||
162934170|NCT00434161|588464297|FG002|Overall Study|Death|1|||
162934171|NCT00434161|588464295|FG000|Overall Study|Non-Compliance|1|||
162934172|NCT00434161|588464296|FG001|Overall Study|Non-Compliance|1|||
162934173|NCT00434161|588464297|FG002|Overall Study|Non-Compliance|0|||
162934174|NCT00434161|588464295|FG000|Overall Study|Withdrawal by Subject|2|||
162934175|NCT00434161|588464296|FG001|Overall Study|Withdrawal by Subject|0|||
162934176|NCT00434161|588464297|FG002|Overall Study|Withdrawal by Subject|3|||
162934177|NCT00434161|588464295|FG000|Overall Study|Logistical error study assessments|1|||
162934178|NCT00434161|588464296|FG001|Overall Study|Logistical error study assessments|0|||
162934179|NCT00434161|588464297|FG002|Overall Study|Logistical error study assessments|3|||
162934180|NCT03342898|588464298|FG000|Overall Study|Adverse Event|3|||
162934181|NCT03342898|588464299|FG001|Overall Study|Adverse Event|1|||
162934182|NCT03342898|588464300|FG002|Overall Study|Adverse Event|0|||
162934183|NCT03342898|588464298|FG000|Overall Study|Lost to Follow-up|44|||
162934184|NCT03342898|588464299|FG001|Overall Study|Lost to Follow-up|40|||
163283767|NCT01729871|589747597|FG001|Overall Study|Death|1|||
163283768|NCT01729871|589747596|FG000|Overall Study|Lack of Efficacy|0|||
162934185|NCT03342898|588464300|FG002|Overall Study|Lost to Follow-up|42|||
162934186|NCT03342898|588464298|FG000|Overall Study|Withdrawal of Consent|5|||
163042827|NCT01990768|588863968|FG000|6-Month Follow-up|No contact information|5|||
163283769|NCT01729871|589747597|FG001|Overall Study|Lack of Efficacy|1|||
163283770|NCT01729871|589747596|FG000|Overall Study|Physician Decision|0|||
162934187|NCT03342898|588464299|FG001|Overall Study|Withdrawal of Consent|9|||
162934188|NCT03342898|588464300|FG002|Overall Study|Withdrawal of Consent|11|||
162934189|NCT03342898|588464298|FG000|Overall Study|Death|0|||
162934190|NCT03342898|588464299|FG001|Overall Study|Death|1|||
162934191|NCT03342898|588464300|FG002|Overall Study|Death|1|||
162934192|NCT03342898|588464298|FG000|Overall Study|Reason not Specified|2|||
162934193|NCT03342898|588464299|FG001|Overall Study|Reason not Specified|2|||
162934194|NCT03342898|588464300|FG002|Overall Study|Reason not Specified|0|||
162934195|NCT03997448|588464301|FG000|Study Treatment|Disease Progression|1|||
162934196|NCT03997448|588464301|FG000|Study Treatment|Symptomatic Deterioration|1|||
162934197|NCT03997448|588464301|FG000|Follow up|Death|2|||
162934198|NCT03997448|588464301|FG000|Follow up|study terminated|1|||
163283771|NCT01729871|589747597|FG001|Overall Study|Physician Decision|2|||
163283772|NCT01729871|589747596|FG000|Overall Study|Protocol Violation|1|||
162934199|NCT01312779|588464302|FG000|Overall Study|Withdrawal by Subject|2|||
162934200|NCT01312779|588464302|FG000|Overall Study|Death|3|||
162934201|NCT01312779|588464302|FG000|Overall Study|Not Implanted with Device|27|||
162934202|NCT01621490|588464303|FG000|Overall Study|Subject no longer meets study criteria|0|||
162934203|NCT01621490|588464304|FG001|Overall Study|Subject no longer meets study criteria|0|||
162934204|NCT01621490|588464305|FG002|Overall Study|Subject no longer meets study criteria|0|||
162934205|NCT01621490|588464306|FG003|Overall Study|Subject no longer meets study criteria|0|||
162934206|NCT01621490|588464307|FG004|Overall Study|Subject no longer meets study criteria|1|||
162934207|NCT01621490|588464308|FG005|Overall Study|Subject no longer meets study criteria|0|||
162934208|NCT01621490|588464309|FG006|Overall Study|Subject no longer meets study criteria|0|||
162934209|NCT01621490|588464310|FG007|Overall Study|Subject no longer meets study criteria|0|||
162934210|NCT01621490|588464311|FG008|Overall Study|Subject no longer meets study criteria|0|||
162934211|NCT01621490|588464312|FG009|Overall Study|Subject no longer meets study criteria|0|||
162934212|NCT01621490|588464313|FG010|Overall Study|Subject no longer meets study criteria|0|||
162934213|NCT01621490|588464303|FG000|Overall Study|Maximum clinical benefit|3|||
162934214|NCT01621490|588464304|FG001|Overall Study|Maximum clinical benefit|2|||
162934215|NCT01621490|588464305|FG002|Overall Study|Maximum clinical benefit|0|||
162934216|NCT01621490|588464306|FG003|Overall Study|Maximum clinical benefit|0|||
162934217|NCT01621490|588464307|FG004|Overall Study|Maximum clinical benefit|0|||
162934218|NCT01621490|588464308|FG005|Overall Study|Maximum clinical benefit|0|||
162934219|NCT01621490|588464309|FG006|Overall Study|Maximum clinical benefit|1|||
162934220|NCT01621490|588464310|FG007|Overall Study|Maximum clinical benefit|2|||
162934221|NCT01621490|588464311|FG008|Overall Study|Maximum clinical benefit|2|||
162934222|NCT01621490|588464312|FG009|Overall Study|Maximum clinical benefit|0|||
162934223|NCT01621490|588464313|FG010|Overall Study|Maximum clinical benefit|0|||
162934224|NCT01621490|588464303|FG000|Overall Study|Withdrawal by Subject|1|||
162934225|NCT01621490|588464304|FG001|Overall Study|Withdrawal by Subject|0|||
162934226|NCT01621490|588464305|FG002|Overall Study|Withdrawal by Subject|0|||
162934227|NCT01621490|588464306|FG003|Overall Study|Withdrawal by Subject|0|||
162934228|NCT01621490|588464307|FG004|Overall Study|Withdrawal by Subject|0|||
162934229|NCT01621490|588464308|FG005|Overall Study|Withdrawal by Subject|1|||
162934230|NCT01621490|588464309|FG006|Overall Study|Withdrawal by Subject|0|||
162934231|NCT01621490|588464310|FG007|Overall Study|Withdrawal by Subject|0|||
162934232|NCT01621490|588464311|FG008|Overall Study|Withdrawal by Subject|0|||
162934233|NCT01621490|588464312|FG009|Overall Study|Withdrawal by Subject|0|||
162934234|NCT01621490|588464313|FG010|Overall Study|Withdrawal by Subject|0|||
162934235|NCT01621490|588464303|FG000|Overall Study|Subject request to discontinue study|1|||
162934236|NCT01621490|588464304|FG001|Overall Study|Subject request to discontinue study|3|||
162934237|NCT01621490|588464305|FG002|Overall Study|Subject request to discontinue study|1|||
162934238|NCT01621490|588464306|FG003|Overall Study|Subject request to discontinue study|1|||
162934239|NCT01621490|588464307|FG004|Overall Study|Subject request to discontinue study|0|||
162934240|NCT01621490|588464308|FG005|Overall Study|Subject request to discontinue study|2|||
162934241|NCT01621490|588464309|FG006|Overall Study|Subject request to discontinue study|1|||
162934242|NCT01621490|588464310|FG007|Overall Study|Subject request to discontinue study|0|||
162934243|NCT01621490|588464311|FG008|Overall Study|Subject request to discontinue study|1|||
162934244|NCT01621490|588464312|FG009|Overall Study|Subject request to discontinue study|0|||
162934245|NCT01621490|588464313|FG010|Overall Study|Subject request to discontinue study|0|||
162934246|NCT01621490|588464303|FG000|Overall Study|Adverse event unrelated to study drug|1|||
162934247|NCT01621490|588464304|FG001|Overall Study|Adverse event unrelated to study drug|1|||
162934248|NCT01621490|588464305|FG002|Overall Study|Adverse event unrelated to study drug|0|||
162934249|NCT01621490|588464306|FG003|Overall Study|Adverse event unrelated to study drug|0|||
163283773|NCT01729871|589747597|FG001|Overall Study|Protocol Violation|0|||
163283774|NCT01729871|589747596|FG000|Overall Study|Withdrawal by Subject|0|||
163283775|NCT01729871|589747597|FG001|Overall Study|Withdrawal by Subject|3|||
163283776|NCT01729871|589747596|FG000|Overall Study|Other|4|||
163283777|NCT01729871|589747597|FG001|Overall Study|Other|9|||
163283778|NCT03971357|589747598|FG000|Overall Study|Lack of Efficacy|0|||
163283779|NCT03971357|589747599|FG001|Overall Study|Lack of Efficacy|1|||
163283780|NCT01143077|589747603|FG000|Overall Study|Lack of Efficacy|0|||
163283781|NCT01143077|589747604|FG001|Overall Study|Lack of Efficacy|2|||
163283782|NCT01143077|589747605|FG002|Overall Study|Lack of Efficacy|1|||
162934250|NCT01621490|588464307|FG004|Overall Study|Adverse event unrelated to study drug|0|||
162934251|NCT01621490|588464308|FG005|Overall Study|Adverse event unrelated to study drug|0|||
162934252|NCT01621490|588464309|FG006|Overall Study|Adverse event unrelated to study drug|0|||
162934253|NCT01621490|588464310|FG007|Overall Study|Adverse event unrelated to study drug|2|||
162934254|NCT01621490|588464311|FG008|Overall Study|Adverse event unrelated to study drug|0|||
162934255|NCT01621490|588464312|FG009|Overall Study|Adverse event unrelated to study drug|0|||
162934256|NCT01621490|588464313|FG010|Overall Study|Adverse event unrelated to study drug|0|||
162934257|NCT01621490|588464303|FG000|Overall Study|Disease progression|27|||
163283783|NCT01143077|589747603|FG000|Overall Study|Adverse Event|5|||
163283784|NCT01143077|589747604|FG001|Overall Study|Adverse Event|6|||
162934258|NCT01621490|588464304|FG001|Overall Study|Disease progression|28|||
162934259|NCT01621490|588464305|FG002|Overall Study|Disease progression|1|||
162934260|NCT01621490|588464306|FG003|Overall Study|Disease progression|5|||
162934261|NCT01621490|588464307|FG004|Overall Study|Disease progression|3|||
162934262|NCT01621490|588464308|FG005|Overall Study|Disease progression|8|||
162934263|NCT01621490|588464309|FG006|Overall Study|Disease progression|7|||
162934264|NCT01621490|588464310|FG007|Overall Study|Disease progression|1|||
162934265|NCT01621490|588464311|FG008|Overall Study|Disease progression|4|||
163178515|NCT04393298|589369212|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178516|NCT04393298|589369213|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178517|NCT04393298|589369214|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178518|NCT04393298|589369215|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178519|NCT04393298|589369216|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178520|NCT04393298|589369202|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178521|NCT04393298|589369203|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178522|NCT04393298|589369204|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178523|NCT04393298|589369205|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178524|NCT04393298|589369206|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178525|NCT04393298|589369207|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
163178526|NCT04393298|589369208|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178527|NCT04393298|589369209|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178528|NCT04393298|589369210|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178529|NCT04393298|589369211|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178530|NCT04393298|589369212|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178531|NCT04393298|589369213|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178532|NCT04393298|589369214|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178533|NCT04393298|589369215|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178534|NCT04393298|589369216|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
163178535|NCT04393298|589369202|FG000|Overall Study|Death|0|||
163178536|NCT04393298|589369203|FG001|Overall Study|Death|0|||
163178537|NCT04393298|589369204|FG002|Overall Study|Death|0|||
163178538|NCT04393298|589369205|FG003|Overall Study|Death|0|||
163178539|NCT04393298|589369206|FG004|Overall Study|Death|0|||
163178540|NCT04393298|589369207|FG005|Overall Study|Death|1|||
163178541|NCT04393298|589369208|FG006|Overall Study|Death|1|||
163178542|NCT04393298|589369209|FG007|Overall Study|Death|0|||
163178543|NCT04393298|589369210|FG008|Overall Study|Death|1|||
163178544|NCT04393298|589369211|FG009|Overall Study|Death|1|||
163178545|NCT04393298|589369212|FG010|Overall Study|Death|0|||
163178546|NCT04393298|589369213|FG011|Overall Study|Death|1|||
163178547|NCT04393298|589369214|FG012|Overall Study|Death|1|||
163178548|NCT04393298|589369215|FG013|Overall Study|Death|0|||
163178549|NCT04393298|589369216|FG014|Overall Study|Death|1|||
163178550|NCT04393298|589369202|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178551|NCT04393298|589369203|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178552|NCT04393298|589369204|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178553|NCT04393298|589369205|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178554|NCT04393298|589369206|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178555|NCT04393298|589369207|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
163178556|NCT04393298|589369208|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178557|NCT04393298|589369209|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178558|NCT04393298|589369210|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178559|NCT04393298|589369211|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178560|NCT04393298|589369212|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178561|NCT04393298|589369213|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178562|NCT04393298|589369214|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178563|NCT04393298|589369215|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178564|NCT04393298|589369216|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178565|NCT04393298|589369202|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
163178566|NCT04393298|589369203|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
163283785|NCT01143077|589747605|FG002|Overall Study|Adverse Event|5|||
163178567|NCT04393298|589369204|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
163178568|NCT04393298|589369205|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
163178569|NCT04393298|589369206|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
163178570|NCT04393298|589369207|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
163283786|NCT01143077|589747603|FG000|Overall Study|Lost to Follow-up|2|||
163283787|NCT01143077|589747604|FG001|Overall Study|Lost to Follow-up|3|||
163283788|NCT01143077|589747605|FG002|Overall Study|Lost to Follow-up|4|||
162934266|NCT01621490|588464312|FG009|Overall Study|Disease progression|1|||
162934267|NCT01621490|588464313|FG010|Overall Study|Disease progression|1|||
162934268|NCT01621490|588464303|FG000|Overall Study|Study drug toxicity|1|||
162934269|NCT01621490|588464304|FG001|Overall Study|Study drug toxicity|4|||
162934270|NCT01621490|588464305|FG002|Overall Study|Study drug toxicity|5|||
162934271|NCT01621490|588464306|FG003|Overall Study|Study drug toxicity|3|||
162934272|NCT01621490|588464307|FG004|Overall Study|Study drug toxicity|1|||
162934273|NCT01621490|588464308|FG005|Overall Study|Study drug toxicity|10|||
162934274|NCT01621490|588464309|FG006|Overall Study|Study drug toxicity|1|||
162934275|NCT01621490|588464310|FG007|Overall Study|Study drug toxicity|4|||
162934276|NCT01621490|588464311|FG008|Overall Study|Study drug toxicity|1|||
162934277|NCT01621490|588464312|FG009|Overall Study|Study drug toxicity|0|||
162934278|NCT01621490|588464313|FG010|Overall Study|Study drug toxicity|0|||
162934279|NCT01621490|588464303|FG000|Overall Study|Death|0|||
162934280|NCT01621490|588464304|FG001|Overall Study|Death|0|||
162934281|NCT01621490|588464305|FG002|Overall Study|Death|0|||
162934282|NCT01621490|588464306|FG003|Overall Study|Death|0|||
162934283|NCT01621490|588464307|FG004|Overall Study|Death|0|||
162934284|NCT01621490|588464308|FG005|Overall Study|Death|0|||
162934285|NCT01621490|588464309|FG006|Overall Study|Death|0|||
162934286|NCT01621490|588464310|FG007|Overall Study|Death|0|||
162934287|NCT01621490|588464311|FG008|Overall Study|Death|1|||
162934288|NCT01621490|588464312|FG009|Overall Study|Death|0|||
162934289|NCT01621490|588464313|FG010|Overall Study|Death|0|||
162934290|NCT01621490|588464303|FG000|Overall Study|Other reasons|7|||
162934291|NCT01621490|588464304|FG001|Overall Study|Other reasons|6|||
162934292|NCT01621490|588464305|FG002|Overall Study|Other reasons|4|||
162934293|NCT01621490|588464306|FG003|Overall Study|Other reasons|1|||
162934294|NCT01621490|588464307|FG004|Overall Study|Other reasons|1|||
162934295|NCT01621490|588464308|FG005|Overall Study|Other reasons|3|||
162934296|NCT01621490|588464309|FG006|Overall Study|Other reasons|1|||
162934297|NCT01621490|588464310|FG007|Overall Study|Other reasons|1|||
162934298|NCT01621490|588464311|FG008|Overall Study|Other reasons|1|||
162934299|NCT01621490|588464312|FG009|Overall Study|Other reasons|0|||
162934300|NCT01621490|588464313|FG010|Overall Study|Other reasons|0|||
162934301|NCT00506753|588464314|FG000|Overall Study|Lost to Follow-up|21|||
162934302|NCT00506753|588464315|FG001|Overall Study|Lost to Follow-up|15|||
162934303|NCT00461500|588464316|FG000|Overall Study|Adverse Event|1|||
162934304|NCT00461500|588464317|FG001|Overall Study|Adverse Event|0|||
162934305|NCT00461500|588464316|FG000|Overall Study|Lack of Efficacy|0|||
162934306|NCT00461500|588464317|FG001|Overall Study|Lack of Efficacy|1|||
162934307|NCT00461500|588464316|FG000|Overall Study|Expired Drug Treatment|1|||
162934308|NCT00461500|588464317|FG001|Overall Study|Expired Drug Treatment|1|||
162934309|NCT00461500|588464316|FG000|Overall Study|Study Stopped|1|||
162934310|NCT00461500|588464317|FG001|Overall Study|Study Stopped|2|||
162934311|NCT00461500|588464316|FG000|Overall Study|Drug Treatment Misuse|1|||
162934312|NCT00461500|588464317|FG001|Overall Study|Drug Treatment Misuse|0|||
162934313|NCT00461500|588464316|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
162934314|NCT00461500|588464317|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
162934315|NCT00461500|588464316|FG000|Overall Study|Lost to Follow-up|2|||
162934316|NCT00461500|588464317|FG001|Overall Study|Lost to Follow-up|2|||
162934317|NCT02482805|588464323|FG000|Overall Study|Lost to Follow-up|4|||
162934318|NCT02482805|588464324|FG001|Overall Study|Lost to Follow-up|4|||
162934319|NCT02482805|588464325|FG002|Overall Study|Lost to Follow-up|0|||
162934320|NCT01144663|588464326|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
162934321|NCT01144663|588464327|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
162934322|NCT01144663|588464328|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
162934323|NCT01144663|588464329|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
162934324|NCT01144663|588464326|FG000|Primary Vaccination Phase|Adverse Event|1|||
162934325|NCT01144663|588464327|FG001|Primary Vaccination Phase|Adverse Event|0|||
162934326|NCT01144663|588464328|FG002|Primary Vaccination Phase|Adverse Event|0|||
162934327|NCT01144663|588464329|FG003|Primary Vaccination Phase|Adverse Event|1|||
162934328|NCT01144663|588464326|FG000|Primary Vaccination Phase|Protocol Violation|2|||
163178571|NCT04393298|589369208|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
162934329|NCT01144663|588464327|FG001|Primary Vaccination Phase|Protocol Violation|0|||
162934330|NCT01144663|588464328|FG002|Primary Vaccination Phase|Protocol Violation|1|||
162934331|NCT01144663|588464329|FG003|Primary Vaccination Phase|Protocol Violation|0|||
162934332|NCT01144663|588464326|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
162934333|NCT01144663|588464327|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
162934334|NCT01144663|588464328|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
162934335|NCT01144663|588464329|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
162934336|NCT01144663|588464326|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
162934337|NCT01144663|588464327|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
163178572|NCT04393298|589369209|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
162934338|NCT01144663|588464328|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
162934339|NCT01144663|588464329|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
162934340|NCT01144663|588464326|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
162934341|NCT01144663|588464327|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
162934342|NCT01144663|588464328|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
162934343|NCT01144663|588464329|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
162934344|NCT01144663|588464326|FG000|Primary Vaccination Phase|Other|0|||
162934345|NCT01144663|588464327|FG001|Primary Vaccination Phase|Other|1|||
162934346|NCT01144663|588464328|FG002|Primary Vaccination Phase|Other|0|||
162934347|NCT01144663|588464329|FG003|Primary Vaccination Phase|Other|2|||
162934348|NCT01144663|588464326|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
162934349|NCT01144663|588464327|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
162934350|NCT01144663|588464328|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
162934351|NCT01144663|588464329|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
162934352|NCT01144663|588464326|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
162934353|NCT01144663|588464327|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
162934354|NCT01144663|588464328|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
162934355|NCT01144663|588464329|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
162934356|NCT01144663|588464326|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
162934357|NCT01144663|588464327|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
162934358|NCT01144663|588464328|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
162934359|NCT01144663|588464329|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
162934360|NCT01144663|588464326|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
162934361|NCT01144663|588464327|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
162934362|NCT01144663|588464328|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
162934363|NCT01144663|588464329|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
162934364|NCT01144663|588464326|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
162934365|NCT01144663|588464327|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
162934366|NCT01144663|588464328|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
162934367|NCT01144663|588464329|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
162934368|NCT01144663|588464326|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
162934369|NCT01144663|588464327|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
162934370|NCT01144663|588464328|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
162934371|NCT01144663|588464329|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
162934372|NCT01267266|588464332|FG000|Enrollment Phase|Withdrawal by Subject|2|||
162934373|NCT01267266|588464333|FG001|Enrollment Phase|Withdrawal by Subject|0|||
162934374|NCT01267266|588464332|FG000|Lead-in Phase|Lack of Efficacy|20|||
162934375|NCT01267266|588464333|FG001|Lead-in Phase|Lack of Efficacy|0|||
162934376|NCT01267266|588464332|FG000|Lead-in Phase|Adverse Event|2|||
162934377|NCT01267266|588464333|FG001|Lead-in Phase|Adverse Event|0|||
162934378|NCT01267266|588464332|FG000|Lead-in Phase|Withdrawal by Subject|1|||
163283789|NCT01143077|589747603|FG000|Overall Study|Protocol Violation|2|||
163283790|NCT01143077|589747604|FG001|Overall Study|Protocol Violation|0|||
163283791|NCT01143077|589747605|FG002|Overall Study|Protocol Violation|0|||
163283792|NCT01143077|589747603|FG000|Overall Study|Withdrawal by Subject|4|||
163283793|NCT01143077|589747604|FG001|Overall Study|Withdrawal by Subject|3|||
163283794|NCT01143077|589747605|FG002|Overall Study|Withdrawal by Subject|3|||
163283795|NCT01143077|589747603|FG000|Overall Study|Non-compliance with study drug|0|||
163283796|NCT01143077|589747604|FG001|Overall Study|Non-compliance with study drug|1|||
163283797|NCT01143077|589747605|FG002|Overall Study|Non-compliance with study drug|1|||
163283798|NCT01143077|589747603|FG000|Overall Study|Administrative|1|||
163283799|NCT01143077|589747604|FG001|Overall Study|Administrative|0|||
163283800|NCT01143077|589747605|FG002|Overall Study|Administrative|0|||
162934379|NCT01267266|588464333|FG001|Lead-in Phase|Withdrawal by Subject|0|||
162934380|NCT01335477|588464335|FG000|Overall Study|Adverse Event|30|||
163283801|NCT01143077|589747603|FG000|Overall Study|Principal Investigator Decision|2|||
163283802|NCT01143077|589747604|FG001|Overall Study|Principal Investigator Decision|0|||
163283803|NCT01143077|589747605|FG002|Overall Study|Principal Investigator Decision|1|||
163283804|NCT00819910|589747611|FG000|Overall Study|Adverse Event|0|||
163283805|NCT00819910|589747612|FG001|Overall Study|Adverse Event|0|||
163283806|NCT00819910|589747613|FG002|Overall Study|Adverse Event|2|||
163283807|NCT00819910|589747614|FG003|Overall Study|Adverse Event|1|||
162934381|NCT01335477|588464336|FG001|Overall Study|Adverse Event|42|||
163283808|NCT00819910|589747611|FG000|Overall Study|Withdrawal by Subject|1|||
163283809|NCT00819910|589747612|FG001|Overall Study|Withdrawal by Subject|1|||
163283810|NCT00819910|589747613|FG002|Overall Study|Withdrawal by Subject|1|||
163178573|NCT04393298|589369210|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
163178574|NCT04393298|589369211|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
163178575|NCT04393298|589369212|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
163178576|NCT04393298|589369213|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
163178577|NCT04393298|589369214|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
163178578|NCT04393298|589369215|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
163178579|NCT04393298|589369216|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
163178580|NCT04393298|589369202|FG000|Overall Study|Patient Passed Away|0|||
163178581|NCT04393298|589369203|FG001|Overall Study|Patient Passed Away|0|||
163178582|NCT04393298|589369204|FG002|Overall Study|Patient Passed Away|0|||
163178583|NCT04393298|589369205|FG003|Overall Study|Patient Passed Away|0|||
163178584|NCT04393298|589369206|FG004|Overall Study|Patient Passed Away|0|||
163178585|NCT04393298|589369207|FG005|Overall Study|Patient Passed Away|0|||
163178586|NCT04393298|589369208|FG006|Overall Study|Patient Passed Away|0|||
163178587|NCT04393298|589369209|FG007|Overall Study|Patient Passed Away|1|||
163178588|NCT04393298|589369210|FG008|Overall Study|Patient Passed Away|0|||
163178589|NCT04393298|589369211|FG009|Overall Study|Patient Passed Away|0|||
163178590|NCT04393298|589369212|FG010|Overall Study|Patient Passed Away|0|||
163178591|NCT04393298|589369213|FG011|Overall Study|Patient Passed Away|0|||
163178592|NCT04393298|589369214|FG012|Overall Study|Patient Passed Away|0|||
163178593|NCT04393298|589369215|FG013|Overall Study|Patient Passed Away|0|||
163178594|NCT04393298|589369216|FG014|Overall Study|Patient Passed Away|0|||
163178595|NCT04393298|589369202|FG000|Overall Study|Patient Deceased|0|||
163178596|NCT04393298|589369203|FG001|Overall Study|Patient Deceased|0|||
163178597|NCT04393298|589369204|FG002|Overall Study|Patient Deceased|0|||
162934382|NCT01335477|588464335|FG000|Overall Study|Non compliant with protocol|0|||
162934383|NCT01335477|588464336|FG001|Overall Study|Non compliant with protocol|2|||
162934384|NCT01335477|588464335|FG000|Overall Study|Lost to Follow-up|1|||
162934385|NCT01335477|588464336|FG001|Overall Study|Lost to Follow-up|2|||
162934386|NCT01335477|588464335|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
162934387|NCT01335477|588464336|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
162934388|NCT01335477|588464335|FG000|Overall Study|Not treated|1|||
162934389|NCT01335477|588464336|FG001|Overall Study|Not treated|2|||
162934390|NCT01335477|588464335|FG000|Overall Study|Reason other than those stated above|2|||
162934391|NCT01335477|588464336|FG001|Overall Study|Reason other than those stated above|2|||
162934392|NCT03549130|588464338|FG000|Overall Study|Adverse Event|0|||
162934393|NCT03549130|588464339|FG001|Overall Study|Adverse Event|1|||
162934394|NCT03549130|588464338|FG000|Overall Study|Lost to Follow-up|0|||
162934395|NCT03549130|588464339|FG001|Overall Study|Lost to Follow-up|1|||
162934396|NCT01078623|588464340|FG000|Treatment Period 1|Adverse Event|1|||
162934397|NCT01078623|588464341|FG001|Treatment Period 1|Adverse Event|1|||
162934398|NCT01078623|588464342|FG002|Treatment Period 1|Adverse Event|1|||
162934399|NCT01078623|588464343|FG003|Treatment Period 1|Adverse Event|0|||
162934400|NCT01078623|588464344|FG004|Treatment Period 1|Adverse Event|0|||
162934401|NCT01078623|588464345|FG005|Treatment Period 1|Adverse Event|0|||
162934402|NCT01078623|588464346|FG006|Treatment Period 1|Adverse Event|1|||
162934403|NCT01078623|588464347|FG007|Treatment Period 1|Adverse Event|0|||
162934404|NCT01078623|588464348|FG008|Treatment Period 1|Adverse Event|1|||
162934405|NCT01078623|588464349|FG009|Treatment Period 1|Adverse Event|1|||
162934406|NCT01078623|588464350|FG010|Treatment Period 1|Adverse Event|0|||
162934407|NCT01078623|588464351|FG011|Treatment Period 1|Adverse Event|0|||
163178598|NCT04393298|589369205|FG003|Overall Study|Patient Deceased|0|||
163178599|NCT04393298|589369206|FG004|Overall Study|Patient Deceased|0|||
163178600|NCT04393298|589369207|FG005|Overall Study|Patient Deceased|0|||
163178601|NCT04393298|589369208|FG006|Overall Study|Patient Deceased|0|||
163178602|NCT04393298|589369209|FG007|Overall Study|Patient Deceased|1|||
163178603|NCT04393298|589369210|FG008|Overall Study|Patient Deceased|0|||
163178604|NCT04393298|589369211|FG009|Overall Study|Patient Deceased|0|||
163178605|NCT04393298|589369212|FG010|Overall Study|Patient Deceased|0|||
163178606|NCT04393298|589369213|FG011|Overall Study|Patient Deceased|0|||
163178607|NCT04393298|589369214|FG012|Overall Study|Patient Deceased|0|||
163178608|NCT04393298|589369215|FG013|Overall Study|Patient Deceased|0|||
163178609|NCT04393298|589369216|FG014|Overall Study|Patient Deceased|0|||
163178610|NCT04393298|589369202|FG000|Overall Study|Patient Discharged to Hospice|0|||
163178611|NCT04393298|589369203|FG001|Overall Study|Patient Discharged to Hospice|0|||
163178612|NCT04393298|589369204|FG002|Overall Study|Patient Discharged to Hospice|0|||
163178613|NCT04393298|589369205|FG003|Overall Study|Patient Discharged to Hospice|0|||
163178614|NCT04393298|589369206|FG004|Overall Study|Patient Discharged to Hospice|0|||
163178615|NCT04393298|589369207|FG005|Overall Study|Patient Discharged to Hospice|0|||
163178616|NCT04393298|589369208|FG006|Overall Study|Patient Discharged to Hospice|0|||
163178617|NCT04393298|589369209|FG007|Overall Study|Patient Discharged to Hospice|0|||
163178618|NCT04393298|589369210|FG008|Overall Study|Patient Discharged to Hospice|1|||
163178619|NCT04393298|589369211|FG009|Overall Study|Patient Discharged to Hospice|0|||
163178620|NCT04393298|589369212|FG010|Overall Study|Patient Discharged to Hospice|0|||
163178621|NCT04393298|589369213|FG011|Overall Study|Patient Discharged to Hospice|0|||
163178622|NCT04393298|589369214|FG012|Overall Study|Patient Discharged to Hospice|0|||
163178623|NCT04393298|589369215|FG013|Overall Study|Patient Discharged to Hospice|0|||
163178624|NCT04393298|589369216|FG014|Overall Study|Patient Discharged to Hospice|0|||
163178625|NCT04393298|589369202|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178626|NCT04393298|589369203|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178627|NCT04393298|589369204|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178628|NCT04393298|589369205|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178629|NCT04393298|589369206|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163283811|NCT00819910|589747614|FG003|Overall Study|Withdrawal by Subject|0|||
163283812|NCT00819910|589747611|FG000|Overall Study|Lost to Follow-up|1|||
163283813|NCT00819910|589747612|FG001|Overall Study|Lost to Follow-up|0|||
163283814|NCT00819910|589747613|FG002|Overall Study|Lost to Follow-up|0|||
163283815|NCT00819910|589747614|FG003|Overall Study|Lost to Follow-up|0|||
163283816|NCT00871429|589747616|FG000|Overall Study|Lost to Follow-up|6|||
163178630|NCT04393298|589369207|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162934408|NCT01078623|588464352|FG012|Treatment Period 1|Adverse Event|0|||
162934409|NCT01078623|588464353|FG013|Treatment Period 1|Adverse Event|0|||
162934410|NCT01078623|588464354|FG014|Treatment Period 1|Adverse Event|0|||
162934411|NCT01078623|588464355|FG015|Treatment Period 1|Adverse Event|0|||
162934412|NCT01078623|588464356|FG016|Treatment Period 1|Adverse Event|0|||
162934413|NCT01078623|588464357|FG017|Treatment Period 1|Adverse Event|0|||
162934414|NCT01078623|588464358|FG018|Treatment Period 1|Adverse Event|0|||
162934415|NCT01078623|588464359|FG019|Treatment Period 1|Adverse Event|0|||
162934416|NCT01078623|588464340|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162934417|NCT01078623|588464341|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163178631|NCT04393298|589369208|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163283817|NCT00871429|589747616|FG000|Overall Study|Withdrawal by Subject|17|||
162934418|NCT01078623|588464342|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162934419|NCT01078623|588464343|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162934420|NCT01078623|588464344|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162934421|NCT01078623|588464345|FG005|Treatment Period 1|Withdrawal by Subject|0|||
162934422|NCT01078623|588464346|FG006|Treatment Period 1|Withdrawal by Subject|0|||
162934423|NCT01078623|588464347|FG007|Treatment Period 1|Withdrawal by Subject|1|||
162934424|NCT01078623|588464348|FG008|Treatment Period 1|Withdrawal by Subject|0|||
162934425|NCT01078623|588464349|FG009|Treatment Period 1|Withdrawal by Subject|0|||
162934426|NCT01078623|588464350|FG010|Treatment Period 1|Withdrawal by Subject|1|||
162934427|NCT01078623|588464351|FG011|Treatment Period 1|Withdrawal by Subject|0|||
162934428|NCT01078623|588464352|FG012|Treatment Period 1|Withdrawal by Subject|0|||
162934429|NCT01078623|588464353|FG013|Treatment Period 1|Withdrawal by Subject|0|||
162934430|NCT01078623|588464354|FG014|Treatment Period 1|Withdrawal by Subject|0|||
162934431|NCT01078623|588464355|FG015|Treatment Period 1|Withdrawal by Subject|0|||
162934432|NCT01078623|588464356|FG016|Treatment Period 1|Withdrawal by Subject|0|||
162934433|NCT01078623|588464357|FG017|Treatment Period 1|Withdrawal by Subject|0|||
162934434|NCT01078623|588464358|FG018|Treatment Period 1|Withdrawal by Subject|0|||
162934435|NCT01078623|588464359|FG019|Treatment Period 1|Withdrawal by Subject|0|||
162934436|NCT01078623|588464340|FG000|Treatment Period 1|Protocol Violation|0|||
162934437|NCT01078623|588464341|FG001|Treatment Period 1|Protocol Violation|0|||
162934438|NCT01078623|588464342|FG002|Treatment Period 1|Protocol Violation|0|||
162934439|NCT01078623|588464343|FG003|Treatment Period 1|Protocol Violation|0|||
162934440|NCT01078623|588464344|FG004|Treatment Period 1|Protocol Violation|0|||
162934441|NCT01078623|588464345|FG005|Treatment Period 1|Protocol Violation|1|||
162934442|NCT01078623|588464346|FG006|Treatment Period 1|Protocol Violation|0|||
162934443|NCT01078623|588464347|FG007|Treatment Period 1|Protocol Violation|0|||
162934444|NCT01078623|588464348|FG008|Treatment Period 1|Protocol Violation|0|||
162934445|NCT01078623|588464349|FG009|Treatment Period 1|Protocol Violation|0|||
162934446|NCT01078623|588464350|FG010|Treatment Period 1|Protocol Violation|0|||
162934447|NCT01078623|588464351|FG011|Treatment Period 1|Protocol Violation|0|||
162934448|NCT01078623|588464352|FG012|Treatment Period 1|Protocol Violation|0|||
162934449|NCT01078623|588464353|FG013|Treatment Period 1|Protocol Violation|0|||
162934450|NCT01078623|588464354|FG014|Treatment Period 1|Protocol Violation|0|||
162934451|NCT01078623|588464355|FG015|Treatment Period 1|Protocol Violation|0|||
162934452|NCT01078623|588464356|FG016|Treatment Period 1|Protocol Violation|0|||
162934453|NCT01078623|588464357|FG017|Treatment Period 1|Protocol Violation|0|||
162934454|NCT01078623|588464358|FG018|Treatment Period 1|Protocol Violation|0|||
162934455|NCT01078623|588464359|FG019|Treatment Period 1|Protocol Violation|0|||
162934456|NCT01078623|588464340|FG000|Treatment Period 2|Adverse Event|0|||
162934457|NCT01078623|588464341|FG001|Treatment Period 2|Adverse Event|0|||
162934458|NCT01078623|588464342|FG002|Treatment Period 2|Adverse Event|0|||
162934459|NCT01078623|588464343|FG003|Treatment Period 2|Adverse Event|0|||
162934460|NCT01078623|588464344|FG004|Treatment Period 2|Adverse Event|0|||
162934461|NCT01078623|588464345|FG005|Treatment Period 2|Adverse Event|0|||
162934462|NCT01078623|588464346|FG006|Treatment Period 2|Adverse Event|1|||
162934463|NCT01078623|588464347|FG007|Treatment Period 2|Adverse Event|0|||
163283818|NCT00871429|589747616|FG000|Overall Study|Questionnaire not completed|1|||
163283819|NCT01772719|589747617|FG000|Overall Study|Withdrawal by Subject|3|||
163283820|NCT01772719|589747617|FG000|Overall Study|Adverse Event|2|||
163283821|NCT01772719|589747617|FG000|Overall Study|Protocol Violation|1|||
163283822|NCT01772719|589747617|FG000|Overall Study|Lost to Follow-up|1|||
163283823|NCT00477412|589747618|FG000|Overall Study|Death|0|||
163283824|NCT00477412|589747619|FG001|Overall Study|Death|0|||
163283825|NCT00477412|589747620|FG002|Overall Study|Death|0|||
163283826|NCT00477412|589747621|FG003|Overall Study|Death|4|||
163283827|NCT00477412|589747618|FG000|Overall Study|Lost to Follow-up|0|||
163283828|NCT00477412|589747619|FG001|Overall Study|Lost to Follow-up|0|||
163283829|NCT00477412|589747620|FG002|Overall Study|Lost to Follow-up|0|||
162934464|NCT01078623|588464348|FG008|Treatment Period 2|Adverse Event|0|||
162934465|NCT01078623|588464349|FG009|Treatment Period 2|Adverse Event|0|||
163283830|NCT00477412|589747621|FG003|Overall Study|Lost to Follow-up|1|||
163283831|NCT00477412|589747618|FG000|Overall Study|Withdrawal by Subject|0|||
163283832|NCT00477412|589747619|FG001|Overall Study|Withdrawal by Subject|0|||
163283833|NCT00477412|589747620|FG002|Overall Study|Withdrawal by Subject|0|||
163283834|NCT00477412|589747621|FG003|Overall Study|Withdrawal by Subject|2|||
162934466|NCT01078623|588464350|FG010|Treatment Period 2|Adverse Event|0|||
162934467|NCT01078623|588464351|FG011|Treatment Period 2|Adverse Event|0|||
163283835|NCT00477412|589747618|FG000|Overall Study|Second Malignancy|0|||
162934468|NCT01078623|588464352|FG012|Treatment Period 2|Adverse Event|0|||
162934469|NCT01078623|588464353|FG013|Treatment Period 2|Adverse Event|0|||
162934470|NCT01078623|588464354|FG014|Treatment Period 2|Adverse Event|0|||
162934471|NCT01078623|588464355|FG015|Treatment Period 2|Adverse Event|0|||
162934472|NCT01078623|588464356|FG016|Treatment Period 2|Adverse Event|0|||
162934473|NCT01078623|588464357|FG017|Treatment Period 2|Adverse Event|0|||
162934474|NCT01078623|588464358|FG018|Treatment Period 2|Adverse Event|1|||
162934475|NCT01078623|588464359|FG019|Treatment Period 2|Adverse Event|0|||
163283836|NCT00477412|589747619|FG001|Overall Study|Second Malignancy|0|||
163283837|NCT00477412|589747620|FG002|Overall Study|Second Malignancy|0|||
162934476|NCT01078623|588464340|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162934477|NCT01078623|588464341|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162934478|NCT01078623|588464342|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162934479|NCT01078623|588464343|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162934480|NCT01078623|588464344|FG004|Treatment Period 2|Withdrawal by Subject|0|||
162934481|NCT01078623|588464345|FG005|Treatment Period 2|Withdrawal by Subject|1|||
162934482|NCT01078623|588464346|FG006|Treatment Period 2|Withdrawal by Subject|0|||
162934483|NCT01078623|588464347|FG007|Treatment Period 2|Withdrawal by Subject|0|||
162934484|NCT01078623|588464348|FG008|Treatment Period 2|Withdrawal by Subject|0|||
162934485|NCT01078623|588464349|FG009|Treatment Period 2|Withdrawal by Subject|0|||
162934486|NCT01078623|588464350|FG010|Treatment Period 2|Withdrawal by Subject|0|||
162934487|NCT01078623|588464351|FG011|Treatment Period 2|Withdrawal by Subject|0|||
162934488|NCT01078623|588464352|FG012|Treatment Period 2|Withdrawal by Subject|0|||
162934489|NCT01078623|588464353|FG013|Treatment Period 2|Withdrawal by Subject|0|||
162934490|NCT01078623|588464354|FG014|Treatment Period 2|Withdrawal by Subject|0|||
162934491|NCT01078623|588464355|FG015|Treatment Period 2|Withdrawal by Subject|0|||
162934492|NCT01078623|588464356|FG016|Treatment Period 2|Withdrawal by Subject|0|||
162934493|NCT01078623|588464357|FG017|Treatment Period 2|Withdrawal by Subject|0|||
162934494|NCT01078623|588464358|FG018|Treatment Period 2|Withdrawal by Subject|0|||
162934495|NCT01078623|588464359|FG019|Treatment Period 2|Withdrawal by Subject|0|||
162934496|NCT01078623|588464340|FG000|Treatment Period 3|Adverse Event|0|||
162934497|NCT01078623|588464341|FG001|Treatment Period 3|Adverse Event|0|||
162934498|NCT01078623|588464342|FG002|Treatment Period 3|Adverse Event|0|||
162934499|NCT01078623|588464343|FG003|Treatment Period 3|Adverse Event|0|||
162934500|NCT01078623|588464344|FG004|Treatment Period 3|Adverse Event|1|||
162934501|NCT01078623|588464345|FG005|Treatment Period 3|Adverse Event|0|||
162934502|NCT01078623|588464346|FG006|Treatment Period 3|Adverse Event|0|||
162934503|NCT01078623|588464347|FG007|Treatment Period 3|Adverse Event|0|||
162934504|NCT01078623|588464348|FG008|Treatment Period 3|Adverse Event|0|||
162934505|NCT01078623|588464349|FG009|Treatment Period 3|Adverse Event|0|||
162934506|NCT01078623|588464350|FG010|Treatment Period 3|Adverse Event|0|||
162934507|NCT01078623|588464351|FG011|Treatment Period 3|Adverse Event|0|||
162934508|NCT01078623|588464352|FG012|Treatment Period 3|Adverse Event|0|||
162934509|NCT01078623|588464353|FG013|Treatment Period 3|Adverse Event|1|||
162934510|NCT01078623|588464354|FG014|Treatment Period 3|Adverse Event|0|||
162934511|NCT01078623|588464355|FG015|Treatment Period 3|Adverse Event|0|||
162934512|NCT01078623|588464356|FG016|Treatment Period 3|Adverse Event|0|||
162934513|NCT01078623|588464357|FG017|Treatment Period 3|Adverse Event|0|||
162934514|NCT01078623|588464358|FG018|Treatment Period 3|Adverse Event|0|||
162934515|NCT01078623|588464359|FG019|Treatment Period 3|Adverse Event|0|||
162934516|NCT01078623|588464340|FG000|Treatment Period 4|Adverse Event|0|||
162934517|NCT01078623|588464341|FG001|Treatment Period 4|Adverse Event|0|||
162934518|NCT01078623|588464342|FG002|Treatment Period 4|Adverse Event|1|||
162934519|NCT01078623|588464343|FG003|Treatment Period 4|Adverse Event|0|||
162934520|NCT01078623|588464344|FG004|Treatment Period 4|Adverse Event|0|||
162934521|NCT01078623|588464345|FG005|Treatment Period 4|Adverse Event|0|||
162934522|NCT01078623|588464346|FG006|Treatment Period 4|Adverse Event|0|||
162934523|NCT01078623|588464347|FG007|Treatment Period 4|Adverse Event|0|||
162934524|NCT01078623|588464348|FG008|Treatment Period 4|Adverse Event|0|||
162934525|NCT01078623|588464349|FG009|Treatment Period 4|Adverse Event|0|||
162934526|NCT01078623|588464350|FG010|Treatment Period 4|Adverse Event|0|||
162934527|NCT01078623|588464351|FG011|Treatment Period 4|Adverse Event|0|||
162934528|NCT01078623|588464352|FG012|Treatment Period 4|Adverse Event|0|||
162934529|NCT01078623|588464353|FG013|Treatment Period 4|Adverse Event|0|||
162934530|NCT01078623|588464354|FG014|Treatment Period 4|Adverse Event|0|||
162934531|NCT01078623|588464355|FG015|Treatment Period 4|Adverse Event|0|||
162934532|NCT01078623|588464356|FG016|Treatment Period 4|Adverse Event|0|||
162934533|NCT01078623|588464357|FG017|Treatment Period 4|Adverse Event|0|||
162934534|NCT01078623|588464358|FG018|Treatment Period 4|Adverse Event|0|||
163178632|NCT04393298|589369209|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178633|NCT04393298|589369210|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178634|NCT04393298|589369211|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
163178635|NCT04393298|589369212|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163283838|NCT00477412|589747621|FG003|Overall Study|Second Malignancy|1|||
162934535|NCT01078623|588464359|FG019|Treatment Period 4|Adverse Event|0|||
162934536|NCT01078623|588464340|FG000|Treatment Period 4|Withdrawal by Subject|0|||
162934537|NCT01078623|588464341|FG001|Treatment Period 4|Withdrawal by Subject|0|||
162934538|NCT01078623|588464342|FG002|Treatment Period 4|Withdrawal by Subject|0|||
162934539|NCT01078623|588464343|FG003|Treatment Period 4|Withdrawal by Subject|0|||
162934540|NCT01078623|588464344|FG004|Treatment Period 4|Withdrawal by Subject|0|||
162934541|NCT01078623|588464345|FG005|Treatment Period 4|Withdrawal by Subject|0|||
162934542|NCT01078623|588464346|FG006|Treatment Period 4|Withdrawal by Subject|0|||
162934543|NCT01078623|588464347|FG007|Treatment Period 4|Withdrawal by Subject|0|||
162934544|NCT01078623|588464348|FG008|Treatment Period 4|Withdrawal by Subject|0|||
162934545|NCT01078623|588464349|FG009|Treatment Period 4|Withdrawal by Subject|0|||
162934546|NCT01078623|588464350|FG010|Treatment Period 4|Withdrawal by Subject|0|||
162934547|NCT01078623|588464351|FG011|Treatment Period 4|Withdrawal by Subject|0|||
162934548|NCT01078623|588464352|FG012|Treatment Period 4|Withdrawal by Subject|0|||
163283839|NCT00477412|589747618|FG000|Overall Study|Adverse Event|1|||
163283840|NCT00477412|589747619|FG001|Overall Study|Adverse Event|0|||
163283841|NCT00477412|589747620|FG002|Overall Study|Adverse Event|1|||
163283842|NCT00477412|589747621|FG003|Overall Study|Adverse Event|0|||
163283843|NCT01560949|589747622|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
163283844|NCT01560949|589747622|FG000|Surgery Phase|Physician Decision|3|||
163283845|NCT05460663|589747627|FG000|Overall Study|Withdrawal by Subject|2|||
163283846|NCT05460663|589747628|FG001|Overall Study|Withdrawal by Subject|5|||
163283847|NCT00681811|589747629|FG000|Overall Study|Adverse Event|1|||
163283848|NCT00681811|589747630|FG001|Overall Study|Adverse Event|1|||
163283849|NCT00681811|589747629|FG000|Overall Study|Withdrawal by Subject|2|||
163283850|NCT00681811|589747630|FG001|Overall Study|Withdrawal by Subject|2|||
163283851|NCT00681811|589747629|FG000|Overall Study|Non-compliance|0|||
163283852|NCT00681811|589747630|FG001|Overall Study|Non-compliance|1|||
163283853|NCT01140347|589747637|FG000|Overall Study|Lost to Follow-up|5|||
163283854|NCT01140347|589747638|FG001|Overall Study|Lost to Follow-up|6|||
163283855|NCT01140347|589747637|FG000|Overall Study|Withdrawal by Subject|13|||
163283856|NCT01140347|589747638|FG001|Overall Study|Withdrawal by Subject|8|||
163283857|NCT00828919|589747639|FG000|Overall Study|Death|0|||
163283858|NCT00828919|589747640|FG001|Overall Study|Death|1|||
163283859|NCT00828919|589747641|FG002|Overall Study|Death|2|||
163283860|NCT00828919|589747642|FG003|Overall Study|Death|0|||
163283861|NCT00828919|589747643|FG004|Overall Study|Death|0|||
163283862|NCT00828919|589747639|FG000|Overall Study|Adverse Event|2|||
163283863|NCT00828919|589747640|FG001|Overall Study|Adverse Event|2|||
163283864|NCT00828919|589747641|FG002|Overall Study|Adverse Event|2|||
163283865|NCT00828919|589747642|FG003|Overall Study|Adverse Event|1|||
163283866|NCT00828919|589747643|FG004|Overall Study|Adverse Event|3|||
163283867|NCT00828919|589747639|FG000|Overall Study|Objective progression or relapse|4|||
163283868|NCT00828919|589747640|FG001|Overall Study|Objective progression or relapse|4|||
162934549|NCT01078623|588464353|FG013|Treatment Period 4|Withdrawal by Subject|0|||
162934550|NCT01078623|588464354|FG014|Treatment Period 4|Withdrawal by Subject|0|||
163283869|NCT00828919|589747641|FG002|Overall Study|Objective progression or relapse|11|||
163283870|NCT00828919|589747642|FG003|Overall Study|Objective progression or relapse|0|||
163283871|NCT00828919|589747643|FG004|Overall Study|Objective progression or relapse|5|||
163283872|NCT00828919|589747639|FG000|Overall Study|No longer willing to participate in study|0|||
163178636|NCT04393298|589369213|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178637|NCT04393298|589369214|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178638|NCT04393298|589369215|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178639|NCT04393298|589369216|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178640|NCT04393298|589369202|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
163178641|NCT04393298|589369203|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
163178642|NCT04393298|589369204|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
163178643|NCT04393298|589369205|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
163178644|NCT04393298|589369206|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
163178645|NCT04393298|589369207|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
163178646|NCT04393298|589369208|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
163178647|NCT04393298|589369209|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
163178648|NCT04393298|589369210|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
163178649|NCT04393298|589369211|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
163178650|NCT04393298|589369212|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
163178651|NCT04393298|589369213|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
163178652|NCT04393298|589369214|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
163178653|NCT04393298|589369215|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
163178654|NCT04393298|589369216|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
163178655|NCT01315236|589369227|FG000|Double-blind Phase|Death|1|||
163178656|NCT01315236|589369228|FG001|Double-blind Phase|Death|0|||
163178657|NCT01315236|589369227|FG000|Double-blind Phase|Adverse Event|1|||
163178658|NCT01315236|589369228|FG001|Double-blind Phase|Adverse Event|0|||
163178659|NCT01315236|589369227|FG000|Double-blind Phase|Withdrawal of Consent|1|||
163178660|NCT01315236|589369228|FG001|Double-blind Phase|Withdrawal of Consent|0|||
163178661|NCT01315236|589369227|FG000|Double-blind Phase|Lost to Follow-up|1|||
163178662|NCT01315236|589369228|FG001|Double-blind Phase|Lost to Follow-up|0|||
163178663|NCT01315236|589369227|FG000|Open-label Phase|Death|1|||
163178664|NCT01315236|589369228|FG001|Open-label Phase|Death|0|||
163178665|NCT01315236|589369227|FG000|Open-label Phase|Adverse Event|0|||
163178666|NCT01315236|589369228|FG001|Open-label Phase|Adverse Event|1|||
163178667|NCT01315236|589369227|FG000|Open-label Phase|Other|0|||
163178668|NCT01315236|589369228|FG001|Open-label Phase|Other|1|||
163178669|NCT01315236|589369227|FG000|12-Month Follow-up Period|Death|0|||
163178670|NCT01315236|589369228|FG001|12-Month Follow-up Period|Death|1|||
163178671|NCT01315236|589369227|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
163178672|NCT01315236|589369228|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
163178673|NCT01101191|589369236|FG000|Period 1|Withdrawal by Subject|1|||
163178674|NCT01101191|589369237|FG001|Period 1|Withdrawal by Subject|0|||
163178675|NCT01101191|589369236|FG000|Period 1|Adverse Event|1|||
163178676|NCT01101191|589369237|FG001|Period 1|Adverse Event|2|||
163178677|NCT01146860|589369238|FG000|Overall Study|Withdrawal by Subject|0|||
163178678|NCT01146860|589369239|FG001|Overall Study|Withdrawal by Subject|1|||
163178679|NCT04779216|589369240|FG000|Overall Study|Lost to Follow-up|1|||
163178680|NCT04779216|589369241|FG001|Overall Study|Lost to Follow-up|0|||
163178681|NCT04779216|589369240|FG000|Overall Study|Withdrawal by Subject|1|||
163178682|NCT04779216|589369241|FG001|Overall Study|Withdrawal by Subject|0|||
163178683|NCT02674854|589369246|FG000|Overall Study|Adverse Event|17|||
163178684|NCT02674854|589369247|FG001|Overall Study|Adverse Event|15|||
163178685|NCT02674854|589369248|FG002|Overall Study|Adverse Event|5|||
163178686|NCT02674854|589369246|FG000|Overall Study|Withdrawal by Subject|1|||
163178687|NCT02674854|589369247|FG001|Overall Study|Withdrawal by Subject|5|||
163178688|NCT02674854|589369248|FG002|Overall Study|Withdrawal by Subject|4|||
163178689|NCT02674854|589369246|FG000|Overall Study|No-compliant subject|1|||
163283873|NCT00828919|589747640|FG001|Overall Study|No longer willing to participate in study|0|||
162924223|NCT00077766|588423833|FG000|Overall Study|Participant's decision|1|||
163178690|NCT02674854|589369247|FG001|Overall Study|No-compliant subject|0|||
163178691|NCT02674854|589369248|FG002|Overall Study|No-compliant subject|1|||
163178692|NCT02674854|589369246|FG000|Overall Study|Lost to Follow-up|1|||
163178693|NCT02674854|589369247|FG001|Overall Study|Lost to Follow-up|0|||
163178694|NCT02674854|589369248|FG002|Overall Study|Lost to Follow-up|2|||
163178695|NCT02674854|589369246|FG000|Overall Study|Lack of Efficacy|0|||
163178696|NCT02674854|589369247|FG001|Overall Study|Lack of Efficacy|3|||
163178697|NCT02674854|589369248|FG002|Overall Study|Lack of Efficacy|0|||
163178698|NCT02674854|589369246|FG000|Overall Study|Disallowed Concurrent Medication|2|||
163178699|NCT02674854|589369247|FG001|Overall Study|Disallowed Concurrent Medication|2|||
162934551|NCT01078623|588464355|FG015|Treatment Period 4|Withdrawal by Subject|1|||
162934552|NCT01078623|588464356|FG016|Treatment Period 4|Withdrawal by Subject|0|||
162934553|NCT01078623|588464357|FG017|Treatment Period 4|Withdrawal by Subject|0|||
162934554|NCT01078623|588464358|FG018|Treatment Period 4|Withdrawal by Subject|0|||
162934555|NCT01078623|588464359|FG019|Treatment Period 4|Withdrawal by Subject|0|||
162934556|NCT00447603|588464377|FG000|Screening|Withdrawal by Subject|1|||
162934557|NCT00447603|588464378|FG001|Screening|Withdrawal by Subject|0|||
162934558|NCT00447603|588464379|FG002|Screening|Withdrawal by Subject|0|||
162934559|NCT00447603|588464377|FG000|Screening|Protocol Violation|1|||
162934560|NCT00447603|588464378|FG001|Screening|Protocol Violation|0|||
162934561|NCT00447603|588464379|FG002|Screening|Protocol Violation|0|||
162934562|NCT00447603|588464377|FG000|Screening|Screen Failure|4|||
162934563|NCT00447603|588464378|FG001|Screening|Screen Failure|0|||
162934564|NCT00447603|588464379|FG002|Screening|Screen Failure|0|||
162934565|NCT00447603|588464377|FG000|Screening|Study Terminated by Sponsor|15|||
162934566|NCT00447603|588464378|FG001|Screening|Study Terminated by Sponsor|0|||
162934567|NCT00447603|588464379|FG002|Screening|Study Terminated by Sponsor|0|||
162934568|NCT00447603|588464377|FG000|Filter Period|Adverse Event|0|||
162934569|NCT00447603|588464378|FG001|Filter Period|Adverse Event|0|||
162934570|NCT00447603|588464379|FG002|Filter Period|Adverse Event|1|||
162934571|NCT00447603|588464377|FG000|Filter Period|Screen Failure|0|||
162934572|NCT00447603|588464378|FG001|Filter Period|Screen Failure|3|||
162934573|NCT00447603|588464379|FG002|Filter Period|Screen Failure|4|||
162934574|NCT00447603|588464377|FG000|Filter Period|Study terminated by Sponsor|0|||
162934575|NCT00447603|588464378|FG001|Filter Period|Study terminated by Sponsor|1|||
162934576|NCT00447603|588464379|FG002|Filter Period|Study terminated by Sponsor|10|||
162934577|NCT01797120|588464382|FG000|Overall Study|Disesae progression|37|||
162934578|NCT01797120|588464383|FG001|Overall Study|Disesae progression|49|||
162934579|NCT01797120|588464382|FG000|Overall Study|Adverse Event|13|||
162934580|NCT01797120|588464383|FG001|Overall Study|Adverse Event|5|||
162934581|NCT01797120|588464382|FG000|Overall Study|Withdrawal by Subject|6|||
162934582|NCT01797120|588464383|FG001|Overall Study|Withdrawal by Subject|6|||
162934583|NCT01797120|588464382|FG000|Overall Study|Symptomatic progression|2|||
162934584|NCT01797120|588464383|FG001|Overall Study|Symptomatic progression|1|||
162934585|NCT01797120|588464382|FG000|Overall Study|Non-compliance|1|||
162934586|NCT01797120|588464383|FG001|Overall Study|Non-compliance|0|||
162934587|NCT01797120|588464382|FG000|Overall Study|Physician Decision|3|||
162934588|NCT01797120|588464383|FG001|Overall Study|Physician Decision|0|||
162934589|NCT01797120|588464382|FG000|Overall Study|still on treatment|2|||
162934590|NCT01797120|588464383|FG001|Overall Study|still on treatment|4|||
162934591|NCT01797120|588464382|FG000|Overall Study|never start protocol therapy|2|||
162934592|NCT01797120|588464383|FG001|Overall Study|never start protocol therapy|0|||
162934593|NCT01003886|588464384|FG000|Overall Study|Lack of Efficacy|5|||
162934594|NCT01003886|588464384|FG000|Overall Study|Lost to Follow-up|169|||
162934595|NCT01003886|588464384|FG000|Overall Study|Withdrawal by Subject|39|||
162934596|NCT01003886|588464384|FG000|Overall Study|Other|14|||
162934597|NCT01003886|588464384|FG000|Overall Study|Adverse Event|3|||
162934598|NCT00909727|588464402|FG000|Overall Study|Adverse Event|1|||
162934599|NCT00909727|588464403|FG001|Overall Study|Adverse Event|0|||
162934600|NCT00909727|588464402|FG000|Overall Study|Wrong Genotype|1|||
162934601|NCT00909727|588464403|FG001|Overall Study|Wrong Genotype|0|||
162934602|NCT00909727|588464402|FG000|Overall Study|Withdrawal of Consent|1|||
162934603|NCT00909727|588464403|FG001|Overall Study|Withdrawal of Consent|0|||
162934604|NCT00909727|588464402|FG000|Overall Study|Prohibited Medication|1|||
162934605|NCT00909727|588464403|FG001|Overall Study|Prohibited Medication|0|||
162934606|NCT05751629|588464404|FG000|Overall Study|Withdrawal by Subject|6|||
162934607|NCT05751629|588464404|FG000|Overall Study|Death|25|||
162934608|NCT05751629|588464404|FG000|Overall Study|Study Site Closed|9|||
162934609|NCT05751629|588464404|FG000|Overall Study|Physician Decision|1|||
162934610|NCT01909466|588464406|FG000|Overall Study|Lost to Follow-up|5|||
162934611|NCT01909466|588464407|FG001|Overall Study|Lost to Follow-up|7|||
162934612|NCT01909466|588464406|FG000|Overall Study|Adverse Event|3|||
163178700|NCT02674854|589369248|FG002|Overall Study|Disallowed Concurrent Medication|0|||
163178701|NCT02674854|589369246|FG000|Overall Study|Protocol Violation|1|||
163178702|NCT02674854|589369247|FG001|Overall Study|Protocol Violation|1|||
163178703|NCT02674854|589369248|FG002|Overall Study|Protocol Violation|2|||
163178704|NCT02674854|589369246|FG000|Overall Study|Death|0|||
162934613|NCT01909466|588464407|FG001|Overall Study|Adverse Event|4|||
162934614|NCT01909466|588464406|FG000|Overall Study|Met Withdrawal Criteria|0|||
162934615|NCT01909466|588464407|FG001|Overall Study|Met Withdrawal Criteria|3|||
162934616|NCT01909466|588464406|FG000|Overall Study|Physician Decision|2|||
162934617|NCT01909466|588464407|FG001|Overall Study|Physician Decision|0|||
162934618|NCT01909466|588464406|FG000|Overall Study|Withdrawal by Subject|11|||
162934619|NCT01909466|588464407|FG001|Overall Study|Withdrawal by Subject|9|||
162934620|NCT01909466|588464406|FG000|Overall Study|Lack of Efficacy|1|||
162934621|NCT01909466|588464407|FG001|Overall Study|Lack of Efficacy|0|||
162934622|NCT00672620|588464413|FG000|Overall Study|Adverse Event|7|||
162934623|NCT00672620|588464414|FG001|Overall Study|Adverse Event|7|||
162934624|NCT00672620|588464415|FG002|Overall Study|Adverse Event|12|||
163178705|NCT02674854|589369247|FG001|Overall Study|Death|1|||
163178706|NCT02674854|589369248|FG002|Overall Study|Death|0|||
163178707|NCT02674854|589369246|FG000|Overall Study|Subject missed V6.2|1|||
163178708|NCT02674854|589369247|FG001|Overall Study|Subject missed V6.2|0|||
163178709|NCT02674854|589369248|FG002|Overall Study|Subject missed V6.2|0|||
163178710|NCT00879879|589369249|FG000|Overall Study|Death|1|||
163178711|NCT00879879|589369249|FG000|Overall Study|Withdrawal by Subject|1|||
163178712|NCT00879879|589369249|FG000|Overall Study|Physician Decision|1|||
163178713|NCT00745615|589369250|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
163178714|NCT00745615|589369251|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
163178715|NCT00745615|589369252|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
163178716|NCT00745615|589369253|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
163178717|NCT00745615|589369254|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
163178718|NCT00745615|589369255|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
163178719|NCT00745615|589369250|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
163178720|NCT00745615|589369251|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
163178721|NCT00745615|589369252|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
163178722|NCT00745615|589369253|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
163178723|NCT00745615|589369254|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
163178724|NCT00745615|589369255|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
163178725|NCT00745615|589369250|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
163178726|NCT00745615|589369251|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
163178727|NCT00745615|589369252|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
162934625|NCT00672620|588464416|FG003|Overall Study|Adverse Event|17|||
162934626|NCT00672620|588464413|FG000|Overall Study|Lack of Efficacy|1|||
163178728|NCT00745615|589369253|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
162934627|NCT00672620|588464414|FG001|Overall Study|Lack of Efficacy|2|||
162934628|NCT00672620|588464415|FG002|Overall Study|Lack of Efficacy|2|||
162934629|NCT00672620|588464416|FG003|Overall Study|Lack of Efficacy|0|||
162934630|NCT00672620|588464413|FG000|Overall Study|Noncompliance with Study Drug|3|||
162934631|NCT00672620|588464414|FG001|Overall Study|Noncompliance with Study Drug|4|||
162934632|NCT00672620|588464415|FG002|Overall Study|Noncompliance with Study Drug|0|||
163283874|NCT00828919|589747641|FG002|Overall Study|No longer willing to participate in study|2|||
163283875|NCT00828919|589747642|FG003|Overall Study|No longer willing to participate in study|0|||
163283876|NCT00828919|589747643|FG004|Overall Study|No longer willing to participate in study|0|||
163283877|NCT00828919|589747639|FG000|Overall Study|Insufficient Clinical Response|0|||
163283878|NCT00828919|589747640|FG001|Overall Study|Insufficient Clinical Response|1|||
163283879|NCT00828919|589747641|FG002|Overall Study|Insufficient Clinical Response|2|||
163283880|NCT00828919|589747642|FG003|Overall Study|Insufficient Clinical Response|0|||
163283881|NCT00828919|589747643|FG004|Overall Study|Insufficient Clinical Response|0|||
163283882|NCT00828919|589747639|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
163283883|NCT00828919|589747640|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
163283884|NCT00828919|589747641|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
163283885|NCT00828919|589747642|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
163283886|NCT00828919|589747643|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
163283887|NCT00828919|589747639|FG000|Overall Study|Other|1|||
163283888|NCT00828919|589747640|FG001|Overall Study|Other|0|||
163283889|NCT00828919|589747641|FG002|Overall Study|Other|1|||
163283890|NCT00828919|589747642|FG003|Overall Study|Other|1|||
163283891|NCT00828919|589747643|FG004|Overall Study|Other|0|||
163283892|NCT00828919|589747639|FG000|Overall Study|Lost to Follow-up|0|||
163283893|NCT00828919|589747640|FG001|Overall Study|Lost to Follow-up|1|||
162934633|NCT00672620|588464416|FG003|Overall Study|Noncompliance with Study Drug|2|||
162934634|NCT00672620|588464413|FG000|Overall Study|Protocol Deviations|5|||
162934635|NCT00672620|588464414|FG001|Overall Study|Protocol Deviations|7|||
162934636|NCT00672620|588464415|FG002|Overall Study|Protocol Deviations|2|||
162934637|NCT00672620|588464416|FG003|Overall Study|Protocol Deviations|5|||
162934638|NCT00672620|588464413|FG000|Overall Study|Withdrawal of Consent|6|||
162934639|NCT00672620|588464414|FG001|Overall Study|Withdrawal of Consent|12|||
162934640|NCT00672620|588464415|FG002|Overall Study|Withdrawal of Consent|5|||
162934641|NCT00672620|588464416|FG003|Overall Study|Withdrawal of Consent|6|||
162934642|NCT00672620|588464413|FG000|Overall Study|Lost to Follow-up|8|||
162934643|NCT00672620|588464414|FG001|Overall Study|Lost to Follow-up|19|||
162934644|NCT00672620|588464415|FG002|Overall Study|Lost to Follow-up|8|||
162934645|NCT00672620|588464416|FG003|Overall Study|Lost to Follow-up|11|||
162934646|NCT00672620|588464413|FG000|Overall Study|Reason not Specified|3|||
162934647|NCT00672620|588464414|FG001|Overall Study|Reason not Specified|3|||
162934648|NCT00672620|588464415|FG002|Overall Study|Reason not Specified|2|||
162934649|NCT00672620|588464416|FG003|Overall Study|Reason not Specified|1|||
162934650|NCT00772577|588464417|FG000|Overall Study|Adverse Event|6|||
162934651|NCT00772577|588464418|FG001|Overall Study|Adverse Event|3|||
162934652|NCT00772577|588464417|FG000|Overall Study|Abnormal laboratory values|0|||
162934653|NCT00772577|588464418|FG001|Overall Study|Abnormal laboratory values|1|||
162934654|NCT00772577|588464417|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162934655|NCT00772577|588464418|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
162934656|NCT00772577|588464417|FG000|Overall Study|Patient withdrew consent|8|||
162934657|NCT00772577|588464418|FG001|Overall Study|Patient withdrew consent|5|||
162934658|NCT00772577|588464417|FG000|Overall Study|Lost to Follow-up|4|||
162934659|NCT00772577|588464418|FG001|Overall Study|Lost to Follow-up|3|||
162934660|NCT00772577|588464417|FG000|Overall Study|Administrative problems|2|||
162934661|NCT00772577|588464418|FG001|Overall Study|Administrative problems|1|||
162934662|NCT00772577|588464417|FG000|Overall Study|Protocol Deviation|3|||
162934663|NCT00772577|588464418|FG001|Overall Study|Protocol Deviation|2|||
162934664|NCT02965820|588464419|FG000|Period 2, Second 30 Days|Adverse Event|1|||
162934665|NCT02965820|588464420|FG001|Period 2, Second 30 Days|Adverse Event|1|||
162934666|NCT01567306|588464421|FG000|Overall Study|Protocol Violation|2|||
162934667|NCT01567306|588464422|FG001|Overall Study|Protocol Violation|2|||
163283894|NCT00828919|589747641|FG002|Overall Study|Lost to Follow-up|0|||
162934668|NCT01567306|588464423|FG002|Overall Study|Protocol Violation|0|||
162934669|NCT01567306|588464424|FG003|Overall Study|Protocol Violation|3|||
162934670|NCT01567306|588464425|FG004|Overall Study|Protocol Violation|1|||
162934671|NCT01567306|588464426|FG005|Overall Study|Protocol Violation|1|||
163283895|NCT00828919|589747642|FG003|Overall Study|Lost to Follow-up|0|||
163283896|NCT00828919|589747643|FG004|Overall Study|Lost to Follow-up|0|||
163283897|NCT05567159|589747644|FG000|Overall Study|Adverse Event|4|||
163283898|NCT05567159|589747644|FG000|Overall Study|Physician Decision|3|||
162934672|NCT01567306|588464421|FG000|Overall Study|Change site living|1|||
162934673|NCT01567306|588464422|FG001|Overall Study|Change site living|0|||
162934674|NCT01567306|588464423|FG002|Overall Study|Change site living|0|||
162934675|NCT01567306|588464424|FG003|Overall Study|Change site living|0|||
163283899|NCT05567159|589747644|FG000|Overall Study|Protocol deviation|1|||
163178729|NCT00745615|589369254|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
163178730|NCT00745615|589369255|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
163178731|NCT00745615|589369250|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
163178732|NCT00745615|589369251|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
163178733|NCT00745615|589369252|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
163178734|NCT00745615|589369253|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
162934676|NCT01567306|588464425|FG004|Overall Study|Change site living|0|||
162934677|NCT01567306|588464426|FG005|Overall Study|Change site living|0|||
162934678|NCT01567306|588464421|FG000|Overall Study|Adverse Event|0|||
162934679|NCT01567306|588464422|FG001|Overall Study|Adverse Event|0|||
162934680|NCT01567306|588464423|FG002|Overall Study|Adverse Event|0|||
162934681|NCT01567306|588464424|FG003|Overall Study|Adverse Event|2|||
162934682|NCT01567306|588464425|FG004|Overall Study|Adverse Event|4|||
162934683|NCT01567306|588464426|FG005|Overall Study|Adverse Event|1|||
162934684|NCT01567306|588464421|FG000|Overall Study|Lost to Follow-up|0|||
162934685|NCT01567306|588464422|FG001|Overall Study|Lost to Follow-up|0|||
162934686|NCT01567306|588464423|FG002|Overall Study|Lost to Follow-up|0|||
162934687|NCT01567306|588464424|FG003|Overall Study|Lost to Follow-up|0|||
162934688|NCT01567306|588464425|FG004|Overall Study|Lost to Follow-up|2|||
162934689|NCT01567306|588464426|FG005|Overall Study|Lost to Follow-up|0|||
162934690|NCT01567306|588464421|FG000|Overall Study|Withdrawal by Subject|0|||
162934691|NCT01567306|588464422|FG001|Overall Study|Withdrawal by Subject|0|||
162934692|NCT01567306|588464423|FG002|Overall Study|Withdrawal by Subject|0|||
162934693|NCT01567306|588464424|FG003|Overall Study|Withdrawal by Subject|0|||
162934694|NCT01567306|588464425|FG004|Overall Study|Withdrawal by Subject|0|||
162934695|NCT01567306|588464426|FG005|Overall Study|Withdrawal by Subject|1|||
162934696|NCT04272775|588464434|FG000|Overall Study|Study Terminated by Sponsor|1|||
162934697|NCT04272775|588464435|FG001|Overall Study|Study Terminated by Sponsor|0|||
162934698|NCT04272775|588464434|FG000|Overall Study|Protocol Violation|0|||
162934699|NCT04272775|588464435|FG001|Overall Study|Protocol Violation|1|||
162934700|NCT04272775|588464434|FG000|Overall Study|Symptomatic Deterioration|1|||
162934701|NCT04272775|588464435|FG001|Overall Study|Symptomatic Deterioration|1|||
162934702|NCT04272775|588464434|FG000|Overall Study|Withdrawal by Subject|1|||
162934703|NCT04272775|588464435|FG001|Overall Study|Withdrawal by Subject|2|||
162934704|NCT04272775|588464434|FG000|Overall Study|Adverse Event|1|||
162934705|NCT04272775|588464435|FG001|Overall Study|Adverse Event|2|||
162934706|NCT04272775|588464434|FG000|Overall Study|Progressive Disease|3|||
162934707|NCT04272775|588464435|FG001|Overall Study|Progressive Disease|1|||
162934708|NCT02063698|588464438|FG000|Overall Study|did not complete booklet for days 2-8|1|||
162934709|NCT02063698|588464439|FG001|Overall Study|did not complete booklet for days 2-8|2|||
162934710|NCT01092702|588464440|FG000|Overall Study|Withdrawal by Subject|7|||
162934711|NCT01092702|588464440|FG000|Overall Study|Lost to Follow-up|2|||
162934712|NCT00449930|588464441|FG000|Overall Study|Adverse Event|9|||
162934713|NCT00449930|588464442|FG001|Overall Study|Adverse Event|19|||
162934714|NCT00449930|588464441|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
162934715|NCT00449930|588464442|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
162934716|NCT00449930|588464441|FG000|Overall Study|Lack of Efficacy|10|||
162934717|NCT00449930|588464442|FG001|Overall Study|Lack of Efficacy|1|||
162934718|NCT00449930|588464441|FG000|Overall Study|Lost to Follow-up|9|||
162934719|NCT00449930|588464442|FG001|Overall Study|Lost to Follow-up|14|||
162934720|NCT00449930|588464441|FG000|Overall Study|Physician Decision|1|||
162934721|NCT00449930|588464442|FG001|Overall Study|Physician Decision|2|||
162934722|NCT00449930|588464441|FG000|Overall Study|Protocol Violation|14|||
162934723|NCT00449930|588464442|FG001|Overall Study|Protocol Violation|15|||
162934724|NCT00449930|588464441|FG000|Overall Study|Withdrawal by Subject|16|||
162934725|NCT00449930|588464442|FG001|Overall Study|Withdrawal by Subject|23|||
162934726|NCT00449930|588464441|FG000|Overall Study|Glycemic discontinuation criteria|1|||
162934727|NCT00449930|588464442|FG001|Overall Study|Glycemic discontinuation criteria|1|||
162934728|NCT00575328|588464444|FG000|Overall Study|Adverse Event|1|||
162934729|NCT00575328|588464445|FG001|Overall Study|Adverse Event|1|||
163178735|NCT00745615|589369254|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
163178736|NCT00745615|589369255|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
163178737|NCT00745615|589369250|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
163178738|NCT00745615|589369251|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
163178739|NCT00745615|589369252|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
163178740|NCT00745615|589369253|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
163178741|NCT00745615|589369254|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
163178742|NCT00745615|589369255|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
163178743|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
163178744|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
163178745|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
163042828|NCT01990768|588863969|FG001|6-Month Follow-up|No contact information|6|||
163042829|NCT01990768|588863970|FG002|6-Month Follow-up|No contact information|5|||
163042830|NCT01990768|588863968|FG000|6-Month Follow-up|Homeless|4|||
163042831|NCT01990768|588863969|FG001|6-Month Follow-up|Homeless|3|||
163178746|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
162934730|NCT00575328|588464444|FG000|Overall Study|Lost to Follow-up|2|||
162934731|NCT00575328|588464445|FG001|Overall Study|Lost to Follow-up|1|||
162934732|NCT02124746|588464446|FG000|Overall Study|Adverse Event|2|||
162934733|NCT02124746|588464447|FG001|Overall Study|Adverse Event|1|||
162934734|NCT02124746|588464448|FG002|Overall Study|Adverse Event|2|||
162934735|NCT02124746|588464446|FG000|Overall Study|Death|2|||
162934736|NCT02124746|588464447|FG001|Overall Study|Death|1|||
162934737|NCT02124746|588464448|FG002|Overall Study|Death|3|||
162934738|NCT02124746|588464446|FG000|Overall Study|Lack of Efficacy|3|||
162934739|NCT02124746|588464447|FG001|Overall Study|Lack of Efficacy|2|||
162934740|NCT02124746|588464448|FG002|Overall Study|Lack of Efficacy|2|||
162934741|NCT02124746|588464446|FG000|Overall Study|Physician Decision|6|||
162934742|NCT02124746|588464447|FG001|Overall Study|Physician Decision|4|||
162934743|NCT02124746|588464448|FG002|Overall Study|Physician Decision|5|||
162934744|NCT02124746|588464446|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162934745|NCT02124746|588464447|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162934746|NCT02124746|588464448|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162934747|NCT02124746|588464446|FG000|Overall Study|Withdrawal by Subject|3|||
162934748|NCT02124746|588464447|FG001|Overall Study|Withdrawal by Subject|3|||
162934749|NCT02124746|588464448|FG002|Overall Study|Withdrawal by Subject|0|||
162934750|NCT02124746|588464446|FG000|Overall Study|Study Terminated by Sponsor|0|||
162934751|NCT02124746|588464447|FG001|Overall Study|Study Terminated by Sponsor|0|||
162934752|NCT02124746|588464448|FG002|Overall Study|Study Terminated by Sponsor|6|||
162934753|NCT02124746|588464446|FG000|Overall Study|Disease Progression|3|||
162934754|NCT02124746|588464447|FG001|Overall Study|Disease Progression|6|||
162934755|NCT02124746|588464448|FG002|Overall Study|Disease Progression|4|||
162934756|NCT01722266|588464453|FG000|Overall Study|Withdrawal by Subject|1|||
162934757|NCT01722266|588464454|FG001|Overall Study|Withdrawal by Subject|2|||
162934758|NCT01722266|588464455|FG002|Overall Study|Withdrawal by Subject|0|||
162934759|NCT01722266|588464456|FG003|Overall Study|Withdrawal by Subject|0|||
162934760|NCT01722266|588464453|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
162934761|NCT01722266|588464454|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
162934762|NCT01722266|588464455|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
162934763|NCT01722266|588464456|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
162934764|NCT01722266|588464453|FG000|Overall Study|Dropped out due to Nausea|0|||
162934765|NCT01722266|588464454|FG001|Overall Study|Dropped out due to Nausea|0|||
162934766|NCT01722266|588464455|FG002|Overall Study|Dropped out due to Nausea|2|||
162934767|NCT01722266|588464456|FG003|Overall Study|Dropped out due to Nausea|0|||
162934768|NCT03811249|588464457|FG000|Overall Study|Withdrawal by Subject|44|||
163178747|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
163178748|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
163178749|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
163178750|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
163178751|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
163178752|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
163178753|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
163178754|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
163178755|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
163178756|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
163178757|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
163178758|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
163178759|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
163178760|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
163178761|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
163178762|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
163178763|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
163178764|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
163178765|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
163178766|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
163178767|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
163178768|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
163178769|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
163178770|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
163178771|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
162934769|NCT03811249|588464457|FG000|Overall Study|Missed Visit|24|||
163178772|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
163178773|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
163178774|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
163178775|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
163178776|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
163178777|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
163178778|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
163283900|NCT04155424|589747645|FG000|Overall Study|Other than specified|3|||
162934770|NCT00124449|588464458|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
162934771|NCT00124449|588464459|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
162934772|NCT00124449|588464458|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
163283901|NCT04155424|589747645|FG000|Overall Study|Withdrawal by Subject|1|||
163283902|NCT04155424|589747645|FG000|Overall Study|Adverse Event|1|||
163283903|NCT01091454|589749333|FG000|Overall Study|Ineligible|1|||
163283904|NCT01510912|589749334|FG000|Overall Study|Adverse Event|99|||
163283905|NCT01510912|589749334|FG000|Overall Study|Lack of Efficacy|12|||
163283906|NCT01510912|589749334|FG000|Overall Study|Non-compliance with trial drug|23|||
163283907|NCT01510912|589749334|FG000|Overall Study|Withdrawal by Subject|49|||
163283908|NCT01510912|589749334|FG000|Overall Study|Physician Decision|1|||
163283909|NCT01510912|589749334|FG000|Overall Study|Protocol Violation|27|||
163283910|NCT01510912|589749334|FG000|Overall Study|Lost to Follow-up|26|||
163283911|NCT01510912|589749334|FG000|Overall Study|Other, including joint replacement|5|||
163283912|NCT02030028|589749335|FG000|Overall Study|Withdrawal by Subject|4|||
163283913|NCT02030028|589749335|FG000|Overall Study|lack of transportation|1|||
163283914|NCT00661778|589749336|FG000|Overall Study|Disease Progression|23|||
163283915|NCT00661778|589749336|FG000|Overall Study|Adverse Event|18|||
163283916|NCT00661778|589749336|FG000|Overall Study|Reason not Specified|6|||
163283917|NCT00661778|589749336|FG000|Overall Study|Protocol Violation|2|||
163283918|NCT00661778|589749336|FG000|Overall Study|Withdrawal of Consent|1|||
163283919|NCT00817635|589749341|FG000|Overall Study|Adverse Event|1|||
163283920|NCT00817635|589749342|FG001|Overall Study|Adverse Event|0|||
162934773|NCT00124449|588464459|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
162934774|NCT00124449|588464458|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
162934775|NCT00124449|588464459|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
162934776|NCT00124449|588464458|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
162934777|NCT00124449|588464459|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
162934778|NCT00124449|588464458|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
162934779|NCT00124449|588464459|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
162934780|NCT00124449|588464458|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
162934781|NCT00124449|588464459|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
162934782|NCT00124449|588464458|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
162934783|NCT00124449|588464459|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
162934784|NCT00124449|588464458|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
162934785|NCT00124449|588464459|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
162934786|NCT00124449|588464458|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
162934787|NCT00124449|588464459|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
162934788|NCT00124449|588464458|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
162934789|NCT00124449|588464459|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
162934790|NCT00124449|588464458|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
162934791|NCT00124449|588464459|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
162934792|NCT00124449|588464458|FG000|18-Month Untreated Observation Period|Relocated|1|||
162934793|NCT00124449|588464459|FG001|18-Month Untreated Observation Period|Relocated|0|||
162934794|NCT03124381|588464468|FG000|Overall Study|Lost to Follow-up|1|||
162934795|NCT03124381|588464469|FG001|Overall Study|Lost to Follow-up|1|||
162934796|NCT03124381|588464468|FG000|Overall Study|Withdrawal by Subject|6|||
162934797|NCT03124381|588464469|FG001|Overall Study|Withdrawal by Subject|3|||
162934798|NCT03124381|588464468|FG000|Overall Study|Protocol Violation|0|||
162934799|NCT03124381|588464469|FG001|Overall Study|Protocol Violation|1|||
162934800|NCT03124381|588464468|FG000|Overall Study|Adverse Event|1|||
162934801|NCT03124381|588464469|FG001|Overall Study|Adverse Event|1|||
162934802|NCT03124381|588464468|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
162934803|NCT03124381|588464469|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
162934804|NCT02473510|588464470|FG000|Overall Study|Lost to Follow-up|1|||
162934805|NCT02473510|588464471|FG001|Overall Study|Lost to Follow-up|2|||
162934806|NCT00990093|588464472|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
162934807|NCT00990093|588464473|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
162934808|NCT00990093|588464472|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
162934809|NCT00990093|588464473|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
162934810|NCT00990093|588464472|FG000|Test Period 1 (1-14 Days)|Other|1|||
162934811|NCT00990093|588464473|FG001|Test Period 1 (1-14 Days)|Other|0|||
162934812|NCT00990093|588464472|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
162934813|NCT00990093|588464473|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
163283921|NCT00817635|589749343|FG002|Overall Study|Adverse Event|0|||
163283922|NCT00817635|589749344|FG003|Overall Study|Adverse Event|1|||
162934814|NCT00990093|588464472|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
163283923|NCT00817635|589749345|FG004|Overall Study|Adverse Event|1|||
163283924|NCT00817635|589749341|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
163283925|NCT00817635|589749342|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
162934815|NCT00990093|588464473|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
162934816|NCT00990093|588464472|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
163042832|NCT01990768|588863970|FG002|6-Month Follow-up|Homeless|6|||
163283926|NCT00817635|589749343|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
163283927|NCT00817635|589749344|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
163283928|NCT00817635|589749345|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
163178779|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
163178780|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
163178781|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
163178782|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
163178783|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
163178784|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
163178785|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
163178786|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
163178787|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
163178788|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
163178789|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
163178790|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
163178791|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
162934817|NCT00990093|588464473|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
162934818|NCT00990093|588464472|FG000|Test Period 2 (15-28 Days)|Other|0|||
162934819|NCT00990093|588464473|FG001|Test Period 2 (15-28 Days)|Other|1|||
162934820|NCT03185949|588464474|FG000|ITT Analysis|Withdrawal by Subject|4|||
162934821|NCT03185949|588464475|FG001|ITT Analysis|Withdrawal by Subject|3|||
162934822|NCT03185949|588464474|FG000|PP Analysis|Protocol Violation|2|||
162934823|NCT03185949|588464475|FG001|PP Analysis|Protocol Violation|2|||
162934824|NCT03185949|588464474|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
162934825|NCT03185949|588464475|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
162934826|NCT01806597|588466078|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
162934827|NCT01806597|588466079|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
162934828|NCT01806597|588466080|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
162934829|NCT01806597|588466081|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
162934830|NCT01806597|588466082|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
163178792|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
163178793|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
163178794|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
163178795|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
163178796|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
163178797|NCT00570232|589369256|FG000|Overall Study|Adverse Event|10|||
163178798|NCT00570232|589369256|FG000|Overall Study|discontinued due to medical condition|3|||
163178799|NCT00570232|589369256|FG000|Overall Study|discontinued due to recurrence|8|||
163178800|NCT00570232|589369256|FG000|Overall Study|discontinued due to noncompliance|2|||
163178801|NCT01076075|589369257|FG000|Overall Study|Adverse Event|3|||
163178802|NCT01076075|589369258|FG001|Overall Study|Adverse Event|9|||
163178803|NCT01076075|589369257|FG000|Overall Study|Lack of Efficacy|5|||
163178804|NCT01076075|589369258|FG001|Overall Study|Lack of Efficacy|4|||
163178805|NCT01076075|589369257|FG000|Overall Study|Lost to Follow-up|6|||
162934831|NCT01806597|588466083|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
163178806|NCT01076075|589369258|FG001|Overall Study|Lost to Follow-up|5|||
163178807|NCT01076075|589369257|FG000|Overall Study|other|19|||
163178808|NCT01076075|589369258|FG001|Overall Study|other|9|||
163178809|NCT01076075|589369257|FG000|Overall Study|Protocol Violation|0|||
163178810|NCT01076075|589369258|FG001|Overall Study|Protocol Violation|1|||
163178811|NCT01076075|589369257|FG000|Overall Study|Withdrawal by Subject|8|||
162934832|NCT01806597|588466078|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
162934833|NCT01806597|588466079|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
162934834|NCT01806597|588466080|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
162934835|NCT01806597|588466081|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
162934836|NCT01806597|588466082|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
162934837|NCT01806597|588466083|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
162934838|NCT01806597|588466078|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
162934839|NCT01806597|588466079|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
162934840|NCT01806597|588466080|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
162934841|NCT01806597|588466081|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
162934842|NCT01806597|588466082|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
162934843|NCT01806597|588466083|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
162934844|NCT01806597|588466078|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
162934845|NCT01806597|588466079|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
162934846|NCT01806597|588466080|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
162934847|NCT01806597|588466081|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
162934848|NCT01806597|588466082|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
162934849|NCT01806597|588466083|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
162934850|NCT01806597|588466078|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
162934851|NCT01806597|588466079|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
162934852|NCT01806597|588466080|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
162934853|NCT01806597|588466081|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
162934854|NCT01806597|588466082|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
162934855|NCT01806597|588466083|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
162934856|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
162934857|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
162934858|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
162934859|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
162934860|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
162934861|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
162934862|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
162934863|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
162934864|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
162934865|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
162934866|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
162934867|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
162934868|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
162934869|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
162934870|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
162934871|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
162934872|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
162934873|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
162934874|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
162934875|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
162934876|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
162934877|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
162934878|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
162934879|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
162934880|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
162934881|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
162934882|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
162934883|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
162934884|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
162934885|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
162934886|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
162934887|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
162934888|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
162934889|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
162934890|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
162934891|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
162934892|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
162934893|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
162934894|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
163283929|NCT00817635|589749341|FG000|Overall Study|Withdrawal by Subject|2|||
163283930|NCT00817635|589749342|FG001|Overall Study|Withdrawal by Subject|1|||
162934895|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
162934896|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
162934897|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
162934898|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
162934899|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
162934900|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
162934901|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
162934902|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
162934903|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
162934904|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
162934905|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
162934906|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
162934907|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
162934908|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
162934909|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
162934910|NCT01806597|588466078|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
162934911|NCT01806597|588466079|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
162934912|NCT01806597|588466080|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
162934913|NCT01806597|588466081|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
162934914|NCT01806597|588466082|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
162934915|NCT01806597|588466083|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
162934916|NCT01806597|588466078|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
162934917|NCT01806597|588466079|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
162934918|NCT01806597|588466080|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
162934919|NCT01806597|588466081|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
162934920|NCT01806597|588466082|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
162934921|NCT01806597|588466083|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
162934922|NCT01806597|588466078|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
162934923|NCT01806597|588466079|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
162934924|NCT01806597|588466080|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
162934925|NCT01806597|588466081|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
162934926|NCT01806597|588466082|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
162934927|NCT01806597|588466083|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
162934928|NCT01806597|588466078|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
162934929|NCT01806597|588466079|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
162934930|NCT01806597|588466080|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
162934931|NCT01806597|588466081|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
162934932|NCT01806597|588466082|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
162934933|NCT01806597|588466083|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
162934934|NCT01806597|588466078|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
162934935|NCT01806597|588466079|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
162934936|NCT01806597|588466080|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
162934937|NCT01806597|588466081|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
162934938|NCT01806597|588466082|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
162934939|NCT01806597|588466083|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
162934940|NCT01473758|588466085|FG000|Cycle 1|Adverse Event|10|||
162934941|NCT01473758|588466086|FG001|Cycle 1|Adverse Event|2|||
162934942|NCT01473758|588466087|FG002|Cycle 1|Adverse Event|0|||
162934943|NCT01473758|588466088|FG003|Cycle 1|Adverse Event|0|||
162934944|NCT01473758|588466085|FG000|Cycle 1|Withdrawal by Subject|1|||
162934945|NCT01473758|588466086|FG001|Cycle 1|Withdrawal by Subject|1|||
162934946|NCT01473758|588466087|FG002|Cycle 1|Withdrawal by Subject|0|||
162934947|NCT01473758|588466088|FG003|Cycle 1|Withdrawal by Subject|0|||
162934948|NCT01473758|588466085|FG000|Cycle 2|Adverse Event|0|||
162934949|NCT01473758|588466086|FG001|Cycle 2|Adverse Event|0|||
162934950|NCT01473758|588466087|FG002|Cycle 2|Adverse Event|5|||
162934951|NCT01473758|588466088|FG003|Cycle 2|Adverse Event|0|||
162934952|NCT02763579|588466089|FG000|Global Period|Death|167|||
162934953|NCT02763579|588466090|FG001|Global Period|Death|151|||
162934954|NCT02763579|588466091|FG002|Global Period|Death|0|||
162934955|NCT02763579|588466092|FG003|Global Period|Death|0|||
162934956|NCT02763579|588466089|FG000|Global Period|Lost to Follow-up|2|||
162934957|NCT02763579|588466090|FG001|Global Period|Lost to Follow-up|4|||
162934958|NCT02763579|588466091|FG002|Global Period|Lost to Follow-up|0|||
162934959|NCT02763579|588466092|FG003|Global Period|Lost to Follow-up|0|||
162934960|NCT02763579|588466089|FG000|Global Period|Physician Decision|0|||
162934961|NCT02763579|588466090|FG001|Global Period|Physician Decision|2|||
163283931|NCT00817635|589749343|FG002|Overall Study|Withdrawal by Subject|0|||
162934962|NCT02763579|588466091|FG002|Global Period|Physician Decision|0|||
162934963|NCT02763579|588466092|FG003|Global Period|Physician Decision|0|||
162934964|NCT02763579|588466089|FG000|Global Period|Study Terminated By Sponsor|21|||
162934965|NCT02763579|588466090|FG001|Global Period|Study Terminated By Sponsor|26|||
162934966|NCT02763579|588466091|FG002|Global Period|Study Terminated By Sponsor|0|||
162934967|NCT02763579|588466092|FG003|Global Period|Study Terminated By Sponsor|0|||
162934968|NCT02763579|588466089|FG000|Global Period|Withdrawal by Subject|12|||
162934969|NCT02763579|588466090|FG001|Global Period|Withdrawal by Subject|18|||
162934970|NCT02763579|588466091|FG002|Global Period|Withdrawal by Subject|0|||
162934971|NCT02763579|588466092|FG003|Global Period|Withdrawal by Subject|0|||
162934972|NCT02763579|588466089|FG000|China Period|Death|0|||
162934973|NCT02763579|588466090|FG001|China Period|Death|0|||
162934974|NCT02763579|588466091|FG002|China Period|Death|46|||
162934975|NCT02763579|588466092|FG003|China Period|Death|48|||
162934976|NCT02763579|588466089|FG000|China Period|Lost to Follow-up|0|||
162934977|NCT02763579|588466090|FG001|China Period|Lost to Follow-up|0|||
162934978|NCT02763579|588466091|FG002|China Period|Lost to Follow-up|1|||
162934979|NCT02763579|588466092|FG003|China Period|Lost to Follow-up|1|||
162934980|NCT02763579|588466089|FG000|China Period|Physician Decision|0|||
162934981|NCT02763579|588466090|FG001|China Period|Physician Decision|0|||
162934982|NCT02763579|588466091|FG002|China Period|Physician Decision|0|||
162934983|NCT02763579|588466092|FG003|China Period|Physician Decision|1|||
162934984|NCT02763579|588466089|FG000|China Period|Study Terminated By Sponsor|0|||
162934985|NCT02763579|588466090|FG001|China Period|Study Terminated By Sponsor|0|||
162934986|NCT02763579|588466091|FG002|China Period|Study Terminated By Sponsor|3|||
162934987|NCT02763579|588466092|FG003|China Period|Study Terminated By Sponsor|4|||
162934988|NCT02763579|588466089|FG000|China Period|Withdrawal by Subject|0|||
162934989|NCT02763579|588466090|FG001|China Period|Withdrawal by Subject|0|||
162934990|NCT02763579|588466091|FG002|China Period|Withdrawal by Subject|3|||
162934991|NCT02763579|588466092|FG003|China Period|Withdrawal by Subject|3|||
162934992|NCT00829413|588466096|FG000|Overall Study|No study drug admimnistered|13|||
162934993|NCT00829413|588466096|FG000|Overall Study|Training Patients|67|||
162934994|NCT00829413|588466096|FG000|Overall Study|No truth standard procedure available|9|||
162934995|NCT00829413|588466096|FG000|Overall Study|Technically inadequate truth standard|2|||
162934996|NCT00829413|588466096|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
162934997|NCT00294723|588466100|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
162934998|NCT00294723|588466101|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
162934999|NCT00294723|588466102|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
162935000|NCT00294723|588466100|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
162935001|NCT00294723|588466101|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
162935002|NCT00294723|588466102|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
162935003|NCT00294723|588466100|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
162935004|NCT00294723|588466101|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
162935005|NCT00294723|588466102|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
162935006|NCT00294723|588466100|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
162935007|NCT00294723|588466101|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
162935008|NCT00294723|588466102|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
162935009|NCT00294723|588466100|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
162935010|NCT00294723|588466101|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
162935011|NCT00294723|588466102|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
162935012|NCT00294723|588466100|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
162935013|NCT00294723|588466101|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
162935014|NCT00294723|588466102|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
163178812|NCT01076075|589369258|FG001|Overall Study|Withdrawal by Subject|19|||
163178813|NCT03326206|589369265|FG000|Overall Study - 24 months|Unable to match cases with controls|17|||
163178814|NCT03326206|589369266|FG001|Overall Study - 24 months|Unable to match cases with controls|22721|||
163178815|NCT03326206|589369265|FG000|Overall Study - 24 months|Death|8|||
163178816|NCT03326206|589369266|FG001|Overall Study - 24 months|Death|92|||
163178817|NCT03326206|589369265|FG000|Overall Study - 24 months|Observational data not available|43|||
163178818|NCT03326206|589369266|FG001|Overall Study - 24 months|Observational data not available|2879|||
163178819|NCT03326206|589369265|FG000|12 months|Unable to match cases with controls|17|||
163178820|NCT03326206|589369266|FG001|12 months|Unable to match cases with controls|22721|||
163283932|NCT00817635|589749344|FG003|Overall Study|Withdrawal by Subject|1|||
162935015|NCT00294723|588466100|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
162935016|NCT00294723|588466101|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
162935017|NCT00294723|588466102|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
162935018|NCT00294723|588466100|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
163283933|NCT00817635|589749345|FG004|Overall Study|Withdrawal by Subject|2|||
162935019|NCT00294723|588466101|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
162935020|NCT00294723|588466102|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
162935021|NCT00294723|588466100|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
163178821|NCT03326206|589369265|FG000|12 months|Death|2|||
163178822|NCT03326206|589369266|FG001|12 months|Death|50|||
163178823|NCT03326206|589369265|FG000|12 months|Observational data not available|49|||
162935022|NCT00294723|588466101|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
162935023|NCT00294723|588466102|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
162935024|NCT00294723|588466100|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
162935025|NCT00294723|588466101|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
162935026|NCT00294723|588466102|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
162935027|NCT00294723|588466100|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
162935028|NCT00294723|588466101|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
162935029|NCT00294723|588466102|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
162935030|NCT00294723|588466100|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
162935031|NCT00294723|588466101|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
162935032|NCT00294723|588466102|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
162935033|NCT00891774|588466107|FG000|Overall Study|Lost to Follow-up|5|||
162935034|NCT00891774|588466107|FG000|Overall Study|Illness (Self/Mother)|3|||
162935035|NCT00891774|588466107|FG000|Overall Study|Withdrawal by Subject|2|||
162935036|NCT00891774|588466107|FG000|Overall Study|Protocol Violation|4|||
162935037|NCT03255031|588466112|FG000|Overall Study|Adverse Event|5|||
162935038|NCT03255031|588466113|FG001|Overall Study|Adverse Event|3|||
162935039|NCT03255031|588466112|FG000|Overall Study|Physician Decision|2|||
162935040|NCT03255031|588466113|FG001|Overall Study|Physician Decision|1|||
162935041|NCT03255031|588466112|FG000|Overall Study|Withdrawal by Subject|9|||
162935042|NCT03255031|588466113|FG001|Overall Study|Withdrawal by Subject|3|||
162935043|NCT01809314|588466114|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
162935044|NCT01809314|588466114|FG000|Overall Study|Adverse Event|6|||
162935045|NCT01809314|588466114|FG000|Overall Study|Insufficient Therapeutic Response|14|||
162935046|NCT01809314|588466114|FG000|Overall Study|Lost to Follow-up|724|||
162935047|NCT00863057|588466117|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
162935048|NCT00863057|588466118|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
162935049|NCT00863057|588466119|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
162935050|NCT00863057|588466120|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
162935051|NCT00863057|588466117|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
162935052|NCT00863057|588466118|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
162935053|NCT00863057|588466119|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
162935054|NCT00863057|588466120|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
162935055|NCT00863057|588466117|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
162935056|NCT00863057|588466118|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
162935057|NCT00863057|588466119|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
163178824|NCT03326206|589369266|FG001|12 months|Observational data not available|2921|||
163178825|NCT01958827|589369267|FG000|Overall Study|Adverse Event|3|||
163178826|NCT01958827|589369267|FG000|Overall Study|Lack of Efficacy|6|||
163178827|NCT01958827|589369267|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
163178828|NCT01163318|589369268|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
163178829|NCT01163318|589369268|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
163178830|NCT01163318|589369268|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
163178831|NCT01163318|589369268|FG000|Overall Study|Participants Without Case Report Form|7|||
163178832|NCT01163318|589369268|FG000|Overall Study|Multiple Reasons Per Participant|224|||
163178833|NCT03587727|589369269|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
163178834|NCT03587727|589369269|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
163178835|NCT04770753|589370466|FG000|Overall Study|Randomized, never treated|1|||
163178836|NCT04770753|589370467|FG001|Overall Study|Randomized, never treated|1|||
163178837|NCT04770753|589370466|FG000|Overall Study|Withdrawal by Subject|3|||
163178838|NCT04770753|589370467|FG001|Overall Study|Withdrawal by Subject|1|||
163178839|NCT04770753|589370466|FG000|Overall Study|Adverse Event|2|||
163178840|NCT04770753|589370467|FG001|Overall Study|Adverse Event|0|||
163178841|NCT04770753|589370466|FG000|Overall Study|Pregnancy|1|||
163178842|NCT04770753|589370467|FG001|Overall Study|Pregnancy|0|||
163178843|NCT04770753|589370466|FG000|Overall Study|Other un-specified|1|||
163178844|NCT04770753|589370467|FG001|Overall Study|Other un-specified|0|||
163178845|NCT04562480|589370468|FG000|Overall Study|Withdrawal by Subject|1|||
163178852|NCT04001829|589370477|FG000|Overall Study|Never start protocol therapy|5|||
163178853|NCT04001829|589370478|FG001|Overall Study|Never start protocol therapy|5|||
163178854|NCT04001829|589370477|FG000|Overall Study|Adverse Event|11|||
163178855|NCT04001829|589370478|FG001|Overall Study|Adverse Event|7|||
163178856|NCT04001829|589370477|FG000|Overall Study|Alternative therapy|1|||
163178857|NCT04001829|589370478|FG001|Overall Study|Alternative therapy|2|||
163178858|NCT04001829|589370477|FG000|Overall Study|Disease progression/relapse|2|||
163178859|NCT04001829|589370478|FG001|Overall Study|Disease progression/relapse|1|||
162935058|NCT00863057|588466120|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
162935059|NCT00863057|588466117|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
162935060|NCT00863057|588466118|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
162935061|NCT00863057|588466119|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
162935062|NCT00863057|588466120|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
162935063|NCT02974114|588466124|FG000|Overall Study|Other (Not specified)|0|||
162935064|NCT02974114|588466125|FG001|Overall Study|Other (Not specified)|1|||
162935065|NCT02974114|588466126|FG002|Overall Study|Other (Not specified)|2|||
162935066|NCT00545233|588466129|FG000|Overall Study|Adverse Event|10|||
162935067|NCT00545233|588466130|FG001|Overall Study|Adverse Event|5|||
162935068|NCT00545233|588466129|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
162935069|NCT00545233|588466130|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
162935070|NCT00545233|588466129|FG000|Overall Study|Protocol Violation|2|||
162935071|NCT00545233|588466130|FG001|Overall Study|Protocol Violation|0|||
162935072|NCT00545233|588466129|FG000|Overall Study|Refused Treatment|9|||
162935073|NCT00545233|588466130|FG001|Overall Study|Refused Treatment|7|||
162935074|NCT00545233|588466129|FG000|Overall Study|Failure to Return|4|||
162935075|NCT00545233|588466130|FG001|Overall Study|Failure to Return|6|||
162935076|NCT00545233|588466129|FG000|Overall Study|Insufficient response|14|||
162935077|NCT00545233|588466130|FG001|Overall Study|Insufficient response|15|||
162935078|NCT00545233|588466129|FG000|Overall Study|Physician Decision|2|||
162935079|NCT00545233|588466130|FG001|Overall Study|Physician Decision|1|||
162935080|NCT06371079|588466131|FG000|Overall Study|Missing data|88|||
162935081|NCT06371079|588466132|FG001|Overall Study|Missing data|247|||
162935082|NCT01238211|588466133|FG000|Overall Study|Continues active treatment|31|||
162935083|NCT01238211|588466133|FG000|Overall Study|Adverse Event|7|||
162935084|NCT01238211|588466133|FG000|Overall Study|Death|4|||
162935085|NCT01238211|588466133|FG000|Overall Study|Relapse/Progression|2|||
163178860|NCT04001829|589370477|FG000|Overall Study|Other complicating disease|1|||
163178861|NCT04001829|589370478|FG001|Overall Study|Other complicating disease|0|||
163178862|NCT04001829|589370477|FG000|Overall Study|Withdrawal by Subject|1|||
163178863|NCT04001829|589370478|FG001|Overall Study|Withdrawal by Subject|4|||
163178864|NCT04001829|589370477|FG000|Overall Study|Ineligible|2|||
163178865|NCT04001829|589370478|FG001|Overall Study|Ineligible|2|||
163178866|NCT04001829|589370477|FG000|Overall Study|Reason missing due to delinquent data|1|||
163178867|NCT04001829|589370478|FG001|Overall Study|Reason missing due to delinquent data|0|||
163178868|NCT05859698|589370479|FG000|Overall Study|Adverse Event|1|||
163178869|NCT05859698|589370479|FG000|Overall Study|Death|1|||
163178870|NCT05859698|589370479|FG000|Overall Study|Physician Decision|1|||
163178871|NCT05859698|589370479|FG000|Overall Study|Lost to Follow-up|2|||
163178872|NCT05859698|589370479|FG000|Overall Study|Other Than Specified|2|||
163178873|NCT05859698|589370479|FG000|Overall Study|Withdrawal by Subject|1|||
163178874|NCT05900999|589370480|FG000|Overall Study|Withdrawal by Subject|9|||
163178875|NCT05900999|589370480|FG000|Overall Study|transfer to another facility; too complex of a therapy schedule; physician withdrawal|3|||
163178878|NCT05388058|589370484|FG000|Initial Treatment|Withdrawal by Subject|0|||
163178879|NCT05388058|589370485|FG001|Initial Treatment|Withdrawal by Subject|1|||
163178880|NCT05388058|589370484|FG000|Initial Treatment|Ineligible|0|||
163178881|NCT05388058|589370485|FG001|Initial Treatment|Ineligible|1|||
162935086|NCT01238211|588466133|FG000|Overall Study|Withdrawal by Subject|7|||
163178890|NCT04527549|589370492|FG000|Overall Study|Withdrawal by Subject|1|||
163178891|NCT04527549|589370493|FG001|Overall Study|Withdrawal by Subject|1|||
163178892|NCT04831216|589370498|FG000|Overall Study|Lost to Follow-up|32|||
163178905|NCT03470441|589370504|FG000|Overall Study|Death|0|||
163178906|NCT03470441|589370505|FG001|Overall Study|Death|1|||
163178907|NCT03470441|589370506|FG002|Overall Study|Death|1|||
163178908|NCT03470441|589370507|FG003|Overall Study|Death|0|||
163178909|NCT03470441|589370504|FG000|Overall Study|Adverse Event|0|||
163178910|NCT03470441|589370505|FG001|Overall Study|Adverse Event|0|||
163178911|NCT03470441|589370506|FG002|Overall Study|Adverse Event|0|||
163178912|NCT03470441|589370507|FG003|Overall Study|Adverse Event|1|||
163178913|NCT03470441|589370504|FG000|Overall Study|Withdrawal by Subject|1|||
163178914|NCT03470441|589370505|FG001|Overall Study|Withdrawal by Subject|4|||
163178915|NCT03470441|589370506|FG002|Overall Study|Withdrawal by Subject|1|||
163178916|NCT03470441|589370507|FG003|Overall Study|Withdrawal by Subject|3|||
163178926|NCT05411367|589370512|FG000|Overall Study|Adverse Event|9|||
163178927|NCT05411367|589370513|FG001|Overall Study|Adverse Event|3|||
163178928|NCT05411367|589370512|FG000|Overall Study|Protocol Violation|0|||
163178929|NCT05411367|589370513|FG001|Overall Study|Protocol Violation|2|||
163178930|NCT05411367|589370512|FG000|Overall Study|Administrative Reasons|2|||
163178931|NCT05411367|589370513|FG001|Overall Study|Administrative Reasons|1|||
163178932|NCT05411367|589370512|FG000|Overall Study|Withdrawal by Subject|3|||
163178933|NCT05411367|589370513|FG001|Overall Study|Withdrawal by Subject|4|||
163178934|NCT05411367|589370512|FG000|Overall Study|Inclusion Criteria Not Met|0|||
163178935|NCT05411367|589370513|FG001|Overall Study|Inclusion Criteria Not Met|1|||
163178936|NCT02032823|589370516|FG000|Overall Study|Death|75|||
163178937|NCT02032823|589370517|FG001|Overall Study|Death|109|||
163178938|NCT02032823|589370516|FG000|Overall Study|Lost to Follow-up|18|||
163178939|NCT02032823|589370517|FG001|Overall Study|Lost to Follow-up|17|||
163178940|NCT02032823|589370516|FG000|Overall Study|Withdrawal by Subject|70|||
163178941|NCT02032823|589370517|FG001|Overall Study|Withdrawal by Subject|53|||
163178942|NCT02032823|589370516|FG000|Overall Study|Ongoing study at data cut-off|755|||
163178943|NCT02032823|589370517|FG001|Overall Study|Ongoing study at data cut-off|731|||
163178944|NCT02032823|589370516|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
163178945|NCT02032823|589370517|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
163283934|NCT00817635|589749341|FG000|Overall Study|Lost to Follow-up|0|||
162935087|NCT01238211|588466133|FG000|Overall Study|Non-protocol treatment|4|||
162935088|NCT01238211|588466133|FG000|Overall Study|Investigator/Patient Decision|3|||
162935089|NCT02868281|588466134|FG000|Overall Study|Adverse Event|2|||
162935090|NCT02868281|588466135|FG001|Overall Study|Adverse Event|2|||
162935091|NCT02868281|588466134|FG000|Overall Study|Protocol Violation|13|||
162935092|NCT02868281|588466135|FG001|Overall Study|Protocol Violation|10|||
162935093|NCT02868281|588466134|FG000|Overall Study|Lost to Follow-up|3|||
162935094|NCT02868281|588466135|FG001|Overall Study|Lost to Follow-up|6|||
162935095|NCT02868281|588466134|FG000|Overall Study|Withdrawal by Subject|11|||
162935096|NCT02868281|588466135|FG001|Overall Study|Withdrawal by Subject|15|||
162935097|NCT02868281|588466134|FG000|Overall Study|Physician Decision|2|||
162935098|NCT02868281|588466135|FG001|Overall Study|Physician Decision|0|||
162935099|NCT02868281|588466134|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
162935100|NCT02868281|588466135|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
162935101|NCT02868281|588466134|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
162935102|NCT02868281|588466135|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
162935103|NCT02868281|588466134|FG000|Overall Study|Long journey/moving away|1|||
162935104|NCT02868281|588466135|FG001|Overall Study|Long journey/moving away|1|||
162935105|NCT01335464|588466136|FG000|Overall Study|Adverse Event|15|||
162935106|NCT01335464|588466137|FG001|Overall Study|Adverse Event|25|||
162935107|NCT01335464|588466136|FG000|Overall Study|Non compliant with protocol|2|||
162935108|NCT01335464|588466137|FG001|Overall Study|Non compliant with protocol|0|||
162935109|NCT01335464|588466136|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
162935110|NCT01335464|588466137|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
162935111|NCT01335464|588466136|FG000|Overall Study|Not treated|2|||
162935112|NCT01335464|588466137|FG001|Overall Study|Not treated|0|||
162935113|NCT01335464|588466136|FG000|Overall Study|Reason other than those stated above|1|||
162935114|NCT01335464|588466137|FG001|Overall Study|Reason other than those stated above|1|||
162935115|NCT02533999|588466144|FG000|Overall Study|Lost to Follow-up|3|||
162935116|NCT02533999|588466145|FG001|Overall Study|Lost to Follow-up|5|||
162935117|NCT02533999|588466144|FG000|Overall Study|Protocol Violation|3|||
162935118|NCT02533999|588466145|FG001|Overall Study|Protocol Violation|0|||
162935119|NCT02533999|588466144|FG000|Overall Study|Adverse Event|0|||
162935120|NCT02533999|588466145|FG001|Overall Study|Adverse Event|1|||
162935121|NCT02533999|588466144|FG000|Overall Study|Randomized but intervention not received|0|||
162935122|NCT02533999|588466145|FG001|Overall Study|Randomized but intervention not received|1|||
162935123|NCT03210259|588466146|FG000|12-Week Run-in Period|Adverse Event|1|||
162935124|NCT03210259|588466147|FG001|12-Week Run-in Period|Adverse Event|0|||
162935125|NCT03210259|588466148|FG002|12-Week Run-in Period|Adverse Event|0|||
162935126|NCT03210259|588466146|FG000|12-Week Run-in Period|Death|1|||
162935127|NCT03210259|588466147|FG001|12-Week Run-in Period|Death|0|||
162935128|NCT03210259|588466148|FG002|12-Week Run-in Period|Death|0|||
162935129|NCT03210259|588466146|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
162935130|NCT03210259|588466147|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
162935131|NCT03210259|588466148|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
162935132|NCT03210259|588466146|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
162935133|NCT03210259|588466147|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
162935134|NCT03210259|588466148|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
162935135|NCT03210259|588466146|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
162935136|NCT03210259|588466147|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
162935137|NCT03210259|588466148|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
162935138|NCT03210259|588466146|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
162935139|NCT03210259|588466147|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
162935140|NCT03210259|588466148|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
162935141|NCT03210259|588466146|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
162935142|NCT03210259|588466147|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
162935143|NCT03210259|588466148|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
162935144|NCT03210259|588466146|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
162935145|NCT03210259|588466147|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
163283935|NCT00817635|589749342|FG001|Overall Study|Lost to Follow-up|1|||
163283936|NCT00817635|589749343|FG002|Overall Study|Lost to Follow-up|0|||
163283937|NCT00817635|589749344|FG003|Overall Study|Lost to Follow-up|1|||
162935146|NCT03210259|588466148|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
162935147|NCT03210259|588466146|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
162935148|NCT03210259|588466147|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
162935149|NCT03210259|588466148|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
162935150|NCT03210259|588466146|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
162935151|NCT03210259|588466147|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
162935152|NCT03210259|588466148|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
162935153|NCT03210259|588466146|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
162935154|NCT03210259|588466147|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
163283938|NCT00817635|589749345|FG004|Overall Study|Lost to Follow-up|0|||
162935155|NCT03210259|588466148|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
162935156|NCT05017493|588466149|FG000|Overall Study|Withdrawal by Subject|26|||
163283939|NCT00817635|589749341|FG000|Overall Study|Administrative Problems|0|||
163283940|NCT00817635|589749342|FG001|Overall Study|Administrative Problems|0|||
162935157|NCT05017493|588466150|FG001|Overall Study|Withdrawal by Subject|0|||
162935158|NCT05017493|588466149|FG000|Overall Study|Physician Decision|15|||
162935159|NCT05017493|588466150|FG001|Overall Study|Physician Decision|0|||
162935160|NCT05017493|588466149|FG000|Overall Study|Protocol Violation|81|||
162935161|NCT05017493|588466150|FG001|Overall Study|Protocol Violation|0|||
162935162|NCT03940586|588466154|FG000|Overall Study|Death|3|||
162935163|NCT03940586|588466155|FG001|Overall Study|Death|2|||
162935164|NCT03940586|588466156|FG002|Overall Study|Death|0|||
162935165|NCT03940586|588466154|FG000|Overall Study|Physician Decision|1|||
162935166|NCT03940586|588466155|FG001|Overall Study|Physician Decision|0|||
162935167|NCT03940586|588466156|FG002|Overall Study|Physician Decision|1|||
162935168|NCT03940586|588466154|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
162935169|NCT03940586|588466155|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
162935170|NCT03940586|588466156|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
162935171|NCT03940586|588466154|FG000|Overall Study|Not Treated|0|||
162935172|NCT03940586|588466155|FG001|Overall Study|Not Treated|2|||
162935173|NCT03940586|588466156|FG002|Overall Study|Not Treated|0|||
162935174|NCT04304950|588466157|FG000|Overall Study|Lost to Follow-up|1|||
162935175|NCT04304950|588466158|FG001|Overall Study|Lost to Follow-up|1|||
162935176|NCT02006147|588466159|FG000|Overall Study|Protocol Violation|1|||
162935177|NCT02006147|588466160|FG001|Overall Study|Protocol Violation|1|||
162935178|NCT02006147|588466161|FG002|Overall Study|Protocol Violation|0|||
162935179|NCT02006147|588466162|FG003|Overall Study|Protocol Violation|0|||
162935180|NCT02006147|588466159|FG000|Overall Study|Withdrawal by Subject|0|||
162935181|NCT02006147|588466160|FG001|Overall Study|Withdrawal by Subject|1|||
162935182|NCT02006147|588466161|FG002|Overall Study|Withdrawal by Subject|0|||
162935183|NCT02006147|588466162|FG003|Overall Study|Withdrawal by Subject|0|||
162935184|NCT02006147|588466159|FG000|Overall Study|Withdrawal by Sponsor|1|||
162935185|NCT02006147|588466160|FG001|Overall Study|Withdrawal by Sponsor|0|||
162935186|NCT02006147|588466161|FG002|Overall Study|Withdrawal by Sponsor|0|||
162935187|NCT02006147|588466162|FG003|Overall Study|Withdrawal by Sponsor|0|||
162935188|NCT00345683|588466167|FG000|Overall Study|Lost to Follow-up|19|||
162935189|NCT00345683|588466168|FG001|Overall Study|Lost to Follow-up|7|||
162935190|NCT00345683|588466167|FG000|Overall Study|Other|6|||
162935191|NCT00345683|588466168|FG001|Overall Study|Other|2|||
162935192|NCT03182686|588466169|FG000|Overall Study|Lost to Follow-up|2|||
162935193|NCT03182686|588466170|FG001|Overall Study|Lost to Follow-up|0|||
162935194|NCT03182686|588466169|FG000|Overall Study|Adverse Event|2|||
162935195|NCT03182686|588466170|FG001|Overall Study|Adverse Event|0|||
162935196|NCT03182686|588466169|FG000|Overall Study|Withdrawal by Subject|3|||
162935197|NCT03182686|588466170|FG001|Overall Study|Withdrawal by Subject|0|||
162935198|NCT01154127|588466171|FG000|Period 1 (21 Days)|Adverse Event|3|||
162935199|NCT01154127|588466172|FG001|Period 1 (21 Days)|Adverse Event|4|||
162935200|NCT01154127|588466171|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
162935201|NCT01154127|588466172|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
162935202|NCT01154127|588466171|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
162935203|NCT01154127|588466172|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
162935204|NCT01154127|588466171|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
162935205|NCT01154127|588466172|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
162935206|NCT01154127|588466171|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
162935207|NCT01154127|588466172|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
162935208|NCT01697449|588466173|FG000|Overall Study|Disease progression|47|||
162935209|NCT01697449|588466173|FG000|Overall Study|Adverse Event|7|||
162935210|NCT01697449|588466173|FG000|Overall Study|Lost to Follow-up|5|||
162935211|NCT01697449|588466173|FG000|Overall Study|Withdrawal by Subject|2|||
162935212|NCT01697449|588466173|FG000|Overall Study|Physician Decision|1|||
162935213|NCT01697449|588466173|FG000|Overall Study|Death|2|||
162935214|NCT01697449|588466173|FG000|Overall Study|Other|1|||
162935215|NCT01697449|588466173|FG000|Overall Study|Missing|25|||
162935216|NCT01337050|588466174|FG000|Overall Study|Death|0|||
162935217|NCT01337050|588466175|FG001|Overall Study|Death|0|||
162935218|NCT01337050|588466176|FG002|Overall Study|Death|4|||
162935219|NCT01337050|588466174|FG000|Overall Study|Other|4|||
162935220|NCT01337050|588466175|FG001|Overall Study|Other|6|||
162935221|NCT01337050|588466176|FG002|Overall Study|Other|8|||
162935222|NCT01337050|588466174|FG000|Overall Study|Participants refused further follow-up|0|||
162935223|NCT01337050|588466175|FG001|Overall Study|Participants refused further follow-up|7|||
162935224|NCT01337050|588466176|FG002|Overall Study|Participants refused further follow-up|7|||
162935225|NCT00003102|588466177|FG000|Overall Study|Physician Decision|1|||
162935226|NCT00003102|588466178|FG001|Overall Study|Physician Decision|1|||
162935227|NCT00003102|588466179|FG002|Overall Study|Physician Decision|0|||
162935228|NCT00003102|588466177|FG000|Overall Study|Progressive Disease|0|||
162935229|NCT00003102|588466178|FG001|Overall Study|Progressive Disease|1|||
162935230|NCT00003102|588466179|FG002|Overall Study|Progressive Disease|0|||
162935231|NCT00003102|588466177|FG000|Overall Study|Adverse Event|0|||
162935232|NCT00003102|588466178|FG001|Overall Study|Adverse Event|1|||
162935233|NCT00003102|588466179|FG002|Overall Study|Adverse Event|1|||
162935234|NCT00003102|588466177|FG000|Overall Study|Death|0|||
162935235|NCT00003102|588466178|FG001|Overall Study|Death|0|||
162935236|NCT00003102|588466179|FG002|Overall Study|Death|1|||
162935237|NCT05037409|588466180|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
162935238|NCT05037409|588466181|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
162935239|NCT05037409|588466182|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
162935240|NCT00096486|588466185|FG000|Overall Study|Withdrawal by Subject|0|||
162935241|NCT00096486|588466186|FG001|Overall Study|Withdrawal by Subject|0|||
162935242|NCT00096486|588466187|FG002|Overall Study|Withdrawal by Subject|1|||
162935243|NCT00096486|588466188|FG003|Overall Study|Withdrawal by Subject|1|||
162935244|NCT00096486|588466185|FG000|Overall Study|Not Treated|0|||
162935245|NCT00096486|588466186|FG001|Overall Study|Not Treated|0|||
162935246|NCT00096486|588466187|FG002|Overall Study|Not Treated|1|||
162935247|NCT00096486|588466188|FG003|Overall Study|Not Treated|1|||
162935248|NCT01559818|588466189|FG000|Overall Study|Physician Decision|1|||
162935249|NCT01559818|588466189|FG000|Overall Study|Pregnancy|1|||
162935250|NCT01559818|588466189|FG000|Overall Study|Study terminated by Sponsor|4|||
162935251|NCT01559818|588466189|FG000|Overall Study|Withdrawal by Subject|1|||
162935252|NCT01512979|588466191|FG000|Overall Study|Adverse Event|2|||
162935253|NCT01512979|588466192|FG001|Overall Study|Adverse Event|2|||
162935254|NCT01512979|588466191|FG000|Overall Study|Protocol Violation|1|||
162935255|NCT01512979|588466192|FG001|Overall Study|Protocol Violation|4|||
162935256|NCT01512979|588466191|FG000|Overall Study|Lost to Follow-up|2|||
162935257|NCT01512979|588466192|FG001|Overall Study|Lost to Follow-up|5|||
162935258|NCT01512979|588466191|FG000|Overall Study|Withdrawal by Subject|1|||
162935259|NCT01512979|588466192|FG001|Overall Study|Withdrawal by Subject|2|||
162935260|NCT01512979|588466191|FG000|Overall Study|Reason other than stated above|13|||
162935261|NCT01512979|588466192|FG001|Overall Study|Reason other than stated above|9|||
162935262|NCT00125359|588466193|FG000|Overall Study|Death|4|||
162935263|NCT00125359|588466193|FG000|Overall Study|Adverse Event|5|||
162935264|NCT00125359|588466193|FG000|Overall Study|Physician Decision|14|||
162935265|NCT00529568|588466194|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
162935266|NCT00529568|588466195|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
162935267|NCT00529568|588466196|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
162935268|NCT00529568|588466194|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
162935269|NCT00529568|588466195|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
162935270|NCT00529568|588466196|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
162935271|NCT00529568|588466194|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
162935272|NCT00529568|588466195|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
162935273|NCT00529568|588466196|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
162935274|NCT00529568|588466194|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
162935275|NCT00529568|588466195|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
162935276|NCT00529568|588466196|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
162935277|NCT00529568|588466194|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
162935278|NCT00529568|588466195|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
162935279|NCT00529568|588466196|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
162935280|NCT00529568|588466194|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
162935281|NCT00529568|588466195|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
162935282|NCT00529568|588466196|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
162935283|NCT00529568|588466194|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
162935284|NCT00529568|588466195|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
162935285|NCT00529568|588466196|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
162935286|NCT00529568|588466194|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
162935287|NCT00529568|588466195|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
162935288|NCT00529568|588466196|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
162935289|NCT00529568|588466194|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
162935290|NCT00529568|588466195|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
162935291|NCT00529568|588466196|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
162935292|NCT00529568|588466194|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
162935293|NCT00529568|588466195|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
162935294|NCT00529568|588466196|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
162935295|NCT00529568|588466194|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
162935296|NCT00529568|588466195|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
162935297|NCT00529568|588466196|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
162935298|NCT04049552|588466197|FG000|Overall Study|Lost to Follow-up|1|||
162935299|NCT00738920|588466199|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
162935300|NCT00738920|588466200|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
162935301|NCT00738920|588466201|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
162935302|NCT00738920|588466199|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
162935303|NCT00738920|588466200|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
162935304|NCT00738920|588466201|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
162935305|NCT00738920|588466199|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
162935306|NCT00738920|588466200|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
162935307|NCT00738920|588466201|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
163283941|NCT00817635|589749343|FG002|Overall Study|Administrative Problems|0|||
162935308|NCT00738920|588466199|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
162935309|NCT00738920|588466200|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
162935310|NCT00738920|588466201|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
162935311|NCT00738920|588466199|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
162935312|NCT00738920|588466200|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
162935313|NCT00738920|588466201|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
162935314|NCT00738920|588466199|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
162935315|NCT00738920|588466200|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
162935316|NCT00738920|588466201|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
162935317|NCT00738920|588466199|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
162935318|NCT00738920|588466200|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
162935319|NCT00738920|588466201|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
163283942|NCT00817635|589749344|FG003|Overall Study|Administrative Problems|0|||
163283943|NCT00817635|589749345|FG004|Overall Study|Administrative Problems|1|||
163283944|NCT00817635|589749341|FG000|Overall Study|Protocol Violation|5|||
163283945|NCT00817635|589749342|FG001|Overall Study|Protocol Violation|1|||
163283946|NCT00817635|589749343|FG002|Overall Study|Protocol Violation|3|||
163283947|NCT00817635|589749344|FG003|Overall Study|Protocol Violation|2|||
163283948|NCT00817635|589749345|FG004|Overall Study|Protocol Violation|3|||
163283949|NCT01259102|589749346|FG000|Overall Study|Adverse Event|1|||
163283950|NCT01259102|589749347|FG001|Overall Study|Adverse Event|0|||
163283951|NCT01259102|589749348|FG002|Overall Study|Adverse Event|1|||
163283952|NCT01259102|589749349|FG003|Overall Study|Adverse Event|1|||
163283953|NCT01259102|589749350|FG004|Overall Study|Adverse Event|0|||
163283954|NCT01259102|589749346|FG000|Overall Study|Other|0|||
163283955|NCT01259102|589749347|FG001|Overall Study|Other|0|||
163283956|NCT01259102|589749348|FG002|Overall Study|Other|1|||
163283957|NCT01259102|589749349|FG003|Overall Study|Other|1|||
163283958|NCT01259102|589749350|FG004|Overall Study|Other|1|||
163283959|NCT00918957|589749352|FG000|Overall Study|Adverse Event|2|||
163283960|NCT00918957|589749353|FG001|Overall Study|Adverse Event|0|||
163283961|NCT00918957|589749352|FG000|Overall Study|Withdrawal by Subject|1|||
163283962|NCT00918957|589749353|FG001|Overall Study|Withdrawal by Subject|0|||
163283963|NCT03107611|589749354|FG000|Overall Study|Adverse Event|1|||
163283964|NCT03107611|589749355|FG001|Overall Study|Adverse Event|0|||
163283965|NCT03107611|589749356|FG002|Overall Study|Adverse Event|2|||
163283966|NCT03107611|589749354|FG000|Overall Study|Lost to Follow-up|3|||
163283967|NCT03107611|589749355|FG001|Overall Study|Lost to Follow-up|3|||
163283968|NCT03107611|589749356|FG002|Overall Study|Lost to Follow-up|3|||
163283969|NCT03107611|589749354|FG000|Overall Study|Protocol Violation|0|||
163283970|NCT03107611|589749355|FG001|Overall Study|Protocol Violation|0|||
163283971|NCT03107611|589749356|FG002|Overall Study|Protocol Violation|1|||
163283972|NCT03107611|589749354|FG000|Overall Study|Withdrawal by Subject|1|||
163283973|NCT03107611|589749355|FG001|Overall Study|Withdrawal by Subject|0|||
163283974|NCT03107611|589749356|FG002|Overall Study|Withdrawal by Subject|1|||
163283975|NCT03107611|589749354|FG000|Overall Study|Worsening signs/symptoms|2|||
163283976|NCT03107611|589749355|FG001|Overall Study|Worsening signs/symptoms|1|||
163283977|NCT03107611|589749356|FG002|Overall Study|Worsening signs/symptoms|2|||
162935320|NCT00738920|588466199|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
163283978|NCT01720446|589749359|FG000|Overall Study|Lost to Follow-up|12|||
163283979|NCT01720446|589749360|FG001|Overall Study|Lost to Follow-up|6|||
163283980|NCT01720446|589749361|FG002|Overall Study|Lost to Follow-up|16|||
163283981|NCT01720446|589749362|FG003|Overall Study|Lost to Follow-up|16|||
163283982|NCT01720446|589749359|FG000|Overall Study|Withdrawal by Subject|2|||
163283983|NCT01720446|589749360|FG001|Overall Study|Withdrawal by Subject|5|||
163283984|NCT01720446|589749361|FG002|Overall Study|Withdrawal by Subject|4|||
163283985|NCT01720446|589749362|FG003|Overall Study|Withdrawal by Subject|4|||
163283986|NCT01020838|589749363|FG000|Overall Study|Death|90|||
163283987|NCT01020838|589749363|FG000|Overall Study|Adverse Event|1|||
163283988|NCT01020838|589749363|FG000|Overall Study|Withdrawal by Subject|9|||
163283989|NCT01020838|589749363|FG000|Overall Study|Lost to Follow-up|6|||
163283990|NCT01020838|589749363|FG000|Overall Study|Most common: Study ended by sponsor|77|||
163283991|NCT04176458|589749364|FG000|Overall Study|Covid 19|4|||
163283992|NCT00891618|589749365|FG000|Overall Study|Withdrawal by Subject|1|||
163283993|NCT03999554|589749367|FG000|Overall Study|Lost to Follow-up|4|||
162935321|NCT00738920|588466200|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
162935322|NCT00738920|588466201|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
162935323|NCT00738920|588466199|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
162935324|NCT00738920|588466200|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
163283994|NCT03999554|589749368|FG001|Overall Study|Lost to Follow-up|5|||
163283995|NCT03999554|589749369|FG002|Overall Study|Lost to Follow-up|4|||
163283996|NCT03999554|589749370|FG003|Overall Study|Lost to Follow-up|5|||
163283997|NCT03999554|589749371|FG004|Overall Study|Lost to Follow-up|8|||
163283998|NCT03999554|589749367|FG000|Overall Study|Protocol Violation|0|||
163283999|NCT03999554|589749368|FG001|Overall Study|Protocol Violation|0|||
163284000|NCT03999554|589749369|FG002|Overall Study|Protocol Violation|5|||
163284001|NCT03999554|589749370|FG003|Overall Study|Protocol Violation|0|||
163284002|NCT03999554|589749371|FG004|Overall Study|Protocol Violation|0|||
163284003|NCT03999554|589749367|FG000|Overall Study|Pregnancy|0|||
163284004|NCT03999554|589749368|FG001|Overall Study|Pregnancy|0|||
163284005|NCT03999554|589749369|FG002|Overall Study|Pregnancy|1|||
163284006|NCT03999554|589749370|FG003|Overall Study|Pregnancy|0|||
163284007|NCT03999554|589749371|FG004|Overall Study|Pregnancy|0|||
163284008|NCT03999554|589749367|FG000|Overall Study|Withdrawal by Subject|2|||
163284009|NCT03999554|589749368|FG001|Overall Study|Withdrawal by Subject|2|||
162935325|NCT00738920|588466201|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
162935326|NCT00738920|588466199|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
162935327|NCT00738920|588466200|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
162935328|NCT00738920|588466201|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
162935329|NCT04147611|588466205|FG000|Overall Study|Physician Decision|0|||
162935330|NCT04147611|588466206|FG001|Overall Study|Physician Decision|1|||
162935331|NCT01123980|588466211|FG000|Overall Study|Adverse Event|1|||
162935332|NCT01123980|588466212|FG001|Overall Study|Adverse Event|1|||
162935333|NCT01123980|588466211|FG000|Overall Study|Lack of Efficacy|1|||
162935334|NCT01123980|588466212|FG001|Overall Study|Lack of Efficacy|0|||
162935335|NCT01123980|588466211|FG000|Overall Study|Physician Decision|0|||
162935336|NCT01123980|588466212|FG001|Overall Study|Physician Decision|1|||
162935337|NCT01123980|588466211|FG000|Overall Study|Lost to Follow-up|0|||
162935338|NCT01123980|588466212|FG001|Overall Study|Lost to Follow-up|6|||
162935339|NCT01123980|588466211|FG000|Overall Study|Protocol Violation|6|||
162935340|NCT01123980|588466212|FG001|Overall Study|Protocol Violation|6|||
162935341|NCT01123980|588466211|FG000|Overall Study|Withdrawal by Subject|5|||
162935342|NCT01123980|588466212|FG001|Overall Study|Withdrawal by Subject|3|||
162935343|NCT01123980|588466211|FG000|Overall Study|Unclassified|6|||
162935344|NCT01123980|588466212|FG001|Overall Study|Unclassified|7|||
162935345|NCT04385199|588466213|FG000|Overall Study|Withdrawal by Subject|1|||
162935346|NCT04385199|588466214|FG001|Overall Study|Withdrawal by Subject|0|||
162935347|NCT02557672|588466215|FG000|Overall Study|Withdrawal by Subject|4|||
162935348|NCT02557672|588466216|FG001|Overall Study|Withdrawal by Subject|2|||
162935349|NCT03705169|588466217|FG000|Overall Study|Lost to Follow-up|0|||
162935350|NCT03705169|588466218|FG001|Overall Study|Lost to Follow-up|0|||
162935351|NCT03705169|588466219|FG002|Overall Study|Lost to Follow-up|0|||
162935352|NCT03705169|588466220|FG003|Overall Study|Lost to Follow-up|2|||
162935353|NCT03705169|588466221|FG004|Overall Study|Lost to Follow-up|0|||
162935354|NCT03705169|588466222|FG005|Overall Study|Lost to Follow-up|2|||
162935355|NCT03705169|588466223|FG006|Overall Study|Lost to Follow-up|1|||
162935356|NCT03705169|588466224|FG007|Overall Study|Lost to Follow-up|0|||
162935357|NCT03705169|588466225|FG008|Overall Study|Lost to Follow-up|0|||
162935358|NCT03705169|588466226|FG009|Overall Study|Lost to Follow-up|1|||
162935359|NCT03705169|588466217|FG000|Overall Study|Adverse Event|0|||
162935360|NCT03705169|588466218|FG001|Overall Study|Adverse Event|0|||
162935361|NCT03705169|588466219|FG002|Overall Study|Adverse Event|0|||
162935362|NCT03705169|588466220|FG003|Overall Study|Adverse Event|1|||
162935363|NCT03705169|588466221|FG004|Overall Study|Adverse Event|0|||
162935364|NCT03705169|588466222|FG005|Overall Study|Adverse Event|0|||
162935365|NCT03705169|588466223|FG006|Overall Study|Adverse Event|0|||
162935366|NCT03705169|588466224|FG007|Overall Study|Adverse Event|0|||
162935367|NCT03705169|588466225|FG008|Overall Study|Adverse Event|0|||
162935368|NCT03705169|588466226|FG009|Overall Study|Adverse Event|0|||
162935369|NCT03705169|588466217|FG000|Overall Study|Site Closure|0|||
162935370|NCT03705169|588466218|FG001|Overall Study|Site Closure|0|||
162935371|NCT03705169|588466219|FG002|Overall Study|Site Closure|0|||
162935372|NCT03705169|588466220|FG003|Overall Study|Site Closure|1|||
162935373|NCT03705169|588466221|FG004|Overall Study|Site Closure|0|||
162935374|NCT03705169|588466222|FG005|Overall Study|Site Closure|0|||
163284010|NCT03999554|589749369|FG002|Overall Study|Withdrawal by Subject|2|||
163284011|NCT03999554|589749370|FG003|Overall Study|Withdrawal by Subject|1|||
163284012|NCT03999554|589749371|FG004|Overall Study|Withdrawal by Subject|1|||
163284013|NCT03999554|589749367|FG000|Overall Study|failure to comply with protocol requirements|0|||
163284014|NCT03999554|589749368|FG001|Overall Study|failure to comply with protocol requirements|0|||
162935375|NCT03705169|588466223|FG006|Overall Study|Site Closure|0|||
162935376|NCT03705169|588466224|FG007|Overall Study|Site Closure|0|||
162935377|NCT03705169|588466225|FG008|Overall Study|Site Closure|0|||
162935378|NCT03705169|588466226|FG009|Overall Study|Site Closure|0|||
162935379|NCT03705169|588466217|FG000|Overall Study|Did not receive study treatment|0|||
162935380|NCT03705169|588466218|FG001|Overall Study|Did not receive study treatment|0|||
162935381|NCT03705169|588466219|FG002|Overall Study|Did not receive study treatment|0|||
162935382|NCT03705169|588466220|FG003|Overall Study|Did not receive study treatment|1|||
162935383|NCT03705169|588466221|FG004|Overall Study|Did not receive study treatment|0|||
162935384|NCT03705169|588466222|FG005|Overall Study|Did not receive study treatment|0|||
162935385|NCT03705169|588466223|FG006|Overall Study|Did not receive study treatment|0|||
162935386|NCT03705169|588466224|FG007|Overall Study|Did not receive study treatment|0|||
162935387|NCT03705169|588466225|FG008|Overall Study|Did not receive study treatment|0|||
162935388|NCT03705169|588466226|FG009|Overall Study|Did not receive study treatment|0|||
162935389|NCT03705169|588466217|FG000|Overall Study|Concerns about study visit compliance|0|||
162935390|NCT03705169|588466218|FG001|Overall Study|Concerns about study visit compliance|0|||
162935391|NCT03705169|588466219|FG002|Overall Study|Concerns about study visit compliance|0|||
162935392|NCT03705169|588466220|FG003|Overall Study|Concerns about study visit compliance|1|||
162935393|NCT03705169|588466221|FG004|Overall Study|Concerns about study visit compliance|0|||
162935394|NCT03705169|588466222|FG005|Overall Study|Concerns about study visit compliance|0|||
162935395|NCT03705169|588466223|FG006|Overall Study|Concerns about study visit compliance|0|||
162935396|NCT03705169|588466224|FG007|Overall Study|Concerns about study visit compliance|0|||
162935397|NCT03705169|588466225|FG008|Overall Study|Concerns about study visit compliance|0|||
162935398|NCT03705169|588466226|FG009|Overall Study|Concerns about study visit compliance|0|||
162935399|NCT00458302|588468000|FG000|Overall Study|Adverse Event|4|||
162935400|NCT00458302|588468001|FG001|Overall Study|Adverse Event|14|||
162935401|NCT00458302|588468000|FG000|Overall Study|Pregnancy|2|||
162935402|NCT00458302|588468001|FG001|Overall Study|Pregnancy|1|||
162935403|NCT00458302|588468000|FG000|Overall Study|Protocol Violation|0|||
162935404|NCT00458302|588468001|FG001|Overall Study|Protocol Violation|2|||
162935405|NCT00458302|588468000|FG000|Overall Study|Withdrawal by Subject|6|||
162935406|NCT00458302|588468001|FG001|Overall Study|Withdrawal by Subject|4|||
162935407|NCT00458302|588468000|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
162935408|NCT00458302|588468001|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
162935409|NCT00458302|588468000|FG000|Overall Study|Study Termination By Sponsor|1|||
162935410|NCT00458302|588468001|FG001|Overall Study|Study Termination By Sponsor|0|||
162935411|NCT00458302|588468000|FG000|Overall Study|Lost to Follow-up|2|||
162935412|NCT00458302|588468001|FG001|Overall Study|Lost to Follow-up|0|||
162935413|NCT00458302|588468000|FG000|Overall Study|Other|4|||
162935414|NCT00458302|588468001|FG001|Overall Study|Other|2|||
162935415|NCT01513551|588468004|FG000|Overall Study|Death|0|||
162935416|NCT01513551|588468005|FG001|Overall Study|Death|1|||
162935417|NCT01513551|588468006|FG002|Overall Study|Death|0|||
162935418|NCT01513551|588468004|FG000|Overall Study|Lost to Follow-up|3|||
162935419|NCT01513551|588468005|FG001|Overall Study|Lost to Follow-up|5|||
162935420|NCT01513551|588468006|FG002|Overall Study|Lost to Follow-up|2|||
162935421|NCT01513551|588468004|FG000|Overall Study|Withdrawal by Subject|1|||
162935422|NCT01513551|588468005|FG001|Overall Study|Withdrawal by Subject|0|||
162935423|NCT01513551|588468006|FG002|Overall Study|Withdrawal by Subject|2|||
162935424|NCT01513551|588468004|FG000|Overall Study|Randomized but not vaccinated|0|||
162935425|NCT01513551|588468005|FG001|Overall Study|Randomized but not vaccinated|0|||
162935426|NCT01513551|588468006|FG002|Overall Study|Randomized but not vaccinated|1|||
162935427|NCT02038634|588468009|FG000|Overall Study|Lost to Follow-up|0|||
162935428|NCT02038634|588468010|FG001|Overall Study|Lost to Follow-up|1|||
162935429|NCT01706198|588468011|FG000|Overall Study|Adverse Event|12|||
162935430|NCT01706198|588468012|FG001|Overall Study|Adverse Event|15|||
162935431|NCT01706198|588468011|FG000|Overall Study|Protocol Violation|7|||
162935432|NCT01706198|588468012|FG001|Overall Study|Protocol Violation|5|||
162935433|NCT01706198|588468011|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
162935434|NCT01706198|588468012|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
162935435|NCT01706198|588468011|FG000|Overall Study|Lost to Follow-up|97|||
162935436|NCT01706198|588468012|FG001|Overall Study|Lost to Follow-up|93|||
162935437|NCT01706198|588468011|FG000|Overall Study|Physician Decision|23|||
162935438|NCT01706198|588468012|FG001|Overall Study|Physician Decision|37|||
162935439|NCT01706198|588468011|FG000|Overall Study|Withdrawal by Subject|23|||
162935440|NCT01706198|588468012|FG001|Overall Study|Withdrawal by Subject|31|||
162935441|NCT00549198|588468013|FG000|Overall Study|Adverse Event|28|||
162935442|NCT00549198|588468014|FG001|Overall Study|Adverse Event|26|||
162935443|NCT00549198|588468013|FG000|Overall Study|Insufficient Viral Load Response|4|||
162935444|NCT00549198|588468014|FG001|Overall Study|Insufficient Viral Load Response|2|||
162935445|NCT00549198|588468013|FG000|Overall Study|Protocol-defined Virological Failure|7|||
162935446|NCT00549198|588468014|FG001|Overall Study|Protocol-defined Virological Failure|0|||
162935447|NCT00549198|588468013|FG000|Overall Study|Non-compliance|2|||
162935448|NCT00549198|588468014|FG001|Overall Study|Non-compliance|4|||
162935449|NCT00549198|588468013|FG000|Overall Study|Lost to Follow-up|7|||
162935450|NCT00549198|588468014|FG001|Overall Study|Lost to Follow-up|8|||
163284015|NCT03999554|589749369|FG002|Overall Study|failure to comply with protocol requirements|0|||
162935451|NCT00549198|588468013|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
162935452|NCT00549198|588468014|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162935453|NCT00549198|588468013|FG000|Overall Study|Protocol Violation|7|||
162935454|NCT00549198|588468014|FG001|Overall Study|Protocol Violation|2|||
162935455|NCT00549198|588468013|FG000|Overall Study|Investigator Decision|4|||
162935456|NCT00549198|588468014|FG001|Overall Study|Investigator Decision|3|||
162935457|NCT00549198|588468013|FG000|Overall Study|Withdrawal by Subject|7|||
162935458|NCT00549198|588468014|FG001|Overall Study|Withdrawal by Subject|7|||
162935459|NCT00549198|588468013|FG000|Overall Study|Disease Progression|1|||
162935460|NCT00549198|588468014|FG001|Overall Study|Disease Progression|0|||
163179052|NCT02411448|589370532|FG000|Overall Study|Withdrawal by Subject|1|||
163179053|NCT02411448|589370533|FG001|Overall Study|Withdrawal by Subject|14|||
163179054|NCT02411448|589370534|FG002|Overall Study|Withdrawal by Subject|9|||
163179055|NCT02411448|589370532|FG000|Overall Study|Other|0|||
163179056|NCT02411448|589370533|FG001|Overall Study|Other|2|||
163179057|NCT02411448|589370534|FG002|Overall Study|Other|0|||
163179058|NCT02411448|589370532|FG000|Overall Study|Did not receive study treatment|0|||
163179059|NCT02411448|589370533|FG001|Overall Study|Did not receive study treatment|3|||
163179060|NCT02411448|589370534|FG002|Overall Study|Did not receive study treatment|0|||
163179061|NCT02411448|589370532|FG000|Overall Study|Alive on study treatment|3|||
163179062|NCT02411448|589370533|FG001|Overall Study|Alive on study treatment|64|||
163179063|NCT02411448|589370534|FG002|Overall Study|Alive on study treatment|43|||
163179066|NCT06066697|589370549|FG000|Overall Study|Lost to Follow-up|5|||
163179067|NCT06066697|589370550|FG001|Overall Study|Lost to Follow-up|0|||
163179068|NCT02616562|589370552|FG000|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179069|NCT02616562|589370553|FG001|Main Period (26 Weeks)|Withdrawal by parent/guardian|1|||
163179070|NCT02616562|589370554|FG002|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179071|NCT02616562|589370555|FG003|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179072|NCT02616562|589370556|FG004|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179073|NCT02616562|589370557|FG005|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179074|NCT02616562|589370558|FG006|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179075|NCT02616562|589370559|FG007|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179076|NCT02616562|589370560|FG008|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179077|NCT02616562|589370561|FG009|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179078|NCT02616562|589370562|FG010|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179079|NCT02616562|589370563|FG011|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179080|NCT02616562|589370564|FG012|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179081|NCT02616562|589370565|FG013|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179082|NCT02616562|589370566|FG014|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179083|NCT02616562|589370567|FG015|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179084|NCT02616562|589370568|FG016|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179085|NCT02616562|589370552|FG000|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179086|NCT02616562|589370553|FG001|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179087|NCT02616562|589370554|FG002|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179088|NCT02616562|589370555|FG003|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179089|NCT02616562|589370556|FG004|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179090|NCT02616562|589370557|FG005|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179091|NCT02616562|589370558|FG006|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179092|NCT02616562|589370559|FG007|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179093|NCT02616562|589370560|FG008|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179094|NCT02616562|589370561|FG009|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|1|||
163179095|NCT02616562|589370562|FG010|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179096|NCT02616562|589370563|FG011|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179097|NCT02616562|589370564|FG012|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179098|NCT02616562|589370565|FG013|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179099|NCT02616562|589370566|FG014|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179100|NCT02616562|589370567|FG015|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179101|NCT02616562|589370568|FG016|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179102|NCT02616562|589370552|FG000|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179103|NCT02616562|589370553|FG001|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163284016|NCT03999554|589749370|FG003|Overall Study|failure to comply with protocol requirements|1|||
163284017|NCT03999554|589749371|FG004|Overall Study|failure to comply with protocol requirements|0|||
163284018|NCT02082158|589749372|FG000|Overall Study|Withdrawal by Subject|0|||
163284019|NCT02082158|589749373|FG001|Overall Study|Withdrawal by Subject|0|||
163284020|NCT02082158|589749374|FG002|Overall Study|Withdrawal by Subject|0|||
163179104|NCT02616562|589370554|FG002|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162935461|NCT00549198|588468013|FG000|Overall Study|Participant Moved|2|||
162935462|NCT00549198|588468014|FG001|Overall Study|Participant Moved|0|||
162935463|NCT00549198|588468013|FG000|Overall Study|Participant not able to perform Week 96|1|||
162935464|NCT00549198|588468014|FG001|Overall Study|Participant not able to perform Week 96|0|||
162935465|NCT00549198|588468013|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
162935466|NCT00549198|588468014|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
162935467|NCT00549198|588468013|FG000|Overall Study|Prohibited Medication|1|||
162935468|NCT00549198|588468014|FG001|Overall Study|Prohibited Medication|2|||
162935469|NCT00549198|588468013|FG000|Overall Study|Participant planning pregnancy|1|||
162935470|NCT00549198|588468014|FG001|Overall Study|Participant planning pregnancy|0|||
162935471|NCT00549198|588468013|FG000|Overall Study|Participant overweight, no scan possible|1|||
162935472|NCT00549198|588468014|FG001|Overall Study|Participant overweight, no scan possible|0|||
162935473|NCT00549198|588468013|FG000|Overall Study|No scan facilities|0|||
162935474|NCT00549198|588468014|FG001|Overall Study|No scan facilities|2|||
162935475|NCT00549198|588468013|FG000|Overall Study|Pregnancy|0|||
162935476|NCT00549198|588468014|FG001|Overall Study|Pregnancy|3|||
162935477|NCT00549198|588468013|FG000|Overall Study|Not Exposed to Study Drug|3|||
162935478|NCT00549198|588468014|FG001|Overall Study|Not Exposed to Study Drug|4|||
162935479|NCT03572933|588468025|FG000|Overall Study|Adverse Event|4|||
162935480|NCT03572933|588468026|FG001|Overall Study|Adverse Event|1|||
162935481|NCT03572933|588468025|FG000|Overall Study|Withdrawal by Subject|0|||
162935482|NCT03572933|588468026|FG001|Overall Study|Withdrawal by Subject|1|||
162935483|NCT01764854|588468027|FG000|Overall Study|Adverse Event|0|||
162935484|NCT01764854|588468028|FG001|Overall Study|Adverse Event|0|||
162935485|NCT01764854|588468029|FG002|Overall Study|Adverse Event|2|||
162935486|NCT01764854|588468030|FG003|Overall Study|Adverse Event|0|||
162935487|NCT01764854|588468027|FG000|Overall Study|Withdrawal by Subject|0|||
162935488|NCT01764854|588468028|FG001|Overall Study|Withdrawal by Subject|0|||
162935489|NCT01764854|588468029|FG002|Overall Study|Withdrawal by Subject|1|||
162935490|NCT01764854|588468030|FG003|Overall Study|Withdrawal by Subject|0|||
162935491|NCT01764854|588468027|FG000|Overall Study|relocation|0|||
162935492|NCT01764854|588468028|FG001|Overall Study|relocation|0|||
162935493|NCT01764854|588468029|FG002|Overall Study|relocation|2|||
162935494|NCT01764854|588468030|FG003|Overall Study|relocation|0|||
162935495|NCT01764854|588468027|FG000|Overall Study|Protocol Violation|0|||
162935496|NCT01764854|588468028|FG001|Overall Study|Protocol Violation|0|||
162935497|NCT01764854|588468029|FG002|Overall Study|Protocol Violation|1|||
162935498|NCT01764854|588468030|FG003|Overall Study|Protocol Violation|2|||
162935499|NCT03273387|588468031|FG000|Overall Study|Death|2|||
162935500|NCT03273387|588468032|FG001|Overall Study|Death|2|||
162935501|NCT03273387|588468031|FG000|Overall Study|Withdrawal by Subject|1|||
162935502|NCT03273387|588468032|FG001|Overall Study|Withdrawal by Subject|1|||
162935503|NCT02668783|588468033|FG000|Overall Study|Pregnancy|0|||
162935504|NCT02668783|588468034|FG001|Overall Study|Pregnancy|1|||
162935505|NCT02668783|588468033|FG000|Overall Study|Protocol Violation|2|||
162935506|NCT02668783|588468034|FG001|Overall Study|Protocol Violation|1|||
162935507|NCT02668783|588468033|FG000|Overall Study|Study terminated by sponsor|9|||
162935508|NCT02668783|588468034|FG001|Overall Study|Study terminated by sponsor|10|||
162935509|NCT02668783|588468033|FG000|Overall Study|Subject moved|1|||
162935510|NCT02668783|588468034|FG001|Overall Study|Subject moved|0|||
162935511|NCT02668783|588468033|FG000|Overall Study|Withdrawal by Subject|1|||
162935512|NCT02668783|588468034|FG001|Overall Study|Withdrawal by Subject|0|||
162935513|NCT04480463|588468035|FG000|Overall Study|Death|0|||
162935514|NCT04480463|588468036|FG001|Overall Study|Death|1|||
162935515|NCT04480463|588468035|FG000|Overall Study|Adverse Event|6|||
162935516|NCT04480463|588468036|FG001|Overall Study|Adverse Event|8|||
162935517|NCT04480463|588468035|FG000|Overall Study|Lost to Follow-up|3|||
162935518|NCT04480463|588468036|FG001|Overall Study|Lost to Follow-up|2|||
162935519|NCT04480463|588468035|FG000|Overall Study|Physician Decision|2|||
162935520|NCT04480463|588468036|FG001|Overall Study|Physician Decision|5|||
162935521|NCT04480463|588468035|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
162935522|NCT04480463|588468036|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
162935523|NCT04480463|588468035|FG000|Overall Study|Protocol Violation|2|||
162935524|NCT04480463|588468036|FG001|Overall Study|Protocol Violation|1|||
162935525|NCT04480463|588468035|FG000|Overall Study|Withdrawal by Subject|6|||
162935526|NCT04480463|588468036|FG001|Overall Study|Withdrawal by Subject|7|||
162935527|NCT04480463|588468035|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
162935528|NCT04480463|588468036|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
162935529|NCT04480463|588468035|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
162935530|NCT04480463|588468036|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
163179105|NCT02616562|589370555|FG003|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179106|NCT02616562|589370556|FG004|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179107|NCT02616562|589370557|FG005|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163284021|NCT02082158|589749375|FG003|Overall Study|Withdrawal by Subject|0|||
163284022|NCT02082158|589749376|FG004|Overall Study|Withdrawal by Subject|1|||
163284023|NCT02082158|589749377|FG005|Overall Study|Withdrawal by Subject|0|||
163284024|NCT02082158|589749372|FG000|Overall Study|Failed Fit-testing|8|||
163284025|NCT02082158|589749373|FG001|Overall Study|Failed Fit-testing|8|||
163284026|NCT02082158|589749374|FG002|Overall Study|Failed Fit-testing|14|||
163284027|NCT02082158|589749375|FG003|Overall Study|Failed Fit-testing|4|||
163284028|NCT02082158|589749376|FG004|Overall Study|Failed Fit-testing|3|||
163284029|NCT02082158|589749377|FG005|Overall Study|Failed Fit-testing|7|||
163284030|NCT00742274|589749380|FG000|Overall Study|Death|1|||
163284031|NCT00742274|589749381|FG001|Overall Study|Death|0|||
163284032|NCT00742274|589749380|FG000|Overall Study|Withdrawal by Subject|1|||
163179108|NCT02616562|589370558|FG006|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179109|NCT02616562|589370559|FG007|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179110|NCT02616562|589370560|FG008|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|1|||
163179111|NCT02616562|589370561|FG009|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|1|||
163179112|NCT02616562|589370562|FG010|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179113|NCT02616562|589370563|FG011|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179114|NCT02616562|589370564|FG012|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179115|NCT02616562|589370565|FG013|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179116|NCT02616562|589370566|FG014|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179117|NCT02616562|589370567|FG015|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179118|NCT02616562|589370568|FG016|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179119|NCT02616562|589370552|FG000|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179120|NCT02616562|589370553|FG001|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179121|NCT02616562|589370554|FG002|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179122|NCT02616562|589370555|FG003|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179123|NCT02616562|589370556|FG004|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179124|NCT02616562|589370557|FG005|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179125|NCT02616562|589370558|FG006|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179126|NCT02616562|589370559|FG007|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179127|NCT02616562|589370560|FG008|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179128|NCT02616562|589370561|FG009|Safety Extension Period (104 Weeks)|Lost to Follow-up|1|||
163179129|NCT02616562|589370562|FG010|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179130|NCT02616562|589370563|FG011|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179131|NCT02616562|589370564|FG012|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179132|NCT02616562|589370565|FG013|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179133|NCT02616562|589370566|FG014|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179134|NCT02616562|589370567|FG015|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179135|NCT02616562|589370568|FG016|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179136|NCT02616562|589370552|FG000|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179137|NCT02616562|589370553|FG001|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179138|NCT02616562|589370554|FG002|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179139|NCT02616562|589370555|FG003|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179140|NCT02616562|589370556|FG004|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179141|NCT02616562|589370557|FG005|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179142|NCT02616562|589370558|FG006|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179143|NCT02616562|589370559|FG007|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179144|NCT02616562|589370560|FG008|Safety Extension Period (104 Weeks)|Protocol Violation|1|||
163179145|NCT02616562|589370561|FG009|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179146|NCT02616562|589370562|FG010|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179147|NCT02616562|589370563|FG011|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179148|NCT02616562|589370564|FG012|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179149|NCT02616562|589370565|FG013|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179150|NCT02616562|589370566|FG014|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179151|NCT02616562|589370567|FG015|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163284033|NCT00742274|589749381|FG001|Overall Study|Withdrawal by Subject|2|||
163284034|NCT00742274|589749380|FG000|Overall Study|Removed for medical reasons|1|||
163284035|NCT00742274|589749381|FG001|Overall Study|Removed for medical reasons|1|||
163284036|NCT01101165|589749382|FG000|Period 1|Adverse Event|1|||
163284037|NCT01101165|589749383|FG001|Period 1|Adverse Event|2|||
163284038|NCT01101165|589749382|FG000|Period 1|Withdrawal by Subject|0|||
163284039|NCT01101165|589749383|FG001|Period 1|Withdrawal by Subject|2|||
163284040|NCT01101165|589749382|FG000|Period 1|Positive Drug Screen|0|||
163284041|NCT01101165|589749383|FG001|Period 1|Positive Drug Screen|1|||
163284042|NCT01101165|589749382|FG000|Period 1|Lost to Follow-up|1|||
163284043|NCT01101165|589749383|FG001|Period 1|Lost to Follow-up|0|||
163284044|NCT01101165|589749382|FG000|Period 2|Withdrawal by Subject|3|||
163284045|NCT01101165|589749383|FG001|Period 2|Withdrawal by Subject|1|||
163284046|NCT01101165|589749382|FG000|Period 2|Adverse Event|1|||
163284047|NCT01101165|589749383|FG001|Period 2|Adverse Event|0|||
163179152|NCT02616562|589370568|FG016|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179153|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163284048|NCT00619151|589749385|FG000|Overall Study|Study terminated prior to followup|1|||
163284049|NCT00619151|589749386|FG001|Overall Study|Study terminated prior to followup|0|||
163284050|NCT03124108|589749392|FG000|Overall Study|Adverse Event|0|||
163284051|NCT03124108|589749393|FG001|Overall Study|Adverse Event|1|||
163284052|NCT03124108|589749394|FG002|Overall Study|Adverse Event|0|||
163284053|NCT01670019|589749404|FG000|Overall Study|Adverse Event|3|||
163284054|NCT01670019|589749405|FG001|Overall Study|Adverse Event|0|||
163284055|NCT01670019|589749404|FG000|Overall Study|Withdrawal by Subject|6|||
163284056|NCT01670019|589749405|FG001|Overall Study|Withdrawal by Subject|0|||
163284057|NCT03586167|589749407|FG000|Overall Study|Other|1|||
163284058|NCT03586167|589749408|FG001|Overall Study|Other|0|||
163284059|NCT03537651|589749411|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
163284060|NCT03537651|589749411|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
163284061|NCT03537651|589749411|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
163284062|NCT03537651|589749411|FG000|Part A (Up to 96 Weeks)|Other|1|||
163284063|NCT03537651|589749411|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
163284064|NCT03537651|589749411|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
163284065|NCT03537651|589749411|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
163284066|NCT03537651|589749411|FG000|Part B (Up to 192 Weeks)|Other|1|||
163284067|NCT05487703|589749413|FG000|Overall Study|Other|19|||
163284068|NCT05487703|589749413|FG000|Overall Study|Participant not well|5|||
163284069|NCT05487703|589749413|FG000|Overall Study|Insurance Reasons|6|||
163284070|NCT05487703|589749413|FG000|Overall Study|Physician Decision|19|||
163284071|NCT05487703|589749413|FG000|Overall Study|Lack of Efficacy|60|||
163284072|NCT02403323|589749414|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
163179154|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179155|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179156|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179157|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179158|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179159|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179160|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179161|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179162|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163284073|NCT02403323|589749415|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
163284074|NCT02403323|589749416|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
163284075|NCT02403323|589749414|FG000|Part 1: Open Label Extension Period|Death|3|||
163284076|NCT02403323|589749415|FG001|Part 1: Open Label Extension Period|Death|0|||
163284077|NCT02403323|589749416|FG002|Part 1: Open Label Extension Period|Death|0|||
163284078|NCT02403323|589749414|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
162935531|NCT04480463|588468035|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
162935532|NCT04480463|588468036|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
162935533|NCT04480463|588468035|FG000|Overall Study|Other|6|||
162935534|NCT04480463|588468036|FG001|Overall Study|Other|4|||
162935535|NCT02231710|588468037|FG000|Overall Study|Physician Decision|1|||
162935536|NCT01399723|588468038|FG000|Overall Study|Lost to Follow-up|0|||
162935537|NCT01399723|588468039|FG001|Overall Study|Lost to Follow-up|1|||
163042833|NCT01990768|588863968|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
163179163|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179164|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|4|||
163179165|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179166|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179167|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|1|||
163179168|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179169|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179170|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179171|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179172|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179173|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179174|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179175|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179176|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179177|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179178|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179179|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179180|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179181|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Protocol Violation|1|||
163179182|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179183|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179184|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179185|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179186|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179187|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179188|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179189|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179190|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179191|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179192|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179193|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179194|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179195|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179196|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179197|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179198|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Adverse Event|1|||
163179199|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179200|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179201|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179202|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179203|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179204|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179205|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179206|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179207|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179208|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179209|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179210|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179211|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179212|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179213|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179214|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
163179215|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179216|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179217|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
163179218|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
162935538|NCT00673361|588468040|FG000|Overall Study|Screen Failure|2|||
162935539|NCT01799590|588468042|FG000|Overall Study|Adverse Event|13|||
162935540|NCT01799590|588468043|FG001|Overall Study|Adverse Event|7|||
162935541|NCT01799590|588468044|FG002|Overall Study|Adverse Event|5|||
162935542|NCT01799590|588468042|FG000|Overall Study|Pregnancy|2|||
162935543|NCT01799590|588468043|FG001|Overall Study|Pregnancy|0|||
162935544|NCT01799590|588468044|FG002|Overall Study|Pregnancy|0|||
163179219|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162935545|NCT01799590|588468042|FG000|Overall Study|Lack of Efficacy|3|||
163179220|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179221|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179222|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179223|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179224|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
162935546|NCT01799590|588468043|FG001|Overall Study|Lack of Efficacy|1|||
162935547|NCT01799590|588468044|FG002|Overall Study|Lack of Efficacy|3|||
162935548|NCT01799590|588468042|FG000|Overall Study|Participants convenience|4|||
162935549|NCT01799590|588468043|FG001|Overall Study|Participants convenience|4|||
162935550|NCT01799590|588468044|FG002|Overall Study|Participants convenience|2|||
162935551|NCT01799590|588468042|FG000|Overall Study|Aggravation of complications|0|||
162935552|NCT01799590|588468043|FG001|Overall Study|Aggravation of complications|1|||
162935553|NCT01799590|588468044|FG002|Overall Study|Aggravation of complications|1|||
162935554|NCT01799590|588468042|FG000|Overall Study|Using drugs with restricted days of use|0|||
162935555|NCT01799590|588468043|FG001|Overall Study|Using drugs with restricted days of use|3|||
162935556|NCT01799590|588468044|FG002|Overall Study|Using drugs with restricted days of use|2|||
162935557|NCT01799590|588468042|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
162935558|NCT01799590|588468043|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
162935559|NCT01799590|588468044|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
162935560|NCT01799590|588468042|FG000|Overall Study|Other|3|||
162935561|NCT01799590|588468043|FG001|Overall Study|Other|0|||
162935562|NCT01799590|588468044|FG002|Overall Study|Other|1|||
162935563|NCT00752791|588468047|FG000|Overall Study|Adverse Event|7|||
162935564|NCT00752791|588468047|FG000|Overall Study|Withdrawal by Subject|1|||
162935565|NCT00752791|588468047|FG000|Overall Study|Physician Decision|1|||
162935566|NCT00752791|588468047|FG000|Overall Study|Death|1|||
162935567|NCT00752791|588468047|FG000|Overall Study|Renal transplant|3|||
162935568|NCT00752791|588468047|FG000|Overall Study|Switched to hemodialysis|2|||
162935569|NCT00752791|588468047|FG000|Overall Study|Protocol deviation|1|||
162935570|NCT01769378|588468052|FG000|Overall Study|Adverse Event|10|||
162935571|NCT01769378|588468053|FG001|Overall Study|Adverse Event|0|||
163179225|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179226|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179227|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179228|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179229|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179230|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179231|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|1|||
163179232|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179233|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179234|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179235|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179236|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179237|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179238|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179239|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179240|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179241|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179242|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179243|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179244|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179245|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179246|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179247|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179248|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179249|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|1|||
163179250|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179251|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179252|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179253|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179254|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179255|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179256|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162935572|NCT01769378|588468052|FG000|Overall Study|Entry criteria not met|1|||
162935573|NCT01769378|588468053|FG001|Overall Study|Entry criteria not met|0|||
162935574|NCT01769378|588468052|FG000|Overall Study|Protocol Violation|1|||
162935575|NCT01769378|588468053|FG001|Overall Study|Protocol Violation|1|||
162935576|NCT01769378|588468052|FG000|Overall Study|Withdrawal by Subject|10|||
163284079|NCT02403323|589749415|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
163284080|NCT02403323|589749416|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
163284081|NCT02403323|589749414|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
163284082|NCT02403323|589749415|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
163284083|NCT02403323|589749416|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
163284084|NCT02403323|589749414|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
163284085|NCT02403323|589749415|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
163284086|NCT02403323|589749416|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
163284087|NCT02403323|589749414|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
163284088|NCT02403323|589749415|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
163284089|NCT02403323|589749416|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
163284090|NCT02403323|589749414|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
163284091|NCT02403323|589749415|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
163284092|NCT02403323|589749416|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
163284093|NCT02403323|589749414|FG000|Part 1: Open Label Extension Period|Other|1|||
163284094|NCT02403323|589749415|FG001|Part 1: Open Label Extension Period|Other|0|||
163284095|NCT02403323|589749416|FG002|Part 1: Open Label Extension Period|Other|0|||
163284096|NCT02403323|589749414|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
163284097|NCT02403323|589749415|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
163284098|NCT02403323|589749416|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
163284099|NCT02403323|589749414|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
163284100|NCT02403323|589749415|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
163284101|NCT02403323|589749416|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
163284102|NCT02403323|589749414|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
163284103|NCT02403323|589749415|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
163284104|NCT02403323|589749416|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
163284105|NCT02403323|589749414|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
163284106|NCT02403323|589749415|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
163284107|NCT02403323|589749416|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
163284108|NCT02403323|589749414|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
163284109|NCT02403323|589749415|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
163284110|NCT02403323|589749416|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
163284111|NCT02403323|589749414|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
163284112|NCT02403323|589749415|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
163284113|NCT02403323|589749416|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
163284114|NCT02403323|589749414|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
163284115|NCT02403323|589749415|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
163284116|NCT02403323|589749416|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
163284117|NCT02403323|589749414|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
163284118|NCT02403323|589749415|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
163284119|NCT02403323|589749416|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
163284120|NCT02403323|589749414|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
163284121|NCT02403323|589749415|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
163284122|NCT02403323|589749416|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
163284123|NCT02403323|589749414|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
163284124|NCT02403323|589749415|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
163284125|NCT02403323|589749416|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
163284126|NCT03885596|589749424|FG000|Overall Study|Withdrawal by Subject|2|||
163284127|NCT03885596|589749425|FG001|Overall Study|Withdrawal by Subject|1|||
163284128|NCT03885596|589749426|FG002|Overall Study|Withdrawal by Subject|0|||
163284129|NCT03885596|589749427|FG003|Overall Study|Withdrawal by Subject|0|||
163284130|NCT00746330|589749428|FG000|Period 1|Abnormal test procedure result|0|||
163284131|NCT00746330|589749429|FG001|Period 1|Abnormal test procedure result|0|||
163284132|NCT00746330|589749430|FG002|Period 1|Abnormal test procedure result|1|||
163284133|NCT00746330|589749431|FG003|Period 1|Abnormal test procedure result|0|||
163284134|NCT01076335|589749432|FG000|Overall Study|Withdrawal by Subject|3|||
163284135|NCT01076335|589749432|FG000|Overall Study|Withdrawal without treatment|1|||
162935577|NCT01769378|588468053|FG001|Overall Study|Withdrawal by Subject|3|||
162935578|NCT01769378|588468052|FG000|Overall Study|Sponsor Decision|1|||
162935579|NCT01769378|588468053|FG001|Overall Study|Sponsor Decision|0|||
162935580|NCT01769378|588468052|FG000|Overall Study|Lost to Follow-up|2|||
163284136|NCT00517933|589749434|FG000|Period 1|Death|2|||
163284137|NCT00517933|589749435|FG001|Period 1|Death|1|||
163284138|NCT00517933|589749434|FG000|Period 1|Adverse Event|4|||
163284139|NCT00517933|589749435|FG001|Period 1|Adverse Event|4|||
163284140|NCT00517933|589749434|FG000|Period 1|Lost to Follow-up|2|||
163284141|NCT00517933|589749435|FG001|Period 1|Lost to Follow-up|0|||
162935581|NCT01769378|588468053|FG001|Overall Study|Lost to Follow-up|0|||
162935582|NCT01977092|588468054|FG000|Overall Study|Death|3|||
162935583|NCT01977092|588468055|FG001|Overall Study|Death|4|||
162935584|NCT01977092|588468054|FG000|Overall Study|Lost to Follow-up|23|||
163284142|NCT00517933|589749434|FG000|Period 1|Underwent lung transplant|0|||
162935585|NCT01977092|588468055|FG001|Overall Study|Lost to Follow-up|14|||
163284143|NCT00517933|589749435|FG001|Period 1|Underwent lung transplant|1|||
163284144|NCT00517933|589749434|FG000|Period 2|Death|2|||
163284145|NCT00517933|589749435|FG001|Period 2|Death|4|||
163284146|NCT00517933|589749434|FG000|Period 2|Adverse Event|2|||
163284147|NCT00517933|589749435|FG001|Period 2|Adverse Event|4|||
162935586|NCT01977092|588468054|FG000|Overall Study|Withdrawal by Subject|2|||
162935587|NCT01977092|588468055|FG001|Overall Study|Withdrawal by Subject|1|||
162935588|NCT01977092|588468054|FG000|Overall Study|In prison|3|||
163284148|NCT00517933|589749434|FG000|Period 2|Physician Decision|1|||
163284149|NCT00517933|589749435|FG001|Period 2|Physician Decision|0|||
163284150|NCT00517933|589749434|FG000|Period 2|Withdrawal by Subject|1|||
163284151|NCT00517933|589749435|FG001|Period 2|Withdrawal by Subject|3|||
162935589|NCT01977092|588468055|FG001|Overall Study|In prison|11|||
162935590|NCT01958281|588468056|FG000|Overall Study|Lack of Efficacy|5|||
162935591|NCT01958281|588468057|FG001|Overall Study|Lack of Efficacy|2|||
162935592|NCT01958281|588468058|FG002|Overall Study|Lack of Efficacy|0|||
162935593|NCT01958281|588468056|FG000|Overall Study|Adverse Event|0|||
162935594|NCT01958281|588468057|FG001|Overall Study|Adverse Event|2|||
162935595|NCT01958281|588468058|FG002|Overall Study|Adverse Event|0|||
162935596|NCT01958281|588468056|FG000|Overall Study|Withdrew Consent|1|||
162935597|NCT01958281|588468057|FG001|Overall Study|Withdrew Consent|0|||
162935598|NCT01958281|588468058|FG002|Overall Study|Withdrew Consent|0|||
162935599|NCT03038113|588468059|FG000|Overall Study|Withdrawal by Subject|0|||
162935600|NCT03038113|588468060|FG001|Overall Study|Withdrawal by Subject|0|||
162935601|NCT03038113|588468061|FG002|Overall Study|Withdrawal by Subject|1|||
162935602|NCT03038113|588468062|FG003|Overall Study|Withdrawal by Subject|0|||
162935603|NCT03038113|588468063|FG004|Overall Study|Withdrawal by Subject|0|||
162935604|NCT03038113|588468064|FG005|Overall Study|Withdrawal by Subject|0|||
162935605|NCT03038113|588468065|FG006|Overall Study|Withdrawal by Subject|0|||
162935606|NCT03038113|588468066|FG007|Overall Study|Withdrawal by Subject|0|||
162935607|NCT03038113|588468067|FG008|Overall Study|Withdrawal by Subject|0|||
162935608|NCT03038113|588468068|FG009|Overall Study|Withdrawal by Subject|0|||
162935609|NCT03038113|588468069|FG010|Overall Study|Withdrawal by Subject|0|||
162935610|NCT03038113|588468070|FG011|Overall Study|Withdrawal by Subject|0|||
162935611|NCT03038113|588468071|FG012|Overall Study|Withdrawal by Subject|0|||
162935612|NCT03038113|588468072|FG013|Overall Study|Withdrawal by Subject|1|||
162935613|NCT03038113|588468059|FG000|Overall Study|Lost to Follow-up|0|||
162935614|NCT03038113|588468060|FG001|Overall Study|Lost to Follow-up|0|||
162935615|NCT03038113|588468061|FG002|Overall Study|Lost to Follow-up|0|||
162935616|NCT03038113|588468062|FG003|Overall Study|Lost to Follow-up|0|||
162935617|NCT03038113|588468063|FG004|Overall Study|Lost to Follow-up|0|||
162935618|NCT03038113|588468064|FG005|Overall Study|Lost to Follow-up|0|||
163284152|NCT00517933|589749434|FG000|Period 2|Underwent lung transplant|0|||
163284153|NCT00517933|589749435|FG001|Period 2|Underwent lung transplant|2|||
163284154|NCT00235495|589749443|FG000|Overall Study|Death|52|||
163284155|NCT00235495|589749444|FG001|Overall Study|Death|42|||
163284156|NCT00235495|589749443|FG000|Overall Study|Withdrawal by Subject|5|||
163284157|NCT00235495|589749444|FG001|Overall Study|Withdrawal by Subject|3|||
163284158|NCT00235495|589749443|FG000|Overall Study|Lost to Follow-up|11|||
163284159|NCT00235495|589749444|FG001|Overall Study|Lost to Follow-up|13|||
163284160|NCT00235495|589749443|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
163284161|NCT00235495|589749444|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
162935619|NCT03038113|588468065|FG006|Overall Study|Lost to Follow-up|1|||
162935620|NCT03038113|588468066|FG007|Overall Study|Lost to Follow-up|0|||
162935621|NCT03038113|588468067|FG008|Overall Study|Lost to Follow-up|0|||
162935622|NCT03038113|588468068|FG009|Overall Study|Lost to Follow-up|0|||
162935623|NCT03038113|588468069|FG010|Overall Study|Lost to Follow-up|0|||
162935624|NCT03038113|588468070|FG011|Overall Study|Lost to Follow-up|0|||
162935625|NCT03038113|588468071|FG012|Overall Study|Lost to Follow-up|0|||
162935626|NCT03038113|588468072|FG013|Overall Study|Lost to Follow-up|0|||
162935627|NCT02784106|588468073|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
162935628|NCT02784106|588468074|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
162935629|NCT02784106|588468075|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
162935630|NCT02784106|588468076|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
162935631|NCT02784106|588468073|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
162935632|NCT02784106|588468074|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
162935633|NCT02784106|588468075|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162935634|NCT02784106|588468076|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162935635|NCT02784106|588468073|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
162935636|NCT02784106|588468074|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
162935637|NCT02784106|588468075|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
162935638|NCT02784106|588468076|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
163284162|NCT01268566|589749451|FG000|Overall Study|Lost to Follow-up|1|||
163284163|NCT01268566|589749451|FG000|Overall Study|Withdrawal by Subject|12|||
162935639|NCT02784106|588468073|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
162935640|NCT02784106|588468074|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
162935641|NCT02784106|588468075|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
162935642|NCT02784106|588468076|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
162935643|NCT02784106|588468073|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
162935644|NCT02784106|588468074|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
162935645|NCT02784106|588468075|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
162935646|NCT02784106|588468076|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
162935647|NCT02784106|588468073|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
162935648|NCT02784106|588468074|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
162935649|NCT02784106|588468075|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
162935650|NCT02784106|588468076|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
162935651|NCT02927847|588468078|FG000|Overall Study|Lost to Follow-up|1|||
162935652|NCT02927847|588468079|FG001|Overall Study|Lost to Follow-up|0|||
162935653|NCT02927847|588468078|FG000|Overall Study|Withdrawal by Subject|4|||
162935654|NCT02927847|588468079|FG001|Overall Study|Withdrawal by Subject|2|||
162935655|NCT02927847|588468078|FG000|Overall Study|PI withdrawn due to missed visits|1|||
162935656|NCT02927847|588468079|FG001|Overall Study|PI withdrawn due to missed visits|1|||
162935657|NCT00553540|588468080|FG000|Overall Study|discharged after first visit|2|||
162935658|NCT00553540|588468081|FG001|Overall Study|discharged after first visit|5|||
162935659|NCT01755858|588468084|FG000|Overall Study|Adverse Event|1|||
162935660|NCT01755858|588468085|FG001|Overall Study|Adverse Event|1|||
162935661|NCT03882047|588468086|FG000|Overall Study|Adverse Event|0|||
162935662|NCT03882047|588468087|FG001|Overall Study|Adverse Event|2|||
162935663|NCT03882047|588468088|FG002|Overall Study|Adverse Event|2|||
162935664|NCT03882047|588468086|FG000|Overall Study|Treatment Failure|3|||
162935665|NCT03882047|588468087|FG001|Overall Study|Treatment Failure|3|||
162935666|NCT03882047|588468088|FG002|Overall Study|Treatment Failure|12|||
162935667|NCT03882047|588468086|FG000|Overall Study|Lost to Follow-up|0|||
162935668|NCT03882047|588468087|FG001|Overall Study|Lost to Follow-up|1|||
162935669|NCT03882047|588468088|FG002|Overall Study|Lost to Follow-up|0|||
162935670|NCT03882047|588468086|FG000|Overall Study|Did Not Wish to Continue|1|||
162935671|NCT03882047|588468087|FG001|Overall Study|Did Not Wish to Continue|4|||
162935672|NCT03882047|588468088|FG002|Overall Study|Did Not Wish to Continue|1|||
162935673|NCT03882047|588468086|FG000|Overall Study|Noncompliance With Protocol|2|||
162935674|NCT03882047|588468087|FG001|Overall Study|Noncompliance With Protocol|0|||
162935675|NCT03882047|588468088|FG002|Overall Study|Noncompliance With Protocol|0|||
162935676|NCT03882047|588468086|FG000|Overall Study|Did Not Meet Eligibility|0|||
162935677|NCT03882047|588468087|FG001|Overall Study|Did Not Meet Eligibility|0|||
162935678|NCT03882047|588468088|FG002|Overall Study|Did Not Meet Eligibility|1|||
162935679|NCT00175019|588468090|FG000|Overall Study|Adverse Event|54|||
162935680|NCT00175019|588468091|FG001|Overall Study|Adverse Event|22|||
162935681|NCT00175019|588468092|FG002|Overall Study|Adverse Event|2|||
162935682|NCT00175019|588468090|FG000|Overall Study|Protocol Violation|6|||
162935683|NCT00175019|588468091|FG001|Overall Study|Protocol Violation|3|||
162935684|NCT00175019|588468092|FG002|Overall Study|Protocol Violation|3|||
162935685|NCT00175019|588468090|FG000|Overall Study|Lost to Follow-up|42|||
162935686|NCT00175019|588468091|FG001|Overall Study|Lost to Follow-up|39|||
162935687|NCT00175019|588468092|FG002|Overall Study|Lost to Follow-up|9|||
162935688|NCT00175019|588468090|FG000|Overall Study|Did not continue under Amendment 4|1|||
162935689|NCT00175019|588468091|FG001|Overall Study|Did not continue under Amendment 4|1|||
162935690|NCT00175019|588468092|FG002|Overall Study|Did not continue under Amendment 4|2|||
162935691|NCT00175019|588468090|FG000|Overall Study|Personal Reason(s)|39|||
162935692|NCT00175019|588468091|FG001|Overall Study|Personal Reason(s)|31|||
162935693|NCT00175019|588468092|FG002|Overall Study|Personal Reason(s)|8|||
162935694|NCT00175019|588468090|FG000|Overall Study|Therapeutic Failure|10|||
162935695|NCT00175019|588468091|FG001|Overall Study|Therapeutic Failure|38|||
162935696|NCT00175019|588468092|FG002|Overall Study|Therapeutic Failure|22|||
162935697|NCT00175019|588468090|FG000|Overall Study|Gout Flare|2|||
162935698|NCT00175019|588468091|FG001|Overall Study|Gout Flare|3|||
162935699|NCT00175019|588468092|FG002|Overall Study|Gout Flare|0|||
162935700|NCT00175019|588468090|FG000|Overall Study|Reason Not Specified|40|||
162935701|NCT00175019|588468091|FG001|Overall Study|Reason Not Specified|34|||
162935702|NCT00175019|588468092|FG002|Overall Study|Reason Not Specified|11|||
163179257|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179258|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162935703|NCT00475852|588468096|FG000|Overall Study|Death|444|||
162935704|NCT00475852|588468097|FG001|Overall Study|Death|456|||
162935705|NCT00475852|588468096|FG000|Overall Study|Withdrawal by Subject|19|||
162935706|NCT00475852|588468097|FG001|Overall Study|Withdrawal by Subject|24|||
162935707|NCT00475852|588468096|FG000|Overall Study|Lost to Follow-up|54|||
162935708|NCT00475852|588468097|FG001|Overall Study|Lost to Follow-up|68|||
162935709|NCT00297479|588468098|FG000|Overall Study|Lost to Follow-up|37|||
163179259|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162935710|NCT00297479|588468099|FG001|Overall Study|Lost to Follow-up|54|||
163179260|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179261|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179262|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179263|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179264|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179265|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179266|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|1|||
163179267|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179268|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179269|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179270|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179271|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179272|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179273|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179274|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179275|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179276|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179277|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179278|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179279|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179280|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179281|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179282|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179283|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179284|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179285|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|1|||
163179286|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179287|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179288|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179289|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179290|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179291|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179292|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179293|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179294|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163284164|NCT01268566|589749451|FG000|Overall Study|Death|30|||
163284165|NCT02784704|589749456|FG000|Overall Study|Adverse Event|4|||
162935711|NCT00297479|588468100|FG002|Overall Study|Lost to Follow-up|51|||
162935712|NCT03263819|588468101|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
162935713|NCT03263819|588468102|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
162935714|NCT00686920|588468107|FG000|Overall Study|Death|45|||
162935715|NCT00686920|588468108|FG001|Overall Study|Death|14|||
162935716|NCT00686920|588468107|FG000|Overall Study|Liver Transplant|23|||
162935717|NCT00686920|588468108|FG001|Overall Study|Liver Transplant|8|||
162935718|NCT00686920|588468107|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
162935719|NCT00686920|588468108|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
162935720|NCT00686920|588468107|FG000|Overall Study|Withdrawal by Subject|23|||
162935721|NCT00686920|588468108|FG001|Overall Study|Withdrawal by Subject|5|||
162935722|NCT00686920|588468107|FG000|Overall Study|Protocol Violation|2|||
162935723|NCT00686920|588468108|FG001|Overall Study|Protocol Violation|1|||
162935724|NCT00686920|588468107|FG000|Overall Study|Adverse Event|10|||
162935725|NCT00686920|588468108|FG001|Overall Study|Adverse Event|2|||
162935726|NCT00686920|588468107|FG000|Overall Study|Personal Reason|0|||
162935727|NCT00686920|588468108|FG001|Overall Study|Personal Reason|1|||
162935728|NCT00686920|588468107|FG000|Overall Study|Lost to Follow-up|15|||
162935729|NCT00686920|588468108|FG001|Overall Study|Lost to Follow-up|3|||
162935730|NCT00686920|588468107|FG000|Overall Study|Moved to Another State|1|||
162935731|NCT00686920|588468108|FG001|Overall Study|Moved to Another State|0|||
162935732|NCT00686920|588468107|FG000|Overall Study|Transferred to Nursing Home|1|||
162935733|NCT00686920|588468108|FG001|Overall Study|Transferred to Nursing Home|0|||
162935734|NCT00686920|588468107|FG000|Overall Study|Noncompliance|9|||
162935735|NCT00686920|588468108|FG001|Overall Study|Noncompliance|0|||
162935736|NCT00686920|588468107|FG000|Overall Study|Principal Investigator Decision|2|||
162935737|NCT00686920|588468108|FG001|Overall Study|Principal Investigator Decision|0|||
162935738|NCT00814658|588468112|FG000|Overall Study|Lost to Follow-up|0|||
162935739|NCT00814658|588468113|FG001|Overall Study|Lost to Follow-up|1|||
162935740|NCT00814658|588468112|FG000|Overall Study|Physician Decision|1|||
162935741|NCT00814658|588468113|FG001|Overall Study|Physician Decision|0|||
162935742|NCT00814658|588468112|FG000|Overall Study|Adverse Event|3|||
162935743|NCT00814658|588468113|FG001|Overall Study|Adverse Event|3|||
162935744|NCT02087046|588468114|FG000|Overall Study|Adverse Event|4|||
162935745|NCT02087046|588468114|FG000|Overall Study|Death|1|||
162935746|NCT02087046|588468114|FG000|Overall Study|Lost to Follow-up|3|||
162935747|NCT02087046|588468114|FG000|Overall Study|Withdrawal by Subject|2|||
162935748|NCT02087046|588468114|FG000|Overall Study|Physician Decision|1|||
162935749|NCT02444533|588468115|FG000|Overall Study|Not able to complete forms|0|||
162935750|NCT02444533|588468116|FG001|Overall Study|Not able to complete forms|2|||
162935751|NCT02444533|588468115|FG000|Overall Study|Only gave post-procedure complications|2|||
162935752|NCT02444533|588468116|FG001|Overall Study|Only gave post-procedure complications|2|||
162935753|NCT01141283|588468117|FG000|Overall Study|Adverse Event|56|||
162935754|NCT01141283|588468117|FG000|Overall Study|Lost to Follow-up|4|||
162935755|NCT01141283|588468117|FG000|Overall Study|Withdrawal by Subject|14|||
162935756|NCT01141283|588468117|FG000|Overall Study|Administrative|4|||
162935757|NCT01141283|588468117|FG000|Overall Study|Lack of Efficacy|10|||
162935758|NCT01208402|588468122|FG000|Overall Study|Withdrawal by Subject|1|||
162935759|NCT01208402|588468123|FG001|Overall Study|Withdrawal by Subject|0|||
162935760|NCT01571635|588468124|FG000|Overall Study|Adverse Event|3|||
162935761|NCT01571635|588468125|FG001|Overall Study|Adverse Event|0|||
162935762|NCT01571635|588468126|FG002|Overall Study|Adverse Event|2|||
162935763|NCT01571635|588468127|FG003|Overall Study|Adverse Event|3|||
163179295|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179296|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179297|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179298|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179299|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179300|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179301|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179302|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163042834|NCT01990768|588863969|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
163179303|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Adult height reached|1|||
163179304|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162935764|NCT01571635|588468128|FG004|Overall Study|Adverse Event|5|||
162935765|NCT01571635|588468124|FG000|Overall Study|Other reasons|2|||
162935766|NCT01571635|588468125|FG001|Overall Study|Other reasons|1|||
162935767|NCT01571635|588468126|FG002|Overall Study|Other reasons|2|||
162935768|NCT01571635|588468127|FG003|Overall Study|Other reasons|2|||
162935769|NCT01571635|588468128|FG004|Overall Study|Other reasons|1|||
162935770|NCT01571635|588468124|FG000|Overall Study|Study terminated by sponsor|0|||
162935771|NCT01571635|588468125|FG001|Overall Study|Study terminated by sponsor|4|||
162935772|NCT01571635|588468126|FG002|Overall Study|Study terminated by sponsor|1|||
162935773|NCT01571635|588468127|FG003|Overall Study|Study terminated by sponsor|3|||
162935774|NCT01571635|588468128|FG004|Overall Study|Study terminated by sponsor|1|||
162935775|NCT01571635|588468124|FG000|Overall Study|Withdrew consent|1|||
162935776|NCT01571635|588468125|FG001|Overall Study|Withdrew consent|1|||
162935777|NCT01571635|588468126|FG002|Overall Study|Withdrew consent|2|||
162935778|NCT01571635|588468127|FG003|Overall Study|Withdrew consent|3|||
162935779|NCT01571635|588468128|FG004|Overall Study|Withdrew consent|0|||
162935780|NCT01571635|588468124|FG000|Overall Study|Lack of Efficacy|0|||
162935781|NCT01571635|588468125|FG001|Overall Study|Lack of Efficacy|2|||
162935782|NCT01571635|588468126|FG002|Overall Study|Lack of Efficacy|0|||
162935783|NCT01571635|588468127|FG003|Overall Study|Lack of Efficacy|1|||
162935784|NCT01571635|588468128|FG004|Overall Study|Lack of Efficacy|2|||
162935785|NCT01201356|588468133|FG000|Overall Study|Adverse Event|170|||
162935786|NCT01201356|588468133|FG000|Overall Study|Abnormal laboratory value(s)|51|||
162935787|NCT01201356|588468133|FG000|Overall Study|Abnormal test procedure result(s)|3|||
162935788|NCT01201356|588468133|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
162935789|NCT01201356|588468133|FG000|Overall Study|Condition no longer requires study drug|12|||
162935790|NCT01201356|588468133|FG000|Overall Study|Withdrawal by Subject|144|||
162935791|NCT01201356|588468133|FG000|Overall Study|Lost to Follow-up|50|||
162935792|NCT01201356|588468133|FG000|Overall Study|administrative problems|74|||
162935793|NCT01201356|588468133|FG000|Overall Study|Death|16|||
162935794|NCT01201356|588468133|FG000|Overall Study|Protocol Violation|12|||
162935795|NCT00585039|588468134|FG000|Overall Study|medication spilled|2|||
162935796|NCT00585039|588468135|FG001|Overall Study|medication spilled|0|||
162935797|NCT02173301|588468136|FG000|Overall Study|Adverse Event|7|||
162935798|NCT02173301|588468137|FG001|Overall Study|Adverse Event|8|||
162935799|NCT02173301|588468138|FG002|Overall Study|Adverse Event|13|||
162935800|NCT02173301|588468139|FG003|Overall Study|Adverse Event|5|||
162935801|NCT02173301|588468136|FG000|Overall Study|Withdrawal by Subject|8|||
162935802|NCT02173301|588468137|FG001|Overall Study|Withdrawal by Subject|10|||
162935803|NCT02173301|588468138|FG002|Overall Study|Withdrawal by Subject|4|||
162935804|NCT02173301|588468139|FG003|Overall Study|Withdrawal by Subject|8|||
162935805|NCT02173301|588468136|FG000|Overall Study|Lost to Follow-up|4|||
162935806|NCT02173301|588468137|FG001|Overall Study|Lost to Follow-up|4|||
162935807|NCT02173301|588468138|FG002|Overall Study|Lost to Follow-up|2|||
162935808|NCT02173301|588468139|FG003|Overall Study|Lost to Follow-up|2|||
162935809|NCT02173301|588468136|FG000|Overall Study|Protocol Violation|0|||
162935810|NCT02173301|588468137|FG001|Overall Study|Protocol Violation|1|||
162935811|NCT02173301|588468138|FG002|Overall Study|Protocol Violation|0|||
162935812|NCT02173301|588468139|FG003|Overall Study|Protocol Violation|0|||
162935813|NCT02173301|588468136|FG000|Overall Study|Physician Decision|0|||
162935814|NCT02173301|588468137|FG001|Overall Study|Physician Decision|0|||
162935815|NCT02173301|588468138|FG002|Overall Study|Physician Decision|1|||
162935816|NCT02173301|588468139|FG003|Overall Study|Physician Decision|0|||
162935817|NCT02173301|588468136|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
162935818|NCT02173301|588468137|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
162935819|NCT02173301|588468138|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
162935820|NCT02173301|588468139|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
162935821|NCT01585831|588468140|FG000|Overall Study|Physician Decision|0|||
162935822|NCT01585831|588468141|FG001|Overall Study|Physician Decision|1|||
162935823|NCT01585831|588468140|FG000|Overall Study|Withdrawal by Subject|2|||
162935824|NCT01585831|588468141|FG001|Overall Study|Withdrawal by Subject|1|||
162935825|NCT01225991|588468142|FG000|Overall Study|Withdrawal by Subject|6|||
162935826|NCT04079842|588468143|FG000|Overall Study|Request of subject|2|||
162935827|NCT04079842|588468143|FG000|Overall Study|Unable to draw Arterial samples|1|||
162935828|NCT02904200|588468144|FG000|Overall Study|Withdrawal by Subject|1|||
163179305|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179306|NCT02616562|589370552|FG000|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179307|NCT02616562|589370553|FG001|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179308|NCT02616562|589370554|FG002|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179309|NCT02616562|589370555|FG003|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179310|NCT02616562|589370556|FG004|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179311|NCT02616562|589370557|FG005|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179312|NCT02616562|589370558|FG006|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179313|NCT02616562|589370559|FG007|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163284166|NCT02784704|589749457|FG001|Overall Study|Adverse Event|2|||
162935829|NCT02904200|588468145|FG001|Overall Study|Withdrawal by Subject|0|||
162935830|NCT02133352|588468146|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
162935831|NCT04444752|588468147|FG000|Overall Study|Adverse Event|1|||
162935832|NCT04444752|588468148|FG001|Overall Study|Adverse Event|0|||
162935833|NCT04444752|588468149|FG002|Overall Study|Adverse Event|0|||
162935834|NCT04444752|588468150|FG003|Overall Study|Adverse Event|2|||
162935835|NCT04444752|588468147|FG000|Overall Study|Lost to Follow-up|2|||
163179314|NCT02616562|589370560|FG008|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179315|NCT02616562|589370561|FG009|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179316|NCT02616562|589370562|FG010|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179317|NCT02616562|589370563|FG011|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179318|NCT02616562|589370564|FG012|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179319|NCT02616562|589370565|FG013|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163284167|NCT02784704|589749456|FG000|Overall Study|Lost to Follow-up|6|||
163284168|NCT02784704|589749457|FG001|Overall Study|Lost to Follow-up|4|||
163284169|NCT02784704|589749456|FG000|Overall Study|Withdrawal by Subject|1|||
163284170|NCT02784704|589749457|FG001|Overall Study|Withdrawal by Subject|3|||
163284171|NCT02784704|589749456|FG000|Overall Study|Subject Non Compliance|2|||
163284172|NCT02784704|589749457|FG001|Overall Study|Subject Non Compliance|0|||
163284173|NCT00603538|589749458|FG000|Overall Study|Adverse Event|0|||
163284174|NCT00603538|589749459|FG001|Overall Study|Adverse Event|4|||
163284175|NCT00603538|589749460|FG002|Overall Study|Adverse Event|2|||
162935836|NCT04444752|588468148|FG001|Overall Study|Lost to Follow-up|6|||
162935837|NCT04444752|588468149|FG002|Overall Study|Lost to Follow-up|2|||
162935838|NCT04444752|588468150|FG003|Overall Study|Lost to Follow-up|5|||
162935839|NCT04444752|588468147|FG000|Overall Study|Physician Decision|0|||
162935840|NCT04444752|588468148|FG001|Overall Study|Physician Decision|0|||
162935841|NCT04444752|588468149|FG002|Overall Study|Physician Decision|0|||
162935842|NCT04444752|588468150|FG003|Overall Study|Physician Decision|2|||
162935843|NCT04444752|588468147|FG000|Overall Study|Pregnancy|0|||
162935844|NCT04444752|588468148|FG001|Overall Study|Pregnancy|0|||
162935845|NCT04444752|588468149|FG002|Overall Study|Pregnancy|0|||
162935846|NCT04444752|588468150|FG003|Overall Study|Pregnancy|1|||
162935847|NCT04444752|588468147|FG000|Overall Study|Withdrawal by Subject|6|||
162935848|NCT04444752|588468148|FG001|Overall Study|Withdrawal by Subject|5|||
162935849|NCT04444752|588468149|FG002|Overall Study|Withdrawal by Subject|3|||
162935850|NCT04444752|588468150|FG003|Overall Study|Withdrawal by Subject|4|||
162935851|NCT04444752|588468147|FG000|Overall Study|Protocol Violation|1|||
162935852|NCT04444752|588468148|FG001|Overall Study|Protocol Violation|1|||
162935853|NCT04444752|588468149|FG002|Overall Study|Protocol Violation|0|||
162935854|NCT04444752|588468150|FG003|Overall Study|Protocol Violation|0|||
162935855|NCT04444752|588468147|FG000|Overall Study|Patient moving out of town|1|||
162935856|NCT04444752|588468148|FG001|Overall Study|Patient moving out of town|0|||
162935857|NCT04444752|588468149|FG002|Overall Study|Patient moving out of town|0|||
162935858|NCT04444752|588468150|FG003|Overall Study|Patient moving out of town|1|||
162935859|NCT04444752|588468147|FG000|Overall Study|Lack of Efficacy|0|||
162935860|NCT04444752|588468148|FG001|Overall Study|Lack of Efficacy|0|||
162935861|NCT04444752|588468149|FG002|Overall Study|Lack of Efficacy|0|||
162935862|NCT04444752|588468150|FG003|Overall Study|Lack of Efficacy|1|||
162935863|NCT04444752|588468147|FG000|Overall Study|Death|0|||
162935864|NCT04444752|588468148|FG001|Overall Study|Death|0|||
162935865|NCT04444752|588468149|FG002|Overall Study|Death|1|||
162935866|NCT04444752|588468150|FG003|Overall Study|Death|0|||
162935867|NCT00579254|588468151|FG000|Overall Study|Lost to Follow-up|39|||
162935868|NCT00579254|588468151|FG000|Overall Study|Discontinued when study terminated|73|||
162935869|NCT00433381|588470235|FG000|Overall Study|Ineligible / no protocol treatment|3|||
162935870|NCT00433381|588470236|FG001|Overall Study|Ineligible / no protocol treatment|3|||
162935871|NCT01387282|588470237|FG000|Overall Study|Death|47|||
162935872|NCT01387282|588470238|FG001|Overall Study|Death|16|||
162935873|NCT01387282|588470237|FG000|Overall Study|Other|5|||
162935874|NCT01387282|588470238|FG001|Overall Study|Other|1|||
162935875|NCT01387282|588470237|FG000|Overall Study|Unrelated AE|6|||
162935876|NCT01387282|588470238|FG001|Overall Study|Unrelated AE|4|||
162935877|NCT01387282|588470237|FG000|Overall Study|Withdrawal by patient|33|||
162935878|NCT01387282|588470238|FG001|Overall Study|Withdrawal by patient|23|||
162935879|NCT01387282|588470237|FG000|Overall Study|Study drug-related AE|2|||
162935880|NCT01387282|588470238|FG001|Overall Study|Study drug-related AE|2|||
162935881|NCT01387282|588470237|FG000|Overall Study|Lost to Follow-up|4|||
162935882|NCT01387282|588470238|FG001|Overall Study|Lost to Follow-up|1|||
162935883|NCT04582266|588470239|FG000|Overall Study|Lost to Follow-up|7|||
162935884|NCT04582266|588470240|FG001|Overall Study|Lost to Follow-up|5|||
162935885|NCT04582266|588470239|FG000|Overall Study|Withdrawal by Subject|1|||
162935886|NCT04582266|588470240|FG001|Overall Study|Withdrawal by Subject|0|||
162935887|NCT04582266|588470239|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
162935888|NCT04582266|588470240|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
163284176|NCT00603538|589749458|FG000|Overall Study|Objective progression or relapse|3|||
163284177|NCT00603538|589749459|FG001|Overall Study|Objective progression or relapse|0|||
163284178|NCT00603538|589749460|FG002|Overall Study|Objective progression or relapse|0|||
163284179|NCT04794179|589749462|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
163284180|NCT04794179|589749463|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
162935889|NCT01034137|588470242|FG000|Overall Study|Adverse Event|9|||
162935890|NCT01034137|588470243|FG001|Overall Study|Adverse Event|10|||
162935891|NCT01034137|588470244|FG002|Overall Study|Adverse Event|8|||
162935892|NCT01034137|588470242|FG000|Overall Study|Withdrawal by Subject|4|||
162935893|NCT01034137|588470243|FG001|Overall Study|Withdrawal by Subject|3|||
162935894|NCT01034137|588470244|FG002|Overall Study|Withdrawal by Subject|3|||
162935895|NCT01034137|588470242|FG000|Overall Study|Lack of Efficacy|9|||
162935896|NCT01034137|588470243|FG001|Overall Study|Lack of Efficacy|4|||
162935897|NCT01034137|588470244|FG002|Overall Study|Lack of Efficacy|13|||
162935898|NCT01034137|588470242|FG000|Overall Study|Protocol Violation|2|||
162935899|NCT01034137|588470243|FG001|Overall Study|Protocol Violation|2|||
162935900|NCT01034137|588470244|FG002|Overall Study|Protocol Violation|1|||
162935901|NCT01034137|588470242|FG000|Overall Study|Refused treatment or did not cooperate|2|||
162935902|NCT01034137|588470243|FG001|Overall Study|Refused treatment or did not cooperate|0|||
162935903|NCT01034137|588470244|FG002|Overall Study|Refused treatment or did not cooperate|1|||
162935904|NCT01034137|588470242|FG000|Overall Study|Administrative or other|2|||
162935905|NCT01034137|588470243|FG001|Overall Study|Administrative or other|3|||
162935906|NCT01034137|588470244|FG002|Overall Study|Administrative or other|4|||
162935907|NCT01466686|588470245|FG000|Overall Study|Withdrawal by Subject|1|||
162935908|NCT01405950|588470246|FG000|Overall Study|Withdrawal by Subject|1|||
162935909|NCT01405950|588470247|FG001|Overall Study|Withdrawal by Subject|0|||
162935910|NCT01405950|588470248|FG002|Overall Study|Withdrawal by Subject|0|||
162935911|NCT01405950|588470249|FG003|Overall Study|Withdrawal by Subject|0|||
162935912|NCT01381900|588470250|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
162935913|NCT01381900|588470251|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
162935914|NCT01381900|588470252|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
162935915|NCT01381900|588470250|FG000|Overall Study|Adverse Event|4|||
162935916|NCT01381900|588470251|FG001|Overall Study|Adverse Event|6|||
162935917|NCT01381900|588470252|FG002|Overall Study|Adverse Event|7|||
162935918|NCT01381900|588470250|FG000|Overall Study|Noncompliance with study drug|0|||
162935919|NCT01381900|588470251|FG001|Overall Study|Noncompliance with study drug|0|||
162935920|NCT01381900|588470252|FG002|Overall Study|Noncompliance with study drug|1|||
162935921|NCT01381900|588470250|FG000|Overall Study|Physician Decision|0|||
162935922|NCT01381900|588470251|FG001|Overall Study|Physician Decision|1|||
162935923|NCT01381900|588470252|FG002|Overall Study|Physician Decision|1|||
162935924|NCT01381900|588470250|FG000|Overall Study|Protocol Violation|0|||
162935925|NCT01381900|588470251|FG001|Overall Study|Protocol Violation|1|||
162935926|NCT01381900|588470252|FG002|Overall Study|Protocol Violation|1|||
162935927|NCT01381900|588470250|FG000|Overall Study|Withdrawal by Subject|0|||
162935928|NCT01381900|588470251|FG001|Overall Study|Withdrawal by Subject|0|||
162935929|NCT01381900|588470252|FG002|Overall Study|Withdrawal by Subject|1|||
162935930|NCT01381900|588470250|FG000|Overall Study|Early withdraw|3|||
162935931|NCT01381900|588470251|FG001|Overall Study|Early withdraw|1|||
162935932|NCT01381900|588470252|FG002|Overall Study|Early withdraw|1|||
162935933|NCT01772368|588470253|FG000|Overall Study|Adverse Event|1|||
162935934|NCT01772368|588470253|FG000|Overall Study|Withdrawal by Subject|3|||
162935935|NCT01772368|588470253|FG000|Overall Study|Protocol Violation|2|||
162935936|NCT01772368|588470253|FG000|Overall Study|Other|1|||
162935937|NCT00112489|588470257|FG000|Overall Study|Refused further treatment|8|||
162935938|NCT00112489|588470257|FG000|Overall Study|Adverse Event|12|||
162935939|NCT00112489|588470257|FG000|Overall Study|Death|2|||
162935940|NCT00112489|588470257|FG000|Overall Study|Other, Not Specified|9|||
162935941|NCT00112489|588470257|FG000|Overall Study|Patient never treated|2|||
162935942|NCT00112489|588470257|FG000|Overall Study|Ineligible|7|||
162935943|NCT02891200|588470262|FG000|Overall Study|Lost to Follow-up|31|||
162935944|NCT02891200|588470263|FG001|Overall Study|Lost to Follow-up|36|||
162935945|NCT02891200|588470262|FG000|Overall Study|Death|10|||
162935946|NCT02891200|588470263|FG001|Overall Study|Death|9|||
162935947|NCT02891200|588470262|FG000|Overall Study|Withdrawal by Subject|1|||
162935948|NCT02891200|588470263|FG001|Overall Study|Withdrawal by Subject|4|||
162935949|NCT01339910|588470264|FG000|Overall Study|Withdrawal by Subject|1|||
162935950|NCT01339910|588470265|FG001|Overall Study|Withdrawal by Subject|0|||
162935951|NCT01339910|588470264|FG000|Overall Study|Physician Decision|1|||
162935952|NCT01339910|588470265|FG001|Overall Study|Physician Decision|0|||
162935953|NCT01339910|588470264|FG000|Overall Study|Disease relapse|1|||
162935954|NCT01339910|588470265|FG001|Overall Study|Disease relapse|4|||
162935955|NCT02322879|588470266|FG000|First Intervention|Physician Decision|1|||
162935956|NCT02322879|588470267|FG001|First Intervention|Physician Decision|0|||
162935957|NCT00124020|588470274|FG000|Overall Study|Death|67|||
162935958|NCT00124020|588470275|FG001|Overall Study|Death|71|||
162935959|NCT00124020|588470274|FG000|Overall Study|Withdrawal by Subject|13|||
162935960|NCT00124020|588470275|FG001|Overall Study|Withdrawal by Subject|11|||
163179320|NCT02616562|589370566|FG014|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179321|NCT02616562|589370567|FG015|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|5|||
163179322|NCT02616562|589370568|FG016|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|16|||
163179323|NCT04770779|589370570|FG000|Overall Study|Randomized, never treated|0|||
162935961|NCT00124020|588470274|FG000|Overall Study|Lost to Follow-up|5|||
162935962|NCT00124020|588470275|FG001|Overall Study|Lost to Follow-up|8|||
162935963|NCT00124020|588470274|FG000|Overall Study|Other|1|||
163179324|NCT04770779|589370571|FG001|Overall Study|Randomized, never treated|1|||
163179325|NCT04770779|589370570|FG000|Overall Study|Adverse Event|9|||
162935964|NCT00124020|588470275|FG001|Overall Study|Other|1|||
162935965|NCT00124020|588470274|FG000|Overall Study|Transfer to another hospital|2|||
162935966|NCT00124020|588470275|FG001|Overall Study|Transfer to another hospital|0|||
162935967|NCT01155583|588470278|FG000|Phase I|Screen failure - did not start treatment|0|||
162935968|NCT01155583|588470279|FG001|Phase I|Screen failure - did not start treatment|0|||
162935969|NCT01155583|588470280|FG002|Phase I|Screen failure - did not start treatment|0|||
163179326|NCT04770779|589370571|FG001|Overall Study|Adverse Event|1|||
162935970|NCT01155583|588470281|FG003|Phase I|Screen failure - did not start treatment|0|||
162935971|NCT01155583|588470282|FG004|Phase I|Screen failure - did not start treatment|1|||
162935972|NCT01155583|588470283|FG005|Phase I|Screen failure - did not start treatment|0|||
162935973|NCT01155583|588470284|FG006|Phase I|Screen failure - did not start treatment|0|||
162935974|NCT01155583|588470285|FG007|Phase I|Screen failure - did not start treatment|2|||
162935975|NCT01155583|588470286|FG008|Phase I|Screen failure - did not start treatment|0|||
162935976|NCT01155583|588470278|FG000|Phase I|Withdrawal by Subject|0|||
162935977|NCT01155583|588470279|FG001|Phase I|Withdrawal by Subject|0|||
162935978|NCT01155583|588470280|FG002|Phase I|Withdrawal by Subject|0|||
162935979|NCT01155583|588470281|FG003|Phase I|Withdrawal by Subject|0|||
162935980|NCT01155583|588470282|FG004|Phase I|Withdrawal by Subject|0|||
162935981|NCT01155583|588470283|FG005|Phase I|Withdrawal by Subject|0|||
162935982|NCT01155583|588470284|FG006|Phase I|Withdrawal by Subject|0|||
162935983|NCT01155583|588470285|FG007|Phase I|Withdrawal by Subject|1|||
162935984|NCT01155583|588470286|FG008|Phase I|Withdrawal by Subject|0|||
162935985|NCT00886483|588470293|FG000|Overall Study|Lost to Follow-up|0|||
162935986|NCT00886483|588470294|FG001|Overall Study|Lost to Follow-up|1|||
162935987|NCT00886483|588470293|FG000|Overall Study|Pursue medications|1|||
162935988|NCT00886483|588470294|FG001|Overall Study|Pursue medications|2|||
162935989|NCT00886483|588470293|FG000|Overall Study|Distance to center, poor grades|1|||
162935990|NCT00886483|588470294|FG001|Overall Study|Distance to center, poor grades|0|||
162935991|NCT01001169|588470295|FG000|Overall Study|Withdrawal by Subject|2|||
162935992|NCT01001169|588470296|FG001|Overall Study|Withdrawal by Subject|1|||
162935993|NCT00602030|588470297|FG000|Lead-in Phase|Disease Progression|2|||
162935994|NCT00602030|588470298|FG001|Lead-in Phase|Disease Progression|3|||
162935995|NCT00602030|588470299|FG002|Lead-in Phase|Disease Progression|0|||
162935996|NCT00602030|588470300|FG003|Lead-in Phase|Disease Progression|0|||
162935997|NCT00602030|588470301|FG004|Lead-in Phase|Disease Progression|0|||
162935998|NCT00602030|588470297|FG000|Lead-in Phase|Adverse Event|0|||
162935999|NCT00602030|588470298|FG001|Lead-in Phase|Adverse Event|2|||
162936000|NCT00602030|588470299|FG002|Lead-in Phase|Adverse Event|0|||
162936001|NCT00602030|588470300|FG003|Lead-in Phase|Adverse Event|0|||
162936002|NCT00602030|588470301|FG004|Lead-in Phase|Adverse Event|0|||
162936003|NCT00602030|588470297|FG000|Double-blind Phase|Disease progression|0|||
162936004|NCT00602030|588470298|FG001|Double-blind Phase|Disease progression|0|||
162936005|NCT00602030|588470299|FG002|Double-blind Phase|Disease progression|33|||
162936006|NCT00602030|588470300|FG003|Double-blind Phase|Disease progression|30|||
162936007|NCT00602030|588470301|FG004|Double-blind Phase|Disease progression|0|||
162936008|NCT00602030|588470297|FG000|Double-blind Phase|Adverse Event|0|||
162936009|NCT00602030|588470298|FG001|Double-blind Phase|Adverse Event|0|||
162936010|NCT00602030|588470299|FG002|Double-blind Phase|Adverse Event|9|||
162936011|NCT00602030|588470300|FG003|Double-blind Phase|Adverse Event|18|||
162936012|NCT00602030|588470301|FG004|Double-blind Phase|Adverse Event|0|||
162936013|NCT00602030|588470297|FG000|Double-blind Phase|Consent withdrawal|0|||
162936014|NCT00602030|588470298|FG001|Double-blind Phase|Consent withdrawal|0|||
162936015|NCT00602030|588470299|FG002|Double-blind Phase|Consent withdrawal|4|||
162936016|NCT00602030|588470300|FG003|Double-blind Phase|Consent withdrawal|3|||
162936017|NCT00602030|588470301|FG004|Double-blind Phase|Consent withdrawal|0|||
162936018|NCT00602030|588470297|FG000|Double-blind Phase|Death|0|||
162936019|NCT00602030|588470298|FG001|Double-blind Phase|Death|0|||
162936020|NCT00602030|588470299|FG002|Double-blind Phase|Death|3|||
162936021|NCT00602030|588470300|FG003|Double-blind Phase|Death|3|||
162936022|NCT00602030|588470301|FG004|Double-blind Phase|Death|0|||
162936023|NCT00602030|588470297|FG000|Double-blind Phase|Administrative decision|0|||
162936024|NCT00602030|588470298|FG001|Double-blind Phase|Administrative decision|0|||
162936025|NCT00602030|588470299|FG002|Double-blind Phase|Administrative decision|0|||
162936026|NCT00602030|588470300|FG003|Double-blind Phase|Administrative decision|2|||
162936027|NCT00602030|588470301|FG004|Double-blind Phase|Administrative decision|0|||
162936028|NCT00602030|588470297|FG000|Double-blind Phase|Ineligibility|0|||
162936029|NCT00602030|588470298|FG001|Double-blind Phase|Ineligibility|0|||
162936030|NCT00602030|588470299|FG002|Double-blind Phase|Ineligibility|0|||
162936031|NCT00602030|588470300|FG003|Double-blind Phase|Ineligibility|1|||
162936032|NCT00602030|588470301|FG004|Double-blind Phase|Ineligibility|0|||
162936033|NCT00602030|588470297|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
162936034|NCT00602030|588470298|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
162936035|NCT00602030|588470299|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
162936036|NCT00602030|588470300|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
162936037|NCT00602030|588470301|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
163284181|NCT03781804|589749465|FG000|Overall Study|Adverse Event|2|||
162936038|NCT00602030|588470297|FG000|Double-blind Phase|Reason not specified|0|||
162936039|NCT00602030|588470298|FG001|Double-blind Phase|Reason not specified|0|||
162936040|NCT00602030|588470299|FG002|Double-blind Phase|Reason not specified|4|||
162936041|NCT00602030|588470300|FG003|Double-blind Phase|Reason not specified|2|||
162936042|NCT00602030|588470301|FG004|Double-blind Phase|Reason not specified|0|||
162936043|NCT00602030|588470297|FG000|Crossover Phase|Disease Progression|0|||
162936044|NCT00602030|588470298|FG001|Crossover Phase|Disease Progression|0|||
162936045|NCT00602030|588470299|FG002|Crossover Phase|Disease Progression|0|||
162936046|NCT00602030|588470300|FG003|Crossover Phase|Disease Progression|0|||
162936047|NCT00602030|588470301|FG004|Crossover Phase|Disease Progression|11|||
162936048|NCT00602030|588470297|FG000|Crossover Phase|Adverse Event|0|||
162936049|NCT00602030|588470298|FG001|Crossover Phase|Adverse Event|0|||
162936050|NCT00602030|588470299|FG002|Crossover Phase|Adverse Event|0|||
162936051|NCT00602030|588470300|FG003|Crossover Phase|Adverse Event|0|||
162936052|NCT00602030|588470301|FG004|Crossover Phase|Adverse Event|3|||
162936053|NCT00602030|588470297|FG000|Crossover Phase|Consent withdrawal|0|||
162936054|NCT00602030|588470298|FG001|Crossover Phase|Consent withdrawal|0|||
162936055|NCT00602030|588470299|FG002|Crossover Phase|Consent withdrawal|0|||
162936056|NCT00602030|588470300|FG003|Crossover Phase|Consent withdrawal|0|||
162936057|NCT00602030|588470301|FG004|Crossover Phase|Consent withdrawal|2|||
162936058|NCT01138150|588470302|FG000|Overall Study|blood unable to be processed|0|||
162936059|NCT01138150|588470303|FG001|Overall Study|blood unable to be processed|1|||
162936060|NCT01138150|588470302|FG000|Overall Study|Physician Decision|1|||
162936061|NCT01138150|588470303|FG001|Overall Study|Physician Decision|0|||
162936062|NCT01580020|588470304|FG000|Overall Study|Lack of Efficacy|0|||
162936063|NCT01580020|588470305|FG001|Overall Study|Lack of Efficacy|5|||
162936064|NCT01580020|588470306|FG002|Overall Study|Lack of Efficacy|0|||
162936065|NCT01580020|588470307|FG003|Overall Study|Lack of Efficacy|1|||
162936066|NCT01580020|588470304|FG000|Overall Study|Withdrawal by Subject|0|||
162936067|NCT01580020|588470305|FG001|Overall Study|Withdrawal by Subject|1|||
162936068|NCT01580020|588470306|FG002|Overall Study|Withdrawal by Subject|1|||
162936069|NCT01580020|588470307|FG003|Overall Study|Withdrawal by Subject|0|||
162936070|NCT01580020|588470304|FG000|Overall Study|Adverse Event|1|||
162936071|NCT01580020|588470305|FG001|Overall Study|Adverse Event|1|||
162936072|NCT01580020|588470306|FG002|Overall Study|Adverse Event|1|||
162936073|NCT01580020|588470307|FG003|Overall Study|Adverse Event|1|||
162936074|NCT01580020|588470304|FG000|Overall Study|Administrative Problems|0|||
162936075|NCT01580020|588470305|FG001|Overall Study|Administrative Problems|0|||
162936076|NCT01580020|588470306|FG002|Overall Study|Administrative Problems|1|||
162936077|NCT01580020|588470307|FG003|Overall Study|Administrative Problems|0|||
162936078|NCT01580020|588470304|FG000|Overall Study|Lost to Follow-up|0|||
162936079|NCT01580020|588470305|FG001|Overall Study|Lost to Follow-up|0|||
162936080|NCT01580020|588470306|FG002|Overall Study|Lost to Follow-up|1|||
162936081|NCT01580020|588470307|FG003|Overall Study|Lost to Follow-up|0|||
162936082|NCT01724359|588470308|FG000|Overall Study|Adverse Event|10|||
162936083|NCT01724359|588470308|FG000|Overall Study|Death|1|||
162936084|NCT01724359|588470308|FG000|Overall Study|Other|20|||
162936085|NCT02151461|588470315|FG000|Overall Study|Adverse Event|5|||
162936086|NCT02151461|588470316|FG001|Overall Study|Adverse Event|1|||
162936087|NCT02151461|588470317|FG002|Overall Study|Adverse Event|0|||
162936088|NCT02151461|588470318|FG003|Overall Study|Adverse Event|2|||
162936089|NCT02151461|588470315|FG000|Overall Study|Lost to Follow-up|0|||
162936090|NCT02151461|588470316|FG001|Overall Study|Lost to Follow-up|0|||
162936091|NCT02151461|588470317|FG002|Overall Study|Lost to Follow-up|1|||
162936092|NCT02151461|588470318|FG003|Overall Study|Lost to Follow-up|1|||
162936093|NCT02151461|588470315|FG000|Overall Study|Withdrawal by Subject|1|||
162936094|NCT02151461|588470316|FG001|Overall Study|Withdrawal by Subject|0|||
162936095|NCT02151461|588470317|FG002|Overall Study|Withdrawal by Subject|1|||
163179327|NCT04770779|589370570|FG000|Overall Study|Withdrawal by Subject|7|||
163179328|NCT04770779|589370571|FG001|Overall Study|Withdrawal by Subject|1|||
163179329|NCT04770779|589370570|FG000|Overall Study|Pregnancy|0|||
162936096|NCT02151461|588470318|FG003|Overall Study|Withdrawal by Subject|1|||
162936097|NCT02151461|588470315|FG000|Overall Study|Treatment discontinuation|0|||
162936098|NCT02151461|588470316|FG001|Overall Study|Treatment discontinuation|0|||
162936099|NCT02151461|588470317|FG002|Overall Study|Treatment discontinuation|1|||
162936100|NCT02151461|588470318|FG003|Overall Study|Treatment discontinuation|0|||
162936101|NCT02168270|588470319|FG000|Overall Study|Lack of Efficacy|4|||
162936102|NCT01738581|588470320|FG000|Overall Study|Lost to Follow-up|1|||
162936103|NCT01738581|588470321|FG001|Overall Study|Lost to Follow-up|0|||
162936104|NCT02191579|588470328|FG000|Treatment 1|Multiple Reasons Specified|27|||
162936105|NCT02191579|588470329|FG001|Treatment 1|Multiple Reasons Specified|58|||
162936106|NCT02191579|588470328|FG000|Treatment 2|Multiple Reasons Specified|0|||
162936107|NCT02191579|588470329|FG001|Treatment 2|Multiple Reasons Specified|25|||
162936108|NCT02862535|588470330|FG000|Overall Study|Death|7|||
162936109|NCT02862535|588470331|FG001|Overall Study|Death|3|||
162936110|NCT02862535|588470332|FG002|Overall Study|Death|2|||
163179330|NCT04770779|589370571|FG001|Overall Study|Pregnancy|1|||
163284182|NCT03781804|589749466|FG001|Overall Study|Adverse Event|2|||
162936111|NCT02862535|588470333|FG003|Overall Study|Death|5|||
162936112|NCT02862535|588470330|FG000|Overall Study|Study Terminated by Sponsor|1|||
162936113|NCT02862535|588470331|FG001|Overall Study|Study Terminated by Sponsor|3|||
162936114|NCT02862535|588470332|FG002|Overall Study|Study Terminated by Sponsor|8|||
162936115|NCT02862535|588470333|FG003|Overall Study|Study Terminated by Sponsor|5|||
162936116|NCT02862535|588470330|FG000|Overall Study|Enrolled, not Treated|1|||
162936117|NCT02862535|588470331|FG001|Overall Study|Enrolled, not Treated|0|||
162936118|NCT02862535|588470332|FG002|Overall Study|Enrolled, not Treated|0|||
162936119|NCT02862535|588470333|FG003|Overall Study|Enrolled, not Treated|1|||
162936120|NCT02280356|588470334|FG000|Overall Study|Not Treated|2|||
162936121|NCT02280356|588470334|FG000|Overall Study|Withdrawal by Subject|1|||
162936122|NCT02280356|588470334|FG000|Overall Study|Not evaluable|2|||
162936123|NCT01086215|588470338|FG000|Overall Study|Death|14|||
162936124|NCT01086215|588470339|FG001|Overall Study|Death|8|||
162936125|NCT01086215|588470340|FG002|Overall Study|Death|8|||
162936126|NCT01086215|588470341|FG003|Overall Study|Death|1|||
162936127|NCT01086215|588470338|FG000|Overall Study|Lost to Follow-up|22|||
162936128|NCT01086215|588470339|FG001|Overall Study|Lost to Follow-up|39|||
162936129|NCT01086215|588470340|FG002|Overall Study|Lost to Follow-up|18|||
162936130|NCT01086215|588470341|FG003|Overall Study|Lost to Follow-up|2|||
162936131|NCT01965652|588470342|FG000|Overall Study|Adverse Event|40|||
162936132|NCT01965652|588470343|FG001|Overall Study|Adverse Event|37|||
162936133|NCT01965652|588470342|FG000|Overall Study|Withdrawal by Subject|62|||
162936134|NCT01965652|588470343|FG001|Overall Study|Withdrawal by Subject|69|||
162936135|NCT01965652|588470342|FG000|Overall Study|Lost to Follow-up|53|||
162936136|NCT01965652|588470343|FG001|Overall Study|Lost to Follow-up|40|||
162936137|NCT01965652|588470342|FG000|Overall Study|Protocol Violation|34|||
162936138|NCT01965652|588470343|FG001|Overall Study|Protocol Violation|38|||
162936139|NCT01965652|588470342|FG000|Overall Study|Death|3|||
162936140|NCT01965652|588470343|FG001|Overall Study|Death|4|||
162936141|NCT01965652|588470342|FG000|Overall Study|Other - Miscellaneous|18|||
162936142|NCT01965652|588470343|FG001|Overall Study|Other - Miscellaneous|21|||
162936143|NCT01965652|588470342|FG000|Overall Study|Pregnancy|0|||
162936144|NCT01965652|588470343|FG001|Overall Study|Pregnancy|1|||
162936145|NCT01121900|588470348|FG000|First Intervention Period|Adverse Event|1|||
162936146|NCT01121900|588470349|FG001|First Intervention Period|Adverse Event|1|||
162936147|NCT01121900|588470348|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
162936148|NCT01121900|588470349|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
162936149|NCT03493698|588470350|FG000|Treatment Period C|Adverse Event|1|||
162936150|NCT03493698|588470350|FG000|Treatment Period C|Withdrawal by Subject|1|||
162936151|NCT00408876|588470351|FG000|Overall Study|Adverse Event|9|||
162936152|NCT00408876|588470352|FG001|Overall Study|Adverse Event|17|||
162936153|NCT00408876|588470353|FG002|Overall Study|Adverse Event|27|||
162936154|NCT00408876|588470354|FG003|Overall Study|Adverse Event|10|||
162936155|NCT00408876|588470351|FG000|Overall Study|Withdrawal by Subject|3|||
162936156|NCT00408876|588470352|FG001|Overall Study|Withdrawal by Subject|6|||
162936157|NCT00408876|588470353|FG002|Overall Study|Withdrawal by Subject|6|||
162936158|NCT00408876|588470354|FG003|Overall Study|Withdrawal by Subject|14|||
162936159|NCT00408876|588470351|FG000|Overall Study|Lack of Efficacy|2|||
162936160|NCT00408876|588470352|FG001|Overall Study|Lack of Efficacy|4|||
162936161|NCT00408876|588470353|FG002|Overall Study|Lack of Efficacy|5|||
162936162|NCT00408876|588470354|FG003|Overall Study|Lack of Efficacy|6|||
162936163|NCT00408876|588470351|FG000|Overall Study|Lost to Follow-up|1|||
162936164|NCT00408876|588470352|FG001|Overall Study|Lost to Follow-up|6|||
162936165|NCT00408876|588470353|FG002|Overall Study|Lost to Follow-up|5|||
162936166|NCT00408876|588470354|FG003|Overall Study|Lost to Follow-up|2|||
162936167|NCT00408876|588470351|FG000|Overall Study|Protocol Violation|0|||
162936168|NCT00408876|588470352|FG001|Overall Study|Protocol Violation|3|||
162936169|NCT00408876|588470353|FG002|Overall Study|Protocol Violation|4|||
162936170|NCT00408876|588470354|FG003|Overall Study|Protocol Violation|3|||
162936171|NCT00408876|588470351|FG000|Overall Study|Physician Decision|1|||
162936172|NCT00408876|588470352|FG001|Overall Study|Physician Decision|0|||
162936173|NCT00408876|588470353|FG002|Overall Study|Physician Decision|3|||
162936174|NCT00408876|588470354|FG003|Overall Study|Physician Decision|0|||
162936175|NCT00291330|588470355|FG000|Overall Study|Adverse Event|47|||
163284183|NCT03781804|589749467|FG002|Overall Study|Adverse Event|3|||
163284184|NCT03781804|589749465|FG000|Overall Study|Lost to Follow-up|1|||
162936176|NCT00291330|588470356|FG001|Overall Study|Adverse Event|40|||
162936177|NCT00291330|588470355|FG000|Overall Study|Protocol Violation|13|||
162936178|NCT00291330|588470356|FG001|Overall Study|Protocol Violation|20|||
162936179|NCT00291330|588470355|FG000|Overall Study|Lost to Follow-up|16|||
163284185|NCT03781804|589749466|FG001|Overall Study|Lost to Follow-up|1|||
162936180|NCT00291330|588470356|FG001|Overall Study|Lost to Follow-up|11|||
162936181|NCT00291330|588470355|FG000|Overall Study|Withdrawal by Subject|22|||
162936182|NCT00291330|588470356|FG001|Overall Study|Withdrawal by Subject|25|||
162936183|NCT00291330|588470355|FG000|Overall Study|Other|3|||
162936184|NCT00291330|588470356|FG001|Overall Study|Other|1|||
162936185|NCT00566709|588470357|FG000|Overall Study|Protocol Violation|5|||
162936186|NCT00566709|588470358|FG001|Overall Study|Protocol Violation|0|||
162936187|NCT03443869|588470359|FG000|Overall Study|Death|3|||
163284186|NCT03781804|589749467|FG002|Overall Study|Lost to Follow-up|2|||
163284187|NCT03781804|589749465|FG000|Overall Study|Lack of Efficacy|4|||
163284188|NCT03781804|589749466|FG001|Overall Study|Lack of Efficacy|2|||
163284189|NCT03781804|589749467|FG002|Overall Study|Lack of Efficacy|9|||
163284190|NCT03781804|589749465|FG000|Overall Study|Protocol Violation|0|||
163284191|NCT03781804|589749466|FG001|Overall Study|Protocol Violation|0|||
163284192|NCT03781804|589749467|FG002|Overall Study|Protocol Violation|1|||
163284193|NCT03781804|589749465|FG000|Overall Study|Withdrawal by Subject|0|||
163284194|NCT03781804|589749466|FG001|Overall Study|Withdrawal by Subject|1|||
163284195|NCT03781804|589749467|FG002|Overall Study|Withdrawal by Subject|1|||
163284196|NCT03781804|589749465|FG000|Overall Study|Reason not provided|2|||
163284197|NCT03781804|589749466|FG001|Overall Study|Reason not provided|2|||
163284198|NCT03781804|589749467|FG002|Overall Study|Reason not provided|0|||
163284199|NCT04678830|589749468|FG000|Overall Study|Lack of Efficacy|2|||
163284200|NCT04678830|589749469|FG001|Overall Study|Lack of Efficacy|0|||
163284201|NCT04678830|589749468|FG000|Overall Study|Withdrawal by Subject|0|||
163284202|NCT04678830|589749469|FG001|Overall Study|Withdrawal by Subject|1|||
163284203|NCT01836458|589749472|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
163284204|NCT01836458|589749473|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163284205|NCT01836458|589749474|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
163284206|NCT01836458|589749475|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
163284207|NCT00429793|589749476|FG000|Overall Study|Improper pre-protocol treatment|3|||
162936188|NCT03443869|588470360|FG001|Overall Study|Death|3|||
163284208|NCT00429793|589749476|FG000|Overall Study|Required test not done|1|||
163284209|NCT00429793|589749476|FG000|Overall Study|Never treated|1|||
163284210|NCT00429793|589749476|FG000|Overall Study|Non-measurable|1|||
163284211|NCT01333514|589749477|FG000|Overall Study|Withdrawal by Subject|1|||
163284212|NCT01333514|589749478|FG001|Overall Study|Withdrawal by Subject|0|||
163284213|NCT00836810|589749479|FG000|Overall Study|New diagnosis|1|||
162936189|NCT03443869|588470359|FG000|Overall Study|Withdrawal by Subject|34|||
162936190|NCT03443869|588470360|FG001|Overall Study|Withdrawal by Subject|22|||
162936191|NCT03443869|588470359|FG000|Overall Study|Lost to Follow-up|1|||
162936192|NCT03443869|588470360|FG001|Overall Study|Lost to Follow-up|2|||
162936193|NCT03443869|588470359|FG000|Overall Study|Physician Decision|3|||
162936194|NCT03443869|588470360|FG001|Overall Study|Physician Decision|3|||
162936195|NCT03443869|588470359|FG000|Overall Study|Other|4|||
162936196|NCT03443869|588470360|FG001|Overall Study|Other|4|||
162936197|NCT02390219|588470361|FG000|Overall Study|Death|1|||
163179335|NCT03692052|589370574|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
163179336|NCT03692052|589370574|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
163179337|NCT03692052|589370574|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
163179338|NCT03692052|589370574|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
163179339|NCT02656706|589371030|FG000|Overall Study|Insurance Denial|1|||
163179373|NCT05076266|589371034|FG000|Overall Study|Survey not complete - Participant refusal|2|||
163179374|NCT05076266|589371035|FG001|Overall Study|Survey not complete - Participant refusal|0|||
163179375|NCT05169567|589371036|FG000|Overall Study|On study treatment|116|||
163179376|NCT05169567|589371037|FG001|Overall Study|On study treatment|128|||
163179377|NCT05169567|589371036|FG000|Overall Study|Lost to Follow-up|1|||
163179378|NCT05169567|589371037|FG001|Overall Study|Lost to Follow-up|0|||
163179379|NCT05169567|589371036|FG000|Overall Study|Withdrawal by Subject|25|||
163179380|NCT05169567|589371037|FG001|Overall Study|Withdrawal by Subject|21|||
163179381|NCT04576455|589371040|FG000|Overall Study|Ongoing in the Study|48|||
163179382|NCT04576455|589371041|FG001|Overall Study|Ongoing in the Study|58|||
163179383|NCT04576455|589371040|FG000|Overall Study|Death|83|||
163179384|NCT04576455|589371041|FG001|Overall Study|Death|77|||
163284214|NCT00836810|589749480|FG001|Overall Study|New diagnosis|0|||
163284215|NCT04257058|589751338|FG000|Overall Study|Lost to Follow-up|31|||
163284216|NCT03227757|589751339|FG000|Overall Study|Death|25|||
162936198|NCT02390219|588470361|FG000|Overall Study|Physician Decision|1|||
162936199|NCT02390219|588470361|FG000|Overall Study|Adverse Event|6|||
163179385|NCT04576455|589371040|FG000|Overall Study|Lost to Follow-up|4|||
163179386|NCT04576455|589371041|FG001|Overall Study|Lost to Follow-up|5|||
162936200|NCT02390219|588470361|FG000|Overall Study|Withdrawal by Subject|1|||
162936201|NCT02390219|588470361|FG000|Overall Study|Lost to Follow-up|2|||
162936202|NCT02390219|588470361|FG000|Overall Study|Other|2|||
162936203|NCT00299728|588470362|FG000|Overall Study|Lost to Follow-up|0|||
162936204|NCT00299728|588470363|FG001|Overall Study|Lost to Follow-up|1|||
162936205|NCT00299728|588470362|FG000|Overall Study|Withdrawal by Subject|0|||
162936206|NCT00299728|588470363|FG001|Overall Study|Withdrawal by Subject|1|||
162936207|NCT00299728|588470362|FG000|Overall Study|Progressive disease|0|||
162936208|NCT00299728|588470363|FG001|Overall Study|Progressive disease|1|||
162936209|NCT04071626|588470367|FG000|Overall Study|Withdrawal by Subject|1|||
162936210|NCT04071626|588470368|FG001|Overall Study|Withdrawal by Subject|1|||
162936211|NCT04071626|588470367|FG000|Overall Study|Protocol Violation|0|||
162936212|NCT04071626|588470368|FG001|Overall Study|Protocol Violation|1|||
162936213|NCT00931385|588470369|FG000|Overall Study|Adverse Event|2|||
162936214|NCT00931385|588470370|FG001|Overall Study|Adverse Event|1|||
162936215|NCT00931385|588470371|FG002|Overall Study|Adverse Event|0|||
162936216|NCT00931385|588470372|FG003|Overall Study|Adverse Event|3|||
162936217|NCT00931385|588470369|FG000|Overall Study|Protocol Violation|0|||
162936218|NCT00931385|588470370|FG001|Overall Study|Protocol Violation|0|||
162936219|NCT00931385|588470371|FG002|Overall Study|Protocol Violation|1|||
162936220|NCT00931385|588470372|FG003|Overall Study|Protocol Violation|0|||
162936221|NCT00931385|588470369|FG000|Overall Study|Withdrawal by Subject|0|||
162936222|NCT00931385|588470370|FG001|Overall Study|Withdrawal by Subject|1|||
162936223|NCT00931385|588470371|FG002|Overall Study|Withdrawal by Subject|0|||
162936224|NCT00931385|588470372|FG003|Overall Study|Withdrawal by Subject|1|||
162936225|NCT00931385|588470369|FG000|Overall Study|Lost to Follow-up|0|||
162936226|NCT00931385|588470370|FG001|Overall Study|Lost to Follow-up|0|||
162936227|NCT00931385|588470371|FG002|Overall Study|Lost to Follow-up|0|||
162936228|NCT00931385|588470372|FG003|Overall Study|Lost to Follow-up|1|||
162936229|NCT02230085|588470375|FG000|Overall Study|Physician Decision|1|||
162936230|NCT02230085|588470375|FG000|Overall Study|Withdrawal by Subject|3|||
162936231|NCT00580983|588470376|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
162936232|NCT01360632|588470377|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
162936233|NCT01360632|588470378|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
162936234|NCT01360632|588470379|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
162936235|NCT01360632|588470380|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
162936236|NCT01360632|588470381|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
162936237|NCT01360632|588470377|FG000|Phase A (8 Weeks)|Adverse Event|60|||
162936238|NCT01360632|588470378|FG001|Phase A (8 Weeks)|Adverse Event|0|||
162936239|NCT01360632|588470379|FG002|Phase A (8 Weeks)|Adverse Event|0|||
162936240|NCT01360632|588470380|FG003|Phase A (8 Weeks)|Adverse Event|0|||
162936241|NCT01360632|588470381|FG004|Phase A (8 Weeks)|Adverse Event|0|||
163179387|NCT04576455|589371040|FG000|Overall Study|Withdrawal by Subject|16|||
163179388|NCT04576455|589371041|FG001|Overall Study|Withdrawal by Subject|12|||
163179389|NCT04449055|589371042|FG000|Overall Study|Lost to Follow-up|2|||
163179390|NCT04449055|589371043|FG001|Overall Study|Lost to Follow-up|1|||
163179391|NCT04449055|589371042|FG000|Overall Study|Missed 4 treatments--removed by PI|1|||
163179392|NCT04449055|589371043|FG001|Overall Study|Missed 4 treatments--removed by PI|1|||
163179393|NCT04449055|589371042|FG000|Overall Study|Could not refrain from methamphetamine for 24 hours before treatment--removed by PI|1|||
163179394|NCT04449055|589371043|FG001|Overall Study|Could not refrain from methamphetamine for 24 hours before treatment--removed by PI|0|||
163179395|NCT04449055|589371042|FG000|Overall Study|Incarcerated|1|||
163179396|NCT04449055|589371043|FG001|Overall Study|Incarcerated|0|||
162936242|NCT01360632|588470377|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
162936243|NCT01360632|588470378|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
162936244|NCT01360632|588470379|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
162936245|NCT01360632|588470380|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
162936246|NCT01360632|588470381|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
162936247|NCT01360632|588470377|FG000|Phase A (8 Weeks)|Physician Decision|10|||
162936248|NCT01360632|588470378|FG001|Phase A (8 Weeks)|Physician Decision|0|||
162936249|NCT01360632|588470379|FG002|Phase A (8 Weeks)|Physician Decision|0|||
162936250|NCT01360632|588470380|FG003|Phase A (8 Weeks)|Physician Decision|0|||
162936251|NCT01360632|588470381|FG004|Phase A (8 Weeks)|Physician Decision|0|||
163284217|NCT03227757|589751339|FG000|Overall Study|Withdrawal|10|||
162936252|NCT01360632|588470377|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
162936253|NCT01360632|588470378|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
162936254|NCT01360632|588470379|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
163284218|NCT03227757|589751339|FG000|Overall Study|Missed visits|1|||
162936255|NCT01360632|588470380|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
162936256|NCT01360632|588470381|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
162936257|NCT01360632|588470377|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
162936258|NCT01360632|588470378|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
162936259|NCT01360632|588470379|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
162936260|NCT01360632|588470380|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
162936261|NCT01360632|588470381|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
162936262|NCT01360632|588470377|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
162936263|NCT01360632|588470378|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
162936264|NCT01360632|588470379|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
162936265|NCT01360632|588470380|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
162936266|NCT01360632|588470381|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
162936267|NCT01360632|588470377|FG000|Phase B (6 Weeks)|Adverse Event|0|||
162936268|NCT01360632|588470378|FG001|Phase B (6 Weeks)|Adverse Event|3|||
162936269|NCT01360632|588470379|FG002|Phase B (6 Weeks)|Adverse Event|9|||
162936270|NCT01360632|588470380|FG003|Phase B (6 Weeks)|Adverse Event|3|||
162936271|NCT01360632|588470381|FG004|Phase B (6 Weeks)|Adverse Event|0|||
162936272|NCT01360632|588470377|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
162936273|NCT01360632|588470378|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
162936274|NCT01360632|588470379|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
162936275|NCT01360632|588470380|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
162936276|NCT01360632|588470381|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
162936277|NCT01360632|588470377|FG000|Phase B (6 Weeks)|Physician Decision|0|||
162936278|NCT01360632|588470378|FG001|Phase B (6 Weeks)|Physician Decision|0|||
162936279|NCT01360632|588470379|FG002|Phase B (6 Weeks)|Physician Decision|0|||
162936280|NCT01360632|588470380|FG003|Phase B (6 Weeks)|Physician Decision|1|||
162936281|NCT01360632|588470381|FG004|Phase B (6 Weeks)|Physician Decision|0|||
162936282|NCT01360632|588470377|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
162936283|NCT01360632|588470378|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
162936284|NCT01360632|588470379|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
162936285|NCT01360632|588470380|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
162936286|NCT01360632|588470381|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
162936287|NCT01360632|588470377|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
162936288|NCT01360632|588470378|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
162936289|NCT01360632|588470379|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
162936290|NCT01360632|588470380|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
162936291|NCT01360632|588470381|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
162936292|NCT01360632|588470377|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
162936293|NCT01360632|588470378|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
162936294|NCT01360632|588470379|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
162936295|NCT01360632|588470380|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
162936296|NCT01360632|588470381|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
162936297|NCT01360632|588470377|FG000|Phase A+|Lost to Follow-up|0|||
162936298|NCT01360632|588470378|FG001|Phase A+|Lost to Follow-up|0|||
162936299|NCT01360632|588470379|FG002|Phase A+|Lost to Follow-up|0|||
162936300|NCT01360632|588470380|FG003|Phase A+|Lost to Follow-up|0|||
162936301|NCT01360632|588470381|FG004|Phase A+|Lost to Follow-up|2|||
162936302|NCT01360632|588470377|FG000|Phase A+|Adverse Event|0|||
162936303|NCT01360632|588470378|FG001|Phase A+|Adverse Event|0|||
162936304|NCT01360632|588470379|FG002|Phase A+|Adverse Event|0|||
162936305|NCT01360632|588470380|FG003|Phase A+|Adverse Event|0|||
162936306|NCT01360632|588470381|FG004|Phase A+|Adverse Event|2|||
162936307|NCT01360632|588470377|FG000|Phase A+|Met Withdrawal Criteria|0|||
162936308|NCT01360632|588470378|FG001|Phase A+|Met Withdrawal Criteria|0|||
162936309|NCT01360632|588470379|FG002|Phase A+|Met Withdrawal Criteria|0|||
162936310|NCT01360632|588470380|FG003|Phase A+|Met Withdrawal Criteria|0|||
162936311|NCT01360632|588470381|FG004|Phase A+|Met Withdrawal Criteria|7|||
162936312|NCT01360632|588470377|FG000|Phase A+|Physician Decision|0|||
162936313|NCT01360632|588470378|FG001|Phase A+|Physician Decision|0|||
162936314|NCT01360632|588470379|FG002|Phase A+|Physician Decision|0|||
162936315|NCT01360632|588470380|FG003|Phase A+|Physician Decision|0|||
162936316|NCT01360632|588470381|FG004|Phase A+|Physician Decision|3|||
162936317|NCT01360632|588470377|FG000|Phase A+|Withdrawal by Subject|0|||
162936318|NCT01360632|588470378|FG001|Phase A+|Withdrawal by Subject|0|||
162936319|NCT01360632|588470379|FG002|Phase A+|Withdrawal by Subject|0|||
162936320|NCT01360632|588470380|FG003|Phase A+|Withdrawal by Subject|0|||
162936321|NCT01360632|588470381|FG004|Phase A+|Withdrawal by Subject|8|||
162936322|NCT01360632|588470377|FG000|Phase A+|Protocol Deviation|0|||
162936323|NCT01360632|588470378|FG001|Phase A+|Protocol Deviation|0|||
162936324|NCT01360632|588470379|FG002|Phase A+|Protocol Deviation|0|||
162936325|NCT01360632|588470380|FG003|Phase A+|Protocol Deviation|0|||
162936326|NCT01360632|588470381|FG004|Phase A+|Protocol Deviation|3|||
162936327|NCT00811070|588470382|FG000|Overall Study|Death|0|||
162936328|NCT00811070|588470383|FG001|Overall Study|Death|0|||
162936329|NCT00811070|588470384|FG002|Overall Study|Death|0|||
162936330|NCT00811070|588470385|FG003|Overall Study|Death|2|||
162936331|NCT00811070|588470386|FG004|Overall Study|Death|5|||
162936332|NCT00811070|588470387|FG005|Overall Study|Death|0|||
162936333|NCT00811070|588470382|FG000|Overall Study|Other|1|||
162936334|NCT00811070|588470383|FG001|Overall Study|Other|0|||
162936335|NCT00811070|588470384|FG002|Overall Study|Other|0|||
163284219|NCT03227757|589751339|FG000|Overall Study|Lost to Follow-up|2|||
163284220|NCT05570006|589751340|FG000|Overall Study|Lost to Follow-up|2|||
163284221|NCT05570006|589751340|FG000|Overall Study|Withdrawal by Subject|5|||
163284222|NCT05570006|589751340|FG000|Overall Study|Other than Specified|5|||
163284223|NCT01144468|589751343|FG000|Overall Study|Lost to Follow-up|4|||
163284224|NCT01144468|589751344|FG001|Overall Study|Lost to Follow-up|7|||
163284225|NCT01144468|589751343|FG000|Overall Study|Adverse Event|3|||
163284226|NCT01144468|589751344|FG001|Overall Study|Adverse Event|2|||
163284227|NCT01144468|589751343|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
163284228|NCT01144468|589751344|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
163284229|NCT02960659|589751345|FG000|Overall Study|Withdrawal by Subject|1|||
163284230|NCT02960659|589751346|FG001|Overall Study|Withdrawal by Subject|0|||
163179419|NCT06596005|589371052|FG000|Overall Study|Withdrawal by Subject|2|||
163179420|NCT06596005|589371053|FG001|Overall Study|Withdrawal by Subject|2|||
163179421|NCT06596005|589371054|FG002|Overall Study|Withdrawal by Subject|1|||
163284231|NCT02960659|589751345|FG000|Overall Study|Poor compliance|0|||
163284232|NCT02960659|589751346|FG001|Overall Study|Poor compliance|1|||
163284233|NCT04199728|589751352|FG000|Overall Study|Adverse Event|1|||
163284234|NCT04199728|589751353|FG001|Overall Study|Adverse Event|0|||
163284235|NCT04199728|589751352|FG000|Overall Study|Withdrawal by Subject|8|||
163284236|NCT04199728|589751353|FG001|Overall Study|Withdrawal by Subject|3|||
163284237|NCT04199728|589751352|FG000|Overall Study|Screen fail after consent|0|||
163284238|NCT04199728|589751353|FG001|Overall Study|Screen fail after consent|1|||
162936336|NCT00811070|588470385|FG003|Overall Study|Other|0|||
162936337|NCT00811070|588470386|FG004|Overall Study|Other|0|||
162936338|NCT00811070|588470387|FG005|Overall Study|Other|0|||
162936339|NCT00811070|588470382|FG000|Overall Study|Withdrawal by Subject|0|||
162936340|NCT00811070|588470383|FG001|Overall Study|Withdrawal by Subject|1|||
162936341|NCT00811070|588470384|FG002|Overall Study|Withdrawal by Subject|0|||
162936342|NCT00811070|588470385|FG003|Overall Study|Withdrawal by Subject|0|||
162936343|NCT00811070|588470386|FG004|Overall Study|Withdrawal by Subject|0|||
162936344|NCT00811070|588470387|FG005|Overall Study|Withdrawal by Subject|0|||
162936345|NCT00811070|588470382|FG000|Overall Study|Physician Decision|0|||
162936346|NCT00811070|588470383|FG001|Overall Study|Physician Decision|0|||
162936347|NCT00811070|588470384|FG002|Overall Study|Physician Decision|0|||
162936348|NCT00811070|588470385|FG003|Overall Study|Physician Decision|0|||
162936349|NCT00811070|588470386|FG004|Overall Study|Physician Decision|0|||
162936350|NCT00811070|588470387|FG005|Overall Study|Physician Decision|1|||
162936351|NCT00665626|588470390|FG000|Overall Study|Lack of Efficacy|8|||
162936352|NCT00665626|588470391|FG001|Overall Study|Lack of Efficacy|5|||
162936353|NCT00665626|588470390|FG000|Overall Study|Lost to Follow-up|0|||
163179422|NCT06596005|589371052|FG000|Overall Study|Other|0|||
163179423|NCT06596005|589371053|FG001|Overall Study|Other|2|||
163179424|NCT06596005|589371054|FG002|Overall Study|Other|0|||
163179425|NCT02445391|589371055|FG000|Overall Study|No active protocol treatment|3|||
163179426|NCT02445391|589371056|FG001|Overall Study|No active protocol treatment|0|||
163284239|NCT04199728|589751352|FG000|Overall Study|Early withdraw criteria met|0|||
163284240|NCT04199728|589751353|FG001|Overall Study|Early withdraw criteria met|1|||
163284241|NCT04199728|589751352|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
163284242|NCT04199728|589751353|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
163284243|NCT03068468|589751362|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
163284244|NCT03068468|589751363|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
162936354|NCT00665626|588470391|FG001|Overall Study|Lost to Follow-up|2|||
162936355|NCT00665626|588470390|FG000|Overall Study|Withdrawal by Subject|0|||
162936356|NCT00665626|588470391|FG001|Overall Study|Withdrawal by Subject|1|||
162936357|NCT00665626|588470390|FG000|Overall Study|Protocol Violation|0|||
162936358|NCT00665626|588470391|FG001|Overall Study|Protocol Violation|2|||
162936359|NCT00665626|588470390|FG000|Overall Study|Adverse Event|1|||
162936360|NCT00665626|588470391|FG001|Overall Study|Adverse Event|9|||
162936361|NCT00665626|588470390|FG000|Overall Study|Due to exclusion criteria|0|||
162936362|NCT00665626|588470391|FG001|Overall Study|Due to exclusion criteria|1|||
162936363|NCT00665626|588470390|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
162936364|NCT00665626|588470391|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
162936365|NCT00665626|588470390|FG000|Overall Study|Unably to comply with dosing regimen|0|||
163284245|NCT03068468|589751364|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
163284246|NCT03068468|589751365|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
163284247|NCT03068468|589751362|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
163284248|NCT03068468|589751363|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
163284249|NCT03068468|589751364|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
163284250|NCT03068468|589751365|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
163284251|NCT03068468|589751362|FG000|Placebo-Controlled Period|Adverse Event|16|||
163284252|NCT03068468|589751363|FG001|Placebo-Controlled Period|Adverse Event|21|||
163284253|NCT03068468|589751364|FG002|Placebo-Controlled Period|Adverse Event|0|||
163284254|NCT03068468|589751365|FG003|Placebo-Controlled Period|Adverse Event|0|||
163284255|NCT03068468|589751362|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
163284256|NCT03068468|589751363|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
163284257|NCT03068468|589751364|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
163284258|NCT03068468|589751365|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
163284259|NCT03068468|589751362|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
163284260|NCT03068468|589751363|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
163284261|NCT03068468|589751364|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162936366|NCT00665626|588470391|FG001|Overall Study|Unably to comply with dosing regimen|1|||
162936367|NCT00665626|588470390|FG000|Overall Study|Death|1|||
162936368|NCT00665626|588470391|FG001|Overall Study|Death|0|||
162936369|NCT02046369|588470392|FG000|Overall Study|Adverse Event|3|||
162936370|NCT02046369|588470393|FG001|Overall Study|Adverse Event|3|||
162936371|NCT02046369|588470392|FG000|Overall Study|Lack of Efficacy|3|||
162936372|NCT02046369|588470393|FG001|Overall Study|Lack of Efficacy|3|||
162936373|NCT02046369|588470392|FG000|Overall Study|Lost to Follow-up|3|||
162936374|NCT02046369|588470393|FG001|Overall Study|Lost to Follow-up|3|||
162936375|NCT02046369|588470392|FG000|Overall Study|Protocol Violation|1|||
162936376|NCT02046369|588470393|FG001|Overall Study|Protocol Violation|2|||
162936377|NCT02046369|588470392|FG000|Overall Study|Withdrawal by Subject|3|||
162936378|NCT02046369|588470393|FG001|Overall Study|Withdrawal by Subject|6|||
162936379|NCT02046369|588470392|FG000|Overall Study|never received study drug|0|||
162936380|NCT02046369|588470393|FG001|Overall Study|never received study drug|1|||
162936381|NCT02046369|588470392|FG000|Overall Study|non compliance|1|||
162936382|NCT02046369|588470393|FG001|Overall Study|non compliance|0|||
162936383|NCT03120520|588470394|FG000|Overall Study|Lost to Follow-up|1|||
162936384|NCT03120520|588470395|FG001|Overall Study|Lost to Follow-up|1|||
162936385|NCT03120520|588470396|FG002|Overall Study|Lost to Follow-up|1|||
162936386|NCT03120520|588470397|FG003|Overall Study|Lost to Follow-up|1|||
162936387|NCT03120520|588470394|FG000|Overall Study|Withdrawal by Subject|3|||
162936388|NCT03120520|588470395|FG001|Overall Study|Withdrawal by Subject|2|||
162936389|NCT03120520|588470396|FG002|Overall Study|Withdrawal by Subject|3|||
162936390|NCT03120520|588470397|FG003|Overall Study|Withdrawal by Subject|2|||
162936391|NCT03120520|588470394|FG000|Overall Study|Other|0|||
162936392|NCT03120520|588470395|FG001|Overall Study|Other|1|||
162936393|NCT03120520|588470396|FG002|Overall Study|Other|0|||
162936394|NCT03120520|588470397|FG003|Overall Study|Other|0|||
162936395|NCT01025193|588470399|FG000|Overall Study|Protocol Violation|1|||
162936396|NCT01025193|588470399|FG000|Overall Study|Adverse Event|3|||
162936397|NCT04345471|588470400|FG000|Overall Study|Adverse Event|8|||
162936398|NCT04345471|588470401|FG001|Overall Study|Adverse Event|5|||
162936399|NCT04345471|588470402|FG002|Overall Study|Adverse Event|6|||
162936400|NCT04345471|588470400|FG000|Overall Study|Lack of Efficacy|1|||
162936401|NCT04345471|588470401|FG001|Overall Study|Lack of Efficacy|1|||
162936402|NCT04345471|588470402|FG002|Overall Study|Lack of Efficacy|0|||
162936403|NCT04345471|588470400|FG000|Overall Study|Protocol Violation|0|||
162936404|NCT04345471|588470401|FG001|Overall Study|Protocol Violation|1|||
162936405|NCT04345471|588470402|FG002|Overall Study|Protocol Violation|2|||
162936406|NCT04345471|588470400|FG000|Overall Study|Withdrawal by Subject|10|||
162936407|NCT04345471|588470401|FG001|Overall Study|Withdrawal by Subject|5|||
162936408|NCT04345471|588470402|FG002|Overall Study|Withdrawal by Subject|10|||
163284262|NCT03068468|589751365|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
163284263|NCT03068468|589751362|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
162936409|NCT02378506|588470407|FG000|Overall Study|Lack of Efficacy|3|||
162936410|NCT02378506|588470407|FG000|Overall Study|Withdrawal by Subject|4|||
162936411|NCT02378506|588470407|FG000|Overall Study|Protocol Violation|2|||
162936412|NCT02378506|588470407|FG000|Overall Study|Death|1|||
162936413|NCT02378506|588470407|FG000|Overall Study|Adverse Event|14|||
162936414|NCT02378506|588470407|FG000|Overall Study|Randomized But Not Treated|1|||
163284264|NCT03068468|589751363|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
163284265|NCT03068468|589751364|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
163042835|NCT01990768|588863970|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
163284266|NCT03068468|589751365|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
163284267|NCT03068468|589751362|FG000|Placebo-Controlled Period|Death|0|||
162936415|NCT00185211|588470408|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
162936416|NCT00185211|588470409|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
162936417|NCT00185211|588470408|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
162936418|NCT00185211|588470409|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
162936419|NCT00185211|588470408|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
162936420|NCT00185211|588470409|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
162936421|NCT00185211|588470408|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
162936422|NCT00185211|588470409|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
162936423|NCT00185211|588470408|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
162936424|NCT00185211|588470409|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
162936425|NCT00185211|588470408|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
162936426|NCT00185211|588470409|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
162936427|NCT00185211|588470408|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
162936428|NCT00185211|588470409|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
162936429|NCT00185211|588470408|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
162936430|NCT00185211|588470409|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
162936431|NCT00185211|588470408|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
162936432|NCT00185211|588470409|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
162936433|NCT00185211|588470408|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
162936434|NCT00185211|588470409|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
162936435|NCT00185211|588470408|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
162936436|NCT00185211|588470409|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
162936437|NCT00185211|588470408|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
162936438|NCT00185211|588470409|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
162936439|NCT01759537|588470410|FG000|Overall Study|Death|1|||
162936440|NCT01759537|588470411|FG001|Overall Study|Death|1|||
162936441|NCT01759537|588470410|FG000|Overall Study|Pregnancy|1|||
162936442|NCT01759537|588470411|FG001|Overall Study|Pregnancy|1|||
162936443|NCT01759537|588470410|FG000|Overall Study|Lost to Follow-up|9|||
162936444|NCT01759537|588470411|FG001|Overall Study|Lost to Follow-up|9|||
162936445|NCT01759537|588470410|FG000|Overall Study|Accident involving jaw fracture|1|||
162936446|NCT01759537|588470411|FG001|Overall Study|Accident involving jaw fracture|1|||
162936447|NCT01759537|588470410|FG000|Overall Study|Subcrestal implant too coronal|1|||
162936448|NCT01759537|588470411|FG001|Overall Study|Subcrestal implant too coronal|1|||
162936449|NCT01015612|588470412|FG000|Overall Study|Death|113|||
162936450|NCT01015612|588470412|FG000|Overall Study|Withdrawal by Subject|40|||
162936451|NCT00420290|588470413|FG000|Overall Study|Adverse Event|3|||
162936452|NCT00420290|588470414|FG001|Overall Study|Adverse Event|1|||
162936453|NCT00420290|588470413|FG000|Overall Study|Withdrawal by Subject|0|||
162936454|NCT00420290|588470414|FG001|Overall Study|Withdrawal by Subject|2|||
162936455|NCT00420290|588470413|FG000|Overall Study|did not meet inclusion/exclusion|1|||
162936456|NCT00420290|588470414|FG001|Overall Study|did not meet inclusion/exclusion|1|||
162936457|NCT00972153|588470417|FG000|Overall Study|Equipment malfunction during case|0|||
162936458|NCT00972153|588470418|FG001|Overall Study|Equipment malfunction during case|1|||
162936459|NCT00972153|588470419|FG002|Overall Study|Equipment malfunction during case|0|||
162936460|NCT01077713|588470420|FG000|Overall Study|Withdrawal by Subject|1|||
162936461|NCT01077713|588470421|FG001|Overall Study|Withdrawal by Subject|2|||
162936462|NCT01077713|588470420|FG000|Overall Study|Progressive Disease (PD)|0|||
162936463|NCT01077713|588470421|FG001|Overall Study|Progressive Disease (PD)|1|||
162936464|NCT01077713|588470420|FG000|Overall Study|Death|28|||
162936465|NCT01077713|588470421|FG001|Overall Study|Death|29|||
162936466|NCT01077713|588470420|FG000|Overall Study|Lost to Follow-up|1|||
162936467|NCT01077713|588470421|FG001|Overall Study|Lost to Follow-up|1|||
162936468|NCT01077713|588470420|FG000|Overall Study|Adverse Event|2|||
162936469|NCT01077713|588470421|FG001|Overall Study|Adverse Event|1|||
162936470|NCT01077713|588470420|FG000|Overall Study|Other|4|||
162936471|NCT01077713|588470421|FG001|Overall Study|Other|2|||
162936472|NCT04136626|588470422|FG000|Treatment Phase|Withdrawal by Subject|1|||
162936473|NCT04136626|588470423|FG001|Treatment Phase|Withdrawal by Subject|9|||
162936474|NCT04136626|588470422|FG000|Treatment Phase|Adverse Event|1|||
162936475|NCT04136626|588470423|FG001|Treatment Phase|Adverse Event|0|||
162936476|NCT04136626|588470422|FG000|Treatment Phase|Lost to Follow-up|1|||
162936477|NCT04136626|588470423|FG001|Treatment Phase|Lost to Follow-up|5|||
162936478|NCT04136626|588470422|FG000|12-month Follow-up|Lost to Follow-up|8|||
162936479|NCT04136626|588470423|FG001|12-month Follow-up|Lost to Follow-up|7|||
162936480|NCT02049359|588471697|FG000|Overall Study|Lost to Follow-up|26|||
163179427|NCT02445391|589371057|FG002|Overall Study|No active protocol treatment|0|||
163179428|NCT02445391|589371055|FG000|Overall Study|Adverse Event|0|||
162936481|NCT02049359|588471698|FG001|Overall Study|Lost to Follow-up|19|||
162936482|NCT00658320|588471699|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
162936483|NCT00658320|588471700|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
162936484|NCT00658320|588471699|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
162936485|NCT00658320|588471700|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
162936486|NCT00658320|588471699|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
163179429|NCT02445391|589371056|FG001|Overall Study|Adverse Event|21|||
162936487|NCT00658320|588471700|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
162936488|NCT00658320|588471699|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
162936489|NCT00658320|588471700|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
162936490|NCT02410252|588471702|FG000|Overall Study|Withdrawal by Subject|4|||
162936491|NCT02410252|588471702|FG000|Overall Study|Physician Decision|2|||
162936492|NCT01007916|588471706|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
162936493|NCT01007916|588471707|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
162936494|NCT01007916|588471706|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
162936495|NCT01007916|588471707|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
162936496|NCT00387712|588471710|FG000|Overall Study|Physician Decision|6|||
162936497|NCT00387712|588471711|FG001|Overall Study|Physician Decision|4|||
162936498|NCT00387712|588471710|FG000|Overall Study|Lost to Follow-up|17|||
162936499|NCT00387712|588471711|FG001|Overall Study|Lost to Follow-up|20|||
162936500|NCT00387712|588471710|FG000|Overall Study|Withdrawal by Subject|6|||
162936501|NCT00387712|588471711|FG001|Overall Study|Withdrawal by Subject|12|||
162936502|NCT00268346|588471728|FG000|Overall Study|Adverse Event|0|||
162936503|NCT00268346|588471729|FG001|Overall Study|Adverse Event|1|||
162936504|NCT00268346|588471728|FG000|Overall Study|Death|0|||
162936505|NCT00268346|588471729|FG001|Overall Study|Death|1|||
162936506|NCT00268346|588471728|FG000|Overall Study|Withdrawal by Subject|0|||
162936507|NCT00268346|588471729|FG001|Overall Study|Withdrawal by Subject|1|||
162936508|NCT02043366|588471732|FG000|Overall Study|Lost to Follow-up|2|||
162936509|NCT02043366|588471733|FG001|Overall Study|Lost to Follow-up|2|||
162936510|NCT02043366|588471734|FG002|Overall Study|Lost to Follow-up|2|||
162936511|NCT02043366|588471735|FG003|Overall Study|Lost to Follow-up|2|||
162936512|NCT02043366|588471736|FG004|Overall Study|Lost to Follow-up|2|||
162936513|NCT02043366|588471737|FG005|Overall Study|Lost to Follow-up|2|||
162936514|NCT01489956|588471738|FG000|Overall Study|Lost to Follow-up|1|||
162936515|NCT01489956|588471739|FG001|Overall Study|Lost to Follow-up|0|||
162936516|NCT01489956|588471740|FG002|Overall Study|Lost to Follow-up|0|||
162936517|NCT01489956|588471738|FG000|Overall Study|Withdrawal by Subject|0|||
162936518|NCT01489956|588471739|FG001|Overall Study|Withdrawal by Subject|0|||
162936519|NCT01489956|588471740|FG002|Overall Study|Withdrawal by Subject|1|||
162936520|NCT00723554|588471742|FG000|Overall Study|Adverse Event|12|||
162936521|NCT00723554|588471742|FG000|Overall Study|Investigator's judgement|5|||
162936522|NCT00723554|588471742|FG000|Overall Study|Inhaled medication other than iloprost|4|||
162936523|NCT00723554|588471742|FG000|Overall Study|Withdrawal of consent|3|||
162936524|NCT00723554|588471742|FG000|Overall Study|Other|3|||
162936525|NCT00723554|588471742|FG000|Overall Study|Lost to Follow-up|1|||
162936526|NCT00723554|588471742|FG000|Overall Study|Non-compliance|1|||
162936527|NCT01405820|588471743|FG000|Randomized Treatment Period|Adverse Event|3|||
162936528|NCT01405820|588471744|FG001|Randomized Treatment Period|Adverse Event|3|||
162936529|NCT01405820|588471745|FG002|Randomized Treatment Period|Adverse Event|3|||
162936530|NCT01405820|588471746|FG003|Randomized Treatment Period|Adverse Event|0|||
162936531|NCT01405820|588471747|FG004|Randomized Treatment Period|Adverse Event|2|||
162936532|NCT01405820|588471748|FG005|Randomized Treatment Period|Adverse Event|1|||
162936533|NCT01405820|588471743|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
162936534|NCT01405820|588471744|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
162936535|NCT01405820|588471745|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
162936536|NCT01405820|588471746|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
162936537|NCT01405820|588471747|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
162936538|NCT01405820|588471748|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
162936539|NCT01405820|588471743|FG000|Randomized Treatment Period|Other|2|||
162936540|NCT01405820|588471744|FG001|Randomized Treatment Period|Other|2|||
162936541|NCT01405820|588471745|FG002|Randomized Treatment Period|Other|1|||
162936542|NCT01405820|588471746|FG003|Randomized Treatment Period|Other|1|||
162936543|NCT01405820|588471747|FG004|Randomized Treatment Period|Other|0|||
162936544|NCT01405820|588471748|FG005|Randomized Treatment Period|Other|0|||
162936545|NCT01405820|588471743|FG000|Randomized Treatment Period|Physician Decision|0|||
162936546|NCT01405820|588471744|FG001|Randomized Treatment Period|Physician Decision|2|||
162936547|NCT01405820|588471745|FG002|Randomized Treatment Period|Physician Decision|1|||
162936548|NCT01405820|588471746|FG003|Randomized Treatment Period|Physician Decision|0|||
163042836|NCT01990768|588863968|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
163284268|NCT03068468|589751363|FG001|Placebo-Controlled Period|Death|1|||
163284269|NCT03068468|589751364|FG002|Placebo-Controlled Period|Death|0|||
162936549|NCT01405820|588471747|FG004|Randomized Treatment Period|Physician Decision|0|||
162936550|NCT01405820|588471748|FG005|Randomized Treatment Period|Physician Decision|0|||
162936551|NCT01405820|588471743|FG000|Randomized Treatment Period|Rescue|0|||
162936552|NCT01405820|588471744|FG001|Randomized Treatment Period|Rescue|1|||
162936553|NCT01405820|588471745|FG002|Randomized Treatment Period|Rescue|13|||
162936554|NCT01405820|588471746|FG003|Randomized Treatment Period|Rescue|10|||
162936555|NCT01405820|588471747|FG004|Randomized Treatment Period|Rescue|8|||
162936556|NCT01405820|588471748|FG005|Randomized Treatment Period|Rescue|8|||
162936557|NCT01405820|588471743|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
163042837|NCT01990768|588863969|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
162936558|NCT01405820|588471744|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
162936559|NCT01405820|588471745|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
162936560|NCT01405820|588471746|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
162936561|NCT01405820|588471747|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
162936562|NCT01405820|588471748|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
162936563|NCT01405820|588471743|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
162936564|NCT01405820|588471744|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
162936565|NCT01405820|588471745|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
162936566|NCT01405820|588471746|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
162936567|NCT01405820|588471747|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
162936568|NCT01405820|588471748|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
162936569|NCT01405820|588471743|FG000|Randomized Treatment Period|Death|0|||
162936570|NCT01405820|588471744|FG001|Randomized Treatment Period|Death|0|||
162936571|NCT01405820|588471745|FG002|Randomized Treatment Period|Death|0|||
162936572|NCT01405820|588471746|FG003|Randomized Treatment Period|Death|1|||
162936573|NCT01405820|588471747|FG004|Randomized Treatment Period|Death|0|||
162936574|NCT01405820|588471748|FG005|Randomized Treatment Period|Death|0|||
162936575|NCT01405820|588471743|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
162936576|NCT01405820|588471744|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
162936577|NCT01405820|588471745|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
162936578|NCT01405820|588471746|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
162936579|NCT01405820|588471747|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
162936580|NCT01405820|588471748|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
162936581|NCT01405820|588471743|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
162936582|NCT01405820|588471744|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
162936583|NCT01405820|588471745|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
162936584|NCT01405820|588471746|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
162936585|NCT01405820|588471747|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
162936586|NCT01405820|588471748|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
162936587|NCT01405820|588471743|FG000|Open-Label Treatment Period|Other|1|||
162936588|NCT01405820|588471744|FG001|Open-Label Treatment Period|Other|1|||
162936589|NCT01405820|588471745|FG002|Open-Label Treatment Period|Other|1|||
162936590|NCT01405820|588471746|FG003|Open-Label Treatment Period|Other|1|||
162936591|NCT01405820|588471747|FG004|Open-Label Treatment Period|Other|1|||
162936592|NCT01405820|588471748|FG005|Open-Label Treatment Period|Other|1|||
162936593|NCT01405820|588471743|FG000|Open-Label Treatment Period|Physician Decision|0|||
162936594|NCT01405820|588471744|FG001|Open-Label Treatment Period|Physician Decision|0|||
162936595|NCT01405820|588471745|FG002|Open-Label Treatment Period|Physician Decision|1|||
162936596|NCT01405820|588471746|FG003|Open-Label Treatment Period|Physician Decision|2|||
162936597|NCT01405820|588471747|FG004|Open-Label Treatment Period|Physician Decision|1|||
162936598|NCT01405820|588471748|FG005|Open-Label Treatment Period|Physician Decision|0|||
162936599|NCT01405820|588471743|FG000|Open-Label Treatment Period|Adverse Event|0|||
162936600|NCT01405820|588471744|FG001|Open-Label Treatment Period|Adverse Event|0|||
162936601|NCT01405820|588471745|FG002|Open-Label Treatment Period|Adverse Event|0|||
162936602|NCT01405820|588471746|FG003|Open-Label Treatment Period|Adverse Event|1|||
162936603|NCT01405820|588471747|FG004|Open-Label Treatment Period|Adverse Event|0|||
162936604|NCT01405820|588471748|FG005|Open-Label Treatment Period|Adverse Event|0|||
162936605|NCT03222141|588471751|FG000|Overall Study|Death|15|||
162936606|NCT03222141|588471751|FG000|Overall Study|Lost to Follow-up|3|||
162936607|NCT01894984|588471755|FG000|Overall Study|Other|314|||
162936608|NCT01894984|588471756|FG001|Overall Study|Other|175|||
162936609|NCT00827359|588471757|FG000|Overall Study|Progressive Diseas|19|||
162936610|NCT00827359|588471757|FG000|Overall Study|Unacceptable Toxicity|5|||
162936611|NCT00827359|588471757|FG000|Overall Study|Ineligible|1|||
162936612|NCT02436135|588471758|FG000|Overall Study|Progressive Disease|3|||
162936613|NCT02436135|588471759|FG001|Overall Study|Progressive Disease|1|||
162936614|NCT02436135|588471758|FG000|Overall Study|Investigator Discretion|1|||
162936615|NCT02436135|588471759|FG001|Overall Study|Investigator Discretion|2|||
162936616|NCT02436135|588471758|FG000|Overall Study|Adverse Event|1|||
162936617|NCT02436135|588471759|FG001|Overall Study|Adverse Event|0|||
162936618|NCT02436135|588471758|FG000|Overall Study|Withdrawal by Participant|1|||
162936619|NCT02436135|588471759|FG001|Overall Study|Withdrawal by Participant|0|||
162936620|NCT02436135|588471758|FG000|Overall Study|Study Terminated By Sponsor|0|||
162936621|NCT02436135|588471759|FG001|Overall Study|Study Terminated By Sponsor|1|||
162936622|NCT01427803|588471760|FG000|Overall Study|Lost to Follow-up|32|||
162936623|NCT01427803|588471761|FG001|Overall Study|Lost to Follow-up|26|||
162936624|NCT01427803|588471760|FG000|Overall Study|Withdrawal by Subject|20|||
162936625|NCT01427803|588471761|FG001|Overall Study|Withdrawal by Subject|0|||
162936626|NCT01427803|588471760|FG000|Overall Study|Unable to complete full treatment period|6|||
162936627|NCT01427803|588471761|FG001|Overall Study|Unable to complete full treatment period|0|||
162936628|NCT01427803|588471760|FG000|Overall Study|Protocol Violation|1|||
163284270|NCT03068468|589751365|FG003|Placebo-Controlled Period|Death|0|||
162936629|NCT01427803|588471761|FG001|Overall Study|Protocol Violation|0|||
163284271|NCT03068468|589751362|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
162936630|NCT01427803|588471760|FG000|Overall Study|Physician Decision|3|||
162936631|NCT01427803|588471761|FG001|Overall Study|Physician Decision|0|||
162936632|NCT01427803|588471760|FG000|Overall Study|did not take product|1|||
162936633|NCT01427803|588471761|FG001|Overall Study|did not take product|0|||
162936634|NCT03412019|588471764|FG000|Overall Study|Withdrawal by Subject|1|||
162936635|NCT03412019|588471765|FG001|Overall Study|Withdrawal by Subject|1|||
162936636|NCT00415532|588471767|FG000|Treatment Period|Adverse Event|2|||
162936637|NCT00415532|588471768|FG001|Treatment Period|Adverse Event|3|||
162936638|NCT00415532|588471767|FG000|Treatment Period|Death|2|||
162936639|NCT00415532|588471768|FG001|Treatment Period|Death|1|||
162936640|NCT00415532|588471767|FG000|Treatment Period|Lost to Follow-up|1|||
162936641|NCT00415532|588471768|FG001|Treatment Period|Lost to Follow-up|1|||
162936642|NCT00415532|588471767|FG000|Treatment Period|Protocol Violation|1|||
162936643|NCT00415532|588471768|FG001|Treatment Period|Protocol Violation|0|||
162936644|NCT00415532|588471767|FG000|Treatment Period|Withdrawal by Subject|6|||
162936645|NCT00415532|588471768|FG001|Treatment Period|Withdrawal by Subject|6|||
162936646|NCT00415532|588471767|FG000|Treatment Period|Other|2|||
162936647|NCT00415532|588471768|FG001|Treatment Period|Other|2|||
162936648|NCT00415532|588471767|FG000|Treatment Period|Ineligibility determined|1|||
162936649|NCT00415532|588471768|FG001|Treatment Period|Ineligibility determined|1|||
162936650|NCT00415532|588471767|FG000|Treatment Period|Noncompliance|1|||
162936651|NCT00415532|588471768|FG001|Treatment Period|Noncompliance|1|||
162936652|NCT00415532|588471767|FG000|Treatment Period|Requirement for alternative therapy|1|||
163284272|NCT03068468|589751363|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
163284273|NCT03068468|589751364|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
163284274|NCT03068468|589751365|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
163284275|NCT03068468|589751362|FG000|Open-Label Extension Period|Adverse Event|0|||
163284276|NCT03068468|589751363|FG001|Open-Label Extension Period|Adverse Event|0|||
163284277|NCT03068468|589751364|FG002|Open-Label Extension Period|Adverse Event|13|||
163284278|NCT03068468|589751365|FG003|Open-Label Extension Period|Adverse Event|17|||
163284279|NCT03068468|589751362|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
163284280|NCT03068468|589751363|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
163284281|NCT03068468|589751364|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
163284282|NCT03068468|589751365|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
163284283|NCT03068468|589751362|FG000|Open-Label Extension Period|Death|0|||
163284284|NCT03068468|589751363|FG001|Open-Label Extension Period|Death|0|||
163284285|NCT03068468|589751364|FG002|Open-Label Extension Period|Death|0|||
163284286|NCT03068468|589751365|FG003|Open-Label Extension Period|Death|1|||
163284287|NCT03068468|589751362|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
163284288|NCT03068468|589751363|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
163284289|NCT03068468|589751364|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
163284290|NCT03068468|589751365|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
163284291|NCT03068468|589751362|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
163284292|NCT03068468|589751363|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
163284293|NCT03068468|589751364|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
163284294|NCT03068468|589751365|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
163284295|NCT03068468|589751362|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
162936653|NCT00415532|588471768|FG001|Treatment Period|Requirement for alternative therapy|0|||
162936654|NCT00415532|588471767|FG000|Safety Follow Up Period|Adverse Event|1|||
162936655|NCT00415532|588471768|FG001|Safety Follow Up Period|Adverse Event|3|||
162936656|NCT00415532|588471767|FG000|Safety Follow Up Period|Death|3|||
162936657|NCT00415532|588471768|FG001|Safety Follow Up Period|Death|0|||
162936658|NCT00415532|588471767|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
162936659|NCT00415532|588471768|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
162936660|NCT00415532|588471767|FG000|Safety Follow Up Period|Other|1|||
162936661|NCT00415532|588471768|FG001|Safety Follow Up Period|Other|4|||
162936662|NCT00415532|588471767|FG000|Safety Follow Up Period|Ineligibility determined|1|||
162936663|NCT00415532|588471768|FG001|Safety Follow Up Period|Ineligibility determined|1|||
162936664|NCT00415532|588471767|FG000|Safety Follow Up Period|Noncompliance|1|||
162936665|NCT00415532|588471768|FG001|Safety Follow Up Period|Noncompliance|0|||
162936666|NCT00415532|588471767|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
162936667|NCT00415532|588471768|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
162936668|NCT01698320|588471769|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
162936669|NCT01698320|588471770|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
162936670|NCT01698320|588471771|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
163284296|NCT03068468|589751363|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
163284297|NCT03068468|589751364|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
162936671|NCT01698320|588471769|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
162936672|NCT01698320|588471770|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
162936673|NCT01698320|588471771|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
162936674|NCT01698320|588471769|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
162936675|NCT01698320|588471770|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
162936676|NCT01698320|588471771|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
162936677|NCT01698320|588471769|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
162936678|NCT01698320|588471770|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
162936679|NCT01698320|588471771|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
162936680|NCT01698320|588471769|FG000|12-Week Double-Blind Period|Adverse Event|0|||
162936681|NCT01698320|588471770|FG001|12-Week Double-Blind Period|Adverse Event|1|||
162936682|NCT01698320|588471771|FG002|12-Week Double-Blind Period|Adverse Event|1|||
162936683|NCT01698320|588471769|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
162936684|NCT01698320|588471770|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
162936685|NCT01698320|588471771|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
162936686|NCT01698320|588471769|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
162936687|NCT01698320|588471770|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
162936688|NCT01698320|588471771|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
162936689|NCT01698320|588471769|FG000|12-Week Double-Blind Period|Pregnancy|0|||
162936690|NCT01698320|588471770|FG001|12-Week Double-Blind Period|Pregnancy|1|||
162936691|NCT01698320|588471771|FG002|12-Week Double-Blind Period|Pregnancy|1|||
162936692|NCT01698320|588471769|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
162936693|NCT01698320|588471770|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
162936694|NCT01698320|588471771|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
162936695|NCT01698320|588471769|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
162936696|NCT01698320|588471770|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
162936697|NCT01698320|588471771|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
162936698|NCT01698320|588471769|FG000|40-Week Open-Label Period|Adverse Event|0|||
162936699|NCT01698320|588471770|FG001|40-Week Open-Label Period|Adverse Event|3|||
162936700|NCT01698320|588471771|FG002|40-Week Open-Label Period|Adverse Event|2|||
162936701|NCT01698320|588471769|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
162936702|NCT01698320|588471770|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
162936703|NCT01698320|588471771|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
162936704|NCT01698320|588471769|FG000|40-Week Open-Label Period|Pregnancy|0|||
162936705|NCT01698320|588471770|FG001|40-Week Open-Label Period|Pregnancy|2|||
162936706|NCT01698320|588471771|FG002|40-Week Open-Label Period|Pregnancy|1|||
162936707|NCT01698320|588471769|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
162936708|NCT01698320|588471770|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
162936709|NCT01698320|588471771|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
162936710|NCT01698320|588471769|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
162936711|NCT01698320|588471770|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
162936712|NCT01698320|588471771|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
162936713|NCT01952574|588471772|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
162936714|NCT01952574|588471773|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
162936715|NCT01952574|588471774|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
162936716|NCT01952574|588471775|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
162936717|NCT01952574|588471776|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162936718|NCT01952574|588471777|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162936719|NCT01952574|588471778|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162936720|NCT01952574|588471772|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
163179430|NCT02445391|589371057|FG002|Overall Study|Adverse Event|12|||
163179431|NCT02445391|589371055|FG000|Overall Study|Alternative therapy|0|||
163179432|NCT02445391|589371056|FG001|Overall Study|Alternative therapy|0|||
163179433|NCT02445391|589371057|FG002|Overall Study|Alternative therapy|1|||
163179434|NCT02445391|589371055|FG000|Overall Study|Disease progression|0|||
163179435|NCT02445391|589371056|FG001|Overall Study|Disease progression|7|||
163179436|NCT02445391|589371057|FG002|Overall Study|Disease progression|22|||
163179437|NCT02445391|589371055|FG000|Overall Study|Complicating disease|0|||
163179438|NCT02445391|589371056|FG001|Overall Study|Complicating disease|2|||
163179439|NCT02445391|589371057|FG002|Overall Study|Complicating disease|1|||
163179440|NCT02445391|589371055|FG000|Overall Study|Withdrawal by Subject|0|||
163179441|NCT02445391|589371056|FG001|Overall Study|Withdrawal by Subject|4|||
163179442|NCT02445391|589371057|FG002|Overall Study|Withdrawal by Subject|9|||
163179443|NCT02445391|589371055|FG000|Overall Study|Financial issue|0|||
163179444|NCT02445391|589371056|FG001|Overall Study|Financial issue|0|||
163179445|NCT02445391|589371057|FG002|Overall Study|Financial issue|2|||
163284298|NCT03068468|589751365|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
162936721|NCT01952574|588471773|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
162936722|NCT01952574|588471774|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
162936723|NCT01952574|588471775|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
162936724|NCT01952574|588471776|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
162936725|NCT01952574|588471777|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
163179446|NCT02445391|589371055|FG000|Overall Study|Still on treatment|0|||
163179447|NCT02445391|589371056|FG001|Overall Study|Still on treatment|7|||
163179448|NCT02445391|589371057|FG002|Overall Study|Still on treatment|16|||
163179449|NCT02445391|589371055|FG000|Overall Study|Not start protocol therapy|0|||
163284299|NCT03068468|589751362|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
163179450|NCT02445391|589371056|FG001|Overall Study|Not start protocol therapy|12|||
163179451|NCT02445391|589371057|FG002|Overall Study|Not start protocol therapy|9|||
163042838|NCT01990768|588863970|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
163179473|NCT03961555|589371270|FG000|Overall Study|Lost to Follow-up|0|||
163179474|NCT03961555|589371271|FG001|Overall Study|Lost to Follow-up|0|||
163179475|NCT03961555|589371272|FG002|Overall Study|Lost to Follow-up|1|||
163179476|NCT03961555|589371273|FG003|Overall Study|Lost to Follow-up|0|||
163179477|NCT03961555|589371270|FG000|Overall Study|Withdrawal by Subject|0|||
163179478|NCT03961555|589371271|FG001|Overall Study|Withdrawal by Subject|0|||
163179479|NCT03961555|589371272|FG002|Overall Study|Withdrawal by Subject|2|||
163179480|NCT03961555|589371273|FG003|Overall Study|Withdrawal by Subject|4|||
163179481|NCT03961555|589371270|FG000|Overall Study|Death|0|||
163179482|NCT03961555|589371271|FG001|Overall Study|Death|1|||
163179483|NCT03961555|589371272|FG002|Overall Study|Death|0|||
163179484|NCT03961555|589371273|FG003|Overall Study|Death|0|||
163179485|NCT03961555|589371270|FG000|Overall Study|Other|0|||
163284300|NCT03068468|589751363|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
162936726|NCT01952574|588471778|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
162936727|NCT01952574|588471772|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
162936728|NCT01952574|588471773|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
162936729|NCT01952574|588471774|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
162936730|NCT01952574|588471775|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
162936731|NCT01952574|588471776|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
162936732|NCT01952574|588471777|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
162936733|NCT01952574|588471778|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
162936734|NCT01952574|588471772|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
162936735|NCT01952574|588471773|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
162936736|NCT01952574|588471774|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
162936737|NCT01952574|588471775|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
162936738|NCT01952574|588471776|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
162936739|NCT01952574|588471777|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
162936740|NCT01952574|588471778|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
162936741|NCT01952574|588471772|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
162936742|NCT01952574|588471773|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
162936743|NCT01952574|588471774|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
162936744|NCT01952574|588471775|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
162936745|NCT01952574|588471776|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
162936746|NCT01952574|588471777|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
162936747|NCT01952574|588471778|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
162936748|NCT01952574|588471772|FG000|Open-label Treatment Phase|Missing|0|||
162936749|NCT01952574|588471773|FG001|Open-label Treatment Phase|Missing|0|||
162936750|NCT01952574|588471774|FG002|Open-label Treatment Phase|Missing|0|||
162936751|NCT01952574|588471775|FG003|Open-label Treatment Phase|Missing|0|||
162936752|NCT01952574|588471776|FG004|Open-label Treatment Phase|Missing|4|||
162936753|NCT01952574|588471777|FG005|Open-label Treatment Phase|Missing|0|||
162936754|NCT01952574|588471778|FG006|Open-label Treatment Phase|Missing|0|||
162936755|NCT01952574|588471772|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
162936756|NCT01952574|588471773|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
162936757|NCT01952574|588471774|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
162936758|NCT01952574|588471775|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
162936759|NCT01952574|588471776|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
162936760|NCT01952574|588471777|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
162936761|NCT01952574|588471778|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
162936762|NCT01952574|588471772|FG000|Open-label Treatment Phase|Death|0|||
162936763|NCT01952574|588471773|FG001|Open-label Treatment Phase|Death|0|||
162936764|NCT01952574|588471774|FG002|Open-label Treatment Phase|Death|0|||
162936765|NCT01952574|588471775|FG003|Open-label Treatment Phase|Death|0|||
162936766|NCT01952574|588471776|FG004|Open-label Treatment Phase|Death|1|||
162936767|NCT01952574|588471777|FG005|Open-label Treatment Phase|Death|0|||
162936768|NCT01952574|588471778|FG006|Open-label Treatment Phase|Death|0|||
162936769|NCT01952574|588471772|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
163179486|NCT03961555|589371271|FG001|Overall Study|Other|0|||
163179487|NCT03961555|589371272|FG002|Overall Study|Other|2|||
163179488|NCT03961555|589371273|FG003|Overall Study|Other|2|||
163179489|NCT03961555|589371270|FG000|Overall Study|No treatment received|0|||
163179490|NCT03961555|589371271|FG001|Overall Study|No treatment received|0|||
163179491|NCT03961555|589371272|FG002|Overall Study|No treatment received|1|||
163179492|NCT03961555|589371273|FG003|Overall Study|No treatment received|0|||
163284301|NCT03068468|589751364|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
163284302|NCT03068468|589751365|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
163284303|NCT03068468|589751362|FG000|Open-Label Extension Period|Reason not Specified|0|||
162936770|NCT01952574|588471773|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
162936771|NCT01952574|588471774|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
162936772|NCT01952574|588471775|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
162936773|NCT01952574|588471776|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
163284304|NCT03068468|589751363|FG001|Open-Label Extension Period|Reason not Specified|0|||
162936774|NCT01952574|588471777|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
163179503|NCT05222555|589371277|FG000|Overall Study|Ongoing|2|||
163179504|NCT05222555|589371278|FG001|Overall Study|Ongoing|18|||
163179505|NCT05222555|589371277|FG000|Overall Study|Adverse Event|1|||
162936775|NCT01952574|588471778|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
162936776|NCT01952574|588471772|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
162936777|NCT01952574|588471773|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
162936778|NCT01952574|588471774|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
162936779|NCT01952574|588471775|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
162936780|NCT01952574|588471776|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
162936781|NCT01952574|588471777|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
162936782|NCT01952574|588471778|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
162936783|NCT01107535|588471782|FG000|Overall Study|Death|5|||
162936784|NCT03567057|588471783|FG000|Overall Study|Adverse Event|56|||
162936785|NCT03567057|588471784|FG001|Overall Study|Adverse Event|53|||
162936786|NCT03567057|588471785|FG002|Overall Study|Adverse Event|28|||
162936787|NCT03567057|588471783|FG000|Overall Study|Withdrawal by Subject|22|||
162936788|NCT03567057|588471784|FG001|Overall Study|Withdrawal by Subject|24|||
162936789|NCT03567057|588471785|FG002|Overall Study|Withdrawal by Subject|13|||
162936790|NCT03567057|588471783|FG000|Overall Study|Lost to Follow-up|3|||
162936791|NCT03567057|588471784|FG001|Overall Study|Lost to Follow-up|5|||
162936792|NCT03567057|588471785|FG002|Overall Study|Lost to Follow-up|2|||
162936793|NCT03567057|588471783|FG000|Overall Study|COVID-19 pandemic|4|||
162936794|NCT03567057|588471784|FG001|Overall Study|COVID-19 pandemic|3|||
162936795|NCT03567057|588471785|FG002|Overall Study|COVID-19 pandemic|0|||
162936796|NCT03567057|588471783|FG000|Overall Study|Non-compliance with study drug|4|||
162936797|NCT03567057|588471784|FG001|Overall Study|Non-compliance with study drug|2|||
162936798|NCT03567057|588471785|FG002|Overall Study|Non-compliance with study drug|0|||
162936799|NCT03567057|588471783|FG000|Overall Study|Lack of Efficacy|3|||
162936800|NCT03567057|588471784|FG001|Overall Study|Lack of Efficacy|0|||
162936801|NCT03567057|588471785|FG002|Overall Study|Lack of Efficacy|1|||
162936802|NCT03567057|588471783|FG000|Overall Study|Death|1|||
162936803|NCT03567057|588471784|FG001|Overall Study|Death|0|||
162936804|NCT03567057|588471785|FG002|Overall Study|Death|0|||
162936805|NCT03567057|588471783|FG000|Overall Study|Physician Decision|1|||
162936806|NCT03567057|588471784|FG001|Overall Study|Physician Decision|0|||
162936807|NCT03567057|588471785|FG002|Overall Study|Physician Decision|0|||
162936808|NCT03567057|588471783|FG000|Overall Study|Unstable medical condition|1|||
162936809|NCT03567057|588471784|FG001|Overall Study|Unstable medical condition|0|||
162936810|NCT03567057|588471785|FG002|Overall Study|Unstable medical condition|0|||
162936811|NCT03567057|588471783|FG000|Overall Study|Medical history event|0|||
162936812|NCT03567057|588471784|FG001|Overall Study|Medical history event|0|||
162936813|NCT03567057|588471785|FG002|Overall Study|Medical history event|1|||
162936814|NCT03567057|588471783|FG000|Overall Study|Other|0|||
162936815|NCT03567057|588471784|FG001|Overall Study|Other|0|||
162936816|NCT03567057|588471785|FG002|Overall Study|Other|1|||
162936817|NCT01271933|588471786|FG000|Single-Blind Phase|Lack of Efficacy|37|||
162936818|NCT01271933|588471787|FG001|Single-Blind Phase|Lack of Efficacy|0|||
162936819|NCT01271933|588471788|FG002|Single-Blind Phase|Lack of Efficacy|0|||
162936820|NCT01271933|588471786|FG000|Single-Blind Phase|Lost to Follow-up|10|||
162936821|NCT01271933|588471787|FG001|Single-Blind Phase|Lost to Follow-up|0|||
162936822|NCT01271933|588471788|FG002|Single-Blind Phase|Lost to Follow-up|0|||
162936823|NCT01271933|588471786|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
162936824|NCT01271933|588471787|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
162936825|NCT01271933|588471788|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
162936826|NCT01271933|588471786|FG000|Single-Blind Phase|Protocol Violation|3|||
162936827|NCT01271933|588471787|FG001|Single-Blind Phase|Protocol Violation|0|||
162936828|NCT01271933|588471788|FG002|Single-Blind Phase|Protocol Violation|0|||
162936829|NCT01271933|588471786|FG000|Single-Blind Phase|Adverse Event|52|||
162936830|NCT01271933|588471787|FG001|Single-Blind Phase|Adverse Event|0|||
162936831|NCT01271933|588471788|FG002|Single-Blind Phase|Adverse Event|0|||
162936832|NCT01271933|588471786|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
162936833|NCT01271933|588471787|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
162936834|NCT01271933|588471788|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
162936835|NCT01271933|588471786|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
162936836|NCT01271933|588471787|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
162936837|NCT01271933|588471788|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
162936838|NCT01271933|588471786|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
162936839|NCT01271933|588471787|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
162936840|NCT01271933|588471788|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
162936841|NCT01271933|588471786|FG000|Double-Blind Phase|Randomized but not treated|0|||
163179506|NCT05222555|589371278|FG001|Overall Study|Adverse Event|1|||
163179507|NCT05222555|589371277|FG000|Overall Study|Death|0|||
163179508|NCT05222555|589371278|FG001|Overall Study|Death|6|||
163179509|NCT05222555|589371277|FG000|Overall Study|Withdrawal by Subject|0|||
163179510|NCT05222555|589371278|FG001|Overall Study|Withdrawal by Subject|11|||
163179511|NCT03516942|589371285|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
163179512|NCT03516942|589371285|FG000|Registration through baseline survey com|Death|8|||
163179513|NCT03516942|589371285|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
162936842|NCT01271933|588471787|FG001|Double-Blind Phase|Randomized but not treated|0|||
162936843|NCT01271933|588471788|FG002|Double-Blind Phase|Randomized but not treated|1|||
162936844|NCT01271933|588471786|FG000|Double-Blind Phase|Lack of Efficacy|0|||
162936845|NCT01271933|588471787|FG001|Double-Blind Phase|Lack of Efficacy|6|||
162936846|NCT01271933|588471788|FG002|Double-Blind Phase|Lack of Efficacy|9|||
162936847|NCT01271933|588471786|FG000|Double-Blind Phase|Lost to Follow-up|0|||
162936848|NCT01271933|588471787|FG001|Double-Blind Phase|Lost to Follow-up|1|||
162936849|NCT01271933|588471788|FG002|Double-Blind Phase|Lost to Follow-up|1|||
162936850|NCT01271933|588471786|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
162936851|NCT01271933|588471787|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
162936852|NCT01271933|588471788|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
162936853|NCT01271933|588471786|FG000|Double-Blind Phase|Adverse Event|0|||
162936854|NCT01271933|588471787|FG001|Double-Blind Phase|Adverse Event|3|||
162936855|NCT01271933|588471788|FG002|Double-Blind Phase|Adverse Event|0|||
162936856|NCT01271933|588471786|FG000|Double-Blind Phase|Participant request-personal reason|0|||
162936857|NCT01271933|588471787|FG001|Double-Blind Phase|Participant request-personal reason|1|||
162936858|NCT01271933|588471788|FG002|Double-Blind Phase|Participant request-personal reason|0|||
162936859|NCT01620983|588471789|FG000|Overall Study|Lost to Follow-up|8|||
162936860|NCT01620983|588471790|FG001|Overall Study|Lost to Follow-up|4|||
162936861|NCT01620983|588471791|FG002|Overall Study|Lost to Follow-up|9|||
162936862|NCT01620983|588471789|FG000|Overall Study|Withdrawal by Subject|6|||
162936863|NCT01620983|588471790|FG001|Overall Study|Withdrawal by Subject|8|||
162936864|NCT01620983|588471791|FG002|Overall Study|Withdrawal by Subject|1|||
162936865|NCT01620983|588471789|FG000|Overall Study|Death|2|||
162936866|NCT01620983|588471790|FG001|Overall Study|Death|0|||
162936867|NCT01620983|588471791|FG002|Overall Study|Death|0|||
162936868|NCT01620983|588471789|FG000|Overall Study|Physician Decision|3|||
162936869|NCT01620983|588471790|FG001|Overall Study|Physician Decision|10|||
162936870|NCT01620983|588471791|FG002|Overall Study|Physician Decision|5|||
162936871|NCT03156270|588471794|FG000|Overall Study|Failed pre-treatment screening|1|||
162936872|NCT03156270|588471794|FG000|Overall Study|Lost to Follow-up|1|||
162936873|NCT00591253|588471795|FG000|Overall Study|Adverse Event|3|||
162936874|NCT00591253|588471796|FG001|Overall Study|Adverse Event|3|||
162936875|NCT00591253|588471797|FG002|Overall Study|Adverse Event|1|||
162936876|NCT00591253|588471795|FG000|Overall Study|Protocol Violation|2|||
162936877|NCT00591253|588471796|FG001|Overall Study|Protocol Violation|2|||
162936878|NCT00591253|588471797|FG002|Overall Study|Protocol Violation|2|||
162936879|NCT00591253|588471795|FG000|Overall Study|Lost to Follow-up|2|||
162936880|NCT00591253|588471796|FG001|Overall Study|Lost to Follow-up|4|||
162936881|NCT00591253|588471797|FG002|Overall Study|Lost to Follow-up|0|||
162936882|NCT00591253|588471795|FG000|Overall Study|Withdrawal by Subject|1|||
162936883|NCT00591253|588471796|FG001|Overall Study|Withdrawal by Subject|7|||
162936884|NCT00591253|588471797|FG002|Overall Study|Withdrawal by Subject|6|||
162936885|NCT00591253|588471795|FG000|Overall Study|Lack of Efficacy|1|||
162936886|NCT00591253|588471796|FG001|Overall Study|Lack of Efficacy|0|||
162936887|NCT00591253|588471797|FG002|Overall Study|Lack of Efficacy|3|||
162936888|NCT00591253|588471795|FG000|Overall Study|Other|5|||
162936889|NCT00591253|588471796|FG001|Overall Study|Other|5|||
162936890|NCT00591253|588471797|FG002|Overall Study|Other|3|||
162936891|NCT01783730|588471801|FG000|Overall Study|Failed to meet inclusion criteria|6|||
162936892|NCT01841359|588471802|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
162936893|NCT01841359|588471802|FG000|Overall Study|Concommitant medical issues|2|||
162936894|NCT01841359|588471802|FG000|Overall Study|Adverse Event|3|||
163179514|NCT03516942|589371285|FG000|T0: Baseline|LOST|13|||
163179515|NCT03516942|589371285|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
163179516|NCT03516942|589371285|FG000|T1: 3 Months Survey|Death|10|||
163179517|NCT03516942|589371285|FG000|T1: 3 Months Survey|Lost|163|||
163179518|NCT03516942|589371285|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
163179519|NCT03516942|589371285|FG000|T2: 6 Month Survey|Death|14|||
163179520|NCT03516942|589371285|FG000|T2: 6 Month Survey|Lost|180|||
163179521|NCT03516942|589371285|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
163179522|NCT03516942|589371285|FG000|T3: 12 Month Survey|Death|19|||
163179523|NCT03516942|589371285|FG000|T3: 12 Month Survey|Lost|209|||
163210533|NCT03045887|589485286|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
163210534|NCT03045887|589485287|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
163210535|NCT03045887|589485288|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
163210536|NCT03045887|589485289|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
163210537|NCT03045887|589485290|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
163210538|NCT03045887|589485291|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
163210539|NCT03045887|589485282|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162936895|NCT01841359|588471802|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
162936896|NCT00871169|588471803|FG000|Overall Study|Protocol Violation|1|||
162936897|NCT00871169|588471803|FG000|Overall Study|Patient did not receive study treatment|2|||
162936898|NCT00252187|588471804|FG000|Overall Study|Adverse Event|3|||
162936899|NCT00252187|588471805|FG001|Overall Study|Adverse Event|1|||
162936900|NCT00252187|588471804|FG000|Overall Study|Withdrawal by Subject|1|||
163210540|NCT03045887|589485283|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
163179524|NCT00478881|589372105|FG000|Overall Study|Adverse Event|31|||
163179525|NCT00478881|589372106|FG001|Overall Study|Adverse Event|12|||
163179526|NCT00478881|589372105|FG000|Overall Study|Lack of Efficacy|0|||
163179527|NCT00478881|589372106|FG001|Overall Study|Lack of Efficacy|3|||
163179528|NCT00478881|589372105|FG000|Overall Study|Lost to Follow-up|0|||
163179529|NCT00478881|589372106|FG001|Overall Study|Lost to Follow-up|1|||
163179530|NCT00478881|589372105|FG000|Overall Study|Protocol Violation|2|||
163179531|NCT00478881|589372106|FG001|Overall Study|Protocol Violation|2|||
163179532|NCT00478881|589372105|FG000|Overall Study|Withdrawal by Subject|6|||
163179533|NCT00478881|589372106|FG001|Overall Study|Withdrawal by Subject|2|||
163179534|NCT00478881|589372105|FG000|Overall Study|Non-Compliance with Study Medication|0|||
163179535|NCT00478881|589372106|FG001|Overall Study|Non-Compliance with Study Medication|2|||
163179536|NCT04950608|589372110|FG000|Overall Study|Withdrawal by Subject|2|||
163179537|NCT04950608|589372110|FG000|Overall Study|Physician Decision|3|||
163179538|NCT04104438|589372111|FG000|Overall Study|Death|2|||
163179539|NCT04104438|589372112|FG001|Overall Study|Death|1|||
163179540|NCT04104438|589372113|FG002|Overall Study|Death|2|||
163179541|NCT04104438|589372111|FG000|Overall Study|Adverse Event|0|||
163179542|NCT04104438|589372112|FG001|Overall Study|Adverse Event|3|||
163179543|NCT04104438|589372113|FG002|Overall Study|Adverse Event|0|||
163179544|NCT04104438|589372111|FG000|Overall Study|Withdrawal by Subject|0|||
163179545|NCT04104438|589372112|FG001|Overall Study|Withdrawal by Subject|1|||
163179546|NCT04104438|589372113|FG002|Overall Study|Withdrawal by Subject|0|||
163179547|NCT04104438|589372111|FG000|Overall Study|Disenrolled due to noncompliance|0|||
163179548|NCT04104438|589372112|FG001|Overall Study|Disenrolled due to noncompliance|1|||
163284305|NCT03068468|589751364|FG002|Open-Label Extension Period|Reason not Specified|1|||
163284306|NCT03068468|589751365|FG003|Open-Label Extension Period|Reason not Specified|4|||
163284307|NCT03140176|589751373|FG000|Overall Study|Reason missing|23|||
163284308|NCT03140176|589751373|FG000|Overall Study|Death|33|||
163284309|NCT03140176|589751373|FG000|Overall Study|Disease progression|1|||
163284310|NCT03140176|589751373|FG000|Overall Study|Physician Decision|1|||
163284311|NCT03140176|589751373|FG000|Overall Study|Withdrawal by Subject|1|||
163284312|NCT03140176|589751373|FG000|Overall Study|Lost to Follow-up|15|||
163284313|NCT03179787|589751377|FG000|Overall Study|Lost to Follow-up|15|||
163284314|NCT03179787|589751377|FG000|Overall Study|Case report failures|2|||
163284315|NCT03179787|589751377|FG000|Overall Study|Treatment not administered|1|||
162936901|NCT00252187|588471805|FG001|Overall Study|Withdrawal by Subject|0|||
163179549|NCT04104438|589372113|FG002|Overall Study|Disenrolled due to noncompliance|0|||
163179550|NCT04104438|589372111|FG000|Overall Study|stopped due to possible operation|0|||
163179551|NCT04104438|589372112|FG001|Overall Study|stopped due to possible operation|1|||
163179552|NCT04104438|589372113|FG002|Overall Study|stopped due to possible operation|0|||
163179553|NCT04104438|589372111|FG000|Overall Study|everolimus not started due to bile duct injury|0|||
163179554|NCT04104438|589372112|FG001|Overall Study|everolimus not started due to bile duct injury|1|||
163179555|NCT04104438|589372113|FG002|Overall Study|everolimus not started due to bile duct injury|0|||
163179556|NCT01282203|589372116|FG000|Overall Study|Adverse Event|1|||
163179557|NCT03977454|589372117|FG000|Overall Study|immediate postoperative revision|2|||
163284316|NCT03181958|589751378|FG000|Overall Study|Lost to Follow-up|17|||
163284317|NCT03181958|589751379|FG001|Overall Study|Lost to Follow-up|21|||
163284318|NCT03181958|589751380|FG002|Overall Study|Lost to Follow-up|15|||
163284319|NCT02236559|589751385|FG000|Overall Study|Met Exclusion|3|||
163284320|NCT02236559|589751386|FG001|Overall Study|Met Exclusion|6|||
163284321|NCT02236559|589751385|FG000|Overall Study|Did not Meet Inclusion|3|||
163284322|NCT02236559|589751386|FG001|Overall Study|Did not Meet Inclusion|3|||
163179558|NCT03977454|589372118|FG001|Overall Study|immediate postoperative revision|2|||
163179559|NCT00930982|589372119|FG000|Overall Study|Adverse Event|19|||
163179560|NCT00930982|589372120|FG001|Overall Study|Adverse Event|23|||
163179561|NCT00930982|589372119|FG000|Overall Study|Protocol Violation|1|||
163284323|NCT02236559|589751385|FG000|Overall Study|Subject Did Not Consent|4|||
163284324|NCT02236559|589751386|FG001|Overall Study|Subject Did Not Consent|2|||
163284325|NCT02236559|589751385|FG000|Overall Study|Physician Decision|1|||
162936902|NCT00593333|588471808|FG000|Overall Study|Lost to Follow-up|10|||
162936903|NCT00593333|588471809|FG001|Overall Study|Lost to Follow-up|11|||
162936904|NCT01752920|588471810|FG000|Overall Study|Adverse Event|1|||
162936905|NCT01752920|588471811|FG001|Overall Study|Adverse Event|0|||
162936906|NCT01752920|588471812|FG002|Overall Study|Adverse Event|5|||
162936907|NCT01752920|588471813|FG003|Overall Study|Adverse Event|10|||
162936908|NCT01752920|588471810|FG000|Overall Study|Clinical Disease Progression|6|||
162936909|NCT01752920|588471811|FG001|Overall Study|Clinical Disease Progression|4|||
162936910|NCT01752920|588471812|FG002|Overall Study|Clinical Disease Progression|1|||
162936911|NCT01752920|588471813|FG003|Overall Study|Clinical Disease Progression|13|||
162936912|NCT01752920|588471810|FG000|Overall Study|Physician Decision|1|||
162936913|NCT01752920|588471811|FG001|Overall Study|Physician Decision|0|||
162936914|NCT01752920|588471812|FG002|Overall Study|Physician Decision|0|||
162936915|NCT01752920|588471813|FG003|Overall Study|Physician Decision|3|||
162936916|NCT01752920|588471810|FG000|Overall Study|Radiographic Disease Progression|20|||
162936917|NCT01752920|588471811|FG001|Overall Study|Radiographic Disease Progression|7|||
162936918|NCT01752920|588471812|FG002|Overall Study|Radiographic Disease Progression|12|||
162936919|NCT01752920|588471813|FG003|Overall Study|Radiographic Disease Progression|29|||
162936920|NCT01752920|588471810|FG000|Overall Study|Study Terminated by Sponsor|0|||
162936921|NCT01752920|588471811|FG001|Overall Study|Study Terminated by Sponsor|0|||
162936922|NCT01752920|588471812|FG002|Overall Study|Study Terminated by Sponsor|0|||
162936923|NCT01752920|588471813|FG003|Overall Study|Study Terminated by Sponsor|1|||
162936924|NCT01752920|588471810|FG000|Overall Study|Withdrawal by Subject|0|||
162936925|NCT01752920|588471811|FG001|Overall Study|Withdrawal by Subject|1|||
163179562|NCT00930982|589372120|FG001|Overall Study|Protocol Violation|5|||
163179563|NCT00930982|589372119|FG000|Overall Study|Withdrawal by Subject|1|||
163179564|NCT00930982|589372120|FG001|Overall Study|Withdrawal by Subject|1|||
163179565|NCT00518973|589372121|FG000|Overall Study|Withdrawal by Subject|3|||
163179566|NCT00518973|589372122|FG001|Overall Study|Withdrawal by Subject|2|||
163179567|NCT00582816|589372123|FG000|Overall Study|Engraftment Failure|3|||
163179568|NCT01001299|589372124|FG000|Overall Study|Insufficient Therapeutic Response|20|||
163179569|NCT01001299|589372124|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
163179570|NCT01001299|589372124|FG000|Overall Study|Death|1|||
163179571|NCT01001299|589372124|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
163179572|NCT01001299|589372124|FG000|Overall Study|Withdrew Consent|1|||
163179573|NCT01565499|589372125|FG000|Overall Study|Physician Decision|1|||
163179574|NCT01565499|589372125|FG000|Overall Study|Adverse Event|5|||
163179575|NCT01565499|589372125|FG000|Overall Study|Withdrawal by Subject|2|||
163179576|NCT01923168|589372126|FG000|Overall Study|Protocol Violation|1|||
163179577|NCT01923168|589372127|FG001|Overall Study|Protocol Violation|1|||
163179578|NCT01923168|589372128|FG002|Overall Study|Protocol Violation|0|||
163179579|NCT01923168|589372126|FG000|Overall Study|Subject/guardian decision|14|||
163179580|NCT01923168|589372127|FG001|Overall Study|Subject/guardian decision|14|||
163179581|NCT01923168|589372128|FG002|Overall Study|Subject/guardian decision|4|||
163179582|NCT01923168|589372126|FG000|Overall Study|Adverse Event|12|||
163179583|NCT01923168|589372127|FG001|Overall Study|Adverse Event|12|||
163179584|NCT01923168|589372128|FG002|Overall Study|Adverse Event|0|||
163179585|NCT01923168|589372126|FG000|Overall Study|Physician Decision|6|||
163179586|NCT01923168|589372127|FG001|Overall Study|Physician Decision|9|||
163179587|NCT01923168|589372128|FG002|Overall Study|Physician Decision|5|||
163179588|NCT01923168|589372126|FG000|Overall Study|Progressive disease|4|||
163179589|NCT01923168|589372127|FG001|Overall Study|Progressive disease|3|||
163179590|NCT01923168|589372128|FG002|Overall Study|Progressive disease|7|||
163179591|NCT01923168|589372126|FG000|Overall Study|Death|0|||
163179592|NCT01923168|589372127|FG001|Overall Study|Death|0|||
163179593|NCT01923168|589372128|FG002|Overall Study|Death|1|||
163179594|NCT04193410|589372129|FG000|Overall Study|Lost to Follow-up|7|||
163179595|NCT04193410|589372130|FG001|Overall Study|Lost to Follow-up|6|||
163179596|NCT02241889|589372135|FG000|Overall Study|device issues|0|||
163284326|NCT02236559|589751386|FG001|Overall Study|Physician Decision|1|||
163284327|NCT02236559|589751385|FG000|Overall Study|Withdrawal by Subject|1|||
163284328|NCT02236559|589751386|FG001|Overall Study|Withdrawal by Subject|0|||
162936926|NCT01752920|588471812|FG002|Overall Study|Withdrawal by Subject|0|||
162936927|NCT01752920|588471813|FG003|Overall Study|Withdrawal by Subject|1|||
162936928|NCT01752920|588471810|FG000|Overall Study|Lack of clinical benefit|1|||
162936929|NCT01752920|588471811|FG001|Overall Study|Lack of clinical benefit|1|||
162936930|NCT01752920|588471812|FG002|Overall Study|Lack of clinical benefit|1|||
162936931|NCT01752920|588471813|FG003|Overall Study|Lack of clinical benefit|1|||
162936932|NCT00947856|588471814|FG000|Treatment Period|Progressive Disease|33|||
162936933|NCT00947856|588471815|FG001|Treatment Period|Progressive Disease|12|||
162936934|NCT00947856|588471814|FG000|Treatment Period|Adverse Event|15|||
162936935|NCT00947856|588471815|FG001|Treatment Period|Adverse Event|9|||
162936936|NCT00947856|588471814|FG000|Treatment Period|Physician Decision|14|||
163179597|NCT02241889|589372136|FG001|Overall Study|device issues|0|||
163179598|NCT02241889|589372137|FG002|Overall Study|device issues|1|||
163179599|NCT02241889|589372138|FG003|Overall Study|device issues|0|||
163179600|NCT02241889|589372139|FG004|Overall Study|device issues|0|||
162936937|NCT00947856|588471815|FG001|Treatment Period|Physician Decision|6|||
162936938|NCT00947856|588471814|FG000|Treatment Period|Study Stopped by Sponsor|4|||
162936939|NCT00947856|588471815|FG001|Treatment Period|Study Stopped by Sponsor|4|||
162936940|NCT00947856|588471814|FG000|Treatment Period|Withdrawal by Subject|12|||
162936941|NCT00947856|588471815|FG001|Treatment Period|Withdrawal by Subject|1|||
162936942|NCT00947856|588471814|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
162936943|NCT00947856|588471815|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
162936944|NCT00947856|588471814|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
162936945|NCT00947856|588471815|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
162936946|NCT00947856|588471814|FG000|Follow-up Period|Lost to Follow-up|7|||
162936947|NCT00947856|588471815|FG001|Follow-up Period|Lost to Follow-up|0|||
162936948|NCT00947856|588471814|FG000|Follow-up Period|Patient unavailable for site visits|1|||
162936949|NCT00947856|588471815|FG001|Follow-up Period|Patient unavailable for site visits|0|||
162936950|NCT00947856|588471814|FG000|Follow-up Period|Withdrawal by Subject|1|||
162936951|NCT00947856|588471815|FG001|Follow-up Period|Withdrawal by Subject|0|||
162936952|NCT00771901|588471818|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
162936953|NCT00771901|588471819|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
162936954|NCT00771901|588471820|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
162936955|NCT01328054|588471823|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
162936956|NCT01328054|588471824|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
162936957|NCT01328054|588471823|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
162936958|NCT01328054|588471824|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
162936959|NCT01328054|588471823|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
162936960|NCT01328054|588471824|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
162936961|NCT01855126|588471825|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
162936962|NCT01855126|588471826|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
163179601|NCT02241889|589372140|FG005|Overall Study|device issues|0|||
163179602|NCT02241889|589372135|FG000|Overall Study|Withdrawal by Subject|0|||
163179603|NCT02241889|589372136|FG001|Overall Study|Withdrawal by Subject|0|||
163179604|NCT02241889|589372137|FG002|Overall Study|Withdrawal by Subject|0|||
163179605|NCT02241889|589372138|FG003|Overall Study|Withdrawal by Subject|0|||
163179606|NCT02241889|589372139|FG004|Overall Study|Withdrawal by Subject|0|||
163179607|NCT02241889|589372140|FG005|Overall Study|Withdrawal by Subject|1|||
163179608|NCT00773838|589372141|FG000|Overall Study|Adverse Event|29|||
163179609|NCT00773838|589372141|FG000|Overall Study|Lost to Follow-up|1|||
163179610|NCT00773838|589372141|FG000|Overall Study|Physician Decision|8|||
163179611|NCT00773838|589372141|FG000|Overall Study|Progressive Disease|82|||
163179612|NCT00773838|589372141|FG000|Overall Study|Protocol Violation|2|||
163179613|NCT00773838|589372141|FG000|Overall Study|Withdrawal by Subject|21|||
163179614|NCT00459056|589372144|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
163179615|NCT00459056|589372145|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
163179616|NCT02522871|589372146|FG000|Overall Study|Protocol Violation|1|||
163179617|NCT02522871|589372147|FG001|Overall Study|Protocol Violation|4|||
163179618|NCT02522871|589372146|FG000|Overall Study|Treated without randomization|1|||
163179619|NCT02522871|589372147|FG001|Overall Study|Treated without randomization|0|||
163179620|NCT02522871|589372146|FG000|Overall Study|Death|9|||
163179621|NCT02522871|589372147|FG001|Overall Study|Death|9|||
163179622|NCT02522871|589372146|FG000|Overall Study|Died in operating room prior to transplant|0|||
163179623|NCT02522871|589372147|FG001|Overall Study|Died in operating room prior to transplant|1|||
163179624|NCT02398227|589372148|FG000|Overall Study|Lost to Follow-up|21|||
163179625|NCT02398227|589372149|FG001|Overall Study|Lost to Follow-up|12|||
163179626|NCT02398227|589372148|FG000|Overall Study|Withdrawal by Subject|5|||
163179627|NCT02398227|589372149|FG001|Overall Study|Withdrawal by Subject|6|||
163179628|NCT02398227|589372148|FG000|Overall Study|Removed from treatment and dropped out|1|||
163179629|NCT02398227|589372149|FG001|Overall Study|Removed from treatment and dropped out|0|||
163179630|NCT01715129|589372150|FG000|Overall Study|Adverse Event, fatal|1|||
163179631|NCT01715129|589372150|FG000|Overall Study|Lack of Efficacy|3|||
163179632|NCT01715129|589372150|FG000|Overall Study|Protocol Violation|1|||
163179633|NCT01715129|589372150|FG000|Overall Study|Consent Withdrawn|2|||
163179634|NCT01715129|589372150|FG000|Overall Study|Lost to Follow-up|1|||
162936963|NCT01855126|588471825|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
162936964|NCT01855126|588471826|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
162936965|NCT01298596|588471829|FG000|Overall Study|Withdrawal by Subject|1|||
162936966|NCT01298596|588471830|FG001|Overall Study|Withdrawal by Subject|1|||
162936967|NCT01298596|588471829|FG000|Overall Study|Death|5|||
162936968|NCT01298596|588471830|FG001|Overall Study|Death|3|||
162936969|NCT01298596|588471829|FG000|Overall Study|Lost to Follow-up|6|||
162936970|NCT01298596|588471830|FG001|Overall Study|Lost to Follow-up|14|||
162936971|NCT01298596|588471829|FG000|Overall Study|Referred for further management|16|||
162936972|NCT01298596|588471830|FG001|Overall Study|Referred for further management|15|||
163179635|NCT01715129|589372150|FG000|Overall Study|Other|1|||
163179636|NCT02793622|589372151|FG000|Overall Study|Lost to Follow-up|31|||
163179637|NCT02793622|589372152|FG001|Overall Study|Lost to Follow-up|19|||
163179638|NCT02793622|589372151|FG000|Overall Study|Withdrawal by Subject|21|||
162936973|NCT01629693|588471831|FG000|Overall Study|Lost to Follow-up|2|||
162936974|NCT01629693|588471832|FG001|Overall Study|Lost to Follow-up|4|||
162936975|NCT01629693|588471831|FG000|Overall Study|Withdrawal by Subject|2|||
162936976|NCT01629693|588471832|FG001|Overall Study|Withdrawal by Subject|2|||
162936977|NCT01629693|588471831|FG000|Overall Study|Adverse Event|1|||
162936978|NCT01629693|588471832|FG001|Overall Study|Adverse Event|0|||
162936979|NCT01629693|588471831|FG000|Overall Study|Investigator decision|0|||
162936980|NCT01629693|588471832|FG001|Overall Study|Investigator decision|1|||
162936981|NCT01629693|588471831|FG000|Overall Study|Poor comfort of study lenses|0|||
162936982|NCT01629693|588471832|FG001|Overall Study|Poor comfort of study lenses|2|||
162936983|NCT01629693|588471831|FG000|Overall Study|Subject decision unrelated to AE|0|||
162936984|NCT01629693|588471832|FG001|Overall Study|Subject decision unrelated to AE|1|||
162936985|NCT03740100|588471833|FG000|Overall Study|Adverse Event|1|||
162936986|NCT03740100|588471833|FG000|Overall Study|Death|1|||
162936987|NCT00254397|588471839|FG000|Overall Study|Disease Progression|4|||
162936988|NCT00254397|588471840|FG001|Overall Study|Disease Progression|1|||
162936989|NCT00254397|588471841|FG002|Overall Study|Disease Progression|16|||
162936990|NCT00254397|588471842|FG003|Overall Study|Disease Progression|23|||
162936991|NCT00254397|588471839|FG000|Overall Study|Non-Compliant|0|||
162936992|NCT00254397|588471840|FG001|Overall Study|Non-Compliant|0|||
162936993|NCT00254397|588471841|FG002|Overall Study|Non-Compliant|0|||
162936994|NCT00254397|588471842|FG003|Overall Study|Non-Compliant|1|||
162936995|NCT00254397|588471839|FG000|Overall Study|Adverse Event|2|||
162936996|NCT00254397|588471840|FG001|Overall Study|Adverse Event|0|||
162936997|NCT00254397|588471841|FG002|Overall Study|Adverse Event|3|||
162936998|NCT00254397|588471842|FG003|Overall Study|Adverse Event|1|||
162936999|NCT01715415|588471846|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
162937000|NCT01715415|588471847|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
162937001|NCT01715415|588471846|FG000|Double-blind Treatment|Adverse Event|3|||
162937002|NCT01715415|588471847|FG001|Double-blind Treatment|Adverse Event|0|||
162937003|NCT01715415|588471846|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
162937004|NCT01715415|588471847|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
162937005|NCT01715415|588471846|FG000|Double-blind Treatment|Other|1|||
162937006|NCT01715415|588471847|FG001|Double-blind Treatment|Other|0|||
162937007|NCT01715415|588471846|FG000|Open-label Treatment|Adverse Event|0|||
162937008|NCT01715415|588471847|FG001|Open-label Treatment|Adverse Event|1|||
162937009|NCT01715415|588471846|FG000|Open-label Treatment|Subject Noncompliant|0|||
162937010|NCT01715415|588471847|FG001|Open-label Treatment|Subject Noncompliant|1|||
162937011|NCT04578548|588471848|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
162937012|NCT04578548|588471849|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
162937013|NCT04578548|588471848|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
162937014|NCT04578548|588471849|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
162937015|NCT04578548|588471848|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
162937016|NCT04578548|588471849|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
162937017|NCT04578548|588471848|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
162937018|NCT04578548|588471849|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
162937019|NCT04578548|588471848|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
162937020|NCT04578548|588471849|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
162937021|NCT04578548|588471848|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
162937022|NCT04578548|588471849|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
162937023|NCT02224456|588473473|FG000|Overall Study|Lack of Efficacy|1|||
162937024|NCT02224456|588473473|FG000|Overall Study|Lost to Follow-up|15|||
162937025|NCT02224456|588473473|FG000|Overall Study|Withdrawal by Subject|9|||
162937026|NCT02224456|588473473|FG000|Overall Study|Physician Decision|3|||
162937027|NCT02224456|588473473|FG000|Overall Study|Death|2|||
162937028|NCT02224456|588473473|FG000|Overall Study|Pregnancy|4|||
162937029|NCT02224456|588473473|FG000|Overall Study|Protocol Violation|1|||
162937030|NCT02224456|588473473|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
162937031|NCT01241461|588473474|FG000|Overall Study|Progressive Disease|3|||
162937032|NCT01241461|588473475|FG001|Overall Study|Progressive Disease|6|||
162937033|NCT01379781|588473476|FG000|Overall Study|Lost to Follow-up|11|||
162937034|NCT01379781|588473477|FG001|Overall Study|Lost to Follow-up|8|||
162937035|NCT02247479|588473478|FG000|Overall Study|Adverse Event|8|||
162937036|NCT02247479|588473479|FG001|Overall Study|Adverse Event|9|||
162937037|NCT02247479|588473480|FG002|Overall Study|Adverse Event|8|||
162937038|NCT02247479|588473478|FG000|Overall Study|Death|5|||
162937039|NCT02247479|588473479|FG001|Overall Study|Death|4|||
162937040|NCT02247479|588473480|FG002|Overall Study|Death|6|||
163179639|NCT02793622|589372152|FG001|Overall Study|Withdrawal by Subject|17|||
163179640|NCT02793622|589372151|FG000|Overall Study|Adverse Event|0|||
163179641|NCT02793622|589372152|FG001|Overall Study|Adverse Event|1|||
163179642|NCT02793622|589372151|FG000|Overall Study|Protocol Violation|1|||
162937041|NCT02247479|588473478|FG000|Overall Study|Lost to Follow-up|3|||
162937042|NCT02247479|588473479|FG001|Overall Study|Lost to Follow-up|3|||
162937043|NCT02247479|588473480|FG002|Overall Study|Lost to Follow-up|1|||
163179643|NCT02793622|589372152|FG001|Overall Study|Protocol Violation|5|||
163179644|NCT03149848|589372153|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
163179645|NCT03149848|589372153|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
163179646|NCT00378079|589372156|FG000|Overall Study|Lost to Follow-up|6|||
163179647|NCT00378079|589372157|FG001|Overall Study|Lost to Follow-up|1|||
163179648|NCT00378079|589372158|FG002|Overall Study|Lost to Follow-up|0|||
163284329|NCT02263508|589751387|FG000|Overall Study|Withdrawal by Subject|1|||
163284330|NCT02263508|589751388|FG001|Overall Study|Withdrawal by Subject|23|||
163284331|NCT02263508|589751389|FG002|Overall Study|Withdrawal by Subject|17|||
163284332|NCT02263508|589751387|FG000|Overall Study|Sponsor Decision|12|||
163284333|NCT02263508|589751388|FG001|Overall Study|Sponsor Decision|165|||
163284334|NCT02263508|589751389|FG002|Overall Study|Sponsor Decision|182|||
163284335|NCT02263508|589751387|FG000|Overall Study|Lost to Follow-up|2|||
163284336|NCT02263508|589751388|FG001|Overall Study|Lost to Follow-up|7|||
163284337|NCT02263508|589751389|FG002|Overall Study|Lost to Follow-up|7|||
163284338|NCT02263508|589751387|FG000|Overall Study|Death|6|||
163284339|NCT02263508|589751388|FG001|Overall Study|Death|151|||
163284340|NCT02263508|589751389|FG002|Overall Study|Death|140|||
163284341|NCT04148937|589751390|FG000|Overall Study|Withdrawal by Subject|0|||
163284342|NCT04148937|589751391|FG001|Overall Study|Withdrawal by Subject|0|||
163284343|NCT04148937|589751392|FG002|Overall Study|Withdrawal by Subject|0|||
163284344|NCT04148937|589751393|FG003|Overall Study|Withdrawal by Subject|1|||
163284345|NCT04148937|589751394|FG004|Overall Study|Withdrawal by Subject|0|||
163284346|NCT04148937|589751395|FG005|Overall Study|Withdrawal by Subject|1|||
163284347|NCT04148937|589751396|FG006|Overall Study|Withdrawal by Subject|1|||
163284348|NCT04148937|589751397|FG007|Overall Study|Withdrawal by Subject|0|||
163284349|NCT04148937|589751390|FG000|Overall Study|Lost to Follow-up|0|||
163284350|NCT04148937|589751391|FG001|Overall Study|Lost to Follow-up|0|||
163284351|NCT04148937|589751392|FG002|Overall Study|Lost to Follow-up|1|||
163284352|NCT04148937|589751393|FG003|Overall Study|Lost to Follow-up|0|||
163284353|NCT04148937|589751394|FG004|Overall Study|Lost to Follow-up|0|||
163284354|NCT04148937|589751395|FG005|Overall Study|Lost to Follow-up|2|||
163284355|NCT04148937|589751396|FG006|Overall Study|Lost to Follow-up|0|||
163284356|NCT04148937|589751397|FG007|Overall Study|Lost to Follow-up|0|||
163284357|NCT01149681|589751398|FG000|Overall Study|Withdrawal by Subject|7|||
163284358|NCT01149681|589751398|FG000|Overall Study|Progressive disease|1|||
163284359|NCT01149681|589751398|FG000|Overall Study|Physician Decision|2|||
162937044|NCT02247479|588473478|FG000|Overall Study|Non-compliance|0|||
162937045|NCT02247479|588473479|FG001|Overall Study|Non-compliance|0|||
162937046|NCT02247479|588473480|FG002|Overall Study|Non-compliance|1|||
162937047|NCT02247479|588473478|FG000|Overall Study|Withdrawal by Subject|25|||
162937048|NCT02247479|588473479|FG001|Overall Study|Withdrawal by Subject|29|||
162937049|NCT02247479|588473480|FG002|Overall Study|Withdrawal by Subject|24|||
162937050|NCT02247479|588473478|FG000|Overall Study|Study Terminated by Sponsor|98|||
162937051|NCT02247479|588473479|FG001|Overall Study|Study Terminated by Sponsor|88|||
162937052|NCT02247479|588473480|FG002|Overall Study|Study Terminated by Sponsor|94|||
162937053|NCT02247479|588473478|FG000|Overall Study|Physician Decision|1|||
162937054|NCT02247479|588473479|FG001|Overall Study|Physician Decision|0|||
162937055|NCT02247479|588473480|FG002|Overall Study|Physician Decision|2|||
162937056|NCT02247479|588473478|FG000|Overall Study|Unspecified Reason|2|||
162937057|NCT02247479|588473479|FG001|Overall Study|Unspecified Reason|5|||
162937058|NCT02247479|588473480|FG002|Overall Study|Unspecified Reason|2|||
162937059|NCT03740698|588473481|FG000|Overall Study|Physician Decision|0|||
162937060|NCT03740698|588473482|FG001|Overall Study|Physician Decision|1|||
162937061|NCT03740698|588473483|FG002|Overall Study|Physician Decision|1|||
162937062|NCT05216978|588473493|FG000|Overall Study|Withdrawal by Subject|3|||
162937063|NCT05216978|588473493|FG000|Overall Study|Lost to Follow-up|5|||
162937064|NCT03433001|588473512|FG000|Overall Study|Lack of Efficacy|109|||
162937065|NCT03433001|588473512|FG000|Overall Study|Adverse Event|69|||
162937066|NCT03433001|588473512|FG000|Overall Study|Withdrawal by Subject|10|||
162937067|NCT03433001|588473512|FG000|Overall Study|Death|12|||
162937068|NCT03433001|588473512|FG000|Overall Study|Lost to Follow-up|4|||
162937069|NCT03433001|588473512|FG000|Overall Study|Other|25|||
162937070|NCT01299038|588473513|FG000|Overall Study|Withdrawal by Subject|1|||
162937071|NCT01299038|588473514|FG001|Overall Study|Withdrawal by Subject|0|||
162937072|NCT01162499|588473515|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
162937073|NCT01162499|588473516|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
162937074|NCT00322556|588473517|FG000|Overall Study|Adverse Event|1|||
162937075|NCT00322556|588473517|FG000|Overall Study|Withdrawal by Subject|1|||
162937076|NCT00322556|588473517|FG000|Overall Study|Lost to Follow-up|3|||
162937077|NCT00322556|588473517|FG000|Overall Study|Other Reason|7|||
162937078|NCT01506323|588473518|FG000|Overall Study|Lost to Follow-up|5|||
162937079|NCT01506323|588473519|FG001|Overall Study|Lost to Follow-up|4|||
162937080|NCT01506323|588473518|FG000|Overall Study|Withdrawal by Subject|4|||
162937081|NCT01506323|588473519|FG001|Overall Study|Withdrawal by Subject|4|||
162937082|NCT01506323|588473518|FG000|Overall Study|Lack of Efficacy|1|||
162937083|NCT01506323|588473519|FG001|Overall Study|Lack of Efficacy|3|||
162937084|NCT01506323|588473518|FG000|Overall Study|Moved out of area|5|||
162937085|NCT01506323|588473519|FG001|Overall Study|Moved out of area|2|||
162937086|NCT01506323|588473518|FG000|Overall Study|Schedule or Transportation conflict|8|||
162937087|NCT01506323|588473519|FG001|Overall Study|Schedule or Transportation conflict|0|||
162937088|NCT01506323|588473518|FG000|Overall Study|Started another treatment|1|||
162937089|NCT01506323|588473519|FG001|Overall Study|Started another treatment|0|||
162937090|NCT04467697|588473520|FG000|Overall Study|Adverse Event|2|||
162937091|NCT04467697|588473520|FG000|Overall Study|Lost to Follow-up|6|||
162937092|NCT04467697|588473520|FG000|Overall Study|Withdrawal by Subject|9|||
162937093|NCT04467697|588473520|FG000|Overall Study|Protocol Violation|3|||
162937094|NCT03907280|588473521|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
162937095|NCT03907280|588473522|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
162937096|NCT03907280|588473523|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
162937097|NCT02637076|588473527|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
162937098|NCT02637076|588473528|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
162937099|NCT02637076|588473527|FG000|Overall Study|Withdrawal by Subject|0|||
162937100|NCT02637076|588473528|FG001|Overall Study|Withdrawal by Subject|4|||
162937101|NCT00130520|588473529|FG000|Overall Study|Adverse Event|11|||
162937102|NCT00130520|588473529|FG000|Overall Study|Death|1|||
162937103|NCT00130520|588473529|FG000|Overall Study|Physician Decision|1|||
163179649|NCT02274038|589372159|FG000|Overall Study|Death|1|||
163179650|NCT00586664|589372164|FG000|Overall Study|Withdrawal by Subject|3|||
163179651|NCT00586664|589372165|FG001|Overall Study|Withdrawal by Subject|7|||
163179652|NCT00586664|589372166|FG002|Overall Study|Withdrawal by Subject|1|||
163179653|NCT00586664|589372164|FG000|Overall Study|Exclusion criteria met|2|||
163179654|NCT00586664|589372165|FG001|Overall Study|Exclusion criteria met|0|||
163179655|NCT00586664|589372166|FG002|Overall Study|Exclusion criteria met|0|||
163179656|NCT01602666|589372170|FG000|Induction Chemotherapy|Death|2|||
162937104|NCT00130520|588473529|FG000|Overall Study|Withdrawal by Subject|1|||
162937105|NCT00130520|588473529|FG000|Overall Study|Disease Progression|23|||
162937106|NCT00130520|588473529|FG000|Overall Study|Protocol non-compliance|1|||
163179657|NCT01602666|589372171|FG001|Induction Chemotherapy|Death|1|||
163179658|NCT01602666|589372170|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
163179659|NCT01602666|589372171|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
163179660|NCT01602666|589372170|FG000|Induction Chemotherapy|Physician Decision|12|||
163179661|NCT01602666|589372171|FG001|Induction Chemotherapy|Physician Decision|5|||
163179662|NCT01602666|589372170|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
163179663|NCT01602666|589372171|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
163179664|NCT01602666|589372170|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
163179665|NCT01602666|589372171|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
163179666|NCT01602666|589372170|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
163179667|NCT01602666|589372171|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
163179668|NCT01602666|589372170|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
162937107|NCT00130520|588473529|FG000|Overall Study|Did not meet re-treatment criteria|1|||
162937108|NCT03487796|588473530|FG000|Overall Study|Lost to Follow-up|18|||
162937109|NCT03487796|588473531|FG001|Overall Study|Lost to Follow-up|6|||
162937110|NCT00613574|588473535|FG000|Overall Study|Adverse Event|3|||
162937111|NCT00613574|588473535|FG000|Overall Study|Lost to Follow-up|2|||
162937112|NCT00613574|588473535|FG000|Overall Study|Other|1|||
162937113|NCT04604184|588473539|FG000|Overall Study|Adverse Event|5|||
162937114|NCT04604184|588473540|FG001|Overall Study|Adverse Event|5|||
162937115|NCT04604184|588473539|FG000|Overall Study|Death|2|||
162937116|NCT04604184|588473540|FG001|Overall Study|Death|1|||
162937117|NCT04604184|588473539|FG000|Overall Study|Withdrawal by Subject|1|||
162937118|NCT04604184|588473540|FG001|Overall Study|Withdrawal by Subject|3|||
162937119|NCT04604184|588473539|FG000|Overall Study|Not treated|2|||
162937120|NCT04604184|588473540|FG001|Overall Study|Not treated|2|||
162937121|NCT04604184|588473539|FG000|Overall Study|Due to sponsor decision|9|||
162937122|NCT04604184|588473540|FG001|Overall Study|Due to sponsor decision|7|||
162937123|NCT04604184|588473539|FG000|Overall Study|Physician Decision|0|||
162937124|NCT04604184|588473540|FG001|Overall Study|Physician Decision|1|||
162937125|NCT04604184|588473539|FG000|Overall Study|Transfer to healthcare|1|||
162937126|NCT04604184|588473540|FG001|Overall Study|Transfer to healthcare|0|||
162937127|NCT01751412|588473541|FG000|Overall Study|Disease Progression Before Treatment|1|||
162937128|NCT00582036|588473542|FG000|Overall Study|Withdrawal by Subject|0|||
162937129|NCT00582036|588473543|FG001|Overall Study|Withdrawal by Subject|1|||
162937130|NCT03734237|588473544|FG000|Overall Study|Lost to Follow-up|1|||
162937131|NCT03734237|588473545|FG001|Overall Study|Lost to Follow-up|3|||
162937132|NCT03734237|588473546|FG002|Overall Study|Lost to Follow-up|0|||
162937133|NCT03734237|588473544|FG000|Overall Study|Withdrawal by Subject|7|||
162937134|NCT03734237|588473545|FG001|Overall Study|Withdrawal by Subject|9|||
162937135|NCT03734237|588473546|FG002|Overall Study|Withdrawal by Subject|10|||
162937136|NCT02711956|588473547|FG000|Overall Study|Adverse Event|0|||
162937137|NCT02711956|588473548|FG001|Overall Study|Adverse Event|0|||
162937138|NCT02711956|588473549|FG002|Overall Study|Adverse Event|0|||
162937139|NCT02711956|588473550|FG003|Overall Study|Adverse Event|1|||
162937140|NCT02711956|588473551|FG004|Overall Study|Adverse Event|2|||
162937141|NCT02711956|588473552|FG005|Overall Study|Adverse Event|0|||
162937142|NCT02711956|588473553|FG006|Overall Study|Adverse Event|0|||
162937143|NCT02711956|588473554|FG007|Overall Study|Adverse Event|1|||
162937144|NCT02711956|588473555|FG008|Overall Study|Adverse Event|1|||
162937145|NCT02711956|588473556|FG009|Overall Study|Adverse Event|1|||
162937146|NCT02711956|588473557|FG010|Overall Study|Adverse Event|1|||
162937147|NCT02711956|588473558|FG011|Overall Study|Adverse Event|0|||
162937148|NCT02711956|588473559|FG012|Overall Study|Adverse Event|0|||
163284360|NCT01149681|589751398|FG000|Overall Study|adverse events nonrelated study drug|2|||
163284361|NCT00686517|589751399|FG000|Treatment|Serious Adverse Event|1|||
163284362|NCT00686517|589751400|FG001|Treatment|Serious Adverse Event|2|||
163284363|NCT00686517|589751401|FG002|Treatment|Serious Adverse Event|1|||
163284364|NCT00686517|589751399|FG000|Treatment|Adverse Event|2|||
163284365|NCT00686517|589751400|FG001|Treatment|Adverse Event|0|||
163284366|NCT00686517|589751401|FG002|Treatment|Adverse Event|0|||
163284367|NCT00686517|589751399|FG000|Treatment|Poor Protocol Compliance|1|||
163284368|NCT00686517|589751400|FG001|Treatment|Poor Protocol Compliance|0|||
163284369|NCT00686517|589751401|FG002|Treatment|Poor Protocol Compliance|0|||
163284370|NCT00686517|589751399|FG000|Treatment|Protocol Violation|2|||
163284371|NCT00686517|589751400|FG001|Treatment|Protocol Violation|1|||
163284372|NCT00686517|589751401|FG002|Treatment|Protocol Violation|0|||
163284373|NCT01803646|589751402|FG000|Overall Study|Protocol Violation|1|||
163284374|NCT01803646|589751403|FG001|Overall Study|Protocol Violation|0|||
163284375|NCT01803646|589751402|FG000|Overall Study|Adverse Event|1|||
163284376|NCT01803646|589751403|FG001|Overall Study|Adverse Event|1|||
163284377|NCT01803646|589751402|FG000|Overall Study|Withdrawal by Subject|9|||
163284378|NCT01803646|589751403|FG001|Overall Study|Withdrawal by Subject|6|||
163284379|NCT01803646|589751402|FG000|Overall Study|Randomization error|1|||
163284380|NCT01803646|589751403|FG001|Overall Study|Randomization error|2|||
163284381|NCT01803646|589751402|FG000|Overall Study|Lost to Follow-up|5|||
163284382|NCT01803646|589751403|FG001|Overall Study|Lost to Follow-up|1|||
163284383|NCT01167426|589751404|FG000|Overall Study|Lost to Follow-up|6|||
162937149|NCT02711956|588473560|FG013|Overall Study|Adverse Event|0|||
162937150|NCT02711956|588473561|FG014|Overall Study|Adverse Event|2|||
162937151|NCT02711956|588473547|FG000|Overall Study|Physician Decision|0|||
162937152|NCT02711956|588473548|FG001|Overall Study|Physician Decision|0|||
163284384|NCT01167426|589751404|FG000|Overall Study|Protocol Violation|1|||
163284385|NCT01167426|589751404|FG000|Overall Study|Withdrawal by Subject|2|||
163284386|NCT01167426|589751404|FG000|Overall Study|Sponsor Decision|1|||
162937153|NCT02711956|588473549|FG002|Overall Study|Physician Decision|0|||
162937154|NCT02711956|588473550|FG003|Overall Study|Physician Decision|2|||
162937155|NCT02711956|588473551|FG004|Overall Study|Physician Decision|0|||
162937156|NCT02711956|588473552|FG005|Overall Study|Physician Decision|0|||
162937157|NCT02711956|588473553|FG006|Overall Study|Physician Decision|0|||
162937158|NCT02711956|588473554|FG007|Overall Study|Physician Decision|0|||
162937159|NCT02711956|588473555|FG008|Overall Study|Physician Decision|0|||
163284387|NCT02993471|589751405|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
163042839|NCT01990768|588863968|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
162937160|NCT02711956|588473556|FG009|Overall Study|Physician Decision|0|||
162937161|NCT02711956|588473557|FG010|Overall Study|Physician Decision|0|||
162937162|NCT02711956|588473558|FG011|Overall Study|Physician Decision|0|||
162937163|NCT02711956|588473559|FG012|Overall Study|Physician Decision|0|||
162937164|NCT02711956|588473560|FG013|Overall Study|Physician Decision|0|||
162937165|NCT02711956|588473561|FG014|Overall Study|Physician Decision|0|||
162937166|NCT02711956|588473547|FG000|Overall Study|Withdrawal by Subject|0|||
162937167|NCT02711956|588473548|FG001|Overall Study|Withdrawal by Subject|0|||
162937168|NCT02711956|588473549|FG002|Overall Study|Withdrawal by Subject|0|||
162937169|NCT02711956|588473550|FG003|Overall Study|Withdrawal by Subject|0|||
162937170|NCT02711956|588473551|FG004|Overall Study|Withdrawal by Subject|0|||
162937171|NCT02711956|588473552|FG005|Overall Study|Withdrawal by Subject|0|||
162937172|NCT02711956|588473553|FG006|Overall Study|Withdrawal by Subject|1|||
162937173|NCT02711956|588473554|FG007|Overall Study|Withdrawal by Subject|0|||
162937174|NCT02711956|588473555|FG008|Overall Study|Withdrawal by Subject|0|||
162937175|NCT02711956|588473556|FG009|Overall Study|Withdrawal by Subject|0|||
162937176|NCT02711956|588473557|FG010|Overall Study|Withdrawal by Subject|0|||
162937177|NCT02711956|588473558|FG011|Overall Study|Withdrawal by Subject|1|||
162937178|NCT02711956|588473559|FG012|Overall Study|Withdrawal by Subject|6|||
162937179|NCT02711956|588473560|FG013|Overall Study|Withdrawal by Subject|0|||
162937180|NCT02711956|588473561|FG014|Overall Study|Withdrawal by Subject|1|||
162937181|NCT02711956|588473547|FG000|Overall Study|Clinical progression|1|||
162937182|NCT02711956|588473548|FG001|Overall Study|Clinical progression|0|||
162937183|NCT02711956|588473549|FG002|Overall Study|Clinical progression|0|||
162937184|NCT02711956|588473550|FG003|Overall Study|Clinical progression|0|||
162937185|NCT02711956|588473551|FG004|Overall Study|Clinical progression|0|||
162937186|NCT02711956|588473552|FG005|Overall Study|Clinical progression|0|||
162937187|NCT02711956|588473553|FG006|Overall Study|Clinical progression|1|||
162937188|NCT02711956|588473554|FG007|Overall Study|Clinical progression|0|||
162937189|NCT02711956|588473555|FG008|Overall Study|Clinical progression|1|||
162937190|NCT02711956|588473556|FG009|Overall Study|Clinical progression|0|||
162937191|NCT02711956|588473557|FG010|Overall Study|Clinical progression|0|||
162937192|NCT02711956|588473558|FG011|Overall Study|Clinical progression|2|||
162937193|NCT02711956|588473559|FG012|Overall Study|Clinical progression|4|||
162937194|NCT02711956|588473560|FG013|Overall Study|Clinical progression|1|||
163179669|NCT01602666|589372171|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
163179670|NCT01602666|589372170|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
162937195|NCT02711956|588473561|FG014|Overall Study|Clinical progression|1|||
163179671|NCT01602666|589372171|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
163179672|NCT01602666|589372170|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
163179673|NCT01602666|589372171|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
163179674|NCT01602666|589372170|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
163179675|NCT01602666|589372171|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
163179676|NCT01602666|589372170|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
163179677|NCT01602666|589372171|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
163179678|NCT05458648|589372172|FG000|Overall Study|Physician Decision|1|||
163179679|NCT05458648|589372172|FG000|Overall Study|Patient presented in atrial flutter|1|||
163179680|NCT03610555|589372176|FG000|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
163179681|NCT03610555|589372177|FG001|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
163179682|NCT03610555|589372178|FG002|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
163179683|NCT03610555|589372179|FG003|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
163179684|NCT01892722|589372180|FG000|Overall Study|Protocol deviation|0|||
163179685|NCT01892722|589372181|FG001|Overall Study|Protocol deviation|1|||
163179686|NCT01892722|589372180|FG000|Overall Study|Administrative problems|0|||
163179687|NCT01892722|589372181|FG001|Overall Study|Administrative problems|1|||
162937196|NCT02711956|588473547|FG000|Overall Study|Radiographic progression|1|||
162937197|NCT02711956|588473548|FG001|Overall Study|Radiographic progression|1|||
162937198|NCT02711956|588473549|FG002|Overall Study|Radiographic progression|2|||
162937199|NCT02711956|588473550|FG003|Overall Study|Radiographic progression|0|||
162937200|NCT02711956|588473551|FG004|Overall Study|Radiographic progression|1|||
163179688|NCT01892722|589372180|FG000|Overall Study|Patient/guardian decision|0|||
163179689|NCT01892722|589372181|FG001|Overall Study|Patient/guardian decision|2|||
163179690|NCT01892722|589372180|FG000|Overall Study|Physician Decision|1|||
163179691|NCT01892722|589372181|FG001|Overall Study|Physician Decision|2|||
163179692|NCT01892722|589372180|FG000|Overall Study|Adverse Event|3|||
163179693|NCT01892722|589372181|FG001|Overall Study|Adverse Event|2|||
163179694|NCT01892722|589372180|FG000|Overall Study|Lack of Efficacy|0|||
163179695|NCT01892722|589372181|FG001|Overall Study|Lack of Efficacy|7|||
163179696|NCT01892722|589372180|FG000|Overall Study|Withdrawal by Subject|3|||
163179697|NCT01892722|589372181|FG001|Overall Study|Withdrawal by Subject|5|||
163179698|NCT02275910|589372182|FG000|Overall Study|Subject Choice|0|||
163179699|NCT02275910|589372183|FG001|Overall Study|Subject Choice|0|||
163179700|NCT02275910|589372184|FG002|Overall Study|Subject Choice|0|||
163179701|NCT02275910|589372185|FG003|Overall Study|Subject Choice|0|||
163179702|NCT02275910|589372186|FG004|Overall Study|Subject Choice|0|||
163179703|NCT02275910|589372187|FG005|Overall Study|Subject Choice|0|||
163179704|NCT02275910|589372188|FG006|Overall Study|Subject Choice|0|||
163179705|NCT02275910|589372189|FG007|Overall Study|Subject Choice|0|||
163179706|NCT02275910|589372190|FG008|Overall Study|Subject Choice|1|||
163179707|NCT02275910|589372191|FG009|Overall Study|Subject Choice|0|||
163179708|NCT02275910|589372192|FG010|Overall Study|Subject Choice|0|||
163179709|NCT02275910|589372193|FG011|Overall Study|Subject Choice|0|||
163179710|NCT02275910|589372182|FG000|Overall Study|Radiological Disease Progression|0|||
163179711|NCT02275910|589372183|FG001|Overall Study|Radiological Disease Progression|0|||
163179712|NCT02275910|589372184|FG002|Overall Study|Radiological Disease Progression|0|||
163179713|NCT02275910|589372185|FG003|Overall Study|Radiological Disease Progression|0|||
163179714|NCT02275910|589372186|FG004|Overall Study|Radiological Disease Progression|0|||
163179715|NCT02275910|589372187|FG005|Overall Study|Radiological Disease Progression|0|||
163179716|NCT02275910|589372188|FG006|Overall Study|Radiological Disease Progression|1|||
163179717|NCT02275910|589372189|FG007|Overall Study|Radiological Disease Progression|1|||
163179718|NCT02275910|589372190|FG008|Overall Study|Radiological Disease Progression|0|||
163179719|NCT02275910|589372191|FG009|Overall Study|Radiological Disease Progression|1|||
163179720|NCT02275910|589372192|FG010|Overall Study|Radiological Disease Progression|0|||
163179721|NCT02275910|589372193|FG011|Overall Study|Radiological Disease Progression|0|||
163179722|NCT05217927|589372194|FG000|DBT Phase|Adverse Event|7|||
163179723|NCT05217927|589372195|FG001|DBT Phase|Adverse Event|2|||
163179724|NCT05217927|589372196|FG002|DBT Phase|Adverse Event|5|||
163179725|NCT05217927|589372194|FG000|DBT Phase|Lack of Efficacy|1|||
163179726|NCT05217927|589372195|FG001|DBT Phase|Lack of Efficacy|0|||
163179727|NCT05217927|589372196|FG002|DBT Phase|Lack of Efficacy|0|||
163179728|NCT05217927|589372194|FG000|DBT Phase|Lost to Follow-up|0|||
163179729|NCT05217927|589372195|FG001|DBT Phase|Lost to Follow-up|2|||
163179730|NCT05217927|589372196|FG002|DBT Phase|Lost to Follow-up|0|||
163179731|NCT05217927|589372194|FG000|DBT Phase|Non-compliance|1|||
163179732|NCT05217927|589372195|FG001|DBT Phase|Non-compliance|0|||
163179733|NCT05217927|589372196|FG002|DBT Phase|Non-compliance|0|||
163179734|NCT05217927|589372194|FG000|DBT Phase|Pregnancy|0|||
163179735|NCT05217927|589372195|FG001|DBT Phase|Pregnancy|0|||
163179736|NCT05217927|589372196|FG002|DBT Phase|Pregnancy|1|||
163179737|NCT05217927|589372194|FG000|DBT Phase|Protocol Violation|0|||
163179738|NCT05217927|589372195|FG001|DBT Phase|Protocol Violation|2|||
163179739|NCT05217927|589372196|FG002|DBT Phase|Protocol Violation|1|||
163179740|NCT05217927|589372194|FG000|DBT Phase|Protocol-specified withdrawal criterion met|4|||
163179741|NCT05217927|589372195|FG001|DBT Phase|Protocol-specified withdrawal criterion met|6|||
163179742|NCT05217927|589372196|FG002|DBT Phase|Protocol-specified withdrawal criterion met|5|||
163179743|NCT05217927|589372194|FG000|DBT Phase|Withdrawal of consent|8|||
163179744|NCT05217927|589372195|FG001|DBT Phase|Withdrawal of consent|5|||
163179745|NCT05217927|589372196|FG002|DBT Phase|Withdrawal of consent|7|||
163179746|NCT05217927|589372194|FG000|DBT Phase|Other|7|||
163179747|NCT05217927|589372195|FG001|DBT Phase|Other|3|||
163179748|NCT05217927|589372196|FG002|DBT Phase|Other|4|||
163179749|NCT05217927|589372194|FG000|DBT Phase|Randomized, not treated|2|||
163179750|NCT05217927|589372195|FG001|DBT Phase|Randomized, not treated|3|||
163179751|NCT05217927|589372196|FG002|DBT Phase|Randomized, not treated|2|||
163179752|NCT05217927|589372194|FG000|OLE Phase|Adverse Event|4|||
163179753|NCT05217927|589372195|FG001|OLE Phase|Adverse Event|1|||
163179754|NCT05217927|589372196|FG002|OLE Phase|Adverse Event|1|||
163179755|NCT05217927|589372194|FG000|OLE Phase|Extension phase eligibility failure|1|||
163179756|NCT05217927|589372195|FG001|OLE Phase|Extension phase eligibility failure|0|||
163179757|NCT05217927|589372196|FG002|OLE Phase|Extension phase eligibility failure|0|||
163179758|NCT05217927|589372194|FG000|OLE Phase|Lost to Follow-up|1|||
163179759|NCT05217927|589372195|FG001|OLE Phase|Lost to Follow-up|2|||
163179760|NCT05217927|589372196|FG002|OLE Phase|Lost to Follow-up|1|||
163179761|NCT05217927|589372194|FG000|OLE Phase|Non-compliance|0|||
163179762|NCT05217927|589372195|FG001|OLE Phase|Non-compliance|0|||
163179763|NCT05217927|589372196|FG002|OLE Phase|Non-compliance|1|||
163179764|NCT05217927|589372194|FG000|OLE Phase|Other|3|||
163179765|NCT05217927|589372195|FG001|OLE Phase|Other|5|||
163179766|NCT05217927|589372196|FG002|OLE Phase|Other|4|||
163179767|NCT05217927|589372194|FG000|OLE Phase|Withdrawal of consent|3|||
163284388|NCT02993471|589751405|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
163284389|NCT04044664|589751414|FG000|Stage 1|Adverse Event|3|||
163284390|NCT04044664|589751415|FG001|Stage 1|Adverse Event|3|||
163284391|NCT04044664|589751416|FG002|Stage 1|Adverse Event|1|||
163284392|NCT04044664|589751414|FG000|Stage 1|Lost to Follow-up|3|||
163284393|NCT04044664|589751415|FG001|Stage 1|Lost to Follow-up|2|||
163284394|NCT04044664|589751416|FG002|Stage 1|Lost to Follow-up|2|||
163284395|NCT04044664|589751414|FG000|Stage 1|Withdrawal by Subject|9|||
163284396|NCT04044664|589751415|FG001|Stage 1|Withdrawal by Subject|1|||
163284397|NCT04044664|589751416|FG002|Stage 1|Withdrawal by Subject|0|||
163284398|NCT04044664|589751414|FG000|Stage 1|noncompliance, personal reason|2|||
163284399|NCT04044664|589751415|FG001|Stage 1|noncompliance, personal reason|0|||
163284400|NCT04044664|589751416|FG002|Stage 1|noncompliance, personal reason|0|||
163284401|NCT04044664|589751414|FG000|Stage 1|randomization error|0|||
163284402|NCT04044664|589751415|FG001|Stage 1|randomization error|1|||
163284403|NCT04044664|589751416|FG002|Stage 1|randomization error|0|||
163284404|NCT04044664|589751414|FG000|Stage 2|Adverse Event|2|||
163284405|NCT04044664|589751415|FG001|Stage 2|Adverse Event|0|||
163284406|NCT04044664|589751416|FG002|Stage 2|Adverse Event|0|||
163284407|NCT04044664|589751414|FG000|Stage 2|Lost to Follow-up|3|||
163284408|NCT04044664|589751415|FG001|Stage 2|Lost to Follow-up|2|||
163284409|NCT04044664|589751416|FG002|Stage 2|Lost to Follow-up|1|||
163284410|NCT04044664|589751414|FG000|Stage 2|Withdrawal by Subject|3|||
163284411|NCT04044664|589751415|FG001|Stage 2|Withdrawal by Subject|0|||
163284412|NCT04044664|589751416|FG002|Stage 2|Withdrawal by Subject|0|||
163284413|NCT04044664|589751414|FG000|Stage 2|protocol deviation|1|||
163284414|NCT04044664|589751415|FG001|Stage 2|protocol deviation|0|||
163284415|NCT04044664|589751416|FG002|Stage 2|protocol deviation|0|||
163284416|NCT00001575|589751420|FG000|Overall Study|Screening failures-Ph I portion|22|||
163179768|NCT05217927|589372195|FG001|OLE Phase|Withdrawal of consent|1|||
163179769|NCT05217927|589372196|FG002|OLE Phase|Withdrawal of consent|5|||
163179770|NCT00076024|589373497|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
163179771|NCT00076024|589373498|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
163179772|NCT00076024|589373499|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
163179773|NCT00076024|589373500|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
163179774|NCT00076024|589373497|FG000|Phase 1, Lead-in|Adverse Event|1|||
163179775|NCT00076024|589373498|FG001|Phase 1, Lead-in|Adverse Event|0|||
163179776|NCT00076024|589373499|FG002|Phase 1, Lead-in|Adverse Event|0|||
163179777|NCT00076024|589373500|FG003|Phase 1, Lead-in|Adverse Event|0|||
163179778|NCT00076024|589373497|FG000|Phase 1, Lead-in|Clinical progression|1|||
163179779|NCT00076024|589373498|FG001|Phase 1, Lead-in|Clinical progression|0|||
163179780|NCT00076024|589373499|FG002|Phase 1, Lead-in|Clinical progression|0|||
163179781|NCT00076024|589373500|FG003|Phase 1, Lead-in|Clinical progression|0|||
163179782|NCT00076024|589373497|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
163179783|NCT00076024|589373498|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
163179784|NCT00076024|589373499|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
163179785|NCT00076024|589373500|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
163179786|NCT00076024|589373497|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
163179787|NCT00076024|589373498|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
163179788|NCT00076024|589373499|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
163179789|NCT00076024|589373500|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
163179790|NCT00076024|589373497|FG000|Phase 2, Double-blind|Adverse Event|0|||
163179791|NCT00076024|589373498|FG001|Phase 2, Double-blind|Adverse Event|25|||
163179792|NCT00076024|589373499|FG002|Phase 2, Double-blind|Adverse Event|6|||
163179793|NCT00076024|589373500|FG003|Phase 2, Double-blind|Adverse Event|0|||
163179794|NCT00076024|589373497|FG000|Phase 2, Double-blind|Un-specified|0|||
163179795|NCT00076024|589373498|FG001|Phase 2, Double-blind|Un-specified|14|||
163179796|NCT00076024|589373499|FG002|Phase 2, Double-blind|Un-specified|6|||
163179797|NCT00076024|589373500|FG003|Phase 2, Double-blind|Un-specified|0|||
163179798|NCT00076024|589373497|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
163179799|NCT00076024|589373498|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
163179800|NCT00076024|589373499|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
163284417|NCT00001575|589751420|FG000|Overall Study|Withdrawn/deaths|23|||
163284418|NCT00831792|589751423|FG000|Overall Study|Not Eligible|3|||
163284419|NCT00831792|589751423|FG000|Overall Study|Adverse Event|1|||
163284420|NCT00831792|589751423|FG000|Overall Study|Death|1|||
163284421|NCT00831792|589751423|FG000|Overall Study|Lack of Efficacy|1|||
163179801|NCT00076024|589373500|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
163179802|NCT00076024|589373497|FG000|Phase 2, Open-label|Adverse Event|0|||
163179803|NCT00076024|589373498|FG001|Phase 2, Open-label|Adverse Event|0|||
163179804|NCT00076024|589373499|FG002|Phase 2, Open-label|Adverse Event|0|||
163284422|NCT03736785|589751424|FG000|Overall Study|Adverse Event|1|||
163284423|NCT03736785|589751425|FG001|Overall Study|Adverse Event|1|||
163284424|NCT03736785|589751426|FG002|Overall Study|Adverse Event|1|||
163284425|NCT03736785|589751424|FG000|Overall Study|Death|1|||
163284426|NCT03736785|589751425|FG001|Overall Study|Death|0|||
163284427|NCT03736785|589751426|FG002|Overall Study|Death|1|||
163284428|NCT03736785|589751424|FG000|Overall Study|Lost to Follow-up|0|||
163284429|NCT03736785|589751425|FG001|Overall Study|Lost to Follow-up|2|||
163179805|NCT00076024|589373500|FG003|Phase 2, Open-label|Adverse Event|2|||
163284430|NCT03736785|589751426|FG002|Overall Study|Lost to Follow-up|3|||
163284431|NCT03736785|589751424|FG000|Overall Study|Non compliance with study drug|1|||
163284432|NCT03736785|589751425|FG001|Overall Study|Non compliance with study drug|1|||
163284433|NCT03736785|589751426|FG002|Overall Study|Non compliance with study drug|0|||
163284434|NCT03736785|589751424|FG000|Overall Study|Physician Decision|0|||
163284435|NCT03736785|589751425|FG001|Overall Study|Physician Decision|1|||
163284436|NCT03736785|589751426|FG002|Overall Study|Physician Decision|1|||
163284437|NCT03736785|589751424|FG000|Overall Study|Protocol Violation|1|||
163284438|NCT03736785|589751425|FG001|Overall Study|Protocol Violation|4|||
163284439|NCT03736785|589751426|FG002|Overall Study|Protocol Violation|3|||
163284440|NCT03736785|589751424|FG000|Overall Study|Sponsor Decision|1|||
163284441|NCT03736785|589751425|FG001|Overall Study|Sponsor Decision|0|||
163284442|NCT03736785|589751426|FG002|Overall Study|Sponsor Decision|0|||
163284443|NCT03736785|589751424|FG000|Overall Study|Unknown/Missing data|3|||
163284444|NCT03736785|589751425|FG001|Overall Study|Unknown/Missing data|2|||
163284445|NCT03736785|589751426|FG002|Overall Study|Unknown/Missing data|1|||
163284446|NCT03736785|589751424|FG000|Overall Study|Withdrawal by Subject|9|||
163284447|NCT03736785|589751425|FG001|Overall Study|Withdrawal by Subject|6|||
163284448|NCT03736785|589751426|FG002|Overall Study|Withdrawal by Subject|4|||
163284449|NCT02974010|589751427|FG000|Overall Study|Lost to Follow-up|3|||
163284450|NCT02974010|589751428|FG001|Overall Study|Lost to Follow-up|1|||
163284451|NCT02974010|589751429|FG002|Overall Study|Lost to Follow-up|0|||
163284452|NCT02974010|589751430|FG003|Overall Study|Lost to Follow-up|0|||
163284453|NCT02974010|589751427|FG000|Overall Study|Withdrawal by Subject|2|||
163284454|NCT02974010|589751428|FG001|Overall Study|Withdrawal by Subject|1|||
163284455|NCT02974010|589751429|FG002|Overall Study|Withdrawal by Subject|0|||
163284456|NCT02974010|589751430|FG003|Overall Study|Withdrawal by Subject|0|||
163284457|NCT02974010|589751427|FG000|Overall Study|Adverse Event|0|||
163284458|NCT02974010|589751428|FG001|Overall Study|Adverse Event|1|||
163284459|NCT02974010|589751429|FG002|Overall Study|Adverse Event|0|||
163284460|NCT02974010|589751430|FG003|Overall Study|Adverse Event|0|||
163284461|NCT02974010|589751427|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
163179806|NCT00076024|589373497|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
163179807|NCT00076024|589373498|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
163179808|NCT00076024|589373499|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
163179809|NCT00076024|589373500|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
163179810|NCT00076024|589373497|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
163179811|NCT00076024|589373498|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
163179812|NCT00076024|589373499|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
163179813|NCT00076024|589373500|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
163179814|NCT00076024|589373497|FG000|Phase 2, Open-label|Other|0|||
163179815|NCT00076024|589373498|FG001|Phase 2, Open-label|Other|0|||
163179816|NCT00076024|589373499|FG002|Phase 2, Open-label|Other|0|||
163179817|NCT00076024|589373500|FG003|Phase 2, Open-label|Other|2|||
163179818|NCT01155219|589373507|FG000|Overall Study|Adverse Event|3|||
163179819|NCT01155219|589373508|FG001|Overall Study|Adverse Event|1|||
163179820|NCT01155219|589373507|FG000|Overall Study|non-medical reason|1|||
163179821|NCT01155219|589373508|FG001|Overall Study|non-medical reason|2|||
163179822|NCT03052764|589373509|FG000|Double-Blind Treatment Period|Adverse Event|2|||
163179823|NCT03052764|589373510|FG001|Double-Blind Treatment Period|Adverse Event|0|||
163179824|NCT03052764|589373509|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
163179825|NCT03052764|589373510|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
163179826|NCT03052764|589373509|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
163179827|NCT03052764|589373510|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
163179828|NCT03052764|589373509|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
163179829|NCT03052764|589373510|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
163179830|NCT03052764|589373509|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
163179831|NCT03052764|589373510|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
163179832|NCT01314911|589373511|FG000|Overall Study|Lost to Follow-up|3|||
163179833|NCT01314911|589373512|FG001|Overall Study|Lost to Follow-up|2|||
163179834|NCT01314911|589373511|FG000|Overall Study|Withdrawal by Subject|1|||
163179835|NCT01314911|589373512|FG001|Overall Study|Withdrawal by Subject|3|||
163179836|NCT01314911|589373511|FG000|Overall Study|Received Non-randomized Study Drug|0|||
163179837|NCT01314911|589373512|FG001|Overall Study|Received Non-randomized Study Drug|1|||
163179838|NCT01314911|589373511|FG000|Overall Study|Never Started Treatment|1|||
163179839|NCT01314911|589373512|FG001|Overall Study|Never Started Treatment|0|||
163284462|NCT02974010|589751428|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
163284463|NCT02974010|589751429|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
163284464|NCT02974010|589751430|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
163284465|NCT02974010|589751427|FG000|Overall Study|Lack of Efficacy|0|||
163284466|NCT02974010|589751428|FG001|Overall Study|Lack of Efficacy|0|||
163284467|NCT02974010|589751429|FG002|Overall Study|Lack of Efficacy|1|||
163284468|NCT02974010|589751430|FG003|Overall Study|Lack of Efficacy|0|||
163179840|NCT03150485|589373516|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
163284469|NCT03256344|589751433|FG000|Overall Study|Death|6|||
163284470|NCT03256344|589751434|FG001|Overall Study|Death|22|||
163284471|NCT03256344|589751433|FG000|Overall Study|Withdrawal by Subject|3|||
163284472|NCT03256344|589751434|FG001|Overall Study|Withdrawal by Subject|3|||
163284473|NCT03256344|589751433|FG000|Overall Study|Sponsor Decision|1|||
163284474|NCT03256344|589751434|FG001|Overall Study|Sponsor Decision|0|||
163284475|NCT00880906|589751435|FG000|Overall Study|Lost to Follow-up|0|||
163284476|NCT00880906|589751436|FG001|Overall Study|Lost to Follow-up|1|||
163284477|NCT00880906|589751435|FG000|Overall Study|Did not meet criteria following patholog|12|||
163284478|NCT00880906|589751436|FG001|Overall Study|Did not meet criteria following patholog|6|||
163284479|NCT04163458|589751437|FG000|Overall Study|Protocol Deviation|7|||
163284480|NCT04163458|589751438|FG001|Overall Study|Protocol Deviation|13|||
163284481|NCT04163458|589751437|FG000|Overall Study|Adverse Event|5|||
163284482|NCT04163458|589751438|FG001|Overall Study|Adverse Event|8|||
163284483|NCT04163458|589751437|FG000|Overall Study|Due to COVID-19 pandemic|4|||
163284484|NCT04163458|589751438|FG001|Overall Study|Due to COVID-19 pandemic|2|||
163284485|NCT04163458|589751437|FG000|Overall Study|Participant withdrew consent|2|||
163284486|NCT04163458|589751438|FG001|Overall Study|Participant withdrew consent|3|||
163284487|NCT04163458|589751437|FG000|Overall Study|Randomization failure|2|||
163284488|NCT04163458|589751438|FG001|Overall Study|Randomization failure|2|||
163284489|NCT04163458|589751437|FG000|Overall Study|Other|4|||
163284490|NCT04163458|589751438|FG001|Overall Study|Other|2|||
163284491|NCT03852433|589751439|FG000|Overall Study|Withdrawal of consent|5|||
163284492|NCT03852433|589751440|FG001|Overall Study|Withdrawal of consent|8|||
163284493|NCT03852433|589751441|FG002|Overall Study|Withdrawal of consent|1|||
163284494|NCT03852433|589751442|FG003|Overall Study|Withdrawal of consent|1|||
163284495|NCT03852433|589751439|FG000|Overall Study|Adverse Event|1|||
163284496|NCT03852433|589751440|FG001|Overall Study|Adverse Event|1|||
163284497|NCT03852433|589751441|FG002|Overall Study|Adverse Event|1|||
163284498|NCT03852433|589751442|FG003|Overall Study|Adverse Event|1|||
163284499|NCT03852433|589751439|FG000|Overall Study|Lost to Follow-up|0|||
163284500|NCT03852433|589751440|FG001|Overall Study|Lost to Follow-up|1|||
163284501|NCT03852433|589751441|FG002|Overall Study|Lost to Follow-up|0|||
163284502|NCT03852433|589751442|FG003|Overall Study|Lost to Follow-up|1|||
163284503|NCT03852433|589751439|FG000|Overall Study|Pregnancy|0|||
163284504|NCT03852433|589751440|FG001|Overall Study|Pregnancy|1|||
163284505|NCT03852433|589751441|FG002|Overall Study|Pregnancy|1|||
163284506|NCT03852433|589751442|FG003|Overall Study|Pregnancy|0|||
163284507|NCT03852433|589751439|FG000|Overall Study|Protocol Violation|0|||
163284508|NCT03852433|589751440|FG001|Overall Study|Protocol Violation|0|||
163284509|NCT03852433|589751441|FG002|Overall Study|Protocol Violation|1|||
163284510|NCT03852433|589751442|FG003|Overall Study|Protocol Violation|1|||
163284511|NCT03852433|589751439|FG000|Overall Study|Death|0|||
163284512|NCT03852433|589751440|FG001|Overall Study|Death|0|||
163284513|NCT03852433|589751441|FG002|Overall Study|Death|1|||
163284514|NCT03852433|589751442|FG003|Overall Study|Death|0|||
163284515|NCT03852433|589751439|FG000|Overall Study|Lack of Efficacy|0|||
163284516|NCT03852433|589751440|FG001|Overall Study|Lack of Efficacy|1|||
163284517|NCT03852433|589751441|FG002|Overall Study|Lack of Efficacy|0|||
163284518|NCT03852433|589751442|FG003|Overall Study|Lack of Efficacy|0|||
163284519|NCT03852433|589751439|FG000|Overall Study|Non-compliance with study drug|0|||
163284520|NCT03852433|589751440|FG001|Overall Study|Non-compliance with study drug|0|||
163284521|NCT03852433|589751441|FG002|Overall Study|Non-compliance with study drug|0|||
163284522|NCT03852433|589751442|FG003|Overall Study|Non-compliance with study drug|1|||
163284523|NCT03852433|589751439|FG000|Overall Study|Physician Decision|1|||
163284524|NCT03852433|589751440|FG001|Overall Study|Physician Decision|0|||
163284525|NCT03852433|589751441|FG002|Overall Study|Physician Decision|0|||
163284526|NCT03852433|589751442|FG003|Overall Study|Physician Decision|0|||
163284527|NCT03852433|589751439|FG000|Overall Study|Randomized but never treated|1|||
163284528|NCT03852433|589751440|FG001|Overall Study|Randomized but never treated|0|||
163284529|NCT03852433|589751441|FG002|Overall Study|Randomized but never treated|0|||
163284530|NCT03852433|589751442|FG003|Overall Study|Randomized but never treated|0|||
163284531|NCT03717194|589751453|FG000|Overall Study|Withdrawal by Subject|2|||
163284532|NCT03717194|589751454|FG001|Overall Study|Withdrawal by Subject|4|||
163284533|NCT03717194|589751453|FG000|Overall Study|Adverse Event|1|||
163284534|NCT03717194|589751454|FG001|Overall Study|Adverse Event|1|||
163284535|NCT03102242|589751455|FG000|Overall Study|Adverse Event|2|||
163284536|NCT00389519|589751456|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
163284537|NCT00389519|589751457|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
163284538|NCT00389519|589751458|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
163284539|NCT00389519|589751459|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
163284540|NCT00389519|589751456|FG000|Placebo Run-In|Withdrawal by Subject|19|||
163284541|NCT00389519|589751457|FG001|Placebo Run-In|Withdrawal by Subject|0|||
163284542|NCT00389519|589751458|FG002|Placebo Run-In|Withdrawal by Subject|0|||
163284543|NCT00389519|589751459|FG003|Placebo Run-In|Withdrawal by Subject|0|||
163284544|NCT00389519|589751456|FG000|Placebo Run-In|Reason not specified|40|||
163284545|NCT00389519|589751457|FG001|Placebo Run-In|Reason not specified|0|||
163284546|NCT00389519|589751458|FG002|Placebo Run-In|Reason not specified|0|||
162937201|NCT02711956|588473552|FG005|Overall Study|Radiographic progression|0|||
162937202|NCT02711956|588473553|FG006|Overall Study|Radiographic progression|0|||
162937203|NCT02711956|588473554|FG007|Overall Study|Radiographic progression|0|||
162937204|NCT02711956|588473555|FG008|Overall Study|Radiographic progression|2|||
162937205|NCT02711956|588473556|FG009|Overall Study|Radiographic progression|1|||
162937206|NCT02711956|588473557|FG010|Overall Study|Radiographic progression|0|||
162937207|NCT02711956|588473558|FG011|Overall Study|Radiographic progression|5|||
162937208|NCT02711956|588473559|FG012|Overall Study|Radiographic progression|3|||
162937209|NCT02711956|588473560|FG013|Overall Study|Radiographic progression|0|||
162937210|NCT02711956|588473561|FG014|Overall Study|Radiographic progression|1|||
162937211|NCT02711956|588473547|FG000|Overall Study|PSA progression with clinical progression|0|||
162937212|NCT02711956|588473548|FG001|Overall Study|PSA progression with clinical progression|0|||
162937213|NCT02711956|588473549|FG002|Overall Study|PSA progression with clinical progression|0|||
162937214|NCT02711956|588473550|FG003|Overall Study|PSA progression with clinical progression|0|||
162937215|NCT02711956|588473551|FG004|Overall Study|PSA progression with clinical progression|1|||
162937216|NCT02711956|588473552|FG005|Overall Study|PSA progression with clinical progression|0|||
162937217|NCT02711956|588473553|FG006|Overall Study|PSA progression with clinical progression|0|||
162937218|NCT02711956|588473554|FG007|Overall Study|PSA progression with clinical progression|0|||
162937219|NCT02711956|588473555|FG008|Overall Study|PSA progression with clinical progression|0|||
162937220|NCT02711956|588473556|FG009|Overall Study|PSA progression with clinical progression|0|||
162937221|NCT02711956|588473557|FG010|Overall Study|PSA progression with clinical progression|0|||
162937222|NCT02711956|588473558|FG011|Overall Study|PSA progression with clinical progression|0|||
162937223|NCT02711956|588473559|FG012|Overall Study|PSA progression with clinical progression|1|||
163179841|NCT03150485|589373517|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
163179842|NCT03150485|589373518|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
163179843|NCT03150485|589373519|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
163179844|NCT03150485|589373520|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
163179845|NCT03150485|589373521|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
163179846|NCT01695005|589373523|FG000|Overall Study|Lost to Follow-up|0|||
163179847|NCT01695005|589373524|FG001|Overall Study|Lost to Follow-up|1|||
163179848|NCT01695005|589373525|FG002|Overall Study|Lost to Follow-up|1|||
163179849|NCT01695005|589373526|FG003|Overall Study|Lost to Follow-up|0|||
163179850|NCT01695005|589373527|FG004|Overall Study|Lost to Follow-up|0|||
163179851|NCT01695005|589373528|FG005|Overall Study|Lost to Follow-up|1|||
163179852|NCT01695005|589373529|FG006|Overall Study|Lost to Follow-up|1|||
163179853|NCT01695005|589373530|FG007|Overall Study|Lost to Follow-up|1|||
163179854|NCT01695005|589373531|FG008|Overall Study|Lost to Follow-up|3|||
163179855|NCT01695005|589373532|FG009|Overall Study|Lost to Follow-up|3|||
163179856|NCT01695005|589373533|FG010|Overall Study|Lost to Follow-up|8|||
163179857|NCT01695005|589373534|FG011|Overall Study|Lost to Follow-up|5|||
163179858|NCT01695005|589373535|FG012|Overall Study|Lost to Follow-up|2|||
163179859|NCT01695005|589373536|FG013|Overall Study|Lost to Follow-up|5|||
163179860|NCT01695005|589373537|FG014|Overall Study|Lost to Follow-up|0|||
163179861|NCT01695005|589373538|FG015|Overall Study|Lost to Follow-up|4|||
163179862|NCT01695005|589373539|FG016|Overall Study|Lost to Follow-up|0|||
163179863|NCT01695005|589373540|FG017|Overall Study|Lost to Follow-up|0|||
163179864|NCT01695005|589373541|FG018|Overall Study|Lost to Follow-up|0|||
163179865|NCT01695005|589373542|FG019|Overall Study|Lost to Follow-up|1|||
163179866|NCT01695005|589373543|FG020|Overall Study|Lost to Follow-up|1|||
163179867|NCT01695005|589373544|FG021|Overall Study|Lost to Follow-up|0|||
163179868|NCT01695005|589373545|FG022|Overall Study|Lost to Follow-up|2|||
163179869|NCT01695005|589373546|FG023|Overall Study|Lost to Follow-up|4|||
163179870|NCT01695005|589373547|FG024|Overall Study|Lost to Follow-up|2|||
163179871|NCT01695005|589373548|FG025|Overall Study|Lost to Follow-up|0|||
163179872|NCT01695005|589373549|FG026|Overall Study|Lost to Follow-up|0|||
163179873|NCT01695005|589373550|FG027|Overall Study|Lost to Follow-up|0|||
163179874|NCT01695005|589373551|FG028|Overall Study|Lost to Follow-up|1|||
163179875|NCT01695005|589373523|FG000|Overall Study|Withdrawal by Subject|0|||
163179876|NCT01695005|589373524|FG001|Overall Study|Withdrawal by Subject|0|||
163179877|NCT01695005|589373525|FG002|Overall Study|Withdrawal by Subject|0|||
163179878|NCT01695005|589373526|FG003|Overall Study|Withdrawal by Subject|2|||
163179879|NCT01695005|589373527|FG004|Overall Study|Withdrawal by Subject|0|||
163179880|NCT01695005|589373528|FG005|Overall Study|Withdrawal by Subject|1|||
163179881|NCT01695005|589373529|FG006|Overall Study|Withdrawal by Subject|0|||
163179882|NCT01695005|589373530|FG007|Overall Study|Withdrawal by Subject|1|||
163179883|NCT01695005|589373531|FG008|Overall Study|Withdrawal by Subject|0|||
163179884|NCT01695005|589373532|FG009|Overall Study|Withdrawal by Subject|1|||
163179885|NCT01695005|589373533|FG010|Overall Study|Withdrawal by Subject|2|||
162937224|NCT02711956|588473560|FG013|Overall Study|PSA progression with clinical progression|1|||
163179886|NCT01695005|589373534|FG011|Overall Study|Withdrawal by Subject|1|||
163179887|NCT01695005|589373535|FG012|Overall Study|Withdrawal by Subject|1|||
163179888|NCT01695005|589373536|FG013|Overall Study|Withdrawal by Subject|0|||
163179889|NCT01695005|589373537|FG014|Overall Study|Withdrawal by Subject|0|||
163179890|NCT01695005|589373538|FG015|Overall Study|Withdrawal by Subject|0|||
163179891|NCT01695005|589373539|FG016|Overall Study|Withdrawal by Subject|0|||
162937225|NCT02711956|588473561|FG014|Overall Study|PSA progression with clinical progression|0|||
162937226|NCT02711956|588473547|FG000|Overall Study|PSA progression with radiographic progression|0|||
162937227|NCT02711956|588473548|FG001|Overall Study|PSA progression with radiographic progression|1|||
162937228|NCT02711956|588473549|FG002|Overall Study|PSA progression with radiographic progression|0|||
162937229|NCT02711956|588473550|FG003|Overall Study|PSA progression with radiographic progression|0|||
162937230|NCT02711956|588473551|FG004|Overall Study|PSA progression with radiographic progression|0|||
162937231|NCT02711956|588473552|FG005|Overall Study|PSA progression with radiographic progression|2|||
162937232|NCT02711956|588473553|FG006|Overall Study|PSA progression with radiographic progression|2|||
162937233|NCT02711956|588473554|FG007|Overall Study|PSA progression with radiographic progression|1|||
162937234|NCT02711956|588473555|FG008|Overall Study|PSA progression with radiographic progression|0|||
162937235|NCT02711956|588473556|FG009|Overall Study|PSA progression with radiographic progression|1|||
162937236|NCT02711956|588473557|FG010|Overall Study|PSA progression with radiographic progression|0|||
162937237|NCT02711956|588473558|FG011|Overall Study|PSA progression with radiographic progression|1|||
162937238|NCT02711956|588473559|FG012|Overall Study|PSA progression with radiographic progression|2|||
162937239|NCT02711956|588473560|FG013|Overall Study|PSA progression with radiographic progression|3|||
162937240|NCT02711956|588473561|FG014|Overall Study|PSA progression with radiographic progression|3|||
162937241|NCT01844583|588473562|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
162937242|NCT01844583|588473563|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
162937243|NCT01625377|588473564|FG000|Overall Study|Death|1|||
162937244|NCT01625377|588473565|FG001|Overall Study|Death|1|||
162937245|NCT01625377|588473564|FG000|Overall Study|Administrative Problem|1|||
162937246|NCT01625377|588473565|FG001|Overall Study|Administrative Problem|1|||
162937247|NCT01625377|588473564|FG000|Overall Study|Protocol Violation|0|||
162937248|NCT01625377|588473565|FG001|Overall Study|Protocol Violation|3|||
162937249|NCT01625377|588473564|FG000|Overall Study|Adverse Event|3|||
162937250|NCT01625377|588473565|FG001|Overall Study|Adverse Event|16|||
162937251|NCT01625377|588473564|FG000|Overall Study|Graft loss|1|||
162937252|NCT01625377|588473565|FG001|Overall Study|Graft loss|0|||
162937253|NCT01625377|588473564|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162937254|NCT01625377|588473565|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162937255|NCT01625377|588473564|FG000|Overall Study|Abnormal laboratory values|1|||
162937256|NCT01625377|588473565|FG001|Overall Study|Abnormal laboratory values|0|||
162937257|NCT03294538|588473570|FG000|Overall Study|Adverse Event|0|||
162937258|NCT03294538|588473571|FG001|Overall Study|Adverse Event|1|||
162937259|NCT03294538|588473572|FG002|Overall Study|Adverse Event|1|||
162937260|NCT03294538|588473570|FG000|Overall Study|Lost to Follow-up|1|||
162937261|NCT03294538|588473571|FG001|Overall Study|Lost to Follow-up|0|||
162937262|NCT03294538|588473572|FG002|Overall Study|Lost to Follow-up|0|||
162937263|NCT03294538|588473570|FG000|Overall Study|Outside of Visit Window|4|||
162937264|NCT03294538|588473571|FG001|Overall Study|Outside of Visit Window|4|||
162937265|NCT03294538|588473572|FG002|Overall Study|Outside of Visit Window|1|||
162937266|NCT01090765|588473574|FG000|Overall Study|Patient withdrew consent|0|||
162937267|NCT01090765|588473575|FG001|Overall Study|Patient withdrew consent|0|||
162937268|NCT01090765|588473576|FG002|Overall Study|Patient withdrew consent|0|||
162937269|NCT01090765|588473577|FG003|Overall Study|Patient withdrew consent|0|||
162937270|NCT01090765|588473578|FG004|Overall Study|Patient withdrew consent|1|||
162937271|NCT01090765|588473579|FG005|Overall Study|Patient withdrew consent|1|||
162937272|NCT01090765|588473574|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
162937273|NCT01090765|588473575|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
162937274|NCT01090765|588473576|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
162937275|NCT01090765|588473577|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
162937276|NCT01090765|588473578|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
162937277|NCT01090765|588473579|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
162937278|NCT01090765|588473574|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
162937279|NCT01090765|588473575|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
162937280|NCT01090765|588473576|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
162937281|NCT01090765|588473577|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
162937282|NCT01090765|588473578|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
163179892|NCT01695005|589373540|FG017|Overall Study|Withdrawal by Subject|0|||
163179893|NCT01695005|589373541|FG018|Overall Study|Withdrawal by Subject|2|||
163179894|NCT01695005|589373542|FG019|Overall Study|Withdrawal by Subject|0|||
163179895|NCT01695005|589373543|FG020|Overall Study|Withdrawal by Subject|1|||
163179896|NCT01695005|589373544|FG021|Overall Study|Withdrawal by Subject|0|||
163179897|NCT01695005|589373545|FG022|Overall Study|Withdrawal by Subject|0|||
163179898|NCT01695005|589373546|FG023|Overall Study|Withdrawal by Subject|0|||
163179899|NCT01695005|589373547|FG024|Overall Study|Withdrawal by Subject|1|||
163179900|NCT01695005|589373548|FG025|Overall Study|Withdrawal by Subject|0|||
163179901|NCT01695005|589373549|FG026|Overall Study|Withdrawal by Subject|0|||
163179902|NCT01695005|589373550|FG027|Overall Study|Withdrawal by Subject|1|||
163179903|NCT01695005|589373551|FG028|Overall Study|Withdrawal by Subject|0|||
163284547|NCT00389519|589751459|FG003|Placebo Run-In|Reason not specified|0|||
162937283|NCT01090765|588473579|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
162937284|NCT01787825|588473580|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
162937285|NCT01787825|588473581|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
163179904|NCT00472459|589373552|FG000|Overall Study|Adverse Event|13|||
163179905|NCT00472459|589373553|FG001|Overall Study|Adverse Event|13|||
163179906|NCT00472459|589373552|FG000|Overall Study|Withdrawal by Subject|5|||
163179907|NCT00472459|589373553|FG001|Overall Study|Withdrawal by Subject|5|||
163179908|NCT00472459|589373552|FG000|Overall Study|Protocol Violation|3|||
163179909|NCT00472459|589373553|FG001|Overall Study|Protocol Violation|3|||
163179910|NCT00472459|589373552|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
163179911|NCT00472459|589373553|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
163179912|NCT00472459|589373552|FG000|Overall Study|Lost to Follow-up|1|||
163179913|NCT00472459|589373553|FG001|Overall Study|Lost to Follow-up|1|||
163179914|NCT04478123|589373554|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
163179915|NCT04478123|589373554|FG000|Overall Study|NE|1|||
163179916|NCT00588952|589373555|FG000|Overall Study|Adverse Event|0|||
163179917|NCT00588952|589373556|FG001|Overall Study|Adverse Event|2|||
163179918|NCT00588952|589373555|FG000|Overall Study|Withdrawal by Subject|3|||
163179919|NCT00588952|589373556|FG001|Overall Study|Withdrawal by Subject|5|||
163179920|NCT01362595|589373558|FG000|Overall Study|Screen failure|10|||
163179921|NCT01362595|589373558|FG000|Overall Study|Withdrawal by Subject|2|||
163179922|NCT02448680|589373559|FG000|Overall Study|Physician Decision|1|||
163179923|NCT02448680|589373560|FG001|Overall Study|Physician Decision|1|||
163179924|NCT02448680|589373559|FG000|Overall Study|Withdrawal by Subject|0|||
163179925|NCT02448680|589373560|FG001|Overall Study|Withdrawal by Subject|2|||
163179926|NCT01739400|589373561|FG000|Overall Study|Physician Decision|3|||
163179927|NCT01739400|589373562|FG001|Overall Study|Physician Decision|0|||
163179928|NCT01739400|589373561|FG000|Overall Study|Lost to Follow-up|2|||
163179929|NCT01739400|589373562|FG001|Overall Study|Lost to Follow-up|0|||
163179930|NCT01739400|589373561|FG000|Overall Study|Death|5|||
163179931|NCT01739400|589373562|FG001|Overall Study|Death|2|||
163179932|NCT01739400|589373561|FG000|Overall Study|Withdrawal by Subject|7|||
163179933|NCT01739400|589373562|FG001|Overall Study|Withdrawal by Subject|7|||
163179934|NCT01736657|589373563|FG000|Overall Study|insufficient vascular access|1|||
163179935|NCT03350984|589373564|FG000|Overall Study|Death|1|||
163179936|NCT03350984|589373565|FG001|Overall Study|Death|0|||
163179937|NCT03350984|589373564|FG000|Overall Study|Lost to Follow-up|5|||
163179938|NCT03350984|589373565|FG001|Overall Study|Lost to Follow-up|6|||
163179939|NCT03350984|589373564|FG000|Overall Study|Protocol Violation|1|||
163179940|NCT03350984|589373565|FG001|Overall Study|Protocol Violation|2|||
163179941|NCT03350984|589373564|FG000|Overall Study|Physician Decision|1|||
163179942|NCT03350984|589373565|FG001|Overall Study|Physician Decision|0|||
163179943|NCT00642473|589373574|FG000|Overall Study|Withdrawal by Subject|0|||
163179944|NCT00642473|589373575|FG001|Overall Study|Withdrawal by Subject|5|||
163179945|NCT00642473|589373574|FG000|Overall Study|Progression or death|2|||
163179946|NCT00642473|589373575|FG001|Overall Study|Progression or death|4|||
163179947|NCT00642473|589373574|FG000|Overall Study|Other|2|||
163179948|NCT00642473|589373575|FG001|Overall Study|Other|2|||
163179949|NCT04533880|589373576|FG000|Overall Study|Lost to Follow-up|0|||
163179950|NCT04533880|589373577|FG001|Overall Study|Lost to Follow-up|1|||
163179951|NCT04533880|589373578|FG002|Overall Study|Lost to Follow-up|1|||
163179952|NCT02284178|589373580|FG000|Overall Study|Met exclusion criteria|49|||
163179953|NCT02284178|589373581|FG001|Overall Study|Met exclusion criteria|54|||
163179954|NCT01741012|589373582|FG000|Overall Study|Lost to Follow-up|1|||
163179955|NCT01741012|589373582|FG000|Overall Study|Withdrawal by Subject|2|||
163179956|NCT04123665|589373583|FG000|Overall Study|Withdrawal by Subject|7|||
163179957|NCT04123665|589373584|FG001|Overall Study|Withdrawal by Subject|0|||
163179958|NCT04123665|589373583|FG000|Overall Study|Lost to Follow-up|1|||
163179959|NCT04123665|589373584|FG001|Overall Study|Lost to Follow-up|0|||
163179960|NCT01711879|589373587|FG000|Overall Study|Death|1|||
163179961|NCT01711879|589373588|FG001|Overall Study|Death|0|||
163179962|NCT00958789|589373592|FG000|Overall Study|Death|5|||
163179963|NCT00958789|589373592|FG000|Overall Study|Lost to Follow-up|14|||
163179964|NCT00958789|589373592|FG000|Overall Study|Withdrawal by Subject|17|||
163179965|NCT00958789|589373592|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
163179966|NCT00958789|589373592|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
163179967|NCT00958789|589373592|FG000|Overall Study|Subject terminated|2|||
163179968|NCT00958789|589373592|FG000|Overall Study|Revision|7|||
163179969|NCT01466179|589373597|FG000|Overall Study|Ongoing in core study|2|||
163179970|NCT01466179|589373597|FG000|Overall Study|Physician Decision|46|||
163179971|NCT01466179|589373597|FG000|Overall Study|Progressive disease|43|||
163179972|NCT01466179|589373597|FG000|Overall Study|Adverse Event|32|||
163179973|NCT01466179|589373597|FG000|Overall Study|Disease relapse|23|||
163179974|NCT01466179|589373597|FG000|Overall Study|Lack of Efficacy|14|||
163179975|NCT01466179|589373597|FG000|Overall Study|Death|7|||
163179976|NCT01466179|589373597|FG000|Overall Study|Withdrawal by Subject|7|||
163179977|NCT01466179|589373597|FG000|Overall Study|Protocol Violation|2|||
163179978|NCT01466179|589373597|FG000|Overall Study|Other|3|||
163284548|NCT00389519|589751456|FG000|Randomized|Did not receive study drug|2|||
163284549|NCT00389519|589751457|FG001|Randomized|Did not receive study drug|0|||
163284550|NCT00389519|589751458|FG002|Randomized|Did not receive study drug|0|||
163284551|NCT00389519|589751459|FG003|Randomized|Did not receive study drug|0|||
163284552|NCT00389519|589751456|FG000|Treated|Adverse Event|1|||
163284553|NCT00389519|589751457|FG001|Treated|Adverse Event|0|||
163284554|NCT00389519|589751458|FG002|Treated|Adverse Event|0|||
163284555|NCT00389519|589751459|FG003|Treated|Adverse Event|2|||
163284556|NCT00389519|589751456|FG000|Treated|Reason not specified|1|||
163284557|NCT00389519|589751457|FG001|Treated|Reason not specified|1|||
163284558|NCT00389519|589751458|FG002|Treated|Reason not specified|0|||
163284559|NCT00389519|589751459|FG003|Treated|Reason not specified|2|||
163284560|NCT03425539|589751462|FG000|Overall Study|Randomized but not treated|0|||
163284561|NCT03425539|589751463|FG001|Overall Study|Randomized but not treated|1|||
163284562|NCT03425539|589751462|FG000|Overall Study|Adverse Event|2|||
163284563|NCT03425539|589751463|FG001|Overall Study|Adverse Event|2|||
163284564|NCT03425539|589751462|FG000|Overall Study|Withdrawal by Subject|3|||
163284565|NCT03425539|589751463|FG001|Overall Study|Withdrawal by Subject|0|||
163284566|NCT03425539|589751462|FG000|Overall Study|Lost to Follow-up|0|||
163284567|NCT03425539|589751463|FG001|Overall Study|Lost to Follow-up|1|||
163284568|NCT02040844|589751464|FG000|Overall Study|Adverse Event|0|||
163284569|NCT02040844|589751465|FG001|Overall Study|Adverse Event|0|||
163284570|NCT02040844|589751466|FG002|Overall Study|Adverse Event|1|||
163284571|NCT02040844|589751464|FG000|Overall Study|Withdrawal by Subject|16|||
163284572|NCT02040844|589751465|FG001|Overall Study|Withdrawal by Subject|22|||
163284573|NCT02040844|589751466|FG002|Overall Study|Withdrawal by Subject|25|||
163284574|NCT02040844|589751464|FG000|Overall Study|Lost to Follow-up|12|||
163284575|NCT02040844|589751465|FG001|Overall Study|Lost to Follow-up|9|||
163284576|NCT02040844|589751466|FG002|Overall Study|Lost to Follow-up|13|||
163284577|NCT02040844|589751464|FG000|Overall Study|Missing|13|||
163284578|NCT02040844|589751465|FG001|Overall Study|Missing|3|||
163284579|NCT02040844|589751466|FG002|Overall Study|Missing|2|||
163284580|NCT02040844|589751464|FG000|Overall Study|Non-specified|8|||
163284581|NCT02040844|589751465|FG001|Overall Study|Non-specified|2|||
163284582|NCT02040844|589751466|FG002|Overall Study|Non-specified|5|||
163284583|NCT02040844|589751464|FG000|Overall Study|Concomitant medication|1|||
163284584|NCT02040844|589751465|FG001|Overall Study|Concomitant medication|3|||
163284585|NCT02040844|589751466|FG002|Overall Study|Concomitant medication|1|||
163284586|NCT00946192|589751467|FG000|Overall Study|Lost to Follow-up|6|||
163284587|NCT00946192|589751468|FG001|Overall Study|Lost to Follow-up|11|||
163284588|NCT00946192|589751469|FG002|Overall Study|Lost to Follow-up|9|||
163284589|NCT00946192|589751467|FG000|Overall Study|Withdrawal by Subject|10|||
163284590|NCT00946192|589751468|FG001|Overall Study|Withdrawal by Subject|7|||
163284591|NCT00946192|589751469|FG002|Overall Study|Withdrawal by Subject|3|||
163284592|NCT00946192|589751467|FG000|Overall Study|Did not start medication|2|||
163284593|NCT00946192|589751468|FG001|Overall Study|Did not start medication|0|||
163284594|NCT00946192|589751469|FG002|Overall Study|Did not start medication|0|||
163284595|NCT01080131|589751470|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
163284596|NCT01080131|589751471|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
163284597|NCT01080131|589751470|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
163284598|NCT01080131|589751471|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
163284599|NCT01080131|589751470|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
163284600|NCT01080131|589751471|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
163284601|NCT01080131|589751470|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
163284602|NCT01080131|589751471|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
163284603|NCT01080131|589751470|FG000|Core Study (0- 12 Weeks)|Death|1|||
163284604|NCT01080131|589751471|FG001|Core Study (0- 12 Weeks)|Death|0|||
163284605|NCT01080131|589751470|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
163284606|NCT01080131|589751471|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
163284607|NCT01080131|589751470|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
163284608|NCT01080131|589751471|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
163284609|NCT01080131|589751470|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
163284610|NCT01080131|589751471|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
163284611|NCT01080131|589751470|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
163284612|NCT01080131|589751471|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
163284613|NCT01080131|589751470|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
163284614|NCT01080131|589751471|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
163284615|NCT01080131|589751470|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
163284616|NCT01080131|589751471|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
163284617|NCT01080131|589751470|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
163284618|NCT01080131|589751471|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
163284619|NCT01080131|589751470|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
163284620|NCT01080131|589751471|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
163284621|NCT02014558|589751472|FG000|Overall Study|Never Received Study Drug|0|||
162937286|NCT01787825|588473580|FG000|Overall Study|Data Not Analyzable|5|||
162937287|NCT01787825|588473581|FG001|Overall Study|Data Not Analyzable|1|||
162937288|NCT00718159|588473586|FG000|Overall Study|Progressive Disease|3|||
162937289|NCT00718159|588473587|FG001|Overall Study|Progressive Disease|3|||
162937290|NCT00718159|588473588|FG002|Overall Study|Progressive Disease|2|||
162937291|NCT00718159|588473589|FG003|Overall Study|Progressive Disease|0|||
162937292|NCT00718159|588473590|FG004|Overall Study|Progressive Disease|6|||
162937293|NCT00718159|588473591|FG005|Overall Study|Progressive Disease|0|||
162937294|NCT00718159|588473592|FG006|Overall Study|Progressive Disease|0|||
162937295|NCT00718159|588473586|FG000|Overall Study|Death due to Adverse Event|0|||
162937296|NCT00718159|588473587|FG001|Overall Study|Death due to Adverse Event|0|||
162937297|NCT00718159|588473588|FG002|Overall Study|Death due to Adverse Event|0|||
162937298|NCT00718159|588473589|FG003|Overall Study|Death due to Adverse Event|2|||
162937299|NCT00718159|588473590|FG004|Overall Study|Death due to Adverse Event|2|||
162937300|NCT00718159|588473591|FG005|Overall Study|Death due to Adverse Event|0|||
162937301|NCT00718159|588473592|FG006|Overall Study|Death due to Adverse Event|0|||
162937302|NCT00718159|588473586|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
162937303|NCT00718159|588473587|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
162937304|NCT00718159|588473588|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
162937305|NCT00718159|588473589|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
163179979|NCT03410823|589373598|FG000|Overall Study|Death|1|||
163179980|NCT03410823|589373598|FG000|Overall Study|Withdrawal by Subject|2|||
163179981|NCT03410823|589373598|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
163179982|NCT03707184|589373601|FG000|Overall Study|Withdrawal by Subject|2|||
163179983|NCT04704154|589373602|FG000|Overall Study|Adverse Event|3|||
163179984|NCT04704154|589373603|FG001|Overall Study|Adverse Event|2|||
163179985|NCT04704154|589373604|FG002|Overall Study|Adverse Event|4|||
163179986|NCT04704154|589373605|FG003|Overall Study|Adverse Event|2|||
163179987|NCT04704154|589373606|FG004|Overall Study|Adverse Event|3|||
163179988|NCT04704154|589373607|FG005|Overall Study|Adverse Event|0|||
163179989|NCT04704154|589373602|FG000|Overall Study|Death|3|||
163179990|NCT04704154|589373603|FG001|Overall Study|Death|0|||
163179991|NCT04704154|589373604|FG002|Overall Study|Death|0|||
163179992|NCT04704154|589373605|FG003|Overall Study|Death|0|||
163179993|NCT04704154|589373606|FG004|Overall Study|Death|3|||
163179994|NCT04704154|589373607|FG005|Overall Study|Death|0|||
163179995|NCT04704154|589373602|FG000|Overall Study|Physician Decision|1|||
163179996|NCT04704154|589373603|FG001|Overall Study|Physician Decision|0|||
163179997|NCT04704154|589373604|FG002|Overall Study|Physician Decision|1|||
163179998|NCT04704154|589373605|FG003|Overall Study|Physician Decision|0|||
163179999|NCT04704154|589373606|FG004|Overall Study|Physician Decision|2|||
163180000|NCT04704154|589373607|FG005|Overall Study|Physician Decision|0|||
163180001|NCT04704154|589373602|FG000|Overall Study|Participant Decision|1|||
163180002|NCT04704154|589373603|FG001|Overall Study|Participant Decision|1|||
163180003|NCT04704154|589373604|FG002|Overall Study|Participant Decision|0|||
163180004|NCT04704154|589373605|FG003|Overall Study|Participant Decision|0|||
163180005|NCT04704154|589373606|FG004|Overall Study|Participant Decision|0|||
163180006|NCT04704154|589373607|FG005|Overall Study|Participant Decision|0|||
163180007|NCT04704154|589373602|FG000|Overall Study|Progressive Disease|19|||
163180008|NCT04704154|589373603|FG001|Overall Study|Progressive Disease|17|||
163180009|NCT04704154|589373604|FG002|Overall Study|Progressive Disease|20|||
163180010|NCT04704154|589373605|FG003|Overall Study|Progressive Disease|18|||
163180011|NCT04704154|589373606|FG004|Overall Study|Progressive Disease|36|||
163180012|NCT04704154|589373607|FG005|Overall Study|Progressive Disease|30|||
163180013|NCT04704154|589373602|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
163180014|NCT04704154|589373603|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
163180015|NCT04704154|589373604|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
163180016|NCT04704154|589373605|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
163180017|NCT04704154|589373606|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
163180018|NCT04704154|589373607|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
163180019|NCT04704154|589373602|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
163180020|NCT04704154|589373603|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
163180021|NCT04704154|589373604|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
163180022|NCT04704154|589373605|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
163180023|NCT04704154|589373606|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
163180024|NCT04704154|589373607|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
163180025|NCT03220438|589373608|FG000|Overall Study|Lost to Follow-up|0|||
163180026|NCT03220438|589373609|FG001|Overall Study|Lost to Follow-up|0|||
163180027|NCT03220438|589373610|FG002|Overall Study|Lost to Follow-up|1|||
163180028|NCT03220438|589373611|FG003|Overall Study|Lost to Follow-up|0|||
162937306|NCT00718159|588473590|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
162937307|NCT00718159|588473591|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
163180029|NCT04062123|589373612|FG000|Overall Study|Withdrawal by Subject|0|||
163284622|NCT02014558|589751473|FG001|Overall Study|Never Received Study Drug|0|||
163284623|NCT02014558|589751474|FG002|Overall Study|Never Received Study Drug|0|||
163284624|NCT02014558|589751475|FG003|Overall Study|Never Received Study Drug|0|||
163284625|NCT02014558|589751476|FG004|Overall Study|Never Received Study Drug|1|||
163284626|NCT02014558|589751477|FG005|Overall Study|Never Received Study Drug|0|||
163284627|NCT02014558|589751478|FG006|Overall Study|Never Received Study Drug|1|||
163284628|NCT02014558|589751479|FG007|Overall Study|Never Received Study Drug|0|||
163284629|NCT02014558|589751480|FG008|Overall Study|Never Received Study Drug|2|||
162937308|NCT00718159|588473592|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
163284630|NCT02014558|589751481|FG009|Overall Study|Never Received Study Drug|0|||
163284631|NCT02014558|589751482|FG010|Overall Study|Never Received Study Drug|2|||
162937309|NCT00718159|588473586|FG000|Overall Study|Investigator Decision|0|||
162937310|NCT00718159|588473587|FG001|Overall Study|Investigator Decision|0|||
163284632|NCT02014558|589751483|FG011|Overall Study|Never Received Study Drug|2|||
163284633|NCT02014558|589751484|FG012|Overall Study|Never Received Study Drug|0|||
163284634|NCT02014558|589751472|FG000|Overall Study|Adverse Event|0|||
163284635|NCT02014558|589751473|FG001|Overall Study|Adverse Event|0|||
163284636|NCT02014558|589751474|FG002|Overall Study|Adverse Event|0|||
163284637|NCT02014558|589751475|FG003|Overall Study|Adverse Event|0|||
163284638|NCT02014558|589751476|FG004|Overall Study|Adverse Event|1|||
163284639|NCT02014558|589751477|FG005|Overall Study|Adverse Event|0|||
163284640|NCT02014558|589751478|FG006|Overall Study|Adverse Event|0|||
163284641|NCT02014558|589751479|FG007|Overall Study|Adverse Event|0|||
163284642|NCT02014558|589751480|FG008|Overall Study|Adverse Event|2|||
163284643|NCT02014558|589751481|FG009|Overall Study|Adverse Event|2|||
163284644|NCT02014558|589751482|FG010|Overall Study|Adverse Event|5|||
163284645|NCT02014558|589751483|FG011|Overall Study|Adverse Event|21|||
163284646|NCT02014558|589751484|FG012|Overall Study|Adverse Event|3|||
163284647|NCT02014558|589751472|FG000|Overall Study|Death|1|||
163284648|NCT02014558|589751473|FG001|Overall Study|Death|0|||
163284649|NCT02014558|589751474|FG002|Overall Study|Death|0|||
163284650|NCT02014558|589751475|FG003|Overall Study|Death|0|||
163284651|NCT02014558|589751476|FG004|Overall Study|Death|0|||
163284652|NCT02014558|589751477|FG005|Overall Study|Death|0|||
163284653|NCT02014558|589751478|FG006|Overall Study|Death|1|||
163284654|NCT02014558|589751479|FG007|Overall Study|Death|1|||
163284655|NCT02014558|589751480|FG008|Overall Study|Death|2|||
163284656|NCT02014558|589751481|FG009|Overall Study|Death|5|||
163284657|NCT02014558|589751482|FG010|Overall Study|Death|5|||
163284658|NCT02014558|589751483|FG011|Overall Study|Death|19|||
163284659|NCT02014558|589751484|FG012|Overall Study|Death|2|||
163284660|NCT02014558|589751472|FG000|Overall Study|Lack of Efficacy|1|||
163284661|NCT02014558|589751473|FG001|Overall Study|Lack of Efficacy|2|||
163284662|NCT02014558|589751474|FG002|Overall Study|Lack of Efficacy|1|||
163284663|NCT02014558|589751475|FG003|Overall Study|Lack of Efficacy|1|||
163284664|NCT02014558|589751476|FG004|Overall Study|Lack of Efficacy|0|||
163284665|NCT02014558|589751477|FG005|Overall Study|Lack of Efficacy|0|||
163284666|NCT02014558|589751478|FG006|Overall Study|Lack of Efficacy|1|||
163284667|NCT02014558|589751479|FG007|Overall Study|Lack of Efficacy|3|||
163284668|NCT02014558|589751480|FG008|Overall Study|Lack of Efficacy|3|||
163284669|NCT02014558|589751481|FG009|Overall Study|Lack of Efficacy|3|||
163284670|NCT02014558|589751482|FG010|Overall Study|Lack of Efficacy|16|||
163284671|NCT02014558|589751483|FG011|Overall Study|Lack of Efficacy|8|||
163284672|NCT02014558|589751484|FG012|Overall Study|Lack of Efficacy|5|||
163284673|NCT02014558|589751472|FG000|Overall Study|Lost to Follow-up|0|||
163284674|NCT02014558|589751473|FG001|Overall Study|Lost to Follow-up|0|||
163284675|NCT02014558|589751474|FG002|Overall Study|Lost to Follow-up|0|||
163284676|NCT02014558|589751475|FG003|Overall Study|Lost to Follow-up|0|||
163284677|NCT02014558|589751476|FG004|Overall Study|Lost to Follow-up|0|||
163284678|NCT02014558|589751477|FG005|Overall Study|Lost to Follow-up|0|||
163284679|NCT02014558|589751478|FG006|Overall Study|Lost to Follow-up|0|||
163284680|NCT02014558|589751479|FG007|Overall Study|Lost to Follow-up|0|||
163284681|NCT02014558|589751480|FG008|Overall Study|Lost to Follow-up|0|||
163284682|NCT02014558|589751481|FG009|Overall Study|Lost to Follow-up|0|||
163284683|NCT02014558|589751482|FG010|Overall Study|Lost to Follow-up|1|||
163284684|NCT02014558|589751483|FG011|Overall Study|Lost to Follow-up|0|||
163284685|NCT02014558|589751484|FG012|Overall Study|Lost to Follow-up|0|||
163284686|NCT02014558|589751472|FG000|Overall Study|Progressive Disease|1|||
163284687|NCT02014558|589751473|FG001|Overall Study|Progressive Disease|0|||
163284688|NCT02014558|589751474|FG002|Overall Study|Progressive Disease|1|||
163284689|NCT02014558|589751475|FG003|Overall Study|Progressive Disease|1|||
163284690|NCT02014558|589751476|FG004|Overall Study|Progressive Disease|1|||
163284691|NCT02014558|589751477|FG005|Overall Study|Progressive Disease|2|||
163284692|NCT02014558|589751478|FG006|Overall Study|Progressive Disease|1|||
163284693|NCT02014558|589751479|FG007|Overall Study|Progressive Disease|6|||
163284694|NCT02014558|589751480|FG008|Overall Study|Progressive Disease|5|||
163284695|NCT02014558|589751481|FG009|Overall Study|Progressive Disease|6|||
163284696|NCT02014558|589751482|FG010|Overall Study|Progressive Disease|22|||
163284697|NCT02014558|589751483|FG011|Overall Study|Progressive Disease|31|||
163284698|NCT02014558|589751484|FG012|Overall Study|Progressive Disease|6|||
163284699|NCT02014558|589751472|FG000|Overall Study|Withdrawal by Subject|0|||
163180030|NCT04062123|589373613|FG001|Overall Study|Withdrawal by Subject|1|||
163180031|NCT04062123|589373614|FG002|Overall Study|Withdrawal by Subject|0|||
163180032|NCT04190680|589373615|FG000|Overall Study|Not meeting criteria for data analysis|1|||
163180033|NCT04190680|589373616|FG001|Overall Study|Not meeting criteria for data analysis|15|||
163180034|NCT04190680|589373615|FG000|Overall Study|Administrative error|0|||
163180035|NCT04190680|589373616|FG001|Overall Study|Administrative error|18|||
163180036|NCT03780400|589373617|FG000|Overall Study|Lost to Follow-up|5|||
163180037|NCT03780400|589373617|FG000|Overall Study|Withdrawal by Subject|2|||
163180038|NCT01850602|589373618|FG000|Overall Study|Adverse Event|7|||
163180039|NCT01850602|589373619|FG001|Overall Study|Adverse Event|10|||
163180040|NCT01850602|589373618|FG000|Overall Study|Physician Decision|2|||
163180041|NCT01850602|589373619|FG001|Overall Study|Physician Decision|1|||
163180042|NCT01850602|589373618|FG000|Overall Study|Withdrawal by Subject|2|||
163180043|NCT01850602|589373619|FG001|Overall Study|Withdrawal by Subject|4|||
163180044|NCT01850602|589373618|FG000|Overall Study|Decrease in serum calcium|2|||
163180045|NCT01850602|589373619|FG001|Overall Study|Decrease in serum calcium|3|||
163180046|NCT01850602|589373618|FG000|Overall Study|Increase in serum ferritin|1|||
163180047|NCT01850602|589373619|FG001|Overall Study|Increase in serum ferritin|0|||
163180048|NCT00740051|589373622|FG000|Overall Study|Lack of Efficacy|2|||
163180049|NCT00740051|589373623|FG001|Overall Study|Lack of Efficacy|5|||
163180050|NCT00740051|589373622|FG000|Overall Study|Adverse Event|1|||
163180051|NCT00740051|589373623|FG001|Overall Study|Adverse Event|4|||
163180052|NCT00740051|589373622|FG000|Overall Study|Protocol Violation|2|||
163180053|NCT00740051|589373623|FG001|Overall Study|Protocol Violation|6|||
163180054|NCT00740051|589373622|FG000|Overall Study|Lost to Follow-up|3|||
163180055|NCT00740051|589373623|FG001|Overall Study|Lost to Follow-up|8|||
163180056|NCT00740051|589373622|FG000|Overall Study|Withdrawal by Subject|6|||
163180057|NCT00740051|589373623|FG001|Overall Study|Withdrawal by Subject|8|||
163180058|NCT00740051|589373622|FG000|Overall Study|Other reason (not specified)|4|||
163284700|NCT02014558|589751473|FG001|Overall Study|Withdrawal by Subject|0|||
163284701|NCT02014558|589751474|FG002|Overall Study|Withdrawal by Subject|0|||
163284702|NCT02014558|589751475|FG003|Overall Study|Withdrawal by Subject|0|||
163284703|NCT02014558|589751476|FG004|Overall Study|Withdrawal by Subject|1|||
163284704|NCT02014558|589751477|FG005|Overall Study|Withdrawal by Subject|0|||
163284705|NCT02014558|589751478|FG006|Overall Study|Withdrawal by Subject|0|||
163284706|NCT02014558|589751479|FG007|Overall Study|Withdrawal by Subject|0|||
163284707|NCT02014558|589751480|FG008|Overall Study|Withdrawal by Subject|0|||
163284708|NCT02014558|589751481|FG009|Overall Study|Withdrawal by Subject|2|||
163284709|NCT02014558|589751482|FG010|Overall Study|Withdrawal by Subject|6|||
163284710|NCT02014558|589751483|FG011|Overall Study|Withdrawal by Subject|10|||
163284711|NCT02014558|589751484|FG012|Overall Study|Withdrawal by Subject|0|||
163284712|NCT02014558|589751472|FG000|Overall Study|Miscellaneous|2|||
163284713|NCT02014558|589751473|FG001|Overall Study|Miscellaneous|1|||
163284714|NCT02014558|589751474|FG002|Overall Study|Miscellaneous|1|||
163284715|NCT02014558|589751475|FG003|Overall Study|Miscellaneous|1|||
163284716|NCT02014558|589751476|FG004|Overall Study|Miscellaneous|0|||
163284717|NCT02014558|589751477|FG005|Overall Study|Miscellaneous|1|||
163284718|NCT02014558|589751478|FG006|Overall Study|Miscellaneous|0|||
163284719|NCT02014558|589751479|FG007|Overall Study|Miscellaneous|1|||
163284720|NCT02014558|589751480|FG008|Overall Study|Miscellaneous|1|||
163284721|NCT02014558|589751481|FG009|Overall Study|Miscellaneous|3|||
163284722|NCT02014558|589751482|FG010|Overall Study|Miscellaneous|12|||
163284723|NCT02014558|589751483|FG011|Overall Study|Miscellaneous|11|||
163284724|NCT02014558|589751484|FG012|Overall Study|Miscellaneous|1|||
163284725|NCT05273801|589751485|FG000|Overall Study|Physician Decision|1|||
163284726|NCT04159506|589751488|FG000|Overall Study|Lost to Follow-up|2|||
163284727|NCT04159506|589751489|FG001|Overall Study|Lost to Follow-up|5|||
163284728|NCT01875250|589753075|FG000|Overall Study|Adverse Event|2|||
163284729|NCT01875250|589753076|FG001|Overall Study|Adverse Event|0|||
163284730|NCT04057196|589753077|FG000|Overall Study|Withdrawal by Subject|3|||
163284731|NCT04057196|589753077|FG000|Overall Study|Death|3|||
163284732|NCT03895034|589753079|FG000|Overall Study|Lost to Follow-up|2|||
163284733|NCT01118377|589753080|FG000|Overall Study|Did Not Receive Study Medication|1|||
163284734|NCT01118377|589753080|FG000|Overall Study|Death|38|||
163284735|NCT01118377|589753080|FG000|Overall Study|Failure to Return|3|||
163284736|NCT00739102|589753081|FG000|Overall Study|Death|5|||
163284737|NCT00739102|589753081|FG000|Overall Study|Withdrawal by Subject|10|||
163180059|NCT00740051|589373623|FG001|Overall Study|Other reason (not specified)|1|||
163180060|NCT03452527|589373624|FG000|Overall Study|Withdrawal by Subject|1|||
163284738|NCT01331824|589753083|FG000|Overall Study|Adverse Event|2|||
163284739|NCT01331824|589753083|FG000|Overall Study|Death|1|||
163284740|NCT01331824|589753083|FG000|Overall Study|Disease Progression|9|||
163284741|NCT01331824|589753083|FG000|Overall Study|Withdrawal by Subject|1|||
163284742|NCT00149630|589753090|FG000|Overall Study|Incarceration|2|||
163284743|NCT00149630|589753091|FG001|Overall Study|Incarceration|0|||
163284744|NCT00149630|589753090|FG000|Overall Study|Treatment Programs|4|||
163180061|NCT03452527|589373625|FG001|Overall Study|Withdrawal by Subject|1|||
163180062|NCT03452527|589373624|FG000|Overall Study|Study Terminated|2|||
163180063|NCT03452527|589373625|FG001|Overall Study|Study Terminated|3|||
163180064|NCT00476047|589373626|FG000|Overall Study|Lost to Follow-up|1|||
163180065|NCT04738318|589373628|FG000|Overall Study|Protocol Violation|1|||
163180066|NCT04738318|589373629|FG001|Overall Study|Protocol Violation|0|||
163180067|NCT01585584|589373630|FG000|Overall Study|Lack of Efficacy|1|||
163180068|NCT01585584|589373630|FG000|Overall Study|Withdrawal by Subject|1|||
163180069|NCT01585584|589373630|FG000|Overall Study|Physician Decision|2|||
163180070|NCT04369053|589374706|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
163180071|NCT04369053|589374706|FG000|Overall Study|Withdrawal by Subject|773|||
163180072|NCT04369053|589374706|FG000|Overall Study|Lost to Follow-up|182|||
163180073|NCT04369053|589374706|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
163180074|NCT01394718|589374707|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
163180075|NCT01394718|589374708|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
163180076|NCT02395016|589374709|FG000|Overall Study|Adverse Event|4|||
163180077|NCT02395016|589374710|FG001|Overall Study|Adverse Event|3|||
163180078|NCT02395016|589374709|FG000|Overall Study|Withdrawal by Subject|9|||
163180079|NCT02395016|589374710|FG001|Overall Study|Withdrawal by Subject|6|||
163180080|NCT02395016|589374709|FG000|Overall Study|Protocol Violation|2|||
163180081|NCT02395016|589374710|FG001|Overall Study|Protocol Violation|3|||
163180082|NCT01547780|589374711|FG000|Baseline PET Scan|Physician Decision|1|||
163180083|NCT01547780|589374712|FG001|Baseline PET Scan|Physician Decision|0|||
163180084|NCT01547780|589374713|FG002|Baseline PET Scan|Physician Decision|1|||
163180085|NCT01547780|589374714|FG003|Baseline PET Scan|Physician Decision|0|||
163180086|NCT01547780|589374711|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
163180087|NCT01547780|589374712|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
163180088|NCT01547780|589374713|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
163180089|NCT01547780|589374714|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
163180090|NCT00814879|589374716|FG000|By Week 24|Cancer Diagnosis|1|||
163180091|NCT00814879|589374717|FG001|By Week 24|Cancer Diagnosis|0|||
163180092|NCT00814879|589374716|FG000|By Week 24|Incarceration|0|||
163180093|NCT00814879|589374717|FG001|By Week 24|Incarceration|1|||
163180094|NCT00814879|589374716|FG000|By Week 48|Lost to Follow-up|2|||
163180095|NCT00814879|589374717|FG001|By Week 48|Lost to Follow-up|2|||
163180096|NCT00814879|589374716|FG000|By Week 48|Death|0|||
163180097|NCT00814879|589374717|FG001|By Week 48|Death|1|||
163180098|NCT01461057|589374718|FG000|Overall Study|Death|10|||
163180099|NCT01461057|589374719|FG001|Overall Study|Death|9|||
163180100|NCT01461057|589374718|FG000|Overall Study|Withdrawal by Subject|2|||
163180101|NCT01461057|589374719|FG001|Overall Study|Withdrawal by Subject|3|||
163180102|NCT01461057|589374718|FG000|Overall Study|Physician Decision|0|||
163180103|NCT01461057|589374719|FG001|Overall Study|Physician Decision|2|||
163180104|NCT01461057|589374718|FG000|Overall Study|Adverse Event|0|||
163180105|NCT01461057|589374719|FG001|Overall Study|Adverse Event|1|||
163180106|NCT01461057|589374718|FG000|Overall Study|Progression of Disease|1|||
163180107|NCT01461057|589374719|FG001|Overall Study|Progression of Disease|0|||
163180108|NCT01461057|589374718|FG000|Overall Study|Study Terminated by Sponsor|2|||
163180109|NCT01461057|589374719|FG001|Overall Study|Study Terminated by Sponsor|0|||
163180110|NCT01288976|589374720|FG000|Overall Study|Withdrawal by Subject|58|||
163180111|NCT01288976|589374721|FG001|Overall Study|Withdrawal by Subject|12|||
163180112|NCT01288976|589374722|FG002|Overall Study|Withdrawal by Subject|9|||
163180113|NCT01288976|589374720|FG000|Overall Study|Death|98|||
163180114|NCT01288976|589374721|FG001|Overall Study|Death|6|||
163180115|NCT01288976|589374722|FG002|Overall Study|Death|4|||
163180116|NCT01288976|589374720|FG000|Overall Study|Data unavailable|22|||
163180117|NCT01288976|589374721|FG001|Overall Study|Data unavailable|9|||
163180118|NCT01288976|589374722|FG002|Overall Study|Data unavailable|7|||
163180119|NCT03560739|589374723|FG000|Overall Study|Adverse Event|0|||
163180120|NCT03560739|589374724|FG001|Overall Study|Adverse Event|1|||
163180121|NCT03560739|589374725|FG002|Overall Study|Adverse Event|0|||
163180122|NCT03560739|589374726|FG003|Overall Study|Adverse Event|0|||
163180123|NCT00959374|589374727|FG000|Overall Study|Withdrawal by Subject|2|||
163180124|NCT00959374|589374727|FG000|Overall Study|Lost to Follow-up|14|||
163180125|NCT00959374|589374727|FG000|Overall Study|Death|1|||
163180126|NCT00959374|589374727|FG000|Overall Study|Protocol Violation|1|||
163180127|NCT00959374|589374727|FG000|Overall Study|Implant Removed/Not Replaced|4|||
163180128|NCT00959374|589374727|FG000|Overall Study|Physician Decision|1|||
163180129|NCT03183778|589374728|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
163180130|NCT03228420|589374733|FG000|Overall Study|Lost to Follow-up|5|||
163180131|NCT03228420|589374734|FG001|Overall Study|Lost to Follow-up|3|||
163180132|NCT03228420|589374733|FG000|Overall Study|Withdrawal by Subject|10|||
163180133|NCT03228420|589374734|FG001|Overall Study|Withdrawal by Subject|0|||
163180134|NCT03228420|589374733|FG000|Overall Study|Adverse Event|5|||
163180135|NCT03228420|589374734|FG001|Overall Study|Adverse Event|2|||
163180136|NCT01083173|589374735|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
163180137|NCT01083173|589374736|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
163180138|NCT01083173|589374735|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
163180139|NCT01083173|589374736|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
163180140|NCT01083173|589374735|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
163180141|NCT01083173|589374736|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
163180142|NCT01083173|589374735|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
163180143|NCT01083173|589374736|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
163180144|NCT01083173|589374735|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
163180145|NCT01083173|589374736|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
163180146|NCT01083173|589374735|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
163180147|NCT01083173|589374736|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
163180148|NCT01083173|589374735|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
163180149|NCT01083173|589374736|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
163180150|NCT01083173|589374735|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
163180151|NCT01083173|589374736|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
163180152|NCT01083173|589374735|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
163180153|NCT01083173|589374736|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
163180154|NCT01083173|589374735|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
163180155|NCT01083173|589374736|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
163180156|NCT01083173|589374735|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
163180157|NCT01083173|589374736|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
163180158|NCT04626310|589374738|FG000|Overall Study|4-miss from treatment|6|||
163180159|NCT04626310|589374739|FG001|Overall Study|4-miss from treatment|5|||
163180160|NCT04626310|589374740|FG002|Overall Study|4-miss from treatment|5|||
163180161|NCT04626310|589374738|FG000|Overall Study|Withdrawal by Subject|1|||
163180162|NCT04626310|589374739|FG001|Overall Study|Withdrawal by Subject|0|||
163180163|NCT04626310|589374740|FG002|Overall Study|Withdrawal by Subject|3|||
163284745|NCT00149630|589753091|FG001|Overall Study|Treatment Programs|5|||
163284746|NCT00149630|589753090|FG000|Overall Study|Adverse Event|2|||
163284747|NCT00149630|589753091|FG001|Overall Study|Adverse Event|0|||
163284748|NCT05298111|589753095|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
163284749|NCT05298111|589753096|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
163284750|NCT01268891|589753104|FG000|Overall Study|Adverse Event|3|||
163284751|NCT01268891|589753105|FG001|Overall Study|Adverse Event|7|||
163284752|NCT01268891|589753104|FG000|Overall Study|Lack of Efficacy|1|||
163284753|NCT01268891|589753105|FG001|Overall Study|Lack of Efficacy|0|||
163284754|NCT01268891|589753104|FG000|Overall Study|Withdrawal of Consent|3|||
163284755|NCT01268891|589753105|FG001|Overall Study|Withdrawal of Consent|1|||
163284756|NCT01268891|589753104|FG000|Overall Study|Administrative or other reason(s)|1|||
163284757|NCT01268891|589753105|FG001|Overall Study|Administrative or other reason(s)|0|||
163284758|NCT00991276|589753106|FG000|First Intervention Period|Adverse Event|0|||
163284759|NCT00991276|589753107|FG001|First Intervention Period|Adverse Event|1|||
163284760|NCT00991276|589753108|FG002|First Intervention Period|Adverse Event|0|||
163284761|NCT00991276|589753109|FG003|First Intervention Period|Adverse Event|1|||
163284762|NCT00991276|589753110|FG004|First Intervention Period|Adverse Event|0|||
163284763|NCT00991276|589753111|FG005|First Intervention Period|Adverse Event|0|||
163284764|NCT00991276|589753106|FG000|First Intervention Period|Protocol Violation|0|||
163284765|NCT00991276|589753107|FG001|First Intervention Period|Protocol Violation|0|||
163284766|NCT00991276|589753108|FG002|First Intervention Period|Protocol Violation|0|||
163284767|NCT00991276|589753109|FG003|First Intervention Period|Protocol Violation|0|||
163284768|NCT00991276|589753110|FG004|First Intervention Period|Protocol Violation|2|||
163284769|NCT00991276|589753111|FG005|First Intervention Period|Protocol Violation|0|||
163284770|NCT00991276|589753106|FG000|First Intervention Period|Insufficient clinical response|0|||
163284771|NCT00991276|589753107|FG001|First Intervention Period|Insufficient clinical response|0|||
163284772|NCT00991276|589753108|FG002|First Intervention Period|Insufficient clinical response|0|||
163284773|NCT00991276|589753109|FG003|First Intervention Period|Insufficient clinical response|0|||
163284774|NCT00991276|589753110|FG004|First Intervention Period|Insufficient clinical response|1|||
163284775|NCT00991276|589753111|FG005|First Intervention Period|Insufficient clinical response|0|||
163284776|NCT00991276|589753106|FG000|First Intervention Period|Other|0|||
163284777|NCT00991276|589753107|FG001|First Intervention Period|Other|0|||
163284778|NCT00991276|589753108|FG002|First Intervention Period|Other|0|||
163284779|NCT00991276|589753109|FG003|First Intervention Period|Other|1|||
163284780|NCT00991276|589753110|FG004|First Intervention Period|Other|1|||
163284781|NCT00991276|589753111|FG005|First Intervention Period|Other|0|||
163284782|NCT00991276|589753106|FG000|First Intervention Period|Withdrawal by Subject|0|||
163284783|NCT00991276|589753107|FG001|First Intervention Period|Withdrawal by Subject|1|||
163284784|NCT00991276|589753108|FG002|First Intervention Period|Withdrawal by Subject|0|||
163284785|NCT00991276|589753109|FG003|First Intervention Period|Withdrawal by Subject|1|||
163284786|NCT00991276|589753110|FG004|First Intervention Period|Withdrawal by Subject|0|||
163284787|NCT00991276|589753111|FG005|First Intervention Period|Withdrawal by Subject|1|||
163284788|NCT00991276|589753106|FG000|First Intervention Period|Lost to Follow-up|0|||
163284789|NCT00991276|589753107|FG001|First Intervention Period|Lost to Follow-up|1|||
163284790|NCT00991276|589753108|FG002|First Intervention Period|Lost to Follow-up|0|||
163284791|NCT00991276|589753109|FG003|First Intervention Period|Lost to Follow-up|1|||
163284792|NCT00991276|589753110|FG004|First Intervention Period|Lost to Follow-up|0|||
163284793|NCT00991276|589753111|FG005|First Intervention Period|Lost to Follow-up|0|||
163284794|NCT00991276|589753106|FG000|Second Intervention Period|Adverse Event|0|||
163284795|NCT00991276|589753107|FG001|Second Intervention Period|Adverse Event|2|||
163284796|NCT00991276|589753108|FG002|Second Intervention Period|Adverse Event|0|||
163284797|NCT00991276|589753109|FG003|Second Intervention Period|Adverse Event|1|||
163284798|NCT00991276|589753110|FG004|Second Intervention Period|Adverse Event|1|||
163284799|NCT00991276|589753111|FG005|Second Intervention Period|Adverse Event|0|||
163284800|NCT00991276|589753106|FG000|Second Intervention Period|Protocol Violation|1|||
163284801|NCT00991276|589753107|FG001|Second Intervention Period|Protocol Violation|0|||
163284802|NCT00991276|589753108|FG002|Second Intervention Period|Protocol Violation|0|||
163284803|NCT00991276|589753109|FG003|Second Intervention Period|Protocol Violation|0|||
163284804|NCT00991276|589753110|FG004|Second Intervention Period|Protocol Violation|0|||
163284805|NCT00991276|589753111|FG005|Second Intervention Period|Protocol Violation|0|||
163284806|NCT00991276|589753106|FG000|Second Intervention Period|Other|0|||
163284807|NCT00991276|589753107|FG001|Second Intervention Period|Other|0|||
163284808|NCT00991276|589753108|FG002|Second Intervention Period|Other|0|||
163284809|NCT00991276|589753109|FG003|Second Intervention Period|Other|1|||
163284810|NCT00991276|589753110|FG004|Second Intervention Period|Other|0|||
163284811|NCT00991276|589753111|FG005|Second Intervention Period|Other|1|||
163284812|NCT00991276|589753106|FG000|Third Intervention Period|Protocol Violation|1|||
163284813|NCT00991276|589753107|FG001|Third Intervention Period|Protocol Violation|0|||
163284814|NCT00991276|589753108|FG002|Third Intervention Period|Protocol Violation|0|||
163284815|NCT00991276|589753109|FG003|Third Intervention Period|Protocol Violation|0|||
163284816|NCT00991276|589753110|FG004|Third Intervention Period|Protocol Violation|0|||
163284817|NCT00991276|589753111|FG005|Third Intervention Period|Protocol Violation|0|||
163284818|NCT00991276|589753106|FG000|Third Intervention Period|Other|0|||
163284819|NCT00991276|589753107|FG001|Third Intervention Period|Other|0|||
163284820|NCT00991276|589753108|FG002|Third Intervention Period|Other|0|||
163284821|NCT00991276|589753109|FG003|Third Intervention Period|Other|0|||
163284822|NCT00991276|589753110|FG004|Third Intervention Period|Other|0|||
163284823|NCT00991276|589753111|FG005|Third Intervention Period|Other|1|||
163284824|NCT00991276|589753106|FG000|Third Intervention Period|Adverse Event|0|||
163284825|NCT00991276|589753107|FG001|Third Intervention Period|Adverse Event|0|||
163284826|NCT00991276|589753108|FG002|Third Intervention Period|Adverse Event|1|||
163284827|NCT00991276|589753109|FG003|Third Intervention Period|Adverse Event|0|||
163284828|NCT00991276|589753110|FG004|Third Intervention Period|Adverse Event|0|||
163284829|NCT00991276|589753111|FG005|Third Intervention Period|Adverse Event|0|||
163284830|NCT00991276|589753106|FG000|Third Intervention Period|Withdrawal by Subject|0|||
163284831|NCT00991276|589753107|FG001|Third Intervention Period|Withdrawal by Subject|0|||
163284832|NCT00991276|589753108|FG002|Third Intervention Period|Withdrawal by Subject|0|||
163284833|NCT00991276|589753109|FG003|Third Intervention Period|Withdrawal by Subject|1|||
163284834|NCT00991276|589753110|FG004|Third Intervention Period|Withdrawal by Subject|0|||
163284835|NCT00991276|589753111|FG005|Third Intervention Period|Withdrawal by Subject|0|||
163284836|NCT02001623|589753114|FG000|Overall Study|Disease Progression|2|||
163284837|NCT02001623|589753115|FG001|Overall Study|Disease Progression|2|||
163284838|NCT02001623|589753116|FG002|Overall Study|Disease Progression|3|||
163284839|NCT02001623|589753117|FG003|Overall Study|Disease Progression|2|||
163284840|NCT02001623|589753118|FG004|Overall Study|Disease Progression|3|||
163284841|NCT02001623|589753119|FG005|Overall Study|Disease Progression|2|||
163284842|NCT02001623|589753120|FG006|Overall Study|Disease Progression|3|||
163284843|NCT02001623|589753121|FG007|Overall Study|Disease Progression|3|||
163180188|NCT01853618|589374748|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
163180189|NCT01853618|589374749|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
163180190|NCT01853618|589374750|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
163180191|NCT01853618|589374751|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
163180192|NCT01853618|589374752|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
163180193|NCT01853618|589374748|FG000|Overall Study|Progressive disease|1|||
163180194|NCT01853618|589374749|FG001|Overall Study|Progressive disease|1|||
163180195|NCT01853618|589374750|FG002|Overall Study|Progressive disease|1|||
163180196|NCT01853618|589374751|FG003|Overall Study|Progressive disease|1|||
163180197|NCT01853618|589374752|FG004|Overall Study|Progressive disease|2|||
163180198|NCT01853618|589374748|FG000|Overall Study|Physician Decision|0|||
163180199|NCT01853618|589374749|FG001|Overall Study|Physician Decision|1|||
163180200|NCT01853618|589374750|FG002|Overall Study|Physician Decision|1|||
163180201|NCT01853618|589374751|FG003|Overall Study|Physician Decision|0|||
163180202|NCT01853618|589374752|FG004|Overall Study|Physician Decision|0|||
163180203|NCT01853618|589374748|FG000|Overall Study|Refused further treatment|0|||
163180204|NCT01853618|589374749|FG001|Overall Study|Refused further treatment|0|||
163180205|NCT01853618|589374750|FG002|Overall Study|Refused further treatment|0|||
163180206|NCT01853618|589374751|FG003|Overall Study|Refused further treatment|0|||
163180207|NCT01853618|589374752|FG004|Overall Study|Refused further treatment|1|||
163180208|NCT01658813|589374753|FG000|Overall Study|Disease progression|3|||
163180209|NCT01092832|589374758|FG000|Overall Study|Other|1|||
163180210|NCT01092832|589374759|FG001|Overall Study|Other|0|||
163180211|NCT04777331|589374760|FG000|DBT Period|Death|2|||
163180212|NCT04777331|589374761|FG001|DBT Period|Death|1|||
163180213|NCT04777331|589374762|FG002|DBT Period|Death|0|||
163180214|NCT04777331|589374760|FG000|DBT Period|Reason not Specified|1|||
163180215|NCT04777331|589374761|FG001|DBT Period|Reason not Specified|1|||
163180216|NCT04777331|589374762|FG002|DBT Period|Reason not Specified|0|||
163180217|NCT04777331|589374760|FG000|DBT Period|Physician Decision|4|||
163180218|NCT04777331|589374761|FG001|DBT Period|Physician Decision|0|||
163180219|NCT04777331|589374762|FG002|DBT Period|Physician Decision|0|||
163180220|NCT04777331|589374760|FG000|DBT Period|Withdrawal by Subject|12|||
163180221|NCT04777331|589374761|FG001|DBT Period|Withdrawal by Subject|11|||
163180222|NCT04777331|589374762|FG002|DBT Period|Withdrawal by Subject|0|||
163180223|NCT04777331|589374760|FG000|DBT Period|Randomized but not Treated|1|||
163180224|NCT04777331|589374761|FG001|DBT Period|Randomized but not Treated|3|||
163180225|NCT04777331|589374762|FG002|DBT Period|Randomized but not Treated|0|||
163180226|NCT04777331|589374760|FG000|OLE Period|Ongoing in OLE|0|||
163180227|NCT04777331|589374761|FG001|OLE Period|Ongoing in OLE|0|||
163180228|NCT04777331|589374762|FG002|OLE Period|Ongoing in OLE|534|||
163180229|NCT01401959|589374763|FG000|Enrolled|Withdrawal by Subject|1|||
163180230|NCT01401959|589374764|FG001|Enrolled|Withdrawal by Subject|0|||
163180231|NCT01401959|589374765|FG002|Enrolled|Withdrawal by Subject|0|||
163180232|NCT01401959|589374763|FG000|Treated|Disease Progression|2|||
163180233|NCT01401959|589374764|FG001|Treated|Disease Progression|2|||
163180234|NCT01401959|589374765|FG002|Treated|Disease Progression|1|||
163180235|NCT01401959|589374763|FG000|Treated|Adverse Event|4|||
163180236|NCT01401959|589374764|FG001|Treated|Adverse Event|3|||
163180237|NCT01401959|589374765|FG002|Treated|Adverse Event|2|||
163180238|NCT01401959|589374763|FG000|Treated|Withdrawal by Subject|1|||
163180239|NCT01401959|589374764|FG001|Treated|Withdrawal by Subject|2|||
163180240|NCT01401959|589374765|FG002|Treated|Withdrawal by Subject|2|||
163284844|NCT02001623|589753122|FG008|Overall Study|Disease Progression|7|||
163284845|NCT02001623|589753123|FG009|Overall Study|Disease Progression|40|||
163284846|NCT02001623|589753124|FG010|Overall Study|Disease Progression|5|||
163284847|NCT02001623|589753125|FG011|Overall Study|Disease Progression|9|||
163284848|NCT02001623|589753126|FG012|Overall Study|Disease Progression|9|||
163284849|NCT02001623|589753127|FG013|Overall Study|Disease Progression|20|||
163284850|NCT02001623|589753128|FG014|Overall Study|Disease Progression|9|||
163284851|NCT02001623|589753114|FG000|Overall Study|Physician Decision|0|||
163284852|NCT02001623|589753115|FG001|Overall Study|Physician Decision|0|||
163284853|NCT02001623|589753116|FG002|Overall Study|Physician Decision|0|||
163284854|NCT02001623|589753117|FG003|Overall Study|Physician Decision|0|||
163284855|NCT02001623|589753118|FG004|Overall Study|Physician Decision|0|||
163284856|NCT02001623|589753119|FG005|Overall Study|Physician Decision|0|||
163284857|NCT02001623|589753120|FG006|Overall Study|Physician Decision|0|||
163284858|NCT02001623|589753121|FG007|Overall Study|Physician Decision|0|||
163284859|NCT02001623|589753122|FG008|Overall Study|Physician Decision|3|||
163284860|NCT02001623|589753123|FG009|Overall Study|Physician Decision|2|||
163284861|NCT02001623|589753124|FG010|Overall Study|Physician Decision|3|||
163284862|NCT02001623|589753125|FG011|Overall Study|Physician Decision|3|||
163284863|NCT02001623|589753126|FG012|Overall Study|Physician Decision|1|||
163284864|NCT02001623|589753127|FG013|Overall Study|Physician Decision|2|||
163284865|NCT02001623|589753128|FG014|Overall Study|Physician Decision|1|||
163284866|NCT02001623|589753114|FG000|Overall Study|Death|0|||
163284867|NCT02001623|589753115|FG001|Overall Study|Death|1|||
163284868|NCT02001623|589753116|FG002|Overall Study|Death|0|||
163284869|NCT02001623|589753117|FG003|Overall Study|Death|0|||
163284870|NCT02001623|589753118|FG004|Overall Study|Death|0|||
163284871|NCT02001623|589753119|FG005|Overall Study|Death|0|||
163284872|NCT02001623|589753120|FG006|Overall Study|Death|0|||
163284873|NCT02001623|589753121|FG007|Overall Study|Death|0|||
162937311|NCT00718159|588473588|FG002|Overall Study|Investigator Decision|0|||
162937312|NCT00718159|588473589|FG003|Overall Study|Investigator Decision|0|||
162937313|NCT00718159|588473590|FG004|Overall Study|Investigator Decision|0|||
162937314|NCT00718159|588473591|FG005|Overall Study|Investigator Decision|1|||
163284874|NCT02001623|589753122|FG008|Overall Study|Death|0|||
163180241|NCT01401959|589374763|FG000|Treated|Protocol Violation|0|||
163284875|NCT02001623|589753123|FG009|Overall Study|Death|0|||
163284876|NCT02001623|589753124|FG010|Overall Study|Death|0|||
163284877|NCT02001623|589753125|FG011|Overall Study|Death|0|||
163284878|NCT02001623|589753126|FG012|Overall Study|Death|0|||
163284879|NCT02001623|589753127|FG013|Overall Study|Death|0|||
163284880|NCT02001623|589753128|FG014|Overall Study|Death|0|||
163284881|NCT02001623|589753114|FG000|Overall Study|Adverse Event|0|||
163284882|NCT02001623|589753115|FG001|Overall Study|Adverse Event|0|||
163284883|NCT02001623|589753116|FG002|Overall Study|Adverse Event|0|||
163284884|NCT02001623|589753117|FG003|Overall Study|Adverse Event|0|||
163284885|NCT02001623|589753118|FG004|Overall Study|Adverse Event|0|||
163284886|NCT02001623|589753119|FG005|Overall Study|Adverse Event|1|||
163180242|NCT01401959|589374764|FG001|Treated|Protocol Violation|1|||
163180243|NCT01401959|589374765|FG002|Treated|Protocol Violation|0|||
163180244|NCT00400153|589374766|FG000|Overall Study|AE due to study disease worsening|14|||
163180245|NCT00400153|589374767|FG001|Overall Study|AE due to study disease worsening|19|||
163180246|NCT00400153|589374768|FG002|Overall Study|AE due to study disease worsening|20|||
163180247|NCT00400153|589374766|FG000|Overall Study|AE due to other disease worsening|2|||
163180248|NCT00400153|589374767|FG001|Overall Study|AE due to other disease worsening|1|||
163180249|NCT00400153|589374768|FG002|Overall Study|AE due to other disease worsening|0|||
163180250|NCT00400153|589374766|FG000|Overall Study|AE due to other condition|3|||
163180251|NCT00400153|589374767|FG001|Overall Study|AE due to other condition|14|||
163180252|NCT00400153|589374768|FG002|Overall Study|AE due to other condition|15|||
163180253|NCT00400153|589374766|FG000|Overall Study|Protocol Violation|7|||
163180254|NCT00400153|589374767|FG001|Overall Study|Protocol Violation|4|||
163180255|NCT00400153|589374768|FG002|Overall Study|Protocol Violation|9|||
163180256|NCT00400153|589374766|FG000|Overall Study|Lost to Follow-up|2|||
163180257|NCT00400153|589374767|FG001|Overall Study|Lost to Follow-up|1|||
163180258|NCT00400153|589374768|FG002|Overall Study|Lost to Follow-up|4|||
163180259|NCT00400153|589374766|FG000|Overall Study|Withdrawal by Subject|12|||
163180260|NCT00400153|589374767|FG001|Overall Study|Withdrawal by Subject|11|||
163180261|NCT00400153|589374768|FG002|Overall Study|Withdrawal by Subject|10|||
163180262|NCT00400153|589374766|FG000|Overall Study|Other reasons - not mentioned above|8|||
163180263|NCT00400153|589374767|FG001|Overall Study|Other reasons - not mentioned above|5|||
163180264|NCT00400153|589374768|FG002|Overall Study|Other reasons - not mentioned above|3|||
163180265|NCT01423604|589374769|FG000|Safety Run-In|Adverse Event|3|||
163180266|NCT01423604|589374770|FG001|Safety Run-In|Adverse Event|0|||
163180267|NCT01423604|589374769|FG000|Safety Run-In|Death|1|||
163180268|NCT01423604|589374770|FG001|Safety Run-In|Death|0|||
163180269|NCT01423604|589374769|FG000|Safety Run-In|Physician Decision|1|||
163284887|NCT02001623|589753120|FG006|Overall Study|Adverse Event|0|||
163284888|NCT02001623|589753121|FG007|Overall Study|Adverse Event|3|||
163284889|NCT02001623|589753122|FG008|Overall Study|Adverse Event|4|||
163284890|NCT02001623|589753123|FG009|Overall Study|Adverse Event|6|||
163284891|NCT02001623|589753124|FG010|Overall Study|Adverse Event|4|||
163284892|NCT02001623|589753125|FG011|Overall Study|Adverse Event|0|||
163284893|NCT02001623|589753126|FG012|Overall Study|Adverse Event|3|||
163284894|NCT02001623|589753127|FG013|Overall Study|Adverse Event|5|||
163284895|NCT02001623|589753128|FG014|Overall Study|Adverse Event|6|||
163284896|NCT02001623|589753114|FG000|Overall Study|Other - Miscellaneous|0|||
163284897|NCT02001623|589753115|FG001|Overall Study|Other - Miscellaneous|0|||
163284898|NCT02001623|589753116|FG002|Overall Study|Other - Miscellaneous|0|||
163284899|NCT02001623|589753117|FG003|Overall Study|Other - Miscellaneous|0|||
163284900|NCT02001623|589753118|FG004|Overall Study|Other - Miscellaneous|0|||
163284901|NCT02001623|589753119|FG005|Overall Study|Other - Miscellaneous|0|||
163284902|NCT02001623|589753120|FG006|Overall Study|Other - Miscellaneous|0|||
163284903|NCT02001623|589753121|FG007|Overall Study|Other - Miscellaneous|0|||
163284904|NCT02001623|589753122|FG008|Overall Study|Other - Miscellaneous|0|||
163284905|NCT02001623|589753123|FG009|Overall Study|Other - Miscellaneous|1|||
163284906|NCT02001623|589753124|FG010|Overall Study|Other - Miscellaneous|0|||
163284907|NCT02001623|589753125|FG011|Overall Study|Other - Miscellaneous|0|||
163284908|NCT02001623|589753126|FG012|Overall Study|Other - Miscellaneous|0|||
163284909|NCT02001623|589753127|FG013|Overall Study|Other - Miscellaneous|1|||
163284910|NCT02001623|589753128|FG014|Overall Study|Other - Miscellaneous|0|||
163284911|NCT02001623|589753114|FG000|Overall Study|Withdrawal by Subject|1|||
163284912|NCT02001623|589753115|FG001|Overall Study|Withdrawal by Subject|0|||
163284913|NCT02001623|589753116|FG002|Overall Study|Withdrawal by Subject|0|||
163284914|NCT02001623|589753117|FG003|Overall Study|Withdrawal by Subject|0|||
163284915|NCT02001623|589753118|FG004|Overall Study|Withdrawal by Subject|0|||
163284916|NCT02001623|589753119|FG005|Overall Study|Withdrawal by Subject|0|||
163284917|NCT02001623|589753120|FG006|Overall Study|Withdrawal by Subject|0|||
163284918|NCT02001623|589753121|FG007|Overall Study|Withdrawal by Subject|0|||
163284919|NCT02001623|589753122|FG008|Overall Study|Withdrawal by Subject|1|||
163284920|NCT02001623|589753123|FG009|Overall Study|Withdrawal by Subject|3|||
163284921|NCT02001623|589753124|FG010|Overall Study|Withdrawal by Subject|2|||
163284922|NCT02001623|589753125|FG011|Overall Study|Withdrawal by Subject|2|||
163284923|NCT02001623|589753126|FG012|Overall Study|Withdrawal by Subject|1|||
163284924|NCT02001623|589753127|FG013|Overall Study|Withdrawal by Subject|5|||
163284925|NCT02001623|589753128|FG014|Overall Study|Withdrawal by Subject|2|||
163284926|NCT02001623|589753114|FG000|Overall Study|Lost to Follow-up|0|||
163284927|NCT02001623|589753115|FG001|Overall Study|Lost to Follow-up|0|||
163284928|NCT02001623|589753116|FG002|Overall Study|Lost to Follow-up|0|||
163284929|NCT02001623|589753117|FG003|Overall Study|Lost to Follow-up|0|||
163284930|NCT02001623|589753118|FG004|Overall Study|Lost to Follow-up|0|||
163284931|NCT02001623|589753119|FG005|Overall Study|Lost to Follow-up|0|||
163284932|NCT02001623|589753120|FG006|Overall Study|Lost to Follow-up|0|||
163284933|NCT02001623|589753121|FG007|Overall Study|Lost to Follow-up|0|||
163284934|NCT02001623|589753122|FG008|Overall Study|Lost to Follow-up|0|||
163284935|NCT02001623|589753123|FG009|Overall Study|Lost to Follow-up|1|||
163284936|NCT02001623|589753124|FG010|Overall Study|Lost to Follow-up|0|||
163284937|NCT02001623|589753125|FG011|Overall Study|Lost to Follow-up|0|||
163284938|NCT02001623|589753126|FG012|Overall Study|Lost to Follow-up|0|||
163284939|NCT02001623|589753127|FG013|Overall Study|Lost to Follow-up|0|||
163284940|NCT02001623|589753128|FG014|Overall Study|Lost to Follow-up|0|||
163284941|NCT02001623|589753114|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
163284942|NCT02001623|589753115|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
163284943|NCT02001623|589753116|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
163284944|NCT02001623|589753117|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
163284945|NCT02001623|589753118|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
163284946|NCT02001623|589753119|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
163284947|NCT02001623|589753120|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
163284948|NCT02001623|589753121|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
163284949|NCT02001623|589753122|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
163284950|NCT02001623|589753123|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
163284951|NCT02001623|589753124|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
163284952|NCT02001623|589753125|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
163284953|NCT02001623|589753126|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
163284954|NCT02001623|589753127|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
163284955|NCT02001623|589753128|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
163284956|NCT02001623|589753114|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
163284957|NCT02001623|589753115|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
163284958|NCT02001623|589753116|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
163284959|NCT02001623|589753117|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
163284960|NCT02001623|589753118|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
163284961|NCT02001623|589753119|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
163284962|NCT02001623|589753120|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
163284963|NCT02001623|589753121|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
163284964|NCT02001623|589753122|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
163284965|NCT02001623|589753123|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
163284966|NCT02001623|589753124|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
163284967|NCT02001623|589753125|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
163284968|NCT02001623|589753126|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
163284969|NCT02001623|589753127|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
163284970|NCT02001623|589753128|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
163284971|NCT00109967|589753135|FG000|Overall Study|Cancel Prior to Treatment|2|||
163284972|NCT00109967|589753136|FG001|Overall Study|Cancel Prior to Treatment|0|||
163284973|NCT00109967|589753135|FG000|Overall Study|Adverse Event|12|||
163284974|NCT00109967|589753136|FG001|Overall Study|Adverse Event|1|||
163284975|NCT00109967|589753135|FG000|Overall Study|Withdrawal by Subject|5|||
163284976|NCT00109967|589753136|FG001|Overall Study|Withdrawal by Subject|0|||
163284977|NCT00109967|589753135|FG000|Overall Study|Physician Decision|1|||
163284978|NCT00109967|589753136|FG001|Overall Study|Physician Decision|3|||
163284979|NCT00109967|589753135|FG000|Overall Study|Death|0|||
163284980|NCT00109967|589753136|FG001|Overall Study|Death|2|||
163284981|NCT01063036|589753143|FG000|Participants Treated With Study Drug|Adverse Event|1|||
163284982|NCT01063036|589753143|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
163284983|NCT01063036|589753143|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
163284984|NCT01063036|589753143|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
163284985|NCT01063036|589753143|FG000|Participants Treated With Study Drug|Pregnancy|1|||
163284986|NCT01063036|589753143|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
163284987|NCT01063036|589753143|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
163284988|NCT01063036|589753143|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
163284989|NCT01107626|589753144|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
163284990|NCT01107626|589753145|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
163284991|NCT01107626|589753146|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
163284992|NCT01107626|589753147|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
163284993|NCT01107626|589753144|FG000|Step 1: Induction Therapy|Adverse Event|198|||
163284994|NCT01107626|589753145|FG001|Step 1: Induction Therapy|Adverse Event|0|||
163284995|NCT01107626|589753146|FG002|Step 1: Induction Therapy|Adverse Event|0|||
163284996|NCT01107626|589753147|FG003|Step 1: Induction Therapy|Adverse Event|0|||
163284997|NCT01107626|589753144|FG000|Step 1: Induction Therapy|Death|62|||
163284998|NCT01107626|589753145|FG001|Step 1: Induction Therapy|Death|0|||
163284999|NCT01107626|589753146|FG002|Step 1: Induction Therapy|Death|0|||
163285000|NCT01107626|589753147|FG003|Step 1: Induction Therapy|Death|0|||
163285001|NCT01107626|589753144|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
163285002|NCT01107626|589753145|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
163285003|NCT01107626|589753146|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
163285004|NCT01107626|589753147|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
163285005|NCT01107626|589753144|FG000|Step 1: Induction Therapy|Complicating disease|13|||
163285006|NCT01107626|589753145|FG001|Step 1: Induction Therapy|Complicating disease|0|||
163285007|NCT01107626|589753146|FG002|Step 1: Induction Therapy|Complicating disease|0|||
163285008|NCT01107626|589753147|FG003|Step 1: Induction Therapy|Complicating disease|0|||
163285009|NCT01107626|589753144|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
163285010|NCT01107626|589753145|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
163285011|NCT01107626|589753146|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
163285012|NCT01107626|589753147|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
163285013|NCT01107626|589753144|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
163285014|NCT01107626|589753145|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
163285015|NCT01107626|589753146|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
163285016|NCT01107626|589753147|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
163285017|NCT01107626|589753144|FG000|Step 1: Induction Therapy|Non-compliance|4|||
163285018|NCT01107626|589753145|FG001|Step 1: Induction Therapy|Non-compliance|0|||
163285019|NCT01107626|589753146|FG002|Step 1: Induction Therapy|Non-compliance|0|||
163285020|NCT01107626|589753147|FG003|Step 1: Induction Therapy|Non-compliance|0|||
163285021|NCT01107626|589753144|FG000|Step 1: Induction Therapy|Pain|4|||
163285022|NCT01107626|589753145|FG001|Step 1: Induction Therapy|Pain|0|||
163285023|NCT01107626|589753146|FG002|Step 1: Induction Therapy|Pain|0|||
163285024|NCT01107626|589753147|FG003|Step 1: Induction Therapy|Pain|0|||
163285025|NCT01107626|589753144|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
163285026|NCT01107626|589753145|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
163285027|NCT01107626|589753146|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
163285028|NCT01107626|589753147|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
163285029|NCT01107626|589753144|FG000|Step 1: Induction Therapy|Hospice care|1|||
163285030|NCT01107626|589753145|FG001|Step 1: Induction Therapy|Hospice care|0|||
163285031|NCT01107626|589753146|FG002|Step 1: Induction Therapy|Hospice care|0|||
163285032|NCT01107626|589753147|FG003|Step 1: Induction Therapy|Hospice care|0|||
163285033|NCT01107626|589753144|FG000|Step 1: Induction Therapy|Physician Decision|1|||
163285034|NCT01107626|589753145|FG001|Step 1: Induction Therapy|Physician Decision|0|||
163285035|NCT01107626|589753146|FG002|Step 1: Induction Therapy|Physician Decision|0|||
163285036|NCT01107626|589753147|FG003|Step 1: Induction Therapy|Physician Decision|0|||
163285037|NCT01107626|589753144|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
163285038|NCT01107626|589753145|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
163285039|NCT01107626|589753146|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
163285040|NCT01107626|589753147|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
163285041|NCT01107626|589753144|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
163285042|NCT01107626|589753145|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
163285043|NCT01107626|589753146|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
163285044|NCT01107626|589753147|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
163285045|NCT01107626|589753144|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
163285046|NCT01107626|589753145|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
163285047|NCT01107626|589753146|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
163285048|NCT01107626|589753147|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
163285049|NCT01107626|589753144|FG000|Step 2: Maintenance Therapy|Death|0|||
163285050|NCT01107626|589753145|FG001|Step 2: Maintenance Therapy|Death|8|||
163285051|NCT01107626|589753146|FG002|Step 2: Maintenance Therapy|Death|2|||
163285052|NCT01107626|589753147|FG003|Step 2: Maintenance Therapy|Death|13|||
163285053|NCT01107626|589753144|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
163285054|NCT01107626|589753145|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
163285055|NCT01107626|589753146|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
163285056|NCT01107626|589753147|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
163285057|NCT01107626|589753144|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
163285058|NCT01107626|589753145|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
163285059|NCT01107626|589753146|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
163285060|NCT01107626|589753147|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
163285061|NCT01107626|589753144|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
163285062|NCT01107626|589753145|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
163180270|NCT01423604|589374770|FG001|Safety Run-In|Physician Decision|0|||
163180271|NCT01423604|589374769|FG000|Safety Run-In|Disease progression|3|||
163180272|NCT01423604|589374770|FG001|Safety Run-In|Disease progression|0|||
163180273|NCT01423604|589374769|FG000|Safety Run-In|Patient decision|1|||
163180274|NCT01423604|589374770|FG001|Safety Run-In|Patient decision|0|||
163180275|NCT01423604|589374769|FG000|Randomized|Adverse Event|4|||
163180276|NCT01423604|589374770|FG001|Randomized|Adverse Event|10|||
163180277|NCT01423604|589374769|FG000|Randomized|Death|1|||
163180278|NCT01423604|589374770|FG001|Randomized|Death|0|||
163180279|NCT01423604|589374769|FG000|Randomized|Physician Decision|16|||
163180280|NCT01423604|589374770|FG001|Randomized|Physician Decision|13|||
163180281|NCT01423604|589374769|FG000|Randomized|Other - unspecified|37|||
163180282|NCT01423604|589374770|FG001|Randomized|Other - unspecified|31|||
163180283|NCT01423604|589374769|FG000|Randomized|Patient decision|5|||
163180284|NCT01423604|589374770|FG001|Randomized|Patient decision|9|||
163180285|NCT06785857|589374786|FG000|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|2|||
163180286|NCT06785857|589374787|FG001|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|3|||
163180287|NCT05952401|589374795|FG000|Overall Study|Lost to Follow-up|4|||
163180288|NCT05952401|589374796|FG001|Overall Study|Lost to Follow-up|1|||
163180289|NCT00096954|589375927|FG000|Overall Study|Adverse Event|3|||
163180290|NCT00096954|589375928|FG001|Overall Study|Adverse Event|1|||
163180291|NCT00096954|589375927|FG000|Overall Study|Withdrawal by Subject|9|||
163180292|NCT00096954|589375928|FG001|Overall Study|Withdrawal by Subject|8|||
163180293|NCT00096954|589375927|FG000|Overall Study|Physician Decision|1|||
163180294|NCT00096954|589375928|FG001|Overall Study|Physician Decision|1|||
163180295|NCT00096954|589375927|FG000|Overall Study|Sponsors Decision|1|||
163180296|NCT00096954|589375928|FG001|Overall Study|Sponsors Decision|1|||
163180297|NCT00096954|589375927|FG000|Overall Study|Pregnancy|1|||
163180298|NCT00096954|589375928|FG001|Overall Study|Pregnancy|1|||
163285063|NCT01107626|589753146|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
163285064|NCT01107626|589753147|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
163285065|NCT01107626|589753144|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
163285066|NCT01107626|589753145|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
163285067|NCT01107626|589753146|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
163285068|NCT01107626|589753147|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
163285069|NCT01107626|589753144|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
163285070|NCT01107626|589753145|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
163285071|NCT01107626|589753146|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
163285072|NCT01107626|589753147|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
163285073|NCT01107626|589753144|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
163285074|NCT01107626|589753145|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
163285075|NCT01107626|589753146|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
163285076|NCT01107626|589753147|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
163180299|NCT00096954|589375927|FG000|Overall Study|Initiation of immunotherapy|1|||
163180300|NCT00096954|589375928|FG001|Overall Study|Initiation of immunotherapy|0|||
163180301|NCT00096954|589375927|FG000|Overall Study|Non-compliance|0|||
163180302|NCT00096954|589375928|FG001|Overall Study|Non-compliance|3|||
163180303|NCT00096954|589375927|FG000|Overall Study|Lost to Follow-up|8|||
163180304|NCT00096954|589375928|FG001|Overall Study|Lost to Follow-up|5|||
163180305|NCT01483690|589375929|FG000|Overall Study|Adverse Event|1|||
163180306|NCT01483690|589375930|FG001|Overall Study|Adverse Event|2|||
163180307|NCT01483690|589375929|FG000|Overall Study|clinical deterioration|1|||
163180308|NCT01483690|589375930|FG001|Overall Study|clinical deterioration|0|||
163180309|NCT01483690|589375929|FG000|Overall Study|Physician Decision|0|||
163180310|NCT01483690|589375930|FG001|Overall Study|Physician Decision|2|||
163180311|NCT01483690|589375929|FG000|Overall Study|exclusionary procedure|0|||
163180312|NCT01483690|589375930|FG001|Overall Study|exclusionary procedure|1|||
163180313|NCT02239224|589375931|FG000|Overall Study|Administrative|0|||
163180314|NCT02239224|589375932|FG001|Overall Study|Administrative|0|||
163180315|NCT02239224|589375933|FG002|Overall Study|Administrative|3|||
163180316|NCT02239224|589375934|FG003|Overall Study|Administrative|1|||
163180317|NCT04565236|589375941|FG000|Overall Study|Patient/Guardian Decision|0|||
163180318|NCT04565236|589375942|FG001|Overall Study|Patient/Guardian Decision|0|||
163180319|NCT04565236|589375943|FG002|Overall Study|Patient/Guardian Decision|1|||
163180320|NCT04565236|589375944|FG003|Overall Study|Patient/Guardian Decision|0|||
163180321|NCT00740246|589375947|FG000|Overall Study|Received Blood Transfusion|0|||
163180322|NCT00740246|589375948|FG001|Overall Study|Received Blood Transfusion|1|||
163180323|NCT00740246|589375947|FG000|Overall Study|Adverse Event|1|||
163180324|NCT00740246|589375948|FG001|Overall Study|Adverse Event|2|||
163180325|NCT00740246|589375947|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
163180326|NCT00740246|589375948|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
163180327|NCT00740246|589375947|FG000|Overall Study|Lost to Follow-up|2|||
163180328|NCT00740246|589375948|FG001|Overall Study|Lost to Follow-up|2|||
163180329|NCT00740246|589375947|FG000|Overall Study|Withdrawal by Subject|4|||
163180330|NCT00740246|589375948|FG001|Overall Study|Withdrawal by Subject|3|||
163180331|NCT00740246|589375947|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
163180332|NCT00740246|589375948|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
163180333|NCT00740246|589375947|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
163180334|NCT00740246|589375948|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
163180335|NCT00740246|589375947|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
163180336|NCT00740246|589375948|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
163180337|NCT00740246|589375947|FG000|Overall Study|Unable To Comply With Study Visits|2|||
163180338|NCT00740246|589375948|FG001|Overall Study|Unable To Comply With Study Visits|0|||
163180339|NCT00740246|589375947|FG000|Overall Study|Unable to Access Vein|0|||
163180340|NCT00740246|589375948|FG001|Overall Study|Unable to Access Vein|2|||
163180341|NCT00740246|589375947|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
163180342|NCT00740246|589375948|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
163180343|NCT01041495|589375949|FG000|Overall Study|Withdrawal by Subject|2|||
163180344|NCT01041495|589375950|FG001|Overall Study|Withdrawal by Subject|5|||
163180345|NCT01041495|589375949|FG000|Overall Study|Adverse Event|2|||
163180346|NCT01041495|589375950|FG001|Overall Study|Adverse Event|1|||
163180347|NCT01041495|589375949|FG000|Overall Study|Lost to Follow-up|0|||
163180348|NCT01041495|589375950|FG001|Overall Study|Lost to Follow-up|1|||
163180349|NCT03584373|589375951|FG000|Overall Study|Lost to Follow-up|7|||
163180350|NCT03584373|589375952|FG001|Overall Study|Lost to Follow-up|8|||
163180351|NCT00662532|589375954|FG000|Overall Study|Adverse Event|0|||
163180352|NCT00662532|589375955|FG001|Overall Study|Adverse Event|1|||
163180353|NCT00662532|589375954|FG000|Overall Study|Lost to Follow-up|0|||
163180354|NCT00662532|589375955|FG001|Overall Study|Lost to Follow-up|1|||
163180355|NCT00366340|589375956|FG000|Infant Series|Protocol Violation|3|||
163180356|NCT00366340|589375957|FG001|Infant Series|Protocol Violation|4|||
163180357|NCT00366340|589375956|FG000|Infant Series|Withdrawal by Subject|3|||
163180358|NCT00366340|589375957|FG001|Infant Series|Withdrawal by Subject|3|||
163180359|NCT00366340|589375956|FG000|Infant Series|Adverse Event|0|||
163180360|NCT00366340|589375957|FG001|Infant Series|Adverse Event|2|||
163180361|NCT00366340|589375956|FG000|Infant Series|Lost to Follow-up|1|||
163180362|NCT00366340|589375957|FG001|Infant Series|Lost to Follow-up|1|||
163180363|NCT00366340|589375956|FG000|Infant Series|Failure to return|1|||
163180364|NCT00366340|589375957|FG001|Infant Series|Failure to return|0|||
163180365|NCT00366340|589375956|FG000|After the Infant Series|Parent/legal guardian request|1|||
163180366|NCT00366340|589375957|FG001|After the Infant Series|Parent/legal guardian request|1|||
163180367|NCT00366340|589375956|FG000|After the Infant Series|Failed to return|0|||
163180368|NCT00366340|589375957|FG001|After the Infant Series|Failed to return|1|||
163180369|NCT00366340|589375956|FG000|After the Infant Series|Protocol Violation|2|||
162937315|NCT00718159|588473592|FG006|Overall Study|Investigator Decision|1|||
162937316|NCT01238848|588473594|FG000|Overall Study|Physician Decision|13|||
162937317|NCT01238848|588473595|FG001|Overall Study|Physician Decision|5|||
162937318|NCT02040766|588473596|FG000|Overall Study|Adverse Event|1|||
162937319|NCT02040766|588473597|FG001|Overall Study|Adverse Event|1|||
162937320|NCT02040766|588473598|FG002|Overall Study|Adverse Event|1|||
162937321|NCT02040766|588473599|FG003|Overall Study|Adverse Event|0|||
162937322|NCT02040766|588473600|FG004|Overall Study|Adverse Event|2|||
162937323|NCT02040766|588473596|FG000|Overall Study|Withdrawal by Subject|4|||
162937324|NCT02040766|588473597|FG001|Overall Study|Withdrawal by Subject|3|||
162937325|NCT02040766|588473598|FG002|Overall Study|Withdrawal by Subject|2|||
162937326|NCT02040766|588473599|FG003|Overall Study|Withdrawal by Subject|3|||
162937327|NCT02040766|588473600|FG004|Overall Study|Withdrawal by Subject|2|||
162937328|NCT02040766|588473596|FG000|Overall Study|Non-compliance|0|||
162937329|NCT02040766|588473597|FG001|Overall Study|Non-compliance|1|||
162937330|NCT02040766|588473598|FG002|Overall Study|Non-compliance|0|||
162937331|NCT02040766|588473599|FG003|Overall Study|Non-compliance|0|||
162937332|NCT02040766|588473600|FG004|Overall Study|Non-compliance|0|||
162937333|NCT02040766|588473596|FG000|Overall Study|Protocol Violation|2|||
162937334|NCT02040766|588473597|FG001|Overall Study|Protocol Violation|1|||
162937335|NCT02040766|588473598|FG002|Overall Study|Protocol Violation|2|||
162937336|NCT02040766|588473599|FG003|Overall Study|Protocol Violation|3|||
162937337|NCT02040766|588473600|FG004|Overall Study|Protocol Violation|0|||
162937338|NCT02040766|588473596|FG000|Overall Study|Lost to Follow-up|4|||
162937339|NCT02040766|588473597|FG001|Overall Study|Lost to Follow-up|1|||
162937340|NCT02040766|588473598|FG002|Overall Study|Lost to Follow-up|3|||
162937341|NCT02040766|588473599|FG003|Overall Study|Lost to Follow-up|1|||
162937342|NCT02040766|588473600|FG004|Overall Study|Lost to Follow-up|4|||
162937343|NCT02040766|588473596|FG000|Overall Study|Not reported|1|||
162937344|NCT02040766|588473597|FG001|Overall Study|Not reported|0|||
162937345|NCT02040766|588473598|FG002|Overall Study|Not reported|0|||
162937346|NCT02040766|588473599|FG003|Overall Study|Not reported|0|||
163180370|NCT00366340|589375957|FG001|After the Infant Series|Protocol Violation|2|||
162937347|NCT02040766|588473600|FG004|Overall Study|Not reported|0|||
162937348|NCT02040766|588473596|FG000|Overall Study|Lack of Efficacy|6|||
162937349|NCT02040766|588473597|FG001|Overall Study|Lack of Efficacy|3|||
162937350|NCT02040766|588473598|FG002|Overall Study|Lack of Efficacy|4|||
162937351|NCT02040766|588473599|FG003|Overall Study|Lack of Efficacy|6|||
162937352|NCT02040766|588473600|FG004|Overall Study|Lack of Efficacy|5|||
162937353|NCT00798889|588473606|FG000|Overall Study|Adverse Event|53|||
162937354|NCT00798889|588473606|FG000|Overall Study|Protocol Violation|2|||
162937355|NCT00798889|588473606|FG000|Overall Study|Withdrawal by Subject|31|||
162937356|NCT00798889|588473606|FG000|Overall Study|Lost to Follow-up|1|||
162937357|NCT00798889|588473606|FG000|Overall Study|Lack of Efficacy|213|||
162937358|NCT00798889|588473606|FG000|Overall Study|Decision of Sponsor|11|||
162937359|NCT00798889|588473606|FG000|Overall Study|Enrolled, Not treated|3|||
162937360|NCT00617461|588473607|FG000|First Treatment Intervention Period|Adverse Event|2|||
162937361|NCT00617461|588473608|FG001|First Treatment Intervention Period|Adverse Event|0|||
163180371|NCT00366340|589375956|FG000|After the Infant Series|Adverse Event|0|||
163180372|NCT00366340|589375957|FG001|After the Infant Series|Adverse Event|1|||
163180373|NCT00366340|589375956|FG000|After the Infant Series|Lost to Follow-up|0|||
163180374|NCT00366340|589375957|FG001|After the Infant Series|Lost to Follow-up|1|||
163180375|NCT00366340|589375956|FG000|Toddler Dose|Failed to return|1|||
163180376|NCT00366340|589375957|FG001|Toddler Dose|Failed to return|0|||
163180377|NCT00366340|589375956|FG000|Toddler Dose|Parent/legal guardian request|0|||
163180378|NCT00366340|589375957|FG001|Toddler Dose|Parent/legal guardian request|1|||
163180379|NCT00367770|589375958|FG000|Overall Study|Adverse Event|1|||
163180380|NCT00367770|589375958|FG000|Overall Study|Withdrawal by Subject|1|||
163180381|NCT03282565|589375963|FG000|Overall Study|COVID-19 Research Shutdown|0|||
163180382|NCT03282565|589375964|FG001|Overall Study|COVID-19 Research Shutdown|2|||
163180383|NCT03282565|589375965|FG002|Overall Study|COVID-19 Research Shutdown|2|||
163180384|NCT02011893|589375967|FG000|Enrollment to Randomization|Adverse Event|2|||
163180385|NCT02011893|589375968|FG001|Enrollment to Randomization|Adverse Event|0|||
163180386|NCT02011893|589375969|FG002|Enrollment to Randomization|Adverse Event|0|||
162937362|NCT00617461|588473607|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
162937363|NCT00617461|588473608|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
162937364|NCT00617461|588473607|FG000|First Treatment Intervention Period|Protocol Violation|2|||
162937365|NCT00617461|588473608|FG001|First Treatment Intervention Period|Protocol Violation|1|||
162937366|NCT00617461|588473607|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
163180387|NCT02011893|589375967|FG000|Enrollment to Randomization|Physician Decision|10|||
163180388|NCT02011893|589375968|FG001|Enrollment to Randomization|Physician Decision|0|||
163180389|NCT02011893|589375969|FG002|Enrollment to Randomization|Physician Decision|0|||
162937367|NCT00617461|588473608|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
163180390|NCT02011893|589375967|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
162937368|NCT00617461|588473607|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
162937369|NCT00617461|588473608|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
163180391|NCT02011893|589375968|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
163180392|NCT02011893|589375969|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
163180393|NCT02011893|589375967|FG000|Enrollment to Randomization|Screening Failure|29|||
163180394|NCT02011893|589375968|FG001|Enrollment to Randomization|Screening Failure|0|||
163180395|NCT02011893|589375969|FG002|Enrollment to Randomization|Screening Failure|0|||
163180396|NCT02011893|589375967|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
163180397|NCT02011893|589375968|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
163180398|NCT02011893|589375969|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
163180399|NCT02011893|589375967|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
163180400|NCT02011893|589375968|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
163180401|NCT02011893|589375969|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
163180402|NCT02011893|589375967|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
163180403|NCT02011893|589375968|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
163180404|NCT02011893|589375969|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
163180405|NCT02011893|589375967|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
163180406|NCT02011893|589375968|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
163180407|NCT02011893|589375969|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
163180408|NCT02011893|589375967|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
163180409|NCT02011893|589375968|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
163180410|NCT02011893|589375969|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
163180411|NCT00991952|589375970|FG000|Overall Study|Adverse Event|0|||
163180412|NCT00991952|589375971|FG001|Overall Study|Adverse Event|1|||
163180413|NCT03116347|589375972|FG000|Overall Study|Withdrawal by Subject|1|||
163180414|NCT03116347|589375973|FG001|Overall Study|Withdrawal by Subject|2|||
163180415|NCT01255787|589375974|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
163180416|NCT01255787|589375975|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
163285077|NCT01107626|589753144|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
163042840|NCT01990768|588863969|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
162937370|NCT00617461|588473607|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
163180417|NCT01255787|589375976|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
163180418|NCT01255787|589375977|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
163180419|NCT01255787|589375974|FG000|Overall Study|Major Protocol Deviation|1|||
163180420|NCT01255787|589375975|FG001|Overall Study|Major Protocol Deviation|1|||
163180421|NCT01255787|589375976|FG002|Overall Study|Major Protocol Deviation|0|||
163180422|NCT01255787|589375977|FG003|Overall Study|Major Protocol Deviation|4|||
163180423|NCT01255787|589375974|FG000|Overall Study|Lost to Follow-up|1|||
163180424|NCT01255787|589375975|FG001|Overall Study|Lost to Follow-up|2|||
163180425|NCT01255787|589375976|FG002|Overall Study|Lost to Follow-up|4|||
163180426|NCT01255787|589375977|FG003|Overall Study|Lost to Follow-up|2|||
163180427|NCT01255787|589375974|FG000|Overall Study|Withdrawal of Consent|3|||
163180428|NCT01255787|589375975|FG001|Overall Study|Withdrawal of Consent|9|||
163180429|NCT01255787|589375976|FG002|Overall Study|Withdrawal of Consent|3|||
163180430|NCT01255787|589375977|FG003|Overall Study|Withdrawal of Consent|4|||
163180431|NCT01255787|589375974|FG000|Overall Study|Pregnancy|0|||
163180432|NCT01255787|589375975|FG001|Overall Study|Pregnancy|0|||
163180433|NCT01255787|589375976|FG002|Overall Study|Pregnancy|0|||
163180434|NCT01255787|589375977|FG003|Overall Study|Pregnancy|1|||
162937371|NCT00617461|588473608|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
162937372|NCT00617461|588473607|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
162937373|NCT00617461|588473608|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
163180435|NCT01255787|589375974|FG000|Overall Study|Lack of Efficacy|2|||
163180436|NCT01255787|589375975|FG001|Overall Study|Lack of Efficacy|2|||
163180437|NCT01255787|589375976|FG002|Overall Study|Lack of Efficacy|2|||
163180438|NCT01255787|589375977|FG003|Overall Study|Lack of Efficacy|2|||
163180439|NCT01255787|589375974|FG000|Overall Study|Noncompliance with Study Drug|3|||
163180440|NCT01255787|589375975|FG001|Overall Study|Noncompliance with Study Drug|1|||
163180441|NCT01255787|589375976|FG002|Overall Study|Noncompliance with Study Drug|0|||
163180442|NCT01255787|589375977|FG003|Overall Study|Noncompliance with Study Drug|0|||
163180443|NCT04966741|589375978|FG000|Overall Study|Lost to Follow-up|1|||
163180444|NCT04966741|589375979|FG001|Overall Study|Lost to Follow-up|0|||
163180445|NCT05764265|589375982|FG000|Overall Study|Adverse Event|1|||
163180446|NCT05764265|589375983|FG001|Overall Study|Adverse Event|0|||
163180447|NCT05764265|589375982|FG000|Overall Study|Physician Decision|1|||
163180448|NCT05764265|589375983|FG001|Overall Study|Physician Decision|8|||
163180449|NCT05764265|589375982|FG000|Overall Study|Study Terminated By Sponsor|20|||
163180450|NCT05764265|589375983|FG001|Overall Study|Study Terminated By Sponsor|0|||
163180451|NCT05764265|589375982|FG000|Overall Study|Participant Decision|1|||
163180452|NCT05764265|589375983|FG001|Overall Study|Participant Decision|0|||
163180453|NCT00509262|589375984|FG000|Overall Study|Adverse Event|16|||
163180454|NCT00509262|589375985|FG001|Overall Study|Adverse Event|18|||
163180455|NCT00509262|589375984|FG000|Overall Study|Other|2|||
163180456|NCT00509262|589375985|FG001|Overall Study|Other|2|||
163180457|NCT00509262|589375984|FG000|Overall Study|Lack of Efficacy|1|||
163180458|NCT00509262|589375985|FG001|Overall Study|Lack of Efficacy|0|||
163180459|NCT00509262|589375984|FG000|Overall Study|Lost to Follow-up|1|||
163180460|NCT00509262|589375985|FG001|Overall Study|Lost to Follow-up|6|||
163180461|NCT00509262|589375984|FG000|Overall Study|Physician Decision|1|||
163180462|NCT00509262|589375985|FG001|Overall Study|Physician Decision|3|||
163180463|NCT00509262|589375984|FG000|Overall Study|Protocol Violation|2|||
163180464|NCT00509262|589375985|FG001|Overall Study|Protocol Violation|2|||
163180465|NCT00509262|589375984|FG000|Overall Study|Withdrawal by Subject|24|||
163180466|NCT00509262|589375985|FG001|Overall Study|Withdrawal by Subject|11|||
163180467|NCT00725842|589375986|FG000|Overall Study|Lost to Follow-up|19|||
163180468|NCT00725842|589375986|FG000|Overall Study|Death|1|||
163180469|NCT00725842|589375986|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
163180470|NCT00725842|589375986|FG000|Overall Study|Consent date prior to study start date|5|||
163180471|NCT00725842|589375986|FG000|Overall Study|Inclusion criterion not met|1|||
163285078|NCT01107626|589753145|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
163285079|NCT01107626|589753146|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
163285080|NCT01107626|589753147|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
163180472|NCT00725842|589375986|FG000|Overall Study|No Visit 1 data|1|||
163180473|NCT02009384|589375990|FG000|Overall Study|Death|2|||
163180474|NCT01075191|589375991|FG000|Overall Study|Death|1|||
163180475|NCT01075191|589375991|FG000|Overall Study|Intensification|3|||
163285081|NCT01107626|589753144|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
163285082|NCT01107626|589753145|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
163285083|NCT01107626|589753146|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
163285084|NCT01107626|589753147|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
163285085|NCT01107626|589753144|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
163285086|NCT01107626|589753145|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
163285087|NCT01107626|589753146|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
163285088|NCT01107626|589753147|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
163285089|NCT01107626|589753144|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
163285090|NCT01107626|589753145|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
163285091|NCT01107626|589753146|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
163285092|NCT01107626|589753147|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
163285093|NCT01107626|589753144|FG000|Step 2: Maintenance Therapy|Pain|0|||
163285094|NCT01107626|589753145|FG001|Step 2: Maintenance Therapy|Pain|0|||
163285095|NCT01107626|589753146|FG002|Step 2: Maintenance Therapy|Pain|0|||
163285096|NCT01107626|589753147|FG003|Step 2: Maintenance Therapy|Pain|1|||
162937374|NCT00617461|588473607|FG000|Second Treatment Intervention Period|Adverse Event|0|||
162937375|NCT00617461|588473608|FG001|Second Treatment Intervention Period|Adverse Event|1|||
163285097|NCT01107626|589753144|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
163285098|NCT01107626|589753145|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
163285099|NCT01107626|589753146|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
163285100|NCT01107626|589753147|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
163285101|NCT04381494|589753148|FG000|Overall Study|Early termination of trial|19|||
163285102|NCT04381494|589753148|FG000|Overall Study|Investigator's discretion|1|||
163180476|NCT01075191|589375991|FG000|Overall Study|Co-morbidities|1|||
163180477|NCT01075191|589375991|FG000|Overall Study|Adverse Event|4|||
163180478|NCT01075191|589375991|FG000|Overall Study|Noncompliance|3|||
163180479|NCT01075191|589375991|FG000|Overall Study|Therapy Break|3|||
163180480|NCT01075191|589375991|FG000|Overall Study|Patient's Wish|2|||
163180481|NCT01075191|589375991|FG000|Overall Study|Unknown Reasons|1|||
163180482|NCT01244490|589375996|FG000|Overall Study|Lack of Efficacy|14|||
163180483|NCT01244490|589375997|FG001|Overall Study|Lack of Efficacy|5|||
163180484|NCT01244490|589375998|FG002|Overall Study|Lack of Efficacy|5|||
163180485|NCT01244490|589375996|FG000|Overall Study|Withdrawal by Subject|4|||
163180486|NCT01244490|589375997|FG001|Overall Study|Withdrawal by Subject|4|||
163180487|NCT01244490|589375998|FG002|Overall Study|Withdrawal by Subject|9|||
163180488|NCT01244490|589375996|FG000|Overall Study|Adverse Event|1|||
163180489|NCT01244490|589375997|FG001|Overall Study|Adverse Event|9|||
163180490|NCT01244490|589375998|FG002|Overall Study|Adverse Event|5|||
163180491|NCT01244490|589375996|FG000|Overall Study|Lost to Follow-up|0|||
163180492|NCT01244490|589375997|FG001|Overall Study|Lost to Follow-up|6|||
163180493|NCT01244490|589375998|FG002|Overall Study|Lost to Follow-up|3|||
163180494|NCT01244490|589375996|FG000|Overall Study|Other|0|||
163180495|NCT01244490|589375997|FG001|Overall Study|Other|0|||
163180496|NCT01244490|589375998|FG002|Overall Study|Other|1|||
163180497|NCT02414139|589376003|FG000|Treatment Period|Adverse Event|11|||
163180498|NCT02414139|589376004|FG001|Treatment Period|Adverse Event|6|||
163180499|NCT02414139|589376005|FG002|Treatment Period|Adverse Event|8|||
163180500|NCT02414139|589376006|FG003|Treatment Period|Adverse Event|5|||
163180501|NCT02414139|589376007|FG004|Treatment Period|Adverse Event|14|||
163180502|NCT02414139|589376008|FG005|Treatment Period|Adverse Event|3|||
163180503|NCT02414139|589376009|FG006|Treatment Period|Adverse Event|6|||
163180504|NCT02414139|589376010|FG007|Treatment Period|Adverse Event|1|||
163180505|NCT02414139|589376011|FG008|Treatment Period|Adverse Event|6|||
163180506|NCT02414139|589376012|FG009|Treatment Period|Adverse Event|8|||
163180507|NCT02414139|589376003|FG000|Treatment Period|Death|0|||
163180508|NCT02414139|589376004|FG001|Treatment Period|Death|0|||
163180509|NCT02414139|589376005|FG002|Treatment Period|Death|1|||
163180510|NCT02414139|589376006|FG003|Treatment Period|Death|1|||
163180511|NCT02414139|589376007|FG004|Treatment Period|Death|0|||
163180512|NCT02414139|589376008|FG005|Treatment Period|Death|0|||
163180513|NCT02414139|589376009|FG006|Treatment Period|Death|0|||
163180514|NCT02414139|589376010|FG007|Treatment Period|Death|0|||
163180515|NCT02414139|589376011|FG008|Treatment Period|Death|0|||
163180516|NCT02414139|589376012|FG009|Treatment Period|Death|1|||
163180517|NCT02414139|589376003|FG000|Treatment Period|Physician Decision|5|||
163180518|NCT02414139|589376004|FG001|Treatment Period|Physician Decision|4|||
163180519|NCT02414139|589376005|FG002|Treatment Period|Physician Decision|6|||
163180520|NCT02414139|589376006|FG003|Treatment Period|Physician Decision|1|||
163180521|NCT02414139|589376007|FG004|Treatment Period|Physician Decision|4|||
163180522|NCT02414139|589376008|FG005|Treatment Period|Physician Decision|0|||
163180523|NCT02414139|589376009|FG006|Treatment Period|Physician Decision|2|||
163180524|NCT02414139|589376010|FG007|Treatment Period|Physician Decision|0|||
163180525|NCT02414139|589376011|FG008|Treatment Period|Physician Decision|1|||
163180526|NCT02414139|589376012|FG009|Treatment Period|Physician Decision|4|||
163180527|NCT02414139|589376003|FG000|Treatment Period|Progressive disease|48|||
163180528|NCT02414139|589376004|FG001|Treatment Period|Progressive disease|31|||
163180529|NCT02414139|589376005|FG002|Treatment Period|Progressive disease|37|||
163180530|NCT02414139|589376006|FG003|Treatment Period|Progressive disease|21|||
163180531|NCT02414139|589376007|FG004|Treatment Period|Progressive disease|43|||
163180532|NCT02414139|589376008|FG005|Treatment Period|Progressive disease|12|||
163180533|NCT02414139|589376009|FG006|Treatment Period|Progressive disease|16|||
163180534|NCT02414139|589376010|FG007|Treatment Period|Progressive disease|2|||
163180535|NCT02414139|589376011|FG008|Treatment Period|Progressive disease|20|||
163180536|NCT02414139|589376012|FG009|Treatment Period|Progressive disease|14|||
163180537|NCT02414139|589376003|FG000|Treatment Period|Protocol deviation|0|||
163180538|NCT02414139|589376004|FG001|Treatment Period|Protocol deviation|0|||
163180539|NCT02414139|589376005|FG002|Treatment Period|Protocol deviation|1|||
163180540|NCT02414139|589376006|FG003|Treatment Period|Protocol deviation|0|||
163180541|NCT02414139|589376007|FG004|Treatment Period|Protocol deviation|0|||
163180542|NCT02414139|589376008|FG005|Treatment Period|Protocol deviation|0|||
163180543|NCT02414139|589376009|FG006|Treatment Period|Protocol deviation|0|||
163180544|NCT02414139|589376010|FG007|Treatment Period|Protocol deviation|0|||
163180545|NCT02414139|589376011|FG008|Treatment Period|Protocol deviation|0|||
163180546|NCT02414139|589376012|FG009|Treatment Period|Protocol deviation|0|||
163180547|NCT02414139|589376003|FG000|Treatment Period|Subject/Guardian decision|5|||
163180548|NCT02414139|589376004|FG001|Treatment Period|Subject/Guardian decision|1|||
163180549|NCT02414139|589376005|FG002|Treatment Period|Subject/Guardian decision|1|||
163180550|NCT02414139|589376006|FG003|Treatment Period|Subject/Guardian decision|2|||
163180551|NCT02414139|589376007|FG004|Treatment Period|Subject/Guardian decision|5|||
163180552|NCT02414139|589376008|FG005|Treatment Period|Subject/Guardian decision|0|||
163180553|NCT02414139|589376009|FG006|Treatment Period|Subject/Guardian decision|2|||
163180554|NCT02414139|589376010|FG007|Treatment Period|Subject/Guardian decision|0|||
163180555|NCT02414139|589376011|FG008|Treatment Period|Subject/Guardian decision|1|||
163180556|NCT02414139|589376012|FG009|Treatment Period|Subject/Guardian decision|1|||
163180557|NCT02414139|589376003|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
163180558|NCT02414139|589376004|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
163180559|NCT02414139|589376005|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
163180560|NCT02414139|589376006|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
163180561|NCT02414139|589376007|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
163180562|NCT02414139|589376008|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
163180563|NCT02414139|589376009|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
163180564|NCT02414139|589376010|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
163180565|NCT02414139|589376011|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
163180566|NCT02414139|589376012|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
163180567|NCT02414139|589376003|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
163180568|NCT02414139|589376004|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
163180569|NCT02414139|589376005|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
163180570|NCT02414139|589376006|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
163180571|NCT02414139|589376007|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
163180572|NCT02414139|589376008|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
163180573|NCT02414139|589376009|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
163180574|NCT02414139|589376010|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
163180575|NCT02414139|589376011|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
163180576|NCT02414139|589376012|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
163180577|NCT02414139|589376003|FG000|Post-treatment Efficacy Follow-up|Death|0|||
163180578|NCT02414139|589376004|FG001|Post-treatment Efficacy Follow-up|Death|1|||
163180579|NCT02414139|589376005|FG002|Post-treatment Efficacy Follow-up|Death|0|||
163180580|NCT02414139|589376006|FG003|Post-treatment Efficacy Follow-up|Death|0|||
163180581|NCT02414139|589376007|FG004|Post-treatment Efficacy Follow-up|Death|1|||
163180582|NCT02414139|589376008|FG005|Post-treatment Efficacy Follow-up|Death|0|||
163180583|NCT02414139|589376009|FG006|Post-treatment Efficacy Follow-up|Death|0|||
163180584|NCT02414139|589376010|FG007|Post-treatment Efficacy Follow-up|Death|0|||
163180585|NCT02414139|589376011|FG008|Post-treatment Efficacy Follow-up|Death|0|||
163180586|NCT02414139|589376012|FG009|Post-treatment Efficacy Follow-up|Death|1|||
163180587|NCT02414139|589376003|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
163180588|NCT02414139|589376004|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
163180589|NCT02414139|589376005|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
163180590|NCT02414139|589376006|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
163180591|NCT02414139|589376007|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
163180592|NCT02414139|589376008|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
163180593|NCT02414139|589376009|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
163180594|NCT02414139|589376010|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
163180595|NCT02414139|589376011|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
163180596|NCT02414139|589376012|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
163180597|NCT02414139|589376003|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
163180598|NCT02414139|589376004|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
163180599|NCT02414139|589376005|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
163180600|NCT02414139|589376006|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
163180601|NCT02414139|589376007|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
163180602|NCT02414139|589376008|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
163180603|NCT02414139|589376009|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
163180604|NCT02414139|589376010|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
163180605|NCT02414139|589376011|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
163180606|NCT02414139|589376012|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
163180607|NCT02414139|589376003|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
163180608|NCT02414139|589376004|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
163180609|NCT02414139|589376005|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
163180610|NCT02414139|589376006|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
163180611|NCT02414139|589376007|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
163180612|NCT02414139|589376008|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
163180613|NCT02414139|589376009|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
163180614|NCT02414139|589376010|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
163180615|NCT02414139|589376011|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
163180616|NCT02414139|589376012|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
163180617|NCT02414139|589376003|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
163180618|NCT02414139|589376004|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
163180619|NCT02414139|589376005|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
163180620|NCT02414139|589376006|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
163285103|NCT04381494|589753148|FG000|Overall Study|Withdrawal by Subject|9|||
163285104|NCT04381494|589753148|FG000|Overall Study|NSCLC disease progression|4|||
163285105|NCT04381494|589753148|FG000|Overall Study|Device-Related Adverse Event|2|||
163285106|NCT01977612|589753149|FG000|Overall Study|Lost to Follow-up|1|||
163285107|NCT01977612|589753150|FG001|Overall Study|Lost to Follow-up|1|||
163285108|NCT02715258|589753152|FG000|Overall Study|Withdrawal by Subject|6|||
163285109|NCT02715258|589753153|FG001|Overall Study|Withdrawal by Subject|1|||
163285110|NCT02715258|589753152|FG000|Overall Study|Lost to Follow-up|7|||
163285111|NCT02715258|589753153|FG001|Overall Study|Lost to Follow-up|1|||
163285112|NCT02715258|589753152|FG000|Overall Study|Terminated by Sponsor|0|||
163285113|NCT02715258|589753153|FG001|Overall Study|Terminated by Sponsor|1|||
163285114|NCT02715258|589753152|FG000|Overall Study|Death|0|||
163285115|NCT02715258|589753153|FG001|Overall Study|Death|1|||
163285116|NCT02715258|589753152|FG000|Overall Study|Subject non-compliant|1|||
163285117|NCT02715258|589753153|FG001|Overall Study|Subject non-compliant|1|||
163285118|NCT02715258|589753152|FG000|Overall Study|GCP violation|2|||
163285119|NCT02715258|589753153|FG001|Overall Study|GCP violation|1|||
163285120|NCT04310579|589753160|FG000|Overall Study|Adverse Event|0|||
163285121|NCT04310579|589753161|FG001|Overall Study|Adverse Event|0|||
163285122|NCT04310579|589753162|FG002|Overall Study|Adverse Event|0|||
163285123|NCT04310579|589753163|FG003|Overall Study|Adverse Event|0|||
163285124|NCT04310579|589753164|FG004|Overall Study|Adverse Event|0|||
163285125|NCT04310579|589753165|FG005|Overall Study|Adverse Event|0|||
163285126|NCT04310579|589753166|FG006|Overall Study|Adverse Event|2|||
163285127|NCT04310579|589753167|FG007|Overall Study|Adverse Event|0|||
163285128|NCT04310579|589753168|FG008|Overall Study|Adverse Event|1|||
163285129|NCT04310579|589753169|FG009|Overall Study|Adverse Event|1|||
163285130|NCT04310579|589753170|FG010|Overall Study|Adverse Event|0|||
163285131|NCT04310579|589753160|FG000|Overall Study|Withdrawal by Subject|0|||
163285132|NCT04310579|589753161|FG001|Overall Study|Withdrawal by Subject|0|||
163285133|NCT04310579|589753162|FG002|Overall Study|Withdrawal by Subject|0|||
163285134|NCT04310579|589753163|FG003|Overall Study|Withdrawal by Subject|0|||
163285135|NCT04310579|589753164|FG004|Overall Study|Withdrawal by Subject|0|||
163285136|NCT04310579|589753165|FG005|Overall Study|Withdrawal by Subject|1|||
163285137|NCT04310579|589753166|FG006|Overall Study|Withdrawal by Subject|0|||
163285138|NCT04310579|589753167|FG007|Overall Study|Withdrawal by Subject|0|||
163285139|NCT04310579|589753168|FG008|Overall Study|Withdrawal by Subject|0|||
163285140|NCT04310579|589753169|FG009|Overall Study|Withdrawal by Subject|0|||
163285141|NCT04310579|589753170|FG010|Overall Study|Withdrawal by Subject|0|||
163285142|NCT04310579|589753160|FG000|Overall Study|Positive COVID-19 test|0|||
163285143|NCT04310579|589753161|FG001|Overall Study|Positive COVID-19 test|0|||
163285144|NCT04310579|589753162|FG002|Overall Study|Positive COVID-19 test|0|||
163285145|NCT04310579|589753163|FG003|Overall Study|Positive COVID-19 test|0|||
163285146|NCT04310579|589753164|FG004|Overall Study|Positive COVID-19 test|0|||
163285147|NCT04310579|589753165|FG005|Overall Study|Positive COVID-19 test|0|||
163285148|NCT04310579|589753166|FG006|Overall Study|Positive COVID-19 test|0|||
163285149|NCT04310579|589753167|FG007|Overall Study|Positive COVID-19 test|0|||
163285150|NCT04310579|589753168|FG008|Overall Study|Positive COVID-19 test|0|||
163285151|NCT04310579|589753169|FG009|Overall Study|Positive COVID-19 test|0|||
163285152|NCT04310579|589753170|FG010|Overall Study|Positive COVID-19 test|1|||
163285153|NCT01280591|589753174|FG000|Overall Study|Withdrawal by Subject|0|||
163285154|NCT01280591|589753175|FG001|Overall Study|Withdrawal by Subject|0|||
163285155|NCT01280591|589753176|FG002|Overall Study|Withdrawal by Subject|0|||
163285156|NCT01280591|589753177|FG003|Overall Study|Withdrawal by Subject|2|||
163180621|NCT02414139|589376007|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
163180622|NCT02414139|589376008|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
163180623|NCT02414139|589376009|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
163180624|NCT02414139|589376010|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
163180625|NCT02414139|589376011|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
163180626|NCT02414139|589376012|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
163180627|NCT02414139|589376003|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
163180628|NCT02414139|589376004|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
163285157|NCT01280591|589753174|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
163285158|NCT01280591|589753175|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
163285159|NCT01280591|589753176|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
163285160|NCT01280591|589753177|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
163285161|NCT01117480|589753178|FG000|Overall Study|Protocol Violation|8|||
163285162|NCT01117480|589753178|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
163285163|NCT02955069|589753180|FG000|Overall Study|Adverse Event|7|||
163285164|NCT02955069|589753181|FG001|Overall Study|Adverse Event|2|||
163285165|NCT02955069|589753180|FG000|Overall Study|Death|7|||
163180629|NCT02414139|589376005|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
163180630|NCT02414139|589376006|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
163285166|NCT02955069|589753181|FG001|Overall Study|Death|3|||
163285167|NCT02955069|589753180|FG000|Overall Study|Physician Decision|10|||
163285168|NCT02955069|589753181|FG001|Overall Study|Physician Decision|2|||
163285169|NCT02955069|589753180|FG000|Overall Study|Progressive disease|64|||
163285170|NCT02955069|589753181|FG001|Overall Study|Progressive disease|13|||
163285171|NCT02955069|589753180|FG000|Overall Study|Study terminated by sponsor|4|||
163285172|NCT02955069|589753181|FG001|Overall Study|Study terminated by sponsor|0|||
163285173|NCT02955069|589753180|FG000|Overall Study|Subject/Guardian decision|3|||
163285174|NCT02955069|589753181|FG001|Overall Study|Subject/Guardian decision|1|||
163285175|NCT04083976|589753182|FG000|Overall Study|Lost to Follow-up|3|||
163285176|NCT04083976|589753183|FG001|Overall Study|Lost to Follow-up|0|||
163285177|NCT04083976|589753184|FG002|Overall Study|Lost to Follow-up|0|||
163285178|NCT04083976|589753185|FG003|Overall Study|Lost to Follow-up|1|||
163285179|NCT04083976|589753182|FG000|Overall Study|Withdrawal by Subject|16|||
163285180|NCT04083976|589753183|FG001|Overall Study|Withdrawal by Subject|1|||
163285181|NCT04083976|589753184|FG002|Overall Study|Withdrawal by Subject|9|||
163285182|NCT04083976|589753185|FG003|Overall Study|Withdrawal by Subject|0|||
163285183|NCT04083976|589753182|FG000|Overall Study|Sponsor Decision|14|||
163285184|NCT04083976|589753183|FG001|Overall Study|Sponsor Decision|0|||
163285185|NCT04083976|589753184|FG002|Overall Study|Sponsor Decision|0|||
163285186|NCT04083976|589753185|FG003|Overall Study|Sponsor Decision|7|||
163285187|NCT04083976|589753182|FG000|Overall Study|Other|1|||
163285188|NCT04083976|589753183|FG001|Overall Study|Other|0|||
163285189|NCT04083976|589753184|FG002|Overall Study|Other|1|||
163285190|NCT04083976|589753185|FG003|Overall Study|Other|0|||
163285191|NCT03721016|589753186|FG000|Overall Study|Adverse Event|0|||
163285192|NCT03721016|589753187|FG001|Overall Study|Adverse Event|1|||
163285193|NCT03721016|589753188|FG002|Overall Study|Adverse Event|1|||
163285194|NCT03721016|589753186|FG000|Overall Study|Withdrawal by Subject|8|||
163285195|NCT03721016|589753187|FG001|Overall Study|Withdrawal by Subject|16|||
163285196|NCT03721016|589753188|FG002|Overall Study|Withdrawal by Subject|13|||
163285197|NCT03721016|589753186|FG000|Overall Study|Lost to Follow-up|4|||
163285198|NCT03721016|589753187|FG001|Overall Study|Lost to Follow-up|6|||
163285199|NCT03721016|589753188|FG002|Overall Study|Lost to Follow-up|5|||
163285200|NCT03721016|589753186|FG000|Overall Study|Physician Decision|0|||
163285201|NCT03721016|589753187|FG001|Overall Study|Physician Decision|1|||
163285202|NCT03721016|589753188|FG002|Overall Study|Physician Decision|2|||
163285203|NCT03721016|589753186|FG000|Overall Study|Protocol Violation|0|||
163285204|NCT03721016|589753187|FG001|Overall Study|Protocol Violation|1|||
163285205|NCT03721016|589753188|FG002|Overall Study|Protocol Violation|0|||
163285206|NCT03721016|589753186|FG000|Overall Study|Site terminated by sponsor|3|||
163285207|NCT03721016|589753187|FG001|Overall Study|Site terminated by sponsor|7|||
163285208|NCT03721016|589753188|FG002|Overall Study|Site terminated by sponsor|6|||
163285209|NCT03721016|589753186|FG000|Overall Study|Subject exited early due to COVID-19|1|||
163285210|NCT03721016|589753187|FG001|Overall Study|Subject exited early due to COVID-19|0|||
163285211|NCT03721016|589753188|FG002|Overall Study|Subject exited early due to COVID-19|0|||
163285212|NCT03357341|589753189|FG000|Overall Study|Withdrawal by Subject|3|||
163180631|NCT02414139|589376007|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
163180632|NCT02414139|589376008|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
163180633|NCT02414139|589376009|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
163180634|NCT02414139|589376010|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
163180635|NCT02414139|589376011|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
163180636|NCT02414139|589376012|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
163180637|NCT01226121|589376013|FG000|Overall Study|Lost to Follow-up|2|||
163180638|NCT01226121|589376014|FG001|Overall Study|Lost to Follow-up|0|||
163180639|NCT01226121|589376015|FG002|Overall Study|Lost to Follow-up|1|||
163180640|NCT03324581|589376016|FG000|Overall Study|Adverse Event|18|||
163180641|NCT03324581|589376017|FG001|Overall Study|Adverse Event|11|||
163180642|NCT03324581|589376018|FG002|Overall Study|Adverse Event|7|||
163180643|NCT03324581|589376016|FG000|Overall Study|Lack of Efficacy|0|||
163180644|NCT03324581|589376017|FG001|Overall Study|Lack of Efficacy|1|||
163180645|NCT03324581|589376018|FG002|Overall Study|Lack of Efficacy|0|||
163180646|NCT03324581|589376016|FG000|Overall Study|Lost to Follow-up|5|||
163180647|NCT03324581|589376017|FG001|Overall Study|Lost to Follow-up|3|||
163180648|NCT03324581|589376018|FG002|Overall Study|Lost to Follow-up|6|||
163180649|NCT03324581|589376016|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
163180650|NCT03324581|589376017|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
163180651|NCT03324581|589376018|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
163285213|NCT03357341|589753190|FG001|Overall Study|Withdrawal by Subject|6|||
163285214|NCT03357341|589753189|FG000|Overall Study|Lost to Follow-up|4|||
163285215|NCT03357341|589753190|FG001|Overall Study|Lost to Follow-up|5|||
163285216|NCT03357341|589753189|FG000|Overall Study|Death|0|||
163285217|NCT03357341|589753190|FG001|Overall Study|Death|1|||
163285218|NCT01908634|589753193|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
163180652|NCT03324581|589376016|FG000|Overall Study|Physician Decision|0|||
163285219|NCT01908634|589753193|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
163285220|NCT01072357|589753195|FG000|Overall Study|Lost to Follow-up|0|||
163285221|NCT01072357|589753196|FG001|Overall Study|Lost to Follow-up|1|||
163285222|NCT01876511|589753197|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
163285223|NCT01876511|589753198|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
163285224|NCT01876511|589753199|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
163285225|NCT01876511|589753197|FG000|Overall Study|Death (unrelated)|3|||
163285226|NCT01876511|589753198|FG001|Overall Study|Death (unrelated)|0|||
163285227|NCT01876511|589753199|FG002|Overall Study|Death (unrelated)|2|||
163285228|NCT01876511|589753197|FG000|Overall Study|Drug-related Toxicity|5|||
163285229|NCT01876511|589753198|FG001|Overall Study|Drug-related Toxicity|1|||
163285230|NCT01876511|589753199|FG002|Overall Study|Drug-related Toxicity|6|||
163285231|NCT01876511|589753197|FG000|Overall Study|Patient Decision|3|||
163285232|NCT01876511|589753198|FG001|Overall Study|Patient Decision|0|||
163285233|NCT01876511|589753199|FG002|Overall Study|Patient Decision|6|||
163285234|NCT01876511|589753197|FG000|Overall Study|Physician Decision|1|||
163285235|NCT01876511|589753198|FG001|Overall Study|Physician Decision|0|||
163285236|NCT01876511|589753199|FG002|Overall Study|Physician Decision|1|||
163285237|NCT02131324|589753200|FG000|Overall Study|Withdrawal by Subject|1|||
163285238|NCT02131324|589753201|FG001|Overall Study|Withdrawal by Subject|2|||
163285239|NCT02131324|589753200|FG000|Overall Study|Lost to Follow-up|1|||
163285240|NCT02131324|589753201|FG001|Overall Study|Lost to Follow-up|1|||
163285241|NCT05790408|589753202|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
163285242|NCT01048788|589753203|FG000|Overall Study|Adverse Event|5|||
163285243|NCT01048788|589753204|FG001|Overall Study|Adverse Event|1|||
163285244|NCT01048788|589753205|FG002|Overall Study|Adverse Event|1|||
163285245|NCT01048788|589753203|FG000|Overall Study|Lack of Efficacy|0|||
163285246|NCT01048788|589753204|FG001|Overall Study|Lack of Efficacy|0|||
163285247|NCT01048788|589753205|FG002|Overall Study|Lack of Efficacy|1|||
163285248|NCT01048788|589753203|FG000|Overall Study|Withdrawal by Subject|0|||
163285249|NCT01048788|589753204|FG001|Overall Study|Withdrawal by Subject|1|||
163285250|NCT01048788|589753205|FG002|Overall Study|Withdrawal by Subject|0|||
163285251|NCT01233050|589753206|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
163285252|NCT01233050|589753207|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
163285253|NCT04582877|589753212|FG000|Overall Study|Did not use device measurement|5|||
163285254|NCT04582877|589753212|FG000|Overall Study|No fractional flow reserve test results|2|||
163180653|NCT03324581|589376017|FG001|Overall Study|Physician Decision|1|||
163180654|NCT03324581|589376018|FG002|Overall Study|Physician Decision|2|||
163180655|NCT03324581|589376016|FG000|Overall Study|Protocol Deviation|8|||
163180656|NCT03324581|589376017|FG001|Overall Study|Protocol Deviation|9|||
163180657|NCT03324581|589376018|FG002|Overall Study|Protocol Deviation|4|||
163180658|NCT03324581|589376016|FG000|Overall Study|Withdrawal by Subject|6|||
163180659|NCT03324581|589376017|FG001|Overall Study|Withdrawal by Subject|8|||
163180660|NCT03324581|589376018|FG002|Overall Study|Withdrawal by Subject|6|||
163180661|NCT03324581|589376016|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
163180662|NCT03324581|589376017|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
163180663|NCT03324581|589376018|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
163180664|NCT04473482|589376019|FG000|Overall Study|Death|0|||
163180665|NCT04473482|589376020|FG001|Overall Study|Death|3|||
163180666|NCT04473482|589376019|FG000|Overall Study|Lost to Follow-up|9|||
163180667|NCT04473482|589376020|FG001|Overall Study|Lost to Follow-up|7|||
163180668|NCT04473482|589376019|FG000|Overall Study|Withdrawal by Subject|2|||
163180669|NCT04473482|589376020|FG001|Overall Study|Withdrawal by Subject|1|||
163180670|NCT00266864|589376022|FG000|Overall Study|Lost to Follow-up|4|||
163180671|NCT00266864|589376023|FG001|Overall Study|Lost to Follow-up|1|||
163180672|NCT00266864|589376022|FG000|Overall Study|Withdrawal by Subject|1|||
163180673|NCT00266864|589376023|FG001|Overall Study|Withdrawal by Subject|1|||
163180674|NCT00727532|589376024|FG000|Overall Study|Adverse Event|1|||
163180675|NCT00727532|589376024|FG000|Overall Study|Withdrawal by Subject|1|||
163180676|NCT00829933|589376025|FG000|Overall Study|Adverse Event|2|||
163180677|NCT00829933|589376026|FG001|Overall Study|Adverse Event|3|||
163180678|NCT00829933|589376027|FG002|Overall Study|Adverse Event|2|||
163180679|NCT00829933|589376028|FG003|Overall Study|Adverse Event|1|||
163180680|NCT00829933|589376025|FG000|Overall Study|Death|0|||
163180681|NCT00829933|589376026|FG001|Overall Study|Death|0|||
163285255|NCT04582877|589753212|FG000|Overall Study|Protocol Violation|1|||
163285256|NCT01664104|589753219|FG000|Overall Study|Adverse Event|6|||
163180682|NCT00829933|589376027|FG002|Overall Study|Death|1|||
163180683|NCT00829933|589376028|FG003|Overall Study|Death|1|||
163180684|NCT00829933|589376025|FG000|Overall Study|Lack of Efficacy|0|||
163180685|NCT00829933|589376026|FG001|Overall Study|Lack of Efficacy|1|||
163180686|NCT00829933|589376027|FG002|Overall Study|Lack of Efficacy|0|||
163180687|NCT00829933|589376028|FG003|Overall Study|Lack of Efficacy|0|||
163180688|NCT00829933|589376025|FG000|Overall Study|Physician Decision|5|||
163180689|NCT00829933|589376026|FG001|Overall Study|Physician Decision|7|||
163180690|NCT00829933|589376027|FG002|Overall Study|Physician Decision|8|||
163285257|NCT01664104|589753219|FG000|Overall Study|Lack of Efficacy|2|||
163285258|NCT01664104|589753219|FG000|Overall Study|Withdrawal by Subject|1|||
163285259|NCT01664104|589753219|FG000|Overall Study|Lost to Follow-up|4|||
163285260|NCT01664104|589753219|FG000|Overall Study|Other|1|||
163285261|NCT01664104|589753219|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
163285262|NCT02449044|589753227|FG000|Overall Study|Lost to Follow-up|2|||
163285263|NCT02449044|589753227|FG000|Overall Study|Withdrawal by Subject|13|||
163285264|NCT02449044|589753227|FG000|Overall Study|Adverse Event|30|||
163285265|NCT02449044|589753227|FG000|Overall Study|Met Withdrawal Criteria|7|||
163285266|NCT02449044|589753227|FG000|Overall Study|Physician Decision|9|||
163285267|NCT02449044|589753227|FG000|Overall Study|Sponsor Discontinued Trial|3|||
163285268|NCT00943605|589755440|FG000|Overall Study|Study termination|30|||
163285269|NCT00943605|589755441|FG001|Overall Study|Study termination|30|||
163285270|NCT02232178|589755443|FG000|Overall Study|Lost to Follow-up|0|||
163285271|NCT02232178|589755444|FG001|Overall Study|Lost to Follow-up|1|||
163285272|NCT02232178|589755445|FG002|Overall Study|Lost to Follow-up|0|||
163285273|NCT02232178|589755443|FG000|Overall Study|ineligibility|0|||
163285274|NCT02232178|589755444|FG001|Overall Study|ineligibility|0|||
163285275|NCT02232178|589755445|FG002|Overall Study|ineligibility|1|||
163285276|NCT02232178|589755443|FG000|Overall Study|surgical complication|1|||
163285277|NCT02232178|589755444|FG001|Overall Study|surgical complication|0|||
163285278|NCT02232178|589755445|FG002|Overall Study|surgical complication|0|||
163285279|NCT01956669|589755448|FG000|Overall Study|Disease Progression|12|||
163285280|NCT01956669|589755449|FG001|Overall Study|Disease Progression|7|||
163285281|NCT01956669|589755450|FG002|Overall Study|Disease Progression|7|||
163285282|NCT01956669|589755451|FG003|Overall Study|Disease Progression|8|||
163285283|NCT01956669|589755452|FG004|Overall Study|Disease Progression|4|||
163285284|NCT01956669|589755453|FG005|Overall Study|Disease Progression|3|||
163285285|NCT01956669|589755454|FG006|Overall Study|Disease Progression|5|||
163285286|NCT01956669|589755448|FG000|Overall Study|Adverse Event|0|||
163285287|NCT01956669|589755449|FG001|Overall Study|Adverse Event|2|||
163285288|NCT01956669|589755450|FG002|Overall Study|Adverse Event|2|||
163285289|NCT01956669|589755451|FG003|Overall Study|Adverse Event|1|||
163285290|NCT01956669|589755452|FG004|Overall Study|Adverse Event|0|||
163285291|NCT01956669|589755453|FG005|Overall Study|Adverse Event|0|||
163285292|NCT01956669|589755454|FG006|Overall Study|Adverse Event|0|||
163285293|NCT01956669|589755448|FG000|Overall Study|Physician Decision|0|||
163285294|NCT01956669|589755449|FG001|Overall Study|Physician Decision|2|||
163285295|NCT01956669|589755450|FG002|Overall Study|Physician Decision|0|||
163285296|NCT01956669|589755451|FG003|Overall Study|Physician Decision|0|||
163285297|NCT01956669|589755452|FG004|Overall Study|Physician Decision|0|||
163285298|NCT01956669|589755453|FG005|Overall Study|Physician Decision|1|||
163285299|NCT01956669|589755454|FG006|Overall Study|Physician Decision|0|||
163285300|NCT01956669|589755448|FG000|Overall Study|Withdrawal by Subject|0|||
163285301|NCT01956669|589755449|FG001|Overall Study|Withdrawal by Subject|0|||
163285302|NCT01956669|589755450|FG002|Overall Study|Withdrawal by Subject|1|||
163285303|NCT01956669|589755451|FG003|Overall Study|Withdrawal by Subject|1|||
163285304|NCT01956669|589755452|FG004|Overall Study|Withdrawal by Subject|0|||
163285305|NCT01956669|589755453|FG005|Overall Study|Withdrawal by Subject|0|||
163285306|NCT01956669|589755454|FG006|Overall Study|Withdrawal by Subject|1|||
163285307|NCT01570751|589755455|FG000|Period A (16 Weeks)|Protocol Violation|1|||
163285308|NCT01570751|589755456|FG001|Period A (16 Weeks)|Protocol Violation|1|||
163285309|NCT01570751|589755455|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
163285310|NCT01570751|589755456|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
163285311|NCT01570751|589755455|FG000|Period A (16 Weeks)|Unclassified|2|||
163285312|NCT01570751|589755456|FG001|Period A (16 Weeks)|Unclassified|3|||
163285313|NCT01570751|589755455|FG000|Period B (16 Weeks)|Adverse Event|1|||
163285314|NCT01570751|589755456|FG001|Period B (16 Weeks)|Adverse Event|0|||
163285315|NCT01570751|589755455|FG000|Period B (16 Weeks)|Protocol Violation|0|||
163285316|NCT01570751|589755456|FG001|Period B (16 Weeks)|Protocol Violation|1|||
163285317|NCT01131494|589755461|FG000|Overall Study|Withdrawal by Subject|2|||
163285318|NCT05419557|589755462|FG000|Overall Study|Lost to Follow-up|11|||
163285319|NCT05419557|589755463|FG001|Overall Study|Lost to Follow-up|4|||
163285320|NCT01196988|589755465|FG000|Overall Study|Adverse Event|1|||
163285321|NCT01196988|589755466|FG001|Overall Study|Adverse Event|2|||
163285322|NCT01196988|589755467|FG002|Overall Study|Adverse Event|0|||
163285323|NCT01196988|589755468|FG003|Overall Study|Adverse Event|0|||
163285324|NCT01196988|589755465|FG000|Overall Study|Withdrawal by Subject|5|||
163285325|NCT01196988|589755466|FG001|Overall Study|Withdrawal by Subject|1|||
163285326|NCT01196988|589755467|FG002|Overall Study|Withdrawal by Subject|4|||
163285327|NCT01196988|589755468|FG003|Overall Study|Withdrawal by Subject|0|||
163285328|NCT01196988|589755465|FG000|Overall Study|Lost to Follow-up|16|||
163285329|NCT01196988|589755466|FG001|Overall Study|Lost to Follow-up|29|||
163285330|NCT01196988|589755467|FG002|Overall Study|Lost to Follow-up|21|||
163285331|NCT01196988|589755468|FG003|Overall Study|Lost to Follow-up|1|||
163285332|NCT01196988|589755465|FG000|Overall Study|Other|2|||
163285333|NCT01196988|589755466|FG001|Overall Study|Other|0|||
163285334|NCT01196988|589755467|FG002|Overall Study|Other|0|||
163285335|NCT01196988|589755468|FG003|Overall Study|Other|0|||
163285336|NCT02281318|589755470|FG000|Overall Study|Adverse Event|2|||
163285337|NCT02281318|589755471|FG001|Overall Study|Adverse Event|2|||
163285338|NCT02281318|589755470|FG000|Overall Study|Lack of Efficacy|2|||
162937376|NCT00617461|588473607|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
163180691|NCT00829933|589376028|FG003|Overall Study|Physician Decision|1|||
163180692|NCT00829933|589376025|FG000|Overall Study|Pregnancy|0|||
163180693|NCT00829933|589376026|FG001|Overall Study|Pregnancy|0|||
163180694|NCT00829933|589376027|FG002|Overall Study|Pregnancy|0|||
163180695|NCT00829933|589376028|FG003|Overall Study|Pregnancy|2|||
163180696|NCT00829933|589376025|FG000|Overall Study|Protocol Violation|2|||
163180697|NCT00829933|589376026|FG001|Overall Study|Protocol Violation|1|||
163180698|NCT00829933|589376027|FG002|Overall Study|Protocol Violation|0|||
163180699|NCT00829933|589376028|FG003|Overall Study|Protocol Violation|0|||
163180700|NCT00829933|589376025|FG000|Overall Study|withdrew before treatment started|5|||
163180701|NCT00829933|589376026|FG001|Overall Study|withdrew before treatment started|1|||
163180702|NCT00829933|589376027|FG002|Overall Study|withdrew before treatment started|2|||
163180703|NCT00829933|589376028|FG003|Overall Study|withdrew before treatment started|9|||
163180704|NCT03687970|589376032|FG000|Overall Study|visit scheduling conflicts|2|||
163180705|NCT03687970|589376033|FG001|Overall Study|visit scheduling conflicts|0|||
163180706|NCT00686998|589376034|FG000|Overall Study|Adverse Event|3|||
163180707|NCT00686998|589376035|FG001|Overall Study|Adverse Event|2|||
163180708|NCT00686998|589376036|FG002|Overall Study|Adverse Event|1|||
163180709|NCT00686998|589376034|FG000|Overall Study|Withdrawal by Subject|2|||
163180710|NCT00686998|589376035|FG001|Overall Study|Withdrawal by Subject|1|||
163180711|NCT00686998|589376036|FG002|Overall Study|Withdrawal by Subject|2|||
163180712|NCT00686998|589376034|FG000|Overall Study|Lack of Efficacy|7|||
163180713|NCT00686998|589376035|FG001|Overall Study|Lack of Efficacy|5|||
163180714|NCT00686998|589376036|FG002|Overall Study|Lack of Efficacy|0|||
163180715|NCT00686998|589376034|FG000|Overall Study|Other|0|||
163180716|NCT00686998|589376035|FG001|Overall Study|Other|0|||
163180717|NCT00686998|589376036|FG002|Overall Study|Other|1|||
163180718|NCT00686998|589376034|FG000|Overall Study|Safety Reasons|1|||
163180719|NCT00686998|589376035|FG001|Overall Study|Safety Reasons|0|||
163180720|NCT00686998|589376036|FG002|Overall Study|Safety Reasons|0|||
163180721|NCT06374394|589376040|FG000|Overall Study|Adverse Event|0|||
163180722|NCT06374394|589376041|FG001|Overall Study|Adverse Event|2|||
163180723|NCT06374394|589376040|FG000|Overall Study|Lost to Follow-up|6|||
163180724|NCT06374394|589376041|FG001|Overall Study|Lost to Follow-up|9|||
163180725|NCT06374394|589376040|FG000|Overall Study|Withdrawal by Subject|1|||
163180726|NCT06374394|589376041|FG001|Overall Study|Withdrawal by Subject|7|||
163180727|NCT06374394|589376040|FG000|Overall Study|Other|1|||
163180728|NCT06374394|589376041|FG001|Overall Study|Other|0|||
163180729|NCT00356122|589376042|FG000|TREATMENT|Lack of Efficacy|26|||
163180730|NCT00356122|589376042|FG000|TREATMENT|Adverse Event|10|||
163180731|NCT00356122|589376042|FG000|TREATMENT|Subject's request|4|||
163180732|NCT00356122|589376042|FG000|TREATMENT|Other|4|||
163180733|NCT00356122|589376042|FG000|TREATMENT|Did not receive study medication|1|||
163180734|NCT00356122|589376042|FG000|FOLLOW-UP|Death|37|||
163180735|NCT00356122|589376042|FG000|FOLLOW-UP|Lost to Follow-up|2|||
163180736|NCT00356122|589376042|FG000|FOLLOW-UP|Other|2|||
163180737|NCT00543855|589377117|FG000|Overall Study|Adverse Event|3|||
163180738|NCT00543855|589377118|FG001|Overall Study|Adverse Event|1|||
163180739|NCT00543855|589377119|FG002|Overall Study|Adverse Event|3|||
163180740|NCT00543855|589377120|FG003|Overall Study|Adverse Event|4|||
163180741|NCT00543855|589377117|FG000|Overall Study|Lost to Follow-up|0|||
163180742|NCT00543855|589377118|FG001|Overall Study|Lost to Follow-up|0|||
163180743|NCT00543855|589377119|FG002|Overall Study|Lost to Follow-up|1|||
163180744|NCT00543855|589377120|FG003|Overall Study|Lost to Follow-up|0|||
163180745|NCT00543855|589377117|FG000|Overall Study|Withdrawal by Subject|0|||
163180746|NCT00543855|589377118|FG001|Overall Study|Withdrawal by Subject|1|||
163180747|NCT00543855|589377119|FG002|Overall Study|Withdrawal by Subject|2|||
163180748|NCT00543855|589377120|FG003|Overall Study|Withdrawal by Subject|0|||
163180749|NCT00543855|589377117|FG000|Overall Study|Protocol Violation|1|||
163180750|NCT00543855|589377118|FG001|Overall Study|Protocol Violation|0|||
163180751|NCT00543855|589377119|FG002|Overall Study|Protocol Violation|0|||
163180752|NCT00543855|589377120|FG003|Overall Study|Protocol Violation|0|||
163180753|NCT01994590|589377124|FG000|Overall Study|Adverse Event|1|||
163180754|NCT01994590|589377124|FG000|Overall Study|Trial Terminated|1|||
163180755|NCT00719264|589377126|FG000|Overall Study|Adverse Event|41|||
163180756|NCT00719264|589377127|FG001|Overall Study|Adverse Event|49|||
163180757|NCT00719264|589377126|FG000|Overall Study|Death|13|||
163180758|NCT00719264|589377127|FG001|Overall Study|Death|10|||
163180759|NCT00719264|589377126|FG000|Overall Study|Administrative Problems|6|||
163180760|NCT00719264|589377127|FG001|Overall Study|Administrative Problems|4|||
163180761|NCT00719264|589377126|FG000|Overall Study|Lost to Follow-up|1|||
163180762|NCT00719264|589377127|FG001|Overall Study|Lost to Follow-up|1|||
163180763|NCT00719264|589377126|FG000|Overall Study|Withdrawal by Subject|12|||
163180764|NCT00719264|589377127|FG001|Overall Study|Withdrawal by Subject|7|||
163180765|NCT00719264|589377126|FG000|Overall Study|Protocol Deviation|1|||
163180766|NCT00719264|589377127|FG001|Overall Study|Protocol Deviation|3|||
163180767|NCT00719264|589377126|FG000|Overall Study|New Cancer Therapy|4|||
163180768|NCT00719264|589377127|FG001|Overall Study|New Cancer Therapy|2|||
163180769|NCT00719264|589377126|FG000|Overall Study|Disease Progression|104|||
163285339|NCT02281318|589755471|FG001|Overall Study|Lack of Efficacy|0|||
163285340|NCT02281318|589755470|FG000|Overall Study|Lost to Follow-up|2|||
163285341|NCT02281318|589755471|FG001|Overall Study|Lost to Follow-up|1|||
163285342|NCT02281318|589755470|FG000|Overall Study|Physician Decision|2|||
163285343|NCT02281318|589755471|FG001|Overall Study|Physician Decision|0|||
163285344|NCT02281318|589755470|FG000|Overall Study|Withdrawal by Subject|6|||
163285345|NCT02281318|589755471|FG001|Overall Study|Withdrawal by Subject|2|||
163285346|NCT05257798|589755472|FG000|Follow-up Phase|Lost to Follow-up|1|||
163285347|NCT05257798|589755473|FG001|Follow-up Phase|Lost to Follow-up|0|||
163285348|NCT00703911|589755474|FG000|Overall Study|Death|1|||
163285349|NCT00703911|589755474|FG000|Overall Study|Physician Decision|6|||
163285350|NCT00703911|589755474|FG000|Overall Study|Lost to Follow-up|1|||
163285351|NCT00703911|589755474|FG000|Overall Study|Withdrawal by Subject|2|||
163285352|NCT01064817|589755475|FG000|Study Completion|Physician Decision|1|||
163285353|NCT01064817|589755476|FG001|Study Completion|Physician Decision|0|||
163285354|NCT01064817|589755475|FG000|Study Completion|Withdrawal by Subject|1|||
163285355|NCT01064817|589755476|FG001|Study Completion|Withdrawal by Subject|0|||
163285356|NCT03102710|589755477|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
163285357|NCT03102710|589755478|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
163285358|NCT03102710|589755479|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
163285359|NCT03102710|589755477|FG000|Overall Study|Technical issues during final MRI scan|0|||
163285360|NCT03102710|589755478|FG001|Overall Study|Technical issues during final MRI scan|1|||
163285361|NCT03102710|589755479|FG002|Overall Study|Technical issues during final MRI scan|0|||
163285362|NCT03102710|589755477|FG000|Overall Study|Nausea during MRI scan|0|||
163285363|NCT03102710|589755478|FG001|Overall Study|Nausea during MRI scan|1|||
163285364|NCT03102710|589755479|FG002|Overall Study|Nausea during MRI scan|0|||
163285365|NCT03102710|589755477|FG000|Overall Study|Subject unable to attend final session|0|||
163285366|NCT03102710|589755478|FG001|Overall Study|Subject unable to attend final session|1|||
163285367|NCT03102710|589755479|FG002|Overall Study|Subject unable to attend final session|0|||
163285368|NCT01368406|589755480|FG000|Overall Study|Lost to Follow-up|8|||
163285369|NCT01368406|589755481|FG001|Overall Study|Lost to Follow-up|4|||
163285370|NCT01368406|589755480|FG000|Overall Study|Withdrawal by Subject|8|||
163285371|NCT01368406|589755481|FG001|Overall Study|Withdrawal by Subject|4|||
163285372|NCT01368406|589755480|FG000|Overall Study|relapse of the disease|3|||
163285373|NCT01368406|589755481|FG001|Overall Study|relapse of the disease|2|||
163285374|NCT01368406|589755480|FG000|Overall Study|started working|2|||
163285375|NCT01368406|589755481|FG001|Overall Study|started working|3|||
163285376|NCT04304534|589755482|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
163285377|NCT04304534|589755483|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
163285378|NCT04304534|589755484|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
163285379|NCT04304534|589755485|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
163285380|NCT04304534|589755482|FG000|Overall Study|Non-Compliance with study drug|0|||
163285381|NCT04304534|589755483|FG001|Overall Study|Non-Compliance with study drug|1|||
163285382|NCT04304534|589755484|FG002|Overall Study|Non-Compliance with study drug|1|||
163285383|NCT04304534|589755485|FG003|Overall Study|Non-Compliance with study drug|1|||
163285384|NCT04304534|589755482|FG000|Overall Study|Lost to Follow-up|0|||
163285385|NCT04304534|589755483|FG001|Overall Study|Lost to Follow-up|1|||
163285386|NCT04304534|589755484|FG002|Overall Study|Lost to Follow-up|2|||
163285387|NCT04304534|589755485|FG003|Overall Study|Lost to Follow-up|3|||
163285388|NCT04304534|589755482|FG000|Overall Study|Unspecific|4|||
163285389|NCT04304534|589755483|FG001|Overall Study|Unspecific|2|||
163285390|NCT04304534|589755484|FG002|Overall Study|Unspecific|2|||
163285391|NCT04304534|589755485|FG003|Overall Study|Unspecific|2|||
163285392|NCT04304534|589755482|FG000|Overall Study|Technical Problems|2|||
163285393|NCT04304534|589755483|FG001|Overall Study|Technical Problems|2|||
163285394|NCT04304534|589755484|FG002|Overall Study|Technical Problems|3|||
163285395|NCT04304534|589755485|FG003|Overall Study|Technical Problems|4|||
163285396|NCT04304534|589755482|FG000|Overall Study|Death|7|||
163285397|NCT04304534|589755483|FG001|Overall Study|Death|2|||
163285398|NCT04304534|589755484|FG002|Overall Study|Death|4|||
163285399|NCT04304534|589755485|FG003|Overall Study|Death|3|||
163285400|NCT04304534|589755482|FG000|Overall Study|Withdrawal by Subject|7|||
163285401|NCT04304534|589755483|FG001|Overall Study|Withdrawal by Subject|2|||
163285402|NCT04304534|589755484|FG002|Overall Study|Withdrawal by Subject|7|||
163285403|NCT04304534|589755485|FG003|Overall Study|Withdrawal by Subject|4|||
163285404|NCT04304534|589755482|FG000|Overall Study|Physician Decision|4|||
163285405|NCT04304534|589755483|FG001|Overall Study|Physician Decision|9|||
163285406|NCT04304534|589755484|FG002|Overall Study|Physician Decision|9|||
163285407|NCT04304534|589755485|FG003|Overall Study|Physician Decision|5|||
163285408|NCT04304534|589755482|FG000|Overall Study|Subject Decision|34|||
163285409|NCT04304534|589755483|FG001|Overall Study|Subject Decision|25|||
163285410|NCT04304534|589755484|FG002|Overall Study|Subject Decision|25|||
163285411|NCT04304534|589755485|FG003|Overall Study|Subject Decision|26|||
163285412|NCT04304534|589755482|FG000|Overall Study|Adverse Event|35|||
163285413|NCT04304534|589755483|FG001|Overall Study|Adverse Event|40|||
163285414|NCT04304534|589755484|FG002|Overall Study|Adverse Event|39|||
163180770|NCT00719264|589377127|FG001|Overall Study|Disease Progression|107|||
163180771|NCT01277042|589377128|FG000|Overall Study|Adverse Event|4|||
163180772|NCT01277042|589377129|FG001|Overall Study|Adverse Event|3|||
163180773|NCT01277042|589377128|FG000|Overall Study|Lost to Follow-up|2|||
163180774|NCT01277042|589377129|FG001|Overall Study|Lost to Follow-up|2|||
163180775|NCT01277042|589377128|FG000|Overall Study|Withdrawal by Subject|2|||
163180776|NCT01277042|589377129|FG001|Overall Study|Withdrawal by Subject|0|||
163180777|NCT03581786|589377134|FG000|Overall Study|Death|67|||
163180778|NCT03581786|589377135|FG001|Overall Study|Death|47|||
163180779|NCT03581786|589377134|FG000|Overall Study|Withdrawal by Subject|2|||
163180780|NCT03581786|589377135|FG001|Overall Study|Withdrawal by Subject|5|||
163180781|NCT03581786|589377134|FG000|Overall Study|Lost to Follow-up|7|||
163180782|NCT03581786|589377135|FG001|Overall Study|Lost to Follow-up|4|||
163180783|NCT03581786|589377134|FG000|Overall Study|reason other than specified above|0|||
163180784|NCT03581786|589377135|FG001|Overall Study|reason other than specified above|1|||
163180785|NCT02469038|589377138|FG000|Overall Study|Physician Decision|4|||
163180786|NCT02469038|589377139|FG001|Overall Study|Physician Decision|5|||
163180787|NCT03435640|589377140|FG000|Overall Study|Withdrawal by Subject|0|||
163180788|NCT03435640|589377141|FG001|Overall Study|Withdrawal by Subject|1|||
163180789|NCT03435640|589377142|FG002|Overall Study|Withdrawal by Subject|0|||
163180790|NCT03435640|589377143|FG003|Overall Study|Withdrawal by Subject|2|||
163180791|NCT03435640|589377144|FG004|Overall Study|Withdrawal by Subject|0|||
163180792|NCT03435640|589377145|FG005|Overall Study|Withdrawal by Subject|0|||
163180793|NCT03435640|589377146|FG006|Overall Study|Withdrawal by Subject|3|||
163180794|NCT03435640|589377147|FG007|Overall Study|Withdrawal by Subject|0|||
163180795|NCT03435640|589377148|FG008|Overall Study|Withdrawal by Subject|0|||
163180796|NCT03435640|589377149|FG009|Overall Study|Withdrawal by Subject|2|||
163180797|NCT03435640|589377150|FG010|Overall Study|Withdrawal by Subject|3|||
163180798|NCT03435640|589377140|FG000|Overall Study|Lost to Follow-up|0|||
163180799|NCT03435640|589377141|FG001|Overall Study|Lost to Follow-up|0|||
163180800|NCT03435640|589377142|FG002|Overall Study|Lost to Follow-up|1|||
163180801|NCT03435640|589377143|FG003|Overall Study|Lost to Follow-up|0|||
163180802|NCT03435640|589377144|FG004|Overall Study|Lost to Follow-up|0|||
163180803|NCT03435640|589377145|FG005|Overall Study|Lost to Follow-up|0|||
163180804|NCT03435640|589377146|FG006|Overall Study|Lost to Follow-up|0|||
163180805|NCT03435640|589377147|FG007|Overall Study|Lost to Follow-up|0|||
163180806|NCT03435640|589377148|FG008|Overall Study|Lost to Follow-up|0|||
163180807|NCT03435640|589377149|FG009|Overall Study|Lost to Follow-up|0|||
163180808|NCT03435640|589377150|FG010|Overall Study|Lost to Follow-up|0|||
163180809|NCT01347307|589377151|FG000|Overall Study|Death|0|||
163180810|NCT01347307|589377152|FG001|Overall Study|Death|4|||
163180811|NCT01347307|589377151|FG000|Overall Study|Physician Decision|0|||
163180812|NCT01347307|589377152|FG001|Overall Study|Physician Decision|1|||
163180813|NCT03954041|589377158|FG000|Overall Study|Lost to Follow-up|3|||
163180814|NCT03954041|589377159|FG001|Overall Study|Lost to Follow-up|3|||
163180815|NCT03954041|589377160|FG002|Overall Study|Lost to Follow-up|6|||
163180816|NCT03954041|589377158|FG000|Overall Study|Death|4|||
163180817|NCT03954041|589377159|FG001|Overall Study|Death|0|||
163180818|NCT03954041|589377160|FG002|Overall Study|Death|1|||
163180819|NCT03954041|589377158|FG000|Overall Study|Death by neurologic criteria|0|||
163180820|NCT03954041|589377159|FG001|Overall Study|Death by neurologic criteria|0|||
163180821|NCT03954041|589377160|FG002|Overall Study|Death by neurologic criteria|1|||
163180822|NCT03954041|589377158|FG000|Overall Study|Reason not specified|7|||
163180823|NCT03954041|589377159|FG001|Overall Study|Reason not specified|4|||
163180824|NCT03954041|589377160|FG002|Overall Study|Reason not specified|2|||
163180825|NCT03954041|589377158|FG000|Overall Study|Withdrew prior to dosing|4|||
163180826|NCT03954041|589377159|FG001|Overall Study|Withdrew prior to dosing|2|||
163180827|NCT03954041|589377160|FG002|Overall Study|Withdrew prior to dosing|0|||
163180828|NCT00442468|589377168|FG000|Overall Study|Adverse Event|4|||
163180829|NCT00442468|589377168|FG000|Overall Study|Withdrawal by Subject|91|||
163180830|NCT00442468|589377168|FG000|Overall Study|Did not complete all study procedures|88|||
163180831|NCT00589784|589377169|FG000|Overall Study|Withdrawal by Subject|0|||
163285415|NCT04304534|589755485|FG003|Overall Study|Adverse Event|44|||
163180832|NCT00589784|589377170|FG001|Overall Study|Withdrawal by Subject|6|||
163180833|NCT00589784|589377169|FG000|Overall Study|Patient inevaluable|1|||
163180834|NCT00589784|589377170|FG001|Overall Study|Patient inevaluable|0|||
163180835|NCT00589784|589377169|FG000|Overall Study|Adverse Event|0|||
163180836|NCT00589784|589377170|FG001|Overall Study|Adverse Event|4|||
163180837|NCT00287079|589377172|FG000|Overall Study|Qualifying relapse|12|||
163180838|NCT00287079|589377173|FG001|Overall Study|Qualifying relapse|1|||
163180839|NCT00287079|589377172|FG000|Overall Study|Non-qualifying relapse|1|||
163180840|NCT00287079|589377173|FG001|Overall Study|Non-qualifying relapse|0|||
163285416|NCT04012853|589755486|FG000|Overall Study|Withdrawal by Subject|1|||
163285417|NCT04012853|589755487|FG001|Overall Study|Withdrawal by Subject|1|||
163285418|NCT04012853|589755486|FG000|Overall Study|Protocol Violation|1|||
163285419|NCT04012853|589755487|FG001|Overall Study|Protocol Violation|0|||
163285420|NCT04012853|589755486|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
163285421|NCT04012853|589755487|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
163285422|NCT01313182|589755488|FG000|Overall Study|Protocol Violation|66|||
163285423|NCT01313182|589755489|FG001|Overall Study|Protocol Violation|92|||
163285424|NCT01695317|589755490|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
163285425|NCT01695317|589755491|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
163285426|NCT01695317|589755490|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
163285427|NCT01695317|589755491|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
163285428|NCT00003656|589755492|FG000|Overall Study|Adverse Event|0|||
163285429|NCT00003656|589755493|FG001|Overall Study|Adverse Event|1|||
163285430|NCT00464672|589755494|FG000|Overall Study|withdrawal of consent|0|||
163285431|NCT00464672|589755495|FG001|Overall Study|withdrawal of consent|0|||
163285432|NCT00464672|589755496|FG002|Overall Study|withdrawal of consent|0|||
163285433|NCT00464672|589755497|FG003|Overall Study|withdrawal of consent|1|||
163285434|NCT00464672|589755498|FG004|Overall Study|withdrawal of consent|9|||
163285435|NCT00464672|589755499|FG005|Overall Study|withdrawal of consent|4|||
163285436|NCT00464672|589755494|FG000|Overall Study|Lost to Follow-up|25|||
163285437|NCT00464672|589755495|FG001|Overall Study|Lost to Follow-up|10|||
163285438|NCT00464672|589755496|FG002|Overall Study|Lost to Follow-up|0|||
163285439|NCT00464672|589755497|FG003|Overall Study|Lost to Follow-up|0|||
163285440|NCT00464672|589755498|FG004|Overall Study|Lost to Follow-up|1|||
163285441|NCT00464672|589755499|FG005|Overall Study|Lost to Follow-up|0|||
163285442|NCT03055767|589755500|FG000|Open-Label Period|Lost to Follow-up|0|||
163285443|NCT03055767|589755501|FG001|Open-Label Period|Lost to Follow-up|0|||
163285444|NCT03055767|589755502|FG002|Open-Label Period|Lost to Follow-up|2|||
163285445|NCT03055767|589755503|FG003|Open-Label Period|Lost to Follow-up|0|||
163285446|NCT03055767|589755500|FG000|Open-Label Period|Withdrawal by Subject|0|||
163285447|NCT03055767|589755501|FG001|Open-Label Period|Withdrawal by Subject|0|||
163285448|NCT03055767|589755502|FG002|Open-Label Period|Withdrawal by Subject|0|||
163285449|NCT03055767|589755503|FG003|Open-Label Period|Withdrawal by Subject|1|||
163285450|NCT02759731|589755506|FG000|Overall Study|Did not complete treatment.|8|||
163285451|NCT00763282|589755512|FG000|Overall Study|Withdrawal by Subject|6|||
163285452|NCT00763282|589755513|FG001|Overall Study|Withdrawal by Subject|5|||
163285453|NCT00763282|589755512|FG000|Overall Study|Death|4|||
163285454|NCT00763282|589755513|FG001|Overall Study|Death|3|||
163180841|NCT00287079|589377172|FG000|Overall Study|Adverse Event|5|||
163180842|NCT00287079|589377173|FG001|Overall Study|Adverse Event|0|||
163180843|NCT00287079|589377172|FG000|Overall Study|Protocol Violation|1|||
163180844|NCT00287079|589377173|FG001|Overall Study|Protocol Violation|0|||
163180845|NCT00287079|589377172|FG000|Overall Study|Other|3|||
163180846|NCT00287079|589377173|FG001|Overall Study|Other|0|||
163180847|NCT02953509|589377178|FG000|Overall Study|Death|1|||
163180848|NCT02953509|589377179|FG001|Overall Study|Death|3|||
163180849|NCT02953509|589377180|FG002|Overall Study|Death|3|||
163180850|NCT02953509|589377181|FG003|Overall Study|Death|4|||
163180851|NCT02953509|589377182|FG004|Overall Study|Death|12|||
163180852|NCT02953509|589377183|FG005|Overall Study|Death|3|||
163180853|NCT02953509|589377184|FG006|Overall Study|Death|25|||
163180854|NCT02953509|589377185|FG007|Overall Study|Death|10|||
163180855|NCT02953509|589377186|FG008|Overall Study|Death|21|||
163180856|NCT02953509|589377187|FG009|Overall Study|Death|20|||
163180857|NCT02953509|589377178|FG000|Overall Study|Reason Not Specified|0|||
163180858|NCT02953509|589377179|FG001|Overall Study|Reason Not Specified|2|||
163180859|NCT02953509|589377180|FG002|Overall Study|Reason Not Specified|8|||
163180860|NCT02953509|589377181|FG003|Overall Study|Reason Not Specified|2|||
163285455|NCT00763282|589755512|FG000|Overall Study|Lost to Follow-up|22|||
163285456|NCT00763282|589755513|FG001|Overall Study|Lost to Follow-up|26|||
162937377|NCT00617461|588473608|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
163180861|NCT02953509|589377182|FG004|Overall Study|Reason Not Specified|11|||
163180862|NCT02953509|589377183|FG005|Overall Study|Reason Not Specified|4|||
163180863|NCT02953509|589377184|FG006|Overall Study|Reason Not Specified|12|||
163180864|NCT02953509|589377185|FG007|Overall Study|Reason Not Specified|2|||
163180865|NCT02953509|589377186|FG008|Overall Study|Reason Not Specified|7|||
163180866|NCT02953509|589377187|FG009|Overall Study|Reason Not Specified|2|||
163180867|NCT02953509|589377178|FG000|Overall Study|Consent Withdrawn|1|||
163285457|NCT00957229|589755514|FG000|Study Start|Adverse Event|0|||
163285458|NCT00957229|589755515|FG001|Study Start|Adverse Event|3|||
163285459|NCT00957229|589755514|FG000|Study Start|Disease Progression|1|||
163285460|NCT00957229|589755515|FG001|Study Start|Disease Progression|0|||
163285461|NCT00957229|589755514|FG000|Reallocated to or Continued Vismodegib|Death|1|||
163285462|NCT00957229|589755515|FG001|Reallocated to or Continued Vismodegib|Death|1|||
163285463|NCT00957229|589755514|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
163285464|NCT00957229|589755515|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
163285465|NCT00606580|589755516|FG000|Overall Study|Lost to Follow-up|1|||
163285466|NCT00606580|589755517|FG001|Overall Study|Lost to Follow-up|1|||
163285467|NCT00606580|589755518|FG002|Overall Study|Lost to Follow-up|4|||
163285468|NCT00606580|589755516|FG000|Overall Study|Clinical failures|1|||
163285469|NCT00606580|589755517|FG001|Overall Study|Clinical failures|0|||
163285470|NCT00606580|589755518|FG002|Overall Study|Clinical failures|12|||
163285471|NCT00606580|589755516|FG000|Overall Study|Withdrawal by investigator|0|||
163285472|NCT00606580|589755517|FG001|Overall Study|Withdrawal by investigator|1|||
163285473|NCT00606580|589755518|FG002|Overall Study|Withdrawal by investigator|6|||
163285474|NCT00606580|589755516|FG000|Overall Study|Withdrawal by Subject|0|||
163285475|NCT00606580|589755517|FG001|Overall Study|Withdrawal by Subject|1|||
163285476|NCT00606580|589755518|FG002|Overall Study|Withdrawal by Subject|0|||
163285477|NCT04580303|589755519|FG000|Overall Study|Adverse Event|0|||
163285478|NCT04580303|589755520|FG001|Overall Study|Adverse Event|1|||
163285479|NCT04580303|589755521|FG002|Overall Study|Adverse Event|0|||
163285480|NCT04580303|589755522|FG003|Overall Study|Adverse Event|0|||
163285481|NCT04580303|589755519|FG000|Overall Study|Withdrawal by Subject|0|||
163285482|NCT04580303|589755520|FG001|Overall Study|Withdrawal by Subject|0|||
163180868|NCT02953509|589377179|FG001|Overall Study|Consent Withdrawn|1|||
163180869|NCT02953509|589377180|FG002|Overall Study|Consent Withdrawn|2|||
163180870|NCT02953509|589377181|FG003|Overall Study|Consent Withdrawn|1|||
163180871|NCT02953509|589377182|FG004|Overall Study|Consent Withdrawn|3|||
163180872|NCT02953509|589377183|FG005|Overall Study|Consent Withdrawn|0|||
163180873|NCT02953509|589377184|FG006|Overall Study|Consent Withdrawn|4|||
163180874|NCT02953509|589377185|FG007|Overall Study|Consent Withdrawn|1|||
163180875|NCT02953509|589377186|FG008|Overall Study|Consent Withdrawn|1|||
163180876|NCT02953509|589377187|FG009|Overall Study|Consent Withdrawn|4|||
163180877|NCT02953509|589377178|FG000|Overall Study|Lost to Follow-up|0|||
163180878|NCT02953509|589377179|FG001|Overall Study|Lost to Follow-up|0|||
163180879|NCT02953509|589377180|FG002|Overall Study|Lost to Follow-up|0|||
163180880|NCT02953509|589377181|FG003|Overall Study|Lost to Follow-up|0|||
163180881|NCT02953509|589377182|FG004|Overall Study|Lost to Follow-up|0|||
163180882|NCT02953509|589377183|FG005|Overall Study|Lost to Follow-up|0|||
163180883|NCT02953509|589377184|FG006|Overall Study|Lost to Follow-up|1|||
163180884|NCT02953509|589377185|FG007|Overall Study|Lost to Follow-up|1|||
163180885|NCT02953509|589377186|FG008|Overall Study|Lost to Follow-up|1|||
163180886|NCT02953509|589377187|FG009|Overall Study|Lost to Follow-up|1|||
163180887|NCT02953509|589377178|FG000|Overall Study|Study terminated by sponsor|1|||
163180888|NCT02953509|589377179|FG001|Overall Study|Study terminated by sponsor|0|||
163180889|NCT02953509|589377180|FG002|Overall Study|Study terminated by sponsor|0|||
163180890|NCT02953509|589377181|FG003|Overall Study|Study terminated by sponsor|0|||
163180891|NCT02953509|589377182|FG004|Overall Study|Study terminated by sponsor|0|||
163180892|NCT02953509|589377183|FG005|Overall Study|Study terminated by sponsor|0|||
163180893|NCT02953509|589377184|FG006|Overall Study|Study terminated by sponsor|1|||
163180894|NCT02953509|589377185|FG007|Overall Study|Study terminated by sponsor|0|||
163180895|NCT02953509|589377186|FG008|Overall Study|Study terminated by sponsor|1|||
163180896|NCT02953509|589377187|FG009|Overall Study|Study terminated by sponsor|1|||
163180897|NCT02325791|589377190|FG000|Overall Study|Adverse Event|0|||
163180898|NCT02325791|589377191|FG001|Overall Study|Adverse Event|1|||
163180899|NCT02325791|589377192|FG002|Overall Study|Adverse Event|1|||
163285483|NCT04580303|589755521|FG002|Overall Study|Withdrawal by Subject|1|||
163285484|NCT04580303|589755522|FG003|Overall Study|Withdrawal by Subject|0|||
163285485|NCT01833065|589755524|FG000|Overall Study|Adverse Event|6|||
163285486|NCT01833065|589755525|FG001|Overall Study|Adverse Event|1|||
163285487|NCT01833065|589755526|FG002|Overall Study|Adverse Event|0|||
163285488|NCT01833065|589755527|FG003|Overall Study|Adverse Event|2|||
163285489|NCT01833065|589755528|FG004|Overall Study|Adverse Event|3|||
163285490|NCT01833065|589755524|FG000|Overall Study|Protocol Violation|1|||
163285491|NCT01833065|589755525|FG001|Overall Study|Protocol Violation|0|||
163285492|NCT01833065|589755526|FG002|Overall Study|Protocol Violation|0|||
163285493|NCT01833065|589755527|FG003|Overall Study|Protocol Violation|0|||
163180900|NCT02325791|589377193|FG003|Overall Study|Adverse Event|0|||
163180901|NCT02325791|589377190|FG000|Overall Study|Death|0|||
163180902|NCT02325791|589377191|FG001|Overall Study|Death|3|||
163180903|NCT02325791|589377192|FG002|Overall Study|Death|0|||
163180904|NCT02325791|589377193|FG003|Overall Study|Death|1|||
163180905|NCT02325791|589377190|FG000|Overall Study|Lost to Follow-up|0|||
163180906|NCT02325791|589377191|FG001|Overall Study|Lost to Follow-up|15|||
163180907|NCT02325791|589377192|FG002|Overall Study|Lost to Follow-up|14|||
163180908|NCT02325791|589377193|FG003|Overall Study|Lost to Follow-up|9|||
163180909|NCT02325791|589377190|FG000|Overall Study|Physician Decision|0|||
163180910|NCT02325791|589377191|FG001|Overall Study|Physician Decision|1|||
163285494|NCT01833065|589755528|FG004|Overall Study|Protocol Violation|2|||
163285495|NCT01833065|589755524|FG000|Overall Study|Lost to Follow-up|1|||
163180911|NCT02325791|589377192|FG002|Overall Study|Physician Decision|1|||
163180912|NCT02325791|589377193|FG003|Overall Study|Physician Decision|0|||
163180913|NCT02325791|589377190|FG000|Overall Study|Protocol Violation|0|||
163285496|NCT01833065|589755525|FG001|Overall Study|Lost to Follow-up|0|||
163285497|NCT01833065|589755526|FG002|Overall Study|Lost to Follow-up|0|||
163285498|NCT01833065|589755527|FG003|Overall Study|Lost to Follow-up|0|||
163285499|NCT01833065|589755528|FG004|Overall Study|Lost to Follow-up|3|||
163285500|NCT01833065|589755524|FG000|Overall Study|Withdrawal by Subject|6|||
163285501|NCT01833065|589755525|FG001|Overall Study|Withdrawal by Subject|2|||
163285502|NCT01833065|589755526|FG002|Overall Study|Withdrawal by Subject|4|||
163285503|NCT01833065|589755527|FG003|Overall Study|Withdrawal by Subject|3|||
163285504|NCT01833065|589755528|FG004|Overall Study|Withdrawal by Subject|11|||
163285505|NCT01833065|589755524|FG000|Overall Study|Subject's substantial non-compliance|0|||
163285506|NCT01833065|589755525|FG001|Overall Study|Subject's substantial non-compliance|1|||
163285507|NCT01833065|589755526|FG002|Overall Study|Subject's substantial non-compliance|0|||
163285508|NCT01833065|589755527|FG003|Overall Study|Subject's substantial non-compliance|0|||
163285509|NCT01833065|589755528|FG004|Overall Study|Subject's substantial non-compliance|0|||
163285510|NCT01833065|589755524|FG000|Overall Study|Trial terminated by sponsor|8|||
163285511|NCT01833065|589755525|FG001|Overall Study|Trial terminated by sponsor|8|||
163285512|NCT01833065|589755526|FG002|Overall Study|Trial terminated by sponsor|7|||
163285513|NCT01833065|589755527|FG003|Overall Study|Trial terminated by sponsor|3|||
163285514|NCT01833065|589755528|FG004|Overall Study|Trial terminated by sponsor|13|||
163285515|NCT01833065|589755524|FG000|Overall Study|Others|2|||
163285516|NCT01833065|589755525|FG001|Overall Study|Others|1|||
163285517|NCT01833065|589755526|FG002|Overall Study|Others|1|||
163285518|NCT01833065|589755527|FG003|Overall Study|Others|1|||
163285519|NCT01833065|589755528|FG004|Overall Study|Others|4|||
163285520|NCT00543725|589755531|FG000|Overall Study|Adverse Event|18|||
163285521|NCT00543725|589755532|FG001|Overall Study|Adverse Event|27|||
163285522|NCT00543725|589755531|FG000|Overall Study|Sponsor's Decision|0|||
163285523|NCT00543725|589755532|FG001|Overall Study|Sponsor's Decision|1|||
163285524|NCT00543725|589755531|FG000|Overall Study|Subject Non-Compliant|4|||
163285525|NCT00543725|589755532|FG001|Overall Study|Subject Non-Compliant|4|||
163285526|NCT00543725|589755531|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
163285527|NCT00543725|589755532|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
163285528|NCT00543725|589755531|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
163285529|NCT00543725|589755532|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
163285530|NCT00543725|589755531|FG000|Overall Study|Protocol Violation|0|||
163285531|NCT00543725|589755532|FG001|Overall Study|Protocol Violation|1|||
163285532|NCT00543725|589755531|FG000|Overall Study|Withdrawal by Subject|4|||
163285533|NCT00543725|589755532|FG001|Overall Study|Withdrawal by Subject|13|||
163285534|NCT00543725|589755531|FG000|Overall Study|Lost to Follow-up|15|||
163285535|NCT00543725|589755532|FG001|Overall Study|Lost to Follow-up|11|||
163285536|NCT00543725|589755531|FG000|Overall Study|Other|3|||
163285537|NCT00543725|589755532|FG001|Overall Study|Other|3|||
163285538|NCT01250002|589755533|FG000|Overall Study|Change to open surgical procedure|4|||
163180914|NCT02325791|589377191|FG001|Overall Study|Protocol Violation|0|||
163180915|NCT02325791|589377192|FG002|Overall Study|Protocol Violation|1|||
163180916|NCT02325791|589377193|FG003|Overall Study|Protocol Violation|0|||
163180917|NCT02325791|589377190|FG000|Overall Study|Withdrawal by Subject|0|||
163180918|NCT02325791|589377191|FG001|Overall Study|Withdrawal by Subject|5|||
163180919|NCT02325791|589377192|FG002|Overall Study|Withdrawal by Subject|8|||
163180920|NCT02325791|589377193|FG003|Overall Study|Withdrawal by Subject|16|||
163180921|NCT00722371|589377194|FG000|Overall Study|Adverse Event|6|||
163180922|NCT00722371|589377195|FG001|Overall Study|Adverse Event|13|||
163180923|NCT00722371|589377196|FG002|Overall Study|Adverse Event|9|||
163180924|NCT00722371|589377197|FG003|Overall Study|Adverse Event|10|||
163180925|NCT00722371|589377198|FG004|Overall Study|Adverse Event|6|||
163180926|NCT00722371|589377199|FG005|Overall Study|Adverse Event|8|||
163180927|NCT00722371|589377200|FG006|Overall Study|Adverse Event|4|||
163180928|NCT00722371|589377194|FG000|Overall Study|Contraindication|0|||
163180929|NCT00722371|589377195|FG001|Overall Study|Contraindication|0|||
163180930|NCT00722371|589377196|FG002|Overall Study|Contraindication|1|||
163180931|NCT00722371|589377197|FG003|Overall Study|Contraindication|0|||
163180932|NCT00722371|589377198|FG004|Overall Study|Contraindication|0|||
163180933|NCT00722371|589377199|FG005|Overall Study|Contraindication|0|||
163180934|NCT00722371|589377200|FG006|Overall Study|Contraindication|0|||
163180935|NCT00722371|589377194|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
163180936|NCT00722371|589377195|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
163180937|NCT00722371|589377196|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
163180938|NCT00722371|589377197|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
163180939|NCT00722371|589377198|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
163180940|NCT00722371|589377199|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
162937378|NCT00617461|588473607|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
163180941|NCT00722371|589377200|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
163180942|NCT00722371|589377194|FG000|Overall Study|Excluded medication|0|||
163180943|NCT00722371|589377195|FG001|Overall Study|Excluded medication|1|||
163180944|NCT00722371|589377196|FG002|Overall Study|Excluded medication|1|||
163180945|NCT00722371|589377197|FG003|Overall Study|Excluded medication|0|||
163285539|NCT01250002|589755534|FG001|Overall Study|Change to open surgical procedure|3|||
163285540|NCT03095508|589755535|FG000|Overall Study|Adverse Event|0|||
163285541|NCT03095508|589755536|FG001|Overall Study|Adverse Event|1|||
163285542|NCT02317705|589755537|FG000|Overall Study|Withdrawal by Subject|3|||
163285543|NCT02317705|589755537|FG000|Overall Study|Physician Decision|1|||
163285544|NCT02317705|589755537|FG000|Overall Study|Drug not usable|1|||
163285545|NCT00335556|589755538|FG000|Overall Study|Death|0|||
163285546|NCT00335556|589755539|FG001|Overall Study|Death|5|||
163285547|NCT00335556|589755540|FG002|Overall Study|Death|0|||
163285548|NCT00335556|589755541|FG003|Overall Study|Death|0|||
163285549|NCT00335556|589755542|FG004|Overall Study|Death|1|||
163285550|NCT00335556|589755543|FG005|Overall Study|Death|0|||
163285551|NCT00335556|589755538|FG000|Overall Study|Lack of Efficacy|0|||
163285552|NCT00335556|589755539|FG001|Overall Study|Lack of Efficacy|19|||
163285553|NCT00335556|589755540|FG002|Overall Study|Lack of Efficacy|3|||
163285554|NCT00335556|589755541|FG003|Overall Study|Lack of Efficacy|3|||
163285555|NCT00335556|589755542|FG004|Overall Study|Lack of Efficacy|0|||
163285556|NCT00335556|589755543|FG005|Overall Study|Lack of Efficacy|1|||
163285557|NCT00335556|589755538|FG000|Overall Study|Physician Decision|0|||
163285558|NCT00335556|589755539|FG001|Overall Study|Physician Decision|6|||
163285559|NCT00335556|589755540|FG002|Overall Study|Physician Decision|2|||
163285560|NCT00335556|589755541|FG003|Overall Study|Physician Decision|1|||
163285561|NCT00335556|589755542|FG004|Overall Study|Physician Decision|0|||
163285562|NCT00335556|589755543|FG005|Overall Study|Physician Decision|0|||
163285563|NCT00335556|589755538|FG000|Overall Study|Ineligible|2|||
163285564|NCT00335556|589755539|FG001|Overall Study|Ineligible|0|||
163285565|NCT00335556|589755540|FG002|Overall Study|Ineligible|0|||
163180946|NCT00722371|589377198|FG004|Overall Study|Excluded medication|0|||
163180947|NCT00722371|589377199|FG005|Overall Study|Excluded medication|0|||
163180948|NCT00722371|589377200|FG006|Overall Study|Excluded medication|1|||
163180949|NCT00722371|589377194|FG000|Overall Study|Hyperglycemia|2|||
163180950|NCT00722371|589377195|FG001|Overall Study|Hyperglycemia|6|||
163180951|NCT00722371|589377196|FG002|Overall Study|Hyperglycemia|4|||
163180952|NCT00722371|589377197|FG003|Overall Study|Hyperglycemia|2|||
163180953|NCT00722371|589377198|FG004|Overall Study|Hyperglycemia|5|||
163180954|NCT00722371|589377199|FG005|Overall Study|Hyperglycemia|1|||
163180955|NCT00722371|589377200|FG006|Overall Study|Hyperglycemia|1|||
163180956|NCT00722371|589377194|FG000|Overall Study|Hypoglycemia|1|||
163180957|NCT00722371|589377195|FG001|Overall Study|Hypoglycemia|0|||
163180958|NCT00722371|589377196|FG002|Overall Study|Hypoglycemia|0|||
163180959|NCT00722371|589377197|FG003|Overall Study|Hypoglycemia|0|||
163180960|NCT00722371|589377198|FG004|Overall Study|Hypoglycemia|0|||
163180961|NCT00722371|589377199|FG005|Overall Study|Hypoglycemia|0|||
163180962|NCT00722371|589377200|FG006|Overall Study|Hypoglycemia|0|||
163180963|NCT00722371|589377194|FG000|Overall Study|Lack of Efficacy|4|||
163180964|NCT00722371|589377195|FG001|Overall Study|Lack of Efficacy|6|||
163180965|NCT00722371|589377196|FG002|Overall Study|Lack of Efficacy|6|||
163180966|NCT00722371|589377197|FG003|Overall Study|Lack of Efficacy|6|||
163180967|NCT00722371|589377198|FG004|Overall Study|Lack of Efficacy|2|||
163180968|NCT00722371|589377199|FG005|Overall Study|Lack of Efficacy|3|||
163180969|NCT00722371|589377200|FG006|Overall Study|Lack of Efficacy|0|||
163180970|NCT00722371|589377194|FG000|Overall Study|Lost to Follow-up|11|||
163180971|NCT00722371|589377195|FG001|Overall Study|Lost to Follow-up|14|||
163180972|NCT00722371|589377196|FG002|Overall Study|Lost to Follow-up|21|||
163180973|NCT00722371|589377197|FG003|Overall Study|Lost to Follow-up|13|||
163180974|NCT00722371|589377198|FG004|Overall Study|Lost to Follow-up|8|||
163180975|NCT00722371|589377199|FG005|Overall Study|Lost to Follow-up|16|||
163180976|NCT00722371|589377200|FG006|Overall Study|Lost to Follow-up|13|||
163180977|NCT00722371|589377194|FG000|Overall Study|Physician Decision|5|||
163180978|NCT00722371|589377195|FG001|Overall Study|Physician Decision|2|||
163180979|NCT00722371|589377196|FG002|Overall Study|Physician Decision|2|||
163180980|NCT00722371|589377197|FG003|Overall Study|Physician Decision|5|||
163180981|NCT00722371|589377198|FG004|Overall Study|Physician Decision|2|||
163285566|NCT00335556|589755541|FG003|Overall Study|Ineligible|0|||
163285567|NCT00335556|589755542|FG004|Overall Study|Ineligible|0|||
163285568|NCT00335556|589755543|FG005|Overall Study|Ineligible|0|||
163285569|NCT00335556|589755538|FG000|Overall Study|Refusal of further protocol therapy|0|||
163285570|NCT00335556|589755539|FG001|Overall Study|Refusal of further protocol therapy|4|||
163180982|NCT00722371|589377199|FG005|Overall Study|Physician Decision|3|||
163180983|NCT00722371|589377200|FG006|Overall Study|Physician Decision|4|||
163180984|NCT00722371|589377194|FG000|Overall Study|Pregnancy|1|||
163180985|NCT00722371|589377195|FG001|Overall Study|Pregnancy|1|||
163180986|NCT00722371|589377196|FG002|Overall Study|Pregnancy|0|||
163180987|NCT00722371|589377197|FG003|Overall Study|Pregnancy|0|||
163180988|NCT00722371|589377198|FG004|Overall Study|Pregnancy|0|||
163180989|NCT00722371|589377199|FG005|Overall Study|Pregnancy|1|||
163180990|NCT00722371|589377200|FG006|Overall Study|Pregnancy|0|||
163180991|NCT00722371|589377194|FG000|Overall Study|Protocol Violation|6|||
163180992|NCT00722371|589377195|FG001|Overall Study|Protocol Violation|1|||
163180993|NCT00722371|589377196|FG002|Overall Study|Protocol Violation|0|||
163285571|NCT00335556|589755540|FG002|Overall Study|Refusal of further protocol therapy|0|||
163285572|NCT00335556|589755541|FG003|Overall Study|Refusal of further protocol therapy|1|||
163285573|NCT00335556|589755542|FG004|Overall Study|Refusal of further protocol therapy|0|||
163285574|NCT00335556|589755543|FG005|Overall Study|Refusal of further protocol therapy|0|||
163285575|NCT01674569|589755544|FG000|Overall Study|Adverse Event|0|||
163285576|NCT01674569|589755545|FG001|Overall Study|Adverse Event|2|||
163285577|NCT01674569|589755546|FG002|Overall Study|Adverse Event|0|||
163285578|NCT01674569|589755547|FG003|Overall Study|Adverse Event|1|||
163285579|NCT01674569|589755548|FG004|Overall Study|Adverse Event|2|||
163285580|NCT01674569|589755549|FG005|Overall Study|Adverse Event|2|||
163285581|NCT01674569|589755544|FG000|Overall Study|Protocol Violation|0|||
163285582|NCT01674569|589755545|FG001|Overall Study|Protocol Violation|1|||
163285583|NCT01674569|589755546|FG002|Overall Study|Protocol Violation|1|||
163285584|NCT01674569|589755547|FG003|Overall Study|Protocol Violation|0|||
163285585|NCT01674569|589755548|FG004|Overall Study|Protocol Violation|0|||
163285586|NCT01674569|589755549|FG005|Overall Study|Protocol Violation|0|||
163285587|NCT01674569|589755544|FG000|Overall Study|Withdrawal by Subject|0|||
163285588|NCT01674569|589755545|FG001|Overall Study|Withdrawal by Subject|0|||
163285589|NCT01674569|589755546|FG002|Overall Study|Withdrawal by Subject|1|||
163285590|NCT01674569|589755547|FG003|Overall Study|Withdrawal by Subject|0|||
163285591|NCT01674569|589755548|FG004|Overall Study|Withdrawal by Subject|0|||
163285592|NCT01674569|589755549|FG005|Overall Study|Withdrawal by Subject|0|||
163285593|NCT01599325|589755557|FG000|Primary Parent Phase|Adverse Event|5|||
163285594|NCT01599325|589755557|FG000|Primary Parent Phase|Disease Progression|7|||
163285595|NCT01599325|589755557|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
163285596|NCT01599325|589755557|FG000|Primary Parent Phase|Death|13|||
163285597|NCT01599325|589755557|FG000|Primary Parent Phase|Protocol Violation|1|||
163285598|NCT01599325|589755557|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
163285599|NCT01599325|589755557|FG000|Primary Parent Phase|Other|2|||
163285600|NCT01599325|589755557|FG000|Extension Phase|Study Closure|1|||
163285601|NCT01599325|589755557|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
163285602|NCT01599325|589755557|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
163285603|NCT01599325|589755557|FG000|Extension Phase|Disease Progression|1|||
163285604|NCT01599325|589755557|FG000|Extension Phase|Withdrawal by Subject|8|||
163285605|NCT02365298|589755558|FG000|Period 2|incorrect Rx dispensed|1|||
163285606|NCT02365298|589755559|FG001|Period 2|incorrect Rx dispensed|0|||
163285607|NCT02365298|589755558|FG000|Period 2|Discontinued at request of Sponsor|1|||
163285608|NCT02365298|589755559|FG001|Period 2|Discontinued at request of Sponsor|0|||
163285609|NCT02365298|589755558|FG000|Period 2|Test Article longer available|0|||
163285610|NCT02365298|589755559|FG001|Period 2|Test Article longer available|1|||
163285611|NCT02365298|589755558|FG000|Period 2|Protocol Violation|0|||
163285612|NCT02365298|589755559|FG001|Period 2|Protocol Violation|1|||
163285613|NCT01878890|589755560|FG000|Overall Study|Protocol Violation|0|||
163285614|NCT01878890|589755561|FG001|Overall Study|Protocol Violation|1|||
163285615|NCT01878890|589755562|FG002|Overall Study|Protocol Violation|0|||
163285616|NCT01878890|589755563|FG003|Overall Study|Protocol Violation|0|||
163285617|NCT01710514|589755568|FG000|Overall Study|Adverse Event|6|||
163285618|NCT01710514|589755569|FG001|Overall Study|Adverse Event|7|||
163285619|NCT01710514|589755568|FG000|Overall Study|Withdrawal by Subject|1|||
163285620|NCT01710514|589755569|FG001|Overall Study|Withdrawal by Subject|0|||
163285621|NCT02846415|589755570|FG000|Overall Study|Lost to Follow-up|2|||
163285622|NCT02846415|589755571|FG001|Overall Study|Lost to Follow-up|0|||
163285623|NCT02846415|589755570|FG000|Overall Study|Withdrawal by Subject|1|||
163285624|NCT02846415|589755571|FG001|Overall Study|Withdrawal by Subject|1|||
163285625|NCT03404843|589755572|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
163285626|NCT03404843|589755573|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
163285627|NCT00567164|589755574|FG000|Overall Study|Withdrawal by Subject|171|||
163285628|NCT00567164|589755575|FG001|Overall Study|Withdrawal by Subject|21|||
163285629|NCT00567164|589755576|FG002|Overall Study|Withdrawal by Subject|17|||
163285630|NCT00567164|589755574|FG000|Overall Study|Protocol Violation|23|||
163285631|NCT00567164|589755575|FG001|Overall Study|Protocol Violation|4|||
163285632|NCT00567164|589755576|FG002|Overall Study|Protocol Violation|2|||
163285633|NCT00567164|589755574|FG000|Overall Study|Adverse Event|92|||
163285634|NCT00567164|589755575|FG001|Overall Study|Adverse Event|13|||
163285635|NCT00567164|589755576|FG002|Overall Study|Adverse Event|9|||
163285636|NCT00567164|589755574|FG000|Overall Study|Death|0|||
163285637|NCT00567164|589755575|FG001|Overall Study|Death|0|||
163285638|NCT00567164|589755576|FG002|Overall Study|Death|1|||
163285639|NCT00567164|589755574|FG000|Overall Study|Lost to Follow-up|202|||
163285640|NCT00567164|589755575|FG001|Overall Study|Lost to Follow-up|23|||
163285641|NCT00567164|589755576|FG002|Overall Study|Lost to Follow-up|21|||
163285642|NCT00567164|589755574|FG000|Overall Study|Pregnancy|20|||
163285643|NCT00567164|589755575|FG001|Overall Study|Pregnancy|4|||
163285644|NCT00567164|589755576|FG002|Overall Study|Pregnancy|6|||
163285645|NCT00567164|589755574|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
163285646|NCT00567164|589755575|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
163285647|NCT00567164|589755576|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
163285648|NCT00567164|589755574|FG000|Overall Study|Missing|1|||
163285649|NCT00567164|589755575|FG001|Overall Study|Missing|0|||
163285650|NCT00567164|589755576|FG002|Overall Study|Missing|0|||
163285651|NCT00853827|589755585|FG000|Single Blind Period (1 Week)|Other|4|||
163285652|NCT00853827|589755586|FG001|Single Blind Period (1 Week)|Other|0|||
163285653|NCT00853827|589755585|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
163285654|NCT00853827|589755586|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
163285655|NCT00853827|589755585|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
163285656|NCT00853827|589755586|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
163285657|NCT00853827|589755585|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
163285658|NCT00853827|589755586|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
163285659|NCT00853827|589755585|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
163285660|NCT00853827|589755586|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
163285661|NCT00853827|589755585|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
163285662|NCT00853827|589755586|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
163285663|NCT00853827|589755585|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
163285664|NCT00853827|589755586|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
163285665|NCT00853827|589755585|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
163285666|NCT00853827|589755586|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
163285667|NCT00853827|589755585|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
163285668|NCT00853827|589755586|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
163285669|NCT00853827|589755585|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
163285670|NCT00853827|589755586|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
163285671|NCT00853827|589755585|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
163285672|NCT00853827|589755586|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
163285673|NCT00853827|589755585|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
163285674|NCT00853827|589755586|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
163285675|NCT00853827|589755585|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
163285676|NCT00853827|589755586|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
163285677|NCT00853827|589755585|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
163285678|NCT00853827|589755586|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
163285679|NCT00853827|589755585|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
163285680|NCT00853827|589755586|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
163285681|NCT00853827|589755585|FG000|Double Blind Period (103 Weeks)|Death|1|||
163285682|NCT00853827|589755586|FG001|Double Blind Period (103 Weeks)|Death|6|||
163285683|NCT00580801|589755597|FG000|Overall Study|Physician Decision|1|||
163285684|NCT00580801|589755598|FG001|Overall Study|Physician Decision|0|||
163285685|NCT00580801|589755599|FG002|Overall Study|Physician Decision|0|||
163285686|NCT00580801|589755597|FG000|Overall Study|Adverse Event|2|||
163285687|NCT00580801|589755598|FG001|Overall Study|Adverse Event|0|||
163285688|NCT00580801|589755599|FG002|Overall Study|Adverse Event|0|||
163285689|NCT00580801|589755597|FG000|Overall Study|Lost to Follow-up|2|||
163285690|NCT00580801|589755598|FG001|Overall Study|Lost to Follow-up|0|||
163285691|NCT00580801|589755599|FG002|Overall Study|Lost to Follow-up|0|||
163285692|NCT00580801|589755597|FG000|Overall Study|Reached a virologic endpoint|0|||
163285693|NCT00580801|589755598|FG001|Overall Study|Reached a virologic endpoint|1|||
163285694|NCT00580801|589755599|FG002|Overall Study|Reached a virologic endpoint|2|||
163285695|NCT00580801|589755597|FG000|Overall Study|Participant non-compliant|0|||
163285696|NCT00580801|589755598|FG001|Overall Study|Participant non-compliant|0|||
163285697|NCT00580801|589755599|FG002|Overall Study|Participant non-compliant|1|||
163285698|NCT00580801|589755597|FG000|Overall Study|Travel|1|||
163285699|NCT00580801|589755598|FG001|Overall Study|Travel|0|||
163285700|NCT00580801|589755599|FG002|Overall Study|Travel|0|||
163285701|NCT02595398|589755600|FG000|Overall Study|Non-compliance|1|||
163285702|NCT02595398|589755601|FG001|Overall Study|Non-compliance|0|||
163285703|NCT02595398|589755600|FG000|Overall Study|Withdrawal by Subject|2|||
162937379|NCT00617461|588473608|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
162937380|NCT00617461|588473607|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
163285704|NCT02595398|589755601|FG001|Overall Study|Withdrawal by Subject|1|||
163285705|NCT02595398|589755600|FG000|Overall Study|Lost to Follow-up|1|||
163285706|NCT02595398|589755601|FG001|Overall Study|Lost to Follow-up|0|||
163285707|NCT00502593|589755602|FG000|Overall Study|Withdrawn unspecified reason|1|||
163285708|NCT00502593|589755603|FG001|Overall Study|Withdrawn unspecified reason|1|||
163285709|NCT00502593|589755604|FG002|Overall Study|Withdrawn unspecified reason|3|||
163285710|NCT00502593|589755605|FG003|Overall Study|Withdrawn unspecified reason|1|||
163285711|NCT00502593|589755606|FG004|Overall Study|Withdrawn unspecified reason|2|||
163285712|NCT00502593|589755607|FG005|Overall Study|Withdrawn unspecified reason|0|||
163285713|NCT00502593|589755608|FG006|Overall Study|Withdrawn unspecified reason|2|||
163285714|NCT00502593|589755609|FG007|Overall Study|Withdrawn unspecified reason|0|||
163285715|NCT00502593|589755610|FG008|Overall Study|Withdrawn unspecified reason|0|||
163285716|NCT00502593|589755611|FG009|Overall Study|Withdrawn unspecified reason|0|||
163285717|NCT00502593|589755612|FG010|Overall Study|Withdrawn unspecified reason|0|||
163285718|NCT00502593|589755613|FG011|Overall Study|Withdrawn unspecified reason|0|||
163285719|NCT00502593|589755602|FG000|Overall Study|Withdrawal by Subject|0|||
163285720|NCT00502593|589755603|FG001|Overall Study|Withdrawal by Subject|0|||
163285721|NCT00502593|589755604|FG002|Overall Study|Withdrawal by Subject|6|||
163285722|NCT00502593|589755605|FG003|Overall Study|Withdrawal by Subject|2|||
163285723|NCT00502593|589755606|FG004|Overall Study|Withdrawal by Subject|2|||
163285724|NCT00502593|589755607|FG005|Overall Study|Withdrawal by Subject|0|||
163285725|NCT00502593|589755608|FG006|Overall Study|Withdrawal by Subject|3|||
163285726|NCT00502593|589755609|FG007|Overall Study|Withdrawal by Subject|0|||
163285727|NCT00502593|589755610|FG008|Overall Study|Withdrawal by Subject|3|||
163285728|NCT00502593|589755611|FG009|Overall Study|Withdrawal by Subject|0|||
163285729|NCT00502593|589755612|FG010|Overall Study|Withdrawal by Subject|1|||
163285730|NCT00502593|589755613|FG011|Overall Study|Withdrawal by Subject|0|||
163285731|NCT00502593|589755602|FG000|Overall Study|Lost to Follow-up|2|||
163285732|NCT00502593|589755603|FG001|Overall Study|Lost to Follow-up|1|||
163285733|NCT00502593|589755604|FG002|Overall Study|Lost to Follow-up|1|||
163285734|NCT00502593|589755605|FG003|Overall Study|Lost to Follow-up|1|||
163285735|NCT00502593|589755606|FG004|Overall Study|Lost to Follow-up|0|||
163285736|NCT00502593|589755607|FG005|Overall Study|Lost to Follow-up|0|||
163285737|NCT00502593|589755608|FG006|Overall Study|Lost to Follow-up|0|||
163285738|NCT00502593|589755609|FG007|Overall Study|Lost to Follow-up|0|||
163285739|NCT00502593|589755610|FG008|Overall Study|Lost to Follow-up|3|||
163285740|NCT00502593|589755611|FG009|Overall Study|Lost to Follow-up|0|||
163285741|NCT00502593|589755612|FG010|Overall Study|Lost to Follow-up|1|||
163285742|NCT00502593|589755613|FG011|Overall Study|Lost to Follow-up|0|||
163285743|NCT05576051|589755614|FG000|Overall Study|Lack of Efficacy|543|||
163285744|NCT05576051|589755615|FG001|Overall Study|Lack of Efficacy|343|||
163285745|NCT05576051|589755616|FG002|Overall Study|Lack of Efficacy|108|||
163285746|NCT05576051|589755617|FG003|Overall Study|Lack of Efficacy|72|||
163285747|NCT05576051|589755618|FG004|Overall Study|Lack of Efficacy|28|||
163285748|NCT05576051|589755619|FG005|Overall Study|Lack of Efficacy|50|||
163285749|NCT05576051|589755614|FG000|Overall Study|Safety|78|||
163285750|NCT05576051|589755615|FG001|Overall Study|Safety|74|||
163285751|NCT05576051|589755616|FG002|Overall Study|Safety|16|||
163285752|NCT05576051|589755617|FG003|Overall Study|Safety|14|||
163285753|NCT05576051|589755618|FG004|Overall Study|Safety|4|||
163285754|NCT05576051|589755619|FG005|Overall Study|Safety|5|||
163285755|NCT05576051|589755614|FG000|Overall Study|Efficacy + Safety|10|||
163285756|NCT05576051|589755615|FG001|Overall Study|Efficacy + Safety|7|||
163285757|NCT05576051|589755616|FG002|Overall Study|Efficacy + Safety|3|||
163285758|NCT05576051|589755617|FG003|Overall Study|Efficacy + Safety|0|||
163285759|NCT05576051|589755618|FG004|Overall Study|Efficacy + Safety|0|||
163285760|NCT05576051|589755619|FG005|Overall Study|Efficacy + Safety|0|||
163285761|NCT05576051|589755614|FG000|Overall Study|Other|231|||
163285762|NCT05576051|589755615|FG001|Overall Study|Other|127|||
163285763|NCT05576051|589755616|FG002|Overall Study|Other|35|||
163285764|NCT05576051|589755617|FG003|Overall Study|Other|14|||
163285765|NCT05576051|589755618|FG004|Overall Study|Other|6|||
163285766|NCT05576051|589755619|FG005|Overall Study|Other|0|||
163285767|NCT00544440|589755620|FG000|Overall Study|Other|1|||
163285768|NCT00544440|589755620|FG000|Overall Study|Adverse Event|1|||
163285769|NCT00544440|589755620|FG000|Overall Study|Withdrawal by Subject|2|||
163285770|NCT00544440|589755620|FG000|Overall Study|Subject Non-compliance|1|||
163285771|NCT00544440|589755620|FG000|Overall Study|Progressive Disease|47|||
163285772|NCT00544440|589755620|FG000|Overall Study|Other|5|||
163285773|NCT03601507|589755621|FG000|Overall Study|Adverse Event|1|||
163285774|NCT00559949|589755624|FG000|Overall Study|Progressive Disease during cycle 1|1|||
163285775|NCT00559949|589755624|FG000|Overall Study|Adverse Event|1|||
163285776|NCT00559949|589755624|FG000|Overall Study|Withdrawal by Subject|4|||
163285777|NCT00559949|589755624|FG000|Overall Study|No disease evaluation per protocol|1|||
163285778|NCT03381274|589755625|FG000|Overall Study|Death|2|||
163285779|NCT03381274|589755626|FG001|Overall Study|Death|9|||
163285780|NCT03381274|589755627|FG002|Overall Study|Death|3|||
163285781|NCT03381274|589755628|FG003|Overall Study|Death|2|||
163285782|NCT03381274|589755629|FG004|Overall Study|Death|3|||
163285783|NCT03381274|589755625|FG000|Overall Study|Lost to Follow-up|0|||
163285784|NCT03381274|589755626|FG001|Overall Study|Lost to Follow-up|0|||
163285785|NCT03381274|589755627|FG002|Overall Study|Lost to Follow-up|0|||
163285786|NCT03381274|589755628|FG003|Overall Study|Lost to Follow-up|1|||
163285787|NCT03381274|589755629|FG004|Overall Study|Lost to Follow-up|0|||
163285788|NCT03381274|589755625|FG000|Overall Study|Withdrawal by Subject|2|||
163285789|NCT03381274|589755626|FG001|Overall Study|Withdrawal by Subject|1|||
163285790|NCT03381274|589755627|FG002|Overall Study|Withdrawal by Subject|3|||
163285791|NCT03381274|589755628|FG003|Overall Study|Withdrawal by Subject|1|||
163285792|NCT03381274|589755629|FG004|Overall Study|Withdrawal by Subject|0|||
163285793|NCT03381274|589755625|FG000|Overall Study|Other|1|||
163285794|NCT03381274|589755626|FG001|Overall Study|Other|11|||
163285795|NCT03381274|589755627|FG002|Overall Study|Other|0|||
163285796|NCT03381274|589755628|FG003|Overall Study|Other|2|||
163285797|NCT03381274|589755629|FG004|Overall Study|Other|2|||
163285798|NCT00121199|589755630|FG000|Overall Study|Adverse Event|11|||
163285799|NCT00121199|589755630|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
163285800|NCT00121199|589755630|FG000|Overall Study|Progression/Relapse|1|||
163285801|NCT00121199|589755630|FG000|Overall Study|Death|3|||
163285802|NCT00121199|589755630|FG000|Overall Study|Other - Not Protocol Specified|3|||
163285803|NCT00121199|589755630|FG000|Overall Study|Ineligible|9|||
163285804|NCT03168438|589755631|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
163285805|NCT03168438|589755632|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
163285806|NCT01458275|589755634|FG000|Overall Study|Adverse Event|3|||
163285807|NCT01458275|589755635|FG001|Overall Study|Adverse Event|4|||
163285808|NCT01458275|589755636|FG002|Overall Study|Adverse Event|1|||
163285809|NCT01458275|589755634|FG000|Overall Study|Lost to Follow-up|3|||
163285810|NCT01458275|589755635|FG001|Overall Study|Lost to Follow-up|2|||
163285811|NCT01458275|589755636|FG002|Overall Study|Lost to Follow-up|5|||
163285812|NCT01458275|589755634|FG000|Overall Study|Protocol Violation|5|||
163285813|NCT01458275|589755635|FG001|Overall Study|Protocol Violation|5|||
163285814|NCT01458275|589755636|FG002|Overall Study|Protocol Violation|2|||
163285815|NCT01458275|589755634|FG000|Overall Study|Withdrawal by Subject|3|||
163285816|NCT01458275|589755635|FG001|Overall Study|Withdrawal by Subject|2|||
163285817|NCT01458275|589755636|FG002|Overall Study|Withdrawal by Subject|1|||
163285818|NCT00751036|589755637|FG000|Overall Study|Disease Progression|28|||
163285819|NCT00751036|589755638|FG001|Overall Study|Disease Progression|29|||
163285820|NCT00751036|589755637|FG000|Overall Study|Adverse Event|6|||
163285821|NCT00751036|589755638|FG001|Overall Study|Adverse Event|4|||
163285822|NCT00751036|589755637|FG000|Overall Study|Administrative Problems|3|||
163285823|NCT00751036|589755638|FG001|Overall Study|Administrative Problems|4|||
163285824|NCT00751036|589755637|FG000|Overall Study|Withdrawal by Subject|5|||
163285825|NCT00751036|589755638|FG001|Overall Study|Withdrawal by Subject|2|||
163285826|NCT00751036|589755637|FG000|Overall Study|Death|3|||
163285827|NCT00751036|589755638|FG001|Overall Study|Death|3|||
163285828|NCT00751036|589755637|FG000|Overall Study|Lost to Follow-up|0|||
163285829|NCT00751036|589755638|FG001|Overall Study|Lost to Follow-up|1|||
163285830|NCT00751036|589755637|FG000|Overall Study|Protocol Violation|1|||
163285831|NCT00751036|589755638|FG001|Overall Study|Protocol Violation|0|||
163285832|NCT00751036|589755637|FG000|Overall Study|Missing end of Treatment Page|2|||
163285833|NCT00751036|589755638|FG001|Overall Study|Missing end of Treatment Page|3|||
163285834|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
163285835|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
163285836|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
163285837|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
163285838|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
163285839|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
163285840|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
163285841|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
163285842|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
163285843|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
163285844|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
163285845|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
163285846|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
163285847|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
163285848|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
163285849|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
163285850|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
163285851|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
163285852|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
163285853|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
163285854|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
163285855|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
163285856|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
163285857|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
163285858|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
163285859|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
163285860|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
163285861|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
163285862|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
163285863|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
163285864|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
163285865|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
163285866|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
163285867|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
163285868|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
163285869|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
163180994|NCT00722371|589377197|FG003|Overall Study|Protocol Violation|1|||
163180995|NCT00722371|589377198|FG004|Overall Study|Protocol Violation|4|||
163180996|NCT00722371|589377199|FG005|Overall Study|Protocol Violation|2|||
163180997|NCT00722371|589377200|FG006|Overall Study|Protocol Violation|1|||
163180998|NCT00722371|589377194|FG000|Overall Study|Withdrawal by Subject|18|||
163180999|NCT00722371|589377195|FG001|Overall Study|Withdrawal by Subject|27|||
163181000|NCT00722371|589377196|FG002|Overall Study|Withdrawal by Subject|19|||
163181001|NCT00722371|589377197|FG003|Overall Study|Withdrawal by Subject|23|||
163181002|NCT00722371|589377198|FG004|Overall Study|Withdrawal by Subject|19|||
163181003|NCT00722371|589377199|FG005|Overall Study|Withdrawal by Subject|18|||
163181004|NCT00722371|589377200|FG006|Overall Study|Withdrawal by Subject|26|||
163181005|NCT00718237|589377201|FG000|Overall Study|Adverse Event|1|||
163181006|NCT00718237|589377202|FG001|Overall Study|Adverse Event|3|||
163181007|NCT00718237|589377201|FG000|Overall Study|Lost to Follow-up|2|||
163181008|NCT00718237|589377202|FG001|Overall Study|Lost to Follow-up|2|||
163181009|NCT00718237|589377201|FG000|Overall Study|Physician Decision|1|||
163181010|NCT00718237|589377202|FG001|Overall Study|Physician Decision|0|||
163181011|NCT00718237|589377201|FG000|Overall Study|Withdrawal by Subject|9|||
163181012|NCT00718237|589377202|FG001|Overall Study|Withdrawal by Subject|10|||
163181013|NCT02694718|589377204|FG000|Overall Study|Death|1|||
163181014|NCT02694718|589377204|FG000|Overall Study|Withdrawal by Subject|1|||
163181015|NCT00322153|589377206|FG000|Overall Study|Adverse Event|21|||
163181016|NCT00322153|589377207|FG001|Overall Study|Adverse Event|34|||
163181017|NCT00322153|589377206|FG000|Overall Study|Protocol Violation|6|||
163181018|NCT00322153|589377207|FG001|Overall Study|Protocol Violation|14|||
163181019|NCT00322153|589377206|FG000|Overall Study|Withdrawal by Subject|18|||
163181020|NCT00322153|589377207|FG001|Overall Study|Withdrawal by Subject|10|||
163181021|NCT00322153|589377206|FG000|Overall Study|Lack of Efficacy|8|||
163181022|NCT00322153|589377207|FG001|Overall Study|Lack of Efficacy|3|||
163181023|NCT00322153|589377206|FG000|Overall Study|Lost to Follow-up|5|||
163181024|NCT00322153|589377207|FG001|Overall Study|Lost to Follow-up|4|||
163181025|NCT00322153|589377206|FG000|Overall Study|Withdrawn for other reasons|5|||
163181026|NCT00322153|589377207|FG001|Overall Study|Withdrawn for other reasons|4|||
163181027|NCT03523000|589377209|FG000|Overall Study|Withdrawal by Subject|3|||
163181028|NCT03523000|589377210|FG001|Overall Study|Withdrawal by Subject|0|||
163181029|NCT03523000|589377209|FG000|Overall Study|Unsuccessful trial|2|||
163181030|NCT03523000|589377210|FG001|Overall Study|Unsuccessful trial|0|||
163181031|NCT00772070|589377211|FG000|Overall Study|Lost to Follow-up|0|||
163181032|NCT00772070|589377212|FG001|Overall Study|Lost to Follow-up|8|||
163181033|NCT00772070|589377211|FG000|Overall Study|Withdrawal by Subject|0|||
163181034|NCT00772070|589377212|FG001|Overall Study|Withdrawal by Subject|2|||
163181035|NCT00772070|589377211|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
163181036|NCT00772070|589377212|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
163181037|NCT03993379|589377217|FG000|Overall Study|The study was terminated early due to business decision.|0|||
163181038|NCT03993379|589377218|FG001|Overall Study|The study was terminated early due to business decision.|2|||
163181039|NCT03993379|589377219|FG002|Overall Study|The study was terminated early due to business decision.|0|||
163181040|NCT03993379|589377220|FG003|Overall Study|The study was terminated early due to business decision.|0|||
163181041|NCT03993379|589377217|FG000|Overall Study|Withdrawal by Subject|0|||
163181042|NCT03993379|589377218|FG001|Overall Study|Withdrawal by Subject|1|||
163181043|NCT03993379|589377219|FG002|Overall Study|Withdrawal by Subject|0|||
163181044|NCT03993379|589377220|FG003|Overall Study|Withdrawal by Subject|0|||
163181045|NCT02380690|589377221|FG000|Overall Study|Lost to Follow-up|14|||
163181046|NCT02380690|589377222|FG001|Overall Study|Lost to Follow-up|4|||
163181047|NCT02380690|589377221|FG000|Overall Study|Withdrawal by Subject|20|||
163181048|NCT02380690|589377222|FG001|Overall Study|Withdrawal by Subject|8|||
163181049|NCT02361346|589377223|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
163181050|NCT02361346|589377224|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
163181051|NCT02361346|589377225|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
163181052|NCT02361346|589377226|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
163181053|NCT02361346|589377227|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
163181054|NCT02361346|589377228|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
163181055|NCT02361346|589377229|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
163181056|NCT02361346|589377230|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
163181057|NCT02361346|589377231|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
163181058|NCT02361346|589377223|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
163181059|NCT02361346|589377224|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
163181060|NCT02361346|589377225|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
163181061|NCT02361346|589377226|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
163181062|NCT02361346|589377227|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
163181063|NCT02361346|589377228|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
163181064|NCT02361346|589377229|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
163181065|NCT02361346|589377230|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
163181066|NCT02361346|589377231|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
163181067|NCT02361346|589377223|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
163181068|NCT02361346|589377224|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
163181069|NCT02361346|589377225|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
163181070|NCT02361346|589377226|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
163181071|NCT02361346|589377227|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
163181072|NCT02361346|589377228|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
163181073|NCT02361346|589377229|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
163181074|NCT02361346|589377230|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
163181075|NCT02361346|589377231|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
163181076|NCT02361346|589377223|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
163181077|NCT02361346|589377224|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
163181078|NCT02361346|589377225|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
163181079|NCT02361346|589377226|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
163181080|NCT02361346|589377227|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
163181081|NCT02361346|589377228|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
163181082|NCT02361346|589377229|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
163181083|NCT02361346|589377230|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
163181084|NCT02361346|589377231|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
163181085|NCT02361346|589377223|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
163181086|NCT02361346|589377224|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
163181087|NCT02361346|589377225|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
163181088|NCT02361346|589377226|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
163181089|NCT02361346|589377227|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
163181090|NCT02361346|589377228|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
163181091|NCT02361346|589377229|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
163181092|NCT02361346|589377230|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
163181093|NCT02361346|589377231|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
163181094|NCT02361346|589377223|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
163181095|NCT02361346|589377224|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
163181096|NCT02361346|589377225|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
163181097|NCT02361346|589377226|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
163181098|NCT02361346|589377227|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
163181099|NCT02361346|589377228|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
163181100|NCT02361346|589377229|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
163181101|NCT02361346|589377230|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
163181102|NCT02361346|589377231|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
163181103|NCT02483429|589377235|FG000|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|8|||
163181104|NCT02483429|589377236|FG001|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|9|||
163181105|NCT03576274|589377237|FG000|Overall Study|Lost to Follow-up|3|||
163181106|NCT03576274|589377238|FG001|Overall Study|Lost to Follow-up|2|||
163181107|NCT03576274|589377239|FG002|Overall Study|Lost to Follow-up|3|||
163181108|NCT03576274|589377240|FG003|Overall Study|Lost to Follow-up|1|||
163181109|NCT03576274|589377241|FG004|Overall Study|Lost to Follow-up|3|||
163181110|NCT03576274|589377237|FG000|Overall Study|Withdrawal by Subject|5|||
163181111|NCT03576274|589377238|FG001|Overall Study|Withdrawal by Subject|3|||
163181112|NCT03576274|589377239|FG002|Overall Study|Withdrawal by Subject|2|||
163181113|NCT03576274|589377240|FG003|Overall Study|Withdrawal by Subject|8|||
163181114|NCT03576274|589377241|FG004|Overall Study|Withdrawal by Subject|6|||
163181115|NCT04854642|589378700|FG000|Overall Study|Adverse Event|1|||
163181116|NCT04854642|589378701|FG001|Overall Study|Adverse Event|2|||
163181117|NCT04854642|589378700|FG000|Overall Study|Withdrawal by Subject|0|||
163181118|NCT04854642|589378701|FG001|Overall Study|Withdrawal by Subject|1|||
163181119|NCT02294773|589378703|FG000|Overall Study|Withdrawal by Subject|0|||
163181120|NCT02294773|589378704|FG001|Overall Study|Withdrawal by Subject|2|||
163181121|NCT01865084|589378705|FG000|Double Blind Period (DB)|Adverse Event|2|||
163181122|NCT01865084|589378706|FG001|Double Blind Period (DB)|Adverse Event|2|||
163181123|NCT01865084|589378707|FG002|Double Blind Period (DB)|Adverse Event|1|||
163181124|NCT01865084|589378705|FG000|Double Blind Period (DB)|Protocol Violation|0|||
163181125|NCT01865084|589378706|FG001|Double Blind Period (DB)|Protocol Violation|0|||
163181126|NCT01865084|589378707|FG002|Double Blind Period (DB)|Protocol Violation|1|||
163181127|NCT01865084|589378705|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
163181128|NCT01865084|589378706|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
163181129|NCT01865084|589378707|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
163181130|NCT01865084|589378705|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
163181131|NCT01865084|589378706|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
163181132|NCT01865084|589378707|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
163181133|NCT01865084|589378705|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
163181134|NCT01865084|589378706|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
163181135|NCT01865084|589378707|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
163181136|NCT01865084|589378705|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
163181137|NCT01865084|589378706|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
163181138|NCT01865084|589378707|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
163181139|NCT01865084|589378705|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
163181140|NCT01865084|589378706|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
163181141|NCT01865084|589378707|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
163181142|NCT01865084|589378705|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
163181143|NCT01865084|589378706|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
163181144|NCT01865084|589378707|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
163181145|NCT01865084|589378705|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
163181146|NCT01865084|589378706|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
163181147|NCT01865084|589378707|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
163181148|NCT03442764|589378708|FG000|Overall Study|Adverse Event|1|||
163181149|NCT03442764|589378709|FG001|Overall Study|Adverse Event|0|||
163181150|NCT03442764|589378710|FG002|Overall Study|Adverse Event|0|||
163181151|NCT01801072|589378711|FG000|Overall Study|Lost to Follow-up|17|||
163181152|NCT01801072|589378712|FG001|Overall Study|Lost to Follow-up|14|||
163181153|NCT01801072|589378711|FG000|Overall Study|Physician Decision|2|||
163181154|NCT01801072|589378712|FG001|Overall Study|Physician Decision|3|||
163181155|NCT01801072|589378711|FG000|Overall Study|Withdrawal by Subject|1|||
163181156|NCT01801072|589378712|FG001|Overall Study|Withdrawal by Subject|0|||
163181157|NCT01801072|589378711|FG000|Overall Study|Protocol Violation|2|||
163181158|NCT01801072|589378712|FG001|Overall Study|Protocol Violation|0|||
163181159|NCT01801072|589378711|FG000|Overall Study|Death|7|||
163181160|NCT01801072|589378712|FG001|Overall Study|Death|8|||
163181161|NCT03693170|589378713|FG000|Overall Study|Disease Progression|48|||
163181162|NCT03693170|589378713|FG000|Overall Study|Adverse Event|16|||
163181163|NCT03693170|589378713|FG000|Overall Study|Physician Decision|6|||
163181164|NCT03693170|589378713|FG000|Overall Study|Protocol Violation|2|||
163181165|NCT03693170|589378713|FG000|Overall Study|Death|1|||
163181166|NCT03693170|589378713|FG000|Overall Study|Non compliance with study drug|1|||
163181167|NCT03693170|589378713|FG000|Overall Study|Withdrawal by Subject|1|||
163181168|NCT04444895|589378714|FG000|Overall Study|Adverse Event|2|||
163181169|NCT04444895|589378714|FG000|Overall Study|Lost to Follow-up|2|||
163181170|NCT04444895|589378714|FG000|Overall Study|Withdrawal by Subject|5|||
163181171|NCT03034200|589378715|FG000|Overall Study|Disease progression|8|||
163181172|NCT03034200|589378716|FG001|Overall Study|Disease progression|10|||
163181173|NCT03034200|589378717|FG002|Overall Study|Disease progression|4|||
163181174|NCT03034200|589378715|FG000|Overall Study|Physician Decision|2|||
163181175|NCT03034200|589378716|FG001|Overall Study|Physician Decision|0|||
163181176|NCT03034200|589378717|FG002|Overall Study|Physician Decision|3|||
163181177|NCT03034200|589378715|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
163181178|NCT03034200|589378716|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
163285870|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
163285871|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
163285872|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
163285873|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
163285874|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
163285875|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
163285876|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
163285877|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
163285878|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
163285879|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
163285880|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163285881|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163285882|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163285883|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163285884|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163285885|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163285886|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163285887|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163285888|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163285889|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
163285890|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163285891|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163285892|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163285893|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163285894|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163285895|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163285896|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163285897|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163285898|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163285899|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
163285900|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163285901|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163285902|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163285903|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163285904|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163285905|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163285906|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
163285907|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163285908|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163285909|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163285910|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163285911|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163285912|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163285913|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163285914|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163285915|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
163285916|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163285917|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163285918|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163285919|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163285920|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163285921|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163285922|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163285923|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163285924|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
163285925|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163285926|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163285927|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163285928|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163285929|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163285930|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163285931|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163285932|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163285933|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163285934|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
163285935|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
163285936|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163285937|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163285938|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163285939|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163285940|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163285941|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163285942|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
163285943|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
163285944|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
163285945|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
163285946|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
163285947|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
163285948|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
163285949|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
163285950|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
163285951|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
163285952|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
163285953|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
163285954|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
163285955|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
163285956|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
163285957|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
163285958|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
163285959|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
163285960|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163285961|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
163285962|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163285963|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163285964|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163285965|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163285966|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163285967|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163285968|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163285969|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163285970|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163285971|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
163285972|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163285973|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163285974|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163285975|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163285976|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163285977|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163285978|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163285979|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163285980|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
163285981|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163285982|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163285983|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163285984|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163285985|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163285986|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163285987|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
163285988|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
163285989|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
163285990|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
163285991|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
163181179|NCT03034200|589378717|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
163181180|NCT03034200|589378715|FG000|Overall Study|Adjuvant Therapy|0|||
163181181|NCT03034200|589378716|FG001|Overall Study|Adjuvant Therapy|0|||
163181182|NCT03034200|589378717|FG002|Overall Study|Adjuvant Therapy|1|||
163181183|NCT00510874|589378718|FG000|Overall Study|Withdrawal by Subject|1|||
163181184|NCT00510874|589378719|FG001|Overall Study|Withdrawal by Subject|1|||
163181185|NCT00510874|589378720|FG002|Overall Study|Withdrawal by Subject|0|||
163181186|NCT00510874|589378721|FG003|Overall Study|Withdrawal by Subject|0|||
163181187|NCT00510874|589378722|FG004|Overall Study|Withdrawal by Subject|3|||
163181188|NCT00510874|589378723|FG005|Overall Study|Withdrawal by Subject|0|||
163181189|NCT00510874|589378724|FG006|Overall Study|Withdrawal by Subject|0|||
163181190|NCT00510874|589378718|FG000|Overall Study|Lost to Follow-up|2|||
163181191|NCT00510874|589378719|FG001|Overall Study|Lost to Follow-up|3|||
163181192|NCT00510874|589378720|FG002|Overall Study|Lost to Follow-up|1|||
163181193|NCT00510874|589378721|FG003|Overall Study|Lost to Follow-up|3|||
163181194|NCT00510874|589378722|FG004|Overall Study|Lost to Follow-up|4|||
163181195|NCT00510874|589378723|FG005|Overall Study|Lost to Follow-up|0|||
163181196|NCT00510874|589378724|FG006|Overall Study|Lost to Follow-up|1|||
163181197|NCT00636987|589378725|FG000|Overall Study|Death|44|||
163181198|NCT00636987|589378725|FG000|Overall Study|Explanted|13|||
163181199|NCT00636987|589378725|FG000|Overall Study|Lost to Follow-up|63|||
163181200|NCT00636987|589378725|FG000|Overall Study|5 year visit window not complete|69|||
163181201|NCT01251146|589378726|FG000|Overall Study|Lost to Follow-up|3|||
163181202|NCT01251146|589378727|FG001|Overall Study|Lost to Follow-up|10|||
163181203|NCT00053365|589378728|FG000|Overall Study|Incorrect cell type|1|||
163181204|NCT00053365|589378728|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
163181205|NCT00053365|589378728|FG000|Overall Study|Never treated|4|||
163181206|NCT03347188|589378737|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
163181207|NCT03347188|589378738|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
163181208|NCT03347188|589378737|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
163181209|NCT03347188|589378738|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
163181210|NCT03347188|589378737|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
163181211|NCT03347188|589378738|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
163181212|NCT03347188|589378737|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
163181213|NCT03347188|589378738|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
163181214|NCT03347188|589378737|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
163181215|NCT03347188|589378738|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
163181216|NCT03347188|589378737|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
163181217|NCT03347188|589378738|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
163181218|NCT03347188|589378737|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
163181219|NCT03347188|589378738|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
163181220|NCT03347188|589378737|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
163181221|NCT03347188|589378738|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
163181222|NCT04177355|589378740|FG000|Overall Study|Lost to Follow-up|0|||
163181223|NCT04177355|589378741|FG001|Overall Study|Lost to Follow-up|2|||
163181224|NCT04177355|589378742|FG002|Overall Study|Lost to Follow-up|0|||
163181225|NCT04177355|589378743|FG003|Overall Study|Lost to Follow-up|1|||
163181226|NCT04177355|589378744|FG004|Overall Study|Lost to Follow-up|2|||
163181227|NCT04177355|589378745|FG005|Overall Study|Lost to Follow-up|0|||
163181228|NCT04177355|589378746|FG006|Overall Study|Lost to Follow-up|1|||
163181229|NCT04177355|589378747|FG007|Overall Study|Lost to Follow-up|0|||
163181230|NCT04177355|589378748|FG008|Overall Study|Lost to Follow-up|0|||
163181231|NCT04177355|589378749|FG009|Overall Study|Lost to Follow-up|0|||
163181232|NCT04177355|589378750|FG010|Overall Study|Lost to Follow-up|0|||
163181233|NCT04177355|589378740|FG000|Overall Study|Withdrawal by Subject|0|||
163181234|NCT04177355|589378741|FG001|Overall Study|Withdrawal by Subject|0|||
163181235|NCT04177355|589378742|FG002|Overall Study|Withdrawal by Subject|0|||
163181236|NCT04177355|589378743|FG003|Overall Study|Withdrawal by Subject|1|||
163181237|NCT04177355|589378744|FG004|Overall Study|Withdrawal by Subject|1|||
163181238|NCT04177355|589378745|FG005|Overall Study|Withdrawal by Subject|0|||
163181239|NCT04177355|589378746|FG006|Overall Study|Withdrawal by Subject|0|||
163181240|NCT04177355|589378747|FG007|Overall Study|Withdrawal by Subject|0|||
163181241|NCT04177355|589378748|FG008|Overall Study|Withdrawal by Subject|1|||
163181242|NCT04177355|589378749|FG009|Overall Study|Withdrawal by Subject|0|||
163181243|NCT04177355|589378750|FG010|Overall Study|Withdrawal by Subject|0|||
163181244|NCT03139604|589378751|FG000|Overall Study|Other|7|||
163181245|NCT03139604|589378752|FG001|Overall Study|Other|3|||
163181246|NCT03139604|589378751|FG000|Overall Study|Withdrawal by Subject|16|||
163181247|NCT03139604|589378752|FG001|Overall Study|Withdrawal by Subject|17|||
163181248|NCT03139604|589378751|FG000|Overall Study|Physician Decision|1|||
163181249|NCT03139604|589378752|FG001|Overall Study|Physician Decision|2|||
163181250|NCT03139604|589378751|FG000|Overall Study|Lost to Follow-up|3|||
163181251|NCT03139604|589378752|FG001|Overall Study|Lost to Follow-up|1|||
163181252|NCT03139604|589378751|FG000|Overall Study|Death|65|||
163181253|NCT03139604|589378752|FG001|Overall Study|Death|67|||
163285992|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
163285993|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
163285994|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
163285995|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
163285996|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163285997|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163285998|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163285999|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163286000|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163286001|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163286002|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
163286003|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163286004|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163286005|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
163286006|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
163181254|NCT03139604|589378751|FG000|Overall Study|Study Terminated by Sponsor|122|||
163286007|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
163286008|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
163286009|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
163181255|NCT03139604|589378752|FG001|Overall Study|Study Terminated by Sponsor|127|||
163181256|NCT03139604|589378751|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
163181257|NCT03139604|589378752|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
163181258|NCT04148911|589378753|FG000|Overall Study|Death|104|||
163181259|NCT04148911|589378753|FG000|Overall Study|Lost to Follow-up|5|||
163181260|NCT04148911|589378753|FG000|Overall Study|Withdrawal by Subject|17|||
163181261|NCT04148911|589378753|FG000|Overall Study|Study Ended by Sponsor|56|||
163181262|NCT00470184|589378756|FG000|Overall Study|Not Treated(became ineligible)|4|||
163181263|NCT00470184|589378756|FG000|Overall Study|Not treated (other)|1|||
163181264|NCT00470184|589378756|FG000|Overall Study|disease Progression|4|||
163181265|NCT00470184|589378756|FG000|Overall Study|Adverse Event|3|||
163181266|NCT00470184|589378756|FG000|Overall Study|Withdrawal by Subject|4|||
163181267|NCT00470184|589378756|FG000|Overall Study|other|5|||
163181268|NCT00470184|589378756|FG000|Overall Study|recurrence|1|||
163181269|NCT01606254|589378759|FG000|Overall Study|Withdrawal by Subject|1|||
163181270|NCT01606254|589378760|FG001|Overall Study|Withdrawal by Subject|3|||
163181271|NCT01606254|589378761|FG002|Overall Study|Withdrawal by Subject|0|||
163181272|NCT01606254|589378762|FG003|Overall Study|Withdrawal by Subject|2|||
163181273|NCT01606254|589378759|FG000|Overall Study|Adverse Event|1|||
163181274|NCT01606254|589378760|FG001|Overall Study|Adverse Event|1|||
163181275|NCT01606254|589378761|FG002|Overall Study|Adverse Event|0|||
163181276|NCT01606254|589378762|FG003|Overall Study|Adverse Event|1|||
163181277|NCT04543409|589378763|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
163181278|NCT04543409|589378764|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
163181279|NCT04543409|589378763|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
163181280|NCT04543409|589378764|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
163181281|NCT04543409|589378763|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
163181282|NCT04543409|589378764|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
163181283|NCT04543409|589378763|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
163181284|NCT04543409|589378764|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
163181285|NCT04543409|589378763|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
163181286|NCT04543409|589378764|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
163181287|NCT04543409|589378763|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
163181288|NCT04543409|589378764|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
163181289|NCT04543409|589378763|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
163181290|NCT04543409|589378764|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
163181291|NCT04543409|589378763|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
163181292|NCT04543409|589378764|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
163181293|NCT04543409|589378763|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
163181294|NCT04543409|589378764|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
163286010|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
163286011|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
163286012|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
163286013|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
163286014|NCT03598790|589757233|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163286015|NCT03598790|589757234|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163286016|NCT03598790|589757235|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
163286017|NCT03598790|589757236|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163286018|NCT03598790|589757237|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163286019|NCT03598790|589757238|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163286020|NCT03598790|589757239|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163286021|NCT03598790|589757240|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163181295|NCT04543409|589378763|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
163181296|NCT04543409|589378764|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
163181297|NCT04543409|589378763|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
163181298|NCT04543409|589378764|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
163181299|NCT01052844|589378765|FG000|Overall Study|Adverse Event|0|||
163181300|NCT01052844|589378766|FG001|Overall Study|Adverse Event|1|||
163181301|NCT02093026|589378767|FG000|Overall Study|Adverse Event|26|||
163181302|NCT02093026|589378767|FG000|Overall Study|Death|10|||
163181303|NCT02093026|589378767|FG000|Overall Study|Other|157|||
163181304|NCT02195011|589378776|FG000|Overall Study|Adverse Event|4|||
163181305|NCT02195011|589378777|FG001|Overall Study|Adverse Event|0|||
163181306|NCT02195011|589378776|FG000|Overall Study|Progressive Disease|18|||
163181307|NCT02195011|589378777|FG001|Overall Study|Progressive Disease|1|||
163181308|NCT02195011|589378776|FG000|Overall Study|Withdrawal by Subject|3|||
163181309|NCT02195011|589378777|FG001|Overall Study|Withdrawal by Subject|0|||
163181310|NCT00174291|589378779|FG000|Overall Study|Lost to Follow-up|1|||
163181311|NCT00174291|589378780|FG001|Overall Study|Lost to Follow-up|1|||
163181312|NCT00174291|589378779|FG000|Overall Study|Protocol Violation|0|||
163181313|NCT00174291|589378780|FG001|Overall Study|Protocol Violation|2|||
163181314|NCT00174291|589378779|FG000|Overall Study|Study terminated by sponsor|1|||
163181315|NCT00174291|589378780|FG001|Overall Study|Study terminated by sponsor|0|||
163181316|NCT00174291|589378779|FG000|Overall Study|Withdrawal by Subject|3|||
163181317|NCT00174291|589378780|FG001|Overall Study|Withdrawal by Subject|3|||
163181318|NCT01466595|589378781|FG000|Overall Study|Withdrawal by Subject|0|||
163181319|NCT01466595|589378782|FG001|Overall Study|Withdrawal by Subject|1|||
163181320|NCT00450112|589378785|FG000|Overall Study|Other Treatment Required|5|||
163181321|NCT00450112|589378786|FG001|Overall Study|Other Treatment Required|1|||
163181322|NCT00450112|589378785|FG000|Overall Study|Withdrawal by Subject|4|||
163181323|NCT00450112|589378786|FG001|Overall Study|Withdrawal by Subject|1|||
163181324|NCT00450112|589378785|FG000|Overall Study|Lost to Follow-up|2|||
163181325|NCT00450112|589378786|FG001|Overall Study|Lost to Follow-up|1|||
163181326|NCT00450112|589378785|FG000|Overall Study|Others|2|||
163181327|NCT00450112|589378786|FG001|Overall Study|Others|3|||
163181328|NCT03418571|589378787|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
163181329|NCT03418571|589378788|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
163181330|NCT00559754|589378789|FG000|Overall Study|Disease progression|1|||
163181331|NCT00559754|589378789|FG000|Overall Study|Adverse Event|5|||
163181332|NCT00559754|589378789|FG000|Overall Study|Protocol Violation|1|||
163181333|NCT00559754|589378789|FG000|Overall Study|Investigator criteria|2|||
163181334|NCT00559754|589378789|FG000|Overall Study|Withdrawal by Subject|2|||
163181335|NCT00586326|589378790|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
163181336|NCT00586326|589378790|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
163181337|NCT00586326|589378790|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
163181338|NCT00586326|589378790|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
163181339|NCT00586326|589378790|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
163181340|NCT00586326|589378790|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
163181341|NCT00586326|589378790|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
163181342|NCT00586326|589378790|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
163181343|NCT00586326|589378790|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
163181344|NCT00586326|589378790|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
163181345|NCT00586326|589378790|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
163181346|NCT00586326|589378790|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
163181347|NCT00586326|589378790|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
163181348|NCT00586326|589378790|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
163181349|NCT00586326|589378790|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
163181350|NCT00586326|589378790|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
163286022|NCT03598790|589757241|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163286023|NCT03598790|589757233|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163286024|NCT03598790|589757234|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163286025|NCT03598790|589757235|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163286026|NCT03598790|589757236|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
163286027|NCT03598790|589757237|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
163286028|NCT03598790|589757238|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
163286029|NCT03598790|589757239|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163286030|NCT03598790|589757240|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163286031|NCT03598790|589757241|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163286032|NCT03598790|589757233|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163286033|NCT03598790|589757234|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163286034|NCT03598790|589757235|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163286035|NCT03598790|589757236|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
163286036|NCT03598790|589757237|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163286037|NCT03598790|589757238|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163286038|NCT03598790|589757239|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163286039|NCT03598790|589757240|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163286040|NCT03598790|589757241|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163286041|NCT03598790|589757233|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163286042|NCT03598790|589757234|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163286043|NCT03598790|589757235|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163286044|NCT03598790|589757236|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
163286045|NCT03598790|589757237|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163286046|NCT03598790|589757238|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163286047|NCT03598790|589757239|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163286048|NCT03598790|589757240|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163286049|NCT03598790|589757241|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163286050|NCT03598790|589757233|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
163286051|NCT03598790|589757234|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
163286052|NCT03598790|589757235|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
163286053|NCT03598790|589757236|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
163286054|NCT03598790|589757237|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
163286055|NCT03598790|589757238|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
163286056|NCT03598790|589757239|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
163286057|NCT03598790|589757240|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
163286058|NCT03598790|589757241|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
163286059|NCT03598790|589757233|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163286060|NCT03598790|589757234|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163286061|NCT03598790|589757235|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163286062|NCT03598790|589757236|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
163286063|NCT03598790|589757237|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163286064|NCT03598790|589757238|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163286065|NCT03598790|589757239|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163286066|NCT03598790|589757240|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163286067|NCT03598790|589757241|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163286068|NCT03410992|589757243|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163286069|NCT03410992|589757244|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
163286070|NCT03410992|589757245|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163286071|NCT03410992|589757246|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163286072|NCT03410992|589757247|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163286073|NCT03410992|589757248|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163286074|NCT03410992|589757249|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163286075|NCT03410992|589757250|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163286076|NCT03410992|589757251|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163286077|NCT03410992|589757252|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163286078|NCT03410992|589757253|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163286079|NCT03410992|589757243|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
163286080|NCT03410992|589757244|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
163286081|NCT03410992|589757245|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163286082|NCT03410992|589757246|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163286083|NCT03410992|589757247|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163181351|NCT00586326|589378790|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
163181352|NCT01439347|589378791|FG000|Overall Study|Death|10|||
163181353|NCT01439347|589378792|FG001|Overall Study|Death|9|||
163181354|NCT01439347|589378791|FG000|Overall Study|Withdrawal by Subject|0|||
163181355|NCT01439347|589378792|FG001|Overall Study|Withdrawal by Subject|1|||
163181356|NCT01439347|589378791|FG000|Overall Study|Physician Decision|1|||
163181357|NCT01439347|589378792|FG001|Overall Study|Physician Decision|0|||
163181358|NCT01439347|589378791|FG000|Overall Study|Sponsor Terminated Study|2|||
163181359|NCT01439347|589378792|FG001|Overall Study|Sponsor Terminated Study|3|||
163181360|NCT03595774|589378793|FG000|Overall Study|Adverse Event|1|||
163181361|NCT03595774|589378794|FG001|Overall Study|Adverse Event|0|||
163181362|NCT03595774|589378795|FG002|Overall Study|Adverse Event|1|||
163181363|NCT03595774|589378796|FG003|Overall Study|Adverse Event|0|||
163181364|NCT03595774|589378793|FG000|Overall Study|screen failure|0|||
163181365|NCT03595774|589378794|FG001|Overall Study|screen failure|1|||
163181366|NCT03595774|589378795|FG002|Overall Study|screen failure|0|||
163181367|NCT03595774|589378796|FG003|Overall Study|screen failure|1|||
163181368|NCT03882008|589378797|FG000|Overall Study|Withdrawal by Subject|1|||
163181369|NCT03882008|589378797|FG000|Overall Study|Lost to Follow-up|1|||
163181370|NCT03519386|589378802|FG000|Overall Study|Withdrawal by Subject|4|||
163181371|NCT03519386|589378803|FG001|Overall Study|Withdrawal by Subject|1|||
163181372|NCT03519386|589378804|FG002|Overall Study|Withdrawal by Subject|2|||
163181373|NCT03519386|589378802|FG000|Overall Study|Physician Decision|1|||
163181374|NCT03519386|589378803|FG001|Overall Study|Physician Decision|1|||
163181375|NCT03519386|589378804|FG002|Overall Study|Physician Decision|1|||
163181376|NCT03519386|589378802|FG000|Overall Study|Lost to Follow-up|0|||
163181377|NCT03519386|589378803|FG001|Overall Study|Lost to Follow-up|1|||
163181378|NCT03519386|589378804|FG002|Overall Study|Lost to Follow-up|1|||
163181379|NCT03519386|589378802|FG000|Overall Study|Death|1|||
163181380|NCT03519386|589378803|FG001|Overall Study|Death|0|||
163181381|NCT03519386|589378804|FG002|Overall Study|Death|4|||
163181382|NCT03519386|589378802|FG000|Overall Study|Adverse Event|2|||
163181383|NCT03519386|589378803|FG001|Overall Study|Adverse Event|1|||
163181384|NCT03519386|589378804|FG002|Overall Study|Adverse Event|2|||
163181385|NCT03519386|589378802|FG000|Overall Study|Explanted|2|||
163181386|NCT03519386|589378803|FG001|Overall Study|Explanted|1|||
163181387|NCT03519386|589378804|FG002|Overall Study|Explanted|0|||
163181388|NCT03519386|589378802|FG000|Overall Study|Ongoing in study|190|||
163181389|NCT03519386|589378803|FG001|Overall Study|Ongoing in study|192|||
163181390|NCT03519386|589378804|FG002|Overall Study|Ongoing in study|183|||
163181391|NCT01582854|589378808|FG000|Overall Study|Death|8|||
163181392|NCT01582854|589378809|FG001|Overall Study|Death|5|||
163286084|NCT03410992|589757248|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163286085|NCT03410992|589757249|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163286086|NCT03410992|589757250|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163286087|NCT03410992|589757251|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163286088|NCT03410992|589757252|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163286089|NCT03410992|589757253|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163181393|NCT01582854|589378808|FG000|Overall Study|Adverse Event|2|||
163181394|NCT01582854|589378809|FG001|Overall Study|Adverse Event|3|||
163181395|NCT01582854|589378808|FG000|Overall Study|Withdrawal by Participant|8|||
163181396|NCT01582854|589378809|FG001|Overall Study|Withdrawal by Participant|11|||
163181397|NCT01582854|589378808|FG000|Overall Study|Lost to Follow-up|1|||
163181398|NCT01582854|589378809|FG001|Overall Study|Lost to Follow-up|2|||
163286090|NCT03410992|589757243|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
163286091|NCT03410992|589757244|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
163286092|NCT03410992|589757245|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163181399|NCT01582854|589378808|FG000|Overall Study|Physician Decision|0|||
163181400|NCT01582854|589378809|FG001|Overall Study|Physician Decision|1|||
163181401|NCT01582854|589378808|FG000|Overall Study|Recurrent Stroke|13|||
163181402|NCT01582854|589378809|FG001|Overall Study|Recurrent Stroke|8|||
163181403|NCT01582854|589378808|FG000|Overall Study|Disallowed Concomitant Medication|3|||
163181404|NCT01582854|589378809|FG001|Overall Study|Disallowed Concomitant Medication|2|||
163181405|NCT01582854|589378808|FG000|Overall Study|Carotid or Neurosurgery|0|||
163181406|NCT01582854|589378809|FG001|Overall Study|Carotid or Neurosurgery|1|||
163181407|NCT01582854|589378808|FG000|Overall Study|General Anaesthesia|0|||
163181408|NCT01582854|589378809|FG001|Overall Study|General Anaesthesia|1|||
163181409|NCT01582854|589378808|FG000|Overall Study|Other Miscellaneous Reason|1|||
163181410|NCT01582854|589378809|FG001|Overall Study|Other Miscellaneous Reason|0|||
163181411|NCT03101267|589378810|FG000|Primary Study Period|Withdrawal by Subject|1|||
163181412|NCT03101267|589378811|FG001|Primary Study Period|Withdrawal by Subject|2|||
163181413|NCT03101267|589378812|FG002|Primary Study Period|Withdrawal by Subject|3|||
163181414|NCT03101267|589378810|FG000|Primary Study Period|Miscellaneous|2|||
163181415|NCT03101267|589378811|FG001|Primary Study Period|Miscellaneous|0|||
163181416|NCT03101267|589378812|FG002|Primary Study Period|Miscellaneous|0|||
163181417|NCT04068896|589378813|FG000|Overall Study|Adverse Event|2|||
163181418|NCT04068896|589378814|FG001|Overall Study|Adverse Event|0|||
163286093|NCT03410992|589757246|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163286094|NCT03410992|589757247|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163286095|NCT03410992|589757248|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163286096|NCT03410992|589757249|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163286097|NCT03410992|589757250|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163286098|NCT03410992|589757251|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163286099|NCT03410992|589757252|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163286100|NCT03410992|589757253|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163286101|NCT03410992|589757243|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
163286102|NCT03410992|589757244|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163286103|NCT03410992|589757245|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163286104|NCT03410992|589757246|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163286105|NCT03410992|589757247|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163286106|NCT03410992|589757248|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163286107|NCT03410992|589757249|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163286108|NCT03410992|589757250|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163286109|NCT03410992|589757251|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163286110|NCT03410992|589757252|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163286111|NCT03410992|589757253|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163286112|NCT03410992|589757243|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
163286113|NCT03410992|589757244|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
163286114|NCT03410992|589757245|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163286115|NCT03410992|589757246|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163286116|NCT03410992|589757247|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163286117|NCT03410992|589757248|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163286118|NCT03410992|589757249|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163286119|NCT03410992|589757250|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163286120|NCT03410992|589757251|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163286121|NCT03410992|589757252|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163286122|NCT03410992|589757253|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163286123|NCT03410992|589757243|FG000|Week 16 Assessment|Incorrect escapers|0|||
163286124|NCT03410992|589757244|FG001|Week 16 Assessment|Incorrect escapers|6|||
163286125|NCT03410992|589757245|FG002|Week 16 Assessment|Incorrect escapers|0|||
163286126|NCT03410992|589757246|FG003|Week 16 Assessment|Incorrect escapers|0|||
163286127|NCT03410992|589757247|FG004|Week 16 Assessment|Incorrect escapers|0|||
163286128|NCT03410992|589757248|FG005|Week 16 Assessment|Incorrect escapers|0|||
163286129|NCT03410992|589757249|FG006|Week 16 Assessment|Incorrect escapers|0|||
163286130|NCT03410992|589757250|FG007|Week 16 Assessment|Incorrect escapers|0|||
163286131|NCT03410992|589757251|FG008|Week 16 Assessment|Incorrect escapers|0|||
163286132|NCT03410992|589757252|FG009|Week 16 Assessment|Incorrect escapers|0|||
163286133|NCT03410992|589757253|FG010|Week 16 Assessment|Incorrect escapers|0|||
163286134|NCT03410992|589757243|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163286135|NCT03410992|589757244|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163286136|NCT03410992|589757245|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163286137|NCT03410992|589757246|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
163286138|NCT03410992|589757247|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
163286139|NCT03410992|589757248|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163286140|NCT03410992|589757249|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163286141|NCT03410992|589757250|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163286142|NCT03410992|589757251|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163286143|NCT03410992|589757252|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163286144|NCT03410992|589757253|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163286145|NCT03410992|589757243|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163286146|NCT03410992|589757244|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163286147|NCT03410992|589757245|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163286148|NCT03410992|589757246|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
163286149|NCT03410992|589757247|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
163286150|NCT03410992|589757248|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
163286151|NCT03410992|589757249|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163286152|NCT03410992|589757250|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163286153|NCT03410992|589757251|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163286154|NCT03410992|589757252|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163286155|NCT03410992|589757253|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163286156|NCT03410992|589757243|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163286157|NCT03410992|589757244|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162937381|NCT00617461|588473608|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
163181419|NCT04068896|589378815|FG002|Overall Study|Adverse Event|1|||
163181420|NCT04068896|589378816|FG003|Overall Study|Adverse Event|0|||
163181421|NCT04068896|589378817|FG004|Overall Study|Adverse Event|0|||
163181422|NCT04068896|589378818|FG005|Overall Study|Adverse Event|0|||
163181423|NCT04068896|589378813|FG000|Overall Study|Death|3|||
163181424|NCT04068896|589378814|FG001|Overall Study|Death|1|||
163181425|NCT04068896|589378815|FG002|Overall Study|Death|3|||
163181426|NCT04068896|589378816|FG003|Overall Study|Death|19|||
163181427|NCT04068896|589378817|FG004|Overall Study|Death|17|||
163181428|NCT04068896|589378818|FG005|Overall Study|Death|0|||
163181429|NCT04068896|589378813|FG000|Overall Study|Physician Decision|0|||
163181430|NCT04068896|589378814|FG001|Overall Study|Physician Decision|0|||
163181431|NCT04068896|589378815|FG002|Overall Study|Physician Decision|0|||
163181432|NCT04068896|589378816|FG003|Overall Study|Physician Decision|1|||
163181433|NCT04068896|589378817|FG004|Overall Study|Physician Decision|0|||
163181434|NCT04068896|589378818|FG005|Overall Study|Physician Decision|0|||
163181435|NCT04068896|589378813|FG000|Overall Study|progressive disease|3|||
163181436|NCT04068896|589378814|FG001|Overall Study|progressive disease|5|||
163181437|NCT04068896|589378815|FG002|Overall Study|progressive disease|3|||
163181438|NCT04068896|589378816|FG003|Overall Study|progressive disease|2|||
163181439|NCT04068896|589378817|FG004|Overall Study|progressive disease|1|||
163181440|NCT04068896|589378818|FG005|Overall Study|progressive disease|2|||
163181441|NCT04068896|589378813|FG000|Overall Study|Study terminated by sponsor|0|||
163181442|NCT04068896|589378814|FG001|Overall Study|Study terminated by sponsor|0|||
163181443|NCT04068896|589378815|FG002|Overall Study|Study terminated by sponsor|1|||
163181444|NCT04068896|589378816|FG003|Overall Study|Study terminated by sponsor|2|||
163181445|NCT04068896|589378817|FG004|Overall Study|Study terminated by sponsor|1|||
163181446|NCT04068896|589378818|FG005|Overall Study|Study terminated by sponsor|4|||
163181447|NCT04068896|589378813|FG000|Overall Study|Protocol Violation|0|||
163181448|NCT04068896|589378814|FG001|Overall Study|Protocol Violation|0|||
163181449|NCT04068896|589378815|FG002|Overall Study|Protocol Violation|0|||
163181450|NCT04068896|589378816|FG003|Overall Study|Protocol Violation|1|||
163181451|NCT04068896|589378817|FG004|Overall Study|Protocol Violation|0|||
163181452|NCT04068896|589378818|FG005|Overall Study|Protocol Violation|0|||
163181453|NCT04068896|589378813|FG000|Overall Study|Withdrawal by Subject|0|||
163181454|NCT04068896|589378814|FG001|Overall Study|Withdrawal by Subject|3|||
163181455|NCT04068896|589378815|FG002|Overall Study|Withdrawal by Subject|0|||
163181456|NCT04068896|589378816|FG003|Overall Study|Withdrawal by Subject|2|||
163181457|NCT04068896|589378817|FG004|Overall Study|Withdrawal by Subject|1|||
163181458|NCT04068896|589378818|FG005|Overall Study|Withdrawal by Subject|0|||
163181459|NCT04068896|589378813|FG000|Overall Study|Symptomatic deterioration|2|||
163181460|NCT04068896|589378814|FG001|Overall Study|Symptomatic deterioration|0|||
163181461|NCT04068896|589378815|FG002|Overall Study|Symptomatic deterioration|0|||
163181462|NCT04068896|589378816|FG003|Overall Study|Symptomatic deterioration|0|||
163181463|NCT04068896|589378817|FG004|Overall Study|Symptomatic deterioration|0|||
163181464|NCT04068896|589378818|FG005|Overall Study|Symptomatic deterioration|0|||
163181465|NCT00484185|589378821|FG000|Overall Study|Lost to Follow-up|44|||
163181466|NCT00484185|589378821|FG000|Overall Study|Other|20|||
163181467|NCT00484185|589378821|FG000|Overall Study|Randomized but not treated|5|||
163181468|NCT00484185|589378821|FG000|Overall Study|Death|2|||
163181469|NCT01222403|589378822|FG000|Overall Study|Inappropriate enrollment|0|||
163181470|NCT01222403|589378823|FG001|Overall Study|Inappropriate enrollment|2|||
163181471|NCT02068768|589378825|FG000|Overall Study|Lost to Follow-up|5|||
163181472|NCT02068768|589378825|FG000|Overall Study|Early Termination by Sponsor|2|||
163181473|NCT00555425|589378826|FG000|Overall Study|Missed Medication > 1 wk|34|||
163181474|NCT00555425|589378827|FG001|Overall Study|Missed Medication > 1 wk|15|||
163181475|NCT00555425|589378826|FG000|Overall Study|Missed 3 physician management visits|1|||
163286158|NCT03410992|589757245|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162937382|NCT05085964|588473609|FG000|Overall Study|Premature termination of study|21|||
162937383|NCT05085964|588473610|FG001|Overall Study|Premature termination of study|0|||
162937384|NCT01821625|588473611|FG000|Overall Study|Withdrawal by Subject|2|||
162937385|NCT01821625|588473611|FG000|Overall Study|Lack of Efficacy|2|||
162937386|NCT01821625|588473611|FG000|Overall Study|Adverse Event|1|||
163181476|NCT00555425|589378827|FG001|Overall Study|Missed 3 physician management visits|0|||
163181477|NCT00555425|589378826|FG000|Overall Study|Met criteria for protective transfer|16|||
163181478|NCT00555425|589378827|FG001|Overall Study|Met criteria for protective transfer|3|||
163181479|NCT00555425|589378826|FG000|Overall Study|Became pregnant and transferred care|0|||
163181480|NCT00555425|589378827|FG001|Overall Study|Became pregnant and transferred care|1|||
163181481|NCT01185834|589378828|FG000|Overall Study|Lost to Follow-up|2|||
163181482|NCT01185834|589378828|FG000|Overall Study|Discomfort|4|||
163181483|NCT01185834|589378828|FG000|Overall Study|Biomicroscopy|4|||
163181484|NCT01185834|589378828|FG000|Overall Study|Time/Job Conflict|2|||
163181485|NCT01185834|589378828|FG000|Overall Study|Early exit - Site error|2|||
163181486|NCT00913692|589378829|FG000|Screening (4 Months)|Physician Decision|3|||
163181487|NCT00913692|589378829|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
163181488|NCT00913692|589378829|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
163181489|NCT02290431|589378831|FG000|Overall Study|Adverse Event|20|||
163181490|NCT02290431|589378831|FG000|Overall Study|Progressive disease|4|||
163181491|NCT02290431|589378831|FG000|Overall Study|Study terminated by Sponsor|1|||
163181492|NCT02290431|589378831|FG000|Overall Study|Physician Decision|2|||
163181493|NCT00321893|589378832|FG000|Overall Study|Non-Compliance/Refusal|16|||
163181494|NCT00321893|589378833|FG001|Overall Study|Non-Compliance/Refusal|10|||
163181495|NCT00321893|589378832|FG000|Overall Study|Lost to Follow-up|2|||
163181496|NCT00321893|589378833|FG001|Overall Study|Lost to Follow-up|1|||
163181497|NCT00321893|589378832|FG000|Overall Study|Adverse Event|6|||
163181498|NCT00321893|589378833|FG001|Overall Study|Adverse Event|3|||
163181499|NCT03455764|589378834|FG000|Overall Study|Adverse Event|1|||
163181500|NCT03455764|589378835|FG001|Overall Study|Adverse Event|0|||
163181501|NCT03455764|589378836|FG002|Overall Study|Adverse Event|0|||
163181502|NCT03455764|589378837|FG003|Overall Study|Adverse Event|0|||
163181503|NCT03455764|589378838|FG004|Overall Study|Adverse Event|0|||
163181504|NCT03455764|589378834|FG000|Overall Study|Disease Progression|4|||
163181505|NCT03455764|589378835|FG001|Overall Study|Disease Progression|0|||
163181506|NCT03455764|589378836|FG002|Overall Study|Disease Progression|0|||
163181507|NCT03455764|589378837|FG003|Overall Study|Disease Progression|0|||
163181508|NCT03455764|589378838|FG004|Overall Study|Disease Progression|0|||
163181509|NCT03455764|589378834|FG000|Overall Study|On Treatment|1|||
163181510|NCT03455764|589378835|FG001|Overall Study|On Treatment|0|||
163181511|NCT03455764|589378836|FG002|Overall Study|On Treatment|0|||
163181512|NCT03455764|589378837|FG003|Overall Study|On Treatment|0|||
163181513|NCT03455764|589378838|FG004|Overall Study|On Treatment|0|||
163181514|NCT01683019|589380526|FG000|Overall Study|Withdrawal by Subject|2|||
163181515|NCT01683019|589380527|FG001|Overall Study|Withdrawal by Subject|1|||
163181516|NCT01683019|589380528|FG002|Overall Study|Withdrawal by Subject|4|||
163181517|NCT03437512|589380529|FG000|Randomized|Withdrawal by Subject|0|||
163181518|NCT03437512|589380530|FG001|Randomized|Withdrawal by Subject|2|||
163181519|NCT03437512|589380529|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
163181520|NCT03437512|589380530|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
163181521|NCT00301821|589380533|FG000|Overall Study|Ineligible|25|||
163181522|NCT00301821|589380533|FG000|Overall Study|Cancel|1|||
163181523|NCT03332771|589380534|FG000|Overall Study|Adverse Event|6|||
163181524|NCT03332771|589380535|FG001|Overall Study|Adverse Event|4|||
163181525|NCT03332771|589380536|FG002|Overall Study|Adverse Event|1|||
163181526|NCT03332771|589380537|FG003|Overall Study|Adverse Event|3|||
163181527|NCT03332771|589380534|FG000|Overall Study|Poor Compliance to Protocol|0|||
163181528|NCT03332771|589380535|FG001|Overall Study|Poor Compliance to Protocol|1|||
163181529|NCT03332771|589380536|FG002|Overall Study|Poor Compliance to Protocol|0|||
163181530|NCT03332771|589380537|FG003|Overall Study|Poor Compliance to Protocol|1|||
163181531|NCT03332771|589380534|FG000|Overall Study|Lost to Follow-up|2|||
163181532|NCT03332771|589380535|FG001|Overall Study|Lost to Follow-up|2|||
163181533|NCT03332771|589380536|FG002|Overall Study|Lost to Follow-up|1|||
163181534|NCT03332771|589380537|FG003|Overall Study|Lost to Follow-up|2|||
163181535|NCT03332771|589380534|FG000|Overall Study|At the Participant's own request|20|||
163181536|NCT03332771|589380535|FG001|Overall Study|At the Participant's own request|26|||
163181537|NCT03332771|589380536|FG002|Overall Study|At the Participant's own request|14|||
163181538|NCT03332771|589380537|FG003|Overall Study|At the Participant's own request|23|||
163181539|NCT03332771|589380534|FG000|Overall Study|Reason Not Specified|6|||
163181540|NCT03332771|589380535|FG001|Overall Study|Reason Not Specified|18|||
163181541|NCT03332771|589380536|FG002|Overall Study|Reason Not Specified|16|||
163181542|NCT03332771|589380537|FG003|Overall Study|Reason Not Specified|19|||
163181543|NCT00737464|589380542|FG000|Overall Study|Adverse Event|1|||
163181544|NCT00737464|589380542|FG000|Overall Study|Death|6|||
163181545|NCT00737464|589380542|FG000|Overall Study|Other - Failure to Return|1|||
163181546|NCT00737464|589380542|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
163181547|NCT00737464|589380542|FG000|Overall Study|Other reasons|4|||
163181548|NCT02423109|589380543|FG000|Lens 1|Adverse Event|1|||
163181549|NCT02423109|589380544|FG001|Lens 1|Adverse Event|0|||
163181550|NCT03868124|589380545|FG000|Overall Study|Withdrawal by Subject|4|||
163181551|NCT03868124|589380546|FG001|Overall Study|Withdrawal by Subject|0|||
163181552|NCT03868124|589380547|FG002|Overall Study|Withdrawal by Subject|1|||
163181553|NCT03868124|589380545|FG000|Overall Study|Physician Decision|1|||
163181554|NCT03868124|589380546|FG001|Overall Study|Physician Decision|0|||
163181555|NCT03868124|589380547|FG002|Overall Study|Physician Decision|1|||
163181556|NCT03868124|589380545|FG000|Overall Study|Lost to Follow-up|1|||
163181557|NCT03868124|589380546|FG001|Overall Study|Lost to Follow-up|1|||
163181558|NCT03868124|589380547|FG002|Overall Study|Lost to Follow-up|2|||
163181559|NCT03868124|589380545|FG000|Overall Study|Death|1|||
163181560|NCT03868124|589380546|FG001|Overall Study|Death|1|||
163181561|NCT03868124|589380547|FG002|Overall Study|Death|2|||
163181562|NCT03868124|589380545|FG000|Overall Study|Adverse Event|0|||
163181563|NCT03868124|589380546|FG001|Overall Study|Adverse Event|0|||
163181564|NCT03868124|589380547|FG002|Overall Study|Adverse Event|3|||
163181565|NCT03868124|589380545|FG000|Overall Study|Explanted|2|||
163181566|NCT03868124|589380546|FG001|Overall Study|Explanted|1|||
163181567|NCT03868124|589380547|FG002|Overall Study|Explanted|0|||
163181568|NCT03868124|589380545|FG000|Overall Study|Ongoing in study|176|||
163181569|NCT03868124|589380546|FG001|Overall Study|Ongoing in study|180|||
163181570|NCT03868124|589380547|FG002|Overall Study|Ongoing in study|183|||
163181571|NCT02742246|589380548|FG000|Overall Study|Never initiated treatment|5|||
163181572|NCT02742246|589380549|FG001|Overall Study|Never initiated treatment|3|||
163181573|NCT02742246|589380550|FG002|Overall Study|Never initiated treatment|1|||
163181574|NCT02742246|589380548|FG000|Overall Study|dropped out during treatment|7|||
163181575|NCT02742246|589380549|FG001|Overall Study|dropped out during treatment|13|||
163181576|NCT02742246|589380550|FG002|Overall Study|dropped out during treatment|10|||
163181577|NCT02742246|589380548|FG000|Overall Study|Death|1|||
163181578|NCT02742246|589380549|FG001|Overall Study|Death|0|||
163181579|NCT02742246|589380550|FG002|Overall Study|Death|0|||
163181580|NCT03489551|589380551|FG000|Overall Study|Withdrawal by Subject|2|||
163181581|NCT00054717|589380552|FG000|Overall Study|Randomized but not treated|2|||
163181582|NCT00054717|589380553|FG001|Overall Study|Randomized but not treated|8|||
163181583|NCT00054717|589380552|FG000|Overall Study|Adverse Event|70|||
163181584|NCT00054717|589380553|FG001|Overall Study|Adverse Event|22|||
163181585|NCT00054717|589380552|FG000|Overall Study|Protocol Violation|18|||
163181586|NCT00054717|589380553|FG001|Overall Study|Protocol Violation|19|||
163181587|NCT00054717|589380552|FG000|Overall Study|Lost to Follow-up|23|||
163181588|NCT00054717|589380553|FG001|Overall Study|Lost to Follow-up|13|||
163181589|NCT00054717|589380552|FG000|Overall Study|Withdrawal by Subject|32|||
163181590|NCT00054717|589380553|FG001|Overall Study|Withdrawal by Subject|20|||
163181591|NCT00054717|589380552|FG000|Overall Study|Other reason not defined above|117|||
163181592|NCT00054717|589380553|FG001|Overall Study|Other reason not defined above|217|||
163181593|NCT00521001|589380560|FG000|Overall Study|Ineligible|1|||
163181594|NCT01082640|589380564|FG000|Overall Study|Adverse Event|9|||
163181595|NCT01082640|589380565|FG001|Overall Study|Adverse Event|5|||
163181596|NCT01082640|589380566|FG002|Overall Study|Adverse Event|3|||
163181597|NCT01082640|589380564|FG000|Overall Study|Withdrawal by Subject|3|||
163181598|NCT01082640|589380565|FG001|Overall Study|Withdrawal by Subject|3|||
163181599|NCT01082640|589380566|FG002|Overall Study|Withdrawal by Subject|2|||
163181600|NCT01082640|589380564|FG000|Overall Study|Major protocol deviation|3|||
163181601|NCT01082640|589380565|FG001|Overall Study|Major protocol deviation|3|||
163181602|NCT01082640|589380566|FG002|Overall Study|Major protocol deviation|0|||
163181603|NCT01082640|589380564|FG000|Overall Study|Lost to Follow-up|0|||
163181604|NCT01082640|589380565|FG001|Overall Study|Lost to Follow-up|3|||
163181605|NCT01082640|589380566|FG002|Overall Study|Lost to Follow-up|0|||
163181606|NCT01082640|589380564|FG000|Overall Study|Other|2|||
163181607|NCT01082640|589380565|FG001|Overall Study|Other|1|||
163181608|NCT01082640|589380566|FG002|Overall Study|Other|3|||
163181609|NCT03823378|589380571|FG000|Overall Study|Adverse Event|2|||
163181610|NCT03823378|589380572|FG001|Overall Study|Adverse Event|2|||
163181611|NCT03823378|589380573|FG002|Overall Study|Adverse Event|0|||
163181612|NCT03823378|589380574|FG003|Overall Study|Adverse Event|0|||
163181613|NCT03823378|589380575|FG004|Overall Study|Adverse Event|0|||
163181614|NCT03823378|589380576|FG005|Overall Study|Adverse Event|0|||
163286159|NCT03410992|589757246|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163286160|NCT03410992|589757247|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163286161|NCT03410992|589757248|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
163286162|NCT03410992|589757249|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163286163|NCT03410992|589757250|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163286164|NCT03410992|589757251|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163181615|NCT03823378|589380571|FG000|Overall Study|Lost to Follow-up|0|||
163181616|NCT03823378|589380572|FG001|Overall Study|Lost to Follow-up|1|||
163181617|NCT03823378|589380573|FG002|Overall Study|Lost to Follow-up|0|||
163181618|NCT03823378|589380574|FG003|Overall Study|Lost to Follow-up|0|||
163181619|NCT03823378|589380575|FG004|Overall Study|Lost to Follow-up|1|||
163286165|NCT03410992|589757252|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163286166|NCT03410992|589757253|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163286167|NCT03410992|589757243|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163286168|NCT03410992|589757244|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163286169|NCT03410992|589757245|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163286170|NCT03410992|589757246|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
163042841|NCT01990768|588863970|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
163181620|NCT03823378|589380576|FG005|Overall Study|Lost to Follow-up|0|||
163181621|NCT03823378|589380571|FG000|Overall Study|Withdrawal by Subject|0|||
163181622|NCT03823378|589380572|FG001|Overall Study|Withdrawal by Subject|1|||
163181623|NCT03823378|589380573|FG002|Overall Study|Withdrawal by Subject|4|||
163181624|NCT03823378|589380574|FG003|Overall Study|Withdrawal by Subject|2|||
163181625|NCT03823378|589380575|FG004|Overall Study|Withdrawal by Subject|0|||
163181626|NCT03823378|589380576|FG005|Overall Study|Withdrawal by Subject|1|||
163286171|NCT03410992|589757247|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
163286172|NCT03410992|589757248|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
163286173|NCT03410992|589757249|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163286174|NCT03410992|589757250|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163286175|NCT03410992|589757251|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163286176|NCT03410992|589757252|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163286177|NCT03410992|589757253|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163286178|NCT03410992|589757243|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
163286179|NCT03410992|589757244|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
163286180|NCT03410992|589757245|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
163286181|NCT03410992|589757246|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
163286182|NCT03410992|589757247|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
163286183|NCT03410992|589757248|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
163286184|NCT03410992|589757249|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
163286185|NCT03410992|589757250|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
163286186|NCT03410992|589757251|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
163286187|NCT03410992|589757252|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
163286188|NCT03410992|589757253|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
163286189|NCT03410992|589757243|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163286190|NCT03410992|589757244|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163286191|NCT03410992|589757245|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163286192|NCT03410992|589757246|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163286193|NCT03410992|589757247|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163286194|NCT03410992|589757248|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163286195|NCT03410992|589757249|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163286196|NCT03410992|589757250|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163286197|NCT03410992|589757251|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
163286198|NCT03410992|589757252|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163286199|NCT03410992|589757253|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163286200|NCT04018066|589757254|FG000|Overall Study|participants started taking medications during the study period|3|||
163286201|NCT04018066|589757254|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
163286202|NCT03568318|589757255|FG000|Overall Study|Adverse Event|3|||
163286203|NCT03568318|589757256|FG001|Overall Study|Adverse Event|1|||
163286204|NCT03568318|589757257|FG002|Overall Study|Adverse Event|1|||
163286205|NCT03568318|589757258|FG003|Overall Study|Adverse Event|0|||
163286206|NCT03568318|589757259|FG004|Overall Study|Adverse Event|1|||
163286207|NCT03568318|589757260|FG005|Overall Study|Adverse Event|0|||
163286208|NCT03568318|589757255|FG000|Overall Study|Withdrawal by Subject|6|||
163286209|NCT03568318|589757256|FG001|Overall Study|Withdrawal by Subject|5|||
163286210|NCT03568318|589757257|FG002|Overall Study|Withdrawal by Subject|2|||
163286211|NCT03568318|589757258|FG003|Overall Study|Withdrawal by Subject|1|||
163286212|NCT03568318|589757259|FG004|Overall Study|Withdrawal by Subject|0|||
163286213|NCT03568318|589757260|FG005|Overall Study|Withdrawal by Subject|0|||
163286214|NCT03568318|589757255|FG000|Overall Study|Lost to Follow-up|3|||
163286215|NCT03568318|589757256|FG001|Overall Study|Lost to Follow-up|2|||
163286216|NCT03568318|589757257|FG002|Overall Study|Lost to Follow-up|2|||
163286217|NCT03568318|589757258|FG003|Overall Study|Lost to Follow-up|2|||
163286218|NCT03568318|589757259|FG004|Overall Study|Lost to Follow-up|1|||
163286219|NCT03568318|589757260|FG005|Overall Study|Lost to Follow-up|0|||
163286220|NCT03568318|589757255|FG000|Overall Study|Other|3|||
163286221|NCT03568318|589757256|FG001|Overall Study|Other|1|||
163286222|NCT03568318|589757257|FG002|Overall Study|Other|3|||
163286223|NCT03568318|589757258|FG003|Overall Study|Other|0|||
163286224|NCT03568318|589757259|FG004|Overall Study|Other|0|||
163286225|NCT03568318|589757260|FG005|Overall Study|Other|0|||
163286226|NCT03568318|589757255|FG000|Overall Study|Ongoing at Time of Analysis|5|||
163286227|NCT03568318|589757256|FG001|Overall Study|Ongoing at Time of Analysis|3|||
163286228|NCT03568318|589757257|FG002|Overall Study|Ongoing at Time of Analysis|2|||
163286229|NCT03568318|589757258|FG003|Overall Study|Ongoing at Time of Analysis|1|||
163286230|NCT03568318|589757259|FG004|Overall Study|Ongoing at Time of Analysis|0|||
163286231|NCT03568318|589757260|FG005|Overall Study|Ongoing at Time of Analysis|0|||
163286232|NCT04988295|589757266|FG000|Overall Study|Withdrawal by Subject|9|||
163286233|NCT04988295|589757267|FG001|Overall Study|Withdrawal by Subject|29|||
163286234|NCT04988295|589757268|FG002|Overall Study|Withdrawal by Subject|6|||
163286235|NCT04988295|589757269|FG003|Overall Study|Withdrawal by Subject|0|||
163286236|NCT04988295|589757266|FG000|Overall Study|Lost to Follow-up|1|||
163286237|NCT04988295|589757267|FG001|Overall Study|Lost to Follow-up|0|||
163286238|NCT04988295|589757268|FG002|Overall Study|Lost to Follow-up|0|||
163286239|NCT04988295|589757269|FG003|Overall Study|Lost to Follow-up|0|||
163286240|NCT04988295|589757266|FG000|Overall Study|Study participation ongoing|186|||
163286241|NCT04988295|589757267|FG001|Overall Study|Study participation ongoing|169|||
163286242|NCT04988295|589757268|FG002|Overall Study|Study participation ongoing|99|||
163286243|NCT04988295|589757269|FG003|Overall Study|Study participation ongoing|119|||
163286244|NCT00930813|589757274|FG000|Overall Study|Death|4|||
163286245|NCT00930813|589757275|FG001|Overall Study|Death|5|||
163286246|NCT00930813|589757274|FG000|Overall Study|Withdrawal by Subject|2|||
163286247|NCT00930813|589757275|FG001|Overall Study|Withdrawal by Subject|5|||
163286248|NCT00930813|589757274|FG000|Overall Study|Lost to Follow-up|2|||
163286249|NCT00930813|589757275|FG001|Overall Study|Lost to Follow-up|4|||
163286250|NCT01693614|589757276|FG000|Overall Study|Adverse Event|7|||
163286251|NCT01693614|589757277|FG001|Overall Study|Adverse Event|11|||
163286252|NCT01693614|589757278|FG002|Overall Study|Adverse Event|5|||
163286253|NCT01693614|589757276|FG000|Overall Study|Disease progression|11|||
163286254|NCT01693614|589757277|FG001|Overall Study|Disease progression|8|||
163286255|NCT01693614|589757278|FG002|Overall Study|Disease progression|7|||
163286256|NCT01693614|589757276|FG000|Overall Study|Protocol Violation|5|||
163286257|NCT01693614|589757277|FG001|Overall Study|Protocol Violation|2|||
163286258|NCT01693614|589757278|FG002|Overall Study|Protocol Violation|1|||
163286259|NCT01693614|589757276|FG000|Overall Study|Death|1|||
163286260|NCT01693614|589757277|FG001|Overall Study|Death|0|||
163286261|NCT01693614|589757278|FG002|Overall Study|Death|0|||
163286262|NCT01693614|589757276|FG000|Overall Study|Physician Decision|1|||
163286263|NCT01693614|589757277|FG001|Overall Study|Physician Decision|1|||
163181627|NCT03823378|589380571|FG000|Overall Study|Other, not specified|19|||
163181628|NCT03823378|589380572|FG001|Overall Study|Other, not specified|12|||
163181629|NCT03823378|589380573|FG002|Overall Study|Other, not specified|6|||
163181630|NCT03823378|589380574|FG003|Overall Study|Other, not specified|8|||
163181631|NCT03823378|589380575|FG004|Overall Study|Other, not specified|17|||
163181632|NCT03823378|589380576|FG005|Overall Study|Other, not specified|7|||
163181633|NCT03190369|589380577|FG000|Overall Study|Poor compliance to protocol|0|||
163181634|NCT03190369|589380578|FG001|Overall Study|Poor compliance to protocol|1|||
163181635|NCT03190369|589380577|FG000|Overall Study|Withdraw before treatment|1|||
163181636|NCT03190369|589380578|FG001|Overall Study|Withdraw before treatment|5|||
163181637|NCT03190369|589380577|FG000|Overall Study|Randomized but not treated|0|||
163181638|NCT03190369|589380578|FG001|Overall Study|Randomized but not treated|2|||
163181639|NCT01289782|589380579|FG000|Overall Study|Lost to Follow-up|14|||
163181640|NCT01289782|589380580|FG001|Overall Study|Lost to Follow-up|7|||
163181641|NCT01289782|589380579|FG000|Overall Study|Protocol Violation|1|||
163181642|NCT01289782|589380580|FG001|Overall Study|Protocol Violation|1|||
163181643|NCT01289782|589380579|FG000|Overall Study|Withdrawal by Subject|8|||
163181644|NCT01289782|589380580|FG001|Overall Study|Withdrawal by Subject|2|||
163181645|NCT01289782|589380579|FG000|Overall Study|Sponsor's Decision|1|||
163181646|NCT01289782|589380580|FG001|Overall Study|Sponsor's Decision|0|||
163181647|NCT01289782|589380579|FG000|Overall Study|Reason not specified|1|||
163181648|NCT01289782|589380580|FG001|Overall Study|Reason not specified|2|||
163181649|NCT01264016|589380586|FG000|Overall Study|Withdrawal by Subject|1|||
163181650|NCT01264016|589380586|FG000|Overall Study|Felt faint at sight of blood|1|||
163181651|NCT01629706|589380587|FG000|Phase 1 PureVision|Screen Failure|4|||
163181652|NCT01629706|589380587|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
163181653|NCT01629706|589380587|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
163181654|NCT01629706|589380587|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
163181655|NCT01629706|589380587|FG000|Phase 2 Habitual|Screen Failure|6|||
163181656|NCT01629706|589380587|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
163181657|NCT01629706|589380587|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
163181658|NCT01629706|589380587|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
163181659|NCT01629706|589380587|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
163181660|NCT00048061|589380588|FG000|Overall Study|Adverse Event|41|||
163181661|NCT00048061|589380589|FG001|Overall Study|Adverse Event|32|||
163181662|NCT00048061|589380590|FG002|Overall Study|Adverse Event|44|||
163181663|NCT00048061|589380591|FG003|Overall Study|Adverse Event|37|||
163181664|NCT00048061|589380588|FG000|Overall Study|Lost to Follow-up|3|||
163181665|NCT00048061|589380589|FG001|Overall Study|Lost to Follow-up|2|||
163181666|NCT00048061|589380590|FG002|Overall Study|Lost to Follow-up|4|||
163181667|NCT00048061|589380591|FG003|Overall Study|Lost to Follow-up|5|||
163181668|NCT00048061|589380588|FG000|Overall Study|Withdrawal by Subject|20|||
163181669|NCT00048061|589380589|FG001|Overall Study|Withdrawal by Subject|29|||
163181670|NCT00048061|589380590|FG002|Overall Study|Withdrawal by Subject|29|||
163286264|NCT01693614|589757278|FG002|Overall Study|Physician Decision|4|||
163286265|NCT01693614|589757276|FG000|Overall Study|Withdrawal by subject/guardian|0|||
163286266|NCT01693614|589757277|FG001|Overall Study|Withdrawal by subject/guardian|0|||
163181671|NCT00048061|589380591|FG003|Overall Study|Withdrawal by Subject|32|||
163181672|NCT00048061|589380588|FG000|Overall Study|Did not follow-up|5|||
163181673|NCT00048061|589380589|FG001|Overall Study|Did not follow-up|5|||
163181674|NCT00048061|589380590|FG002|Overall Study|Did not follow-up|4|||
163181675|NCT00048061|589380591|FG003|Overall Study|Did not follow-up|5|||
163181676|NCT00048061|589380588|FG000|Overall Study|Early improvement|6|||
163286267|NCT01693614|589757278|FG002|Overall Study|Withdrawal by subject/guardian|2|||
163286268|NCT01693614|589757276|FG000|Overall Study|Withdrawal by Subject|1|||
163286269|NCT01693614|589757277|FG001|Overall Study|Withdrawal by Subject|0|||
163286270|NCT01693614|589757278|FG002|Overall Study|Withdrawal by Subject|5|||
163286271|NCT04618471|589757279|FG000|Overall Study|Screen Failure|62|||
163286272|NCT04618471|589757279|FG000|Overall Study|Withdrawal by Subject|6|||
163286273|NCT04618471|589757279|FG000|Overall Study|Physician Decision|2|||
163286274|NCT04618471|589757279|FG000|Overall Study|Lost to Follow-up|1|||
163286275|NCT04618471|589757279|FG000|Overall Study|Various other reasons|2|||
163286276|NCT04618471|589757279|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
163286277|NCT00588666|589757280|FG000|Overall Study|Adverse Event|4|||
163286278|NCT05197049|589757281|FG000|Overall Study|Death|0|||
163286279|NCT05197049|589757282|FG001|Overall Study|Death|1|||
163286280|NCT05197049|589757283|FG002|Overall Study|Death|0|||
163286281|NCT05197049|589757281|FG000|Overall Study|Lost to Follow-up|3|||
163286282|NCT05197049|589757282|FG001|Overall Study|Lost to Follow-up|1|||
163286283|NCT05197049|589757283|FG002|Overall Study|Lost to Follow-up|0|||
163286284|NCT05197049|589757281|FG000|Overall Study|Withdrawal by Subject|15|||
163286285|NCT05197049|589757282|FG001|Overall Study|Withdrawal by Subject|3|||
163286286|NCT05197049|589757283|FG002|Overall Study|Withdrawal by Subject|1|||
163286287|NCT05197049|589757281|FG000|Overall Study|GCP non-compliance|1|||
163286288|NCT05197049|589757282|FG001|Overall Study|GCP non-compliance|2|||
163286289|NCT05197049|589757283|FG002|Overall Study|GCP non-compliance|0|||
163286290|NCT00927823|589757286|FG000|Continuous Dosing Period|Death|0|||
163286291|NCT00927823|589757287|FG001|Continuous Dosing Period|Death|0|||
163181677|NCT00048061|589380589|FG001|Overall Study|Early improvement|5|||
163181678|NCT00048061|589380590|FG002|Overall Study|Early improvement|3|||
163181679|NCT00048061|589380591|FG003|Overall Study|Early improvement|0|||
163181680|NCT01262352|589380594|FG000|Period 1|Illness after randomization|1|||
163181681|NCT01262352|589380595|FG001|Period 1|Illness after randomization|0|||
163181682|NCT01262352|589380594|FG000|Washout|Adverse Event|1|||
163181683|NCT01262352|589380595|FG001|Washout|Adverse Event|1|||
163181684|NCT01262352|589380594|FG000|Washout|Extended Washout|0|||
163181685|NCT01262352|589380595|FG001|Washout|Extended Washout|1|||
163181686|NCT01298193|589380596|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
163181687|NCT01298193|589380596|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
163181688|NCT01298193|589380596|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
163181689|NCT01298193|589380596|FG000|Efficacy Phase (Second Cycle)|Death|1|||
163181690|NCT01975831|589380597|FG000|Overall Study|Adverse Event|1|||
163181691|NCT01975831|589380598|FG001|Overall Study|Adverse Event|2|||
163181692|NCT01975831|589380599|FG002|Overall Study|Adverse Event|2|||
163181693|NCT01975831|589380600|FG003|Overall Study|Adverse Event|0|||
163181694|NCT01975831|589380601|FG004|Overall Study|Adverse Event|1|||
163181695|NCT01975831|589380602|FG005|Overall Study|Adverse Event|1|||
163181696|NCT01975831|589380603|FG006|Overall Study|Adverse Event|3|||
163181697|NCT01975831|589380604|FG007|Overall Study|Adverse Event|4|||
163181698|NCT01975831|589380605|FG008|Overall Study|Adverse Event|1|||
163181699|NCT01975831|589380597|FG000|Overall Study|Death|1|||
163181700|NCT01975831|589380598|FG001|Overall Study|Death|1|||
163181701|NCT01975831|589380599|FG002|Overall Study|Death|0|||
163181702|NCT01975831|589380600|FG003|Overall Study|Death|0|||
163181703|NCT01975831|589380601|FG004|Overall Study|Death|1|||
163181704|NCT01975831|589380602|FG005|Overall Study|Death|0|||
163181705|NCT01975831|589380603|FG006|Overall Study|Death|1|||
163181706|NCT01975831|589380604|FG007|Overall Study|Death|0|||
163181707|NCT01975831|589380605|FG008|Overall Study|Death|0|||
163181708|NCT01975831|589380597|FG000|Overall Study|Progressive Disease|1|||
163181709|NCT01975831|589380598|FG001|Overall Study|Progressive Disease|3|||
163181710|NCT01975831|589380599|FG002|Overall Study|Progressive Disease|2|||
163181711|NCT01975831|589380600|FG003|Overall Study|Progressive Disease|4|||
163181712|NCT01975831|589380601|FG004|Overall Study|Progressive Disease|13|||
163181713|NCT01975831|589380602|FG005|Overall Study|Progressive Disease|9|||
163181714|NCT01975831|589380603|FG006|Overall Study|Progressive Disease|10|||
163181715|NCT01975831|589380604|FG007|Overall Study|Progressive Disease|8|||
163181716|NCT01975831|589380605|FG008|Overall Study|Progressive Disease|10|||
163181717|NCT01975831|589380597|FG000|Overall Study|Withdrawal by Subject|0|||
163181718|NCT01975831|589380598|FG001|Overall Study|Withdrawal by Subject|3|||
163181719|NCT01975831|589380599|FG002|Overall Study|Withdrawal by Subject|0|||
163181720|NCT01975831|589380600|FG003|Overall Study|Withdrawal by Subject|0|||
163181721|NCT01975831|589380601|FG004|Overall Study|Withdrawal by Subject|3|||
163181722|NCT01975831|589380602|FG005|Overall Study|Withdrawal by Subject|1|||
163181723|NCT01975831|589380603|FG006|Overall Study|Withdrawal by Subject|1|||
163181724|NCT01975831|589380604|FG007|Overall Study|Withdrawal by Subject|0|||
163181725|NCT01975831|589380605|FG008|Overall Study|Withdrawal by Subject|0|||
163181726|NCT01975831|589380597|FG000|Overall Study|Physician Decision|0|||
163181727|NCT01975831|589380598|FG001|Overall Study|Physician Decision|0|||
163181728|NCT01975831|589380599|FG002|Overall Study|Physician Decision|0|||
163181729|NCT01975831|589380600|FG003|Overall Study|Physician Decision|0|||
163181730|NCT01975831|589380601|FG004|Overall Study|Physician Decision|0|||
163181731|NCT01975831|589380602|FG005|Overall Study|Physician Decision|1|||
163286292|NCT00927823|589757288|FG002|Continuous Dosing Period|Death|6|||
163286293|NCT00927823|589757289|FG003|Continuous Dosing Period|Death|0|||
163181732|NCT01975831|589380603|FG006|Overall Study|Physician Decision|0|||
163181733|NCT01975831|589380604|FG007|Overall Study|Physician Decision|1|||
163181734|NCT01975831|589380605|FG008|Overall Study|Physician Decision|0|||
163181735|NCT01975831|589380597|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
163181736|NCT01975831|589380598|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
163181737|NCT01975831|589380599|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
163181738|NCT01975831|589380600|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
163181739|NCT01975831|589380601|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
163181740|NCT01975831|589380602|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
163181741|NCT01975831|589380603|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
163181742|NCT01975831|589380604|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
163181743|NCT01975831|589380605|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
163181744|NCT01975831|589380597|FG000|Overall Study|Entered Hospice|0|||
163181745|NCT01975831|589380598|FG001|Overall Study|Entered Hospice|0|||
163181746|NCT01975831|589380599|FG002|Overall Study|Entered Hospice|0|||
163181747|NCT01975831|589380600|FG003|Overall Study|Entered Hospice|0|||
163181748|NCT01975831|589380601|FG004|Overall Study|Entered Hospice|0|||
163181749|NCT01975831|589380602|FG005|Overall Study|Entered Hospice|1|||
163181750|NCT01975831|589380603|FG006|Overall Study|Entered Hospice|0|||
163181751|NCT01975831|589380604|FG007|Overall Study|Entered Hospice|0|||
163181752|NCT01975831|589380605|FG008|Overall Study|Entered Hospice|0|||
163181753|NCT01975831|589380597|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
163181754|NCT01975831|589380598|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
163181755|NCT01975831|589380599|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
163181756|NCT01975831|589380600|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
163181757|NCT01975831|589380601|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
163181758|NCT01975831|589380602|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
163181759|NCT01975831|589380603|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
163181760|NCT01975831|589380604|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
163181761|NCT01975831|589380605|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
163181762|NCT02925793|589380606|FG000|Overall Study|Adverse Event|3|||
163181763|NCT02925793|589380607|FG001|Overall Study|Adverse Event|3|||
163181764|NCT02925793|589380608|FG002|Overall Study|Adverse Event|6|||
163181765|NCT02925793|589380606|FG000|Overall Study|Withdrawal by Subject|16|||
163181766|NCT02925793|589380607|FG001|Overall Study|Withdrawal by Subject|15|||
163181767|NCT02925793|589380608|FG002|Overall Study|Withdrawal by Subject|13|||
163181768|NCT02925793|589380606|FG000|Overall Study|Investigator Discretion|0|||
163181769|NCT02925793|589380607|FG001|Overall Study|Investigator Discretion|1|||
163181770|NCT02925793|589380608|FG002|Overall Study|Investigator Discretion|1|||
163181771|NCT02925793|589380606|FG000|Overall Study|Lost to Follow-up|2|||
163181772|NCT02925793|589380607|FG001|Overall Study|Lost to Follow-up|3|||
163181773|NCT02925793|589380608|FG002|Overall Study|Lost to Follow-up|1|||
163181774|NCT02925793|589380606|FG000|Overall Study|Lack of Efficacy|2|||
163181775|NCT02925793|589380607|FG001|Overall Study|Lack of Efficacy|6|||
163181776|NCT02925793|589380608|FG002|Overall Study|Lack of Efficacy|4|||
163181777|NCT02925793|589380606|FG000|Overall Study|Other:|2|||
163181778|NCT02925793|589380607|FG001|Overall Study|Other:|1|||
163181779|NCT02925793|589380608|FG002|Overall Study|Other:|3|||
163181780|NCT00393042|589380611|FG000|First Intervention|Withdrawal by Subject|1|||
163181781|NCT00393042|589380612|FG001|First Intervention|Withdrawal by Subject|2|||
163181782|NCT00393042|589380611|FG000|First Intervention|Lost to Follow-up|3|||
163181783|NCT00393042|589380612|FG001|First Intervention|Lost to Follow-up|3|||
163181784|NCT00393042|589380611|FG000|First Intervention|Protocol Violation|1|||
163181785|NCT00393042|589380612|FG001|First Intervention|Protocol Violation|0|||
163181786|NCT00393042|589380611|FG000|First Intervention|Adverse Event|0|||
163181787|NCT00393042|589380612|FG001|First Intervention|Adverse Event|1|||
163181788|NCT00393042|589380611|FG000|Second Intervetion|Adverse Event|0|||
163181789|NCT00393042|589380612|FG001|Second Intervetion|Adverse Event|3|||
163181790|NCT00393042|589380611|FG000|Second Intervetion|Withdrawal by Subject|0|||
163181791|NCT00393042|589380612|FG001|Second Intervetion|Withdrawal by Subject|2|||
163181792|NCT00393042|589380611|FG000|Second Intervetion|Lack of Efficacy|1|||
163181793|NCT00393042|589380612|FG001|Second Intervetion|Lack of Efficacy|0|||
163181794|NCT00393042|589380611|FG000|Second Intervetion|Lost to Follow-up|0|||
163181795|NCT00393042|589380612|FG001|Second Intervetion|Lost to Follow-up|2|||
163181796|NCT00393042|589380611|FG000|Second Intervetion|Protocol Violation|1|||
163181797|NCT00393042|589380612|FG001|Second Intervetion|Protocol Violation|1|||
163181798|NCT03475875|589380613|FG000|Period 1|Lost to Follow-up|1|||
163181799|NCT03475875|589380614|FG001|Period 1|Lost to Follow-up|0|||
163181800|NCT03475875|589380613|FG000|Period 1|Adverse Event|2|||
163181801|NCT03475875|589380614|FG001|Period 1|Adverse Event|1|||
163181802|NCT03475875|589380613|FG000|Period 2|Adverse Event|3|||
163181803|NCT03475875|589380614|FG001|Period 2|Adverse Event|0|||
163181804|NCT03475875|589380613|FG000|Period 2|Protocol Violation|0|||
163181805|NCT03475875|589380614|FG001|Period 2|Protocol Violation|1|||
163181806|NCT01642407|589380618|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
163181807|NCT01642407|589380618|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
163181808|NCT01642407|589380618|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
163181809|NCT00256282|589380619|FG000|Overall Study|Disease progression, relapse during acti|12|||
163181810|NCT00256282|589380619|FG000|Overall Study|Adverse Event|3|||
163181811|NCT00256282|589380619|FG000|Overall Study|Physician Decision|1|||
163181812|NCT02431247|589380620|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
163181813|NCT02431247|589380621|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
163181814|NCT02431247|589380622|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
163181815|NCT02431247|589380620|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
163181816|NCT02431247|589380621|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
163181817|NCT02431247|589380622|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
163181818|NCT02431247|589380620|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
163181819|NCT02431247|589380621|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
163181820|NCT02431247|589380622|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
163181821|NCT02431247|589380620|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
163181822|NCT02431247|589380621|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
163181823|NCT02431247|589380622|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
163181824|NCT02431247|589380620|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
163181825|NCT02431247|589380621|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
163181826|NCT02431247|589380622|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
163181827|NCT02431247|589380620|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
163181828|NCT02431247|589380621|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
163181829|NCT02431247|589380622|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
163181830|NCT02431247|589380620|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
163181831|NCT02431247|589380621|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
163181832|NCT02431247|589380622|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
163181833|NCT02431247|589380620|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
163181834|NCT02431247|589380621|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
163181835|NCT02431247|589380622|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
163181836|NCT02431247|589380620|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
163181837|NCT02431247|589380621|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
163181838|NCT02431247|589380622|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
163181839|NCT02431247|589380620|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
163181840|NCT02431247|589380621|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
163181841|NCT02431247|589380622|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
163181842|NCT02431247|589380620|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
163181843|NCT02431247|589380621|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
163181844|NCT02431247|589380622|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
163181845|NCT02431247|589380620|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
163181846|NCT02431247|589380621|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
163181847|NCT02431247|589380622|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
163181848|NCT02431247|589380620|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
163181849|NCT02431247|589380621|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
163181850|NCT02431247|589380622|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
163181851|NCT02431247|589380620|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
163181852|NCT02431247|589380621|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
163181853|NCT02431247|589380622|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
163181854|NCT00667446|589380623|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
163181855|NCT00667446|589380624|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
163181856|NCT00667446|589380623|FG000|Treatment Period (36 Months)|Other|2|||
163286294|NCT00927823|589757286|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
163286295|NCT00927823|589757287|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
163286296|NCT00927823|589757288|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
163286297|NCT00927823|589757289|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
163286298|NCT00927823|589757286|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
163286299|NCT00927823|589757287|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
163286300|NCT00927823|589757288|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
163286301|NCT00927823|589757289|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
162937387|NCT01821625|588473611|FG000|Overall Study|Medical contraindication|1|||
162937388|NCT01620489|588473613|FG000|Overall Study|Adverse Event|17|||
163181857|NCT00667446|589380624|FG001|Treatment Period (36 Months)|Other|2|||
163181858|NCT00667446|589380623|FG000|Treatment Period (36 Months)|Personal reasons|2|||
163181859|NCT00667446|589380624|FG001|Treatment Period (36 Months)|Personal reasons|2|||
163181860|NCT00667446|589380623|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
163181861|NCT00667446|589380624|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
163181862|NCT00667446|589380623|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
163181863|NCT00667446|589380624|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
163181864|NCT00667446|589380623|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
163181865|NCT00667446|589380624|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
163286302|NCT00927823|589757286|FG000|Continuous Dosing Period|Other|1|||
163181866|NCT00667446|589380623|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
163181867|NCT00667446|589380624|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
163181868|NCT00667446|589380623|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
163181869|NCT00667446|589380624|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
163181870|NCT00667446|589380623|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
163181871|NCT00667446|589380624|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
163181872|NCT03631355|589380625|FG000|Overall Study|Lost to Follow-up|1|||
163181873|NCT03631355|589380626|FG001|Overall Study|Lost to Follow-up|2|||
163181874|NCT02810340|589380627|FG000|Overall Study|Withdrawal by Subject|1|||
163181875|NCT02810340|589380628|FG001|Overall Study|Withdrawal by Subject|0|||
163181876|NCT02810340|589380629|FG002|Overall Study|Withdrawal by Subject|0|||
163181877|NCT02810340|589380627|FG000|Overall Study|Incarceration|0|||
163181878|NCT02810340|589380628|FG001|Overall Study|Incarceration|1|||
163181879|NCT02810340|589380629|FG002|Overall Study|Incarceration|0|||
163181880|NCT02810340|589380627|FG000|Overall Study|Lost to Follow-up|0|||
163181881|NCT02810340|589380628|FG001|Overall Study|Lost to Follow-up|0|||
163181882|NCT02810340|589380629|FG002|Overall Study|Lost to Follow-up|1|||
163181883|NCT01307020|589380638|FG000|Overall Study|Lost to Follow-up|0|||
163181884|NCT01307020|589380639|FG001|Overall Study|Lost to Follow-up|0|||
163181885|NCT01307020|589380640|FG002|Overall Study|Lost to Follow-up|1|||
163181886|NCT01307020|589380641|FG003|Overall Study|Lost to Follow-up|1|||
163181887|NCT01307020|589380642|FG004|Overall Study|Lost to Follow-up|0|||
163181888|NCT01307020|589380643|FG005|Overall Study|Lost to Follow-up|0|||
163181889|NCT01307020|589380644|FG006|Overall Study|Lost to Follow-up|1|||
163181890|NCT01307020|589380645|FG007|Overall Study|Lost to Follow-up|0|||
163181891|NCT01307020|589380646|FG008|Overall Study|Lost to Follow-up|0|||
163181892|NCT01307020|589380647|FG009|Overall Study|Lost to Follow-up|0|||
163181893|NCT01307020|589380638|FG000|Overall Study|Electronic data capture failure|0|||
163181894|NCT01307020|589380639|FG001|Overall Study|Electronic data capture failure|1|||
163181895|NCT01307020|589380640|FG002|Overall Study|Electronic data capture failure|0|||
163181896|NCT01307020|589380641|FG003|Overall Study|Electronic data capture failure|0|||
163181897|NCT01307020|589380642|FG004|Overall Study|Electronic data capture failure|0|||
163181898|NCT01307020|589380643|FG005|Overall Study|Electronic data capture failure|0|||
163181899|NCT01307020|589380644|FG006|Overall Study|Electronic data capture failure|0|||
163181900|NCT01307020|589380645|FG007|Overall Study|Electronic data capture failure|0|||
163181901|NCT01307020|589380646|FG008|Overall Study|Electronic data capture failure|0|||
163181902|NCT01307020|589380647|FG009|Overall Study|Electronic data capture failure|0|||
163181903|NCT02125604|589380648|FG000|Overall Study|Other|4|||
163181904|NCT02125604|589380648|FG000|Overall Study|Investigator Decision|1|||
163181905|NCT02125604|589380648|FG000|Overall Study|Lost to Follow-up|2|||
163181906|NCT02125604|589380648|FG000|Overall Study|Consent Withdrawn|4|||
163181907|NCT02125604|589380648|FG000|Overall Study|Adverse Event|20|||
163181908|NCT00782795|589380651|FG000|Overall Study|Withdrawal by Subject|1|||
163181909|NCT00782795|589380652|FG001|Overall Study|Withdrawal by Subject|2|||
163181910|NCT04480424|589380653|FG000|Overall Study|Withdrawal by Subject|0|||
163181911|NCT04480424|589380654|FG001|Overall Study|Withdrawal by Subject|2|||
163181912|NCT04480424|589380653|FG000|Overall Study|Lost to Follow-up|3|||
163181913|NCT04480424|589380654|FG001|Overall Study|Lost to Follow-up|3|||
163181914|NCT04480424|589380653|FG000|Overall Study|Death|14|||
163181915|NCT04480424|589380654|FG001|Overall Study|Death|16|||
163181916|NCT04480424|589380653|FG000|Overall Study|Reason not Specified|5|||
163181917|NCT04480424|589380654|FG001|Overall Study|Reason not Specified|5|||
163181918|NCT01897714|589382376|FG000|Phase I (Dose Escalation)|Disease progression|3|||
163181919|NCT01897714|589382377|FG001|Phase I (Dose Escalation)|Disease progression|5|||
163181920|NCT01897714|589382378|FG002|Phase I (Dose Escalation)|Disease progression|1|||
163181921|NCT01897714|589382379|FG003|Phase I (Dose Escalation)|Disease progression|3|||
163181922|NCT01897714|589382380|FG004|Phase I (Dose Escalation)|Disease progression|0|||
163181923|NCT01897714|589382381|FG005|Phase I (Dose Escalation)|Disease progression|0|||
163181924|NCT01897714|589382376|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
163181925|NCT01897714|589382377|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
163181926|NCT01897714|589382378|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
163181927|NCT01897714|589382379|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
163181928|NCT01897714|589382380|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
163181929|NCT01897714|589382381|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
163181930|NCT01897714|589382376|FG000|Phase I (Dose Escalation)|Other|0|||
163181931|NCT01897714|589382377|FG001|Phase I (Dose Escalation)|Other|1|||
163181932|NCT01897714|589382378|FG002|Phase I (Dose Escalation)|Other|0|||
163181933|NCT01897714|589382379|FG003|Phase I (Dose Escalation)|Other|0|||
163181934|NCT01897714|589382380|FG004|Phase I (Dose Escalation)|Other|0|||
163181935|NCT01897714|589382381|FG005|Phase I (Dose Escalation)|Other|0|||
163181936|NCT01897714|589382376|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
163181937|NCT01897714|589382377|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
163181938|NCT01897714|589382378|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
163181939|NCT01897714|589382379|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
163181940|NCT01897714|589382380|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
163286303|NCT00927823|589757287|FG001|Continuous Dosing Period|Other|2|||
163286304|NCT00927823|589757288|FG002|Continuous Dosing Period|Other|9|||
163286305|NCT00927823|589757289|FG003|Continuous Dosing Period|Other|3|||
163286306|NCT02299635|589757290|FG000|Overall Study|Adverse Event|2|||
163286307|NCT02299635|589757290|FG000|Overall Study|Death|1|||
163286308|NCT02299635|589757290|FG000|Overall Study|Global deterioration of health status|1|||
163286309|NCT02299635|589757290|FG000|Overall Study|Objective progression or relapse|10|||
163286310|NCT02299635|589757290|FG000|Overall Study|Withdrawal by Subject|2|||
163286311|NCT02299635|589757290|FG000|Overall Study|Other|3|||
163286312|NCT00828672|589757291|FG000|Study Treatment|Lost to Follow-up|1|||
163286313|NCT00828672|589757292|FG001|Study Treatment|Lost to Follow-up|0|||
163286314|NCT00828672|589757291|FG000|Study Treatment|Adverse Event|0|||
163286315|NCT00828672|589757292|FG001|Study Treatment|Adverse Event|1|||
163286316|NCT00828672|589757291|FG000|Study Treatment|Complete response, no surgery|1|||
163286317|NCT00828672|589757292|FG001|Study Treatment|Complete response, no surgery|1|||
163286318|NCT00828672|589757291|FG000|Post-surgery (<30 Days)|No central review materials|0|||
163286319|NCT00828672|589757292|FG001|Post-surgery (<30 Days)|No central review materials|1|||
163286320|NCT04889118|589757293|FG000|Overall Study|Death|49|||
163286321|NCT04889118|589757294|FG001|Overall Study|Death|47|||
163286322|NCT04889118|589757293|FG000|Overall Study|Sponsor Decision|15|||
163286323|NCT04889118|589757294|FG001|Overall Study|Sponsor Decision|20|||
163286324|NCT00601640|589757296|FG000|Overall Study|Withdrawal by Subject|3|||
163286325|NCT00601640|589757297|FG001|Overall Study|Withdrawal by Subject|0|||
163286326|NCT00601640|589757298|FG002|Overall Study|Withdrawal by Subject|7|||
163286327|NCT00601640|589757296|FG000|Overall Study|Death|1|||
163286328|NCT00601640|589757297|FG001|Overall Study|Death|0|||
163286329|NCT00601640|589757298|FG002|Overall Study|Death|0|||
163286330|NCT00601640|589757296|FG000|Overall Study|Adverse Event|0|||
163286331|NCT00601640|589757297|FG001|Overall Study|Adverse Event|4|||
163286332|NCT00601640|589757298|FG002|Overall Study|Adverse Event|2|||
163286333|NCT00601640|589757296|FG000|Overall Study|intercurrent illness|1|||
163286334|NCT00601640|589757297|FG001|Overall Study|intercurrent illness|0|||
163286335|NCT00601640|589757298|FG002|Overall Study|intercurrent illness|0|||
163286336|NCT00601640|589757296|FG000|Overall Study|change in eligibility status|0|||
163286337|NCT00601640|589757297|FG001|Overall Study|change in eligibility status|1|||
163286338|NCT00601640|589757298|FG002|Overall Study|change in eligibility status|1|||
163286339|NCT00015457|589757299|FG000|First Intervention|Adverse Event|0|||
163286340|NCT00015457|589757300|FG001|First Intervention|Adverse Event|2|||
163286341|NCT00015457|589757299|FG000|First Intervention|Lack of Efficacy|0|||
163286342|NCT00015457|589757300|FG001|First Intervention|Lack of Efficacy|1|||
163286343|NCT00015457|589757299|FG000|Second Intervention|Withdrawal by Subject|1|||
163286344|NCT00015457|589757300|FG001|Second Intervention|Withdrawal by Subject|0|||
163286345|NCT01456936|589757301|FG000|Overall Study|Other reason|41|||
163286346|NCT01456936|589757302|FG001|Overall Study|Other reason|30|||
163286347|NCT01456936|589757303|FG002|Overall Study|Other reason|36|||
163286348|NCT01456936|589757304|FG003|Overall Study|Other reason|33|||
163286349|NCT01456936|589757301|FG000|Overall Study|No longer meets eligibility criteria|4|||
163286350|NCT01456936|589757302|FG001|Overall Study|No longer meets eligibility criteria|8|||
163286351|NCT01456936|589757303|FG002|Overall Study|No longer meets eligibility criteria|6|||
163286352|NCT01456936|589757304|FG003|Overall Study|No longer meets eligibility criteria|5|||
163286353|NCT01456936|589757301|FG000|Overall Study|Protocol Violation|4|||
163286354|NCT01456936|589757302|FG001|Overall Study|Protocol Violation|2|||
163286355|NCT01456936|589757303|FG002|Overall Study|Protocol Violation|5|||
163286356|NCT01456936|589757304|FG003|Overall Study|Protocol Violation|5|||
163286357|NCT01456936|589757301|FG000|Overall Study|Pregnancy|1|||
163286358|NCT01456936|589757302|FG001|Overall Study|Pregnancy|0|||
163286359|NCT01456936|589757303|FG002|Overall Study|Pregnancy|0|||
163286360|NCT01456936|589757304|FG003|Overall Study|Pregnancy|1|||
163286361|NCT01456936|589757301|FG000|Overall Study|Insufficient clinical response|4|||
163286362|NCT01456936|589757302|FG001|Overall Study|Insufficient clinical response|4|||
163286363|NCT01456936|589757303|FG002|Overall Study|Insufficient clinical response|14|||
163286364|NCT01456936|589757304|FG003|Overall Study|Insufficient clinical response|13|||
163286365|NCT01456936|589757301|FG000|Overall Study|No longer willing to participate|195|||
163286366|NCT01456936|589757302|FG001|Overall Study|No longer willing to participate|218|||
163286367|NCT01456936|589757303|FG002|Overall Study|No longer willing to participate|224|||
163286368|NCT01456936|589757304|FG003|Overall Study|No longer willing to participate|248|||
163286369|NCT01456936|589757301|FG000|Overall Study|Lost to Follow-up|135|||
163286370|NCT01456936|589757302|FG001|Overall Study|Lost to Follow-up|126|||
163286371|NCT01456936|589757303|FG002|Overall Study|Lost to Follow-up|144|||
163286372|NCT01456936|589757304|FG003|Overall Study|Lost to Follow-up|127|||
163286373|NCT01456936|589757301|FG000|Overall Study|Medication error|0|||
163286374|NCT01456936|589757302|FG001|Overall Study|Medication error|1|||
163286375|NCT01456936|589757303|FG002|Overall Study|Medication error|0|||
163286376|NCT01456936|589757304|FG003|Overall Study|Medication error|1|||
163286377|NCT01456936|589757301|FG000|Overall Study|Adverse event (study drug)|25|||
163286378|NCT01456936|589757302|FG001|Overall Study|Adverse event (study drug)|21|||
163286379|NCT01456936|589757303|FG002|Overall Study|Adverse event (study drug)|26|||
163286380|NCT01456936|589757304|FG003|Overall Study|Adverse event (study drug)|17|||
163286381|NCT01456936|589757301|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
163286382|NCT01456936|589757302|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
163286383|NCT01456936|589757303|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
163286384|NCT01456936|589757304|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
163286385|NCT01456936|589757301|FG000|Overall Study|Death|0|||
163286386|NCT01456936|589757302|FG001|Overall Study|Death|3|||
163286387|NCT01456936|589757303|FG002|Overall Study|Death|1|||
163286388|NCT01456936|589757304|FG003|Overall Study|Death|3|||
163286389|NCT01456936|589757301|FG000|Overall Study|Randomized but not treated|21|||
163286390|NCT01456936|589757302|FG001|Overall Study|Randomized but not treated|28|||
163286391|NCT01456936|589757303|FG002|Overall Study|Randomized but not treated|16|||
163286392|NCT01456936|589757304|FG003|Overall Study|Randomized but not treated|21|||
163286393|NCT00906698|589757305|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
163286394|NCT00906698|589757306|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
163286395|NCT00906698|589757307|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
163286396|NCT00906698|589757308|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
163286397|NCT00906698|589757309|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
163286398|NCT00906698|589757310|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
163286399|NCT00906698|589757305|FG000|Overall Study|Adverse Event|0|||
163286400|NCT00906698|589757306|FG001|Overall Study|Adverse Event|0|||
163286401|NCT00906698|589757307|FG002|Overall Study|Adverse Event|2|||
163286402|NCT00906698|589757308|FG003|Overall Study|Adverse Event|0|||
163286403|NCT00906698|589757309|FG004|Overall Study|Adverse Event|4|||
163286404|NCT00906698|589757310|FG005|Overall Study|Adverse Event|1|||
163286405|NCT00906698|589757305|FG000|Overall Study|Disease progression|3|||
163286406|NCT00906698|589757306|FG001|Overall Study|Disease progression|12|||
163286407|NCT00906698|589757307|FG002|Overall Study|Disease progression|4|||
163286408|NCT00906698|589757308|FG003|Overall Study|Disease progression|4|||
163286409|NCT00906698|589757309|FG004|Overall Study|Disease progression|12|||
163286410|NCT00906698|589757310|FG005|Overall Study|Disease progression|4|||
163286411|NCT00906698|589757305|FG000|Overall Study|Withdrawal by Subject|0|||
163286412|NCT00906698|589757306|FG001|Overall Study|Withdrawal by Subject|0|||
163286413|NCT00906698|589757307|FG002|Overall Study|Withdrawal by Subject|0|||
163286414|NCT00906698|589757308|FG003|Overall Study|Withdrawal by Subject|0|||
163286415|NCT00906698|589757309|FG004|Overall Study|Withdrawal by Subject|1|||
163286416|NCT00906698|589757310|FG005|Overall Study|Withdrawal by Subject|0|||
163286417|NCT00906698|589757305|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
163286418|NCT00906698|589757306|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
163286419|NCT00906698|589757307|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
163286420|NCT00906698|589757308|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
163286421|NCT00906698|589757309|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
163286422|NCT00906698|589757310|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
163286423|NCT01744691|589757313|FG000|Overall Study|Progressive Disease|18|||
163286424|NCT01744691|589757313|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
163286425|NCT01744691|589757313|FG000|Overall Study|Withdrawal of consent for treatment|3|||
163286426|NCT01744691|589757313|FG000|Overall Study|Physician Decision|4|||
163286427|NCT02701361|589757314|FG000|Overall Study|Lost to Follow-up|5|||
163286428|NCT02701361|589757315|FG001|Overall Study|Lost to Follow-up|2|||
163286429|NCT02701361|589757316|FG002|Overall Study|Lost to Follow-up|1|||
163286430|NCT02701361|589757314|FG000|Overall Study|Withdrawal by Subject|4|||
163286431|NCT02701361|589757315|FG001|Overall Study|Withdrawal by Subject|0|||
163286432|NCT02701361|589757316|FG002|Overall Study|Withdrawal by Subject|0|||
163286433|NCT02701361|589757314|FG000|Overall Study|timed out in rehab center|0|||
163286434|NCT02701361|589757315|FG001|Overall Study|timed out in rehab center|1|||
163286435|NCT02701361|589757316|FG002|Overall Study|timed out in rehab center|0|||
163286436|NCT02701361|589757314|FG000|Overall Study|incarceration|0|||
163286437|NCT02701361|589757315|FG001|Overall Study|incarceration|0|||
163286438|NCT02701361|589757316|FG002|Overall Study|incarceration|1|||
163286439|NCT00404079|589757321|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
163286440|NCT00404079|589757322|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
163286441|NCT04154943|589757323|FG000|Overall Study|Study Ongoing|68|||
163286442|NCT04154943|589757323|FG000|Overall Study|Lost to Follow-up|1|||
163286443|NCT04154943|589757323|FG000|Overall Study|Decision by the Investigator|1|||
163286444|NCT04154943|589757323|FG000|Overall Study|Death|5|||
163286445|NCT04154943|589757323|FG000|Overall Study|Withdrawal by Subject|4|||
163286446|NCT01460342|589757325|FG000|Overall Study|Adverse Event|5|||
163286447|NCT01460342|589757326|FG001|Overall Study|Adverse Event|4|||
163286448|NCT01460342|589757325|FG000|Overall Study|Lost to Follow-up|1|||
163286449|NCT01460342|589757326|FG001|Overall Study|Lost to Follow-up|2|||
163286450|NCT01460342|589757325|FG000|Overall Study|Protocol Violation|0|||
163286451|NCT01460342|589757326|FG001|Overall Study|Protocol Violation|1|||
163286452|NCT01460342|589757325|FG000|Overall Study|Withdrawal by Subject|3|||
163286453|NCT01460342|589757326|FG001|Overall Study|Withdrawal by Subject|4|||
163286454|NCT01460342|589757325|FG000|Overall Study|Physician Decision|1|||
163286455|NCT01460342|589757326|FG001|Overall Study|Physician Decision|3|||
163286456|NCT01460342|589757325|FG000|Overall Study|Lack of Efficacy|1|||
163286457|NCT01460342|589757326|FG001|Overall Study|Lack of Efficacy|0|||
163286458|NCT02107014|589757327|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
163286459|NCT00591838|589757328|FG000|Overall Study|Withdrawal by Subject|0|||
163286460|NCT00591838|589757329|FG001|Overall Study|Withdrawal by Subject|0|||
163286461|NCT00591838|589757330|FG002|Overall Study|Withdrawal by Subject|0|||
163286462|NCT00591838|589757331|FG003|Overall Study|Withdrawal by Subject|1|||
163286463|NCT00591838|589757332|FG004|Overall Study|Withdrawal by Subject|0|||
163286464|NCT03761784|589757333|FG000|Overall Study|Adverse Event|4|||
163286465|NCT03761784|589757334|FG001|Overall Study|Adverse Event|0|||
163286466|NCT03761784|589757333|FG000|Overall Study|Lost to Follow-up|10|||
163286467|NCT03761784|589757334|FG001|Overall Study|Lost to Follow-up|7|||
163286468|NCT03761784|589757333|FG000|Overall Study|Pregnancy|1|||
163286469|NCT03761784|589757334|FG001|Overall Study|Pregnancy|0|||
163286470|NCT03761784|589757333|FG000|Overall Study|Protocol Violation|2|||
163286471|NCT03761784|589757334|FG001|Overall Study|Protocol Violation|0|||
163286472|NCT03761784|589757333|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
163286473|NCT03761784|589757334|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
163286474|NCT03761784|589757333|FG000|Overall Study|Withdrawal by Subject|9|||
163286475|NCT03761784|589757334|FG001|Overall Study|Withdrawal by Subject|4|||
163286476|NCT03761784|589757333|FG000|Overall Study|Physician Decision|1|||
163286477|NCT03761784|589757334|FG001|Overall Study|Physician Decision|0|||
163286478|NCT03761784|589757333|FG000|Overall Study|Other Than Specified|1|||
163286479|NCT03761784|589757334|FG001|Overall Study|Other Than Specified|0|||
163286480|NCT01549652|589757335|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
163286481|NCT01549652|589757336|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
163286482|NCT01549652|589757337|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
163286483|NCT01549652|589757338|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
163286484|NCT01549652|589757335|FG000|Overall Study|Study Drug Titration Failure|5|||
163286485|NCT01549652|589757336|FG001|Overall Study|Study Drug Titration Failure|6|||
163286486|NCT01549652|589757337|FG002|Overall Study|Study Drug Titration Failure|0|||
163286487|NCT01549652|589757338|FG003|Overall Study|Study Drug Titration Failure|0|||
163286488|NCT01549652|589757335|FG000|Overall Study|Withdrawal Effect|0|||
163286489|NCT01549652|589757336|FG001|Overall Study|Withdrawal Effect|2|||
163286490|NCT01549652|589757337|FG002|Overall Study|Withdrawal Effect|0|||
163286491|NCT01549652|589757338|FG003|Overall Study|Withdrawal Effect|0|||
163286492|NCT01549652|589757335|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
163286493|NCT01549652|589757336|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
163286494|NCT01549652|589757337|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
163286495|NCT01549652|589757338|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
163286496|NCT01549652|589757335|FG000|Overall Study|Problem with Infusion|1|||
163286497|NCT01549652|589757336|FG001|Overall Study|Problem with Infusion|0|||
163286498|NCT01549652|589757337|FG002|Overall Study|Problem with Infusion|0|||
163286499|NCT01549652|589757338|FG003|Overall Study|Problem with Infusion|0|||
163286500|NCT01549652|589757335|FG000|Overall Study|Titration Non-Compliance|1|||
163286501|NCT01549652|589757336|FG001|Overall Study|Titration Non-Compliance|3|||
163286502|NCT01549652|589757337|FG002|Overall Study|Titration Non-Compliance|4|||
163286503|NCT01549652|589757338|FG003|Overall Study|Titration Non-Compliance|5|||
163286504|NCT01549652|589757335|FG000|Overall Study|Titration Side Effects|0|||
163286505|NCT01549652|589757336|FG001|Overall Study|Titration Side Effects|0|||
163286506|NCT01549652|589757337|FG002|Overall Study|Titration Side Effects|6|||
163181941|NCT01897714|589382381|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
163181942|NCT01897714|589382376|FG000|Phase II (MTD)|Lost to Follow-up|0|||
163181943|NCT01897714|589382377|FG001|Phase II (MTD)|Lost to Follow-up|0|||
163181944|NCT01897714|589382378|FG002|Phase II (MTD)|Lost to Follow-up|0|||
163181945|NCT01897714|589382379|FG003|Phase II (MTD)|Lost to Follow-up|0|||
163181946|NCT01897714|589382380|FG004|Phase II (MTD)|Lost to Follow-up|1|||
163181947|NCT01897714|589382381|FG005|Phase II (MTD)|Lost to Follow-up|0|||
163181948|NCT01897714|589382376|FG000|Phase II (MTD)|Death|0|||
163181949|NCT01897714|589382377|FG001|Phase II (MTD)|Death|0|||
163181950|NCT01897714|589382378|FG002|Phase II (MTD)|Death|0|||
163181951|NCT01897714|589382379|FG003|Phase II (MTD)|Death|0|||
163181952|NCT01897714|589382380|FG004|Phase II (MTD)|Death|25|||
163181953|NCT01897714|589382381|FG005|Phase II (MTD)|Death|10|||
163181954|NCT01897714|589382376|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
163181955|NCT01897714|589382377|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
163181956|NCT01897714|589382378|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
163181957|NCT01897714|589382379|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
163181958|NCT01897714|589382380|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
163181959|NCT01897714|589382381|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
163181960|NCT01897714|589382376|FG000|Phase II (MTD)|Other|0|||
163181961|NCT01897714|589382377|FG001|Phase II (MTD)|Other|0|||
163286507|NCT01549652|589757338|FG003|Overall Study|Titration Side Effects|3|||
163286508|NCT01549652|589757335|FG000|Overall Study|Withdrawal by Subject|0|||
163286509|NCT01549652|589757336|FG001|Overall Study|Withdrawal by Subject|0|||
163286510|NCT01549652|589757337|FG002|Overall Study|Withdrawal by Subject|5|||
163286511|NCT01549652|589757338|FG003|Overall Study|Withdrawal by Subject|3|||
163286512|NCT00586339|589757339|FG000|Overall Study|Withdrawal by Subject|1|||
163286513|NCT00586339|589757340|FG001|Overall Study|Withdrawal by Subject|3|||
163286514|NCT00586339|589757341|FG002|Overall Study|Withdrawal by Subject|1|||
163286515|NCT00586339|589757339|FG000|Overall Study|Migrated/moved from study area|3|||
163286516|NCT00586339|589757340|FG001|Overall Study|Migrated/moved from study area|2|||
163286517|NCT00586339|589757341|FG002|Overall Study|Migrated/moved from study area|4|||
163286518|NCT00586339|589757339|FG000|Overall Study|Lost to Follow-up|3|||
163286519|NCT00586339|589757340|FG001|Overall Study|Lost to Follow-up|2|||
163286520|NCT00586339|589757341|FG002|Overall Study|Lost to Follow-up|1|||
163286521|NCT02512042|589757342|FG000|Overall Study|Adverse Event|0|||
163286522|NCT02512042|589757343|FG001|Overall Study|Adverse Event|4|||
163286523|NCT02512042|589757342|FG000|Overall Study|Withdrawal by Subject|6|||
163286524|NCT02512042|589757343|FG001|Overall Study|Withdrawal by Subject|6|||
163286525|NCT02512042|589757342|FG000|Overall Study|Non-compliance with study drug|1|||
163286526|NCT02512042|589757343|FG001|Overall Study|Non-compliance with study drug|2|||
163286527|NCT02512042|589757342|FG000|Overall Study|Lost to Follow-up|5|||
163286528|NCT02512042|589757343|FG001|Overall Study|Lost to Follow-up|2|||
163286529|NCT02512042|589757342|FG000|Overall Study|Other|11|||
163286530|NCT02512042|589757343|FG001|Overall Study|Other|11|||
163286531|NCT01194258|589757347|FG000|Titration Period|Withdrawal by Subject|6|||
163286532|NCT01194258|589757348|FG001|Titration Period|Withdrawal by Subject|0|||
163286533|NCT01194258|589757349|FG002|Titration Period|Withdrawal by Subject|0|||
163286534|NCT01194258|589757350|FG003|Titration Period|Withdrawal by Subject|0|||
163286535|NCT01194258|589757351|FG004|Titration Period|Withdrawal by Subject|0|||
163286536|NCT01194258|589757347|FG000|Titration Period|Lost to Follow-up|2|||
163286537|NCT01194258|589757348|FG001|Titration Period|Lost to Follow-up|0|||
163286538|NCT01194258|589757349|FG002|Titration Period|Lost to Follow-up|0|||
163286539|NCT01194258|589757350|FG003|Titration Period|Lost to Follow-up|0|||
163286540|NCT01194258|589757351|FG004|Titration Period|Lost to Follow-up|0|||
163286541|NCT01194258|589757347|FG000|Titration Period|Titration failure|3|||
163286542|NCT01194258|589757348|FG001|Titration Period|Titration failure|0|||
163286543|NCT01194258|589757349|FG002|Titration Period|Titration failure|0|||
163286544|NCT01194258|589757350|FG003|Titration Period|Titration failure|0|||
163286545|NCT01194258|589757351|FG004|Titration Period|Titration failure|0|||
163286546|NCT01194258|589757347|FG000|Period 1 (12 Weeks)|Death|0|||
163286547|NCT01194258|589757348|FG001|Period 1 (12 Weeks)|Death|0|||
163286548|NCT01194258|589757349|FG002|Period 1 (12 Weeks)|Death|0|||
163286549|NCT01194258|589757350|FG003|Period 1 (12 Weeks)|Death|0|||
163286550|NCT01194258|589757351|FG004|Period 1 (12 Weeks)|Death|1|||
163286551|NCT01194258|589757347|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
163286552|NCT01194258|589757348|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
163286553|NCT01194258|589757349|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
163286554|NCT01194258|589757350|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
163286555|NCT01194258|589757351|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
163286556|NCT01194258|589757347|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
163286557|NCT01194258|589757348|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
163286558|NCT01194258|589757349|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
163286559|NCT01194258|589757350|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
163286560|NCT01194258|589757351|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
163286561|NCT01194258|589757347|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163286562|NCT01194258|589757348|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
163286563|NCT01194258|589757349|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
163286564|NCT01194258|589757350|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163286565|NCT01194258|589757351|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163286566|NCT01467700|589757352|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
163286567|NCT01467700|589757353|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
163286568|NCT01467700|589757354|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
163286569|NCT01467700|589757355|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
163286570|NCT01467700|589757352|FG000|Overall Study|Major Protocol Deviation|3|||
163286571|NCT01467700|589757353|FG001|Overall Study|Major Protocol Deviation|3|||
163286572|NCT01467700|589757354|FG002|Overall Study|Major Protocol Deviation|2|||
163286573|NCT01467700|589757355|FG003|Overall Study|Major Protocol Deviation|3|||
163286574|NCT01467700|589757352|FG000|Overall Study|Lost to Follow-up|6|||
163286575|NCT01467700|589757353|FG001|Overall Study|Lost to Follow-up|5|||
163286576|NCT01467700|589757354|FG002|Overall Study|Lost to Follow-up|2|||
163286577|NCT01467700|589757355|FG003|Overall Study|Lost to Follow-up|3|||
163286578|NCT01467700|589757352|FG000|Overall Study|Voluntary Withdrawal|5|||
163286579|NCT01467700|589757353|FG001|Overall Study|Voluntary Withdrawal|7|||
163286580|NCT01467700|589757354|FG002|Overall Study|Voluntary Withdrawal|6|||
163286581|NCT01467700|589757355|FG003|Overall Study|Voluntary Withdrawal|2|||
163286582|NCT01467700|589757352|FG000|Overall Study|Study Termination|6|||
163286583|NCT01467700|589757353|FG001|Overall Study|Study Termination|5|||
163286584|NCT01467700|589757354|FG002|Overall Study|Study Termination|10|||
163286585|NCT01467700|589757355|FG003|Overall Study|Study Termination|7|||
163286586|NCT01467700|589757352|FG000|Overall Study|Pregnancy|0|||
163286587|NCT01467700|589757353|FG001|Overall Study|Pregnancy|1|||
163286588|NCT01467700|589757354|FG002|Overall Study|Pregnancy|1|||
163286589|NCT01467700|589757355|FG003|Overall Study|Pregnancy|0|||
163286590|NCT01467700|589757352|FG000|Overall Study|Lack of Efficacy|2|||
163286591|NCT01467700|589757353|FG001|Overall Study|Lack of Efficacy|0|||
163286592|NCT01467700|589757354|FG002|Overall Study|Lack of Efficacy|2|||
163286593|NCT01467700|589757355|FG003|Overall Study|Lack of Efficacy|1|||
163286594|NCT01467700|589757352|FG000|Overall Study|Reason not Specified|1|||
163286595|NCT01467700|589757353|FG001|Overall Study|Reason not Specified|3|||
163286596|NCT01467700|589757354|FG002|Overall Study|Reason not Specified|2|||
163286597|NCT01467700|589757355|FG003|Overall Study|Reason not Specified|8|||
163286598|NCT04109118|589757358|FG000|Overall Study|Lost to Follow-up|3|||
163286599|NCT03235349|589757361|FG000|Overall Study|Adverse Event|1|||
163286600|NCT03235349|589757361|FG000|Overall Study|Other|1|||
163286601|NCT03394027|589757362|FG000|Overall Study|Ineligible|3|||
163286602|NCT03394027|589757363|FG001|Overall Study|Ineligible|1|||
163286603|NCT03394027|589757364|FG002|Overall Study|Ineligible|3|||
163286604|NCT03394027|589757362|FG000|Overall Study|Participant declined to participate before treatment started|0|||
163286605|NCT03394027|589757363|FG001|Overall Study|Participant declined to participate before treatment started|0|||
163286606|NCT03394027|589757364|FG002|Overall Study|Participant declined to participate before treatment started|1|||
163286607|NCT02824432|589757368|FG000|Overall Study|Major Protocol Deviation|1|||
163286608|NCT02824432|589757369|FG001|Overall Study|Major Protocol Deviation|0|||
163286609|NCT01348087|589757370|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
163286610|NCT01348087|589757370|FG000|Overall Study|Administrative problems|79|||
163286611|NCT01348087|589757370|FG000|Overall Study|protocol deviation|1|||
163286612|NCT01348087|589757370|FG000|Overall Study|Lost to Follow-up|1|||
163286613|NCT01348087|589757370|FG000|Overall Study|Subject withdrew consent|7|||
163286614|NCT01348087|589757370|FG000|Overall Study|Adverse Event|25|||
163286615|NCT02081391|589757373|FG000|12-hour Treatment|Withdrawal by Subject|3|||
163286616|NCT02081391|589757374|FG001|12-hour Treatment|Withdrawal by Subject|2|||
163286617|NCT02081391|589757375|FG002|12-hour Treatment|Withdrawal by Subject|0|||
163286618|NCT02081391|589757376|FG003|12-hour Treatment|Withdrawal by Subject|0|||
163286619|NCT02081391|589757373|FG000|12-hour Treatment|Physician Decision|4|||
163286620|NCT02081391|589757374|FG001|12-hour Treatment|Physician Decision|1|||
163286621|NCT02081391|589757375|FG002|12-hour Treatment|Physician Decision|0|||
163286622|NCT02081391|589757376|FG003|12-hour Treatment|Physician Decision|0|||
163286623|NCT02081391|589757373|FG000|12-hour Treatment|Lack of Efficacy|3|||
163286624|NCT02081391|589757374|FG001|12-hour Treatment|Lack of Efficacy|0|||
163286625|NCT02081391|589757375|FG002|12-hour Treatment|Lack of Efficacy|0|||
163286626|NCT02081391|589757376|FG003|12-hour Treatment|Lack of Efficacy|0|||
163286627|NCT02081391|589757373|FG000|12-hour Treatment|Adverse Event|4|||
163286628|NCT02081391|589757374|FG001|12-hour Treatment|Adverse Event|2|||
163286629|NCT02081391|589757375|FG002|12-hour Treatment|Adverse Event|0|||
163286630|NCT02081391|589757376|FG003|12-hour Treatment|Adverse Event|0|||
163286631|NCT02081391|589757373|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
163286632|NCT02081391|589757374|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
163286633|NCT02081391|589757375|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
163286634|NCT02081391|589757376|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
163286635|NCT02081391|589757373|FG000|12-hour Treatment|Further reasons|2|||
163286636|NCT02081391|589757374|FG001|12-hour Treatment|Further reasons|1|||
163286637|NCT02081391|589757375|FG002|12-hour Treatment|Further reasons|0|||
163286638|NCT02081391|589757376|FG003|12-hour Treatment|Further reasons|0|||
163286639|NCT02081391|589757373|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
163286640|NCT02081391|589757374|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
163286641|NCT02081391|589757375|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
163286642|NCT02081391|589757376|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
163286643|NCT02081391|589757373|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
163286644|NCT02081391|589757374|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
163286645|NCT02081391|589757375|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
163286646|NCT02081391|589757376|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
163286647|NCT02081391|589757373|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
163286648|NCT02081391|589757374|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
162937389|NCT01620489|588473614|FG001|Overall Study|Adverse Event|4|||
163286649|NCT02081391|589757375|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
163286650|NCT02081391|589757376|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
163286651|NCT02081391|589757373|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
163286652|NCT02081391|589757374|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
163286653|NCT02081391|589757375|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
163286654|NCT02081391|589757376|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
163286655|NCT02081391|589757373|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
163286656|NCT02081391|589757374|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
163286657|NCT02081391|589757375|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
163181962|NCT01897714|589382378|FG002|Phase II (MTD)|Other|0|||
163181963|NCT01897714|589382379|FG003|Phase II (MTD)|Other|0|||
163181964|NCT01897714|589382380|FG004|Phase II (MTD)|Other|3|||
163181965|NCT01897714|589382381|FG005|Phase II (MTD)|Other|0|||
163181966|NCT05828095|589382388|FG000|Overall Study|Lost to Follow-up|1|||
163181967|NCT05828095|589382389|FG001|Overall Study|Lost to Follow-up|0|||
163181968|NCT05828095|589382388|FG000|Overall Study|Reactogenicity symptom|0|||
163181969|NCT05828095|589382389|FG001|Overall Study|Reactogenicity symptom|1|||
163181970|NCT03206073|589382390|FG000|Overall Study|Participant Noncompliance|0|||
163181971|NCT03206073|589382391|FG001|Overall Study|Participant Noncompliance|1|||
163181972|NCT03206073|589382392|FG002|Overall Study|Participant Noncompliance|0|||
163181973|NCT03206073|589382393|FG003|Overall Study|Participant Noncompliance|0|||
163181974|NCT03206073|589382390|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
163181975|NCT03206073|589382391|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
163181976|NCT03206073|589382392|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
163181977|NCT03206073|589382393|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
163181978|NCT03206073|589382390|FG000|Overall Study|Death|0|||
163181979|NCT03206073|589382391|FG001|Overall Study|Death|0|||
163181980|NCT03206073|589382392|FG002|Overall Study|Death|1|||
163181981|NCT03206073|589382393|FG003|Overall Study|Death|0|||
163181982|NCT03206073|589382390|FG000|Overall Study|Taken off active treatment|0|||
163181983|NCT03206073|589382391|FG001|Overall Study|Taken off active treatment|0|||
163181984|NCT03206073|589382392|FG002|Overall Study|Taken off active treatment|3|||
163181985|NCT03206073|589382393|FG003|Overall Study|Taken off active treatment|0|||
163181986|NCT05523323|589382394|FG000|Overall Study|Death|26|||
163181987|NCT05523323|589382395|FG001|Overall Study|Death|21|||
163181988|NCT05523323|589382394|FG000|Overall Study|Ongoing participants|35|||
163181989|NCT05523323|589382395|FG001|Overall Study|Ongoing participants|30|||
163181990|NCT02428608|589382400|FG000|Overall Study|Pregnancy|2|||
163181991|NCT02428608|589382400|FG000|Overall Study|Lost to Follow-up|37|||
163181992|NCT02428608|589382400|FG000|Overall Study|Withdrawal by Subject|2|||
163181993|NCT02428608|589382400|FG000|Overall Study|scheduling conflicts|15|||
163181994|NCT02428608|589382400|FG000|Overall Study|moved away|10|||
163181995|NCT02428608|589382400|FG000|Overall Study|Death|1|||
163181996|NCT02428608|589382400|FG000|Overall Study|various|16|||
163181997|NCT00397943|589382401|FG000|Overall Study|Unspecified reasons|12|||
163181998|NCT00397943|589382402|FG001|Overall Study|Unspecified reasons|9|||
163181999|NCT00397943|589382403|FG002|Overall Study|Unspecified reasons|0|||
163182000|NCT00397943|589382404|FG003|Overall Study|Unspecified reasons|0|||
163182001|NCT00397943|589382405|FG004|Overall Study|Unspecified reasons|0|||
163182002|NCT05007717|589382406|FG000|Overall Study|Death|3|||
163182003|NCT05007717|589382407|FG001|Overall Study|Death|2|||
163182004|NCT01117051|589382408|FG000|Overall Study|Withdrawal by Subject|5|||
163182005|NCT01117051|589382409|FG001|Overall Study|Withdrawal by Subject|3|||
163182006|NCT01117051|589382408|FG000|Overall Study|Adverse Event|4|||
163182007|NCT01117051|589382409|FG001|Overall Study|Adverse Event|3|||
163182008|NCT01117051|589382408|FG000|Overall Study|Lost to Follow-up|0|||
163182009|NCT01117051|589382409|FG001|Overall Study|Lost to Follow-up|1|||
163182010|NCT01117051|589382408|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
163182011|NCT01117051|589382409|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
163182012|NCT01117051|589382408|FG000|Overall Study|Sponsor's decision|3|||
163182013|NCT01117051|589382409|FG001|Overall Study|Sponsor's decision|1|||
163182014|NCT01117051|589382408|FG000|Overall Study|Surgical procedure|0|||
163182015|NCT01117051|589382409|FG001|Overall Study|Surgical procedure|1|||
163182016|NCT01117051|589382408|FG000|Overall Study|Randomized by mistake|0|||
163182017|NCT01117051|589382409|FG001|Overall Study|Randomized by mistake|1|||
163182018|NCT01117051|589382408|FG000|Overall Study|Convenience issue|1|||
163182019|NCT01117051|589382409|FG001|Overall Study|Convenience issue|0|||
163182020|NCT00206076|589382410|FG000|Overall Study|Physician Decision|2|||
163182021|NCT00206076|589382411|FG001|Overall Study|Physician Decision|0|||
163182022|NCT00206076|589382410|FG000|Overall Study|Withdrawal by Subject|1|||
163182023|NCT00206076|589382411|FG001|Overall Study|Withdrawal by Subject|1|||
163182024|NCT00427960|589382412|FG000|Overall Study|Adverse Event|2|||
163182025|NCT00427960|589382413|FG001|Overall Study|Adverse Event|0|||
163182026|NCT00427960|589382412|FG000|Overall Study|Withdrawal by Subject|0|||
163182027|NCT00427960|589382413|FG001|Overall Study|Withdrawal by Subject|3|||
163182028|NCT00427960|589382412|FG000|Overall Study|Other|0|||
163182029|NCT00427960|589382413|FG001|Overall Study|Other|1|||
163182030|NCT01142128|589382414|FG000|Overall Study|Physician Decision|1|||
163182031|NCT01142128|589382414|FG000|Overall Study|Lost to Follow-up|1|||
162937390|NCT01620489|588473613|FG000|Overall Study|Protocol Violation|0|||
163182032|NCT01142128|589382414|FG000|Overall Study|Withdrawal by Subject|2|||
163182033|NCT03355664|589382415|FG000|Overall Study|Adverse Event|1|||
163182034|NCT03355664|589382416|FG001|Overall Study|Adverse Event|2|||
163182035|NCT03355664|589382415|FG000|Overall Study|Lost to Follow-up|11|||
163182036|NCT03355664|589382416|FG001|Overall Study|Lost to Follow-up|7|||
163182037|NCT03355664|589382415|FG000|Overall Study|Protocol Violation|1|||
163286658|NCT02081391|589757376|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
163286659|NCT02081391|589757373|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
163286660|NCT02081391|589757374|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
163286661|NCT02081391|589757375|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
163286662|NCT02081391|589757376|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
163286663|NCT00124982|589757378|FG000|Short-term Period|Death|1|||
163286664|NCT00124982|589757379|FG001|Short-term Period|Death|1|||
163286665|NCT00124982|589757380|FG002|Short-term Period|Death|0|||
163286666|NCT00124982|589757378|FG000|Short-term Period|Adverse Event|17|||
163286667|NCT00124982|589757379|FG001|Short-term Period|Adverse Event|22|||
163286668|NCT00124982|589757380|FG002|Short-term Period|Adverse Event|0|||
163286669|NCT00124982|589757378|FG000|Short-term Period|Lack of Efficacy|32|||
163286670|NCT00124982|589757379|FG001|Short-term Period|Lack of Efficacy|73|||
163286671|NCT00124982|589757380|FG002|Short-term Period|Lack of Efficacy|0|||
163286672|NCT00124982|589757378|FG000|Short-term Period|Lost to Follow-up|8|||
163286673|NCT00124982|589757379|FG001|Short-term Period|Lost to Follow-up|5|||
163286674|NCT00124982|589757380|FG002|Short-term Period|Lost to Follow-up|0|||
163286675|NCT00124982|589757378|FG000|Short-term Period|Withdrawal of Consent|7|||
163286676|NCT00124982|589757379|FG001|Short-term Period|Withdrawal of Consent|9|||
163286677|NCT00124982|589757380|FG002|Short-term Period|Withdrawal of Consent|0|||
163286678|NCT00124982|589757378|FG000|Short-term Period|Poor/Non-compliance|3|||
163286679|NCT00124982|589757379|FG001|Short-term Period|Poor/Non-compliance|1|||
163182038|NCT03355664|589382416|FG001|Overall Study|Protocol Violation|2|||
163182039|NCT03355664|589382415|FG000|Overall Study|Withdrawal by Subject|2|||
163182040|NCT03355664|589382416|FG001|Overall Study|Withdrawal by Subject|1|||
163182041|NCT02821910|589382420|FG000|Overall Study|Withdrawal by Subject|0|||
163182042|NCT02821910|589382421|FG001|Overall Study|Withdrawal by Subject|0|||
163182043|NCT02821910|589382422|FG002|Overall Study|Withdrawal by Subject|1|||
163182044|NCT02821910|589382423|FG003|Overall Study|Withdrawal by Subject|0|||
163182045|NCT02821910|589382424|FG004|Overall Study|Withdrawal by Subject|0|||
163182046|NCT02821910|589382425|FG005|Overall Study|Withdrawal by Subject|1|||
163182047|NCT02821910|589382420|FG000|Overall Study|Other than specified|1|||
163182048|NCT02821910|589382421|FG001|Overall Study|Other than specified|0|||
163182049|NCT02821910|589382422|FG002|Overall Study|Other than specified|1|||
163182050|NCT02821910|589382423|FG003|Overall Study|Other than specified|0|||
163182051|NCT02821910|589382424|FG004|Overall Study|Other than specified|0|||
163182052|NCT02821910|589382425|FG005|Overall Study|Other than specified|0|||
163182053|NCT00423670|589382426|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
163182054|NCT00423670|589382427|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
163182055|NCT00423670|589382428|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
163182056|NCT00423670|589382429|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
163182057|NCT00423670|589382430|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
163182058|NCT00423670|589382431|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
163182059|NCT00423670|589382432|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
163182060|NCT00423670|589382433|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
163182061|NCT00423670|589382426|FG000|Treatment Period|Adverse Event|8|||
163182062|NCT00423670|589382427|FG001|Treatment Period|Adverse Event|12|||
163182063|NCT00423670|589382428|FG002|Treatment Period|Adverse Event|15|||
163182064|NCT00423670|589382429|FG003|Treatment Period|Adverse Event|20|||
163182065|NCT00423670|589382430|FG004|Treatment Period|Adverse Event|9|||
163182066|NCT00423670|589382431|FG005|Treatment Period|Adverse Event|4|||
163182067|NCT00423670|589382432|FG006|Treatment Period|Adverse Event|7|||
163182068|NCT00423670|589382433|FG007|Treatment Period|Adverse Event|2|||
163182069|NCT00423670|589382426|FG000|Treatment Period|Protocol-defined clinical event|0|||
163182070|NCT00423670|589382427|FG001|Treatment Period|Protocol-defined clinical event|7|||
163182071|NCT00423670|589382428|FG002|Treatment Period|Protocol-defined clinical event|4|||
163182072|NCT00423670|589382429|FG003|Treatment Period|Protocol-defined clinical event|12|||
163182073|NCT00423670|589382430|FG004|Treatment Period|Protocol-defined clinical event|5|||
163182074|NCT00423670|589382431|FG005|Treatment Period|Protocol-defined clinical event|4|||
163182075|NCT00423670|589382432|FG006|Treatment Period|Protocol-defined clinical event|16|||
163182076|NCT00423670|589382433|FG007|Treatment Period|Protocol-defined clinical event|15|||
163182077|NCT00423670|589382426|FG000|Treatment Period|Lost to Follow-up|2|||
163182078|NCT00423670|589382427|FG001|Treatment Period|Lost to Follow-up|1|||
163182079|NCT00423670|589382428|FG002|Treatment Period|Lost to Follow-up|3|||
163182080|NCT00423670|589382429|FG003|Treatment Period|Lost to Follow-up|1|||
163182081|NCT00423670|589382430|FG004|Treatment Period|Lost to Follow-up|6|||
163182082|NCT00423670|589382431|FG005|Treatment Period|Lost to Follow-up|0|||
163182083|NCT00423670|589382432|FG006|Treatment Period|Lost to Follow-up|3|||
163182084|NCT00423670|589382433|FG007|Treatment Period|Lost to Follow-up|1|||
163182085|NCT00423670|589382426|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
163182086|NCT00423670|589382427|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
163182087|NCT00423670|589382428|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
163182088|NCT00423670|589382429|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
163182089|NCT00423670|589382430|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
163286680|NCT00124982|589757380|FG002|Short-term Period|Poor/Non-compliance|0|||
163286681|NCT00124982|589757378|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
163286682|NCT00124982|589757379|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
163286683|NCT00124982|589757380|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
163286684|NCT00124982|589757378|FG000|Short-term Period|Participant Decision|1|||
163286685|NCT00124982|589757379|FG001|Short-term Period|Participant Decision|0|||
163286686|NCT00124982|589757380|FG002|Short-term Period|Participant Decision|0|||
163286687|NCT00124982|589757378|FG000|Short-term Period|Participant Chose Own Doctor|0|||
163286688|NCT00124982|589757379|FG001|Short-term Period|Participant Chose Own Doctor|1|||
163286689|NCT00124982|589757380|FG002|Short-term Period|Participant Chose Own Doctor|0|||
163286690|NCT00124982|589757378|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
163286691|NCT00124982|589757379|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
163286692|NCT00124982|589757380|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
163286693|NCT00124982|589757378|FG000|Short-term Period|Participant Had Lymphopenia|1|||
163286694|NCT00124982|589757379|FG001|Short-term Period|Participant Had Lymphopenia|0|||
163286695|NCT00124982|589757380|FG002|Short-term Period|Participant Had Lymphopenia|0|||
163286696|NCT00124982|589757378|FG000|Long-term Period|Death|0|||
163286697|NCT00124982|589757379|FG001|Long-term Period|Death|0|||
163286698|NCT00124982|589757380|FG002|Long-term Period|Death|1|||
163286699|NCT00124982|589757378|FG000|Long-term Period|Adverse Event|0|||
163286700|NCT00124982|589757379|FG001|Long-term Period|Adverse Event|0|||
163286701|NCT00124982|589757380|FG002|Long-term Period|Adverse Event|17|||
163286702|NCT00124982|589757378|FG000|Long-term Period|Lack of Efficacy|0|||
163286703|NCT00124982|589757379|FG001|Long-term Period|Lack of Efficacy|0|||
163286704|NCT00124982|589757380|FG002|Long-term Period|Lack of Efficacy|46|||
163286705|NCT00124982|589757378|FG000|Long-term Period|Lost to Follow-up|0|||
163286706|NCT00124982|589757379|FG001|Long-term Period|Lost to Follow-up|0|||
163286707|NCT00124982|589757380|FG002|Long-term Period|Lost to Follow-up|4|||
163286708|NCT00124982|589757378|FG000|Long-term Period|Withdrawal by Subject|0|||
163286709|NCT00124982|589757379|FG001|Long-term Period|Withdrawal by Subject|0|||
163286710|NCT00124982|589757380|FG002|Long-term Period|Withdrawal by Subject|16|||
163286711|NCT00124982|589757378|FG000|Long-term Period|Pregnancy|0|||
163286712|NCT00124982|589757379|FG001|Long-term Period|Pregnancy|0|||
163286713|NCT00124982|589757380|FG002|Long-term Period|Pregnancy|1|||
163286714|NCT00124982|589757378|FG000|Long-term Period|Poor/Non-compliance|0|||
163286715|NCT00124982|589757379|FG001|Long-term Period|Poor/Non-compliance|0|||
163286716|NCT00124982|589757380|FG002|Long-term Period|Poor/Non-compliance|2|||
163286717|NCT00124982|589757378|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
163286718|NCT00124982|589757379|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
163286719|NCT00124982|589757380|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
163286720|NCT00124982|589757378|FG000|Long-term Period|Neurologist Recommendation|0|||
163286721|NCT00124982|589757379|FG001|Long-term Period|Neurologist Recommendation|0|||
163286722|NCT00124982|589757380|FG002|Long-term Period|Neurologist Recommendation|1|||
163286723|NCT00980538|589757381|FG000|Overall Study|Lost to Follow-up|20|||
163286724|NCT00980538|589757381|FG000|Overall Study|Sponsor's Decision|4|||
163286725|NCT00980538|589757381|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
163286726|NCT00980538|589757381|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
163286727|NCT00980538|589757381|FG000|Overall Study|Switch to Commercially Available Medication|25|||
163286728|NCT00980538|589757381|FG000|Overall Study|Participant Non-Compliant|9|||
163286729|NCT00980538|589757381|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
163286730|NCT00980538|589757381|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
163286731|NCT00980538|589757381|FG000|Overall Study|Other|60|||
163286732|NCT00980538|589757381|FG000|Overall Study|Other|1|||
163286733|NCT05663866|589757382|FG000|Overall Study|Adverse Event|0|||
163286734|NCT05663866|589757383|FG001|Overall Study|Adverse Event|0|||
163286735|NCT05663866|589757384|FG002|Overall Study|Adverse Event|1|||
163286736|NCT05663866|589757385|FG003|Overall Study|Adverse Event|0|||
163286737|NCT05663866|589757382|FG000|Overall Study|Physician Decision|0|||
163286738|NCT05663866|589757383|FG001|Overall Study|Physician Decision|0|||
163286739|NCT05663866|589757384|FG002|Overall Study|Physician Decision|0|||
163286740|NCT05663866|589757385|FG003|Overall Study|Physician Decision|1|||
163286741|NCT05663866|589757382|FG000|Overall Study|Withdrawal by Subject|0|||
163286742|NCT05663866|589757383|FG001|Overall Study|Withdrawal by Subject|2|||
163286743|NCT05663866|589757384|FG002|Overall Study|Withdrawal by Subject|1|||
163286744|NCT05663866|589757385|FG003|Overall Study|Withdrawal by Subject|2|||
163286745|NCT05663866|589757382|FG000|Overall Study|Progressive disease|4|||
163286746|NCT05663866|589757383|FG001|Overall Study|Progressive disease|8|||
163286747|NCT05663866|589757384|FG002|Overall Study|Progressive disease|5|||
163286748|NCT05663866|589757385|FG003|Overall Study|Progressive disease|2|||
163286749|NCT05663866|589757382|FG000|Overall Study|Other|1|||
163286750|NCT05663866|589757383|FG001|Overall Study|Other|0|||
163286751|NCT05663866|589757384|FG002|Overall Study|Other|0|||
163286752|NCT05663866|589757385|FG003|Overall Study|Other|0|||
163286753|NCT05663866|589757382|FG000|Overall Study|Ongoing|1|||
163286754|NCT05663866|589757383|FG001|Overall Study|Ongoing|27|||
163286755|NCT05663866|589757384|FG002|Overall Study|Ongoing|6|||
163286756|NCT05663866|589757385|FG003|Overall Study|Ongoing|1|||
163286757|NCT01249092|589758620|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
163286758|NCT01249092|589758620|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
163286759|NCT03518112|589758621|FG000|Overall Study|Withdrawal by Subject|1|||
163286760|NCT02322216|589758627|FG000|Overall Study|Adverse Event|1|||
163286761|NCT02322216|589758628|FG001|Overall Study|Adverse Event|0|||
163286762|NCT02322216|589758627|FG000|Overall Study|Withdrawal by Subject|1|||
163286763|NCT02322216|589758628|FG001|Overall Study|Withdrawal by Subject|4|||
163286764|NCT05650333|589758630|FG000|Treatment Period (7 Days)|Adverse Event|1|||
163286765|NCT02873754|589758631|FG000|Overall Study|Lost to Follow-up|5|||
163286766|NCT02873754|589758631|FG000|Overall Study|Couldn't complete study procedures|1|||
163286767|NCT01981850|589758632|FG000|Main Phase Stage 1|Death|2|||
163286768|NCT01981850|589758633|FG001|Main Phase Stage 1|Death|0|||
163286769|NCT01981850|589758634|FG002|Main Phase Stage 1|Death|0|||
163286770|NCT01981850|589758635|FG003|Main Phase Stage 1|Death|0|||
163286771|NCT01981850|589758636|FG004|Main Phase Stage 1|Death|0|||
163286772|NCT01981850|589758637|FG005|Main Phase Stage 1|Death|0|||
163286773|NCT01981850|589758638|FG006|Main Phase Stage 1|Death|0|||
163286774|NCT01981850|589758639|FG007|Main Phase Stage 1|Death|0|||
163286775|NCT01981850|589758640|FG008|Main Phase Stage 1|Death|0|||
163286776|NCT01981850|589758641|FG009|Main Phase Stage 1|Death|0|||
163286777|NCT01981850|589758632|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
163286778|NCT01981850|589758633|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163286779|NCT01981850|589758634|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163286780|NCT01981850|589758635|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163286781|NCT01981850|589758636|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163286782|NCT01981850|589758637|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163286783|NCT01981850|589758638|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163286784|NCT01981850|589758639|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163286785|NCT01981850|589758640|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163286786|NCT01981850|589758641|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163286787|NCT01981850|589758632|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
163286788|NCT01981850|589758633|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
163286789|NCT01981850|589758634|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
163286790|NCT01981850|589758635|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
163286791|NCT01981850|589758636|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
163286792|NCT01981850|589758637|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
163286793|NCT01981850|589758638|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
163286794|NCT01981850|589758639|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
163286795|NCT01981850|589758640|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
163286796|NCT01981850|589758641|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
163286797|NCT01981850|589758632|FG000|Main Phase Stage 1|Various reasons|0|||
163286798|NCT01981850|589758633|FG001|Main Phase Stage 1|Various reasons|0|||
163286799|NCT01981850|589758634|FG002|Main Phase Stage 1|Various reasons|2|||
163286800|NCT01981850|589758635|FG003|Main Phase Stage 1|Various reasons|0|||
163286801|NCT01981850|589758636|FG004|Main Phase Stage 1|Various reasons|0|||
163286802|NCT01981850|589758637|FG005|Main Phase Stage 1|Various reasons|0|||
163286803|NCT01981850|589758638|FG006|Main Phase Stage 1|Various reasons|0|||
163286804|NCT01981850|589758639|FG007|Main Phase Stage 1|Various reasons|0|||
163286805|NCT01981850|589758640|FG008|Main Phase Stage 1|Various reasons|0|||
163286806|NCT01981850|589758641|FG009|Main Phase Stage 1|Various reasons|0|||
163286807|NCT01981850|589758632|FG000|Main Phase Stage 2|Adverse Event|0|||
163286808|NCT01981850|589758633|FG001|Main Phase Stage 2|Adverse Event|0|||
163286809|NCT01981850|589758634|FG002|Main Phase Stage 2|Adverse Event|0|||
163286810|NCT01981850|589758635|FG003|Main Phase Stage 2|Adverse Event|0|||
163286811|NCT01981850|589758636|FG004|Main Phase Stage 2|Adverse Event|6|||
163286812|NCT01981850|589758637|FG005|Main Phase Stage 2|Adverse Event|5|||
163286813|NCT01981850|589758638|FG006|Main Phase Stage 2|Adverse Event|7|||
163286814|NCT01981850|589758639|FG007|Main Phase Stage 2|Adverse Event|0|||
163286815|NCT01981850|589758640|FG008|Main Phase Stage 2|Adverse Event|0|||
163286816|NCT01981850|589758641|FG009|Main Phase Stage 2|Adverse Event|0|||
163286817|NCT01981850|589758632|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
163286818|NCT01981850|589758633|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
163286819|NCT01981850|589758634|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
163286820|NCT01981850|589758635|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
163286821|NCT01981850|589758636|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
163286822|NCT01981850|589758637|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
163286823|NCT01981850|589758638|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
163286824|NCT01981850|589758639|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
163286825|NCT01981850|589758640|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
163286826|NCT01981850|589758641|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
163286827|NCT01981850|589758632|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
163286828|NCT01981850|589758633|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
163286829|NCT01981850|589758634|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
163286830|NCT01981850|589758635|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
163286831|NCT01981850|589758636|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
163286832|NCT01981850|589758637|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
163286833|NCT01981850|589758638|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
163286834|NCT01981850|589758639|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
163286835|NCT01981850|589758640|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
163286836|NCT01981850|589758641|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
163286837|NCT01981850|589758632|FG000|Main Phase Stage 2|Various reasons|0|||
163286838|NCT01981850|589758633|FG001|Main Phase Stage 2|Various reasons|0|||
163286839|NCT01981850|589758634|FG002|Main Phase Stage 2|Various reasons|0|||
163286840|NCT01981850|589758635|FG003|Main Phase Stage 2|Various reasons|0|||
163286841|NCT01981850|589758636|FG004|Main Phase Stage 2|Various reasons|2|||
163286842|NCT01981850|589758637|FG005|Main Phase Stage 2|Various reasons|0|||
163286843|NCT01981850|589758638|FG006|Main Phase Stage 2|Various reasons|1|||
163286844|NCT01981850|589758639|FG007|Main Phase Stage 2|Various reasons|0|||
163286845|NCT01981850|589758640|FG008|Main Phase Stage 2|Various reasons|0|||
163286846|NCT01981850|589758641|FG009|Main Phase Stage 2|Various reasons|0|||
163286847|NCT01981850|589758632|FG000|Main Phase Stage 2|Progressive Disease|0|||
163286848|NCT01981850|589758633|FG001|Main Phase Stage 2|Progressive Disease|0|||
163286849|NCT01981850|589758634|FG002|Main Phase Stage 2|Progressive Disease|0|||
163286850|NCT01981850|589758635|FG003|Main Phase Stage 2|Progressive Disease|0|||
163286851|NCT01981850|589758636|FG004|Main Phase Stage 2|Progressive Disease|0|||
163286852|NCT01981850|589758637|FG005|Main Phase Stage 2|Progressive Disease|6|||
163286853|NCT01981850|589758638|FG006|Main Phase Stage 2|Progressive Disease|6|||
163286854|NCT01981850|589758639|FG007|Main Phase Stage 2|Progressive Disease|0|||
163286855|NCT01981850|589758640|FG008|Main Phase Stage 2|Progressive Disease|0|||
163286856|NCT01981850|589758641|FG009|Main Phase Stage 2|Progressive Disease|0|||
163286857|NCT01981850|589758632|FG000|Open Label Extension (OLE)|Adverse Event|0|||
163286858|NCT01981850|589758633|FG001|Open Label Extension (OLE)|Adverse Event|0|||
163286859|NCT01981850|589758634|FG002|Open Label Extension (OLE)|Adverse Event|0|||
163286860|NCT01981850|589758635|FG003|Open Label Extension (OLE)|Adverse Event|0|||
163286861|NCT01981850|589758636|FG004|Open Label Extension (OLE)|Adverse Event|0|||
163286862|NCT01981850|589758637|FG005|Open Label Extension (OLE)|Adverse Event|0|||
163286863|NCT01981850|589758638|FG006|Open Label Extension (OLE)|Adverse Event|0|||
163286864|NCT01981850|589758639|FG007|Open Label Extension (OLE)|Adverse Event|2|||
163286865|NCT01981850|589758640|FG008|Open Label Extension (OLE)|Adverse Event|1|||
163286866|NCT01981850|589758641|FG009|Open Label Extension (OLE)|Adverse Event|8|||
163286867|NCT01981850|589758632|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
163286868|NCT01981850|589758633|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
163286869|NCT01981850|589758634|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
163286870|NCT01981850|589758635|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
163286871|NCT01981850|589758636|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
163286872|NCT01981850|589758637|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
163286873|NCT01981850|589758638|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
163286874|NCT01981850|589758639|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
163286875|NCT01981850|589758640|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
163286876|NCT01981850|589758641|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
163286877|NCT01981850|589758632|FG000|Open Label Extension (OLE)|Various reasons|0|||
163286878|NCT01981850|589758633|FG001|Open Label Extension (OLE)|Various reasons|0|||
163286879|NCT01981850|589758634|FG002|Open Label Extension (OLE)|Various reasons|0|||
163286880|NCT01981850|589758635|FG003|Open Label Extension (OLE)|Various reasons|0|||
163286881|NCT01981850|589758636|FG004|Open Label Extension (OLE)|Various reasons|0|||
163286882|NCT01981850|589758637|FG005|Open Label Extension (OLE)|Various reasons|0|||
163286883|NCT01981850|589758638|FG006|Open Label Extension (OLE)|Various reasons|0|||
163286884|NCT01981850|589758639|FG007|Open Label Extension (OLE)|Various reasons|3|||
163286885|NCT01981850|589758640|FG008|Open Label Extension (OLE)|Various reasons|1|||
163286886|NCT01981850|589758641|FG009|Open Label Extension (OLE)|Various reasons|3|||
163286887|NCT01981850|589758632|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
163286888|NCT01981850|589758633|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
163286889|NCT01981850|589758634|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
163286890|NCT01981850|589758635|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
163286891|NCT01981850|589758636|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
163286892|NCT01981850|589758637|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
163286893|NCT01981850|589758638|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
163286894|NCT01981850|589758639|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
163286895|NCT01981850|589758640|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
163286896|NCT01981850|589758641|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
163286897|NCT01981850|589758632|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163286898|NCT01981850|589758633|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163286899|NCT01981850|589758634|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163286900|NCT01981850|589758635|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163286901|NCT01981850|589758636|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163286902|NCT01981850|589758637|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163286903|NCT01981850|589758638|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163286904|NCT01981850|589758639|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163286905|NCT01981850|589758640|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163286906|NCT01981850|589758641|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
163286907|NCT01981850|589758632|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
163286908|NCT01981850|589758633|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
163286909|NCT01981850|589758634|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
163286910|NCT01981850|589758635|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
163286911|NCT01981850|589758636|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
163286912|NCT01981850|589758637|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
163286913|NCT01981850|589758638|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
163286914|NCT01981850|589758639|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
163286915|NCT01981850|589758640|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
163286916|NCT01981850|589758641|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
163286917|NCT02059980|589758648|FG000|Overall Study|Lost to Follow-up|2|||
163286918|NCT02059980|589758649|FG001|Overall Study|Lost to Follow-up|1|||
163286919|NCT01321606|589758650|FG000|Overall Study|Lost to Follow-up|0|||
163286920|NCT01321606|589758651|FG001|Overall Study|Lost to Follow-up|0|||
163286921|NCT01321606|589758652|FG002|Overall Study|Lost to Follow-up|0|||
163286922|NCT01321606|589758653|FG003|Overall Study|Lost to Follow-up|1|||
163286923|NCT03412747|589758654|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
163286924|NCT03412747|589758655|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
163286925|NCT03412747|589758656|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
163286926|NCT03412747|589758654|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
163286927|NCT03412747|589758655|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
163286928|NCT03412747|589758656|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
163286929|NCT03412747|589758654|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
163286930|NCT03412747|589758655|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
163286931|NCT03412747|589758656|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
163286932|NCT03412747|589758654|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
163286933|NCT03412747|589758655|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
163286934|NCT03412747|589758656|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
163286935|NCT03412747|589758654|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
163286936|NCT03412747|589758655|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
163286937|NCT03412747|589758656|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
163286938|NCT03412747|589758654|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
163286939|NCT03412747|589758655|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
163286940|NCT03412747|589758656|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
163286941|NCT03412747|589758654|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
163286942|NCT03412747|589758655|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
163286943|NCT03412747|589758656|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
163286944|NCT03412747|589758654|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
163286945|NCT03412747|589758655|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
163286946|NCT03412747|589758656|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
163286947|NCT03412747|589758654|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
163286948|NCT03412747|589758655|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
163286949|NCT03412747|589758656|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
163286950|NCT03412747|589758654|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
163286951|NCT03412747|589758655|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
163286952|NCT03412747|589758656|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
163286953|NCT03412747|589758654|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
163286954|NCT03412747|589758655|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
163286955|NCT03412747|589758656|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
163286956|NCT03412747|589758654|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
163286957|NCT03412747|589758655|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
163286958|NCT03412747|589758656|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
163286959|NCT03412747|589758654|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
163286960|NCT03412747|589758655|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
163286961|NCT03412747|589758656|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
163286962|NCT03412747|589758654|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
163286963|NCT03412747|589758655|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
163286964|NCT03412747|589758656|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
163286965|NCT03412747|589758654|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
163286966|NCT03412747|589758655|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
163286967|NCT03412747|589758656|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
163286968|NCT03412747|589758654|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
163286969|NCT03412747|589758655|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
162937391|NCT01620489|588473614|FG001|Overall Study|Protocol Violation|3|||
162937392|NCT01620489|588473613|FG000|Overall Study|Withdrawal Criteria|17|||
163182090|NCT00423670|589382431|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
163182091|NCT00423670|589382432|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
163182092|NCT00423670|589382433|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
163182093|NCT00423670|589382426|FG000|Treatment Period|Investigator decision|0|||
163182094|NCT00423670|589382427|FG001|Treatment Period|Investigator decision|0|||
163182095|NCT00423670|589382428|FG002|Treatment Period|Investigator decision|0|||
163182096|NCT00423670|589382429|FG003|Treatment Period|Investigator decision|0|||
163182097|NCT00423670|589382430|FG004|Treatment Period|Investigator decision|0|||
163182098|NCT00423670|589382431|FG005|Treatment Period|Investigator decision|0|||
163182099|NCT00423670|589382432|FG006|Treatment Period|Investigator decision|0|||
163182100|NCT00423670|589382433|FG007|Treatment Period|Investigator decision|1|||
163182101|NCT00423670|589382426|FG000|Treatment Period|Non-compliance with protocol|3|||
163182102|NCT00423670|589382427|FG001|Treatment Period|Non-compliance with protocol|1|||
163182103|NCT00423670|589382428|FG002|Treatment Period|Non-compliance with protocol|1|||
163182104|NCT00423670|589382429|FG003|Treatment Period|Non-compliance with protocol|3|||
163182105|NCT00423670|589382430|FG004|Treatment Period|Non-compliance with protocol|2|||
163182106|NCT00423670|589382431|FG005|Treatment Period|Non-compliance with protocol|0|||
163182107|NCT00423670|589382432|FG006|Treatment Period|Non-compliance with protocol|2|||
163182108|NCT00423670|589382433|FG007|Treatment Period|Non-compliance with protocol|2|||
163182109|NCT00423670|589382426|FG000|Follow-up Period|Lost to Follow-up|0|||
163182110|NCT00423670|589382427|FG001|Follow-up Period|Lost to Follow-up|12|||
163182111|NCT00423670|589382428|FG002|Follow-up Period|Lost to Follow-up|8|||
163182112|NCT00423670|589382429|FG003|Follow-up Period|Lost to Follow-up|3|||
163182113|NCT00423670|589382430|FG004|Follow-up Period|Lost to Follow-up|1|||
163182114|NCT00423670|589382431|FG005|Follow-up Period|Lost to Follow-up|0|||
163182115|NCT00423670|589382432|FG006|Follow-up Period|Lost to Follow-up|5|||
163182116|NCT00423670|589382433|FG007|Follow-up Period|Lost to Follow-up|0|||
163182117|NCT00423670|589382426|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
163182118|NCT00423670|589382427|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
163182119|NCT00423670|589382428|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
163182120|NCT00423670|589382429|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
163182121|NCT00423670|589382430|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
163182122|NCT00423670|589382431|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
163182123|NCT00423670|589382432|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
163182124|NCT00423670|589382433|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
163182125|NCT00423670|589382426|FG000|Follow-up Period|Non-compliance with protocol|2|||
163182126|NCT00423670|589382427|FG001|Follow-up Period|Non-compliance with protocol|0|||
163182127|NCT00423670|589382428|FG002|Follow-up Period|Non-compliance with protocol|1|||
163182128|NCT00423670|589382429|FG003|Follow-up Period|Non-compliance with protocol|1|||
163182129|NCT00423670|589382430|FG004|Follow-up Period|Non-compliance with protocol|0|||
163182130|NCT00423670|589382431|FG005|Follow-up Period|Non-compliance with protocol|0|||
163182131|NCT00423670|589382432|FG006|Follow-up Period|Non-compliance with protocol|3|||
163182132|NCT00423670|589382433|FG007|Follow-up Period|Non-compliance with protocol|2|||
163182133|NCT00900601|589382434|FG000|Overall Study|Physician Decision|1|||
163182134|NCT02131532|589382435|FG000|Overall Study|Withdrawal by Subject|1|||
163182135|NCT02131532|589382435|FG000|Overall Study|Physician Decision|1|||
163182136|NCT02131532|589382435|FG000|Overall Study|Other health conditions|2|||
163182137|NCT01056380|589382436|FG000|Overall Study|Lost to Follow-up|2|||
163182138|NCT01056380|589382437|FG001|Overall Study|Lost to Follow-up|3|||
163182139|NCT03583073|589382438|FG000|Overall Study|Lost to Follow-up|8|||
163182140|NCT03583073|589382439|FG001|Overall Study|Lost to Follow-up|12|||
163182141|NCT02045303|589382440|FG000|Overall Study|Protocol Violation|2|||
163182142|NCT02045303|589382441|FG001|Overall Study|Protocol Violation|1|||
163182143|NCT02045303|589382442|FG002|Overall Study|Protocol Violation|0|||
163182144|NCT02045303|589382440|FG000|Overall Study|Withdrawal by Subject|0|||
163182145|NCT02045303|589382441|FG001|Overall Study|Withdrawal by Subject|2|||
163182146|NCT02045303|589382442|FG002|Overall Study|Withdrawal by Subject|0|||
163182147|NCT01856023|589382443|FG000|Overall Study|Death|1|||
163182148|NCT01856023|589382444|FG001|Overall Study|Death|2|||
163182149|NCT01856023|589382443|FG000|Overall Study|Adverse Event|2|||
163182150|NCT01856023|589382444|FG001|Overall Study|Adverse Event|1|||
163182151|NCT01856023|589382443|FG000|Overall Study|Lack of Efficacy|5|||
163182152|NCT01856023|589382444|FG001|Overall Study|Lack of Efficacy|5|||
163182153|NCT01856023|589382443|FG000|Overall Study|non compliance, study closure|1|||
162937393|NCT01620489|588473614|FG001|Overall Study|Withdrawal Criteria|25|||
163182154|NCT01856023|589382444|FG001|Overall Study|non compliance, study closure|3|||
163182155|NCT01856023|589382443|FG000|Overall Study|Withdrawal by Subject|1|||
163182156|NCT01856023|589382444|FG001|Overall Study|Withdrawal by Subject|1|||
163182157|NCT00829283|589382445|FG000|Overall Study|Lost to Follow-up|7|||
163182158|NCT00829283|589382446|FG001|Overall Study|Lost to Follow-up|25|||
163182159|NCT00424255|589382447|FG000|Overall Study|Death|115|||
163182160|NCT00424255|589382448|FG001|Overall Study|Death|111|||
163182161|NCT00424255|589382447|FG000|Overall Study|Lost to Follow-up|26|||
163182162|NCT00424255|589382448|FG001|Overall Study|Lost to Follow-up|20|||
163182163|NCT00424255|589382447|FG000|Overall Study|Protocol Violation|0|||
163182164|NCT00424255|589382448|FG001|Overall Study|Protocol Violation|1|||
163182165|NCT00424255|589382447|FG000|Overall Study|Withdrawal by Subject|34|||
163182166|NCT00424255|589382448|FG001|Overall Study|Withdrawal by Subject|38|||
163182167|NCT00424255|589382447|FG000|Overall Study|Physician Decision|3|||
163182168|NCT00424255|589382448|FG001|Overall Study|Physician Decision|7|||
163182169|NCT00424255|589382447|FG000|Overall Study|Cognitive Disturbance|1|||
163182170|NCT00424255|589382448|FG001|Overall Study|Cognitive Disturbance|0|||
163182171|NCT00424255|589382447|FG000|Overall Study|Non-compliance by Participants|1|||
163182172|NCT00424255|589382448|FG001|Overall Study|Non-compliance by Participants|0|||
163182173|NCT00424255|589382447|FG000|Overall Study|Fatigue|1|||
163182174|NCT00424255|589382448|FG001|Overall Study|Fatigue|0|||
163182175|NCT00424255|589382447|FG000|Overall Study|Disease Progression|0|||
163182176|NCT00424255|589382448|FG001|Overall Study|Disease Progression|2|||
163182177|NCT00424255|589382447|FG000|Overall Study|Sponsor Terminated Study|161|||
163182178|NCT00424255|589382448|FG001|Overall Study|Sponsor Terminated Study|167|||
163182179|NCT00591578|589382450|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
163182180|NCT00591578|589382451|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
163182181|NCT00591578|589382452|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
163182182|NCT00591578|589382450|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
163182183|NCT00591578|589382451|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
163182184|NCT00591578|589382452|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
163182185|NCT00591578|589382450|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
163182186|NCT00591578|589382451|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
163182187|NCT00591578|589382452|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
163182188|NCT00591578|589382450|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
163182189|NCT00591578|589382451|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
163182190|NCT00591578|589382452|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
163182191|NCT00591578|589382450|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
163182192|NCT00591578|589382451|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
163182193|NCT00591578|589382452|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
163182194|NCT00591578|589382450|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
163182195|NCT00591578|589382451|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
163182196|NCT00591578|589382452|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
163182197|NCT00591578|589382450|FG000|Double-Blind Treatment Phase|Other|4|||
163182198|NCT00591578|589382451|FG001|Double-Blind Treatment Phase|Other|9|||
163182199|NCT00591578|589382452|FG002|Double-Blind Treatment Phase|Other|4|||
163182200|NCT00591578|589382450|FG000|Open-Label Extension Phase|Adverse Event|3|||
163182201|NCT00591578|589382451|FG001|Open-Label Extension Phase|Adverse Event|5|||
163182202|NCT00591578|589382452|FG002|Open-Label Extension Phase|Adverse Event|0|||
163182203|NCT00591578|589382450|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
163182204|NCT00591578|589382451|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
163182205|NCT00591578|589382452|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
163182206|NCT00591578|589382450|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
163182207|NCT00591578|589382451|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
163182208|NCT00591578|589382452|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
163182209|NCT00591578|589382450|FG000|Open-Label Extension Phase|Other|1|||
163286970|NCT03412747|589758656|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
163286971|NCT01582945|589758657|FG000|Overall Study|Intolerable side-effects|1|||
163286972|NCT01582945|589758657|FG000|Overall Study|Scheduling conflicts|1|||
163286973|NCT04982575|589758662|FG000|Overall Study|Withdrawal by Subject|2|||
163286974|NCT04982575|589758663|FG001|Overall Study|Withdrawal by Subject|0|||
163286975|NCT04982575|589758664|FG002|Overall Study|Withdrawal by Subject|2|||
163286976|NCT03038022|589758667|FG000|Overall Study|Withdrawal by Subject|2|||
163286977|NCT03038022|589758668|FG001|Overall Study|Withdrawal by Subject|0|||
163286978|NCT03038022|589758667|FG000|Overall Study|Adverse Event|4|||
163286979|NCT03038022|589758668|FG001|Overall Study|Adverse Event|2|||
163286980|NCT01467427|589758671|FG000|Overall Study|Withdrawal by Subject|1|||
163286981|NCT01467427|589758672|FG001|Overall Study|Withdrawal by Subject|0|||
163286982|NCT01467427|589758671|FG000|Overall Study|Not continuing in extension phase|0|||
163286983|NCT01467427|589758672|FG001|Overall Study|Not continuing in extension phase|2|||
163286984|NCT01467427|589758671|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
163182210|NCT00591578|589382451|FG001|Open-Label Extension Phase|Other|0|||
163182211|NCT00591578|589382452|FG002|Open-Label Extension Phase|Other|0|||
163182212|NCT03945175|589382455|FG000|Overall Study|Did not meet inclusion criteria|31|||
163182213|NCT03945175|589382455|FG000|Overall Study|Withdrew consent|2|||
163182214|NCT03945175|589382455|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
163182215|NCT03945175|589382455|FG000|Overall Study|Early termination during Mydayis treatment|1|||
163182216|NCT00870233|589382456|FG000|Overall Study|Withdrawal by Subject|18|||
163182217|NCT00870233|589382456|FG000|Overall Study|Did not undergo laparotomy|3|||
163286985|NCT01467427|589758672|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
163182218|NCT00870233|589382456|FG000|Overall Study|Incompatible internet browser|2|||
163182219|NCT00870233|589382456|FG000|Overall Study|Death|1|||
163182220|NCT01369485|589382457|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
163182221|NCT01369485|589382458|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
163182222|NCT01369485|589382457|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
163182223|NCT01369485|589382458|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
163182224|NCT01369485|589382457|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
163182225|NCT01369485|589382458|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
163182226|NCT01369485|589382457|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
163182227|NCT01369485|589382458|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
163182228|NCT01369485|589382457|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
163182229|NCT01369485|589382458|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
163182230|NCT01369485|589382457|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
163182231|NCT01369485|589382458|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
163182232|NCT01369485|589382457|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
163182233|NCT01369485|589382458|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
163182234|NCT01369485|589382457|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
163182235|NCT01369485|589382458|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
163182236|NCT01369485|589382457|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
163182237|NCT01369485|589382458|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
163182238|NCT01369485|589382457|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
163182239|NCT01369485|589382458|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
163182240|NCT02942576|589382464|FG000|Overall Study|Adverse Event|28|||
163182241|NCT02942576|589382465|FG001|Overall Study|Adverse Event|6|||
163182242|NCT02942576|589382464|FG000|Overall Study|Withdrawal by Subject|7|||
163182243|NCT02942576|589382465|FG001|Overall Study|Withdrawal by Subject|5|||
163182244|NCT02942576|589382464|FG000|Overall Study|Physician Decision|1|||
163182245|NCT02942576|589382465|FG001|Overall Study|Physician Decision|4|||
163182246|NCT02942576|589382464|FG000|Overall Study|Other|10|||
163182247|NCT02942576|589382465|FG001|Overall Study|Other|8|||
163182248|NCT00769483|589382466|FG000|Overall Study|Withdrawal by Subject|0|||
163182249|NCT00769483|589382467|FG001|Overall Study|Withdrawal by Subject|1|||
163182250|NCT00769483|589382468|FG002|Overall Study|Withdrawal by Subject|0|||
163182251|NCT00769483|589382469|FG003|Overall Study|Withdrawal by Subject|0|||
163182252|NCT00769483|589382470|FG004|Overall Study|Withdrawal by Subject|1|||
163182253|NCT00769483|589382471|FG005|Overall Study|Withdrawal by Subject|0|||
163182254|NCT01306877|589382472|FG000|Overall Study|Lost to Follow-up|3|||
163182255|NCT01306877|589382473|FG001|Overall Study|Lost to Follow-up|3|||
163182256|NCT01306877|589382472|FG000|Overall Study|Physician Decision|0|||
163182257|NCT01306877|589382473|FG001|Overall Study|Physician Decision|1|||
163182258|NCT00006389|589382474|FG000|Overall Study|Adverse Event|1|||
163182259|NCT01285960|589382482|FG000|Overall Study|Withdrawal by Subject|2|||
163182260|NCT01285960|589382482|FG000|Overall Study|Lost to Follow-up|2|||
163182261|NCT01285960|589382482|FG000|Overall Study|2 subjects received less 10 sonications|2|||
163182262|NCT01309308|589382483|FG000|Overall Study|Lost to Follow-up|6|||
163182263|NCT01309308|589382484|FG001|Overall Study|Lost to Follow-up|4|||
163182264|NCT00473746|589382485|FG000|Period 1 (Phase 1)|Adverse Event|1|||
163182265|NCT00473746|589382486|FG001|Period 1 (Phase 1)|Adverse Event|0|||
163182266|NCT00473746|589382487|FG002|Period 1 (Phase 1)|Adverse Event|0|||
163182267|NCT00473746|589382488|FG003|Period 1 (Phase 1)|Adverse Event|0|||
163182268|NCT00473746|589382489|FG004|Period 1 (Phase 1)|Adverse Event|0|||
163182269|NCT00473746|589382485|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
163182270|NCT00473746|589382486|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
163182271|NCT00473746|589382487|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
163182272|NCT00473746|589382488|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
163182273|NCT00473746|589382489|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
163182274|NCT00473746|589382485|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
163182275|NCT00473746|589382486|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
163182276|NCT00473746|589382487|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
163182277|NCT00473746|589382488|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
163182278|NCT00473746|589382489|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
163182279|NCT00473746|589382485|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
163182280|NCT00473746|589382486|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
163182281|NCT00473746|589382487|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
163182282|NCT00473746|589382488|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
163182283|NCT00473746|589382489|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
163182284|NCT00473746|589382485|FG000|Period 1 (Phase 1)|Reason not specified|0|||
163286986|NCT01467427|589758671|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
163182285|NCT00473746|589382486|FG001|Period 1 (Phase 1)|Reason not specified|1|||
163182286|NCT00473746|589382487|FG002|Period 1 (Phase 1)|Reason not specified|0|||
163182287|NCT00473746|589382488|FG003|Period 1 (Phase 1)|Reason not specified|0|||
163182288|NCT00473746|589382489|FG004|Period 1 (Phase 1)|Reason not specified|0|||
163182289|NCT00473746|589382485|FG000|Period 2 (Phase 2)|Adverse Event|0|||
163182290|NCT00473746|589382486|FG001|Period 2 (Phase 2)|Adverse Event|0|||
163182291|NCT00473746|589382487|FG002|Period 2 (Phase 2)|Adverse Event|0|||
163182292|NCT00473746|589382488|FG003|Period 2 (Phase 2)|Adverse Event|0|||
163182293|NCT00473746|589382489|FG004|Period 2 (Phase 2)|Adverse Event|3|||
163182294|NCT00473746|589382485|FG000|Period 2 (Phase 2)|Death|0|||
163182295|NCT00473746|589382486|FG001|Period 2 (Phase 2)|Death|0|||
163182296|NCT00473746|589382487|FG002|Period 2 (Phase 2)|Death|0|||
163182297|NCT00473746|589382488|FG003|Period 2 (Phase 2)|Death|0|||
163182298|NCT00473746|589382489|FG004|Period 2 (Phase 2)|Death|1|||
163182299|NCT00473746|589382485|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
163182300|NCT00473746|589382486|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
163182301|NCT00473746|589382487|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
163182302|NCT00473746|589382488|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
163182303|NCT00473746|589382489|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
163182304|NCT00473746|589382485|FG000|Period 2 (Phase 2)|Reason not specified|0|||
163182305|NCT00473746|589382486|FG001|Period 2 (Phase 2)|Reason not specified|0|||
163182306|NCT00473746|589382487|FG002|Period 2 (Phase 2)|Reason not specified|0|||
163182307|NCT00473746|589382488|FG003|Period 2 (Phase 2)|Reason not specified|0|||
163182308|NCT00473746|589382489|FG004|Period 2 (Phase 2)|Reason not specified|3|||
163182309|NCT01017575|589382492|FG000|Overall Study|Lack of Efficacy|0|||
163182310|NCT01017575|589382493|FG001|Overall Study|Lack of Efficacy|1|||
163182311|NCT01017575|589382494|FG002|Overall Study|Lack of Efficacy|0|||
163182312|NCT01017575|589382495|FG003|Overall Study|Lack of Efficacy|1|||
163182313|NCT01017575|589382496|FG004|Overall Study|Lack of Efficacy|1|||
163182314|NCT01017575|589382492|FG000|Overall Study|Adverse Event|0|||
163182315|NCT01017575|589382493|FG001|Overall Study|Adverse Event|1|||
163182316|NCT01017575|589382494|FG002|Overall Study|Adverse Event|0|||
163182317|NCT01017575|589382495|FG003|Overall Study|Adverse Event|0|||
163182318|NCT01017575|589382496|FG004|Overall Study|Adverse Event|2|||
163182319|NCT01017575|589382492|FG000|Overall Study|Withdrawal by Subject|1|||
163182320|NCT01017575|589382493|FG001|Overall Study|Withdrawal by Subject|0|||
163182321|NCT01017575|589382494|FG002|Overall Study|Withdrawal by Subject|0|||
163182322|NCT01017575|589382495|FG003|Overall Study|Withdrawal by Subject|0|||
163182323|NCT01017575|589382496|FG004|Overall Study|Withdrawal by Subject|0|||
163182324|NCT01962922|589382497|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
163182325|NCT01962922|589382498|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
163182326|NCT01962922|589382497|FG000|PK Portion Day 7|non-compliance|1|||
163182327|NCT01962922|589382498|FG001|PK Portion Day 7|non-compliance|0|||
163182328|NCT01962922|589382497|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
163182329|NCT01962922|589382498|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
163182330|NCT01962922|589382497|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
163182331|NCT01962922|589382498|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
163182332|NCT00976573|589382506|FG000|Overall Study|Ineligible|0|||
163182333|NCT00976573|589382507|FG001|Overall Study|Ineligible|1|||
163182334|NCT00976573|589382506|FG000|Overall Study|Cancel prior to receiving treatment|4|||
163182335|NCT00976573|589382507|FG001|Overall Study|Cancel prior to receiving treatment|2|||
163182336|NCT02730208|589382508|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
163182337|NCT02730208|589382509|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
163182338|NCT00995865|589382514|FG000|Overall Study|Protocol Violation|2|||
163182339|NCT00995865|589382515|FG001|Overall Study|Protocol Violation|0|||
163182340|NCT00995865|589382516|FG002|Overall Study|Protocol Violation|0|||
163182341|NCT00995865|589382514|FG000|Overall Study|Lost to Follow-up|0|||
163182342|NCT00995865|589382515|FG001|Overall Study|Lost to Follow-up|0|||
163182343|NCT00995865|589382516|FG002|Overall Study|Lost to Follow-up|1|||
163182344|NCT02021656|589382521|FG000|Overall Study|Adverse Event|1|||
163182345|NCT02021656|589382521|FG000|Overall Study|Lack of Efficacy|2|||
163182346|NCT02021656|589382521|FG000|Overall Study|Lost to Follow-up|1|||
163182347|NCT02021656|589382521|FG000|Overall Study|Withdrew Consent|2|||
163182348|NCT00817479|589382524|FG000|Overall Study|Physician Decision|1|||
163182349|NCT00817479|589382525|FG001|Overall Study|Physician Decision|1|||
163182350|NCT05985980|589382528|FG000|Overall Study|Withdrawal by Subject|1|||
163286987|NCT01467427|589758672|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
163182351|NCT05985980|589382528|FG000|Overall Study|Withdrawal by Subject|1|||
163182352|NCT05985980|589382528|FG000|Overall Study|Withdrawal by Subject|1|||
163182353|NCT05985980|589382528|FG000|Overall Study|Withdrawal by Subject|1|||
163182354|NCT02793128|589382529|FG000|Overall Study|Death|4|||
163182355|NCT02793128|589382529|FG000|Overall Study|Withdrawal by Subject|2|||
163182356|NCT02793128|589382529|FG000|Overall Study|Physician Decision|1|||
163182357|NCT02793128|589382529|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
163182358|NCT02793128|589382529|FG000|Overall Study|Patient elected nephroureterectomy|1|||
163182359|NCT02359851|589382530|FG000|Overall Study|Death|1|||
163182360|NCT02359851|589382530|FG000|Overall Study|Disease progression|1|||
163182361|NCT00282347|589382531|FG000|Treatment Period|Death|2|||
163182362|NCT00282347|589382532|FG001|Treatment Period|Death|0|||
163182363|NCT00282347|589382531|FG000|Treatment Period|Lost to Follow-up|2|||
163182364|NCT00282347|589382532|FG001|Treatment Period|Lost to Follow-up|5|||
163182365|NCT00282347|589382531|FG000|Treatment Period|Withdrawal by Subject|1|||
163286988|NCT01467427|589758671|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
163286989|NCT01467427|589758672|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
163286990|NCT01467427|589758671|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
163286991|NCT01467427|589758672|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
163286992|NCT04925752|589758673|FG000|Overall Study|Still on Study|1826|||
163286993|NCT04925752|589758674|FG001|Overall Study|Still on Study|926|||
163286994|NCT04925752|589758673|FG000|Overall Study|Withdrew Consent|128|||
163286995|NCT04925752|589758674|FG001|Overall Study|Withdrew Consent|59|||
163286996|NCT04925752|589758673|FG000|Overall Study|Lost to Follow-up|73|||
163286997|NCT04925752|589758674|FG001|Overall Study|Lost to Follow-up|47|||
163286998|NCT04925752|589758673|FG000|Overall Study|Randomized but Never Treated|12|||
163286999|NCT04925752|589758674|FG001|Overall Study|Randomized but Never Treated|9|||
163287000|NCT04925752|589758673|FG000|Overall Study|Hiv-1 Infection|6|||
163287001|NCT04925752|589758674|FG001|Overall Study|Hiv-1 Infection|7|||
163287002|NCT04925752|589758673|FG000|Overall Study|Investigator's discretion|8|||
163287003|NCT04925752|589758674|FG001|Overall Study|Investigator's discretion|5|||
163287004|NCT04925752|589758673|FG000|Overall Study|Non-compliance with Study Drug|8|||
163287005|NCT04925752|589758674|FG001|Overall Study|Non-compliance with Study Drug|5|||
163287006|NCT04925752|589758673|FG000|Overall Study|Adverse Event|5|||
163287007|NCT04925752|589758674|FG001|Overall Study|Adverse Event|2|||
163287008|NCT04925752|589758673|FG000|Overall Study|Death|4|||
163287009|NCT04925752|589758674|FG001|Overall Study|Death|2|||
163287010|NCT04925752|589758673|FG000|Overall Study|Protocol Violation|1|||
163287011|NCT04925752|589758674|FG001|Overall Study|Protocol Violation|3|||
163287012|NCT04925752|589758673|FG000|Overall Study|Withdrew Assent|1|||
163287013|NCT04925752|589758674|FG001|Overall Study|Withdrew Assent|0|||
163287014|NCT04269200|589758675|FG000|Global Cohort|Death|72|||
163287015|NCT04269200|589758676|FG001|Global Cohort|Death|54|||
163287016|NCT04269200|589758677|FG002|Global Cohort|Death|49|||
163287017|NCT04269200|589758675|FG000|Global Cohort|Lost to Follow-up|0|||
163287018|NCT04269200|589758676|FG001|Global Cohort|Lost to Follow-up|0|||
163287019|NCT04269200|589758677|FG002|Global Cohort|Lost to Follow-up|2|||
163287020|NCT04269200|589758675|FG000|Global Cohort|Withdrawal by Subject|22|||
163287021|NCT04269200|589758676|FG001|Global Cohort|Withdrawal by Subject|25|||
163287022|NCT04269200|589758677|FG002|Global Cohort|Withdrawal by Subject|18|||
163287023|NCT04269200|589758675|FG000|China Cohort|Death|12|||
163287024|NCT04269200|589758676|FG001|China Cohort|Death|11|||
163287025|NCT04269200|589758677|FG002|China Cohort|Death|13|||
163287026|NCT04269200|589758675|FG000|China Cohort|Lost to Follow-up|0|||
163287027|NCT04269200|589758676|FG001|China Cohort|Lost to Follow-up|1|||
163287028|NCT04269200|589758677|FG002|China Cohort|Lost to Follow-up|1|||
163287029|NCT04269200|589758675|FG000|China Cohort|Withdrawal by Subject|2|||
163287030|NCT04269200|589758676|FG001|China Cohort|Withdrawal by Subject|2|||
163287031|NCT04269200|589758677|FG002|China Cohort|Withdrawal by Subject|4|||
163287032|NCT04181827|589758678|FG000|Overall Study|Ongoing|124|||
163287033|NCT04181827|589758679|FG001|Overall Study|Ongoing|157|||
163287034|NCT04181827|589758678|FG000|Overall Study|Death|82|||
163287035|NCT04181827|589758679|FG001|Overall Study|Death|50|||
163287036|NCT04181827|589758678|FG000|Overall Study|Lost to Follow-up|0|||
163287037|NCT04181827|589758679|FG001|Overall Study|Lost to Follow-up|1|||
163287038|NCT04181827|589758678|FG000|Overall Study|Withdrawal by Subject|5|||
163287039|NCT04181827|589758679|FG001|Overall Study|Withdrawal by Subject|0|||
163287040|NCT03887936|589758680|FG000|Overall Study|Relocation|2|||
163287041|NCT03887936|589758681|FG001|Overall Study|Relocation|2|||
163287042|NCT03887936|589758680|FG000|Overall Study|Physician Decision|0|||
163287043|NCT03887936|589758681|FG001|Overall Study|Physician Decision|1|||
163287044|NCT03887936|589758680|FG000|Overall Study|Withdrawal by Subject|0|||
163287045|NCT03887936|589758681|FG001|Overall Study|Withdrawal by Subject|1|||
163287046|NCT06269367|589758682|FG000|Phase I|Unable to perform study procedures|0|||
163287047|NCT06269367|589758683|FG001|Phase I|Unable to perform study procedures|1|||
163287048|NCT06269367|589758682|FG000|Phase I|Could not continue study for personal reasons.|1|||
163287049|NCT06269367|589758683|FG001|Phase I|Could not continue study for personal reasons.|0|||
163287050|NCT03331250|589758684|FG000|Overall Study|Withdrawal by Subject|1|||
163287051|NCT00117988|589758689|FG000|Overall Study|Death|3|||
163287052|NCT00117988|589758689|FG000|Overall Study|Adverse Event|1|||
163287053|NCT05824351|589758690|FG000|Overall Study|Adverse Event|6|||
163287054|NCT02137850|589758691|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
163287055|NCT02137850|589758692|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
163287056|NCT02137850|589758693|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
163287057|NCT02137850|589758691|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
163287058|NCT02137850|589758692|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
163287059|NCT02137850|589758693|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
163287060|NCT02137850|589758691|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
163287061|NCT02137850|589758692|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
163287062|NCT02137850|589758693|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
163287063|NCT02137850|589758691|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
163287064|NCT02137850|589758692|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
163287065|NCT02137850|589758693|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
163287066|NCT02137850|589758691|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
163287067|NCT02137850|589758692|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
163287068|NCT02137850|589758693|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
163287069|NCT02137850|589758691|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
163287070|NCT02137850|589758692|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
163287071|NCT02137850|589758693|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
163287072|NCT02137850|589758691|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
163287073|NCT02137850|589758692|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
163287074|NCT02137850|589758693|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
163287075|NCT02137850|589758691|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
163287076|NCT02137850|589758692|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
163287077|NCT02137850|589758693|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
163287078|NCT02137850|589758691|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
163287079|NCT02137850|589758692|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
163287080|NCT02137850|589758693|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
163287081|NCT02137850|589758691|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
163287082|NCT02137850|589758692|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
163287083|NCT02137850|589758693|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
163287084|NCT02137850|589758691|FG000|Main Phase: Prophylaxis|Other|0|||
163287085|NCT02137850|589758692|FG001|Main Phase: Prophylaxis|Other|1|||
163287086|NCT02137850|589758693|FG002|Main Phase: Prophylaxis|Other|0|||
163287087|NCT02137850|589758691|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
163287088|NCT02137850|589758692|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
163287089|NCT02137850|589758693|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
163287090|NCT02137850|589758691|FG000|Main Phase: Prophylaxis|Early site closure|0|||
163287091|NCT02137850|589758692|FG001|Main Phase: Prophylaxis|Early site closure|2|||
163287092|NCT02137850|589758693|FG002|Main Phase: Prophylaxis|Early site closure|0|||
163287093|NCT02137850|589758691|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
163287094|NCT02137850|589758692|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
163287095|NCT02137850|589758693|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
163287096|NCT02137850|589758691|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
163287097|NCT02137850|589758692|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
163287098|NCT02137850|589758693|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
163287099|NCT02137850|589758691|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
163287100|NCT02137850|589758692|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
163287101|NCT02137850|589758693|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
163287102|NCT02137850|589758691|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
163287103|NCT02137850|589758692|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
163287104|NCT02137850|589758693|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
163287105|NCT02137850|589758691|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
163287106|NCT02137850|589758692|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
163287107|NCT02137850|589758693|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
163287108|NCT02137850|589758691|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
163287109|NCT02137850|589758692|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
163287110|NCT02137850|589758693|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
163287111|NCT02137850|589758691|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
163287112|NCT02137850|589758692|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
163287113|NCT02137850|589758693|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
163287114|NCT02137850|589758691|FG000|Extension Phase: Prophylaxis|Other|0|||
163287115|NCT02137850|589758692|FG001|Extension Phase: Prophylaxis|Other|1|||
163287116|NCT02137850|589758693|FG002|Extension Phase: Prophylaxis|Other|0|||
163287117|NCT02137850|589758691|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
163287118|NCT02137850|589758692|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
163287119|NCT02137850|589758693|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
163287120|NCT02912260|589758694|FG000|Main Study|Lost to Follow-up|5|||
163287121|NCT02912260|589758695|FG001|Main Study|Lost to Follow-up|4|||
163287122|NCT02912260|589758694|FG000|Main Study|Withdrawal by Subject|2|||
163287123|NCT02912260|589758695|FG001|Main Study|Withdrawal by Subject|2|||
163287124|NCT02912260|589758694|FG000|Main Study|Adverse Event|3|||
163287125|NCT02912260|589758695|FG001|Main Study|Adverse Event|0|||
163287126|NCT02912260|589758694|FG000|Main Study|Physician Decision|0|||
163287127|NCT02912260|589758695|FG001|Main Study|Physician Decision|1|||
163287128|NCT02912260|589758694|FG000|Extension Study|Withdrawal by Subject|1|||
163287129|NCT02912260|589758695|FG001|Extension Study|Withdrawal by Subject|1|||
163287130|NCT01311713|589758697|FG000|Overall Study|Death|0|||
163287131|NCT01311713|589758698|FG001|Overall Study|Death|0|||
163287132|NCT01311713|589758699|FG002|Overall Study|Death|1|||
163287133|NCT01311713|589758700|FG003|Overall Study|Death|1|||
163287134|NCT01311713|589758701|FG004|Overall Study|Death|0|||
163287135|NCT01311713|589758702|FG005|Overall Study|Death|1|||
163287136|NCT01311713|589758703|FG006|Overall Study|Death|0|||
163287137|NCT01311713|589758697|FG000|Overall Study|Adverse Event|0|||
163287138|NCT01311713|589758698|FG001|Overall Study|Adverse Event|1|||
163287139|NCT01311713|589758699|FG002|Overall Study|Adverse Event|0|||
163287140|NCT01311713|589758700|FG003|Overall Study|Adverse Event|2|||
163287141|NCT01311713|589758701|FG004|Overall Study|Adverse Event|0|||
163287142|NCT01311713|589758702|FG005|Overall Study|Adverse Event|0|||
163287143|NCT01311713|589758703|FG006|Overall Study|Adverse Event|2|||
163287144|NCT01311713|589758697|FG000|Overall Study|Withdrawal by Subject|0|||
163287145|NCT01311713|589758698|FG001|Overall Study|Withdrawal by Subject|1|||
163287146|NCT01311713|589758699|FG002|Overall Study|Withdrawal by Subject|1|||
163287147|NCT01311713|589758700|FG003|Overall Study|Withdrawal by Subject|0|||
163287148|NCT01311713|589758701|FG004|Overall Study|Withdrawal by Subject|0|||
163287149|NCT01311713|589758702|FG005|Overall Study|Withdrawal by Subject|1|||
163287150|NCT01311713|589758703|FG006|Overall Study|Withdrawal by Subject|2|||
163287151|NCT01311713|589758697|FG000|Overall Study|Disease progression|3|||
163287152|NCT01311713|589758698|FG001|Overall Study|Disease progression|4|||
163287153|NCT01311713|589758699|FG002|Overall Study|Disease progression|3|||
163287154|NCT01311713|589758700|FG003|Overall Study|Disease progression|2|||
163287155|NCT01311713|589758701|FG004|Overall Study|Disease progression|4|||
163287156|NCT01311713|589758702|FG005|Overall Study|Disease progression|4|||
163287157|NCT01311713|589758703|FG006|Overall Study|Disease progression|5|||
163287158|NCT01311713|589758697|FG000|Overall Study|Lost to Follow-up|0|||
163287159|NCT01311713|589758698|FG001|Overall Study|Lost to Follow-up|0|||
163287160|NCT01311713|589758699|FG002|Overall Study|Lost to Follow-up|1|||
163287161|NCT01311713|589758700|FG003|Overall Study|Lost to Follow-up|0|||
163287162|NCT01311713|589758701|FG004|Overall Study|Lost to Follow-up|0|||
163182366|NCT00282347|589382532|FG001|Treatment Period|Withdrawal by Subject|3|||
163182367|NCT00282347|589382531|FG000|Treatment Period|Physician Decision|0|||
163182368|NCT00282347|589382532|FG001|Treatment Period|Physician Decision|1|||
163182369|NCT00282347|589382531|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
163182370|NCT00282347|589382532|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
163182371|NCT00282347|589382531|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
163182372|NCT00282347|589382532|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
163182373|NCT00282347|589382531|FG000|Safety Follow-up Period|Physician Decision|1|||
163182374|NCT00282347|589382532|FG001|Safety Follow-up Period|Physician Decision|1|||
163182375|NCT00282347|589382531|FG000|Safety Follow-up Period|Protocol Deviation|0|||
163182376|NCT00282347|589382532|FG001|Safety Follow-up Period|Protocol Deviation|2|||
163182377|NCT00282347|589382531|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
163182378|NCT00282347|589382532|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
163182379|NCT00282347|589382531|FG000|B Cell Follow-up Period|Physician Decision|1|||
163182380|NCT00282347|589382532|FG001|B Cell Follow-up Period|Physician Decision|0|||
163182381|NCT00282347|589382531|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
163182382|NCT00282347|589382532|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
163182383|NCT02101112|589382533|FG000|Overall Study|Adverse Event|0|||
163182384|NCT02101112|589382534|FG001|Overall Study|Adverse Event|0|||
163182385|NCT02101112|589382535|FG002|Overall Study|Adverse Event|1|||
163182386|NCT02101112|589382536|FG003|Overall Study|Adverse Event|0|||
163182387|NCT02101112|589382537|FG004|Overall Study|Adverse Event|0|||
163182388|NCT02101112|589382538|FG005|Overall Study|Adverse Event|0|||
163182389|NCT02101112|589382533|FG000|Overall Study|Withdrawal by Subject|0|||
163182390|NCT02101112|589382534|FG001|Overall Study|Withdrawal by Subject|0|||
163182391|NCT02101112|589382535|FG002|Overall Study|Withdrawal by Subject|0|||
163182392|NCT02101112|589382536|FG003|Overall Study|Withdrawal by Subject|0|||
163182393|NCT02101112|589382537|FG004|Overall Study|Withdrawal by Subject|1|||
163182394|NCT02101112|589382538|FG005|Overall Study|Withdrawal by Subject|0|||
163182395|NCT04340063|589382539|FG000|Overall Study|Withdrawal by Subject|1|||
163182396|NCT04340063|589382540|FG001|Overall Study|Withdrawal by Subject|2|||
163182397|NCT04340063|589382539|FG000|Overall Study|Lost to Follow-up|3|||
163182398|NCT04340063|589382540|FG001|Overall Study|Lost to Follow-up|1|||
163182399|NCT04340063|589382539|FG000|Overall Study|Protocol Violation|0|||
163182400|NCT04340063|589382540|FG001|Overall Study|Protocol Violation|1|||
163182401|NCT00491556|589382541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
163182402|NCT00491556|589382542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
163287163|NCT01311713|589758702|FG005|Overall Study|Lost to Follow-up|0|||
163287164|NCT01311713|589758703|FG006|Overall Study|Lost to Follow-up|0|||
163182403|NCT00491556|589382541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
163287165|NCT01311713|589758697|FG000|Overall Study|Stopped taking study medication|0|||
163182404|NCT00491556|589382542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
163182405|NCT00491556|589382541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
163287166|NCT01311713|589758698|FG001|Overall Study|Stopped taking study medication|0|||
163287167|NCT01311713|589758699|FG002|Overall Study|Stopped taking study medication|0|||
163182406|NCT00491556|589382542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
163182407|NCT00491556|589382541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
163287168|NCT01311713|589758700|FG003|Overall Study|Stopped taking study medication|1|||
163287169|NCT01311713|589758701|FG004|Overall Study|Stopped taking study medication|1|||
163287170|NCT01311713|589758702|FG005|Overall Study|Stopped taking study medication|0|||
163182408|NCT00491556|589382542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
163182409|NCT00491556|589382541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
163182410|NCT00491556|589382542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
163182411|NCT00491556|589382541|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
163182412|NCT00491556|589382542|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
163182413|NCT00491556|589382541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
163182414|NCT00491556|589382542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
163182415|NCT00491556|589382541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
163182416|NCT00491556|589382542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
163182417|NCT00491556|589382541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
163182418|NCT00491556|589382542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
163182419|NCT00491556|589382541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
163182420|NCT00491556|589382542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
163182421|NCT00491556|589382541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
163182422|NCT00491556|589382542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
163182423|NCT00491556|589382541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
163182424|NCT00491556|589382542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
163182425|NCT00491556|589382541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
163182426|NCT00491556|589382542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
163182427|NCT00491556|589382541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
163182428|NCT00491556|589382542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
163182429|NCT00491556|589382541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
163182430|NCT00491556|589382542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
163182431|NCT00491556|589382541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
163182432|NCT00491556|589382542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
163182433|NCT00491556|589382541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
163182434|NCT00491556|589382542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
163182435|NCT00491556|589382541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
163182436|NCT00491556|589382542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
163182437|NCT00491556|589382541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
163182438|NCT00491556|589382542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
163182439|NCT00491556|589382541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
163182440|NCT00491556|589382542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
163182441|NCT00993044|589382543|FG000|Irinotecan 50 mg|Physician Decision|1|||
163182442|NCT00734747|589382544|FG000|SRS Procedure|No staples placed|3|||
163182443|NCT00734747|589382544|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
163182444|NCT05063318|589382550|FG000|Overall Study|Progressive disease|2|||
163182445|NCT05063318|589382551|FG001|Overall Study|Progressive disease|0|||
163182446|NCT05063318|589382552|FG002|Overall Study|Progressive disease|3|||
163182447|NCT05063318|589382550|FG000|Overall Study|Compassionate use|1|||
163182448|NCT05063318|589382551|FG001|Overall Study|Compassionate use|3|||
163182449|NCT05063318|589382552|FG002|Overall Study|Compassionate use|3|||
163182450|NCT05063318|589382550|FG000|Overall Study|Adverse Event|0|||
163182451|NCT05063318|589382551|FG001|Overall Study|Adverse Event|1|||
163182452|NCT05063318|589382552|FG002|Overall Study|Adverse Event|0|||
163182453|NCT05063318|589382550|FG000|Overall Study|Withdrawal by Subject|0|||
163182454|NCT05063318|589382551|FG001|Overall Study|Withdrawal by Subject|1|||
163182455|NCT05063318|589382552|FG002|Overall Study|Withdrawal by Subject|0|||
163182456|NCT03287635|589382553|FG000|Overall Study|Lost to Follow-up|5|||
163182457|NCT03287635|589382553|FG000|Overall Study|Withdrawal by Subject|1|||
163182458|NCT03287635|589382553|FG000|Overall Study|Physician Decision|1|||
163182459|NCT00920829|589383844|FG000|Allocation|No post randomization data|3|||
163182460|NCT00920829|589383845|FG001|Allocation|No post randomization data|1|||
163182461|NCT00920829|589383846|FG002|Allocation|No post randomization data|0|||
163182462|NCT00920829|589383847|FG003|Allocation|No post randomization data|2|||
163182463|NCT00920829|589383844|FG000|Available for Analysis|Withdrawal by Subject|6|||
163182464|NCT00920829|589383845|FG001|Available for Analysis|Withdrawal by Subject|6|||
163182465|NCT00920829|589383846|FG002|Available for Analysis|Withdrawal by Subject|6|||
163182466|NCT00920829|589383847|FG003|Available for Analysis|Withdrawal by Subject|10|||
163182467|NCT00920829|589383844|FG000|Available for Analysis|Required Medical Treatment|0|||
163182468|NCT00920829|589383845|FG001|Available for Analysis|Required Medical Treatment|1|||
163182469|NCT00920829|589383846|FG002|Available for Analysis|Required Medical Treatment|2|||
163182470|NCT00920829|589383847|FG003|Available for Analysis|Required Medical Treatment|0|||
163182471|NCT00920829|589383844|FG000|Available for Analysis|Adverse Event|1|||
163182472|NCT00920829|589383845|FG001|Available for Analysis|Adverse Event|2|||
163182473|NCT00920829|589383846|FG002|Available for Analysis|Adverse Event|1|||
163182474|NCT00920829|589383847|FG003|Available for Analysis|Adverse Event|0|||
163182475|NCT00920829|589383844|FG000|Available for Analysis|Death|1|||
163287171|NCT01311713|589758703|FG006|Overall Study|Stopped taking study medication|0|||
163287172|NCT01311713|589758697|FG000|Overall Study|Enrolled but not treated|0|||
163182476|NCT00920829|589383845|FG001|Available for Analysis|Death|0|||
163182477|NCT00920829|589383846|FG002|Available for Analysis|Death|0|||
163287173|NCT01311713|589758698|FG001|Overall Study|Enrolled but not treated|0|||
163287174|NCT01311713|589758699|FG002|Overall Study|Enrolled but not treated|1|||
163287175|NCT01311713|589758700|FG003|Overall Study|Enrolled but not treated|0|||
163287176|NCT01311713|589758701|FG004|Overall Study|Enrolled but not treated|0|||
163287177|NCT01311713|589758702|FG005|Overall Study|Enrolled but not treated|0|||
163287178|NCT01311713|589758703|FG006|Overall Study|Enrolled but not treated|0|||
163287179|NCT01311713|589758697|FG000|Overall Study|Other than specified|0|||
163287180|NCT01311713|589758698|FG001|Overall Study|Other than specified|1|||
163287181|NCT01311713|589758699|FG002|Overall Study|Other than specified|2|||
163287182|NCT01311713|589758700|FG003|Overall Study|Other than specified|0|||
163287183|NCT01311713|589758701|FG004|Overall Study|Other than specified|0|||
163287184|NCT01311713|589758702|FG005|Overall Study|Other than specified|0|||
163287185|NCT01311713|589758703|FG006|Overall Study|Other than specified|0|||
163287186|NCT03878446|589758706|FG000|Overall Study|Withdrawn by parent or guardian|1|||
163287187|NCT03878446|589758707|FG001|Overall Study|Withdrawn by parent or guardian|0|||
163287188|NCT03878446|589758708|FG002|Overall Study|Withdrawn by parent or guardian|0|||
163287189|NCT03878446|589758709|FG003|Overall Study|Withdrawn by parent or guardian|0|||
163287190|NCT03878446|589758710|FG004|Overall Study|Withdrawn by parent or guardian|0|||
163287191|NCT05803720|589758711|FG000|Overall Study|Lost to Follow-up|3|||
163287192|NCT05803720|589758712|FG001|Overall Study|Lost to Follow-up|4|||
163287193|NCT05803720|589758711|FG000|Overall Study|Family leave/emergency|1|||
163287194|NCT05803720|589758712|FG001|Overall Study|Family leave/emergency|1|||
163287195|NCT03370133|589758713|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
163287196|NCT03370133|589758714|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
163287197|NCT03370133|589758715|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
163287198|NCT03370133|589758716|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
163182478|NCT00920829|589383847|FG003|Available for Analysis|Death|0|||
163182479|NCT00920829|589383844|FG000|Available for Analysis|Protocol Violation|0|||
163182480|NCT00920829|589383845|FG001|Available for Analysis|Protocol Violation|0|||
163182481|NCT00920829|589383846|FG002|Available for Analysis|Protocol Violation|1|||
163182482|NCT00920829|589383847|FG003|Available for Analysis|Protocol Violation|0|||
163182483|NCT00920829|589383844|FG000|Available for Analysis|Required more treatment|0|||
163182484|NCT00920829|589383845|FG001|Available for Analysis|Required more treatment|2|||
163182485|NCT00920829|589383846|FG002|Available for Analysis|Required more treatment|0|||
163182486|NCT00920829|589383847|FG003|Available for Analysis|Required more treatment|1|||
163182487|NCT03875118|589383848|FG000|Overall Study|Withdrawal by Subject|4|||
163182488|NCT03875118|589383849|FG001|Overall Study|Withdrawal by Subject|4|||
163182489|NCT02237911|589383850|FG000|Overall Study|Withdrawal by Subject|4|||
163182490|NCT02237911|589383851|FG001|Overall Study|Withdrawal by Subject|7|||
163182491|NCT02237911|589383852|FG002|Overall Study|Withdrawal by Subject|2|||
163182492|NCT02237911|589383850|FG000|Overall Study|Lost to Follow-up|3|||
163182493|NCT02237911|589383851|FG001|Overall Study|Lost to Follow-up|1|||
163182494|NCT02237911|589383852|FG002|Overall Study|Lost to Follow-up|1|||
163182495|NCT00721123|589383853|FG000|Overall Study|Adverse Event|96|||
163182496|NCT00721123|589383853|FG000|Overall Study|Death|10|||
163182497|NCT00721123|589383853|FG000|Overall Study|Insufficient Therapeutic Response|21|||
163182498|NCT00721123|589383853|FG000|Overall Study|Protocol Violation|1|||
163182499|NCT00721123|589383853|FG000|Overall Study|Refused Treatment|41|||
163182500|NCT00721123|589383853|FG000|Overall Study|Failure to Return|9|||
163182501|NCT00721123|589383853|FG000|Overall Study|Withdrawal by Subject|5|||
163182502|NCT03468985|589383854|FG000|Overall Study|Adverse Event|0|||
163182503|NCT03468985|589383855|FG001|Overall Study|Adverse Event|2|||
163182504|NCT03468985|589383856|FG002|Overall Study|Adverse Event|0|||
163182505|NCT03468985|589383857|FG003|Overall Study|Adverse Event|0|||
163182506|NCT03468985|589383854|FG000|Overall Study|Withdrawal by Subject|0|||
163182507|NCT03468985|589383855|FG001|Overall Study|Withdrawal by Subject|0|||
163182508|NCT03468985|589383856|FG002|Overall Study|Withdrawal by Subject|0|||
163182509|NCT03468985|589383857|FG003|Overall Study|Withdrawal by Subject|1|||
163182510|NCT03981822|589383858|FG000|Overall Study|Lost to Follow-up|0|||
163182511|NCT03981822|589383859|FG001|Overall Study|Lost to Follow-up|1|||
163182512|NCT03981822|589383860|FG002|Overall Study|Lost to Follow-up|1|||
163182513|NCT03981822|589383861|FG003|Overall Study|Lost to Follow-up|0|||
163182514|NCT03981822|589383862|FG004|Overall Study|Lost to Follow-up|6|||
163182515|NCT03981822|589383863|FG005|Overall Study|Lost to Follow-up|4|||
163287199|NCT03370133|589758717|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
163182516|NCT03981822|589383864|FG006|Overall Study|Lost to Follow-up|4|||
163182517|NCT03981822|589383865|FG007|Overall Study|Lost to Follow-up|2|||
163182518|NCT03981822|589383858|FG000|Overall Study|Withdrawal by Subject|0|||
163182519|NCT03981822|589383859|FG001|Overall Study|Withdrawal by Subject|1|||
163287200|NCT03370133|589758718|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
163287201|NCT03370133|589758713|FG000|Initial Treatment Period (WK 16)|Death|1|||
163287202|NCT03370133|589758714|FG001|Initial Treatment Period (WK 16)|Death|1|||
163287203|NCT03370133|589758715|FG002|Initial Treatment Period (WK 16)|Death|1|||
163287204|NCT03370133|589758716|FG003|Initial Treatment Period (WK 16)|Death|0|||
163287205|NCT03370133|589758717|FG004|Initial Treatment Period (WK 16)|Death|0|||
163287206|NCT03370133|589758718|FG005|Initial Treatment Period (WK 16)|Death|0|||
163287207|NCT03370133|589758713|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
163287208|NCT03370133|589758714|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
163287209|NCT03370133|589758715|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
163287210|NCT03370133|589758716|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
163287211|NCT03370133|589758717|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
163287212|NCT03370133|589758718|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
163287213|NCT03370133|589758713|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
163287214|NCT03370133|589758714|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
163287215|NCT03370133|589758715|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
163287216|NCT03370133|589758716|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
163287217|NCT03370133|589758717|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
163287218|NCT03370133|589758718|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
163287219|NCT03370133|589758713|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
163287220|NCT03370133|589758714|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
163287221|NCT03370133|589758715|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
163287222|NCT03370133|589758716|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
163287223|NCT03370133|589758717|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
163287224|NCT03370133|589758718|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
163287225|NCT03370133|589758713|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
163287226|NCT03370133|589758714|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
163287227|NCT03370133|589758715|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
163287228|NCT03370133|589758716|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
163287229|NCT03370133|589758717|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
163287230|NCT03370133|589758718|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
163287231|NCT03370133|589758713|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
163287232|NCT03370133|589758714|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
163287233|NCT03370133|589758715|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
163287234|NCT03370133|589758716|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
163287235|NCT03370133|589758717|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
163287236|NCT03370133|589758718|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
163287237|NCT03370133|589758713|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
163287238|NCT03370133|589758714|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
163287239|NCT03370133|589758715|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
163287240|NCT03370133|589758716|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
163287241|NCT03370133|589758717|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
163287242|NCT03370133|589758718|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
163287243|NCT03370133|589758713|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
162937394|NCT01620489|588473613|FG000|Overall Study|Unclassified|1|||
163182520|NCT03981822|589383860|FG002|Overall Study|Withdrawal by Subject|0|||
163182521|NCT03981822|589383861|FG003|Overall Study|Withdrawal by Subject|0|||
163287244|NCT03370133|589758714|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
163287245|NCT03370133|589758715|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
163287246|NCT03370133|589758716|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
163182522|NCT03981822|589383862|FG004|Overall Study|Withdrawal by Subject|0|||
163182523|NCT03981822|589383863|FG005|Overall Study|Withdrawal by Subject|1|||
163182524|NCT03981822|589383864|FG006|Overall Study|Withdrawal by Subject|0|||
163182525|NCT03981822|589383865|FG007|Overall Study|Withdrawal by Subject|2|||
163182526|NCT03981822|589383858|FG000|Overall Study|COVID-19 Related|0|||
163182527|NCT03981822|589383859|FG001|Overall Study|COVID-19 Related|0|||
163182528|NCT03981822|589383860|FG002|Overall Study|COVID-19 Related|0|||
163182529|NCT03981822|589383861|FG003|Overall Study|COVID-19 Related|0|||
163182530|NCT03981822|589383862|FG004|Overall Study|COVID-19 Related|2|||
163182531|NCT03981822|589383863|FG005|Overall Study|COVID-19 Related|1|||
163182532|NCT03981822|589383864|FG006|Overall Study|COVID-19 Related|2|||
163182533|NCT03981822|589383865|FG007|Overall Study|COVID-19 Related|1|||
163182534|NCT04521777|589383867|FG000|Overall Study|Death|2|||
163182535|NCT04521777|589383867|FG000|Overall Study|Withdrawal by Subject|2|||
163182536|NCT01143207|589383871|FG000|Overall Study|Lost to Follow-up|2|||
163182537|NCT03463031|589383874|FG000|Overall Study|Withdrawal by Subject|4|||
163182538|NCT03463031|589383875|FG001|Overall Study|Withdrawal by Subject|2|||
163182539|NCT03463031|589383874|FG000|Overall Study|Investigator/Sponsor Decision|0|||
163182540|NCT03463031|589383875|FG001|Overall Study|Investigator/Sponsor Decision|1|||
163287247|NCT03370133|589758717|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
163287248|NCT03370133|589758718|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
163182541|NCT03463031|589383874|FG000|Overall Study|Lost to Follow-up|1|||
163182542|NCT03463031|589383875|FG001|Overall Study|Lost to Follow-up|1|||
163182543|NCT03463031|589383874|FG000|Overall Study|Adverse Event|4|||
163287249|NCT03370133|589758713|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
163182544|NCT03463031|589383875|FG001|Overall Study|Adverse Event|1|||
163182545|NCT03463031|589383874|FG000|Overall Study|Use of prohibited medication by subject|1|||
163182546|NCT03463031|589383875|FG001|Overall Study|Use of prohibited medication by subject|0|||
163182547|NCT01241240|589383876|FG000|Overall Study|Adverse Event|5|||
163182548|NCT01241240|589383877|FG001|Overall Study|Adverse Event|4|||
163182549|NCT01241240|589383876|FG000|Overall Study|Lost to Follow-up|2|||
163182550|NCT01241240|589383877|FG001|Overall Study|Lost to Follow-up|4|||
163182551|NCT01241240|589383876|FG000|Overall Study|Personal Reasons|1|||
163182552|NCT01241240|589383877|FG001|Overall Study|Personal Reasons|1|||
163182553|NCT02376829|589383884|FG000|Overall Study|Withdrawal by Subject|27|||
163182554|NCT02376829|589383885|FG001|Overall Study|Withdrawal by Subject|44|||
163182555|NCT00057954|589383886|FG000|Overall Study|Death|1|||
163182556|NCT00057954|589383886|FG000|Overall Study|Disease progression|1|||
163182557|NCT02147184|589383887|FG000|Overall Study|Lost to Follow-up|28|||
163182558|NCT02147184|589383888|FG001|Overall Study|Lost to Follow-up|15|||
163182559|NCT02147184|589383887|FG000|Overall Study|Study Burden|11|||
163182560|NCT02147184|589383888|FG001|Overall Study|Study Burden|7|||
163182561|NCT02147184|589383887|FG000|Overall Study|Pregnancy|6|||
163182562|NCT02147184|589383888|FG001|Overall Study|Pregnancy|0|||
163182563|NCT02147184|589383887|FG000|Overall Study|Moved out of state|3|||
163182564|NCT02147184|589383888|FG001|Overall Study|Moved out of state|3|||
163182565|NCT02147184|589383887|FG000|Overall Study|Physician Decision|0|||
163182566|NCT02147184|589383888|FG001|Overall Study|Physician Decision|2|||
163182567|NCT02147184|589383887|FG000|Overall Study|Other|1|||
163182568|NCT02147184|589383888|FG001|Overall Study|Other|0|||
163182569|NCT02117414|589383889|FG000|Overall Study|Death|5|||
163182570|NCT02117414|589383890|FG001|Overall Study|Death|2|||
163182571|NCT02117414|589383889|FG000|Overall Study|Withdrawal by Subject|10|||
163182572|NCT02117414|589383890|FG001|Overall Study|Withdrawal by Subject|4|||
163182573|NCT02663687|589383892|FG000|Overall Study|Adverse Event|1|||
163182574|NCT02663687|589383893|FG001|Overall Study|Adverse Event|0|||
163182575|NCT02663687|589383894|FG002|Overall Study|Adverse Event|0|||
163182576|NCT02663687|589383895|FG003|Overall Study|Adverse Event|0|||
163182577|NCT02663687|589383896|FG004|Overall Study|Adverse Event|0|||
163182578|NCT02663687|589383892|FG000|Overall Study|Other|1|||
163182579|NCT02663687|589383893|FG001|Overall Study|Other|0|||
163182580|NCT02663687|589383894|FG002|Overall Study|Other|1|||
163182581|NCT02663687|589383895|FG003|Overall Study|Other|0|||
163182582|NCT02663687|589383896|FG004|Overall Study|Other|0|||
163182583|NCT03189381|589383897|FG000|Overall Study|Death|1|||
163182584|NCT03189381|589383898|FG001|Overall Study|Death|0|||
163182585|NCT04025710|589383904|FG000|Overall Study|Death|3|||
163182586|NCT04025710|589383904|FG000|Overall Study|Lost to Follow-up|5|||
163182587|NCT04025710|589383904|FG000|Overall Study|Withdrawal by Subject|1|||
163182588|NCT04025710|589383904|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
163182589|NCT04025710|589383904|FG000|Overall Study|Drop-out according to protocol|34|||
163182590|NCT01343901|589383907|FG000|Overall Study|Death|85|||
163182591|NCT01343901|589383907|FG000|Overall Study|Physician Decision|4|||
163182592|NCT01343901|589383907|FG000|Overall Study|Lost to Follow-up|12|||
163182593|NCT01343901|589383907|FG000|Overall Study|Management by another medical team|11|||
163182594|NCT01343901|589383907|FG000|Overall Study|Participant decision|1|||
163182595|NCT05308290|589383910|FG000|Overall Study|Death|1|||
163182596|NCT05308290|589383911|FG001|Overall Study|Death|0|||
163182597|NCT05308290|589383910|FG000|Overall Study|Lost to Follow-up|2|||
163182598|NCT05308290|589383911|FG001|Overall Study|Lost to Follow-up|1|||
163182599|NCT05308290|589383910|FG000|Overall Study|still in study followup|0|||
163182600|NCT05308290|589383911|FG001|Overall Study|still in study followup|1|||
163182601|NCT02117427|589383912|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
163182602|NCT02117427|589383913|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
163182603|NCT02117427|589383914|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
163182604|NCT02117427|589383912|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
163182605|NCT02117427|589383913|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
163182606|NCT02117427|589383914|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
163182607|NCT02117427|589383912|FG000|Overall Study|Physician Decision|0|||
163182608|NCT02117427|589383913|FG001|Overall Study|Physician Decision|2|||
163182609|NCT02117427|589383914|FG002|Overall Study|Physician Decision|0|||
163182610|NCT02117427|589383912|FG000|Overall Study|No longer meets inclusion criteria|0|||
163182611|NCT02117427|589383913|FG001|Overall Study|No longer meets inclusion criteria|1|||
163287250|NCT03370133|589758714|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
163182612|NCT02117427|589383914|FG002|Overall Study|No longer meets inclusion criteria|0|||
163287251|NCT03370133|589758715|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
163182613|NCT02117427|589383912|FG000|Overall Study|Death|0|||
163182614|NCT02117427|589383913|FG001|Overall Study|Death|1|||
163182615|NCT02117427|589383914|FG002|Overall Study|Death|0|||
163182616|NCT00410202|589383915|FG000|On-Treatment|Continuing treatment|69|||
163182617|NCT00410202|589383916|FG001|On-Treatment|Continuing treatment|71|||
163182618|NCT00410202|589383917|FG002|On-Treatment|Continuing treatment|66|||
163182619|NCT00410202|589383915|FG000|On-Treatment|Adverse Event|1|||
163182620|NCT00410202|589383916|FG001|On-Treatment|Adverse Event|3|||
163182621|NCT00410202|589383917|FG002|On-Treatment|Adverse Event|2|||
163287252|NCT03370133|589758716|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
163287253|NCT03370133|589758717|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
163287254|NCT03370133|589758718|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
163287255|NCT03370133|589758713|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
163287256|NCT03370133|589758714|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
163287257|NCT03370133|589758715|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
163287258|NCT03370133|589758716|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
163287259|NCT03370133|589758717|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
163287260|NCT03370133|589758718|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
163287261|NCT03370133|589758713|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
163287262|NCT03370133|589758714|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
163287263|NCT03370133|589758715|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
163287264|NCT03370133|589758716|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
163287265|NCT03370133|589758717|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
163287266|NCT03370133|589758718|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
163287267|NCT03370133|589758713|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
163287268|NCT03370133|589758714|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
163287269|NCT03370133|589758715|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
163287270|NCT03370133|589758716|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
163287271|NCT03370133|589758717|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
163287272|NCT03370133|589758718|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
163287273|NCT03370133|589758713|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
163287274|NCT03370133|589758714|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
163287275|NCT03370133|589758715|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
163287276|NCT03370133|589758716|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
163287277|NCT03370133|589758717|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
163287278|NCT03370133|589758718|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
163287279|NCT03370133|589758713|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
163287280|NCT03370133|589758714|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
163287281|NCT03370133|589758715|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
163287282|NCT03370133|589758716|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
163287283|NCT03370133|589758717|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
163287284|NCT03370133|589758718|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
163287285|NCT06688370|589758719|FG000|Overall Study|Discontinued the treatment|1|||
163287286|NCT06688370|589758719|FG000|Overall Study|Prohibited treatment taken|4|||
163287287|NCT02501811|589758720|FG000|Overall Study|Death|1|||
163287288|NCT02501811|589758721|FG001|Overall Study|Death|3|||
162937395|NCT01620489|588473614|FG001|Overall Study|Unclassified|2|||
162937396|NCT01829295|588473615|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
162937397|NCT01829295|588473616|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
162937398|NCT01829295|588473617|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
162937399|NCT01829295|588473618|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
162937400|NCT01829295|588473615|FG000|6-12 Months|Adverse Event|0|||
162937401|NCT01829295|588473616|FG001|6-12 Months|Adverse Event|0|||
162937402|NCT01829295|588473617|FG002|6-12 Months|Adverse Event|3|||
162937403|NCT01829295|588473618|FG003|6-12 Months|Adverse Event|2|||
162937404|NCT01829295|588473615|FG000|6-12 Months|Lost to Follow-up|2|||
162937405|NCT01829295|588473616|FG001|6-12 Months|Lost to Follow-up|0|||
162937406|NCT01829295|588473617|FG002|6-12 Months|Lost to Follow-up|0|||
162937407|NCT01829295|588473618|FG003|6-12 Months|Lost to Follow-up|0|||
162937408|NCT01829295|588473615|FG000|6-12 Months|Withdrawal by Subject|2|||
162937409|NCT01829295|588473616|FG001|6-12 Months|Withdrawal by Subject|2|||
162937410|NCT01829295|588473617|FG002|6-12 Months|Withdrawal by Subject|0|||
162937411|NCT01829295|588473618|FG003|6-12 Months|Withdrawal by Subject|0|||
162937412|NCT02629965|588473621|FG000|Period 1|Adverse Event|1|||
162937413|NCT02629965|588473622|FG001|Period 1|Adverse Event|0|||
162937414|NCT02629965|588473621|FG000|Period 1|Unexpected worsening of disease|2|||
163287289|NCT02501811|589758722|FG002|Overall Study|Death|2|||
163287290|NCT02501811|589758723|FG003|Overall Study|Death|3|||
163287291|NCT02501811|589758720|FG000|Overall Study|Withdrawal by Subject|3|||
162937415|NCT02629965|588473622|FG001|Period 1|Unexpected worsening of disease|0|||
163287292|NCT02501811|589758721|FG001|Overall Study|Withdrawal by Subject|3|||
163287293|NCT02501811|589758722|FG002|Overall Study|Withdrawal by Subject|2|||
163287294|NCT02501811|589758723|FG003|Overall Study|Withdrawal by Subject|3|||
163287295|NCT02501811|589758720|FG000|Overall Study|Lost to Follow-up|0|||
163287296|NCT02501811|589758721|FG001|Overall Study|Lost to Follow-up|0|||
163287297|NCT02501811|589758722|FG002|Overall Study|Lost to Follow-up|2|||
163287298|NCT02501811|589758723|FG003|Overall Study|Lost to Follow-up|1|||
163287299|NCT04804605|589760475|FG000|Overall Study|Withdrawal by Subject|46|||
163287300|NCT04804605|589760476|FG001|Overall Study|Withdrawal by Subject|26|||
163287301|NCT04804605|589760477|FG002|Overall Study|Withdrawal by Subject|37|||
163287302|NCT04804605|589760478|FG003|Overall Study|Withdrawal by Subject|21|||
163287303|NCT04804605|589760475|FG000|Overall Study|Lost to Follow-up|47|||
163287304|NCT04804605|589760476|FG001|Overall Study|Lost to Follow-up|21|||
163287305|NCT04804605|589760477|FG002|Overall Study|Lost to Follow-up|30|||
163287306|NCT04804605|589760478|FG003|Overall Study|Lost to Follow-up|17|||
163287307|NCT04804605|589760475|FG000|Overall Study|Lack of Efficacy|28|||
163287308|NCT04804605|589760476|FG001|Overall Study|Lack of Efficacy|11|||
163287309|NCT04804605|589760477|FG002|Overall Study|Lack of Efficacy|37|||
163287310|NCT04804605|589760478|FG003|Overall Study|Lack of Efficacy|8|||
163287311|NCT04804605|589760475|FG000|Overall Study|Adverse Event|10|||
163287312|NCT04804605|589760476|FG001|Overall Study|Adverse Event|10|||
163287313|NCT04804605|589760477|FG002|Overall Study|Adverse Event|10|||
163287314|NCT04804605|589760478|FG003|Overall Study|Adverse Event|7|||
163287315|NCT04804605|589760475|FG000|Overall Study|Non-compliance|8|||
163287316|NCT04804605|589760476|FG001|Overall Study|Non-compliance|3|||
163287317|NCT04804605|589760477|FG002|Overall Study|Non-compliance|5|||
163287318|NCT04804605|589760478|FG003|Overall Study|Non-compliance|1|||
163287319|NCT04804605|589760475|FG000|Overall Study|Physician Decision|3|||
163287320|NCT04804605|589760476|FG001|Overall Study|Physician Decision|0|||
163287321|NCT04804605|589760477|FG002|Overall Study|Physician Decision|5|||
163287322|NCT04804605|589760478|FG003|Overall Study|Physician Decision|0|||
163287323|NCT04804605|589760475|FG000|Overall Study|Protocol Violation|1|||
163287324|NCT04804605|589760476|FG001|Overall Study|Protocol Violation|0|||
163287325|NCT04804605|589760477|FG002|Overall Study|Protocol Violation|0|||
163287326|NCT04804605|589760478|FG003|Overall Study|Protocol Violation|1|||
163287327|NCT04804605|589760475|FG000|Overall Study|Miscellaneous|7|||
163287328|NCT04804605|589760476|FG001|Overall Study|Miscellaneous|3|||
163287329|NCT04804605|589760477|FG002|Overall Study|Miscellaneous|4|||
163287330|NCT04804605|589760478|FG003|Overall Study|Miscellaneous|2|||
163287331|NCT00567879|589760481|FG000|Overall Study|Adverse Event|2|||
163287332|NCT00567879|589760482|FG001|Overall Study|Adverse Event|0|||
163287333|NCT00567879|589760483|FG002|Overall Study|Adverse Event|1|||
163287334|NCT00567879|589760484|FG003|Overall Study|Adverse Event|0|||
163287335|NCT00567879|589760485|FG004|Overall Study|Adverse Event|1|||
163287336|NCT00567879|589760486|FG005|Overall Study|Adverse Event|0|||
163287337|NCT00567879|589760481|FG000|Overall Study|Abnormal test procedure(s)|0|||
163287338|NCT00567879|589760482|FG001|Overall Study|Abnormal test procedure(s)|0|||
163287339|NCT00567879|589760483|FG002|Overall Study|Abnormal test procedure(s)|1|||
163287340|NCT00567879|589760484|FG003|Overall Study|Abnormal test procedure(s)|0|||
163287341|NCT00567879|589760485|FG004|Overall Study|Abnormal test procedure(s)|0|||
163287342|NCT00567879|589760486|FG005|Overall Study|Abnormal test procedure(s)|0|||
163287343|NCT00567879|589760481|FG000|Overall Study|Withdrawal by Subject|0|||
163287344|NCT00567879|589760482|FG001|Overall Study|Withdrawal by Subject|0|||
163287345|NCT00567879|589760483|FG002|Overall Study|Withdrawal by Subject|3|||
163287346|NCT00567879|589760484|FG003|Overall Study|Withdrawal by Subject|1|||
163287347|NCT00567879|589760485|FG004|Overall Study|Withdrawal by Subject|0|||
163287348|NCT00567879|589760486|FG005|Overall Study|Withdrawal by Subject|0|||
163287349|NCT00567879|589760481|FG000|Overall Study|New cancer therapy|0|||
163287350|NCT00567879|589760482|FG001|Overall Study|New cancer therapy|0|||
163287351|NCT00567879|589760483|FG002|Overall Study|New cancer therapy|1|||
163287352|NCT00567879|589760484|FG003|Overall Study|New cancer therapy|0|||
163287353|NCT00567879|589760485|FG004|Overall Study|New cancer therapy|0|||
163287354|NCT00567879|589760486|FG005|Overall Study|New cancer therapy|0|||
163287355|NCT00567879|589760481|FG000|Overall Study|Disease progression|5|||
163287356|NCT00567879|589760482|FG001|Overall Study|Disease progression|7|||
163287357|NCT00567879|589760483|FG002|Overall Study|Disease progression|15|||
163287358|NCT00567879|589760484|FG003|Overall Study|Disease progression|5|||
163287359|NCT00567879|589760485|FG004|Overall Study|Disease progression|11|||
163287360|NCT00567879|589760486|FG005|Overall Study|Disease progression|3|||
163287361|NCT00151996|589760489|FG000|Overall Study|Adverse Event|3|||
163287362|NCT00151996|589760490|FG001|Overall Study|Adverse Event|2|||
163287363|NCT00151996|589760489|FG000|Overall Study|Withdrawal by Subject|1|||
163287364|NCT00151996|589760490|FG001|Overall Study|Withdrawal by Subject|1|||
163287365|NCT00151996|589760489|FG000|Overall Study|Protocol Violation|1|||
163287366|NCT00151996|589760490|FG001|Overall Study|Protocol Violation|2|||
163287367|NCT00151996|589760489|FG000|Overall Study|Sponsor's decision|0|||
163287368|NCT00151996|589760490|FG001|Overall Study|Sponsor's decision|2|||
163287369|NCT01546155|589760491|FG000|Overall Study|could not tolerate long scan duration|3|||
163287370|NCT00420316|589760497|FG000|Overall Study|Withdrawal by Subject|0|||
163287371|NCT00420316|589760498|FG001|Overall Study|Withdrawal by Subject|1|||
163287372|NCT00420316|589760497|FG000|Overall Study|Lost to Follow-up|12|||
163287373|NCT00420316|589760498|FG001|Overall Study|Lost to Follow-up|8|||
163287374|NCT03546907|589760499|FG000|Overall Study|Lack of Efficacy|1|||
163287375|NCT03546907|589760500|FG001|Overall Study|Lack of Efficacy|1|||
163287376|NCT03546907|589760499|FG000|Overall Study|Withdrawal by Subject|8|||
163287377|NCT03546907|589760500|FG001|Overall Study|Withdrawal by Subject|9|||
163287378|NCT03546907|589760499|FG000|Overall Study|Adverse events (AEs)|7|||
163287379|NCT03546907|589760500|FG001|Overall Study|Adverse events (AEs)|10|||
163287380|NCT03546907|589760499|FG000|Overall Study|Other-unspecified|1|||
163287381|NCT03546907|589760500|FG001|Overall Study|Other-unspecified|1|||
163287382|NCT04033432|589760501|FG000|Overall Study|Progressive Disease|8|||
163287383|NCT04033432|589760501|FG000|Overall Study|Adverse Event|4|||
163287384|NCT04033432|589760501|FG000|Overall Study|Death|1|||
163287385|NCT04936035|589760509|FG000|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163287386|NCT04936035|589760510|FG001|6-Month Placebo-controlled DB Period|Adverse Event|1|||
163287387|NCT04936035|589760511|FG002|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163287388|NCT04936035|589760512|FG003|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163287389|NCT04936035|589760513|FG004|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163287390|NCT04936035|589760514|FG005|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163287391|NCT04936035|589760515|FG006|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163287392|NCT04936035|589760516|FG007|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163287393|NCT04936035|589760517|FG008|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163287394|NCT04936035|589760518|FG009|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163287395|NCT04936035|589760519|FG010|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163287396|NCT04936035|589760520|FG011|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163287397|NCT04936035|589760521|FG012|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163287398|NCT04936035|589760509|FG000|6-Month Placebo-controlled DB Period|Death|0|||
163287399|NCT04936035|589760510|FG001|6-Month Placebo-controlled DB Period|Death|0|||
163287400|NCT04936035|589760511|FG002|6-Month Placebo-controlled DB Period|Death|0|||
163287401|NCT04936035|589760512|FG003|6-Month Placebo-controlled DB Period|Death|1|||
163287402|NCT04936035|589760513|FG004|6-Month Placebo-controlled DB Period|Death|0|||
163287403|NCT04936035|589760514|FG005|6-Month Placebo-controlled DB Period|Death|0|||
163287404|NCT04936035|589760515|FG006|6-Month Placebo-controlled DB Period|Death|0|||
163287405|NCT04936035|589760516|FG007|6-Month Placebo-controlled DB Period|Death|0|||
163287406|NCT04936035|589760517|FG008|6-Month Placebo-controlled DB Period|Death|0|||
163287407|NCT04936035|589760518|FG009|6-Month Placebo-controlled DB Period|Death|0|||
163287408|NCT04936035|589760519|FG010|6-Month Placebo-controlled DB Period|Death|0|||
163287409|NCT04936035|589760520|FG011|6-Month Placebo-controlled DB Period|Death|0|||
163287410|NCT04936035|589760521|FG012|6-Month Placebo-controlled DB Period|Death|0|||
163287411|NCT04936035|589760509|FG000|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163287412|NCT04936035|589760510|FG001|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
163287413|NCT04936035|589760511|FG002|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
163287414|NCT04936035|589760512|FG003|6-Month Placebo-controlled DB Period|Lost to Follow-up|2|||
163182622|NCT00410202|589383915|FG000|On-Treatment|Death|1|||
163182623|NCT00410202|589383916|FG001|On-Treatment|Death|0|||
163182624|NCT00410202|589383917|FG002|On-Treatment|Death|0|||
163182625|NCT00410202|589383915|FG000|On-Treatment|Lost to Follow-up|1|||
163182626|NCT00410202|589383916|FG001|On-Treatment|Lost to Follow-up|0|||
163182627|NCT00410202|589383917|FG002|On-Treatment|Lost to Follow-up|1|||
163182628|NCT00410202|589383915|FG000|On-Treatment|Lack of Efficacy|1|||
163182629|NCT00410202|589383916|FG001|On-Treatment|Lack of Efficacy|4|||
163182630|NCT00410202|589383917|FG002|On-Treatment|Lack of Efficacy|0|||
163182631|NCT00410202|589383915|FG000|On-Treatment|Withdrawal by Subject|2|||
163182632|NCT00410202|589383916|FG001|On-Treatment|Withdrawal by Subject|1|||
163182633|NCT00410202|589383917|FG002|On-Treatment|Withdrawal by Subject|1|||
163182634|NCT00410202|589383915|FG000|On-Treatment|Other Reason|0|||
163182635|NCT00410202|589383916|FG001|On-Treatment|Other Reason|0|||
163182636|NCT00410202|589383917|FG002|On-Treatment|Other Reason|1|||
163182637|NCT00410202|589383915|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
163182638|NCT00410202|589383916|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
163182639|NCT00410202|589383917|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
163182640|NCT00410202|589383915|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
163182641|NCT00410202|589383916|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
163182642|NCT00410202|589383917|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
163182643|NCT00410202|589383915|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
163182644|NCT00410202|589383916|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
163182645|NCT00410202|589383917|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
163182646|NCT01178073|589383918|FG000|Overall Study|Adverse Event|34|||
163182647|NCT01178073|589383919|FG001|Overall Study|Adverse Event|27|||
163182648|NCT01178073|589383920|FG002|Overall Study|Adverse Event|24|||
163182649|NCT01178073|589383918|FG000|Overall Study|Protocol Violation|1|||
163182650|NCT01178073|589383919|FG001|Overall Study|Protocol Violation|1|||
163182651|NCT01178073|589383920|FG002|Overall Study|Protocol Violation|1|||
163182652|NCT01178073|589383918|FG000|Overall Study|Lost to Follow-up|2|||
163182653|NCT01178073|589383919|FG001|Overall Study|Lost to Follow-up|0|||
163182654|NCT01178073|589383920|FG002|Overall Study|Lost to Follow-up|3|||
163182655|NCT01178073|589383918|FG000|Overall Study|Physician Decision|14|||
163182656|NCT01178073|589383919|FG001|Overall Study|Physician Decision|10|||
163182657|NCT01178073|589383920|FG002|Overall Study|Physician Decision|10|||
163182658|NCT01178073|589383918|FG000|Overall Study|Withdrawal by Subject|10|||
163182659|NCT01178073|589383919|FG001|Overall Study|Withdrawal by Subject|6|||
163182660|NCT01178073|589383920|FG002|Overall Study|Withdrawal by Subject|8|||
163182661|NCT01178073|589383918|FG000|Overall Study|Missing Completion Status|1|||
163182662|NCT01178073|589383919|FG001|Overall Study|Missing Completion Status|0|||
163182663|NCT01178073|589383920|FG002|Overall Study|Missing Completion Status|0|||
163182664|NCT01674634|589383923|FG000|Overall Study|Withdrawal by Subject|3|||
163182665|NCT01674634|589383923|FG000|Overall Study|Lost to Follow-up|3|||
163182666|NCT00937391|589383924|FG000|Stage 2|Withdrawal by Subject|1|||
163182667|NCT01226043|589383934|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
163182668|NCT01226043|589383935|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
163182669|NCT01226043|589383936|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
163182670|NCT01226043|589383937|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
163182671|NCT01226043|589383934|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
163182672|NCT01226043|589383935|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
163182673|NCT01226043|589383936|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
163182674|NCT01226043|589383937|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
163182675|NCT01226043|589383934|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
163182676|NCT01226043|589383935|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
163182677|NCT01226043|589383936|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
163182678|NCT01226043|589383937|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
163182679|NCT01226043|589383934|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
163182680|NCT01226043|589383935|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
163182681|NCT01226043|589383936|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
163182682|NCT01226043|589383937|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
163182683|NCT01226043|589383934|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
163182684|NCT01226043|589383935|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
163182685|NCT01226043|589383936|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
163182686|NCT01226043|589383937|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
163182687|NCT01226043|589383934|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
163182688|NCT01226043|589383935|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
163182689|NCT01226043|589383936|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
163182690|NCT01226043|589383937|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
163182691|NCT01226043|589383934|FG000|6-week Re-randomization Phase|Adverse Event|0|||
163182692|NCT01226043|589383935|FG001|6-week Re-randomization Phase|Adverse Event|0|||
163182693|NCT01226043|589383936|FG002|6-week Re-randomization Phase|Adverse Event|1|||
163287415|NCT04936035|589760513|FG004|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
163287416|NCT04936035|589760514|FG005|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163287417|NCT04936035|589760515|FG006|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163287418|NCT04936035|589760516|FG007|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163287419|NCT04936035|589760517|FG008|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163287420|NCT04936035|589760518|FG009|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163287421|NCT04936035|589760519|FG010|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163287422|NCT04936035|589760520|FG011|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163287423|NCT04936035|589760521|FG012|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163287424|NCT04936035|589760509|FG000|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163287425|NCT04936035|589760510|FG001|6-Month Placebo-controlled DB Period|Physician Decision|1|||
163287426|NCT04936035|589760511|FG002|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163287427|NCT04936035|589760512|FG003|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163287428|NCT04936035|589760513|FG004|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163287429|NCT04936035|589760514|FG005|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163287430|NCT04936035|589760515|FG006|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163287431|NCT04936035|589760516|FG007|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163287432|NCT04936035|589760517|FG008|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163287433|NCT04936035|589760518|FG009|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163287434|NCT04936035|589760519|FG010|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163287435|NCT04936035|589760520|FG011|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163287436|NCT04936035|589760521|FG012|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163287437|NCT04936035|589760509|FG000|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163287438|NCT04936035|589760510|FG001|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163287439|NCT04936035|589760511|FG002|6-Month Placebo-controlled DB Period|Protocol Deviation|1|||
163287440|NCT04936035|589760512|FG003|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163287441|NCT04936035|589760513|FG004|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163287442|NCT04936035|589760514|FG005|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163287443|NCT04936035|589760515|FG006|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163287444|NCT04936035|589760516|FG007|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163287445|NCT04936035|589760517|FG008|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163287446|NCT04936035|589760518|FG009|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163287447|NCT04936035|589760519|FG010|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163287448|NCT04936035|589760520|FG011|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163287449|NCT04936035|589760521|FG012|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163287450|NCT04936035|589760509|FG000|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
163287451|NCT04936035|589760510|FG001|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
163287452|NCT04936035|589760511|FG002|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|1|||
163287453|NCT04936035|589760512|FG003|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|2|||
163287454|NCT04936035|589760513|FG004|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|3|||
163287455|NCT04936035|589760514|FG005|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163287456|NCT04936035|589760515|FG006|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163287457|NCT04936035|589760516|FG007|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163287458|NCT04936035|589760517|FG008|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163287459|NCT04936035|589760518|FG009|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163287460|NCT04936035|589760519|FG010|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163287461|NCT04936035|589760520|FG011|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163287462|NCT04936035|589760521|FG012|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163287463|NCT04936035|589760509|FG000|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163287464|NCT04936035|589760510|FG001|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163287465|NCT04936035|589760511|FG002|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163287466|NCT04936035|589760512|FG003|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163287467|NCT04936035|589760513|FG004|6-Month Placebo-controlled DB Period|Reason Unknown|1|||
163287468|NCT04936035|589760514|FG005|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163287469|NCT04936035|589760515|FG006|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163287470|NCT04936035|589760516|FG007|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163287471|NCT04936035|589760517|FG008|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163287472|NCT04936035|589760518|FG009|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163287473|NCT04936035|589760519|FG010|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163287474|NCT04936035|589760520|FG011|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163287475|NCT04936035|589760521|FG012|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163287476|NCT04936035|589760509|FG000|6-Month Placebo-controlled DB Period|Withdrawal by Subject|1|||
163287477|NCT04936035|589760510|FG001|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163287478|NCT04936035|589760511|FG002|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163287479|NCT04936035|589760512|FG003|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163287480|NCT04936035|589760513|FG004|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163287481|NCT04936035|589760514|FG005|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163287482|NCT04936035|589760515|FG006|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163287483|NCT04936035|589760516|FG007|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163287484|NCT04936035|589760517|FG008|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163287485|NCT04936035|589760518|FG009|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163287486|NCT04936035|589760519|FG010|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163287487|NCT04936035|589760520|FG011|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163287488|NCT04936035|589760521|FG012|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163287489|NCT04936035|589760509|FG000|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
163287490|NCT04936035|589760510|FG001|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
163287491|NCT04936035|589760511|FG002|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
163287492|NCT04936035|589760512|FG003|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
163287493|NCT04936035|589760513|FG004|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
163287494|NCT04936035|589760514|FG005|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
163287495|NCT04936035|589760515|FG006|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|1|||
163287496|NCT04936035|589760516|FG007|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
163287497|NCT04936035|589760517|FG008|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
163287498|NCT04936035|589760518|FG009|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
163287499|NCT04936035|589760519|FG010|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|7|||
163287500|NCT04936035|589760520|FG011|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|5|||
163287501|NCT04936035|589760521|FG012|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|3|||
163287502|NCT04936035|589760509|FG000|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
163287503|NCT04936035|589760510|FG001|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
163287504|NCT04936035|589760511|FG002|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
163287505|NCT04936035|589760512|FG003|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
163287506|NCT04936035|589760513|FG004|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
163287507|NCT04936035|589760514|FG005|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
163287508|NCT04936035|589760515|FG006|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
163287509|NCT04936035|589760516|FG007|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
163287510|NCT04936035|589760517|FG008|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
163287511|NCT04936035|589760518|FG009|Post-6-Month DB Period (30months)|Lost to Follow-up|3|||
163287512|NCT04936035|589760519|FG010|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
163287513|NCT04936035|589760520|FG011|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
163287514|NCT04936035|589760521|FG012|Post-6-Month DB Period (30months)|Lost to Follow-up|4|||
163287515|NCT04936035|589760509|FG000|Post-6-Month DB Period (30months)|Physician Decision|0|||
163287516|NCT04936035|589760510|FG001|Post-6-Month DB Period (30months)|Physician Decision|0|||
163287517|NCT04936035|589760511|FG002|Post-6-Month DB Period (30months)|Physician Decision|0|||
163287518|NCT04936035|589760512|FG003|Post-6-Month DB Period (30months)|Physician Decision|0|||
163287519|NCT04936035|589760513|FG004|Post-6-Month DB Period (30months)|Physician Decision|0|||
163287520|NCT04936035|589760514|FG005|Post-6-Month DB Period (30months)|Physician Decision|0|||
163287521|NCT04936035|589760515|FG006|Post-6-Month DB Period (30months)|Physician Decision|0|||
163287522|NCT04936035|589760516|FG007|Post-6-Month DB Period (30months)|Physician Decision|0|||
163287523|NCT04936035|589760517|FG008|Post-6-Month DB Period (30months)|Physician Decision|0|||
163287524|NCT04936035|589760518|FG009|Post-6-Month DB Period (30months)|Physician Decision|2|||
163287525|NCT04936035|589760519|FG010|Post-6-Month DB Period (30months)|Physician Decision|0|||
163287526|NCT04936035|589760520|FG011|Post-6-Month DB Period (30months)|Physician Decision|1|||
163287527|NCT04936035|589760521|FG012|Post-6-Month DB Period (30months)|Physician Decision|0|||
163287528|NCT04936035|589760509|FG000|Post-6-Month DB Period (30months)|Adverse Event|0|||
163287529|NCT04936035|589760510|FG001|Post-6-Month DB Period (30months)|Adverse Event|0|||
163287530|NCT04936035|589760511|FG002|Post-6-Month DB Period (30months)|Adverse Event|0|||
163287531|NCT04936035|589760512|FG003|Post-6-Month DB Period (30months)|Adverse Event|0|||
163287532|NCT04936035|589760513|FG004|Post-6-Month DB Period (30months)|Adverse Event|0|||
163287533|NCT04936035|589760514|FG005|Post-6-Month DB Period (30months)|Adverse Event|1|||
163287534|NCT04936035|589760515|FG006|Post-6-Month DB Period (30months)|Adverse Event|0|||
163287535|NCT04936035|589760516|FG007|Post-6-Month DB Period (30months)|Adverse Event|1|||
163287536|NCT04936035|589760517|FG008|Post-6-Month DB Period (30months)|Adverse Event|0|||
163287537|NCT04936035|589760518|FG009|Post-6-Month DB Period (30months)|Adverse Event|0|||
163287538|NCT04936035|589760519|FG010|Post-6-Month DB Period (30months)|Adverse Event|0|||
163287539|NCT04936035|589760520|FG011|Post-6-Month DB Period (30months)|Adverse Event|0|||
163287540|NCT04936035|589760521|FG012|Post-6-Month DB Period (30months)|Adverse Event|0|||
163287541|NCT04936035|589760509|FG000|Post-6-Month DB Period (30months)|Death|0|||
163287542|NCT04936035|589760510|FG001|Post-6-Month DB Period (30months)|Death|0|||
163287543|NCT04936035|589760511|FG002|Post-6-Month DB Period (30months)|Death|0|||
163287544|NCT04936035|589760512|FG003|Post-6-Month DB Period (30months)|Death|0|||
163287545|NCT04936035|589760513|FG004|Post-6-Month DB Period (30months)|Death|0|||
163287546|NCT04936035|589760514|FG005|Post-6-Month DB Period (30months)|Death|0|||
163287547|NCT04936035|589760515|FG006|Post-6-Month DB Period (30months)|Death|0|||
163287548|NCT04936035|589760516|FG007|Post-6-Month DB Period (30months)|Death|0|||
163287549|NCT04936035|589760517|FG008|Post-6-Month DB Period (30months)|Death|0|||
163287550|NCT04936035|589760518|FG009|Post-6-Month DB Period (30months)|Death|1|||
163287551|NCT04936035|589760519|FG010|Post-6-Month DB Period (30months)|Death|0|||
163287552|NCT04936035|589760520|FG011|Post-6-Month DB Period (30months)|Death|0|||
163287553|NCT04936035|589760521|FG012|Post-6-Month DB Period (30months)|Death|0|||
163287554|NCT04936035|589760509|FG000|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163287555|NCT04936035|589760510|FG001|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163287556|NCT04936035|589760511|FG002|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163287557|NCT04936035|589760512|FG003|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163287558|NCT04936035|589760513|FG004|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163287559|NCT04936035|589760514|FG005|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
163287560|NCT04936035|589760515|FG006|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163287561|NCT04936035|589760516|FG007|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163287562|NCT04936035|589760517|FG008|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163287563|NCT04936035|589760518|FG009|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
163287564|NCT04936035|589760519|FG010|Post-6-Month DB Period (30months)|Reason Not Specified|2|||
163287565|NCT04936035|589760520|FG011|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163287566|NCT04936035|589760521|FG012|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163287567|NCT05827926|589760524|FG000|Overall Study|Lost to Follow-up|1|||
163287568|NCT05827926|589760525|FG001|Overall Study|Lost to Follow-up|0|||
163287569|NCT05827926|589760526|FG002|Overall Study|Lost to Follow-up|0|||
163287570|NCT05827926|589760527|FG003|Overall Study|Lost to Follow-up|0|||
163287571|NCT05827926|589760528|FG004|Overall Study|Lost to Follow-up|0|||
163287572|NCT05827926|589760529|FG005|Overall Study|Lost to Follow-up|1|||
163287573|NCT05827926|589760530|FG006|Overall Study|Lost to Follow-up|0|||
163287574|NCT05827926|589760531|FG007|Overall Study|Lost to Follow-up|0|||
163287575|NCT05827926|589760532|FG008|Overall Study|Lost to Follow-up|0|||
163287576|NCT05827926|589760533|FG009|Overall Study|Lost to Follow-up|0|||
163287577|NCT05827926|589760534|FG010|Overall Study|Lost to Follow-up|0|||
163287578|NCT05827926|589760535|FG011|Overall Study|Lost to Follow-up|0|||
163287579|NCT05827926|589760536|FG012|Overall Study|Lost to Follow-up|1|||
163287580|NCT05827926|589760537|FG013|Overall Study|Lost to Follow-up|1|||
163287581|NCT05827926|589760538|FG014|Overall Study|Lost to Follow-up|0|||
163287582|NCT05827926|589760539|FG015|Overall Study|Lost to Follow-up|1|||
163287583|NCT05827926|589760540|FG016|Overall Study|Lost to Follow-up|2|||
163287584|NCT05827926|589760541|FG017|Overall Study|Lost to Follow-up|0|||
163287585|NCT05827926|589760542|FG018|Overall Study|Lost to Follow-up|0|||
163287586|NCT05827926|589760543|FG019|Overall Study|Lost to Follow-up|0|||
163287587|NCT05827926|589760544|FG020|Overall Study|Lost to Follow-up|1|||
163287588|NCT05827926|589760545|FG021|Overall Study|Lost to Follow-up|2|||
163287589|NCT05827926|589760546|FG022|Overall Study|Lost to Follow-up|1|||
163287590|NCT05827926|589760547|FG023|Overall Study|Lost to Follow-up|1|||
163287591|NCT05827926|589760548|FG024|Overall Study|Lost to Follow-up|2|||
163287592|NCT05827926|589760549|FG025|Overall Study|Lost to Follow-up|1|||
163287593|NCT05827926|589760550|FG026|Overall Study|Lost to Follow-up|4|||
163287594|NCT05827926|589760551|FG027|Overall Study|Lost to Follow-up|1|||
163287595|NCT05827926|589760552|FG028|Overall Study|Lost to Follow-up|2|||
163287596|NCT05827926|589760553|FG029|Overall Study|Lost to Follow-up|1|||
163287597|NCT05827926|589760554|FG030|Overall Study|Lost to Follow-up|5|||
163287598|NCT05827926|589760555|FG031|Overall Study|Lost to Follow-up|0|||
163287599|NCT05827926|589760556|FG032|Overall Study|Lost to Follow-up|3|||
163287600|NCT05827926|589760557|FG033|Overall Study|Lost to Follow-up|2|||
163287601|NCT05827926|589760558|FG034|Overall Study|Lost to Follow-up|1|||
163287602|NCT05827926|589760559|FG035|Overall Study|Lost to Follow-up|3|||
163287603|NCT05827926|589760560|FG036|Overall Study|Lost to Follow-up|4|||
163287604|NCT05827926|589760524|FG000|Overall Study|Withdrawal by Subject|1|||
163287605|NCT05827926|589760525|FG001|Overall Study|Withdrawal by Subject|0|||
163287606|NCT05827926|589760526|FG002|Overall Study|Withdrawal by Subject|1|||
163287607|NCT05827926|589760527|FG003|Overall Study|Withdrawal by Subject|1|||
163287608|NCT05827926|589760528|FG004|Overall Study|Withdrawal by Subject|0|||
163287609|NCT05827926|589760529|FG005|Overall Study|Withdrawal by Subject|0|||
163287610|NCT05827926|589760530|FG006|Overall Study|Withdrawal by Subject|0|||
163287611|NCT05827926|589760531|FG007|Overall Study|Withdrawal by Subject|0|||
163287612|NCT05827926|589760532|FG008|Overall Study|Withdrawal by Subject|0|||
163287613|NCT05827926|589760533|FG009|Overall Study|Withdrawal by Subject|0|||
163287614|NCT05827926|589760534|FG010|Overall Study|Withdrawal by Subject|0|||
163287615|NCT05827926|589760535|FG011|Overall Study|Withdrawal by Subject|0|||
163287616|NCT05827926|589760536|FG012|Overall Study|Withdrawal by Subject|1|||
163287617|NCT05827926|589760537|FG013|Overall Study|Withdrawal by Subject|1|||
163287618|NCT05827926|589760538|FG014|Overall Study|Withdrawal by Subject|1|||
163287619|NCT05827926|589760539|FG015|Overall Study|Withdrawal by Subject|2|||
163287620|NCT05827926|589760540|FG016|Overall Study|Withdrawal by Subject|1|||
163287621|NCT05827926|589760541|FG017|Overall Study|Withdrawal by Subject|1|||
163287622|NCT05827926|589760542|FG018|Overall Study|Withdrawal by Subject|0|||
163287623|NCT05827926|589760543|FG019|Overall Study|Withdrawal by Subject|0|||
163287624|NCT05827926|589760544|FG020|Overall Study|Withdrawal by Subject|1|||
163287625|NCT05827926|589760545|FG021|Overall Study|Withdrawal by Subject|0|||
163287626|NCT05827926|589760546|FG022|Overall Study|Withdrawal by Subject|0|||
163287627|NCT05827926|589760547|FG023|Overall Study|Withdrawal by Subject|2|||
163287628|NCT05827926|589760548|FG024|Overall Study|Withdrawal by Subject|1|||
163287629|NCT05827926|589760549|FG025|Overall Study|Withdrawal by Subject|0|||
163287630|NCT05827926|589760550|FG026|Overall Study|Withdrawal by Subject|0|||
163287631|NCT05827926|589760551|FG027|Overall Study|Withdrawal by Subject|1|||
163287632|NCT05827926|589760552|FG028|Overall Study|Withdrawal by Subject|0|||
163287633|NCT05827926|589760553|FG029|Overall Study|Withdrawal by Subject|0|||
163287634|NCT05827926|589760554|FG030|Overall Study|Withdrawal by Subject|0|||
163287635|NCT05827926|589760555|FG031|Overall Study|Withdrawal by Subject|2|||
163287636|NCT05827926|589760556|FG032|Overall Study|Withdrawal by Subject|0|||
163287637|NCT05827926|589760557|FG033|Overall Study|Withdrawal by Subject|0|||
163287638|NCT05827926|589760558|FG034|Overall Study|Withdrawal by Subject|0|||
163287639|NCT05827926|589760559|FG035|Overall Study|Withdrawal by Subject|0|||
163287640|NCT05827926|589760560|FG036|Overall Study|Withdrawal by Subject|1|||
163287641|NCT05827926|589760524|FG000|Overall Study|Other Than Specified|0|||
163287642|NCT05827926|589760525|FG001|Overall Study|Other Than Specified|0|||
163287643|NCT05827926|589760526|FG002|Overall Study|Other Than Specified|0|||
163287644|NCT05827926|589760527|FG003|Overall Study|Other Than Specified|1|||
163287645|NCT05827926|589760528|FG004|Overall Study|Other Than Specified|0|||
163287646|NCT05827926|589760529|FG005|Overall Study|Other Than Specified|0|||
163287647|NCT05827926|589760530|FG006|Overall Study|Other Than Specified|1|||
163287648|NCT05827926|589760531|FG007|Overall Study|Other Than Specified|0|||
163287649|NCT05827926|589760532|FG008|Overall Study|Other Than Specified|0|||
163287650|NCT05827926|589760533|FG009|Overall Study|Other Than Specified|0|||
163287651|NCT05827926|589760534|FG010|Overall Study|Other Than Specified|0|||
163287652|NCT05827926|589760535|FG011|Overall Study|Other Than Specified|0|||
163287653|NCT05827926|589760536|FG012|Overall Study|Other Than Specified|0|||
163287654|NCT05827926|589760537|FG013|Overall Study|Other Than Specified|1|||
163287655|NCT05827926|589760538|FG014|Overall Study|Other Than Specified|0|||
163287656|NCT05827926|589760539|FG015|Overall Study|Other Than Specified|1|||
163287657|NCT05827926|589760540|FG016|Overall Study|Other Than Specified|0|||
163287658|NCT05827926|589760541|FG017|Overall Study|Other Than Specified|0|||
163287659|NCT05827926|589760542|FG018|Overall Study|Other Than Specified|0|||
163287660|NCT05827926|589760543|FG019|Overall Study|Other Than Specified|0|||
163287661|NCT05827926|589760544|FG020|Overall Study|Other Than Specified|0|||
163287662|NCT05827926|589760545|FG021|Overall Study|Other Than Specified|1|||
163287663|NCT05827926|589760546|FG022|Overall Study|Other Than Specified|1|||
163287664|NCT05827926|589760547|FG023|Overall Study|Other Than Specified|0|||
163287665|NCT05827926|589760548|FG024|Overall Study|Other Than Specified|0|||
163287666|NCT05827926|589760549|FG025|Overall Study|Other Than Specified|1|||
163287667|NCT05827926|589760550|FG026|Overall Study|Other Than Specified|0|||
163287668|NCT05827926|589760551|FG027|Overall Study|Other Than Specified|0|||
163287669|NCT05827926|589760552|FG028|Overall Study|Other Than Specified|0|||
163287670|NCT05827926|589760553|FG029|Overall Study|Other Than Specified|0|||
163287671|NCT05827926|589760554|FG030|Overall Study|Other Than Specified|0|||
163287672|NCT05827926|589760555|FG031|Overall Study|Other Than Specified|1|||
163287673|NCT05827926|589760556|FG032|Overall Study|Other Than Specified|0|||
163287674|NCT05827926|589760557|FG033|Overall Study|Other Than Specified|0|||
163287675|NCT05827926|589760558|FG034|Overall Study|Other Than Specified|0|||
163287676|NCT05827926|589760559|FG035|Overall Study|Other Than Specified|0|||
163287677|NCT05827926|589760560|FG036|Overall Study|Other Than Specified|0|||
163287678|NCT05827926|589760524|FG000|Overall Study|Physician Decision|0|||
163287679|NCT05827926|589760525|FG001|Overall Study|Physician Decision|0|||
163287680|NCT05827926|589760526|FG002|Overall Study|Physician Decision|0|||
163287681|NCT05827926|589760527|FG003|Overall Study|Physician Decision|0|||
163287682|NCT05827926|589760528|FG004|Overall Study|Physician Decision|0|||
163287683|NCT05827926|589760529|FG005|Overall Study|Physician Decision|0|||
163287684|NCT05827926|589760530|FG006|Overall Study|Physician Decision|0|||
163287685|NCT05827926|589760531|FG007|Overall Study|Physician Decision|0|||
163287686|NCT05827926|589760532|FG008|Overall Study|Physician Decision|0|||
163287687|NCT05827926|589760533|FG009|Overall Study|Physician Decision|0|||
163287688|NCT05827926|589760534|FG010|Overall Study|Physician Decision|0|||
163287689|NCT05827926|589760535|FG011|Overall Study|Physician Decision|0|||
163287690|NCT05827926|589760536|FG012|Overall Study|Physician Decision|0|||
163287691|NCT05827926|589760537|FG013|Overall Study|Physician Decision|0|||
163287692|NCT05827926|589760538|FG014|Overall Study|Physician Decision|0|||
163287693|NCT05827926|589760539|FG015|Overall Study|Physician Decision|0|||
163287694|NCT05827926|589760540|FG016|Overall Study|Physician Decision|0|||
163287695|NCT05827926|589760541|FG017|Overall Study|Physician Decision|0|||
163287696|NCT05827926|589760542|FG018|Overall Study|Physician Decision|1|||
163287697|NCT05827926|589760543|FG019|Overall Study|Physician Decision|0|||
163287698|NCT05827926|589760544|FG020|Overall Study|Physician Decision|0|||
163287699|NCT05827926|589760545|FG021|Overall Study|Physician Decision|0|||
163287700|NCT05827926|589760546|FG022|Overall Study|Physician Decision|0|||
163287701|NCT05827926|589760547|FG023|Overall Study|Physician Decision|0|||
163287702|NCT05827926|589760548|FG024|Overall Study|Physician Decision|0|||
163287703|NCT05827926|589760549|FG025|Overall Study|Physician Decision|0|||
163287704|NCT05827926|589760550|FG026|Overall Study|Physician Decision|0|||
163287705|NCT05827926|589760551|FG027|Overall Study|Physician Decision|0|||
163287706|NCT05827926|589760552|FG028|Overall Study|Physician Decision|0|||
163287707|NCT05827926|589760553|FG029|Overall Study|Physician Decision|0|||
163287708|NCT05827926|589760554|FG030|Overall Study|Physician Decision|0|||
163287709|NCT05827926|589760555|FG031|Overall Study|Physician Decision|0|||
163287710|NCT05827926|589760556|FG032|Overall Study|Physician Decision|0|||
163287711|NCT05827926|589760557|FG033|Overall Study|Physician Decision|0|||
163287712|NCT05827926|589760558|FG034|Overall Study|Physician Decision|0|||
163287713|NCT05827926|589760559|FG035|Overall Study|Physician Decision|0|||
163287714|NCT05827926|589760560|FG036|Overall Study|Physician Decision|0|||
163287715|NCT04588480|589760568|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
163287716|NCT04588480|589760569|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
163287717|NCT04588480|589760570|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
163287718|NCT04588480|589760568|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
163287719|NCT04588480|589760569|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
163287720|NCT04588480|589760570|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
163287721|NCT01242085|589760571|FG000|Overall Study|Withdrawal by Subject|4|||
163287722|NCT01242085|589760572|FG001|Overall Study|Withdrawal by Subject|2|||
163287723|NCT01242085|589760573|FG002|Overall Study|Withdrawal by Subject|0|||
163287724|NCT01242085|589760571|FG000|Overall Study|medically unable to have surgery|4|||
163287725|NCT01242085|589760572|FG001|Overall Study|medically unable to have surgery|5|||
163287726|NCT01242085|589760573|FG002|Overall Study|medically unable to have surgery|0|||
163287727|NCT02430532|589760575|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
163287728|NCT02430532|589760576|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
163287729|NCT02430532|589760575|FG000|Overall Study|Consent Withdrawn|0|||
163287730|NCT02430532|589760576|FG001|Overall Study|Consent Withdrawn|2|||
163287731|NCT02430532|589760575|FG000|Overall Study|Adverse Event|0|||
163287732|NCT02430532|589760576|FG001|Overall Study|Adverse Event|1|||
163287733|NCT04511650|589760577|FG000|Overall Study|Lost to Follow-up|1|||
163287734|NCT04511650|589760578|FG001|Overall Study|Lost to Follow-up|0|||
163287735|NCT04511650|589760579|FG002|Overall Study|Lost to Follow-up|0|||
163287736|NCT04511650|589760577|FG000|Overall Study|Withdrawal by Subject|1|||
163287737|NCT04511650|589760578|FG001|Overall Study|Withdrawal by Subject|0|||
163287738|NCT04511650|589760579|FG002|Overall Study|Withdrawal by Subject|0|||
163287739|NCT04511650|589760577|FG000|Overall Study|reason not provided|0|||
163287740|NCT04511650|589760578|FG001|Overall Study|reason not provided|0|||
163287741|NCT04511650|589760579|FG002|Overall Study|reason not provided|1|||
163287742|NCT04511650|589760577|FG000|Overall Study|Death|1|||
163287743|NCT04511650|589760578|FG001|Overall Study|Death|1|||
163287744|NCT04511650|589760579|FG002|Overall Study|Death|1|||
163287745|NCT02982213|589760580|FG000|Overall Study|Did not complete follow up questionnaire|5|||
163287746|NCT02982213|589760581|FG001|Overall Study|Did not complete follow up questionnaire|1|||
163287747|NCT03247543|589760583|FG000|Overall Study|Adverse Event|3|||
163287748|NCT03247543|589760584|FG001|Overall Study|Adverse Event|6|||
163287749|NCT03247543|589760585|FG002|Overall Study|Adverse Event|4|||
163287750|NCT03247543|589760583|FG000|Overall Study|Lost to Follow-up|10|||
163287751|NCT03247543|589760584|FG001|Overall Study|Lost to Follow-up|7|||
163287752|NCT03247543|589760585|FG002|Overall Study|Lost to Follow-up|8|||
163287753|NCT03247543|589760583|FG000|Overall Study|Consent withdrawn by caregiver|2|||
163287754|NCT03247543|589760584|FG001|Overall Study|Consent withdrawn by caregiver|2|||
163287755|NCT03247543|589760585|FG002|Overall Study|Consent withdrawn by caregiver|9|||
163287756|NCT03247543|589760583|FG000|Overall Study|Withdrawal by Subject|0|||
163287757|NCT03247543|589760584|FG001|Overall Study|Withdrawal by Subject|0|||
163287758|NCT03247543|589760585|FG002|Overall Study|Withdrawal by Subject|1|||
163287759|NCT03247543|589760583|FG000|Overall Study|Failure to Follow study procedures|1|||
163287760|NCT03247543|589760584|FG001|Overall Study|Failure to Follow study procedures|3|||
163287761|NCT03247543|589760585|FG002|Overall Study|Failure to Follow study procedures|1|||
163287762|NCT03247543|589760583|FG000|Overall Study|Lack of Efficacy|1|||
163287763|NCT03247543|589760584|FG001|Overall Study|Lack of Efficacy|0|||
163287764|NCT03247543|589760585|FG002|Overall Study|Lack of Efficacy|0|||
163287765|NCT03247543|589760583|FG000|Overall Study|Non-compliance with study visits|0|||
163287766|NCT03247543|589760584|FG001|Overall Study|Non-compliance with study visits|1|||
163287767|NCT03247543|589760585|FG002|Overall Study|Non-compliance with study visits|0|||
163287768|NCT01253226|589760587|FG000|Overall Study|Adverse Event|0|||
162937416|NCT02629965|588473621|FG000|Period 1|Other than listed above|1|||
162937417|NCT02629965|588473622|FG001|Period 1|Other than listed above|2|||
162937418|NCT02629965|588473621|FG000|Period 2|Adverse Event|1|||
162937419|NCT02629965|588473622|FG001|Period 2|Adverse Event|0|||
162937420|NCT03387059|588473626|FG000|Overall Study|Study termination|5|||
162937421|NCT03387059|588473627|FG001|Overall Study|Study termination|4|||
163182694|NCT01226043|589383937|FG003|6-week Re-randomization Phase|Adverse Event|1|||
163182695|NCT01226043|589383934|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
163182696|NCT01226043|589383935|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
163182697|NCT01226043|589383936|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
163182698|NCT01226043|589383937|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
163182699|NCT01226043|589383934|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
163182700|NCT01226043|589383935|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
163182701|NCT01226043|589383936|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
163182702|NCT01226043|589383937|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
163182703|NCT01226043|589383934|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
163182704|NCT01226043|589383935|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
163182705|NCT01226043|589383936|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
163182706|NCT01226043|589383937|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
163182707|NCT01226043|589383934|FG000|6-week Re-randomization Phase|Physician Decision|0|||
163182708|NCT01226043|589383935|FG001|6-week Re-randomization Phase|Physician Decision|0|||
163182709|NCT01226043|589383936|FG002|6-week Re-randomization Phase|Physician Decision|3|||
163182710|NCT01226043|589383937|FG003|6-week Re-randomization Phase|Physician Decision|2|||
163182711|NCT01226043|589383934|FG000|6-week Re-randomization Phase|completed in error|0|||
163182712|NCT01226043|589383935|FG001|6-week Re-randomization Phase|completed in error|0|||
163182713|NCT01226043|589383936|FG002|6-week Re-randomization Phase|completed in error|0|||
163182714|NCT01226043|589383937|FG003|6-week Re-randomization Phase|completed in error|1|||
163182715|NCT01226043|589383934|FG000|30-week Observational Phase|Adverse Event|0|||
163182716|NCT01226043|589383935|FG001|30-week Observational Phase|Adverse Event|0|||
163182717|NCT01226043|589383936|FG002|30-week Observational Phase|Adverse Event|1|||
163182718|NCT01226043|589383937|FG003|30-week Observational Phase|Adverse Event|1|||
163182719|NCT01226043|589383934|FG000|30-week Observational Phase|Protocol Violation|0|||
163182720|NCT01226043|589383935|FG001|30-week Observational Phase|Protocol Violation|0|||
163182721|NCT01226043|589383936|FG002|30-week Observational Phase|Protocol Violation|0|||
163182722|NCT01226043|589383937|FG003|30-week Observational Phase|Protocol Violation|1|||
163182723|NCT01226043|589383934|FG000|30-week Observational Phase|Lost to Follow-up|0|||
163182724|NCT01226043|589383935|FG001|30-week Observational Phase|Lost to Follow-up|0|||
163182725|NCT01226043|589383936|FG002|30-week Observational Phase|Lost to Follow-up|2|||
163182726|NCT01226043|589383937|FG003|30-week Observational Phase|Lost to Follow-up|2|||
163182727|NCT01226043|589383934|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
163182728|NCT01226043|589383935|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
163182729|NCT01226043|589383936|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
163182730|NCT01226043|589383937|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
163182731|NCT01226043|589383934|FG000|30-week Observational Phase|Physician Decision|0|||
163182732|NCT01226043|589383935|FG001|30-week Observational Phase|Physician Decision|0|||
163182733|NCT01226043|589383936|FG002|30-week Observational Phase|Physician Decision|2|||
163182734|NCT01226043|589383937|FG003|30-week Observational Phase|Physician Decision|2|||
163182735|NCT00510952|589383946|FG000|Overall Study|Adverse Event|1|||
163182736|NCT00510952|589383947|FG001|Overall Study|Adverse Event|0|||
163182737|NCT00510952|589383946|FG000|Overall Study|Entry Criteria Not Met|3|||
163182738|NCT00510952|589383947|FG001|Overall Study|Entry Criteria Not Met|1|||
163182739|NCT00510952|589383946|FG000|Overall Study|Lost to Follow-up|5|||
163182740|NCT00510952|589383947|FG001|Overall Study|Lost to Follow-up|3|||
163182741|NCT00510952|589383946|FG000|Overall Study|Physician Decision|1|||
163182742|NCT00510952|589383947|FG001|Overall Study|Physician Decision|1|||
163182743|NCT00510952|589383946|FG000|Overall Study|Protocol Violation|7|||
163182744|NCT00510952|589383947|FG001|Overall Study|Protocol Violation|4|||
163182745|NCT00510952|589383946|FG000|Overall Study|Sponsor Decision|1|||
163182746|NCT00510952|589383947|FG001|Overall Study|Sponsor Decision|0|||
163182747|NCT00510952|589383946|FG000|Overall Study|Withdrawal by Subject|6|||
163182748|NCT00510952|589383947|FG001|Overall Study|Withdrawal by Subject|7|||
163182749|NCT00510952|589383946|FG000|Overall Study|Did Not Receive Study Drug|2|||
163182750|NCT00510952|589383947|FG001|Overall Study|Did Not Receive Study Drug|0|||
163182751|NCT00596362|589383955|FG000|Overall Study|Progressive Disease|1|||
163182752|NCT00523367|589383956|FG000|Overall Study|19 screen failures|19|||
163182753|NCT00523367|589383956|FG000|Overall Study|4 Withdrawn by PI|4|||
163182754|NCT00055471|589383960|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
163182755|NCT00055471|589383961|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
163182756|NCT00055471|589383962|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
163182757|NCT00055471|589383960|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
163182758|NCT00055471|589383961|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
163182759|NCT00055471|589383962|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
163287769|NCT01253226|589760588|FG001|Overall Study|Adverse Event|0|||
163287770|NCT01253226|589760589|FG002|Overall Study|Adverse Event|1|||
163287771|NCT01253226|589760590|FG003|Overall Study|Adverse Event|0|||
163287772|NCT01253226|589760591|FG004|Overall Study|Adverse Event|0|||
163287773|NCT01253226|589760587|FG000|Overall Study|Death|0|||
163287774|NCT01253226|589760588|FG001|Overall Study|Death|1|||
163287775|NCT01253226|589760589|FG002|Overall Study|Death|0|||
163287776|NCT01253226|589760590|FG003|Overall Study|Death|0|||
163287777|NCT01253226|589760591|FG004|Overall Study|Death|0|||
163287778|NCT01253226|589760587|FG000|Overall Study|Physician Decision|0|||
163287779|NCT01253226|589760588|FG001|Overall Study|Physician Decision|0|||
163287780|NCT01253226|589760589|FG002|Overall Study|Physician Decision|0|||
163287781|NCT01253226|589760590|FG003|Overall Study|Physician Decision|0|||
163287782|NCT01253226|589760591|FG004|Overall Study|Physician Decision|2|||
163287783|NCT01253226|589760587|FG000|Overall Study|Withdrawal by Subject|0|||
163287784|NCT01253226|589760588|FG001|Overall Study|Withdrawal by Subject|0|||
163287785|NCT01253226|589760589|FG002|Overall Study|Withdrawal by Subject|0|||
163287786|NCT01253226|589760590|FG003|Overall Study|Withdrawal by Subject|1|||
163287787|NCT01253226|589760591|FG004|Overall Study|Withdrawal by Subject|0|||
163287788|NCT04075266|589760593|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
163287789|NCT04075266|589760594|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
163287790|NCT04075266|589760593|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
163287791|NCT04075266|589760594|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
163287792|NCT01726023|589760595|FG000|Overall Study|Death|1|||
163287793|NCT01726023|589760596|FG001|Overall Study|Death|1|||
163287794|NCT01726023|589760595|FG000|Overall Study|Lost to Follow-up|5|||
163287795|NCT01726023|589760596|FG001|Overall Study|Lost to Follow-up|10|||
163287796|NCT01726023|589760595|FG000|Overall Study|Other Eligibility criteria|7|||
163287797|NCT01726023|589760596|FG001|Overall Study|Other Eligibility criteria|7|||
163287798|NCT01726023|589760595|FG000|Overall Study|Withdrawal by Subject|16|||
163287799|NCT01726023|589760596|FG001|Overall Study|Withdrawal by Subject|8|||
163287800|NCT04858425|589760599|FG000|Overall Study|Adverse Event|2|||
163287801|NCT04858425|589760600|FG001|Overall Study|Adverse Event|2|||
163287802|NCT04858425|589760599|FG000|Overall Study|Withdrawal by Subject|3|||
163287803|NCT04858425|589760600|FG001|Overall Study|Withdrawal by Subject|1|||
163287804|NCT04858425|589760599|FG000|Overall Study|Lost to Follow-up|4|||
163287805|NCT04858425|589760600|FG001|Overall Study|Lost to Follow-up|2|||
163287806|NCT04858425|589760599|FG000|Overall Study|Lost to Follow-up|1|||
163287807|NCT04858425|589760600|FG001|Overall Study|Lost to Follow-up|0|||
163287808|NCT03473743|589760601|FG000|Overall Study|Withdrawal by Subject|0|||
163287809|NCT03473743|589760602|FG001|Overall Study|Withdrawal by Subject|0|||
163287810|NCT03473743|589760603|FG002|Overall Study|Withdrawal by Subject|0|||
163287811|NCT03473743|589760604|FG003|Overall Study|Withdrawal by Subject|0|||
163287812|NCT03473743|589760605|FG004|Overall Study|Withdrawal by Subject|0|||
163287813|NCT03473743|589760606|FG005|Overall Study|Withdrawal by Subject|0|||
163287814|NCT03473743|589760607|FG006|Overall Study|Withdrawal by Subject|0|||
163287815|NCT03473743|589760608|FG007|Overall Study|Withdrawal by Subject|3|||
163287816|NCT03473743|589760601|FG000|Overall Study|Other|0|||
163287817|NCT03473743|589760602|FG001|Overall Study|Other|0|||
163287818|NCT03473743|589760603|FG002|Overall Study|Other|0|||
163287819|NCT03473743|589760604|FG003|Overall Study|Other|1|||
163287820|NCT03473743|589760605|FG004|Overall Study|Other|0|||
163287821|NCT03473743|589760606|FG005|Overall Study|Other|0|||
163287822|NCT03473743|589760607|FG006|Overall Study|Other|0|||
163287823|NCT03473743|589760608|FG007|Overall Study|Other|0|||
163287824|NCT03473743|589760601|FG000|Overall Study|Ongoing|0|||
163287825|NCT03473743|589760602|FG001|Overall Study|Ongoing|0|||
163287826|NCT03473743|589760603|FG002|Overall Study|Ongoing|6|||
163287827|NCT03473743|589760604|FG003|Overall Study|Ongoing|8|||
163287828|NCT03473743|589760605|FG004|Overall Study|Ongoing|1|||
163287829|NCT03473743|589760606|FG005|Overall Study|Ongoing|1|||
163287830|NCT03473743|589760607|FG006|Overall Study|Ongoing|22|||
163287831|NCT03473743|589760608|FG007|Overall Study|Ongoing|24|||
163287832|NCT03473743|589760601|FG000|Overall Study|Randomized but not treated|0|||
163287833|NCT03473743|589760602|FG001|Overall Study|Randomized but not treated|0|||
163287834|NCT03473743|589760603|FG002|Overall Study|Randomized but not treated|0|||
163287835|NCT03473743|589760604|FG003|Overall Study|Randomized but not treated|0|||
163287836|NCT03473743|589760605|FG004|Overall Study|Randomized but not treated|0|||
163287837|NCT03473743|589760606|FG005|Overall Study|Randomized but not treated|0|||
163287838|NCT03473743|589760607|FG006|Overall Study|Randomized but not treated|1|||
163287839|NCT03473743|589760608|FG007|Overall Study|Randomized but not treated|1|||
163287840|NCT02864992|589760609|FG000|Overall Study|still on treatment|15|||
163287841|NCT02864992|589760610|FG001|Overall Study|still on treatment|1|||
163287842|NCT02864992|589760611|FG002|Overall Study|still on treatment|33|||
163287843|NCT04536077|589760613|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
163287844|NCT04536077|589760614|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
163287845|NCT04536077|589760613|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
163287846|NCT04536077|589760614|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
163287847|NCT04948333|589760615|FG000|Overall Study|Adverse Event|6|||
163287848|NCT04948333|589760616|FG001|Overall Study|Adverse Event|4|||
163287849|NCT04948333|589760617|FG002|Overall Study|Adverse Event|0|||
163287850|NCT04948333|589760618|FG003|Overall Study|Adverse Event|2|||
163287851|NCT04948333|589760615|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
163287852|NCT04948333|589760616|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
163287853|NCT04948333|589760617|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163287854|NCT04948333|589760618|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163287855|NCT04948333|589760615|FG000|Overall Study|Progressive Disease|1|||
163287856|NCT04948333|589760616|FG001|Overall Study|Progressive Disease|5|||
163287857|NCT04948333|589760617|FG002|Overall Study|Progressive Disease|0|||
163287858|NCT04948333|589760618|FG003|Overall Study|Progressive Disease|0|||
163287859|NCT04948333|589760615|FG000|Overall Study|Physician Decision|2|||
163287860|NCT04948333|589760616|FG001|Overall Study|Physician Decision|2|||
163287861|NCT04948333|589760617|FG002|Overall Study|Physician Decision|0|||
163287862|NCT04948333|589760618|FG003|Overall Study|Physician Decision|0|||
163287863|NCT04948333|589760615|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
163287864|NCT04948333|589760616|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
163287865|NCT04948333|589760617|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
163287866|NCT04948333|589760618|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
163287867|NCT04948333|589760615|FG000|Overall Study|Withdrawal by Subject|2|||
163287868|NCT04948333|589760616|FG001|Overall Study|Withdrawal by Subject|0|||
163287869|NCT04948333|589760617|FG002|Overall Study|Withdrawal by Subject|0|||
163287870|NCT04948333|589760618|FG003|Overall Study|Withdrawal by Subject|1|||
163287871|NCT04948333|589760615|FG000|Overall Study|Protocol Violation|0|||
163287872|NCT04948333|589760616|FG001|Overall Study|Protocol Violation|1|||
163287873|NCT04948333|589760617|FG002|Overall Study|Protocol Violation|0|||
163287874|NCT04948333|589760618|FG003|Overall Study|Protocol Violation|0|||
163287875|NCT04948333|589760615|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
163287876|NCT04948333|589760616|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
163287877|NCT04948333|589760617|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
163287878|NCT04948333|589760618|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
163287879|NCT03805295|589760620|FG000|Overall Study|Lost to Follow-up|17|||
163287880|NCT03805295|589760621|FG001|Overall Study|Lost to Follow-up|43|||
163287881|NCT00539591|589760622|FG000|Overall Study|Toxicity|3|||
163287882|NCT00539591|589760623|FG001|Overall Study|Toxicity|0|||
163287883|NCT00539591|589760624|FG002|Overall Study|Toxicity|0|||
163287884|NCT00539591|589760622|FG000|Overall Study|Disease progression|2|||
163287885|NCT00539591|589760623|FG001|Overall Study|Disease progression|2|||
163287886|NCT00539591|589760624|FG002|Overall Study|Disease progression|3|||
163287887|NCT04305912|589760626|FG000|First Intervention|COVID-19 Suspension|2|||
163287888|NCT04305912|589760627|FG001|First Intervention|COVID-19 Suspension|0|||
163287889|NCT04305912|589760626|FG000|First Intervention|Withdrawal by Subject|0|||
163287890|NCT04305912|589760627|FG001|First Intervention|Withdrawal by Subject|1|||
163287891|NCT04305912|589760626|FG000|Second Intervention|Adverse Event|0|||
163287892|NCT04305912|589760627|FG001|Second Intervention|Adverse Event|1|||
163287893|NCT01155869|589760633|FG000|Overall Study|Lost to Follow-up|3|||
163287894|NCT01155869|589760634|FG001|Overall Study|Lost to Follow-up|1|||
163287895|NCT04538664|589760638|FG000|Overall Study|Withdrawal by Subject|5|||
163287896|NCT04538664|589760639|FG001|Overall Study|Withdrawal by Subject|9|||
163287897|NCT04538664|589760638|FG000|Overall Study|Lost to Follow-up|2|||
163287898|NCT04538664|589760639|FG001|Overall Study|Lost to Follow-up|1|||
163287899|NCT04538664|589760638|FG000|Overall Study|Ongoing|106|||
163287900|NCT04538664|589760639|FG001|Overall Study|Ongoing|115|||
163287901|NCT03681678|589760640|FG000|Overall Study|Lost to Follow-up|20|||
163287902|NCT00828945|589760643|FG000|Overall Study|Death|4|||
163287903|NCT00828945|589760643|FG000|Overall Study|Participant was missing|1|||
163287904|NCT00828945|589760643|FG000|Overall Study|Other|36|||
163287905|NCT02141074|589760644|FG000|Pre-prophylaxis|Adverse Event|3|||
163287906|NCT02141074|589760645|FG001|Pre-prophylaxis|Adverse Event|0|||
163287907|NCT02141074|589760644|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
163287908|NCT02141074|589760645|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
163287909|NCT02141074|589760644|FG000|Prophylaxis|Adverse Event|0|||
163287910|NCT02141074|589760645|FG001|Prophylaxis|Adverse Event|4|||
163287911|NCT02141074|589760644|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
163287912|NCT02141074|589760645|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
163287913|NCT02141074|589760644|FG000|Prophylaxis|Withdrawal by Subject|0|||
163287914|NCT02141074|589760645|FG001|Prophylaxis|Withdrawal by Subject|1|||
163287915|NCT03563053|589760646|FG000|Overall Study|Withdrawal by Subject|17|||
163287916|NCT03563053|589760646|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
163287917|NCT03563053|589760646|FG000|Overall Study|Adverse Event|3|||
163287918|NCT03563053|589760646|FG000|Overall Study|Physician Decision|1|||
163287919|NCT03563053|589760646|FG000|Overall Study|study terminated by sponsor|71|||
163287920|NCT03536884|589760647|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
163287921|NCT03536884|589760648|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
163287922|NCT03536884|589760649|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163287923|NCT03536884|589760650|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163287924|NCT03536884|589760651|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163287925|NCT03536884|589760652|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163287926|NCT03536884|589760653|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163287927|NCT03536884|589760654|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163287928|NCT03536884|589760655|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163287929|NCT03536884|589760656|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163287930|NCT03536884|589760657|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163287931|NCT03536884|589760658|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163287932|NCT03536884|589760647|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163287933|NCT03536884|589760648|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
163287934|NCT03536884|589760649|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163287935|NCT03536884|589760650|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162937422|NCT01606137|588473628|FG000|Overall Study|Adverse Event|85|||
162937423|NCT01606137|588473628|FG000|Overall Study|Withdrawal by Subject|74|||
162937424|NCT01606137|588473628|FG000|Overall Study|Lack of Efficacy|56|||
163287936|NCT03536884|589760651|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163287937|NCT03536884|589760652|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163287938|NCT03536884|589760653|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163287939|NCT03536884|589760654|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163287940|NCT03536884|589760655|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163287941|NCT03536884|589760656|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163287942|NCT03536884|589760657|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163287943|NCT03536884|589760658|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163287944|NCT03536884|589760647|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
163287945|NCT03536884|589760648|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
163287946|NCT03536884|589760649|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163287947|NCT03536884|589760650|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163287948|NCT03536884|589760651|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163287949|NCT03536884|589760652|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163287950|NCT03536884|589760653|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163287951|NCT03536884|589760654|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163287952|NCT03536884|589760655|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163287953|NCT03536884|589760656|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163287954|NCT03536884|589760657|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163287955|NCT03536884|589760658|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163287956|NCT03536884|589760647|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163287957|NCT03536884|589760648|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
163287958|NCT03536884|589760649|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163287959|NCT03536884|589760650|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163287960|NCT03536884|589760651|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163287961|NCT03536884|589760652|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163287962|NCT03536884|589760653|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163287963|NCT03536884|589760654|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163287964|NCT03536884|589760655|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163287965|NCT03536884|589760656|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163287966|NCT03536884|589760657|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162937425|NCT01606137|588473628|FG000|Overall Study|Lost to Follow-up|15|||
162937426|NCT01606137|588473628|FG000|Overall Study|Protocol Violation|1|||
162937427|NCT01606137|588473628|FG000|Overall Study|Patient non-compliance|9|||
162937428|NCT01606137|588473628|FG000|Overall Study|Death|1|||
162937429|NCT01606137|588473628|FG000|Overall Study|Decreased/no pain|4|||
163287967|NCT03536884|589760658|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163287968|NCT03536884|589760647|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163182760|NCT00055471|589383960|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
163182761|NCT00055471|589383961|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
163182762|NCT00055471|589383962|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
163182763|NCT01854944|589383963|FG000|Overall Study|Withdrawal by Subject|0|||
163182764|NCT01854944|589383964|FG001|Overall Study|Withdrawal by Subject|0|||
163182765|NCT01854944|589383965|FG002|Overall Study|Withdrawal by Subject|1|||
163182766|NCT02782923|589383968|FG000|Overall Study|Lost to Follow-up|15|||
163182767|NCT02418156|589383969|FG000|Overall Study|Lost to Follow-up|12|||
163182768|NCT02418156|589383969|FG000|Overall Study|Death|2|||
163182769|NCT02418156|589383969|FG000|Overall Study|Physician Decision|1|||
163182770|NCT02418156|589383969|FG000|Overall Study|Withdrawal by Subject|1|||
163182771|NCT02418156|589383969|FG000|Overall Study|Subject refused to return|1|||
163182772|NCT00323869|589383974|FG000|Overall Study|Death|1|||
163182773|NCT01751802|589385871|FG000|Overall Study|Adverse Event|4|||
163182774|NCT01751802|589385872|FG001|Overall Study|Adverse Event|2|||
163182775|NCT00608543|589385873|FG000|Overall Study|Adverse Event|4|||
163182776|NCT01869725|589385874|FG000|Overall Study|ineligible after registration|1|||
163182777|NCT01869725|589385874|FG000|Overall Study|Death|1|||
163182778|NCT01869725|589385874|FG000|Overall Study|Lost to Follow-up|2|||
163182779|NCT03416374|589385875|FG000|Between Treatment Period I and II|Other|0|||
163182780|NCT03416374|589385876|FG001|Between Treatment Period I and II|Other|9|||
163182781|NCT03416374|589385875|FG000|Treatment Period II|Lack of Efficacy|3|||
163182782|NCT03416374|589385876|FG001|Treatment Period II|Lack of Efficacy|11|||
163182783|NCT03416374|589385875|FG000|Treatment Period II|Adverse Event|1|||
163182784|NCT03416374|589385876|FG001|Treatment Period II|Adverse Event|4|||
163182785|NCT03416374|589385875|FG000|Treatment Period II|Death|0|||
163182786|NCT03416374|589385876|FG001|Treatment Period II|Death|1|||
163182787|NCT03416374|589385875|FG000|Treatment Period II|Other|0|||
163182788|NCT03416374|589385876|FG001|Treatment Period II|Other|2|||
163182789|NCT01025154|589385879|FG000|Overall Study|Lost to Follow-up|1|||
163182790|NCT01025154|589385879|FG000|Overall Study|Withdrawal by Subject|1|||
163182791|NCT01251744|589385880|FG000|Overall Study|Lost to Follow-up|1|||
163182792|NCT01251744|589385881|FG001|Overall Study|Lost to Follow-up|0|||
163182793|NCT00417482|589385882|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
163182794|NCT00417482|589385883|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
163182795|NCT00417482|589385884|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
163182796|NCT00417482|589385882|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
163182797|NCT00417482|589385883|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
163182798|NCT00417482|589385884|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
163182799|NCT00417482|589385882|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
163182800|NCT00417482|589385883|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
163182801|NCT00417482|589385884|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
163182802|NCT00417482|589385882|FG000|Phase B 1st 16 Weeks|Death|1|||
163182803|NCT00417482|589385883|FG001|Phase B 1st 16 Weeks|Death|0|||
163182804|NCT00417482|589385884|FG002|Phase B 1st 16 Weeks|Death|0|||
163182805|NCT00417482|589385882|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
163182806|NCT00417482|589385883|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
163182807|NCT00417482|589385884|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
163182808|NCT00417482|589385882|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
163182809|NCT00417482|589385883|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
163182810|NCT00417482|589385884|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
163182811|NCT00417482|589385882|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
163182812|NCT00417482|589385883|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
163182813|NCT00417482|589385884|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
163182814|NCT00417482|589385882|FG000|Phase B 2nd 16 Weeks|Death|1|||
163182815|NCT00417482|589385883|FG001|Phase B 2nd 16 Weeks|Death|1|||
163182816|NCT00417482|589385884|FG002|Phase B 2nd 16 Weeks|Death|0|||
163182817|NCT01323946|589385885|FG000|Overall Study|Lost to Follow-up|0|||
163182818|NCT01323946|589385886|FG001|Overall Study|Lost to Follow-up|1|||
163182819|NCT01323946|589385887|FG002|Overall Study|Lost to Follow-up|0|||
163182820|NCT01323946|589385885|FG000|Overall Study|Parents refused the last blood draw|1|||
163182821|NCT01323946|589385886|FG001|Overall Study|Parents refused the last blood draw|0|||
162937430|NCT01606137|588473628|FG000|Overall Study|Issues with driving|4|||
163182822|NCT01323946|589385887|FG002|Overall Study|Parents refused the last blood draw|0|||
163182823|NCT01323946|589385885|FG000|Overall Study|Withdrawal by Subject|2|||
163182824|NCT01323946|589385886|FG001|Overall Study|Withdrawal by Subject|2|||
163182825|NCT01323946|589385887|FG002|Overall Study|Withdrawal by Subject|0|||
163182826|NCT00107952|589385889|FG000|Overall Study|Death|75|||
163182827|NCT00107952|589385890|FG001|Overall Study|Death|61|||
163182828|NCT00107952|589385889|FG000|Overall Study|Lost to Follow-up|0|||
163182829|NCT00107952|589385890|FG001|Overall Study|Lost to Follow-up|3|||
163182830|NCT00107952|589385889|FG000|Overall Study|Withdrawal by Subject|9|||
163182831|NCT00107952|589385890|FG001|Overall Study|Withdrawal by Subject|6|||
163182832|NCT00107952|589385889|FG000|Overall Study|Other|2|||
163182833|NCT00107952|589385890|FG001|Overall Study|Other|5|||
163182834|NCT00107952|589385889|FG000|Overall Study|Never received study treatment|9|||
163182835|NCT00107952|589385890|FG001|Overall Study|Never received study treatment|6|||
163182836|NCT00251004|589385891|FG000|Overall Study|Withdrawal by Subject|23|||
163182837|NCT00251004|589385892|FG001|Overall Study|Withdrawal by Subject|16|||
163182838|NCT00251004|589385893|FG002|Overall Study|Withdrawal by Subject|14|||
163182839|NCT00251004|589385891|FG000|Overall Study|Death|9|||
163182840|NCT00251004|589385892|FG001|Overall Study|Death|10|||
163182841|NCT00251004|589385893|FG002|Overall Study|Death|8|||
163182842|NCT00251004|589385891|FG000|Overall Study|Lost to Follow-up|1|||
163182843|NCT00251004|589385892|FG001|Overall Study|Lost to Follow-up|2|||
163182844|NCT00251004|589385893|FG002|Overall Study|Lost to Follow-up|1|||
163182845|NCT00251004|589385891|FG000|Overall Study|Graft Loss|12|||
163182846|NCT00251004|589385892|FG001|Overall Study|Graft Loss|13|||
163182847|NCT00251004|589385893|FG002|Overall Study|Graft Loss|8|||
163182848|NCT00887744|589385894|FG000|Overall Study|Adverse Event|3|||
163182849|NCT00887744|589385894|FG000|Overall Study|Death|1|||
163182850|NCT00887744|589385894|FG000|Overall Study|Lost to Follow-up|3|||
163182851|NCT00887744|589385894|FG000|Overall Study|Withdrawal by Subject|18|||
163182852|NCT00887744|589385894|FG000|Overall Study|Various reasons|9|||
163182853|NCT01569464|589385895|FG000|Overall Study|Adverse Event|4|||
163182854|NCT01569464|589385896|FG001|Overall Study|Adverse Event|0|||
163182855|NCT01569464|589385895|FG000|Overall Study|Lack of Efficacy|1|||
163182856|NCT01569464|589385896|FG001|Overall Study|Lack of Efficacy|0|||
163182857|NCT01569464|589385895|FG000|Overall Study|Protocol Violation|1|||
163182858|NCT01569464|589385896|FG001|Overall Study|Protocol Violation|0|||
163182859|NCT01569464|589385895|FG000|Overall Study|Lost to Follow-up|2|||
163182860|NCT01569464|589385896|FG001|Overall Study|Lost to Follow-up|3|||
163182861|NCT01569464|589385895|FG000|Overall Study|Withdrawal by Subject|1|||
163182862|NCT01569464|589385896|FG001|Overall Study|Withdrawal by Subject|1|||
163182863|NCT01569464|589385895|FG000|Overall Study|Other|1|||
163182864|NCT01569464|589385896|FG001|Overall Study|Other|1|||
163182865|NCT03533686|589385897|FG000|Overall Study|Withdrawal by Subject|1|||
163182866|NCT03533686|589385898|FG001|Overall Study|Withdrawal by Subject|0|||
163182867|NCT03533686|589385899|FG002|Overall Study|Withdrawal by Subject|0|||
163182868|NCT03533686|589385900|FG003|Overall Study|Withdrawal by Subject|3|||
163182869|NCT03533686|589385901|FG004|Overall Study|Withdrawal by Subject|5|||
163182870|NCT03533686|589385902|FG005|Overall Study|Withdrawal by Subject|1|||
163182871|NCT03533686|589385897|FG000|Overall Study|Lost to Follow-up|0|||
163182872|NCT03533686|589385898|FG001|Overall Study|Lost to Follow-up|1|||
163182873|NCT03533686|589385899|FG002|Overall Study|Lost to Follow-up|0|||
163182874|NCT03533686|589385900|FG003|Overall Study|Lost to Follow-up|0|||
163182875|NCT03533686|589385901|FG004|Overall Study|Lost to Follow-up|2|||
163182876|NCT03533686|589385902|FG005|Overall Study|Lost to Follow-up|0|||
163182877|NCT03533686|589385897|FG000|Overall Study|Screen Failure|0|||
163182878|NCT03533686|589385898|FG001|Overall Study|Screen Failure|0|||
163182879|NCT03533686|589385899|FG002|Overall Study|Screen Failure|0|||
163182880|NCT03533686|589385900|FG003|Overall Study|Screen Failure|2|||
163182881|NCT03533686|589385901|FG004|Overall Study|Screen Failure|0|||
163182882|NCT03533686|589385902|FG005|Overall Study|Screen Failure|0|||
163182883|NCT02632838|589385903|FG000|Overall Study|Withdrawal by Subject|3|||
163182884|NCT02632838|589385904|FG001|Overall Study|Withdrawal by Subject|0|||
163182885|NCT02632838|589385903|FG000|Overall Study|Lost to Follow-up|0|||
163182886|NCT02632838|589385904|FG001|Overall Study|Lost to Follow-up|2|||
163182887|NCT01562873|589385908|FG000|Overall Study|Disease Progression per RECIST|10|||
163182888|NCT01562873|589385909|FG001|Overall Study|Disease Progression per RECIST|0|||
163182889|NCT01562873|589385908|FG000|Overall Study|Adverse Event|1|||
163182890|NCT01562873|589385909|FG001|Overall Study|Adverse Event|0|||
163182891|NCT01562873|589385908|FG000|Overall Study|Clinical Disease Progression|9|||
163182892|NCT01562873|589385909|FG001|Overall Study|Clinical Disease Progression|0|||
163182893|NCT01562873|589385908|FG000|Overall Study|Clinical PD and adverse event|1|||
163182894|NCT01562873|589385909|FG001|Overall Study|Clinical PD and adverse event|0|||
162937431|NCT01606137|588473628|FG000|Overall Study|multiple sclerosis less stable|1|||
163182895|NCT03370289|589385914|FG000|Overall Study|Screen Failure|1|||
163182896|NCT03370289|589385914|FG000|Overall Study|Sample Size Sufficient|4|||
163182897|NCT02140775|589385916|FG000|Overall Study|Withdrawal by Subject|30|||
163182898|NCT02140775|589385917|FG001|Overall Study|Withdrawal by Subject|7|||
163182899|NCT00938964|589385919|FG000|Overall Study|Death|3|||
163182900|NCT00938964|589385920|FG001|Overall Study|Death|3|||
163182901|NCT00938964|589385919|FG000|Overall Study|Lost to Follow-up|2|||
163182902|NCT00938964|589385920|FG001|Overall Study|Lost to Follow-up|3|||
163182903|NCT00938964|589385919|FG000|Overall Study|Withdrawal by Subject|22|||
163182904|NCT00938964|589385920|FG001|Overall Study|Withdrawal by Subject|18|||
163182905|NCT00938964|589385919|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
163182906|NCT00938964|589385920|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
163182907|NCT01858636|589385921|FG000|Overall Study|No Device Deployment Attempted|24|||
163182908|NCT01858636|589385921|FG000|Overall Study|Physician Decision|1|||
163182909|NCT01858636|589385921|FG000|Overall Study|Death|1|||
163182910|NCT01858636|589385921|FG000|Overall Study|Lost to Follow-up|1|||
163182911|NCT01858636|589385921|FG000|Overall Study|Withdrawal by Subject|1|||
163182912|NCT01227564|589385925|FG000|Overall Study|No Longer Willing to Participate|4|||
163182913|NCT01227564|589385926|FG001|Overall Study|No Longer Willing to Participate|2|||
163182914|NCT01227564|589385927|FG002|Overall Study|No Longer Willing to Participate|5|||
163182915|NCT01227564|589385925|FG000|Overall Study|Participant moved to another town|0|||
163182916|NCT01227564|589385926|FG001|Overall Study|Participant moved to another town|0|||
163182917|NCT01227564|589385927|FG002|Overall Study|Participant moved to another town|1|||
163182918|NCT00999921|589385943|FG000|Overall Study|Lost to Follow-up|10|||
163182919|NCT00999921|589385944|FG001|Overall Study|Lost to Follow-up|19|||
163182920|NCT04650854|589385945|FG000|Overall Study|Adverse Event|1|||
163182921|NCT04650854|589385946|FG001|Overall Study|Adverse Event|12|||
163182922|NCT04650854|589385947|FG002|Overall Study|Adverse Event|14|||
163182923|NCT04650854|589385945|FG000|Overall Study|Lack of Efficacy|1|||
163182924|NCT04650854|589385946|FG001|Overall Study|Lack of Efficacy|3|||
163182925|NCT04650854|589385947|FG002|Overall Study|Lack of Efficacy|6|||
163182926|NCT04650854|589385945|FG000|Overall Study|Lost to Follow-up|1|||
163182927|NCT04650854|589385946|FG001|Overall Study|Lost to Follow-up|1|||
163182928|NCT04650854|589385947|FG002|Overall Study|Lost to Follow-up|0|||
163182929|NCT04650854|589385945|FG000|Overall Study|Withdrawal by Subject|2|||
163182930|NCT04650854|589385946|FG001|Overall Study|Withdrawal by Subject|17|||
163182931|NCT04650854|589385947|FG002|Overall Study|Withdrawal by Subject|9|||
163182932|NCT04650854|589385945|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
163182933|NCT04650854|589385946|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
163182934|NCT04650854|589385947|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
163182935|NCT04650854|589385945|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
163182936|NCT04650854|589385946|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
163182937|NCT04650854|589385947|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
163182938|NCT04650854|589385945|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
163182939|NCT04650854|589385946|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
163182940|NCT04650854|589385947|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
163182941|NCT04650854|589385945|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
163182942|NCT04650854|589385946|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
163182943|NCT04650854|589385947|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
163182944|NCT04650854|589385945|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
163182945|NCT04650854|589385946|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
163182946|NCT04650854|589385947|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
163182947|NCT04650854|589385945|FG000|Overall Study|Use of Rescue Medication|0|||
163182948|NCT04650854|589385946|FG001|Overall Study|Use of Rescue Medication|0|||
163182949|NCT04650854|589385947|FG002|Overall Study|Use of Rescue Medication|1|||
163182950|NCT04650854|589385945|FG000|Overall Study|Last Treatment Per Sponsor|0|||
163182951|NCT04650854|589385946|FG001|Overall Study|Last Treatment Per Sponsor|0|||
163182952|NCT04650854|589385947|FG002|Overall Study|Last Treatment Per Sponsor|2|||
163182953|NCT04650854|589385945|FG000|Overall Study|Rescue Medication|0|||
163182954|NCT04650854|589385946|FG001|Overall Study|Rescue Medication|0|||
163182955|NCT04650854|589385947|FG002|Overall Study|Rescue Medication|1|||
163182956|NCT04650854|589385945|FG000|Overall Study|Participant Want to Start a Family|0|||
163182957|NCT04650854|589385946|FG001|Overall Study|Participant Want to Start a Family|0|||
163182958|NCT04650854|589385947|FG002|Overall Study|Participant Want to Start a Family|1|||
163182959|NCT04650854|589385945|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
163182960|NCT04650854|589385946|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
163182961|NCT04650854|589385947|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
163182962|NCT04650854|589385945|FG000|Overall Study|Participant Screened For MG0020|0|||
163182963|NCT04650854|589385946|FG001|Overall Study|Participant Screened For MG0020|2|||
163182964|NCT04650854|589385947|FG002|Overall Study|Participant Screened For MG0020|3|||
163182965|NCT04650854|589385945|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
163182966|NCT04650854|589385946|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
163182967|NCT04650854|589385947|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
163182968|NCT04650854|589385945|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
163182969|NCT04650854|589385946|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
163182970|NCT04650854|589385947|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
163182971|NCT04650854|589385945|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
163182972|NCT04650854|589385946|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
163182973|NCT04650854|589385947|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
163182974|NCT04650854|589385945|FG000|Overall Study|End Of Study|0|||
163182975|NCT04650854|589385946|FG001|Overall Study|End Of Study|2|||
163287969|NCT03536884|589760648|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
163287970|NCT03536884|589760649|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163287971|NCT03536884|589760650|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163287972|NCT03536884|589760651|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163287973|NCT03536884|589760652|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163287974|NCT03536884|589760653|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162937432|NCT01606137|588473628|FG000|Overall Study|Increased bilirubin|1|||
163182976|NCT04650854|589385947|FG002|Overall Study|End Of Study|1|||
163287975|NCT03536884|589760654|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163287976|NCT03536884|589760655|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163287977|NCT03536884|589760656|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163287978|NCT03536884|589760657|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163287979|NCT03536884|589760658|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163287980|NCT03536884|589760647|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163287981|NCT03536884|589760648|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
163287982|NCT03536884|589760649|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163287983|NCT03536884|589760650|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163287984|NCT03536884|589760651|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163287985|NCT03536884|589760652|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163182977|NCT04650854|589385945|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
163182978|NCT04650854|589385946|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
163182979|NCT04650854|589385947|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
163182980|NCT04650854|589385945|FG000|Overall Study|Participant Received Rescue Medication|0|||
163182981|NCT04650854|589385946|FG001|Overall Study|Participant Received Rescue Medication|1|||
163182982|NCT04650854|589385947|FG002|Overall Study|Participant Received Rescue Medication|0|||
163182983|NCT04650854|589385945|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
163182984|NCT04650854|589385946|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
163182985|NCT04650854|589385947|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
163182986|NCT04650854|589385945|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
163182987|NCT04650854|589385946|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
163182988|NCT04650854|589385947|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
163182989|NCT04650854|589385945|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
163182990|NCT04650854|589385946|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
163182991|NCT04650854|589385947|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
163182992|NCT04650854|589385945|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
163182993|NCT04650854|589385946|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
163182994|NCT04650854|589385947|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
163182995|NCT04650854|589385945|FG000|Overall Study|Enrollment Cup|0|||
163182996|NCT04650854|589385946|FG001|Overall Study|Enrollment Cup|0|||
163182997|NCT04650854|589385947|FG002|Overall Study|Enrollment Cup|1|||
163182998|NCT00704808|589385962|FG000|Overall Study|Discontinued prior to starting treatment|14|||
163182999|NCT00704808|589385962|FG000|Overall Study|Death|7|||
163183000|NCT00704808|589385962|FG000|Overall Study|Tumor progression|80|||
163183001|NCT00704808|589385962|FG000|Overall Study|Patient's decision|11|||
163183002|NCT00704808|589385962|FG000|Overall Study|Early therapy discontinuation|16|||
163183003|NCT00704808|589385962|FG000|Overall Study|Adverse Event|1|||
163183004|NCT00704808|589385962|FG000|Overall Study|Lost to Follow-up|1|||
163183005|NCT00704808|589385962|FG000|Overall Study|Treatment change|1|||
163183006|NCT01982331|589385971|FG000|Received Vaccination 2|Adverse Event|1|||
163183007|NCT01982331|589385972|FG001|Received Vaccination 2|Adverse Event|2|||
163183008|NCT01982331|589385971|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
163183009|NCT01982331|589385972|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
163183010|NCT01982331|589385971|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
163183011|NCT01982331|589385972|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
163183012|NCT03500679|589385973|FG000|Overall Study|Lost to Follow-up|6|||
163183013|NCT03500679|589385974|FG001|Overall Study|Lost to Follow-up|3|||
163183014|NCT03500679|589385973|FG000|Overall Study|Withdrawal by Subject|3|||
163183015|NCT03500679|589385974|FG001|Overall Study|Withdrawal by Subject|0|||
163183016|NCT00744471|589385976|FG000|Overall Study|Randomized but not treated|1|||
163183017|NCT00744471|589385977|FG001|Overall Study|Randomized but not treated|1|||
163183018|NCT00744471|589385978|FG002|Overall Study|Randomized but not treated|4|||
163183019|NCT00744471|589385979|FG003|Overall Study|Randomized but not treated|0|||
163183020|NCT00744471|589385976|FG000|Overall Study|Death|0|||
163183021|NCT00744471|589385977|FG001|Overall Study|Death|0|||
163183022|NCT00744471|589385978|FG002|Overall Study|Death|0|||
163183023|NCT00744471|589385979|FG003|Overall Study|Death|1|||
163183024|NCT00744471|589385976|FG000|Overall Study|Adverse Event|6|||
163287986|NCT03536884|589760653|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163287987|NCT03536884|589760654|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163287988|NCT03536884|589760655|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163287989|NCT03536884|589760656|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163287990|NCT03536884|589760657|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163287991|NCT03536884|589760658|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163287992|NCT03536884|589760647|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
163287993|NCT03536884|589760648|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
163287994|NCT03536884|589760649|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
163287995|NCT03536884|589760650|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
163287996|NCT03536884|589760651|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
163287997|NCT03536884|589760652|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
163287998|NCT03536884|589760653|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
162937433|NCT01606137|588473628|FG000|Overall Study|Spray causes nausea|1|||
162937434|NCT01606137|588473628|FG000|Overall Study|Not enough improvement|4|||
162937435|NCT01606137|588473628|FG000|Overall Study|Wanted to try another treatment|1|||
162937436|NCT01606137|588473628|FG000|Overall Study|Patient leaving country|1|||
162937437|NCT01606137|588473628|FG000|Overall Study|Personal reasons|1|||
162937438|NCT01606137|588473628|FG000|Overall Study|Unable to tolerate study med. taste|1|||
162937439|NCT01606137|588473628|FG000|Overall Study|Patient moving|1|||
163287999|NCT03536884|589760654|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
163288000|NCT03536884|589760655|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
163288001|NCT03536884|589760656|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
163288002|NCT03536884|589760657|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
163288003|NCT03536884|589760658|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
163288004|NCT03536884|589760647|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163288005|NCT03536884|589760648|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163288006|NCT03536884|589760649|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
163288007|NCT03536884|589760650|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
163288008|NCT03536884|589760651|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
163288009|NCT03536884|589760652|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163288010|NCT03536884|589760653|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163288011|NCT03536884|589760654|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163288012|NCT03536884|589760655|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163288013|NCT03536884|589760656|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163288014|NCT03536884|589760657|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163288015|NCT03536884|589760658|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163288016|NCT03536884|589760647|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163288017|NCT03536884|589760648|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163288018|NCT03536884|589760649|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163288019|NCT03536884|589760650|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
163288020|NCT03536884|589760651|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
163288021|NCT03536884|589760652|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163288022|NCT03536884|589760653|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163288023|NCT03536884|589760654|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163288024|NCT03536884|589760655|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163288025|NCT03536884|589760656|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163288026|NCT03536884|589760657|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163288027|NCT03536884|589760658|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163288028|NCT03536884|589760647|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163288029|NCT03536884|589760648|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163288030|NCT03536884|589760649|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
163288031|NCT03536884|589760650|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
163288032|NCT03536884|589760651|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
163288033|NCT03536884|589760652|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163288034|NCT03536884|589760653|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163288035|NCT03536884|589760654|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163288036|NCT03536884|589760655|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163288037|NCT03536884|589760656|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163288038|NCT03536884|589760657|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163288039|NCT03536884|589760658|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163288040|NCT03536884|589760647|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163288041|NCT03536884|589760648|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163288042|NCT03536884|589760649|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
163288043|NCT03536884|589760650|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
163288044|NCT03536884|589760651|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
163288045|NCT03536884|589760652|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163288046|NCT03536884|589760653|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163288047|NCT03536884|589760654|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163288048|NCT03536884|589760655|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163288049|NCT03536884|589760656|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163288050|NCT03536884|589760657|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163183025|NCT00744471|589385977|FG001|Overall Study|Adverse Event|7|||
163183026|NCT00744471|589385978|FG002|Overall Study|Adverse Event|5|||
162937440|NCT01606137|588473628|FG000|Overall Study|Unable to collect consistent data|1|||
162937441|NCT05028751|588473638|FG000|Overall Study|Study Terminated by Sponsor|3|||
162937442|NCT05028751|588473639|FG001|Overall Study|Study Terminated by Sponsor|0|||
162937443|NCT05028751|588473640|FG002|Overall Study|Study Terminated by Sponsor|0|||
162937444|NCT05028751|588473641|FG003|Overall Study|Study Terminated by Sponsor|0|||
162937445|NCT05028751|588473638|FG000|Overall Study|Death|9|||
162937446|NCT05028751|588473639|FG001|Overall Study|Death|3|||
163183027|NCT00744471|589385979|FG003|Overall Study|Adverse Event|9|||
163183028|NCT00744471|589385976|FG000|Overall Study|Withdrawal by Subject|9|||
163183029|NCT00744471|589385977|FG001|Overall Study|Withdrawal by Subject|9|||
163183030|NCT00744471|589385978|FG002|Overall Study|Withdrawal by Subject|15|||
163183031|NCT00744471|589385979|FG003|Overall Study|Withdrawal by Subject|12|||
163183032|NCT00744471|589385976|FG000|Overall Study|Protocol Violation|1|||
163183033|NCT00744471|589385977|FG001|Overall Study|Protocol Violation|4|||
163183034|NCT00744471|589385978|FG002|Overall Study|Protocol Violation|1|||
163183035|NCT00744471|589385979|FG003|Overall Study|Protocol Violation|2|||
163183036|NCT00744471|589385976|FG000|Overall Study|Entered extension study|41|||
163183037|NCT00744471|589385977|FG001|Overall Study|Entered extension study|84|||
163183038|NCT00744471|589385978|FG002|Overall Study|Entered extension study|100|||
163183039|NCT00744471|589385979|FG003|Overall Study|Entered extension study|91|||
163183040|NCT00744471|589385976|FG000|Overall Study|Other|2|||
163183041|NCT00744471|589385977|FG001|Overall Study|Other|3|||
163183042|NCT00744471|589385978|FG002|Overall Study|Other|6|||
163183043|NCT00744471|589385979|FG003|Overall Study|Other|2|||
163183044|NCT00744471|589385976|FG000|Overall Study|Lack of Efficacy|83|||
163183045|NCT00744471|589385977|FG001|Overall Study|Lack of Efficacy|37|||
163183046|NCT00744471|589385978|FG002|Overall Study|Lack of Efficacy|19|||
163183047|NCT00744471|589385979|FG003|Overall Study|Lack of Efficacy|31|||
163183048|NCT00744471|589385976|FG000|Overall Study|Lost to Follow-up|0|||
163183049|NCT00744471|589385977|FG001|Overall Study|Lost to Follow-up|0|||
163183050|NCT00744471|589385978|FG002|Overall Study|Lost to Follow-up|2|||
163183051|NCT00744471|589385979|FG003|Overall Study|Lost to Follow-up|0|||
163183052|NCT04706416|589385982|FG000|Overall Study|Lost to Follow-up|2|||
163183053|NCT04706416|589385983|FG001|Overall Study|Lost to Follow-up|0|||
163183054|NCT01280955|589385984|FG000|Overall Study|Death|2|||
163183055|NCT01280955|589385984|FG000|Overall Study|Withdrawal by Subject|1|||
163183056|NCT01484054|589385985|FG000|Period 1|Withdrawal by Subject|0|||
163183057|NCT01484054|589385986|FG001|Period 1|Withdrawal by Subject|1|||
163183058|NCT05281601|589385989|FG000|Overall Study|Physician Decision|2|||
163183059|NCT05281601|589385990|FG001|Overall Study|Physician Decision|0|||
163183060|NCT05281601|589385989|FG000|Overall Study|Lost to Follow-up|2|||
163183061|NCT05281601|589385990|FG001|Overall Study|Lost to Follow-up|0|||
163183062|NCT05281601|589385989|FG000|Overall Study|Death|1|||
163183063|NCT05281601|589385990|FG001|Overall Study|Death|0|||
163183064|NCT05281601|589385989|FG000|Overall Study|Withdrawal by parent/guardian|2|||
163183065|NCT05281601|589385990|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163183066|NCT03119701|589386003|FG000|6-day Dosing|Death|4|||
163183067|NCT03119701|589386004|FG001|6-day Dosing|Death|1|||
163183068|NCT03119701|589386003|FG000|6-day Dosing|Adverse Event|3|||
163183069|NCT03119701|589386004|FG001|6-day Dosing|Adverse Event|0|||
163183070|NCT03119701|589386003|FG000|6-day Dosing|Physician Decision|0|||
163183071|NCT03119701|589386004|FG001|6-day Dosing|Physician Decision|1|||
163183072|NCT03119701|589386003|FG000|6-day Dosing|Withdrawal by Subject|0|||
163183073|NCT03119701|589386004|FG001|6-day Dosing|Withdrawal by Subject|1|||
163183074|NCT03119701|589386003|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
163183075|NCT03119701|589386004|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
163183076|NCT00406718|589386010|FG000|Overall Study|Withdrawal by Subject|2|||
163183077|NCT00406718|589386011|FG001|Overall Study|Withdrawal by Subject|9|||
163183078|NCT00406718|589386012|FG002|Overall Study|Withdrawal by Subject|4|||
163183079|NCT00406718|589386010|FG000|Overall Study|Lost to Follow-up|2|||
163183080|NCT00406718|589386011|FG001|Overall Study|Lost to Follow-up|5|||
163183081|NCT00406718|589386012|FG002|Overall Study|Lost to Follow-up|4|||
163183082|NCT01888003|589386015|FG000|Overall Study|Study Terminated|5|||
163183083|NCT01888003|589386016|FG001|Overall Study|Study Terminated|6|||
163288051|NCT03536884|589760658|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162937447|NCT05028751|588473640|FG002|Overall Study|Death|2|||
163183084|NCT01888003|589386017|FG002|Overall Study|Study Terminated|40|||
163183085|NCT03187756|589386018|FG000|Overall Study|Termination of study|4|||
163183086|NCT04090957|589386019|FG000|Overall Study|Lost to Follow-up|22|||
163183087|NCT04090957|589386020|FG001|Overall Study|Lost to Follow-up|25|||
163183088|NCT04090957|589386021|FG002|Overall Study|Lost to Follow-up|25|||
163183089|NCT04090957|589386022|FG003|Overall Study|Lost to Follow-up|36|||
163288052|NCT03536884|589760647|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
163288053|NCT03536884|589760648|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
163288054|NCT03536884|589760649|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
163288055|NCT03536884|589760650|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
163288056|NCT03536884|589760651|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
163288057|NCT03536884|589760652|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
163288058|NCT03536884|589760653|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
163288059|NCT03536884|589760654|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
163288060|NCT03536884|589760655|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
163288061|NCT03536884|589760656|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
163288062|NCT03536884|589760657|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
163288063|NCT03536884|589760658|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
163288064|NCT03536884|589760647|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163288065|NCT03536884|589760648|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163288066|NCT03536884|589760649|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163288067|NCT03536884|589760650|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163288068|NCT03536884|589760651|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163288069|NCT03536884|589760652|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
163288070|NCT03536884|589760653|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
163288071|NCT03536884|589760654|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
163288072|NCT03536884|589760655|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
163288073|NCT03536884|589760656|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163288074|NCT03536884|589760657|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163288075|NCT03536884|589760658|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163288076|NCT03536884|589760647|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163288077|NCT03536884|589760648|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163288078|NCT03536884|589760649|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163288079|NCT03536884|589760650|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163288080|NCT03536884|589760651|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163288081|NCT03536884|589760652|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
163288082|NCT03536884|589760653|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163288083|NCT03536884|589760654|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
163288084|NCT03536884|589760655|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163288085|NCT03536884|589760656|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163288086|NCT03536884|589760657|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163288087|NCT03536884|589760658|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163288088|NCT03536884|589760647|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163288089|NCT03536884|589760648|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163288090|NCT03536884|589760649|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163288091|NCT03536884|589760650|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163288092|NCT03536884|589760651|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163288093|NCT03536884|589760652|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
163288094|NCT03536884|589760653|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163288095|NCT03536884|589760654|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
163288096|NCT03536884|589760655|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
163288097|NCT03536884|589760656|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163288098|NCT03536884|589760657|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163288099|NCT03536884|589760658|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163288100|NCT03536884|589760647|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163288101|NCT03536884|589760648|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163288102|NCT03536884|589760649|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163288103|NCT03536884|589760650|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163288104|NCT03536884|589760651|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163288105|NCT03536884|589760652|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
163288106|NCT03536884|589760653|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
163288107|NCT03536884|589760654|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
163288108|NCT03536884|589760655|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
163288109|NCT03536884|589760656|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163288110|NCT03536884|589760657|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163288111|NCT03536884|589760658|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163288112|NCT03536884|589760647|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163288113|NCT03536884|589760648|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163288114|NCT03536884|589760649|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163288115|NCT03536884|589760650|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163288116|NCT03536884|589760651|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163288117|NCT03536884|589760652|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
163288118|NCT03536884|589760653|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163288119|NCT03536884|589760654|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163288120|NCT03536884|589760655|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163288121|NCT03536884|589760656|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163288122|NCT03536884|589760657|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163288123|NCT03536884|589760658|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163288124|NCT03536884|589760647|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163288125|NCT03536884|589760648|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163288126|NCT03536884|589760649|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163288127|NCT03536884|589760650|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163288128|NCT03536884|589760651|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163288129|NCT03536884|589760652|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163288130|NCT03536884|589760653|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
163288131|NCT03536884|589760654|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163288132|NCT03536884|589760655|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163288133|NCT03536884|589760656|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163288134|NCT03536884|589760657|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163288135|NCT03536884|589760658|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163288136|NCT03536884|589760647|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163288137|NCT03536884|589760648|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163288138|NCT03536884|589760649|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163288139|NCT03536884|589760650|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163288140|NCT03536884|589760651|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163288141|NCT03536884|589760652|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163288142|NCT03536884|589760653|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
163288143|NCT03536884|589760654|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163288144|NCT03536884|589760655|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163288145|NCT03536884|589760656|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163288146|NCT03536884|589760657|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163288147|NCT03536884|589760658|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163288148|NCT03536884|589760647|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
163288149|NCT03536884|589760648|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
163288150|NCT03536884|589760649|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
163288151|NCT03536884|589760650|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
163288152|NCT03536884|589760651|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
163183090|NCT04090957|589386019|FG000|Overall Study|Withdrawal of Consent for Another Reason|15|||
163183091|NCT04090957|589386020|FG001|Overall Study|Withdrawal of Consent for Another Reason|17|||
163183092|NCT04090957|589386021|FG002|Overall Study|Withdrawal of Consent for Another Reason|21|||
163183093|NCT04090957|589386022|FG003|Overall Study|Withdrawal of Consent for Another Reason|39|||
163183094|NCT04090957|589386019|FG000|Overall Study|Adverse Event|19|||
163183095|NCT04090957|589386020|FG001|Overall Study|Adverse Event|25|||
163183096|NCT04090957|589386021|FG002|Overall Study|Adverse Event|8|||
163183097|NCT04090957|589386022|FG003|Overall Study|Adverse Event|104|||
163183098|NCT04090957|589386019|FG000|Overall Study|Other|10|||
163183099|NCT04090957|589386020|FG001|Overall Study|Other|6|||
163183100|NCT04090957|589386021|FG002|Overall Study|Other|5|||
163183101|NCT04090957|589386022|FG003|Overall Study|Other|12|||
163183102|NCT04090957|589386019|FG000|Overall Study|Serious Adverse Event|7|||
163183103|NCT04090957|589386020|FG001|Overall Study|Serious Adverse Event|11|||
163183104|NCT04090957|589386021|FG002|Overall Study|Serious Adverse Event|1|||
163183105|NCT04090957|589386022|FG003|Overall Study|Serious Adverse Event|32|||
163183106|NCT04090957|589386019|FG000|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|7|||
163183107|NCT04090957|589386020|FG001|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|9|||
163183108|NCT04090957|589386021|FG002|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|1|||
163183109|NCT04090957|589386022|FG003|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|26|||
163183110|NCT04090957|589386019|FG000|Overall Study|Lack of Efficacy|1|||
163183111|NCT04090957|589386020|FG001|Overall Study|Lack of Efficacy|1|||
163183112|NCT04090957|589386021|FG002|Overall Study|Lack of Efficacy|9|||
163183113|NCT04090957|589386022|FG003|Overall Study|Lack of Efficacy|0|||
163183114|NCT04090957|589386019|FG000|Overall Study|Protocol Violation|3|||
163183115|NCT04090957|589386020|FG001|Overall Study|Protocol Violation|5|||
163183116|NCT04090957|589386021|FG002|Overall Study|Protocol Violation|2|||
163183117|NCT04090957|589386022|FG003|Overall Study|Protocol Violation|1|||
163183118|NCT04090957|589386019|FG000|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
163183119|NCT04090957|589386020|FG001|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
163183120|NCT04090957|589386021|FG002|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|6|||
163183121|NCT04090957|589386022|FG003|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|3|||
163183122|NCT04090957|589386019|FG000|Overall Study|COVID-19|2|||
163183123|NCT04090957|589386020|FG001|Overall Study|COVID-19|2|||
163183124|NCT04090957|589386021|FG002|Overall Study|COVID-19|3|||
163183125|NCT04090957|589386022|FG003|Overall Study|COVID-19|7|||
163183126|NCT04090957|589386019|FG000|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
163183127|NCT04090957|589386020|FG001|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
163183128|NCT04090957|589386021|FG002|Overall Study|Non-Compliance with Trial Protocol: Other|1|||
163183129|NCT04090957|589386022|FG003|Overall Study|Non-Compliance with Trial Protocol: Other|4|||
163183130|NCT04090957|589386019|FG000|Overall Study|Physician Decision|2|||
163183131|NCT04090957|589386020|FG001|Overall Study|Physician Decision|1|||
163183132|NCT04090957|589386021|FG002|Overall Study|Physician Decision|1|||
163183133|NCT04090957|589386022|FG003|Overall Study|Physician Decision|5|||
163183134|NCT04090957|589386019|FG000|Overall Study|Sponsor Decision|1|||
163183135|NCT04090957|589386020|FG001|Overall Study|Sponsor Decision|1|||
163183136|NCT04090957|589386021|FG002|Overall Study|Sponsor Decision|1|||
163183137|NCT04090957|589386022|FG003|Overall Study|Sponsor Decision|3|||
163183138|NCT04090957|589386019|FG000|Overall Study|Endometrial Findings - Physician Decision|1|||
163183139|NCT04090957|589386020|FG001|Overall Study|Endometrial Findings - Physician Decision|1|||
163183140|NCT04090957|589386021|FG002|Overall Study|Endometrial Findings - Physician Decision|0|||
163183141|NCT04090957|589386022|FG003|Overall Study|Endometrial Findings - Physician Decision|5|||
163183142|NCT04090957|589386019|FG000|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
163183143|NCT04090957|589386020|FG001|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|0|||
163183144|NCT04090957|589386021|FG002|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
163183145|NCT04090957|589386022|FG003|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|4|||
163183146|NCT04090957|589386019|FG000|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
163183147|NCT04090957|589386020|FG001|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
163183148|NCT04090957|589386021|FG002|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|1|||
163183149|NCT04090957|589386022|FG003|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
163183150|NCT04090957|589386019|FG000|Overall Study|Death|1|||
163183151|NCT04090957|589386020|FG001|Overall Study|Death|0|||
163183152|NCT04090957|589386021|FG002|Overall Study|Death|0|||
163183153|NCT04090957|589386022|FG003|Overall Study|Death|0|||
163183154|NCT04090957|589386019|FG000|Overall Study|No Treatment Administered|2|||
163183155|NCT04090957|589386020|FG001|Overall Study|No Treatment Administered|1|||
163183156|NCT04090957|589386021|FG002|Overall Study|No Treatment Administered|2|||
163183157|NCT04090957|589386022|FG003|Overall Study|No Treatment Administered|1|||
163183158|NCT01909453|589386023|FG000|Overall Study|Ongoing|118|||
163183159|NCT01909453|589386024|FG001|Overall Study|Ongoing|103|||
163183160|NCT01909453|589386025|FG002|Overall Study|Ongoing|83|||
163183161|NCT01909453|589386026|FG003|Overall Study|Ongoing|164|||
163183162|NCT01909453|589386027|FG004|Overall Study|Ongoing|50|||
163183163|NCT01909453|589386023|FG000|Overall Study|Death|69|||
163183164|NCT01909453|589386024|FG001|Overall Study|Death|74|||
163183165|NCT01909453|589386025|FG002|Overall Study|Death|88|||
163183166|NCT01909453|589386026|FG003|Overall Study|Death|86|||
163183167|NCT01909453|589386027|FG004|Overall Study|Death|29|||
163183168|NCT01909453|589386023|FG000|Overall Study|Lost to Follow-up|3|||
163183169|NCT01909453|589386024|FG001|Overall Study|Lost to Follow-up|4|||
163183170|NCT01909453|589386025|FG002|Overall Study|Lost to Follow-up|4|||
163183171|NCT01909453|589386026|FG003|Overall Study|Lost to Follow-up|3|||
163183172|NCT01909453|589386027|FG004|Overall Study|Lost to Follow-up|3|||
163183173|NCT01909453|589386023|FG000|Overall Study|Withdrawal by Subject|2|||
163183174|NCT01909453|589386024|FG001|Overall Study|Withdrawal by Subject|13|||
163183175|NCT01909453|589386025|FG002|Overall Study|Withdrawal by Subject|16|||
163183176|NCT01909453|589386026|FG003|Overall Study|Withdrawal by Subject|5|||
163183177|NCT01909453|589386027|FG004|Overall Study|Withdrawal by Subject|4|||
163183178|NCT03172910|589387764|FG000|Overall Study|Adverse Event|0|||
163183179|NCT03172910|589387765|FG001|Overall Study|Adverse Event|0|||
163183180|NCT03172910|589387766|FG002|Overall Study|Adverse Event|0|||
163183181|NCT03172910|589387767|FG003|Overall Study|Adverse Event|0|||
163183182|NCT03172910|589387768|FG004|Overall Study|Adverse Event|1|||
163183183|NCT02247531|589387771|FG000|Overall Study|Adverse Event|3|||
163183184|NCT02247531|589387772|FG001|Overall Study|Adverse Event|4|||
163183185|NCT02247531|589387773|FG002|Overall Study|Adverse Event|9|||
163183186|NCT02247531|589387771|FG000|Overall Study|Death|8|||
163183187|NCT02247531|589387772|FG001|Overall Study|Death|9|||
163183188|NCT02247531|589387773|FG002|Overall Study|Death|5|||
163183189|NCT02247531|589387771|FG000|Overall Study|Lost to Follow-up|1|||
163183190|NCT02247531|589387772|FG001|Overall Study|Lost to Follow-up|8|||
163183191|NCT02247531|589387773|FG002|Overall Study|Lost to Follow-up|3|||
163183192|NCT02247531|589387771|FG000|Overall Study|Non-compliance|2|||
163183193|NCT02247531|589387772|FG001|Overall Study|Non-compliance|2|||
163183194|NCT02247531|589387773|FG002|Overall Study|Non-compliance|0|||
163183195|NCT02247531|589387771|FG000|Overall Study|Withdrawal by Subject|26|||
163183196|NCT02247531|589387772|FG001|Overall Study|Withdrawal by Subject|31|||
163183197|NCT02247531|589387773|FG002|Overall Study|Withdrawal by Subject|25|||
163288153|NCT03536884|589760652|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
163183198|NCT02247531|589387771|FG000|Overall Study|Study Terminated by Sponsor|64|||
163183199|NCT02247531|589387772|FG001|Overall Study|Study Terminated by Sponsor|66|||
163288154|NCT03536884|589760653|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
162937448|NCT05028751|588473641|FG003|Overall Study|Death|4|||
162937449|NCT05028751|588473638|FG000|Overall Study|Withdrawal by Subject|0|||
162937450|NCT05028751|588473639|FG001|Overall Study|Withdrawal by Subject|0|||
162937451|NCT05028751|588473640|FG002|Overall Study|Withdrawal by Subject|1|||
163183200|NCT02247531|589387773|FG002|Overall Study|Study Terminated by Sponsor|62|||
163183201|NCT02247531|589387771|FG000|Overall Study|Physician Decision|0|||
163183202|NCT02247531|589387772|FG001|Overall Study|Physician Decision|2|||
163183203|NCT02247531|589387773|FG002|Overall Study|Physician Decision|2|||
163183204|NCT02247531|589387771|FG000|Overall Study|Unspecified Reason|2|||
163183205|NCT02247531|589387772|FG001|Overall Study|Unspecified Reason|3|||
163183206|NCT02247531|589387773|FG002|Overall Study|Unspecified Reason|4|||
163183207|NCT04879225|589387776|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
163183208|NCT04879225|589387776|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
163183209|NCT01229397|589387782|FG000|Overall Study|Withdrawal by Subject|3|||
163183210|NCT01229397|589387783|FG001|Overall Study|Withdrawal by Subject|3|||
163183211|NCT01229397|589387782|FG000|Overall Study|Lost to Follow-up|7|||
163183212|NCT01229397|589387783|FG001|Overall Study|Lost to Follow-up|6|||
163183213|NCT01229397|589387782|FG000|Overall Study|Migrated/moved from study area|1|||
163183214|NCT01229397|589387783|FG001|Overall Study|Migrated/moved from study area|0|||
163183215|NCT01810432|589387786|FG000|Washout|Protocol Violation|0|||
163183216|NCT01810432|589387787|FG001|Washout|Protocol Violation|1|||
163183217|NCT01810432|589387786|FG000|Washout|Adverse Event|1|||
163183218|NCT01810432|589387787|FG001|Washout|Adverse Event|0|||
163183219|NCT01810432|589387786|FG000|Period 2|Withdrawal by Subject|2|||
163183220|NCT01810432|589387787|FG001|Period 2|Withdrawal by Subject|1|||
163183221|NCT01810432|589387786|FG000|Period 2|Physician Decision|1|||
163183222|NCT01810432|589387787|FG001|Period 2|Physician Decision|0|||
163183223|NCT01810432|589387786|FG000|Period 2|Lost to Follow-up|1|||
163183224|NCT01810432|589387787|FG001|Period 2|Lost to Follow-up|1|||
163183225|NCT00214500|589387788|FG000|Treatment Period|Adverse Event|1|||
163183226|NCT00214500|589387788|FG000|Extension Period|Withdrawal by Subject|2|||
163183227|NCT01068652|589387789|FG000|Overall Study|Adverse Event|4|||
163183228|NCT01068652|589387790|FG001|Overall Study|Adverse Event|0|||
163183229|NCT01068652|589387789|FG000|Overall Study|Lack of Efficacy|0|||
163183230|NCT01068652|589387790|FG001|Overall Study|Lack of Efficacy|2|||
163183231|NCT01068652|589387789|FG000|Overall Study|Lost to Follow-up|2|||
163183232|NCT01068652|589387790|FG001|Overall Study|Lost to Follow-up|1|||
163183233|NCT01068652|589387789|FG000|Overall Study|Protocol Violation|3|||
163183234|NCT01068652|589387790|FG001|Overall Study|Protocol Violation|6|||
163183235|NCT01068652|589387789|FG000|Overall Study|Withdrawal criteria|1|||
163183236|NCT01068652|589387790|FG001|Overall Study|Withdrawal criteria|2|||
163183237|NCT01068652|589387789|FG000|Overall Study|Patient was not eligible|1|||
163183238|NCT01068652|589387790|FG001|Overall Study|Patient was not eligible|0|||
163183239|NCT01068652|589387789|FG000|Overall Study|Unclassified|7|||
163183240|NCT01068652|589387790|FG001|Overall Study|Unclassified|4|||
163183241|NCT03170232|589387791|FG000|Overall Study|Adverse Event|0|||
163183242|NCT03170232|589387792|FG001|Overall Study|Adverse Event|1|||
163183243|NCT03170232|589387791|FG000|Overall Study|Protocol Violation|0|||
163183244|NCT03170232|589387792|FG001|Overall Study|Protocol Violation|1|||
163183245|NCT03170232|589387791|FG000|Overall Study|Lack of Efficacy|0|||
163183246|NCT03170232|589387792|FG001|Overall Study|Lack of Efficacy|1|||
163183247|NCT03170232|589387791|FG000|Overall Study|Study closed/terminated|26|||
163183248|NCT03170232|589387792|FG001|Overall Study|Study closed/terminated|23|||
163183249|NCT03170232|589387791|FG000|Overall Study|Lost to Follow-up|1|||
163183250|NCT03170232|589387792|FG001|Overall Study|Lost to Follow-up|0|||
163183251|NCT03170232|589387791|FG000|Overall Study|Withdrawal by Subject|0|||
163183252|NCT03170232|589387792|FG001|Overall Study|Withdrawal by Subject|1|||
163183253|NCT00147251|589387793|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
163183254|NCT00147251|589387794|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
163183255|NCT02537574|589387795|FG000|Overall Study|Adverse Event|1|||
163183256|NCT02537574|589387796|FG001|Overall Study|Adverse Event|3|||
163183257|NCT02537574|589387797|FG002|Overall Study|Adverse Event|2|||
163183258|NCT02537574|589387795|FG000|Overall Study|Lost to Follow-up|40|||
163183259|NCT02537574|589387796|FG001|Overall Study|Lost to Follow-up|51|||
163183260|NCT02537574|589387797|FG002|Overall Study|Lost to Follow-up|55|||
163183261|NCT02537574|589387795|FG000|Overall Study|Noncompliance with study drug|0|||
163288155|NCT03536884|589760654|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
163288156|NCT03536884|589760655|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
162937452|NCT05028751|588473641|FG003|Overall Study|Withdrawal by Subject|0|||
162937453|NCT05028751|588473638|FG000|Overall Study|Miscellaneous|2|||
163183262|NCT02537574|589387796|FG001|Overall Study|Noncompliance with study drug|1|||
163183263|NCT02537574|589387797|FG002|Overall Study|Noncompliance with study drug|1|||
163183264|NCT02537574|589387795|FG000|Overall Study|Physician Decision|2|||
163183265|NCT02537574|589387796|FG001|Overall Study|Physician Decision|0|||
163183266|NCT02537574|589387797|FG002|Overall Study|Physician Decision|0|||
163183267|NCT02537574|589387795|FG000|Overall Study|Protocol Violation|4|||
163183268|NCT02537574|589387796|FG001|Overall Study|Protocol Violation|2|||
163183269|NCT02537574|589387797|FG002|Overall Study|Protocol Violation|3|||
162937454|NCT05028751|588473639|FG001|Overall Study|Miscellaneous|0|||
162937455|NCT05028751|588473640|FG002|Overall Study|Miscellaneous|0|||
162937456|NCT05028751|588473641|FG003|Overall Study|Miscellaneous|0|||
162937457|NCT03586830|588473643|FG000|Overall Study|Site terminated by Sponsor|1|||
162937458|NCT03586830|588473644|FG001|Overall Study|Site terminated by Sponsor|4|||
162937459|NCT03586830|588473645|FG002|Overall Study|Site terminated by Sponsor|3|||
163183270|NCT02537574|589387795|FG000|Overall Study|Withdrawal by Subject|37|||
163183271|NCT02537574|589387796|FG001|Overall Study|Withdrawal by Subject|27|||
163183272|NCT02537574|589387797|FG002|Overall Study|Withdrawal by Subject|29|||
163183273|NCT02537574|589387795|FG000|Overall Study|Lack of Efficacy|14|||
163183274|NCT02537574|589387796|FG001|Overall Study|Lack of Efficacy|16|||
163183275|NCT02537574|589387797|FG002|Overall Study|Lack of Efficacy|15|||
163183276|NCT02537574|589387795|FG000|Overall Study|Duplicate Patient|1|||
163183277|NCT02537574|589387796|FG001|Overall Study|Duplicate Patient|0|||
163183278|NCT02537574|589387797|FG002|Overall Study|Duplicate Patient|0|||
163183279|NCT02537574|589387795|FG000|Overall Study|Patient not Stable|0|||
163183280|NCT02537574|589387796|FG001|Overall Study|Patient not Stable|1|||
163183281|NCT02537574|589387797|FG002|Overall Study|Patient not Stable|0|||
163183282|NCT02537574|589387795|FG000|Overall Study|Incarceration|0|||
163183283|NCT02537574|589387796|FG001|Overall Study|Incarceration|1|||
163183284|NCT02537574|589387797|FG002|Overall Study|Incarceration|0|||
163183285|NCT02537574|589387795|FG000|Overall Study|Failed Naloxone Challenge|0|||
163183286|NCT02537574|589387796|FG001|Overall Study|Failed Naloxone Challenge|1|||
163183287|NCT02537574|589387797|FG002|Overall Study|Failed Naloxone Challenge|0|||
163183288|NCT02537574|589387795|FG000|Overall Study|Transportation Issues|0|||
163183289|NCT02537574|589387796|FG001|Overall Study|Transportation Issues|0|||
163183290|NCT02537574|589387797|FG002|Overall Study|Transportation Issues|1|||
163183291|NCT02537574|589387795|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
163183292|NCT02537574|589387796|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
163183293|NCT02537574|589387797|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
163183294|NCT02537574|589387795|FG000|Overall Study|Noncompliance with Protocol|0|||
163183295|NCT02537574|589387796|FG001|Overall Study|Noncompliance with Protocol|0|||
163183296|NCT02537574|589387797|FG002|Overall Study|Noncompliance with Protocol|1|||
163183297|NCT01151098|589387798|FG000|Overall Study|Adverse Event|82|||
163183298|NCT01151098|589387798|FG000|Overall Study|Lost to Follow-up|6|||
163183299|NCT01151098|589387798|FG000|Overall Study|Lack of Efficacy|15|||
163183300|NCT01151098|589387798|FG000|Overall Study|Protocol Violation|1|||
163183301|NCT01151098|589387798|FG000|Overall Study|Miscellaneous|13|||
163183302|NCT03343067|589387801|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
163183303|NCT03343067|589387802|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
163183304|NCT03343067|589387803|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
163183305|NCT00542451|589387804|FG000|Overall Study|Adverse Event|31|||
163183306|NCT00542451|589387804|FG000|Overall Study|Withdrawal by Subject|30|||
163183307|NCT00542451|589387804|FG000|Overall Study|Physician Decision|4|||
163183308|NCT00542451|589387804|FG000|Overall Study|Recurrent disease|1|||
163183309|NCT00542451|589387804|FG000|Overall Study|unknown reason|1|||
163183310|NCT00542451|589387804|FG000|Overall Study|Death|2|||
163183311|NCT00542451|589387804|FG000|Overall Study|Lost to Follow-up|10|||
163183312|NCT00116168|589387807|FG000|Overall Study|Lost to Follow-up|6|||
163183313|NCT00116168|589387808|FG001|Overall Study|Lost to Follow-up|5|||
163183314|NCT00116168|589387809|FG002|Overall Study|Lost to Follow-up|0|||
163183315|NCT00116168|589387810|FG003|Overall Study|Lost to Follow-up|0|||
163183316|NCT05153473|589387811|FG000|Overall Study|Death|46|||
163183317|NCT05153473|589387811|FG000|Overall Study|Lost to Follow-up|3|||
163183318|NCT00245583|589387817|FG000|Overall Study|Lost to Follow-up|1|||
163183319|NCT00245583|589387818|FG001|Overall Study|Lost to Follow-up|5|||
163183320|NCT00245583|589387817|FG000|Overall Study|Adverse Event|2|||
163183321|NCT00245583|589387818|FG001|Overall Study|Adverse Event|1|||
163183322|NCT00245583|589387817|FG000|Overall Study|Lack of Efficacy|1|||
163183323|NCT00245583|589387818|FG001|Overall Study|Lack of Efficacy|0|||
163183324|NCT00245583|589387817|FG000|Overall Study|Withdrawal by Subject|2|||
163183325|NCT00245583|589387818|FG001|Overall Study|Withdrawal by Subject|3|||
163183326|NCT01309893|589387819|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
163183327|NCT01309893|589387820|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
163183328|NCT01309893|589387819|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
163183329|NCT01309893|589387820|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
163288157|NCT03536884|589760656|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
162937460|NCT03586830|588473646|FG003|Overall Study|Site terminated by Sponsor|3|||
162937461|NCT03586830|588473643|FG000|Overall Study|Lost to Follow-up|0|||
162937462|NCT03586830|588473644|FG001|Overall Study|Lost to Follow-up|2|||
162937463|NCT03586830|588473645|FG002|Overall Study|Lost to Follow-up|2|||
163183330|NCT02017171|589387821|FG000|Overall Study|Death|10|||
163183331|NCT02017171|589387822|FG001|Overall Study|Death|4|||
163183332|NCT02017171|589387821|FG000|Overall Study|Withdrawal by Subject|23|||
163183333|NCT02017171|589387822|FG001|Overall Study|Withdrawal by Subject|17|||
163183334|NCT02017171|589387821|FG000|Overall Study|Lost to Follow-up|21|||
163183335|NCT02017171|589387822|FG001|Overall Study|Lost to Follow-up|20|||
162937464|NCT03586830|588473646|FG003|Overall Study|Lost to Follow-up|1|||
162937465|NCT03586830|588473643|FG000|Overall Study|Withdrawal by Subject|1|||
162937466|NCT03586830|588473644|FG001|Overall Study|Withdrawal by Subject|0|||
162937467|NCT03586830|588473645|FG002|Overall Study|Withdrawal by Subject|3|||
162937468|NCT03586830|588473646|FG003|Overall Study|Withdrawal by Subject|1|||
163183336|NCT02017171|589387821|FG000|Overall Study|ESKD|6|||
163183337|NCT02017171|589387822|FG001|Overall Study|ESKD|2|||
163183338|NCT02017171|589387821|FG000|Overall Study|Miscellaneous|2|||
163183339|NCT02017171|589387822|FG001|Overall Study|Miscellaneous|3|||
163183340|NCT01484938|589387823|FG000|Overall Study|Adverse Event|2|||
163183341|NCT01484938|589387823|FG000|Overall Study|Lost to Follow-up|1|||
163183342|NCT01484938|589387823|FG000|Overall Study|Noncompliance|1|||
163183343|NCT01172275|589387828|FG000|Overall Study|Lost to Follow-up|1|||
163183344|NCT01172275|589387829|FG001|Overall Study|Lost to Follow-up|0|||
163183345|NCT01172275|589387828|FG000|Overall Study|Protocol Violation|1|||
163183346|NCT01172275|589387829|FG001|Overall Study|Protocol Violation|0|||
163183347|NCT02862600|589387830|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
163183348|NCT02862600|589387830|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
163183349|NCT02862600|589387830|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
163183350|NCT02862600|589387830|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
163183351|NCT00194675|589387831|FG000|Overall Study|Lost to Follow-up|1|||
163183352|NCT00194675|589387832|FG001|Overall Study|Lost to Follow-up|1|||
163183353|NCT00194675|589387831|FG000|Overall Study|lack of interest|1|||
163183354|NCT00194675|589387832|FG001|Overall Study|lack of interest|1|||
163183355|NCT00194675|589387831|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
163183356|NCT00194675|589387832|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
163183357|NCT00194675|589387831|FG000|Overall Study|Protocol Violation|1|||
163183358|NCT00194675|589387832|FG001|Overall Study|Protocol Violation|0|||
163183359|NCT00194675|589387831|FG000|Overall Study|Death|1|||
163183360|NCT00194675|589387832|FG001|Overall Study|Death|0|||
163183361|NCT00667420|589387837|FG000|Overall Study|Adverse Event|2|||
163183362|NCT00667420|589387837|FG000|Overall Study|Lack of Efficacy|5|||
163183363|NCT00667420|589387837|FG000|Overall Study|Physician Decision|1|||
163183364|NCT00667420|589387837|FG000|Overall Study|Withdrawal by Subject|2|||
163183365|NCT04437368|589387838|FG000|Overall Study|Death|3|||
163183366|NCT04437368|589387839|FG001|Overall Study|Death|0|||
163183367|NCT04437368|589387840|FG002|Overall Study|Death|2|||
163183368|NCT04437368|589387838|FG000|Overall Study|Study terminated by sponsor|16|||
163183369|NCT04437368|589387839|FG001|Overall Study|Study terminated by sponsor|1|||
163183370|NCT04437368|589387840|FG002|Overall Study|Study terminated by sponsor|25|||
163183371|NCT04437368|589387838|FG000|Overall Study|Withdrawal by Subject|4|||
163183372|NCT04437368|589387839|FG001|Overall Study|Withdrawal by Subject|0|||
163183373|NCT04437368|589387840|FG002|Overall Study|Withdrawal by Subject|3|||
163183374|NCT04437368|589387838|FG000|Overall Study|Sponsor instructions|23|||
163183375|NCT04437368|589387839|FG001|Overall Study|Sponsor instructions|0|||
163183376|NCT04437368|589387840|FG002|Overall Study|Sponsor instructions|0|||
163183377|NCT00095628|589387841|FG000|Overall Study|Disease progression prior to treatment|1|||
163183378|NCT04271280|589387842|FG000|Overall Study|Lost to Follow-up|300|||
163183379|NCT04271280|589387842|FG000|Overall Study|Death|153|||
163183380|NCT04271280|589387842|FG000|Overall Study|Withdrawal of consent by patient|59|||
163183381|NCT04271280|589387842|FG000|Overall Study|Other|51|||
163183382|NCT04271280|589387842|FG000|Overall Study|No end of study information|42|||
163183383|NCT00495131|589387843|FG000|Overall Study|Adverse Event|6|||
163183384|NCT00495131|589387844|FG001|Overall Study|Adverse Event|2|||
163183385|NCT00495131|589387843|FG000|Overall Study|Lack of Efficacy|0|||
163183386|NCT00495131|589387844|FG001|Overall Study|Lack of Efficacy|2|||
163183387|NCT00495131|589387843|FG000|Overall Study|Lost to Follow-up|0|||
163183388|NCT00495131|589387844|FG001|Overall Study|Lost to Follow-up|2|||
163183389|NCT00495131|589387843|FG000|Overall Study|Withdrawal by Subject|1|||
163183390|NCT00495131|589387844|FG001|Overall Study|Withdrawal by Subject|0|||
163183391|NCT03224546|589387845|FG000|Overall Study|Lost to Follow-up|9|||
163183392|NCT03224546|589387846|FG001|Overall Study|Lost to Follow-up|8|||
163183393|NCT03224546|589387847|FG002|Overall Study|Lost to Follow-up|3|||
163183394|NCT03224546|589387845|FG000|Overall Study|Withdrawal by Subject|7|||
163183395|NCT03224546|589387846|FG001|Overall Study|Withdrawal by Subject|14|||
163183396|NCT03224546|589387847|FG002|Overall Study|Withdrawal by Subject|12|||
163183397|NCT01539317|589387850|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
163183398|NCT01539317|589387851|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
163183399|NCT04223232|589387852|FG000|Overall Study|Withdrawal by Subject|1|||
163183400|NCT00364130|589387853|FG000|Intervention Period|Lost to Follow-up|4|||
163183401|NCT00364130|589387854|FG001|Intervention Period|Lost to Follow-up|3|||
163288158|NCT03536884|589760657|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
163183402|NCT00364130|589387853|FG000|Intervention Period|Pregnancy|1|||
163183403|NCT00364130|589387854|FG001|Intervention Period|Pregnancy|0|||
163183404|NCT00364130|589387853|FG000|Intervention Period|Withdrawal by Subject|4|||
163183405|NCT00364130|589387854|FG001|Intervention Period|Withdrawal by Subject|5|||
163183406|NCT00364130|589387853|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
163288159|NCT03536884|589760658|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
163288160|NCT03536884|589760647|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163288161|NCT03536884|589760648|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163288162|NCT03536884|589760649|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163288163|NCT03536884|589760650|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163288164|NCT03536884|589760651|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163288165|NCT03536884|589760652|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163288166|NCT03536884|589760653|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163288167|NCT03536884|589760654|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163288168|NCT03536884|589760655|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
163288169|NCT03536884|589760656|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163288170|NCT03536884|589760657|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163288171|NCT03536884|589760658|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163288172|NCT03536884|589760647|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163288173|NCT03536884|589760648|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163288174|NCT03536884|589760649|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163288175|NCT03536884|589760650|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163288176|NCT03536884|589760651|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163288177|NCT03536884|589760652|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163288178|NCT03536884|589760653|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163288179|NCT03536884|589760654|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163288180|NCT03536884|589760655|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163288181|NCT03536884|589760656|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
162937469|NCT00395083|588473647|FG000|Overall Study|Withdrawal by Subject|6|||
162937470|NCT00395083|588473648|FG001|Overall Study|Withdrawal by Subject|5|||
162937471|NCT00395083|588473647|FG000|Overall Study|Developed another disease|4|||
162937472|NCT00395083|588473648|FG001|Overall Study|Developed another disease|3|||
162937473|NCT00628745|588473653|FG000|Overall Study|Withdrawal by Subject|63|||
162937474|NCT00628745|588473654|FG001|Overall Study|Withdrawal by Subject|3|||
162937475|NCT00628745|588473655|FG002|Overall Study|Withdrawal by Subject|9|||
162937476|NCT00628745|588473656|FG003|Overall Study|Withdrawal by Subject|2|||
163288182|NCT03536884|589760657|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
163288183|NCT03536884|589760658|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
163288184|NCT03536884|589760647|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163288185|NCT03536884|589760648|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163288186|NCT03536884|589760649|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163288187|NCT03536884|589760650|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163288188|NCT03536884|589760651|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163288189|NCT03536884|589760652|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163288190|NCT03536884|589760653|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163288191|NCT03536884|589760654|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162937477|NCT00628745|588473657|FG004|Overall Study|Withdrawal by Subject|69|||
162937478|NCT00628745|588473653|FG000|Overall Study|Does not meet inclusion criteria|0|||
162937479|NCT00628745|588473654|FG001|Overall Study|Does not meet inclusion criteria|12|||
162937480|NCT00628745|588473655|FG002|Overall Study|Does not meet inclusion criteria|0|||
162937481|NCT00628745|588473656|FG003|Overall Study|Does not meet inclusion criteria|0|||
162937482|NCT00628745|588473657|FG004|Overall Study|Does not meet inclusion criteria|18|||
162937483|NCT00628745|588473653|FG000|Overall Study|Participation in an interventional clinical trial|81|||
163288192|NCT03536884|589760655|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163288193|NCT03536884|589760656|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
163288194|NCT03536884|589760657|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
163288195|NCT03536884|589760658|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
163288196|NCT03536884|589760647|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163288197|NCT03536884|589760648|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163288198|NCT03536884|589760649|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163288199|NCT03536884|589760650|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163288200|NCT03536884|589760651|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163288201|NCT03536884|589760652|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163288202|NCT03536884|589760653|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163288203|NCT03536884|589760654|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163288204|NCT03536884|589760655|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162937484|NCT00628745|588473654|FG001|Overall Study|Participation in an interventional clinical trial|4|||
162937485|NCT00628745|588473655|FG002|Overall Study|Participation in an interventional clinical trial|7|||
163288205|NCT03536884|589760656|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163288206|NCT03536884|589760657|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
163288207|NCT03536884|589760658|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163288208|NCT03536884|589760647|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163288209|NCT03536884|589760648|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163288210|NCT03536884|589760649|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163288211|NCT03536884|589760650|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163288212|NCT03536884|589760651|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163288213|NCT03536884|589760652|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163288214|NCT03536884|589760653|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163288215|NCT03536884|589760654|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163183407|NCT00364130|589387854|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
163288216|NCT03536884|589760655|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163288217|NCT03536884|589760656|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163288218|NCT03536884|589760657|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163288219|NCT03536884|589760658|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
163288220|NCT03536884|589760647|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163288221|NCT03536884|589760648|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163288222|NCT03536884|589760649|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163288223|NCT03536884|589760650|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163288224|NCT03536884|589760651|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163288225|NCT03536884|589760652|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163288226|NCT03536884|589760653|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163288227|NCT03536884|589760654|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163288228|NCT03536884|589760655|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163288229|NCT03536884|589760656|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163288230|NCT03536884|589760657|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163288231|NCT03536884|589760658|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
163288232|NCT03722446|589760659|FG000|Overall Study|Protocol Violation|15|||
163288233|NCT03722446|589760660|FG001|Overall Study|Protocol Violation|2|||
163183408|NCT00901927|589387864|FG000|Overall Study|Lack of Efficacy|1|||
163183409|NCT00901927|589387864|FG000|Overall Study|Protocol Violation|3|||
163183410|NCT00901927|589387864|FG000|Overall Study|Withdrawal by Subject|2|||
163183411|NCT00586846|589387865|FG000|Overall Study|Physician Decision|1|||
163183412|NCT00586846|589387865|FG000|Overall Study|Death|1|||
163183413|NCT00586846|589387865|FG000|Overall Study|Evaluable for Toxicity Only|4|||
163183414|NCT01702571|589387874|FG000|Overall Study|Death|1067|||
163183415|NCT01702571|589387875|FG001|Overall Study|Death|76|||
163183416|NCT01702571|589387874|FG000|Overall Study|Lost to Follow-up|144|||
163183417|NCT01702571|589387875|FG001|Overall Study|Lost to Follow-up|10|||
163183418|NCT01702571|589387874|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
163183419|NCT01702571|589387875|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
163183420|NCT01702571|589387874|FG000|Overall Study|Investigator Decision|5|||
163183421|NCT01702571|589387875|FG001|Overall Study|Investigator Decision|0|||
163183422|NCT01702571|589387874|FG000|Overall Study|Not Classifiable|1|||
163183423|NCT01702571|589387875|FG001|Overall Study|Not Classifiable|0|||
163183424|NCT01702571|589387874|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
163183425|NCT01702571|589387875|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
163183426|NCT01702571|589387874|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
163183427|NCT01702571|589387875|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
163183428|NCT01702571|589387874|FG000|Overall Study|Progressive Disease|3|||
163183429|NCT01702571|589387875|FG001|Overall Study|Progressive Disease|0|||
163183430|NCT01702571|589387874|FG000|Overall Study|Protocol Violation|2|||
163183431|NCT01702571|589387875|FG001|Overall Study|Protocol Violation|0|||
163183432|NCT01702571|589387874|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
163183433|NCT01702571|589387875|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
163183434|NCT01702571|589387874|FG000|Overall Study|Termination By Sponsor|4|||
163183435|NCT01702571|589387875|FG001|Overall Study|Termination By Sponsor|0|||
163183436|NCT01702571|589387874|FG000|Overall Study|Withdrawal by Subject|177|||
163183437|NCT01702571|589387875|FG001|Overall Study|Withdrawal by Subject|29|||
163183438|NCT03004443|589387876|FG000|Overall Study|Pregnancy|0|||
163183439|NCT03004443|589387877|FG001|Overall Study|Pregnancy|1|||
163183440|NCT00828854|589387878|FG000|Overall Study|Disease Progression|17|||
163183441|NCT00828854|589387878|FG000|Overall Study|Adverse Event|9|||
163183442|NCT00828854|589387878|FG000|Overall Study|Reason not Specified|1|||
163183443|NCT04221230|589387879|FG000|Overall Study|Lost to Follow-up|12|||
163183444|NCT04221230|589387880|FG001|Overall Study|Lost to Follow-up|12|||
163183445|NCT04221230|589387879|FG000|Overall Study|Protocol Violation|2|||
163183446|NCT04221230|589387880|FG001|Overall Study|Protocol Violation|2|||
163183447|NCT04221230|589387879|FG000|Overall Study|Adverse Event|0|||
163183448|NCT04221230|589387880|FG001|Overall Study|Adverse Event|8|||
162937486|NCT00628745|588473656|FG003|Overall Study|Participation in an interventional clinical trial|0|||
162937487|NCT00628745|588473657|FG004|Overall Study|Participation in an interventional clinical trial|63|||
162937488|NCT00628745|588473653|FG000|Overall Study|Physician Decision|8|||
162937489|NCT00628745|588473654|FG001|Overall Study|Physician Decision|4|||
162937490|NCT00628745|588473655|FG002|Overall Study|Physician Decision|3|||
162937491|NCT00628745|588473656|FG003|Overall Study|Physician Decision|0|||
162937492|NCT00628745|588473657|FG004|Overall Study|Physician Decision|30|||
163183449|NCT04221230|589387879|FG000|Overall Study|Physician Decision|1|||
163183450|NCT04221230|589387880|FG001|Overall Study|Physician Decision|0|||
163183451|NCT04221230|589387879|FG000|Overall Study|Withdrawal by Subject|13|||
163183452|NCT04221230|589387880|FG001|Overall Study|Withdrawal by Subject|11|||
163183453|NCT04221230|589387879|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163183454|NCT04221230|589387880|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163183455|NCT04221230|589387879|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163183456|NCT04221230|589387880|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
163183457|NCT04221230|589387879|FG000|Overall Study|Pregnancy|0|||
163183458|NCT04221230|589387880|FG001|Overall Study|Pregnancy|1|||
163183459|NCT04221230|589387879|FG000|Overall Study|Other|1|||
163183460|NCT04221230|589387880|FG001|Overall Study|Other|2|||
163183461|NCT00915356|589387881|FG000|Overall Study|Withdrawal by Subject|1|||
163183462|NCT00915356|589387882|FG001|Overall Study|Withdrawal by Subject|0|||
163183463|NCT00915356|589387883|FG002|Overall Study|Withdrawal by Subject|0|||
163183464|NCT00915356|589387884|FG003|Overall Study|Withdrawal by Subject|0|||
163183465|NCT00915356|589387885|FG004|Overall Study|Withdrawal by Subject|0|||
163183466|NCT00191646|589387887|FG000|Overall Study|Toxicity|26|||
163183467|NCT00191646|589387888|FG001|Overall Study|Toxicity|37|||
163183468|NCT00191646|589387887|FG000|Overall Study|Disease Progression|5|||
163183469|NCT00191646|589387888|FG001|Overall Study|Disease Progression|6|||
163183470|NCT00191646|589387887|FG000|Overall Study|Physician Decision|20|||
163183471|NCT00191646|589387888|FG001|Overall Study|Physician Decision|11|||
163183472|NCT00191646|589387887|FG000|Overall Study|Withdrawal by Subject|58|||
163183473|NCT00191646|589387888|FG001|Overall Study|Withdrawal by Subject|39|||
163183474|NCT00191646|589387887|FG000|Overall Study|Protocol Violation|5|||
163183475|NCT00191646|589387888|FG001|Overall Study|Protocol Violation|7|||
163183476|NCT00191646|589387887|FG000|Overall Study|Death|6|||
163183477|NCT00191646|589387888|FG001|Overall Study|Death|8|||
163183478|NCT00191646|589387887|FG000|Overall Study|Other|33|||
163183479|NCT00191646|589387888|FG001|Overall Study|Other|34|||
163183480|NCT00191646|589387887|FG000|Overall Study|Missing Data|18|||
163183481|NCT00191646|589387888|FG001|Overall Study|Missing Data|11|||
163183482|NCT05211284|589387896|FG000|Overall Study|Study Terminated|3|||
163183483|NCT05211284|589387897|FG001|Overall Study|Study Terminated|1|||
163183484|NCT00395538|589387903|FG000|Overall Study|Did not re-consent to revised protocol|1|||
163183485|NCT00395538|589387904|FG001|Overall Study|Did not re-consent to revised protocol|10|||
163183486|NCT00395538|589387905|FG002|Overall Study|Did not re-consent to revised protocol|0|||
163183487|NCT00395538|589387903|FG000|Overall Study|FDA partial hold on PTH|0|||
163183488|NCT00395538|589387904|FG001|Overall Study|FDA partial hold on PTH|0|||
163183489|NCT00395538|589387905|FG002|Overall Study|FDA partial hold on PTH|11|||
163183490|NCT00395538|589387903|FG000|Overall Study|Failed screening|0|||
163183491|NCT00395538|589387904|FG001|Overall Study|Failed screening|0|||
163183492|NCT00395538|589387905|FG002|Overall Study|Failed screening|4|||
163183493|NCT00395538|589387903|FG000|Overall Study|Switch to Natpara|0|||
163183494|NCT00395538|589387904|FG001|Overall Study|Switch to Natpara|0|||
163183495|NCT00395538|589387905|FG002|Overall Study|Switch to Natpara|3|||
163183496|NCT00395538|589387903|FG000|Overall Study|Adverse Event|1|||
163183497|NCT00395538|589387904|FG001|Overall Study|Adverse Event|0|||
163183498|NCT00395538|589387905|FG002|Overall Study|Adverse Event|2|||
163183499|NCT00395538|589387903|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
163183500|NCT00395538|589387904|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
163183501|NCT00395538|589387905|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
163183502|NCT00395538|589387903|FG000|Overall Study|Non-compliance with study protocol|0|||
163183503|NCT00395538|589387904|FG001|Overall Study|Non-compliance with study protocol|1|||
163183504|NCT00395538|589387905|FG002|Overall Study|Non-compliance with study protocol|0|||
163183505|NCT00395538|589387903|FG000|Overall Study|PTH resistance|0|||
163183506|NCT00395538|589387904|FG001|Overall Study|PTH resistance|0|||
163183507|NCT00395538|589387905|FG002|Overall Study|PTH resistance|1|||
163183508|NCT00395538|589387903|FG000|Overall Study|Pregnancy|1|||
163183509|NCT00395538|589387904|FG001|Overall Study|Pregnancy|0|||
163183510|NCT00395538|589387905|FG002|Overall Study|Pregnancy|0|||
163183511|NCT00395538|589387903|FG000|Overall Study|Partial recovery of parathyroid function|0|||
163183512|NCT00395538|589387904|FG001|Overall Study|Partial recovery of parathyroid function|0|||
162937493|NCT00628745|588473653|FG000|Overall Study|Lost to Follow-up|109|||
163183513|NCT00395538|589387905|FG002|Overall Study|Partial recovery of parathyroid function|1|||
163183514|NCT00395538|589387903|FG000|Overall Study|Participant elected to discontinue|0|||
163183515|NCT00395538|589387904|FG001|Overall Study|Participant elected to discontinue|0|||
163183516|NCT00395538|589387905|FG002|Overall Study|Participant elected to discontinue|1|||
163183517|NCT05140382|589387906|FG000|Overall Study|Death|3|||
162937494|NCT00628745|588473654|FG001|Overall Study|Lost to Follow-up|7|||
162937495|NCT00628745|588473655|FG002|Overall Study|Lost to Follow-up|7|||
163183518|NCT05140382|589387907|FG001|Overall Study|Death|0|||
163183519|NCT05140382|589387908|FG002|Overall Study|Death|0|||
163183520|NCT05140382|589387906|FG000|Overall Study|Investigator decision|1|||
163183521|NCT05140382|589387907|FG001|Overall Study|Investigator decision|0|||
163183522|NCT05140382|589387908|FG002|Overall Study|Investigator decision|0|||
163183523|NCT05140382|589387906|FG000|Overall Study|Other|4|||
163183524|NCT05140382|589387907|FG001|Overall Study|Other|0|||
163183525|NCT05140382|589387908|FG002|Overall Study|Other|1|||
163183526|NCT05140382|589387906|FG000|Overall Study|Progressive disease|20|||
163183527|NCT05140382|589387907|FG001|Overall Study|Progressive disease|1|||
163183528|NCT05140382|589387908|FG002|Overall Study|Progressive disease|12|||
163183529|NCT05140382|589387906|FG000|Overall Study|Subjective disease progression|2|||
163183530|NCT05140382|589387907|FG001|Overall Study|Subjective disease progression|1|||
163183531|NCT05140382|589387908|FG002|Overall Study|Subjective disease progression|0|||
163183532|NCT05140382|589387906|FG000|Overall Study|Unknown at data cut-off|0|||
163183533|NCT05140382|589387907|FG001|Overall Study|Unknown at data cut-off|0|||
163183534|NCT05140382|589387908|FG002|Overall Study|Unknown at data cut-off|1|||
163183535|NCT05140382|589387906|FG000|Overall Study|Withdrawal by Subject|1|||
163183536|NCT05140382|589387907|FG001|Overall Study|Withdrawal by Subject|0|||
163183537|NCT05140382|589387908|FG002|Overall Study|Withdrawal by Subject|4|||
163183538|NCT05140382|589387906|FG000|Overall Study|Withdrawal of consent|0|||
163183539|NCT05140382|589387907|FG001|Overall Study|Withdrawal of consent|0|||
163183540|NCT05140382|589387908|FG002|Overall Study|Withdrawal of consent|1|||
163183541|NCT01397201|589389314|FG000|Overall Study|Not treated|0|||
163183542|NCT01397201|589389315|FG001|Overall Study|Not treated|0|||
163183543|NCT01397201|589389316|FG002|Overall Study|Not treated|1|||
163183544|NCT01397201|589389317|FG003|Overall Study|Not treated|0|||
163183545|NCT01397201|589389318|FG004|Overall Study|Not treated|0|||
163183546|NCT01397201|589389314|FG000|Overall Study|Not yet defined|3|||
163183547|NCT01397201|589389315|FG001|Overall Study|Not yet defined|6|||
163183548|NCT01397201|589389316|FG002|Overall Study|Not yet defined|5|||
163183549|NCT01397201|589389317|FG003|Overall Study|Not yet defined|5|||
163183550|NCT01397201|589389318|FG004|Overall Study|Not yet defined|4|||
163183551|NCT01397201|589389314|FG000|Overall Study|Adverse Event|2|||
163183552|NCT01397201|589389315|FG001|Overall Study|Adverse Event|0|||
163183553|NCT01397201|589389316|FG002|Overall Study|Adverse Event|0|||
163183554|NCT01397201|589389317|FG003|Overall Study|Adverse Event|0|||
163183555|NCT01397201|589389318|FG004|Overall Study|Adverse Event|0|||
163183556|NCT00122278|589389319|FG000|Overall Study|Lost to Follow-up|2|||
163183557|NCT00122278|589389320|FG001|Overall Study|Lost to Follow-up|0|||
163183558|NCT01002482|589389321|FG000|Overall Study|Withdrawal by Subject|14|||
163183559|NCT01002482|589389322|FG001|Overall Study|Withdrawal by Subject|21|||
163183560|NCT01002482|589389321|FG000|Overall Study|Included twice|1|||
163183561|NCT01002482|589389322|FG001|Overall Study|Included twice|0|||
163183562|NCT02598960|589389326|FG000|Treatment Period|Disease Progression|4|||
163183563|NCT02598960|589389327|FG001|Treatment Period|Disease Progression|4|||
163183564|NCT02598960|589389328|FG002|Treatment Period|Disease Progression|4|||
163183565|NCT02598960|589389329|FG003|Treatment Period|Disease Progression|6|||
163183566|NCT02598960|589389330|FG004|Treatment Period|Disease Progression|8|||
163183567|NCT02598960|589389331|FG005|Treatment Period|Disease Progression|2|||
163183568|NCT02598960|589389332|FG006|Treatment Period|Disease Progression|2|||
163183569|NCT02598960|589389333|FG007|Treatment Period|Disease Progression|3|||
163183570|NCT02598960|589389334|FG008|Treatment Period|Disease Progression|7|||
163183571|NCT02598960|589389335|FG009|Treatment Period|Disease Progression|9|||
163183572|NCT02598960|589389336|FG010|Treatment Period|Disease Progression|7|||
163183573|NCT02598960|589389337|FG011|Treatment Period|Disease Progression|143|||
163183574|NCT02598960|589389338|FG012|Treatment Period|Disease Progression|23|||
163183575|NCT02598960|589389326|FG000|Treatment Period|Study drug toxicity|0|||
163183576|NCT02598960|589389327|FG001|Treatment Period|Study drug toxicity|0|||
163183577|NCT02598960|589389328|FG002|Treatment Period|Study drug toxicity|0|||
163183578|NCT02598960|589389329|FG003|Treatment Period|Study drug toxicity|0|||
163183579|NCT02598960|589389330|FG004|Treatment Period|Study drug toxicity|0|||
163183580|NCT02598960|589389331|FG005|Treatment Period|Study drug toxicity|0|||
163183581|NCT02598960|589389332|FG006|Treatment Period|Study drug toxicity|0|||
163183582|NCT02598960|589389333|FG007|Treatment Period|Study drug toxicity|0|||
163183583|NCT02598960|589389334|FG008|Treatment Period|Study drug toxicity|0|||
163183584|NCT02598960|589389335|FG009|Treatment Period|Study drug toxicity|1|||
163183585|NCT02598960|589389336|FG010|Treatment Period|Study drug toxicity|0|||
163183586|NCT02598960|589389337|FG011|Treatment Period|Study drug toxicity|3|||
163183587|NCT02598960|589389338|FG012|Treatment Period|Study drug toxicity|0|||
163183588|NCT02598960|589389326|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
163183589|NCT02598960|589389327|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
163183590|NCT02598960|589389328|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
163183591|NCT02598960|589389329|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
163183592|NCT02598960|589389330|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
163288234|NCT01137292|589760661|FG000|Overall Study|Death|30|||
163288235|NCT01137292|589760661|FG000|Overall Study|Adverse Event|3|||
163288236|NCT01137292|589760661|FG000|Overall Study|Lack of Efficacy|13|||
163288237|NCT01137292|589760661|FG000|Overall Study|Lost to Follow-up|1|||
163288238|NCT01137292|589760661|FG000|Overall Study|Other|7|||
163288239|NCT04540835|589760663|FG000|Week 1|Lost to Follow-up|1|||
163288240|NCT04540835|589760663|FG000|Week 6|Pregnancy|1|||
163288241|NCT04540835|589760663|FG000|Week 6|Lack of Efficacy|1|||
163288242|NCT01838200|589760664|FG000|Overall Study|Adverse Event|0|||
163288243|NCT01838200|589760665|FG001|Overall Study|Adverse Event|2|||
163288244|NCT01838200|589760664|FG000|Overall Study|Progressive disease|3|||
163288245|NCT01838200|589760665|FG001|Overall Study|Progressive disease|0|||
163183593|NCT02598960|589389331|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
163183594|NCT02598960|589389332|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
163183595|NCT02598960|589389333|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
163183596|NCT02598960|589389334|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
163183597|NCT02598960|589389335|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
163183598|NCT02598960|589389336|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
163183599|NCT02598960|589389337|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
163183600|NCT02598960|589389338|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
163183601|NCT02598960|589389326|FG000|Treatment Period|participant request to discontinue|0|||
163183602|NCT02598960|589389327|FG001|Treatment Period|participant request to discontinue|1|||
163183603|NCT02598960|589389328|FG002|Treatment Period|participant request to discontinue|0|||
163183604|NCT02598960|589389329|FG003|Treatment Period|participant request to discontinue|0|||
163183605|NCT02598960|589389330|FG004|Treatment Period|participant request to discontinue|1|||
163183606|NCT02598960|589389331|FG005|Treatment Period|participant request to discontinue|0|||
163183607|NCT02598960|589389332|FG006|Treatment Period|participant request to discontinue|0|||
163183608|NCT02598960|589389333|FG007|Treatment Period|participant request to discontinue|0|||
163183609|NCT02598960|589389334|FG008|Treatment Period|participant request to discontinue|0|||
163183610|NCT02598960|589389335|FG009|Treatment Period|participant request to discontinue|0|||
163183611|NCT02598960|589389336|FG010|Treatment Period|participant request to discontinue|1|||
163183612|NCT02598960|589389337|FG011|Treatment Period|participant request to discontinue|4|||
163183613|NCT02598960|589389338|FG012|Treatment Period|participant request to discontinue|0|||
163183614|NCT02598960|589389326|FG000|Treatment Period|participant withdrew consent|0|||
163183615|NCT02598960|589389327|FG001|Treatment Period|participant withdrew consent|0|||
163183616|NCT02598960|589389328|FG002|Treatment Period|participant withdrew consent|0|||
163183617|NCT02598960|589389329|FG003|Treatment Period|participant withdrew consent|0|||
163183618|NCT02598960|589389330|FG004|Treatment Period|participant withdrew consent|0|||
163183619|NCT02598960|589389331|FG005|Treatment Period|participant withdrew consent|0|||
163183620|NCT02598960|589389332|FG006|Treatment Period|participant withdrew consent|0|||
163183621|NCT02598960|589389333|FG007|Treatment Period|participant withdrew consent|0|||
163183622|NCT02598960|589389334|FG008|Treatment Period|participant withdrew consent|0|||
163183623|NCT02598960|589389335|FG009|Treatment Period|participant withdrew consent|0|||
163183624|NCT02598960|589389336|FG010|Treatment Period|participant withdrew consent|0|||
163183625|NCT02598960|589389337|FG011|Treatment Period|participant withdrew consent|3|||
163183626|NCT02598960|589389338|FG012|Treatment Period|participant withdrew consent|0|||
163183627|NCT02598960|589389326|FG000|Treatment Period|No longer meets study criteria|0|||
163183628|NCT02598960|589389327|FG001|Treatment Period|No longer meets study criteria|0|||
163183629|NCT02598960|589389328|FG002|Treatment Period|No longer meets study criteria|0|||
163183630|NCT02598960|589389329|FG003|Treatment Period|No longer meets study criteria|0|||
163183631|NCT02598960|589389330|FG004|Treatment Period|No longer meets study criteria|0|||
163183632|NCT02598960|589389331|FG005|Treatment Period|No longer meets study criteria|0|||
163183633|NCT02598960|589389332|FG006|Treatment Period|No longer meets study criteria|0|||
163183634|NCT02598960|589389333|FG007|Treatment Period|No longer meets study criteria|0|||
163183635|NCT02598960|589389334|FG008|Treatment Period|No longer meets study criteria|0|||
163183636|NCT02598960|589389335|FG009|Treatment Period|No longer meets study criteria|0|||
163183637|NCT02598960|589389336|FG010|Treatment Period|No longer meets study criteria|0|||
163183638|NCT02598960|589389337|FG011|Treatment Period|No longer meets study criteria|1|||
163183639|NCT02598960|589389338|FG012|Treatment Period|No longer meets study criteria|0|||
163183640|NCT02598960|589389326|FG000|Treatment Period|Other Reasons|0|||
163183641|NCT02598960|589389327|FG001|Treatment Period|Other Reasons|0|||
163183642|NCT02598960|589389328|FG002|Treatment Period|Other Reasons|0|||
163183643|NCT02598960|589389329|FG003|Treatment Period|Other Reasons|0|||
163183644|NCT02598960|589389330|FG004|Treatment Period|Other Reasons|0|||
163183645|NCT02598960|589389331|FG005|Treatment Period|Other Reasons|0|||
163183646|NCT02598960|589389332|FG006|Treatment Period|Other Reasons|0|||
163183647|NCT02598960|589389333|FG007|Treatment Period|Other Reasons|0|||
163183648|NCT02598960|589389334|FG008|Treatment Period|Other Reasons|0|||
163288246|NCT03105336|589760666|FG000|Overall Study|Rollover to Longterm Follow-up Study Criteria|61|||
163288247|NCT03105336|589760667|FG001|Overall Study|Rollover to Longterm Follow-up Study Criteria|15|||
163288248|NCT03105336|589760666|FG000|Overall Study|Death|40|||
163288249|NCT03105336|589760667|FG001|Overall Study|Death|8|||
163288250|NCT03105336|589760666|FG000|Overall Study|Lost to Follow-up|13|||
163288251|NCT03105336|589760667|FG001|Overall Study|Lost to Follow-up|2|||
163288252|NCT03105336|589760666|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|7|||
163288253|NCT03105336|589760667|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
163288254|NCT03105336|589760666|FG000|Overall Study|Reason Not Specified|3|||
163288255|NCT03105336|589760667|FG001|Overall Study|Reason Not Specified|3|||
163288256|NCT03105336|589760666|FG000|Overall Study|Investigator Decision|3|||
163288257|NCT03105336|589760667|FG001|Overall Study|Investigator Decision|0|||
163288258|NCT03451851|589760668|FG000|PCP: Week 0 -16|Adverse Event|1|||
163288259|NCT03451851|589760669|FG001|PCP: Week 0 -16|Adverse Event|0|||
163288260|NCT03451851|589760670|FG002|PCP: Week 0 -16|Adverse Event|0|||
163288261|NCT03451851|589760671|FG003|PCP: Week 0 -16|Adverse Event|0|||
163288262|NCT03451851|589760672|FG004|PCP: Week 0 -16|Adverse Event|0|||
163288263|NCT03451851|589760673|FG005|PCP: Week 0 -16|Adverse Event|0|||
163288264|NCT03451851|589760674|FG006|PCP: Week 0 -16|Adverse Event|1|||
163288265|NCT03451851|589760675|FG007|PCP: Week 0 -16|Adverse Event|0|||
163288266|NCT03451851|589760668|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
163288267|NCT03451851|589760669|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
163288268|NCT03451851|589760670|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
163288269|NCT03451851|589760671|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
163288270|NCT03451851|589760672|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
163288271|NCT03451851|589760673|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
163288272|NCT03451851|589760674|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
163288273|NCT03451851|589760675|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
163288274|NCT03451851|589760668|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
163288275|NCT03451851|589760669|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
163288276|NCT03451851|589760670|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
163288277|NCT03451851|589760671|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
163288278|NCT03451851|589760672|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
163288279|NCT03451851|589760673|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
163288280|NCT03451851|589760674|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
163288281|NCT03451851|589760675|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
163288282|NCT03451851|589760668|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
163288283|NCT03451851|589760669|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
163288284|NCT03451851|589760670|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
163288285|NCT03451851|589760671|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
163288286|NCT03451851|589760672|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
163288287|NCT03451851|589760673|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
163288288|NCT03451851|589760674|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
163288289|NCT03451851|589760675|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
163288290|NCT03451851|589760668|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
163288291|NCT03451851|589760669|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
163288292|NCT03451851|589760670|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
163288293|NCT03451851|589760671|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
163288294|NCT03451851|589760672|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
163288295|NCT03451851|589760673|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
163288296|NCT03451851|589760674|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
163288297|NCT03451851|589760675|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
163288298|NCT03451851|589760668|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
163288299|NCT03451851|589760669|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
163288300|NCT03451851|589760670|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
163288301|NCT03451851|589760671|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
163288302|NCT03451851|589760672|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
163288303|NCT03451851|589760673|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
163183649|NCT02598960|589389335|FG009|Treatment Period|Other Reasons|0|||
163183650|NCT02598960|589389336|FG010|Treatment Period|Other Reasons|0|||
163183651|NCT02598960|589389337|FG011|Treatment Period|Other Reasons|0|||
163183652|NCT02598960|589389338|FG012|Treatment Period|Other Reasons|1|||
163183653|NCT02598960|589389326|FG000|Participants Entering Follow Up Period|Death|1|||
163183654|NCT02598960|589389327|FG001|Participants Entering Follow Up Period|Death|0|||
163183655|NCT02598960|589389328|FG002|Participants Entering Follow Up Period|Death|0|||
163183656|NCT02598960|589389329|FG003|Participants Entering Follow Up Period|Death|0|||
163183657|NCT02598960|589389330|FG004|Participants Entering Follow Up Period|Death|0|||
163183658|NCT02598960|589389331|FG005|Participants Entering Follow Up Period|Death|0|||
163183659|NCT02598960|589389332|FG006|Participants Entering Follow Up Period|Death|0|||
163183660|NCT02598960|589389333|FG007|Participants Entering Follow Up Period|Death|0|||
163183661|NCT02598960|589389334|FG008|Participants Entering Follow Up Period|Death|0|||
163183662|NCT02598960|589389335|FG009|Participants Entering Follow Up Period|Death|1|||
163183663|NCT02598960|589389336|FG010|Participants Entering Follow Up Period|Death|0|||
163288304|NCT03451851|589760674|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
163288305|NCT03451851|589760675|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
163288306|NCT01090024|589761788|FG000|Period 1|Met exclusion criteria|0|||
163288307|NCT01090024|589761789|FG001|Period 1|Met exclusion criteria|0|||
163288308|NCT01090024|589761790|FG002|Period 1|Met exclusion criteria|0|||
163288309|NCT01090024|589761791|FG003|Period 1|Met exclusion criteria|0|||
163288310|NCT01090024|589761792|FG004|Period 1|Met exclusion criteria|0|||
163288311|NCT01090024|589761793|FG005|Period 1|Met exclusion criteria|0|||
163288312|NCT01090024|589761794|FG006|Period 1|Met exclusion criteria|0|||
163288313|NCT01090024|589761795|FG007|Period 1|Met exclusion criteria|0|||
163288314|NCT01090024|589761796|FG008|Period 1|Met exclusion criteria|0|||
163288315|NCT01090024|589761797|FG009|Period 1|Met exclusion criteria|0|||
163288316|NCT01090024|589761798|FG010|Period 1|Met exclusion criteria|0|||
163288317|NCT01090024|589761799|FG011|Period 1|Met exclusion criteria|0|||
163288318|NCT01090024|589761800|FG012|Period 1|Met exclusion criteria|0|||
163288319|NCT01090024|589761801|FG013|Period 1|Met exclusion criteria|0|||
163288320|NCT01090024|589761802|FG014|Period 1|Met exclusion criteria|1|||
163288321|NCT01090024|589761803|FG015|Period 1|Met exclusion criteria|0|||
163288322|NCT01090024|589761804|FG016|Period 1|Met exclusion criteria|0|||
163288323|NCT01090024|589761805|FG017|Period 1|Met exclusion criteria|0|||
163288324|NCT01090024|589761788|FG000|Period 1|Adverse Event|0|||
163288325|NCT01090024|589761789|FG001|Period 1|Adverse Event|0|||
163288326|NCT01090024|589761790|FG002|Period 1|Adverse Event|0|||
163288327|NCT01090024|589761791|FG003|Period 1|Adverse Event|0|||
163288328|NCT01090024|589761792|FG004|Period 1|Adverse Event|0|||
163288329|NCT01090024|589761793|FG005|Period 1|Adverse Event|0|||
163288330|NCT01090024|589761794|FG006|Period 1|Adverse Event|0|||
163288331|NCT01090024|589761795|FG007|Period 1|Adverse Event|0|||
163288332|NCT01090024|589761796|FG008|Period 1|Adverse Event|0|||
163288333|NCT01090024|589761797|FG009|Period 1|Adverse Event|1|||
163288334|NCT01090024|589761798|FG010|Period 1|Adverse Event|0|||
163288335|NCT01090024|589761799|FG011|Period 1|Adverse Event|1|||
163288336|NCT01090024|589761800|FG012|Period 1|Adverse Event|0|||
163288337|NCT01090024|589761801|FG013|Period 1|Adverse Event|0|||
163288338|NCT01090024|589761802|FG014|Period 1|Adverse Event|0|||
163288339|NCT01090024|589761803|FG015|Period 1|Adverse Event|0|||
163288340|NCT01090024|589761804|FG016|Period 1|Adverse Event|0|||
163288341|NCT01090024|589761805|FG017|Period 1|Adverse Event|1|||
163288342|NCT01090024|589761788|FG000|Period 1|Withdrawal by Subject|0|||
163288343|NCT01090024|589761789|FG001|Period 1|Withdrawal by Subject|0|||
163288344|NCT01090024|589761790|FG002|Period 1|Withdrawal by Subject|0|||
163288345|NCT01090024|589761791|FG003|Period 1|Withdrawal by Subject|1|||
163288346|NCT01090024|589761792|FG004|Period 1|Withdrawal by Subject|0|||
163288347|NCT01090024|589761793|FG005|Period 1|Withdrawal by Subject|0|||
163288348|NCT01090024|589761794|FG006|Period 1|Withdrawal by Subject|0|||
163288349|NCT01090024|589761795|FG007|Period 1|Withdrawal by Subject|0|||
163288350|NCT01090024|589761796|FG008|Period 1|Withdrawal by Subject|0|||
163288351|NCT01090024|589761797|FG009|Period 1|Withdrawal by Subject|0|||
163288352|NCT01090024|589761798|FG010|Period 1|Withdrawal by Subject|0|||
163288353|NCT01090024|589761799|FG011|Period 1|Withdrawal by Subject|0|||
163288354|NCT01090024|589761800|FG012|Period 1|Withdrawal by Subject|0|||
163288355|NCT01090024|589761801|FG013|Period 1|Withdrawal by Subject|0|||
163288356|NCT01090024|589761802|FG014|Period 1|Withdrawal by Subject|0|||
163288357|NCT01090024|589761803|FG015|Period 1|Withdrawal by Subject|0|||
163288358|NCT01090024|589761804|FG016|Period 1|Withdrawal by Subject|0|||
163288359|NCT01090024|589761805|FG017|Period 1|Withdrawal by Subject|0|||
163288360|NCT01090024|589761788|FG000|Period 1|Lost to Follow-up|0|||
163288361|NCT01090024|589761789|FG001|Period 1|Lost to Follow-up|1|||
163288362|NCT01090024|589761790|FG002|Period 1|Lost to Follow-up|0|||
163288363|NCT01090024|589761791|FG003|Period 1|Lost to Follow-up|0|||
163288364|NCT01090024|589761792|FG004|Period 1|Lost to Follow-up|0|||
163288365|NCT01090024|589761793|FG005|Period 1|Lost to Follow-up|0|||
163288366|NCT01090024|589761794|FG006|Period 1|Lost to Follow-up|0|||
163288367|NCT01090024|589761795|FG007|Period 1|Lost to Follow-up|0|||
163288368|NCT01090024|589761796|FG008|Period 1|Lost to Follow-up|0|||
163288369|NCT01090024|589761797|FG009|Period 1|Lost to Follow-up|0|||
163288370|NCT01090024|589761798|FG010|Period 1|Lost to Follow-up|0|||
163288371|NCT01090024|589761799|FG011|Period 1|Lost to Follow-up|0|||
163288372|NCT01090024|589761800|FG012|Period 1|Lost to Follow-up|0|||
163288373|NCT01090024|589761801|FG013|Period 1|Lost to Follow-up|0|||
163288374|NCT01090024|589761802|FG014|Period 1|Lost to Follow-up|0|||
163288375|NCT01090024|589761803|FG015|Period 1|Lost to Follow-up|0|||
163288376|NCT01090024|589761804|FG016|Period 1|Lost to Follow-up|0|||
163288377|NCT01090024|589761805|FG017|Period 1|Lost to Follow-up|0|||
163288378|NCT01090024|589761788|FG000|Period 2|Lost to Follow-up|0|||
163288379|NCT01090024|589761789|FG001|Period 2|Lost to Follow-up|0|||
163288380|NCT01090024|589761790|FG002|Period 2|Lost to Follow-up|0|||
163288381|NCT01090024|589761791|FG003|Period 2|Lost to Follow-up|1|||
163288382|NCT01090024|589761792|FG004|Period 2|Lost to Follow-up|0|||
163288383|NCT01090024|589761793|FG005|Period 2|Lost to Follow-up|0|||
163288384|NCT01090024|589761794|FG006|Period 2|Lost to Follow-up|0|||
163288385|NCT01090024|589761795|FG007|Period 2|Lost to Follow-up|0|||
163288386|NCT01090024|589761796|FG008|Period 2|Lost to Follow-up|0|||
163288387|NCT01090024|589761797|FG009|Period 2|Lost to Follow-up|0|||
163288388|NCT01090024|589761798|FG010|Period 2|Lost to Follow-up|0|||
163288389|NCT01090024|589761799|FG011|Period 2|Lost to Follow-up|0|||
163288390|NCT01090024|589761800|FG012|Period 2|Lost to Follow-up|0|||
163288391|NCT01090024|589761801|FG013|Period 2|Lost to Follow-up|0|||
163288392|NCT01090024|589761802|FG014|Period 2|Lost to Follow-up|0|||
163288393|NCT01090024|589761803|FG015|Period 2|Lost to Follow-up|0|||
163288394|NCT01090024|589761804|FG016|Period 2|Lost to Follow-up|0|||
163288395|NCT01090024|589761805|FG017|Period 2|Lost to Follow-up|0|||
163288396|NCT01090024|589761788|FG000|Period 2|Adverse Event|1|||
163288397|NCT01090024|589761789|FG001|Period 2|Adverse Event|0|||
163288398|NCT01090024|589761790|FG002|Period 2|Adverse Event|0|||
163288399|NCT01090024|589761791|FG003|Period 2|Adverse Event|0|||
163288400|NCT01090024|589761792|FG004|Period 2|Adverse Event|0|||
163288401|NCT01090024|589761793|FG005|Period 2|Adverse Event|0|||
163288402|NCT01090024|589761794|FG006|Period 2|Adverse Event|0|||
163288403|NCT01090024|589761795|FG007|Period 2|Adverse Event|0|||
163288404|NCT01090024|589761796|FG008|Period 2|Adverse Event|0|||
163288405|NCT01090024|589761797|FG009|Period 2|Adverse Event|0|||
163288406|NCT01090024|589761798|FG010|Period 2|Adverse Event|0|||
163288407|NCT01090024|589761799|FG011|Period 2|Adverse Event|0|||
163288408|NCT01090024|589761800|FG012|Period 2|Adverse Event|0|||
163288409|NCT01090024|589761801|FG013|Period 2|Adverse Event|0|||
163288410|NCT01090024|589761802|FG014|Period 2|Adverse Event|0|||
163288411|NCT01090024|589761803|FG015|Period 2|Adverse Event|0|||
163288412|NCT01090024|589761804|FG016|Period 2|Adverse Event|0|||
163288413|NCT01090024|589761805|FG017|Period 2|Adverse Event|0|||
163288414|NCT01090024|589761788|FG000|Period 3|Withdrawal by Subject|0|||
163288415|NCT01090024|589761789|FG001|Period 3|Withdrawal by Subject|0|||
163288416|NCT01090024|589761790|FG002|Period 3|Withdrawal by Subject|0|||
163288417|NCT01090024|589761791|FG003|Period 3|Withdrawal by Subject|0|||
163288418|NCT01090024|589761792|FG004|Period 3|Withdrawal by Subject|0|||
163288419|NCT01090024|589761793|FG005|Period 3|Withdrawal by Subject|0|||
163288420|NCT01090024|589761794|FG006|Period 3|Withdrawal by Subject|0|||
163288421|NCT01090024|589761795|FG007|Period 3|Withdrawal by Subject|0|||
163288422|NCT01090024|589761796|FG008|Period 3|Withdrawal by Subject|0|||
163288423|NCT01090024|589761797|FG009|Period 3|Withdrawal by Subject|0|||
163288424|NCT01090024|589761798|FG010|Period 3|Withdrawal by Subject|0|||
163288425|NCT01090024|589761799|FG011|Period 3|Withdrawal by Subject|0|||
163288426|NCT01090024|589761800|FG012|Period 3|Withdrawal by Subject|0|||
163288427|NCT01090024|589761801|FG013|Period 3|Withdrawal by Subject|0|||
163288428|NCT01090024|589761802|FG014|Period 3|Withdrawal by Subject|0|||
163288429|NCT01090024|589761803|FG015|Period 3|Withdrawal by Subject|1|||
163288430|NCT01090024|589761804|FG016|Period 3|Withdrawal by Subject|0|||
163288431|NCT01090024|589761805|FG017|Period 3|Withdrawal by Subject|0|||
163288432|NCT01090024|589761788|FG000|Period 3|Protocol Violation|0|||
163288433|NCT01090024|589761789|FG001|Period 3|Protocol Violation|0|||
163288434|NCT01090024|589761790|FG002|Period 3|Protocol Violation|0|||
163288435|NCT01090024|589761791|FG003|Period 3|Protocol Violation|0|||
163288436|NCT01090024|589761792|FG004|Period 3|Protocol Violation|0|||
163288437|NCT01090024|589761793|FG005|Period 3|Protocol Violation|0|||
163288438|NCT01090024|589761794|FG006|Period 3|Protocol Violation|0|||
163288439|NCT01090024|589761795|FG007|Period 3|Protocol Violation|0|||
163288440|NCT01090024|589761796|FG008|Period 3|Protocol Violation|1|||
163288441|NCT01090024|589761797|FG009|Period 3|Protocol Violation|0|||
163288442|NCT01090024|589761798|FG010|Period 3|Protocol Violation|0|||
163288443|NCT01090024|589761799|FG011|Period 3|Protocol Violation|0|||
163288444|NCT01090024|589761800|FG012|Period 3|Protocol Violation|0|||
163288445|NCT01090024|589761801|FG013|Period 3|Protocol Violation|0|||
163288446|NCT01090024|589761802|FG014|Period 3|Protocol Violation|0|||
163288447|NCT01090024|589761803|FG015|Period 3|Protocol Violation|0|||
163288448|NCT01090024|589761804|FG016|Period 3|Protocol Violation|0|||
163288449|NCT01090024|589761805|FG017|Period 3|Protocol Violation|0|||
163288450|NCT01090024|589761788|FG000|Period 3|Adverse Event|0|||
163288451|NCT01090024|589761789|FG001|Period 3|Adverse Event|0|||
163288452|NCT01090024|589761790|FG002|Period 3|Adverse Event|0|||
163288453|NCT01090024|589761791|FG003|Period 3|Adverse Event|0|||
163288454|NCT01090024|589761792|FG004|Period 3|Adverse Event|0|||
163288455|NCT01090024|589761793|FG005|Period 3|Adverse Event|1|||
163288456|NCT01090024|589761794|FG006|Period 3|Adverse Event|0|||
163288457|NCT01090024|589761795|FG007|Period 3|Adverse Event|0|||
163288458|NCT01090024|589761796|FG008|Period 3|Adverse Event|0|||
163288459|NCT01090024|589761797|FG009|Period 3|Adverse Event|0|||
163288460|NCT01090024|589761798|FG010|Period 3|Adverse Event|0|||
163288461|NCT01090024|589761799|FG011|Period 3|Adverse Event|0|||
163288462|NCT01090024|589761800|FG012|Period 3|Adverse Event|0|||
163288463|NCT01090024|589761801|FG013|Period 3|Adverse Event|0|||
163288464|NCT01090024|589761802|FG014|Period 3|Adverse Event|0|||
163288465|NCT01090024|589761803|FG015|Period 3|Adverse Event|0|||
163288466|NCT01090024|589761804|FG016|Period 3|Adverse Event|0|||
163288467|NCT01090024|589761805|FG017|Period 3|Adverse Event|0|||
163288468|NCT00470626|589761807|FG000|Overall Study|Lost to Follow-up|10|||
163288469|NCT00470626|589761807|FG000|Overall Study|Withdrawal by Subject|7|||
163288470|NCT00777556|589761808|FG000|Overall Study|Inappropriate self-selection|34|||
163288471|NCT00777556|589761808|FG000|Overall Study|Dispensed but did not use product|12|||
163288472|NCT00777556|589761808|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
163288473|NCT02380742|589761809|FG000|Overall Study|Withdrawal by Subject|1|||
163288474|NCT02380742|589761810|FG001|Overall Study|Withdrawal by Subject|0|||
163288475|NCT02689349|589761811|FG000|Overall Study|Not implanted|4|||
163288476|NCT02689349|589761812|FG001|Overall Study|Not implanted|0|||
163288477|NCT02689349|589761811|FG000|Overall Study|Withdrawal by Subject|9|||
163288478|NCT02689349|589761812|FG001|Overall Study|Withdrawal by Subject|0|||
163288479|NCT02930343|589761813|FG000|Overall Study|Lost to Follow-up|9|||
163288480|NCT02930343|589761814|FG001|Overall Study|Lost to Follow-up|7|||
163288481|NCT01185522|589761815|FG000|Overall Study|Lack of Efficacy|28|||
163288482|NCT01185522|589761815|FG000|Overall Study|Lost to Follow-up|19|||
163288483|NCT01185522|589761815|FG000|Overall Study|Withdrawal by Subject|10|||
163288484|NCT01185522|589761815|FG000|Overall Study|Poor tolerance|39|||
163288485|NCT01185522|589761815|FG000|Overall Study|Other reasons|12|||
163288486|NCT01729819|589761816|FG000|Overall Study|Adverse Event|2|||
163288487|NCT01729819|589761817|FG001|Overall Study|Adverse Event|4|||
163288488|NCT01729819|589761816|FG000|Overall Study|Lack of Efficacy|1|||
163288489|NCT01729819|589761817|FG001|Overall Study|Lack of Efficacy|0|||
163288490|NCT01729819|589761816|FG000|Overall Study|Lost to Follow-up|2|||
163288491|NCT01729819|589761817|FG001|Overall Study|Lost to Follow-up|0|||
163288492|NCT01729819|589761816|FG000|Overall Study|Other reason|1|||
163288493|NCT01729819|589761817|FG001|Overall Study|Other reason|0|||
163288494|NCT01729819|589761816|FG000|Overall Study|Protocol Violation|0|||
163288495|NCT01729819|589761817|FG001|Overall Study|Protocol Violation|1|||
163288496|NCT01729819|589761816|FG000|Overall Study|Withdrawal by Subject|0|||
163288497|NCT01729819|589761817|FG001|Overall Study|Withdrawal by Subject|2|||
163288498|NCT01025843|589761818|FG000|Washout 4|Withdrawal by Subject|0|||
163288499|NCT01025843|589761819|FG001|Washout 4|Withdrawal by Subject|0|||
163288500|NCT01025843|589761820|FG002|Washout 4|Withdrawal by Subject|1|||
163288501|NCT01025843|589761821|FG003|Washout 4|Withdrawal by Subject|1|||
163288502|NCT01025843|589761822|FG004|Washout 4|Withdrawal by Subject|0|||
163288503|NCT01025843|589761823|FG005|Washout 4|Withdrawal by Subject|0|||
163288504|NCT01025843|589761824|FG006|Washout 4|Withdrawal by Subject|0|||
163288505|NCT01025843|589761825|FG007|Washout 4|Withdrawal by Subject|0|||
163288506|NCT01025843|589761826|FG008|Washout 4|Withdrawal by Subject|0|||
163288507|NCT01025843|589761827|FG009|Washout 4|Withdrawal by Subject|0|||
163288508|NCT01649791|589761828|FG000|Overall Study|Disease Progression|2|||
163288509|NCT01649791|589761828|FG000|Overall Study|Adverse Event|1|||
163288510|NCT02987543|589761829|FG000|Overall Study|Ongoing study at data cut off|49|||
163288511|NCT02987543|589761830|FG001|Overall Study|Ongoing study at data cut off|21|||
163288512|NCT02987543|589761831|FG002|Overall Study|Ongoing study at data cut off|19|||
163288513|NCT02987543|589761832|FG003|Overall Study|Ongoing study at data cut off|12|||
163288514|NCT02987543|589761829|FG000|Overall Study|Death|88|||
163288515|NCT02987543|589761830|FG001|Overall Study|Death|54|||
163288516|NCT02987543|589761831|FG002|Overall Study|Death|67|||
163288517|NCT02987543|589761832|FG003|Overall Study|Death|28|||
163288518|NCT02987543|589761829|FG000|Overall Study|Lost to Follow-up|3|||
163288519|NCT02987543|589761830|FG001|Overall Study|Lost to Follow-up|0|||
163288520|NCT02987543|589761831|FG002|Overall Study|Lost to Follow-up|1|||
163288521|NCT02987543|589761832|FG003|Overall Study|Lost to Follow-up|0|||
163288522|NCT02987543|589761829|FG000|Overall Study|Screen failure|0|||
163288523|NCT02987543|589761830|FG001|Overall Study|Screen failure|0|||
163288524|NCT02987543|589761831|FG002|Overall Study|Screen failure|0|||
163288525|NCT02987543|589761832|FG003|Overall Study|Screen failure|1|||
163288526|NCT02987543|589761829|FG000|Overall Study|Withdrawal by Subject|21|||
163288527|NCT02987543|589761830|FG001|Overall Study|Withdrawal by Subject|7|||
163288528|NCT02987543|589761831|FG002|Overall Study|Withdrawal by Subject|7|||
163288529|NCT02987543|589761832|FG003|Overall Study|Withdrawal by Subject|6|||
163288530|NCT02987543|589761829|FG000|Overall Study|Study terminated by sponsor|1|||
163288531|NCT02987543|589761830|FG001|Overall Study|Study terminated by sponsor|0|||
163288532|NCT02987543|589761831|FG002|Overall Study|Study terminated by sponsor|0|||
163288533|NCT02987543|589761832|FG003|Overall Study|Study terminated by sponsor|0|||
163288534|NCT02987543|589761829|FG000|Overall Study|Investigator decision|0|||
163288535|NCT02987543|589761830|FG001|Overall Study|Investigator decision|1|||
163288536|NCT02987543|589761831|FG002|Overall Study|Investigator decision|0|||
163288537|NCT02987543|589761832|FG003|Overall Study|Investigator decision|0|||
163288538|NCT02987543|589761829|FG000|Overall Study|Disease progression|0|||
163288539|NCT02987543|589761830|FG001|Overall Study|Disease progression|0|||
163288540|NCT02987543|589761831|FG002|Overall Study|Disease progression|0|||
163288541|NCT02987543|589761832|FG003|Overall Study|Disease progression|1|||
163288542|NCT03646669|589761835|FG000|Overall Study|Withdrawal by Subject|5|||
163288543|NCT03646669|589761836|FG001|Overall Study|Withdrawal by Subject|0|||
163288544|NCT01227278|589761837|FG000|Overall Study|Withdrawal by Subject|4|||
163288545|NCT01227278|589761838|FG001|Overall Study|Withdrawal by Subject|4|||
163288546|NCT01227278|589761837|FG000|Overall Study|Death|0|||
163288547|NCT01227278|589761838|FG001|Overall Study|Death|2|||
163288548|NCT01227278|589761837|FG000|Overall Study|Other|1|||
163288549|NCT01227278|589761838|FG001|Overall Study|Other|2|||
163288550|NCT03720210|589761845|FG000|Overall Study|Lost to Follow-up|1|||
163288551|NCT02274493|589761848|FG000|Overall Study|Withdrawal by Subject|1|||
163288552|NCT00868192|589761849|FG000|Overall Study|Ineligible|4|||
163288553|NCT01178762|589761851|FG000|Overall Study|Lost to Follow-up|15|||
163288554|NCT01190150|589761854|FG000|First Treatment|Withdrawal by Subject|1|||
163288555|NCT01190150|589761855|FG001|First Treatment|Withdrawal by Subject|0|||
163288556|NCT01190150|589761854|FG000|Washout|Withdrawal by Subject|0|||
163288557|NCT01190150|589761855|FG001|Washout|Withdrawal by Subject|1|||
163288558|NCT01190150|589761854|FG000|Washout|Difficulty in adherence|0|||
163288559|NCT01190150|589761855|FG001|Washout|Difficulty in adherence|1|||
163288560|NCT00608907|589761856|FG000|Overall Study|Adverse Event|6|||
163288561|NCT00608907|589761857|FG001|Overall Study|Adverse Event|0|||
163288562|NCT00608907|589761858|FG002|Overall Study|Adverse Event|1|||
163288563|NCT00608907|589761856|FG000|Overall Study|Death|1|||
163288564|NCT00608907|589761857|FG001|Overall Study|Death|0|||
163288565|NCT00608907|589761858|FG002|Overall Study|Death|0|||
163288566|NCT00608907|589761856|FG000|Overall Study|Withdrawal by Subject|4|||
163288567|NCT00608907|589761857|FG001|Overall Study|Withdrawal by Subject|0|||
163288568|NCT00608907|589761858|FG002|Overall Study|Withdrawal by Subject|0|||
163288569|NCT00608907|589761856|FG000|Overall Study|Progressive Disease|1|||
163288570|NCT00608907|589761857|FG001|Overall Study|Progressive Disease|0|||
163288571|NCT00608907|589761858|FG002|Overall Study|Progressive Disease|0|||
163288572|NCT03523962|589761866|FG000|Closed Fractures|Death|86|||
163288573|NCT03523962|589761867|FG001|Closed Fractures|Death|71|||
163288574|NCT03523962|589761868|FG002|Closed Fractures|Death|0|||
163288575|NCT03523962|589761869|FG003|Closed Fractures|Death|0|||
163288576|NCT03523962|589761866|FG000|Closed Fractures|Lost to Follow-up|62|||
163288577|NCT03523962|589761867|FG001|Closed Fractures|Lost to Follow-up|36|||
163288578|NCT03523962|589761868|FG002|Closed Fractures|Lost to Follow-up|0|||
163288579|NCT03523962|589761869|FG003|Closed Fractures|Lost to Follow-up|0|||
163288580|NCT03523962|589761866|FG000|Closed Fractures|Withdrawal by Subject|19|||
163288581|NCT03523962|589761867|FG001|Closed Fractures|Withdrawal by Subject|29|||
163288582|NCT03523962|589761868|FG002|Closed Fractures|Withdrawal by Subject|0|||
163288583|NCT03523962|589761869|FG003|Closed Fractures|Withdrawal by Subject|0|||
163288584|NCT03523962|589761866|FG000|Closed Fractures|Incarceration|1|||
163288585|NCT03523962|589761867|FG001|Closed Fractures|Incarceration|4|||
163288586|NCT03523962|589761868|FG002|Closed Fractures|Incarceration|0|||
163288587|NCT03523962|589761869|FG003|Closed Fractures|Incarceration|0|||
163288588|NCT03523962|589761866|FG000|Open Fractures|Death|0|||
163288589|NCT03523962|589761867|FG001|Open Fractures|Death|0|||
163288590|NCT03523962|589761868|FG002|Open Fractures|Death|11|||
163288591|NCT03523962|589761869|FG003|Open Fractures|Death|6|||
163288592|NCT03523962|589761866|FG000|Open Fractures|Lost to Follow-up|0|||
163288593|NCT03523962|589761867|FG001|Open Fractures|Lost to Follow-up|0|||
163288594|NCT03523962|589761868|FG002|Open Fractures|Lost to Follow-up|15|||
163288595|NCT03523962|589761869|FG003|Open Fractures|Lost to Follow-up|8|||
163288596|NCT03523962|589761866|FG000|Open Fractures|Withdrawal by Subject|0|||
163288597|NCT03523962|589761867|FG001|Open Fractures|Withdrawal by Subject|0|||
163288598|NCT03523962|589761868|FG002|Open Fractures|Withdrawal by Subject|6|||
163288599|NCT03523962|589761869|FG003|Open Fractures|Withdrawal by Subject|2|||
163288600|NCT03523962|589761866|FG000|Open Fractures|Incarceration|0|||
163288601|NCT03523962|589761867|FG001|Open Fractures|Incarceration|0|||
163288602|NCT03523962|589761868|FG002|Open Fractures|Incarceration|1|||
163288603|NCT03523962|589761869|FG003|Open Fractures|Incarceration|0|||
163288604|NCT00835380|589761870|FG000|Overall Study|Withdrawal by Subject|2|||
163288605|NCT01081145|589761873|FG000|Open-Label Phase|Lack of Efficacy|56|||
163288606|NCT01081145|589761874|FG001|Open-Label Phase|Lack of Efficacy|0|||
163288607|NCT01081145|589761873|FG000|Open-Label Phase|Response criteria not met|46|||
163288608|NCT01081145|589761874|FG001|Open-Label Phase|Response criteria not met|0|||
163288609|NCT01081145|589761873|FG000|Open-Label Phase|Adverse Event|42|||
163288610|NCT01081145|589761874|FG001|Open-Label Phase|Adverse Event|0|||
163288611|NCT01081145|589761873|FG000|Open-Label Phase|Withdrawal by Subject|41|||
163288612|NCT01081145|589761874|FG001|Open-Label Phase|Withdrawal by Subject|0|||
163288613|NCT01081145|589761873|FG000|Open-Label Phase|Other|12|||
163288614|NCT01081145|589761874|FG001|Open-Label Phase|Other|0|||
163288615|NCT01081145|589761873|FG000|Open-Label Phase|Lost to Follow-up|11|||
163288616|NCT01081145|589761874|FG001|Open-Label Phase|Lost to Follow-up|0|||
163288617|NCT01081145|589761873|FG000|Open-Label Phase|Protocol Violation|4|||
163288618|NCT01081145|589761874|FG001|Open-Label Phase|Protocol Violation|0|||
163288619|NCT01081145|589761873|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
163288620|NCT01081145|589761874|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
163288621|NCT01081145|589761873|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
163288622|NCT01081145|589761874|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
163288623|NCT01081145|589761873|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
163288624|NCT01081145|589761874|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
163288625|NCT01081145|589761873|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
163288626|NCT01081145|589761874|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
163288627|NCT01081145|589761873|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
163288628|NCT01081145|589761874|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
163288629|NCT01081145|589761873|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
163288630|NCT01081145|589761874|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
163288631|NCT01081145|589761873|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
162937496|NCT00628745|588473656|FG003|Overall Study|Lost to Follow-up|0|||
163288632|NCT01081145|589761874|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
163288633|NCT03593070|589761875|FG000|Overall Study|administrative withdrawal|1|||
163288634|NCT03593070|589761876|FG001|Overall Study|administrative withdrawal|1|||
163288635|NCT03643211|589761877|FG000|Overall Study|Contract violation/deficiency|12|||
163288636|NCT03643211|589761877|FG000|Overall Study|Invalid registration|3|||
163288637|NCT03643211|589761877|FG000|Overall Study|No treatment information|2|||
163288638|NCT03643211|589761877|FG000|Overall Study|No adverse event information - No revisit|4|||
163288639|NCT00881335|589761878|FG000|Overall Study|Lost to Follow-up|3|||
163288640|NCT00881335|589761879|FG001|Overall Study|Lost to Follow-up|2|||
163288641|NCT03431350|589761884|FG000|Overall Study|ONGOING|0|||
163288642|NCT03431350|589761885|FG001|Overall Study|ONGOING|0|||
163288643|NCT03431350|589761886|FG002|Overall Study|ONGOING|2|||
163288644|NCT03431350|589761887|FG003|Overall Study|ONGOING|0|||
163288645|NCT03431350|589761888|FG004|Overall Study|ONGOING|1|||
163288646|NCT03431350|589761889|FG005|Overall Study|ONGOING|3|||
163288647|NCT03431350|589761890|FG006|Overall Study|ONGOING|0|||
163288648|NCT03431350|589761891|FG007|Overall Study|ONGOING|1|||
163288649|NCT03431350|589761892|FG008|Overall Study|ONGOING|3|||
163288650|NCT03431350|589761893|FG009|Overall Study|ONGOING|4|||
163288651|NCT03431350|589761894|FG010|Overall Study|ONGOING|2|||
163288652|NCT03431350|589761895|FG011|Overall Study|ONGOING|1|||
163288653|NCT03431350|589761884|FG000|Overall Study|Death|6|||
163288654|NCT03431350|589761885|FG001|Overall Study|Death|5|||
163288655|NCT03431350|589761886|FG002|Overall Study|Death|18|||
163288656|NCT03431350|589761887|FG003|Overall Study|Death|7|||
163288657|NCT03431350|589761888|FG004|Overall Study|Death|4|||
163288658|NCT03431350|589761889|FG005|Overall Study|Death|3|||
163288659|NCT03431350|589761890|FG006|Overall Study|Death|2|||
163288660|NCT03431350|589761891|FG007|Overall Study|Death|0|||
163288661|NCT03431350|589761892|FG008|Overall Study|Death|0|||
163288662|NCT03431350|589761893|FG009|Overall Study|Death|0|||
163288663|NCT03431350|589761894|FG010|Overall Study|Death|4|||
163288664|NCT03431350|589761895|FG011|Overall Study|Death|0|||
163288665|NCT03431350|589761884|FG000|Overall Study|Lost to Follow-up|0|||
163288666|NCT03431350|589761885|FG001|Overall Study|Lost to Follow-up|1|||
163288667|NCT03431350|589761886|FG002|Overall Study|Lost to Follow-up|0|||
163288668|NCT03431350|589761887|FG003|Overall Study|Lost to Follow-up|0|||
163288669|NCT03431350|589761888|FG004|Overall Study|Lost to Follow-up|0|||
163288670|NCT03431350|589761889|FG005|Overall Study|Lost to Follow-up|0|||
163288671|NCT03431350|589761890|FG006|Overall Study|Lost to Follow-up|0|||
163288672|NCT03431350|589761891|FG007|Overall Study|Lost to Follow-up|0|||
163288673|NCT03431350|589761892|FG008|Overall Study|Lost to Follow-up|0|||
163288674|NCT03431350|589761893|FG009|Overall Study|Lost to Follow-up|0|||
163288675|NCT03431350|589761894|FG010|Overall Study|Lost to Follow-up|0|||
163288676|NCT03431350|589761895|FG011|Overall Study|Lost to Follow-up|0|||
163288677|NCT03431350|589761884|FG000|Overall Study|Withdrawal by Subject|0|||
163288678|NCT03431350|589761885|FG001|Overall Study|Withdrawal by Subject|0|||
163288679|NCT03431350|589761886|FG002|Overall Study|Withdrawal by Subject|0|||
163288680|NCT03431350|589761887|FG003|Overall Study|Withdrawal by Subject|1|||
163288681|NCT03431350|589761888|FG004|Overall Study|Withdrawal by Subject|1|||
163288682|NCT03431350|589761889|FG005|Overall Study|Withdrawal by Subject|1|||
163288683|NCT03431350|589761890|FG006|Overall Study|Withdrawal by Subject|0|||
163288684|NCT03431350|589761891|FG007|Overall Study|Withdrawal by Subject|0|||
163288685|NCT03431350|589761892|FG008|Overall Study|Withdrawal by Subject|0|||
163288686|NCT03431350|589761893|FG009|Overall Study|Withdrawal by Subject|2|||
163288687|NCT03431350|589761894|FG010|Overall Study|Withdrawal by Subject|0|||
163288688|NCT03431350|589761895|FG011|Overall Study|Withdrawal by Subject|1|||
163288689|NCT03431350|589761884|FG000|Overall Study|Other|0|||
163288690|NCT03431350|589761885|FG001|Overall Study|Other|0|||
163288691|NCT03431350|589761886|FG002|Overall Study|Other|1|||
163288692|NCT03431350|589761887|FG003|Overall Study|Other|3|||
163288693|NCT03431350|589761888|FG004|Overall Study|Other|2|||
163288694|NCT03431350|589761889|FG005|Overall Study|Other|2|||
163288695|NCT03431350|589761890|FG006|Overall Study|Other|4|||
163288696|NCT03431350|589761891|FG007|Overall Study|Other|0|||
163288697|NCT03431350|589761892|FG008|Overall Study|Other|14|||
163288698|NCT03431350|589761893|FG009|Overall Study|Other|11|||
163288699|NCT03431350|589761894|FG010|Overall Study|Other|11|||
163288700|NCT03431350|589761895|FG011|Overall Study|Other|15|||
163288701|NCT04487080|589761904|FG000|Overall Study|Withdrawal by Subject|19|||
163288702|NCT04487080|589761905|FG001|Overall Study|Withdrawal by Subject|18|||
163288703|NCT04487080|589761906|FG002|Overall Study|Withdrawal by Subject|13|||
163288704|NCT04487080|589761904|FG000|Overall Study|Lost to Follow-up|3|||
163288705|NCT04487080|589761905|FG001|Overall Study|Lost to Follow-up|1|||
163288706|NCT04487080|589761906|FG002|Overall Study|Lost to Follow-up|0|||
163288707|NCT04487080|589761904|FG000|Overall Study|Ongoing|313|||
163288708|NCT04487080|589761905|FG001|Overall Study|Ongoing|297|||
163288709|NCT04487080|589761906|FG002|Overall Study|Ongoing|149|||
163288710|NCT03354390|589761910|FG000|Level 1|Death|2|||
163288711|NCT03354390|589761911|FG001|Level 1|Death|0|||
163288712|NCT03354390|589761912|FG002|Level 1|Death|0|||
163288713|NCT03354390|589761913|FG003|Level 1|Death|0|||
163288714|NCT03354390|589761910|FG000|Level 1|Physician Decision|1|||
163288715|NCT03354390|589761911|FG001|Level 1|Physician Decision|0|||
163288716|NCT03354390|589761912|FG002|Level 1|Physician Decision|0|||
163288717|NCT03354390|589761913|FG003|Level 1|Physician Decision|0|||
163288718|NCT03354390|589761910|FG000|Level 2|Physician Decision|0|||
163288719|NCT03354390|589761911|FG001|Level 2|Physician Decision|2|||
163288720|NCT03354390|589761912|FG002|Level 2|Physician Decision|0|||
163288721|NCT03354390|589761913|FG003|Level 2|Physician Decision|0|||
163288722|NCT03354390|589761910|FG000|Level 2|Lack of Efficacy|0|||
163288723|NCT03354390|589761911|FG001|Level 2|Lack of Efficacy|1|||
163288724|NCT03354390|589761912|FG002|Level 2|Lack of Efficacy|0|||
163288725|NCT03354390|589761913|FG003|Level 2|Lack of Efficacy|0|||
163288726|NCT03354390|589761910|FG000|Level 2|Lost to Follow-up|0|||
163288727|NCT03354390|589761911|FG001|Level 2|Lost to Follow-up|1|||
163288728|NCT03354390|589761912|FG002|Level 2|Lost to Follow-up|0|||
163288729|NCT03354390|589761913|FG003|Level 2|Lost to Follow-up|0|||
163288730|NCT03354390|589761910|FG000|Level 3|Death|0|||
163288731|NCT03354390|589761911|FG001|Level 3|Death|0|||
163288732|NCT03354390|589761912|FG002|Level 3|Death|1|||
163288733|NCT03354390|589761913|FG003|Level 3|Death|0|||
163288734|NCT03354390|589761910|FG000|Level 3|Physician Decision|0|||
163288735|NCT03354390|589761911|FG001|Level 3|Physician Decision|0|||
163288736|NCT03354390|589761912|FG002|Level 3|Physician Decision|2|||
163288737|NCT03354390|589761913|FG003|Level 3|Physician Decision|0|||
163288738|NCT03354390|589761910|FG000|Level 4|Death|0|||
163288739|NCT03354390|589761911|FG001|Level 4|Death|0|||
163288740|NCT03354390|589761912|FG002|Level 4|Death|0|||
163288741|NCT03354390|589761913|FG003|Level 4|Death|3|||
163288742|NCT03944512|589761915|FG000|Overall Study|Death|0|||
163288743|NCT03944512|589761916|FG001|Overall Study|Death|0|||
163288744|NCT03944512|589761917|FG002|Overall Study|Death|1|||
163288745|NCT03944512|589761918|FG003|Overall Study|Death|2|||
163288746|NCT03944512|589761915|FG000|Overall Study|Lost to Follow-up|0|||
163288747|NCT03944512|589761916|FG001|Overall Study|Lost to Follow-up|0|||
163288748|NCT03944512|589761917|FG002|Overall Study|Lost to Follow-up|4|||
163288749|NCT03944512|589761918|FG003|Overall Study|Lost to Follow-up|4|||
163288750|NCT03944512|589761915|FG000|Overall Study|refused follow-up|0|||
163288751|NCT03944512|589761916|FG001|Overall Study|refused follow-up|0|||
163288752|NCT03944512|589761917|FG002|Overall Study|refused follow-up|2|||
163288753|NCT03944512|589761918|FG003|Overall Study|refused follow-up|2|||
163288754|NCT00486759|589763091|FG000|Treatment|Adverse event/intercurrent illness|86|||
163288755|NCT00486759|589763092|FG001|Treatment|Adverse event/intercurrent illness|39|||
163288756|NCT00486759|589763091|FG000|Treatment|Insufficient therapeutic response|37|||
163288757|NCT00486759|589763092|FG001|Treatment|Insufficient therapeutic response|39|||
163288758|NCT00486759|589763091|FG000|Treatment|Death|17|||
163288759|NCT00486759|589763092|FG001|Treatment|Death|10|||
163288760|NCT00486759|589763091|FG000|Treatment|Withdrew consent|15|||
163288761|NCT00486759|589763092|FG001|Treatment|Withdrew consent|12|||
163288762|NCT00486759|589763091|FG000|Treatment|Administrative/reason not specified|17|||
163288763|NCT00486759|589763092|FG001|Treatment|Administrative/reason not specified|21|||
163288764|NCT00486759|589763091|FG000|Treatment|Refused treatment|10|||
163288765|NCT00486759|589763092|FG001|Treatment|Refused treatment|7|||
163288766|NCT00486759|589763091|FG000|Treatment|Violation of selection criteria at entry|3|||
163288767|NCT00486759|589763092|FG001|Treatment|Violation of selection criteria at entry|3|||
163288768|NCT00486759|589763091|FG000|Treatment|Other protocol violation|1|||
163288769|NCT00486759|589763092|FG001|Treatment|Other protocol violation|5|||
163288770|NCT00486759|589763091|FG000|Treatment|Failure to return|1|||
163288771|NCT00486759|589763092|FG001|Treatment|Failure to return|1|||
163288772|NCT00486759|589763091|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
163288773|NCT00486759|589763092|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
162937497|NCT00628745|588473657|FG004|Overall Study|Lost to Follow-up|498|||
162937498|NCT00628745|588473653|FG000|Overall Study|Death|197|||
162937499|NCT00628745|588473654|FG001|Overall Study|Death|81|||
162937500|NCT00628745|588473655|FG002|Overall Study|Death|12|||
162937501|NCT00628745|588473656|FG003|Overall Study|Death|4|||
162937502|NCT00628745|588473657|FG004|Overall Study|Death|939|||
162937503|NCT00628745|588473653|FG000|Overall Study|Participant transferred to another THAOS site|6|||
162937504|NCT00628745|588473654|FG001|Overall Study|Participant transferred to another THAOS site|0|||
162937505|NCT00628745|588473655|FG002|Overall Study|Participant transferred to another THAOS site|0|||
162937506|NCT00628745|588473656|FG003|Overall Study|Participant transferred to another THAOS site|0|||
162937507|NCT00628745|588473657|FG004|Overall Study|Participant transferred to another THAOS site|7|||
162937508|NCT00628745|588473653|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
162937509|NCT00628745|588473654|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
162937510|NCT00628745|588473655|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
162937511|NCT00628745|588473656|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
162937512|NCT00628745|588473657|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
162937513|NCT00628745|588473653|FG000|Overall Study|Site closure|152|||
162937514|NCT00628745|588473654|FG001|Overall Study|Site closure|146|||
162937515|NCT00628745|588473655|FG002|Overall Study|Site closure|6|||
162937516|NCT00628745|588473656|FG003|Overall Study|Site closure|8|||
162937517|NCT00628745|588473657|FG004|Overall Study|Site closure|691|||
162937518|NCT00628745|588473653|FG000|Overall Study|Duplicate participant|0|||
162937519|NCT00628745|588473654|FG001|Overall Study|Duplicate participant|0|||
162937520|NCT00628745|588473655|FG002|Overall Study|Duplicate participant|0|||
162937521|NCT00628745|588473656|FG003|Overall Study|Duplicate participant|0|||
162937522|NCT00628745|588473657|FG004|Overall Study|Duplicate participant|1|||
162937523|NCT00628745|588473653|FG000|Overall Study|Missing|4|||
162937524|NCT00628745|588473654|FG001|Overall Study|Missing|3|||
162937525|NCT00628745|588473655|FG002|Overall Study|Missing|0|||
162937526|NCT00628745|588473656|FG003|Overall Study|Missing|0|||
162937527|NCT00628745|588473657|FG004|Overall Study|Missing|10|||
162937528|NCT00628745|588473653|FG000|Overall Study|Othe reasons|987|||
162937529|NCT00628745|588473654|FG001|Overall Study|Othe reasons|373|||
162937530|NCT00628745|588473655|FG002|Overall Study|Othe reasons|105|||
162937531|NCT00628745|588473656|FG003|Overall Study|Othe reasons|1|||
162937532|NCT00628745|588473657|FG004|Overall Study|Othe reasons|1772|||
162937533|NCT00982410|588475473|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
162937534|NCT00982410|588475474|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
162937535|NCT00982410|588475473|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
162937536|NCT00982410|588475474|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
162937537|NCT00982410|588475473|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
162937538|NCT00982410|588475474|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
162937539|NCT00982410|588475473|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
162937540|NCT00982410|588475474|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
162937541|NCT00982410|588475473|FG000|6-month Follow-up Assessment|participant no transportation|1|||
162937542|NCT00982410|588475474|FG001|6-month Follow-up Assessment|participant no transportation|0|||
162937543|NCT00982410|588475473|FG000|6-month Follow-up Assessment|incarceration|0|||
162937544|NCT00982410|588475474|FG001|6-month Follow-up Assessment|incarceration|2|||
162937545|NCT00982410|588475473|FG000|6-month Follow-up Assessment|patent surgery|0|||
162937546|NCT00982410|588475474|FG001|6-month Follow-up Assessment|patent surgery|1|||
162937547|NCT00982410|588475473|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
162937548|NCT00982410|588475474|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
162937549|NCT00982410|588475473|FG000|12-month Follow-up Assessment|Death|0|||
162937550|NCT00982410|588475474|FG001|12-month Follow-up Assessment|Death|2|||
162937551|NCT00982410|588475473|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
162937552|NCT00982410|588475474|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
162937553|NCT00982410|588475473|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
163183664|NCT02598960|589389337|FG011|Participants Entering Follow Up Period|Death|11|||
163183665|NCT02598960|589389338|FG012|Participants Entering Follow Up Period|Death|2|||
163183666|NCT02598960|589389326|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
163183667|NCT02598960|589389327|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
163183668|NCT02598960|589389328|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
163183669|NCT02598960|589389329|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
163183670|NCT02598960|589389330|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
163183671|NCT02598960|589389331|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
163183672|NCT02598960|589389332|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
163183673|NCT02598960|589389333|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
163183674|NCT02598960|589389334|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
163288774|NCT00486759|589763091|FG000|Safety Follow-up|Death|40|||
162937554|NCT00982410|588475474|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
162937555|NCT00982410|588475473|FG000|12-month Follow-up Assessment|incarceration|2|||
162937556|NCT00982410|588475474|FG001|12-month Follow-up Assessment|incarceration|1|||
162937557|NCT00982410|588475473|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
162937558|NCT00982410|588475474|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
162937559|NCT02034799|588475477|FG000|Overall Study|Withdrawal by Subject|0|||
162937560|NCT02034799|588475478|FG001|Overall Study|Withdrawal by Subject|2|||
162937561|NCT02034799|588475477|FG000|Overall Study|Lost to Follow-up|0|||
162937562|NCT02034799|588475478|FG001|Overall Study|Lost to Follow-up|1|||
162937563|NCT02034799|588475477|FG000|Overall Study|Death|2|||
162937564|NCT02034799|588475478|FG001|Overall Study|Death|1|||
162937565|NCT03381248|588475482|FG000|0-6 Months|Withdrawal by Subject|4|||
162937566|NCT03381248|588475483|FG001|0-6 Months|Withdrawal by Subject|1|||
162937567|NCT03381248|588475482|FG000|0-6 Months|Lost to Follow-up|3|||
162937568|NCT03381248|588475483|FG001|0-6 Months|Lost to Follow-up|2|||
162937569|NCT03381248|588475482|FG000|0-6 Months|Lack of Efficacy|1|||
162937570|NCT03381248|588475483|FG001|0-6 Months|Lack of Efficacy|0|||
162937571|NCT03381248|588475482|FG000|0-6 Months|Adverse Event|1|||
162937572|NCT03381248|588475483|FG001|0-6 Months|Adverse Event|0|||
162937573|NCT03381248|588475482|FG000|0-6 Months|Protocol Violation|2|||
162937574|NCT03381248|588475483|FG001|0-6 Months|Protocol Violation|1|||
162937575|NCT03381248|588475482|FG000|0-6 Months|Physician Decision|1|||
162937576|NCT03381248|588475483|FG001|0-6 Months|Physician Decision|0|||
162937577|NCT03381248|588475482|FG000|0-6 Months|Planning another procedure|1|||
162937578|NCT03381248|588475483|FG001|0-6 Months|Planning another procedure|2|||
162937579|NCT03381248|588475482|FG000|6-12 Months|Withdrawal by Subject|1|||
162937580|NCT03381248|588475483|FG001|6-12 Months|Withdrawal by Subject|3|||
162937581|NCT03381248|588475482|FG000|6-12 Months|Lost to Follow-up|0|||
162937582|NCT03381248|588475483|FG001|6-12 Months|Lost to Follow-up|2|||
162937583|NCT03381248|588475482|FG000|6-12 Months|Protocol Violation|3|||
162937584|NCT03381248|588475483|FG001|6-12 Months|Protocol Violation|2|||
162937585|NCT03381248|588475482|FG000|6-12 Months|Planning another procedure|6|||
162937586|NCT03381248|588475483|FG001|6-12 Months|Planning another procedure|2|||
163183675|NCT02598960|589389335|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
163183676|NCT02598960|589389336|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
163183677|NCT02598960|589389337|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
163183678|NCT02598960|589389338|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
163183679|NCT02598960|589389326|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
163183680|NCT02598960|589389327|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
163183681|NCT02598960|589389328|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
163183682|NCT02598960|589389329|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
163183683|NCT02598960|589389330|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
163183684|NCT02598960|589389331|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
163183685|NCT02598960|589389332|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
163183686|NCT02598960|589389333|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
163183687|NCT02598960|589389334|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
163183688|NCT02598960|589389335|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
163183689|NCT02598960|589389336|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
163183690|NCT02598960|589389337|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
163183691|NCT02598960|589389338|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
163183692|NCT02598960|589389326|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
163183693|NCT02598960|589389327|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
163183694|NCT02598960|589389328|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
163183695|NCT02598960|589389329|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
163183696|NCT02598960|589389330|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
163183697|NCT02598960|589389331|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
163183698|NCT02598960|589389332|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
163183699|NCT02598960|589389333|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
163183700|NCT02598960|589389334|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
163183701|NCT02598960|589389335|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
163183702|NCT02598960|589389336|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
163183703|NCT02598960|589389337|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
163183704|NCT02598960|589389338|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
163183705|NCT02598960|589389326|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
163183706|NCT02598960|589389327|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
163183707|NCT02598960|589389328|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
163183708|NCT02598960|589389329|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
163183709|NCT02598960|589389330|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
163288775|NCT00486759|589763092|FG001|Safety Follow-up|Death|29|||
163288776|NCT00486759|589763091|FG000|Safety Follow-up|Withdrew consent|32|||
163288777|NCT00486759|589763092|FG001|Safety Follow-up|Withdrew consent|23|||
163288778|NCT00486759|589763091|FG000|Safety Follow-up|Failure to return|9|||
163288779|NCT00486759|589763092|FG001|Safety Follow-up|Failure to return|6|||
163288780|NCT00486759|589763091|FG000|Safety Follow-up|Administrative/not specified|8|||
163288781|NCT00486759|589763092|FG001|Safety Follow-up|Administrative/not specified|6|||
163288782|NCT00486759|589763091|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
163288783|NCT00486759|589763092|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
163288784|NCT00486759|589763091|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
163288785|NCT00486759|589763092|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
163288786|NCT00377455|589763093|FG000|Overall Study|Withdrawal by Subject|1|||
163288787|NCT00309452|589763094|FG000|Overall Study|Withdrawal by Subject|3|||
163288788|NCT00309452|589763095|FG001|Overall Study|Withdrawal by Subject|0|||
163288789|NCT02962674|589763096|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
163288790|NCT00771667|589763098|FG000|Induction Phase|Adverse Event|5|||
163288791|NCT00771667|589763099|FG001|Induction Phase|Adverse Event|2|||
163288792|NCT00771667|589763100|FG002|Induction Phase|Adverse Event|4|||
163288793|NCT00771667|589763101|FG003|Induction Phase|Adverse Event|1|||
163288794|NCT00771667|589763102|FG004|Induction Phase|Adverse Event|0|||
163288795|NCT00771667|589763103|FG005|Induction Phase|Adverse Event|0|||
163288796|NCT00771667|589763104|FG006|Induction Phase|Adverse Event|0|||
163288797|NCT00771667|589763105|FG007|Induction Phase|Adverse Event|0|||
163288798|NCT00771667|589763106|FG008|Induction Phase|Adverse Event|0|||
163288799|NCT00771667|589763107|FG009|Induction Phase|Adverse Event|0|||
163288800|NCT00771667|589763098|FG000|Induction Phase|Lack of Efficacy|9|||
163288801|NCT00771667|589763099|FG001|Induction Phase|Lack of Efficacy|2|||
162937587|NCT03381248|588475482|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
163288802|NCT00771667|589763100|FG002|Induction Phase|Lack of Efficacy|4|||
163288803|NCT00771667|589763101|FG003|Induction Phase|Lack of Efficacy|3|||
163288804|NCT00771667|589763102|FG004|Induction Phase|Lack of Efficacy|0|||
163288805|NCT00771667|589763103|FG005|Induction Phase|Lack of Efficacy|0|||
163288806|NCT00771667|589763104|FG006|Induction Phase|Lack of Efficacy|0|||
163288807|NCT00771667|589763105|FG007|Induction Phase|Lack of Efficacy|0|||
163288808|NCT00771667|589763106|FG008|Induction Phase|Lack of Efficacy|0|||
163288809|NCT00771667|589763107|FG009|Induction Phase|Lack of Efficacy|0|||
163288810|NCT00771667|589763098|FG000|Induction Phase|Lost to Follow-up|1|||
163288811|NCT00771667|589763099|FG001|Induction Phase|Lost to Follow-up|0|||
163288812|NCT00771667|589763100|FG002|Induction Phase|Lost to Follow-up|1|||
163288813|NCT00771667|589763101|FG003|Induction Phase|Lost to Follow-up|0|||
163288814|NCT00771667|589763102|FG004|Induction Phase|Lost to Follow-up|0|||
162937588|NCT03381248|588475483|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
162937589|NCT03381248|588475482|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
162937590|NCT03381248|588475483|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
162937591|NCT03381248|588475482|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
162937592|NCT03381248|588475483|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
162937593|NCT05188521|588475488|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
162937594|NCT05188521|588475489|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
162937595|NCT01341639|588475490|FG000|Infant Series|Protocol Violation|1|||
162937596|NCT01341639|588475491|FG001|Infant Series|Protocol Violation|0|||
162937597|NCT01341639|588475490|FG000|Infant Series|Not Vaccinated|0|||
162937598|NCT01341639|588475491|FG001|Infant Series|Not Vaccinated|1|||
162937599|NCT01341639|588475490|FG000|Infant Series|Adverse Event|0|||
162937600|NCT01341639|588475491|FG001|Infant Series|Adverse Event|5|||
162937601|NCT01341639|588475490|FG000|Infant Series|Withdrawal by Subject|11|||
162937602|NCT01341639|588475491|FG001|Infant Series|Withdrawal by Subject|8|||
162937603|NCT01341639|588475490|FG000|Infant Series|Lost to Follow-up|0|||
162937604|NCT01341639|588475491|FG001|Infant Series|Lost to Follow-up|2|||
162937605|NCT01341639|588475490|FG000|Infant Series|Site 0048 Participants|17|||
162937606|NCT01341639|588475491|FG001|Infant Series|Site 0048 Participants|16|||
162937607|NCT01341639|588475490|FG000|Interim Period|Withdrawal by Subject|6|||
162937608|NCT01341639|588475491|FG001|Interim Period|Withdrawal by Subject|7|||
162937609|NCT01341639|588475490|FG000|Interim Period|Lost to Follow-up|2|||
162937610|NCT01341639|588475491|FG001|Interim Period|Lost to Follow-up|0|||
162937611|NCT01341639|588475490|FG000|Interim Period|Physician Decision|0|||
163288815|NCT00771667|589763103|FG005|Induction Phase|Lost to Follow-up|0|||
163288816|NCT00771667|589763104|FG006|Induction Phase|Lost to Follow-up|0|||
163288817|NCT00771667|589763105|FG007|Induction Phase|Lost to Follow-up|0|||
163288818|NCT00771667|589763106|FG008|Induction Phase|Lost to Follow-up|0|||
163288819|NCT00771667|589763107|FG009|Induction Phase|Lost to Follow-up|0|||
163288820|NCT00771667|589763098|FG000|Induction Phase|Other|4|||
163288821|NCT00771667|589763099|FG001|Induction Phase|Other|6|||
163288822|NCT00771667|589763100|FG002|Induction Phase|Other|3|||
163288823|NCT00771667|589763101|FG003|Induction Phase|Other|4|||
163288824|NCT00771667|589763102|FG004|Induction Phase|Other|0|||
163288825|NCT00771667|589763103|FG005|Induction Phase|Other|0|||
163288826|NCT00771667|589763104|FG006|Induction Phase|Other|0|||
163288827|NCT00771667|589763105|FG007|Induction Phase|Other|0|||
163288828|NCT00771667|589763106|FG008|Induction Phase|Other|0|||
163288829|NCT00771667|589763107|FG009|Induction Phase|Other|0|||
163288830|NCT00771667|589763098|FG000|Maintenance Phase|Adverse Event|0|||
163288831|NCT00771667|589763099|FG001|Maintenance Phase|Adverse Event|0|||
163288832|NCT00771667|589763100|FG002|Maintenance Phase|Adverse Event|0|||
163288833|NCT00771667|589763101|FG003|Maintenance Phase|Adverse Event|0|||
163288834|NCT00771667|589763102|FG004|Maintenance Phase|Adverse Event|1|||
163288835|NCT00771667|589763103|FG005|Maintenance Phase|Adverse Event|3|||
163288836|NCT00771667|589763104|FG006|Maintenance Phase|Adverse Event|5|||
163288837|NCT00771667|589763105|FG007|Maintenance Phase|Adverse Event|1|||
163288838|NCT00771667|589763106|FG008|Maintenance Phase|Adverse Event|8|||
163288839|NCT00771667|589763107|FG009|Maintenance Phase|Adverse Event|7|||
163288840|NCT00771667|589763098|FG000|Maintenance Phase|Lack of Efficacy|0|||
163288841|NCT00771667|589763099|FG001|Maintenance Phase|Lack of Efficacy|0|||
163288842|NCT00771667|589763100|FG002|Maintenance Phase|Lack of Efficacy|0|||
163288843|NCT00771667|589763101|FG003|Maintenance Phase|Lack of Efficacy|0|||
163288844|NCT00771667|589763102|FG004|Maintenance Phase|Lack of Efficacy|1|||
163288845|NCT00771667|589763103|FG005|Maintenance Phase|Lack of Efficacy|3|||
163288846|NCT00771667|589763104|FG006|Maintenance Phase|Lack of Efficacy|3|||
163288847|NCT00771667|589763105|FG007|Maintenance Phase|Lack of Efficacy|2|||
163288848|NCT00771667|589763106|FG008|Maintenance Phase|Lack of Efficacy|11|||
163288849|NCT00771667|589763107|FG009|Maintenance Phase|Lack of Efficacy|7|||
163288850|NCT00771667|589763098|FG000|Maintenance Phase|Other|0|||
163288851|NCT00771667|589763099|FG001|Maintenance Phase|Other|0|||
163288852|NCT00771667|589763100|FG002|Maintenance Phase|Other|0|||
163288853|NCT00771667|589763101|FG003|Maintenance Phase|Other|0|||
163288854|NCT00771667|589763102|FG004|Maintenance Phase|Other|0|||
163288855|NCT00771667|589763103|FG005|Maintenance Phase|Other|1|||
163288856|NCT00771667|589763104|FG006|Maintenance Phase|Other|2|||
163288857|NCT00771667|589763105|FG007|Maintenance Phase|Other|2|||
163288858|NCT00771667|589763106|FG008|Maintenance Phase|Other|3|||
163288859|NCT00771667|589763107|FG009|Maintenance Phase|Other|3|||
163288860|NCT01897233|589763108|FG000|Part B (24 Weeks)|Adverse Event|1|||
163288861|NCT01897233|589763108|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
163288862|NCT01897233|589763108|FG000|Part B (24 Weeks)|Physician Decision|1|||
163288863|NCT00628862|589763113|FG000|Overall Study|Adverse Event|6|||
163288864|NCT00628862|589763114|FG001|Overall Study|Adverse Event|8|||
163288865|NCT00628862|589763115|FG002|Overall Study|Adverse Event|10|||
163288866|NCT00628862|589763113|FG000|Overall Study|Withdrawal by Subject|4|||
163288867|NCT00628862|589763114|FG001|Overall Study|Withdrawal by Subject|6|||
163288868|NCT00628862|589763115|FG002|Overall Study|Withdrawal by Subject|11|||
163288869|NCT00628862|589763113|FG000|Overall Study|Lost to Follow-up|0|||
163288870|NCT00628862|589763114|FG001|Overall Study|Lost to Follow-up|2|||
163288871|NCT00628862|589763115|FG002|Overall Study|Lost to Follow-up|1|||
163288872|NCT00628862|589763113|FG000|Overall Study|Protocol Violation|1|||
163288873|NCT00628862|589763114|FG001|Overall Study|Protocol Violation|0|||
163288874|NCT00628862|589763115|FG002|Overall Study|Protocol Violation|0|||
163288875|NCT00628862|589763113|FG000|Overall Study|COPD Exacerbation|0|||
163183710|NCT02598960|589389331|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
163183711|NCT02598960|589389332|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
163183712|NCT02598960|589389333|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
163183713|NCT02598960|589389334|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
163183714|NCT02598960|589389335|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
163183715|NCT02598960|589389336|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
163183716|NCT02598960|589389337|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
163183717|NCT02598960|589389338|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
163183718|NCT00398411|589389339|FG000|Overall Study|Death|0|||
163288876|NCT00628862|589763114|FG001|Overall Study|COPD Exacerbation|1|||
163288877|NCT00628862|589763115|FG002|Overall Study|COPD Exacerbation|0|||
163288878|NCT02814643|589763116|FG000|Overall Study|Lost to Follow-up|0|||
163288879|NCT02814643|589763117|FG001|Overall Study|Lost to Follow-up|1|||
163288880|NCT02814643|589763116|FG000|Overall Study|Withdrawal by Subject|1|||
163288881|NCT02814643|589763117|FG001|Overall Study|Withdrawal by Subject|2|||
163288882|NCT01883492|589763121|FG000|Overall Study|Lost to Follow-up|3|||
163288883|NCT01883492|589763122|FG001|Overall Study|Lost to Follow-up|4|||
163288884|NCT01883492|589763121|FG000|Overall Study|Surgery on contra-lateral hip|0|||
163288885|NCT01883492|589763122|FG001|Overall Study|Surgery on contra-lateral hip|1|||
163288886|NCT01883492|589763121|FG000|Overall Study|Poor X-ray quality|7|||
163288887|NCT01883492|589763122|FG001|Overall Study|Poor X-ray quality|4|||
163288888|NCT01883492|589763121|FG000|Overall Study|Withdrawal by Subject|1|||
163288889|NCT01883492|589763122|FG001|Overall Study|Withdrawal by Subject|0|||
163288890|NCT01883492|589763121|FG000|Overall Study|inappropriate implant used|1|||
163288891|NCT01883492|589763122|FG001|Overall Study|inappropriate implant used|1|||
163288892|NCT01883492|589763121|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
163288893|NCT01883492|589763122|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
163288894|NCT01281813|589763137|FG000|Overall Study|Adverse Event|0|||
163288895|NCT01281813|589763138|FG001|Overall Study|Adverse Event|0|||
163288896|NCT01281813|589763139|FG002|Overall Study|Adverse Event|10|||
163288897|NCT01281813|589763137|FG000|Overall Study|Lost to Follow-up|0|||
163288898|NCT01281813|589763138|FG001|Overall Study|Lost to Follow-up|0|||
163288899|NCT01281813|589763139|FG002|Overall Study|Lost to Follow-up|31|||
162937612|NCT01341639|588475491|FG001|Interim Period|Physician Decision|1|||
162937613|NCT01341639|588475490|FG000|Interim Period|Protocol Violation|0|||
162937614|NCT01341639|588475491|FG001|Interim Period|Protocol Violation|1|||
162937615|NCT01341639|588475490|FG000|Post-Treatment|Withdrawal by Subject|0|||
162937616|NCT01341639|588475491|FG001|Post-Treatment|Withdrawal by Subject|1|||
162937617|NCT01341639|588475490|FG000|Post-Treatment|Adverse Event|0|||
162937618|NCT01341639|588475491|FG001|Post-Treatment|Adverse Event|2|||
162937619|NCT01590433|588475492|FG000|Overall Study|Lost to Follow-up|20|||
162937620|NCT01590433|588475493|FG001|Overall Study|Lost to Follow-up|8|||
162937621|NCT01590433|588475492|FG000|Overall Study|Withdrawal by Subject|21|||
163288900|NCT01281813|589763137|FG000|Overall Study|Withdrawal by Subject|0|||
163288901|NCT01281813|589763138|FG001|Overall Study|Withdrawal by Subject|0|||
163288902|NCT01281813|589763139|FG002|Overall Study|Withdrawal by Subject|13|||
163288903|NCT01281813|589763137|FG000|Overall Study|Subject Non-Compliant|0|||
163288904|NCT01281813|589763138|FG001|Overall Study|Subject Non-Compliant|0|||
163288905|NCT01281813|589763139|FG002|Overall Study|Subject Non-Compliant|6|||
163288906|NCT01281813|589763137|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
163288907|NCT01281813|589763138|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
163288908|NCT01281813|589763139|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
163288909|NCT01281813|589763137|FG000|Overall Study|Sponsor's Decision|4|||
163288910|NCT01281813|589763138|FG001|Overall Study|Sponsor's Decision|3|||
163288911|NCT01281813|589763139|FG002|Overall Study|Sponsor's Decision|7|||
163288912|NCT01281813|589763137|FG000|Overall Study|Switched to Commercially Available Medication|0|||
163288913|NCT01281813|589763138|FG001|Overall Study|Switched to Commercially Available Medication|0|||
163288914|NCT01281813|589763139|FG002|Overall Study|Switched to Commercially Available Medication|26|||
163288915|NCT01281813|589763137|FG000|Overall Study|Other|0|||
163288916|NCT01281813|589763138|FG001|Overall Study|Other|1|||
163288917|NCT01281813|589763139|FG002|Overall Study|Other|39|||
163288918|NCT02192606|589763140|FG000|Overall Study|surgery type was changed|1|||
163288919|NCT02192606|589763141|FG001|Overall Study|surgery type was changed|1|||
163288920|NCT02192606|589763140|FG000|Overall Study|Physician Decision|1|||
163288921|NCT02192606|589763141|FG001|Overall Study|Physician Decision|2|||
163288922|NCT02192606|589763140|FG000|Overall Study|3D equipment rep unable to join|0|||
163288923|NCT02192606|589763141|FG001|Overall Study|3D equipment rep unable to join|1|||
163288924|NCT00558363|589763142|FG000|Overall Study|Physician Decision|18|||
163288925|NCT00558363|589763143|FG001|Overall Study|Physician Decision|4|||
163288926|NCT00558363|589763142|FG000|Overall Study|Withdrawal by Subject|11|||
163288927|NCT00558363|589763143|FG001|Overall Study|Withdrawal by Subject|4|||
163288928|NCT00558363|589763142|FG000|Overall Study|Adverse Event|5|||
163288929|NCT00558363|589763143|FG001|Overall Study|Adverse Event|5|||
163288930|NCT00558363|589763142|FG000|Overall Study|Lack of Efficacy|2|||
163288931|NCT00558363|589763143|FG001|Overall Study|Lack of Efficacy|2|||
163288932|NCT00558363|589763142|FG000|Overall Study|Protocol Violation|2|||
163288933|NCT00558363|589763143|FG001|Overall Study|Protocol Violation|1|||
163288934|NCT00558363|589763142|FG000|Overall Study|Lost to Follow-up|0|||
163288935|NCT00558363|589763143|FG001|Overall Study|Lost to Follow-up|1|||
163288936|NCT00558363|589763142|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
163288937|NCT00558363|589763143|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
163288938|NCT00558363|589763142|FG000|Overall Study|Randomized in Error|1|||
163288939|NCT00558363|589763143|FG001|Overall Study|Randomized in Error|2|||
163288940|NCT00558363|589763142|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
163288941|NCT00558363|589763143|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
163288942|NCT03673124|589763144|FG000|Overall Study|Eligible with no protocol therapy|2|||
163288943|NCT02174562|589763145|FG000|Overall Study|Withdrawal by Subject|7|||
162937622|NCT01590433|588475493|FG001|Overall Study|Withdrawal by Subject|11|||
162937623|NCT01590433|588475492|FG000|Overall Study|Adverse Event|11|||
162937624|NCT01590433|588475493|FG001|Overall Study|Adverse Event|3|||
163288944|NCT02174562|589763146|FG001|Overall Study|Withdrawal by Subject|2|||
163288945|NCT02174562|589763145|FG000|Overall Study|Death|2|||
163288946|NCT02174562|589763146|FG001|Overall Study|Death|0|||
163288947|NCT02174562|589763145|FG000|Overall Study|Lost to Follow-up|0|||
162937625|NCT00555009|588475494|FG000|Overall Study|Withdrawal by Subject|0|||
162937626|NCT00555009|588475495|FG001|Overall Study|Withdrawal by Subject|1|||
162937627|NCT00555009|588475494|FG000|Overall Study|Terminated by Sponsor|2|||
163288948|NCT02174562|589763146|FG001|Overall Study|Lost to Follow-up|3|||
163288949|NCT00798096|589763148|FG000|Overall Study|Ongoing|2|||
163288950|NCT01651949|589763150|FG000|Overall Study|Unknown status|4|||
163288951|NCT01651949|589763151|FG001|Overall Study|Unknown status|4|||
163288952|NCT01651949|589763152|FG002|Overall Study|Unknown status|0|||
163288953|NCT01651949|589763150|FG000|Overall Study|Lost to Follow-up|30|||
163288954|NCT01651949|589763151|FG001|Overall Study|Lost to Follow-up|56|||
163288955|NCT01651949|589763152|FG002|Overall Study|Lost to Follow-up|20|||
163288956|NCT01651949|589763150|FG000|Overall Study|Protocol Violation|0|||
162937628|NCT00555009|588475495|FG001|Overall Study|Terminated by Sponsor|5|||
163183719|NCT00398411|589389340|FG001|Overall Study|Death|1|||
163183720|NCT00401531|589389341|FG000|Overall Study|Adverse Event|2|||
163183721|NCT00401531|589389342|FG001|Overall Study|Adverse Event|0|||
163183722|NCT00401531|589389341|FG000|Overall Study|Protocol Violation|3|||
163183723|NCT00401531|589389342|FG001|Overall Study|Protocol Violation|7|||
163183724|NCT00401531|589389341|FG000|Overall Study|Lost to Follow-up|1|||
163183725|NCT00401531|589389342|FG001|Overall Study|Lost to Follow-up|1|||
163183726|NCT00401531|589389341|FG000|Overall Study|Withdrawal by Subject|3|||
163183727|NCT00401531|589389342|FG001|Overall Study|Withdrawal by Subject|2|||
163183728|NCT01614600|589389347|FG000|Overall Study|Unacceptable fit|1|||
163183729|NCT01614600|589389347|FG000|Overall Study|Discomfort|1|||
163183730|NCT01614600|589389347|FG000|Overall Study|Unable to remove lens at the end of day|1|||
163183731|NCT01614600|589389347|FG000|Overall Study|Protocol deviation|1|||
163183732|NCT03403374|589389348|FG000|Overall Study|Lost to Follow-up|1|||
163183733|NCT00736957|589389354|FG000|Overall Study|Adverse Event|43|||
163183734|NCT00736957|589389354|FG000|Overall Study|Withdrawal by Subject|49|||
163183735|NCT00736957|589389354|FG000|Overall Study|violation of eligibility criteria|2|||
163183736|NCT00736957|589389354|FG000|Overall Study|did not attend hospital appointments|1|||
163183737|NCT00736957|589389354|FG000|Overall Study|not eligible for Treatment Period I|22|||
163183738|NCT00736957|589389354|FG000|Overall Study|Physician Decision|5|||
163183739|NCT03646643|589389355|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
163183740|NCT03646643|589389356|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
163183741|NCT03646643|589389355|FG000|Overall Study|Lost to Follow-up|0|||
163183742|NCT03646643|589389356|FG001|Overall Study|Lost to Follow-up|1|||
163183743|NCT02806973|589389357|FG000|Period 1|Withdrawal by Subject|0|||
163183744|NCT02806973|589389358|FG001|Period 1|Withdrawal by Subject|2|||
163183745|NCT02806973|589389359|FG002|Period 1|Withdrawal by Subject|1|||
163183746|NCT02806973|589389360|FG003|Period 1|Withdrawal by Subject|1|||
163183747|NCT02806973|589389357|FG000|Period 1|Adverse Event|0|||
163183748|NCT02806973|589389358|FG001|Period 1|Adverse Event|0|||
163183749|NCT02806973|589389359|FG002|Period 1|Adverse Event|0|||
163183750|NCT02806973|589389360|FG003|Period 1|Adverse Event|1|||
163183751|NCT02806973|589389357|FG000|Period 3|Withdrawal by Subject|0|||
163183752|NCT02806973|589389358|FG001|Period 3|Withdrawal by Subject|0|||
163183753|NCT02806973|589389359|FG002|Period 3|Withdrawal by Subject|0|||
163183754|NCT02806973|589389360|FG003|Period 3|Withdrawal by Subject|3|||
163183755|NCT02806973|589389357|FG000|Period 3|Adverse Event|0|||
163183756|NCT02806973|589389358|FG001|Period 3|Adverse Event|0|||
163183757|NCT02806973|589389359|FG002|Period 3|Adverse Event|1|||
163183758|NCT02806973|589389360|FG003|Period 3|Adverse Event|0|||
163183759|NCT04209426|589389363|FG000|Overall Study|Lost to Follow-up|3|||
163183760|NCT04209426|589389364|FG001|Overall Study|Lost to Follow-up|2|||
163183761|NCT04060862|589389365|FG000|Overall Study|Symptomatic Deterioration|1|||
163183762|NCT04060862|589389365|FG000|Overall Study|Un-specified|6|||
163183763|NCT04060862|589389365|FG000|Overall Study|Progressive disease|12|||
163183764|NCT04060862|589389365|FG000|Overall Study|Physician Decision|1|||
163183765|NCT01031381|589389370|FG000|Overall Study|Physician Decision|3|||
163183766|NCT01031381|589389370|FG000|Overall Study|Withdrawal by Subject|6|||
163183767|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
163183768|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
163183769|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
162937629|NCT02040428|588475496|FG000|Overall Study|Death|4|||
162937630|NCT02040428|588475497|FG001|Overall Study|Death|3|||
162937631|NCT02040428|588475496|FG000|Overall Study|Withdrawal by Subject|1|||
162937632|NCT02040428|588475497|FG001|Overall Study|Withdrawal by Subject|1|||
162937633|NCT02058628|588475498|FG000|Overall Study|Adverse Event|1|||
162937634|NCT02058628|588475499|FG001|Overall Study|Adverse Event|0|||
162937635|NCT02058628|588475498|FG000|Overall Study|Withdrawal by Subject|2|||
162937636|NCT02058628|588475499|FG001|Overall Study|Withdrawal by Subject|2|||
162937637|NCT02058628|588475498|FG000|Overall Study|Lost to Follow-up|2|||
162937638|NCT02058628|588475499|FG001|Overall Study|Lost to Follow-up|4|||
162937639|NCT02058628|588475498|FG000|Overall Study|Not in time schedule|0|||
162937640|NCT02058628|588475499|FG001|Overall Study|Not in time schedule|1|||
162937641|NCT02058628|588475498|FG000|Overall Study|The visit date was not in timeline|0|||
162937642|NCT02058628|588475499|FG001|Overall Study|The visit date was not in timeline|1|||
163183770|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
163183771|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
163183772|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
163183773|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
163183774|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
163183775|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
163183776|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
163042842|NCT01066871|588863974|FG000|Overall Study|Lost to Follow-up|0|||
163183777|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
163183778|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
163183779|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
163183780|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
163183781|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
163183782|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
163183783|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Program Termination|3|||
163183784|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Program Termination|0|||
163183785|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Program Termination|1|||
163183786|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Program Termination|1|||
163288957|NCT01651949|589763151|FG001|Overall Study|Protocol Violation|2|||
163288958|NCT01651949|589763152|FG002|Overall Study|Protocol Violation|1|||
163288959|NCT01651949|589763150|FG000|Overall Study|Physician Decision|0|||
163288960|NCT01651949|589763151|FG001|Overall Study|Physician Decision|2|||
163288961|NCT01651949|589763152|FG002|Overall Study|Physician Decision|0|||
163288962|NCT01651949|589763150|FG000|Overall Study|Adverse Event|0|||
163288963|NCT01651949|589763151|FG001|Overall Study|Adverse Event|2|||
163288964|NCT01651949|589763152|FG002|Overall Study|Adverse Event|1|||
163288965|NCT01651949|589763150|FG000|Overall Study|Screen failure|2|||
163288966|NCT01651949|589763151|FG001|Overall Study|Screen failure|2|||
163288967|NCT01651949|589763152|FG002|Overall Study|Screen failure|0|||
163288968|NCT01651949|589763150|FG000|Overall Study|Withdrawal by Subject|17|||
163288969|NCT01651949|589763151|FG001|Overall Study|Withdrawal by Subject|18|||
163288970|NCT01651949|589763152|FG002|Overall Study|Withdrawal by Subject|9|||
163288971|NCT02155829|589763155|FG000|Overall Study|Adverse Event|1|||
163288972|NCT02155829|589763156|FG001|Overall Study|Adverse Event|0|||
163288973|NCT02155829|589763155|FG000|Overall Study|Withdrawal by Subject|3|||
163288974|NCT02155829|589763156|FG001|Overall Study|Withdrawal by Subject|3|||
163288975|NCT02155829|589763155|FG000|Overall Study|Protocol Violation|2|||
163288976|NCT02155829|589763156|FG001|Overall Study|Protocol Violation|0|||
163288977|NCT00678795|589763157|FG000|Overall Study|Adverse Event|7|||
163288978|NCT00678795|589763158|FG001|Overall Study|Adverse Event|3|||
163288979|NCT00678795|589763157|FG000|Overall Study|Withdrawal by Subject|3|||
163288980|NCT00678795|589763158|FG001|Overall Study|Withdrawal by Subject|0|||
163288981|NCT00678795|589763157|FG000|Overall Study|Protocol Violation|0|||
163288982|NCT00678795|589763158|FG001|Overall Study|Protocol Violation|1|||
163288983|NCT00678795|589763157|FG000|Overall Study|Lost to Follow-up|0|||
163288984|NCT00678795|589763158|FG001|Overall Study|Lost to Follow-up|1|||
163288985|NCT00678795|589763157|FG000|Overall Study|Lack of Efficacy|1|||
163288986|NCT00678795|589763158|FG001|Overall Study|Lack of Efficacy|1|||
163288987|NCT01585038|589763159|FG000|Overall Study|Adverse Event|2|||
163288988|NCT01585038|589763160|FG001|Overall Study|Adverse Event|2|||
163288989|NCT02750709|589763161|FG000|Treatment Period 1|Adverse Event|0|||
163288990|NCT02750709|589763162|FG001|Treatment Period 1|Adverse Event|0|||
163288991|NCT02750709|589763163|FG002|Treatment Period 1|Adverse Event|0|||
163288992|NCT02750709|589763164|FG003|Treatment Period 1|Adverse Event|0|||
163288993|NCT02750709|589763165|FG004|Treatment Period 1|Adverse Event|0|||
163288994|NCT02750709|589763166|FG005|Treatment Period 1|Adverse Event|1|||
163288995|NCT00771849|589763168|FG000|Overall Study|Lost to Follow-up|1|||
163288996|NCT00771849|589763169|FG001|Overall Study|Lost to Follow-up|2|||
163288997|NCT00771849|589763168|FG000|Overall Study|Withdrawal by Subject|1|||
163288998|NCT00771849|589763169|FG001|Overall Study|Withdrawal by Subject|1|||
163288999|NCT00771849|589763168|FG000|Overall Study|Not vaccinated|0|||
163289000|NCT00771849|589763169|FG001|Overall Study|Not vaccinated|1|||
163289001|NCT00290732|589763170|FG000|Overall Study|Inability to instill drug intraductally.|0|||
163289002|NCT00290732|589763171|FG001|Overall Study|Inability to instill drug intraductally.|1|||
163289003|NCT00290732|589763172|FG002|Overall Study|Inability to instill drug intraductally.|1|||
163289004|NCT00290732|589763173|FG003|Overall Study|Inability to instill drug intraductally.|0|||
163289005|NCT00290732|589763174|FG004|Overall Study|Inability to instill drug intraductally.|0|||
163289006|NCT02736799|589763178|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
163289007|NCT02736799|589763179|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
163289008|NCT02736799|589763180|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
163289009|NCT02736799|589763181|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
163289010|NCT00843193|589763182|FG000|Overall Study|Adverse Event|2|||
163289011|NCT00843193|589763183|FG001|Overall Study|Adverse Event|4|||
163289012|NCT00843193|589763182|FG000|Overall Study|Lack of Efficacy|1|||
163289013|NCT00843193|589763183|FG001|Overall Study|Lack of Efficacy|1|||
163289014|NCT00843193|589763182|FG000|Overall Study|Protocol Violation|1|||
163289015|NCT00843193|589763183|FG001|Overall Study|Protocol Violation|2|||
163289016|NCT00843193|589763182|FG000|Overall Study|Lost to Follow-up|1|||
163289017|NCT00843193|589763183|FG001|Overall Study|Lost to Follow-up|0|||
163289018|NCT00843193|589763182|FG000|Overall Study|Physician Decision|0|||
163289019|NCT00843193|589763183|FG001|Overall Study|Physician Decision|1|||
163289020|NCT00843193|589763182|FG000|Overall Study|Withdrawal by Subject|3|||
163289021|NCT00843193|589763183|FG001|Overall Study|Withdrawal by Subject|3|||
163289022|NCT00197015|589763184|FG000|Overall Study|Adverse Event|3|||
163289023|NCT00197015|589763185|FG001|Overall Study|Adverse Event|0|||
163289024|NCT00197015|589763186|FG002|Overall Study|Adverse Event|1|||
163289025|NCT00197015|589763184|FG000|Overall Study|Protocol Violation|0|||
163289026|NCT00197015|589763185|FG001|Overall Study|Protocol Violation|3|||
163289027|NCT00197015|589763186|FG002|Overall Study|Protocol Violation|3|||
163289028|NCT00197015|589763184|FG000|Overall Study|Withdrawal by Subject|17|||
163289029|NCT00197015|589763185|FG001|Overall Study|Withdrawal by Subject|37|||
163289030|NCT00197015|589763186|FG002|Overall Study|Withdrawal by Subject|34|||
163289031|NCT00197015|589763184|FG000|Overall Study|Lost to Follow-up|28|||
163289032|NCT00197015|589763185|FG001|Overall Study|Lost to Follow-up|46|||
163289033|NCT00197015|589763186|FG002|Overall Study|Lost to Follow-up|37|||
163289034|NCT00197015|589763184|FG000|Overall Study|Other|2|||
163289035|NCT00197015|589763185|FG001|Overall Study|Other|3|||
163289036|NCT00197015|589763186|FG002|Overall Study|Other|2|||
163289037|NCT02596035|589763187|FG000|Overall Study|Disease Progression|64|||
163289038|NCT02596035|589763188|FG001|Overall Study|Disease Progression|32|||
163289039|NCT02596035|589763189|FG002|Overall Study|Disease Progression|1|||
163289040|NCT02596035|589763187|FG000|Overall Study|study drug toxicity|12|||
163289041|NCT02596035|589763188|FG001|Overall Study|study drug toxicity|3|||
162937643|NCT02058628|588475498|FG000|Overall Study|A lot of time for study for participant|1|||
162937644|NCT02058628|588475499|FG001|Overall Study|A lot of time for study for participant|0|||
162937645|NCT02058628|588475498|FG000|Overall Study|Non compliance|1|||
162937646|NCT02058628|588475499|FG001|Overall Study|Non compliance|0|||
162937647|NCT00832078|588475500|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
162937648|NCT00832078|588475501|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
162937649|NCT00832078|588475500|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
162937650|NCT00832078|588475501|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
162937651|NCT02961920|588475502|FG000|Overall Study|did not achive stydy protocol schedule|1|||
162937652|NCT02961920|588475503|FG001|Overall Study|did not achive stydy protocol schedule|1|||
162937653|NCT01452529|588475506|FG000|Run-in Period|Adverse Event|96|||
162937654|NCT01452529|588475507|FG001|Run-in Period|Adverse Event|0|||
162937655|NCT01452529|588475508|FG002|Run-in Period|Adverse Event|0|||
162937656|NCT01452529|588475506|FG000|Run-in Period|Withdrawal by Subject|49|||
162937657|NCT01452529|588475507|FG001|Run-in Period|Withdrawal by Subject|0|||
162937658|NCT01452529|588475508|FG002|Run-in Period|Withdrawal by Subject|0|||
162937659|NCT01452529|588475506|FG000|Run-in Period|Lost to Follow-up|19|||
162937660|NCT01452529|588475507|FG001|Run-in Period|Lost to Follow-up|0|||
162937661|NCT01452529|588475508|FG002|Run-in Period|Lost to Follow-up|0|||
162937662|NCT01452529|588475506|FG000|Run-in Period|Lack of Efficacy|46|||
162937663|NCT01452529|588475507|FG001|Run-in Period|Lack of Efficacy|0|||
162937664|NCT01452529|588475508|FG002|Run-in Period|Lack of Efficacy|0|||
162937665|NCT01452529|588475506|FG000|Run-in Period|Confirmed or suspected diversion|23|||
162937666|NCT01452529|588475507|FG001|Run-in Period|Confirmed or suspected diversion|0|||
162937667|NCT01452529|588475508|FG002|Run-in Period|Confirmed or suspected diversion|0|||
162937668|NCT01452529|588475506|FG000|Run-in Period|Administrative|21|||
162937669|NCT01452529|588475507|FG001|Run-in Period|Administrative|0|||
162937670|NCT01452529|588475508|FG002|Run-in Period|Administrative|0|||
162937671|NCT01452529|588475506|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
162937672|NCT01452529|588475507|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
162937673|NCT01452529|588475508|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
162937674|NCT01452529|588475506|FG000|Double-blind (DB) Period|Adverse Event|0|||
162937675|NCT01452529|588475507|FG001|Double-blind (DB) Period|Adverse Event|18|||
162937676|NCT01452529|588475508|FG002|Double-blind (DB) Period|Adverse Event|11|||
162937677|NCT01452529|588475506|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
162937678|NCT01452529|588475507|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
162937679|NCT01452529|588475508|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
162937680|NCT01452529|588475506|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
162937681|NCT01452529|588475507|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
162937682|NCT01452529|588475508|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
162937683|NCT01452529|588475506|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
162937684|NCT01452529|588475507|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
162937685|NCT01452529|588475508|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
162937686|NCT01452529|588475506|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
162937687|NCT01452529|588475507|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
163289042|NCT02596035|589763189|FG002|Overall Study|study drug toxicity|0|||
163289043|NCT02596035|589763187|FG000|Overall Study|AE unrelated to study drug|5|||
163289044|NCT02596035|589763188|FG001|Overall Study|AE unrelated to study drug|2|||
163289045|NCT02596035|589763189|FG002|Overall Study|AE unrelated to study drug|0|||
162937688|NCT01452529|588475508|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
162937689|NCT01452529|588475506|FG000|Double-blind (DB) Period|Administrative|0|||
162937690|NCT01452529|588475507|FG001|Double-blind (DB) Period|Administrative|11|||
162937691|NCT01452529|588475508|FG002|Double-blind (DB) Period|Administrative|7|||
162937692|NCT03551730|588475509|FG000|Overall Study|Adverse Event|1|||
162937693|NCT03551730|588475510|FG001|Overall Study|Adverse Event|0|||
162937694|NCT03551730|588475511|FG002|Overall Study|Adverse Event|0|||
162937695|NCT03551730|588475512|FG003|Overall Study|Adverse Event|0|||
162937696|NCT03347695|588475519|FG000|Overall Study|Death|0|||
163289046|NCT02596035|589763187|FG000|Overall Study|participant request to discontinue study treatment|2|||
163289047|NCT02596035|589763188|FG001|Overall Study|participant request to discontinue study treatment|0|||
162937697|NCT03347695|588475520|FG001|Overall Study|Death|4|||
162937698|NCT03347695|588475519|FG000|Overall Study|Lost to Follow-up|0|||
162937699|NCT03347695|588475520|FG001|Overall Study|Lost to Follow-up|1|||
162937700|NCT00671879|588475523|FG000|Overall Study|Withdrawal by Subject|0|||
162937701|NCT00671879|588475524|FG001|Overall Study|Withdrawal by Subject|4|||
162937702|NCT00671879|588475525|FG002|Overall Study|Withdrawal by Subject|6|||
162937703|NCT04633837|588475526|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
162937704|NCT04633837|588475527|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
162937705|NCT04527471|588475530|FG000|Overall Study|Adverse Event|1|||
162937706|NCT04527471|588475531|FG001|Overall Study|Adverse Event|0|||
162937707|NCT04527471|588475530|FG000|Overall Study|Lost to Follow-up|1|||
162937708|NCT04527471|588475531|FG001|Overall Study|Lost to Follow-up|0|||
162937709|NCT02884206|588475540|FG000|Valsartan Run-in Period|Death|1|||
162937710|NCT02884206|588475541|FG001|Valsartan Run-in Period|Death|0|||
162937711|NCT02884206|588475542|FG002|Valsartan Run-in Period|Death|0|||
162937712|NCT02884206|588475540|FG000|Valsartan Run-in Period|Adverse Event|31|||
162937713|NCT02884206|588475541|FG001|Valsartan Run-in Period|Adverse Event|0|||
163289048|NCT02596035|589763189|FG002|Overall Study|participant request to discontinue study treatment|0|||
163289049|NCT02596035|589763187|FG000|Overall Study|participant withdrew consent|2|||
163289050|NCT02596035|589763188|FG001|Overall Study|participant withdrew consent|2|||
163289051|NCT02596035|589763189|FG002|Overall Study|participant withdrew consent|0|||
163289052|NCT02596035|589763187|FG000|Overall Study|Poor/Non Comlpiance|0|||
163289053|NCT02596035|589763188|FG001|Overall Study|Poor/Non Comlpiance|1|||
163289054|NCT02596035|589763189|FG002|Overall Study|Poor/Non Comlpiance|0|||
163289055|NCT02596035|589763187|FG000|Overall Study|participant no longer meets study criteria|1|||
163289056|NCT02596035|589763188|FG001|Overall Study|participant no longer meets study criteria|0|||
163289057|NCT02596035|589763189|FG002|Overall Study|participant no longer meets study criteria|0|||
163289058|NCT02596035|589763187|FG000|Overall Study|other reasons|11|||
163289059|NCT02596035|589763188|FG001|Overall Study|other reasons|4|||
163289060|NCT02596035|589763189|FG002|Overall Study|other reasons|0|||
163289061|NCT03395353|589763191|FG000|Overall Study|Adverse Event|20|||
163289062|NCT03395353|589763191|FG000|Overall Study|Protocol Violation|1|||
163289063|NCT03395353|589763191|FG000|Overall Study|Lack of Efficacy|3|||
163289064|NCT03395353|589763191|FG000|Overall Study|Withdrawal by Subject|24|||
163289065|NCT03395353|589763191|FG000|Overall Study|Discontinued visit|1|||
162937714|NCT02884206|588475542|FG002|Valsartan Run-in Period|Adverse Event|0|||
162937715|NCT02884206|588475540|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
162937716|NCT02884206|588475541|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
162937717|NCT02884206|588475542|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
162937718|NCT02884206|588475540|FG000|Valsartan Run-in Period|Protocol deviation|4|||
162937719|NCT02884206|588475541|FG001|Valsartan Run-in Period|Protocol deviation|0|||
162937720|NCT02884206|588475542|FG002|Valsartan Run-in Period|Protocol deviation|0|||
162937721|NCT02884206|588475540|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
162937722|NCT02884206|588475541|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
162937723|NCT02884206|588475542|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
162937724|NCT02884206|588475540|FG000|Valsartan Run-in Period|Physician Decision|1|||
162937725|NCT02884206|588475541|FG001|Valsartan Run-in Period|Physician Decision|0|||
162937726|NCT02884206|588475542|FG002|Valsartan Run-in Period|Physician Decision|0|||
163289066|NCT03395353|589763191|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
163289067|NCT03395353|589763191|FG000|Overall Study|Physician Decision|4|||
163289068|NCT03395353|589763191|FG000|Overall Study|Early termination of overall study|33|||
163289069|NCT03301220|589763192|FG000|Overall Study|Death|26|||
163289070|NCT03301220|589763193|FG001|Overall Study|Death|15|||
163289071|NCT03301220|589763192|FG000|Overall Study|Withdrawal by Subject|23|||
162937727|NCT02884206|588475540|FG000|LCZ696 Run-in Period|Adverse Event|38|||
162937728|NCT02884206|588475541|FG001|LCZ696 Run-in Period|Adverse Event|0|||
162937729|NCT02884206|588475542|FG002|LCZ696 Run-in Period|Adverse Event|0|||
162937730|NCT02884206|588475540|FG000|LCZ696 Run-in Period|Death|2|||
162937731|NCT02884206|588475541|FG001|LCZ696 Run-in Period|Death|0|||
163289072|NCT03301220|589763193|FG001|Overall Study|Withdrawal by Subject|12|||
163289073|NCT03301220|589763192|FG000|Overall Study|Lost to Follow-up|1|||
163289074|NCT03301220|589763193|FG001|Overall Study|Lost to Follow-up|1|||
163289075|NCT03301220|589763192|FG000|Overall Study|Randomized in error|1|||
163289076|NCT03301220|589763193|FG001|Overall Study|Randomized in error|1|||
163289077|NCT03301220|589763192|FG000|Overall Study|Randomized but not treated|0|||
162937732|NCT02884206|588475542|FG002|LCZ696 Run-in Period|Death|0|||
162937733|NCT02884206|588475540|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
162937734|NCT02884206|588475541|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
162937735|NCT02884206|588475542|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
162937736|NCT02884206|588475540|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
162937737|NCT02884206|588475541|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
163289078|NCT03301220|589763193|FG001|Overall Study|Randomized but not treated|1|||
163289079|NCT03301220|589763192|FG000|Overall Study|Ongoing followup|145|||
163289080|NCT03301220|589763193|FG001|Overall Study|Ongoing followup|163|||
163289081|NCT03301220|589763192|FG000|Overall Study|Principal Investigator and participant decision|0|||
163289082|NCT03301220|589763193|FG001|Overall Study|Principal Investigator and participant decision|1|||
162937738|NCT02884206|588475542|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
162937739|NCT02884206|588475540|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
162937740|NCT02884206|588475541|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
162937741|NCT02884206|588475542|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
162937742|NCT02884206|588475540|FG000|LCZ696 Run-in Period|Physician Decision|1|||
162937743|NCT02884206|588475541|FG001|LCZ696 Run-in Period|Physician Decision|0|||
162937744|NCT02884206|588475542|FG002|LCZ696 Run-in Period|Physician Decision|0|||
162937745|NCT02884206|588475540|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
162937746|NCT02884206|588475541|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
162937747|NCT02884206|588475542|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
162937748|NCT02884206|588475540|FG000|Double-Blind Period|Death|0|||
162937749|NCT02884206|588475541|FG001|Double-Blind Period|Death|28|||
162937750|NCT02884206|588475542|FG002|Double-Blind Period|Death|39|||
162937751|NCT02884206|588475540|FG000|Double-Blind Period|Patient/guardian decision|0|||
162937752|NCT02884206|588475541|FG001|Double-Blind Period|Patient/guardian decision|10|||
162937753|NCT02884206|588475542|FG002|Double-Blind Period|Patient/guardian decision|13|||
162937754|NCT02884206|588475540|FG000|Double-Blind Period|Lost to Follow-up|0|||
162937755|NCT02884206|588475541|FG001|Double-Blind Period|Lost to Follow-up|4|||
162937756|NCT02884206|588475542|FG002|Double-Blind Period|Lost to Follow-up|4|||
162937757|NCT02884206|588475540|FG000|Double-Blind Period|Physician Decision|0|||
162937758|NCT02884206|588475541|FG001|Double-Blind Period|Physician Decision|2|||
162937759|NCT02884206|588475542|FG002|Double-Blind Period|Physician Decision|0|||
162937760|NCT02884206|588475540|FG000|Double-Blind Period|Adverse Event|0|||
162937761|NCT02884206|588475541|FG001|Double-Blind Period|Adverse Event|0|||
162937762|NCT02884206|588475542|FG002|Double-Blind Period|Adverse Event|3|||
162937763|NCT02884206|588475540|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
162937764|NCT02884206|588475541|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
162937765|NCT02884206|588475542|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
162937766|NCT01628120|588475547|FG000|Overall Study|Withdrawal by Subject|7|||
162937767|NCT01628120|588475547|FG000|Overall Study|Adverse Event|12|||
162937768|NCT01628120|588475547|FG000|Overall Study|Lost to Follow-up|1|||
162937769|NCT01628120|588475547|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
162937770|NCT01628120|588475547|FG000|Overall Study|Non-compliant with Study Procedures|1|||
162937771|NCT01628120|588475547|FG000|Overall Study|Not Treated|3|||
162937772|NCT01628120|588475547|FG000|Overall Study|Sponsor Decision|5|||
163289083|NCT04845620|589763198|FG000|Overall Study|Withdrawal by Subject|11|||
163289084|NCT04845620|589763199|FG001|Overall Study|Withdrawal by Subject|10|||
163289085|NCT04845620|589763198|FG000|Overall Study|Adverse Event|5|||
163289086|NCT04845620|589763199|FG001|Overall Study|Adverse Event|4|||
163289087|NCT04845620|589763198|FG000|Overall Study|Lost to Follow-up|5|||
163289088|NCT04845620|589763199|FG001|Overall Study|Lost to Follow-up|4|||
163289089|NCT04845620|589763198|FG000|Overall Study|Lack of Efficacy|4|||
163289090|NCT04845620|589763199|FG001|Overall Study|Lack of Efficacy|4|||
163289091|NCT04845620|589763198|FG000|Overall Study|Physician Decision|2|||
163289092|NCT04845620|589763199|FG001|Overall Study|Physician Decision|1|||
163289093|NCT00708097|589763200|FG000|Period 1|Protocol Violation|0|||
163289094|NCT00708097|589763201|FG001|Period 1|Protocol Violation|1|||
163289095|NCT00708097|589763202|FG002|Period 1|Protocol Violation|0|||
163289096|NCT00708097|589763203|FG003|Period 1|Protocol Violation|2|||
163289097|NCT00708097|589763204|FG004|Period 1|Protocol Violation|0|||
163289098|NCT00708097|589763200|FG000|Period 1|Other Reason|0|||
163289099|NCT00708097|589763201|FG001|Period 1|Other Reason|0|||
163289100|NCT00708097|589763202|FG002|Period 1|Other Reason|0|||
163289101|NCT00708097|589763203|FG003|Period 1|Other Reason|0|||
163289102|NCT00708097|589763204|FG004|Period 1|Other Reason|1|||
163289103|NCT00708097|589763200|FG000|Period 2|Protocol Violation|0|||
163289104|NCT00708097|589763201|FG001|Period 2|Protocol Violation|1|||
163289105|NCT00708097|589763202|FG002|Period 2|Protocol Violation|1|||
163289106|NCT00708097|589763203|FG003|Period 2|Protocol Violation|1|||
163289107|NCT00708097|589763204|FG004|Period 2|Protocol Violation|0|||
163289108|NCT03425643|589763205|FG000|Overall Study|Withdrawal by Subject|10|||
162937773|NCT01628120|588475547|FG000|Overall Study|Switched Dialysis Method|2|||
162937774|NCT01628120|588475547|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
162937775|NCT01628120|588475547|FG000|Overall Study|Moved or Relocated|5|||
162937776|NCT01628120|588475547|FG000|Overall Study|Kidney Transplant|2|||
162937777|NCT01628120|588475547|FG000|Overall Study|Use of Standard of Care|1|||
162937778|NCT01165996|588475548|FG000|Overall Study|Death|1|||
162937779|NCT01165996|588475548|FG000|Overall Study|Physician Decision|1|||
162937780|NCT00096265|588475549|FG000|Overall Study|Ineligible|1|||
162937781|NCT00096265|588475550|FG001|Overall Study|Ineligible|0|||
163289109|NCT03425643|589763206|FG001|Overall Study|Withdrawal by Subject|12|||
162937782|NCT00096265|588475551|FG002|Overall Study|Ineligible|0|||
163289110|NCT03425643|589763205|FG000|Overall Study|Lost to Follow-up|2|||
163289111|NCT03425643|589763206|FG001|Overall Study|Lost to Follow-up|0|||
163289112|NCT03425643|589763205|FG000|Overall Study|Death|109|||
163289113|NCT03425643|589763206|FG001|Overall Study|Death|141|||
162937783|NCT02232074|588475554|FG000|Overall Study|Withdrawal by Subject|5|||
162937784|NCT02232074|588475555|FG001|Overall Study|Withdrawal by Subject|3|||
162937785|NCT02232074|588475554|FG000|Overall Study|No legal concerns at baseline|36|||
162937786|NCT02232074|588475555|FG001|Overall Study|No legal concerns at baseline|41|||
162937787|NCT02232074|588475554|FG000|Overall Study|deemed ineligible|0|||
162937788|NCT02232074|588475555|FG001|Overall Study|deemed ineligible|1|||
162937789|NCT01927757|588475556|FG000|Overall Study|Withdrawal by Subject|14|||
162937790|NCT01927757|588475556|FG000|Overall Study|Lost to Follow-up|2|||
162937791|NCT01927757|588475556|FG000|Overall Study|Decision by Sponsor|2|||
162937792|NCT01927757|588475556|FG000|Overall Study|Other|1|||
163183787|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
163183788|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
163183789|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
163183790|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
163183791|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
163183792|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
163183793|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
163183794|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
163183795|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
163183796|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
163183797|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
163183798|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
163183799|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
163183800|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
163183801|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
163183802|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
163183803|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
163183804|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
163183805|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
163183806|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
163183807|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
163183808|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
163183809|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
163183810|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
163183811|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
163183812|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
163183813|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
163183814|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
163183815|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
163183816|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
163183817|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
163183818|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
163183819|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
163183820|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
163183821|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
163183822|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
163183823|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
163183824|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
163183825|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
163183826|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
163183827|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
163183828|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
163183829|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
163183830|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
163183831|NCT03739840|589389371|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
163183832|NCT03739840|589389372|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
163183833|NCT03739840|589389373|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
163183834|NCT03739840|589389374|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
163183835|NCT03739840|589389371|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
163183836|NCT03739840|589389372|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
163183837|NCT03739840|589389373|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
163183838|NCT03739840|589389374|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
163183839|NCT03739840|589389371|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
163183840|NCT03739840|589389372|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
163183841|NCT03739840|589389373|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
163183842|NCT03739840|589389374|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
163183843|NCT03739840|589389371|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
162937793|NCT01927757|588475556|FG000|Overall Study|Ethical Reasons|4|||
162937794|NCT00444795|588475558|FG000|Overall Study|Not Treated|1|||
162937795|NCT00444795|588475558|FG000|Overall Study|Treated Prior to the Contract Date|2|||
162937796|NCT00988169|588475559|FG000|Overall Study|Withdrawal by Subject|1|||
162937797|NCT00704418|588475560|FG000|Overall Study|Withdrawal by Subject|2|||
162937798|NCT00704418|588475561|FG001|Overall Study|Withdrawal by Subject|0|||
162937799|NCT00704418|588475560|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
162937800|NCT00704418|588475561|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
162937801|NCT01464827|588475562|FG000|Overall Study|Adverse Event|0|||
162937802|NCT01464827|588475563|FG001|Overall Study|Adverse Event|0|||
162937803|NCT01464827|588475564|FG002|Overall Study|Adverse Event|0|||
162937804|NCT01464827|588475565|FG003|Overall Study|Adverse Event|0|||
162937805|NCT01464827|588475566|FG004|Overall Study|Adverse Event|0|||
162937806|NCT01464827|588475567|FG005|Overall Study|Adverse Event|0|||
162937807|NCT01464827|588475568|FG006|Overall Study|Adverse Event|0|||
162937808|NCT01464827|588475569|FG007|Overall Study|Adverse Event|0|||
162937809|NCT01464827|588475570|FG008|Overall Study|Adverse Event|0|||
162937810|NCT01464827|588475571|FG009|Overall Study|Adverse Event|0|||
162937811|NCT01464827|588475572|FG010|Overall Study|Adverse Event|0|||
162937812|NCT01464827|588475573|FG011|Overall Study|Adverse Event|0|||
162937813|NCT01464827|588475574|FG012|Overall Study|Adverse Event|1|||
162937814|NCT01464827|588475575|FG013|Overall Study|Adverse Event|0|||
163289114|NCT03425643|589763205|FG000|Overall Study|Ongoing in study|276|||
163289115|NCT03425643|589763206|FG001|Overall Study|Ongoing in study|247|||
162937815|NCT01464827|588475562|FG000|Overall Study|Withdrawal by Subject|1|||
162937816|NCT01464827|588475563|FG001|Overall Study|Withdrawal by Subject|0|||
162937817|NCT01464827|588475564|FG002|Overall Study|Withdrawal by Subject|0|||
162937818|NCT01464827|588475565|FG003|Overall Study|Withdrawal by Subject|0|||
162937819|NCT01464827|588475566|FG004|Overall Study|Withdrawal by Subject|1|||
162937820|NCT01464827|588475567|FG005|Overall Study|Withdrawal by Subject|0|||
162937821|NCT01464827|588475568|FG006|Overall Study|Withdrawal by Subject|0|||
162937822|NCT01464827|588475569|FG007|Overall Study|Withdrawal by Subject|1|||
162937823|NCT01464827|588475570|FG008|Overall Study|Withdrawal by Subject|0|||
162937824|NCT01464827|588475571|FG009|Overall Study|Withdrawal by Subject|0|||
162937825|NCT01464827|588475572|FG010|Overall Study|Withdrawal by Subject|0|||
162937826|NCT01464827|588475573|FG011|Overall Study|Withdrawal by Subject|0|||
162937827|NCT01464827|588475574|FG012|Overall Study|Withdrawal by Subject|0|||
162937828|NCT01464827|588475575|FG013|Overall Study|Withdrawal by Subject|0|||
162937829|NCT01464827|588475562|FG000|Overall Study|Lost to Follow-up|0|||
162937830|NCT01464827|588475563|FG001|Overall Study|Lost to Follow-up|2|||
162937831|NCT01464827|588475564|FG002|Overall Study|Lost to Follow-up|0|||
162937832|NCT01464827|588475565|FG003|Overall Study|Lost to Follow-up|2|||
162937833|NCT01464827|588475566|FG004|Overall Study|Lost to Follow-up|3|||
162937834|NCT01464827|588475567|FG005|Overall Study|Lost to Follow-up|1|||
162937835|NCT01464827|588475568|FG006|Overall Study|Lost to Follow-up|2|||
162937836|NCT01464827|588475569|FG007|Overall Study|Lost to Follow-up|2|||
162937837|NCT01464827|588475570|FG008|Overall Study|Lost to Follow-up|0|||
162937838|NCT01464827|588475571|FG009|Overall Study|Lost to Follow-up|0|||
162937839|NCT01464827|588475572|FG010|Overall Study|Lost to Follow-up|0|||
162937840|NCT01464827|588475573|FG011|Overall Study|Lost to Follow-up|1|||
162937841|NCT01464827|588475574|FG012|Overall Study|Lost to Follow-up|0|||
162937842|NCT01464827|588475575|FG013|Overall Study|Lost to Follow-up|1|||
162937843|NCT01464827|588475562|FG000|Overall Study|Other|2|||
162937844|NCT01464827|588475563|FG001|Overall Study|Other|3|||
162937845|NCT01464827|588475564|FG002|Overall Study|Other|0|||
163289116|NCT04133363|589763207|FG000|Overall Study|Lost to Follow-up|2|||
163289117|NCT04133363|589763208|FG001|Overall Study|Lost to Follow-up|1|||
163289118|NCT04133363|589763209|FG002|Overall Study|Lost to Follow-up|4|||
163289119|NCT07214922|589763212|FG000|Overall Study|Adverse Event|0|||
162937846|NCT01464827|588475565|FG003|Overall Study|Other|2|||
162937847|NCT01464827|588475566|FG004|Overall Study|Other|3|||
162937848|NCT01464827|588475567|FG005|Overall Study|Other|0|||
162937849|NCT01464827|588475568|FG006|Overall Study|Other|1|||
162937850|NCT01464827|588475569|FG007|Overall Study|Other|0|||
162937851|NCT01464827|588475570|FG008|Overall Study|Other|3|||
162937852|NCT01464827|588475571|FG009|Overall Study|Other|1|||
163289120|NCT07214922|589763213|FG001|Overall Study|Adverse Event|0|||
163289121|NCT07214922|589763214|FG002|Overall Study|Adverse Event|1|||
163289122|NCT07214922|589763215|FG003|Overall Study|Adverse Event|0|||
163289123|NCT07214922|589763212|FG000|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
163183844|NCT03739840|589389372|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
163183845|NCT03739840|589389373|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
163183846|NCT03739840|589389374|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
163183847|NCT03739840|589389371|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
163183848|NCT03739840|589389372|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
163183849|NCT03739840|589389373|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
163183850|NCT03739840|589389374|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
163289124|NCT07214922|589763213|FG001|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|1|||
162937853|NCT01464827|588475572|FG010|Overall Study|Other|2|||
162937854|NCT01464827|588475573|FG011|Overall Study|Other|0|||
162937855|NCT01464827|588475574|FG012|Overall Study|Other|1|||
162937856|NCT01464827|588475575|FG013|Overall Study|Other|0|||
162937857|NCT01464827|588475562|FG000|Overall Study|Not Treated|0|||
162937858|NCT01464827|588475563|FG001|Overall Study|Not Treated|2|||
162937859|NCT01464827|588475564|FG002|Overall Study|Not Treated|0|||
162937860|NCT01464827|588475565|FG003|Overall Study|Not Treated|0|||
162937861|NCT01464827|588475566|FG004|Overall Study|Not Treated|1|||
162937862|NCT01464827|588475567|FG005|Overall Study|Not Treated|0|||
162937863|NCT01464827|588475568|FG006|Overall Study|Not Treated|1|||
162937864|NCT01464827|588475569|FG007|Overall Study|Not Treated|0|||
162937865|NCT01464827|588475570|FG008|Overall Study|Not Treated|0|||
162937866|NCT01464827|588475571|FG009|Overall Study|Not Treated|2|||
163289125|NCT07214922|589763214|FG002|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
163289126|NCT07214922|589763215|FG003|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
163289127|NCT00726596|589764895|FG000|Overall Study|Adverse Event|2|||
163289128|NCT00726596|589764896|FG001|Overall Study|Adverse Event|1|||
163289129|NCT00726596|589764895|FG000|Overall Study|Withdrawal by Subject|3|||
163289130|NCT00726596|589764896|FG001|Overall Study|Withdrawal by Subject|3|||
163289131|NCT00482729|589764897|FG000|Overall Study|Adverse Event|29|||
163289132|NCT00482729|589764898|FG001|Overall Study|Adverse Event|33|||
163289133|NCT00482729|589764897|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
163289134|NCT00482729|589764898|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
163289135|NCT00482729|589764897|FG000|Overall Study|Hyperglycemia Criteria|7|||
163289136|NCT00482729|589764898|FG001|Overall Study|Hyperglycemia Criteria|5|||
163289137|NCT00482729|589764897|FG000|Overall Study|Lack of Efficacy|4|||
163289138|NCT00482729|589764898|FG001|Overall Study|Lack of Efficacy|16|||
163289139|NCT00482729|589764897|FG000|Overall Study|Lost to Follow-up|86|||
163289140|NCT00482729|589764898|FG001|Overall Study|Lost to Follow-up|66|||
163289141|NCT00482729|589764897|FG000|Overall Study|Physician Decision|10|||
163289142|NCT00482729|589764898|FG001|Overall Study|Physician Decision|7|||
163289143|NCT00482729|589764897|FG000|Overall Study|Pregnancy|4|||
163289144|NCT00482729|589764898|FG001|Overall Study|Pregnancy|2|||
163289145|NCT00482729|589764897|FG000|Overall Study|Protocol Violation|10|||
163289146|NCT00482729|589764898|FG001|Overall Study|Protocol Violation|18|||
163289147|NCT00482729|589764897|FG000|Overall Study|Withdrawal by Subject|67|||
163289148|NCT00482729|589764898|FG001|Overall Study|Withdrawal by Subject|69|||
163289149|NCT00954707|589764908|FG000|Overall Study|Death|34|||
163289150|NCT00954707|589764908|FG000|Overall Study|Withdrawal by Subject|100|||
163289151|NCT00954707|589764908|FG000|Overall Study|Lost to Follow-up|33|||
163289152|NCT03265210|589764909|FG000|Overall Study|Withdrawal by Subject|7|||
163289153|NCT03265210|589764910|FG001|Overall Study|Withdrawal by Subject|9|||
163289154|NCT03265210|589764909|FG000|Overall Study|Lost to Follow-up|2|||
163289155|NCT03265210|589764910|FG001|Overall Study|Lost to Follow-up|0|||
163289156|NCT03265210|589764909|FG000|Overall Study|Physician Decision|2|||
163289157|NCT03265210|589764910|FG001|Overall Study|Physician Decision|0|||
163289158|NCT03265210|589764909|FG000|Overall Study|Adverse Event|1|||
163289159|NCT03265210|589764910|FG001|Overall Study|Adverse Event|0|||
163289160|NCT02488980|589764912|FG000|Overall Study|Protocol Violation|2|||
163289161|NCT02488980|589764913|FG001|Overall Study|Protocol Violation|2|||
163289162|NCT02488980|589764914|FG002|Overall Study|Protocol Violation|2|||
163289163|NCT02614560|589764918|FG000|Overall Study|Death|6|||
163289164|NCT02614560|589764919|FG001|Overall Study|Death|2|||
163289165|NCT00738699|589764920|FG000|Overall Study|Withdrawal by Subject|5|||
163289166|NCT00738699|589764921|FG001|Overall Study|Withdrawal by Subject|0|||
163289167|NCT00738699|589764920|FG000|Overall Study|Lost to Follow-up|1|||
163289168|NCT00738699|589764921|FG001|Overall Study|Lost to Follow-up|0|||
163289169|NCT00738699|589764920|FG000|Overall Study|Death|144|||
163289170|NCT00738699|589764921|FG001|Overall Study|Death|68|||
162937867|NCT01464827|588475572|FG010|Overall Study|Not Treated|0|||
162937868|NCT01464827|588475573|FG011|Overall Study|Not Treated|1|||
162937869|NCT01464827|588475574|FG012|Overall Study|Not Treated|0|||
163289171|NCT00738699|589764920|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
163289172|NCT00738699|589764921|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
162937870|NCT01464827|588475575|FG013|Overall Study|Not Treated|2|||
162937871|NCT01075763|588475576|FG000|Overall Study|Lost to Follow-up|2|||
162937872|NCT01075763|588475577|FG001|Overall Study|Lost to Follow-up|1|||
162937873|NCT01075763|588475576|FG000|Overall Study|Lack of Efficacy|0|||
163289173|NCT00738699|589764920|FG000|Overall Study|Other|2|||
163289174|NCT00738699|589764921|FG001|Overall Study|Other|0|||
162937874|NCT01075763|588475577|FG001|Overall Study|Lack of Efficacy|1|||
163289175|NCT00549848|589764922|FG000|Overall Study|Death|1|||
163289176|NCT00549848|589764923|FG001|Overall Study|Death|4|||
163289177|NCT00549848|589764924|FG002|Overall Study|Death|13|||
162937875|NCT01075763|588475576|FG000|Overall Study|Withdrawal by Subject|2|||
162937876|NCT01075763|588475577|FG001|Overall Study|Withdrawal by Subject|2|||
162937877|NCT00586521|588475578|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
162937878|NCT03083483|588475582|FG000|Overall Study|Adverse Event|1|||
163289178|NCT00549848|589764922|FG000|Overall Study|Physician Decision|0|||
163289179|NCT00549848|589764923|FG001|Overall Study|Physician Decision|0|||
163289180|NCT00549848|589764924|FG002|Overall Study|Physician Decision|4|||
163289181|NCT00549848|589764922|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
163289182|NCT00549848|589764923|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
163289183|NCT00549848|589764924|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
163289184|NCT00549848|589764922|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
163289185|NCT00549848|589764923|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
163289186|NCT00549848|589764924|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
163289187|NCT00549848|589764922|FG000|Overall Study|Participant/Family Withdraw|2|||
163289188|NCT00549848|589764923|FG001|Overall Study|Participant/Family Withdraw|3|||
163289189|NCT00549848|589764924|FG002|Overall Study|Participant/Family Withdraw|5|||
163289190|NCT00549848|589764922|FG000|Overall Study|Second Malignancy|1|||
163289191|NCT00549848|589764923|FG001|Overall Study|Second Malignancy|0|||
163289192|NCT00549848|589764924|FG002|Overall Study|Second Malignancy|0|||
163289193|NCT00549848|589764922|FG000|Overall Study|Transplant|3|||
163289194|NCT00549848|589764923|FG001|Overall Study|Transplant|3|||
163289195|NCT00549848|589764924|FG002|Overall Study|Transplant|18|||
163289196|NCT00549848|589764922|FG000|Overall Study|Unacceptable Toxicity|1|||
163289197|NCT00549848|589764923|FG001|Overall Study|Unacceptable Toxicity|6|||
163289198|NCT00549848|589764924|FG002|Overall Study|Unacceptable Toxicity|6|||
163289199|NCT05193318|589764925|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
163289200|NCT05193318|589764925|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
163289201|NCT03670602|589764926|FG000|Overall Study|Lost to Follow-up|1|||
163289202|NCT03670602|589764927|FG001|Overall Study|Lost to Follow-up|0|||
163289203|NCT03670602|589764926|FG000|Overall Study|Withdrawal by Subject|0|||
163289204|NCT03670602|589764927|FG001|Overall Study|Withdrawal by Subject|3|||
163289205|NCT03201809|589764928|FG000|Overall Study|Lost to Follow-up|2|||
163289206|NCT03201809|589764929|FG001|Overall Study|Lost to Follow-up|0|||
163289207|NCT00957658|589764930|FG000|Overall Study|Death|1|||
163289208|NCT00957658|589764930|FG000|Overall Study|Lost to Follow-up|4|||
163289209|NCT00957658|589764930|FG000|Overall Study|Withdrawal by Subject|12|||
163183851|NCT03739840|589389371|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
163183852|NCT03739840|589389372|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
163183853|NCT03739840|589389373|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
163183854|NCT03739840|589389374|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
163183855|NCT03739840|589389371|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
163183856|NCT03739840|589389372|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
163183857|NCT03739840|589389373|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
163183858|NCT03739840|589389374|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
163183859|NCT03739840|589389371|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
163183860|NCT03739840|589389372|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
163183861|NCT03739840|589389373|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
163183862|NCT03739840|589389374|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
163183863|NCT03739840|589389371|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
163183864|NCT03739840|589389372|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
163183865|NCT03739840|589389373|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
163183866|NCT03739840|589389374|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
163183867|NCT02788474|589389375|FG000|Double Blind Treatment Period|Not treated|1|||
163183868|NCT02788474|589389376|FG001|Double Blind Treatment Period|Not treated|0|||
163183869|NCT02788474|589389375|FG000|Double Blind Treatment Period|Patient's refusal|3|||
163183870|NCT02788474|589389376|FG001|Double Blind Treatment Period|Patient's refusal|0|||
163183871|NCT02788474|589389375|FG000|Double Blind Treatment Period|Adverse Event|6|||
163183872|NCT02788474|589389376|FG001|Double Blind Treatment Period|Adverse Event|4|||
163183873|NCT02788474|589389375|FG000|Open Label Treatment Period|Adverse Event|29|||
163183874|NCT02788474|589389376|FG001|Open Label Treatment Period|Adverse Event|9|||
163183875|NCT02788474|589389375|FG000|Open Label Treatment Period|Other than reason specified|1|||
163183876|NCT02788474|589389376|FG001|Open Label Treatment Period|Other than reason specified|0|||
163183877|NCT02788474|589389375|FG000|Open Label Treatment Period|Patient's refusal|1|||
163183878|NCT02788474|589389376|FG001|Open Label Treatment Period|Patient's refusal|3|||
163183879|NCT02788474|589389375|FG000|Open Label Treatment Period|Non-compliance|1|||
163183880|NCT02788474|589389376|FG001|Open Label Treatment Period|Non-compliance|0|||
163183881|NCT03555435|589389377|FG000|Overall Study|Lost to Follow-up|17|||
163183882|NCT03555435|589389378|FG001|Overall Study|Lost to Follow-up|19|||
163183883|NCT03555435|589389379|FG002|Overall Study|Lost to Follow-up|8|||
163183884|NCT02694523|589389382|FG000|Part A|Adverse Event|7|||
163183885|NCT02694523|589389383|FG001|Part A|Adverse Event|3|||
163183886|NCT02694523|589389384|FG002|Part A|Adverse Event|0|||
163183887|NCT02694523|589389385|FG003|Part A|Adverse Event|0|||
163289210|NCT00957658|589764930|FG000|Overall Study|Revision|1|||
163289211|NCT00957658|589764930|FG000|Overall Study|Incomplete 2 yr data|28|||
163289212|NCT00957658|589764930|FG000|Overall Study|Site termination|10|||
163289213|NCT00957658|589764930|FG000|Overall Study|unwilling/unable to return|2|||
163289214|NCT00957658|589764930|FG000|Overall Study|surgery cancelled|2|||
163289215|NCT00957658|589764930|FG000|Overall Study|Protocol Violation|5|||
162937879|NCT03083483|588475583|FG001|Overall Study|Adverse Event|1|||
162937880|NCT03083483|588475584|FG002|Overall Study|Adverse Event|1|||
162937881|NCT03083483|588475582|FG000|Overall Study|Lost to Follow-up|2|||
162937882|NCT03083483|588475583|FG001|Overall Study|Lost to Follow-up|1|||
162937883|NCT03083483|588475584|FG002|Overall Study|Lost to Follow-up|1|||
162937884|NCT03083483|588475582|FG000|Overall Study|technological issues|1|||
162937885|NCT03083483|588475583|FG001|Overall Study|technological issues|0|||
162937886|NCT03083483|588475584|FG002|Overall Study|technological issues|1|||
162937887|NCT02710071|588475585|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
162937888|NCT02710071|588475586|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
162937889|NCT02710071|588475585|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
162937890|NCT02710071|588475586|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
162937891|NCT05487456|588475589|FG000|Overall Study|Withdrawal by Subject|0|||
162937892|NCT05487456|588475590|FG001|Overall Study|Withdrawal by Subject|0|||
162937893|NCT05487456|588475591|FG002|Overall Study|Withdrawal by Subject|1|||
162937894|NCT05487456|588475592|FG003|Overall Study|Withdrawal by Subject|0|||
162937895|NCT00958256|588475594|FG000|Overall Study|Adverse Event|3|||
163289216|NCT03383887|589764931|FG000|Overall Study|Lost to Follow-up|0|||
163289217|NCT03383887|589764932|FG001|Overall Study|Lost to Follow-up|1|||
163289218|NCT00975806|589764939|FG000|Overall Study|Adverse Event|2|||
163289219|NCT00975806|589764940|FG001|Overall Study|Adverse Event|1|||
163289220|NCT00975806|589764941|FG002|Overall Study|Adverse Event|2|||
163289221|NCT00975806|589764939|FG000|Overall Study|Disease Progression|1|||
163289222|NCT00975806|589764940|FG001|Overall Study|Disease Progression|5|||
163289223|NCT00975806|589764941|FG002|Overall Study|Disease Progression|1|||
163289224|NCT00975806|589764939|FG000|Overall Study|Withdrawal by Subject|1|||
163289225|NCT00975806|589764940|FG001|Overall Study|Withdrawal by Subject|0|||
163289226|NCT00975806|589764941|FG002|Overall Study|Withdrawal by Subject|0|||
163289227|NCT00975806|589764939|FG000|Overall Study|Death|0|||
163289228|NCT00975806|589764940|FG001|Overall Study|Death|1|||
163289229|NCT00975806|589764941|FG002|Overall Study|Death|0|||
163289230|NCT00975806|589764939|FG000|Overall Study|Physician decision and disease related|1|||
163289231|NCT00975806|589764940|FG001|Overall Study|Physician decision and disease related|0|||
163289232|NCT00975806|589764941|FG002|Overall Study|Physician decision and disease related|1|||
163289233|NCT00246012|589764942|FG000|Overall Study|Adverse Event|0|||
163289234|NCT00246012|589764943|FG001|Overall Study|Adverse Event|0|||
163289235|NCT00246012|589764944|FG002|Overall Study|Adverse Event|0|||
163289236|NCT00246012|589764945|FG003|Overall Study|Adverse Event|0|||
163289237|NCT00246012|589764946|FG004|Overall Study|Adverse Event|0|||
163289238|NCT00246012|589764947|FG005|Overall Study|Adverse Event|1|||
163289239|NCT00246012|589764948|FG006|Overall Study|Adverse Event|0|||
162937896|NCT05431153|588475595|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162937897|NCT05431153|588475596|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163289240|NCT00246012|589764949|FG007|Overall Study|Adverse Event|0|||
163289241|NCT00246012|589764950|FG008|Overall Study|Adverse Event|2|||
163289242|NCT00246012|589764942|FG000|Overall Study|Withdrawal by Subject|0|||
163289243|NCT00246012|589764943|FG001|Overall Study|Withdrawal by Subject|0|||
163289244|NCT00246012|589764944|FG002|Overall Study|Withdrawal by Subject|0|||
163289245|NCT00246012|589764945|FG003|Overall Study|Withdrawal by Subject|0|||
163289246|NCT00246012|589764946|FG004|Overall Study|Withdrawal by Subject|0|||
163289247|NCT00246012|589764947|FG005|Overall Study|Withdrawal by Subject|1|||
163289248|NCT00246012|589764948|FG006|Overall Study|Withdrawal by Subject|0|||
163289249|NCT00246012|589764949|FG007|Overall Study|Withdrawal by Subject|0|||
163289250|NCT00246012|589764950|FG008|Overall Study|Withdrawal by Subject|0|||
163289251|NCT00246012|589764942|FG000|Overall Study|Disease progression|3|||
163289252|NCT00246012|589764943|FG001|Overall Study|Disease progression|1|||
163289253|NCT00246012|589764944|FG002|Overall Study|Disease progression|2|||
163289254|NCT00246012|589764945|FG003|Overall Study|Disease progression|3|||
163289255|NCT00246012|589764946|FG004|Overall Study|Disease progression|3|||
163289256|NCT00246012|589764947|FG005|Overall Study|Disease progression|25|||
163289257|NCT00246012|589764948|FG006|Overall Study|Disease progression|30|||
163289258|NCT00246012|589764949|FG007|Overall Study|Disease progression|27|||
163289259|NCT00246012|589764950|FG008|Overall Study|Disease progression|26|||
163289260|NCT00246012|589764942|FG000|Overall Study|Other|0|||
163289261|NCT00246012|589764943|FG001|Overall Study|Other|0|||
163289262|NCT00246012|589764944|FG002|Overall Study|Other|0|||
163289263|NCT00246012|589764945|FG003|Overall Study|Other|0|||
163289264|NCT00246012|589764946|FG004|Overall Study|Other|0|||
163289265|NCT00246012|589764947|FG005|Overall Study|Other|0|||
163289266|NCT00246012|589764948|FG006|Overall Study|Other|0|||
163289267|NCT00246012|589764949|FG007|Overall Study|Other|1|||
163289268|NCT00246012|589764950|FG008|Overall Study|Other|0|||
163289269|NCT00246012|589764942|FG000|Overall Study|Randomly assigned but not treated|0|||
163289270|NCT00246012|589764943|FG001|Overall Study|Randomly assigned but not treated|0|||
163042843|NCT01066871|588863975|FG001|Overall Study|Lost to Follow-up|2|||
163289271|NCT00246012|589764944|FG002|Overall Study|Randomly assigned but not treated|0|||
163289272|NCT00246012|589764945|FG003|Overall Study|Randomly assigned but not treated|0|||
163289273|NCT00246012|589764946|FG004|Overall Study|Randomly assigned but not treated|0|||
162937898|NCT05431153|588475597|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163289274|NCT00246012|589764947|FG005|Overall Study|Randomly assigned but not treated|1|||
163289275|NCT00246012|589764948|FG006|Overall Study|Randomly assigned but not treated|1|||
162937899|NCT05431153|588475598|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163289276|NCT00246012|589764949|FG007|Overall Study|Randomly assigned but not treated|0|||
163289277|NCT00246012|589764950|FG008|Overall Study|Randomly assigned but not treated|0|||
163289278|NCT02377362|589764951|FG000|Part A Second Treatment|Protocol Violation|0|||
163289279|NCT02377362|589764952|FG001|Part A Second Treatment|Protocol Violation|0|||
163289280|NCT02377362|589764953|FG002|Part A Second Treatment|Protocol Violation|0|||
163289281|NCT02377362|589764954|FG003|Part A Second Treatment|Protocol Violation|0|||
163289282|NCT02377362|589764955|FG004|Part A Second Treatment|Protocol Violation|1|||
163289283|NCT02377362|589764956|FG005|Part A Second Treatment|Protocol Violation|0|||
163289284|NCT02377362|589764957|FG006|Part A Second Treatment|Protocol Violation|0|||
163289285|NCT02377362|589764958|FG007|Part A Second Treatment|Protocol Violation|0|||
163289286|NCT02377362|589764959|FG008|Part A Second Treatment|Protocol Violation|0|||
163289287|NCT02377362|589764960|FG009|Part A Second Treatment|Protocol Violation|0|||
163289288|NCT02377362|589764961|FG010|Part A Second Treatment|Protocol Violation|0|||
163289289|NCT02377362|589764962|FG011|Part A Second Treatment|Protocol Violation|0|||
163289290|NCT02377362|589764963|FG012|Part A Second Treatment|Protocol Violation|0|||
163289291|NCT02377362|589764951|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
163289292|NCT02377362|589764952|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
163289293|NCT02377362|589764953|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
163289294|NCT02377362|589764954|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
163289295|NCT02377362|589764955|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
163289296|NCT02377362|589764956|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
163289297|NCT02377362|589764957|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
163289298|NCT02377362|589764958|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
163289299|NCT02377362|589764959|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
163289300|NCT02377362|589764960|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
163289301|NCT02377362|589764961|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
163289302|NCT02377362|589764962|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
162937900|NCT05431153|588475599|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
162937901|NCT05431153|588475600|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162937902|NCT00678392|588475601|FG000|Overall Study|Adverse Event|0|||
162937903|NCT00678392|588475602|FG001|Overall Study|Adverse Event|6|||
162937904|NCT00678392|588475601|FG000|Overall Study|Death|280|||
162937905|NCT00678392|588475602|FG001|Overall Study|Death|269|||
162937906|NCT00678392|588475601|FG000|Overall Study|Lost to Follow-up|15|||
163289303|NCT02377362|589764963|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
163289304|NCT02377362|589764951|FG000|Part B Overall|Protocol Violation|0|||
163289305|NCT02377362|589764952|FG001|Part B Overall|Protocol Violation|0|||
163289306|NCT02377362|589764953|FG002|Part B Overall|Protocol Violation|0|||
163289307|NCT02377362|589764954|FG003|Part B Overall|Protocol Violation|0|||
163289308|NCT02377362|589764955|FG004|Part B Overall|Protocol Violation|0|||
163289309|NCT02377362|589764956|FG005|Part B Overall|Protocol Violation|0|||
163289310|NCT02377362|589764957|FG006|Part B Overall|Protocol Violation|0|||
163289311|NCT02377362|589764958|FG007|Part B Overall|Protocol Violation|0|||
163289312|NCT02377362|589764959|FG008|Part B Overall|Protocol Violation|0|||
163289313|NCT02377362|589764960|FG009|Part B Overall|Protocol Violation|1|||
163289314|NCT02377362|589764961|FG010|Part B Overall|Protocol Violation|0|||
163289315|NCT02377362|589764962|FG011|Part B Overall|Protocol Violation|0|||
163289316|NCT02377362|589764963|FG012|Part B Overall|Protocol Violation|0|||
163289317|NCT02377362|589764951|FG000|Part B Overall|Adverse Event|0|||
163289318|NCT02377362|589764952|FG001|Part B Overall|Adverse Event|0|||
163289319|NCT02377362|589764953|FG002|Part B Overall|Adverse Event|0|||
163289320|NCT02377362|589764954|FG003|Part B Overall|Adverse Event|0|||
163289321|NCT02377362|589764955|FG004|Part B Overall|Adverse Event|0|||
163289322|NCT02377362|589764956|FG005|Part B Overall|Adverse Event|0|||
163289323|NCT02377362|589764957|FG006|Part B Overall|Adverse Event|1|||
163289324|NCT02377362|589764958|FG007|Part B Overall|Adverse Event|1|||
163289325|NCT02377362|589764959|FG008|Part B Overall|Adverse Event|0|||
162937907|NCT00678392|588475602|FG001|Overall Study|Lost to Follow-up|13|||
162937908|NCT00678392|588475601|FG000|Overall Study|Objective Progression or Relapse|3|||
162937909|NCT00678392|588475602|FG001|Overall Study|Objective Progression or Relapse|8|||
163289326|NCT02377362|589764960|FG009|Part B Overall|Adverse Event|0|||
163289327|NCT02377362|589764961|FG010|Part B Overall|Adverse Event|0|||
163289328|NCT02377362|589764962|FG011|Part B Overall|Adverse Event|0|||
162937910|NCT00678392|588475601|FG000|Overall Study|Sponsor's Decision|1|||
163289329|NCT02377362|589764963|FG012|Part B Overall|Adverse Event|0|||
163289330|NCT02377362|589764951|FG000|Part B Overall|Withdrawal by Subject|0|||
163289331|NCT02377362|589764952|FG001|Part B Overall|Withdrawal by Subject|0|||
163289332|NCT02377362|589764953|FG002|Part B Overall|Withdrawal by Subject|0|||
163289333|NCT02377362|589764954|FG003|Part B Overall|Withdrawal by Subject|0|||
163289334|NCT02377362|589764955|FG004|Part B Overall|Withdrawal by Subject|0|||
163183888|NCT02694523|589389386|FG004|Part A|Adverse Event|0|||
163183889|NCT02694523|589389387|FG005|Part A|Adverse Event|0|||
163183890|NCT02694523|589389388|FG006|Part A|Adverse Event|0|||
163183891|NCT02694523|589389382|FG000|Part A|Protocol Violation|1|||
163183892|NCT02694523|589389383|FG001|Part A|Protocol Violation|0|||
163183893|NCT02694523|589389384|FG002|Part A|Protocol Violation|0|||
163183894|NCT02694523|589389385|FG003|Part A|Protocol Violation|0|||
163183895|NCT02694523|589389386|FG004|Part A|Protocol Violation|0|||
163183896|NCT02694523|589389387|FG005|Part A|Protocol Violation|0|||
163183897|NCT02694523|589389388|FG006|Part A|Protocol Violation|0|||
163183898|NCT02694523|589389382|FG000|Part A|Lost to Follow-up|1|||
163183899|NCT02694523|589389383|FG001|Part A|Lost to Follow-up|2|||
163183900|NCT02694523|589389384|FG002|Part A|Lost to Follow-up|0|||
163183901|NCT02694523|589389385|FG003|Part A|Lost to Follow-up|0|||
163183902|NCT02694523|589389386|FG004|Part A|Lost to Follow-up|0|||
163183903|NCT02694523|589389387|FG005|Part A|Lost to Follow-up|0|||
163183904|NCT02694523|589389388|FG006|Part A|Lost to Follow-up|0|||
163183905|NCT02694523|589389382|FG000|Part A|Withdrawal by Subject|3|||
163183906|NCT02694523|589389383|FG001|Part A|Withdrawal by Subject|1|||
163183907|NCT02694523|589389384|FG002|Part A|Withdrawal by Subject|0|||
163183908|NCT02694523|589389385|FG003|Part A|Withdrawal by Subject|0|||
163183909|NCT02694523|589389386|FG004|Part A|Withdrawal by Subject|0|||
163183910|NCT02694523|589389387|FG005|Part A|Withdrawal by Subject|0|||
163183911|NCT02694523|589389388|FG006|Part A|Withdrawal by Subject|0|||
163183912|NCT02694523|589389382|FG000|Part A|Other|1|||
163289335|NCT02377362|589764956|FG005|Part B Overall|Withdrawal by Subject|0|||
163183913|NCT02694523|589389383|FG001|Part A|Other|1|||
163183914|NCT02694523|589389384|FG002|Part A|Other|0|||
163183915|NCT02694523|589389385|FG003|Part A|Other|0|||
163183916|NCT02694523|589389386|FG004|Part A|Other|0|||
163183917|NCT02694523|589389387|FG005|Part A|Other|0|||
163183918|NCT02694523|589389388|FG006|Part A|Other|0|||
163183919|NCT02694523|589389382|FG000|Part B|Adverse Event|0|||
163183920|NCT02694523|589389383|FG001|Part B|Adverse Event|0|||
163183921|NCT02694523|589389384|FG002|Part B|Adverse Event|7|||
163183922|NCT02694523|589389385|FG003|Part B|Adverse Event|1|||
163183923|NCT02694523|589389386|FG004|Part B|Adverse Event|1|||
163183924|NCT02694523|589389387|FG005|Part B|Adverse Event|2|||
163183925|NCT02694523|589389388|FG006|Part B|Adverse Event|0|||
163183926|NCT02694523|589389382|FG000|Part B|Protocol Violation|0|||
163183927|NCT02694523|589389383|FG001|Part B|Protocol Violation|0|||
163183928|NCT02694523|589389384|FG002|Part B|Protocol Violation|1|||
163183929|NCT02694523|589389385|FG003|Part B|Protocol Violation|0|||
163183930|NCT02694523|589389386|FG004|Part B|Protocol Violation|0|||
163183931|NCT02694523|589389387|FG005|Part B|Protocol Violation|0|||
163183932|NCT02694523|589389388|FG006|Part B|Protocol Violation|0|||
163183933|NCT02694523|589389382|FG000|Part B|Lost to Follow-up|0|||
163289336|NCT02377362|589764957|FG006|Part B Overall|Withdrawal by Subject|1|||
162937911|NCT00678392|588475602|FG001|Overall Study|Sponsor's Decision|2|||
163183934|NCT02694523|589389383|FG001|Part B|Lost to Follow-up|0|||
163183935|NCT02694523|589389384|FG002|Part B|Lost to Follow-up|2|||
163183936|NCT02694523|589389385|FG003|Part B|Lost to Follow-up|3|||
163289337|NCT02377362|589764958|FG007|Part B Overall|Withdrawal by Subject|0|||
163183937|NCT02694523|589389386|FG004|Part B|Lost to Follow-up|2|||
163183938|NCT02694523|589389387|FG005|Part B|Lost to Follow-up|0|||
163183939|NCT02694523|589389388|FG006|Part B|Lost to Follow-up|1|||
163183940|NCT02694523|589389382|FG000|Part B|Withdrawal by Subject|0|||
163183941|NCT02694523|589389383|FG001|Part B|Withdrawal by Subject|0|||
163183942|NCT02694523|589389384|FG002|Part B|Withdrawal by Subject|9|||
163183943|NCT02694523|589389385|FG003|Part B|Withdrawal by Subject|0|||
163183944|NCT02694523|589389386|FG004|Part B|Withdrawal by Subject|1|||
163289338|NCT02377362|589764959|FG008|Part B Overall|Withdrawal by Subject|0|||
163289339|NCT02377362|589764960|FG009|Part B Overall|Withdrawal by Subject|0|||
163289340|NCT02377362|589764961|FG010|Part B Overall|Withdrawal by Subject|0|||
163183945|NCT02694523|589389387|FG005|Part B|Withdrawal by Subject|3|||
163183946|NCT02694523|589389388|FG006|Part B|Withdrawal by Subject|0|||
163183947|NCT02694523|589389382|FG000|Part B|Other|0|||
163183948|NCT02694523|589389383|FG001|Part B|Other|0|||
163183949|NCT02694523|589389384|FG002|Part B|Other|1|||
163183950|NCT02694523|589389385|FG003|Part B|Other|0|||
163183951|NCT02694523|589389386|FG004|Part B|Other|0|||
163183952|NCT02694523|589389387|FG005|Part B|Other|0|||
163183953|NCT02694523|589389388|FG006|Part B|Other|1|||
163183954|NCT01058265|589389390|FG000|Overall Study|Lost to Follow-up|11|||
163183955|NCT01058265|589389391|FG001|Overall Study|Lost to Follow-up|12|||
163183956|NCT01243671|589389392|FG000|Overall Study|Adverse Event|3|||
163183957|NCT01243671|589389392|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
163183958|NCT01243671|589389392|FG000|Overall Study|Other|1|||
163183959|NCT02962765|589389393|FG000|Overall Study|Protocol Violation|9|||
163183960|NCT02962765|589389393|FG000|Overall Study|Withdrawal by Subject|3|||
163183961|NCT02962765|589389393|FG000|Overall Study|Lost to Follow-up|1|||
163183962|NCT02962765|589389393|FG000|Overall Study|Death|1|||
163183963|NCT02962765|589389393|FG000|Overall Study|Limited access to study medication|3|||
163183964|NCT02169284|589389394|FG000|Overall Study|Physician Decision|0|||
163183965|NCT02169284|589389395|FG001|Overall Study|Physician Decision|1|||
163183966|NCT01367119|589389396|FG000|Overall Study|Adverse Event|1|||
163183967|NCT01367119|589389397|FG001|Overall Study|Adverse Event|0|||
163183968|NCT01367119|589389396|FG000|Overall Study|Withdrawal by Subject|1|||
163183969|NCT01367119|589389397|FG001|Overall Study|Withdrawal by Subject|1|||
163183970|NCT02964507|589389400|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
163289341|NCT02377362|589764962|FG011|Part B Overall|Withdrawal by Subject|1|||
163289342|NCT02377362|589764963|FG012|Part B Overall|Withdrawal by Subject|0|||
163289343|NCT01806714|589764966|FG000|Overall Study|No functioning phone number|200|||
162937912|NCT00678392|588475601|FG000|Overall Study|Withdrawal by Subject|4|||
162937913|NCT00678392|588475602|FG001|Overall Study|Withdrawal by Subject|4|||
162937914|NCT00678392|588475601|FG000|Overall Study|Randomized But Not Treated|2|||
162937915|NCT00678392|588475602|FG001|Overall Study|Randomized But Not Treated|7|||
162937916|NCT00678392|588475601|FG000|Overall Study|Other|56|||
162937917|NCT00678392|588475602|FG001|Overall Study|Other|53|||
162937918|NCT03341507|588475603|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
162937919|NCT00989261|588475605|FG000|Overall Study|Still in follow up|12|||
162937920|NCT00989261|588475606|FG001|Overall Study|Still in follow up|21|||
162937921|NCT00989261|588475605|FG000|Overall Study|Withdrawal by Subject|0|||
162937922|NCT00989261|588475606|FG001|Overall Study|Withdrawal by Subject|1|||
162937923|NCT00989261|588475605|FG000|Overall Study|Lost to Follow-up|3|||
162937924|NCT00989261|588475606|FG001|Overall Study|Lost to Follow-up|0|||
162937925|NCT00782509|588475607|FG000|Overall Study|Adverse Event|20|||
162937926|NCT00782509|588475608|FG001|Overall Study|Adverse Event|10|||
162937927|NCT00782509|588475609|FG002|Overall Study|Adverse Event|20|||
162937928|NCT00782509|588475607|FG000|Overall Study|Lost to Follow-up|1|||
162937929|NCT00782509|588475608|FG001|Overall Study|Lost to Follow-up|2|||
162937930|NCT00782509|588475609|FG002|Overall Study|Lost to Follow-up|3|||
162937931|NCT00782509|588475607|FG000|Overall Study|Withdrawal by Subject|3|||
162937932|NCT00782509|588475608|FG001|Overall Study|Withdrawal by Subject|5|||
162937933|NCT00782509|588475609|FG002|Overall Study|Withdrawal by Subject|8|||
162937934|NCT00782509|588475607|FG000|Overall Study|Non compliance with protocol|2|||
162937935|NCT00782509|588475608|FG001|Overall Study|Non compliance with protocol|0|||
163183971|NCT02964507|589389401|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
163183972|NCT02964507|589389402|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
163183973|NCT02964507|589389403|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
163183974|NCT02964507|589389404|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
163183975|NCT02964507|589389405|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
163183976|NCT02964507|589389406|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
163183977|NCT02964507|589389407|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
163183978|NCT02964507|589389400|FG000|Overall Study|Study terminated by Sponsor|9|||
162937936|NCT00782509|588475609|FG002|Overall Study|Non compliance with protocol|0|||
162937937|NCT00782509|588475607|FG000|Overall Study|Other reasons not stated above|5|||
162937938|NCT00782509|588475608|FG001|Overall Study|Other reasons not stated above|2|||
162937939|NCT00782509|588475609|FG002|Overall Study|Other reasons not stated above|3|||
162937940|NCT00782509|588475607|FG000|Overall Study|Lack of Efficacy|10|||
162937941|NCT00782509|588475608|FG001|Overall Study|Lack of Efficacy|5|||
162937942|NCT00782509|588475609|FG002|Overall Study|Lack of Efficacy|2|||
162937943|NCT01401478|588475620|FG000|Overall Study|Study drug not available|6|||
162937944|NCT01401478|588475620|FG000|Overall Study|Adverse Event|5|||
162937945|NCT01401478|588475620|FG000|Overall Study|Hyperphosphatemia|5|||
162937946|NCT01401478|588475620|FG000|Overall Study|Lost to Follow-up|5|||
162937947|NCT01401478|588475620|FG000|Overall Study|Kidney transplantation|3|||
162937948|NCT01401478|588475620|FG000|Overall Study|Withdrawal by Subject|3|||
162937949|NCT01401478|588475620|FG000|Overall Study|Blood samples not available|1|||
162937950|NCT01401478|588475620|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
162937951|NCT01401478|588475620|FG000|Overall Study|Low intact parathyroid hormone|1|||
162937952|NCT01401478|588475620|FG000|Overall Study|Serious adverse event|1|||
162937953|NCT01814137|588475622|FG000|Overall Study|Adverse Event|0|||
162937954|NCT01814137|588475623|FG001|Overall Study|Adverse Event|1|||
162937955|NCT01814137|588475622|FG000|Overall Study|Withdrawal by Subject|2|||
162937956|NCT01814137|588475623|FG001|Overall Study|Withdrawal by Subject|2|||
162937957|NCT01814137|588475622|FG000|Overall Study|Physician Decision|1|||
162937958|NCT01814137|588475623|FG001|Overall Study|Physician Decision|1|||
162937959|NCT01814137|588475622|FG000|Overall Study|Unclassified|2|||
162937960|NCT01814137|588475623|FG001|Overall Study|Unclassified|1|||
162937961|NCT01798485|588475624|FG000|Overall Study|Adverse Event|32|||
162937962|NCT01798485|588475625|FG001|Overall Study|Adverse Event|40|||
162937963|NCT01798485|588475624|FG000|Overall Study|Withdrawal by Subject|27|||
162937964|NCT01798485|588475625|FG001|Overall Study|Withdrawal by Subject|31|||
162937965|NCT01798485|588475624|FG000|Overall Study|Lost to Follow-up|0|||
162937966|NCT01798485|588475625|FG001|Overall Study|Lost to Follow-up|3|||
162937967|NCT01798485|588475624|FG000|Overall Study|Physician Decision|14|||
162937968|NCT01798485|588475625|FG001|Overall Study|Physician Decision|10|||
162937969|NCT01798485|588475624|FG000|Overall Study|Objective Disease Progression|152|||
162937970|NCT01798485|588475625|FG001|Overall Study|Objective Disease Progression|106|||
162937971|NCT01798485|588475624|FG000|Overall Study|Death|25|||
162937972|NCT01798485|588475625|FG001|Overall Study|Death|22|||
162937973|NCT01798485|588475624|FG000|Overall Study|Sponsor Decision|61|||
162937974|NCT01798485|588475625|FG001|Overall Study|Sponsor Decision|54|||
162937975|NCT01798485|588475624|FG000|Overall Study|Clinical Progression|35|||
162937976|NCT01798485|588475625|FG001|Overall Study|Clinical Progression|24|||
162937977|NCT03687125|588475626|FG000|Overall Study|Progressive Disease|2|||
162937978|NCT03687125|588475627|FG001|Overall Study|Progressive Disease|1|||
163183979|NCT02964507|589389401|FG001|Overall Study|Study terminated by Sponsor|1|||
162937979|NCT03687125|588475626|FG000|Overall Study|Protocol Violation|1|||
162937980|NCT03687125|588475627|FG001|Overall Study|Protocol Violation|0|||
162937981|NCT00770991|588475628|FG000|Overall Study|Physician Decision|2|||
162937982|NCT00770991|588475629|FG001|Overall Study|Physician Decision|0|||
162937983|NCT00770991|588475628|FG000|Overall Study|Withdrawal by Subject|1|||
162937984|NCT00770991|588475629|FG001|Overall Study|Withdrawal by Subject|0|||
163289344|NCT01806714|589764967|FG001|Overall Study|No functioning phone number|170|||
163289345|NCT04107805|589764970|FG000|Overall Study|Adverse Event|0|||
163289346|NCT04107805|589764971|FG001|Overall Study|Adverse Event|0|||
163289347|NCT04107805|589764972|FG002|Overall Study|Adverse Event|0|||
163289348|NCT04107805|589764973|FG003|Overall Study|Adverse Event|1|||
163289349|NCT04107805|589764974|FG004|Overall Study|Adverse Event|0|||
163289350|NCT04107805|589764975|FG005|Overall Study|Adverse Event|1|||
163289351|NCT04107805|589764976|FG006|Overall Study|Adverse Event|0|||
163289352|NCT04107805|589764977|FG007|Overall Study|Adverse Event|0|||
163289353|NCT04107805|589764978|FG008|Overall Study|Adverse Event|1|||
163289354|NCT01120275|589764980|FG000|Overall Study|Adverse Event|3|||
163289355|NCT01120275|589764980|FG000|Overall Study|Progression|27|||
163289356|NCT01120275|589764980|FG000|Overall Study|Ineligible|3|||
163289357|NCT01120275|589764980|FG000|Overall Study|Withdrawal by Subject|1|||
163289358|NCT01120275|589764980|FG000|Overall Study|Refusal|1|||
163289359|NCT01120275|589764980|FG000|Overall Study|Not specific|1|||
163289360|NCT01191086|589764982|FG000|Overall Study|Adverse Event|20|||
163289361|NCT01191086|589764982|FG000|Overall Study|Lack of Efficacy|10|||
163289362|NCT01191086|589764982|FG000|Overall Study|Lost to Follow-up|4|||
163289363|NCT01191086|589764982|FG000|Overall Study|Physician Decision|2|||
163289364|NCT01191086|589764982|FG000|Overall Study|Withdrawal by Subject|24|||
163289365|NCT01191086|589764982|FG000|Overall Study|Discontinuation criterion met|1|||
163289366|NCT01191086|589764982|FG000|Overall Study|Other|1|||
163289367|NCT01833832|589764983|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
163289368|NCT01156116|589764984|FG000|Overall Study|Withdrawal by Subject|3|||
163289369|NCT01156116|589764985|FG001|Overall Study|Withdrawal by Subject|1|||
163289370|NCT01156116|589764984|FG000|Overall Study|CPAP intolerance|2|||
163289371|NCT01156116|589764985|FG001|Overall Study|CPAP intolerance|0|||
163289372|NCT02057718|589764986|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
163289373|NCT02057718|589764987|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
163289374|NCT02057718|589764986|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
163289375|NCT02057718|589764987|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
163289376|NCT02057718|589764986|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
163289377|NCT02057718|589764987|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
163289378|NCT02057718|589764986|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
163289379|NCT02057718|589764987|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
163289380|NCT02057718|589764986|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
163289381|NCT02057718|589764987|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
163289382|NCT02057718|589764986|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
163289383|NCT02057718|589764987|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
163289384|NCT02057718|589764986|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
163289385|NCT02057718|589764987|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
163289386|NCT02057718|589764986|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
163289387|NCT02057718|589764987|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
163289388|NCT02057718|589764986|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
163289389|NCT02057718|589764987|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
163289390|NCT02057718|589764986|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
163289391|NCT02057718|589764987|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
162937985|NCT00770991|588475628|FG000|Overall Study|Adverse Event|1|||
162937986|NCT00770991|588475629|FG001|Overall Study|Adverse Event|5|||
162937987|NCT00770991|588475628|FG000|Overall Study|Pregnancy|1|||
162937988|NCT00770991|588475629|FG001|Overall Study|Pregnancy|0|||
162937989|NCT00490061|588475631|FG000|Overall Study|Physician Decision|1|||
162937990|NCT00585351|588475634|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
162937991|NCT00585351|588475635|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
162937992|NCT00585351|588475636|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
162937993|NCT00585351|588475637|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
162937994|NCT00585351|588475638|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
162937995|NCT00585351|588475639|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
162937996|NCT00585351|588475640|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
162937997|NCT00585351|588475641|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
162937998|NCT00585351|588475634|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
162937999|NCT00585351|588475635|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
162938000|NCT00585351|588475636|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
162938001|NCT00585351|588475637|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
162938002|NCT00585351|588475638|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
163183980|NCT02964507|589389402|FG002|Overall Study|Study terminated by Sponsor|9|||
163183981|NCT02964507|589389403|FG003|Overall Study|Study terminated by Sponsor|3|||
163183982|NCT02964507|589389404|FG004|Overall Study|Study terminated by Sponsor|3|||
163183983|NCT02964507|589389405|FG005|Overall Study|Study terminated by Sponsor|2|||
163183984|NCT02964507|589389406|FG006|Overall Study|Study terminated by Sponsor|0|||
163183985|NCT02964507|589389407|FG007|Overall Study|Study terminated by Sponsor|0|||
163183986|NCT02964507|589389400|FG000|Overall Study|Other|3|||
163183987|NCT02964507|589389401|FG001|Overall Study|Other|0|||
163183988|NCT02964507|589389402|FG002|Overall Study|Other|0|||
163183989|NCT02964507|589389403|FG003|Overall Study|Other|0|||
163183990|NCT02964507|589389404|FG004|Overall Study|Other|1|||
163183991|NCT02964507|589389405|FG005|Overall Study|Other|0|||
163183992|NCT02964507|589389406|FG006|Overall Study|Other|0|||
163183993|NCT02964507|589389407|FG007|Overall Study|Other|0|||
163183994|NCT02964507|589389400|FG000|Overall Study|Death|11|||
163183995|NCT02964507|589389401|FG001|Overall Study|Death|9|||
163183996|NCT02964507|589389402|FG002|Overall Study|Death|12|||
163183997|NCT02964507|589389403|FG003|Overall Study|Death|2|||
163183998|NCT02964507|589389404|FG004|Overall Study|Death|10|||
163183999|NCT02964507|589389405|FG005|Overall Study|Death|5|||
163184000|NCT02964507|589389406|FG006|Overall Study|Death|0|||
163184001|NCT02964507|589389407|FG007|Overall Study|Death|0|||
163184002|NCT02964507|589389400|FG000|Overall Study|Withdrawal by Subject|1|||
163184003|NCT02964507|589389401|FG001|Overall Study|Withdrawal by Subject|0|||
163184004|NCT02964507|589389402|FG002|Overall Study|Withdrawal by Subject|1|||
163184005|NCT02964507|589389403|FG003|Overall Study|Withdrawal by Subject|1|||
163184006|NCT02964507|589389404|FG004|Overall Study|Withdrawal by Subject|0|||
163184007|NCT02964507|589389405|FG005|Overall Study|Withdrawal by Subject|1|||
163184008|NCT02964507|589389406|FG006|Overall Study|Withdrawal by Subject|0|||
163184009|NCT02964507|589389407|FG007|Overall Study|Withdrawal by Subject|0|||
163184010|NCT02964507|589389400|FG000|Overall Study|Physician Decision|2|||
163184011|NCT02964507|589389401|FG001|Overall Study|Physician Decision|0|||
163184012|NCT02964507|589389402|FG002|Overall Study|Physician Decision|3|||
163184013|NCT02964507|589389403|FG003|Overall Study|Physician Decision|0|||
163184014|NCT02964507|589389404|FG004|Overall Study|Physician Decision|1|||
163184015|NCT02964507|589389405|FG005|Overall Study|Physician Decision|0|||
163184016|NCT02964507|589389406|FG006|Overall Study|Physician Decision|0|||
163184017|NCT02964507|589389407|FG007|Overall Study|Physician Decision|0|||
163184018|NCT04341662|589389408|FG000|Overall Study|Did not have source-verified blood loss data|423|||
163184019|NCT04341662|589389409|FG001|Overall Study|Did not have source-verified blood loss data|514|||
163184020|NCT02675231|589389410|FG000|Overall Study|Withdrawal by Subject|2|||
163184021|NCT02675231|589389411|FG001|Overall Study|Withdrawal by Subject|4|||
163184022|NCT02675231|589389412|FG002|Overall Study|Withdrawal by Subject|2|||
163184023|NCT02675231|589389410|FG000|Overall Study|Lost to Follow-up|3|||
163184024|NCT02675231|589389411|FG001|Overall Study|Lost to Follow-up|4|||
163184025|NCT02675231|589389412|FG002|Overall Study|Lost to Follow-up|3|||
163184026|NCT00064298|589389413|FG000|Overall Study|Withdrawal by Subject|2|||
163184027|NCT00064298|589389414|FG001|Overall Study|Withdrawal by Subject|1|||
163184028|NCT00064298|589389413|FG000|Overall Study|Lost to Follow-up|2|||
163042844|NCT01066871|588863976|FG002|Overall Study|Lost to Follow-up|2|||
163184029|NCT00064298|589389414|FG001|Overall Study|Lost to Follow-up|2|||
163184030|NCT00064298|589389413|FG000|Overall Study|Death|0|||
163184031|NCT00064298|589389414|FG001|Overall Study|Death|1|||
163184032|NCT00064298|589389413|FG000|Overall Study|Disease Progression|2|||
163184033|NCT00064298|589389414|FG001|Overall Study|Disease Progression|1|||
163184034|NCT02220998|589389415|FG000|Overall Study|Randomized but Never Treated|1|||
163184035|NCT02220998|589389416|FG001|Overall Study|Randomized but Never Treated|2|||
163184036|NCT02220998|589389415|FG000|Overall Study|Death|2|||
163184037|NCT02220998|589389416|FG001|Overall Study|Death|0|||
162938003|NCT00585351|588475639|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
162938004|NCT00585351|588475640|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
162938005|NCT00585351|588475641|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
162938006|NCT00585351|588475634|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
162938007|NCT00585351|588475635|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
162938008|NCT00585351|588475636|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
162938009|NCT00585351|588475637|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
162938010|NCT00585351|588475638|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
162938011|NCT00585351|588475639|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
162938012|NCT00585351|588475640|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
162938013|NCT00585351|588475641|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
162938014|NCT00585351|588475634|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
162938015|NCT00585351|588475635|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
162938016|NCT00585351|588475636|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
162938017|NCT00585351|588475637|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
162938018|NCT00585351|588475638|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
162938019|NCT00585351|588475639|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
162938020|NCT00585351|588475640|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
162938021|NCT00585351|588475641|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
162938022|NCT00585351|588475634|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
162938023|NCT00585351|588475635|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
162938024|NCT00585351|588475636|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
162938025|NCT00585351|588475637|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
162938026|NCT00585351|588475638|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
162938027|NCT00585351|588475639|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
162938028|NCT00585351|588475640|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
162938029|NCT00585351|588475641|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
162938030|NCT00585351|588475634|FG000|Enrollment Period (Intervention)|Death|0|||
162938031|NCT00585351|588475635|FG001|Enrollment Period (Intervention)|Death|0|||
162938032|NCT00585351|588475636|FG002|Enrollment Period (Intervention)|Death|0|||
162938033|NCT00585351|588475637|FG003|Enrollment Period (Intervention)|Death|0|||
162938034|NCT00585351|588475638|FG004|Enrollment Period (Intervention)|Death|1|||
162938035|NCT00585351|588475639|FG005|Enrollment Period (Intervention)|Death|0|||
162938036|NCT00585351|588475640|FG006|Enrollment Period (Intervention)|Death|1|||
162938037|NCT00585351|588475641|FG007|Enrollment Period (Intervention)|Death|0|||
162938038|NCT00585351|588475634|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
162938039|NCT00585351|588475635|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
162938040|NCT00585351|588475636|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
162938041|NCT00585351|588475637|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
162938042|NCT00585351|588475638|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
162938043|NCT00585351|588475639|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
162938044|NCT00585351|588475640|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
162938045|NCT00585351|588475641|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
162938046|NCT00192296|588475642|FG000|Overall Study|Withdrawal by Subject|0|||
162938047|NCT00192296|588475643|FG001|Overall Study|Withdrawal by Subject|1|||
162938048|NCT00192296|588475644|FG002|Overall Study|Withdrawal by Subject|0|||
162938049|NCT00192296|588475645|FG003|Overall Study|Withdrawal by Subject|0|||
162938050|NCT02536378|588475650|FG000|Overall Study|Physician Decision|0|||
162938051|NCT02536378|588475651|FG001|Overall Study|Physician Decision|2|||
162938052|NCT02536378|588475650|FG000|Overall Study|Withdrawal by Subject|0|||
162938053|NCT02536378|588475651|FG001|Overall Study|Withdrawal by Subject|1|||
162938054|NCT02536378|588475650|FG000|Overall Study|Death|1|||
162938055|NCT02536378|588475651|FG001|Overall Study|Death|2|||
162938056|NCT02536378|588475650|FG000|Overall Study|Patient refused further follow up|6|||
162938057|NCT02536378|588475651|FG001|Overall Study|Patient refused further follow up|2|||
162938058|NCT02418910|588475652|FG000|Overall Study|Lost to Follow-up|3|||
162938059|NCT02418910|588475652|FG000|Overall Study|Withdrawal by Subject|4|||
162938060|NCT02472977|588475653|FG000|Overall Study|Disease progression|4|||
162938061|NCT02472977|588475654|FG001|Overall Study|Disease progression|25|||
162938062|NCT02472977|588475655|FG002|Overall Study|Disease progression|6|||
162938063|NCT02472977|588475653|FG000|Overall Study|Withdrawal by Subject|0|||
162938064|NCT02472977|588475654|FG001|Overall Study|Withdrawal by Subject|1|||
162938065|NCT02472977|588475655|FG002|Overall Study|Withdrawal by Subject|0|||
162938066|NCT02472977|588475653|FG000|Overall Study|Study drug toxicity|2|||
162938067|NCT02472977|588475654|FG001|Overall Study|Study drug toxicity|0|||
162938068|NCT02472977|588475655|FG002|Overall Study|Study drug toxicity|2|||
162938069|NCT02472977|588475653|FG000|Overall Study|Subject request to discontinue treatment|0|||
162938070|NCT02472977|588475654|FG001|Overall Study|Subject request to discontinue treatment|1|||
163289392|NCT02057718|589764986|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
163289393|NCT02057718|589764987|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
162938071|NCT02472977|588475655|FG002|Overall Study|Subject request to discontinue treatment|0|||
162938072|NCT01132118|588477439|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
163289394|NCT00130637|589764994|FG000|Overall Study|Adverse Event|2|||
163289395|NCT00130637|589764994|FG000|Overall Study|Withdrawal by Subject|1|||
163289396|NCT00139737|589764995|FG000|Overall Study|Withdrawal by Subject|190|||
163289397|NCT00139737|589764995|FG000|Overall Study|Adverse Event|58|||
163289398|NCT00139737|589764995|FG000|Overall Study|Lack of Efficacy|40|||
163289399|NCT00139737|589764995|FG000|Overall Study|Lost to Follow-up|8|||
163289400|NCT00139737|589764995|FG000|Overall Study|Death|3|||
163289401|NCT00139737|589764995|FG000|Overall Study|Laboratory Abnormality|2|||
163289402|NCT00139737|589764995|FG000|Overall Study|Protocol Violation|18|||
163289403|NCT00139737|589764995|FG000|Overall Study|Withdrew During Screening Phase|8|||
163289404|NCT00139737|589764995|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
163289405|NCT00139737|589764995|FG000|Overall Study|Screened, Not Treated|13|||
163289406|NCT00217672|589764996|FG000|Allocation|Ineligible|2|||
163289407|NCT00217672|589764997|FG001|Allocation|Ineligible|0|||
163289408|NCT00217672|589764996|FG000|Treatment|disease progression|33|||
163289409|NCT00217672|589764997|FG001|Treatment|disease progression|4|||
163289410|NCT00217672|589764996|FG000|Treatment|Adverse Event|18|||
163289411|NCT00217672|589764997|FG001|Treatment|Adverse Event|2|||
163289412|NCT00217672|589764996|FG000|Treatment|reqd treatment not permitted by protocol|6|||
163289413|NCT00217672|589764997|FG001|Treatment|reqd treatment not permitted by protocol|0|||
163289414|NCT00217672|589764996|FG000|Treatment|Physician Decision|6|||
163289415|NCT00217672|589764997|FG001|Treatment|Physician Decision|0|||
163289416|NCT00217672|589764996|FG000|Treatment|insurance issues|1|||
163289417|NCT00217672|589764997|FG001|Treatment|insurance issues|1|||
163289418|NCT00217672|589764996|FG000|Treatment|Death|2|||
163289419|NCT00217672|589764997|FG001|Treatment|Death|0|||
163289420|NCT00217672|589764996|FG000|Treatment|secondary malignancy|1|||
163289421|NCT00217672|589764997|FG001|Treatment|secondary malignancy|0|||
163289422|NCT00217672|589764996|FG000|Follow-up|Withdrawal by Subject|4|||
163289423|NCT00217672|589764997|FG001|Follow-up|Withdrawal by Subject|0|||
163289424|NCT00217672|589764996|FG000|Follow-up|Lost to Follow-up|1|||
163289425|NCT00217672|589764997|FG001|Follow-up|Lost to Follow-up|0|||
163289426|NCT04379713|589765003|FG000|Overall Study|Adverse Event|2|||
163289427|NCT04379713|589765004|FG001|Overall Study|Adverse Event|0|||
163289428|NCT04379713|589765003|FG000|Overall Study|Physician Decision|2|||
163289429|NCT04379713|589765004|FG001|Overall Study|Physician Decision|1|||
163289430|NCT04379713|589765003|FG000|Overall Study|Protocol Violation|11|||
163289431|NCT04379713|589765004|FG001|Overall Study|Protocol Violation|6|||
163289432|NCT04379713|589765003|FG000|Overall Study|No longer met eligibility criteria|14|||
163289433|NCT04379713|589765004|FG001|Overall Study|No longer met eligibility criteria|11|||
163289434|NCT04379713|589765003|FG000|Overall Study|Withdrawal by parent/guardian|36|||
163289435|NCT04379713|589765004|FG001|Overall Study|Withdrawal by parent/guardian|15|||
163289436|NCT04379713|589765003|FG000|Overall Study|Lost to Follow-up|31|||
163289437|NCT04379713|589765004|FG001|Overall Study|Lost to Follow-up|21|||
163289438|NCT04567888|589765005|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
163289439|NCT04567888|589765006|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
163289440|NCT04567888|589765005|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
163289441|NCT04567888|589765006|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
162938073|NCT01132118|588477440|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
162938074|NCT01132118|588477439|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
162938075|NCT01132118|588477440|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
162938076|NCT01132118|588477439|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
162938077|NCT01132118|588477440|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
162938078|NCT01644890|588477441|FG000|Overall Study|Adverse Event|7|||
162938079|NCT01644890|588477442|FG001|Overall Study|Adverse Event|20|||
162938080|NCT01644890|588477441|FG000|Overall Study|Death|1|||
162938081|NCT01644890|588477442|FG001|Overall Study|Death|3|||
162938082|NCT01644890|588477441|FG000|Overall Study|Physician Decision|3|||
162938083|NCT01644890|588477442|FG001|Overall Study|Physician Decision|9|||
162938084|NCT01644890|588477441|FG000|Overall Study|Protocol Violation|6|||
162938085|NCT01644890|588477442|FG001|Overall Study|Protocol Violation|7|||
162938086|NCT01644890|588477441|FG000|Overall Study|Withdrawal by Subject|19|||
162938087|NCT01644890|588477442|FG001|Overall Study|Withdrawal by Subject|27|||
162938088|NCT01644890|588477441|FG000|Overall Study|Progression Disease|160|||
162938089|NCT01644890|588477442|FG001|Overall Study|Progression Disease|131|||
162938090|NCT01644890|588477441|FG000|Overall Study|Clinical Progression|6|||
162938091|NCT01644890|588477442|FG001|Overall Study|Clinical Progression|6|||
162938092|NCT01644890|588477441|FG000|Overall Study|> 28 days since last dose of study drug|6|||
162938093|NCT01644890|588477442|FG001|Overall Study|> 28 days since last dose of study drug|3|||
162938094|NCT01644890|588477441|FG000|Overall Study|Other|8|||
162938095|NCT01644890|588477442|FG001|Overall Study|Other|9|||
162938096|NCT01413204|588477445|FG000|Overall Study|Adverse Event|1|||
162938097|NCT01413204|588477446|FG001|Overall Study|Adverse Event|2|||
162938098|NCT01413204|588477447|FG002|Overall Study|Adverse Event|2|||
162938099|NCT01413204|588477445|FG000|Overall Study|Physician Decision|3|||
162938100|NCT01413204|588477446|FG001|Overall Study|Physician Decision|0|||
162938101|NCT01413204|588477447|FG002|Overall Study|Physician Decision|2|||
162938102|NCT01413204|588477445|FG000|Overall Study|Withdrawal by Subject|1|||
162938103|NCT01413204|588477446|FG001|Overall Study|Withdrawal by Subject|4|||
162938104|NCT01413204|588477447|FG002|Overall Study|Withdrawal by Subject|4|||
162938105|NCT01413204|588477445|FG000|Overall Study|Clearly not eligible for the study|0|||
162938106|NCT01413204|588477446|FG001|Overall Study|Clearly not eligible for the study|0|||
162938107|NCT01413204|588477447|FG002|Overall Study|Clearly not eligible for the study|1|||
162938108|NCT01413204|588477445|FG000|Overall Study|Fasting plasma glucose level increased|1|||
162938109|NCT01413204|588477446|FG001|Overall Study|Fasting plasma glucose level increased|0|||
162938110|NCT01413204|588477447|FG002|Overall Study|Fasting plasma glucose level increased|10|||
162938111|NCT00313703|588477449|FG000|Overall Study|Lost to Follow-up|11|||
162938112|NCT00313703|588477450|FG001|Overall Study|Lost to Follow-up|2|||
162938113|NCT00313703|588477451|FG002|Overall Study|Lost to Follow-up|5|||
162938114|NCT00313703|588477452|FG003|Overall Study|Lost to Follow-up|12|||
162938115|NCT02497391|588477453|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
162938116|NCT02497391|588477454|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
162938117|NCT02497391|588477455|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
162938118|NCT02497391|588477456|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
162938119|NCT02497391|588477457|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
162938120|NCT02497391|588477458|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
162938121|NCT02497391|588477453|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
162938122|NCT02497391|588477454|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
163184038|NCT02220998|589389415|FG000|Overall Study|Lack of Efficacy|0|||
163184039|NCT02220998|589389416|FG001|Overall Study|Lack of Efficacy|5|||
163184040|NCT02220998|589389415|FG000|Overall Study|Lost to Follow-up|4|||
163184041|NCT02220998|589389416|FG001|Overall Study|Lost to Follow-up|4|||
163184042|NCT03309046|589389417|FG000|Overall Study|Withdrawal by Subject|4|||
163184043|NCT03309046|589389418|FG001|Overall Study|Withdrawal by Subject|17|||
163184044|NCT00873860|589389419|FG000|Overall Study|Lost to Follow-up|1|||
162938123|NCT02497391|588477455|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
162938124|NCT02497391|588477456|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
162938125|NCT02497391|588477457|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
162938126|NCT02497391|588477458|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
162938127|NCT02497391|588477453|FG000|Period 3 (14 Days)|Adverse Event|0|||
162938128|NCT02497391|588477454|FG001|Period 3 (14 Days)|Adverse Event|1|||
162938129|NCT02497391|588477455|FG002|Period 3 (14 Days)|Adverse Event|0|||
162938130|NCT02497391|588477456|FG003|Period 3 (14 Days)|Adverse Event|0|||
162938131|NCT02497391|588477457|FG004|Period 3 (14 Days)|Adverse Event|0|||
162938132|NCT02497391|588477458|FG005|Period 3 (14 Days)|Adverse Event|0|||
163184045|NCT00873860|589389420|FG001|Overall Study|Lost to Follow-up|0|||
163184046|NCT00873860|589389421|FG002|Overall Study|Lost to Follow-up|0|||
162938133|NCT02497391|588477453|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
162938134|NCT02497391|588477454|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
162938135|NCT02497391|588477455|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
162938136|NCT02497391|588477456|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
162938137|NCT02497391|588477457|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
162938138|NCT02497391|588477458|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
162938139|NCT02497391|588477453|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
162938140|NCT02497391|588477454|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
162938141|NCT02497391|588477455|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
162938142|NCT02497391|588477456|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
162938143|NCT02497391|588477457|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
162938144|NCT02497391|588477458|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
162938145|NCT03031899|588477461|FG000|Overall Study|Protocol Violation|1|||
162938146|NCT03031899|588477461|FG000|Overall Study|lesion disappeared after stopping habit|1|||
162938147|NCT01664052|588477462|FG000|Phase 1|No device placement|6|||
162938148|NCT01664052|588477463|FG001|Phase 1|No device placement|0|||
162938149|NCT01664052|588477462|FG000|Phase 1|No HSG 1 hr post placement|1|||
162938150|NCT01664052|588477463|FG001|Phase 1|No HSG 1 hr post placement|0|||
162938151|NCT01664052|588477462|FG000|Phase 2|No device placement|0|||
162938152|NCT01664052|588477463|FG001|Phase 2|No device placement|4|||
162938153|NCT01060670|588477464|FG000|Run In|screen failure|0|||
162938154|NCT01060670|588477465|FG001|Run In|screen failure|238|||
162938155|NCT03705351|588477471|FG000|Overall Study|Study termination|3|||
162938156|NCT03705351|588477471|FG000|Overall Study|Death|1|||
162938157|NCT03705351|588477471|FG000|Overall Study|Lack of Efficacy|2|||
162938158|NCT03705351|588477471|FG000|Overall Study|Withdrawal by Subject|1|||
162938159|NCT00633152|588477478|FG000|Overall Study|Adverse Event|1|||
162938160|NCT00633152|588477479|FG001|Overall Study|Adverse Event|0|||
162938161|NCT00633152|588477478|FG000|Overall Study|Randomized, did not receive study drug|5|||
162938162|NCT00633152|588477479|FG001|Overall Study|Randomized, did not receive study drug|2|||
162938163|NCT00633152|588477478|FG000|Overall Study|Withdrawal by Subject|1|||
162938164|NCT00633152|588477479|FG001|Overall Study|Withdrawal by Subject|1|||
162938165|NCT00633152|588477478|FG000|Overall Study|Lost to Follow-up|4|||
162938166|NCT00633152|588477479|FG001|Overall Study|Lost to Follow-up|1|||
162938167|NCT00633152|588477478|FG000|Overall Study|Miscellaneous Other|3|||
162938168|NCT00633152|588477479|FG001|Overall Study|Miscellaneous Other|2|||
162938169|NCT02180061|588477480|FG000|Overall Study|Adverse Event|4|||
162938170|NCT02180061|588477481|FG001|Overall Study|Adverse Event|2|||
162938171|NCT02180061|588477480|FG000|Overall Study|Clinical Progression|5|||
162938172|NCT02180061|588477481|FG001|Overall Study|Clinical Progression|1|||
162938173|NCT02180061|588477480|FG000|Overall Study|Progressive Disease|15|||
162938174|NCT02180061|588477481|FG001|Overall Study|Progressive Disease|5|||
162938175|NCT02180061|588477480|FG000|Overall Study|Physician Decision|1|||
162938176|NCT02180061|588477481|FG001|Overall Study|Physician Decision|0|||
162938177|NCT00056160|588477484|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
162938178|NCT00056160|588477485|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
162938179|NCT00056160|588477484|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
162938180|NCT00056160|588477485|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
162938181|NCT00056160|588477484|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
162938182|NCT00056160|588477485|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
162938183|NCT00056160|588477484|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
162938184|NCT00056160|588477485|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
162938185|NCT00056160|588477484|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
162938186|NCT00056160|588477485|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
162938187|NCT00056160|588477484|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
162938188|NCT00056160|588477485|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
162938189|NCT00056160|588477484|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
162938190|NCT00056160|588477485|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
162938191|NCT00056160|588477484|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
162938192|NCT00056160|588477485|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
162938193|NCT00056160|588477484|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
162938194|NCT00056160|588477485|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
162938195|NCT00056160|588477484|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
162938196|NCT00056160|588477485|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
162938197|NCT00056160|588477484|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
162938198|NCT00056160|588477485|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
162938199|NCT00056160|588477484|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
162938200|NCT00056160|588477485|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
162938201|NCT00056160|588477484|FG000|Final Follow-up|Transferred into expanded access study.|3|||
162938202|NCT00056160|588477485|FG001|Final Follow-up|Transferred into expanded access study.|0|||
163289442|NCT04567888|589765005|FG000|Overall Study|Reported Unusual Birth Year|2|||
162938203|NCT00056160|588477484|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
163289443|NCT04567888|589765006|FG001|Overall Study|Reported Unusual Birth Year|3|||
163289444|NCT04567888|589765005|FG000|Overall Study|Duplicate Responses|0|||
162938204|NCT00056160|588477485|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
162938205|NCT00056160|588477484|FG000|Final Follow-up|Adverse Event|1|||
162938206|NCT00056160|588477485|FG001|Final Follow-up|Adverse Event|0|||
162938207|NCT01469364|588477486|FG000|Overall Study|Adverse Event|1|||
162938208|NCT01469364|588477486|FG000|Overall Study|Withdrawal by Subject|1|||
162938209|NCT01579474|588477487|FG000|Overall Study|Adverse Event|1|||
162938210|NCT01579474|588477488|FG001|Overall Study|Adverse Event|13|||
162938211|NCT01579474|588477489|FG002|Overall Study|Adverse Event|2|||
162938212|NCT01579474|588477490|FG003|Overall Study|Adverse Event|0|||
162938213|NCT01579474|588477491|FG004|Overall Study|Adverse Event|0|||
162938214|NCT01579474|588477492|FG005|Overall Study|Adverse Event|1|||
162938215|NCT01579474|588477487|FG000|Overall Study|Lack of Efficacy|1|||
162938216|NCT01579474|588477488|FG001|Overall Study|Lack of Efficacy|0|||
162938217|NCT01579474|588477489|FG002|Overall Study|Lack of Efficacy|0|||
162938218|NCT01579474|588477490|FG003|Overall Study|Lack of Efficacy|0|||
162938219|NCT01579474|588477491|FG004|Overall Study|Lack of Efficacy|1|||
162938220|NCT01579474|588477492|FG005|Overall Study|Lack of Efficacy|0|||
162938221|NCT01579474|588477487|FG000|Overall Study|Withdrawal by Subject|1|||
162938222|NCT01579474|588477488|FG001|Overall Study|Withdrawal by Subject|0|||
162938223|NCT01579474|588477489|FG002|Overall Study|Withdrawal by Subject|0|||
162938224|NCT01579474|588477490|FG003|Overall Study|Withdrawal by Subject|0|||
162938225|NCT01579474|588477491|FG004|Overall Study|Withdrawal by Subject|0|||
162938226|NCT01579474|588477492|FG005|Overall Study|Withdrawal by Subject|0|||
162938227|NCT02295774|588477493|FG000|Overall Study|Physician Decision|1|||
162938228|NCT02295774|588477493|FG000|Overall Study|Withdrawal by Subject|2|||
162938229|NCT03532009|588477497|FG000|Overall Study|Other|1|||
162938230|NCT03532009|588477498|FG001|Overall Study|Other|1|||
162938231|NCT03532009|588477497|FG000|Overall Study|Death|1|||
162938232|NCT03532009|588477498|FG001|Overall Study|Death|1|||
162938233|NCT03532009|588477497|FG000|Overall Study|Withdrawal by Patient|0|||
162938234|NCT03532009|588477498|FG001|Overall Study|Withdrawal by Patient|2|||
162938235|NCT00368966|588477499|FG000|Infant Series|Withdrawal by Subject|11|||
162938236|NCT00368966|588477500|FG001|Infant Series|Withdrawal by Subject|6|||
162938237|NCT00368966|588477499|FG000|Infant Series|Protocol Violation|2|||
162938238|NCT00368966|588477500|FG001|Infant Series|Protocol Violation|1|||
162938239|NCT00368966|588477499|FG000|Infant Series|Lost to Follow-up|2|||
162938240|NCT00368966|588477500|FG001|Infant Series|Lost to Follow-up|0|||
162938241|NCT00368966|588477499|FG000|Infant Series|Randomization error|0|||
162938242|NCT00368966|588477500|FG001|Infant Series|Randomization error|1|||
162938243|NCT00368966|588477499|FG000|Infant Series|Failed to meet eligibility criteria|0|||
162938244|NCT00368966|588477500|FG001|Infant Series|Failed to meet eligibility criteria|1|||
162938245|NCT00368966|588477499|FG000|Infant Series|Adverse Event|0|||
162938246|NCT00368966|588477500|FG001|Infant Series|Adverse Event|1|||
162938247|NCT00368966|588477499|FG000|Infant Series|Failed to return|1|||
162938248|NCT00368966|588477500|FG001|Infant Series|Failed to return|0|||
162938249|NCT00368966|588477499|FG000|After Infant|Failed to return|3|||
162938250|NCT00368966|588477500|FG001|After Infant|Failed to return|1|||
162938251|NCT00368966|588477499|FG000|After Infant|Adverse Event|1|||
162938252|NCT00368966|588477500|FG001|After Infant|Adverse Event|2|||
162938253|NCT00368966|588477499|FG000|After Infant|Withdrawal by Subject|1|||
162938254|NCT00368966|588477500|FG001|After Infant|Withdrawal by Subject|1|||
162938255|NCT00368966|588477499|FG000|After Infant|Death|1|||
162938256|NCT00368966|588477500|FG001|After Infant|Death|0|||
162938257|NCT00368966|588477499|FG000|After Infant|Lost to Follow-up|0|||
162938258|NCT00368966|588477500|FG001|After Infant|Lost to Follow-up|1|||
162938259|NCT00368966|588477499|FG000|Toddler Dose|Withdrawal by Subject|1|||
162938260|NCT00368966|588477500|FG001|Toddler Dose|Withdrawal by Subject|1|||
162938261|NCT00368966|588477499|FG000|Toddler Dose|Lost to Follow-up|0|||
162938262|NCT00368966|588477500|FG001|Toddler Dose|Lost to Follow-up|2|||
162938263|NCT02866175|588477505|FG000|Overall Study|Adverse Event|56|||
162938264|NCT02866175|588477506|FG001|Overall Study|Adverse Event|54|||
162938265|NCT02866175|588477505|FG000|Overall Study|Withdrawal by Subject|31|||
162938266|NCT02866175|588477506|FG001|Overall Study|Withdrawal by Subject|52|||
162938267|NCT02866175|588477505|FG000|Overall Study|Death|30|||
162938268|NCT02866175|588477506|FG001|Overall Study|Death|23|||
162938269|NCT02866175|588477505|FG000|Overall Study|Other|7|||
162938270|NCT02866175|588477506|FG001|Overall Study|Other|14|||
162938271|NCT02866175|588477505|FG000|Overall Study|Progressive disease|1|||
162938272|NCT02866175|588477506|FG001|Overall Study|Progressive disease|1|||
162938273|NCT02866175|588477505|FG000|Overall Study|Lost to Follow-up|2|||
162938274|NCT02866175|588477506|FG001|Overall Study|Lost to Follow-up|0|||
162938275|NCT02866175|588477505|FG000|Overall Study|Lack of Efficacy|0|||
162938276|NCT02866175|588477506|FG001|Overall Study|Lack of Efficacy|1|||
162938277|NCT02866175|588477505|FG000|Overall Study|Physician Decision|3|||
162938278|NCT02866175|588477506|FG001|Overall Study|Physician Decision|15|||
162938279|NCT02866175|588477505|FG000|Overall Study|Did not receive treatment|5|||
162938280|NCT02866175|588477506|FG001|Overall Study|Did not receive treatment|15|||
162938281|NCT01694485|588477509|FG000|Overall Study|Withdrawal by Subject|20|||
162938282|NCT01694485|588477510|FG001|Overall Study|Withdrawal by Subject|6|||
162938283|NCT01694485|588477511|FG002|Overall Study|Withdrawal by Subject|7|||
162938284|NCT01694485|588477512|FG003|Overall Study|Withdrawal by Subject|25|||
162938285|NCT01694485|588477513|FG004|Overall Study|Withdrawal by Subject|18|||
162938286|NCT01694485|588477509|FG000|Overall Study|Sponsor Decision|3|||
162938287|NCT01694485|588477510|FG001|Overall Study|Sponsor Decision|0|||
162938288|NCT01694485|588477511|FG002|Overall Study|Sponsor Decision|0|||
162938289|NCT01694485|588477512|FG003|Overall Study|Sponsor Decision|2|||
162938290|NCT01694485|588477513|FG004|Overall Study|Sponsor Decision|0|||
162938291|NCT01694485|588477509|FG000|Overall Study|Lost to Follow-up|9|||
162938292|NCT01694485|588477510|FG001|Overall Study|Lost to Follow-up|1|||
162938293|NCT01694485|588477511|FG002|Overall Study|Lost to Follow-up|6|||
162938294|NCT01694485|588477512|FG003|Overall Study|Lost to Follow-up|10|||
162938295|NCT01694485|588477513|FG004|Overall Study|Lost to Follow-up|7|||
162938296|NCT01694485|588477509|FG000|Overall Study|Death|1|||
162938297|NCT01694485|588477510|FG001|Overall Study|Death|0|||
162938298|NCT01694485|588477511|FG002|Overall Study|Death|0|||
162938299|NCT01694485|588477512|FG003|Overall Study|Death|1|||
162938300|NCT01694485|588477513|FG004|Overall Study|Death|0|||
162938301|NCT02907203|588477514|FG000|Overall Study|Death|1|||
162938302|NCT02907203|588477514|FG000|Overall Study|Lost to Follow-up|3|||
162938303|NCT02907203|588477514|FG000|Overall Study|Withdrawal by Subject|3|||
162938304|NCT02907203|588477514|FG000|Overall Study|Surgical bypass|1|||
162938305|NCT00952484|588477515|FG000|Overall Study|Withdrawal by Subject|0|||
162938306|NCT00952484|588477516|FG001|Overall Study|Withdrawal by Subject|1|||
162938307|NCT00952484|588477517|FG002|Overall Study|Withdrawal by Subject|0|||
162938308|NCT02750306|588477518|FG000|Overall Study|Withdrawal by Subject|5|||
162938309|NCT02750306|588477519|FG001|Overall Study|Withdrawal by Subject|2|||
162938310|NCT02750306|588477518|FG000|Overall Study|Protocol Violation|1|||
162938311|NCT02750306|588477519|FG001|Overall Study|Protocol Violation|0|||
162938312|NCT02227849|588477525|FG000|Overall Study|Adverse Event|4|||
162938313|NCT02227849|588477525|FG000|Overall Study|Physician Decision|1|||
162938314|NCT02227849|588477525|FG000|Overall Study|Withdrawal by Subject|3|||
162938315|NCT00457665|588477528|FG000|12 Months|Drug allergy|1|||
162938316|NCT00457665|588477529|FG001|12 Months|Drug allergy|1|||
162938317|NCT00457665|588477528|FG000|12 Months|High HIV viral load|5|||
162938318|NCT00457665|588477529|FG001|12 Months|High HIV viral load|1|||
162938319|NCT00457665|588477528|FG000|12 Months|Lipodystrophy|2|||
162938320|NCT00457665|588477529|FG001|12 Months|Lipodystrophy|0|||
162938321|NCT00457665|588477528|FG000|12 Months|Withdrawal by Subject|0|||
162938322|NCT00457665|588477529|FG001|12 Months|Withdrawal by Subject|2|||
162938323|NCT00457665|588477528|FG000|12 Months|Abnormal Liver function tests|0|||
162938324|NCT00457665|588477529|FG001|12 Months|Abnormal Liver function tests|5|||
162938325|NCT00457665|588477528|FG000|24 Months|Withdrawal by Subject|3|||
162938326|NCT00457665|588477529|FG001|24 Months|Withdrawal by Subject|2|||
162938327|NCT00457665|588477528|FG000|24 Months|Lipodystrophy|1|||
162938328|NCT00457665|588477529|FG001|24 Months|Lipodystrophy|1|||
162938329|NCT00457665|588477528|FG000|24 Months|Abnormal liver function tests|1|||
162938330|NCT00457665|588477529|FG001|24 Months|Abnormal liver function tests|5|||
162938331|NCT02535000|588477531|FG000|Overall Study|Cancellation of surgery.|1|||
162938332|NCT02535000|588477532|FG001|Overall Study|Cancellation of surgery.|2|||
162938333|NCT04317781|588477533|FG000|Overall Study|Adverse Event|1|||
162938334|NCT04317781|588477533|FG000|Overall Study|Disease relapse|1|||
162938335|NCT04317781|588477533|FG000|Overall Study|Withdrawal by Subject|1|||
162938336|NCT01102777|588477539|FG000|Overall Study|Death|2|||
162938337|NCT01102777|588477540|FG001|Overall Study|Death|6|||
162938338|NCT01102777|588477539|FG000|Overall Study|Lost to Follow-up|7|||
162938339|NCT01102777|588477540|FG001|Overall Study|Lost to Follow-up|10|||
162938340|NCT00706706|588477541|FG000|Overall Study|Death|53|||
162938341|NCT00706706|588477541|FG000|Overall Study|Lost to Follow-up|7|||
162938342|NCT00706706|588477541|FG000|Overall Study|Study endpoint had reached|45|||
162938343|NCT02175966|588477546|FG000|Follow-up Period|Lack of Efficacy|10|||
162938344|NCT02175966|588477547|FG001|Follow-up Period|Lack of Efficacy|6|||
162938345|NCT00210626|588477548|FG000|Overall Study|Adverse Event|1|||
162938346|NCT00210626|588477549|FG001|Overall Study|Adverse Event|2|||
162938347|NCT00210626|588477548|FG000|Overall Study|Protocol Violation|1|||
162938348|NCT00210626|588477549|FG001|Overall Study|Protocol Violation|5|||
162938349|NCT00210626|588477548|FG000|Overall Study|Lost to Follow-up|11|||
162938350|NCT00210626|588477549|FG001|Overall Study|Lost to Follow-up|11|||
162938351|NCT00210626|588477548|FG000|Overall Study|Death|1|||
162938352|NCT00210626|588477549|FG001|Overall Study|Death|0|||
162938353|NCT00210626|588477548|FG000|Overall Study|Withdrawal by Subject|29|||
162938354|NCT00210626|588477549|FG001|Overall Study|Withdrawal by Subject|20|||
162938355|NCT00210626|588477548|FG000|Overall Study|Physician Decision|0|||
162938356|NCT00210626|588477549|FG001|Overall Study|Physician Decision|2|||
162938357|NCT00210626|588477548|FG000|Overall Study|Sponser Request|1|||
162938358|NCT00210626|588477549|FG001|Overall Study|Sponser Request|0|||
162938359|NCT00210626|588477548|FG000|Overall Study|Other|4|||
162938360|NCT00210626|588477549|FG001|Overall Study|Other|5|||
162938361|NCT03361956|588477550|FG000|Overall Study|Adverse Event|1|||
162938362|NCT03361956|588477551|FG001|Overall Study|Adverse Event|0|||
162938363|NCT03361956|588477552|FG002|Overall Study|Adverse Event|1|||
162938364|NCT03361956|588477553|FG003|Overall Study|Adverse Event|1|||
162938365|NCT03361956|588477554|FG004|Overall Study|Adverse Event|0|||
162938366|NCT03361956|588477550|FG000|Overall Study|Other|0|||
162938367|NCT03361956|588477551|FG001|Overall Study|Other|0|||
162938368|NCT03361956|588477552|FG002|Overall Study|Other|0|||
162938369|NCT03361956|588477553|FG003|Overall Study|Other|1|||
162938370|NCT03361956|588477554|FG004|Overall Study|Other|0|||
162938371|NCT03361956|588477550|FG000|Overall Study|Withdrawal by Subject|2|||
162938372|NCT03361956|588477551|FG001|Overall Study|Withdrawal by Subject|2|||
162938373|NCT03361956|588477552|FG002|Overall Study|Withdrawal by Subject|2|||
162938374|NCT03361956|588477553|FG003|Overall Study|Withdrawal by Subject|0|||
162938375|NCT03361956|588477554|FG004|Overall Study|Withdrawal by Subject|3|||
162938376|NCT03361956|588477550|FG000|Overall Study|Disease Relapse|0|||
162938377|NCT03361956|588477551|FG001|Overall Study|Disease Relapse|0|||
162938378|NCT03361956|588477552|FG002|Overall Study|Disease Relapse|1|||
162938379|NCT03361956|588477553|FG003|Overall Study|Disease Relapse|0|||
162938380|NCT03361956|588477554|FG004|Overall Study|Disease Relapse|0|||
162938381|NCT03361956|588477550|FG000|Overall Study|Physician Decision|0|||
162938382|NCT03361956|588477551|FG001|Overall Study|Physician Decision|2|||
162938383|NCT03361956|588477552|FG002|Overall Study|Physician Decision|0|||
162938384|NCT03361956|588477553|FG003|Overall Study|Physician Decision|1|||
162938385|NCT03361956|588477554|FG004|Overall Study|Physician Decision|0|||
162938386|NCT03361956|588477550|FG000|Overall Study|Lost to Follow-up|0|||
162938387|NCT03361956|588477551|FG001|Overall Study|Lost to Follow-up|0|||
162938388|NCT03361956|588477552|FG002|Overall Study|Lost to Follow-up|1|||
162938389|NCT03361956|588477553|FG003|Overall Study|Lost to Follow-up|1|||
162938390|NCT03361956|588477554|FG004|Overall Study|Lost to Follow-up|2|||
162938391|NCT03760510|588477555|FG000|Overall Study|Not ventilated for 24 hours|105|||
162938392|NCT03760510|588477556|FG001|Overall Study|Not ventilated for 24 hours|97|||
162938393|NCT00871728|588477558|FG000|Overall Study|Adverse Event|1|||
162938394|NCT00871728|588477558|FG000|Overall Study|Protocol Violation|7|||
162938395|NCT00871728|588477558|FG000|Overall Study|Lost to Follow-up|2|||
162938396|NCT00871728|588477558|FG000|Overall Study|Failed to Visit Hospital|4|||
162938397|NCT00871728|588477558|FG000|Overall Study|Participant Non-compliance|1|||
162938398|NCT00871728|588477558|FG000|Overall Study|Withdrawal of Informed Consent|5|||
162938399|NCT04147715|588477559|FG000|Overall Study|Adverse Event|0|||
162938400|NCT04147715|588477560|FG001|Overall Study|Adverse Event|0|||
162938401|NCT04147715|588477561|FG002|Overall Study|Adverse Event|0|||
162938402|NCT04147715|588477562|FG003|Overall Study|Adverse Event|0|||
162938403|NCT04147715|588477563|FG004|Overall Study|Adverse Event|0|||
162938404|NCT04147715|588477564|FG005|Overall Study|Adverse Event|0|||
162938405|NCT04147715|588477565|FG006|Overall Study|Adverse Event|0|||
162938406|NCT04147715|588477566|FG007|Overall Study|Adverse Event|2|||
162938407|NCT04147715|588477567|FG008|Overall Study|Adverse Event|1|||
162938408|NCT04147715|588477568|FG009|Overall Study|Adverse Event|0|||
162938409|NCT04147715|588477569|FG010|Overall Study|Adverse Event|0|||
162938410|NCT04147715|588477570|FG011|Overall Study|Adverse Event|0|||
162938411|NCT02330081|588477582|FG000|Overall Study|Adverse Event|1|||
162938412|NCT02330081|588477582|FG000|Overall Study|Donation did not meet criteria|1|||
162938413|NCT02330081|588477582|FG000|Overall Study|Protocol Violation|6|||
162938414|NCT02277769|588477583|FG000|Overall Study|Protocol Violation|3|||
162938415|NCT02277769|588477584|FG001|Overall Study|Protocol Violation|3|||
162938416|NCT02277769|588477585|FG002|Overall Study|Protocol Violation|5|||
162938417|NCT02277769|588477583|FG000|Overall Study|Lack of Efficacy|17|||
162938418|NCT02277769|588477584|FG001|Overall Study|Lack of Efficacy|0|||
163184047|NCT00873860|589389422|FG003|Overall Study|Lost to Follow-up|1|||
163184048|NCT00873860|589389419|FG000|Overall Study|Withdrawal by Subject|1|||
163184049|NCT00873860|589389420|FG001|Overall Study|Withdrawal by Subject|0|||
163184050|NCT00873860|589389421|FG002|Overall Study|Withdrawal by Subject|2|||
163184051|NCT00873860|589389422|FG003|Overall Study|Withdrawal by Subject|0|||
163184052|NCT00873860|589389419|FG000|Overall Study|Death|1|||
163184053|NCT00873860|589389420|FG001|Overall Study|Death|0|||
163184054|NCT00873860|589389421|FG002|Overall Study|Death|0|||
163184055|NCT00873860|589389422|FG003|Overall Study|Death|0|||
163184056|NCT00873860|589389419|FG000|Overall Study|Other|1|||
163184057|NCT00873860|589389420|FG001|Overall Study|Other|0|||
163184058|NCT00873860|589389421|FG002|Overall Study|Other|1|||
163184059|NCT00873860|589389422|FG003|Overall Study|Other|0|||
163184060|NCT02764190|589389423|FG000|Overall Study|Lost to Follow-up|17|||
163184061|NCT02764190|589389424|FG001|Overall Study|Lost to Follow-up|13|||
162938419|NCT02277769|588477585|FG002|Overall Study|Lack of Efficacy|4|||
163184062|NCT00591266|589389425|FG000|Overall Study|Adverse Event|2|||
163184063|NCT00591266|589389426|FG001|Overall Study|Adverse Event|2|||
163184064|NCT00591266|589389427|FG002|Overall Study|Adverse Event|3|||
163184065|NCT00591266|589389425|FG000|Overall Study|Lost to Follow-up|0|||
163184066|NCT00591266|589389426|FG001|Overall Study|Lost to Follow-up|1|||
162938420|NCT02277769|588477583|FG000|Overall Study|Adverse Event|14|||
162938421|NCT02277769|588477584|FG001|Overall Study|Adverse Event|2|||
162938422|NCT02277769|588477585|FG002|Overall Study|Adverse Event|4|||
162938423|NCT02277769|588477583|FG000|Overall Study|Other than specified above|12|||
162938424|NCT02277769|588477584|FG001|Overall Study|Other than specified above|8|||
163184067|NCT00591266|589389427|FG002|Overall Study|Lost to Follow-up|0|||
163184068|NCT00591266|589389425|FG000|Overall Study|Protocol Violation|0|||
162938425|NCT02277769|588477585|FG002|Overall Study|Other than specified above|5|||
162938426|NCT03775681|588477589|FG000|Overall Study|Physician Decision|3|||
162938427|NCT02123459|588477592|FG000|Washout Period (1 Day)|Adverse Event|1|||
162938428|NCT02123459|588477593|FG001|Washout Period (1 Day)|Adverse Event|0|||
162938429|NCT02196506|588477594|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
162938430|NCT02196506|588477595|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
162938431|NCT02196506|588477596|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
162938432|NCT02196506|588477597|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
162938433|NCT02196506|588477594|FG000|Phase A|Withdrawal by Subject|34|||
162938434|NCT02196506|588477595|FG001|Phase A|Withdrawal by Subject|0|||
162938435|NCT02196506|588477596|FG002|Phase A|Withdrawal by Subject|0|||
162938436|NCT02196506|588477597|FG003|Phase A|Withdrawal by Subject|0|||
162938437|NCT02196506|588477594|FG000|Phase A|Adverse Event|22|||
162938438|NCT02196506|588477595|FG001|Phase A|Adverse Event|0|||
162938439|NCT02196506|588477596|FG002|Phase A|Adverse Event|0|||
162938440|NCT02196506|588477597|FG003|Phase A|Adverse Event|0|||
162938441|NCT02196506|588477594|FG000|Phase A|Lost to Follow-up|9|||
162938442|NCT02196506|588477595|FG001|Phase A|Lost to Follow-up|0|||
162938443|NCT02196506|588477596|FG002|Phase A|Lost to Follow-up|0|||
162938444|NCT02196506|588477597|FG003|Phase A|Lost to Follow-up|0|||
162938445|NCT02196506|588477594|FG000|Phase A|Protocol deviation|12|||
162938446|NCT02196506|588477595|FG001|Phase A|Protocol deviation|0|||
162938447|NCT02196506|588477596|FG002|Phase A|Protocol deviation|0|||
162938448|NCT02196506|588477597|FG003|Phase A|Protocol deviation|0|||
162938449|NCT02196506|588477594|FG000|Phase A|Participant withdrawn by investigator|10|||
162938450|NCT02196506|588477595|FG001|Phase A|Participant withdrawn by investigator|0|||
162938451|NCT02196506|588477596|FG002|Phase A|Participant withdrawn by investigator|0|||
162938452|NCT02196506|588477597|FG003|Phase A|Participant withdrawn by investigator|0|||
162938453|NCT02196506|588477594|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
162938454|NCT02196506|588477595|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
162938455|NCT02196506|588477596|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
162938456|NCT02196506|588477597|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
162938457|NCT02196506|588477594|FG000|Phase B|Lack of Efficacy|0|||
162938458|NCT02196506|588477595|FG001|Phase B|Lack of Efficacy|1|||
162938459|NCT02196506|588477596|FG002|Phase B|Lack of Efficacy|2|||
162938460|NCT02196506|588477597|FG003|Phase B|Lack of Efficacy|0|||
162938461|NCT02196506|588477594|FG000|Phase B|Withdrawal by Participant|0|||
162938462|NCT02196506|588477595|FG001|Phase B|Withdrawal by Participant|8|||
162938463|NCT02196506|588477596|FG002|Phase B|Withdrawal by Participant|1|||
162938464|NCT02196506|588477597|FG003|Phase B|Withdrawal by Participant|0|||
162938465|NCT02196506|588477594|FG000|Phase B|Adverse Event|0|||
162938466|NCT02196506|588477595|FG001|Phase B|Adverse Event|4|||
162938467|NCT02196506|588477596|FG002|Phase B|Adverse Event|1|||
162938468|NCT02196506|588477597|FG003|Phase B|Adverse Event|0|||
162938469|NCT02196506|588477594|FG000|Phase B|Lost to Follow-up|0|||
162938470|NCT02196506|588477595|FG001|Phase B|Lost to Follow-up|2|||
162938471|NCT02196506|588477596|FG002|Phase B|Lost to Follow-up|1|||
162938472|NCT02196506|588477597|FG003|Phase B|Lost to Follow-up|0|||
162938473|NCT02196506|588477594|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
162938474|NCT02196506|588477595|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
162938475|NCT02196506|588477596|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
162938476|NCT02196506|588477597|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
162938477|NCT02196506|588477594|FG000|Phase A+|Withdrawal by Participant|0|||
162938478|NCT02196506|588477595|FG001|Phase A+|Withdrawal by Participant|0|||
162938479|NCT02196506|588477596|FG002|Phase A+|Withdrawal by Participant|0|||
163184069|NCT00591266|589389426|FG001|Overall Study|Protocol Violation|0|||
163184070|NCT00591266|589389427|FG002|Overall Study|Protocol Violation|1|||
163184071|NCT00591266|589389425|FG000|Overall Study|Withdrawal by Subject|6|||
163184072|NCT00591266|589389426|FG001|Overall Study|Withdrawal by Subject|2|||
163184073|NCT00591266|589389427|FG002|Overall Study|Withdrawal by Subject|5|||
163184074|NCT00591266|589389425|FG000|Overall Study|Lack of Efficacy|0|||
163184075|NCT00591266|589389426|FG001|Overall Study|Lack of Efficacy|2|||
163184076|NCT00591266|589389427|FG002|Overall Study|Lack of Efficacy|0|||
163184077|NCT00591266|589389425|FG000|Overall Study|Other|1|||
162938480|NCT02196506|588477597|FG003|Phase A+|Withdrawal by Participant|5|||
162938481|NCT02196506|588477594|FG000|Phase A+|Adverse Event|0|||
162938482|NCT02196506|588477595|FG001|Phase A+|Adverse Event|0|||
162938483|NCT02196506|588477596|FG002|Phase A+|Adverse Event|0|||
162938484|NCT02196506|588477597|FG003|Phase A+|Adverse Event|1|||
162938485|NCT02196506|588477594|FG000|Phase A+|Lost to Follow-up|0|||
163184078|NCT00591266|589389426|FG001|Overall Study|Other|4|||
163184079|NCT00591266|589389427|FG002|Overall Study|Other|5|||
162938486|NCT02196506|588477595|FG001|Phase A+|Lost to Follow-up|0|||
162938487|NCT02196506|588477596|FG002|Phase A+|Lost to Follow-up|0|||
162938488|NCT02196506|588477597|FG003|Phase A+|Lost to Follow-up|6|||
162938489|NCT02196506|588477594|FG000|Phase A+|Participant withdrawn by investigator|0|||
163184080|NCT03488927|589389428|FG000|Overall Study|Withdrawal by Subject|44|||
163289445|NCT04567888|589765006|FG001|Overall Study|Duplicate Responses|1|||
162938490|NCT02196506|588477595|FG001|Phase A+|Participant withdrawn by investigator|0|||
163042845|NCT01066871|588863977|FG003|Overall Study|Lost to Follow-up|0|||
163289446|NCT01157182|589765007|FG000|Washout of 28 Days|Adverse Event|2|||
163289447|NCT01157182|589765008|FG001|Washout of 28 Days|Adverse Event|0|||
163289448|NCT00878722|589765009|FG000|Overall Study|Progressive disease|3|||
163289449|NCT00878722|589765010|FG001|Overall Study|Progressive disease|3|||
163289450|NCT00878722|589765011|FG002|Overall Study|Progressive disease|3|||
163289451|NCT00878722|589765012|FG003|Overall Study|Progressive disease|7|||
163289452|NCT00878722|589765013|FG004|Overall Study|Progressive disease|7|||
163289453|NCT00878722|589765014|FG005|Overall Study|Progressive disease|1|||
163289454|NCT00878722|589765015|FG006|Overall Study|Progressive disease|4|||
162938491|NCT02196506|588477596|FG002|Phase A+|Participant withdrawn by investigator|0|||
162938492|NCT02196506|588477597|FG003|Phase A+|Participant withdrawn by investigator|1|||
162938493|NCT01070394|588477598|FG000|Overall Study|Adverse Event|6|||
162938494|NCT01070394|588477598|FG000|Overall Study|Withdrawal by Subject|1|||
162938495|NCT01098240|588477599|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
162938496|NCT01098240|588477600|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
162938497|NCT01098240|588477601|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
162938498|NCT01098240|588477599|FG000|Open-Label Phase|Protocol Violation|4|||
162938499|NCT01098240|588477600|FG001|Open-Label Phase|Protocol Violation|0|||
162938500|NCT01098240|588477601|FG002|Open-Label Phase|Protocol Violation|0|||
162938501|NCT01098240|588477599|FG000|Open-Label Phase|Lost to Follow-up|13|||
162938502|NCT01098240|588477600|FG001|Open-Label Phase|Lost to Follow-up|0|||
162938503|NCT01098240|588477601|FG002|Open-Label Phase|Lost to Follow-up|0|||
162938504|NCT01098240|588477599|FG000|Open-Label Phase|Other|19|||
162938505|NCT01098240|588477600|FG001|Open-Label Phase|Other|0|||
162938506|NCT01098240|588477601|FG002|Open-Label Phase|Other|0|||
162938507|NCT01098240|588477599|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
162938508|NCT01098240|588477600|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
162938509|NCT01098240|588477601|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
162938510|NCT01098240|588477599|FG000|Open-Label Phase|Pregnancy|1|||
162938511|NCT01098240|588477600|FG001|Open-Label Phase|Pregnancy|0|||
162938512|NCT01098240|588477601|FG002|Open-Label Phase|Pregnancy|0|||
162938513|NCT01098240|588477599|FG000|Open-Label Phase|Withdrawal by Subject|9|||
162938514|NCT01098240|588477600|FG001|Open-Label Phase|Withdrawal by Subject|0|||
162938515|NCT01098240|588477601|FG002|Open-Label Phase|Withdrawal by Subject|0|||
162938516|NCT01098240|588477599|FG000|Open-Label Phase|Adverse Event|12|||
162938517|NCT01098240|588477600|FG001|Open-Label Phase|Adverse Event|0|||
162938518|NCT01098240|588477601|FG002|Open-Label Phase|Adverse Event|0|||
162938519|NCT01098240|588477599|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
162938520|NCT01098240|588477600|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
162938521|NCT01098240|588477601|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
162938522|NCT01098240|588477599|FG000|Double-Blind Phase|Protocol Violation|0|||
162938523|NCT01098240|588477600|FG001|Double-Blind Phase|Protocol Violation|2|||
162938524|NCT01098240|588477601|FG002|Double-Blind Phase|Protocol Violation|4|||
162938525|NCT01098240|588477599|FG000|Double-Blind Phase|Lost to Follow-up|0|||
162938526|NCT01098240|588477600|FG001|Double-Blind Phase|Lost to Follow-up|2|||
162938527|NCT01098240|588477601|FG002|Double-Blind Phase|Lost to Follow-up|0|||
162938528|NCT01098240|588477599|FG000|Double-Blind Phase|Other|0|||
162938529|NCT01098240|588477600|FG001|Double-Blind Phase|Other|2|||
162938530|NCT01098240|588477601|FG002|Double-Blind Phase|Other|2|||
162938531|NCT01098240|588477599|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
162938532|NCT01098240|588477600|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
162938533|NCT01098240|588477601|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
162938534|NCT01098240|588477599|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
162938535|NCT01098240|588477600|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
162938536|NCT01098240|588477601|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
162938537|NCT01098240|588477599|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
162938538|NCT01098240|588477600|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
162938539|NCT01098240|588477601|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
162938540|NCT01098240|588477599|FG000|Double-Blind Phase|Adverse Event|0|||
162938541|NCT01098240|588477600|FG001|Double-Blind Phase|Adverse Event|3|||
162938542|NCT01098240|588477601|FG002|Double-Blind Phase|Adverse Event|3|||
162938543|NCT00066807|588477602|FG000|Overall Study|Study was terminated early|14|||
162938544|NCT00066807|588477603|FG001|Overall Study|Study was terminated early|15|||
162938545|NCT03507439|588477604|FG000|Overall Study|Other|2|||
162938546|NCT03507439|588477605|FG001|Overall Study|Other|1|||
163289455|NCT00878722|589765016|FG007|Overall Study|Progressive disease|3|||
163289456|NCT00878722|589765009|FG000|Overall Study|Death|0|||
163289457|NCT00878722|589765010|FG001|Overall Study|Death|0|||
163289458|NCT00878722|589765011|FG002|Overall Study|Death|0|||
163289459|NCT00878722|589765012|FG003|Overall Study|Death|1|||
163289460|NCT00878722|589765013|FG004|Overall Study|Death|0|||
162938547|NCT03507439|588477604|FG000|Overall Study|Withdrawal by Subject|1|||
162938548|NCT03507439|588477605|FG001|Overall Study|Withdrawal by Subject|0|||
162938549|NCT03507439|588477604|FG000|Overall Study|Death|1|||
162938550|NCT03507439|588477605|FG001|Overall Study|Death|1|||
162938551|NCT00874757|588477606|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
163289461|NCT00878722|589765014|FG005|Overall Study|Death|1|||
163289462|NCT00878722|589765015|FG006|Overall Study|Death|0|||
162938552|NCT03346538|588478999|FG000|Overall Study|Physician Decision|0|||
162938553|NCT03346538|588479000|FG001|Overall Study|Physician Decision|1|||
162938554|NCT03346538|588479001|FG002|Overall Study|Physician Decision|0|||
162938555|NCT03346538|588478999|FG000|Overall Study|Withdrawal by Subject|3|||
162938556|NCT03346538|588479000|FG001|Overall Study|Withdrawal by Subject|2|||
162938557|NCT03346538|588479001|FG002|Overall Study|Withdrawal by Subject|0|||
162938558|NCT03346538|588478999|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
162938559|NCT03346538|588479000|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
162938560|NCT03346538|588479001|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
162938561|NCT04014959|588479003|FG000|Baseline MRI and Assessments|Physician Decision|2|||
162938562|NCT04014959|588479003|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
162938563|NCT04014959|588479003|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
162938564|NCT02004847|588479005|FG000|Overall Study|Protocol Violation|1|||
162938565|NCT02004847|588479006|FG001|Overall Study|Protocol Violation|1|||
162938566|NCT02220920|588479007|FG000|Overall Study|Adverse Event|1|||
162938567|NCT02220920|588479008|FG001|Overall Study|Adverse Event|0|||
162938568|NCT02220920|588479007|FG000|Overall Study|Lack of Efficacy|0|||
162938569|NCT02220920|588479008|FG001|Overall Study|Lack of Efficacy|1|||
162938570|NCT02220920|588479007|FG000|Overall Study|Withdrawal by Subject|1|||
162938571|NCT02220920|588479008|FG001|Overall Study|Withdrawal by Subject|0|||
162938572|NCT02220920|588479007|FG000|Overall Study|Conflict with the stopping criteria|1|||
162938573|NCT02220920|588479008|FG001|Overall Study|Conflict with the stopping criteria|2|||
162938574|NCT02811861|588479015|FG000|Overall Study|Radiological Disease Progression|123|||
162938575|NCT02811861|588479016|FG001|Overall Study|Radiological Disease Progression|97|||
162938576|NCT02811861|588479017|FG002|Overall Study|Radiological Disease Progression|174|||
162938577|NCT02811861|588479015|FG000|Overall Study|Clinical Disease Progression|20|||
162938578|NCT02811861|588479016|FG001|Overall Study|Clinical Disease Progression|19|||
162938579|NCT02811861|588479017|FG002|Overall Study|Clinical Disease Progression|22|||
162938580|NCT02811861|588479015|FG000|Overall Study|Adverse Event|63|||
162938581|NCT02811861|588479016|FG001|Overall Study|Adverse Event|60|||
162938582|NCT02811861|588479017|FG002|Overall Study|Adverse Event|41|||
162938583|NCT02811861|588479015|FG000|Overall Study|Lost to Follow-up|0|||
162938584|NCT02811861|588479016|FG001|Overall Study|Lost to Follow-up|0|||
162938585|NCT02811861|588479017|FG002|Overall Study|Lost to Follow-up|1|||
162938586|NCT02811861|588479015|FG000|Overall Study|Subject Choice|29|||
162938587|NCT02811861|588479016|FG001|Overall Study|Subject Choice|17|||
162938588|NCT02811861|588479017|FG002|Overall Study|Subject Choice|23|||
162938589|NCT02811861|588479015|FG000|Overall Study|Withdrawal by Subject|4|||
162938590|NCT02811861|588479016|FG001|Overall Study|Withdrawal by Subject|4|||
162938591|NCT02811861|588479017|FG002|Overall Study|Withdrawal by Subject|9|||
162938592|NCT02811861|588479015|FG000|Overall Study|Other|4|||
162938593|NCT02811861|588479016|FG001|Overall Study|Other|13|||
162938594|NCT02811861|588479017|FG002|Overall Study|Other|3|||
162938595|NCT02811861|588479015|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
162938596|NCT02811861|588479016|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
162938597|NCT02811861|588479017|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
162938598|NCT02811861|588479015|FG000|Overall Study|Randomized but not treated|2|||
162938599|NCT02811861|588479016|FG001|Overall Study|Randomized but not treated|3|||
162938600|NCT02811861|588479017|FG002|Overall Study|Randomized but not treated|17|||
162938601|NCT04081337|588479021|FG000|Overall Study|Adverse Event|0|||
162938602|NCT04081337|588479022|FG001|Overall Study|Adverse Event|1|||
162938603|NCT04081337|588479021|FG000|Overall Study|Withdrawal by Subject|2|||
162938604|NCT04081337|588479022|FG001|Overall Study|Withdrawal by Subject|0|||
162938605|NCT04081337|588479021|FG000|Overall Study|Physician Decision|1|||
162938606|NCT04081337|588479022|FG001|Overall Study|Physician Decision|2|||
162938607|NCT04081337|588479021|FG000|Overall Study|Lost to Follow-up|1|||
163184081|NCT03488927|589389429|FG001|Overall Study|Withdrawal by Subject|118|||
163184082|NCT03488927|589389430|FG002|Overall Study|Withdrawal by Subject|217|||
163184083|NCT03497676|589389431|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
163184084|NCT03497676|589389432|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
163184085|NCT03497676|589389433|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
162938608|NCT04081337|588479022|FG001|Overall Study|Lost to Follow-up|0|||
162938609|NCT06624072|588479023|FG000|Washout Period 1 (7 days)|Adverse Event|0|||
162938610|NCT06624072|588479024|FG001|Washout Period 1 (7 days)|Adverse Event|0|||
162938611|NCT06624072|588479025|FG002|Washout Period 1 (7 days)|Adverse Event|1|||
162938612|NCT00416520|588479038|FG000|Open-label Period|Adverse Event|28|||
162938613|NCT00416520|588479039|FG001|Open-label Period|Adverse Event|10|||
162938614|NCT00416520|588479040|FG002|Open-label Period|Adverse Event|0|||
162938615|NCT00416520|588479041|FG003|Open-label Period|Adverse Event|0|||
162938616|NCT00416520|588479038|FG000|Open-label Period|Death|2|||
162938617|NCT00416520|588479039|FG001|Open-label Period|Death|1|||
162938618|NCT00416520|588479040|FG002|Open-label Period|Death|0|||
163184086|NCT03497676|589389434|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
163184087|NCT03497676|589389431|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
162938619|NCT00416520|588479041|FG003|Open-label Period|Death|0|||
162938620|NCT00416520|588479038|FG000|Open-label Period|Lack of Efficacy|8|||
162938621|NCT00416520|588479039|FG001|Open-label Period|Lack of Efficacy|1|||
162938622|NCT00416520|588479040|FG002|Open-label Period|Lack of Efficacy|0|||
162938623|NCT00416520|588479041|FG003|Open-label Period|Lack of Efficacy|0|||
162938624|NCT00416520|588479038|FG000|Open-label Period|Protocol Violation|3|||
162938625|NCT00416520|588479039|FG001|Open-label Period|Protocol Violation|3|||
162938626|NCT00416520|588479040|FG002|Open-label Period|Protocol Violation|0|||
162938627|NCT00416520|588479041|FG003|Open-label Period|Protocol Violation|0|||
162938628|NCT00416520|588479038|FG000|Open-label Period|Withdrawal by Subject|16|||
162938629|NCT00416520|588479039|FG001|Open-label Period|Withdrawal by Subject|5|||
162938630|NCT00416520|588479040|FG002|Open-label Period|Withdrawal by Subject|0|||
162938631|NCT00416520|588479041|FG003|Open-label Period|Withdrawal by Subject|0|||
162938632|NCT00416520|588479038|FG000|Open-label Period|Other Reasons|3|||
162938633|NCT00416520|588479039|FG001|Open-label Period|Other Reasons|12|||
162938634|NCT00416520|588479040|FG002|Open-label Period|Other Reasons|0|||
162938635|NCT00416520|588479041|FG003|Open-label Period|Other Reasons|0|||
162938636|NCT00416520|588479038|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
162938637|NCT00416520|588479039|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
162938638|NCT00416520|588479040|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
162938639|NCT00416520|588479041|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
162938640|NCT00416520|588479038|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
162938641|NCT00416520|588479039|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
162938642|NCT00416520|588479040|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
162938643|NCT00416520|588479041|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
162938644|NCT00416520|588479038|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
162938645|NCT00416520|588479039|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
162938646|NCT00416520|588479040|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
162938647|NCT00416520|588479041|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
162938648|NCT01387737|588479042|FG000|Overall Study|Adverse Event|20|||
162938649|NCT01387737|588479043|FG001|Overall Study|Adverse Event|30|||
162938650|NCT01387737|588479042|FG000|Overall Study|Lack of Efficacy|1|||
162938651|NCT01387737|588479043|FG001|Overall Study|Lack of Efficacy|0|||
162938652|NCT01387737|588479042|FG000|Overall Study|Physician Decision|3|||
162938653|NCT01387737|588479043|FG001|Overall Study|Physician Decision|10|||
162938654|NCT01387737|588479042|FG000|Overall Study|Withdrawal by Subject|27|||
162938655|NCT01387737|588479043|FG001|Overall Study|Withdrawal by Subject|31|||
162938656|NCT01387737|588479042|FG000|Overall Study|Clearly not eligible for the study|1|||
162938657|NCT01387737|588479043|FG001|Overall Study|Clearly not eligible for the study|3|||
162938658|NCT00707954|588479045|FG000|Overall Study|Physician Decision|0|||
162938659|NCT00707954|588479046|FG001|Overall Study|Physician Decision|0|||
162938660|NCT00707954|588479047|FG002|Overall Study|Physician Decision|0|||
162938661|NCT00707954|588479048|FG003|Overall Study|Physician Decision|0|||
162938662|NCT00707954|588479049|FG004|Overall Study|Physician Decision|1|||
162938663|NCT00449072|588479052|FG000|Overall Study|Adverse Event|3|||
162938664|NCT00449072|588479053|FG001|Overall Study|Adverse Event|1|||
162938665|NCT00449072|588479052|FG000|Overall Study|Protocol Violation|14|||
162938666|NCT00449072|588479053|FG001|Overall Study|Protocol Violation|12|||
162938667|NCT00449072|588479052|FG000|Overall Study|Lost to Follow-up|5|||
162938668|NCT00449072|588479053|FG001|Overall Study|Lost to Follow-up|7|||
162938669|NCT00449072|588479052|FG000|Overall Study|Withdrawal by Subject|11|||
162938670|NCT00449072|588479053|FG001|Overall Study|Withdrawal by Subject|8|||
162938671|NCT00449072|588479052|FG000|Overall Study|Lack of Efficacy|1|||
162938672|NCT00449072|588479053|FG001|Overall Study|Lack of Efficacy|1|||
162938673|NCT00449072|588479052|FG000|Overall Study|Physician Decision|1|||
162938674|NCT00449072|588479053|FG001|Overall Study|Physician Decision|0|||
162938675|NCT00449072|588479052|FG000|Overall Study|Not treated|0|||
163289463|NCT00878722|589765016|FG007|Overall Study|Death|2|||
163289464|NCT00878722|589765009|FG000|Overall Study|Adverse Event|0|||
163289465|NCT00878722|589765010|FG001|Overall Study|Adverse Event|0|||
162938676|NCT00449072|588479053|FG001|Overall Study|Not treated|1|||
162938677|NCT00449072|588479052|FG000|Overall Study|Excluded medication|0|||
162938678|NCT00449072|588479053|FG001|Overall Study|Excluded medication|2|||
162938679|NCT00449072|588479052|FG000|Overall Study|Non-compliance|2|||
162938680|NCT00449072|588479053|FG001|Overall Study|Non-compliance|5|||
162938681|NCT00449072|588479052|FG000|Overall Study|Sponsor decision|1|||
162938682|NCT00449072|588479053|FG001|Overall Study|Sponsor decision|3|||
162938683|NCT00449072|588479052|FG000|Overall Study|Relocation|3|||
162938684|NCT00449072|588479053|FG001|Overall Study|Relocation|2|||
162938685|NCT06509100|588479056|FG000|Overall Study|Withdrawal by Subject|1|||
162938686|NCT06509100|588479056|FG000|Overall Study|Lost to Follow-up|1|||
162938687|NCT05002569|588479059|FG000|Randomized|Withdrew Consent|3|||
162938688|NCT05002569|588479060|FG001|Randomized|Withdrew Consent|0|||
162938689|NCT05002569|588479059|FG000|Randomized|No longer meets study criteria|0|||
162938690|NCT05002569|588479060|FG001|Randomized|No longer meets study criteria|1|||
163042846|NCT01066871|588863974|FG000|Overall Study|Protocol Violation|1|||
163289466|NCT00878722|589765011|FG002|Overall Study|Adverse Event|0|||
162938691|NCT05002569|588479059|FG000|Randomized|AE unrelated to study drug|1|||
162938692|NCT05002569|588479060|FG001|Randomized|AE unrelated to study drug|0|||
162938693|NCT05002569|588479059|FG000|Treatment Period|Requested to Discontinue|26|||
162938694|NCT05002569|588479060|FG001|Treatment Period|Requested to Discontinue|5|||
162938695|NCT05002569|588479059|FG000|Treatment Period|Withdrew Consent|7|||
162938696|NCT05002569|588479060|FG001|Treatment Period|Withdrew Consent|1|||
162938697|NCT05002569|588479059|FG000|Treatment Period|Study Drug Toxicity|114|||
162938698|NCT05002569|588479060|FG001|Treatment Period|Study Drug Toxicity|64|||
162938699|NCT05002569|588479059|FG000|Treatment Period|AE unrelated to study drug|6|||
162938700|NCT05002569|588479060|FG001|Treatment Period|AE unrelated to study drug|12|||
162938701|NCT05002569|588479059|FG000|Treatment Period|Disease Recurrence|102|||
162938702|NCT05002569|588479060|FG001|Treatment Period|Disease Recurrence|128|||
162938703|NCT05002569|588479059|FG000|Treatment Period|Other Reasons|4|||
162938704|NCT05002569|588479060|FG001|Treatment Period|Other Reasons|7|||
162938705|NCT05002569|588479059|FG000|Treatment Period|Death|1|||
162938706|NCT05002569|588479060|FG001|Treatment Period|Death|1|||
162938707|NCT05002569|588479059|FG000|Follow Up|Death|78|||
162938708|NCT05002569|588479060|FG001|Follow Up|Death|69|||
162938709|NCT05002569|588479059|FG000|Follow Up|Lost to Follow-up|3|||
162938710|NCT05002569|588479060|FG001|Follow Up|Lost to Follow-up|3|||
162938711|NCT05002569|588479059|FG000|Follow Up|Withdrew consent|17|||
162938712|NCT05002569|588479060|FG001|Follow Up|Withdrew consent|16|||
162938713|NCT05002569|588479059|FG000|Follow Up|Other Reasons|444|||
162938714|NCT05002569|588479060|FG001|Follow Up|Other Reasons|452|||
162938715|NCT04041570|588479066|FG000|Overall Study|Moved from Area|0|||
162938716|NCT04041570|588479067|FG001|Overall Study|Moved from Area|2|||
162938717|NCT05211336|588479068|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
162938718|NCT05211336|588479069|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
162938719|NCT05211336|588479068|FG000|Overall Study|Progressive disease|0|||
162938720|NCT05211336|588479069|FG001|Overall Study|Progressive disease|4|||
162938721|NCT05211336|588479068|FG000|Overall Study|Death due to myocardial infarction|0|||
162938722|NCT05211336|588479069|FG001|Overall Study|Death due to myocardial infarction|1|||
162938723|NCT05211336|588479068|FG000|Overall Study|Death due to unknown cause|0|||
162938724|NCT05211336|588479069|FG001|Overall Study|Death due to unknown cause|1|||
162938725|NCT05211336|588479068|FG000|Overall Study|Worsening kidney function and quality of response|0|||
162938726|NCT05211336|588479069|FG001|Overall Study|Worsening kidney function and quality of response|1|||
162938727|NCT02337829|588479070|FG000|Overall Study|Death|0|||
162938728|NCT02337829|588479071|FG001|Overall Study|Death|1|||
162938729|NCT02337829|588479072|FG002|Overall Study|Death|0|||
162938730|NCT02337829|588479073|FG003|Overall Study|Death|0|||
163184088|NCT03497676|589389432|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
163184089|NCT03497676|589389433|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
163184090|NCT03497676|589389434|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
162938731|NCT02337829|588479070|FG000|Overall Study|Study terminated by sponsor|12|||
162938732|NCT02337829|588479071|FG001|Overall Study|Study terminated by sponsor|10|||
162938733|NCT02337829|588479072|FG002|Overall Study|Study terminated by sponsor|5|||
162938734|NCT02337829|588479073|FG003|Overall Study|Study terminated by sponsor|6|||
162938735|NCT02337829|588479070|FG000|Overall Study|discontinued for other reasons|6|||
162938736|NCT02337829|588479071|FG001|Overall Study|discontinued for other reasons|3|||
162938737|NCT02337829|588479072|FG002|Overall Study|discontinued for other reasons|1|||
162938738|NCT02337829|588479073|FG003|Overall Study|discontinued for other reasons|4|||
162938739|NCT01418352|588479074|FG000|Overall Study|Lost to Follow-up|2|||
162938740|NCT01418352|588479075|FG001|Overall Study|Lost to Follow-up|0|||
162938741|NCT01418352|588479076|FG002|Overall Study|Lost to Follow-up|0|||
162938742|NCT01418352|588479077|FG003|Overall Study|Lost to Follow-up|0|||
162938743|NCT01418352|588479074|FG000|Overall Study|Adverse Event|0|||
162938744|NCT01418352|588479075|FG001|Overall Study|Adverse Event|1|||
162938745|NCT01418352|588479076|FG002|Overall Study|Adverse Event|0|||
162938746|NCT01418352|588479077|FG003|Overall Study|Adverse Event|0|||
162938747|NCT01418352|588479074|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
162938748|NCT01418352|588479075|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
162938749|NCT01418352|588479076|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
162938750|NCT01418352|588479077|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
162938751|NCT01418352|588479074|FG000|Overall Study|Subject Withdrew Consent|0|||
162938752|NCT01418352|588479075|FG001|Overall Study|Subject Withdrew Consent|1|||
162938753|NCT01418352|588479076|FG002|Overall Study|Subject Withdrew Consent|2|||
162938754|NCT01418352|588479077|FG003|Overall Study|Subject Withdrew Consent|1|||
162938755|NCT01418352|588479074|FG000|Overall Study|Protocol Deviation|0|||
162938756|NCT01418352|588479075|FG001|Overall Study|Protocol Deviation|0|||
162938757|NCT01418352|588479076|FG002|Overall Study|Protocol Deviation|1|||
162938758|NCT01418352|588479077|FG003|Overall Study|Protocol Deviation|0|||
162938759|NCT01418352|588479074|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
162938760|NCT01418352|588479075|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
162938761|NCT01418352|588479076|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
162938762|NCT01418352|588479077|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
162938763|NCT00619619|588479078|FG000|Overall Study|Physician Decision|0|||
162938764|NCT00619619|588479079|FG001|Overall Study|Physician Decision|0|||
162938765|NCT00619619|588479080|FG002|Overall Study|Physician Decision|1|||
162938766|NCT00619619|588479081|FG003|Overall Study|Physician Decision|0|||
162938767|NCT00619619|588479082|FG004|Overall Study|Physician Decision|0|||
162938768|NCT00619619|588479083|FG005|Overall Study|Physician Decision|0|||
162938769|NCT00619619|588479084|FG006|Overall Study|Physician Decision|0|||
162938770|NCT00619619|588479085|FG007|Overall Study|Physician Decision|0|||
162938771|NCT00619619|588479078|FG000|Overall Study|Protocol Violation|0|||
162938772|NCT00619619|588479079|FG001|Overall Study|Protocol Violation|0|||
162938773|NCT00619619|588479080|FG002|Overall Study|Protocol Violation|0|||
162938774|NCT00619619|588479081|FG003|Overall Study|Protocol Violation|1|||
162938775|NCT00619619|588479082|FG004|Overall Study|Protocol Violation|0|||
162938776|NCT00619619|588479083|FG005|Overall Study|Protocol Violation|0|||
162938777|NCT00619619|588479084|FG006|Overall Study|Protocol Violation|1|||
162938778|NCT00619619|588479085|FG007|Overall Study|Protocol Violation|1|||
162938779|NCT00619619|588479078|FG000|Overall Study|Adverse Event|0|||
162938780|NCT00619619|588479079|FG001|Overall Study|Adverse Event|0|||
162938781|NCT00619619|588479080|FG002|Overall Study|Adverse Event|0|||
162938782|NCT00619619|588479081|FG003|Overall Study|Adverse Event|0|||
162938783|NCT00619619|588479082|FG004|Overall Study|Adverse Event|2|||
162938784|NCT00619619|588479083|FG005|Overall Study|Adverse Event|0|||
162938785|NCT00619619|588479084|FG006|Overall Study|Adverse Event|0|||
162938786|NCT00619619|588479085|FG007|Overall Study|Adverse Event|2|||
162938787|NCT01992107|588479088|FG000|Overall Study|Administrative reasons|2|||
162938788|NCT01992107|588479089|FG001|Overall Study|Administrative reasons|0|||
162938789|NCT01992107|588479090|FG002|Overall Study|Administrative reasons|0|||
162938790|NCT01992107|588479088|FG000|Overall Study|Adverse Event|0|||
162938791|NCT01992107|588479089|FG001|Overall Study|Adverse Event|1|||
162938792|NCT01992107|588479090|FG002|Overall Study|Adverse Event|0|||
162938793|NCT01992107|588479088|FG000|Overall Study|Lost to Follow-up|46|||
162938794|NCT01992107|588479089|FG001|Overall Study|Lost to Follow-up|22|||
162938795|NCT01992107|588479090|FG002|Overall Study|Lost to Follow-up|26|||
162938796|NCT01992107|588479088|FG000|Overall Study|noncompliance and were unavailable|7|||
162938797|NCT01992107|588479089|FG001|Overall Study|noncompliance and were unavailable|3|||
162938798|NCT01992107|588479090|FG002|Overall Study|noncompliance and were unavailable|2|||
162938799|NCT01992107|588479088|FG000|Overall Study|Withdrawal by Subject|13|||
162938800|NCT01992107|588479089|FG001|Overall Study|Withdrawal by Subject|7|||
162938801|NCT01992107|588479090|FG002|Overall Study|Withdrawal by Subject|8|||
162938802|NCT02022007|588479091|FG000|Overall Study|Withdrawal by Subject|1|||
162938803|NCT02022007|588479092|FG001|Overall Study|Withdrawal by Subject|1|||
162938804|NCT02022007|588479093|FG002|Overall Study|Withdrawal by Subject|1|||
162938805|NCT02022007|588479091|FG000|Overall Study|Noncompliant|0|||
162938806|NCT02022007|588479092|FG001|Overall Study|Noncompliant|0|||
162938807|NCT02022007|588479093|FG002|Overall Study|Noncompliant|1|||
163184091|NCT03497676|589389431|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
163184092|NCT03497676|589389432|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
163184093|NCT03497676|589389433|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
163184094|NCT03497676|589389434|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
163184095|NCT03497676|589389431|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
163184096|NCT03497676|589389432|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
163184097|NCT03497676|589389433|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
163184098|NCT03497676|589389434|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
162938808|NCT01214603|588479094|FG000|Overall Study|Adverse Event|0|||
162938809|NCT01214603|588479095|FG001|Overall Study|Adverse Event|0|||
162938810|NCT01214603|588479096|FG002|Overall Study|Adverse Event|1|||
162938811|NCT01214603|588479094|FG000|Overall Study|Death|1|||
162938812|NCT01214603|588479095|FG001|Overall Study|Death|0|||
162938813|NCT01214603|588479096|FG002|Overall Study|Death|0|||
162938814|NCT01214603|588479094|FG000|Overall Study|Progressive Disease|4|||
162938815|NCT01214603|588479095|FG001|Overall Study|Progressive Disease|1|||
162938816|NCT01214603|588479096|FG002|Overall Study|Progressive Disease|3|||
162938817|NCT00542386|588479097|FG000|Overall Study|Adverse Event|1|||
162938818|NCT00542386|588479098|FG001|Overall Study|Adverse Event|7|||
162938819|NCT00542386|588479099|FG002|Overall Study|Adverse Event|7|||
162938820|NCT00542386|588479100|FG003|Overall Study|Adverse Event|8|||
162938821|NCT00542386|588479101|FG004|Overall Study|Adverse Event|13|||
162938822|NCT00542386|588479102|FG005|Overall Study|Adverse Event|4|||
162938823|NCT00542386|588479097|FG000|Overall Study|Death|0|||
162938824|NCT00542386|588479098|FG001|Overall Study|Death|0|||
162938825|NCT00542386|588479099|FG002|Overall Study|Death|1|||
162938826|NCT00542386|588479100|FG003|Overall Study|Death|2|||
162938827|NCT00542386|588479101|FG004|Overall Study|Death|1|||
162938828|NCT00542386|588479102|FG005|Overall Study|Death|2|||
162938829|NCT00542386|588479097|FG000|Overall Study|Lack of Efficacy|32|||
162938830|NCT00542386|588479098|FG001|Overall Study|Lack of Efficacy|12|||
162938831|NCT00542386|588479099|FG002|Overall Study|Lack of Efficacy|10|||
162938832|NCT00542386|588479100|FG003|Overall Study|Lack of Efficacy|13|||
162938833|NCT00542386|588479101|FG004|Overall Study|Lack of Efficacy|7|||
162938834|NCT00542386|588479102|FG005|Overall Study|Lack of Efficacy|31|||
162938835|NCT00542386|588479097|FG000|Overall Study|Physician Decision|1|||
162938836|NCT00542386|588479098|FG001|Overall Study|Physician Decision|0|||
162938837|NCT00542386|588479099|FG002|Overall Study|Physician Decision|0|||
162938838|NCT00542386|588479100|FG003|Overall Study|Physician Decision|1|||
162938839|NCT00542386|588479101|FG004|Overall Study|Physician Decision|0|||
162938840|NCT00542386|588479102|FG005|Overall Study|Physician Decision|0|||
162938841|NCT00542386|588479097|FG000|Overall Study|Protocol Violation|0|||
162938842|NCT00542386|588479098|FG001|Overall Study|Protocol Violation|0|||
162938843|NCT00542386|588479099|FG002|Overall Study|Protocol Violation|1|||
162938844|NCT00542386|588479100|FG003|Overall Study|Protocol Violation|0|||
162938845|NCT00542386|588479101|FG004|Overall Study|Protocol Violation|0|||
162938846|NCT00542386|588479102|FG005|Overall Study|Protocol Violation|4|||
162938847|NCT00542386|588479097|FG000|Overall Study|Withdrawal by Subject|5|||
162938848|NCT00542386|588479098|FG001|Overall Study|Withdrawal by Subject|8|||
162938849|NCT00542386|588479099|FG002|Overall Study|Withdrawal by Subject|10|||
162938850|NCT00542386|588479100|FG003|Overall Study|Withdrawal by Subject|11|||
162938851|NCT00542386|588479101|FG004|Overall Study|Withdrawal by Subject|15|||
162938852|NCT00542386|588479102|FG005|Overall Study|Withdrawal by Subject|7|||
162938853|NCT00542386|588479097|FG000|Overall Study|Other Reasons|4|||
162938854|NCT00542386|588479098|FG001|Overall Study|Other Reasons|1|||
162938855|NCT00542386|588479099|FG002|Overall Study|Other Reasons|4|||
162938856|NCT00542386|588479100|FG003|Overall Study|Other Reasons|3|||
162938857|NCT00542386|588479101|FG004|Overall Study|Other Reasons|4|||
163184099|NCT03497676|589389431|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
163184100|NCT03497676|589389432|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
163184101|NCT03497676|589389433|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
163184102|NCT03497676|589389434|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
163184103|NCT03497676|589389431|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
163184104|NCT03497676|589389432|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
163184105|NCT03497676|589389433|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
163184106|NCT03497676|589389434|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
163184107|NCT03497676|589389431|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
163184108|NCT03497676|589389432|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
163184109|NCT03497676|589389433|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
163184110|NCT03497676|589389434|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
163184111|NCT03497676|589389431|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
163184112|NCT03497676|589389432|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
162938858|NCT00542386|588479102|FG005|Overall Study|Other Reasons|2|||
162938859|NCT01507896|588479103|FG000|Overall Study|Withdrawal by Subject|1|||
162938860|NCT01507896|588479103|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
162938861|NCT00446654|588479111|FG000|Overall Study|Withdrawal by Subject|1|||
162938862|NCT00446654|588479112|FG001|Overall Study|Withdrawal by Subject|0|||
162938863|NCT00446654|588479111|FG000|Overall Study|Adverse Event|1|||
162938864|NCT00446654|588479112|FG001|Overall Study|Adverse Event|0|||
162938865|NCT01875445|588479113|FG000|Overall Study|Lost to Follow-up|5|||
162938866|NCT01875445|588479114|FG001|Overall Study|Lost to Follow-up|0|||
162938867|NCT01875445|588479113|FG000|Overall Study|Withdrawal by Subject|2|||
162938868|NCT01875445|588479114|FG001|Overall Study|Withdrawal by Subject|0|||
162938869|NCT04029090|588479115|FG000|Overall Study|Protocol Violation|1|||
162938870|NCT04029090|588479116|FG001|Overall Study|Protocol Violation|0|||
162938871|NCT04029090|588479117|FG002|Overall Study|Protocol Violation|0|||
162938872|NCT04029090|588479115|FG000|Overall Study|Withdrawal by Subject|0|||
162938873|NCT04029090|588479116|FG001|Overall Study|Withdrawal by Subject|1|||
162938874|NCT04029090|588479117|FG002|Overall Study|Withdrawal by Subject|0|||
162938875|NCT00506441|588479118|FG000|Period 1; Open-label Period|Adverse Event|21|||
162938876|NCT00506441|588479119|FG001|Period 1; Open-label Period|Adverse Event|0|||
162938877|NCT00506441|588479118|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
163184113|NCT03497676|589389433|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
163184114|NCT03497676|589389434|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
163184115|NCT00880165|589389436|FG000|Overall Study|Withdrawal by Subject|27|||
163184116|NCT00880165|589389437|FG001|Overall Study|Withdrawal by Subject|23|||
163184117|NCT00880165|589389436|FG000|Overall Study|Not diagnosed with OSA|14|||
163184118|NCT00880165|589389437|FG001|Overall Study|Not diagnosed with OSA|8|||
163184119|NCT00880165|589389436|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
163184120|NCT00880165|589389437|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
163184121|NCT00880165|589389436|FG000|Overall Study|Lost to follow|9|||
163184122|NCT00880165|589389437|FG001|Overall Study|Lost to follow|15|||
163184123|NCT01074047|589389438|FG000|Treatment Phase|Adverse Event|89|||
163184124|NCT01074047|589389439|FG001|Treatment Phase|Adverse Event|66|||
163184125|NCT01074047|589389438|FG000|Treatment Phase|Disease Progression|16|||
163184126|NCT01074047|589389439|FG001|Treatment Phase|Disease Progression|21|||
163184127|NCT01074047|589389438|FG000|Treatment Phase|Withdrawal by Subject|27|||
163184128|NCT01074047|589389439|FG001|Treatment Phase|Withdrawal by Subject|48|||
163184129|NCT01074047|589389438|FG000|Treatment Phase|Death|53|||
163184130|NCT01074047|589389439|FG001|Treatment Phase|Death|58|||
163184131|NCT01074047|589389438|FG000|Treatment Phase|Lost to Follow-up|0|||
163184132|NCT01074047|589389439|FG001|Treatment Phase|Lost to Follow-up|1|||
163184133|NCT01074047|589389438|FG000|Treatment Phase|Protocol Violation|0|||
163184134|NCT01074047|589389439|FG001|Treatment Phase|Protocol Violation|1|||
163184135|NCT01074047|589389438|FG000|Treatment Phase|Miscellaneous|32|||
163184136|NCT01074047|589389439|FG001|Treatment Phase|Miscellaneous|39|||
163184137|NCT01074047|589389438|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
163184138|NCT01074047|589389439|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
163184139|NCT01074047|589389438|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
163184140|NCT01074047|589389439|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
163184141|NCT01074047|589389438|FG000|Survival Follow-Up Phase|Death|116|||
163184142|NCT01074047|589389439|FG001|Survival Follow-Up Phase|Death|124|||
163184143|NCT01074047|589389438|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
163184144|NCT01074047|589389439|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
163184145|NCT01074047|589389438|FG000|Extension Phase|Physician Decision|1|||
163184146|NCT01074047|589389439|FG001|Extension Phase|Physician Decision|0|||
163184147|NCT01074047|589389438|FG000|Extension Phase|Adverse Event|5|||
163184148|NCT01074047|589389439|FG001|Extension Phase|Adverse Event|0|||
163184149|NCT01074047|589389438|FG000|Extension Phase|Disease Progression|9|||
163184150|NCT01074047|589389439|FG001|Extension Phase|Disease Progression|0|||
163184151|NCT01074047|589389438|FG000|Extension Phase|Withdrawal by Subject|2|||
163184152|NCT01074047|589389439|FG001|Extension Phase|Withdrawal by Subject|0|||
163184153|NCT01074047|589389438|FG000|Extension Phase|Death|5|||
163184154|NCT01074047|589389439|FG001|Extension Phase|Death|0|||
163184155|NCT02211638|589389440|FG000|Overall Study|Case Report Forms Uncollected|291|||
163184156|NCT02211638|589389440|FG000|Overall Study|Protocol Violation|692|||
163184157|NCT03120624|589389442|FG000|Overall Study|Withdrawal by Subject|0|||
163184158|NCT03120624|589389443|FG001|Overall Study|Withdrawal by Subject|1|||
163184159|NCT03120624|589389444|FG002|Overall Study|Withdrawal by Subject|0|||
163184160|NCT03120624|589389445|FG003|Overall Study|Withdrawal by Subject|0|||
163184161|NCT03120624|589389446|FG004|Overall Study|Withdrawal by Subject|0|||
163184162|NCT03120624|589389447|FG005|Overall Study|Withdrawal by Subject|0|||
163184163|NCT03120624|589389448|FG006|Overall Study|Withdrawal by Subject|0|||
163184164|NCT03120624|589389449|FG007|Overall Study|Withdrawal by Subject|0|||
163210541|NCT03045887|589485284|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
163210542|NCT03045887|589485285|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
163210543|NCT03045887|589485286|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162938878|NCT00506441|588479119|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
162938879|NCT00506441|588479118|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
162938880|NCT00506441|588479119|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
163210544|NCT03045887|589485287|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
163210545|NCT03045887|589485288|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
163210546|NCT03045887|589485289|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
163210547|NCT03045887|589485290|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
163210548|NCT03045887|589485291|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
163210549|NCT03045887|589485282|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
163210550|NCT03045887|589485283|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
163210551|NCT03045887|589485284|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
163184165|NCT01659658|589391156|FG000|Overall Study|Withdrawal by Patient|18|||
163184166|NCT01659658|589391157|FG001|Overall Study|Withdrawal by Patient|4|||
163184167|NCT01659658|589391158|FG002|Overall Study|Withdrawal by Patient|2|||
163184168|NCT01659658|589391159|FG003|Overall Study|Withdrawal by Patient|0|||
163184169|NCT01659658|589391160|FG004|Overall Study|Withdrawal by Patient|11|||
163184170|NCT01659658|589391156|FG000|Overall Study|Study Terminated by Sponsor|9|||
163184171|NCT01659658|589391157|FG001|Overall Study|Study Terminated by Sponsor|7|||
163184172|NCT01659658|589391158|FG002|Overall Study|Study Terminated by Sponsor|0|||
163184173|NCT01659658|589391159|FG003|Overall Study|Study Terminated by Sponsor|1|||
163184174|NCT01659658|589391160|FG004|Overall Study|Study Terminated by Sponsor|4|||
163184175|NCT01659658|589391156|FG000|Overall Study|Reason not Specified|61|||
163184176|NCT01659658|589391157|FG001|Overall Study|Reason not Specified|15|||
163184177|NCT01659658|589391158|FG002|Overall Study|Reason not Specified|8|||
163184178|NCT01659658|589391159|FG003|Overall Study|Reason not Specified|1|||
163184179|NCT01659658|589391160|FG004|Overall Study|Reason not Specified|34|||
163184180|NCT01659658|589391156|FG000|Overall Study|Lost to Follow-up|2|||
163184181|NCT01659658|589391157|FG001|Overall Study|Lost to Follow-up|0|||
163184182|NCT01659658|589391158|FG002|Overall Study|Lost to Follow-up|0|||
163184183|NCT01659658|589391159|FG003|Overall Study|Lost to Follow-up|0|||
163184184|NCT01659658|589391160|FG004|Overall Study|Lost to Follow-up|0|||
163184185|NCT01927341|589391161|FG000|Phase 1b|Lost to Follow-up|1|||
163184186|NCT01927341|589391162|FG001|Phase 1b|Lost to Follow-up|0|||
163184187|NCT01927341|589391163|FG002|Phase 1b|Lost to Follow-up|0|||
163184188|NCT01927341|589391164|FG003|Phase 1b|Lost to Follow-up|0|||
163184189|NCT01927341|589391165|FG004|Phase 1b|Lost to Follow-up|0|||
163184190|NCT01927341|589391161|FG000|Phase 1b|Death|2|||
163184191|NCT01927341|589391162|FG001|Phase 1b|Death|0|||
163184192|NCT01927341|589391163|FG002|Phase 1b|Death|0|||
163184193|NCT01927341|589391164|FG003|Phase 1b|Death|0|||
163184194|NCT01927341|589391165|FG004|Phase 1b|Death|0|||
163184195|NCT01927341|589391161|FG000|Phase 1b|Follow-up completed|7|||
163184196|NCT01927341|589391162|FG001|Phase 1b|Follow-up completed|0|||
163184197|NCT01927341|589391163|FG002|Phase 1b|Follow-up completed|0|||
163184198|NCT01927341|589391164|FG003|Phase 1b|Follow-up completed|0|||
163184199|NCT01927341|589391165|FG004|Phase 1b|Follow-up completed|0|||
163184200|NCT01927341|589391161|FG000|Phase 2|Lost to Follow-up|0|||
163184201|NCT01927341|589391162|FG001|Phase 2|Lost to Follow-up|1|||
163184202|NCT01927341|589391163|FG002|Phase 2|Lost to Follow-up|0|||
163184203|NCT01927341|589391164|FG003|Phase 2|Lost to Follow-up|0|||
163184204|NCT01927341|589391165|FG004|Phase 2|Lost to Follow-up|0|||
163184205|NCT01927341|589391161|FG000|Phase 2|Participant withdrew consent|0|||
163184206|NCT01927341|589391162|FG001|Phase 2|Participant withdrew consent|2|||
163184207|NCT01927341|589391163|FG002|Phase 2|Participant withdrew consent|1|||
163184208|NCT01927341|589391164|FG003|Phase 2|Participant withdrew consent|2|||
163184209|NCT01927341|589391165|FG004|Phase 2|Participant withdrew consent|3|||
163184210|NCT01927341|589391161|FG000|Phase 2|Death|0|||
163184211|NCT01927341|589391162|FG001|Phase 2|Death|4|||
163184212|NCT01927341|589391163|FG002|Phase 2|Death|0|||
163184213|NCT01927341|589391164|FG003|Phase 2|Death|3|||
163184214|NCT01927341|589391165|FG004|Phase 2|Death|2|||
163184215|NCT01927341|589391161|FG000|Phase 2|New cancer therapy|0|||
163184216|NCT01927341|589391162|FG001|Phase 2|New cancer therapy|1|||
162938881|NCT00506441|588479118|FG000|Period 1; Open-label Period|Physician Decision|5|||
162938882|NCT00506441|588479119|FG001|Period 1; Open-label Period|Physician Decision|0|||
162938883|NCT00506441|588479118|FG000|Period 1; Open-label Period|Protocol Violation|9|||
162938884|NCT00506441|588479119|FG001|Period 1; Open-label Period|Protocol Violation|0|||
162938885|NCT00506441|588479118|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
162938886|NCT00506441|588479119|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
162938887|NCT00506441|588479118|FG000|Period 1; Open-label Period|Other Reasons|13|||
162938888|NCT00506441|588479119|FG001|Period 1; Open-label Period|Other Reasons|0|||
162938889|NCT00506441|588479118|FG000|Period 2; Double-blind Period|Adverse Event|0|||
162938890|NCT00506441|588479119|FG001|Period 2; Double-blind Period|Adverse Event|1|||
162938891|NCT00506441|588479118|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
162938892|NCT00506441|588479119|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
162938893|NCT00506441|588479118|FG000|Period 2; Double-blind Period|Physician Decision|1|||
162938894|NCT00506441|588479119|FG001|Period 2; Double-blind Period|Physician Decision|1|||
162938895|NCT00506441|588479118|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
162938896|NCT00506441|588479119|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
162938897|NCT00506441|588479118|FG000|Period 2; Double-blind Period|Other Reason|1|||
162938898|NCT00506441|588479119|FG001|Period 2; Double-blind Period|Other Reason|1|||
162938899|NCT00501046|588479120|FG000|Overall Study|Adverse Event|21|||
162938900|NCT00501046|588479121|FG001|Overall Study|Adverse Event|25|||
162938901|NCT00501046|588479120|FG000|Overall Study|Death|23|||
162938902|NCT00501046|588479121|FG001|Overall Study|Death|30|||
162938903|NCT00501046|588479120|FG000|Overall Study|Lost to Follow-up|14|||
162938904|NCT00501046|588479121|FG001|Overall Study|Lost to Follow-up|13|||
162938905|NCT00501046|588479120|FG000|Overall Study|Physician Decision|7|||
162938906|NCT00501046|588479121|FG001|Overall Study|Physician Decision|2|||
162938907|NCT00501046|588479120|FG000|Overall Study|Pregnancy|0|||
162938908|NCT00501046|588479121|FG001|Overall Study|Pregnancy|3|||
162938909|NCT00501046|588479120|FG000|Overall Study|Protocol Violation|2|||
162938910|NCT00501046|588479121|FG001|Overall Study|Protocol Violation|1|||
162938911|NCT00501046|588479120|FG000|Overall Study|Withdrawal by Subject|84|||
162938912|NCT00501046|588479121|FG001|Overall Study|Withdrawal by Subject|83|||
162938913|NCT00501046|588479120|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
162938914|NCT00501046|588479121|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
162938915|NCT05056727|588479122|FG000|Initiation Phase|Lost to Follow-up|1|||
162938916|NCT05056727|588479123|FG001|Initiation Phase|Lost to Follow-up|0|||
162938917|NCT05056727|588479124|FG002|Initiation Phase|Lost to Follow-up|0|||
163184217|NCT01927341|589391163|FG002|Phase 2|New cancer therapy|0|||
163184218|NCT01927341|589391164|FG003|Phase 2|New cancer therapy|4|||
163184219|NCT01927341|589391165|FG004|Phase 2|New cancer therapy|1|||
163184220|NCT01927341|589391161|FG000|Phase 2|Disease progression|0|||
163184221|NCT01927341|589391162|FG001|Phase 2|Disease progression|1|||
163184222|NCT01927341|589391163|FG002|Phase 2|Disease progression|1|||
163184223|NCT01927341|589391164|FG003|Phase 2|Disease progression|1|||
163184224|NCT01927341|589391165|FG004|Phase 2|Disease progression|0|||
163184225|NCT01927341|589391161|FG000|Phase 2|Follow-up completed|0|||
163184226|NCT01927341|589391162|FG001|Phase 2|Follow-up completed|6|||
163184227|NCT01927341|589391163|FG002|Phase 2|Follow-up completed|3|||
163184228|NCT01927341|589391164|FG003|Phase 2|Follow-up completed|5|||
163184229|NCT01927341|589391165|FG004|Phase 2|Follow-up completed|2|||
163184230|NCT00674973|589391169|FG000|Overall Study|Insufficient Therapeutic Response|77|||
163184231|NCT00674973|589391170|FG001|Overall Study|Insufficient Therapeutic Response|72|||
163184232|NCT00674973|589391169|FG000|Overall Study|Refused Treatment|1|||
163184233|NCT00674973|589391170|FG001|Overall Study|Refused Treatment|5|||
162938918|NCT05056727|588479125|FG003|Initiation Phase|Lost to Follow-up|0|||
162938919|NCT05056727|588479122|FG000|Initiation Phase|Study-specific; Study terminated; Other|20|||
162938920|NCT05056727|588479123|FG001|Initiation Phase|Study-specific; Study terminated; Other|0|||
163184234|NCT00674973|589391169|FG000|Overall Study|Failure to Return|1|||
163184235|NCT00674973|589391170|FG001|Overall Study|Failure to Return|0|||
163184236|NCT00674973|589391169|FG000|Overall Study|Adverse Event|2|||
163184237|NCT00674973|589391170|FG001|Overall Study|Adverse Event|9|||
162938921|NCT05056727|588479124|FG002|Initiation Phase|Study-specific; Study terminated; Other|0|||
162938922|NCT05056727|588479125|FG003|Initiation Phase|Study-specific; Study terminated; Other|0|||
162938923|NCT05056727|588479122|FG000|Initiation Phase|Withdrawal by Subject|9|||
162938924|NCT05056727|588479123|FG001|Initiation Phase|Withdrawal by Subject|0|||
162938925|NCT05056727|588479124|FG002|Initiation Phase|Withdrawal by Subject|0|||
162938926|NCT05056727|588479125|FG003|Initiation Phase|Withdrawal by Subject|0|||
162938927|NCT05056727|588479122|FG000|Initiation Phase|Physician Decision|4|||
162938928|NCT05056727|588479123|FG001|Initiation Phase|Physician Decision|0|||
162938929|NCT05056727|588479124|FG002|Initiation Phase|Physician Decision|0|||
162938930|NCT05056727|588479125|FG003|Initiation Phase|Physician Decision|0|||
162938931|NCT05056727|588479122|FG000|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
162938932|NCT05056727|588479123|FG001|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|237|||
162938933|NCT05056727|588479124|FG002|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
162938934|NCT05056727|588479125|FG003|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
162938935|NCT05056727|588479122|FG000|Run-in Phase|Death|0|||
162938936|NCT05056727|588479123|FG001|Run-in Phase|Death|3|||
162938937|NCT05056727|588479124|FG002|Run-in Phase|Death|0|||
162938938|NCT05056727|588479125|FG003|Run-in Phase|Death|0|||
162938939|NCT05056727|588479122|FG000|Run-in Phase|Withdrawal by Subject|0|||
162938940|NCT05056727|588479123|FG001|Run-in Phase|Withdrawal by Subject|25|||
162938941|NCT05056727|588479124|FG002|Run-in Phase|Withdrawal by Subject|0|||
162938942|NCT05056727|588479125|FG003|Run-in Phase|Withdrawal by Subject|0|||
162938943|NCT05056727|588479122|FG000|Run-in Phase|Physician Decision|0|||
162938944|NCT05056727|588479123|FG001|Run-in Phase|Physician Decision|20|||
162938945|NCT05056727|588479124|FG002|Run-in Phase|Physician Decision|0|||
162938946|NCT05056727|588479125|FG003|Run-in Phase|Physician Decision|0|||
162938947|NCT05056727|588479122|FG000|Run-in Phase|Lost to Follow-up|0|||
162938948|NCT05056727|588479123|FG001|Run-in Phase|Lost to Follow-up|1|||
162938949|NCT05056727|588479124|FG002|Run-in Phase|Lost to Follow-up|0|||
162938950|NCT05056727|588479125|FG003|Run-in Phase|Lost to Follow-up|0|||
162938951|NCT05056727|588479122|FG000|Maintenance Phase|Site terminated; Study terminated; Other|0|||
162938952|NCT05056727|588479123|FG001|Maintenance Phase|Site terminated; Study terminated; Other|0|||
162938953|NCT05056727|588479124|FG002|Maintenance Phase|Site terminated; Study terminated; Other|332|||
162938954|NCT05056727|588479125|FG003|Maintenance Phase|Site terminated; Study terminated; Other|314|||
162938955|NCT05056727|588479122|FG000|Maintenance Phase|Withdrawal by Subject|0|||
162938956|NCT05056727|588479123|FG001|Maintenance Phase|Withdrawal by Subject|0|||
162938957|NCT05056727|588479124|FG002|Maintenance Phase|Withdrawal by Subject|19|||
162938958|NCT05056727|588479125|FG003|Maintenance Phase|Withdrawal by Subject|21|||
162938959|NCT05056727|588479122|FG000|Maintenance Phase|Physician Decision|0|||
162938960|NCT05056727|588479123|FG001|Maintenance Phase|Physician Decision|0|||
162938961|NCT05056727|588479124|FG002|Maintenance Phase|Physician Decision|4|||
162938962|NCT05056727|588479125|FG003|Maintenance Phase|Physician Decision|16|||
162938963|NCT05056727|588479122|FG000|Maintenance Phase|Lost to Follow-up|0|||
162938964|NCT05056727|588479123|FG001|Maintenance Phase|Lost to Follow-up|0|||
162938965|NCT05056727|588479124|FG002|Maintenance Phase|Lost to Follow-up|2|||
162938966|NCT05056727|588479125|FG003|Maintenance Phase|Lost to Follow-up|2|||
162938967|NCT05056727|588479122|FG000|Maintenance Phase|Death|0|||
162938968|NCT05056727|588479123|FG001|Maintenance Phase|Death|0|||
162938969|NCT05056727|588479124|FG002|Maintenance Phase|Death|4|||
162938970|NCT05056727|588479125|FG003|Maintenance Phase|Death|2|||
162938971|NCT02622113|588479126|FG000|Overall Study|Adverse Event|4|||
162938972|NCT02622113|588479127|FG001|Overall Study|Adverse Event|4|||
162938973|NCT02622113|588479126|FG000|Overall Study|Physician Decision|0|||
162938974|NCT02622113|588479127|FG001|Overall Study|Physician Decision|1|||
162938975|NCT02622113|588479126|FG000|Overall Study|Withdrawal by Subject|0|||
162938976|NCT02622113|588479127|FG001|Overall Study|Withdrawal by Subject|2|||
162938977|NCT02622113|588479126|FG000|Overall Study|Stopping Criteria|1|||
162938978|NCT02622113|588479127|FG001|Overall Study|Stopping Criteria|3|||
162938979|NCT03289208|588479129|FG000|Overall Study|Adverse Event|1|||
162938980|NCT03289208|588479130|FG001|Overall Study|Adverse Event|0|||
162938981|NCT03289208|588479131|FG002|Overall Study|Adverse Event|0|||
162938982|NCT01840605|588479133|FG000|Overall Study|Adverse Event|0|||
162938983|NCT01840605|588479134|FG001|Overall Study|Adverse Event|1|||
162938984|NCT01840605|588479133|FG000|Overall Study|Physician Decision|2|||
163184238|NCT00674973|589391169|FG000|Overall Study|Death|19|||
163184239|NCT00674973|589391170|FG001|Overall Study|Death|15|||
163184240|NCT00674973|589391169|FG000|Overall Study|Protocol Violation|0|||
163184241|NCT00674973|589391170|FG001|Overall Study|Protocol Violation|1|||
163184242|NCT00451451|589391171|FG000|Overall Study|Adverse Event|11|||
163184243|NCT00451451|589391172|FG001|Overall Study|Adverse Event|21|||
163184244|NCT00451451|589391173|FG002|Overall Study|Adverse Event|26|||
163184245|NCT00451451|589391174|FG003|Overall Study|Adverse Event|10|||
163184246|NCT00451451|589391171|FG000|Overall Study|Lost to Follow-up|11|||
163184247|NCT00451451|589391172|FG001|Overall Study|Lost to Follow-up|9|||
163289467|NCT00878722|589765012|FG003|Overall Study|Adverse Event|0|||
163289468|NCT00878722|589765013|FG004|Overall Study|Adverse Event|0|||
163289469|NCT00878722|589765014|FG005|Overall Study|Adverse Event|0|||
163289470|NCT00878722|589765015|FG006|Overall Study|Adverse Event|2|||
163184248|NCT00451451|589391173|FG002|Overall Study|Lost to Follow-up|8|||
163184249|NCT00451451|589391174|FG003|Overall Study|Lost to Follow-up|11|||
163184250|NCT00451451|589391171|FG000|Overall Study|Consent Withdrawn|14|||
163184251|NCT00451451|589391172|FG001|Overall Study|Consent Withdrawn|9|||
163184252|NCT00451451|589391173|FG002|Overall Study|Consent Withdrawn|17|||
163184253|NCT00451451|589391174|FG003|Overall Study|Consent Withdrawn|17|||
163184254|NCT00451451|589391171|FG000|Overall Study|Investigator Decision|6|||
163184255|NCT00451451|589391172|FG001|Overall Study|Investigator Decision|2|||
163184256|NCT00451451|589391173|FG002|Overall Study|Investigator Decision|1|||
163184257|NCT00451451|589391174|FG003|Overall Study|Investigator Decision|2|||
163184258|NCT00451451|589391171|FG000|Overall Study|Subject Non-Compliance|8|||
163184259|NCT00451451|589391172|FG001|Overall Study|Subject Non-Compliance|4|||
163184260|NCT00451451|589391173|FG002|Overall Study|Subject Non-Compliance|3|||
163184261|NCT00451451|589391174|FG003|Overall Study|Subject Non-Compliance|3|||
163184262|NCT00451451|589391171|FG000|Overall Study|Death|1|||
163184263|NCT00451451|589391172|FG001|Overall Study|Death|0|||
163184264|NCT00451451|589391173|FG002|Overall Study|Death|0|||
163184265|NCT00451451|589391174|FG003|Overall Study|Death|1|||
163184266|NCT00451451|589391171|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
163184267|NCT00451451|589391172|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
163184268|NCT00451451|589391173|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
163184269|NCT00451451|589391174|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
163184270|NCT00084838|589391177|FG000|Overall Study|Death|1|||
163184271|NCT00084838|589391177|FG000|Overall Study|Adverse Event|2|||
163184272|NCT00084838|589391177|FG000|Overall Study|Withdrawal by Subject|1|||
163184273|NCT00084838|589391177|FG000|Overall Study|Progressive Disease|4|||
163184274|NCT00084838|589391177|FG000|Overall Study|Pt Non-Compliance|1|||
163184275|NCT00084838|589391177|FG000|Overall Study|Ineligible|4|||
163184276|NCT00518687|589391178|FG000|Overall Study|Adverse Event|201|||
163184277|NCT00518687|589391179|FG001|Overall Study|Adverse Event|177|||
163184278|NCT00518687|589391178|FG000|Overall Study|Lost to Follow-up|144|||
163184279|NCT00518687|589391179|FG001|Overall Study|Lost to Follow-up|155|||
163184280|NCT00518687|589391178|FG000|Overall Study|Physician Decision|42|||
163184281|NCT00518687|589391179|FG001|Overall Study|Physician Decision|48|||
163184282|NCT00518687|589391178|FG000|Overall Study|Progressive disease|2|||
163184283|NCT00518687|589391179|FG001|Overall Study|Progressive disease|2|||
163184284|NCT00518687|589391178|FG000|Overall Study|Protocol Violation|8|||
163289471|NCT00878722|589765016|FG007|Overall Study|Adverse Event|0|||
163184285|NCT00518687|589391179|FG001|Overall Study|Protocol Violation|10|||
163184286|NCT00518687|589391178|FG000|Overall Study|Study terminated by sponsor|930|||
163184287|NCT00518687|589391179|FG001|Overall Study|Study terminated by sponsor|918|||
163184288|NCT00518687|589391178|FG000|Overall Study|Withdrawal by Subject|110|||
163184289|NCT00518687|589391179|FG001|Overall Study|Withdrawal by Subject|110|||
163184290|NCT01442038|589391182|FG000|Overall Study|Death|35|||
162938985|NCT01840605|588479134|FG001|Overall Study|Physician Decision|1|||
162938986|NCT05308472|588479135|FG000|Overall Study|Adverse Event|0|||
162938987|NCT05308472|588479136|FG001|Overall Study|Adverse Event|0|||
162938988|NCT05308472|588479137|FG002|Overall Study|Adverse Event|3|||
162938989|NCT03469271|588479138|FG000|Overall Study|Withdrawal by Subject|2|||
162938990|NCT03469271|588479139|FG001|Overall Study|Withdrawal by Subject|0|||
162938991|NCT03469271|588479140|FG002|Overall Study|Withdrawal by Subject|0|||
162938992|NCT03469271|588479141|FG003|Overall Study|Withdrawal by Subject|1|||
162938993|NCT00895583|588479143|FG000|Overall Study|Adverse Event|28|||
162938994|NCT00895583|588479144|FG001|Overall Study|Adverse Event|4|||
162938995|NCT00895583|588479143|FG000|Overall Study|Death|2|||
162938996|NCT00895583|588479144|FG001|Overall Study|Death|1|||
162938997|NCT00895583|588479143|FG000|Overall Study|Physician Decision|3|||
162938998|NCT00895583|588479144|FG001|Overall Study|Physician Decision|1|||
163184291|NCT01442038|589391183|FG001|Overall Study|Death|29|||
163184292|NCT01442038|589391182|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
162938999|NCT00895583|588479143|FG000|Overall Study|Lost to Follow-up|1|||
162939000|NCT00895583|588479144|FG001|Overall Study|Lost to Follow-up|3|||
162939001|NCT00895583|588479143|FG000|Overall Study|Protocol Violation|1|||
162939002|NCT00895583|588479144|FG001|Overall Study|Protocol Violation|0|||
162939003|NCT00895583|588479143|FG000|Overall Study|Withdrawal by Subject|4|||
162939004|NCT00895583|588479144|FG001|Overall Study|Withdrawal by Subject|2|||
162939005|NCT00895583|588479143|FG000|Overall Study|Lack of Efficacy|5|||
162939006|NCT00895583|588479144|FG001|Overall Study|Lack of Efficacy|0|||
162939007|NCT00895583|588479143|FG000|Overall Study|Other|0|||
162939008|NCT00895583|588479144|FG001|Overall Study|Other|1|||
162939009|NCT04535583|588479147|FG000|Overall Study|Lost to Follow-up|1|||
162939010|NCT04535583|588479147|FG000|Overall Study|Physician Decision|1|||
162939011|NCT04535583|588479147|FG000|Overall Study|Withdrawal by Subject|1|||
162939012|NCT01078090|588479148|FG000|Overall Study|Lost to Follow-up|2363|||
162939013|NCT01078090|588479148|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
162939014|NCT01078090|588479148|FG000|Overall Study|Lack of Efficacy|1193|||
162939015|NCT01078090|588479148|FG000|Overall Study|ADR and lack of efficacy|61|||
162939016|NCT01078090|588479148|FG000|Overall Study|Other|523|||
162939017|NCT01748890|588479150|FG000|Overall Study|Insufficient recruitment for analysis|4|||
162939018|NCT03035227|588479151|FG000|Overall Study|study stopped due to PI leaving institut|1|||
162939019|NCT03035227|588479152|FG001|Overall Study|study stopped due to PI leaving institut|1|||
162939020|NCT02100956|588479153|FG000|At Least One Week Between Injections|Adverse Event|0|||
162939021|NCT02100956|588479154|FG001|At Least One Week Between Injections|Adverse Event|1|||
162939022|NCT03529955|588479155|FG000|Overall Study|Adverse Event|1|||
162939023|NCT03529955|588479155|FG000|Overall Study|Lack of Efficacy|1|||
162939024|NCT03016078|588479162|FG000|Overall Study|Protocol Violation|1|||
162939025|NCT03016078|588479162|FG000|Overall Study|Protocol Violation|1|||
162939026|NCT04526899|588479163|FG000|Overall Study|Withdrawal by Subject|3|||
162939027|NCT04526899|588479164|FG001|Overall Study|Withdrawal by Subject|2|||
162939028|NCT04526899|588479165|FG002|Overall Study|Withdrawal by Subject|2|||
162939029|NCT04526899|588479163|FG000|Overall Study|Lost to Follow-up|3|||
162939030|NCT04526899|588479164|FG001|Overall Study|Lost to Follow-up|3|||
162939031|NCT04526899|588479165|FG002|Overall Study|Lost to Follow-up|1|||
162939032|NCT04526899|588479163|FG000|Overall Study|Investigator's decision|1|||
162939033|NCT04526899|588479164|FG001|Overall Study|Investigator's decision|0|||
163184293|NCT01442038|589391183|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
162939034|NCT04526899|588479165|FG002|Overall Study|Investigator's decision|0|||
162939035|NCT04526899|588479163|FG000|Overall Study|Death|33|||
162939036|NCT04526899|588479164|FG001|Overall Study|Death|17|||
162939037|NCT04526899|588479165|FG002|Overall Study|Death|13|||
162939038|NCT04526899|588479163|FG000|Overall Study|Other|1|||
162939039|NCT04526899|588479164|FG001|Overall Study|Other|0|||
162939040|NCT04526899|588479165|FG002|Overall Study|Other|0|||
162939041|NCT04526899|588479163|FG000|Overall Study|On-Treatment|19|||
162939042|NCT04526899|588479164|FG001|Overall Study|On-Treatment|10|||
162939043|NCT04526899|588479165|FG002|Overall Study|On-Treatment|12|||
162939044|NCT04526899|588479163|FG000|Overall Study|Survival Follow-up|34|||
162939045|NCT04526899|588479164|FG001|Overall Study|Survival Follow-up|14|||
162939046|NCT04526899|588479165|FG002|Overall Study|Survival Follow-up|16|||
162939047|NCT01259869|588480276|FG000|Overall Study|Duplicated registration|1|||
162939048|NCT00220701|588480278|FG000|Overall Study|Lost to Follow-up|5|||
162939049|NCT00220701|588480279|FG001|Overall Study|Lost to Follow-up|4|||
162939050|NCT05245617|588480280|FG000|Overall Study|Withdrawal by Subject|1|||
163184294|NCT01442038|589391182|FG000|Overall Study|Participant Withdrew Consent|137|||
162939051|NCT01612000|588480284|FG000|Overall Study|Lost to Follow-up|6|||
162939052|NCT01612000|588480285|FG001|Overall Study|Lost to Follow-up|4|||
162939053|NCT01612000|588480286|FG002|Overall Study|Lost to Follow-up|4|||
162939054|NCT01612000|588480287|FG003|Overall Study|Lost to Follow-up|8|||
163289472|NCT00878722|589765009|FG000|Overall Study|Withdrawal by Subject|0|||
162939055|NCT01612000|588480284|FG000|Overall Study|Physician Decision|0|||
162939056|NCT01612000|588480285|FG001|Overall Study|Physician Decision|0|||
162939057|NCT01612000|588480286|FG002|Overall Study|Physician Decision|1|||
162939058|NCT01612000|588480287|FG003|Overall Study|Physician Decision|0|||
163184295|NCT01442038|589391183|FG001|Overall Study|Participant Withdrew Consent|102|||
163184296|NCT01442038|589391182|FG000|Overall Study|Lost to Follow-up|37|||
162939059|NCT01612000|588480284|FG000|Overall Study|Withdrawal by Subject|3|||
162939060|NCT01612000|588480285|FG001|Overall Study|Withdrawal by Subject|1|||
162939061|NCT01612000|588480286|FG002|Overall Study|Withdrawal by Subject|2|||
162939062|NCT01612000|588480287|FG003|Overall Study|Withdrawal by Subject|2|||
162939063|NCT03425331|588480288|FG000|Overall Study|Withdrawal by Subject|1|||
162939064|NCT03425331|588480288|FG000|Overall Study|Death|1|||
162939065|NCT03425331|588480288|FG000|Overall Study|Adverse Event|1|||
162939066|NCT03425331|588480288|FG000|Overall Study|Disease Progression|2|||
162939067|NCT03433274|588480289|FG000|Overall Study|Withdrawal by Subject|2|||
162939068|NCT03433274|588480289|FG000|Overall Study|Missed visit|5|||
162939069|NCT03433274|588480289|FG000|Overall Study|Death|23|||
162939070|NCT00441584|588480290|FG000|Overall Study|Lack of Efficacy|79|||
162939071|NCT00441584|588480290|FG000|Overall Study|Withdrawal by Subject|8|||
162939072|NCT00441584|588480290|FG000|Overall Study|Adverse Event|6|||
162939073|NCT00441584|588480290|FG000|Overall Study|Protocol Violation|5|||
162939074|NCT00441584|588480290|FG000|Overall Study|Lost to Follow-up|4|||
162939075|NCT00441584|588480290|FG000|Overall Study|Failure to meet eligibility criteria|3|||
162939076|NCT04864405|588480291|FG000|Overall Study|Withdrawal by Subject|4|||
162939077|NCT04864405|588480292|FG001|Overall Study|Withdrawal by Subject|6|||
162939078|NCT04864405|588480291|FG000|Overall Study|Did not want endocrine therapy|3|||
162939079|NCT04864405|588480292|FG001|Overall Study|Did not want endocrine therapy|5|||
162939080|NCT04969939|588480293|FG000|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
162939081|NCT04969939|588480294|FG001|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
162939082|NCT04969939|588480295|FG002|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
162939083|NCT04969939|588480296|FG003|Part 2a: Run in Period (32 Weeks)|Adverse Event|4|||
162939084|NCT04969939|588480297|FG004|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
162939085|NCT04969939|588480298|FG005|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
162939086|NCT04969939|588480299|FG006|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
162939087|NCT04969939|588480293|FG000|Part 2a: Run in Period (32 Weeks)|Other|0|||
162939088|NCT04969939|588480294|FG001|Part 2a: Run in Period (32 Weeks)|Other|0|||
162939089|NCT04969939|588480295|FG002|Part 2a: Run in Period (32 Weeks)|Other|0|||
162939090|NCT04969939|588480296|FG003|Part 2a: Run in Period (32 Weeks)|Other|5|||
162939091|NCT04969939|588480297|FG004|Part 2a: Run in Period (32 Weeks)|Other|0|||
162939092|NCT04969939|588480298|FG005|Part 2a: Run in Period (32 Weeks)|Other|0|||
162939093|NCT04969939|588480299|FG006|Part 2a: Run in Period (32 Weeks)|Other|0|||
162939094|NCT04969939|588480293|FG000|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
162939095|NCT04969939|588480294|FG001|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
162939096|NCT04969939|588480295|FG002|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
162939097|NCT04969939|588480296|FG003|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|2|||
162939098|NCT04969939|588480297|FG004|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
162939099|NCT04969939|588480298|FG005|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
162939100|NCT04969939|588480299|FG006|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
162939101|NCT04969939|588480293|FG000|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
162939102|NCT04969939|588480294|FG001|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
162939103|NCT04969939|588480295|FG002|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
162939104|NCT04969939|588480296|FG003|Part 2a: Run in Period (32 Weeks)|Pregnancy|1|||
162939105|NCT04969939|588480297|FG004|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
163184297|NCT01442038|589391183|FG001|Overall Study|Lost to Follow-up|51|||
163184298|NCT01442038|589391182|FG000|Overall Study|Adverse Event|26|||
163184299|NCT01442038|589391183|FG001|Overall Study|Adverse Event|15|||
163184300|NCT01442038|589391182|FG000|Overall Study|Protocol Deviation|9|||
163184301|NCT01442038|589391183|FG001|Overall Study|Protocol Deviation|20|||
163184302|NCT01442038|589391182|FG000|Overall Study|Investigator's Discretion|13|||
163184303|NCT01442038|589391183|FG001|Overall Study|Investigator's Discretion|16|||
163184304|NCT01442038|589391182|FG000|Overall Study|Study Terminated By Sponsor|2|||
163184305|NCT01442038|589391183|FG001|Overall Study|Study Terminated By Sponsor|3|||
163184306|NCT00089284|589391184|FG000|Overall Study|Adverse event before starting treatment|0|||
163184307|NCT00089284|589391185|FG001|Overall Study|Adverse event before starting treatment|0|||
163184308|NCT00089284|589391186|FG002|Overall Study|Adverse event before starting treatment|0|||
163289473|NCT00878722|589765010|FG001|Overall Study|Withdrawal by Subject|0|||
163289474|NCT00878722|589765011|FG002|Overall Study|Withdrawal by Subject|0|||
162939106|NCT04969939|588480298|FG005|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
162939107|NCT04969939|588480299|FG006|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
162939108|NCT04969939|588480293|FG000|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
162939109|NCT04969939|588480294|FG001|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
162939110|NCT04969939|588480295|FG002|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
162939111|NCT04969939|588480296|FG003|Part 2a: Run in Period (32 Weeks)|Protocol Violation|1|||
162939112|NCT04969939|588480297|FG004|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
162939113|NCT04969939|588480298|FG005|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
163184309|NCT00089284|589391187|FG003|Overall Study|Adverse event before starting treatment|0|||
163184310|NCT00089284|589391188|FG004|Overall Study|Adverse event before starting treatment|0|||
163184311|NCT00089284|589391189|FG005|Overall Study|Adverse event before starting treatment|0|||
162939114|NCT04969939|588480299|FG006|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
162939115|NCT04969939|588480293|FG000|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
162939116|NCT04969939|588480294|FG001|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
162939117|NCT04969939|588480295|FG002|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
162939118|NCT04969939|588480296|FG003|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
162939119|NCT04969939|588480297|FG004|Part 2b (16 Weeks)|Withdrawal by Subject|3|||
162939120|NCT04969939|588480298|FG005|Part 2b (16 Weeks)|Withdrawal by Subject|1|||
162939121|NCT04969939|588480299|FG006|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
162939122|NCT03843359|588480300|FG000|Escalation Phase|Lost to Follow-up|0|||
162939123|NCT03843359|588480301|FG001|Escalation Phase|Lost to Follow-up|0|||
162939124|NCT03843359|588480302|FG002|Escalation Phase|Lost to Follow-up|0|||
162939125|NCT03843359|588480303|FG003|Escalation Phase|Lost to Follow-up|0|||
162939126|NCT03843359|588480304|FG004|Escalation Phase|Lost to Follow-up|0|||
162939127|NCT03843359|588480305|FG005|Escalation Phase|Lost to Follow-up|0|||
162939128|NCT03843359|588480306|FG006|Escalation Phase|Lost to Follow-up|0|||
162939129|NCT03843359|588480307|FG007|Escalation Phase|Lost to Follow-up|0|||
162939130|NCT03843359|588480308|FG008|Escalation Phase|Lost to Follow-up|1|||
162939131|NCT03843359|588480309|FG009|Escalation Phase|Lost to Follow-up|0|||
162939132|NCT03843359|588480310|FG010|Escalation Phase|Lost to Follow-up|0|||
162939133|NCT03843359|588480311|FG011|Escalation Phase|Lost to Follow-up|0|||
162939134|NCT03843359|588480312|FG012|Escalation Phase|Lost to Follow-up|0|||
162939135|NCT03843359|588480313|FG013|Escalation Phase|Lost to Follow-up|0|||
162939136|NCT03843359|588480314|FG014|Escalation Phase|Lost to Follow-up|0|||
162939137|NCT03843359|588480315|FG015|Escalation Phase|Lost to Follow-up|0|||
162939138|NCT03843359|588480300|FG000|Escalation Phase|Physician Decision|0|||
162939139|NCT03843359|588480301|FG001|Escalation Phase|Physician Decision|0|||
162939140|NCT03843359|588480302|FG002|Escalation Phase|Physician Decision|1|||
162939141|NCT03843359|588480303|FG003|Escalation Phase|Physician Decision|0|||
162939142|NCT03843359|588480304|FG004|Escalation Phase|Physician Decision|0|||
162939143|NCT03843359|588480305|FG005|Escalation Phase|Physician Decision|1|||
162939144|NCT03843359|588480306|FG006|Escalation Phase|Physician Decision|0|||
162939145|NCT03843359|588480307|FG007|Escalation Phase|Physician Decision|0|||
162939146|NCT03843359|588480308|FG008|Escalation Phase|Physician Decision|0|||
162939147|NCT03843359|588480309|FG009|Escalation Phase|Physician Decision|0|||
162939148|NCT03843359|588480310|FG010|Escalation Phase|Physician Decision|0|||
162939149|NCT03843359|588480311|FG011|Escalation Phase|Physician Decision|0|||
162939150|NCT03843359|588480312|FG012|Escalation Phase|Physician Decision|0|||
162939151|NCT03843359|588480313|FG013|Escalation Phase|Physician Decision|0|||
162939152|NCT03843359|588480314|FG014|Escalation Phase|Physician Decision|0|||
162939153|NCT03843359|588480315|FG015|Escalation Phase|Physician Decision|0|||
162939154|NCT03843359|588480300|FG000|Escalation Phase|Investigator site closed|0|||
162939155|NCT03843359|588480301|FG001|Escalation Phase|Investigator site closed|1|||
162939156|NCT03843359|588480302|FG002|Escalation Phase|Investigator site closed|0|||
162939157|NCT03843359|588480303|FG003|Escalation Phase|Investigator site closed|1|||
162939158|NCT03843359|588480304|FG004|Escalation Phase|Investigator site closed|1|||
162939159|NCT03843359|588480305|FG005|Escalation Phase|Investigator site closed|0|||
162939160|NCT03843359|588480306|FG006|Escalation Phase|Investigator site closed|1|||
162939161|NCT03843359|588480307|FG007|Escalation Phase|Investigator site closed|0|||
162939162|NCT03843359|588480308|FG008|Escalation Phase|Investigator site closed|2|||
162939163|NCT03843359|588480309|FG009|Escalation Phase|Investigator site closed|0|||
162939164|NCT03843359|588480310|FG010|Escalation Phase|Investigator site closed|0|||
162939165|NCT03843359|588480311|FG011|Escalation Phase|Investigator site closed|0|||
162939166|NCT03843359|588480312|FG012|Escalation Phase|Investigator site closed|0|||
162939167|NCT03843359|588480313|FG013|Escalation Phase|Investigator site closed|0|||
162939168|NCT03843359|588480314|FG014|Escalation Phase|Investigator site closed|0|||
162939169|NCT03843359|588480315|FG015|Escalation Phase|Investigator site closed|0|||
162939170|NCT03843359|588480300|FG000|Escalation Phase|Ongoing at the time of analysis|0|||
162939171|NCT03843359|588480301|FG001|Escalation Phase|Ongoing at the time of analysis|0|||
162939172|NCT03843359|588480302|FG002|Escalation Phase|Ongoing at the time of analysis|0|||
162939173|NCT03843359|588480303|FG003|Escalation Phase|Ongoing at the time of analysis|0|||
162939174|NCT03843359|588480304|FG004|Escalation Phase|Ongoing at the time of analysis|0|||
162939175|NCT03843359|588480305|FG005|Escalation Phase|Ongoing at the time of analysis|0|||
162939176|NCT03843359|588480306|FG006|Escalation Phase|Ongoing at the time of analysis|0|||
162939177|NCT03843359|588480307|FG007|Escalation Phase|Ongoing at the time of analysis|0|||
162939178|NCT03843359|588480308|FG008|Escalation Phase|Ongoing at the time of analysis|1|||
162939179|NCT03843359|588480309|FG009|Escalation Phase|Ongoing at the time of analysis|0|||
162939180|NCT03843359|588480310|FG010|Escalation Phase|Ongoing at the time of analysis|0|||
162939181|NCT03843359|588480311|FG011|Escalation Phase|Ongoing at the time of analysis|1|||
162939182|NCT03843359|588480312|FG012|Escalation Phase|Ongoing at the time of analysis|1|||
162939183|NCT03843359|588480313|FG013|Escalation Phase|Ongoing at the time of analysis|0|||
162939184|NCT03843359|588480314|FG014|Escalation Phase|Ongoing at the time of analysis|0|||
162939185|NCT03843359|588480315|FG015|Escalation Phase|Ongoing at the time of analysis|0|||
162939186|NCT03843359|588480300|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939187|NCT03843359|588480301|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939188|NCT03843359|588480302|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|7|||
162939189|NCT03843359|588480303|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939190|NCT03843359|588480304|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
162939191|NCT03843359|588480305|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939192|NCT03843359|588480306|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939193|NCT03843359|588480307|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939194|NCT03843359|588480308|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939195|NCT03843359|588480309|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939196|NCT03843359|588480310|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939197|NCT03843359|588480311|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939198|NCT03843359|588480312|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939199|NCT03843359|588480313|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939200|NCT03843359|588480314|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939201|NCT03843359|588480315|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939202|NCT03843359|588480300|FG000|Crossover|Withdrawal by Subject|0|||
162939203|NCT03843359|588480301|FG001|Crossover|Withdrawal by Subject|0|||
162939204|NCT03843359|588480302|FG002|Crossover|Withdrawal by Subject|0|||
162939205|NCT03843359|588480303|FG003|Crossover|Withdrawal by Subject|0|||
162939206|NCT03843359|588480304|FG004|Crossover|Withdrawal by Subject|0|||
162939207|NCT03843359|588480305|FG005|Crossover|Withdrawal by Subject|0|||
162939208|NCT03843359|588480306|FG006|Crossover|Withdrawal by Subject|0|||
162939209|NCT03843359|588480307|FG007|Crossover|Withdrawal by Subject|0|||
162939210|NCT03843359|588480308|FG008|Crossover|Withdrawal by Subject|0|||
162939211|NCT03843359|588480309|FG009|Crossover|Withdrawal by Subject|0|||
162939212|NCT03843359|588480310|FG010|Crossover|Withdrawal by Subject|0|||
162939213|NCT03843359|588480311|FG011|Crossover|Withdrawal by Subject|0|||
162939214|NCT03843359|588480312|FG012|Crossover|Withdrawal by Subject|0|||
162939215|NCT03843359|588480313|FG013|Crossover|Withdrawal by Subject|0|||
162939216|NCT03843359|588480314|FG014|Crossover|Withdrawal by Subject|0|||
162939217|NCT03843359|588480315|FG015|Crossover|Withdrawal by Subject|1|||
162939218|NCT03843359|588480300|FG000|Crossover|Investigator site closed|0|||
162939219|NCT03843359|588480301|FG001|Crossover|Investigator site closed|0|||
162939220|NCT03843359|588480302|FG002|Crossover|Investigator site closed|0|||
162939221|NCT03843359|588480303|FG003|Crossover|Investigator site closed|0|||
162939222|NCT03843359|588480304|FG004|Crossover|Investigator site closed|0|||
162939223|NCT03843359|588480305|FG005|Crossover|Investigator site closed|0|||
162939224|NCT03843359|588480306|FG006|Crossover|Investigator site closed|0|||
162939225|NCT03843359|588480307|FG007|Crossover|Investigator site closed|0|||
162939226|NCT03843359|588480308|FG008|Crossover|Investigator site closed|0|||
162939227|NCT03843359|588480309|FG009|Crossover|Investigator site closed|0|||
162939228|NCT03843359|588480310|FG010|Crossover|Investigator site closed|0|||
162939229|NCT03843359|588480311|FG011|Crossover|Investigator site closed|0|||
162939230|NCT03843359|588480312|FG012|Crossover|Investigator site closed|0|||
162939231|NCT03843359|588480313|FG013|Crossover|Investigator site closed|0|||
162939232|NCT03843359|588480314|FG014|Crossover|Investigator site closed|2|||
163184312|NCT00089284|589391190|FG006|Overall Study|Adverse event before starting treatment|1|||
163184313|NCT00137631|589391191|FG000|Overall Study|Lost to Follow-up|37|||
163184314|NCT00137631|589391192|FG001|Overall Study|Lost to Follow-up|41|||
163184315|NCT02611960|589391193|FG000|Overall Study|Adverse Event|7|||
163184316|NCT02611960|589391194|FG001|Overall Study|Adverse Event|8|||
163184317|NCT02611960|589391193|FG000|Overall Study|Death|98|||
163184318|NCT02611960|589391194|FG001|Overall Study|Death|92|||
163184319|NCT02611960|589391193|FG000|Overall Study|Withdrawal by Subject|1|||
163184320|NCT02611960|589391194|FG001|Overall Study|Withdrawal by Subject|5|||
163184321|NCT02611960|589391193|FG000|Overall Study|Sponsor Decision|11|||
163184322|NCT02611960|589391194|FG001|Overall Study|Sponsor Decision|11|||
163184323|NCT02395666|589391195|FG000|Overall Study|Physician Decision|3|||
163184324|NCT02395666|589391196|FG001|Overall Study|Physician Decision|0|||
163184325|NCT02395666|589391195|FG000|Overall Study|Lost to Follow-up|1|||
163184326|NCT02395666|589391196|FG001|Overall Study|Lost to Follow-up|0|||
163289475|NCT00878722|589765012|FG003|Overall Study|Withdrawal by Subject|0|||
162939233|NCT03843359|588480315|FG015|Crossover|Investigator site closed|2|||
162939234|NCT03843359|588480300|FG000|Crossover|Ongoing at the time of analysis|0|||
162939235|NCT03843359|588480301|FG001|Crossover|Ongoing at the time of analysis|0|||
162939236|NCT03843359|588480302|FG002|Crossover|Ongoing at the time of analysis|0|||
162939237|NCT03843359|588480303|FG003|Crossover|Ongoing at the time of analysis|0|||
163184327|NCT02395666|589391195|FG000|Overall Study|Withdrawal by Subject|2|||
163184328|NCT02395666|589391196|FG001|Overall Study|Withdrawal by Subject|1|||
163184329|NCT01092507|589391197|FG000|Overall Study|Withdrawal by Subject|2|||
163289476|NCT00878722|589765013|FG004|Overall Study|Withdrawal by Subject|0|||
162939238|NCT03843359|588480304|FG004|Crossover|Ongoing at the time of analysis|0|||
162939239|NCT03843359|588480305|FG005|Crossover|Ongoing at the time of analysis|0|||
163184330|NCT01092507|589391198|FG001|Overall Study|Withdrawal by Subject|0|||
163184331|NCT00085709|589391210|FG000|Overall Study|Adverse Event|8|||
163184332|NCT00085709|589391211|FG001|Overall Study|Adverse Event|0|||
163184333|NCT00085709|589391210|FG000|Overall Study|Death|8|||
163184334|NCT00085709|589391211|FG001|Overall Study|Death|2|||
163184335|NCT00085709|589391210|FG000|Overall Study|Refusal unrelated to adverse events|1|||
163184336|NCT00085709|589391211|FG001|Overall Study|Refusal unrelated to adverse events|2|||
163184337|NCT00085709|589391210|FG000|Overall Study|Progression|3|||
163184338|NCT00085709|589391211|FG001|Overall Study|Progression|4|||
163184339|NCT00085709|589391210|FG000|Overall Study|Not protocol specified|12|||
163184340|NCT00085709|589391211|FG001|Overall Study|Not protocol specified|22|||
163184341|NCT00085709|589391210|FG000|Overall Study|Not eligible|19|||
163184342|NCT00085709|589391211|FG001|Overall Study|Not eligible|19|||
163184343|NCT00085709|589391210|FG000|Overall Study|Withdrawal by Subject|2|||
163184344|NCT00085709|589391211|FG001|Overall Study|Withdrawal by Subject|1|||
163184345|NCT04131556|589391212|FG000|Overall Study|Adverse Event|1|||
163184346|NCT04131556|589391212|FG000|Overall Study|Withdrawal by Subject|1|||
163184347|NCT01229371|589391213|FG000|Overall Study|Withdrawal by Subject|0|||
163184348|NCT01229371|589391214|FG001|Overall Study|Withdrawal by Subject|1|||
163184349|NCT01229371|589391215|FG002|Overall Study|Withdrawal by Subject|0|||
163184350|NCT01229371|589391216|FG003|Overall Study|Withdrawal by Subject|0|||
163184351|NCT05314478|589391217|FG000|Overall Study|Physician Decision|1|||
163184352|NCT00145600|589391218|FG000|Overall Study|Death|1|||
163184353|NCT00145600|589391219|FG001|Overall Study|Death|2|||
163184354|NCT00145600|589391220|FG002|Overall Study|Death|2|||
163184355|NCT00145600|589391221|FG003|Overall Study|Death|6|||
163184356|NCT00145600|589391218|FG000|Overall Study|Ineligible|3|||
163184357|NCT00145600|589391219|FG001|Overall Study|Ineligible|0|||
163184358|NCT00145600|589391220|FG002|Overall Study|Ineligible|1|||
163184359|NCT00145600|589391221|FG003|Overall Study|Ineligible|5|||
163184360|NCT00145600|589391218|FG000|Overall Study|Lost to Follow-up|2|||
163184361|NCT00145600|589391219|FG001|Overall Study|Lost to Follow-up|6|||
163184362|NCT00145600|589391220|FG002|Overall Study|Lost to Follow-up|2|||
163184363|NCT00145600|589391221|FG003|Overall Study|Lost to Follow-up|4|||
163184364|NCT00145600|589391218|FG000|Overall Study|Noncompliance|1|||
163184365|NCT00145600|589391219|FG001|Overall Study|Noncompliance|0|||
163184366|NCT00145600|589391220|FG002|Overall Study|Noncompliance|0|||
163184367|NCT00145600|589391221|FG003|Overall Study|Noncompliance|0|||
163184368|NCT00145600|589391218|FG000|Overall Study|Withdrawal by Subject|1|||
163184369|NCT00145600|589391219|FG001|Overall Study|Withdrawal by Subject|2|||
163184370|NCT00145600|589391220|FG002|Overall Study|Withdrawal by Subject|0|||
163184371|NCT00145600|589391221|FG003|Overall Study|Withdrawal by Subject|1|||
163184372|NCT00736879|589391225|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
163184373|NCT00736879|589391226|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
163184374|NCT00736879|589391227|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
163184375|NCT00736879|589391228|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
163184376|NCT00736879|589391225|FG000|Double Blind Treatment Period|Adverse Event|0|||
163184377|NCT00736879|589391226|FG001|Double Blind Treatment Period|Adverse Event|1|||
163184378|NCT00736879|589391227|FG002|Double Blind Treatment Period|Adverse Event|1|||
163184379|NCT00736879|589391228|FG003|Double Blind Treatment Period|Adverse Event|0|||
163184380|NCT00736879|589391225|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
163184381|NCT00736879|589391226|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
163184382|NCT00736879|589391227|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
163184383|NCT00736879|589391228|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
163184384|NCT00736879|589391225|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
163184385|NCT00736879|589391226|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
163184386|NCT00736879|589391227|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
163184387|NCT00736879|589391228|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
163184388|NCT00736879|589391225|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
163289477|NCT00878722|589765014|FG005|Overall Study|Withdrawal by Subject|0|||
163289478|NCT00878722|589765015|FG006|Overall Study|Withdrawal by Subject|0|||
163184389|NCT00736879|589391226|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
163184390|NCT00736879|589391227|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
163184391|NCT00736879|589391228|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
163184392|NCT00736879|589391225|FG000|Double Blind Treatment Period|No longer met criteria|0|||
163184393|NCT00736879|589391226|FG001|Double Blind Treatment Period|No longer met criteria|1|||
163184394|NCT00736879|589391227|FG002|Double Blind Treatment Period|No longer met criteria|0|||
163184395|NCT00736879|589391228|FG003|Double Blind Treatment Period|No longer met criteria|0|||
163184396|NCT00736879|589391225|FG000|Double Blind Treatment Period|non-specified|0|||
163289479|NCT00878722|589765016|FG007|Overall Study|Withdrawal by Subject|2|||
163184397|NCT00736879|589391226|FG001|Double Blind Treatment Period|non-specified|1|||
163184398|NCT00736879|589391227|FG002|Double Blind Treatment Period|non-specified|0|||
163184399|NCT00736879|589391228|FG003|Double Blind Treatment Period|non-specified|0|||
163184400|NCT00736879|589391225|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
163184401|NCT00736879|589391226|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
163184402|NCT00736879|589391227|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
163289480|NCT00878722|589765009|FG000|Overall Study|Relapse|0|||
163289481|NCT00878722|589765010|FG001|Overall Study|Relapse|0|||
163289482|NCT00878722|589765011|FG002|Overall Study|Relapse|0|||
163289483|NCT00878722|589765012|FG003|Overall Study|Relapse|1|||
163042847|NCT01066871|588863975|FG001|Overall Study|Protocol Violation|0|||
163289484|NCT00878722|589765013|FG004|Overall Study|Relapse|0|||
163289485|NCT00878722|589765014|FG005|Overall Study|Relapse|0|||
162939240|NCT03843359|588480306|FG006|Crossover|Ongoing at the time of analysis|0|||
162939241|NCT03843359|588480307|FG007|Crossover|Ongoing at the time of analysis|0|||
162939242|NCT03843359|588480308|FG008|Crossover|Ongoing at the time of analysis|0|||
162939243|NCT03843359|588480309|FG009|Crossover|Ongoing at the time of analysis|0|||
162939244|NCT03843359|588480310|FG010|Crossover|Ongoing at the time of analysis|0|||
162939245|NCT03843359|588480311|FG011|Crossover|Ongoing at the time of analysis|0|||
162939246|NCT03843359|588480312|FG012|Crossover|Ongoing at the time of analysis|0|||
162939247|NCT03843359|588480313|FG013|Crossover|Ongoing at the time of analysis|1|||
162939248|NCT03843359|588480314|FG014|Crossover|Ongoing at the time of analysis|0|||
162939249|NCT03843359|588480315|FG015|Crossover|Ongoing at the time of analysis|0|||
162939250|NCT03075527|588480316|FG000|Overall Study|Death|1|||
162939251|NCT03075527|588480316|FG000|Overall Study|Withdrawal by Subject|1|||
162939252|NCT03075527|588480316|FG000|Overall Study|Physician Decision|3|||
162939253|NCT03075527|588480316|FG000|Overall Study|Progression/Relapse|14|||
162939254|NCT05359003|588480321|FG000|Overall Study|Withdrawal by Subject|1|||
162939255|NCT05359003|588480322|FG001|Overall Study|Withdrawal by Subject|3|||
162939256|NCT06202521|588480325|FG000|Overall Study|Withdrawal by Subject|0|||
162939257|NCT06202521|588480326|FG001|Overall Study|Withdrawal by Subject|1|||
162939258|NCT06202521|588480327|FG002|Overall Study|Withdrawal by Subject|0|||
162939259|NCT06202521|588480328|FG003|Overall Study|Withdrawal by Subject|1|||
162939260|NCT06202521|588480325|FG000|Overall Study|Adverse Event|0|||
162939261|NCT06202521|588480326|FG001|Overall Study|Adverse Event|0|||
162939262|NCT06202521|588480327|FG002|Overall Study|Adverse Event|1|||
162939263|NCT06202521|588480328|FG003|Overall Study|Adverse Event|0|||
162939264|NCT02717611|588480331|FG000|Overall Study|Death|13|||
162939265|NCT02717611|588480331|FG000|Overall Study|Withdrawal by Subject|6|||
162939266|NCT02717611|588480331|FG000|Overall Study|Active, not recruiting|40|||
162939267|NCT02717611|588480331|FG000|Overall Study|Complicating disease|1|||
162939268|NCT00616928|588480334|FG000|Overall Study|Adverse Event|6|||
162939269|NCT00616928|588480335|FG001|Overall Study|Adverse Event|3|||
162939270|NCT00616928|588480336|FG002|Overall Study|Adverse Event|2|||
162939271|NCT00616928|588480337|FG003|Overall Study|Adverse Event|2|||
162939272|NCT00616928|588480334|FG000|Overall Study|Other|51|||
162939273|NCT00616928|588480335|FG001|Overall Study|Other|8|||
162939274|NCT00616928|588480336|FG002|Overall Study|Other|15|||
162939275|NCT00616928|588480337|FG003|Overall Study|Other|5|||
162939276|NCT00616928|588480334|FG000|Overall Study|Lost to Follow-up|5|||
162939277|NCT00616928|588480335|FG001|Overall Study|Lost to Follow-up|7|||
162939278|NCT00616928|588480336|FG002|Overall Study|Lost to Follow-up|0|||
162939279|NCT00616928|588480337|FG003|Overall Study|Lost to Follow-up|0|||
162939280|NCT05182606|588480340|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|29|||
162939281|NCT02669264|588480345|FG000|Overall Study|Death|5|||
162939282|NCT02669264|588480346|FG001|Overall Study|Death|5|||
162939283|NCT02669264|588480347|FG002|Overall Study|Death|3|||
162939284|NCT02669264|588480348|FG003|Overall Study|Death|3|||
162939285|NCT02669264|588480349|FG004|Overall Study|Death|3|||
162939286|NCT02669264|588480350|FG005|Overall Study|Death|6|||
162939287|NCT02669264|588480351|FG006|Overall Study|Death|3|||
162939288|NCT02669264|588480345|FG000|Overall Study|Withdrawal by Subject|0|||
162939289|NCT02669264|588480346|FG001|Overall Study|Withdrawal by Subject|1|||
162939290|NCT02669264|588480347|FG002|Overall Study|Withdrawal by Subject|0|||
162939291|NCT02669264|588480348|FG003|Overall Study|Withdrawal by Subject|0|||
162939292|NCT02669264|588480349|FG004|Overall Study|Withdrawal by Subject|1|||
162939293|NCT02669264|588480350|FG005|Overall Study|Withdrawal by Subject|0|||
162939294|NCT02669264|588480351|FG006|Overall Study|Withdrawal by Subject|0|||
162939295|NCT02669264|588480345|FG000|Overall Study|Lost to Follow-up|0|||
162939296|NCT02669264|588480346|FG001|Overall Study|Lost to Follow-up|0|||
162939297|NCT02669264|588480347|FG002|Overall Study|Lost to Follow-up|0|||
162939298|NCT02669264|588480348|FG003|Overall Study|Lost to Follow-up|0|||
162939299|NCT02669264|588480349|FG004|Overall Study|Lost to Follow-up|1|||
162939300|NCT02669264|588480350|FG005|Overall Study|Lost to Follow-up|0|||
162939301|NCT02669264|588480351|FG006|Overall Study|Lost to Follow-up|0|||
162939302|NCT02669264|588480345|FG000|Overall Study|Miscellaneous|0|||
162939303|NCT02669264|588480346|FG001|Overall Study|Miscellaneous|0|||
162939304|NCT02669264|588480347|FG002|Overall Study|Miscellaneous|0|||
162939305|NCT02669264|588480348|FG003|Overall Study|Miscellaneous|0|||
162939306|NCT02669264|588480349|FG004|Overall Study|Miscellaneous|0|||
162939307|NCT02669264|588480350|FG005|Overall Study|Miscellaneous|0|||
162939308|NCT02669264|588480351|FG006|Overall Study|Miscellaneous|2|||
162939309|NCT00500682|588480352|FG000|Overall Study|Adverse Event|37|||
162939310|NCT00500682|588480353|FG001|Overall Study|Adverse Event|29|||
162939311|NCT00500682|588480352|FG000|Overall Study|Death|25|||
162939312|NCT00500682|588480353|FG001|Overall Study|Death|16|||
162939313|NCT00500682|588480352|FG000|Overall Study|Lost to Follow-up|11|||
162939314|NCT00500682|588480353|FG001|Overall Study|Lost to Follow-up|11|||
162939315|NCT00500682|588480352|FG000|Overall Study|Physician Decision|6|||
162939316|NCT00500682|588480353|FG001|Overall Study|Physician Decision|10|||
162939317|NCT00500682|588480352|FG000|Overall Study|Pregnancy|2|||
162939318|NCT00500682|588480353|FG001|Overall Study|Pregnancy|0|||
162939319|NCT00500682|588480352|FG000|Overall Study|Protocol Violation|1|||
162939320|NCT00500682|588480353|FG001|Overall Study|Protocol Violation|3|||
162939321|NCT00500682|588480352|FG000|Overall Study|Withdrawal by Subject|80|||
162939322|NCT00500682|588480353|FG001|Overall Study|Withdrawal by Subject|74|||
162939323|NCT00500682|588480352|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
162939324|NCT00500682|588480353|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
162939325|NCT01680159|588480354|FG000|Screening Period|Not meet criteria for dose-up period|7|||
162939326|NCT01680159|588480354|FG000|Increased Dose Period|Adverse Event|6|||
162939327|NCT01680159|588480354|FG000|Increased Dose Period|Withdrawal by Subject|2|||
162939328|NCT00772382|588480355|FG000|Overall Study|Adverse Event|19|||
162939329|NCT00772382|588480355|FG000|Overall Study|Death|6|||
162939330|NCT00772382|588480355|FG000|Overall Study|Lack of Efficacy|4|||
162939331|NCT00772382|588480355|FG000|Overall Study|Physician Decision|5|||
162939332|NCT00772382|588480355|FG000|Overall Study|Protocol Violation|1|||
162939333|NCT00772382|588480355|FG000|Overall Study|Withdrawal by Subject|10|||
162939334|NCT00772382|588480355|FG000|Overall Study|Other Reasons|10|||
162939335|NCT05576012|588480360|FG000|Overall Study|Physician Decision|0|||
162939336|NCT05576012|588480361|FG001|Overall Study|Physician Decision|0|||
162939337|NCT05576012|588480362|FG002|Overall Study|Physician Decision|0|||
162939338|NCT05576012|588480363|FG003|Overall Study|Physician Decision|0|||
162939339|NCT05576012|588480364|FG004|Overall Study|Physician Decision|0|||
162939340|NCT05576012|588480365|FG005|Overall Study|Physician Decision|0|||
162939341|NCT05576012|588480366|FG006|Overall Study|Physician Decision|0|||
162939342|NCT05576012|588480367|FG007|Overall Study|Physician Decision|0|||
162939343|NCT05576012|588480368|FG008|Overall Study|Physician Decision|1|||
162939344|NCT05576012|588480369|FG009|Overall Study|Physician Decision|0|||
162939345|NCT03731182|588481530|FG000|Overall Study|Lost to Follow-up|2|||
162939346|NCT03731182|588481531|FG001|Overall Study|Lost to Follow-up|0|||
162939347|NCT03731182|588481530|FG000|Overall Study|Physician Decision|1|||
162939348|NCT03731182|588481531|FG001|Overall Study|Physician Decision|0|||
162939349|NCT03731182|588481530|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
162939350|NCT03731182|588481531|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
162939351|NCT03036579|588481538|FG000|2 Years|Lost to Follow-up|1|||
162939352|NCT03036579|588481539|FG001|2 Years|Lost to Follow-up|0|||
162939353|NCT03036579|588481538|FG000|3 Years|Lost to Follow-up|0|||
162939354|NCT03036579|588481539|FG001|3 Years|Lost to Follow-up|1|||
162939355|NCT02352337|588481540|FG000|Overall Study|Patients never treated|4|||
162939356|NCT02352337|588481541|FG001|Overall Study|Patients never treated|1|||
162939357|NCT02352337|588481542|FG002|Overall Study|Patients never treated|2|||
162939358|NCT02458638|588481545|FG000|Overall Study|Death|309|||
162939359|NCT02458638|588481545|FG000|Overall Study|End of Cohort/End of Study|67|||
162939360|NCT02458638|588481545|FG000|Overall Study|Lost to Follow-up|31|||
162939361|NCT02458638|588481545|FG000|Overall Study|Other Reasons|4|||
162939362|NCT02458638|588481545|FG000|Overall Study|Physician Decision|1|||
162939363|NCT02458638|588481545|FG000|Overall Study|Withdrawal by Subject|47|||
162939364|NCT00576901|588481557|FG000|Overall Study|Withdrawal by Subject|1|||
162939365|NCT00576901|588481557|FG000|Overall Study|Disease course|1|||
162939366|NCT00576901|588481557|FG000|Overall Study|Protocol Violation|1|||
162939367|NCT02398188|588481558|FG000|Overall Study|Adverse Event|2|||
162939368|NCT02398188|588481559|FG001|Overall Study|Adverse Event|3|||
162939369|NCT02398188|588481558|FG000|Overall Study|Lost to Follow-up|5|||
162939370|NCT02398188|588481559|FG001|Overall Study|Lost to Follow-up|0|||
162939371|NCT02398188|588481558|FG000|Overall Study|Non-compliance|4|||
162939372|NCT02398188|588481559|FG001|Overall Study|Non-compliance|4|||
162939373|NCT02398188|588481558|FG000|Overall Study|Protocol Violation|6|||
162939374|NCT02398188|588481559|FG001|Overall Study|Protocol Violation|10|||
162939375|NCT02398188|588481558|FG000|Overall Study|Sponsor Decision|2|||
162939376|NCT02398188|588481559|FG001|Overall Study|Sponsor Decision|1|||
162939377|NCT02398188|588481558|FG000|Overall Study|Pregnancy|1|||
162939378|NCT02398188|588481559|FG001|Overall Study|Pregnancy|0|||
162939379|NCT02398188|588481558|FG000|Overall Study|Withdrawal by Subject|7|||
162939380|NCT02398188|588481559|FG001|Overall Study|Withdrawal by Subject|16|||
162939381|NCT00620763|588481560|FG000|Period: First Intervention|Withdrawal by Subject|0|||
162939382|NCT00620763|588481561|FG001|Period: First Intervention|Withdrawal by Subject|2|||
162939383|NCT00620763|588481560|FG000|Period: First Intervention|Protocol Violation|0|||
162939384|NCT00620763|588481561|FG001|Period: First Intervention|Protocol Violation|3|||
162939385|NCT00620763|588481560|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
162939386|NCT00620763|588481561|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
162939387|NCT00729859|588481562|FG000|Overall Study|Adverse Event|0|||
162939388|NCT00729859|588481563|FG001|Overall Study|Adverse Event|1|||
162939389|NCT00729859|588481564|FG002|Overall Study|Adverse Event|0|||
162939390|NCT00729859|588481562|FG000|Overall Study|Withdrawal by Subject|0|||
162939391|NCT00729859|588481563|FG001|Overall Study|Withdrawal by Subject|1|||
162939392|NCT00729859|588481564|FG002|Overall Study|Withdrawal by Subject|0|||
162939393|NCT00760383|588481565|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
162939394|NCT00760383|588481566|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
162939395|NCT05034731|588481567|FG000|Overall Study|Screen fail|1|||
162939396|NCT05034731|588481568|FG001|Overall Study|Screen fail|1|||
162939397|NCT01725451|588481574|FG000|Period 1|Withdrawal by Subject|1|||
163184403|NCT00736879|589391228|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
163184404|NCT00736879|589391225|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
163184405|NCT00736879|589391226|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
163184406|NCT00736879|589391227|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
163184407|NCT00736879|589391228|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
163184408|NCT03583164|589391235|FG000|Overall Study|Death in Main Phase|35|||
163184409|NCT03583164|589391235|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
163184410|NCT03583164|589391235|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
163184411|NCT03583164|589391235|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
163184412|NCT03583164|589391235|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
163184413|NCT03583164|589391235|FG000|Overall Study|Physician decision in Main Phase|1|||
163184414|NCT03583164|589391235|FG000|Overall Study|Physician decision in Extended Phase|2|||
163289486|NCT00878722|589765015|FG006|Overall Study|Relapse|0|||
163289487|NCT00878722|589765016|FG007|Overall Study|Relapse|0|||
163289488|NCT00383188|589765017|FG000|Overall Study|Adverse Event|4|||
163289489|NCT00383188|589765018|FG001|Overall Study|Adverse Event|7|||
163289490|NCT00383188|589765019|FG002|Overall Study|Adverse Event|9|||
162939398|NCT01725451|588481575|FG001|Period 1|Withdrawal by Subject|0|||
162939399|NCT01725451|588481576|FG002|Period 1|Withdrawal by Subject|0|||
162939400|NCT01725451|588481577|FG003|Period 1|Withdrawal by Subject|0|||
162939401|NCT01725451|588481574|FG000|Washout From Period 3|Protocol Violation|0|||
162939402|NCT01725451|588481575|FG001|Washout From Period 3|Protocol Violation|0|||
162939403|NCT01725451|588481576|FG002|Washout From Period 3|Protocol Violation|1|||
162939404|NCT01725451|588481577|FG003|Washout From Period 3|Protocol Violation|0|||
162939405|NCT01725451|588481574|FG000|Washout From Period 3|Adverse Event|0|||
162939406|NCT01725451|588481575|FG001|Washout From Period 3|Adverse Event|1|||
162939407|NCT01725451|588481576|FG002|Washout From Period 3|Adverse Event|0|||
162939408|NCT01725451|588481577|FG003|Washout From Period 3|Adverse Event|0|||
162939409|NCT01725451|588481574|FG000|Period 4|Adverse Event|0|||
162939410|NCT01725451|588481575|FG001|Period 4|Adverse Event|0|||
162939411|NCT01725451|588481576|FG002|Period 4|Adverse Event|1|||
162939412|NCT01725451|588481577|FG003|Period 4|Adverse Event|0|||
162939413|NCT00696709|588481579|FG000|Overall Study|Withdrawal by Subject|1|||
162939414|NCT00696709|588481580|FG001|Overall Study|Withdrawal by Subject|2|||
162939415|NCT00696709|588481581|FG002|Overall Study|Withdrawal by Subject|1|||
162939416|NCT00696709|588481582|FG003|Overall Study|Withdrawal by Subject|4|||
162939417|NCT00696709|588481583|FG004|Overall Study|Withdrawal by Subject|3|||
162939418|NCT00696709|588481579|FG000|Overall Study|Protocol Violation|1|||
162939419|NCT00696709|588481580|FG001|Overall Study|Protocol Violation|0|||
162939420|NCT00696709|588481581|FG002|Overall Study|Protocol Violation|0|||
162939421|NCT00696709|588481582|FG003|Overall Study|Protocol Violation|0|||
162939422|NCT00696709|588481583|FG004|Overall Study|Protocol Violation|0|||
162939423|NCT00696709|588481579|FG000|Overall Study|Lost to Follow-up|1|||
162939424|NCT00696709|588481580|FG001|Overall Study|Lost to Follow-up|1|||
162939425|NCT00696709|588481581|FG002|Overall Study|Lost to Follow-up|0|||
162939426|NCT00696709|588481582|FG003|Overall Study|Lost to Follow-up|0|||
162939427|NCT00696709|588481583|FG004|Overall Study|Lost to Follow-up|0|||
162939428|NCT00696709|588481579|FG000|Overall Study|Adverse Event|0|||
162939429|NCT00696709|588481580|FG001|Overall Study|Adverse Event|0|||
162939430|NCT00696709|588481581|FG002|Overall Study|Adverse Event|0|||
162939431|NCT00696709|588481582|FG003|Overall Study|Adverse Event|1|||
162939432|NCT00696709|588481583|FG004|Overall Study|Adverse Event|0|||
162939433|NCT00310856|588481584|FG000|Overall Study|Withdrawal by Subject|2|||
162939434|NCT00310856|588481585|FG001|Overall Study|Withdrawal by Subject|2|||
162939435|NCT00310856|588481586|FG002|Overall Study|Withdrawal by Subject|2|||
162939436|NCT00310856|588481584|FG000|Overall Study|Lost to Follow-up|1|||
162939437|NCT00310856|588481585|FG001|Overall Study|Lost to Follow-up|2|||
162939438|NCT00310856|588481586|FG002|Overall Study|Lost to Follow-up|6|||
162939439|NCT00310856|588481584|FG000|Overall Study|Inappropriate enrollment|1|||
162939440|NCT00310856|588481585|FG001|Overall Study|Inappropriate enrollment|1|||
162939441|NCT00310856|588481586|FG002|Overall Study|Inappropriate enrollment|0|||
162939442|NCT00310856|588481584|FG000|Overall Study|Unable to classify|1|||
162939443|NCT00310856|588481585|FG001|Overall Study|Unable to classify|0|||
162939444|NCT00310856|588481586|FG002|Overall Study|Unable to classify|0|||
162939445|NCT01306253|588481587|FG000|Overall Study|Lost to Follow-up|1|||
162939446|NCT01306253|588481588|FG001|Overall Study|Lost to Follow-up|1|||
162939447|NCT01261325|588481589|FG000|Overall Study|Lack of Efficacy|1|||
162939448|NCT01261325|588481590|FG001|Overall Study|Lack of Efficacy|1|||
162939449|NCT01261325|588481591|FG002|Overall Study|Lack of Efficacy|0|||
162939450|NCT01261325|588481589|FG000|Overall Study|Withdrawal by Subject|2|||
162939451|NCT01261325|588481590|FG001|Overall Study|Withdrawal by Subject|2|||
162939452|NCT01261325|588481591|FG002|Overall Study|Withdrawal by Subject|4|||
162939453|NCT01261325|588481589|FG000|Overall Study|SAE, non-fatal|1|||
162939454|NCT01261325|588481590|FG001|Overall Study|SAE, non-fatal|5|||
162939455|NCT01261325|588481591|FG002|Overall Study|SAE, non-fatal|1|||
162939456|NCT01261325|588481589|FG000|Overall Study|AE, non-serious non-fatal|9|||
162939457|NCT01261325|588481590|FG001|Overall Study|AE, non-serious non-fatal|15|||
162939458|NCT01261325|588481591|FG002|Overall Study|AE, non-serious non-fatal|13|||
162939459|NCT01261325|588481589|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
162939460|NCT01261325|588481590|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
162939461|NCT01261325|588481591|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
162939462|NCT01261325|588481589|FG000|Overall Study|Non Compliance|2|||
162939463|NCT01261325|588481590|FG001|Overall Study|Non Compliance|0|||
162939464|NCT01261325|588481591|FG002|Overall Study|Non Compliance|0|||
162939465|NCT01261325|588481589|FG000|Overall Study|Patient Randomized by Mistake|0|||
162939466|NCT01261325|588481590|FG001|Overall Study|Patient Randomized by Mistake|1|||
162939467|NCT01261325|588481591|FG002|Overall Study|Patient Randomized by Mistake|0|||
162939468|NCT01261325|588481589|FG000|Overall Study|Erroneously Randomized|1|||
162939469|NCT01261325|588481590|FG001|Overall Study|Erroneously Randomized|0|||
162939470|NCT01261325|588481591|FG002|Overall Study|Erroneously Randomized|0|||
162939471|NCT01261325|588481589|FG000|Overall Study|Screen Failure|1|||
162939472|NCT01261325|588481590|FG001|Overall Study|Screen Failure|0|||
162939473|NCT01261325|588481591|FG002|Overall Study|Screen Failure|0|||
162939474|NCT01261325|588481589|FG000|Overall Study|Randomized in Error|0|||
162939475|NCT01261325|588481590|FG001|Overall Study|Randomized in Error|0|||
163184415|NCT03583164|589391235|FG000|Overall Study|Death in Extended Phase|13|||
163184416|NCT03583164|589391235|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
163184417|NCT03583164|589391235|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
163184418|NCT03583164|589391235|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
162939476|NCT01261325|588481591|FG002|Overall Study|Randomized in Error|1|||
162939477|NCT01261325|588481589|FG000|Overall Study|Protocol Violation|0|||
162939478|NCT01261325|588481590|FG001|Overall Study|Protocol Violation|3|||
162939479|NCT01261325|588481591|FG002|Overall Study|Protocol Violation|1|||
162939480|NCT01261325|588481589|FG000|Overall Study|Lost to Follow-up|0|||
162939481|NCT01261325|588481590|FG001|Overall Study|Lost to Follow-up|1|||
162939482|NCT01261325|588481591|FG002|Overall Study|Lost to Follow-up|3|||
162939483|NCT01261325|588481589|FG000|Overall Study|AE, serious fatal|0|||
162939484|NCT01261325|588481590|FG001|Overall Study|AE, serious fatal|0|||
162939485|NCT01261325|588481591|FG002|Overall Study|AE, serious fatal|2|||
162939486|NCT02668302|588481592|FG000|Overall Study|Withdrawal by Subject|1|||
162939487|NCT02668302|588481593|FG001|Overall Study|Withdrawal by Subject|0|||
162939488|NCT02619682|588481600|FG000|Overall Study|Withdrawal by Subject|3|||
162939489|NCT02619682|588481600|FG000|Overall Study|Lack of Efficacy|8|||
162939490|NCT02619682|588481600|FG000|Overall Study|new secondary cancer|1|||
162939491|NCT02619682|588481600|FG000|Overall Study|post surgery complications|2|||
162939492|NCT01861522|588481601|FG000|Overall Study|Adverse Event|1|||
162939493|NCT01861522|588481602|FG001|Overall Study|Adverse Event|0|||
162939494|NCT01861522|588481601|FG000|Overall Study|Withdrawal by Subject|2|||
162939495|NCT01861522|588481602|FG001|Overall Study|Withdrawal by Subject|0|||
162939496|NCT00526890|588481603|FG000|Overall Study|Adverse Event|2|||
162939497|NCT01995058|588481604|FG000|Overall Study|Sponsor Decision to terminate study|14|||
162939498|NCT01995058|588481605|FG001|Overall Study|Sponsor Decision to terminate study|12|||
162939499|NCT01995058|588481606|FG002|Overall Study|Sponsor Decision to terminate study|12|||
162939500|NCT01995058|588481607|FG003|Overall Study|Sponsor Decision to terminate study|10|||
162939501|NCT01995058|588481604|FG000|Overall Study|Progressive Disease|0|||
162939502|NCT01995058|588481605|FG001|Overall Study|Progressive Disease|1|||
162939503|NCT01995058|588481606|FG002|Overall Study|Progressive Disease|1|||
162939504|NCT01995058|588481607|FG003|Overall Study|Progressive Disease|1|||
162939505|NCT01995058|588481604|FG000|Overall Study|Adverse Event|0|||
162939506|NCT01995058|588481605|FG001|Overall Study|Adverse Event|0|||
162939507|NCT01995058|588481606|FG002|Overall Study|Adverse Event|0|||
162939508|NCT01995058|588481607|FG003|Overall Study|Adverse Event|1|||
162939509|NCT01995058|588481604|FG000|Overall Study|Lack of Efficacy|0|||
162939510|NCT01995058|588481605|FG001|Overall Study|Lack of Efficacy|0|||
162939511|NCT01995058|588481606|FG002|Overall Study|Lack of Efficacy|0|||
162939512|NCT01995058|588481607|FG003|Overall Study|Lack of Efficacy|1|||
162939513|NCT01995058|588481604|FG000|Overall Study|No Treatment Given|0|||
162939514|NCT01995058|588481605|FG001|Overall Study|No Treatment Given|0|||
162939515|NCT01995058|588481606|FG002|Overall Study|No Treatment Given|0|||
162939516|NCT01995058|588481607|FG003|Overall Study|No Treatment Given|1|||
162939517|NCT03611309|588481610|FG000|Overall Study|Lost to Follow-up|16|||
162939518|NCT03611309|588481611|FG001|Overall Study|Lost to Follow-up|8|||
162939519|NCT03611309|588481610|FG000|Overall Study|Withdrawal by Subject|5|||
162939520|NCT03611309|588481611|FG001|Overall Study|Withdrawal by Subject|5|||
162939521|NCT03611309|588481610|FG000|Overall Study|Physician Decision|0|||
162939522|NCT03611309|588481611|FG001|Overall Study|Physician Decision|2|||
162939523|NCT04128696|588481612|FG000|Overall Study|Lost to Follow-up|3|||
162939524|NCT04128696|588481613|FG001|Overall Study|Lost to Follow-up|7|||
162939525|NCT04128696|588481612|FG000|Overall Study|Withdrawal by Subject|12|||
162939526|NCT04128696|588481613|FG001|Overall Study|Withdrawal by Subject|11|||
162939527|NCT04128696|588481612|FG000|Overall Study|Study Closed/Terminated|26|||
162939528|NCT04128696|588481613|FG001|Overall Study|Study Closed/Terminated|38|||
162939529|NCT04128696|588481612|FG000|Overall Study|Physician Decision|2|||
162939530|NCT04128696|588481613|FG001|Overall Study|Physician Decision|3|||
162939531|NCT03280537|588481618|FG000|Overall Study|Withdrawal by Subject|2|||
162939532|NCT03280537|588481619|FG001|Overall Study|Withdrawal by Subject|4|||
162939533|NCT01588106|588481620|FG000|Overall Study|Withdrawal by Subject|5|||
162939534|NCT01588106|588481621|FG001|Overall Study|Withdrawal by Subject|4|||
162939535|NCT03083132|588481622|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
162939536|NCT03083132|588481623|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
162939537|NCT03083132|588481622|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
162939538|NCT03083132|588481623|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
162939539|NCT03083132|588481622|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
162939540|NCT03083132|588481623|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
162939541|NCT03118739|588481624|FG000|Overall Study|Physician Decision|0|||
162939542|NCT03118739|588481625|FG001|Overall Study|Physician Decision|1|||
162939543|NCT03118739|588481624|FG000|Overall Study|Withdrawal by Subject|5|||
162939544|NCT03118739|588481625|FG001|Overall Study|Withdrawal by Subject|3|||
162939545|NCT03118739|588481624|FG000|Overall Study|Lost to Follow-up|2|||
162939546|NCT03118739|588481625|FG001|Overall Study|Lost to Follow-up|0|||
162939547|NCT02995837|588481626|FG000|Overall Study|Lost to Follow-up|9|||
162939548|NCT02995837|588481627|FG001|Overall Study|Lost to Follow-up|8|||
162939549|NCT01859702|588481628|FG000|Overall Study|Protocol deviation|3|||
162939550|NCT01859702|588481628|FG000|Overall Study|Adverse Event|2|||
162939551|NCT01893138|588481629|FG000|Double-Blind Period|Withdrawal by Subject|1|||
162939552|NCT01893138|588481630|FG001|Double-Blind Period|Withdrawal by Subject|1|||
162939553|NCT01893138|588481629|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
162939554|NCT01893138|588481630|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
162939555|NCT01893138|588481629|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
162939556|NCT01893138|588481630|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
162939557|NCT01893138|588481629|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
162939558|NCT01893138|588481630|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
162939559|NCT01893138|588481629|FG000|Open Label - Unblinded Period|Adverse Event|1|||
162939560|NCT01893138|588481630|FG001|Open Label - Unblinded Period|Adverse Event|0|||
162939561|NCT01326026|588481631|FG000|Overall Study|Adverse Event|4|||
162939562|NCT01326026|588481632|FG001|Overall Study|Adverse Event|3|||
162939563|NCT01326026|588481631|FG000|Overall Study|Withdrawal Criteria|5|||
162939564|NCT01326026|588481632|FG001|Overall Study|Withdrawal Criteria|7|||
162939565|NCT01326026|588481631|FG000|Overall Study|Other|3|||
162939566|NCT01326026|588481632|FG001|Overall Study|Other|3|||
162939567|NCT03996005|588481635|FG000|Overall Study|Withdrawal by Subject|1|||
162939568|NCT00289458|588481636|FG000|Overall Study|Death|1|||
162939569|NCT00289458|588481637|FG001|Overall Study|Death|0|||
162939570|NCT00289458|588481638|FG002|Overall Study|Death|0|||
162939571|NCT00289458|588481636|FG000|Overall Study|Physician Decision|3|||
162939572|NCT00289458|588481637|FG001|Overall Study|Physician Decision|4|||
162939573|NCT00289458|588481638|FG002|Overall Study|Physician Decision|2|||
162939574|NCT00289458|588481636|FG000|Overall Study|Withdrawal by Subject|2|||
162939575|NCT00289458|588481637|FG001|Overall Study|Withdrawal by Subject|2|||
162939576|NCT00289458|588481638|FG002|Overall Study|Withdrawal by Subject|4|||
162939577|NCT04274192|588481639|FG000|Overall Study|Protocol Violation|1|||
162939578|NCT04274192|588481640|FG001|Overall Study|Protocol Violation|0|||
162939579|NCT07174544|588481641|FG000|Overall Study|Lost to Follow-up|43|||
162939580|NCT07174544|588481642|FG001|Overall Study|Lost to Follow-up|15|||
162939581|NCT03419234|588481643|FG000|Overall Study|Disease progression|37|||
162939582|NCT03419234|588481644|FG001|Overall Study|Disease progression|36|||
162939583|NCT03419234|588481643|FG000|Overall Study|Adverse Event|6|||
162939584|NCT03419234|588481644|FG001|Overall Study|Adverse Event|9|||
162939585|NCT03419234|588481643|FG000|Overall Study|Withdrawal by Subject|9|||
162939586|NCT03419234|588481644|FG001|Overall Study|Withdrawal by Subject|7|||
162939587|NCT03419234|588481643|FG000|Overall Study|Death|5|||
162939588|NCT03419234|588481644|FG001|Overall Study|Death|1|||
162939589|NCT03419234|588481643|FG000|Overall Study|Alternative therapy|4|||
162939590|NCT03419234|588481644|FG001|Overall Study|Alternative therapy|2|||
162939591|NCT03419234|588481643|FG000|Overall Study|PSA progression|8|||
162939592|NCT03419234|588481644|FG001|Overall Study|PSA progression|10|||
162939593|NCT03419234|588481643|FG000|Overall Study|Rising PSA and bone issues|3|||
162939594|NCT03419234|588481644|FG001|Overall Study|Rising PSA and bone issues|2|||
162939595|NCT03419234|588481643|FG000|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|10|||
162939596|NCT03419234|588481644|FG001|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|16|||
162939597|NCT03419234|588481643|FG000|Overall Study|Physician Decision|12|||
162939598|NCT03419234|588481644|FG001|Overall Study|Physician Decision|11|||
162939599|NCT03419234|588481643|FG000|Overall Study|Second malignancy|1|||
162939600|NCT03419234|588481644|FG001|Overall Study|Second malignancy|0|||
162939601|NCT03419234|588481643|FG000|Overall Study|Insurance status change/patient could not afford|2|||
162939602|NCT03419234|588481644|FG001|Overall Study|Insurance status change/patient could not afford|1|||
162939603|NCT03419234|588481643|FG000|Overall Study|Non-compliance|1|||
162939604|NCT03419234|588481644|FG001|Overall Study|Non-compliance|3|||
162939605|NCT03419234|588481643|FG000|Overall Study|Mistakenly off treatment|1|||
162939606|NCT03419234|588481644|FG001|Overall Study|Mistakenly off treatment|0|||
162939607|NCT03419234|588481643|FG000|Overall Study|Transition to hospice|1|||
162939608|NCT03419234|588481644|FG001|Overall Study|Transition to hospice|0|||
162939609|NCT03419234|588481643|FG000|Overall Study|Still on treatment|9|||
162939610|NCT03419234|588481644|FG001|Overall Study|Still on treatment|8|||
162939611|NCT03419234|588481643|FG000|Overall Study|Never received protocol therapy|2|||
162939612|NCT03419234|588481644|FG001|Overall Study|Never received protocol therapy|4|||
163184419|NCT03583164|589391235|FG000|Overall Study|Treatment failure in Main Phase|2|||
163184420|NCT03583164|589391235|FG000|Overall Study|Treatment failure in Extended Phase|4|||
163184421|NCT03583164|589391235|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
163184422|NCT03583164|589391235|FG000|Overall Study|Other not specified reason in Main Phase|2|||
163184423|NCT02869438|589391243|FG000|Overall Study|Lost to Follow-up|1|||
162939613|NCT03419234|588481643|FG000|Overall Study|Other complicating disease|0|||
162939614|NCT03419234|588481644|FG001|Overall Study|Other complicating disease|1|||
163184424|NCT02869438|589391244|FG001|Overall Study|Lost to Follow-up|0|||
163184425|NCT02869438|589391243|FG000|Overall Study|Adverse Event|1|||
162939615|NCT03419234|588481643|FG000|Overall Study|patient switched from prednisone to another steroid|0|||
163184426|NCT02869438|589391244|FG001|Overall Study|Adverse Event|0|||
162939616|NCT03419234|588481644|FG001|Overall Study|patient switched from prednisone to another steroid|1|||
162939617|NCT00101582|588482938|FG000|Overall Study|Ineligibility determined|0|||
162939618|NCT00101582|588482939|FG001|Overall Study|Ineligibility determined|1|||
162939619|NCT00101582|588482938|FG000|Overall Study|Adverse Event|1|||
162939620|NCT00101582|588482939|FG001|Overall Study|Adverse Event|4|||
162939621|NCT00101582|588482938|FG000|Overall Study|Withdrawal by Subject|6|||
162939622|NCT00101582|588482939|FG001|Overall Study|Withdrawal by Subject|4|||
162939623|NCT00101582|588482938|FG000|Overall Study|Physician Decision|1|||
162939624|NCT00101582|588482939|FG001|Overall Study|Physician Decision|0|||
162939625|NCT00101582|588482938|FG000|Overall Study|Death|3|||
162939626|NCT00101582|588482939|FG001|Overall Study|Death|5|||
162939627|NCT00101582|588482938|FG000|Overall Study|Other|0|||
162939628|NCT00101582|588482939|FG001|Overall Study|Other|1|||
162939629|NCT01907087|588482940|FG000|Overall Study|Withdrawal by Subject|1|||
162939630|NCT01919190|588482941|FG000|Overall Study|Intra-op findings, etc.|3|||
162939631|NCT01919190|588482942|FG001|Overall Study|Intra-op findings, etc.|0|||
162939632|NCT03355742|588482943|FG000|Overall Study|Lost to Follow-up|4|||
162939633|NCT03355742|588482943|FG000|Overall Study|Withdrawal by Subject|29|||
162939634|NCT03355742|588482943|FG000|Overall Study|Physician Decision|6|||
162939635|NCT03355742|588482943|FG000|Overall Study|Death|55|||
162939636|NCT03355742|588482943|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
162939637|NCT02207621|588482945|FG000|Overall Study|Adverse Event|71|||
162939638|NCT02207621|588482946|FG001|Overall Study|Adverse Event|15|||
162939639|NCT02207621|588482947|FG002|Overall Study|Adverse Event|132|||
162939640|NCT02207621|588482945|FG000|Overall Study|Withdrawal by Subject|9|||
162939641|NCT02207621|588482946|FG001|Overall Study|Withdrawal by Subject|9|||
162939642|NCT02207621|588482947|FG002|Overall Study|Withdrawal by Subject|13|||
162939643|NCT02207621|588482945|FG000|Overall Study|Non-Compliant|3|||
162939644|NCT02207621|588482946|FG001|Overall Study|Non-Compliant|3|||
162939645|NCT02207621|588482947|FG002|Overall Study|Non-Compliant|1|||
162939646|NCT02207621|588482945|FG000|Overall Study|Lost to Follow-up|1|||
162939647|NCT02207621|588482946|FG001|Overall Study|Lost to Follow-up|0|||
162939648|NCT02207621|588482947|FG002|Overall Study|Lost to Follow-up|3|||
162939649|NCT02207621|588482945|FG000|Overall Study|Lack of Efficacy|10|||
162939650|NCT02207621|588482946|FG001|Overall Study|Lack of Efficacy|2|||
162939651|NCT02207621|588482947|FG002|Overall Study|Lack of Efficacy|4|||
162939652|NCT02207621|588482945|FG000|Overall Study|Disallowed Concurrent Medication|2|||
162939653|NCT02207621|588482946|FG001|Overall Study|Disallowed Concurrent Medication|5|||
162939654|NCT02207621|588482947|FG002|Overall Study|Disallowed Concurrent Medication|2|||
162939655|NCT02207621|588482945|FG000|Overall Study|Physician Decision|1|||
162939656|NCT02207621|588482946|FG001|Overall Study|Physician Decision|2|||
162939657|NCT02207621|588482947|FG002|Overall Study|Physician Decision|2|||
162939658|NCT02207621|588482945|FG000|Overall Study|Protocol Violation|4|||
162939659|NCT02207621|588482946|FG001|Overall Study|Protocol Violation|10|||
162939660|NCT02207621|588482947|FG002|Overall Study|Protocol Violation|6|||
162939661|NCT02207621|588482945|FG000|Overall Study|Death|2|||
162939662|NCT02207621|588482946|FG001|Overall Study|Death|0|||
162939663|NCT02207621|588482947|FG002|Overall Study|Death|0|||
162939664|NCT02207621|588482945|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
162939665|NCT02207621|588482946|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
162939666|NCT02207621|588482947|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
162939667|NCT02623959|588482948|FG000|Overall Study|Progression|0|||
162939668|NCT02623959|588482949|FG001|Overall Study|Progression|1|||
162939669|NCT00135707|588482950|FG000|Overall Study|Lost to Follow-up|94|||
162939670|NCT00135707|588482951|FG001|Overall Study|Lost to Follow-up|89|||
162939671|NCT00135707|588482950|FG000|Overall Study|Withdrawal by Subject|0|||
162939672|NCT00135707|588482951|FG001|Overall Study|Withdrawal by Subject|1|||
162939673|NCT00135707|588482950|FG000|Overall Study|Institutional review board request|1|||
162939674|NCT00135707|588482951|FG001|Overall Study|Institutional review board request|0|||
162939675|NCT00635778|588482955|FG000|Overall Study|Adverse Event|1|||
162939676|NCT00635778|588482956|FG001|Overall Study|Adverse Event|0|||
162939677|NCT00635778|588482957|FG002|Overall Study|Adverse Event|0|||
162939678|NCT00635778|588482958|FG003|Overall Study|Adverse Event|3|||
162939679|NCT00635778|588482959|FG004|Overall Study|Adverse Event|3|||
162939680|NCT00635778|588482960|FG005|Overall Study|Adverse Event|6|||
162939681|NCT00635778|588482961|FG006|Overall Study|Adverse Event|1|||
162939682|NCT00635778|588482955|FG000|Overall Study|Withdrawal by Subject|0|||
162939683|NCT00635778|588482956|FG001|Overall Study|Withdrawal by Subject|0|||
162939684|NCT00635778|588482957|FG002|Overall Study|Withdrawal by Subject|0|||
162939685|NCT00635778|588482958|FG003|Overall Study|Withdrawal by Subject|1|||
162939686|NCT00635778|588482959|FG004|Overall Study|Withdrawal by Subject|0|||
162939687|NCT00635778|588482960|FG005|Overall Study|Withdrawal by Subject|1|||
162939688|NCT00635778|588482961|FG006|Overall Study|Withdrawal by Subject|1|||
162939689|NCT00635778|588482955|FG000|Overall Study|Progressive disease|0|||
162939690|NCT00635778|588482956|FG001|Overall Study|Progressive disease|3|||
162939691|NCT00635778|588482957|FG002|Overall Study|Progressive disease|3|||
162939692|NCT00635778|588482958|FG003|Overall Study|Progressive disease|4|||
162939693|NCT00635778|588482959|FG004|Overall Study|Progressive disease|5|||
162939694|NCT00635778|588482960|FG005|Overall Study|Progressive disease|14|||
162939695|NCT00635778|588482961|FG006|Overall Study|Progressive disease|4|||
162939696|NCT00812253|588482962|FG000|Overall Study|Withdrawal by Subject|3|||
162939697|NCT00812253|588482963|FG001|Overall Study|Withdrawal by Subject|2|||
162939698|NCT00812253|588482962|FG000|Overall Study|Protocol Violation|1|||
162939699|NCT00812253|588482963|FG001|Overall Study|Protocol Violation|1|||
162939700|NCT00812253|588482962|FG000|Overall Study|Lost to Follow-up|2|||
162939701|NCT00812253|588482963|FG001|Overall Study|Lost to Follow-up|0|||
162939702|NCT04903288|588482964|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
162939703|NCT04903288|588482964|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
162939704|NCT04903288|588482964|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
162939705|NCT04903288|588482964|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
162939706|NCT00634907|588482974|FG000|Overall Study|Withdrawal by Subject|3|||
162939707|NCT00634907|588482975|FG001|Overall Study|Withdrawal by Subject|0|||
162939708|NCT00634907|588482974|FG000|Overall Study|Physician Decision|3|||
162939709|NCT00634907|588482975|FG001|Overall Study|Physician Decision|9|||
162939710|NCT00634907|588482974|FG000|Overall Study|Withdrawal by Subject|11|||
162939711|NCT00634907|588482975|FG001|Overall Study|Withdrawal by Subject|8|||
162939712|NCT01180244|588482982|FG000|Overall Study|Lack of Efficacy|0|||
162939713|NCT01180244|588482983|FG001|Overall Study|Lack of Efficacy|7|||
162939714|NCT01180244|588482982|FG000|Overall Study|Physician Decision|3|||
162939715|NCT01180244|588482983|FG001|Overall Study|Physician Decision|0|||
162939716|NCT01180244|588482982|FG000|Overall Study|Adverse Event|1|||
162939717|NCT01180244|588482983|FG001|Overall Study|Adverse Event|0|||
162939718|NCT01180244|588482982|FG000|Overall Study|Withdrawal by Subject|0|||
162939719|NCT01180244|588482983|FG001|Overall Study|Withdrawal by Subject|1|||
162939720|NCT01180244|588482982|FG000|Overall Study|Protocol Violation|1|||
162939721|NCT01180244|588482983|FG001|Overall Study|Protocol Violation|0|||
162939722|NCT01180244|588482982|FG000|Overall Study|Lost to Follow-up|1|||
162939723|NCT01180244|588482983|FG001|Overall Study|Lost to Follow-up|0|||
162939724|NCT01338636|588482984|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
162939725|NCT01689974|588482990|FG000|Overall Study|Termination of Study|5|||
162939726|NCT01689974|588482991|FG001|Overall Study|Termination of Study|5|||
162939727|NCT00681863|588482992|FG000|Overall Study|Adverse Event|1|||
162939728|NCT00681863|588482992|FG000|Overall Study|Lost to Follow-up|2|||
162939729|NCT00681863|588482992|FG000|Overall Study|Lack of Efficacy|2|||
162939730|NCT00681863|588482992|FG000|Overall Study|Other|18|||
162939731|NCT01388647|588482995|FG000|Overall Study|Adverse Event|1|||
162939732|NCT01388647|588482996|FG001|Overall Study|Adverse Event|2|||
162939733|NCT01006707|588482997|FG000|Study Session 1|Lost to Follow-up|2|||
162939734|NCT01006707|588482998|FG001|Study Session 1|Lost to Follow-up|0|||
162939735|NCT01006707|588482999|FG002|Study Session 1|Lost to Follow-up|0|||
162939736|NCT01006707|588482997|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
162939737|NCT01006707|588482998|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
162939738|NCT01006707|588482999|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
162939739|NCT01336894|588483002|FG000|Follow-up|Study terminated prematurely|2|||
162939740|NCT01336894|588483003|FG001|Follow-up|Study terminated prematurely|7|||
162939741|NCT03937466|588483004|FG000|Overall Study|not eligbile after the 2-week diary|9|||
162939742|NCT03937466|588483004|FG000|Overall Study|never returned their diary|6|||
162939743|NCT03937466|588483004|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
162939744|NCT03937466|588483004|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
162939745|NCT00622908|588483005|FG000|Overall Study|Protocol Violation|1|||
162939746|NCT00622908|588483006|FG001|Overall Study|Protocol Violation|0|||
162939747|NCT00622908|588483005|FG000|Overall Study|Adverse Event|0|||
162939748|NCT00622908|588483006|FG001|Overall Study|Adverse Event|1|||
162939749|NCT00622908|588483005|FG000|Overall Study|Lack of Efficacy|1|||
162939750|NCT00622908|588483006|FG001|Overall Study|Lack of Efficacy|7|||
162939751|NCT00622908|588483005|FG000|Overall Study|Lost to Follow-up|1|||
162939752|NCT00622908|588483006|FG001|Overall Study|Lost to Follow-up|0|||
162939753|NCT00622908|588483005|FG000|Overall Study|Refusal|0|||
162939754|NCT00622908|588483006|FG001|Overall Study|Refusal|1|||
162939755|NCT00622908|588483005|FG000|Overall Study|Termination by study sponser|0|||
162939756|NCT00622908|588483006|FG001|Overall Study|Termination by study sponser|1|||
162939757|NCT00358826|588483012|FG000|Core Study|Adverse Event|1|||
162939758|NCT00358826|588483013|FG001|Core Study|Adverse Event|3|||
162939759|NCT00358826|588483014|FG002|Core Study|Adverse Event|1|||
162939760|NCT00358826|588483015|FG003|Core Study|Adverse Event|1|||
162939761|NCT00358826|588483016|FG004|Core Study|Adverse Event|0|||
162939762|NCT00358826|588483017|FG005|Core Study|Adverse Event|0|||
162939763|NCT00358826|588483018|FG006|Core Study|Adverse Event|0|||
162939764|NCT00358826|588483019|FG007|Core Study|Adverse Event|0|||
162939765|NCT00358826|588483012|FG000|Core Study|Withdrawal by Subject|2|||
162939766|NCT00358826|588483013|FG001|Core Study|Withdrawal by Subject|2|||
162939767|NCT00358826|588483014|FG002|Core Study|Withdrawal by Subject|0|||
162939768|NCT00358826|588483015|FG003|Core Study|Withdrawal by Subject|0|||
162939769|NCT00358826|588483016|FG004|Core Study|Withdrawal by Subject|0|||
162939770|NCT00358826|588483017|FG005|Core Study|Withdrawal by Subject|0|||
162939771|NCT00358826|588483018|FG006|Core Study|Withdrawal by Subject|0|||
162939772|NCT00358826|588483019|FG007|Core Study|Withdrawal by Subject|0|||
162939773|NCT00358826|588483012|FG000|Core Study|Lost to Follow-up|0|||
162939774|NCT00358826|588483013|FG001|Core Study|Lost to Follow-up|0|||
162939775|NCT00358826|588483014|FG002|Core Study|Lost to Follow-up|0|||
162939776|NCT00358826|588483015|FG003|Core Study|Lost to Follow-up|1|||
162939777|NCT00358826|588483016|FG004|Core Study|Lost to Follow-up|0|||
162939778|NCT00358826|588483017|FG005|Core Study|Lost to Follow-up|0|||
162939779|NCT00358826|588483018|FG006|Core Study|Lost to Follow-up|0|||
162939780|NCT00358826|588483019|FG007|Core Study|Lost to Follow-up|0|||
162939781|NCT00358826|588483012|FG000|Core Study|Physician Decision|0|||
162939782|NCT00358826|588483013|FG001|Core Study|Physician Decision|0|||
162939783|NCT00358826|588483014|FG002|Core Study|Physician Decision|1|||
162939784|NCT00358826|588483015|FG003|Core Study|Physician Decision|0|||
162939785|NCT00358826|588483016|FG004|Core Study|Physician Decision|0|||
162939786|NCT00358826|588483017|FG005|Core Study|Physician Decision|0|||
162939787|NCT00358826|588483018|FG006|Core Study|Physician Decision|0|||
162939788|NCT00358826|588483019|FG007|Core Study|Physician Decision|0|||
162939789|NCT00358826|588483012|FG000|MDCT Substudy|Adverse Event|0|||
162939790|NCT00358826|588483013|FG001|MDCT Substudy|Adverse Event|0|||
162939791|NCT00358826|588483014|FG002|MDCT Substudy|Adverse Event|0|||
162939792|NCT00358826|588483015|FG003|MDCT Substudy|Adverse Event|0|||
162939793|NCT00358826|588483016|FG004|MDCT Substudy|Adverse Event|1|||
162939794|NCT00358826|588483017|FG005|MDCT Substudy|Adverse Event|0|||
162939795|NCT00358826|588483018|FG006|MDCT Substudy|Adverse Event|0|||
162939796|NCT00358826|588483019|FG007|MDCT Substudy|Adverse Event|0|||
162939797|NCT00358826|588483012|FG000|MDCT Substudy|Lost to Follow-up|0|||
162939798|NCT00358826|588483013|FG001|MDCT Substudy|Lost to Follow-up|0|||
162939799|NCT00358826|588483014|FG002|MDCT Substudy|Lost to Follow-up|0|||
162939800|NCT00358826|588483015|FG003|MDCT Substudy|Lost to Follow-up|0|||
162939801|NCT00358826|588483016|FG004|MDCT Substudy|Lost to Follow-up|0|||
162939802|NCT00358826|588483017|FG005|MDCT Substudy|Lost to Follow-up|1|||
162939803|NCT00358826|588483018|FG006|MDCT Substudy|Lost to Follow-up|0|||
162939804|NCT00358826|588483019|FG007|MDCT Substudy|Lost to Follow-up|0|||
162939805|NCT00358826|588483012|FG000|MDCT Substudy|Withdrawal by Subject|0|||
162939806|NCT00358826|588483013|FG001|MDCT Substudy|Withdrawal by Subject|0|||
162939807|NCT00358826|588483014|FG002|MDCT Substudy|Withdrawal by Subject|0|||
162939808|NCT00358826|588483015|FG003|MDCT Substudy|Withdrawal by Subject|0|||
162939809|NCT00358826|588483016|FG004|MDCT Substudy|Withdrawal by Subject|0|||
162939810|NCT00358826|588483017|FG005|MDCT Substudy|Withdrawal by Subject|1|||
162939811|NCT00358826|588483018|FG006|MDCT Substudy|Withdrawal by Subject|0|||
162939812|NCT00358826|588483019|FG007|MDCT Substudy|Withdrawal by Subject|0|||
162939813|NCT00283686|588483020|FG000|Overall Study|Death|1|||
162939814|NCT00283686|588483021|FG001|Overall Study|Death|1|||
162939815|NCT00283686|588483022|FG002|Overall Study|Death|1|||
162939816|NCT00283686|588483023|FG003|Overall Study|Death|0|||
162939817|NCT00283686|588483020|FG000|Overall Study|Lost to Follow-up|21|||
162939818|NCT00283686|588483021|FG001|Overall Study|Lost to Follow-up|31|||
162939819|NCT00283686|588483022|FG002|Overall Study|Lost to Follow-up|26|||
162939820|NCT00283686|588483023|FG003|Overall Study|Lost to Follow-up|20|||
162939821|NCT00283686|588483020|FG000|Overall Study|Less than full participation|7|||
162939822|NCT00283686|588483021|FG001|Overall Study|Less than full participation|9|||
162939823|NCT00283686|588483022|FG002|Overall Study|Less than full participation|6|||
162939824|NCT00283686|588483023|FG003|Overall Study|Less than full participation|12|||
162939825|NCT00543439|588483024|FG000|Period 1|Adverse Event|0|||
162939826|NCT00543439|588483025|FG001|Period 1|Adverse Event|2|||
162939827|NCT00543439|588483026|FG002|Period 1|Adverse Event|1|||
162939828|NCT00543439|588483024|FG000|Period 1|Withdrawal by Subject|1|||
162939829|NCT00543439|588483025|FG001|Period 1|Withdrawal by Subject|1|||
162939830|NCT00543439|588483026|FG002|Period 1|Withdrawal by Subject|0|||
162939831|NCT00543439|588483024|FG000|Period 1|Physician Decision|0|||
162939832|NCT00543439|588483025|FG001|Period 1|Physician Decision|0|||
162939833|NCT00543439|588483026|FG002|Period 1|Physician Decision|1|||
162939834|NCT00543439|588483024|FG000|Period 2|Protocol Violation|1|||
162939835|NCT00543439|588483025|FG001|Period 2|Protocol Violation|0|||
162939836|NCT00543439|588483026|FG002|Period 2|Protocol Violation|1|||
162939837|NCT00543439|588483024|FG000|Period 2|Adverse Event|0|||
162939838|NCT00543439|588483025|FG001|Period 2|Adverse Event|1|||
162939839|NCT00543439|588483026|FG002|Period 2|Adverse Event|1|||
162939840|NCT03264066|588483029|FG000|Overall Study|Adverse Event|1|||
162939841|NCT03264066|588483030|FG001|Overall Study|Adverse Event|1|||
162939842|NCT03264066|588483031|FG002|Overall Study|Adverse Event|0|||
162939843|NCT03264066|588483032|FG003|Overall Study|Adverse Event|0|||
162939844|NCT03264066|588483033|FG004|Overall Study|Adverse Event|0|||
162939845|NCT03264066|588483034|FG005|Overall Study|Adverse Event|0|||
162939846|NCT03264066|588483029|FG000|Overall Study|Death|12|||
162939847|NCT03264066|588483030|FG001|Overall Study|Death|12|||
162939848|NCT03264066|588483031|FG002|Overall Study|Death|8|||
162939849|NCT03264066|588483032|FG003|Overall Study|Death|10|||
162939850|NCT03264066|588483033|FG004|Overall Study|Death|6|||
162939851|NCT03264066|588483034|FG005|Overall Study|Death|1|||
162939852|NCT03264066|588483029|FG000|Overall Study|Lost to Follow-up|1|||
162939853|NCT03264066|588483030|FG001|Overall Study|Lost to Follow-up|0|||
162939854|NCT03264066|588483031|FG002|Overall Study|Lost to Follow-up|0|||
162939855|NCT03264066|588483032|FG003|Overall Study|Lost to Follow-up|0|||
162939856|NCT03264066|588483033|FG004|Overall Study|Lost to Follow-up|0|||
162939857|NCT03264066|588483034|FG005|Overall Study|Lost to Follow-up|0|||
162939858|NCT03264066|588483029|FG000|Overall Study|Progressive Disease|0|||
162939859|NCT03264066|588483030|FG001|Overall Study|Progressive Disease|2|||
162939860|NCT03264066|588483031|FG002|Overall Study|Progressive Disease|1|||
162939861|NCT03264066|588483032|FG003|Overall Study|Progressive Disease|0|||
162939862|NCT03264066|588483033|FG004|Overall Study|Progressive Disease|0|||
162939863|NCT03264066|588483034|FG005|Overall Study|Progressive Disease|0|||
162939864|NCT03264066|588483029|FG000|Overall Study|Study Terminated by Sponsor|5|||
162939865|NCT03264066|588483030|FG001|Overall Study|Study Terminated by Sponsor|5|||
162939866|NCT03264066|588483031|FG002|Overall Study|Study Terminated by Sponsor|8|||
162939867|NCT03264066|588483032|FG003|Overall Study|Study Terminated by Sponsor|5|||
162939868|NCT03264066|588483033|FG004|Overall Study|Study Terminated by Sponsor|1|||
162939869|NCT03264066|588483034|FG005|Overall Study|Study Terminated by Sponsor|2|||
162939870|NCT03264066|588483029|FG000|Overall Study|Withdrawal by Subject|1|||
162939871|NCT03264066|588483030|FG001|Overall Study|Withdrawal by Subject|0|||
162939872|NCT03264066|588483031|FG002|Overall Study|Withdrawal by Subject|0|||
162939873|NCT03264066|588483032|FG003|Overall Study|Withdrawal by Subject|5|||
162939874|NCT03264066|588483033|FG004|Overall Study|Withdrawal by Subject|0|||
162939875|NCT03264066|588483034|FG005|Overall Study|Withdrawal by Subject|0|||
162939876|NCT01484028|588483035|FG000|Period 1|Lost to Follow-up|0|||
162939877|NCT01484028|588483036|FG001|Period 1|Lost to Follow-up|1|||
162939878|NCT01484028|588483037|FG002|Period 1|Lost to Follow-up|0|||
162939879|NCT01484028|588483038|FG003|Period 1|Lost to Follow-up|0|||
162939880|NCT01484028|588483035|FG000|Period 1|Non-Compliance to Protocol|0|||
162939881|NCT01484028|588483036|FG001|Period 1|Non-Compliance to Protocol|1|||
162939882|NCT01484028|588483037|FG002|Period 1|Non-Compliance to Protocol|0|||
162939883|NCT01484028|588483038|FG003|Period 1|Non-Compliance to Protocol|1|||
162939884|NCT01484028|588483035|FG000|Period 1|Lens Discomfort|0|||
162939885|NCT01484028|588483036|FG001|Period 1|Lens Discomfort|1|||
162939886|NCT01484028|588483037|FG002|Period 1|Lens Discomfort|0|||
162939887|NCT01484028|588483038|FG003|Period 1|Lens Discomfort|0|||
162939888|NCT00146770|588483054|FG000|Overall Study|Adverse Event|2|||
162939889|NCT00146770|588483055|FG001|Overall Study|Adverse Event|0|||
162939890|NCT00146770|588483054|FG000|Overall Study|Pregnancy|1|||
162939891|NCT00146770|588483055|FG001|Overall Study|Pregnancy|0|||
162939892|NCT00146770|588483054|FG000|Overall Study|Withdrawal by Subject|2|||
162939893|NCT00146770|588483055|FG001|Overall Study|Withdrawal by Subject|0|||
162939894|NCT02826603|588483058|FG000|Overall Study|Adverse Event|17|||
162939895|NCT02826603|588483059|FG001|Overall Study|Adverse Event|9|||
162939896|NCT02826603|588483058|FG000|Overall Study|Lack of Efficacy|4|||
162939897|NCT02826603|588483059|FG001|Overall Study|Lack of Efficacy|9|||
162939898|NCT02826603|588483058|FG000|Overall Study|Lost to Follow-up|13|||
162939899|NCT02826603|588483059|FG001|Overall Study|Lost to Follow-up|12|||
162939900|NCT02826603|588483058|FG000|Overall Study|Noncompliance with treatment|0|||
162939901|NCT02826603|588483059|FG001|Overall Study|Noncompliance with treatment|2|||
162939902|NCT02826603|588483058|FG000|Overall Study|Physician Decision|1|||
162939903|NCT02826603|588483059|FG001|Overall Study|Physician Decision|7|||
162939904|NCT02826603|588483058|FG000|Overall Study|Pregnancy|1|||
162939905|NCT02826603|588483059|FG001|Overall Study|Pregnancy|2|||
162939906|NCT02826603|588483058|FG000|Overall Study|Protocol Violation|3|||
162939907|NCT02826603|588483059|FG001|Overall Study|Protocol Violation|3|||
162939908|NCT02826603|588483058|FG000|Overall Study|Withdrawal by Subject|20|||
162939909|NCT02826603|588483059|FG001|Overall Study|Withdrawal by Subject|19|||
162939910|NCT02826603|588483058|FG000|Overall Study|Death|2|||
162939911|NCT02826603|588483059|FG001|Overall Study|Death|0|||
162939912|NCT02826603|588483058|FG000|Overall Study|New therapy for study indication|0|||
162939913|NCT02826603|588483059|FG001|Overall Study|New therapy for study indication|1|||
162939914|NCT00905489|588483060|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
162939915|NCT00905489|588483060|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
162939916|NCT00905489|588483060|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
163184427|NCT02869438|589391243|FG000|Overall Study|Withdrawal by Subject|1|||
163184428|NCT02869438|589391244|FG001|Overall Study|Withdrawal by Subject|2|||
163184429|NCT05323656|589391247|FG000|Overall Study|Still On-Treatment|6|||
163184430|NCT05323656|589391248|FG001|Overall Study|Still On-Treatment|6|||
163184431|NCT05323656|589391247|FG000|Overall Study|Progressive Disease|15|||
163184432|NCT05323656|589391248|FG001|Overall Study|Progressive Disease|14|||
163184433|NCT05323656|589391247|FG000|Overall Study|Adverse Event|2|||
163184434|NCT05323656|589391248|FG001|Overall Study|Adverse Event|3|||
163184435|NCT05323656|589391247|FG000|Overall Study|Death|1|||
163184436|NCT05323656|589391248|FG001|Overall Study|Death|2|||
163184437|NCT05323656|589391247|FG000|Overall Study|Withdrawal by Subject|1|||
163184438|NCT05323656|589391248|FG001|Overall Study|Withdrawal by Subject|0|||
162939917|NCT00583596|588483061|FG000|Overall Study|Lost to Follow-up|110|||
162939918|NCT00583596|588483061|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
162939919|NCT00583596|588483061|FG000|Overall Study|Death|2|||
162939920|NCT00583596|588483061|FG000|Overall Study|Withdrawal by Subject|6|||
162939921|NCT00583596|588483061|FG000|Overall Study|Lost to Follow-up|94|||
162939922|NCT00583596|588483061|FG000|Overall Study|Data not complete|1|||
162939923|NCT00583596|588483061|FG000|Overall Study|Not consented|15|||
163184439|NCT05323656|589391247|FG000|Overall Study|Clinical disease progression|0|||
163289491|NCT00383188|589765020|FG003|Overall Study|Adverse Event|8|||
163289492|NCT00383188|589765021|FG004|Overall Study|Adverse Event|8|||
163289493|NCT00383188|589765017|FG000|Overall Study|Lack of Efficacy|9|||
162939924|NCT00583596|588483061|FG000|Overall Study|Outside f-up window|26|||
163289494|NCT00383188|589765018|FG001|Overall Study|Lack of Efficacy|3|||
163289495|NCT00383188|589765019|FG002|Overall Study|Lack of Efficacy|3|||
163289496|NCT00383188|589765020|FG003|Overall Study|Lack of Efficacy|2|||
163289497|NCT00383188|589765021|FG004|Overall Study|Lack of Efficacy|6|||
163289498|NCT00383188|589765017|FG000|Overall Study|Other|3|||
163289499|NCT00383188|589765018|FG001|Overall Study|Other|1|||
163289500|NCT00383188|589765019|FG002|Overall Study|Other|0|||
163289501|NCT00383188|589765020|FG003|Overall Study|Other|2|||
163289502|NCT00383188|589765021|FG004|Overall Study|Other|6|||
163289503|NCT00383188|589765017|FG000|Overall Study|No longer willing to participate|1|||
163289504|NCT00383188|589765018|FG001|Overall Study|No longer willing to participate|0|||
163289505|NCT00383188|589765019|FG002|Overall Study|No longer willing to participate|1|||
163289506|NCT00383188|589765020|FG003|Overall Study|No longer willing to participate|0|||
163289507|NCT00383188|589765021|FG004|Overall Study|No longer willing to participate|2|||
163289508|NCT00383188|589765017|FG000|Overall Study|Lost to Follow-up|0|||
163289509|NCT00383188|589765018|FG001|Overall Study|Lost to Follow-up|0|||
162939925|NCT03558997|588483062|FG000|Overall Study|Adverse Event|0|||
162939926|NCT03558997|588483063|FG001|Overall Study|Adverse Event|2|||
162939927|NCT03558997|588483064|FG002|Overall Study|Adverse Event|5|||
162939928|NCT03558997|588483065|FG003|Overall Study|Adverse Event|1|||
162939929|NCT03558997|588483062|FG000|Overall Study|Physician Decision|0|||
162939930|NCT03558997|588483063|FG001|Overall Study|Physician Decision|0|||
162939931|NCT03558997|588483064|FG002|Overall Study|Physician Decision|1|||
162939932|NCT03558997|588483065|FG003|Overall Study|Physician Decision|0|||
162939933|NCT03558997|588483062|FG000|Overall Study|Withdrawal by Subject|1|||
162939934|NCT03558997|588483063|FG001|Overall Study|Withdrawal by Subject|0|||
162939935|NCT03558997|588483064|FG002|Overall Study|Withdrawal by Subject|1|||
162939936|NCT03558997|588483065|FG003|Overall Study|Withdrawal by Subject|1|||
162939937|NCT03558997|588483062|FG000|Overall Study|Lost to Follow-up|0|||
162939938|NCT03558997|588483063|FG001|Overall Study|Lost to Follow-up|0|||
162939939|NCT03558997|588483064|FG002|Overall Study|Lost to Follow-up|1|||
162939940|NCT03558997|588483065|FG003|Overall Study|Lost to Follow-up|0|||
162939941|NCT04567615|588483075|FG000|Randomization|Participant withdrew consent|1|||
162939942|NCT04567615|588483076|FG001|Randomization|Participant withdrew consent|0|||
162939943|NCT04567615|588483077|FG002|Randomization|Participant withdrew consent|0|||
162939944|NCT04567615|588483075|FG000|Randomization|Adverse event unrelated to study drug|0|||
162939945|NCT04567615|588483076|FG001|Randomization|Adverse event unrelated to study drug|1|||
162939946|NCT04567615|588483077|FG002|Randomization|Adverse event unrelated to study drug|0|||
162939947|NCT04567615|588483075|FG000|Treatment Period|Participant Withdrew Consent|2|||
162939948|NCT04567615|588483076|FG001|Treatment Period|Participant Withdrew Consent|5|||
162939949|NCT04567615|588483077|FG002|Treatment Period|Participant Withdrew Consent|1|||
162939950|NCT04567615|588483075|FG000|Treatment Period|Death|1|||
162939951|NCT04567615|588483076|FG001|Treatment Period|Death|2|||
162939952|NCT04567615|588483077|FG002|Treatment Period|Death|0|||
162939953|NCT04567615|588483075|FG000|Treatment Period|Lost to Follow-up|0|||
162939954|NCT04567615|588483076|FG001|Treatment Period|Lost to Follow-up|1|||
163289510|NCT00383188|589765019|FG002|Overall Study|Lost to Follow-up|0|||
163289511|NCT00383188|589765020|FG003|Overall Study|Lost to Follow-up|0|||
163289512|NCT00383188|589765021|FG004|Overall Study|Lost to Follow-up|1|||
163289513|NCT00554801|589765029|FG000|Overall Study|left area before completion|5|||
163289514|NCT00554801|589765030|FG001|Overall Study|left area before completion|0|||
163289515|NCT00554801|589765029|FG000|Overall Study|Withdrawal by Subject|14|||
163289516|NCT00554801|589765030|FG001|Overall Study|Withdrawal by Subject|0|||
163289517|NCT02104765|589765033|FG000|Overall Study|Lost to Follow-up|0|||
163289518|NCT02104765|589765034|FG001|Overall Study|Lost to Follow-up|0|||
163289519|NCT02104765|589765035|FG002|Overall Study|Lost to Follow-up|1|||
163289520|NCT02104765|589765036|FG003|Overall Study|Lost to Follow-up|0|||
162939955|NCT04567615|588483077|FG002|Treatment Period|Lost to Follow-up|0|||
162939956|NCT04567615|588483075|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
162939957|NCT04567615|588483076|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
163289521|NCT02104765|589765037|FG004|Overall Study|Lost to Follow-up|0|||
162939958|NCT04567615|588483077|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
162939959|NCT04567615|588483075|FG000|Treatment Period|Disease Progression|85|||
162939960|NCT04567615|588483076|FG001|Treatment Period|Disease Progression|63|||
162939961|NCT04567615|588483077|FG002|Treatment Period|Disease Progression|16|||
162939962|NCT04567615|588483075|FG000|Treatment Period|Study Drug Toxicity|3|||
162939963|NCT04567615|588483076|FG001|Treatment Period|Study Drug Toxicity|10|||
163042848|NCT01066871|588863976|FG002|Overall Study|Protocol Violation|3|||
163289522|NCT02104765|589765038|FG005|Overall Study|Lost to Follow-up|0|||
163289523|NCT02104765|589765039|FG006|Overall Study|Lost to Follow-up|0|||
163289524|NCT02104765|589765033|FG000|Overall Study|Withdrawal by Subject|0|||
163289525|NCT02104765|589765034|FG001|Overall Study|Withdrawal by Subject|0|||
163289526|NCT02104765|589765035|FG002|Overall Study|Withdrawal by Subject|0|||
163289527|NCT02104765|589765036|FG003|Overall Study|Withdrawal by Subject|1|||
163289528|NCT02104765|589765037|FG004|Overall Study|Withdrawal by Subject|1|||
163289529|NCT02104765|589765038|FG005|Overall Study|Withdrawal by Subject|0|||
163289530|NCT02104765|589765039|FG006|Overall Study|Withdrawal by Subject|1|||
163289531|NCT04771273|589765040|FG000|Dose Escalation Period|Not treated with trial medication|0|||
163289532|NCT04771273|589765041|FG001|Dose Escalation Period|Not treated with trial medication|1|||
163289533|NCT04771273|589765042|FG002|Dose Escalation Period|Not treated with trial medication|1|||
163289534|NCT04771273|589765043|FG003|Dose Escalation Period|Not treated with trial medication|0|||
163289535|NCT04771273|589765040|FG000|Dose Escalation Period|Other reasons than listed|2|||
163289536|NCT04771273|589765041|FG001|Dose Escalation Period|Other reasons than listed|0|||
163289537|NCT04771273|589765042|FG002|Dose Escalation Period|Other reasons than listed|2|||
163289538|NCT04771273|589765043|FG003|Dose Escalation Period|Other reasons than listed|1|||
163289539|NCT04771273|589765040|FG000|Dose Escalation Period|Protocol Violation|0|||
163289540|NCT04771273|589765041|FG001|Dose Escalation Period|Protocol Violation|0|||
163289541|NCT04771273|589765042|FG002|Dose Escalation Period|Protocol Violation|3|||
163289542|NCT04771273|589765043|FG003|Dose Escalation Period|Protocol Violation|1|||
163289543|NCT04771273|589765040|FG000|Dose Escalation Period|Burden of study procedures|1|||
163289544|NCT04771273|589765041|FG001|Dose Escalation Period|Burden of study procedures|0|||
163289545|NCT04771273|589765042|FG002|Dose Escalation Period|Burden of study procedures|0|||
163289546|NCT04771273|589765043|FG003|Dose Escalation Period|Burden of study procedures|0|||
163289547|NCT04771273|589765040|FG000|Dose Escalation Period|Change of residence|0|||
163289548|NCT04771273|589765041|FG001|Dose Escalation Period|Change of residence|0|||
163289549|NCT04771273|589765042|FG002|Dose Escalation Period|Change of residence|0|||
163289550|NCT04771273|589765043|FG003|Dose Escalation Period|Change of residence|1|||
163289551|NCT04771273|589765040|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
163289552|NCT04771273|589765041|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
163289553|NCT04771273|589765042|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
163289554|NCT04771273|589765043|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
163289555|NCT04771273|589765040|FG000|Dose Escalation Period|Adverse Event|8|||
163289556|NCT04771273|589765041|FG001|Dose Escalation Period|Adverse Event|9|||
163289557|NCT04771273|589765042|FG002|Dose Escalation Period|Adverse Event|12|||
163289558|NCT04771273|589765043|FG003|Dose Escalation Period|Adverse Event|2|||
163289559|NCT04771273|589765040|FG000|Maintenance Period|Other than listed|4|||
163289560|NCT04771273|589765041|FG001|Maintenance Period|Other than listed|2|||
163289561|NCT04771273|589765042|FG002|Maintenance Period|Other than listed|0|||
163289562|NCT04771273|589765043|FG003|Maintenance Period|Other than listed|3|||
163289563|NCT04771273|589765040|FG000|Maintenance Period|Burden of study procedures|1|||
163289564|NCT04771273|589765041|FG001|Maintenance Period|Burden of study procedures|0|||
163289565|NCT04771273|589765042|FG002|Maintenance Period|Burden of study procedures|0|||
163289566|NCT04771273|589765043|FG003|Maintenance Period|Burden of study procedures|0|||
163289567|NCT04771273|589765040|FG000|Maintenance Period|Change of residence|0|||
163289568|NCT04771273|589765041|FG001|Maintenance Period|Change of residence|1|||
163289569|NCT04771273|589765042|FG002|Maintenance Period|Change of residence|3|||
163289570|NCT04771273|589765043|FG003|Maintenance Period|Change of residence|0|||
163289571|NCT04771273|589765040|FG000|Maintenance Period|Perceived lack of efficacy|0|||
163289572|NCT04771273|589765041|FG001|Maintenance Period|Perceived lack of efficacy|0|||
163289573|NCT04771273|589765042|FG002|Maintenance Period|Perceived lack of efficacy|0|||
163289574|NCT04771273|589765043|FG003|Maintenance Period|Perceived lack of efficacy|1|||
163289575|NCT04771273|589765040|FG000|Maintenance Period|Adverse Event|4|||
163289576|NCT04771273|589765041|FG001|Maintenance Period|Adverse Event|5|||
163289577|NCT04771273|589765042|FG002|Maintenance Period|Adverse Event|5|||
163184440|NCT05323656|589391248|FG001|Overall Study|Clinical disease progression|1|||
163184441|NCT05323656|589391247|FG000|Overall Study|Patient and Investigator decision|1|||
163184442|NCT05323656|589391248|FG001|Overall Study|Patient and Investigator decision|0|||
163184443|NCT05323656|589391247|FG000|Overall Study|Physician Decision|0|||
163184444|NCT05323656|589391248|FG001|Overall Study|Physician Decision|1|||
163184445|NCT03880461|589391249|FG000|Overall Study|Determined ineligible after enrollment|45|||
163184446|NCT03880461|589391250|FG001|Overall Study|Determined ineligible after enrollment|44|||
163184447|NCT03880461|589391249|FG000|Overall Study|No weight measurement after enrollment|24|||
163184448|NCT03880461|589391250|FG001|Overall Study|No weight measurement after enrollment|17|||
163184449|NCT03953183|589391252|FG000|Overall Study|Physician Decision|0|||
163184450|NCT03953183|589391253|FG001|Overall Study|Physician Decision|1|||
163184451|NCT03953183|589391252|FG000|Overall Study|Withdrawal by Subject|0|||
163184452|NCT03953183|589391253|FG001|Overall Study|Withdrawal by Subject|1|||
163184453|NCT01115803|589391267|FG000|Overall Study|Withdrawal by Subject|0|||
163184454|NCT01115803|589391268|FG001|Overall Study|Withdrawal by Subject|0|||
163184455|NCT01115803|589391269|FG002|Overall Study|Withdrawal by Subject|0|||
163289578|NCT04771273|589765043|FG003|Maintenance Period|Adverse Event|0|||
163289579|NCT05196737|589765044|FG000|Non-intervention Week|Lost to Follow-up|2|||
163289580|NCT05196737|589765044|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
163289581|NCT02357784|589765045|FG000|Overall Study|Withdrawal by Subject|1|||
163289582|NCT00462943|589765046|FG000|Overall Study|Failure to achieve a response|5|||
163289583|NCT00462943|589765047|FG001|Overall Study|Failure to achieve a response|5|||
163289584|NCT00462943|589765048|FG002|Overall Study|Failure to achieve a response|1|||
163289585|NCT00462943|589765046|FG000|Overall Study|Adverse Event|6|||
163289586|NCT00462943|589765047|FG001|Overall Study|Adverse Event|4|||
163289587|NCT00462943|589765048|FG002|Overall Study|Adverse Event|1|||
163289588|NCT00462943|589765046|FG000|Overall Study|Protocol Violation|1|||
163289589|NCT00462943|589765047|FG001|Overall Study|Protocol Violation|0|||
163289590|NCT00462943|589765048|FG002|Overall Study|Protocol Violation|0|||
163289591|NCT00462943|589765046|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
163289592|NCT00462943|589765047|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
163289593|NCT00462943|589765048|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
163289594|NCT00462943|589765046|FG000|Overall Study|Disease Progression|15|||
163289595|NCT00462943|589765047|FG001|Overall Study|Disease Progression|15|||
163289596|NCT00462943|589765048|FG002|Overall Study|Disease Progression|9|||
163289597|NCT00462943|589765046|FG000|Overall Study|Death|5|||
163289598|NCT00462943|589765047|FG001|Overall Study|Death|2|||
162939964|NCT04567615|588483077|FG002|Treatment Period|Study Drug Toxicity|4|||
162939965|NCT04567615|588483075|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
162939966|NCT04567615|588483076|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
162939967|NCT04567615|588483077|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
162939968|NCT04567615|588483075|FG000|Treatment Period|Other Reasons|1|||
162939969|NCT04567615|588483076|FG001|Treatment Period|Other Reasons|2|||
162939970|NCT04567615|588483077|FG002|Treatment Period|Other Reasons|0|||
162939971|NCT04567615|588483075|FG000|Treatment Period|Still On-going Treatment|21|||
162939972|NCT04567615|588483076|FG001|Treatment Period|Still On-going Treatment|22|||
162939973|NCT04567615|588483077|FG002|Treatment Period|Still On-going Treatment|2|||
162939974|NCT04317053|588483078|FG000|Overall Study|Withdrawn (screen failure)|4|||
162939975|NCT04317053|588483079|FG001|Overall Study|Withdrawn (screen failure)|2|||
162939976|NCT01022112|588483080|FG000|Overall Study|Adverse Event|1|||
162939977|NCT01022112|588483081|FG001|Overall Study|Adverse Event|2|||
162939978|NCT01022112|588483082|FG002|Overall Study|Adverse Event|0|||
162939979|NCT01022112|588483083|FG003|Overall Study|Adverse Event|1|||
162939980|NCT01022112|588483084|FG004|Overall Study|Adverse Event|0|||
162939981|NCT01022112|588483080|FG000|Overall Study|Lack of Efficacy|1|||
162939982|NCT01022112|588483081|FG001|Overall Study|Lack of Efficacy|0|||
162939983|NCT01022112|588483082|FG002|Overall Study|Lack of Efficacy|0|||
162939984|NCT01022112|588483083|FG003|Overall Study|Lack of Efficacy|0|||
162939985|NCT01022112|588483084|FG004|Overall Study|Lack of Efficacy|1|||
162939986|NCT01022112|588483080|FG000|Overall Study|Physician Decision|0|||
162939987|NCT01022112|588483081|FG001|Overall Study|Physician Decision|0|||
162939988|NCT01022112|588483082|FG002|Overall Study|Physician Decision|1|||
162939989|NCT01022112|588483083|FG003|Overall Study|Physician Decision|0|||
162939990|NCT01022112|588483084|FG004|Overall Study|Physician Decision|1|||
162939991|NCT01022112|588483080|FG000|Overall Study|Withdrawal by Subject|0|||
162939992|NCT01022112|588483081|FG001|Overall Study|Withdrawal by Subject|1|||
162939993|NCT01022112|588483082|FG002|Overall Study|Withdrawal by Subject|2|||
162939994|NCT01022112|588483083|FG003|Overall Study|Withdrawal by Subject|2|||
162939995|NCT01022112|588483084|FG004|Overall Study|Withdrawal by Subject|1|||
162939996|NCT01022112|588483080|FG000|Overall Study|Fasting plasma glucose level increased|1|||
162939997|NCT01022112|588483081|FG001|Overall Study|Fasting plasma glucose level increased|0|||
162939998|NCT01022112|588483082|FG002|Overall Study|Fasting plasma glucose level increased|0|||
162939999|NCT01022112|588483083|FG003|Overall Study|Fasting plasma glucose level increased|0|||
162940000|NCT01022112|588483084|FG004|Overall Study|Fasting plasma glucose level increased|7|||
162940001|NCT04680052|588484418|FG000|Overall Study|Ongoing|244|||
162940002|NCT04680052|588484419|FG001|Overall Study|Ongoing|229|||
162940003|NCT04680052|588484420|FG002|Overall Study|Ongoing|39|||
162940004|NCT04680052|588484421|FG003|Overall Study|Ongoing|46|||
162940005|NCT04680052|588484418|FG000|Overall Study|Death|15|||
162940006|NCT04680052|588484419|FG001|Overall Study|Death|22|||
162940007|NCT04680052|588484420|FG002|Overall Study|Death|7|||
162940008|NCT04680052|588484421|FG003|Overall Study|Death|1|||
162940009|NCT04680052|588484418|FG000|Overall Study|Lost to Follow-up|3|||
162940010|NCT04680052|588484419|FG001|Overall Study|Lost to Follow-up|2|||
162940011|NCT04680052|588484420|FG002|Overall Study|Lost to Follow-up|0|||
162940012|NCT04680052|588484421|FG003|Overall Study|Lost to Follow-up|1|||
162940013|NCT04680052|588484418|FG000|Overall Study|Withdrawal by Subject|11|||
162940014|NCT04680052|588484419|FG001|Overall Study|Withdrawal by Subject|19|||
162940015|NCT04680052|588484420|FG002|Overall Study|Withdrawal by Subject|7|||
162940016|NCT04680052|588484421|FG003|Overall Study|Withdrawal by Subject|5|||
162940017|NCT04680052|588484418|FG000|Overall Study|Missing|0|||
162940018|NCT04680052|588484419|FG001|Overall Study|Missing|1|||
162940019|NCT04680052|588484420|FG002|Overall Study|Missing|0|||
162940020|NCT04680052|588484421|FG003|Overall Study|Missing|0|||
162940021|NCT04680052|588484418|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
162940022|NCT04680052|588484419|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
162940023|NCT04680052|588484420|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
162940024|NCT04680052|588484421|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
162940025|NCT04680052|588484418|FG000|Overall Study|Physician Decision|0|||
162940026|NCT04680052|588484419|FG001|Overall Study|Physician Decision|1|||
162940027|NCT04680052|588484420|FG002|Overall Study|Physician Decision|0|||
162940028|NCT04680052|588484421|FG003|Overall Study|Physician Decision|0|||
162940029|NCT00759148|588484423|FG000|Overall Study|Adverse Event|1|||
162940030|NCT00759148|588484424|FG001|Overall Study|Adverse Event|6|||
162940031|NCT00759148|588484423|FG000|Overall Study|Withdrawal by Subject|3|||
162940032|NCT00759148|588484424|FG001|Overall Study|Withdrawal by Subject|7|||
162940033|NCT00759148|588484423|FG000|Overall Study|Lost to Follow-up|3|||
162940034|NCT00759148|588484424|FG001|Overall Study|Lost to Follow-up|9|||
162940035|NCT00759148|588484423|FG000|Overall Study|Treatment Failure|6|||
162940036|NCT00759148|588484424|FG001|Overall Study|Treatment Failure|10|||
162940037|NCT00759148|588484423|FG000|Overall Study|Reason not given|1|||
162940038|NCT00759148|588484424|FG001|Overall Study|Reason not given|0|||
162940039|NCT01073020|588484425|FG000|Overall Study|Withdrawal by Subject|6|||
162940040|NCT01073020|588484426|FG001|Overall Study|Withdrawal by Subject|4|||
162940041|NCT01073020|588484427|FG002|Overall Study|Withdrawal by Subject|1|||
162940042|NCT01073020|588484428|FG003|Overall Study|Withdrawal by Subject|2|||
162940043|NCT01073020|588484425|FG000|Overall Study|Physician Decision|1|||
162940044|NCT01073020|588484426|FG001|Overall Study|Physician Decision|0|||
162940045|NCT01073020|588484427|FG002|Overall Study|Physician Decision|2|||
162940046|NCT01073020|588484428|FG003|Overall Study|Physician Decision|0|||
162940047|NCT01073020|588484425|FG000|Overall Study|Death|0|||
162940048|NCT01073020|588484426|FG001|Overall Study|Death|1|||
162940049|NCT01073020|588484427|FG002|Overall Study|Death|0|||
162940050|NCT01073020|588484428|FG003|Overall Study|Death|0|||
162940051|NCT00094302|588484431|FG000|Overall Study|Lost to Follow-up|43|||
162940052|NCT00094302|588484432|FG001|Overall Study|Lost to Follow-up|41|||
162940053|NCT00094302|588484431|FG000|Overall Study|Physician Decision|5|||
162940054|NCT00094302|588484432|FG001|Overall Study|Physician Decision|8|||
162940055|NCT00094302|588484431|FG000|Overall Study|Withdrawal by Subject|103|||
162940056|NCT00094302|588484432|FG001|Overall Study|Withdrawal by Subject|111|||
162940057|NCT00094302|588484431|FG000|Overall Study|Death|266|||
162940058|NCT00094302|588484432|FG001|Overall Study|Death|246|||
162940059|NCT03329027|588484435|FG000|Overall Study|Lost to Follow-up|1|||
162940060|NCT03329027|588484436|FG001|Overall Study|Lost to Follow-up|0|||
162940061|NCT03329027|588484437|FG002|Overall Study|Lost to Follow-up|1|||
162940062|NCT03329027|588484435|FG000|Overall Study|Protocol Violation|9|||
162940063|NCT03329027|588484436|FG001|Overall Study|Protocol Violation|5|||
162940064|NCT03329027|588484437|FG002|Overall Study|Protocol Violation|7|||
162940065|NCT02761980|588484442|FG000|Overall Study|Adverse Event|4|||
162940066|NCT02761980|588484443|FG001|Overall Study|Adverse Event|6|||
162940067|NCT02761980|588484444|FG002|Overall Study|Adverse Event|5|||
162940068|NCT02761980|588484445|FG003|Overall Study|Adverse Event|6|||
162940069|NCT02761980|588484442|FG000|Overall Study|Withdrawal by Subject|0|||
162940070|NCT02761980|588484443|FG001|Overall Study|Withdrawal by Subject|1|||
162940071|NCT02761980|588484444|FG002|Overall Study|Withdrawal by Subject|0|||
162940072|NCT02761980|588484445|FG003|Overall Study|Withdrawal by Subject|0|||
162940073|NCT02761980|588484442|FG000|Overall Study|Other|0|||
162940074|NCT02761980|588484443|FG001|Overall Study|Other|0|||
162940075|NCT02761980|588484444|FG002|Overall Study|Other|1|||
162940076|NCT02761980|588484445|FG003|Overall Study|Other|0|||
162940077|NCT02848599|588484448|FG000|Overall Study|Protocol Violation|7|||
162940078|NCT02848599|588484449|FG001|Overall Study|Protocol Violation|9|||
162940079|NCT01829464|588484458|FG000|Overall Study|Adverse Event|1|||
162940080|NCT01829464|588484459|FG001|Overall Study|Adverse Event|0|||
162940081|NCT01829464|588484460|FG002|Overall Study|Adverse Event|0|||
162940082|NCT01829464|588484458|FG000|Overall Study|Lost to Follow-up|0|||
162940083|NCT01829464|588484459|FG001|Overall Study|Lost to Follow-up|0|||
162940084|NCT01829464|588484460|FG002|Overall Study|Lost to Follow-up|1|||
162940085|NCT01829464|588484458|FG000|Overall Study|Withdrawal by Subject|2|||
162940086|NCT01829464|588484459|FG001|Overall Study|Withdrawal by Subject|0|||
162940087|NCT01829464|588484460|FG002|Overall Study|Withdrawal by Subject|0|||
162940088|NCT01829464|588484458|FG000|Overall Study|Study terminated by sponsor|25|||
162940089|NCT01829464|588484459|FG001|Overall Study|Study terminated by sponsor|28|||
162940090|NCT01829464|588484460|FG002|Overall Study|Study terminated by sponsor|25|||
162940091|NCT01829464|588484458|FG000|Overall Study|Lack of Efficacy|0|||
162940092|NCT01829464|588484459|FG001|Overall Study|Lack of Efficacy|1|||
162940093|NCT01829464|588484460|FG002|Overall Study|Lack of Efficacy|0|||
162940094|NCT00755326|588484465|FG000|Overall Study|Lost to Follow-up|2|||
162940095|NCT00755326|588484466|FG001|Overall Study|Lost to Follow-up|3|||
162940096|NCT02385526|588484469|FG000|Overall Study|Withdrawal by Subject|0|||
162940097|NCT02385526|588484470|FG001|Overall Study|Withdrawal by Subject|2|||
162940098|NCT02385526|588484471|FG002|Overall Study|Withdrawal by Subject|0|||
162940099|NCT02385526|588484469|FG000|Overall Study|Lost to Follow-up|0|||
162940100|NCT02385526|588484470|FG001|Overall Study|Lost to Follow-up|1|||
162940101|NCT02385526|588484471|FG002|Overall Study|Lost to Follow-up|0|||
162940102|NCT02385526|588484469|FG000|Overall Study|Physician Decision|1|||
162940103|NCT02385526|588484470|FG001|Overall Study|Physician Decision|0|||
162940104|NCT02385526|588484471|FG002|Overall Study|Physician Decision|0|||
162940105|NCT02385526|588484469|FG000|Overall Study|Protocol Violation|1|||
162940106|NCT02385526|588484470|FG001|Overall Study|Protocol Violation|0|||
162940107|NCT02385526|588484471|FG002|Overall Study|Protocol Violation|0|||
162940108|NCT01595009|588484474|FG000|Core|Patients completed per protocol|85|||
162940109|NCT01595009|588484475|FG001|Core|Patients completed per protocol|44|||
162940110|NCT01595009|588484476|FG002|Core|Patients completed per protocol|0|||
162940111|NCT01595009|588484477|FG003|Core|Patients completed per protocol|0|||
162940112|NCT01595009|588484474|FG000|Core|Adverse Event|19|||
162940113|NCT01595009|588484475|FG001|Core|Adverse Event|23|||
162940114|NCT01595009|588484476|FG002|Core|Adverse Event|0|||
162940115|NCT01595009|588484477|FG003|Core|Adverse Event|0|||
162940116|NCT01595009|588484474|FG000|Core|Disease progression|14|||
162940117|NCT01595009|588484475|FG001|Core|Disease progression|26|||
162940118|NCT01595009|588484476|FG002|Core|Disease progression|0|||
162940119|NCT01595009|588484477|FG003|Core|Disease progression|0|||
162940120|NCT01595009|588484474|FG000|Core|Withdrawal by Subject|4|||
162940121|NCT01595009|588484475|FG001|Core|Withdrawal by Subject|17|||
162940122|NCT01595009|588484476|FG002|Core|Withdrawal by Subject|0|||
162940123|NCT01595009|588484477|FG003|Core|Withdrawal by Subject|0|||
162940124|NCT01595009|588484474|FG000|Core|Death|3|||
162940125|NCT01595009|588484475|FG001|Core|Death|6|||
162940126|NCT01595009|588484476|FG002|Core|Death|0|||
162940127|NCT01595009|588484477|FG003|Core|Death|0|||
162940128|NCT01595009|588484474|FG000|Core|Lost to Follow-up|1|||
162940129|NCT01595009|588484475|FG001|Core|Lost to Follow-up|2|||
162940130|NCT01595009|588484476|FG002|Core|Lost to Follow-up|0|||
162940131|NCT01595009|588484477|FG003|Core|Lost to Follow-up|0|||
162940132|NCT01595009|588484474|FG000|Core|Protocol deviation|0|||
162940133|NCT01595009|588484475|FG001|Core|Protocol deviation|1|||
162940134|NCT01595009|588484476|FG002|Core|Protocol deviation|0|||
162940135|NCT01595009|588484477|FG003|Core|Protocol deviation|0|||
162940136|NCT01595009|588484474|FG000|Core|Administrative problems|0|||
162940137|NCT01595009|588484475|FG001|Core|Administrative problems|1|||
162940138|NCT01595009|588484476|FG002|Core|Administrative problems|0|||
162940139|NCT01595009|588484477|FG003|Core|Administrative problems|0|||
162940140|NCT01595009|588484474|FG000|Extension|Administrative problems|0|||
162940141|NCT01595009|588484475|FG001|Extension|Administrative problems|0|||
162940142|NCT01595009|588484476|FG002|Extension|Administrative problems|0|||
162940143|NCT01595009|588484477|FG003|Extension|Administrative problems|1|||
162940144|NCT01595009|588484474|FG000|Extension|Patients completed per protocol|0|||
162940145|NCT01595009|588484475|FG001|Extension|Patients completed per protocol|0|||
162940146|NCT01595009|588484476|FG002|Extension|Patients completed per protocol|0|||
162940147|NCT01595009|588484477|FG003|Extension|Patients completed per protocol|2|||
162940148|NCT01595009|588484474|FG000|Extension|Disease progression|0|||
162940149|NCT01595009|588484475|FG001|Extension|Disease progression|0|||
162940150|NCT01595009|588484476|FG002|Extension|Disease progression|4|||
162940151|NCT01595009|588484477|FG003|Extension|Disease progression|7|||
162940152|NCT01595009|588484474|FG000|Extension|Adverse Event|0|||
162940153|NCT01595009|588484475|FG001|Extension|Adverse Event|0|||
162940154|NCT01595009|588484476|FG002|Extension|Adverse Event|0|||
162940155|NCT01595009|588484477|FG003|Extension|Adverse Event|1|||
162940156|NCT02623829|588484483|FG000|Overall Study|Lost to Follow-up|1|||
162940157|NCT02623829|588484484|FG001|Overall Study|Lost to Follow-up|1|||
162940158|NCT00662025|588484485|FG000|Overall Study|Objective progression or relapse|51|||
162940159|NCT00662025|588484485|FG000|Overall Study|Adverse Event|7|||
162940160|NCT00662025|588484485|FG000|Overall Study|Withdrawal by Subject|1|||
162940161|NCT00662025|588484485|FG000|Overall Study|Results of other clinical study|2|||
162940162|NCT00662025|588484485|FG000|Overall Study|Target lesion cannot be evaluated|1|||
162940163|NCT00662025|588484485|FG000|Overall Study|Domestic circumstances|1|||
162940164|NCT01333033|588484489|FG000|Overall Study|Ineligible|0|||
162940165|NCT01333033|588484490|FG001|Overall Study|Ineligible|0|||
162940166|NCT01333033|588484491|FG002|Overall Study|Ineligible|0|||
162940167|NCT01333033|588484492|FG003|Overall Study|Ineligible|0|||
162940168|NCT01333033|588484493|FG004|Overall Study|Ineligible|6|||
162940169|NCT01333033|588484494|FG005|Overall Study|Ineligible|8|||
162940170|NCT01333033|588484489|FG000|Overall Study|Withdrawal by Subject|0|||
162940171|NCT01333033|588484490|FG001|Overall Study|Withdrawal by Subject|0|||
162940172|NCT01333033|588484491|FG002|Overall Study|Withdrawal by Subject|0|||
162940173|NCT01333033|588484492|FG003|Overall Study|Withdrawal by Subject|0|||
162940174|NCT01333033|588484493|FG004|Overall Study|Withdrawal by Subject|4|||
162940175|NCT01333033|588484494|FG005|Overall Study|Withdrawal by Subject|2|||
162940176|NCT01333033|588484489|FG000|Overall Study|PET inevaluable|0|||
162940177|NCT01333033|588484490|FG001|Overall Study|PET inevaluable|0|||
162940178|NCT01333033|588484491|FG002|Overall Study|PET inevaluable|0|||
162940179|NCT01333033|588484492|FG003|Overall Study|PET inevaluable|0|||
162940180|NCT01333033|588484493|FG004|Overall Study|PET inevaluable|2|||
162940181|NCT01333033|588484494|FG005|Overall Study|PET inevaluable|4|||
162940182|NCT01333033|588484489|FG000|Overall Study|Adverse Event|0|||
162940183|NCT01333033|588484490|FG001|Overall Study|Adverse Event|0|||
162940184|NCT01333033|588484491|FG002|Overall Study|Adverse Event|0|||
162940185|NCT01333033|588484492|FG003|Overall Study|Adverse Event|0|||
162940186|NCT01333033|588484493|FG004|Overall Study|Adverse Event|2|||
162940187|NCT01333033|588484494|FG005|Overall Study|Adverse Event|1|||
162940188|NCT01333033|588484489|FG000|Overall Study|Progression|0|||
162940189|NCT01333033|588484490|FG001|Overall Study|Progression|0|||
162940190|NCT01333033|588484491|FG002|Overall Study|Progression|0|||
162940191|NCT01333033|588484492|FG003|Overall Study|Progression|0|||
162940192|NCT01333033|588484493|FG004|Overall Study|Progression|0|||
162940193|NCT01333033|588484494|FG005|Overall Study|Progression|1|||
163289599|NCT00462943|589765048|FG002|Overall Study|Death|7|||
162940194|NCT01333033|588484489|FG000|Overall Study|MD Decision|0|||
162940195|NCT01333033|588484490|FG001|Overall Study|MD Decision|0|||
162940196|NCT01333033|588484491|FG002|Overall Study|MD Decision|0|||
162940197|NCT01333033|588484492|FG003|Overall Study|MD Decision|0|||
162940198|NCT01333033|588484493|FG004|Overall Study|MD Decision|0|||
162940199|NCT01333033|588484494|FG005|Overall Study|MD Decision|2|||
162940200|NCT01842958|588484496|FG000|Overall Study|Lost to Follow-up|1|||
162940201|NCT01842958|588484497|FG001|Overall Study|Lost to Follow-up|1|||
162940202|NCT01829477|588484498|FG000|Overall Study|Study Terminated by Sponsor|15|||
162940203|NCT01829477|588484499|FG001|Overall Study|Study Terminated by Sponsor|15|||
162940204|NCT01829477|588484498|FG000|Overall Study|Withdrawal by Subject|1|||
162940205|NCT01829477|588484499|FG001|Overall Study|Withdrawal by Subject|0|||
162940206|NCT03465891|588484501|FG000|Overall Study|Withdrawal by Subject|0|||
162940207|NCT03465891|588484502|FG001|Overall Study|Withdrawal by Subject|1|||
162940208|NCT03465891|588484501|FG000|Overall Study|Disease progression|1|||
162940209|NCT03465891|588484502|FG001|Overall Study|Disease progression|0|||
162940210|NCT02737306|588484503|FG000|Overall Study|Adverse Event|3|||
162940211|NCT02737306|588484504|FG001|Overall Study|Adverse Event|0|||
162940212|NCT02737306|588484503|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
162940213|NCT02737306|588484504|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
162940214|NCT03361423|588484505|FG000|Overall Study|Withdrawal by Subject|4|||
162940215|NCT03361423|588484506|FG001|Overall Study|Withdrawal by Subject|3|||
162940216|NCT03361423|588484505|FG000|Overall Study|Did not treat|19|||
162940217|NCT03361423|588484506|FG001|Overall Study|Did not treat|18|||
162940218|NCT03361423|588484505|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
163289600|NCT00462943|589765046|FG000|Overall Study|Stem Cell Transplant|1|||
163289601|NCT00462943|589765047|FG001|Overall Study|Stem Cell Transplant|1|||
163289602|NCT00462943|589765048|FG002|Overall Study|Stem Cell Transplant|0|||
163289603|NCT00462943|589765046|FG000|Overall Study|Bone Marrow Transplant|1|||
163289604|NCT00462943|589765047|FG001|Overall Study|Bone Marrow Transplant|0|||
163289605|NCT00462943|589765048|FG002|Overall Study|Bone Marrow Transplant|0|||
163289606|NCT00462943|589765046|FG000|Overall Study|Required Lymphocyte Infusion|1|||
163289607|NCT00462943|589765047|FG001|Overall Study|Required Lymphocyte Infusion|0|||
163289608|NCT00462943|589765048|FG002|Overall Study|Required Lymphocyte Infusion|0|||
163289609|NCT00462943|589765046|FG000|Overall Study|Transplant - not specified|1|||
163289610|NCT00462943|589765047|FG001|Overall Study|Transplant - not specified|0|||
163289611|NCT00462943|589765048|FG002|Overall Study|Transplant - not specified|1|||
163289612|NCT00462943|589765046|FG000|Overall Study|Physician Decision|1|||
163289613|NCT00462943|589765047|FG001|Overall Study|Physician Decision|0|||
163289614|NCT00462943|589765048|FG002|Overall Study|Physician Decision|0|||
163289615|NCT00462943|589765046|FG000|Overall Study|Withdrawal by Subject|0|||
163289616|NCT00462943|589765047|FG001|Overall Study|Withdrawal by Subject|1|||
163289617|NCT00462943|589765048|FG002|Overall Study|Withdrawal by Subject|0|||
163289618|NCT02698241|589765049|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
163289619|NCT02698241|589765049|FG000|Overall Study|Screening not met|7|||
163289620|NCT02698241|589765049|FG000|Overall Study|Withdrawal by Subject|7|||
163289621|NCT02698241|589765049|FG000|Overall Study|Physician Decision|2|||
163289622|NCT02698241|589765049|FG000|Overall Study|Subject underwent system modification|2|||
163289623|NCT02698241|589765049|FG000|Overall Study|Lost to Follow-up|3|||
163289624|NCT02698241|589765049|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
163289625|NCT02698241|589765049|FG000|Overall Study|geographic and licensing issue|1|||
163289626|NCT02698241|589765049|FG000|Overall Study|Death|2|||
163289627|NCT01144182|589765052|FG000|Overall Study|Death|5|||
163289628|NCT01144182|589765053|FG001|Overall Study|Death|6|||
163289629|NCT01144182|589765052|FG000|Overall Study|Withdrawal by Subject|3|||
163289630|NCT01144182|589765053|FG001|Overall Study|Withdrawal by Subject|6|||
163289631|NCT01144182|589765052|FG000|Overall Study|Lost to Follow-up|9|||
163289632|NCT01144182|589765053|FG001|Overall Study|Lost to Follow-up|9|||
163289633|NCT01751724|589765061|FG000|Overall Study|extubated bef.start assigned treatment|1|||
163289634|NCT01751724|589765062|FG001|Overall Study|extubated bef.start assigned treatment|0|||
163289635|NCT01751724|589765061|FG000|Overall Study|withdrawn by parent|0|||
163289636|NCT01751724|589765062|FG001|Overall Study|withdrawn by parent|2|||
163289637|NCT02685033|589765065|FG000|Overall Study|Withdrawal of Consent|0|||
163289638|NCT02685033|589765066|FG001|Overall Study|Withdrawal of Consent|1|||
163289639|NCT02685033|589765065|FG000|Overall Study|Lost to Follow-up|2|||
163289640|NCT02685033|589765066|FG001|Overall Study|Lost to Follow-up|1|||
163289641|NCT02685033|589765065|FG000|Overall Study|Adverse Event|1|||
163289642|NCT02685033|589765066|FG001|Overall Study|Adverse Event|0|||
163289643|NCT00603447|589765067|FG000|Overall Study|Adverse Event|0|||
163289644|NCT00603447|589765068|FG001|Overall Study|Adverse Event|1|||
163289645|NCT00603447|589765069|FG002|Overall Study|Adverse Event|1|||
163289646|NCT00603447|589765070|FG003|Overall Study|Adverse Event|2|||
163289647|NCT00603447|589765071|FG004|Overall Study|Adverse Event|1|||
163289648|NCT00603447|589765072|FG005|Overall Study|Adverse Event|2|||
163289649|NCT00603447|589765073|FG006|Overall Study|Adverse Event|10|||
163289650|NCT00603447|589765067|FG000|Overall Study|Other|0|||
163289651|NCT00603447|589765068|FG001|Overall Study|Other|0|||
163289652|NCT00603447|589765069|FG002|Overall Study|Other|1|||
163289653|NCT00603447|589765070|FG003|Overall Study|Other|0|||
163289654|NCT00603447|589765071|FG004|Overall Study|Other|3|||
162940219|NCT03361423|588484506|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
162940220|NCT03361423|588484505|FG000|Overall Study|Missing data|4|||
163289655|NCT00603447|589765072|FG005|Overall Study|Other|0|||
163289656|NCT00603447|589765073|FG006|Overall Study|Other|13|||
163289657|NCT00603447|589765067|FG000|Overall Study|Withdrew Consent|0|||
163289658|NCT00603447|589765068|FG001|Overall Study|Withdrew Consent|2|||
163289659|NCT00603447|589765069|FG002|Overall Study|Withdrew Consent|0|||
162940221|NCT03361423|588484506|FG001|Overall Study|Missing data|1|||
162940222|NCT00818623|588484507|FG000|Overall Study|Adverse Event|1|||
162940223|NCT00818623|588484508|FG001|Overall Study|Adverse Event|0|||
162940224|NCT00818623|588484509|FG002|Overall Study|Adverse Event|1|||
162940225|NCT00818623|588484510|FG003|Overall Study|Adverse Event|0|||
162940226|NCT00818623|588484511|FG004|Overall Study|Adverse Event|0|||
162940227|NCT00818623|588484512|FG005|Overall Study|Adverse Event|1|||
162940228|NCT00818623|588484513|FG006|Overall Study|Adverse Event|0|||
162940229|NCT00818623|588484514|FG007|Overall Study|Adverse Event|0|||
162940230|NCT00818623|588484507|FG000|Overall Study|Bad prostate specific antigen response|0|||
162940231|NCT00818623|588484508|FG001|Overall Study|Bad prostate specific antigen response|3|||
162940232|NCT00818623|588484509|FG002|Overall Study|Bad prostate specific antigen response|2|||
162940233|NCT00818623|588484510|FG003|Overall Study|Bad prostate specific antigen response|5|||
162940234|NCT00818623|588484511|FG004|Overall Study|Bad prostate specific antigen response|0|||
162940235|NCT00818623|588484512|FG005|Overall Study|Bad prostate specific antigen response|1|||
162940236|NCT00818623|588484513|FG006|Overall Study|Bad prostate specific antigen response|0|||
162940237|NCT00818623|588484514|FG007|Overall Study|Bad prostate specific antigen response|0|||
162940238|NCT00818623|588484507|FG000|Overall Study|Withdrawal by Subject|0|||
162940239|NCT00818623|588484508|FG001|Overall Study|Withdrawal by Subject|1|||
162940240|NCT00818623|588484509|FG002|Overall Study|Withdrawal by Subject|1|||
162940241|NCT00818623|588484510|FG003|Overall Study|Withdrawal by Subject|0|||
162940242|NCT00818623|588484511|FG004|Overall Study|Withdrawal by Subject|0|||
162940243|NCT00818623|588484512|FG005|Overall Study|Withdrawal by Subject|1|||
162940244|NCT00818623|588484513|FG006|Overall Study|Withdrawal by Subject|1|||
162940245|NCT00818623|588484514|FG007|Overall Study|Withdrawal by Subject|1|||
162940246|NCT00818623|588484507|FG000|Overall Study|Protocol Violation|1|||
162940247|NCT00818623|588484508|FG001|Overall Study|Protocol Violation|0|||
162940248|NCT00818623|588484509|FG002|Overall Study|Protocol Violation|0|||
162940249|NCT00818623|588484510|FG003|Overall Study|Protocol Violation|0|||
162940250|NCT00818623|588484511|FG004|Overall Study|Protocol Violation|1|||
162940251|NCT00818623|588484512|FG005|Overall Study|Protocol Violation|0|||
162940252|NCT00818623|588484513|FG006|Overall Study|Protocol Violation|1|||
162940253|NCT00818623|588484514|FG007|Overall Study|Protocol Violation|0|||
162940254|NCT00818623|588484507|FG000|Overall Study|Need of additional treatment|0|||
162940255|NCT00818623|588484508|FG001|Overall Study|Need of additional treatment|0|||
162940256|NCT00818623|588484509|FG002|Overall Study|Need of additional treatment|0|||
162940257|NCT00818623|588484510|FG003|Overall Study|Need of additional treatment|0|||
162940258|NCT00818623|588484511|FG004|Overall Study|Need of additional treatment|1|||
162940259|NCT00818623|588484512|FG005|Overall Study|Need of additional treatment|0|||
162940260|NCT00818623|588484513|FG006|Overall Study|Need of additional treatment|0|||
162940261|NCT00818623|588484514|FG007|Overall Study|Need of additional treatment|0|||
162940262|NCT00818623|588484507|FG000|Overall Study|Lack of trial drug at site|0|||
162940263|NCT00818623|588484508|FG001|Overall Study|Lack of trial drug at site|0|||
162940264|NCT00818623|588484509|FG002|Overall Study|Lack of trial drug at site|0|||
162940265|NCT00818623|588484510|FG003|Overall Study|Lack of trial drug at site|0|||
162940266|NCT00818623|588484511|FG004|Overall Study|Lack of trial drug at site|2|||
162940267|NCT00818623|588484512|FG005|Overall Study|Lack of trial drug at site|0|||
162940268|NCT00818623|588484513|FG006|Overall Study|Lack of trial drug at site|1|||
162940269|NCT00818623|588484514|FG007|Overall Study|Lack of trial drug at site|0|||
162940270|NCT00818623|588484507|FG000|Overall Study|Disease progression|0|||
162940271|NCT00818623|588484508|FG001|Overall Study|Disease progression|0|||
162940272|NCT00818623|588484509|FG002|Overall Study|Disease progression|0|||
162940273|NCT00818623|588484510|FG003|Overall Study|Disease progression|0|||
162940274|NCT00818623|588484511|FG004|Overall Study|Disease progression|0|||
162940275|NCT00818623|588484512|FG005|Overall Study|Disease progression|0|||
162940276|NCT00818623|588484513|FG006|Overall Study|Disease progression|1|||
162940277|NCT00818623|588484514|FG007|Overall Study|Disease progression|0|||
162940278|NCT00299156|588484515|FG000|Period 2 (Randomized)|Screen Failure|0|||
162940279|NCT00299156|588484516|FG001|Period 2 (Randomized)|Screen Failure|1|||
162940280|NCT00299156|588484517|FG002|Period 2 (Randomized)|Screen Failure|0|||
162940281|NCT01166568|588484518|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
162940282|NCT01166568|588484519|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
162940283|NCT01166568|588484520|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
163184456|NCT01115803|589391270|FG003|Overall Study|Withdrawal by Subject|0|||
163184457|NCT01115803|589391271|FG004|Overall Study|Withdrawal by Subject|0|||
163184458|NCT01115803|589391272|FG005|Overall Study|Withdrawal by Subject|0|||
163184459|NCT01115803|589391273|FG006|Overall Study|Withdrawal by Subject|1|||
163184460|NCT01115803|589391267|FG000|Overall Study|Lost to Follow-up|0|||
162940284|NCT01166568|588484518|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
162940285|NCT01166568|588484519|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
162940286|NCT01166568|588484520|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
162940287|NCT01166568|588484518|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
163184461|NCT01115803|589391268|FG001|Overall Study|Lost to Follow-up|0|||
163184462|NCT01115803|589391269|FG002|Overall Study|Lost to Follow-up|1|||
162940288|NCT01166568|588484519|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
162940289|NCT01166568|588484520|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
162940290|NCT00903383|588484521|FG000|Overall Study|Adverse Event|1|||
162940291|NCT00903383|588484522|FG001|Overall Study|Adverse Event|2|||
162940292|NCT00903383|588484523|FG002|Overall Study|Adverse Event|3|||
162940293|NCT00903383|588484524|FG003|Overall Study|Adverse Event|1|||
162940294|NCT00903383|588484521|FG000|Overall Study|Physician Decision|1|||
162940295|NCT00903383|588484522|FG001|Overall Study|Physician Decision|2|||
162940296|NCT00903383|588484523|FG002|Overall Study|Physician Decision|0|||
162940297|NCT00903383|588484524|FG003|Overall Study|Physician Decision|0|||
162940298|NCT00903383|588484521|FG000|Overall Study|Lost to Follow-up|0|||
162940299|NCT00903383|588484522|FG001|Overall Study|Lost to Follow-up|0|||
162940300|NCT00903383|588484523|FG002|Overall Study|Lost to Follow-up|0|||
162940301|NCT00903383|588484524|FG003|Overall Study|Lost to Follow-up|1|||
162940302|NCT00903383|588484521|FG000|Overall Study|Decision of Sponsor|1|||
162940303|NCT00903383|588484522|FG001|Overall Study|Decision of Sponsor|0|||
162940304|NCT00903383|588484523|FG002|Overall Study|Decision of Sponsor|0|||
162940305|NCT00903383|588484524|FG003|Overall Study|Decision of Sponsor|0|||
162940306|NCT00903383|588484521|FG000|Overall Study|Withdrawal by Subject|4|||
162940307|NCT00903383|588484522|FG001|Overall Study|Withdrawal by Subject|1|||
162940308|NCT00903383|588484523|FG002|Overall Study|Withdrawal by Subject|0|||
162940309|NCT00903383|588484524|FG003|Overall Study|Withdrawal by Subject|2|||
162940310|NCT00903383|588484521|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
162940311|NCT00903383|588484522|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
162940312|NCT00903383|588484523|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
162940313|NCT00903383|588484524|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
162940314|NCT00903383|588484521|FG000|Overall Study|Patient Decision|0|||
162940315|NCT00903383|588484522|FG001|Overall Study|Patient Decision|0|||
162940316|NCT00903383|588484523|FG002|Overall Study|Patient Decision|0|||
162940317|NCT00903383|588484524|FG003|Overall Study|Patient Decision|1|||
162940318|NCT02015793|588484532|FG000|Overall Study|Adverse Event|3|||
162940319|NCT02015793|588484533|FG001|Overall Study|Adverse Event|3|||
162940320|NCT02015793|588484532|FG000|Overall Study|Withdrawal by Subject|1|||
162940321|NCT02015793|588484533|FG001|Overall Study|Withdrawal by Subject|1|||
162940322|NCT00320593|588484534|FG000|Overall Study|Lost to Follow-up|3|||
162940323|NCT00320593|588484535|FG001|Overall Study|Lost to Follow-up|0|||
162940324|NCT00320593|588484534|FG000|Overall Study|Moved to another state|1|||
162940325|NCT00320593|588484535|FG001|Overall Study|Moved to another state|0|||
162940326|NCT00320593|588484534|FG000|Overall Study|Withdrawal by Subject|2|||
162940327|NCT00320593|588484535|FG001|Overall Study|Withdrawal by Subject|1|||
162940328|NCT00320593|588484534|FG000|Overall Study|Withdrawal by clinical center|1|||
162940329|NCT00320593|588484535|FG001|Overall Study|Withdrawal by clinical center|0|||
162940330|NCT01076166|588484536|FG000|Overall Study|Adverse Event|3|||
162940331|NCT01076166|588484536|FG000|Overall Study|Symptoms improved/resolved|6|||
162940332|NCT02087059|588484537|FG000|Overall Study|Disease Progression|1|||
162940333|NCT02087059|588484537|FG000|Overall Study|Adverse Event|5|||
162940334|NCT02087059|588484537|FG000|Overall Study|Lost to Follow-up|1|||
162940335|NCT01851590|588484538|FG000|Overall Study|Withdrawal by Subject|0|||
162940336|NCT01851590|588484539|FG001|Overall Study|Withdrawal by Subject|0|||
162940337|NCT01851590|588484540|FG002|Overall Study|Withdrawal by Subject|1|||
162940338|NCT01851590|588484538|FG000|Overall Study|Adverse Event|0|||
162940339|NCT01851590|588484539|FG001|Overall Study|Adverse Event|0|||
162940340|NCT01851590|588484540|FG002|Overall Study|Adverse Event|2|||
162940341|NCT01851590|588484538|FG000|Overall Study|Lack of Efficacy|0|||
162940342|NCT01851590|588484539|FG001|Overall Study|Lack of Efficacy|1|||
162940343|NCT01851590|588484540|FG002|Overall Study|Lack of Efficacy|0|||
162940344|NCT00321711|588484543|FG000|Part A|Adverse Event|3|||
162940345|NCT00321711|588484544|FG001|Part A|Adverse Event|3|||
162940346|NCT00321711|588484545|FG002|Part A|Adverse Event|2|||
162940347|NCT00321711|588484546|FG003|Part A|Adverse Event|0|||
162940348|NCT00321711|588484547|FG004|Part A|Adverse Event|0|||
162940349|NCT00321711|588484543|FG000|Part A|Withdrawal by Subject|1|||
162940350|NCT00321711|588484544|FG001|Part A|Withdrawal by Subject|1|||
162940351|NCT00321711|588484545|FG002|Part A|Withdrawal by Subject|1|||
162940352|NCT00321711|588484546|FG003|Part A|Withdrawal by Subject|0|||
162940353|NCT00321711|588484547|FG004|Part A|Withdrawal by Subject|0|||
162940354|NCT00321711|588484543|FG000|Part A|Disease progression|0|||
162940355|NCT00321711|588484544|FG001|Part A|Disease progression|1|||
162940356|NCT00321711|588484545|FG002|Part A|Disease progression|0|||
162940357|NCT00321711|588484546|FG003|Part A|Disease progression|0|||
162940358|NCT00321711|588484547|FG004|Part A|Disease progression|0|||
162940359|NCT00321711|588484543|FG000|Part A|Requirement for alternative therapy|0|||
162940360|NCT00321711|588484544|FG001|Part A|Requirement for alternative therapy|2|||
163289660|NCT00603447|589765070|FG003|Overall Study|Withdrew Consent|0|||
162940361|NCT00321711|588484545|FG002|Part A|Requirement for alternative therapy|1|||
162940362|NCT00321711|588484546|FG003|Part A|Requirement for alternative therapy|0|||
162940363|NCT00321711|588484547|FG004|Part A|Requirement for alternative therapy|0|||
162940364|NCT00321711|588484543|FG000|Part A|Physician Decision|0|||
163184463|NCT01115803|589391270|FG003|Overall Study|Lost to Follow-up|0|||
163184464|NCT01115803|589391271|FG004|Overall Study|Lost to Follow-up|0|||
163184465|NCT01115803|589391272|FG005|Overall Study|Lost to Follow-up|0|||
163184466|NCT01115803|589391273|FG006|Overall Study|Lost to Follow-up|0|||
163184467|NCT01115803|589391267|FG000|Overall Study|Progressive Disease during Cycle1|0|||
163184468|NCT01115803|589391268|FG001|Overall Study|Progressive Disease during Cycle1|0|||
163184469|NCT01115803|589391269|FG002|Overall Study|Progressive Disease during Cycle1|0|||
163184470|NCT01115803|589391270|FG003|Overall Study|Progressive Disease during Cycle1|0|||
163184471|NCT01115803|589391271|FG004|Overall Study|Progressive Disease during Cycle1|0|||
162940365|NCT00321711|588484544|FG001|Part A|Physician Decision|1|||
162940366|NCT00321711|588484545|FG002|Part A|Physician Decision|3|||
162940367|NCT00321711|588484546|FG003|Part A|Physician Decision|0|||
162940368|NCT00321711|588484547|FG004|Part A|Physician Decision|0|||
162940369|NCT00321711|588484543|FG000|Part A|Other|1|||
162940370|NCT00321711|588484544|FG001|Part A|Other|2|||
162940371|NCT00321711|588484545|FG002|Part A|Other|3|||
162940372|NCT00321711|588484546|FG003|Part A|Other|0|||
162940373|NCT00321711|588484547|FG004|Part A|Other|0|||
162940374|NCT00321711|588484543|FG000|Part A|Protocol deviation|0|||
162940375|NCT00321711|588484544|FG001|Part A|Protocol deviation|0|||
162940376|NCT00321711|588484545|FG002|Part A|Protocol deviation|1|||
162940377|NCT00321711|588484546|FG003|Part A|Protocol deviation|0|||
162940378|NCT00321711|588484547|FG004|Part A|Protocol deviation|0|||
162940379|NCT00321711|588484543|FG000|Part B|Noncompliance|0|||
162940380|NCT00321711|588484544|FG001|Part B|Noncompliance|0|||
162940381|NCT00321711|588484545|FG002|Part B|Noncompliance|0|||
163184472|NCT01115803|589391272|FG005|Overall Study|Progressive Disease during Cycle1|0|||
163184473|NCT01115803|589391273|FG006|Overall Study|Progressive Disease during Cycle1|1|||
163184474|NCT03063203|589391274|FG000|Overall Study|Chose alternative therapy|3|||
163184475|NCT03063203|589391274|FG000|Overall Study|Death|2|||
163184476|NCT03063203|589391274|FG000|Overall Study|Disease progression|4|||
163184477|NCT03063203|589391274|FG000|Overall Study|Physician Decision|5|||
163184478|NCT02273739|589391275|FG000|Overall Study|Progression of Disease|3|||
163184479|NCT02273739|589391276|FG001|Overall Study|Progression of Disease|4|||
163184480|NCT02273739|589391277|FG002|Overall Study|Progression of Disease|5|||
163184481|NCT02273739|589391278|FG003|Overall Study|Progression of Disease|2|||
163184482|NCT02273739|589391275|FG000|Overall Study|Death|0|||
163184483|NCT02273739|589391276|FG001|Overall Study|Death|0|||
163184484|NCT02273739|589391277|FG002|Overall Study|Death|0|||
163184485|NCT02273739|589391278|FG003|Overall Study|Death|2|||
163184486|NCT02273739|589391275|FG000|Overall Study|Adverse Event|0|||
163184487|NCT02273739|589391276|FG001|Overall Study|Adverse Event|0|||
163184488|NCT02273739|589391277|FG002|Overall Study|Adverse Event|0|||
163184489|NCT02273739|589391278|FG003|Overall Study|Adverse Event|1|||
163184490|NCT02273739|589391275|FG000|Overall Study|Withdrawal by Subject|0|||
163184491|NCT02273739|589391276|FG001|Overall Study|Withdrawal by Subject|0|||
163184492|NCT02273739|589391277|FG002|Overall Study|Withdrawal by Subject|2|||
163184493|NCT02273739|589391278|FG003|Overall Study|Withdrawal by Subject|1|||
163184494|NCT02273739|589391275|FG000|Overall Study|Physician Decision|0|||
163184495|NCT02273739|589391276|FG001|Overall Study|Physician Decision|0|||
163184496|NCT02273739|589391277|FG002|Overall Study|Physician Decision|0|||
163184497|NCT02273739|589391278|FG003|Overall Study|Physician Decision|1|||
163184498|NCT04718103|589391279|FG000|Overall Study|Adverse Event|1|||
163184499|NCT04718103|589391280|FG001|Overall Study|Adverse Event|1|||
163184500|NCT04718103|589391279|FG000|Overall Study|Lack of Efficacy|4|||
163184501|NCT04718103|589391280|FG001|Overall Study|Lack of Efficacy|1|||
163184502|NCT04718103|589391279|FG000|Overall Study|Lost to Follow-up|2|||
163184503|NCT04718103|589391280|FG001|Overall Study|Lost to Follow-up|2|||
163184504|NCT04718103|589391279|FG000|Overall Study|Physician Decision|2|||
163289661|NCT00603447|589765071|FG004|Overall Study|Withdrew Consent|1|||
163184505|NCT04718103|589391280|FG001|Overall Study|Physician Decision|0|||
163184506|NCT04718103|589391279|FG000|Overall Study|Pregnancy|0|||
163184507|NCT04718103|589391280|FG001|Overall Study|Pregnancy|1|||
163184508|NCT04718103|589391279|FG000|Overall Study|Withdrawal by Subject|10|||
163184509|NCT04718103|589391280|FG001|Overall Study|Withdrawal by Subject|6|||
163184510|NCT04718103|589391279|FG000|Overall Study|Randomized, not treated|4|||
163184511|NCT04718103|589391280|FG001|Overall Study|Randomized, not treated|1|||
163289662|NCT00603447|589765072|FG005|Overall Study|Withdrew Consent|0|||
162940382|NCT00321711|588484546|FG003|Part B|Noncompliance|0|||
162940383|NCT00321711|588484547|FG004|Part B|Noncompliance|1|||
162940384|NCT00321711|588484543|FG000|Part B|Adverse Event|0|||
162940385|NCT00321711|588484544|FG001|Part B|Adverse Event|0|||
162940386|NCT00321711|588484545|FG002|Part B|Adverse Event|0|||
162940387|NCT00321711|588484546|FG003|Part B|Adverse Event|2|||
162940388|NCT00321711|588484547|FG004|Part B|Adverse Event|1|||
163184512|NCT04718103|589391279|FG000|Overall Study|GCP violations|7|||
163184513|NCT04718103|589391280|FG001|Overall Study|GCP violations|5|||
163184514|NCT02280473|589391282|FG000|Overall Study|Adverse Event|1|||
163184515|NCT02280473|589391283|FG001|Overall Study|Adverse Event|1|||
163184516|NCT02280473|589391282|FG000|Overall Study|Lack of Efficacy|0|||
163184517|NCT02280473|589391283|FG001|Overall Study|Lack of Efficacy|1|||
163184518|NCT02280473|589391282|FG000|Overall Study|Lost to Follow-up|0|||
163289663|NCT00603447|589765073|FG006|Overall Study|Withdrew Consent|1|||
163289664|NCT00798265|589765074|FG000|Overall Study|Lost to Follow-up|1|||
163289665|NCT00798265|589765075|FG001|Overall Study|Lost to Follow-up|10|||
163289666|NCT00798265|589765074|FG000|Overall Study|Study closing|7|||
163289667|NCT00798265|589765075|FG001|Overall Study|Study closing|6|||
163289668|NCT00798265|589765074|FG000|Overall Study|Withdrawal by Subject|0|||
163289669|NCT00798265|589765075|FG001|Overall Study|Withdrawal by Subject|1|||
163289670|NCT00798265|589765074|FG000|Overall Study|Screen failure|0|||
163289671|NCT00798265|589765075|FG001|Overall Study|Screen failure|1|||
163289672|NCT00589667|589766328|FG000|Overall Study|Adverse Event|2|||
163289673|NCT00589667|589766328|FG000|Overall Study|Withdrawal by Subject|1|||
163289674|NCT03538041|589766331|FG000|12-Week Treatment Period|Adverse Event|1|||
163289675|NCT03538041|589766332|FG001|12-Week Treatment Period|Adverse Event|1|||
163289676|NCT03538041|589766331|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
163289677|NCT03538041|589766332|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
163289678|NCT03538041|589766331|FG000|Treatment Extension Period|Adverse Event|4|||
163289679|NCT03538041|589766332|FG001|Treatment Extension Period|Adverse Event|1|||
163289680|NCT03538041|589766331|FG000|Treatment Extension Period|Physician Decision|1|||
163289681|NCT03538041|589766332|FG001|Treatment Extension Period|Physician Decision|1|||
163289682|NCT03538041|589766331|FG000|Treatment Extension Period|Lack of Efficacy|1|||
163289683|NCT03538041|589766332|FG001|Treatment Extension Period|Lack of Efficacy|4|||
163289684|NCT03538041|589766331|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
163289685|NCT03538041|589766332|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
163289686|NCT03538041|589766331|FG000|Treatment Extension Period|Death|0|||
163289687|NCT03538041|589766332|FG001|Treatment Extension Period|Death|1|||
163289688|NCT00094809|589766333|FG000|Overall Study|Protocol deviation|2|||
163289689|NCT00094809|589766334|FG001|Overall Study|Protocol deviation|2|||
163289690|NCT00094809|589766333|FG000|Overall Study|Noncompliance|1|||
163289691|NCT00094809|589766334|FG001|Overall Study|Noncompliance|0|||
163289692|NCT00094809|589766333|FG000|Overall Study|Adverse Event|3|||
163289693|NCT00094809|589766334|FG001|Overall Study|Adverse Event|1|||
163289694|NCT00094809|589766333|FG000|Overall Study|Withdrawal by Subject|8|||
163289695|NCT00094809|589766334|FG001|Overall Study|Withdrawal by Subject|9|||
163289696|NCT00094809|589766333|FG000|Overall Study|Disease progression|3|||
163289697|NCT00094809|589766334|FG001|Overall Study|Disease progression|3|||
163289698|NCT00094809|589766333|FG000|Overall Study|Physician Decision|3|||
163289699|NCT00094809|589766334|FG001|Overall Study|Physician Decision|5|||
163289700|NCT00094809|589766333|FG000|Overall Study|Lost to Follow-up|6|||
163289701|NCT00094809|589766334|FG001|Overall Study|Lost to Follow-up|6|||
163289702|NCT00094809|589766333|FG000|Overall Study|Death|19|||
163289703|NCT00094809|589766334|FG001|Overall Study|Death|25|||
163289704|NCT00094809|589766333|FG000|Overall Study|Protocol-specified criteria|1|||
163289705|NCT00094809|589766334|FG001|Overall Study|Protocol-specified criteria|1|||
163289706|NCT00094809|589766333|FG000|Overall Study|Other|2|||
163289707|NCT00094809|589766334|FG001|Overall Study|Other|4|||
163289708|NCT00094809|589766333|FG000|Overall Study|Informed consent signed after treatment|1|||
163289709|NCT00094809|589766334|FG001|Overall Study|Informed consent signed after treatment|0|||
163289710|NCT00094809|589766333|FG000|Overall Study|Study drug not received|2|||
163289711|NCT00094809|589766334|FG001|Overall Study|Study drug not received|8|||
163289712|NCT00094809|589766333|FG000|Overall Study|Other|1|||
163289713|NCT00094809|589766334|FG001|Overall Study|Other|1|||
163289714|NCT04889664|589766335|FG000|Screen|Lost to Follow-up|1|||
163289715|NCT04889664|589766335|FG000|Screen|Failed to meet screening criteria|1|||
163289716|NCT04889664|589766335|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
163289717|NCT02469064|589766341|FG000|Overall Study|Request not to receive intervention.|1|||
163289718|NCT02469064|589766342|FG001|Overall Study|Request not to receive intervention.|3|||
163289719|NCT00964366|589766355|FG000|Overall Study|Did not qualify at Day 1|1|||
163289720|NCT00964366|589766356|FG001|Overall Study|Did not qualify at Day 1|0|||
163289721|NCT00964366|589766355|FG000|Overall Study|Withdrawal by Subject|0|||
163289722|NCT00964366|589766356|FG001|Overall Study|Withdrawal by Subject|1|||
163289723|NCT02046616|589766358|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
163289724|NCT02046616|589766358|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
163289725|NCT02046616|589766358|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
163289726|NCT02046616|589766358|FG000|24-Week Treatment Period|Physician Decision|3|||
163289727|NCT02046616|589766358|FG000|24-Week Treatment Period|Other|1|||
163289728|NCT02046616|589766358|FG000|8-Week FU Period|Lost to Follow-up|1|||
162940389|NCT00321711|588484543|FG000|Part B|Disease progression|0|||
162940390|NCT00321711|588484544|FG001|Part B|Disease progression|0|||
162940391|NCT00321711|588484545|FG002|Part B|Disease progression|0|||
162940392|NCT00321711|588484546|FG003|Part B|Disease progression|1|||
162940393|NCT00321711|588484547|FG004|Part B|Disease progression|0|||
162940394|NCT00321711|588484543|FG000|Part B|Physician Decision|0|||
162940395|NCT00321711|588484544|FG001|Part B|Physician Decision|0|||
162940396|NCT00321711|588484545|FG002|Part B|Physician Decision|0|||
162940397|NCT00321711|588484546|FG003|Part B|Physician Decision|1|||
162940398|NCT00321711|588484547|FG004|Part B|Physician Decision|2|||
162940399|NCT00321711|588484543|FG000|Part B|Death|0|||
162940400|NCT00321711|588484544|FG001|Part B|Death|0|||
162940401|NCT00321711|588484545|FG002|Part B|Death|0|||
162940402|NCT00321711|588484546|FG003|Part B|Death|2|||
162940403|NCT00321711|588484547|FG004|Part B|Death|1|||
162940404|NCT01211769|588484553|FG000|Overall Study|Lost to Follow-up|7|||
162940405|NCT01211769|588484554|FG001|Overall Study|Lost to Follow-up|9|||
163184519|NCT02280473|589391283|FG001|Overall Study|Lost to Follow-up|1|||
163184520|NCT02393690|589391284|FG000|Overall Study|Ineligible|0|||
163184521|NCT02393690|589391285|FG001|Overall Study|Ineligible|1|||
163184522|NCT05298306|589391286|FG000|Overall Study|Physician Decision|0|||
163184523|NCT05298306|589391287|FG001|Overall Study|Physician Decision|0|||
163184524|NCT05298306|589391288|FG002|Overall Study|Physician Decision|0|||
163184525|NCT05298306|589391289|FG003|Overall Study|Physician Decision|1|||
163184526|NCT05298306|589391290|FG004|Overall Study|Physician Decision|0|||
163184527|NCT05298306|589391291|FG005|Overall Study|Physician Decision|0|||
163184528|NCT00144027|589391293|FG000|Overall Study|Lost to Follow-up|1|||
163184529|NCT00144027|589391294|FG001|Overall Study|Lost to Follow-up|3|||
163184530|NCT00144027|589391293|FG000|Overall Study|Withdrawal by Subject|2|||
163184531|NCT00144027|589391294|FG001|Overall Study|Withdrawal by Subject|2|||
163184532|NCT00144027|589391293|FG000|Overall Study|did not complete baseline assessment|0|||
163184533|NCT00144027|589391294|FG001|Overall Study|did not complete baseline assessment|6|||
163184534|NCT05080660|589391295|FG000|Overall Study|Adverse Event|4|||
163184535|NCT05080660|589391296|FG001|Overall Study|Adverse Event|0|||
163184536|NCT05080660|589391295|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
163184537|NCT05080660|589391296|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
163184538|NCT05080660|589391295|FG000|Overall Study|Physician Decision|1|||
163184539|NCT05080660|589391296|FG001|Overall Study|Physician Decision|0|||
163184540|NCT05080660|589391295|FG000|Overall Study|Protocol Deviation|2|||
163184541|NCT05080660|589391296|FG001|Overall Study|Protocol Deviation|0|||
163184542|NCT05080660|589391295|FG000|Overall Study|Withdrawal by Subject|5|||
163184543|NCT05080660|589391296|FG001|Overall Study|Withdrawal by Subject|2|||
163184544|NCT00237185|589391297|FG000|Core|Adverse Event|3|||
163184545|NCT00237185|589391298|FG001|Core|Adverse Event|4|||
163184546|NCT00237185|589391297|FG000|Core|Abnormal laboratory value|0|||
163184547|NCT00237185|589391298|FG001|Core|Abnormal laboratory value|4|||
163184548|NCT00237185|589391297|FG000|Core|Abnormal test procedure results|1|||
163184549|NCT00237185|589391298|FG001|Core|Abnormal test procedure results|0|||
163184550|NCT00237185|589391297|FG000|Core|Lack of Efficacy|30|||
163184551|NCT00237185|589391298|FG001|Core|Lack of Efficacy|23|||
163184552|NCT00237185|589391297|FG000|Core|Protocol Violation|1|||
163184553|NCT00237185|589391298|FG001|Core|Protocol Violation|1|||
163184554|NCT00237185|589391297|FG000|Core|Withdrawal by Subject|4|||
163184555|NCT00237185|589391298|FG001|Core|Withdrawal by Subject|4|||
163289729|NCT02957539|589766361|FG000|Baseline to Week 16|Lost to Follow-up|8|||
163289730|NCT02957539|589766362|FG001|Baseline to Week 16|Lost to Follow-up|10|||
163184556|NCT00237185|589391297|FG000|Core|Administrative problems|0|||
162940406|NCT01211769|588484555|FG002|Overall Study|Lost to Follow-up|5|||
162940407|NCT01211769|588484556|FG003|Overall Study|Lost to Follow-up|9|||
162940408|NCT01211769|588484553|FG000|Overall Study|Physician Decision|2|||
162940409|NCT01211769|588484554|FG001|Overall Study|Physician Decision|0|||
162940410|NCT01211769|588484555|FG002|Overall Study|Physician Decision|2|||
162940411|NCT01211769|588484556|FG003|Overall Study|Physician Decision|1|||
162940412|NCT01211769|588484553|FG000|Overall Study|Adverse Event|0|||
162940413|NCT01211769|588484554|FG001|Overall Study|Adverse Event|1|||
162940414|NCT01211769|588484555|FG002|Overall Study|Adverse Event|1|||
162940415|NCT01211769|588484556|FG003|Overall Study|Adverse Event|1|||
162940416|NCT01709383|588484561|FG000|Overall Study|Lost to Follow-up|1|||
162940417|NCT01709383|588484562|FG001|Overall Study|Lost to Follow-up|0|||
162940418|NCT01193517|588484563|FG000|Overall Study|Early Progression|1|||
162940419|NCT01193517|588484564|FG001|Overall Study|Early Progression|0|||
162940420|NCT01193517|588484565|FG002|Overall Study|Early Progression|0|||
162940421|NCT01688037|588484566|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
163289731|NCT02957539|589766363|FG002|Baseline to Week 16|Lost to Follow-up|16|||
163289732|NCT02957539|589766361|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
163289733|NCT02957539|589766362|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
163289734|NCT02957539|589766363|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
163289735|NCT02957539|589766361|FG000|Week 16 to 32|Withdrawal by Subject|3|||
163289736|NCT02957539|589766362|FG001|Week 16 to 32|Withdrawal by Subject|3|||
163289737|NCT02957539|589766363|FG002|Week 16 to 32|Withdrawal by Subject|1|||
163289738|NCT02957539|589766361|FG000|Week 16 to 32|Lost to Follow-up|8|||
163289739|NCT02957539|589766362|FG001|Week 16 to 32|Lost to Follow-up|7|||
162940422|NCT01688037|588484567|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
163289740|NCT02957539|589766363|FG002|Week 16 to 32|Lost to Follow-up|5|||
163289741|NCT02957539|589766361|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
163289742|NCT02957539|589766362|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
163289743|NCT02957539|589766363|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
163289744|NCT02957539|589766361|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
163289745|NCT02957539|589766362|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
163289746|NCT02957539|589766363|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
163289747|NCT00906035|589766366|FG000|Overall Study|Withdrawal by Subject|2|||
163289748|NCT00906035|589766367|FG001|Overall Study|Withdrawal by Subject|3|||
163289749|NCT00906035|589766368|FG002|Overall Study|Withdrawal by Subject|0|||
163289750|NCT01689519|589766376|FG000|Intent to Treat|Death|157|||
163289751|NCT01689519|589766377|FG001|Intent to Treat|Death|167|||
163289752|NCT01689519|589766376|FG000|Intent to Treat|Lost to Follow-up|4|||
163289753|NCT01689519|589766377|FG001|Intent to Treat|Lost to Follow-up|8|||
163289754|NCT01689519|589766376|FG000|Intent to Treat|Other|2|||
163289755|NCT01689519|589766377|FG001|Intent to Treat|Other|4|||
163289756|NCT01689519|589766376|FG000|Intent to Treat|Physician Decision|4|||
163289757|NCT01689519|589766377|FG001|Intent to Treat|Physician Decision|1|||
163289758|NCT01689519|589766376|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
163289759|NCT01689519|589766377|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
163289760|NCT01689519|589766376|FG000|Intent to Treat|Withdrawal by Subject|21|||
163289761|NCT01689519|589766377|FG001|Intent to Treat|Withdrawal by Subject|20|||
163289762|NCT01689519|589766376|FG000|Safety Population|Death|158|||
163289763|NCT01689519|589766377|FG001|Safety Population|Death|165|||
163289764|NCT01689519|589766376|FG000|Safety Population|Lost to Follow-up|4|||
163289765|NCT01689519|589766377|FG001|Safety Population|Lost to Follow-up|8|||
163289766|NCT01689519|589766376|FG000|Safety Population|Other|2|||
163289767|NCT01689519|589766377|FG001|Safety Population|Other|4|||
163289768|NCT01689519|589766376|FG000|Safety Population|Physician Decision|4|||
163289769|NCT01689519|589766377|FG001|Safety Population|Physician Decision|1|||
163289770|NCT01689519|589766376|FG000|Safety Population|Study Terminated By Sponsor|60|||
163289771|NCT01689519|589766377|FG001|Safety Population|Study Terminated By Sponsor|47|||
163289772|NCT01689519|589766376|FG000|Safety Population|Withdrawal by Subject|20|||
163289773|NCT01689519|589766377|FG001|Safety Population|Withdrawal by Subject|20|||
162940423|NCT01688037|588484568|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
162940424|NCT01688037|588484566|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
162940425|NCT01688037|588484567|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
162940426|NCT01688037|588484568|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
162940427|NCT01688037|588484566|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
162940428|NCT01688037|588484567|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
163289774|NCT01050569|589766379|FG000|Overall Study|Lost to Follow-up|20|||
163289775|NCT01050569|589766380|FG001|Overall Study|Lost to Follow-up|14|||
163289776|NCT01050569|589766381|FG002|Overall Study|Lost to Follow-up|16|||
163289777|NCT01050569|589766379|FG000|Overall Study|Withdrawal by Subject|9|||
163289778|NCT01050569|589766380|FG001|Overall Study|Withdrawal by Subject|3|||
162940429|NCT01688037|588484568|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
162940430|NCT01688037|588484566|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
162940431|NCT01688037|588484567|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
163289779|NCT01050569|589766381|FG002|Overall Study|Withdrawal by Subject|11|||
163289780|NCT01050569|589766379|FG000|Overall Study|Lack of Efficacy|5|||
163289781|NCT01050569|589766380|FG001|Overall Study|Lack of Efficacy|4|||
163289782|NCT01050569|589766381|FG002|Overall Study|Lack of Efficacy|3|||
163289783|NCT01050569|589766379|FG000|Overall Study|Adverse Event|1|||
162940432|NCT01688037|588484568|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
162940433|NCT01688037|588484566|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
163289784|NCT01050569|589766380|FG001|Overall Study|Adverse Event|0|||
163289785|NCT01050569|589766381|FG002|Overall Study|Adverse Event|0|||
163289786|NCT01050569|589766379|FG000|Overall Study|Physician Decision|3|||
163289787|NCT01050569|589766380|FG001|Overall Study|Physician Decision|3|||
163289788|NCT01050569|589766381|FG002|Overall Study|Physician Decision|3|||
163289789|NCT03781336|589766382|FG000|Overall Study|Withdrawal by Subject|2|||
163289790|NCT03781336|589766383|FG001|Overall Study|Withdrawal by Subject|2|||
163289791|NCT01972152|589766384|FG000|First Treatment Visit|Lost to Follow-up|0|||
163289792|NCT01972152|589766385|FG001|First Treatment Visit|Lost to Follow-up|1|||
163289793|NCT01972152|589766386|FG002|First Treatment Visit|Lost to Follow-up|0|||
163289794|NCT01972152|589766387|FG003|First Treatment Visit|Lost to Follow-up|0|||
162940434|NCT01688037|588484567|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
162940435|NCT01688037|588484568|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
162940436|NCT01688037|588484566|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
162940437|NCT01688037|588484567|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
162940438|NCT01688037|588484568|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
162940439|NCT01688037|588484566|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
162940440|NCT01688037|588484567|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
162940441|NCT01688037|588484568|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
162940442|NCT01688037|588484566|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
162940443|NCT01688037|588484567|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
162940444|NCT01688037|588484568|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
162940445|NCT01688037|588484566|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
162940446|NCT01688037|588484567|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
162940447|NCT01688037|588484568|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
162940448|NCT01688037|588484566|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
162940449|NCT01688037|588484567|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
162940450|NCT01688037|588484568|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
162940451|NCT05440097|588485641|FG000|Overall Study|Withdrawal by Subject|154|||
162940452|NCT05440097|588485641|FG000|Overall Study|Death|2|||
162940453|NCT05440097|588485641|FG000|Overall Study|Physician Decision|2|||
162940454|NCT05440097|588485641|FG000|Overall Study|Lost to Follow-up|56|||
162940455|NCT05440097|588485641|FG000|Overall Study|"Include enrolled by mistake and withdrawed by mistake."|15|||
162940456|NCT05590585|588485645|FG000|Overall Study|Lost to Follow-up|3|||
162940457|NCT05590585|588485645|FG000|Overall Study|Withdrawal by Subject|1|||
162940458|NCT01673009|588485646|FG000|Overall Study|Physician Decision|5|||
162940459|NCT01673009|588485646|FG000|Overall Study|Withdrawal by Subject|8|||
163289795|NCT01972152|589766388|FG004|First Treatment Visit|Lost to Follow-up|0|||
163289796|NCT01972152|589766389|FG005|First Treatment Visit|Lost to Follow-up|0|||
163289797|NCT01972152|589766384|FG000|Second Treatment Visit|Protocol Violation|0|||
163289798|NCT01972152|589766385|FG001|Second Treatment Visit|Protocol Violation|1|||
163289799|NCT01972152|589766386|FG002|Second Treatment Visit|Protocol Violation|0|||
163289800|NCT01972152|589766387|FG003|Second Treatment Visit|Protocol Violation|0|||
163289801|NCT01972152|589766388|FG004|Second Treatment Visit|Protocol Violation|0|||
163289802|NCT01972152|589766389|FG005|Second Treatment Visit|Protocol Violation|0|||
163289803|NCT00972504|589766390|FG000|Overall Study|Adverse Event|2|||
163289804|NCT00972504|589766390|FG000|Overall Study|Investigator discretion|1|||
163289805|NCT00319436|589766391|FG000|Overall Study|Withdrawal by Subject|6|||
163289806|NCT00319436|589766392|FG001|Overall Study|Withdrawal by Subject|7|||
163289807|NCT00639002|589766395|FG000|Overall Study|Death|1|||
163289808|NCT00639002|589766395|FG000|Overall Study|Adverse Event|1|||
163289809|NCT00639002|589766395|FG000|Overall Study|Protocol Violation|1|||
163289810|NCT00639002|589766395|FG000|Overall Study|Disease progression|3|||
163289811|NCT00639002|589766395|FG000|Overall Study|Physician Decision|6|||
163289812|NCT00639002|589766395|FG000|Overall Study|Lack of Efficacy|1|||
163289813|NCT01839877|589766399|FG000|Overall Study|Protocol Violation|1|||
163289814|NCT00597519|589766404|FG000|Overall Study|Death|1|||
163289815|NCT04391309|589766406|FG000|Overall Study|Death|1|||
163289816|NCT04391309|589766407|FG001|Overall Study|Death|1|||
163289817|NCT04391309|589766406|FG000|Overall Study|Lost to Follow-up|3|||
163289818|NCT04391309|589766407|FG001|Overall Study|Lost to Follow-up|2|||
163289819|NCT04391309|589766406|FG000|Overall Study|Withdrawal by Subject|2|||
163289820|NCT04391309|589766407|FG001|Overall Study|Withdrawal by Subject|2|||
163289821|NCT02781584|589766408|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
163289822|NCT02781584|589766409|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
163289823|NCT02781584|589766410|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
163289824|NCT02781584|589766411|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
163289825|NCT02781584|589766412|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
163289826|NCT02781584|589766413|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
163289827|NCT02781584|589766414|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
163289828|NCT02781584|589766415|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
163289829|NCT02781584|589766416|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
163289830|NCT02781584|589766417|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
162940460|NCT04161144|588485648|FG000|Overall Study|Withdrawal by Subject|0|||
162940461|NCT04161144|588485649|FG001|Overall Study|Withdrawal by Subject|1|||
163289831|NCT02781584|589766418|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
163289832|NCT02781584|589766419|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
163289833|NCT02781584|589766420|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
163289834|NCT02781584|589766408|FG000|Pre-treatment Phase|Adverse Event|0|||
163289835|NCT02781584|589766409|FG001|Pre-treatment Phase|Adverse Event|0|||
163289836|NCT02781584|589766410|FG002|Pre-treatment Phase|Adverse Event|0|||
163289837|NCT02781584|589766411|FG003|Pre-treatment Phase|Adverse Event|0|||
163289838|NCT02781584|589766412|FG004|Pre-treatment Phase|Adverse Event|0|||
162940462|NCT04161144|588485648|FG000|Overall Study|Protocol Violation|1|||
162940463|NCT04161144|588485649|FG001|Overall Study|Protocol Violation|0|||
162940464|NCT04828161|588485650|FG000|Overall Study|Withdrawal by Subject|0|||
162940465|NCT04828161|588485651|FG001|Overall Study|Withdrawal by Subject|3|||
162940466|NCT04828161|588485652|FG002|Overall Study|Withdrawal by Subject|3|||
162940467|NCT04828161|588485653|FG003|Overall Study|Withdrawal by Subject|4|||
162940468|NCT04828161|588485650|FG000|Overall Study|Lost to Follow-up|1|||
162940469|NCT04828161|588485651|FG001|Overall Study|Lost to Follow-up|4|||
162940470|NCT04828161|588485652|FG002|Overall Study|Lost to Follow-up|2|||
162940471|NCT04828161|588485653|FG003|Overall Study|Lost to Follow-up|2|||
163289839|NCT02781584|589766413|FG005|Pre-treatment Phase|Adverse Event|0|||
163289840|NCT02781584|589766414|FG006|Pre-treatment Phase|Adverse Event|0|||
163289841|NCT02781584|589766415|FG007|Pre-treatment Phase|Adverse Event|0|||
163289842|NCT02781584|589766416|FG008|Pre-treatment Phase|Adverse Event|0|||
163289843|NCT02781584|589766417|FG009|Pre-treatment Phase|Adverse Event|0|||
163289844|NCT02781584|589766418|FG010|Pre-treatment Phase|Adverse Event|0|||
163289845|NCT02781584|589766419|FG011|Pre-treatment Phase|Adverse Event|1|||
163289846|NCT02781584|589766420|FG012|Pre-treatment Phase|Adverse Event|0|||
163289847|NCT02781584|589766408|FG000|Treatment Phase|Withdrew Consent|0|||
163289848|NCT02781584|589766409|FG001|Treatment Phase|Withdrew Consent|0|||
163289849|NCT02781584|589766410|FG002|Treatment Phase|Withdrew Consent|0|||
163289850|NCT02781584|589766411|FG003|Treatment Phase|Withdrew Consent|0|||
163289851|NCT02781584|589766412|FG004|Treatment Phase|Withdrew Consent|0|||
163289852|NCT02781584|589766413|FG005|Treatment Phase|Withdrew Consent|1|||
162940472|NCT04828161|588485650|FG000|Overall Study|Other|2|||
162940473|NCT04828161|588485651|FG001|Overall Study|Other|0|||
162940474|NCT04828161|588485652|FG002|Overall Study|Other|2|||
162940475|NCT04828161|588485653|FG003|Overall Study|Other|0|||
162940476|NCT04828161|588485650|FG000|Overall Study|Death|0|||
162940477|NCT04828161|588485651|FG001|Overall Study|Death|0|||
162940478|NCT04828161|588485652|FG002|Overall Study|Death|0|||
162940479|NCT04828161|588485653|FG003|Overall Study|Death|2|||
162940480|NCT03093454|588485654|FG000|Overall Study|Withdrawal by Subject|1|||
162940481|NCT03093454|588485655|FG001|Overall Study|Withdrawal by Subject|1|||
162940482|NCT03093454|588485654|FG000|Overall Study|Scheduling conflict|3|||
162940483|NCT03093454|588485655|FG001|Overall Study|Scheduling conflict|1|||
162940484|NCT03093454|588485654|FG000|Overall Study|Physician Decision|2|||
162940485|NCT03093454|588485655|FG001|Overall Study|Physician Decision|1|||
162940486|NCT02524379|588485656|FG000|Overall Study|Death|1|||
162940487|NCT01884025|588485657|FG000|Overall Study|Lost to Follow-up|3|||
162940488|NCT01884025|588485658|FG001|Overall Study|Lost to Follow-up|4|||
162940489|NCT02854436|588485660|FG000|Overall Study|Adverse Event|1|||
162940490|NCT02854436|588485660|FG000|Overall Study|Death|208|||
162940491|NCT02854436|588485660|FG000|Overall Study|Lost to Follow-up|5|||
162940492|NCT02854436|588485660|FG000|Overall Study|Withdrawal by Subject|24|||
162940493|NCT02854436|588485660|FG000|Overall Study|Other|45|||
162940494|NCT02854436|588485660|FG000|Overall Study|Physician Decision|6|||
162940495|NCT01700621|588485661|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
162940496|NCT01700621|588485662|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
162940497|NCT01700621|588485661|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
162940498|NCT01700621|588485662|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
162940499|NCT01700621|588485661|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
162940500|NCT01700621|588485662|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
162940501|NCT00384033|588485672|FG000|Overall Study|Adverse Event|10|||
162940502|NCT00384033|588485673|FG001|Overall Study|Adverse Event|8|||
162940503|NCT00384033|588485674|FG002|Overall Study|Adverse Event|11|||
162940504|NCT00384033|588485675|FG003|Overall Study|Adverse Event|20|||
162940505|NCT00384033|588485672|FG000|Overall Study|Failed to return|1|||
162940506|NCT00384033|588485673|FG001|Overall Study|Failed to return|3|||
162940507|NCT00384033|588485674|FG002|Overall Study|Failed to return|2|||
162940508|NCT00384033|588485675|FG003|Overall Study|Failed to return|2|||
162940509|NCT00384033|588485672|FG000|Overall Study|Physician Decision|1|||
162940510|NCT00384033|588485673|FG001|Overall Study|Physician Decision|0|||
162940511|NCT00384033|588485674|FG002|Overall Study|Physician Decision|0|||
162940512|NCT00384033|588485675|FG003|Overall Study|Physician Decision|0|||
163289853|NCT02781584|589766414|FG006|Treatment Phase|Withdrew Consent|0|||
163289854|NCT02781584|589766415|FG007|Treatment Phase|Withdrew Consent|0|||
163289855|NCT02781584|589766416|FG008|Treatment Phase|Withdrew Consent|0|||
163289856|NCT02781584|589766417|FG009|Treatment Phase|Withdrew Consent|0|||
163289857|NCT02781584|589766418|FG010|Treatment Phase|Withdrew Consent|1|||
163289858|NCT02781584|589766419|FG011|Treatment Phase|Withdrew Consent|2|||
162940513|NCT00384033|588485672|FG000|Overall Study|Lost to Follow-up|6|||
162940514|NCT00384033|588485673|FG001|Overall Study|Lost to Follow-up|12|||
162940515|NCT00384033|588485674|FG002|Overall Study|Lost to Follow-up|7|||
162940516|NCT00384033|588485675|FG003|Overall Study|Lost to Follow-up|7|||
162940517|NCT00384033|588485672|FG000|Overall Study|Other|2|||
162940518|NCT00384033|588485673|FG001|Overall Study|Other|0|||
162940519|NCT00384033|588485674|FG002|Overall Study|Other|0|||
162940520|NCT00384033|588485675|FG003|Overall Study|Other|0|||
162940521|NCT00384033|588485672|FG000|Overall Study|Protocol Violation|5|||
162940522|NCT00384033|588485673|FG001|Overall Study|Protocol Violation|0|||
162940523|NCT00384033|588485674|FG002|Overall Study|Protocol Violation|5|||
163289859|NCT02781584|589766420|FG012|Treatment Phase|Withdrew Consent|0|||
163289860|NCT02781584|589766408|FG000|Treatment Phase|Adverse Event|0|||
163289861|NCT02781584|589766409|FG001|Treatment Phase|Adverse Event|0|||
163289862|NCT02781584|589766410|FG002|Treatment Phase|Adverse Event|0|||
163289863|NCT02781584|589766411|FG003|Treatment Phase|Adverse Event|0|||
163289864|NCT02781584|589766412|FG004|Treatment Phase|Adverse Event|0|||
162940524|NCT00384033|588485675|FG003|Overall Study|Protocol Violation|6|||
162940525|NCT00384033|588485672|FG000|Overall Study|Withdrawal by Subject|6|||
162940526|NCT00384033|588485673|FG001|Overall Study|Withdrawal by Subject|2|||
162940527|NCT00384033|588485674|FG002|Overall Study|Withdrawal by Subject|5|||
162940528|NCT00384033|588485675|FG003|Overall Study|Withdrawal by Subject|2|||
162940529|NCT00384033|588485672|FG000|Overall Study|Lack of Efficacy|7|||
162940530|NCT00384033|588485673|FG001|Overall Study|Lack of Efficacy|3|||
162940531|NCT00384033|588485674|FG002|Overall Study|Lack of Efficacy|3|||
162940532|NCT00384033|588485675|FG003|Overall Study|Lack of Efficacy|1|||
162940533|NCT00384033|588485672|FG000|Overall Study|Randomized but not treated|3|||
162940534|NCT00384033|588485673|FG001|Overall Study|Randomized but not treated|7|||
163184557|NCT00237185|589391298|FG001|Core|Administrative problems|1|||
163184558|NCT00237185|589391297|FG000|Core|Death|4|||
163184559|NCT00237185|589391298|FG001|Core|Death|0|||
163184560|NCT00237185|589391297|FG000|Core|Determined ineligible post randomization|1|||
163184561|NCT00237185|589391298|FG001|Core|Determined ineligible post randomization|0|||
163184562|NCT00237185|589391297|FG000|Extension|Adverse Event|1|||
163184563|NCT00237185|589391298|FG001|Extension|Adverse Event|0|||
163184564|NCT00237185|589391297|FG000|Extension|Abnormal laboratory value|0|||
163184565|NCT00237185|589391298|FG001|Extension|Abnormal laboratory value|1|||
163184566|NCT00237185|589391297|FG000|Extension|Lack of Efficacy|9|||
163184567|NCT00237185|589391298|FG001|Extension|Lack of Efficacy|14|||
163184568|NCT00237185|589391297|FG000|Extension|Condition no longer required study drug|0|||
163184569|NCT00237185|589391298|FG001|Extension|Condition no longer required study drug|1|||
163184570|NCT00237185|589391297|FG000|Extension|Withdrawal by Subject|3|||
163184571|NCT00237185|589391298|FG001|Extension|Withdrawal by Subject|2|||
163184572|NCT00237185|589391297|FG000|Extension|Lost to Follow-up|1|||
163184573|NCT00237185|589391298|FG001|Extension|Lost to Follow-up|0|||
163184574|NCT00237185|589391297|FG000|Extension|Administrative problems|1|||
163184575|NCT00237185|589391298|FG001|Extension|Administrative problems|0|||
163184576|NCT00237185|589391297|FG000|Extension|Death|1|||
163184577|NCT00237185|589391298|FG001|Extension|Death|1|||
163184578|NCT02204007|589391299|FG000|Overall Study|Surgery Canceled|1|||
163184579|NCT02204007|589391300|FG001|Overall Study|Surgery Canceled|1|||
163184580|NCT01977937|589391301|FG000|Overall Study|Withdrawal by Subject|2|||
163184581|NCT01977937|589391302|FG001|Overall Study|Withdrawal by Subject|1|||
163184582|NCT01977937|589391301|FG000|Overall Study|Adverse Event|1|||
163184583|NCT01977937|589391302|FG001|Overall Study|Adverse Event|0|||
163184584|NCT01977937|589391301|FG000|Overall Study|Physician Decision|0|||
163184585|NCT01977937|589391302|FG001|Overall Study|Physician Decision|1|||
163289865|NCT02781584|589766413|FG005|Treatment Phase|Adverse Event|0|||
163289866|NCT02781584|589766414|FG006|Treatment Phase|Adverse Event|0|||
163289867|NCT02781584|589766415|FG007|Treatment Phase|Adverse Event|1|||
163289868|NCT02781584|589766416|FG008|Treatment Phase|Adverse Event|0|||
163289869|NCT02781584|589766417|FG009|Treatment Phase|Adverse Event|0|||
163289870|NCT02781584|589766418|FG010|Treatment Phase|Adverse Event|0|||
163289871|NCT02781584|589766419|FG011|Treatment Phase|Adverse Event|0|||
163289872|NCT02781584|589766420|FG012|Treatment Phase|Adverse Event|0|||
163289873|NCT00768651|589766425|FG000|Overall Study|Withdrawal by Subject|1|||
163289874|NCT00995709|589766426|FG000|Overall Study|Adverse Event|4|||
163289875|NCT00995709|589766427|FG001|Overall Study|Adverse Event|2|||
163289876|NCT00995709|589766428|FG002|Overall Study|Adverse Event|0|||
163289877|NCT00995709|589766426|FG000|Overall Study|Lack of Efficacy|0|||
163289878|NCT00995709|589766427|FG001|Overall Study|Lack of Efficacy|1|||
163289879|NCT00995709|589766428|FG002|Overall Study|Lack of Efficacy|4|||
163289880|NCT00995709|589766426|FG000|Overall Study|Withdrawal by Subject|0|||
163289881|NCT00995709|589766427|FG001|Overall Study|Withdrawal by Subject|4|||
163289882|NCT00995709|589766428|FG002|Overall Study|Withdrawal by Subject|1|||
163289883|NCT00995709|589766426|FG000|Overall Study|Lost to Follow-up|1|||
163289884|NCT00995709|589766427|FG001|Overall Study|Lost to Follow-up|0|||
163289885|NCT00995709|589766428|FG002|Overall Study|Lost to Follow-up|0|||
163289886|NCT00995709|589766426|FG000|Overall Study|Death|0|||
163289887|NCT00995709|589766427|FG001|Overall Study|Death|1|||
163289888|NCT00995709|589766428|FG002|Overall Study|Death|0|||
162940535|NCT00384033|588485674|FG002|Overall Study|Randomized but not treated|10|||
162940536|NCT00384033|588485675|FG003|Overall Study|Randomized but not treated|2|||
163289889|NCT00995709|589766426|FG000|Overall Study|Protocol Violation|2|||
163289890|NCT00995709|589766427|FG001|Overall Study|Protocol Violation|1|||
163289891|NCT00995709|589766428|FG002|Overall Study|Protocol Violation|0|||
162940537|NCT02985151|588485676|FG000|Original Randomization|Withdrawal by Subject|0|||
163184586|NCT03194490|589391305|FG000|Overall Study|Lost to Follow-up|1|||
163184587|NCT03194490|589391306|FG001|Overall Study|Lost to Follow-up|3|||
163184588|NCT03194490|589391305|FG000|Overall Study|participant developed specific neck pain|1|||
163289892|NCT01543685|589766430|FG000|Overall Study|Lack of Efficacy|1|||
163289893|NCT01543685|589766431|FG001|Overall Study|Lack of Efficacy|2|||
163184589|NCT03194490|589391306|FG001|Overall Study|participant developed specific neck pain|0|||
163184590|NCT03911843|589391307|FG000|Overall Study|Adverse Event|2|||
163184591|NCT03911843|589391308|FG001|Overall Study|Adverse Event|0|||
163184592|NCT03911843|589391307|FG000|Overall Study|Protocol Violation|2|||
163184593|NCT03911843|589391308|FG001|Overall Study|Protocol Violation|0|||
163184594|NCT03911843|589391307|FG000|Overall Study|Lost to Follow-up|0|||
163184595|NCT03911843|589391308|FG001|Overall Study|Lost to Follow-up|1|||
163184596|NCT02819518|589391309|FG000|Overall Study|Death|9|||
163184597|NCT02819518|589391310|FG001|Overall Study|Death|12|||
163184598|NCT02819518|589391311|FG002|Overall Study|Death|9|||
163184599|NCT02819518|589391312|FG003|Overall Study|Death|475|||
163184600|NCT02819518|589391313|FG004|Overall Study|Death|244|||
163184601|NCT02819518|589391309|FG000|Overall Study|Withdrawal by Subject|0|||
163184602|NCT02819518|589391310|FG001|Overall Study|Withdrawal by Subject|0|||
163184603|NCT02819518|589391311|FG002|Overall Study|Withdrawal by Subject|0|||
163184604|NCT02819518|589391312|FG003|Overall Study|Withdrawal by Subject|25|||
163184605|NCT02819518|589391313|FG004|Overall Study|Withdrawal by Subject|8|||
163184606|NCT02819518|589391309|FG000|Overall Study|Lost to Follow-up|0|||
163184607|NCT02819518|589391310|FG001|Overall Study|Lost to Follow-up|0|||
163184608|NCT02819518|589391311|FG002|Overall Study|Lost to Follow-up|0|||
163184609|NCT02819518|589391312|FG003|Overall Study|Lost to Follow-up|0|||
163184610|NCT02819518|589391313|FG004|Overall Study|Lost to Follow-up|1|||
163184611|NCT02819518|589391309|FG000|Overall Study|Sponsor Decision|1|||
163184612|NCT02819518|589391310|FG001|Overall Study|Sponsor Decision|1|||
163184613|NCT02819518|589391311|FG002|Overall Study|Sponsor Decision|0|||
163184614|NCT02819518|589391312|FG003|Overall Study|Sponsor Decision|34|||
163184615|NCT02819518|589391313|FG004|Overall Study|Sponsor Decision|17|||
163184616|NCT02819518|589391309|FG000|Overall Study|Transferred to extension study|1|||
163184617|NCT02819518|589391310|FG001|Overall Study|Transferred to extension study|1|||
163184618|NCT02819518|589391311|FG002|Overall Study|Transferred to extension study|1|||
163184619|NCT02819518|589391312|FG003|Overall Study|Transferred to extension study|32|||
163184620|NCT02819518|589391313|FG004|Overall Study|Transferred to extension study|11|||
163184621|NCT01505647|589391314|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
163184622|NCT01505647|589391315|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
163184623|NCT01505647|589391314|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
163184624|NCT01505647|589391315|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
163184625|NCT01505647|589391314|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
163184626|NCT01505647|589391315|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
163184627|NCT01505647|589391314|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
163184628|NCT01505647|589391315|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
163184629|NCT01505647|589391314|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
163184630|NCT01505647|589391315|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
163184631|NCT02750943|589391319|FG000|Overall Study|Lost to Follow-up|1|||
163184632|NCT02750943|589391320|FG001|Overall Study|Lost to Follow-up|2|||
163184633|NCT02750943|589391319|FG000|Overall Study|Withdrawal by Subject|5|||
163184634|NCT02750943|589391320|FG001|Overall Study|Withdrawal by Subject|7|||
163184635|NCT04597918|589391321|FG000|Overall Study|Withdrawal by Subject|6|||
163184636|NCT04597918|589391321|FG000|Overall Study|Lost to Follow-up|3|||
163184637|NCT04597918|589391321|FG000|Overall Study|Death|1|||
163184638|NCT04041700|589391328|FG000|Overall Study|Pregnancy|1|||
163184639|NCT04041700|589391328|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
163184640|NCT05419908|589391329|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
163184641|NCT05419908|589391330|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
163184642|NCT05419908|589391329|FG000|Overall Study|Serious Adverse Event|0|||
163184643|NCT05419908|589391330|FG001|Overall Study|Serious Adverse Event|2|||
163184644|NCT05419908|589391329|FG000|Overall Study|Withdrawal by Subject|2|||
163184645|NCT05419908|589391330|FG001|Overall Study|Withdrawal by Subject|0|||
163184646|NCT05419908|589391329|FG000|Overall Study|Miscellaneous|1|||
163184647|NCT05419908|589391330|FG001|Overall Study|Miscellaneous|1|||
163184648|NCT00423722|589392706|FG000|Overall Study|Death|4|||
163184649|NCT00423722|589392707|FG001|Overall Study|Death|4|||
163184650|NCT00423722|589392706|FG000|Overall Study|Declined to participate|2|||
163184651|NCT00423722|589392707|FG001|Overall Study|Declined to participate|3|||
163184652|NCT00423722|589392706|FG000|Overall Study|Unable to complete questionnaires|4|||
163184653|NCT00423722|589392707|FG001|Overall Study|Unable to complete questionnaires|4|||
163184654|NCT00423722|589392706|FG000|Overall Study|Withdrawal by Subject|4|||
163184655|NCT00423722|589392707|FG001|Overall Study|Withdrawal by Subject|2|||
163184656|NCT00215683|589392708|FG000|Overall Study|Adverse Event|15|||
163184657|NCT00215683|589392709|FG001|Overall Study|Adverse Event|16|||
163184658|NCT00215683|589392710|FG002|Overall Study|Adverse Event|15|||
163184659|NCT00215683|589392708|FG000|Overall Study|Lack of Efficacy|5|||
163184660|NCT00215683|589392709|FG001|Overall Study|Lack of Efficacy|1|||
163184661|NCT00215683|589392710|FG002|Overall Study|Lack of Efficacy|2|||
162940538|NCT02985151|588485677|FG001|Original Randomization|Withdrawal by Subject|1|||
163184662|NCT00215683|589392708|FG000|Overall Study|Lost to Follow-up|0|||
163184663|NCT00215683|589392709|FG001|Overall Study|Lost to Follow-up|2|||
162940539|NCT02843074|588485687|FG000|Overall Study|Withdrawal by Subject|5|||
162940540|NCT02843074|588485687|FG000|Overall Study|Progressive disease|1|||
162940541|NCT02843074|588485687|FG000|Overall Study|Physician Decision|1|||
162940542|NCT02843074|588485687|FG000|Overall Study|Lost to Follow-up|1|||
162940543|NCT02843074|588485687|FG000|Overall Study|Death|9|||
162940544|NCT01564758|588485688|FG000|Overall Study|Death|8|||
162940545|NCT01564758|588485688|FG000|Overall Study|Adverse Event|3|||
162940546|NCT01564758|588485688|FG000|Overall Study|Other|3|||
162940547|NCT01186978|588485689|FG000|Overall Study|Withdrawal by Subject|1|||
162940548|NCT01227668|588485690|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
162940549|NCT01227668|588485691|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
162940550|NCT01227668|588485690|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
162940551|NCT01227668|588485691|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
162940552|NCT01227668|588485690|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
162940553|NCT01227668|588485691|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
162940554|NCT01227668|588485690|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
162940555|NCT01227668|588485691|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
162940556|NCT01227668|588485690|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
162940557|NCT01227668|588485691|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
162940558|NCT01227668|588485690|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
162940559|NCT01227668|588485691|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
162940560|NCT01227668|588485690|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
162940561|NCT01227668|588485691|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
162940562|NCT01227668|588485690|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
162940563|NCT01227668|588485691|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
162940564|NCT01227668|588485690|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
162940565|NCT01227668|588485691|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
162940566|NCT01227668|588485690|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
162940567|NCT01227668|588485691|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
162940568|NCT01227668|588485690|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
162940569|NCT01227668|588485691|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
162940570|NCT01227668|588485690|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
162940571|NCT01227668|588485691|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
162940572|NCT04281485|588485692|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
162940573|NCT04281485|588485693|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
162940574|NCT04281485|588485692|FG000|Overall Study|Ongoing (Safety data collection)|10|||
162940575|NCT04281485|588485693|FG001|Overall Study|Ongoing (Safety data collection)|5|||
162940576|NCT04317599|588485694|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
162940577|NCT04317599|588485694|FG000|Overall Study|treatment outside standard of care|4|||
162940578|NCT02115256|588485704|FG000|Overall Study|Withdrawal by Subject|0|||
162940579|NCT02115256|588485705|FG001|Overall Study|Withdrawal by Subject|1|||
162940580|NCT02427607|588485708|FG000|Overall Study|Withdrawal by Subject|1|||
162940581|NCT03211416|588485709|FG000|Overall Study|Adverse Event|7|||
162940582|NCT03211416|588485709|FG000|Overall Study|Lack of Efficacy|2|||
162940583|NCT03211416|588485709|FG000|Overall Study|Physician Decision|1|||
162940584|NCT01789320|588485710|FG000|Overall Study|Re-enrolled into study|1|||
162940585|NCT01789320|588485710|FG000|Overall Study|Lost to Follow-up|1|||
162940586|NCT03199274|588485713|FG000|Overall Study|Withdrawal by Subject|4|||
162940587|NCT03199274|588485714|FG001|Overall Study|Withdrawal by Subject|0|||
162940588|NCT03199274|588485713|FG000|Overall Study|Lost to Follow-up|0|||
162940589|NCT03199274|588485714|FG001|Overall Study|Lost to Follow-up|1|||
162940590|NCT03199274|588485713|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
162940591|NCT03199274|588485714|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
162940592|NCT01533428|588485725|FG000|Overall Study|Adverse Event|0|||
162940593|NCT01533428|588485726|FG001|Overall Study|Adverse Event|1|||
162940594|NCT01533428|588485725|FG000|Overall Study|Lost to Follow-up|2|||
162940595|NCT01533428|588485726|FG001|Overall Study|Lost to Follow-up|1|||
162940596|NCT01533428|588485725|FG000|Overall Study|Withdrawal by Subject|7|||
162940597|NCT01533428|588485726|FG001|Overall Study|Withdrawal by Subject|6|||
162940598|NCT02102490|588485727|FG000|Overall Study|Death|6|||
162940599|NCT02102490|588485727|FG000|Overall Study|Lost to Follow-up|1|||
162940600|NCT00095199|588485728|FG000|Overall Study|Adverse Event|40|||
162940601|NCT00095199|588485729|FG001|Overall Study|Adverse Event|22|||
162940602|NCT00095199|588485730|FG002|Overall Study|Adverse Event|26|||
162940603|NCT00095199|588485731|FG003|Overall Study|Adverse Event|11|||
162940604|NCT00095199|588485728|FG000|Overall Study|Progressive disease|213|||
162940605|NCT00095199|588485729|FG001|Overall Study|Progressive disease|179|||
162940606|NCT00095199|588485730|FG002|Overall Study|Progressive disease|105|||
162940607|NCT00095199|588485731|FG003|Overall Study|Progressive disease|98|||
162940608|NCT00095199|588485728|FG000|Overall Study|Death|10|||
162940609|NCT00095199|588485729|FG001|Overall Study|Death|6|||
162940610|NCT00095199|588485730|FG002|Overall Study|Death|11|||
162940611|NCT00095199|588485731|FG003|Overall Study|Death|9|||
162940612|NCT00095199|588485728|FG000|Overall Study|Withdrawal by Subject|21|||
162940613|NCT00095199|588485729|FG001|Overall Study|Withdrawal by Subject|16|||
162940614|NCT00095199|588485730|FG002|Overall Study|Withdrawal by Subject|13|||
162940615|NCT00095199|588485731|FG003|Overall Study|Withdrawal by Subject|22|||
162940616|NCT00095199|588485728|FG000|Overall Study|Protocol Violation|4|||
162940617|NCT00095199|588485729|FG001|Overall Study|Protocol Violation|4|||
162940618|NCT00095199|588485730|FG002|Overall Study|Protocol Violation|2|||
162940619|NCT00095199|588485731|FG003|Overall Study|Protocol Violation|0|||
162940620|NCT00095199|588485728|FG000|Overall Study|Liver function test results elevated|0|||
162940621|NCT00095199|588485729|FG001|Overall Study|Liver function test results elevated|0|||
162940622|NCT00095199|588485730|FG002|Overall Study|Liver function test results elevated|1|||
162940623|NCT00095199|588485731|FG003|Overall Study|Liver function test results elevated|1|||
162940624|NCT00095199|588485728|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
162940625|NCT00095199|588485729|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
162940626|NCT00095199|588485730|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
162940627|NCT00095199|588485731|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
162940628|NCT00095199|588485728|FG000|Overall Study|Physician Decision|5|||
162940629|NCT00095199|588485729|FG001|Overall Study|Physician Decision|6|||
162940630|NCT00095199|588485730|FG002|Overall Study|Physician Decision|1|||
162940631|NCT00095199|588485731|FG003|Overall Study|Physician Decision|1|||
162940632|NCT00095199|588485728|FG000|Overall Study|Not eligible|1|||
162940633|NCT00095199|588485729|FG001|Overall Study|Not eligible|7|||
162940634|NCT00095199|588485730|FG002|Overall Study|Not eligible|0|||
162940635|NCT00095199|588485731|FG003|Overall Study|Not eligible|1|||
162940636|NCT00095199|588485728|FG000|Overall Study|Started Palliative Radiotherapy|1|||
162940637|NCT00095199|588485729|FG001|Overall Study|Started Palliative Radiotherapy|0|||
162940638|NCT00095199|588485730|FG002|Overall Study|Started Palliative Radiotherapy|0|||
162940639|NCT00095199|588485731|FG003|Overall Study|Started Palliative Radiotherapy|0|||
162940640|NCT00095199|588485728|FG000|Overall Study|Started radiotherapy regimen|0|||
162940641|NCT00095199|588485729|FG001|Overall Study|Started radiotherapy regimen|1|||
162940642|NCT00095199|588485730|FG002|Overall Study|Started radiotherapy regimen|0|||
162940643|NCT00095199|588485731|FG003|Overall Study|Started radiotherapy regimen|0|||
162940644|NCT00095199|588485728|FG000|Overall Study|Primary tumor removed in other surgery|0|||
162940645|NCT00095199|588485729|FG001|Overall Study|Primary tumor removed in other surgery|1|||
162940646|NCT00095199|588485730|FG002|Overall Study|Primary tumor removed in other surgery|0|||
162940647|NCT00095199|588485731|FG003|Overall Study|Primary tumor removed in other surgery|0|||
162940648|NCT00095199|588485728|FG000|Overall Study|Data inadvertently lost by site|1|||
162940649|NCT00095199|588485729|FG001|Overall Study|Data inadvertently lost by site|0|||
162940650|NCT00095199|588485730|FG002|Overall Study|Data inadvertently lost by site|0|||
162940651|NCT00095199|588485731|FG003|Overall Study|Data inadvertently lost by site|0|||
162940652|NCT03896490|588485732|FG000|Overall Study|Withdrawal by Subject|1|||
162940653|NCT03896490|588485733|FG001|Overall Study|Withdrawal by Subject|1|||
162940654|NCT00385541|588485736|FG000|Overall Study|severe pain, clinician requested unblind|0|||
162940655|NCT00385541|588485737|FG001|Overall Study|severe pain, clinician requested unblind|1|||
162940656|NCT00929708|588485738|FG000|Overall Study|Protocol Violation|2|||
162940657|NCT00929708|588485739|FG001|Overall Study|Protocol Violation|1|||
162940658|NCT00929708|588485740|FG002|Overall Study|Protocol Violation|1|||
162940659|NCT00929708|588485741|FG003|Overall Study|Protocol Violation|1|||
162940660|NCT00929708|588485742|FG004|Overall Study|Protocol Violation|1|||
162940661|NCT00929708|588485738|FG000|Overall Study|Withdrawal by Subject|2|||
162940662|NCT00929708|588485739|FG001|Overall Study|Withdrawal by Subject|0|||
162940663|NCT00929708|588485740|FG002|Overall Study|Withdrawal by Subject|0|||
162940664|NCT00929708|588485741|FG003|Overall Study|Withdrawal by Subject|2|||
162940665|NCT00929708|588485742|FG004|Overall Study|Withdrawal by Subject|1|||
162940666|NCT00929708|588485738|FG000|Overall Study|Adverse Event|0|||
162940667|NCT00929708|588485739|FG001|Overall Study|Adverse Event|0|||
162940668|NCT00929708|588485740|FG002|Overall Study|Adverse Event|0|||
162940669|NCT00929708|588485741|FG003|Overall Study|Adverse Event|0|||
162940670|NCT00929708|588485742|FG004|Overall Study|Adverse Event|3|||
162940671|NCT00929708|588485738|FG000|Overall Study|Physician Decision|0|||
162940672|NCT00929708|588485739|FG001|Overall Study|Physician Decision|2|||
162940673|NCT00929708|588485740|FG002|Overall Study|Physician Decision|2|||
162940674|NCT00929708|588485741|FG003|Overall Study|Physician Decision|2|||
163289894|NCT01543685|589766432|FG002|Overall Study|Lack of Efficacy|2|||
162940675|NCT00929708|588485742|FG004|Overall Study|Physician Decision|1|||
162940676|NCT00929708|588485738|FG000|Overall Study|Lost to Follow-up|0|||
162940677|NCT00929708|588485739|FG001|Overall Study|Lost to Follow-up|0|||
162940678|NCT00929708|588485740|FG002|Overall Study|Lost to Follow-up|0|||
162940679|NCT00929708|588485741|FG003|Overall Study|Lost to Follow-up|1|||
162940680|NCT00929708|588485742|FG004|Overall Study|Lost to Follow-up|0|||
162940681|NCT02154529|588485743|FG000|Overall Study|Death|1|||
162940682|NCT02154529|588485744|FG001|Overall Study|Death|1|||
162940683|NCT02154529|588485745|FG002|Overall Study|Death|5|||
162940684|NCT02154529|588485746|FG003|Overall Study|Death|1|||
162940685|NCT02154529|588485743|FG000|Overall Study|Termination of study by sponsor|2|||
162940686|NCT02154529|588485744|FG001|Overall Study|Termination of study by sponsor|2|||
162940687|NCT02154529|588485745|FG002|Overall Study|Termination of study by sponsor|3|||
162940688|NCT02154529|588485746|FG003|Overall Study|Termination of study by sponsor|1|||
162940689|NCT02154529|588485743|FG000|Overall Study|Lost to Follow-up|1|||
162940690|NCT02154529|588485744|FG001|Overall Study|Lost to Follow-up|0|||
162940691|NCT02154529|588485745|FG002|Overall Study|Lost to Follow-up|0|||
162940692|NCT02154529|588485746|FG003|Overall Study|Lost to Follow-up|0|||
162940693|NCT02081599|588486984|FG000|Period 1：Double-blind Period|Adverse Event|3|||
162940694|NCT02081599|588486985|FG001|Period 1：Double-blind Period|Adverse Event|0|||
162940695|NCT02081599|588486984|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
162940696|NCT02081599|588486985|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
162940697|NCT02081599|588486984|FG000|Period 1：Double-blind Period|Physician Decision|1|||
162940698|NCT02081599|588486985|FG001|Period 1：Double-blind Period|Physician Decision|0|||
162940699|NCT02081599|588486984|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
162940700|NCT02081599|588486985|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
162940701|NCT02081599|588486984|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
162940702|NCT02081599|588486985|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
162940703|NCT02081599|588486984|FG000|Period 1：Double-blind Period|stopping criteria|1|||
162940704|NCT02081599|588486985|FG001|Period 1：Double-blind Period|stopping criteria|0|||
162940705|NCT02081599|588486984|FG000|Period 2：Open-label Period|Adverse Event|1|||
162940706|NCT02081599|588486985|FG001|Period 2：Open-label Period|Adverse Event|0|||
162940707|NCT02081599|588486984|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
162940708|NCT02081599|588486985|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
162940709|NCT02081599|588486984|FG000|Period 2：Open-label Period|Physician Decision|1|||
162940710|NCT02081599|588486985|FG001|Period 2：Open-label Period|Physician Decision|0|||
162940711|NCT02081599|588486984|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
162940712|NCT02081599|588486985|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
162940713|NCT02146430|588486994|FG000|Overall Study|Protocol Violation|5|||
162940714|NCT02146430|588486995|FG001|Overall Study|Protocol Violation|4|||
162940715|NCT02146430|588486996|FG002|Overall Study|Protocol Violation|8|||
162940716|NCT02146430|588486997|FG003|Overall Study|Protocol Violation|6|||
162940717|NCT02146430|588486994|FG000|Overall Study|Lack of Efficacy|13|||
162940718|NCT02146430|588486995|FG001|Overall Study|Lack of Efficacy|11|||
162940719|NCT02146430|588486996|FG002|Overall Study|Lack of Efficacy|8|||
162940720|NCT02146430|588486997|FG003|Overall Study|Lack of Efficacy|5|||
162940721|NCT02146430|588486994|FG000|Overall Study|Adverse Event|20|||
162940722|NCT02146430|588486995|FG001|Overall Study|Adverse Event|40|||
162940723|NCT02146430|588486996|FG002|Overall Study|Adverse Event|32|||
162940724|NCT02146430|588486997|FG003|Overall Study|Adverse Event|49|||
162940725|NCT02146430|588486994|FG000|Overall Study|Reason missing or not reported|2|||
162940726|NCT02146430|588486995|FG001|Overall Study|Reason missing or not reported|3|||
162940727|NCT02146430|588486996|FG002|Overall Study|Reason missing or not reported|4|||
162940728|NCT02146430|588486997|FG003|Overall Study|Reason missing or not reported|5|||
162940729|NCT02146430|588486994|FG000|Overall Study|Withdrawal by Subject|27|||
162940730|NCT02146430|588486995|FG001|Overall Study|Withdrawal by Subject|29|||
162940731|NCT02146430|588486996|FG002|Overall Study|Withdrawal by Subject|30|||
162940732|NCT02146430|588486997|FG003|Overall Study|Withdrawal by Subject|34|||
162940733|NCT03093324|588486998|FG000|Overall Study|Adverse Event|4|||
162940734|NCT03093324|588486999|FG001|Overall Study|Adverse Event|15|||
162940735|NCT03093324|588486998|FG000|Overall Study|Lost to Follow-up|1|||
162940736|NCT03093324|588486999|FG001|Overall Study|Lost to Follow-up|0|||
162940737|NCT03093324|588486998|FG000|Overall Study|Protocol Deviation|2|||
162940738|NCT03093324|588486999|FG001|Overall Study|Protocol Deviation|2|||
162940739|NCT03093324|588486998|FG000|Overall Study|Withdrawal by Subject|2|||
162940740|NCT03093324|588486999|FG001|Overall Study|Withdrawal by Subject|2|||
162940741|NCT01767597|588487000|FG000|Overall Study|Incomplete intervention|3|||
162940742|NCT01767597|588487001|FG001|Overall Study|Incomplete intervention|1|||
162940743|NCT01767597|588487000|FG000|Overall Study|Withdrawal by Subject|1|||
162940744|NCT01767597|588487001|FG001|Overall Study|Withdrawal by Subject|0|||
162940745|NCT05342753|588487002|FG000|Overall Study|Withdrawal by Subject|6|||
162940746|NCT05342753|588487002|FG000|Overall Study|Lost to Follow-up|1|||
162940747|NCT00836927|588487003|FG000|Overall Study|Progressive disease|2|||
162940748|NCT00836927|588487004|FG001|Overall Study|Progressive disease|0|||
162940749|NCT00836927|588487005|FG002|Overall Study|Progressive disease|0|||
162940750|NCT00836927|588487006|FG003|Overall Study|Progressive disease|1|||
162940751|NCT00836927|588487007|FG004|Overall Study|Progressive disease|1|||
162940752|NCT00836927|588487003|FG000|Overall Study|Withdrawal by Subject|1|||
162940753|NCT00836927|588487004|FG001|Overall Study|Withdrawal by Subject|0|||
162940754|NCT00836927|588487005|FG002|Overall Study|Withdrawal by Subject|0|||
162940755|NCT00836927|588487006|FG003|Overall Study|Withdrawal by Subject|0|||
162940756|NCT00836927|588487007|FG004|Overall Study|Withdrawal by Subject|0|||
162940757|NCT04583579|588487010|FG000|Overall Study|Lost to Follow-up|4|||
162940758|NCT02006706|588487011|FG000|Overall Study|Lost to Follow-up|1|||
162940759|NCT04700449|588487014|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
162940760|NCT04700449|588487015|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
162940761|NCT04700449|588487016|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
162940762|NCT04700449|588487017|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
162940763|NCT04700449|588487014|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
162940764|NCT04700449|588487015|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
162940765|NCT04700449|588487016|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
162940766|NCT04700449|588487017|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
162940767|NCT04700449|588487014|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
162940768|NCT04700449|588487015|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
162940769|NCT04700449|588487016|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
162940770|NCT04700449|588487017|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
162940771|NCT04700449|588487014|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
162940772|NCT04700449|588487015|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
162940773|NCT04700449|588487016|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
162940774|NCT04700449|588487017|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
162940775|NCT04700449|588487014|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
162940776|NCT04700449|588487015|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
162940777|NCT04700449|588487016|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
162940778|NCT04700449|588487017|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
162940779|NCT04700449|588487014|FG000|Stage 1: Double-Blind Period|Other|0|||
162940780|NCT04700449|588487015|FG001|Stage 1: Double-Blind Period|Other|0|||
162940781|NCT04700449|588487016|FG002|Stage 1: Double-Blind Period|Other|1|||
162940782|NCT04700449|588487017|FG003|Stage 1: Double-Blind Period|Other|0|||
163289895|NCT01543685|589766433|FG003|Overall Study|Lack of Efficacy|0|||
163289896|NCT01543685|589766434|FG004|Overall Study|Lack of Efficacy|2|||
163289897|NCT01543685|589766430|FG000|Overall Study|Adverse Event|2|||
163289898|NCT01543685|589766431|FG001|Overall Study|Adverse Event|1|||
163289899|NCT01543685|589766432|FG002|Overall Study|Adverse Event|0|||
163289900|NCT01543685|589766433|FG003|Overall Study|Adverse Event|0|||
163289901|NCT01543685|589766434|FG004|Overall Study|Adverse Event|2|||
163289902|NCT00604721|589766435|FG000|Overall Study|Physician Decision|1|||
163289903|NCT00604721|589766435|FG000|Overall Study|Withdrawal by Subject|1|||
163289904|NCT04776213|589766436|FG000|Overall Study|Other|1|||
163289905|NCT04776213|589766436|FG000|Overall Study|Withdrawal by Subject|7|||
163289906|NCT04776213|589766436|FG000|Overall Study|Protocol Violation|1|||
163289907|NCT04776213|589766436|FG000|Overall Study|Lost to Follow-up|2|||
163289908|NCT01838551|589766440|FG000|Overall Study|Adverse Event|16|||
163289909|NCT01838551|589766440|FG000|Overall Study|Death|1|||
163289910|NCT01838551|589766440|FG000|Overall Study|Lack of Efficacy|10|||
163289911|NCT01838551|589766440|FG000|Overall Study|Physician Decision|4|||
163289912|NCT01838551|589766440|FG000|Overall Study|Withdrawal by Subject|10|||
163289913|NCT01838551|589766440|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
163289914|NCT00906282|589766441|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
163289915|NCT00906282|589766441|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
163289916|NCT00906282|589766441|FG000|Preoperative Chemotherapy|Progressive disease|6|||
163289917|NCT00906282|589766441|FG000|Preoperative Chemotherapy|Toxicity|1|||
163289918|NCT00038103|589766442|FG000|Overall Study|Adverse Event|5|||
163289919|NCT00038103|589766443|FG001|Overall Study|Adverse Event|6|||
163289920|NCT00038103|589766442|FG000|Overall Study|Lack of Efficacy|48|||
163289921|NCT00038103|589766443|FG001|Overall Study|Lack of Efficacy|41|||
163289922|NCT00038103|589766442|FG000|Overall Study|Withdrawal by Subject|0|||
163289923|NCT00038103|589766443|FG001|Overall Study|Withdrawal by Subject|3|||
163289924|NCT00038103|589766442|FG000|Overall Study|Lost to Follow-up|0|||
163289925|NCT00038103|589766443|FG001|Overall Study|Lost to Follow-up|3|||
163289926|NCT00038103|589766442|FG000|Overall Study|Protocol Violation|0|||
163289927|NCT00038103|589766443|FG001|Overall Study|Protocol Violation|2|||
163289928|NCT00038103|589766442|FG000|Overall Study|Sponsor Decision|0|||
163289929|NCT00038103|589766443|FG001|Overall Study|Sponsor Decision|1|||
163184664|NCT00215683|589392710|FG002|Overall Study|Lost to Follow-up|1|||
163184665|NCT00215683|589392708|FG000|Overall Study|Withdrawal by Subject|9|||
163184666|NCT00215683|589392709|FG001|Overall Study|Withdrawal by Subject|4|||
163184667|NCT00215683|589392710|FG002|Overall Study|Withdrawal by Subject|13|||
163184668|NCT00215683|589392708|FG000|Overall Study|Physician Decision|0|||
163184669|NCT00215683|589392709|FG001|Overall Study|Physician Decision|0|||
163289930|NCT00038103|589766442|FG000|Overall Study|Randomized/never treated|2|||
162940783|NCT04700449|588487014|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
162940784|NCT04700449|588487015|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
163184670|NCT00215683|589392710|FG002|Overall Study|Physician Decision|1|||
163184671|NCT00215683|589392708|FG000|Overall Study|Difficult to attend visits|0|||
163184672|NCT00215683|589392709|FG001|Overall Study|Difficult to attend visits|1|||
163184673|NCT00215683|589392710|FG002|Overall Study|Difficult to attend visits|0|||
163184674|NCT00215683|589392708|FG000|Overall Study|No study drug available|0|||
163289931|NCT00038103|589766443|FG001|Overall Study|Randomized/never treated|0|||
163289932|NCT02163915|589766448|FG000|Overall Study|Withdrawal by Subject|2|||
163289933|NCT02163915|589766449|FG001|Overall Study|Withdrawal by Subject|0|||
163289934|NCT02163915|589766450|FG002|Overall Study|Withdrawal by Subject|2|||
163289935|NCT02163915|589766451|FG003|Overall Study|Withdrawal by Subject|2|||
163289936|NCT02163915|589766452|FG004|Overall Study|Withdrawal by Subject|2|||
163289937|NCT02163915|589766448|FG000|Overall Study|Study termination|1|||
163289938|NCT02163915|589766449|FG001|Overall Study|Study termination|0|||
163289939|NCT02163915|589766450|FG002|Overall Study|Study termination|0|||
163289940|NCT02163915|589766451|FG003|Overall Study|Study termination|0|||
163289941|NCT02163915|589766452|FG004|Overall Study|Study termination|2|||
163289942|NCT02163915|589766448|FG000|Overall Study|Physician Decision|0|||
163289943|NCT02163915|589766449|FG001|Overall Study|Physician Decision|0|||
163289944|NCT02163915|589766450|FG002|Overall Study|Physician Decision|0|||
163289945|NCT02163915|589766451|FG003|Overall Study|Physician Decision|1|||
163289946|NCT02163915|589766452|FG004|Overall Study|Physician Decision|0|||
163289947|NCT02299336|589766457|FG000|Overall Study|Withdrawal by Subject|11|||
163289948|NCT02299336|589766457|FG000|Overall Study|Adverse Event|1|||
163289949|NCT02299336|589766457|FG000|Overall Study|Death|1|||
163289950|NCT02299336|589766457|FG000|Overall Study|Lost to Follow-up|1|||
163289951|NCT02013037|589766459|FG000|Overall Study|Death|6|||
163289952|NCT02013037|589766459|FG000|Overall Study|Withdrawal by Subject|1|||
163289953|NCT02013037|589766459|FG000|Overall Study|Awaiting Transplantation|7|||
163289954|NCT02013037|589766459|FG000|Overall Study|Transplanted without DSA|2|||
163289955|NCT02465359|589766460|FG000|Overall Study|Lack of Efficacy|1|||
163289956|NCT02465359|589766460|FG000|Overall Study|Withdrawal by Subject|1|||
163289957|NCT02465359|589766460|FG000|Overall Study|Adverse Event|1|||
163289958|NCT01304147|589766461|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
163289959|NCT01304147|589766462|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
163289960|NCT03141788|589766463|FG000|Overall Study|Lost to Follow-up|1|||
163289961|NCT03141788|589766463|FG000|Overall Study|Protocol Violation|3|||
163289962|NCT03141788|589766463|FG000|Overall Study|Withdrawal by Subject|4|||
163289963|NCT02812966|589766466|FG000|Overall Study|Death|1|||
163289964|NCT02812966|589766467|FG001|Overall Study|Death|0|||
163289965|NCT01066923|589766468|FG000|Overall Study|Withdrawal by Subject|3|||
163289966|NCT01066923|589766469|FG001|Overall Study|Withdrawal by Subject|3|||
163289967|NCT01066923|589766470|FG002|Overall Study|Withdrawal by Subject|8|||
163289968|NCT01066923|589766471|FG003|Overall Study|Withdrawal by Subject|8|||
163289969|NCT02577523|589768242|FG000|Overall Study|Adverse Event|1|||
163289970|NCT02577523|589768243|FG001|Overall Study|Adverse Event|1|||
163289971|NCT02577523|589768242|FG000|Overall Study|Lack of Efficacy|1|||
163289972|NCT02577523|589768243|FG001|Overall Study|Lack of Efficacy|1|||
163289973|NCT02577523|589768242|FG000|Overall Study|Withdrawal by Subject|1|||
163289974|NCT02577523|589768243|FG001|Overall Study|Withdrawal by Subject|0|||
163289975|NCT00864682|589768253|FG000|Overall Study|Protocol Violation|2|||
163289976|NCT00864682|589768254|FG001|Overall Study|Protocol Violation|1|||
163289977|NCT00864682|589768255|FG002|Overall Study|Protocol Violation|2|||
163289978|NCT02506257|589768258|FG000|Overall Study|Adverse Event|0|||
163289979|NCT02506257|589768259|FG001|Overall Study|Adverse Event|2|||
163289980|NCT02506257|589768260|FG002|Overall Study|Adverse Event|3|||
163289981|NCT02506257|589768261|FG003|Overall Study|Adverse Event|0|||
163289982|NCT02506257|589768258|FG000|Overall Study|Protocol Violation|0|||
163289983|NCT02506257|589768259|FG001|Overall Study|Protocol Violation|0|||
163289984|NCT02506257|589768260|FG002|Overall Study|Protocol Violation|1|||
162940785|NCT04700449|588487016|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
162940786|NCT04700449|588487017|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
162940787|NCT04700449|588487014|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
162940788|NCT04700449|588487015|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
162940789|NCT04700449|588487016|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
162940790|NCT04700449|588487017|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
162940791|NCT04700449|588487014|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
162940792|NCT04700449|588487015|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
162940793|NCT04700449|588487016|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
162940794|NCT04700449|588487017|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
162940795|NCT04700449|588487014|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
162940796|NCT04700449|588487015|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
162940797|NCT04700449|588487016|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
162940798|NCT04700449|588487017|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
162940799|NCT04700449|588487014|FG000|Stage 2 Sub-study 1|Other|1|||
162940800|NCT04700449|588487015|FG001|Stage 2 Sub-study 1|Other|2|||
162940801|NCT04700449|588487016|FG002|Stage 2 Sub-study 1|Other|0|||
162940802|NCT04700449|588487017|FG003|Stage 2 Sub-study 1|Other|0|||
162940803|NCT04700449|588487014|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
162940804|NCT04700449|588487015|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
162940805|NCT04700449|588487016|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
162940806|NCT04700449|588487017|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
162940807|NCT04700449|588487014|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
162940808|NCT04700449|588487015|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
162940809|NCT04700449|588487016|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
162940810|NCT04700449|588487017|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
162940811|NCT04700449|588487014|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
162940812|NCT04700449|588487015|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
162940813|NCT04700449|588487016|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
162940814|NCT04700449|588487017|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
162940815|NCT04700449|588487014|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
163289985|NCT02506257|589768261|FG003|Overall Study|Protocol Violation|0|||
163289986|NCT01563354|589768265|FG000|Core Phase|Adverse Event|5|||
163289987|NCT01563354|589768266|FG001|Core Phase|Adverse Event|15|||
163289988|NCT01563354|589768267|FG002|Core Phase|Adverse Event|13|||
163289989|NCT01563354|589768265|FG000|Core Phase|Withdrawal by Subject|1|||
163289990|NCT01563354|589768266|FG001|Core Phase|Withdrawal by Subject|0|||
162940816|NCT04700449|588487015|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
162940817|NCT04700449|588487016|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
162940818|NCT04700449|588487017|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
162940819|NCT04700449|588487014|FG000|Stage 2 Sub-study 2|Other|0|||
162940820|NCT04700449|588487015|FG001|Stage 2 Sub-study 2|Other|0|||
162940821|NCT04700449|588487016|FG002|Stage 2 Sub-study 2|Other|0|||
162940822|NCT04700449|588487017|FG003|Stage 2 Sub-study 2|Other|5|||
162940823|NCT06041646|588487018|FG000|Overall Study|Withdrawal by Subject|1|||
162940824|NCT00356200|588487019|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
162940825|NCT00356200|588487020|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
162940826|NCT00356200|588487019|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
162940827|NCT00356200|588487020|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
162940828|NCT03209570|588487021|FG000|Overall Study|Death|1|||
163289991|NCT01563354|589768267|FG002|Core Phase|Withdrawal by Subject|3|||
163289992|NCT01563354|589768265|FG000|Core Phase|Lost to Follow-up|1|||
162940829|NCT03209570|588487022|FG001|Overall Study|Death|0|||
162940830|NCT03209570|588487021|FG000|Overall Study|Incomplete Data|8|||
163289993|NCT01563354|589768266|FG001|Core Phase|Lost to Follow-up|0|||
163289994|NCT01563354|589768267|FG002|Core Phase|Lost to Follow-up|0|||
163289995|NCT01563354|589768265|FG000|Core Phase|Death|1|||
163289996|NCT01563354|589768266|FG001|Core Phase|Death|5|||
163289997|NCT01563354|589768267|FG002|Core Phase|Death|2|||
163289998|NCT01563354|589768265|FG000|Core Phase|Diseasse progression|18|||
163289999|NCT01563354|589768266|FG001|Core Phase|Diseasse progression|7|||
163290000|NCT01563354|589768267|FG002|Core Phase|Diseasse progression|8|||
163290001|NCT01563354|589768265|FG000|Core Phase|Protocol deviation|2|||
163290002|NCT01563354|589768266|FG001|Core Phase|Protocol deviation|0|||
163290003|NCT01563354|589768267|FG002|Core Phase|Protocol deviation|0|||
163290004|NCT01563354|589768265|FG000|Core Phase|PI decision - did not enter extension|0|||
163290005|NCT01563354|589768266|FG001|Core Phase|PI decision - did not enter extension|1|||
163290006|NCT01563354|589768267|FG002|Core Phase|PI decision - did not enter extension|0|||
163290007|NCT01563354|589768265|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
163290008|NCT01563354|589768266|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
163290009|NCT01563354|589768267|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
163290010|NCT01563354|589768265|FG000|Extension Phase|Adverse Event|0|||
163290011|NCT01563354|589768266|FG001|Extension Phase|Adverse Event|3|||
163290012|NCT01563354|589768267|FG002|Extension Phase|Adverse Event|2|||
162940831|NCT03209570|588487022|FG001|Overall Study|Incomplete Data|10|||
162940832|NCT03209570|588487021|FG000|Overall Study|Protocol Violation|1|||
162940833|NCT03209570|588487022|FG001|Overall Study|Protocol Violation|0|||
162940834|NCT03209570|588487021|FG000|Overall Study|Withdrawal by Subject|0|||
162940835|NCT03209570|588487022|FG001|Overall Study|Withdrawal by Subject|3|||
162940836|NCT01000337|588487023|FG000|Overall Study|Lost to Follow-up|4|||
162940837|NCT01000337|588487024|FG001|Overall Study|Lost to Follow-up|3|||
162940838|NCT02173704|588487025|FG000|Overall Study|Adverse Event|1|||
162940839|NCT02173704|588487026|FG001|Overall Study|Adverse Event|0|||
162940840|NCT02173704|588487025|FG000|Overall Study|Lost to Follow-up|1|||
162940841|NCT02173704|588487026|FG001|Overall Study|Lost to Follow-up|0|||
162940842|NCT02173704|588487025|FG000|Overall Study|Other|1|||
162940843|NCT02173704|588487026|FG001|Overall Study|Other|0|||
162940844|NCT02173704|588487025|FG000|Overall Study|Protocol Violation|1|||
162940845|NCT02173704|588487026|FG001|Overall Study|Protocol Violation|0|||
162940846|NCT02173704|588487025|FG000|Overall Study|Withdrawal by Subject|9|||
162940847|NCT02173704|588487026|FG001|Overall Study|Withdrawal by Subject|4|||
162940848|NCT03901963|588487027|FG000|Overall Study|Lost to Follow-up|1|||
162940849|NCT03901963|588487028|FG001|Overall Study|Lost to Follow-up|1|||
162940850|NCT03901963|588487027|FG000|Overall Study|Physician Decision|1|||
162940851|NCT03901963|588487028|FG001|Overall Study|Physician Decision|2|||
162940852|NCT03901963|588487027|FG000|Overall Study|Protocol Violation|1|||
162940853|NCT03901963|588487028|FG001|Overall Study|Protocol Violation|1|||
162940854|NCT03901963|588487027|FG000|Overall Study|Withdrawal by Subject|4|||
162940855|NCT03901963|588487028|FG001|Overall Study|Withdrawal by Subject|11|||
162940856|NCT03901963|588487027|FG000|Overall Study|Ongoing|84|||
162940857|NCT03901963|588487028|FG001|Overall Study|Ongoing|73|||
162940858|NCT03901963|588487027|FG000|Overall Study|Randomized but not treated|3|||
162940859|NCT03901963|588487028|FG001|Overall Study|Randomized but not treated|3|||
162940860|NCT04956666|588487029|FG000|Overall Study|Adverse Event|18|||
162940861|NCT04956666|588487029|FG000|Overall Study|Physician Decision|5|||
162940862|NCT02909673|588487030|FG000|Overall Study|Did not meet inclusion criteria|129|||
162940863|NCT02909673|588487031|FG001|Overall Study|Did not meet inclusion criteria|29|||
162940864|NCT02909673|588487030|FG000|Overall Study|Surveys lost by scanner|95|||
162940865|NCT02909673|588487031|FG001|Overall Study|Surveys lost by scanner|2|||
162940866|NCT02909673|588487030|FG000|Overall Study|Tracking info missing|0|||
162940867|NCT02909673|588487031|FG001|Overall Study|Tracking info missing|5|||
162940868|NCT03349333|588487040|FG000|Overall Study|Progression of Disease|36|||
162940869|NCT03349333|588487040|FG000|Overall Study|Adverse Event|11|||
162940870|NCT03349333|588487040|FG000|Overall Study|Other|6|||
162940871|NCT03349333|588487040|FG000|Overall Study|Withdrawal by Subject|5|||
163184675|NCT00215683|589392709|FG001|Overall Study|No study drug available|1|||
163184676|NCT00215683|589392710|FG002|Overall Study|No study drug available|0|||
163184677|NCT00215683|589392708|FG000|Overall Study|Intermittent therapy required|0|||
163184678|NCT00215683|589392709|FG001|Overall Study|Intermittent therapy required|1|||
163184679|NCT00215683|589392710|FG002|Overall Study|Intermittent therapy required|0|||
163184680|NCT02437513|589392712|FG000|Overall Study|Withdrawal by Subject|2|||
163184681|NCT00595465|589392713|FG000|Overall Study|Adverse Event|4|||
163184682|NCT00595465|589392714|FG001|Overall Study|Adverse Event|3|||
163184683|NCT00595465|589392715|FG002|Overall Study|Adverse Event|3|||
163184684|NCT00595465|589392713|FG000|Overall Study|Pregnancy|0|||
163184685|NCT00595465|589392714|FG001|Overall Study|Pregnancy|0|||
163184686|NCT00595465|589392715|FG002|Overall Study|Pregnancy|1|||
163184687|NCT00595465|589392713|FG000|Overall Study|Protocol Violation|2|||
163184688|NCT00595465|589392714|FG001|Overall Study|Protocol Violation|1|||
163184689|NCT00595465|589392715|FG002|Overall Study|Protocol Violation|0|||
163184690|NCT00595465|589392713|FG000|Overall Study|Lost to Follow-up|0|||
163184691|NCT00595465|589392714|FG001|Overall Study|Lost to Follow-up|0|||
163184692|NCT00595465|589392715|FG002|Overall Study|Lost to Follow-up|2|||
163184693|NCT00595465|589392713|FG000|Overall Study|administrative reason|0|||
163184694|NCT00595465|589392714|FG001|Overall Study|administrative reason|0|||
163184695|NCT00595465|589392715|FG002|Overall Study|administrative reason|1|||
163184696|NCT00107783|589392716|FG000|Overall Study|Adverse Event|0|||
163184697|NCT00107783|589392717|FG001|Overall Study|Adverse Event|2|||
163184698|NCT00107783|589392716|FG000|Overall Study|Death|0|||
163184699|NCT00107783|589392717|FG001|Overall Study|Death|1|||
163184700|NCT00107783|589392716|FG000|Overall Study|Withdrawal by Subject|2|||
163184701|NCT00107783|589392717|FG001|Overall Study|Withdrawal by Subject|0|||
163184702|NCT00107783|589392716|FG000|Overall Study|Second hip replacement|1|||
163184703|NCT00107783|589392717|FG001|Overall Study|Second hip replacement|1|||
163184704|NCT01298531|589392718|FG000|Overall Study|Lack of Efficacy|0|||
163184705|NCT01298531|589392719|FG001|Overall Study|Lack of Efficacy|1|||
163184706|NCT01298531|589392718|FG000|Overall Study|Lost to Follow-up|2|||
163184707|NCT01298531|589392719|FG001|Overall Study|Lost to Follow-up|0|||
163184708|NCT01298531|589392718|FG000|Overall Study|Protocol Violation|1|||
162940872|NCT03349333|588487040|FG000|Overall Study|Conditions interfere with participation|2|||
162940873|NCT03349333|588487040|FG000|Overall Study|Physician Decision|2|||
162940874|NCT03349333|588487040|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
162940875|NCT03349333|588487040|FG000|Overall Study|Patients in treatment less than 24 month|8|||
162940876|NCT00783796|588487041|FG000|Overall Study|Did not receive any stent|4|||
162940877|NCT00783796|588487041|FG000|Overall Study|Received non-XIENCE V stent|1|||
162940878|NCT00783796|588487041|FG000|Overall Study|Received commercial XIENCE V stent|1|||
162940879|NCT02752776|588487044|FG000|Overall Study|Adverse Event|15|||
162940880|NCT02752776|588487045|FG001|Overall Study|Adverse Event|23|||
162940881|NCT02752776|588487046|FG002|Overall Study|Adverse Event|11|||
163290013|NCT01563354|589768265|FG000|Extension Phase|Withdrawal by Subject|0|||
163290014|NCT01563354|589768266|FG001|Extension Phase|Withdrawal by Subject|1|||
163290015|NCT01563354|589768267|FG002|Extension Phase|Withdrawal by Subject|0|||
163290016|NCT01563354|589768265|FG000|Extension Phase|Administration problems|3|||
163290017|NCT01563354|589768266|FG001|Extension Phase|Administration problems|2|||
163290018|NCT01563354|589768267|FG002|Extension Phase|Administration problems|3|||
163290019|NCT01563354|589768265|FG000|Extension Phase|Disease progression|9|||
163290020|NCT01563354|589768266|FG001|Extension Phase|Disease progression|8|||
163290021|NCT01563354|589768267|FG002|Extension Phase|Disease progression|10|||
163290022|NCT01119950|589768268|FG000|Overall Study|Adverse Event|25|||
163290023|NCT01119950|589768268|FG000|Overall Study|Withdrawal by Subject|9|||
163290024|NCT01119950|589768268|FG000|Overall Study|Protocol Violation|5|||
163290025|NCT01119950|589768268|FG000|Overall Study|Lost to Follow-up|4|||
163290026|NCT01119950|589768268|FG000|Overall Study|Administrative|2|||
163290027|NCT01119950|589768268|FG000|Overall Study|Abnormal lab value|1|||
163290028|NCT01119950|589768268|FG000|Overall Study|Death|1|||
163290029|NCT03058991|589768280|FG000|Overall Study|Lost to Follow-up|17|||
163290030|NCT03058991|589768281|FG001|Overall Study|Lost to Follow-up|12|||
163290031|NCT03058991|589768282|FG002|Overall Study|Lost to Follow-up|12|||
163290032|NCT03058991|589768280|FG000|Overall Study|Withdrawal by Subject|1|||
163290033|NCT03058991|589768281|FG001|Overall Study|Withdrawal by Subject|0|||
163290034|NCT03058991|589768282|FG002|Overall Study|Withdrawal by Subject|0|||
163290035|NCT01988233|589768283|FG000|Overall Study|Lost to Follow-up|64|||
163290036|NCT01988233|589768284|FG001|Overall Study|Lost to Follow-up|51|||
163290037|NCT03525119|589768285|FG000|Overall Study|Adverse Event|0|||
163290038|NCT03525119|589768286|FG001|Overall Study|Adverse Event|1|||
163290039|NCT03525119|589768287|FG002|Overall Study|Adverse Event|0|||
162940882|NCT02752776|588487044|FG000|Overall Study|Lack of Efficacy|2|||
162940883|NCT02752776|588487045|FG001|Overall Study|Lack of Efficacy|6|||
162940884|NCT02752776|588487046|FG002|Overall Study|Lack of Efficacy|14|||
162940885|NCT02752776|588487044|FG000|Overall Study|Lost to Follow-up|11|||
162940886|NCT02752776|588487045|FG001|Overall Study|Lost to Follow-up|12|||
162940887|NCT02752776|588487046|FG002|Overall Study|Lost to Follow-up|4|||
163290040|NCT03525119|589768285|FG000|Overall Study|Lost to Follow-up|32|||
163290041|NCT03525119|589768286|FG001|Overall Study|Lost to Follow-up|33|||
163290042|NCT03525119|589768287|FG002|Overall Study|Lost to Follow-up|37|||
163290043|NCT03525119|589768285|FG000|Overall Study|Withdrawal by Subject|5|||
163290044|NCT03525119|589768286|FG001|Overall Study|Withdrawal by Subject|4|||
163290045|NCT03525119|589768287|FG002|Overall Study|Withdrawal by Subject|2|||
163290046|NCT03525119|589768285|FG000|Overall Study|Reason not Specified|2|||
163290047|NCT03525119|589768286|FG001|Overall Study|Reason not Specified|1|||
163290048|NCT03525119|589768287|FG002|Overall Study|Reason not Specified|2|||
163290049|NCT03525119|589768285|FG000|Overall Study|Randomized but not Vaccinated|1|||
163290050|NCT03525119|589768286|FG001|Overall Study|Randomized but not Vaccinated|0|||
163290051|NCT03525119|589768287|FG002|Overall Study|Randomized but not Vaccinated|2|||
163290052|NCT05046132|589768288|FG000|Overall Study|Adverse Event|4|||
163290053|NCT05046132|589768289|FG001|Overall Study|Adverse Event|0|||
163290054|NCT05046132|589768290|FG002|Overall Study|Adverse Event|0|||
163290055|NCT05046132|589768288|FG000|Overall Study|Withdrawal by Subject|3|||
163290056|NCT05046132|589768289|FG001|Overall Study|Withdrawal by Subject|0|||
163290057|NCT05046132|589768290|FG002|Overall Study|Withdrawal by Subject|0|||
163290058|NCT05046132|589768288|FG000|Overall Study|Positive Covid19 Result.|0|||
163290059|NCT05046132|589768289|FG001|Overall Study|Positive Covid19 Result.|1|||
163290060|NCT05046132|589768290|FG002|Overall Study|Positive Covid19 Result.|0|||
162940888|NCT02752776|588487044|FG000|Overall Study|Non-compliance with study treatment|0|||
162940889|NCT02752776|588487045|FG001|Overall Study|Non-compliance with study treatment|0|||
162940890|NCT02752776|588487046|FG002|Overall Study|Non-compliance with study treatment|1|||
163290061|NCT01959412|589768291|FG000|Overall Study|Protocol deviation|1|||
163290062|NCT01959412|589768292|FG001|Overall Study|Protocol deviation|1|||
163290063|NCT01959412|589768293|FG002|Overall Study|Protocol deviation|0|||
163290064|NCT01959412|589768294|FG003|Overall Study|Protocol deviation|1|||
163290065|NCT01959412|589768295|FG004|Overall Study|Protocol deviation|3|||
163290066|NCT01959412|589768296|FG005|Overall Study|Protocol deviation|0|||
163290067|NCT01959412|589768291|FG000|Overall Study|Adverse Event|0|||
163290068|NCT01959412|589768292|FG001|Overall Study|Adverse Event|0|||
163290069|NCT01959412|589768293|FG002|Overall Study|Adverse Event|0|||
163290070|NCT01959412|589768294|FG003|Overall Study|Adverse Event|1|||
163290071|NCT01959412|589768295|FG004|Overall Study|Adverse Event|0|||
163290072|NCT01959412|589768296|FG005|Overall Study|Adverse Event|0|||
163290073|NCT01186848|589768297|FG000|Overall Study|Lost to Follow-up|4|||
163290074|NCT01186848|589768297|FG000|Overall Study|Withdrawal by Subject|2|||
163290075|NCT01186848|589768297|FG000|Overall Study|Adverse Event|2|||
162940891|NCT02752776|588487044|FG000|Overall Study|Physician Decision|2|||
162940892|NCT02752776|588487045|FG001|Overall Study|Physician Decision|6|||
162940893|NCT02752776|588487046|FG002|Overall Study|Physician Decision|2|||
162940894|NCT02752776|588487044|FG000|Overall Study|Pregnancy|1|||
162940895|NCT02752776|588487045|FG001|Overall Study|Pregnancy|6|||
162940896|NCT02752776|588487046|FG002|Overall Study|Pregnancy|3|||
162940897|NCT02752776|588487044|FG000|Overall Study|Protocol Violation|10|||
162940898|NCT02752776|588487045|FG001|Overall Study|Protocol Violation|13|||
162940899|NCT02752776|588487046|FG002|Overall Study|Protocol Violation|6|||
162940900|NCT02752776|588487044|FG000|Overall Study|Subject/guardian decision|8|||
162940901|NCT02752776|588487045|FG001|Overall Study|Subject/guardian decision|6|||
162940902|NCT02752776|588487046|FG002|Overall Study|Subject/guardian decision|4|||
162940903|NCT02752776|588487044|FG000|Overall Study|Death|0|||
162940904|NCT02752776|588487045|FG001|Overall Study|Death|0|||
162940905|NCT02752776|588487046|FG002|Overall Study|Death|1|||
162940906|NCT02752776|588487044|FG000|Overall Study|Withdrawal by Subject|3|||
162940907|NCT02752776|588487045|FG001|Overall Study|Withdrawal by Subject|4|||
162940908|NCT02752776|588487046|FG002|Overall Study|Withdrawal by Subject|2|||
162940909|NCT01816477|588487047|FG000|Overall Study|Withdrawal by Subject|13|||
162940910|NCT01816477|588487048|FG001|Overall Study|Withdrawal by Subject|1|||
162940911|NCT01816477|588487047|FG000|Overall Study|Unable to tolerate catheter placement|3|||
162940912|NCT01816477|588487048|FG001|Overall Study|Unable to tolerate catheter placement|0|||
162940913|NCT02162758|588487049|FG000|Overall Study|Study termination|0|||
162940914|NCT02162758|588487050|FG001|Overall Study|Study termination|1|||
162940915|NCT02116803|588487051|FG000|Overall Study|Adverse Event|2|||
162940916|NCT02116803|588487052|FG001|Overall Study|Adverse Event|1|||
162940917|NCT02116803|588487051|FG000|Overall Study|Physician Decision|1|||
162940918|NCT02116803|588487052|FG001|Overall Study|Physician Decision|0|||
162940919|NCT02116803|588487051|FG000|Overall Study|Progressive disease|4|||
162940920|NCT02116803|588487052|FG001|Overall Study|Progressive disease|0|||
162940921|NCT02116803|588487051|FG000|Overall Study|Study terminated by sponsor|2|||
162940922|NCT02116803|588487052|FG001|Overall Study|Study terminated by sponsor|1|||
162940923|NCT02116803|588487051|FG000|Overall Study|Death|1|||
162940924|NCT02116803|588487052|FG001|Overall Study|Death|0|||
162940925|NCT03213210|588487053|FG000|Overall Study|Lost to Follow-up|2|||
162940926|NCT03213210|588487053|FG000|Overall Study|Study termination|3|||
162940927|NCT00684671|588487054|FG000|Overall Study|Adverse Event|1|||
162940928|NCT00684671|588487055|FG001|Overall Study|Adverse Event|0|||
162940929|NCT00684671|588487056|FG002|Overall Study|Adverse Event|0|||
162940930|NCT00684671|588487054|FG000|Overall Study|Lost to Follow-up|1|||
162940931|NCT00684671|588487055|FG001|Overall Study|Lost to Follow-up|0|||
162940932|NCT00684671|588487056|FG002|Overall Study|Lost to Follow-up|0|||
162940933|NCT00684671|588487054|FG000|Overall Study|Alcoholic dependance|1|||
162940934|NCT00684671|588487055|FG001|Overall Study|Alcoholic dependance|0|||
162940935|NCT00684671|588487056|FG002|Overall Study|Alcoholic dependance|0|||
162940936|NCT04128007|588487057|FG000|Overall Study|Withdrawal by Subject|9|||
162940937|NCT04128007|588487058|FG001|Overall Study|Withdrawal by Subject|6|||
162940938|NCT04128007|588487057|FG000|Overall Study|Protocol Violation|1|||
162940939|NCT04128007|588487058|FG001|Overall Study|Protocol Violation|0|||
162940940|NCT04128007|588487057|FG000|Overall Study|Lost to Follow-up|8|||
162940941|NCT04128007|588487058|FG001|Overall Study|Lost to Follow-up|7|||
162940942|NCT04128007|588487057|FG000|Overall Study|Adverse Event|5|||
162940943|NCT04128007|588487058|FG001|Overall Study|Adverse Event|2|||
163290076|NCT00158054|589768308|FG000|Overall Study|Refused to continue|3|||
162940944|NCT04128007|588487057|FG000|Overall Study|Not reported|0|||
162940945|NCT04128007|588487058|FG001|Overall Study|Not reported|2|||
162940946|NCT00481247|588487061|FG000|Overall Study|Death|0|||
162940947|NCT00481247|588487062|FG001|Overall Study|Death|1|||
162940948|NCT00481247|588487061|FG000|Overall Study|Disease progression|18|||
162940949|NCT00481247|588487062|FG001|Overall Study|Disease progression|22|||
162940950|NCT00481247|588487061|FG000|Overall Study|Intolerance|42|||
162940951|NCT00481247|588487062|FG001|Overall Study|Intolerance|17|||
162940952|NCT00481247|588487061|FG000|Overall Study|Treatment failure|10|||
162940953|NCT00481247|588487062|FG001|Overall Study|Treatment failure|14|||
162940954|NCT00481247|588487061|FG000|Overall Study|AE unrelated to study drug|13|||
162940955|NCT00481247|588487062|FG001|Overall Study|AE unrelated to study drug|4|||
162940956|NCT00481247|588487061|FG000|Overall Study|Withdrawal by Subject|8|||
162940957|NCT00481247|588487062|FG001|Overall Study|Withdrawal by Subject|13|||
162940958|NCT00481247|588487061|FG000|Overall Study|Pregnancy|2|||
162940959|NCT00481247|588487062|FG001|Overall Study|Pregnancy|1|||
162940960|NCT00481247|588487061|FG000|Overall Study|Lost to Follow-up|1|||
162940961|NCT00481247|588487062|FG001|Overall Study|Lost to Follow-up|2|||
162940962|NCT00481247|588487061|FG000|Overall Study|Poor compliance/noncompliance|1|||
162940963|NCT00481247|588487062|FG001|Overall Study|Poor compliance/noncompliance|7|||
162940964|NCT00481247|588487061|FG000|Overall Study|Administrative reason by sponsor|157|||
162940965|NCT00481247|588487062|FG001|Overall Study|Administrative reason by sponsor|162|||
162940966|NCT00481247|588487061|FG000|Overall Study|Varied|6|||
162940967|NCT00481247|588487062|FG001|Overall Study|Varied|15|||
162940968|NCT00481247|588487061|FG000|Overall Study|Did not receive treatment|1|||
162940969|NCT00481247|588487062|FG001|Overall Study|Did not receive treatment|2|||
162940970|NCT01716754|588487063|FG000|Overall Study|Death|0|||
162940971|NCT01716754|588487064|FG001|Overall Study|Death|0|||
162940972|NCT01716754|588487065|FG002|Overall Study|Death|0|||
162940973|NCT01716754|588487066|FG003|Overall Study|Death|1|||
162940974|NCT01716754|588487063|FG000|Overall Study|Protocol deviation|0|||
162940975|NCT01716754|588487064|FG001|Overall Study|Protocol deviation|2|||
162940976|NCT01716754|588487065|FG002|Overall Study|Protocol deviation|7|||
162940977|NCT01716754|588487066|FG003|Overall Study|Protocol deviation|2|||
162940978|NCT01716754|588487063|FG000|Overall Study|Non-compliance with study treatment|0|||
163184709|NCT01298531|589392719|FG001|Overall Study|Protocol Violation|1|||
163184710|NCT01298531|589392718|FG000|Overall Study|Adverse Event|4|||
163184711|NCT01298531|589392719|FG001|Overall Study|Adverse Event|3|||
163184712|NCT01298531|589392718|FG000|Overall Study|Does not meet entrance criteria|0|||
163184713|NCT01298531|589392719|FG001|Overall Study|Does not meet entrance criteria|1|||
163184714|NCT01298531|589392718|FG000|Overall Study|Other|2|||
163184715|NCT01298531|589392719|FG001|Overall Study|Other|1|||
163184716|NCT00422097|589392720|FG000|Dose Level 2|Still on treatment|0|||
163184717|NCT00422097|589392721|FG001|Dose Level 2|Still on treatment|1|||
163184718|NCT00422097|589392722|FG002|Dose Level 2|Still on treatment|0|||
163184719|NCT00422097|589392723|FG003|Dose Level 2|Still on treatment|0|||
163184720|NCT00422097|589392724|FG004|Dose Level 2|Still on treatment|0|||
163184721|NCT00422097|589392725|FG005|Dose Level 2|Still on treatment|0|||
163184722|NCT00422097|589392726|FG006|Dose Level 2|Still on treatment|0|||
163184723|NCT00422097|589392727|FG007|Dose Level 2|Still on treatment|0|||
163184724|NCT02360995|589392728|FG000|Overall Study|Lost to Follow-up|2|||
163184725|NCT02360995|589392729|FG001|Overall Study|Lost to Follow-up|0|||
163184726|NCT02360995|589392730|FG002|Overall Study|Lost to Follow-up|2|||
163184727|NCT02360995|589392728|FG000|Overall Study|Withdrawal by Subject|0|||
163184728|NCT02360995|589392729|FG001|Overall Study|Withdrawal by Subject|1|||
163184729|NCT02360995|589392730|FG002|Overall Study|Withdrawal by Subject|0|||
163184730|NCT04622735|589392731|FG000|Overall Study|Lost to Follow-up|1|||
163184731|NCT04622735|589392732|FG001|Overall Study|Lost to Follow-up|2|||
163184732|NCT04622735|589392733|FG002|Overall Study|Lost to Follow-up|1|||
163184733|NCT04622735|589392731|FG000|Overall Study|Adverse Event|0|||
163184734|NCT04622735|589392732|FG001|Overall Study|Adverse Event|0|||
163184735|NCT04622735|589392733|FG002|Overall Study|Adverse Event|1|||
163184736|NCT04622735|589392731|FG000|Overall Study|Protocol Violation|1|||
163184737|NCT04622735|589392732|FG001|Overall Study|Protocol Violation|0|||
163184738|NCT04622735|589392733|FG002|Overall Study|Protocol Violation|0|||
163184739|NCT02476422|589392738|FG000|Overall Study|Subject/guardian decision|0|||
163184740|NCT02476422|589392739|FG001|Overall Study|Subject/guardian decision|1|||
163184741|NCT03960554|589392745|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
163184742|NCT03960554|589392746|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
163184743|NCT02545075|589392747|FG000|Randomization|Lost to Follow-up|0|||
163184744|NCT02545075|589392748|FG001|Randomization|Lost to Follow-up|1|||
163184745|NCT02545075|589392747|FG000|Randomization|Withdrawal by Subject|0|||
163184746|NCT02545075|589392748|FG001|Randomization|Withdrawal by Subject|6|||
163184747|NCT02545075|589392747|FG000|Treatment|Disease progression|71|||
163184748|NCT02545075|589392748|FG001|Treatment|Disease progression|32|||
163184749|NCT02545075|589392747|FG000|Treatment|Participant dicontinued study treatment|7|||
163184750|NCT02545075|589392748|FG001|Treatment|Participant dicontinued study treatment|9|||
163184751|NCT02545075|589392747|FG000|Treatment|Withdrawal by Subject|1|||
163184752|NCT02545075|589392748|FG001|Treatment|Withdrawal by Subject|0|||
163184753|NCT02545075|589392747|FG000|Treatment|Adverse event not related to study drug|1|||
163184754|NCT02545075|589392748|FG001|Treatment|Adverse event not related to study drug|0|||
163184755|NCT02545075|589392747|FG000|Treatment|Death|1|||
163184756|NCT02545075|589392748|FG001|Treatment|Death|0|||
163184757|NCT02545075|589392747|FG000|Treatment|Participant drug toxicity|1|||
163184758|NCT02545075|589392748|FG001|Treatment|Participant drug toxicity|0|||
163184759|NCT02545075|589392747|FG000|Treatment|Completed treatment|40|||
163184760|NCT02545075|589392748|FG001|Treatment|Completed treatment|12|||
163184761|NCT00735254|589392753|FG000|Overall Study|Protocol Violation|1|||
163184762|NCT00735254|589392754|FG001|Overall Study|Protocol Violation|1|||
163184763|NCT00735254|589392755|FG002|Overall Study|Protocol Violation|1|||
163184764|NCT00735254|589392756|FG003|Overall Study|Protocol Violation|0|||
163184765|NCT06400979|589392757|FG000|Overall Study|Lost to Follow-up|29|||
163184766|NCT06400979|589392757|FG000|Overall Study|Withdrawal by Subject|1|||
163184767|NCT00925990|589392764|FG000|Overall Study|Adverse Event|1|||
163184768|NCT00925990|589392765|FG001|Overall Study|Adverse Event|3|||
163184769|NCT00925990|589392764|FG000|Overall Study|Withdrawal by Subject|2|||
163184770|NCT00925990|589392765|FG001|Overall Study|Withdrawal by Subject|2|||
163184771|NCT00925990|589392764|FG000|Overall Study|Lost to Follow-up|1|||
163184772|NCT00925990|589392765|FG001|Overall Study|Lost to Follow-up|3|||
163184773|NCT00925990|589392764|FG000|Overall Study|Physician Decision|1|||
163184774|NCT00925990|589392765|FG001|Overall Study|Physician Decision|1|||
163184775|NCT00925990|589392764|FG000|Overall Study|moved out of state, missed medication|0|||
163184776|NCT00925990|589392765|FG001|Overall Study|moved out of state, missed medication|2|||
162940979|NCT01716754|588487064|FG001|Overall Study|Non-compliance with study treatment|0|||
162940980|NCT01716754|588487065|FG002|Overall Study|Non-compliance with study treatment|1|||
162940981|NCT01716754|588487066|FG003|Overall Study|Non-compliance with study treatment|0|||
162940982|NCT01716754|588487063|FG000|Overall Study|Physician Decision|1|||
162940983|NCT01716754|588487064|FG001|Overall Study|Physician Decision|0|||
162940984|NCT01716754|588487065|FG002|Overall Study|Physician Decision|0|||
162940985|NCT01716754|588487066|FG003|Overall Study|Physician Decision|0|||
162940986|NCT01716754|588487063|FG000|Overall Study|Lost to Follow-up|1|||
162940987|NCT01716754|588487064|FG001|Overall Study|Lost to Follow-up|0|||
162940988|NCT01716754|588487065|FG002|Overall Study|Lost to Follow-up|0|||
162940989|NCT01716754|588487066|FG003|Overall Study|Lost to Follow-up|1|||
162940990|NCT01716754|588487063|FG000|Overall Study|Adverse Event|4|||
162940991|NCT01716754|588487064|FG001|Overall Study|Adverse Event|2|||
162940992|NCT01716754|588487065|FG002|Overall Study|Adverse Event|2|||
162940993|NCT01716754|588487066|FG003|Overall Study|Adverse Event|1|||
162940994|NCT01716754|588487063|FG000|Overall Study|Withdrawal by Subject|5|||
162940995|NCT01716754|588487064|FG001|Overall Study|Withdrawal by Subject|0|||
162940996|NCT01716754|588487065|FG002|Overall Study|Withdrawal by Subject|4|||
162940997|NCT01716754|588487066|FG003|Overall Study|Withdrawal by Subject|3|||
162940998|NCT02110706|588487086|FG000|Overall Study|Adverse Event|2|||
162940999|NCT02110706|588487087|FG001|Overall Study|Adverse Event|3|||
162941000|NCT02110706|588487086|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
162941001|NCT02110706|588487087|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
162941002|NCT03521999|588487089|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
162941003|NCT03521999|588487090|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
162941004|NCT03521999|588487089|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
162941005|NCT03521999|588487090|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
162941006|NCT03521999|588487089|FG000|Completed 3 Month Follow up|Death|0|||
162941007|NCT03521999|588487090|FG001|Completed 3 Month Follow up|Death|1|||
162941008|NCT03521999|588487089|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
162941009|NCT03521999|588487090|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
162941010|NCT04182204|588487093|FG000|Safety Run-in|Lost to Follow-up|1|||
162941011|NCT04182204|588487094|FG001|Safety Run-in|Lost to Follow-up|0|||
162941012|NCT04182204|588487095|FG002|Safety Run-in|Lost to Follow-up|0|||
162941013|NCT04182204|588487093|FG000|Safety Run-in|Withdrawal by Subject|2|||
162941014|NCT04182204|588487094|FG001|Safety Run-in|Withdrawal by Subject|0|||
162941015|NCT04182204|588487095|FG002|Safety Run-in|Withdrawal by Subject|0|||
162941016|NCT04182204|588487093|FG000|Safety Run-in|Death|7|||
162941017|NCT04182204|588487094|FG001|Safety Run-in|Death|0|||
162941018|NCT04182204|588487095|FG002|Safety Run-in|Death|0|||
162941019|NCT04182204|588487093|FG000|Randomized Controlled Trial|Lost to Follow-up|0|||
162941020|NCT04182204|588487094|FG001|Randomized Controlled Trial|Lost to Follow-up|1|||
162941021|NCT04182204|588487095|FG002|Randomized Controlled Trial|Lost to Follow-up|2|||
162941022|NCT04182204|588487093|FG000|Randomized Controlled Trial|Withdrawal by Subject|0|||
162941023|NCT04182204|588487094|FG001|Randomized Controlled Trial|Withdrawal by Subject|10|||
162941024|NCT04182204|588487095|FG002|Randomized Controlled Trial|Withdrawal by Subject|6|||
163290077|NCT00158054|589768309|FG001|Overall Study|Refused to continue|0|||
163290078|NCT00158054|589768308|FG000|Overall Study|Unavailable for follow up|7|||
163290079|NCT00158054|589768309|FG001|Overall Study|Unavailable for follow up|3|||
162941025|NCT04182204|588487093|FG000|Randomized Controlled Trial|Death|0|||
162941026|NCT04182204|588487094|FG001|Randomized Controlled Trial|Death|83|||
162941027|NCT04182204|588487095|FG002|Randomized Controlled Trial|Death|66|||
162941028|NCT03933202|588487096|FG000|Overall Study|Participant withdrawn by Principal Investigator|1|||
162941029|NCT03933202|588487097|FG001|Overall Study|Participant withdrawn by Principal Investigator|0|||
162941030|NCT03933202|588487096|FG000|Overall Study|Participant transferred care|1|||
162941031|NCT03933202|588487097|FG001|Overall Study|Participant transferred care|0|||
162941032|NCT03933202|588487096|FG000|Overall Study|Site research department closing|1|||
162941033|NCT03933202|588487097|FG001|Overall Study|Site research department closing|0|||
162941034|NCT03933202|588487096|FG000|Overall Study|Site closed prematurely due to unexpected circumstances|0|||
162941035|NCT03933202|588487097|FG001|Overall Study|Site closed prematurely due to unexpected circumstances|1|||
162941036|NCT03933202|588487096|FG000|Overall Study|Participant discontinuation due to Sponsor decision to close study|0|||
162941037|NCT03933202|588487097|FG001|Overall Study|Participant discontinuation due to Sponsor decision to close study|2|||
162941038|NCT03933202|588487096|FG000|Overall Study|Participant changed primary neurology provider|1|||
163042849|NCT01066871|588863977|FG003|Overall Study|Protocol Violation|2|||
163184777|NCT00750880|589392766|FG000|Overall Study|Adverse Event|76|||
163184778|NCT00750880|589392766|FG000|Overall Study|Death|4|||
163184779|NCT00750880|589392766|FG000|Overall Study|Lack of Efficacy|46|||
163184780|NCT00750880|589392766|FG000|Overall Study|Lost to Follow-up|10|||
163184781|NCT00750880|589392766|FG000|Overall Study|Protocol Violation|15|||
163184782|NCT00750880|589392766|FG000|Overall Study|Withdrawal by Subject|33|||
163184783|NCT00750880|589392766|FG000|Overall Study|Physician Decision|20|||
163184784|NCT00750880|589392766|FG000|Overall Study|Administrative|11|||
163184785|NCT00573248|589392775|FG000|Overall Study|scheduling conflicts|15|||
163184786|NCT00573248|589392776|FG001|Overall Study|scheduling conflicts|11|||
163184787|NCT02536833|589392779|FG000|Overall Study|Discontinued Before Treatment|0|||
163184788|NCT02536833|589392780|FG001|Overall Study|Discontinued Before Treatment|0|||
163184789|NCT02536833|589392781|FG002|Overall Study|Discontinued Before Treatment|1|||
163184790|NCT02536833|589392782|FG003|Overall Study|Discontinued Before Treatment|2|||
163184791|NCT02536833|589392779|FG000|Overall Study|Adverse Event|1|||
163184792|NCT02536833|589392780|FG001|Overall Study|Adverse Event|3|||
163184793|NCT02536833|589392781|FG002|Overall Study|Adverse Event|4|||
163184794|NCT02536833|589392782|FG003|Overall Study|Adverse Event|1|||
163184795|NCT02536833|589392779|FG000|Overall Study|Lost to Follow-up|2|||
163184796|NCT02536833|589392780|FG001|Overall Study|Lost to Follow-up|1|||
163184797|NCT02536833|589392781|FG002|Overall Study|Lost to Follow-up|2|||
163184798|NCT02536833|589392782|FG003|Overall Study|Lost to Follow-up|2|||
163184799|NCT02536833|589392779|FG000|Overall Study|Physician Decision|0|||
163184800|NCT02536833|589392780|FG001|Overall Study|Physician Decision|0|||
163184801|NCT02536833|589392781|FG002|Overall Study|Physician Decision|0|||
163184802|NCT02536833|589392782|FG003|Overall Study|Physician Decision|1|||
163184803|NCT02536833|589392779|FG000|Overall Study|Site Terminated by Sponsor|2|||
163184804|NCT02536833|589392780|FG001|Overall Study|Site Terminated by Sponsor|2|||
163184805|NCT02536833|589392781|FG002|Overall Study|Site Terminated by Sponsor|2|||
163184806|NCT02536833|589392782|FG003|Overall Study|Site Terminated by Sponsor|2|||
163184807|NCT02536833|589392779|FG000|Overall Study|Subject Non-Compliance|0|||
163184808|NCT02536833|589392780|FG001|Overall Study|Subject Non-Compliance|1|||
163184809|NCT02536833|589392781|FG002|Overall Study|Subject Non-Compliance|1|||
163184810|NCT02536833|589392782|FG003|Overall Study|Subject Non-Compliance|0|||
163184811|NCT02536833|589392779|FG000|Overall Study|Withdrawal by Subject|4|||
163184812|NCT02536833|589392780|FG001|Overall Study|Withdrawal by Subject|3|||
163184813|NCT02536833|589392781|FG002|Overall Study|Withdrawal by Subject|5|||
163184814|NCT02536833|589392782|FG003|Overall Study|Withdrawal by Subject|11|||
163184815|NCT00586066|589392785|FG000|Overall Study|Lost to Follow-up|6|||
163184816|NCT00586066|589392786|FG001|Overall Study|Lost to Follow-up|3|||
163184817|NCT00586066|589392785|FG000|Overall Study|Lack of Efficacy|5|||
163184818|NCT00586066|589392786|FG001|Overall Study|Lack of Efficacy|3|||
163184819|NCT00586066|589392785|FG000|Overall Study|Adverse Event|2|||
163184820|NCT00586066|589392786|FG001|Overall Study|Adverse Event|2|||
163184821|NCT00586066|589392785|FG000|Overall Study|Physician Decision|1|||
163184822|NCT00586066|589392786|FG001|Overall Study|Physician Decision|0|||
163184823|NCT00586066|589392785|FG000|Overall Study|Withdrawal of consent|4|||
163184824|NCT00586066|589392786|FG001|Overall Study|Withdrawal of consent|2|||
163184825|NCT00910988|589392787|FG000|Overall Study|Lost to Follow-up|2|||
163184826|NCT00910988|589392788|FG001|Overall Study|Lost to Follow-up|4|||
163184827|NCT00910988|589392789|FG002|Overall Study|Lost to Follow-up|3|||
163184828|NCT00910988|589392790|FG003|Overall Study|Lost to Follow-up|0|||
163184829|NCT02766465|589392791|FG000|Overall Study|Withdrawal by Subject|0|||
163184830|NCT02766465|589392792|FG001|Overall Study|Withdrawal by Subject|10|||
163184831|NCT01907100|589392793|FG000|Overall Study|PD based on modified RECIST criteria|31|||
163184832|NCT01907100|589392794|FG001|Overall Study|PD based on modified RECIST criteria|32|||
163184833|NCT01907100|589392795|FG002|Overall Study|PD based on modified RECIST criteria|95|||
163184834|NCT01907100|589392796|FG003|Overall Study|PD based on modified RECIST criteria|92|||
163184835|NCT01907100|589392793|FG000|Overall Study|Withdrawal by Subject|2|||
163184836|NCT01907100|589392794|FG001|Overall Study|Withdrawal by Subject|5|||
163290080|NCT00770965|589768314|FG000|Safety Set|Withdrawal by Subject|0|||
163290081|NCT00770965|589768315|FG001|Safety Set|Withdrawal by Subject|0|||
163290082|NCT00770965|589768316|FG002|Safety Set|Withdrawal by Subject|0|||
163290083|NCT00770965|589768317|FG003|Safety Set|Withdrawal by Subject|1|||
163290084|NCT00770965|589768314|FG000|Safety Set|Protocol deviation|0|||
163290085|NCT00770965|589768315|FG001|Safety Set|Protocol deviation|0|||
163290086|NCT00770965|589768316|FG002|Safety Set|Protocol deviation|1|||
163290087|NCT00770965|589768317|FG003|Safety Set|Protocol deviation|0|||
163290088|NCT00770965|589768314|FG000|Excluded Set|Administrative problems|14|||
163290089|NCT00770965|589768315|FG001|Excluded Set|Administrative problems|12|||
163290090|NCT00770965|589768316|FG002|Excluded Set|Administrative problems|12|||
163290091|NCT00770965|589768317|FG003|Excluded Set|Administrative problems|10|||
163290092|NCT00770965|589768314|FG000|Excluded Set|Withdrawal by Subject|1|||
163290093|NCT00770965|589768315|FG001|Excluded Set|Withdrawal by Subject|1|||
163290094|NCT00770965|589768316|FG002|Excluded Set|Withdrawal by Subject|2|||
163290095|NCT00770965|589768317|FG003|Excluded Set|Withdrawal by Subject|3|||
163290096|NCT00509769|589768318|FG000|Overall Study|Progressive disease|77|||
163290097|NCT00509769|589768318|FG000|Overall Study|Adverse Event|4|||
163290098|NCT00509769|589768318|FG000|Overall Study|Patient's decision|1|||
163290099|NCT00509769|589768318|FG000|Overall Study|Physician Decision|8|||
163290100|NCT00509769|589768318|FG000|Overall Study|Use of prohibited therapies during study|1|||
163290101|NCT00414648|589768319|FG000|Overall Study|Adverse Event|5|||
163290102|NCT00414648|589768320|FG001|Overall Study|Adverse Event|5|||
163290103|NCT00414648|589768319|FG000|Overall Study|Death|0|||
163290104|NCT00414648|589768320|FG001|Overall Study|Death|1|||
163290105|NCT00414648|589768319|FG000|Overall Study|Lack of Efficacy|0|||
163290106|NCT00414648|589768320|FG001|Overall Study|Lack of Efficacy|2|||
163290107|NCT00414648|589768319|FG000|Overall Study|Withdrawal by Subject|0|||
163290108|NCT00414648|589768320|FG001|Overall Study|Withdrawal by Subject|1|||
163290109|NCT02371746|589768321|FG000|Overall Study|Consent withdrawn|0|||
163290110|NCT02371746|589768322|FG001|Overall Study|Consent withdrawn|0|||
163290111|NCT02371746|589768323|FG002|Overall Study|Consent withdrawn|0|||
163290112|NCT02371746|589768324|FG003|Overall Study|Consent withdrawn|0|||
163290113|NCT02371746|589768325|FG004|Overall Study|Consent withdrawn|0|||
163290114|NCT02371746|589768326|FG005|Overall Study|Consent withdrawn|0|||
163290115|NCT02371746|589768327|FG006|Overall Study|Consent withdrawn|1|||
163290116|NCT00754936|589768328|FG000|Overall Study|Lost to Follow-up|3|||
163290117|NCT00754936|589768328|FG000|Overall Study|Physician Decision|1|||
163290118|NCT00754936|589768328|FG000|Overall Study|Withdrawal by Subject|2|||
163290119|NCT00754936|589768328|FG000|Overall Study|Side Effects|3|||
163290120|NCT00754936|589768328|FG000|Overall Study|Inter-current medical events|3|||
163290121|NCT00436644|589768329|FG000|Overall Study|Adverse Event|2|||
163290122|NCT00436644|589768329|FG000|Overall Study|Death|1|||
163290123|NCT00619645|589768330|FG000|Overall Study|Adverse Event|1|||
163290124|NCT04364269|589768335|FG000|Overall Study|Adverse Event|1|||
163290125|NCT04364269|589768336|FG001|Overall Study|Adverse Event|0|||
163290126|NCT04364269|589768337|FG002|Overall Study|Adverse Event|0|||
163290127|NCT04364269|589768335|FG000|Overall Study|Withdrawal by Subject|0|||
163290128|NCT04364269|589768336|FG001|Overall Study|Withdrawal by Subject|1|||
163290129|NCT04364269|589768337|FG002|Overall Study|Withdrawal by Subject|0|||
163290130|NCT04173572|589768338|FG000|Overall Study|Withdrawal by Subject|1|||
163290131|NCT04173572|589768339|FG001|Overall Study|Withdrawal by Subject|5|||
163290132|NCT04173572|589768338|FG000|Overall Study|Lost to Follow-up|3|||
163184837|NCT01907100|589392795|FG002|Overall Study|Withdrawal by Subject|10|||
163184838|NCT01907100|589392796|FG003|Overall Study|Withdrawal by Subject|13|||
163184839|NCT01907100|589392793|FG000|Overall Study|Protocol Violation|0|||
163184840|NCT01907100|589392794|FG001|Overall Study|Protocol Violation|0|||
163184841|NCT01907100|589392795|FG002|Overall Study|Protocol Violation|1|||
163184842|NCT01907100|589392796|FG003|Overall Study|Protocol Violation|1|||
163184843|NCT01907100|589392793|FG000|Overall Study|Lost to Follow-up|0|||
163184844|NCT01907100|589392794|FG001|Overall Study|Lost to Follow-up|0|||
163290133|NCT04173572|589768339|FG001|Overall Study|Lost to Follow-up|1|||
163290134|NCT01490580|589768340|FG000|Overall Study|Parents withdrew consent|0|||
163184845|NCT01907100|589392795|FG002|Overall Study|Lost to Follow-up|0|||
163184846|NCT01907100|589392796|FG003|Overall Study|Lost to Follow-up|1|||
163184847|NCT01907100|589392793|FG000|Overall Study|Not treated|2|||
163290135|NCT01490580|589768341|FG001|Overall Study|Parents withdrew consent|2|||
163290136|NCT02026258|589768344|FG000|Randomized|Did not start treatment|2|||
163290137|NCT02026258|589768345|FG001|Randomized|Did not start treatment|1|||
163290138|NCT02026258|589768344|FG000|Randomized|Change in treatment plan|1|||
163290139|NCT02026258|589768345|FG001|Randomized|Change in treatment plan|0|||
163290140|NCT02026258|589768344|FG000|Randomized|Presence of periodontal disease|1|||
163290141|NCT02026258|589768345|FG001|Randomized|Presence of periodontal disease|1|||
163290142|NCT02026258|589768344|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
163290143|NCT02026258|589768345|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
163290144|NCT02026258|589768344|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
163290145|NCT02026258|589768345|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
163184848|NCT01907100|589392794|FG001|Overall Study|Not treated|0|||
163290146|NCT03478696|589768349|FG000|Overall Study|Adverse Event|1|||
163290147|NCT03478696|589768350|FG001|Overall Study|Adverse Event|5|||
163290148|NCT03478696|589768349|FG000|Overall Study|Lost to Follow-up|1|||
163290149|NCT03478696|589768350|FG001|Overall Study|Lost to Follow-up|0|||
163290150|NCT03478696|589768349|FG000|Overall Study|Physician Decision|6|||
163290151|NCT03478696|589768350|FG001|Overall Study|Physician Decision|3|||
163290152|NCT03478696|589768349|FG000|Overall Study|Withdrawal by Subject|9|||
163290153|NCT03478696|589768350|FG001|Overall Study|Withdrawal by Subject|4|||
163290154|NCT00410124|589768351|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
163290155|NCT00410124|589768352|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
163290156|NCT00410124|589768351|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
163290157|NCT00410124|589768352|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
163290158|NCT00410124|589768351|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
163290159|NCT00410124|589768352|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
163290160|NCT00410124|589768351|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
163290161|NCT00410124|589768352|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
163290162|NCT00410124|589768351|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
163290163|NCT00410124|589768352|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
163290164|NCT00410124|589768351|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
163290165|NCT00410124|589768352|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
163290166|NCT00410124|589768351|FG000|Core Phase Double Blind (15 Months)|Death|7|||
163290167|NCT00410124|589768352|FG001|Core Phase Double Blind (15 Months)|Death|4|||
163290168|NCT00410124|589768351|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
163290169|NCT00410124|589768352|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
163290170|NCT00410124|589768351|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
163290171|NCT00410124|589768352|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
163290172|NCT00410124|589768351|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
163290173|NCT00410124|589768352|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
163290174|NCT00410124|589768351|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
163290175|NCT00410124|589768352|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
163290176|NCT00410124|589768351|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
163290177|NCT00410124|589768352|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
163290178|NCT00410124|589768351|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
163290179|NCT00410124|589768352|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
163290180|NCT00410124|589768351|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
163290181|NCT00410124|589768352|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
163290182|NCT00410124|589768351|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
163290183|NCT00410124|589768352|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
163290184|NCT00410124|589768351|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
163290185|NCT00410124|589768352|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
163290186|NCT00880048|589768357|FG000|Overall Study|Adverse Event|2|||
163290187|NCT00880048|589768358|FG001|Overall Study|Adverse Event|3|||
163290188|NCT00880048|589768359|FG002|Overall Study|Adverse Event|5|||
163290189|NCT00880048|589768357|FG000|Overall Study|Lack of Efficacy|1|||
163290190|NCT00880048|589768358|FG001|Overall Study|Lack of Efficacy|2|||
163290191|NCT00880048|589768359|FG002|Overall Study|Lack of Efficacy|2|||
163290192|NCT00880048|589768357|FG000|Overall Study|Protocol Violation|4|||
163290193|NCT00880048|589768358|FG001|Overall Study|Protocol Violation|6|||
163290194|NCT00880048|589768359|FG002|Overall Study|Protocol Violation|5|||
163290195|NCT00880048|589768357|FG000|Overall Study|Lost to Follow-up|6|||
163290196|NCT00880048|589768358|FG001|Overall Study|Lost to Follow-up|6|||
163290197|NCT00880048|589768359|FG002|Overall Study|Lost to Follow-up|5|||
163290198|NCT00880048|589768357|FG000|Overall Study|Physician Decision|1|||
163290199|NCT00880048|589768358|FG001|Overall Study|Physician Decision|1|||
163290200|NCT00880048|589768359|FG002|Overall Study|Physician Decision|7|||
163290201|NCT00880048|589768357|FG000|Overall Study|Withdrawal by Subject|5|||
163290202|NCT00880048|589768358|FG001|Overall Study|Withdrawal by Subject|8|||
162941039|NCT03933202|588487097|FG001|Overall Study|Participant changed primary neurology provider|0|||
163290203|NCT00880048|589768359|FG002|Overall Study|Withdrawal by Subject|5|||
162941040|NCT03933202|588487096|FG000|Overall Study|Participant could not be entered as a follow-up|0|||
162941041|NCT03933202|588487097|FG001|Overall Study|Participant could not be entered as a follow-up|1|||
162941042|NCT03933202|588487096|FG000|Overall Study|Participant non-compliant, therefore, has been discontinued|1|||
162941043|NCT03933202|588487097|FG001|Overall Study|Participant non-compliant, therefore, has been discontinued|0|||
162941044|NCT03933202|588487096|FG000|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|1|||
162941045|NCT03933202|588487097|FG001|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|0|||
162941046|NCT03933202|588487096|FG000|Overall Study|Missed visit|0|||
162941047|NCT03933202|588487097|FG001|Overall Study|Missed visit|1|||
162941048|NCT03933202|588487096|FG000|Overall Study|Investigator decision|4|||
162941049|NCT03933202|588487097|FG001|Overall Study|Investigator decision|0|||
162941050|NCT03933202|588487096|FG000|Overall Study|Discontinuation due to safety extension removal by Sponsor|0|||
162941051|NCT03933202|588487097|FG001|Overall Study|Discontinuation due to safety extension removal by Sponsor|1|||
162941052|NCT03933202|588487096|FG000|Overall Study|Withdrawal by Subject|10|||
162941053|NCT03933202|588487097|FG001|Overall Study|Withdrawal by Subject|8|||
162941054|NCT03933202|588487096|FG000|Overall Study|Death|2|||
162941055|NCT03933202|588487097|FG001|Overall Study|Death|0|||
162941056|NCT03933202|588487096|FG000|Overall Study|Progressive disease|0|||
162941057|NCT03933202|588487097|FG001|Overall Study|Progressive disease|3|||
162941058|NCT03933202|588487096|FG000|Overall Study|Protocol non-compliance|6|||
162941059|NCT03933202|588487097|FG001|Overall Study|Protocol non-compliance|3|||
162941060|NCT03933202|588487096|FG000|Overall Study|Lost to Follow-up|16|||
162941061|NCT03933202|588487097|FG001|Overall Study|Lost to Follow-up|8|||
162941062|NCT03933202|588487096|FG000|Overall Study|Adverse Event|3|||
162941063|NCT03933202|588487097|FG001|Overall Study|Adverse Event|0|||
162941064|NCT00947427|588487098|FG000|Overall Study|Withdrawal by Subject|1|||
162941065|NCT00947427|588487099|FG001|Overall Study|Withdrawal by Subject|3|||
162941066|NCT00947427|588487098|FG000|Overall Study|Protocol Violation|0|||
162941067|NCT00947427|588487099|FG001|Overall Study|Protocol Violation|1|||
162941068|NCT01348542|588487101|FG000|Overall Study|Withdrawal by Subject|3|||
162941069|NCT01348542|588487102|FG001|Overall Study|Withdrawal by Subject|0|||
162941070|NCT00686036|588487105|FG000|Overall Study|Adverse Event|3|||
162941071|NCT00686036|588487106|FG001|Overall Study|Adverse Event|0|||
162941072|NCT00686036|588487105|FG000|Overall Study|Withdrawal by Subject|3|||
162941073|NCT00686036|588487106|FG001|Overall Study|Withdrawal by Subject|1|||
162941074|NCT00686036|588487105|FG000|Overall Study|Study terminated by AstraZeneca|2|||
162941075|NCT00686036|588487106|FG001|Overall Study|Study terminated by AstraZeneca|1|||
162941076|NCT00686036|588487105|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
162941077|NCT00686036|588487106|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
162941078|NCT00686036|588487105|FG000|Overall Study|Other reasons not identified|0|||
162941079|NCT00686036|588487106|FG001|Overall Study|Other reasons not identified|4|||
162941080|NCT01411995|588487107|FG000|Overall Study|Failed IUD insertion|0|||
162941081|NCT01411995|588487108|FG001|Overall Study|Failed IUD insertion|1|||
162941082|NCT05658523|588487109|FG000|Baseline|No blood draw|1|||
162941083|NCT05658523|588487110|FG001|Baseline|No blood draw|0|||
162941084|NCT05658523|588487111|FG002|Baseline|No blood draw|0|||
162941085|NCT05658523|588487109|FG000|28 Days|Lost to Follow-up|1|||
162941086|NCT05658523|588487110|FG001|28 Days|Lost to Follow-up|0|||
162941087|NCT05658523|588487111|FG002|28 Days|Lost to Follow-up|0|||
162941088|NCT05658523|588487109|FG000|28 Days|Withdrawal by Subject|1|||
162941089|NCT05658523|588487110|FG001|28 Days|Withdrawal by Subject|1|||
162941090|NCT05658523|588487111|FG002|28 Days|Withdrawal by Subject|0|||
162941091|NCT05658523|588487109|FG000|28 Days|Visit missed|0|||
162941092|NCT05658523|588487110|FG001|28 Days|Visit missed|4|||
162941093|NCT05658523|588487111|FG002|28 Days|Visit missed|0|||
162941094|NCT05658523|588487109|FG000|6 Months|Lost to Follow-up|1|||
162941095|NCT05658523|588487110|FG001|6 Months|Lost to Follow-up|7|||
162941096|NCT05658523|588487111|FG002|6 Months|Lost to Follow-up|2|||
162941097|NCT05658523|588487109|FG000|6 Months|Withdrawal by Subject|1|||
162941098|NCT05658523|588487110|FG001|6 Months|Withdrawal by Subject|3|||
162941099|NCT05658523|588487111|FG002|6 Months|Withdrawal by Subject|4|||
162941100|NCT05658523|588487109|FG000|6 Months|Visit missed|5|||
162941101|NCT05658523|588487110|FG001|6 Months|Visit missed|7|||
162941102|NCT05658523|588487111|FG002|6 Months|Visit missed|0|||
162941103|NCT05658523|588487109|FG000|6 Months|No blood draw|0|||
162941104|NCT05658523|588487110|FG001|6 Months|No blood draw|0|||
162941105|NCT05658523|588487111|FG002|6 Months|No blood draw|1|||
162941106|NCT05658523|588487109|FG000|12 Months|Lost to Follow-up|2|||
162941107|NCT05658523|588487110|FG001|12 Months|Lost to Follow-up|6|||
162941108|NCT05658523|588487111|FG002|12 Months|Lost to Follow-up|3|||
162941109|NCT05658523|588487109|FG000|12 Months|Withdrawal by Subject|4|||
162941110|NCT05658523|588487110|FG001|12 Months|Withdrawal by Subject|4|||
162941111|NCT05658523|588487111|FG002|12 Months|Withdrawal by Subject|2|||
162941112|NCT05658523|588487109|FG000|12 Months|Visit missed|4|||
162941113|NCT05658523|588487110|FG001|12 Months|Visit missed|8|||
162941114|NCT05658523|588487111|FG002|12 Months|Visit missed|8|||
162941115|NCT05658523|588487109|FG000|18 Months|Lost to Follow-up|5|||
162941116|NCT05658523|588487110|FG001|18 Months|Lost to Follow-up|8|||
162941117|NCT05658523|588487111|FG002|18 Months|Lost to Follow-up|2|||
163290204|NCT00880048|589768357|FG000|Overall Study|Study closed/terminated|9|||
163290205|NCT00880048|589768358|FG001|Overall Study|Study closed/terminated|7|||
163290206|NCT00880048|589768359|FG002|Overall Study|Study closed/terminated|6|||
163290207|NCT01104415|589768363|FG000|Core Phase|Consent withdrawn by subjects|1|||
163290208|NCT01104415|589768364|FG001|Core Phase|Consent withdrawn by subjects|0|||
163290209|NCT01104415|589768363|FG000|Extension Period|Progressive disease|0|||
163290210|NCT01104415|589768364|FG001|Extension Period|Progressive disease|4|||
163290211|NCT01104415|589768363|FG000|Extension Period|Death|0|||
163290212|NCT01104415|589768364|FG001|Extension Period|Death|1|||
163290213|NCT01104415|589768363|FG000|Extension Period|Physician Decision|0|||
163290214|NCT01104415|589768364|FG001|Extension Period|Physician Decision|1|||
163290215|NCT01104415|589768363|FG000|Extension Period|Transition to Study LX1606.302|0|||
163290216|NCT01104415|589768364|FG001|Extension Period|Transition to Study LX1606.302|4|||
163290217|NCT01104415|589768363|FG000|Extension Period|Heart surgery/feeling miserable|0|||
163290218|NCT01104415|589768364|FG001|Extension Period|Heart surgery/feeling miserable|1|||
163290219|NCT02914522|589768369|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
163290220|NCT02914522|589768370|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
163290221|NCT02914522|589768371|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
163290222|NCT02914522|589768372|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
163290223|NCT02914522|589768373|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
163290224|NCT02914522|589768374|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
163290225|NCT02914522|589768375|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
163290226|NCT02914522|589768376|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
163290227|NCT02914522|589768377|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
163290228|NCT02914522|589768378|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
163290229|NCT02914522|589768379|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
163290230|NCT02914522|589768369|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
163290231|NCT02914522|589768370|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
163290232|NCT02914522|589768371|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
163290233|NCT02914522|589768372|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
163290234|NCT02914522|589768373|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
163290235|NCT02914522|589768374|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
163290236|NCT02914522|589768375|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
163290237|NCT02914522|589768376|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
163290238|NCT02914522|589768377|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
163290239|NCT02914522|589768378|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
163290240|NCT02914522|589768379|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
163290241|NCT02914522|589768369|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
163290242|NCT02914522|589768370|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
163290243|NCT02914522|589768371|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
163290244|NCT02914522|589768372|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
163290245|NCT02914522|589768373|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
163290246|NCT02914522|589768374|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
163290247|NCT02914522|589768375|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
163290248|NCT02914522|589768376|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
162941118|NCT05658523|588487109|FG000|18 Months|Withdrawal by Subject|17|||
162941119|NCT05658523|588487110|FG001|18 Months|Withdrawal by Subject|9|||
162941120|NCT05658523|588487111|FG002|18 Months|Withdrawal by Subject|16|||
162941121|NCT05658523|588487109|FG000|18 Months|Visit missed|12|||
162941122|NCT05658523|588487110|FG001|18 Months|Visit missed|14|||
162941123|NCT05658523|588487111|FG002|18 Months|Visit missed|6|||
162941124|NCT03212170|588487112|FG000|Overall Study|Withdrawal by Subject|1|||
162941125|NCT01937364|588487113|FG000|Overall Study|Adverse Event|2|||
162941126|NCT01937364|588487114|FG001|Overall Study|Adverse Event|1|||
162941127|NCT00628212|588487117|FG000|Overall Study|Adverse Event|2|||
162941128|NCT00628212|588487118|FG001|Overall Study|Adverse Event|0|||
163290249|NCT02914522|589768377|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
163290250|NCT02914522|589768378|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
163290251|NCT02914522|589768379|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
163290252|NCT02914522|589768369|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163290253|NCT02914522|589768370|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
163290254|NCT02914522|589768371|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
163290255|NCT02914522|589768372|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
163290256|NCT02914522|589768373|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163290257|NCT02914522|589768374|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163290258|NCT02914522|589768375|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163290259|NCT02914522|589768376|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163290260|NCT02914522|589768377|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163290261|NCT02914522|589768378|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163290262|NCT02914522|589768379|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163290263|NCT02914522|589768369|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163290264|NCT02914522|589768370|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163290265|NCT02914522|589768371|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163290266|NCT02914522|589768372|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163290267|NCT02914522|589768373|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
163290268|NCT02914522|589768374|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163290269|NCT02914522|589768375|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163290270|NCT02914522|589768376|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163290271|NCT02914522|589768377|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163290272|NCT02914522|589768378|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163290273|NCT02914522|589768379|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163290274|NCT02914522|589768369|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
163290275|NCT02914522|589768370|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163290276|NCT02914522|589768371|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163290277|NCT02914522|589768372|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163290278|NCT02914522|589768373|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163290279|NCT02914522|589768374|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163290280|NCT02914522|589768375|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163290281|NCT02914522|589768376|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163290282|NCT02914522|589768377|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163290283|NCT02914522|589768378|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163290284|NCT02914522|589768379|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163290285|NCT02914522|589768369|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
163290286|NCT02914522|589768370|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
163290287|NCT02914522|589768371|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
163290288|NCT02914522|589768372|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
163290289|NCT02914522|589768373|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
163290290|NCT02914522|589768374|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
162941129|NCT00628212|588487119|FG002|Overall Study|Adverse Event|1|||
162941130|NCT00628212|588487120|FG003|Overall Study|Adverse Event|2|||
163290291|NCT02914522|589768375|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
163290292|NCT02914522|589768376|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
163290293|NCT02914522|589768377|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
163290294|NCT02914522|589768378|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
163290295|NCT02914522|589768379|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
163290296|NCT02914522|589768369|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163290297|NCT02914522|589768370|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
163290298|NCT02914522|589768371|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163290299|NCT02914522|589768372|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163290300|NCT02914522|589768373|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
163290301|NCT02914522|589768374|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
163290302|NCT02914522|589768375|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163290303|NCT02914522|589768376|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163290304|NCT02914522|589768377|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163290305|NCT02914522|589768378|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163290306|NCT02914522|589768379|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163290307|NCT02914522|589768369|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
163290308|NCT02914522|589768370|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
163290309|NCT02914522|589768371|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
162941131|NCT00628212|588487117|FG000|Overall Study|Physician Decision|1|||
162941132|NCT00628212|588487118|FG001|Overall Study|Physician Decision|1|||
162941133|NCT00628212|588487119|FG002|Overall Study|Physician Decision|2|||
162941134|NCT00628212|588487120|FG003|Overall Study|Physician Decision|3|||
162941135|NCT02482571|588487121|FG000|Overall Study|Adverse Event|1|||
162941136|NCT02482571|588487121|FG000|Overall Study|Scanner or Respiract failure|3|||
162941137|NCT02482571|588487121|FG000|Overall Study|Withdrawal by Subject|4|||
162941138|NCT04071769|588487127|FG000|Overall Study|Lost to Follow-up|3|||
162941139|NCT04071769|588487127|FG000|Overall Study|Physician Decision|2|||
162941140|NCT04071769|588487127|FG000|Overall Study|Withdrawal by Subject|8|||
162941141|NCT01890707|588487128|FG000|Overall Study|Lost to Follow-up|1|||
162941142|NCT01890707|588487129|FG001|Overall Study|Lost to Follow-up|1|||
162941143|NCT00669955|588487130|FG000|Overall Study|Adverse Event|3|||
162941144|NCT00669955|588487131|FG001|Overall Study|Adverse Event|5|||
162941145|NCT00669955|588487130|FG000|Overall Study|Death|0|||
162941146|NCT00669955|588487131|FG001|Overall Study|Death|1|||
162941147|NCT00669955|588487130|FG000|Overall Study|Withdrawal by Subject|2|||
162941148|NCT00669955|588487131|FG001|Overall Study|Withdrawal by Subject|3|||
162941149|NCT00669955|588487130|FG000|Overall Study|Lost to Follow-up|5|||
162941150|NCT00669955|588487131|FG001|Overall Study|Lost to Follow-up|7|||
162941151|NCT00669955|588487130|FG000|Overall Study|Protocol Violation|2|||
162941152|NCT00669955|588487131|FG001|Overall Study|Protocol Violation|7|||
162941153|NCT00669955|588487130|FG000|Overall Study|Investigator Sponsor Judgement|0|||
162941154|NCT00669955|588487131|FG001|Overall Study|Investigator Sponsor Judgement|1|||
162941155|NCT00669955|588487130|FG000|Overall Study|not compliant with study drug/visit|2|||
162941156|NCT00669955|588487131|FG001|Overall Study|not compliant with study drug/visit|3|||
162941157|NCT03495869|588487132|FG000|Overall Study|Lost to Follow-up|4|||
162941158|NCT03495869|588487133|FG001|Overall Study|Lost to Follow-up|17|||
162941159|NCT03495869|588487134|FG002|Overall Study|Lost to Follow-up|8|||
162941160|NCT03495869|588487135|FG003|Overall Study|Lost to Follow-up|14|||
162941161|NCT03495869|588487132|FG000|Overall Study|Withdrawal by Subject|0|||
162941162|NCT03495869|588487133|FG001|Overall Study|Withdrawal by Subject|3|||
162941163|NCT03495869|588487134|FG002|Overall Study|Withdrawal by Subject|0|||
162941164|NCT03495869|588487135|FG003|Overall Study|Withdrawal by Subject|3|||
162941165|NCT03495869|588487132|FG000|Overall Study|Dropped from study|0|||
162941166|NCT03495869|588487133|FG001|Overall Study|Dropped from study|7|||
162941167|NCT03495869|588487134|FG002|Overall Study|Dropped from study|2|||
162941168|NCT03495869|588487135|FG003|Overall Study|Dropped from study|4|||
162941169|NCT03312530|588488531|FG000|Overall Study|Death|5|||
162941170|NCT03312530|588488532|FG001|Overall Study|Death|5|||
162941171|NCT03312530|588488533|FG002|Overall Study|Death|4|||
162941172|NCT03312530|588488534|FG003|Overall Study|Death|10|||
162941173|NCT03312530|588488535|FG004|Overall Study|Death|8|||
162941174|NCT03312530|588488531|FG000|Overall Study|Lost to Follow-up|0|||
162941175|NCT03312530|588488532|FG001|Overall Study|Lost to Follow-up|0|||
162941176|NCT03312530|588488533|FG002|Overall Study|Lost to Follow-up|0|||
162941177|NCT03312530|588488534|FG003|Overall Study|Lost to Follow-up|1|||
162941178|NCT03312530|588488535|FG004|Overall Study|Lost to Follow-up|0|||
162941179|NCT03312530|588488531|FG000|Overall Study|Participant in another sponsor study.|0|||
162941180|NCT03312530|588488532|FG001|Overall Study|Participant in another sponsor study.|0|||
162941181|NCT03312530|588488533|FG002|Overall Study|Participant in another sponsor study.|0|||
162941182|NCT03312530|588488534|FG003|Overall Study|Participant in another sponsor study.|1|||
162941183|NCT03312530|588488535|FG004|Overall Study|Participant in another sponsor study.|0|||
162941184|NCT03312530|588488531|FG000|Overall Study|Study terminated by sponsor|1|||
162941185|NCT03312530|588488532|FG001|Overall Study|Study terminated by sponsor|0|||
162941186|NCT03312530|588488533|FG002|Overall Study|Study terminated by sponsor|2|||
162941187|NCT03312530|588488534|FG003|Overall Study|Study terminated by sponsor|3|||
162941188|NCT03312530|588488535|FG004|Overall Study|Study terminated by sponsor|7|||
162941189|NCT03312530|588488531|FG000|Overall Study|Withdrawal by Subject|0|||
162941190|NCT03312530|588488532|FG001|Overall Study|Withdrawal by Subject|1|||
162941191|NCT03312530|588488533|FG002|Overall Study|Withdrawal by Subject|0|||
162941192|NCT03312530|588488534|FG003|Overall Study|Withdrawal by Subject|0|||
162941193|NCT03312530|588488535|FG004|Overall Study|Withdrawal by Subject|0|||
162941194|NCT03312530|588488531|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
162941195|NCT03312530|588488532|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
163184849|NCT01907100|589392795|FG002|Overall Study|Not treated|1|||
163184850|NCT01907100|589392796|FG003|Overall Study|Not treated|2|||
163184851|NCT01907100|589392793|FG000|Overall Study|Other than reasons specified|1|||
163184852|NCT01907100|589392794|FG001|Overall Study|Other than reasons specified|0|||
163184853|NCT01907100|589392795|FG002|Overall Study|Other than reasons specified|10|||
162941196|NCT03312530|588488533|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
162941197|NCT03312530|588488534|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
162941198|NCT03312530|588488535|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
162941199|NCT00614055|588488536|FG000|Overall Study|Adverse Event|1|||
162941200|NCT00614055|588488537|FG001|Overall Study|Adverse Event|0|||
162941201|NCT00614055|588488538|FG002|Overall Study|Adverse Event|0|||
162941202|NCT00614055|588488536|FG000|Overall Study|Protocol Violation|2|||
162941203|NCT00614055|588488537|FG001|Overall Study|Protocol Violation|2|||
162941204|NCT00614055|588488538|FG002|Overall Study|Protocol Violation|1|||
162941205|NCT00614055|588488536|FG000|Overall Study|Lack of Efficacy|0|||
162941206|NCT00614055|588488537|FG001|Overall Study|Lack of Efficacy|0|||
162941207|NCT00614055|588488538|FG002|Overall Study|Lack of Efficacy|2|||
162941208|NCT00614055|588488536|FG000|Overall Study|Unclassified|1|||
162941209|NCT00614055|588488537|FG001|Overall Study|Unclassified|4|||
162941210|NCT00614055|588488538|FG002|Overall Study|Unclassified|2|||
162941211|NCT02489318|588488541|FG000|Randomized|Withdrawal by Subject|0|||
162941212|NCT02489318|588488542|FG001|Randomized|Withdrawal by Subject|1|||
162941213|NCT02489318|588488541|FG000|Treated|Adverse Event|19|||
162941214|NCT02489318|588488542|FG001|Treated|Adverse Event|62|||
162941215|NCT02489318|588488541|FG000|Treated|Death|13|||
162941216|NCT02489318|588488542|FG001|Treated|Death|11|||
162941217|NCT02489318|588488541|FG000|Treated|Physician Decision|4|||
162941218|NCT02489318|588488542|FG001|Treated|Physician Decision|6|||
162941219|NCT02489318|588488541|FG000|Treated|Protocol Violation|1|||
162941220|NCT02489318|588488542|FG001|Treated|Protocol Violation|2|||
162941221|NCT02489318|588488541|FG000|Treated|Withdrawal by Subject|37|||
162941222|NCT02489318|588488542|FG001|Treated|Withdrawal by Subject|36|||
162941223|NCT02489318|588488541|FG000|Treated|Other: Progressive Disease|245|||
162941224|NCT02489318|588488542|FG001|Treated|Other: Progressive Disease|138|||
162941225|NCT02489318|588488541|FG000|Treated|Other|0|||
162941226|NCT02489318|588488542|FG001|Treated|Other|2|||
162941227|NCT02489318|588488541|FG000|Treated|Ongoing|0|||
162941228|NCT02489318|588488542|FG001|Treated|Ongoing|267|||
162941229|NCT03679741|588488545|FG000|Period 1|No longer meet eligibility criteria|1|||
162941230|NCT03679741|588488546|FG001|Period 1|No longer meet eligibility criteria|0|||
162941231|NCT03679741|588488545|FG000|Period 1|Lost to Follow-up|0|||
162941232|NCT03679741|588488546|FG001|Period 1|Lost to Follow-up|1|||
162941233|NCT03679741|588488545|FG000|Period 1|Adverse Event|1|||
162941234|NCT03679741|588488546|FG001|Period 1|Adverse Event|1|||
162941235|NCT03679741|588488545|FG000|Period 1|Withdrawal by Subject|0|||
162941236|NCT03679741|588488546|FG001|Period 1|Withdrawal by Subject|1|||
162941237|NCT03679741|588488545|FG000|Period 2|Adverse Event|2|||
162941238|NCT03679741|588488546|FG001|Period 2|Adverse Event|1|||
162941239|NCT03679741|588488545|FG000|Period 2|Withdrawal by Subject|1|||
162941240|NCT03679741|588488546|FG001|Period 2|Withdrawal by Subject|1|||
162941241|NCT02035137|588488548|FG000|Overall Study|Physician Decision|0|||
162941242|NCT02035137|588488549|FG001|Overall Study|Physician Decision|0|||
162941243|NCT02035137|588488550|FG002|Overall Study|Physician Decision|1|||
162941244|NCT02035137|588488548|FG000|Overall Study|Withdrawal by Subject|0|||
162941245|NCT02035137|588488549|FG001|Overall Study|Withdrawal by Subject|1|||
162941246|NCT02035137|588488550|FG002|Overall Study|Withdrawal by Subject|2|||
162941247|NCT02035137|588488548|FG000|Overall Study|Ineligible|0|||
162941248|NCT02035137|588488549|FG001|Overall Study|Ineligible|1|||
162941249|NCT02035137|588488550|FG002|Overall Study|Ineligible|2|||
162941250|NCT02035137|588488548|FG000|Overall Study|Disease progression prior to treatment start|2|||
162941251|NCT02035137|588488549|FG001|Overall Study|Disease progression prior to treatment start|0|||
162941252|NCT02035137|588488550|FG002|Overall Study|Disease progression prior to treatment start|0|||
162941253|NCT01215942|588488551|FG000|Treatment Period|Adverse Event|15|||
162941254|NCT01215942|588488552|FG001|Treatment Period|Adverse Event|26|||
162941255|NCT01215942|588488551|FG000|Treatment Period|Death|2|||
162941256|NCT01215942|588488552|FG001|Treatment Period|Death|4|||
162941257|NCT01215942|588488551|FG000|Treatment Period|Lack of Efficacy|23|||
162941258|NCT01215942|588488552|FG001|Treatment Period|Lack of Efficacy|62|||
162941259|NCT01215942|588488551|FG000|Treatment Period|Lost to Follow-up|3|||
163184854|NCT01907100|589392796|FG003|Overall Study|Other than reasons specified|6|||
162941260|NCT01215942|588488552|FG001|Treatment Period|Lost to Follow-up|4|||
162941261|NCT01215942|588488551|FG000|Treatment Period|Withdrawal by Subject|17|||
162941262|NCT01215942|588488552|FG001|Treatment Period|Withdrawal by Subject|40|||
162941263|NCT01215942|588488551|FG000|Treatment Period|Physician Decision|5|||
162941264|NCT01215942|588488552|FG001|Treatment Period|Physician Decision|5|||
162941265|NCT01215942|588488551|FG000|Treatment Period|Protocol Violation|0|||
162941266|NCT01215942|588488552|FG001|Treatment Period|Protocol Violation|1|||
162941267|NCT01215942|588488551|FG000|Treatment Period|Sponsor Decision|349|||
162941268|NCT01215942|588488552|FG001|Treatment Period|Sponsor Decision|530|||
162941269|NCT01215942|588488551|FG000|Post-Treatment Follow-Up Period|Death|0|||
162941270|NCT01215942|588488552|FG001|Post-Treatment Follow-Up Period|Death|1|||
162941271|NCT01215942|588488551|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
162941272|NCT01215942|588488552|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
162941273|NCT01215942|588488551|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
162941274|NCT01215942|588488552|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
162941275|NCT01215942|588488551|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
162941276|NCT01215942|588488552|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
162941277|NCT01215942|588488551|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
163290310|NCT02914522|589768372|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
163290311|NCT02914522|589768373|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
163290312|NCT02914522|589768374|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
162941278|NCT01215942|588488552|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
162941279|NCT03305055|588488553|FG000|Overall Study|Withdrawal by Subject|0|||
162941280|NCT03305055|588488554|FG001|Overall Study|Withdrawal by Subject|1|||
162941281|NCT03305055|588488553|FG000|Overall Study|Adverse Event|1|||
162941282|NCT03305055|588488554|FG001|Overall Study|Adverse Event|1|||
162941283|NCT04471935|588488555|FG000|Overall Study|Withdrawal by Subject|1|||
162941284|NCT04471935|588488555|FG000|Overall Study|Deemed ineligible to participate|1|||
162941285|NCT02540356|588488556|FG000|Overall Study|Terminated due to disease progression|1|||
162941286|NCT02540356|588488557|FG001|Overall Study|Terminated due to disease progression|0|||
162941287|NCT01399736|588488558|FG000|Overall Study|Withdrawal by Subject|4|||
162941288|NCT01399736|588488559|FG001|Overall Study|Withdrawal by Subject|2|||
162941289|NCT01399736|588488558|FG000|Overall Study|Lost to Follow-up|0|||
162941290|NCT01399736|588488559|FG001|Overall Study|Lost to Follow-up|2|||
162941291|NCT03500484|588488560|FG000|Overall Study|Adverse Event|2|||
162941292|NCT03500484|588488561|FG001|Overall Study|Adverse Event|0|||
162941293|NCT03500484|588488560|FG000|Overall Study|Physician Decision|1|||
162941294|NCT03500484|588488561|FG001|Overall Study|Physician Decision|0|||
162941295|NCT03500484|588488560|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
162941296|NCT03500484|588488561|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
162941297|NCT02795104|588488562|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
162941298|NCT02795104|588488563|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
162941299|NCT02795104|588488564|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
162941300|NCT02795104|588488562|FG000|Overall Study|Withdrawal by Subject|0|||
162941301|NCT02795104|588488563|FG001|Overall Study|Withdrawal by Subject|2|||
162941302|NCT02795104|588488564|FG002|Overall Study|Withdrawal by Subject|0|||
162941303|NCT02795104|588488562|FG000|Overall Study|Lost to Follow-up|0|||
162941304|NCT02795104|588488563|FG001|Overall Study|Lost to Follow-up|0|||
162941305|NCT02795104|588488564|FG002|Overall Study|Lost to Follow-up|1|||
162941306|NCT00948675|588488565|FG000|Overall Study|Lost to Follow-up|1|||
162941307|NCT00948675|588488566|FG001|Overall Study|Lost to Follow-up|0|||
162941308|NCT01654380|588488570|FG000|Part B, Period 1|Physician Decision|0|||
162941309|NCT01654380|588488571|FG001|Part B, Period 1|Physician Decision|0|||
162941310|NCT01654380|588488572|FG002|Part B, Period 1|Physician Decision|1|||
162941311|NCT01654380|588488573|FG003|Part B, Period 1|Physician Decision|0|||
162941312|NCT03335371|588488574|FG000|Overall Study|Lost to Follow-up|0|||
162941313|NCT03335371|588488575|FG001|Overall Study|Lost to Follow-up|0|||
162941314|NCT03335371|588488576|FG002|Overall Study|Lost to Follow-up|0|||
162941315|NCT03335371|588488577|FG003|Overall Study|Lost to Follow-up|0|||
162941316|NCT03335371|588488578|FG004|Overall Study|Lost to Follow-up|1|||
162941317|NCT03335371|588488574|FG000|Overall Study|Withdrawal by Subject|0|||
162941318|NCT03335371|588488575|FG001|Overall Study|Withdrawal by Subject|0|||
162941319|NCT03335371|588488576|FG002|Overall Study|Withdrawal by Subject|0|||
162941320|NCT03335371|588488577|FG003|Overall Study|Withdrawal by Subject|0|||
162941321|NCT03335371|588488578|FG004|Overall Study|Withdrawal by Subject|1|||
162941322|NCT03335371|588488574|FG000|Overall Study|Randomization Error|0|||
163290313|NCT02914522|589768375|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
163290314|NCT02914522|589768376|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
163290315|NCT02914522|589768377|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
163290316|NCT02914522|589768378|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
163290317|NCT02914522|589768379|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
163290318|NCT02914522|589768369|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
163290319|NCT02914522|589768370|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
163290320|NCT02914522|589768371|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
163290321|NCT02914522|589768372|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
163290322|NCT02914522|589768373|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
163290323|NCT02914522|589768374|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
162941323|NCT03335371|588488575|FG001|Overall Study|Randomization Error|0|||
162941324|NCT03335371|588488576|FG002|Overall Study|Randomization Error|1|||
162941325|NCT03335371|588488577|FG003|Overall Study|Randomization Error|0|||
162941326|NCT03335371|588488578|FG004|Overall Study|Randomization Error|0|||
162941327|NCT06331156|588488580|FG000|Overall Study|Adverse Event|1|||
162941328|NCT06331156|588488581|FG001|Overall Study|Adverse Event|0|||
162941329|NCT06331156|588488580|FG000|Overall Study|Lost to Follow-up|1|||
163290324|NCT02914522|589768375|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
163290325|NCT02914522|589768376|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
163290326|NCT02914522|589768377|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
163290327|NCT02914522|589768378|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
163290328|NCT02914522|589768379|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
162941330|NCT06331156|588488581|FG001|Overall Study|Lost to Follow-up|0|||
162941331|NCT06331156|588488580|FG000|Overall Study|Migrated / Moved from the study area|4|||
162941332|NCT06331156|588488581|FG001|Overall Study|Migrated / Moved from the study area|3|||
162941333|NCT06331156|588488580|FG000|Overall Study|Other|7|||
162941334|NCT06331156|588488581|FG001|Overall Study|Other|0|||
162941335|NCT06331156|588488580|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
162941336|NCT06331156|588488581|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
162941337|NCT05845645|588488582|FG000|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941338|NCT05845645|588488583|FG001|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941339|NCT05845645|588488584|FG002|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|1|||
162941340|NCT05845645|588488585|FG003|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941341|NCT05845645|588488586|FG004|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941342|NCT05845645|588488587|FG005|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941343|NCT05845645|588488588|FG006|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941344|NCT05845645|588488589|FG007|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941345|NCT05845645|588488590|FG008|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941346|NCT05845645|588488591|FG009|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941347|NCT05845645|588488592|FG010|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941348|NCT05845645|588488593|FG011|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941349|NCT05845645|588488582|FG000|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941350|NCT05845645|588488583|FG001|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941351|NCT05845645|588488584|FG002|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941352|NCT05845645|588488585|FG003|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941353|NCT05845645|588488586|FG004|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941354|NCT05845645|588488587|FG005|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941355|NCT05845645|588488588|FG006|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941356|NCT05845645|588488589|FG007|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941357|NCT05845645|588488590|FG008|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941358|NCT05845645|588488591|FG009|Part B- Period 1 (Day 1)|Adverse Event|1|||
162941359|NCT05845645|588488592|FG010|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941360|NCT05845645|588488593|FG011|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941361|NCT00998881|588488598|FG000|Overall Study|Adverse Event|2|||
162941362|NCT00998881|588488599|FG001|Overall Study|Adverse Event|2|||
162941363|NCT00998881|588488598|FG000|Overall Study|Lack of Efficacy|1|||
162941364|NCT00998881|588488599|FG001|Overall Study|Lack of Efficacy|0|||
162941365|NCT00998881|588488598|FG000|Overall Study|Physician Decision|3|||
162941366|NCT00998881|588488599|FG001|Overall Study|Physician Decision|0|||
162941367|NCT00998881|588488598|FG000|Overall Study|Withdrawal by Subject|1|||
162941368|NCT00998881|588488599|FG001|Overall Study|Withdrawal by Subject|0|||
162941369|NCT00998881|588488598|FG000|Overall Study|Personal matter|1|||
162941370|NCT00998881|588488599|FG001|Overall Study|Personal matter|0|||
162941371|NCT02649231|588488600|FG000|Overall Study|Adverse Event|0|||
162941372|NCT02649231|588488601|FG001|Overall Study|Adverse Event|0|||
162941373|NCT02649231|588488602|FG002|Overall Study|Adverse Event|0|||
162941374|NCT02649231|588488603|FG003|Overall Study|Adverse Event|1|||
162941375|NCT02649231|588488600|FG000|Overall Study|Lost to Follow-up|2|||
162941376|NCT02649231|588488601|FG001|Overall Study|Lost to Follow-up|1|||
162941377|NCT02649231|588488602|FG002|Overall Study|Lost to Follow-up|1|||
162941378|NCT02649231|588488603|FG003|Overall Study|Lost to Follow-up|0|||
162941379|NCT02649231|588488600|FG000|Overall Study|Withdrawal by Subject|0|||
162941380|NCT02649231|588488601|FG001|Overall Study|Withdrawal by Subject|1|||
162941381|NCT02649231|588488602|FG002|Overall Study|Withdrawal by Subject|0|||
162941382|NCT02649231|588488603|FG003|Overall Study|Withdrawal by Subject|1|||
162941383|NCT02649231|588488600|FG000|Overall Study|Protocol Violation|2|||
162941384|NCT02649231|588488601|FG001|Overall Study|Protocol Violation|1|||
162941385|NCT02649231|588488602|FG002|Overall Study|Protocol Violation|1|||
162941386|NCT02649231|588488603|FG003|Overall Study|Protocol Violation|0|||
162941387|NCT02970669|588488606|FG000|Double-blind Period|Adverse Event|4|||
162941388|NCT02970669|588488607|FG001|Double-blind Period|Adverse Event|0|||
162941389|NCT02970669|588488606|FG000|Double-blind Period|Death|1|||
162941390|NCT02970669|588488607|FG001|Double-blind Period|Death|0|||
162941391|NCT02970669|588488606|FG000|Double-blind Period|Study terminated by sponsor|1|||
162941392|NCT02970669|588488607|FG001|Double-blind Period|Study terminated by sponsor|2|||
162941393|NCT02970669|588488606|FG000|Double-blind Period|Physician Decision|0|||
162941394|NCT02970669|588488607|FG001|Double-blind Period|Physician Decision|2|||
162941395|NCT02970669|588488606|FG000|Double-blind Period|Withdrawal by Subject|2|||
162941396|NCT02970669|588488607|FG001|Double-blind Period|Withdrawal by Subject|2|||
162941397|NCT02970669|588488606|FG000|Open-label Period|Withdrawal by Subject|2|||
162941398|NCT02970669|588488607|FG001|Open-label Period|Withdrawal by Subject|2|||
163184855|NCT01907100|589392793|FG000|Overall Study|Adverse event (AE)|6|||
162941399|NCT02970669|588488606|FG000|Open-label Period|Adverse Event|1|||
162941400|NCT02970669|588488607|FG001|Open-label Period|Adverse Event|0|||
162941401|NCT02970669|588488606|FG000|Open-label Period|Physician Decision|1|||
162941402|NCT02970669|588488607|FG001|Open-label Period|Physician Decision|0|||
163184856|NCT01907100|589392794|FG001|Overall Study|Adverse event (AE)|3|||
163184857|NCT01907100|589392795|FG002|Overall Study|Adverse event (AE)|22|||
162941403|NCT00876733|588488608|FG000|Overall Study|Adverse Event|34|||
162941404|NCT00876733|588488609|FG001|Overall Study|Adverse Event|20|||
162941405|NCT00876733|588488610|FG002|Overall Study|Adverse Event|10|||
162941406|NCT00876733|588488611|FG003|Overall Study|Adverse Event|3|||
162941407|NCT00876733|588488608|FG000|Overall Study|Lack of Efficacy|17|||
162941408|NCT00876733|588488609|FG001|Overall Study|Lack of Efficacy|9|||
162941409|NCT00876733|588488610|FG002|Overall Study|Lack of Efficacy|10|||
162941410|NCT00876733|588488611|FG003|Overall Study|Lack of Efficacy|1|||
162941411|NCT00876733|588488608|FG000|Overall Study|Lost to Follow-up|26|||
162941412|NCT00876733|588488609|FG001|Overall Study|Lost to Follow-up|10|||
162941413|NCT00876733|588488610|FG002|Overall Study|Lost to Follow-up|3|||
162941414|NCT00876733|588488611|FG003|Overall Study|Lost to Follow-up|2|||
162941415|NCT00876733|588488608|FG000|Overall Study|Data not available|14|||
162941416|NCT00876733|588488609|FG001|Overall Study|Data not available|3|||
162941417|NCT00876733|588488610|FG002|Overall Study|Data not available|7|||
162941418|NCT00876733|588488611|FG003|Overall Study|Data not available|1|||
162941419|NCT02611752|588488614|FG000|Overall Study|Adverse Event|0|||
162941420|NCT02611752|588488615|FG001|Overall Study|Adverse Event|1|||
162941421|NCT03495986|588488616|FG000|Overall Study|Physician Decision|1|||
162941422|NCT03495986|588488617|FG001|Overall Study|Physician Decision|0|||
162941423|NCT03495986|588488616|FG000|Overall Study|Withdrawal by Subject|1|||
162941424|NCT03495986|588488617|FG001|Overall Study|Withdrawal by Subject|1|||
162941425|NCT03495986|588488616|FG000|Overall Study|Withdrawal by Subject|1|||
162941426|NCT03495986|588488617|FG001|Overall Study|Withdrawal by Subject|0|||
162941427|NCT05476679|588488618|FG000|Overall Study|Withdrawal by Subject|0|||
162941428|NCT05476679|588488619|FG001|Overall Study|Withdrawal by Subject|0|||
162941429|NCT05476679|588488620|FG002|Overall Study|Withdrawal by Subject|0|||
162941430|NCT05476679|588488621|FG003|Overall Study|Withdrawal by Subject|1|||
162941431|NCT05476679|588488622|FG004|Overall Study|Withdrawal by Subject|0|||
162941432|NCT05476679|588488618|FG000|Overall Study|Lost to Follow-up|0|||
162941433|NCT05476679|588488619|FG001|Overall Study|Lost to Follow-up|0|||
162941434|NCT05476679|588488620|FG002|Overall Study|Lost to Follow-up|0|||
162941435|NCT05476679|588488621|FG003|Overall Study|Lost to Follow-up|1|||
162941436|NCT05476679|588488622|FG004|Overall Study|Lost to Follow-up|0|||
162941437|NCT01214330|588488623|FG000|Overall Study|Withdrawal by Subject|2|||
162941438|NCT01214330|588488623|FG000|Overall Study|Withdrawal by Subject|2|||
162941439|NCT00249821|588488624|FG000|Overall Study|Technical problem|0|||
162941440|NCT00249821|588488625|FG001|Overall Study|Technical problem|1|||
162941441|NCT00467584|588488626|FG000|Overall Study|Withdrawal by Subject|4|||
162941442|NCT00467584|588488627|FG001|Overall Study|Withdrawal by Subject|5|||
162941443|NCT00467584|588488628|FG002|Overall Study|Withdrawal by Subject|1|||
162941444|NCT01498484|588488632|FG000|Overall Study|Death|6|||
162941445|NCT01498484|588488633|FG001|Overall Study|Death|3|||
162941446|NCT01498484|588488634|FG002|Overall Study|Death|1|||
162941447|NCT01498484|588488635|FG003|Overall Study|Death|1|||
162941448|NCT01498484|588488636|FG004|Overall Study|Death|0|||
162941449|NCT01498484|588488637|FG005|Overall Study|Death|0|||
162941450|NCT01498484|588488638|FG006|Overall Study|Death|10|||
162941451|NCT01498484|588488639|FG007|Overall Study|Death|1|||
162941452|NCT01498484|588488640|FG008|Overall Study|Death|0|||
162941453|NCT01498484|588488632|FG000|Overall Study|Physician Decision|3|||
162941454|NCT01498484|588488633|FG001|Overall Study|Physician Decision|2|||
162941455|NCT01498484|588488634|FG002|Overall Study|Physician Decision|1|||
162941456|NCT01498484|588488635|FG003|Overall Study|Physician Decision|1|||
162941457|NCT01498484|588488636|FG004|Overall Study|Physician Decision|0|||
162941458|NCT01498484|588488637|FG005|Overall Study|Physician Decision|0|||
162941459|NCT01498484|588488638|FG006|Overall Study|Physician Decision|8|||
162941460|NCT01498484|588488639|FG007|Overall Study|Physician Decision|13|||
162941461|NCT01498484|588488640|FG008|Overall Study|Physician Decision|1|||
162941462|NCT01498484|588488632|FG000|Overall Study|Adverse Event|0|||
162941463|NCT01498484|588488633|FG001|Overall Study|Adverse Event|0|||
162941464|NCT01498484|588488634|FG002|Overall Study|Adverse Event|0|||
162941465|NCT01498484|588488635|FG003|Overall Study|Adverse Event|0|||
163184858|NCT01907100|589392796|FG003|Overall Study|Adverse event (AE)|23|||
163184859|NCT01907100|589392793|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
163184860|NCT01907100|589392794|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
163184861|NCT01907100|589392795|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
163184862|NCT01907100|589392796|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
163184863|NCT01758289|589392797|FG000|Overall Study|Premature Study Termination|44|||
163184864|NCT01758289|589392797|FG000|Overall Study|Adverse Event|9|||
163184865|NCT01574079|589392798|FG000|Overall Study|Physician Decision|0|||
163184866|NCT01574079|589392799|FG001|Overall Study|Physician Decision|2|||
163184867|NCT01574079|589392798|FG000|Overall Study|Lost to Follow-up|1|||
163184868|NCT01574079|589392799|FG001|Overall Study|Lost to Follow-up|0|||
163184869|NCT02059005|589392800|FG000|Overall Study|Death|1|||
162941466|NCT01498484|588488636|FG004|Overall Study|Adverse Event|0|||
162941467|NCT01498484|588488637|FG005|Overall Study|Adverse Event|1|||
162941468|NCT01498484|588488638|FG006|Overall Study|Adverse Event|0|||
162941469|NCT01498484|588488639|FG007|Overall Study|Adverse Event|0|||
162941470|NCT01498484|588488640|FG008|Overall Study|Adverse Event|0|||
163184870|NCT02059005|589392801|FG001|Overall Study|Death|3|||
163184871|NCT02059005|589392800|FG000|Overall Study|Lost to Follow-up|19|||
163184872|NCT02059005|589392801|FG001|Overall Study|Lost to Follow-up|19|||
163184873|NCT02059005|589392800|FG000|Overall Study|Incarceration|0|||
163184874|NCT02059005|589392801|FG001|Overall Study|Incarceration|1|||
163184875|NCT02059005|589392800|FG000|Overall Study|Inpatient|0|||
163184876|NCT02059005|589392801|FG001|Overall Study|Inpatient|1|||
163184877|NCT00908011|589392804|FG000|Overall Study|Withdrawal by Subject|2|||
163184878|NCT00908011|589392805|FG001|Overall Study|Withdrawal by Subject|2|||
163184879|NCT00843726|589392806|FG000|Overall Study|Death|1|||
163290329|NCT02914522|589768369|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163290330|NCT02914522|589768370|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163290331|NCT02914522|589768371|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163290332|NCT02914522|589768372|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163290333|NCT02914522|589768373|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163290334|NCT02914522|589768374|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163290335|NCT02914522|589768375|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
163290336|NCT02914522|589768376|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
163290337|NCT02914522|589768377|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
163290338|NCT02914522|589768378|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163290339|NCT02914522|589768379|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
163290340|NCT02914522|589768369|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163290341|NCT02914522|589768370|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163290342|NCT02914522|589768371|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163290343|NCT02914522|589768372|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163184880|NCT00843726|589392807|FG001|Overall Study|Death|0|||
163184881|NCT00843726|589392806|FG000|Overall Study|Withdrawal by Subject|0|||
163184882|NCT00843726|589392807|FG001|Overall Study|Withdrawal by Subject|1|||
163184883|NCT00667602|589392808|FG000|Overall Study|Withdrawal by Subject|4|||
163184884|NCT00667602|589392809|FG001|Overall Study|Withdrawal by Subject|9|||
163184885|NCT00667602|589392810|FG002|Overall Study|Withdrawal by Subject|10|||
163184886|NCT00667602|589392808|FG000|Overall Study|Lost to Follow-up|4|||
163184887|NCT00667602|589392809|FG001|Overall Study|Lost to Follow-up|5|||
163184888|NCT00667602|589392810|FG002|Overall Study|Lost to Follow-up|6|||
163184889|NCT00667602|589392808|FG000|Overall Study|Administrative reason|0|||
163290344|NCT02914522|589768373|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163184890|NCT00667602|589392809|FG001|Overall Study|Administrative reason|0|||
163184891|NCT00667602|589392810|FG002|Overall Study|Administrative reason|2|||
163184892|NCT00667602|589392808|FG000|Overall Study|Protocol Violation|0|||
163184893|NCT00667602|589392809|FG001|Overall Study|Protocol Violation|1|||
163184894|NCT00667602|589392810|FG002|Overall Study|Protocol Violation|0|||
163290345|NCT02914522|589768374|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163290346|NCT02914522|589768375|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
163290347|NCT02914522|589768376|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
163290348|NCT02914522|589768377|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
163290349|NCT02914522|589768378|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
163290350|NCT02914522|589768379|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
163290351|NCT02914522|589768369|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
163290352|NCT02914522|589768370|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
163290353|NCT02914522|589768371|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
163290354|NCT02914522|589768372|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
163290355|NCT02914522|589768373|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
163290356|NCT02914522|589768374|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
163290357|NCT02914522|589768375|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
163290358|NCT02914522|589768376|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
163290359|NCT02914522|589768377|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
163290360|NCT02914522|589768378|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
163290361|NCT02914522|589768379|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
163290362|NCT02914522|589768369|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163290363|NCT02914522|589768370|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163290364|NCT02914522|589768371|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
162941471|NCT01498484|588488632|FG000|Overall Study|Withdrawal by Subject|0|||
162941472|NCT01498484|588488633|FG001|Overall Study|Withdrawal by Subject|0|||
162941473|NCT01498484|588488634|FG002|Overall Study|Withdrawal by Subject|0|||
162941474|NCT01498484|588488635|FG003|Overall Study|Withdrawal by Subject|1|||
162941475|NCT01498484|588488636|FG004|Overall Study|Withdrawal by Subject|0|||
162941476|NCT01498484|588488637|FG005|Overall Study|Withdrawal by Subject|0|||
162941477|NCT01498484|588488638|FG006|Overall Study|Withdrawal by Subject|1|||
162941478|NCT01498484|588488639|FG007|Overall Study|Withdrawal by Subject|0|||
162941479|NCT01498484|588488640|FG008|Overall Study|Withdrawal by Subject|0|||
162941480|NCT01498484|588488632|FG000|Overall Study|Other|5|||
162941481|NCT01498484|588488633|FG001|Overall Study|Other|2|||
162941482|NCT01498484|588488634|FG002|Overall Study|Other|0|||
162941483|NCT01498484|588488635|FG003|Overall Study|Other|0|||
162941484|NCT01498484|588488636|FG004|Overall Study|Other|1|||
162941485|NCT01498484|588488637|FG005|Overall Study|Other|0|||
162941486|NCT01498484|588488638|FG006|Overall Study|Other|3|||
162941487|NCT01498484|588488639|FG007|Overall Study|Other|0|||
162941488|NCT01498484|588488640|FG008|Overall Study|Other|1|||
162941489|NCT00423800|588488641|FG000|Overall Study|Protocol Violation|0|||
162941490|NCT00423800|588488642|FG001|Overall Study|Protocol Violation|1|||
162941491|NCT00814320|588488643|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
162941492|NCT00814320|588488644|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
162941493|NCT00814320|588488643|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
162941494|NCT00814320|588488644|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
162941495|NCT00814320|588488643|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
162941496|NCT00814320|588488644|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
162941497|NCT00814320|588488643|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
162941498|NCT00814320|588488644|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
162941499|NCT00814320|588488643|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
162941500|NCT00814320|588488644|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
162941501|NCT00814320|588488643|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
162941502|NCT00814320|588488644|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
162941503|NCT00814320|588488643|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
162941504|NCT00814320|588488644|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
162941505|NCT00814320|588488643|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
162941506|NCT00814320|588488644|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
162941507|NCT00814320|588488643|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
162941508|NCT00814320|588488644|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
162941509|NCT00814320|588488643|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
162941510|NCT00814320|588488644|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
162941511|NCT00619385|588488645|FG000|Overall Study|Adverse Event|0|||
162941512|NCT00619385|588488646|FG001|Overall Study|Adverse Event|0|||
162941513|NCT00619385|588488647|FG002|Overall Study|Adverse Event|3|||
162941514|NCT00619385|588488645|FG000|Overall Study|Other|1|||
162941515|NCT00619385|588488646|FG001|Overall Study|Other|2|||
162941516|NCT00619385|588488647|FG002|Overall Study|Other|1|||
162941517|NCT00656019|588488648|FG000|Overall Study|Not Eligible|10|||
162941518|NCT00656019|588488649|FG001|Overall Study|Not Eligible|0|||
162941519|NCT00656019|588488650|FG002|Overall Study|Not Eligible|0|||
163290365|NCT02914522|589768372|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163290366|NCT02914522|589768373|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163290367|NCT02914522|589768374|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163290368|NCT02914522|589768375|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163290369|NCT02914522|589768376|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
163290370|NCT02914522|589768377|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
163290371|NCT02914522|589768378|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163290372|NCT02914522|589768379|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163290373|NCT02914522|589768369|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163290374|NCT02914522|589768370|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163290375|NCT02914522|589768371|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163290376|NCT02914522|589768372|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163290377|NCT02914522|589768373|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163184895|NCT03640559|589392813|FG000|Overall Study|Physician Decision|1|||
163184896|NCT03640559|589392814|FG001|Overall Study|Physician Decision|1|||
163184897|NCT03640559|589392813|FG000|Overall Study|Withdrawal by Subject|1|||
163184898|NCT03640559|589392814|FG001|Overall Study|Withdrawal by Subject|0|||
163184899|NCT01436162|589392815|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
163184900|NCT01436162|589392816|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
163184901|NCT01436162|589392817|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
163184902|NCT01436162|589392815|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
163184903|NCT01436162|589392816|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
163184904|NCT01436162|589392817|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
163184905|NCT01436162|589392815|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
163290378|NCT02914522|589768374|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163290379|NCT02914522|589768375|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163290380|NCT02914522|589768376|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163290381|NCT02914522|589768377|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
163290382|NCT02914522|589768378|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
163290383|NCT02914522|589768379|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163290384|NCT02914522|589768369|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163290385|NCT02914522|589768370|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163290386|NCT02914522|589768371|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163290387|NCT02914522|589768372|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163290388|NCT02914522|589768373|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163290389|NCT02914522|589768374|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163290390|NCT02914522|589768375|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163290391|NCT02914522|589768376|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163290392|NCT02914522|589768377|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163290393|NCT02914522|589768378|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
163290394|NCT02914522|589768379|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163290395|NCT03098030|589768380|FG000|Overall Study|Death|10|||
163290396|NCT03098030|589768381|FG001|Overall Study|Death|156|||
163290397|NCT03098030|589768382|FG002|Overall Study|Death|156|||
163290398|NCT03098030|589768383|FG003|Overall Study|Death|82|||
163290399|NCT03098030|589768380|FG000|Overall Study|Withdrawal by Subject|0|||
163290400|NCT03098030|589768381|FG001|Overall Study|Withdrawal by Subject|7|||
163290401|NCT03098030|589768382|FG002|Overall Study|Withdrawal by Subject|8|||
163290402|NCT03098030|589768383|FG003|Overall Study|Withdrawal by Subject|2|||
163290403|NCT03098030|589768380|FG000|Overall Study|Lost to Follow-up|0|||
163290404|NCT03098030|589768381|FG001|Overall Study|Lost to Follow-up|0|||
163290405|NCT03098030|589768382|FG002|Overall Study|Lost to Follow-up|2|||
163290406|NCT03098030|589768383|FG003|Overall Study|Lost to Follow-up|1|||
163290407|NCT03368001|589768384|FG000|Allocation|Lost to Pretest|16|||
163290408|NCT03368001|589768385|FG001|Allocation|Lost to Pretest|25|||
163290409|NCT03368001|589768384|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
163290410|NCT03368001|589768385|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
163290411|NCT03368001|589768384|FG000|Posttest|Lost to Posttest|7|||
163290412|NCT03368001|589768385|FG001|Posttest|Lost to Posttest|11|||
162941520|NCT00656019|588488651|FG003|Overall Study|Not Eligible|0|||
162941521|NCT00656019|588488648|FG000|Overall Study|Withdrawal by Subject|2|||
162941522|NCT00656019|588488649|FG001|Overall Study|Withdrawal by Subject|0|||
162941523|NCT00656019|588488650|FG002|Overall Study|Withdrawal by Subject|0|||
162941524|NCT00656019|588488651|FG003|Overall Study|Withdrawal by Subject|0|||
162941525|NCT00656019|588488648|FG000|Overall Study|Lost to Follow-up|2|||
162941526|NCT00656019|588488649|FG001|Overall Study|Lost to Follow-up|1|||
162941527|NCT00656019|588488650|FG002|Overall Study|Lost to Follow-up|0|||
162941528|NCT00656019|588488651|FG003|Overall Study|Lost to Follow-up|0|||
162941529|NCT01488578|588488652|FG000|Overall Study|Protocol Violation|1836|||
162941530|NCT05550532|588488657|FG000|Overall Study|Withdrawal by Subject|8|||
162941531|NCT05550532|588488658|FG001|Overall Study|Withdrawal by Subject|3|||
162941532|NCT05550532|588488657|FG000|Overall Study|Adverse Event|2|||
162941533|NCT05550532|588488658|FG001|Overall Study|Adverse Event|3|||
163290413|NCT03368001|589768384|FG000|Posttest|Discontinued Intervention|6|||
162941534|NCT05550532|588488657|FG000|Overall Study|Lost to Follow-up|4|||
162941535|NCT05550532|588488658|FG001|Overall Study|Lost to Follow-up|0|||
162941536|NCT05550532|588488657|FG000|Overall Study|Other|0|||
162941537|NCT05550532|588488658|FG001|Overall Study|Other|4|||
162941538|NCT00859469|588488659|FG000|Overall Study|Adverse Event|2|||
162941539|NCT00859469|588488659|FG000|Overall Study|Lack of Efficacy|9|||
162941540|NCT00859469|588488659|FG000|Overall Study|Withdrawal by Subject|1|||
162941541|NCT00859469|588488659|FG000|Overall Study|Death|16|||
162941542|NCT04820842|588490334|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
162941543|NCT04820842|588490335|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
162941544|NCT04820842|588490336|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
162941545|NCT04820842|588490337|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
162941546|NCT04820842|588490338|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
162941547|NCT04820842|588490339|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
162941548|NCT04820842|588490340|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
162941549|NCT04820842|588490334|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
162941550|NCT04820842|588490335|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
162941551|NCT04820842|588490336|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
162941552|NCT04820842|588490337|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941553|NCT04820842|588490338|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941554|NCT04820842|588490339|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941555|NCT04820842|588490340|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941556|NCT04820842|588490334|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
162941557|NCT04820842|588490335|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
162941558|NCT04820842|588490336|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
162941559|NCT04820842|588490337|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
162941560|NCT04820842|588490338|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
162941561|NCT04820842|588490339|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
162941562|NCT04820842|588490340|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
162941563|NCT04820842|588490334|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941564|NCT04820842|588490335|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941565|NCT04820842|588490336|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941566|NCT04820842|588490337|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
162941567|NCT04820842|588490338|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941568|NCT04820842|588490339|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941569|NCT04820842|588490340|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
162941570|NCT01691508|588490341|FG000|Overall Study|Adverse Event|3|||
162941571|NCT01691508|588490342|FG001|Overall Study|Adverse Event|3|||
162941572|NCT01691508|588490341|FG000|Overall Study|Withdrawal by Subject|1|||
162941573|NCT01691508|588490342|FG001|Overall Study|Withdrawal by Subject|0|||
162941574|NCT01296932|588490343|FG000|Overall Study|Dose limiting toxicity|0|||
163290414|NCT03368001|589768385|FG001|Posttest|Discontinued Intervention|19|||
163290415|NCT03368001|589768384|FG000|Follow-up|Lost to Follow-up|6|||
163290416|NCT03368001|589768385|FG001|Follow-up|Lost to Follow-up|3|||
162941575|NCT01296932|588490344|FG001|Overall Study|Dose limiting toxicity|0|||
162941576|NCT01296932|588490345|FG002|Overall Study|Dose limiting toxicity|0|||
162941577|NCT01296932|588490346|FG003|Overall Study|Dose limiting toxicity|0|||
162941578|NCT01296932|588490347|FG004|Overall Study|Dose limiting toxicity|0|||
162941579|NCT01296932|588490348|FG005|Overall Study|Dose limiting toxicity|0|||
162941580|NCT01296932|588490349|FG006|Overall Study|Dose limiting toxicity|1|||
162941581|NCT01296932|588490350|FG007|Overall Study|Dose limiting toxicity|0|||
162941582|NCT01296932|588490351|FG008|Overall Study|Dose limiting toxicity|1|||
162941583|NCT01296932|588490343|FG000|Overall Study|Progressive disease|2|||
162941584|NCT01296932|588490344|FG001|Overall Study|Progressive disease|0|||
162941585|NCT01296932|588490345|FG002|Overall Study|Progressive disease|1|||
162941586|NCT01296932|588490346|FG003|Overall Study|Progressive disease|1|||
162941587|NCT01296932|588490347|FG004|Overall Study|Progressive disease|2|||
162941588|NCT01296932|588490348|FG005|Overall Study|Progressive disease|3|||
162941589|NCT01296932|588490349|FG006|Overall Study|Progressive disease|1|||
162941590|NCT01296932|588490350|FG007|Overall Study|Progressive disease|0|||
162941591|NCT01296932|588490351|FG008|Overall Study|Progressive disease|0|||
162941592|NCT01296932|588490343|FG000|Overall Study|Withdrawal by Subject|0|||
162941593|NCT01296932|588490344|FG001|Overall Study|Withdrawal by Subject|0|||
162941594|NCT01296932|588490345|FG002|Overall Study|Withdrawal by Subject|1|||
162941595|NCT01296932|588490346|FG003|Overall Study|Withdrawal by Subject|1|||
162941596|NCT01296932|588490347|FG004|Overall Study|Withdrawal by Subject|0|||
162941597|NCT01296932|588490348|FG005|Overall Study|Withdrawal by Subject|0|||
162941598|NCT01296932|588490349|FG006|Overall Study|Withdrawal by Subject|3|||
162941599|NCT01296932|588490350|FG007|Overall Study|Withdrawal by Subject|0|||
162941600|NCT01296932|588490351|FG008|Overall Study|Withdrawal by Subject|0|||
162941601|NCT01296932|588490343|FG000|Overall Study|Adverse Event|1|||
162941602|NCT01296932|588490344|FG001|Overall Study|Adverse Event|1|||
162941603|NCT01296932|588490345|FG002|Overall Study|Adverse Event|1|||
163290417|NCT03612804|589768386|FG000|Overall Study|Death|0|||
162941604|NCT01296932|588490346|FG003|Overall Study|Adverse Event|2|||
162941605|NCT01296932|588490347|FG004|Overall Study|Adverse Event|1|||
162941606|NCT01296932|588490348|FG005|Overall Study|Adverse Event|0|||
162941607|NCT01296932|588490349|FG006|Overall Study|Adverse Event|0|||
162941608|NCT01296932|588490350|FG007|Overall Study|Adverse Event|0|||
162941609|NCT01296932|588490351|FG008|Overall Study|Adverse Event|1|||
162941610|NCT01296932|588490343|FG000|Overall Study|Investigator decision|0|||
163290418|NCT03612804|589768387|FG001|Overall Study|Death|7|||
163290419|NCT03612804|589768388|FG002|Overall Study|Death|0|||
163290420|NCT03612804|589768389|FG003|Overall Study|Death|8|||
163290421|NCT03612804|589768386|FG000|Overall Study|Medication copay coverage issues|0|||
163184906|NCT01436162|589392816|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
163184907|NCT01436162|589392817|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
163184908|NCT01436162|589392815|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
163184909|NCT01436162|589392816|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
163184910|NCT01436162|589392817|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
163184911|NCT01436162|589392815|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
163184912|NCT01436162|589392816|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
163184913|NCT01436162|589392817|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
163184914|NCT01436162|589392815|FG000|Single-blind Lead-in Phase|Other|107|||
163184915|NCT01436162|589392816|FG001|Single-blind Lead-in Phase|Other|0|||
163184916|NCT01436162|589392817|FG002|Single-blind Lead-in Phase|Other|0|||
163184917|NCT01436162|589392815|FG000|Randomized Phase|Adverse Event|1|||
163184918|NCT01436162|589392816|FG001|Randomized Phase|Adverse Event|5|||
163184919|NCT01436162|589392817|FG002|Randomized Phase|Adverse Event|6|||
163184920|NCT01436162|589392815|FG000|Randomized Phase|Protocol Violation|4|||
163184921|NCT01436162|589392816|FG001|Randomized Phase|Protocol Violation|4|||
163184922|NCT01436162|589392817|FG002|Randomized Phase|Protocol Violation|2|||
163184923|NCT01436162|589392815|FG000|Randomized Phase|Withdrawal by Subject|16|||
163184924|NCT01436162|589392816|FG001|Randomized Phase|Withdrawal by Subject|9|||
163184925|NCT01436162|589392817|FG002|Randomized Phase|Withdrawal by Subject|8|||
163184926|NCT01436162|589392815|FG000|Randomized Phase|Lost to Follow-up|17|||
163184927|NCT01436162|589392816|FG001|Randomized Phase|Lost to Follow-up|5|||
163290422|NCT03612804|589768387|FG001|Overall Study|Medication copay coverage issues|0|||
162941611|NCT01296932|588490344|FG001|Overall Study|Investigator decision|1|||
162941612|NCT01296932|588490345|FG002|Overall Study|Investigator decision|0|||
163290423|NCT03612804|589768388|FG002|Overall Study|Medication copay coverage issues|0|||
163290424|NCT03612804|589768389|FG003|Overall Study|Medication copay coverage issues|17|||
163290425|NCT03612804|589768386|FG000|Overall Study|Not current smoker at time of screening|0|||
163290426|NCT03612804|589768387|FG001|Overall Study|Not current smoker at time of screening|1|||
163290427|NCT03612804|589768388|FG002|Overall Study|Not current smoker at time of screening|0|||
163290428|NCT03612804|589768389|FG003|Overall Study|Not current smoker at time of screening|3|||
163290429|NCT03612804|589768386|FG000|Overall Study|Non-veteran status|0|||
163290430|NCT03612804|589768387|FG001|Overall Study|Non-veteran status|1|||
163290431|NCT03612804|589768388|FG002|Overall Study|Non-veteran status|0|||
163290432|NCT03612804|589768389|FG003|Overall Study|Non-veteran status|0|||
163290433|NCT03612804|589768386|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
162941613|NCT01296932|588490346|FG003|Overall Study|Investigator decision|1|||
162941614|NCT01296932|588490347|FG004|Overall Study|Investigator decision|0|||
162941615|NCT01296932|588490348|FG005|Overall Study|Investigator decision|0|||
162941616|NCT01296932|588490349|FG006|Overall Study|Investigator decision|1|||
162941617|NCT01296932|588490350|FG007|Overall Study|Investigator decision|0|||
162941618|NCT01296932|588490351|FG008|Overall Study|Investigator decision|1|||
162941619|NCT01296932|588490343|FG000|Overall Study|No clinical benefit anymore|0|||
162941620|NCT01296932|588490344|FG001|Overall Study|No clinical benefit anymore|1|||
162941621|NCT01296932|588490345|FG002|Overall Study|No clinical benefit anymore|0|||
162941622|NCT01296932|588490346|FG003|Overall Study|No clinical benefit anymore|0|||
162941623|NCT01296932|588490347|FG004|Overall Study|No clinical benefit anymore|0|||
162941624|NCT01296932|588490348|FG005|Overall Study|No clinical benefit anymore|0|||
162941625|NCT01296932|588490349|FG006|Overall Study|No clinical benefit anymore|0|||
162941626|NCT01296932|588490350|FG007|Overall Study|No clinical benefit anymore|0|||
162941627|NCT01296932|588490351|FG008|Overall Study|No clinical benefit anymore|0|||
162941628|NCT01296932|588490343|FG000|Overall Study|Physician Decision|0|||
162941629|NCT01296932|588490344|FG001|Overall Study|Physician Decision|0|||
162941630|NCT01296932|588490345|FG002|Overall Study|Physician Decision|1|||
162941631|NCT01296932|588490346|FG003|Overall Study|Physician Decision|0|||
162941632|NCT01296932|588490347|FG004|Overall Study|Physician Decision|0|||
162941633|NCT01296932|588490348|FG005|Overall Study|Physician Decision|0|||
162941634|NCT01296932|588490349|FG006|Overall Study|Physician Decision|0|||
162941635|NCT01296932|588490350|FG007|Overall Study|Physician Decision|0|||
163290434|NCT03612804|589768387|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
162941636|NCT01296932|588490351|FG008|Overall Study|Physician Decision|0|||
162941637|NCT01296932|588490343|FG000|Overall Study|IV problems, administration not possible|0|||
162941638|NCT01296932|588490344|FG001|Overall Study|IV problems, administration not possible|0|||
162941639|NCT01296932|588490345|FG002|Overall Study|IV problems, administration not possible|1|||
162941640|NCT01296932|588490346|FG003|Overall Study|IV problems, administration not possible|0|||
162941641|NCT01296932|588490347|FG004|Overall Study|IV problems, administration not possible|0|||
162941642|NCT01296932|588490348|FG005|Overall Study|IV problems, administration not possible|0|||
162941643|NCT01296932|588490349|FG006|Overall Study|IV problems, administration not possible|0|||
162941644|NCT01296932|588490350|FG007|Overall Study|IV problems, administration not possible|0|||
162941645|NCT01296932|588490351|FG008|Overall Study|IV problems, administration not possible|0|||
162941646|NCT01296932|588490343|FG000|Overall Study|per protocol|0|||
162941647|NCT01296932|588490344|FG001|Overall Study|per protocol|0|||
162941648|NCT01296932|588490345|FG002|Overall Study|per protocol|1|||
162941649|NCT01296932|588490346|FG003|Overall Study|per protocol|1|||
162941650|NCT01296932|588490347|FG004|Overall Study|per protocol|0|||
162941651|NCT01296932|588490348|FG005|Overall Study|per protocol|0|||
162941652|NCT01296932|588490349|FG006|Overall Study|per protocol|0|||
162941653|NCT01296932|588490350|FG007|Overall Study|per protocol|0|||
162941654|NCT01296932|588490351|FG008|Overall Study|per protocol|0|||
162941655|NCT01296932|588490343|FG000|Overall Study|Low benefit and too many side effects|0|||
162941656|NCT01296932|588490344|FG001|Overall Study|Low benefit and too many side effects|0|||
162941657|NCT01296932|588490345|FG002|Overall Study|Low benefit and too many side effects|0|||
162941658|NCT01296932|588490346|FG003|Overall Study|Low benefit and too many side effects|0|||
162941659|NCT01296932|588490347|FG004|Overall Study|Low benefit and too many side effects|0|||
162941660|NCT01296932|588490348|FG005|Overall Study|Low benefit and too many side effects|0|||
162941661|NCT01296932|588490349|FG006|Overall Study|Low benefit and too many side effects|0|||
162941662|NCT01296932|588490350|FG007|Overall Study|Low benefit and too many side effects|1|||
162941663|NCT01296932|588490351|FG008|Overall Study|Low benefit and too many side effects|0|||
162941664|NCT01296932|588490343|FG000|Overall Study|No adequate treatment response|0|||
162941665|NCT01296932|588490344|FG001|Overall Study|No adequate treatment response|0|||
162941666|NCT01296932|588490345|FG002|Overall Study|No adequate treatment response|0|||
162941667|NCT01296932|588490346|FG003|Overall Study|No adequate treatment response|0|||
162941668|NCT01296932|588490347|FG004|Overall Study|No adequate treatment response|0|||
162941669|NCT01296932|588490348|FG005|Overall Study|No adequate treatment response|0|||
162941670|NCT01296932|588490349|FG006|Overall Study|No adequate treatment response|0|||
162941671|NCT01296932|588490350|FG007|Overall Study|No adequate treatment response|1|||
162941672|NCT01296932|588490351|FG008|Overall Study|No adequate treatment response|0|||
162941673|NCT01296932|588490343|FG000|Overall Study|Dosage already reduced, AE still present|0|||
162941674|NCT01296932|588490344|FG001|Overall Study|Dosage already reduced, AE still present|0|||
162941675|NCT01296932|588490345|FG002|Overall Study|Dosage already reduced, AE still present|0|||
162941676|NCT01296932|588490346|FG003|Overall Study|Dosage already reduced, AE still present|0|||
162941677|NCT01296932|588490347|FG004|Overall Study|Dosage already reduced, AE still present|0|||
162941678|NCT01296932|588490348|FG005|Overall Study|Dosage already reduced, AE still present|0|||
162941679|NCT01296932|588490349|FG006|Overall Study|Dosage already reduced, AE still present|0|||
162941680|NCT01296932|588490350|FG007|Overall Study|Dosage already reduced, AE still present|0|||
162941681|NCT01296932|588490351|FG008|Overall Study|Dosage already reduced, AE still present|1|||
162941682|NCT02918162|588490353|FG000|Overall Study|Withdrawal by Subject|1|||
162941683|NCT02918162|588490353|FG000|Overall Study|Omental Disease|1|||
163184928|NCT01436162|589392817|FG002|Randomized Phase|Lost to Follow-up|4|||
163184929|NCT01436162|589392815|FG000|Randomized Phase|Lack of Efficacy|0|||
163184930|NCT01436162|589392816|FG001|Randomized Phase|Lack of Efficacy|1|||
163184931|NCT01436162|589392817|FG002|Randomized Phase|Lack of Efficacy|1|||
163184932|NCT01436162|589392815|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
163184933|NCT01436162|589392816|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
163184934|NCT01436162|589392817|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
163184935|NCT01436162|589392815|FG000|Randomized Phase|Other|2|||
163184936|NCT01436162|589392816|FG001|Randomized Phase|Other|5|||
163184937|NCT01436162|589392817|FG002|Randomized Phase|Other|4|||
163184938|NCT02567552|589392818|FG000|Overall Study|Adverse Event|0|||
163184939|NCT02567552|589392819|FG001|Overall Study|Adverse Event|1|||
163184940|NCT00171054|589392824|FG000|Overall Study|Protocol Violation|1|||
163184941|NCT00171054|589392825|FG001|Overall Study|Protocol Violation|2|||
163184942|NCT00171054|589392824|FG000|Overall Study|Patient withdrew consent|1|||
163184943|NCT00171054|589392825|FG001|Overall Study|Patient withdrew consent|0|||
163184944|NCT00171054|589392824|FG000|Overall Study|Lost to Follow-up|0|||
163184945|NCT00171054|589392825|FG001|Overall Study|Lost to Follow-up|1|||
163290435|NCT03612804|589768388|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
163290436|NCT03612804|589768389|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
163290437|NCT03612804|589768386|FG000|Overall Study|Provider retired from VA|0|||
162941684|NCT00395226|588490354|FG000|Overall Study|Adverse Event|4|||
162941685|NCT00395226|588490355|FG001|Overall Study|Adverse Event|3|||
162941686|NCT00395226|588490354|FG000|Overall Study|Withdrawal by Subject|0|||
162941687|NCT00395226|588490355|FG001|Overall Study|Withdrawal by Subject|1|||
162941688|NCT00395226|588490354|FG000|Overall Study|Lost to Follow-up|0|||
162941689|NCT00395226|588490355|FG001|Overall Study|Lost to Follow-up|1|||
162941690|NCT02655237|588490358|FG000|Overall Study|Adverse Event|10|||
163184946|NCT00171054|589392824|FG000|Overall Study|Adverse Event|8|||
163184947|NCT00171054|589392825|FG001|Overall Study|Adverse Event|8|||
163184948|NCT00171054|589392824|FG000|Overall Study|Condition no longer required study drug|0|||
163184949|NCT00171054|589392825|FG001|Overall Study|Condition no longer required study drug|1|||
163184950|NCT04669535|589392826|FG000|Overall Study|Death|1|||
163184951|NCT04669535|589392827|FG001|Overall Study|Death|1|||
163184952|NCT04669535|589392828|FG002|Overall Study|Death|0|||
163184953|NCT04669535|589392829|FG003|Overall Study|Death|0|||
163184954|NCT01876810|589392830|FG000|Overall Study|Physician Decision|0|||
163184955|NCT01876810|589392831|FG001|Overall Study|Physician Decision|1|||
163184956|NCT04382755|589392835|FG000|Overall Study|Withdrawal by Subject|1|||
163184957|NCT04382755|589392836|FG001|Overall Study|Withdrawal by Subject|0|||
163184958|NCT04382755|589392835|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
163184959|NCT04382755|589392836|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
163184960|NCT04382755|589392835|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
163184961|NCT04382755|589392836|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
163184962|NCT00458536|589392844|FG000|Overall Study|Disease progression prior to treatment|7|||
163184963|NCT00458536|589392844|FG000|Overall Study|Unable to make vaccine|3|||
163184964|NCT00458536|589392844|FG000|Overall Study|No measurable disease after surgery|2|||
163184965|NCT00458536|589392844|FG000|Overall Study|Did not have renal cell carcinoma|2|||
163184966|NCT00458536|589392844|FG000|Overall Study|Patient did not have surgery|1|||
163184967|NCT00458536|589392844|FG000|Overall Study|Ineligible due to toxicity|1|||
163184968|NCT00458536|589392844|FG000|Overall Study|Withdrawal by Subject|1|||
163184969|NCT00458536|589392844|FG000|Overall Study|Progressive disease during treatment|2|||
163184970|NCT00285207|589392845|FG000|Overall Study|Lost to Follow-up|3|||
163184971|NCT00285207|589392846|FG001|Overall Study|Lost to Follow-up|2|||
163184972|NCT00285207|589392845|FG000|Overall Study|Withdrawal by Subject|5|||
163184973|NCT00285207|589392846|FG001|Overall Study|Withdrawal by Subject|2|||
163184974|NCT00285207|589392845|FG000|Overall Study|Pregnancy|1|||
163184975|NCT00285207|589392846|FG001|Overall Study|Pregnancy|1|||
163184976|NCT00285207|589392845|FG000|Overall Study|non-compliance|0|||
163184977|NCT00285207|589392846|FG001|Overall Study|non-compliance|1|||
163184978|NCT03670836|589392847|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
163184979|NCT03670836|589392848|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
163184980|NCT03670836|589392847|FG000|Per Protocol Population (PP)|Physician Decision|9|||
163184981|NCT03670836|589392848|FG001|Per Protocol Population (PP)|Physician Decision|10|||
163184982|NCT03670836|589392847|FG000|Per Protocol Population (PP)|Physician Decision|4|||
163184983|NCT03670836|589392848|FG001|Per Protocol Population (PP)|Physician Decision|6|||
163184984|NCT03670836|589392847|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
163184985|NCT03670836|589392848|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
163184986|NCT02160782|589394275|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
163184987|NCT02160782|589394276|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
163184988|NCT02160782|589394277|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
163184989|NCT02160782|589394278|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
163184990|NCT02160782|589394279|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
163184991|NCT02160782|589394275|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
163184992|NCT02160782|589394276|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
163184993|NCT02160782|589394277|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
163184994|NCT02160782|589394278|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
163184995|NCT02160782|589394279|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
163184996|NCT02160782|589394275|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
163184997|NCT02160782|589394276|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
163184998|NCT02160782|589394277|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
163184999|NCT02160782|589394278|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
163185000|NCT02160782|589394279|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
163185001|NCT02160782|589394275|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
163185002|NCT02160782|589394276|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
163185003|NCT02160782|589394277|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
163185004|NCT02160782|589394278|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
163185005|NCT02160782|589394279|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
163185006|NCT02160782|589394275|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
163185007|NCT02160782|589394276|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
163185008|NCT02160782|589394277|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
163290438|NCT03612804|589768387|FG001|Overall Study|Provider retired from VA|0|||
163290439|NCT03612804|589768388|FG002|Overall Study|Provider retired from VA|2|||
162941691|NCT02655237|588490359|FG001|Overall Study|Adverse Event|7|||
162941692|NCT02655237|588490358|FG000|Overall Study|Protocol Deviation|2|||
162941693|NCT02655237|588490359|FG001|Overall Study|Protocol Deviation|0|||
162941694|NCT02655237|588490358|FG000|Overall Study|Withdrawal by Participant|1|||
162941695|NCT02655237|588490359|FG001|Overall Study|Withdrawal by Participant|2|||
162941696|NCT02655237|588490358|FG000|Overall Study|Lack of Efficacy|0|||
162941697|NCT02655237|588490359|FG001|Overall Study|Lack of Efficacy|1|||
163185009|NCT02160782|589394278|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
163185010|NCT02160782|589394279|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
163185011|NCT02160782|589394275|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
163185012|NCT02160782|589394276|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
163185013|NCT02160782|589394277|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
163185014|NCT02160782|589394278|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
163185015|NCT02160782|589394279|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
163185016|NCT02160782|589394275|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
163185017|NCT02160782|589394276|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
162941698|NCT02655237|588490358|FG000|Overall Study|Recovery Leading to Surgery|2|||
162941699|NCT02655237|588490359|FG001|Overall Study|Recovery Leading to Surgery|1|||
162941700|NCT02655237|588490358|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
162941701|NCT02655237|588490359|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
162941702|NCT02655237|588490358|FG000|Overall Study|Randomized but Not Treated|1|||
163290440|NCT03612804|589768389|FG003|Overall Study|Provider retired from VA|0|||
163290441|NCT03612804|589768386|FG000|Overall Study|Withdrawal by Subject|0|||
162941703|NCT02655237|588490359|FG001|Overall Study|Randomized but Not Treated|0|||
162941704|NCT02227862|588490360|FG000|Overall Study|Protocol Violation|7|||
162941705|NCT02227862|588490361|FG001|Overall Study|Protocol Violation|9|||
162941706|NCT02227862|588490360|FG000|Overall Study|Other|0|||
162941707|NCT02227862|588490361|FG001|Overall Study|Other|2|||
162941708|NCT02227862|588490360|FG000|Overall Study|Adverse Event|4|||
162941709|NCT02227862|588490361|FG001|Overall Study|Adverse Event|3|||
162941710|NCT02227862|588490360|FG000|Overall Study|Withdrawal by Subject|7|||
162941711|NCT02227862|588490361|FG001|Overall Study|Withdrawal by Subject|6|||
162941712|NCT02227862|588490360|FG000|Overall Study|Lost to Follow-up|1|||
162941713|NCT02227862|588490361|FG001|Overall Study|Lost to Follow-up|2|||
162941714|NCT05014204|588490362|FG000|Overall Study|Withdrawal by Subject|1|||
162941715|NCT05014204|588490362|FG000|Overall Study|Physician Decision|1|||
162941716|NCT00819247|588490366|FG000|Overall Study|Adverse Event|0|||
162941717|NCT00819247|588490367|FG001|Overall Study|Adverse Event|5|||
162941718|NCT00819247|588490368|FG002|Overall Study|Adverse Event|3|||
162941719|NCT00819247|588490366|FG000|Overall Study|Insufficient testosterone response|5|||
162941720|NCT00819247|588490367|FG001|Overall Study|Insufficient testosterone response|8|||
162941721|NCT00819247|588490368|FG002|Overall Study|Insufficient testosterone response|10|||
162941722|NCT00819247|588490366|FG000|Overall Study|Withdrawal by Subject|1|||
162941723|NCT00819247|588490367|FG001|Overall Study|Withdrawal by Subject|0|||
162941724|NCT00819247|588490368|FG002|Overall Study|Withdrawal by Subject|0|||
162941725|NCT00819247|588490366|FG000|Overall Study|Protocol Violation|1|||
162941726|NCT00819247|588490367|FG001|Overall Study|Protocol Violation|0|||
162941727|NCT00819247|588490368|FG002|Overall Study|Protocol Violation|1|||
162941728|NCT00819247|588490366|FG000|Overall Study|Mistakenly withdrawn|0|||
162941729|NCT00819247|588490367|FG001|Overall Study|Mistakenly withdrawn|1|||
162941730|NCT00819247|588490368|FG002|Overall Study|Mistakenly withdrawn|0|||
162941731|NCT00819247|588490366|FG000|Overall Study|Bad prostate-specific antigen response|3|||
162941732|NCT00819247|588490367|FG001|Overall Study|Bad prostate-specific antigen response|2|||
162941733|NCT00819247|588490368|FG002|Overall Study|Bad prostate-specific antigen response|0|||
162941734|NCT00819247|588490366|FG000|Overall Study|Other|1|||
162941735|NCT00819247|588490367|FG001|Overall Study|Other|0|||
162941736|NCT00819247|588490368|FG002|Overall Study|Other|0|||
162941737|NCT03748641|588490372|FG000|Overall Study|Ongoing|155|||
162941738|NCT03748641|588490373|FG001|Overall Study|Ongoing|148|||
162941739|NCT03748641|588490374|FG002|Overall Study|Ongoing|66|||
162941740|NCT03748641|588490375|FG003|Overall Study|Ongoing|79|||
162941741|NCT03748641|588490376|FG004|Overall Study|Ongoing|84|||
162941742|NCT03748641|588490372|FG000|Overall Study|Death|54|||
162941743|NCT03748641|588490373|FG001|Overall Study|Death|59|||
162941744|NCT03748641|588490374|FG002|Overall Study|Death|51|||
162941745|NCT03748641|588490375|FG003|Overall Study|Death|42|||
162941746|NCT03748641|588490376|FG004|Overall Study|Death|9|||
162941747|NCT03748641|588490372|FG000|Overall Study|Lost to Follow-up|0|||
162941748|NCT03748641|588490373|FG001|Overall Study|Lost to Follow-up|2|||
162941749|NCT03748641|588490374|FG002|Overall Study|Lost to Follow-up|1|||
162941750|NCT03748641|588490375|FG003|Overall Study|Lost to Follow-up|0|||
162941751|NCT03748641|588490376|FG004|Overall Study|Lost to Follow-up|0|||
162941752|NCT03748641|588490372|FG000|Overall Study|Withdrawal by Subject|3|||
162941753|NCT03748641|588490373|FG001|Overall Study|Withdrawal by Subject|2|||
163290442|NCT03612804|589768387|FG001|Overall Study|Withdrawal by Subject|0|||
163290443|NCT03612804|589768388|FG002|Overall Study|Withdrawal by Subject|7|||
163290444|NCT03612804|589768389|FG003|Overall Study|Withdrawal by Subject|0|||
163290445|NCT03612804|589768386|FG000|Overall Study|Provider involved with study activities|1|||
163290446|NCT03612804|589768387|FG001|Overall Study|Provider involved with study activities|0|||
163290447|NCT03612804|589768388|FG002|Overall Study|Provider involved with study activities|0|||
163290448|NCT03612804|589768389|FG003|Overall Study|Provider involved with study activities|0|||
163290449|NCT05484726|589768390|FG000|Overall Study|Protocol Violation|3|||
163290450|NCT05484726|589768391|FG001|Overall Study|Protocol Violation|3|||
163290451|NCT05484726|589768390|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
162941754|NCT03748641|588490374|FG002|Overall Study|Withdrawal by Subject|5|||
162941755|NCT03748641|588490375|FG003|Overall Study|Withdrawal by Subject|3|||
162941756|NCT03748641|588490376|FG004|Overall Study|Withdrawal by Subject|2|||
162941757|NCT00437281|588490377|FG000|Overall Study|Adverse Event|0|||
162941758|NCT00437281|588490378|FG001|Overall Study|Adverse Event|0|||
162941759|NCT00437281|588490379|FG002|Overall Study|Adverse Event|0|||
162941760|NCT00437281|588490380|FG003|Overall Study|Adverse Event|1|||
162941761|NCT00437281|588490381|FG004|Overall Study|Adverse Event|0|||
162941762|NCT00437281|588490382|FG005|Overall Study|Adverse Event|1|||
162941763|NCT00437281|588490383|FG006|Overall Study|Adverse Event|0|||
162941764|NCT00437281|588490384|FG007|Overall Study|Adverse Event|0|||
162941765|NCT00437281|588490385|FG008|Overall Study|Adverse Event|0|||
162941766|NCT00437281|588490386|FG009|Overall Study|Adverse Event|1|||
162941767|NCT00437281|588490387|FG010|Overall Study|Adverse Event|0|||
162941768|NCT00437281|588490388|FG011|Overall Study|Adverse Event|0|||
162941769|NCT00437281|588490389|FG012|Overall Study|Adverse Event|0|||
162941770|NCT00437281|588490390|FG013|Overall Study|Adverse Event|1|||
162941771|NCT00437281|588490391|FG014|Overall Study|Adverse Event|1|||
162941772|NCT00437281|588490392|FG015|Overall Study|Adverse Event|0|||
162941773|NCT00437281|588490393|FG016|Overall Study|Adverse Event|0|||
162941774|NCT00437281|588490394|FG017|Overall Study|Adverse Event|0|||
162941775|NCT00437281|588490395|FG018|Overall Study|Adverse Event|1|||
162941776|NCT00437281|588490396|FG019|Overall Study|Adverse Event|0|||
162941777|NCT00437281|588490377|FG000|Overall Study|Lost to Follow-up|0|||
162941778|NCT00437281|588490378|FG001|Overall Study|Lost to Follow-up|0|||
162941779|NCT00437281|588490379|FG002|Overall Study|Lost to Follow-up|0|||
162941780|NCT00437281|588490380|FG003|Overall Study|Lost to Follow-up|0|||
162941781|NCT00437281|588490381|FG004|Overall Study|Lost to Follow-up|0|||
162941782|NCT00437281|588490382|FG005|Overall Study|Lost to Follow-up|0|||
162941783|NCT00437281|588490383|FG006|Overall Study|Lost to Follow-up|0|||
162941784|NCT00437281|588490384|FG007|Overall Study|Lost to Follow-up|0|||
162941785|NCT00437281|588490385|FG008|Overall Study|Lost to Follow-up|0|||
162941786|NCT00437281|588490386|FG009|Overall Study|Lost to Follow-up|0|||
162941787|NCT00437281|588490387|FG010|Overall Study|Lost to Follow-up|0|||
162941788|NCT00437281|588490388|FG011|Overall Study|Lost to Follow-up|0|||
162941789|NCT00437281|588490389|FG012|Overall Study|Lost to Follow-up|0|||
162941790|NCT00437281|588490390|FG013|Overall Study|Lost to Follow-up|0|||
162941791|NCT00437281|588490391|FG014|Overall Study|Lost to Follow-up|0|||
162941792|NCT00437281|588490392|FG015|Overall Study|Lost to Follow-up|0|||
162941793|NCT00437281|588490393|FG016|Overall Study|Lost to Follow-up|0|||
162941794|NCT00437281|588490394|FG017|Overall Study|Lost to Follow-up|0|||
162941795|NCT00437281|588490395|FG018|Overall Study|Lost to Follow-up|0|||
162941796|NCT00437281|588490396|FG019|Overall Study|Lost to Follow-up|1|||
162941797|NCT00926289|588490397|FG000|Overall Study|Adverse Event|9|||
162941798|NCT00926289|588490398|FG001|Overall Study|Adverse Event|11|||
162941799|NCT00926289|588490397|FG000|Overall Study|Protocol Violation|8|||
162941800|NCT00926289|588490398|FG001|Overall Study|Protocol Violation|12|||
162941801|NCT00926289|588490397|FG000|Overall Study|Lost to Follow-up|3|||
162941802|NCT00926289|588490398|FG001|Overall Study|Lost to Follow-up|6|||
162941803|NCT00926289|588490397|FG000|Overall Study|Withdrawal by Subject|4|||
162941804|NCT00926289|588490398|FG001|Overall Study|Withdrawal by Subject|4|||
162941805|NCT00926289|588490397|FG000|Overall Study|Other|1|||
162941806|NCT00926289|588490398|FG001|Overall Study|Other|3|||
162941807|NCT04104646|588490399|FG000|Overall Study|Withdrawal by Subject|1|||
162941808|NCT04104646|588490400|FG001|Overall Study|Withdrawal by Subject|1|||
162941809|NCT04104646|588490399|FG000|Overall Study|Lost to Follow-up|1|||
162941810|NCT04104646|588490400|FG001|Overall Study|Lost to Follow-up|0|||
162941811|NCT04104646|588490399|FG000|Overall Study|Physician Decision|2|||
162941812|NCT04104646|588490400|FG001|Overall Study|Physician Decision|0|||
162941813|NCT01199601|588490401|FG000|Overall Study|Lost to Follow-up|47|||
162941814|NCT01199601|588490402|FG001|Overall Study|Lost to Follow-up|66|||
162941815|NCT01199601|588490401|FG000|Overall Study|Withdrawal by Subject|15|||
162941816|NCT01199601|588490402|FG001|Overall Study|Withdrawal by Subject|3|||
162941817|NCT01199601|588490401|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
162941818|NCT01199601|588490402|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
162941819|NCT00753714|588490403|FG000|Overall Study|Lack of Efficacy|21|||
162941820|NCT00753714|588490404|FG001|Overall Study|Lack of Efficacy|34|||
162941821|NCT00753714|588490403|FG000|Overall Study|Adverse Event|26|||
162941822|NCT00753714|588490404|FG001|Overall Study|Adverse Event|18|||
162941823|NCT00753714|588490403|FG000|Overall Study|Protocol Violation|1|||
162941824|NCT00753714|588490404|FG001|Overall Study|Protocol Violation|0|||
162941825|NCT00753714|588490403|FG000|Overall Study|Lost to Follow-up|0|||
162941826|NCT00753714|588490404|FG001|Overall Study|Lost to Follow-up|1|||
162941827|NCT00753714|588490403|FG000|Overall Study|Withdrawal by Subject|2|||
162941828|NCT00753714|588490404|FG001|Overall Study|Withdrawal by Subject|1|||
162941829|NCT00753714|588490403|FG000|Overall Study|Death|3|||
162941830|NCT00753714|588490404|FG001|Overall Study|Death|3|||
162941831|NCT00753714|588490403|FG000|Overall Study|Other|7|||
162941832|NCT00753714|588490404|FG001|Overall Study|Other|5|||
162941833|NCT03387098|588490405|FG000|Overall Study|progressive disease|1|||
162941834|NCT03387098|588490405|FG000|Overall Study|Withdrawal by Subject|2|||
162941835|NCT03387098|588490405|FG000|Overall Study|study terminated by sponsor|1|||
162941836|NCT00278512|588490406|FG000|Overall Study|Death|1|||
162941837|NCT00278512|588490407|FG001|Overall Study|Death|0|||
162941838|NCT01620177|588490408|FG000|Overall Study|Failure at Screening Visit|43|||
162941839|NCT01620177|588490408|FG000|Overall Study|Withdrawal by Subject|26|||
162941840|NCT01620177|588490408|FG000|Overall Study|Lost to Follow-up|7|||
162941841|NCT01620177|588490408|FG000|Overall Study|Physician Decision|2|||
162941842|NCT01620177|588490408|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
162941843|NCT02292238|588490409|FG000|Overall Study|Protocol Violation|1|||
162941844|NCT02292238|588490410|FG001|Overall Study|Protocol Violation|2|||
162941845|NCT02292238|588490409|FG000|Overall Study|Withdrawal by Subject|2|||
162941846|NCT02292238|588490410|FG001|Overall Study|Withdrawal by Subject|1|||
162941847|NCT02292238|588490409|FG000|Overall Study|Lost to Follow-up|1|||
162941848|NCT02292238|588490410|FG001|Overall Study|Lost to Follow-up|0|||
162941849|NCT02292238|588490409|FG000|Overall Study|Physician Decision|0|||
162941850|NCT02292238|588490410|FG001|Overall Study|Physician Decision|1|||
162941851|NCT04000009|588490411|FG000|Overall Study|Adverse Event|13|||
162941852|NCT04000009|588490411|FG000|Overall Study|Lack of Efficacy|7|||
162941853|NCT04000009|588490411|FG000|Overall Study|Lost to Follow-up|8|||
162941854|NCT04000009|588490411|FG000|Overall Study|Noncompliance with study drug|4|||
162941855|NCT04000009|588490411|FG000|Overall Study|Physician Decision|1|||
162941856|NCT04000009|588490411|FG000|Overall Study|Use of prohibited medication|3|||
162941857|NCT04000009|588490411|FG000|Overall Study|Pregnancy|1|||
162941858|NCT04000009|588490411|FG000|Overall Study|Withdrawal by Subject|22|||
162941859|NCT04000009|588490411|FG000|Overall Study|Study terminated by sponsor|98|||
162941860|NCT04000009|588490411|FG000|Overall Study|Not further specified|8|||
162941861|NCT01754259|588490414|FG000|Overall Study|Withdrawal by Subject|2|||
162941862|NCT01754259|588490415|FG001|Overall Study|Withdrawal by Subject|4|||
162941863|NCT01754259|588490414|FG000|Overall Study|Adverse Event|3|||
163185018|NCT02160782|589394277|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
163185019|NCT02160782|589394278|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
162941864|NCT01754259|588490415|FG001|Overall Study|Adverse Event|1|||
163185020|NCT02160782|589394279|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
162941865|NCT01754259|588490414|FG000|Overall Study|Lost to Follow-up|0|||
162941866|NCT01754259|588490415|FG001|Overall Study|Lost to Follow-up|1|||
162941867|NCT02829918|588490416|FG000|Overall Study|Death|2|||
162941868|NCT02829918|588490416|FG000|Overall Study|Withdrawal by Subject|4|||
162941869|NCT02829918|588490416|FG000|Overall Study|Adverse Event|1|||
162941870|NCT02829918|588490416|FG000|Overall Study|Progression|1|||
162941871|NCT00491504|588490419|FG000|Overall Study|Adverse Event|0|||
162941872|NCT00491504|588490420|FG001|Overall Study|Adverse Event|1|||
162941873|NCT00491504|588490421|FG002|Overall Study|Adverse Event|0|||
162941874|NCT00491504|588490422|FG003|Overall Study|Adverse Event|0|||
162941875|NCT00491504|588490419|FG000|Overall Study|Withdrawal by Subject|0|||
162941876|NCT00491504|588490420|FG001|Overall Study|Withdrawal by Subject|0|||
162941877|NCT00491504|588490421|FG002|Overall Study|Withdrawal by Subject|1|||
162941878|NCT00491504|588490422|FG003|Overall Study|Withdrawal by Subject|2|||
162941879|NCT00491504|588490419|FG000|Overall Study|Protocol Violation|0|||
162941880|NCT00491504|588490420|FG001|Overall Study|Protocol Violation|0|||
162941881|NCT00491504|588490421|FG002|Overall Study|Protocol Violation|3|||
162941882|NCT00491504|588490422|FG003|Overall Study|Protocol Violation|2|||
162941883|NCT02041702|588490427|FG000|Overall Study|Lost to Follow-up|1|||
162941884|NCT02041702|588490428|FG001|Overall Study|Lost to Follow-up|6|||
162941885|NCT02041702|588490427|FG000|Overall Study|Death|4|||
162941886|NCT02041702|588490428|FG001|Overall Study|Death|0|||
162941887|NCT02041702|588490427|FG000|Overall Study|Withdrawal by Subject|4|||
162941888|NCT02041702|588490428|FG001|Overall Study|Withdrawal by Subject|3|||
162941889|NCT02041702|588490427|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
162941890|NCT02041702|588490428|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
162941891|NCT02041702|588490427|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
162941892|NCT02041702|588490428|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
162941893|NCT00203307|588490429|FG000|First Intervention|Adverse Event|2|||
162941894|NCT00203307|588490430|FG001|First Intervention|Adverse Event|0|||
162941895|NCT03730103|588490431|FG000|Overall Study|Did not meet inclusion criteria|0|||
162941896|NCT03730103|588490432|FG001|Overall Study|Did not meet inclusion criteria|5|||
162941897|NCT02789111|588490433|FG000|Overall Study|Withdrawal by Subject|1|||
162941898|NCT02789111|588490434|FG001|Overall Study|Withdrawal by Subject|4|||
162941899|NCT02308111|588490435|FG000|Overall Study|Adverse Event|31|||
162941900|NCT02308111|588490436|FG001|Overall Study|Adverse Event|19|||
162941901|NCT02308111|588490435|FG000|Overall Study|Death|9|||
162941902|NCT02308111|588490436|FG001|Overall Study|Death|6|||
162941903|NCT02308111|588490435|FG000|Overall Study|Lost to Follow-up|2|||
162941904|NCT02308111|588490436|FG001|Overall Study|Lost to Follow-up|7|||
162941905|NCT02308111|588490435|FG000|Overall Study|Physician Decision|6|||
162941906|NCT02308111|588490436|FG001|Overall Study|Physician Decision|17|||
162941907|NCT02308111|588490435|FG000|Overall Study|Protocol Violation|0|||
162941908|NCT02308111|588490436|FG001|Overall Study|Protocol Violation|1|||
162941909|NCT02308111|588490435|FG000|Overall Study|Withdrawal by Subject|28|||
162941910|NCT02308111|588490436|FG001|Overall Study|Withdrawal by Subject|38|||
162941911|NCT02308111|588490435|FG000|Overall Study|Study Terminated by Sponsor|72|||
162941912|NCT02308111|588490436|FG001|Overall Study|Study Terminated by Sponsor|61|||
162941913|NCT02308111|588490435|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
162941914|NCT02308111|588490436|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
162941915|NCT02308111|588490435|FG000|Overall Study|Site Closure|3|||
162941916|NCT02308111|588490436|FG001|Overall Study|Site Closure|3|||
162941917|NCT02308111|588490435|FG000|Overall Study|Non-compliance with Study Drug|3|||
162941918|NCT02308111|588490436|FG001|Overall Study|Non-compliance with Study Drug|1|||
162941919|NCT02308111|588490435|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
162941920|NCT02308111|588490436|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
162941921|NCT02308111|588490435|FG000|Overall Study|Liver Transplant|3|||
162941922|NCT02308111|588490436|FG001|Overall Study|Liver Transplant|3|||
162941923|NCT02308111|588490435|FG000|Overall Study|Liver Transplant Waitlist|2|||
162941924|NCT02308111|588490436|FG001|Overall Study|Liver Transplant Waitlist|2|||
162941925|NCT02308111|588490435|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
162941926|NCT02308111|588490436|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
162941927|NCT03271528|588490438|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
162941928|NCT03271528|588490439|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
162941929|NCT03271528|588490438|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
162941930|NCT03271528|588490439|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
162941931|NCT03271528|588490438|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
162941932|NCT03271528|588490439|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
162941933|NCT03271528|588490438|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
162941934|NCT03271528|588490439|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
162941935|NCT03271528|588490438|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
162941936|NCT03271528|588490439|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
162941937|NCT03271528|588490438|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
162941938|NCT03271528|588490439|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
162941939|NCT03271528|588490438|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
162941940|NCT03271528|588490439|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
162941941|NCT03977584|588490442|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
162941942|NCT03977584|588490443|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
162941943|NCT03977584|588490444|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
162941944|NCT02257736|588490448|FG000|Overall Study|Progressive disease|365|||
162941945|NCT02257736|588490449|FG001|Overall Study|Progressive disease|327|||
162941946|NCT02257736|588490448|FG000|Overall Study|Adverse Event|45|||
162941947|NCT02257736|588490449|FG001|Overall Study|Adverse Event|56|||
162941948|NCT02257736|588490448|FG000|Overall Study|Withdrawal by Subject|21|||
162941949|NCT02257736|588490449|FG001|Overall Study|Withdrawal by Subject|38|||
162941950|NCT02257736|588490448|FG000|Overall Study|Death|11|||
162941951|NCT02257736|588490449|FG001|Overall Study|Death|6|||
162941952|NCT02257736|588490448|FG000|Overall Study|Physician Decision|5|||
162941953|NCT02257736|588490449|FG001|Overall Study|Physician Decision|9|||
162941954|NCT02257736|588490448|FG000|Overall Study|Non-Compliance with study drug|1|||
162941955|NCT02257736|588490449|FG001|Overall Study|Non-Compliance with study drug|2|||
162941956|NCT02257736|588490448|FG000|Overall Study|Protocol Violation|1|||
162941957|NCT02257736|588490449|FG001|Overall Study|Protocol Violation|0|||
162941958|NCT02257736|588490448|FG000|Overall Study|Other|1|||
162941959|NCT02257736|588490449|FG001|Overall Study|Other|7|||
162941960|NCT02257736|588490448|FG000|Overall Study|Randomized, not treated|1|||
162941961|NCT02257736|588490449|FG001|Overall Study|Randomized, not treated|2|||
162941962|NCT00745251|588490457|FG000|Overall Study|Adverse Event|1|||
162941963|NCT00745251|588490458|FG001|Overall Study|Adverse Event|2|||
162941964|NCT00745251|588490457|FG000|Overall Study|Withdrawal by Subject|1|||
162941965|NCT00745251|588490458|FG001|Overall Study|Withdrawal by Subject|1|||
162941966|NCT03390504|588490459|FG000|Overall Study|Lost to Follow-up|2|||
162941967|NCT03390504|588490460|FG001|Overall Study|Lost to Follow-up|4|||
162941968|NCT03390504|588490461|FG002|Overall Study|Lost to Follow-up|0|||
162941969|NCT03390504|588490462|FG003|Overall Study|Lost to Follow-up|1|||
162941970|NCT03390504|588490459|FG000|Overall Study|Withdrawal by Subject|3|||
162941971|NCT03390504|588490460|FG001|Overall Study|Withdrawal by Subject|15|||
162941972|NCT03390504|588490461|FG002|Overall Study|Withdrawal by Subject|5|||
162941973|NCT03390504|588490462|FG003|Overall Study|Withdrawal by Subject|2|||
162941974|NCT03390504|588490459|FG000|Overall Study|Other|1|||
162941975|NCT03390504|588490460|FG001|Overall Study|Other|2|||
162941976|NCT03390504|588490461|FG002|Overall Study|Other|2|||
163185021|NCT01104701|589394283|FG000|Overall Study|Withdrawal by Subject|0|||
163185022|NCT01104701|589394284|FG001|Overall Study|Withdrawal by Subject|1|||
163318864|NCT01208662|589878794|FG000|Induction and Consolidation|Adverse Event|16|||
162941977|NCT03390504|588490462|FG003|Overall Study|Other|6|||
162941978|NCT05431686|588490463|FG000|Overall Study|unable to schedule|10|||
162941979|NCT01118728|588490478|FG000|Overall Study|Adverse Event|17|||
162941980|NCT01118728|588490478|FG000|Overall Study|Lack of Efficacy|27|||
162941981|NCT01118728|588490478|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
162941982|NCT01118728|588490478|FG000|Overall Study|Withdrawal by Subject|3|||
162941983|NCT01118728|588490478|FG000|Overall Study|Lost to Follow-up|4|||
162941984|NCT01309919|588490482|FG000|Overall Study|Did not receive a postpartum IUD|17|||
162941985|NCT01309919|588490483|FG001|Overall Study|Did not receive a postpartum IUD|48|||
163185023|NCT01104701|589394285|FG002|Overall Study|Withdrawal by Subject|2|||
163185024|NCT01104701|589394286|FG003|Overall Study|Withdrawal by Subject|1|||
163185025|NCT01104701|589394283|FG000|Overall Study|Adverse Event|0|||
163185026|NCT01104701|589394284|FG001|Overall Study|Adverse Event|0|||
163185027|NCT01104701|589394285|FG002|Overall Study|Adverse Event|0|||
163185028|NCT01104701|589394286|FG003|Overall Study|Adverse Event|1|||
163185029|NCT01104701|589394283|FG000|Overall Study|Physician Decision|0|||
163185030|NCT01104701|589394284|FG001|Overall Study|Physician Decision|2|||
163185031|NCT01104701|589394285|FG002|Overall Study|Physician Decision|0|||
163185032|NCT01104701|589394286|FG003|Overall Study|Physician Decision|0|||
163185033|NCT00891462|589394287|FG000|Overall Study|Withdrawal by Subject|9|||
163185034|NCT00891462|589394288|FG001|Overall Study|Withdrawal by Subject|6|||
163185035|NCT00891462|589394289|FG002|Overall Study|Withdrawal by Subject|7|||
163185036|NCT00891462|589394287|FG000|Overall Study|Adverse Event|7|||
163185037|NCT00891462|589394288|FG001|Overall Study|Adverse Event|8|||
163185038|NCT00891462|589394289|FG002|Overall Study|Adverse Event|7|||
163185039|NCT00891462|589394287|FG000|Overall Study|Lack of Efficacy|10|||
163185040|NCT00891462|589394288|FG001|Overall Study|Lack of Efficacy|5|||
163185041|NCT00891462|589394289|FG002|Overall Study|Lack of Efficacy|1|||
163185042|NCT00891462|589394287|FG000|Overall Study|COPD exacerbation|7|||
163185043|NCT00891462|589394288|FG001|Overall Study|COPD exacerbation|4|||
163185044|NCT00891462|589394289|FG002|Overall Study|COPD exacerbation|1|||
163185045|NCT00891462|589394287|FG000|Overall Study|Other Reason|2|||
163185046|NCT00891462|589394288|FG001|Overall Study|Other Reason|5|||
163185047|NCT00891462|589394289|FG002|Overall Study|Other Reason|3|||
163185048|NCT00891462|589394287|FG000|Overall Study|Protocol Violation|2|||
163185049|NCT00891462|589394288|FG001|Overall Study|Protocol Violation|1|||
163185050|NCT00891462|589394289|FG002|Overall Study|Protocol Violation|3|||
163185051|NCT00891462|589394287|FG000|Overall Study|Inclusion/exclusion criteria|0|||
163185052|NCT00891462|589394288|FG001|Overall Study|Inclusion/exclusion criteria|2|||
163185053|NCT00891462|589394289|FG002|Overall Study|Inclusion/exclusion criteria|2|||
163185054|NCT00891462|589394287|FG000|Overall Study|Lost to Follow-up|0|||
163185055|NCT00891462|589394288|FG001|Overall Study|Lost to Follow-up|2|||
163185056|NCT00891462|589394289|FG002|Overall Study|Lost to Follow-up|0|||
163185057|NCT01083485|589394292|FG000|Overall Study|Adverse Event|0|||
163185058|NCT01083485|589394293|FG001|Overall Study|Adverse Event|1|||
163185059|NCT01083485|589394292|FG000|Overall Study|Protocol Violation|1|||
163185060|NCT01083485|589394293|FG001|Overall Study|Protocol Violation|0|||
163185061|NCT01083485|589394292|FG000|Overall Study|Withdrawal by Subject|5|||
162941986|NCT01736553|588490490|FG000|Overall Study|Death|12|||
163185062|NCT01083485|589394293|FG001|Overall Study|Withdrawal by Subject|2|||
163185063|NCT01083485|589394292|FG000|Overall Study|Other|1|||
163185064|NCT01083485|589394293|FG001|Overall Study|Other|0|||
163185065|NCT02171065|589394294|FG000|Overall Study|Withdrawal by Subject|1|||
163185066|NCT02171065|589394295|FG001|Overall Study|Withdrawal by Subject|0|||
163290452|NCT05484726|589768391|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
163185067|NCT02171065|589394296|FG002|Overall Study|Withdrawal by Subject|0|||
163185068|NCT02171065|589394294|FG000|Overall Study|Lost to Follow-up|0|||
163185069|NCT02171065|589394295|FG001|Overall Study|Lost to Follow-up|0|||
163185070|NCT02171065|589394296|FG002|Overall Study|Lost to Follow-up|1|||
163185071|NCT00851630|589394298|FG000|Overall Study|Death|2|||
163185072|NCT00851630|589394299|FG001|Overall Study|Death|1|||
163185073|NCT00851630|589394298|FG000|Overall Study|Clinical failure|0|||
163185074|NCT00851630|589394299|FG001|Overall Study|Clinical failure|1|||
163185075|NCT03061097|589394306|FG000|Overall Study|Withdrawal by Subject|0|||
163185076|NCT03061097|589394307|FG001|Overall Study|Withdrawal by Subject|3|||
163185077|NCT03956056|589394308|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
163185078|NCT03956056|589394308|FG000|Overall Study|Lack of Efficacy|1|||
163290453|NCT05484726|589768390|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
163290454|NCT05484726|589768391|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
163290455|NCT05484726|589768390|FG000|Overall Study|continued need of mechanical ventilation|2|||
163290456|NCT05484726|589768391|FG001|Overall Study|continued need of mechanical ventilation|3|||
163290457|NCT05484726|589768390|FG000|Overall Study|Withdrawal by Subject|2|||
163290458|NCT05484726|589768391|FG001|Overall Study|Withdrawal by Subject|3|||
162941987|NCT01736553|588490491|FG001|Overall Study|Death|0|||
163185079|NCT02231918|589394309|FG000|Overall Study|Withdrawal by Subject|0|||
163185080|NCT02231918|589394310|FG001|Overall Study|Withdrawal by Subject|1|||
163185081|NCT02231918|589394311|FG002|Overall Study|Withdrawal by Subject|0|||
163185082|NCT02231918|589394309|FG000|Overall Study|Adverse Event|0|||
163185083|NCT02231918|589394310|FG001|Overall Study|Adverse Event|0|||
163185084|NCT02231918|589394311|FG002|Overall Study|Adverse Event|1|||
163185085|NCT04629508|589394320|FG000|Overall Study|Adverse Event|1|||
163185086|NCT04629508|589394320|FG000|Overall Study|Death|2|||
163185087|NCT04629508|589394320|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
163185088|NCT04073368|589394321|FG000|Overall Study|Adverse Event|2|||
163185089|NCT04073368|589394322|FG001|Overall Study|Adverse Event|0|||
163185090|NCT04073368|589394323|FG002|Overall Study|Adverse Event|1|||
163185091|NCT04073368|589394324|FG003|Overall Study|Adverse Event|1|||
163185092|NCT04073368|589394321|FG000|Overall Study|Withdrawal by Subject|2|||
163185093|NCT04073368|589394322|FG001|Overall Study|Withdrawal by Subject|2|||
163185094|NCT04073368|589394323|FG002|Overall Study|Withdrawal by Subject|1|||
163185095|NCT04073368|589394324|FG003|Overall Study|Withdrawal by Subject|1|||
163185096|NCT04073368|589394321|FG000|Overall Study|Lost to Follow-up|1|||
163185097|NCT04073368|589394322|FG001|Overall Study|Lost to Follow-up|1|||
163185098|NCT04073368|589394323|FG002|Overall Study|Lost to Follow-up|1|||
163185099|NCT04073368|589394324|FG003|Overall Study|Lost to Follow-up|0|||
163185100|NCT04073368|589394321|FG000|Overall Study|Protocol Violation|0|||
163185101|NCT04073368|589394322|FG001|Overall Study|Protocol Violation|1|||
163185102|NCT04073368|589394323|FG002|Overall Study|Protocol Violation|0|||
163185103|NCT04073368|589394324|FG003|Overall Study|Protocol Violation|0|||
163185104|NCT04073368|589394321|FG000|Overall Study|Subject noncompliance|7|||
163185105|NCT04073368|589394322|FG001|Overall Study|Subject noncompliance|4|||
163185106|NCT04073368|589394323|FG002|Overall Study|Subject noncompliance|0|||
163185107|NCT04073368|589394324|FG003|Overall Study|Subject noncompliance|0|||
163185108|NCT03026088|589394325|FG000|Overall Study|Study termination|20|||
163185109|NCT00761579|589394326|FG000|Overall Study|Adverse Event|10|||
163185110|NCT00761579|589394326|FG000|Overall Study|Death|2|||
163185111|NCT00761579|589394326|FG000|Overall Study|Lack of Efficacy|21|||
163185112|NCT00761579|589394326|FG000|Overall Study|Lost to Follow-up|16|||
163185113|NCT00761579|589394326|FG000|Overall Study|Pregnancy|1|||
163185114|NCT00761579|589394326|FG000|Overall Study|Withdrawal by Subject|34|||
163185115|NCT00761579|589394326|FG000|Overall Study|Lack of compliance|2|||
163185116|NCT00761579|589394326|FG000|Overall Study|Protocol deviation|1|||
163185117|NCT00761579|589394326|FG000|Overall Study|Drug overdose|1|||
163185118|NCT00761579|589394326|FG000|Overall Study|Aggravation of depression|1|||
163185119|NCT00761579|589394326|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
163185120|NCT00761579|589394326|FG000|Overall Study|Lost survey form|1|||
163185121|NCT00761579|589394326|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
163185122|NCT00950911|589394327|FG000|Overall Study|Adverse Event|0|||
163185123|NCT00950911|589394328|FG001|Overall Study|Adverse Event|2|||
163185124|NCT00950911|589394327|FG000|Overall Study|Death|4|||
163185125|NCT00950911|589394328|FG001|Overall Study|Death|6|||
163185126|NCT00950911|589394327|FG000|Overall Study|Disease progression|2|||
163185127|NCT00950911|589394328|FG001|Overall Study|Disease progression|2|||
163185128|NCT00950911|589394327|FG000|Overall Study|Consent withdrawn|1|||
163185129|NCT00950911|589394328|FG001|Overall Study|Consent withdrawn|3|||
162941988|NCT01736553|588490490|FG000|Overall Study|Withdrawal by Subject|5|||
162941989|NCT01736553|588490491|FG001|Overall Study|Withdrawal by Subject|2|||
162941990|NCT01736553|588490490|FG000|Overall Study|Lost to Follow-up|2|||
162941991|NCT01736553|588490491|FG001|Overall Study|Lost to Follow-up|2|||
162941992|NCT01896297|588490492|FG000|Overall Study|Died in post treatment phase|1|||
162941993|NCT00003782|588490495|FG000|Overall Study|No follow up data|30|||
162941994|NCT00003782|588490496|FG001|Overall Study|No follow up data|31|||
162941995|NCT00003782|588490497|FG002|Overall Study|No follow up data|26|||
162941996|NCT03626857|588490500|FG000|Overall Study|Adverse Event|9|||
162941997|NCT03626857|588490501|FG001|Overall Study|Adverse Event|7|||
162941998|NCT03626857|588490500|FG000|Overall Study|Lost to Follow-up|8|||
162941999|NCT03626857|588490501|FG001|Overall Study|Lost to Follow-up|8|||
162942000|NCT03626857|588490500|FG000|Overall Study|Withdrawal by Subject|2|||
162942001|NCT03626857|588490501|FG001|Overall Study|Withdrawal by Subject|2|||
162942002|NCT03626857|588490500|FG000|Overall Study|Protocol Violation|1|||
162942003|NCT03626857|588490501|FG001|Overall Study|Protocol Violation|3|||
162942004|NCT01301833|588490502|FG000|Overall Study|Adverse Event|7|||
163185130|NCT00950911|589394327|FG000|Overall Study|Administrative decision|3|||
163185131|NCT00950911|589394328|FG001|Overall Study|Administrative decision|1|||
163185132|NCT00950911|589394327|FG000|Overall Study|Ineligibility determined|1|||
163185133|NCT00950911|589394328|FG001|Overall Study|Ineligibility determined|0|||
163185134|NCT00950911|589394327|FG000|Overall Study|Noncompliance|1|||
163185135|NCT00950911|589394328|FG001|Overall Study|Noncompliance|0|||
163185136|NCT00950911|589394327|FG000|Overall Study|Poor performance status|0|||
162942005|NCT01301833|588490503|FG001|Overall Study|Adverse Event|5|||
163185137|NCT00950911|589394328|FG001|Overall Study|Poor performance status|1|||
163185138|NCT02600351|589394329|FG000|Overall Study|Lack of Efficacy|3|||
162942006|NCT01301833|588490504|FG002|Overall Study|Adverse Event|5|||
162942007|NCT01301833|588490505|FG003|Overall Study|Adverse Event|5|||
162942008|NCT01301833|588490502|FG000|Overall Study|Lack of Efficacy|1|||
162942009|NCT01301833|588490503|FG001|Overall Study|Lack of Efficacy|1|||
162942010|NCT01301833|588490504|FG002|Overall Study|Lack of Efficacy|0|||
162942011|NCT01301833|588490505|FG003|Overall Study|Lack of Efficacy|0|||
162942012|NCT01301833|588490502|FG000|Overall Study|Physician Decision|3|||
162942013|NCT01301833|588490503|FG001|Overall Study|Physician Decision|1|||
162942014|NCT01301833|588490504|FG002|Overall Study|Physician Decision|1|||
162942015|NCT01301833|588490505|FG003|Overall Study|Physician Decision|0|||
162942016|NCT01301833|588490502|FG000|Overall Study|Withdrawal by Subject|3|||
162942017|NCT01301833|588490503|FG001|Overall Study|Withdrawal by Subject|1|||
162942018|NCT01301833|588490504|FG002|Overall Study|Withdrawal by Subject|1|||
162942019|NCT01301833|588490505|FG003|Overall Study|Withdrawal by Subject|2|||
162942020|NCT01301833|588490502|FG000|Overall Study|Personal matter|1|||
163185139|NCT02600351|589394330|FG001|Overall Study|Lack of Efficacy|0|||
163185140|NCT02600351|589394331|FG002|Overall Study|Lack of Efficacy|5|||
163185141|NCT02600351|589394332|FG003|Overall Study|Lack of Efficacy|2|||
163185142|NCT02600351|589394329|FG000|Overall Study|Lost to Follow-up|1|||
163185143|NCT02600351|589394330|FG001|Overall Study|Lost to Follow-up|0|||
163185144|NCT02600351|589394331|FG002|Overall Study|Lost to Follow-up|0|||
163185145|NCT02600351|589394332|FG003|Overall Study|Lost to Follow-up|0|||
163185146|NCT02600351|589394329|FG000|Overall Study|Randomized but Not Treated|1|||
163185147|NCT02600351|589394330|FG001|Overall Study|Randomized but Not Treated|0|||
163185148|NCT02600351|589394331|FG002|Overall Study|Randomized but Not Treated|1|||
163185149|NCT02600351|589394332|FG003|Overall Study|Randomized but Not Treated|3|||
163185150|NCT02063880|589394333|FG000|Overall Study|Death|21|||
163185151|NCT02063880|589394334|FG001|Overall Study|Death|18|||
163185152|NCT02063880|589394333|FG000|Overall Study|Lost to Follow-up|7|||
163185153|NCT02063880|589394334|FG001|Overall Study|Lost to Follow-up|7|||
163185154|NCT02063880|589394333|FG000|Overall Study|Ineligible|0|||
163185155|NCT02063880|589394334|FG001|Overall Study|Ineligible|2|||
163185156|NCT02106910|589394335|FG000|Overall Study|Lost to Follow-up|1|||
162942021|NCT01301833|588490503|FG001|Overall Study|Personal matter|0|||
163185157|NCT02106910|589394336|FG001|Overall Study|Lost to Follow-up|1|||
163185158|NCT00567593|589394339|FG000|Overall Study|Adverse Event|1|||
163185159|NCT00567593|589394339|FG000|Overall Study|Physician Decision|1|||
163185160|NCT04087213|589394340|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
162942022|NCT01301833|588490504|FG002|Overall Study|Personal matter|0|||
162942023|NCT01301833|588490505|FG003|Overall Study|Personal matter|0|||
163185161|NCT04087213|589394340|FG000|In-Facility Introduction|Adverse Event|1|||
163185162|NCT04087213|589394340|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
163185163|NCT04087213|589394340|FG000|Assisted Evaluable Period|Personal reasons|3|||
163185164|NCT04087213|589394340|FG000|Transition Period B|Renal Transplantation|1|||
163185165|NCT01272661|589394343|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
163185166|NCT01272661|589394344|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
163185167|NCT01272661|589394345|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
163185168|NCT01086423|589394346|FG000|Overall Study|Protocol Violation|0|||
163185169|NCT01086423|589394347|FG001|Overall Study|Protocol Violation|0|||
163185170|NCT01086423|589394348|FG002|Overall Study|Protocol Violation|1|||
163185171|NCT01086423|589394346|FG000|Overall Study|Migrated/moved from study area|2|||
163185172|NCT01086423|589394347|FG001|Overall Study|Migrated/moved from study area|0|||
163290459|NCT05484726|589768390|FG000|Overall Study|IVH (G III & IV)|2|||
163290460|NCT05484726|589768391|FG001|Overall Study|IVH (G III & IV)|1|||
163290461|NCT05484726|589768390|FG000|Overall Study|NEC (stage II & III)|2|||
163290462|NCT05484726|589768391|FG001|Overall Study|NEC (stage II & III)|3|||
163290463|NCT04550039|589768399|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
163290464|NCT04550039|589768400|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
163290465|NCT04550039|589768399|FG000|Overall Study|patient self-withdrew from study|0|||
163290466|NCT04550039|589768400|FG001|Overall Study|patient self-withdrew from study|1|||
163290467|NCT05826431|589768401|FG000|Overall Study|Withdrawal by Subject|1|||
163290468|NCT01697319|589768404|FG000|Primary Phase|Withdrawal by Subject|1|||
163290469|NCT01697319|589768404|FG000|Extension Phase|Terminated by Sponsor|15|||
163290470|NCT04222959|589768407|FG000|Overall Study|Lost to Follow-up|76|||
163290471|NCT04222959|589768408|FG001|Overall Study|Lost to Follow-up|28|||
163290472|NCT03254394|589768411|FG000|Overall Study|Withdrawal by Subject|0|||
162942024|NCT02178709|588491659|FG000|Overall Study|Adverse Event|5|||
163185173|NCT01086423|589394348|FG002|Overall Study|Migrated/moved from study area|4|||
163290473|NCT03254394|589768412|FG001|Overall Study|Withdrawal by Subject|2|||
163290474|NCT04248829|589768413|FG000|Overall Study|Disease progression|44|||
163290475|NCT04248829|589768414|FG001|Overall Study|Disease progression|109|||
162942025|NCT02178709|588491659|FG000|Overall Study|Death|2|||
162942026|NCT02178709|588491659|FG000|Overall Study|Withdrawal by Subject|2|||
162942027|NCT02178709|588491659|FG000|Overall Study|Physician Decision|2|||
162942028|NCT02178709|588491659|FG000|Overall Study|Disease Progression|5|||
162942029|NCT02192905|588491662|FG000|Overall Study|Lost to Follow-up|1|||
162942030|NCT05218655|588491663|FG000|Overall Study|Adverse Event|6|||
162942031|NCT05218655|588491663|FG000|Overall Study|Sponsor's decision|85|||
162942032|NCT05218655|588491663|FG000|Overall Study|Death|1|||
162942033|NCT05218655|588491663|FG000|Overall Study|Lost to Follow-up|3|||
162942034|NCT05218655|588491663|FG000|Overall Study|Withdrawal by Subject|3|||
162942035|NCT05218655|588491663|FG000|Overall Study|Other than specified|3|||
162942036|NCT02228382|588491664|FG000|Overall Study|Death|5|||
162942037|NCT02228382|588491665|FG001|Overall Study|Death|7|||
162942038|NCT02228382|588491666|FG002|Overall Study|Death|5|||
162942039|NCT02228382|588491667|FG003|Overall Study|Death|0|||
162942040|NCT02228382|588491668|FG004|Overall Study|Death|2|||
162942041|NCT02228382|588491664|FG000|Overall Study|Participant refused further follow-up|0|||
162942042|NCT02228382|588491665|FG001|Overall Study|Participant refused further follow-up|0|||
162942043|NCT02228382|588491666|FG002|Overall Study|Participant refused further follow-up|1|||
162942044|NCT02228382|588491667|FG003|Overall Study|Participant refused further follow-up|0|||
162942045|NCT02228382|588491668|FG004|Overall Study|Participant refused further follow-up|0|||
162942046|NCT02228382|588491664|FG000|Overall Study|Study terminated by sponsor|3|||
162942047|NCT02228382|588491665|FG001|Overall Study|Study terminated by sponsor|5|||
162942048|NCT02228382|588491666|FG002|Overall Study|Study terminated by sponsor|7|||
162942049|NCT02228382|588491667|FG003|Overall Study|Study terminated by sponsor|0|||
163290476|NCT04248829|589768413|FG000|Overall Study|Adverse Event|19|||
163290477|NCT04248829|589768414|FG001|Overall Study|Adverse Event|18|||
163290478|NCT04248829|589768413|FG000|Overall Study|Withdrawal by Subject|11|||
163185174|NCT01086423|589394346|FG000|Overall Study|Adverse event, fatal|1|||
163290479|NCT04248829|589768414|FG001|Overall Study|Withdrawal by Subject|2|||
163290480|NCT04248829|589768413|FG000|Overall Study|Lost to Follow-up|0|||
163290481|NCT04248829|589768414|FG001|Overall Study|Lost to Follow-up|1|||
163290482|NCT04248829|589768413|FG000|Overall Study|Death|12|||
163290483|NCT04248829|589768414|FG001|Overall Study|Death|14|||
163290484|NCT04248829|589768413|FG000|Overall Study|Physician Decision|2|||
163185175|NCT01086423|589394347|FG001|Overall Study|Adverse event, fatal|1|||
163185176|NCT01086423|589394348|FG002|Overall Study|Adverse event, fatal|0|||
163185177|NCT01086423|589394346|FG000|Overall Study|Adverse event, non-fatal|2|||
163185178|NCT01086423|589394347|FG001|Overall Study|Adverse event, non-fatal|1|||
163185179|NCT01086423|589394348|FG002|Overall Study|Adverse event, non-fatal|0|||
163185180|NCT01086423|589394346|FG000|Overall Study|Withdrawal by Subject|5|||
163185181|NCT01086423|589394347|FG001|Overall Study|Withdrawal by Subject|1|||
163290485|NCT04248829|589768414|FG001|Overall Study|Physician Decision|4|||
163290486|NCT04248829|589768413|FG000|Overall Study|Any reason not specifically recorded|0|||
163290487|NCT04248829|589768414|FG001|Overall Study|Any reason not specifically recorded|2|||
163185182|NCT01086423|589394348|FG002|Overall Study|Withdrawal by Subject|3|||
163185183|NCT01086423|589394346|FG000|Overall Study|Lost to Follow-up|0|||
163185184|NCT01086423|589394347|FG001|Overall Study|Lost to Follow-up|0|||
163185185|NCT01086423|589394348|FG002|Overall Study|Lost to Follow-up|1|||
163185186|NCT02057393|589394349|FG000|Overall Study|Withdrawal by Subject|1|||
163185187|NCT02057393|589394349|FG000|Overall Study|Patient did not meet criteria|1|||
163185188|NCT02652767|589394350|FG000|Overall Study|Death|2|||
163185189|NCT02652767|589394350|FG000|Overall Study|Lost to Follow-up|1|||
163185190|NCT02652767|589394350|FG000|Overall Study|Withdrawal by Subject|1|||
163185191|NCT01130103|589394351|FG000|Randomized Treatment|Adverse Event|1|||
163185192|NCT01130103|589394352|FG001|Randomized Treatment|Adverse Event|1|||
163185193|NCT01130103|589394351|FG000|Randomized Treatment|Lost to Follow-up|1|||
163185194|NCT01130103|589394352|FG001|Randomized Treatment|Lost to Follow-up|0|||
163185195|NCT01130103|589394351|FG000|Randomized Treatment|Protocol Violation|3|||
163185196|NCT01130103|589394352|FG001|Randomized Treatment|Protocol Violation|2|||
163185197|NCT01130103|589394351|FG000|Randomized Treatment|Withdrawal by Subject|1|||
163185198|NCT01130103|589394352|FG001|Randomized Treatment|Withdrawal by Subject|2|||
163185199|NCT01130103|589394351|FG000|Maintenance Treatment|Lack of Efficacy|0|||
163185200|NCT01130103|589394352|FG001|Maintenance Treatment|Lack of Efficacy|1|||
163185201|NCT01130103|589394351|FG000|Maintenance Treatment|Lost to Follow-up|1|||
163185202|NCT01130103|589394352|FG001|Maintenance Treatment|Lost to Follow-up|1|||
163185203|NCT01130103|589394351|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
163185204|NCT01130103|589394352|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
163185205|NCT01028378|589394353|FG000|Overall Study|Lost to Follow-up|12|||
163185206|NCT01028378|589394353|FG000|Overall Study|Withdrawal by Subject|1|||
163185207|NCT01028378|589394353|FG000|Overall Study|Adminstrative Reasons|4|||
163185208|NCT00450385|589394354|FG000|Overall Study|Death|3|||
163185209|NCT00450385|589394354|FG000|Overall Study|Protocol Violation|1|||
163185210|NCT00450385|589394354|FG000|Overall Study|Withdrawal by Subject|2|||
163185211|NCT00450385|589394354|FG000|Overall Study|Lack of Efficacy|2|||
163185212|NCT00450385|589394354|FG000|Overall Study|Adverse Event|1|||
163185213|NCT00450385|589394354|FG000|Overall Study|Physician Decision|1|||
163185214|NCT00450385|589394354|FG000|Overall Study|Other|3|||
163185215|NCT00249288|589394355|FG000|Overall Study|Lost to Follow-up|3|||
163185216|NCT00249288|589394356|FG001|Overall Study|Lost to Follow-up|3|||
163185217|NCT00249288|589394355|FG000|Overall Study|Withdrawal by Subject|2|||
163185218|NCT00249288|589394356|FG001|Overall Study|Withdrawal by Subject|2|||
163185219|NCT03091777|589394357|FG000|Overall Study|Pregnancy|2|||
163185220|NCT03091777|589394358|FG001|Overall Study|Pregnancy|1|||
163185221|NCT03091777|589394359|FG002|Overall Study|Pregnancy|0|||
163185222|NCT03091777|589394357|FG000|Overall Study|Adverse Event|2|||
163185223|NCT03091777|589394358|FG001|Overall Study|Adverse Event|1|||
163185224|NCT03091777|589394359|FG002|Overall Study|Adverse Event|4|||
163185225|NCT03091777|589394357|FG000|Overall Study|Withdrawal by Subject|4|||
163185226|NCT03091777|589394358|FG001|Overall Study|Withdrawal by Subject|2|||
163185227|NCT03091777|589394359|FG002|Overall Study|Withdrawal by Subject|6|||
163290488|NCT01867580|589768417|FG000|Overall Study|Withdrawal by Subject|2|||
163290489|NCT01867580|589768418|FG001|Overall Study|Withdrawal by Subject|3|||
162942050|NCT02228382|588491668|FG004|Overall Study|Study terminated by sponsor|0|||
162942051|NCT02228382|588491664|FG000|Overall Study|Lost to Follow-up|0|||
162942052|NCT02228382|588491665|FG001|Overall Study|Lost to Follow-up|0|||
162942053|NCT02228382|588491666|FG002|Overall Study|Lost to Follow-up|3|||
162942054|NCT02228382|588491667|FG003|Overall Study|Lost to Follow-up|1|||
162942055|NCT02228382|588491668|FG004|Overall Study|Lost to Follow-up|0|||
162942056|NCT02228382|588491664|FG000|Overall Study|Withdrawal by Subject|0|||
162942057|NCT02228382|588491665|FG001|Overall Study|Withdrawal by Subject|3|||
162942058|NCT02228382|588491666|FG002|Overall Study|Withdrawal by Subject|2|||
162942059|NCT02228382|588491667|FG003|Overall Study|Withdrawal by Subject|1|||
162942060|NCT02228382|588491668|FG004|Overall Study|Withdrawal by Subject|0|||
162942061|NCT02228382|588491664|FG000|Overall Study|Other|2|||
162942062|NCT02228382|588491665|FG001|Overall Study|Other|3|||
162942063|NCT02228382|588491666|FG002|Overall Study|Other|3|||
162942064|NCT02228382|588491667|FG003|Overall Study|Other|0|||
162942065|NCT02228382|588491668|FG004|Overall Study|Other|0|||
162942066|NCT02396381|588491670|FG000|Overall Study|Adverse Event|3|||
162942067|NCT02396381|588491671|FG001|Overall Study|Adverse Event|2|||
162942068|NCT02396381|588491670|FG000|Overall Study|Withdrawal by Subject|33|||
162942069|NCT02396381|588491671|FG001|Overall Study|Withdrawal by Subject|24|||
162942070|NCT02396381|588491670|FG000|Overall Study|Lost to Follow-up|49|||
162942071|NCT02396381|588491671|FG001|Overall Study|Lost to Follow-up|31|||
162942072|NCT02396381|588491670|FG000|Overall Study|Protocol Violation|1|||
162942073|NCT02396381|588491671|FG001|Overall Study|Protocol Violation|0|||
162942074|NCT02396381|588491670|FG000|Overall Study|Site terminated by sponsor|7|||
162942075|NCT02396381|588491671|FG001|Overall Study|Site terminated by sponsor|8|||
162942076|NCT02396381|588491670|FG000|Overall Study|Physician Decision|5|||
162942077|NCT02396381|588491671|FG001|Overall Study|Physician Decision|5|||
162942078|NCT02396381|588491670|FG000|Overall Study|Pregnancy|2|||
162942079|NCT02396381|588491671|FG001|Overall Study|Pregnancy|0|||
162942080|NCT02396381|588491670|FG000|Overall Study|Non-compliance with study procedures|1|||
162942081|NCT02396381|588491671|FG001|Overall Study|Non-compliance with study procedures|0|||
162942082|NCT02396381|588491670|FG000|Overall Study|Moved out of town/state|1|||
162942083|NCT02396381|588491671|FG001|Overall Study|Moved out of town/state|3|||
162942084|NCT02396381|588491670|FG000|Overall Study|Could not complete visit|1|||
162942085|NCT02396381|588491671|FG001|Overall Study|Could not complete visit|0|||
162942086|NCT02396381|588491670|FG000|Overall Study|Possible conflict of interest|1|||
162942087|NCT02396381|588491671|FG001|Overall Study|Possible conflict of interest|0|||
162942088|NCT02396381|588491670|FG000|Overall Study|Randomization/Screening Error|3|||
162942089|NCT02396381|588491671|FG001|Overall Study|Randomization/Screening Error|1|||
162942090|NCT00275002|588491672|FG000|Overall Study|Death|1|||
162942091|NCT00275002|588491673|FG001|Overall Study|Death|0|||
162942092|NCT00275002|588491672|FG000|Overall Study|Disease progression|21|||
162942093|NCT00275002|588491673|FG001|Overall Study|Disease progression|15|||
162942094|NCT00275002|588491672|FG000|Overall Study|Adverse Event|0|||
162942095|NCT00275002|588491673|FG001|Overall Study|Adverse Event|1|||
162942096|NCT00113490|588491674|FG000|Overall Study|Withdrawal by Subject|1|||
162942097|NCT00113490|588491675|FG001|Overall Study|Withdrawal by Subject|3|||
162942098|NCT00113490|588491674|FG000|Overall Study|Lost to Follow-up|1|||
162942099|NCT00113490|588491675|FG001|Overall Study|Lost to Follow-up|0|||
162942100|NCT04652453|588491677|FG000|Overall Study|Death|8|||
162942101|NCT04652453|588491678|FG001|Overall Study|Death|2|||
162942102|NCT04652453|588491679|FG002|Overall Study|Death|0|||
162942103|NCT04652453|588491677|FG000|Overall Study|Hospice|5|||
162942104|NCT04652453|588491678|FG001|Overall Study|Hospice|5|||
162942105|NCT04652453|588491679|FG002|Overall Study|Hospice|0|||
162942106|NCT04652453|588491677|FG000|Overall Study|Withdrawal by Subject|2|||
162942107|NCT04652453|588491678|FG001|Overall Study|Withdrawal by Subject|0|||
162942108|NCT04652453|588491679|FG002|Overall Study|Withdrawal by Subject|0|||
162942109|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
162942110|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
162942111|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942112|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942113|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942114|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
162942115|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
162942116|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942117|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942118|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
163290490|NCT01867580|589768417|FG000|Overall Study|Physician Decision|17|||
162942119|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942120|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942121|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942122|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942123|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942124|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942125|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
163290491|NCT01867580|589768418|FG001|Overall Study|Physician Decision|12|||
163290492|NCT01867580|589768417|FG000|Overall Study|Lost to Follow-up|3|||
163290493|NCT01867580|589768418|FG001|Overall Study|Lost to Follow-up|5|||
163290494|NCT01867580|589768417|FG000|Overall Study|Sponsor terminated study|1|||
163290495|NCT01867580|589768418|FG001|Overall Study|Sponsor terminated study|0|||
163290496|NCT01867580|589768417|FG000|Overall Study|Missed follow-up assessment|2|||
163290497|NCT01867580|589768418|FG001|Overall Study|Missed follow-up assessment|1|||
163290498|NCT01867580|589768417|FG000|Overall Study|Interruption to therapy|3|||
163290499|NCT01867580|589768418|FG001|Overall Study|Interruption to therapy|0|||
163290500|NCT01867580|589768417|FG000|Overall Study|Osteomyelitis|0|||
163290501|NCT01867580|589768418|FG001|Overall Study|Osteomyelitis|1|||
163290502|NCT01867580|589768417|FG000|Overall Study|Continuation of therapy|0|||
163290503|NCT01867580|589768418|FG001|Overall Study|Continuation of therapy|1|||
163290504|NCT01867580|589768417|FG000|Overall Study|Wound recurrence|0|||
163290505|NCT01867580|589768418|FG001|Overall Study|Wound recurrence|1|||
163185228|NCT03091777|589394357|FG000|Overall Study|Protocol Violation|2|||
163185229|NCT03091777|589394358|FG001|Overall Study|Protocol Violation|1|||
163185230|NCT03091777|589394359|FG002|Overall Study|Protocol Violation|1|||
163185231|NCT03091777|589394357|FG000|Overall Study|Lost to Follow-up|12|||
163185232|NCT03091777|589394358|FG001|Overall Study|Lost to Follow-up|14|||
163185233|NCT03091777|589394359|FG002|Overall Study|Lost to Follow-up|7|||
163185234|NCT03091777|589394357|FG000|Overall Study|Lack of Efficacy|0|||
163185235|NCT03091777|589394358|FG001|Overall Study|Lack of Efficacy|0|||
163185236|NCT03091777|589394359|FG002|Overall Study|Lack of Efficacy|5|||
163185237|NCT03091777|589394357|FG000|Overall Study|Noncompliance with study drug|2|||
163185238|NCT03091777|589394358|FG001|Overall Study|Noncompliance with study drug|3|||
162942126|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942127|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942128|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
162942129|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
162942130|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942131|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942132|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942133|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942134|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942135|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942136|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942137|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
162942138|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942139|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942140|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942141|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942142|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942143|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
162942144|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942145|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942146|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
163185239|NCT03091777|589394359|FG002|Overall Study|Noncompliance with study drug|1|||
163185240|NCT03091777|589394357|FG000|Overall Study|Physician Decision|1|||
163185241|NCT03091777|589394358|FG001|Overall Study|Physician Decision|0|||
163290506|NCT01212757|589768419|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
163290507|NCT01212757|589768420|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
163290508|NCT01212757|589768421|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
163290509|NCT01212757|589768422|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163185242|NCT03091777|589394359|FG002|Overall Study|Physician Decision|1|||
163185243|NCT03091777|589394357|FG000|Overall Study|Abnormal Laboratory Value|7|||
163185244|NCT03091777|589394358|FG001|Overall Study|Abnormal Laboratory Value|11|||
163185245|NCT03091777|589394359|FG002|Overall Study|Abnormal Laboratory Value|12|||
163185246|NCT00089674|589394360|FG000|Overall Study|Physician Decision|4|||
163185247|NCT00089674|589394361|FG001|Overall Study|Physician Decision|2|||
163185248|NCT00089674|589394360|FG000|Overall Study|Adverse Event|23|||
163185249|NCT00089674|589394361|FG001|Overall Study|Adverse Event|29|||
163185250|NCT00089674|589394360|FG000|Overall Study|Withdrawal by Subject|143|||
163185251|NCT00089674|589394361|FG001|Overall Study|Withdrawal by Subject|127|||
163185252|NCT00089674|589394360|FG000|Overall Study|Death|43|||
163185253|NCT00089674|589394361|FG001|Overall Study|Death|43|||
163185254|NCT00089674|589394360|FG000|Overall Study|Disease progression|21|||
163185255|NCT00089674|589394361|FG001|Overall Study|Disease progression|23|||
163185256|NCT00089674|589394360|FG000|Overall Study|Ineligibility determined|8|||
162942147|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
163185257|NCT00089674|589394361|FG001|Overall Study|Ineligibility determined|10|||
163185258|NCT00089674|589394360|FG000|Overall Study|Lost to Follow-up|21|||
163185259|NCT00089674|589394361|FG001|Overall Study|Lost to Follow-up|17|||
163185260|NCT00089674|589394360|FG000|Overall Study|Noncompliance|7|||
163185261|NCT00089674|589394361|FG001|Overall Study|Noncompliance|3|||
163185262|NCT00089674|589394360|FG000|Overall Study|Other|5|||
163185263|NCT00089674|589394361|FG001|Overall Study|Other|9|||
163185264|NCT00089674|589394360|FG000|Overall Study|Requirement for alternative therapy|14|||
163185265|NCT00089674|589394361|FG001|Overall Study|Requirement for alternative therapy|4|||
163185266|NCT01437878|589394362|FG000|Overall Study|Withdrawal by Subject|1|||
163185267|NCT01437878|589394363|FG001|Overall Study|Withdrawal by Subject|0|||
163185268|NCT01476644|589394370|FG000|Overall Study|Death|5|||
163185269|NCT01476644|589394370|FG000|Overall Study|moved to another state|2|||
163185270|NCT01476644|589394370|FG000|Overall Study|Lost to Follow-up|19|||
163185271|NCT01476644|589394370|FG000|Overall Study|Withdrawal by Subject|13|||
163185272|NCT01462227|589394372|FG000|Second Assignment|Lost to Follow-up|1|||
163185273|NCT01462227|589394373|FG001|Second Assignment|Lost to Follow-up|0|||
163185274|NCT01462227|589394374|FG002|Second Assignment|Lost to Follow-up|0|||
162942148|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942149|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942150|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942151|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942152|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942153|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942154|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942155|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942156|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
162942157|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
162942158|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942159|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942160|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942161|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942162|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
163185275|NCT01462227|589394375|FG003|Second Assignment|Lost to Follow-up|0|||
163185276|NCT01462227|589394372|FG000|Second Assignment|Protocol Violation|0|||
163185277|NCT01462227|589394373|FG001|Second Assignment|Protocol Violation|1|||
163185278|NCT01462227|589394374|FG002|Second Assignment|Protocol Violation|1|||
163185279|NCT01462227|589394375|FG003|Second Assignment|Protocol Violation|0|||
163185280|NCT00471146|589394376|FG000|Overall Study|Adverse Event|32|||
163185281|NCT00471146|589394377|FG001|Overall Study|Adverse Event|33|||
163185282|NCT00471146|589394376|FG000|Overall Study|Withdrawal by Subject|14|||
163185283|NCT00471146|589394377|FG001|Overall Study|Withdrawal by Subject|11|||
163185284|NCT00471146|589394376|FG000|Overall Study|Death|11|||
163185285|NCT00471146|589394377|FG001|Overall Study|Death|12|||
163185286|NCT00471146|589394376|FG000|Overall Study|Lost to Follow-up|4|||
163185287|NCT00471146|589394377|FG001|Overall Study|Lost to Follow-up|2|||
163185288|NCT00471146|589394376|FG000|Overall Study|Protocol Violation|2|||
163185289|NCT00471146|589394377|FG001|Overall Study|Protocol Violation|2|||
163185290|NCT00471146|589394376|FG000|Overall Study|Objective progression or relapse|84|||
163185291|NCT00471146|589394377|FG001|Overall Study|Objective progression or relapse|87|||
163185292|NCT00471146|589394376|FG000|Overall Study|Global deterioration of health status|12|||
163185293|NCT00471146|589394377|FG001|Overall Study|Global deterioration of health status|14|||
163185294|NCT00471146|589394376|FG000|Overall Study|Randomized but not treated|9|||
163185295|NCT00471146|589394377|FG001|Overall Study|Randomized but not treated|8|||
163185296|NCT00471146|589394376|FG000|Overall Study|Other|4|||
163185297|NCT00471146|589394377|FG001|Overall Study|Other|5|||
163185298|NCT00467610|589394380|FG000|Overall Study|Withdrawal by Subject|1|||
163185299|NCT02676466|589394381|FG000|Overall Study|Death|0|||
163185300|NCT02676466|589394382|FG001|Overall Study|Death|2|||
163185301|NCT02676466|589394383|FG002|Overall Study|Death|1|||
163185302|NCT02676466|589394384|FG003|Overall Study|Death|0|||
163185303|NCT02676466|589394385|FG004|Overall Study|Death|0|||
163185304|NCT02676466|589394386|FG005|Overall Study|Death|0|||
163185305|NCT02676466|589394387|FG006|Overall Study|Death|0|||
163185306|NCT02676466|589394388|FG007|Overall Study|Death|0|||
163185307|NCT02676466|589394381|FG000|Overall Study|Withdrawal by Subject|4|||
163185308|NCT02676466|589394382|FG001|Overall Study|Withdrawal by Subject|3|||
163185309|NCT02676466|589394383|FG002|Overall Study|Withdrawal by Subject|1|||
163185310|NCT02676466|589394384|FG003|Overall Study|Withdrawal by Subject|0|||
163185311|NCT02676466|589394385|FG004|Overall Study|Withdrawal by Subject|3|||
163185312|NCT02676466|589394386|FG005|Overall Study|Withdrawal by Subject|1|||
163185313|NCT02676466|589394387|FG006|Overall Study|Withdrawal by Subject|1|||
163185314|NCT02676466|589394388|FG007|Overall Study|Withdrawal by Subject|1|||
163185315|NCT02001181|589394390|FG000|Overall Study|Adverse Event|0|||
163185316|NCT02001181|589394391|FG001|Overall Study|Adverse Event|2|||
163185317|NCT02001181|589394390|FG000|Overall Study|Lost to Follow-up|1|||
163185318|NCT02001181|589394391|FG001|Overall Study|Lost to Follow-up|0|||
163185319|NCT02001181|589394390|FG000|Overall Study|Withdrawal by Subject|0|||
163185320|NCT02001181|589394391|FG001|Overall Study|Withdrawal by Subject|1|||
163185321|NCT02520661|589394393|FG000|Overall Study|Lost to Follow-up|7|||
163185322|NCT02520661|589394394|FG001|Overall Study|Lost to Follow-up|3|||
163185323|NCT02520661|589394393|FG000|Overall Study|Admitted from ED|49|||
163290510|NCT01212757|589768423|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162942163|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
163042850|NCT01066871|588863974|FG000|Overall Study|Lack of Efficacy|0|||
163185324|NCT02520661|589394394|FG001|Overall Study|Admitted from ED|48|||
163185325|NCT02520661|589394393|FG000|Overall Study|ED greater than 24 hours|29|||
163185326|NCT02520661|589394394|FG001|Overall Study|ED greater than 24 hours|38|||
163185327|NCT02520661|589394393|FG000|Overall Study|other ineligibility|14|||
163185328|NCT02520661|589394394|FG001|Overall Study|other ineligibility|22|||
163185329|NCT02520661|589394393|FG000|Overall Study|Withdrawal by Subject|7|||
163185330|NCT02520661|589394394|FG001|Overall Study|Withdrawal by Subject|16|||
163185331|NCT01414608|589394398|FG000|Overall Study|Ineligible|5|||
162942164|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942165|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942166|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942167|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942168|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942169|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942170|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942171|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
162942172|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942173|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942174|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942175|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942176|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942177|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942178|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942179|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
162942180|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
162942181|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
162942182|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162942183|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162942184|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
162942185|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
163185332|NCT01414608|589394399|FG001|Overall Study|Ineligible|2|||
163185333|NCT00760084|589394401|FG000|Overall Study|Physician Decision|5|||
163185334|NCT00760084|589394401|FG000|Overall Study|Withdrawal by Subject|2|||
163185335|NCT00760084|589394401|FG000|Overall Study|Progressive Disease|3|||
162942186|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162942187|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
163185336|NCT02301988|589394402|FG000|Overall Study|Withdrawal by Subject|2|||
162942188|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162942189|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162942190|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162942191|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162942192|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162942193|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942194|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
162942195|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942196|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942197|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942198|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
162942199|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942200|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942201|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942202|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942203|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942204|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942205|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942206|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942207|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
162942208|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942209|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942210|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942211|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942212|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
162942213|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942214|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942215|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942216|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942217|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942218|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942219|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942220|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942221|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942222|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942223|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942224|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
162942225|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
162942226|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942227|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942228|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
162942229|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
162942230|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942231|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942232|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942233|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942234|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942235|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942236|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942237|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942238|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942239|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942240|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942241|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942242|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
162942243|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
162942244|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942245|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942246|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942247|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942248|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942249|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942250|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942251|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942252|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942253|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942254|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942255|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942256|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942257|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
162942258|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942259|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942260|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942261|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942262|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942263|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942264|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
163185337|NCT02301988|589394403|FG001|Overall Study|Withdrawal by Subject|1|||
163185338|NCT02301988|589394402|FG000|Overall Study|Physician Decision|2|||
163185339|NCT02301988|589394403|FG001|Overall Study|Physician Decision|2|||
163185340|NCT02301988|589394402|FG000|Overall Study|Unknown Reason|1|||
163185341|NCT02301988|589394403|FG001|Overall Study|Unknown Reason|3|||
163185342|NCT02301988|589394402|FG000|Overall Study|Lack of Efficacy|3|||
163185343|NCT02301988|589394403|FG001|Overall Study|Lack of Efficacy|2|||
163185344|NCT02301988|589394402|FG000|Overall Study|Death|1|||
163185345|NCT02301988|589394403|FG001|Overall Study|Death|0|||
163185346|NCT02301988|589394402|FG000|Overall Study|Adverse Event|1|||
163185347|NCT02301988|589394403|FG001|Overall Study|Adverse Event|1|||
163185348|NCT02891161|589394404|FG000|Study Treatment|Disease Progression|2|||
163185349|NCT02891161|589394405|FG001|Study Treatment|Disease Progression|4|||
163185350|NCT02891161|589394404|FG000|Study Treatment|AE/Side Effects/Complications|1|||
163185351|NCT02891161|589394405|FG001|Study Treatment|AE/Side Effects/Complications|5|||
163185352|NCT02891161|589394404|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
163185353|NCT02891161|589394405|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
163185354|NCT02891161|589394404|FG000|Follow up|Death|4|||
163185355|NCT02891161|589394405|FG001|Follow up|Death|8|||
163185356|NCT02891161|589394404|FG000|Follow up|Refused to Follow up|0|||
163185357|NCT02891161|589394405|FG001|Follow up|Refused to Follow up|2|||
163185358|NCT02891161|589394404|FG000|Follow up|Symptomatic deterioration|0|||
163185359|NCT02891161|589394405|FG001|Follow up|Symptomatic deterioration|1|||
163185360|NCT02891161|589394404|FG000|Follow up|Study terminated|0|||
163185361|NCT02891161|589394405|FG001|Follow up|Study terminated|6|||
163185362|NCT01931202|589394408|FG000|Overall Study|Withdrawal by Subject|0|||
163185363|NCT01931202|589394409|FG001|Overall Study|Withdrawal by Subject|0|||
163185364|NCT01931202|589394410|FG002|Overall Study|Withdrawal by Subject|2|||
163185365|NCT01931202|589394408|FG000|Overall Study|Lost to Follow-up|0|||
163185366|NCT01931202|589394409|FG001|Overall Study|Lost to Follow-up|5|||
163185367|NCT01931202|589394410|FG002|Overall Study|Lost to Follow-up|2|||
163185368|NCT01857583|589394411|FG000|Overall Study|Adverse Event|0|||
163185369|NCT01857583|589394412|FG001|Overall Study|Adverse Event|0|||
163185370|NCT01857583|589394413|FG002|Overall Study|Adverse Event|1|||
163185371|NCT01857583|589394414|FG003|Overall Study|Adverse Event|1|||
163185372|NCT01857583|589394411|FG000|Overall Study|Death|0|||
163185373|NCT01857583|589394412|FG001|Overall Study|Death|1|||
163185374|NCT01857583|589394413|FG002|Overall Study|Death|1|||
163185375|NCT01857583|589394414|FG003|Overall Study|Death|0|||
163185376|NCT01857583|589394411|FG000|Overall Study|Physician Decision|0|||
163185377|NCT01857583|589394412|FG001|Overall Study|Physician Decision|0|||
163185378|NCT01857583|589394413|FG002|Overall Study|Physician Decision|0|||
163185379|NCT01857583|589394414|FG003|Overall Study|Physician Decision|1|||
163185380|NCT01857583|589394411|FG000|Overall Study|Withdrawal by Subject|1|||
163185381|NCT01857583|589394412|FG001|Overall Study|Withdrawal by Subject|0|||
163185382|NCT01857583|589394413|FG002|Overall Study|Withdrawal by Subject|1|||
163185383|NCT01857583|589394414|FG003|Overall Study|Withdrawal by Subject|2|||
163185384|NCT02775903|589394419|FG000|Overall Study|Death|7|||
163185385|NCT02775903|589394420|FG001|Overall Study|Death|11|||
163185386|NCT02775903|589394421|FG002|Overall Study|Death|12|||
163185387|NCT02775903|589394422|FG003|Overall Study|Death|11|||
163185388|NCT02775903|589394419|FG000|Overall Study|Adverse Event|0|||
163185389|NCT02775903|589394420|FG001|Overall Study|Adverse Event|1|||
163185390|NCT02775903|589394421|FG002|Overall Study|Adverse Event|12|||
163185391|NCT02775903|589394422|FG003|Overall Study|Adverse Event|3|||
163185392|NCT02775903|589394419|FG000|Overall Study|Progressive disease|15|||
163185393|NCT02775903|589394420|FG001|Overall Study|Progressive disease|14|||
163185394|NCT02775903|589394421|FG002|Overall Study|Progressive disease|30|||
163185395|NCT02775903|589394422|FG003|Overall Study|Progressive disease|20|||
163185396|NCT02775903|589394419|FG000|Overall Study|Lack of Efficacy|2|||
163185397|NCT02775903|589394420|FG001|Overall Study|Lack of Efficacy|2|||
163185398|NCT02775903|589394421|FG002|Overall Study|Lack of Efficacy|2|||
163185399|NCT02775903|589394422|FG003|Overall Study|Lack of Efficacy|6|||
163185400|NCT02775903|589394419|FG000|Overall Study|Withdrawal by Subject|7|||
163185401|NCT02775903|589394420|FG001|Overall Study|Withdrawal by Subject|5|||
162942265|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942266|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
162942267|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942268|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942269|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942270|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942271|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942272|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942273|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942274|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942275|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942276|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942277|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942278|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942279|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942280|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942281|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942282|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942283|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942284|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
162942285|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
162942286|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942287|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942288|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942289|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942290|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942291|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942292|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942293|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942294|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942295|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942296|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942297|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942298|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
162942299|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942300|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942301|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942302|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942303|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942304|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942305|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942306|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942307|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942308|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942309|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942310|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942311|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942312|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
162942313|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942314|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942315|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942316|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942317|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942318|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942319|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162942320|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162942321|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162942322|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162942323|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
163290511|NCT01212757|589768424|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163290512|NCT01212757|589768425|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162942324|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
163290513|NCT01212757|589768426|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163290514|NCT01212757|589768427|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163185402|NCT02775903|589394421|FG002|Overall Study|Withdrawal by Subject|5|||
163185403|NCT02775903|589394422|FG003|Overall Study|Withdrawal by Subject|8|||
163185404|NCT02775903|589394419|FG000|Overall Study|Other reasons|7|||
163185405|NCT02775903|589394420|FG001|Overall Study|Other reasons|8|||
163185406|NCT02775903|589394421|FG002|Overall Study|Other reasons|2|||
163185407|NCT02775903|589394422|FG003|Overall Study|Other reasons|12|||
163185408|NCT03552965|589394426|FG000|Overall Study|Death|1|||
163185409|NCT03552965|589394427|FG001|Overall Study|Death|1|||
163185410|NCT03552965|589394426|FG000|Overall Study|Lost to Follow-up|1|||
163185411|NCT03552965|589394427|FG001|Overall Study|Lost to Follow-up|1|||
163185412|NCT03552965|589394426|FG000|Overall Study|Physician Decision|1|||
163185413|NCT03552965|589394427|FG001|Overall Study|Physician Decision|1|||
163185414|NCT03552965|589394426|FG000|Overall Study|Withdrawal by Subject|0|||
163185415|NCT03552965|589394427|FG001|Overall Study|Withdrawal by Subject|2|||
163185416|NCT03552965|589394426|FG000|Overall Study|Continuation not in patient best interest|1|||
163185417|NCT03552965|589394427|FG001|Overall Study|Continuation not in patient best interest|0|||
163185418|NCT03552965|589394426|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
163185419|NCT03552965|589394427|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
163185420|NCT05108922|589395574|FG000|Overall Study|Adverse Event|2|||
163185421|NCT05108922|589395575|FG001|Overall Study|Adverse Event|3|||
163185422|NCT05108922|589395574|FG000|Overall Study|Lost to Follow-up|2|||
163185423|NCT05108922|589395575|FG001|Overall Study|Lost to Follow-up|1|||
163185424|NCT05108922|589395574|FG000|Overall Study|Inadvertent enrollment|0|||
163185425|NCT05108922|589395575|FG001|Overall Study|Inadvertent enrollment|1|||
163185426|NCT05108922|589395574|FG000|Overall Study|Physician Decision|2|||
163185427|NCT05108922|589395575|FG001|Overall Study|Physician Decision|3|||
163185428|NCT05108922|589395574|FG000|Overall Study|Protocol deviation|1|||
163185429|NCT05108922|589395575|FG001|Overall Study|Protocol deviation|0|||
163185430|NCT05108922|589395574|FG000|Overall Study|Screen failure|1|||
163185431|NCT05108922|589395575|FG001|Overall Study|Screen failure|0|||
163185432|NCT05108922|589395574|FG000|Overall Study|Withdrawal by Subject|11|||
163185433|NCT05108922|589395575|FG001|Overall Study|Withdrawal by Subject|8|||
163185434|NCT05036369|589395576|FG000|Overall Study|Run In non compliance|1|||
163185435|NCT05036369|589395577|FG001|Overall Study|Run In non compliance|2|||
163185436|NCT05036369|589395576|FG000|Overall Study|Change in eligibility criteria|0|||
163185437|NCT05036369|589395577|FG001|Overall Study|Change in eligibility criteria|1|||
163185438|NCT01846104|589395578|FG000|Overall Study|Withdrawal by Subject|1|||
163185439|NCT01854658|589395583|FG000|Overall Study|Protocol Violation|6|||
163185440|NCT01854658|589395584|FG001|Overall Study|Protocol Violation|2|||
163185441|NCT01854658|589395585|FG002|Overall Study|Protocol Violation|2|||
163185442|NCT01854658|589395586|FG003|Overall Study|Protocol Violation|1|||
163185443|NCT01854658|589395583|FG000|Overall Study|Physician Decision|7|||
163185444|NCT01854658|589395584|FG001|Overall Study|Physician Decision|5|||
163185445|NCT01854658|589395585|FG002|Overall Study|Physician Decision|2|||
163185446|NCT01854658|589395586|FG003|Overall Study|Physician Decision|4|||
163185447|NCT01854658|589395583|FG000|Overall Study|Lost to Follow-up|8|||
163185448|NCT01854658|589395584|FG001|Overall Study|Lost to Follow-up|9|||
163185449|NCT01854658|589395585|FG002|Overall Study|Lost to Follow-up|8|||
163185450|NCT01854658|589395586|FG003|Overall Study|Lost to Follow-up|4|||
163185451|NCT01854658|589395583|FG000|Overall Study|Withdrawal by Subject|28|||
162942325|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162942326|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162942327|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162942328|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
162942329|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
162942330|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
162942331|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
162942332|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
163185452|NCT01854658|589395584|FG001|Overall Study|Withdrawal by Subject|21|||
163185453|NCT01854658|589395585|FG002|Overall Study|Withdrawal by Subject|29|||
163185454|NCT01854658|589395586|FG003|Overall Study|Withdrawal by Subject|15|||
163185455|NCT01854658|589395583|FG000|Overall Study|Protocol-specified criteria|15|||
163185456|NCT01854658|589395584|FG001|Overall Study|Protocol-specified criteria|15|||
163185457|NCT01854658|589395585|FG002|Overall Study|Protocol-specified criteria|10|||
163185458|NCT01854658|589395586|FG003|Overall Study|Protocol-specified criteria|7|||
163185459|NCT01854658|589395583|FG000|Overall Study|Lack of Efficacy|3|||
163185460|NCT01854658|589395584|FG001|Overall Study|Lack of Efficacy|8|||
163185461|NCT01854658|589395585|FG002|Overall Study|Lack of Efficacy|4|||
163185462|NCT01854658|589395586|FG003|Overall Study|Lack of Efficacy|7|||
163185463|NCT01854658|589395583|FG000|Overall Study|Adverse Event|21|||
163185464|NCT01854658|589395584|FG001|Overall Study|Adverse Event|14|||
163185465|NCT01854658|589395585|FG002|Overall Study|Adverse Event|23|||
163185466|NCT01854658|589395586|FG003|Overall Study|Adverse Event|19|||
163185467|NCT01854658|589395583|FG000|Overall Study|Administrative reasons|5|||
163185468|NCT01854658|589395584|FG001|Overall Study|Administrative reasons|1|||
163185469|NCT01854658|589395585|FG002|Overall Study|Administrative reasons|2|||
163185470|NCT01854658|589395586|FG003|Overall Study|Administrative reasons|2|||
163185471|NCT03906461|589395587|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
163185472|NCT03906461|589395587|FG000|Completed 12-month Follow-up|Missed Visit|6|||
163185473|NCT01795638|589395590|FG000|Overall Study|Death|0|||
163185474|NCT01795638|589395591|FG001|Overall Study|Death|3|||
163185475|NCT01795638|589395590|FG000|Overall Study|transferred to quaternary hospital|2|||
163185476|NCT01795638|589395591|FG001|Overall Study|transferred to quaternary hospital|3|||
163185477|NCT01795638|589395590|FG000|Overall Study|Protocol Violation|3|||
163185478|NCT01795638|589395591|FG001|Overall Study|Protocol Violation|0|||
163185479|NCT01795638|589395590|FG000|Overall Study|discharged from hospital|7|||
163185480|NCT01795638|589395591|FG001|Overall Study|discharged from hospital|5|||
163185481|NCT01795638|589395590|FG000|Overall Study|Withdrawal by Subject|1|||
163185482|NCT01795638|589395591|FG001|Overall Study|Withdrawal by Subject|0|||
163185483|NCT00331864|589395600|FG000|Overall Study|Adverse Event|30|||
163185484|NCT00331864|589395601|FG001|Overall Study|Adverse Event|1|||
163185485|NCT00331864|589395600|FG000|Overall Study|Lack of Efficacy|4|||
163185486|NCT00331864|589395601|FG001|Overall Study|Lack of Efficacy|0|||
163185487|NCT00331864|589395600|FG000|Overall Study|Protocol Violation|3|||
163185488|NCT00331864|589395601|FG001|Overall Study|Protocol Violation|0|||
163185489|NCT00331864|589395600|FG000|Overall Study|Withdrawal by Subject|10|||
163185490|NCT00331864|589395601|FG001|Overall Study|Withdrawal by Subject|0|||
163290515|NCT01212757|589768419|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
163290516|NCT01212757|589768420|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
163290517|NCT01212757|589768421|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
163290518|NCT01212757|589768422|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163290519|NCT01212757|589768423|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163290520|NCT01212757|589768424|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163290521|NCT01212757|589768425|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163290522|NCT01212757|589768426|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163290523|NCT01212757|589768427|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163290524|NCT01212757|589768419|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
163290525|NCT01212757|589768420|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
163185491|NCT00331864|589395600|FG000|Overall Study|Lost to Follow-up|4|||
162942333|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942334|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942335|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942336|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942337|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942338|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942339|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942340|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942341|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942342|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
162942343|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
162942344|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
162942345|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
162942346|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
162942347|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942348|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942349|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942350|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942351|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942352|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942353|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942354|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942355|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942356|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942357|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
162942358|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
162942359|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942360|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
162942361|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942362|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942363|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942364|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942365|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942366|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942367|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942368|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942369|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942370|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942371|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
162942372|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
162942373|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
162942374|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
162942375|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
162942376|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
163185492|NCT00331864|589395601|FG001|Overall Study|Lost to Follow-up|3|||
163185493|NCT00331864|589395600|FG000|Overall Study|Administrative Problems|1|||
163185494|NCT00331864|589395601|FG001|Overall Study|Administrative Problems|0|||
163185495|NCT00331864|589395600|FG000|Overall Study|Death|6|||
163185496|NCT00331864|589395601|FG001|Overall Study|Death|0|||
163185497|NCT01409434|589395603|FG000|Overall Study|Protocol Violation|4|||
163185498|NCT00293215|589395604|FG000|Overall Study|Progressive disease|3|||
163185499|NCT00293215|589395605|FG001|Overall Study|Progressive disease|1|||
163185500|NCT00293215|589395604|FG000|Overall Study|Adverse Event|2|||
163185501|NCT00293215|589395605|FG001|Overall Study|Adverse Event|2|||
163185502|NCT02213042|589395606|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
163185503|NCT02213042|589395607|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
163185504|NCT02213042|589395608|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
163185505|NCT02213042|589395606|FG000|Overall Study|Adverse Event|2|||
163290526|NCT01212757|589768421|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
162942377|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
162942378|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
162942379|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
162942380|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
162942381|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
163042851|NCT01066871|588863975|FG001|Overall Study|Lack of Efficacy|0|||
163185506|NCT02213042|589395607|FG001|Overall Study|Adverse Event|1|||
163290527|NCT01212757|589768422|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163290528|NCT01212757|589768423|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162942382|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
162942383|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
162942384|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
162942385|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
162942386|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
162942387|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
162942388|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
162942389|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942390|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942391|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942392|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942393|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942394|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942395|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942396|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942397|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942398|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942399|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942400|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942401|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942402|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
162942403|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942404|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942405|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942406|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942407|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942408|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942409|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942410|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942411|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942412|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
162942413|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
162942414|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
162942415|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
162942416|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
162942417|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942418|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
163290529|NCT01212757|589768424|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162942419|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942420|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942421|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942422|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942423|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942424|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942425|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942426|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
162942427|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942428|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
162942429|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
162942430|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942431|NCT02985957|588491699|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162942432|NCT02985957|588491700|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162942433|NCT02985957|588491701|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162942434|NCT02985957|588491702|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162942435|NCT02985957|588491703|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
162942436|NCT02985957|588491704|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162942437|NCT02985957|588491705|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162942438|NCT02985957|588491699|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
163290530|NCT01212757|589768425|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163290531|NCT01212757|589768426|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163290532|NCT01212757|589768427|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163290533|NCT01212757|589768419|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
162942439|NCT02985957|588491700|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
162942440|NCT02985957|588491701|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
162942441|NCT02985957|588491702|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
162942442|NCT02985957|588491703|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
162942443|NCT02985957|588491704|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
162942444|NCT02985957|588491705|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
162942445|NCT02985957|588491699|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
162942446|NCT02985957|588491700|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
162942447|NCT02985957|588491701|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
162942448|NCT02985957|588491702|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
162942449|NCT02985957|588491703|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
162942450|NCT02985957|588491704|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
162942451|NCT02985957|588491705|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
162942452|NCT02985957|588491699|FG000|Treatment Period|Death|0|||
162942453|NCT02985957|588491700|FG001|Treatment Period|Death|0|||
162942454|NCT02985957|588491701|FG002|Treatment Period|Death|0|||
162942455|NCT02985957|588491702|FG003|Treatment Period|Death|0|||
162942456|NCT02985957|588491703|FG004|Treatment Period|Death|1|||
162942457|NCT02985957|588491704|FG005|Treatment Period|Death|0|||
162942458|NCT02985957|588491705|FG006|Treatment Period|Death|0|||
162942459|NCT02985957|588491699|FG000|Treatment Period|Participant withdrew consent|0|||
162942460|NCT02985957|588491700|FG001|Treatment Period|Participant withdrew consent|0|||
162942461|NCT02985957|588491701|FG002|Treatment Period|Participant withdrew consent|0|||
162942462|NCT02985957|588491702|FG003|Treatment Period|Participant withdrew consent|1|||
162942463|NCT02985957|588491703|FG004|Treatment Period|Participant withdrew consent|3|||
162942464|NCT02985957|588491704|FG005|Treatment Period|Participant withdrew consent|0|||
162942465|NCT02985957|588491705|FG006|Treatment Period|Participant withdrew consent|1|||
162942466|NCT02985957|588491699|FG000|Treatment Period|Lost to Follow-up|0|||
162942467|NCT02985957|588491700|FG001|Treatment Period|Lost to Follow-up|0|||
162942468|NCT02985957|588491701|FG002|Treatment Period|Lost to Follow-up|0|||
162942469|NCT02985957|588491702|FG003|Treatment Period|Lost to Follow-up|0|||
162942470|NCT02985957|588491703|FG004|Treatment Period|Lost to Follow-up|1|||
162942471|NCT02985957|588491704|FG005|Treatment Period|Lost to Follow-up|0|||
162942472|NCT02985957|588491705|FG006|Treatment Period|Lost to Follow-up|0|||
162942473|NCT02985957|588491699|FG000|Treatment Period|Other reasons|0|||
162942474|NCT02985957|588491700|FG001|Treatment Period|Other reasons|0|||
162942475|NCT02985957|588491701|FG002|Treatment Period|Other reasons|1|||
162942476|NCT02985957|588491702|FG003|Treatment Period|Other reasons|3|||
162942477|NCT02985957|588491703|FG004|Treatment Period|Other reasons|5|||
162942478|NCT02985957|588491704|FG005|Treatment Period|Other reasons|0|||
162942479|NCT02985957|588491705|FG006|Treatment Period|Other reasons|1|||
162942480|NCT02985957|588491699|FG000|Treatment Period|Not reported|0|||
162942481|NCT02985957|588491700|FG001|Treatment Period|Not reported|2|||
162942482|NCT02985957|588491701|FG002|Treatment Period|Not reported|2|||
162942483|NCT02985957|588491702|FG003|Treatment Period|Not reported|5|||
162942484|NCT02985957|588491703|FG004|Treatment Period|Not reported|0|||
162942485|NCT02985957|588491704|FG005|Treatment Period|Not reported|0|||
162942486|NCT02985957|588491705|FG006|Treatment Period|Not reported|0|||
162942487|NCT02985957|588491699|FG000|Treatment Period|Maximum clinical benefit|0|||
162942488|NCT02985957|588491700|FG001|Treatment Period|Maximum clinical benefit|0|||
162942489|NCT02985957|588491701|FG002|Treatment Period|Maximum clinical benefit|1|||
162942490|NCT02985957|588491702|FG003|Treatment Period|Maximum clinical benefit|1|||
162942491|NCT02985957|588491703|FG004|Treatment Period|Maximum clinical benefit|0|||
162942492|NCT02985957|588491704|FG005|Treatment Period|Maximum clinical benefit|0|||
162942493|NCT02985957|588491705|FG006|Treatment Period|Maximum clinical benefit|2|||
162942494|NCT02985957|588491699|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
162942495|NCT02985957|588491700|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
162942496|NCT02985957|588491701|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
162942497|NCT02985957|588491702|FG003|Treatment Period|Adverse event unrelated to study drug|2|||
162942498|NCT02985957|588491703|FG004|Treatment Period|Adverse event unrelated to study drug|8|||
162942499|NCT02985957|588491704|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
162942500|NCT02985957|588491705|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
162942501|NCT02985957|588491699|FG000|Treatment Period|Study drug toxicity|1|||
162942502|NCT02985957|588491700|FG001|Treatment Period|Study drug toxicity|23|||
162942503|NCT02985957|588491701|FG002|Treatment Period|Study drug toxicity|20|||
162942504|NCT02985957|588491702|FG003|Treatment Period|Study drug toxicity|12|||
163290534|NCT01212757|589768420|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162942505|NCT02985957|588491703|FG004|Treatment Period|Study drug toxicity|20|||
162942506|NCT02985957|588491704|FG005|Treatment Period|Study drug toxicity|3|||
162942507|NCT02985957|588491705|FG006|Treatment Period|Study drug toxicity|5|||
162942508|NCT02985957|588491699|FG000|Treatment Period|Disease progression|0|||
162942509|NCT02985957|588491700|FG001|Treatment Period|Disease progression|16|||
163042852|NCT01066871|588863976|FG002|Overall Study|Lack of Efficacy|0|||
162942510|NCT02985957|588491701|FG002|Treatment Period|Disease progression|20|||
162942511|NCT02985957|588491702|FG003|Treatment Period|Disease progression|40|||
162942512|NCT02985957|588491703|FG004|Treatment Period|Disease progression|29|||
162942513|NCT02985957|588491704|FG005|Treatment Period|Disease progression|11|||
162942514|NCT02985957|588491705|FG006|Treatment Period|Disease progression|28|||
162942515|NCT02985957|588491699|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
162942516|NCT02985957|588491700|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
162942517|NCT02985957|588491701|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
162942518|NCT02985957|588491702|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
162942519|NCT02985957|588491703|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
163185507|NCT02213042|589395608|FG002|Overall Study|Adverse Event|0|||
163185508|NCT02213042|589395606|FG000|Overall Study|Withdrawal by Subject|0|||
163185509|NCT02213042|589395607|FG001|Overall Study|Withdrawal by Subject|1|||
163185510|NCT02213042|589395608|FG002|Overall Study|Withdrawal by Subject|1|||
163185511|NCT02213042|589395606|FG000|Overall Study|Protocol Violation|1|||
163185512|NCT02213042|589395607|FG001|Overall Study|Protocol Violation|0|||
163185513|NCT02213042|589395608|FG002|Overall Study|Protocol Violation|0|||
163185514|NCT02213042|589395606|FG000|Overall Study|Investigator discretion|0|||
163185515|NCT02213042|589395607|FG001|Overall Study|Investigator discretion|0|||
163185516|NCT02213042|589395608|FG002|Overall Study|Investigator discretion|1|||
163185517|NCT02007512|589395609|FG000|Double Blind Treatment Period|Adverse Event|4|||
163185518|NCT02007512|589395610|FG001|Double Blind Treatment Period|Adverse Event|6|||
163185519|NCT02007512|589395611|FG002|Double Blind Treatment Period|Adverse Event|2|||
163185520|NCT02007512|589395612|FG003|Double Blind Treatment Period|Adverse Event|2|||
163185521|NCT02007512|589395609|FG000|Double Blind Treatment Period|Death|1|||
163185522|NCT02007512|589395610|FG001|Double Blind Treatment Period|Death|0|||
163185523|NCT02007512|589395611|FG002|Double Blind Treatment Period|Death|0|||
163185524|NCT02007512|589395612|FG003|Double Blind Treatment Period|Death|0|||
163185525|NCT02007512|589395609|FG000|Double Blind Treatment Period|Disease progression|51|||
163185526|NCT02007512|589395610|FG001|Double Blind Treatment Period|Disease progression|50|||
163185527|NCT02007512|589395611|FG002|Double Blind Treatment Period|Disease progression|57|||
163185528|NCT02007512|589395612|FG003|Double Blind Treatment Period|Disease progression|52|||
163185529|NCT02007512|589395609|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
163185530|NCT02007512|589395610|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
163185531|NCT02007512|589395611|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
163185532|NCT02007512|589395612|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
163185533|NCT02007512|589395609|FG000|Double Blind Treatment Period|Protocol Violation|1|||
163185534|NCT02007512|589395610|FG001|Double Blind Treatment Period|Protocol Violation|0|||
163185535|NCT02007512|589395611|FG002|Double Blind Treatment Period|Protocol Violation|0|||
163185536|NCT02007512|589395612|FG003|Double Blind Treatment Period|Protocol Violation|1|||
163185537|NCT02007512|589395609|FG000|Double Blind Treatment Period|Other|2|||
163185538|NCT02007512|589395610|FG001|Double Blind Treatment Period|Other|1|||
163185539|NCT02007512|589395611|FG002|Double Blind Treatment Period|Other|1|||
163185540|NCT02007512|589395612|FG003|Double Blind Treatment Period|Other|2|||
163185541|NCT02007512|589395609|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
163185542|NCT02007512|589395610|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
163185543|NCT02007512|589395611|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
163185544|NCT02007512|589395612|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
163185545|NCT02007512|589395609|FG000|Open Label Treatment Period|Adverse Event|1|||
163185546|NCT02007512|589395610|FG001|Open Label Treatment Period|Adverse Event|0|||
163185547|NCT02007512|589395611|FG002|Open Label Treatment Period|Adverse Event|0|||
163185548|NCT02007512|589395612|FG003|Open Label Treatment Period|Adverse Event|0|||
163185549|NCT02007512|589395609|FG000|Open Label Treatment Period|Other|1|||
163185550|NCT02007512|589395610|FG001|Open Label Treatment Period|Other|1|||
163185551|NCT02007512|589395611|FG002|Open Label Treatment Period|Other|0|||
163185552|NCT02007512|589395612|FG003|Open Label Treatment Period|Other|0|||
163185553|NCT02007512|589395609|FG000|Open Label Treatment Period|Disease progression|23|||
163185554|NCT02007512|589395610|FG001|Open Label Treatment Period|Disease progression|11|||
163185555|NCT02007512|589395611|FG002|Open Label Treatment Period|Disease progression|0|||
163185556|NCT02007512|589395612|FG003|Open Label Treatment Period|Disease progression|0|||
163185557|NCT01225887|589395618|FG000|Overall Study|Ineligible:required test not done|2|||
163185558|NCT01225887|589395618|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
163185559|NCT01225887|589395618|FG000|Overall Study|Ineligible:inadequate pathology|2|||
163185560|NCT04505540|589395621|FG000|Baseline|Protocol Violation|10|||
163185561|NCT04505540|589395621|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
162942520|NCT02985957|588491704|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
163185562|NCT04505540|589395621|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
163185563|NCT04505540|589395621|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
163387590|NCT02202551|590129964|FG000|Overall Study|Unable to complete visits per protocol|1|||
163387591|NCT02202551|590129965|FG001|Overall Study|Unable to complete visits per protocol|0|||
163185564|NCT04505540|589395621|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
163185565|NCT04505540|589395621|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
163185566|NCT04505540|589395621|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
163185567|NCT04505540|589395621|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
163185568|NCT04505540|589395621|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
163185569|NCT04505540|589395621|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
163185570|NCT04505540|589395621|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
163185571|NCT04505540|589395621|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
163185572|NCT04505540|589395621|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
163185573|NCT05342532|589395624|FG000|Overall Study|Adverse Event|5|||
163185574|NCT05342532|589395625|FG001|Overall Study|Adverse Event|20|||
163185575|NCT05342532|589395624|FG000|Overall Study|Lost to Follow-up|10|||
163185576|NCT05342532|589395625|FG001|Overall Study|Lost to Follow-up|15|||
163185577|NCT01123850|589395628|FG000|Overall Study|Slow enrollment|45|||
163185578|NCT03180684|589395631|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
163185579|NCT03180684|589395632|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
163185580|NCT03180684|589395631|FG000|Overall Study|Physician Decision|1|||
163185581|NCT03180684|589395632|FG001|Overall Study|Physician Decision|0|||
163185582|NCT03180684|589395631|FG000|Overall Study|Lost to Follow-up|1|||
163185583|NCT03180684|589395632|FG001|Overall Study|Lost to Follow-up|0|||
163185584|NCT03180684|589395631|FG000|Overall Study|Progressive Disease|1|||
163185585|NCT03180684|589395632|FG001|Overall Study|Progressive Disease|0|||
163185586|NCT02495233|589395636|FG000|Overall Study|Miscellaneous|0|||
163185587|NCT02495233|589395637|FG001|Overall Study|Miscellaneous|1|||
163185588|NCT01369615|589395641|FG000|Overall Study|Withdrawal by Subject|0|||
163185589|NCT01369615|589395642|FG001|Overall Study|Withdrawal by Subject|1|||
163185590|NCT01369615|589395641|FG000|Overall Study|Lost to Follow-up|0|||
163185591|NCT01369615|589395642|FG001|Overall Study|Lost to Follow-up|1|||
163185592|NCT04263454|589395643|FG000|Overall Study|Adverse Event|0|||
163185593|NCT04263454|589395644|FG001|Overall Study|Adverse Event|2|||
163185594|NCT04263454|589395643|FG000|Overall Study|Physician Decision|3|||
163185595|NCT04263454|589395644|FG001|Overall Study|Physician Decision|5|||
163185596|NCT04263454|589395643|FG000|Overall Study|Poor Data Quality|0|||
163185597|NCT04263454|589395644|FG001|Overall Study|Poor Data Quality|1|||
163185598|NCT01231347|589395645|FG000|Overall Study|Full Consent withdrawn|19|||
163185599|NCT01231347|589395646|FG001|Overall Study|Full Consent withdrawn|19|||
163185600|NCT01231347|589395647|FG002|Overall Study|Full Consent withdrawn|11|||
163185601|NCT01231347|589395645|FG000|Overall Study|Lost to Follow-up|4|||
163185602|NCT01231347|589395646|FG001|Overall Study|Lost to Follow-up|2|||
163185603|NCT01231347|589395647|FG002|Overall Study|Lost to Follow-up|2|||
163185604|NCT01231347|589395645|FG000|Overall Study|Death|202|||
163185605|NCT01231347|589395646|FG001|Overall Study|Death|210|||
163185606|NCT01231347|589395647|FG002|Overall Study|Death|101|||
163185607|NCT01231347|589395645|FG000|Overall Study|other event|7|||
163185608|NCT01231347|589395646|FG001|Overall Study|other event|9|||
163185609|NCT01231347|589395647|FG002|Overall Study|other event|3|||
163185610|NCT01460368|589395648|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
163185611|NCT01460368|589395649|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
163185612|NCT01460368|589395650|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
163185613|NCT01460368|589395651|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
163185614|NCT01460368|589395652|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
163185615|NCT01460368|589395653|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
163185616|NCT01460368|589395654|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
163185617|NCT01460368|589395648|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
163185618|NCT01460368|589395649|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
163185619|NCT01460368|589395650|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
163185620|NCT01460368|589395651|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
163185621|NCT01460368|589395652|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
163185622|NCT01460368|589395653|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
163185623|NCT01460368|589395654|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
163185624|NCT01460368|589395648|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
163185625|NCT01460368|589395649|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
163185626|NCT01460368|589395650|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
163185627|NCT01460368|589395651|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
163185628|NCT01460368|589395652|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
163185629|NCT01460368|589395653|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
163185630|NCT01460368|589395654|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
163185631|NCT01460368|589395648|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
163185632|NCT01460368|589395649|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
163185633|NCT01460368|589395650|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
163185634|NCT01460368|589395651|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
163185635|NCT01460368|589395652|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
163185636|NCT01460368|589395653|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
162942521|NCT02985957|588491705|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
162942522|NCT02985957|588491699|FG000|Treatment Period|Poor/Non-Compliance|0|||
162942523|NCT02985957|588491700|FG001|Treatment Period|Poor/Non-Compliance|0|||
162942524|NCT02985957|588491701|FG002|Treatment Period|Poor/Non-Compliance|0|||
162942525|NCT02985957|588491702|FG003|Treatment Period|Poor/Non-Compliance|0|||
162942526|NCT02985957|588491703|FG004|Treatment Period|Poor/Non-Compliance|1|||
162942527|NCT02985957|588491704|FG005|Treatment Period|Poor/Non-Compliance|1|||
162942528|NCT02985957|588491705|FG006|Treatment Period|Poor/Non-Compliance|0|||
162942529|NCT02978326|588491707|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
162942530|NCT02978326|588491708|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
162942531|NCT02978326|588491709|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
162942532|NCT02978326|588491707|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
162942533|NCT02978326|588491708|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
162942534|NCT02978326|588491709|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
162942535|NCT02978326|588491707|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
162942536|NCT02978326|588491708|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
162942537|NCT02978326|588491709|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
162942538|NCT02978326|588491707|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
162942539|NCT02978326|588491708|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
162942540|NCT02978326|588491709|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
162942541|NCT02365597|588491712|FG000|Overall Study|Lost to Follow-up|0|||
162942542|NCT02365597|588491713|FG001|Overall Study|Lost to Follow-up|1|||
162942543|NCT02365597|588491714|FG002|Overall Study|Lost to Follow-up|0|||
162942544|NCT02365597|588491715|FG003|Overall Study|Lost to Follow-up|1|||
162942545|NCT02365597|588491712|FG000|Overall Study|Withdrawal by Subject|1|||
162942546|NCT02365597|588491713|FG001|Overall Study|Withdrawal by Subject|8|||
162942547|NCT02365597|588491714|FG002|Overall Study|Withdrawal by Subject|5|||
162942548|NCT02365597|588491715|FG003|Overall Study|Withdrawal by Subject|1|||
162942549|NCT02365597|588491712|FG000|Overall Study|Sponsor's decision|1|||
162942550|NCT02365597|588491713|FG001|Overall Study|Sponsor's decision|3|||
162942551|NCT02365597|588491714|FG002|Overall Study|Sponsor's decision|13|||
162942552|NCT02365597|588491715|FG003|Overall Study|Sponsor's decision|0|||
162942553|NCT02365597|588491712|FG000|Overall Study|Other|0|||
162942554|NCT02365597|588491713|FG001|Overall Study|Other|4|||
162942555|NCT02365597|588491714|FG002|Overall Study|Other|0|||
162942556|NCT02365597|588491715|FG003|Overall Study|Other|0|||
162942557|NCT02365597|588491712|FG000|Overall Study|Enrolled but not treated|0|||
162942558|NCT02365597|588491713|FG001|Overall Study|Enrolled but not treated|1|||
162942559|NCT02365597|588491714|FG002|Overall Study|Enrolled but not treated|1|||
162942560|NCT02365597|588491715|FG003|Overall Study|Enrolled but not treated|0|||
162942561|NCT02365597|588491712|FG000|Overall Study|Ongoing|0|||
162942562|NCT02365597|588491713|FG001|Overall Study|Ongoing|0|||
162942563|NCT02365597|588491714|FG002|Overall Study|Ongoing|0|||
162942564|NCT02365597|588491715|FG003|Overall Study|Ongoing|17|||
162942565|NCT04309474|588491716|FG000|Overall Study|Randomized but not treated|0|||
162942566|NCT04309474|588491717|FG001|Overall Study|Randomized but not treated|2|||
162942567|NCT04309474|588491716|FG000|Overall Study|Adverse Event|4|||
162942568|NCT04309474|588491717|FG001|Overall Study|Adverse Event|1|||
162942569|NCT04309474|588491716|FG000|Overall Study|Withdrawal by Subject|6|||
162942570|NCT04309474|588491717|FG001|Overall Study|Withdrawal by Subject|9|||
162942571|NCT04309474|588491716|FG000|Overall Study|Lost to Follow-up|1|||
163185637|NCT01460368|589395654|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
163185638|NCT01460368|589395648|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
163185639|NCT01460368|589395649|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
163185640|NCT01460368|589395650|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
163185641|NCT01460368|589395651|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
163185642|NCT01460368|589395652|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
163185643|NCT01460368|589395653|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
163290535|NCT01212757|589768421|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
162942572|NCT04309474|588491717|FG001|Overall Study|Lost to Follow-up|2|||
162942573|NCT04309474|588491716|FG000|Overall Study|Not disclosed|10|||
162942574|NCT04309474|588491717|FG001|Overall Study|Not disclosed|6|||
162942575|NCT04670068|588491718|FG000|Overall Study|Progressive Disease|1|||
162942576|NCT04670068|588491719|FG001|Overall Study|Progressive Disease|1|||
162942577|NCT04670068|588491718|FG000|Overall Study|Withdrawal by Subject|1|||
162942578|NCT04670068|588491719|FG001|Overall Study|Withdrawal by Subject|0|||
162942579|NCT02974153|588491720|FG000|Overall Study|Adverse Event|6|||
162942580|NCT02974153|588491721|FG001|Overall Study|Adverse Event|0|||
162942581|NCT02974153|588491722|FG002|Overall Study|Adverse Event|1|||
162942582|NCT02974153|588491720|FG000|Overall Study|Lack of Efficacy|6|||
162942583|NCT02974153|588491721|FG001|Overall Study|Lack of Efficacy|5|||
162942584|NCT02974153|588491722|FG002|Overall Study|Lack of Efficacy|10|||
162942585|NCT02974153|588491720|FG000|Overall Study|Lost to Follow-up|9|||
162942586|NCT02974153|588491721|FG001|Overall Study|Lost to Follow-up|10|||
162942587|NCT02974153|588491722|FG002|Overall Study|Lost to Follow-up|17|||
162942588|NCT02974153|588491720|FG000|Overall Study|Physician Decision|0|||
162942589|NCT02974153|588491721|FG001|Overall Study|Physician Decision|2|||
162942590|NCT02974153|588491722|FG002|Overall Study|Physician Decision|1|||
162942591|NCT02974153|588491720|FG000|Overall Study|Withdrawal by Subject|9|||
162942592|NCT02974153|588491721|FG001|Overall Study|Withdrawal by Subject|16|||
162942593|NCT02974153|588491722|FG002|Overall Study|Withdrawal by Subject|11|||
162942594|NCT02974153|588491720|FG000|Overall Study|Study Burden|8|||
162942595|NCT02974153|588491721|FG001|Overall Study|Study Burden|7|||
162942596|NCT02974153|588491722|FG002|Overall Study|Study Burden|3|||
162942597|NCT02974153|588491720|FG000|Overall Study|Other|14|||
162942598|NCT02974153|588491721|FG001|Overall Study|Other|8|||
162942599|NCT02974153|588491722|FG002|Overall Study|Other|7|||
162942600|NCT02521948|588491723|FG000|Overall Study|Adverse Event|2|||
162942601|NCT02521948|588491723|FG000|Overall Study|Death|4|||
162942602|NCT02521948|588491723|FG000|Overall Study|Lost to Follow-up|1|||
162942603|NCT02521948|588491723|FG000|Overall Study|Did not attend one or both follow-ups|6|||
162942604|NCT00717756|588491726|FG000|Overall Study|Withdrawal by Subject|1|||
162942605|NCT00673790|588491727|FG000|Overall Study|Adverse Event|23|||
162942606|NCT00673790|588491728|FG001|Overall Study|Adverse Event|14|||
162942607|NCT00673790|588491729|FG002|Overall Study|Adverse Event|2|||
162942608|NCT00673790|588491727|FG000|Overall Study|Lack of Efficacy|2|||
162942609|NCT00673790|588491728|FG001|Overall Study|Lack of Efficacy|2|||
162942610|NCT00673790|588491729|FG002|Overall Study|Lack of Efficacy|2|||
162942611|NCT00673790|588491727|FG000|Overall Study|Protocol Violation|6|||
162942612|NCT00673790|588491728|FG001|Overall Study|Protocol Violation|9|||
162942613|NCT00673790|588491729|FG002|Overall Study|Protocol Violation|1|||
162942614|NCT00673790|588491727|FG000|Overall Study|Withdrawal by Subject|7|||
162942615|NCT00673790|588491728|FG001|Overall Study|Withdrawal by Subject|4|||
162942616|NCT00673790|588491729|FG002|Overall Study|Withdrawal by Subject|1|||
162942617|NCT00673790|588491727|FG000|Overall Study|Lost to Follow-up|6|||
162942618|NCT00673790|588491728|FG001|Overall Study|Lost to Follow-up|6|||
162942619|NCT00673790|588491729|FG002|Overall Study|Lost to Follow-up|5|||
162942620|NCT00673790|588491727|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
162942621|NCT00673790|588491728|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
162942622|NCT00673790|588491729|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
162942623|NCT00673790|588491727|FG000|Overall Study|Poor compliance|1|||
162942624|NCT00673790|588491728|FG001|Overall Study|Poor compliance|0|||
162942625|NCT00673790|588491729|FG002|Overall Study|Poor compliance|0|||
162942626|NCT00673790|588491727|FG000|Overall Study|Participated in two Nebivolol studies|0|||
162942627|NCT00673790|588491728|FG001|Overall Study|Participated in two Nebivolol studies|0|||
162942628|NCT00673790|588491729|FG002|Overall Study|Participated in two Nebivolol studies|1|||
162942629|NCT00673790|588491727|FG000|Overall Study|Unconfirmed pregnancy|0|||
162942630|NCT00673790|588491728|FG001|Overall Study|Unconfirmed pregnancy|1|||
162942631|NCT00673790|588491729|FG002|Overall Study|Unconfirmed pregnancy|0|||
162942632|NCT00673790|588491727|FG000|Overall Study|Randomization criteria not met|0|||
162942633|NCT00673790|588491728|FG001|Overall Study|Randomization criteria not met|1|||
162942634|NCT00673790|588491729|FG002|Overall Study|Randomization criteria not met|0|||
162942635|NCT01364870|588491730|FG000|Overall Study|Withdrawal by Subject|13|||
162942636|NCT01364870|588491731|FG001|Overall Study|Withdrawal by Subject|24|||
162942637|NCT01364870|588491732|FG002|Overall Study|Withdrawal by Subject|10|||
162942638|NCT01364870|588491730|FG000|Overall Study|Adverse Event|8|||
162942639|NCT01364870|588491731|FG001|Overall Study|Adverse Event|6|||
162942640|NCT01364870|588491732|FG002|Overall Study|Adverse Event|4|||
162942641|NCT01364870|588491730|FG000|Overall Study|Protocol Violation|1|||
162942642|NCT01364870|588491731|FG001|Overall Study|Protocol Violation|0|||
162942643|NCT01364870|588491732|FG002|Overall Study|Protocol Violation|0|||
162942644|NCT01873859|588491733|FG000|Overall Study|Withdrawal by Subject|0|||
162942645|NCT01873859|588491734|FG001|Overall Study|Withdrawal by Subject|4|||
162942646|NCT04471428|588491735|FG000|Overall Study|Withdrawal by Subject|29|||
162942647|NCT04471428|588491736|FG001|Overall Study|Withdrawal by Subject|4|||
162942648|NCT04471428|588491735|FG000|Overall Study|Physician Decision|0|||
162942649|NCT04471428|588491736|FG001|Overall Study|Physician Decision|1|||
162942650|NCT04471428|588491735|FG000|Overall Study|Reason Not Specified|0|||
162942651|NCT04471428|588491736|FG001|Overall Study|Reason Not Specified|2|||
162942652|NCT04471428|588491735|FG000|Overall Study|Death|131|||
162942653|NCT04471428|588491736|FG001|Overall Study|Death|147|||
162942654|NCT04471428|588491735|FG000|Overall Study|Lost to Follow-up|0|||
162942655|NCT04471428|588491736|FG001|Overall Study|Lost to Follow-up|3|||
162942656|NCT04471428|588491735|FG000|Overall Study|Study Terminated by Sponsor|20|||
162942657|NCT04471428|588491736|FG001|Overall Study|Study Terminated by Sponsor|29|||
162942658|NCT03504852|588491737|FG000|Overall Study|Withdrawal of informed consent|2|||
162942659|NCT03504852|588491738|FG001|Overall Study|Withdrawal of informed consent|1|||
162942660|NCT03504852|588491739|FG002|Overall Study|Withdrawal of informed consent|0|||
162942661|NCT03504852|588491737|FG000|Overall Study|Withdrawal by Subject|5|||
162942662|NCT03504852|588491738|FG001|Overall Study|Withdrawal by Subject|5|||
162942663|NCT03504852|588491739|FG002|Overall Study|Withdrawal by Subject|1|||
162942664|NCT03504852|588491737|FG000|Overall Study|Lost to Follow-up|4|||
162942665|NCT03504852|588491738|FG001|Overall Study|Lost to Follow-up|1|||
162942666|NCT03504852|588491739|FG002|Overall Study|Lost to Follow-up|0|||
162942667|NCT03504852|588491737|FG000|Overall Study|New therapy for study indication|1|||
162942668|NCT03504852|588491738|FG001|Overall Study|New therapy for study indication|0|||
162942669|NCT03504852|588491739|FG002|Overall Study|New therapy for study indication|0|||
162942670|NCT03504852|588491737|FG000|Overall Study|Lack of Efficacy|1|||
162942671|NCT03504852|588491738|FG001|Overall Study|Lack of Efficacy|2|||
162942672|NCT03504852|588491739|FG002|Overall Study|Lack of Efficacy|0|||
162942673|NCT03504852|588491737|FG000|Overall Study|Death|0|||
162942674|NCT03504852|588491738|FG001|Overall Study|Death|1|||
162942675|NCT03504852|588491739|FG002|Overall Study|Death|0|||
162942676|NCT03504852|588491737|FG000|Overall Study|Adverse Event|4|||
162942677|NCT03504852|588491738|FG001|Overall Study|Adverse Event|8|||
162942678|NCT03504852|588491739|FG002|Overall Study|Adverse Event|2|||
162942679|NCT03290079|588491740|FG000|Overall Study|Death|2|||
162942680|NCT03850509|588491741|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
162942681|NCT03850509|588491742|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
162942682|NCT02666430|588491743|FG000|Period 1|Lost to Follow-up|1|||
162942683|NCT02666430|588491744|FG001|Period 1|Lost to Follow-up|0|||
162942684|NCT02666430|588491743|FG000|Period 1|Adverse Event|0|||
162942685|NCT02666430|588491744|FG001|Period 1|Adverse Event|1|||
162942686|NCT02666430|588491743|FG000|Period 2|Withdrawal by Subject|1|||
162942687|NCT02666430|588491744|FG001|Period 2|Withdrawal by Subject|4|||
162942688|NCT02666430|588491743|FG000|Period 3|Lost to Follow-up|1|||
162942689|NCT02666430|588491744|FG001|Period 3|Lost to Follow-up|0|||
162942690|NCT03922477|588491745|FG000|Overall Study|Death|9|||
162942691|NCT03922477|588491745|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
162942692|NCT03922477|588491745|FG000|Overall Study|Physician Decision|1|||
162942693|NCT03922477|588491745|FG000|Overall Study|Withdrawal by Subject|2|||
162942694|NCT01618305|588491749|FG000|Overall Study|Death|0|||
162942695|NCT01618305|588491750|FG001|Overall Study|Death|1|||
162942696|NCT01618305|588491749|FG000|Overall Study|Lost to Follow-up|11|||
162942697|NCT01618305|588491750|FG001|Overall Study|Lost to Follow-up|7|||
162942698|NCT01618305|588491749|FG000|Overall Study|Protocol Violation|1|||
162942699|NCT01618305|588491750|FG001|Overall Study|Protocol Violation|0|||
162942700|NCT01618305|588491749|FG000|Overall Study|Withdrawal by Subject|3|||
162942701|NCT01618305|588491750|FG001|Overall Study|Withdrawal by Subject|2|||
162942702|NCT01565083|588491751|FG000|Overall Study|Withdrawal by Subject|6|||
162942703|NCT01565083|588491752|FG001|Overall Study|Withdrawal by Subject|4|||
162942704|NCT01565083|588491751|FG000|Overall Study|Lost to Follow-up|2|||
162942705|NCT01565083|588491752|FG001|Overall Study|Lost to Follow-up|7|||
162942706|NCT01565083|588491751|FG000|Overall Study|Death|22|||
162942707|NCT01565083|588491752|FG001|Overall Study|Death|23|||
162942708|NCT01565083|588491751|FG000|Overall Study|Other|3|||
162942709|NCT01565083|588491752|FG001|Overall Study|Other|5|||
162942710|NCT01960816|588491753|FG000|Overall Study|Lost to Follow-up|1|||
162942711|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
162942712|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
162942713|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
162942714|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
162942715|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
163185644|NCT01460368|589395654|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
163185645|NCT02047227|589395655|FG000|Overall Study|Adverse Event|2|||
163185646|NCT02047227|589395656|FG001|Overall Study|Adverse Event|4|||
163185647|NCT02047227|589395655|FG000|Overall Study|Lost to Follow-up|0|||
163185648|NCT02047227|589395656|FG001|Overall Study|Lost to Follow-up|3|||
163185649|NCT02047227|589395655|FG000|Overall Study|Protocol Violation|1|||
163185650|NCT02047227|589395656|FG001|Overall Study|Protocol Violation|0|||
163185651|NCT02047227|589395655|FG000|Overall Study|Spontaneous pregnancy|1|||
163185652|NCT02047227|589395656|FG001|Overall Study|Spontaneous pregnancy|0|||
163185653|NCT02047227|589395655|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
163185654|NCT02047227|589395656|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
163185655|NCT02047227|589395655|FG000|Overall Study|No oocytes retrieved|21|||
163185656|NCT02047227|589395656|FG001|Overall Study|No oocytes retrieved|20|||
163185657|NCT02047227|589395655|FG000|Overall Study|No fertilization|61|||
163185658|NCT02047227|589395656|FG001|Overall Study|No fertilization|51|||
163185659|NCT02047227|589395655|FG000|Overall Study|Intention to freeze all embryos|1|||
163185660|NCT02047227|589395656|FG001|Overall Study|Intention to freeze all embryos|0|||
163185661|NCT02047227|589395655|FG000|Overall Study|All embryos discarded|12|||
163387592|NCT02202551|590129966|FG002|Overall Study|Unable to complete visits per protocol|0|||
162942716|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
162942717|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
163185662|NCT02047227|589395656|FG001|Overall Study|All embryos discarded|11|||
163185663|NCT02047227|589395655|FG000|Overall Study|Other|10|||
162942718|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
162942719|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
162942720|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
162942721|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
162942722|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
162942723|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
162942724|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
162942725|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
162942726|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
162942727|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
162942728|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
162942729|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
162942730|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
162942731|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
162942732|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
162942733|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
162942734|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
162942735|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
162942736|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
162942737|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
162942738|NCT00455533|588491754|FG000|Period Two: Randomized Period|Death|0|||
162942739|NCT00455533|588491755|FG001|Period Two: Randomized Period|Death|0|||
162942740|NCT00455533|588491756|FG002|Period Two: Randomized Period|Death|3|||
162942741|NCT00455533|588491754|FG000|Period Two: Randomized Period|Disease Progression|0|||
162942742|NCT00455533|588491755|FG001|Period Two: Randomized Period|Disease Progression|1|||
162942743|NCT00455533|588491756|FG002|Period Two: Randomized Period|Disease Progression|1|||
162942744|NCT00455533|588491754|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
162942745|NCT00455533|588491755|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
162942746|NCT00455533|588491756|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
162942747|NCT00455533|588491754|FG000|Period Two: Randomized Period|Other - need reasons|0|||
162942748|NCT00455533|588491755|FG001|Period Two: Randomized Period|Other - need reasons|1|||
162942749|NCT00455533|588491756|FG002|Period Two: Randomized Period|Other - need reasons|0|||
162942750|NCT00455533|588491754|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
162942751|NCT00455533|588491755|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
162942752|NCT00455533|588491756|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
162942753|NCT00455533|588491754|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
162942754|NCT00455533|588491755|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
162942755|NCT00455533|588491756|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
162942756|NCT02415959|588491757|FG000|Overall Study|Adverse Event|0|||
162942757|NCT02415959|588491758|FG001|Overall Study|Adverse Event|1|||
162942758|NCT02415959|588491759|FG002|Overall Study|Adverse Event|0|||
162942759|NCT02415959|588491760|FG003|Overall Study|Adverse Event|0|||
162942760|NCT02415959|588491761|FG004|Overall Study|Adverse Event|0|||
162942761|NCT02415959|588491757|FG000|Overall Study|Protocol Violation|0|||
162942762|NCT02415959|588491758|FG001|Overall Study|Protocol Violation|0|||
162942763|NCT02415959|588491759|FG002|Overall Study|Protocol Violation|0|||
162942764|NCT02415959|588491760|FG003|Overall Study|Protocol Violation|1|||
162942765|NCT02415959|588491761|FG004|Overall Study|Protocol Violation|0|||
162942766|NCT01402908|588493172|FG000|Overall Study|Withdrawal by Subject|30|||
162942767|NCT01402908|588493173|FG001|Overall Study|Withdrawal by Subject|17|||
162942768|NCT01402908|588493172|FG000|Overall Study|Lost to Follow-up|3|||
162942769|NCT01402908|588493173|FG001|Overall Study|Lost to Follow-up|1|||
162942770|NCT01402908|588493172|FG000|Overall Study|Physician Decision|1|||
162942771|NCT01402908|588493173|FG001|Overall Study|Physician Decision|0|||
162942772|NCT01739790|588493174|FG000|Overall Study|Early Trial Termination|2|||
162942773|NCT01739790|588493175|FG001|Overall Study|Early Trial Termination|4|||
162942774|NCT01691859|588493177|FG000|Overall Study|Adverse Event|19|||
162942775|NCT01691859|588493177|FG000|Overall Study|Lack of Efficacy|11|||
162942776|NCT01691859|588493177|FG000|Overall Study|Protocol Violation|4|||
162942777|NCT01691859|588493177|FG000|Overall Study|Product commercially available|221|||
162942778|NCT01691859|588493177|FG000|Overall Study|Study closed/terminated|50|||
162942779|NCT01691859|588493177|FG000|Overall Study|Lost to Follow-up|5|||
162942780|NCT01691859|588493177|FG000|Overall Study|Physician Decision|6|||
162942781|NCT01691859|588493177|FG000|Overall Study|Withdrawal by Subject|31|||
162942782|NCT00862979|588493178|FG000|Overall Study|Adverse Event|6|||
162942783|NCT00862979|588493179|FG001|Overall Study|Adverse Event|3|||
162942784|NCT00862979|588493178|FG000|Overall Study|Protocol Violation|0|||
162942785|NCT00862979|588493179|FG001|Overall Study|Protocol Violation|1|||
162942786|NCT00862979|588493178|FG000|Overall Study|Patient withdrew consent|2|||
162942787|NCT00862979|588493179|FG001|Overall Study|Patient withdrew consent|1|||
162942788|NCT00862979|588493178|FG000|Overall Study|Administrative problems|0|||
162942789|NCT00862979|588493179|FG001|Overall Study|Administrative problems|1|||
162942790|NCT00862979|588493178|FG000|Overall Study|Death|0|||
162942791|NCT00862979|588493179|FG001|Overall Study|Death|1|||
162942792|NCT05568225|588493180|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
162942793|NCT05568225|588493181|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
162942794|NCT05568225|588493182|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
162942795|NCT05568225|588493180|FG000|Primary Treatment Period|Physician Decision|0|||
162942796|NCT05568225|588493181|FG001|Primary Treatment Period|Physician Decision|1|||
162942797|NCT05568225|588493182|FG002|Primary Treatment Period|Physician Decision|0|||
162942798|NCT05568225|588493180|FG000|Primary Treatment Period|Disease progression|0|||
162942799|NCT05568225|588493181|FG001|Primary Treatment Period|Disease progression|1|||
162942800|NCT05568225|588493182|FG002|Primary Treatment Period|Disease progression|0|||
162942801|NCT05568225|588493180|FG000|Primary Treatment Period|Lack of Efficacy|0|||
162942802|NCT05568225|588493181|FG001|Primary Treatment Period|Lack of Efficacy|1|||
162942803|NCT05568225|588493182|FG002|Primary Treatment Period|Lack of Efficacy|0|||
162942804|NCT05568225|588493180|FG000|Primary Treatment Period|Withdrawal of conset|1|||
162942805|NCT05568225|588493181|FG001|Primary Treatment Period|Withdrawal of conset|0|||
162942806|NCT05568225|588493182|FG002|Primary Treatment Period|Withdrawal of conset|4|||
162942807|NCT05568225|588493180|FG000|Primary Treatment Period|Adverse Event|1|||
162942808|NCT05568225|588493181|FG001|Primary Treatment Period|Adverse Event|0|||
162942809|NCT05568225|588493182|FG002|Primary Treatment Period|Adverse Event|0|||
162942810|NCT05568225|588493180|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
162942811|NCT05568225|588493181|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
162942812|NCT05568225|588493182|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
162942813|NCT05568225|588493180|FG000|Extension Treatment Period|Protocol Violation|0|||
162942814|NCT05568225|588493181|FG001|Extension Treatment Period|Protocol Violation|0|||
162942815|NCT05568225|588493182|FG002|Extension Treatment Period|Protocol Violation|1|||
163290536|NCT01212757|589768422|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163290537|NCT01212757|589768423|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163290538|NCT01212757|589768424|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163290539|NCT01212757|589768425|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163290540|NCT01212757|589768426|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163290541|NCT01212757|589768427|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163290542|NCT01212757|589768419|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
163290543|NCT01212757|589768420|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
162942816|NCT05568225|588493180|FG000|Extension Treatment Period|Lack of Efficacy|0|||
162942817|NCT05568225|588493181|FG001|Extension Treatment Period|Lack of Efficacy|0|||
162942818|NCT05568225|588493182|FG002|Extension Treatment Period|Lack of Efficacy|1|||
162942819|NCT01027143|588493185|FG000|Overall Study|Lost to Follow-up|9|||
162942820|NCT01027143|588493186|FG001|Overall Study|Lost to Follow-up|4|||
162942821|NCT02637557|588493191|FG000|Overall Study|Adverse Event|3|||
162942822|NCT02637557|588493192|FG001|Overall Study|Adverse Event|1|||
162942823|NCT02637557|588493193|FG002|Overall Study|Adverse Event|3|||
162942824|NCT02637557|588493194|FG003|Overall Study|Adverse Event|3|||
162942825|NCT02637557|588493191|FG000|Overall Study|Lost to Follow-up|1|||
162942826|NCT02637557|588493192|FG001|Overall Study|Lost to Follow-up|1|||
162942827|NCT02637557|588493193|FG002|Overall Study|Lost to Follow-up|0|||
162942828|NCT02637557|588493194|FG003|Overall Study|Lost to Follow-up|1|||
162942829|NCT02637557|588493191|FG000|Overall Study|Physician Decision|1|||
162942830|NCT02637557|588493192|FG001|Overall Study|Physician Decision|0|||
162942831|NCT02637557|588493193|FG002|Overall Study|Physician Decision|0|||
162942832|NCT02637557|588493194|FG003|Overall Study|Physician Decision|0|||
162942833|NCT02637557|588493191|FG000|Overall Study|Protocol Violation|2|||
162942834|NCT02637557|588493192|FG001|Overall Study|Protocol Violation|0|||
163290544|NCT01212757|589768421|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
163290545|NCT01212757|589768422|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163290546|NCT01212757|589768423|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163290547|NCT01212757|589768424|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163290548|NCT01212757|589768425|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163290549|NCT01212757|589768426|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163290550|NCT01212757|589768427|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163290551|NCT01212757|589768419|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162942835|NCT02637557|588493193|FG002|Overall Study|Protocol Violation|2|||
162942836|NCT02637557|588493194|FG003|Overall Study|Protocol Violation|1|||
162942837|NCT02637557|588493191|FG000|Overall Study|Withdrawal by Subject|1|||
162942838|NCT02637557|588493192|FG001|Overall Study|Withdrawal by Subject|3|||
162942839|NCT02637557|588493193|FG002|Overall Study|Withdrawal by Subject|4|||
162942840|NCT02637557|588493194|FG003|Overall Study|Withdrawal by Subject|2|||
162942841|NCT00992407|588493195|FG000|Overall Study|Protocol Violation|2|||
162942842|NCT00992407|588493196|FG001|Overall Study|Protocol Violation|1|||
162942843|NCT00992407|588493195|FG000|Overall Study|Lost to Follow-up|3|||
163290552|NCT01212757|589768420|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
163290553|NCT01212757|589768421|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
163290554|NCT01212757|589768422|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163290555|NCT01212757|589768423|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163290556|NCT01212757|589768424|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163290557|NCT01212757|589768425|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163290558|NCT01212757|589768426|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163290559|NCT01212757|589768427|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163290560|NCT01212757|589768419|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
163290561|NCT01212757|589768420|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
163290562|NCT01212757|589768421|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163290563|NCT01212757|589768422|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163290564|NCT01212757|589768423|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163290565|NCT01212757|589768424|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163290566|NCT01212757|589768425|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163290567|NCT01212757|589768426|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163290568|NCT01212757|589768427|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163290569|NCT01212757|589768419|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
163290570|NCT01212757|589768420|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
163290571|NCT01212757|589768421|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
163290572|NCT01212757|589768422|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
163290573|NCT01212757|589768423|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
163290574|NCT01212757|589768424|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
163290575|NCT01212757|589768425|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
163290576|NCT01212757|589768426|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
163290577|NCT01212757|589768427|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
163290578|NCT01212757|589768419|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
163290579|NCT01212757|589768420|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
163290580|NCT01212757|589768421|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
163290581|NCT01212757|589768422|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
163290582|NCT01212757|589768423|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
163290583|NCT01212757|589768424|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
163290584|NCT01212757|589768425|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
163290585|NCT01212757|589768426|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
163290586|NCT01212757|589768427|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
163290587|NCT01212757|589768419|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163290588|NCT01212757|589768420|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163290589|NCT01212757|589768421|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
163290590|NCT01212757|589768422|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163290591|NCT01212757|589768423|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163290592|NCT01212757|589768424|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163290593|NCT01212757|589768425|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163290594|NCT01212757|589768426|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163290595|NCT01212757|589768427|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163290596|NCT01212757|589768419|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
163290597|NCT01212757|589768420|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
163290598|NCT01212757|589768421|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
163290599|NCT01212757|589768422|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
163290600|NCT01212757|589768423|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
163290601|NCT01212757|589768424|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
163290602|NCT01212757|589768425|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
163290603|NCT01212757|589768426|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
163290604|NCT01212757|589768427|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
163290605|NCT01212757|589768419|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163290606|NCT01212757|589768420|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
163290607|NCT01212757|589768421|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163290608|NCT01212757|589768422|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163290609|NCT01212757|589768423|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
163290610|NCT01212757|589768424|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163290611|NCT01212757|589768425|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163290612|NCT01212757|589768426|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163290613|NCT01212757|589768427|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163290614|NCT01212757|589768419|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
163290615|NCT01212757|589768420|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
162942844|NCT00992407|588493196|FG001|Overall Study|Lost to Follow-up|3|||
162942845|NCT00992407|588493195|FG000|Overall Study|Adverse Event|3|||
162942846|NCT00992407|588493196|FG001|Overall Study|Adverse Event|2|||
162942847|NCT00992407|588493195|FG000|Overall Study|protocol Violation & Adverse events|2|||
162942848|NCT00992407|588493196|FG001|Overall Study|protocol Violation & Adverse events|4|||
162942849|NCT00992407|588493195|FG000|Overall Study|Other|2|||
162942850|NCT00992407|588493196|FG001|Overall Study|Other|0|||
162942851|NCT00992407|588493195|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
162942852|NCT00992407|588493196|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
162942853|NCT00992407|588493195|FG000|Overall Study|Study medication not administered|17|||
162942854|NCT00992407|588493196|FG001|Overall Study|Study medication not administered|13|||
162942855|NCT03738332|588493199|FG000|Overall Study|Withdrawal by Subject|1|||
162942856|NCT01521559|588493200|FG000|Overall Study|Adverse Event|0|||
162942857|NCT01521559|588493201|FG001|Overall Study|Adverse Event|4|||
162942858|NCT01521559|588493200|FG000|Overall Study|Death|1|||
162942859|NCT01521559|588493201|FG001|Overall Study|Death|0|||
162942860|NCT01521559|588493200|FG000|Overall Study|Withdrawal by Subject|9|||
162942861|NCT01521559|588493201|FG001|Overall Study|Withdrawal by Subject|11|||
162942862|NCT01521559|588493200|FG000|Overall Study|Lost to Follow-up|3|||
162942863|NCT01521559|588493201|FG001|Overall Study|Lost to Follow-up|1|||
162942864|NCT01521559|588493200|FG000|Overall Study|Protocol Violation|1|||
162942865|NCT01521559|588493201|FG001|Overall Study|Protocol Violation|0|||
162942866|NCT01521559|588493200|FG000|Overall Study|Other|1|||
162942867|NCT01521559|588493201|FG001|Overall Study|Other|2|||
162942868|NCT02336737|588493202|FG000|Overall Study|Withdrawal by Subject|5|||
162942869|NCT02336737|588493202|FG000|Overall Study|Physician Decision|8|||
162942870|NCT00576381|588493207|FG000|Overall Study|Reoperation|3|||
162942871|NCT00576381|588493207|FG000|Overall Study|Adverse Event|4|||
162942872|NCT00287118|588493208|FG000|Overall Study|Adverse Event|30|||
162942873|NCT00287118|588493208|FG000|Overall Study|Death|1|||
162942874|NCT00287118|588493208|FG000|Overall Study|Lack of Efficacy|11|||
162942875|NCT00287118|588493208|FG000|Overall Study|Lost to Follow-up|1|||
162942876|NCT00287118|588493208|FG000|Overall Study|Protocol Violation|2|||
162942877|NCT00287118|588493208|FG000|Overall Study|Other|7|||
162942878|NCT02324465|588493209|FG000|Overall Study|device failure|0|||
162942879|NCT02324465|588493210|FG001|Overall Study|device failure|1|||
162942880|NCT01631864|588493211|FG000|Overall Study|Withdrawal by Subject|0|||
162942881|NCT01631864|588493212|FG001|Overall Study|Withdrawal by Subject|1|||
162942882|NCT01631864|588493211|FG000|Overall Study|Adverse Event|2|||
162942883|NCT01631864|588493212|FG001|Overall Study|Adverse Event|3|||
162942884|NCT04543136|588493225|FG000|Overall Study|Withdrawal by Subject|0|||
162942885|NCT04543136|588493226|FG001|Overall Study|Withdrawal by Subject|1|||
162942886|NCT04543136|588493227|FG002|Overall Study|Withdrawal by Subject|0|||
162942887|NCT04543136|588493228|FG003|Overall Study|Withdrawal by Subject|1|||
162942888|NCT04543136|588493229|FG004|Overall Study|Withdrawal by Subject|0|||
162942889|NCT04543136|588493230|FG005|Overall Study|Withdrawal by Subject|0|||
162942890|NCT00638157|588493234|FG000|Overall Study|Adverse Event|0|||
162942891|NCT00638157|588493235|FG001|Overall Study|Adverse Event|1|||
162942892|NCT00638157|588493234|FG000|Overall Study|Clinical (symptomatic) failure|1|||
162942893|NCT00638157|588493235|FG001|Overall Study|Clinical (symptomatic) failure|1|||
162942894|NCT00638157|588493234|FG000|Overall Study|Microbiological failure|1|||
162942895|NCT00638157|588493235|FG001|Overall Study|Microbiological failure|0|||
163185664|NCT02047227|589395656|FG001|Overall Study|Other|9|||
163185665|NCT01385371|589395669|FG000|Overall Study|Adverse Event|54|||
163185666|NCT01385371|589395670|FG001|Overall Study|Adverse Event|19|||
163185667|NCT01385371|589395669|FG000|Overall Study|Lost to Follow-up|16|||
163185668|NCT01385371|589395670|FG001|Overall Study|Lost to Follow-up|16|||
163185669|NCT01385371|589395669|FG000|Overall Study|Withdrawal by Subject|52|||
163185670|NCT01385371|589395670|FG001|Overall Study|Withdrawal by Subject|39|||
163290616|NCT01212757|589768421|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
163185671|NCT01385371|589395669|FG000|Overall Study|Protocol Violation|25|||
163185672|NCT01385371|589395670|FG001|Overall Study|Protocol Violation|21|||
163290617|NCT01212757|589768422|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
163185673|NCT01385371|589395669|FG000|Overall Study|Administrative|2|||
163290618|NCT01212757|589768423|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
163290619|NCT01212757|589768424|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162942896|NCT00638157|588493234|FG000|Overall Study|Lost to Follow-up|1|||
162942897|NCT00638157|588493235|FG001|Overall Study|Lost to Follow-up|0|||
162942898|NCT00638157|588493234|FG000|Overall Study|Physician Decision|1|||
162942899|NCT00638157|588493235|FG001|Overall Study|Physician Decision|0|||
162942900|NCT00638157|588493234|FG000|Overall Study|Other|1|||
162942901|NCT00638157|588493235|FG001|Overall Study|Other|2|||
163290620|NCT01212757|589768425|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162942902|NCT00638157|588493234|FG000|Overall Study|Randomized, not treated|2|||
162942903|NCT00638157|588493235|FG001|Overall Study|Randomized, not treated|0|||
162942904|NCT04684524|588493236|FG000|Overall Study|Other|2|||
162942905|NCT04684524|588493237|FG001|Overall Study|Other|0|||
162942906|NCT04684524|588493236|FG000|Overall Study|Withdrawal by Subject|5|||
162942907|NCT04684524|588493237|FG001|Overall Study|Withdrawal by Subject|3|||
163290621|NCT01212757|589768426|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
163290622|NCT01212757|589768427|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
163290623|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163290624|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163290625|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163290626|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163290627|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163290628|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163290629|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163290630|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163290631|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
163290632|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
163290633|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
163290634|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
163290635|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
163290636|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
163290637|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
163290638|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
163290639|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
163290640|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
163290641|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
163290642|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
163290643|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
163290644|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
163290645|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
163290646|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
163290647|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
163290648|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
163290649|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
163290650|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163290651|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
163290652|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
163290653|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163290654|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163290655|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163290656|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163290657|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
162942908|NCT04684524|588493236|FG000|Overall Study|Adverse Event|1|||
162942909|NCT04684524|588493237|FG001|Overall Study|Adverse Event|1|||
162942910|NCT00601354|588493241|FG000|Overall Study|Lost to Follow-up|4|||
163290658|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
163290659|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163290660|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163290661|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
163290662|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163290663|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163290664|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163290665|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163290666|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163290667|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163290668|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
163290669|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
163290670|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
163290671|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
163290672|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
163290673|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
163290674|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
163290675|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
163290676|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
163290677|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
163290678|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
163290679|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
163290680|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
163290681|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
162942911|NCT00601354|588493242|FG001|Overall Study|Lost to Follow-up|5|||
162942912|NCT05876091|588493243|FG000|Sessions 2-5: Tobacco Flavors|Lost to Follow-up|1|||
163290682|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
163290683|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
162942913|NCT03402893|588493244|FG000|Overall Study|Withdrawal by Subject|1|||
162942914|NCT03466411|588493245|FG000|Overall Study|Lost to Follow-up|0|||
162942915|NCT03466411|588493246|FG001|Overall Study|Lost to Follow-up|1|||
162942916|NCT03466411|588493247|FG002|Overall Study|Lost to Follow-up|1|||
162942917|NCT03466411|588493248|FG003|Overall Study|Lost to Follow-up|0|||
162942918|NCT03466411|588493249|FG004|Overall Study|Lost to Follow-up|0|||
162942919|NCT03466411|588493250|FG005|Overall Study|Lost to Follow-up|0|||
162942920|NCT03466411|588493251|FG006|Overall Study|Lost to Follow-up|1|||
162942921|NCT03466411|588493252|FG007|Overall Study|Lost to Follow-up|1|||
162942922|NCT03466411|588493253|FG008|Overall Study|Lost to Follow-up|0|||
162942923|NCT03466411|588493254|FG009|Overall Study|Lost to Follow-up|1|||
162942924|NCT03466411|588493255|FG010|Overall Study|Lost to Follow-up|1|||
162942925|NCT03466411|588493256|FG011|Overall Study|Lost to Follow-up|1|||
162942926|NCT03466411|588493257|FG012|Overall Study|Lost to Follow-up|0|||
162942927|NCT03466411|588493245|FG000|Overall Study|Withdrawal by Subject|14|||
162942928|NCT03466411|588493246|FG001|Overall Study|Withdrawal by Subject|7|||
162942929|NCT03466411|588493247|FG002|Overall Study|Withdrawal by Subject|8|||
162942930|NCT03466411|588493248|FG003|Overall Study|Withdrawal by Subject|4|||
162942931|NCT03466411|588493249|FG004|Overall Study|Withdrawal by Subject|6|||
162942932|NCT03466411|588493250|FG005|Overall Study|Withdrawal by Subject|3|||
162942933|NCT03466411|588493251|FG006|Overall Study|Withdrawal by Subject|6|||
162942934|NCT03466411|588493252|FG007|Overall Study|Withdrawal by Subject|9|||
162942935|NCT03466411|588493253|FG008|Overall Study|Withdrawal by Subject|6|||
162942936|NCT03466411|588493254|FG009|Overall Study|Withdrawal by Subject|11|||
162942937|NCT03466411|588493255|FG010|Overall Study|Withdrawal by Subject|14|||
162942938|NCT03466411|588493256|FG011|Overall Study|Withdrawal by Subject|12|||
162942939|NCT03466411|588493257|FG012|Overall Study|Withdrawal by Subject|7|||
162942940|NCT03466411|588493245|FG000|Overall Study|Other|1|||
162942941|NCT03466411|588493246|FG001|Overall Study|Other|1|||
163185674|NCT01385371|589395670|FG001|Overall Study|Administrative|2|||
163185675|NCT01090973|589395675|FG000|Overall Study|Disease progression|1|||
163185676|NCT00445978|589395678|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
163185677|NCT00445978|589395678|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
163185678|NCT00445978|589395678|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
163185679|NCT00445978|589395678|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
163185680|NCT00445978|589395678|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
163185681|NCT00445978|589395678|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
163185682|NCT00445978|589395678|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
163185683|NCT00445978|589395678|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
163185684|NCT00445978|589395678|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
163185685|NCT03112590|589395679|FG000|Overall Study|Adverse Event|0|||
163185686|NCT03112590|589395680|FG001|Overall Study|Adverse Event|1|||
163185687|NCT03112590|589395681|FG002|Overall Study|Adverse Event|0|||
163185688|NCT02436681|589395682|FG000|Overall Study|Lost to Follow-up|10|||
163185689|NCT02436681|589395682|FG000|Overall Study|Withdrawal by Subject|2|||
163185690|NCT02436681|589395682|FG000|Overall Study|Death|2|||
163185691|NCT00739596|589395687|FG000|Overall Study|Adverse Event|12|||
163185692|NCT00739596|589395688|FG001|Overall Study|Adverse Event|6|||
163185693|NCT00739596|589395687|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
163185694|NCT00739596|589395688|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163185695|NCT00739596|589395687|FG000|Overall Study|Patient Withdrew Consent|8|||
163185696|NCT00739596|589395688|FG001|Overall Study|Patient Withdrew Consent|8|||
163185697|NCT00739596|589395687|FG000|Overall Study|Lost to Follow-up|0|||
163185698|NCT00739596|589395688|FG001|Overall Study|Lost to Follow-up|2|||
163185699|NCT00739596|589395687|FG000|Overall Study|Protocol Deviation|1|||
163185700|NCT00739596|589395688|FG001|Overall Study|Protocol Deviation|1|||
163185701|NCT03635788|589395694|FG000|Step 1|Death|1|||
163185702|NCT03635788|589395695|FG001|Step 1|Death|0|||
163185703|NCT03635788|589395696|FG002|Step 1|Death|0|||
163185704|NCT03635788|589395694|FG000|Step 1|Lost to Follow-up|31|||
163185705|NCT03635788|589395695|FG001|Step 1|Lost to Follow-up|0|||
163185706|NCT03635788|589395696|FG002|Step 1|Lost to Follow-up|0|||
163185707|NCT03635788|589395694|FG000|Step 1|Pregnancy|1|||
163185708|NCT03635788|589395695|FG001|Step 1|Pregnancy|0|||
163185709|NCT03635788|589395696|FG002|Step 1|Pregnancy|0|||
163185710|NCT03635788|589395694|FG000|Step 1|Protocol Violation|8|||
162942942|NCT03466411|588493247|FG002|Overall Study|Other|0|||
162942943|NCT03466411|588493248|FG003|Overall Study|Other|1|||
163185711|NCT03635788|589395695|FG001|Step 1|Protocol Violation|0|||
163185712|NCT03635788|589395696|FG002|Step 1|Protocol Violation|0|||
163185713|NCT03635788|589395694|FG000|Step 1|Withdrawal by Subject|13|||
162942944|NCT03466411|588493249|FG004|Overall Study|Other|2|||
162942945|NCT03466411|588493250|FG005|Overall Study|Other|0|||
162942946|NCT03466411|588493251|FG006|Overall Study|Other|0|||
162942947|NCT03466411|588493252|FG007|Overall Study|Other|0|||
162942948|NCT03466411|588493253|FG008|Overall Study|Other|0|||
163185714|NCT03635788|589395695|FG001|Step 1|Withdrawal by Subject|0|||
162942949|NCT03466411|588493254|FG009|Overall Study|Other|1|||
162942950|NCT03466411|588493255|FG010|Overall Study|Other|2|||
163185715|NCT03635788|589395696|FG002|Step 1|Withdrawal by Subject|0|||
163185716|NCT03635788|589395694|FG000|Step 1|Other reasons|12|||
163185717|NCT03635788|589395695|FG001|Step 1|Other reasons|0|||
163185718|NCT03635788|589395696|FG002|Step 1|Other reasons|0|||
163290684|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
163290685|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
163290686|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163290687|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163290688|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
163290689|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163290690|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163290691|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163290692|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163290693|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163290694|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163290695|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163290696|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
163290697|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
163290698|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163290699|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163290700|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163290701|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163290702|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
163290703|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
163290704|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163290705|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163290706|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163290707|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163290708|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163290709|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163290710|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163290711|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163290712|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
163290713|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163290714|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
163290715|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163290716|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163290717|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163290718|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163290719|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163290720|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163290721|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163290722|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
163290723|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
163290724|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
163290725|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
163290726|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
163290727|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
163290728|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
163290729|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
163290730|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
163290731|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
163290732|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
163290733|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
163290734|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
163290735|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
163290736|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
163290737|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
163290738|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
163290739|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
162942951|NCT03466411|588493256|FG011|Overall Study|Other|0|||
162942952|NCT03466411|588493257|FG012|Overall Study|Other|0|||
162942953|NCT03466411|588493245|FG000|Overall Study|Randomized but not Treated|0|||
163290740|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
163290741|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
163290742|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
163290743|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
163290744|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
162942954|NCT03466411|588493246|FG001|Overall Study|Randomized but not Treated|0|||
163290745|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
163290746|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
163290747|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
163185719|NCT03635788|589395694|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
163185720|NCT03635788|589395695|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
163185721|NCT03635788|589395696|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
163185722|NCT03635788|589395694|FG000|Step 2|Lost to Follow-up|0|||
163185723|NCT03635788|589395695|FG001|Step 2|Lost to Follow-up|8|||
163185724|NCT03635788|589395696|FG002|Step 2|Lost to Follow-up|15|||
163185725|NCT03635788|589395694|FG000|Step 2|Withdrawal by Subject|0|||
163185726|NCT03635788|589395695|FG001|Step 2|Withdrawal by Subject|6|||
163185727|NCT03635788|589395696|FG002|Step 2|Withdrawal by Subject|6|||
163185728|NCT03635788|589395694|FG000|Step 2|Death|0|||
163185729|NCT03635788|589395695|FG001|Step 2|Death|2|||
163185730|NCT03635788|589395696|FG002|Step 2|Death|0|||
163185731|NCT03635788|589395694|FG000|Step 2|Incarceration|0|||
163185732|NCT03635788|589395695|FG001|Step 2|Incarceration|2|||
163185733|NCT03635788|589395696|FG002|Step 2|Incarceration|0|||
163185734|NCT03635788|589395694|FG000|Step 2|Non-Compliance With Study Requirements|0|||
163185735|NCT03635788|589395695|FG001|Step 2|Non-Compliance With Study Requirements|1|||
163185736|NCT03635788|589395696|FG002|Step 2|Non-Compliance With Study Requirements|1|||
163185737|NCT03635788|589395694|FG000|Step 2|Confounding Medical Condition|0|||
163185738|NCT03635788|589395695|FG001|Step 2|Confounding Medical Condition|0|||
163185739|NCT03635788|589395696|FG002|Step 2|Confounding Medical Condition|1|||
163185740|NCT03635788|589395694|FG000|Step 2|Out Of State With No Plan To Return|0|||
163290748|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
163290749|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
163185741|NCT03635788|589395695|FG001|Step 2|Out Of State With No Plan To Return|1|||
163185742|NCT03635788|589395696|FG002|Step 2|Out Of State With No Plan To Return|0|||
163185743|NCT03635788|589395694|FG000|Step 2|Switched To Injectables|0|||
163185744|NCT03635788|589395695|FG001|Step 2|Switched To Injectables|0|||
163185745|NCT03635788|589395696|FG002|Step 2|Switched To Injectables|1|||
163185746|NCT03635788|589395694|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
163185747|NCT03635788|589395695|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
163185748|NCT03635788|589395696|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
163185749|NCT04571515|589395700|FG000|Overall Study|Physician Decision|0|||
163185750|NCT04571515|589395701|FG001|Overall Study|Physician Decision|0|||
163185751|NCT04571515|589395702|FG002|Overall Study|Physician Decision|0|||
163185752|NCT04571515|589395703|FG003|Overall Study|Physician Decision|0|||
163185753|NCT04571515|589395704|FG004|Overall Study|Physician Decision|1|||
163185754|NCT04571515|589395700|FG000|Overall Study|Withdrawal by Subject|0|||
163185755|NCT04571515|589395701|FG001|Overall Study|Withdrawal by Subject|0|||
163185756|NCT04571515|589395702|FG002|Overall Study|Withdrawal by Subject|0|||
163185757|NCT04571515|589395703|FG003|Overall Study|Withdrawal by Subject|0|||
163185758|NCT04571515|589395704|FG004|Overall Study|Withdrawal by Subject|1|||
163185759|NCT04571515|589395700|FG000|Overall Study|insufficient pain|1|||
163185760|NCT04571515|589395701|FG001|Overall Study|insufficient pain|0|||
163185761|NCT04571515|589395702|FG002|Overall Study|insufficient pain|0|||
163185762|NCT04571515|589395703|FG003|Overall Study|insufficient pain|0|||
163185763|NCT04571515|589395704|FG004|Overall Study|insufficient pain|1|||
163185764|NCT05098938|589395713|FG000|Overall Study|Adverse Event|4|||
163185765|NCT05098938|589395714|FG001|Overall Study|Adverse Event|3|||
163185766|NCT05098938|589395713|FG000|Overall Study|inclusion/exclusion criteria change|11|||
163185767|NCT05098938|589395714|FG001|Overall Study|inclusion/exclusion criteria change|5|||
163185768|NCT05098938|589395713|FG000|Overall Study|lack of compliance|26|||
163185769|NCT05098938|589395714|FG001|Overall Study|lack of compliance|19|||
163185770|NCT05098938|589395713|FG000|Overall Study|Lost to Follow-up|37|||
163185771|NCT05098938|589395714|FG001|Overall Study|Lost to Follow-up|40|||
163185772|NCT05098938|589395713|FG000|Overall Study|Lost in treatment period|17|||
163185773|NCT05098938|589395714|FG001|Overall Study|Lost in treatment period|13|||
163185774|NCT05098938|589395713|FG000|Overall Study|Met an exclusion criterion|0|||
163185775|NCT05098938|589395714|FG001|Overall Study|Met an exclusion criterion|3|||
163185776|NCT05098938|589395713|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
163185777|NCT05098938|589395714|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
163185778|NCT05098938|589395713|FG000|Overall Study|Physician Decision|25|||
163185779|NCT05098938|589395714|FG001|Overall Study|Physician Decision|32|||
163185780|NCT05098938|589395713|FG000|Overall Study|Run in failure in treatment phase|1|||
163185781|NCT05098938|589395714|FG001|Overall Study|Run in failure in treatment phase|1|||
163185782|NCT05098938|589395713|FG000|Overall Study|Withdrawal by Subject|0|||
163185783|NCT05098938|589395714|FG001|Overall Study|Withdrawal by Subject|3|||
163185784|NCT05098938|589395713|FG000|Overall Study|Run-in Failure in early study|505|||
163185785|NCT05098938|589395714|FG001|Overall Study|Run-in Failure in early study|514|||
163185786|NCT05098938|589395713|FG000|Overall Study|IMP delivery missed|1|||
163185787|NCT05098938|589395714|FG001|Overall Study|IMP delivery missed|5|||
163185788|NCT05098938|589395713|FG000|Overall Study|6 months visit was missed|2|||
163185789|NCT05098938|589395714|FG001|Overall Study|6 months visit was missed|0|||
163185790|NCT05098938|589395713|FG000|Overall Study|fit for use was not completed within window|3|||
163185791|NCT05098938|589395714|FG001|Overall Study|fit for use was not completed within window|0|||
163042853|NCT01066871|588863977|FG003|Overall Study|Lack of Efficacy|1|||
163185792|NCT05098938|589395713|FG000|Overall Study|V2 visit was not completed within window|0|||
163185793|NCT05098938|589395714|FG001|Overall Study|V2 visit was not completed within window|1|||
163185794|NCT05098938|589395713|FG000|Overall Study|exclusionary medication use|1|||
163185795|NCT05098938|589395714|FG001|Overall Study|exclusionary medication use|2|||
163185796|NCT05098938|589395713|FG000|Overall Study|change in medication|1|||
163185797|NCT05098938|589395714|FG001|Overall Study|change in medication|0|||
163185798|NCT05098938|589395713|FG000|Overall Study|treatment failure|2|||
162942955|NCT03466411|588493247|FG002|Overall Study|Randomized but not Treated|0|||
162942956|NCT03466411|588493248|FG003|Overall Study|Randomized but not Treated|0|||
162942957|NCT03466411|588493249|FG004|Overall Study|Randomized but not Treated|0|||
162942958|NCT03466411|588493250|FG005|Overall Study|Randomized but not Treated|0|||
162942959|NCT03466411|588493251|FG006|Overall Study|Randomized but not Treated|1|||
162942960|NCT03466411|588493252|FG007|Overall Study|Randomized but not Treated|0|||
162942961|NCT03466411|588493253|FG008|Overall Study|Randomized but not Treated|0|||
162942962|NCT03466411|588493254|FG009|Overall Study|Randomized but not Treated|0|||
162942963|NCT03466411|588493255|FG010|Overall Study|Randomized but not Treated|0|||
162942964|NCT03466411|588493256|FG011|Overall Study|Randomized but not Treated|0|||
162942965|NCT03466411|588493257|FG012|Overall Study|Randomized but not Treated|0|||
162942966|NCT03462719|588493258|FG000|Overall Study|Withdrawal by Subject|4|||
162942967|NCT03462719|588493259|FG001|Overall Study|Withdrawal by Subject|3|||
162942968|NCT03462719|588493258|FG000|Overall Study|Ongoing|87|||
162942969|NCT03462719|588493259|FG001|Overall Study|Ongoing|72|||
162942970|NCT04799158|588493260|FG000|Run-In Period|Adverse Event|6|||
162942971|NCT04799158|588493261|FG001|Run-In Period|Adverse Event|0|||
162942972|NCT04799158|588493262|FG002|Run-In Period|Adverse Event|0|||
162942973|NCT04799158|588493263|FG003|Run-In Period|Adverse Event|0|||
162942974|NCT04799158|588493264|FG004|Run-In Period|Adverse Event|0|||
162942975|NCT04799158|588493260|FG000|Run-In Period|Lost to Follow-up|4|||
162942976|NCT04799158|588493261|FG001|Run-In Period|Lost to Follow-up|0|||
162942977|NCT04799158|588493262|FG002|Run-In Period|Lost to Follow-up|0|||
162942978|NCT04799158|588493263|FG003|Run-In Period|Lost to Follow-up|0|||
162942979|NCT04799158|588493264|FG004|Run-In Period|Lost to Follow-up|0|||
162942980|NCT04799158|588493260|FG000|Run-In Period|Significant Protocol Deviation|1|||
162942981|NCT04799158|588493261|FG001|Run-In Period|Significant Protocol Deviation|0|||
162942982|NCT04799158|588493262|FG002|Run-In Period|Significant Protocol Deviation|0|||
162942983|NCT04799158|588493263|FG003|Run-In Period|Significant Protocol Deviation|0|||
162942984|NCT04799158|588493264|FG004|Run-In Period|Significant Protocol Deviation|0|||
162942985|NCT04799158|588493260|FG000|Run-In Period|Withdrawal by Subject|11|||
162942986|NCT04799158|588493261|FG001|Run-In Period|Withdrawal by Subject|0|||
162942987|NCT04799158|588493262|FG002|Run-In Period|Withdrawal by Subject|0|||
163185799|NCT05098938|589395714|FG001|Overall Study|treatment failure|1|||
163185800|NCT02570074|589397593|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
163185801|NCT02570074|589397594|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
163185802|NCT01859143|589397595|FG000|Overall Study|Lost to Follow-up|2|||
163185803|NCT01859143|589397596|FG001|Overall Study|Lost to Follow-up|0|||
163185804|NCT00760214|589397597|FG000|Overall Study|Adverse Event|8|||
163185805|NCT00760214|589397598|FG001|Overall Study|Adverse Event|9|||
163185806|NCT00760214|589397599|FG002|Overall Study|Adverse Event|12|||
163185807|NCT00760214|589397597|FG000|Overall Study|Protocol Violation|3|||
163185808|NCT00760214|589397598|FG001|Overall Study|Protocol Violation|0|||
163185809|NCT00760214|589397599|FG002|Overall Study|Protocol Violation|3|||
163185810|NCT00760214|589397597|FG000|Overall Study|Lost to Follow-up|0|||
163185811|NCT00760214|589397598|FG001|Overall Study|Lost to Follow-up|0|||
163185812|NCT00760214|589397599|FG002|Overall Study|Lost to Follow-up|1|||
163185813|NCT00760214|589397597|FG000|Overall Study|Withdrawal by Subject|12|||
163185814|NCT00760214|589397598|FG001|Overall Study|Withdrawal by Subject|14|||
163185815|NCT00760214|589397599|FG002|Overall Study|Withdrawal by Subject|13|||
163185816|NCT00760214|589397597|FG000|Overall Study|Lack of Efficacy|3|||
163185817|NCT00760214|589397598|FG001|Overall Study|Lack of Efficacy|2|||
163185818|NCT00760214|589397599|FG002|Overall Study|Lack of Efficacy|4|||
163185819|NCT00760214|589397597|FG000|Overall Study|Pregnancy|0|||
163185820|NCT00760214|589397598|FG001|Overall Study|Pregnancy|0|||
163185821|NCT00760214|589397599|FG002|Overall Study|Pregnancy|1|||
163185822|NCT00760214|589397597|FG000|Overall Study|Physician Decision|1|||
163185823|NCT00760214|589397598|FG001|Overall Study|Physician Decision|1|||
163185824|NCT00760214|589397599|FG002|Overall Study|Physician Decision|1|||
163185825|NCT00760214|589397597|FG000|Overall Study|Other|3|||
163185826|NCT00760214|589397598|FG001|Overall Study|Other|4|||
163185827|NCT00760214|589397599|FG002|Overall Study|Other|6|||
163185828|NCT00700570|589397600|FG000|Overall Study|Adverse Event|2|||
163185829|NCT00700570|589397601|FG001|Overall Study|Adverse Event|6|||
163185830|NCT00700570|589397600|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
163185831|NCT00700570|589397601|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
163185832|NCT00700570|589397600|FG000|Overall Study|Disease Progression|8|||
163185833|NCT00700570|589397601|FG001|Overall Study|Disease Progression|11|||
163185834|NCT00700570|589397600|FG000|Overall Study|Withdrawal by Subject|1|||
163185835|NCT00700570|589397601|FG001|Overall Study|Withdrawal by Subject|6|||
163185836|NCT01134315|589397602|FG000|Overall Study|Adverse Event|1|||
163185837|NCT01134315|589397603|FG001|Overall Study|Adverse Event|2|||
163185838|NCT01134315|589397602|FG000|Overall Study|Other Reason|8|||
163185839|NCT01134315|589397603|FG001|Overall Study|Other Reason|17|||
163185840|NCT04587271|589397606|FG000|Overall Study|Lost to Follow-up|2|||
163185841|NCT04587271|589397607|FG001|Overall Study|Lost to Follow-up|2|||
163185842|NCT04587271|589397608|FG002|Overall Study|Lost to Follow-up|0|||
163290750|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
163290751|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
163290752|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
163290753|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
163290754|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
163290755|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
163290756|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
163290757|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
163290758|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163290759|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
163290760|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
163290761|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163290762|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163290763|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163290764|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163290765|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
163290766|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
162942988|NCT04799158|588493263|FG003|Run-In Period|Withdrawal by Subject|0|||
162942989|NCT04799158|588493264|FG004|Run-In Period|Withdrawal by Subject|0|||
162942990|NCT04799158|588493260|FG000|Run-In Period|Miscellaneous|3|||
162942991|NCT04799158|588493261|FG001|Run-In Period|Miscellaneous|0|||
162942992|NCT04799158|588493262|FG002|Run-In Period|Miscellaneous|0|||
162942993|NCT04799158|588493263|FG003|Run-In Period|Miscellaneous|0|||
162942994|NCT04799158|588493264|FG004|Run-In Period|Miscellaneous|0|||
162942995|NCT04799158|588493260|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
162942996|NCT04799158|588493261|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
162942997|NCT04799158|588493262|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
162942998|NCT04799158|588493263|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
162942999|NCT04799158|588493264|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
162943000|NCT04799158|588493260|FG000|On-Demand Treatment Period|Adverse Event|0|||
163290767|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
163290768|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
163290769|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
163290770|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
163290771|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
163290772|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
163290773|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
163290774|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
163290775|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
163290776|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163290777|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163290778|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163290779|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163290780|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163290781|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163290782|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163290783|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
163290784|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163290785|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163290786|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
163290787|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
163290788|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163290789|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163290790|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163290791|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163290792|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
163290793|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
163290794|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
163290795|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
163290796|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
163290797|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
163290798|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
162943001|NCT04799158|588493261|FG001|On-Demand Treatment Period|Adverse Event|1|||
162943002|NCT04799158|588493262|FG002|On-Demand Treatment Period|Adverse Event|0|||
162943003|NCT04799158|588493263|FG003|On-Demand Treatment Period|Adverse Event|0|||
162943004|NCT04799158|588493264|FG004|On-Demand Treatment Period|Adverse Event|1|||
162943005|NCT04799158|588493260|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
162943006|NCT04799158|588493261|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
163290799|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
162943007|NCT04799158|588493262|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
162943008|NCT04799158|588493263|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
162943009|NCT04799158|588493264|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
162943010|NCT04799158|588493260|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
162943011|NCT04799158|588493261|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
162943012|NCT04799158|588493262|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
162943013|NCT04799158|588493263|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
162943014|NCT04799158|588493264|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
162943015|NCT04799158|588493260|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
162943016|NCT04799158|588493261|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
162943017|NCT04799158|588493262|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
162943018|NCT04799158|588493263|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
162943019|NCT04799158|588493264|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
162943020|NCT04799158|588493260|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
162943021|NCT04799158|588493261|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
162943022|NCT04799158|588493262|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
162943023|NCT04799158|588493263|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
162943024|NCT04799158|588493264|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
162943025|NCT04799158|588493260|FG000|On-Demand Treatment Period|Miscellaneous|0|||
162943026|NCT04799158|588493261|FG001|On-Demand Treatment Period|Miscellaneous|0|||
162943027|NCT04799158|588493262|FG002|On-Demand Treatment Period|Miscellaneous|0|||
162943028|NCT04799158|588493263|FG003|On-Demand Treatment Period|Miscellaneous|0|||
162943029|NCT04799158|588493264|FG004|On-Demand Treatment Period|Miscellaneous|1|||
162943030|NCT00319956|588493265|FG000|Overall Study|Death|20|||
162943031|NCT00319956|588493266|FG001|Overall Study|Death|24|||
162943032|NCT02607800|588493267|FG000|Overall Study|Lost to Follow-up|7|||
162943033|NCT02607800|588493268|FG001|Overall Study|Lost to Follow-up|10|||
162943034|NCT02607800|588493267|FG000|Overall Study|Withdrew Consent|2|||
162943035|NCT02607800|588493268|FG001|Overall Study|Withdrew Consent|0|||
162943036|NCT02607800|588493267|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
162943037|NCT02607800|588493268|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
162943038|NCT01185288|588493269|FG000|Overall Study|Adverse Event|7|||
162943039|NCT01185288|588493270|FG001|Overall Study|Adverse Event|6|||
162943040|NCT01185288|588493269|FG000|Overall Study|Withdrawal by Subject|6|||
162943041|NCT01185288|588493270|FG001|Overall Study|Withdrawal by Subject|4|||
162943042|NCT01185288|588493269|FG000|Overall Study|Lost to Follow-up|2|||
162943043|NCT01185288|588493270|FG001|Overall Study|Lost to Follow-up|5|||
162943044|NCT01185288|588493269|FG000|Overall Study|Lack of Efficacy|2|||
162943045|NCT01185288|588493270|FG001|Overall Study|Lack of Efficacy|0|||
162943046|NCT01185288|588493269|FG000|Overall Study|Investigator discretion|1|||
162943047|NCT01185288|588493270|FG001|Overall Study|Investigator discretion|0|||
162943048|NCT01185288|588493269|FG000|Overall Study|Did not meet inclusion criteria|1|||
162943049|NCT01185288|588493270|FG001|Overall Study|Did not meet inclusion criteria|0|||
162943050|NCT01185288|588493269|FG000|Overall Study|Noncompliance|0|||
162943051|NCT01185288|588493270|FG001|Overall Study|Noncompliance|1|||
162943052|NCT01202747|588493271|FG000|Overall Study|Withdrawal by Subject|1|||
162943053|NCT01446913|588493275|FG000|Overall Study|Significant illness|1|||
162943054|NCT01446913|588493276|FG001|Overall Study|Significant illness|1|||
162943055|NCT01446913|588493277|FG002|Overall Study|Significant illness|1|||
162943056|NCT01446913|588493275|FG000|Overall Study|Withdrawal by Subject|5|||
162943057|NCT01446913|588493276|FG001|Overall Study|Withdrawal by Subject|3|||
162943058|NCT01446913|588493277|FG002|Overall Study|Withdrawal by Subject|5|||
162943059|NCT01446913|588493275|FG000|Overall Study|Physician Decision|0|||
163185843|NCT04587271|589397609|FG003|Overall Study|Lost to Follow-up|2|||
163185844|NCT04587271|589397610|FG004|Overall Study|Lost to Follow-up|2|||
163185845|NCT04587271|589397611|FG005|Overall Study|Lost to Follow-up|0|||
163185846|NCT04587271|589397606|FG000|Overall Study|Caregiver brought child to visits|0|||
163185847|NCT04587271|589397607|FG001|Overall Study|Caregiver brought child to visits|0|||
163185848|NCT04587271|589397608|FG002|Overall Study|Caregiver brought child to visits|0|||
163185849|NCT04587271|589397609|FG003|Overall Study|Caregiver brought child to visits|1|||
163185850|NCT04587271|589397610|FG004|Overall Study|Caregiver brought child to visits|0|||
163185851|NCT04587271|589397611|FG005|Overall Study|Caregiver brought child to visits|0|||
163185852|NCT02360111|589397612|FG000|Overall Study|Death|2|||
163185853|NCT00611533|589397613|FG000|First Intervention (6 Weeks)|Never started study|0|||
163185854|NCT00611533|589397614|FG001|First Intervention (6 Weeks)|Never started study|1|||
162943060|NCT01446913|588493276|FG001|Overall Study|Physician Decision|0|||
162943061|NCT01446913|588493277|FG002|Overall Study|Physician Decision|2|||
162943062|NCT01446913|588493275|FG000|Overall Study|Lost to Follow-up|3|||
162943063|NCT01446913|588493276|FG001|Overall Study|Lost to Follow-up|5|||
162943064|NCT01446913|588493277|FG002|Overall Study|Lost to Follow-up|3|||
162943065|NCT00679783|588493279|FG000|Overall Study|Adverse Event|0|||
162943066|NCT00679783|588493280|FG001|Overall Study|Adverse Event|0|||
162943067|NCT00679783|588493281|FG002|Overall Study|Adverse Event|0|||
162943068|NCT00679783|588493282|FG003|Overall Study|Adverse Event|3|||
162943069|NCT00679783|588493283|FG004|Overall Study|Adverse Event|0|||
162943070|NCT00679783|588493284|FG005|Overall Study|Adverse Event|0|||
162943071|NCT00679783|588493285|FG006|Overall Study|Adverse Event|1|||
162943072|NCT00679783|588493279|FG000|Overall Study|Lack of Efficacy|0|||
162943073|NCT00679783|588493280|FG001|Overall Study|Lack of Efficacy|1|||
162943074|NCT00679783|588493281|FG002|Overall Study|Lack of Efficacy|0|||
162943075|NCT00679783|588493282|FG003|Overall Study|Lack of Efficacy|2|||
162943076|NCT00679783|588493283|FG004|Overall Study|Lack of Efficacy|0|||
162943077|NCT00679783|588493284|FG005|Overall Study|Lack of Efficacy|0|||
162943078|NCT00679783|588493285|FG006|Overall Study|Lack of Efficacy|0|||
162943079|NCT00679783|588493279|FG000|Overall Study|Withdrawal by Subject|0|||
162943080|NCT00679783|588493280|FG001|Overall Study|Withdrawal by Subject|0|||
162943081|NCT00679783|588493281|FG002|Overall Study|Withdrawal by Subject|1|||
162943082|NCT00679783|588493282|FG003|Overall Study|Withdrawal by Subject|1|||
162943083|NCT00679783|588493283|FG004|Overall Study|Withdrawal by Subject|0|||
162943084|NCT00679783|588493284|FG005|Overall Study|Withdrawal by Subject|0|||
162943085|NCT00679783|588493285|FG006|Overall Study|Withdrawal by Subject|0|||
163185855|NCT00611533|589397613|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
163185856|NCT00611533|589397614|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
163185857|NCT00611533|589397613|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
163185858|NCT00611533|589397614|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
163185859|NCT01933217|589397615|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
163185860|NCT01933217|589397616|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
163185861|NCT01933217|589397615|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
163185862|NCT01933217|589397616|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
163185863|NCT03923738|589397620|FG000|Period 1|Adverse Event|1|||
163185864|NCT03923738|589397620|FG000|Period 1|Withdrawal by Subject|1|||
163185865|NCT05246397|589397621|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
163185866|NCT03875768|589397623|FG000|Overall Study|Lost to Follow-up|16|||
163185867|NCT03875768|589397624|FG001|Overall Study|Lost to Follow-up|13|||
163185868|NCT03875768|589397623|FG000|Overall Study|Withdrawal by Subject|10|||
163185869|NCT03875768|589397624|FG001|Overall Study|Withdrawal by Subject|21|||
163185870|NCT03875768|589397623|FG000|Overall Study|Did not complete assessment|21|||
163185871|NCT03875768|589397624|FG001|Overall Study|Did not complete assessment|12|||
163185872|NCT03875768|589397623|FG000|Overall Study|Became ineligible|1|||
163185873|NCT03875768|589397624|FG001|Overall Study|Became ineligible|0|||
163185874|NCT01925274|589397625|FG000|Overall Study|Death|1|||
163185875|NCT01925274|589397626|FG001|Overall Study|Death|0|||
163185876|NCT01925274|589397627|FG002|Overall Study|Death|0|||
163185877|NCT01925274|589397625|FG000|Overall Study|Lost to Follow-up|0|||
163185878|NCT01925274|589397626|FG001|Overall Study|Lost to Follow-up|1|||
163185879|NCT01925274|589397627|FG002|Overall Study|Lost to Follow-up|0|||
163185880|NCT01925274|589397625|FG000|Overall Study|Withdrawal by Subject|1|||
163185881|NCT01925274|589397626|FG001|Overall Study|Withdrawal by Subject|2|||
163185882|NCT01925274|589397627|FG002|Overall Study|Withdrawal by Subject|0|||
163185883|NCT01925274|589397625|FG000|Overall Study|Study terminated by sponsor|4|||
163185884|NCT01925274|589397626|FG001|Overall Study|Study terminated by sponsor|0|||
163185885|NCT01925274|589397627|FG002|Overall Study|Study terminated by sponsor|0|||
163185886|NCT01925274|589397625|FG000|Overall Study|Protocol amendment|1|||
163185887|NCT01925274|589397626|FG001|Overall Study|Protocol amendment|3|||
163185888|NCT01925274|589397627|FG002|Overall Study|Protocol amendment|6|||
163185889|NCT04327674|589397632|FG000|Overall Study|Protocol Violation|19|||
163185890|NCT00723398|589397633|FG000|Overall Study|Withdrawal by Subject|2|||
163185891|NCT00723398|589397634|FG001|Overall Study|Withdrawal by Subject|6|||
163185892|NCT00723398|589397635|FG002|Overall Study|Withdrawal by Subject|4|||
163185893|NCT00723398|589397636|FG003|Overall Study|Withdrawal by Subject|4|||
163185894|NCT00723398|589397637|FG004|Overall Study|Withdrawal by Subject|4|||
163185895|NCT00723398|589397633|FG000|Overall Study|Protocol Violation|2|||
163185896|NCT00723398|589397634|FG001|Overall Study|Protocol Violation|1|||
163185897|NCT00723398|589397635|FG002|Overall Study|Protocol Violation|5|||
163185898|NCT00723398|589397636|FG003|Overall Study|Protocol Violation|0|||
163185899|NCT00723398|589397637|FG004|Overall Study|Protocol Violation|0|||
163185900|NCT00723398|589397633|FG000|Overall Study|Physician Decision|2|||
163185901|NCT00723398|589397634|FG001|Overall Study|Physician Decision|2|||
163185902|NCT00723398|589397635|FG002|Overall Study|Physician Decision|5|||
163185903|NCT00723398|589397636|FG003|Overall Study|Physician Decision|0|||
163185904|NCT00723398|589397637|FG004|Overall Study|Physician Decision|1|||
163185905|NCT00723398|589397633|FG000|Overall Study|Adverse Event|0|||
163185906|NCT00723398|589397634|FG001|Overall Study|Adverse Event|5|||
163185907|NCT00723398|589397635|FG002|Overall Study|Adverse Event|3|||
163185908|NCT00723398|589397636|FG003|Overall Study|Adverse Event|1|||
163185909|NCT00723398|589397637|FG004|Overall Study|Adverse Event|4|||
163185910|NCT00723398|589397633|FG000|Overall Study|Lost to Follow-up|0|||
163185911|NCT00723398|589397634|FG001|Overall Study|Lost to Follow-up|1|||
162943086|NCT00679783|588493279|FG000|Overall Study|Not Captured|0|||
162943087|NCT00679783|588493280|FG001|Overall Study|Not Captured|0|||
162943088|NCT00679783|588493281|FG002|Overall Study|Not Captured|0|||
162943089|NCT00679783|588493282|FG003|Overall Study|Not Captured|5|||
162943090|NCT00679783|588493283|FG004|Overall Study|Not Captured|0|||
162943091|NCT00679783|588493284|FG005|Overall Study|Not Captured|0|||
162943092|NCT00679783|588493285|FG006|Overall Study|Not Captured|0|||
162943093|NCT00679783|588493279|FG000|Overall Study|Ongoing at data cut-off|2|||
162943094|NCT00679783|588493280|FG001|Overall Study|Ongoing at data cut-off|2|||
162943095|NCT00679783|588493281|FG002|Overall Study|Ongoing at data cut-off|0|||
162943096|NCT00679783|588493282|FG003|Overall Study|Ongoing at data cut-off|9|||
162943097|NCT00679783|588493283|FG004|Overall Study|Ongoing at data cut-off|1|||
162943098|NCT00679783|588493284|FG005|Overall Study|Ongoing at data cut-off|0|||
162943099|NCT00679783|588493285|FG006|Overall Study|Ongoing at data cut-off|0|||
162943100|NCT01485536|588493286|FG000|Overall Study|Withdrawal by Subject|3|||
162943101|NCT01485536|588493286|FG000|Overall Study|Adverse Event|1|||
162943102|NCT02626949|588493287|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
162943103|NCT02626949|588493288|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
162943104|NCT02626949|588493287|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
162943105|NCT02626949|588493288|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
162943106|NCT02626949|588493287|FG000|Enrolled|Lost to Follow-up|7|||
162943107|NCT02626949|588493288|FG001|Enrolled|Lost to Follow-up|6|||
162943108|NCT02626949|588493287|FG000|Enrolled|Withdrawal by Subject|3|||
162943109|NCT02626949|588493288|FG001|Enrolled|Withdrawal by Subject|2|||
162943110|NCT00601484|588493289|FG000|Overall Study|Adverse Event|0|||
162943111|NCT00601484|588493290|FG001|Overall Study|Adverse Event|1|||
162943112|NCT00601484|588493289|FG000|Overall Study|Lost to Follow-up|4|||
162943113|NCT00601484|588493290|FG001|Overall Study|Lost to Follow-up|3|||
162943114|NCT00601484|588493289|FG000|Overall Study|Lack of Efficacy|0|||
162943115|NCT00601484|588493290|FG001|Overall Study|Lack of Efficacy|2|||
162943116|NCT00601484|588493289|FG000|Overall Study|Withdrawal by Subject|1|||
162943117|NCT00601484|588493290|FG001|Overall Study|Withdrawal by Subject|1|||
162943118|NCT00601484|588493289|FG000|Overall Study|Randomized, but not treated|0|||
162943119|NCT00601484|588493290|FG001|Overall Study|Randomized, but not treated|1|||
162943120|NCT02928848|588493291|FG000|Arm 2|Withdrawal by Subject|1|||
162943121|NCT02928848|588493292|FG001|Arm 2|Withdrawal by Subject|0|||
162943122|NCT00969332|588493293|FG000|Overall Study|Physician Decision|8|||
162943123|NCT00969332|588493293|FG000|Overall Study|Withdrawal by Subject|3|||
162943124|NCT03828461|588493294|FG000|Overall Study|Lost to Follow-up|1|||
162943125|NCT03828461|588493294|FG000|Overall Study|Withdrawal by Subject|3|||
162943126|NCT00576199|588493295|FG000|Overall Study|Adverse Event|12|||
162943127|NCT00576199|588493295|FG000|Overall Study|Insufficient Therapeutic Response|14|||
162943128|NCT00576199|588493295|FG000|Overall Study|Refused Treatment|2|||
162943129|NCT00576199|588493295|FG000|Overall Study|Reason Unspecified|2|||
162943130|NCT00663871|588493297|FG000|Overall Study|Lost to Follow-up|5|||
162943131|NCT00663871|588493298|FG001|Overall Study|Lost to Follow-up|5|||
162943132|NCT00663871|588493297|FG000|Overall Study|Withdrawal by Subject|5|||
162943133|NCT00663871|588493298|FG001|Overall Study|Withdrawal by Subject|2|||
162943134|NCT00582309|588493299|FG000|Overall Study|Protocol Violation|0|||
162943135|NCT00582309|588493300|FG001|Overall Study|Protocol Violation|0|||
162943136|NCT00582309|588493301|FG002|Overall Study|Protocol Violation|2|||
162943137|NCT03095352|588493305|FG000|Treatment assigned at enrollment|Withdrawal by Subject|1|||
162943138|NCT03095352|588493306|FG001|Treatment assigned at enrollment|Withdrawal by Subject|0|||
162943139|NCT00319449|588493309|FG000|Overall Study|Subject did not wish to continue|1|||
162943140|NCT00319449|588493310|FG001|Overall Study|Subject did not wish to continue|0|||
162943141|NCT00319449|588493309|FG000|Overall Study|Noncompliance with the protocol|1|||
162943142|NCT00319449|588493310|FG001|Overall Study|Noncompliance with the protocol|0|||
163185912|NCT00723398|589397635|FG002|Overall Study|Lost to Follow-up|0|||
163185913|NCT00723398|589397636|FG003|Overall Study|Lost to Follow-up|0|||
163185914|NCT00723398|589397637|FG004|Overall Study|Lost to Follow-up|0|||
163185915|NCT00267189|589397638|FG000|Overall Study|Patient withdrew consent|1|||
163185916|NCT00267189|589397639|FG001|Overall Study|Patient withdrew consent|1|||
163185917|NCT00267189|589397638|FG000|Overall Study|Death|1|||
163185918|NCT00267189|589397639|FG001|Overall Study|Death|0|||
163185919|NCT00267189|589397638|FG000|Overall Study|Missing|3|||
162943143|NCT01497938|588493313|FG000|Overall Study|Adverse Event|0|||
162943144|NCT01497938|588493314|FG001|Overall Study|Adverse Event|1|||
162943145|NCT01497938|588493313|FG000|Overall Study|Physician Decision|0|||
162943146|NCT01497938|588493314|FG001|Overall Study|Physician Decision|1|||
162943147|NCT01497938|588493313|FG000|Overall Study|Withdrawal by Subject|4|||
162943148|NCT01497938|588493314|FG001|Overall Study|Withdrawal by Subject|0|||
162943149|NCT01497938|588493313|FG000|Overall Study|Device Violation|1|||
162943150|NCT01497938|588493314|FG001|Overall Study|Device Violation|0|||
162943151|NCT03708211|588493315|FG000|Overall Study|Progressive Disease|10|||
162943152|NCT03708211|588493316|FG001|Overall Study|Progressive Disease|7|||
162943153|NCT03708211|588493315|FG000|Overall Study|Withdrawal by Subject|0|||
162943154|NCT03708211|588493316|FG001|Overall Study|Withdrawal by Subject|1|||
162943155|NCT03708211|588493315|FG000|Overall Study|Other|2|||
162943156|NCT03708211|588493316|FG001|Overall Study|Other|0|||
162943157|NCT00462982|588493321|FG000|Overall Study|Adverse Event|1|||
162943158|NCT00462982|588493321|FG000|Overall Study|Patient Not Treated|2|||
162943159|NCT05328375|588494386|FG000|Overall Study|Withdrawal by Subject|0|||
163185920|NCT00267189|589397639|FG001|Overall Study|Missing|0|||
162943160|NCT05328375|588494387|FG001|Overall Study|Withdrawal by Subject|1|||
162943161|NCT05514119|588494392|FG000|Overall Study|Ineligible due to disease progression|1|||
162943162|NCT02946385|588494393|FG000|Overall Study|Lost to Follow-up|0|||
162943163|NCT02946385|588494394|FG001|Overall Study|Lost to Follow-up|0|||
162943164|NCT02946385|588494395|FG002|Overall Study|Lost to Follow-up|3|||
162943165|NCT02946385|588494396|FG003|Overall Study|Lost to Follow-up|0|||
162943166|NCT02946385|588494397|FG004|Overall Study|Lost to Follow-up|2|||
162943167|NCT02946385|588494398|FG005|Overall Study|Lost to Follow-up|1|||
162943168|NCT04849988|588494399|FG000|Overall Study|Lack of Efficacy|3|||
162943169|NCT04849988|588494400|FG001|Overall Study|Lack of Efficacy|4|||
162943170|NCT04849988|588494401|FG002|Overall Study|Lack of Efficacy|1|||
162943171|NCT04849988|588494402|FG003|Overall Study|Lack of Efficacy|4|||
162943172|NCT04849988|588494399|FG000|Overall Study|Other reasons|1|||
162943173|NCT04849988|588494400|FG001|Overall Study|Other reasons|2|||
162943174|NCT04849988|588494401|FG002|Overall Study|Other reasons|2|||
162943175|NCT04849988|588494402|FG003|Overall Study|Other reasons|1|||
162943176|NCT01893905|588494407|FG000|Overall Study|Withdrawal by Subject|1|||
162943177|NCT01893905|588494408|FG001|Overall Study|Withdrawal by Subject|0|||
162943178|NCT01893905|588494407|FG000|Overall Study|Adverse Event|9|||
162943179|NCT01893905|588494408|FG001|Overall Study|Adverse Event|3|||
162943180|NCT01893905|588494407|FG000|Overall Study|Lack of Efficacy|5|||
162943181|NCT01893905|588494408|FG001|Overall Study|Lack of Efficacy|7|||
162943182|NCT01893905|588494407|FG000|Overall Study|Lost to Follow-up|1|||
162943183|NCT01893905|588494408|FG001|Overall Study|Lost to Follow-up|0|||
162943184|NCT01893905|588494407|FG000|Overall Study|Protocol Violation|6|||
162943185|NCT01893905|588494408|FG001|Overall Study|Protocol Violation|1|||
162943186|NCT01893905|588494407|FG000|Overall Study|Lack of adherence to treatment|2|||
162943187|NCT01893905|588494408|FG001|Overall Study|Lack of adherence to treatment|0|||
162943188|NCT01893905|588494407|FG000|Overall Study|Other reason|1|||
162943189|NCT01893905|588494408|FG001|Overall Study|Other reason|3|||
162943190|NCT00278200|588494415|FG000|Overall Study|Death|1|||
162943191|NCT00278200|588494416|FG001|Overall Study|Death|3|||
162943192|NCT00278200|588494415|FG000|Overall Study|Physician Decision|0|||
162943193|NCT00278200|588494416|FG001|Overall Study|Physician Decision|1|||
162943194|NCT02688400|588494422|FG000|Overall Study|Protocol Violation|2|||
162943195|NCT02688400|588494423|FG001|Overall Study|Protocol Violation|5|||
162943196|NCT02688400|588494422|FG000|Overall Study|Lack of Efficacy|7|||
162943197|NCT02688400|588494423|FG001|Overall Study|Lack of Efficacy|7|||
162943198|NCT02688400|588494422|FG000|Overall Study|Adverse Event|21|||
162943199|NCT02688400|588494423|FG001|Overall Study|Adverse Event|12|||
162943200|NCT02688400|588494422|FG000|Overall Study|Withdrawal by Subject|15|||
162943201|NCT02688400|588494423|FG001|Overall Study|Withdrawal by Subject|13|||
162943202|NCT02688400|588494422|FG000|Overall Study|No study medication intake|1|||
162943203|NCT02688400|588494423|FG001|Overall Study|No study medication intake|4|||
162943204|NCT02688400|588494422|FG000|Overall Study|Lost to Follow-up|0|||
162943205|NCT02688400|588494423|FG001|Overall Study|Lost to Follow-up|3|||
162943206|NCT03519256|588494436|FG000|Overall Study|Disease recurrence|4|||
162943207|NCT03519256|588494437|FG001|Overall Study|Disease recurrence|4|||
162943208|NCT03519256|588494438|FG002|Overall Study|Disease recurrence|5|||
162943209|NCT03519256|588494439|FG003|Overall Study|Disease recurrence|2|||
162943210|NCT03519256|588494436|FG000|Overall Study|Study drug toxicity|0|||
162943211|NCT03519256|588494437|FG001|Overall Study|Study drug toxicity|2|||
162943212|NCT03519256|588494438|FG002|Overall Study|Study drug toxicity|5|||
162943213|NCT03519256|588494439|FG003|Overall Study|Study drug toxicity|2|||
162943214|NCT03519256|588494436|FG000|Overall Study|Adverse event unrelated to study drug|0|||
163185921|NCT00751621|589397640|FG000|Overall Study|Adverse Event|1|||
163185922|NCT00751621|589397640|FG000|Overall Study|Withdrawal by Subject|1|||
163185923|NCT00751621|589397640|FG000|Overall Study|Subject moved to another country|1|||
163185924|NCT00751621|589397640|FG000|Overall Study|Poor adherence to asthma treatment|1|||
163185925|NCT03719586|589397641|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
163185926|NCT03719586|589397642|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
163185927|NCT03719586|589397643|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
162943215|NCT03519256|588494437|FG001|Overall Study|Adverse event unrelated to study drug|1|||
162943216|NCT03519256|588494438|FG002|Overall Study|Adverse event unrelated to study drug|1|||
162943217|NCT03519256|588494439|FG003|Overall Study|Adverse event unrelated to study drug|0|||
162943218|NCT03519256|588494436|FG000|Overall Study|Participant request to discontinue study treatment|0|||
162943219|NCT03519256|588494437|FG001|Overall Study|Participant request to discontinue study treatment|0|||
162943220|NCT03519256|588494438|FG002|Overall Study|Participant request to discontinue study treatment|0|||
162943221|NCT03519256|588494439|FG003|Overall Study|Participant request to discontinue study treatment|2|||
162943222|NCT03519256|588494436|FG000|Overall Study|Other reasons|0|||
162943223|NCT03519256|588494437|FG001|Overall Study|Other reasons|0|||
162943224|NCT03519256|588494438|FG002|Overall Study|Other reasons|2|||
162943225|NCT03519256|588494439|FG003|Overall Study|Other reasons|0|||
162943226|NCT03519256|588494436|FG000|Overall Study|Disease progression|6|||
162943227|NCT03519256|588494437|FG001|Overall Study|Disease progression|3|||
163290800|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
162943228|NCT03519256|588494438|FG002|Overall Study|Disease progression|2|||
162943229|NCT03519256|588494439|FG003|Overall Study|Disease progression|1|||
162943230|NCT03519256|588494436|FG000|Overall Study|Lost to Follow-up|0|||
163185928|NCT03719586|589397644|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
163185929|NCT02791594|589397645|FG000|Overall Study|Physician Decision|2|||
163185930|NCT02310321|589397646|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
163185931|NCT02310321|589397647|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
163185932|NCT02310321|589397648|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
163185933|NCT02310321|589397646|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
163185934|NCT02310321|589397647|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
163185935|NCT02310321|589397648|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
163185936|NCT02310321|589397646|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
163185937|NCT02310321|589397647|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
163185938|NCT02310321|589397648|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
163185939|NCT02310321|589397646|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
163185940|NCT02310321|589397647|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
163185941|NCT02310321|589397648|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
163185942|NCT02310321|589397646|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
163185943|NCT02310321|589397647|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
163185944|NCT02310321|589397648|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
163185945|NCT02310321|589397646|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
163185946|NCT02310321|589397647|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
163185947|NCT02310321|589397648|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
163185948|NCT02310321|589397646|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
163185949|NCT02310321|589397647|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
163185950|NCT02310321|589397648|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
163185951|NCT02310321|589397646|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
163185952|NCT02310321|589397647|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
163185953|NCT02310321|589397648|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
163185954|NCT02310321|589397646|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
163185955|NCT02310321|589397647|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
163185956|NCT02310321|589397648|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
163185957|NCT02310321|589397646|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
163185958|NCT02310321|589397647|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
163185959|NCT02310321|589397648|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
163185960|NCT02310321|589397646|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
163185961|NCT02310321|589397647|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
163185962|NCT02310321|589397648|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
163185963|NCT02310321|589397646|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
163185964|NCT02310321|589397647|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
163185965|NCT02310321|589397648|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
163185966|NCT02310321|589397646|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
163185967|NCT02310321|589397647|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
163185968|NCT02310321|589397648|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
163185969|NCT02310321|589397646|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
163185970|NCT02310321|589397647|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
163185971|NCT02310321|589397648|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
163185972|NCT02310321|589397646|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
163185973|NCT02310321|589397647|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
163185974|NCT02310321|589397648|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
163185975|NCT02310321|589397646|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
163185976|NCT02310321|589397647|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
163185977|NCT02310321|589397648|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
163185978|NCT02310321|589397646|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
163185979|NCT02310321|589397647|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
163185980|NCT02310321|589397648|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
163185981|NCT02310321|589397646|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
163185982|NCT02310321|589397647|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
163185983|NCT02310321|589397648|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
163290801|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
163290802|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
163290803|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
163290804|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
163290805|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
162943231|NCT03519256|588494437|FG001|Overall Study|Lost to Follow-up|1|||
162943232|NCT03519256|588494438|FG002|Overall Study|Lost to Follow-up|0|||
162943233|NCT03519256|588494439|FG003|Overall Study|Lost to Follow-up|0|||
162943234|NCT02207231|588494440|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
162943235|NCT02207231|588494441|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
162943236|NCT02207231|588494442|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
162943237|NCT02207231|588494443|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
162943238|NCT02207231|588494440|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
162943239|NCT02207231|588494441|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
162943240|NCT02207231|588494442|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
162943241|NCT02207231|588494443|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
162943242|NCT02207231|588494440|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
162943243|NCT02207231|588494441|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
162943244|NCT02207231|588494442|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
162943245|NCT02207231|588494443|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
162943246|NCT02207231|588494440|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
162943247|NCT02207231|588494441|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
162943248|NCT02207231|588494442|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
162943249|NCT02207231|588494443|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
162943250|NCT02207231|588494440|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
162943251|NCT02207231|588494441|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
162943252|NCT02207231|588494442|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
162943253|NCT02207231|588494443|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
162943254|NCT02207231|588494440|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
162943255|NCT02207231|588494441|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
162943256|NCT02207231|588494442|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
162943257|NCT02207231|588494443|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
162943258|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
162943259|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
162943260|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
162943261|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
162943262|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
162943263|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
162943264|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
162943265|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
162943266|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
162943267|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
162943268|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
162943269|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
162943270|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
162943271|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
162943272|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
162943273|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
162943274|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
162943275|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
162943276|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
162943277|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
162943278|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
162943279|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
162943280|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
162943281|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
162943282|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
162943283|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
162943284|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
162943285|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
162943286|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
162943287|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
162943288|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
162943289|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
162943290|NCT02207231|588494440|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
162943291|NCT02207231|588494441|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
162943292|NCT02207231|588494442|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
162943293|NCT02207231|588494443|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
162943294|NCT02207231|588494440|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
162943295|NCT02207231|588494441|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
162943296|NCT02207231|588494442|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
162943297|NCT02207231|588494443|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
162943298|NCT02207231|588494440|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
162943299|NCT02207231|588494441|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
162943300|NCT02207231|588494442|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
163290806|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
163290807|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
163290808|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
163290809|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
163290810|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
163290811|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
163290812|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163290813|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
163290814|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163290815|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163290816|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163290817|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163290818|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163290819|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163290820|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163290821|NCT01212757|589768419|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
163290822|NCT01212757|589768420|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
163290823|NCT01212757|589768421|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
163290824|NCT01212757|589768422|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
163290825|NCT01212757|589768423|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
163290826|NCT01212757|589768424|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
163290827|NCT01212757|589768425|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
163290828|NCT01212757|589768426|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
163290829|NCT01212757|589768427|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
163290830|NCT01049503|589771121|FG000|Overall Study|Lost to Follow-up|11|||
163290831|NCT01049503|589771122|FG001|Overall Study|Lost to Follow-up|12|||
163290832|NCT01049503|589771123|FG002|Overall Study|Lost to Follow-up|24|||
163290833|NCT01049503|589771124|FG003|Overall Study|Lost to Follow-up|26|||
163290834|NCT01049503|589771125|FG004|Overall Study|Lost to Follow-up|27|||
163290835|NCT01049503|589771126|FG005|Overall Study|Lost to Follow-up|8|||
163290836|NCT01070888|589771132|FG000|First Intervention (14 Days)|Adverse Event|0|||
163290837|NCT01070888|589771133|FG001|First Intervention (14 Days)|Adverse Event|1|||
163290838|NCT01070888|589771132|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
163290839|NCT01070888|589771133|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
163290840|NCT01070888|589771132|FG000|Washout (14 Days)|Physician Decision|1|||
163290841|NCT01070888|589771133|FG001|Washout (14 Days)|Physician Decision|0|||
163290842|NCT02525796|589771137|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
163290843|NCT02525796|589771138|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
163290844|NCT02525796|589771139|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
163290845|NCT02525796|589771137|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
163290846|NCT02525796|589771138|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
163290847|NCT02525796|589771139|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
163290848|NCT02525796|589771137|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
163290849|NCT02525796|589771138|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
163290850|NCT02525796|589771139|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
163290851|NCT02525796|589771137|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
163290852|NCT02525796|589771138|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
163290853|NCT02525796|589771139|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
163290854|NCT02525796|589771137|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
163290855|NCT02525796|589771138|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
163290856|NCT02525796|589771139|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
163290857|NCT00726999|589771142|FG000|Overall Study|Physician Decision|0|||
163290858|NCT00726999|589771143|FG001|Overall Study|Physician Decision|1|||
163290859|NCT00726999|589771142|FG000|Overall Study|Withdrawal by Subject|2|||
163290860|NCT00726999|589771143|FG001|Overall Study|Withdrawal by Subject|0|||
163290861|NCT00726999|589771142|FG000|Overall Study|Protocol Violation|1|||
163290862|NCT00726999|589771143|FG001|Overall Study|Protocol Violation|0|||
163290863|NCT01198275|589771144|FG000|Overall Study|Adverse Event|2|||
163290864|NCT01198275|589771145|FG001|Overall Study|Adverse Event|3|||
163290865|NCT01198275|589771144|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
163387593|NCT02202551|590129967|FG003|Overall Study|Unable to complete visits per protocol|0|||
163290866|NCT01198275|589771145|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
163290867|NCT00391846|589771146|FG000|Overall Study|Adverse Event|4|||
163290868|NCT00391846|589771147|FG001|Overall Study|Adverse Event|1|||
163290869|NCT00391846|589771146|FG000|Overall Study|Did not meet the required elig. crit|2|||
163387594|NCT02202551|590129964|FG000|Overall Study|Worsening Dyskinesia|0|||
162943301|NCT02207231|588494443|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
163290870|NCT00391846|589771147|FG001|Overall Study|Did not meet the required elig. crit|2|||
163290871|NCT00391846|589771146|FG000|Overall Study|Withdrawal by Subject|2|||
163290872|NCT00391846|589771147|FG001|Overall Study|Withdrawal by Subject|3|||
162943302|NCT02207231|588494440|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
162943303|NCT02207231|588494441|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
162943304|NCT02207231|588494442|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
162943305|NCT02207231|588494443|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
162943306|NCT02207231|588494440|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
162943307|NCT02207231|588494441|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
162943308|NCT02207231|588494442|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
162943309|NCT02207231|588494443|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
162943310|NCT02207231|588494440|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
162943311|NCT02207231|588494441|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
162943312|NCT02207231|588494442|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
162943313|NCT02207231|588494443|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
162943314|NCT02207231|588494440|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
162943315|NCT02207231|588494441|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
162943316|NCT02207231|588494442|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
162943317|NCT02207231|588494443|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
162943318|NCT00421174|588494444|FG000|Overall Study|Withdrawal by Subject|0|||
162943319|NCT00421174|588494445|FG001|Overall Study|Withdrawal by Subject|1|||
162943320|NCT00421174|588494444|FG000|Overall Study|Ineligible due to infection|2|||
162943321|NCT00421174|588494445|FG001|Overall Study|Ineligible due to infection|0|||
162943322|NCT01290263|588494448|FG000|Overall Study|Adverse Event|0|||
162943323|NCT01290263|588494449|FG001|Overall Study|Adverse Event|0|||
162943324|NCT01290263|588494450|FG002|Overall Study|Adverse Event|0|||
162943325|NCT01290263|588494451|FG003|Overall Study|Adverse Event|1|||
162943326|NCT01290263|588494452|FG004|Overall Study|Adverse Event|1|||
162943327|NCT01290263|588494448|FG000|Overall Study|Lack of Efficacy|8|||
162943328|NCT01290263|588494449|FG001|Overall Study|Lack of Efficacy|2|||
162943329|NCT01290263|588494450|FG002|Overall Study|Lack of Efficacy|7|||
162943330|NCT01290263|588494451|FG003|Overall Study|Lack of Efficacy|24|||
162943331|NCT01290263|588494452|FG004|Overall Study|Lack of Efficacy|33|||
162943332|NCT01290263|588494448|FG000|Overall Study|Withdrawal by Subject|3|||
162943333|NCT01290263|588494449|FG001|Overall Study|Withdrawal by Subject|1|||
162943334|NCT01290263|588494450|FG002|Overall Study|Withdrawal by Subject|0|||
162943335|NCT01290263|588494451|FG003|Overall Study|Withdrawal by Subject|1|||
162943336|NCT01290263|588494452|FG004|Overall Study|Withdrawal by Subject|2|||
162943337|NCT01290263|588494448|FG000|Overall Study|Participant Non-Compliance|0|||
162943338|NCT01290263|588494449|FG001|Overall Study|Participant Non-Compliance|0|||
162943339|NCT01290263|588494450|FG002|Overall Study|Participant Non-Compliance|0|||
162943340|NCT01290263|588494451|FG003|Overall Study|Participant Non-Compliance|1|||
162943341|NCT01290263|588494452|FG004|Overall Study|Participant Non-Compliance|1|||
162943342|NCT02309099|588494453|FG000|Overall Study|Adverse Event|2|||
162943343|NCT02309099|588494454|FG001|Overall Study|Adverse Event|0|||
162943344|NCT01545076|588494455|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
162943345|NCT01545076|588494456|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
162943346|NCT01545076|588494457|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
162943347|NCT01545076|588494458|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
162943348|NCT01545076|588494459|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
163290873|NCT00391846|589771146|FG000|Overall Study|Developed study specific DC criteria|0|||
163290874|NCT00391846|589771147|FG001|Overall Study|Developed study specific DC criteria|1|||
163290875|NCT02477670|589771151|FG000|Stage 1|Adverse Event|2|||
163290876|NCT02477670|589771152|FG001|Stage 1|Adverse Event|7|||
163290877|NCT02477670|589771153|FG002|Stage 1|Adverse Event|0|||
163290878|NCT02477670|589771154|FG003|Stage 1|Adverse Event|0|||
163290879|NCT02477670|589771155|FG004|Stage 1|Adverse Event|0|||
162943349|NCT01545076|588494455|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
163290880|NCT02477670|589771156|FG005|Stage 1|Adverse Event|0|||
162943350|NCT01545076|588494456|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
162943351|NCT01545076|588494457|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
162943352|NCT01545076|588494458|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
163290881|NCT02477670|589771157|FG006|Stage 1|Adverse Event|0|||
162943353|NCT01545076|588494459|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
162943354|NCT01545076|588494455|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
163290882|NCT02477670|589771151|FG000|Stage 1|Lost to Follow-up|0|||
162943355|NCT01545076|588494456|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
162943356|NCT01545076|588494457|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
162943357|NCT01545076|588494458|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
162943358|NCT01545076|588494459|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
163290883|NCT02477670|589771152|FG001|Stage 1|Lost to Follow-up|2|||
163290884|NCT02477670|589771153|FG002|Stage 1|Lost to Follow-up|0|||
163290885|NCT02477670|589771154|FG003|Stage 1|Lost to Follow-up|0|||
163290886|NCT02477670|589771155|FG004|Stage 1|Lost to Follow-up|0|||
163290887|NCT02477670|589771156|FG005|Stage 1|Lost to Follow-up|0|||
163290888|NCT02477670|589771157|FG006|Stage 1|Lost to Follow-up|0|||
163290889|NCT02477670|589771151|FG000|Stage 1|Withdrawal by Subject|1|||
163290890|NCT02477670|589771152|FG001|Stage 1|Withdrawal by Subject|2|||
163290891|NCT02477670|589771153|FG002|Stage 1|Withdrawal by Subject|0|||
163290892|NCT02477670|589771154|FG003|Stage 1|Withdrawal by Subject|0|||
163290893|NCT02477670|589771155|FG004|Stage 1|Withdrawal by Subject|0|||
163290894|NCT02477670|589771156|FG005|Stage 1|Withdrawal by Subject|0|||
163290895|NCT02477670|589771157|FG006|Stage 1|Withdrawal by Subject|0|||
163290896|NCT02477670|589771151|FG000|Stage 1|Non-compliance with Study Drug|1|||
163290897|NCT02477670|589771152|FG001|Stage 1|Non-compliance with Study Drug|2|||
163290898|NCT02477670|589771153|FG002|Stage 1|Non-compliance with Study Drug|0|||
163290899|NCT02477670|589771154|FG003|Stage 1|Non-compliance with Study Drug|0|||
163290900|NCT02477670|589771155|FG004|Stage 1|Non-compliance with Study Drug|0|||
163290901|NCT02477670|589771156|FG005|Stage 1|Non-compliance with Study Drug|0|||
163290902|NCT02477670|589771157|FG006|Stage 1|Non-compliance with Study Drug|0|||
163290903|NCT02477670|589771151|FG000|Stage 2|Adverse Event|0|||
163290904|NCT02477670|589771152|FG001|Stage 2|Adverse Event|0|||
163290905|NCT02477670|589771153|FG002|Stage 2|Adverse Event|1|||
163290906|NCT02477670|589771154|FG003|Stage 2|Adverse Event|0|||
163290907|NCT02477670|589771155|FG004|Stage 2|Adverse Event|0|||
163290908|NCT02477670|589771156|FG005|Stage 2|Adverse Event|0|||
163290909|NCT02477670|589771157|FG006|Stage 2|Adverse Event|0|||
163290910|NCT02477670|589771151|FG000|Stage 2|Antipsychotic Medication Changed|0|||
163290911|NCT02477670|589771152|FG001|Stage 2|Antipsychotic Medication Changed|0|||
163290912|NCT02477670|589771153|FG002|Stage 2|Antipsychotic Medication Changed|1|||
163290913|NCT02477670|589771154|FG003|Stage 2|Antipsychotic Medication Changed|0|||
163290914|NCT02477670|589771155|FG004|Stage 2|Antipsychotic Medication Changed|0|||
163290915|NCT02477670|589771156|FG005|Stage 2|Antipsychotic Medication Changed|0|||
163290916|NCT02477670|589771157|FG006|Stage 2|Antipsychotic Medication Changed|0|||
163290917|NCT02477670|589771151|FG000|Stage 2|Withdrawal by Subject|0|||
163290918|NCT02477670|589771152|FG001|Stage 2|Withdrawal by Subject|0|||
163290919|NCT02477670|589771153|FG002|Stage 2|Withdrawal by Subject|0|||
163290920|NCT02477670|589771154|FG003|Stage 2|Withdrawal by Subject|1|||
163290921|NCT02477670|589771155|FG004|Stage 2|Withdrawal by Subject|0|||
163290922|NCT02477670|589771156|FG005|Stage 2|Withdrawal by Subject|0|||
163290923|NCT02477670|589771157|FG006|Stage 2|Withdrawal by Subject|0|||
163290924|NCT00970307|589771158|FG000|Overall Study|Serious Adverse Event|1|||
163290925|NCT00970307|589771159|FG001|Overall Study|Serious Adverse Event|0|||
163290926|NCT00970307|589771160|FG002|Overall Study|Serious Adverse Event|0|||
163290927|NCT00970307|589771158|FG000|Overall Study|Withdrawal by Subject|2|||
163290928|NCT00970307|589771159|FG001|Overall Study|Withdrawal by Subject|3|||
163290929|NCT00970307|589771160|FG002|Overall Study|Withdrawal by Subject|2|||
163290930|NCT02810080|589771161|FG000|Overall Study|Adverse Event|3|||
163290931|NCT02810080|589771162|FG001|Overall Study|Adverse Event|0|||
163290932|NCT02810080|589771161|FG000|Overall Study|Death|0|||
163290933|NCT02810080|589771162|FG001|Overall Study|Death|2|||
163290934|NCT02810080|589771161|FG000|Overall Study|Physician Decision|4|||
163290935|NCT02810080|589771162|FG001|Overall Study|Physician Decision|0|||
163290936|NCT02810080|589771161|FG000|Overall Study|Withdrawal by Subject|0|||
163290937|NCT02810080|589771162|FG001|Overall Study|Withdrawal by Subject|2|||
163290938|NCT01759264|589771163|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
163290939|NCT01759264|589771163|FG000|Overall Study|Adverse Event|1|||
163290940|NCT01759264|589771163|FG000|Overall Study|Other|2|||
163290941|NCT01759264|589771163|FG000|Overall Study|Lost to Follow-up|2|||
163290942|NCT01759264|589771163|FG000|Overall Study|Withdrawal by Subject|3|||
163290943|NCT01759264|589771163|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
163290944|NCT05174013|589771168|FG000|Overall Study|Lost to Follow-up|0|||
163290945|NCT05174013|589771169|FG001|Overall Study|Lost to Follow-up|0|||
163290946|NCT05174013|589771170|FG002|Overall Study|Lost to Follow-up|0|||
163290947|NCT05174013|589771171|FG003|Overall Study|Lost to Follow-up|1|||
163290948|NCT05174013|589771172|FG004|Overall Study|Lost to Follow-up|0|||
163290949|NCT05174013|589771173|FG005|Overall Study|Lost to Follow-up|0|||
163290950|NCT05174013|589771168|FG000|Overall Study|Withdrawal by Subject|0|||
163290951|NCT05174013|589771169|FG001|Overall Study|Withdrawal by Subject|0|||
163290952|NCT05174013|589771170|FG002|Overall Study|Withdrawal by Subject|1|||
163290953|NCT05174013|589771171|FG003|Overall Study|Withdrawal by Subject|0|||
163290954|NCT05174013|589771172|FG004|Overall Study|Withdrawal by Subject|0|||
163290955|NCT05174013|589771173|FG005|Overall Study|Withdrawal by Subject|0|||
163290956|NCT02034916|589771174|FG000|Overall Study|Death|39|||
163290957|NCT02034916|589771175|FG001|Overall Study|Death|28|||
163290958|NCT02034916|589771174|FG000|Overall Study|Withdrawal by Subject|2|||
163290959|NCT02034916|589771175|FG001|Overall Study|Withdrawal by Subject|1|||
163290960|NCT02034916|589771174|FG000|Overall Study|Lost to Follow-up|4|||
163290961|NCT02034916|589771175|FG001|Overall Study|Lost to Follow-up|1|||
163290962|NCT02034916|589771174|FG000|Overall Study|Study terminated by sponsor|4|||
163290963|NCT02034916|589771175|FG001|Overall Study|Study terminated by sponsor|5|||
163290964|NCT00753012|589771179|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
163290965|NCT00753012|589771180|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
163290966|NCT00753012|589771179|FG000|Overall Study|Adverse Event|2|||
163290967|NCT00753012|589771180|FG001|Overall Study|Adverse Event|0|||
163290968|NCT00753012|589771179|FG000|Overall Study|Withdrawal by Subject|0|||
163290969|NCT00753012|589771180|FG001|Overall Study|Withdrawal by Subject|1|||
163290970|NCT00753012|589771179|FG000|Overall Study|Lost to Follow-up|4|||
163290971|NCT00753012|589771180|FG001|Overall Study|Lost to Follow-up|0|||
163290972|NCT00753012|589771179|FG000|Overall Study|Confounded endpoint data|1|||
163290973|NCT00753012|589771180|FG001|Overall Study|Confounded endpoint data|0|||
163290974|NCT01930045|589771181|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
163290975|NCT01930045|589771182|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
163290976|NCT01930045|589771183|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
163290977|NCT01930045|589771184|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
163290978|NCT01930045|589771185|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
163290979|NCT01930045|589771186|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
163290980|NCT01930045|589771181|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
163290981|NCT01930045|589771182|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
163290982|NCT01930045|589771183|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
163290983|NCT01930045|589771184|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
163290984|NCT01930045|589771185|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
163290985|NCT01930045|589771186|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
163290986|NCT00241644|589771187|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
163290987|NCT00241644|589771188|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
163290988|NCT00241644|589771189|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
163290989|NCT00241644|589771190|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
163290990|NCT00241644|589771187|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
163290991|NCT00241644|589771188|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
163290992|NCT00241644|589771189|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
163290993|NCT00241644|589771190|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
163290994|NCT00241644|589771187|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
163290995|NCT00241644|589771188|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
163290996|NCT00241644|589771189|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
163290997|NCT00241644|589771190|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
163290998|NCT00241644|589771187|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
163290999|NCT00241644|589771188|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
163291000|NCT00241644|589771189|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
163291001|NCT00241644|589771190|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
163291002|NCT00241644|589771187|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
163291003|NCT00241644|589771188|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
163291004|NCT00241644|589771189|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
163291005|NCT00241644|589771190|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
163291006|NCT00241644|589771187|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
163291007|NCT00241644|589771188|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
163291008|NCT00241644|589771189|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
163291009|NCT00241644|589771190|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
163291010|NCT00241644|589771187|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
163291011|NCT00241644|589771188|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
163291012|NCT00241644|589771189|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
163291013|NCT00241644|589771190|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
163291014|NCT00241644|589771187|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
163291015|NCT00241644|589771188|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
163291016|NCT00241644|589771189|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
163291017|NCT00241644|589771190|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
163291018|NCT00241644|589771187|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
163185984|NCT02310321|589397646|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
163185985|NCT02310321|589397647|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
163185986|NCT02310321|589397648|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
163185987|NCT02310321|589397646|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
163185988|NCT02310321|589397647|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
163185989|NCT02310321|589397648|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
163185990|NCT02310321|589397646|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
163185991|NCT02310321|589397647|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
163185992|NCT02310321|589397648|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
163185993|NCT02310321|589397646|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
163185994|NCT02310321|589397647|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
163185995|NCT02310321|589397648|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
163185996|NCT02310321|589397646|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
163185997|NCT02310321|589397647|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
163185998|NCT02310321|589397648|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
163185999|NCT04950166|589397649|FG000|Overall Study|Withdrawal by Subject|1|||
163186000|NCT01698905|589397650|FG000|Overall Study|Adverse Event|4|||
163186001|NCT01698905|589397650|FG000|Overall Study|Physician Decision|2|||
163186002|NCT01698905|589397650|FG000|Overall Study|Pregnancy|1|||
163186003|NCT01698905|589397650|FG000|Overall Study|Protocol Violation|1|||
163186004|NCT01698905|589397650|FG000|Overall Study|Subject/guardian decision|2|||
162943359|NCT01545076|588494455|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
163186005|NCT01698905|589397650|FG000|Overall Study|Death|1|||
163186006|NCT05896748|589397651|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
163291019|NCT00241644|589771188|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
163291020|NCT00241644|589771189|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
163291021|NCT00241644|589771190|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
162943360|NCT01545076|588494456|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
162943361|NCT01545076|588494457|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
162943362|NCT01545076|588494458|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
162943363|NCT01545076|588494459|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
162943364|NCT01545076|588494455|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
162943365|NCT01545076|588494456|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
162943366|NCT01545076|588494457|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
162943367|NCT01545076|588494458|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
162943368|NCT01545076|588494459|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
162943369|NCT01545076|588494455|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
162943370|NCT01545076|588494456|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
162943371|NCT01545076|588494457|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
162943372|NCT01545076|588494458|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
162943373|NCT01545076|588494459|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
162943374|NCT01545076|588494455|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
162943375|NCT01545076|588494456|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
162943376|NCT01545076|588494457|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
162943377|NCT01545076|588494458|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
162943378|NCT01545076|588494459|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
162943379|NCT01545076|588494455|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
162943380|NCT01545076|588494456|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
162943381|NCT01545076|588494457|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
162943382|NCT01545076|588494458|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
162943383|NCT01545076|588494459|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
162943384|NCT01545076|588494455|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
162943385|NCT01545076|588494456|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
162943386|NCT01545076|588494457|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
162943387|NCT01545076|588494458|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
162943388|NCT01545076|588494459|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
162943389|NCT00797108|588494463|FG000|Overall Study|Adverse Event|1|||
162943390|NCT00797108|588494464|FG001|Overall Study|Adverse Event|0|||
162943391|NCT00797108|588494465|FG002|Overall Study|Adverse Event|3|||
162943392|NCT00797108|588494463|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
162943393|NCT00797108|588494464|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
162943394|NCT00797108|588494465|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
162943395|NCT00797108|588494463|FG000|Overall Study|Global Deterioration of Health Status|0|||
162943396|NCT00797108|588494464|FG001|Overall Study|Global Deterioration of Health Status|1|||
162943397|NCT00797108|588494465|FG002|Overall Study|Global Deterioration of Health Status|0|||
162943398|NCT00797108|588494463|FG000|Overall Study|Lack of Efficacy|1|||
162943399|NCT00797108|588494464|FG001|Overall Study|Lack of Efficacy|0|||
162943400|NCT00797108|588494465|FG002|Overall Study|Lack of Efficacy|1|||
162943401|NCT00797108|588494463|FG000|Overall Study|Other|0|||
162943402|NCT00797108|588494464|FG001|Overall Study|Other|0|||
162943403|NCT00797108|588494465|FG002|Overall Study|Other|2|||
162943404|NCT00797108|588494463|FG000|Overall Study|Randomized but not Treated|2|||
162943405|NCT00797108|588494464|FG001|Overall Study|Randomized but not Treated|0|||
162943406|NCT00797108|588494465|FG002|Overall Study|Randomized but not Treated|0|||
162943407|NCT01031537|588494466|FG000|Overall Study|medical reasons not related to study|3|||
162943408|NCT01031537|588494466|FG000|Overall Study|Lack of Efficacy|1|||
162943409|NCT01031537|588494466|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
162943410|NCT01031537|588494466|FG000|Overall Study|moved, met exclusion criteria|10|||
162943411|NCT01031537|588494466|FG000|Overall Study|Withdrawal by Subject|5|||
162943412|NCT01031537|588494466|FG000|Overall Study|PI removal, no longer met eligibility|12|||
162943413|NCT00561730|588494475|FG000|Overall Study|Adverse Event|2|||
162943414|NCT00561730|588494475|FG000|Overall Study|Handling of the drug|1|||
162943415|NCT00561730|588494475|FG000|Overall Study|Lost to Follow-up|5|||
162943416|NCT00561730|588494475|FG000|Overall Study|Not specified reasons|1|||
162943417|NCT03194464|588494476|FG000|Overall Study|data not usable|2|||
162943418|NCT03594123|588494477|FG000|Overall Study|Lost to Follow-up|0|||
162943419|NCT03594123|588494478|FG001|Overall Study|Lost to Follow-up|1|||
162943420|NCT03594123|588494477|FG000|Overall Study|Adverse Event|8|||
162943421|NCT03594123|588494478|FG001|Overall Study|Adverse Event|5|||
162943422|NCT03594123|588494477|FG000|Overall Study|Site Terminated by Sponsor|4|||
162943423|NCT03594123|588494478|FG001|Overall Study|Site Terminated by Sponsor|1|||
163291022|NCT00241644|589771187|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
162943424|NCT03594123|588494477|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
162943425|NCT03594123|588494478|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
162943426|NCT03594123|588494477|FG000|Overall Study|Lack of Efficacy|1|||
163291023|NCT00241644|589771188|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
163291024|NCT00241644|589771189|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
162943427|NCT03594123|588494478|FG001|Overall Study|Lack of Efficacy|0|||
162943428|NCT03594123|588494477|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
162943429|NCT03594123|588494478|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
162943430|NCT01766921|588494479|FG000|Overall Study|Administrative Reason|5|||
162943431|NCT01766921|588494480|FG001|Overall Study|Administrative Reason|5|||
162943432|NCT01766921|588494479|FG000|Overall Study|Death|1|||
162943433|NCT01766921|588494480|FG001|Overall Study|Death|1|||
162943434|NCT01766921|588494479|FG000|Overall Study|Lost to Follow-up|1|||
162943435|NCT01766921|588494480|FG001|Overall Study|Lost to Follow-up|3|||
162943436|NCT01766921|588494479|FG000|Overall Study|Unclassified|2|||
162943437|NCT01766921|588494480|FG001|Overall Study|Unclassified|2|||
162943438|NCT01766921|588494479|FG000|Overall Study|Protocol Violation|1|||
162943439|NCT01766921|588494480|FG001|Overall Study|Protocol Violation|1|||
162943440|NCT01766921|588494479|FG000|Overall Study|Withdrawal by Subject|14|||
162943441|NCT01766921|588494480|FG001|Overall Study|Withdrawal by Subject|5|||
162943442|NCT02549495|588494486|FG000|Overall Study|Death|2|||
162943443|NCT02549495|588494486|FG000|Overall Study|Withdrawal by Subject|5|||
162943444|NCT02549495|588494486|FG000|Overall Study|Physician Decision|22|||
162943445|NCT02549495|588494486|FG000|Overall Study|Lost to Follow-up|6|||
162943446|NCT02549495|588494486|FG000|Overall Study|Protocol Violation|6|||
162943447|NCT03276975|588494489|FG000|Overall Study|Withdrawal by Subject|1|||
162943448|NCT03276975|588494490|FG001|Overall Study|Withdrawal by Subject|0|||
162943449|NCT01463683|588494491|FG000|Overall Study|Adverse Event|2|||
162943450|NCT01463683|588494492|FG001|Overall Study|Adverse Event|0|||
162943451|NCT01463683|588494493|FG002|Overall Study|Adverse Event|0|||
162943452|NCT01463683|588494491|FG000|Overall Study|Lost to Follow-up|10|||
162943453|NCT01463683|588494492|FG001|Overall Study|Lost to Follow-up|9|||
162943454|NCT01463683|588494493|FG002|Overall Study|Lost to Follow-up|7|||
162943455|NCT01463683|588494491|FG000|Overall Study|Physician Decision|0|||
162943456|NCT01463683|588494492|FG001|Overall Study|Physician Decision|3|||
162943457|NCT01463683|588494493|FG002|Overall Study|Physician Decision|1|||
162943458|NCT01463683|588494491|FG000|Overall Study|Pregnancy|2|||
162943459|NCT01463683|588494492|FG001|Overall Study|Pregnancy|2|||
162943460|NCT01463683|588494493|FG002|Overall Study|Pregnancy|1|||
162943461|NCT01463683|588494491|FG000|Overall Study|Withdrawal by Subject|5|||
162943462|NCT01463683|588494492|FG001|Overall Study|Withdrawal by Subject|17|||
162943463|NCT01463683|588494493|FG002|Overall Study|Withdrawal by Subject|2|||
162943464|NCT03111147|588494494|FG000|Overall Study|Lost to Follow-up|2|||
162943465|NCT03111147|588494495|FG001|Overall Study|Lost to Follow-up|5|||
162943466|NCT03111147|588494494|FG000|Overall Study|Withdrawal by Subject|4|||
162943467|NCT03111147|588494495|FG001|Overall Study|Withdrawal by Subject|3|||
162943468|NCT03111147|588494494|FG000|Overall Study|Protocol Violation|2|||
162943469|NCT03111147|588494495|FG001|Overall Study|Protocol Violation|1|||
162943470|NCT03111147|588494494|FG000|Overall Study|Death|1|||
162943471|NCT03111147|588494495|FG001|Overall Study|Death|1|||
162943472|NCT01058421|588494496|FG000|1 Month Outcomes|Death|10|||
162943473|NCT01058421|588494497|FG001|1 Month Outcomes|Death|6|||
162943474|NCT01058421|588494496|FG000|1 Month Outcomes|Lost to Follow-up|8|||
162943475|NCT01058421|588494497|FG001|1 Month Outcomes|Lost to Follow-up|7|||
162943476|NCT01058421|588494496|FG000|1 Month Outcomes|Remained in Hospital|5|||
162943477|NCT01058421|588494497|FG001|1 Month Outcomes|Remained in Hospital|12|||
162943478|NCT01058421|588494496|FG000|1 Month Outcomes|Remained in Other Facility|16|||
162943479|NCT01058421|588494497|FG001|1 Month Outcomes|Remained in Other Facility|17|||
163186007|NCT05896748|589397651|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
163186008|NCT05896748|589397651|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
163186009|NCT05896748|589397651|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
163186010|NCT05896748|589397651|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
163186011|NCT00857415|589397659|FG000|Overall Study|Image acquisition failure|2|||
163186012|NCT00857415|589397660|FG001|Overall Study|Image acquisition failure|0|||
163186013|NCT00857415|589397659|FG000|Overall Study|Invalid image or not imaged|3|||
163186014|NCT00857415|589397660|FG001|Overall Study|Invalid image or not imaged|0|||
162943480|NCT01058421|588494496|FG000|3 Month Outcomes|Death|3|||
162943481|NCT01058421|588494497|FG001|3 Month Outcomes|Death|5|||
162943482|NCT01058421|588494496|FG000|3 Month Outcomes|Lost to Follow-up|12|||
162943483|NCT01058421|588494497|FG001|3 Month Outcomes|Lost to Follow-up|11|||
162943484|NCT01058421|588494496|FG000|3 Month Outcomes|Remained in Hospital|0|||
162943485|NCT01058421|588494497|FG001|3 Month Outcomes|Remained in Hospital|2|||
162943486|NCT01058421|588494496|FG000|3 Month Outcomes|Remained in Other Facility|5|||
162943487|NCT01058421|588494497|FG001|3 Month Outcomes|Remained in Other Facility|8|||
162943488|NCT01058421|588494496|FG000|6 Month Outcomes|Death|2|||
162943489|NCT01058421|588494497|FG001|6 Month Outcomes|Death|2|||
163186015|NCT00857415|589397659|FG000|Overall Study|Subject still living at end of study|110|||
163186016|NCT00857415|589397660|FG001|Overall Study|Subject still living at end of study|0|||
163186017|NCT00857415|589397659|FG000|Overall Study|Deceased with no autopsy|2|||
163186018|NCT00857415|589397660|FG001|Overall Study|Deceased with no autopsy|0|||
163186019|NCT04508140|589397661|FG000|Overall Study|Adverse Event|2|||
163186020|NCT04508140|589397662|FG001|Overall Study|Adverse Event|2|||
163186021|NCT04508140|589397661|FG000|Overall Study|Withdrawal by Subject|0|||
162943490|NCT01058421|588494496|FG000|6 Month Outcomes|Lost to Follow-up|16|||
162943491|NCT01058421|588494497|FG001|6 Month Outcomes|Lost to Follow-up|21|||
162943492|NCT01058421|588494496|FG000|6 Month Outcomes|Remained in Other Facility|1|||
162943493|NCT01058421|588494497|FG001|6 Month Outcomes|Remained in Other Facility|3|||
162943494|NCT02779855|588494498|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
162943495|NCT02779855|588494499|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
162943496|NCT02779855|588494500|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
162943497|NCT00365352|588494507|FG000|Overall Study|Adverse Event|6|||
162943498|NCT00365352|588494508|FG001|Overall Study|Adverse Event|7|||
162943499|NCT00365352|588494509|FG002|Overall Study|Adverse Event|8|||
162943500|NCT00365352|588494507|FG000|Overall Study|Participant Withdrew Consent|8|||
162943501|NCT00365352|588494508|FG001|Overall Study|Participant Withdrew Consent|3|||
162943502|NCT00365352|588494509|FG002|Overall Study|Participant Withdrew Consent|4|||
162943503|NCT00365352|588494507|FG000|Overall Study|Lack of Efficacy|3|||
162943504|NCT00365352|588494508|FG001|Overall Study|Lack of Efficacy|0|||
162943505|NCT00365352|588494509|FG002|Overall Study|Lack of Efficacy|0|||
162943506|NCT00365352|588494507|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
162943507|NCT00365352|588494508|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
162943508|NCT00365352|588494509|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
162943509|NCT00365352|588494507|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
162943510|NCT00365352|588494508|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
162943511|NCT00365352|588494509|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
162943512|NCT00365352|588494507|FG000|Overall Study|Lost to Follow-up|1|||
162943513|NCT00365352|588494508|FG001|Overall Study|Lost to Follow-up|1|||
162943514|NCT00365352|588494509|FG002|Overall Study|Lost to Follow-up|0|||
162943515|NCT00365352|588494507|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
162943516|NCT00365352|588494508|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
162943517|NCT00365352|588494509|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
162943518|NCT02581345|588496170|FG000|Part 1: up to Week 16|Adverse Event|3|||
162943519|NCT02581345|588496171|FG001|Part 1: up to Week 16|Adverse Event|8|||
162943520|NCT02581345|588496172|FG002|Part 1: up to Week 16|Adverse Event|0|||
162943521|NCT02581345|588496173|FG003|Part 1: up to Week 16|Adverse Event|0|||
162943522|NCT02581345|588496170|FG000|Part 1: up to Week 16|Physician Decision|2|||
162943523|NCT02581345|588496171|FG001|Part 1: up to Week 16|Physician Decision|4|||
162943524|NCT02581345|588496172|FG002|Part 1: up to Week 16|Physician Decision|0|||
162943525|NCT02581345|588496173|FG003|Part 1: up to Week 16|Physician Decision|0|||
162943526|NCT02581345|588496170|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
162943527|NCT02581345|588496171|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
162943528|NCT02581345|588496172|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
163186022|NCT04508140|589397662|FG001|Overall Study|Withdrawal by Subject|2|||
163186023|NCT04508140|589397661|FG000|Overall Study|progressive disease|9|||
163186024|NCT04508140|589397662|FG001|Overall Study|progressive disease|3|||
163186025|NCT01822678|589397663|FG000|Overall Study|Withdrawal by Subject|5|||
163186026|NCT01822678|589397664|FG001|Overall Study|Withdrawal by Subject|4|||
163186027|NCT01822678|589397665|FG002|Overall Study|Withdrawal by Subject|4|||
163186028|NCT01822678|589397663|FG000|Overall Study|Adverse Event|4|||
163186029|NCT01822678|589397664|FG001|Overall Study|Adverse Event|3|||
163186030|NCT01822678|589397665|FG002|Overall Study|Adverse Event|1|||
163186031|NCT01822678|589397663|FG000|Overall Study|Lack of Efficacy|3|||
163186032|NCT01822678|589397664|FG001|Overall Study|Lack of Efficacy|6|||
163186033|NCT01822678|589397665|FG002|Overall Study|Lack of Efficacy|5|||
163186034|NCT01822678|589397663|FG000|Overall Study|Lost to Follow-up|0|||
163186035|NCT01822678|589397664|FG001|Overall Study|Lost to Follow-up|2|||
163186036|NCT01822678|589397665|FG002|Overall Study|Lost to Follow-up|1|||
163186037|NCT00764504|589397666|FG000|Overall Study|Death|12|||
163186038|NCT00764504|589397667|FG001|Overall Study|Death|6|||
163186039|NCT00764504|589397668|FG002|Overall Study|Death|13|||
163186040|NCT00764504|589397666|FG000|Overall Study|Revision of Device|12|||
163186041|NCT00764504|589397667|FG001|Overall Study|Revision of Device|23|||
163186042|NCT00764504|589397668|FG002|Overall Study|Revision of Device|14|||
163186043|NCT00764504|589397666|FG000|Overall Study|Physician Decision|1|||
163291025|NCT00241644|589771190|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
162943529|NCT02581345|588496173|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
162943530|NCT02581345|588496170|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
162943531|NCT02581345|588496171|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
162943532|NCT02581345|588496172|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
162943533|NCT02581345|588496173|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
162943534|NCT02581345|588496170|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
162943535|NCT02581345|588496171|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
163186044|NCT00764504|589397667|FG001|Overall Study|Physician Decision|0|||
163186045|NCT00764504|589397668|FG002|Overall Study|Physician Decision|0|||
163186046|NCT00764504|589397666|FG000|Overall Study|Withdrawal by Subject|1|||
163186047|NCT00764504|589397667|FG001|Overall Study|Withdrawal by Subject|7|||
163186048|NCT00764504|589397668|FG002|Overall Study|Withdrawal by Subject|4|||
163186049|NCT00764504|589397666|FG000|Overall Study|Lost to Follow-up|40|||
163186050|NCT00764504|589397667|FG001|Overall Study|Lost to Follow-up|34|||
163186051|NCT00764504|589397668|FG002|Overall Study|Lost to Follow-up|72|||
163186052|NCT02456103|589397672|FG000|Overall Study|Study Closure|207|||
163186053|NCT02456103|589397672|FG000|Overall Study|Physician Decision|1|||
163186054|NCT02456103|589397672|FG000|Overall Study|Required prohibited medications|5|||
163186055|NCT02456103|589397672|FG000|Overall Study|Protocol Violation|1|||
163186056|NCT02456103|589397672|FG000|Overall Study|Adverse Event|5|||
163186057|NCT02456103|589397672|FG000|Overall Study|Abnormal Laboratory Value|2|||
163186058|NCT02456103|589397672|FG000|Overall Study|Lost to Follow-up|1|||
163186059|NCT02456103|589397672|FG000|Overall Study|Withdrawal by Subject|24|||
163186060|NCT01465191|589397673|FG000|Overall Study|Protocol Violation|6|||
163186061|NCT01465191|589397674|FG001|Overall Study|Protocol Violation|3|||
163186062|NCT01465191|589397675|FG002|Overall Study|Protocol Violation|3|||
163186063|NCT01465191|589397673|FG000|Overall Study|Lost to Follow-up|3|||
163186064|NCT01465191|589397674|FG001|Overall Study|Lost to Follow-up|6|||
163186065|NCT01465191|589397675|FG002|Overall Study|Lost to Follow-up|4|||
163186066|NCT03614975|589397676|FG000|Overall Study|Physician Decision|7|||
163186067|NCT03614975|589397677|FG001|Overall Study|Physician Decision|5|||
163186068|NCT03614975|589397676|FG000|Overall Study|Withdrawal by Subject|2|||
163186069|NCT03614975|589397677|FG001|Overall Study|Withdrawal by Subject|2|||
163186070|NCT03614975|589397676|FG000|Overall Study|Specimens not in lab batch shipment|1|||
163186071|NCT03614975|589397677|FG001|Overall Study|Specimens not in lab batch shipment|1|||
163186072|NCT01390220|589397678|FG000|Test Dose Phase|Adverse Event|17|||
163186073|NCT01390220|589397679|FG001|Test Dose Phase|Adverse Event|0|||
163186074|NCT01390220|589397680|FG002|Test Dose Phase|Adverse Event|0|||
163186075|NCT01390220|589397678|FG000|Test Dose Phase|Withdrawal by Subject|8|||
163186076|NCT01390220|589397679|FG001|Test Dose Phase|Withdrawal by Subject|0|||
163186077|NCT01390220|589397680|FG002|Test Dose Phase|Withdrawal by Subject|0|||
163186078|NCT01390220|589397678|FG000|Test Dose Phase|Lost to Follow-up|2|||
163186079|NCT01390220|589397679|FG001|Test Dose Phase|Lost to Follow-up|0|||
163186080|NCT01390220|589397680|FG002|Test Dose Phase|Lost to Follow-up|0|||
163186081|NCT01390220|589397678|FG000|Test Dose Phase|Protocol Violation|8|||
163186082|NCT01390220|589397679|FG001|Test Dose Phase|Protocol Violation|0|||
163186083|NCT01390220|589397680|FG002|Test Dose Phase|Protocol Violation|0|||
163186084|NCT01390220|589397678|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
163186085|NCT01390220|589397679|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
163186086|NCT01390220|589397680|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
163186087|NCT01390220|589397678|FG000|Test Dose Phase|Study/Site closure|6|||
163186088|NCT01390220|589397679|FG001|Test Dose Phase|Study/Site closure|0|||
163186089|NCT01390220|589397680|FG002|Test Dose Phase|Study/Site closure|0|||
163186090|NCT01390220|589397678|FG000|Test Dose Phase|Caregiver no longer available|5|||
163186091|NCT01390220|589397679|FG001|Test Dose Phase|Caregiver no longer available|0|||
163186092|NCT01390220|589397680|FG002|Test Dose Phase|Caregiver no longer available|0|||
163186093|NCT01390220|589397678|FG000|Test Dose Phase|Noncompliance|2|||
163186094|NCT01390220|589397679|FG001|Test Dose Phase|Noncompliance|0|||
163186095|NCT01390220|589397680|FG002|Test Dose Phase|Noncompliance|0|||
163186096|NCT01390220|589397678|FG000|Test Dose Phase|Logistical|6|||
163186097|NCT01390220|589397679|FG001|Test Dose Phase|Logistical|0|||
163186098|NCT01390220|589397680|FG002|Test Dose Phase|Logistical|0|||
162943536|NCT02581345|588496172|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
162943537|NCT02581345|588496173|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
163186099|NCT01390220|589397678|FG000|Comparative Phase|Withdrawal by Subject|0|||
163186100|NCT01390220|589397679|FG001|Comparative Phase|Withdrawal by Subject|1|||
163186101|NCT01390220|589397680|FG002|Comparative Phase|Withdrawal by Subject|0|||
163186102|NCT00943124|589397681|FG000|Period 1|Withdrawal by Subject|1|||
163186103|NCT00943124|589397682|FG001|Period 1|Withdrawal by Subject|1|||
163186104|NCT00943124|589397681|FG000|Period 1|Did Not Follow Study Procedures|1|||
163186105|NCT00943124|589397682|FG001|Period 1|Did Not Follow Study Procedures|0|||
163186106|NCT00943124|589397681|FG000|Period 1|Personal Reasons|0|||
163186107|NCT00943124|589397682|FG001|Period 1|Personal Reasons|1|||
163186108|NCT03059446|589397683|FG000|Overall Study|Adverse Event|11|||
163186109|NCT03059446|589397683|FG000|Overall Study|Withdrawal of Consent|16|||
163186110|NCT03059446|589397683|FG000|Overall Study|Lost to Follow-up|3|||
163291026|NCT00241644|589771187|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
163291027|NCT00241644|589771188|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
163291028|NCT00241644|589771189|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
163291029|NCT00241644|589771190|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
162943538|NCT02581345|588496170|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
162943539|NCT02581345|588496171|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
162943540|NCT02581345|588496172|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
162943541|NCT02581345|588496173|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
162943542|NCT02581345|588496170|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
162943543|NCT02581345|588496171|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
162943544|NCT02581345|588496172|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
162943545|NCT02581345|588496173|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
162943546|NCT02581345|588496170|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
162943547|NCT02581345|588496171|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
162943548|NCT02581345|588496172|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
162943549|NCT02581345|588496173|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
162943550|NCT02581345|588496170|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
162943551|NCT02581345|588496171|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
162943552|NCT02581345|588496172|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
162943553|NCT02581345|588496173|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
162943554|NCT02581345|588496170|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
162943555|NCT02581345|588496171|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
162943556|NCT02581345|588496172|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
162943557|NCT02581345|588496173|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
162943558|NCT02581345|588496170|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
162943559|NCT02581345|588496171|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
162943560|NCT02581345|588496172|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
162943561|NCT02581345|588496173|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
162943562|NCT02581345|588496170|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
162943563|NCT02581345|588496171|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
162943564|NCT02581345|588496172|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
162943565|NCT02581345|588496173|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
162943566|NCT02819362|588496183|FG000|Overall Study|On-site MRI could not be performed|70|||
162943567|NCT05456529|588496184|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
162943568|NCT05456529|588496184|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
162943569|NCT05456529|588496184|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
162943570|NCT05456529|588496184|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
162943571|NCT05456529|588496184|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
162943572|NCT05456529|588496184|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
162943573|NCT05456529|588496184|FG000|44-week Long-term Safety Period|Physician Decision|2|||
162943574|NCT05456529|588496184|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
162943575|NCT05456529|588496184|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
162943576|NCT05456529|588496184|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
162943577|NCT05456529|588496184|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
162943578|NCT02518113|588496185|FG000|Overall Study|Adverse Event|1|||
162943579|NCT02518113|588496186|FG001|Overall Study|Adverse Event|0|||
162943580|NCT02518113|588496187|FG002|Overall Study|Adverse Event|1|||
162943581|NCT02518113|588496188|FG003|Overall Study|Adverse Event|0|||
162943582|NCT02518113|588496185|FG000|Overall Study|Death|1|||
162943583|NCT02518113|588496186|FG001|Overall Study|Death|2|||
162943584|NCT02518113|588496187|FG002|Overall Study|Death|0|||
162943585|NCT02518113|588496188|FG003|Overall Study|Death|0|||
162943586|NCT02518113|588496185|FG000|Overall Study|Physician Decision|0|||
162943587|NCT02518113|588496186|FG001|Overall Study|Physician Decision|1|||
162943588|NCT02518113|588496187|FG002|Overall Study|Physician Decision|0|||
162943589|NCT02518113|588496188|FG003|Overall Study|Physician Decision|0|||
162943590|NCT02518113|588496185|FG000|Overall Study|Progressive Disease|1|||
162943591|NCT02518113|588496186|FG001|Overall Study|Progressive Disease|2|||
162943592|NCT02518113|588496187|FG002|Overall Study|Progressive Disease|3|||
162943593|NCT02518113|588496188|FG003|Overall Study|Progressive Disease|0|||
162943594|NCT02710123|588496189|FG000|Overall Study|Lost to Follow-up|3|||
162943595|NCT02710123|588496190|FG001|Overall Study|Lost to Follow-up|4|||
162943596|NCT02710123|588496189|FG000|Overall Study|Withdrawal by Subject|1|||
162943597|NCT02710123|588496190|FG001|Overall Study|Withdrawal by Subject|1|||
162943598|NCT02710123|588496189|FG000|Overall Study|Illness unrelated to study intervention|1|||
162943599|NCT02710123|588496190|FG001|Overall Study|Illness unrelated to study intervention|0|||
162943600|NCT02750761|588496196|FG000|Overall Study|Lost to Follow-up|0|||
162943601|NCT02750761|588496197|FG001|Overall Study|Lost to Follow-up|0|||
162943602|NCT02750761|588496198|FG002|Overall Study|Lost to Follow-up|1|||
163291030|NCT00241644|589771187|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
163291031|NCT00241644|589771188|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
162943603|NCT02750761|588496199|FG003|Overall Study|Lost to Follow-up|0|||
162943604|NCT02750761|588496200|FG004|Overall Study|Lost to Follow-up|0|||
162943605|NCT02750761|588496201|FG005|Overall Study|Lost to Follow-up|0|||
162943606|NCT01860976|588496202|FG000|Blinded Treatment|Adverse Event|1|||
162943607|NCT01860976|588496203|FG001|Blinded Treatment|Adverse Event|3|||
162943608|NCT01860976|588496202|FG000|Blinded Treatment|Lack of Efficacy|5|||
162943609|NCT01860976|588496203|FG001|Blinded Treatment|Lack of Efficacy|12|||
162943610|NCT01860976|588496202|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
162943611|NCT01860976|588496203|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
162943612|NCT01860976|588496202|FG000|Blinded Treatment|Withdrawal by Subject|3|||
162943613|NCT01860976|588496203|FG001|Blinded Treatment|Withdrawal by Subject|5|||
163291032|NCT00241644|589771189|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
163291033|NCT00241644|589771190|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
163291034|NCT00241644|589771187|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
163291035|NCT00241644|589771188|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
162943614|NCT01860976|588496202|FG000|Blinded Treatment|Subject no longer met criteria|1|||
162943615|NCT01860976|588496203|FG001|Blinded Treatment|Subject no longer met criteria|0|||
162943616|NCT01860976|588496202|FG000|Blinded Treatment|Entered Open-Label in error|0|||
162943617|NCT01860976|588496203|FG001|Blinded Treatment|Entered Open-Label in error|1|||
162943618|NCT01860976|588496202|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
162943619|NCT01860976|588496203|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
162943620|NCT01860976|588496202|FG000|Open-Label|Adverse Event|2|||
162943621|NCT01860976|588496203|FG001|Open-Label|Adverse Event|4|||
162943622|NCT01860976|588496202|FG000|Open-Label|Lack of Efficacy|16|||
162943623|NCT01860976|588496203|FG001|Open-Label|Lack of Efficacy|8|||
162943624|NCT01860976|588496202|FG000|Open-Label|Lost to Follow-up|1|||
162943625|NCT01860976|588496203|FG001|Open-Label|Lost to Follow-up|2|||
162943626|NCT01860976|588496202|FG000|Open-Label|Subject request discontinue treatment|4|||
162943627|NCT01860976|588496203|FG001|Open-Label|Subject request discontinue treatment|3|||
162943628|NCT01860976|588496202|FG000|Open-Label|Withdrawal by Subject|4|||
162943629|NCT01860976|588496203|FG001|Open-Label|Withdrawal by Subject|1|||
162943630|NCT01860976|588496202|FG000|Open-Label|Other Reasons|1|||
162943631|NCT01860976|588496203|FG001|Open-Label|Other Reasons|1|||
162943632|NCT01860976|588496202|FG000|Long Term Extension|Adverse Event|4|||
162943633|NCT01860976|588496203|FG001|Long Term Extension|Adverse Event|0|||
162943634|NCT01860976|588496202|FG000|Long Term Extension|Lack of Efficacy|2|||
162943635|NCT01860976|588496203|FG001|Long Term Extension|Lack of Efficacy|0|||
162943636|NCT01860976|588496202|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
162943637|NCT01860976|588496203|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
162943638|NCT01860976|588496202|FG000|Long Term Extension|Lost to Follow-up|2|||
162943639|NCT01860976|588496203|FG001|Long Term Extension|Lost to Follow-up|0|||
162943640|NCT01860976|588496202|FG000|Long Term Extension|subject withdrew consent|7|||
162943641|NCT01860976|588496203|FG001|Long Term Extension|subject withdrew consent|0|||
162943642|NCT00419926|588496204|FG000|Overall Study|Withdrawal by Subject|7|||
162943643|NCT00419926|588496205|FG001|Overall Study|Withdrawal by Subject|3|||
162943644|NCT00419926|588496204|FG000|Overall Study|Administrative Problem|4|||
162943645|NCT00419926|588496205|FG001|Overall Study|Administrative Problem|4|||
162943646|NCT00419926|588496204|FG000|Overall Study|Lost to Follow-up|1|||
162943647|NCT00419926|588496205|FG001|Overall Study|Lost to Follow-up|2|||
162943648|NCT00419926|588496204|FG000|Overall Study|Death|2|||
162943649|NCT00419926|588496205|FG001|Overall Study|Death|1|||
162943650|NCT02153398|588496207|FG000|Overall Study|Withdrawal by Subject|1|||
162943651|NCT02153398|588496208|FG001|Overall Study|Withdrawal by Subject|0|||
162943652|NCT02153398|588496209|FG002|Overall Study|Withdrawal by Subject|0|||
162943653|NCT02153398|588496210|FG003|Overall Study|Withdrawal by Subject|0|||
162943654|NCT02153398|588496211|FG004|Overall Study|Withdrawal by Subject|0|||
162943655|NCT02153398|588496207|FG000|Overall Study|Adverse Event|0|||
162943656|NCT02153398|588496208|FG001|Overall Study|Adverse Event|0|||
162943657|NCT02153398|588496209|FG002|Overall Study|Adverse Event|1|||
162943658|NCT02153398|588496210|FG003|Overall Study|Adverse Event|1|||
162943659|NCT02153398|588496211|FG004|Overall Study|Adverse Event|0|||
163291036|NCT00241644|589771189|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
162943660|NCT02374918|588496212|FG000|Overall Study|Protocol Violation|2|||
162943661|NCT02374918|588496213|FG001|Overall Study|Protocol Violation|0|||
162943662|NCT02374918|588496214|FG002|Overall Study|Protocol Violation|2|||
162943663|NCT02374918|588496215|FG003|Overall Study|Protocol Violation|1|||
162943664|NCT02374918|588496212|FG000|Overall Study|Withdrawal by Subject|1|||
162943665|NCT02374918|588496213|FG001|Overall Study|Withdrawal by Subject|1|||
162943666|NCT02374918|588496214|FG002|Overall Study|Withdrawal by Subject|1|||
162943667|NCT02374918|588496215|FG003|Overall Study|Withdrawal by Subject|0|||
162943668|NCT02374918|588496212|FG000|Overall Study|Lack of Efficacy|0|||
162943669|NCT02374918|588496213|FG001|Overall Study|Lack of Efficacy|0|||
162943670|NCT02374918|588496214|FG002|Overall Study|Lack of Efficacy|1|||
162943671|NCT02374918|588496215|FG003|Overall Study|Lack of Efficacy|1|||
163291037|NCT00241644|589771190|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
163291038|NCT01370694|589771194|FG000|Overall Study|Switched to rituximab|4|||
163291039|NCT01370694|589771194|FG000|Overall Study|Progressive disease|2|||
163291040|NCT04842604|589771198|FG000|Overall Study|Death|1|||
163291041|NCT04842604|589771199|FG001|Overall Study|Death|0|||
163291042|NCT04842604|589771198|FG000|Overall Study|Other|4|||
163291043|NCT04842604|589771199|FG001|Overall Study|Other|4|||
163291044|NCT04842604|589771198|FG000|Overall Study|Randomized but not treated|1|||
163291045|NCT04842604|589771199|FG001|Overall Study|Randomized but not treated|0|||
163291046|NCT01193153|589771200|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
163291047|NCT01193153|589771201|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
163291048|NCT01193153|589771200|FG000|Open-label Lead in Period|Pregnancy|1|||
163291049|NCT01193153|589771201|FG001|Open-label Lead in Period|Pregnancy|0|||
163291050|NCT01193153|589771200|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
163291051|NCT01193153|589771201|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
163291052|NCT01193153|589771200|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
163291053|NCT01193153|589771201|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
163291054|NCT01193153|589771200|FG000|Open-label Lead in Period|Other|14|||
163291055|NCT01193153|589771201|FG001|Open-label Lead in Period|Other|0|||
163291056|NCT01193153|589771200|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
163291057|NCT01193153|589771201|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
163291058|NCT01193153|589771200|FG000|Open-label Lead in Period|Adverse Event|41|||
163291059|NCT01193153|589771201|FG001|Open-label Lead in Period|Adverse Event|0|||
163291060|NCT01193153|589771200|FG000|Open-label Lead in Period|Death|1|||
163291061|NCT01193153|589771201|FG001|Open-label Lead in Period|Death|0|||
163291062|NCT01193153|589771200|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
163291063|NCT01193153|589771201|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
163291064|NCT01193153|589771200|FG000|Open-label Stabilization Period|Adverse Event|9|||
163291065|NCT01193153|589771201|FG001|Open-label Stabilization Period|Adverse Event|0|||
163291066|NCT01193153|589771200|FG000|Open-label Stabilization Period|Death|2|||
163291067|NCT01193153|589771201|FG001|Open-label Stabilization Period|Death|0|||
163291068|NCT01193153|589771200|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
163291069|NCT01193153|589771201|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
163291070|NCT01193153|589771200|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
163291071|NCT01193153|589771201|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
163291072|NCT01193153|589771200|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
163291073|NCT01193153|589771201|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
162943672|NCT02204371|588496217|FG000|Overall Study|Adverse Event|1|||
162943673|NCT00810368|588496218|FG000|Overall Study|Lost to Follow-up|4|||
162943674|NCT00810368|588496219|FG001|Overall Study|Lost to Follow-up|2|||
162943675|NCT00810368|588496218|FG000|Overall Study|Lack of Efficacy|2|||
162943676|NCT00810368|588496219|FG001|Overall Study|Lack of Efficacy|0|||
162943677|NCT01506947|588496220|FG000|Overall Study|Lost to Follow-up|7|||
162943678|NCT01506947|588496220|FG000|Overall Study|Adverse Event|5|||
162943679|NCT01506947|588496220|FG000|Overall Study|Death|1|||
162943680|NCT01506947|588496220|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
162943681|NCT03803943|588496223|FG000|Overall Study|Withdrawal by Subject|2|||
162943682|NCT03803943|588496224|FG001|Overall Study|Withdrawal by Subject|2|||
162943683|NCT03803943|588496225|FG002|Overall Study|Withdrawal by Subject|2|||
162943684|NCT03803943|588496226|FG003|Overall Study|Withdrawal by Subject|2|||
162943685|NCT01781286|588496229|FG000|Overall Study|Lost to Follow-up|0|||
162943686|NCT01781286|588496230|FG001|Overall Study|Lost to Follow-up|0|||
162943687|NCT01781286|588496231|FG002|Overall Study|Lost to Follow-up|0|||
162943688|NCT01781286|588496232|FG003|Overall Study|Lost to Follow-up|0|||
162943689|NCT01781286|588496233|FG004|Overall Study|Lost to Follow-up|0|||
162943690|NCT01781286|588496234|FG005|Overall Study|Lost to Follow-up|1|||
162943691|NCT01781286|588496229|FG000|Overall Study|Time Constraints|2|||
162943692|NCT01781286|588496230|FG001|Overall Study|Time Constraints|0|||
162943693|NCT01781286|588496231|FG002|Overall Study|Time Constraints|2|||
162943694|NCT01781286|588496232|FG003|Overall Study|Time Constraints|0|||
163291074|NCT01193153|589771200|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
163291075|NCT01193153|589771201|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
163291076|NCT01193153|589771200|FG000|Open-label Stabilization Period|Other|8|||
163291077|NCT01193153|589771201|FG001|Open-label Stabilization Period|Other|0|||
163291078|NCT01193153|589771200|FG000|Double Blind Relapse Prevention Period|Other|2|||
163291079|NCT01193153|589771201|FG001|Double Blind Relapse Prevention Period|Other|3|||
162943695|NCT01781286|588496233|FG004|Overall Study|Time Constraints|0|||
162943696|NCT01781286|588496234|FG005|Overall Study|Time Constraints|0|||
163291080|NCT01193153|589771200|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
162943697|NCT01781286|588496229|FG000|Overall Study|Noncompliance|0|||
162943698|NCT01781286|588496230|FG001|Overall Study|Noncompliance|0|||
162943699|NCT01781286|588496231|FG002|Overall Study|Noncompliance|0|||
162943700|NCT01781286|588496232|FG003|Overall Study|Noncompliance|1|||
162943701|NCT01781286|588496233|FG004|Overall Study|Noncompliance|0|||
162943702|NCT01781286|588496234|FG005|Overall Study|Noncompliance|0|||
163291081|NCT01193153|589771201|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
162943703|NCT00995410|588496235|FG000|Overall Study|Adverse Event|51|||
162943704|NCT00995410|588496235|FG000|Overall Study|Withdrawal by Subject|7|||
162943705|NCT00995410|588496235|FG000|Overall Study|Lost to Follow-up|2|||
162943706|NCT00995410|588496235|FG000|Overall Study|Misc|28|||
162943707|NCT03365375|588496236|FG000|Overall Study|Withdrawal by Subject|0|||
162943708|NCT03365375|588496237|FG001|Overall Study|Withdrawal by Subject|1|||
162943709|NCT03365375|588496236|FG000|Overall Study|Lost to Follow-up|0|||
162943710|NCT03365375|588496237|FG001|Overall Study|Lost to Follow-up|4|||
162943711|NCT02187042|588496238|FG000|Overall Study|Death|1|||
162943712|NCT02187042|588496239|FG001|Overall Study|Death|1|||
162943713|NCT02187042|588496238|FG000|Overall Study|Toxicity|6|||
162943714|NCT02187042|588496239|FG001|Overall Study|Toxicity|5|||
162943715|NCT02187042|588496238|FG000|Overall Study|Participant choice|1|||
162943716|NCT02187042|588496239|FG001|Overall Study|Participant choice|0|||
162943717|NCT02187042|588496238|FG000|Overall Study|Doctor choice|1|||
162943718|NCT02187042|588496239|FG001|Overall Study|Doctor choice|0|||
162943719|NCT02187042|588496238|FG000|Overall Study|Progressive disease|4|||
162943720|NCT02187042|588496239|FG001|Overall Study|Progressive disease|8|||
162943721|NCT03019965|588496246|FG000|Overall Study|Withdrawal by Subject|1|||
162943722|NCT03019965|588496247|FG001|Overall Study|Withdrawal by Subject|0|||
162943723|NCT03019965|588496246|FG000|Overall Study|Protocol Violation|1|||
162943724|NCT03019965|588496247|FG001|Overall Study|Protocol Violation|3|||
162943725|NCT03019965|588496246|FG000|Overall Study|viral or fungal infection|3|||
162943726|NCT03019965|588496247|FG001|Overall Study|viral or fungal infection|4|||
162943727|NCT03019965|588496246|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
162943728|NCT03019965|588496247|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
162943729|NCT03019965|588496246|FG000|Overall Study|Physician Decision|1|||
162943730|NCT03019965|588496247|FG001|Overall Study|Physician Decision|1|||
162943731|NCT00337571|588496248|FG000|Overall Study|Lack of Efficacy|3|||
162943732|NCT00337571|588496249|FG001|Overall Study|Lack of Efficacy|0|||
162943733|NCT00337571|588496250|FG002|Overall Study|Lack of Efficacy|0|||
162943734|NCT00337571|588496251|FG003|Overall Study|Lack of Efficacy|0|||
162943735|NCT00337571|588496248|FG000|Overall Study|Adverse Event|4|||
162943736|NCT00337571|588496249|FG001|Overall Study|Adverse Event|5|||
162943737|NCT00337571|588496250|FG002|Overall Study|Adverse Event|8|||
162943738|NCT00337571|588496251|FG003|Overall Study|Adverse Event|4|||
162943739|NCT00337571|588496248|FG000|Overall Study|Withdrawal by Subject|2|||
162943740|NCT00337571|588496249|FG001|Overall Study|Withdrawal by Subject|2|||
162943741|NCT00337571|588496250|FG002|Overall Study|Withdrawal by Subject|1|||
162943742|NCT00337571|588496251|FG003|Overall Study|Withdrawal by Subject|0|||
162943743|NCT00337571|588496248|FG000|Overall Study|Lost to Follow-up|3|||
162943744|NCT00337571|588496249|FG001|Overall Study|Lost to Follow-up|1|||
162943745|NCT00337571|588496250|FG002|Overall Study|Lost to Follow-up|0|||
162943746|NCT00337571|588496251|FG003|Overall Study|Lost to Follow-up|1|||
162943747|NCT00337571|588496248|FG000|Overall Study|Poor/noncompliance|1|||
162943748|NCT00337571|588496249|FG001|Overall Study|Poor/noncompliance|1|||
162943749|NCT00337571|588496250|FG002|Overall Study|Poor/noncompliance|1|||
162943750|NCT00337571|588496251|FG003|Overall Study|Poor/noncompliance|1|||
162943751|NCT00337571|588496248|FG000|Overall Study|No longer met study criteria|1|||
162943752|NCT00337571|588496249|FG001|Overall Study|No longer met study criteria|0|||
162943753|NCT00337571|588496250|FG002|Overall Study|No longer met study criteria|0|||
162943754|NCT00337571|588496251|FG003|Overall Study|No longer met study criteria|0|||
162943755|NCT00337571|588496248|FG000|Overall Study|High Potassium level|0|||
162943756|NCT00337571|588496249|FG001|Overall Study|High Potassium level|0|||
162943757|NCT00337571|588496250|FG002|Overall Study|High Potassium level|0|||
162943758|NCT00337571|588496251|FG003|Overall Study|High Potassium level|1|||
162943759|NCT01890915|588496258|FG000|Overall Study|Adverse Event|1|||
162943760|NCT01890915|588496259|FG001|Overall Study|Adverse Event|0|||
162943761|NCT01890915|588496258|FG000|Overall Study|Protocol Violation|2|||
162943762|NCT01890915|588496259|FG001|Overall Study|Protocol Violation|0|||
162943763|NCT01890915|588496258|FG000|Overall Study|Equipment Malfunction|0|||
162943764|NCT01890915|588496259|FG001|Overall Study|Equipment Malfunction|1|||
162943765|NCT01974895|588496260|FG000|Overall Study|Protocol Violation|1|||
162943766|NCT01974895|588496261|FG001|Overall Study|Protocol Violation|0|||
162943767|NCT01974895|588496260|FG000|Overall Study|Lost to Follow-up|4|||
162943768|NCT01974895|588496261|FG001|Overall Study|Lost to Follow-up|6|||
162943769|NCT01974895|588496260|FG000|Overall Study|Withdrawal by Subject|0|||
162943770|NCT01974895|588496261|FG001|Overall Study|Withdrawal by Subject|1|||
162943771|NCT01974895|588496260|FG000|Overall Study|Other (Missed Visit)|1|||
162943772|NCT01974895|588496261|FG001|Overall Study|Other (Missed Visit)|0|||
162943773|NCT01974895|588496260|FG000|Overall Study|Other (Reason unknown)|9|||
162943774|NCT01974895|588496261|FG001|Overall Study|Other (Reason unknown)|8|||
162943775|NCT01513148|588496262|FG000|Overall Study|Protocol Violation|2|||
162943776|NCT01513148|588496263|FG001|Overall Study|Protocol Violation|2|||
162943777|NCT03552757|588496264|FG000|Overall Study|Withdrawal by Subject|10|||
162943778|NCT03552757|588496265|FG001|Overall Study|Withdrawal by Subject|5|||
162943779|NCT03552757|588496266|FG002|Overall Study|Withdrawal by Subject|12|||
162943780|NCT03552757|588496264|FG000|Overall Study|Lost to Follow-up|2|||
162943781|NCT03552757|588496265|FG001|Overall Study|Lost to Follow-up|7|||
162943782|NCT03552757|588496266|FG002|Overall Study|Lost to Follow-up|7|||
162943783|NCT03552757|588496264|FG000|Overall Study|Death|1|||
162943784|NCT03552757|588496265|FG001|Overall Study|Death|1|||
162943785|NCT03552757|588496266|FG002|Overall Study|Death|1|||
162943786|NCT02192099|588496269|FG000|Overall Study|Adverse Event|1|||
162943787|NCT02192099|588496269|FG000|Overall Study|Lost to Follow-up|2|||
162943788|NCT02192099|588496269|FG000|Overall Study|Physician Decision|1|||
162943789|NCT02192099|588496269|FG000|Overall Study|Pregnancy|1|||
162943790|NCT02192099|588496269|FG000|Overall Study|Protocol Violation|8|||
162943791|NCT02192099|588496269|FG000|Overall Study|Study Terminated by Sponsor|32|||
162943792|NCT02192099|588496269|FG000|Overall Study|Withdrawal by Subject|11|||
162943793|NCT02192099|588496269|FG000|Overall Study|Miscellaneous Reasons|5|||
162943794|NCT00386009|588496270|FG000|Overall Study|Adverse Event|0|||
162943795|NCT00386009|588496271|FG001|Overall Study|Adverse Event|2|||
162943796|NCT00386009|588496270|FG000|Overall Study|Death|1|||
162943797|NCT00386009|588496271|FG001|Overall Study|Death|0|||
162943798|NCT00386009|588496270|FG000|Overall Study|Entry Criteria Not Met|0|||
162943799|NCT00386009|588496271|FG001|Overall Study|Entry Criteria Not Met|2|||
162943800|NCT00386009|588496270|FG000|Overall Study|Lost to Follow-up|1|||
162943801|NCT00386009|588496271|FG001|Overall Study|Lost to Follow-up|1|||
162943802|NCT00386009|588496270|FG000|Overall Study|Protocol Violation|1|||
162943803|NCT00386009|588496271|FG001|Overall Study|Protocol Violation|0|||
162943804|NCT00386009|588496270|FG000|Overall Study|Sponsor Decision|1|||
162943805|NCT00386009|588496271|FG001|Overall Study|Sponsor Decision|1|||
162943806|NCT00386009|588496270|FG000|Overall Study|Withdrawal by Subject|5|||
162943807|NCT00386009|588496271|FG001|Overall Study|Withdrawal by Subject|4|||
162943808|NCT00536575|588496274|FG000|Overall Study|Withdrawal by Subject|1|||
162943809|NCT00536575|588496274|FG000|Overall Study|Death|1|||
162943810|NCT01862328|588496281|FG000|Overall Study|Progressive Disease|3|||
162943811|NCT01862328|588496282|FG001|Overall Study|Progressive Disease|11|||
162943812|NCT01862328|588496283|FG002|Overall Study|Progressive Disease|5|||
162943813|NCT01862328|588496284|FG003|Overall Study|Progressive Disease|6|||
162943814|NCT01862328|588496285|FG004|Overall Study|Progressive Disease|7|||
162943815|NCT01862328|588496286|FG005|Overall Study|Progressive Disease|4|||
162943816|NCT01862328|588496287|FG006|Overall Study|Progressive Disease|3|||
162943817|NCT01862328|588496281|FG000|Overall Study|Adverse Event|0|||
162943818|NCT01862328|588496282|FG001|Overall Study|Adverse Event|4|||
162943819|NCT01862328|588496283|FG002|Overall Study|Adverse Event|0|||
162943820|NCT01862328|588496284|FG003|Overall Study|Adverse Event|1|||
162943821|NCT01862328|588496285|FG004|Overall Study|Adverse Event|0|||
162943822|NCT01862328|588496286|FG005|Overall Study|Adverse Event|2|||
162943823|NCT01862328|588496287|FG006|Overall Study|Adverse Event|4|||
162943824|NCT01862328|588496281|FG000|Overall Study|Other|0|||
162943825|NCT01862328|588496282|FG001|Overall Study|Other|2|||
162943826|NCT01862328|588496283|FG002|Overall Study|Other|1|||
162943827|NCT01862328|588496284|FG003|Overall Study|Other|0|||
162943828|NCT01862328|588496285|FG004|Overall Study|Other|4|||
162943829|NCT01862328|588496286|FG005|Overall Study|Other|0|||
162943830|NCT01862328|588496287|FG006|Overall Study|Other|1|||
162943831|NCT01862328|588496281|FG000|Overall Study|Withdrawal by Subject|1|||
162943832|NCT01862328|588496282|FG001|Overall Study|Withdrawal by Subject|1|||
162943833|NCT01862328|588496283|FG002|Overall Study|Withdrawal by Subject|0|||
162943834|NCT01862328|588496284|FG003|Overall Study|Withdrawal by Subject|0|||
162943835|NCT01862328|588496285|FG004|Overall Study|Withdrawal by Subject|1|||
162943836|NCT01862328|588496286|FG005|Overall Study|Withdrawal by Subject|1|||
162943837|NCT01862328|588496287|FG006|Overall Study|Withdrawal by Subject|1|||
162943838|NCT01862328|588496281|FG000|Overall Study|Symptomatic Deterioration|0|||
162943839|NCT01862328|588496282|FG001|Overall Study|Symptomatic Deterioration|0|||
162943840|NCT01862328|588496283|FG002|Overall Study|Symptomatic Deterioration|0|||
162943841|NCT01862328|588496284|FG003|Overall Study|Symptomatic Deterioration|0|||
162943842|NCT01862328|588496285|FG004|Overall Study|Symptomatic Deterioration|0|||
162943843|NCT01862328|588496286|FG005|Overall Study|Symptomatic Deterioration|0|||
162943844|NCT01862328|588496287|FG006|Overall Study|Symptomatic Deterioration|1|||
162943845|NCT00936975|588496288|FG000|Overall Study|Withdrawal by Subject|1|||
162943846|NCT00936975|588496288|FG000|Overall Study|Disease progression|3|||
162943847|NCT00936975|588496288|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
162943848|NCT01656889|588496292|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
162943849|NCT01656889|588496293|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
162943850|NCT01656889|588496292|FG000|Treatment Period, 12 Weeks|Death|0|||
162943851|NCT01656889|588496293|FG001|Treatment Period, 12 Weeks|Death|1|||
162943852|NCT01656889|588496292|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
162943853|NCT01656889|588496293|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
162943854|NCT01656889|588496292|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
162943855|NCT01656889|588496293|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
162943856|NCT01656889|588496292|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
162943857|NCT01656889|588496293|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
162943858|NCT01656889|588496292|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
162943859|NCT01656889|588496293|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
162943860|NCT01656889|588496292|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
162943861|NCT01656889|588496293|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
162943862|NCT01656889|588496292|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
162943863|NCT01656889|588496293|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
162943864|NCT01656889|588496292|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
162943865|NCT01656889|588496293|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
162943866|NCT01656889|588496292|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
162943867|NCT01656889|588496293|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
162943868|NCT02486796|588496294|FG000|Overall Study|Withdrawal by Subject|1|||
162943869|NCT02486796|588496295|FG001|Overall Study|Withdrawal by Subject|1|||
162943870|NCT02486796|588496294|FG000|Overall Study|Physician Decision|1|||
162943871|NCT02486796|588496295|FG001|Overall Study|Physician Decision|0|||
162943872|NCT00306384|588496298|FG000|Overall Study|Adverse Event|103|||
162943873|NCT00306384|588496299|FG001|Overall Study|Adverse Event|87|||
162943874|NCT00306384|588496300|FG002|Overall Study|Adverse Event|40|||
162943875|NCT00306384|588496298|FG000|Overall Study|Major protocol deviation|43|||
162943876|NCT00306384|588496299|FG001|Overall Study|Major protocol deviation|51|||
162943877|NCT00306384|588496300|FG002|Overall Study|Major protocol deviation|18|||
162943878|NCT00306384|588496298|FG000|Overall Study|Lost to Follow-up|57|||
162943879|NCT00306384|588496299|FG001|Overall Study|Lost to Follow-up|41|||
162943880|NCT00306384|588496300|FG002|Overall Study|Lost to Follow-up|35|||
162943881|NCT00306384|588496298|FG000|Overall Study|Voluntary withdrawal|199|||
162943882|NCT00306384|588496299|FG001|Overall Study|Voluntary withdrawal|187|||
162943883|NCT00306384|588496300|FG002|Overall Study|Voluntary withdrawal|91|||
162943884|NCT00306384|588496298|FG000|Overall Study|Study termination|1|||
162943885|NCT00306384|588496299|FG001|Overall Study|Study termination|0|||
162943886|NCT00306384|588496300|FG002|Overall Study|Study termination|1|||
162943887|NCT00306384|588496298|FG000|Overall Study|Pregnancy|3|||
162943888|NCT00306384|588496299|FG001|Overall Study|Pregnancy|1|||
162943889|NCT00306384|588496300|FG002|Overall Study|Pregnancy|1|||
162943890|NCT00306384|588496298|FG000|Overall Study|Lack of Efficacy|26|||
162943891|NCT00306384|588496299|FG001|Overall Study|Lack of Efficacy|40|||
162943892|NCT00306384|588496300|FG002|Overall Study|Lack of Efficacy|38|||
162943893|NCT00306384|588496298|FG000|Overall Study|Investigator discretion|28|||
162943894|NCT00306384|588496299|FG001|Overall Study|Investigator discretion|31|||
162943895|NCT00306384|588496300|FG002|Overall Study|Investigator discretion|21|||
162943896|NCT00306384|588496298|FG000|Overall Study|Other|80|||
162943897|NCT00306384|588496299|FG001|Overall Study|Other|70|||
162943898|NCT00306384|588496300|FG002|Overall Study|Other|32|||
162943899|NCT00306384|588496298|FG000|Overall Study|Site closure|2|||
162943900|NCT00306384|588496299|FG001|Overall Study|Site closure|0|||
162943901|NCT00306384|588496300|FG002|Overall Study|Site closure|0|||
162943902|NCT02275364|588496301|FG000|Period 1|Withdrawal by Subject|1|||
162943903|NCT02275364|588496302|FG001|Period 1|Withdrawal by Subject|0|||
162943904|NCT02275364|588496301|FG000|Period 1|Other reason|1|||
162943905|NCT02275364|588496302|FG001|Period 1|Other reason|0|||
162943906|NCT03384745|588496305|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
162943907|NCT03384745|588496306|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
162943908|NCT03384745|588496307|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
162943909|NCT03384745|588496308|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
162943910|NCT03384745|588496309|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
162943911|NCT03384745|588496310|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
162943912|NCT03384745|588496305|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
162943913|NCT03384745|588496306|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
162943914|NCT03384745|588496307|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
162943915|NCT03384745|588496308|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
162943916|NCT03384745|588496309|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
162943917|NCT03384745|588496310|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
162943918|NCT03384745|588496305|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
162943919|NCT03384745|588496306|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
162943920|NCT03384745|588496307|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
162943921|NCT03384745|588496308|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
162943922|NCT03384745|588496309|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
162943923|NCT03384745|588496310|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
162943924|NCT03384745|588496305|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
162943925|NCT03384745|588496306|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
162943926|NCT03384745|588496307|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
162943927|NCT03384745|588496308|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
162943928|NCT03384745|588496309|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
162943929|NCT03384745|588496310|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
162943930|NCT03384745|588496305|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
162943931|NCT03384745|588496306|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
162943932|NCT03384745|588496307|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
162943933|NCT03384745|588496308|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
162943934|NCT03384745|588496309|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
162943935|NCT03384745|588496310|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
162943936|NCT03384745|588496305|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
162943937|NCT03384745|588496306|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
162943938|NCT03384745|588496307|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
162943939|NCT03384745|588496308|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
162943940|NCT03384745|588496309|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
162943941|NCT03384745|588496310|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
162943942|NCT03384745|588496305|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
162943943|NCT03384745|588496306|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
162943944|NCT03384745|588496307|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
162943945|NCT03384745|588496308|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
162943946|NCT03384745|588496309|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
162943947|NCT03384745|588496310|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
162943948|NCT03384745|588496305|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
162943949|NCT03384745|588496306|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
162943950|NCT03384745|588496307|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
162943951|NCT03384745|588496308|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
163186111|NCT03059446|589397683|FG000|Overall Study|Protocol Violation|1|||
163186112|NCT03059446|589397683|FG000|Overall Study|Study Terminated by Sponsor|131|||
163186113|NCT03059446|589397683|FG000|Overall Study|Reason not Specified|5|||
162943952|NCT03384745|588496309|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
162943953|NCT03384745|588496310|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
162943954|NCT03384745|588496305|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
163186114|NCT02992132|589397684|FG000|Overall Study|Adverse Event|4|||
163186115|NCT02992132|589397685|FG001|Overall Study|Adverse Event|1|||
162943955|NCT03384745|588496306|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
162943956|NCT03384745|588496307|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
162943957|NCT03384745|588496308|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
162943958|NCT03384745|588496309|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
162943959|NCT03384745|588496310|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
162943960|NCT03384745|588496305|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
162943961|NCT03384745|588496306|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
162943962|NCT03384745|588496307|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
162943963|NCT03384745|588496308|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
162943964|NCT03384745|588496309|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
162943965|NCT03384745|588496310|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
162943966|NCT03384745|588496305|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
162943967|NCT03384745|588496306|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
162943968|NCT03384745|588496307|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
162943969|NCT03384745|588496308|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
162943970|NCT03384745|588496309|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
162943971|NCT03384745|588496310|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
163186116|NCT02992132|589397686|FG002|Overall Study|Adverse Event|3|||
163186117|NCT02992132|589397684|FG000|Overall Study|Lack of Efficacy|2|||
163186118|NCT02992132|589397685|FG001|Overall Study|Lack of Efficacy|0|||
163387595|NCT02202551|590129965|FG001|Overall Study|Worsening Dyskinesia|0|||
163387596|NCT02202551|590129966|FG002|Overall Study|Worsening Dyskinesia|0|||
163387597|NCT02202551|590129967|FG003|Overall Study|Worsening Dyskinesia|1|||
163387598|NCT02202551|590129964|FG000|Overall Study|Protocol Violation|0|||
163387599|NCT02202551|590129965|FG001|Overall Study|Protocol Violation|1|||
163387600|NCT02202551|590129966|FG002|Overall Study|Protocol Violation|0|||
163387601|NCT02202551|590129967|FG003|Overall Study|Protocol Violation|0|||
163387602|NCT02202551|590129964|FG000|Overall Study|Sponsor's decision|2|||
163387603|NCT02202551|590129965|FG001|Overall Study|Sponsor's decision|0|||
163387604|NCT02202551|590129966|FG002|Overall Study|Sponsor's decision|0|||
163387605|NCT02202551|590129967|FG003|Overall Study|Sponsor's decision|0|||
163387606|NCT02202551|590129964|FG000|Overall Study|Subject unwilling to proceed|1|||
163387607|NCT02202551|590129965|FG001|Overall Study|Subject unwilling to proceed|5|||
163387608|NCT02202551|590129966|FG002|Overall Study|Subject unwilling to proceed|3|||
163387609|NCT02202551|590129967|FG003|Overall Study|Subject unwilling to proceed|5|||
163387610|NCT02202551|590129964|FG000|Overall Study|Subject consent withdrawn|0|||
163387611|NCT02202551|590129965|FG001|Overall Study|Subject consent withdrawn|3|||
163387612|NCT02202551|590129966|FG002|Overall Study|Subject consent withdrawn|1|||
163387613|NCT02202551|590129967|FG003|Overall Study|Subject consent withdrawn|2|||
163387614|NCT02202551|590129964|FG000|Overall Study|eGFR<50mL/min/m2|2|||
163387615|NCT02202551|590129965|FG001|Overall Study|eGFR<50mL/min/m2|2|||
163387616|NCT02202551|590129966|FG002|Overall Study|eGFR<50mL/min/m2|0|||
163387617|NCT02202551|590129967|FG003|Overall Study|eGFR<50mL/min/m2|1|||
163387618|NCT02349451|590129971|FG000|Overall Study|Withdrawal by Subject|0|||
163387619|NCT02349451|590129972|FG001|Overall Study|Withdrawal by Subject|1|||
163387620|NCT02349451|590129973|FG002|Overall Study|Withdrawal by Subject|2|||
163387621|NCT02349451|590129974|FG003|Overall Study|Withdrawal by Subject|1|||
163387622|NCT02168842|590129975|FG000|Overall Study|Withdrawal by Subject|5|||
163387623|NCT02168842|590129976|FG001|Overall Study|Withdrawal by Subject|3|||
163387624|NCT02168842|590129975|FG000|Overall Study|Lost to Follow-up|0|||
163387625|NCT02168842|590129976|FG001|Overall Study|Lost to Follow-up|2|||
163387626|NCT02168842|590129975|FG000|Overall Study|Death|2|||
163387627|NCT02168842|590129976|FG001|Overall Study|Death|1|||
163387628|NCT02168842|590129975|FG000|Overall Study|Physician Decision|1|||
163387629|NCT02168842|590129976|FG001|Overall Study|Physician Decision|2|||
163387630|NCT02147353|590129977|FG000|Overall Study|Lost to Follow-up|2|||
163387631|NCT02147353|590129978|FG001|Overall Study|Lost to Follow-up|0|||
163387632|NCT02147353|590129977|FG000|Overall Study|unable to make visits|4|||
163387633|NCT02147353|590129978|FG001|Overall Study|unable to make visits|0|||
163387634|NCT02147353|590129977|FG000|Overall Study|medication noncompliance|3|||
163387635|NCT02147353|590129978|FG001|Overall Study|medication noncompliance|0|||
163387636|NCT02121834|590129986|FG000|Overall Study|Protocol Violation|0|||
163387637|NCT02121834|590129987|FG001|Overall Study|Protocol Violation|1|||
163387638|NCT02121834|590129988|FG002|Overall Study|Protocol Violation|0|||
163387639|NCT02121834|590129989|FG003|Overall Study|Protocol Violation|0|||
163387640|NCT02121834|590129990|FG004|Overall Study|Protocol Violation|0|||
163387641|NCT02121834|590129991|FG005|Overall Study|Protocol Violation|0|||
163387642|NCT02121834|590129992|FG006|Overall Study|Protocol Violation|0|||
163387643|NCT02121834|590129986|FG000|Overall Study|Withdrawal by Subject|0|||
163387644|NCT02121834|590129987|FG001|Overall Study|Withdrawal by Subject|1|||
163387645|NCT02121834|590129988|FG002|Overall Study|Withdrawal by Subject|1|||
163387646|NCT02121834|590129989|FG003|Overall Study|Withdrawal by Subject|0|||
163387647|NCT02121834|590129990|FG004|Overall Study|Withdrawal by Subject|0|||
163387648|NCT02121834|590129991|FG005|Overall Study|Withdrawal by Subject|0|||
162943972|NCT02984683|588496313|FG000|Overall Study|Adverse Event|3|||
163186119|NCT02992132|589397686|FG002|Overall Study|Lack of Efficacy|0|||
162943973|NCT02984683|588496314|FG001|Overall Study|Adverse Event|3|||
162943974|NCT02984683|588496313|FG000|Overall Study|Withdrawal by Subject|1|||
162943975|NCT02984683|588496314|FG001|Overall Study|Withdrawal by Subject|0|||
162943976|NCT02984683|588496313|FG000|Overall Study|Disease progression|7|||
162943977|NCT02984683|588496314|FG001|Overall Study|Disease progression|9|||
162943978|NCT03131999|588496315|FG000|Overall Study|Withdrawal by Subject|0|||
162943979|NCT03131999|588496316|FG001|Overall Study|Withdrawal by Subject|1|||
162943980|NCT02260492|588496317|FG000|Overall Study|Adverse Event|6|||
162943981|NCT02260492|588496318|FG001|Overall Study|Adverse Event|1|||
162943982|NCT02260492|588496319|FG002|Overall Study|Adverse Event|2|||
162943983|NCT02260492|588496317|FG000|Overall Study|Death|0|||
162943984|NCT02260492|588496318|FG001|Overall Study|Death|1|||
162943985|NCT02260492|588496319|FG002|Overall Study|Death|0|||
162943986|NCT02260492|588496317|FG000|Overall Study|Lost to Follow-up|12|||
162943987|NCT02260492|588496318|FG001|Overall Study|Lost to Follow-up|9|||
162943988|NCT02260492|588496319|FG002|Overall Study|Lost to Follow-up|0|||
162943989|NCT02260492|588496317|FG000|Overall Study|Physician Decision|2|||
162943990|NCT02260492|588496318|FG001|Overall Study|Physician Decision|0|||
162943991|NCT02260492|588496319|FG002|Overall Study|Physician Decision|1|||
162943992|NCT02260492|588496317|FG000|Overall Study|Withdrawal by Subject|3|||
162943993|NCT02260492|588496318|FG001|Overall Study|Withdrawal by Subject|2|||
162943994|NCT02260492|588496319|FG002|Overall Study|Withdrawal by Subject|2|||
162943995|NCT04634409|588496320|FG000|Overall Study|Death|0|||
162943996|NCT04634409|588496321|FG001|Overall Study|Death|0|||
162943997|NCT04634409|588496322|FG002|Overall Study|Death|0|||
162943998|NCT04634409|588496323|FG003|Overall Study|Death|0|||
162943999|NCT04634409|588496324|FG004|Overall Study|Death|0|||
162944000|NCT04634409|588496325|FG005|Overall Study|Death|0|||
162944001|NCT04634409|588496326|FG006|Overall Study|Death|0|||
162944002|NCT04634409|588496327|FG007|Overall Study|Death|0|||
162944003|NCT04634409|588496328|FG008|Overall Study|Death|0|||
162944004|NCT04634409|588496329|FG009|Overall Study|Death|0|||
162944005|NCT04634409|588496330|FG010|Overall Study|Death|1|||
162944006|NCT04634409|588496331|FG011|Overall Study|Death|0|||
162944007|NCT04634409|588496332|FG012|Overall Study|Death|1|||
162944008|NCT04634409|588496333|FG013|Overall Study|Death|0|||
162944009|NCT04634409|588496334|FG014|Overall Study|Death|0|||
162944010|NCT04634409|588496335|FG015|Overall Study|Death|0|||
162944011|NCT04634409|588496336|FG016|Overall Study|Death|0|||
162944012|NCT04634409|588496337|FG017|Overall Study|Death|0|||
162944013|NCT04634409|588496338|FG018|Overall Study|Death|0|||
162944014|NCT04634409|588496339|FG019|Overall Study|Death|0|||
162944015|NCT04634409|588496340|FG020|Overall Study|Death|0|||
162944016|NCT04634409|588496341|FG021|Overall Study|Death|0|||
162944017|NCT04634409|588496342|FG022|Overall Study|Death|0|||
162944018|NCT04634409|588496343|FG023|Overall Study|Death|0|||
162944019|NCT04634409|588496344|FG024|Overall Study|Death|0|||
162944020|NCT04634409|588496345|FG025|Overall Study|Death|0|||
162944021|NCT04634409|588496346|FG026|Overall Study|Death|0|||
162944022|NCT04634409|588496320|FG000|Overall Study|Adverse Event|0|||
162944023|NCT04634409|588496321|FG001|Overall Study|Adverse Event|0|||
162944024|NCT04634409|588496322|FG002|Overall Study|Adverse Event|1|||
162944025|NCT04634409|588496323|FG003|Overall Study|Adverse Event|0|||
162944026|NCT04634409|588496324|FG004|Overall Study|Adverse Event|0|||
162944027|NCT04634409|588496325|FG005|Overall Study|Adverse Event|1|||
162944028|NCT04634409|588496326|FG006|Overall Study|Adverse Event|0|||
162944029|NCT04634409|588496327|FG007|Overall Study|Adverse Event|0|||
162944030|NCT04634409|588496328|FG008|Overall Study|Adverse Event|0|||
162944031|NCT04634409|588496329|FG009|Overall Study|Adverse Event|0|||
162944032|NCT04634409|588496330|FG010|Overall Study|Adverse Event|0|||
162944033|NCT04634409|588496331|FG011|Overall Study|Adverse Event|0|||
162944034|NCT04634409|588496332|FG012|Overall Study|Adverse Event|0|||
162944035|NCT04634409|588496333|FG013|Overall Study|Adverse Event|0|||
162944036|NCT04634409|588496334|FG014|Overall Study|Adverse Event|0|||
162944037|NCT04634409|588496335|FG015|Overall Study|Adverse Event|0|||
162944038|NCT04634409|588496336|FG016|Overall Study|Adverse Event|0|||
162944039|NCT04634409|588496337|FG017|Overall Study|Adverse Event|0|||
162944040|NCT04634409|588496338|FG018|Overall Study|Adverse Event|0|||
162944041|NCT04634409|588496339|FG019|Overall Study|Adverse Event|0|||
162944042|NCT04634409|588496340|FG020|Overall Study|Adverse Event|0|||
162944043|NCT04634409|588496341|FG021|Overall Study|Adverse Event|0|||
162944044|NCT04634409|588496342|FG022|Overall Study|Adverse Event|0|||
162944045|NCT04634409|588496343|FG023|Overall Study|Adverse Event|0|||
162944046|NCT04634409|588496344|FG024|Overall Study|Adverse Event|0|||
162944047|NCT04634409|588496345|FG025|Overall Study|Adverse Event|0|||
162944048|NCT04634409|588496346|FG026|Overall Study|Adverse Event|0|||
162944049|NCT04634409|588496320|FG000|Overall Study|Lost to Follow-up|3|||
162944050|NCT04634409|588496321|FG001|Overall Study|Lost to Follow-up|1|||
162944051|NCT04634409|588496322|FG002|Overall Study|Lost to Follow-up|1|||
162944052|NCT04634409|588496323|FG003|Overall Study|Lost to Follow-up|3|||
162944053|NCT04634409|588496324|FG004|Overall Study|Lost to Follow-up|1|||
162944054|NCT04634409|588496325|FG005|Overall Study|Lost to Follow-up|1|||
162944055|NCT04634409|588496326|FG006|Overall Study|Lost to Follow-up|1|||
162944056|NCT04634409|588496327|FG007|Overall Study|Lost to Follow-up|3|||
162944057|NCT04634409|588496328|FG008|Overall Study|Lost to Follow-up|3|||
162944058|NCT04634409|588496329|FG009|Overall Study|Lost to Follow-up|11|||
162944059|NCT04634409|588496330|FG010|Overall Study|Lost to Follow-up|8|||
162944060|NCT04634409|588496331|FG011|Overall Study|Lost to Follow-up|15|||
162944061|NCT04634409|588496332|FG012|Overall Study|Lost to Follow-up|3|||
162944062|NCT04634409|588496333|FG013|Overall Study|Lost to Follow-up|2|||
162944063|NCT04634409|588496334|FG014|Overall Study|Lost to Follow-up|7|||
162944064|NCT04634409|588496335|FG015|Overall Study|Lost to Follow-up|0|||
162944065|NCT04634409|588496336|FG016|Overall Study|Lost to Follow-up|0|||
162944066|NCT04634409|588496337|FG017|Overall Study|Lost to Follow-up|0|||
162944067|NCT04634409|588496338|FG018|Overall Study|Lost to Follow-up|0|||
162944068|NCT04634409|588496339|FG019|Overall Study|Lost to Follow-up|0|||
162944069|NCT04634409|588496340|FG020|Overall Study|Lost to Follow-up|0|||
162944070|NCT04634409|588496341|FG021|Overall Study|Lost to Follow-up|0|||
162944071|NCT04634409|588496342|FG022|Overall Study|Lost to Follow-up|0|||
162944072|NCT04634409|588496343|FG023|Overall Study|Lost to Follow-up|0|||
162944073|NCT04634409|588496344|FG024|Overall Study|Lost to Follow-up|0|||
162944074|NCT04634409|588496345|FG025|Overall Study|Lost to Follow-up|0|||
162944075|NCT04634409|588496346|FG026|Overall Study|Lost to Follow-up|0|||
162944076|NCT04634409|588496320|FG000|Overall Study|Withdrawal by Subject|3|||
162944077|NCT04634409|588496321|FG001|Overall Study|Withdrawal by Subject|1|||
162944078|NCT04634409|588496322|FG002|Overall Study|Withdrawal by Subject|6|||
162944079|NCT04634409|588496323|FG003|Overall Study|Withdrawal by Subject|4|||
162944080|NCT04634409|588496324|FG004|Overall Study|Withdrawal by Subject|2|||
162944081|NCT04634409|588496325|FG005|Overall Study|Withdrawal by Subject|0|||
162944082|NCT04634409|588496326|FG006|Overall Study|Withdrawal by Subject|0|||
162944083|NCT04634409|588496327|FG007|Overall Study|Withdrawal by Subject|2|||
162944084|NCT04634409|588496328|FG008|Overall Study|Withdrawal by Subject|3|||
162944085|NCT04634409|588496329|FG009|Overall Study|Withdrawal by Subject|2|||
162944086|NCT04634409|588496330|FG010|Overall Study|Withdrawal by Subject|3|||
162944087|NCT04634409|588496331|FG011|Overall Study|Withdrawal by Subject|2|||
162944088|NCT04634409|588496332|FG012|Overall Study|Withdrawal by Subject|2|||
162944089|NCT04634409|588496333|FG013|Overall Study|Withdrawal by Subject|1|||
162944090|NCT04634409|588496334|FG014|Overall Study|Withdrawal by Subject|5|||
162944091|NCT04634409|588496335|FG015|Overall Study|Withdrawal by Subject|0|||
162944092|NCT04634409|588496336|FG016|Overall Study|Withdrawal by Subject|0|||
162944093|NCT04634409|588496337|FG017|Overall Study|Withdrawal by Subject|1|||
162944094|NCT04634409|588496338|FG018|Overall Study|Withdrawal by Subject|0|||
162944095|NCT04634409|588496339|FG019|Overall Study|Withdrawal by Subject|0|||
162944096|NCT04634409|588496340|FG020|Overall Study|Withdrawal by Subject|0|||
162944097|NCT04634409|588496341|FG021|Overall Study|Withdrawal by Subject|0|||
162944098|NCT04634409|588496342|FG022|Overall Study|Withdrawal by Subject|0|||
162944099|NCT04634409|588496343|FG023|Overall Study|Withdrawal by Subject|1|||
162944100|NCT04634409|588496344|FG024|Overall Study|Withdrawal by Subject|0|||
162944101|NCT04634409|588496345|FG025|Overall Study|Withdrawal by Subject|0|||
162944102|NCT04634409|588496346|FG026|Overall Study|Withdrawal by Subject|0|||
162944103|NCT04634409|588496320|FG000|Overall Study|Other - As reported by Investigator|1|||
162944104|NCT04634409|588496321|FG001|Overall Study|Other - As reported by Investigator|0|||
162944105|NCT04634409|588496322|FG002|Overall Study|Other - As reported by Investigator|0|||
162944106|NCT04634409|588496323|FG003|Overall Study|Other - As reported by Investigator|0|||
162944107|NCT04634409|588496324|FG004|Overall Study|Other - As reported by Investigator|0|||
162944108|NCT04634409|588496325|FG005|Overall Study|Other - As reported by Investigator|0|||
162944109|NCT04634409|588496326|FG006|Overall Study|Other - As reported by Investigator|0|||
162944110|NCT04634409|588496327|FG007|Overall Study|Other - As reported by Investigator|6|||
162944111|NCT04634409|588496328|FG008|Overall Study|Other - As reported by Investigator|4|||
162944112|NCT04634409|588496329|FG009|Overall Study|Other - As reported by Investigator|0|||
162944113|NCT04634409|588496330|FG010|Overall Study|Other - As reported by Investigator|1|||
162944114|NCT04634409|588496331|FG011|Overall Study|Other - As reported by Investigator|2|||
162944115|NCT04634409|588496332|FG012|Overall Study|Other - As reported by Investigator|2|||
162944116|NCT04634409|588496333|FG013|Overall Study|Other - As reported by Investigator|1|||
162944117|NCT04634409|588496334|FG014|Overall Study|Other - As reported by Investigator|0|||
162944118|NCT04634409|588496335|FG015|Overall Study|Other - As reported by Investigator|0|||
162944119|NCT04634409|588496336|FG016|Overall Study|Other - As reported by Investigator|0|||
162944120|NCT04634409|588496337|FG017|Overall Study|Other - As reported by Investigator|0|||
162944121|NCT04634409|588496338|FG018|Overall Study|Other - As reported by Investigator|0|||
162944122|NCT04634409|588496339|FG019|Overall Study|Other - As reported by Investigator|0|||
162944123|NCT04634409|588496340|FG020|Overall Study|Other - As reported by Investigator|0|||
162944124|NCT04634409|588496341|FG021|Overall Study|Other - As reported by Investigator|0|||
162944125|NCT04634409|588496342|FG022|Overall Study|Other - As reported by Investigator|0|||
162944126|NCT04634409|588496343|FG023|Overall Study|Other - As reported by Investigator|0|||
162944127|NCT04634409|588496344|FG024|Overall Study|Other - As reported by Investigator|0|||
162944128|NCT04634409|588496345|FG025|Overall Study|Other - As reported by Investigator|0|||
162944129|NCT04634409|588496346|FG026|Overall Study|Other - As reported by Investigator|0|||
163387649|NCT02121834|590129992|FG006|Overall Study|Withdrawal by Subject|0|||
163387650|NCT02121834|590129986|FG000|Overall Study|Lost to Follow-up|0|||
163387651|NCT02121834|590129987|FG001|Overall Study|Lost to Follow-up|0|||
163387652|NCT02121834|590129988|FG002|Overall Study|Lost to Follow-up|1|||
163387653|NCT02121834|590129989|FG003|Overall Study|Lost to Follow-up|0|||
163387654|NCT02121834|590129990|FG004|Overall Study|Lost to Follow-up|0|||
163387655|NCT02121834|590129991|FG005|Overall Study|Lost to Follow-up|0|||
163387656|NCT02121834|590129992|FG006|Overall Study|Lost to Follow-up|0|||
163387657|NCT02578862|590129993|FG000|Overall Study|Withdrawal by Subject|0|||
163387658|NCT02578862|590129994|FG001|Overall Study|Withdrawal by Subject|1|||
163387659|NCT02578862|590129993|FG000|Overall Study|Unplanned unilateral procedure|0|||
163387660|NCT02578862|590129994|FG001|Overall Study|Unplanned unilateral procedure|1|||
163387661|NCT01230788|590130003|FG000|Overall Study|Prescribed exclusion drug|1|||
163387662|NCT01142596|590130004|FG000|Overall Study|Withdrawal by Subject|9|||
163387663|NCT01142596|590130005|FG001|Overall Study|Withdrawal by Subject|35|||
163387664|NCT01142596|590130004|FG000|Overall Study|Adverse Event|8|||
163387665|NCT01142596|590130005|FG001|Overall Study|Adverse Event|35|||
163387666|NCT01142596|590130004|FG000|Overall Study|Lack of Efficacy|5|||
163387667|NCT01142596|590130005|FG001|Overall Study|Lack of Efficacy|9|||
163387668|NCT01142596|590130004|FG000|Overall Study|Lost to Follow-up|2|||
163387669|NCT01142596|590130005|FG001|Overall Study|Lost to Follow-up|3|||
163387670|NCT01142596|590130004|FG000|Overall Study|Other reason (not specified)|5|||
163387671|NCT01142596|590130005|FG001|Overall Study|Other reason (not specified)|4|||
163387672|NCT01794923|590130006|FG000|Overall Study|Adverse Event|0|||
163387673|NCT01794923|590130007|FG001|Overall Study|Adverse Event|0|||
163387674|NCT01794923|590130008|FG002|Overall Study|Adverse Event|1|||
162944130|NCT02683187|588496347|FG000|Overall Study|Failed IV access|3|||
162944131|NCT02683187|588496347|FG000|Overall Study|Withdrawal by Subject|5|||
162944132|NCT05665595|588498692|FG000|Overall Study|Ongoing|692|||
162944133|NCT05665595|588498693|FG001|Overall Study|Ongoing|698|||
162944134|NCT05665595|588498692|FG000|Overall Study|Withdrawal by Subject|2|||
162944135|NCT05665595|588498693|FG001|Overall Study|Withdrawal by Subject|2|||
162944136|NCT05665595|588498692|FG000|Overall Study|Lost to Follow-up|1|||
162944137|NCT05665595|588498693|FG001|Overall Study|Lost to Follow-up|0|||
162944138|NCT05665595|588498692|FG000|Overall Study|Death|6|||
162944139|NCT05665595|588498693|FG001|Overall Study|Death|1|||
162944140|NCT01768858|588498694|FG000|Overall Study|Lost to Follow-up|9|||
162944141|NCT01768858|588498694|FG000|Overall Study|Lack of Efficacy|8|||
162944142|NCT01768858|588498694|FG000|Overall Study|Serious Adverse Event|1|||
162944143|NCT01768858|588498694|FG000|Overall Study|Participant moved to Germany|1|||
162944144|NCT01768858|588498694|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
162944145|NCT01768858|588498694|FG000|Overall Study|Exanthema|1|||
162944146|NCT01768858|588498694|FG000|Overall Study|Withdrawal by Subject|1|||
162944147|NCT03471078|588498702|FG000|Overall Study|Withdrawal by Subject|9|||
162944148|NCT03471078|588498703|FG001|Overall Study|Withdrawal by Subject|1|||
162944149|NCT03471078|588498702|FG000|Overall Study|Adverse Event|4|||
162944150|NCT03471078|588498703|FG001|Overall Study|Adverse Event|1|||
162944151|NCT03471078|588498702|FG000|Overall Study|Physician Decision|3|||
162944152|NCT03471078|588498703|FG001|Overall Study|Physician Decision|2|||
162944153|NCT03471078|588498702|FG000|Overall Study|Death|2|||
162944154|NCT03471078|588498703|FG001|Overall Study|Death|0|||
162944155|NCT03471078|588498702|FG000|Overall Study|Other|3|||
162944156|NCT03471078|588498703|FG001|Overall Study|Other|2|||
162944157|NCT00502775|588498704|FG000|Overall Study|Adverse Event|1|||
162944158|NCT00502775|588498705|FG001|Overall Study|Adverse Event|2|||
162944159|NCT00502775|588498706|FG002|Overall Study|Adverse Event|1|||
162944160|NCT00502775|588498704|FG000|Overall Study|Protocol Violation|1|||
162944161|NCT00502775|588498705|FG001|Overall Study|Protocol Violation|5|||
162944162|NCT00502775|588498706|FG002|Overall Study|Protocol Violation|2|||
162944163|NCT00502775|588498704|FG000|Overall Study|Withdrawal by Subject|1|||
162944164|NCT00502775|588498705|FG001|Overall Study|Withdrawal by Subject|1|||
162944165|NCT00502775|588498706|FG002|Overall Study|Withdrawal by Subject|2|||
162944166|NCT00502775|588498704|FG000|Overall Study|Sponsor Terminated Study|1|||
162944167|NCT00502775|588498705|FG001|Overall Study|Sponsor Terminated Study|0|||
162944168|NCT00502775|588498706|FG002|Overall Study|Sponsor Terminated Study|1|||
162944169|NCT00502775|588498704|FG000|Overall Study|Non-compliance with eDiary|4|||
162944170|NCT00502775|588498705|FG001|Overall Study|Non-compliance with eDiary|1|||
162944171|NCT00502775|588498706|FG002|Overall Study|Non-compliance with eDiary|1|||
162944172|NCT00502775|588498704|FG000|Overall Study|Subject unable to swallow capsule|1|||
162944173|NCT00502775|588498705|FG001|Overall Study|Subject unable to swallow capsule|0|||
162944174|NCT00502775|588498706|FG002|Overall Study|Subject unable to swallow capsule|1|||
163291082|NCT01193153|589771200|FG000|Double Blind Relapse Prevention Period|Death|2|||
162944175|NCT00502775|588498704|FG000|Overall Study|Logpad compliance <80%|1|||
162944176|NCT00502775|588498705|FG001|Overall Study|Logpad compliance <80%|0|||
162944177|NCT00502775|588498706|FG002|Overall Study|Logpad compliance <80%|0|||
162944178|NCT00502775|588498704|FG000|Overall Study|Randomized in error|0|||
162944179|NCT00502775|588498705|FG001|Overall Study|Randomized in error|1|||
162944180|NCT00502775|588498706|FG002|Overall Study|Randomized in error|1|||
162944181|NCT00502775|588498704|FG000|Overall Study|Non-compliance|0|||
162944182|NCT00502775|588498705|FG001|Overall Study|Non-compliance|2|||
162944183|NCT00502775|588498706|FG002|Overall Study|Non-compliance|2|||
162944184|NCT00502775|588498704|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
162944185|NCT00502775|588498705|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
162944186|NCT00502775|588498706|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
162944187|NCT00502775|588498704|FG000|Overall Study|Declining pollen counts|0|||
162944188|NCT00502775|588498705|FG001|Overall Study|Declining pollen counts|1|||
162944189|NCT00502775|588498706|FG002|Overall Study|Declining pollen counts|1|||
163291083|NCT01193153|589771201|FG001|Double Blind Relapse Prevention Period|Death|0|||
163291084|NCT01193153|589771200|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
163291085|NCT01193153|589771201|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
163291086|NCT01193153|589771200|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
163291087|NCT01193153|589771201|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
162944190|NCT00502775|588498704|FG000|Overall Study|Subject in jail|0|||
162944191|NCT00502775|588498705|FG001|Overall Study|Subject in jail|1|||
162944192|NCT00502775|588498706|FG002|Overall Study|Subject in jail|0|||
162944193|NCT00502775|588498704|FG000|Overall Study|Subject took disallowed drug|0|||
162944194|NCT00502775|588498705|FG001|Overall Study|Subject took disallowed drug|0|||
162944195|NCT00502775|588498706|FG002|Overall Study|Subject took disallowed drug|1|||
162944196|NCT05381948|588498709|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
162944197|NCT05381948|588498710|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
162944198|NCT05381948|588498711|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
162944199|NCT05381948|588498709|FG000|Overall Study|Adverse Event: Non-ocular|0|||
162944200|NCT05381948|588498710|FG001|Overall Study|Adverse Event: Non-ocular|1|||
162944201|NCT05381948|588498711|FG002|Overall Study|Adverse Event: Non-ocular|0|||
162944202|NCT05381948|588498709|FG000|Overall Study|Lost to Follow-up|1|||
162944203|NCT05381948|588498710|FG001|Overall Study|Lost to Follow-up|0|||
162944204|NCT05381948|588498711|FG002|Overall Study|Lost to Follow-up|0|||
162944205|NCT05381948|588498709|FG000|Overall Study|Protocol Deviation|0|||
162944206|NCT05381948|588498710|FG001|Overall Study|Protocol Deviation|2|||
162944207|NCT05381948|588498711|FG002|Overall Study|Protocol Deviation|0|||
162944208|NCT05381948|588498709|FG000|Overall Study|Withdrawal by Subject|1|||
162944209|NCT05381948|588498710|FG001|Overall Study|Withdrawal by Subject|0|||
162944210|NCT05381948|588498711|FG002|Overall Study|Withdrawal by Subject|1|||
162944211|NCT05381948|588498709|FG000|Overall Study|Death|0|||
162944212|NCT05381948|588498710|FG001|Overall Study|Death|2|||
162944213|NCT05381948|588498711|FG002|Overall Study|Death|0|||
162944214|NCT05381948|588498709|FG000|Overall Study|Discontinued study without receiving study drug|0|||
162944215|NCT05381948|588498710|FG001|Overall Study|Discontinued study without receiving study drug|0|||
162944216|NCT05381948|588498711|FG002|Overall Study|Discontinued study without receiving study drug|1|||
162944217|NCT04471207|588498712|FG000|Overall Study|Lost to Follow-up|4|||
162944218|NCT04471207|588498713|FG001|Overall Study|Lost to Follow-up|1|||
162944219|NCT04471207|588498712|FG000|Overall Study|Medication Contraindication|0|||
162944220|NCT04471207|588498713|FG001|Overall Study|Medication Contraindication|1|||
162944221|NCT04471207|588498712|FG000|Overall Study|Loss of Interest|2|||
162944222|NCT04471207|588498713|FG001|Overall Study|Loss of Interest|1|||
162944223|NCT04471207|588498712|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
162944224|NCT04471207|588498713|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
162944225|NCT04471207|588498712|FG000|Overall Study|Scheduling Conflicts|3|||
162944226|NCT04471207|588498713|FG001|Overall Study|Scheduling Conflicts|1|||
162944227|NCT04471207|588498712|FG000|Overall Study|Physician Decision|1|||
162944228|NCT04471207|588498713|FG001|Overall Study|Physician Decision|0|||
162944229|NCT04471207|588498712|FG000|Overall Study|Unwilling to Use System|0|||
162944230|NCT04471207|588498713|FG001|Overall Study|Unwilling to Use System|1|||
163186120|NCT02992132|589397684|FG000|Overall Study|Non-compliance with study drug|2|||
163186121|NCT02992132|589397685|FG001|Overall Study|Non-compliance with study drug|0|||
163186122|NCT02992132|589397686|FG002|Overall Study|Non-compliance with study drug|0|||
163186123|NCT02992132|589397684|FG000|Overall Study|Progressive disease|1|||
163186124|NCT02992132|589397685|FG001|Overall Study|Progressive disease|0|||
163186125|NCT02992132|589397686|FG002|Overall Study|Progressive disease|0|||
163186126|NCT02992132|589397684|FG000|Overall Study|Protocol Violation|2|||
163186127|NCT02992132|589397685|FG001|Overall Study|Protocol Violation|2|||
163186128|NCT02992132|589397686|FG002|Overall Study|Protocol Violation|0|||
163186129|NCT02992132|589397684|FG000|Overall Study|Caregiver withdrew consent|2|||
163186130|NCT02992132|589397685|FG001|Overall Study|Caregiver withdrew consent|3|||
163186131|NCT02992132|589397686|FG002|Overall Study|Caregiver withdrew consent|2|||
163186132|NCT02992132|589397684|FG000|Overall Study|Withdrawal by Subject|0|||
163186133|NCT02992132|589397685|FG001|Overall Study|Withdrawal by Subject|2|||
163186134|NCT02992132|589397686|FG002|Overall Study|Withdrawal by Subject|1|||
163186135|NCT02992132|589397684|FG000|Overall Study|Physician Decision|0|||
163186136|NCT02992132|589397685|FG001|Overall Study|Physician Decision|0|||
163186137|NCT02992132|589397686|FG002|Overall Study|Physician Decision|1|||
163186138|NCT02448810|589397687|FG000|Overall Study|Adverse Event|0|||
162944231|NCT00520741|588498716|FG000|Overall Study|Adverse Event|16|||
162944232|NCT00520741|588498717|FG001|Overall Study|Adverse Event|56|||
162944233|NCT00520741|588498716|FG000|Overall Study|Lack of Efficacy|11|||
162944234|NCT00520741|588498717|FG001|Overall Study|Lack of Efficacy|30|||
162944235|NCT00520741|588498716|FG000|Overall Study|Withdrawal by Subject|0|||
162944236|NCT00520741|588498717|FG001|Overall Study|Withdrawal by Subject|11|||
163291088|NCT01193153|589771200|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
163291089|NCT01193153|589771201|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
163291090|NCT01193153|589771200|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
163291091|NCT01193153|589771201|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
163291092|NCT01193153|589771200|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
163291093|NCT01193153|589771201|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
163291094|NCT00344019|589771202|FG000|Overall Study|did not meet final inclusion criteria|0|||
163291095|NCT00344019|589771203|FG001|Overall Study|did not meet final inclusion criteria|0|||
163291096|NCT00344019|589771204|FG002|Overall Study|did not meet final inclusion criteria|74|||
163291097|NCT02503202|589771205|FG000|Base Study: Up to Month 6|Death|1|||
163291098|NCT02503202|589771206|FG001|Base Study: Up to Month 6|Death|1|||
163291099|NCT02503202|589771207|FG002|Base Study: Up to Month 6|Death|0|||
163291100|NCT02503202|589771208|FG003|Base Study: Up to Month 6|Death|0|||
163291101|NCT02503202|589771209|FG004|Base Study: Up to Month 6|Death|0|||
163291102|NCT02503202|589771205|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
163291103|NCT02503202|589771206|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
163291104|NCT02503202|589771207|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
163291105|NCT02503202|589771208|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
163291106|NCT02503202|589771209|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
163291107|NCT02503202|589771205|FG000|Base Study: Up to Month 6|Physician Decision|0|||
163291108|NCT02503202|589771206|FG001|Base Study: Up to Month 6|Physician Decision|0|||
163291109|NCT02503202|589771207|FG002|Base Study: Up to Month 6|Physician Decision|0|||
163291110|NCT02503202|589771208|FG003|Base Study: Up to Month 6|Physician Decision|0|||
163291111|NCT02503202|589771209|FG004|Base Study: Up to Month 6|Physician Decision|1|||
163291112|NCT02503202|589771205|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
163291113|NCT02503202|589771206|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
163291114|NCT02503202|589771207|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
163291115|NCT02503202|589771208|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
163291116|NCT02503202|589771209|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
163291117|NCT02503202|589771205|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
163291118|NCT02503202|589771206|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
163291119|NCT02503202|589771207|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
163291120|NCT02503202|589771208|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
163291121|NCT02503202|589771209|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
163291122|NCT02503202|589771205|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
163291123|NCT02503202|589771206|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
163291124|NCT02503202|589771207|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
163291125|NCT02503202|589771208|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
163291126|NCT02503202|589771209|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
163291127|NCT02503202|589771205|FG000|Extension: Month 6 to 24|Death|1|||
163291128|NCT02503202|589771206|FG001|Extension: Month 6 to 24|Death|0|||
163291129|NCT02503202|589771207|FG002|Extension: Month 6 to 24|Death|0|||
163291130|NCT02503202|589771208|FG003|Extension: Month 6 to 24|Death|0|||
163291131|NCT02503202|589771209|FG004|Extension: Month 6 to 24|Death|0|||
163291132|NCT02503202|589771205|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
163291133|NCT02503202|589771206|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
163291134|NCT02503202|589771207|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
163291135|NCT02503202|589771208|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
163291136|NCT02503202|589771209|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
163291137|NCT02503202|589771205|FG000|Extension: Month 6 to 24|Physician Decision|1|||
163291138|NCT02503202|589771206|FG001|Extension: Month 6 to 24|Physician Decision|0|||
163291139|NCT02503202|589771207|FG002|Extension: Month 6 to 24|Physician Decision|1|||
163291140|NCT02503202|589771208|FG003|Extension: Month 6 to 24|Physician Decision|3|||
163291141|NCT02503202|589771209|FG004|Extension: Month 6 to 24|Physician Decision|0|||
163291142|NCT02503202|589771205|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
163291143|NCT02503202|589771206|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
163186139|NCT02448810|589397688|FG001|Overall Study|Adverse Event|0|||
163186140|NCT02448810|589397689|FG002|Overall Study|Adverse Event|1|||
163186141|NCT02448810|589397690|FG003|Overall Study|Adverse Event|0|||
163186142|NCT02448810|589397691|FG004|Overall Study|Adverse Event|0|||
163186143|NCT02448810|589397692|FG005|Overall Study|Adverse Event|0|||
163186144|NCT02448810|589397693|FG006|Overall Study|Adverse Event|0|||
163186145|NCT02448810|589397694|FG007|Overall Study|Adverse Event|0|||
163186146|NCT02448810|589397687|FG000|Overall Study|Withdrawal by Subject|0|||
163186147|NCT02448810|589397688|FG001|Overall Study|Withdrawal by Subject|0|||
163186148|NCT02448810|589397689|FG002|Overall Study|Withdrawal by Subject|1|||
163186149|NCT02448810|589397690|FG003|Overall Study|Withdrawal by Subject|0|||
163291144|NCT02503202|589771207|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
163291145|NCT02503202|589771208|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
163291146|NCT02503202|589771209|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
163186150|NCT02448810|589397691|FG004|Overall Study|Withdrawal by Subject|3|||
163291147|NCT01591616|589771212|FG000|Overall Study|Withdrawal by Subject|1|||
163291148|NCT00758602|589771213|FG000|Overall Study|Adverse Event|11|||
163291149|NCT00758602|589771214|FG001|Overall Study|Adverse Event|10|||
163291150|NCT00758602|589771213|FG000|Overall Study|Lost to Follow-up|4|||
163291151|NCT00758602|589771214|FG001|Overall Study|Lost to Follow-up|3|||
163291152|NCT00758602|589771213|FG000|Overall Study|Withdrawal by Subject|1|||
163291153|NCT00758602|589771214|FG001|Overall Study|Withdrawal by Subject|3|||
163291154|NCT00758602|589771213|FG000|Overall Study|Protocol Violation|0|||
163291155|NCT00758602|589771214|FG001|Overall Study|Protocol Violation|2|||
163291156|NCT00758602|589771213|FG000|Overall Study|Death|0|||
163291157|NCT00758602|589771214|FG001|Overall Study|Death|1|||
163291158|NCT00758602|589771213|FG000|Overall Study|Reason not specified|3|||
163291159|NCT00758602|589771214|FG001|Overall Study|Reason not specified|3|||
163291160|NCT02148133|589771223|FG000|Overall Study|Investigator discretion|1|||
163291161|NCT02148133|589771223|FG000|Overall Study|Lack of Efficacy|1|||
163291162|NCT02148133|589771223|FG000|Overall Study|Protocol deviation|1|||
163291163|NCT02148133|589771223|FG000|Overall Study|Protocol-defined stopping criteria|2|||
163291164|NCT03808883|589771224|FG000|Overall Study|Withdrawal by Subject|2|||
163291165|NCT03808883|589771225|FG001|Overall Study|Withdrawal by Subject|0|||
163291166|NCT03808883|589771224|FG000|Overall Study|Did not complete pre test or post test survey|4|||
163291167|NCT03808883|589771225|FG001|Overall Study|Did not complete pre test or post test survey|3|||
163291168|NCT00855465|589771229|FG000|Treatment Period|Adverse Event|4|||
163291169|NCT00855465|589771230|FG001|Treatment Period|Adverse Event|2|||
163291170|NCT00855465|589771229|FG000|Treatment Period|Death|2|||
163291171|NCT00855465|589771230|FG001|Treatment Period|Death|2|||
163291172|NCT00855465|589771229|FG000|Treatment Period|Lack of Efficacy|2|||
163291173|NCT00855465|589771230|FG001|Treatment Period|Lack of Efficacy|1|||
163291174|NCT00855465|589771229|FG000|Treatment Period|Non-compliance|1|||
163291175|NCT00855465|589771230|FG001|Treatment Period|Non-compliance|0|||
163291176|NCT00855465|589771229|FG000|Treatment Period|Protocol Violation|2|||
163291177|NCT00855465|589771230|FG001|Treatment Period|Protocol Violation|0|||
163291178|NCT00855465|589771229|FG000|Treatment Period|Withdrawal by Subject|2|||
163291179|NCT00855465|589771230|FG001|Treatment Period|Withdrawal by Subject|0|||
163291180|NCT00855465|589771229|FG000|Treatment Period|Not treated|1|||
163291181|NCT00855465|589771230|FG001|Treatment Period|Not treated|0|||
163291182|NCT00855465|589771229|FG000|Follow-up Period (FUP)|Adverse Event|0|||
163291183|NCT00855465|589771230|FG001|Follow-up Period (FUP)|Adverse Event|1|||
163291184|NCT00855465|589771229|FG000|Follow-up Period (FUP)|Death|0|||
163291185|NCT00855465|589771230|FG001|Follow-up Period (FUP)|Death|1|||
163291186|NCT00855465|589771229|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
163291187|NCT00855465|589771230|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
163291188|NCT00855465|589771229|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
163291189|NCT00855465|589771230|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
163291190|NCT00855465|589771229|FG000|Follow-up Period (FUP)|Missing|1|||
163291191|NCT00855465|589771230|FG001|Follow-up Period (FUP)|Missing|0|||
163291192|NCT00612586|589771239|FG000|Overall Study|Adverse Event|6|||
163291193|NCT00612586|589771240|FG001|Overall Study|Adverse Event|2|||
163291194|NCT00612586|589771239|FG000|Overall Study|Death|1|||
163291195|NCT00612586|589771240|FG001|Overall Study|Death|0|||
163291196|NCT00612586|589771239|FG000|Overall Study|Entry Criteria Not Met|0|||
163291197|NCT00612586|589771240|FG001|Overall Study|Entry Criteria Not Met|2|||
163291198|NCT00612586|589771239|FG000|Overall Study|Withdrawal by Subject|7|||
163291199|NCT00612586|589771240|FG001|Overall Study|Withdrawal by Subject|9|||
163291200|NCT00612586|589771239|FG000|Overall Study|Physician Decision|1|||
163291201|NCT00612586|589771240|FG001|Overall Study|Physician Decision|2|||
163291202|NCT00612586|589771239|FG000|Overall Study|Sponsor Decision|1|||
163291203|NCT00612586|589771240|FG001|Overall Study|Sponsor Decision|1|||
163291204|NCT00612586|589771239|FG000|Overall Study|Progressive Disease|26|||
163291205|NCT00612586|589771240|FG001|Overall Study|Progressive Disease|24|||
163291206|NCT00612586|589771239|FG000|Overall Study|Randomized and Not Treated|1|||
163291207|NCT00612586|589771240|FG001|Overall Study|Randomized and Not Treated|1|||
163291208|NCT02613364|589771241|FG000|Overall Study|Other|19|||
163291209|NCT02613364|589771242|FG001|Overall Study|Other|29|||
163291210|NCT02613364|589771243|FG002|Overall Study|Other|17|||
163291211|NCT02613364|589771241|FG000|Overall Study|Too time consuming|21|||
163291212|NCT02613364|589771242|FG001|Overall Study|Too time consuming|26|||
163291213|NCT02613364|589771243|FG002|Overall Study|Too time consuming|26|||
163291214|NCT02613364|589771241|FG000|Overall Study|Withdrawal by Subject|13|||
163291215|NCT02613364|589771242|FG001|Overall Study|Withdrawal by Subject|18|||
163291216|NCT02613364|589771243|FG002|Overall Study|Withdrawal by Subject|17|||
163291217|NCT02613364|589771241|FG000|Overall Study|Medical|12|||
163291218|NCT02613364|589771242|FG001|Overall Study|Medical|13|||
163291219|NCT02613364|589771243|FG002|Overall Study|Medical|9|||
163291220|NCT02613364|589771241|FG000|Overall Study|Disliked Study Procedure|1|||
163291221|NCT02613364|589771242|FG001|Overall Study|Disliked Study Procedure|1|||
163291222|NCT02613364|589771243|FG002|Overall Study|Disliked Study Procedure|4|||
163291223|NCT02613364|589771241|FG000|Overall Study|Disliked Intervention|0|||
163291224|NCT02613364|589771242|FG001|Overall Study|Disliked Intervention|3|||
163291225|NCT02613364|589771243|FG002|Overall Study|Disliked Intervention|3|||
163291226|NCT01909336|589771244|FG000|Overall Study|Lost to Follow-up|4|||
163291227|NCT01909336|589771245|FG001|Overall Study|Lost to Follow-up|2|||
163291228|NCT01909336|589771246|FG002|Overall Study|Lost to Follow-up|2|||
163291229|NCT01909336|589771244|FG000|Overall Study|Physician Decision|0|||
163291230|NCT01909336|589771245|FG001|Overall Study|Physician Decision|1|||
163291231|NCT01909336|589771246|FG002|Overall Study|Physician Decision|1|||
163291232|NCT01235949|589771247|FG000|Primary Phase|Migrated/moved from study area|1|||
163291233|NCT01235949|589771248|FG001|Primary Phase|Migrated/moved from study area|1|||
163291234|NCT01235949|589771249|FG002|Primary Phase|Migrated/moved from study area|0|||
163291235|NCT01235949|589771250|FG003|Primary Phase|Migrated/moved from study area|0|||
163291236|NCT01235949|589771251|FG004|Primary Phase|Migrated/moved from study area|1|||
163291237|NCT01235949|589771252|FG005|Primary Phase|Migrated/moved from study area|2|||
163291238|NCT01235949|589771253|FG006|Primary Phase|Migrated/moved from study area|0|||
163291239|NCT01235949|589771254|FG007|Primary Phase|Migrated/moved from study area|0|||
163291240|NCT01235949|589771255|FG008|Primary Phase|Migrated/moved from study area|0|||
163291241|NCT01235949|589771256|FG009|Primary Phase|Migrated/moved from study area|0|||
163291242|NCT01235949|589771257|FG010|Primary Phase|Migrated/moved from study area|0|||
163291243|NCT01235949|589771258|FG011|Primary Phase|Migrated/moved from study area|0|||
163291244|NCT01235949|589771259|FG012|Primary Phase|Migrated/moved from study area|0|||
163291245|NCT01235949|589771260|FG013|Primary Phase|Migrated/moved from study area|0|||
163291246|NCT01235949|589771261|FG014|Primary Phase|Migrated/moved from study area|0|||
163291247|NCT01235949|589771262|FG015|Primary Phase|Migrated/moved from study area|0|||
163291248|NCT01235949|589771263|FG016|Primary Phase|Migrated/moved from study area|0|||
163291249|NCT01235949|589771264|FG017|Primary Phase|Migrated/moved from study area|0|||
163291250|NCT01235949|589771247|FG000|Primary Phase|Adverse Event|0|||
163291251|NCT01235949|589771248|FG001|Primary Phase|Adverse Event|0|||
163291252|NCT01235949|589771249|FG002|Primary Phase|Adverse Event|0|||
163291253|NCT01235949|589771250|FG003|Primary Phase|Adverse Event|1|||
163291254|NCT01235949|589771251|FG004|Primary Phase|Adverse Event|0|||
163291255|NCT01235949|589771252|FG005|Primary Phase|Adverse Event|0|||
163291256|NCT01235949|589771253|FG006|Primary Phase|Adverse Event|0|||
163291257|NCT01235949|589771254|FG007|Primary Phase|Adverse Event|0|||
163291258|NCT01235949|589771255|FG008|Primary Phase|Adverse Event|0|||
163291259|NCT01235949|589771256|FG009|Primary Phase|Adverse Event|0|||
163291260|NCT01235949|589771257|FG010|Primary Phase|Adverse Event|0|||
163291261|NCT01235949|589771258|FG011|Primary Phase|Adverse Event|0|||
163291262|NCT01235949|589771259|FG012|Primary Phase|Adverse Event|0|||
163291263|NCT01235949|589771260|FG013|Primary Phase|Adverse Event|0|||
163291264|NCT01235949|589771261|FG014|Primary Phase|Adverse Event|0|||
163291265|NCT01235949|589771262|FG015|Primary Phase|Adverse Event|0|||
163291266|NCT01235949|589771263|FG016|Primary Phase|Adverse Event|0|||
163291267|NCT01235949|589771264|FG017|Primary Phase|Adverse Event|0|||
163291268|NCT01235949|589771247|FG000|Primary Phase|Withdrawal by Subject|3|||
163291269|NCT01235949|589771248|FG001|Primary Phase|Withdrawal by Subject|2|||
163291270|NCT01235949|589771249|FG002|Primary Phase|Withdrawal by Subject|2|||
163291271|NCT01235949|589771250|FG003|Primary Phase|Withdrawal by Subject|0|||
163291272|NCT01235949|589771251|FG004|Primary Phase|Withdrawal by Subject|0|||
163291273|NCT01235949|589771252|FG005|Primary Phase|Withdrawal by Subject|3|||
163291274|NCT01235949|589771253|FG006|Primary Phase|Withdrawal by Subject|0|||
163291275|NCT01235949|589771254|FG007|Primary Phase|Withdrawal by Subject|0|||
163291276|NCT01235949|589771255|FG008|Primary Phase|Withdrawal by Subject|0|||
163291277|NCT01235949|589771256|FG009|Primary Phase|Withdrawal by Subject|0|||
163291278|NCT01235949|589771257|FG010|Primary Phase|Withdrawal by Subject|0|||
163291279|NCT01235949|589771258|FG011|Primary Phase|Withdrawal by Subject|0|||
163291280|NCT01235949|589771259|FG012|Primary Phase|Withdrawal by Subject|0|||
163291281|NCT01235949|589771260|FG013|Primary Phase|Withdrawal by Subject|0|||
163291282|NCT01235949|589771261|FG014|Primary Phase|Withdrawal by Subject|0|||
163291283|NCT01235949|589771262|FG015|Primary Phase|Withdrawal by Subject|0|||
163291284|NCT01235949|589771263|FG016|Primary Phase|Withdrawal by Subject|0|||
163291285|NCT01235949|589771264|FG017|Primary Phase|Withdrawal by Subject|0|||
163291286|NCT01235949|589771247|FG000|Primary Phase|Lost to Follow-up|0|||
163291287|NCT01235949|589771248|FG001|Primary Phase|Lost to Follow-up|0|||
163291288|NCT01235949|589771249|FG002|Primary Phase|Lost to Follow-up|1|||
163291289|NCT01235949|589771250|FG003|Primary Phase|Lost to Follow-up|1|||
163291290|NCT01235949|589771251|FG004|Primary Phase|Lost to Follow-up|0|||
163291291|NCT01235949|589771252|FG005|Primary Phase|Lost to Follow-up|2|||
163291292|NCT01235949|589771253|FG006|Primary Phase|Lost to Follow-up|0|||
163291293|NCT01235949|589771254|FG007|Primary Phase|Lost to Follow-up|0|||
163291294|NCT01235949|589771255|FG008|Primary Phase|Lost to Follow-up|0|||
163291295|NCT01235949|589771256|FG009|Primary Phase|Lost to Follow-up|0|||
163291296|NCT01235949|589771257|FG010|Primary Phase|Lost to Follow-up|0|||
163291297|NCT01235949|589771258|FG011|Primary Phase|Lost to Follow-up|0|||
163291298|NCT01235949|589771259|FG012|Primary Phase|Lost to Follow-up|0|||
163291299|NCT01235949|589771260|FG013|Primary Phase|Lost to Follow-up|0|||
163291300|NCT01235949|589771261|FG014|Primary Phase|Lost to Follow-up|0|||
163291301|NCT01235949|589771262|FG015|Primary Phase|Lost to Follow-up|0|||
163291302|NCT01235949|589771263|FG016|Primary Phase|Lost to Follow-up|0|||
163291303|NCT01235949|589771264|FG017|Primary Phase|Lost to Follow-up|0|||
163291304|NCT01235949|589771247|FG000|Booster Phase|Migrated/moved from study area|0|||
163291305|NCT01235949|589771248|FG001|Booster Phase|Migrated/moved from study area|0|||
163291306|NCT01235949|589771249|FG002|Booster Phase|Migrated/moved from study area|0|||
163291307|NCT01235949|589771250|FG003|Booster Phase|Migrated/moved from study area|0|||
163291308|NCT01235949|589771251|FG004|Booster Phase|Migrated/moved from study area|0|||
163291309|NCT01235949|589771252|FG005|Booster Phase|Migrated/moved from study area|0|||
163291310|NCT01235949|589771253|FG006|Booster Phase|Migrated/moved from study area|0|||
163291311|NCT01235949|589771254|FG007|Booster Phase|Migrated/moved from study area|0|||
163291312|NCT01235949|589771255|FG008|Booster Phase|Migrated/moved from study area|0|||
163291313|NCT01235949|589771256|FG009|Booster Phase|Migrated/moved from study area|0|||
163291314|NCT01235949|589771257|FG010|Booster Phase|Migrated/moved from study area|0|||
163291315|NCT01235949|589771258|FG011|Booster Phase|Migrated/moved from study area|1|||
163291316|NCT01235949|589771259|FG012|Booster Phase|Migrated/moved from study area|1|||
163291317|NCT01235949|589771260|FG013|Booster Phase|Migrated/moved from study area|0|||
163291318|NCT01235949|589771261|FG014|Booster Phase|Migrated/moved from study area|0|||
163291319|NCT01235949|589771262|FG015|Booster Phase|Migrated/moved from study area|0|||
163291320|NCT01235949|589771263|FG016|Booster Phase|Migrated/moved from study area|0|||
163291321|NCT01235949|589771264|FG017|Booster Phase|Migrated/moved from study area|1|||
163291322|NCT01235949|589771247|FG000|Booster Phase|Adverse Event|0|||
163291323|NCT01235949|589771248|FG001|Booster Phase|Adverse Event|0|||
163291324|NCT01235949|589771249|FG002|Booster Phase|Adverse Event|0|||
163291325|NCT01235949|589771250|FG003|Booster Phase|Adverse Event|0|||
163291326|NCT01235949|589771251|FG004|Booster Phase|Adverse Event|0|||
162944237|NCT00520741|588498716|FG000|Overall Study|Protocol Violation|2|||
162944238|NCT00520741|588498717|FG001|Overall Study|Protocol Violation|15|||
162944239|NCT00520741|588498716|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
163291327|NCT01235949|589771252|FG005|Booster Phase|Adverse Event|0|||
163291328|NCT01235949|589771253|FG006|Booster Phase|Adverse Event|0|||
163291329|NCT01235949|589771254|FG007|Booster Phase|Adverse Event|0|||
163291330|NCT01235949|589771255|FG008|Booster Phase|Adverse Event|0|||
163291331|NCT01235949|589771256|FG009|Booster Phase|Adverse Event|0|||
163291332|NCT01235949|589771257|FG010|Booster Phase|Adverse Event|0|||
163291333|NCT01235949|589771258|FG011|Booster Phase|Adverse Event|0|||
163291334|NCT01235949|589771259|FG012|Booster Phase|Adverse Event|0|||
163291335|NCT01235949|589771260|FG013|Booster Phase|Adverse Event|0|||
163291336|NCT01235949|589771261|FG014|Booster Phase|Adverse Event|0|||
163291337|NCT01235949|589771262|FG015|Booster Phase|Adverse Event|1|||
163291338|NCT01235949|589771263|FG016|Booster Phase|Adverse Event|0|||
163291339|NCT01235949|589771264|FG017|Booster Phase|Adverse Event|0|||
163291340|NCT01235949|589771247|FG000|Booster Phase|Withdrawal by Subject|0|||
163291341|NCT01235949|589771248|FG001|Booster Phase|Withdrawal by Subject|0|||
163291342|NCT01235949|589771249|FG002|Booster Phase|Withdrawal by Subject|0|||
163291343|NCT01235949|589771250|FG003|Booster Phase|Withdrawal by Subject|0|||
163291344|NCT01235949|589771251|FG004|Booster Phase|Withdrawal by Subject|0|||
163291345|NCT01235949|589771252|FG005|Booster Phase|Withdrawal by Subject|0|||
163291346|NCT01235949|589771253|FG006|Booster Phase|Withdrawal by Subject|0|||
163291347|NCT01235949|589771254|FG007|Booster Phase|Withdrawal by Subject|1|||
163291348|NCT01235949|589771255|FG008|Booster Phase|Withdrawal by Subject|1|||
163291349|NCT01235949|589771256|FG009|Booster Phase|Withdrawal by Subject|0|||
163291350|NCT01235949|589771257|FG010|Booster Phase|Withdrawal by Subject|1|||
163291351|NCT01235949|589771258|FG011|Booster Phase|Withdrawal by Subject|1|||
163291352|NCT01235949|589771259|FG012|Booster Phase|Withdrawal by Subject|2|||
163291353|NCT01235949|589771260|FG013|Booster Phase|Withdrawal by Subject|0|||
163291354|NCT01235949|589771261|FG014|Booster Phase|Withdrawal by Subject|2|||
163291355|NCT01235949|589771262|FG015|Booster Phase|Withdrawal by Subject|0|||
163291356|NCT01235949|589771263|FG016|Booster Phase|Withdrawal by Subject|0|||
163291357|NCT01235949|589771264|FG017|Booster Phase|Withdrawal by Subject|0|||
163291358|NCT01235949|589771247|FG000|Booster Phase|Lost to Follow-up|0|||
163291359|NCT01235949|589771248|FG001|Booster Phase|Lost to Follow-up|0|||
163291360|NCT01235949|589771249|FG002|Booster Phase|Lost to Follow-up|0|||
162944240|NCT00520741|588498717|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
162944241|NCT00520741|588498716|FG000|Overall Study|Lost to Follow-up|4|||
162944242|NCT00520741|588498717|FG001|Overall Study|Lost to Follow-up|4|||
163291361|NCT01235949|589771250|FG003|Booster Phase|Lost to Follow-up|0|||
162944243|NCT00520741|588498716|FG000|Overall Study|Other reasons for premature termination|0|||
163291362|NCT01235949|589771251|FG004|Booster Phase|Lost to Follow-up|0|||
163291363|NCT01235949|589771252|FG005|Booster Phase|Lost to Follow-up|0|||
163291364|NCT01235949|589771253|FG006|Booster Phase|Lost to Follow-up|0|||
163291365|NCT01235949|589771254|FG007|Booster Phase|Lost to Follow-up|0|||
163291366|NCT01235949|589771255|FG008|Booster Phase|Lost to Follow-up|1|||
163291367|NCT01235949|589771256|FG009|Booster Phase|Lost to Follow-up|1|||
163291368|NCT01235949|589771257|FG010|Booster Phase|Lost to Follow-up|1|||
163291369|NCT01235949|589771258|FG011|Booster Phase|Lost to Follow-up|1|||
163291370|NCT01235949|589771259|FG012|Booster Phase|Lost to Follow-up|0|||
163291371|NCT01235949|589771260|FG013|Booster Phase|Lost to Follow-up|0|||
163291372|NCT01235949|589771261|FG014|Booster Phase|Lost to Follow-up|0|||
163291373|NCT01235949|589771262|FG015|Booster Phase|Lost to Follow-up|0|||
163291374|NCT01235949|589771263|FG016|Booster Phase|Lost to Follow-up|0|||
163291375|NCT01235949|589771264|FG017|Booster Phase|Lost to Follow-up|1|||
163291376|NCT03743246|589771265|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
163291377|NCT03743246|589771266|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
163291378|NCT03743246|589771267|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
163291379|NCT03743246|589771268|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
163291380|NCT03743246|589771265|FG000|Pre-Treatment Period|Death|0|||
163291381|NCT03743246|589771266|FG001|Pre-Treatment Period|Death|1|||
163291382|NCT03743246|589771267|FG002|Pre-Treatment Period|Death|0|||
163291383|NCT03743246|589771268|FG003|Pre-Treatment Period|Death|1|||
163291384|NCT03743246|589771265|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
163291385|NCT03743246|589771266|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
163291386|NCT03743246|589771267|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
163291387|NCT03743246|589771268|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
163291388|NCT03743246|589771265|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
163291389|NCT03743246|589771266|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
163291390|NCT03743246|589771267|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
163291391|NCT03743246|589771268|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
163291392|NCT03743246|589771265|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
163291393|NCT03743246|589771266|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
163291394|NCT03743246|589771267|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
163291395|NCT03743246|589771268|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
163291396|NCT03743246|589771265|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
163291397|NCT03743246|589771266|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
163291398|NCT03743246|589771267|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
163291399|NCT03743246|589771268|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
163291400|NCT03743246|589771265|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
163291401|NCT03743246|589771266|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
163291402|NCT03743246|589771267|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
163291403|NCT03743246|589771268|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
163291404|NCT03743246|589771265|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
163291405|NCT03743246|589771266|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
163291406|NCT03743246|589771267|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
163291407|NCT03743246|589771268|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
163291408|NCT03743246|589771265|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
163291409|NCT03743246|589771266|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
163291410|NCT03743246|589771267|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
163291411|NCT03743246|589771268|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
163291412|NCT00395018|589771269|FG000|On-Treatment|Death|4|||
163291413|NCT00395018|589771269|FG000|On-Treatment|Other Reason|2|||
163291414|NCT00395018|589771269|FG000|On-Treatment|Poor/non-compliance|2|||
163291415|NCT00395018|589771269|FG000|On-Treatment|Subject no longer meets study criteria|2|||
163291416|NCT00395018|589771269|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
163291417|NCT00395018|589771269|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
163291418|NCT00395018|589771269|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
163291419|NCT02534350|589771270|FG000|Overall Study|Randomized But Not Treated|1|||
163291420|NCT02534350|589771271|FG001|Overall Study|Randomized But Not Treated|0|||
163291421|NCT02534350|589771270|FG000|Overall Study|Protocol Violation|1|||
163291422|NCT02534350|589771271|FG001|Overall Study|Protocol Violation|0|||
163291423|NCT02534350|589771270|FG000|Overall Study|Withdrew Consent|2|||
163291424|NCT02534350|589771271|FG001|Overall Study|Withdrew Consent|0|||
163291425|NCT00716144|589771284|FG000|Overall Study|Withdrawal by Subject|4|||
163291426|NCT00716144|589771285|FG001|Overall Study|Withdrawal by Subject|2|||
163291427|NCT00716144|589771286|FG002|Overall Study|Withdrawal by Subject|6|||
163291428|NCT00716144|589771287|FG003|Overall Study|Withdrawal by Subject|6|||
163291429|NCT00716144|589771284|FG000|Overall Study|Lost to Follow-up|2|||
163291430|NCT00716144|589771285|FG001|Overall Study|Lost to Follow-up|2|||
163291431|NCT00716144|589771286|FG002|Overall Study|Lost to Follow-up|1|||
163291432|NCT00716144|589771287|FG003|Overall Study|Lost to Follow-up|2|||
163291433|NCT00716144|589771284|FG000|Overall Study|Adverse Event|0|||
163291434|NCT00716144|589771285|FG001|Overall Study|Adverse Event|0|||
163387675|NCT01881750|590130009|FG000|Overall Study|Changes in concomitant therapies|2|||
163291435|NCT00716144|589771286|FG002|Overall Study|Adverse Event|0|||
163291436|NCT00716144|589771287|FG003|Overall Study|Adverse Event|2|||
163291437|NCT00716144|589771284|FG000|Overall Study|Non-compliance|1|||
163291438|NCT00716144|589771285|FG001|Overall Study|Non-compliance|0|||
163291439|NCT00716144|589771286|FG002|Overall Study|Non-compliance|0|||
163291440|NCT00716144|589771287|FG003|Overall Study|Non-compliance|0|||
163291441|NCT00716144|589771284|FG000|Overall Study|Protocol Violation|2|||
163291442|NCT00716144|589771285|FG001|Overall Study|Protocol Violation|0|||
163291443|NCT00716144|589771286|FG002|Overall Study|Protocol Violation|1|||
163291444|NCT00716144|589771287|FG003|Overall Study|Protocol Violation|0|||
163291445|NCT00716144|589771284|FG000|Overall Study|Physician Decision|0|||
163291446|NCT00716144|589771285|FG001|Overall Study|Physician Decision|1|||
163291447|NCT00716144|589771286|FG002|Overall Study|Physician Decision|2|||
163291448|NCT00716144|589771287|FG003|Overall Study|Physician Decision|2|||
163291449|NCT00716144|589771284|FG000|Overall Study|Intercurrent illness|0|||
163291450|NCT00716144|589771285|FG001|Overall Study|Intercurrent illness|0|||
163291451|NCT00716144|589771286|FG002|Overall Study|Intercurrent illness|1|||
163291452|NCT00716144|589771287|FG003|Overall Study|Intercurrent illness|0|||
163291453|NCT00716144|589771284|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
163291454|NCT00716144|589771285|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
163291455|NCT00716144|589771286|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
163291456|NCT00716144|589771287|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
163291457|NCT00716144|589771284|FG000|Overall Study|Adverse event: left foot pain|0|||
163291458|NCT00716144|589771285|FG001|Overall Study|Adverse event: left foot pain|1|||
163291459|NCT00716144|589771286|FG002|Overall Study|Adverse event: left foot pain|0|||
163291460|NCT00716144|589771287|FG003|Overall Study|Adverse event: left foot pain|0|||
163291461|NCT00716144|589771284|FG000|Overall Study|Clinical Depression|0|||
163291462|NCT00716144|589771285|FG001|Overall Study|Clinical Depression|1|||
163291463|NCT00716144|589771286|FG002|Overall Study|Clinical Depression|0|||
163291464|NCT00716144|589771287|FG003|Overall Study|Clinical Depression|0|||
163291465|NCT02341625|589771292|FG000|Overall Study|Disease Progression|2|||
163291466|NCT02341625|589771293|FG001|Overall Study|Disease Progression|2|||
163291467|NCT02341625|589771294|FG002|Overall Study|Disease Progression|3|||
163291468|NCT02341625|589771295|FG003|Overall Study|Disease Progression|6|||
163291469|NCT02341625|589771296|FG004|Overall Study|Disease Progression|7|||
163291470|NCT02341625|589771297|FG005|Overall Study|Disease Progression|7|||
163291471|NCT02341625|589771298|FG006|Overall Study|Disease Progression|28|||
163291472|NCT02341625|589771299|FG007|Overall Study|Disease Progression|5|||
163291473|NCT02341625|589771300|FG008|Overall Study|Disease Progression|4|||
163291474|NCT02341625|589771301|FG009|Overall Study|Disease Progression|19|||
163291475|NCT02341625|589771292|FG000|Overall Study|Study Drug Toxicity|0|||
163291476|NCT02341625|589771293|FG001|Overall Study|Study Drug Toxicity|0|||
163291477|NCT02341625|589771294|FG002|Overall Study|Study Drug Toxicity|0|||
163291478|NCT02341625|589771295|FG003|Overall Study|Study Drug Toxicity|1|||
163291479|NCT02341625|589771296|FG004|Overall Study|Study Drug Toxicity|0|||
163291480|NCT02341625|589771297|FG005|Overall Study|Study Drug Toxicity|3|||
163291481|NCT02341625|589771298|FG006|Overall Study|Study Drug Toxicity|10|||
163291482|NCT02341625|589771299|FG007|Overall Study|Study Drug Toxicity|0|||
163291483|NCT02341625|589771300|FG008|Overall Study|Study Drug Toxicity|0|||
163291484|NCT02341625|589771301|FG009|Overall Study|Study Drug Toxicity|3|||
163291485|NCT02341625|589771292|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163291486|NCT02341625|589771293|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163291487|NCT02341625|589771294|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163291488|NCT02341625|589771295|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163291489|NCT02341625|589771296|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163291490|NCT02341625|589771297|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163291491|NCT02341625|589771298|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
163291492|NCT02341625|589771299|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
163291493|NCT02341625|589771300|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163291494|NCT02341625|589771301|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
163291495|NCT02341625|589771292|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163291496|NCT02341625|589771293|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163291497|NCT02341625|589771294|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163291498|NCT02341625|589771295|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163291499|NCT02341625|589771296|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163291500|NCT02341625|589771297|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163291501|NCT02341625|589771298|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
163291502|NCT02341625|589771299|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
163291503|NCT02341625|589771300|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163291504|NCT02341625|589771301|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163291505|NCT02341625|589771292|FG000|Overall Study|Participant Withdrew Consent|0|||
163291506|NCT02341625|589771293|FG001|Overall Study|Participant Withdrew Consent|0|||
163291507|NCT02341625|589771294|FG002|Overall Study|Participant Withdrew Consent|0|||
163291508|NCT02341625|589771295|FG003|Overall Study|Participant Withdrew Consent|1|||
163291509|NCT02341625|589771296|FG004|Overall Study|Participant Withdrew Consent|0|||
163291510|NCT02341625|589771297|FG005|Overall Study|Participant Withdrew Consent|0|||
162944244|NCT00520741|588498717|FG001|Overall Study|Other reasons for premature termination|6|||
163291511|NCT02341625|589771298|FG006|Overall Study|Participant Withdrew Consent|0|||
163387676|NCT01881750|590130010|FG001|Overall Study|Changes in concomitant therapies|3|||
163291512|NCT02341625|589771299|FG007|Overall Study|Participant Withdrew Consent|0|||
163291513|NCT02341625|589771300|FG008|Overall Study|Participant Withdrew Consent|0|||
163291514|NCT02341625|589771301|FG009|Overall Study|Participant Withdrew Consent|0|||
163291515|NCT02341625|589771292|FG000|Overall Study|Completed Treatment as per Protocol|0|||
163291516|NCT02341625|589771293|FG001|Overall Study|Completed Treatment as per Protocol|0|||
163291517|NCT02341625|589771294|FG002|Overall Study|Completed Treatment as per Protocol|0|||
163291518|NCT02341625|589771295|FG003|Overall Study|Completed Treatment as per Protocol|0|||
163291519|NCT02341625|589771296|FG004|Overall Study|Completed Treatment as per Protocol|0|||
163291520|NCT02341625|589771297|FG005|Overall Study|Completed Treatment as per Protocol|0|||
163291521|NCT02341625|589771298|FG006|Overall Study|Completed Treatment as per Protocol|0|||
163291522|NCT02341625|589771299|FG007|Overall Study|Completed Treatment as per Protocol|0|||
163291523|NCT02341625|589771300|FG008|Overall Study|Completed Treatment as per Protocol|0|||
163291524|NCT02341625|589771301|FG009|Overall Study|Completed Treatment as per Protocol|1|||
163291525|NCT02341625|589771292|FG000|Overall Study|Other Reasons|0|||
163291526|NCT02341625|589771293|FG001|Overall Study|Other Reasons|0|||
163291527|NCT02341625|589771294|FG002|Overall Study|Other Reasons|0|||
163291528|NCT02341625|589771295|FG003|Overall Study|Other Reasons|0|||
163291529|NCT02341625|589771296|FG004|Overall Study|Other Reasons|1|||
163291530|NCT02341625|589771297|FG005|Overall Study|Other Reasons|0|||
163291531|NCT02341625|589771298|FG006|Overall Study|Other Reasons|5|||
163291532|NCT02341625|589771299|FG007|Overall Study|Other Reasons|0|||
163291533|NCT02341625|589771300|FG008|Overall Study|Other Reasons|0|||
163291534|NCT02341625|589771301|FG009|Overall Study|Other Reasons|2|||
163291535|NCT02341625|589771292|FG000|Overall Study|Not Reported|0|||
163291536|NCT02341625|589771293|FG001|Overall Study|Not Reported|0|||
163291537|NCT02341625|589771294|FG002|Overall Study|Not Reported|0|||
163291538|NCT02341625|589771295|FG003|Overall Study|Not Reported|0|||
163291539|NCT02341625|589771296|FG004|Overall Study|Not Reported|0|||
163291540|NCT02341625|589771297|FG005|Overall Study|Not Reported|0|||
163291541|NCT02341625|589771298|FG006|Overall Study|Not Reported|0|||
163291542|NCT02341625|589771299|FG007|Overall Study|Not Reported|0|||
163291543|NCT02341625|589771300|FG008|Overall Study|Not Reported|0|||
163291544|NCT02341625|589771301|FG009|Overall Study|Not Reported|3|||
163291545|NCT03396913|589771302|FG000|Overall Study|Lost to Follow-up|0|||
163291546|NCT03396913|589771303|FG001|Overall Study|Lost to Follow-up|6|||
163291547|NCT01981356|589771313|FG000|Overall Study|Lost to Follow-up|4|||
163291548|NCT01981356|589771314|FG001|Overall Study|Lost to Follow-up|1|||
163291549|NCT01981356|589771313|FG000|Overall Study|Withdrawal by Subject|1|||
163291550|NCT01981356|589771314|FG001|Overall Study|Withdrawal by Subject|1|||
163291551|NCT01981356|589771313|FG000|Overall Study|Protocol Violation|2|||
163291552|NCT01981356|589771314|FG001|Overall Study|Protocol Violation|0|||
163291553|NCT01278862|589771316|FG000|Overall Study|Lost to Follow-up|1|||
163291554|NCT01278862|589771317|FG001|Overall Study|Lost to Follow-up|1|||
163291555|NCT02952261|589771319|FG000|Overall Study|Withdrawal by Subject|4|||
163291556|NCT02952261|589771320|FG001|Overall Study|Withdrawal by Subject|5|||
163291557|NCT02952261|589771319|FG000|Overall Study|Protocol Violation|1|||
163291558|NCT02952261|589771320|FG001|Overall Study|Protocol Violation|0|||
163291559|NCT05233085|589771321|FG000|Overall Study|Adverse Event|1|||
163291560|NCT05233085|589771322|FG001|Overall Study|Adverse Event|0|||
163291561|NCT05233085|589771323|FG002|Overall Study|Adverse Event|0|||
163291562|NCT05233085|589771324|FG003|Overall Study|Adverse Event|0|||
163291563|NCT03284957|589773066|FG000|Overall Study|Adverse Event|0|||
163291564|NCT03284957|589773067|FG001|Overall Study|Adverse Event|0|||
163291565|NCT03284957|589773068|FG002|Overall Study|Adverse Event|0|||
163291566|NCT03284957|589773069|FG003|Overall Study|Adverse Event|0|||
163291567|NCT03284957|589773070|FG004|Overall Study|Adverse Event|0|||
163291568|NCT03284957|589773071|FG005|Overall Study|Adverse Event|1|||
163291569|NCT03284957|589773072|FG006|Overall Study|Adverse Event|1|||
163291570|NCT03284957|589773073|FG007|Overall Study|Adverse Event|1|||
163291571|NCT03284957|589773074|FG008|Overall Study|Adverse Event|0|||
163291572|NCT03284957|589773075|FG009|Overall Study|Adverse Event|4|||
163291573|NCT03284957|589773076|FG010|Overall Study|Adverse Event|1|||
163291574|NCT03284957|589773077|FG011|Overall Study|Adverse Event|1|||
163291575|NCT03284957|589773078|FG012|Overall Study|Adverse Event|0|||
163291576|NCT03284957|589773079|FG013|Overall Study|Adverse Event|0|||
163291577|NCT03284957|589773080|FG014|Overall Study|Adverse Event|0|||
163291578|NCT03284957|589773081|FG015|Overall Study|Adverse Event|0|||
163291579|NCT03284957|589773066|FG000|Overall Study|Progressive Disease|3|||
163291580|NCT03284957|589773067|FG001|Overall Study|Progressive Disease|3|||
163291581|NCT03284957|589773068|FG002|Overall Study|Progressive Disease|4|||
163291582|NCT03284957|589773069|FG003|Overall Study|Progressive Disease|3|||
163291583|NCT03284957|589773070|FG004|Overall Study|Progressive Disease|3|||
163291584|NCT03284957|589773071|FG005|Overall Study|Progressive Disease|5|||
163291585|NCT03284957|589773072|FG006|Overall Study|Progressive Disease|45|||
163291586|NCT03284957|589773073|FG007|Overall Study|Progressive Disease|8|||
163291587|NCT03284957|589773074|FG008|Overall Study|Progressive Disease|5|||
163291588|NCT03284957|589773075|FG009|Overall Study|Progressive Disease|18|||
163291589|NCT03284957|589773076|FG010|Overall Study|Progressive Disease|7|||
163291590|NCT03284957|589773077|FG011|Overall Study|Progressive Disease|2|||
163291591|NCT03284957|589773078|FG012|Overall Study|Progressive Disease|3|||
163291592|NCT03284957|589773079|FG013|Overall Study|Progressive Disease|1|||
163291593|NCT03284957|589773080|FG014|Overall Study|Progressive Disease|1|||
163291594|NCT03284957|589773081|FG015|Overall Study|Progressive Disease|2|||
163291595|NCT03284957|589773066|FG000|Overall Study|Withdrawal by Subject|0|||
163291596|NCT03284957|589773067|FG001|Overall Study|Withdrawal by Subject|0|||
163291597|NCT03284957|589773068|FG002|Overall Study|Withdrawal by Subject|0|||
163291598|NCT03284957|589773069|FG003|Overall Study|Withdrawal by Subject|0|||
163291599|NCT03284957|589773070|FG004|Overall Study|Withdrawal by Subject|0|||
163291600|NCT03284957|589773071|FG005|Overall Study|Withdrawal by Subject|0|||
163291601|NCT03284957|589773072|FG006|Overall Study|Withdrawal by Subject|0|||
163291602|NCT03284957|589773073|FG007|Overall Study|Withdrawal by Subject|0|||
163291603|NCT03284957|589773074|FG008|Overall Study|Withdrawal by Subject|0|||
163291604|NCT03284957|589773075|FG009|Overall Study|Withdrawal by Subject|2|||
163291605|NCT03284957|589773076|FG010|Overall Study|Withdrawal by Subject|0|||
163291606|NCT03284957|589773077|FG011|Overall Study|Withdrawal by Subject|0|||
163291607|NCT03284957|589773078|FG012|Overall Study|Withdrawal by Subject|0|||
163291608|NCT03284957|589773079|FG013|Overall Study|Withdrawal by Subject|0|||
163291609|NCT03284957|589773080|FG014|Overall Study|Withdrawal by Subject|0|||
163291610|NCT03284957|589773081|FG015|Overall Study|Withdrawal by Subject|0|||
163291611|NCT03284957|589773066|FG000|Overall Study|Other|0|||
163291612|NCT03284957|589773067|FG001|Overall Study|Other|0|||
163291613|NCT03284957|589773068|FG002|Overall Study|Other|0|||
163291614|NCT03284957|589773069|FG003|Overall Study|Other|0|||
163291615|NCT03284957|589773070|FG004|Overall Study|Other|0|||
163291616|NCT03284957|589773071|FG005|Overall Study|Other|0|||
163291617|NCT03284957|589773072|FG006|Overall Study|Other|3|||
163291618|NCT03284957|589773073|FG007|Overall Study|Other|0|||
163291619|NCT03284957|589773074|FG008|Overall Study|Other|1|||
163291620|NCT03284957|589773075|FG009|Overall Study|Other|6|||
163291621|NCT03284957|589773076|FG010|Overall Study|Other|0|||
163291622|NCT03284957|589773077|FG011|Overall Study|Other|0|||
163291623|NCT03284957|589773078|FG012|Overall Study|Other|0|||
163291624|NCT03284957|589773079|FG013|Overall Study|Other|0|||
163291625|NCT03284957|589773080|FG014|Overall Study|Other|2|||
163291626|NCT03284957|589773081|FG015|Overall Study|Other|0|||
163291627|NCT03169244|589773087|FG000|Overall Study|Lost to Follow-up|1|||
163291628|NCT03169244|589773088|FG001|Overall Study|Lost to Follow-up|2|||
163291629|NCT03169244|589773087|FG000|Overall Study|Adverse Event|1|||
163291630|NCT03169244|589773088|FG001|Overall Study|Adverse Event|0|||
163291631|NCT03169244|589773087|FG000|Overall Study|Withdrawal by Subject|2|||
163291632|NCT03169244|589773088|FG001|Overall Study|Withdrawal by Subject|2|||
163291633|NCT03169244|589773087|FG000|Overall Study|Physician Decision|1|||
163291634|NCT03169244|589773088|FG001|Overall Study|Physician Decision|0|||
163291635|NCT00178399|589773089|FG000|Overall Study|Physician Decision|4|||
163291636|NCT00178399|589773089|FG000|Overall Study|Withdrawal by Subject|8|||
163291637|NCT00178399|589773089|FG000|Overall Study|Lost to Follow-up|1|||
163291638|NCT02631148|589773090|FG000|Overall Study|8 were ineligible|8|||
163291639|NCT02631148|589773091|FG001|Overall Study|8 were ineligible|0|||
163291640|NCT02631148|589773090|FG000|Overall Study|Withdrawal by Subject|1|||
163291641|NCT02631148|589773091|FG001|Overall Study|Withdrawal by Subject|0|||
163291642|NCT02631148|589773090|FG000|Overall Study|PAH not available to study participant|1|||
163291643|NCT02631148|589773091|FG001|Overall Study|PAH not available to study participant|0|||
163291644|NCT00357396|589773094|FG000|Overall Study|Adverse Event|1|||
163291645|NCT00357396|589773095|FG001|Overall Study|Adverse Event|0|||
163291646|NCT00487578|589773096|FG000|Overall Study|Adverse Event|1|||
163291647|NCT00487578|589773097|FG001|Overall Study|Adverse Event|2|||
163291648|NCT00487578|589773096|FG000|Overall Study|Lack of Efficacy|0|||
163291649|NCT00487578|589773097|FG001|Overall Study|Lack of Efficacy|1|||
163291650|NCT00487578|589773096|FG000|Overall Study|Lost to Follow-up|0|||
163291651|NCT00487578|589773097|FG001|Overall Study|Lost to Follow-up|1|||
163291652|NCT00955825|589773098|FG000|Overall Study|Adverse Event|15|||
163291653|NCT00955825|589773099|FG001|Overall Study|Adverse Event|2|||
163291654|NCT00955825|589773098|FG000|Overall Study|Withdrawal by Subject|4|||
163291655|NCT00955825|589773099|FG001|Overall Study|Withdrawal by Subject|6|||
163291656|NCT00955825|589773098|FG000|Overall Study|Any other reason not above-mentioned|7|||
163291657|NCT00955825|589773099|FG001|Overall Study|Any other reason not above-mentioned|9|||
163291658|NCT00708032|589773100|FG000|Overall Study|Adverse Event|0|||
163291659|NCT00708032|589773101|FG001|Overall Study|Adverse Event|2|||
163291660|NCT00708032|589773100|FG000|Overall Study|Lost to Follow-up|1|||
163291661|NCT00708032|589773101|FG001|Overall Study|Lost to Follow-up|2|||
163291662|NCT00708032|589773100|FG000|Overall Study|Pregnancy|0|||
163291663|NCT00708032|589773101|FG001|Overall Study|Pregnancy|1|||
163291664|NCT00708032|589773100|FG000|Overall Study|Poor vision|0|||
163291665|NCT00708032|589773101|FG001|Overall Study|Poor vision|6|||
163291666|NCT00708032|589773100|FG000|Overall Study|Visit out of range at month 12|4|||
163291667|NCT00708032|589773101|FG001|Overall Study|Visit out of range at month 12|1|||
163291668|NCT00708032|589773100|FG000|Overall Study|Did not meet protocol criteria|1|||
163291669|NCT00708032|589773101|FG001|Overall Study|Did not meet protocol criteria|2|||
163291670|NCT00708032|589773100|FG000|Overall Study|Protocol Violation|4|||
163291671|NCT00708032|589773101|FG001|Overall Study|Protocol Violation|1|||
163291672|NCT00708032|589773100|FG000|Overall Study|Withdrawal by Subject|0|||
163291673|NCT00708032|589773101|FG001|Overall Study|Withdrawal by Subject|1|||
163291674|NCT00150176|589773102|FG000|Overall Study|Adverse Event|16|||
163291675|NCT00150176|589773103|FG001|Overall Study|Adverse Event|53|||
163291676|NCT00150176|589773102|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
163291677|NCT00150176|589773103|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
163291678|NCT00150176|589773102|FG000|Overall Study|Withdrawal by Subject|19|||
163291679|NCT00150176|589773103|FG001|Overall Study|Withdrawal by Subject|12|||
163291680|NCT00150176|589773102|FG000|Overall Study|Lost to Follow-up|3|||
163291681|NCT00150176|589773103|FG001|Overall Study|Lost to Follow-up|3|||
163291682|NCT00150176|589773102|FG000|Overall Study|OTHER|11|||
163291683|NCT00150176|589773103|FG001|Overall Study|OTHER|13|||
163291684|NCT04035668|589773107|FG000|Overall Study|Adverse Event|3|||
163291685|NCT04035668|589773108|FG001|Overall Study|Adverse Event|4|||
163291686|NCT04035668|589773109|FG002|Overall Study|Adverse Event|2|||
163291687|NCT04035668|589773107|FG000|Overall Study|Lost to Follow-up|0|||
163291688|NCT04035668|589773108|FG001|Overall Study|Lost to Follow-up|1|||
163291689|NCT04035668|589773109|FG002|Overall Study|Lost to Follow-up|0|||
163291690|NCT04035668|589773107|FG000|Overall Study|Physician Decision|2|||
163291691|NCT04035668|589773108|FG001|Overall Study|Physician Decision|1|||
163291692|NCT04035668|589773109|FG002|Overall Study|Physician Decision|1|||
163291693|NCT04035668|589773107|FG000|Overall Study|Subject Decision|2|||
163291694|NCT04035668|589773108|FG001|Overall Study|Subject Decision|2|||
163291695|NCT04035668|589773109|FG002|Overall Study|Subject Decision|0|||
163291696|NCT02385669|589773111|FG000|Overall Study|Adverse Event|2|||
163291697|NCT00004124|589773112|FG000|Overall Study|Received no protocol therapy|12|||
163291698|NCT00004124|589773113|FG001|Overall Study|Received no protocol therapy|20|||
163291699|NCT02937831|589773114|FG000|Overall Study|Protocol Violation|4|||
163291700|NCT00114244|589773117|FG000|Overall Study|Adverse Event|2|||
163291701|NCT00114244|589773118|FG001|Overall Study|Adverse Event|5|||
163291702|NCT00114244|589773117|FG000|Overall Study|Withdrawal by Subject|0|||
163291703|NCT00114244|589773118|FG001|Overall Study|Withdrawal by Subject|2|||
163291704|NCT01376089|589773125|FG000|Overall Study|Patient received no contrast media|3|||
162944245|NCT03702621|588498718|FG000|Overall Study|Physician Decision|6|||
162944246|NCT03702621|588498719|FG001|Overall Study|Physician Decision|6|||
163291705|NCT01376089|589773126|FG001|Overall Study|Patient received no contrast media|4|||
163291706|NCT03262935|589773127|FG000|Overall Study|Withdrawal by Subject|6|||
163291707|NCT03262935|589773128|FG001|Overall Study|Withdrawal by Subject|7|||
163291708|NCT03262935|589773127|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
163291709|NCT03262935|589773128|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
163291710|NCT03262935|589773127|FG000|Overall Study|Death|181|||
163291711|NCT03262935|589773128|FG001|Overall Study|Death|94|||
163291712|NCT03262935|589773127|FG000|Overall Study|Lost to Follow-up|9|||
163291713|NCT03262935|589773128|FG001|Overall Study|Lost to Follow-up|4|||
163291714|NCT03262935|589773127|FG000|Overall Study|Other reason|5|||
163291715|NCT03262935|589773128|FG001|Overall Study|Other reason|0|||
163291716|NCT01811706|589773129|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
163291717|NCT01811706|589773130|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
163291718|NCT03557008|589773131|FG000|Overall Study|Withdrawal by Subject|2|||
163291719|NCT03557008|589773132|FG001|Overall Study|Withdrawal by Subject|2|||
163291720|NCT03557008|589773131|FG000|Overall Study|Early termination from study|3|||
163291721|NCT03557008|589773132|FG001|Overall Study|Early termination from study|1|||
163291722|NCT01458210|589773135|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
163291723|NCT01458210|589773135|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
163291724|NCT01458210|589773135|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
163291725|NCT01458210|589773135|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
163291726|NCT02224924|589773136|FG000|Overall Study|Withdrawal by Subject|7|||
163291727|NCT02224924|589773137|FG001|Overall Study|Withdrawal by Subject|6|||
163291728|NCT02224924|589773136|FG000|Overall Study|Biopsy cancelled|20|||
163291729|NCT02224924|589773137|FG001|Overall Study|Biopsy cancelled|14|||
163291730|NCT02224924|589773136|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
163291731|NCT02224924|589773137|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
163291732|NCT02224924|589773136|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
163291733|NCT02224924|589773137|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
163291734|NCT00943735|589773140|FG000|Overall Study|Adverse Event|12|||
163291735|NCT00943735|589773140|FG000|Overall Study|Withdrawal by Subject|8|||
163291736|NCT00943735|589773140|FG000|Overall Study|Death|1|||
163291737|NCT00943735|589773140|FG000|Overall Study|Other|8|||
163291738|NCT00943735|589773140|FG000|Overall Study|Other|3|||
163291739|NCT00545844|589773141|FG000|Overall Study|Lost to Follow-up|9|||
163291740|NCT00545844|589773141|FG000|Overall Study|Protocol Violation|1|||
163291741|NCT00545844|589773141|FG000|Overall Study|Withdrawal by Subject|2|||
163291742|NCT01329328|589773142|FG000|Overall Study|Withdrawal by Subject|2|||
163291743|NCT01329328|589773143|FG001|Overall Study|Withdrawal by Subject|4|||
163291744|NCT01329328|589773144|FG002|Overall Study|Withdrawal by Subject|3|||
163291745|NCT04439799|589773146|FG000|Overall Study|Lost to Follow-up|6|||
163291746|NCT04439799|589773147|FG001|Overall Study|Lost to Follow-up|6|||
163291747|NCT04439799|589773146|FG000|Overall Study|Withdrawal by Subject|2|||
163291748|NCT04439799|589773147|FG001|Overall Study|Withdrawal by Subject|6|||
163291749|NCT04439799|589773146|FG000|Overall Study|Adverse Event|2|||
163291750|NCT04439799|589773147|FG001|Overall Study|Adverse Event|5|||
163291751|NCT00371566|589773148|FG000|Treatment Phase|Withdrawal by Subject|0|||
163291752|NCT00371566|589773149|FG001|Treatment Phase|Withdrawal by Subject|1|||
163291753|NCT00371566|589773148|FG000|Treatment Phase|Adverse Event|0|||
163291754|NCT00371566|589773149|FG001|Treatment Phase|Adverse Event|1|||
163291755|NCT00371566|589773148|FG000|Treatment Phase|Protocol Violation|0|||
163291756|NCT00371566|589773149|FG001|Treatment Phase|Protocol Violation|1|||
163291757|NCT00371566|589773148|FG000|Chemoradiation Phase|Physician Decision|2|||
163291758|NCT00371566|589773149|FG001|Chemoradiation Phase|Physician Decision|0|||
163291759|NCT00371566|589773148|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
163291760|NCT00371566|589773149|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
163291761|NCT00371566|589773148|FG000|Chemoradiation Phase|Non compliant|0|||
163291762|NCT00371566|589773149|FG001|Chemoradiation Phase|Non compliant|1|||
163291763|NCT00371566|589773148|FG000|Chemoradiation Phase|Progressive Disease|1|||
163291764|NCT00371566|589773149|FG001|Chemoradiation Phase|Progressive Disease|1|||
163291765|NCT00371566|589773148|FG000|Chemoradiation Phase|Death|2|||
163291766|NCT00371566|589773149|FG001|Chemoradiation Phase|Death|0|||
163291767|NCT00371566|589773148|FG000|Follow Up Phase|Death|0|||
163291768|NCT00371566|589773149|FG001|Follow Up Phase|Death|5|||
163291769|NCT00371566|589773148|FG000|Follow Up Phase|Disease progression|1|||
163291770|NCT00371566|589773149|FG001|Follow Up Phase|Disease progression|0|||
163291771|NCT00371566|589773148|FG000|Follow Up Phase|Withdrawal by Subject|0|||
163291772|NCT00371566|589773149|FG001|Follow Up Phase|Withdrawal by Subject|1|||
163291773|NCT00371566|589773148|FG000|Follow Up Phase|Physician Decision|1|||
163291774|NCT00371566|589773149|FG001|Follow Up Phase|Physician Decision|1|||
163291775|NCT00371566|589773148|FG000|Follow Up Phase|Lost to Follow-up|1|||
163291776|NCT00371566|589773149|FG001|Follow Up Phase|Lost to Follow-up|0|||
163291777|NCT00530842|589773154|FG000|Overall Study|Adverse Event|10|||
163291778|NCT00530842|589773155|FG001|Overall Study|Adverse Event|6|||
163291779|NCT00530842|589773154|FG000|Overall Study|Lack of Efficacy|2|||
163291780|NCT00530842|589773155|FG001|Overall Study|Lack of Efficacy|1|||
163291781|NCT00530842|589773154|FG000|Overall Study|Lost to Follow-up|0|||
163291782|NCT00530842|589773155|FG001|Overall Study|Lost to Follow-up|4|||
163291783|NCT00530842|589773154|FG000|Overall Study|Protocol Violation|3|||
163291784|NCT00530842|589773155|FG001|Overall Study|Protocol Violation|2|||
163387677|NCT01881750|590130009|FG000|Overall Study|Lost to Follow-up|0|||
163387678|NCT01881750|590130010|FG001|Overall Study|Lost to Follow-up|1|||
163387679|NCT01423253|590130011|FG000|Overall Study|Adverse Event|2|||
163387680|NCT01423253|590130011|FG000|Overall Study|Lack of Efficacy|2|||
163387681|NCT01423253|590130011|FG000|Overall Study|Lost to Follow-up|1|||
163387682|NCT01423253|590130011|FG000|Overall Study|Protocol Violation|2|||
163387683|NCT01423253|590130011|FG000|Overall Study|Withdrawal by Subject|2|||
163387684|NCT01572922|590130020|FG000|Overall Study|Adverse Event|1|||
163387685|NCT01572922|590130020|FG000|Overall Study|Protocol Violation|1|||
163387686|NCT01572922|590130020|FG000|Overall Study|Death|1|||
163387687|NCT05089656|590130022|FG000|Period 1 - First Intervention (52 weeks)|Physician Decision|1|||
163387688|NCT05089656|590130023|FG001|Period 1 - First Intervention (52 weeks)|Physician Decision|0|||
163387689|NCT05089656|590130022|FG000|Period 1 - First Intervention (52 weeks)|Guardian decision|1|||
163387690|NCT05089656|590130023|FG001|Period 1 - First Intervention (52 weeks)|Guardian decision|0|||
163387691|NCT05089656|590130022|FG000|Period 1 - First Intervention (52 weeks)|Adverse Event|0|||
163387692|NCT05089656|590130023|FG001|Period 1 - First Intervention (52 weeks)|Adverse Event|1|||
163387693|NCT05089656|590130022|FG000|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|6|||
163387694|NCT05089656|590130023|FG001|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|4|||
163387695|NCT02535416|590130024|FG000|Overall Study|Family bereavement overseas|1|||
163387696|NCT02535416|590130025|FG001|Overall Study|Family bereavement overseas|0|||
163387697|NCT02535416|590130026|FG002|Overall Study|Family bereavement overseas|0|||
163387698|NCT02535416|590130027|FG003|Overall Study|Family bereavement overseas|0|||
163387699|NCT02535416|590130028|FG004|Overall Study|Family bereavement overseas|0|||
163387700|NCT02535416|590130029|FG005|Overall Study|Family bereavement overseas|0|||
163387701|NCT02535416|590130030|FG006|Overall Study|Family bereavement overseas|0|||
163387702|NCT02535416|590130031|FG007|Overall Study|Family bereavement overseas|0|||
163387703|NCT02535416|590130032|FG008|Overall Study|Family bereavement overseas|0|||
163387704|NCT04641299|590131864|FG000|Overall Study|Adverse Event|0|||
163387705|NCT04641299|590131865|FG001|Overall Study|Adverse Event|0|||
163387706|NCT04641299|590131866|FG002|Overall Study|Adverse Event|2|||
163186151|NCT02448810|589397692|FG005|Overall Study|Withdrawal by Subject|5|||
163186152|NCT02448810|589397693|FG006|Overall Study|Withdrawal by Subject|0|||
163186153|NCT02448810|589397694|FG007|Overall Study|Withdrawal by Subject|2|||
163186154|NCT02448810|589397687|FG000|Overall Study|Other (study terminated by sponsor)|0|||
163186155|NCT02448810|589397688|FG001|Overall Study|Other (study terminated by sponsor)|0|||
163186156|NCT02448810|589397689|FG002|Overall Study|Other (study terminated by sponsor)|0|||
163186157|NCT02448810|589397690|FG003|Overall Study|Other (study terminated by sponsor)|0|||
163186158|NCT02448810|589397691|FG004|Overall Study|Other (study terminated by sponsor)|4|||
163186159|NCT02448810|589397692|FG005|Overall Study|Other (study terminated by sponsor)|2|||
163186160|NCT02448810|589397693|FG006|Overall Study|Other (study terminated by sponsor)|2|||
163186161|NCT02448810|589397694|FG007|Overall Study|Other (study terminated by sponsor)|1|||
163186162|NCT02448810|589397687|FG000|Overall Study|Death|1|||
163186163|NCT02448810|589397688|FG001|Overall Study|Death|0|||
163291785|NCT00530842|589773154|FG000|Overall Study|Withdrawal by Subject|4|||
163291786|NCT00530842|589773155|FG001|Overall Study|Withdrawal by Subject|5|||
163291787|NCT00530842|589773154|FG000|Overall Study|Individual different reasons|4|||
163291788|NCT00530842|589773155|FG001|Overall Study|Individual different reasons|3|||
163291789|NCT00530842|589773154|FG000|Period 1|Adverse Event|7|||
163291790|NCT00530842|589773155|FG001|Period 1|Adverse Event|3|||
163291791|NCT00530842|589773154|FG000|Period 1|Lack of Efficacy|1|||
163291792|NCT00530842|589773155|FG001|Period 1|Lack of Efficacy|1|||
163291793|NCT00530842|589773154|FG000|Period 1|Protocol Violation|2|||
163291794|NCT00530842|589773155|FG001|Period 1|Protocol Violation|1|||
163291795|NCT00530842|589773154|FG000|Period 1|Withdrawal by Subject|2|||
163291796|NCT00530842|589773155|FG001|Period 1|Withdrawal by Subject|3|||
163291797|NCT00530842|589773154|FG000|Period 1|Individual different reasons|2|||
163291798|NCT00530842|589773155|FG001|Period 1|Individual different reasons|3|||
163291799|NCT00530842|589773154|FG000|Period 2|Adverse Event|3|||
163291800|NCT00530842|589773155|FG001|Period 2|Adverse Event|3|||
163291801|NCT00530842|589773154|FG000|Period 2|Lack of Efficacy|1|||
163291802|NCT00530842|589773155|FG001|Period 2|Lack of Efficacy|0|||
163291803|NCT00530842|589773154|FG000|Period 2|Lost to Follow-up|0|||
163291804|NCT00530842|589773155|FG001|Period 2|Lost to Follow-up|4|||
163291805|NCT00530842|589773154|FG000|Period 2|Protocol Violation|1|||
163291806|NCT00530842|589773155|FG001|Period 2|Protocol Violation|0|||
163291807|NCT00530842|589773154|FG000|Period 2|Withdrawal by Subject|1|||
163291808|NCT00530842|589773155|FG001|Period 2|Withdrawal by Subject|2|||
163291809|NCT00530842|589773154|FG000|Period 2|Individual different reasons|2|||
163291810|NCT00530842|589773155|FG001|Period 2|Individual different reasons|0|||
163291811|NCT00082810|589773157|FG000|Overall Study|Adverse Event|3|||
163291812|NCT00082810|589773157|FG000|Overall Study|Progressive disease|24|||
163291813|NCT00082810|589773157|FG000|Overall Study|Withdrawal by Subject|4|||
163291814|NCT00177216|589773158|FG000|Overall Study|Withdrawal by Subject|6|||
163291815|NCT00177216|589773159|FG001|Overall Study|Withdrawal by Subject|3|||
163291816|NCT00177216|589773160|FG002|Overall Study|Withdrawal by Subject|1|||
163291817|NCT01161498|589773163|FG000|Overall Study|Disease Progression|0|||
163291818|NCT01161498|589773164|FG001|Overall Study|Disease Progression|1|||
163291819|NCT03310983|589773170|FG000|Overall Study|Lost to Follow-up|15|||
163291820|NCT03310983|589773171|FG001|Overall Study|Lost to Follow-up|17|||
163291821|NCT01656304|589773172|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
163291822|NCT00823979|589773175|FG000|Overall Study|Lack of Efficacy|13|||
163291823|NCT00823979|589773176|FG001|Overall Study|Lack of Efficacy|16|||
163291824|NCT00823979|589773177|FG002|Overall Study|Lack of Efficacy|9|||
163291825|NCT00823979|589773175|FG000|Overall Study|Lost to Follow-up|2|||
163291826|NCT00823979|589773176|FG001|Overall Study|Lost to Follow-up|1|||
163291827|NCT00823979|589773177|FG002|Overall Study|Lost to Follow-up|0|||
163291828|NCT00823979|589773175|FG000|Overall Study|Withdrawal by Subject|2|||
163291829|NCT00823979|589773176|FG001|Overall Study|Withdrawal by Subject|3|||
163291830|NCT00823979|589773177|FG002|Overall Study|Withdrawal by Subject|2|||
163291831|NCT00823979|589773175|FG000|Overall Study|Protocol Violation|1|||
163291832|NCT00823979|589773176|FG001|Overall Study|Protocol Violation|1|||
163291833|NCT00823979|589773177|FG002|Overall Study|Protocol Violation|0|||
163291834|NCT00823979|589773175|FG000|Overall Study|Pregnancy|0|||
163291835|NCT00823979|589773176|FG001|Overall Study|Pregnancy|1|||
163291836|NCT00823979|589773177|FG002|Overall Study|Pregnancy|0|||
163291837|NCT00823979|589773175|FG000|Overall Study|Adverse Event|0|||
163291838|NCT00823979|589773176|FG001|Overall Study|Adverse Event|2|||
163291839|NCT00823979|589773177|FG002|Overall Study|Adverse Event|4|||
163291840|NCT00823979|589773175|FG000|Overall Study|Other|2|||
163291841|NCT00823979|589773176|FG001|Overall Study|Other|0|||
163291842|NCT00823979|589773177|FG002|Overall Study|Other|1|||
163291843|NCT00823979|589773175|FG000|Overall Study|Randomized but not Treated|4|||
163291844|NCT00823979|589773176|FG001|Overall Study|Randomized but not Treated|3|||
163291845|NCT00823979|589773177|FG002|Overall Study|Randomized but not Treated|1|||
163291846|NCT00823979|589773175|FG000|Overall Study|Study Terminated by Sponsor|5|||
163387707|NCT04641299|590131867|FG003|Overall Study|Adverse Event|0|||
162944247|NCT02402166|588498720|FG000|Overall Study|Adverse Event|2|||
162944248|NCT02402166|588498720|FG000|Overall Study|Withdrawal by Subject|2|||
162944249|NCT02402166|588498720|FG000|Overall Study|Lost to Follow-up|1|||
162944250|NCT00623103|588498721|FG000|Overall Study|Adverse Event|70|||
162944251|NCT00623103|588498722|FG001|Overall Study|Adverse Event|60|||
162944252|NCT00623103|588498721|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
162944253|NCT00623103|588498722|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
162944254|NCT00623103|588498721|FG000|Overall Study|Withdrawal by Subject|18|||
162944255|NCT00623103|588498722|FG001|Overall Study|Withdrawal by Subject|24|||
162944256|NCT00623103|588498721|FG000|Overall Study|Lost to Follow-up|4|||
162944257|NCT00623103|588498722|FG001|Overall Study|Lost to Follow-up|1|||
162944258|NCT00623103|588498721|FG000|Overall Study|Administrative problems|2|||
162944259|NCT00623103|588498722|FG001|Overall Study|Administrative problems|4|||
162944260|NCT00623103|588498721|FG000|Overall Study|Death|11|||
162944261|NCT00623103|588498722|FG001|Overall Study|Death|11|||
162944262|NCT00623103|588498721|FG000|Overall Study|Protocol deviation|2|||
162944263|NCT00623103|588498722|FG001|Overall Study|Protocol deviation|1|||
162944264|NCT02433678|588498727|FG000|Overall Study|Lost to Follow-up|1|||
162944265|NCT02433678|588498728|FG001|Overall Study|Lost to Follow-up|2|||
162944266|NCT02684578|588498732|FG000|Overall Study|Withdrawal by Subject|10|||
162944267|NCT02684578|588498733|FG001|Overall Study|Withdrawal by Subject|7|||
162944268|NCT02684578|588498732|FG000|Overall Study|Lost to Follow-up|0|||
162944269|NCT02684578|588498733|FG001|Overall Study|Lost to Follow-up|3|||
162944270|NCT02684578|588498732|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
162944271|NCT02684578|588498733|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
162944272|NCT02684578|588498732|FG000|Overall Study|Missing follow-up data|0|||
162944273|NCT02684578|588498733|FG001|Overall Study|Missing follow-up data|1|||
162944274|NCT01505530|588498734|FG000|Overall Study|Progressive Disease|19|||
162944275|NCT01505530|588498735|FG001|Overall Study|Progressive Disease|17|||
163186164|NCT02448810|589397689|FG002|Overall Study|Death|1|||
163186165|NCT02448810|589397690|FG003|Overall Study|Death|0|||
163186166|NCT02448810|589397691|FG004|Overall Study|Death|1|||
163186167|NCT02448810|589397692|FG005|Overall Study|Death|0|||
163186168|NCT02448810|589397693|FG006|Overall Study|Death|0|||
163186169|NCT02448810|589397694|FG007|Overall Study|Death|0|||
163186170|NCT02448810|589397687|FG000|Overall Study|Other (Progressive disease)|2|||
163186171|NCT02448810|589397688|FG001|Overall Study|Other (Progressive disease)|2|||
163186172|NCT02448810|589397689|FG002|Overall Study|Other (Progressive disease)|0|||
163186173|NCT02448810|589397690|FG003|Overall Study|Other (Progressive disease)|3|||
163186174|NCT02448810|589397691|FG004|Overall Study|Other (Progressive disease)|23|||
163186175|NCT02448810|589397692|FG005|Overall Study|Other (Progressive disease)|9|||
163186176|NCT02448810|589397693|FG006|Overall Study|Other (Progressive disease)|14|||
163186177|NCT02448810|589397694|FG007|Overall Study|Other (Progressive disease)|5|||
163186178|NCT02448810|589397687|FG000|Overall Study|Lost to Follow-up|0|||
163186179|NCT02448810|589397688|FG001|Overall Study|Lost to Follow-up|1|||
163186180|NCT02448810|589397689|FG002|Overall Study|Lost to Follow-up|0|||
163186181|NCT02448810|589397690|FG003|Overall Study|Lost to Follow-up|0|||
163186182|NCT02448810|589397691|FG004|Overall Study|Lost to Follow-up|0|||
163186183|NCT02448810|589397692|FG005|Overall Study|Lost to Follow-up|0|||
163186184|NCT02448810|589397693|FG006|Overall Study|Lost to Follow-up|0|||
163186185|NCT02448810|589397694|FG007|Overall Study|Lost to Follow-up|0|||
163186186|NCT02448810|589397687|FG000|Overall Study|Other (unspecified)|0|||
163186187|NCT02448810|589397688|FG001|Overall Study|Other (unspecified)|0|||
163186188|NCT02448810|589397689|FG002|Overall Study|Other (unspecified)|0|||
163186189|NCT02448810|589397690|FG003|Overall Study|Other (unspecified)|0|||
163186190|NCT02448810|589397691|FG004|Overall Study|Other (unspecified)|0|||
163186191|NCT02448810|589397692|FG005|Overall Study|Other (unspecified)|0|||
163186192|NCT02448810|589397693|FG006|Overall Study|Other (unspecified)|2|||
163186193|NCT02448810|589397694|FG007|Overall Study|Other (unspecified)|0|||
163186194|NCT00136604|589397695|FG000|Overall Study|Lost to Follow-up|1|||
163186195|NCT00136604|589397696|FG001|Overall Study|Lost to Follow-up|0|||
163186196|NCT00136604|589397697|FG002|Overall Study|Lost to Follow-up|0|||
163186197|NCT00136604|589397698|FG003|Overall Study|Lost to Follow-up|0|||
163186198|NCT00136604|589397699|FG004|Overall Study|Lost to Follow-up|1|||
163186199|NCT00136604|589397695|FG000|Overall Study|Migrated/moved from study area|0|||
163291847|NCT00823979|589773176|FG001|Overall Study|Study Terminated by Sponsor|5|||
163186200|NCT00136604|589397696|FG001|Overall Study|Migrated/moved from study area|1|||
163291848|NCT00823979|589773177|FG002|Overall Study|Study Terminated by Sponsor|7|||
162944276|NCT01505530|588498736|FG002|Overall Study|Progressive Disease|18|||
163186201|NCT00136604|589397697|FG002|Overall Study|Migrated/moved from study area|0|||
163186202|NCT00136604|589397698|FG003|Overall Study|Migrated/moved from study area|0|||
163186203|NCT00136604|589397699|FG004|Overall Study|Migrated/moved from study area|0|||
163186204|NCT04795622|589397700|FG000|Overall Study|Adverse Event|1|||
163291849|NCT03523091|589773178|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
162944277|NCT01505530|588498734|FG000|Overall Study|Adverse Event|1|||
162944278|NCT01505530|588498735|FG001|Overall Study|Adverse Event|1|||
163186205|NCT04795622|589397701|FG001|Overall Study|Adverse Event|0|||
163186206|NCT04795622|589397700|FG000|Overall Study|Withdrawal by Subject|3|||
163186207|NCT04795622|589397701|FG001|Overall Study|Withdrawal by Subject|3|||
163186208|NCT04795622|589397700|FG000|Overall Study|Protocol Violation|0|||
163387708|NCT04641299|590131864|FG000|Overall Study|Lost to Follow-up|0|||
163387709|NCT04641299|590131865|FG001|Overall Study|Lost to Follow-up|1|||
163387710|NCT04641299|590131866|FG002|Overall Study|Lost to Follow-up|0|||
163387711|NCT04641299|590131867|FG003|Overall Study|Lost to Follow-up|0|||
163387712|NCT04641299|590131864|FG000|Overall Study|Withdrawal by Subject|1|||
163387713|NCT04641299|590131865|FG001|Overall Study|Withdrawal by Subject|0|||
163387714|NCT04641299|590131866|FG002|Overall Study|Withdrawal by Subject|0|||
163387715|NCT04641299|590131867|FG003|Overall Study|Withdrawal by Subject|0|||
163387716|NCT04641299|590131864|FG000|Overall Study|Reason not given|1|||
163387717|NCT04641299|590131865|FG001|Overall Study|Reason not given|0|||
163387718|NCT04641299|590131866|FG002|Overall Study|Reason not given|0|||
163387719|NCT04641299|590131867|FG003|Overall Study|Reason not given|0|||
163387720|NCT01890148|590131870|FG000|Overall Study|Adverse Event|1|||
163387721|NCT04658186|590131882|FG000|Overall Study|Adverse Event|4|||
163387722|NCT04658186|590131883|FG001|Overall Study|Adverse Event|18|||
163387723|NCT04658186|590131884|FG002|Overall Study|Adverse Event|15|||
163387724|NCT04658186|590131882|FG000|Overall Study|Lack of Efficacy|1|||
163387725|NCT04658186|590131883|FG001|Overall Study|Lack of Efficacy|1|||
163387726|NCT04658186|590131884|FG002|Overall Study|Lack of Efficacy|0|||
163387727|NCT04658186|590131882|FG000|Overall Study|Protocol Violation|0|||
163387728|NCT04658186|590131883|FG001|Overall Study|Protocol Violation|0|||
163387729|NCT04658186|590131884|FG002|Overall Study|Protocol Violation|1|||
163387730|NCT04658186|590131882|FG000|Overall Study|Lost to Follow-up|0|||
163387731|NCT04658186|590131883|FG001|Overall Study|Lost to Follow-up|0|||
163387732|NCT04658186|590131884|FG002|Overall Study|Lost to Follow-up|2|||
163387733|NCT04658186|590131882|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
163387734|NCT04658186|590131883|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
163387735|NCT04658186|590131884|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
163387736|NCT04658186|590131882|FG000|Overall Study|Participant is Moving in Another Province|0|||
163387737|NCT04658186|590131883|FG001|Overall Study|Participant is Moving in Another Province|1|||
163387738|NCT04658186|590131884|FG002|Overall Study|Participant is Moving in Another Province|0|||
163387739|NCT04658186|590131882|FG000|Overall Study|Non-Compliance|0|||
163387740|NCT04658186|590131883|FG001|Overall Study|Non-Compliance|1|||
163387741|NCT04658186|590131884|FG002|Overall Study|Non-Compliance|1|||
163387742|NCT04658186|590131882|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
163387743|NCT04658186|590131883|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
163387744|NCT04658186|590131884|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
163387745|NCT04658186|590131882|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
163387746|NCT04658186|590131883|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
163387747|NCT04658186|590131884|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
163387748|NCT04658186|590131882|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
163387749|NCT04658186|590131883|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
163387750|NCT04658186|590131884|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
163387751|NCT04658186|590131882|FG000|Overall Study|PI Decision due to Participant Safety|0|||
163387752|NCT04658186|590131883|FG001|Overall Study|PI Decision due to Participant Safety|0|||
163387753|NCT04658186|590131884|FG002|Overall Study|PI Decision due to Participant Safety|1|||
163387754|NCT04658186|590131882|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
163387755|NCT04658186|590131883|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
163387756|NCT04658186|590131884|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
163387757|NCT01290601|590131902|FG000|Overall Study|Adverse Event|0|||
163387758|NCT01290601|590131903|FG001|Overall Study|Adverse Event|2|||
163387759|NCT01290601|590131904|FG002|Overall Study|Adverse Event|0|||
163387760|NCT01290601|590131905|FG003|Overall Study|Adverse Event|0|||
163387761|NCT01290601|590131902|FG000|Overall Study|Lack of Efficacy|2|||
163387762|NCT01290601|590131903|FG001|Overall Study|Lack of Efficacy|1|||
163387763|NCT01290601|590131904|FG002|Overall Study|Lack of Efficacy|0|||
163387764|NCT01290601|590131905|FG003|Overall Study|Lack of Efficacy|0|||
163387765|NCT01290601|590131902|FG000|Overall Study|Lost to Follow-up|7|||
163387766|NCT01290601|590131903|FG001|Overall Study|Lost to Follow-up|2|||
163387767|NCT01290601|590131904|FG002|Overall Study|Lost to Follow-up|0|||
163387768|NCT01290601|590131905|FG003|Overall Study|Lost to Follow-up|0|||
163387769|NCT01290601|590131902|FG000|Overall Study|Other|1|||
163387770|NCT01290601|590131903|FG001|Overall Study|Other|0|||
163387771|NCT01290601|590131904|FG002|Overall Study|Other|0|||
163387772|NCT01290601|590131905|FG003|Overall Study|Other|0|||
163387773|NCT01290601|590131902|FG000|Overall Study|Protocol Violation|1|||
163387774|NCT01290601|590131903|FG001|Overall Study|Protocol Violation|0|||
163387775|NCT01290601|590131904|FG002|Overall Study|Protocol Violation|0|||
163387776|NCT01290601|590131905|FG003|Overall Study|Protocol Violation|0|||
163387777|NCT00775450|590131906|FG000|Overall Study|Serious Adverse Event|2|||
163387778|NCT00775450|590131907|FG001|Overall Study|Serious Adverse Event|0|||
162944279|NCT01505530|588498736|FG002|Overall Study|Adverse Event|0|||
162944280|NCT01505530|588498734|FG000|Overall Study|Withdrawal by Subject|7|||
162944281|NCT01505530|588498735|FG001|Overall Study|Withdrawal by Subject|8|||
162944282|NCT01505530|588498736|FG002|Overall Study|Withdrawal by Subject|6|||
162944283|NCT01505530|588498734|FG000|Overall Study|Physician Decision|6|||
162944284|NCT01505530|588498735|FG001|Overall Study|Physician Decision|2|||
162944285|NCT01505530|588498736|FG002|Overall Study|Physician Decision|5|||
162944286|NCT01505530|588498734|FG000|Overall Study|Sponsor Decision|1|||
162944287|NCT01505530|588498735|FG001|Overall Study|Sponsor Decision|8|||
162944288|NCT01505530|588498736|FG002|Overall Study|Sponsor Decision|7|||
162944289|NCT01505530|588498734|FG000|Overall Study|Death|7|||
162944290|NCT01505530|588498735|FG001|Overall Study|Death|6|||
162944291|NCT01505530|588498736|FG002|Overall Study|Death|5|||
162944292|NCT01505530|588498734|FG000|Overall Study|entry criteria not met|0|||
162944293|NCT01505530|588498735|FG001|Overall Study|entry criteria not met|1|||
162944294|NCT01505530|588498736|FG002|Overall Study|entry criteria not met|0|||
162944295|NCT00626925|588498740|FG000|Overall Study|Lost to Follow-up|1|||
162944296|NCT00626925|588498741|FG001|Overall Study|Lost to Follow-up|2|||
162944297|NCT00626925|588498740|FG000|Overall Study|relapse|1|||
162944298|NCT00626925|588498741|FG001|Overall Study|relapse|0|||
162944299|NCT00626925|588498740|FG000|Overall Study|Adverse effect|6|||
162944300|NCT00626925|588498741|FG001|Overall Study|Adverse effect|2|||
162944301|NCT00626925|588498740|FG000|Overall Study|Lack of Efficacy|1|||
162944302|NCT00626925|588498741|FG001|Overall Study|Lack of Efficacy|4|||
162944303|NCT00626925|588498740|FG000|Overall Study|Time constraints|3|||
162944304|NCT00626925|588498741|FG001|Overall Study|Time constraints|1|||
162944305|NCT01966042|588498742|FG000|Overall Study|Death|2|||
162944306|NCT00625807|588498743|FG000|Overall Study|schedule conflict|2|||
162944307|NCT00625807|588498744|FG001|Overall Study|schedule conflict|8|||
162944308|NCT03267264|588498745|FG000|Overall Study|Withdrawal by Subject|1|||
162944309|NCT03267264|588498746|FG001|Overall Study|Withdrawal by Subject|0|||
162944310|NCT03267264|588498747|FG002|Overall Study|Withdrawal by Subject|2|||
162944311|NCT03267264|588498748|FG003|Overall Study|Withdrawal by Subject|4|||
162944312|NCT01802879|588498749|FG000|Overall Study|Administrative problems|2|||
162944313|NCT01802879|588498749|FG000|Overall Study|Disease progression|6|||
162944314|NCT00266409|588498750|FG000|Overall Study|Lack of Efficacy|2|||
162944315|NCT00266409|588498751|FG001|Overall Study|Lack of Efficacy|6|||
162944316|NCT00266409|588498752|FG002|Overall Study|Lack of Efficacy|1|||
162944317|NCT00266409|588498753|FG003|Overall Study|Lack of Efficacy|2|||
162944318|NCT00266409|588498750|FG000|Overall Study|Adverse Event|7|||
162944319|NCT00266409|588498751|FG001|Overall Study|Adverse Event|2|||
162944320|NCT00266409|588498752|FG002|Overall Study|Adverse Event|1|||
162944321|NCT00266409|588498753|FG003|Overall Study|Adverse Event|1|||
162944322|NCT00266409|588498750|FG000|Overall Study|Lost to Follow-up|18|||
162944323|NCT00266409|588498751|FG001|Overall Study|Lost to Follow-up|21|||
162944324|NCT00266409|588498752|FG002|Overall Study|Lost to Follow-up|6|||
162944325|NCT00266409|588498753|FG003|Overall Study|Lost to Follow-up|8|||
162944326|NCT00266409|588498750|FG000|Overall Study|Withdrawal by Subject|6|||
162944327|NCT00266409|588498751|FG001|Overall Study|Withdrawal by Subject|10|||
162944328|NCT00266409|588498752|FG002|Overall Study|Withdrawal by Subject|3|||
162944329|NCT00266409|588498753|FG003|Overall Study|Withdrawal by Subject|9|||
162944330|NCT00266409|588498750|FG000|Overall Study|Protocol Violation|5|||
162944331|NCT00266409|588498751|FG001|Overall Study|Protocol Violation|3|||
162944332|NCT00266409|588498752|FG002|Overall Study|Protocol Violation|4|||
162944333|NCT00266409|588498753|FG003|Overall Study|Protocol Violation|2|||
162944334|NCT00266409|588498750|FG000|Overall Study|Other|7|||
162944335|NCT00266409|588498751|FG001|Overall Study|Other|4|||
162944336|NCT00266409|588498752|FG002|Overall Study|Other|2|||
162944337|NCT00266409|588498753|FG003|Overall Study|Other|0|||
162944338|NCT00108732|588498761|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
162944339|NCT00108732|588498761|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
162944340|NCT00108732|588498761|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
162944341|NCT00108732|588498761|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
162944342|NCT00108732|588498761|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
162944343|NCT00108732|588498761|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
162944344|NCT00108732|588498761|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
162944345|NCT01946165|588498763|FG000|Overall Study|Physician Decision|2|||
162944346|NCT01946165|588498764|FG001|Overall Study|Physician Decision|0|||
162944347|NCT01946165|588498763|FG000|Overall Study|Withdrawal by Subject|0|||
162944348|NCT01946165|588498764|FG001|Overall Study|Withdrawal by Subject|2|||
162944349|NCT01901055|588498765|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
162944350|NCT01901055|588498766|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
162944351|NCT01901055|588498765|FG000|Randomization But Not Titrated|Physician Decision|0|||
162944352|NCT01901055|588498766|FG001|Randomization But Not Titrated|Physician Decision|1|||
162944353|NCT01901055|588498765|FG000|Started Protocol to Week 6|Physician Decision|2|||
162944354|NCT01901055|588498766|FG001|Started Protocol to Week 6|Physician Decision|1|||
162944355|NCT01901055|588498765|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
162944356|NCT01901055|588498766|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
162944357|NCT01901055|588498765|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
162944358|NCT01901055|588498766|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
162944359|NCT01901055|588498765|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
162944360|NCT01901055|588498766|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
162944361|NCT01901055|588498765|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
163387779|NCT00775450|590131908|FG002|Overall Study|Serious Adverse Event|0|||
163387780|NCT00775450|590131909|FG003|Overall Study|Serious Adverse Event|0|||
162944362|NCT01901055|588498766|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
162944363|NCT01901055|588498765|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
162944364|NCT01901055|588498766|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
162944365|NCT01901055|588498765|FG000|Week 24|Withdrawal by Subject|13|||
162944366|NCT01901055|588498766|FG001|Week 24|Withdrawal by Subject|19|||
162944367|NCT01901055|588498765|FG000|Week 24|Physician Decision|1|||
162944368|NCT01901055|588498766|FG001|Week 24|Physician Decision|0|||
162944369|NCT01901055|588498765|FG000|Week 36|Withdrawal by Subject|0|||
162944370|NCT01901055|588498766|FG001|Week 36|Withdrawal by Subject|5|||
162944371|NCT01659567|588498767|FG000|Overall Study|Lack of Efficacy|22|||
162944372|NCT01659567|588498767|FG000|Overall Study|Switched to Pegferon|6|||
162944373|NCT01659567|588498767|FG000|Overall Study|Adverse Event|12|||
162944374|NCT01659567|588498767|FG000|Overall Study|Good result at early stage of treatment|5|||
162944375|NCT01659567|588498767|FG000|Overall Study|Withdrawal by Subject|64|||
162944376|NCT01659567|588498767|FG000|Overall Study|Progression of the main disease|1|||
162944377|NCT01659567|588498767|FG000|Overall Study|Other|13|||
162944378|NCT01179919|588498772|FG000|Overall Study|Protocol Violation|1|||
162944379|NCT01179919|588498772|FG000|Overall Study|Adverse Event|1|||
162944380|NCT01915732|588498781|FG000|Overall Study|Withdrawal by Subject|18|||
162944381|NCT01915732|588498782|FG001|Overall Study|Withdrawal by Subject|18|||
162944382|NCT01915732|588498781|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
162944383|NCT01915732|588498782|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
162944384|NCT01915732|588498781|FG000|Overall Study|Adverse Event|12|||
162944385|NCT01915732|588498782|FG001|Overall Study|Adverse Event|4|||
162944386|NCT01915732|588498781|FG000|Overall Study|Protocol Violation|5|||
162944387|NCT01915732|588498782|FG001|Overall Study|Protocol Violation|5|||
162944388|NCT01915732|588498781|FG000|Overall Study|Lack of Efficacy|6|||
162944389|NCT01915732|588498782|FG001|Overall Study|Lack of Efficacy|11|||
162944390|NCT01915732|588498781|FG000|Overall Study|Lost to Follow-up|22|||
162944391|NCT01915732|588498782|FG001|Overall Study|Lost to Follow-up|26|||
162944392|NCT01915732|588498781|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
163186209|NCT04795622|589397701|FG001|Overall Study|Protocol Violation|2|||
163387781|NCT00775450|590131910|FG004|Overall Study|Serious Adverse Event|0|||
163387782|NCT00775450|590131906|FG000|Overall Study|Protocol Violation|0|||
162944393|NCT01915732|588498782|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
162944394|NCT01915732|588498781|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
162944395|NCT01915732|588498782|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
162944396|NCT01915732|588498781|FG000|Overall Study|Drug Release Error|1|||
162944397|NCT01915732|588498782|FG001|Overall Study|Drug Release Error|0|||
163387783|NCT00775450|590131907|FG001|Overall Study|Protocol Violation|0|||
163387784|NCT00775450|590131908|FG002|Overall Study|Protocol Violation|0|||
163387785|NCT00775450|590131909|FG003|Overall Study|Protocol Violation|0|||
163387786|NCT00775450|590131910|FG004|Overall Study|Protocol Violation|1|||
162944398|NCT01915732|588498781|FG000|Overall Study|Recovered|1|||
162944399|NCT01915732|588498782|FG001|Overall Study|Recovered|0|||
162944400|NCT01915732|588498781|FG000|Overall Study|Pregnancy|1|||
162944401|NCT01915732|588498782|FG001|Overall Study|Pregnancy|0|||
162944402|NCT01915732|588498781|FG000|Overall Study|Poor Perceived Efficacy|1|||
162944403|NCT01915732|588498782|FG001|Overall Study|Poor Perceived Efficacy|0|||
162944404|NCT01915732|588498781|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
162944405|NCT01915732|588498782|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
162944406|NCT01915732|588498781|FG000|Overall Study|Got Well|0|||
162944407|NCT01915732|588498782|FG001|Overall Study|Got Well|1|||
162944408|NCT01915732|588498781|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
162944409|NCT01915732|588498782|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
162944410|NCT01915732|588498781|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
162944411|NCT01915732|588498782|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
162944412|NCT01915732|588498781|FG000|Overall Study|Job Transfer|0|||
162944413|NCT01915732|588498782|FG001|Overall Study|Job Transfer|1|||
162944414|NCT01915732|588498781|FG000|Overall Study|Improper Facial Procedure|0|||
162944415|NCT01915732|588498782|FG001|Overall Study|Improper Facial Procedure|1|||
162944416|NCT01915732|588498781|FG000|Overall Study|Poor Conscious Effect|0|||
163186210|NCT04795622|589397700|FG000|Overall Study|Lost to Follow-up|2|||
163186211|NCT04795622|589397701|FG001|Overall Study|Lost to Follow-up|3|||
163387787|NCT00775450|590131906|FG000|Overall Study|Withdrawal by Subject|1|||
163387788|NCT00775450|590131907|FG001|Overall Study|Withdrawal by Subject|0|||
163387789|NCT00775450|590131908|FG002|Overall Study|Withdrawal by Subject|0|||
163387790|NCT00775450|590131909|FG003|Overall Study|Withdrawal by Subject|0|||
163387791|NCT00775450|590131910|FG004|Overall Study|Withdrawal by Subject|1|||
163387792|NCT01749540|590131918|FG000|Overall Study|Protocol Violation|0|||
163387793|NCT01749540|590131919|FG001|Overall Study|Protocol Violation|0|||
163387794|NCT01749540|590131920|FG002|Overall Study|Protocol Violation|0|||
163387795|NCT01749540|590131921|FG003|Overall Study|Protocol Violation|0|||
163387796|NCT01749540|590131922|FG004|Overall Study|Protocol Violation|0|||
163186212|NCT04795622|589397700|FG000|Overall Study|Other|7|||
162944417|NCT01915732|588498782|FG001|Overall Study|Poor Conscious Effect|1|||
163186213|NCT04795622|589397701|FG001|Overall Study|Other|8|||
163387797|NCT01749540|590131923|FG005|Overall Study|Protocol Violation|1|||
163387798|NCT01749540|590131924|FG006|Overall Study|Protocol Violation|1|||
163186214|NCT00470847|589397702|FG000|Overall Study|Pt still receiving treatment|1|||
163387799|NCT01749540|590131918|FG000|Overall Study|Withdrawal by Subject|0|||
163387800|NCT01749540|590131919|FG001|Overall Study|Withdrawal by Subject|0|||
163387801|NCT01749540|590131920|FG002|Overall Study|Withdrawal by Subject|0|||
163387802|NCT01749540|590131921|FG003|Overall Study|Withdrawal by Subject|1|||
163387803|NCT01749540|590131922|FG004|Overall Study|Withdrawal by Subject|0|||
163387804|NCT01749540|590131923|FG005|Overall Study|Withdrawal by Subject|0|||
163387805|NCT01749540|590131924|FG006|Overall Study|Withdrawal by Subject|0|||
163387806|NCT01749540|590131918|FG000|Overall Study|Initiated into extension study A536-06|0|||
163387807|NCT01749540|590131919|FG001|Overall Study|Initiated into extension study A536-06|0|||
163387808|NCT01749540|590131920|FG002|Overall Study|Initiated into extension study A536-06|0|||
163387809|NCT01749540|590131921|FG003|Overall Study|Initiated into extension study A536-06|0|||
163387810|NCT01749540|590131922|FG004|Overall Study|Initiated into extension study A536-06|0|||
163387811|NCT01749540|590131923|FG005|Overall Study|Initiated into extension study A536-06|2|||
163387812|NCT01749540|590131924|FG006|Overall Study|Initiated into extension study A536-06|24|||
163387813|NCT00752622|590131936|FG000|Induction Phase|Adverse Event|3|||
163387814|NCT00752622|590131936|FG000|Induction Phase|Other|3|||
163387815|NCT00752622|590131936|FG000|Induction Phase|Non-responder|14|||
163387816|NCT00752622|590131936|FG000|Induction Phase|Withdrawal by Subject|1|||
163387817|NCT00752622|590131936|FG000|Induction Phase|Premature study termination|14|||
163387818|NCT00752622|590131936|FG000|Observational Phase|Premature Study Termination|36|||
162944418|NCT00698685|588498783|FG000|Overall Study|Sister withdrew as donor|1|||
162944419|NCT00698685|588498783|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
162944420|NCT01325207|588498784|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
162944421|NCT01325207|588498785|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
162944422|NCT01325207|588498786|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
162944423|NCT01325207|588498787|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
162944424|NCT01325207|588498788|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
162944425|NCT01325207|588498789|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
162944426|NCT01325207|588498784|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
162944427|NCT01325207|588498785|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
162944428|NCT01325207|588498786|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
162944429|NCT01325207|588498787|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
162944430|NCT01325207|588498788|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
162944431|NCT01325207|588498789|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
162944432|NCT01325207|588498784|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
162944433|NCT01325207|588498785|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
162944434|NCT01325207|588498786|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
162944435|NCT01325207|588498787|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
162944436|NCT01325207|588498788|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
162944437|NCT01325207|588498789|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
162944438|NCT01325207|588498784|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
162944439|NCT01325207|588498785|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
162944440|NCT01325207|588498786|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
162944441|NCT01325207|588498787|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
162944442|NCT01325207|588498788|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
162944443|NCT01325207|588498789|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
162944444|NCT01325207|588498784|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
162944445|NCT01325207|588498785|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
162944446|NCT01325207|588498786|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
162944447|NCT01325207|588498787|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
162944448|NCT01325207|588498788|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
162944449|NCT01325207|588498789|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
162944450|NCT01325207|588498784|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
162944451|NCT01325207|588498785|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
162944452|NCT01325207|588498786|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
162944453|NCT01325207|588498787|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
162944454|NCT01325207|588498788|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
162944455|NCT01325207|588498789|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
162944456|NCT01325207|588498784|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
162944457|NCT01325207|588498785|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
162944458|NCT01325207|588498786|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
162978983|NCT01660022|588623540|FG002|First Sequence (7 Days)|Adverse Event|0|||
163387819|NCT00752622|590131936|FG000|Observational Phase|Non-responder|2|||
163387820|NCT00752622|590131936|FG000|Observational Phase|Withdrawal by Subject|2|||
163387821|NCT00752622|590131936|FG000|Observational Phase|Adverse Event|1|||
163387822|NCT00752622|590131936|FG000|Observational Phase|Other|2|||
162944459|NCT01325207|588498787|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
162944460|NCT01325207|588498788|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
162944461|NCT01325207|588498789|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
162944462|NCT00708422|588498790|FG000|Overall Study|Adverse Event|3|||
162944463|NCT00708422|588498791|FG001|Overall Study|Adverse Event|1|||
162944464|NCT00708422|588498790|FG000|Overall Study|Withdrawal by Subject|1|||
162944465|NCT00708422|588498791|FG001|Overall Study|Withdrawal by Subject|0|||
162944466|NCT01254409|588498792|FG000|Overall Study|Adverse Event|0|||
162944467|NCT01254409|588498793|FG001|Overall Study|Adverse Event|1|||
162944468|NCT01254409|588498794|FG002|Overall Study|Adverse Event|0|||
162944469|NCT01254409|588498795|FG003|Overall Study|Adverse Event|0|||
162944470|NCT00635154|588498802|FG000|Overall Study|Alternative Treatment|8|||
162944471|NCT00635154|588498802|FG000|Overall Study|Other|4|||
162944472|NCT00635154|588498802|FG000|Overall Study|Still on treatment|21|||
162944473|NCT02114697|588498803|FG000|Overall Study|Study terminated|5|||
162944474|NCT02114697|588498804|FG001|Overall Study|Study terminated|4|||
162944475|NCT02660242|588498809|FG000|Glucose Tabs|Lost to Follow-up|1|||
162944476|NCT02660242|588498809|FG000|Glucagon Injection|Lost to Follow-up|1|||
162944477|NCT02796664|588498812|FG000|Overall Study|Withdrawal by Subject|0|||
162944478|NCT02796664|588498813|FG001|Overall Study|Withdrawal by Subject|3|||
162944479|NCT02796664|588498812|FG000|Overall Study|Noncompliance|1|||
162944480|NCT02796664|588498813|FG001|Overall Study|Noncompliance|1|||
162944481|NCT02796664|588498812|FG000|Overall Study|Death|0|||
162944482|NCT02796664|588498813|FG001|Overall Study|Death|1|||
162944483|NCT02246478|588498814|FG000|Multiple-dose Phase|Protocol Violation|1|||
162944484|NCT02246478|588498815|FG001|Multiple-dose Phase|Protocol Violation|0|||
162944485|NCT02246478|588498816|FG002|Multiple-dose Phase|Protocol Violation|0|||
162944486|NCT02246478|588498817|FG003|Multiple-dose Phase|Protocol Violation|1|||
162944487|NCT00198029|588498818|FG000|Overall Study|Withdrawal by Subject|4|||
162944488|NCT01626079|588498819|FG000|Overall Study|Death|167|||
162944489|NCT01626079|588498820|FG001|Overall Study|Death|192|||
162944490|NCT01626079|588498821|FG002|Overall Study|Death|39|||
162944491|NCT01626079|588498819|FG000|Overall Study|Withdrawal by Subject|23|||
162944492|NCT01626079|588498820|FG001|Overall Study|Withdrawal by Subject|37|||
162944493|NCT01626079|588498821|FG002|Overall Study|Withdrawal by Subject|5|||
162944494|NCT01626079|588498819|FG000|Overall Study|Lost to Follow-up|7|||
162944495|NCT01626079|588498820|FG001|Overall Study|Lost to Follow-up|4|||
162944496|NCT01626079|588498821|FG002|Overall Study|Lost to Follow-up|2|||
162944497|NCT01626079|588498819|FG000|Overall Study|Missed Visits|1|||
162944498|NCT01626079|588498820|FG001|Overall Study|Missed Visits|4|||
162944499|NCT01626079|588498821|FG002|Overall Study|Missed Visits|6|||
162944500|NCT02430870|588498823|FG000|Part 2|Voluntary Withdrawal|0|||
162944501|NCT02430870|588498824|FG001|Part 2|Voluntary Withdrawal|0|||
162944502|NCT02430870|588498825|FG002|Part 2|Voluntary Withdrawal|0|||
162944503|NCT02430870|588498826|FG003|Part 2|Voluntary Withdrawal|0|||
162944504|NCT02430870|588498827|FG004|Part 2|Voluntary Withdrawal|0|||
162944505|NCT02430870|588498828|FG005|Part 2|Voluntary Withdrawal|0|||
162944506|NCT02430870|588498829|FG006|Part 2|Voluntary Withdrawal|1|||
162944507|NCT02430870|588498830|FG007|Part 2|Voluntary Withdrawal|0|||
162944508|NCT02430870|588498823|FG000|Part 2|Other Reason Not Specified|0|||
162944509|NCT02430870|588498824|FG001|Part 2|Other Reason Not Specified|0|||
162944510|NCT02430870|588498825|FG002|Part 2|Other Reason Not Specified|0|||
162944511|NCT02430870|588498826|FG003|Part 2|Other Reason Not Specified|0|||
162944512|NCT02430870|588498827|FG004|Part 2|Other Reason Not Specified|0|||
162944513|NCT02430870|588498828|FG005|Part 2|Other Reason Not Specified|0|||
162944514|NCT02430870|588498829|FG006|Part 2|Other Reason Not Specified|0|||
162944515|NCT02430870|588498830|FG007|Part 2|Other Reason Not Specified|1|||
162944516|NCT00865709|588498833|FG000|Treatment|Adverse Event|9|||
162944517|NCT00865709|588498834|FG001|Treatment|Adverse Event|6|||
163186215|NCT03963401|589397704|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
162944518|NCT00865709|588498833|FG000|Treatment|Withdrawal by Subject|10|||
162944519|NCT00865709|588498834|FG001|Treatment|Withdrawal by Subject|7|||
162944520|NCT00865709|588498833|FG000|Treatment|Physician Decision|3|||
162944521|NCT00865709|588498834|FG001|Treatment|Physician Decision|2|||
162944522|NCT00865709|588498833|FG000|Treatment|Surgery|8|||
162944523|NCT00865709|588498834|FG001|Treatment|Surgery|3|||
162944524|NCT00429923|588498835|FG000|Overall Study|Adverse Event|0|||
162944525|NCT00429923|588498836|FG001|Overall Study|Adverse Event|2|||
162944526|NCT00429923|588498837|FG002|Overall Study|Adverse Event|3|||
162944527|NCT00429923|588498835|FG000|Overall Study|Lack of Efficacy|4|||
162944528|NCT00429923|588498836|FG001|Overall Study|Lack of Efficacy|1|||
162944529|NCT00429923|588498837|FG002|Overall Study|Lack of Efficacy|33|||
162944530|NCT00429923|588498835|FG000|Overall Study|Lost to Follow-up|0|||
162944531|NCT00429923|588498836|FG001|Overall Study|Lost to Follow-up|0|||
162944532|NCT00429923|588498837|FG002|Overall Study|Lost to Follow-up|2|||
162944533|NCT00429923|588498835|FG000|Overall Study|Withdrew Consent|1|||
162944534|NCT00429923|588498836|FG001|Overall Study|Withdrew Consent|0|||
162944535|NCT00429923|588498837|FG002|Overall Study|Withdrew Consent|1|||
162944536|NCT00429923|588498835|FG000|Overall Study|Early Termination|0|||
163186216|NCT03963401|589397705|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
162944537|NCT00429923|588498836|FG001|Overall Study|Early Termination|1|||
162944538|NCT00429923|588498837|FG002|Overall Study|Early Termination|0|||
162944539|NCT01265784|588498838|FG000|Overall Study|Lost to Follow-up|5|||
162944540|NCT01265784|588498839|FG001|Overall Study|Lost to Follow-up|3|||
162944541|NCT01265784|588498840|FG002|Overall Study|Lost to Follow-up|2|||
162944542|NCT01265784|588498838|FG000|Overall Study|Withdrawal by Subject|0|||
162944543|NCT01265784|588498839|FG001|Overall Study|Withdrawal by Subject|5|||
162944544|NCT01265784|588498840|FG002|Overall Study|Withdrawal by Subject|0|||
162944545|NCT01265784|588498838|FG000|Overall Study|Physician Decision|1|||
162944546|NCT01265784|588498839|FG001|Overall Study|Physician Decision|0|||
162944547|NCT01265784|588498840|FG002|Overall Study|Physician Decision|1|||
162944548|NCT01265784|588498838|FG000|Overall Study|Adverse Event|1|||
162944549|NCT01265784|588498839|FG001|Overall Study|Adverse Event|0|||
162944550|NCT01265784|588498840|FG002|Overall Study|Adverse Event|0|||
162944551|NCT01265784|588498838|FG000|Overall Study|Death|3|||
162944552|NCT01265784|588498839|FG001|Overall Study|Death|0|||
162944553|NCT01265784|588498840|FG002|Overall Study|Death|0|||
162944554|NCT01265784|588498838|FG000|Overall Study|Protocol Violation|2|||
162944555|NCT01265784|588498839|FG001|Overall Study|Protocol Violation|0|||
162944556|NCT01265784|588498840|FG002|Overall Study|Protocol Violation|0|||
162944557|NCT01265784|588498838|FG000|Overall Study|Incorrectly Randomized|0|||
162944558|NCT01265784|588498839|FG001|Overall Study|Incorrectly Randomized|0|||
162944559|NCT01265784|588498840|FG002|Overall Study|Incorrectly Randomized|1|||
162944560|NCT03740165|588498843|FG000|Overall Study|Death|232|||
162944561|NCT03740165|588498844|FG001|Overall Study|Death|242|||
162944562|NCT03740165|588498845|FG002|Overall Study|Death|229|||
162944563|NCT03740165|588498843|FG000|Overall Study|Lost to Follow-up|0|||
163186217|NCT03963401|589397706|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
163186218|NCT03963401|589397707|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
163186219|NCT03963401|589397708|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
163186220|NCT03963401|589397709|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
163186221|NCT03963401|589397704|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
163186222|NCT03963401|589397705|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
163186223|NCT03963401|589397706|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
163186224|NCT03963401|589397707|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
163186225|NCT03963401|589397708|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
163186226|NCT03963401|589397709|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
163186227|NCT03963401|589397704|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
163186228|NCT03963401|589397705|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
163186229|NCT03963401|589397706|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
163186230|NCT03963401|589397707|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
163186231|NCT03963401|589397708|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
163186232|NCT03963401|589397709|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
163186233|NCT03963401|589397704|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
163186234|NCT03963401|589397705|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
163186235|NCT03963401|589397706|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
163186236|NCT03963401|589397707|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
163186237|NCT03963401|589397708|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
163186238|NCT03963401|589397709|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
163186239|NCT03963401|589397704|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
163186240|NCT03963401|589397705|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
163186241|NCT03963401|589397706|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
163186242|NCT03963401|589397707|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
163186243|NCT03963401|589397708|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
163186244|NCT03963401|589397709|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
163186245|NCT03963401|589397704|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
163186246|NCT03963401|589397705|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
163186247|NCT03963401|589397706|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
163186248|NCT03963401|589397707|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
163186249|NCT03963401|589397708|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
163291850|NCT03523091|589773179|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
162944564|NCT03740165|588498844|FG001|Overall Study|Lost to Follow-up|0|||
162944565|NCT03740165|588498845|FG002|Overall Study|Lost to Follow-up|1|||
162944566|NCT03740165|588498843|FG000|Overall Study|Withdrawal by Subject|7|||
162944567|NCT03740165|588498844|FG001|Overall Study|Withdrawal by Subject|4|||
162944568|NCT03740165|588498845|FG002|Overall Study|Withdrawal by Subject|3|||
162944569|NCT03740165|588498843|FG000|Overall Study|Ongoing in Study|216|||
162944570|NCT03740165|588498844|FG001|Overall Study|Ongoing in Study|212|||
163186250|NCT03963401|589397709|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
162944571|NCT03740165|588498845|FG002|Overall Study|Ongoing in Study|221|||
162944572|NCT03049618|588498846|FG000|Overall Study|Death|1|||
162944573|NCT03049618|588498847|FG001|Overall Study|Death|0|||
162944574|NCT03049618|588498846|FG000|Overall Study|Lack of Efficacy|1|||
162944575|NCT03049618|588498847|FG001|Overall Study|Lack of Efficacy|2|||
162944576|NCT02785913|588500715|FG000|Overall Study|Adverse Event|5|||
162944577|NCT02785913|588500715|FG000|Overall Study|Death|2|||
162944578|NCT02785913|588500715|FG000|Overall Study|Progression|18|||
162944579|NCT02785913|588500715|FG000|Overall Study|Not protocol specified|1|||
162944580|NCT03717064|588500716|FG000|Period 2|Adverse Event|1|||
162944581|NCT01298570|588500717|FG000|Overall Study|Disease progression, relapse during acti|64|||
162944582|NCT01298570|588500718|FG001|Overall Study|Disease progression, relapse during acti|40|||
162944583|NCT01298570|588500717|FG000|Overall Study|Adverse Event|20|||
162944584|NCT01298570|588500718|FG001|Overall Study|Adverse Event|2|||
162944585|NCT01298570|588500717|FG000|Overall Study|Withdrawal by Subject|21|||
162944586|NCT01298570|588500718|FG001|Overall Study|Withdrawal by Subject|6|||
162944587|NCT01298570|588500717|FG000|Overall Study|Treatment delay > 4 weeks|4|||
162944588|NCT01298570|588500718|FG001|Overall Study|Treatment delay > 4 weeks|5|||
162944589|NCT01298570|588500717|FG000|Overall Study|Physician Decision|4|||
162944590|NCT01298570|588500718|FG001|Overall Study|Physician Decision|2|||
162944591|NCT01298570|588500717|FG000|Overall Study|Other complicating disease|2|||
162944592|NCT01298570|588500718|FG001|Overall Study|Other complicating disease|1|||
162944593|NCT01298570|588500717|FG000|Overall Study|Surgery|2|||
163186251|NCT03963401|589397704|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
162944594|NCT01298570|588500718|FG001|Overall Study|Surgery|1|||
162944595|NCT01298570|588500717|FG000|Overall Study|Symptomatic progression/deterioration|3|||
162944596|NCT01298570|588500718|FG001|Overall Study|Symptomatic progression/deterioration|2|||
162944597|NCT01298570|588500717|FG000|Overall Study|Death|0|||
162944598|NCT01298570|588500718|FG001|Overall Study|Death|1|||
162944599|NCT01298570|588500717|FG000|Overall Study|Ineligibility|0|||
162944600|NCT01298570|588500718|FG001|Overall Study|Ineligibility|1|||
162944601|NCT01929109|588500719|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
162944602|NCT01929109|588500720|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
162944603|NCT01929109|588500721|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
162944604|NCT01929109|588500722|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
162944605|NCT01929109|588500723|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
162944606|NCT00076102|588500724|FG000|Overall Study|Clinical progression|1|||
162944607|NCT00076102|588500724|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
162944608|NCT00076102|588500724|FG000|Overall Study|plexiform neurofibroma surgery|1|||
162944609|NCT00076102|588500724|FG000|Overall Study|refusal of further therapy|2|||
162944610|NCT01052116|588500725|FG000|Overall Study|Lost to Follow-up|11|||
162944611|NCT01052116|588500726|FG001|Overall Study|Lost to Follow-up|17|||
162944612|NCT01052116|588500725|FG000|Overall Study|Withdrawal by Subject|3|||
162944613|NCT01052116|588500726|FG001|Overall Study|Withdrawal by Subject|6|||
162944614|NCT01052116|588500725|FG000|Overall Study|Spirometry not performed|0|||
162944615|NCT01052116|588500726|FG001|Overall Study|Spirometry not performed|4|||
162944616|NCT02180711|588500728|FG000|Overall Study|Death|0|||
162944617|NCT02180711|588500729|FG001|Overall Study|Death|1|||
162944618|NCT02180711|588500730|FG002|Overall Study|Death|0|||
162944619|NCT02180711|588500731|FG003|Overall Study|Death|0|||
162944620|NCT02180711|588500732|FG004|Overall Study|Death|7|||
162944621|NCT02180711|588500733|FG005|Overall Study|Death|0|||
162944622|NCT02180711|588500734|FG006|Overall Study|Death|1|||
162944623|NCT02180711|588500735|FG007|Overall Study|Death|3|||
162944624|NCT02180711|588500728|FG000|Overall Study|Lost to Follow-up|0|||
162944625|NCT02180711|588500729|FG001|Overall Study|Lost to Follow-up|1|||
162944626|NCT02180711|588500730|FG002|Overall Study|Lost to Follow-up|0|||
162944627|NCT02180711|588500731|FG003|Overall Study|Lost to Follow-up|0|||
162944628|NCT02180711|588500732|FG004|Overall Study|Lost to Follow-up|1|||
162944629|NCT02180711|588500733|FG005|Overall Study|Lost to Follow-up|1|||
162944630|NCT02180711|588500734|FG006|Overall Study|Lost to Follow-up|0|||
162944631|NCT02180711|588500735|FG007|Overall Study|Lost to Follow-up|3|||
162944632|NCT02180711|588500728|FG000|Overall Study|Withdrawal by Subject|2|||
162944633|NCT02180711|588500729|FG001|Overall Study|Withdrawal by Subject|1|||
162944634|NCT02180711|588500730|FG002|Overall Study|Withdrawal by Subject|0|||
162944635|NCT02180711|588500731|FG003|Overall Study|Withdrawal by Subject|4|||
162944636|NCT02180711|588500732|FG004|Overall Study|Withdrawal by Subject|3|||
162944637|NCT02180711|588500733|FG005|Overall Study|Withdrawal by Subject|0|||
162944638|NCT02180711|588500734|FG006|Overall Study|Withdrawal by Subject|3|||
162944639|NCT02180711|588500735|FG007|Overall Study|Withdrawal by Subject|2|||
163186252|NCT03963401|589397705|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
163186253|NCT03963401|589397706|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
163186254|NCT03963401|589397707|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
162944640|NCT02180711|588500728|FG000|Overall Study|- Disease Progression|0|||
162944641|NCT02180711|588500729|FG001|Overall Study|- Disease Progression|1|||
162944642|NCT02180711|588500730|FG002|Overall Study|- Disease Progression|0|||
162944643|NCT02180711|588500731|FG003|Overall Study|- Disease Progression|0|||
162944644|NCT02180711|588500732|FG004|Overall Study|- Disease Progression|0|||
162944645|NCT02180711|588500733|FG005|Overall Study|- Disease Progression|0|||
162944646|NCT02180711|588500734|FG006|Overall Study|- Disease Progression|0|||
163186255|NCT03963401|589397708|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
163186256|NCT03963401|589397709|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
163186257|NCT03963401|589397704|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
163186258|NCT03963401|589397705|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
163186259|NCT03963401|589397706|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
163186260|NCT03963401|589397707|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
163186261|NCT03963401|589397708|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
163186262|NCT03963401|589397709|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
163186263|NCT03963401|589397704|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
163186264|NCT03963401|589397705|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
163186265|NCT03963401|589397706|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
163186266|NCT03963401|589397707|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
163186267|NCT03963401|589397708|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
163186268|NCT03963401|589397709|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
163186269|NCT03963401|589397704|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
163186270|NCT03963401|589397705|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
163186271|NCT03963401|589397706|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
163186272|NCT03963401|589397707|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
163186273|NCT03963401|589397708|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
163186274|NCT03963401|589397709|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
163186275|NCT03963401|589397704|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
163186276|NCT03963401|589397705|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
163186277|NCT03963401|589397706|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
163186278|NCT03963401|589397707|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
163186279|NCT03963401|589397708|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
163186280|NCT03963401|589397709|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
163186281|NCT01610271|589397714|FG000|Overall Study|Surgery not complete|0|||
163186282|NCT01610271|589397715|FG001|Overall Study|Surgery not complete|1|||
163186283|NCT01610271|589397714|FG000|Overall Study|Prosthesis not implanted|2|||
163186284|NCT01610271|589397715|FG001|Overall Study|Prosthesis not implanted|3|||
163186285|NCT01638819|589397716|FG000|Overall Study|Lost to Follow-up|1|||
163186286|NCT01638819|589397717|FG001|Overall Study|Lost to Follow-up|0|||
163186287|NCT00923936|589397718|FG000|Overall Study|progressive disease on study|2|||
163186288|NCT00923936|589397719|FG001|Overall Study|progressive disease on study|1|||
163186289|NCT00923936|589397718|FG000|Overall Study|Adverse Event|2|||
163186290|NCT00923936|589397719|FG001|Overall Study|Adverse Event|1|||
163186291|NCT00923936|589397718|FG000|Overall Study|Lost to follow up|2|||
163186292|NCT00923936|589397719|FG001|Overall Study|Lost to follow up|0|||
163186293|NCT00923936|589397718|FG000|Overall Study|Continuing in follow up period|2|||
163186294|NCT00923936|589397719|FG001|Overall Study|Continuing in follow up period|1|||
163387823|NCT00752622|590131936|FG000|Interventional Phase|Non-responder|2|||
163387824|NCT00752622|590131936|FG000|Interventional Phase|Physician Decision|1|||
163387825|NCT00752622|590131936|FG000|Interventional Phase|Premature Study Termination|5|||
163387826|NCT00576836|590131937|FG000|Overall Study|Death|0|||
163186295|NCT02038452|589397720|FG000|Overall Study|Withdrawal by Subject|7|||
163387827|NCT00576836|590131938|FG001|Overall Study|Death|1|||
163387828|NCT00576836|590131937|FG000|Overall Study|Physician Decision|0|||
162944647|NCT02180711|588500735|FG007|Overall Study|- Disease Progression|0|||
162944648|NCT02180711|588500728|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
162944649|NCT02180711|588500729|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
162944650|NCT02180711|588500730|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
162944651|NCT02180711|588500731|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
162944652|NCT02180711|588500732|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
162944653|NCT02180711|588500733|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
162944654|NCT02180711|588500734|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
162944655|NCT02180711|588500735|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
162944656|NCT02180711|588500728|FG000|Overall Study|- Study Terminated by Sponsor|2|||
163387829|NCT00576836|590131938|FG001|Overall Study|Physician Decision|1|||
163387830|NCT00392327|590131941|FG000|Overall Study|Death|1|||
163387831|NCT00392327|590131942|FG001|Overall Study|Death|0|||
163387832|NCT00392327|590131943|FG002|Overall Study|Death|1|||
163387833|NCT00392327|590131944|FG003|Overall Study|Death|0|||
163387834|NCT00392327|590131945|FG004|Overall Study|Death|0|||
163387835|NCT00392327|590131946|FG005|Overall Study|Death|0|||
163387836|NCT00392327|590131947|FG006|Overall Study|Death|0|||
163387837|NCT00392327|590131948|FG007|Overall Study|Death|0|||
163387838|NCT00392327|590131941|FG000|Overall Study|Lack of Efficacy|8|||
163387839|NCT00392327|590131942|FG001|Overall Study|Lack of Efficacy|8|||
163387840|NCT00392327|590131943|FG002|Overall Study|Lack of Efficacy|9|||
163387841|NCT00392327|590131944|FG003|Overall Study|Lack of Efficacy|6|||
163387842|NCT00392327|590131945|FG004|Overall Study|Lack of Efficacy|3|||
163387843|NCT00392327|590131946|FG005|Overall Study|Lack of Efficacy|3|||
163387844|NCT00392327|590131947|FG006|Overall Study|Lack of Efficacy|3|||
163387845|NCT00392327|590131948|FG007|Overall Study|Lack of Efficacy|3|||
163387846|NCT00392327|590131941|FG000|Overall Study|Physician Decision|3|||
163387847|NCT00392327|590131942|FG001|Overall Study|Physician Decision|5|||
163387848|NCT00392327|590131943|FG002|Overall Study|Physician Decision|2|||
163387849|NCT00392327|590131944|FG003|Overall Study|Physician Decision|2|||
163387850|NCT00392327|590131945|FG004|Overall Study|Physician Decision|0|||
163387851|NCT00392327|590131946|FG005|Overall Study|Physician Decision|1|||
163387852|NCT00392327|590131947|FG006|Overall Study|Physician Decision|5|||
163387853|NCT00392327|590131948|FG007|Overall Study|Physician Decision|3|||
163387854|NCT00392327|590131941|FG000|Overall Study|Protocol Violation|0|||
163387855|NCT00392327|590131942|FG001|Overall Study|Protocol Violation|0|||
163387856|NCT00392327|590131943|FG002|Overall Study|Protocol Violation|1|||
163387857|NCT00392327|590131944|FG003|Overall Study|Protocol Violation|0|||
163387858|NCT00392327|590131945|FG004|Overall Study|Protocol Violation|0|||
163387859|NCT00392327|590131946|FG005|Overall Study|Protocol Violation|0|||
163387860|NCT00392327|590131947|FG006|Overall Study|Protocol Violation|0|||
162944657|NCT02180711|588500729|FG001|Overall Study|- Study Terminated by Sponsor|3|||
162944658|NCT02180711|588500730|FG002|Overall Study|- Study Terminated by Sponsor|0|||
162944659|NCT02180711|588500731|FG003|Overall Study|- Study Terminated by Sponsor|5|||
162944660|NCT02180711|588500732|FG004|Overall Study|- Study Terminated by Sponsor|32|||
162944661|NCT02180711|588500733|FG005|Overall Study|- Study Terminated by Sponsor|0|||
162944662|NCT02180711|588500734|FG006|Overall Study|- Study Terminated by Sponsor|4|||
162944663|NCT02180711|588500735|FG007|Overall Study|- Study Terminated by Sponsor|13|||
162944664|NCT02180711|588500728|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
162944665|NCT02180711|588500729|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
162944666|NCT02180711|588500730|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
162944667|NCT02180711|588500731|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
162944668|NCT02180711|588500732|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
162944669|NCT02180711|588500733|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
162944670|NCT02180711|588500734|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
162944671|NCT02180711|588500735|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
162944672|NCT02180711|588500728|FG000|Overall Study|- Other|1|||
162944673|NCT02180711|588500729|FG001|Overall Study|- Other|0|||
162944674|NCT02180711|588500730|FG002|Overall Study|- Other|0|||
162944675|NCT02180711|588500731|FG003|Overall Study|- Other|1|||
162944676|NCT02180711|588500732|FG004|Overall Study|- Other|0|||
162944677|NCT02180711|588500733|FG005|Overall Study|- Other|0|||
162944678|NCT02180711|588500734|FG006|Overall Study|- Other|0|||
162944679|NCT02180711|588500735|FG007|Overall Study|- Other|0|||
163387861|NCT00392327|590131948|FG007|Overall Study|Protocol Violation|0|||
163387862|NCT00392327|590131941|FG000|Overall Study|Withdrawal by Subject|3|||
163387863|NCT00392327|590131942|FG001|Overall Study|Withdrawal by Subject|2|||
163387864|NCT00392327|590131943|FG002|Overall Study|Withdrawal by Subject|4|||
163387865|NCT00392327|590131944|FG003|Overall Study|Withdrawal by Subject|6|||
163387866|NCT00392327|590131945|FG004|Overall Study|Withdrawal by Subject|0|||
163387867|NCT00392327|590131946|FG005|Overall Study|Withdrawal by Subject|1|||
162944680|NCT00444145|588500736|FG000|Overall Study|Withdrawal by Subject|2|||
162944681|NCT00444145|588500736|FG000|Overall Study|Lost to Follow-up|1|||
162944682|NCT00444145|588500736|FG000|Overall Study|non-compliant|11|||
163387868|NCT00392327|590131947|FG006|Overall Study|Withdrawal by Subject|1|||
163387869|NCT00392327|590131948|FG007|Overall Study|Withdrawal by Subject|5|||
163387870|NCT00392327|590131941|FG000|Overall Study|Ineligible|0|||
163387871|NCT00392327|590131942|FG001|Overall Study|Ineligible|4|||
163387872|NCT00392327|590131943|FG002|Overall Study|Ineligible|3|||
163387873|NCT00392327|590131944|FG003|Overall Study|Ineligible|2|||
163387874|NCT00392327|590131945|FG004|Overall Study|Ineligible|0|||
163387875|NCT00392327|590131946|FG005|Overall Study|Ineligible|0|||
163387876|NCT00392327|590131947|FG006|Overall Study|Ineligible|0|||
163387877|NCT00392327|590131948|FG007|Overall Study|Ineligible|0|||
163387878|NCT00894686|590131949|FG000|Overall Study|Withdrawal by Subject|50|||
163387879|NCT00894686|590131949|FG000|Overall Study|Physician Decision|1|||
163387880|NCT00894686|590131949|FG000|Overall Study|Other|5|||
163387881|NCT03267940|590131950|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
163387882|NCT03267940|590131951|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
163387883|NCT03267940|590131952|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
163387884|NCT03267940|590131953|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
163387885|NCT03267940|590131954|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
163387886|NCT03267940|590131955|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
163387887|NCT03267940|590131950|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
163387888|NCT03267940|590131951|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
163387889|NCT03267940|590131952|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
163387890|NCT03267940|590131953|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
163387891|NCT03267940|590131954|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
163387892|NCT03267940|590131955|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
163387893|NCT03267940|590131950|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
163387894|NCT03267940|590131951|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
163387895|NCT03267940|590131952|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
163387896|NCT03267940|590131953|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
163291851|NCT03523091|589773178|FG000|Overall Study|Withdrawal by Subject|0|||
163291852|NCT03523091|589773179|FG001|Overall Study|Withdrawal by Subject|3|||
163291853|NCT03523091|589773178|FG000|Overall Study|Increase Botox dose|0|||
163291854|NCT03523091|589773179|FG001|Overall Study|Increase Botox dose|1|||
163291855|NCT01093534|589773180|FG000|Overall Study|Adverse Event|2|||
163291856|NCT01093534|589773181|FG001|Overall Study|Adverse Event|5|||
163291857|NCT01093534|589773182|FG002|Overall Study|Adverse Event|2|||
163291858|NCT01093534|589773180|FG000|Overall Study|Lack of Efficacy|2|||
163291859|NCT01093534|589773181|FG001|Overall Study|Lack of Efficacy|1|||
163291860|NCT01093534|589773182|FG002|Overall Study|Lack of Efficacy|1|||
163291861|NCT01093534|589773180|FG000|Overall Study|Withdrawal by Subject|5|||
163291862|NCT01093534|589773181|FG001|Overall Study|Withdrawal by Subject|7|||
163291863|NCT01093534|589773182|FG002|Overall Study|Withdrawal by Subject|2|||
163291864|NCT01093534|589773180|FG000|Overall Study|Other|1|||
163291865|NCT01093534|589773181|FG001|Overall Study|Other|3|||
163291866|NCT01093534|589773182|FG002|Overall Study|Other|4|||
163291867|NCT00741988|589773186|FG000|Overall Study|Adverse Event|2|||
163291868|NCT00741988|589773187|FG001|Overall Study|Adverse Event|4|||
163291869|NCT00741988|589773186|FG000|Overall Study|Lack of Efficacy|2|||
163291870|NCT00741988|589773187|FG001|Overall Study|Lack of Efficacy|0|||
163291871|NCT03863834|589773194|FG000|Overall Study|Lost to Follow-up|3|||
163291872|NCT02685488|589773195|FG000|Overall Study|Withdrawal by Subject|0|||
163291873|NCT02685488|589773196|FG001|Overall Study|Withdrawal by Subject|1|||
163291874|NCT04436120|589773197|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
163291875|NCT04436120|589773198|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
163291876|NCT04436120|589773199|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
163291877|NCT04436120|589773200|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
163291878|NCT04436120|589773201|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
163291879|NCT04436120|589773202|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
163291880|NCT04436120|589773203|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
163291881|NCT01769391|589773204|FG000|Overall Study|Death|10|||
163291882|NCT01769391|589773205|FG001|Overall Study|Death|1|||
163291883|NCT01769391|589773204|FG000|Overall Study|Adverse Event|0|||
163291884|NCT01769391|589773205|FG001|Overall Study|Adverse Event|3|||
163291885|NCT01769391|589773204|FG000|Overall Study|Progressive Disease|1|||
163291886|NCT01769391|589773205|FG001|Overall Study|Progressive Disease|2|||
163291887|NCT01769391|589773204|FG000|Overall Study|Withdrawal by Subject|4|||
163291888|NCT01769391|589773205|FG001|Overall Study|Withdrawal by Subject|3|||
163291889|NCT01769391|589773204|FG000|Overall Study|Investigator Decision|2|||
163291890|NCT01769391|589773205|FG001|Overall Study|Investigator Decision|0|||
163291891|NCT03386929|589773206|FG000|Overall Study|Death|0|||
163291892|NCT03386929|589773207|FG001|Overall Study|Death|0|||
163291893|NCT03386929|589773208|FG002|Overall Study|Death|1|||
163291894|NCT03386929|589773206|FG000|Overall Study|Withdrawal by Subject|0|||
163291895|NCT03386929|589773207|FG001|Overall Study|Withdrawal by Subject|1|||
163291896|NCT03386929|589773208|FG002|Overall Study|Withdrawal by Subject|0|||
163291897|NCT03386929|589773206|FG000|Overall Study|Physician Decision|0|||
162944683|NCT00444145|588500736|FG000|Overall Study|Screen Failures|5|||
162944684|NCT01619800|588500737|FG000|Overall Study|study terminated|2|||
162944685|NCT01619800|588500738|FG001|Overall Study|study terminated|0|||
162944686|NCT00414466|588500740|FG000|Overall Study|Adverse Event|0|||
162944687|NCT00414466|588500741|FG001|Overall Study|Adverse Event|0|||
162944688|NCT00414466|588500742|FG002|Overall Study|Adverse Event|1|||
162944689|NCT00414466|588500743|FG003|Overall Study|Adverse Event|1|||
162944690|NCT00414466|588500740|FG000|Overall Study|Lack of Efficacy|1|||
162944691|NCT00414466|588500741|FG001|Overall Study|Lack of Efficacy|0|||
162944692|NCT00414466|588500742|FG002|Overall Study|Lack of Efficacy|0|||
162944693|NCT00414466|588500743|FG003|Overall Study|Lack of Efficacy|0|||
162944694|NCT00414466|588500740|FG000|Overall Study|Withdrawn by Sponsor|1|||
162944695|NCT00414466|588500741|FG001|Overall Study|Withdrawn by Sponsor|0|||
162944696|NCT00414466|588500742|FG002|Overall Study|Withdrawn by Sponsor|0|||
162944697|NCT00414466|588500743|FG003|Overall Study|Withdrawn by Sponsor|0|||
162944698|NCT02742090|588500746|FG000|Overall Study|Adverse Event|10|||
162944699|NCT02742090|588500746|FG000|Overall Study|Death|3|||
162944700|NCT02742090|588500746|FG000|Overall Study|Disease Progression|25|||
162944701|NCT02742090|588500746|FG000|Overall Study|Investigator's Decision|1|||
162944702|NCT02742090|588500746|FG000|Overall Study|Lost to Follow-up|1|||
162944703|NCT02742090|588500746|FG000|Overall Study|Non-compliance with Study|1|||
162944704|NCT02742090|588500746|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
162944705|NCT02742090|588500746|FG000|Overall Study|Withdrawal by Subject|4|||
162944706|NCT02742090|588500746|FG000|Overall Study|Reason Not Specified|1|||
162944707|NCT02016300|588500751|FG000|Overall Study|Lost to Follow-up|0|||
162944708|NCT02016300|588500752|FG001|Overall Study|Lost to Follow-up|3|||
162944709|NCT05301751|588500757|FG000|Overall Study|Withdrawal by Subject|0|||
162944710|NCT05301751|588500758|FG001|Overall Study|Withdrawal by Subject|0|||
162944711|NCT05301751|588500759|FG002|Overall Study|Withdrawal by Subject|1|||
162944712|NCT05301751|588500760|FG003|Overall Study|Withdrawal by Subject|0|||
162944713|NCT06165744|588500763|FG000|Overall Study|Non device-related adverse event|1|||
162944714|NCT01546987|588500764|FG000|Overall Study|Protocol Violation|3|||
163387897|NCT03267940|590131954|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
163387898|NCT03267940|590131955|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
163387899|NCT03267940|590131950|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
163387900|NCT03267940|590131951|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
163387901|NCT03267940|590131952|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
163387902|NCT03267940|590131953|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
163387903|NCT03267940|590131954|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
163387904|NCT03267940|590131955|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
162944715|NCT01546987|588500765|FG001|Overall Study|Protocol Violation|4|||
162944716|NCT02270736|588500766|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
162944717|NCT02270736|588500767|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
162944718|NCT02270736|588500768|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
162944719|NCT02270736|588500769|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
162944720|NCT02270736|588500770|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
162944721|NCT02270736|588500766|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
162944722|NCT02270736|588500767|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
163387905|NCT03267940|590131950|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
163387906|NCT03267940|590131951|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
163387907|NCT03267940|590131952|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
163387908|NCT03267940|590131953|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
163387909|NCT03267940|590131954|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
163387910|NCT03267940|590131955|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
163387911|NCT03267940|590131950|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
163387912|NCT03267940|590131951|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
162944723|NCT02270736|588500768|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
162944724|NCT02270736|588500769|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
162944725|NCT02270736|588500770|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
162944726|NCT02270736|588500766|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
162944727|NCT02270736|588500767|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
162944728|NCT02270736|588500768|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
162944729|NCT02270736|588500769|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
162944730|NCT02270736|588500770|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
162944731|NCT02270736|588500766|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
162944732|NCT02270736|588500767|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
163387913|NCT03267940|590131952|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
163387914|NCT03267940|590131953|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
163387915|NCT03267940|590131954|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
163387916|NCT03267940|590131955|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
163186296|NCT02038452|589397721|FG001|Overall Study|Withdrawal by Subject|9|||
163186297|NCT02038452|589397720|FG000|Overall Study|Lost to Follow-up|31|||
163186298|NCT02038452|589397721|FG001|Overall Study|Lost to Follow-up|28|||
163186299|NCT00986479|589397722|FG000|Period 1|Improved mood|1|||
163186300|NCT00986479|589397723|FG001|Period 1|Improved mood|0|||
163186301|NCT00986479|589397722|FG000|Period 1|Administrative reasons|1|||
163186302|NCT00986479|589397723|FG001|Period 1|Administrative reasons|0|||
163186303|NCT01721070|589397724|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
163186304|NCT02035475|589397725|FG000|Overall Study|Withdrawal by Subject|4|||
163186305|NCT02035475|589397725|FG000|Overall Study|Physician Decision|1|||
163186306|NCT02035475|589397725|FG000|Overall Study|Equipment Error|1|||
163186307|NCT01626495|589397731|FG000|Overall Study|Adverse Event|3|||
163186308|NCT01626495|589397731|FG000|Overall Study|Disease progression|27|||
163186309|NCT01626495|589397731|FG000|Overall Study|Withdrawal by Subject|1|||
163186310|NCT01626495|589397731|FG000|Overall Study|Administrative problem|1|||
163186311|NCT01626495|589397731|FG000|Overall Study|Death|2|||
163186312|NCT01626495|589397731|FG000|Overall Study|Physician Decision|1|||
163186313|NCT01626495|589397731|FG000|Overall Study|New cancer therapy|16|||
163186314|NCT01626495|589397731|FG000|Overall Study|Manufacturing failure|1|||
163186315|NCT00304239|589397732|FG000|Overall Study|Protocol Deviations/Violations|15|||
163186316|NCT00304239|589397733|FG001|Overall Study|Protocol Deviations/Violations|0|||
163186317|NCT00304239|589397732|FG000|Overall Study|Adverse Event|2|||
163186318|NCT00304239|589397733|FG001|Overall Study|Adverse Event|0|||
163186319|NCT05430022|589397744|FG000|Overall Study|Withdrawal by Subject|4|||
163186320|NCT05430022|589397745|FG001|Overall Study|Withdrawal by Subject|4|||
163186321|NCT05521906|589397746|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
163186322|NCT05521906|589397747|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
163186323|NCT01828320|589397749|FG000|Overall Study|Lost to Follow-up|1|||
163186324|NCT01828320|589397750|FG001|Overall Study|Lost to Follow-up|3|||
163186325|NCT01828320|589397749|FG000|Overall Study|Withdrawal by Subject|7|||
163186326|NCT01828320|589397750|FG001|Overall Study|Withdrawal by Subject|2|||
163186327|NCT00866788|589400092|FG000|Overall Study|Adverse Event|0|||
163186328|NCT00866788|589400093|FG001|Overall Study|Adverse Event|2|||
163186329|NCT00866788|589400094|FG002|Overall Study|Adverse Event|0|||
163186330|NCT00866788|589400095|FG003|Overall Study|Adverse Event|1|||
163186331|NCT00866788|589400092|FG000|Overall Study|Lost to Follow-up|1|||
163186332|NCT00866788|589400093|FG001|Overall Study|Lost to Follow-up|1|||
163186333|NCT00866788|589400094|FG002|Overall Study|Lost to Follow-up|0|||
163186334|NCT00866788|589400095|FG003|Overall Study|Lost to Follow-up|2|||
163186335|NCT00866788|589400092|FG000|Overall Study|Withdrawal by Subject|2|||
163186336|NCT00866788|589400093|FG001|Overall Study|Withdrawal by Subject|1|||
163186337|NCT00866788|589400094|FG002|Overall Study|Withdrawal by Subject|0|||
163186338|NCT00866788|589400095|FG003|Overall Study|Withdrawal by Subject|1|||
163186339|NCT00866788|589400092|FG000|Overall Study|Pregnancy|0|||
163186340|NCT00866788|589400093|FG001|Overall Study|Pregnancy|1|||
163186341|NCT00866788|589400094|FG002|Overall Study|Pregnancy|0|||
163186342|NCT00866788|589400095|FG003|Overall Study|Pregnancy|0|||
163186343|NCT00866788|589400092|FG000|Overall Study|Disease progression|3|||
163186344|NCT00866788|589400093|FG001|Overall Study|Disease progression|1|||
163186345|NCT00866788|589400094|FG002|Overall Study|Disease progression|1|||
163186346|NCT00866788|589400095|FG003|Overall Study|Disease progression|0|||
163186347|NCT00866788|589400092|FG000|Overall Study|Physician Decision|0|||
163186348|NCT00866788|589400093|FG001|Overall Study|Physician Decision|0|||
163186349|NCT00866788|589400094|FG002|Overall Study|Physician Decision|1|||
163186350|NCT00866788|589400095|FG003|Overall Study|Physician Decision|1|||
163186351|NCT02349061|589400097|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
163186352|NCT02349061|589400098|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
163186353|NCT02349061|589400099|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
163186354|NCT02349061|589400097|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
163186355|NCT02349061|589400098|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
163186356|NCT02349061|589400099|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
163186357|NCT02349061|589400097|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
163186358|NCT02349061|589400098|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
163186359|NCT02349061|589400099|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
163186360|NCT02349061|589400097|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
163186361|NCT02349061|589400098|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
163387917|NCT03267940|590131950|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
162944733|NCT02270736|588500768|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
162944734|NCT02270736|588500769|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
162944735|NCT02270736|588500770|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
162944736|NCT02270736|588500766|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
162944737|NCT02270736|588500767|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
162944738|NCT02270736|588500768|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
162944739|NCT02270736|588500769|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
162944740|NCT02270736|588500770|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
162944741|NCT02270736|588500766|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
162944742|NCT02270736|588500767|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
162944743|NCT02270736|588500768|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
162944744|NCT02270736|588500769|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
162944745|NCT02270736|588500770|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
162944746|NCT02270736|588500766|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
162944747|NCT02270736|588500767|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
162944748|NCT02270736|588500768|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
162944749|NCT02270736|588500769|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
162944750|NCT02270736|588500770|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
162944751|NCT02270736|588500766|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
162944752|NCT02270736|588500767|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
162944753|NCT02270736|588500768|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
162944754|NCT02270736|588500769|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
162944755|NCT02270736|588500770|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
162944756|NCT02270736|588500766|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
162944757|NCT02270736|588500767|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
162944758|NCT02270736|588500768|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
162944759|NCT02270736|588500769|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
162944760|NCT02270736|588500770|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
162944761|NCT00262600|588500771|FG000|Overall Study|Lost to Follow-up|17|||
162944762|NCT00262600|588500772|FG001|Overall Study|Lost to Follow-up|31|||
162944763|NCT00262600|588500773|FG002|Overall Study|Lost to Follow-up|41|||
162944764|NCT00262600|588500771|FG000|Overall Study|Withdrawal by Subject|128|||
162944765|NCT00262600|588500772|FG001|Overall Study|Withdrawal by Subject|145|||
162944766|NCT00262600|588500773|FG002|Overall Study|Withdrawal by Subject|139|||
162944767|NCT00262600|588500771|FG000|Overall Study|Not Treated|32|||
162944768|NCT00262600|588500772|FG001|Overall Study|Not Treated|17|||
162944769|NCT00262600|588500773|FG002|Overall Study|Not Treated|24|||
162944770|NCT00262600|588500771|FG000|Overall Study|Other|58|||
162944771|NCT00262600|588500772|FG001|Overall Study|Other|59|||
162944772|NCT00262600|588500773|FG002|Overall Study|Other|62|||
162944773|NCT02132247|588500780|FG000|Overall Study|Protocol Violation|1|||
162944774|NCT02132247|588500781|FG001|Overall Study|Protocol Violation|0|||
162944775|NCT04373434|588500786|FG000|Overall Study|Lost to Follow-up|37|||
162944776|NCT04373434|588500787|FG001|Overall Study|Lost to Follow-up|32|||
162944777|NCT04373434|588500786|FG000|Overall Study|Refused at 9 months|1|||
162944778|NCT04373434|588500787|FG001|Overall Study|Refused at 9 months|2|||
162944779|NCT04373434|588500786|FG000|Overall Study|Refused at 4 months|7|||
162944780|NCT04373434|588500787|FG001|Overall Study|Refused at 4 months|3|||
162944781|NCT04373434|588500786|FG000|Overall Study|Excluded|2|||
162944782|NCT04373434|588500787|FG001|Overall Study|Excluded|0|||
162944783|NCT00527423|588500788|FG000|Overall Study|Protocol Violation|1|||
162944784|NCT00527423|588500788|FG000|Overall Study|Adverse Event|5|||
162944785|NCT00527423|588500788|FG000|Overall Study|Physician Decision|4|||
162944786|NCT00527423|588500788|FG000|Overall Study|Withdrawal by Subject|10|||
162944787|NCT00527423|588500788|FG000|Overall Study|Lost to Follow-up|4|||
162944788|NCT00527423|588500788|FG000|Overall Study|OTHER|4|||
162944789|NCT00527423|588500788|FG000|Overall Study|Death|9|||
162944790|NCT02446132|588500789|FG000|Overall Study|Adverse Event|10|||
162944791|NCT02446132|588500790|FG001|Overall Study|Adverse Event|27|||
162944792|NCT02446132|588500791|FG002|Overall Study|Adverse Event|27|||
162944793|NCT02446132|588500789|FG000|Overall Study|Death|2|||
162944794|NCT02446132|588500790|FG001|Overall Study|Death|13|||
162944795|NCT02446132|588500791|FG002|Overall Study|Death|10|||
162944796|NCT02446132|588500789|FG000|Overall Study|Lack of Efficacy|1|||
162944797|NCT02446132|588500790|FG001|Overall Study|Lack of Efficacy|10|||
162944798|NCT02446132|588500791|FG002|Overall Study|Lack of Efficacy|6|||
162944799|NCT02446132|588500789|FG000|Overall Study|Lost to Follow-up|2|||
162944800|NCT02446132|588500790|FG001|Overall Study|Lost to Follow-up|4|||
162944801|NCT02446132|588500791|FG002|Overall Study|Lost to Follow-up|5|||
162944802|NCT02446132|588500789|FG000|Overall Study|Non-compliance With Study Drug|2|||
162944803|NCT02446132|588500790|FG001|Overall Study|Non-compliance With Study Drug|2|||
162944804|NCT02446132|588500791|FG002|Overall Study|Non-compliance With Study Drug|3|||
162944805|NCT02446132|588500789|FG000|Overall Study|Physician Decision|1|||
162944806|NCT02446132|588500790|FG001|Overall Study|Physician Decision|8|||
162944807|NCT02446132|588500791|FG002|Overall Study|Physician Decision|13|||
162944808|NCT02446132|588500789|FG000|Overall Study|Protocol Deviation|0|||
162944809|NCT02446132|588500790|FG001|Overall Study|Protocol Deviation|0|||
162944810|NCT02446132|588500791|FG002|Overall Study|Protocol Deviation|1|||
162944811|NCT02446132|588500789|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
162944812|NCT02446132|588500790|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
162944813|NCT02446132|588500791|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
162944814|NCT02446132|588500789|FG000|Overall Study|Study Terminated by Sponsor|4|||
162944815|NCT02446132|588500790|FG001|Overall Study|Study Terminated by Sponsor|35|||
163387918|NCT03267940|590131951|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
163387919|NCT03267940|590131952|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
163387920|NCT03267940|590131953|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
163387921|NCT03267940|590131954|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
163387922|NCT03267940|590131955|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
163387923|NCT03267940|590131950|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
163387924|NCT03267940|590131951|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
163387925|NCT03267940|590131952|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
163387926|NCT03267940|590131953|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
163387927|NCT03267940|590131954|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
163387928|NCT03267940|590131955|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
163387929|NCT03267940|590131950|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
163387930|NCT03267940|590131951|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
163387931|NCT03267940|590131952|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
163387932|NCT03267940|590131953|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
163387933|NCT03267940|590131954|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
163387934|NCT03267940|590131955|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
163387935|NCT00178126|590131962|FG000|Overall Study|Lost to Follow-up|21|||
162944816|NCT02446132|588500791|FG002|Overall Study|Study Terminated by Sponsor|58|||
162944817|NCT02446132|588500789|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
162944818|NCT02446132|588500790|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
162944819|NCT02446132|588500791|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
162944820|NCT02446132|588500789|FG000|Overall Study|Withdrawal by Subject|11|||
162944821|NCT02446132|588500790|FG001|Overall Study|Withdrawal by Subject|29|||
162944822|NCT02446132|588500791|FG002|Overall Study|Withdrawal by Subject|25|||
162944823|NCT02446132|588500789|FG000|Overall Study|Reason not Specified|4|||
162944824|NCT02446132|588500790|FG001|Overall Study|Reason not Specified|16|||
162944825|NCT02446132|588500791|FG002|Overall Study|Reason not Specified|10|||
162944826|NCT02446132|588500789|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
162944827|NCT02446132|588500790|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
162944828|NCT02446132|588500791|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
162944829|NCT03444038|588500792|FG000|Overall Study|Adverse Event|12|||
162944830|NCT03444038|588500792|FG000|Overall Study|Withdrawal by Subject|7|||
162944831|NCT03444038|588500792|FG000|Overall Study|Lost to Follow-up|1|||
162944832|NCT03444038|588500792|FG000|Overall Study|Physician Decision|2|||
162944833|NCT03444038|588500792|FG000|Overall Study|Lack of Efficacy|7|||
162944834|NCT02354586|588500794|FG000|Overall Study|Death|230|||
162944835|NCT02354586|588500794|FG000|Overall Study|Withdrawal by Subject|59|||
162944836|NCT02354586|588500794|FG000|Overall Study|Lost to Follow-up|11|||
162944837|NCT02354586|588500794|FG000|Overall Study|Sponsor decision|51|||
162944838|NCT02354586|588500794|FG000|Overall Study|Site closure|2|||
162944839|NCT02354586|588500794|FG000|Overall Study|Intercurrent illness|1|||
162944840|NCT02354586|588500794|FG000|Overall Study|Protocol Violation|3|||
162944841|NCT02354586|588500794|FG000|Overall Study|Physician Decision|13|||
162944842|NCT02354586|588500794|FG000|Overall Study|Lack of Efficacy|86|||
162944843|NCT02354586|588500794|FG000|Overall Study|Adverse Event|7|||
162944844|NCT00436007|588500795|FG000|Overall Study|Withdrawal by Subject|5|||
162944845|NCT00436007|588500796|FG001|Overall Study|Withdrawal by Subject|3|||
162944846|NCT00436007|588500797|FG002|Overall Study|Withdrawal by Subject|4|||
162944847|NCT00436007|588500795|FG000|Overall Study|Lost to Follow-up|14|||
162944848|NCT00436007|588500796|FG001|Overall Study|Lost to Follow-up|10|||
163186362|NCT02349061|589400099|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
163186363|NCT02349061|589400097|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
162944849|NCT00436007|588500797|FG002|Overall Study|Lost to Follow-up|13|||
162944850|NCT00436007|588500795|FG000|Overall Study|Physician Decision|0|||
162944851|NCT00436007|588500796|FG001|Overall Study|Physician Decision|0|||
162944852|NCT00436007|588500797|FG002|Overall Study|Physician Decision|2|||
162944853|NCT00436007|588500795|FG000|Overall Study|Death|0|||
162944854|NCT00436007|588500796|FG001|Overall Study|Death|1|||
162944855|NCT00436007|588500797|FG002|Overall Study|Death|3|||
162944856|NCT00436007|588500795|FG000|Overall Study|Other|0|||
162944857|NCT00436007|588500796|FG001|Overall Study|Other|0|||
163186364|NCT02349061|589400098|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
162944858|NCT00436007|588500797|FG002|Overall Study|Other|1|||
162944859|NCT01957488|588500798|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
162944860|NCT01957488|588500799|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
162944861|NCT01957488|588500800|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
162944862|NCT01957488|588500801|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
162944863|NCT01957488|588500802|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
162944864|NCT01957488|588500803|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
162944865|NCT01957488|588500798|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
163042854|NCT01066871|588863974|FG000|Overall Study|Withdrawal by Subject|3|||
163042855|NCT01066871|588863975|FG001|Overall Study|Withdrawal by Subject|1|||
163042856|NCT01066871|588863976|FG002|Overall Study|Withdrawal by Subject|0|||
163042857|NCT01066871|588863977|FG003|Overall Study|Withdrawal by Subject|0|||
163042858|NCT01066871|588863974|FG000|Overall Study|Other|0|||
163042859|NCT01066871|588863975|FG001|Overall Study|Other|2|||
162944866|NCT01957488|588500799|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
162944867|NCT01957488|588500800|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
162944868|NCT01957488|588500801|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
162944869|NCT01957488|588500802|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
162944870|NCT01957488|588500803|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
162944871|NCT01957488|588500798|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
162944872|NCT01957488|588500799|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
162944873|NCT01957488|588500800|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
162944874|NCT01957488|588500801|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
162944875|NCT01957488|588500802|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
162944876|NCT01957488|588500803|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
162944877|NCT01957488|588500798|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
162944878|NCT01957488|588500799|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
162944879|NCT01957488|588500800|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
162944880|NCT01957488|588500801|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
162944881|NCT01957488|588500802|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
162944882|NCT01957488|588500803|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
162944883|NCT01957488|588500798|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
162944884|NCT01957488|588500799|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
162944885|NCT01957488|588500800|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
162944886|NCT01957488|588500801|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
162944887|NCT01957488|588500802|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
162944888|NCT01957488|588500803|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
162944889|NCT01957488|588500798|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
162944890|NCT01957488|588500799|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
162944891|NCT01957488|588500800|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
162944892|NCT01957488|588500801|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
162944893|NCT01957488|588500802|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
162944894|NCT01957488|588500803|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
162944895|NCT01957488|588500798|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
162944896|NCT01957488|588500799|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
162944897|NCT01957488|588500800|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
162944898|NCT01957488|588500801|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
162944899|NCT01957488|588500802|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
162944900|NCT01957488|588500803|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
162944901|NCT01957488|588500798|FG000|Test Period 2 (2 Weeks)|Other|1|||
162944902|NCT01957488|588500799|FG001|Test Period 2 (2 Weeks)|Other|0|||
162944903|NCT01957488|588500800|FG002|Test Period 2 (2 Weeks)|Other|0|||
162944904|NCT01957488|588500801|FG003|Test Period 2 (2 Weeks)|Other|0|||
162944905|NCT01957488|588500802|FG004|Test Period 2 (2 Weeks)|Other|0|||
162944906|NCT01957488|588500803|FG005|Test Period 2 (2 Weeks)|Other|0|||
162944907|NCT01957488|588500798|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
162944908|NCT01957488|588500799|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
162944909|NCT01957488|588500800|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
162944910|NCT01957488|588500801|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
162944911|NCT01957488|588500802|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
162944912|NCT01957488|588500803|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
162944913|NCT01957488|588500798|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
162944914|NCT01957488|588500799|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
162944915|NCT01957488|588500800|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
162944916|NCT01957488|588500801|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
162944917|NCT01957488|588500802|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
162944918|NCT01957488|588500803|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
162944919|NCT01957488|588500798|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
162944920|NCT01957488|588500799|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
163387936|NCT00178126|590131963|FG001|Overall Study|Lost to Follow-up|21|||
162944921|NCT01957488|588500800|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
162944922|NCT01957488|588500801|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
162944923|NCT01957488|588500802|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
163042860|NCT01066871|588863976|FG002|Overall Study|Other|1|||
162944924|NCT01957488|588500803|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
162944925|NCT01957488|588500798|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
162944926|NCT01957488|588500799|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
162944927|NCT01957488|588500800|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
162944928|NCT01957488|588500801|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
162944929|NCT01957488|588500802|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
162944930|NCT01957488|588500803|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
162944931|NCT01957488|588500798|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
162944932|NCT01957488|588500799|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
162944933|NCT01957488|588500800|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
162944934|NCT01957488|588500801|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
162944935|NCT01957488|588500802|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
162944936|NCT01957488|588500803|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
162944937|NCT00721409|588500804|FG000|Overall Study|Global deterioration of health status|2|||
162944938|NCT00721409|588500805|FG001|Overall Study|Global deterioration of health status|6|||
162944939|NCT00721409|588500806|FG002|Overall Study|Global deterioration of health status|3|||
162944940|NCT00721409|588500804|FG000|Overall Study|Death|0|||
162944941|NCT00721409|588500805|FG001|Overall Study|Death|1|||
162944942|NCT00721409|588500806|FG002|Overall Study|Death|0|||
162944943|NCT00721409|588500804|FG000|Overall Study|Randomized not Treated|0|||
162944944|NCT00721409|588500805|FG001|Overall Study|Randomized not Treated|1|||
162944945|NCT00721409|588500806|FG002|Overall Study|Randomized not Treated|4|||
162944946|NCT00721409|588500804|FG000|Overall Study|Reason not specified|1|||
162944947|NCT00721409|588500805|FG001|Overall Study|Reason not specified|0|||
162944948|NCT00721409|588500806|FG002|Overall Study|Reason not specified|2|||
162944949|NCT00721409|588500804|FG000|Overall Study|Adverse Event|0|||
162944950|NCT00721409|588500805|FG001|Overall Study|Adverse Event|13|||
162944951|NCT00721409|588500806|FG002|Overall Study|Adverse Event|2|||
162944952|NCT00721409|588500804|FG000|Overall Study|Lost to Follow-up|0|||
162944953|NCT00721409|588500805|FG001|Overall Study|Lost to Follow-up|0|||
162944954|NCT00721409|588500806|FG002|Overall Study|Lost to Follow-up|1|||
162944955|NCT00721409|588500804|FG000|Overall Study|Withdrawal by Subject|1|||
162944956|NCT00721409|588500805|FG001|Overall Study|Withdrawal by Subject|6|||
162944957|NCT00721409|588500806|FG002|Overall Study|Withdrawal by Subject|5|||
162944958|NCT00721409|588500804|FG000|Overall Study|Objective progression or relapse|8|||
162944959|NCT00721409|588500805|FG001|Overall Study|Objective progression or relapse|55|||
162944960|NCT00721409|588500806|FG002|Overall Study|Objective progression or relapse|62|||
162944961|NCT01424722|588500807|FG000|Overall Study|Sponsor terminated investigation|2258|||
162944962|NCT02483975|588500808|FG000|Overall Study|Adverse Event|0|||
162944963|NCT02483975|588500809|FG001|Overall Study|Adverse Event|1|||
162944964|NCT02483975|588500808|FG000|Overall Study|Lost to Follow-up|0|||
162944965|NCT02483975|588500809|FG001|Overall Study|Lost to Follow-up|1|||
162944966|NCT02483975|588500808|FG000|Overall Study|Physician Decision|2|||
162944967|NCT02483975|588500809|FG001|Overall Study|Physician Decision|0|||
162944968|NCT00818883|588500810|FG000|Overall Study|Adverse Event|28|||
162944969|NCT00818883|588500811|FG001|Overall Study|Adverse Event|19|||
162944970|NCT00818883|588500810|FG000|Overall Study|Protocol Violation|2|||
162944971|NCT00818883|588500811|FG001|Overall Study|Protocol Violation|2|||
162944972|NCT00818883|588500810|FG000|Overall Study|Lost to Follow-up|3|||
162944973|NCT00818883|588500811|FG001|Overall Study|Lost to Follow-up|2|||
162944974|NCT00818883|588500810|FG000|Overall Study|Withdrawal by Subject|16|||
162944975|NCT00818883|588500811|FG001|Overall Study|Withdrawal by Subject|14|||
162944976|NCT00818883|588500810|FG000|Overall Study|Lack of Efficacy|0|||
162944977|NCT00818883|588500811|FG001|Overall Study|Lack of Efficacy|2|||
162944978|NCT00818883|588500810|FG000|Overall Study|Other|2|||
162944979|NCT00818883|588500811|FG001|Overall Study|Other|7|||
162944980|NCT02166697|588500812|FG000|Overall Study|Protocol Violation|347|||
162944981|NCT01153984|588500819|FG000|Overall Study|Withdrawal by Subject|1|||
162944982|NCT01153984|588500819|FG000|Overall Study|Adverse Event|1|||
162944983|NCT00973700|588500820|FG000|Overall Study|Withdrawal by Subject|2|||
162944984|NCT00973700|588500821|FG001|Overall Study|Withdrawal by Subject|2|||
162944985|NCT00973700|588500822|FG002|Overall Study|Withdrawal by Subject|8|||
162944986|NCT00973700|588500823|FG003|Overall Study|Withdrawal by Subject|4|||
162944987|NCT00973700|588500824|FG004|Overall Study|Withdrawal by Subject|4|||
162944988|NCT00973700|588500820|FG000|Overall Study|Lost to Follow-up|5|||
162944989|NCT00973700|588500821|FG001|Overall Study|Lost to Follow-up|0|||
162944990|NCT00973700|588500822|FG002|Overall Study|Lost to Follow-up|1|||
162944991|NCT00973700|588500823|FG003|Overall Study|Lost to Follow-up|8|||
162944992|NCT00973700|588500824|FG004|Overall Study|Lost to Follow-up|5|||
162944993|NCT00973700|588500820|FG000|Overall Study|Inappropriate enrolment|0|||
162944994|NCT00973700|588500821|FG001|Overall Study|Inappropriate enrolment|0|||
162944995|NCT00973700|588500822|FG002|Overall Study|Inappropriate enrolment|0|||
162944996|NCT00973700|588500823|FG003|Overall Study|Inappropriate enrolment|4|||
162944997|NCT00973700|588500824|FG004|Overall Study|Inappropriate enrolment|0|||
162944998|NCT00973700|588500820|FG000|Overall Study|Unable to Classify|0|||
162944999|NCT00973700|588500821|FG001|Overall Study|Unable to Classify|0|||
162945000|NCT00973700|588500822|FG002|Overall Study|Unable to Classify|1|||
162945001|NCT00973700|588500823|FG003|Overall Study|Unable to Classify|2|||
162945002|NCT00973700|588500824|FG004|Overall Study|Unable to Classify|1|||
162945003|NCT01618266|588500833|FG000|Overall Study|Lost to Follow-up|9|||
162945004|NCT01618266|588500833|FG000|Overall Study|Treatment satisfaction|10|||
162945005|NCT01618266|588500833|FG000|Overall Study|Other reasons|11|||
162945006|NCT01618266|588500833|FG000|Overall Study|Lack of Efficacy|23|||
162945007|NCT01618266|588500833|FG000|Overall Study|Protocol Violation|43|||
162945008|NCT00290745|588500834|FG000|Overall Study|Withdrawal by Subject|4|||
162945009|NCT00290745|588500834|FG000|Overall Study|Physician Decision|2|||
162945010|NCT00290745|588500834|FG000|Overall Study|Surgery after 3 months for progression|3|||
162945011|NCT00290745|588500834|FG000|Overall Study|Baseline MRI not available|3|||
162945012|NCT02224391|588500839|FG000|Overall Study|Lost to Follow-up|26|||
162945013|NCT02224391|588500840|FG001|Overall Study|Lost to Follow-up|19|||
162945014|NCT02224391|588500839|FG000|Overall Study|Withdrawal by Subject|6|||
162945015|NCT02224391|588500840|FG001|Overall Study|Withdrawal by Subject|5|||
162945016|NCT02492958|588500841|FG000|Overall Study|Withdrawal by Subject|0|||
162945017|NCT02492958|588500842|FG001|Overall Study|Withdrawal by Subject|0|||
162945018|NCT02492958|588500843|FG002|Overall Study|Withdrawal by Subject|1|||
162945019|NCT02492958|588500844|FG003|Overall Study|Withdrawal by Subject|0|||
162945020|NCT02492958|588500841|FG000|Overall Study|Adverse Event|1|||
162945021|NCT02492958|588500842|FG001|Overall Study|Adverse Event|0|||
162945022|NCT02492958|588500843|FG002|Overall Study|Adverse Event|1|||
162945023|NCT02492958|588500844|FG003|Overall Study|Adverse Event|0|||
162945024|NCT03522948|588500845|FG000|Overall Study|Lost to Follow-up|1|||
162945025|NCT02236130|588500847|FG000|Overall Study|Lost to Follow-up|7|||
162945026|NCT02236130|588500848|FG001|Overall Study|Lost to Follow-up|12|||
162945027|NCT00424489|588500851|FG000|Overall Study|Death|3|||
162945028|NCT01984242|588500852|FG000|Overall Study|Death|52|||
162945029|NCT01984242|588500853|FG001|Overall Study|Death|50|||
162945030|NCT01984242|588500854|FG002|Overall Study|Death|52|||
162945031|NCT01984242|588500852|FG000|Overall Study|Withdrawal by Subject|5|||
162945032|NCT01984242|588500853|FG001|Overall Study|Withdrawal by Subject|3|||
162945033|NCT01984242|588500854|FG002|Overall Study|Withdrawal by Subject|10|||
162945034|NCT01984242|588500852|FG000|Overall Study|Physician Decision|0|||
162945035|NCT01984242|588500853|FG001|Overall Study|Physician Decision|0|||
162945036|NCT01984242|588500854|FG002|Overall Study|Physician Decision|1|||
162945037|NCT01984242|588500852|FG000|Overall Study|Lost to Follow-up|4|||
162945038|NCT01984242|588500853|FG001|Overall Study|Lost to Follow-up|0|||
162945039|NCT01984242|588500854|FG002|Overall Study|Lost to Follow-up|3|||
162945040|NCT01984242|588500852|FG000|Overall Study|Sponsor Decision|1|||
162945041|NCT01984242|588500853|FG001|Overall Study|Sponsor Decision|0|||
162945042|NCT01984242|588500854|FG002|Overall Study|Sponsor Decision|0|||
162945043|NCT01984242|588500852|FG000|Overall Study|Non-Compliance|1|||
162945044|NCT01984242|588500853|FG001|Overall Study|Non-Compliance|0|||
162945045|NCT01984242|588500854|FG002|Overall Study|Non-Compliance|0|||
162945046|NCT01984242|588500852|FG000|Overall Study|Study terminated by Sponsor|38|||
162945047|NCT01984242|588500853|FG001|Overall Study|Study terminated by Sponsor|50|||
162945048|NCT01984242|588500854|FG002|Overall Study|Study terminated by Sponsor|34|||
162945049|NCT01984242|588500852|FG000|Overall Study|Disease Progression|0|||
162945050|NCT01984242|588500853|FG001|Overall Study|Disease Progression|0|||
162945051|NCT01984242|588500854|FG002|Overall Study|Disease Progression|1|||
162945052|NCT00449150|588500857|FG000|Overall Study|Adverse Event|11|||
162945053|NCT00449150|588500858|FG001|Overall Study|Adverse Event|18|||
162945054|NCT00449150|588500859|FG002|Overall Study|Adverse Event|9|||
162945055|NCT00449150|588500857|FG000|Overall Study|Lack of Efficacy|1|||
162945056|NCT00449150|588500858|FG001|Overall Study|Lack of Efficacy|2|||
162945057|NCT00449150|588500859|FG002|Overall Study|Lack of Efficacy|2|||
162945058|NCT00449150|588500857|FG000|Overall Study|Other|16|||
162945059|NCT00449150|588500858|FG001|Overall Study|Other|13|||
162945060|NCT00449150|588500859|FG002|Overall Study|Other|14|||
162945061|NCT00449150|588500857|FG000|Overall Study|Withdrawal by Subject|17|||
162945062|NCT00449150|588500858|FG001|Overall Study|Withdrawal by Subject|18|||
162945063|NCT00449150|588500859|FG002|Overall Study|Withdrawal by Subject|21|||
162945064|NCT00449150|588500857|FG000|Overall Study|Protocol Violation|1|||
162945065|NCT00449150|588500858|FG001|Overall Study|Protocol Violation|2|||
162945066|NCT00449150|588500859|FG002|Overall Study|Protocol Violation|1|||
162945067|NCT00770510|588500860|FG000|Overall Study|Lost to Follow-up|2|||
162945068|NCT00770510|588500860|FG000|Overall Study|Pregnancy|1|||
162945069|NCT00770510|588500860|FG000|Overall Study|Withdrawal by Subject|2|||
162945070|NCT01089647|588500866|FG000|Overall Study|Lost to Follow-up|2|||
162945071|NCT01089647|588500867|FG001|Overall Study|Lost to Follow-up|2|||
162945072|NCT01089647|588500866|FG000|Overall Study|Withdrawal by Subject|2|||
162945073|NCT01089647|588500867|FG001|Overall Study|Withdrawal by Subject|1|||
162945074|NCT01089647|588500866|FG000|Overall Study|Adverse Event|0|||
162945075|NCT01089647|588500867|FG001|Overall Study|Adverse Event|1|||
162945076|NCT02001558|588500870|FG000|Overall Study|Lost to Follow-up|8|||
162945077|NCT02001558|588500871|FG001|Overall Study|Lost to Follow-up|14|||
162945078|NCT04117607|588500872|FG000|Overall Study|Early Termination|0|||
162945079|NCT04117607|588500873|FG001|Overall Study|Early Termination|1|||
162945080|NCT04117607|588500874|FG002|Overall Study|Early Termination|0|||
162945081|NCT04117607|588500875|FG003|Overall Study|Early Termination|0|||
162945082|NCT04117607|588500876|FG004|Overall Study|Early Termination|0|||
162945083|NCT04117607|588500877|FG005|Overall Study|Early Termination|0|||
162945084|NCT04117607|588500878|FG006|Overall Study|Early Termination|1|||
162945085|NCT04117607|588500879|FG007|Overall Study|Early Termination|0|||
162945086|NCT04117607|588500880|FG008|Overall Study|Early Termination|0|||
162945087|NCT04117607|588500881|FG009|Overall Study|Early Termination|0|||
162945088|NCT04117607|588500882|FG010|Overall Study|Early Termination|0|||
162945089|NCT04117607|588500883|FG011|Overall Study|Early Termination|0|||
162945090|NCT04117607|588500884|FG012|Overall Study|Early Termination|0|||
162945091|NCT04117607|588500885|FG013|Overall Study|Early Termination|0|||
162945092|NCT01457053|588500889|FG000|Overall Study|Unable to undergo selected treatment|1|||
162945093|NCT01457053|588500890|FG001|Overall Study|Unable to undergo selected treatment|1|||
162945094|NCT02073643|588500891|FG000|Overall Study|Lost to Follow-up|24|||
162945095|NCT04333095|588500894|FG000|Overall Study|Protocol Violation|4|||
162945096|NCT04333095|588500895|FG001|Overall Study|Protocol Violation|0|||
162945097|NCT04333095|588500894|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
162945098|NCT04333095|588500895|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
162945099|NCT04333095|588500894|FG000|Overall Study|Mini Sternotomy|4|||
162945100|NCT04333095|588500895|FG001|Overall Study|Mini Sternotomy|5|||
162945101|NCT02364557|588500896|FG000|Overall Study|Protocol Violation|3|||
162945102|NCT02364557|588500897|FG001|Overall Study|Protocol Violation|1|||
162945103|NCT04347239|588500898|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
162945104|NCT04347239|588500899|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
162945105|NCT04347239|588500900|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
162945106|NCT04347239|588500898|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
162945107|NCT04347239|588500899|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
162945108|NCT04347239|588500900|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
162945109|NCT00788957|588500909|FG000|Part 1|Death|8|||
162945110|NCT00788957|588500910|FG001|Part 1|Death|0|||
162945111|NCT00788957|588500911|FG002|Part 1|Death|0|||
162945112|NCT00788957|588500912|FG003|Part 1|Death|0|||
162945113|NCT00788957|588500913|FG004|Part 1|Death|0|||
162945114|NCT00788957|588500914|FG005|Part 1|Death|0|||
162945115|NCT00788957|588500909|FG000|Part 1|Lost to Follow-up|1|||
162945116|NCT00788957|588500910|FG001|Part 1|Lost to Follow-up|0|||
162945117|NCT00788957|588500911|FG002|Part 1|Lost to Follow-up|0|||
162945118|NCT00788957|588500912|FG003|Part 1|Lost to Follow-up|0|||
162945119|NCT00788957|588500913|FG004|Part 1|Lost to Follow-up|0|||
162945120|NCT00788957|588500914|FG005|Part 1|Lost to Follow-up|0|||
162945121|NCT00788957|588500909|FG000|Part 2|Withdrawal by Subject|0|||
162945122|NCT00788957|588500910|FG001|Part 2|Withdrawal by Subject|9|||
162945123|NCT00788957|588500911|FG002|Part 2|Withdrawal by Subject|5|||
162945124|NCT00788957|588500912|FG003|Part 2|Withdrawal by Subject|3|||
162945125|NCT00788957|588500913|FG004|Part 2|Withdrawal by Subject|0|||
162945126|NCT00788957|588500914|FG005|Part 2|Withdrawal by Subject|0|||
162945127|NCT00788957|588500909|FG000|Part 2|Death|0|||
162945128|NCT00788957|588500910|FG001|Part 2|Death|32|||
162945129|NCT00788957|588500911|FG002|Part 2|Death|35|||
162945130|NCT00788957|588500912|FG003|Part 2|Death|37|||
162945131|NCT00788957|588500913|FG004|Part 2|Death|0|||
162945132|NCT00788957|588500914|FG005|Part 2|Death|0|||
162945133|NCT00788957|588500909|FG000|Part 2|Lost to Follow-up|0|||
162945134|NCT00788957|588500910|FG001|Part 2|Lost to Follow-up|0|||
162945135|NCT00788957|588500911|FG002|Part 2|Lost to Follow-up|3|||
162945136|NCT00788957|588500912|FG003|Part 2|Lost to Follow-up|0|||
162945137|NCT00788957|588500913|FG004|Part 2|Lost to Follow-up|0|||
162945138|NCT00788957|588500914|FG005|Part 2|Lost to Follow-up|0|||
162945139|NCT00788957|588500909|FG000|Part 2|On-study at time of data cut-off|0|||
162945140|NCT00788957|588500910|FG001|Part 2|On-study at time of data cut-off|1|||
162945141|NCT00788957|588500911|FG002|Part 2|On-study at time of data cut-off|1|||
162945142|NCT00788957|588500912|FG003|Part 2|On-study at time of data cut-off|1|||
163387937|NCT00178126|590131962|FG000|Overall Study|did not receive intervention|4|||
162945143|NCT00788957|588500913|FG004|Part 2|On-study at time of data cut-off|0|||
162945144|NCT00788957|588500914|FG005|Part 2|On-study at time of data cut-off|0|||
162945145|NCT00788957|588500909|FG000|Part 3|Withdrawal by Subject|0|||
162945146|NCT00788957|588500910|FG001|Part 3|Withdrawal by Subject|0|||
162945147|NCT00788957|588500911|FG002|Part 3|Withdrawal by Subject|0|||
162945148|NCT00788957|588500912|FG003|Part 3|Withdrawal by Subject|0|||
162945149|NCT00788957|588500913|FG004|Part 3|Withdrawal by Subject|0|||
162945150|NCT00788957|588500914|FG005|Part 3|Withdrawal by Subject|2|||
162945151|NCT00788957|588500909|FG000|Part 3|Death|0|||
162945152|NCT00788957|588500910|FG001|Part 3|Death|0|||
162945153|NCT00788957|588500911|FG002|Part 3|Death|0|||
162945154|NCT00788957|588500912|FG003|Part 3|Death|0|||
162945155|NCT00788957|588500913|FG004|Part 3|Death|8|||
162945156|NCT00788957|588500914|FG005|Part 3|Death|8|||
162945157|NCT00788957|588500909|FG000|Part 3|On-study at time of data cut-off|0|||
162945158|NCT00788957|588500910|FG001|Part 3|On-study at time of data cut-off|0|||
162945159|NCT00788957|588500911|FG002|Part 3|On-study at time of data cut-off|0|||
162945160|NCT00788957|588500912|FG003|Part 3|On-study at time of data cut-off|0|||
162945161|NCT00788957|588500913|FG004|Part 3|On-study at time of data cut-off|1|||
162945162|NCT00788957|588500914|FG005|Part 3|On-study at time of data cut-off|0|||
162945163|NCT00796510|588500923|FG000|Overall Study|Death|1|||
162945164|NCT00796510|588500924|FG001|Overall Study|Death|0|||
162945165|NCT00796510|588500923|FG000|Overall Study|Study Terminated|2|||
162945166|NCT00796510|588500924|FG001|Overall Study|Study Terminated|0|||
162945167|NCT02841709|588502842|FG000|5th Intervention|Adverse Event|2|||
162945168|NCT02841709|588502843|FG001|5th Intervention|Adverse Event|0|||
162945169|NCT02841709|588502844|FG002|5th Intervention|Adverse Event|0|||
162945170|NCT02841709|588502845|FG003|5th Intervention|Adverse Event|0|||
162945171|NCT02841709|588502846|FG004|5th Intervention|Adverse Event|2|||
162945172|NCT01210001|588502847|FG000|Overall Study|Not treated|1|||
162945173|NCT01210001|588502848|FG001|Overall Study|Not treated|0|||
162945174|NCT01210001|588502849|FG002|Overall Study|Not treated|0|||
162945175|NCT01210001|588502847|FG000|Overall Study|Adverse Event|4|||
162945176|NCT01210001|588502848|FG001|Overall Study|Adverse Event|2|||
162945177|NCT01210001|588502849|FG002|Overall Study|Adverse Event|5|||
162945178|NCT01210001|588502847|FG000|Overall Study|Non compliant with protocol|2|||
162945179|NCT01210001|588502848|FG001|Overall Study|Non compliant with protocol|2|||
162945180|NCT01210001|588502849|FG002|Overall Study|Non compliant with protocol|3|||
162945181|NCT01210001|588502847|FG000|Overall Study|Lost to Follow-up|4|||
162945182|NCT01210001|588502848|FG001|Overall Study|Lost to Follow-up|3|||
162945183|NCT01210001|588502849|FG002|Overall Study|Lost to Follow-up|2|||
162945184|NCT01210001|588502847|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
162945185|NCT01210001|588502848|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
162945186|NCT01210001|588502849|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
162945187|NCT01210001|588502847|FG000|Overall Study|Other reason not defined above|2|||
162945188|NCT01210001|588502848|FG001|Overall Study|Other reason not defined above|2|||
162945189|NCT01210001|588502849|FG002|Overall Study|Other reason not defined above|1|||
162945190|NCT00788125|588502850|FG000|Overall Study|Death|6|||
162945191|NCT04526210|588502854|FG000|Overall Study|Sponsor decision|7|||
162945192|NCT04526210|588502855|FG001|Overall Study|Sponsor decision|5|||
162945193|NCT04526210|588502854|FG000|Overall Study|Withdrawal by Subject|3|||
162945194|NCT04526210|588502855|FG001|Overall Study|Withdrawal by Subject|2|||
162945195|NCT01781637|588502856|FG000|Overall Study|Adverse Event|1|||
162945196|NCT01781637|588502857|FG001|Overall Study|Adverse Event|0|||
162945197|NCT01781637|588502856|FG000|Overall Study|Lack of Efficacy|2|||
162945198|NCT01781637|588502857|FG001|Overall Study|Lack of Efficacy|6|||
162945199|NCT01781637|588502856|FG000|Overall Study|Withdrawal by Subject|1|||
162945200|NCT01781637|588502857|FG001|Overall Study|Withdrawal by Subject|0|||
162945201|NCT02637232|588502858|FG000|Overall Study|Lost to Follow-up|42|||
162945202|NCT02637232|588502858|FG000|Overall Study|Adverse Event|11|||
162945203|NCT02637232|588502858|FG000|Overall Study|patient 's decision|2|||
162945204|NCT00090857|588502859|FG000|Overall Study|Lost to Follow-up|0|||
162945205|NCT00090857|588502860|FG001|Overall Study|Lost to Follow-up|1|||
162945206|NCT00090857|588502859|FG000|Overall Study|Withdrawal by Subject|2|||
162945207|NCT00090857|588502860|FG001|Overall Study|Withdrawal by Subject|0|||
162945208|NCT00090857|588502859|FG000|Overall Study|Adverse Event|2|||
162945209|NCT00090857|588502860|FG001|Overall Study|Adverse Event|2|||
162945210|NCT05097326|588502862|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
162945211|NCT05097326|588502863|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
162945212|NCT03480425|588502864|FG000|Overall Study|Force transducer technical failure|1|||
162945213|NCT02473640|588502874|FG000|Treatment Period 1|Adverse Event|1|||
162945214|NCT03292653|588502875|FG000|Overall Study|Adverse Event|0|||
162945215|NCT03292653|588502876|FG001|Overall Study|Adverse Event|0|||
162945216|NCT03292653|588502877|FG002|Overall Study|Adverse Event|1|||
162945217|NCT03292653|588502875|FG000|Overall Study|Did not Receive Treatment|1|||
162945218|NCT03292653|588502876|FG001|Overall Study|Did not Receive Treatment|0|||
162945219|NCT03292653|588502877|FG002|Overall Study|Did not Receive Treatment|0|||
162945220|NCT04720664|588502878|FG000|Overall Study|Adverse Event|2|||
162945221|NCT04720664|588502878|FG000|Overall Study|Lack of Efficacy|9|||
162945222|NCT03103100|588502881|FG000|Overall Study|Adverse Event|1|||
162945223|NCT03103100|588502882|FG001|Overall Study|Adverse Event|0|||
162945224|NCT03103100|588502883|FG002|Overall Study|Adverse Event|0|||
162945225|NCT03103100|588502881|FG000|Overall Study|Physician Decision|1|||
162945226|NCT03103100|588502882|FG001|Overall Study|Physician Decision|0|||
162945227|NCT03103100|588502883|FG002|Overall Study|Physician Decision|2|||
162945228|NCT02720510|588502893|FG000|Overall Study|Study Terminated by the sponsor|2|||
162945229|NCT02720510|588502894|FG001|Overall Study|Study Terminated by the sponsor|0|||
162945230|NCT02720510|588502893|FG000|Overall Study|Adverse Event|0|||
162945231|NCT02720510|588502894|FG001|Overall Study|Adverse Event|1|||
162945232|NCT02720510|588502893|FG000|Overall Study|Physician Decision|1|||
162945233|NCT02720510|588502894|FG001|Overall Study|Physician Decision|2|||
162945234|NCT02460159|588502895|FG000|Overall Study|Adverse Event|4|||
162945235|NCT02460159|588502896|FG001|Overall Study|Adverse Event|1|||
162945236|NCT02460159|588502895|FG000|Overall Study|Withdrawal by Subject|2|||
162945237|NCT02460159|588502896|FG001|Overall Study|Withdrawal by Subject|0|||
162945238|NCT00084084|588502897|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
162945239|NCT00084084|588502897|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
162945240|NCT01531205|588502901|FG000|Overall Study|Did not proceed to surgery|1|||
162945241|NCT02465567|588502902|FG000|Overall Study|Adverse Event|118|||
162945242|NCT02465567|588502903|FG001|Overall Study|Adverse Event|113|||
162945243|NCT02465567|588502904|FG002|Overall Study|Adverse Event|147|||
162945244|NCT02465567|588502905|FG003|Overall Study|Adverse Event|138|||
162945245|NCT02465567|588502902|FG000|Overall Study|Lack of Efficacy|103|||
162945246|NCT02465567|588502903|FG001|Overall Study|Lack of Efficacy|102|||
162945247|NCT02465567|588502904|FG002|Overall Study|Lack of Efficacy|171|||
162945248|NCT02465567|588502905|FG003|Overall Study|Lack of Efficacy|135|||
162945249|NCT02465567|588502902|FG000|Overall Study|Withdrawal by Subject|104|||
162945250|NCT02465567|588502903|FG001|Overall Study|Withdrawal by Subject|94|||
162945251|NCT02465567|588502904|FG002|Overall Study|Withdrawal by Subject|123|||
162945252|NCT02465567|588502905|FG003|Overall Study|Withdrawal by Subject|130|||
162945253|NCT02465567|588502902|FG000|Overall Study|Physician Decision|23|||
162945254|NCT02465567|588502903|FG001|Overall Study|Physician Decision|33|||
162945255|NCT02465567|588502904|FG002|Overall Study|Physician Decision|38|||
162945256|NCT02465567|588502905|FG003|Overall Study|Physician Decision|28|||
162945257|NCT02465567|588502902|FG000|Overall Study|Major Protocol Deviation|24|||
162945258|NCT02465567|588502903|FG001|Overall Study|Major Protocol Deviation|26|||
162945259|NCT02465567|588502904|FG002|Overall Study|Major Protocol Deviation|22|||
162945260|NCT02465567|588502905|FG003|Overall Study|Major Protocol Deviation|25|||
162945261|NCT02465567|588502902|FG000|Overall Study|Lost to Follow-up|25|||
162945262|NCT02465567|588502903|FG001|Overall Study|Lost to Follow-up|21|||
162945263|NCT02465567|588502904|FG002|Overall Study|Lost to Follow-up|19|||
162945264|NCT02465567|588502905|FG003|Overall Study|Lost to Follow-up|15|||
162945265|NCT02465567|588502902|FG000|Overall Study|Protocol Specified Criteria|20|||
162945266|NCT02465567|588502903|FG001|Overall Study|Protocol Specified Criteria|10|||
162945267|NCT02465567|588502904|FG002|Overall Study|Protocol Specified Criteria|9|||
162945268|NCT02465567|588502905|FG003|Overall Study|Protocol Specified Criteria|12|||
162945269|NCT02465567|588502902|FG000|Overall Study|Administrative Reasons|12|||
162945270|NCT02465567|588502903|FG001|Overall Study|Administrative Reasons|9|||
162945271|NCT02465567|588502904|FG002|Overall Study|Administrative Reasons|11|||
162945272|NCT02465567|588502905|FG003|Overall Study|Administrative Reasons|5|||
162945273|NCT02465567|588502902|FG000|Overall Study|Randomized but not treated|1|||
162945274|NCT02465567|588502903|FG001|Overall Study|Randomized but not treated|5|||
162945275|NCT02465567|588502904|FG002|Overall Study|Randomized but not treated|4|||
162945276|NCT02465567|588502905|FG003|Overall Study|Randomized but not treated|5|||
162945277|NCT02465567|588502902|FG000|Overall Study|enrolled in >1 studies|18|||
162945278|NCT02465567|588502903|FG001|Overall Study|enrolled in >1 studies|11|||
162945279|NCT02465567|588502904|FG002|Overall Study|enrolled in >1 studies|19|||
162945280|NCT02465567|588502905|FG003|Overall Study|enrolled in >1 studies|15|||
162945281|NCT02465567|588502902|FG000|Overall Study|missing PI Signature|1|||
162945282|NCT02465567|588502903|FG001|Overall Study|missing PI Signature|0|||
162945283|NCT02465567|588502904|FG002|Overall Study|missing PI Signature|0|||
162945284|NCT02465567|588502905|FG003|Overall Study|missing PI Signature|0|||
162945285|NCT00337077|588502909|FG000|Overall Study|Progressive disease|25|||
162945286|NCT00337077|588502910|FG001|Overall Study|Progressive disease|37|||
162945287|NCT00337077|588502911|FG002|Overall Study|Progressive disease|19|||
162945288|NCT00337077|588502909|FG000|Overall Study|Adverse Event|7|||
162945289|NCT00337077|588502910|FG001|Overall Study|Adverse Event|7|||
162945290|NCT00337077|588502911|FG002|Overall Study|Adverse Event|1|||
162945291|NCT00337077|588502909|FG000|Overall Study|Death|0|||
162945292|NCT00337077|588502910|FG001|Overall Study|Death|1|||
162945293|NCT00337077|588502911|FG002|Overall Study|Death|0|||
162945294|NCT00337077|588502909|FG000|Overall Study|Withdrawal by Subject|7|||
162945295|NCT00337077|588502910|FG001|Overall Study|Withdrawal by Subject|2|||
162945296|NCT00337077|588502911|FG002|Overall Study|Withdrawal by Subject|2|||
162945297|NCT00337077|588502909|FG000|Overall Study|Alternative therapy|1|||
162945298|NCT00337077|588502910|FG001|Overall Study|Alternative therapy|0|||
162945299|NCT00337077|588502911|FG002|Overall Study|Alternative therapy|0|||
162945300|NCT00337077|588502909|FG000|Overall Study|Physician Decision|1|||
162945301|NCT00337077|588502910|FG001|Overall Study|Physician Decision|4|||
162945302|NCT00337077|588502911|FG002|Overall Study|Physician Decision|2|||
163387938|NCT00178126|590131963|FG001|Overall Study|did not receive intervention|6|||
162945303|NCT00337077|588502909|FG000|Overall Study|Never started treatment|1|||
162945304|NCT00337077|588502910|FG001|Overall Study|Never started treatment|1|||
162945305|NCT00337077|588502911|FG002|Overall Study|Never started treatment|0|||
162945306|NCT00337077|588502909|FG000|Overall Study|Ineligible|1|||
162945307|NCT00337077|588502910|FG001|Overall Study|Ineligible|1|||
162945308|NCT00337077|588502911|FG002|Overall Study|Ineligible|1|||
162945309|NCT00984295|588502913|FG000|Overall Study|Lost to Follow-up|31|||
162945310|NCT00984295|588502914|FG001|Overall Study|Lost to Follow-up|12|||
162945311|NCT00984295|588502915|FG002|Overall Study|Lost to Follow-up|13|||
162945312|NCT00984295|588502913|FG000|Overall Study|Protocol Violation|2|||
162945313|NCT00984295|588502914|FG001|Overall Study|Protocol Violation|1|||
163387939|NCT01074216|590131964|FG000|Overall Study|Physician Decision|1|||
163387940|NCT01074216|590131964|FG000|Overall Study|Not Treated|12|||
163387941|NCT01323634|590131965|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
163387942|NCT01323634|590131966|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
162945314|NCT00984295|588502915|FG002|Overall Study|Protocol Violation|4|||
162945315|NCT00984295|588502913|FG000|Overall Study|Withdrawal by Subject|18|||
162945316|NCT00984295|588502914|FG001|Overall Study|Withdrawal by Subject|9|||
162945317|NCT00984295|588502915|FG002|Overall Study|Withdrawal by Subject|12|||
162945318|NCT00984295|588502913|FG000|Overall Study|CAE - discontinued test vaccine|0|||
162945319|NCT00984295|588502914|FG001|Overall Study|CAE - discontinued test vaccine|1|||
162945320|NCT00984295|588502915|FG002|Overall Study|CAE - discontinued test vaccine|3|||
162945321|NCT00984295|588502913|FG000|Overall Study|Missed one or more blood samplings|3|||
162945322|NCT00984295|588502914|FG001|Overall Study|Missed one or more blood samplings|7|||
162945323|NCT00984295|588502915|FG002|Overall Study|Missed one or more blood samplings|2|||
162945324|NCT00984295|588502913|FG000|Overall Study|Incomplete safety follow-up|11|||
162945325|NCT00984295|588502914|FG001|Overall Study|Incomplete safety follow-up|2|||
162945326|NCT00984295|588502915|FG002|Overall Study|Incomplete safety follow-up|3|||
162945327|NCT04582539|588502916|FG000|Overall Study|Death|1|||
162945328|NCT04582539|588502917|FG001|Overall Study|Death|1|||
162945329|NCT04582539|588502918|FG002|Overall Study|Death|0|||
162945330|NCT04582539|588502919|FG003|Overall Study|Death|1|||
162945331|NCT04582539|588502920|FG004|Overall Study|Death|0|||
162945332|NCT04582539|588502916|FG000|Overall Study|Lost to Follow-up|1|||
162945333|NCT04582539|588502917|FG001|Overall Study|Lost to Follow-up|0|||
162945334|NCT04582539|588502918|FG002|Overall Study|Lost to Follow-up|0|||
162945335|NCT04582539|588502919|FG003|Overall Study|Lost to Follow-up|0|||
162945336|NCT04582539|588502920|FG004|Overall Study|Lost to Follow-up|0|||
162945337|NCT04582539|588502916|FG000|Overall Study|Study Terminated by Sponsor|1|||
162945338|NCT04582539|588502917|FG001|Overall Study|Study Terminated by Sponsor|3|||
162945339|NCT04582539|588502918|FG002|Overall Study|Study Terminated by Sponsor|2|||
162945340|NCT04582539|588502919|FG003|Overall Study|Study Terminated by Sponsor|2|||
162945341|NCT04582539|588502920|FG004|Overall Study|Study Terminated by Sponsor|3|||
162945342|NCT04582539|588502916|FG000|Overall Study|Physician Decision|0|||
162945343|NCT04582539|588502917|FG001|Overall Study|Physician Decision|1|||
162945344|NCT04582539|588502918|FG002|Overall Study|Physician Decision|0|||
162945345|NCT04582539|588502919|FG003|Overall Study|Physician Decision|0|||
162945346|NCT04582539|588502920|FG004|Overall Study|Physician Decision|0|||
162945347|NCT04582539|588502916|FG000|Overall Study|Withdrawal by Subject|1|||
162945348|NCT04582539|588502917|FG001|Overall Study|Withdrawal by Subject|0|||
162945349|NCT04582539|588502918|FG002|Overall Study|Withdrawal by Subject|2|||
162945350|NCT04582539|588502919|FG003|Overall Study|Withdrawal by Subject|1|||
162945351|NCT04582539|588502920|FG004|Overall Study|Withdrawal by Subject|0|||
162945352|NCT04582539|588502916|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
162945353|NCT04582539|588502917|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
162945354|NCT04582539|588502918|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
162945355|NCT04582539|588502919|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
162945356|NCT04582539|588502920|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
162945357|NCT00662129|588502921|FG000|Overall Study|Protocol Violation|1|||
162945358|NCT00662129|588502921|FG000|Overall Study|Cancel prior to beginning treatment|1|||
162945359|NCT00662129|588502921|FG000|Overall Study|Ineligible|1|||
162945360|NCT05030753|588502926|FG000|9-week|Lost to Follow-up|10|||
162945361|NCT05030753|588502927|FG001|9-week|Lost to Follow-up|7|||
162945362|NCT05030753|588502926|FG000|9-week|Withdrawal by Subject|1|||
162945363|NCT05030753|588502927|FG001|9-week|Withdrawal by Subject|0|||
162945364|NCT05030753|588502926|FG000|9-week|Excluded from analysis due to missing covariates|2|||
162945365|NCT05030753|588502927|FG001|9-week|Excluded from analysis due to missing covariates|1|||
162945366|NCT05030753|588502926|FG000|6-month post intervention|Lost to Follow-up|5|||
162945367|NCT05030753|588502927|FG001|6-month post intervention|Lost to Follow-up|4|||
162945368|NCT05030753|588502926|FG000|6-month post intervention|Withdrawal by Subject|4|||
162945369|NCT05030753|588502927|FG001|6-month post intervention|Withdrawal by Subject|0|||
162945370|NCT05030753|588502926|FG000|18-month post intervention|Lost to Follow-up|3|||
162945371|NCT05030753|588502927|FG001|18-month post intervention|Lost to Follow-up|1|||
162945372|NCT03072459|588502932|FG000|Overall Study|Device revised/removed|1|||
162945373|NCT03072459|588502932|FG000|Overall Study|Subject not able to return|1|||
162945374|NCT00329602|588502933|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
162945375|NCT00329602|588502934|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
162945376|NCT00329602|588502935|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
163387943|NCT01323634|590131967|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
163387944|NCT01323634|590131965|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
162945377|NCT00329602|588502933|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
162945378|NCT00329602|588502934|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
162945379|NCT00329602|588502935|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
162945380|NCT00329602|588502933|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
162945381|NCT00329602|588502934|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
162945382|NCT00329602|588502935|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
162945383|NCT00329602|588502933|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
162945384|NCT00329602|588502934|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
162945385|NCT00329602|588502935|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
162945386|NCT00329602|588502933|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
162945387|NCT00329602|588502934|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
162945388|NCT00329602|588502935|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
162945389|NCT00329602|588502933|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
162945390|NCT00329602|588502934|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
162945391|NCT00329602|588502935|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
162945392|NCT02579096|588502936|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
162945393|NCT02579096|588502937|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
162945394|NCT02579096|588502936|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
162945395|NCT02579096|588502937|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
162945396|NCT02579096|588502936|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
162945397|NCT02579096|588502937|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
162945398|NCT02579096|588502936|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
162945399|NCT02579096|588502937|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
162945400|NCT02579096|588502936|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
162945401|NCT02579096|588502937|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
162945402|NCT02579096|588502936|FG000|Phase 2, Weeks 25 - 48|Death|2|||
162945403|NCT02579096|588502937|FG001|Phase 2, Weeks 25 - 48|Death|4|||
162945404|NCT02579096|588502936|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
162945405|NCT02579096|588502937|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
162945406|NCT02579096|588502936|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
162945407|NCT02579096|588502937|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
162945408|NCT02579096|588502936|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
162945409|NCT02579096|588502937|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
162945410|NCT02579096|588502936|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
162945411|NCT02579096|588502937|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
162945412|NCT02579096|588502936|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
162945413|NCT02579096|588502937|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
162945414|NCT02579096|588502936|FG000|Phase 3, Weeks 49 - 72|Death|3|||
162945415|NCT02579096|588502937|FG001|Phase 3, Weeks 49 - 72|Death|2|||
162945416|NCT02579096|588502936|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
162945417|NCT02579096|588502937|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
162945418|NCT02579096|588502936|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
162945419|NCT02579096|588502937|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
162945420|NCT02579096|588502936|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
162945421|NCT02579096|588502937|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
162945422|NCT02579096|588502936|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
162945423|NCT02579096|588502937|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
162945424|NCT02579096|588502936|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
163042861|NCT01066871|588863977|FG003|Overall Study|Other|2|||
163291898|NCT03386929|589773207|FG001|Overall Study|Physician Decision|0|||
163291899|NCT03386929|589773208|FG002|Overall Study|Physician Decision|1|||
163291900|NCT03386929|589773206|FG000|Overall Study|Progression|4|||
163291901|NCT03386929|589773207|FG001|Overall Study|Progression|4|||
163291902|NCT03386929|589773208|FG002|Overall Study|Progression|0|||
163291903|NCT03386929|589773206|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
163291904|NCT03386929|589773207|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
163291905|NCT03386929|589773208|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
163291906|NCT03386929|589773206|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
163291907|NCT03386929|589773207|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
163291908|NCT03386929|589773208|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
163291909|NCT03538054|589773209|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
163291910|NCT03538054|589773209|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
163291911|NCT03538054|589773209|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
163291912|NCT02351180|589773212|FG000|Overall Study|Withdrawal by Subject|1|||
163291913|NCT02351180|589773213|FG001|Overall Study|Withdrawal by Subject|0|||
163291914|NCT00208767|589773214|FG000|Overall Study|Adverse Event|9|||
163291915|NCT00208767|589773215|FG001|Overall Study|Adverse Event|1|||
163291916|NCT00208767|589773214|FG000|Overall Study|Withdrawal by Subject|14|||
163291917|NCT00208767|589773215|FG001|Overall Study|Withdrawal by Subject|3|||
163291918|NCT00208767|589773214|FG000|Overall Study|Death|1|||
163291919|NCT00208767|589773215|FG001|Overall Study|Death|0|||
163291920|NCT00208767|589773214|FG000|Overall Study|Lost to Follow-up|3|||
163291921|NCT00208767|589773215|FG001|Overall Study|Lost to Follow-up|3|||
163291922|NCT02317016|589773216|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
163387945|NCT01323634|590131966|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
163387946|NCT01323634|590131967|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
163387947|NCT01323634|590131965|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
163387948|NCT01323634|590131966|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
163387949|NCT01323634|590131967|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
163387950|NCT01323634|590131965|FG000|2-week Run-in Period|Physician Decision|5|||
163387951|NCT01323634|590131966|FG001|2-week Run-in Period|Physician Decision|0|||
163387952|NCT01323634|590131967|FG002|2-week Run-in Period|Physician Decision|0|||
163387953|NCT01323634|590131965|FG000|2-week Run-in Period|Protocol Violation|1|||
163387954|NCT01323634|590131966|FG001|2-week Run-in Period|Protocol Violation|0|||
163387955|NCT01323634|590131967|FG002|2-week Run-in Period|Protocol Violation|0|||
163387956|NCT01323634|590131965|FG000|2-week Run-in Period|Adverse Event|1|||
163387957|NCT01323634|590131966|FG001|2-week Run-in Period|Adverse Event|0|||
163387958|NCT01323634|590131967|FG002|2-week Run-in Period|Adverse Event|0|||
163387959|NCT01323634|590131965|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
163387960|NCT01323634|590131966|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
163387961|NCT01323634|590131967|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
163387962|NCT01323634|590131965|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
163387963|NCT01323634|590131966|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
163387964|NCT01323634|590131967|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
163387965|NCT01323634|590131965|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
163387966|NCT01323634|590131966|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
163387967|NCT01323634|590131967|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
163387968|NCT01323634|590131965|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163387969|NCT01323634|590131966|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
163387970|NCT01323634|590131967|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
163387971|NCT01323634|590131965|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
163387972|NCT01323634|590131966|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
163387973|NCT01323634|590131967|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
163387974|NCT01323634|590131965|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
163387975|NCT01323634|590131966|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
163387976|NCT01323634|590131967|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
163387977|NCT01323634|590131965|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
163387978|NCT01323634|590131966|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
163387979|NCT01323634|590131967|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
163387980|NCT05056987|590131968|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
163387981|NCT05056987|590131969|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
163387982|NCT05056987|590131968|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
163387983|NCT05056987|590131969|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
163387984|NCT01575028|590131970|FG000|Overall Study|Physician Decision|0|||
163387985|NCT01575028|590131971|FG001|Overall Study|Physician Decision|1|||
163387986|NCT01182194|590131972|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
163387987|NCT01182194|590131973|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
162945425|NCT02579096|588502937|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
162945426|NCT02579096|588502936|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
162945427|NCT02579096|588502937|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
162945428|NCT02097121|588502942|FG000|Overall Study|Other, not specified|4|||
162945429|NCT02097121|588502943|FG001|Overall Study|Other, not specified|2|||
162945430|NCT02097121|588502944|FG002|Overall Study|Other, not specified|3|||
162945431|NCT02097121|588502942|FG000|Overall Study|Lack of Efficacy|2|||
163186365|NCT02349061|589400099|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
163186366|NCT02349061|589400097|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
163186367|NCT02349061|589400098|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
163186368|NCT02349061|589400099|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
163186369|NCT02349061|589400097|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
163186370|NCT02349061|589400098|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
163186371|NCT02349061|589400099|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
163186372|NCT02349061|589400097|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
163186373|NCT02349061|589400098|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
163186374|NCT02349061|589400099|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
163186375|NCT02349061|589400097|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
163186376|NCT02349061|589400098|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
163186377|NCT02349061|589400099|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
163186378|NCT02349061|589400097|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
163186379|NCT02349061|589400098|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
163186380|NCT02349061|589400099|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
163186381|NCT02349061|589400097|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
163186382|NCT02349061|589400098|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
163186383|NCT02349061|589400099|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
162945432|NCT02097121|588502943|FG001|Overall Study|Lack of Efficacy|1|||
162945433|NCT02097121|588502944|FG002|Overall Study|Lack of Efficacy|3|||
162945434|NCT02097121|588502942|FG000|Overall Study|Withdrawal by Subject|0|||
162945435|NCT02097121|588502943|FG001|Overall Study|Withdrawal by Subject|1|||
162945436|NCT02097121|588502944|FG002|Overall Study|Withdrawal by Subject|2|||
162945437|NCT02097121|588502942|FG000|Overall Study|Adverse Event|0|||
162945438|NCT02097121|588502943|FG001|Overall Study|Adverse Event|1|||
162945439|NCT02097121|588502944|FG002|Overall Study|Adverse Event|0|||
162945440|NCT02097121|588502942|FG000|Overall Study|Lost to Follow-up|1|||
162945441|NCT02097121|588502943|FG001|Overall Study|Lost to Follow-up|1|||
162945442|NCT02097121|588502944|FG002|Overall Study|Lost to Follow-up|2|||
162945443|NCT00510510|588502945|FG000|Overall Study|Adverse Event|4|||
162945444|NCT00510510|588502946|FG001|Overall Study|Adverse Event|3|||
162945445|NCT00510510|588502947|FG002|Overall Study|Adverse Event|6|||
162945446|NCT00510510|588502945|FG000|Overall Study|Lack of Efficacy|0|||
162945447|NCT00510510|588502946|FG001|Overall Study|Lack of Efficacy|1|||
162945448|NCT00510510|588502947|FG002|Overall Study|Lack of Efficacy|1|||
162945449|NCT00510510|588502945|FG000|Overall Study|Subjects no longer requires study drug|0|||
162945450|NCT00510510|588502946|FG001|Overall Study|Subjects no longer requires study drug|0|||
162945451|NCT00510510|588502947|FG002|Overall Study|Subjects no longer requires study drug|2|||
162945452|NCT00510510|588502945|FG000|Overall Study|Withdrawal by Subject|1|||
162945453|NCT00510510|588502946|FG001|Overall Study|Withdrawal by Subject|2|||
162945454|NCT00510510|588502947|FG002|Overall Study|Withdrawal by Subject|3|||
162945455|NCT00510510|588502945|FG000|Overall Study|Lost to Follow-up|0|||
162945456|NCT00510510|588502946|FG001|Overall Study|Lost to Follow-up|0|||
162945457|NCT00510510|588502947|FG002|Overall Study|Lost to Follow-up|1|||
162945458|NCT00510510|588502945|FG000|Overall Study|Protocol Violation|0|||
162945459|NCT00510510|588502946|FG001|Overall Study|Protocol Violation|3|||
162945460|NCT00510510|588502947|FG002|Overall Study|Protocol Violation|4|||
162945461|NCT03595657|588502948|FG000|Overall Study|Adverse Event|14|||
162945462|NCT03595657|588502948|FG000|Overall Study|Death|1|||
162945463|NCT03595657|588502948|FG000|Overall Study|Lack of Efficacy|40|||
162945464|NCT03595657|588502948|FG000|Overall Study|Withdrawal by Subject|10|||
162945465|NCT03595657|588502948|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
162945466|NCT03595657|588502948|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
162945467|NCT01066052|588502949|FG000|Overall Study|Enrolled But Not Treated|3|||
162945468|NCT01066052|588502950|FG001|Overall Study|Enrolled But Not Treated|0|||
162945469|NCT03184441|588502951|FG000|Overall Study|Withdrawal by Subject|1|||
162945470|NCT01200394|588502952|FG000|Overall Study|Adverse Event|0|||
162945471|NCT01200394|588502953|FG001|Overall Study|Adverse Event|14|||
162945472|NCT01200394|588502952|FG000|Overall Study|Death|1|||
163186384|NCT02349061|589400097|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
163186385|NCT02349061|589400098|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
163186386|NCT02349061|589400099|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
163186387|NCT02349061|589400097|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
163186388|NCT02349061|589400098|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
163186389|NCT02349061|589400099|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
163186390|NCT02095223|589400100|FG000|Overall Study|Withdrawal by Subject|1|||
163186391|NCT02095223|589400101|FG001|Overall Study|Withdrawal by Subject|0|||
163186392|NCT01397162|589400102|FG000|Overall Study|Adverse Event|4|||
163186393|NCT01397162|589400103|FG001|Overall Study|Adverse Event|0|||
163186394|NCT01397162|589400104|FG002|Overall Study|Adverse Event|0|||
163186395|NCT01397162|589400105|FG003|Overall Study|Adverse Event|0|||
163186396|NCT01397162|589400106|FG004|Overall Study|Adverse Event|0|||
163186397|NCT01397162|589400102|FG000|Overall Study|Not yet defined|3|||
163186398|NCT01397162|589400103|FG001|Overall Study|Not yet defined|4|||
163186399|NCT01397162|589400104|FG002|Overall Study|Not yet defined|3|||
163186400|NCT01397162|589400105|FG003|Overall Study|Not yet defined|5|||
163186401|NCT01397162|589400106|FG004|Overall Study|Not yet defined|3|||
163186402|NCT02339285|589400107|FG000|Overall Study|Withdrawal by Subject|0|||
163186403|NCT02339285|589400108|FG001|Overall Study|Withdrawal by Subject|1|||
162945473|NCT01200394|588502953|FG001|Overall Study|Death|0|||
162945474|NCT01200394|588502952|FG000|Overall Study|Lost to Follow-up|0|||
162945475|NCT01200394|588502953|FG001|Overall Study|Lost to Follow-up|1|||
162945476|NCT01200394|588502952|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
162945477|NCT01200394|588502953|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
162945478|NCT01200394|588502952|FG000|Overall Study|Protocol Violation|0|||
162945479|NCT01200394|588502953|FG001|Overall Study|Protocol Violation|3|||
162945480|NCT01200394|588502952|FG000|Overall Study|Withdrawal by Subject|0|||
162945481|NCT01200394|588502953|FG001|Overall Study|Withdrawal by Subject|5|||
162945482|NCT01200394|588502952|FG000|Overall Study|Other|0|||
162945483|NCT01200394|588502953|FG001|Overall Study|Other|1|||
162945484|NCT01835145|588502956|FG000|Overall Study|Ineligible prior to treatment|1|||
162945485|NCT01835145|588502957|FG001|Overall Study|Ineligible prior to treatment|0|||
163186404|NCT02339285|589400109|FG002|Overall Study|Withdrawal by Subject|1|||
163186405|NCT02339285|589400107|FG000|Overall Study|Lost to Follow-up|1|||
163186406|NCT02339285|589400108|FG001|Overall Study|Lost to Follow-up|1|||
163387988|NCT01948908|590131974|FG000|Overall Study|Protocol Violation|1|||
162945486|NCT02729896|588502958|FG000|Overall Study|Death|0|||
162945487|NCT02729896|588502959|FG001|Overall Study|Death|2|||
162945488|NCT02729896|588502960|FG002|Overall Study|Death|13|||
162945489|NCT02729896|588502958|FG000|Overall Study|Lost to Follow-up|0|||
162945490|NCT02729896|588502959|FG001|Overall Study|Lost to Follow-up|2|||
162945491|NCT02729896|588502960|FG002|Overall Study|Lost to Follow-up|3|||
162945492|NCT02729896|588502958|FG000|Overall Study|Other|0|||
162945493|NCT02729896|588502959|FG001|Overall Study|Other|2|||
162945494|NCT02729896|588502960|FG002|Overall Study|Other|0|||
162945495|NCT02729896|588502958|FG000|Overall Study|Physician Decision|1|||
162945496|NCT02729896|588502959|FG001|Overall Study|Physician Decision|2|||
162945497|NCT02729896|588502960|FG002|Overall Study|Physician Decision|3|||
162945498|NCT02729896|588502958|FG000|Overall Study|Progressive Disease|0|||
162945499|NCT02729896|588502959|FG001|Overall Study|Progressive Disease|1|||
162945500|NCT02729896|588502960|FG002|Overall Study|Progressive Disease|0|||
162945501|NCT02729896|588502958|FG000|Overall Study|Withdrawal by Subject|1|||
162945502|NCT02729896|588502959|FG001|Overall Study|Withdrawal by Subject|0|||
162945503|NCT02729896|588502960|FG002|Overall Study|Withdrawal by Subject|3|||
162945504|NCT02199509|588502961|FG000|Overall Study|Suicidal Ideation|0|||
162945505|NCT02199509|588502962|FG001|Overall Study|Suicidal Ideation|1|||
162945506|NCT02199509|588502961|FG000|Overall Study|Misunderstood titration schedule|1|||
162945507|NCT02199509|588502962|FG001|Overall Study|Misunderstood titration schedule|0|||
162945508|NCT04094870|588502963|FG000|Overall Study|Lost to Follow-up|1|||
162945509|NCT04094870|588502964|FG001|Overall Study|Lost to Follow-up|1|||
162945510|NCT02708277|588502966|FG000|Overall Study|Lost to Follow-up|7|||
162945511|NCT02708277|588502967|FG001|Overall Study|Lost to Follow-up|4|||
162945512|NCT01592370|588502970|FG000|Overall Study|Disease Progression|62|||
162945513|NCT01592370|588502971|FG001|Overall Study|Disease Progression|16|||
162945514|NCT01592370|588502972|FG002|Overall Study|Disease Progression|52|||
162945515|NCT01592370|588502973|FG003|Overall Study|Disease Progression|3|||
162945516|NCT01592370|588502974|FG004|Overall Study|Disease Progression|3|||
162945517|NCT01592370|588502975|FG005|Overall Study|Disease Progression|31|||
162945518|NCT01592370|588502976|FG006|Overall Study|Disease Progression|14|||
162945519|NCT01592370|588502970|FG000|Overall Study|Study Drug Toxicity|14|||
162945520|NCT01592370|588502971|FG001|Overall Study|Study Drug Toxicity|3|||
162945521|NCT01592370|588502972|FG002|Overall Study|Study Drug Toxicity|0|||
162945522|NCT01592370|588502973|FG003|Overall Study|Study Drug Toxicity|0|||
162945523|NCT01592370|588502974|FG004|Overall Study|Study Drug Toxicity|0|||
162945524|NCT01592370|588502975|FG005|Overall Study|Study Drug Toxicity|0|||
162945525|NCT01592370|588502976|FG006|Overall Study|Study Drug Toxicity|1|||
162945526|NCT01592370|588502970|FG000|Overall Study|AE unrelated to study drug|4|||
162945527|NCT01592370|588502971|FG001|Overall Study|AE unrelated to study drug|3|||
162945528|NCT01592370|588502972|FG002|Overall Study|AE unrelated to study drug|0|||
162945529|NCT01592370|588502973|FG003|Overall Study|AE unrelated to study drug|0|||
162945530|NCT01592370|588502974|FG004|Overall Study|AE unrelated to study drug|0|||
162945531|NCT01592370|588502975|FG005|Overall Study|AE unrelated to study drug|0|||
162945532|NCT01592370|588502976|FG006|Overall Study|AE unrelated to study drug|1|||
162945533|NCT01592370|588502970|FG000|Overall Study|Request to discontinue study treatment|5|||
162945534|NCT01592370|588502971|FG001|Overall Study|Request to discontinue study treatment|0|||
162945535|NCT01592370|588502972|FG002|Overall Study|Request to discontinue study treatment|2|||
162945536|NCT01592370|588502973|FG003|Overall Study|Request to discontinue study treatment|0|||
162945537|NCT01592370|588502974|FG004|Overall Study|Request to discontinue study treatment|1|||
162945538|NCT01592370|588502975|FG005|Overall Study|Request to discontinue study treatment|2|||
162945539|NCT01592370|588502976|FG006|Overall Study|Request to discontinue study treatment|0|||
162945540|NCT01592370|588502970|FG000|Overall Study|Withdrew consent|1|||
162945541|NCT01592370|588502971|FG001|Overall Study|Withdrew consent|2|||
162945542|NCT01592370|588502972|FG002|Overall Study|Withdrew consent|1|||
162945543|NCT01592370|588502973|FG003|Overall Study|Withdrew consent|1|||
162945544|NCT01592370|588502974|FG004|Overall Study|Withdrew consent|0|||
162945545|NCT01592370|588502975|FG005|Overall Study|Withdrew consent|0|||
162945546|NCT01592370|588502976|FG006|Overall Study|Withdrew consent|0|||
162945547|NCT01592370|588502970|FG000|Overall Study|Maximum clinical benefit|11|||
162945548|NCT01592370|588502971|FG001|Overall Study|Maximum clinical benefit|1|||
162945549|NCT01592370|588502972|FG002|Overall Study|Maximum clinical benefit|7|||
162945550|NCT01592370|588502973|FG003|Overall Study|Maximum clinical benefit|1|||
162945551|NCT01592370|588502974|FG004|Overall Study|Maximum clinical benefit|0|||
162945552|NCT01592370|588502975|FG005|Overall Study|Maximum clinical benefit|0|||
162945553|NCT01592370|588502976|FG006|Overall Study|Maximum clinical benefit|0|||
163291923|NCT02317016|589773216|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
163291924|NCT02317016|589773216|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
162945554|NCT01592370|588502970|FG000|Overall Study|No longer meets study criteria|1|||
162945555|NCT01592370|588502971|FG001|Overall Study|No longer meets study criteria|0|||
162945556|NCT01592370|588502972|FG002|Overall Study|No longer meets study criteria|0|||
162945557|NCT01592370|588502973|FG003|Overall Study|No longer meets study criteria|0|||
162945558|NCT01592370|588502974|FG004|Overall Study|No longer meets study criteria|0|||
162945559|NCT01592370|588502975|FG005|Overall Study|No longer meets study criteria|0|||
162945560|NCT01592370|588502976|FG006|Overall Study|No longer meets study criteria|0|||
162945561|NCT01592370|588502970|FG000|Overall Study|Other Reasons|6|||
162945562|NCT01592370|588502971|FG001|Overall Study|Other Reasons|0|||
162945563|NCT01592370|588502972|FG002|Overall Study|Other Reasons|10|||
162945564|NCT01592370|588502973|FG003|Overall Study|Other Reasons|0|||
162945565|NCT01592370|588502974|FG004|Overall Study|Other Reasons|0|||
162945566|NCT01592370|588502975|FG005|Overall Study|Other Reasons|1|||
162945567|NCT01592370|588502976|FG006|Overall Study|Other Reasons|0|||
162945568|NCT01592370|588502970|FG000|Overall Study|Not Treated|0|||
162945569|NCT01592370|588502971|FG001|Overall Study|Not Treated|0|||
162945570|NCT01592370|588502972|FG002|Overall Study|Not Treated|0|||
162945571|NCT01592370|588502973|FG003|Overall Study|Not Treated|0|||
162945572|NCT01592370|588502974|FG004|Overall Study|Not Treated|2|||
162945573|NCT01592370|588502975|FG005|Overall Study|Not Treated|2|||
162945574|NCT01592370|588502976|FG006|Overall Study|Not Treated|0|||
162945575|NCT02742181|588502977|FG000|Overall Study|Physician Decision|1|||
162945576|NCT02742181|588502978|FG001|Overall Study|Physician Decision|0|||
162945577|NCT02739984|588502979|FG000|Overall Study|Sponsor Decision|1|||
162945578|NCT02739984|588502980|FG001|Overall Study|Sponsor Decision|0|||
162945579|NCT02739984|588502979|FG000|Overall Study|Withdrawal by Subject|1|||
162945580|NCT02739984|588502980|FG001|Overall Study|Withdrawal by Subject|1|||
162945581|NCT02739984|588502979|FG000|Overall Study|Death|0|||
162945582|NCT02739984|588502980|FG001|Overall Study|Death|1|||
162945583|NCT02739984|588502979|FG000|Overall Study|Lost to Follow-up|3|||
162945584|NCT02739984|588502980|FG001|Overall Study|Lost to Follow-up|0|||
162945585|NCT01048333|588502985|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
162945586|NCT01048333|588502986|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
162945587|NCT01048333|588502987|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
162945588|NCT01048333|588502988|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
162945589|NCT01048333|588502989|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
162945590|NCT01048333|588502990|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
162945591|NCT04947579|588502992|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
162945592|NCT04947579|588502993|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
162945593|NCT04947579|588502994|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
162945594|NCT04947579|588502995|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
162945595|NCT04947579|588502996|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
162945596|NCT04947579|588502997|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
162945597|NCT04947579|588502992|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
162945598|NCT04947579|588502993|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
162945599|NCT04947579|588502994|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
162945600|NCT04947579|588502995|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
162945601|NCT04947579|588502996|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
162945602|NCT04947579|588502997|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
162945603|NCT04947579|588502992|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
162945604|NCT04947579|588502993|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
162945605|NCT04947579|588502994|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
162945606|NCT04947579|588502995|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
162945607|NCT04947579|588502996|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
162945608|NCT04947579|588502997|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
162945609|NCT04947579|588502992|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
162945610|NCT04947579|588502993|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
162945611|NCT04947579|588502994|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
162945612|NCT04947579|588502995|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
162945613|NCT04947579|588502996|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
162945614|NCT04947579|588502997|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
162945615|NCT04947579|588502992|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
162945616|NCT04947579|588502993|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
162945617|NCT04947579|588502994|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
162945618|NCT04947579|588502995|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
162945619|NCT04947579|588502996|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
162945620|NCT04947579|588502997|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
162945621|NCT04947579|588502992|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
162945622|NCT04947579|588502993|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
162945623|NCT04947579|588502994|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
163186407|NCT02339285|589400109|FG002|Overall Study|Lost to Follow-up|1|||
163186408|NCT02339285|589400107|FG000|Overall Study|Protocol Deviation|0|||
162945624|NCT04947579|588502995|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
162945625|NCT04947579|588502996|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
163186409|NCT02339285|589400108|FG001|Overall Study|Protocol Deviation|1|||
163186410|NCT02339285|589400109|FG002|Overall Study|Protocol Deviation|0|||
163186411|NCT00195273|589400112|FG000|Overall Study|Adverse Event|9|||
163186412|NCT00195273|589400113|FG001|Overall Study|Adverse Event|9|||
163186413|NCT00195273|589400112|FG000|Overall Study|Protocol deviation|0|||
162945626|NCT04947579|588502997|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
162945627|NCT04947579|588502992|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
162945628|NCT04947579|588502993|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
162945629|NCT04947579|588502994|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
162945630|NCT04947579|588502995|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
162945631|NCT04947579|588502996|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
162945632|NCT04947579|588502997|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
162945633|NCT04947579|588502992|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
162945634|NCT04947579|588502993|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
162945635|NCT04947579|588502994|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
162945636|NCT04947579|588502995|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
162945637|NCT04947579|588502996|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
162945638|NCT04947579|588502997|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
162945639|NCT04947579|588502992|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
162945640|NCT04947579|588502993|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
162945641|NCT04947579|588502994|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
162945642|NCT04947579|588502995|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
162945643|NCT04947579|588502996|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
162945644|NCT04947579|588502997|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
162945645|NCT04947579|588502992|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
162945646|NCT04947579|588502993|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
162945647|NCT04947579|588502994|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
162945648|NCT04947579|588502995|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
162945649|NCT04947579|588502996|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
162945650|NCT04947579|588502997|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
162945651|NCT04947579|588502992|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
162945652|NCT04947579|588502993|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
162945653|NCT04947579|588502994|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
162945654|NCT04947579|588502995|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
162945655|NCT04947579|588502996|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
162945656|NCT04947579|588502997|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
162945657|NCT00634179|588502998|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
162945658|NCT00767325|588502999|FG000|Overall Study|Lack of Efficacy|2|||
162945659|NCT00767325|588502999|FG000|Overall Study|Adverse Event|7|||
162945660|NCT00767325|588502999|FG000|Overall Study|Lost to Follow-up|3|||
162945661|NCT00767325|588502999|FG000|Overall Study|No longer met study criteria|2|||
162945662|NCT00767325|588502999|FG000|Overall Study|Missed visit due to family reasons|1|||
162945663|NCT03538756|588503000|FG000|Long-Term Follow-up|Adverse Event|0|||
162945664|NCT03538756|588503001|FG001|Long-Term Follow-up|Adverse Event|0|||
162945665|NCT03538756|588503002|FG002|Long-Term Follow-up|Adverse Event|6|||
162945666|NCT03538756|588503000|FG000|Long-Term Follow-up|Death|0|||
162945667|NCT03538756|588503001|FG001|Long-Term Follow-up|Death|0|||
162945668|NCT03538756|588503002|FG002|Long-Term Follow-up|Death|1|||
162945669|NCT03538756|588503000|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
162945670|NCT03538756|588503001|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
162945671|NCT03538756|588503002|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
162945672|NCT03538756|588503000|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
162945673|NCT03538756|588503001|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
162945674|NCT03538756|588503002|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
162945675|NCT03538756|588503000|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
162945676|NCT03538756|588503001|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
162945677|NCT03538756|588503002|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
162945678|NCT00752856|588503003|FG000|Overall Study|randomized but did not do viral kinetics|0|||
162945679|NCT00752856|588503004|FG001|Overall Study|randomized but did not do viral kinetics|1|||
162945680|NCT00996736|588503005|FG000|Overall Study|Death|1|||
162945681|NCT00996736|588503006|FG001|Overall Study|Death|1|||
162945682|NCT00996736|588503005|FG000|Overall Study|Lost to Follow-up|15|||
162945683|NCT00996736|588503006|FG001|Overall Study|Lost to Follow-up|14|||
162945684|NCT00996736|588503005|FG000|Overall Study|Visit not within 3-month window|5|||
162945685|NCT00996736|588503006|FG001|Overall Study|Visit not within 3-month window|3|||
162945686|NCT02688608|588503007|FG000|Overall Study|Lost to Follow-up|1|||
162945687|NCT02346201|588503008|FG000|Overall Study|Adverse Event|3|||
162945688|NCT02346201|588503009|FG001|Overall Study|Adverse Event|2|||
162945689|NCT02346201|588503008|FG000|Overall Study|Lost to Follow-up|1|||
162945690|NCT02346201|588503009|FG001|Overall Study|Lost to Follow-up|0|||
163291925|NCT02317016|589773216|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
163291926|NCT02317016|589773216|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
163291927|NCT02317016|589773216|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
163291928|NCT02317016|589773216|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
162945691|NCT02346201|588503008|FG000|Overall Study|Withdrawal by Subject|6|||
162945692|NCT02346201|588503009|FG001|Overall Study|Withdrawal by Subject|3|||
162945693|NCT02346201|588503008|FG000|Overall Study|Unavailable for future follow-up|0|||
162945694|NCT02346201|588503009|FG001|Overall Study|Unavailable for future follow-up|1|||
162945695|NCT02346201|588503008|FG000|Overall Study|Physician Decision|0|||
162945696|NCT02346201|588503009|FG001|Overall Study|Physician Decision|1|||
162945697|NCT02346201|588503008|FG000|Overall Study|Missed final visit|0|||
162945698|NCT02346201|588503009|FG001|Overall Study|Missed final visit|2|||
162945699|NCT02109133|588503010|FG000|Overall Study|Lost to Follow-up|1|||
162945700|NCT02109133|588503011|FG001|Overall Study|Lost to Follow-up|0|||
162945701|NCT05200858|588503012|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
162945702|NCT05200858|588503013|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
162945703|NCT05200858|588503014|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
162945704|NCT05200858|588503015|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
162945705|NCT00409578|588503018|FG000|Overall Study|Adverse Event|27|||
162945706|NCT00409578|588503019|FG001|Overall Study|Adverse Event|37|||
162945707|NCT00409578|588503020|FG002|Overall Study|Adverse Event|25|||
162945708|NCT00409578|588503021|FG003|Overall Study|Adverse Event|33|||
162945709|NCT00409578|588503018|FG000|Overall Study|Abnormal laboratory value(s)|2|||
162945710|NCT00409578|588503019|FG001|Overall Study|Abnormal laboratory value(s)|2|||
162945711|NCT00409578|588503020|FG002|Overall Study|Abnormal laboratory value(s)|2|||
162945712|NCT00409578|588503021|FG003|Overall Study|Abnormal laboratory value(s)|4|||
162945713|NCT00409578|588503018|FG000|Overall Study|Lack of Efficacy|0|||
162945714|NCT00409578|588503019|FG001|Overall Study|Lack of Efficacy|0|||
162945715|NCT00409578|588503020|FG002|Overall Study|Lack of Efficacy|0|||
162945716|NCT00409578|588503021|FG003|Overall Study|Lack of Efficacy|2|||
162945717|NCT00409578|588503018|FG000|Overall Study|Subject no longer requires study drug|0|||
162945718|NCT00409578|588503019|FG001|Overall Study|Subject no longer requires study drug|0|||
162945719|NCT00409578|588503020|FG002|Overall Study|Subject no longer requires study drug|0|||
162945720|NCT00409578|588503021|FG003|Overall Study|Subject no longer requires study drug|1|||
162945721|NCT00409578|588503018|FG000|Overall Study|Withdrawal by Subject|8|||
162945722|NCT00409578|588503019|FG001|Overall Study|Withdrawal by Subject|15|||
162945723|NCT00409578|588503020|FG002|Overall Study|Withdrawal by Subject|16|||
162945724|NCT00409578|588503021|FG003|Overall Study|Withdrawal by Subject|17|||
162945725|NCT00409578|588503018|FG000|Overall Study|Lost to Follow-up|2|||
162945726|NCT00409578|588503019|FG001|Overall Study|Lost to Follow-up|0|||
162945727|NCT00409578|588503020|FG002|Overall Study|Lost to Follow-up|2|||
162945728|NCT00409578|588503021|FG003|Overall Study|Lost to Follow-up|2|||
162945729|NCT00409578|588503018|FG000|Overall Study|Administrative problems|8|||
162945730|NCT00409578|588503019|FG001|Overall Study|Administrative problems|9|||
162945731|NCT00409578|588503020|FG002|Overall Study|Administrative problems|2|||
162945732|NCT00409578|588503021|FG003|Overall Study|Administrative problems|4|||
162945733|NCT00409578|588503018|FG000|Overall Study|Death|2|||
162945734|NCT00409578|588503019|FG001|Overall Study|Death|4|||
162945735|NCT00409578|588503020|FG002|Overall Study|Death|4|||
162945736|NCT00409578|588503021|FG003|Overall Study|Death|2|||
162945737|NCT00409578|588503018|FG000|Overall Study|Protocol Violation|3|||
162945738|NCT00409578|588503019|FG001|Overall Study|Protocol Violation|2|||
162945739|NCT00409578|588503020|FG002|Overall Study|Protocol Violation|3|||
162945740|NCT00409578|588503021|FG003|Overall Study|Protocol Violation|1|||
162945741|NCT00409578|588503018|FG000|Overall Study|Missing|0|||
162945742|NCT00409578|588503019|FG001|Overall Study|Missing|1|||
162945743|NCT00409578|588503020|FG002|Overall Study|Missing|0|||
162945744|NCT00409578|588503021|FG003|Overall Study|Missing|1|||
162945745|NCT02448771|588503022|FG000|Overall Study|Disease Progression|30|||
162945746|NCT02448771|588503022|FG000|Overall Study|Unacceptable Toxicity|1|||
162945747|NCT02448771|588503022|FG000|Overall Study|Physician Decision|3|||
162945748|NCT02448771|588503022|FG000|Overall Study|Started new therapy|2|||
162945749|NCT00770315|588503024|FG000|Overall Study|Adverse Event|11|||
162945750|NCT00770315|588503025|FG001|Overall Study|Adverse Event|17|||
162945751|NCT00770315|588503026|FG002|Overall Study|Adverse Event|16|||
162945752|NCT00770315|588503027|FG003|Overall Study|Adverse Event|6|||
162945753|NCT00770315|588503024|FG000|Overall Study|Lost to Follow-up|9|||
162945754|NCT00770315|588503025|FG001|Overall Study|Lost to Follow-up|5|||
162945755|NCT00770315|588503026|FG002|Overall Study|Lost to Follow-up|10|||
162945756|NCT00770315|588503027|FG003|Overall Study|Lost to Follow-up|3|||
162945757|NCT00770315|588503024|FG000|Overall Study|Withdrawal by Subject|13|||
162945758|NCT00770315|588503025|FG001|Overall Study|Withdrawal by Subject|17|||
162945759|NCT00770315|588503026|FG002|Overall Study|Withdrawal by Subject|24|||
162945760|NCT00770315|588503027|FG003|Overall Study|Withdrawal by Subject|20|||
162945761|NCT00770315|588503024|FG000|Overall Study|Noncompliance with Protocol|7|||
162945762|NCT00770315|588503025|FG001|Overall Study|Noncompliance with Protocol|4|||
162945763|NCT00770315|588503026|FG002|Overall Study|Noncompliance with Protocol|7|||
162945764|NCT00770315|588503027|FG003|Overall Study|Noncompliance with Protocol|9|||
162945765|NCT02999178|588504549|FG000|Overall Study|Adverse Event|85|||
162945766|NCT02999178|588504550|FG001|Overall Study|Adverse Event|62|||
162945767|NCT02999178|588504549|FG000|Overall Study|Protocol Violation|1|||
162945768|NCT02999178|588504550|FG001|Overall Study|Protocol Violation|2|||
162945769|NCT02999178|588504549|FG000|Overall Study|Lost to Follow-up|0|||
162945770|NCT02999178|588504550|FG001|Overall Study|Lost to Follow-up|2|||
162945771|NCT02999178|588504549|FG000|Overall Study|Withdrawal by Subject|21|||
162945772|NCT02999178|588504550|FG001|Overall Study|Withdrawal by Subject|21|||
162945773|NCT02999178|588504549|FG000|Overall Study|Other reason not defined above|7|||
162945774|NCT02999178|588504550|FG001|Overall Study|Other reason not defined above|13|||
162945775|NCT01244126|588504552|FG000|Overall Study|Protocol Violation|3|||
162945776|NCT01244126|588504553|FG001|Overall Study|Protocol Violation|3|||
162945777|NCT01244126|588504554|FG002|Overall Study|Protocol Violation|9|||
162945778|NCT00630305|588504555|FG000|Overall Study|Withdrawal by Subject|1|||
162945779|NCT00630305|588504555|FG000|Overall Study|Inability to insert contact lens|1|||
162945780|NCT01085045|588504556|FG000|Part A|Withdrawal by Subject|4|||
162945781|NCT01085045|588504556|FG000|Part A|Adverse Event|6|||
162945782|NCT01085045|588504556|FG000|Part A|Protocol Violation|1|||
162945783|NCT01085045|588504556|FG000|Part A|Protocol Specified Criteria|7|||
162945784|NCT01085045|588504556|FG000|Part B|Withdrawal by Subject|2|||
162945785|NCT01085045|588504556|FG000|Part B|Protocol Specified Criteria|6|||
162945786|NCT01085045|588504556|FG000|Part B|Lost to Follow-up|1|||
162945787|NCT01085045|588504556|FG000|Part B|Adverse Event|6|||
162945788|NCT00863746|588504557|FG000|Treatment|Not treated|4|||
162945789|NCT00863746|588504558|FG001|Treatment|Not treated|2|||
162945790|NCT00863746|588504557|FG000|Treatment|Adverse Event|41|||
162945791|NCT00863746|588504558|FG001|Treatment|Adverse Event|16|||
162945792|NCT00863746|588504557|FG000|Treatment|non-compliant with study medication|4|||
162945793|NCT00863746|588504558|FG001|Treatment|non-compliant with study medication|0|||
162945794|NCT00863746|588504557|FG000|Treatment|Consent withdrawn|15|||
162945795|NCT00863746|588504558|FG001|Treatment|Consent withdrawn|14|||
162945796|NCT00863746|588504557|FG000|Treatment|Lost to Follow-up|1|||
162945797|NCT00863746|588504558|FG001|Treatment|Lost to Follow-up|0|||
162945798|NCT00863746|588504557|FG000|Treatment|Protocol Violation|5|||
162945799|NCT00863746|588504558|FG001|Treatment|Protocol Violation|3|||
162945800|NCT00863746|588504557|FG000|Treatment|Other|1|||
163387989|NCT01948908|590131975|FG001|Overall Study|Protocol Violation|0|||
162945801|NCT00863746|588504558|FG001|Treatment|Other|0|||
162945802|NCT00863746|588504557|FG000|Survival Follow up|Death|244|||
162945803|NCT00863746|588504558|FG001|Survival Follow up|Death|271|||
162945804|NCT00863746|588504557|FG000|Survival Follow up|Lost to Follow-up|2|||
162945805|NCT00863746|588504558|FG001|Survival Follow up|Lost to Follow-up|1|||
162945806|NCT00863746|588504557|FG000|Survival Follow up|Consent Withdrawn|7|||
162945807|NCT00863746|588504558|FG001|Survival Follow up|Consent Withdrawn|8|||
162945808|NCT02924038|588504559|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
162945809|NCT02924038|588504560|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
162945810|NCT02395822|588504561|FG000|Overall Study|Withdrawal by Subject|1|||
162945811|NCT02395822|588504561|FG000|Overall Study|Death|1|||
162945812|NCT03311646|588504568|FG000|Overall Study|Physician Decision|1|||
162945813|NCT03311646|588504568|FG000|Overall Study|Withdrawal by Subject|5|||
162945814|NCT03311646|588504568|FG000|Overall Study|Lost to Follow-up|5|||
162945815|NCT03311646|588504568|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
162945816|NCT00531206|588504571|FG000|Overall Study|Adverse Event related|5|||
162945817|NCT00531206|588504571|FG000|Overall Study|Lack of Efficacy|2|||
162945818|NCT00531206|588504571|FG000|Overall Study|Lost to Follow-up|5|||
163186414|NCT00195273|589400113|FG001|Overall Study|Protocol deviation|1|||
163186415|NCT00195273|589400112|FG000|Overall Study|Lack of Efficacy|3|||
163186416|NCT00195273|589400113|FG001|Overall Study|Lack of Efficacy|1|||
163186417|NCT00195273|589400112|FG000|Overall Study|Procedural complications|9|||
163186418|NCT00195273|589400113|FG001|Overall Study|Procedural complications|3|||
163186419|NCT02367131|589400114|FG000|Overall Study|Adverse Event|64|||
163186420|NCT02367131|589400114|FG000|Overall Study|No visit since the first visit|3|||
163186421|NCT02367131|589400114|FG000|Overall Study|Request by patient|53|||
163186422|NCT02367131|589400114|FG000|Overall Study|Improvement/remission|2|||
163186423|NCT02367131|589400114|FG000|Overall Study|No change/progressive disease|78|||
163186424|NCT02367131|589400114|FG000|Overall Study|Other than stated above|20|||
163186425|NCT02367131|589400114|FG000|Overall Study|Not treated|2|||
163186426|NCT00810108|589400120|FG000|Overall Study|Withdrawal by Subject|1|||
163186427|NCT00810108|589400121|FG001|Overall Study|Withdrawal by Subject|0|||
163186428|NCT02556203|589400136|FG000|Overall Study|Withdrawal by Subject|21|||
163186429|NCT02556203|589400137|FG001|Overall Study|Withdrawal by Subject|21|||
163186430|NCT02556203|589400136|FG000|Overall Study|Lost to Follow-up|5|||
163186431|NCT02556203|589400137|FG001|Overall Study|Lost to Follow-up|5|||
163186432|NCT02556203|589400136|FG000|Overall Study|Adverse Event|1|||
163186433|NCT02556203|589400137|FG001|Overall Study|Adverse Event|0|||
163186434|NCT02180165|589400142|FG000|Overall Study|Not Treated|0|||
163186435|NCT02180165|589400143|FG001|Overall Study|Not Treated|0|||
163186436|NCT02180165|589400144|FG002|Overall Study|Not Treated|1|||
163186437|NCT02180165|589400145|FG003|Overall Study|Not Treated|0|||
163186438|NCT02180165|589400142|FG000|Overall Study|Adverse Event|7|||
163186439|NCT02180165|589400143|FG001|Overall Study|Adverse Event|0|||
162945819|NCT00531206|588504571|FG000|Overall Study|including non-related adverse events|8|||
162945820|NCT01439165|588504582|FG000|Overall Study|Protocol Violation|3|||
162945821|NCT01439165|588504583|FG001|Overall Study|Protocol Violation|0|||
162945822|NCT01439165|588504582|FG000|Overall Study|Lost to Follow-up|11|||
162945823|NCT01439165|588504583|FG001|Overall Study|Lost to Follow-up|1|||
162945824|NCT01439165|588504582|FG000|Overall Study|Withdrawal by Subject|7|||
162945825|NCT01439165|588504583|FG001|Overall Study|Withdrawal by Subject|1|||
162945826|NCT03331042|588504584|FG000|Overall Study|Protocol Violation|1|||
162945827|NCT03331042|588504585|FG001|Overall Study|Protocol Violation|0|||
162945828|NCT03331042|588504586|FG002|Overall Study|Protocol Violation|0|||
162945829|NCT03331042|588504587|FG003|Overall Study|Protocol Violation|0|||
162945830|NCT03331042|588504584|FG000|Overall Study|Physician Decision|0|||
162945831|NCT03331042|588504585|FG001|Overall Study|Physician Decision|0|||
162945832|NCT03331042|588504586|FG002|Overall Study|Physician Decision|1|||
162945833|NCT03331042|588504587|FG003|Overall Study|Physician Decision|0|||
162945834|NCT03331042|588504584|FG000|Overall Study|Lost to Follow-up|0|||
162945835|NCT03331042|588504585|FG001|Overall Study|Lost to Follow-up|0|||
162945836|NCT03331042|588504586|FG002|Overall Study|Lost to Follow-up|0|||
162945837|NCT03331042|588504587|FG003|Overall Study|Lost to Follow-up|1|||
162945838|NCT03499964|588504590|FG000|Overall Study|Lack of Efficacy|6|||
162945839|NCT03499964|588504591|FG001|Overall Study|Lack of Efficacy|26|||
162945840|NCT03499964|588504590|FG000|Overall Study|Adverse Event|1|||
162945841|NCT03499964|588504591|FG001|Overall Study|Adverse Event|0|||
162945842|NCT03499964|588504590|FG000|Overall Study|Death|1|||
162945843|NCT03499964|588504591|FG001|Overall Study|Death|0|||
162945844|NCT03499964|588504590|FG000|Overall Study|Withdrawal by Subject|2|||
162945845|NCT03499964|588504591|FG001|Overall Study|Withdrawal by Subject|1|||
162945846|NCT03499964|588504590|FG000|Overall Study|Lost to Follow-up|1|||
162945847|NCT03499964|588504591|FG001|Overall Study|Lost to Follow-up|0|||
162945848|NCT01047345|588504592|FG000|Base Study|Adverse Event|3|||
162945849|NCT01047345|588504593|FG001|Base Study|Adverse Event|0|||
162945850|NCT01047345|588504594|FG002|Base Study|Adverse Event|0|||
162945851|NCT01047345|588504592|FG000|Base Study|Lost to Follow-up|4|||
162945852|NCT01047345|588504593|FG001|Base Study|Lost to Follow-up|1|||
162945853|NCT01047345|588504594|FG002|Base Study|Lost to Follow-up|0|||
162945854|NCT01047345|588504592|FG000|Base Study|Protocol Violation|3|||
162945855|NCT01047345|588504593|FG001|Base Study|Protocol Violation|1|||
162945856|NCT01047345|588504594|FG002|Base Study|Protocol Violation|0|||
162945857|NCT01047345|588504592|FG000|Base Study|Withdrawal by Subject|12|||
162945858|NCT01047345|588504593|FG001|Base Study|Withdrawal by Subject|4|||
162945859|NCT01047345|588504594|FG002|Base Study|Withdrawal by Subject|0|||
162945860|NCT01047345|588504592|FG000|Extension|Withdrawal by Subject|0|||
162945861|NCT01047345|588504593|FG001|Extension|Withdrawal by Subject|0|||
162945862|NCT01047345|588504594|FG002|Extension|Withdrawal by Subject|1|||
162945863|NCT01047345|588504592|FG000|Extension|Lost to Follow-up|0|||
162945864|NCT01047345|588504593|FG001|Extension|Lost to Follow-up|0|||
162945865|NCT01047345|588504594|FG002|Extension|Lost to Follow-up|5|||
162945866|NCT00712010|588504595|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
162945867|NCT00995553|588504596|FG000|Overall Study|Withdrawal by Subject|2|||
162945868|NCT00995553|588504597|FG001|Overall Study|Withdrawal by Subject|6|||
162945869|NCT00927810|588504598|FG000|Overall Study|Withdrawal by Subject|0|||
162945870|NCT00927810|588504599|FG001|Overall Study|Withdrawal by Subject|3|||
162945871|NCT00927810|588504600|FG002|Overall Study|Withdrawal by Subject|0|||
162945872|NCT00927810|588504601|FG003|Overall Study|Withdrawal by Subject|1|||
162945873|NCT00927810|588504598|FG000|Overall Study|Lost to Follow-up|0|||
162945874|NCT00927810|588504599|FG001|Overall Study|Lost to Follow-up|2|||
162945875|NCT00927810|588504600|FG002|Overall Study|Lost to Follow-up|1|||
162945876|NCT00927810|588504601|FG003|Overall Study|Lost to Follow-up|1|||
163186440|NCT02180165|589400144|FG002|Overall Study|Adverse Event|18|||
163186441|NCT02180165|589400145|FG003|Overall Study|Adverse Event|3|||
163186442|NCT02180165|589400142|FG000|Overall Study|Lack of Efficacy|0|||
163186443|NCT02180165|589400143|FG001|Overall Study|Lack of Efficacy|1|||
162945877|NCT00927810|588504598|FG000|Overall Study|Death|0|||
162945878|NCT00927810|588504599|FG001|Overall Study|Death|2|||
162945879|NCT00927810|588504600|FG002|Overall Study|Death|0|||
162945880|NCT00927810|588504601|FG003|Overall Study|Death|0|||
162945881|NCT00927810|588504598|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163186444|NCT02180165|589400144|FG002|Overall Study|Lack of Efficacy|3|||
162945882|NCT00927810|588504599|FG001|Overall Study|Abnormal laboratory value(s)|1|||
162945883|NCT00927810|588504600|FG002|Overall Study|Abnormal laboratory value(s)|0|||
162945884|NCT00927810|588504601|FG003|Overall Study|Abnormal laboratory value(s)|0|||
162945885|NCT00950807|588504602|FG000|Treatment Period 1|Lack of Efficacy|1|||
162945886|NCT00950807|588504603|FG001|Treatment Period 1|Lack of Efficacy|0|||
162945887|NCT00950807|588504604|FG002|Treatment Period 1|Lack of Efficacy|0|||
162945888|NCT00950807|588504605|FG003|Treatment Period 1|Lack of Efficacy|0|||
162945889|NCT00950807|588504606|FG004|Treatment Period 1|Lack of Efficacy|0|||
162945890|NCT00950807|588504607|FG005|Treatment Period 1|Lack of Efficacy|1|||
162945891|NCT00950807|588504608|FG006|Treatment Period 1|Lack of Efficacy|0|||
162945892|NCT00950807|588504609|FG007|Treatment Period 1|Lack of Efficacy|0|||
162945893|NCT00950807|588504610|FG008|Treatment Period 1|Lack of Efficacy|0|||
162945894|NCT00950807|588504611|FG009|Treatment Period 1|Lack of Efficacy|0|||
162945895|NCT00950807|588504602|FG000|Treatment Period 1|Protocol Violation|1|||
162945896|NCT00950807|588504603|FG001|Treatment Period 1|Protocol Violation|0|||
162945897|NCT00950807|588504604|FG002|Treatment Period 1|Protocol Violation|0|||
162945898|NCT00950807|588504605|FG003|Treatment Period 1|Protocol Violation|0|||
162945899|NCT00950807|588504606|FG004|Treatment Period 1|Protocol Violation|0|||
162945900|NCT00950807|588504607|FG005|Treatment Period 1|Protocol Violation|0|||
162945901|NCT00950807|588504608|FG006|Treatment Period 1|Protocol Violation|0|||
162945902|NCT00950807|588504609|FG007|Treatment Period 1|Protocol Violation|0|||
162945903|NCT00950807|588504610|FG008|Treatment Period 1|Protocol Violation|0|||
162945904|NCT00950807|588504611|FG009|Treatment Period 1|Protocol Violation|0|||
162945905|NCT00950807|588504602|FG000|Treatment Period 1|Lost to Follow-up|0|||
162945906|NCT00950807|588504603|FG001|Treatment Period 1|Lost to Follow-up|0|||
162945907|NCT00950807|588504604|FG002|Treatment Period 1|Lost to Follow-up|1|||
162945908|NCT00950807|588504605|FG003|Treatment Period 1|Lost to Follow-up|0|||
162945909|NCT00950807|588504606|FG004|Treatment Period 1|Lost to Follow-up|0|||
162945910|NCT00950807|588504607|FG005|Treatment Period 1|Lost to Follow-up|0|||
162945911|NCT00950807|588504608|FG006|Treatment Period 1|Lost to Follow-up|0|||
162945912|NCT00950807|588504609|FG007|Treatment Period 1|Lost to Follow-up|0|||
162945913|NCT00950807|588504610|FG008|Treatment Period 1|Lost to Follow-up|0|||
162945914|NCT00950807|588504611|FG009|Treatment Period 1|Lost to Follow-up|0|||
162945915|NCT00950807|588504602|FG000|Treatment Period 1|Withdrawal by Subject|1|||
162945916|NCT00950807|588504603|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162945917|NCT00950807|588504604|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162945918|NCT00950807|588504605|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162945919|NCT00950807|588504606|FG004|Treatment Period 1|Withdrawal by Subject|1|||
162945920|NCT00950807|588504607|FG005|Treatment Period 1|Withdrawal by Subject|0|||
162945921|NCT00950807|588504608|FG006|Treatment Period 1|Withdrawal by Subject|0|||
162945922|NCT00950807|588504609|FG007|Treatment Period 1|Withdrawal by Subject|0|||
162945923|NCT00950807|588504610|FG008|Treatment Period 1|Withdrawal by Subject|1|||
162945924|NCT00950807|588504611|FG009|Treatment Period 1|Withdrawal by Subject|0|||
162945925|NCT00950807|588504602|FG000|Treatment Period 1|Adverse Event|0|||
162945926|NCT00950807|588504603|FG001|Treatment Period 1|Adverse Event|0|||
162945927|NCT00950807|588504604|FG002|Treatment Period 1|Adverse Event|0|||
162945928|NCT00950807|588504605|FG003|Treatment Period 1|Adverse Event|0|||
162945929|NCT00950807|588504606|FG004|Treatment Period 1|Adverse Event|0|||
162945930|NCT00950807|588504607|FG005|Treatment Period 1|Adverse Event|1|||
162945931|NCT00950807|588504608|FG006|Treatment Period 1|Adverse Event|0|||
162945932|NCT00950807|588504609|FG007|Treatment Period 1|Adverse Event|0|||
162945933|NCT00950807|588504610|FG008|Treatment Period 1|Adverse Event|0|||
162945934|NCT00950807|588504611|FG009|Treatment Period 1|Adverse Event|0|||
162945935|NCT00950807|588504602|FG000|Washout Period 1|Lack of Efficacy|0|||
162945936|NCT00950807|588504603|FG001|Washout Period 1|Lack of Efficacy|0|||
162945937|NCT00950807|588504604|FG002|Washout Period 1|Lack of Efficacy|0|||
162945938|NCT00950807|588504605|FG003|Washout Period 1|Lack of Efficacy|0|||
162945939|NCT00950807|588504606|FG004|Washout Period 1|Lack of Efficacy|0|||
162945940|NCT00950807|588504607|FG005|Washout Period 1|Lack of Efficacy|0|||
162945941|NCT00950807|588504608|FG006|Washout Period 1|Lack of Efficacy|1|||
162945942|NCT00950807|588504609|FG007|Washout Period 1|Lack of Efficacy|0|||
162945943|NCT00950807|588504610|FG008|Washout Period 1|Lack of Efficacy|0|||
163186445|NCT02180165|589400145|FG003|Overall Study|Lack of Efficacy|2|||
162945944|NCT00950807|588504611|FG009|Washout Period 1|Lack of Efficacy|0|||
162945945|NCT00950807|588504602|FG000|Washout Period 1|Withdrawal by Subject|0|||
162945946|NCT00950807|588504603|FG001|Washout Period 1|Withdrawal by Subject|0|||
162945947|NCT00950807|588504604|FG002|Washout Period 1|Withdrawal by Subject|0|||
162945948|NCT00950807|588504605|FG003|Washout Period 1|Withdrawal by Subject|0|||
162945949|NCT00950807|588504606|FG004|Washout Period 1|Withdrawal by Subject|0|||
162945950|NCT00950807|588504607|FG005|Washout Period 1|Withdrawal by Subject|0|||
162945951|NCT00950807|588504608|FG006|Washout Period 1|Withdrawal by Subject|0|||
162945952|NCT00950807|588504609|FG007|Washout Period 1|Withdrawal by Subject|0|||
162945953|NCT00950807|588504610|FG008|Washout Period 1|Withdrawal by Subject|1|||
162945954|NCT00950807|588504611|FG009|Washout Period 1|Withdrawal by Subject|0|||
162945955|NCT00950807|588504602|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
162945956|NCT00950807|588504603|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
162945957|NCT00950807|588504604|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
162945958|NCT00950807|588504605|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
162945959|NCT00950807|588504606|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
162945960|NCT00950807|588504607|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
162945961|NCT00950807|588504608|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
162945962|NCT00950807|588504609|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
162945963|NCT00950807|588504610|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
162945964|NCT00950807|588504611|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
162945965|NCT00950807|588504602|FG000|Washout Period 1|Adverse Event|2|||
162945966|NCT00950807|588504603|FG001|Washout Period 1|Adverse Event|0|||
162945967|NCT00950807|588504604|FG002|Washout Period 1|Adverse Event|0|||
162945968|NCT00950807|588504605|FG003|Washout Period 1|Adverse Event|1|||
162945969|NCT00950807|588504606|FG004|Washout Period 1|Adverse Event|1|||
162945970|NCT00950807|588504607|FG005|Washout Period 1|Adverse Event|0|||
162945971|NCT00950807|588504608|FG006|Washout Period 1|Adverse Event|0|||
162945972|NCT00950807|588504609|FG007|Washout Period 1|Adverse Event|0|||
162945973|NCT00950807|588504610|FG008|Washout Period 1|Adverse Event|0|||
162945974|NCT00950807|588504611|FG009|Washout Period 1|Adverse Event|0|||
162945975|NCT00950807|588504602|FG000|Treatment Period 2|Lack of Efficacy|1|||
162945976|NCT00950807|588504603|FG001|Treatment Period 2|Lack of Efficacy|0|||
162945977|NCT00950807|588504604|FG002|Treatment Period 2|Lack of Efficacy|0|||
162945978|NCT00950807|588504605|FG003|Treatment Period 2|Lack of Efficacy|0|||
162945979|NCT00950807|588504606|FG004|Treatment Period 2|Lack of Efficacy|0|||
162945980|NCT00950807|588504607|FG005|Treatment Period 2|Lack of Efficacy|0|||
162945981|NCT00950807|588504608|FG006|Treatment Period 2|Lack of Efficacy|0|||
162945982|NCT00950807|588504609|FG007|Treatment Period 2|Lack of Efficacy|0|||
162945983|NCT00950807|588504610|FG008|Treatment Period 2|Lack of Efficacy|0|||
162945984|NCT00950807|588504611|FG009|Treatment Period 2|Lack of Efficacy|0|||
162945985|NCT00950807|588504602|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162945986|NCT00950807|588504603|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162945987|NCT00950807|588504604|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162945988|NCT00950807|588504605|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162945989|NCT00950807|588504606|FG004|Treatment Period 2|Withdrawal by Subject|0|||
162945990|NCT00950807|588504607|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162945991|NCT00950807|588504608|FG006|Treatment Period 2|Withdrawal by Subject|1|||
162945992|NCT00950807|588504609|FG007|Treatment Period 2|Withdrawal by Subject|2|||
162945993|NCT00950807|588504610|FG008|Treatment Period 2|Withdrawal by Subject|0|||
162945994|NCT00950807|588504611|FG009|Treatment Period 2|Withdrawal by Subject|0|||
162945995|NCT00950807|588504602|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
162945996|NCT00950807|588504603|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162945997|NCT00950807|588504604|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162945998|NCT00950807|588504605|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162945999|NCT00950807|588504606|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162946000|NCT00950807|588504607|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162946001|NCT00950807|588504608|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162946002|NCT00950807|588504609|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162946003|NCT00950807|588504610|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162946004|NCT00950807|588504611|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162946005|NCT00950807|588504602|FG000|Treatment Period 2|Adverse Event|0|||
162946006|NCT00950807|588504603|FG001|Treatment Period 2|Adverse Event|1|||
162946007|NCT00950807|588504604|FG002|Treatment Period 2|Adverse Event|0|||
162946008|NCT00950807|588504605|FG003|Treatment Period 2|Adverse Event|1|||
162946009|NCT00950807|588504606|FG004|Treatment Period 2|Adverse Event|0|||
162946010|NCT00950807|588504607|FG005|Treatment Period 2|Adverse Event|1|||
162946011|NCT00950807|588504608|FG006|Treatment Period 2|Adverse Event|0|||
162946012|NCT00950807|588504609|FG007|Treatment Period 2|Adverse Event|1|||
162946013|NCT00950807|588504610|FG008|Treatment Period 2|Adverse Event|0|||
162946014|NCT00950807|588504611|FG009|Treatment Period 2|Adverse Event|0|||
162946015|NCT00950807|588504602|FG000|Washout Period 2|Lack of Efficacy|1|||
162946016|NCT00950807|588504603|FG001|Washout Period 2|Lack of Efficacy|0|||
163186446|NCT02180165|589400142|FG000|Overall Study|Physician Decision|1|||
163186447|NCT02180165|589400143|FG001|Overall Study|Physician Decision|0|||
162946017|NCT00950807|588504604|FG002|Washout Period 2|Lack of Efficacy|0|||
162946018|NCT00950807|588504605|FG003|Washout Period 2|Lack of Efficacy|0|||
162946019|NCT00950807|588504606|FG004|Washout Period 2|Lack of Efficacy|0|||
162946020|NCT00950807|588504607|FG005|Washout Period 2|Lack of Efficacy|0|||
162946021|NCT00950807|588504608|FG006|Washout Period 2|Lack of Efficacy|0|||
162946022|NCT00950807|588504609|FG007|Washout Period 2|Lack of Efficacy|0|||
162946023|NCT00950807|588504610|FG008|Washout Period 2|Lack of Efficacy|0|||
162946024|NCT00950807|588504611|FG009|Washout Period 2|Lack of Efficacy|0|||
162946025|NCT00950807|588504602|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
162946026|NCT00950807|588504603|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
162946027|NCT00950807|588504604|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
162946028|NCT00950807|588504605|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
162946029|NCT00950807|588504606|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
162946030|NCT00950807|588504607|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
162946031|NCT00950807|588504608|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
162946032|NCT00950807|588504609|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
162946033|NCT00950807|588504610|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
162946034|NCT00950807|588504611|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
162946035|NCT00950807|588504602|FG000|Washout Period 2|Adverse Event|3|||
162946036|NCT00950807|588504603|FG001|Washout Period 2|Adverse Event|0|||
162946037|NCT00950807|588504604|FG002|Washout Period 2|Adverse Event|0|||
162946038|NCT00950807|588504605|FG003|Washout Period 2|Adverse Event|1|||
162946039|NCT00950807|588504606|FG004|Washout Period 2|Adverse Event|0|||
162946040|NCT00950807|588504607|FG005|Washout Period 2|Adverse Event|0|||
162946041|NCT00950807|588504608|FG006|Washout Period 2|Adverse Event|0|||
162946042|NCT00950807|588504609|FG007|Washout Period 2|Adverse Event|0|||
162946043|NCT00950807|588504610|FG008|Washout Period 2|Adverse Event|0|||
162946044|NCT00950807|588504611|FG009|Washout Period 2|Adverse Event|0|||
162946045|NCT00950807|588504602|FG000|Treatment Period 3|Withdrawal by Subject|0|||
162946046|NCT00950807|588504603|FG001|Treatment Period 3|Withdrawal by Subject|0|||
162946047|NCT00950807|588504604|FG002|Treatment Period 3|Withdrawal by Subject|0|||
162946048|NCT00950807|588504605|FG003|Treatment Period 3|Withdrawal by Subject|0|||
162946049|NCT00950807|588504606|FG004|Treatment Period 3|Withdrawal by Subject|0|||
162946050|NCT00950807|588504607|FG005|Treatment Period 3|Withdrawal by Subject|0|||
162946051|NCT00950807|588504608|FG006|Treatment Period 3|Withdrawal by Subject|0|||
162946052|NCT00950807|588504609|FG007|Treatment Period 3|Withdrawal by Subject|0|||
162946053|NCT00950807|588504610|FG008|Treatment Period 3|Withdrawal by Subject|0|||
162946054|NCT00950807|588504611|FG009|Treatment Period 3|Withdrawal by Subject|1|||
162946055|NCT00950807|588504602|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
162946056|NCT00950807|588504603|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946057|NCT00950807|588504604|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946058|NCT00950807|588504605|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946059|NCT00950807|588504606|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946060|NCT00950807|588504607|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946061|NCT00950807|588504608|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946062|NCT00950807|588504609|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
162946063|NCT00950807|588504610|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946064|NCT00950807|588504611|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946065|NCT00950807|588504602|FG000|Treatment Period 3|Adverse Event|0|||
162946066|NCT00950807|588504603|FG001|Treatment Period 3|Adverse Event|0|||
162946067|NCT00950807|588504604|FG002|Treatment Period 3|Adverse Event|0|||
162946068|NCT00950807|588504605|FG003|Treatment Period 3|Adverse Event|0|||
162946069|NCT00950807|588504606|FG004|Treatment Period 3|Adverse Event|0|||
162946070|NCT00950807|588504607|FG005|Treatment Period 3|Adverse Event|0|||
162946071|NCT00950807|588504608|FG006|Treatment Period 3|Adverse Event|1|||
162946072|NCT00950807|588504609|FG007|Treatment Period 3|Adverse Event|0|||
162946073|NCT00950807|588504610|FG008|Treatment Period 3|Adverse Event|0|||
162946074|NCT00950807|588504611|FG009|Treatment Period 3|Adverse Event|0|||
162946075|NCT01492400|588504615|FG000|Overall Study|Miscellaneous Reasons|2|||
162946076|NCT01492400|588504616|FG001|Overall Study|Miscellaneous Reasons|3|||
162946077|NCT01492400|588504615|FG000|Overall Study|Personal Reasons|0|||
162946078|NCT01492400|588504616|FG001|Overall Study|Personal Reasons|5|||
162946079|NCT01492400|588504615|FG000|Overall Study|Lost to Follow-up|3|||
162946080|NCT01492400|588504616|FG001|Overall Study|Lost to Follow-up|1|||
162946081|NCT01492400|588504615|FG000|Overall Study|Pregnancy|0|||
162946082|NCT01492400|588504616|FG001|Overall Study|Pregnancy|1|||
162946083|NCT01492400|588504615|FG000|Overall Study|Lack of Efficacy|1|||
162946084|NCT01492400|588504616|FG001|Overall Study|Lack of Efficacy|1|||
162946085|NCT01492400|588504615|FG000|Overall Study|Adverse Event|10|||
162946086|NCT01492400|588504616|FG001|Overall Study|Adverse Event|5|||
162946087|NCT00659607|588504617|FG000|Overall Study|No blood pressure recorded|147|||
162946088|NCT00659607|588504617|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
162946089|NCT00659607|588504617|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
162946090|NCT00659607|588504617|FG000|Overall Study|No recorded efficacy data|15|||
162946091|NCT00659607|588504617|FG000|Overall Study|Inconsistent BP measuring date|2|||
162946092|NCT02153736|588504628|FG000|Overall Study|Lost to Follow-up|1|||
162946093|NCT02153736|588504629|FG001|Overall Study|Lost to Follow-up|0|||
162946094|NCT02153736|588504628|FG000|Overall Study|Medical status change made ineligible|1|||
162946095|NCT02153736|588504629|FG001|Overall Study|Medical status change made ineligible|0|||
162946096|NCT02153736|588504628|FG000|Overall Study|Death|0|||
162946097|NCT02153736|588504629|FG001|Overall Study|Death|1|||
162946098|NCT02153736|588504628|FG000|Overall Study|Withdrawal by Subject|0|||
162946099|NCT02153736|588504629|FG001|Overall Study|Withdrawal by Subject|1|||
162946100|NCT02568384|588504630|FG000|Overall Study|Mobile devices incompatible with App|2|||
162946101|NCT01734772|588504631|FG000|Overall Study|Adverse Event|1|||
162946102|NCT01734772|588504632|FG001|Overall Study|Adverse Event|2|||
162946103|NCT01734772|588504631|FG000|Overall Study|Withdrawal by Subject|0|||
162946104|NCT01734772|588504632|FG001|Overall Study|Withdrawal by Subject|1|||
162946105|NCT00720122|588504635|FG000|Overall Study|Lost to Follow-up|1|||
162946106|NCT00720122|588504635|FG000|Overall Study|Physician Decision|1|||
162946107|NCT00720122|588504635|FG000|Overall Study|Withdrawal by Subject|7|||
162946108|NCT03066999|588504636|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
162946109|NCT03066999|588504637|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
162946110|NCT00661999|588504638|FG000|Overall Study|Adverse Event|11|||
162946111|NCT00661999|588504639|FG001|Overall Study|Adverse Event|5|||
162946112|NCT00661999|588504640|FG002|Overall Study|Adverse Event|8|||
162946113|NCT00661999|588504638|FG000|Overall Study|Death|8|||
162946114|NCT00661999|588504639|FG001|Overall Study|Death|6|||
162946115|NCT00661999|588504640|FG002|Overall Study|Death|3|||
162946116|NCT00661999|588504638|FG000|Overall Study|Other Reasons|5|||
162946117|NCT00661999|588504639|FG001|Overall Study|Other Reasons|12|||
162946118|NCT00661999|588504640|FG002|Overall Study|Other Reasons|23|||
162946119|NCT00661999|588504638|FG000|Overall Study|Withdrawal by Subject|30|||
162946120|NCT00661999|588504639|FG001|Overall Study|Withdrawal by Subject|23|||
162946121|NCT00661999|588504640|FG002|Overall Study|Withdrawal by Subject|14|||
162946122|NCT00661999|588504638|FG000|Overall Study|Alternative Treatment|1|||
162946123|NCT00661999|588504639|FG001|Overall Study|Alternative Treatment|0|||
162946124|NCT00661999|588504640|FG002|Overall Study|Alternative Treatment|0|||
162946125|NCT00661999|588504638|FG000|Overall Study|Other Medical Problems|4|||
162946126|NCT00661999|588504639|FG001|Overall Study|Other Medical Problems|4|||
162946127|NCT00661999|588504640|FG002|Overall Study|Other Medical Problems|9|||
162946128|NCT01139164|588504643|FG000|Overall Study|Withdrawn prior to study start|0|||
162946129|NCT01139164|588504644|FG001|Overall Study|Withdrawn prior to study start|2|||
162946130|NCT01139164|588504645|FG002|Overall Study|Withdrawn prior to study start|0|||
162946131|NCT01790568|588504646|FG000|Overall Study|Progression prior to transplant|0|||
162946132|NCT01790568|588504647|FG001|Overall Study|Progression prior to transplant|1|||
162946133|NCT01361126|588504648|FG000|Overall Study|Sponsor decision|0|||
162946134|NCT01361126|588504649|FG001|Overall Study|Sponsor decision|2|||
162946135|NCT00264810|588504650|FG000|Baseline|Withdrawal by Subject|10|||
162946136|NCT00264810|588504651|FG001|Baseline|Withdrawal by Subject|10|||
162946137|NCT00264810|588504650|FG000|Baseline|Physician Decision|7|||
162946138|NCT00264810|588504651|FG001|Baseline|Physician Decision|8|||
162946139|NCT00264810|588504650|FG000|Baseline|Subject Compliance Failure|3|||
162946140|NCT00264810|588504651|FG001|Baseline|Subject Compliance Failure|3|||
162946141|NCT00264810|588504650|FG000|Baseline|Insufficient Seizure Frequency|2|||
162946142|NCT00264810|588504651|FG001|Baseline|Insufficient Seizure Frequency|2|||
162946143|NCT00264810|588504650|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
162946144|NCT00264810|588504651|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
162946145|NCT00264810|588504650|FG000|Baseline|Other|0|||
162946146|NCT00264810|588504651|FG001|Baseline|Other|1|||
162946147|NCT00264810|588504650|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
162946148|NCT00264810|588504651|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
162946149|NCT00264810|588504650|FG000|Stimulation Optimization Period|Death|0|||
162946150|NCT00264810|588504651|FG001|Stimulation Optimization Period|Death|1|||
162946151|NCT00264810|588504650|FG000|Blinded Evaluation Period|Explant due to infection|1|||
162946152|NCT00264810|588504651|FG001|Blinded Evaluation Period|Explant due to infection|1|||
162946153|NCT00264810|588504650|FG000|Open Label Evaluation Period|Explant due to infection|1|||
162946154|NCT00264810|588504651|FG001|Open Label Evaluation Period|Explant due to infection|1|||
162946155|NCT00264810|588504650|FG000|Open Label Evaluation Period|Death|3|||
162946156|NCT00264810|588504651|FG001|Open Label Evaluation Period|Death|2|||
162946157|NCT00264810|588504650|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
162946158|NCT00264810|588504651|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
162946159|NCT02994056|588504652|FG000|Overall Study|Death|8|||
162946160|NCT02994056|588504652|FG000|Overall Study|Withdrew Consent|1|||
162946161|NCT01658943|588504657|FG000|Overall Study|Adverse Event|6|||
162946162|NCT01658943|588504658|FG001|Overall Study|Adverse Event|13|||
162946163|NCT01658943|588504657|FG000|Overall Study|Withdrawal by Subject|9|||
162946164|NCT01658943|588504658|FG001|Overall Study|Withdrawal by Subject|2|||
162946165|NCT01658943|588504657|FG000|Overall Study|Progression/Relapse|39|||
162946166|NCT01658943|588504658|FG001|Overall Study|Progression/Relapse|40|||
162946167|NCT01658943|588504657|FG000|Overall Study|Death|4|||
163186448|NCT02180165|589400144|FG002|Overall Study|Physician Decision|5|||
162946168|NCT01658943|588504658|FG001|Overall Study|Death|2|||
162946169|NCT01658943|588504657|FG000|Overall Study|not protocol specified|4|||
162946170|NCT01658943|588504658|FG001|Overall Study|not protocol specified|1|||
162946171|NCT01658943|588504657|FG000|Overall Study|Not eligible|7|||
162946172|NCT01658943|588504658|FG001|Overall Study|Not eligible|9|||
162946173|NCT01658943|588504657|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
162946174|NCT01658943|588504658|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
162946175|NCT01346410|588504660|FG000|Overall Study|Death|1|||
162946176|NCT00979628|588504661|FG000|Overall Study|received regimen < 24 hours|7|||
162946177|NCT00979628|588504662|FG001|Overall Study|received regimen < 24 hours|6|||
162946178|NCT00979628|588504663|FG002|Overall Study|received regimen < 24 hours|5|||
163186449|NCT02180165|589400145|FG003|Overall Study|Physician Decision|0|||
163186450|NCT02180165|589400142|FG000|Overall Study|Withdrawal by Subject|3|||
162946179|NCT00979628|588504661|FG000|Overall Study|received steroids|1|||
162946180|NCT00979628|588504662|FG001|Overall Study|received steroids|1|||
162946181|NCT00979628|588504663|FG002|Overall Study|received steroids|0|||
162946182|NCT00979628|588504661|FG000|Overall Study|transferred to ICU|1|||
162946183|NCT00979628|588504662|FG001|Overall Study|transferred to ICU|2|||
162946184|NCT00979628|588504663|FG002|Overall Study|transferred to ICU|1|||
162946185|NCT05905783|588504664|FG000|Overall Study|Lost to Follow-up|12|||
162946186|NCT05905783|588504665|FG001|Overall Study|Lost to Follow-up|18|||
162946187|NCT05905783|588504664|FG000|Overall Study|Withdrawal by Subject|29|||
162946188|NCT05905783|588504665|FG001|Overall Study|Withdrawal by Subject|37|||
162946189|NCT05905783|588504664|FG000|Overall Study|Decision by sponsor|69|||
162946190|NCT05905783|588504665|FG001|Overall Study|Decision by sponsor|65|||
162946191|NCT00911859|588504666|FG000|Treatment Period|Adverse Event|3|||
162946192|NCT00911859|588504667|FG001|Treatment Period|Adverse Event|3|||
162946193|NCT00911859|588504668|FG002|Treatment Period|Adverse Event|7|||
162946194|NCT00911859|588504666|FG000|Treatment Period|Death|1|||
162946195|NCT00911859|588504667|FG001|Treatment Period|Death|3|||
162946196|NCT00911859|588504668|FG002|Treatment Period|Death|5|||
162946197|NCT00911859|588504666|FG000|Treatment Period|Lack of Efficacy|1|||
162946198|NCT00911859|588504667|FG001|Treatment Period|Lack of Efficacy|7|||
162946199|NCT00911859|588504668|FG002|Treatment Period|Lack of Efficacy|5|||
162946200|NCT00911859|588504666|FG000|Treatment Period|Physician Decision|3|||
162946201|NCT00911859|588504667|FG001|Treatment Period|Physician Decision|3|||
162946202|NCT00911859|588504668|FG002|Treatment Period|Physician Decision|3|||
162946203|NCT00911859|588504666|FG000|Treatment Period|Withdrawal by Subject|0|||
162946204|NCT00911859|588504667|FG001|Treatment Period|Withdrawal by Subject|4|||
162946205|NCT00911859|588504668|FG002|Treatment Period|Withdrawal by Subject|5|||
162946206|NCT00911859|588504666|FG000|Treatment Period|Did not receive study treatment|0|||
162946207|NCT00911859|588504667|FG001|Treatment Period|Did not receive study treatment|1|||
162946208|NCT00911859|588504668|FG002|Treatment Period|Did not receive study treatment|0|||
162946209|NCT00911859|588504666|FG000|Maintainance Period|Lack of Efficacy|0|||
162946210|NCT00911859|588504667|FG001|Maintainance Period|Lack of Efficacy|0|||
162946211|NCT00911859|588504668|FG002|Maintainance Period|Lack of Efficacy|9|||
162946212|NCT00911859|588504666|FG000|Maintainance Period|Physician Decision|0|||
162946213|NCT00911859|588504667|FG001|Maintainance Period|Physician Decision|0|||
162946214|NCT00911859|588504668|FG002|Maintainance Period|Physician Decision|9|||
162946215|NCT00911859|588504666|FG000|Maintainance Period|Withdrawal by Subject|0|||
162946216|NCT00911859|588504667|FG001|Maintainance Period|Withdrawal by Subject|0|||
162946217|NCT00911859|588504668|FG002|Maintainance Period|Withdrawal by Subject|3|||
162946218|NCT00911859|588504666|FG000|Follow-up Period|Death|5|||
162946219|NCT00911859|588504667|FG001|Follow-up Period|Death|8|||
162946220|NCT00911859|588504668|FG002|Follow-up Period|Death|10|||
162946221|NCT00911859|588504666|FG000|Follow-up Period|Lost to Follow-up|1|||
162946222|NCT00911859|588504667|FG001|Follow-up Period|Lost to Follow-up|1|||
162946223|NCT00911859|588504668|FG002|Follow-up Period|Lost to Follow-up|0|||
162946224|NCT00911859|588504666|FG000|Follow-up Period|Withdrawal by Subject|0|||
162946225|NCT00911859|588504667|FG001|Follow-up Period|Withdrawal by Subject|4|||
162946226|NCT00911859|588504668|FG002|Follow-up Period|Withdrawal by Subject|4|||
162946227|NCT00911859|588504666|FG000|Follow-up Period|Study terminated by sponsor|5|||
162946228|NCT00911859|588504667|FG001|Follow-up Period|Study terminated by sponsor|33|||
162946229|NCT00911859|588504668|FG002|Follow-up Period|Study terminated by sponsor|27|||
162946230|NCT03008460|588504673|FG000|Overall Study|Protocol deviation|0|||
162946231|NCT03008460|588504674|FG001|Overall Study|Protocol deviation|2|||
162946232|NCT03008460|588504673|FG000|Overall Study|Study drug not dispensed|0|||
162946233|NCT03008460|588504674|FG001|Overall Study|Study drug not dispensed|1|||
162946234|NCT03008460|588504673|FG000|Overall Study|Adverse Event|0|||
162946235|NCT03008460|588504674|FG001|Overall Study|Adverse Event|1|||
162946236|NCT03008460|588504673|FG000|Overall Study|Withdrawal by Subject|5|||
162946237|NCT03008460|588504674|FG001|Overall Study|Withdrawal by Subject|6|||
162946238|NCT03008460|588504673|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
162946239|NCT03008460|588504674|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
162946240|NCT03008460|588504673|FG000|Overall Study|End of study visit outside permitted time window|0|||
162946241|NCT03008460|588504674|FG001|Overall Study|End of study visit outside permitted time window|1|||
162946242|NCT03008460|588504673|FG000|Overall Study|Lost to Follow-up|1|||
162946243|NCT03008460|588504674|FG001|Overall Study|Lost to Follow-up|3|||
162946244|NCT04272801|588504680|FG000|Overall Study|Withdrawal by Subject|4|||
162946245|NCT04272801|588504680|FG000|Overall Study|Lost to Follow-up|4|||
162946246|NCT04272801|588504680|FG000|Overall Study|Ineligible|1|||
163387990|NCT01948908|590131976|FG002|Overall Study|Protocol Violation|2|||
162946247|NCT02456909|588504681|FG000|Overall Study|Did not receive allocated intervention|24|||
162946248|NCT02456909|588504682|FG001|Overall Study|Did not receive allocated intervention|26|||
162946249|NCT02456909|588504681|FG000|Overall Study|Did not complete the primary outcome|0|||
162946250|NCT02456909|588504682|FG001|Overall Study|Did not complete the primary outcome|1|||
162946251|NCT02130466|588504683|FG000|Overall Study|Death|4|||
162946252|NCT02130466|588504684|FG001|Overall Study|Death|1|||
162946253|NCT02130466|588504685|FG002|Overall Study|Death|1|||
162946254|NCT02130466|588504686|FG003|Overall Study|Death|3|||
162946255|NCT02130466|588504687|FG004|Overall Study|Death|2|||
162946256|NCT02130466|588504688|FG005|Overall Study|Death|30|||
162946257|NCT02130466|588504689|FG006|Overall Study|Death|45|||
162946258|NCT02130466|588504690|FG007|Overall Study|Death|2|||
162946259|NCT02130466|588504691|FG008|Overall Study|Death|3|||
162946260|NCT02130466|588504692|FG009|Overall Study|Death|4|||
162946261|NCT02130466|588504693|FG010|Overall Study|Death|5|||
162946262|NCT02130466|588504694|FG011|Overall Study|Death|3|||
162946263|NCT02130466|588504695|FG012|Overall Study|Death|11|||
162946264|NCT02130466|588504696|FG013|Overall Study|Death|7|||
162946265|NCT02130466|588504683|FG000|Overall Study|Lost to Follow-up|1|||
162946266|NCT02130466|588504684|FG001|Overall Study|Lost to Follow-up|0|||
162946267|NCT02130466|588504685|FG002|Overall Study|Lost to Follow-up|0|||
162946268|NCT02130466|588504686|FG003|Overall Study|Lost to Follow-up|0|||
162946269|NCT02130466|588504687|FG004|Overall Study|Lost to Follow-up|0|||
162946270|NCT02130466|588504688|FG005|Overall Study|Lost to Follow-up|1|||
162946271|NCT02130466|588504689|FG006|Overall Study|Lost to Follow-up|0|||
162946272|NCT02130466|588504690|FG007|Overall Study|Lost to Follow-up|0|||
162946273|NCT02130466|588504691|FG008|Overall Study|Lost to Follow-up|0|||
162946274|NCT02130466|588504692|FG009|Overall Study|Lost to Follow-up|0|||
162946275|NCT02130466|588504693|FG010|Overall Study|Lost to Follow-up|0|||
162946276|NCT02130466|588504694|FG011|Overall Study|Lost to Follow-up|0|||
162946277|NCT02130466|588504695|FG012|Overall Study|Lost to Follow-up|1|||
162946278|NCT02130466|588504696|FG013|Overall Study|Lost to Follow-up|0|||
162946279|NCT02130466|588504683|FG000|Overall Study|Physician Decision|0|||
162946280|NCT02130466|588504684|FG001|Overall Study|Physician Decision|0|||
162946281|NCT02130466|588504685|FG002|Overall Study|Physician Decision|0|||
162946282|NCT02130466|588504686|FG003|Overall Study|Physician Decision|0|||
162946283|NCT02130466|588504687|FG004|Overall Study|Physician Decision|0|||
162946284|NCT02130466|588504688|FG005|Overall Study|Physician Decision|1|||
162946285|NCT02130466|588504689|FG006|Overall Study|Physician Decision|1|||
162946286|NCT02130466|588504690|FG007|Overall Study|Physician Decision|0|||
162946287|NCT02130466|588504691|FG008|Overall Study|Physician Decision|0|||
162946288|NCT02130466|588504692|FG009|Overall Study|Physician Decision|0|||
162946289|NCT02130466|588504693|FG010|Overall Study|Physician Decision|0|||
162946290|NCT02130466|588504694|FG011|Overall Study|Physician Decision|0|||
162946291|NCT02130466|588504695|FG012|Overall Study|Physician Decision|0|||
162946292|NCT02130466|588504696|FG013|Overall Study|Physician Decision|0|||
162946293|NCT02130466|588504683|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
162946294|NCT02130466|588504684|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
162946295|NCT02130466|588504685|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
162946296|NCT02130466|588504686|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
162946297|NCT02130466|588504687|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
162946298|NCT02130466|588504688|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
162946299|NCT02130466|588504689|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
162946300|NCT02130466|588504690|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
162946301|NCT02130466|588504691|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
162946302|NCT02130466|588504692|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
162946303|NCT02130466|588504693|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
162946304|NCT02130466|588504694|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
162946305|NCT02130466|588504695|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
162946306|NCT02130466|588504696|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
162946307|NCT02130466|588504683|FG000|Overall Study|Withdrawal by Subject|1|||
162946308|NCT02130466|588504684|FG001|Overall Study|Withdrawal by Subject|0|||
162946309|NCT02130466|588504685|FG002|Overall Study|Withdrawal by Subject|0|||
162946310|NCT02130466|588504686|FG003|Overall Study|Withdrawal by Subject|0|||
162946311|NCT02130466|588504687|FG004|Overall Study|Withdrawal by Subject|0|||
162946312|NCT02130466|588504688|FG005|Overall Study|Withdrawal by Subject|1|||
162946313|NCT02130466|588504689|FG006|Overall Study|Withdrawal by Subject|0|||
163291929|NCT03545984|589773217|FG000|Overall Study|CSF cases not present during rotation|11|||
162946314|NCT02130466|588504690|FG007|Overall Study|Withdrawal by Subject|0|||
162946315|NCT02130466|588504691|FG008|Overall Study|Withdrawal by Subject|1|||
162946316|NCT02130466|588504692|FG009|Overall Study|Withdrawal by Subject|0|||
162946317|NCT02130466|588504693|FG010|Overall Study|Withdrawal by Subject|0|||
162946318|NCT02130466|588504694|FG011|Overall Study|Withdrawal by Subject|0|||
162946319|NCT02130466|588504695|FG012|Overall Study|Withdrawal by Subject|0|||
162946320|NCT02130466|588504696|FG013|Overall Study|Withdrawal by Subject|0|||
162946321|NCT04529109|588504698|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
163291930|NCT03545984|589773218|FG001|Overall Study|CSF cases not present during rotation|9|||
163291931|NCT03418324|589773219|FG000|Overall Study|Death|0|||
162946322|NCT04529109|588504699|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
162946323|NCT01508936|588504701|FG000|Overall Study|Adverse Event|11|||
162946324|NCT01508936|588504702|FG001|Overall Study|Adverse Event|32|||
163291932|NCT03418324|589773220|FG001|Overall Study|Death|1|||
162946325|NCT01508936|588504701|FG000|Overall Study|Lack of Efficacy|0|||
162946326|NCT01508936|588504702|FG001|Overall Study|Lack of Efficacy|1|||
162946327|NCT01508936|588504701|FG000|Overall Study|Withdrawal by Subject|4|||
162946328|NCT01508936|588504702|FG001|Overall Study|Withdrawal by Subject|18|||
162946329|NCT01508936|588504701|FG000|Overall Study|Protocol Violation|2|||
162946330|NCT01508936|588504702|FG001|Overall Study|Protocol Violation|3|||
162946331|NCT01508936|588504701|FG000|Overall Study|Lost to Follow-up|2|||
162946332|NCT01508936|588504702|FG001|Overall Study|Lost to Follow-up|9|||
162946333|NCT01508936|588504701|FG000|Overall Study|Other|0|||
162946334|NCT01508936|588504702|FG001|Overall Study|Other|5|||
162946335|NCT01508936|588504701|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
162946336|NCT01508936|588504702|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
162946337|NCT00679367|588504703|FG000|Overall Study|Adverse Event|7|||
162946338|NCT00679367|588504703|FG000|Overall Study|inability to swallow oral drugs|1|||
162946339|NCT00679367|588504703|FG000|Overall Study|Lack of Efficacy|3|||
162946340|NCT00679367|588504703|FG000|Overall Study|Withdrawal by Subject|1|||
162946341|NCT00922779|588504704|FG000|Overall Study|Adverse Event|67|||
163186451|NCT02180165|589400143|FG001|Overall Study|Withdrawal by Subject|0|||
162946342|NCT00922779|588504704|FG000|Overall Study|Pregnancy|7|||
162946343|NCT00922779|588504704|FG000|Overall Study|Withdrawal by Subject|308|||
162946344|NCT00922779|588504704|FG000|Overall Study|Lost to Follow-up|44|||
162946345|NCT00922779|588504704|FG000|Overall Study|Other|27|||
162946346|NCT00922779|588504704|FG000|Overall Study|Missing|1874|||
162946347|NCT01611090|588504705|FG000|Randomized Period|Lost to Follow-up|8|||
162946348|NCT01611090|588504706|FG001|Randomized Period|Lost to Follow-up|3|||
162946349|NCT01611090|588504707|FG002|Randomized Period|Lost to Follow-up|0|||
162946350|NCT01611090|588504705|FG000|Randomized Period|Withdrawal by Subject|22|||
162946351|NCT01611090|588504706|FG001|Randomized Period|Withdrawal by Subject|26|||
162946352|NCT01611090|588504707|FG002|Randomized Period|Withdrawal by Subject|0|||
162946353|NCT01611090|588504705|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
162946354|NCT01611090|588504706|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
162946355|NCT01611090|588504707|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
162946356|NCT01611090|588504705|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
162946357|NCT01611090|588504706|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
162946358|NCT01611090|588504707|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
162946359|NCT03968224|588504708|FG000|Overall Study|Lost to Follow-up|11|||
162946360|NCT03968224|588504709|FG001|Overall Study|Lost to Follow-up|18|||
162946361|NCT05771428|588506363|FG000|Overall Study|Adverse Event|0|||
162946362|NCT05771428|588506364|FG001|Overall Study|Adverse Event|1|||
162946363|NCT05771428|588506365|FG002|Overall Study|Adverse Event|1|||
162946364|NCT05771428|588506366|FG003|Overall Study|Adverse Event|1|||
162946365|NCT05771428|588506363|FG000|Overall Study|Withdrawal by Subject|3|||
162946366|NCT05771428|588506364|FG001|Overall Study|Withdrawal by Subject|2|||
162946367|NCT05771428|588506365|FG002|Overall Study|Withdrawal by Subject|1|||
162946368|NCT05771428|588506366|FG003|Overall Study|Withdrawal by Subject|4|||
162946369|NCT05771428|588506363|FG000|Overall Study|Other|0|||
162946370|NCT05771428|588506364|FG001|Overall Study|Other|1|||
162946371|NCT05771428|588506365|FG002|Overall Study|Other|2|||
162946372|NCT05771428|588506366|FG003|Overall Study|Other|1|||
162946373|NCT05771428|588506363|FG000|Overall Study|Randomized but Not Treated|0|||
162946374|NCT05771428|588506364|FG001|Overall Study|Randomized but Not Treated|0|||
162946375|NCT05771428|588506365|FG002|Overall Study|Randomized but Not Treated|1|||
162946376|NCT05771428|588506366|FG003|Overall Study|Randomized but Not Treated|0|||
162946377|NCT04025229|588506367|FG000|Overall Study|Adverse Event|1|||
162946378|NCT04025229|588506368|FG001|Overall Study|Adverse Event|0|||
162946379|NCT04025229|588506367|FG000|Overall Study|Withdrawal by Subject|0|||
162946380|NCT04025229|588506368|FG001|Overall Study|Withdrawal by Subject|2|||
162946381|NCT04025229|588506367|FG000|Overall Study|Death|0|||
162946382|NCT04025229|588506368|FG001|Overall Study|Death|1|||
162946383|NCT04025229|588506367|FG000|Overall Study|Physician Decision|0|||
162946384|NCT04025229|588506368|FG001|Overall Study|Physician Decision|1|||
162946385|NCT03815942|588506369|FG000|Overall Study|Withdrawal by Subject|0|||
162946386|NCT03815942|588506370|FG001|Overall Study|Withdrawal by Subject|17|||
162946387|NCT01374919|588506371|FG000|Overall Study|Withdrawal by Subject|2|||
162946388|NCT00366899|588506372|FG000|Infant Series|Withdrawal by Subject|4|||
162946389|NCT00366899|588506373|FG001|Infant Series|Withdrawal by Subject|7|||
162946390|NCT00366899|588506372|FG000|Infant Series|Protocol Violation|2|||
162946391|NCT00366899|588506373|FG001|Infant Series|Protocol Violation|1|||
163186452|NCT02180165|589400144|FG002|Overall Study|Withdrawal by Subject|2|||
162946392|NCT00366899|588506372|FG000|Infant Series|Failed to return|1|||
162946393|NCT00366899|588506373|FG001|Infant Series|Failed to return|1|||
162946394|NCT00366899|588506372|FG000|Infant Series|Lost to Follow-up|0|||
162946395|NCT00366899|588506373|FG001|Infant Series|Lost to Follow-up|2|||
162946396|NCT00366899|588506372|FG000|Infant Series|Adverse Event|0|||
162946397|NCT00366899|588506373|FG001|Infant Series|Adverse Event|1|||
162946398|NCT00366899|588506372|FG000|Infant Series|Physician Decision|1|||
162946399|NCT00366899|588506373|FG001|Infant Series|Physician Decision|0|||
162946400|NCT00366899|588506372|FG000|Infant Series|Randomized but not consented|1|||
163186453|NCT02180165|589400145|FG003|Overall Study|Withdrawal by Subject|1|||
163186454|NCT02943460|589400147|FG000|Blinded Study Phase|Adverse Event|3|||
162946401|NCT00366899|588506373|FG001|Infant Series|Randomized but not consented|0|||
162946402|NCT00366899|588506372|FG000|After Infant Series|Lost to Follow-up|4|||
162946403|NCT00366899|588506373|FG001|After Infant Series|Lost to Follow-up|3|||
162946404|NCT00366899|588506372|FG000|After Infant Series|Withdrawal by Subject|1|||
162946405|NCT00366899|588506373|FG001|After Infant Series|Withdrawal by Subject|4|||
162946406|NCT00366899|588506372|FG000|After Infant Series|Adverse Event|1|||
162946407|NCT00366899|588506373|FG001|After Infant Series|Adverse Event|2|||
162946408|NCT00366899|588506372|FG000|After Infant Series|Protocol Violation|1|||
162946409|NCT00366899|588506373|FG001|After Infant Series|Protocol Violation|0|||
162946410|NCT00366899|588506372|FG000|Toddler Dose|Withdrawal by Subject|1|||
162946411|NCT00366899|588506373|FG001|Toddler Dose|Withdrawal by Subject|1|||
162946412|NCT00366899|588506372|FG000|Toddler Dose|Protocol Violation|1|||
162946413|NCT00366899|588506373|FG001|Toddler Dose|Protocol Violation|0|||
162946414|NCT03601637|588506374|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
162946415|NCT03601637|588506375|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
162946416|NCT03601637|588506374|FG000|Overall Study|Adverse Event|1|||
162946417|NCT03601637|588506375|FG001|Overall Study|Adverse Event|1|||
162946418|NCT03601637|588506374|FG000|Overall Study|Other|0|||
162946419|NCT03601637|588506375|FG001|Overall Study|Other|1|||
162946420|NCT02322047|588506377|FG000|Overall Study|Physician Decision|1|||
162946421|NCT02322047|588506378|FG001|Overall Study|Physician Decision|0|||
162946422|NCT02322047|588506379|FG002|Overall Study|Physician Decision|0|||
162946423|NCT02322047|588506380|FG003|Overall Study|Physician Decision|0|||
162946424|NCT02322047|588506377|FG000|Overall Study|Withdrawal by Subject|1|||
162946425|NCT02322047|588506378|FG001|Overall Study|Withdrawal by Subject|0|||
162946426|NCT02322047|588506379|FG002|Overall Study|Withdrawal by Subject|0|||
162946427|NCT02322047|588506380|FG003|Overall Study|Withdrawal by Subject|1|||
162946428|NCT02322047|588506377|FG000|Overall Study|Adverse Event|0|||
162946429|NCT02322047|588506378|FG001|Overall Study|Adverse Event|1|||
162946430|NCT02322047|588506379|FG002|Overall Study|Adverse Event|0|||
162946431|NCT02322047|588506380|FG003|Overall Study|Adverse Event|0|||
162946432|NCT02322047|588506377|FG000|Overall Study|Lost to Follow-up|0|||
162946433|NCT02322047|588506378|FG001|Overall Study|Lost to Follow-up|0|||
162946434|NCT02322047|588506379|FG002|Overall Study|Lost to Follow-up|1|||
162946435|NCT02322047|588506380|FG003|Overall Study|Lost to Follow-up|1|||
162946436|NCT00920140|588506383|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
162946437|NCT00920140|588506384|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
162946438|NCT00920140|588506385|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
162946439|NCT00920140|588506386|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
162946440|NCT00920140|588506387|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
162946441|NCT00920140|588506383|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
162946442|NCT00920140|588506384|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
162946443|NCT00920140|588506385|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
162946444|NCT00920140|588506386|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
162946445|NCT00920140|588506387|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
162946446|NCT00920140|588506383|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162946447|NCT00920140|588506384|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
162946448|NCT00920140|588506385|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162946449|NCT00920140|588506386|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162946450|NCT00920140|588506387|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162946451|NCT00920140|588506383|FG000|Phase 2|Adverse Event|0|||
162946452|NCT00920140|588506384|FG001|Phase 2|Adverse Event|0|||
162946453|NCT00920140|588506385|FG002|Phase 2|Adverse Event|14|||
162946454|NCT00920140|588506386|FG003|Phase 2|Adverse Event|2|||
162946455|NCT00920140|588506387|FG004|Phase 2|Adverse Event|3|||
162946456|NCT00920140|588506383|FG000|Phase 2|Lack of Efficacy|0|||
162946457|NCT00920140|588506384|FG001|Phase 2|Lack of Efficacy|0|||
162946458|NCT00920140|588506385|FG002|Phase 2|Lack of Efficacy|29|||
162946459|NCT00920140|588506386|FG003|Phase 2|Lack of Efficacy|14|||
162946460|NCT00920140|588506387|FG004|Phase 2|Lack of Efficacy|5|||
162946461|NCT00920140|588506383|FG000|Phase 2|Lost to Follow-up|0|||
162946462|NCT00920140|588506384|FG001|Phase 2|Lost to Follow-up|0|||
162946463|NCT00920140|588506385|FG002|Phase 2|Lost to Follow-up|0|||
162946464|NCT00920140|588506386|FG003|Phase 2|Lost to Follow-up|1|||
162946465|NCT00920140|588506387|FG004|Phase 2|Lost to Follow-up|0|||
162946466|NCT00920140|588506383|FG000|Phase 2|Physician Decision|0|||
162946467|NCT00920140|588506384|FG001|Phase 2|Physician Decision|0|||
162946468|NCT00920140|588506385|FG002|Phase 2|Physician Decision|3|||
162946469|NCT00920140|588506386|FG003|Phase 2|Physician Decision|3|||
162946470|NCT00920140|588506387|FG004|Phase 2|Physician Decision|2|||
162946471|NCT00920140|588506383|FG000|Phase 2|Withdrawal by Subject|0|||
162946472|NCT00920140|588506384|FG001|Phase 2|Withdrawal by Subject|0|||
162946473|NCT00920140|588506385|FG002|Phase 2|Withdrawal by Subject|4|||
162946474|NCT00920140|588506386|FG003|Phase 2|Withdrawal by Subject|2|||
162946475|NCT00920140|588506387|FG004|Phase 2|Withdrawal by Subject|1|||
162946476|NCT01400425|588506388|FG000|Overall Study|Withdrawal by Subject|10|||
162946477|NCT00720096|588506390|FG000|Overall Study|Withdrawal by Subject|0|||
162946478|NCT00720096|588506391|FG001|Overall Study|Withdrawal by Subject|2|||
163186455|NCT02943460|589400148|FG001|Blinded Study Phase|Adverse Event|0|||
162946479|NCT04557124|588506392|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
162946480|NCT04557124|588506393|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
162946481|NCT04557124|588506392|FG000|Mid-point (1 Month)|Missed testing|5|||
162946482|NCT04557124|588506393|FG001|Mid-point (1 Month)|Missed testing|4|||
162946483|NCT04557124|588506392|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
162946484|NCT04557124|588506393|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
162946485|NCT04557124|588506392|FG000|Post-testing (2 Months)|Missed testing|1|||
162946486|NCT04557124|588506393|FG001|Post-testing (2 Months)|Missed testing|5|||
162946487|NCT04557124|588506392|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
162946488|NCT04557124|588506393|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
162946489|NCT04557124|588506392|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
162946490|NCT04557124|588506393|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
162946491|NCT00001849|588506394|FG000|Overall Study|Death|4|||
162946492|NCT00001849|588506394|FG000|Overall Study|Lost to Follow-up|2|||
162946493|NCT00001849|588506394|FG000|Overall Study|Withdrawal by Subject|2|||
162946494|NCT00001849|588506394|FG000|Overall Study|tumor remained occult|6|||
162946495|NCT00442936|588506395|FG000|Overall Study|Protocol Violation|1|||
162946496|NCT00442936|588506396|FG001|Overall Study|Protocol Violation|0|||
162946497|NCT00442936|588506397|FG002|Overall Study|Protocol Violation|1|||
162946498|NCT00442936|588506398|FG003|Overall Study|Protocol Violation|1|||
162946499|NCT02428699|588506399|FG000|Washout Period 1|Screen Failure|1|||
162946500|NCT02428699|588506400|FG001|Washout Period 1|Screen Failure|2|||
162946501|NCT03127137|588506401|FG000|Overall Study|Requested sedation after consent|1|||
162946502|NCT03127137|588506402|FG001|Overall Study|Requested sedation after consent|0|||
162946503|NCT03127137|588506401|FG000|Overall Study|Malfunction in electronic data collection|1|||
162946504|NCT03127137|588506402|FG001|Overall Study|Malfunction in electronic data collection|0|||
162946505|NCT03127137|588506401|FG000|Overall Study|Post procedure testing could not be obtained|0|||
162946506|NCT03127137|588506402|FG001|Overall Study|Post procedure testing could not be obtained|1|||
162946507|NCT04424407|588506403|FG000|Overall Study|Withdrawal by Subject|2|||
162946508|NCT04424407|588506403|FG000|Overall Study|Lost to Follow-up|1|||
162946509|NCT00264797|588506404|FG000|Overall Study|Withdrawal by Subject|11|||
162946510|NCT00264797|588506405|FG001|Overall Study|Withdrawal by Subject|11|||
162946511|NCT00264797|588506404|FG000|Overall Study|Lost to Follow-up|9|||
162946512|NCT00264797|588506405|FG001|Overall Study|Lost to Follow-up|17|||
162946513|NCT00264797|588506404|FG000|Overall Study|Moved from area|3|||
162946514|NCT00264797|588506405|FG001|Overall Study|Moved from area|1|||
162946515|NCT00264797|588506404|FG000|Overall Study|Practical Problems|2|||
162946516|NCT00264797|588506405|FG001|Overall Study|Practical Problems|3|||
162946517|NCT00264797|588506404|FG000|Overall Study|Incarceration|4|||
162946518|NCT00264797|588506405|FG001|Overall Study|Incarceration|5|||
162946519|NCT00264797|588506404|FG000|Overall Study|Pressure/advice from Outsiders|1|||
162946520|NCT00264797|588506405|FG001|Overall Study|Pressure/advice from Outsiders|1|||
162946521|NCT00264797|588506404|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
162946522|NCT00264797|588506405|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
162946523|NCT00264797|588506404|FG000|Overall Study|Other|3|||
162946524|NCT00264797|588506405|FG001|Overall Study|Other|4|||
162946525|NCT03992196|588506406|FG000|Enrollment|lost to follow-up prior dosing|1|||
162946526|NCT03992196|588506407|FG001|Enrollment|lost to follow-up prior dosing|0|||
162946527|NCT03992196|588506408|FG002|Enrollment|lost to follow-up prior dosing|0|||
162946528|NCT03992196|588506406|FG000|Treatment|Protocol Violation|0|||
162946529|NCT03992196|588506407|FG001|Treatment|Protocol Violation|0|||
162946530|NCT03992196|588506408|FG002|Treatment|Protocol Violation|1|||
162946531|NCT03992196|588506406|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
162946532|NCT03992196|588506407|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
162946533|NCT03992196|588506408|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
162946534|NCT03992196|588506406|FG000|Treatment|Withdrawal due to non-compliance|0|||
162946535|NCT03992196|588506407|FG001|Treatment|Withdrawal due to non-compliance|0|||
162946536|NCT03992196|588506408|FG002|Treatment|Withdrawal due to non-compliance|1|||
162946537|NCT03992196|588506406|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
162946538|NCT03992196|588506407|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
162946539|NCT03992196|588506408|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
162946540|NCT03992196|588506406|FG000|Treatment|Withdrawal by parent/guardian|0|||
162946541|NCT03992196|588506407|FG001|Treatment|Withdrawal by parent/guardian|0|||
162946542|NCT03992196|588506408|FG002|Treatment|Withdrawal by parent/guardian|2|||
162946543|NCT00755196|588506410|FG000|Overall Study|Lost to Follow-up|1|||
162946544|NCT00755196|588506410|FG000|Overall Study|Lack of Efficiency|1|||
162946545|NCT02388763|588506411|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
162946546|NCT02388763|588506412|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
162946547|NCT02388763|588506411|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
162946548|NCT02388763|588506412|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
162946549|NCT01604850|588506413|FG000|Overall Study|Enrolled but never treated|0|||
162946550|NCT01604850|588506414|FG001|Overall Study|Enrolled but never treated|1|||
162946551|NCT01604850|588506413|FG000|Overall Study|Efficacy Failure|50|||
162946552|NCT01604850|588506414|FG001|Overall Study|Efficacy Failure|29|||
162946553|NCT01604850|588506413|FG000|Overall Study|Lost to Follow-up|1|||
162946554|NCT01604850|588506414|FG001|Overall Study|Lost to Follow-up|0|||
162946555|NCT01604850|588506413|FG000|Overall Study|Subject withdrew consent|1|||
162946556|NCT01604850|588506414|FG001|Overall Study|Subject withdrew consent|0|||
162946557|NCT01703832|588506415|FG000|Overall Study|Withdrawal by Subject|1|||
162946558|NCT01703832|588506416|FG001|Overall Study|Withdrawal by Subject|0|||
162946559|NCT00243932|588506417|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
162946560|NCT00243932|588506418|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
162946561|NCT00243932|588506419|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
162946562|NCT01458405|588506422|FG000|Phase 1 (up to 12 Months)|Other|0|||
162946563|NCT01458405|588506423|FG001|Phase 1 (up to 12 Months)|Other|1|||
162946564|NCT01458405|588506424|FG002|Phase 1 (up to 12 Months)|Other|0|||
162946565|NCT01458405|588506425|FG003|Phase 1 (up to 12 Months)|Other|0|||
162946566|NCT01458405|588506422|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
162946567|NCT01458405|588506423|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
162946568|NCT01458405|588506424|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
162946569|NCT01458405|588506425|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
162946570|NCT01458405|588506422|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
162946571|NCT01458405|588506423|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
162946572|NCT01458405|588506424|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
162946573|NCT01458405|588506425|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
162946574|NCT01458405|588506422|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
162946575|NCT01458405|588506423|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
162946576|NCT01458405|588506424|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
162946577|NCT01458405|588506425|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
162946578|NCT02497781|588506429|FG000|Overall Study|Withdrawal by Subject|2|||
162946579|NCT02497781|588506430|FG001|Overall Study|Withdrawal by Subject|0|||
162946580|NCT02497781|588506429|FG000|Overall Study|Lack of Efficacy|0|||
162946581|NCT02497781|588506430|FG001|Overall Study|Lack of Efficacy|1|||
162946582|NCT02497781|588506429|FG000|Overall Study|Randomised but not treated|1|||
162946583|NCT02497781|588506430|FG001|Overall Study|Randomised but not treated|1|||
162946584|NCT02497781|588506429|FG000|Overall Study|Lost to Follow-up|1|||
162946585|NCT02497781|588506430|FG001|Overall Study|Lost to Follow-up|1|||
162946586|NCT01193608|588506431|FG000|Overall Study|Other|0|||
162946587|NCT01193608|588506432|FG001|Overall Study|Other|1|||
162946588|NCT01193608|588506433|FG002|Overall Study|Other|0|||
162946589|NCT01193608|588506434|FG003|Overall Study|Other|0|||
162946590|NCT01193608|588506435|FG004|Overall Study|Other|0|||
162946591|NCT01193608|588506436|FG005|Overall Study|Other|0|||
162946592|NCT01193608|588506431|FG000|Overall Study|Withdrawal by Subject|0|||
162946593|NCT01193608|588506432|FG001|Overall Study|Withdrawal by Subject|1|||
162946594|NCT01193608|588506433|FG002|Overall Study|Withdrawal by Subject|2|||
162946595|NCT01193608|588506434|FG003|Overall Study|Withdrawal by Subject|3|||
162946596|NCT01193608|588506435|FG004|Overall Study|Withdrawal by Subject|3|||
162946597|NCT01193608|588506436|FG005|Overall Study|Withdrawal by Subject|0|||
162946598|NCT01193608|588506431|FG000|Overall Study|Lost to Follow-up|0|||
162946599|NCT01193608|588506432|FG001|Overall Study|Lost to Follow-up|0|||
162946600|NCT01193608|588506433|FG002|Overall Study|Lost to Follow-up|0|||
162946601|NCT01193608|588506434|FG003|Overall Study|Lost to Follow-up|0|||
162946602|NCT01193608|588506435|FG004|Overall Study|Lost to Follow-up|1|||
162946603|NCT01193608|588506436|FG005|Overall Study|Lost to Follow-up|2|||
162946604|NCT01193608|588506431|FG000|Overall Study|Adverse Event|0|||
162946605|NCT01193608|588506432|FG001|Overall Study|Adverse Event|0|||
162946606|NCT01193608|588506433|FG002|Overall Study|Adverse Event|0|||
162946607|NCT01193608|588506434|FG003|Overall Study|Adverse Event|0|||
162946608|NCT01193608|588506435|FG004|Overall Study|Adverse Event|1|||
162946609|NCT01193608|588506436|FG005|Overall Study|Adverse Event|0|||
162946610|NCT01249664|588506437|FG000|Overall Study|Withdrawal by Subject|5|||
162946611|NCT01249664|588506438|FG001|Overall Study|Withdrawal by Subject|0|||
162946612|NCT01249664|588506437|FG000|Overall Study|Adverse Event|1|||
162946613|NCT01249664|588506438|FG001|Overall Study|Adverse Event|0|||
162946614|NCT00454636|588506439|FG000|Overall Study|Adverse Event|10|||
162946615|NCT00454636|588506440|FG001|Overall Study|Adverse Event|6|||
162946616|NCT00454636|588506441|FG002|Overall Study|Adverse Event|9|||
162946617|NCT00454636|588506442|FG003|Overall Study|Adverse Event|15|||
162946618|NCT00454636|588506439|FG000|Overall Study|Disease Progression|11|||
163186456|NCT02943460|589400149|FG002|Blinded Study Phase|Adverse Event|0|||
162946619|NCT00454636|588506440|FG001|Overall Study|Disease Progression|12|||
162946620|NCT00454636|588506441|FG002|Overall Study|Disease Progression|4|||
162946621|NCT00454636|588506442|FG003|Overall Study|Disease Progression|11|||
162946622|NCT00454636|588506439|FG000|Overall Study|Protocol Violation|3|||
162946623|NCT00454636|588506440|FG001|Overall Study|Protocol Violation|2|||
162946624|NCT00454636|588506441|FG002|Overall Study|Protocol Violation|3|||
162946625|NCT00454636|588506442|FG003|Overall Study|Protocol Violation|3|||
162946626|NCT00454636|588506439|FG000|Overall Study|Death|6|||
162946627|NCT00454636|588506440|FG001|Overall Study|Death|1|||
162946628|NCT00454636|588506441|FG002|Overall Study|Death|1|||
162946629|NCT00454636|588506442|FG003|Overall Study|Death|1|||
162946630|NCT00454636|588506439|FG000|Overall Study|Patient refusal|1|||
162946631|NCT00454636|588506440|FG001|Overall Study|Patient refusal|1|||
162946632|NCT00454636|588506441|FG002|Overall Study|Patient refusal|3|||
162946633|NCT00454636|588506442|FG003|Overall Study|Patient refusal|2|||
162946634|NCT00454636|588506439|FG000|Overall Study|Lost to Follow-up|0|||
162946635|NCT00454636|588506440|FG001|Overall Study|Lost to Follow-up|1|||
162946636|NCT00454636|588506441|FG002|Overall Study|Lost to Follow-up|0|||
162946637|NCT00454636|588506442|FG003|Overall Study|Lost to Follow-up|0|||
162946638|NCT00806156|588506443|FG000|Overall Study|Death|35|||
162946639|NCT00806156|588506444|FG001|Overall Study|Death|95|||
162946640|NCT00806156|588506443|FG000|Overall Study|Did not meet eligibility criteria|1|||
162946641|NCT00806156|588506444|FG001|Overall Study|Did not meet eligibility criteria|0|||
162946642|NCT00806156|588506443|FG000|Overall Study|Study terminated by Sponsor|2|||
162946643|NCT00806156|588506444|FG001|Overall Study|Study terminated by Sponsor|40|||
162946644|NCT00806156|588506443|FG000|Overall Study|Consent withdrawn by subject|1|||
162946645|NCT00806156|588506444|FG001|Overall Study|Consent withdrawn by subject|3|||
162946646|NCT00806156|588506443|FG000|Overall Study|Lost to Follow-up|0|||
162946647|NCT00806156|588506444|FG001|Overall Study|Lost to Follow-up|1|||
162946648|NCT01025037|588506449|FG000|Overall Study|Adverse Event|3|||
162946649|NCT01025037|588506449|FG000|Overall Study|Lost to Follow-up|7|||
162946650|NCT01025037|588506449|FG000|Overall Study|Withdrawal by Subject|1|||
162946651|NCT02674334|588506454|FG000|Overall Study|Lost to Follow-up|5|||
162946652|NCT02674334|588506455|FG001|Overall Study|Lost to Follow-up|3|||
162946653|NCT02674334|588506454|FG000|Overall Study|participant difficulty breathing|1|||
162946654|NCT02674334|588506455|FG001|Overall Study|participant difficulty breathing|0|||
162946655|NCT02674334|588506454|FG000|Overall Study|NIRS not recording|1|||
162946656|NCT02674334|588506455|FG001|Overall Study|NIRS not recording|0|||
162946657|NCT00860405|588506466|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
162946658|NCT00860405|588506467|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
162946659|NCT00864097|588506468|FG000|Overall Study|Death|0|||
162946660|NCT00864097|588506469|FG001|Overall Study|Death|1|||
162946661|NCT00864097|588506470|FG002|Overall Study|Death|0|||
162946662|NCT00864097|588506471|FG003|Overall Study|Death|0|||
162946663|NCT00864097|588506468|FG000|Overall Study|Adverse Event|6|||
162946664|NCT00864097|588506469|FG001|Overall Study|Adverse Event|8|||
162946665|NCT00864097|588506470|FG002|Overall Study|Adverse Event|11|||
162946666|NCT00864097|588506471|FG003|Overall Study|Adverse Event|9|||
162946667|NCT00864097|588506468|FG000|Overall Study|Lack of Efficacy|9|||
162946668|NCT00864097|588506469|FG001|Overall Study|Lack of Efficacy|3|||
162946669|NCT00864097|588506470|FG002|Overall Study|Lack of Efficacy|7|||
162946670|NCT00864097|588506471|FG003|Overall Study|Lack of Efficacy|2|||
162946671|NCT00864097|588506468|FG000|Overall Study|Lost to Follow-up|0|||
162946672|NCT00864097|588506469|FG001|Overall Study|Lost to Follow-up|1|||
162946673|NCT00864097|588506470|FG002|Overall Study|Lost to Follow-up|0|||
162946674|NCT00864097|588506471|FG003|Overall Study|Lost to Follow-up|1|||
162946675|NCT00864097|588506468|FG000|Overall Study|Withdrawal by Subject|15|||
162946676|NCT00864097|588506469|FG001|Overall Study|Withdrawal by Subject|11|||
162946677|NCT00864097|588506470|FG002|Overall Study|Withdrawal by Subject|11|||
162946678|NCT00864097|588506471|FG003|Overall Study|Withdrawal by Subject|12|||
162946679|NCT00864097|588506468|FG000|Overall Study|Protocol Violation|2|||
162946680|NCT00864097|588506469|FG001|Overall Study|Protocol Violation|1|||
162946681|NCT00864097|588506470|FG002|Overall Study|Protocol Violation|0|||
162946682|NCT00864097|588506471|FG003|Overall Study|Protocol Violation|1|||
162946683|NCT00864097|588506468|FG000|Overall Study|Terminated by sponsor|105|||
162946684|NCT00864097|588506469|FG001|Overall Study|Terminated by sponsor|112|||
162946685|NCT00864097|588506470|FG002|Overall Study|Terminated by sponsor|102|||
162946686|NCT00864097|588506471|FG003|Overall Study|Terminated by sponsor|99|||
162946687|NCT00864097|588506468|FG000|Overall Study|Randomized but not treated|2|||
162946688|NCT00864097|588506469|FG001|Overall Study|Randomized but not treated|0|||
162946689|NCT00864097|588506470|FG002|Overall Study|Randomized but not treated|1|||
162946690|NCT00864097|588506471|FG003|Overall Study|Randomized but not treated|0|||
162946691|NCT00864097|588506468|FG000|Overall Study|Other|0|||
162946692|NCT00864097|588506469|FG001|Overall Study|Other|0|||
162946693|NCT00864097|588506470|FG002|Overall Study|Other|0|||
162946694|NCT00864097|588506471|FG003|Overall Study|Other|1|||
162946695|NCT00320112|588506474|FG000|Overall Study|Lost to Follow-up|3|||
162946696|NCT00320112|588506475|FG001|Overall Study|Lost to Follow-up|4|||
162946697|NCT00320112|588506474|FG000|Overall Study|Withdrawal by Subject|3|||
162946698|NCT00320112|588506475|FG001|Overall Study|Withdrawal by Subject|0|||
162946699|NCT00320112|588506474|FG000|Overall Study|Death|2|||
162946700|NCT00320112|588506475|FG001|Overall Study|Death|1|||
162946701|NCT02899338|588506476|FG000|Overall Study|Adverse Event|1|||
162946702|NCT02899338|588506477|FG001|Overall Study|Adverse Event|2|||
162946703|NCT02899338|588506476|FG000|Overall Study|Withdrawal by Subject|2|||
162946704|NCT02899338|588506477|FG001|Overall Study|Withdrawal by Subject|0|||
162946705|NCT06179108|588506478|FG000|Overall Study|Withdrawal by Subject|16|||
162946706|NCT06179108|588506479|FG001|Overall Study|Withdrawal by Subject|19|||
162946707|NCT06179108|588506480|FG002|Overall Study|Withdrawal by Subject|10|||
162946708|NCT06179108|588506481|FG003|Overall Study|Withdrawal by Subject|11|||
162946709|NCT06179108|588506478|FG000|Overall Study|Lost to Follow-up|12|||
162946710|NCT06179108|588506479|FG001|Overall Study|Lost to Follow-up|4|||
162946711|NCT06179108|588506480|FG002|Overall Study|Lost to Follow-up|1|||
162946712|NCT06179108|588506481|FG003|Overall Study|Lost to Follow-up|9|||
162946713|NCT06179108|588506478|FG000|Overall Study|Adverse Event|2|||
162946714|NCT06179108|588506479|FG001|Overall Study|Adverse Event|3|||
162946715|NCT06179108|588506480|FG002|Overall Study|Adverse Event|3|||
162946716|NCT06179108|588506481|FG003|Overall Study|Adverse Event|2|||
162946717|NCT06179108|588506478|FG000|Overall Study|Protocol Violation|0|||
162946718|NCT06179108|588506479|FG001|Overall Study|Protocol Violation|1|||
162946719|NCT06179108|588506480|FG002|Overall Study|Protocol Violation|0|||
162946720|NCT06179108|588506481|FG003|Overall Study|Protocol Violation|1|||
162946721|NCT06179108|588506478|FG000|Overall Study|Physician Decision|1|||
162946722|NCT06179108|588506479|FG001|Overall Study|Physician Decision|1|||
162946723|NCT06179108|588506480|FG002|Overall Study|Physician Decision|0|||
162946724|NCT06179108|588506481|FG003|Overall Study|Physician Decision|0|||
162946725|NCT06179108|588506478|FG000|Overall Study|Lack of Efficacy|0|||
162946726|NCT06179108|588506479|FG001|Overall Study|Lack of Efficacy|0|||
162946727|NCT06179108|588506480|FG002|Overall Study|Lack of Efficacy|0|||
162946728|NCT06179108|588506481|FG003|Overall Study|Lack of Efficacy|1|||
162946729|NCT06179108|588506478|FG000|Overall Study|Death|0|||
162946730|NCT06179108|588506479|FG001|Overall Study|Death|0|||
162946731|NCT06179108|588506480|FG002|Overall Study|Death|0|||
162946732|NCT06179108|588506481|FG003|Overall Study|Death|1|||
162946733|NCT00814463|588506482|FG000|Overall Study|Lost to Follow-up|1|||
162946734|NCT01370408|588506484|FG000|Overall Study|treatment failure|9|||
162946735|NCT02780687|588506489|FG000|Overall Study|Adverse Event|1|||
162946736|NCT02780687|588506490|FG001|Overall Study|Adverse Event|1|||
162946737|NCT02780687|588506489|FG000|Overall Study|Withdrawal by Subject|2|||
162946738|NCT02780687|588506490|FG001|Overall Study|Withdrawal by Subject|1|||
162946739|NCT02780687|588506489|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
162946740|NCT02780687|588506490|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
162946741|NCT02780687|588506489|FG000|Overall Study|progressive disease|29|||
162946742|NCT02780687|588506490|FG001|Overall Study|progressive disease|6|||
162946743|NCT00414765|588506492|FG000|Overall Study|Adverse Event|5|||
162946744|NCT00414765|588506493|FG001|Overall Study|Adverse Event|9|||
162946745|NCT00414765|588506492|FG000|Overall Study|Withdrawal by Subject|1|||
162946746|NCT00414765|588506493|FG001|Overall Study|Withdrawal by Subject|1|||
162946747|NCT00414765|588506492|FG000|Overall Study|Disease Progression|0|||
162946748|NCT00414765|588506493|FG001|Overall Study|Disease Progression|1|||
162946749|NCT05694013|588506495|FG000|Overall Study|Death|6|||
162946750|NCT05694013|588506496|FG001|Overall Study|Death|2|||
162946751|NCT05694013|588506495|FG000|Overall Study|Participant Decision|0|||
162946752|NCT05694013|588506496|FG001|Overall Study|Participant Decision|1|||
162946753|NCT05694013|588506495|FG000|Overall Study|Physician Decision|1|||
162946754|NCT05694013|588506496|FG001|Overall Study|Physician Decision|0|||
162946755|NCT05694013|588506495|FG000|Overall Study|Progressive Disease|0|||
162946756|NCT05694013|588506496|FG001|Overall Study|Progressive Disease|1|||
162946757|NCT05694013|588506495|FG000|Overall Study|Study Terminated by Sponsor|12|||
162946758|NCT05694013|588506496|FG001|Overall Study|Study Terminated by Sponsor|17|||
162946759|NCT05694013|588506495|FG000|Overall Study|Withdrawal by Subject|3|||
162946760|NCT05694013|588506496|FG001|Overall Study|Withdrawal by Subject|0|||
162946761|NCT01199861|588506497|FG000|Overall Study|Administrative problems|1|||
162946762|NCT01199861|588506498|FG001|Overall Study|Administrative problems|0|||
162946763|NCT01199861|588506497|FG000|Overall Study|Adverse Event|1|||
162946764|NCT01199861|588506498|FG001|Overall Study|Adverse Event|0|||
162946765|NCT04817891|588506499|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
162946766|NCT04817891|588506499|FG000|Overall Study|Adverse Event|1|||
162946767|NCT04817891|588506499|FG000|Overall Study|Withdrawal by Subject|1|||
162946768|NCT03982433|588506500|FG000|Overall Study|Lost to Follow-up|1|||
162946769|NCT04256421|588506503|FG000|Overall Study|Death|171|||
162946770|NCT04256421|588506504|FG001|Overall Study|Death|180|||
162946771|NCT04256421|588506503|FG000|Overall Study|Lost to Follow-up|1|||
162946772|NCT04256421|588506504|FG001|Overall Study|Lost to Follow-up|1|||
162946773|NCT04256421|588506503|FG000|Overall Study|Withdrawal by Subject|9|||
162946774|NCT04256421|588506504|FG001|Overall Study|Withdrawal by Subject|10|||
162946775|NCT04256421|588506503|FG000|Overall Study|Ongoing in Study|66|||
162946776|NCT04256421|588506504|FG001|Overall Study|Ongoing in Study|52|||
162946777|NCT00419770|588508090|FG000|Overall Study|Withdrawal by Subject|5|||
162946778|NCT00419770|588508091|FG001|Overall Study|Withdrawal by Subject|1|||
163186457|NCT02943460|589400147|FG000|Blinded Study Phase|Withdrew Consent|0|||
163186458|NCT02943460|589400148|FG001|Blinded Study Phase|Withdrew Consent|1|||
163186459|NCT02943460|589400149|FG002|Blinded Study Phase|Withdrew Consent|0|||
163186460|NCT02943460|589400147|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
163186461|NCT02943460|589400148|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
162946779|NCT02424188|588508099|FG000|Overall Study|Death|2|||
162946780|NCT02424188|588508100|FG001|Overall Study|Death|2|||
162946781|NCT02424188|588508099|FG000|Overall Study|Lost to Follow-up|1|||
162946782|NCT02424188|588508100|FG001|Overall Study|Lost to Follow-up|3|||
162946783|NCT02424188|588508099|FG000|Overall Study|Incarceration|1|||
162946784|NCT02424188|588508100|FG001|Overall Study|Incarceration|0|||
162946785|NCT00453362|588508105|FG000|Overall Study|Adverse Event|5|||
162946786|NCT00453362|588508105|FG000|Overall Study|Death|7|||
162946787|NCT00453362|588508105|FG000|Overall Study|Physician Decision|2|||
162946788|NCT00453362|588508105|FG000|Overall Study|Withdrawal by Subject|3|||
162946789|NCT00453362|588508105|FG000|Overall Study|Progression of disease|56|||
162946790|NCT00453362|588508105|FG000|Overall Study|Screening Failure|14|||
162946791|NCT04885296|588508106|FG000|Period 1|Covid-19 Related|1|||
162946792|NCT04885296|588508107|FG001|Period 1|Covid-19 Related|0|||
162946793|NCT04885296|588508106|FG000|Period 1|Adverse Event|0|||
162946794|NCT04885296|588508107|FG001|Period 1|Adverse Event|1|||
162946795|NCT04885296|588508106|FG000|Period 1|Withdrawal by Subject|1|||
162946796|NCT04885296|588508107|FG001|Period 1|Withdrawal by Subject|1|||
162946797|NCT04885296|588508106|FG000|Period 1|Test Article No Longer Available|1|||
162946798|NCT04885296|588508107|FG001|Period 1|Test Article No Longer Available|0|||
162946799|NCT04885296|588508106|FG000|Period 1|Dispensed Study lens in Error|1|||
162946800|NCT04885296|588508107|FG001|Period 1|Dispensed Study lens in Error|0|||
162946801|NCT04885296|588508106|FG000|Period 1|Lost to Follow-up|1|||
162946802|NCT04885296|588508107|FG001|Period 1|Lost to Follow-up|0|||
162946803|NCT04885296|588508106|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
162946804|NCT04885296|588508107|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
162946805|NCT00433147|588508108|FG000|Overall Study|Adverse Event|0|||
162946806|NCT00433147|588508109|FG001|Overall Study|Adverse Event|1|||
162946807|NCT00433147|588508110|FG002|Overall Study|Adverse Event|0|||
162946808|NCT00433147|588508111|FG003|Overall Study|Adverse Event|0|||
162946809|NCT04510857|588508115|FG000|Overall Study|Withdrawal by Subject|1|||
162946810|NCT04510857|588508116|FG001|Overall Study|Withdrawal by Subject|2|||
162946811|NCT01124149|588508119|FG000|Acute Phase|Withdrawal by Subject|22|||
162946812|NCT01124149|588508119|FG000|Acute Phase|Adverse Event|21|||
162946813|NCT01124149|588508119|FG000|Acute Phase|Lack of Efficacy|17|||
162946814|NCT01124149|588508119|FG000|Acute Phase|Protocol Violation|14|||
162946815|NCT01124149|588508119|FG000|Acute Phase|Lost to Follow-up|2|||
162946816|NCT01124149|588508119|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
162946817|NCT01124149|588508119|FG000|Acute Phase|Sponsor request|1|||
162946818|NCT01124149|588508119|FG000|Acute Phase|UC symptoms not ameliorated|1|||
162946819|NCT01124149|588508119|FG000|Acute Phase|Non-compliance|1|||
162946820|NCT01124149|588508119|FG000|Acute Phase|Low hemoglobin|1|||
162946821|NCT01124149|588508119|FG000|Acute Phase|Travelling to another country|1|||
162946822|NCT01124149|588508119|FG000|Acute Phase|Sponsor decision|1|||
162946823|NCT01124149|588508119|FG000|Maintenance Phase|Lack of Efficacy|40|||
162946824|NCT01124149|588508119|FG000|Maintenance Phase|Adverse Event|24|||
162946825|NCT01124149|588508119|FG000|Maintenance Phase|Lost to Follow-up|15|||
162946826|NCT01124149|588508119|FG000|Maintenance Phase|Withdrawal by Subject|10|||
162946827|NCT01124149|588508119|FG000|Maintenance Phase|Protocol Violation|5|||
162946828|NCT01124149|588508119|FG000|Maintenance Phase|Coordinator error|1|||
162946829|NCT01124149|588508119|FG000|Maintenance Phase|Non-compliance|1|||
162946830|NCT00977106|588508120|FG000|Overall Study|Adverse Event|5|||
162946831|NCT00977106|588508121|FG001|Overall Study|Adverse Event|6|||
162946832|NCT00977106|588508120|FG000|Overall Study|Withdrawal by Subject|2|||
162946833|NCT00977106|588508121|FG001|Overall Study|Withdrawal by Subject|2|||
162946834|NCT00977106|588508120|FG000|Overall Study|Lack of Efficacy|2|||
162946835|NCT00977106|588508121|FG001|Overall Study|Lack of Efficacy|2|||
162946836|NCT00977106|588508120|FG000|Overall Study|Protocol Violation|0|||
162946837|NCT00977106|588508121|FG001|Overall Study|Protocol Violation|1|||
162946838|NCT00977106|588508120|FG000|Overall Study|Other|1|||
162946839|NCT00977106|588508121|FG001|Overall Study|Other|0|||
162946840|NCT01644500|588508122|FG000|Overall Study|Adverse Event|6|||
162946841|NCT01644500|588508123|FG001|Overall Study|Adverse Event|1|||
162946842|NCT01644500|588508124|FG002|Overall Study|Adverse Event|2|||
162946843|NCT01644500|588508122|FG000|Overall Study|Death|0|||
162946844|NCT01644500|588508123|FG001|Overall Study|Death|1|||
162946845|NCT01644500|588508124|FG002|Overall Study|Death|0|||
162946846|NCT01644500|588508122|FG000|Overall Study|Lost to Follow-up|3|||
162946847|NCT01644500|588508123|FG001|Overall Study|Lost to Follow-up|8|||
162946848|NCT01644500|588508124|FG002|Overall Study|Lost to Follow-up|0|||
162946849|NCT01644500|588508122|FG000|Overall Study|Protocol Violation|1|||
162946850|NCT01644500|588508123|FG001|Overall Study|Protocol Violation|1|||
162946851|NCT01644500|588508124|FG002|Overall Study|Protocol Violation|0|||
162946852|NCT01644500|588508122|FG000|Overall Study|Withdrawal by Subject|11|||
162946853|NCT01644500|588508123|FG001|Overall Study|Withdrawal by Subject|12|||
162946854|NCT01644500|588508124|FG002|Overall Study|Withdrawal by Subject|12|||
162946855|NCT01644500|588508122|FG000|Overall Study|Physician Decision|1|||
162946856|NCT01644500|588508123|FG001|Overall Study|Physician Decision|1|||
162946857|NCT01644500|588508124|FG002|Overall Study|Physician Decision|1|||
162946858|NCT05518487|588508127|FG000|Overall Study|Withdrawal by Subject|3|||
162946859|NCT00543309|588508128|FG000|Overall Study|Physician Decision|0|||
162946860|NCT00543309|588508129|FG001|Overall Study|Physician Decision|1|||
162946861|NCT00543309|588508130|FG002|Overall Study|Physician Decision|0|||
162946862|NCT05014412|588508137|FG000|Overall Study|Death|11|||
163291933|NCT03418324|589773219|FG000|Overall Study|Physician Decision|1|||
163291934|NCT03418324|589773220|FG001|Overall Study|Physician Decision|1|||
163291935|NCT01768676|589773221|FG000|Overall Study|Adverse Event|3|||
163291936|NCT01768676|589773222|FG001|Overall Study|Adverse Event|3|||
163291937|NCT01768676|589773221|FG000|Overall Study|Lost to Follow-up|13|||
163291938|NCT01768676|589773222|FG001|Overall Study|Lost to Follow-up|16|||
163291939|NCT01768676|589773221|FG000|Overall Study|Protocol Violation|1|||
163291940|NCT01768676|589773222|FG001|Overall Study|Protocol Violation|1|||
162946863|NCT05014412|588508138|FG001|Overall Study|Death|7|||
162946864|NCT05014412|588508139|FG002|Overall Study|Death|4|||
162946865|NCT05014412|588508140|FG003|Overall Study|Death|7|||
162946866|NCT05014412|588508137|FG000|Overall Study|Withdrawal by Subject|1|||
162946867|NCT05014412|588508138|FG001|Overall Study|Withdrawal by Subject|1|||
162946868|NCT05014412|588508139|FG002|Overall Study|Withdrawal by Subject|1|||
162946869|NCT05014412|588508140|FG003|Overall Study|Withdrawal by Subject|2|||
162946870|NCT05014412|588508137|FG000|Overall Study|Ongoing|21|||
163186462|NCT02943460|589400149|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
163186463|NCT02943460|589400147|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
163186464|NCT02943460|589400148|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
163186465|NCT02943460|589400149|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
163186466|NCT02943460|589400147|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
163186467|NCT02943460|589400148|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
163186468|NCT02943460|589400149|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
163186469|NCT00369122|589400150|FG000|Overall Study|Ineligible|10|||
163186470|NCT00369122|589400150|FG000|Overall Study|No protocol treatment|1|||
163186471|NCT04171765|589400151|FG000|Overall Study|Adverse Event|2|||
163186472|NCT04171765|589400152|FG001|Overall Study|Adverse Event|0|||
163186473|NCT04171765|589400153|FG002|Overall Study|Adverse Event|1|||
163186474|NCT04171765|589400154|FG003|Overall Study|Adverse Event|0|||
163186475|NCT04171765|589400151|FG000|Overall Study|Lost to Follow-up|0|||
163186476|NCT04171765|589400152|FG001|Overall Study|Lost to Follow-up|2|||
163186477|NCT04171765|589400153|FG002|Overall Study|Lost to Follow-up|2|||
163186478|NCT04171765|589400154|FG003|Overall Study|Lost to Follow-up|2|||
163186479|NCT04171765|589400151|FG000|Overall Study|Week 58 visit missed|0|||
163186480|NCT04171765|589400152|FG001|Overall Study|Week 58 visit missed|0|||
163186481|NCT04171765|589400153|FG002|Overall Study|Week 58 visit missed|1|||
163186482|NCT04171765|589400154|FG003|Overall Study|Week 58 visit missed|0|||
163186483|NCT04171765|589400151|FG000|Overall Study|Study terminated by sponsor|2|||
163186484|NCT04171765|589400152|FG001|Overall Study|Study terminated by sponsor|0|||
163186485|NCT04171765|589400153|FG002|Overall Study|Study terminated by sponsor|0|||
163186486|NCT04171765|589400154|FG003|Overall Study|Study terminated by sponsor|0|||
163186487|NCT04171765|589400151|FG000|Overall Study|Withdrawal by Subject|1|||
163186488|NCT04171765|589400152|FG001|Overall Study|Withdrawal by Subject|0|||
163186489|NCT04171765|589400153|FG002|Overall Study|Withdrawal by Subject|0|||
163186490|NCT04171765|589400154|FG003|Overall Study|Withdrawal by Subject|3|||
163186491|NCT03633617|589400155|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
163186492|NCT03633617|589400156|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
163186493|NCT03633617|589400157|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
163186494|NCT03633617|589400158|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
163186495|NCT03633617|589400159|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
163186496|NCT03633617|589400160|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
163186497|NCT03633617|589400161|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
163186498|NCT03633617|589400162|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
163186499|NCT03633617|589400163|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
163186500|NCT03633617|589400164|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
163186501|NCT03633617|589400165|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
163186502|NCT03633617|589400155|FG000|Part A|Unconfirmed early termination visit|1|||
163186503|NCT03633617|589400156|FG001|Part A|Unconfirmed early termination visit|0|||
163186504|NCT03633617|589400157|FG002|Part A|Unconfirmed early termination visit|0|||
163186505|NCT03633617|589400158|FG003|Part A|Unconfirmed early termination visit|0|||
163186506|NCT03633617|589400159|FG004|Part A|Unconfirmed early termination visit|0|||
163186507|NCT03633617|589400160|FG005|Part A|Unconfirmed early termination visit|0|||
163186508|NCT03633617|589400161|FG006|Part A|Unconfirmed early termination visit|0|||
163186509|NCT03633617|589400162|FG007|Part A|Unconfirmed early termination visit|0|||
163186510|NCT03633617|589400163|FG008|Part A|Unconfirmed early termination visit|0|||
163186511|NCT03633617|589400164|FG009|Part A|Unconfirmed early termination visit|0|||
163186512|NCT03633617|589400165|FG010|Part A|Unconfirmed early termination visit|0|||
163186513|NCT03633617|589400155|FG000|Part A|Adverse Event|0|||
163186514|NCT03633617|589400156|FG001|Part A|Adverse Event|1|||
163186515|NCT03633617|589400157|FG002|Part A|Adverse Event|0|||
163186516|NCT03633617|589400158|FG003|Part A|Adverse Event|0|||
163186517|NCT03633617|589400159|FG004|Part A|Adverse Event|0|||
163186518|NCT03633617|589400160|FG005|Part A|Adverse Event|0|||
163291941|NCT01768676|589773221|FG000|Overall Study|Physician Decision|4|||
163291942|NCT01768676|589773222|FG001|Overall Study|Physician Decision|1|||
163291943|NCT01768676|589773221|FG000|Overall Study|Withdrawal by Subject|3|||
163291944|NCT01768676|589773222|FG001|Overall Study|Withdrawal by Subject|10|||
163291945|NCT00605033|589773223|FG000|Overall Study|Adverse Event|2|||
163291946|NCT00605033|589773224|FG001|Overall Study|Adverse Event|2|||
163291947|NCT00605033|589773223|FG000|Overall Study|Lost to Follow-up|1|||
163291948|NCT00605033|589773224|FG001|Overall Study|Lost to Follow-up|1|||
163291949|NCT00605033|589773223|FG000|Overall Study|Withdrawal by Subject|3|||
162946871|NCT05014412|588508138|FG001|Overall Study|Ongoing|4|||
162946872|NCT05014412|588508139|FG002|Overall Study|Ongoing|6|||
163291950|NCT00605033|589773224|FG001|Overall Study|Withdrawal by Subject|4|||
163291951|NCT00605033|589773223|FG000|Overall Study|Protocol Violation|1|||
163291952|NCT00605033|589773224|FG001|Overall Study|Protocol Violation|1|||
163291953|NCT03121950|589773225|FG000|Overall Study|Withdrawal by Subject|11|||
163291954|NCT03121950|589773226|FG001|Overall Study|Withdrawal by Subject|2|||
163291955|NCT05147233|589775224|FG000|Overall Study|Adverse Event|0|||
163291956|NCT05147233|589775225|FG001|Overall Study|Adverse Event|1|||
163291957|NCT05147233|589775224|FG000|Overall Study|Lost to Follow-up|1|||
163291958|NCT05147233|589775225|FG001|Overall Study|Lost to Follow-up|1|||
163291959|NCT05147233|589775224|FG000|Overall Study|Protocol Violation|0|||
163291960|NCT05147233|589775225|FG001|Overall Study|Protocol Violation|1|||
163291961|NCT05147233|589775224|FG000|Overall Study|Withdrawal by Subject|2|||
163291962|NCT05147233|589775225|FG001|Overall Study|Withdrawal by Subject|1|||
163291963|NCT04513522|589775226|FG000|Overall Study|Other reasons|1|||
163291964|NCT04513522|589775226|FG000|Overall Study|Adverse event unrelated to study drug|9|||
163291965|NCT04513522|589775226|FG000|Overall Study|Study drug toxicity|14|||
162946873|NCT05014412|588508140|FG003|Overall Study|Ongoing|20|||
162946874|NCT02353169|588508141|FG000|Overall Study|QTc > 450 msec|1|||
162946875|NCT02353169|588508142|FG001|Overall Study|QTc > 450 msec|1|||
162946876|NCT02353169|588508143|FG002|Overall Study|QTc > 450 msec|1|||
162946877|NCT02353169|588508144|FG003|Overall Study|QTc > 450 msec|1|||
162946878|NCT02353169|588508141|FG000|Overall Study|OR team declined|2|||
162946879|NCT02353169|588508142|FG001|Overall Study|OR team declined|0|||
162946880|NCT02353169|588508143|FG002|Overall Study|OR team declined|0|||
162946881|NCT02353169|588508144|FG003|Overall Study|OR team declined|0|||
163186519|NCT03633617|589400161|FG006|Part A|Adverse Event|0|||
163291966|NCT04513522|589775226|FG000|Overall Study|Disease progression|39|||
162946882|NCT02353169|588508141|FG000|Overall Study|Inhalational induction|0|||
162946883|NCT02353169|588508142|FG001|Overall Study|Inhalational induction|2|||
163186520|NCT03633617|589400162|FG007|Part A|Adverse Event|0|||
163186521|NCT03633617|589400163|FG008|Part A|Adverse Event|0|||
163186522|NCT03633617|589400164|FG009|Part A|Adverse Event|0|||
163186523|NCT03633617|589400165|FG010|Part A|Adverse Event|0|||
163186524|NCT03633617|589400155|FG000|Part A|Pregnancy|1|||
163186525|NCT03633617|589400156|FG001|Part A|Pregnancy|0|||
163186526|NCT03633617|589400157|FG002|Part A|Pregnancy|0|||
163186527|NCT03633617|589400158|FG003|Part A|Pregnancy|0|||
163186528|NCT03633617|589400159|FG004|Part A|Pregnancy|0|||
163186529|NCT03633617|589400160|FG005|Part A|Pregnancy|0|||
163186530|NCT03633617|589400161|FG006|Part A|Pregnancy|0|||
163186531|NCT03633617|589400162|FG007|Part A|Pregnancy|0|||
163186532|NCT03633617|589400163|FG008|Part A|Pregnancy|0|||
163186533|NCT03633617|589400164|FG009|Part A|Pregnancy|0|||
163186534|NCT03633617|589400165|FG010|Part A|Pregnancy|0|||
163186535|NCT03633617|589400155|FG000|Part A|Withdrawal by Subject|0|||
163186536|NCT03633617|589400156|FG001|Part A|Withdrawal by Subject|1|||
163186537|NCT03633617|589400157|FG002|Part A|Withdrawal by Subject|0|||
163186538|NCT03633617|589400158|FG003|Part A|Withdrawal by Subject|0|||
163186539|NCT03633617|589400159|FG004|Part A|Withdrawal by Subject|0|||
163186540|NCT03633617|589400160|FG005|Part A|Withdrawal by Subject|0|||
163186541|NCT03633617|589400161|FG006|Part A|Withdrawal by Subject|0|||
163186542|NCT03633617|589400162|FG007|Part A|Withdrawal by Subject|0|||
162946884|NCT02353169|588508143|FG002|Overall Study|Inhalational induction|0|||
162946885|NCT02353169|588508144|FG003|Overall Study|Inhalational induction|0|||
162946886|NCT02353169|588508141|FG000|Overall Study|ECG data error|0|||
163186543|NCT03633617|589400163|FG008|Part A|Withdrawal by Subject|0|||
163186544|NCT03633617|589400164|FG009|Part A|Withdrawal by Subject|0|||
163291967|NCT04513522|589775226|FG000|Overall Study|Participants withdrew consent|2|||
163291968|NCT04517864|589775229|FG000|Placebo-Controlled Phase|Adverse Event|1|||
162946887|NCT02353169|588508142|FG001|Overall Study|ECG data error|3|||
162946888|NCT02353169|588508143|FG002|Overall Study|ECG data error|2|||
163186545|NCT03633617|589400165|FG010|Part A|Withdrawal by Subject|0|||
163186546|NCT03633617|589400155|FG000|Part B|Adverse Event|0|||
163186547|NCT03633617|589400156|FG001|Part B|Adverse Event|0|||
163186548|NCT03633617|589400157|FG002|Part B|Adverse Event|2|||
163186549|NCT03633617|589400158|FG003|Part B|Adverse Event|2|||
163186550|NCT03633617|589400159|FG004|Part B|Adverse Event|1|||
163186551|NCT03633617|589400160|FG005|Part B|Adverse Event|0|||
163186552|NCT03633617|589400161|FG006|Part B|Adverse Event|0|||
163186553|NCT03633617|589400162|FG007|Part B|Adverse Event|0|||
163186554|NCT03633617|589400163|FG008|Part B|Adverse Event|0|||
163291969|NCT04517864|589775230|FG001|Placebo-Controlled Phase|Adverse Event|0|||
163186555|NCT03633617|589400164|FG009|Part B|Adverse Event|0|||
163186556|NCT03633617|589400165|FG010|Part B|Adverse Event|0|||
163186557|NCT03633617|589400155|FG000|Part B|Withdrawal by Subject|0|||
163186558|NCT03633617|589400156|FG001|Part B|Withdrawal by Subject|0|||
163186559|NCT03633617|589400157|FG002|Part B|Withdrawal by Subject|1|||
163186560|NCT03633617|589400158|FG003|Part B|Withdrawal by Subject|0|||
163186561|NCT03633617|589400159|FG004|Part B|Withdrawal by Subject|2|||
163186562|NCT03633617|589400160|FG005|Part B|Withdrawal by Subject|0|||
163186563|NCT03633617|589400161|FG006|Part B|Withdrawal by Subject|0|||
163186564|NCT03633617|589400162|FG007|Part B|Withdrawal by Subject|0|||
163186565|NCT03633617|589400163|FG008|Part B|Withdrawal by Subject|0|||
163186566|NCT03633617|589400164|FG009|Part B|Withdrawal by Subject|0|||
163186567|NCT03633617|589400165|FG010|Part B|Withdrawal by Subject|0|||
163186568|NCT03633617|589400155|FG000|Part B|Lost to Follow-up|0|||
163186569|NCT03633617|589400156|FG001|Part B|Lost to Follow-up|0|||
163186570|NCT03633617|589400157|FG002|Part B|Lost to Follow-up|0|||
163186571|NCT03633617|589400158|FG003|Part B|Lost to Follow-up|0|||
163186572|NCT03633617|589400159|FG004|Part B|Lost to Follow-up|1|||
163186573|NCT03633617|589400160|FG005|Part B|Lost to Follow-up|0|||
163186574|NCT03633617|589400161|FG006|Part B|Lost to Follow-up|0|||
163186575|NCT03633617|589400162|FG007|Part B|Lost to Follow-up|0|||
163186576|NCT03633617|589400163|FG008|Part B|Lost to Follow-up|0|||
163186577|NCT03633617|589400164|FG009|Part B|Lost to Follow-up|0|||
163186578|NCT03633617|589400165|FG010|Part B|Lost to Follow-up|0|||
163186579|NCT03633617|589400155|FG000|Part B|Physician Decision|0|||
163186580|NCT03633617|589400156|FG001|Part B|Physician Decision|0|||
163186581|NCT03633617|589400157|FG002|Part B|Physician Decision|0|||
163186582|NCT03633617|589400158|FG003|Part B|Physician Decision|0|||
163186583|NCT03633617|589400159|FG004|Part B|Physician Decision|1|||
163186584|NCT03633617|589400160|FG005|Part B|Physician Decision|0|||
163186585|NCT03633617|589400161|FG006|Part B|Physician Decision|0|||
163186586|NCT03633617|589400162|FG007|Part B|Physician Decision|0|||
163186587|NCT03633617|589400163|FG008|Part B|Physician Decision|0|||
163186588|NCT03633617|589400164|FG009|Part B|Physician Decision|0|||
163186589|NCT03633617|589400165|FG010|Part B|Physician Decision|0|||
163186590|NCT03633617|589400155|FG000|Part B|COVID-19 Restrictions|0|||
163186591|NCT03633617|589400156|FG001|Part B|COVID-19 Restrictions|0|||
163186592|NCT03633617|589400157|FG002|Part B|COVID-19 Restrictions|1|||
163186593|NCT03633617|589400158|FG003|Part B|COVID-19 Restrictions|0|||
163186594|NCT03633617|589400159|FG004|Part B|COVID-19 Restrictions|0|||
163186595|NCT03633617|589400160|FG005|Part B|COVID-19 Restrictions|0|||
163186596|NCT03633617|589400161|FG006|Part B|COVID-19 Restrictions|0|||
163186597|NCT03633617|589400162|FG007|Part B|COVID-19 Restrictions|0|||
163186598|NCT03633617|589400163|FG008|Part B|COVID-19 Restrictions|0|||
163186599|NCT03633617|589400164|FG009|Part B|COVID-19 Restrictions|0|||
163186600|NCT03633617|589400165|FG010|Part B|COVID-19 Restrictions|0|||
163186601|NCT03633617|589400155|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
163186602|NCT03633617|589400156|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
163186603|NCT03633617|589400157|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
163186604|NCT03633617|589400158|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
163186605|NCT03633617|589400159|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
163186606|NCT03633617|589400160|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
163186607|NCT03633617|589400161|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
163186608|NCT03633617|589400162|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
163186609|NCT03633617|589400163|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
163186610|NCT03633617|589400164|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
163186611|NCT03633617|589400165|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
163186612|NCT03633617|589400155|FG000|Part C (& Follow-up)|Adverse Event|0|||
163186613|NCT03633617|589400156|FG001|Part C (& Follow-up)|Adverse Event|0|||
163186614|NCT03633617|589400157|FG002|Part C (& Follow-up)|Adverse Event|0|||
163186615|NCT03633617|589400158|FG003|Part C (& Follow-up)|Adverse Event|0|||
163186616|NCT03633617|589400159|FG004|Part C (& Follow-up)|Adverse Event|0|||
163186617|NCT03633617|589400160|FG005|Part C (& Follow-up)|Adverse Event|1|||
163291970|NCT04517864|589775231|FG002|Placebo-Controlled Phase|Adverse Event|0|||
163291971|NCT04517864|589775229|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
163186618|NCT03633617|589400161|FG006|Part C (& Follow-up)|Adverse Event|0|||
163186619|NCT03633617|589400162|FG007|Part C (& Follow-up)|Adverse Event|1|||
163186620|NCT03633617|589400163|FG008|Part C (& Follow-up)|Adverse Event|0|||
163186621|NCT03633617|589400164|FG009|Part C (& Follow-up)|Adverse Event|0|||
163186622|NCT03633617|589400165|FG010|Part C (& Follow-up)|Adverse Event|0|||
163186623|NCT03633617|589400155|FG000|Part C (& Follow-up)|Pregnancy|0|||
163186624|NCT03633617|589400156|FG001|Part C (& Follow-up)|Pregnancy|0|||
163186625|NCT03633617|589400157|FG002|Part C (& Follow-up)|Pregnancy|0|||
163186626|NCT03633617|589400158|FG003|Part C (& Follow-up)|Pregnancy|0|||
163186627|NCT03633617|589400159|FG004|Part C (& Follow-up)|Pregnancy|0|||
163186628|NCT03633617|589400160|FG005|Part C (& Follow-up)|Pregnancy|0|||
162946889|NCT02353169|588508144|FG003|Overall Study|ECG data error|2|||
162946890|NCT02353169|588508141|FG000|Overall Study|Pre-op medication|0|||
162946891|NCT02353169|588508142|FG001|Overall Study|Pre-op medication|0|||
162946892|NCT02353169|588508143|FG002|Overall Study|Pre-op medication|1|||
162946893|NCT02353169|588508144|FG003|Overall Study|Pre-op medication|0|||
162946894|NCT00486837|588508145|FG000|Overall Study|Withdrawal by Subject|1|||
162946895|NCT00486837|588508146|FG001|Overall Study|Withdrawal by Subject|0|||
162946896|NCT00486837|588508145|FG000|Overall Study|Adverse Event|1|||
162946897|NCT00486837|588508146|FG001|Overall Study|Adverse Event|1|||
162946898|NCT00486837|588508145|FG000|Overall Study|Protocol Violation|4|||
162946899|NCT00486837|588508146|FG001|Overall Study|Protocol Violation|2|||
162946900|NCT00486837|588508145|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
162946901|NCT00486837|588508146|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
162946902|NCT05295953|588508147|FG000|Overall Study|Withdrawal by Subject|0|||
162946903|NCT05295953|588508148|FG001|Overall Study|Withdrawal by Subject|1|||
162946904|NCT04981912|588508150|FG000|Overall Study|Physician Decision|2|||
162946905|NCT05630547|588508153|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
162946906|NCT05630547|588508154|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
162946907|NCT05630547|588508155|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
162946908|NCT05630547|588508156|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
162946909|NCT05630547|588508153|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
162946910|NCT05630547|588508154|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
162946911|NCT05630547|588508155|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
162946912|NCT05630547|588508156|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
162946913|NCT05630547|588508153|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
162946914|NCT05630547|588508154|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
162946915|NCT05630547|588508155|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
162946916|NCT05630547|588508156|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
162946917|NCT05630547|588508153|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
162946918|NCT05630547|588508154|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
162946919|NCT05630547|588508155|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
162946920|NCT05630547|588508156|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
162946921|NCT05630547|588508153|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
162946922|NCT05630547|588508154|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
162946923|NCT05630547|588508155|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
162946924|NCT05630547|588508156|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
162946925|NCT05630547|588508153|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
162946926|NCT05630547|588508154|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
162946927|NCT05630547|588508155|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
162946928|NCT05630547|588508156|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
162946929|NCT05630547|588508153|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
162946930|NCT05630547|588508154|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
162946931|NCT05630547|588508155|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
162946932|NCT05630547|588508156|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
162946933|NCT05630547|588508153|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
163186629|NCT03633617|589400161|FG006|Part C (& Follow-up)|Pregnancy|0|||
163186630|NCT03633617|589400162|FG007|Part C (& Follow-up)|Pregnancy|0|||
163186631|NCT03633617|589400163|FG008|Part C (& Follow-up)|Pregnancy|0|||
163186632|NCT03633617|589400164|FG009|Part C (& Follow-up)|Pregnancy|1|||
163186633|NCT03633617|589400165|FG010|Part C (& Follow-up)|Pregnancy|0|||
163186634|NCT03633617|589400155|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
163387991|NCT01585987|590131977|FG000|Randomized|Withdrawal by Subject|0|||
163186635|NCT03633617|589400156|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
163387992|NCT01585987|590131978|FG001|Randomized|Withdrawal by Subject|4|||
163387993|NCT01585987|590131977|FG000|Randomized|No longer met criteria|0|||
163387994|NCT01585987|590131978|FG001|Randomized|No longer met criteria|2|||
163387995|NCT01585987|590131977|FG000|Treated|Disease Progression|39|||
163387996|NCT01585987|590131978|FG001|Treated|Disease Progression|36|||
163387997|NCT01585987|590131977|FG000|Treated|Study Drug Toxicity|9|||
163387998|NCT01585987|590131978|FG001|Treated|Study Drug Toxicity|5|||
163387999|NCT01585987|590131977|FG000|Treated|Adverse Event|3|||
162946934|NCT05630547|588508154|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
162946935|NCT05630547|588508155|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
162946936|NCT05630547|588508156|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
162946937|NCT05630547|588508153|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
162946938|NCT05630547|588508154|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
162946939|NCT05630547|588508155|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
162946940|NCT05630547|588508156|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
162946941|NCT05630547|588508153|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
162946942|NCT05630547|588508154|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
162946943|NCT05630547|588508155|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
163186636|NCT03633617|589400157|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
163186637|NCT03633617|589400158|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
163186638|NCT03633617|589400159|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
163186639|NCT03633617|589400160|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
163186640|NCT03633617|589400161|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
163186641|NCT03633617|589400162|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
163186642|NCT03633617|589400163|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
163186643|NCT03633617|589400164|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
163186644|NCT03633617|589400165|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
163186645|NCT03633617|589400155|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
163186646|NCT03633617|589400156|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
163186647|NCT03633617|589400157|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
163186648|NCT03633617|589400158|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
163186649|NCT03633617|589400159|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
163186650|NCT03633617|589400160|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
163186651|NCT03633617|589400161|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
163186652|NCT03633617|589400162|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
163186653|NCT03633617|589400163|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
163186654|NCT03633617|589400164|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
163186655|NCT03633617|589400165|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
163186656|NCT03633617|589400155|FG000|Part C (& Follow-up)|Physician Decision|0|||
163186657|NCT03633617|589400156|FG001|Part C (& Follow-up)|Physician Decision|0|||
163186658|NCT03633617|589400157|FG002|Part C (& Follow-up)|Physician Decision|0|||
163186659|NCT03633617|589400158|FG003|Part C (& Follow-up)|Physician Decision|0|||
163186660|NCT03633617|589400159|FG004|Part C (& Follow-up)|Physician Decision|0|||
163186661|NCT03633617|589400160|FG005|Part C (& Follow-up)|Physician Decision|0|||
163186662|NCT03633617|589400161|FG006|Part C (& Follow-up)|Physician Decision|0|||
163186663|NCT03633617|589400162|FG007|Part C (& Follow-up)|Physician Decision|1|||
163186664|NCT03633617|589400163|FG008|Part C (& Follow-up)|Physician Decision|0|||
163186665|NCT03633617|589400164|FG009|Part C (& Follow-up)|Physician Decision|0|||
163186666|NCT03633617|589400165|FG010|Part C (& Follow-up)|Physician Decision|1|||
163186667|NCT03633617|589400155|FG000|Part C (& Follow-up)|COVID-19 related|0|||
163186668|NCT03633617|589400156|FG001|Part C (& Follow-up)|COVID-19 related|0|||
163186669|NCT03633617|589400157|FG002|Part C (& Follow-up)|COVID-19 related|0|||
163186670|NCT03633617|589400158|FG003|Part C (& Follow-up)|COVID-19 related|0|||
163186671|NCT03633617|589400159|FG004|Part C (& Follow-up)|COVID-19 related|0|||
163186672|NCT03633617|589400160|FG005|Part C (& Follow-up)|COVID-19 related|1|||
163186673|NCT03633617|589400161|FG006|Part C (& Follow-up)|COVID-19 related|0|||
163186674|NCT03633617|589400162|FG007|Part C (& Follow-up)|COVID-19 related|0|||
163186675|NCT03633617|589400163|FG008|Part C (& Follow-up)|COVID-19 related|0|||
163186676|NCT03633617|589400164|FG009|Part C (& Follow-up)|COVID-19 related|0|||
163186677|NCT03633617|589400165|FG010|Part C (& Follow-up)|COVID-19 related|0|||
163186678|NCT03633617|589400155|FG000|Part C (& Follow-up)|Protocol Violation|0|||
163186679|NCT03633617|589400156|FG001|Part C (& Follow-up)|Protocol Violation|0|||
163186680|NCT03633617|589400157|FG002|Part C (& Follow-up)|Protocol Violation|0|||
163186681|NCT03633617|589400158|FG003|Part C (& Follow-up)|Protocol Violation|0|||
163186682|NCT03633617|589400159|FG004|Part C (& Follow-up)|Protocol Violation|0|||
163186683|NCT03633617|589400160|FG005|Part C (& Follow-up)|Protocol Violation|0|||
163186684|NCT03633617|589400161|FG006|Part C (& Follow-up)|Protocol Violation|0|||
163186685|NCT03633617|589400162|FG007|Part C (& Follow-up)|Protocol Violation|0|||
163186686|NCT03633617|589400163|FG008|Part C (& Follow-up)|Protocol Violation|0|||
163186687|NCT03633617|589400164|FG009|Part C (& Follow-up)|Protocol Violation|3|||
163186688|NCT03633617|589400165|FG010|Part C (& Follow-up)|Protocol Violation|1|||
163186689|NCT03633617|589400155|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
163186690|NCT03633617|589400156|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
163186691|NCT03633617|589400157|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
163186692|NCT03633617|589400158|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
163186693|NCT03633617|589400159|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
163186694|NCT03633617|589400160|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
163186695|NCT03633617|589400161|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
163186696|NCT03633617|589400162|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
163388000|NCT01585987|590131978|FG001|Treated|Adverse Event|0|||
162946944|NCT05630547|588508156|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
162946945|NCT05049460|588508157|FG000|Overall Study|Withdrawal by Subject|2|||
162946946|NCT05049460|588508158|FG001|Overall Study|Withdrawal by Subject|2|||
162946947|NCT05049460|588508157|FG000|Overall Study|Lost to Follow-up|2|||
162946948|NCT05049460|588508158|FG001|Overall Study|Lost to Follow-up|2|||
162946949|NCT00368277|588508161|FG000|Overall Study|Adverse Event|33|||
162946950|NCT00368277|588508162|FG001|Overall Study|Adverse Event|49|||
162946951|NCT00368277|588508161|FG000|Overall Study|Death|2|||
162946952|NCT00368277|588508162|FG001|Overall Study|Death|1|||
162946953|NCT00368277|588508161|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
162946954|NCT00368277|588508162|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
162946955|NCT00368277|588508161|FG000|Overall Study|Protocol deviation|7|||
162946956|NCT00368277|588508162|FG001|Overall Study|Protocol deviation|0|||
162946957|NCT00368277|588508161|FG000|Overall Study|Patient withdrew consent|32|||
162946958|NCT00368277|588508162|FG001|Overall Study|Patient withdrew consent|28|||
162946959|NCT00368277|588508161|FG000|Overall Study|Lost to Follow-up|8|||
162946960|NCT00368277|588508162|FG001|Overall Study|Lost to Follow-up|6|||
162946961|NCT00117949|588508165|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
162946962|NCT00117949|588508166|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
162946963|NCT00117949|588508167|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
162946964|NCT00117949|588508168|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
162946965|NCT00117949|588508165|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
162946966|NCT00117949|588508166|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
162946967|NCT00117949|588508167|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
162946968|NCT00117949|588508168|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
162946969|NCT00117949|588508165|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
162946970|NCT00117949|588508166|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
162946971|NCT00117949|588508167|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
162946972|NCT00117949|588508168|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
162946973|NCT00117949|588508165|FG000|Overall Study|PSA increase >=10ng/mL|0|||
162946974|NCT00117949|588508166|FG001|Overall Study|PSA increase >=10ng/mL|1|||
162946975|NCT00117949|588508167|FG002|Overall Study|PSA increase >=10ng/mL|1|||
162946976|NCT00117949|588508168|FG003|Overall Study|PSA increase >=10ng/mL|0|||
162946977|NCT00117949|588508165|FG000|Overall Study|PSA reduction <=50%|0|||
162946978|NCT00117949|588508166|FG001|Overall Study|PSA reduction <=50%|2|||
162946979|NCT00117949|588508167|FG002|Overall Study|PSA reduction <=50%|2|||
162946980|NCT00117949|588508168|FG003|Overall Study|PSA reduction <=50%|4|||
162946981|NCT00117949|588508165|FG000|Overall Study|Hepatic abnormalities|0|||
162946982|NCT00117949|588508166|FG001|Overall Study|Hepatic abnormalities|1|||
162946983|NCT00117949|588508167|FG002|Overall Study|Hepatic abnormalities|0|||
162946984|NCT00117949|588508168|FG003|Overall Study|Hepatic abnormalities|1|||
162946985|NCT01974141|588508169|FG000|Overall Study|Other Reasons|28|||
162946986|NCT01974141|588508170|FG001|Overall Study|Other Reasons|18|||
162946987|NCT01974141|588508169|FG000|Overall Study|Protocol Violation|2|||
163186697|NCT03633617|589400163|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
163186698|NCT03633617|589400164|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
163186699|NCT03633617|589400165|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
163186700|NCT00809354|589400168|FG000|Overall Study|Adverse Event|32|||
163186701|NCT00809354|589400169|FG001|Overall Study|Adverse Event|45|||
163186702|NCT00809354|589400170|FG002|Overall Study|Adverse Event|37|||
163186703|NCT00809354|589400171|FG003|Overall Study|Adverse Event|53|||
163186704|NCT00809354|589400172|FG004|Overall Study|Adverse Event|26|||
163186705|NCT00809354|589400173|FG005|Overall Study|Adverse Event|33|||
163186706|NCT00809354|589400174|FG006|Overall Study|Adverse Event|44|||
163186707|NCT00809354|589400175|FG007|Overall Study|Adverse Event|40|||
163186708|NCT00809354|589400176|FG008|Overall Study|Adverse Event|46|||
163186709|NCT00809354|589400177|FG009|Overall Study|Adverse Event|26|||
163186710|NCT00809354|589400168|FG000|Overall Study|Lack of Efficacy|23|||
163186711|NCT00809354|589400169|FG001|Overall Study|Lack of Efficacy|23|||
163186712|NCT00809354|589400170|FG002|Overall Study|Lack of Efficacy|22|||
163186713|NCT00809354|589400171|FG003|Overall Study|Lack of Efficacy|15|||
163186714|NCT00809354|589400172|FG004|Overall Study|Lack of Efficacy|40|||
163186715|NCT00809354|589400173|FG005|Overall Study|Lack of Efficacy|19|||
163186716|NCT00809354|589400174|FG006|Overall Study|Lack of Efficacy|21|||
162946988|NCT01974141|588508170|FG001|Overall Study|Protocol Violation|6|||
162946989|NCT01974141|588508169|FG000|Overall Study|Personal Reasons|21|||
162946990|NCT01974141|588508170|FG001|Overall Study|Personal Reasons|20|||
162946991|NCT01974141|588508169|FG000|Overall Study|Lost to Follow-up|38|||
162946992|NCT01974141|588508170|FG001|Overall Study|Lost to Follow-up|29|||
162946993|NCT01974141|588508169|FG000|Overall Study|Pregnancy|3|||
162946994|NCT01974141|588508170|FG001|Overall Study|Pregnancy|3|||
162946995|NCT01974141|588508169|FG000|Overall Study|Lack of Efficacy|0|||
163186717|NCT00809354|589400175|FG007|Overall Study|Lack of Efficacy|15|||
163186718|NCT00809354|589400176|FG008|Overall Study|Lack of Efficacy|18|||
163186719|NCT00809354|589400177|FG009|Overall Study|Lack of Efficacy|38|||
163186720|NCT00809354|589400168|FG000|Overall Study|Lost to Follow-up|10|||
163186721|NCT00809354|589400169|FG001|Overall Study|Lost to Follow-up|11|||
163186722|NCT00809354|589400170|FG002|Overall Study|Lost to Follow-up|8|||
162946996|NCT01974141|588508170|FG001|Overall Study|Lack of Efficacy|1|||
162946997|NCT01974141|588508169|FG000|Overall Study|Adverse Event|4|||
163291972|NCT04517864|589775230|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
163291973|NCT04517864|589775231|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
163291974|NCT04517864|589775229|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
163291975|NCT04517864|589775230|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
163291976|NCT04517864|589775231|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
163291977|NCT04517864|589775229|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
163291978|NCT04517864|589775230|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
163291979|NCT04517864|589775231|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
163291980|NCT04517864|589775229|FG000|Active Therapy Extension Phase|Adverse Event|1|||
163291981|NCT04517864|589775230|FG001|Active Therapy Extension Phase|Adverse Event|0|||
163291982|NCT04517864|589775231|FG002|Active Therapy Extension Phase|Adverse Event|0|||
163291983|NCT04517864|589775229|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
163291984|NCT04517864|589775230|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
163291985|NCT04517864|589775231|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
163291986|NCT04517864|589775229|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
163291987|NCT04517864|589775230|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
163291988|NCT04517864|589775231|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
163291989|NCT04517864|589775229|FG000|Active Therapy Extension Phase|Physician Decision|1|||
163291990|NCT04517864|589775230|FG001|Active Therapy Extension Phase|Physician Decision|0|||
163291991|NCT04517864|589775231|FG002|Active Therapy Extension Phase|Physician Decision|0|||
163291992|NCT04517864|589775229|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
162946998|NCT01974141|588508170|FG001|Overall Study|Adverse Event|5|||
162946999|NCT04028843|588508171|FG000|Overall Study|Lost to Follow-up|32|||
163186723|NCT00809354|589400171|FG003|Overall Study|Lost to Follow-up|13|||
163186724|NCT00809354|589400172|FG004|Overall Study|Lost to Follow-up|6|||
163186725|NCT00809354|589400173|FG005|Overall Study|Lost to Follow-up|2|||
163186726|NCT00809354|589400174|FG006|Overall Study|Lost to Follow-up|0|||
163186727|NCT00809354|589400175|FG007|Overall Study|Lost to Follow-up|5|||
163186728|NCT00809354|589400176|FG008|Overall Study|Lost to Follow-up|4|||
163186729|NCT00809354|589400177|FG009|Overall Study|Lost to Follow-up|0|||
163186730|NCT00809354|589400168|FG000|Overall Study|Protocol Violation|7|||
163186731|NCT00809354|589400169|FG001|Overall Study|Protocol Violation|14|||
163186732|NCT00809354|589400170|FG002|Overall Study|Protocol Violation|14|||
163186733|NCT00809354|589400171|FG003|Overall Study|Protocol Violation|12|||
163186734|NCT00809354|589400172|FG004|Overall Study|Protocol Violation|14|||
163186735|NCT00809354|589400173|FG005|Overall Study|Protocol Violation|6|||
163186736|NCT00809354|589400174|FG006|Overall Study|Protocol Violation|4|||
163186737|NCT00809354|589400175|FG007|Overall Study|Protocol Violation|6|||
163186738|NCT00809354|589400176|FG008|Overall Study|Protocol Violation|9|||
163186739|NCT00809354|589400177|FG009|Overall Study|Protocol Violation|3|||
163186740|NCT00809354|589400168|FG000|Overall Study|Withdrawal by Subject|32|||
163186741|NCT00809354|589400169|FG001|Overall Study|Withdrawal by Subject|27|||
163186742|NCT00809354|589400170|FG002|Overall Study|Withdrawal by Subject|31|||
163186743|NCT00809354|589400171|FG003|Overall Study|Withdrawal by Subject|33|||
163186744|NCT00809354|589400172|FG004|Overall Study|Withdrawal by Subject|34|||
163186745|NCT00809354|589400173|FG005|Overall Study|Withdrawal by Subject|29|||
163186746|NCT00809354|589400174|FG006|Overall Study|Withdrawal by Subject|27|||
163186747|NCT00809354|589400175|FG007|Overall Study|Withdrawal by Subject|19|||
163186748|NCT00809354|589400176|FG008|Overall Study|Withdrawal by Subject|18|||
163291993|NCT04517864|589775230|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
163291994|NCT04517864|589775231|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
163291995|NCT04517864|589775229|FG000|Extension Phase|Adverse Event|0|||
163186749|NCT00809354|589400177|FG009|Overall Study|Withdrawal by Subject|20|||
163186750|NCT00809354|589400168|FG000|Overall Study|Other|10|||
163186751|NCT00809354|589400169|FG001|Overall Study|Other|2|||
163186752|NCT00809354|589400170|FG002|Overall Study|Other|7|||
163186753|NCT00809354|589400171|FG003|Overall Study|Other|10|||
163186754|NCT00809354|589400172|FG004|Overall Study|Other|5|||
163186755|NCT00809354|589400173|FG005|Overall Study|Other|3|||
163291996|NCT04517864|589775230|FG001|Extension Phase|Adverse Event|0|||
163291997|NCT04517864|589775231|FG002|Extension Phase|Adverse Event|1|||
163291998|NCT04517864|589775229|FG000|Extension Phase|Lack of Efficacy|0|||
163291999|NCT04517864|589775230|FG001|Extension Phase|Lack of Efficacy|0|||
163292000|NCT04517864|589775231|FG002|Extension Phase|Lack of Efficacy|2|||
163292001|NCT04517864|589775229|FG000|Extension Phase|Study Terminated By Sponsor|0|||
163292002|NCT04517864|589775230|FG001|Extension Phase|Study Terminated By Sponsor|0|||
163292003|NCT04517864|589775231|FG002|Extension Phase|Study Terminated By Sponsor|32|||
163292004|NCT04517864|589775229|FG000|Extension Phase|Withdrawal by Subject|0|||
163292005|NCT04517864|589775230|FG001|Extension Phase|Withdrawal by Subject|0|||
163292006|NCT04517864|589775231|FG002|Extension Phase|Withdrawal by Subject|3|||
163292007|NCT04517864|589775229|FG000|Extension Phase|Approved Drug Available for Indication|0|||
163292008|NCT04517864|589775230|FG001|Extension Phase|Approved Drug Available for Indication|0|||
163292009|NCT04517864|589775231|FG002|Extension Phase|Approved Drug Available for Indication|7|||
163292010|NCT04722003|589775234|FG000|Overall Study|Lost to Follow-up|2|||
163292011|NCT04722003|589775235|FG001|Overall Study|Lost to Follow-up|0|||
163292012|NCT04722003|589775234|FG000|Overall Study|Physician Decision|1|||
163292013|NCT04722003|589775235|FG001|Overall Study|Physician Decision|0|||
163292014|NCT03351075|589775236|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
163292015|NCT03351075|589775237|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
163292016|NCT03351075|589775236|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
163292017|NCT03351075|589775237|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
163292018|NCT03351075|589775236|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
163292019|NCT03351075|589775237|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
163292020|NCT03351075|589775236|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
163292021|NCT03351075|589775237|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
163292022|NCT05219253|589775238|FG000|Overall Study|Withdrawal by Subject|1|||
163292023|NCT05219253|589775239|FG001|Overall Study|Withdrawal by Subject|2|||
163292024|NCT03086369|589775240|FG000|Overall Study|Lost to Follow-up|1|||
163292025|NCT03086369|589775241|FG001|Overall Study|Lost to Follow-up|0|||
163292026|NCT03086369|589775242|FG002|Overall Study|Lost to Follow-up|0|||
163292027|NCT03086369|589775243|FG003|Overall Study|Lost to Follow-up|2|||
163292028|NCT03086369|589775244|FG004|Overall Study|Lost to Follow-up|1|||
163292029|NCT03086369|589775240|FG000|Overall Study|Physician Decision|0|||
163292030|NCT03086369|589775241|FG001|Overall Study|Physician Decision|0|||
163292031|NCT03086369|589775242|FG002|Overall Study|Physician Decision|0|||
163292032|NCT03086369|589775243|FG003|Overall Study|Physician Decision|1|||
163292033|NCT03086369|589775244|FG004|Overall Study|Physician Decision|2|||
163292034|NCT03086369|589775240|FG000|Overall Study|Withdrawal by Subject|0|||
163292035|NCT03086369|589775241|FG001|Overall Study|Withdrawal by Subject|0|||
163292036|NCT03086369|589775242|FG002|Overall Study|Withdrawal by Subject|0|||
163292037|NCT03086369|589775243|FG003|Overall Study|Withdrawal by Subject|5|||
163292038|NCT03086369|589775244|FG004|Overall Study|Withdrawal by Subject|3|||
163292039|NCT03086369|589775240|FG000|Overall Study|Progressive Disease|0|||
163292040|NCT03086369|589775241|FG001|Overall Study|Progressive Disease|0|||
163292041|NCT03086369|589775242|FG002|Overall Study|Progressive Disease|0|||
163292042|NCT03086369|589775243|FG003|Overall Study|Progressive Disease|1|||
163292043|NCT03086369|589775244|FG004|Overall Study|Progressive Disease|1|||
163292044|NCT03544515|589775245|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
163292045|NCT03544515|589775246|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
163292046|NCT03544515|589775245|FG000|Overall Study|Lost to Follow-up|2|||
163292047|NCT03544515|589775246|FG001|Overall Study|Lost to Follow-up|0|||
163292048|NCT04218110|589775249|FG000|Overall Study|Withdrawal by Subject|0|||
163292049|NCT04218110|589775250|FG001|Overall Study|Withdrawal by Subject|0|||
163292050|NCT04218110|589775251|FG002|Overall Study|Withdrawal by Subject|0|||
163292051|NCT04218110|589775252|FG003|Overall Study|Withdrawal by Subject|1|||
163292052|NCT02698891|589775253|FG000|Overall Study|Withdrawal by Subject|2|||
163292053|NCT02698891|589775253|FG000|Overall Study|deemed ineligible|1|||
163292054|NCT02698891|589775253|FG000|Overall Study|Adverse Event|9|||
163292055|NCT00516386|589775254|FG000|Overall Study|not interested in the study|4|||
163292056|NCT00516386|589775254|FG000|Overall Study|Lost to Follow-up|2|||
163292057|NCT00393848|589775255|FG000|Overall Study|Surgical schedule|0|||
163292058|NCT00393848|589775256|FG001|Overall Study|Surgical schedule|0|||
163292059|NCT00393848|589775257|FG002|Overall Study|Surgical schedule|0|||
163292060|NCT00393848|589775258|FG003|Overall Study|Surgical schedule|1|||
163292061|NCT00393848|589775255|FG000|Overall Study|Personal reasons|0|||
163292062|NCT00393848|589775256|FG001|Overall Study|Personal reasons|0|||
163292063|NCT00393848|589775257|FG002|Overall Study|Personal reasons|2|||
163388001|NCT01585987|590131977|FG000|Treated|Withdrawal by Subject|1|||
163388002|NCT01585987|590131978|FG001|Treated|Withdrawal by Subject|2|||
163292064|NCT00393848|589775258|FG003|Overall Study|Personal reasons|0|||
163292065|NCT01867216|589775259|FG000|Overall Study|Withdrawal by Subject|2|||
163292066|NCT01867216|589775260|FG001|Overall Study|Withdrawal by Subject|0|||
163292067|NCT01867216|589775261|FG002|Overall Study|Withdrawal by Subject|0|||
163292068|NCT01867216|589775262|FG003|Overall Study|Withdrawal by Subject|0|||
163292069|NCT01867216|589775263|FG004|Overall Study|Withdrawal by Subject|1|||
163292070|NCT01867216|589775264|FG005|Overall Study|Withdrawal by Subject|0|||
163292071|NCT01867216|589775265|FG006|Overall Study|Withdrawal by Subject|1|||
163186756|NCT00809354|589400174|FG006|Overall Study|Other|2|||
163186757|NCT00809354|589400175|FG007|Overall Study|Other|3|||
163186758|NCT00809354|589400176|FG008|Overall Study|Other|4|||
163186759|NCT00809354|589400177|FG009|Overall Study|Other|3|||
163186760|NCT00809354|589400168|FG000|Overall Study|Study terminated by sponsor|138|||
163186761|NCT00809354|589400169|FG001|Overall Study|Study terminated by sponsor|134|||
163186762|NCT00809354|589400170|FG002|Overall Study|Study terminated by sponsor|129|||
163186763|NCT00809354|589400171|FG003|Overall Study|Study terminated by sponsor|120|||
163186764|NCT00809354|589400172|FG004|Overall Study|Study terminated by sponsor|126|||
163186765|NCT00809354|589400173|FG005|Overall Study|Study terminated by sponsor|133|||
163186766|NCT00809354|589400174|FG006|Overall Study|Study terminated by sponsor|124|||
163186767|NCT00809354|589400175|FG007|Overall Study|Study terminated by sponsor|148|||
163186768|NCT00809354|589400176|FG008|Overall Study|Study terminated by sponsor|127|||
163186769|NCT00809354|589400177|FG009|Overall Study|Study terminated by sponsor|135|||
163186770|NCT00809354|589400168|FG000|Overall Study|Withdrawn due to pregnancy|0|||
163186771|NCT00809354|589400169|FG001|Overall Study|Withdrawn due to pregnancy|1|||
163186772|NCT00809354|589400170|FG002|Overall Study|Withdrawn due to pregnancy|0|||
163186773|NCT00809354|589400171|FG003|Overall Study|Withdrawn due to pregnancy|0|||
163186774|NCT00809354|589400172|FG004|Overall Study|Withdrawn due to pregnancy|0|||
163186775|NCT00809354|589400173|FG005|Overall Study|Withdrawn due to pregnancy|0|||
163186776|NCT00809354|589400174|FG006|Overall Study|Withdrawn due to pregnancy|0|||
163186777|NCT00809354|589400175|FG007|Overall Study|Withdrawn due to pregnancy|0|||
163186778|NCT00809354|589400176|FG008|Overall Study|Withdrawn due to pregnancy|0|||
163186779|NCT00809354|589400177|FG009|Overall Study|Withdrawn due to pregnancy|0|||
163186780|NCT00809354|589400168|FG000|Overall Study|Randomized but not Treated|3|||
163186781|NCT00809354|589400169|FG001|Overall Study|Randomized but not Treated|1|||
163186782|NCT00809354|589400170|FG002|Overall Study|Randomized but not Treated|6|||
163186783|NCT00809354|589400171|FG003|Overall Study|Randomized but not Treated|0|||
163186784|NCT00809354|589400172|FG004|Overall Study|Randomized but not Treated|5|||
163186785|NCT00809354|589400173|FG005|Overall Study|Randomized but not Treated|0|||
163186786|NCT00809354|589400174|FG006|Overall Study|Randomized but not Treated|1|||
163186787|NCT00809354|589400175|FG007|Overall Study|Randomized but not Treated|1|||
163186788|NCT00809354|589400176|FG008|Overall Study|Randomized but not Treated|2|||
163186789|NCT00809354|589400177|FG009|Overall Study|Randomized but not Treated|1|||
163186790|NCT00809354|589400168|FG000|Overall Study|Death|0|||
163186791|NCT00809354|589400169|FG001|Overall Study|Death|0|||
163186792|NCT00809354|589400170|FG002|Overall Study|Death|0|||
163186793|NCT00809354|589400171|FG003|Overall Study|Death|0|||
163186794|NCT00809354|589400172|FG004|Overall Study|Death|0|||
163186795|NCT00809354|589400173|FG005|Overall Study|Death|0|||
163186796|NCT00809354|589400174|FG006|Overall Study|Death|0|||
163186797|NCT00809354|589400175|FG007|Overall Study|Death|1|||
163186798|NCT00809354|589400176|FG008|Overall Study|Death|0|||
163186799|NCT00809354|589400177|FG009|Overall Study|Death|0|||
163186800|NCT04137224|589400180|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
163186801|NCT04137224|589400181|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
163186802|NCT04137224|589400180|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
163186803|NCT04137224|589400181|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
163186804|NCT04137224|589400180|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
163186805|NCT04137224|589400181|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
163186806|NCT01669928|589400182|FG000|First Intervention|Withdrawal by Subject|3|||
163186807|NCT01669928|589400183|FG001|First Intervention|Withdrawal by Subject|5|||
163186808|NCT05085730|589400192|FG000|Overall Study|Withdrawal by Subject|4|||
163186809|NCT05085730|589400192|FG000|Overall Study|Physician Decision|1|||
162947000|NCT04028843|588508172|FG001|Overall Study|Lost to Follow-up|39|||
163186810|NCT01400815|589400193|FG000|Overall Study|Adverse Event|3|||
163186811|NCT01400815|589400194|FG001|Overall Study|Adverse Event|0|||
163186812|NCT01400815|589400193|FG000|Overall Study|Death|0|||
163186813|NCT01400815|589400194|FG001|Overall Study|Death|1|||
163186814|NCT01400815|589400193|FG000|Overall Study|Lost to Follow-up|18|||
163186815|NCT01400815|589400194|FG001|Overall Study|Lost to Follow-up|11|||
163186816|NCT01400815|589400193|FG000|Overall Study|Protocol Violation|0|||
163186817|NCT01400815|589400194|FG001|Overall Study|Protocol Violation|1|||
163186818|NCT01400815|589400193|FG000|Overall Study|Physician Decision|1|||
163186819|NCT01400815|589400194|FG001|Overall Study|Physician Decision|0|||
163186820|NCT01400815|589400193|FG000|Overall Study|Withdrawal by Subject|15|||
163186821|NCT01400815|589400194|FG001|Overall Study|Withdrawal by Subject|8|||
163292072|NCT01867216|589775259|FG000|Overall Study|Physician Decision|1|||
163292073|NCT01867216|589775260|FG001|Overall Study|Physician Decision|0|||
163292074|NCT01867216|589775261|FG002|Overall Study|Physician Decision|0|||
163292075|NCT01867216|589775262|FG003|Overall Study|Physician Decision|0|||
163292076|NCT01867216|589775263|FG004|Overall Study|Physician Decision|0|||
163292077|NCT01867216|589775264|FG005|Overall Study|Physician Decision|0|||
163292078|NCT01867216|589775265|FG006|Overall Study|Physician Decision|0|||
163292079|NCT01867216|589775259|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
163292080|NCT01867216|589775260|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
163292081|NCT01867216|589775261|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
163292082|NCT01867216|589775262|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
163292083|NCT01867216|589775263|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
163388003|NCT01585987|590131977|FG000|Treated|Death|1|||
163388004|NCT01585987|590131978|FG001|Treated|Death|0|||
163388005|NCT01585987|590131977|FG000|Treated|Lost to Follow-up|0|||
163388006|NCT01585987|590131978|FG001|Treated|Lost to Follow-up|1|||
163388007|NCT01585987|590131977|FG000|Treated|Maximum Clinical Benefit|0|||
163292084|NCT01867216|589775264|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
163292085|NCT01867216|589775265|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
163292086|NCT03020745|589775266|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
163292087|NCT03020745|589775267|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
163292088|NCT03020745|589775268|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
163292089|NCT03020745|589775269|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
163292090|NCT03020745|589775270|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
163292091|NCT03020745|589775271|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
163292092|NCT03020745|589775272|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
163292093|NCT03020745|589775273|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
163292094|NCT03020745|589775274|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
163292095|NCT03020745|589775275|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
163292096|NCT03020745|589775266|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163292097|NCT03020745|589775267|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163292098|NCT03020745|589775268|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163292099|NCT03020745|589775269|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163292100|NCT03020745|589775270|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163292101|NCT03020745|589775271|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163292102|NCT03020745|589775272|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163292103|NCT03020745|589775273|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
163292104|NCT03020745|589775274|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163292105|NCT03020745|589775275|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163186822|NCT01400815|589400193|FG000|Overall Study|Subject in jail|1|||
163186823|NCT01400815|589400194|FG001|Overall Study|Subject in jail|0|||
163186824|NCT01199731|589400196|FG000|Overall Study|Adverse Event|0|||
163186825|NCT01199731|589400197|FG001|Overall Study|Adverse Event|1|||
163186826|NCT01199731|589400198|FG002|Overall Study|Adverse Event|0|||
163186827|NCT01199731|589400196|FG000|Overall Study|Study closed/terminated|7|||
163186828|NCT01199731|589400197|FG001|Overall Study|Study closed/terminated|9|||
163186829|NCT01199731|589400198|FG002|Overall Study|Study closed/terminated|7|||
163186830|NCT01199731|589400196|FG000|Overall Study|Lost to Follow-up|0|||
163186831|NCT01199731|589400197|FG001|Overall Study|Lost to Follow-up|0|||
163186832|NCT01199731|589400198|FG002|Overall Study|Lost to Follow-up|2|||
163186833|NCT01199731|589400196|FG000|Overall Study|Physician Decision|0|||
163186834|NCT01199731|589400197|FG001|Overall Study|Physician Decision|1|||
163186835|NCT01199731|589400198|FG002|Overall Study|Physician Decision|1|||
163186836|NCT01199731|589400196|FG000|Overall Study|Withdrawal by Subject|2|||
163186837|NCT01199731|589400197|FG001|Overall Study|Withdrawal by Subject|0|||
163186838|NCT01199731|589400198|FG002|Overall Study|Withdrawal by Subject|0|||
163186839|NCT04010539|589400199|FG000|Overall Study|Withdrawal by Subject|4|||
163186840|NCT04010539|589400200|FG001|Overall Study|Withdrawal by Subject|1|||
163186841|NCT04010539|589400199|FG000|Overall Study|Physician Decision|0|||
163186842|NCT04010539|589400200|FG001|Overall Study|Physician Decision|2|||
163292106|NCT03020745|589775266|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
163186843|NCT04010539|589400199|FG000|Overall Study|Lost to Follow-up|10|||
163292107|NCT03020745|589775267|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
163388008|NCT01585987|590131978|FG001|Treated|Maximum Clinical Benefit|1|||
163388009|NCT01585987|590131977|FG000|Treated|Non-Specified|1|||
163388010|NCT01585987|590131978|FG001|Treated|Non-Specified|2|||
163388011|NCT01585987|590131977|FG000|Treated|Subject Request|0|||
163388012|NCT01585987|590131978|FG001|Treated|Subject Request|1|||
163186844|NCT04010539|589400200|FG001|Overall Study|Lost to Follow-up|14|||
163186845|NCT04010539|589400199|FG000|Overall Study|Adverse Event|3|||
163186846|NCT04010539|589400200|FG001|Overall Study|Adverse Event|0|||
163186847|NCT04010539|589400199|FG000|Overall Study|Participant Did Not Receive IP|0|||
163186848|NCT04010539|589400200|FG001|Overall Study|Participant Did Not Receive IP|1|||
162947001|NCT04028843|588508171|FG000|Overall Study|Adverse Event|1|||
162947002|NCT04028843|588508172|FG001|Overall Study|Adverse Event|0|||
163186849|NCT04010539|589400199|FG000|Overall Study|Protocol Deviation|0|||
163186850|NCT04010539|589400200|FG001|Overall Study|Protocol Deviation|1|||
163186851|NCT04010539|589400199|FG000|Overall Study|Randomized in Error/ Mistake|2|||
163186852|NCT04010539|589400200|FG001|Overall Study|Randomized in Error/ Mistake|0|||
163186853|NCT04010539|589400199|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
163186854|NCT04010539|589400200|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
163186855|NCT02028871|589400201|FG000|Overall Study|Positive urine drug screen|1|||
163186856|NCT02028871|589400202|FG001|Overall Study|Positive urine drug screen|1|||
163186857|NCT02028871|589400201|FG000|Overall Study|Withdrawal by Subject|1|||
163186858|NCT02028871|589400202|FG001|Overall Study|Withdrawal by Subject|2|||
163186859|NCT02028871|589400201|FG000|Overall Study|IV placement difficulty|1|||
163186860|NCT02028871|589400202|FG001|Overall Study|IV placement difficulty|0|||
163186861|NCT02028871|589400201|FG000|Overall Study|Current Illness|1|||
163186862|NCT02028871|589400202|FG001|Overall Study|Current Illness|0|||
163186863|NCT02314143|589400205|FG000|Overall Study|Adverse Event|0|||
163186864|NCT02314143|589400206|FG001|Overall Study|Adverse Event|6|||
163186865|NCT02314143|589400207|FG002|Overall Study|Adverse Event|4|||
163186866|NCT02314143|589400205|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
163186867|NCT02314143|589400206|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
163186868|NCT02314143|589400207|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
163186869|NCT02314143|589400205|FG000|Overall Study|Physician Decision|2|||
163186870|NCT02314143|589400206|FG001|Overall Study|Physician Decision|1|||
163186871|NCT02314143|589400207|FG002|Overall Study|Physician Decision|0|||
163186872|NCT02314143|589400205|FG000|Overall Study|Withdrawal by Subject|1|||
163186873|NCT02314143|589400206|FG001|Overall Study|Withdrawal by Subject|0|||
163186874|NCT02314143|589400207|FG002|Overall Study|Withdrawal by Subject|1|||
163186875|NCT01916967|589400220|FG000|Overall Study|Adverse Event|0|||
163186876|NCT01916967|589400221|FG001|Overall Study|Adverse Event|0|||
163186877|NCT01916967|589400222|FG002|Overall Study|Adverse Event|2|||
163186878|NCT01916967|589400220|FG000|Overall Study|Lack of Efficacy|0|||
163186879|NCT01916967|589400221|FG001|Overall Study|Lack of Efficacy|0|||
163186880|NCT01916967|589400222|FG002|Overall Study|Lack of Efficacy|6|||
163186881|NCT01916967|589400220|FG000|Overall Study|Physician Decision|0|||
163186882|NCT01916967|589400221|FG001|Overall Study|Physician Decision|0|||
163186883|NCT01916967|589400222|FG002|Overall Study|Physician Decision|1|||
163186884|NCT01916967|589400220|FG000|Overall Study|Protocol Violation|0|||
163186885|NCT01916967|589400221|FG001|Overall Study|Protocol Violation|1|||
163186886|NCT01916967|589400222|FG002|Overall Study|Protocol Violation|0|||
163186887|NCT01070043|589400225|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
163186888|NCT01070043|589400226|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
163186889|NCT01070043|589400227|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
163186890|NCT01070043|589400225|FG000|Double-Blind Treatment|Adverse Event|0|||
163186891|NCT01070043|589400226|FG001|Double-Blind Treatment|Adverse Event|0|||
163186892|NCT01070043|589400227|FG002|Double-Blind Treatment|Adverse Event|2|||
163186893|NCT01528215|589400228|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
163186894|NCT01528215|589400229|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
163186895|NCT01528215|589400228|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
163186896|NCT01528215|589400229|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
163186897|NCT01528215|589400228|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
163186898|NCT01528215|589400229|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
163186899|NCT01528215|589400228|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
163186900|NCT01528215|589400229|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
163186901|NCT02337738|589400230|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
163186902|NCT02337738|589400231|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
163186903|NCT02337738|589400232|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
163186904|NCT02337738|589400230|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
163186905|NCT02337738|589400231|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
163186906|NCT02337738|589400232|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
163186907|NCT02337738|589400230|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
162947003|NCT04028843|588508171|FG000|Overall Study|Non-viable Pregnancy|0|||
163186908|NCT02337738|589400231|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
163186909|NCT02337738|589400232|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
163186910|NCT02337738|589400230|FG000|Overall Study|Voluntary Withdrawal|10|||
163186911|NCT02337738|589400231|FG001|Overall Study|Voluntary Withdrawal|5|||
163186912|NCT02337738|589400232|FG002|Overall Study|Voluntary Withdrawal|2|||
163186913|NCT02337738|589400230|FG000|Overall Study|Lack of Efficacy|2|||
163186914|NCT02337738|589400231|FG001|Overall Study|Lack of Efficacy|4|||
163186915|NCT02337738|589400232|FG002|Overall Study|Lack of Efficacy|0|||
163186916|NCT02337738|589400230|FG000|Overall Study|Investigator's Judgment|1|||
163186917|NCT02337738|589400231|FG001|Overall Study|Investigator's Judgment|1|||
163292108|NCT03020745|589775268|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
163292109|NCT03020745|589775269|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162947004|NCT04028843|588508172|FG001|Overall Study|Non-viable Pregnancy|1|||
162947005|NCT04028843|588508171|FG000|Overall Study|Withdrawal by Subject|4|||
162947006|NCT04028843|588508172|FG001|Overall Study|Withdrawal by Subject|2|||
162947007|NCT01867242|588508177|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
162947008|NCT01867242|588508178|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
162947009|NCT01867242|588508179|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
162947010|NCT00406848|588508180|FG000|Overall Study|Withdrawal by Subject|27|||
162947011|NCT00406848|588508181|FG001|Overall Study|Withdrawal by Subject|22|||
162947012|NCT00406848|588508180|FG000|Overall Study|Adverse Event|38|||
162947013|NCT00406848|588508181|FG001|Overall Study|Adverse Event|7|||
162947014|NCT00406848|588508180|FG000|Overall Study|Lack of Efficacy|9|||
162947015|NCT00406848|588508181|FG001|Overall Study|Lack of Efficacy|14|||
162947016|NCT00406848|588508180|FG000|Overall Study|Protocol Violation|10|||
162947017|NCT00406848|588508181|FG001|Overall Study|Protocol Violation|6|||
162947018|NCT00406848|588508180|FG000|Overall Study|Lost to Follow-up|6|||
162947019|NCT00406848|588508181|FG001|Overall Study|Lost to Follow-up|2|||
163186918|NCT02337738|589400232|FG002|Overall Study|Investigator's Judgment|3|||
162947020|NCT00406848|588508180|FG000|Overall Study|Physician Decision|2|||
162947021|NCT00406848|588508181|FG001|Overall Study|Physician Decision|2|||
163186919|NCT02322021|589400233|FG000|Core Phase|Adverse Event|1|||
163186920|NCT02322021|589400234|FG001|Core Phase|Adverse Event|3|||
163186921|NCT02322021|589400235|FG002|Core Phase|Adverse Event|4|||
163186922|NCT02322021|589400236|FG003|Core Phase|Adverse Event|2|||
163186923|NCT02322021|589400237|FG004|Core Phase|Adverse Event|0|||
163186924|NCT02322021|589400233|FG000|Core Phase|Participant Choice|4|||
163186925|NCT02322021|589400234|FG001|Core Phase|Participant Choice|5|||
163186926|NCT02322021|589400235|FG002|Core Phase|Participant Choice|4|||
163186927|NCT02322021|589400236|FG003|Core Phase|Participant Choice|2|||
163186928|NCT02322021|589400237|FG004|Core Phase|Participant Choice|0|||
163186929|NCT02322021|589400233|FG000|Core Phase|Lost to Follow-up|0|||
163186930|NCT02322021|589400234|FG001|Core Phase|Lost to Follow-up|0|||
163186931|NCT02322021|589400235|FG002|Core Phase|Lost to Follow-up|0|||
163186932|NCT02322021|589400236|FG003|Core Phase|Lost to Follow-up|1|||
163186933|NCT02322021|589400237|FG004|Core Phase|Lost to Follow-up|0|||
163186934|NCT02322021|589400233|FG000|Core Phase|Other|0|||
163186935|NCT02322021|589400234|FG001|Core Phase|Other|0|||
163186936|NCT02322021|589400235|FG002|Core Phase|Other|1|||
163186937|NCT02322021|589400236|FG003|Core Phase|Other|0|||
163186938|NCT02322021|589400237|FG004|Core Phase|Other|0|||
163186939|NCT02322021|589400233|FG000|Extension Phase|Adverse Event|0|||
163186940|NCT02322021|589400234|FG001|Extension Phase|Adverse Event|0|||
163186941|NCT02322021|589400235|FG002|Extension Phase|Adverse Event|0|||
163186942|NCT02322021|589400236|FG003|Extension Phase|Adverse Event|0|||
163186943|NCT02322021|589400237|FG004|Extension Phase|Adverse Event|3|||
163186944|NCT02322021|589400233|FG000|Extension Phase|Participant Choice|0|||
163186945|NCT02322021|589400234|FG001|Extension Phase|Participant Choice|0|||
163186946|NCT02322021|589400235|FG002|Extension Phase|Participant Choice|0|||
163186947|NCT02322021|589400236|FG003|Extension Phase|Participant Choice|0|||
163186948|NCT02322021|589400237|FG004|Extension Phase|Participant Choice|6|||
163186949|NCT02322021|589400233|FG000|Extension Phase|Other|0|||
163186950|NCT02322021|589400234|FG001|Extension Phase|Other|0|||
163186951|NCT02322021|589400235|FG002|Extension Phase|Other|0|||
163186952|NCT02322021|589400236|FG003|Extension Phase|Other|0|||
163186953|NCT02322021|589400237|FG004|Extension Phase|Other|3|||
163186954|NCT02322021|589400233|FG000|Extension Phase|Lost to Follow-up|0|||
163186955|NCT02322021|589400234|FG001|Extension Phase|Lost to Follow-up|0|||
163186956|NCT02322021|589400235|FG002|Extension Phase|Lost to Follow-up|0|||
163186957|NCT02322021|589400236|FG003|Extension Phase|Lost to Follow-up|0|||
163186958|NCT02322021|589400237|FG004|Extension Phase|Lost to Follow-up|1|||
163186959|NCT02322021|589400233|FG000|Extension Phase|Study terminated by sponsor|0|||
163186960|NCT02322021|589400234|FG001|Extension Phase|Study terminated by sponsor|0|||
163186961|NCT02322021|589400235|FG002|Extension Phase|Study terminated by sponsor|0|||
163186962|NCT02322021|589400236|FG003|Extension Phase|Study terminated by sponsor|0|||
162947022|NCT00406848|588508180|FG000|Overall Study|Sponsor Decision|1|||
163186963|NCT02322021|589400237|FG004|Extension Phase|Study terminated by sponsor|28|||
163186964|NCT01934972|589400238|FG000|Overall Study|Withdrawal by Subject|9|||
163292110|NCT03020745|589775270|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
163292111|NCT03020745|589775271|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
163292112|NCT03020745|589775272|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162947023|NCT00406848|588508181|FG001|Overall Study|Sponsor Decision|1|||
163186965|NCT01934972|589400239|FG001|Overall Study|Withdrawal by Subject|6|||
163186966|NCT01278160|589400240|FG000|Overall Study|Adverse Event|1|||
163186967|NCT01278160|589400241|FG001|Overall Study|Adverse Event|1|||
163186968|NCT01278160|589400240|FG000|Overall Study|Lost to Follow-up|0|||
162947024|NCT04803357|588508182|FG000|Overall Study|Withdrawal by Subject|31|||
162947025|NCT04803357|588508183|FG001|Overall Study|Withdrawal by Subject|5|||
162947026|NCT02879643|588508185|FG000|Overall Study|Adverse Event|0|||
163186969|NCT01278160|589400241|FG001|Overall Study|Lost to Follow-up|1|||
163186970|NCT01278160|589400240|FG000|Overall Study|Withdrawal by Subject|3|||
162947027|NCT02879643|588508186|FG001|Overall Study|Adverse Event|0|||
162947028|NCT02879643|588508187|FG002|Overall Study|Adverse Event|1|||
163186971|NCT01278160|589400241|FG001|Overall Study|Withdrawal by Subject|2|||
163186972|NCT01278160|589400240|FG000|Overall Study|Unclassified|1|||
163186973|NCT01278160|589400241|FG001|Overall Study|Unclassified|2|||
163186974|NCT02979197|589400242|FG000|Overall Study|Adverse Event|4|||
163186975|NCT02979197|589400243|FG001|Overall Study|Adverse Event|2|||
163186976|NCT02979197|589400244|FG002|Overall Study|Adverse Event|0|||
162947029|NCT02879643|588508188|FG003|Overall Study|Adverse Event|1|||
163186977|NCT02979197|589400242|FG000|Overall Study|Protocol Violation|0|||
163186978|NCT02979197|589400243|FG001|Overall Study|Protocol Violation|1|||
162947030|NCT02879643|588508189|FG004|Overall Study|Adverse Event|0|||
162947031|NCT00182091|588508190|FG000|Overall Study|Withdrawal by Subject|1|||
162947032|NCT00182091|588508191|FG001|Overall Study|Withdrawal by Subject|0|||
162947033|NCT00182091|588508192|FG002|Overall Study|Withdrawal by Subject|0|||
162947034|NCT00182091|588508193|FG003|Overall Study|Withdrawal by Subject|0|||
162947035|NCT01046253|588508194|FG000|Second Intervention|Adverse Event|0|||
162947036|NCT01046253|588508195|FG001|Second Intervention|Adverse Event|1|||
162947037|NCT01046253|588508194|FG000|Second Intervention|Protocol Violation|0|||
162947038|NCT01046253|588508195|FG001|Second Intervention|Protocol Violation|1|||
162947039|NCT02339909|588508196|FG000|Overall Study|Became ineligible after randomisation|89|||
162947040|NCT02339909|588508197|FG001|Overall Study|Became ineligible after randomisation|63|||
163186979|NCT02979197|589400244|FG002|Overall Study|Protocol Violation|0|||
163292113|NCT03020745|589775273|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
163292114|NCT03020745|589775274|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
163292115|NCT03020745|589775275|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
163292116|NCT03020745|589775266|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163292117|NCT03020745|589775267|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163292118|NCT03020745|589775268|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163292119|NCT03020745|589775269|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163292120|NCT03020745|589775270|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163292121|NCT03020745|589775271|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163292122|NCT03020745|589775272|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163292123|NCT03020745|589775273|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163186980|NCT02979197|589400242|FG000|Overall Study|Subject unable to commit to study dates|0|||
163186981|NCT02979197|589400243|FG001|Overall Study|Subject unable to commit to study dates|1|||
163186982|NCT02979197|589400244|FG002|Overall Study|Subject unable to commit to study dates|0|||
163186983|NCT02949700|589400245|FG000|Phase I|Withdrawal by Subject|1|||
163186984|NCT02949700|589400246|FG001|Phase I|Withdrawal by Subject|1|||
163186985|NCT02949700|589400247|FG002|Phase I|Withdrawal by Subject|0|||
163186986|NCT02949700|589400248|FG003|Phase I|Withdrawal by Subject|0|||
163186987|NCT02949700|589400245|FG000|Phase I|Protocol Violation|1|||
163186988|NCT02949700|589400246|FG001|Phase I|Protocol Violation|0|||
163186989|NCT02949700|589400247|FG002|Phase I|Protocol Violation|0|||
163186990|NCT02949700|589400248|FG003|Phase I|Protocol Violation|0|||
163186991|NCT02949700|589400245|FG000|Phase II|Withdrawal by Subject|0|||
163186992|NCT02949700|589400246|FG001|Phase II|Withdrawal by Subject|0|||
163292124|NCT03020745|589775274|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
163186993|NCT02949700|589400247|FG002|Phase II|Withdrawal by Subject|0|||
163186994|NCT02949700|589400248|FG003|Phase II|Withdrawal by Subject|2|||
163186995|NCT02949700|589400245|FG000|Phase II|Protocol Violation|0|||
163292125|NCT03020745|589775275|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163292126|NCT00186186|589775276|FG000|Overall Study|Lack of Efficacy|3|||
163388013|NCT01585987|590131977|FG000|Treated|Poor/Non-Compliance|0|||
163388014|NCT01585987|590131978|FG001|Treated|Poor/Non-Compliance|1|||
163388015|NCT03291587|590131979|FG000|Overall Study|Lost to Follow-up|62|||
163388016|NCT03291587|590131980|FG001|Overall Study|Lost to Follow-up|43|||
163388017|NCT03291587|590131979|FG000|Overall Study|Refused to Answer|5|||
163388018|NCT03291587|590131980|FG001|Overall Study|Refused to Answer|2|||
163388019|NCT03291587|590131979|FG000|Overall Study|Death|2|||
163388020|NCT03291587|590131980|FG001|Overall Study|Death|4|||
163388021|NCT03291587|590131979|FG000|Overall Study|Not interested in participating|8|||
163388022|NCT03291587|590131980|FG001|Overall Study|Not interested in participating|6|||
163388023|NCT03291587|590131979|FG000|Overall Study|Too busy to participate|4|||
163388024|NCT03291587|590131980|FG001|Overall Study|Too busy to participate|2|||
163388025|NCT00796120|590131981|FG000|Overall Study|Death|3|||
163388026|NCT00796120|590131982|FG001|Overall Study|Death|0|||
163388027|NCT00796120|590131981|FG000|Overall Study|Adverse Event|11|||
163388028|NCT00796120|590131982|FG001|Overall Study|Adverse Event|6|||
163388029|NCT00796120|590131981|FG000|Overall Study|Progressive disease|22|||
163388030|NCT00796120|590131982|FG001|Overall Study|Progressive disease|13|||
163388031|NCT00796120|590131981|FG000|Overall Study|Participant refusal|3|||
163388032|NCT00796120|590131982|FG001|Overall Study|Participant refusal|4|||
163388033|NCT00796120|590131981|FG000|Overall Study|Other|6|||
163388034|NCT00796120|590131982|FG001|Overall Study|Other|17|||
163388035|NCT00796120|590131981|FG000|Overall Study|Physician Decision|16|||
163388036|NCT00796120|590131982|FG001|Overall Study|Physician Decision|17|||
163388037|NCT00796120|590131981|FG000|Overall Study|Randomized but not treated|0|||
163388038|NCT00796120|590131982|FG001|Overall Study|Randomized but not treated|3|||
163388039|NCT01759407|590131986|FG000|Overall Study|Protocol Violation|0|||
163388040|NCT01759407|590131987|FG001|Overall Study|Protocol Violation|2|||
163388041|NCT04526197|590131990|FG000|Period 1|Adverse Event|0|||
163388042|NCT04526197|590131991|FG001|Period 1|Adverse Event|1|||
163388043|NCT04526197|590131990|FG000|Period 1|Withdrawal by Subject|1|||
163388044|NCT04526197|590131991|FG001|Period 1|Withdrawal by Subject|0|||
163388045|NCT04526197|590131990|FG000|Period 2|Adverse Event|0|||
163388046|NCT04526197|590131991|FG001|Period 2|Adverse Event|1|||
163388047|NCT04526197|590131990|FG000|Period 2|Withdrawal by Subject|0|||
163388048|NCT04526197|590131991|FG001|Period 2|Withdrawal by Subject|1|||
163388049|NCT01209143|590131992|FG000|Overall Study|Adverse Event|2|||
163388050|NCT01209143|590131993|FG001|Overall Study|Adverse Event|1|||
163388051|NCT01209143|590131992|FG000|Overall Study|Death|0|||
163388052|NCT01209143|590131993|FG001|Overall Study|Death|1|||
163388053|NCT01209143|590131992|FG000|Overall Study|Physician Decision|3|||
163388054|NCT01209143|590131993|FG001|Overall Study|Physician Decision|1|||
163388055|NCT01209143|590131992|FG000|Overall Study|Lost to Follow-up|1|||
163388056|NCT01209143|590131993|FG001|Overall Study|Lost to Follow-up|0|||
163388057|NCT01209143|590131992|FG000|Overall Study|Withdrawal by Subject|2|||
163388058|NCT01209143|590131993|FG001|Overall Study|Withdrawal by Subject|1|||
163388059|NCT01209143|590131992|FG000|Overall Study|Disease progression|11|||
163388060|NCT01209143|590131993|FG001|Overall Study|Disease progression|16|||
163388061|NCT01136811|590131994|FG000|Overall Study|Physician Decision|11|||
163388062|NCT01116882|590132003|FG000|30-day|Lost to Follow-up|50|||
163388063|NCT01116882|590132004|FG001|30-day|Lost to Follow-up|21|||
163388064|NCT01116882|590132003|FG000|30-day|Withdrawal by Subject|2|||
163388065|NCT01116882|590132004|FG001|30-day|Withdrawal by Subject|4|||
163388066|NCT01116882|590132003|FG000|30-day|Other Reasons|16|||
163388067|NCT01116882|590132004|FG001|30-day|Other Reasons|6|||
163388068|NCT01116882|590132003|FG000|12-month|Lost to Follow-up|111|||
163388069|NCT01116882|590132004|FG001|12-month|Lost to Follow-up|42|||
163388070|NCT01116882|590132003|FG000|12-month|Other Reasons|151|||
163388071|NCT01116882|590132004|FG001|12-month|Other Reasons|49|||
163388072|NCT01116882|590132003|FG000|12-month|Withdrawal by Subject|5|||
163388073|NCT01116882|590132004|FG001|12-month|Withdrawal by Subject|8|||
163388074|NCT00547365|590132005|FG000|Overall Study|Physician Decision|1|||
163388075|NCT00547365|590132005|FG000|Overall Study|Lost to Follow-up|1|||
163388076|NCT00547365|590132005|FG000|Overall Study|Protocol Violation|2|||
163388077|NCT00547365|590132005|FG000|Overall Study|death (not related to study)|4|||
163388078|NCT01139658|590132006|FG000|Overall Study|Adverse Event|10|||
163388079|NCT01139658|590132007|FG001|Overall Study|Adverse Event|27|||
163388080|NCT01139658|590132006|FG000|Overall Study|Lack of Efficacy|15|||
163388081|NCT01139658|590132007|FG001|Overall Study|Lack of Efficacy|7|||
163388082|NCT01139658|590132006|FG000|Overall Study|Withdrawal by Subject|2|||
163388083|NCT01139658|590132007|FG001|Overall Study|Withdrawal by Subject|4|||
163388084|NCT01139658|590132006|FG000|Overall Study|No documentation of treatment|1|||
163388085|NCT01139658|590132007|FG001|Overall Study|No documentation of treatment|0|||
163388086|NCT01139658|590132006|FG000|Overall Study|Other|28|||
163388087|NCT01139658|590132007|FG001|Overall Study|Other|75|||
163388088|NCT00753272|590132017|FG000|Overall Study|Adverse Event|878|||
163388089|NCT00753272|590132018|FG001|Overall Study|Adverse Event|869|||
163388090|NCT00753272|590132017|FG000|Overall Study|Protocol Violation|28|||
163186996|NCT02949700|589400246|FG001|Phase II|Protocol Violation|0|||
163186997|NCT02949700|589400247|FG002|Phase II|Protocol Violation|1|||
163186998|NCT02949700|589400248|FG003|Phase II|Protocol Violation|3|||
163186999|NCT00560885|589400249|FG000|Overall Study|Death|7|||
163187000|NCT00560885|589400249|FG000|Overall Study|Withdrawal by Subject|1|||
163187001|NCT03148275|589400250|FG000|Overall Study|Death|6|||
163187002|NCT03148275|589400250|FG000|Overall Study|Adverse Event|3|||
163187003|NCT03148275|589400250|FG000|Overall Study|Liver transplant|2|||
163187004|NCT03148275|589400250|FG000|Overall Study|Patient decision|5|||
163187005|NCT03148275|589400250|FG000|Overall Study|transition to commercial drug|1|||
163187006|NCT03148275|589400250|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
163187007|NCT03803683|589400251|FG000|Overall Study|Lost to Follow-up|41|||
163187008|NCT03803683|589400252|FG001|Overall Study|Lost to Follow-up|18|||
163187009|NCT03803683|589400253|FG002|Overall Study|Lost to Follow-up|12|||
163187010|NCT03803683|589400251|FG000|Overall Study|Withdrawal by Subject|9|||
163388091|NCT00753272|590132018|FG001|Overall Study|Protocol Violation|46|||
163388092|NCT00753272|590132017|FG000|Overall Study|Withdrawal by Subject|2481|||
163388093|NCT00753272|590132018|FG001|Overall Study|Withdrawal by Subject|2407|||
163388094|NCT00753272|590132017|FG000|Overall Study|Lost to Follow-up|491|||
163388095|NCT00753272|590132018|FG001|Overall Study|Lost to Follow-up|497|||
163388096|NCT00753272|590132017|FG000|Overall Study|Other|1104|||
163388097|NCT00753272|590132018|FG001|Overall Study|Other|1088|||
163388098|NCT00803270|590132019|FG000|Overall Study|Lost to Follow-up|1|||
163388099|NCT00803270|590132020|FG001|Overall Study|Lost to Follow-up|2|||
163388100|NCT01966471|590132021|FG000|Overall Study|Death|44|||
163388101|NCT01966471|590132022|FG001|Overall Study|Death|56|||
163388102|NCT01966471|590132021|FG000|Overall Study|Lost to Follow-up|46|||
163388103|NCT01966471|590132022|FG001|Overall Study|Lost to Follow-up|39|||
163388104|NCT01966471|590132021|FG000|Overall Study|Various reasons|4|||
163388105|NCT01966471|590132022|FG001|Overall Study|Various reasons|4|||
163388106|NCT01966471|590132021|FG000|Overall Study|Physician Decision|7|||
163388107|NCT01966471|590132022|FG001|Overall Study|Physician Decision|5|||
163388108|NCT01966471|590132021|FG000|Overall Study|Study Terminated By Sponsor|758|||
163388109|NCT01966471|590132022|FG001|Overall Study|Study Terminated By Sponsor|773|||
163388110|NCT01966471|590132021|FG000|Overall Study|Withdrawal by Subject|59|||
163388111|NCT01966471|590132022|FG001|Overall Study|Withdrawal by Subject|51|||
163388112|NCT02092220|590132025|FG000|Period 1|Unrelated Illness|0|||
163388113|NCT02092220|590132026|FG001|Period 1|Unrelated Illness|2|||
163388114|NCT02092220|590132025|FG000|Period 2|Severe Hypoglycaemia|1|||
163388115|NCT02092220|590132026|FG001|Period 2|Severe Hypoglycaemia|0|||
163388116|NCT02092220|590132025|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
163388117|NCT02092220|590132026|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
163388118|NCT00960531|590132027|FG000|Overall Study|Lack of Efficacy|1|||
163388119|NCT00960531|590132028|FG001|Overall Study|Lack of Efficacy|0|||
163388120|NCT00960531|590132029|FG002|Overall Study|Lack of Efficacy|0|||
163388121|NCT00960531|590132030|FG003|Overall Study|Lack of Efficacy|0|||
163388122|NCT00960531|590132031|FG004|Overall Study|Lack of Efficacy|0|||
163388123|NCT00960531|590132032|FG005|Overall Study|Lack of Efficacy|0|||
163388124|NCT00960531|590132033|FG006|Overall Study|Lack of Efficacy|0|||
163388125|NCT00960531|590132034|FG007|Overall Study|Lack of Efficacy|0|||
163388126|NCT00960531|590132035|FG008|Overall Study|Lack of Efficacy|0|||
163388127|NCT00960531|590132036|FG009|Overall Study|Lack of Efficacy|0|||
163388128|NCT00960531|590132027|FG000|Overall Study|Withdrawal by Subject|1|||
163388129|NCT00960531|590132028|FG001|Overall Study|Withdrawal by Subject|0|||
163388130|NCT00960531|590132029|FG002|Overall Study|Withdrawal by Subject|5|||
163388131|NCT00960531|590132030|FG003|Overall Study|Withdrawal by Subject|2|||
163388132|NCT00960531|590132031|FG004|Overall Study|Withdrawal by Subject|0|||
163388133|NCT00960531|590132032|FG005|Overall Study|Withdrawal by Subject|0|||
163388134|NCT00960531|590132033|FG006|Overall Study|Withdrawal by Subject|2|||
163388135|NCT00960531|590132034|FG007|Overall Study|Withdrawal by Subject|0|||
163388136|NCT00960531|590132035|FG008|Overall Study|Withdrawal by Subject|1|||
163388137|NCT00960531|590132036|FG009|Overall Study|Withdrawal by Subject|0|||
163388138|NCT00960531|590132027|FG000|Overall Study|Caregiver Request|2|||
163388139|NCT00960531|590132028|FG001|Overall Study|Caregiver Request|0|||
163388140|NCT00960531|590132029|FG002|Overall Study|Caregiver Request|6|||
163388141|NCT00960531|590132030|FG003|Overall Study|Caregiver Request|5|||
163388142|NCT00960531|590132031|FG004|Overall Study|Caregiver Request|0|||
163388143|NCT00960531|590132032|FG005|Overall Study|Caregiver Request|2|||
163388144|NCT00960531|590132033|FG006|Overall Study|Caregiver Request|3|||
163388145|NCT00960531|590132034|FG007|Overall Study|Caregiver Request|1|||
163388146|NCT00960531|590132035|FG008|Overall Study|Caregiver Request|3|||
163388147|NCT00960531|590132036|FG009|Overall Study|Caregiver Request|0|||
163388148|NCT00960531|590132027|FG000|Overall Study|Investigator Request|0|||
163388149|NCT00960531|590132028|FG001|Overall Study|Investigator Request|0|||
163388150|NCT00960531|590132029|FG002|Overall Study|Investigator Request|1|||
163388151|NCT00960531|590132030|FG003|Overall Study|Investigator Request|0|||
163388152|NCT00960531|590132031|FG004|Overall Study|Investigator Request|0|||
163388153|NCT00960531|590132032|FG005|Overall Study|Investigator Request|0|||
163388154|NCT00960531|590132033|FG006|Overall Study|Investigator Request|0|||
163388155|NCT00960531|590132034|FG007|Overall Study|Investigator Request|0|||
163388156|NCT00960531|590132035|FG008|Overall Study|Investigator Request|0|||
163388157|NCT00960531|590132036|FG009|Overall Study|Investigator Request|0|||
163388158|NCT00960531|590132027|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
163388159|NCT00960531|590132028|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
163388160|NCT00960531|590132029|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
163388161|NCT00960531|590132030|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
163388162|NCT00960531|590132031|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
163388163|NCT00960531|590132032|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
163388164|NCT00960531|590132033|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
163388165|NCT00960531|590132034|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
163388166|NCT00960531|590132035|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
163292127|NCT00186186|589775276|FG000|Overall Study|Withdrawal by Subject|3|||
163292128|NCT00186186|589775276|FG000|Overall Study|Not reported as to reason|2|||
163292129|NCT03622580|589775281|FG000|Overall Study|Death|16|||
163292130|NCT03622580|589775282|FG001|Overall Study|Death|21|||
163292131|NCT03622580|589775283|FG002|Overall Study|Death|13|||
163292132|NCT03622580|589775281|FG000|Overall Study|Adverse Event|6|||
163292133|NCT03622580|589775282|FG001|Overall Study|Adverse Event|6|||
163292134|NCT03622580|589775283|FG002|Overall Study|Adverse Event|5|||
163388167|NCT00960531|590132036|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
163388168|NCT00960531|590132027|FG000|Overall Study|Lost to Follow-up|0|||
163388169|NCT00960531|590132028|FG001|Overall Study|Lost to Follow-up|0|||
163388170|NCT00960531|590132029|FG002|Overall Study|Lost to Follow-up|1|||
163388171|NCT00960531|590132030|FG003|Overall Study|Lost to Follow-up|0|||
163388172|NCT00960531|590132031|FG004|Overall Study|Lost to Follow-up|0|||
163388173|NCT00960531|590132032|FG005|Overall Study|Lost to Follow-up|0|||
163388174|NCT00960531|590132033|FG006|Overall Study|Lost to Follow-up|1|||
163388175|NCT00960531|590132034|FG007|Overall Study|Lost to Follow-up|0|||
163388176|NCT00960531|590132035|FG008|Overall Study|Lost to Follow-up|0|||
163388177|NCT00960531|590132036|FG009|Overall Study|Lost to Follow-up|0|||
163388178|NCT00960531|590132027|FG000|Overall Study|Failed to Return|2|||
163388179|NCT00960531|590132028|FG001|Overall Study|Failed to Return|0|||
163388180|NCT00960531|590132029|FG002|Overall Study|Failed to Return|0|||
163388181|NCT00960531|590132030|FG003|Overall Study|Failed to Return|0|||
163388182|NCT00960531|590132031|FG004|Overall Study|Failed to Return|0|||
163388183|NCT00960531|590132032|FG005|Overall Study|Failed to Return|0|||
163388184|NCT00960531|590132033|FG006|Overall Study|Failed to Return|0|||
163388185|NCT00960531|590132034|FG007|Overall Study|Failed to Return|2|||
163388186|NCT00960531|590132035|FG008|Overall Study|Failed to Return|0|||
163388187|NCT00960531|590132036|FG009|Overall Study|Failed to Return|0|||
163388188|NCT00960531|590132027|FG000|Overall Study|Adverse Event (AE)|2|||
163388189|NCT00960531|590132028|FG001|Overall Study|Adverse Event (AE)|0|||
163388190|NCT00960531|590132029|FG002|Overall Study|Adverse Event (AE)|0|||
163388191|NCT00960531|590132030|FG003|Overall Study|Adverse Event (AE)|0|||
163388192|NCT00960531|590132031|FG004|Overall Study|Adverse Event (AE)|0|||
163388193|NCT00960531|590132032|FG005|Overall Study|Adverse Event (AE)|1|||
163388194|NCT00960531|590132033|FG006|Overall Study|Adverse Event (AE)|2|||
163388195|NCT00960531|590132034|FG007|Overall Study|Adverse Event (AE)|0|||
163388196|NCT00960531|590132035|FG008|Overall Study|Adverse Event (AE)|2|||
163388197|NCT00960531|590132036|FG009|Overall Study|Adverse Event (AE)|0|||
163388198|NCT00960531|590132027|FG000|Overall Study|Reason not Specified|2|||
163388199|NCT00960531|590132028|FG001|Overall Study|Reason not Specified|1|||
163388200|NCT00960531|590132029|FG002|Overall Study|Reason not Specified|13|||
163388201|NCT00960531|590132030|FG003|Overall Study|Reason not Specified|1|||
163388202|NCT00960531|590132031|FG004|Overall Study|Reason not Specified|2|||
163388203|NCT00960531|590132032|FG005|Overall Study|Reason not Specified|0|||
163388204|NCT00960531|590132033|FG006|Overall Study|Reason not Specified|16|||
163388205|NCT00960531|590132034|FG007|Overall Study|Reason not Specified|0|||
163388206|NCT00960531|590132035|FG008|Overall Study|Reason not Specified|8|||
163388207|NCT00960531|590132036|FG009|Overall Study|Reason not Specified|1|||
163388208|NCT00593957|590132037|FG000|Overall Study|Physician Decision|0|||
162947041|NCT02339909|588508198|FG002|Overall Study|Became ineligible after randomisation|71|||
162947042|NCT00860028|588508199|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
162947043|NCT00860028|588508200|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
163187011|NCT03803683|589400252|FG001|Overall Study|Withdrawal by Subject|1|||
163187012|NCT03803683|589400253|FG002|Overall Study|Withdrawal by Subject|4|||
163388209|NCT00593957|590132038|FG001|Overall Study|Physician Decision|1|||
163388210|NCT00593957|590132039|FG002|Overall Study|Physician Decision|2|||
163388211|NCT00494481|590132042|FG000|Overall Study|Condition under investigation worsened|11|||
163388212|NCT00494481|590132043|FG001|Overall Study|Condition under investigation worsened|13|||
163388213|NCT00494481|590132042|FG000|Overall Study|Adverse Event|15|||
163388214|NCT00494481|590132043|FG001|Overall Study|Adverse Event|11|||
163388215|NCT00494481|590132042|FG000|Overall Study|Other|1|||
163388216|NCT00494481|590132043|FG001|Overall Study|Other|0|||
163388217|NCT00494481|590132042|FG000|Overall Study|Never received IP|2|||
163388218|NCT00494481|590132043|FG001|Overall Study|Never received IP|0|||
163388219|NCT01030198|590132044|FG000|Overall Study|Could not measure efficacy accurately|0|||
163388220|NCT01030198|590132045|FG001|Overall Study|Could not measure efficacy accurately|7|||
163388221|NCT01411839|590132047|FG000|Overall Study|Lost to Follow-up|4|||
163388222|NCT01411839|590132048|FG001|Overall Study|Lost to Follow-up|3|||
163388223|NCT05736211|590133921|FG000|Overall Study|Lost to Follow-up|6|||
163388224|NCT05736211|590133922|FG001|Overall Study|Lost to Follow-up|0|||
163388225|NCT05104476|590133925|FG000|Overall Study|Randomized But Not Treated|1|||
163388226|NCT05104476|590133926|FG001|Overall Study|Randomized But Not Treated|2|||
163388227|NCT05104476|590133925|FG000|Overall Study|Adverse Event|2|||
162947044|NCT02576990|588508201|FG000|Overall Study|Death|29|||
162947045|NCT02576990|588508202|FG001|Overall Study|Death|18|||
162947046|NCT02576990|588508201|FG000|Overall Study|Physician Decision|1|||
162947047|NCT02576990|588508202|FG001|Overall Study|Physician Decision|0|||
162947048|NCT02576990|588508201|FG000|Overall Study|Screen failure|2|||
162947049|NCT02576990|588508202|FG001|Overall Study|Screen failure|0|||
162947050|NCT02576990|588508201|FG000|Overall Study|Sponsor's decision|24|||
162947051|NCT02576990|588508202|FG001|Overall Study|Sponsor's decision|4|||
162947052|NCT02576990|588508201|FG000|Overall Study|Withdrawal by Subject|0|||
162947053|NCT02576990|588508202|FG001|Overall Study|Withdrawal by Subject|2|||
162947054|NCT00936390|588508203|FG000|Overall Study|Protocol Violation|21|||
162947055|NCT00936390|588508204|FG001|Overall Study|Protocol Violation|25|||
162947056|NCT02093689|588508205|FG000|Overall Study|Physician Decision|4|||
162947057|NCT02093689|588508206|FG001|Overall Study|Physician Decision|0|||
162947058|NCT02093689|588508207|FG002|Overall Study|Physician Decision|0|||
162947059|NCT00475020|588508208|FG000|Overall Study|Physician Decision|3|||
162947060|NCT00475020|588508208|FG000|Overall Study|Insurance Denial|1|||
162947061|NCT00475020|588508208|FG000|Overall Study|Donor not able to donate the last minute|1|||
162947062|NCT01575054|588508209|FG000|Overall Study|Other Reasons|5|||
162947063|NCT01575054|588508210|FG001|Overall Study|Other Reasons|3|||
162947064|NCT01575054|588508209|FG000|Overall Study|Protocol Violation|2|||
162947065|NCT01575054|588508210|FG001|Overall Study|Protocol Violation|1|||
162947066|NCT01575054|588508209|FG000|Overall Study|Personal Reasons|10|||
162947067|NCT01575054|588508210|FG001|Overall Study|Personal Reasons|11|||
162947068|NCT01575054|588508209|FG000|Overall Study|Lost to Follow-up|3|||
162947069|NCT01575054|588508210|FG001|Overall Study|Lost to Follow-up|3|||
162947070|NCT01575054|588508209|FG000|Overall Study|Adverse Event|9|||
162947071|NCT01575054|588508210|FG001|Overall Study|Adverse Event|8|||
162947072|NCT03481309|588508211|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
162947073|NCT03481309|588508212|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
162947074|NCT03481309|588508213|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
162947075|NCT03481309|588508214|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
162947076|NCT03481309|588508215|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
162947077|NCT03481309|588508216|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
162947078|NCT03309956|588508219|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
162947079|NCT02768298|588508220|FG000|Overall Study|Adverse Event|1|||
162947080|NCT02768298|588508221|FG001|Overall Study|Adverse Event|4|||
162947081|NCT02768298|588508220|FG000|Overall Study|Death|2|||
162947082|NCT02768298|588508221|FG001|Overall Study|Death|1|||
162947083|NCT02768298|588508220|FG000|Overall Study|Non-compliance with study treatment|0|||
162947084|NCT02768298|588508221|FG001|Overall Study|Non-compliance with study treatment|1|||
162947085|NCT02768298|588508220|FG000|Overall Study|Subject/guardian decision|1|||
162947086|NCT02768298|588508221|FG001|Overall Study|Subject/guardian decision|0|||
162947087|NCT02768298|588508220|FG000|Overall Study|Withdrawal of informed consent|0|||
162947088|NCT02768298|588508221|FG001|Overall Study|Withdrawal of informed consent|1|||
162947089|NCT03365947|588508222|FG000|Overall Study|Lost to Follow-up|0|||
162947090|NCT03365947|588508223|FG001|Overall Study|Lost to Follow-up|0|||
162947091|NCT03365947|588508224|FG002|Overall Study|Lost to Follow-up|0|||
162947092|NCT03365947|588508225|FG003|Overall Study|Lost to Follow-up|0|||
162947093|NCT03365947|588508226|FG004|Overall Study|Lost to Follow-up|0|||
162947094|NCT03365947|588508227|FG005|Overall Study|Lost to Follow-up|1|||
162947095|NCT03365947|588508228|FG006|Overall Study|Lost to Follow-up|0|||
162947096|NCT03365947|588508229|FG007|Overall Study|Lost to Follow-up|0|||
162947097|NCT03365947|588508230|FG008|Overall Study|Lost to Follow-up|0|||
163187013|NCT01507298|589401787|FG000|Overall Study|Protocol Violation|0|||
163187014|NCT01507298|589401788|FG001|Overall Study|Protocol Violation|6|||
163187015|NCT01920555|589401789|FG000|Overall Study|Physician Decision|1|||
163187016|NCT01920555|589401790|FG001|Overall Study|Physician Decision|2|||
163187017|NCT01920555|589401791|FG002|Overall Study|Physician Decision|1|||
163187018|NCT01920555|589401792|FG003|Overall Study|Physician Decision|2|||
163187019|NCT01920555|589401793|FG004|Overall Study|Physician Decision|0|||
163187020|NCT01920555|589401789|FG000|Overall Study|Lack of Efficacy|2|||
163292135|NCT03622580|589775281|FG000|Overall Study|Withdrawal by Subject|12|||
163292136|NCT03622580|589775282|FG001|Overall Study|Withdrawal by Subject|7|||
163292137|NCT03622580|589775283|FG002|Overall Study|Withdrawal by Subject|19|||
162947098|NCT03365947|588508231|FG009|Overall Study|Lost to Follow-up|0|||
162947099|NCT03365947|588508232|FG010|Overall Study|Lost to Follow-up|0|||
162947100|NCT03365947|588508233|FG011|Overall Study|Lost to Follow-up|0|||
162947101|NCT03365947|588508234|FG012|Overall Study|Lost to Follow-up|0|||
162947102|NCT03365947|588508235|FG013|Overall Study|Lost to Follow-up|0|||
162947103|NCT03365947|588508236|FG014|Overall Study|Lost to Follow-up|0|||
162947104|NCT03365947|588508237|FG015|Overall Study|Lost to Follow-up|0|||
162947105|NCT03365947|588508238|FG016|Overall Study|Lost to Follow-up|0|||
162947106|NCT03365947|588508239|FG017|Overall Study|Lost to Follow-up|0|||
162947107|NCT03365947|588508240|FG018|Overall Study|Lost to Follow-up|0|||
162947108|NCT02518685|588508241|FG000|Overall Study|Adverse Event|29|||
162947109|NCT02518685|588508242|FG001|Overall Study|Adverse Event|1|||
162947110|NCT02518685|588508241|FG000|Overall Study|Withdrawal by Subject|10|||
162947111|NCT02518685|588508242|FG001|Overall Study|Withdrawal by Subject|3|||
162947112|NCT02518685|588508241|FG000|Overall Study|relocation, study fatigue|7|||
162947113|NCT02518685|588508242|FG001|Overall Study|relocation, study fatigue|2|||
162947114|NCT02518685|588508241|FG000|Overall Study|Pregnancy|1|||
163292138|NCT03622580|589775281|FG000|Overall Study|Lost to Follow-up|12|||
163292139|NCT03622580|589775282|FG001|Overall Study|Lost to Follow-up|9|||
163292140|NCT03622580|589775283|FG002|Overall Study|Lost to Follow-up|9|||
163292141|NCT03622580|589775281|FG000|Overall Study|Protocol Violation|1|||
163292142|NCT03622580|589775282|FG001|Overall Study|Protocol Violation|0|||
163292143|NCT03622580|589775283|FG002|Overall Study|Protocol Violation|1|||
163292144|NCT03622580|589775281|FG000|Overall Study|Physician Decision|3|||
163292145|NCT03622580|589775282|FG001|Overall Study|Physician Decision|0|||
163292146|NCT03622580|589775283|FG002|Overall Study|Physician Decision|1|||
163292147|NCT03622580|589775281|FG000|Overall Study|Pregnancy|0|||
163292148|NCT03622580|589775282|FG001|Overall Study|Pregnancy|1|||
163292149|NCT03622580|589775283|FG002|Overall Study|Pregnancy|0|||
163292150|NCT03622580|589775281|FG000|Overall Study|Lack of Efficacy|0|||
163292151|NCT03622580|589775282|FG001|Overall Study|Lack of Efficacy|0|||
163292152|NCT03622580|589775283|FG002|Overall Study|Lack of Efficacy|1|||
163292153|NCT03622580|589775281|FG000|Overall Study|Other|2|||
163292154|NCT03622580|589775282|FG001|Overall Study|Other|0|||
163292155|NCT03622580|589775283|FG002|Overall Study|Other|3|||
163292156|NCT03959241|589775286|FG000|Overall Study|Withdrawal by Subject|7|||
163292157|NCT03959241|589775287|FG001|Overall Study|Withdrawal by Subject|8|||
163292158|NCT03959241|589775286|FG000|Overall Study|Lost to Follow-up|1|||
163292159|NCT03959241|589775287|FG001|Overall Study|Lost to Follow-up|0|||
163292160|NCT03959241|589775286|FG000|Overall Study|Move to Hospice Care|1|||
163292161|NCT03959241|589775287|FG001|Overall Study|Move to Hospice Care|0|||
163292162|NCT03959241|589775286|FG000|Overall Study|Screen Failure|1|||
163292163|NCT03959241|589775287|FG001|Overall Study|Screen Failure|0|||
163292164|NCT03959241|589775286|FG000|Overall Study|Disease Relapse|0|||
163292165|NCT03959241|589775287|FG001|Overall Study|Disease Relapse|1|||
163292166|NCT03959241|589775286|FG000|Overall Study|Off Study|1|||
163292167|NCT03959241|589775287|FG001|Overall Study|Off Study|0|||
163292168|NCT01713530|589775288|FG000|Overall Study|Adverse Event|0|||
163292169|NCT01713530|589775289|FG001|Overall Study|Adverse Event|5|||
163292170|NCT01713530|589775288|FG000|Overall Study|Withdrawal criteria|21|||
163292171|NCT01713530|589775289|FG001|Overall Study|Withdrawal criteria|12|||
163292172|NCT01713530|589775288|FG000|Overall Study|Unclassified|4|||
163292173|NCT01713530|589775289|FG001|Overall Study|Unclassified|2|||
163292174|NCT03939819|589775290|FG000|Overall Study|Death|2|||
163292175|NCT03939819|589775291|FG001|Overall Study|Death|0|||
163292176|NCT03987451|589775292|FG000|Overall Study|Lost to Follow-up|1|||
163292177|NCT03987451|589775293|FG001|Overall Study|Lost to Follow-up|0|||
163292178|NCT03987451|589775292|FG000|Overall Study|Withdrawal by Subject|1|||
163292179|NCT03987451|589775293|FG001|Overall Study|Withdrawal by Subject|1|||
163292180|NCT00790790|589775295|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
163292181|NCT00790790|589775296|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
163292182|NCT00790790|589775297|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
163292183|NCT00790790|589775295|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
163292184|NCT00790790|589775296|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
163292185|NCT00790790|589775297|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
163292186|NCT00790790|589775295|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
163292187|NCT00790790|589775296|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
162947115|NCT02518685|588508242|FG001|Overall Study|Pregnancy|0|||
162947116|NCT02518685|588508241|FG000|Overall Study|Physician Decision|1|||
162947117|NCT02518685|588508242|FG001|Overall Study|Physician Decision|0|||
162947118|NCT02518685|588508241|FG000|Overall Study|Lost to Follow-up|1|||
162947119|NCT02518685|588508242|FG001|Overall Study|Lost to Follow-up|4|||
162947120|NCT01922349|588508243|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
162947121|NCT01922349|588508244|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
162947122|NCT01922349|588508245|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
162947123|NCT01922349|588508246|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
163187021|NCT01920555|589401790|FG001|Overall Study|Lack of Efficacy|0|||
163187022|NCT01920555|589401791|FG002|Overall Study|Lack of Efficacy|0|||
163187023|NCT01920555|589401792|FG003|Overall Study|Lack of Efficacy|0|||
163187024|NCT01920555|589401793|FG004|Overall Study|Lack of Efficacy|0|||
163187025|NCT01920555|589401789|FG000|Overall Study|Travel Difficulties|1|||
163187026|NCT01920555|589401790|FG001|Overall Study|Travel Difficulties|1|||
163187027|NCT01920555|589401791|FG002|Overall Study|Travel Difficulties|0|||
163187028|NCT01920555|589401792|FG003|Overall Study|Travel Difficulties|0|||
163187029|NCT01920555|589401793|FG004|Overall Study|Travel Difficulties|1|||
163187030|NCT01920555|589401789|FG000|Overall Study|Lost to Follow-up|0|||
163187031|NCT01920555|589401790|FG001|Overall Study|Lost to Follow-up|1|||
163187032|NCT01920555|589401791|FG002|Overall Study|Lost to Follow-up|0|||
163187033|NCT01920555|589401792|FG003|Overall Study|Lost to Follow-up|1|||
163187034|NCT01920555|589401793|FG004|Overall Study|Lost to Follow-up|0|||
163187035|NCT00426231|589401794|FG000|Overall Study|Withdrawal by Subject|9|||
163187036|NCT00426231|589401795|FG001|Overall Study|Withdrawal by Subject|12|||
163187037|NCT00108433|589401796|FG000|Overall Study|Lack of Efficacy|1|||
163187038|NCT00108433|589401797|FG001|Overall Study|Lack of Efficacy|2|||
163187039|NCT00108433|589401796|FG000|Overall Study|Death|3|||
163292188|NCT00790790|589775297|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
163187040|NCT00108433|589401797|FG001|Overall Study|Death|0|||
163187041|NCT00108433|589401796|FG000|Overall Study|Adverse Event|3|||
163187042|NCT00108433|589401797|FG001|Overall Study|Adverse Event|1|||
163187043|NCT00108433|589401796|FG000|Overall Study|Other|14|||
163187044|NCT00108433|589401797|FG001|Overall Study|Other|14|||
163187045|NCT01193660|589401798|FG000|Overall Study|Withdrawal by Subject|2|||
163388228|NCT05104476|590133926|FG001|Overall Study|Adverse Event|2|||
163388229|NCT05104476|590133925|FG000|Overall Study|Withdrawal by Subject|3|||
163388230|NCT05104476|590133926|FG001|Overall Study|Withdrawal by Subject|3|||
163388231|NCT05104476|590133925|FG000|Overall Study|Other Than Specified|0|||
163388232|NCT05104476|590133926|FG001|Overall Study|Other Than Specified|3|||
163388233|NCT00992511|590133930|FG000|Overall Study|Migrated/moved from study area|1|||
163388234|NCT00992511|590133931|FG001|Overall Study|Migrated/moved from study area|0|||
163388235|NCT00992511|590133932|FG002|Overall Study|Migrated/moved from study area|1|||
163388236|NCT00992511|590133933|FG003|Overall Study|Migrated/moved from study area|2|||
163388237|NCT00992511|590133930|FG000|Overall Study|Lost to Follow-up|1|||
163388238|NCT00992511|590133931|FG001|Overall Study|Lost to Follow-up|0|||
163388239|NCT00992511|590133932|FG002|Overall Study|Lost to Follow-up|0|||
163388240|NCT00992511|590133933|FG003|Overall Study|Lost to Follow-up|2|||
163388241|NCT00992511|590133930|FG000|Overall Study|Withdrawal by Subject|0|||
163388242|NCT00992511|590133931|FG001|Overall Study|Withdrawal by Subject|0|||
163388243|NCT00992511|590133932|FG002|Overall Study|Withdrawal by Subject|1|||
163388244|NCT00992511|590133933|FG003|Overall Study|Withdrawal by Subject|1|||
163388245|NCT01180998|590133934|FG000|Overall Study|Poor Vision|0|||
163388246|NCT01180998|590133935|FG001|Overall Study|Poor Vision|2|||
163388247|NCT01180998|590133936|FG002|Overall Study|Poor Vision|2|||
163388248|NCT01180998|590133934|FG000|Overall Study|Lost to Follow-up|0|||
163388249|NCT01180998|590133935|FG001|Overall Study|Lost to Follow-up|0|||
163388250|NCT01180998|590133936|FG002|Overall Study|Lost to Follow-up|1|||
163388251|NCT01180998|590133934|FG000|Overall Study|Protocol Violation|1|||
163388252|NCT01180998|590133935|FG001|Overall Study|Protocol Violation|2|||
163388253|NCT01180998|590133936|FG002|Overall Study|Protocol Violation|0|||
163388254|NCT01180998|590133934|FG000|Overall Study|Withdrawal by Subject|0|||
163388255|NCT01180998|590133935|FG001|Overall Study|Withdrawal by Subject|0|||
163388256|NCT01180998|590133936|FG002|Overall Study|Withdrawal by Subject|1|||
163388257|NCT01180998|590133934|FG000|Overall Study|Poor comfort|3|||
163388258|NCT01180998|590133935|FG001|Overall Study|Poor comfort|0|||
163388259|NCT01180998|590133936|FG002|Overall Study|Poor comfort|4|||
163388260|NCT01180998|590133934|FG000|Overall Study|Poor lens handling|0|||
163388261|NCT01180998|590133935|FG001|Overall Study|Poor lens handling|0|||
163388262|NCT01180998|590133936|FG002|Overall Study|Poor lens handling|2|||
162947124|NCT05109234|588508247|FG000|Overall Study|Adverse Event|2|||
163388263|NCT01176968|590133937|FG000|Overall Study|Adverse Event|10|||
163388264|NCT01176968|590133938|FG001|Overall Study|Adverse Event|11|||
163388265|NCT01176968|590133937|FG000|Overall Study|Death|2|||
163388266|NCT01176968|590133938|FG001|Overall Study|Death|3|||
163388267|NCT01176968|590133937|FG000|Overall Study|Lack of Efficacy|0|||
163187046|NCT01193660|589401799|FG001|Overall Study|Withdrawal by Subject|3|||
163187047|NCT01193660|589401800|FG002|Overall Study|Withdrawal by Subject|1|||
163187048|NCT01193660|589401798|FG000|Overall Study|Death|1|||
163187049|NCT01193660|589401799|FG001|Overall Study|Death|0|||
163187050|NCT01193660|589401800|FG002|Overall Study|Death|0|||
163187051|NCT01193660|589401798|FG000|Overall Study|Physician Decision|1|||
163187052|NCT01193660|589401799|FG001|Overall Study|Physician Decision|0|||
163187053|NCT01193660|589401800|FG002|Overall Study|Physician Decision|1|||
163187054|NCT01886716|589401801|FG000|Week 1|Lost to Follow-up|0|||
163187055|NCT01886716|589401802|FG001|Week 1|Lost to Follow-up|0|||
163187056|NCT01886716|589401803|FG002|Week 1|Lost to Follow-up|2|||
163187057|NCT01886716|589401804|FG003|Week 1|Lost to Follow-up|2|||
163187058|NCT01886716|589401801|FG000|Week 2|Lost to Follow-up|3|||
163187059|NCT01886716|589401802|FG001|Week 2|Lost to Follow-up|2|||
163187060|NCT01886716|589401803|FG002|Week 2|Lost to Follow-up|1|||
163187061|NCT01886716|589401804|FG003|Week 2|Lost to Follow-up|3|||
163187062|NCT01886716|589401801|FG000|Week 3|Lost to Follow-up|1|||
163187063|NCT01886716|589401802|FG001|Week 3|Lost to Follow-up|1|||
163187064|NCT01886716|589401803|FG002|Week 3|Lost to Follow-up|0|||
163187065|NCT01886716|589401804|FG003|Week 3|Lost to Follow-up|1|||
163388268|NCT01176968|590133938|FG001|Overall Study|Lack of Efficacy|1|||
163388269|NCT01176968|590133937|FG000|Overall Study|Lost to Follow-up|16|||
163388270|NCT01176968|590133938|FG001|Overall Study|Lost to Follow-up|14|||
163388271|NCT01176968|590133937|FG000|Overall Study|Withdrawal by Subject|48|||
163388272|NCT01176968|590133938|FG001|Overall Study|Withdrawal by Subject|48|||
163388273|NCT01176968|590133937|FG000|Overall Study|Protocol Violation|2|||
163388274|NCT01176968|590133938|FG001|Overall Study|Protocol Violation|1|||
163388275|NCT01176968|590133937|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
163388276|NCT01176968|590133938|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
163388277|NCT01176968|590133937|FG000|Overall Study|Study terminated by sponsor|0|||
163388278|NCT01176968|590133938|FG001|Overall Study|Study terminated by sponsor|1|||
163388279|NCT01176968|590133937|FG000|Overall Study|Reason not defined|5|||
163388280|NCT01176968|590133938|FG001|Overall Study|Reason not defined|3|||
163388281|NCT04098068|590133939|FG000|Overall Study|Disease Progression|7|||
163388282|NCT04098068|590133939|FG000|Overall Study|Withdrawal by Subject|2|||
163388283|NCT04098068|590133939|FG000|Overall Study|New Cancer Diagnosis|1|||
163388284|NCT00744523|590133940|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
163388285|NCT00744523|590133941|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
163388286|NCT05057247|590133942|FG000|Overall Study|Death|4|||
163388287|NCT05057247|590133942|FG000|Overall Study|Physician Decision|3|||
163388288|NCT05057247|590133942|FG000|Overall Study|Progressive Disease|7|||
163388289|NCT05057247|590133942|FG000|Overall Study|Withdrawal by Subject|3|||
163388290|NCT05057247|590133942|FG000|Overall Study|Adverse Event|6|||
163388291|NCT05057247|590133942|FG000|Overall Study|Subject Non-Compliance|1|||
163388292|NCT05057247|590133942|FG000|Overall Study|On treatment|2|||
163388293|NCT03588728|590133946|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
163388294|NCT03588728|590133947|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
163388295|NCT03588728|590133948|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
163388296|NCT03588728|590133949|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
163388297|NCT03588728|590133946|FG000|Overall Study|Lab shut down due to COVID-19|0|||
163388298|NCT03588728|590133947|FG001|Overall Study|Lab shut down due to COVID-19|0|||
163388299|NCT03588728|590133948|FG002|Overall Study|Lab shut down due to COVID-19|0|||
163388300|NCT03588728|590133949|FG003|Overall Study|Lab shut down due to COVID-19|1|||
163388301|NCT03588728|590133946|FG000|Overall Study|multiple technical issues|1|||
163388302|NCT03588728|590133947|FG001|Overall Study|multiple technical issues|0|||
163388303|NCT03588728|590133948|FG002|Overall Study|multiple technical issues|0|||
163388304|NCT03588728|590133949|FG003|Overall Study|multiple technical issues|0|||
163388305|NCT03588728|590133946|FG000|Overall Study|Hospitalized for COVID|1|||
163388306|NCT03588728|590133947|FG001|Overall Study|Hospitalized for COVID|0|||
163187066|NCT01051466|589401806|FG000|Overall Study|Adverse Event|1|||
163187067|NCT01051466|589401807|FG001|Overall Study|Adverse Event|0|||
163187068|NCT01051466|589401806|FG000|Overall Study|Lost to Follow-up|1|||
163187069|NCT01051466|589401807|FG001|Overall Study|Lost to Follow-up|1|||
163187070|NCT01051466|589401806|FG000|Overall Study|Withdrawal by Subject|5|||
163187071|NCT01051466|589401807|FG001|Overall Study|Withdrawal by Subject|1|||
163187072|NCT01051466|589401806|FG000|Overall Study|Entry Criteria Not Met|0|||
163187073|NCT01051466|589401807|FG001|Overall Study|Entry Criteria Not Met|3|||
163187074|NCT01051466|589401806|FG000|Overall Study|Physician Decision|1|||
163187075|NCT01051466|589401807|FG001|Overall Study|Physician Decision|0|||
163187076|NCT04806503|589401810|FG000|Overall Study|Lost to Follow-up|0|||
163187077|NCT04806503|589401811|FG001|Overall Study|Lost to Follow-up|0|||
163187078|NCT04806503|589401812|FG002|Overall Study|Lost to Follow-up|1|||
163187079|NCT04806503|589401813|FG003|Overall Study|Lost to Follow-up|0|||
163187080|NCT04806503|589401814|FG004|Overall Study|Lost to Follow-up|0|||
163187081|NCT04806503|589401810|FG000|Overall Study|Withdrawal by Subject|1|||
163187082|NCT04806503|589401811|FG001|Overall Study|Withdrawal by Subject|0|||
163187083|NCT04806503|589401812|FG002|Overall Study|Withdrawal by Subject|1|||
163388307|NCT03588728|590133948|FG002|Overall Study|Hospitalized for COVID|0|||
163388308|NCT03588728|590133949|FG003|Overall Study|Hospitalized for COVID|0|||
163388309|NCT03588728|590133946|FG000|Overall Study|Schedule change unable to attend sessions|1|||
163388310|NCT03588728|590133947|FG001|Overall Study|Schedule change unable to attend sessions|0|||
163388311|NCT03588728|590133948|FG002|Overall Study|Schedule change unable to attend sessions|0|||
163187084|NCT04806503|589401813|FG003|Overall Study|Withdrawal by Subject|1|||
163187085|NCT04806503|589401814|FG004|Overall Study|Withdrawal by Subject|1|||
163187086|NCT04806503|589401810|FG000|Overall Study|Adverse Event|1|||
163187087|NCT04806503|589401811|FG001|Overall Study|Adverse Event|1|||
163187088|NCT04806503|589401812|FG002|Overall Study|Adverse Event|0|||
163187089|NCT04806503|589401813|FG003|Overall Study|Adverse Event|1|||
163187090|NCT04806503|589401814|FG004|Overall Study|Adverse Event|0|||
162947125|NCT05109234|588508248|FG001|Overall Study|Adverse Event|2|||
162947126|NCT05109234|588508247|FG000|Overall Study|Lack of Efficacy|5|||
162947127|NCT05109234|588508248|FG001|Overall Study|Lack of Efficacy|0|||
162947128|NCT05109234|588508247|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
163187091|NCT03589469|589401815|FG000|Overall Study|Withdrawal by Subject|8|||
163187092|NCT03589469|589401815|FG000|Overall Study|Physician Decision|20|||
163187093|NCT03589469|589401815|FG000|Overall Study|Death|97|||
163187094|NCT03589469|589401815|FG000|Overall Study|Lost to Follow-up|8|||
163187095|NCT03589469|589401815|FG000|Overall Study|Miscellaneous|1|||
163187096|NCT05061966|589401818|FG000|Overall Study|Lost to Follow-up|13|||
163187097|NCT05061966|589401819|FG001|Overall Study|Lost to Follow-up|13|||
163187098|NCT03793556|589401820|FG000|Overall Study|Withdrawal by Subject|12|||
162947129|NCT05109234|588508248|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
162947130|NCT05109234|588508247|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
163187099|NCT03793556|589401821|FG001|Overall Study|Withdrawal by Subject|1|||
163187100|NCT03793556|589401820|FG000|Overall Study|Lost to Follow-up|1|||
163388312|NCT03588728|590133949|FG003|Overall Study|Schedule change unable to attend sessions|0|||
163388313|NCT01388790|590133950|FG000|Overall Study|Ongoing at data cut-off date|8|||
163388314|NCT00528866|590133951|FG000|Overall Study|Protocol Violation|6|||
163388315|NCT00993915|590133952|FG000|Overall Study|Insufficient clinical response|3|||
163388316|NCT00993915|590133952|FG000|Overall Study|Withdrawal by Subject|2|||
163388317|NCT00993915|590133952|FG000|Overall Study|Other|1|||
163388318|NCT00993915|590133952|FG000|Overall Study|Ongoing|3|||
163388319|NCT01386658|590133953|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
163388320|NCT01386658|590133954|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
163388321|NCT01386658|590133953|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
163388322|NCT01386658|590133954|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
163388323|NCT02465463|590133955|FG000|Overall Study|Lost to Follow-up|2|||
163388324|NCT02465463|590133956|FG001|Overall Study|Lost to Follow-up|1|||
163388325|NCT02465463|590133955|FG000|Overall Study|Death|1|||
163388326|NCT02465463|590133956|FG001|Overall Study|Death|0|||
163388327|NCT02465463|590133955|FG000|Overall Study|Protocol Violation|1|||
163388328|NCT02465463|590133956|FG001|Overall Study|Protocol Violation|0|||
163388329|NCT01067326|590133961|FG000|Overall Study|Adverse Event|0|||
163388330|NCT01067326|590133962|FG001|Overall Study|Adverse Event|2|||
163388331|NCT01067326|590133961|FG000|Overall Study|Withdrawal by Subject|1|||
163388332|NCT01067326|590133962|FG001|Overall Study|Withdrawal by Subject|0|||
163388333|NCT01067326|590133961|FG000|Overall Study|Early Study Termination|1|||
163388334|NCT01067326|590133962|FG001|Overall Study|Early Study Termination|1|||
163388335|NCT00323297|590133963|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
163388336|NCT00323297|590133964|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
163388337|NCT00323297|590133963|FG000|Part A (Double Blind Randomized)|Death|0|||
163388338|NCT00323297|590133964|FG001|Part A (Double Blind Randomized)|Death|1|||
163388339|NCT00323297|590133963|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
163388340|NCT00323297|590133964|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
163388341|NCT00323297|590133963|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
163388342|NCT00323297|590133964|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
163388343|NCT00323297|590133963|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
163388344|NCT00323297|590133964|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
163388345|NCT00323297|590133963|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
163187101|NCT03793556|589401821|FG001|Overall Study|Lost to Follow-up|1|||
163187102|NCT01325623|589401822|FG000|Overall Study|Withdrawal by Subject|3|||
163187103|NCT00598702|589401823|FG000|Overall Study|Other|0|||
163187104|NCT00598702|589401824|FG001|Overall Study|Other|2|||
163187105|NCT00598702|589401825|FG002|Overall Study|Other|0|||
163187106|NCT00598702|589401826|FG003|Overall Study|Other|0|||
163187107|NCT00598702|589401827|FG004|Overall Study|Other|0|||
163187108|NCT00598702|589401828|FG005|Overall Study|Other|1|||
163187109|NCT00598702|589401829|FG006|Overall Study|Other|0|||
163187110|NCT00598702|589401830|FG007|Overall Study|Other|0|||
163187111|NCT00598702|589401823|FG000|Overall Study|Early discharge from hospital|0|||
163187112|NCT00598702|589401824|FG001|Overall Study|Early discharge from hospital|0|||
163187113|NCT00598702|589401825|FG002|Overall Study|Early discharge from hospital|2|||
163187114|NCT00598702|589401826|FG003|Overall Study|Early discharge from hospital|5|||
163187115|NCT00598702|589401827|FG004|Overall Study|Early discharge from hospital|0|||
163187116|NCT00598702|589401828|FG005|Overall Study|Early discharge from hospital|10|||
163187117|NCT00598702|589401829|FG006|Overall Study|Early discharge from hospital|1|||
163187118|NCT00598702|589401830|FG007|Overall Study|Early discharge from hospital|0|||
163187119|NCT00598702|589401823|FG000|Overall Study|Adverse Event|0|||
163187120|NCT00598702|589401824|FG001|Overall Study|Adverse Event|0|||
163187121|NCT00598702|589401825|FG002|Overall Study|Adverse Event|0|||
163187122|NCT00598702|589401826|FG003|Overall Study|Adverse Event|1|||
163187123|NCT00598702|589401827|FG004|Overall Study|Adverse Event|0|||
163187124|NCT00598702|589401828|FG005|Overall Study|Adverse Event|0|||
163187125|NCT00598702|589401829|FG006|Overall Study|Adverse Event|0|||
163187126|NCT00598702|589401830|FG007|Overall Study|Adverse Event|0|||
163388346|NCT00323297|590133964|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
163388347|NCT00323297|590133963|FG000|Part B (Open-label)|Death|0|||
163388348|NCT00323297|590133964|FG001|Part B (Open-label)|Death|1|||
163388349|NCT00323297|590133963|FG000|Part B (Open-label)|Reason unspecified|0|||
163388350|NCT00323297|590133964|FG001|Part B (Open-label)|Reason unspecified|1|||
163388351|NCT00323297|590133963|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
163388352|NCT00323297|590133964|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
163388353|NCT00323297|590133963|FG000|Part B (Open-label)|Lack of Efficacy|3|||
163388354|NCT00323297|590133964|FG001|Part B (Open-label)|Lack of Efficacy|1|||
163388355|NCT00323297|590133963|FG000|Part B (Open-label)|Adverse Event|5|||
163388356|NCT00323297|590133964|FG001|Part B (Open-label)|Adverse Event|5|||
163388357|NCT00323297|590133963|FG000|Part B (Open-label)|Protocol Violation|0|||
163388358|NCT00323297|590133964|FG001|Part B (Open-label)|Protocol Violation|1|||
163388359|NCT01176773|590133965|FG000|Overall Study|Screen Failure|2|||
163388360|NCT01176773|590133965|FG000|Overall Study|Withdrew consent|1|||
163388361|NCT01498289|590133967|FG000|Overall Study|Adverse Event|16|||
163388362|NCT01498289|590133968|FG001|Overall Study|Adverse Event|18|||
163388363|NCT01498289|590133967|FG000|Overall Study|Death|6|||
163388364|NCT01498289|590133968|FG001|Overall Study|Death|8|||
163388365|NCT01498289|590133967|FG000|Overall Study|Withdrawal unrelated to AE|16|||
163388366|NCT01498289|590133968|FG001|Overall Study|Withdrawal unrelated to AE|16|||
163388367|NCT01498289|590133967|FG000|Overall Study|Progression/relapse|53|||
163388368|NCT01498289|590133968|FG001|Overall Study|Progression/relapse|59|||
163388369|NCT01498289|590133967|FG000|Overall Study|Not protocol specified|7|||
163388370|NCT01498289|590133968|FG001|Overall Study|Not protocol specified|2|||
163388371|NCT01498289|590133967|FG000|Overall Study|Reason under review|0|||
163388372|NCT01498289|590133968|FG001|Overall Study|Reason under review|1|||
163388373|NCT00132496|590133978|FG000|Overall Study|Withdrawal by Subject|1|||
163388374|NCT00132496|590133979|FG001|Overall Study|Withdrawal by Subject|2|||
163388375|NCT00132496|590133978|FG000|Overall Study|Physician Decision|1|||
163388376|NCT00132496|590133979|FG001|Overall Study|Physician Decision|0|||
163388377|NCT00986440|590133982|FG000|Overall Study|Progressive disease|27|||
163388378|NCT00986440|590133983|FG001|Overall Study|Progressive disease|37|||
163388379|NCT00986440|590133982|FG000|Overall Study|Serious adverse event or adverse event|9|||
163388380|NCT00986440|590133983|FG001|Overall Study|Serious adverse event or adverse event|2|||
163388381|NCT00986440|590133982|FG000|Overall Study|Withdrawal by Subject|1|||
163388382|NCT00986440|590133983|FG001|Overall Study|Withdrawal by Subject|2|||
163388383|NCT00986440|590133982|FG000|Overall Study|Screen failure (not dosed)|4|||
163388384|NCT00986440|590133983|FG001|Overall Study|Screen failure (not dosed)|2|||
163388385|NCT00388154|590133984|FG000|Overall Study|Withdrawal by Subject|1|||
163388386|NCT02520284|590133987|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
163388387|NCT02520284|590133988|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
163388388|NCT02520284|590133989|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
163388389|NCT02520284|590133987|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
163388390|NCT02520284|590133988|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
163388391|NCT02520284|590133989|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
163388392|NCT02520284|590133987|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
163388393|NCT02520284|590133988|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
163388394|NCT02520284|590133989|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
163388395|NCT02520284|590133987|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
163388396|NCT02520284|590133988|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
163388397|NCT02520284|590133989|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
163388398|NCT02520284|590133987|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
163388399|NCT02520284|590133988|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
163388400|NCT02520284|590133989|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
163388401|NCT02520284|590133987|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
163388402|NCT02520284|590133988|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
163388403|NCT02520284|590133989|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
163388404|NCT02520284|590133987|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
163292189|NCT00790790|589775295|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
163292190|NCT00790790|589775296|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
163292191|NCT00790790|589775297|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
163292192|NCT00790790|589775295|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
163292193|NCT00790790|589775296|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
163292194|NCT00790790|589775297|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
163292195|NCT02194933|589775299|FG000|Overall Study|Lost to Follow-up|1|||
163292196|NCT02194933|589775300|FG001|Overall Study|Lost to Follow-up|2|||
163292197|NCT02194933|589775299|FG000|Overall Study|Participant met withdrawal criteria|1|||
163292198|NCT02194933|589775300|FG001|Overall Study|Participant met withdrawal criteria|3|||
163292199|NCT02194933|589775299|FG000|Overall Study|Withdrawal by Subject|0|||
163292200|NCT02194933|589775300|FG001|Overall Study|Withdrawal by Subject|2|||
163292201|NCT02194933|589775299|FG000|Overall Study|Lack of Efficacy|1|||
163292202|NCT02194933|589775300|FG001|Overall Study|Lack of Efficacy|2|||
163292203|NCT00988637|589775301|FG000|Overall Study|Lost to Follow-up|2|||
163292204|NCT00988637|589775302|FG001|Overall Study|Lost to Follow-up|1|||
163292205|NCT00988637|589775301|FG000|Overall Study|Withdrawal by Subject|1|||
163292206|NCT00988637|589775302|FG001|Overall Study|Withdrawal by Subject|1|||
163292207|NCT00988637|589775301|FG000|Overall Study|non-compliance with study drug|0|||
163292208|NCT00988637|589775302|FG001|Overall Study|non-compliance with study drug|1|||
163292209|NCT02807493|589775304|FG000|Overall Study|Adverse Event|5|||
163292210|NCT02807493|589775305|FG001|Overall Study|Adverse Event|2|||
163292211|NCT02807493|589775304|FG000|Overall Study|Lost to Follow-up|6|||
163292212|NCT02807493|589775305|FG001|Overall Study|Lost to Follow-up|0|||
163292213|NCT02807493|589775304|FG000|Overall Study|Physician Decision|4|||
163292214|NCT02807493|589775305|FG001|Overall Study|Physician Decision|1|||
163292215|NCT02807493|589775304|FG000|Overall Study|Protocol Violation|7|||
163292216|NCT02807493|589775305|FG001|Overall Study|Protocol Violation|0|||
163292217|NCT02807493|589775304|FG000|Overall Study|Withdrawal by Subject|17|||
163292218|NCT02807493|589775305|FG001|Overall Study|Withdrawal by Subject|10|||
163292219|NCT02807493|589775304|FG000|Overall Study|Other withdrawal|17|||
163292220|NCT02807493|589775305|FG001|Overall Study|Other withdrawal|0|||
163292221|NCT02807493|589775304|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
163292222|NCT02807493|589775305|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
163292223|NCT05190419|589775306|FG000|Overall Study|Lack of Efficacy|8|||
163292224|NCT05190419|589775307|FG001|Overall Study|Lack of Efficacy|0|||
163292225|NCT05190419|589775308|FG002|Overall Study|Lack of Efficacy|1|||
163292226|NCT05190419|589775309|FG003|Overall Study|Lack of Efficacy|0|||
163292227|NCT05190419|589775306|FG000|Overall Study|Withdrawal by Subject|7|||
163292228|NCT05190419|589775307|FG001|Overall Study|Withdrawal by Subject|1|||
163292229|NCT05190419|589775308|FG002|Overall Study|Withdrawal by Subject|2|||
163292230|NCT05190419|589775309|FG003|Overall Study|Withdrawal by Subject|2|||
163292231|NCT05190419|589775306|FG000|Overall Study|Adverse Event|2|||
163292232|NCT05190419|589775307|FG001|Overall Study|Adverse Event|10|||
163292233|NCT05190419|589775308|FG002|Overall Study|Adverse Event|11|||
163292234|NCT05190419|589775309|FG003|Overall Study|Adverse Event|21|||
163292235|NCT05190419|589775306|FG000|Overall Study|Lost to Follow-up|1|||
163292236|NCT05190419|589775307|FG001|Overall Study|Lost to Follow-up|2|||
163292237|NCT05190419|589775308|FG002|Overall Study|Lost to Follow-up|3|||
163388405|NCT02520284|590133988|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
163388406|NCT02520284|590133989|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
163388407|NCT02520284|590133987|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
163388408|NCT02520284|590133988|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
163388409|NCT02520284|590133989|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
163388410|NCT02520284|590133987|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
163388411|NCT02520284|590133988|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
163292238|NCT05190419|589775309|FG003|Overall Study|Lost to Follow-up|1|||
163292239|NCT05190419|589775306|FG000|Overall Study|Other|1|||
163292240|NCT05190419|589775307|FG001|Overall Study|Other|1|||
163187127|NCT00598702|589401823|FG000|Overall Study|Withdrawal by Subject|0|||
163187128|NCT00598702|589401824|FG001|Overall Study|Withdrawal by Subject|0|||
163187129|NCT00598702|589401825|FG002|Overall Study|Withdrawal by Subject|0|||
163187130|NCT00598702|589401826|FG003|Overall Study|Withdrawal by Subject|1|||
163187131|NCT00598702|589401827|FG004|Overall Study|Withdrawal by Subject|1|||
163187132|NCT00598702|589401828|FG005|Overall Study|Withdrawal by Subject|0|||
163187133|NCT00598702|589401829|FG006|Overall Study|Withdrawal by Subject|0|||
163388412|NCT02520284|590133989|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
163388413|NCT02520284|590133987|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
163388414|NCT02520284|590133988|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
163388415|NCT02520284|590133989|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
163388416|NCT02520284|590133987|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
163388417|NCT02520284|590133988|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
163388418|NCT02520284|590133989|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
163388419|NCT03737474|590133990|FG000|Overall Study|Adverse Event|18|||
163388420|NCT03737474|590133991|FG001|Overall Study|Adverse Event|48|||
163388421|NCT03737474|590133990|FG000|Overall Study|Lack of Efficacy|1|||
163388422|NCT03737474|590133991|FG001|Overall Study|Lack of Efficacy|3|||
163388423|NCT03737474|590133990|FG000|Overall Study|Protocol Violation|0|||
163388424|NCT03737474|590133991|FG001|Overall Study|Protocol Violation|8|||
163388425|NCT03737474|590133990|FG000|Overall Study|Withdrawal by Subject|5|||
163388426|NCT03737474|590133991|FG001|Overall Study|Withdrawal by Subject|20|||
163388427|NCT03737474|590133990|FG000|Overall Study|Non-compliance With Study Drug|0|||
163388428|NCT03737474|590133991|FG001|Overall Study|Non-compliance With Study Drug|1|||
163388429|NCT03737474|590133990|FG000|Overall Study|Physician Decision|1|||
163388430|NCT03737474|590133991|FG001|Overall Study|Physician Decision|4|||
163388431|NCT02513745|590133992|FG000|Overall Study|Criteria at time of surgery not met.|3|||
163388432|NCT02513745|590133993|FG001|Overall Study|Criteria at time of surgery not met.|3|||
163388433|NCT00381303|590133994|FG000|Overall Study|Lost to Follow-up|25|||
163388434|NCT00381303|590133995|FG001|Overall Study|Lost to Follow-up|9|||
163388435|NCT00381303|590133994|FG000|Overall Study|AE/HIV-related event|22|||
163388436|NCT00381303|590133995|FG001|Overall Study|AE/HIV-related event|6|||
163388437|NCT00381303|590133994|FG000|Overall Study|Non-Adherence|13|||
163388438|NCT00381303|590133995|FG001|Overall Study|Non-Adherence|6|||
163388439|NCT00381303|590133994|FG000|Overall Study|Withdrawal by Subject|13|||
163388440|NCT00381303|590133995|FG001|Overall Study|Withdrawal by Subject|6|||
163388441|NCT00381303|590133994|FG000|Overall Study|Virologic failure|6|||
163388442|NCT00381303|590133995|FG001|Overall Study|Virologic failure|4|||
163388443|NCT00381303|590133994|FG000|Overall Study|Ineligible to continue the trial|2|||
163388444|NCT00381303|590133995|FG001|Overall Study|Ineligible to continue the trial|1|||
163388445|NCT00381303|590133994|FG000|Overall Study|Pregnancy|2|||
163388446|NCT00381303|590133995|FG001|Overall Study|Pregnancy|0|||
163388447|NCT00381303|590133994|FG000|Overall Study|Physician Decision|1|||
163388448|NCT00381303|590133995|FG001|Overall Study|Physician Decision|0|||
163388449|NCT00381303|590133994|FG000|Overall Study|Physician's decision to close the site|3|||
163388450|NCT00381303|590133995|FG001|Overall Study|Physician's decision to close the site|1|||
163187134|NCT00598702|589401830|FG007|Overall Study|Withdrawal by Subject|0|||
163388451|NCT00381303|590133994|FG000|Overall Study|Subject moved out of state|2|||
163388452|NCT00381303|590133995|FG001|Overall Study|Subject moved out of state|0|||
163388453|NCT00381303|590133994|FG000|Overall Study|Subject taking too many different meds|1|||
163388454|NCT00381303|590133995|FG001|Overall Study|Subject taking too many different meds|0|||
163388455|NCT00381303|590133994|FG000|Overall Study|No virologic response by week 12|1|||
162947131|NCT05109234|588508248|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
163187135|NCT00598702|589401823|FG000|Overall Study|Physician Decision|0|||
163187136|NCT00598702|589401824|FG001|Overall Study|Physician Decision|0|||
163187137|NCT00598702|589401825|FG002|Overall Study|Physician Decision|0|||
163187138|NCT00598702|589401826|FG003|Overall Study|Physician Decision|0|||
163187139|NCT00598702|589401827|FG004|Overall Study|Physician Decision|1|||
163187140|NCT00598702|589401828|FG005|Overall Study|Physician Decision|0|||
163187141|NCT00598702|589401829|FG006|Overall Study|Physician Decision|0|||
163187142|NCT00598702|589401830|FG007|Overall Study|Physician Decision|0|||
163187143|NCT00598702|589401823|FG000|Overall Study|Dose limiting toxicity|0|||
163187144|NCT00598702|589401824|FG001|Overall Study|Dose limiting toxicity|0|||
163292241|NCT05190419|589775308|FG002|Overall Study|Other|0|||
163292242|NCT05190419|589775309|FG003|Overall Study|Other|3|||
163292243|NCT02020616|589775310|FG000|Overall Study|Adverse Event|0|||
163292244|NCT02020616|589775311|FG001|Overall Study|Adverse Event|0|||
163292245|NCT02020616|589775312|FG002|Overall Study|Adverse Event|0|||
162947132|NCT05109234|588508247|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
163292246|NCT02020616|589775313|FG003|Overall Study|Adverse Event|0|||
163292247|NCT02020616|589775314|FG004|Overall Study|Adverse Event|0|||
163292248|NCT02020616|589775315|FG005|Overall Study|Adverse Event|1|||
162947133|NCT05109234|588508248|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
163292249|NCT02020616|589775316|FG006|Overall Study|Adverse Event|1|||
163187145|NCT00598702|589401825|FG002|Overall Study|Dose limiting toxicity|0|||
163187146|NCT00598702|589401826|FG003|Overall Study|Dose limiting toxicity|1|||
163187147|NCT00598702|589401827|FG004|Overall Study|Dose limiting toxicity|1|||
163187148|NCT00598702|589401828|FG005|Overall Study|Dose limiting toxicity|1|||
163187149|NCT00598702|589401829|FG006|Overall Study|Dose limiting toxicity|0|||
163187150|NCT00598702|589401830|FG007|Overall Study|Dose limiting toxicity|0|||
163187151|NCT02413372|589401834|FG000|Treatment|Lost to Follow-up|0|||
163187152|NCT02413372|589401835|FG001|Treatment|Lost to Follow-up|2|||
162947134|NCT05109234|588508247|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
162947135|NCT05109234|588508248|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
162947136|NCT00336024|588508249|FG000|Overall Study|Death|2|||
163187153|NCT02413372|589401836|FG002|Treatment|Lost to Follow-up|1|||
163187154|NCT02413372|589401834|FG000|Treatment|Withdrawal by Subject|1|||
163187155|NCT02413372|589401835|FG001|Treatment|Withdrawal by Subject|0|||
163187156|NCT02413372|589401836|FG002|Treatment|Withdrawal by Subject|0|||
163187157|NCT02413372|589401834|FG000|Follow-up|Lost to Follow-up|1|||
163187158|NCT02413372|589401835|FG001|Follow-up|Lost to Follow-up|1|||
163187159|NCT02413372|589401836|FG002|Follow-up|Lost to Follow-up|0|||
163187160|NCT02413372|589401834|FG000|Follow-up|Subject Withdrew Consent|1|||
163292250|NCT02020616|589775310|FG000|Overall Study|Physician Decision|0|||
163292251|NCT02020616|589775311|FG001|Overall Study|Physician Decision|0|||
162947137|NCT00336024|588508250|FG001|Overall Study|Death|1|||
163292252|NCT02020616|589775312|FG002|Overall Study|Physician Decision|0|||
163292253|NCT02020616|589775313|FG003|Overall Study|Physician Decision|0|||
163292254|NCT02020616|589775314|FG004|Overall Study|Physician Decision|0|||
163292255|NCT02020616|589775315|FG005|Overall Study|Physician Decision|1|||
163292256|NCT02020616|589775316|FG006|Overall Study|Physician Decision|2|||
163292257|NCT02020616|589775310|FG000|Overall Study|Withdrawal by Subject|0|||
163292258|NCT02020616|589775311|FG001|Overall Study|Withdrawal by Subject|0|||
163292259|NCT02020616|589775312|FG002|Overall Study|Withdrawal by Subject|1|||
163292260|NCT02020616|589775313|FG003|Overall Study|Withdrawal by Subject|0|||
163292261|NCT02020616|589775314|FG004|Overall Study|Withdrawal by Subject|0|||
163292262|NCT02020616|589775315|FG005|Overall Study|Withdrawal by Subject|1|||
163292263|NCT02020616|589775316|FG006|Overall Study|Withdrawal by Subject|1|||
163292264|NCT02020616|589775310|FG000|Overall Study|Lost to Follow-up|0|||
163292265|NCT02020616|589775311|FG001|Overall Study|Lost to Follow-up|1|||
163292266|NCT02020616|589775312|FG002|Overall Study|Lost to Follow-up|0|||
163292267|NCT02020616|589775313|FG003|Overall Study|Lost to Follow-up|1|||
163292268|NCT02020616|589775314|FG004|Overall Study|Lost to Follow-up|1|||
163292269|NCT02020616|589775315|FG005|Overall Study|Lost to Follow-up|1|||
163292270|NCT02020616|589775316|FG006|Overall Study|Lost to Follow-up|0|||
163292271|NCT02020616|589775310|FG000|Overall Study|Early Termination Criteria Met|0|||
163292272|NCT02020616|589775311|FG001|Overall Study|Early Termination Criteria Met|0|||
163292273|NCT02020616|589775312|FG002|Overall Study|Early Termination Criteria Met|1|||
163292274|NCT02020616|589775313|FG003|Overall Study|Early Termination Criteria Met|0|||
163292275|NCT02020616|589775314|FG004|Overall Study|Early Termination Criteria Met|0|||
163292276|NCT02020616|589775315|FG005|Overall Study|Early Termination Criteria Met|1|||
163292277|NCT02020616|589775316|FG006|Overall Study|Early Termination Criteria Met|0|||
163292278|NCT02020616|589775310|FG000|Overall Study|Randomized in Error|0|||
163292279|NCT02020616|589775311|FG001|Overall Study|Randomized in Error|0|||
163292280|NCT02020616|589775312|FG002|Overall Study|Randomized in Error|0|||
163292281|NCT02020616|589775313|FG003|Overall Study|Randomized in Error|1|||
163292282|NCT02020616|589775314|FG004|Overall Study|Randomized in Error|0|||
163292283|NCT02020616|589775315|FG005|Overall Study|Randomized in Error|0|||
163292284|NCT02020616|589775316|FG006|Overall Study|Randomized in Error|0|||
163292285|NCT02020616|589775310|FG000|Overall Study|Lack of Efficacy|0|||
163292286|NCT02020616|589775311|FG001|Overall Study|Lack of Efficacy|0|||
163292287|NCT02020616|589775312|FG002|Overall Study|Lack of Efficacy|0|||
163292288|NCT02020616|589775313|FG003|Overall Study|Lack of Efficacy|0|||
163292289|NCT02020616|589775314|FG004|Overall Study|Lack of Efficacy|1|||
163292290|NCT02020616|589775315|FG005|Overall Study|Lack of Efficacy|0|||
163292291|NCT02020616|589775316|FG006|Overall Study|Lack of Efficacy|0|||
163292292|NCT05019729|589775319|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
163292293|NCT05019729|589775320|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
163292294|NCT05019729|589775321|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
163292295|NCT05019729|589775322|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
163292296|NCT05019729|589775323|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
163292297|NCT05019729|589775324|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
163292298|NCT03008915|589775329|FG000|Treatment 1|Withdrawal by Subject|0|||
163292299|NCT03008915|589775330|FG001|Treatment 1|Withdrawal by Subject|1|||
163292300|NCT00712166|589775333|FG000|Overall Study|Noncompliance|0|||
163292301|NCT00712166|589775334|FG001|Overall Study|Noncompliance|1|||
163292302|NCT01773122|589775335|FG000|Overall Study|Due to amended age eligibility criteria|3|||
163292303|NCT01773122|589775336|FG001|Overall Study|Due to amended age eligibility criteria|1|||
163292304|NCT01773122|589775337|FG002|Overall Study|Due to amended age eligibility criteria|0|||
163292305|NCT01773122|589775338|FG003|Overall Study|Due to amended age eligibility criteria|1|||
163292306|NCT02540213|589775341|FG000|Overall Study|Death/adverse event|18|||
162947138|NCT00336024|588508249|FG000|Overall Study|Physician Decision|4|||
163187161|NCT02413372|589401835|FG001|Follow-up|Subject Withdrew Consent|0|||
163187162|NCT02413372|589401836|FG002|Follow-up|Subject Withdrew Consent|1|||
163292307|NCT02540213|589775341|FG000|Overall Study|Administrative reasons|3|||
162947139|NCT00336024|588508250|FG001|Overall Study|Physician Decision|1|||
163292308|NCT02540213|589775341|FG000|Overall Study|Kidney transplant|3|||
162947140|NCT00336024|588508249|FG000|Overall Study|Protocol Violation|1|||
162947141|NCT00336024|588508250|FG001|Overall Study|Protocol Violation|0|||
163292309|NCT02540213|589775341|FG000|Overall Study|Lack of Efficacy|6|||
163292310|NCT02540213|589775341|FG000|Overall Study|Consent withdrawn|7|||
163292311|NCT02540213|589775341|FG000|Overall Study|Enrolled but not treated|2|||
163292312|NCT02289560|589775342|FG000|Overall Study|Lost to Follow-up|6|||
163292313|NCT02289560|589775342|FG000|Overall Study|Alternative Treatment|4|||
163292314|NCT02289560|589775342|FG000|Overall Study|Inadequate Treatment|2|||
163292315|NCT02289560|589775342|FG000|Overall Study|Withdrawal by Subject|23|||
163292316|NCT02908464|589775343|FG000|Overall Study|Withdrawal by Subject|2|||
163292317|NCT02908464|589775344|FG001|Overall Study|Withdrawal by Subject|1|||
163388456|NCT00381303|590133995|FG001|Overall Study|No virologic response by week 12|0|||
163388457|NCT00381303|590133994|FG000|Overall Study|Subject was too busy for appointments|1|||
163388458|NCT00381303|590133995|FG001|Overall Study|Subject was too busy for appointments|0|||
162947142|NCT00336024|588508249|FG000|Overall Study|Withdrawal by Subject|1|||
162947143|NCT00336024|588508250|FG001|Overall Study|Withdrawal by Subject|2|||
162947144|NCT00336024|588508249|FG000|Overall Study|Failure to fulfill consolidation|1|||
162947145|NCT00336024|588508250|FG001|Overall Study|Failure to fulfill consolidation|1|||
162947146|NCT00336024|588508249|FG000|Overall Study|Progressive Disease|4|||
162947147|NCT00336024|588508250|FG001|Overall Study|Progressive Disease|7|||
162947148|NCT00336024|588508249|FG000|Overall Study|Ineligible|7|||
162947149|NCT00336024|588508250|FG001|Overall Study|Ineligible|7|||
162947150|NCT05067504|588508252|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
162947151|NCT05067504|588508253|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
162947152|NCT05067504|588508252|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
162947153|NCT05067504|588508253|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
162947154|NCT05067504|588508252|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
162947155|NCT05067504|588508253|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
162947156|NCT03805438|588510144|FG000|Overall Study|Lack of Efficacy|1|||
162947157|NCT03805438|588510144|FG000|Overall Study|Protocol Violation|1|||
162947158|NCT02684344|588510145|FG000|Overall Study|Withdrawal by Subject|0|||
163388459|NCT00381303|590133994|FG000|Overall Study|Subject did not continue visits|1|||
163388460|NCT00381303|590133995|FG001|Overall Study|Subject did not continue visits|0|||
163388461|NCT00381303|590133994|FG000|Overall Study|Subject primary physician's decision|1|||
163388462|NCT00381303|590133995|FG001|Overall Study|Subject primary physician's decision|0|||
163388463|NCT01211522|590133996|FG000|Overall Study|Withdrawal by Subject|3|||
163388464|NCT01211522|590133997|FG001|Overall Study|Withdrawal by Subject|7|||
163388465|NCT01211522|590133998|FG002|Overall Study|Withdrawal by Subject|5|||
163388466|NCT01777269|590133999|FG000|Overall Study|Adverse Event|24|||
162947159|NCT02684344|588510146|FG001|Overall Study|Withdrawal by Subject|1|||
162947160|NCT01494506|588510150|FG000|Overall Study|Lack of Efficacy|77|||
162947161|NCT01494506|588510151|FG001|Overall Study|Lack of Efficacy|83|||
162947162|NCT01494506|588510152|FG002|Overall Study|Lack of Efficacy|57|||
162947163|NCT01494506|588510150|FG000|Overall Study|Adverse Event|17|||
162947164|NCT01494506|588510151|FG001|Overall Study|Adverse Event|10|||
162947165|NCT01494506|588510152|FG002|Overall Study|Adverse Event|11|||
162947166|NCT01494506|588510150|FG000|Overall Study|Death|9|||
162947167|NCT01494506|588510151|FG001|Overall Study|Death|5|||
162947168|NCT01494506|588510152|FG002|Overall Study|Death|2|||
162947169|NCT01494506|588510150|FG000|Overall Study|Physician Decision|7|||
162947170|NCT01494506|588510151|FG001|Overall Study|Physician Decision|5|||
162947171|NCT01494506|588510152|FG002|Overall Study|Physician Decision|4|||
162947172|NCT01494506|588510150|FG000|Overall Study|Withdrawal by Subject|17|||
162947173|NCT01494506|588510151|FG001|Overall Study|Withdrawal by Subject|20|||
162947174|NCT01494506|588510152|FG002|Overall Study|Withdrawal by Subject|14|||
162947175|NCT01494506|588510150|FG000|Overall Study|Clinical Deterioration|21|||
162947176|NCT01494506|588510151|FG001|Overall Study|Clinical Deterioration|17|||
162947177|NCT01494506|588510152|FG002|Overall Study|Clinical Deterioration|13|||
162947178|NCT01494506|588510150|FG000|Overall Study|Sponsor Decision|0|||
162947179|NCT01494506|588510151|FG001|Overall Study|Sponsor Decision|0|||
162947180|NCT01494506|588510152|FG002|Overall Study|Sponsor Decision|1|||
162947181|NCT01494506|588510150|FG000|Overall Study|Other|0|||
162947182|NCT01494506|588510151|FG001|Overall Study|Other|3|||
162947183|NCT01494506|588510152|FG002|Overall Study|Other|1|||
162947184|NCT02777528|588510154|FG000|Overall Study|Still in study|24|||
163388467|NCT01777269|590134000|FG001|Overall Study|Adverse Event|33|||
163388468|NCT01777269|590133999|FG000|Overall Study|Lack of Efficacy|8|||
162947185|NCT02777528|588510155|FG001|Overall Study|Still in study|10|||
162947186|NCT02777528|588510156|FG002|Overall Study|Still in study|1|||
163388469|NCT01777269|590134000|FG001|Overall Study|Lack of Efficacy|10|||
163388470|NCT01777269|590133999|FG000|Overall Study|Protocol Violation|4|||
162947187|NCT02777528|588510154|FG000|Overall Study|Study Device Explanted|1|||
162947188|NCT02777528|588510155|FG001|Overall Study|Study Device Explanted|0|||
162947189|NCT02777528|588510156|FG002|Overall Study|Study Device Explanted|0|||
162947190|NCT02777528|588510154|FG000|Overall Study|Death|14|||
163292318|NCT02908464|589775343|FG000|Overall Study|Found ineligible after randomization|0|||
162947191|NCT02777528|588510155|FG001|Overall Study|Death|7|||
162947192|NCT02777528|588510156|FG002|Overall Study|Death|1|||
162947193|NCT02777528|588510154|FG000|Overall Study|Withdrawal by Subject|2|||
162947194|NCT02777528|588510155|FG001|Overall Study|Withdrawal by Subject|2|||
162947195|NCT02777528|588510156|FG002|Overall Study|Withdrawal by Subject|1|||
163292319|NCT02908464|589775344|FG001|Overall Study|Found ineligible after randomization|2|||
163292320|NCT01264718|589775345|FG000|Overall Study|Lost to Follow-up|3|||
163292321|NCT01264718|589775346|FG001|Overall Study|Lost to Follow-up|2|||
163292322|NCT01264718|589775345|FG000|Overall Study|Withdrawal by Subject|9|||
163292323|NCT01264718|589775346|FG001|Overall Study|Withdrawal by Subject|15|||
163292324|NCT01264718|589775345|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
163292325|NCT01264718|589775346|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
163292326|NCT00536380|589775351|FG000|Overall Study|Adverse Event|0|||
163292327|NCT00536380|589775352|FG001|Overall Study|Adverse Event|2|||
163292328|NCT00536380|589775353|FG002|Overall Study|Adverse Event|2|||
163292329|NCT00536380|589775351|FG000|Overall Study|Lost to Follow-up|0|||
163292330|NCT00536380|589775352|FG001|Overall Study|Lost to Follow-up|0|||
163292331|NCT00536380|589775353|FG002|Overall Study|Lost to Follow-up|1|||
163292332|NCT00536380|589775351|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
163292333|NCT00536380|589775352|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
163292334|NCT00536380|589775353|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
163292335|NCT00536380|589775351|FG000|Overall Study|Withdrawal related to study drug|7|||
163292336|NCT00536380|589775352|FG001|Overall Study|Withdrawal related to study drug|5|||
163292337|NCT00536380|589775353|FG002|Overall Study|Withdrawal related to study drug|2|||
163292338|NCT00536380|589775351|FG000|Overall Study|Noncompliance with protocol|3|||
163292339|NCT00536380|589775352|FG001|Overall Study|Noncompliance with protocol|2|||
163292340|NCT00536380|589775353|FG002|Overall Study|Noncompliance with protocol|2|||
163292341|NCT00536380|589775351|FG000|Overall Study|Did not meet protocol eligibility|0|||
163292342|NCT00536380|589775352|FG001|Overall Study|Did not meet protocol eligibility|0|||
163292343|NCT00536380|589775353|FG002|Overall Study|Did not meet protocol eligibility|1|||
163292344|NCT00536380|589775351|FG000|Overall Study|Administrative|0|||
163187163|NCT02413372|589401834|FG000|Follow-up|Subject unable to return for visit|0|||
163187164|NCT02413372|589401835|FG001|Follow-up|Subject unable to return for visit|0|||
163187165|NCT02413372|589401836|FG002|Follow-up|Subject unable to return for visit|1|||
163187166|NCT03053271|589401846|FG000|Overall Study|Did not meet randomization criteria|3|||
163187167|NCT03053271|589401846|FG000|Overall Study|Withdrawal by Subject|1|||
163187168|NCT00580970|589401847|FG000|Pre-treatment|Non-compliance|1|||
163187169|NCT00580970|589401847|FG000|Treatment (Lovastatin)|Non-compliance|6|||
163187170|NCT00580970|589401847|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
163187171|NCT00580970|589401847|FG000|Treatment (Lovastatin)|Physician Decision|4|||
163187172|NCT00580970|589401847|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
163187173|NCT00580970|589401847|FG000|Treatment (Lovastatin)|Death|1|||
163187174|NCT03161093|589401850|FG000|Overall Study|Protocol Violation|11|||
163187175|NCT03161093|589401851|FG001|Overall Study|Protocol Violation|14|||
163187176|NCT03161093|589401852|FG002|Overall Study|Protocol Violation|6|||
163187177|NCT03161093|589401853|FG003|Overall Study|Protocol Violation|13|||
163187178|NCT03161093|589401854|FG004|Overall Study|Protocol Violation|1|||
163187179|NCT03161093|589401855|FG005|Overall Study|Protocol Violation|0|||
163187180|NCT03161093|589401850|FG000|Overall Study|Adverse Event|5|||
163187181|NCT03161093|589401851|FG001|Overall Study|Adverse Event|21|||
163187182|NCT03161093|589401852|FG002|Overall Study|Adverse Event|16|||
163187183|NCT03161093|589401853|FG003|Overall Study|Adverse Event|35|||
163187184|NCT03161093|589401854|FG004|Overall Study|Adverse Event|2|||
163187185|NCT03161093|589401855|FG005|Overall Study|Adverse Event|1|||
163187186|NCT03161093|589401850|FG000|Overall Study|Lack of Efficacy|9|||
163187187|NCT03161093|589401851|FG001|Overall Study|Lack of Efficacy|13|||
163187188|NCT03161093|589401852|FG002|Overall Study|Lack of Efficacy|9|||
163187189|NCT03161093|589401853|FG003|Overall Study|Lack of Efficacy|24|||
163187190|NCT03161093|589401854|FG004|Overall Study|Lack of Efficacy|4|||
163187191|NCT03161093|589401855|FG005|Overall Study|Lack of Efficacy|1|||
163187192|NCT03161093|589401850|FG000|Overall Study|Physician Decision|0|||
163187193|NCT03161093|589401851|FG001|Overall Study|Physician Decision|1|||
163187194|NCT03161093|589401852|FG002|Overall Study|Physician Decision|0|||
163187195|NCT03161093|589401853|FG003|Overall Study|Physician Decision|2|||
163187196|NCT03161093|589401854|FG004|Overall Study|Physician Decision|17|||
163187197|NCT03161093|589401855|FG005|Overall Study|Physician Decision|15|||
163292345|NCT00536380|589775352|FG001|Overall Study|Administrative|0|||
163292346|NCT00536380|589775353|FG002|Overall Study|Administrative|1|||
162947196|NCT02777528|588510154|FG000|Overall Study|Physician Decision|2|||
163187198|NCT03161093|589401850|FG000|Overall Study|Withdrawal by Subject|24|||
162947197|NCT02777528|588510155|FG001|Overall Study|Physician Decision|1|||
162947198|NCT02777528|588510156|FG002|Overall Study|Physician Decision|0|||
163187199|NCT03161093|589401851|FG001|Overall Study|Withdrawal by Subject|73|||
163187200|NCT03161093|589401852|FG002|Overall Study|Withdrawal by Subject|44|||
163187201|NCT03161093|589401853|FG003|Overall Study|Withdrawal by Subject|97|||
163292347|NCT00387465|589775354|FG000|Overall Study|Withdrawal by Subject|0|||
162947199|NCT02777528|588510154|FG000|Overall Study|Lost to Follow-up|2|||
163187202|NCT03161093|589401854|FG004|Overall Study|Withdrawal by Subject|11|||
163187203|NCT03161093|589401855|FG005|Overall Study|Withdrawal by Subject|10|||
163187204|NCT03161093|589401850|FG000|Overall Study|Lost to Follow-up|3|||
163187205|NCT03161093|589401851|FG001|Overall Study|Lost to Follow-up|12|||
163187206|NCT03161093|589401852|FG002|Overall Study|Lost to Follow-up|4|||
163187207|NCT03161093|589401853|FG003|Overall Study|Lost to Follow-up|7|||
163187208|NCT03161093|589401854|FG004|Overall Study|Lost to Follow-up|8|||
163187209|NCT03161093|589401855|FG005|Overall Study|Lost to Follow-up|13|||
163187210|NCT03161093|589401850|FG000|Overall Study|Death|3|||
163187211|NCT03161093|589401851|FG001|Overall Study|Death|9|||
163187212|NCT03161093|589401852|FG002|Overall Study|Death|7|||
163187213|NCT03161093|589401853|FG003|Overall Study|Death|9|||
163187214|NCT03161093|589401854|FG004|Overall Study|Death|0|||
163187215|NCT03161093|589401855|FG005|Overall Study|Death|0|||
163187216|NCT03161093|589401850|FG000|Overall Study|Unknown - Not reported|0|||
163187217|NCT03161093|589401851|FG001|Overall Study|Unknown - Not reported|1|||
162947200|NCT02777528|588510155|FG001|Overall Study|Lost to Follow-up|0|||
162947201|NCT02777528|588510156|FG002|Overall Study|Lost to Follow-up|0|||
162947202|NCT02777528|588510154|FG000|Overall Study|Discontinued due to Other|1|||
163187218|NCT03161093|589401852|FG002|Overall Study|Unknown - Not reported|0|||
162947203|NCT02777528|588510155|FG001|Overall Study|Discontinued due to Other|0|||
162947204|NCT02777528|588510156|FG002|Overall Study|Discontinued due to Other|0|||
162947205|NCT02127281|588510157|FG000|Overall Study|Lost to Follow-up|1|||
162947206|NCT02127281|588510158|FG001|Overall Study|Lost to Follow-up|0|||
163388471|NCT01777269|590134000|FG001|Overall Study|Protocol Violation|4|||
163388472|NCT01777269|590133999|FG000|Overall Study|Participants reached stopping criteria|1|||
163388473|NCT01777269|590134000|FG001|Overall Study|Participants reached stopping criteria|1|||
163388474|NCT01777269|590133999|FG000|Overall Study|Lost to Follow-up|4|||
163388475|NCT01777269|590134000|FG001|Overall Study|Lost to Follow-up|0|||
162947207|NCT01882647|588510160|FG000|Overall Study|Lost to Follow-up|2|||
162947208|NCT01882647|588510161|FG001|Overall Study|Lost to Follow-up|2|||
162947209|NCT01882647|588510160|FG000|Overall Study|Withdrawal by Subject|0|||
163388476|NCT01777269|590133999|FG000|Overall Study|Physician Decision|5|||
162947210|NCT01882647|588510161|FG001|Overall Study|Withdrawal by Subject|4|||
162947211|NCT01108094|588510162|FG000|Overall Study|Adverse Event|2|||
162947212|NCT01108094|588510163|FG001|Overall Study|Adverse Event|0|||
162947213|NCT01108094|588510164|FG002|Overall Study|Adverse Event|0|||
162947214|NCT01108094|588510165|FG003|Overall Study|Adverse Event|0|||
162947215|NCT01108094|588510162|FG000|Overall Study|Withdrawal by Subject|1|||
162947216|NCT01108094|588510163|FG001|Overall Study|Withdrawal by Subject|0|||
162947217|NCT01108094|588510164|FG002|Overall Study|Withdrawal by Subject|0|||
162947218|NCT01108094|588510165|FG003|Overall Study|Withdrawal by Subject|0|||
162947219|NCT05037097|588510168|FG000|Overall Study|Withdrawal by Subject|0|||
162947220|NCT05037097|588510169|FG001|Overall Study|Withdrawal by Subject|1|||
162947221|NCT05037097|588510170|FG002|Overall Study|Withdrawal by Subject|0|||
162947222|NCT05037097|588510171|FG003|Overall Study|Withdrawal by Subject|1|||
163388477|NCT01777269|590134000|FG001|Overall Study|Physician Decision|2|||
163388478|NCT01777269|590133999|FG000|Overall Study|Withdrawal by Subject|9|||
162947223|NCT05037097|588510172|FG004|Overall Study|Withdrawal by Subject|0|||
162947224|NCT05037097|588510173|FG005|Overall Study|Withdrawal by Subject|2|||
162947225|NCT05037097|588510174|FG006|Overall Study|Withdrawal by Subject|0|||
162947226|NCT05037097|588510175|FG007|Overall Study|Withdrawal by Subject|0|||
163292348|NCT00387465|589775355|FG001|Overall Study|Withdrawal by Subject|1|||
162947227|NCT05037097|588510168|FG000|Overall Study|Lost to Follow-up|0|||
162947228|NCT05037097|588510169|FG001|Overall Study|Lost to Follow-up|1|||
162947229|NCT05037097|588510170|FG002|Overall Study|Lost to Follow-up|0|||
163292349|NCT00387465|589775356|FG002|Overall Study|Withdrawal by Subject|0|||
163292350|NCT02754479|589775359|FG000|Overall Study|Lost to Follow-up|1|||
163292351|NCT03183518|589775360|FG000|Overall Study|Other (Not specified)|2|||
162947230|NCT05037097|588510171|FG003|Overall Study|Lost to Follow-up|0|||
162947231|NCT05037097|588510172|FG004|Overall Study|Lost to Follow-up|1|||
162947232|NCT05037097|588510173|FG005|Overall Study|Lost to Follow-up|1|||
162947233|NCT05037097|588510174|FG006|Overall Study|Lost to Follow-up|0|||
162947234|NCT05037097|588510175|FG007|Overall Study|Lost to Follow-up|0|||
162947235|NCT02918877|588510176|FG000|Overall Study|Withdrawal by Subject|2|||
162947236|NCT02918877|588510177|FG001|Overall Study|Withdrawal by Subject|2|||
162947237|NCT02918877|588510176|FG000|Overall Study|Surgery cancelled|1|||
162947238|NCT02918877|588510177|FG001|Overall Study|Surgery cancelled|0|||
162947239|NCT02918877|588510176|FG000|Overall Study|Physician Decision|1|||
162947240|NCT02918877|588510177|FG001|Overall Study|Physician Decision|0|||
162947241|NCT02918877|588510176|FG000|Overall Study|Received intraoperative steroids|1|||
162947242|NCT02918877|588510177|FG001|Overall Study|Received intraoperative steroids|0|||
162947243|NCT02918877|588510176|FG000|Overall Study|Unable to obtain lab samples|1|||
162947244|NCT02918877|588510177|FG001|Overall Study|Unable to obtain lab samples|0|||
162947245|NCT02918877|588510176|FG000|Overall Study|Unsafe to perform BAL|0|||
162947246|NCT02918877|588510177|FG001|Overall Study|Unsafe to perform BAL|1|||
162947247|NCT05346055|588510178|FG000|Overall Study|Withdrawal by Subject|1|||
162947248|NCT05346055|588510178|FG000|Overall Study|Protocol Violation|1|||
162947249|NCT05346055|588510178|FG000|Overall Study|Therapist decision|1|||
162947250|NCT00376220|588510179|FG000|Overall Study|Lost to Follow-up|7|||
162947251|NCT00376220|588510180|FG001|Overall Study|Lost to Follow-up|10|||
163187219|NCT03161093|589401853|FG003|Overall Study|Unknown - Not reported|0|||
163187220|NCT03161093|589401854|FG004|Overall Study|Unknown - Not reported|0|||
163187221|NCT03161093|589401855|FG005|Overall Study|Unknown - Not reported|1|||
163187222|NCT00570765|589401856|FG000|DB Phase|Withdrawal by Subject|1|||
163187223|NCT00570765|589401857|FG001|DB Phase|Withdrawal by Subject|0|||
163187224|NCT00570765|589401858|FG002|DB Phase|Withdrawal by Subject|0|||
163187225|NCT00570765|589401859|FG003|DB Phase|Withdrawal by Subject|0|||
162947252|NCT00376220|588510179|FG000|Overall Study|Withdrawal by Subject|3|||
163187226|NCT00570765|589401856|FG000|DB Phase|Protocol Violation|0|||
162947253|NCT00376220|588510180|FG001|Overall Study|Withdrawal by Subject|2|||
162947254|NCT02564263|588510181|FG000|Overall Study|Adverse Event|31|||
162947255|NCT02564263|588510182|FG001|Overall Study|Adverse Event|29|||
162947256|NCT02564263|588510181|FG000|Overall Study|Death|270|||
162947257|NCT02564263|588510182|FG001|Overall Study|Death|262|||
163187227|NCT00570765|589401857|FG001|DB Phase|Protocol Violation|1|||
163187228|NCT00570765|589401858|FG002|DB Phase|Protocol Violation|0|||
162947258|NCT02564263|588510181|FG000|Overall Study|Withdrawal by Subject|4|||
162947259|NCT02564263|588510182|FG001|Overall Study|Withdrawal by Subject|19|||
162947260|NCT02564263|588510181|FG000|Overall Study|Sponsor's decision|9|||
162947261|NCT02564263|588510182|FG001|Overall Study|Sponsor's decision|4|||
162947262|NCT02906709|588510183|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
162947263|NCT02906709|588510184|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
162947264|NCT02906709|588510183|FG000|Phase A (Week 0 to Week 16)|Death|0|||
162947265|NCT02906709|588510184|FG001|Phase A (Week 0 to Week 16)|Death|1|||
162947266|NCT02906709|588510183|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
162947267|NCT02906709|588510184|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
162947268|NCT02906709|588510183|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
162947269|NCT02906709|588510184|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
162947270|NCT02419313|588510185|FG000|First Intervention|Lost to Follow-up|2|||
162947271|NCT02419313|588510186|FG001|First Intervention|Lost to Follow-up|0|||
162947272|NCT02419313|588510185|FG000|Second Intervention|Lost to Follow-up|1|||
162947273|NCT02419313|588510186|FG001|Second Intervention|Lost to Follow-up|0|||
162947274|NCT00322491|588510193|FG000|Overall Study|Adverse Event|1|||
162947275|NCT00322491|588510194|FG001|Overall Study|Adverse Event|0|||
162947276|NCT00322491|588510193|FG000|Overall Study|Death|1|||
162947277|NCT00322491|588510194|FG001|Overall Study|Death|2|||
162947278|NCT00688064|588510195|FG000|Overall Study|Protocol Violation|0|||
162947279|NCT00688064|588510196|FG001|Overall Study|Protocol Violation|1|||
162947280|NCT00688064|588510195|FG000|Overall Study|Adverse Event|2|||
162947281|NCT00688064|588510196|FG001|Overall Study|Adverse Event|4|||
162947282|NCT00688064|588510195|FG000|Overall Study|Withdrawal by Subject|7|||
162947283|NCT00688064|588510196|FG001|Overall Study|Withdrawal by Subject|7|||
162947284|NCT00688064|588510195|FG000|Overall Study|Lost to Follow-up|10|||
162947285|NCT00688064|588510196|FG001|Overall Study|Lost to Follow-up|10|||
162947286|NCT00688064|588510195|FG000|Overall Study|Lack of Efficacy|0|||
162947287|NCT00688064|588510196|FG001|Overall Study|Lack of Efficacy|1|||
162947288|NCT00688064|588510195|FG000|Overall Study|Pregnancy|1|||
162947289|NCT00688064|588510196|FG001|Overall Study|Pregnancy|0|||
162947290|NCT00688064|588510195|FG000|Overall Study|Any other reasons|1|||
162947291|NCT00688064|588510196|FG001|Overall Study|Any other reasons|3|||
162947292|NCT00524459|588510200|FG000|Overall Study|Withdrawal by Subject|1|||
163187229|NCT00570765|589401859|FG003|DB Phase|Protocol Violation|0|||
162947293|NCT00524459|588510200|FG000|Overall Study|Other|1|||
162947294|NCT00728949|588510201|FG000|Overall Study|Adverse Event|8|||
163187230|NCT00570765|589401856|FG000|DB Phase|Adverse Event|3|||
163187231|NCT00570765|589401857|FG001|DB Phase|Adverse Event|6|||
163187232|NCT00570765|589401858|FG002|DB Phase|Adverse Event|0|||
163187233|NCT00570765|589401859|FG003|DB Phase|Adverse Event|0|||
163187234|NCT00570765|589401856|FG000|DB Phase|Did Not Receive Study Drug|0|||
163187235|NCT00570765|589401857|FG001|DB Phase|Did Not Receive Study Drug|0|||
162947295|NCT00728949|588510202|FG001|Overall Study|Adverse Event|0|||
162947296|NCT00728949|588510201|FG000|Overall Study|Withdrawal by Subject|2|||
162947297|NCT00728949|588510202|FG001|Overall Study|Withdrawal by Subject|2|||
162947298|NCT00728949|588510201|FG000|Overall Study|Abnormal Lab Results|0|||
162947299|NCT00728949|588510202|FG001|Overall Study|Abnormal Lab Results|2|||
162947300|NCT00728949|588510201|FG000|Overall Study|On treatment at cutoff date|1|||
162947301|NCT00728949|588510202|FG001|Overall Study|On treatment at cutoff date|0|||
162947302|NCT02319148|588510207|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
163187236|NCT00570765|589401858|FG002|DB Phase|Did Not Receive Study Drug|1|||
162947303|NCT02319148|588510208|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
162947304|NCT02319148|588510209|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
162947305|NCT02319148|588510210|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
162947306|NCT02319148|588510207|FG000|Second Intervention Period|No longer willing to participate|0|||
162947307|NCT02319148|588510208|FG001|Second Intervention Period|No longer willing to participate|1|||
162947308|NCT02319148|588510209|FG002|Second Intervention Period|No longer willing to participate|0|||
162947309|NCT02319148|588510210|FG003|Second Intervention Period|No longer willing to participate|0|||
162947310|NCT02319148|588510207|FG000|Second Intervention Period|Other|0|||
162947311|NCT02319148|588510208|FG001|Second Intervention Period|Other|0|||
162947312|NCT02319148|588510209|FG002|Second Intervention Period|Other|0|||
162947313|NCT02319148|588510210|FG003|Second Intervention Period|Other|1|||
162947314|NCT01574248|588510211|FG000|Overall Study|Withdrawal by Subject|2|||
162947315|NCT01574248|588510212|FG001|Overall Study|Withdrawal by Subject|0|||
162947316|NCT01574248|588510211|FG000|Overall Study|Missing primary endpoint data|1|||
162947317|NCT01574248|588510212|FG001|Overall Study|Missing primary endpoint data|0|||
162947318|NCT00048048|588510215|FG000|Core Treatment|Withdrawal by Subject|0|||
162947319|NCT00048048|588510216|FG001|Core Treatment|Withdrawal by Subject|0|||
162947320|NCT00048048|588510217|FG002|Core Treatment|Withdrawal by Subject|1|||
162947321|NCT00048048|588510218|FG003|Core Treatment|Withdrawal by Subject|0|||
162947322|NCT00048048|588510219|FG004|Core Treatment|Withdrawal by Subject|0|||
163187237|NCT00570765|589401859|FG003|DB Phase|Did Not Receive Study Drug|0|||
163187238|NCT00570765|589401856|FG000|LTSE Phase|Withdrawal by Subject|0|||
163187239|NCT00570765|589401857|FG001|LTSE Phase|Withdrawal by Subject|0|||
163187240|NCT00570765|589401858|FG002|LTSE Phase|Withdrawal by Subject|0|||
162947323|NCT00048048|588510220|FG005|Core Treatment|Withdrawal by Subject|0|||
162947324|NCT00048048|588510221|FG006|Core Treatment|Withdrawal by Subject|0|||
162947325|NCT00048048|588510222|FG007|Core Treatment|Withdrawal by Subject|0|||
162947326|NCT00048048|588510223|FG008|Core Treatment|Withdrawal by Subject|0|||
162947327|NCT00048048|588510224|FG009|Core Treatment|Withdrawal by Subject|0|||
162947328|NCT00048048|588510225|FG010|Core Treatment|Withdrawal by Subject|0|||
162947329|NCT00048048|588510226|FG011|Core Treatment|Withdrawal by Subject|0|||
163187241|NCT00570765|589401859|FG003|LTSE Phase|Withdrawal by Subject|1|||
163187242|NCT00570765|589401856|FG000|LTSE Phase|Adverse Event|0|||
163187243|NCT00570765|589401857|FG001|LTSE Phase|Adverse Event|0|||
163187244|NCT00570765|589401858|FG002|LTSE Phase|Adverse Event|0|||
163187245|NCT00570765|589401859|FG003|LTSE Phase|Adverse Event|7|||
163187246|NCT00570765|589401856|FG000|LTSE Phase|Physician Decision|0|||
163187247|NCT00570765|589401857|FG001|LTSE Phase|Physician Decision|0|||
163187248|NCT00570765|589401858|FG002|LTSE Phase|Physician Decision|0|||
163187249|NCT00570765|589401859|FG003|LTSE Phase|Physician Decision|4|||
163187250|NCT01031706|589401860|FG000|Overall Study|Adverse Event|1|||
163187251|NCT01031706|589401861|FG001|Overall Study|Adverse Event|0|||
163187252|NCT01031706|589401860|FG000|Overall Study|Withdrawal by Subject|1|||
163187253|NCT01031706|589401861|FG001|Overall Study|Withdrawal by Subject|1|||
163187254|NCT02124161|589401862|FG000|Overall Study|Other unspecified|0|||
163187255|NCT02124161|589401863|FG001|Overall Study|Other unspecified|1|||
163187256|NCT02124161|589401862|FG000|Overall Study|Death|1|||
163187257|NCT02124161|589401863|FG001|Overall Study|Death|0|||
163187258|NCT02124161|589401862|FG000|Overall Study|Protocol Violation|2|||
163187259|NCT02124161|589401863|FG001|Overall Study|Protocol Violation|1|||
163187260|NCT02124161|589401862|FG000|Overall Study|Withdrawal by Subject|1|||
163187261|NCT02124161|589401863|FG001|Overall Study|Withdrawal by Subject|2|||
163187262|NCT02124161|589401862|FG000|Overall Study|Adverse Event|2|||
163187263|NCT02124161|589401863|FG001|Overall Study|Adverse Event|0|||
162947330|NCT00048048|588510215|FG000|Core Treatment|Adverse Event|0|||
162947331|NCT00048048|588510216|FG001|Core Treatment|Adverse Event|0|||
162947332|NCT00048048|588510217|FG002|Core Treatment|Adverse Event|0|||
162947333|NCT00048048|588510218|FG003|Core Treatment|Adverse Event|0|||
162947334|NCT00048048|588510219|FG004|Core Treatment|Adverse Event|0|||
162947335|NCT00048048|588510220|FG005|Core Treatment|Adverse Event|0|||
162947336|NCT00048048|588510221|FG006|Core Treatment|Adverse Event|0|||
162947337|NCT00048048|588510222|FG007|Core Treatment|Adverse Event|1|||
162947338|NCT00048048|588510223|FG008|Core Treatment|Adverse Event|0|||
162947339|NCT00048048|588510224|FG009|Core Treatment|Adverse Event|0|||
162947340|NCT00048048|588510225|FG010|Core Treatment|Adverse Event|0|||
162947341|NCT00048048|588510226|FG011|Core Treatment|Adverse Event|0|||
162947342|NCT00048048|588510215|FG000|Extension Year 1|Early withdrawals|0|||
162947343|NCT00048048|588510216|FG001|Extension Year 1|Early withdrawals|0|||
162947344|NCT00048048|588510217|FG002|Extension Year 1|Early withdrawals|0|||
162947345|NCT00048048|588510218|FG003|Extension Year 1|Early withdrawals|0|||
162947346|NCT00048048|588510219|FG004|Extension Year 1|Early withdrawals|0|||
162947347|NCT00048048|588510220|FG005|Extension Year 1|Early withdrawals|0|||
162947348|NCT00048048|588510221|FG006|Extension Year 1|Early withdrawals|0|||
162947349|NCT00048048|588510222|FG007|Extension Year 1|Early withdrawals|0|||
162947350|NCT00048048|588510223|FG008|Extension Year 1|Early withdrawals|0|||
162947351|NCT00048048|588510224|FG009|Extension Year 1|Early withdrawals|2|||
162947352|NCT00048048|588510225|FG010|Extension Year 1|Early withdrawals|2|||
162947353|NCT00048048|588510226|FG011|Extension Year 1|Early withdrawals|4|||
162947354|NCT00048048|588510215|FG000|Extension Year 2|Early withdrawals|0|||
162947355|NCT00048048|588510216|FG001|Extension Year 2|Early withdrawals|0|||
162947356|NCT00048048|588510217|FG002|Extension Year 2|Early withdrawals|0|||
162947357|NCT00048048|588510218|FG003|Extension Year 2|Early withdrawals|0|||
162947358|NCT00048048|588510219|FG004|Extension Year 2|Early withdrawals|0|||
162947359|NCT00048048|588510220|FG005|Extension Year 2|Early withdrawals|0|||
162947360|NCT00048048|588510221|FG006|Extension Year 2|Early withdrawals|0|||
162947361|NCT00048048|588510222|FG007|Extension Year 2|Early withdrawals|0|||
162947362|NCT00048048|588510223|FG008|Extension Year 2|Early withdrawals|0|||
162947363|NCT00048048|588510224|FG009|Extension Year 2|Early withdrawals|0|||
162947364|NCT00048048|588510225|FG010|Extension Year 2|Early withdrawals|4|||
162947365|NCT00048048|588510226|FG011|Extension Year 2|Early withdrawals|2|||
162947366|NCT02194998|588510245|FG000|On-HCV Treatment|Did not pick up study medication|0|||
162947367|NCT02194998|588510246|FG001|On-HCV Treatment|Did not pick up study medication|1|||
162947368|NCT02194998|588510247|FG002|On-HCV Treatment|Did not pick up study medication|0|||
162947369|NCT02194998|588510248|FG003|On-HCV Treatment|Did not pick up study medication|0|||
162947370|NCT02194998|588510245|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
162947371|NCT02194998|588510246|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
162947372|NCT02194998|588510247|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
162947373|NCT02194998|588510248|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
162947374|NCT01400113|588510249|FG000|Overall Study|Withdrawal by Subject|1|||
162947375|NCT01400113|588510250|FG001|Overall Study|Withdrawal by Subject|1|||
162947376|NCT00282256|588510251|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
162947377|NCT00282256|588510251|FG000|Extension Treatment Period|Adverse Event|2|||
162947378|NCT01345019|588510252|FG000|Blinded Treatment Phase|Death|147|||
162947379|NCT01345019|588510253|FG001|Blinded Treatment Phase|Death|137|||
162947380|NCT01345019|588510252|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
162947381|NCT01345019|588510253|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
162947382|NCT01345019|588510252|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
162947383|NCT01345019|588510253|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
162947384|NCT01345019|588510252|FG000|Blinded Treatment Phase|Disease Progression|12|||
162947385|NCT01345019|588510253|FG001|Blinded Treatment Phase|Disease Progression|10|||
162947386|NCT01345019|588510252|FG000|Blinded Treatment Phase|Adverse Event|6|||
162947387|NCT01345019|588510253|FG001|Blinded Treatment Phase|Adverse Event|13|||
163292352|NCT03183518|589775360|FG000|Overall Study|Other (Withdrawal of consent)|1|||
163292353|NCT02132702|589775361|FG000|Overall Study|Protocol Violation|2|||
163292354|NCT02132702|589775361|FG000|Overall Study|Adverse Event|3|||
163292355|NCT02132702|589775361|FG000|Overall Study|Withdrawal by Subject|3|||
162947388|NCT01345019|588510252|FG000|Blinded Treatment Phase|Administrative Decision|10|||
162947389|NCT01345019|588510253|FG001|Blinded Treatment Phase|Administrative Decision|8|||
163292356|NCT01244828|589775364|FG000|Overall Study|Adverse Event|37|||
163292357|NCT01244828|589775364|FG000|Overall Study|Withdrawal by Subject|31|||
162947390|NCT01345019|588510252|FG000|Blinded Treatment Phase|Noncompliance|5|||
162947391|NCT01345019|588510253|FG001|Blinded Treatment Phase|Noncompliance|3|||
162947392|NCT01345019|588510252|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
162947393|NCT01345019|588510253|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
162947394|NCT01345019|588510252|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
162947395|NCT01345019|588510253|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
162947396|NCT01345019|588510252|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
162947397|NCT01345019|588510253|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
162947398|NCT01345019|588510252|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
162947399|NCT01345019|588510253|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
162947400|NCT01345019|588510252|FG000|Open Label Treatment Phase|Death|49|||
162947401|NCT01345019|588510253|FG001|Open Label Treatment Phase|Death|48|||
162947402|NCT01345019|588510252|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
162947403|NCT01345019|588510253|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
162947404|NCT01345019|588510252|FG000|Open Label Treatment Phase|Adverse Event|30|||
162947405|NCT01345019|588510253|FG001|Open Label Treatment Phase|Adverse Event|51|||
162947406|NCT01345019|588510252|FG000|Open Label Treatment Phase|Administrative Decision|30|||
162947407|NCT01345019|588510253|FG001|Open Label Treatment Phase|Administrative Decision|15|||
162947408|NCT01345019|588510252|FG000|Open Label Treatment Phase|Disease Progression|17|||
162947409|NCT01345019|588510253|FG001|Open Label Treatment Phase|Disease Progression|18|||
162947410|NCT01345019|588510252|FG000|Open Label Treatment Phase|Noncompliance|5|||
162947411|NCT01345019|588510253|FG001|Open Label Treatment Phase|Noncompliance|4|||
162947412|NCT01345019|588510252|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
162947413|NCT01345019|588510253|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
162947414|NCT01345019|588510252|FG000|Open Label Treatment Phase|Pregnancy|1|||
162947415|NCT01345019|588510253|FG001|Open Label Treatment Phase|Pregnancy|0|||
162947416|NCT01345019|588510252|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
162947417|NCT01345019|588510253|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
162947418|NCT01345019|588510252|FG000|Open Label Treatment Phase|Protocol Violation|0|||
162947419|NCT01345019|588510253|FG001|Open Label Treatment Phase|Protocol Violation|1|||
162947420|NCT02636907|588510254|FG000|Autoinjector Assessment Period|Adverse Event|2|||
162947421|NCT02636907|588510254|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
162947422|NCT02636907|588510254|FG000|Extension Phase|Adverse Event|2|||
162947423|NCT02636907|588510254|FG000|Extension Phase|Withdrawal by Subject|4|||
162947424|NCT02636907|588510254|FG000|Extension Phase|Physician Decision|1|||
162947425|NCT02636907|588510254|FG000|Extension Phase|Lost to Follow-up|2|||
162947426|NCT02636907|588510254|FG000|Extension Phase|Lack of Efficacy|1|||
162947427|NCT00762086|588510255|FG000|Overall Study|Adverse Event|2|||
162947428|NCT00762086|588510256|FG001|Overall Study|Adverse Event|0|||
162947429|NCT00762086|588510255|FG000|Overall Study|Lost to Follow-up|0|||
162947430|NCT00762086|588510256|FG001|Overall Study|Lost to Follow-up|2|||
162947431|NCT00762086|588510255|FG000|Overall Study|Non compliance|1|||
162947432|NCT00762086|588510256|FG001|Overall Study|Non compliance|0|||
162947433|NCT00762086|588510255|FG000|Overall Study|Withdrawal by Subject|2|||
162947434|NCT00762086|588510256|FG001|Overall Study|Withdrawal by Subject|2|||
162947435|NCT00762086|588510255|FG000|Overall Study|Ineligible to participate in the study|1|||
162947436|NCT00762086|588510256|FG001|Overall Study|Ineligible to participate in the study|0|||
162947437|NCT01074554|588510266|FG000|Overall Study|Adverse Event|3|||
162947438|NCT01074554|588510267|FG001|Overall Study|Adverse Event|3|||
162947439|NCT01074554|588510266|FG000|Overall Study|Lost to Follow-up|0|||
162947440|NCT01074554|588510267|FG001|Overall Study|Lost to Follow-up|1|||
162947441|NCT00497796|588510268|FG000|Overall Study|Adverse event (not related)|9|||
162947442|NCT00497796|588510269|FG001|Overall Study|Adverse event (not related)|9|||
162947443|NCT00497796|588510268|FG000|Overall Study|Adverse event (related)|5|||
162947444|NCT00497796|588510269|FG001|Overall Study|Adverse event (related)|4|||
162947445|NCT00497796|588510268|FG000|Overall Study|CMV infection or disease treatment|30|||
162947446|NCT00497796|588510269|FG001|Overall Study|CMV infection or disease treatment|4|||
162947447|NCT00497796|588510268|FG000|Overall Study|Consent withdrawn|10|||
162947448|NCT00497796|588510269|FG001|Overall Study|Consent withdrawn|3|||
162947449|NCT00497796|588510268|FG000|Overall Study|Investigator/sponsor discretion|31|||
162947450|NCT00497796|588510269|FG001|Overall Study|Investigator/sponsor discretion|34|||
162947451|NCT00497796|588510268|FG000|Overall Study|Lost to Follow-up|0|||
162947452|NCT00497796|588510269|FG001|Overall Study|Lost to Follow-up|1|||
162947453|NCT00497796|588510268|FG000|Overall Study|Not applicable (randomized not treated)|0|||
162947454|NCT00497796|588510269|FG001|Overall Study|Not applicable (randomized not treated)|4|||
162947455|NCT01856309|588510271|FG000|Overall Study|Death|4|||
162947456|NCT01856309|588510272|FG001|Overall Study|Death|6|||
162947457|NCT01856309|588510273|FG002|Overall Study|Death|11|||
162947458|NCT01856309|588510274|FG003|Overall Study|Death|6|||
162947459|NCT01856309|588510271|FG000|Overall Study|Lost to Follow-up|6|||
162947460|NCT01856309|588510272|FG001|Overall Study|Lost to Follow-up|2|||
162947461|NCT01856309|588510273|FG002|Overall Study|Lost to Follow-up|4|||
162947462|NCT01856309|588510274|FG003|Overall Study|Lost to Follow-up|8|||
162947463|NCT01856309|588510271|FG000|Overall Study|Withdrawal by Subject|11|||
162947464|NCT01856309|588510272|FG001|Overall Study|Withdrawal by Subject|13|||
162947465|NCT01856309|588510273|FG002|Overall Study|Withdrawal by Subject|28|||
162947466|NCT01856309|588510274|FG003|Overall Study|Withdrawal by Subject|26|||
162947467|NCT01856309|588510271|FG000|Overall Study|Other|227|||
162947468|NCT01856309|588510272|FG001|Overall Study|Other|225|||
162947469|NCT01856309|588510273|FG002|Overall Study|Other|447|||
162947470|NCT01856309|588510274|FG003|Overall Study|Other|469|||
162947471|NCT01856309|588510271|FG000|Overall Study|Lack of Efficacy|14|||
162947472|NCT01856309|588510272|FG001|Overall Study|Lack of Efficacy|9|||
162947473|NCT01856309|588510273|FG002|Overall Study|Lack of Efficacy|40|||
162947474|NCT01856309|588510274|FG003|Overall Study|Lack of Efficacy|25|||
162947475|NCT01856309|588510271|FG000|Overall Study|Adverse Event|31|||
162947476|NCT01856309|588510272|FG001|Overall Study|Adverse Event|31|||
162947477|NCT01856309|588510273|FG002|Overall Study|Adverse Event|55|||
162947478|NCT01856309|588510274|FG003|Overall Study|Adverse Event|65|||
162947479|NCT01856309|588510271|FG000|Overall Study|Pregnancy|0|||
162947480|NCT01856309|588510272|FG001|Overall Study|Pregnancy|0|||
162947481|NCT01856309|588510273|FG002|Overall Study|Pregnancy|0|||
162947482|NCT01856309|588510274|FG003|Overall Study|Pregnancy|1|||
162947483|NCT01856309|588510271|FG000|Overall Study|Physician Decision|6|||
162947484|NCT01856309|588510272|FG001|Overall Study|Physician Decision|1|||
162947485|NCT01856309|588510273|FG002|Overall Study|Physician Decision|6|||
162947486|NCT01856309|588510274|FG003|Overall Study|Physician Decision|8|||
162947487|NCT01856309|588510271|FG000|Overall Study|Noncompliance With Study Drug|0|||
162947488|NCT01856309|588510272|FG001|Overall Study|Noncompliance With Study Drug|1|||
162947489|NCT01856309|588510273|FG002|Overall Study|Noncompliance With Study Drug|4|||
162947490|NCT01856309|588510274|FG003|Overall Study|Noncompliance With Study Drug|1|||
162947491|NCT00220337|588510275|FG000|Overall Study|Adverse Event|70|||
162947492|NCT00220337|588510275|FG000|Overall Study|Lack of Efficacy|17|||
162947493|NCT00220337|588510275|FG000|Overall Study|Withdrawal by Subject|68|||
162947494|NCT00220337|588510275|FG000|Overall Study|Protocol Violation|2|||
162947495|NCT00220337|588510275|FG000|Overall Study|Lost to Follow-up|5|||
162947496|NCT00220337|588510275|FG000|Overall Study|Other|12|||
162947497|NCT00220337|588510275|FG000|Overall Study|Unsatisfactory compliance|5|||
162947498|NCT00832377|588510276|FG000|Overall Study|Protocol Violation|1|||
162947499|NCT00944697|588510277|FG000|Overall Study|Withdrawal by Subject|1|||
162947500|NCT00944697|588510278|FG001|Overall Study|Withdrawal by Subject|1|||
162947501|NCT00944697|588510277|FG000|Overall Study|Adverse Event|0|||
162947502|NCT00944697|588510278|FG001|Overall Study|Adverse Event|3|||
162947503|NCT00944697|588510277|FG000|Overall Study|Administrative|1|||
162947504|NCT00944697|588510278|FG001|Overall Study|Administrative|1|||
162947505|NCT03661528|588510279|FG000|Overall Study|Death|1|||
162947506|NCT03661528|588510280|FG001|Overall Study|Death|0|||
162947507|NCT03661528|588510279|FG000|Overall Study|Physician Decision|3|||
162947508|NCT03661528|588510280|FG001|Overall Study|Physician Decision|1|||
162947509|NCT03661528|588510279|FG000|Overall Study|Other than Specified|5|||
162947510|NCT03661528|588510280|FG001|Overall Study|Other than Specified|2|||
162947511|NCT03661528|588510279|FG000|Overall Study|Withdrawal by Subject|5|||
162947512|NCT03661528|588510280|FG001|Overall Study|Withdrawal by Subject|3|||
162947513|NCT03661528|588510279|FG000|Overall Study|Disease Progression|8|||
162947514|NCT03661528|588510280|FG001|Overall Study|Disease Progression|13|||
162947515|NCT03661528|588510279|FG000|Overall Study|Adverse Event|61|||
163292358|NCT01244828|589775364|FG000|Overall Study|Lack of Efficacy|7|||
163292359|NCT01244828|589775364|FG000|Overall Study|Lost to Follow-up|2|||
163292360|NCT01244828|589775364|FG000|Overall Study|Other reason (not specified)|1|||
163292361|NCT00573833|589775365|FG000|Overall Study|Not Treated|2|||
163292362|NCT05052983|589775366|FG000|Overall Study|Lack of Efficacy|3|||
163292363|NCT05052983|589775367|FG001|Overall Study|Lack of Efficacy|12|||
163292364|NCT05052983|589775366|FG000|Overall Study|Adverse Event|1|||
163292365|NCT05052983|589775367|FG001|Overall Study|Adverse Event|0|||
163292366|NCT04493242|589775368|FG000|Overall Study|Death|10|||
163292367|NCT04493242|589775369|FG001|Overall Study|Death|14|||
163292368|NCT04493242|589775370|FG002|Overall Study|Death|16|||
163292369|NCT04493242|589775368|FG000|Overall Study|Lost to Follow-up|1|||
163292370|NCT04493242|589775369|FG001|Overall Study|Lost to Follow-up|1|||
163292371|NCT04493242|589775370|FG002|Overall Study|Lost to Follow-up|0|||
163292372|NCT04493242|589775368|FG000|Overall Study|Withdrawal by Subject|1|||
163292373|NCT04493242|589775369|FG001|Overall Study|Withdrawal by Subject|0|||
163292374|NCT04493242|589775370|FG002|Overall Study|Withdrawal by Subject|0|||
163292375|NCT04493242|589775368|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
163292376|NCT04493242|589775369|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
163292377|NCT04493242|589775370|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
163292378|NCT04493242|589775368|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
163292379|NCT04493242|589775369|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
163292380|NCT04493242|589775370|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
163388479|NCT01777269|590134000|FG001|Overall Study|Withdrawal by Subject|9|||
163388480|NCT00504881|590134001|FG000|Overall Study|Lack of Efficacy|1|||
162947516|NCT03661528|588510280|FG001|Overall Study|Adverse Event|55|||
162947517|NCT03130699|588510288|FG000|Overall Study|Lost to Follow-up|34|||
162947518|NCT03130699|588510289|FG001|Overall Study|Lost to Follow-up|37|||
162947519|NCT03130699|588510290|FG002|Overall Study|Lost to Follow-up|26|||
162947520|NCT03130699|588510288|FG000|Overall Study|Withdrawal by Subject|5|||
163292381|NCT00849147|589775371|FG000|Overall Study|Withdrawal by Subject|1|||
163292382|NCT00849147|589775371|FG000|Overall Study|Protocol Violation|2|||
162947521|NCT03130699|588510289|FG001|Overall Study|Withdrawal by Subject|1|||
162947522|NCT03130699|588510290|FG002|Overall Study|Withdrawal by Subject|0|||
162947523|NCT03130699|588510288|FG000|Overall Study|Withdrawal by PI|1|||
162947524|NCT03130699|588510289|FG001|Overall Study|Withdrawal by PI|2|||
162947525|NCT03130699|588510290|FG002|Overall Study|Withdrawal by PI|5|||
162947526|NCT03130699|588510288|FG000|Overall Study|Death|0|||
162947527|NCT03130699|588510289|FG001|Overall Study|Death|0|||
162947528|NCT03130699|588510290|FG002|Overall Study|Death|1|||
162947529|NCT00661505|588510291|FG000|Overall Study|Adverse Event|3|||
162947530|NCT00661505|588510291|FG000|Overall Study|Protocol Violation|14|||
162947531|NCT00661505|588510291|FG000|Overall Study|Withdrawal by Subject|8|||
162947532|NCT00661505|588510291|FG000|Overall Study|Lost to Follow-up|3|||
162947533|NCT00661505|588510291|FG000|Overall Study|Other|2|||
162947534|NCT04534283|588510292|FG000|Overall Study|Physician Decision|2|||
162947535|NCT04534283|588510292|FG000|Overall Study|Withdrawal by Subject|1|||
162947536|NCT04534283|588510292|FG000|Overall Study|Disease Progression|12|||
162947537|NCT04534283|588510292|FG000|Overall Study|Adverse Event|1|||
162947538|NCT05956665|588510293|FG000|Overall Study|Death|1|||
162947539|NCT05956665|588510293|FG000|Overall Study|Withdrawal by Subject|1|||
162947540|NCT00977470|588510294|FG000|Overall Study|Lack of Efficacy|32|||
162947541|NCT00977470|588510295|FG001|Overall Study|Lack of Efficacy|30|||
162947542|NCT00977470|588510294|FG000|Overall Study|Physician Decision|2|||
162947543|NCT00977470|588510295|FG001|Overall Study|Physician Decision|0|||
162947544|NCT00977470|588510294|FG000|Overall Study|Adverse Event|1|||
162947545|NCT00977470|588510295|FG001|Overall Study|Adverse Event|2|||
162947546|NCT00977470|588510294|FG000|Overall Study|Protocol Violation|1|||
162947547|NCT00977470|588510295|FG001|Overall Study|Protocol Violation|0|||
162947548|NCT00977470|588510294|FG000|Overall Study|Withdrawal by Subject|0|||
162947549|NCT00977470|588510295|FG001|Overall Study|Withdrawal by Subject|2|||
162947550|NCT00977470|588510294|FG000|Overall Study|Death|0|||
162947551|NCT00977470|588510295|FG001|Overall Study|Death|2|||
162947552|NCT00977470|588510294|FG000|Overall Study|clinical decline|0|||
162947553|NCT00977470|588510295|FG001|Overall Study|clinical decline|1|||
162947554|NCT00977470|588510294|FG000|Overall Study|prolonged recovery post-surgery|0|||
162947555|NCT00977470|588510295|FG001|Overall Study|prolonged recovery post-surgery|1|||
162947556|NCT00977470|588510294|FG000|Overall Study|Still on-study|2|||
162947557|NCT00977470|588510295|FG001|Overall Study|Still on-study|0|||
162947558|NCT03257462|588510296|FG000|Cohort A|Lost to Follow-up|1|||
162947559|NCT03257462|588510297|FG001|Cohort A|Lost to Follow-up|0|||
162947560|NCT03257462|588510298|FG002|Cohort A|Lost to Follow-up|0|||
162947561|NCT03257462|588510299|FG003|Cohort A|Lost to Follow-up|0|||
162947562|NCT03257462|588510296|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
162947563|NCT03257462|588510297|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
162947564|NCT03257462|588510298|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
162947565|NCT03257462|588510299|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
162947566|NCT00796822|588510300|FG000|Overall Study|Lost to Follow-up|2|||
162947567|NCT00796822|588510301|FG001|Overall Study|Lost to Follow-up|0|||
162947568|NCT00796822|588510300|FG000|Overall Study|Adverse Event|1|||
162947569|NCT00796822|588510301|FG001|Overall Study|Adverse Event|0|||
162947570|NCT06354270|588510307|FG000|Overall Study|Withdrawal by Subject|1|||
162947571|NCT06354270|588510308|FG001|Overall Study|Withdrawal by Subject|0|||
162947572|NCT05097989|588510309|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947573|NCT05097989|588510310|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947574|NCT05097989|588510311|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947575|NCT05097989|588510312|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947576|NCT05097989|588510313|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947577|NCT05097989|588510314|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
162947578|NCT05097989|588510315|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947579|NCT05097989|588510316|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947580|NCT05097989|588510317|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947581|NCT05097989|588510309|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
162947582|NCT05097989|588510310|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
162947583|NCT05097989|588510311|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
162947584|NCT05097989|588510312|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
162947585|NCT05097989|588510313|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
162947586|NCT05097989|588510314|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
162947587|NCT05097989|588510315|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
163187264|NCT02124161|589401862|FG000|Overall Study|Does not meet entrance criteria|2|||
162947588|NCT05097989|588510316|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
162947589|NCT05097989|588510317|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
162947590|NCT05097989|588510309|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
162947591|NCT05097989|588510310|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
162947592|NCT05097989|588510311|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
162947593|NCT05097989|588510312|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
162947594|NCT05097989|588510313|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
162947595|NCT05097989|588510314|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
162947596|NCT05097989|588510315|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
162947597|NCT05097989|588510316|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
162947598|NCT05097989|588510317|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
162947599|NCT05097989|588510309|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
162947600|NCT05097989|588510310|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
162947601|NCT05097989|588510311|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
162947602|NCT05097989|588510312|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
162947603|NCT05097989|588510313|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
162947604|NCT05097989|588510314|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
162947605|NCT05097989|588510315|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
162947606|NCT05097989|588510316|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
163388481|NCT00504881|590134002|FG001|Overall Study|Lack of Efficacy|5|||
163388482|NCT00504881|590134001|FG000|Overall Study|Lost to Follow-up|0|||
163388483|NCT00504881|590134002|FG001|Overall Study|Lost to Follow-up|2|||
163388484|NCT00504881|590134001|FG000|Overall Study|Withdrawal by Subject|1|||
163388485|NCT00504881|590134002|FG001|Overall Study|Withdrawal by Subject|4|||
163388486|NCT00504881|590134001|FG000|Overall Study|Non-Compliance|1|||
163388487|NCT00504881|590134002|FG001|Overall Study|Non-Compliance|0|||
163388488|NCT00504881|590134001|FG000|Overall Study|No Birth Control|0|||
163388489|NCT00504881|590134002|FG001|Overall Study|No Birth Control|1|||
163388490|NCT00504881|590134001|FG000|Overall Study|Safety Visit not performed|0|||
163388491|NCT00504881|590134002|FG001|Overall Study|Safety Visit not performed|1|||
163388492|NCT00504881|590134001|FG000|Overall Study|AE, serious fatal|0|||
163388493|NCT00504881|590134002|FG001|Overall Study|AE, serious fatal|1|||
163388494|NCT00504881|590134001|FG000|Overall Study|SAE, non-fatal|2|||
162947607|NCT05097989|588510317|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
162947608|NCT05097989|588510309|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947609|NCT05097989|588510310|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947610|NCT05097989|588510311|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
162947611|NCT05097989|588510312|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947612|NCT05097989|588510313|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947613|NCT05097989|588510314|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947614|NCT05097989|588510315|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947615|NCT05097989|588510316|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947616|NCT05097989|588510317|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947617|NCT05097989|588510309|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
162947618|NCT05097989|588510310|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
162947619|NCT05097989|588510311|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
163388495|NCT00504881|590134002|FG001|Overall Study|SAE, non-fatal|6|||
163388496|NCT00504881|590134001|FG000|Overall Study|AE, non-serious non-fatal|4|||
163388497|NCT00504881|590134002|FG001|Overall Study|AE, non-serious non-fatal|14|||
163388498|NCT00504881|590134001|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
163388499|NCT00504881|590134002|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
163388500|NCT00504881|590134001|FG000|Overall Study|AE of unknown type|1|||
163388501|NCT00504881|590134002|FG001|Overall Study|AE of unknown type|0|||
163388502|NCT02411578|590134005|FG000|Crossover Trial Phase|Pregnancy|0|||
163388503|NCT02411578|590134006|FG001|Crossover Trial Phase|Pregnancy|1|||
163388504|NCT00332189|590134007|FG000|Overall Study|Adverse Event|3|||
163388505|NCT00332189|590134007|FG000|Overall Study|Uncooperative/Noncompliant|3|||
163388506|NCT00332189|590134007|FG000|Overall Study|Withdrawal by Subject|9|||
163388507|NCT00332189|590134007|FG000|Overall Study|Lack of Efficacy|4|||
163388508|NCT00332189|590134007|FG000|Overall Study|Moved out of country|2|||
163388509|NCT02370043|590134008|FG000|Overall Study|Withdrawal by Subject|0|||
162947620|NCT05097989|588510312|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
162947621|NCT05097989|588510313|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
162947622|NCT05097989|588510314|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
162947623|NCT05097989|588510315|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
162947624|NCT05097989|588510316|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
162947625|NCT05097989|588510317|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
162947626|NCT05097989|588510309|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162947627|NCT05097989|588510310|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162947628|NCT05097989|588510311|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162947629|NCT05097989|588510312|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162947630|NCT05097989|588510313|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162947631|NCT05097989|588510314|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163388510|NCT02370043|590134009|FG001|Overall Study|Withdrawal by Subject|0|||
163388511|NCT02370043|590134010|FG002|Overall Study|Withdrawal by Subject|0|||
163388512|NCT02370043|590134011|FG003|Overall Study|Withdrawal by Subject|0|||
163388513|NCT02370043|590134012|FG004|Overall Study|Withdrawal by Subject|1|||
163388514|NCT02370043|590134013|FG005|Overall Study|Withdrawal by Subject|1|||
163388515|NCT01231516|590134014|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
163388516|NCT01231516|590134015|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
163388517|NCT01231516|590134014|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
163388518|NCT01231516|590134015|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
163388519|NCT01231516|590134014|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
163388520|NCT01231516|590134015|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
163388521|NCT01231516|590134014|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
163388522|NCT01231516|590134015|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
163388523|NCT01231516|590134014|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
163388524|NCT01231516|590134015|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
163388525|NCT01231516|590134014|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
163388526|NCT01231516|590134015|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
163388527|NCT01231516|590134014|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
163388528|NCT01231516|590134015|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
163388529|NCT01231516|590134014|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
163388530|NCT01231516|590134015|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
163388531|NCT01231516|590134014|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
163388532|NCT01231516|590134015|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
163388533|NCT01231516|590134014|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
163388534|NCT01231516|590134015|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
163388535|NCT01231516|590134014|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
163388536|NCT01231516|590134015|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
163388537|NCT01231516|590134014|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
163388538|NCT01231516|590134015|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
163388539|NCT01231516|590134014|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
162947632|NCT05097989|588510315|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162947633|NCT05097989|588510316|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162947634|NCT05097989|588510317|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163292383|NCT00849147|589775371|FG000|Overall Study|Disease Relapse/Progression|2|||
163292384|NCT03175172|589777109|FG000|Overall Study|Death|3|||
163292385|NCT03175172|589777109|FG000|Overall Study|Withdrawal by Subject|3|||
163292386|NCT03175172|589777109|FG000|Overall Study|Lost to Follow-up|1|||
163292387|NCT03175172|589777109|FG000|Overall Study|Study Terminated by Sponsor|3|||
163292388|NCT00028769|589777112|FG000|Overall Study|Adverse Event|2|||
163292389|NCT00028769|589777112|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
163292390|NCT00028769|589777112|FG000|Overall Study|Progression or Death|31|||
163292391|NCT00028769|589777112|FG000|Overall Study|Other - Not Protocol Specified|1|||
163292392|NCT00028769|589777112|FG000|Overall Study|Ineligible|5|||
163292393|NCT00028769|589777112|FG000|Overall Study|Not Analyzable|1|||
163292394|NCT02496702|589777115|FG000|Overall Study|Lost to Follow-up|8|||
163292395|NCT02496702|589777116|FG001|Overall Study|Lost to Follow-up|6|||
163292396|NCT02496702|589777115|FG000|Overall Study|Only partially tested|0|||
163292397|NCT02496702|589777116|FG001|Overall Study|Only partially tested|2|||
163292398|NCT00446550|589777119|FG000|Overall Study|Adverse Event|1|||
163292399|NCT00446550|589777120|FG001|Overall Study|Adverse Event|0|||
163292400|NCT02983617|589777121|FG000|Overall Study|Adverse Event|0|||
163292401|NCT02983617|589777122|FG001|Overall Study|Adverse Event|7|||
163292402|NCT02983617|589777121|FG000|Overall Study|Death|0|||
163292403|NCT02983617|589777122|FG001|Overall Study|Death|1|||
163292404|NCT02983617|589777121|FG000|Overall Study|Investigator's Discretion|0|||
163292405|NCT02983617|589777122|FG001|Overall Study|Investigator's Discretion|1|||
163292406|NCT02027558|589777125|FG000|Overall Study|Death|0|||
163292407|NCT02027558|589777126|FG001|Overall Study|Death|1|||
163292408|NCT02027558|589777125|FG000|Overall Study|Withdrawal by Subject|2|||
163292409|NCT02027558|589777126|FG001|Overall Study|Withdrawal by Subject|0|||
163292410|NCT02027558|589777125|FG000|Overall Study|Lost to Follow-up|4|||
163292411|NCT02027558|589777126|FG001|Overall Study|Lost to Follow-up|1|||
163292412|NCT02027558|589777125|FG000|Overall Study|Refused assessment|3|||
163292413|NCT02027558|589777126|FG001|Overall Study|Refused assessment|0|||
163292414|NCT00002842|589777127|FG000|Overall Study|ineligible for surgical resection|27|||
163292415|NCT02694978|589777130|FG000|Overall Study|Adverse Event|10|||
163292416|NCT02694978|589777131|FG001|Overall Study|Adverse Event|9|||
163292417|NCT02694978|589777130|FG000|Overall Study|Withdrawal by Subject|22|||
163292418|NCT02694978|589777131|FG001|Overall Study|Withdrawal by Subject|19|||
163292419|NCT02694978|589777130|FG000|Overall Study|Lost to Follow-up|14|||
163292420|NCT02694978|589777131|FG001|Overall Study|Lost to Follow-up|17|||
163292421|NCT02694978|589777130|FG000|Overall Study|Death|4|||
163292422|NCT02694978|589777131|FG001|Overall Study|Death|1|||
163292423|NCT02694978|589777130|FG000|Overall Study|Other-Decision of Participant|6|||
163292424|NCT02694978|589777131|FG001|Overall Study|Other-Decision of Participant|1|||
163292425|NCT02694978|589777130|FG000|Overall Study|Other-Investigator's decision|1|||
163292426|NCT02694978|589777131|FG001|Overall Study|Other-Investigator's decision|0|||
163292427|NCT02694978|589777130|FG000|Overall Study|Other-Unable to be reached|0|||
163292428|NCT02694978|589777131|FG001|Overall Study|Other-Unable to be reached|1|||
163292429|NCT02694978|589777130|FG000|Overall Study|Other-Protocol noncompliant|2|||
163292430|NCT02694978|589777131|FG001|Overall Study|Other-Protocol noncompliant|1|||
163292431|NCT02694978|589777130|FG000|Overall Study|Other-Personal reasons|3|||
163292432|NCT02694978|589777131|FG001|Overall Study|Other-Personal reasons|3|||
163292433|NCT02694978|589777130|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
163292434|NCT02694978|589777131|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
163292435|NCT00807144|589777134|FG000|Overall Study|Lost to Follow-up|0|||
163292436|NCT00807144|589777135|FG001|Overall Study|Lost to Follow-up|1|||
163292437|NCT02567656|589777137|FG000|Overall Study|Premature discontinuation due to PD|1|||
163292438|NCT02567656|589777138|FG001|Overall Study|Premature discontinuation due to PD|1|||
163292439|NCT02567656|589777139|FG002|Overall Study|Premature discontinuation due to PD|2|||
163292440|NCT02567656|589777140|FG003|Overall Study|Premature discontinuation due to PD|0|||
163292441|NCT02567656|589777141|FG004|Overall Study|Premature discontinuation due to PD|0|||
163292442|NCT02567656|589777142|FG005|Overall Study|Premature discontinuation due to PD|0|||
163292443|NCT01616654|589777144|FG000|Overall Study|Lack of Efficacy|1|||
163292444|NCT01616654|589777145|FG001|Overall Study|Lack of Efficacy|0|||
163292445|NCT01616654|589777146|FG002|Overall Study|Lack of Efficacy|0|||
163292446|NCT01616654|589777147|FG003|Overall Study|Lack of Efficacy|0|||
163292447|NCT01616654|589777148|FG004|Overall Study|Lack of Efficacy|1|||
163292448|NCT01616654|589777144|FG000|Overall Study|Adverse Event|0|||
163292449|NCT01616654|589777145|FG001|Overall Study|Adverse Event|1|||
163292450|NCT01616654|589777146|FG002|Overall Study|Adverse Event|2|||
163292451|NCT01616654|589777147|FG003|Overall Study|Adverse Event|1|||
163292452|NCT01616654|589777148|FG004|Overall Study|Adverse Event|0|||
163292453|NCT01616654|589777144|FG000|Overall Study|Withdrawal by Subject|2|||
163292454|NCT01616654|589777145|FG001|Overall Study|Withdrawal by Subject|2|||
163292455|NCT01616654|589777146|FG002|Overall Study|Withdrawal by Subject|3|||
163292456|NCT01616654|589777147|FG003|Overall Study|Withdrawal by Subject|1|||
163292457|NCT01616654|589777148|FG004|Overall Study|Withdrawal by Subject|5|||
163292458|NCT01616654|589777144|FG000|Overall Study|Protocol Violation|0|||
163292459|NCT01616654|589777145|FG001|Overall Study|Protocol Violation|5|||
163292460|NCT01616654|589777146|FG002|Overall Study|Protocol Violation|2|||
163292461|NCT01616654|589777147|FG003|Overall Study|Protocol Violation|4|||
163292462|NCT01616654|589777148|FG004|Overall Study|Protocol Violation|4|||
163292463|NCT01616654|589777144|FG000|Overall Study|Lost to Follow-up|1|||
163292464|NCT01616654|589777145|FG001|Overall Study|Lost to Follow-up|0|||
163292465|NCT01616654|589777146|FG002|Overall Study|Lost to Follow-up|3|||
163292466|NCT01616654|589777147|FG003|Overall Study|Lost to Follow-up|2|||
163292467|NCT01616654|589777148|FG004|Overall Study|Lost to Follow-up|1|||
163292468|NCT01616654|589777144|FG000|Overall Study|Pregnancy|1|||
163292469|NCT01616654|589777145|FG001|Overall Study|Pregnancy|0|||
163292470|NCT01616654|589777146|FG002|Overall Study|Pregnancy|0|||
163292471|NCT01616654|589777147|FG003|Overall Study|Pregnancy|0|||
163292472|NCT01616654|589777148|FG004|Overall Study|Pregnancy|1|||
163292473|NCT02057692|589777149|FG000|Overall Study|Adverse Event|1|||
163292474|NCT02057692|589777150|FG001|Overall Study|Adverse Event|0|||
163388540|NCT01231516|590134015|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
163388541|NCT01231516|590134014|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
163388542|NCT01231516|590134015|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
163388543|NCT01231516|590134014|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
163388544|NCT01231516|590134015|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
163388545|NCT01231516|590134014|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
163388546|NCT01231516|590134015|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
163388547|NCT05266586|590134018|FG000|Overall Study|Adverse Event|2|||
163388548|NCT05266586|590134019|FG001|Overall Study|Adverse Event|2|||
163388549|NCT05266586|590134020|FG002|Overall Study|Adverse Event|1|||
163388550|NCT05266586|590134018|FG000|Overall Study|Withdrawal by Subject|1|||
163388551|NCT05266586|590134019|FG001|Overall Study|Withdrawal by Subject|0|||
163388552|NCT05266586|590134020|FG002|Overall Study|Withdrawal by Subject|1|||
163388553|NCT05266586|590134018|FG000|Overall Study|Non-compliance with study drug|0|||
163388554|NCT05266586|590134019|FG001|Overall Study|Non-compliance with study drug|1|||
163388555|NCT05266586|590134020|FG002|Overall Study|Non-compliance with study drug|0|||
163388556|NCT05266586|590134018|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
163388557|NCT05266586|590134019|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
163388558|NCT05266586|590134020|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
163388559|NCT02225353|590134021|FG000|Overall Study|Lost to Follow-up|0|||
163388560|NCT02225353|590134022|FG001|Overall Study|Lost to Follow-up|1|||
163388561|NCT02225353|590134023|FG002|Overall Study|Lost to Follow-up|3|||
163388562|NCT02225353|590134021|FG000|Overall Study|Protocol Violation|4|||
163388563|NCT02225353|590134022|FG001|Overall Study|Protocol Violation|5|||
163388564|NCT02225353|590134023|FG002|Overall Study|Protocol Violation|12|||
163388565|NCT03707925|590134024|FG000|Overall Study|Inevaluable|1|||
163388566|NCT01193920|590134025|FG000|Overall Study|Withdrawal by Subject|1|||
163388567|NCT01193920|590134026|FG001|Overall Study|Withdrawal by Subject|0|||
163388568|NCT01193920|590134027|FG002|Overall Study|Withdrawal by Subject|5|||
163388569|NCT01193920|590134028|FG003|Overall Study|Withdrawal by Subject|1|||
163388570|NCT01193920|590134029|FG004|Overall Study|Withdrawal by Subject|3|||
163388571|NCT01193920|590134030|FG005|Overall Study|Withdrawal by Subject|1|||
163388572|NCT01193920|590134031|FG006|Overall Study|Withdrawal by Subject|3|||
163388573|NCT01193920|590134032|FG007|Overall Study|Withdrawal by Subject|0|||
163388574|NCT01193920|590134033|FG008|Overall Study|Withdrawal by Subject|1|||
163388575|NCT01193920|590134034|FG009|Overall Study|Withdrawal by Subject|0|||
163388576|NCT01193920|590134025|FG000|Overall Study|Lost to Follow-up|1|||
163388577|NCT01193920|590134026|FG001|Overall Study|Lost to Follow-up|0|||
163388578|NCT01193920|590134027|FG002|Overall Study|Lost to Follow-up|1|||
163388579|NCT01193920|590134028|FG003|Overall Study|Lost to Follow-up|1|||
163388580|NCT01193920|590134029|FG004|Overall Study|Lost to Follow-up|3|||
163388581|NCT01193920|590134030|FG005|Overall Study|Lost to Follow-up|3|||
163388582|NCT01193920|590134031|FG006|Overall Study|Lost to Follow-up|1|||
163388583|NCT01193920|590134032|FG007|Overall Study|Lost to Follow-up|0|||
163292475|NCT02057692|589777151|FG002|Overall Study|Adverse Event|0|||
163292476|NCT02057692|589777152|FG003|Overall Study|Adverse Event|0|||
163292477|NCT02057692|589777149|FG000|Overall Study|Lost to Follow-up|0|||
163292478|NCT02057692|589777150|FG001|Overall Study|Lost to Follow-up|0|||
163292479|NCT02057692|589777151|FG002|Overall Study|Lost to Follow-up|0|||
163292480|NCT02057692|589777152|FG003|Overall Study|Lost to Follow-up|1|||
163388584|NCT01193920|590134033|FG008|Overall Study|Lost to Follow-up|2|||
163388585|NCT01193920|590134034|FG009|Overall Study|Lost to Follow-up|3|||
163388586|NCT01193920|590134025|FG000|Overall Study|Protocol Violation|1|||
163388587|NCT01193920|590134026|FG001|Overall Study|Protocol Violation|0|||
163292481|NCT03923491|589777153|FG000|Overall Study|Lost to Follow-up|5|||
163292482|NCT03923491|589777154|FG001|Overall Study|Lost to Follow-up|8|||
163388588|NCT01193920|590134027|FG002|Overall Study|Protocol Violation|0|||
163388589|NCT01193920|590134028|FG003|Overall Study|Protocol Violation|0|||
162947635|NCT05097989|588510309|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947636|NCT05097989|588510310|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947637|NCT05097989|588510311|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947638|NCT05097989|588510312|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947639|NCT05097989|588510313|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
162947640|NCT05097989|588510314|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947641|NCT05097989|588510315|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947642|NCT05097989|588510316|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947643|NCT05097989|588510317|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947644|NCT05097989|588510309|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162947645|NCT05097989|588510310|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
162947646|NCT05097989|588510311|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162947647|NCT05097989|588510312|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
162947648|NCT05097989|588510313|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162947649|NCT05097989|588510314|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162947650|NCT05097989|588510315|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162947651|NCT05097989|588510316|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162947652|NCT05097989|588510317|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162947653|NCT05097989|588510309|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
162947654|NCT05097989|588510310|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
162947655|NCT05097989|588510311|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
162947656|NCT05097989|588510312|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
162947657|NCT05097989|588510313|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
162947658|NCT05097989|588510314|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
162947659|NCT05097989|588510315|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
162947660|NCT05097989|588510316|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
162947661|NCT05097989|588510317|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
162947662|NCT05097989|588510309|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
162947663|NCT05097989|588510310|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
162947664|NCT05097989|588510311|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
162947665|NCT05097989|588510312|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
162947666|NCT05097989|588510313|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
162947667|NCT05097989|588510314|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
162947668|NCT05097989|588510315|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
162947669|NCT05097989|588510316|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
162947670|NCT05097989|588510317|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
162947671|NCT05097989|588510309|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947672|NCT05097989|588510310|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947673|NCT05097989|588510311|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947674|NCT05097989|588510312|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947675|NCT05097989|588510313|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
162947676|NCT05097989|588510314|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947677|NCT05097989|588510315|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947678|NCT05097989|588510316|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947679|NCT05097989|588510317|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947680|NCT05097989|588510309|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
162947681|NCT05097989|588510310|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
162947682|NCT05097989|588510311|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
162947683|NCT05097989|588510312|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
162947684|NCT05097989|588510313|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
162947685|NCT05097989|588510314|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
162947686|NCT05097989|588510315|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
162947687|NCT05097989|588510316|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
162947688|NCT05097989|588510317|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
162947689|NCT05097989|588510309|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
162947690|NCT05097989|588510310|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
162947691|NCT05097989|588510311|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
162947692|NCT05097989|588510312|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
162947693|NCT05097989|588510313|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
162947694|NCT05097989|588510314|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
163187265|NCT02124161|589401863|FG001|Overall Study|Does not meet entrance criteria|3|||
163187266|NCT02124161|589401862|FG000|Overall Study|No longer meets eligibility criteria|5|||
163187267|NCT02124161|589401863|FG001|Overall Study|No longer meets eligibility criteria|4|||
163187268|NCT02124161|589401862|FG000|Overall Study|Lost to Follow-up|3|||
163292483|NCT03923491|589777153|FG000|Overall Study|Withdrawal by Subject|4|||
163292484|NCT03923491|589777154|FG001|Overall Study|Withdrawal by Subject|6|||
163292485|NCT03823300|589777159|FG000|Overall Study|Withdrawal by Subject|16|||
163292486|NCT03823300|589777160|FG001|Overall Study|Withdrawal by Subject|22|||
163292487|NCT03823300|589777159|FG000|Overall Study|Death|10|||
163292488|NCT03823300|589777160|FG001|Overall Study|Death|14|||
163292489|NCT03823300|589777159|FG000|Overall Study|Adverse Event|3|||
163292490|NCT03823300|589777160|FG001|Overall Study|Adverse Event|5|||
163292491|NCT03823300|589777159|FG000|Overall Study|Physician Decision|1|||
163292492|NCT03823300|589777160|FG001|Overall Study|Physician Decision|7|||
163292493|NCT03823300|589777159|FG000|Overall Study|Lost to Follow-up|1|||
163292494|NCT03823300|589777160|FG001|Overall Study|Lost to Follow-up|3|||
163292495|NCT03823300|589777159|FG000|Overall Study|Protocol Violation|1|||
163292496|NCT03823300|589777160|FG001|Overall Study|Protocol Violation|1|||
163292497|NCT03823300|589777159|FG000|Overall Study|Lack of Efficacy|1|||
163292498|NCT03823300|589777160|FG001|Overall Study|Lack of Efficacy|1|||
163292499|NCT03823300|589777159|FG000|Overall Study|Not Eligible|0|||
163292500|NCT03823300|589777160|FG001|Overall Study|Not Eligible|1|||
163292501|NCT03823300|589777159|FG000|Overall Study|Other|1|||
163292502|NCT03823300|589777160|FG001|Overall Study|Other|0|||
163292503|NCT00486330|589777161|FG000|Overall Study|Adverse Event|2|||
163292504|NCT00831415|589777162|FG000|Overall Study|Adverse Event|14|||
163292505|NCT00831415|589777162|FG000|Overall Study|Failed to return|3|||
163292506|NCT00831415|589777162|FG000|Overall Study|Physician Decision|6|||
163292507|NCT00831415|589777162|FG000|Overall Study|Lost to Follow-up|9|||
163292508|NCT00831415|589777162|FG000|Overall Study|Protocol Violation|3|||
163292509|NCT00831415|589777162|FG000|Overall Study|Withdrawal by Subject|35|||
163292510|NCT00831415|589777162|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
163292511|NCT00831415|589777162|FG000|Overall Study|Death|1|||
163292512|NCT01290224|589777163|FG000|Overall Study|Adverse Event|1|||
163292513|NCT01290224|589777163|FG000|Overall Study|Refused Further Treatment|4|||
163292514|NCT01027286|589777164|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
163292515|NCT01027286|589777165|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
163292516|NCT01027286|589777164|FG000|Overall Study|Lost to Follow-up|0|||
163292517|NCT01027286|589777165|FG001|Overall Study|Lost to Follow-up|1|||
163292518|NCT05694065|589777166|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
163292519|NCT05694065|589777166|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
163292520|NCT05694065|589777166|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
163292521|NCT01087762|589777167|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
163292522|NCT01087762|589777168|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
163292523|NCT01087762|589777169|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
163292524|NCT01087762|589777170|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
163292525|NCT01087762|589777171|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
163292526|NCT01087762|589777167|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
163292527|NCT01087762|589777168|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
163292528|NCT01087762|589777169|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
163292529|NCT01087762|589777170|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
163292530|NCT01087762|589777171|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
163292531|NCT01087762|589777167|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
163292532|NCT01087762|589777168|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
163292533|NCT01087762|589777169|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
163292534|NCT01087762|589777170|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
163292535|NCT01087762|589777171|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
163292536|NCT01087762|589777167|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
163292537|NCT01087762|589777168|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
163292538|NCT01087762|589777169|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
163292539|NCT01087762|589777170|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
163292540|NCT01087762|589777171|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
163292541|NCT01087762|589777167|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
163292542|NCT01087762|589777168|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
163388590|NCT01193920|590134029|FG004|Overall Study|Protocol Violation|0|||
163388591|NCT01193920|590134030|FG005|Overall Study|Protocol Violation|0|||
163388592|NCT01193920|590134031|FG006|Overall Study|Protocol Violation|0|||
163292543|NCT01087762|589777169|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
163292544|NCT01087762|589777170|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
163292545|NCT01087762|589777171|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
163292546|NCT01087762|589777167|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
163292547|NCT01087762|589777168|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
163292548|NCT01087762|589777169|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
163292549|NCT01087762|589777170|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
163292550|NCT01087762|589777171|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
163388593|NCT01193920|590134032|FG007|Overall Study|Protocol Violation|0|||
163292551|NCT01087762|589777167|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
163292552|NCT01087762|589777168|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
163292553|NCT01087762|589777169|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
163292554|NCT01087762|589777170|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
163292555|NCT01087762|589777171|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
163292556|NCT01087762|589777167|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
163292557|NCT01087762|589777168|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
163292558|NCT01087762|589777169|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
163292559|NCT01087762|589777170|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
163292560|NCT01087762|589777171|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
163292561|NCT01087762|589777167|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
163292562|NCT01087762|589777168|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
162947695|NCT05097989|588510315|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
162947696|NCT05097989|588510316|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
162947697|NCT05097989|588510317|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
162947698|NCT00918567|588510326|FG000|Overall Study|Lack of Efficacy|3|||
162947699|NCT00918567|588510327|FG001|Overall Study|Lack of Efficacy|1|||
162947700|NCT00918567|588510326|FG000|Overall Study|Withdrawal by Subject|1|||
162947701|NCT00918567|588510327|FG001|Overall Study|Withdrawal by Subject|1|||
162947702|NCT00918567|588510326|FG000|Overall Study|Adverse Event|1|||
162947703|NCT00918567|588510327|FG001|Overall Study|Adverse Event|0|||
162947704|NCT05275998|588510330|FG000|Overall Study|Adverse Event|0|||
162947705|NCT05275998|588510331|FG001|Overall Study|Adverse Event|0|||
162947706|NCT05275998|588510332|FG002|Overall Study|Adverse Event|0|||
162947707|NCT05275998|588510333|FG003|Overall Study|Adverse Event|1|||
162947708|NCT05275998|588510330|FG000|Overall Study|Withdrawal by Subject|0|||
162947709|NCT05275998|588510331|FG001|Overall Study|Withdrawal by Subject|0|||
162947710|NCT05275998|588510332|FG002|Overall Study|Withdrawal by Subject|0|||
162947711|NCT05275998|588510333|FG003|Overall Study|Withdrawal by Subject|1|||
162947712|NCT05275998|588510330|FG000|Overall Study|Physician Decision|0|||
162947713|NCT05275998|588510331|FG001|Overall Study|Physician Decision|0|||
162947714|NCT05275998|588510332|FG002|Overall Study|Physician Decision|0|||
162947715|NCT05275998|588510333|FG003|Overall Study|Physician Decision|1|||
162947716|NCT05275998|588510330|FG000|Overall Study|Protocol Violation|0|||
162947717|NCT05275998|588510331|FG001|Overall Study|Protocol Violation|0|||
162947718|NCT05275998|588510332|FG002|Overall Study|Protocol Violation|1|||
162947719|NCT05275998|588510333|FG003|Overall Study|Protocol Violation|0|||
162947720|NCT01936948|588510334|FG000|Overall Study|no 30-day follow-up data|0|||
162947721|NCT01936948|588510335|FG001|Overall Study|no 30-day follow-up data|3|||
162947722|NCT01936948|588510336|FG002|Overall Study|no 30-day follow-up data|3|||
162947723|NCT01936948|588510337|FG003|Overall Study|no 30-day follow-up data|3|||
162947724|NCT02327130|588510341|FG000|Overall Study|Discharged in less than 5 days|5|||
162947725|NCT02327130|588510341|FG000|Overall Study|Physician Decision|2|||
162947726|NCT02327130|588510341|FG000|Overall Study|Unable to provide breath sample|1|||
162947727|NCT02327130|588510341|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
162947728|NCT02327130|588510341|FG000|Overall Study|Met exclusion criteria|3|||
162947729|NCT01451762|588511596|FG000|Overall Study|Lost to Follow-up|3|||
162947730|NCT01451762|588511597|FG001|Overall Study|Lost to Follow-up|6|||
162947731|NCT01451762|588511598|FG002|Overall Study|Lost to Follow-up|6|||
162947732|NCT04349917|588511606|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
162947733|NCT04349917|588511607|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
162947734|NCT04349917|588511606|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
162947735|NCT04349917|588511607|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
162947736|NCT00088829|588511620|FG000|Overall Study|PI left institution and study was close|22|||
162947737|NCT02532764|588511621|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
162947738|NCT02532764|588511622|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
162947739|NCT02532764|588511623|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
162947740|NCT02532764|588511624|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
162947741|NCT02532764|588511625|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
162947742|NCT02532764|588511626|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
162947743|NCT02532764|588511627|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
162947744|NCT02532764|588511628|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
162947745|NCT02532764|588511629|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
162947746|NCT02532764|588511630|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
162947747|NCT00525590|588511637|FG000|Overall Study|Adverse Event|3|||
162947748|NCT00525590|588511637|FG000|Overall Study|Physician Decision|3|||
162947749|NCT00525590|588511637|FG000|Overall Study|Withdrawal by Subject|16|||
162947750|NCT00525590|588511637|FG000|Overall Study|Lost to Follow-up|1|||
162947751|NCT00525590|588511637|FG000|Overall Study|Death|9|||
163187269|NCT02124161|589401863|FG001|Overall Study|Lost to Follow-up|4|||
163187270|NCT01954342|589401867|FG000|Overall Study|Missing data from 13-16week study visit|0|||
163187271|NCT01954342|589401868|FG001|Overall Study|Missing data from 13-16week study visit|0|||
163187272|NCT01954342|589401869|FG002|Overall Study|Missing data from 13-16week study visit|0|||
163187273|NCT01954342|589401870|FG003|Overall Study|Missing data from 13-16week study visit|1|||
162947752|NCT00525590|588511637|FG000|Overall Study|Other|13|||
162947753|NCT03830164|588511642|FG000|Overall Study|Adverse Event|0|||
163187274|NCT01954342|589401867|FG000|Overall Study|Miscarriage|0|||
163187275|NCT01954342|589401868|FG001|Overall Study|Miscarriage|0|||
162947754|NCT03830164|588511643|FG001|Overall Study|Adverse Event|2|||
162947755|NCT03830164|588511644|FG002|Overall Study|Adverse Event|0|||
162947756|NCT03830164|588511642|FG000|Overall Study|Lack of Efficacy|1|||
162947757|NCT03830164|588511643|FG001|Overall Study|Lack of Efficacy|5|||
162947758|NCT03830164|588511644|FG002|Overall Study|Lack of Efficacy|0|||
162947759|NCT03830164|588511642|FG000|Overall Study|Lost to Follow-up|0|||
162947760|NCT03830164|588511643|FG001|Overall Study|Lost to Follow-up|1|||
163187276|NCT01954342|589401869|FG002|Overall Study|Miscarriage|0|||
163388594|NCT01193920|590134033|FG008|Overall Study|Protocol Violation|0|||
163388595|NCT01193920|590134034|FG009|Overall Study|Protocol Violation|0|||
163388596|NCT01193920|590134025|FG000|Overall Study|Death|0|||
163388597|NCT01193920|590134026|FG001|Overall Study|Death|0|||
163388598|NCT01193920|590134027|FG002|Overall Study|Death|0|||
163388599|NCT01193920|590134028|FG003|Overall Study|Death|1|||
163388600|NCT01193920|590134029|FG004|Overall Study|Death|0|||
163388601|NCT01193920|590134030|FG005|Overall Study|Death|0|||
163388602|NCT01193920|590134031|FG006|Overall Study|Death|2|||
163388603|NCT01193920|590134032|FG007|Overall Study|Death|3|||
163388604|NCT01193920|590134033|FG008|Overall Study|Death|2|||
163388605|NCT01193920|590134034|FG009|Overall Study|Death|4|||
163388606|NCT01193920|590134025|FG000|Overall Study|Unable to classify|0|||
163388607|NCT01193920|590134026|FG001|Overall Study|Unable to classify|0|||
163388608|NCT01193920|590134027|FG002|Overall Study|Unable to classify|0|||
163388609|NCT01193920|590134028|FG003|Overall Study|Unable to classify|1|||
163388610|NCT01193920|590134029|FG004|Overall Study|Unable to classify|0|||
163388611|NCT01193920|590134030|FG005|Overall Study|Unable to classify|0|||
163388612|NCT01193920|590134031|FG006|Overall Study|Unable to classify|0|||
163388613|NCT01193920|590134032|FG007|Overall Study|Unable to classify|1|||
163388614|NCT01193920|590134033|FG008|Overall Study|Unable to classify|0|||
163388615|NCT01193920|590134034|FG009|Overall Study|Unable to classify|0|||
163388616|NCT01323621|590134035|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
163388617|NCT01323621|590134036|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
163388618|NCT01323621|590134037|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
163388619|NCT01323621|590134035|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
163388620|NCT01323621|590134036|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
163388621|NCT01323621|590134037|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
163388622|NCT01323621|590134035|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
163388623|NCT01323621|590134036|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
163388624|NCT01323621|590134037|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
163388625|NCT01323621|590134035|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
163388626|NCT01323621|590134036|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
163388627|NCT01323621|590134037|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
163388628|NCT01323621|590134035|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
163388629|NCT01323621|590134036|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
163388630|NCT01323621|590134037|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
163388631|NCT01323621|590134035|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
163388632|NCT01323621|590134036|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
163388633|NCT01323621|590134037|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
163388634|NCT01323621|590134035|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
163388635|NCT01323621|590134036|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
163388636|NCT01323621|590134037|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
163388637|NCT01323621|590134035|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
163388638|NCT01323621|590134036|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
163388639|NCT01323621|590134037|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
163388640|NCT01323621|590134035|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
163388641|NCT01323621|590134036|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
163388642|NCT01323621|590134037|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
163388643|NCT01323621|590134035|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163388644|NCT01323621|590134036|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
163388645|NCT01323621|590134037|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163388646|NCT01323621|590134035|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
163388647|NCT01323621|590134036|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
163388648|NCT01323621|590134037|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
163388649|NCT01323621|590134035|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
163388650|NCT01323621|590134036|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
163388651|NCT01323621|590134037|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
163388652|NCT00954421|590134038|FG000|Screening|screen failures|3|||
163388653|NCT00954421|590134038|FG000|6 Months of DBS|Withdrawal by Subject|1|||
163388654|NCT00954421|590134038|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
163388655|NCT05245097|590134039|FG000|Overall Study|Adverse Event|13|||
163388656|NCT05245097|590134040|FG001|Overall Study|Adverse Event|2|||
163388657|NCT05245097|590134039|FG000|Overall Study|Protocol Violation|8|||
163187277|NCT01954342|589401870|FG003|Overall Study|Miscarriage|3|||
163187278|NCT01954342|589401867|FG000|Overall Study|Lost to Follow-up|0|||
163187279|NCT01954342|589401868|FG001|Overall Study|Lost to Follow-up|0|||
163187280|NCT01954342|589401869|FG002|Overall Study|Lost to Follow-up|0|||
163187281|NCT01954342|589401870|FG003|Overall Study|Lost to Follow-up|5|||
163187282|NCT01954342|589401867|FG000|Overall Study|Preterm delivery|0|||
163187283|NCT01954342|589401868|FG001|Overall Study|Preterm delivery|0|||
163187284|NCT01954342|589401869|FG002|Overall Study|Preterm delivery|0|||
163187285|NCT01954342|589401870|FG003|Overall Study|Preterm delivery|3|||
163187286|NCT01954342|589401867|FG000|Overall Study|Pre-eclampsia|0|||
163187287|NCT01954342|589401868|FG001|Overall Study|Pre-eclampsia|0|||
163187288|NCT01954342|589401869|FG002|Overall Study|Pre-eclampsia|0|||
163187289|NCT01954342|589401870|FG003|Overall Study|Pre-eclampsia|4|||
163187290|NCT01954342|589401867|FG000|Overall Study|Unreliable Data|0|||
163187291|NCT01954342|589401868|FG001|Overall Study|Unreliable Data|0|||
163187292|NCT01954342|589401869|FG002|Overall Study|Unreliable Data|0|||
163187293|NCT01954342|589401870|FG003|Overall Study|Unreliable Data|2|||
163187294|NCT00984568|589401871|FG000|Overall Study|Withdrawal by Subject|1|||
163187295|NCT00984568|589401872|FG001|Overall Study|Withdrawal by Subject|2|||
163187296|NCT00984568|589401871|FG000|Overall Study|Lack of Efficacy|2|||
163187297|NCT00984568|589401872|FG001|Overall Study|Lack of Efficacy|0|||
163187298|NCT00984568|589401871|FG000|Overall Study|Adverse Event|2|||
163187299|NCT00984568|589401872|FG001|Overall Study|Adverse Event|0|||
163187300|NCT00984568|589401871|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
163187301|NCT00984568|589401872|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
163187302|NCT00984568|589401871|FG000|Overall Study|Lost to Follow-up|0|||
163187303|NCT00984568|589401872|FG001|Overall Study|Lost to Follow-up|1|||
163187304|NCT00984568|589401871|FG000|Overall Study|Opportunistic Infection|1|||
163187305|NCT00984568|589401872|FG001|Overall Study|Opportunistic Infection|0|||
163187306|NCT00984568|589401871|FG000|Overall Study|Unknown Reason|1|||
163187307|NCT00984568|589401872|FG001|Overall Study|Unknown Reason|3|||
163187308|NCT01649804|589401873|FG000|Overall Study|Administrative/Other|8|||
163187309|NCT03845543|589401874|FG000|Overall Study|Death|25|||
163187310|NCT03845543|589401874|FG000|Overall Study|Withdrawal by Subject|2|||
163187311|NCT03845543|589401874|FG000|Overall Study|Lost to Follow-up|12|||
163187312|NCT03845543|589401874|FG000|Overall Study|Adverse Event|17|||
163187313|NCT01912963|589401880|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
163187314|NCT01912963|589401881|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
163187315|NCT01912963|589401882|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
163187316|NCT01912963|589401880|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
163187317|NCT01912963|589401881|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
163187318|NCT01912963|589401882|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
163187319|NCT01912963|589401880|FG000|Overall Study|Adverse Event|0|||
163187320|NCT01912963|589401881|FG001|Overall Study|Adverse Event|1|||
163187321|NCT01912963|589401882|FG002|Overall Study|Adverse Event|1|||
163187322|NCT01912963|589401880|FG000|Overall Study|Withdrawal by Subject|0|||
163187323|NCT01912963|589401881|FG001|Overall Study|Withdrawal by Subject|1|||
163187324|NCT01912963|589401882|FG002|Overall Study|Withdrawal by Subject|0|||
163187325|NCT01912963|589401880|FG000|Overall Study|Sought treatment locally|0|||
163187326|NCT01912963|589401881|FG001|Overall Study|Sought treatment locally|1|||
163187327|NCT01912963|589401882|FG002|Overall Study|Sought treatment locally|0|||
163187328|NCT01336569|589401884|FG000|Overall Study|Lost to Follow-up|4|||
163187329|NCT00406354|589401887|FG000|All Randomized Patients|Protocol Violation|0|||
163187330|NCT00406354|589401888|FG001|All Randomized Patients|Protocol Violation|0|||
163187331|NCT00406354|589401889|FG002|All Randomized Patients|Protocol Violation|1|||
163187332|NCT00406354|589401887|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
163187333|NCT00406354|589401888|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
163187334|NCT00406354|589401889|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
163187335|NCT00406354|589401887|FG000|All Randomized and Treated Patients|Adverse Event|6|||
163187336|NCT00406354|589401888|FG001|All Randomized and Treated Patients|Adverse Event|2|||
163187337|NCT00406354|589401889|FG002|All Randomized and Treated Patients|Adverse Event|1|||
163187338|NCT00406354|589401887|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
163187339|NCT00406354|589401888|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
163187340|NCT00406354|589401889|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
163187341|NCT00406354|589401887|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
163187342|NCT00406354|589401888|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
163187343|NCT00406354|589401889|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
163187344|NCT00406354|589401887|FG000|All Randomized and Treated Patients|Physician Decision|0|||
163187345|NCT00406354|589401888|FG001|All Randomized and Treated Patients|Physician Decision|0|||
163187346|NCT00406354|589401889|FG002|All Randomized and Treated Patients|Physician Decision|1|||
163187347|NCT03438383|589401906|FG000|Overall Study|Protocol Violation|9|||
163187348|NCT03438383|589401907|FG001|Overall Study|Protocol Violation|3|||
163187349|NCT02435069|589401908|FG000|Dose Response - First Intervention|Adverse Event|0|||
163187350|NCT02435069|589401909|FG001|Dose Response - First Intervention|Adverse Event|1|||
163187351|NCT02435069|589401910|FG002|Dose Response - First Intervention|Adverse Event|1|||
163187352|NCT02435069|589401911|FG003|Dose Response - First Intervention|Adverse Event|0|||
163187353|NCT02435069|589401912|FG004|Dose Response - First Intervention|Adverse Event|0|||
163187354|NCT02435069|589401908|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
163187355|NCT02435069|589401909|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
162947761|NCT03830164|588511644|FG002|Overall Study|Lost to Follow-up|0|||
162947762|NCT03830164|588511642|FG000|Overall Study|Withdrawal by Subject|1|||
162947763|NCT03830164|588511643|FG001|Overall Study|Withdrawal by Subject|0|||
162947764|NCT03830164|588511644|FG002|Overall Study|Withdrawal by Subject|0|||
162947765|NCT04099888|588511645|FG000|Overall Study|Study terminated by sponsor|9|||
162947766|NCT04099888|588511646|FG001|Overall Study|Study terminated by sponsor|11|||
162947767|NCT04099888|588511645|FG000|Overall Study|Lost to Follow-up|1|||
162947768|NCT04099888|588511646|FG001|Overall Study|Lost to Follow-up|1|||
162947769|NCT04099888|588511645|FG000|Overall Study|Withdrawal by Subject|5|||
162947770|NCT04099888|588511646|FG001|Overall Study|Withdrawal by Subject|6|||
162947771|NCT04099888|588511645|FG000|Overall Study|Death|5|||
162947772|NCT04099888|588511646|FG001|Overall Study|Death|2|||
162947773|NCT04099888|588511645|FG000|Overall Study|Other|1|||
162947774|NCT04099888|588511646|FG001|Overall Study|Other|0|||
162947775|NCT01273181|588511652|FG000|Phase I, Dose 1|Study termination|1|||
162947776|NCT01273181|588511653|FG001|Phase I, Dose 1|Study termination|0|||
162947777|NCT01273181|588511654|FG002|Phase I, Dose 1|Study termination|0|||
162947778|NCT01273181|588511655|FG003|Phase I, Dose 1|Study termination|0|||
162947779|NCT01273181|588511652|FG000|Phase I, Dose 2|Death during treatment|0|||
162947780|NCT01273181|588511653|FG001|Phase I, Dose 2|Death during treatment|1|||
162947781|NCT01273181|588511654|FG002|Phase I, Dose 2|Death during treatment|0|||
162947782|NCT01273181|588511655|FG003|Phase I, Dose 2|Death during treatment|0|||
162947783|NCT01273181|588511652|FG000|Phase 2, Dose 1|Study termination|0|||
162947784|NCT01273181|588511653|FG001|Phase 2, Dose 1|Study termination|0|||
162947785|NCT01273181|588511654|FG002|Phase 2, Dose 1|Study termination|1|||
162947786|NCT01273181|588511655|FG003|Phase 2, Dose 1|Study termination|0|||
162947787|NCT01273181|588511652|FG000|Phase 2, Dose 2|Death during treatment|0|||
162947788|NCT01273181|588511653|FG001|Phase 2, Dose 2|Death during treatment|0|||
162947789|NCT01273181|588511654|FG002|Phase 2, Dose 2|Death during treatment|0|||
162947790|NCT01273181|588511655|FG003|Phase 2, Dose 2|Death during treatment|1|||
162947791|NCT04276883|588511656|FG000|Overall Study|Withdrawal by Subject|2|||
162947792|NCT04276883|588511657|FG001|Overall Study|Withdrawal by Subject|3|||
162947793|NCT04276883|588511658|FG002|Overall Study|Withdrawal by Subject|6|||
162947794|NCT04276883|588511656|FG000|Overall Study|Lost to Follow-up|1|||
162947795|NCT04276883|588511657|FG001|Overall Study|Lost to Follow-up|3|||
162947796|NCT04276883|588511658|FG002|Overall Study|Lost to Follow-up|0|||
162947797|NCT04276883|588511656|FG000|Overall Study|Adverse Event|0|||
162947798|NCT04276883|588511657|FG001|Overall Study|Adverse Event|1|||
162947799|NCT04276883|588511658|FG002|Overall Study|Adverse Event|0|||
162947800|NCT04276883|588511656|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
162947801|NCT04276883|588511657|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
162947802|NCT04276883|588511658|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
162947803|NCT02458469|588511660|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
162947804|NCT02458469|588511661|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
162947805|NCT02458469|588511662|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
162947806|NCT02458469|588511663|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
162947807|NCT02458469|588511664|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
162947808|NCT02458469|588511665|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
162947809|NCT02458469|588511660|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
162947810|NCT02458469|588511661|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
162947811|NCT02458469|588511662|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
163292563|NCT01087762|589777169|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
163292564|NCT01087762|589777170|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
163292565|NCT01087762|589777171|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
163292566|NCT01087762|589777167|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
163292567|NCT01087762|589777168|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
163292568|NCT01087762|589777169|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
163292569|NCT01087762|589777170|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
163292570|NCT01087762|589777171|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
163292571|NCT01087762|589777167|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
163292572|NCT01087762|589777168|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
163292573|NCT01087762|589777169|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
163292574|NCT01087762|589777170|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
163388658|NCT05245097|590134040|FG001|Overall Study|Protocol Violation|6|||
163388659|NCT05245097|590134039|FG000|Overall Study|Withdrawal by Subject|18|||
162947812|NCT02458469|588511663|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
162947813|NCT02458469|588511664|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
162947814|NCT02458469|588511665|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
162947815|NCT02458469|588511660|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
162947816|NCT02458469|588511661|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
162947817|NCT02458469|588511662|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
162947818|NCT02458469|588511663|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
162947819|NCT02458469|588511664|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
163292575|NCT01087762|589777171|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
163292576|NCT01087762|589777167|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
163292577|NCT01087762|589777168|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
163292578|NCT01087762|589777169|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
163292579|NCT01087762|589777170|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
163292580|NCT01087762|589777171|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
163292581|NCT01087762|589777167|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
163292582|NCT01087762|589777168|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
163292583|NCT01087762|589777169|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
163292584|NCT01087762|589777170|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
163292585|NCT01087762|589777171|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
163292586|NCT00813904|589777172|FG000|Overall Study|Death|1|||
163292587|NCT01405924|589777175|FG000|Overall Study|Protocol Violation|8|||
163292588|NCT01405924|589777175|FG000|Overall Study|Missing/Incomplete Data|2|||
163292589|NCT02393716|589777176|FG000|Overall Study|Death|29|||
163292590|NCT02393716|589777176|FG000|Overall Study|Withdrawal by Subject|8|||
163292591|NCT02393716|589777176|FG000|Overall Study|Device Explanted|8|||
163292592|NCT02393716|589777176|FG000|Overall Study|Missed visit|16|||
163292593|NCT01924767|589777177|FG000|Overall Study|Adverse Event|1|||
163292594|NCT01924767|589777178|FG001|Overall Study|Adverse Event|0|||
163292595|NCT01924767|589777179|FG002|Overall Study|Adverse Event|1|||
163292596|NCT01924767|589777180|FG003|Overall Study|Adverse Event|0|||
163292597|NCT01924767|589777181|FG004|Overall Study|Adverse Event|0|||
163292598|NCT01648140|589777182|FG000|Overall Study|Physician Decision|1|||
163292599|NCT01648140|589777183|FG001|Overall Study|Physician Decision|0|||
163292600|NCT01648140|589777184|FG002|Overall Study|Physician Decision|0|||
163292601|NCT01648140|589777185|FG003|Overall Study|Physician Decision|0|||
163292602|NCT01648140|589777182|FG000|Overall Study|Lack of Efficacy|4|||
163292603|NCT01648140|589777183|FG001|Overall Study|Lack of Efficacy|7|||
163292604|NCT01648140|589777184|FG002|Overall Study|Lack of Efficacy|1|||
163292605|NCT01648140|589777185|FG003|Overall Study|Lack of Efficacy|0|||
163292606|NCT01648140|589777182|FG000|Overall Study|Adverse Event|3|||
163292607|NCT01648140|589777183|FG001|Overall Study|Adverse Event|1|||
163292608|NCT01648140|589777184|FG002|Overall Study|Adverse Event|2|||
163292609|NCT01648140|589777185|FG003|Overall Study|Adverse Event|0|||
163292610|NCT01648140|589777182|FG000|Overall Study|Withdrawal by Subject|2|||
163292611|NCT01648140|589777183|FG001|Overall Study|Withdrawal by Subject|3|||
163292612|NCT01648140|589777184|FG002|Overall Study|Withdrawal by Subject|3|||
163292613|NCT01648140|589777185|FG003|Overall Study|Withdrawal by Subject|2|||
163292614|NCT01648140|589777182|FG000|Overall Study|Lost to Follow-up|2|||
163292615|NCT01648140|589777183|FG001|Overall Study|Lost to Follow-up|1|||
163292616|NCT01648140|589777184|FG002|Overall Study|Lost to Follow-up|2|||
163292617|NCT01648140|589777185|FG003|Overall Study|Lost to Follow-up|0|||
163292618|NCT01565928|589777186|FG000|Overall Study|Adverse Event|3|||
163292619|NCT01565928|589777186|FG000|Overall Study|Other|3|||
163292620|NCT01565928|589777186|FG000|Overall Study|Progressive Disease|13|||
163292621|NCT01565928|589777186|FG000|Overall Study|Withdrawal by Subject|1|||
163292622|NCT01565928|589777186|FG000|Overall Study|Death|2|||
163292623|NCT03621761|589777189|FG000|Overall Study|Lost to Follow-up|1|||
163292624|NCT03621761|589777190|FG001|Overall Study|Lost to Follow-up|1|||
163292625|NCT03621761|589777191|FG002|Overall Study|Lost to Follow-up|2|||
162924224|NCT00077766|588423834|FG001|Overall Study|Participant's decision|0|||
163388660|NCT05245097|590134040|FG001|Overall Study|Withdrawal by Subject|0|||
163388661|NCT05245097|590134039|FG000|Overall Study|Death|6|||
163388662|NCT05245097|590134040|FG001|Overall Study|Death|7|||
163388663|NCT05245097|590134039|FG000|Overall Study|Physician Decision|6|||
163388664|NCT05245097|590134040|FG001|Overall Study|Physician Decision|0|||
163388665|NCT05245097|590134039|FG000|Overall Study|Relocation|4|||
163388666|NCT05245097|590134040|FG001|Overall Study|Relocation|3|||
163388667|NCT04683731|590134043|FG000|Overall Study|Withdrawal by Subject|1|||
163388668|NCT04683731|590134044|FG001|Overall Study|Withdrawal by Subject|0|||
163388669|NCT04683731|590134045|FG002|Overall Study|Withdrawal by Subject|3|||
163388670|NCT04683731|590134046|FG003|Overall Study|Withdrawal by Subject|2|||
163388671|NCT04683731|590134043|FG000|Overall Study|Determined patient was not eligible|3|||
163388672|NCT04683731|590134044|FG001|Overall Study|Determined patient was not eligible|3|||
163388673|NCT04683731|590134045|FG002|Overall Study|Determined patient was not eligible|12|||
163388674|NCT04683731|590134046|FG003|Overall Study|Determined patient was not eligible|3|||
163388675|NCT00883051|590134047|FG000|Overall Study|Lost to Follow-up|0|||
163388676|NCT00883051|590134048|FG001|Overall Study|Lost to Follow-up|0|||
163388677|NCT00883051|590134049|FG002|Overall Study|Lost to Follow-up|0|||
163388678|NCT00883051|590134050|FG003|Overall Study|Lost to Follow-up|0|||
163388679|NCT00883051|590134051|FG004|Overall Study|Lost to Follow-up|1|||
163388680|NCT00883051|590134047|FG000|Overall Study|Did not use study medication|24|||
163388681|NCT00883051|590134048|FG001|Overall Study|Did not use study medication|22|||
163388682|NCT00883051|590134049|FG002|Overall Study|Did not use study medication|29|||
163388683|NCT00883051|590134050|FG003|Overall Study|Did not use study medication|29|||
163388684|NCT00883051|590134051|FG004|Overall Study|Did not use study medication|17|||
163388685|NCT03604523|590134054|FG000|Overall Study|Physician Decision|1|||
163388686|NCT03604523|590134055|FG001|Overall Study|Physician Decision|0|||
163388687|NCT00458341|590134056|FG000|Cycle 1|Adverse Event|1|||
163388688|NCT00458341|590134057|FG001|Cycle 1|Adverse Event|0|||
163388689|NCT00810394|590134060|FG000|Overall Study|Withdrawal by Subject|3|||
163388690|NCT00467285|590134061|FG000|Overall Study|Lost to Follow-up|4|||
163388691|NCT00467285|590134062|FG001|Overall Study|Lost to Follow-up|4|||
163388692|NCT03891524|590134063|FG000|Overall Study|Death|0|||
163388693|NCT03891524|590134064|FG001|Overall Study|Death|0|||
163388694|NCT03891524|590134065|FG002|Overall Study|Death|0|||
163388695|NCT03891524|590134066|FG003|Overall Study|Death|0|||
163388696|NCT03891524|590134067|FG004|Overall Study|Death|0|||
163388697|NCT03891524|590134068|FG005|Overall Study|Death|0|||
163388698|NCT03891524|590134069|FG006|Overall Study|Death|0|||
163388699|NCT03891524|590134070|FG007|Overall Study|Death|1|||
163388700|NCT03891524|590134063|FG000|Overall Study|Withdrawal by Subject|0|||
163388701|NCT03891524|590134064|FG001|Overall Study|Withdrawal by Subject|1|||
163388702|NCT03891524|590134065|FG002|Overall Study|Withdrawal by Subject|2|||
163388703|NCT03891524|590134066|FG003|Overall Study|Withdrawal by Subject|1|||
163388704|NCT03891524|590134067|FG004|Overall Study|Withdrawal by Subject|2|||
163388705|NCT03891524|590134068|FG005|Overall Study|Withdrawal by Subject|2|||
163388706|NCT03891524|590134069|FG006|Overall Study|Withdrawal by Subject|2|||
163388707|NCT03891524|590134070|FG007|Overall Study|Withdrawal by Subject|1|||
163388708|NCT01210118|590134071|FG000|Overall Study|Lost to Follow-up|1|||
163388709|NCT01210118|590134072|FG001|Overall Study|Lost to Follow-up|1|||
163388710|NCT01210118|590134071|FG000|Overall Study|Protocol Violation|1|||
163388711|NCT01210118|590134072|FG001|Overall Study|Protocol Violation|1|||
163388712|NCT01210118|590134071|FG000|Overall Study|Spontaneous abortion|1|||
163388713|NCT01210118|590134072|FG001|Overall Study|Spontaneous abortion|3|||
163388714|NCT01696942|590134073|FG000|Overall Study|Withdrawal by Subject|1|||
163388715|NCT01696942|590134074|FG001|Overall Study|Withdrawal by Subject|0|||
163388716|NCT01696942|590134073|FG000|Overall Study|Protocol Violation|1|||
163388717|NCT01696942|590134074|FG001|Overall Study|Protocol Violation|2|||
163388718|NCT01696942|590134073|FG000|Overall Study|screen failure|0|||
163388719|NCT01696942|590134074|FG001|Overall Study|screen failure|1|||
163388720|NCT01598311|590134075|FG000|Overall Study|Physician Decision|4|||
163388721|NCT01598311|590134076|FG001|Overall Study|Physician Decision|5|||
163388722|NCT01598311|590134075|FG000|Overall Study|Adverse Event|9|||
163388723|NCT01598311|590134076|FG001|Overall Study|Adverse Event|13|||
163388724|NCT01598311|590134075|FG000|Overall Study|Lost to Follow-up|7|||
163388725|NCT01598311|590134076|FG001|Overall Study|Lost to Follow-up|12|||
163388726|NCT01598311|590134075|FG000|Overall Study|Withdrawal by Subject|9|||
162947820|NCT02458469|588511665|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
163388727|NCT01598311|590134076|FG001|Overall Study|Withdrawal by Subject|13|||
163388728|NCT01598311|590134075|FG000|Overall Study|No reason provided.|0|||
163388729|NCT01598311|590134076|FG001|Overall Study|No reason provided.|5|||
163388730|NCT01598311|590134075|FG000|Overall Study|Randomized but never treated|8|||
163388731|NCT01598311|590134076|FG001|Overall Study|Randomized but never treated|5|||
163388732|NCT01598311|590134075|FG000|Overall Study|Treated but no confirmed CDAD|9|||
163388733|NCT01598311|590134076|FG001|Overall Study|Treated but no confirmed CDAD|8|||
163388734|NCT01598311|590134075|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
163388735|NCT01598311|590134076|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
163401993|NCT01840579|590182955|FG002|Overall Study|Follow-up ended by Sponsor|0|||
162947821|NCT02603952|588511670|FG000|Overall Study|Withdrawal by Subject|1|||
162947822|NCT02603952|588511671|FG001|Overall Study|Withdrawal by Subject|0|||
162947823|NCT02603952|588511672|FG002|Overall Study|Withdrawal by Subject|0|||
162947824|NCT02603952|588511673|FG003|Overall Study|Withdrawal by Subject|0|||
162947825|NCT02603952|588511670|FG000|Overall Study|Received oseltamivir by error|0|||
162947826|NCT02603952|588511671|FG001|Overall Study|Received oseltamivir by error|0|||
162947827|NCT02603952|588511672|FG002|Overall Study|Received oseltamivir by error|0|||
162947828|NCT02603952|588511673|FG003|Overall Study|Received oseltamivir by error|1|||
162947829|NCT00958243|588511681|FG000|Overall Study|Withdrawal by Subject|0|||
163187356|NCT02435069|589401910|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
163187357|NCT02435069|589401911|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
163187358|NCT02435069|589401912|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
163187359|NCT02030938|589401915|FG000|Overall Study|Lost to Follow-up|4|||
163187360|NCT02030938|589401915|FG000|Overall Study|Withdrawal by Subject|1|||
163187361|NCT03954132|589401919|FG000|Overall Study|Adverse Event|2|||
163187362|NCT03954132|589401920|FG001|Overall Study|Adverse Event|0|||
163187363|NCT03954132|589401919|FG000|Overall Study|Patient's wish|5|||
163187364|NCT03954132|589401920|FG001|Overall Study|Patient's wish|0|||
163187365|NCT03954132|589401919|FG000|Overall Study|Lost to Follow-up|10|||
163187366|NCT03954132|589401920|FG001|Overall Study|Lost to Follow-up|0|||
163187367|NCT03954132|589401919|FG000|Overall Study|Screening failure|0|||
163187368|NCT03954132|589401920|FG001|Overall Study|Screening failure|1|||
163187369|NCT03954132|589401919|FG000|Overall Study|No registration after Visit 1|5|||
163187370|NCT03954132|589401920|FG001|Overall Study|No registration after Visit 1|2|||
163187371|NCT03954132|589401919|FG000|Overall Study|Other reason than listed|2|||
163187372|NCT03954132|589401920|FG001|Overall Study|Other reason than listed|2|||
163187373|NCT03954132|589401919|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
163187374|NCT03954132|589401920|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
163187375|NCT03954132|589401919|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
163187376|NCT03954132|589401920|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
163187377|NCT00932737|589401923|FG000|Overall Study|Not treated in second episode|1|||
163187378|NCT00932737|589401924|FG001|Overall Study|Not treated in second episode|0|||
163187379|NCT00932737|589401923|FG000|Overall Study|Adverse Event|0|||
163187380|NCT00932737|589401924|FG001|Overall Study|Adverse Event|1|||
163187381|NCT05156073|589401927|FG000|Overall Study|Patient canceled appointment with PCP|1|||
163187382|NCT00973349|589401928|FG000|Overall Study|Adverse Event|0|||
163187383|NCT00973349|589401929|FG001|Overall Study|Adverse Event|0|||
163187384|NCT00973349|589401930|FG002|Overall Study|Adverse Event|0|||
163187385|NCT00973349|589401931|FG003|Overall Study|Adverse Event|0|||
163187386|NCT00973349|589401932|FG004|Overall Study|Adverse Event|1|||
162947830|NCT00958243|588511682|FG001|Overall Study|Withdrawal by Subject|1|||
163187387|NCT00973349|589401933|FG005|Overall Study|Adverse Event|0|||
163187388|NCT00973349|589401934|FG006|Overall Study|Adverse Event|0|||
163187389|NCT00973349|589401935|FG007|Overall Study|Adverse Event|0|||
163187390|NCT00973349|589401936|FG008|Overall Study|Adverse Event|1|||
163388736|NCT03144804|590134077|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
162947831|NCT00958243|588511683|FG002|Overall Study|Withdrawal by Subject|3|||
162947832|NCT00958243|588511684|FG003|Overall Study|Withdrawal by Subject|1|||
162947833|NCT00958243|588511685|FG004|Overall Study|Withdrawal by Subject|1|||
162947834|NCT00958243|588511686|FG005|Overall Study|Withdrawal by Subject|5|||
162947835|NCT00958243|588511681|FG000|Overall Study|Lost to Follow-up|2|||
162947836|NCT00958243|588511682|FG001|Overall Study|Lost to Follow-up|5|||
162947837|NCT00958243|588511683|FG002|Overall Study|Lost to Follow-up|11|||
162947838|NCT00958243|588511684|FG003|Overall Study|Lost to Follow-up|2|||
162947839|NCT00958243|588511685|FG004|Overall Study|Lost to Follow-up|8|||
162947840|NCT00958243|588511686|FG005|Overall Study|Lost to Follow-up|5|||
162947841|NCT03283709|588511694|FG000|Overall Study|trial terminated|0|||
162947842|NCT03283709|588511695|FG001|Overall Study|trial terminated|1|||
162947843|NCT01347710|588511699|FG000|Overall Study|Withdrawal by Subject|2|||
162947844|NCT01347710|588511699|FG000|Overall Study|Adverse Event|4|||
162947845|NCT01347710|588511699|FG000|Overall Study|Angio or SPECT not completed|18|||
162947846|NCT01347710|588511699|FG000|Overall Study|issue with vitals prior to dosing|1|||
162947847|NCT01347710|588511699|FG000|Overall Study|Lost to Follow-up|1|||
162947848|NCT01347710|588511699|FG000|Overall Study|Physician Decision|2|||
162947849|NCT01347710|588511699|FG000|Overall Study|Other|3|||
162947850|NCT04591626|588511701|FG000|Overall Study|Adverse Event|4|||
162947851|NCT04591626|588511702|FG001|Overall Study|Adverse Event|0|||
162947852|NCT04591626|588511701|FG000|Overall Study|Withdrawal by Subject|5|||
162947853|NCT04591626|588511702|FG001|Overall Study|Withdrawal by Subject|3|||
162947854|NCT04591626|588511701|FG000|Overall Study|Physician Decision|0|||
162947855|NCT04591626|588511702|FG001|Overall Study|Physician Decision|1|||
162947856|NCT04591626|588511701|FG000|Overall Study|Death|0|||
162947857|NCT04591626|588511702|FG001|Overall Study|Death|1|||
162947858|NCT04591626|588511701|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162947859|NCT04591626|588511702|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162947860|NCT02003183|588511705|FG000|Overall Study|Lost to Follow-up|0|||
162947861|NCT02003183|588511706|FG001|Overall Study|Lost to Follow-up|2|||
162947862|NCT00841100|588511711|FG000|Phase 1 (28 Days)|Adverse Event|1|||
162947863|NCT00841100|588511711|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
162947864|NCT03338972|588511712|FG000|Overall Study|Death|1|||
162947865|NCT03338972|588511713|FG001|Overall Study|Death|1|||
162947866|NCT03338972|588511714|FG002|Overall Study|Death|0|||
162947867|NCT03338972|588511715|FG003|Overall Study|Death|0|||
162947868|NCT03338972|588511712|FG000|Overall Study|Withdrawal by Subject|1|||
162947869|NCT03338972|588511713|FG001|Overall Study|Withdrawal by Subject|0|||
162947870|NCT03338972|588511714|FG002|Overall Study|Withdrawal by Subject|0|||
162947871|NCT03338972|588511715|FG003|Overall Study|Withdrawal by Subject|0|||
162947872|NCT01355081|588511716|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
162947873|NCT01355081|588511717|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
162947874|NCT01355081|588511718|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
162947875|NCT01355081|588511716|FG000|Overall Study|Major Protocol Deviation|0|||
162947876|NCT01355081|588511717|FG001|Overall Study|Major Protocol Deviation|1|||
162947877|NCT01355081|588511718|FG002|Overall Study|Major Protocol Deviation|0|||
162947878|NCT01355081|588511716|FG000|Overall Study|Lost to Follow-up|0|||
162947879|NCT01355081|588511717|FG001|Overall Study|Lost to Follow-up|0|||
162947880|NCT01355081|588511718|FG002|Overall Study|Lost to Follow-up|1|||
162947881|NCT01355081|588511716|FG000|Overall Study|Withdrawal of Consent|2|||
162947882|NCT01355081|588511717|FG001|Overall Study|Withdrawal of Consent|3|||
162947883|NCT01355081|588511718|FG002|Overall Study|Withdrawal of Consent|3|||
162947884|NCT01355081|588511716|FG000|Overall Study|Lack of Efficacy|2|||
162947885|NCT01355081|588511717|FG001|Overall Study|Lack of Efficacy|1|||
162947886|NCT01355081|588511718|FG002|Overall Study|Lack of Efficacy|1|||
162947887|NCT01355081|588511716|FG000|Overall Study|Non Compliance with Study Medication|0|||
162947888|NCT01355081|588511717|FG001|Overall Study|Non Compliance with Study Medication|1|||
162947889|NCT01355081|588511718|FG002|Overall Study|Non Compliance with Study Medication|0|||
162947890|NCT02719522|588511721|FG000|Overall Study|Implant Failure|4|||
162947891|NCT02719522|588511721|FG000|Overall Study|Death|2|||
162947892|NCT02719522|588511721|FG000|Overall Study|Lost to Follow-up|5|||
162947893|NCT06096168|588511722|FG000|Overall Study|Death|30|||
162947894|NCT06096168|588511722|FG000|Overall Study|Revision|2|||
162947895|NCT01868009|588511723|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
162947896|NCT01868009|588511724|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
162947897|NCT01868009|588511723|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
162947898|NCT01868009|588511724|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
162947899|NCT01868009|588511723|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
162947900|NCT01868009|588511724|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
162947901|NCT04603937|588511725|FG000|Overall Study|Adverse Event|9|||
162947902|NCT04603937|588511726|FG001|Overall Study|Adverse Event|10|||
162947903|NCT04603937|588511725|FG000|Overall Study|Withdrawal by Subject|7|||
162947904|NCT04603937|588511726|FG001|Overall Study|Withdrawal by Subject|6|||
162947905|NCT04603937|588511725|FG000|Overall Study|Lost to Follow-up|5|||
162947906|NCT04603937|588511726|FG001|Overall Study|Lost to Follow-up|6|||
162947907|NCT04603937|588511725|FG000|Overall Study|Physician Decision|0|||
162947908|NCT04603937|588511726|FG001|Overall Study|Physician Decision|1|||
162947909|NCT04603937|588511725|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
162947910|NCT04603937|588511726|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
162947911|NCT02585258|588511727|FG000|Overall Study|Adverse Event|28|||
162947912|NCT02585258|588511728|FG001|Overall Study|Adverse Event|29|||
163292626|NCT03621761|589777189|FG000|Overall Study|Withdrawal by Subject|2|||
162947913|NCT02585258|588511727|FG000|Overall Study|Death|3|||
162947914|NCT02585258|588511728|FG001|Overall Study|Death|2|||
162947915|NCT02585258|588511727|FG000|Overall Study|Lack of Efficacy|7|||
162947916|NCT02585258|588511728|FG001|Overall Study|Lack of Efficacy|9|||
162947917|NCT02585258|588511727|FG000|Overall Study|includes covid-related access problems|42|||
162947918|NCT02585258|588511728|FG001|Overall Study|includes covid-related access problems|46|||
162947919|NCT02585258|588511727|FG000|Overall Study|Lost to Follow-up|5|||
162947920|NCT02585258|588511728|FG001|Overall Study|Lost to Follow-up|2|||
162947921|NCT05125952|588511729|FG000|Overall Study|Physician Decision|1|||
162947922|NCT03946449|588511730|FG000|Treatment Extension II|Rolled over to another study|0|||
162947923|NCT03946449|588511731|FG001|Treatment Extension II|Rolled over to another study|0|||
162947924|NCT03946449|588511732|FG002|Treatment Extension II|Rolled over to another study|2|||
162947925|NCT03946449|588511730|FG000|Treatment Extension II|Withdrawal by Subject|0|||
162947926|NCT03946449|588511731|FG001|Treatment Extension II|Withdrawal by Subject|0|||
162947927|NCT03946449|588511732|FG002|Treatment Extension II|Withdrawal by Subject|1|||
162947928|NCT02848326|588513104|FG000|Treatment Period|Adverse Event|5|||
162947929|NCT02848326|588513105|FG001|Treatment Period|Adverse Event|4|||
162947930|NCT02848326|588513106|FG002|Treatment Period|Adverse Event|11|||
162947931|NCT02848326|588513107|FG003|Treatment Period|Adverse Event|6|||
162947932|NCT02848326|588513108|FG004|Treatment Period|Adverse Event|5|||
162947933|NCT02848326|588513109|FG005|Treatment Period|Adverse Event|7|||
162947934|NCT02848326|588513104|FG000|Treatment Period|Withdrawal of Consent|20|||
162947935|NCT02848326|588513105|FG001|Treatment Period|Withdrawal of Consent|6|||
162947936|NCT02848326|588513106|FG002|Treatment Period|Withdrawal of Consent|9|||
162947937|NCT02848326|588513107|FG003|Treatment Period|Withdrawal of Consent|6|||
162947938|NCT02848326|588513108|FG004|Treatment Period|Withdrawal of Consent|9|||
162947939|NCT02848326|588513109|FG005|Treatment Period|Withdrawal of Consent|6|||
162947940|NCT02848326|588513104|FG000|Treatment Period|Lost to Follow-up|5|||
163292627|NCT03621761|589777190|FG001|Overall Study|Withdrawal by Subject|1|||
163292628|NCT03621761|589777191|FG002|Overall Study|Withdrawal by Subject|1|||
163292629|NCT03621761|589777189|FG000|Overall Study|Became Ineligible|0|||
162947941|NCT02848326|588513105|FG001|Treatment Period|Lost to Follow-up|1|||
162947942|NCT02848326|588513106|FG002|Treatment Period|Lost to Follow-up|11|||
162947943|NCT02848326|588513107|FG003|Treatment Period|Lost to Follow-up|7|||
162947944|NCT02848326|588513108|FG004|Treatment Period|Lost to Follow-up|2|||
163292630|NCT03621761|589777190|FG001|Overall Study|Became Ineligible|2|||
162947945|NCT02848326|588513109|FG005|Treatment Period|Lost to Follow-up|3|||
162947946|NCT02848326|588513104|FG000|Treatment Period|Pregnancy|0|||
163292631|NCT03621761|589777191|FG002|Overall Study|Became Ineligible|0|||
162947947|NCT02848326|588513105|FG001|Treatment Period|Pregnancy|0|||
163292632|NCT01191788|589777196|FG000|Overall Study|Lost to Follow-up|21|||
162947948|NCT02848326|588513106|FG002|Treatment Period|Pregnancy|1|||
162947949|NCT02848326|588513107|FG003|Treatment Period|Pregnancy|1|||
163388737|NCT00959647|590134078|FG000|Overall Study|Adverse Event|2|||
163388738|NCT00959647|590134078|FG000|Overall Study|Progressive disease|6|||
163187391|NCT00973349|589401937|FG009|Overall Study|Adverse Event|0|||
163388739|NCT00959647|590134078|FG000|Overall Study|Study terminated by sponsor|4|||
163388740|NCT00959647|590134078|FG000|Overall Study|Withdrawal by Subject|7|||
163187392|NCT00973349|589401938|FG010|Overall Study|Adverse Event|0|||
162947950|NCT02848326|588513108|FG004|Treatment Period|Pregnancy|0|||
162947951|NCT02848326|588513109|FG005|Treatment Period|Pregnancy|1|||
163187393|NCT00973349|589401939|FG011|Overall Study|Adverse Event|0|||
162947952|NCT02848326|588513104|FG000|Treatment Period|Protocol Violation|4|||
163187394|NCT00973349|589401940|FG012|Overall Study|Adverse Event|0|||
163187395|NCT00973349|589401941|FG013|Overall Study|Adverse Event|0|||
162947953|NCT02848326|588513105|FG001|Treatment Period|Protocol Violation|3|||
162947954|NCT02848326|588513106|FG002|Treatment Period|Protocol Violation|4|||
162947955|NCT02848326|588513107|FG003|Treatment Period|Protocol Violation|2|||
162947956|NCT02848326|588513108|FG004|Treatment Period|Protocol Violation|3|||
162947957|NCT02848326|588513109|FG005|Treatment Period|Protocol Violation|3|||
162947958|NCT02848326|588513104|FG000|Treatment Period|Non-compliance with Study Drug|4|||
162947959|NCT02848326|588513105|FG001|Treatment Period|Non-compliance with Study Drug|0|||
162947960|NCT02848326|588513106|FG002|Treatment Period|Non-compliance with Study Drug|0|||
162947961|NCT02848326|588513107|FG003|Treatment Period|Non-compliance with Study Drug|1|||
162947962|NCT02848326|588513108|FG004|Treatment Period|Non-compliance with Study Drug|0|||
162947963|NCT02848326|588513109|FG005|Treatment Period|Non-compliance with Study Drug|0|||
162947964|NCT02848326|588513104|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
162947965|NCT02848326|588513105|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
162947966|NCT02848326|588513106|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
162947967|NCT02848326|588513107|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
162947968|NCT02848326|588513108|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
162947969|NCT02848326|588513109|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
162947970|NCT02848326|588513104|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
162947971|NCT02848326|588513105|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
162947972|NCT02848326|588513106|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
162947973|NCT02848326|588513107|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
162947974|NCT02848326|588513108|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
162947975|NCT02848326|588513109|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
162947976|NCT00441467|588513123|FG000|Overall Study|Adverse Event|6|||
162947977|NCT00441467|588513123|FG000|Overall Study|Withdrawal by Subject|3|||
162947978|NCT00441467|588513123|FG000|Overall Study|Progressive disease|9|||
162947979|NCT01042522|588513125|FG000|Overall Study|Adverse Event|1|||
162947980|NCT01042522|588513126|FG001|Overall Study|Adverse Event|2|||
162947981|NCT01042522|588513125|FG000|Overall Study|Disease Progression|5|||
162947982|NCT01042522|588513126|FG001|Overall Study|Disease Progression|0|||
162947983|NCT01042522|588513125|FG000|Overall Study|Death|1|||
162947984|NCT01042522|588513126|FG001|Overall Study|Death|0|||
162947985|NCT01042522|588513125|FG000|Overall Study|Patient Refused|0|||
162947986|NCT01042522|588513126|FG001|Overall Study|Patient Refused|3|||
162947987|NCT01042522|588513125|FG000|Overall Study|Withdrawal by Subject|1|||
162947988|NCT01042522|588513126|FG001|Overall Study|Withdrawal by Subject|1|||
162947989|NCT00745420|588513130|FG000|Overall Study|Ineligible|1|||
162947990|NCT01367275|588513131|FG000|Overall Study|Ineligible|1|||
162947991|NCT01367275|588513131|FG000|Overall Study|Disease Progression|2|||
162947992|NCT00048568|588513140|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
162947993|NCT00048568|588513141|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
162947994|NCT00048568|588513142|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
162947995|NCT00048568|588513140|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
162947996|NCT00048568|588513141|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
162947997|NCT00048568|588513142|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
162947998|NCT00048568|588513140|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
162947999|NCT00048568|588513141|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
162948000|NCT00048568|588513142|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
162948001|NCT00048568|588513140|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
162948002|NCT00048568|588513141|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
162948003|NCT00048568|588513142|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
162948004|NCT00048568|588513140|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
162948005|NCT00048568|588513141|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
162948006|NCT00048568|588513142|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
162948007|NCT00048568|588513140|FG000|Double-Blind Period Days 170 to 365|Death|1|||
162948008|NCT00048568|588513141|FG001|Double-Blind Period Days 170 to 365|Death|1|||
162948009|NCT00048568|588513142|FG002|Double-Blind Period Days 170 to 365|Death|0|||
162948010|NCT00048568|588513140|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
162948011|NCT00048568|588513141|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
162948012|NCT00048568|588513142|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
162948013|NCT00048568|588513140|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
162948014|NCT00048568|588513141|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
162948015|NCT00048568|588513142|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
162948016|NCT00048568|588513140|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
162948017|NCT00048568|588513141|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
162948018|NCT00048568|588513142|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
162948019|NCT00048568|588513140|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
162948020|NCT00048568|588513141|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
163388741|NCT04223856|590134079|FG000|Overall Study|Progressive disease|153|||
162948021|NCT00048568|588513142|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
162948022|NCT00048568|588513140|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
162948023|NCT00048568|588513141|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
162948024|NCT00048568|588513142|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
162948025|NCT00048568|588513140|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
162948026|NCT00048568|588513141|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
162948027|NCT00048568|588513142|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
162948028|NCT00048568|588513140|FG000|Open-Label Period|Death|0|||
163187396|NCT00973349|589401942|FG014|Overall Study|Adverse Event|1|||
163187397|NCT00973349|589401943|FG015|Overall Study|Adverse Event|0|||
163187398|NCT00973349|589401928|FG000|Overall Study|Withdrawal by Subject|1|||
163187399|NCT00973349|589401929|FG001|Overall Study|Withdrawal by Subject|2|||
163187400|NCT00973349|589401930|FG002|Overall Study|Withdrawal by Subject|2|||
162948029|NCT00048568|588513141|FG001|Open-Label Period|Death|0|||
162948030|NCT00048568|588513142|FG002|Open-Label Period|Death|13|||
162948031|NCT00048568|588513140|FG000|Open-Label Period|Adverse Event|0|||
162948032|NCT00048568|588513141|FG001|Open-Label Period|Adverse Event|0|||
162948033|NCT00048568|588513142|FG002|Open-Label Period|Adverse Event|49|||
162948034|NCT00048568|588513140|FG000|Open-Label Period|Lack of Efficacy|0|||
162948035|NCT00048568|588513141|FG001|Open-Label Period|Lack of Efficacy|0|||
162948036|NCT00048568|588513142|FG002|Open-Label Period|Lack of Efficacy|32|||
162948037|NCT00048568|588513140|FG000|Open-Label Period|Withdrawal by Subject|0|||
162948038|NCT00048568|588513141|FG001|Open-Label Period|Withdrawal by Subject|0|||
162948039|NCT00048568|588513142|FG002|Open-Label Period|Withdrawal by Subject|26|||
162948040|NCT00048568|588513140|FG000|Open-Label Period|Pregnancy|0|||
162948041|NCT00048568|588513141|FG001|Open-Label Period|Pregnancy|0|||
162948042|NCT00048568|588513142|FG002|Open-Label Period|Pregnancy|5|||
162948043|NCT00048568|588513140|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
162948044|NCT00048568|588513141|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
162948045|NCT00048568|588513142|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
162948046|NCT00048568|588513140|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
162948047|NCT00048568|588513141|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
162948048|NCT00048568|588513142|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
162948049|NCT00048568|588513140|FG000|Open-Label Period|Unknown Reasons|0|||
162948050|NCT00048568|588513141|FG001|Open-Label Period|Unknown Reasons|0|||
162948051|NCT00048568|588513142|FG002|Open-Label Period|Unknown Reasons|25|||
162948052|NCT00048568|588513140|FG000|Open-Label Period|Lost to Follow-up|0|||
162948053|NCT00048568|588513141|FG001|Open-Label Period|Lost to Follow-up|0|||
162948054|NCT00048568|588513142|FG002|Open-Label Period|Lost to Follow-up|7|||
162948055|NCT01717976|588513143|FG000|Overall Study|Protocol Violation|0|||
162948056|NCT01717976|588513144|FG001|Overall Study|Protocol Violation|1|||
162948057|NCT03831048|588513145|FG000|Overall Study|Protocol Violation|9|||
162948058|NCT03831048|588513146|FG001|Overall Study|Protocol Violation|3|||
162948059|NCT03831048|588513145|FG000|Overall Study|Death|4|||
162948060|NCT03831048|588513146|FG001|Overall Study|Death|9|||
162948061|NCT03831048|588513145|FG000|Overall Study|Re-transplant|0|||
162948062|NCT03831048|588513146|FG001|Overall Study|Re-transplant|2|||
162948063|NCT03831048|588513145|FG000|Overall Study|Protocol violation and death|1|||
162948064|NCT03831048|588513146|FG001|Overall Study|Protocol violation and death|1|||
162948065|NCT01996033|588513149|FG000|Overall Study|Death|1|||
162948066|NCT01996033|588513149|FG000|Overall Study|Physician Decision|1|||
162948067|NCT01996033|588513149|FG000|Overall Study|Withdrawal by Subject|4|||
162948068|NCT01996033|588513149|FG000|Overall Study|Lost to Follow-up|3|||
162948069|NCT02896361|588513152|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
162948070|NCT02896361|588513153|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
162948071|NCT02896361|588513154|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
162948072|NCT02896361|588513152|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
162948073|NCT02896361|588513153|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
162948074|NCT02896361|588513154|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
162948075|NCT02143102|588513159|FG000|Overall Study|Lost to Follow-up|11|||
162948076|NCT02143102|588513160|FG001|Overall Study|Lost to Follow-up|0|||
162948077|NCT03164772|588513163|FG000|Overall Study|Death|4|||
162948078|NCT03164772|588513164|FG001|Overall Study|Death|2|||
162948079|NCT03164772|588513163|FG000|Overall Study|Adverse Event|1|||
162948080|NCT03164772|588513164|FG001|Overall Study|Adverse Event|4|||
162948081|NCT03164772|588513163|FG000|Overall Study|Progressive Disease|11|||
162948082|NCT03164772|588513164|FG001|Overall Study|Progressive Disease|21|||
162948083|NCT03164772|588513163|FG000|Overall Study|Physician Decision|2|||
162948084|NCT03164772|588513164|FG001|Overall Study|Physician Decision|0|||
162948085|NCT03164772|588513163|FG000|Overall Study|Withdrawal by Subject|0|||
162948086|NCT03164772|588513164|FG001|Overall Study|Withdrawal by Subject|4|||
162948087|NCT00324168|588513167|FG000|Overall Study|Lost to Follow-up|19|||
162948088|NCT00324168|588513168|FG001|Overall Study|Lost to Follow-up|18|||
162948089|NCT00324168|588513167|FG000|Overall Study|Death|3|||
162948090|NCT00324168|588513168|FG001|Overall Study|Death|3|||
162948091|NCT00324168|588513167|FG000|Overall Study|Patient did not visit in f/u window|6|||
163292633|NCT01191788|589777197|FG001|Overall Study|Lost to Follow-up|22|||
162948092|NCT00324168|588513168|FG001|Overall Study|Patient did not visit in f/u window|9|||
162948093|NCT01203878|588513169|FG000|Overall Study|Withdrawal by Subject|0|||
162948094|NCT01203878|588513170|FG001|Overall Study|Withdrawal by Subject|0|||
162948095|NCT01203878|588513171|FG002|Overall Study|Withdrawal by Subject|1|||
162948096|NCT01203878|588513169|FG000|Overall Study|Adverse Event|0|||
162948097|NCT01203878|588513170|FG001|Overall Study|Adverse Event|0|||
162948098|NCT01203878|588513171|FG002|Overall Study|Adverse Event|2|||
162948099|NCT00274937|588513172|FG000|Overall Study|Physician Decision|10|||
163187401|NCT00973349|589401931|FG003|Overall Study|Withdrawal by Subject|3|||
163187402|NCT00973349|589401932|FG004|Overall Study|Withdrawal by Subject|2|||
163187403|NCT00973349|589401933|FG005|Overall Study|Withdrawal by Subject|0|||
163187404|NCT00973349|589401934|FG006|Overall Study|Withdrawal by Subject|2|||
163187405|NCT00973349|589401935|FG007|Overall Study|Withdrawal by Subject|2|||
163187406|NCT00973349|589401936|FG008|Overall Study|Withdrawal by Subject|0|||
162948100|NCT00274937|588513172|FG000|Overall Study|Withdrawal by Subject|6|||
163187407|NCT00973349|589401937|FG009|Overall Study|Withdrawal by Subject|2|||
163187408|NCT00973349|589401938|FG010|Overall Study|Withdrawal by Subject|0|||
163187409|NCT00973349|589401939|FG011|Overall Study|Withdrawal by Subject|1|||
162948101|NCT00274937|588513172|FG000|Overall Study|Progressive Disease|4|||
162948102|NCT01682083|588513173|FG000|Overall Study|Lost to Follow-up|11|||
162948103|NCT01682083|588513174|FG001|Overall Study|Lost to Follow-up|18|||
162948104|NCT01682083|588513173|FG000|Overall Study|Withdrawal by Subject|31|||
162948105|NCT01682083|588513174|FG001|Overall Study|Withdrawal by Subject|40|||
162948106|NCT01682083|588513173|FG000|Overall Study|Death|60|||
162948107|NCT01682083|588513174|FG001|Overall Study|Death|93|||
162948108|NCT01682083|588513173|FG000|Overall Study|Physician Decision|5|||
162948109|NCT01682083|588513174|FG001|Overall Study|Physician Decision|4|||
162948110|NCT02731157|588513175|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
162948111|NCT03657160|588513178|FG000|Overall Study|Adverse Event|5|||
162948112|NCT03657160|588513179|FG001|Overall Study|Adverse Event|6|||
163388742|NCT04223856|590134080|FG001|Overall Study|Progressive disease|73|||
163388743|NCT04223856|590134079|FG000|Overall Study|Adverse Event|97|||
163388744|NCT04223856|590134080|FG001|Overall Study|Adverse Event|62|||
163388745|NCT04223856|590134079|FG000|Overall Study|Physician Decision|9|||
163388746|NCT04223856|590134080|FG001|Overall Study|Physician Decision|28|||
163388747|NCT04223856|590134079|FG000|Overall Study|Withdrawal by Subject|22|||
163388748|NCT04223856|590134080|FG001|Overall Study|Withdrawal by Subject|24|||
163388749|NCT04223856|590134079|FG000|Overall Study|Other|7|||
163388750|NCT04223856|590134080|FG001|Overall Study|Other|2|||
163388751|NCT04223856|590134079|FG000|Overall Study|Randomized but not treated|2|||
163388752|NCT04223856|590134080|FG001|Overall Study|Randomized but not treated|11|||
163388753|NCT04223856|590134079|FG000|Overall Study|On-treatment|144|||
163388754|NCT04223856|590134080|FG001|Overall Study|On-treatment|0|||
163388755|NCT06515483|590134081|FG000|Overall Study|Subject withdraw due to family issues|1|||
163388756|NCT06515483|590134082|FG001|Overall Study|Subject withdraw due to family issues|0|||
163388757|NCT00523718|590135903|FG000|Overall Study|Withdrawal by Subject|1|||
163388758|NCT00523718|590135904|FG001|Overall Study|Withdrawal by Subject|0|||
162948113|NCT03657160|588513178|FG000|Overall Study|Protocol Deviation|3|||
162948114|NCT03657160|588513179|FG001|Overall Study|Protocol Deviation|0|||
162948115|NCT03657160|588513178|FG000|Overall Study|Withdrawal by Subject|18|||
162948116|NCT03657160|588513179|FG001|Overall Study|Withdrawal by Subject|16|||
162948117|NCT03657160|588513178|FG000|Overall Study|Site Termination|1|||
162948118|NCT03657160|588513179|FG001|Overall Study|Site Termination|0|||
162948119|NCT03657160|588513178|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
162948120|NCT03657160|588513179|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
162948121|NCT03657160|588513178|FG000|Overall Study|Death|33|||
162948122|NCT03657160|588513179|FG001|Overall Study|Death|26|||
162948123|NCT03657160|588513178|FG000|Overall Study|Death (COVID-19-Related)|1|||
162948124|NCT03657160|588513179|FG001|Overall Study|Death (COVID-19-Related)|0|||
162948125|NCT03657160|588513178|FG000|Overall Study|Reason Not Specified|5|||
162948126|NCT03657160|588513179|FG001|Overall Study|Reason Not Specified|5|||
162948127|NCT03657160|588513178|FG000|Overall Study|Other (COVID-19-Related)|0|||
162948128|NCT03657160|588513179|FG001|Overall Study|Other (COVID-19-Related)|1|||
162948129|NCT02732210|588513181|FG000|Overall Study|Site Closed|0|||
162948130|NCT02732210|588513182|FG001|Overall Study|Site Closed|11|||
162948131|NCT02732210|588513181|FG000|Overall Study|Study Ended|13|||
162948132|NCT02732210|588513182|FG001|Overall Study|Study Ended|13|||
162948133|NCT02732210|588513181|FG000|Overall Study|Withdrawal by Subject|28|||
162948134|NCT02732210|588513182|FG001|Overall Study|Withdrawal by Subject|87|||
162948135|NCT02732210|588513181|FG000|Overall Study|Lost to Follow-up|5|||
162948136|NCT02732210|588513182|FG001|Overall Study|Lost to Follow-up|57|||
162948137|NCT02732210|588513181|FG000|Overall Study|Death|4|||
162948138|NCT02732210|588513182|FG001|Overall Study|Death|15|||
162948139|NCT02732210|588513181|FG000|Overall Study|Other|35|||
162948140|NCT02732210|588513182|FG001|Overall Study|Other|103|||
162948141|NCT02732210|588513181|FG000|Overall Study|Missing|0|||
162948142|NCT02732210|588513182|FG001|Overall Study|Missing|8|||
162948143|NCT00686959|588513183|FG000|Overall Study|Participants censored (no death events)|124|||
162948144|NCT00686959|588513184|FG001|Overall Study|Participants censored (no death events)|117|||
162948145|NCT01876706|588513185|FG000|Overall Study|BPH Intervention|9|||
162948146|NCT01876706|588513185|FG000|Overall Study|Lost to Follow-up|7|||
162948147|NCT01876706|588513185|FG000|Overall Study|Withdrawals|6|||
162948148|NCT01876706|588513185|FG000|Overall Study|Death|3|||
162948149|NCT00604500|588513186|FG000|Overall Study|Adverse Event|2|||
162948150|NCT00604500|588513186|FG000|Overall Study|Protocol Violation|2|||
162948151|NCT00604500|588513186|FG000|Overall Study|Treatment Failure|1|||
163388759|NCT00523718|590135903|FG000|Overall Study|Protocol Violation|2|||
162948152|NCT00604500|588513186|FG000|Overall Study|Withdrawal by Subject|4|||
162948153|NCT00604500|588513186|FG000|Overall Study|Administrative|1|||
162948154|NCT00604500|588513186|FG000|Overall Study|Did not meet protocol eligibility|1|||
162948155|NCT02191891|588513187|FG000|Overall Study|Withdrawal by Subject|0|||
162948156|NCT02191891|588513188|FG001|Overall Study|Withdrawal by Subject|1|||
163388760|NCT00523718|590135904|FG001|Overall Study|Protocol Violation|0|||
163388761|NCT01306890|590135905|FG000|Overall Study|Adverse Event|2|||
162948157|NCT02191891|588513189|FG002|Overall Study|Withdrawal by Subject|0|||
162948158|NCT02191891|588513190|FG003|Overall Study|Withdrawal by Subject|0|||
162948159|NCT02191891|588513191|FG004|Overall Study|Withdrawal by Subject|1|||
163187410|NCT00973349|589401940|FG012|Overall Study|Withdrawal by Subject|0|||
163187411|NCT00973349|589401941|FG013|Overall Study|Withdrawal by Subject|0|||
163187412|NCT00973349|589401942|FG014|Overall Study|Withdrawal by Subject|0|||
163187413|NCT00973349|589401943|FG015|Overall Study|Withdrawal by Subject|0|||
163187414|NCT00973349|589401928|FG000|Overall Study|Lost to Follow-up|3|||
163187415|NCT00973349|589401929|FG001|Overall Study|Lost to Follow-up|1|||
163187416|NCT00973349|589401930|FG002|Overall Study|Lost to Follow-up|2|||
163187417|NCT00973349|589401931|FG003|Overall Study|Lost to Follow-up|2|||
163292634|NCT02441036|589777202|FG000|Overall Study|No tissue resected|0|||
163292635|NCT02441036|589777203|FG001|Overall Study|No tissue resected|1|||
163187418|NCT00973349|589401932|FG004|Overall Study|Lost to Follow-up|1|||
163187419|NCT00973349|589401933|FG005|Overall Study|Lost to Follow-up|3|||
163388762|NCT01306890|590135905|FG000|Overall Study|Death|1223|||
163388763|NCT01306890|590135905|FG000|Overall Study|Lost to Follow-up|58|||
163388764|NCT01306890|590135905|FG000|Overall Study|Withdrawal by Subject|88|||
163388765|NCT01306890|590135905|FG000|Overall Study|Unspecified reasons|104|||
163388766|NCT01306890|590135905|FG000|Overall Study|Study Termination|3|||
163388767|NCT01306890|590135905|FG000|Overall Study|No discontinuation documentation|41|||
163388768|NCT02217436|590135906|FG000|Overall Study|Protocol Violation|1|||
163388769|NCT02217436|590135907|FG001|Overall Study|Protocol Violation|1|||
163388770|NCT02217436|590135906|FG000|Overall Study|Incomplete data|0|||
163388771|NCT02217436|590135907|FG001|Overall Study|Incomplete data|1|||
163388772|NCT00234494|590135912|FG000|Overall Study|Protocol Violation|2|||
163388773|NCT02634346|590135916|FG000|Overall Study|Withdrawal by Subject|8|||
163388774|NCT02634346|590135917|FG001|Overall Study|Withdrawal by Subject|9|||
163388775|NCT02634346|590135918|FG002|Overall Study|Withdrawal by Subject|8|||
163388776|NCT02634346|590135916|FG000|Overall Study|Adverse Event|2|||
163388777|NCT02634346|590135917|FG001|Overall Study|Adverse Event|2|||
163388778|NCT02634346|590135918|FG002|Overall Study|Adverse Event|7|||
163388779|NCT02634346|590135916|FG000|Overall Study|Lack of Efficacy|1|||
163388780|NCT02634346|590135917|FG001|Overall Study|Lack of Efficacy|2|||
163388781|NCT02634346|590135918|FG002|Overall Study|Lack of Efficacy|8|||
163388782|NCT02634346|590135916|FG000|Overall Study|Lost to Follow-up|1|||
163388783|NCT02634346|590135917|FG001|Overall Study|Lost to Follow-up|0|||
163388784|NCT02634346|590135918|FG002|Overall Study|Lost to Follow-up|0|||
163388785|NCT02634346|590135916|FG000|Overall Study|Protocol Violation|0|||
163388786|NCT02634346|590135917|FG001|Overall Study|Protocol Violation|1|||
163388787|NCT02634346|590135918|FG002|Overall Study|Protocol Violation|0|||
163388788|NCT02170389|590135919|FG000|Overall Study|Study terminated prior to start of treat|1|||
163388789|NCT04485104|590135925|FG000|Overall Study|Physician Decision|2|||
163388790|NCT04485104|590135926|FG001|Overall Study|Physician Decision|0|||
163388791|NCT04485104|590135925|FG000|Overall Study|Decision by sponsor|0|||
163388792|NCT04485104|590135926|FG001|Overall Study|Decision by sponsor|1|||
163388793|NCT00908232|590135927|FG000|Cycle 1 to 4|Death|5|||
163388794|NCT00908232|590135928|FG001|Cycle 1 to 4|Death|0|||
163388795|NCT00908232|590135929|FG002|Cycle 1 to 4|Death|0|||
163388796|NCT00908232|590135930|FG003|Cycle 1 to 4|Death|0|||
163388797|NCT00908232|590135927|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
163388798|NCT00908232|590135928|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
163388799|NCT00908232|590135929|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
163388800|NCT00908232|590135930|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
163388801|NCT00908232|590135927|FG000|Cycle 1 to 4|Progressive Disease|6|||
163388802|NCT00908232|590135928|FG001|Cycle 1 to 4|Progressive Disease|0|||
163388803|NCT00908232|590135929|FG002|Cycle 1 to 4|Progressive Disease|0|||
163388804|NCT00908232|590135930|FG003|Cycle 1 to 4|Progressive Disease|0|||
163388805|NCT00908232|590135927|FG000|Cycle 1 to 4|Adverse Event|12|||
163388806|NCT00908232|590135928|FG001|Cycle 1 to 4|Adverse Event|0|||
163388807|NCT00908232|590135929|FG002|Cycle 1 to 4|Adverse Event|0|||
163388808|NCT00908232|590135930|FG003|Cycle 1 to 4|Adverse Event|0|||
163388809|NCT00908232|590135927|FG000|Cycle 1 to 4|Other|1|||
163388810|NCT00908232|590135928|FG001|Cycle 1 to 4|Other|0|||
162948160|NCT02191891|588513187|FG000|Overall Study|Adverse Event|0|||
162948161|NCT02191891|588513188|FG001|Overall Study|Adverse Event|1|||
162948162|NCT02191891|588513189|FG002|Overall Study|Adverse Event|0|||
162948163|NCT02191891|588513190|FG003|Overall Study|Adverse Event|0|||
162948164|NCT02191891|588513191|FG004|Overall Study|Adverse Event|2|||
162948165|NCT02191891|588513187|FG000|Overall Study|Disease Progression|4|||
162948166|NCT02191891|588513188|FG001|Overall Study|Disease Progression|10|||
162948167|NCT02191891|588513189|FG002|Overall Study|Disease Progression|4|||
162948168|NCT02191891|588513190|FG003|Overall Study|Disease Progression|2|||
162948169|NCT02191891|588513191|FG004|Overall Study|Disease Progression|7|||
162948170|NCT03099538|588513193|FG000|Overall Study|Lack of Efficacy|3|||
162948171|NCT01448057|588513194|FG000|Overall Study|Protocol Violation|3|||
162948172|NCT01448057|588513195|FG001|Overall Study|Protocol Violation|2|||
162948173|NCT01448057|588513194|FG000|Overall Study|Lost to Follow-up|3|||
162948174|NCT01448057|588513195|FG001|Overall Study|Lost to Follow-up|0|||
162948175|NCT01448057|588513194|FG000|Overall Study|Adverse Event|0|||
162948176|NCT01448057|588513195|FG001|Overall Study|Adverse Event|2|||
162948177|NCT01448057|588513194|FG000|Overall Study|Withdrawal by Subject|2|||
162948178|NCT01448057|588513195|FG001|Overall Study|Withdrawal by Subject|0|||
162948179|NCT02468778|588513198|FG000|Overall Study|Death|2|||
162948180|NCT02468778|588513199|FG001|Overall Study|Death|1|||
162948181|NCT02468778|588513200|FG002|Overall Study|Death|0|||
162948182|NCT02468778|588513198|FG000|Overall Study|Lost to Follow-up|1|||
162948183|NCT02468778|588513199|FG001|Overall Study|Lost to Follow-up|2|||
162948184|NCT02468778|588513200|FG002|Overall Study|Lost to Follow-up|2|||
162948185|NCT02468778|588513198|FG000|Overall Study|Withdrawal by Subject|0|||
162948186|NCT02468778|588513199|FG001|Overall Study|Withdrawal by Subject|1|||
162948187|NCT02468778|588513200|FG002|Overall Study|Withdrawal by Subject|1|||
163187420|NCT00973349|589401934|FG006|Overall Study|Lost to Follow-up|0|||
163187421|NCT00973349|589401935|FG007|Overall Study|Lost to Follow-up|1|||
162948188|NCT03912337|588513205|FG000|Overall Study|Withdrawal of Consent From Study|1|||
162948189|NCT03912337|588513206|FG001|Overall Study|Withdrawal of Consent From Study|0|||
162948190|NCT03912337|588513205|FG000|Overall Study|Lost to Follow-up|1|||
162948191|NCT03912337|588513206|FG001|Overall Study|Lost to Follow-up|1|||
163388811|NCT00908232|590135929|FG002|Cycle 1 to 4|Other|0|||
163388812|NCT00908232|590135930|FG003|Cycle 1 to 4|Other|0|||
162948192|NCT03978624|588513209|FG000|Overall Study|Protocol Violation|1|||
162948193|NCT03978624|588513210|FG001|Overall Study|Protocol Violation|0|||
162948194|NCT04646109|588513211|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
162948195|NCT04646109|588513212|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
162948196|NCT06176768|588513213|FG000|Overall Study|Adverse Event|1|||
163187422|NCT00973349|589401936|FG008|Overall Study|Lost to Follow-up|2|||
162948197|NCT06176768|588513214|FG001|Overall Study|Adverse Event|0|||
162948198|NCT06176768|588513213|FG000|Overall Study|Assigned treatment by mistake|1|||
162948199|NCT06176768|588513214|FG001|Overall Study|Assigned treatment by mistake|0|||
162948200|NCT06176768|588513213|FG000|Overall Study|Lost to Follow-up|0|||
162948201|NCT06176768|588513214|FG001|Overall Study|Lost to Follow-up|3|||
162948202|NCT06176768|588513213|FG000|Overall Study|Physician Decision|1|||
162948203|NCT06176768|588513214|FG001|Overall Study|Physician Decision|0|||
162948204|NCT06176768|588513213|FG000|Overall Study|Protocol deviation|3|||
162948205|NCT06176768|588513214|FG001|Overall Study|Protocol deviation|1|||
162948206|NCT06176768|588513213|FG000|Overall Study|Other|1|||
162948207|NCT06176768|588513214|FG001|Overall Study|Other|0|||
162948208|NCT06176768|588513213|FG000|Overall Study|Withdrawal by Subject|6|||
162948209|NCT06176768|588513214|FG001|Overall Study|Withdrawal by Subject|9|||
162948210|NCT02672553|588513217|FG000|Overall Study|Death|3|||
162948211|NCT02672553|588513218|FG001|Overall Study|Death|5|||
162948212|NCT02672553|588513217|FG000|Overall Study|Valve Explant|1|||
162948213|NCT02672553|588513218|FG001|Overall Study|Valve Explant|0|||
162948214|NCT02672553|588513217|FG000|Overall Study|Conversion to Commercial Valve|3|||
163388813|NCT00908232|590135927|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
163388814|NCT00908232|590135928|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
163388815|NCT00908232|590135929|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
163388816|NCT00908232|590135930|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
163388817|NCT00908232|590135927|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
163388818|NCT00908232|590135928|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
163388819|NCT00908232|590135929|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
163388820|NCT00908232|590135930|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
163388821|NCT00908232|590135927|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
163388822|NCT00908232|590135928|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
163388823|NCT00908232|590135929|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
163388824|NCT00908232|590135930|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
163388825|NCT00908232|590135927|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
163388826|NCT00908232|590135928|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
163388827|NCT00908232|590135929|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
163388828|NCT00908232|590135930|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
163388829|NCT00908232|590135927|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
163388830|NCT00908232|590135928|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
163388831|NCT00908232|590135929|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
163388832|NCT00908232|590135930|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
163388833|NCT00908232|590135927|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
163388834|NCT00908232|590135928|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
163388835|NCT00908232|590135929|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
163388836|NCT00908232|590135930|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
163388837|NCT00908232|590135927|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
163388838|NCT00908232|590135928|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
163388839|NCT00908232|590135929|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
163388840|NCT00908232|590135930|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
163388841|NCT00908232|590135927|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
163388842|NCT00908232|590135928|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
163388843|NCT00908232|590135929|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
163388844|NCT00908232|590135930|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
163388845|NCT03153137|590135931|FG000|Overall Study|Lost to Follow-up|1|||
163388846|NCT03153137|590135932|FG001|Overall Study|Lost to Follow-up|0|||
163388847|NCT03153137|590135931|FG000|Overall Study|Withdrawal by Subject|2|||
163388848|NCT03153137|590135932|FG001|Overall Study|Withdrawal by Subject|1|||
163388849|NCT03153137|590135931|FG000|Overall Study|Physician Decision|0|||
163388850|NCT03153137|590135932|FG001|Overall Study|Physician Decision|3|||
163388851|NCT00195507|590135936|FG000|Overall Study|Adverse Event|24|||
163388852|NCT00195507|590135937|FG001|Overall Study|Adverse Event|13|||
163388853|NCT00195507|590135936|FG000|Overall Study|Death|0|||
163388854|NCT00195507|590135937|FG001|Overall Study|Death|1|||
163388855|NCT00195507|590135936|FG000|Overall Study|Failed to Return|4|||
163388856|NCT00195507|590135937|FG001|Overall Study|Failed to Return|3|||
163388857|NCT00195507|590135936|FG000|Overall Study|Physician Decision|1|||
163388858|NCT00195507|590135937|FG001|Overall Study|Physician Decision|2|||
163388859|NCT00195507|590135936|FG000|Overall Study|Lost to Follow-up|3|||
163388860|NCT00195507|590135937|FG001|Overall Study|Lost to Follow-up|2|||
162948215|NCT02672553|588513218|FG001|Overall Study|Conversion to Commercial Valve|0|||
163388861|NCT00195507|590135936|FG000|Overall Study|Protocol Violation|5|||
163388862|NCT00195507|590135937|FG001|Overall Study|Protocol Violation|4|||
163388863|NCT00195507|590135936|FG000|Overall Study|Lack of Efficacy|40|||
162948216|NCT02672553|588513217|FG000|Overall Study|Withdrawal by Subject|3|||
162948217|NCT02672553|588513218|FG001|Overall Study|Withdrawal by Subject|3|||
163187423|NCT00973349|589401937|FG009|Overall Study|Lost to Follow-up|1|||
163388864|NCT00195507|590135937|FG001|Overall Study|Lack of Efficacy|67|||
163187424|NCT00973349|589401938|FG010|Overall Study|Lost to Follow-up|0|||
163187425|NCT00973349|589401939|FG011|Overall Study|Lost to Follow-up|1|||
163187426|NCT00973349|589401940|FG012|Overall Study|Lost to Follow-up|0|||
163187427|NCT00973349|589401941|FG013|Overall Study|Lost to Follow-up|0|||
163187428|NCT00973349|589401942|FG014|Overall Study|Lost to Follow-up|0|||
162948218|NCT02672553|588513217|FG000|Overall Study|Intraoperative screen failure|2|||
162948219|NCT02672553|588513218|FG001|Overall Study|Intraoperative screen failure|0|||
162948220|NCT01004172|588513219|FG000|Overall Study|Progressive Disease in CNS Only|16|||
162948221|NCT01004172|588513219|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
162948222|NCT01004172|588513219|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
162948223|NCT01004172|588513219|FG000|Overall Study|Adverse Event|1|||
162948224|NCT01004172|588513219|FG000|Overall Study|Physician Decision|1|||
162948225|NCT01004172|588513219|FG000|Overall Study|Symptomatic Deterioration|2|||
162948226|NCT01606306|588513220|FG000|Overall Study|Lack of Efficacy|2|||
162948227|NCT01606306|588513221|FG001|Overall Study|Lack of Efficacy|1|||
162948228|NCT01606306|588513222|FG002|Overall Study|Lack of Efficacy|4|||
162948229|NCT01606306|588513223|FG003|Overall Study|Lack of Efficacy|4|||
162948230|NCT01606306|588513224|FG004|Overall Study|Lack of Efficacy|1|||
162948231|NCT01606306|588513225|FG005|Overall Study|Lack of Efficacy|2|||
162948232|NCT01606306|588513220|FG000|Overall Study|Adverse Event|1|||
162948233|NCT01606306|588513221|FG001|Overall Study|Adverse Event|0|||
162948234|NCT01606306|588513222|FG002|Overall Study|Adverse Event|1|||
162948235|NCT01606306|588513223|FG003|Overall Study|Adverse Event|1|||
162948236|NCT01606306|588513224|FG004|Overall Study|Adverse Event|2|||
162948237|NCT01606306|588513225|FG005|Overall Study|Adverse Event|0|||
162948238|NCT01606306|588513220|FG000|Overall Study|Lost to Follow-up|7|||
162948239|NCT01606306|588513221|FG001|Overall Study|Lost to Follow-up|4|||
162948240|NCT01606306|588513222|FG002|Overall Study|Lost to Follow-up|5|||
162948241|NCT01606306|588513223|FG003|Overall Study|Lost to Follow-up|4|||
162948242|NCT01606306|588513224|FG004|Overall Study|Lost to Follow-up|3|||
162948243|NCT01606306|588513225|FG005|Overall Study|Lost to Follow-up|5|||
162948244|NCT01606306|588513220|FG000|Overall Study|Withdrawal by Subject|4|||
162948245|NCT01606306|588513221|FG001|Overall Study|Withdrawal by Subject|3|||
162948246|NCT01606306|588513222|FG002|Overall Study|Withdrawal by Subject|4|||
162948247|NCT01606306|588513223|FG003|Overall Study|Withdrawal by Subject|4|||
162948248|NCT01606306|588513224|FG004|Overall Study|Withdrawal by Subject|5|||
162948249|NCT01606306|588513225|FG005|Overall Study|Withdrawal by Subject|4|||
162948250|NCT01606306|588513220|FG000|Overall Study|Physician Decision|1|||
162948251|NCT01606306|588513221|FG001|Overall Study|Physician Decision|2|||
162948252|NCT01606306|588513222|FG002|Overall Study|Physician Decision|0|||
162948253|NCT01606306|588513223|FG003|Overall Study|Physician Decision|0|||
162948254|NCT01606306|588513224|FG004|Overall Study|Physician Decision|0|||
162948255|NCT01606306|588513225|FG005|Overall Study|Physician Decision|0|||
162948256|NCT00950872|588513226|FG000|Overall Study|Withdrawal by Subject|1|||
162948257|NCT00950872|588513226|FG000|Overall Study|Did not have surgery|2|||
162948258|NCT00970281|588513227|FG000|Overall Study|Lack of Efficacy|1|||
162948259|NCT00970281|588513228|FG001|Overall Study|Lack of Efficacy|14|||
162948260|NCT00970281|588513227|FG000|Overall Study|Withdrawal by Subject|0|||
162948261|NCT00970281|588513228|FG001|Overall Study|Withdrawal by Subject|1|||
162948262|NCT00970281|588513227|FG000|Overall Study|Physician Decision|1|||
162948263|NCT00970281|588513228|FG001|Overall Study|Physician Decision|1|||
162948264|NCT00993616|588513241|FG000|Overall Study|No tumor at entry|1|||
162948265|NCT00993616|588513241|FG000|Overall Study|Never treated|1|||
162948266|NCT02937701|588515144|FG000|Day 1 to Week 22|Adverse Event|11|||
162948267|NCT02937701|588515145|FG001|Day 1 to Week 22|Adverse Event|14|||
162948268|NCT02937701|588515146|FG002|Day 1 to Week 22|Adverse Event|0|||
162948269|NCT02937701|588515147|FG003|Day 1 to Week 22|Adverse Event|0|||
162948270|NCT02937701|588515148|FG004|Day 1 to Week 22|Adverse Event|0|||
162948271|NCT02937701|588515144|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
162948272|NCT02937701|588515145|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
162948273|NCT02937701|588515146|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
162948274|NCT02937701|588515147|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
162948275|NCT02937701|588515148|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
162948276|NCT02937701|588515144|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
162948277|NCT02937701|588515145|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
162948278|NCT02937701|588515146|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
162948279|NCT02937701|588515147|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
162948280|NCT02937701|588515148|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
162948281|NCT02937701|588515144|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
162948282|NCT02937701|588515145|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
162948283|NCT02937701|588515146|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
162948284|NCT02937701|588515147|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
162948285|NCT02937701|588515148|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
162948286|NCT02937701|588515144|FG000|Day 1 to Week 22|Death|1|||
162948287|NCT02937701|588515145|FG001|Day 1 to Week 22|Death|1|||
162948288|NCT02937701|588515146|FG002|Day 1 to Week 22|Death|0|||
162948289|NCT02937701|588515147|FG003|Day 1 to Week 22|Death|0|||
162948290|NCT02937701|588515148|FG004|Day 1 to Week 22|Death|0|||
162948291|NCT02937701|588515144|FG000|Day 1 to Week 22|Protocol Violation|1|||
162948292|NCT02937701|588515145|FG001|Day 1 to Week 22|Protocol Violation|1|||
162948293|NCT02937701|588515146|FG002|Day 1 to Week 22|Protocol Violation|0|||
162948294|NCT02937701|588515147|FG003|Day 1 to Week 22|Protocol Violation|0|||
162948295|NCT02937701|588515148|FG004|Day 1 to Week 22|Protocol Violation|0|||
162948296|NCT02937701|588515144|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
163187429|NCT00973349|589401943|FG015|Overall Study|Lost to Follow-up|1|||
163187430|NCT00973349|589401928|FG000|Overall Study|Inappropriate enrolment|0|||
163187431|NCT00973349|589401929|FG001|Overall Study|Inappropriate enrolment|0|||
163187432|NCT00973349|589401930|FG002|Overall Study|Inappropriate enrolment|1|||
163187433|NCT00973349|589401931|FG003|Overall Study|Inappropriate enrolment|0|||
163187434|NCT00973349|589401932|FG004|Overall Study|Inappropriate enrolment|0|||
163187435|NCT00973349|589401933|FG005|Overall Study|Inappropriate enrolment|0|||
163187436|NCT00973349|589401934|FG006|Overall Study|Inappropriate enrolment|0|||
163187437|NCT00973349|589401935|FG007|Overall Study|Inappropriate enrolment|0|||
163187438|NCT00973349|589401936|FG008|Overall Study|Inappropriate enrolment|0|||
163187439|NCT00973349|589401937|FG009|Overall Study|Inappropriate enrolment|2|||
163187440|NCT00973349|589401938|FG010|Overall Study|Inappropriate enrolment|0|||
163187441|NCT00973349|589401939|FG011|Overall Study|Inappropriate enrolment|0|||
163187442|NCT00973349|589401940|FG012|Overall Study|Inappropriate enrolment|1|||
163187443|NCT00973349|589401941|FG013|Overall Study|Inappropriate enrolment|0|||
163187444|NCT00973349|589401942|FG014|Overall Study|Inappropriate enrolment|1|||
163187445|NCT00973349|589401943|FG015|Overall Study|Inappropriate enrolment|1|||
163187446|NCT00973349|589401928|FG000|Overall Study|Protocol Violation|0|||
163292636|NCT02441036|589777204|FG002|Overall Study|No tissue resected|0|||
163292637|NCT02441036|589777205|FG003|Overall Study|No tissue resected|1|||
163292638|NCT02441036|589777206|FG004|Overall Study|No tissue resected|0|||
163292639|NCT01183780|589777207|FG000|Overall Study|Withdrawal by Subject|25|||
163292640|NCT01183780|589777208|FG001|Overall Study|Withdrawal by Subject|14|||
163292641|NCT01183780|589777207|FG000|Overall Study|Lost to Follow-up|6|||
163292642|NCT01183780|589777208|FG001|Overall Study|Lost to Follow-up|11|||
163292643|NCT00079183|589777211|FG000|Overall Study|Withdrawal by Subject|4|||
163292644|NCT00079183|589777211|FG000|Overall Study|Study medication non-compliance|2|||
163292645|NCT00079183|589777211|FG000|Overall Study|Specimen collection non-compliance|1|||
163292646|NCT00762606|589777212|FG000|Overall Study|Lost to Follow-up|18|||
163292647|NCT00762606|589777213|FG001|Overall Study|Lost to Follow-up|13|||
163292648|NCT01505881|589777214|FG000|Overall Study|Adverse Event|0|||
163292649|NCT01505881|589777215|FG001|Overall Study|Adverse Event|1|||
163292650|NCT01505881|589777214|FG000|Overall Study|Lost to Follow-up|2|||
163292651|NCT01505881|589777215|FG001|Overall Study|Lost to Follow-up|0|||
163292652|NCT01505881|589777214|FG000|Overall Study|Withdrawal by Subject|2|||
163292653|NCT01505881|589777215|FG001|Overall Study|Withdrawal by Subject|0|||
163292654|NCT01147341|589777216|FG000|Double Blind Period|Lack of Efficacy|1|||
163292655|NCT01147341|589777217|FG001|Double Blind Period|Lack of Efficacy|1|||
163292656|NCT01147341|589777216|FG000|Double Blind Period|Withdrawal by Subject|0|||
163292657|NCT01147341|589777217|FG001|Double Blind Period|Withdrawal by Subject|1|||
163292658|NCT01147341|589777216|FG000|Open Label Period|Lack of Efficacy|3|||
163292659|NCT01147341|589777217|FG001|Open Label Period|Lack of Efficacy|0|||
163292660|NCT01147341|589777216|FG000|Open Label Period|Subject moved|1|||
163292661|NCT01147341|589777217|FG001|Open Label Period|Subject moved|0|||
163292662|NCT01596504|589777218|FG000|Overall Study|Participant's Private Reason|0|||
163292663|NCT01596504|589777219|FG001|Overall Study|Participant's Private Reason|1|||
163292664|NCT01596504|589777220|FG002|Overall Study|Participant's Private Reason|0|||
163292665|NCT01596504|589777218|FG000|Overall Study|Adverse Event|1|||
163292666|NCT01596504|589777219|FG001|Overall Study|Adverse Event|2|||
163292667|NCT01596504|589777220|FG002|Overall Study|Adverse Event|1|||
163292668|NCT01596504|589777218|FG000|Overall Study|Withdrawal by Subject|1|||
163292669|NCT01596504|589777219|FG001|Overall Study|Withdrawal by Subject|0|||
163292670|NCT01596504|589777220|FG002|Overall Study|Withdrawal by Subject|0|||
163292671|NCT00949975|589777224|FG000|Overall Study|Voluntary discontinuation|6|||
163292672|NCT00949975|589777225|FG001|Overall Study|Voluntary discontinuation|5|||
163292673|NCT00949975|589777226|FG002|Overall Study|Voluntary discontinuation|3|||
163292674|NCT00949975|589777227|FG003|Overall Study|Voluntary discontinuation|6|||
163292675|NCT00949975|589777224|FG000|Overall Study|Adverse Event|11|||
163292676|NCT00949975|589777225|FG001|Overall Study|Adverse Event|11|||
163292677|NCT00949975|589777226|FG002|Overall Study|Adverse Event|10|||
163292678|NCT00949975|589777227|FG003|Overall Study|Adverse Event|10|||
163292679|NCT00949975|589777224|FG000|Overall Study|Safety reason|0|||
163292680|NCT00949975|589777225|FG001|Overall Study|Safety reason|1|||
163292681|NCT00949975|589777226|FG002|Overall Study|Safety reason|0|||
163292682|NCT00949975|589777227|FG003|Overall Study|Safety reason|0|||
163292683|NCT00949975|589777224|FG000|Overall Study|Study-specific criteria|0|||
163292684|NCT00949975|589777225|FG001|Overall Study|Study-specific criteria|1|||
163292685|NCT00949975|589777226|FG002|Overall Study|Study-specific criteria|1|||
163292686|NCT00949975|589777227|FG003|Overall Study|Study-specific criteria|0|||
163292687|NCT00949975|589777224|FG000|Overall Study|Incorrect enrolment|5|||
163292688|NCT00949975|589777225|FG001|Overall Study|Incorrect enrolment|10|||
163292689|NCT00949975|589777226|FG002|Overall Study|Incorrect enrolment|4|||
163292690|NCT00949975|589777227|FG003|Overall Study|Incorrect enrolment|7|||
163292691|NCT00949975|589777224|FG000|Overall Study|Severe non-compliance|3|||
163292692|NCT00949975|589777225|FG001|Overall Study|Severe non-compliance|1|||
163292693|NCT00949975|589777226|FG002|Overall Study|Severe non-compliance|0|||
163292694|NCT00949975|589777227|FG003|Overall Study|Severe non-compliance|2|||
163292695|NCT00949975|589777224|FG000|Overall Study|Lost to Follow-up|1|||
163292696|NCT00949975|589777225|FG001|Overall Study|Lost to Follow-up|0|||
163292697|NCT00949975|589777226|FG002|Overall Study|Lost to Follow-up|1|||
163292698|NCT00949975|589777227|FG003|Overall Study|Lost to Follow-up|3|||
163292699|NCT00949975|589777224|FG000|Overall Study|Other|1|||
163292700|NCT00949975|589777225|FG001|Overall Study|Other|0|||
163292701|NCT00949975|589777226|FG002|Overall Study|Other|0|||
163292702|NCT00949975|589777227|FG003|Overall Study|Other|0|||
163292703|NCT04347954|589777228|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
163292704|NCT04347954|589777229|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
163292705|NCT04347954|589777230|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
163292706|NCT04347954|589777228|FG000|Overall Study|Lost to Follow-up|0|||
163292707|NCT04347954|589777229|FG001|Overall Study|Lost to Follow-up|1|||
163292708|NCT04347954|589777230|FG002|Overall Study|Lost to Follow-up|0|||
163292709|NCT03257813|589777231|FG000|Overall Study|Protocol Violation|6|||
163292710|NCT03257813|589777232|FG001|Overall Study|Protocol Violation|3|||
163292711|NCT02878330|589777233|FG000|Overall Study|Death|3|||
163292712|NCT02878330|589777234|FG001|Overall Study|Death|2|||
162948297|NCT02937701|588515145|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
162948298|NCT02937701|588515146|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
162948299|NCT02937701|588515147|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
162948300|NCT02937701|588515148|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
162948301|NCT02937701|588515144|FG000|Day 1 to Week 22|Physician Decision|2|||
162948302|NCT02937701|588515145|FG001|Day 1 to Week 22|Physician Decision|0|||
162948303|NCT02937701|588515146|FG002|Day 1 to Week 22|Physician Decision|0|||
162948304|NCT02937701|588515147|FG003|Day 1 to Week 22|Physician Decision|0|||
162948305|NCT02937701|588515148|FG004|Day 1 to Week 22|Physician Decision|0|||
162948306|NCT02937701|588515144|FG000|Day 1 to Week 22|Other|1|||
162948307|NCT02937701|588515145|FG001|Day 1 to Week 22|Other|0|||
162948308|NCT02937701|588515146|FG002|Day 1 to Week 22|Other|0|||
162948309|NCT02937701|588515147|FG003|Day 1 to Week 22|Other|0|||
162948310|NCT02937701|588515148|FG004|Day 1 to Week 22|Other|0|||
162948311|NCT02937701|588515144|FG000|Week 22 to Week 50|Adverse Event|0|||
162948312|NCT02937701|588515145|FG001|Week 22 to Week 50|Adverse Event|0|||
162948313|NCT02937701|588515146|FG002|Week 22 to Week 50|Adverse Event|10|||
162948314|NCT02937701|588515147|FG003|Week 22 to Week 50|Adverse Event|3|||
162948315|NCT02937701|588515148|FG004|Week 22 to Week 50|Adverse Event|3|||
162948316|NCT02937701|588515144|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
162948317|NCT02937701|588515145|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
162948318|NCT02937701|588515146|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
162948319|NCT02937701|588515147|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
162948320|NCT02937701|588515148|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
162948321|NCT02937701|588515144|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
162948322|NCT02937701|588515145|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
162948323|NCT02937701|588515146|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
162948324|NCT02937701|588515147|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
162948325|NCT02937701|588515148|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
162948326|NCT02937701|588515144|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
162948327|NCT02937701|588515145|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
162948328|NCT02937701|588515146|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
162948329|NCT02937701|588515147|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
162948330|NCT02937701|588515148|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
162948331|NCT02937701|588515144|FG000|Week 22 to Week 50|Physician Decision|0|||
162948332|NCT02937701|588515145|FG001|Week 22 to Week 50|Physician Decision|0|||
162948333|NCT02937701|588515146|FG002|Week 22 to Week 50|Physician Decision|2|||
162948334|NCT02937701|588515147|FG003|Week 22 to Week 50|Physician Decision|0|||
162948335|NCT02937701|588515148|FG004|Week 22 to Week 50|Physician Decision|1|||
162948336|NCT02937701|588515144|FG000|Week 22 to Week 50|Other|0|||
162948337|NCT02937701|588515145|FG001|Week 22 to Week 50|Other|0|||
162948338|NCT02937701|588515146|FG002|Week 22 to Week 50|Other|0|||
162948339|NCT02937701|588515147|FG003|Week 22 to Week 50|Other|0|||
162948340|NCT02937701|588515148|FG004|Week 22 to Week 50|Other|1|||
162948341|NCT01507051|588515149|FG000|Overall Study|Withdrawal by Subject|1|||
162948342|NCT01507051|588515150|FG001|Overall Study|Withdrawal by Subject|3|||
162948343|NCT01507051|588515151|FG002|Overall Study|Withdrawal by Subject|1|||
162948344|NCT01507051|588515152|FG003|Overall Study|Withdrawal by Subject|6|||
162948345|NCT01507051|588515149|FG000|Overall Study|Physician Decision|0|||
162948346|NCT01507051|588515150|FG001|Overall Study|Physician Decision|0|||
162948347|NCT01507051|588515151|FG002|Overall Study|Physician Decision|0|||
162948348|NCT01507051|588515152|FG003|Overall Study|Physician Decision|1|||
162948349|NCT01507051|588515149|FG000|Overall Study|Adverse Event|1|||
162948350|NCT01507051|588515150|FG001|Overall Study|Adverse Event|0|||
162948351|NCT01507051|588515151|FG002|Overall Study|Adverse Event|0|||
162948352|NCT01507051|588515152|FG003|Overall Study|Adverse Event|0|||
162948353|NCT01101022|588515153|FG000|Overall Study|Adverse Event|6|||
162948354|NCT01101022|588515154|FG001|Overall Study|Adverse Event|2|||
162948355|NCT01101022|588515153|FG000|Overall Study|Protocol Violation|4|||
162948356|NCT01101022|588515154|FG001|Overall Study|Protocol Violation|3|||
162948357|NCT01101022|588515153|FG000|Overall Study|Withdrawal by Subject|3|||
162948358|NCT01101022|588515154|FG001|Overall Study|Withdrawal by Subject|8|||
162948359|NCT01101022|588515153|FG000|Overall Study|Lost to Follow-up|1|||
162948360|NCT01101022|588515154|FG001|Overall Study|Lost to Follow-up|4|||
162948361|NCT01101022|588515153|FG000|Overall Study|Lack of Efficacy|0|||
162948362|NCT01101022|588515154|FG001|Overall Study|Lack of Efficacy|7|||
162948363|NCT01101022|588515153|FG000|Overall Study|Sponsor decision|1|||
162948364|NCT01101022|588515154|FG001|Overall Study|Sponsor decision|1|||
162948365|NCT01101022|588515153|FG000|Overall Study|Non-compliance|1|||
162948366|NCT01101022|588515154|FG001|Overall Study|Non-compliance|0|||
162948367|NCT01101022|588515153|FG000|Overall Study|Work schedule|1|||
162948368|NCT01101022|588515154|FG001|Overall Study|Work schedule|1|||
162948369|NCT01101022|588515153|FG000|Overall Study|Vacation|0|||
162948370|NCT01101022|588515154|FG001|Overall Study|Vacation|1|||
162948371|NCT03075761|588515155|FG000|Overall Study|Lost to Follow-up|1|||
162948372|NCT03075761|588515156|FG001|Overall Study|Lost to Follow-up|6|||
162948373|NCT01139047|588515157|FG000|Overall Study|Withdrawal by Subject|1|||
162948374|NCT00420303|588515162|FG000|Overall Study|Serious Adverse Event|1|||
162948375|NCT00420303|588515163|FG001|Overall Study|Serious Adverse Event|0|||
162948376|NCT00420303|588515162|FG000|Overall Study|Lack of Efficacy|0|||
162948377|NCT00420303|588515163|FG001|Overall Study|Lack of Efficacy|3|||
162948378|NCT00420303|588515162|FG000|Overall Study|Physician Decision|0|||
162948379|NCT00420303|588515163|FG001|Overall Study|Physician Decision|1|||
162948380|NCT01941095|588515164|FG000|Overall Study|Insufficient therapeutic response|13|||
162948381|NCT01941095|588515164|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
162948382|NCT01941095|588515164|FG000|Overall Study|Adverse Event|11|||
162948383|NCT01941095|588515164|FG000|Overall Study|Physician Decision|3|||
162948384|NCT01941095|588515164|FG000|Overall Study|Withdrawal by Subject|17|||
163187447|NCT00973349|589401929|FG001|Overall Study|Protocol Violation|0|||
163187448|NCT00973349|589401930|FG002|Overall Study|Protocol Violation|0|||
163187449|NCT00973349|589401931|FG003|Overall Study|Protocol Violation|0|||
163187450|NCT00973349|589401932|FG004|Overall Study|Protocol Violation|0|||
163187451|NCT00973349|589401933|FG005|Overall Study|Protocol Violation|0|||
163187452|NCT00973349|589401934|FG006|Overall Study|Protocol Violation|0|||
163187453|NCT00973349|589401935|FG007|Overall Study|Protocol Violation|0|||
162948385|NCT01941095|588515164|FG000|Overall Study|Lost to Follow-up|10|||
162948386|NCT04455633|588515166|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
162948387|NCT04455633|588515167|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
162948388|NCT04455633|588515168|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
162948389|NCT04455633|588515166|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
162948390|NCT04455633|588515167|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
162948391|NCT04455633|588515168|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
162948392|NCT04455633|588515166|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
162948393|NCT04455633|588515167|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
162948394|NCT04455633|588515168|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
162948395|NCT04455633|588515166|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
162948396|NCT04455633|588515167|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
162948397|NCT04455633|588515168|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
162948398|NCT01648166|588515169|FG000|Overall Study|inadequate toenail samples|53|||
162948399|NCT01648166|588515170|FG001|Overall Study|inadequate toenail samples|100|||
162948400|NCT00883090|588515171|FG000|Overall Study|Sponsor's decision|1|||
162948401|NCT00883090|588515171|FG000|Overall Study|Withdrawal by Subject|1|||
162948402|NCT03527745|588515172|FG000|Overall Study|Lost to Follow-up|3|||
162948403|NCT03527745|588515173|FG001|Overall Study|Lost to Follow-up|6|||
162948404|NCT03527745|588515174|FG002|Overall Study|Lost to Follow-up|7|||
162948405|NCT03527745|588515175|FG003|Overall Study|Lost to Follow-up|9|||
162948406|NCT03527745|588515176|FG004|Overall Study|Lost to Follow-up|0|||
162948407|NCT03527745|588515177|FG005|Overall Study|Lost to Follow-up|2|||
162948408|NCT03527745|588515178|FG006|Overall Study|Lost to Follow-up|3|||
162948409|NCT03527745|588515179|FG007|Overall Study|Lost to Follow-up|2|||
162948410|NCT03527745|588515180|FG008|Overall Study|Lost to Follow-up|3|||
162948411|NCT03527745|588515181|FG009|Overall Study|Lost to Follow-up|2|||
162948412|NCT03527745|588515182|FG010|Overall Study|Lost to Follow-up|1|||
162948413|NCT03527745|588515183|FG011|Overall Study|Lost to Follow-up|1|||
162948414|NCT03527745|588515184|FG012|Overall Study|Lost to Follow-up|0|||
162948415|NCT03527745|588515185|FG013|Overall Study|Lost to Follow-up|0|||
162948416|NCT03527745|588515186|FG014|Overall Study|Lost to Follow-up|0|||
162948417|NCT03527745|588515187|FG015|Overall Study|Lost to Follow-up|0|||
162948418|NCT03527745|588515188|FG016|Overall Study|Lost to Follow-up|1|||
162948419|NCT03527745|588515189|FG017|Overall Study|Lost to Follow-up|0|||
162948420|NCT03527745|588515190|FG018|Overall Study|Lost to Follow-up|0|||
162948421|NCT03527745|588515191|FG019|Overall Study|Lost to Follow-up|1|||
162948422|NCT03527745|588515192|FG020|Overall Study|Lost to Follow-up|1|||
162948423|NCT03527745|588515193|FG021|Overall Study|Lost to Follow-up|5|||
162948424|NCT03527745|588515194|FG022|Overall Study|Lost to Follow-up|6|||
162948425|NCT03527745|588515195|FG023|Overall Study|Lost to Follow-up|8|||
162948426|NCT03527745|588515196|FG024|Overall Study|Lost to Follow-up|1|||
163187454|NCT00973349|589401936|FG008|Overall Study|Protocol Violation|1|||
163187455|NCT00973349|589401937|FG009|Overall Study|Protocol Violation|0|||
163187456|NCT00973349|589401938|FG010|Overall Study|Protocol Violation|0|||
163187457|NCT00973349|589401939|FG011|Overall Study|Protocol Violation|0|||
163187458|NCT00973349|589401940|FG012|Overall Study|Protocol Violation|0|||
163187459|NCT00973349|589401941|FG013|Overall Study|Protocol Violation|0|||
163187460|NCT00973349|589401942|FG014|Overall Study|Protocol Violation|0|||
163187461|NCT00973349|589401943|FG015|Overall Study|Protocol Violation|0|||
163187462|NCT00973349|589401928|FG000|Overall Study|Unable to classify|0|||
163187463|NCT00973349|589401929|FG001|Overall Study|Unable to classify|0|||
163187464|NCT00973349|589401930|FG002|Overall Study|Unable to classify|0|||
163187465|NCT00973349|589401931|FG003|Overall Study|Unable to classify|0|||
162948427|NCT03527745|588515197|FG025|Overall Study|Lost to Follow-up|3|||
162948428|NCT00560235|588515200|FG000|Phase 1|Discontinued|8|||
162948429|NCT00560235|588515201|FG001|Phase 1|Discontinued|0|||
162948430|NCT00560235|588515202|FG002|Phase 1|Discontinued|0|||
162948431|NCT00560235|588515200|FG000|Phase 1B|Discontinued|0|||
162948432|NCT00560235|588515201|FG001|Phase 1B|Discontinued|19|||
162948433|NCT00560235|588515202|FG002|Phase 1B|Discontinued|0|||
162948434|NCT00560235|588515200|FG000|Phase 2|Discontinued|0|||
162948435|NCT00560235|588515201|FG001|Phase 2|Discontinued|0|||
162948436|NCT00560235|588515202|FG002|Phase 2|Discontinued|96|||
162948437|NCT00560235|588515200|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
163187466|NCT00973349|589401932|FG004|Overall Study|Unable to classify|1|||
163187467|NCT00973349|589401933|FG005|Overall Study|Unable to classify|1|||
163187468|NCT00973349|589401934|FG006|Overall Study|Unable to classify|0|||
163187469|NCT00973349|589401935|FG007|Overall Study|Unable to classify|0|||
162948438|NCT00560235|588515201|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
162948439|NCT00560235|588515202|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
162948440|NCT04015232|588515203|FG000|Overall Study|Withdrawal by Subject|7|||
162948441|NCT04015232|588515204|FG001|Overall Study|Withdrawal by Subject|4|||
162948442|NCT04015232|588515203|FG000|Overall Study|Protocol Violation|1|||
162948443|NCT04015232|588515204|FG001|Overall Study|Protocol Violation|0|||
163187470|NCT00973349|589401936|FG008|Overall Study|Unable to classify|0|||
163187471|NCT00973349|589401937|FG009|Overall Study|Unable to classify|1|||
162948444|NCT04015232|588515203|FG000|Overall Study|Medical Grounds|3|||
162948445|NCT04015232|588515204|FG001|Overall Study|Medical Grounds|3|||
162948446|NCT01087970|588515207|FG000|Overall Study|Protocol Violation|2|||
162948447|NCT00365300|588515208|FG000|Open-label Phase|Adverse Event|4|||
162948448|NCT00365300|588515209|FG001|Open-label Phase|Adverse Event|0|||
162948449|NCT00365300|588515208|FG000|Open-label Phase|Failed to Return|1|||
162948450|NCT00365300|588515209|FG001|Open-label Phase|Failed to Return|0|||
162948451|NCT00365300|588515208|FG000|Open-label Phase|Physician Decision|1|||
162948452|NCT00365300|588515209|FG001|Open-label Phase|Physician Decision|0|||
162948453|NCT00365300|588515208|FG000|Open-label Phase|Noncompliance|9|||
162948454|NCT00365300|588515209|FG001|Open-label Phase|Noncompliance|0|||
162948455|NCT00365300|588515208|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
162948456|NCT00365300|588515209|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
162948457|NCT00365300|588515208|FG000|Open-label Phase|Protocol Violation|1|||
162948458|NCT00365300|588515209|FG001|Open-label Phase|Protocol Violation|0|||
162948459|NCT00365300|588515208|FG000|Open-label Phase|Lack of Efficacy|1|||
162948460|NCT00365300|588515209|FG001|Open-label Phase|Lack of Efficacy|0|||
162948461|NCT00365300|588515208|FG000|Open-label Phase|Patient skipped open label phase|1|||
162948462|NCT00365300|588515209|FG001|Open-label Phase|Patient skipped open label phase|0|||
162948463|NCT00365300|588515208|FG000|Double-blind Phase|Failed to return|1|||
163292713|NCT02878330|589777233|FG000|Overall Study|Lost to Follow-up|11|||
163292714|NCT02878330|589777234|FG001|Overall Study|Lost to Follow-up|26|||
163292715|NCT02878330|589777233|FG000|Overall Study|Withdrawal by Subject|11|||
163292716|NCT02878330|589777234|FG001|Overall Study|Withdrawal by Subject|21|||
163292717|NCT02878330|589777233|FG000|Overall Study|Other|4|||
163292718|NCT02878330|589777234|FG001|Overall Study|Other|7|||
163292719|NCT04246762|589777235|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
162948464|NCT00365300|588515209|FG001|Double-blind Phase|Failed to return|0|||
162948465|NCT00365300|588515208|FG000|Double-blind Phase|Noncompliance|1|||
162948466|NCT00365300|588515209|FG001|Double-blind Phase|Noncompliance|1|||
162948467|NCT00365300|588515208|FG000|Double-blind Phase|Withdrawal by Subject|0|||
162948468|NCT00365300|588515209|FG001|Double-blind Phase|Withdrawal by Subject|1|||
162948469|NCT00365300|588515208|FG000|Double-blind Phase|Protocol Violation|3|||
162948470|NCT00365300|588515209|FG001|Double-blind Phase|Protocol Violation|1|||
162948471|NCT00365300|588515208|FG000|Double-blind Phase|Lack of Efficacy|6|||
162948472|NCT00365300|588515209|FG001|Double-blind Phase|Lack of Efficacy|6|||
162948473|NCT01029353|588515210|FG000|Overall Study|Lost to Follow-up|4|||
162948474|NCT01029353|588515211|FG001|Overall Study|Lost to Follow-up|5|||
162948475|NCT01029353|588515212|FG002|Overall Study|Lost to Follow-up|5|||
162948476|NCT01029353|588515213|FG003|Overall Study|Lost to Follow-up|4|||
162948477|NCT01029353|588515210|FG000|Overall Study|Consent Withdrawn|2|||
162948478|NCT01029353|588515211|FG001|Overall Study|Consent Withdrawn|0|||
162948479|NCT01029353|588515212|FG002|Overall Study|Consent Withdrawn|0|||
162948480|NCT01029353|588515213|FG003|Overall Study|Consent Withdrawn|0|||
162948481|NCT01029353|588515210|FG000|Overall Study|Primary Outcome Indeterminate|1|||
162948482|NCT01029353|588515211|FG001|Overall Study|Primary Outcome Indeterminate|3|||
162948483|NCT01029353|588515212|FG002|Overall Study|Primary Outcome Indeterminate|2|||
162948484|NCT01029353|588515213|FG003|Overall Study|Primary Outcome Indeterminate|0|||
162948485|NCT04538170|588515216|FG000|Overall Study|Withdrawal by Subject|104|||
162948486|NCT04538170|588515217|FG001|Overall Study|Withdrawal by Subject|210|||
162948487|NCT02932878|588515221|FG000|Overall Study|Due to Lab Results|2|||
162948488|NCT02932878|588515222|FG001|Overall Study|Due to Lab Results|1|||
162948489|NCT01918397|588515224|FG000|Overall Study|Never started treatment|2|||
162948490|NCT01918397|588515225|FG001|Overall Study|Never started treatment|1|||
162948491|NCT01918397|588515226|FG002|Overall Study|Never started treatment|0|||
162948492|NCT01918397|588515227|FG003|Overall Study|Never started treatment|0|||
162948493|NCT01918397|588515224|FG000|Overall Study|Adverse Event|1|||
162948494|NCT01918397|588515225|FG001|Overall Study|Adverse Event|1|||
162948495|NCT01918397|588515226|FG002|Overall Study|Adverse Event|1|||
162948496|NCT01918397|588515227|FG003|Overall Study|Adverse Event|0|||
163292720|NCT03615924|589777236|FG000|Overall Study|Withdrawal by Subject|2|||
163292721|NCT03615924|589777237|FG001|Overall Study|Withdrawal by Subject|5|||
163292722|NCT03615924|589777236|FG000|Overall Study|Death|3|||
163292723|NCT03615924|589777237|FG001|Overall Study|Death|1|||
162948497|NCT01918397|588515224|FG000|Overall Study|Lack of compliance|2|||
162948498|NCT01918397|588515225|FG001|Overall Study|Lack of compliance|2|||
162948499|NCT01918397|588515226|FG002|Overall Study|Lack of compliance|3|||
162948500|NCT01918397|588515227|FG003|Overall Study|Lack of compliance|0|||
162948501|NCT01918397|588515224|FG000|Overall Study|Pregnancy|0|||
162948502|NCT01918397|588515225|FG001|Overall Study|Pregnancy|1|||
162948503|NCT01918397|588515226|FG002|Overall Study|Pregnancy|0|||
162948504|NCT01918397|588515227|FG003|Overall Study|Pregnancy|0|||
162948505|NCT01918397|588515224|FG000|Overall Study|Rifampin susceptible|0|||
162948506|NCT01918397|588515225|FG001|Overall Study|Rifampin susceptible|0|||
162948507|NCT01918397|588515226|FG002|Overall Study|Rifampin susceptible|0|||
162948508|NCT01918397|588515227|FG003|Overall Study|Rifampin susceptible|2|||
162948509|NCT01918397|588515224|FG000|Overall Study|Treatment failure|0|||
162948510|NCT01918397|588515225|FG001|Overall Study|Treatment failure|0|||
162948511|NCT01918397|588515226|FG002|Overall Study|Treatment failure|0|||
162948512|NCT01918397|588515227|FG003|Overall Study|Treatment failure|1|||
162948513|NCT01918397|588515224|FG000|Overall Study|Withdrawal by Subject|3|||
162948514|NCT01918397|588515225|FG001|Overall Study|Withdrawal by Subject|2|||
162948515|NCT01918397|588515226|FG002|Overall Study|Withdrawal by Subject|1|||
162948516|NCT01918397|588515227|FG003|Overall Study|Withdrawal by Subject|1|||
162948517|NCT01918397|588515224|FG000|Overall Study|XDR at baseline|0|||
162948518|NCT01918397|588515225|FG001|Overall Study|XDR at baseline|0|||
162948519|NCT01918397|588515226|FG002|Overall Study|XDR at baseline|1|||
162948520|NCT01918397|588515227|FG003|Overall Study|XDR at baseline|0|||
162948521|NCT01918397|588515224|FG000|Overall Study|Lost to Follow-up|2|||
163187472|NCT00973349|589401938|FG010|Overall Study|Unable to classify|0|||
162948522|NCT01918397|588515225|FG001|Overall Study|Lost to Follow-up|1|||
162948523|NCT01918397|588515226|FG002|Overall Study|Lost to Follow-up|1|||
162948524|NCT01918397|588515227|FG003|Overall Study|Lost to Follow-up|1|||
162948525|NCT01918397|588515224|FG000|Overall Study|Increased QTc|1|||
162948526|NCT01918397|588515225|FG001|Overall Study|Increased QTc|0|||
162948527|NCT01918397|588515226|FG002|Overall Study|Increased QTc|0|||
162948528|NCT01918397|588515227|FG003|Overall Study|Increased QTc|1|||
162948529|NCT01918397|588515224|FG000|Overall Study|Death|0|||
162948530|NCT01918397|588515225|FG001|Overall Study|Death|0|||
162948531|NCT01918397|588515226|FG002|Overall Study|Death|1|||
162948532|NCT01918397|588515227|FG003|Overall Study|Death|0|||
162948533|NCT01918397|588515224|FG000|Overall Study|Involved in another investigative trial|0|||
162948534|NCT01918397|588515225|FG001|Overall Study|Involved in another investigative trial|0|||
162948535|NCT01918397|588515226|FG002|Overall Study|Involved in another investigative trial|0|||
162948536|NCT01918397|588515227|FG003|Overall Study|Involved in another investigative trial|1|||
162948537|NCT00849901|588515234|FG000|Acute Treatment Phase|Adverse Event|9|||
162948538|NCT00849901|588515235|FG001|Acute Treatment Phase|Adverse Event|1|||
162948539|NCT00849901|588515236|FG002|Acute Treatment Phase|Adverse Event|3|||
162948540|NCT00849901|588515234|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
162948541|NCT00849901|588515235|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
162948542|NCT00849901|588515236|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
162948543|NCT00849901|588515234|FG000|Acute Treatment Phase|Protocol Violation|0|||
162948544|NCT00849901|588515235|FG001|Acute Treatment Phase|Protocol Violation|2|||
162948545|NCT00849901|588515236|FG002|Acute Treatment Phase|Protocol Violation|1|||
162948546|NCT00849901|588515234|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
162948547|NCT00849901|588515235|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
162948548|NCT00849901|588515236|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
162948549|NCT00849901|588515234|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
162948550|NCT00849901|588515235|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
162948551|NCT00849901|588515236|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
162948552|NCT00849901|588515234|FG000|Acute Treatment Phase|Physician Decision|1|||
162948553|NCT00849901|588515235|FG001|Acute Treatment Phase|Physician Decision|1|||
162948554|NCT00849901|588515236|FG002|Acute Treatment Phase|Physician Decision|1|||
162948555|NCT00849901|588515234|FG000|Acute Treatment Phase|Sponsor Decision|1|||
162948556|NCT00849901|588515235|FG001|Acute Treatment Phase|Sponsor Decision|0|||
162948557|NCT00849901|588515236|FG002|Acute Treatment Phase|Sponsor Decision|0|||
162948558|NCT00849901|588515234|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
162948559|NCT00849901|588515235|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
162948560|NCT00849901|588515236|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
162948561|NCT00849901|588515234|FG000|Extension Phase|Adverse Event|2|||
162948562|NCT00849901|588515235|FG001|Extension Phase|Adverse Event|8|||
162948563|NCT00849901|588515236|FG002|Extension Phase|Adverse Event|4|||
162948564|NCT00849901|588515234|FG000|Extension Phase|Lost to Follow-up|3|||
162948565|NCT00849901|588515235|FG001|Extension Phase|Lost to Follow-up|0|||
162948566|NCT00849901|588515236|FG002|Extension Phase|Lost to Follow-up|1|||
162948567|NCT00849901|588515234|FG000|Extension Phase|Protocol Violation|2|||
162948568|NCT00849901|588515235|FG001|Extension Phase|Protocol Violation|2|||
162948569|NCT00849901|588515236|FG002|Extension Phase|Protocol Violation|4|||
162948570|NCT00849901|588515234|FG000|Extension Phase|Withdrawal by Subject|7|||
162948571|NCT00849901|588515235|FG001|Extension Phase|Withdrawal by Subject|6|||
162948572|NCT00849901|588515236|FG002|Extension Phase|Withdrawal by Subject|3|||
162948573|NCT00849901|588515234|FG000|Extension Phase|Parent or Caregiver Decision|10|||
162948574|NCT00849901|588515235|FG001|Extension Phase|Parent or Caregiver Decision|4|||
162948575|NCT00849901|588515236|FG002|Extension Phase|Parent or Caregiver Decision|4|||
162948576|NCT00849901|588515234|FG000|Extension Phase|Physician Decision|1|||
162948577|NCT00849901|588515235|FG001|Extension Phase|Physician Decision|2|||
162948578|NCT00849901|588515236|FG002|Extension Phase|Physician Decision|0|||
162948579|NCT00849901|588515234|FG000|Extension Phase|Lack of Efficacy|2|||
162948580|NCT00849901|588515235|FG001|Extension Phase|Lack of Efficacy|4|||
162948581|NCT00849901|588515236|FG002|Extension Phase|Lack of Efficacy|1|||
162948582|NCT00262223|588515237|FG000|Treatment Phase|Withdrawal by Subject|3|||
163292724|NCT03615924|589777236|FG000|Overall Study|Lost to Follow-up|1|||
162948583|NCT00262223|588515238|FG001|Treatment Phase|Withdrawal by Subject|6|||
162948584|NCT00262223|588515237|FG000|Treatment Phase|Adverse Event|1|||
162948585|NCT00262223|588515238|FG001|Treatment Phase|Adverse Event|2|||
162948586|NCT00262223|588515237|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
162948587|NCT00262223|588515238|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
162948588|NCT00262223|588515237|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
162948589|NCT00262223|588515238|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
162948590|NCT00262223|588515237|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
162948591|NCT00262223|588515238|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
162948592|NCT00437658|588515241|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
162948593|NCT00437658|588515242|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
162948594|NCT00437658|588515243|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
162948595|NCT00437658|588515241|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
163292725|NCT03615924|589777237|FG001|Overall Study|Lost to Follow-up|0|||
163292726|NCT03615924|589777236|FG000|Overall Study|Randomized in error|1|||
163292727|NCT03615924|589777237|FG001|Overall Study|Randomized in error|0|||
163292728|NCT03615924|589777236|FG000|Overall Study|Study termination by Sponsor|94|||
163292729|NCT03615924|589777237|FG001|Overall Study|Study termination by Sponsor|86|||
163292730|NCT02954848|589777240|FG000|Overall Study|Randomized but Not Treated|0|||
163292731|NCT02954848|589777241|FG001|Overall Study|Randomized but Not Treated|1|||
163292732|NCT02954848|589777240|FG000|Overall Study|Adverse Event|2|||
163292733|NCT02954848|589777241|FG001|Overall Study|Adverse Event|3|||
163292734|NCT02954848|589777240|FG000|Overall Study|Withdrawal by Participant|0|||
163292735|NCT02954848|589777241|FG001|Overall Study|Withdrawal by Participant|1|||
163292736|NCT01069341|589777242|FG000|Overall Study|Lost to Follow-up|1|||
163292737|NCT01802632|589777243|FG000|Overall Study|Death|28|||
163292738|NCT01802632|589777244|FG001|Overall Study|Death|1|||
163292739|NCT01802632|589777245|FG002|Overall Study|Death|38|||
163292740|NCT01802632|589777246|FG003|Overall Study|Death|0|||
163292741|NCT01802632|589777247|FG004|Overall Study|Death|2|||
163292742|NCT01802632|589777248|FG005|Overall Study|Death|0|||
163292743|NCT01802632|589777243|FG000|Overall Study|Withdrawal by Subject|4|||
163292744|NCT01802632|589777244|FG001|Overall Study|Withdrawal by Subject|2|||
163292745|NCT01802632|589777245|FG002|Overall Study|Withdrawal by Subject|7|||
163292746|NCT01802632|589777246|FG003|Overall Study|Withdrawal by Subject|3|||
162948596|NCT00437658|588515242|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
162948597|NCT00437658|588515243|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
162948598|NCT00437658|588515241|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
162948599|NCT00437658|588515242|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
163292747|NCT01802632|589777247|FG004|Overall Study|Withdrawal by Subject|0|||
163292748|NCT01802632|589777248|FG005|Overall Study|Withdrawal by Subject|1|||
163292749|NCT01802632|589777243|FG000|Overall Study|Objective Disease Progression|1|||
163292750|NCT01802632|589777244|FG001|Overall Study|Objective Disease Progression|12|||
163292751|NCT01802632|589777245|FG002|Overall Study|Objective Disease Progression|104|||
163292752|NCT01802632|589777246|FG003|Overall Study|Objective Disease Progression|6|||
163292753|NCT01802632|589777247|FG004|Overall Study|Objective Disease Progression|4|||
163292754|NCT01802632|589777248|FG005|Overall Study|Objective Disease Progression|4|||
163292755|NCT01802632|589777243|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
163292756|NCT01802632|589777244|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
163292757|NCT01802632|589777245|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
163292758|NCT01802632|589777246|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
163292759|NCT01802632|589777247|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
163292760|NCT01802632|589777248|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
163292761|NCT01802632|589777243|FG000|Overall Study|Other (not specified)|0|||
163292762|NCT01802632|589777244|FG001|Overall Study|Other (not specified)|0|||
163292763|NCT01802632|589777245|FG002|Overall Study|Other (not specified)|7|||
163292764|NCT01802632|589777246|FG003|Overall Study|Other (not specified)|1|||
163292765|NCT01802632|589777247|FG004|Overall Study|Other (not specified)|0|||
163292766|NCT01802632|589777248|FG005|Overall Study|Other (not specified)|1|||
163292767|NCT03299816|589777249|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
163292768|NCT03299816|589777250|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
163292769|NCT03299816|589777249|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
163292770|NCT03299816|589777250|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
163292771|NCT03299816|589777249|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
163292772|NCT03299816|589777250|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
163292773|NCT01184508|589777251|FG000|Overall Study|Adverse Event|4|||
163292774|NCT01184508|589777252|FG001|Overall Study|Adverse Event|6|||
163292775|NCT01184508|589777251|FG000|Overall Study|Lack of Efficacy|1|||
163292776|NCT01184508|589777252|FG001|Overall Study|Lack of Efficacy|1|||
163292777|NCT01184508|589777251|FG000|Overall Study|Lost to Follow-up|1|||
163292778|NCT01184508|589777252|FG001|Overall Study|Lost to Follow-up|1|||
163292779|NCT01184508|589777251|FG000|Overall Study|Physician Decision|1|||
163292780|NCT01184508|589777252|FG001|Overall Study|Physician Decision|0|||
163292781|NCT01184508|589777251|FG000|Overall Study|Protocol Violation|3|||
163292782|NCT01184508|589777252|FG001|Overall Study|Protocol Violation|1|||
163292783|NCT01184508|589777251|FG000|Overall Study|Sponsor Decision|5|||
163292784|NCT01184508|589777252|FG001|Overall Study|Sponsor Decision|2|||
163292785|NCT01184508|589777251|FG000|Overall Study|Withdrawal by Subject|1|||
163292786|NCT01184508|589777252|FG001|Overall Study|Withdrawal by Subject|3|||
163292787|NCT01184508|589777251|FG000|Overall Study|Randomized, Not Treated|0|||
163292788|NCT01184508|589777252|FG001|Overall Study|Randomized, Not Treated|1|||
163292789|NCT02969863|589777253|FG000|Overall Study|Physician Decision|1|||
163292790|NCT02969863|589777254|FG001|Overall Study|Physician Decision|0|||
163292791|NCT02969863|589777255|FG002|Overall Study|Physician Decision|0|||
163292792|NCT02969863|589777256|FG003|Overall Study|Physician Decision|0|||
163292793|NCT02969863|589777257|FG004|Overall Study|Physician Decision|0|||
163292794|NCT02969863|589777258|FG005|Overall Study|Physician Decision|0|||
163292795|NCT00756730|589777261|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
163292796|NCT00756730|589777262|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
163292797|NCT00756730|589777261|FG000|Overall Study|persistent low-level viremmia|0|||
163292798|NCT00756730|589777262|FG001|Overall Study|persistent low-level viremmia|1|||
163292799|NCT05382104|589777266|FG000|Period 2 (2 Days)|Adverse Event|0|||
163292800|NCT05382104|589777267|FG001|Period 2 (2 Days)|Adverse Event|1|||
163292801|NCT05382104|589777268|FG002|Period 2 (2 Days)|Adverse Event|0|||
163292802|NCT05382104|589777269|FG003|Period 2 (2 Days)|Adverse Event|0|||
163292803|NCT05382104|589777270|FG004|Period 2 (2 Days)|Adverse Event|0|||
163292804|NCT05382104|589777271|FG005|Period 2 (2 Days)|Adverse Event|0|||
163292805|NCT01493778|589777272|FG000|Overall Study|Withdrawal by Subject|8|||
163292806|NCT01227707|589777273|FG000|Overall Study|Adverse Event|10|||
163292807|NCT01227707|589777273|FG000|Overall Study|Progression of disease|3|||
163292808|NCT01227707|589777273|FG000|Overall Study|Withdrawal by Subject|1|||
163292809|NCT01227707|589777273|FG000|Overall Study|Patient non-compliance|3|||
163388865|NCT00195507|590135936|FG000|Overall Study|Withdrawal by Subject|16|||
163292810|NCT01227707|589777273|FG000|Overall Study|Medical decision|6|||
163292811|NCT01227707|589777273|FG000|Overall Study|Death|1|||
163292812|NCT03210402|589777274|FG000|Overall Study|Withdrawal by Subject|0|||
163292813|NCT03210402|589777275|FG001|Overall Study|Withdrawal by Subject|1|||
163292814|NCT00811057|589777276|FG000|Overall Study|Protocol Violation|5|||
163292815|NCT00811057|589777277|FG001|Overall Study|Protocol Violation|10|||
162948600|NCT00437658|588515243|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
162948601|NCT00437658|588515241|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
162948602|NCT00437658|588515242|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
162948603|NCT00437658|588515243|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
162948604|NCT00437658|588515241|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
162948605|NCT00437658|588515242|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
162948606|NCT00437658|588515243|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
162948607|NCT00437658|588515241|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
162948608|NCT00437658|588515242|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
162948609|NCT00437658|588515243|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
162948610|NCT00437658|588515241|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
162948611|NCT00437658|588515242|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
162948612|NCT00437658|588515243|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
163187473|NCT00973349|589401939|FG011|Overall Study|Unable to classify|0|||
163187474|NCT00973349|589401940|FG012|Overall Study|Unable to classify|0|||
163187475|NCT00973349|589401941|FG013|Overall Study|Unable to classify|0|||
163187476|NCT00973349|589401942|FG014|Overall Study|Unable to classify|0|||
163187477|NCT00973349|589401943|FG015|Overall Study|Unable to classify|0|||
163187478|NCT05597020|589401951|FG000|Washout|Forbidden medication|2|||
163187479|NCT05597020|589401952|FG001|Washout|Forbidden medication|0|||
163187480|NCT05597020|589401951|FG000|Treatment Period II|Advice from primary care physician|1|||
163187481|NCT05597020|589401952|FG001|Treatment Period II|Advice from primary care physician|0|||
162948613|NCT00437658|588515241|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
162948614|NCT00437658|588515242|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
162948615|NCT00437658|588515243|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
162948616|NCT00437658|588515241|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
162948617|NCT00437658|588515242|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
162948618|NCT00437658|588515243|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
162948619|NCT00437658|588515241|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
162948620|NCT00437658|588515242|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
162948621|NCT00437658|588515243|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
162948622|NCT00437658|588515241|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
162948623|NCT00437658|588515242|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
162948624|NCT00437658|588515243|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
162948625|NCT00437658|588515241|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
162948626|NCT00437658|588515242|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
162948627|NCT00437658|588515243|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
162948628|NCT03952143|588515244|FG000|Lead-In Period|Adverse Event|2|||
162948629|NCT03952143|588515245|FG001|Lead-In Period|Adverse Event|0|||
162948630|NCT03952143|588515246|FG002|Lead-In Period|Adverse Event|0|||
162948631|NCT03952143|588515244|FG000|Lead-In Period|Lack of Efficacy|2|||
162948632|NCT03952143|588515245|FG001|Lead-In Period|Lack of Efficacy|0|||
162948633|NCT03952143|588515246|FG002|Lead-In Period|Lack of Efficacy|0|||
162948634|NCT03952143|588515244|FG000|Lead-In Period|Physician Decision|5|||
162948635|NCT03952143|588515245|FG001|Lead-In Period|Physician Decision|0|||
162948636|NCT03952143|588515246|FG002|Lead-In Period|Physician Decision|0|||
162948637|NCT03952143|588515244|FG000|Lead-In Period|Protocol Violation|5|||
162948638|NCT03952143|588515245|FG001|Lead-In Period|Protocol Violation|0|||
162948639|NCT03952143|588515246|FG002|Lead-In Period|Protocol Violation|0|||
162948640|NCT03952143|588515244|FG000|Lead-In Period|Withdrawal by Subject|19|||
162948641|NCT03952143|588515245|FG001|Lead-In Period|Withdrawal by Subject|0|||
162948642|NCT03952143|588515246|FG002|Lead-In Period|Withdrawal by Subject|0|||
162948643|NCT03952143|588515244|FG000|Treatment Period|Adverse Event|0|||
162948644|NCT03952143|588515245|FG001|Treatment Period|Adverse Event|0|||
162948645|NCT03952143|588515246|FG002|Treatment Period|Adverse Event|1|||
162948646|NCT03952143|588515244|FG000|Treatment Period|Lost to Follow-up|0|||
162948647|NCT03952143|588515245|FG001|Treatment Period|Lost to Follow-up|2|||
163187482|NCT05597020|589401951|FG000|Treatment Period II|Subject lost investigational product|1|||
163187483|NCT05597020|589401952|FG001|Treatment Period II|Subject lost investigational product|0|||
163187484|NCT05597020|589401951|FG000|Treatment Period II|Private reasons|0|||
163187485|NCT05597020|589401952|FG001|Treatment Period II|Private reasons|1|||
163187486|NCT05736224|589401953|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
162948648|NCT03952143|588515246|FG002|Treatment Period|Lost to Follow-up|0|||
162948649|NCT03952143|588515244|FG000|Treatment Period|Physician Decision|0|||
162948650|NCT03952143|588515245|FG001|Treatment Period|Physician Decision|0|||
162948651|NCT03952143|588515246|FG002|Treatment Period|Physician Decision|2|||
162948652|NCT03952143|588515244|FG000|Treatment Period|Protocol Violation|0|||
162948653|NCT03952143|588515245|FG001|Treatment Period|Protocol Violation|0|||
162948654|NCT03952143|588515246|FG002|Treatment Period|Protocol Violation|1|||
162948655|NCT03952143|588515244|FG000|Treatment Period|Withdrawal by Subject|0|||
162948656|NCT03952143|588515245|FG001|Treatment Period|Withdrawal by Subject|5|||
162948657|NCT03952143|588515246|FG002|Treatment Period|Withdrawal by Subject|26|||
162948658|NCT03952143|588515244|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
162948659|NCT03952143|588515245|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
162948660|NCT03952143|588515246|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
162948661|NCT03952143|588515244|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
162948662|NCT03952143|588515245|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
162948663|NCT03952143|588515246|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
162948664|NCT02152566|588515247|FG000|Overall Study|Lost to Follow-up|1|||
162948665|NCT02152566|588515247|FG000|Overall Study|Withdrawal by Subject|2|||
162948666|NCT01866319|588515248|FG000|Overall Study|Adverse Event|12|||
162948667|NCT01866319|588515249|FG001|Overall Study|Adverse Event|5|||
162948668|NCT01866319|588515250|FG002|Overall Study|Adverse Event|9|||
162948669|NCT01866319|588515248|FG000|Overall Study|Clinical progression|3|||
162948670|NCT01866319|588515249|FG001|Overall Study|Clinical progression|2|||
162948671|NCT01866319|588515250|FG002|Overall Study|Clinical progression|2|||
162948672|NCT01866319|588515248|FG000|Overall Study|Death|153|||
162948673|NCT01866319|588515249|FG001|Overall Study|Death|154|||
162948674|NCT01866319|588515250|FG002|Overall Study|Death|147|||
162948675|NCT01866319|588515248|FG000|Overall Study|Lost to Follow-up|6|||
162948676|NCT01866319|588515249|FG001|Overall Study|Lost to Follow-up|3|||
162948677|NCT01866319|588515250|FG002|Overall Study|Lost to Follow-up|8|||
162948678|NCT01866319|588515248|FG000|Overall Study|Physician Decision|1|||
162948679|NCT01866319|588515249|FG001|Overall Study|Physician Decision|0|||
162948680|NCT01866319|588515250|FG002|Overall Study|Physician Decision|1|||
163187487|NCT01015131|589401954|FG000|Overall Study|Physician Decision|1|||
163187488|NCT01015131|589401954|FG000|Overall Study|Protocol Violation|1|||
162948681|NCT01866319|588515248|FG000|Overall Study|Protocol Violation|0|||
163187489|NCT01015131|589401954|FG000|Overall Study|Withdrawal by Subject|2|||
163187490|NCT01015131|589401954|FG000|Overall Study|Other Protocol Specified Criteria|4|||
163292816|NCT00811057|589777278|FG002|Overall Study|Protocol Violation|10|||
162948682|NCT01866319|588515249|FG001|Overall Study|Protocol Violation|0|||
162948683|NCT01866319|588515250|FG002|Overall Study|Protocol Violation|1|||
162948684|NCT01866319|588515248|FG000|Overall Study|Withdrawal by Subject|32|||
162948685|NCT01866319|588515249|FG001|Overall Study|Withdrawal by Subject|14|||
162948686|NCT01866319|588515250|FG002|Overall Study|Withdrawal by Subject|12|||
162948687|NCT00496964|588515251|FG000|Overall Study|Withdrawal by Subject|0|||
162948688|NCT00496964|588515252|FG001|Overall Study|Withdrawal by Subject|1|||
162948689|NCT02942264|588515253|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
162948690|NCT02942264|588515254|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
162948691|NCT02942264|588515255|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
162948692|NCT02942264|588515256|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
162948693|NCT02942264|588515257|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
162948694|NCT02942264|588515258|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
162948695|NCT02942264|588515259|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
162948696|NCT02942264|588515260|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
162948697|NCT02942264|588515261|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
162948698|NCT02942264|588515253|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948699|NCT02942264|588515254|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948700|NCT02942264|588515255|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948701|NCT02942264|588515256|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948702|NCT02942264|588515257|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948703|NCT02942264|588515258|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948704|NCT02942264|588515259|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948705|NCT02942264|588515260|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948706|NCT02942264|588515261|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
162948707|NCT01328093|588515262|FG000|Double-Blind Phase|Adverse Event|78|||
162948708|NCT01328093|588515263|FG001|Double-Blind Phase|Adverse Event|15|||
162948709|NCT01328093|588515262|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
162948710|NCT01328093|588515263|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
162948711|NCT01328093|588515262|FG000|Double-Blind Phase|Lost to Follow-up|39|||
162948712|NCT01328093|588515263|FG001|Double-Blind Phase|Lost to Follow-up|14|||
162948713|NCT01328093|588515262|FG000|Double-Blind Phase|Protocol Violation|30|||
162948714|NCT01328093|588515263|FG001|Double-Blind Phase|Protocol Violation|10|||
162948715|NCT01328093|588515262|FG000|Double-Blind Phase|Lack of Efficacy|55|||
162948716|NCT01328093|588515263|FG001|Double-Blind Phase|Lack of Efficacy|13|||
162948717|NCT01328093|588515262|FG000|Double-Blind Phase|Sponsor Decision|17|||
162948718|NCT01328093|588515263|FG001|Double-Blind Phase|Sponsor Decision|3|||
162948719|NCT01328093|588515262|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
162948720|NCT01328093|588515263|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
162948721|NCT01328093|588515262|FG000|Double-Blind Phase|Scheduling conflict|8|||
162948722|NCT01328093|588515263|FG001|Double-Blind Phase|Scheduling conflict|3|||
162948723|NCT01328093|588515262|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
162948724|NCT01328093|588515263|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
162948725|NCT01328093|588515262|FG000|Double-Blind Phase|Death|1|||
162948726|NCT01328093|588515263|FG001|Double-Blind Phase|Death|0|||
162948727|NCT01328093|588515262|FG000|Open-Label Phase|Sponsor Decision|98|||
162948728|NCT01328093|588515263|FG001|Open-Label Phase|Sponsor Decision|34|||
162948729|NCT01328093|588515262|FG000|Open-Label Phase|Protocol Violation|8|||
162948730|NCT01328093|588515263|FG001|Open-Label Phase|Protocol Violation|3|||
162948731|NCT01328093|588515262|FG000|Open-Label Phase|Lost to Follow-up|10|||
162948732|NCT01328093|588515263|FG001|Open-Label Phase|Lost to Follow-up|1|||
162948733|NCT01328093|588515262|FG000|Open-Label Phase|Adverse Event|10|||
162948734|NCT01328093|588515263|FG001|Open-Label Phase|Adverse Event|4|||
162948735|NCT01328093|588515262|FG000|Open-Label Phase|Lack of Efficacy|5|||
162948736|NCT01328093|588515263|FG001|Open-Label Phase|Lack of Efficacy|6|||
162948737|NCT01328093|588515262|FG000|Open-Label Phase|Withdrawal by Subject|4|||
162948738|NCT01328093|588515263|FG001|Open-Label Phase|Withdrawal by Subject|1|||
162948739|NCT01328093|588515262|FG000|Open-Label Phase|Scheduling conflict|2|||
162948740|NCT01328093|588515263|FG001|Open-Label Phase|Scheduling conflict|1|||
162948741|NCT01328093|588515262|FG000|Open-Label Phase|Subject is moving or has moved|2|||
162948742|NCT01328093|588515263|FG001|Open-Label Phase|Subject is moving or has moved|0|||
162948743|NCT01328093|588515262|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
162948744|NCT01328093|588515263|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
162948745|NCT03980483|588515266|FG000|Overall Study|Adverse Event|13|||
162948746|NCT03980483|588515267|FG001|Overall Study|Adverse Event|29|||
162948747|NCT03980483|588515268|FG002|Overall Study|Adverse Event|11|||
162948748|NCT03980483|588515269|FG003|Overall Study|Adverse Event|2|||
162948749|NCT03980483|588515270|FG004|Overall Study|Adverse Event|2|||
162948750|NCT03980483|588515271|FG005|Overall Study|Adverse Event|2|||
162948751|NCT03980483|588515266|FG000|Overall Study|Lack of Efficacy|7|||
162948752|NCT03980483|588515267|FG001|Overall Study|Lack of Efficacy|6|||
162948753|NCT03980483|588515268|FG002|Overall Study|Lack of Efficacy|0|||
162948754|NCT03980483|588515269|FG003|Overall Study|Lack of Efficacy|3|||
163292817|NCT03215927|589778745|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
162948755|NCT03980483|588515270|FG004|Overall Study|Lack of Efficacy|1|||
162948756|NCT03980483|588515271|FG005|Overall Study|Lack of Efficacy|1|||
162948757|NCT03980483|588515266|FG000|Overall Study|Lost to Follow-up|2|||
162948758|NCT03980483|588515267|FG001|Overall Study|Lost to Follow-up|4|||
162948759|NCT03980483|588515268|FG002|Overall Study|Lost to Follow-up|2|||
162948760|NCT03980483|588515269|FG003|Overall Study|Lost to Follow-up|1|||
162948761|NCT03980483|588515270|FG004|Overall Study|Lost to Follow-up|2|||
162948762|NCT03980483|588515271|FG005|Overall Study|Lost to Follow-up|0|||
162948763|NCT03980483|588515266|FG000|Overall Study|Protocol Violation|4|||
162948764|NCT03980483|588515267|FG001|Overall Study|Protocol Violation|2|||
163187491|NCT04526509|589401955|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
163187492|NCT04526509|589401956|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
163187493|NCT04526509|589401957|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
163187494|NCT04526509|589401958|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
163187495|NCT04526509|589401959|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
163187496|NCT04526509|589401960|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
163187497|NCT04526509|589401961|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
163187498|NCT04526509|589401955|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
163187499|NCT04526509|589401956|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
163187500|NCT04526509|589401957|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
163187501|NCT04526509|589401958|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
163187502|NCT04526509|589401959|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
163187503|NCT04526509|589401960|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
163187504|NCT04526509|589401961|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
163187505|NCT04526509|589401955|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
163187506|NCT04526509|589401956|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
163187507|NCT04526509|589401957|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
163187508|NCT04526509|589401958|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
163187509|NCT04526509|589401959|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
163187510|NCT04526509|589401960|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
162948765|NCT03980483|588515268|FG002|Overall Study|Protocol Violation|1|||
163187511|NCT04526509|589401961|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
163187512|NCT04526509|589401955|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
162948766|NCT03980483|588515269|FG003|Overall Study|Protocol Violation|1|||
162948767|NCT03980483|588515270|FG004|Overall Study|Protocol Violation|0|||
162948768|NCT03980483|588515271|FG005|Overall Study|Protocol Violation|0|||
162948769|NCT03980483|588515266|FG000|Overall Study|Physician Decision|14|||
162948770|NCT03980483|588515267|FG001|Overall Study|Physician Decision|10|||
162948771|NCT03980483|588515268|FG002|Overall Study|Physician Decision|7|||
162948772|NCT03980483|588515269|FG003|Overall Study|Physician Decision|4|||
162948773|NCT03980483|588515270|FG004|Overall Study|Physician Decision|4|||
162948774|NCT03980483|588515271|FG005|Overall Study|Physician Decision|2|||
162948775|NCT03980483|588515266|FG000|Overall Study|Withdrawal by Subject|38|||
162948776|NCT03980483|588515267|FG001|Overall Study|Withdrawal by Subject|21|||
162948777|NCT03980483|588515268|FG002|Overall Study|Withdrawal by Subject|15|||
162948778|NCT03980483|588515269|FG003|Overall Study|Withdrawal by Subject|5|||
162948779|NCT03980483|588515270|FG004|Overall Study|Withdrawal by Subject|3|||
162948780|NCT03980483|588515271|FG005|Overall Study|Withdrawal by Subject|4|||
162948781|NCT03980483|588515266|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
162948782|NCT03980483|588515267|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
162948783|NCT03980483|588515268|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
162948784|NCT03980483|588515269|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
162948785|NCT03980483|588515270|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
162948786|NCT03980483|588515271|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
162948787|NCT03980483|588515266|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
162948788|NCT03980483|588515267|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
162948789|NCT03980483|588515268|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
162948790|NCT03980483|588515269|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
162948791|NCT03980483|588515270|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
162948792|NCT03980483|588515271|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
162948793|NCT03980483|588515266|FG000|Overall Study|Other|0|||
163292818|NCT03215927|589778746|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
163292819|NCT03215927|589778745|FG000|Open Label Extension|Adverse Event|1|||
163292820|NCT03215927|589778746|FG001|Open Label Extension|Adverse Event|0|||
162948794|NCT03980483|588515267|FG001|Overall Study|Other|1|||
162948795|NCT03980483|588515268|FG002|Overall Study|Other|0|||
163187513|NCT04526509|589401956|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
163187514|NCT04526509|589401957|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
163187515|NCT04526509|589401958|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
163187516|NCT04526509|589401959|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
163187517|NCT04526509|589401960|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
163187518|NCT04526509|589401961|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
163187519|NCT04526509|589401955|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
163187520|NCT04526509|589401956|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
163187521|NCT04526509|589401957|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
163187522|NCT04526509|589401958|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
163187523|NCT04526509|589401959|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
163187524|NCT04526509|589401960|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
163187525|NCT04526509|589401961|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
163187526|NCT04526509|589401955|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
163187527|NCT04526509|589401956|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
163187528|NCT04526509|589401957|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
163187529|NCT04526509|589401958|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
163292821|NCT03215927|589778745|FG000|Open Label Extension|Lack of Efficacy|1|||
163292822|NCT03215927|589778746|FG001|Open Label Extension|Lack of Efficacy|0|||
163292823|NCT03215927|589778745|FG000|Open Label Extension|Death|0|||
163292824|NCT03215927|589778746|FG001|Open Label Extension|Death|1|||
163187530|NCT04526509|589401959|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
163187531|NCT04526509|589401960|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
163187532|NCT04526509|589401961|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
163292825|NCT03779048|589778747|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
163292826|NCT03779048|589778748|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
163292827|NCT03779048|589778749|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
163292828|NCT03779048|589778747|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
163292829|NCT03779048|589778748|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
163292830|NCT03779048|589778749|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
163292831|NCT03779048|589778747|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
163292832|NCT03779048|589778748|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
163292833|NCT03779048|589778749|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
163292834|NCT05328297|589778750|FG000|Overall Study|Adverse Event|5|||
163292835|NCT05328297|589778751|FG001|Overall Study|Adverse Event|7|||
163292836|NCT05328297|589778750|FG000|Overall Study|Withdrawal by Subject|4|||
163292837|NCT05328297|589778751|FG001|Overall Study|Withdrawal by Subject|3|||
163292838|NCT05328297|589778750|FG000|Overall Study|Lack of Efficacy|1|||
163292839|NCT05328297|589778751|FG001|Overall Study|Lack of Efficacy|0|||
163292840|NCT05328297|589778750|FG000|Overall Study|Lost to Follow-up|1|||
163292841|NCT05328297|589778751|FG001|Overall Study|Lost to Follow-up|0|||
163292842|NCT05328297|589778750|FG000|Overall Study|Protocol Violation|1|||
163292843|NCT05328297|589778751|FG001|Overall Study|Protocol Violation|0|||
163292844|NCT05328297|589778750|FG000|Overall Study|Randomized but not treated|1|||
163292845|NCT05328297|589778751|FG001|Overall Study|Randomized but not treated|1|||
163292846|NCT01286272|589778752|FG000|Overall Study|Ineligible after beginning treatment|1|||
163292847|NCT01286272|589778753|FG001|Overall Study|Ineligible after beginning treatment|3|||
163292848|NCT03979365|589778756|FG000|Overall Study|Death|1|||
163292849|NCT03979365|589778757|FG001|Overall Study|Death|3|||
163292850|NCT03979365|589778756|FG000|Overall Study|Withdrawal by Subject|0|||
163292851|NCT03979365|589778757|FG001|Overall Study|Withdrawal by Subject|1|||
163292852|NCT03979365|589778756|FG000|Overall Study|Drug Conversion|0|||
163292853|NCT03979365|589778757|FG001|Overall Study|Drug Conversion|3|||
163292854|NCT04496960|589778758|FG000|Overall Study|Physician Decision|0|||
163292855|NCT04496960|589778759|FG001|Overall Study|Physician Decision|1|||
163292856|NCT00941655|589778762|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
163292857|NCT00941655|589778763|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
163292858|NCT00941655|589778762|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
163292859|NCT00941655|589778763|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
163292860|NCT00941655|589778762|FG000|Overall Study|progressed while on chemo|0|||
163292861|NCT00941655|589778763|FG001|Overall Study|progressed while on chemo|2|||
163292862|NCT00941655|589778762|FG000|Overall Study|refused further treatment|0|||
163292863|NCT00941655|589778763|FG001|Overall Study|refused further treatment|1|||
163292864|NCT00941655|589778762|FG000|Overall Study|withdrew consent|0|||
163292865|NCT00941655|589778763|FG001|Overall Study|withdrew consent|1|||
163292866|NCT00941655|589778762|FG000|Overall Study|non-compliant|0|||
163292867|NCT00941655|589778763|FG001|Overall Study|non-compliant|1|||
163292868|NCT05855655|589778768|FG000|Overall Study|Withdrawal by Subject|0|||
163292869|NCT05855655|589778769|FG001|Overall Study|Withdrawal by Subject|1|||
163292870|NCT05855655|589778768|FG000|Overall Study|Lost to Follow-up|4|||
163292871|NCT05855655|589778769|FG001|Overall Study|Lost to Follow-up|0|||
163292872|NCT01613716|589778770|FG000|Overall Study|screen failures|3|||
163292873|NCT01613716|589778770|FG000|Overall Study|Lost to Follow-up|4|||
163292874|NCT01426269|589778773|FG000|Period 1: 12 Weeks|Adverse Event|5|||
163292875|NCT01426269|589778774|FG001|Period 1: 12 Weeks|Adverse Event|0|||
163292876|NCT01426269|589778775|FG002|Period 1: 12 Weeks|Adverse Event|0|||
163292877|NCT01426269|589778773|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
163292878|NCT01426269|589778774|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
163292879|NCT01426269|589778775|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
163292880|NCT01426269|589778773|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
163292881|NCT01426269|589778774|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
163292882|NCT01426269|589778775|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
163292883|NCT01426269|589778773|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
163292884|NCT01426269|589778774|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
163292885|NCT01426269|589778775|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
163292886|NCT01426269|589778773|FG000|Period 1: 12 Weeks|Pregnancy|1|||
163292887|NCT01426269|589778774|FG001|Period 1: 12 Weeks|Pregnancy|0|||
163292888|NCT01426269|589778775|FG002|Period 1: 12 Weeks|Pregnancy|0|||
163292889|NCT01426269|589778773|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
163292890|NCT01426269|589778774|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
163292891|NCT01426269|589778775|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
163292892|NCT01426269|589778773|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
163292893|NCT01426269|589778774|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
163292894|NCT01426269|589778775|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
163292895|NCT01426269|589778773|FG000|Period 2: 40 Weeks|Adverse Event|0|||
163292896|NCT01426269|589778774|FG001|Period 2: 40 Weeks|Adverse Event|1|||
163292897|NCT01426269|589778775|FG002|Period 2: 40 Weeks|Adverse Event|2|||
162948796|NCT03980483|588515269|FG003|Overall Study|Other|0|||
163292898|NCT01426269|589778773|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
163292899|NCT01426269|589778774|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
163292900|NCT01426269|589778775|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
163292901|NCT01426269|589778773|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
163292902|NCT01426269|589778774|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
163292903|NCT01426269|589778775|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
163292904|NCT01426269|589778773|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
163292905|NCT01426269|589778774|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
163292906|NCT01426269|589778775|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
163292907|NCT01426269|589778773|FG000|Period 2: 40 Weeks|Site closed|0|||
163292908|NCT01426269|589778774|FG001|Period 2: 40 Weeks|Site closed|6|||
163292909|NCT01426269|589778775|FG002|Period 2: 40 Weeks|Site closed|5|||
163292910|NCT01426269|589778773|FG000|Period 2: 40 Weeks|Relapsed|0|||
163292911|NCT01426269|589778774|FG001|Period 2: 40 Weeks|Relapsed|9|||
163292912|NCT01426269|589778775|FG002|Period 2: 40 Weeks|Relapsed|18|||
163187533|NCT04526509|589401955|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
163187534|NCT04526509|589401956|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
163187535|NCT04526509|589401957|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
163187536|NCT04526509|589401958|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
163187537|NCT04526509|589401959|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
163187538|NCT04526509|589401960|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
163187539|NCT04526509|589401961|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
163187540|NCT04526509|589401955|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
163187541|NCT04526509|589401956|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
163187542|NCT04526509|589401957|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
163187543|NCT04526509|589401958|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
163187544|NCT04526509|589401959|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
163187545|NCT04526509|589401960|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
163187546|NCT04526509|589401961|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
163187547|NCT04526509|589401955|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
163187548|NCT04526509|589401956|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
162948797|NCT03980483|588515270|FG004|Overall Study|Other|0|||
162948798|NCT03980483|588515271|FG005|Overall Study|Other|0|||
163292913|NCT00419094|589778777|FG000|Overall Study|Adverse Event|3|||
163292914|NCT00419094|589778778|FG001|Overall Study|Adverse Event|7|||
163292915|NCT00419094|589778777|FG000|Overall Study|Lack of Efficacy|1|||
163292916|NCT00419094|589778778|FG001|Overall Study|Lack of Efficacy|0|||
163292917|NCT00419094|589778777|FG000|Overall Study|Lost to Follow-up|0|||
163292918|NCT00419094|589778778|FG001|Overall Study|Lost to Follow-up|2|||
163292919|NCT00419094|589778777|FG000|Overall Study|Protocol Violation|1|||
163292920|NCT00419094|589778778|FG001|Overall Study|Protocol Violation|14|||
163292921|NCT00419094|589778777|FG000|Overall Study|Withdrawal of consent|1|||
163292922|NCT00419094|589778778|FG001|Overall Study|Withdrawal of consent|5|||
163292923|NCT00419094|589778777|FG000|Overall Study|Other: Error determining exit criteria|1|||
163292924|NCT00419094|589778778|FG001|Overall Study|Other: Error determining exit criteria|0|||
163292925|NCT00419094|589778777|FG000|Overall Study|Other: Patient non-compliant|0|||
163292926|NCT00419094|589778778|FG001|Overall Study|Other: Patient non-compliant|1|||
163292927|NCT00419094|589778777|FG000|Overall Study|Other: No contact for extended period|0|||
163292928|NCT00419094|589778778|FG001|Overall Study|Other: No contact for extended period|1|||
163292929|NCT02296424|589778779|FG000|Part 1|New therapy for study indication|0|||
163292930|NCT02296424|589778780|FG001|Part 1|New therapy for study indication|1|||
163292931|NCT02296424|589778781|FG002|Part 1|New therapy for study indication|0|||
163292932|NCT02296424|589778782|FG003|Part 1|New therapy for study indication|0|||
163292933|NCT02296424|589778779|FG000|Part 1|Protocol Violation|0|||
163292934|NCT02296424|589778780|FG001|Part 1|Protocol Violation|1|||
163292935|NCT02296424|589778781|FG002|Part 1|Protocol Violation|0|||
163292936|NCT02296424|589778782|FG003|Part 1|Protocol Violation|0|||
163292937|NCT02296424|589778779|FG000|Part 1|Withdrawal by Subject|0|||
163292938|NCT02296424|589778780|FG001|Part 1|Withdrawal by Subject|2|||
163292939|NCT02296424|589778781|FG002|Part 1|Withdrawal by Subject|0|||
163292940|NCT02296424|589778782|FG003|Part 1|Withdrawal by Subject|0|||
163292941|NCT02296424|589778779|FG000|Part 1|Study terminated by sponsor|0|||
163292942|NCT02296424|589778780|FG001|Part 1|Study terminated by sponsor|1|||
163292943|NCT02296424|589778781|FG002|Part 1|Study terminated by sponsor|0|||
163292944|NCT02296424|589778782|FG003|Part 1|Study terminated by sponsor|0|||
163292945|NCT02296424|589778779|FG000|Part 1|Adverse Event|2|||
163292946|NCT02296424|589778780|FG001|Part 1|Adverse Event|11|||
163292947|NCT02296424|589778781|FG002|Part 1|Adverse Event|0|||
163292948|NCT02296424|589778782|FG003|Part 1|Adverse Event|0|||
163292949|NCT02296424|589778779|FG000|Part 1|Lack of Efficacy|5|||
163292950|NCT02296424|589778780|FG001|Part 1|Lack of Efficacy|17|||
163292951|NCT02296424|589778781|FG002|Part 1|Lack of Efficacy|0|||
163292952|NCT02296424|589778782|FG003|Part 1|Lack of Efficacy|0|||
163292953|NCT02296424|589778779|FG000|Part 1|16 directly started part II|16|||
163292954|NCT02296424|589778780|FG001|Part 1|16 directly started part II|0|||
163292955|NCT02296424|589778781|FG002|Part 1|16 directly started part II|0|||
163292956|NCT02296424|589778782|FG003|Part 1|16 directly started part II|0|||
163388866|NCT00195507|590135937|FG001|Overall Study|Withdrawal by Subject|23|||
163292957|NCT02296424|589778779|FG000|Part 2|Lack of Efficacy|0|||
163292958|NCT02296424|589778780|FG001|Part 2|Lack of Efficacy|0|||
163292959|NCT02296424|589778781|FG002|Part 2|Lack of Efficacy|1|||
163292960|NCT02296424|589778782|FG003|Part 2|Lack of Efficacy|0|||
163292961|NCT02296424|589778779|FG000|Part 2|Adverse Event|0|||
163292962|NCT02296424|589778780|FG001|Part 2|Adverse Event|0|||
163292963|NCT02296424|589778781|FG002|Part 2|Adverse Event|1|||
163292964|NCT02296424|589778782|FG003|Part 2|Adverse Event|0|||
163292965|NCT02296424|589778779|FG000|Part 2|Lost to Follow-up|0|||
163292966|NCT02296424|589778780|FG001|Part 2|Lost to Follow-up|0|||
163292967|NCT02296424|589778781|FG002|Part 2|Lost to Follow-up|1|||
163292968|NCT02296424|589778782|FG003|Part 2|Lost to Follow-up|0|||
162948799|NCT05150964|588515272|FG000|Overall Study|Lost to Follow-up|2|||
162948800|NCT01062256|588515277|FG000|Overall Study|Adverse Event|1|||
162948801|NCT01062256|588515278|FG001|Overall Study|Adverse Event|0|||
162948802|NCT01062256|588515279|FG002|Overall Study|Adverse Event|0|||
163187549|NCT04526509|589401957|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
163187550|NCT04526509|589401958|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
163187551|NCT04526509|589401959|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
163187552|NCT04526509|589401960|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
163187553|NCT04526509|589401961|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
163187554|NCT04526509|589401955|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
163187555|NCT04526509|589401956|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
163187556|NCT04526509|589401957|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
163187557|NCT04526509|589401958|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
163187558|NCT04526509|589401959|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
163187559|NCT04526509|589401960|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
163187560|NCT04526509|589401961|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
163187561|NCT04526509|589401955|FG000|Enrolled|Study Terminated by Sponsor|0|||
163187562|NCT04526509|589401956|FG001|Enrolled|Study Terminated by Sponsor|0|||
163187563|NCT04526509|589401957|FG002|Enrolled|Study Terminated by Sponsor|0|||
163187564|NCT04526509|589401958|FG003|Enrolled|Study Terminated by Sponsor|0|||
162948803|NCT01062256|588515277|FG000|Overall Study|Withdrawal by Subject|1|||
163187565|NCT04526509|589401959|FG004|Enrolled|Study Terminated by Sponsor|0|||
163187566|NCT04526509|589401960|FG005|Enrolled|Study Terminated by Sponsor|0|||
163187567|NCT04526509|589401961|FG006|Enrolled|Study Terminated by Sponsor|1|||
163187568|NCT04526509|589401955|FG000|Enrolled|Death prior to lymphodepletion|0|||
163187569|NCT04526509|589401956|FG001|Enrolled|Death prior to lymphodepletion|0|||
163187570|NCT04526509|589401957|FG002|Enrolled|Death prior to lymphodepletion|0|||
163187571|NCT04526509|589401958|FG003|Enrolled|Death prior to lymphodepletion|1|||
163292969|NCT00743444|589778783|FG000|First Intervention|Catheter placement problems|0|||
163292970|NCT00743444|589778784|FG001|First Intervention|Catheter placement problems|1|||
163292971|NCT00743444|589778783|FG000|Washout Period|Adverse Event|0|||
163292972|NCT00743444|589778784|FG001|Washout Period|Adverse Event|1|||
163292973|NCT01337635|589778793|FG000|Overall Study|Lost to Follow-up|0|||
163292974|NCT01337635|589778794|FG001|Overall Study|Lost to Follow-up|1|||
163292975|NCT03287622|589778797|FG000|Overall Study|Withdrawal by Subject|1|||
163292976|NCT03287622|589778798|FG001|Overall Study|Withdrawal by Subject|0|||
163292977|NCT03287622|589778797|FG000|Overall Study|Lost to Follow-up|27|||
163292978|NCT03287622|589778798|FG001|Overall Study|Lost to Follow-up|15|||
163292979|NCT03287622|589778797|FG000|Overall Study|No prescripion after surgery|28|||
163292980|NCT03287622|589778798|FG001|Overall Study|No prescripion after surgery|31|||
163292981|NCT03287622|589778797|FG000|Overall Study|prolonged Length of stay|2|||
163292982|NCT03287622|589778798|FG001|Overall Study|prolonged Length of stay|0|||
163292983|NCT03287622|589778797|FG000|Overall Study|surgery related|0|||
163292984|NCT03287622|589778798|FG001|Overall Study|surgery related|2|||
163292985|NCT03804918|589778807|FG000|Overall Study|Participant did not use the app|1|||
163292986|NCT02314117|589778808|FG000|Overall Study|Lost to Follow-up|9|||
163292987|NCT02314117|589778809|FG001|Overall Study|Lost to Follow-up|14|||
163292988|NCT02314117|589778808|FG000|Overall Study|Withdrawal by Subject|3|||
163292989|NCT02314117|589778809|FG001|Overall Study|Withdrawal by Subject|2|||
163292990|NCT05641311|589778810|FG000|Dosing Period 1|Adverse Event|1|||
163292991|NCT05641311|589778811|FG001|Dosing Period 1|Adverse Event|0|||
163292992|NCT00909363|589778812|FG000|Overall Study|Withdrawal by Subject|1|||
163292993|NCT00909363|589778813|FG001|Overall Study|Withdrawal by Subject|0|||
163292994|NCT00909363|589778814|FG002|Overall Study|Withdrawal by Subject|0|||
163292995|NCT00909363|589778812|FG000|Overall Study|Lack of Efficacy|1|||
163292996|NCT00909363|589778813|FG001|Overall Study|Lack of Efficacy|0|||
163292997|NCT00909363|589778814|FG002|Overall Study|Lack of Efficacy|0|||
163292998|NCT00922207|589778821|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
163292999|NCT00922207|589778822|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
163293000|NCT00922207|589778823|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
163293001|NCT00922207|589778821|FG000|Overall Study|Insufficient Therapeutic Response|0|||
163293002|NCT00922207|589778822|FG001|Overall Study|Insufficient Therapeutic Response|0|||
163293003|NCT00922207|589778823|FG002|Overall Study|Insufficient Therapeutic Response|1|||
163293004|NCT00922207|589778821|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
163293005|NCT00922207|589778822|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
163293006|NCT00922207|589778823|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
163293007|NCT00922207|589778821|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
163293008|NCT00922207|589778822|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
163293009|NCT00922207|589778823|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
163293010|NCT00922207|589778821|FG000|Overall Study|Withdrew Consent|2|||
163293011|NCT00922207|589778822|FG001|Overall Study|Withdrew Consent|5|||
163293012|NCT00922207|589778823|FG002|Overall Study|Withdrew Consent|2|||
163187572|NCT04526509|589401959|FG004|Enrolled|Death prior to lymphodepletion|0|||
163187573|NCT04526509|589401960|FG005|Enrolled|Death prior to lymphodepletion|0|||
163187574|NCT04526509|589401961|FG006|Enrolled|Death prior to lymphodepletion|0|||
163293013|NCT00922207|589778821|FG000|Overall Study|Abnormality of Laboratory Test|0|||
163293014|NCT00922207|589778822|FG001|Overall Study|Abnormality of Laboratory Test|1|||
163293015|NCT00922207|589778823|FG002|Overall Study|Abnormality of Laboratory Test|1|||
163293016|NCT00367991|589778828|FG000|Overall Study|Withdrawal by Subject|1|||
163293017|NCT00367991|589778829|FG001|Overall Study|Withdrawal by Subject|1|||
163293018|NCT00367991|589778828|FG000|Overall Study|Adverse Event|1|||
163293019|NCT00367991|589778829|FG001|Overall Study|Adverse Event|1|||
163293020|NCT03515304|589778832|FG000|Overall Study|Lost to Follow-up|0|||
163293021|NCT03515304|589778833|FG001|Overall Study|Lost to Follow-up|3|||
163293022|NCT02705586|589778843|FG000|Overall Study|Health Issues|2|||
163293023|NCT02705586|589778843|FG000|Overall Study|Transportation Difficulties|5|||
163293024|NCT02705586|589778843|FG000|Overall Study|Vacation/Planned Absence|1|||
163293025|NCT02808338|589778844|FG000|Screening|Screen Failure|10|||
163293026|NCT02808338|589778844|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
163293027|NCT02808338|589778844|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
163293028|NCT02045836|589778845|FG000|Overall Study|Adverse Event|4|||
163293029|NCT02045836|589778846|FG001|Overall Study|Adverse Event|4|||
163293030|NCT02045836|589778845|FG000|Overall Study|Withdrawal by Subject|1|||
163293031|NCT02045836|589778846|FG001|Overall Study|Withdrawal by Subject|1|||
163293032|NCT02045836|589778845|FG000|Overall Study|Lost to Follow-up|4|||
163187575|NCT04526509|589401955|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
163293033|NCT02045836|589778846|FG001|Overall Study|Lost to Follow-up|7|||
163293034|NCT02045836|589778845|FG000|Overall Study|Migrated from study area|0|||
163293035|NCT02045836|589778846|FG001|Overall Study|Migrated from study area|2|||
163293036|NCT00057837|589778847|FG000|Overall Study|Progression/relapse|12|||
163293037|NCT00057837|589778848|FG001|Overall Study|Progression/relapse|14|||
163293038|NCT00057837|589778847|FG000|Overall Study|Adverse Event|2|||
163293039|NCT00057837|589778848|FG001|Overall Study|Adverse Event|12|||
163293040|NCT00057837|589778847|FG000|Overall Study|Death|5|||
163293041|NCT00057837|589778848|FG001|Overall Study|Death|4|||
163293042|NCT00057837|589778847|FG000|Overall Study|Withdrawal by Subject|5|||
163293043|NCT00057837|589778848|FG001|Overall Study|Withdrawal by Subject|3|||
163293044|NCT00057837|589778847|FG000|Overall Study|Alternative therapy|0|||
163293045|NCT00057837|589778848|FG001|Overall Study|Alternative therapy|1|||
163293046|NCT00057837|589778847|FG000|Overall Study|Other complicating disease|2|||
163293047|NCT00057837|589778848|FG001|Overall Study|Other complicating disease|1|||
163293048|NCT00057837|589778847|FG000|Overall Study|Physician Decision|1|||
163293049|NCT00057837|589778848|FG001|Overall Study|Physician Decision|0|||
163293050|NCT00057837|589778847|FG000|Overall Study|Ineligible|3|||
163293051|NCT00057837|589778848|FG001|Overall Study|Ineligible|3|||
163293052|NCT00057837|589778847|FG000|Overall Study|Never started treatment|1|||
163293053|NCT00057837|589778848|FG001|Overall Study|Never started treatment|1|||
163293054|NCT02000817|589778849|FG000|Overall Study|Withdrawal by Subject|2|||
163293055|NCT02000817|589778850|FG001|Overall Study|Withdrawal by Subject|0|||
163293056|NCT02000817|589778851|FG002|Overall Study|Withdrawal by Subject|0|||
163187576|NCT04526509|589401956|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
163187577|NCT04526509|589401957|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
163187578|NCT04526509|589401958|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
163187579|NCT04526509|589401959|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
163187580|NCT04526509|589401960|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
163187581|NCT04526509|589401961|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
162948804|NCT01062256|588515278|FG001|Overall Study|Withdrawal by Subject|1|||
162948805|NCT01062256|588515279|FG002|Overall Study|Withdrawal by Subject|1|||
162948806|NCT01062256|588515277|FG000|Overall Study|Ineligible|1|||
162948807|NCT01062256|588515278|FG001|Overall Study|Ineligible|4|||
162948808|NCT01062256|588515279|FG002|Overall Study|Ineligible|3|||
162948809|NCT01062256|588515277|FG000|Overall Study|Administrative|0|||
162948810|NCT01062256|588515278|FG001|Overall Study|Administrative|2|||
162948811|NCT01062256|588515279|FG002|Overall Study|Administrative|0|||
162948812|NCT03883906|588515282|FG000|Overall Study|Withdrawal by Subject|2|||
162948813|NCT03883906|588515282|FG000|Overall Study|Physician Decision|5|||
162948814|NCT03561883|588515295|FG000|Overall Study|Adverse Event|10|||
162948815|NCT03561883|588515296|FG001|Overall Study|Adverse Event|13|||
162948816|NCT03561883|588515295|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162948817|NCT03561883|588515296|FG001|Overall Study|Non-Compliance With Study Drug|2|||
162948818|NCT03561883|588515295|FG000|Overall Study|Protocol Violation|2|||
162948819|NCT03561883|588515296|FG001|Overall Study|Protocol Violation|3|||
162948820|NCT03561883|588515295|FG000|Overall Study|Withdrawal by Subject|14|||
162948821|NCT03561883|588515296|FG001|Overall Study|Withdrawal by Subject|6|||
162948822|NCT03561883|588515295|FG000|Overall Study|Lost to Follow-up|2|||
162948823|NCT03561883|588515296|FG001|Overall Study|Lost to Follow-up|6|||
162948824|NCT03561883|588515295|FG000|Overall Study|Study Terminated by Sponsor|12|||
163187582|NCT04526509|589401955|FG000|Enrolled|Physician Decision|0|||
163187583|NCT04526509|589401956|FG001|Enrolled|Physician Decision|1|||
163187584|NCT04526509|589401957|FG002|Enrolled|Physician Decision|0|||
163187585|NCT04526509|589401958|FG003|Enrolled|Physician Decision|0|||
163187586|NCT04526509|589401959|FG004|Enrolled|Physician Decision|0|||
163187587|NCT04526509|589401960|FG005|Enrolled|Physician Decision|0|||
163187588|NCT04526509|589401961|FG006|Enrolled|Physician Decision|0|||
163187589|NCT02452697|589401962|FG000|Overall Study|Physician Decision|4|||
163187590|NCT02452697|589401963|FG001|Overall Study|Physician Decision|4|||
163187591|NCT02452697|589401964|FG002|Overall Study|Physician Decision|3|||
163187592|NCT02452697|589401965|FG003|Overall Study|Physician Decision|2|||
163187593|NCT02452697|589401962|FG000|Overall Study|Withdrawal by Subject|1|||
163187594|NCT02452697|589401963|FG001|Overall Study|Withdrawal by Subject|0|||
163187595|NCT02452697|589401964|FG002|Overall Study|Withdrawal by Subject|0|||
163187596|NCT02452697|589401965|FG003|Overall Study|Withdrawal by Subject|0|||
163187597|NCT02452697|589401962|FG000|Overall Study|still in follow-up|2|||
163187598|NCT02452697|589401963|FG001|Overall Study|still in follow-up|2|||
163187599|NCT02452697|589401964|FG002|Overall Study|still in follow-up|1|||
163187600|NCT02452697|589401965|FG003|Overall Study|still in follow-up|3|||
163187601|NCT01554397|589401968|FG000|Overall Study|Withdrawal by Subject|1|||
163187602|NCT01554397|589401969|FG001|Overall Study|Withdrawal by Subject|0|||
163187603|NCT01554397|589401968|FG000|Overall Study|Ineligible|7|||
163187604|NCT01554397|589401969|FG001|Overall Study|Ineligible|0|||
163187605|NCT04493333|589403786|FG000|Overall Study|Withdrawal by Subject|1|||
163187606|NCT04493333|589403787|FG001|Overall Study|Withdrawal by Subject|1|||
163187607|NCT04493333|589403786|FG000|Overall Study|Ineligible|0|||
163187608|NCT04493333|589403787|FG001|Overall Study|Ineligible|1|||
163187609|NCT04493333|589403786|FG000|Overall Study|Noncompliance|2|||
162948825|NCT03561883|588515296|FG001|Overall Study|Study Terminated by Sponsor|11|||
162948826|NCT03561883|588515295|FG000|Overall Study|Physician Decision|1|||
162948827|NCT03561883|588515296|FG001|Overall Study|Physician Decision|0|||
162948828|NCT03561883|588515295|FG000|Overall Study|Randomized by Mistake|1|||
162948829|NCT03561883|588515296|FG001|Overall Study|Randomized by Mistake|0|||
163187610|NCT04493333|589403787|FG001|Overall Study|Noncompliance|1|||
163187611|NCT02206048|589403793|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
163187612|NCT02925923|589403794|FG000|Overall Study|blood samples hemolyzed|0|||
163187613|NCT02925923|589403795|FG001|Overall Study|blood samples hemolyzed|2|||
162948830|NCT03561883|588515295|FG000|Overall Study|Other, Not Specified|3|||
162948831|NCT03561883|588515296|FG001|Overall Study|Other, Not Specified|2|||
162948832|NCT02365207|588515301|FG000|Overall Study|Withdrawal by Subject|1|||
162948833|NCT02365207|588515301|FG000|Overall Study|Physician Decision|1|||
162948834|NCT01318499|588515304|FG000|Overall Study|Adverse Event|16|||
162948835|NCT01318499|588515305|FG001|Overall Study|Adverse Event|11|||
162948836|NCT01318499|588515306|FG002|Overall Study|Adverse Event|6|||
162948837|NCT01318499|588515304|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
162948838|NCT01318499|588515305|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
162948839|NCT01318499|588515306|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
162948840|NCT01318499|588515304|FG000|Overall Study|Noncompliance|2|||
162948841|NCT01318499|588515305|FG001|Overall Study|Noncompliance|3|||
162948842|NCT01318499|588515306|FG002|Overall Study|Noncompliance|0|||
162948843|NCT01318499|588515304|FG000|Overall Study|Treatment Failure|19|||
162948844|NCT01318499|588515305|FG001|Overall Study|Treatment Failure|19|||
162948845|NCT01318499|588515306|FG002|Overall Study|Treatment Failure|101|||
162948846|NCT01318499|588515304|FG000|Overall Study|Protocol Violation|2|||
162948847|NCT01318499|588515305|FG001|Overall Study|Protocol Violation|4|||
163293057|NCT02000817|589778852|FG003|Overall Study|Withdrawal by Subject|0|||
163293058|NCT02000817|589778849|FG000|Overall Study|Adverse Event|0|||
162948848|NCT01318499|588515306|FG002|Overall Study|Protocol Violation|2|||
162948849|NCT01318499|588515304|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
163388867|NCT00195507|590135936|FG000|Overall Study|Protocol Deviation|6|||
163388868|NCT00195507|590135937|FG001|Overall Study|Protocol Deviation|3|||
163293059|NCT02000817|589778850|FG001|Overall Study|Adverse Event|1|||
163293060|NCT02000817|589778851|FG002|Overall Study|Adverse Event|0|||
163293061|NCT02000817|589778852|FG003|Overall Study|Adverse Event|0|||
163293062|NCT02000817|589778849|FG000|Overall Study|Lost to Follow-up|0|||
163293063|NCT02000817|589778850|FG001|Overall Study|Lost to Follow-up|0|||
163293064|NCT02000817|589778851|FG002|Overall Study|Lost to Follow-up|1|||
163293065|NCT02000817|589778852|FG003|Overall Study|Lost to Follow-up|0|||
163293066|NCT03383146|589778853|FG000|Overall Study|Screen Failure|1|||
163293067|NCT03383146|589778854|FG001|Overall Study|Screen Failure|0|||
163293068|NCT03383146|589778853|FG000|Overall Study|Adverse Event|6|||
163293069|NCT03383146|589778854|FG001|Overall Study|Adverse Event|18|||
163293070|NCT03383146|589778853|FG000|Overall Study|Lack of Efficacy|0|||
163293071|NCT03383146|589778854|FG001|Overall Study|Lack of Efficacy|3|||
163293072|NCT03383146|589778853|FG000|Overall Study|Withdrawal by Subject|20|||
163293073|NCT03383146|589778854|FG001|Overall Study|Withdrawal by Subject|36|||
163293074|NCT03383146|589778853|FG000|Overall Study|Lost to Follow-up|5|||
163293075|NCT03383146|589778854|FG001|Overall Study|Lost to Follow-up|15|||
163293076|NCT03383146|589778853|FG000|Overall Study|Death|0|||
163293077|NCT03383146|589778854|FG001|Overall Study|Death|2|||
163293078|NCT03383146|589778853|FG000|Overall Study|Physician Decision|0|||
163293079|NCT03383146|589778854|FG001|Overall Study|Physician Decision|1|||
163293080|NCT03383146|589778853|FG000|Overall Study|Protocol Deviation|1|||
163293081|NCT03383146|589778854|FG001|Overall Study|Protocol Deviation|8|||
163293082|NCT03383146|589778853|FG000|Overall Study|Study Terminated by the Sponsor|48|||
163293083|NCT03383146|589778854|FG001|Overall Study|Study Terminated by the Sponsor|95|||
163293084|NCT03383146|589778853|FG000|Overall Study|Reason not Specified|4|||
163293085|NCT03383146|589778854|FG001|Overall Study|Reason not Specified|6|||
163293086|NCT01317420|589778855|FG000|Overall Study|Progressive disease according to RECIST|2|||
163293087|NCT01317420|589778856|FG001|Overall Study|Progressive disease according to RECIST|3|||
163293088|NCT01317420|589778857|FG002|Overall Study|Progressive disease according to RECIST|3|||
163293089|NCT01317420|589778858|FG003|Overall Study|Progressive disease according to RECIST|3|||
163293090|NCT01317420|589778859|FG004|Overall Study|Progressive disease according to RECIST|3|||
163187614|NCT00282412|589403796|FG000|Overall Study|Death|2|||
163187615|NCT00697073|589403797|FG000|Overall Study|Withdrawal by Subject|2|||
163187616|NCT00697073|589403797|FG000|Overall Study|Pregnancy|1|||
163187617|NCT00697073|589403797|FG000|Overall Study|non compliance and other|6|||
163187618|NCT03911713|589403798|FG000|Overall Study|Lost to Follow-up|0|||
163187619|NCT03911713|589403799|FG001|Overall Study|Lost to Follow-up|2|||
163187620|NCT03911713|589403800|FG002|Overall Study|Lost to Follow-up|0|||
163187621|NCT03911713|589403801|FG003|Overall Study|Lost to Follow-up|0|||
163187622|NCT03911713|589403802|FG004|Overall Study|Lost to Follow-up|0|||
163187623|NCT03911713|589403798|FG000|Overall Study|Other|0|||
163187624|NCT03911713|589403799|FG001|Overall Study|Other|0|||
163187625|NCT03911713|589403800|FG002|Overall Study|Other|0|||
163187626|NCT03911713|589403801|FG003|Overall Study|Other|1|||
163187627|NCT03911713|589403802|FG004|Overall Study|Other|0|||
163187628|NCT03911713|589403798|FG000|Overall Study|Randomized, Never Dosed|1|||
163187629|NCT03911713|589403799|FG001|Overall Study|Randomized, Never Dosed|0|||
163187630|NCT03911713|589403800|FG002|Overall Study|Randomized, Never Dosed|0|||
163187631|NCT03911713|589403801|FG003|Overall Study|Randomized, Never Dosed|1|||
163187632|NCT03911713|589403802|FG004|Overall Study|Randomized, Never Dosed|0|||
163187633|NCT02203071|589403805|FG000|Overall Study|Lost to Follow-up|3|||
163187634|NCT02203071|589403806|FG001|Overall Study|Lost to Follow-up|1|||
163187635|NCT01845818|589403807|FG000|Overall Study|Withdrawal by Subject|0|||
163187636|NCT01845818|589403808|FG001|Overall Study|Withdrawal by Subject|1|||
163187637|NCT01845818|589403807|FG000|Overall Study|Lost to Follow-up|7|||
163187638|NCT01845818|589403808|FG001|Overall Study|Lost to Follow-up|5|||
163187639|NCT01845818|589403807|FG000|Overall Study|Administrative Reasons|3|||
163187640|NCT01845818|589403808|FG001|Overall Study|Administrative Reasons|1|||
163187641|NCT01845818|589403807|FG000|Overall Study|Serious Adverse Event|1|||
163187642|NCT01845818|589403808|FG001|Overall Study|Serious Adverse Event|1|||
163187643|NCT01845818|589403807|FG000|Overall Study|Other|25|||
163187644|NCT01845818|589403808|FG001|Overall Study|Other|8|||
163187645|NCT01845818|589403807|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
163187646|NCT01845818|589403808|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
163187647|NCT01845818|589403807|FG000|Overall Study|No Follow-Up Data Available|4|||
163187648|NCT01845818|589403808|FG001|Overall Study|No Follow-Up Data Available|1|||
163187649|NCT02595970|589403809|FG000|Overall Study|Withdrawal by Subject|2|||
163187650|NCT02595970|589403809|FG000|Overall Study|Physician Decision|2|||
163187651|NCT02595970|589403809|FG000|Overall Study|Protocol Violation|4|||
163187652|NCT02595970|589403809|FG000|Overall Study|Adverse Event|5|||
163187653|NCT02595970|589403809|FG000|Overall Study|Lack of Efficacy|7|||
163187654|NCT02572388|589403810|FG000|Overall Study|Withdrawal by Subject|1|||
163187655|NCT02572388|589403811|FG001|Overall Study|Withdrawal by Subject|1|||
163187656|NCT02572388|589403812|FG002|Overall Study|Withdrawal by Subject|2|||
163187657|NCT02572388|589403813|FG003|Overall Study|Withdrawal by Subject|2|||
163293091|NCT01317420|589778860|FG005|Overall Study|Progressive disease according to RECIST|3|||
163293092|NCT01317420|589778861|FG006|Overall Study|Progressive disease according to RECIST|3|||
163293093|NCT01317420|589778862|FG007|Overall Study|Progressive disease according to RECIST|3|||
163293094|NCT01317420|589778863|FG008|Overall Study|Progressive disease according to RECIST|3|||
163293095|NCT01317420|589778864|FG009|Overall Study|Progressive disease according to RECIST|2|||
163293096|NCT01317420|589778865|FG010|Overall Study|Progressive disease according to RECIST|3|||
162948850|NCT01318499|588515305|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
162948851|NCT01318499|588515306|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
163293097|NCT01317420|589778866|FG011|Overall Study|Progressive disease according to RECIST|11|||
163388869|NCT00769860|590135943|FG000|Overall Study|Withdrawal by Subject|2|||
163388870|NCT00769860|590135944|FG001|Overall Study|Withdrawal by Subject|0|||
163388871|NCT01106404|590135946|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
163388872|NCT01106404|590135947|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
163388873|NCT01106404|590135946|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
163388874|NCT01106404|590135947|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
163388875|NCT01106404|590135946|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
163388876|NCT01106404|590135947|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
163388877|NCT01106404|590135946|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
163388878|NCT01106404|590135947|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
163388879|NCT01774084|590135948|FG000|Overall Study|Personal reasons|1|||
163388880|NCT01774084|590135949|FG001|Overall Study|Personal reasons|0|||
163388881|NCT03026127|590135953|FG000|CRISP R61|Adverse Event|5|||
163388882|NCT03026127|590135954|FG001|CRISP R61|Adverse Event|0|||
163388883|NCT03026127|590135955|FG002|CRISP R61|Adverse Event|0|||
163388884|NCT03026127|590135953|FG000|CRISP R61|Lost to Follow-up|2|||
163388885|NCT03026127|590135954|FG001|CRISP R61|Lost to Follow-up|0|||
163388886|NCT03026127|590135955|FG002|CRISP R61|Lost to Follow-up|0|||
163388887|NCT03026127|590135953|FG000|CRISP R61|Dropped before therapy|5|||
163388888|NCT03026127|590135954|FG001|CRISP R61|Dropped before therapy|0|||
163388889|NCT03026127|590135955|FG002|CRISP R61|Dropped before therapy|0|||
163388890|NCT03026127|590135953|FG000|CRISP R33|Lost to Follow-up|0|||
163388891|NCT03026127|590135954|FG001|CRISP R33|Lost to Follow-up|5|||
163388892|NCT03026127|590135955|FG002|CRISP R33|Lost to Follow-up|4|||
163388893|NCT03026127|590135953|FG000|CRISP R33|Adverse Event|0|||
163388894|NCT03026127|590135954|FG001|CRISP R33|Adverse Event|9|||
163388895|NCT03026127|590135955|FG002|CRISP R33|Adverse Event|5|||
163388896|NCT03026127|590135953|FG000|CRISP R33|Withdrawal by Subject|0|||
163388897|NCT03026127|590135954|FG001|CRISP R33|Withdrawal by Subject|9|||
163388898|NCT03026127|590135955|FG002|CRISP R33|Withdrawal by Subject|1|||
163388899|NCT03026127|590135953|FG000|CRISP R33|Lack of Efficacy|0|||
163388900|NCT03026127|590135954|FG001|CRISP R33|Lack of Efficacy|3|||
163388901|NCT03026127|590135955|FG002|CRISP R33|Lack of Efficacy|2|||
163388902|NCT03026127|590135953|FG000|CRISP R33|Physician Decision|0|||
163388903|NCT03026127|590135954|FG001|CRISP R33|Physician Decision|3|||
163388904|NCT03026127|590135955|FG002|CRISP R33|Physician Decision|1|||
163388905|NCT03026127|590135953|FG000|CRISP R33|Transportation|0|||
163388906|NCT03026127|590135954|FG001|CRISP R33|Transportation|2|||
163388907|NCT03026127|590135955|FG002|CRISP R33|Transportation|1|||
163388908|NCT01182766|590135956|FG000|Overall Study|Lost to Follow-up|32|||
163388909|NCT01182766|590135957|FG001|Overall Study|Lost to Follow-up|36|||
163388910|NCT01182766|590135958|FG002|Overall Study|Lost to Follow-up|29|||
163388911|NCT01182766|590135956|FG000|Overall Study|Withdrawal by Subject|14|||
163388912|NCT01182766|590135957|FG001|Overall Study|Withdrawal by Subject|3|||
163388913|NCT01182766|590135958|FG002|Overall Study|Withdrawal by Subject|6|||
163388914|NCT01182766|590135956|FG000|Overall Study|Physician Decision|1|||
163388915|NCT01182766|590135957|FG001|Overall Study|Physician Decision|0|||
163388916|NCT01182766|590135958|FG002|Overall Study|Physician Decision|0|||
163388917|NCT01182766|590135956|FG000|Overall Study|Non-compliance|1|||
163388918|NCT01182766|590135957|FG001|Overall Study|Non-compliance|1|||
163388919|NCT01182766|590135958|FG002|Overall Study|Non-compliance|1|||
163388920|NCT03027557|590135959|FG000|Overall Study|Adverse Event|1|||
163388921|NCT03027557|590135960|FG001|Overall Study|Adverse Event|0|||
163388922|NCT03027557|590135961|FG002|Overall Study|Adverse Event|0|||
163388923|NCT02430051|590135964|FG000|Overall Study|Withdrawal by Subject|6|||
163388924|NCT02430051|590135965|FG001|Overall Study|Withdrawal by Subject|3|||
163388925|NCT02430051|590135964|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
162948852|NCT01318499|588515304|FG000|Overall Study|Other|7|||
163388926|NCT02430051|590135965|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
163388927|NCT02430051|590135964|FG000|Overall Study|Protocol Violation|1|||
163388928|NCT02430051|590135965|FG001|Overall Study|Protocol Violation|0|||
163388929|NCT02030405|590135969|FG000|Overall Study|Withdrawal by Subject|1|||
163388930|NCT02030405|590135969|FG000|Overall Study|Lost to Follow-up|1|||
163388931|NCT00564018|590135970|FG000|Overall Study|Withdrawal by Subject|2|||
163388932|NCT00564018|590135971|FG001|Overall Study|Withdrawal by Subject|3|||
163388933|NCT00564018|590135972|FG002|Overall Study|Withdrawal by Subject|1|||
163388934|NCT01145755|590135980|FG000|Overall Study|Adverse Event|2|||
163388935|NCT01145755|590135981|FG001|Overall Study|Adverse Event|4|||
162948853|NCT01318499|588515305|FG001|Overall Study|Other|10|||
162948854|NCT01318499|588515306|FG002|Overall Study|Other|22|||
162948855|NCT01395030|588515307|FG000|Overall Study|Did not complete FCH PET/CT|7|||
162948856|NCT01759290|588515308|FG000|Overall Study|Subjects withdrawn consent|5|||
162948857|NCT01759290|588515308|FG000|Overall Study|Physician Decision|2|||
162948858|NCT01759290|588515308|FG000|Overall Study|Death|17|||
162948859|NCT01759290|588515308|FG000|Overall Study|Lost to Follow-up|53|||
162948860|NCT01759290|588515308|FG000|Overall Study|Unknown reason|4|||
162948861|NCT01766778|588515312|FG000|Overall Study|Adverse Event|4|||
162948862|NCT01766778|588515313|FG001|Overall Study|Adverse Event|4|||
163388936|NCT01145755|590135982|FG002|Overall Study|Adverse Event|2|||
163388937|NCT01145755|590135980|FG000|Overall Study|Withdrawal by Subject|2|||
163388938|NCT01145755|590135981|FG001|Overall Study|Withdrawal by Subject|2|||
163388939|NCT01145755|590135982|FG002|Overall Study|Withdrawal by Subject|2|||
163388940|NCT01145755|590135980|FG000|Overall Study|Lost to Follow-up|2|||
163388941|NCT01145755|590135981|FG001|Overall Study|Lost to Follow-up|3|||
163388942|NCT01145755|590135982|FG002|Overall Study|Lost to Follow-up|1|||
163388943|NCT01145755|590135980|FG000|Overall Study|Protocol Violation|0|||
163388944|NCT01145755|590135981|FG001|Overall Study|Protocol Violation|3|||
163388945|NCT01145755|590135982|FG002|Overall Study|Protocol Violation|1|||
163388946|NCT01145755|590135980|FG000|Overall Study|Study Closure|14|||
163388947|NCT01145755|590135981|FG001|Overall Study|Study Closure|14|||
163388948|NCT01145755|590135982|FG002|Overall Study|Study Closure|17|||
163388949|NCT01145755|590135980|FG000|Overall Study|Lack of Efficacy|0|||
163388950|NCT01145755|590135981|FG001|Overall Study|Lack of Efficacy|1|||
163388951|NCT01145755|590135982|FG002|Overall Study|Lack of Efficacy|0|||
163388952|NCT01145755|590135980|FG000|Overall Study|Patient could not swollow medication|0|||
163388953|NCT01145755|590135981|FG001|Overall Study|Patient could not swollow medication|0|||
163388954|NCT01145755|590135982|FG002|Overall Study|Patient could not swollow medication|1|||
163388955|NCT01145755|590135980|FG000|Overall Study|Withdrawal by Subject|0|||
163388956|NCT01145755|590135981|FG001|Overall Study|Withdrawal by Subject|0|||
163388957|NCT01145755|590135982|FG002|Overall Study|Withdrawal by Subject|1|||
163388958|NCT01145755|590135980|FG000|Overall Study|Positive urine ethanol|0|||
163388959|NCT01145755|590135981|FG001|Overall Study|Positive urine ethanol|1|||
163388960|NCT01145755|590135982|FG002|Overall Study|Positive urine ethanol|0|||
163388961|NCT01009554|590135985|FG000|Overall Study|Adverse Event|1|||
163388962|NCT01009554|590135986|FG001|Overall Study|Adverse Event|1|||
163388963|NCT01009554|590135985|FG000|Overall Study|Withdrawal by Subject|1|||
163388964|NCT01009554|590135986|FG001|Overall Study|Withdrawal by Subject|3|||
163388965|NCT01009554|590135985|FG000|Overall Study|Noncompliant with Study Product|0|||
163388966|NCT01009554|590135986|FG001|Overall Study|Noncompliant with Study Product|3|||
163388967|NCT01605253|590135987|FG000|Overall Study|Physician Decision|3|||
163388968|NCT01605253|590135988|FG001|Overall Study|Physician Decision|2|||
163388969|NCT01605253|590135987|FG000|Overall Study|Lost to Follow-up|3|||
163388970|NCT01605253|590135988|FG001|Overall Study|Lost to Follow-up|1|||
163388971|NCT02973048|590135989|FG000|Overall Study|Epidural catheter insertion failure|1|||
163388972|NCT02973048|590135990|FG001|Overall Study|Epidural catheter insertion failure|0|||
163388973|NCT02973048|590135989|FG000|Overall Study|Withdrawal by Subject|0|||
163388974|NCT02973048|590135990|FG001|Overall Study|Withdrawal by Subject|3|||
163388975|NCT04427501|590135991|FG000|Overall Study|Death|0|||
163388976|NCT04427501|590135992|FG001|Overall Study|Death|0|||
163388977|NCT04427501|590135993|FG002|Overall Study|Death|0|||
162948863|NCT01766778|588515312|FG000|Overall Study|Withdrawal by Subject|1|||
162948864|NCT01766778|588515313|FG001|Overall Study|Withdrawal by Subject|0|||
162948865|NCT01054599|588515314|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
162948866|NCT01054599|588515315|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
163388978|NCT04427501|590135994|FG003|Overall Study|Death|0|||
162948867|NCT01054599|588515314|FG000|Overall Study|Protocol Violation|1|||
162948868|NCT01054599|588515315|FG001|Overall Study|Protocol Violation|0|||
162948869|NCT01054599|588515314|FG000|Overall Study|Spells/seizure-like episodes|1|||
163388979|NCT04427501|590135995|FG004|Overall Study|Death|0|||
163388980|NCT04427501|590135996|FG005|Overall Study|Death|15|||
163388981|NCT04427501|590135997|FG006|Overall Study|Death|0|||
163388982|NCT04427501|590135998|FG007|Overall Study|Death|0|||
163388983|NCT04427501|590135999|FG008|Overall Study|Death|0|||
163388984|NCT04427501|590136000|FG009|Overall Study|Death|0|||
163388985|NCT04427501|590136001|FG010|Overall Study|Death|0|||
163388986|NCT04427501|590136002|FG011|Overall Study|Death|0|||
163388987|NCT04427501|590135991|FG000|Overall Study|Lost to Follow-up|5|||
163388988|NCT04427501|590135992|FG001|Overall Study|Lost to Follow-up|1|||
163388989|NCT04427501|590135993|FG002|Overall Study|Lost to Follow-up|2|||
163388990|NCT04427501|590135994|FG003|Overall Study|Lost to Follow-up|0|||
162948870|NCT01054599|588515315|FG001|Overall Study|Spells/seizure-like episodes|1|||
162948871|NCT01054599|588515314|FG000|Overall Study|Timing/scheduling difficulties|1|||
163388991|NCT04427501|590135995|FG004|Overall Study|Lost to Follow-up|2|||
163388992|NCT04427501|590135996|FG005|Overall Study|Lost to Follow-up|11|||
163388993|NCT04427501|590135997|FG006|Overall Study|Lost to Follow-up|10|||
163388994|NCT04427501|590135998|FG007|Overall Study|Lost to Follow-up|10|||
163388995|NCT04427501|590135999|FG008|Overall Study|Lost to Follow-up|2|||
163293098|NCT01317420|589778867|FG012|Overall Study|Progressive disease according to RECIST|16|||
163293099|NCT01317420|589778855|FG000|Overall Study|Other adverse event|1|||
163293100|NCT01317420|589778856|FG001|Overall Study|Other adverse event|0|||
162948872|NCT01054599|588515315|FG001|Overall Study|Timing/scheduling difficulties|1|||
162948873|NCT01054599|588515314|FG000|Overall Study|Visual impairment, WTAR <80|0|||
162948874|NCT01054599|588515315|FG001|Overall Study|Visual impairment, WTAR <80|1|||
162948875|NCT01054599|588515314|FG000|Overall Study|Lost to Follow-up|0|||
162948876|NCT01054599|588515315|FG001|Overall Study|Lost to Follow-up|2|||
162948877|NCT01054599|588515314|FG000|Overall Study|Adverse Event|0|||
162948878|NCT01054599|588515315|FG001|Overall Study|Adverse Event|1|||
162948879|NCT01054599|588515314|FG000|Overall Study|Withdrawal by Subject|0|||
162948880|NCT01054599|588515315|FG001|Overall Study|Withdrawal by Subject|1|||
162948881|NCT01104662|588515316|FG000|Overall Study|Adverse Event|2|||
162948882|NCT01104662|588515317|FG001|Overall Study|Adverse Event|2|||
162948883|NCT01104662|588515318|FG002|Overall Study|Adverse Event|0|||
162948884|NCT01104662|588515319|FG003|Overall Study|Adverse Event|1|||
162948885|NCT01104662|588515320|FG004|Overall Study|Adverse Event|1|||
162948886|NCT01104662|588515321|FG005|Overall Study|Adverse Event|1|||
162948887|NCT01104662|588515322|FG006|Overall Study|Adverse Event|0|||
162948888|NCT01104662|588515323|FG007|Overall Study|Adverse Event|0|||
162948889|NCT01104662|588515316|FG000|Overall Study|Clinical Failure|1|||
162948890|NCT01104662|588515317|FG001|Overall Study|Clinical Failure|0|||
162948891|NCT01104662|588515318|FG002|Overall Study|Clinical Failure|0|||
162948892|NCT01104662|588515319|FG003|Overall Study|Clinical Failure|0|||
162948893|NCT01104662|588515320|FG004|Overall Study|Clinical Failure|0|||
162948894|NCT01104662|588515321|FG005|Overall Study|Clinical Failure|1|||
162948895|NCT01104662|588515322|FG006|Overall Study|Clinical Failure|0|||
162948896|NCT01104662|588515323|FG007|Overall Study|Clinical Failure|0|||
162948897|NCT01104662|588515316|FG000|Overall Study|Participant left investigator's care|1|||
162948898|NCT01104662|588515317|FG001|Overall Study|Participant left investigator's care|1|||
162948899|NCT01104662|588515318|FG002|Overall Study|Participant left investigator's care|0|||
162948900|NCT01104662|588515319|FG003|Overall Study|Participant left investigator's care|0|||
162948901|NCT01104662|588515320|FG004|Overall Study|Participant left investigator's care|0|||
162948902|NCT01104662|588515321|FG005|Overall Study|Participant left investigator's care|0|||
162948903|NCT01104662|588515322|FG006|Overall Study|Participant left investigator's care|0|||
162948904|NCT01104662|588515323|FG007|Overall Study|Participant left investigator's care|0|||
162948905|NCT01104662|588515316|FG000|Overall Study|Reason not specified|3|||
162948906|NCT01104662|588515317|FG001|Overall Study|Reason not specified|3|||
162948907|NCT01104662|588515318|FG002|Overall Study|Reason not specified|0|||
162948908|NCT01104662|588515319|FG003|Overall Study|Reason not specified|0|||
162948909|NCT01104662|588515320|FG004|Overall Study|Reason not specified|0|||
162948910|NCT01104662|588515321|FG005|Overall Study|Reason not specified|1|||
162948911|NCT01104662|588515322|FG006|Overall Study|Reason not specified|0|||
162948912|NCT01104662|588515323|FG007|Overall Study|Reason not specified|0|||
162948913|NCT01104662|588515316|FG000|Overall Study|Randomized but not treated|3|||
162948914|NCT01104662|588515317|FG001|Overall Study|Randomized but not treated|4|||
162948915|NCT01104662|588515318|FG002|Overall Study|Randomized but not treated|1|||
162948916|NCT01104662|588515319|FG003|Overall Study|Randomized but not treated|0|||
162948917|NCT01104662|588515320|FG004|Overall Study|Randomized but not treated|0|||
162948918|NCT01104662|588515321|FG005|Overall Study|Randomized but not treated|1|||
162948919|NCT01104662|588515322|FG006|Overall Study|Randomized but not treated|0|||
162948920|NCT01104662|588515323|FG007|Overall Study|Randomized but not treated|0|||
162948921|NCT01478620|588515324|FG000|Overall Study|Lost to Follow-up|6|||
162948922|NCT02888171|588515330|FG000|Overall Study|Lost to Follow-up|2|||
162948923|NCT02888171|588515331|FG001|Overall Study|Lost to Follow-up|1|||
162948924|NCT02888171|588515330|FG000|Overall Study|Withdrawal by Subject|3|||
162948925|NCT02888171|588515331|FG001|Overall Study|Withdrawal by Subject|2|||
162948926|NCT02888171|588515330|FG000|Overall Study|Adverse Event|0|||
163187658|NCT02202837|589403816|FG000|Overall Study|Enbrel treatment discontinued|36|||
163187659|NCT02202837|589403817|FG001|Overall Study|Enbrel treatment discontinued|4|||
163187660|NCT02202837|589403816|FG000|Overall Study|Other|10|||
163187661|NCT02202837|589403817|FG001|Overall Study|Other|0|||
163187662|NCT02202837|589403816|FG000|Overall Study|Lost to Follow-up|7|||
163187663|NCT02202837|589403817|FG001|Overall Study|Lost to Follow-up|1|||
163187664|NCT01871142|589403818|FG000|Overall Study|Adverse Event|1|||
163187665|NCT00231842|589403828|FG000|Overall Study|Withdrawal by Subject|3|||
163187666|NCT00231842|589403828|FG000|Overall Study|Did not complete the last 3 cycle|8|||
163187667|NCT02422303|589403829|FG000|Overall Study|Lost to Follow-up|1|||
163187668|NCT02422303|589403830|FG001|Overall Study|Lost to Follow-up|1|||
163187669|NCT00428792|589403832|FG000|Overall Study|Lack of Efficacy|1|||
163187670|NCT00428792|589403833|FG001|Overall Study|Lack of Efficacy|3|||
163187671|NCT00428792|589403832|FG000|Overall Study|Lost to Follow-up|0|||
162948927|NCT02888171|588515331|FG001|Overall Study|Adverse Event|1|||
162948928|NCT02817841|588516901|FG000|Overall Study|Lost to Follow-up|287|||
162948929|NCT02817841|588516901|FG000|Overall Study|Withdrawal by Subject|183|||
162948930|NCT02817841|588516901|FG000|Overall Study|Adverse event not related to bleeding|131|||
163187672|NCT00428792|589403833|FG001|Overall Study|Lost to Follow-up|1|||
163187673|NCT00850343|589403834|FG000|Overall Study|Withdrawal by Subject|11|||
163187674|NCT00850343|589403835|FG001|Overall Study|Withdrawal by Subject|0|||
162948931|NCT02817841|588516901|FG000|Overall Study|Adverse event related to bleeding|51|||
162948932|NCT02817841|588516901|FG000|Overall Study|Pregnancy|32|||
162948933|NCT02817841|588516901|FG000|Overall Study|Pregnancy wish|17|||
163388996|NCT04427501|590136000|FG009|Overall Study|Lost to Follow-up|5|||
162948934|NCT02817841|588516901|FG000|Overall Study|Other reasons|53|||
162948935|NCT02817841|588516901|FG000|Overall Study|Protocol Violation|94|||
162948936|NCT00705536|588516902|FG000|Start Period 1|Withdrawal by Subject|0|||
162948937|NCT00705536|588516903|FG001|Start Period 1|Withdrawal by Subject|0|||
163187675|NCT00850343|589403836|FG002|Overall Study|Withdrawal by Subject|3|||
163187676|NCT00850343|589403837|FG003|Overall Study|Withdrawal by Subject|2|||
163187677|NCT00850343|589403834|FG000|Overall Study|Adverse Event|15|||
163187678|NCT00850343|589403835|FG001|Overall Study|Adverse Event|2|||
163187679|NCT00850343|589403836|FG002|Overall Study|Adverse Event|6|||
163187680|NCT00850343|589403837|FG003|Overall Study|Adverse Event|6|||
163187681|NCT00850343|589403834|FG000|Overall Study|Pregnancy|0|||
163187682|NCT00850343|589403835|FG001|Overall Study|Pregnancy|0|||
163187683|NCT00850343|589403836|FG002|Overall Study|Pregnancy|0|||
163187684|NCT00850343|589403837|FG003|Overall Study|Pregnancy|1|||
163187685|NCT00850343|589403834|FG000|Overall Study|Lack of Efficacy|17|||
162948938|NCT00705536|588516904|FG002|Start Period 1|Withdrawal by Subject|0|||
162948939|NCT00705536|588516905|FG003|Start Period 1|Withdrawal by Subject|1|||
162948940|NCT04188106|588516906|FG000|Overall Study|Lost to Follow-up|5|||
162948941|NCT04188106|588516906|FG000|Overall Study|Non-Compliance|1|||
163388997|NCT04427501|590136001|FG010|Overall Study|Lost to Follow-up|2|||
163388998|NCT04427501|590136002|FG011|Overall Study|Lost to Follow-up|0|||
163388999|NCT04427501|590135991|FG000|Overall Study|Physician Decision|0|||
163389000|NCT04427501|590135992|FG001|Overall Study|Physician Decision|3|||
162948942|NCT02289963|588516907|FG000|Overall Study|Adverse Event|1|||
163187686|NCT00850343|589403835|FG001|Overall Study|Lack of Efficacy|0|||
163187687|NCT00850343|589403836|FG002|Overall Study|Lack of Efficacy|3|||
163187688|NCT00850343|589403837|FG003|Overall Study|Lack of Efficacy|2|||
163389001|NCT04427501|590135993|FG002|Overall Study|Physician Decision|0|||
163389002|NCT04427501|590135994|FG003|Overall Study|Physician Decision|0|||
163389003|NCT04427501|590135995|FG004|Overall Study|Physician Decision|0|||
163389004|NCT04427501|590135996|FG005|Overall Study|Physician Decision|0|||
163389005|NCT04427501|590135997|FG006|Overall Study|Physician Decision|2|||
163389006|NCT04427501|590135998|FG007|Overall Study|Physician Decision|0|||
163389007|NCT04427501|590135999|FG008|Overall Study|Physician Decision|0|||
163389008|NCT04427501|590136000|FG009|Overall Study|Physician Decision|0|||
163389009|NCT04427501|590136001|FG010|Overall Study|Physician Decision|0|||
163389010|NCT04427501|590136002|FG011|Overall Study|Physician Decision|0|||
163389011|NCT04427501|590135991|FG000|Overall Study|Withdrawal by Subject|9|||
163389012|NCT04427501|590135992|FG001|Overall Study|Withdrawal by Subject|2|||
163389013|NCT04427501|590135993|FG002|Overall Study|Withdrawal by Subject|2|||
163389014|NCT04427501|590135994|FG003|Overall Study|Withdrawal by Subject|3|||
163389015|NCT04427501|590135995|FG004|Overall Study|Withdrawal by Subject|7|||
163389016|NCT04427501|590135996|FG005|Overall Study|Withdrawal by Subject|25|||
163389017|NCT04427501|590135997|FG006|Overall Study|Withdrawal by Subject|15|||
163389018|NCT04427501|590135998|FG007|Overall Study|Withdrawal by Subject|7|||
163389019|NCT04427501|590135999|FG008|Overall Study|Withdrawal by Subject|4|||
163389020|NCT04427501|590136000|FG009|Overall Study|Withdrawal by Subject|1|||
163389021|NCT04427501|590136001|FG010|Overall Study|Withdrawal by Subject|4|||
163389022|NCT04427501|590136002|FG011|Overall Study|Withdrawal by Subject|0|||
163389023|NCT04427501|590135991|FG000|Overall Study|Other - as reported by the investigator|1|||
163389024|NCT04427501|590135992|FG001|Overall Study|Other - as reported by the investigator|0|||
163389025|NCT04427501|590135993|FG002|Overall Study|Other - as reported by the investigator|0|||
163389026|NCT04427501|590135994|FG003|Overall Study|Other - as reported by the investigator|0|||
163389027|NCT04427501|590135995|FG004|Overall Study|Other - as reported by the investigator|0|||
163389028|NCT04427501|590135996|FG005|Overall Study|Other - as reported by the investigator|6|||
163389029|NCT04427501|590135997|FG006|Overall Study|Other - as reported by the investigator|6|||
163389030|NCT04427501|590135998|FG007|Overall Study|Other - as reported by the investigator|0|||
163389031|NCT04427501|590135999|FG008|Overall Study|Other - as reported by the investigator|0|||
163389032|NCT04427501|590136000|FG009|Overall Study|Other - as reported by the investigator|0|||
163389033|NCT04427501|590136001|FG010|Overall Study|Other - as reported by the investigator|0|||
163389034|NCT04427501|590136002|FG011|Overall Study|Other - as reported by the investigator|0|||
163389035|NCT04427501|590135991|FG000|Overall Study|Other|0|||
163389036|NCT04427501|590135992|FG001|Overall Study|Other|0|||
163389037|NCT04427501|590135993|FG002|Overall Study|Other|0|||
163389038|NCT04427501|590135994|FG003|Overall Study|Other|0|||
163389039|NCT04427501|590135995|FG004|Overall Study|Other|0|||
163389040|NCT04427501|590135996|FG005|Overall Study|Other|0|||
163187689|NCT00850343|589403834|FG000|Overall Study|Non-compliance with Study Procedures|1|||
163187690|NCT00850343|589403835|FG001|Overall Study|Non-compliance with Study Procedures|0|||
163187691|NCT00850343|589403836|FG002|Overall Study|Non-compliance with Study Procedures|1|||
163187692|NCT00850343|589403837|FG003|Overall Study|Non-compliance with Study Procedures|1|||
163187693|NCT00850343|589403834|FG000|Overall Study|Physician Decision|2|||
163187694|NCT00850343|589403835|FG001|Overall Study|Physician Decision|1|||
163187695|NCT00850343|589403836|FG002|Overall Study|Physician Decision|1|||
163187696|NCT00850343|589403837|FG003|Overall Study|Physician Decision|1|||
163187697|NCT02468232|589403838|FG000|Core Part of Study|Adverse Event|0|||
163187698|NCT02468232|589403839|FG001|Core Part of Study|Adverse Event|1|||
163187699|NCT02468232|589403840|FG002|Core Part of Study|Adverse Event|0|||
163187700|NCT02468232|589403841|FG003|Core Part of Study|Adverse Event|0|||
163187701|NCT02468232|589403838|FG000|Core Part of Study|Death|20|||
163187702|NCT02468232|589403839|FG001|Core Part of Study|Death|17|||
163187703|NCT02468232|589403840|FG002|Core Part of Study|Death|0|||
163187704|NCT02468232|589403841|FG003|Core Part of Study|Death|0|||
163187705|NCT02468232|589403838|FG000|Core Part of Study|Technical Problems|1|||
163187706|NCT02468232|589403839|FG001|Core Part of Study|Technical Problems|1|||
163187707|NCT02468232|589403840|FG002|Core Part of Study|Technical Problems|0|||
163187708|NCT02468232|589403841|FG003|Core Part of Study|Technical Problems|0|||
163187709|NCT02468232|589403838|FG000|OLE Part of Study|Adverse Event|0|||
163187710|NCT02468232|589403839|FG001|OLE Part of Study|Adverse Event|0|||
163187711|NCT02468232|589403840|FG002|OLE Part of Study|Adverse Event|4|||
163187712|NCT02468232|589403841|FG003|OLE Part of Study|Adverse Event|5|||
163187713|NCT02468232|589403838|FG000|OLE Part of Study|Death|0|||
163187714|NCT02468232|589403839|FG001|OLE Part of Study|Death|0|||
163187715|NCT02468232|589403840|FG002|OLE Part of Study|Death|4|||
163187716|NCT02468232|589403841|FG003|OLE Part of Study|Death|2|||
163187717|NCT02468232|589403838|FG000|OLE Part of Study|Physician Decision|0|||
163187718|NCT02468232|589403839|FG001|OLE Part of Study|Physician Decision|0|||
163187719|NCT02468232|589403840|FG002|OLE Part of Study|Physician Decision|4|||
163187720|NCT02468232|589403841|FG003|OLE Part of Study|Physician Decision|0|||
163187721|NCT02468232|589403838|FG000|OLE Part of Study|Subject/Guardian decision|0|||
163187722|NCT02468232|589403839|FG001|OLE Part of Study|Subject/Guardian decision|0|||
163293101|NCT01317420|589778857|FG002|Overall Study|Other adverse event|0|||
163293102|NCT01317420|589778858|FG003|Overall Study|Other adverse event|0|||
163293103|NCT01317420|589778859|FG004|Overall Study|Other adverse event|0|||
163389041|NCT04427501|590135997|FG006|Overall Study|Other|0|||
163389042|NCT04427501|590135998|FG007|Overall Study|Other|0|||
163389043|NCT04427501|590135999|FG008|Overall Study|Other|0|||
163389044|NCT04427501|590136000|FG009|Overall Study|Other|0|||
163389045|NCT04427501|590136001|FG010|Overall Study|Other|0|||
163389046|NCT04427501|590136002|FG011|Overall Study|Other|1|||
163389047|NCT03170154|590136003|FG000|Overall Study|Lost to Follow-up|4|||
163389048|NCT03170154|590136003|FG000|Overall Study|Death|2|||
163389049|NCT03170154|590136003|FG000|Overall Study|Withdrawal by Subject|2|||
163389050|NCT01906346|590136006|FG000|Overall Study|AEs|1|||
163389051|NCT04936841|590136007|FG000|Overall Study|Death|1|||
163389052|NCT02279862|590136008|FG000|Overall Study|Study drug toxicity|3|||
163389053|NCT02279862|590136009|FG001|Overall Study|Study drug toxicity|6|||
163187723|NCT02468232|589403840|FG002|OLE Part of Study|Subject/Guardian decision|2|||
163187724|NCT02468232|589403841|FG003|OLE Part of Study|Subject/Guardian decision|5|||
163187725|NCT01973569|589403842|FG000|Overall Study|Adverse Event|9|||
163293104|NCT01317420|589778860|FG005|Overall Study|Other adverse event|0|||
163293105|NCT01317420|589778861|FG006|Overall Study|Other adverse event|0|||
163293106|NCT01317420|589778862|FG007|Overall Study|Other adverse event|0|||
163293107|NCT01317420|589778863|FG008|Overall Study|Other adverse event|0|||
163293108|NCT01317420|589778864|FG009|Overall Study|Other adverse event|0|||
163293109|NCT01317420|589778865|FG010|Overall Study|Other adverse event|0|||
163293110|NCT01317420|589778866|FG011|Overall Study|Other adverse event|0|||
163293111|NCT01317420|589778867|FG012|Overall Study|Other adverse event|2|||
163293112|NCT01317420|589778855|FG000|Overall Study|Non-compliant with protocol|0|||
163293113|NCT01317420|589778856|FG001|Overall Study|Non-compliant with protocol|0|||
163293114|NCT01317420|589778857|FG002|Overall Study|Non-compliant with protocol|0|||
163389054|NCT02279862|590136008|FG000|Overall Study|No longer meets criteria|0|||
163389055|NCT02279862|590136009|FG001|Overall Study|No longer meets criteria|1|||
163187726|NCT01973569|589403843|FG001|Overall Study|Adverse Event|2|||
163187727|NCT01973569|589403844|FG002|Overall Study|Adverse Event|4|||
163187728|NCT01973569|589403842|FG000|Overall Study|Protocol Violation|2|||
163293115|NCT01317420|589778858|FG003|Overall Study|Non-compliant with protocol|0|||
163293116|NCT01317420|589778859|FG004|Overall Study|Non-compliant with protocol|0|||
163389056|NCT02279862|590136008|FG000|Overall Study|Administrative reason by sponsor|0|||
163389057|NCT02279862|590136009|FG001|Overall Study|Administrative reason by sponsor|1|||
163187729|NCT01973569|589403843|FG001|Overall Study|Protocol Violation|1|||
163293117|NCT01317420|589778860|FG005|Overall Study|Non-compliant with protocol|0|||
163293118|NCT01317420|589778861|FG006|Overall Study|Non-compliant with protocol|0|||
163187730|NCT01973569|589403844|FG002|Overall Study|Protocol Violation|3|||
163187731|NCT01973569|589403842|FG000|Overall Study|Withdrawal by Subject|7|||
163389058|NCT02279862|590136008|FG000|Overall Study|Disease progression|5|||
163187732|NCT01973569|589403843|FG001|Overall Study|Withdrawal by Subject|5|||
163187733|NCT01973569|589403844|FG002|Overall Study|Withdrawal by Subject|2|||
163187734|NCT01973569|589403842|FG000|Overall Study|Invasive dental treatment|3|||
163293119|NCT01317420|589778862|FG007|Overall Study|Non-compliant with protocol|0|||
163293120|NCT01317420|589778863|FG008|Overall Study|Non-compliant with protocol|0|||
162948943|NCT02289963|588516908|FG001|Overall Study|Adverse Event|2|||
163293121|NCT01317420|589778864|FG009|Overall Study|Non-compliant with protocol|0|||
163293122|NCT01317420|589778865|FG010|Overall Study|Non-compliant with protocol|0|||
163293123|NCT01317420|589778866|FG011|Overall Study|Non-compliant with protocol|0|||
163293124|NCT01317420|589778867|FG012|Overall Study|Non-compliant with protocol|1|||
163293125|NCT01317420|589778855|FG000|Overall Study|Refused to cont. taking trial medication|0|||
163187735|NCT01973569|589403843|FG001|Overall Study|Invasive dental treatment|5|||
163187736|NCT01973569|589403844|FG002|Overall Study|Invasive dental treatment|6|||
163187737|NCT01973569|589403842|FG000|Overall Study|Prohibited concomitant d|1|||
163187738|NCT01973569|589403843|FG001|Overall Study|Prohibited concomitant d|5|||
163187739|NCT01973569|589403844|FG002|Overall Study|Prohibited concomitant d|0|||
163187740|NCT01973569|589403842|FG000|Overall Study|Disease progression|0|||
163187741|NCT01973569|589403843|FG001|Overall Study|Disease progression|3|||
163187742|NCT01973569|589403844|FG002|Overall Study|Disease progression|0|||
163187743|NCT01973569|589403842|FG000|Overall Study|Other|1|||
163187744|NCT01973569|589403843|FG001|Overall Study|Other|1|||
163187745|NCT01973569|589403844|FG002|Overall Study|Other|0|||
163187746|NCT01973569|589403842|FG000|Overall Study|Did not receive study drug|6|||
163187747|NCT01973569|589403843|FG001|Overall Study|Did not receive study drug|3|||
163187748|NCT01973569|589403844|FG002|Overall Study|Did not receive study drug|3|||
163187749|NCT00371826|589403845|FG000|Core Phase (12 Months)|Adverse Event|15|||
163187750|NCT00371826|589403846|FG001|Core Phase (12 Months)|Adverse Event|4|||
163187751|NCT00371826|589403847|FG002|Core Phase (12 Months)|Adverse Event|9|||
163187752|NCT00371826|589403845|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
163187753|NCT00371826|589403846|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
163187754|NCT00371826|589403847|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
163187755|NCT00371826|589403845|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
163187756|NCT00371826|589403846|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
163187757|NCT00371826|589403847|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
163187758|NCT00371826|589403845|FG000|Core Phase (12 Months)|Protocol Violation|1|||
163187759|NCT00371826|589403846|FG001|Core Phase (12 Months)|Protocol Violation|0|||
163187760|NCT00371826|589403847|FG002|Core Phase (12 Months)|Protocol Violation|1|||
163187761|NCT00371826|589403845|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
163187762|NCT00371826|589403846|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
163187763|NCT00371826|589403847|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
163187764|NCT00371826|589403845|FG000|Core Phase (12 Months)|Administrative problems|1|||
163187765|NCT00371826|589403846|FG001|Core Phase (12 Months)|Administrative problems|0|||
163389059|NCT02279862|590136009|FG001|Overall Study|Disease progression|2|||
163293126|NCT01317420|589778856|FG001|Overall Study|Refused to cont. taking trial medication|0|||
163293127|NCT01317420|589778857|FG002|Overall Study|Refused to cont. taking trial medication|0|||
163293128|NCT01317420|589778858|FG003|Overall Study|Refused to cont. taking trial medication|0|||
163293129|NCT01317420|589778859|FG004|Overall Study|Refused to cont. taking trial medication|0|||
163293130|NCT01317420|589778860|FG005|Overall Study|Refused to cont. taking trial medication|0|||
163293131|NCT01317420|589778861|FG006|Overall Study|Refused to cont. taking trial medication|0|||
163293132|NCT01317420|589778862|FG007|Overall Study|Refused to cont. taking trial medication|0|||
163293133|NCT01317420|589778863|FG008|Overall Study|Refused to cont. taking trial medication|0|||
163293134|NCT01317420|589778864|FG009|Overall Study|Refused to cont. taking trial medication|0|||
163293135|NCT01317420|589778865|FG010|Overall Study|Refused to cont. taking trial medication|0|||
163293136|NCT01317420|589778866|FG011|Overall Study|Refused to cont. taking trial medication|0|||
163293137|NCT01317420|589778867|FG012|Overall Study|Refused to cont. taking trial medication|1|||
163293138|NCT01317420|589778855|FG000|Overall Study|Reason other than those specified|0|||
163293139|NCT01317420|589778856|FG001|Overall Study|Reason other than those specified|0|||
163293140|NCT01317420|589778857|FG002|Overall Study|Reason other than those specified|0|||
163293141|NCT01317420|589778858|FG003|Overall Study|Reason other than those specified|0|||
163293142|NCT01317420|589778859|FG004|Overall Study|Reason other than those specified|0|||
163293143|NCT01317420|589778860|FG005|Overall Study|Reason other than those specified|0|||
163293144|NCT01317420|589778861|FG006|Overall Study|Reason other than those specified|0|||
163293145|NCT01317420|589778862|FG007|Overall Study|Reason other than those specified|0|||
163293146|NCT01317420|589778863|FG008|Overall Study|Reason other than those specified|0|||
163293147|NCT01317420|589778864|FG009|Overall Study|Reason other than those specified|1|||
163293148|NCT01317420|589778865|FG010|Overall Study|Reason other than those specified|0|||
163293149|NCT01317420|589778866|FG011|Overall Study|Reason other than those specified|0|||
163293150|NCT01317420|589778867|FG012|Overall Study|Reason other than those specified|0|||
163293151|NCT05686421|589778868|FG000|Overall Study|Screen failure|22|||
163293152|NCT05686421|589778869|FG001|Overall Study|Screen failure|0|||
163293153|NCT05686421|589778870|FG002|Overall Study|Screen failure|0|||
163293154|NCT05686421|589778871|FG003|Overall Study|Screen failure|0|||
163293155|NCT04210180|589778872|FG000|Overall Study|Withdrawal by Subject|2|||
163293156|NCT00367055|589778873|FG000|Overall Study|Adverse Event|6|||
163293157|NCT00367055|589778874|FG001|Overall Study|Adverse Event|3|||
163293158|NCT00367055|589778873|FG000|Overall Study|Patient's Willing|3|||
163293159|NCT00367055|589778874|FG001|Overall Study|Patient's Willing|2|||
163293160|NCT00367055|589778873|FG000|Overall Study|Lack of Efficacy|1|||
163293161|NCT00367055|589778874|FG001|Overall Study|Lack of Efficacy|2|||
163293162|NCT00367055|589778873|FG000|Overall Study|Lost to Follow-up|1|||
163293163|NCT00367055|589778874|FG001|Overall Study|Lost to Follow-up|1|||
163293164|NCT00367055|589778873|FG000|Overall Study|Protocol Violation|0|||
163293165|NCT00367055|589778874|FG001|Overall Study|Protocol Violation|1|||
163293166|NCT00367055|589778873|FG000|Overall Study|Stopping Criterion Met|0|||
163293167|NCT00367055|589778874|FG001|Overall Study|Stopping Criterion Met|1|||
163293168|NCT00367055|589778873|FG000|Overall Study|Participant Living too Far from Hospital|0|||
163293169|NCT00367055|589778874|FG001|Overall Study|Participant Living too Far from Hospital|1|||
163293170|NCT00539292|589778887|FG000|Overall Study|Physician Decision|1|||
163293171|NCT00539292|589778888|FG001|Overall Study|Physician Decision|0|||
163293172|NCT00430300|589778890|FG000|Overall Study|Adverse Event|0|||
163293173|NCT00430300|589778891|FG001|Overall Study|Adverse Event|2|||
163293174|NCT00430300|589778892|FG002|Overall Study|Adverse Event|1|||
163293175|NCT00430300|589778893|FG003|Overall Study|Adverse Event|1|||
163293176|NCT00430300|589778890|FG000|Overall Study|Withdrawal by Subject|1|||
163293177|NCT00430300|589778891|FG001|Overall Study|Withdrawal by Subject|0|||
163293178|NCT00430300|589778892|FG002|Overall Study|Withdrawal by Subject|5|||
163293179|NCT00430300|589778893|FG003|Overall Study|Withdrawal by Subject|0|||
163293180|NCT00430300|589778890|FG000|Overall Study|Laboratory abnormality|1|||
163293181|NCT00430300|589778891|FG001|Overall Study|Laboratory abnormality|0|||
163293182|NCT00430300|589778892|FG002|Overall Study|Laboratory abnormality|0|||
163293183|NCT00430300|589778893|FG003|Overall Study|Laboratory abnormality|0|||
163293184|NCT00430300|589778890|FG000|Overall Study|Other|0|||
163293185|NCT00430300|589778891|FG001|Overall Study|Other|0|||
163293186|NCT00430300|589778892|FG002|Overall Study|Other|0|||
163293187|NCT00430300|589778893|FG003|Overall Study|Other|1|||
163293188|NCT01063517|589778896|FG000|Overall Study|Consent withdrawal|1|||
163293189|NCT01063517|589778897|FG001|Overall Study|Consent withdrawal|0|||
163293190|NCT01063517|589778896|FG000|Overall Study|Study reached data cut-off|19|||
163293191|NCT01063517|589778897|FG001|Overall Study|Study reached data cut-off|7|||
163293192|NCT01063517|589778896|FG000|Overall Study|Lost to Follow-up|4|||
163293193|NCT01063517|589778897|FG001|Overall Study|Lost to Follow-up|3|||
163293194|NCT01063517|589778896|FG000|Overall Study|Withdrawal by Subject|1|||
163293195|NCT01063517|589778897|FG001|Overall Study|Withdrawal by Subject|2|||
163293196|NCT01063517|589778896|FG000|Overall Study|Death|33|||
163293197|NCT01063517|589778897|FG001|Overall Study|Death|48|||
163293198|NCT02041104|589778898|FG000|Overall Study|Lost to Follow-up|1|||
163293199|NCT02041104|589778899|FG001|Overall Study|Lost to Follow-up|4|||
163293200|NCT02041104|589778898|FG000|Overall Study|discomfort during OGTT|0|||
163293201|NCT02041104|589778899|FG001|Overall Study|discomfort during OGTT|3|||
163293202|NCT06269640|589780782|FG000|Overall Study|Death|1|||
163293203|NCT02974634|589780783|FG000|Overall Study|Advanced disease|12|||
163293204|NCT02974634|589780784|FG001|Overall Study|Advanced disease|3|||
163293205|NCT02974634|589780783|FG000|Overall Study|Noncompliance|3|||
163293206|NCT02974634|589780784|FG001|Overall Study|Noncompliance|7|||
163293207|NCT02974634|589780783|FG000|Overall Study|intervention technology related issues|5|||
163293208|NCT02974634|589780784|FG001|Overall Study|intervention technology related issues|0|||
163293209|NCT02974634|589780783|FG000|Overall Study|Death|8|||
163293210|NCT02974634|589780784|FG001|Overall Study|Death|11|||
163293211|NCT05011396|589780785|FG000|Overall Study|Lost to Follow-up|3|||
163293212|NCT05011396|589780786|FG001|Overall Study|Lost to Follow-up|1|||
163293213|NCT05011396|589780785|FG000|Overall Study|Withdrawal by Subject|0|||
163293214|NCT05011396|589780786|FG001|Overall Study|Withdrawal by Subject|1|||
163293215|NCT05011396|589780785|FG000|Overall Study|Positive Drug Screen|0|||
163293216|NCT05011396|589780786|FG001|Overall Study|Positive Drug Screen|1|||
163293217|NCT04668339|589780787|FG000|Overall Study|Physician Decision|1|||
163293218|NCT04668339|589780788|FG001|Overall Study|Physician Decision|0|||
163293219|NCT04668339|589780789|FG002|Overall Study|Physician Decision|1|||
163293220|NCT04668339|589780790|FG003|Overall Study|Physician Decision|1|||
163293221|NCT04668339|589780787|FG000|Overall Study|Lost to Follow-up|14|||
163293222|NCT04668339|589780788|FG001|Overall Study|Lost to Follow-up|12|||
163293223|NCT04668339|589780789|FG002|Overall Study|Lost to Follow-up|8|||
163293224|NCT04668339|589780790|FG003|Overall Study|Lost to Follow-up|5|||
163293225|NCT04668339|589780787|FG000|Overall Study|Adverse Event|0|||
163293226|NCT04668339|589780788|FG001|Overall Study|Adverse Event|0|||
163293227|NCT04668339|589780789|FG002|Overall Study|Adverse Event|1|||
163293228|NCT04668339|589780790|FG003|Overall Study|Adverse Event|0|||
163293229|NCT04668339|589780787|FG000|Overall Study|Other than specified|3|||
163293230|NCT04668339|589780788|FG001|Overall Study|Other than specified|0|||
163293231|NCT04668339|589780789|FG002|Overall Study|Other than specified|1|||
163293232|NCT04668339|589780790|FG003|Overall Study|Other than specified|0|||
163293233|NCT04668339|589780787|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
163293234|NCT04668339|589780788|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
163293235|NCT04668339|589780789|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
163293236|NCT04668339|589780790|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
163293237|NCT04668339|589780787|FG000|Overall Study|Vaccine not Administered|0|||
163293238|NCT04668339|589780788|FG001|Overall Study|Vaccine not Administered|0|||
163293239|NCT04668339|589780789|FG002|Overall Study|Vaccine not Administered|1|||
163293240|NCT04668339|589780790|FG003|Overall Study|Vaccine not Administered|0|||
163293241|NCT04668339|589780787|FG000|Overall Study|Protocol Violation|18|||
163293242|NCT04668339|589780788|FG001|Overall Study|Protocol Violation|23|||
163293243|NCT04668339|589780789|FG002|Overall Study|Protocol Violation|12|||
162948944|NCT02289963|588516907|FG000|Overall Study|Poor compliance to protocol|1|||
162948945|NCT02289963|588516908|FG001|Overall Study|Poor compliance to protocol|0|||
162948946|NCT02289963|588516907|FG000|Overall Study|Withdrawal by Subject|1|||
162948947|NCT02289963|588516908|FG001|Overall Study|Withdrawal by Subject|0|||
162948948|NCT02289963|588516907|FG000|Overall Study|Last injection missed|2|||
162948949|NCT02289963|588516908|FG001|Overall Study|Last injection missed|2|||
162948950|NCT02289963|588516907|FG000|Overall Study|End treatment visit outside visit window|0|||
162948951|NCT02289963|588516908|FG001|Overall Study|End treatment visit outside visit window|4|||
162948952|NCT02289963|588516907|FG000|Overall Study|Other than specified above|0|||
162948953|NCT02289963|588516908|FG001|Overall Study|Other than specified above|2|||
162948954|NCT01746017|588516910|FG000|Period 1|Withdrawal by Subject|0|||
162948955|NCT01746017|588516911|FG001|Period 1|Withdrawal by Subject|0|||
162948956|NCT01746017|588516912|FG002|Period 1|Withdrawal by Subject|0|||
162948957|NCT01746017|588516913|FG003|Period 1|Withdrawal by Subject|0|||
162948958|NCT01746017|588516914|FG004|Period 1|Withdrawal by Subject|0|||
162948959|NCT01746017|588516915|FG005|Period 1|Withdrawal by Subject|0|||
162948960|NCT01746017|588516916|FG006|Period 1|Withdrawal by Subject|1|||
162948961|NCT01746017|588516917|FG007|Period 1|Withdrawal by Subject|0|||
162948962|NCT01746017|588516918|FG008|Period 1|Withdrawal by Subject|0|||
162948963|NCT01746017|588516919|FG009|Period 1|Withdrawal by Subject|0|||
162948964|NCT01746017|588516920|FG010|Period 1|Withdrawal by Subject|0|||
162948965|NCT01746017|588516910|FG000|Period 3|Withdrawal by Subject|0|||
162948966|NCT01746017|588516911|FG001|Period 3|Withdrawal by Subject|0|||
162948967|NCT01746017|588516912|FG002|Period 3|Withdrawal by Subject|0|||
163293244|NCT04668339|589780790|FG003|Overall Study|Protocol Violation|20|||
163293245|NCT04668339|589780787|FG000|Overall Study|Withdrawal by Subject|45|||
162948968|NCT01746017|588516913|FG003|Period 3|Withdrawal by Subject|0|||
162948969|NCT01746017|588516914|FG004|Period 3|Withdrawal by Subject|0|||
162948970|NCT01746017|588516915|FG005|Period 3|Withdrawal by Subject|1|||
163293246|NCT04668339|589780788|FG001|Overall Study|Withdrawal by Subject|46|||
162948971|NCT01746017|588516916|FG006|Period 3|Withdrawal by Subject|0|||
163293247|NCT04668339|589780789|FG002|Overall Study|Withdrawal by Subject|46|||
162948972|NCT01746017|588516917|FG007|Period 3|Withdrawal by Subject|0|||
163293248|NCT04668339|589780790|FG003|Overall Study|Withdrawal by Subject|27|||
163389060|NCT02279862|590136008|FG000|Overall Study|Study closed by sponsor|16|||
163389061|NCT02279862|590136009|FG001|Overall Study|Study closed by sponsor|13|||
163389062|NCT02279862|590136008|FG000|Overall Study|Other|1|||
163389063|NCT02279862|590136009|FG001|Overall Study|Other|2|||
163389064|NCT02279862|590136008|FG000|Overall Study|Withdrawal by Subject|1|||
163389065|NCT02279862|590136009|FG001|Overall Study|Withdrawal by Subject|0|||
163389066|NCT03431857|590136011|FG000|Overall Study|Death|6|||
163389067|NCT03431857|590136011|FG000|Overall Study|Lost to Follow-up|41|||
163389068|NCT03431857|590136011|FG000|Overall Study|Adverse Event|6|||
163389069|NCT03431857|590136011|FG000|Overall Study|Withdrawal by Subject|1|||
163389070|NCT04226833|590136015|FG000|Overall Study|Death|0|||
163389071|NCT04226833|590136016|FG001|Overall Study|Death|0|||
163389072|NCT04226833|590136017|FG002|Overall Study|Death|1|||
163389073|NCT04226833|590136018|FG003|Overall Study|Death|0|||
163389074|NCT01117857|590136021|FG000|Overall Study|Lost to Follow-up|4|||
163389075|NCT01117857|590136021|FG000|Overall Study|Withdrawal by Subject|4|||
163389076|NCT01117857|590136021|FG000|Overall Study|Physician Decision|1|||
163389077|NCT02876835|590136022|FG000|Treatment Period (51.1 Month)|Other|1|||
163389078|NCT02876835|590136023|FG001|Treatment Period (51.1 Month)|Other|0|||
163389079|NCT02876835|590136022|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
163389080|NCT02876835|590136023|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
163389081|NCT02876835|590136022|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
163389082|NCT02876835|590136023|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
163389083|NCT02876835|590136022|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
163389084|NCT02876835|590136023|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
163389085|NCT01119001|590136024|FG000|Overall Study|Withdrawal by Subject|2|||
163389086|NCT00403754|590136025|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
163389087|NCT00403754|590136026|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
163389088|NCT00403754|590136027|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
163389089|NCT00403754|590136028|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
163389090|NCT00403754|590136025|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
163389091|NCT00403754|590136026|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
163389092|NCT00403754|590136027|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
163389093|NCT00403754|590136028|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
163389094|NCT04343248|590136031|FG000|Overall Study|Withdrawal by Subject|5|||
163389095|NCT04343248|590136032|FG001|Overall Study|Withdrawal by Subject|6|||
163389096|NCT04343248|590136031|FG000|Overall Study|Death|1|||
163389097|NCT04343248|590136032|FG001|Overall Study|Death|2|||
163389098|NCT04343248|590136031|FG000|Overall Study|Lost to Follow-up|9|||
163389099|NCT04343248|590136032|FG001|Overall Study|Lost to Follow-up|6|||
163389100|NCT04343248|590136031|FG000|Overall Study|Physician Decision|0|||
163389101|NCT04343248|590136032|FG001|Overall Study|Physician Decision|1|||
163389102|NCT04343248|590136031|FG000|Overall Study|Adverse Event|1|||
163389103|NCT04343248|590136032|FG001|Overall Study|Adverse Event|0|||
163389104|NCT03951220|590136037|FG000|Overall Study|Withdrawal by Subject|9|||
163389105|NCT03951220|590136038|FG001|Overall Study|Withdrawal by Subject|2|||
163389106|NCT03951220|590136039|FG002|Overall Study|Withdrawal by Subject|0|||
163389107|NCT05461794|590136040|FG000|Overall Study|Withdrawal by Subject|1|||
163389108|NCT05461794|590136041|FG001|Overall Study|Withdrawal by Subject|1|||
163389109|NCT05461794|590136042|FG002|Overall Study|Withdrawal by Subject|3|||
163389110|NCT05461794|590136040|FG000|Overall Study|Study Terminated By Sponsor|18|||
163389111|NCT05461794|590136041|FG001|Overall Study|Study Terminated By Sponsor|13|||
163389112|NCT05461794|590136042|FG002|Overall Study|Study Terminated By Sponsor|16|||
163389113|NCT05461794|590136040|FG000|Overall Study|Death|20|||
163389114|NCT05461794|590136041|FG001|Overall Study|Death|5|||
163389115|NCT05461794|590136042|FG002|Overall Study|Death|19|||
163389116|NCT02730598|590136043|FG000|Overall Study|Withdrawal by Subject|3|||
163389117|NCT02730598|590136044|FG001|Overall Study|Withdrawal by Subject|3|||
163389118|NCT02730598|590136043|FG000|Overall Study|Protocol Violation|0|||
163389119|NCT02730598|590136044|FG001|Overall Study|Protocol Violation|1|||
163389120|NCT02730598|590136043|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
163389121|NCT02730598|590136044|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
163389122|NCT01079130|590136047|FG000|Overall Study|Adverse Event|1|||
163389123|NCT01079130|590136048|FG001|Overall Study|Adverse Event|1|||
163389124|NCT01079130|590136049|FG002|Overall Study|Adverse Event|0|||
162948973|NCT01746017|588516918|FG008|Period 3|Withdrawal by Subject|0|||
163389125|NCT01079130|590136050|FG003|Overall Study|Adverse Event|1|||
163389126|NCT01079130|590136051|FG004|Overall Study|Adverse Event|5|||
163389127|NCT01079130|590136052|FG005|Overall Study|Adverse Event|1|||
163389128|NCT01079130|590136047|FG000|Overall Study|Administrative problems|1|||
163389129|NCT01079130|590136048|FG001|Overall Study|Administrative problems|3|||
163389130|NCT01079130|590136049|FG002|Overall Study|Administrative problems|0|||
163389131|NCT01079130|590136050|FG003|Overall Study|Administrative problems|0|||
163389132|NCT01079130|590136051|FG004|Overall Study|Administrative problems|0|||
163389133|NCT01079130|590136052|FG005|Overall Study|Administrative problems|1|||
163389134|NCT01079130|590136047|FG000|Overall Study|Withdrawal by Subject|0|||
163389135|NCT01079130|590136048|FG001|Overall Study|Withdrawal by Subject|1|||
163389136|NCT01079130|590136049|FG002|Overall Study|Withdrawal by Subject|0|||
163389137|NCT01079130|590136050|FG003|Overall Study|Withdrawal by Subject|0|||
163389138|NCT01079130|590136051|FG004|Overall Study|Withdrawal by Subject|1|||
163389139|NCT01079130|590136052|FG005|Overall Study|Withdrawal by Subject|3|||
163389140|NCT01079130|590136047|FG000|Overall Study|Protocol deviation|0|||
163389141|NCT01079130|590136048|FG001|Overall Study|Protocol deviation|2|||
163389142|NCT01079130|590136049|FG002|Overall Study|Protocol deviation|1|||
163389143|NCT01079130|590136050|FG003|Overall Study|Protocol deviation|2|||
163389144|NCT01079130|590136051|FG004|Overall Study|Protocol deviation|0|||
163389145|NCT01079130|590136052|FG005|Overall Study|Protocol deviation|0|||
163389146|NCT01079130|590136047|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163389147|NCT01079130|590136048|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163389148|NCT01079130|590136049|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163389149|NCT01079130|590136050|FG003|Overall Study|Abnormal test procedure result(s)|0|||
163389150|NCT01079130|590136051|FG004|Overall Study|Abnormal test procedure result(s)|1|||
163389151|NCT01079130|590136052|FG005|Overall Study|Abnormal test procedure result(s)|0|||
163389152|NCT01079130|590136047|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163389153|NCT01079130|590136048|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163389154|NCT01079130|590136049|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
163389155|NCT01079130|590136050|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
163389156|NCT01079130|590136051|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
163389157|NCT01079130|590136052|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
163389158|NCT01079130|590136047|FG000|Overall Study|Lost to Follow-up|0|||
163389159|NCT01079130|590136048|FG001|Overall Study|Lost to Follow-up|0|||
163389160|NCT01079130|590136049|FG002|Overall Study|Lost to Follow-up|0|||
163389161|NCT01079130|590136050|FG003|Overall Study|Lost to Follow-up|0|||
163389162|NCT01079130|590136051|FG004|Overall Study|Lost to Follow-up|1|||
163389163|NCT01079130|590136052|FG005|Overall Study|Lost to Follow-up|0|||
163389164|NCT00475033|590136059|FG000|Infant Series|Failed to return|3|||
163389165|NCT00475033|590136060|FG001|Infant Series|Failed to return|4|||
163389166|NCT00475033|590136059|FG000|Infant Series|Parent or legal guardian request|1|||
163389167|NCT00475033|590136060|FG001|Infant Series|Parent or legal guardian request|5|||
163389168|NCT00475033|590136059|FG000|Infant Series|Protocol Violation|1|||
163389169|NCT00475033|590136060|FG001|Infant Series|Protocol Violation|2|||
163389170|NCT00475033|590136059|FG000|Infant Series|Lost to Follow-up|2|||
163389171|NCT00475033|590136060|FG001|Infant Series|Lost to Follow-up|0|||
163389172|NCT00475033|590136059|FG000|Infant Series|Adverse Event|0|||
163389173|NCT00475033|590136060|FG001|Infant Series|Adverse Event|2|||
163389174|NCT00475033|590136059|FG000|After the Infant Series|Adverse Event|0|||
163389175|NCT00475033|590136060|FG001|After the Infant Series|Adverse Event|4|||
163389176|NCT00475033|590136059|FG000|After the Infant Series|Parent or legal guardian request|2|||
163389177|NCT00475033|590136060|FG001|After the Infant Series|Parent or legal guardian request|2|||
163389178|NCT00475033|590136059|FG000|After the Infant Series|Failed to return|2|||
163389179|NCT00475033|590136060|FG001|After the Infant Series|Failed to return|1|||
163389180|NCT00475033|590136059|FG000|After the Infant Series|Protocol Violation|1|||
163389181|NCT00475033|590136060|FG001|After the Infant Series|Protocol Violation|0|||
163389182|NCT00475033|590136059|FG000|After the Infant Series|Lost to Follow-up|1|||
163389183|NCT00475033|590136060|FG001|After the Infant Series|Lost to Follow-up|0|||
163389184|NCT00475033|590136059|FG000|After the Infant Series|Other|0|||
163389185|NCT00475033|590136060|FG001|After the Infant Series|Other|1|||
163389186|NCT00475033|590136059|FG000|Toddler Dose|Parent or legal guardian request|2|||
163389187|NCT00475033|590136060|FG001|Toddler Dose|Parent or legal guardian request|0|||
163389188|NCT00475033|590136059|FG000|Toddler Dose|Failed to return|1|||
163389189|NCT00475033|590136060|FG001|Toddler Dose|Failed to return|0|||
163389190|NCT00475033|590136059|FG000|Toddler Dose|Lost to Follow-up|1|||
163389191|NCT00475033|590136060|FG001|Toddler Dose|Lost to Follow-up|0|||
163389192|NCT01335009|590136063|FG000|Overall Study|Too ill to travel to study sites|1|||
163389193|NCT01335009|590136064|FG001|Overall Study|Too ill to travel to study sites|0|||
163389194|NCT01335009|590136063|FG000|Overall Study|Death|28|||
163389195|NCT01335009|590136064|FG001|Overall Study|Death|32|||
163389196|NCT01335009|590136063|FG000|Overall Study|Withdrawal by Subject|1|||
163389197|NCT01335009|590136064|FG001|Overall Study|Withdrawal by Subject|1|||
163389198|NCT01335009|590136063|FG000|Overall Study|Lost to Follow-up|1|||
163389199|NCT01335009|590136064|FG001|Overall Study|Lost to Follow-up|0|||
163389200|NCT04824521|590136065|FG000|Overall Study|Lost to Follow-up|1|||
163389201|NCT02076113|590137752|FG000|Overall Study|Lost to Follow-up|4|||
163389202|NCT02076113|590137753|FG001|Overall Study|Lost to Follow-up|1|||
163389203|NCT02076113|590137752|FG000|Overall Study|Withdrawal by Subject|2|||
163389204|NCT02076113|590137753|FG001|Overall Study|Withdrawal by Subject|3|||
163389205|NCT02076113|590137752|FG000|Overall Study|Death|1|||
163389206|NCT02076113|590137753|FG001|Overall Study|Death|3|||
163389207|NCT03942406|590137756|FG000|Overall Study|Lost to Follow-up|4|||
163389208|NCT03942406|590137757|FG001|Overall Study|Lost to Follow-up|5|||
163389209|NCT03942406|590137758|FG002|Overall Study|Lost to Follow-up|3|||
163389210|NCT03942406|590137759|FG003|Overall Study|Lost to Follow-up|7|||
163389211|NCT03942406|590137760|FG004|Overall Study|Lost to Follow-up|1|||
163389212|NCT03942406|590137761|FG005|Overall Study|Lost to Follow-up|0|||
163293249|NCT04668339|589780787|FG000|Overall Study|Study Terminated by Sponsor|59|||
163293250|NCT04668339|589780788|FG001|Overall Study|Study Terminated by Sponsor|59|||
163293251|NCT04668339|589780789|FG002|Overall Study|Study Terminated by Sponsor|71|||
162948974|NCT01746017|588516919|FG009|Period 3|Withdrawal by Subject|0|||
162948975|NCT01746017|588516920|FG010|Period 3|Withdrawal by Subject|0|||
163293252|NCT04668339|589780790|FG003|Overall Study|Study Terminated by Sponsor|1|||
163293253|NCT03253848|589780794|FG000|Overall Study|Adverse Event|7|||
162948976|NCT02424097|588516923|FG000|Overall Study|Lost to Follow-up|1|||
162948977|NCT02424097|588516924|FG001|Overall Study|Lost to Follow-up|2|||
162948978|NCT01675622|588516925|FG000|Overall Study|Withdrawal by Subject|2|||
162948979|NCT01675622|588516926|FG001|Overall Study|Withdrawal by Subject|2|||
162948980|NCT01675622|588516925|FG000|Overall Study|Adverse Event|12|||
162948981|NCT01675622|588516926|FG001|Overall Study|Adverse Event|10|||
162948982|NCT01675622|588516925|FG000|Overall Study|Protocol Violation|4|||
162948983|NCT01675622|588516926|FG001|Overall Study|Protocol Violation|1|||
162948984|NCT01675622|588516925|FG000|Overall Study|Lack of Efficacy|2|||
162948985|NCT01675622|588516926|FG001|Overall Study|Lack of Efficacy|4|||
162948986|NCT01675622|588516925|FG000|Overall Study|Lost to Follow-up|1|||
162948987|NCT01675622|588516926|FG001|Overall Study|Lost to Follow-up|3|||
162948988|NCT01675622|588516925|FG000|Overall Study|Other|5|||
162948989|NCT01675622|588516926|FG001|Overall Study|Other|4|||
162948990|NCT04032977|588516927|FG000|Overall Study|Withdrawal by Subject|6|||
162948991|NCT04032977|588516928|FG001|Overall Study|Withdrawal by Subject|1|||
162948992|NCT04032977|588516927|FG000|Overall Study|Lost to Follow-up|2|||
162948993|NCT04032977|588516928|FG001|Overall Study|Lost to Follow-up|7|||
162948994|NCT04032977|588516927|FG000|Overall Study|Pregnancy|1|||
162948995|NCT04032977|588516928|FG001|Overall Study|Pregnancy|0|||
162948996|NCT01519661|588516930|FG000|Overall Study|Protocol deviation|6|||
163187766|NCT00371826|589403847|FG002|Core Phase (12 Months)|Administrative problems|8|||
163187767|NCT00371826|589403845|FG000|Core Phase (12 Months)|Graft Loss|0|||
163187768|NCT00371826|589403846|FG001|Core Phase (12 Months)|Graft Loss|1|||
163187769|NCT00371826|589403847|FG002|Core Phase (12 Months)|Graft Loss|0|||
162948997|NCT01519661|588516930|FG000|Overall Study|Lost to Follow-up|3|||
162948998|NCT01519661|588516930|FG000|Overall Study|Withdrawal by Subject|17|||
162948999|NCT01519661|588516930|FG000|Overall Study|Lack of Efficacy|6|||
162949000|NCT01519661|588516930|FG000|Overall Study|Adverse Event|29|||
162949001|NCT00840632|588516932|FG000|First Intervention|Withdrawal by Subject|0|||
162949002|NCT00840632|588516933|FG001|First Intervention|Withdrawal by Subject|1|||
163293254|NCT03253848|589780794|FG000|Overall Study|Death|5|||
163293255|NCT03253848|589780794|FG000|Overall Study|initiation of other treatments|3|||
163293256|NCT03253848|589780794|FG000|Overall Study|Other complicating disease|1|||
163293257|NCT03253848|589780794|FG000|Overall Study|Withdrawal by Subject|1|||
163293258|NCT03253848|589780794|FG000|Overall Study|Declining health|1|||
163293259|NCT05758415|589780796|FG000|Overall Study|Subject Decision|2|||
163293260|NCT05758415|589780797|FG001|Overall Study|Subject Decision|5|||
163293261|NCT05758415|589780796|FG000|Overall Study|Lost to Follow-up|0|||
163293262|NCT05758415|589780797|FG001|Overall Study|Lost to Follow-up|1|||
163293263|NCT03622593|589780798|FG000|Overall Study|Withdrawal by Subject|11|||
163293264|NCT03622593|589780799|FG001|Overall Study|Withdrawal by Subject|9|||
163293265|NCT03622593|589780800|FG002|Overall Study|Withdrawal by Subject|13|||
163293266|NCT03622593|589780798|FG000|Overall Study|Death|12|||
163293267|NCT03622593|589780799|FG001|Overall Study|Death|9|||
163293268|NCT03622593|589780800|FG002|Overall Study|Death|10|||
163293269|NCT03622593|589780798|FG000|Overall Study|Lost to Follow-up|11|||
163293270|NCT03622593|589780799|FG001|Overall Study|Lost to Follow-up|5|||
163293271|NCT03622593|589780800|FG002|Overall Study|Lost to Follow-up|8|||
163293272|NCT03622593|589780798|FG000|Overall Study|Adverse Event|4|||
163293273|NCT03622593|589780799|FG001|Overall Study|Adverse Event|5|||
163293274|NCT03622593|589780800|FG002|Overall Study|Adverse Event|6|||
163389213|NCT03942406|590137762|FG006|Overall Study|Lost to Follow-up|0|||
163389214|NCT03942406|590137756|FG000|Overall Study|Withdrawal by Subject|3|||
163389215|NCT03942406|590137757|FG001|Overall Study|Withdrawal by Subject|1|||
163389216|NCT03942406|590137758|FG002|Overall Study|Withdrawal by Subject|1|||
163389217|NCT03942406|590137759|FG003|Overall Study|Withdrawal by Subject|3|||
163389218|NCT03942406|590137760|FG004|Overall Study|Withdrawal by Subject|0|||
163389219|NCT03942406|590137761|FG005|Overall Study|Withdrawal by Subject|0|||
163389220|NCT03942406|590137762|FG006|Overall Study|Withdrawal by Subject|0|||
163389221|NCT03942406|590137756|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
163389222|NCT03942406|590137757|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
163389223|NCT03942406|590137758|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
163389224|NCT03942406|590137759|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
163389225|NCT03942406|590137760|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
163389226|NCT03942406|590137761|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
163389227|NCT03942406|590137762|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
163389228|NCT03801902|590137763|FG000|Overall Study|Did not receive protocol treatment.|1|||
163389229|NCT03801902|590137764|FG001|Overall Study|Did not receive protocol treatment.|0|||
163389230|NCT03801902|590137765|FG002|Overall Study|Did not receive protocol treatment.|0|||
163389231|NCT03801902|590137766|FG003|Overall Study|Did not receive protocol treatment.|0|||
163389232|NCT02260882|590137769|FG000|Overall Study|Protocol Violation|0|||
163389233|NCT02260882|590137770|FG001|Overall Study|Protocol Violation|1|||
163389234|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
163389235|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
163389236|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
163389237|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
163389238|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
163389239|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
163389240|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
163389241|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
163389242|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|Death|1|||
163389243|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|Death|1|||
163389244|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
163389245|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
163389246|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
163389247|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
163389248|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
163389249|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
163389250|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
163389251|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
162949003|NCT00840632|588516932|FG000|Washout|Withdrawal by Subject|1|||
163293275|NCT03622593|589780798|FG000|Overall Study|Physician Decision|2|||
163293276|NCT03622593|589780799|FG001|Overall Study|Physician Decision|1|||
163293277|NCT03622593|589780800|FG002|Overall Study|Physician Decision|6|||
163293278|NCT03622593|589780798|FG000|Overall Study|Other|2|||
163293279|NCT03622593|589780799|FG001|Overall Study|Other|2|||
163293280|NCT03622593|589780800|FG002|Overall Study|Other|3|||
162949004|NCT00840632|588516933|FG001|Washout|Withdrawal by Subject|1|||
162949005|NCT05017480|588516934|FG000|Stage 1 Study|Withdrawal by Subject|8|||
162949006|NCT05017480|588516935|FG001|Stage 1 Study|Withdrawal by Subject|6|||
162949007|NCT05017480|588516936|FG002|Stage 1 Study|Withdrawal by Subject|0|||
162949008|NCT05017480|588516937|FG003|Stage 1 Study|Withdrawal by Subject|0|||
162949009|NCT05017480|588516938|FG004|Stage 1 Study|Withdrawal by Subject|0|||
162949010|NCT05017480|588516934|FG000|Stage 1 Study|Adverse Event|1|||
162949011|NCT05017480|588516935|FG001|Stage 1 Study|Adverse Event|1|||
162949012|NCT05017480|588516936|FG002|Stage 1 Study|Adverse Event|0|||
162949013|NCT05017480|588516937|FG003|Stage 1 Study|Adverse Event|0|||
162949014|NCT05017480|588516938|FG004|Stage 1 Study|Adverse Event|0|||
163187770|NCT00371826|589403845|FG000|Extension Phase (24 Months)|Adverse Event|4|||
163187771|NCT00371826|589403846|FG001|Extension Phase (24 Months)|Adverse Event|5|||
163187772|NCT00371826|589403847|FG002|Extension Phase (24 Months)|Adverse Event|0|||
163187773|NCT00371826|589403845|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
162949015|NCT05017480|588516934|FG000|Stage 1 Study|Poor Compliance|1|||
163187774|NCT00371826|589403846|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
163187775|NCT00371826|589403847|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
163187776|NCT00371826|589403845|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
163187777|NCT00371826|589403846|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
163187778|NCT00371826|589403847|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
163187779|NCT00371826|589403845|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
163187780|NCT00371826|589403846|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
163187781|NCT00371826|589403847|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
163389252|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
163389253|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
163389254|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
163389255|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
163389256|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
163389257|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
163389258|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
163389259|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
163389260|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
163389261|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
163389262|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
163389263|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
163389264|NCT00559585|590137773|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
163389265|NCT00559585|590137774|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
163389266|NCT00559585|590137773|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
163389267|NCT00559585|590137774|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
163389268|NCT00559585|590137773|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
163389269|NCT00559585|590137774|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
163389270|NCT00559585|590137773|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
163389271|NCT00559585|590137774|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
163389272|NCT00559585|590137773|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
163389273|NCT00559585|590137774|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
163389274|NCT00559585|590137773|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
163389275|NCT00559585|590137774|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
163389276|NCT00559585|590137773|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
163389277|NCT00559585|590137774|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
163389278|NCT00559585|590137773|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
163389279|NCT00559585|590137774|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
163389280|NCT00559585|590137773|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
163389281|NCT00559585|590137774|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
163389282|NCT00559585|590137773|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
163389283|NCT00559585|590137774|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
163389284|NCT00559585|590137773|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
163389285|NCT00559585|590137774|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
163389286|NCT00559585|590137773|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
163389287|NCT00559585|590137774|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
163389288|NCT00559585|590137773|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
163389289|NCT00559585|590137774|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
163389290|NCT04209621|590137775|FG000|Overall Study|Death|1|||
163389291|NCT04209621|590137775|FG000|Overall Study|Study Terminated Early|2|||
163389292|NCT00372385|590137779|FG000|Overall Study|Adverse Event|6|||
163389293|NCT00372385|590137780|FG001|Overall Study|Adverse Event|11|||
163389294|NCT00372385|590137781|FG002|Overall Study|Adverse Event|9|||
163389295|NCT00372385|590137782|FG003|Overall Study|Adverse Event|7|||
163389296|NCT00372385|590137779|FG000|Overall Study|Noncompliance|0|||
163389297|NCT00372385|590137780|FG001|Overall Study|Noncompliance|1|||
163389298|NCT00372385|590137781|FG002|Overall Study|Noncompliance|1|||
163389299|NCT00372385|590137782|FG003|Overall Study|Noncompliance|1|||
163389300|NCT00372385|590137779|FG000|Overall Study|Physician Decision|1|||
163389301|NCT00372385|590137780|FG001|Overall Study|Physician Decision|0|||
163389302|NCT00372385|590137781|FG002|Overall Study|Physician Decision|0|||
163389303|NCT00372385|590137782|FG003|Overall Study|Physician Decision|0|||
163187782|NCT00371826|589403845|FG000|Extension Phase (24 Months)|Administrative problems|0|||
163187783|NCT00371826|589403846|FG001|Extension Phase (24 Months)|Administrative problems|0|||
163389304|NCT00372385|590137779|FG000|Overall Study|Lost to Follow-up|2|||
163389305|NCT00372385|590137780|FG001|Overall Study|Lost to Follow-up|0|||
163389306|NCT00372385|590137781|FG002|Overall Study|Lost to Follow-up|0|||
163389307|NCT00372385|590137782|FG003|Overall Study|Lost to Follow-up|0|||
163389308|NCT00372385|590137779|FG000|Overall Study|Withdrawal by Subject|2|||
163389309|NCT00372385|590137780|FG001|Overall Study|Withdrawal by Subject|1|||
162949016|NCT05017480|588516935|FG001|Stage 1 Study|Poor Compliance|1|||
162949017|NCT05017480|588516936|FG002|Stage 1 Study|Poor Compliance|0|||
162949018|NCT05017480|588516937|FG003|Stage 1 Study|Poor Compliance|0|||
163187784|NCT00371826|589403847|FG002|Extension Phase (24 Months)|Administrative problems|2|||
163187785|NCT02436304|589403848|FG000|Overall Study|Lost to Follow-up|0|||
163187786|NCT02436304|589403849|FG001|Overall Study|Lost to Follow-up|1|||
163187787|NCT02436304|589403850|FG002|Overall Study|Lost to Follow-up|0|||
163187788|NCT02436304|589403848|FG000|Overall Study|Withdrawal by Subject|0|||
163187789|NCT02436304|589403849|FG001|Overall Study|Withdrawal by Subject|1|||
163187790|NCT02436304|589403850|FG002|Overall Study|Withdrawal by Subject|0|||
163187791|NCT02436304|589403848|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
163187792|NCT02436304|589403849|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
163187793|NCT02436304|589403850|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
163187794|NCT04612790|589403856|FG000|DB Period (Up to 36 Weeks)|Death|1|||
163187795|NCT04612790|589403857|FG001|DB Period (Up to 36 Weeks)|Death|1|||
163187796|NCT04612790|589403858|FG002|DB Period (Up to 36 Weeks)|Death|0|||
163187797|NCT04612790|589403859|FG003|DB Period (Up to 36 Weeks)|Death|0|||
163187798|NCT04612790|589403856|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
163187799|NCT04612790|589403857|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
163187800|NCT04612790|589403858|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
163187801|NCT04612790|589403859|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
163187802|NCT04612790|589403856|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
163187803|NCT04612790|589403857|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
163187804|NCT04612790|589403858|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
163187805|NCT04612790|589403859|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
163187806|NCT04612790|589403856|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
163187807|NCT04612790|589403857|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
163187808|NCT04612790|589403858|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
163187809|NCT04612790|589403859|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
163187810|NCT04612790|589403856|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
163187811|NCT04612790|589403857|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
163187812|NCT04612790|589403858|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
163187813|NCT04612790|589403859|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
163187814|NCT04612790|589403856|FG000|DB Period (Up to 36 Weeks)|Other|1|||
163187815|NCT04612790|589403857|FG001|DB Period (Up to 36 Weeks)|Other|0|||
163187816|NCT04612790|589403858|FG002|DB Period (Up to 36 Weeks)|Other|0|||
163187817|NCT04612790|589403859|FG003|DB Period (Up to 36 Weeks)|Other|0|||
163187818|NCT04612790|589403856|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
163187819|NCT04612790|589403857|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
163187820|NCT04612790|589403858|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
163187821|NCT04612790|589403859|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
163187822|NCT04612790|589403856|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
163187823|NCT04612790|589403857|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
163187824|NCT04612790|589403858|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
163187825|NCT04612790|589403859|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
163187826|NCT04612790|589403856|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
163187827|NCT04612790|589403857|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
163187828|NCT04612790|589403858|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
163187829|NCT04612790|589403859|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
163187830|NCT04612790|589403856|FG000|OLE Period (Up to 1 Year)|Other|0|||
163187831|NCT04612790|589403857|FG001|OLE Period (Up to 1 Year)|Other|0|||
163187832|NCT04612790|589403858|FG002|OLE Period (Up to 1 Year)|Other|0|||
163187833|NCT04612790|589403859|FG003|OLE Period (Up to 1 Year)|Other|1|||
163187834|NCT00785928|589403860|FG000|Treatment Phase|Adverse Event|1|||
163187835|NCT00785928|589403861|FG001|Treatment Phase|Adverse Event|1|||
163187836|NCT00785928|589403862|FG002|Treatment Phase|Adverse Event|2|||
163187837|NCT00785928|589403863|FG003|Treatment Phase|Adverse Event|0|||
163187838|NCT00785928|589403864|FG004|Treatment Phase|Adverse Event|0|||
163187839|NCT00785928|589403865|FG005|Treatment Phase|Adverse Event|0|||
162949019|NCT05017480|588516938|FG004|Stage 1 Study|Poor Compliance|0|||
162949020|NCT05017480|588516934|FG000|Stage 1 Study|Physician Decision|0|||
162949021|NCT05017480|588516935|FG001|Stage 1 Study|Physician Decision|1|||
162949022|NCT05017480|588516936|FG002|Stage 1 Study|Physician Decision|0|||
162949023|NCT05017480|588516937|FG003|Stage 1 Study|Physician Decision|0|||
162949024|NCT05017480|588516938|FG004|Stage 1 Study|Physician Decision|0|||
162949025|NCT05017480|588516934|FG000|Stage 2 Study|Withdrawal by Subject|0|||
162949026|NCT05017480|588516935|FG001|Stage 2 Study|Withdrawal by Subject|0|||
162949027|NCT05017480|588516936|FG002|Stage 2 Study|Withdrawal by Subject|6|||
162949028|NCT05017480|588516937|FG003|Stage 2 Study|Withdrawal by Subject|9|||
162949029|NCT05017480|588516938|FG004|Stage 2 Study|Withdrawal by Subject|11|||
162949030|NCT05017480|588516934|FG000|Stage 2 Study|Lost to Follow-up|0|||
162949031|NCT05017480|588516935|FG001|Stage 2 Study|Lost to Follow-up|0|||
162949032|NCT05017480|588516936|FG002|Stage 2 Study|Lost to Follow-up|0|||
162949033|NCT05017480|588516937|FG003|Stage 2 Study|Lost to Follow-up|2|||
163187840|NCT00785928|589403866|FG006|Treatment Phase|Adverse Event|2|||
162949034|NCT05017480|588516938|FG004|Stage 2 Study|Lost to Follow-up|1|||
162949035|NCT05017480|588516934|FG000|Stage 2 Study|Adverse Event|0|||
163187841|NCT00785928|589403860|FG000|Treatment Phase|Inadequate Response|0|||
163187842|NCT00785928|589403861|FG001|Treatment Phase|Inadequate Response|1|||
163187843|NCT00785928|589403862|FG002|Treatment Phase|Inadequate Response|0|||
162949036|NCT05017480|588516935|FG001|Stage 2 Study|Adverse Event|0|||
163293281|NCT03622593|589780798|FG000|Overall Study|Protocol Violation|0|||
163293282|NCT03622593|589780799|FG001|Overall Study|Protocol Violation|0|||
163293283|NCT03622593|589780800|FG002|Overall Study|Protocol Violation|1|||
163293284|NCT03622593|589780798|FG000|Overall Study|Pregnancy|0|||
163293285|NCT03622593|589780799|FG001|Overall Study|Pregnancy|0|||
163293286|NCT03622593|589780800|FG002|Overall Study|Pregnancy|1|||
163293287|NCT01393119|589780803|FG000|Overall Study|Adverse Event|1|||
163293288|NCT01393119|589780804|FG001|Overall Study|Adverse Event|1|||
163293289|NCT01393119|589780805|FG002|Overall Study|Adverse Event|0|||
163293290|NCT01393119|589780806|FG003|Overall Study|Adverse Event|1|||
163293291|NCT01393119|589780803|FG000|Overall Study|Withdrawal by Subject|0|||
163293292|NCT01393119|589780804|FG001|Overall Study|Withdrawal by Subject|1|||
163293293|NCT01393119|589780805|FG002|Overall Study|Withdrawal by Subject|1|||
163293294|NCT01393119|589780806|FG003|Overall Study|Withdrawal by Subject|0|||
163293295|NCT01393119|589780803|FG000|Overall Study|Lack of Efficacy|1|||
163293296|NCT01393119|589780804|FG001|Overall Study|Lack of Efficacy|0|||
163293297|NCT01393119|589780805|FG002|Overall Study|Lack of Efficacy|2|||
163293298|NCT01393119|589780806|FG003|Overall Study|Lack of Efficacy|1|||
163293299|NCT01393119|589780803|FG000|Overall Study|Protocol Violation|0|||
163293300|NCT01393119|589780804|FG001|Overall Study|Protocol Violation|0|||
163293301|NCT01393119|589780805|FG002|Overall Study|Protocol Violation|1|||
163293302|NCT01393119|589780806|FG003|Overall Study|Protocol Violation|0|||
163293303|NCT01393119|589780803|FG000|Overall Study|Death|0|||
163293304|NCT01393119|589780804|FG001|Overall Study|Death|0|||
163293305|NCT01393119|589780805|FG002|Overall Study|Death|0|||
163293306|NCT01393119|589780806|FG003|Overall Study|Death|1|||
163293307|NCT01393119|589780803|FG000|Overall Study|Randomized but Not treated|1|||
162949037|NCT05017480|588516936|FG002|Stage 2 Study|Adverse Event|0|||
162949038|NCT05017480|588516937|FG003|Stage 2 Study|Adverse Event|1|||
163293308|NCT01393119|589780804|FG001|Overall Study|Randomized but Not treated|0|||
163293309|NCT01393119|589780805|FG002|Overall Study|Randomized but Not treated|1|||
163293310|NCT01393119|589780806|FG003|Overall Study|Randomized but Not treated|1|||
163293311|NCT01393119|589780803|FG000|Overall Study|Sponsor Termination of Study|11|||
163293312|NCT01393119|589780804|FG001|Overall Study|Sponsor Termination of Study|12|||
163293313|NCT01393119|589780805|FG002|Overall Study|Sponsor Termination of Study|9|||
163293314|NCT01393119|589780806|FG003|Overall Study|Sponsor Termination of Study|12|||
163293315|NCT04860258|589780807|FG000|Overall Study|Withdrawal by Subject|0|||
163293316|NCT04860258|589780808|FG001|Overall Study|Withdrawal by Subject|0|||
163293317|NCT04860258|589780809|FG002|Overall Study|Withdrawal by Subject|4|||
163293318|NCT04860258|589780810|FG003|Overall Study|Withdrawal by Subject|1|||
163293319|NCT04860258|589780811|FG004|Overall Study|Withdrawal by Subject|4|||
163293320|NCT04860258|589780812|FG005|Overall Study|Withdrawal by Subject|1|||
163293321|NCT04860258|589780813|FG006|Overall Study|Withdrawal by Subject|0|||
163293322|NCT01266265|589780814|FG000|Overall Study|Death|95|||
163293323|NCT01266265|589780815|FG001|Overall Study|Death|73|||
163293324|NCT01266265|589780814|FG000|Overall Study|Lost to Follow-up|23|||
163293325|NCT01266265|589780815|FG001|Overall Study|Lost to Follow-up|28|||
163293326|NCT01266265|589780814|FG000|Overall Study|Withdrawal by Subject|13|||
163293327|NCT01266265|589780815|FG001|Overall Study|Withdrawal by Subject|11|||
163293328|NCT01266265|589780814|FG000|Overall Study|Respiratory-related adverse event|2|||
163293329|NCT01266265|589780815|FG001|Overall Study|Respiratory-related adverse event|1|||
163293330|NCT01266265|589780814|FG000|Overall Study|Transferred care to another provider|22|||
163293331|NCT01266265|589780815|FG001|Overall Study|Transferred care to another provider|28|||
163293332|NCT01266265|589780814|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
163293333|NCT01266265|589780815|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
162949039|NCT05017480|588516938|FG004|Stage 2 Study|Adverse Event|0|||
162949040|NCT05017480|588516934|FG000|Stage 2 Study|COVID-19|0|||
162949041|NCT05017480|588516935|FG001|Stage 2 Study|COVID-19|0|||
162949042|NCT05017480|588516936|FG002|Stage 2 Study|COVID-19|0|||
162949043|NCT05017480|588516937|FG003|Stage 2 Study|COVID-19|1|||
162949044|NCT05017480|588516938|FG004|Stage 2 Study|COVID-19|0|||
163293334|NCT01266265|589780814|FG000|Overall Study|Enrolled in another clinical study|15|||
163293335|NCT01266265|589780815|FG001|Overall Study|Enrolled in another clinical study|26|||
163293336|NCT01266265|589780814|FG000|Overall Study|Non-compliance|8|||
163293337|NCT01266265|589780815|FG001|Overall Study|Non-compliance|5|||
163293338|NCT01266265|589780814|FG000|Overall Study|Lung transplant|6|||
163293339|NCT01266265|589780815|FG001|Overall Study|Lung transplant|5|||
163293340|NCT01266265|589780814|FG000|Overall Study|Site closed early|4|||
163293341|NCT01266265|589780815|FG001|Overall Study|Site closed early|3|||
163293342|NCT01266265|589780814|FG000|Overall Study|Clinical worsening|1|||
162949045|NCT05017480|588516934|FG000|Stage 2 Study|Pregnancy|0|||
162949046|NCT05017480|588516935|FG001|Stage 2 Study|Pregnancy|0|||
162949047|NCT05017480|588516936|FG002|Stage 2 Study|Pregnancy|0|||
162949048|NCT05017480|588516937|FG003|Stage 2 Study|Pregnancy|0|||
163293343|NCT01266265|589780815|FG001|Overall Study|Clinical worsening|1|||
163293344|NCT01580293|589780816|FG000|Part A_Main Trial|Adverse Event|0|||
162949049|NCT05017480|588516938|FG004|Stage 2 Study|Pregnancy|1|||
162949050|NCT02311361|588516939|FG000|Overall Study|Did not receive treatment|0|||
163293345|NCT01580293|589780817|FG001|Part A_Main Trial|Adverse Event|2|||
163293346|NCT01580293|589780818|FG002|Part A_Main Trial|Adverse Event|0|||
162949051|NCT02311361|588516940|FG001|Overall Study|Did not receive treatment|1|||
162949052|NCT02311361|588516941|FG002|Overall Study|Did not receive treatment|0|||
162949053|NCT02311361|588516942|FG003|Overall Study|Did not receive treatment|1|||
162949054|NCT05628675|588516947|FG000|Overall Study|Lost to Follow-up|2|||
162949055|NCT05628675|588516947|FG000|Overall Study|Withdrawal by Subject|1|||
162949056|NCT00633594|588516950|FG000|Overall Study|Adverse Event|0|||
162949057|NCT00633594|588516951|FG001|Overall Study|Adverse Event|4|||
162949058|NCT00633594|588516952|FG002|Overall Study|Adverse Event|7|||
162949059|NCT00633594|588516950|FG000|Overall Study|Death|0|||
162949060|NCT00633594|588516951|FG001|Overall Study|Death|1|||
162949061|NCT00633594|588516952|FG002|Overall Study|Death|2|||
162949062|NCT00633594|588516950|FG000|Overall Study|Disease Progression|0|||
162949063|NCT00633594|588516951|FG001|Overall Study|Disease Progression|0|||
162949064|NCT00633594|588516952|FG002|Overall Study|Disease Progression|1|||
162949065|NCT02028715|588516953|FG000|Overall Study|Adverse Event|2|||
162949066|NCT02028715|588516954|FG001|Overall Study|Adverse Event|2|||
162949067|NCT02028715|588516953|FG000|Overall Study|Physician Decision|1|||
162949068|NCT02028715|588516954|FG001|Overall Study|Physician Decision|0|||
162949069|NCT02028715|588516953|FG000|Overall Study|Did not complete satisfaction surveys|2|||
162949070|NCT02028715|588516954|FG001|Overall Study|Did not complete satisfaction surveys|2|||
163293347|NCT01580293|589780816|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
163293348|NCT01580293|589780817|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
162949071|NCT01492361|588516955|FG000|Overall Study|Withdrawal by Subject|281|||
163293349|NCT01580293|589780818|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
162949072|NCT01492361|588516956|FG001|Overall Study|Withdrawal by Subject|297|||
162949073|NCT01492361|588516955|FG000|Overall Study|Physician Decision|12|||
163293350|NCT01580293|589780816|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
162949074|NCT01492361|588516956|FG001|Overall Study|Physician Decision|12|||
162949075|NCT01492361|588516955|FG000|Overall Study|Lost to Follow-up|6|||
162949076|NCT01492361|588516956|FG001|Overall Study|Lost to Follow-up|13|||
162949077|NCT01492361|588516955|FG000|Overall Study|Other than specified above|106|||
162949078|NCT01492361|588516956|FG001|Overall Study|Other than specified above|138|||
162949079|NCT01475838|588516957|FG000|Randomized Phase|Randomized but Not Treated|0|||
162949080|NCT01475838|588516958|FG001|Randomized Phase|Randomized but Not Treated|5|||
162949081|NCT01475838|588516957|FG000|Randomized Phase|Adverse Event|6|||
162949082|NCT01475838|588516958|FG001|Randomized Phase|Adverse Event|1|||
162949083|NCT01475838|588516957|FG000|Randomized Phase|Pregnancy|0|||
162949084|NCT01475838|588516958|FG001|Randomized Phase|Pregnancy|1|||
162949085|NCT01475838|588516957|FG000|Randomized Phase|Investigators Discretion|1|||
162949086|NCT01475838|588516958|FG001|Randomized Phase|Investigators Discretion|2|||
162949087|NCT01475838|588516957|FG000|Randomized Phase|Withdrew Consent|10|||
162949088|NCT01475838|588516958|FG001|Randomized Phase|Withdrew Consent|14|||
162949089|NCT01475838|588516957|FG000|Randomized Phase|Lost to Follow-up|3|||
162949090|NCT01475838|588516958|FG001|Randomized Phase|Lost to Follow-up|4|||
162949091|NCT01475838|588516957|FG000|Randomized Phase|Participant Noncompliance|1|||
162949092|NCT01475838|588516958|FG001|Randomized Phase|Participant Noncompliance|5|||
162949093|NCT01475838|588516957|FG000|Randomized Phase|Protocol Violation|9|||
162949094|NCT01475838|588516958|FG001|Randomized Phase|Protocol Violation|4|||
162949095|NCT01475838|588516957|FG000|Extension Phase|Participant Noncompliance|1|||
162949096|NCT01475838|588516958|FG001|Extension Phase|Participant Noncompliance|0|||
162949097|NCT01315249|588516964|FG000|Overall Study|Adverse Event|22|||
162949098|NCT01315249|588516965|FG001|Overall Study|Adverse Event|26|||
162949099|NCT01315249|588516964|FG000|Overall Study|Withdrawal by Subject|11|||
162949100|NCT01315249|588516965|FG001|Overall Study|Withdrawal by Subject|10|||
162949101|NCT01315249|588516964|FG000|Overall Study|Protocol Violation|8|||
162949102|NCT01315249|588516965|FG001|Overall Study|Protocol Violation|5|||
162949103|NCT01315249|588516964|FG000|Overall Study|Abnormal test results|1|||
162949104|NCT01315249|588516965|FG001|Overall Study|Abnormal test results|2|||
162949105|NCT01315249|588516964|FG000|Overall Study|Administrative problems|1|||
162949106|NCT01315249|588516965|FG001|Overall Study|Administrative problems|0|||
163293351|NCT01580293|589780817|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
163293352|NCT01580293|589780818|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
163293353|NCT01580293|589780816|FG000|Part A_Extension|Adverse Event|0|||
163293354|NCT01580293|589780817|FG001|Part A_Extension|Adverse Event|2|||
163293355|NCT01580293|589780818|FG002|Part A_Extension|Adverse Event|0|||
163293356|NCT01580293|589780816|FG000|Part A_Extension|Withdrawal by Subject|0|||
163293357|NCT01580293|589780817|FG001|Part A_Extension|Withdrawal by Subject|3|||
163293358|NCT01580293|589780818|FG002|Part A_Extension|Withdrawal by Subject|0|||
163293359|NCT01580293|589780816|FG000|Part A_Extension|Lost to Follow-up|0|||
163293360|NCT01580293|589780817|FG001|Part A_Extension|Lost to Follow-up|1|||
163293361|NCT01580293|589780818|FG002|Part A_Extension|Lost to Follow-up|0|||
163293362|NCT01580293|589780816|FG000|Part A_Extension|Other Reason|0|||
163293363|NCT01580293|589780817|FG001|Part A_Extension|Other Reason|1|||
163293364|NCT01580293|589780818|FG002|Part A_Extension|Other Reason|0|||
163293365|NCT01580293|589780816|FG000|Part A_Extension|Completed Japan only|0|||
163293366|NCT01580293|589780817|FG001|Part A_Extension|Completed Japan only|5|||
162949107|NCT01315249|588516964|FG000|Overall Study|inability to use device|1|||
162949108|NCT01315249|588516965|FG001|Overall Study|inability to use device|0|||
162949109|NCT01315249|588516964|FG000|Overall Study|Lack of Efficacy|0|||
162949110|NCT01315249|588516965|FG001|Overall Study|Lack of Efficacy|1|||
162949111|NCT01315249|588516964|FG000|Overall Study|Lost to Follow-up|0|||
162949112|NCT01315249|588516965|FG001|Overall Study|Lost to Follow-up|2|||
163293367|NCT01580293|589780818|FG002|Part A_Extension|Completed Japan only|0|||
163293368|NCT01580293|589780816|FG000|Part B|Withdrawal by Subject|0|||
163293369|NCT01580293|589780817|FG001|Part B|Withdrawal by Subject|0|||
162949113|NCT01315249|588516964|FG000|Overall Study|Death|0|||
163293370|NCT01580293|589780818|FG002|Part B|Withdrawal by Subject|1|||
163293371|NCT01580293|589780816|FG000|Part B|Other reason|0|||
163293372|NCT01580293|589780817|FG001|Part B|Other reason|0|||
163293373|NCT01580293|589780818|FG002|Part B|Other reason|1|||
163293374|NCT01134562|589780819|FG000|Overall Study|Adverse Event|0|||
162949114|NCT01315249|588516965|FG001|Overall Study|Death|1|||
163293375|NCT01134562|589780820|FG001|Overall Study|Adverse Event|1|||
163293376|NCT01134562|589780821|FG002|Overall Study|Adverse Event|0|||
163293377|NCT01134562|589780822|FG003|Overall Study|Adverse Event|0|||
163293378|NCT01134562|589780823|FG004|Overall Study|Adverse Event|0|||
163293379|NCT01499134|589780826|FG000|Overall Study|Withdrawal by Subject|0|||
163293380|NCT01499134|589780827|FG001|Overall Study|Withdrawal by Subject|1|||
163293381|NCT01400776|589780828|FG000|Overall Study|Adverse Event|7|||
163293382|NCT01400776|589780829|FG001|Overall Study|Adverse Event|2|||
163293383|NCT01400776|589780830|FG002|Overall Study|Adverse Event|9|||
162949115|NCT03655106|588516966|FG000|Overall Study|Withdrawal by Subject|3|||
162949116|NCT03655106|588516967|FG001|Overall Study|Withdrawal by Subject|2|||
162949117|NCT03655106|588516966|FG000|Overall Study|Lost to Follow-up|2|||
162949118|NCT03655106|588516967|FG001|Overall Study|Lost to Follow-up|1|||
162949119|NCT03655106|588516966|FG000|Overall Study|Duplicate Enrollment|1|||
162949120|NCT03655106|588516967|FG001|Overall Study|Duplicate Enrollment|1|||
162949121|NCT03655106|588516966|FG000|Overall Study|Protocol Violation|3|||
162949122|NCT03655106|588516967|FG001|Overall Study|Protocol Violation|0|||
162949123|NCT03227445|588516968|FG000|Period 1 (28 Days)|Adverse Event|1|||
162949124|NCT03227445|588516969|FG001|Period 1 (28 Days)|Adverse Event|2|||
162949125|NCT03227445|588516970|FG002|Period 1 (28 Days)|Adverse Event|0|||
162949126|NCT03227445|588516971|FG003|Period 1 (28 Days)|Adverse Event|1|||
162949127|NCT03227445|588516968|FG000|Period 1 (28 Days)|Protocol Violation|1|||
162949128|NCT03227445|588516969|FG001|Period 1 (28 Days)|Protocol Violation|0|||
162949129|NCT03227445|588516970|FG002|Period 1 (28 Days)|Protocol Violation|0|||
162949130|NCT03227445|588516971|FG003|Period 1 (28 Days)|Protocol Violation|0|||
162949131|NCT03227445|588516968|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
162949132|NCT03227445|588516969|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
162949133|NCT03227445|588516970|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
162949134|NCT03227445|588516971|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
162949135|NCT03227445|588516968|FG000|Period 2 (28 Days)|Adverse Event|1|||
162949136|NCT03227445|588516969|FG001|Period 2 (28 Days)|Adverse Event|0|||
162949137|NCT03227445|588516970|FG002|Period 2 (28 Days)|Adverse Event|2|||
162949138|NCT03227445|588516971|FG003|Period 2 (28 Days)|Adverse Event|1|||
162949139|NCT03227445|588516968|FG000|Period 2 (28 Days)|Protocol Violation|0|||
162949140|NCT03227445|588516969|FG001|Period 2 (28 Days)|Protocol Violation|0|||
162949141|NCT03227445|588516970|FG002|Period 2 (28 Days)|Protocol Violation|0|||
162949142|NCT03227445|588516971|FG003|Period 2 (28 Days)|Protocol Violation|1|||
162949143|NCT03227445|588516968|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
162949144|NCT03227445|588516969|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
163293384|NCT01400776|589780831|FG003|Overall Study|Adverse Event|2|||
163293385|NCT01400776|589780828|FG000|Overall Study|Lost to Follow-up|1|||
163293386|NCT01400776|589780829|FG001|Overall Study|Lost to Follow-up|0|||
163293387|NCT01400776|589780830|FG002|Overall Study|Lost to Follow-up|4|||
163293388|NCT01400776|589780831|FG003|Overall Study|Lost to Follow-up|1|||
162949145|NCT03227445|588516970|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
162949146|NCT03227445|588516971|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
162949147|NCT01991470|588516972|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
162949148|NCT01991470|588516972|FG000|Enlite 1 Period|Adverse Event|1|||
162949149|NCT01991470|588516972|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
162949150|NCT01991470|588516972|FG000|Enlite 3 Period|Lost to Follow-up|1|||
162949151|NCT01991470|588516972|FG000|Enlite 3 Period|Physician Decision|2|||
162949152|NCT01991470|588516972|FG000|Enlite 3 Period|Physician Decision|8|||
162949153|NCT01991470|588516972|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
162949154|NCT01225146|588516975|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
162949155|NCT01225146|588516976|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
162949156|NCT00623779|588516977|FG000|Overall Study|Adverse Event|1|||
162949157|NCT00623779|588516978|FG001|Overall Study|Adverse Event|3|||
162949158|NCT00623779|588516979|FG002|Overall Study|Adverse Event|0|||
163293389|NCT01400776|589780828|FG000|Overall Study|Withdrew Consent|4|||
163293390|NCT01400776|589780829|FG001|Overall Study|Withdrew Consent|2|||
163293391|NCT01400776|589780830|FG002|Overall Study|Withdrew Consent|6|||
163293392|NCT01400776|589780831|FG003|Overall Study|Withdrew Consent|1|||
163293393|NCT01400776|589780828|FG000|Overall Study|Protocol Deviation|6|||
162949159|NCT00623779|588516977|FG000|Overall Study|Criteria from CSR|2|||
162949160|NCT00623779|588516978|FG001|Overall Study|Criteria from CSR|0|||
162949161|NCT00623779|588516979|FG002|Overall Study|Criteria from CSR|1|||
162949162|NCT01629381|588516983|FG000|Overall Study|Withdrawal by Subject|2|||
162949163|NCT01629381|588516984|FG001|Overall Study|Withdrawal by Subject|5|||
163293394|NCT01400776|589780829|FG001|Overall Study|Protocol Deviation|1|||
163293395|NCT01400776|589780830|FG002|Overall Study|Protocol Deviation|5|||
162949164|NCT00906347|588516987|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
162949165|NCT00906347|588516988|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
162949166|NCT00906347|588516987|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
162949167|NCT00906347|588516988|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
162949168|NCT00906347|588516987|FG000|Received Study Drug|Refused study drug|1|||
162949169|NCT00906347|588516988|FG001|Received Study Drug|Refused study drug|0|||
162949170|NCT00906347|588516987|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
162949171|NCT00906347|588516988|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
162949172|NCT02545998|588516994|FG000|Overall Study|Lost to Follow-up|12|||
162949173|NCT02545998|588516995|FG001|Overall Study|Lost to Follow-up|3|||
162949174|NCT02545998|588516994|FG000|Overall Study|Withdrawal by Subject|3|||
162949175|NCT02545998|588516995|FG001|Overall Study|Withdrawal by Subject|2|||
162949176|NCT00472290|588516996|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
162949177|NCT00472290|588516996|FG000|Overall Study|Protocol Specified Criteria|7|||
162949178|NCT00472290|588516996|FG000|Overall Study|Administrative Decision|37|||
162949179|NCT00472290|588516996|FG000|Overall Study|Death|3|||
162949180|NCT00472290|588516996|FG000|Overall Study|Lost to Follow-up|1|||
162949181|NCT00472290|588516996|FG000|Overall Study|Lack of Efficacy|1|||
162949182|NCT00472290|588516996|FG000|Overall Study|Disease Progression|4|||
162949183|NCT00472290|588516996|FG000|Overall Study|Withdrawal by Subject|5|||
162949184|NCT00472290|588516996|FG000|Overall Study|Adverse Event|6|||
162949185|NCT00472290|588516996|FG000|Overall Study|Requirement for alternative therapy|7|||
162949186|NCT00777829|588516997|FG000|Overall Study|Withdrawal by Subject|0|||
162949187|NCT00777829|588516998|FG001|Overall Study|Withdrawal by Subject|2|||
162949188|NCT00745095|588517000|FG000|Overall Study|Declined to participate|1|||
162949189|NCT00745095|588517001|FG001|Overall Study|Declined to participate|0|||
162949190|NCT00745095|588517002|FG002|Overall Study|Declined to participate|0|||
162949191|NCT00745095|588517003|FG003|Overall Study|Declined to participate|0|||
162949192|NCT00745095|588517004|FG004|Overall Study|Declined to participate|92|||
162949193|NCT00745095|588517005|FG005|Overall Study|Declined to participate|95|||
162949194|NCT00745095|588517000|FG000|Overall Study|Ineligible due to GFR criteria|0|||
162949195|NCT00745095|588517001|FG001|Overall Study|Ineligible due to GFR criteria|2|||
162949196|NCT00745095|588517002|FG002|Overall Study|Ineligible due to GFR criteria|3|||
162949197|NCT00745095|588517003|FG003|Overall Study|Ineligible due to GFR criteria|3|||
162949198|NCT00745095|588517004|FG004|Overall Study|Ineligible due to GFR criteria|30|||
162949199|NCT00745095|588517005|FG005|Overall Study|Ineligible due to GFR criteria|28|||
162949200|NCT01226797|588517010|FG000|Overall Study|Adverse Event|1|||
162949201|NCT01226797|588517011|FG001|Overall Study|Adverse Event|0|||
162949202|NCT01226797|588517010|FG000|Overall Study|No longer willing to participate|1|||
162949203|NCT01226797|588517011|FG001|Overall Study|No longer willing to participate|0|||
162949204|NCT01226797|588517010|FG000|Overall Study|Protocol Violation|0|||
162949205|NCT01226797|588517011|FG001|Overall Study|Protocol Violation|1|||
162949206|NCT00577460|588517012|FG000|Overall Study|Adverse Event|11|||
162949207|NCT00577460|588517013|FG001|Overall Study|Adverse Event|7|||
162949208|NCT00577460|588517014|FG002|Overall Study|Adverse Event|14|||
162949209|NCT00577460|588517012|FG000|Overall Study|Protocol Violation|0|||
162949210|NCT00577460|588517013|FG001|Overall Study|Protocol Violation|1|||
162949211|NCT00577460|588517014|FG002|Overall Study|Protocol Violation|1|||
162949212|NCT00577460|588517012|FG000|Overall Study|Lost to Follow-up|0|||
162949213|NCT00577460|588517013|FG001|Overall Study|Lost to Follow-up|3|||
162949214|NCT00577460|588517014|FG002|Overall Study|Lost to Follow-up|4|||
162949215|NCT00577460|588517012|FG000|Overall Study|Withdrawal by Subject|5|||
162949216|NCT00577460|588517013|FG001|Overall Study|Withdrawal by Subject|5|||
162949217|NCT00577460|588517014|FG002|Overall Study|Withdrawal by Subject|6|||
162949218|NCT00577460|588517012|FG000|Overall Study|Other|0|||
162949219|NCT00577460|588517013|FG001|Overall Study|Other|3|||
162949220|NCT00577460|588517014|FG002|Overall Study|Other|2|||
162949221|NCT00162123|588517015|FG000|Overall Study|Disease progression|27|||
162949222|NCT00162123|588517016|FG001|Overall Study|Disease progression|19|||
162949223|NCT00162123|588517017|FG002|Overall Study|Disease progression|10|||
163187844|NCT00785928|589403863|FG003|Treatment Phase|Inadequate Response|0|||
163187845|NCT00785928|589403864|FG004|Treatment Phase|Inadequate Response|0|||
163187846|NCT00785928|589403865|FG005|Treatment Phase|Inadequate Response|0|||
163187847|NCT00785928|589403866|FG006|Treatment Phase|Inadequate Response|0|||
163187848|NCT00785928|589403860|FG000|Treatment Phase|Lack of Efficacy|0|||
163187849|NCT00785928|589403861|FG001|Treatment Phase|Lack of Efficacy|1|||
163187850|NCT00785928|589403862|FG002|Treatment Phase|Lack of Efficacy|1|||
163187851|NCT00785928|589403863|FG003|Treatment Phase|Lack of Efficacy|0|||
163187852|NCT00785928|589403864|FG004|Treatment Phase|Lack of Efficacy|0|||
163187853|NCT00785928|589403865|FG005|Treatment Phase|Lack of Efficacy|0|||
163187854|NCT00785928|589403866|FG006|Treatment Phase|Lack of Efficacy|0|||
163187855|NCT00785928|589403860|FG000|Treatment Phase|Physician Decision|0|||
163293396|NCT01400776|589780831|FG003|Overall Study|Protocol Deviation|2|||
163293397|NCT01400776|589780828|FG000|Overall Study|Reason not Specified|3|||
163293398|NCT01400776|589780829|FG001|Overall Study|Reason not Specified|0|||
163293399|NCT01400776|589780830|FG002|Overall Study|Reason not Specified|4|||
163293400|NCT01400776|589780831|FG003|Overall Study|Reason not Specified|3|||
163293401|NCT03192046|589780834|FG000|Overall Study|Withdrawal by Subject|1|||
163293402|NCT03192046|589780835|FG001|Overall Study|Withdrawal by Subject|1|||
163293403|NCT01194154|589780838|FG000|Overall Study|Adverse Event|12|||
163293404|NCT01194154|589780839|FG001|Overall Study|Adverse Event|7|||
163293405|NCT01194154|589780838|FG000|Overall Study|Lost to Follow-up|2|||
163293406|NCT01194154|589780839|FG001|Overall Study|Lost to Follow-up|3|||
163293407|NCT01194154|589780838|FG000|Overall Study|Protocol Violation|0|||
163293408|NCT01194154|589780839|FG001|Overall Study|Protocol Violation|1|||
163293409|NCT01194154|589780838|FG000|Overall Study|Withdrawal by Subject|5|||
163293410|NCT01194154|589780839|FG001|Overall Study|Withdrawal by Subject|6|||
163293411|NCT01194154|589780838|FG000|Overall Study|Blood pressure increase|5|||
163293412|NCT01194154|589780839|FG001|Overall Study|Blood pressure increase|3|||
163293413|NCT01194154|589780838|FG000|Overall Study|Hemoglobin decrease|0|||
163293414|NCT01194154|589780839|FG001|Overall Study|Hemoglobin decrease|1|||
163293415|NCT01194154|589780838|FG000|Overall Study|Hemoglobin increase|12|||
163293416|NCT01194154|589780839|FG001|Overall Study|Hemoglobin increase|3|||
163293417|NCT01194154|589780838|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
163293418|NCT01194154|589780839|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
163293419|NCT01194154|589780838|FG000|Overall Study|Treatment with prohibited medication|4|||
163293420|NCT01194154|589780839|FG001|Overall Study|Treatment with prohibited medication|5|||
163293421|NCT01194154|589780838|FG000|Overall Study|Other|4|||
163293422|NCT01194154|589780839|FG001|Overall Study|Other|0|||
163293423|NCT01194154|589780838|FG000|Overall Study|Did not receive study medication|2|||
163293424|NCT01194154|589780839|FG001|Overall Study|Did not receive study medication|4|||
163293425|NCT00842257|589780840|FG000|Overall Study|Adverse Event|1|||
163293426|NCT01901276|589780841|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
163293427|NCT01901276|589780842|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
163293428|NCT03482011|589780847|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
163293429|NCT03482011|589780848|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
163293430|NCT03482011|589780849|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
163293431|NCT03482011|589780850|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
163293432|NCT03482011|589780851|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
163293433|NCT03482011|589780852|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
163293434|NCT03482011|589780853|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
163293435|NCT03482011|589780854|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
163293436|NCT03482011|589780847|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
163293437|NCT03482011|589780848|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
163293438|NCT03482011|589780849|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163293439|NCT03482011|589780850|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163293440|NCT03482011|589780851|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163293441|NCT03482011|589780852|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163293442|NCT03482011|589780853|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163293443|NCT03482011|589780854|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163293444|NCT03482011|589780847|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
163293445|NCT03482011|589780848|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
163293446|NCT03482011|589780849|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
163293447|NCT03482011|589780850|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
163293448|NCT03482011|589780851|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
163293449|NCT03482011|589780852|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
163293450|NCT03482011|589780853|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
163187856|NCT00785928|589403861|FG001|Treatment Phase|Physician Decision|0|||
163187857|NCT00785928|589403862|FG002|Treatment Phase|Physician Decision|0|||
163187858|NCT00785928|589403863|FG003|Treatment Phase|Physician Decision|0|||
163187859|NCT00785928|589403864|FG004|Treatment Phase|Physician Decision|1|||
163293451|NCT03482011|589780854|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
163187860|NCT00785928|589403865|FG005|Treatment Phase|Physician Decision|0|||
163187861|NCT00785928|589403866|FG006|Treatment Phase|Physician Decision|0|||
163187862|NCT00785928|589403860|FG000|Treatment Phase|Sponsor Decision|1|||
162949224|NCT00162123|588517018|FG003|Overall Study|Disease progression|4|||
162949225|NCT00162123|588517019|FG004|Overall Study|Disease progression|8|||
162949226|NCT00162123|588517020|FG005|Overall Study|Disease progression|3|||
162949227|NCT00162123|588517021|FG006|Overall Study|Disease progression|1|||
162949228|NCT00162123|588517022|FG007|Overall Study|Disease progression|0|||
162949229|NCT00162123|588517015|FG000|Overall Study|Study drug toxicity|6|||
162949230|NCT00162123|588517016|FG001|Overall Study|Study drug toxicity|1|||
162949231|NCT00162123|588517017|FG002|Overall Study|Study drug toxicity|5|||
162949232|NCT00162123|588517018|FG003|Overall Study|Study drug toxicity|0|||
162949233|NCT00162123|588517019|FG004|Overall Study|Study drug toxicity|4|||
162949234|NCT00162123|588517020|FG005|Overall Study|Study drug toxicity|1|||
162949235|NCT00162123|588517021|FG006|Overall Study|Study drug toxicity|1|||
162949236|NCT00162123|588517022|FG007|Overall Study|Study drug toxicity|0|||
162949237|NCT00162123|588517015|FG000|Overall Study|Death|3|||
162949238|NCT00162123|588517016|FG001|Overall Study|Death|3|||
162949239|NCT00162123|588517017|FG002|Overall Study|Death|1|||
162949240|NCT00162123|588517018|FG003|Overall Study|Death|1|||
162949241|NCT00162123|588517019|FG004|Overall Study|Death|1|||
162949242|NCT00162123|588517020|FG005|Overall Study|Death|1|||
162949243|NCT00162123|588517021|FG006|Overall Study|Death|0|||
162949244|NCT00162123|588517022|FG007|Overall Study|Death|0|||
162949245|NCT00162123|588517015|FG000|Overall Study|Withdrawal by Subject|2|||
162949246|NCT00162123|588517016|FG001|Overall Study|Withdrawal by Subject|0|||
162949247|NCT00162123|588517017|FG002|Overall Study|Withdrawal by Subject|2|||
162949248|NCT00162123|588517018|FG003|Overall Study|Withdrawal by Subject|1|||
162949249|NCT00162123|588517019|FG004|Overall Study|Withdrawal by Subject|1|||
162949250|NCT00162123|588517020|FG005|Overall Study|Withdrawal by Subject|2|||
162949251|NCT00162123|588517021|FG006|Overall Study|Withdrawal by Subject|1|||
162949252|NCT00162123|588517022|FG007|Overall Study|Withdrawal by Subject|0|||
162949253|NCT00162123|588517015|FG000|Overall Study|Deterioration without progression|2|||
162949254|NCT00162123|588517016|FG001|Overall Study|Deterioration without progression|2|||
162949255|NCT00162123|588517017|FG002|Overall Study|Deterioration without progression|3|||
162949256|NCT00162123|588517018|FG003|Overall Study|Deterioration without progression|0|||
162949257|NCT00162123|588517019|FG004|Overall Study|Deterioration without progression|1|||
162949258|NCT00162123|588517020|FG005|Overall Study|Deterioration without progression|0|||
162949259|NCT00162123|588517021|FG006|Overall Study|Deterioration without progression|0|||
162949260|NCT00162123|588517022|FG007|Overall Study|Deterioration without progression|0|||
162949261|NCT00162123|588517015|FG000|Overall Study|Adverse Event|1|||
162949262|NCT00162123|588517016|FG001|Overall Study|Adverse Event|2|||
162949263|NCT00162123|588517017|FG002|Overall Study|Adverse Event|0|||
162949264|NCT00162123|588517018|FG003|Overall Study|Adverse Event|2|||
162949265|NCT00162123|588517019|FG004|Overall Study|Adverse Event|1|||
162949266|NCT00162123|588517020|FG005|Overall Study|Adverse Event|0|||
162949267|NCT00162123|588517021|FG006|Overall Study|Adverse Event|0|||
162949268|NCT00162123|588517022|FG007|Overall Study|Adverse Event|0|||
162949269|NCT00162123|588517015|FG000|Overall Study|Not specified (before treatment)|2|||
163187863|NCT00785928|589403861|FG001|Treatment Phase|Sponsor Decision|0|||
163187864|NCT00785928|589403862|FG002|Treatment Phase|Sponsor Decision|0|||
163187865|NCT00785928|589403863|FG003|Treatment Phase|Sponsor Decision|0|||
163187866|NCT00785928|589403864|FG004|Treatment Phase|Sponsor Decision|0|||
163187867|NCT00785928|589403865|FG005|Treatment Phase|Sponsor Decision|0|||
163187868|NCT00785928|589403866|FG006|Treatment Phase|Sponsor Decision|1|||
163187869|NCT00785928|589403860|FG000|Treatment Phase|Withdrawal by Subject|1|||
162949270|NCT00162123|588517016|FG001|Overall Study|Not specified (before treatment)|0|||
162949271|NCT00162123|588517017|FG002|Overall Study|Not specified (before treatment)|0|||
162949272|NCT00162123|588517018|FG003|Overall Study|Not specified (before treatment)|0|||
162949273|NCT00162123|588517019|FG004|Overall Study|Not specified (before treatment)|12|||
163187870|NCT00785928|589403861|FG001|Treatment Phase|Withdrawal by Subject|2|||
162949274|NCT00162123|588517020|FG005|Overall Study|Not specified (before treatment)|1|||
162949275|NCT00162123|588517021|FG006|Overall Study|Not specified (before treatment)|0|||
162949276|NCT00162123|588517022|FG007|Overall Study|Not specified (before treatment)|0|||
162949277|NCT00162123|588517015|FG000|Overall Study|Not specified (after start of treatment)|0|||
162949278|NCT00162123|588517016|FG001|Overall Study|Not specified (after start of treatment)|0|||
162949279|NCT00162123|588517017|FG002|Overall Study|Not specified (after start of treatment)|0|||
162949280|NCT00162123|588517018|FG003|Overall Study|Not specified (after start of treatment)|0|||
163187871|NCT00785928|589403862|FG002|Treatment Phase|Withdrawal by Subject|0|||
162949281|NCT00162123|588517019|FG004|Overall Study|Not specified (after start of treatment)|3|||
162949282|NCT00162123|588517020|FG005|Overall Study|Not specified (after start of treatment)|0|||
162949283|NCT00162123|588517021|FG006|Overall Study|Not specified (after start of treatment)|0|||
162949284|NCT00162123|588517022|FG007|Overall Study|Not specified (after start of treatment)|0|||
162949285|NCT00162123|588517015|FG000|Overall Study|Physician Decision|1|||
162949286|NCT00162123|588517016|FG001|Overall Study|Physician Decision|2|||
162949287|NCT00162123|588517017|FG002|Overall Study|Physician Decision|0|||
162949288|NCT00162123|588517018|FG003|Overall Study|Physician Decision|0|||
162949289|NCT00162123|588517019|FG004|Overall Study|Physician Decision|0|||
162949290|NCT00162123|588517020|FG005|Overall Study|Physician Decision|1|||
162949291|NCT00162123|588517021|FG006|Overall Study|Physician Decision|1|||
162949292|NCT00162123|588517022|FG007|Overall Study|Physician Decision|0|||
162949293|NCT00162123|588517015|FG000|Overall Study|Tumor assessment only (not treated)|0|||
162949294|NCT00162123|588517016|FG001|Overall Study|Tumor assessment only (not treated)|0|||
162949295|NCT00162123|588517017|FG002|Overall Study|Tumor assessment only (not treated)|0|||
162949296|NCT00162123|588517018|FG003|Overall Study|Tumor assessment only (not treated)|0|||
162949297|NCT00162123|588517019|FG004|Overall Study|Tumor assessment only (not treated)|0|||
162949298|NCT00162123|588517020|FG005|Overall Study|Tumor assessment only (not treated)|0|||
162949299|NCT00162123|588517021|FG006|Overall Study|Tumor assessment only (not treated)|0|||
162949300|NCT00162123|588517022|FG007|Overall Study|Tumor assessment only (not treated)|1|||
162949301|NCT00162123|588517015|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
162949302|NCT00162123|588517016|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
162949303|NCT00162123|588517017|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
162949304|NCT00162123|588517018|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
162949305|NCT00162123|588517019|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
162949306|NCT00162123|588517020|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
162949307|NCT00162123|588517021|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
162949308|NCT00162123|588517022|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
162949309|NCT02016170|588517023|FG000|Overall Study|Adverse Event|1|||
162949310|NCT02016170|588517024|FG001|Overall Study|Adverse Event|1|||
162949311|NCT02016170|588517025|FG002|Overall Study|Adverse Event|0|||
162949312|NCT02016170|588517023|FG000|Overall Study|Protocol Violation|1|||
162949313|NCT02016170|588517024|FG001|Overall Study|Protocol Violation|0|||
162949314|NCT02016170|588517025|FG002|Overall Study|Protocol Violation|0|||
162949315|NCT05214560|588517028|FG000|Overall Study|Screening Failure|1|||
162949316|NCT05214560|588517028|FG000|Overall Study|Physician Decision|4|||
162949317|NCT05214560|588517028|FG000|Overall Study|Withdrawal by Subject|1|||
162949318|NCT05214560|588517028|FG000|Overall Study|Lost to Follow-up|2|||
162949319|NCT05214560|588517028|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
162949320|NCT05214560|588517028|FG000|Overall Study|Study physician not available for the anesthesia|3|||
162949321|NCT05214560|588517028|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
162949322|NCT05214560|588517028|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
162949323|NCT05214560|588517028|FG000|Overall Study|Surgery not performed|3|||
162949324|NCT00878995|588517032|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
162949325|NCT00878995|588517033|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
162949326|NCT03629249|588517034|FG000|Overall Study|Study terminated by sponsor|197|||
162949327|NCT03629249|588517035|FG001|Overall Study|Study terminated by sponsor|197|||
162949328|NCT03629249|588517036|FG002|Overall Study|Study terminated by sponsor|194|||
162949329|NCT03629249|588517034|FG000|Overall Study|Protocol deviation|0|||
162949330|NCT03629249|588517035|FG001|Overall Study|Protocol deviation|2|||
162949331|NCT03629249|588517036|FG002|Overall Study|Protocol deviation|5|||
162949332|NCT03629249|588517034|FG000|Overall Study|Subject decision|1|||
162949333|NCT03629249|588517035|FG001|Overall Study|Subject decision|1|||
162949334|NCT03629249|588517036|FG002|Overall Study|Subject decision|3|||
162949335|NCT03629249|588517034|FG000|Overall Study|Adverse Event|1|||
162949336|NCT03629249|588517035|FG001|Overall Study|Adverse Event|1|||
162949337|NCT03629249|588517036|FG002|Overall Study|Adverse Event|0|||
162949338|NCT03629249|588517034|FG000|Overall Study|Death|1|||
162949339|NCT03629249|588517035|FG001|Overall Study|Death|0|||
162949340|NCT03629249|588517036|FG002|Overall Study|Death|0|||
162949341|NCT03629249|588517034|FG000|Overall Study|Physician Decision|1|||
162949342|NCT03629249|588517035|FG001|Overall Study|Physician Decision|0|||
162949343|NCT03629249|588517036|FG002|Overall Study|Physician Decision|0|||
162949344|NCT00352690|588517037|FG000|Overall Study|Determined to be ineligible|2|||
162949345|NCT00352690|588517038|FG001|Overall Study|Determined to be ineligible|0|||
162949346|NCT03633721|588517041|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
162949347|NCT03633721|588517042|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
162949348|NCT03633721|588517043|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
162949349|NCT03633721|588517044|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
162949350|NCT01475474|588517048|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
162949351|NCT01475474|588517048|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
162949352|NCT02343120|588517049|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
162949353|NCT02343120|588517050|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
163293452|NCT03482011|589780847|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
162949354|NCT02343120|588517051|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
162949355|NCT02343120|588517052|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
162949356|NCT02343120|588517053|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
163293453|NCT03482011|589780848|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
163293454|NCT03482011|589780849|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
163293455|NCT03482011|589780850|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
163293456|NCT03482011|589780851|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
163293457|NCT03482011|589780852|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
163293458|NCT03482011|589780853|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
162949357|NCT02343120|588517049|FG000|Part 1: Dose Escalation|Death|1|||
162949358|NCT02343120|588517050|FG001|Part 1: Dose Escalation|Death|2|||
162949359|NCT02343120|588517051|FG002|Part 1: Dose Escalation|Death|2|||
162949360|NCT02343120|588517052|FG003|Part 1: Dose Escalation|Death|2|||
162949361|NCT02343120|588517053|FG004|Part 1: Dose Escalation|Death|1|||
162949362|NCT02343120|588517049|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
162949363|NCT02343120|588517050|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
162949364|NCT02343120|588517051|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
162949365|NCT02343120|588517052|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
162949366|NCT02343120|588517053|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
162949367|NCT02343120|588517049|FG000|Part 2: Expansion|Sponsor decision|0|||
162949368|NCT02343120|588517050|FG001|Part 2: Expansion|Sponsor decision|0|||
162949369|NCT02343120|588517051|FG002|Part 2: Expansion|Sponsor decision|0|||
162949370|NCT02343120|588517052|FG003|Part 2: Expansion|Sponsor decision|165|||
162949371|NCT02343120|588517053|FG004|Part 2: Expansion|Sponsor decision|67|||
162949372|NCT02343120|588517049|FG000|Part 2: Expansion|Death|0|||
162949373|NCT02343120|588517050|FG001|Part 2: Expansion|Death|0|||
162949374|NCT02343120|588517051|FG002|Part 2: Expansion|Death|0|||
162949375|NCT02343120|588517052|FG003|Part 2: Expansion|Death|74|||
162949376|NCT02343120|588517053|FG004|Part 2: Expansion|Death|17|||
162949377|NCT02343120|588517049|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
162949378|NCT02343120|588517050|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
162949379|NCT02343120|588517051|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
162949380|NCT02343120|588517052|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
162949381|NCT02343120|588517053|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
162949382|NCT02343120|588517049|FG000|Part 2: Expansion|Lost to Follow-up|0|||
162949383|NCT02343120|588517050|FG001|Part 2: Expansion|Lost to Follow-up|0|||
162949384|NCT02343120|588517051|FG002|Part 2: Expansion|Lost to Follow-up|0|||
162949385|NCT02343120|588517052|FG003|Part 2: Expansion|Lost to Follow-up|5|||
162949386|NCT02343120|588517053|FG004|Part 2: Expansion|Lost to Follow-up|2|||
162949387|NCT02343120|588517049|FG000|Part 2: Expansion|Other|0|||
162949388|NCT02343120|588517050|FG001|Part 2: Expansion|Other|0|||
162949389|NCT02343120|588517051|FG002|Part 2: Expansion|Other|0|||
162949390|NCT02343120|588517052|FG003|Part 2: Expansion|Other|1|||
162949391|NCT02343120|588517053|FG004|Part 2: Expansion|Other|5|||
162949392|NCT02343120|588517049|FG000|Part 2: Expansion|Adverse Event|0|||
162949393|NCT02343120|588517050|FG001|Part 2: Expansion|Adverse Event|0|||
162949394|NCT02343120|588517051|FG002|Part 2: Expansion|Adverse Event|0|||
162949395|NCT02343120|588517052|FG003|Part 2: Expansion|Adverse Event|1|||
162949396|NCT02343120|588517053|FG004|Part 2: Expansion|Adverse Event|1|||
162949397|NCT02534493|588517059|FG000|Overall Study|Lost to Follow-up|1|||
162949398|NCT02534493|588517059|FG000|Overall Study|Withdrawal by Subject|1|||
162949399|NCT01691248|588517060|FG000|Overall Study|Protocol Violation|43|||
162949400|NCT01691248|588517061|FG001|Overall Study|Protocol Violation|27|||
162949401|NCT01691248|588517060|FG000|Overall Study|Adverse Event|24|||
162949402|NCT01691248|588517061|FG001|Overall Study|Adverse Event|22|||
162949403|NCT01691248|588517060|FG000|Overall Study|Withdrawal by Subject|20|||
162949404|NCT01691248|588517061|FG001|Overall Study|Withdrawal by Subject|18|||
162949405|NCT01691248|588517060|FG000|Overall Study|Confirmed CDAD|14|||
162949406|NCT01691248|588517061|FG001|Overall Study|Confirmed CDAD|31|||
162949407|NCT01691248|588517060|FG000|Overall Study|Lost to Follow-up|2|||
162949408|NCT01691248|588517061|FG001|Overall Study|Lost to Follow-up|5|||
162949409|NCT01691248|588517060|FG000|Overall Study|Reason not provided|4|||
162949410|NCT01691248|588517061|FG001|Overall Study|Reason not provided|4|||
162949411|NCT01691248|588517060|FG000|Overall Study|Not Treated|4|||
162949412|NCT01691248|588517061|FG001|Overall Study|Not Treated|7|||
162949413|NCT00549718|588518704|FG000|Overall Study|Insufficient clinical response|20|||
162949414|NCT00549718|588518705|FG001|Overall Study|Insufficient clinical response|7|||
162949415|NCT00549718|588518706|FG002|Overall Study|Insufficient clinical response|18|||
162949416|NCT00549718|588518707|FG003|Overall Study|Insufficient clinical response|32|||
162949417|NCT00549718|588518704|FG000|Overall Study|Adverse Event|6|||
162949418|NCT00549718|588518705|FG001|Overall Study|Adverse Event|8|||
162949419|NCT00549718|588518706|FG002|Overall Study|Adverse Event|7|||
162949420|NCT00549718|588518707|FG003|Overall Study|Adverse Event|3|||
162949421|NCT00549718|588518704|FG000|Overall Study|Lost to Follow-up|4|||
162949422|NCT00549718|588518705|FG001|Overall Study|Lost to Follow-up|2|||
162949423|NCT00549718|588518706|FG002|Overall Study|Lost to Follow-up|0|||
162949424|NCT00549718|588518707|FG003|Overall Study|Lost to Follow-up|6|||
162949425|NCT00549718|588518704|FG000|Overall Study|Withdrawal by Subject|9|||
162949426|NCT00549718|588518705|FG001|Overall Study|Withdrawal by Subject|18|||
162949427|NCT00549718|588518706|FG002|Overall Study|Withdrawal by Subject|12|||
162949428|NCT00549718|588518707|FG003|Overall Study|Withdrawal by Subject|13|||
162949429|NCT00549718|588518704|FG000|Overall Study|Administrative|2|||
162949430|NCT00549718|588518705|FG001|Overall Study|Administrative|2|||
162949431|NCT00549718|588518706|FG002|Overall Study|Administrative|2|||
162949432|NCT00549718|588518707|FG003|Overall Study|Administrative|1|||
162949433|NCT00397488|588518708|FG000|Overall Study|Withdrawal by Subject|3|||
162949434|NCT00397488|588518708|FG000|Overall Study|Adverse Event|3|||
162949435|NCT00397488|588518708|FG000|Overall Study|Death|1|||
162949436|NCT02880761|588518712|FG000|Overall Study|Death|6|||
162949437|NCT02880761|588518713|FG001|Overall Study|Death|8|||
162949438|NCT02880761|588518712|FG000|Overall Study|Withdrawal by Subject|3|||
162949439|NCT02880761|588518713|FG001|Overall Study|Withdrawal by Subject|6|||
162949440|NCT02880761|588518712|FG000|Overall Study|Protocol Violation|4|||
162949441|NCT02880761|588518713|FG001|Overall Study|Protocol Violation|3|||
162949442|NCT02880761|588518712|FG000|Overall Study|Lost to Follow-up|3|||
162949443|NCT02880761|588518713|FG001|Overall Study|Lost to Follow-up|4|||
162949444|NCT02106156|588518714|FG000|Overall Study|Patient Died|19|||
162949445|NCT02106156|588518715|FG001|Overall Study|Patient Died|0|||
162949446|NCT02106156|588518716|FG002|Overall Study|Patient Died|0|||
162949447|NCT02106156|588518714|FG000|Overall Study|Lack of Tolerability|305|||
162949448|NCT02106156|588518715|FG001|Overall Study|Lack of Tolerability|3|||
162949449|NCT02106156|588518716|FG002|Overall Study|Lack of Tolerability|0|||
162949450|NCT02106156|588518714|FG000|Overall Study|Lack of Virological Response|1044|||
162949451|NCT02106156|588518715|FG001|Overall Study|Lack of Virological Response|8|||
162949452|NCT02106156|588518716|FG002|Overall Study|Lack of Virological Response|0|||
162949453|NCT02106156|588518714|FG000|Overall Study|Concomitant Disease|74|||
162949454|NCT02106156|588518715|FG001|Overall Study|Concomitant Disease|2|||
162949455|NCT02106156|588518716|FG002|Overall Study|Concomitant Disease|0|||
162949456|NCT02106156|588518714|FG000|Overall Study|Lack of Compliance|211|||
162949457|NCT02106156|588518715|FG001|Overall Study|Lack of Compliance|7|||
162949458|NCT02106156|588518716|FG002|Overall Study|Lack of Compliance|0|||
162949459|NCT02106156|588518714|FG000|Overall Study|Patients Request|307|||
162949460|NCT02106156|588518715|FG001|Overall Study|Patients Request|9|||
162949461|NCT02106156|588518716|FG002|Overall Study|Patients Request|0|||
162949462|NCT02106156|588518714|FG000|Overall Study|Lost to Follow-up|451|||
162949463|NCT02106156|588518715|FG001|Overall Study|Lost to Follow-up|8|||
162949464|NCT02106156|588518716|FG002|Overall Study|Lost to Follow-up|0|||
162949465|NCT02106156|588518714|FG000|Overall Study|Unplanned Event|82|||
162949466|NCT02106156|588518715|FG001|Overall Study|Unplanned Event|2|||
162949467|NCT02106156|588518716|FG002|Overall Study|Unplanned Event|0|||
162949468|NCT02106156|588518714|FG000|Overall Study|Change of Laboratory Parameter|10|||
162949469|NCT02106156|588518715|FG001|Overall Study|Change of Laboratory Parameter|0|||
162949470|NCT02106156|588518716|FG002|Overall Study|Change of Laboratory Parameter|0|||
162949471|NCT02106156|588518714|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
162949472|NCT02106156|588518715|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
162949473|NCT02106156|588518716|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
162949474|NCT02106156|588518714|FG000|Overall Study|Relocation/Change of Physician|40|||
162949475|NCT02106156|588518715|FG001|Overall Study|Relocation/Change of Physician|1|||
162949476|NCT02106156|588518716|FG002|Overall Study|Relocation/Change of Physician|0|||
162949477|NCT01136382|588518717|FG000|Overall Study|Other|8|||
162949478|NCT01136382|588518718|FG001|Overall Study|Other|3|||
162949479|NCT01136382|588518717|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
162949480|NCT01136382|588518718|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
162949481|NCT01136382|588518717|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
162949482|NCT01136382|588518718|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
162949483|NCT01136382|588518717|FG000|Overall Study|Withdrawal by Subject|4|||
162949484|NCT01136382|588518718|FG001|Overall Study|Withdrawal by Subject|1|||
162949485|NCT01287013|588518726|FG000|Overall Study|Non-evaluable|3|||
162949486|NCT01287013|588518727|FG001|Overall Study|Non-evaluable|5|||
162949487|NCT01287013|588518728|FG002|Overall Study|Non-evaluable|21|||
162949488|NCT00051025|588518729|FG000|Overall Study|Progressive Disease|1|||
162949489|NCT00051025|588518730|FG001|Overall Study|Progressive Disease|1|||
162949490|NCT00051025|588518729|FG000|Overall Study|Adverse Event|1|||
162949491|NCT00051025|588518730|FG001|Overall Study|Adverse Event|1|||
162949492|NCT00051025|588518729|FG000|Overall Study|Withdrawal by Subject|0|||
162949493|NCT00051025|588518730|FG001|Overall Study|Withdrawal by Subject|1|||
162949494|NCT00051025|588518729|FG000|Overall Study|Death|0|||
162949495|NCT00051025|588518730|FG001|Overall Study|Death|1|||
162949496|NCT01179048|588518731|FG000|Overall Study|Withdrawn - does not allow contact|4|||
162949497|NCT01179048|588518732|FG001|Overall Study|Withdrawn - does not allow contact|8|||
162949498|NCT01179048|588518731|FG000|Overall Study|Lost to Follow-up|8|||
162949499|NCT01179048|588518732|FG001|Overall Study|Lost to Follow-up|9|||
162949500|NCT01179048|588518731|FG000|Overall Study|Alive|127|||
162949501|NCT01179048|588518732|FG001|Overall Study|Alive|142|||
163389310|NCT00372385|590137781|FG002|Overall Study|Withdrawal by Subject|0|||
163389311|NCT00372385|590137782|FG003|Overall Study|Withdrawal by Subject|0|||
163389312|NCT00372385|590137779|FG000|Overall Study|Refusal of Treatment|3|||
163389313|NCT00372385|590137780|FG001|Overall Study|Refusal of Treatment|6|||
163389314|NCT00372385|590137781|FG002|Overall Study|Refusal of Treatment|0|||
162949502|NCT01900730|588518733|FG000|Overall Study|Withdrawal by Subject|1|||
162949503|NCT01900730|588518734|FG001|Overall Study|Withdrawal by Subject|0|||
162949504|NCT01900730|588518733|FG000|Overall Study|Screen Failure|1|||
162949505|NCT01900730|588518734|FG001|Overall Study|Screen Failure|0|||
162949506|NCT02109042|588518735|FG000|Overall Study|Sponsor Decision|15|||
162949507|NCT03203447|588518736|FG000|Overall Study|Withdrawal by Subject|2|||
162949508|NCT03203447|588518737|FG001|Overall Study|Withdrawal by Subject|1|||
162949509|NCT03203447|588518736|FG000|Overall Study|Lost to Follow-up|1|||
162949510|NCT03203447|588518737|FG001|Overall Study|Lost to Follow-up|10|||
162949511|NCT03203447|588518736|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
162949512|NCT03203447|588518737|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
162949513|NCT02189941|588518742|FG000|Overall Study|Non-compliance|0|||
162949514|NCT02189941|588518743|FG001|Overall Study|Non-compliance|0|||
162949515|NCT02189941|588518744|FG002|Overall Study|Non-compliance|1|||
162949516|NCT00445003|588518745|FG000|Overall Study|Death|1|||
162949517|NCT00445003|588518746|FG001|Overall Study|Death|2|||
162949518|NCT00445003|588518747|FG002|Overall Study|Death|1|||
162949519|NCT00445003|588518745|FG000|Overall Study|Missed Visit|3|||
162949520|NCT00445003|588518746|FG001|Overall Study|Missed Visit|5|||
162949521|NCT00445003|588518747|FG002|Overall Study|Missed Visit|1|||
162949522|NCT00445003|588518745|FG000|Overall Study|Dropped|1|||
162949523|NCT00445003|588518746|FG001|Overall Study|Dropped|3|||
162949524|NCT00445003|588518747|FG002|Overall Study|Dropped|2|||
162949525|NCT01471093|588518750|FG000|Overall Study|Adverse Event|1|||
162949526|NCT01471093|588518751|FG001|Overall Study|Adverse Event|0|||
162949527|NCT01471093|588518752|FG002|Overall Study|Adverse Event|0|||
162949528|NCT01471093|588518753|FG003|Overall Study|Adverse Event|0|||
162949529|NCT00528606|588518754|FG000|Overall Study|Withdrew consent|4|||
162949530|NCT00528606|588518755|FG001|Overall Study|Withdrew consent|3|||
162949531|NCT00528606|588518754|FG000|Overall Study|Lost to Follow-up|4|||
162949532|NCT00528606|588518755|FG001|Overall Study|Lost to Follow-up|1|||
162949533|NCT00528606|588518754|FG000|Overall Study|Adverse Event|3|||
162949534|NCT00528606|588518755|FG001|Overall Study|Adverse Event|0|||
162949535|NCT00528606|588518754|FG000|Overall Study|Other|2|||
162949536|NCT00528606|588518755|FG001|Overall Study|Other|0|||
162949537|NCT02475954|588518756|FG000|Overall Study|Withdrawal by Subject|2|||
162949538|NCT02475954|588518757|FG001|Overall Study|Withdrawal by Subject|2|||
162949539|NCT02475954|588518756|FG000|Overall Study|Lost to Follow-up|11|||
162949540|NCT02475954|588518757|FG001|Overall Study|Lost to Follow-up|9|||
162949541|NCT02475954|588518756|FG000|Overall Study|Death|1|||
162949542|NCT02475954|588518757|FG001|Overall Study|Death|1|||
162949543|NCT00880568|588518759|FG000|Overall Study|Disease progression|3|||
162949544|NCT00880568|588518760|FG001|Overall Study|Disease progression|3|||
162949545|NCT00880568|588518761|FG002|Overall Study|Disease progression|3|||
162949546|NCT00880568|588518762|FG003|Overall Study|Disease progression|1|||
162949547|NCT00880568|588518763|FG004|Overall Study|Disease progression|3|||
162949548|NCT00880568|588518764|FG005|Overall Study|Disease progression|3|||
162949549|NCT00880568|588518765|FG006|Overall Study|Disease progression|5|||
162949550|NCT00880568|588518766|FG007|Overall Study|Disease progression|0|||
162949551|NCT00880568|588518767|FG008|Overall Study|Disease progression|3|||
162949552|NCT00880568|588518759|FG000|Overall Study|Adverse Event|0|||
162949553|NCT00880568|588518760|FG001|Overall Study|Adverse Event|0|||
162949554|NCT00880568|588518761|FG002|Overall Study|Adverse Event|0|||
162949555|NCT00880568|588518762|FG003|Overall Study|Adverse Event|0|||
163187872|NCT00785928|589403863|FG003|Treatment Phase|Withdrawal by Subject|0|||
163187873|NCT00785928|589403864|FG004|Treatment Phase|Withdrawal by Subject|1|||
163187874|NCT00785928|589403865|FG005|Treatment Phase|Withdrawal by Subject|0|||
163187875|NCT00785928|589403866|FG006|Treatment Phase|Withdrawal by Subject|0|||
163187876|NCT02923427|589403873|FG000|Overall Study|convert to laparatomy|2|||
163187877|NCT02923427|589403874|FG001|Overall Study|convert to laparatomy|2|||
163187878|NCT02923427|589403873|FG000|Overall Study|destaturation|1|||
163187879|NCT02923427|589403874|FG001|Overall Study|destaturation|0|||
163187880|NCT02923427|589403873|FG000|Overall Study|can not replace LMA|1|||
163187881|NCT02923427|589403874|FG001|Overall Study|can not replace LMA|0|||
163187882|NCT01539642|589403879|FG000|Overall Study|Lack of Efficacy|20|||
163187883|NCT01539642|589403880|FG001|Overall Study|Lack of Efficacy|18|||
163187884|NCT01539642|589403879|FG000|Overall Study|Patient ready for early discharge|8|||
163187885|NCT01539642|589403880|FG001|Overall Study|Patient ready for early discharge|7|||
163187886|NCT01539642|589403879|FG000|Overall Study|Adverse Event|6|||
163293459|NCT03482011|589780854|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
163293460|NCT03482011|589780847|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
163187887|NCT01539642|589403880|FG001|Overall Study|Adverse Event|4|||
162949556|NCT00880568|588518763|FG004|Overall Study|Adverse Event|0|||
162949557|NCT00880568|588518764|FG005|Overall Study|Adverse Event|0|||
162949558|NCT00880568|588518765|FG006|Overall Study|Adverse Event|1|||
162949559|NCT00880568|588518766|FG007|Overall Study|Adverse Event|1|||
163187888|NCT01539642|589403879|FG000|Overall Study|Withdrawal by Subject|2|||
162949560|NCT00880568|588518767|FG008|Overall Study|Adverse Event|0|||
162949561|NCT00880568|588518759|FG000|Overall Study|Withdrawal by Subject|0|||
162949562|NCT00880568|588518760|FG001|Overall Study|Withdrawal by Subject|0|||
162949563|NCT00880568|588518761|FG002|Overall Study|Withdrawal by Subject|0|||
162949564|NCT00880568|588518762|FG003|Overall Study|Withdrawal by Subject|0|||
162949565|NCT00880568|588518763|FG004|Overall Study|Withdrawal by Subject|0|||
162949566|NCT00880568|588518764|FG005|Overall Study|Withdrawal by Subject|0|||
162949567|NCT00880568|588518765|FG006|Overall Study|Withdrawal by Subject|0|||
162949568|NCT00880568|588518766|FG007|Overall Study|Withdrawal by Subject|1|||
162949569|NCT00880568|588518767|FG008|Overall Study|Withdrawal by Subject|0|||
162949570|NCT00620022|588518768|FG000|Treatment Period 1|Adverse Event|4|||
162949571|NCT00620022|588518769|FG001|Treatment Period 1|Adverse Event|6|||
162949572|NCT00620022|588518768|FG000|Treatment Period 1|Subject withdrew consent|1|||
162949573|NCT00620022|588518769|FG001|Treatment Period 1|Subject withdrew consent|0|||
162949574|NCT00620022|588518768|FG000|Treatment Period 2|Adverse Event|2|||
162949575|NCT00620022|588518769|FG001|Treatment Period 2|Adverse Event|2|||
162949576|NCT00760266|588518771|FG000|Overall Study|Adverse Event|13|||
162949577|NCT00760266|588518772|FG001|Overall Study|Adverse Event|7|||
162949578|NCT00760266|588518771|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162949579|NCT00760266|588518772|FG001|Overall Study|Abnormal laboratory value(s)|0|||
162949580|NCT00760266|588518771|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162949581|NCT00760266|588518772|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162949582|NCT00760266|588518771|FG000|Overall Study|Lack of Efficacy|2|||
162949583|NCT00760266|588518772|FG001|Overall Study|Lack of Efficacy|2|||
162949584|NCT00760266|588518771|FG000|Overall Study|Protocol deviation|2|||
162949585|NCT00760266|588518772|FG001|Overall Study|Protocol deviation|4|||
162949586|NCT00760266|588518771|FG000|Overall Study|Patient withdrew consent|3|||
162949587|NCT00760266|588518772|FG001|Overall Study|Patient withdrew consent|3|||
162949588|NCT00760266|588518771|FG000|Overall Study|Lost to Follow-up|2|||
163187889|NCT01539642|589403880|FG001|Overall Study|Withdrawal by Subject|2|||
163187890|NCT03611010|589403881|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
163187891|NCT03611010|589403882|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
163187892|NCT03611010|589403883|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
163187893|NCT03611010|589403884|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
163187894|NCT05021081|589403888|FG000|Phase 2|Subject enrolled in error|1|||
163187895|NCT05021081|589403889|FG001|Phase 2|Subject enrolled in error|1|||
163187896|NCT05021081|589403890|FG002|Phase 2|Subject enrolled in error|0|||
163187897|NCT03257371|589403897|FG000|Overall Study|Lost to Follow-up|1|||
163187898|NCT03387683|589403898|FG000|Overall Study|In receipt of disallowed medication|1|||
163187899|NCT03387683|589403899|FG001|Overall Study|In receipt of disallowed medication|0|||
163187900|NCT03387683|589403898|FG000|Overall Study|Did not receive treatment|1|||
163187901|NCT03387683|589403899|FG001|Overall Study|Did not receive treatment|0|||
163187902|NCT00566501|589403902|FG000|Overall Study|Adverse Event|68|||
163187903|NCT00566501|589403903|FG001|Overall Study|Adverse Event|59|||
163187904|NCT00566501|589403902|FG000|Overall Study|Medication Non-compliance|5|||
163187905|NCT00566501|589403903|FG001|Overall Study|Medication Non-compliance|0|||
163187906|NCT00566501|589403902|FG000|Overall Study|Protocol Violation|2|||
163187907|NCT00566501|589403903|FG001|Overall Study|Protocol Violation|2|||
163187908|NCT00566501|589403902|FG000|Overall Study|Request of Investigator or Sponsor|6|||
163187909|NCT00566501|589403903|FG001|Overall Study|Request of Investigator or Sponsor|7|||
163187910|NCT00566501|589403902|FG000|Overall Study|Withdrawal by Subject|33|||
163187911|NCT00566501|589403903|FG001|Overall Study|Withdrawal by Subject|30|||
163187912|NCT00566501|589403902|FG000|Overall Study|Lack of Efficacy|8|||
163187913|NCT00566501|589403903|FG001|Overall Study|Lack of Efficacy|3|||
163187914|NCT00566501|589403902|FG000|Overall Study|Other|25|||
163187915|NCT00566501|589403903|FG001|Overall Study|Other|21|||
163187916|NCT00057876|589403904|FG000|Overall Study|Adverse Event|8|||
163187917|NCT00057876|589403905|FG001|Overall Study|Adverse Event|8|||
163187918|NCT00057876|589403904|FG000|Overall Study|Death|2|||
163187919|NCT00057876|589403905|FG001|Overall Study|Death|1|||
163187920|NCT00057876|589403904|FG000|Overall Study|Withdrawal by Subject|5|||
163187921|NCT00057876|589403905|FG001|Overall Study|Withdrawal by Subject|6|||
163187922|NCT00057876|589403904|FG000|Overall Study|Lack of Efficacy|10|||
163187923|NCT00057876|589403905|FG001|Overall Study|Lack of Efficacy|8|||
163187924|NCT00057876|589403904|FG000|Overall Study|Ineligible|1|||
163187925|NCT00057876|589403905|FG001|Overall Study|Ineligible|2|||
163187926|NCT00057876|589403904|FG000|Overall Study|other reason|2|||
163187927|NCT00057876|589403905|FG001|Overall Study|other reason|2|||
163187928|NCT00057876|589403904|FG000|Overall Study|other complicating disease|1|||
163187929|NCT00057876|589403905|FG001|Overall Study|other complicating disease|0|||
163187930|NCT05095454|589403906|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
163187931|NCT05095454|589403907|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
162949589|NCT00760266|588518772|FG001|Overall Study|Lost to Follow-up|1|||
163187932|NCT01368432|589403908|FG000|Overall Study|Lost to Follow-up|0|||
163187933|NCT01368432|589403909|FG001|Overall Study|Lost to Follow-up|1|||
163187934|NCT02758171|589403910|FG000|Wash-out|Withdrawal by Subject|1|||
163187935|NCT02758171|589403911|FG001|Wash-out|Withdrawal by Subject|0|||
162949590|NCT00760266|588518771|FG000|Overall Study|Administrative Problems|0|||
162949591|NCT00760266|588518772|FG001|Overall Study|Administrative Problems|1|||
163187936|NCT02758171|589403910|FG000|Wash-out|Other reason|1|||
163187937|NCT02758171|589403911|FG001|Wash-out|Other reason|0|||
163187938|NCT00853073|589403912|FG000|Overall Study|Withdrawal by Subject|3|||
163187939|NCT00853073|589403913|FG001|Overall Study|Withdrawal by Subject|2|||
163187940|NCT01999114|589403914|FG000|Overall Study|Adverse Event|8|||
162949592|NCT01239121|588518773|FG000|Overall Study|Withdrawal by Subject|2|||
162949593|NCT01239121|588518774|FG001|Overall Study|Withdrawal by Subject|4|||
162949594|NCT01239121|588518775|FG002|Overall Study|Withdrawal by Subject|0|||
162949595|NCT04006171|588518778|FG000|Overall Study|Withdrawal by Subject|8|||
162949596|NCT04006171|588518779|FG001|Overall Study|Withdrawal by Subject|7|||
162949597|NCT04006171|588518778|FG000|Overall Study|missing serum samples|2|||
162949598|NCT04006171|588518779|FG001|Overall Study|missing serum samples|2|||
162949599|NCT04006171|588518778|FG000|Overall Study|insufficient sample volume|2|||
162949600|NCT04006171|588518779|FG001|Overall Study|insufficient sample volume|3|||
162949601|NCT03049488|588518780|FG000|Overall Study|Lost to Follow-up|1|||
162949602|NCT03049488|588518781|FG001|Overall Study|Lost to Follow-up|1|||
162949603|NCT03049488|588518782|FG002|Overall Study|Lost to Follow-up|0|||
162949604|NCT03049488|588518783|FG003|Overall Study|Lost to Follow-up|0|||
162949605|NCT03049488|588518784|FG004|Overall Study|Lost to Follow-up|0|||
162949606|NCT03049488|588518785|FG005|Overall Study|Lost to Follow-up|0|||
162949607|NCT03049488|588518780|FG000|Overall Study|Moved from Area|1|||
163293461|NCT03482011|589780848|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
162949608|NCT03049488|588518781|FG001|Overall Study|Moved from Area|0|||
162949609|NCT03049488|588518782|FG002|Overall Study|Moved from Area|0|||
162949610|NCT03049488|588518783|FG003|Overall Study|Moved from Area|1|||
162949611|NCT03049488|588518784|FG004|Overall Study|Moved from Area|1|||
162949612|NCT03049488|588518785|FG005|Overall Study|Moved from Area|0|||
162949613|NCT03049488|588518780|FG000|Overall Study|Physician Decision|0|||
162949614|NCT03049488|588518781|FG001|Overall Study|Physician Decision|1|||
162924225|NCT00077766|588423833|FG000|Overall Study|Dialysis Discontinued|1|||
162924226|NCT00077766|588423834|FG001|Overall Study|Dialysis Discontinued|0|||
162924227|NCT00077766|588423833|FG000|Overall Study|Dialysis|0|||
162924228|NCT00077766|588423834|FG001|Overall Study|Dialysis|1|||
162924229|NCT00077766|588423833|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
162924230|NCT00077766|588423834|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
162924231|NCT00077766|588423833|FG000|Overall Study|Started Nocturnal Dialysis|0|||
162924232|NCT00077766|588423834|FG001|Overall Study|Started Nocturnal Dialysis|1|||
162924233|NCT00077766|588423833|FG000|Overall Study|Stop Dialysis|0|||
162924234|NCT00077766|588423834|FG001|Overall Study|Stop Dialysis|1|||
162924235|NCT00077766|588423833|FG000|Overall Study|Participants Vacation|2|||
162924236|NCT00077766|588423834|FG001|Overall Study|Participants Vacation|1|||
162924237|NCT00938015|588423835|FG000|Overall Study|Death|2|||
162924238|NCT00938015|588423835|FG000|Overall Study|Lost to Follow-up|32|||
162924239|NCT00938015|588423835|FG000|Overall Study|Adverse Event|32|||
162924240|NCT00938015|588423835|FG000|Overall Study|Non-responder|52|||
162924241|NCT00938015|588423835|FG000|Overall Study|Reason not related to Etanercept|29|||
162924242|NCT03186794|588423836|FG000|Overall Study|Physician Decision|2|||
162924243|NCT03186794|588423836|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
162924244|NCT01418365|588423840|FG000|First Intervention|Withdrawal by Subject|0|||
162924245|NCT01418365|588423841|FG001|First Intervention|Withdrawal by Subject|1|||
162924246|NCT01418365|588423840|FG000|First Intervention|Non-compliance|1|||
162924247|NCT01418365|588423841|FG001|First Intervention|Non-compliance|0|||
162924248|NCT01418365|588423840|FG000|Second Intervention|Withdrawal by Subject|0|||
162924249|NCT01418365|588423841|FG001|Second Intervention|Withdrawal by Subject|1|||
162924250|NCT02575807|588423846|FG000|Overall Study|Death|8|||
162924251|NCT02575807|588423847|FG001|Overall Study|Death|3|||
162924252|NCT02575807|588423848|FG002|Overall Study|Death|7|||
162924253|NCT02575807|588423849|FG003|Overall Study|Death|0|||
162924254|NCT02575807|588423850|FG004|Overall Study|Death|1|||
162949615|NCT03049488|588518782|FG002|Overall Study|Physician Decision|0|||
162949616|NCT03049488|588518783|FG003|Overall Study|Physician Decision|0|||
162949617|NCT03049488|588518784|FG004|Overall Study|Physician Decision|0|||
162949618|NCT03049488|588518785|FG005|Overall Study|Physician Decision|0|||
162924255|NCT02575807|588423846|FG000|Overall Study|Study terminated by Sponsor|0|||
162949619|NCT03049488|588518780|FG000|Overall Study|Withdrawal by Subject|0|||
162949620|NCT03049488|588518781|FG001|Overall Study|Withdrawal by Subject|0|||
162949621|NCT03049488|588518782|FG002|Overall Study|Withdrawal by Subject|0|||
162949622|NCT03049488|588518783|FG003|Overall Study|Withdrawal by Subject|1|||
162949623|NCT03049488|588518784|FG004|Overall Study|Withdrawal by Subject|1|||
162949624|NCT03049488|588518785|FG005|Overall Study|Withdrawal by Subject|0|||
162949625|NCT00440557|588518786|FG000|Overall Study|Withdrawal by Subject|10|||
162949626|NCT00440557|588518787|FG001|Overall Study|Withdrawal by Subject|5|||
162924256|NCT02575807|588423847|FG001|Overall Study|Study terminated by Sponsor|1|||
162924257|NCT02575807|588423848|FG002|Overall Study|Study terminated by Sponsor|7|||
162924258|NCT02575807|588423849|FG003|Overall Study|Study terminated by Sponsor|0|||
162949627|NCT00440557|588518788|FG002|Overall Study|Withdrawal by Subject|11|||
162949628|NCT00440557|588518786|FG000|Overall Study|Lost to Follow-up|1|||
162949629|NCT00440557|588518787|FG001|Overall Study|Lost to Follow-up|2|||
162949630|NCT00440557|588518788|FG002|Overall Study|Lost to Follow-up|6|||
162924259|NCT02575807|588423850|FG004|Overall Study|Study terminated by Sponsor|1|||
162924260|NCT02575807|588423846|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
162924261|NCT02575807|588423847|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
162949631|NCT00440557|588518786|FG000|Overall Study|Adverse Event|3|||
162949632|NCT00440557|588518787|FG001|Overall Study|Adverse Event|3|||
163293462|NCT03482011|589780849|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162924262|NCT02575807|588423848|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
162924263|NCT02575807|588423849|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
162924264|NCT02575807|588423850|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
162924265|NCT02575807|588423846|FG000|Overall Study|Terminated due to physician decision|0|||
162949633|NCT00440557|588518788|FG002|Overall Study|Adverse Event|5|||
162949634|NCT00440557|588518786|FG000|Overall Study|Death|2|||
162949635|NCT00440557|588518787|FG001|Overall Study|Death|6|||
162949636|NCT00440557|588518788|FG002|Overall Study|Death|3|||
162949637|NCT00440557|588518786|FG000|Overall Study|Began Dialysis|4|||
162949638|NCT00440557|588518787|FG001|Overall Study|Began Dialysis|1|||
162949639|NCT00440557|588518788|FG002|Overall Study|Began Dialysis|4|||
162949640|NCT00440557|588518786|FG000|Overall Study|Principal Investigator decision|0|||
162949641|NCT00440557|588518787|FG001|Overall Study|Principal Investigator decision|3|||
162949642|NCT00440557|588518788|FG002|Overall Study|Principal Investigator decision|1|||
162949643|NCT00440557|588518786|FG000|Overall Study|Patient moved|1|||
162949644|NCT00440557|588518787|FG001|Overall Study|Patient moved|2|||
162949645|NCT00440557|588518788|FG002|Overall Study|Patient moved|1|||
162949646|NCT00440557|588518786|FG000|Overall Study|Principal Investigator's office closed|3|||
162949647|NCT00440557|588518787|FG001|Overall Study|Principal Investigator's office closed|6|||
162949648|NCT00440557|588518788|FG002|Overall Study|Principal Investigator's office closed|4|||
162949649|NCT00440557|588518786|FG000|Overall Study|Patient transferred to nursing home|0|||
162949650|NCT00440557|588518787|FG001|Overall Study|Patient transferred to nursing home|1|||
162949651|NCT00440557|588518788|FG002|Overall Study|Patient transferred to nursing home|0|||
162949652|NCT00440557|588518786|FG000|Overall Study|Patient had surgery|1|||
162949653|NCT00440557|588518787|FG001|Overall Study|Patient had surgery|0|||
162949654|NCT00440557|588518788|FG002|Overall Study|Patient had surgery|0|||
162949655|NCT01939197|588518789|FG000|Overall Study|Withdrawal by Subject|1|||
162949656|NCT01939197|588518790|FG001|Overall Study|Withdrawal by Subject|0|||
162949657|NCT01939197|588518791|FG002|Overall Study|Withdrawal by Subject|0|||
162949658|NCT01939197|588518792|FG003|Overall Study|Withdrawal by Subject|0|||
162949659|NCT01939197|588518793|FG004|Overall Study|Withdrawal by Subject|1|||
162949660|NCT01939197|588518794|FG005|Overall Study|Withdrawal by Subject|0|||
162949661|NCT01939197|588518795|FG006|Overall Study|Withdrawal by Subject|0|||
162949662|NCT01939197|588518789|FG000|Overall Study|Lost to Follow-up|0|||
162949663|NCT01939197|588518790|FG001|Overall Study|Lost to Follow-up|1|||
162949664|NCT01939197|588518791|FG002|Overall Study|Lost to Follow-up|0|||
162949665|NCT01939197|588518792|FG003|Overall Study|Lost to Follow-up|1|||
162949666|NCT01939197|588518793|FG004|Overall Study|Lost to Follow-up|3|||
162949667|NCT01939197|588518794|FG005|Overall Study|Lost to Follow-up|1|||
162949668|NCT01939197|588518795|FG006|Overall Study|Lost to Follow-up|2|||
162949669|NCT00680121|588518796|FG000|Overall Study|Lost to Follow-up|27|||
163187941|NCT01999114|589403915|FG001|Overall Study|Adverse Event|7|||
163187942|NCT01999114|589403916|FG002|Overall Study|Adverse Event|2|||
163187943|NCT01999114|589403917|FG003|Overall Study|Adverse Event|2|||
163187944|NCT01999114|589403918|FG004|Overall Study|Adverse Event|1|||
163187945|NCT01999114|589403914|FG000|Overall Study|Withdrawal by Subject|0|||
163187946|NCT01999114|589403915|FG001|Overall Study|Withdrawal by Subject|0|||
163187947|NCT01999114|589403916|FG002|Overall Study|Withdrawal by Subject|1|||
163187948|NCT01999114|589403917|FG003|Overall Study|Withdrawal by Subject|0|||
163187949|NCT01999114|589403918|FG004|Overall Study|Withdrawal by Subject|1|||
162949670|NCT00680121|588518797|FG001|Overall Study|Lost to Follow-up|23|||
163187950|NCT01999114|589403914|FG000|Overall Study|Lost to Follow-up|0|||
163187951|NCT01999114|589403915|FG001|Overall Study|Lost to Follow-up|0|||
162949671|NCT02849652|588518798|FG000|Overall Study|Lost to Follow-up|104|||
163187952|NCT01999114|589403916|FG002|Overall Study|Lost to Follow-up|1|||
163187953|NCT01999114|589403917|FG003|Overall Study|Lost to Follow-up|0|||
163187954|NCT01999114|589403918|FG004|Overall Study|Lost to Follow-up|0|||
163187955|NCT01999114|589403914|FG000|Overall Study|Administrative|0|||
163187956|NCT01999114|589403915|FG001|Overall Study|Administrative|0|||
163187957|NCT01999114|589403916|FG002|Overall Study|Administrative|1|||
163187958|NCT01999114|589403917|FG003|Overall Study|Administrative|1|||
163187959|NCT01999114|589403918|FG004|Overall Study|Administrative|2|||
163187960|NCT03840174|589403919|FG000|Overall Study|Withdrawal by Subject|1|||
163187961|NCT03840174|589403920|FG001|Overall Study|Withdrawal by Subject|0|||
163187962|NCT03840174|589403921|FG002|Overall Study|Withdrawal by Subject|0|||
163187963|NCT03840174|589403922|FG003|Overall Study|Withdrawal by Subject|0|||
163187964|NCT01008150|589403924|FG000|Overall Study|did not receive study drug|1|||
163187965|NCT01008150|589403925|FG001|Overall Study|did not receive study drug|1|||
163187966|NCT01008150|589403926|FG002|Overall Study|did not receive study drug|1|||
163187967|NCT01008150|589403927|FG003|Overall Study|did not receive study drug|0|||
163187968|NCT01497275|589403928|FG000|Overall Study|Death|1|||
163187969|NCT01497275|589403928|FG000|Overall Study|Adverse Event|1|||
163187970|NCT00381381|589403940|FG000|Overall Study|Adverse Event|3|||
163187971|NCT00381381|589403940|FG000|Overall Study|Lost to Follow-up|52|||
163187972|NCT00381381|589403940|FG000|Overall Study|Withdrawal by Subject|9|||
163187973|NCT00568685|589403941|FG000|Overall Study|Adverse Event|2|||
163187974|NCT00568685|589403942|FG001|Overall Study|Adverse Event|3|||
163187975|NCT00568685|589403943|FG002|Overall Study|Adverse Event|3|||
163187976|NCT00568685|589403941|FG000|Overall Study|Withdrawal by Subject|7|||
163389315|NCT00372385|590137782|FG003|Overall Study|Refusal of Treatment|0|||
163389316|NCT00372385|590137779|FG000|Overall Study|No Response|1|||
163389317|NCT00372385|590137780|FG001|Overall Study|No Response|1|||
163187977|NCT00568685|589403942|FG001|Overall Study|Withdrawal by Subject|2|||
163187978|NCT00568685|589403943|FG002|Overall Study|Withdrawal by Subject|2|||
163187979|NCT00568685|589403941|FG000|Overall Study|Protocol Violation|1|||
163187980|NCT00568685|589403942|FG001|Overall Study|Protocol Violation|0|||
163187981|NCT00568685|589403943|FG002|Overall Study|Protocol Violation|0|||
163187982|NCT02787551|589403944|FG000|Core Period: 26 Weeks|Adverse Event|10|||
163187983|NCT02787551|589403945|FG001|Core Period: 26 Weeks|Adverse Event|0|||
163187984|NCT02787551|589403944|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
163187985|NCT02787551|589403945|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
163187986|NCT02787551|589403944|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
163187987|NCT02787551|589403945|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
163187988|NCT02787551|589403944|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
163187989|NCT02787551|589403945|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
163187990|NCT02787551|589403944|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
163187991|NCT02787551|589403945|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
163187992|NCT02787551|589403944|FG000|Core Period: 26 Weeks|Other than specified|3|||
163187993|NCT02787551|589403945|FG001|Core Period: 26 Weeks|Other than specified|1|||
163187994|NCT02787551|589403944|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
163187995|NCT02787551|589403945|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
163187996|NCT02787551|589403944|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
163187997|NCT02787551|589403945|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
163187998|NCT02787551|589403944|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
163187999|NCT02787551|589403945|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
163188000|NCT03799211|589403946|FG000|Overall Study|Lost to Follow-up|2|||
163188001|NCT03799211|589403947|FG001|Overall Study|Lost to Follow-up|13|||
163293463|NCT03482011|589780850|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163293464|NCT03482011|589780851|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163293465|NCT03482011|589780852|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163293466|NCT03482011|589780853|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163293467|NCT03482011|589780854|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163293468|NCT03482011|589780847|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
163293469|NCT03482011|589780848|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
163293470|NCT03482011|589780849|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
163293471|NCT03482011|589780850|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
163293472|NCT03482011|589780851|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
163293473|NCT03482011|589780852|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
163293474|NCT03482011|589780853|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
163293475|NCT03482011|589780854|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
163293476|NCT03482011|589780847|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
163293477|NCT03482011|589780848|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
163293478|NCT03482011|589780849|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
163293479|NCT03482011|589780850|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
163293480|NCT03482011|589780851|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
163293481|NCT03482011|589780852|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
163293482|NCT03482011|589780853|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
163293483|NCT03482011|589780854|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
163293484|NCT03482011|589780847|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163293485|NCT03482011|589780848|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163293486|NCT03482011|589780849|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163293487|NCT03482011|589780850|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163293488|NCT03482011|589780851|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
163293489|NCT03482011|589780852|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163293490|NCT03482011|589780853|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163293491|NCT03482011|589780854|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
163293492|NCT03482011|589780847|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
163293493|NCT03482011|589780848|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
163293494|NCT03482011|589780849|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
163293495|NCT03482011|589780850|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
163293496|NCT03482011|589780851|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
163293497|NCT03482011|589780852|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
163293498|NCT03482011|589780853|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
163293499|NCT03482011|589780854|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
163293500|NCT03482011|589780847|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163293501|NCT03482011|589780848|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163293502|NCT03482011|589780849|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163389318|NCT00372385|590137781|FG002|Overall Study|No Response|0|||
163188002|NCT03799211|589403946|FG000|Overall Study|Withdrawal by Subject|2|||
163188003|NCT03799211|589403947|FG001|Overall Study|Withdrawal by Subject|0|||
163188004|NCT00764491|589403948|FG000|Overall Study|Lost to Follow-up|35|||
163188005|NCT00764491|589403949|FG001|Overall Study|Lost to Follow-up|17|||
163188006|NCT03139279|589403952|FG000|Overall Study|Physician Decision|2|||
163188007|NCT03139279|589403953|FG001|Overall Study|Physician Decision|0|||
163188008|NCT03139279|589403952|FG000|Overall Study|Protocol Violation|5|||
163188009|NCT03139279|589403953|FG001|Overall Study|Protocol Violation|4|||
163188010|NCT03139279|589403952|FG000|Overall Study|Withdrawal by Subject|0|||
163188011|NCT03139279|589403953|FG001|Overall Study|Withdrawal by Subject|2|||
163188012|NCT02027376|589403956|FG000|Overall Study|Death|1|||
163188013|NCT02027376|589403957|FG001|Overall Study|Death|0|||
163293503|NCT03482011|589780850|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
163293504|NCT03482011|589780851|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
163389319|NCT00372385|590137782|FG003|Overall Study|No Response|0|||
162949672|NCT02849652|588518799|FG001|Overall Study|Lost to Follow-up|35|||
162949673|NCT02849652|588518800|FG002|Overall Study|Lost to Follow-up|116|||
163188014|NCT02027376|589403958|FG002|Overall Study|Death|0|||
163188015|NCT01565642|589403959|FG000|Overall Study|Withdrawal by Subject|2|||
162949674|NCT02849652|588518801|FG003|Overall Study|Lost to Follow-up|22|||
162949675|NCT02849652|588518798|FG000|Overall Study|Withdrawal by Subject|10|||
162949676|NCT02849652|588518799|FG001|Overall Study|Withdrawal by Subject|2|||
162949677|NCT02849652|588518800|FG002|Overall Study|Withdrawal by Subject|8|||
162949678|NCT02849652|588518801|FG003|Overall Study|Withdrawal by Subject|4|||
162949679|NCT04977336|588518804|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
162949680|NCT04977336|588518805|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
162949681|NCT04977336|588518806|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
162949682|NCT04977336|588518807|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
162949683|NCT04977336|588518808|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
162949684|NCT04977336|588518804|FG000|Overall Study|Lost to Follow-up|0|||
162949685|NCT04977336|588518805|FG001|Overall Study|Lost to Follow-up|0|||
162949686|NCT04977336|588518806|FG002|Overall Study|Lost to Follow-up|1|||
162949687|NCT04977336|588518807|FG003|Overall Study|Lost to Follow-up|0|||
162949688|NCT04977336|588518808|FG004|Overall Study|Lost to Follow-up|0|||
162949689|NCT00408902|588518810|FG000|Overall Study|Lack of Efficacy|7|||
162949690|NCT00408902|588518810|FG000|Overall Study|Adverse Event|3|||
163188016|NCT01565642|589403960|FG001|Overall Study|Withdrawal by Subject|1|||
163188017|NCT01528033|589403964|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
163188018|NCT01528033|589403965|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
163188019|NCT01528033|589403964|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
163389320|NCT00372385|590137779|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
162949691|NCT02480764|588518814|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
162949692|NCT02480764|588518815|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
162949693|NCT02480764|588518816|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
162949694|NCT02480764|588518814|FG000|Overall Study|Major Protocol Deviation|1|||
162949695|NCT02480764|588518815|FG001|Overall Study|Major Protocol Deviation|4|||
162949696|NCT02480764|588518816|FG002|Overall Study|Major Protocol Deviation|3|||
162949697|NCT02480764|588518814|FG000|Overall Study|Lost to Follow-up|0|||
162949698|NCT02480764|588518815|FG001|Overall Study|Lost to Follow-up|1|||
162949699|NCT02480764|588518816|FG002|Overall Study|Lost to Follow-up|2|||
162949700|NCT02480764|588518814|FG000|Overall Study|Voluntary Withdrawal|6|||
162949701|NCT02480764|588518815|FG001|Overall Study|Voluntary Withdrawal|5|||
162949702|NCT02480764|588518816|FG002|Overall Study|Voluntary Withdrawal|10|||
162949703|NCT02480764|588518814|FG000|Overall Study|Lack of Efficacy|0|||
162949704|NCT02480764|588518815|FG001|Overall Study|Lack of Efficacy|3|||
162949705|NCT02480764|588518816|FG002|Overall Study|Lack of Efficacy|3|||
162949706|NCT02480764|588518814|FG000|Overall Study|Reason not Specified|0|||
162949707|NCT02480764|588518815|FG001|Overall Study|Reason not Specified|1|||
162949708|NCT02480764|588518816|FG002|Overall Study|Reason not Specified|0|||
162949709|NCT02457832|588518819|FG000|Training|Lost to Follow-up|10|||
162949710|NCT02457832|588518820|FG001|Training|Lost to Follow-up|6|||
162949711|NCT02457832|588518821|FG002|Training|Lost to Follow-up|3|||
162949712|NCT02457832|588518819|FG000|One Month Washout|Lost to Follow-up|0|||
162949713|NCT02457832|588518820|FG001|One Month Washout|Lost to Follow-up|1|||
162949714|NCT02457832|588518821|FG002|One Month Washout|Lost to Follow-up|1|||
162949715|NCT01044732|588518822|FG000|Overall Study|Lost to Follow-up|2|||
162949716|NCT01044732|588518823|FG001|Overall Study|Lost to Follow-up|1|||
162949717|NCT01044732|588518822|FG000|Overall Study|Physician Decision|5|||
162949718|NCT01044732|588518823|FG001|Overall Study|Physician Decision|3|||
162949719|NCT01044732|588518822|FG000|Overall Study|Protocol Violation|11|||
162949720|NCT01044732|588518823|FG001|Overall Study|Protocol Violation|12|||
162949721|NCT01044732|588518822|FG000|Overall Study|Withdrawal by Subject|0|||
162949722|NCT01044732|588518823|FG001|Overall Study|Withdrawal by Subject|1|||
162949723|NCT01044732|588518822|FG000|Overall Study|Inadequate bowel preparation|11|||
162949724|NCT01044732|588518823|FG001|Overall Study|Inadequate bowel preparation|17|||
162949725|NCT01044732|588518822|FG000|Overall Study|Inability to reach cecum|5|||
162949726|NCT01044732|588518823|FG001|Overall Study|Inability to reach cecum|2|||
162949727|NCT01044732|588518822|FG000|Overall Study|Technical error or malfunction|15|||
162949728|NCT01044732|588518823|FG001|Overall Study|Technical error or malfunction|14|||
162949729|NCT01030965|588518824|FG000|Overall Study|Lack of Efficacy|3|||
162949730|NCT01030965|588518825|FG001|Overall Study|Lack of Efficacy|2|||
162949731|NCT01030965|588518826|FG002|Overall Study|Lack of Efficacy|0|||
162949732|NCT01030965|588518827|FG003|Overall Study|Lack of Efficacy|3|||
162949733|NCT01030965|588518824|FG000|Overall Study|Protocol Violation|1|||
162949734|NCT01030965|588518825|FG001|Overall Study|Protocol Violation|1|||
162949735|NCT01030965|588518826|FG002|Overall Study|Protocol Violation|1|||
162949736|NCT01030965|588518827|FG003|Overall Study|Protocol Violation|1|||
162949737|NCT01030965|588518824|FG000|Overall Study|Adverse Event|0|||
162949738|NCT01030965|588518825|FG001|Overall Study|Adverse Event|1|||
162949739|NCT01030965|588518826|FG002|Overall Study|Adverse Event|2|||
162949740|NCT01030965|588518827|FG003|Overall Study|Adverse Event|1|||
162949741|NCT01030965|588518824|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
162949742|NCT01030965|588518825|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
162949743|NCT01030965|588518826|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
162949744|NCT01030965|588518827|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
162949745|NCT01030965|588518824|FG000|Overall Study|Withdrawal by Subject|0|||
162949746|NCT01030965|588518825|FG001|Overall Study|Withdrawal by Subject|1|||
162949747|NCT01030965|588518826|FG002|Overall Study|Withdrawal by Subject|0|||
162949748|NCT01030965|588518827|FG003|Overall Study|Withdrawal by Subject|2|||
162949749|NCT02097290|588518828|FG000|Overall Study|Death|6|||
162949750|NCT02097290|588518828|FG000|Overall Study|Total Withdrawals|3|||
162949751|NCT02097290|588518828|FG000|Overall Study|Attempt|8|||
162949752|NCT03991494|588518833|FG000|Overall Study|Progressive Disease|4|||
162949753|NCT05277389|588518834|FG000|Overall Study|Lost to Follow-up|1|||
162949754|NCT05277389|588518835|FG001|Overall Study|Lost to Follow-up|4|||
162949755|NCT03144687|588518839|FG000|Overall Study|Death|0|||
162949756|NCT03144687|588518840|FG001|Overall Study|Death|2|||
162949757|NCT03144687|588518839|FG000|Overall Study|Lost to Follow-up|0|||
162949758|NCT03144687|588518840|FG001|Overall Study|Lost to Follow-up|1|||
162949759|NCT03144687|588518839|FG000|Overall Study|Physician Decision|0|||
162949760|NCT03144687|588518840|FG001|Overall Study|Physician Decision|1|||
162949761|NCT03144687|588518839|FG000|Overall Study|Withdrawal by Subject|1|||
162949762|NCT03144687|588518840|FG001|Overall Study|Withdrawal by Subject|3|||
162949763|NCT03144687|588518839|FG000|Overall Study|Not Reported|2|||
162949764|NCT03144687|588518840|FG001|Overall Study|Not Reported|0|||
162949765|NCT02514174|588518841|FG000|Overall Study|Patient refused to continue medication|1|||
162949766|NCT02514174|588518841|FG000|Overall Study|Adverse Event|2|||
162949767|NCT02514174|588518841|FG000|Overall Study|Study closed by sponsor|9|||
162949768|NCT02514174|588518841|FG000|Overall Study|Progressive disease|11|||
162949769|NCT02514174|588518841|FG000|Overall Study|Treatment change|1|||
162949770|NCT02514174|588518841|FG000|Overall Study|Treated off study with Afatinib.|1|||
162949771|NCT00824265|588518842|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
162949772|NCT00824265|588518843|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
162949773|NCT00824265|588518842|FG000|Treatment Phase|Protocol Violation|1|||
162949774|NCT00824265|588518843|FG001|Treatment Phase|Protocol Violation|0|||
162949775|NCT00824265|588518842|FG000|Treatment Phase|Lost to Follow-up|1|||
162949776|NCT00824265|588518843|FG001|Treatment Phase|Lost to Follow-up|1|||
162949777|NCT00824265|588518842|FG000|Treatment Phase|Physician Decision|6|||
162949778|NCT00824265|588518843|FG001|Treatment Phase|Physician Decision|12|||
162949779|NCT00824265|588518842|FG000|Treatment Phase|Withdrawal by Subject|6|||
162949780|NCT00824265|588518843|FG001|Treatment Phase|Withdrawal by Subject|15|||
162949781|NCT00824265|588518842|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
162949782|NCT00824265|588518843|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
162949783|NCT00824265|588518842|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
162949784|NCT00824265|588518843|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
162949785|NCT02170688|588518844|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
162949786|NCT02170688|588518845|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
162949787|NCT02170688|588518846|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
162949788|NCT02170688|588518847|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
162949789|NCT02170688|588518848|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
162949790|NCT02170688|588518844|FG000|Overall Study|Full dose not received|0|||
162949791|NCT02170688|588518845|FG001|Overall Study|Full dose not received|1|||
162949792|NCT02170688|588518846|FG002|Overall Study|Full dose not received|0|||
162949793|NCT02170688|588518847|FG003|Overall Study|Full dose not received|0|||
162949794|NCT02170688|588518848|FG004|Overall Study|Full dose not received|0|||
162949795|NCT02170688|588518844|FG000|Overall Study|Physician Decision|0|||
162949796|NCT02170688|588518845|FG001|Overall Study|Physician Decision|0|||
162949797|NCT02170688|588518846|FG002|Overall Study|Physician Decision|1|||
162949798|NCT02170688|588518847|FG003|Overall Study|Physician Decision|0|||
162949799|NCT02170688|588518848|FG004|Overall Study|Physician Decision|0|||
162949800|NCT02079532|588518851|FG000|Overall Study|Adverse Event|7|||
162949801|NCT02079532|588518851|FG000|Overall Study|Additional or changed therapy|2|||
162949802|NCT02079532|588518851|FG000|Overall Study|Lack of Efficacy|9|||
162949803|NCT02079532|588518851|FG000|Overall Study|Protocol Violation|3|||
162949804|NCT02079532|588518851|FG000|Overall Study|Withdrawal by Subject|1|||
162949805|NCT02079532|588518851|FG000|Overall Study|Administrative problems|1|||
162949806|NCT02079532|588518851|FG000|Overall Study|Inclusion into ReFIRST|3|||
163293505|NCT03482011|589780852|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
163293506|NCT03482011|589780853|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
163293507|NCT03482011|589780854|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
163293508|NCT03482011|589780847|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
163293509|NCT03482011|589780848|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
163293510|NCT03482011|589780849|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
163293511|NCT03482011|589780850|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
163293512|NCT03482011|589780851|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
163293513|NCT03482011|589780852|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
163293514|NCT03482011|589780853|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
163293515|NCT03482011|589780854|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
163293516|NCT03482011|589780847|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
163293517|NCT03482011|589780848|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
163293518|NCT03482011|589780849|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
163293519|NCT03482011|589780850|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
163293520|NCT03482011|589780851|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
162949807|NCT02079532|588518851|FG000|Overall Study|Other|3|||
162949808|NCT02920996|588518852|FG000|Overall Study|Adverse Event|8|||
162949809|NCT02920996|588518853|FG001|Overall Study|Adverse Event|0|||
162949810|NCT02920996|588518852|FG000|Overall Study|Physician Decision|1|||
162949811|NCT02920996|588518853|FG001|Overall Study|Physician Decision|0|||
162949812|NCT02920996|588518852|FG000|Overall Study|Death|1|||
162949813|NCT02920996|588518853|FG001|Overall Study|Death|0|||
162949814|NCT02920996|588518852|FG000|Overall Study|Missing|1|||
162949815|NCT02920996|588518853|FG001|Overall Study|Missing|0|||
162949816|NCT02920996|588518852|FG000|Overall Study|Subject Non-Compliance|1|||
162949817|NCT02920996|588518853|FG001|Overall Study|Subject Non-Compliance|0|||
162949818|NCT01402947|588518854|FG000|First Intervention|Adverse Event|0|||
163293521|NCT03482011|589780852|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
163293522|NCT03482011|589780853|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
163293523|NCT03482011|589780854|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
163293524|NCT03482011|589780847|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
163293525|NCT03482011|589780848|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
163293526|NCT03482011|589780849|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
163293527|NCT03482011|589780850|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
163293528|NCT03482011|589780851|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
163293529|NCT03482011|589780852|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
163293530|NCT03482011|589780853|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
163293531|NCT03482011|589780854|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
163293532|NCT03482011|589780847|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
163293533|NCT03482011|589780848|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
163293534|NCT03482011|589780849|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
163293535|NCT03482011|589780850|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
163293536|NCT03482011|589780851|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
163293537|NCT03482011|589780852|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
163293538|NCT03482011|589780853|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
163293539|NCT03482011|589780854|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
163293540|NCT03482011|589780847|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163293541|NCT03482011|589780848|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163293542|NCT03482011|589780849|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163293543|NCT03482011|589780850|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163293544|NCT03482011|589780851|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163293545|NCT03482011|589780852|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163293546|NCT03482011|589780853|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163293547|NCT03482011|589780854|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
163293548|NCT00468052|589780855|FG000|Overall Study|Protocol Violation|7|||
163293549|NCT00468052|589780856|FG001|Overall Study|Protocol Violation|8|||
163293550|NCT04707313|589780858|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
163293551|NCT04707313|589780859|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
163293552|NCT04707313|589780860|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
163293553|NCT04707313|589780861|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
162949819|NCT01402947|588518855|FG001|First Intervention|Adverse Event|1|||
162949820|NCT00591630|588518856|FG000|Overall Study|Death|0|||
162949821|NCT00591630|588518857|FG001|Overall Study|Death|0|||
162949822|NCT00591630|588518858|FG002|Overall Study|Death|1|||
162949823|NCT00591630|588518859|FG003|Overall Study|Death|0|||
162949824|NCT01471522|588518863|FG000|Overall Study|Withdrawal by Subject|28|||
162949825|NCT01471522|588518864|FG001|Overall Study|Withdrawal by Subject|22|||
162949826|NCT01471522|588518863|FG000|Overall Study|Lost to Follow-up|36|||
162949827|NCT01471522|588518864|FG001|Overall Study|Lost to Follow-up|26|||
162949828|NCT01432171|588518866|FG000|Overall Study|Death|1|||
162949829|NCT01432171|588518867|FG001|Overall Study|Death|2|||
162949830|NCT01432171|588518866|FG000|Overall Study|Lost to Follow-up|6|||
162949831|NCT01432171|588518867|FG001|Overall Study|Lost to Follow-up|5|||
162949832|NCT01432171|588518866|FG000|Overall Study|Withdrawal by Subject|3|||
162949833|NCT01432171|588518867|FG001|Overall Study|Withdrawal by Subject|1|||
162949834|NCT01432171|588518866|FG000|Overall Study|Noncompliance|2|||
162949835|NCT01432171|588518867|FG001|Overall Study|Noncompliance|3|||
162949836|NCT01432171|588518866|FG000|Overall Study|Insurance denial trial coverage|1|||
162949837|NCT01432171|588518867|FG001|Overall Study|Insurance denial trial coverage|0|||
162949838|NCT01432171|588518866|FG000|Overall Study|Patient moved to palliative care|1|||
162949839|NCT01432171|588518867|FG001|Overall Study|Patient moved to palliative care|0|||
162949840|NCT02863575|588518868|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
163293554|NCT04707313|589780862|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
163293555|NCT04707313|589780863|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
163293556|NCT04707313|589780864|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
163389321|NCT00372385|590137780|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
162949841|NCT02863575|588518869|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
162949842|NCT02863575|588518870|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
162949843|NCT02863575|588518868|FG000|Overall Study|Withdrawal by Subject|0|||
162949844|NCT02863575|588518869|FG001|Overall Study|Withdrawal by Subject|1|||
162949845|NCT02863575|588518870|FG002|Overall Study|Withdrawal by Subject|1|||
162949846|NCT02863575|588518868|FG000|Overall Study|Adverse Event|0|||
162949847|NCT02863575|588518869|FG001|Overall Study|Adverse Event|1|||
162949848|NCT02863575|588518870|FG002|Overall Study|Adverse Event|0|||
163389322|NCT00372385|590137781|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
162949849|NCT01706926|588518871|FG000|Overall Study|Lost to Follow-up|0|||
162949850|NCT01706926|588518872|FG001|Overall Study|Lost to Follow-up|0|||
163293557|NCT04707313|589780865|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
163389323|NCT00372385|590137782|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
162949851|NCT01706926|588518873|FG002|Overall Study|Lost to Follow-up|1|||
162949852|NCT01706926|588518874|FG003|Overall Study|Lost to Follow-up|0|||
162949853|NCT01706926|588518871|FG000|Overall Study|Withdrawal by Subject|2|||
162949854|NCT01706926|588518872|FG001|Overall Study|Withdrawal by Subject|0|||
162949855|NCT01706926|588518873|FG002|Overall Study|Withdrawal by Subject|1|||
162949856|NCT01706926|588518874|FG003|Overall Study|Withdrawal by Subject|2|||
162949857|NCT01706926|588518871|FG000|Overall Study|Other|4|||
162949858|NCT01706926|588518872|FG001|Overall Study|Other|4|||
162949859|NCT01706926|588518873|FG002|Overall Study|Other|4|||
162949860|NCT01706926|588518874|FG003|Overall Study|Other|3|||
162949861|NCT01248247|588520202|FG000|Overall Study|Adverse Event|2|||
162949862|NCT01248247|588520203|FG001|Overall Study|Adverse Event|4|||
162949863|NCT01248247|588520204|FG002|Overall Study|Adverse Event|4|||
162949864|NCT01248247|588520205|FG003|Overall Study|Adverse Event|2|||
162949865|NCT01248247|588520202|FG000|Overall Study|Death|0|||
162949866|NCT01248247|588520203|FG001|Overall Study|Death|1|||
162949867|NCT01248247|588520204|FG002|Overall Study|Death|4|||
162949868|NCT01248247|588520205|FG003|Overall Study|Death|7|||
162949869|NCT01248247|588520202|FG000|Overall Study|Lost to Follow-up|0|||
162949870|NCT01248247|588520203|FG001|Overall Study|Lost to Follow-up|1|||
162949871|NCT01248247|588520204|FG002|Overall Study|Lost to Follow-up|1|||
162949872|NCT01248247|588520205|FG003|Overall Study|Lost to Follow-up|0|||
162949873|NCT01248247|588520202|FG000|Overall Study|Alternative treatment|0|||
162949874|NCT01248247|588520203|FG001|Overall Study|Alternative treatment|1|||
162949875|NCT01248247|588520204|FG002|Overall Study|Alternative treatment|0|||
162949876|NCT01248247|588520205|FG003|Overall Study|Alternative treatment|0|||
162949877|NCT01248247|588520202|FG000|Overall Study|Other|2|||
162949878|NCT01248247|588520203|FG001|Overall Study|Other|8|||
162949879|NCT01248247|588520204|FG002|Overall Study|Other|8|||
162949880|NCT01248247|588520205|FG003|Overall Study|Other|5|||
162949881|NCT01248247|588520202|FG000|Overall Study|Progression|18|||
162949882|NCT01248247|588520203|FG001|Overall Study|Progression|27|||
162949883|NCT01248247|588520204|FG002|Overall Study|Progression|56|||
162949884|NCT01248247|588520205|FG003|Overall Study|Progression|44|||
162949885|NCT01248247|588520202|FG000|Overall Study|Refuse further treatment|0|||
162949886|NCT01248247|588520203|FG001|Overall Study|Refuse further treatment|0|||
162949887|NCT01248247|588520204|FG002|Overall Study|Refuse further treatment|1|||
162949888|NCT01248247|588520205|FG003|Overall Study|Refuse further treatment|2|||
162949889|NCT01248247|588520202|FG000|Overall Study|Complicating disease|0|||
162949890|NCT01248247|588520203|FG001|Overall Study|Complicating disease|0|||
162949891|NCT01248247|588520204|FG002|Overall Study|Complicating disease|1|||
162949892|NCT01248247|588520205|FG003|Overall Study|Complicating disease|1|||
162949893|NCT03597256|588520206|FG000|Overall Study|Lost to Follow-up|3|||
162949894|NCT03597256|588520207|FG001|Overall Study|Lost to Follow-up|1|||
162949895|NCT03597256|588520206|FG000|Overall Study|Withdrawal by Subject|0|||
162949896|NCT03597256|588520207|FG001|Overall Study|Withdrawal by Subject|1|||
162949897|NCT03597256|588520206|FG000|Overall Study|Could not return for treatment|0|||
162949898|NCT03597256|588520207|FG001|Overall Study|Could not return for treatment|1|||
163188020|NCT01528033|589403965|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
163188021|NCT01528033|589403964|FG000|Primary Endpoint Assessment ITT|Death|2|||
163188022|NCT01528033|589403965|FG001|Primary Endpoint Assessment ITT|Death|2|||
162949899|NCT03597256|588520206|FG000|Overall Study|Moved from location|0|||
162949900|NCT03597256|588520207|FG001|Overall Study|Moved from location|1|||
162949901|NCT03597256|588520206|FG000|Overall Study|Not accepted the treatment|0|||
163188023|NCT01528033|589403964|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
162949902|NCT03597256|588520207|FG001|Overall Study|Not accepted the treatment|1|||
162949903|NCT02943447|588520208|FG000|Blinded Study Phase|Withdrew Consent|1|||
162949904|NCT02943447|588520209|FG001|Blinded Study Phase|Withdrew Consent|2|||
162949905|NCT02943447|588520210|FG002|Blinded Study Phase|Withdrew Consent|1|||
162949906|NCT02943447|588520208|FG000|Blinded Study Phase|Adverse Event|3|||
162949907|NCT02943447|588520209|FG001|Blinded Study Phase|Adverse Event|0|||
162949908|NCT02943447|588520210|FG002|Blinded Study Phase|Adverse Event|0|||
162949909|NCT02943447|588520208|FG000|Blinded Study Phase|Investigator's discretion|1|||
162949910|NCT02943447|588520209|FG001|Blinded Study Phase|Investigator's discretion|0|||
162949911|NCT02943447|588520210|FG002|Blinded Study Phase|Investigator's discretion|0|||
163293558|NCT04707313|589780866|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
163293559|NCT04707313|589780867|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
163293560|NCT04707313|589780868|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
163293561|NCT04707313|589780869|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
163293562|NCT04707313|589780870|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
163293563|NCT04707313|589780858|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
163293564|NCT04707313|589780859|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
163293565|NCT04707313|589780860|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163293566|NCT04707313|589780861|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163293567|NCT04707313|589780862|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
163293568|NCT04707313|589780863|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163293569|NCT04707313|589780864|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163293570|NCT04707313|589780865|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163293571|NCT04707313|589780866|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163293572|NCT04707313|589780867|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163293573|NCT04707313|589780868|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163293574|NCT04707313|589780869|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163293575|NCT04707313|589780870|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162949912|NCT02943447|588520208|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
162949913|NCT02943447|588520209|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
162949914|NCT02943447|588520210|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
162949915|NCT02943447|588520208|FG000|Open-Label Extension Phase|Adverse Event|4|||
162949916|NCT02943447|588520209|FG001|Open-Label Extension Phase|Adverse Event|7|||
162949917|NCT02943447|588520210|FG002|Open-Label Extension Phase|Adverse Event|3|||
162949918|NCT02943447|588520208|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
162949919|NCT02943447|588520209|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
162949920|NCT02943447|588520210|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
162949921|NCT02943447|588520208|FG000|Open-Label Extension Phase|Withdrew consent|1|||
162949922|NCT02943447|588520209|FG001|Open-Label Extension Phase|Withdrew consent|1|||
162949923|NCT02943447|588520210|FG002|Open-Label Extension Phase|Withdrew consent|1|||
162949924|NCT02943447|588520208|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
162949925|NCT02943447|588520209|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
162949926|NCT02943447|588520210|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
162949927|NCT01725529|588520221|FG000|Overall Study|Adverse Event|1|||
162949928|NCT01725529|588520222|FG001|Overall Study|Adverse Event|0|||
162949929|NCT01725529|588520223|FG002|Overall Study|Adverse Event|0|||
162949930|NCT01725529|588520221|FG000|Overall Study|Lost to Follow-up|2|||
162949931|NCT01725529|588520222|FG001|Overall Study|Lost to Follow-up|1|||
162949932|NCT01725529|588520223|FG002|Overall Study|Lost to Follow-up|1|||
162949933|NCT01725529|588520221|FG000|Overall Study|Protocol Violation|0|||
162949934|NCT01725529|588520222|FG001|Overall Study|Protocol Violation|1|||
162949935|NCT01725529|588520223|FG002|Overall Study|Protocol Violation|1|||
162949936|NCT01725529|588520221|FG000|Overall Study|Withdrawal by Subject|12|||
162949937|NCT01725529|588520222|FG001|Overall Study|Withdrawal by Subject|14|||
162949938|NCT01725529|588520223|FG002|Overall Study|Withdrawal by Subject|8|||
162949939|NCT00358449|588520225|FG000|Overall Study|Adverse Event|1|||
162949940|NCT00358449|588520226|FG001|Overall Study|Adverse Event|0|||
162949941|NCT00358449|588520227|FG002|Overall Study|Adverse Event|1|||
162949942|NCT00358449|588520225|FG000|Overall Study|Lost to Follow-up|1|||
162949943|NCT00358449|588520226|FG001|Overall Study|Lost to Follow-up|0|||
162949944|NCT00358449|588520227|FG002|Overall Study|Lost to Follow-up|0|||
162949945|NCT00358449|588520225|FG000|Overall Study|Withdrawal by Subject|2|||
162949946|NCT00358449|588520226|FG001|Overall Study|Withdrawal by Subject|0|||
162949947|NCT00358449|588520227|FG002|Overall Study|Withdrawal by Subject|0|||
162949948|NCT00358449|588520225|FG000|Overall Study|Lack of Efficacy|0|||
162949949|NCT00358449|588520226|FG001|Overall Study|Lack of Efficacy|1|||
162949950|NCT00358449|588520227|FG002|Overall Study|Lack of Efficacy|0|||
162949951|NCT00358449|588520225|FG000|Overall Study|Steriod Inhaler was Increased|0|||
162949952|NCT00358449|588520226|FG001|Overall Study|Steriod Inhaler was Increased|0|||
162949953|NCT00358449|588520227|FG002|Overall Study|Steriod Inhaler was Increased|1|||
162949954|NCT01804270|588520228|FG000|Overall Study|Withdrawal by Subject|1|||
162949955|NCT01804270|588520229|FG001|Overall Study|Withdrawal by Subject|1|||
162949956|NCT02334722|588520231|FG000|Overall Study|Lost to Follow-up|4|||
162949957|NCT02334722|588520232|FG001|Overall Study|Lost to Follow-up|0|||
162949958|NCT02334722|588520231|FG000|Overall Study|6 week questionnaire not completed|2|||
163293576|NCT04707313|589780858|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
163293577|NCT04707313|589780859|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
162949959|NCT02334722|588520232|FG001|Overall Study|6 week questionnaire not completed|0|||
162949960|NCT02334722|588520231|FG000|Overall Study|Unable to obtain medication|1|||
162949961|NCT02334722|588520232|FG001|Overall Study|Unable to obtain medication|1|||
162949962|NCT02334722|588520231|FG000|Overall Study|Withdrawal by Subject|0|||
162949963|NCT02334722|588520232|FG001|Overall Study|Withdrawal by Subject|3|||
162949964|NCT02334722|588520231|FG000|Overall Study|Adverse Event|0|||
162949965|NCT02334722|588520232|FG001|Overall Study|Adverse Event|2|||
162949966|NCT02334722|588520231|FG000|Overall Study|Physician Decision|0|||
162949967|NCT02334722|588520232|FG001|Overall Study|Physician Decision|1|||
162949968|NCT03988803|588520233|FG000|Period 2|Prematurely discontinued from medication|2|||
162949969|NCT03988803|588520233|FG000|Period 2|Adverse Event|1|||
162949970|NCT00925769|588520234|FG000|Overall Study|Major toxicity|1|||
162949971|NCT00925769|588520235|FG001|Overall Study|Major toxicity|0|||
162949972|NCT00925769|588520236|FG002|Overall Study|Major toxicity|1|||
162949973|NCT00925769|588520237|FG003|Overall Study|Major toxicity|1|||
162949974|NCT00925769|588520238|FG004|Overall Study|Major toxicity|0|||
162949975|NCT00925769|588520239|FG005|Overall Study|Major toxicity|0|||
162949976|NCT00925769|588520234|FG000|Overall Study|Disease progression|4|||
162949977|NCT00925769|588520235|FG001|Overall Study|Disease progression|5|||
162949978|NCT00925769|588520236|FG002|Overall Study|Disease progression|3|||
162949979|NCT00925769|588520237|FG003|Overall Study|Disease progression|4|||
162949980|NCT00925769|588520238|FG004|Overall Study|Disease progression|2|||
162949981|NCT00925769|588520239|FG005|Overall Study|Disease progression|3|||
162949982|NCT00925769|588520234|FG000|Overall Study|Death|0|||
162949983|NCT00925769|588520235|FG001|Overall Study|Death|0|||
162949984|NCT00925769|588520236|FG002|Overall Study|Death|1|||
162949985|NCT00925769|588520237|FG003|Overall Study|Death|0|||
162949986|NCT00925769|588520238|FG004|Overall Study|Death|0|||
162949987|NCT00925769|588520239|FG005|Overall Study|Death|0|||
162949988|NCT00925769|588520234|FG000|Overall Study|Physician Decision|1|||
162949989|NCT00925769|588520235|FG001|Overall Study|Physician Decision|0|||
162949990|NCT00925769|588520236|FG002|Overall Study|Physician Decision|0|||
162949991|NCT00925769|588520237|FG003|Overall Study|Physician Decision|0|||
162949992|NCT00925769|588520238|FG004|Overall Study|Physician Decision|0|||
162949993|NCT00925769|588520239|FG005|Overall Study|Physician Decision|0|||
162949994|NCT00925769|588520234|FG000|Overall Study|Missing documentation|0|||
162949995|NCT00925769|588520235|FG001|Overall Study|Missing documentation|1|||
162949996|NCT00925769|588520236|FG002|Overall Study|Missing documentation|0|||
162949997|NCT00925769|588520237|FG003|Overall Study|Missing documentation|0|||
162949998|NCT00925769|588520238|FG004|Overall Study|Missing documentation|0|||
163188024|NCT01528033|589403965|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
163188025|NCT01528033|589403964|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
163188026|NCT01528033|589403965|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
162949999|NCT00925769|588520239|FG005|Overall Study|Missing documentation|0|||
162950000|NCT00925769|588520234|FG000|Overall Study|End of study visit not done|0|||
162950001|NCT00925769|588520235|FG001|Overall Study|End of study visit not done|0|||
163188027|NCT01528033|589403964|FG000|Follow Up|No data available|46|||
163188028|NCT01528033|589403965|FG001|Follow Up|No data available|44|||
163188029|NCT02898116|589403968|FG000|Overall Study|Adverse Event|1|||
162950002|NCT00925769|588520236|FG002|Overall Study|End of study visit not done|1|||
162950003|NCT00925769|588520237|FG003|Overall Study|End of study visit not done|0|||
162950004|NCT00925769|588520238|FG004|Overall Study|End of study visit not done|0|||
163293578|NCT04707313|589780860|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
163293579|NCT04707313|589780861|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
163293580|NCT04707313|589780862|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
163293581|NCT04707313|589780863|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
163293582|NCT04707313|589780864|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
163293583|NCT04707313|589780865|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
163293584|NCT04707313|589780866|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
162950005|NCT00925769|588520239|FG005|Overall Study|End of study visit not done|0|||
162950006|NCT00925769|588520234|FG000|Overall Study|Participant is unable to swallow drug|0|||
162950007|NCT00925769|588520235|FG001|Overall Study|Participant is unable to swallow drug|0|||
162950008|NCT00925769|588520236|FG002|Overall Study|Participant is unable to swallow drug|0|||
162950009|NCT00925769|588520237|FG003|Overall Study|Participant is unable to swallow drug|1|||
162950010|NCT00925769|588520238|FG004|Overall Study|Participant is unable to swallow drug|0|||
162950011|NCT00925769|588520239|FG005|Overall Study|Participant is unable to swallow drug|0|||
162950012|NCT00925769|588520234|FG000|Overall Study|Adverse Event|0|||
162950013|NCT00925769|588520235|FG001|Overall Study|Adverse Event|0|||
162950014|NCT00925769|588520236|FG002|Overall Study|Adverse Event|0|||
162950015|NCT00925769|588520237|FG003|Overall Study|Adverse Event|0|||
162950016|NCT00925769|588520238|FG004|Overall Study|Adverse Event|1|||
162950017|NCT00925769|588520239|FG005|Overall Study|Adverse Event|0|||
162950018|NCT01666730|588520242|FG000|Overall Study|Adverse Event|16|||
162950019|NCT01666730|588520242|FG000|Overall Study|Death|2|||
162950020|NCT01666730|588520242|FG000|Overall Study|Physician Decision|5|||
162950021|NCT01666730|588520242|FG000|Overall Study|Withdrawal by Subject|9|||
162950022|NCT01666730|588520242|FG000|Overall Study|Disease progression/relapse|18|||
162950023|NCT01434693|588520243|FG000|Overall Study|Adverse Event|1|||
162950024|NCT01434693|588520244|FG001|Overall Study|Adverse Event|0|||
162950025|NCT01434693|588520245|FG002|Overall Study|Adverse Event|0|||
162950026|NCT01434693|588520246|FG003|Overall Study|Adverse Event|0|||
162950027|NCT01434693|588520243|FG000|Overall Study|Withdrawal by Subject|1|||
162950028|NCT01434693|588520244|FG001|Overall Study|Withdrawal by Subject|0|||
162950029|NCT01434693|588520245|FG002|Overall Study|Withdrawal by Subject|1|||
162950030|NCT01434693|588520246|FG003|Overall Study|Withdrawal by Subject|1|||
162950031|NCT01434693|588520243|FG000|Overall Study|Lost to Follow-up|1|||
162950032|NCT01434693|588520244|FG001|Overall Study|Lost to Follow-up|0|||
162950033|NCT01434693|588520245|FG002|Overall Study|Lost to Follow-up|0|||
162950034|NCT01434693|588520246|FG003|Overall Study|Lost to Follow-up|0|||
162950035|NCT02087904|588520248|FG000|Overall Study|Did Not Receive Study Drug|0|||
162950036|NCT02087904|588520249|FG001|Overall Study|Did Not Receive Study Drug|0|||
162950037|NCT02087904|588520250|FG002|Overall Study|Did Not Receive Study Drug|2|||
162950038|NCT02087904|588520251|FG003|Overall Study|Did Not Receive Study Drug|1|||
162950039|NCT02087904|588520248|FG000|Overall Study|Adverse Event|8|||
162950040|NCT02087904|588520249|FG001|Overall Study|Adverse Event|4|||
162950041|NCT02087904|588520250|FG002|Overall Study|Adverse Event|4|||
162950042|NCT02087904|588520251|FG003|Overall Study|Adverse Event|12|||
162950043|NCT02087904|588520248|FG000|Overall Study|Lack of Efficacy|3|||
162950044|NCT02087904|588520249|FG001|Overall Study|Lack of Efficacy|6|||
162950045|NCT02087904|588520250|FG002|Overall Study|Lack of Efficacy|3|||
162950046|NCT02087904|588520251|FG003|Overall Study|Lack of Efficacy|2|||
162950047|NCT02087904|588520248|FG000|Overall Study|Other|6|||
162950048|NCT02087904|588520249|FG001|Overall Study|Other|2|||
162950049|NCT02087904|588520250|FG002|Overall Study|Other|4|||
162950050|NCT02087904|588520251|FG003|Overall Study|Other|4|||
162950051|NCT02087904|588520248|FG000|Overall Study|Withdrawal by Subject|8|||
162950052|NCT02087904|588520249|FG001|Overall Study|Withdrawal by Subject|3|||
162950053|NCT02087904|588520250|FG002|Overall Study|Withdrawal by Subject|7|||
162950054|NCT02087904|588520251|FG003|Overall Study|Withdrawal by Subject|4|||
162950055|NCT02087904|588520248|FG000|Overall Study|Lost to Follow-up|0|||
162950056|NCT02087904|588520249|FG001|Overall Study|Lost to Follow-up|4|||
162950057|NCT02087904|588520250|FG002|Overall Study|Lost to Follow-up|2|||
162950058|NCT02087904|588520251|FG003|Overall Study|Lost to Follow-up|2|||
162950059|NCT01735630|588520252|FG000|Overall Study|Adverse Event|8|||
162950060|NCT01735630|588520253|FG001|Overall Study|Adverse Event|7|||
162950061|NCT01735630|588520252|FG000|Overall Study|Lost to Follow-up|1|||
162950062|NCT01735630|588520253|FG001|Overall Study|Lost to Follow-up|0|||
162950063|NCT01735630|588520252|FG000|Overall Study|Physician Decision|0|||
162950064|NCT01735630|588520253|FG001|Overall Study|Physician Decision|1|||
162950065|NCT01735630|588520252|FG000|Overall Study|Sponsor Decision|2|||
162950066|NCT01735630|588520253|FG001|Overall Study|Sponsor Decision|1|||
162950067|NCT01735630|588520252|FG000|Overall Study|Withdrawal by Subject|7|||
162950068|NCT01735630|588520253|FG001|Overall Study|Withdrawal by Subject|9|||
162950069|NCT00891293|588520255|FG000|Overall Study|Adverse Event|2|||
162950070|NCT00891293|588520255|FG000|Overall Study|Protocol Violation|2|||
162950071|NCT00891293|588520255|FG000|Overall Study|Laboratory abnormality|4|||
162950072|NCT00891293|588520255|FG000|Overall Study|Lost to Follow-up|7|||
162950073|NCT00891293|588520255|FG000|Overall Study|Subject withdrew consent|7|||
162950074|NCT00891293|588520255|FG000|Overall Study|Sponsor termination|62|||
162950075|NCT02178722|588520256|FG000|Overall Study|Withdrawal by Subject|0|||
162950076|NCT02178722|588520257|FG001|Overall Study|Withdrawal by Subject|0|||
162950077|NCT02178722|588520258|FG002|Overall Study|Withdrawal by Subject|0|||
162950078|NCT02178722|588520259|FG003|Overall Study|Withdrawal by Subject|2|||
162950079|NCT02178722|588520260|FG004|Overall Study|Withdrawal by Subject|33|||
162950080|NCT02178722|588520256|FG000|Overall Study|Death|2|||
162950081|NCT02178722|588520257|FG001|Overall Study|Death|13|||
162950082|NCT02178722|588520258|FG002|Overall Study|Death|12|||
162950083|NCT02178722|588520259|FG003|Overall Study|Death|12|||
162950084|NCT02178722|588520260|FG004|Overall Study|Death|205|||
162950085|NCT02178722|588520256|FG000|Overall Study|Lost to Follow-up|0|||
162950086|NCT02178722|588520257|FG001|Overall Study|Lost to Follow-up|0|||
162950087|NCT02178722|588520258|FG002|Overall Study|Lost to Follow-up|0|||
162950088|NCT02178722|588520259|FG003|Overall Study|Lost to Follow-up|2|||
162950089|NCT02178722|588520260|FG004|Overall Study|Lost to Follow-up|11|||
162950090|NCT02178722|588520256|FG000|Overall Study|Study terminated by Sponsor|2|||
162950091|NCT02178722|588520257|FG001|Overall Study|Study terminated by Sponsor|7|||
162950092|NCT02178722|588520258|FG002|Overall Study|Study terminated by Sponsor|6|||
162950093|NCT02178722|588520259|FG003|Overall Study|Study terminated by Sponsor|4|||
162950094|NCT02178722|588520260|FG004|Overall Study|Study terminated by Sponsor|128|||
162950095|NCT02178722|588520256|FG000|Overall Study|Physician Decision|0|||
162950096|NCT02178722|588520257|FG001|Overall Study|Physician Decision|0|||
162950097|NCT02178722|588520258|FG002|Overall Study|Physician Decision|0|||
162950098|NCT02178722|588520259|FG003|Overall Study|Physician Decision|0|||
162950099|NCT02178722|588520260|FG004|Overall Study|Physician Decision|3|||
162950100|NCT02178722|588520256|FG000|Overall Study|Other|0|||
162950101|NCT02178722|588520257|FG001|Overall Study|Other|0|||
162950102|NCT02178722|588520258|FG002|Overall Study|Other|0|||
162950103|NCT02178722|588520259|FG003|Overall Study|Other|0|||
162950104|NCT02178722|588520260|FG004|Overall Study|Other|2|||
162950105|NCT01572948|588520261|FG000|Overall Study|Lost to Follow-up|1|||
162950106|NCT01572948|588520262|FG001|Overall Study|Lost to Follow-up|0|||
162950107|NCT01572948|588520261|FG000|Overall Study|unable to contact|0|||
162950108|NCT01572948|588520262|FG001|Overall Study|unable to contact|1|||
162950109|NCT00877032|588520270|FG000|Overall Study|Did not meet entrance criteria|0|||
162950110|NCT00877032|588520271|FG001|Overall Study|Did not meet entrance criteria|0|||
162950111|NCT00877032|588520272|FG002|Overall Study|Did not meet entrance criteria|0|||
162950112|NCT00877032|588520273|FG003|Overall Study|Did not meet entrance criteria|1|||
162950113|NCT00877032|588520274|FG004|Overall Study|Did not meet entrance criteria|0|||
162950114|NCT00877032|588520275|FG005|Overall Study|Did not meet entrance criteria|0|||
162950115|NCT00877032|588520276|FG006|Overall Study|Did not meet entrance criteria|2|||
162950116|NCT02107092|588520278|FG000|Overall Study|Miscellaneous|3|||
162950117|NCT02107092|588520278|FG000|Overall Study|Subject compliance|3|||
162950118|NCT02107092|588520278|FG000|Overall Study|Hypo-or hyperkalemia|2|||
162950119|NCT02107092|588520278|FG000|Overall Study|Met ECG withdrawal criteria|3|||
162950120|NCT02107092|588520278|FG000|Overall Study|Physician Decision|3|||
162950121|NCT02107092|588520278|FG000|Overall Study|Lost to Follow-up|2|||
162950122|NCT02107092|588520278|FG000|Overall Study|Withdrawal by Subject|9|||
162950123|NCT02107092|588520278|FG000|Overall Study|Adverse Event|7|||
162950124|NCT02107092|588520278|FG000|Overall Study|Expected progression of CKD|12|||
162950125|NCT00537030|588520279|FG000|Overall Study|Physician Decision|2|||
162950126|NCT00537030|588520279|FG000|Overall Study|Withdrawal by Subject|2|||
162950127|NCT00537030|588520279|FG000|Overall Study|≥ Grade 2 allergy|7|||
162950128|NCT00537030|588520279|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
162950129|NCT00537030|588520279|FG000|Overall Study|Ineligible|2|||
162950130|NCT00537030|588520279|FG000|Overall Study|Inevaluable|2|||
162950131|NCT04213326|588520281|FG000|Overall Study|Consent withdrawn|51|||
162950132|NCT04213326|588520282|FG001|Overall Study|Consent withdrawn|241|||
162950133|NCT04213326|588520281|FG000|Overall Study|Lost to Follow-up|50|||
162950134|NCT04213326|588520282|FG001|Overall Study|Lost to Follow-up|902|||
162950135|NCT04213326|588520281|FG000|Overall Study|Protocol Violation|3|||
162950136|NCT04213326|588520282|FG001|Overall Study|Protocol Violation|25|||
162950137|NCT04213326|588520281|FG000|Overall Study|Participant eligibility changed|106|||
162950138|NCT04213326|588520282|FG001|Overall Study|Participant eligibility changed|19|||
162950139|NCT04213326|588520281|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
162950140|NCT04213326|588520282|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
162950141|NCT04213326|588520281|FG000|Overall Study|Incomplete study visit|0|||
162950142|NCT04213326|588520282|FG001|Overall Study|Incomplete study visit|367|||
162950143|NCT01496183|588520284|FG000|Overall Study|Physician Decision|3|||
162950144|NCT01496183|588520285|FG001|Overall Study|Physician Decision|1|||
162950145|NCT01496183|588520284|FG000|Overall Study|Withdrawal by Subject|0|||
162950146|NCT01496183|588520285|FG001|Overall Study|Withdrawal by Subject|1|||
162950147|NCT01173692|588520288|FG000|Overall Study|Adverse Event|1|||
162950148|NCT01173692|588520289|FG001|Overall Study|Adverse Event|2|||
162950149|NCT01173692|588520288|FG000|Overall Study|Withdrawal by Subject|1|||
162950150|NCT01173692|588520289|FG001|Overall Study|Withdrawal by Subject|3|||
162950151|NCT00669864|588520292|FG000|Overall Study|Lost to Follow-up|2|||
162950152|NCT00669864|588520292|FG000|Overall Study|Protocol Violation|2|||
162950153|NCT00669864|588520292|FG000|Overall Study|Withdrawal by Subject|3|||
162950154|NCT00669864|588520292|FG000|Overall Study|Other|2|||
162950155|NCT01941030|588520296|FG000|Overall Study|Death|3|||
162950156|NCT01941030|588520297|FG001|Overall Study|Death|2|||
162950157|NCT01941030|588520296|FG000|Overall Study|Lost to Follow-up|6|||
162950158|NCT01941030|588520297|FG001|Overall Study|Lost to Follow-up|5|||
162950159|NCT01941030|588520296|FG000|Overall Study|Withdrawal by Subject|4|||
162950160|NCT01941030|588520297|FG001|Overall Study|Withdrawal by Subject|6|||
162950161|NCT05067647|588520300|FG000|Overall Study|Lost to Follow-up|1|||
162950162|NCT02781727|588520302|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
162950163|NCT02781727|588520303|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
162950164|NCT02781727|588520302|FG000|Treatment Period|Withdrawal by Subject|1|||
162950165|NCT02781727|588520303|FG001|Treatment Period|Withdrawal by Subject|0|||
162950166|NCT02781727|588520302|FG000|Treatment Period|Lost to Follow-up|0|||
162950167|NCT02781727|588520303|FG001|Treatment Period|Lost to Follow-up|1|||
162950168|NCT03069937|588520305|FG000|Overall Study|Second primary malignancy noted|1|||
162950169|NCT01569152|588520309|FG000|Phase IIa, Period 1|Early Escape|5|||
162950170|NCT01569152|588520310|FG001|Phase IIa, Period 1|Early Escape|22|||
162950171|NCT01569152|588520311|FG002|Phase IIa, Period 1|Early Escape|0|||
162950172|NCT01569152|588520309|FG000|Phase IIa, Period 1|Adverse Event|4|||
162950173|NCT01569152|588520310|FG001|Phase IIa, Period 1|Adverse Event|0|||
162950174|NCT01569152|588520311|FG002|Phase IIa, Period 1|Adverse Event|0|||
162950175|NCT01569152|588520309|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
162950176|NCT01569152|588520310|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
162950177|NCT01569152|588520311|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
162950178|NCT01569152|588520309|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
162950179|NCT01569152|588520310|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
162950180|NCT01569152|588520311|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
162950181|NCT01569152|588520309|FG000|Phase IIa, Period 1|Protocol Violation|0|||
162950182|NCT01569152|588520310|FG001|Phase IIa, Period 1|Protocol Violation|1|||
162950183|NCT01569152|588520311|FG002|Phase IIa, Period 1|Protocol Violation|0|||
162950184|NCT01569152|588520309|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
162950185|NCT01569152|588520310|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
162950186|NCT01569152|588520311|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
162950187|NCT01569152|588520309|FG000|Safety Extension, Period 3|Adverse Event|0|||
162950188|NCT01569152|588520310|FG001|Safety Extension, Period 3|Adverse Event|0|||
162950189|NCT01569152|588520311|FG002|Safety Extension, Period 3|Adverse Event|4|||
163389324|NCT00372385|590137779|FG000|Overall Study|Virologic Stopping Rule|17|||
162950190|NCT01569152|588520309|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
162950191|NCT01569152|588520310|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
162950192|NCT01569152|588520311|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
162950193|NCT01569152|588520309|FG000|Safety Extension, Period 3|Physician Decision|0|||
162950194|NCT01569152|588520310|FG001|Safety Extension, Period 3|Physician Decision|0|||
162950195|NCT01569152|588520311|FG002|Safety Extension, Period 3|Physician Decision|2|||
162950196|NCT01569152|588520309|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
162950197|NCT01569152|588520310|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
162950198|NCT01569152|588520311|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
163188030|NCT02898116|589403968|FG000|Overall Study|Progressive disease|1|||
163188031|NCT02130024|589403969|FG000|Overall Study|Adverse Event|10|||
163188032|NCT02130024|589403970|FG001|Overall Study|Adverse Event|11|||
163188033|NCT02130024|589403969|FG000|Overall Study|Death|2|||
163188034|NCT02130024|589403970|FG001|Overall Study|Death|2|||
163188035|NCT02130024|589403969|FG000|Overall Study|Lost to Follow-up|1|||
163188036|NCT02130024|589403970|FG001|Overall Study|Lost to Follow-up|1|||
163188037|NCT02130024|589403969|FG000|Overall Study|Physician Decision|1|||
163188038|NCT02130024|589403970|FG001|Overall Study|Physician Decision|3|||
163188039|NCT02130024|589403969|FG000|Overall Study|Protocol Deviation|4|||
163188040|NCT02130024|589403970|FG001|Overall Study|Protocol Deviation|0|||
163188041|NCT02130024|589403969|FG000|Overall Study|Site Administration Problems|1|||
163188042|NCT02130024|589403970|FG001|Overall Study|Site Administration Problems|0|||
163188043|NCT02130024|589403969|FG000|Overall Study|Subject Withdrew Consent|6|||
163188044|NCT02130024|589403970|FG001|Overall Study|Subject Withdrew Consent|14|||
163188045|NCT03817879|589406005|FG000|Overall Study|Drop out|5|||
163188046|NCT03817879|589406006|FG001|Overall Study|Drop out|12|||
163188047|NCT03817879|589406005|FG000|Overall Study|Withdrawal by Subject|0|||
162950199|NCT00683293|588520318|FG000|Overall Study|Withdrawal by Subject|2|||
162950200|NCT00683293|588520319|FG001|Overall Study|Withdrawal by Subject|3|||
162950201|NCT00743197|588520322|FG000|Overall Study|Study terminated due to departure of PI.|1|||
162950202|NCT00743197|588520323|FG001|Overall Study|Study terminated due to departure of PI.|2|||
162950203|NCT01411332|588520328|FG000|Enrollment|Protocol Violation|0|||
162950204|NCT01411332|588520329|FG001|Enrollment|Protocol Violation|1|||
162950205|NCT01411332|588520328|FG000|Enrollment|Withdrawal by Subject|0|||
162950206|NCT01411332|588520329|FG001|Enrollment|Withdrawal by Subject|1|||
162950207|NCT01411332|588520328|FG000|Treatment|Lost to Follow-up|1|||
162950208|NCT01411332|588520329|FG001|Treatment|Lost to Follow-up|0|||
162950209|NCT02507375|588520330|FG000|Overall Study|Progressive Disease|4|||
162950210|NCT02507375|588520331|FG001|Overall Study|Progressive Disease|5|||
162950211|NCT02507375|588520330|FG000|Overall Study|Death|0|||
162950212|NCT02507375|588520331|FG001|Overall Study|Death|1|||
162950213|NCT02507375|588520330|FG000|Overall Study|Refused treatment|0|||
162950214|NCT02507375|588520331|FG001|Overall Study|Refused treatment|1|||
162950215|NCT02507375|588520330|FG000|Overall Study|Adverse Event|0|||
162950216|NCT02507375|588520331|FG001|Overall Study|Adverse Event|1|||
162950217|NCT01215981|588521644|FG000|Overall Study|Physician Decision|0|||
162950218|NCT01215981|588521645|FG001|Overall Study|Physician Decision|1|||
162950219|NCT01215981|588521644|FG000|Overall Study|Protocol Violation|1|||
162950220|NCT01215981|588521645|FG001|Overall Study|Protocol Violation|0|||
162950221|NCT01215981|588521644|FG000|Overall Study|Withdrawal by Subject|1|||
162950222|NCT01215981|588521645|FG001|Overall Study|Withdrawal by Subject|0|||
162950223|NCT02653664|588521650|FG000|Post-Treatment|Withdrawal by Subject|6|||
162950224|NCT02653664|588521651|FG001|Post-Treatment|Withdrawal by Subject|5|||
162950225|NCT02653664|588521652|FG002|Post-Treatment|Withdrawal by Subject|7|||
162950226|NCT02653664|588521650|FG000|Post-Treatment|Lost to Follow-up|8|||
162950227|NCT02653664|588521651|FG001|Post-Treatment|Lost to Follow-up|1|||
162950228|NCT02653664|588521652|FG002|Post-Treatment|Lost to Follow-up|7|||
162950229|NCT02653664|588521650|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
162950230|NCT02653664|588521651|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
162950231|NCT02653664|588521652|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
162950232|NCT02653664|588521650|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
162950233|NCT02653664|588521651|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
162950234|NCT02653664|588521652|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
162950235|NCT02653664|588521650|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
162950236|NCT02653664|588521651|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
162950237|NCT02653664|588521652|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
162950238|NCT02653664|588521650|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
163188048|NCT03817879|589406006|FG001|Overall Study|Withdrawal by Subject|1|||
162950239|NCT02653664|588521651|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
163188049|NCT03265665|589406007|FG000|24-week Data Collection|Withdrawal by Subject|2|||
163188050|NCT03265665|589406008|FG001|24-week Data Collection|Withdrawal by Subject|2|||
162950240|NCT02653664|588521652|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
162950241|NCT02653664|588521650|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
163188051|NCT03265665|589406007|FG000|24-week Data Collection|Lost to Follow-up|4|||
162950242|NCT02653664|588521651|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
162950243|NCT02653664|588521652|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
162950244|NCT02653664|588521650|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
162950245|NCT02653664|588521651|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
162950246|NCT02653664|588521652|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
162950247|NCT02653664|588521650|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
162950248|NCT02653664|588521651|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
162950249|NCT02653664|588521652|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
162950250|NCT02653664|588521650|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
162950251|NCT02653664|588521651|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
162950252|NCT02653664|588521652|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
162950253|NCT04657770|588521653|FG000|Overall Study|Withdrawal by Subject|3|||
162950254|NCT04657770|588521653|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
162950255|NCT00485472|588521654|FG000|Overall Study|Adverse Event|8|||
162950256|NCT00485472|588521655|FG001|Overall Study|Adverse Event|5|||
162950257|NCT00485472|588521654|FG000|Overall Study|Lack of Efficacy|5|||
162950258|NCT00485472|588521655|FG001|Overall Study|Lack of Efficacy|4|||
162950259|NCT00485472|588521654|FG000|Overall Study|Withdrawal by Subject|1|||
162950260|NCT00485472|588521655|FG001|Overall Study|Withdrawal by Subject|0|||
162950261|NCT00485472|588521654|FG000|Overall Study|Protocol Violation|0|||
162950262|NCT00485472|588521655|FG001|Overall Study|Protocol Violation|1|||
162950263|NCT00485472|588521654|FG000|Overall Study|Other|2|||
162950264|NCT00485472|588521655|FG001|Overall Study|Other|1|||
162950265|NCT00485472|588521654|FG000|Overall Study|Lost to Follow-up|0|||
162950266|NCT00485472|588521655|FG001|Overall Study|Lost to Follow-up|1|||
162950267|NCT00746798|588521656|FG000|Overall Study|Protocol Violation|0|||
162950268|NCT00746798|588521657|FG001|Overall Study|Protocol Violation|1|||
162950269|NCT00746798|588521658|FG002|Overall Study|Protocol Violation|0|||
162950270|NCT00746798|588521659|FG003|Overall Study|Protocol Violation|0|||
162950271|NCT00746798|588521656|FG000|Overall Study|Withdrawal by Subject|0|||
162950272|NCT00746798|588521657|FG001|Overall Study|Withdrawal by Subject|1|||
162950273|NCT00746798|588521658|FG002|Overall Study|Withdrawal by Subject|1|||
162950274|NCT00746798|588521659|FG003|Overall Study|Withdrawal by Subject|0|||
162950275|NCT00746798|588521656|FG000|Overall Study|Death|0|||
162950276|NCT00746798|588521657|FG001|Overall Study|Death|0|||
162950277|NCT00746798|588521658|FG002|Overall Study|Death|2|||
162950278|NCT00746798|588521659|FG003|Overall Study|Death|0|||
162950279|NCT00746798|588521656|FG000|Overall Study|Participant unable to return for visit|1|||
162950280|NCT00746798|588521657|FG001|Overall Study|Participant unable to return for visit|0|||
162950281|NCT00746798|588521658|FG002|Overall Study|Participant unable to return for visit|0|||
162950282|NCT00746798|588521659|FG003|Overall Study|Participant unable to return for visit|0|||
162950283|NCT04915755|588521662|FG000|Overall Study|Physician Decision|3|||
162950284|NCT04915755|588521663|FG001|Overall Study|Physician Decision|2|||
162950285|NCT04915755|588521662|FG000|Overall Study|Withdrawal by Subject|1|||
162950286|NCT04915755|588521663|FG001|Overall Study|Withdrawal by Subject|1|||
162950287|NCT04915755|588521662|FG000|Overall Study|Ongoing for PACT|3|||
162950288|NCT04915755|588521663|FG001|Overall Study|Ongoing for PACT|2|||
163293585|NCT04707313|589780867|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
163293586|NCT04707313|589780868|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
163293587|NCT04707313|589780869|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
163293588|NCT04707313|589780870|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
163293589|NCT04707313|589780858|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162950289|NCT04915755|588521662|FG000|Overall Study|Other|7|||
162950290|NCT04915755|588521663|FG001|Overall Study|Other|11|||
162950291|NCT00727571|588521665|FG000|Overall Study|Ineligibility determined|1|||
162950292|NCT00727571|588521666|FG001|Overall Study|Ineligibility determined|1|||
162950293|NCT00727571|588521667|FG002|Overall Study|Ineligibility determined|1|||
162950294|NCT00727571|588521668|FG003|Overall Study|Ineligibility determined|0|||
162950295|NCT00727571|588521665|FG000|Overall Study|Death|0|||
162950296|NCT00727571|588521666|FG001|Overall Study|Death|19|||
162950297|NCT00727571|588521667|FG002|Overall Study|Death|5|||
162950298|NCT00727571|588521668|FG003|Overall Study|Death|1|||
162950299|NCT00727571|588521665|FG000|Overall Study|Physician Decision|0|||
162950300|NCT00727571|588521666|FG001|Overall Study|Physician Decision|5|||
162950301|NCT00727571|588521667|FG002|Overall Study|Physician Decision|0|||
162950302|NCT00727571|588521668|FG003|Overall Study|Physician Decision|0|||
162950303|NCT00727571|588521665|FG000|Overall Study|Withdrawal by Subject|0|||
162950304|NCT00727571|588521666|FG001|Overall Study|Withdrawal by Subject|10|||
162950305|NCT00727571|588521667|FG002|Overall Study|Withdrawal by Subject|11|||
163293590|NCT04707313|589780859|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
162950306|NCT00727571|588521668|FG003|Overall Study|Withdrawal by Subject|0|||
162950307|NCT00727571|588521665|FG000|Overall Study|Subject Non Compliance|0|||
162950308|NCT00727571|588521666|FG001|Overall Study|Subject Non Compliance|6|||
162950309|NCT00727571|588521667|FG002|Overall Study|Subject Non Compliance|0|||
162950310|NCT00727571|588521668|FG003|Overall Study|Subject Non Compliance|4|||
163389325|NCT00372385|590137780|FG001|Overall Study|Virologic Stopping Rule|0|||
162950311|NCT00727571|588521665|FG000|Overall Study|Dismissed from nursing home|0|||
162950312|NCT00727571|588521666|FG001|Overall Study|Dismissed from nursing home|9|||
162950313|NCT00727571|588521667|FG002|Overall Study|Dismissed from nursing home|5|||
162950314|NCT00727571|588521668|FG003|Overall Study|Dismissed from nursing home|0|||
162950315|NCT00727571|588521665|FG000|Overall Study|Hospitalization|0|||
162950316|NCT00727571|588521666|FG001|Overall Study|Hospitalization|1|||
162950317|NCT00727571|588521667|FG002|Overall Study|Hospitalization|0|||
162950318|NCT00727571|588521668|FG003|Overall Study|Hospitalization|1|||
162950319|NCT00727571|588521665|FG000|Overall Study|AE not leading to hospitalization|0|||
162950320|NCT00727571|588521666|FG001|Overall Study|AE not leading to hospitalization|0|||
162950321|NCT00727571|588521667|FG002|Overall Study|AE not leading to hospitalization|2|||
162950322|NCT00727571|588521668|FG003|Overall Study|AE not leading to hospitalization|0|||
162950323|NCT00727571|588521665|FG000|Overall Study|Other|0|||
162950324|NCT00727571|588521666|FG001|Overall Study|Other|4|||
162950325|NCT00727571|588521667|FG002|Overall Study|Other|6|||
162950326|NCT00727571|588521668|FG003|Overall Study|Other|0|||
162950327|NCT03247556|588521669|FG000|Overall Study|Adverse Event|1|||
162950328|NCT03247556|588521670|FG001|Overall Study|Adverse Event|4|||
162950329|NCT03247556|588521671|FG002|Overall Study|Adverse Event|5|||
162950330|NCT03247556|588521669|FG000|Overall Study|Lost to Follow-up|5|||
162950331|NCT03247556|588521670|FG001|Overall Study|Lost to Follow-up|5|||
162950332|NCT03247556|588521671|FG002|Overall Study|Lost to Follow-up|4|||
162950333|NCT03247556|588521669|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
162950334|NCT03247556|588521670|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
162950335|NCT03247556|588521671|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
162950336|NCT03247556|588521669|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
162950337|NCT03247556|588521670|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
162950338|NCT03247556|588521671|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
162950339|NCT03247556|588521669|FG000|Overall Study|Protocol Violation|2|||
162950340|NCT03247556|588521670|FG001|Overall Study|Protocol Violation|0|||
162950341|NCT03247556|588521671|FG002|Overall Study|Protocol Violation|1|||
162950342|NCT03247556|588521669|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
162950343|NCT03247556|588521670|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
162950344|NCT03247556|588521671|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
162950345|NCT01710657|588521675|FG000|Overall Study|Lost to Follow-up|2|||
162950346|NCT01710657|588521676|FG001|Overall Study|Lost to Follow-up|0|||
162950347|NCT01710657|588521677|FG002|Overall Study|Lost to Follow-up|1|||
162950348|NCT01710657|588521675|FG000|Overall Study|Protocol Violation|2|||
162950349|NCT01710657|588521676|FG001|Overall Study|Protocol Violation|2|||
162950350|NCT01710657|588521677|FG002|Overall Study|Protocol Violation|0|||
162950351|NCT01710657|588521675|FG000|Overall Study|Adverse Event|14|||
162950352|NCT01710657|588521676|FG001|Overall Study|Adverse Event|8|||
162950353|NCT01710657|588521677|FG002|Overall Study|Adverse Event|28|||
162950354|NCT01710657|588521675|FG000|Overall Study|Withdrawal by Subject|0|||
162950355|NCT01710657|588521676|FG001|Overall Study|Withdrawal by Subject|1|||
162950356|NCT01710657|588521677|FG002|Overall Study|Withdrawal by Subject|2|||
162950357|NCT01710657|588521675|FG000|Overall Study|Lack of Efficacy|0|||
162950358|NCT01710657|588521676|FG001|Overall Study|Lack of Efficacy|1|||
162950359|NCT01710657|588521677|FG002|Overall Study|Lack of Efficacy|1|||
162950360|NCT02495857|588521685|FG000|Overall Study|Adverse Event|5|||
162950361|NCT02495857|588521686|FG001|Overall Study|Adverse Event|0|||
162950362|NCT02495857|588521687|FG002|Overall Study|Adverse Event|1|||
162950363|NCT02495857|588521685|FG000|Overall Study|Withdrawal by Subject|9|||
162950364|NCT02495857|588521686|FG001|Overall Study|Withdrawal by Subject|6|||
162950365|NCT02495857|588521687|FG002|Overall Study|Withdrawal by Subject|10|||
162950366|NCT02495857|588521685|FG000|Overall Study|Physician Decision|0|||
162950367|NCT02495857|588521686|FG001|Overall Study|Physician Decision|1|||
162950368|NCT02495857|588521687|FG002|Overall Study|Physician Decision|0|||
162950369|NCT02495857|588521685|FG000|Overall Study|Protocol Violation|1|||
162950370|NCT02495857|588521686|FG001|Overall Study|Protocol Violation|1|||
162950371|NCT02495857|588521687|FG002|Overall Study|Protocol Violation|2|||
162950372|NCT02495857|588521685|FG000|Overall Study|Lost to Follow-up|4|||
163188052|NCT03265665|589406008|FG001|24-week Data Collection|Lost to Follow-up|5|||
163188053|NCT03265665|589406007|FG000|36-week Data Collection|Lost to Follow-up|6|||
163188054|NCT03265665|589406008|FG001|36-week Data Collection|Lost to Follow-up|8|||
163188055|NCT01858376|589406009|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
163188056|NCT01680965|589406013|FG000|Overall Study|Death|0|||
163188057|NCT01680965|589406014|FG001|Overall Study|Death|0|||
163188058|NCT01680965|589406015|FG002|Overall Study|Death|0|||
163188059|NCT01680965|589406016|FG003|Overall Study|Death|6|||
163188060|NCT02486302|589406028|FG000|Overall Study|Discontinued prematurely|410|||
163188061|NCT02486302|589406028|FG000|Overall Study|Documentation not completed|255|||
163188062|NCT02486302|589406028|FG000|Overall Study|Excluded due to legal reasons|8|||
163188063|NCT02486302|589406028|FG000|Overall Study|Not treated|3|||
162950373|NCT02495857|588521686|FG001|Overall Study|Lost to Follow-up|5|||
162950374|NCT02495857|588521687|FG002|Overall Study|Lost to Follow-up|3|||
162950375|NCT02495857|588521685|FG000|Overall Study|Other|3|||
162950376|NCT02495857|588521686|FG001|Overall Study|Other|3|||
162950377|NCT02495857|588521687|FG002|Overall Study|Other|2|||
162950378|NCT01367457|588521688|FG000|Overall Study|Death|2|||
162950379|NCT01367457|588521689|FG001|Overall Study|Death|0|||
162950380|NCT01367457|588521690|FG002|Overall Study|Death|0|||
162950381|NCT01367457|588521688|FG000|Overall Study|Investigator's decision|2|||
162950382|NCT01367457|588521689|FG001|Overall Study|Investigator's decision|0|||
162950383|NCT01367457|588521690|FG002|Overall Study|Investigator's decision|0|||
162950384|NCT01367457|588521688|FG000|Overall Study|Clinical decline (CD)|2|||
162950385|NCT01367457|588521689|FG001|Overall Study|Clinical decline (CD)|0|||
162950386|NCT01367457|588521690|FG002|Overall Study|Clinical decline (CD)|0|||
162950387|NCT01367457|588521688|FG000|Overall Study|Progression and death|8|||
162950388|NCT01367457|588521689|FG001|Overall Study|Progression and death|0|||
162950389|NCT01367457|588521690|FG002|Overall Study|Progression and death|0|||
162950390|NCT01367457|588521688|FG000|Overall Study|Toxicity|16|||
162950391|NCT01367457|588521689|FG001|Overall Study|Toxicity|0|||
162950392|NCT01367457|588521690|FG002|Overall Study|Toxicity|0|||
162950393|NCT01367457|588521688|FG000|Overall Study|Progression|137|||
162950394|NCT01367457|588521689|FG001|Overall Study|Progression|0|||
162950395|NCT01367457|588521690|FG002|Overall Study|Progression|0|||
162950396|NCT01367457|588521688|FG000|Overall Study|Patient asks for rest + slow progression|1|||
162950397|NCT01367457|588521689|FG001|Overall Study|Patient asks for rest + slow progression|0|||
162950398|NCT01367457|588521690|FG002|Overall Study|Patient asks for rest + slow progression|0|||
162950399|NCT01367457|588521688|FG000|Overall Study|Investigator's opinion, stable disease|1|||
162950400|NCT01367457|588521689|FG001|Overall Study|Investigator's opinion, stable disease|0|||
163389326|NCT00372385|590137781|FG002|Overall Study|Virologic Stopping Rule|0|||
163389327|NCT00372385|590137782|FG003|Overall Study|Virologic Stopping Rule|0|||
163389328|NCT02554903|590137785|FG000|Overall Study|Death|1|||
163389329|NCT02554903|590137786|FG001|Overall Study|Death|1|||
163389330|NCT02554903|590137785|FG000|Overall Study|Physician Decision|2|||
163389331|NCT02554903|590137786|FG001|Overall Study|Physician Decision|2|||
163389332|NCT02554903|590137785|FG000|Overall Study|Heart Transplant|1|||
163389333|NCT02554903|590137786|FG001|Overall Study|Heart Transplant|2|||
163389334|NCT02958267|590137812|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
163389335|NCT02958267|590137813|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
163389336|NCT02958267|590137812|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
162950401|NCT01367457|588521690|FG002|Overall Study|Investigator's opinion, stable disease|0|||
162950402|NCT01367457|588521688|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
162950403|NCT01367457|588521689|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
162950404|NCT01367457|588521690|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
162950405|NCT01367457|588521688|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
162950406|NCT01367457|588521689|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
162950407|NCT01367457|588521690|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
163389337|NCT02958267|590137813|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
163389338|NCT02958267|590137812|FG000|Follow-up Visits|Additional treatment pursued|2|||
162950408|NCT01367457|588521688|FG000|Overall Study|low grade toxicities + stable disease|1|||
162950409|NCT01367457|588521689|FG001|Overall Study|low grade toxicities + stable disease|0|||
162950410|NCT01367457|588521690|FG002|Overall Study|low grade toxicities + stable disease|0|||
162950411|NCT01367457|588521688|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
162950412|NCT01367457|588521689|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
162950413|NCT01367457|588521690|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
162950414|NCT01367457|588521688|FG000|Overall Study|Withdrawal by Subject|1|||
162950415|NCT01367457|588521689|FG001|Overall Study|Withdrawal by Subject|0|||
162950416|NCT01367457|588521690|FG002|Overall Study|Withdrawal by Subject|0|||
162950417|NCT01367457|588521688|FG000|Overall Study|CD, associated leukaemia|1|||
162950418|NCT01367457|588521689|FG001|Overall Study|CD, associated leukaemia|0|||
162950419|NCT01367457|588521690|FG002|Overall Study|CD, associated leukaemia|0|||
162950420|NCT01367457|588521688|FG000|Overall Study|Uncontrolled pain|1|||
162950421|NCT01367457|588521689|FG001|Overall Study|Uncontrolled pain|0|||
162950422|NCT01367457|588521690|FG002|Overall Study|Uncontrolled pain|0|||
162950423|NCT01367457|588521688|FG000|Overall Study|Overall status worsens to grade 4|1|||
162950424|NCT01367457|588521689|FG001|Overall Study|Overall status worsens to grade 4|0|||
162950425|NCT01367457|588521690|FG002|Overall Study|Overall status worsens to grade 4|0|||
162950426|NCT01367457|588521688|FG000|Overall Study|Stabilisation + frequent infections|1|||
162950427|NCT01367457|588521689|FG001|Overall Study|Stabilisation + frequent infections|0|||
162950428|NCT01367457|588521690|FG002|Overall Study|Stabilisation + frequent infections|0|||
162950429|NCT01367457|588521688|FG000|Overall Study|No clinical benefit|1|||
162950430|NCT01367457|588521689|FG001|Overall Study|No clinical benefit|0|||
162950431|NCT01367457|588521690|FG002|Overall Study|No clinical benefit|0|||
162950432|NCT01367457|588521688|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
162950433|NCT01367457|588521689|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
162950434|NCT01367457|588521690|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
162950435|NCT01367457|588521688|FG000|Overall Study|Overall decline|1|||
162950436|NCT01367457|588521689|FG001|Overall Study|Overall decline|0|||
163389339|NCT02958267|590137813|FG001|Follow-up Visits|Additional treatment pursued|1|||
163389340|NCT01853982|590137814|FG000|Overall Study|Withdrawal by Subject|1|||
162950437|NCT01367457|588521690|FG002|Overall Study|Overall decline|0|||
162950438|NCT01367457|588521688|FG000|Overall Study|Rejection of treatment|1|||
162950439|NCT01367457|588521689|FG001|Overall Study|Rejection of treatment|0|||
162950440|NCT01367457|588521690|FG002|Overall Study|Rejection of treatment|0|||
162950441|NCT01367457|588521688|FG000|Overall Study|Lost to Follow-up|1|||
162950442|NCT01367457|588521689|FG001|Overall Study|Lost to Follow-up|0|||
162950443|NCT01367457|588521690|FG002|Overall Study|Lost to Follow-up|0|||
162950444|NCT01367457|588521688|FG000|Overall Study|Death from septic shock|1|||
162950445|NCT01367457|588521689|FG001|Overall Study|Death from septic shock|0|||
162950446|NCT01367457|588521690|FG002|Overall Study|Death from septic shock|0|||
162950447|NCT01367457|588521688|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
162950448|NCT01367457|588521689|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
162950449|NCT01367457|588521690|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
162950450|NCT01367457|588521688|FG000|Overall Study|Patient's Wish|1|||
162950451|NCT01367457|588521689|FG001|Overall Study|Patient's Wish|0|||
162950452|NCT01367457|588521690|FG002|Overall Study|Patient's Wish|0|||
162950453|NCT01367457|588521688|FG000|Overall Study|Palliative. Overall decline|1|||
162950454|NCT01367457|588521689|FG001|Overall Study|Palliative. Overall decline|0|||
162950455|NCT01367457|588521690|FG002|Overall Study|Palliative. Overall decline|0|||
162950456|NCT01367457|588521688|FG000|Overall Study|Suspected DP/suspected active infection|1|||
162950457|NCT01367457|588521689|FG001|Overall Study|Suspected DP/suspected active infection|0|||
162950458|NCT01367457|588521690|FG002|Overall Study|Suspected DP/suspected active infection|0|||
162950459|NCT04407806|588521695|FG000|Overall Study|Withdrawal by Subject|1|||
162950460|NCT04407806|588521696|FG001|Overall Study|Withdrawal by Subject|2|||
162950461|NCT02058498|588521698|FG000|Overall Study|Withdrawal by Subject|4|||
163389341|NCT01853982|590137815|FG001|Overall Study|Withdrawal by Subject|0|||
163389342|NCT01853982|590137814|FG000|Overall Study|Death|1|||
163389343|NCT01853982|590137815|FG001|Overall Study|Death|0|||
163389344|NCT01853982|590137814|FG000|Overall Study|Lost to Follow-up|0|||
163389345|NCT01853982|590137815|FG001|Overall Study|Lost to Follow-up|1|||
163389346|NCT05066724|590137816|FG000|Overall Study|Adverse Event|1|||
163389347|NCT05066724|590137816|FG000|Overall Study|Non-Compliance With Study Drug|5|||
163389348|NCT05066724|590137816|FG000|Overall Study|Withdrawal by Subject|6|||
163389349|NCT05066724|590137816|FG000|Overall Study|Physician Decision|2|||
163389350|NCT01422850|590137817|FG000|Overall Study|Physician Decision|3|||
163389351|NCT04484831|590137818|FG000|Overall Study|Withdrawal by Subject|1|||
163389352|NCT04484831|590137819|FG001|Overall Study|Withdrawal by Subject|0|||
163389353|NCT02244996|590137821|FG000|Overall Study|Lack of Efficacy|2|||
163389354|NCT02244996|590137822|FG001|Overall Study|Lack of Efficacy|6|||
163389355|NCT00174265|590137824|FG000|Overall Study|Adverse Event|7|||
163389356|NCT00174265|590137825|FG001|Overall Study|Adverse Event|4|||
163389357|NCT00174265|590137824|FG000|Overall Study|Lack of Efficacy|2|||
163389358|NCT00174265|590137825|FG001|Overall Study|Lack of Efficacy|2|||
163389359|NCT00174265|590137824|FG000|Overall Study|Withdrawal by Subject|3|||
163389360|NCT00174265|590137825|FG001|Overall Study|Withdrawal by Subject|5|||
163389361|NCT00174265|590137824|FG000|Overall Study|Lost to Follow-up|1|||
163389362|NCT00174265|590137825|FG001|Overall Study|Lost to Follow-up|0|||
163389363|NCT00174265|590137824|FG000|Overall Study|Other (Not specified)|16|||
163389364|NCT00174265|590137825|FG001|Overall Study|Other (Not specified)|10|||
163389365|NCT03231943|590137826|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163389366|NCT03231943|590137827|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
163389367|NCT03231943|590137828|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
163389368|NCT03231943|590137829|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163389369|NCT03231943|590137830|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163389370|NCT03231943|590137831|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163389371|NCT03231943|590137832|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163389372|NCT03231943|590137833|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163389373|NCT03231943|590137834|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163389374|NCT03231943|590137835|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163389375|NCT03231943|590137836|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163389376|NCT03231943|590137837|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163389377|NCT03231943|590137838|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163389378|NCT03231943|590137826|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163389379|NCT03231943|590137827|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
163389380|NCT03231943|590137828|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163389381|NCT03231943|590137829|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163389382|NCT03231943|590137830|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163389383|NCT03231943|590137831|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
162950462|NCT04605094|588521699|FG000|Overall Study|Adverse Event|2|||
162950463|NCT04605094|588521700|FG001|Overall Study|Adverse Event|2|||
162950464|NCT04605094|588521699|FG000|Overall Study|Lost to Follow-up|1|||
162950465|NCT04605094|588521700|FG001|Overall Study|Lost to Follow-up|4|||
162950466|NCT04605094|588521699|FG000|Overall Study|Physician Decision|2|||
162950467|NCT04605094|588521700|FG001|Overall Study|Physician Decision|2|||
162950468|NCT04605094|588521699|FG000|Overall Study|Study terminated by Sponsor|31|||
163389384|NCT03231943|590137832|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163389385|NCT03231943|590137833|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163389386|NCT03231943|590137834|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163389387|NCT03231943|590137835|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163389388|NCT03231943|590137836|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163389389|NCT03231943|590137837|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
162950469|NCT04605094|588521700|FG001|Overall Study|Study terminated by Sponsor|33|||
162950470|NCT04605094|588521699|FG000|Overall Study|Withdrawal by Subject|22|||
162950471|NCT04605094|588521700|FG001|Overall Study|Withdrawal by Subject|19|||
162950472|NCT04605094|588521699|FG000|Overall Study|Other|1|||
162950473|NCT04605094|588521700|FG001|Overall Study|Other|1|||
162950474|NCT02724462|588521701|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
162950475|NCT02724462|588521702|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
162950476|NCT02724462|588521701|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
162950477|NCT02724462|588521702|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
163389390|NCT03231943|590137838|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163389391|NCT03231943|590137826|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
163389392|NCT03231943|590137827|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163389393|NCT03231943|590137828|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163389394|NCT03231943|590137829|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
162950478|NCT02724462|588521701|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
163389395|NCT03231943|590137830|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163389396|NCT03231943|590137831|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
162950479|NCT02724462|588521702|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
162950480|NCT02724462|588521701|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
162950481|NCT02724462|588521702|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
163293591|NCT04707313|589780860|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
163293592|NCT04707313|589780861|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162950482|NCT02724462|588521701|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
163389397|NCT03231943|590137832|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163389398|NCT03231943|590137833|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163389399|NCT03231943|590137834|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163389400|NCT03231943|590137835|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163389401|NCT03231943|590137836|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163389402|NCT03231943|590137837|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163389403|NCT03231943|590137838|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163389404|NCT03231943|590137826|FG000|Part 2|Adverse Event|0|||
163389405|NCT03231943|590137827|FG001|Part 2|Adverse Event|0|||
163389406|NCT03231943|590137828|FG002|Part 2|Adverse Event|0|||
163389407|NCT03231943|590137829|FG003|Part 2|Adverse Event|0|||
163389408|NCT03231943|590137830|FG004|Part 2|Adverse Event|0|||
163389409|NCT03231943|590137831|FG005|Part 2|Adverse Event|0|||
162950483|NCT02724462|588521702|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
162950484|NCT02724462|588521701|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
162950485|NCT02724462|588521702|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
162950486|NCT00469417|588521703|FG000|Overall Study|Treatment failure all lesions|18|||
162950487|NCT00469417|588521704|FG001|Overall Study|Treatment failure all lesions|11|||
162950488|NCT00469417|588521703|FG000|Overall Study|Consent withdrawn|1|||
162950489|NCT00469417|588521704|FG001|Overall Study|Consent withdrawn|1|||
162950490|NCT00469417|588521703|FG000|Overall Study|Adverse Event|8|||
162950491|NCT00469417|588521704|FG001|Overall Study|Adverse Event|2|||
162950492|NCT00469417|588521703|FG000|Overall Study|Lost to Follow-up|1|||
162950493|NCT00469417|588521704|FG001|Overall Study|Lost to Follow-up|2|||
162950494|NCT00469417|588521703|FG000|Overall Study|Intercurrent disease|0|||
162950495|NCT00469417|588521704|FG001|Overall Study|Intercurrent disease|1|||
162950496|NCT00469417|588521703|FG000|Overall Study|Randomized but not treated|2|||
162950497|NCT00469417|588521704|FG001|Overall Study|Randomized but not treated|0|||
162950498|NCT02188303|588521709|FG000|Overall Study|Adverse Event|0|||
162950499|NCT02188303|588521710|FG001|Overall Study|Adverse Event|0|||
162950500|NCT02188303|588521711|FG002|Overall Study|Adverse Event|0|||
162950501|NCT02188303|588521712|FG003|Overall Study|Adverse Event|0|||
162950502|NCT02188303|588521713|FG004|Overall Study|Adverse Event|0|||
162950503|NCT02188303|588521714|FG005|Overall Study|Adverse Event|2|||
162950504|NCT02188303|588521715|FG006|Overall Study|Adverse Event|0|||
162950505|NCT02188303|588521716|FG007|Overall Study|Adverse Event|2|||
162950506|NCT02188303|588521709|FG000|Overall Study|Dose Termination Criteria Met|0|||
162950507|NCT02188303|588521710|FG001|Overall Study|Dose Termination Criteria Met|0|||
162950508|NCT02188303|588521711|FG002|Overall Study|Dose Termination Criteria Met|0|||
162950509|NCT02188303|588521712|FG003|Overall Study|Dose Termination Criteria Met|0|||
162950510|NCT02188303|588521713|FG004|Overall Study|Dose Termination Criteria Met|0|||
162950511|NCT02188303|588521714|FG005|Overall Study|Dose Termination Criteria Met|0|||
162950512|NCT02188303|588521715|FG006|Overall Study|Dose Termination Criteria Met|2|||
162950513|NCT02188303|588521716|FG007|Overall Study|Dose Termination Criteria Met|4|||
162950514|NCT04206332|588521718|FG000|Part A|Lost to Follow-up|0|||
162950515|NCT04206332|588521719|FG001|Part A|Lost to Follow-up|1|||
162950516|NCT04206332|588521720|FG002|Part A|Lost to Follow-up|0|||
163188064|NCT00734474|589406031|FG000|Overall Study|Entry Criteria Not Met|0|||
163188065|NCT00734474|589406032|FG001|Overall Study|Entry Criteria Not Met|0|||
163188066|NCT00734474|589406033|FG002|Overall Study|Entry Criteria Not Met|5|||
162950517|NCT04206332|588521721|FG003|Part A|Lost to Follow-up|0|||
162950518|NCT04206332|588521722|FG004|Part A|Lost to Follow-up|0|||
162950519|NCT04206332|588521723|FG005|Part A|Lost to Follow-up|0|||
162950520|NCT04206332|588521724|FG006|Part A|Lost to Follow-up|0|||
162950521|NCT04206332|588521725|FG007|Part A|Lost to Follow-up|0|||
163188067|NCT00734474|589406034|FG003|Overall Study|Entry Criteria Not Met|0|||
163188068|NCT00734474|589406035|FG004|Overall Study|Entry Criteria Not Met|3|||
163188069|NCT00734474|589406036|FG005|Overall Study|Entry Criteria Not Met|1|||
163188070|NCT00734474|589406037|FG006|Overall Study|Entry Criteria Not Met|0|||
163188071|NCT00734474|589406038|FG007|Overall Study|Entry Criteria Not Met|1|||
163188072|NCT00734474|589406039|FG008|Overall Study|Entry Criteria Not Met|1|||
163188073|NCT00734474|589406031|FG000|Overall Study|Lost to Follow-up|1|||
163188074|NCT00734474|589406032|FG001|Overall Study|Lost to Follow-up|0|||
163188075|NCT00734474|589406033|FG002|Overall Study|Lost to Follow-up|13|||
163188076|NCT00734474|589406034|FG003|Overall Study|Lost to Follow-up|0|||
163188077|NCT00734474|589406035|FG004|Overall Study|Lost to Follow-up|11|||
163188078|NCT00734474|589406036|FG005|Overall Study|Lost to Follow-up|1|||
163188079|NCT00734474|589406037|FG006|Overall Study|Lost to Follow-up|0|||
162950522|NCT04206332|588521726|FG008|Part A|Lost to Follow-up|0|||
162950523|NCT04206332|588521727|FG009|Part A|Lost to Follow-up|0|||
162950524|NCT04206332|588521728|FG010|Part A|Lost to Follow-up|0|||
162950525|NCT04206332|588521729|FG011|Part A|Lost to Follow-up|0|||
162950526|NCT04206332|588521730|FG012|Part A|Lost to Follow-up|0|||
162950527|NCT04206332|588521731|FG013|Part A|Lost to Follow-up|0|||
162950528|NCT04206332|588521732|FG014|Part A|Lost to Follow-up|0|||
162950529|NCT04206332|588521733|FG015|Part A|Lost to Follow-up|0|||
162950530|NCT04206332|588521734|FG016|Part A|Lost to Follow-up|0|||
162950531|NCT04206332|588521718|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950532|NCT04206332|588521719|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950533|NCT04206332|588521720|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950534|NCT04206332|588521721|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950535|NCT04206332|588521722|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950536|NCT04206332|588521723|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
162950537|NCT04206332|588521724|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
163389410|NCT03231943|590137832|FG006|Part 2|Adverse Event|0|||
163389411|NCT03231943|590137833|FG007|Part 2|Adverse Event|0|||
163389412|NCT03231943|590137834|FG008|Part 2|Adverse Event|0|||
163389413|NCT03231943|590137835|FG009|Part 2|Adverse Event|0|||
163389414|NCT03231943|590137836|FG010|Part 2|Adverse Event|1|||
163389415|NCT03231943|590137837|FG011|Part 2|Adverse Event|0|||
163389416|NCT03231943|590137838|FG012|Part 2|Adverse Event|0|||
163389417|NCT03231943|590137826|FG000|Part 2|Withdrawal by Subject|0|||
163389418|NCT03231943|590137827|FG001|Part 2|Withdrawal by Subject|0|||
163389419|NCT03231943|590137828|FG002|Part 2|Withdrawal by Subject|0|||
163389420|NCT03231943|590137829|FG003|Part 2|Withdrawal by Subject|0|||
162950538|NCT04206332|588521725|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950539|NCT04206332|588521726|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950540|NCT04206332|588521727|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950541|NCT04206332|588521728|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950542|NCT04206332|588521729|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950543|NCT04206332|588521730|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950544|NCT04206332|588521731|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950545|NCT04206332|588521732|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950546|NCT04206332|588521733|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950547|NCT04206332|588521734|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950548|NCT04206332|588521718|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950549|NCT04206332|588521719|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950550|NCT04206332|588521720|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950551|NCT04206332|588521721|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950552|NCT04206332|588521722|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950553|NCT04206332|588521723|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950554|NCT04206332|588521724|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950555|NCT04206332|588521725|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
162950556|NCT04206332|588521726|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950557|NCT04206332|588521727|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950558|NCT04206332|588521728|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
162950559|NCT04206332|588521729|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950560|NCT04206332|588521730|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950561|NCT04206332|588521731|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950562|NCT04206332|588521732|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950563|NCT04206332|588521733|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950564|NCT04206332|588521734|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950565|NCT04206332|588521718|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950566|NCT04206332|588521719|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950567|NCT04206332|588521720|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950568|NCT04206332|588521721|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
163389421|NCT03231943|590137830|FG004|Part 2|Withdrawal by Subject|0|||
163389422|NCT03231943|590137831|FG005|Part 2|Withdrawal by Subject|0|||
163389423|NCT03231943|590137832|FG006|Part 2|Withdrawal by Subject|0|||
163389424|NCT03231943|590137833|FG007|Part 2|Withdrawal by Subject|0|||
163389425|NCT03231943|590137834|FG008|Part 2|Withdrawal by Subject|0|||
163389426|NCT03231943|590137835|FG009|Part 2|Withdrawal by Subject|0|||
163389427|NCT03231943|590137836|FG010|Part 2|Withdrawal by Subject|0|||
163389428|NCT03231943|590137837|FG011|Part 2|Withdrawal by Subject|1|||
163389429|NCT03231943|590137838|FG012|Part 2|Withdrawal by Subject|0|||
163389430|NCT00047320|590137839|FG000|Overall Study|Lack of Efficacy|8|||
163389431|NCT00047320|590137839|FG000|Overall Study|Lost to Follow-up|1|||
163389432|NCT00047320|590137839|FG000|Overall Study|Physician Decision|8|||
163389433|NCT00047320|590137839|FG000|Overall Study|Withdrawal by Subject|9|||
163389434|NCT00047320|590137839|FG000|Overall Study|Ineligible|2|||
163389435|NCT03471871|590137840|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
163188080|NCT00734474|589406038|FG007|Overall Study|Lost to Follow-up|9|||
163188081|NCT00734474|589406039|FG008|Overall Study|Lost to Follow-up|4|||
163188082|NCT00734474|589406031|FG000|Overall Study|Withdrawal by Subject|2|||
163188083|NCT00734474|589406032|FG001|Overall Study|Withdrawal by Subject|1|||
163188084|NCT00734474|589406033|FG002|Overall Study|Withdrawal by Subject|18|||
163188085|NCT00734474|589406034|FG003|Overall Study|Withdrawal by Subject|0|||
163188086|NCT00734474|589406035|FG004|Overall Study|Withdrawal by Subject|24|||
163188087|NCT00734474|589406036|FG005|Overall Study|Withdrawal by Subject|2|||
163188088|NCT00734474|589406037|FG006|Overall Study|Withdrawal by Subject|0|||
163188089|NCT00734474|589406038|FG007|Overall Study|Withdrawal by Subject|36|||
163389436|NCT03471871|590137841|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
163389437|NCT03471871|590137842|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
163389438|NCT03471871|590137843|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
163389439|NCT03471871|590137844|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
163389440|NCT03471871|590137840|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
163389441|NCT03471871|590137841|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
163389442|NCT03471871|590137842|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
163389443|NCT03471871|590137843|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
163389444|NCT03471871|590137844|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
163389445|NCT03471871|590137840|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
163389446|NCT03471871|590137841|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
163389447|NCT03471871|590137842|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
163389448|NCT03471871|590137843|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
163389449|NCT03471871|590137844|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
163389450|NCT03471871|590137840|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
163389451|NCT03471871|590137841|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
163389452|NCT03471871|590137842|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
163389453|NCT03471871|590137843|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
163389454|NCT03471871|590137844|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
163389455|NCT03471871|590137840|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
163389456|NCT03471871|590137841|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
163389457|NCT03471871|590137842|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
163389458|NCT03471871|590137843|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
163389459|NCT03471871|590137844|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
163389460|NCT03040622|590137845|FG000|Overall Study|unable to implant device|3|||
163188090|NCT00734474|589406039|FG008|Overall Study|Withdrawal by Subject|21|||
163188091|NCT00734474|589406031|FG000|Overall Study|Physician Decision|0|||
163188092|NCT00734474|589406032|FG001|Overall Study|Physician Decision|0|||
163389493|NCT02818920|590137848|FG000|Overall Study|Unresectable|4|||
163188093|NCT00734474|589406033|FG002|Overall Study|Physician Decision|4|||
163389494|NCT02818920|590137848|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
163389495|NCT02818920|590137848|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
163389496|NCT02818920|590137848|FG000|Overall Study|Adverse Event|3|||
163389497|NCT02818920|590137848|FG000|Overall Study|Developed Other Disease|1|||
163389498|NCT02818920|590137848|FG000|Overall Study|Refused Further Treatment|1|||
163389499|NCT00445068|590137849|FG000|Overall Study|Disease progression|26|||
163389500|NCT00445068|590137849|FG000|Overall Study|Adverse Event|5|||
163389501|NCT00445068|590137849|FG000|Overall Study|Abnormal laboratory value|2|||
162950569|NCT04206332|588521722|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
163389502|NCT00445068|590137849|FG000|Overall Study|Withdrawal by Subject|2|||
162950570|NCT04206332|588521723|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162978984|NCT01660022|588623541|FG003|First Sequence (7 Days)|Adverse Event|0|||
163389503|NCT00445068|590137849|FG000|Overall Study|Death|1|||
163389504|NCT02673619|590137850|FG000|Overall Study|Lost to Follow-up|1|||
162950571|NCT04206332|588521724|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950572|NCT04206332|588521725|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950573|NCT04206332|588521726|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950574|NCT04206332|588521727|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950575|NCT04206332|588521728|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950576|NCT04206332|588521729|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950577|NCT04206332|588521730|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950578|NCT04206332|588521731|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950579|NCT04206332|588521732|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950580|NCT04206332|588521733|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950581|NCT04206332|588521734|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
162950582|NCT04206332|588521718|FG000|Part C|Withdrawal by Subject|0|||
162950583|NCT04206332|588521719|FG001|Part C|Withdrawal by Subject|0|||
162950584|NCT04206332|588521720|FG002|Part C|Withdrawal by Subject|0|||
162950585|NCT04206332|588521721|FG003|Part C|Withdrawal by Subject|0|||
163389505|NCT02673619|590137851|FG001|Overall Study|Lost to Follow-up|0|||
163389506|NCT02673619|590137852|FG002|Overall Study|Lost to Follow-up|0|||
163389507|NCT02673619|590137853|FG003|Overall Study|Lost to Follow-up|0|||
162950586|NCT04206332|588521722|FG004|Part C|Withdrawal by Subject|0|||
162950587|NCT04206332|588521723|FG005|Part C|Withdrawal by Subject|0|||
162950588|NCT04206332|588521724|FG006|Part C|Withdrawal by Subject|0|||
162950589|NCT04206332|588521725|FG007|Part C|Withdrawal by Subject|0|||
162950590|NCT04206332|588521726|FG008|Part C|Withdrawal by Subject|0|||
162950591|NCT04206332|588521727|FG009|Part C|Withdrawal by Subject|0|||
162950592|NCT04206332|588521728|FG010|Part C|Withdrawal by Subject|0|||
162950593|NCT04206332|588521729|FG011|Part C|Withdrawal by Subject|0|||
162950594|NCT04206332|588521730|FG012|Part C|Withdrawal by Subject|0|||
162950595|NCT04206332|588521731|FG013|Part C|Withdrawal by Subject|0|||
162950596|NCT04206332|588521732|FG014|Part C|Withdrawal by Subject|2|||
162950597|NCT04206332|588521733|FG015|Part C|Withdrawal by Subject|0|||
162950598|NCT04206332|588521734|FG016|Part C|Withdrawal by Subject|0|||
162950599|NCT05612724|588521736|FG000|Overall Study|Lost to Follow-up|4|||
162950600|NCT04000815|588521743|FG000|Overall Study|Lost to Follow-up|9|||
162950601|NCT04000815|588521744|FG001|Overall Study|Lost to Follow-up|2|||
162950602|NCT04000815|588521745|FG002|Overall Study|Lost to Follow-up|3|||
162950603|NCT04000815|588521743|FG000|Overall Study|Withdrawal by Subject|4|||
162950604|NCT04000815|588521744|FG001|Overall Study|Withdrawal by Subject|3|||
162950605|NCT04000815|588521745|FG002|Overall Study|Withdrawal by Subject|2|||
162950606|NCT04000815|588521743|FG000|Overall Study|Right ovarian cyst occured|1|||
162950607|NCT04000815|588521744|FG001|Overall Study|Right ovarian cyst occured|0|||
162950608|NCT04000815|588521745|FG002|Overall Study|Right ovarian cyst occured|0|||
162950609|NCT04000815|588521743|FG000|Overall Study|Hypertension occured on follow up|0|||
162950610|NCT04000815|588521744|FG001|Overall Study|Hypertension occured on follow up|0|||
162950611|NCT04000815|588521745|FG002|Overall Study|Hypertension occured on follow up|2|||
162950612|NCT00239577|588521746|FG000|Primary Phase|Adverse Event|0|||
162950613|NCT00239577|588521747|FG001|Primary Phase|Adverse Event|0|||
162950614|NCT00239577|588521748|FG002|Primary Phase|Adverse Event|1|||
162950615|NCT00239577|588521749|FG003|Primary Phase|Adverse Event|0|||
162950616|NCT00239577|588521746|FG000|Primary Phase|Other|5|||
163389508|NCT02673619|590137850|FG000|Overall Study|Withdrawal by Subject|1|||
163389509|NCT02673619|590137851|FG001|Overall Study|Withdrawal by Subject|1|||
163389510|NCT02673619|590137852|FG002|Overall Study|Withdrawal by Subject|1|||
163389511|NCT02673619|590137853|FG003|Overall Study|Withdrawal by Subject|0|||
163389512|NCT02673619|590137850|FG000|Overall Study|Adverse Event|0|||
163389513|NCT02673619|590137851|FG001|Overall Study|Adverse Event|0|||
163389514|NCT02673619|590137852|FG002|Overall Study|Adverse Event|1|||
163389515|NCT02673619|590137853|FG003|Overall Study|Adverse Event|0|||
163389516|NCT02673619|590137850|FG000|Overall Study|Lack of Efficacy|0|||
163389517|NCT02673619|590137851|FG001|Overall Study|Lack of Efficacy|0|||
162950617|NCT00239577|588521747|FG001|Primary Phase|Other|3|||
162950618|NCT00239577|588521748|FG002|Primary Phase|Other|2|||
162950619|NCT00239577|588521749|FG003|Primary Phase|Other|0|||
162950620|NCT01034358|588521752|FG000|Overall Study|Withdrawal by Subject|1|||
162950621|NCT01034358|588521752|FG000|Overall Study|Protocol Violation|1|||
162950622|NCT00377260|588521755|FG000|Overall Study|Lost to Follow-up|0|||
162950623|NCT00377260|588521756|FG001|Overall Study|Lost to Follow-up|1|||
162950624|NCT00377260|588521755|FG000|Overall Study|Withdrawal by Subject|2|||
162950625|NCT00377260|588521756|FG001|Overall Study|Withdrawal by Subject|4|||
162950626|NCT01617668|588521757|FG000|Overall Study|Adverse Event|7|||
162950627|NCT01617668|588521758|FG001|Overall Study|Adverse Event|0|||
163389518|NCT02673619|590137852|FG002|Overall Study|Lack of Efficacy|1|||
163389519|NCT02673619|590137853|FG003|Overall Study|Lack of Efficacy|0|||
163389520|NCT03444324|590137854|FG000|Overall Study|Withdrawal by Subject|0|||
162950628|NCT01617668|588521759|FG002|Overall Study|Adverse Event|12|||
162950629|NCT01617668|588521760|FG003|Overall Study|Adverse Event|5|||
162950630|NCT01617668|588521757|FG000|Overall Study|Physician Decision|1|||
162950631|NCT01617668|588521758|FG001|Overall Study|Physician Decision|2|||
162950632|NCT01617668|588521759|FG002|Overall Study|Physician Decision|3|||
162950633|NCT01617668|588521760|FG003|Overall Study|Physician Decision|0|||
162950634|NCT01617668|588521757|FG000|Overall Study|Progressive Disease|4|||
162950635|NCT01617668|588521758|FG001|Overall Study|Progressive Disease|4|||
162950636|NCT01617668|588521759|FG002|Overall Study|Progressive Disease|6|||
162950637|NCT01617668|588521760|FG003|Overall Study|Progressive Disease|9|||
162950638|NCT01617668|588521757|FG000|Overall Study|Subject/guardian decision|1|||
162950639|NCT01617668|588521758|FG001|Overall Study|Subject/guardian decision|3|||
162950640|NCT01617668|588521759|FG002|Overall Study|Subject/guardian decision|2|||
162950641|NCT01617668|588521760|FG003|Overall Study|Subject/guardian decision|1|||
162950642|NCT02017964|588521761|FG000|Overall Study|Patient deemed ineligible|1|||
162950643|NCT02300103|588521764|FG000|Overall Study|Lack of Efficacy|3|||
162950644|NCT02300103|588521764|FG000|Overall Study|Protocol Violation|1|||
162950645|NCT02300103|588521764|FG000|Overall Study|Withdrew Consent|2|||
162950646|NCT04091971|588521765|FG000|Overall Study|Withdrawal by Subject|1|||
162950647|NCT04091971|588521765|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
162950648|NCT04091971|588521765|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
162950649|NCT01391793|588521766|FG000|Overall Study|Ineligible|3|||
162950650|NCT01391793|588521767|FG001|Overall Study|Ineligible|0|||
162950651|NCT01391793|588521766|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
162950652|NCT01391793|588521767|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
162950653|NCT01391793|588521766|FG000|Overall Study|No DMSA|73|||
162950654|NCT01391793|588521767|FG001|Overall Study|No DMSA|57|||
163293593|NCT04707313|589780862|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
163293594|NCT04707313|589780863|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163293595|NCT04707313|589780864|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163293596|NCT04707313|589780865|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163293597|NCT04707313|589780866|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163293598|NCT04707313|589780867|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163293599|NCT04707313|589780868|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163293600|NCT04707313|589780869|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163293601|NCT04707313|589780870|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163293602|NCT04707313|589780858|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
163293603|NCT04707313|589780859|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
163293604|NCT04707313|589780860|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
163293605|NCT04707313|589780861|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
163293606|NCT04707313|589780862|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
163293607|NCT04707313|589780863|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163293608|NCT04707313|589780864|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163293609|NCT04707313|589780865|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163293610|NCT04707313|589780866|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
163293611|NCT04707313|589780867|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163293612|NCT04707313|589780868|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163293613|NCT04707313|589780869|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163389521|NCT03444324|590137855|FG001|Overall Study|Withdrawal by Subject|1|||
162950655|NCT01015625|588521768|FG000|Overall Study|Lost to Follow-up|3|||
162950656|NCT01015625|588521769|FG001|Overall Study|Lost to Follow-up|1|||
162950657|NCT01015625|588521768|FG000|Overall Study|Withdrawal by Subject|2|||
162950658|NCT01015625|588521769|FG001|Overall Study|Withdrawal by Subject|3|||
162950659|NCT01015625|588521768|FG000|Overall Study|Physician Decision|2|||
162950660|NCT01015625|588521769|FG001|Overall Study|Physician Decision|0|||
162950661|NCT01015625|588521768|FG000|Overall Study|Death|30|||
162950662|NCT01015625|588521769|FG001|Overall Study|Death|22|||
162950663|NCT00150462|588521772|FG000|Overall Study|Disease Progression or Relapse|3|||
162950664|NCT00150462|588521773|FG001|Overall Study|Disease Progression or Relapse|1|||
162950665|NCT00150462|588521774|FG002|Overall Study|Disease Progression or Relapse|2|||
162950666|NCT00150462|588521775|FG003|Overall Study|Disease Progression or Relapse|1|||
162950667|NCT00150462|588521776|FG004|Overall Study|Disease Progression or Relapse|2|||
162950668|NCT00150462|588521777|FG005|Overall Study|Disease Progression or Relapse|2|||
162950669|NCT00150462|588521778|FG006|Overall Study|Disease Progression or Relapse|3|||
162950670|NCT00150462|588521779|FG007|Overall Study|Disease Progression or Relapse|5|||
162950671|NCT00150462|588521780|FG008|Overall Study|Disease Progression or Relapse|5|||
163293614|NCT04707313|589780870|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163293615|NCT04707313|589780858|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
163293616|NCT04707313|589780859|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163293617|NCT04707313|589780860|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163389522|NCT03444324|590137854|FG000|Overall Study|Lost to Follow-up|4|||
162950672|NCT00150462|588521781|FG009|Overall Study|Disease Progression or Relapse|3|||
162950673|NCT00150462|588521782|FG010|Overall Study|Disease Progression or Relapse|2|||
163389523|NCT03444324|590137855|FG001|Overall Study|Lost to Follow-up|2|||
163389524|NCT03444324|590137854|FG000|Overall Study|Protocol Violation|0|||
163389525|NCT03444324|590137855|FG001|Overall Study|Protocol Violation|1|||
163389526|NCT03444324|590137854|FG000|Overall Study|Lack of Trial Compliance|1|||
163389527|NCT03444324|590137855|FG001|Overall Study|Lack of Trial Compliance|1|||
163389528|NCT03444324|590137854|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
163389529|NCT03444324|590137855|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
163389530|NCT00658684|590137857|FG000|Overall Study|Adverse Event|10|||
163389531|NCT00658684|590137858|FG001|Overall Study|Adverse Event|8|||
163389532|NCT00658684|590137859|FG002|Overall Study|Adverse Event|2|||
163389533|NCT00658684|590137860|FG003|Overall Study|Adverse Event|0|||
163389534|NCT00658684|590137857|FG000|Overall Study|Withdrawal by Subject|6|||
163389535|NCT00658684|590137858|FG001|Overall Study|Withdrawal by Subject|4|||
163389536|NCT00658684|590137859|FG002|Overall Study|Withdrawal by Subject|1|||
163188094|NCT00734474|589406034|FG003|Overall Study|Physician Decision|1|||
163188095|NCT00734474|589406035|FG004|Overall Study|Physician Decision|11|||
163188096|NCT00734474|589406036|FG005|Overall Study|Physician Decision|0|||
163188097|NCT00734474|589406037|FG006|Overall Study|Physician Decision|0|||
163188098|NCT00734474|589406038|FG007|Overall Study|Physician Decision|9|||
163188099|NCT00734474|589406039|FG008|Overall Study|Physician Decision|9|||
163188100|NCT00734474|589406031|FG000|Overall Study|Adverse Event|4|||
163188101|NCT00734474|589406032|FG001|Overall Study|Adverse Event|4|||
163188102|NCT00734474|589406033|FG002|Overall Study|Adverse Event|63|||
163188103|NCT00734474|589406034|FG003|Overall Study|Adverse Event|1|||
163188104|NCT00734474|589406035|FG004|Overall Study|Adverse Event|64|||
163188105|NCT00734474|589406036|FG005|Overall Study|Adverse Event|0|||
163188106|NCT00734474|589406037|FG006|Overall Study|Adverse Event|1|||
163188107|NCT00734474|589406038|FG007|Overall Study|Adverse Event|65|||
163188108|NCT00734474|589406039|FG008|Overall Study|Adverse Event|39|||
163188109|NCT00734474|589406031|FG000|Overall Study|Protocol Violation|0|||
163188110|NCT00734474|589406032|FG001|Overall Study|Protocol Violation|0|||
163188111|NCT00734474|589406033|FG002|Overall Study|Protocol Violation|4|||
163188112|NCT00734474|589406034|FG003|Overall Study|Protocol Violation|0|||
163188113|NCT00734474|589406035|FG004|Overall Study|Protocol Violation|3|||
163188114|NCT00734474|589406036|FG005|Overall Study|Protocol Violation|0|||
163188115|NCT00734474|589406037|FG006|Overall Study|Protocol Violation|0|||
163188116|NCT00734474|589406038|FG007|Overall Study|Protocol Violation|3|||
163188117|NCT00734474|589406039|FG008|Overall Study|Protocol Violation|1|||
163188118|NCT00734474|589406031|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
163188119|NCT00734474|589406032|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
163188120|NCT00734474|589406033|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
163188121|NCT00734474|589406034|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
163188122|NCT00734474|589406035|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
163188123|NCT00734474|589406036|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
163188124|NCT00734474|589406037|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
163188125|NCT00734474|589406038|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
163188126|NCT00734474|589406039|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
163188127|NCT00734474|589406031|FG000|Overall Study|Sponsor Decision|0|||
163188128|NCT00734474|589406032|FG001|Overall Study|Sponsor Decision|0|||
163188129|NCT00734474|589406033|FG002|Overall Study|Sponsor Decision|0|||
163188130|NCT00734474|589406034|FG003|Overall Study|Sponsor Decision|0|||
163188131|NCT00734474|589406035|FG004|Overall Study|Sponsor Decision|2|||
163188132|NCT00734474|589406036|FG005|Overall Study|Sponsor Decision|0|||
163188133|NCT00734474|589406037|FG006|Overall Study|Sponsor Decision|0|||
163188134|NCT00734474|589406038|FG007|Overall Study|Sponsor Decision|0|||
163188135|NCT00734474|589406039|FG008|Overall Study|Sponsor Decision|0|||
163188136|NCT00734474|589406031|FG000|Overall Study|Death|0|||
163188137|NCT00734474|589406032|FG001|Overall Study|Death|0|||
163188138|NCT00734474|589406033|FG002|Overall Study|Death|1|||
163188139|NCT00734474|589406034|FG003|Overall Study|Death|0|||
163188140|NCT00734474|589406035|FG004|Overall Study|Death|0|||
163188141|NCT00734474|589406036|FG005|Overall Study|Death|0|||
163188142|NCT00734474|589406037|FG006|Overall Study|Death|0|||
163188143|NCT00734474|589406038|FG007|Overall Study|Death|2|||
163188144|NCT00734474|589406039|FG008|Overall Study|Death|1|||
163188145|NCT00734474|589406031|FG000|Overall Study|Lack of Efficacy|0|||
163188146|NCT00734474|589406032|FG001|Overall Study|Lack of Efficacy|0|||
163188147|NCT00734474|589406033|FG002|Overall Study|Lack of Efficacy|4|||
163188148|NCT00734474|589406034|FG003|Overall Study|Lack of Efficacy|0|||
163188149|NCT00734474|589406035|FG004|Overall Study|Lack of Efficacy|0|||
163188150|NCT00734474|589406036|FG005|Overall Study|Lack of Efficacy|0|||
163188151|NCT00734474|589406037|FG006|Overall Study|Lack of Efficacy|0|||
163188152|NCT00734474|589406038|FG007|Overall Study|Lack of Efficacy|4|||
163188153|NCT00734474|589406039|FG008|Overall Study|Lack of Efficacy|6|||
163188154|NCT02104752|589406042|FG000|Overall Study|Withdrawal by Subject|1|||
163188155|NCT02104752|589406043|FG001|Overall Study|Withdrawal by Subject|0|||
163188156|NCT02104752|589406042|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
163188157|NCT02104752|589406043|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
163188158|NCT02899299|589406044|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
163188159|NCT02899299|589406045|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
163188160|NCT02899299|589406044|FG000|Pre-treatment|Participant withdrew consent|1|||
163188161|NCT02899299|589406045|FG001|Pre-treatment|Participant withdrew consent|11|||
163188162|NCT02899299|589406044|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
163188163|NCT02899299|589406045|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
163188164|NCT02899299|589406044|FG000|Pre-treatment|Not reported|0|||
163188165|NCT02899299|589406045|FG001|Pre-treatment|Not reported|1|||
163188166|NCT02899299|589406044|FG000|Treatment|Disease Progression|182|||
163188167|NCT02899299|589406045|FG001|Treatment|Disease Progression|43|||
163188168|NCT02899299|589406044|FG000|Treatment|Study Drug Toxicity|60|||
163188169|NCT02899299|589406045|FG001|Treatment|Study Drug Toxicity|24|||
163188170|NCT02899299|589406044|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
163188171|NCT02899299|589406045|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
163188172|NCT02899299|589406044|FG000|Treatment|Participant request to discontinue Study treatment|4|||
163188173|NCT02899299|589406045|FG001|Treatment|Participant request to discontinue Study treatment|10|||
163188174|NCT02899299|589406044|FG000|Treatment|Participant withdrew consent|6|||
163188175|NCT02899299|589406045|FG001|Treatment|Participant withdrew consent|3|||
163188176|NCT02899299|589406044|FG000|Treatment|Lost to Follow-up|0|||
163188177|NCT02899299|589406045|FG001|Treatment|Lost to Follow-up|2|||
163188178|NCT02899299|589406044|FG000|Treatment|Maximum Clinical Benefit|11|||
163188179|NCT02899299|589406045|FG001|Treatment|Maximum Clinical Benefit|2|||
163188180|NCT02899299|589406044|FG000|Treatment|Poor/Non-compliance|1|||
163188181|NCT02899299|589406045|FG001|Treatment|Poor/Non-compliance|0|||
163188182|NCT02899299|589406044|FG000|Treatment|Participant no longer meets Study criteria|4|||
163188183|NCT02899299|589406045|FG001|Treatment|Participant no longer meets Study criteria|0|||
163188184|NCT02899299|589406044|FG000|Treatment|Administrative reason by Sponsor|2|||
163188185|NCT02899299|589406045|FG001|Treatment|Administrative reason by Sponsor|0|||
163188186|NCT02899299|589406044|FG000|Treatment|Other reasons|12|||
163188187|NCT02899299|589406045|FG001|Treatment|Other reasons|2|||
163188188|NCT02899299|589406044|FG000|Treatment|Not reported|7|||
163188189|NCT02899299|589406045|FG001|Treatment|Not reported|0|||
163188190|NCT00313300|589406046|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
163188191|NCT00313300|589406047|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
163188192|NCT00313300|589406048|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
163188193|NCT00313300|589406049|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
163188194|NCT00313300|589406050|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
163188195|NCT00313300|589406046|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
163188196|NCT00313300|589406047|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
163188197|NCT00313300|589406048|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
163188198|NCT00313300|589406049|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
163188199|NCT00313300|589406050|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
163188200|NCT00313300|589406046|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
163188201|NCT00313300|589406047|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
163188202|NCT00313300|589406048|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
163188203|NCT00313300|589406049|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
163188204|NCT00313300|589406050|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
163188205|NCT00313300|589406046|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
163188206|NCT00313300|589406047|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
163188207|NCT00313300|589406048|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
163188208|NCT00313300|589406049|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
163188209|NCT00313300|589406050|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
163188210|NCT00313300|589406046|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
163188211|NCT00313300|589406047|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
163188212|NCT00313300|589406048|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
163188213|NCT00313300|589406049|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
163188214|NCT00313300|589406050|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
163188215|NCT00313300|589406046|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
163188216|NCT00313300|589406047|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
163188217|NCT00313300|589406048|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
163188218|NCT00313300|589406049|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
163188219|NCT00313300|589406050|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
163188220|NCT00313300|589406046|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
163389537|NCT00658684|590137860|FG003|Overall Study|Withdrawal by Subject|1|||
163188221|NCT00313300|589406047|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
163188222|NCT00313300|589406048|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
163188223|NCT00313300|589406049|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
163188224|NCT00313300|589406050|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
163188225|NCT00313300|589406046|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
163188226|NCT00313300|589406047|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
163188227|NCT00313300|589406048|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
162950674|NCT00150462|588521772|FG000|Overall Study|Withdrawal by Subject|0|||
162950675|NCT00150462|588521773|FG001|Overall Study|Withdrawal by Subject|1|||
162950676|NCT00150462|588521774|FG002|Overall Study|Withdrawal by Subject|1|||
162950677|NCT00150462|588521775|FG003|Overall Study|Withdrawal by Subject|0|||
162950678|NCT00150462|588521776|FG004|Overall Study|Withdrawal by Subject|1|||
162950679|NCT00150462|588521777|FG005|Overall Study|Withdrawal by Subject|2|||
162950680|NCT00150462|588521778|FG006|Overall Study|Withdrawal by Subject|0|||
162950681|NCT00150462|588521779|FG007|Overall Study|Withdrawal by Subject|1|||
162950682|NCT00150462|588521780|FG008|Overall Study|Withdrawal by Subject|0|||
162950683|NCT00150462|588521781|FG009|Overall Study|Withdrawal by Subject|1|||
162950684|NCT00150462|588521782|FG010|Overall Study|Withdrawal by Subject|0|||
162950685|NCT00150462|588521772|FG000|Overall Study|Death|0|||
162950686|NCT00150462|588521773|FG001|Overall Study|Death|1|||
162950687|NCT00150462|588521774|FG002|Overall Study|Death|0|||
162950688|NCT00150462|588521775|FG003|Overall Study|Death|0|||
162950689|NCT00150462|588521776|FG004|Overall Study|Death|0|||
162950690|NCT00150462|588521777|FG005|Overall Study|Death|0|||
162950691|NCT00150462|588521778|FG006|Overall Study|Death|0|||
162950692|NCT00150462|588521779|FG007|Overall Study|Death|0|||
162950693|NCT00150462|588521780|FG008|Overall Study|Death|1|||
162950694|NCT00150462|588521781|FG009|Overall Study|Death|0|||
162950695|NCT00150462|588521782|FG010|Overall Study|Death|0|||
162950696|NCT00150462|588521772|FG000|Overall Study|Adverse Event|0|||
162950697|NCT00150462|588521773|FG001|Overall Study|Adverse Event|0|||
162950698|NCT00150462|588521774|FG002|Overall Study|Adverse Event|0|||
162950699|NCT00150462|588521775|FG003|Overall Study|Adverse Event|1|||
162950700|NCT00150462|588521776|FG004|Overall Study|Adverse Event|0|||
162950701|NCT00150462|588521777|FG005|Overall Study|Adverse Event|0|||
162950702|NCT00150462|588521778|FG006|Overall Study|Adverse Event|0|||
162950703|NCT00150462|588521779|FG007|Overall Study|Adverse Event|2|||
162950704|NCT00150462|588521780|FG008|Overall Study|Adverse Event|0|||
162950705|NCT00150462|588521781|FG009|Overall Study|Adverse Event|1|||
162950706|NCT00150462|588521782|FG010|Overall Study|Adverse Event|0|||
162950707|NCT00150462|588521772|FG000|Overall Study|Physician Decision|0|||
162950708|NCT00150462|588521773|FG001|Overall Study|Physician Decision|0|||
162950709|NCT00150462|588521774|FG002|Overall Study|Physician Decision|1|||
162950710|NCT00150462|588521775|FG003|Overall Study|Physician Decision|1|||
162950711|NCT00150462|588521776|FG004|Overall Study|Physician Decision|0|||
162950712|NCT00150462|588521777|FG005|Overall Study|Physician Decision|0|||
162950713|NCT00150462|588521778|FG006|Overall Study|Physician Decision|0|||
162950714|NCT00150462|588521779|FG007|Overall Study|Physician Decision|0|||
162950715|NCT00150462|588521780|FG008|Overall Study|Physician Decision|0|||
162950716|NCT00150462|588521781|FG009|Overall Study|Physician Decision|0|||
162950717|NCT00150462|588521782|FG010|Overall Study|Physician Decision|0|||
162950718|NCT00150462|588521772|FG000|Overall Study|Other|0|||
162950719|NCT00150462|588521773|FG001|Overall Study|Other|0|||
162950720|NCT00150462|588521774|FG002|Overall Study|Other|0|||
162950721|NCT00150462|588521775|FG003|Overall Study|Other|0|||
162950722|NCT00150462|588521776|FG004|Overall Study|Other|0|||
162950723|NCT00150462|588521777|FG005|Overall Study|Other|0|||
162950724|NCT00150462|588521778|FG006|Overall Study|Other|0|||
162950725|NCT00150462|588521779|FG007|Overall Study|Other|0|||
162950726|NCT00150462|588521780|FG008|Overall Study|Other|0|||
162950727|NCT00150462|588521781|FG009|Overall Study|Other|1|||
162950728|NCT00150462|588521782|FG010|Overall Study|Other|1|||
162950729|NCT03107091|588521785|FG000|Overall Study|Physician Decision|1|||
162950730|NCT00912288|588521788|FG000|Overall Study|Death|0|||
163389538|NCT00658684|590137857|FG000|Overall Study|Lack of Efficacy|1|||
163389539|NCT00658684|590137858|FG001|Overall Study|Lack of Efficacy|1|||
163389540|NCT00658684|590137859|FG002|Overall Study|Lack of Efficacy|0|||
163389541|NCT00658684|590137860|FG003|Overall Study|Lack of Efficacy|0|||
163389542|NCT00658684|590137857|FG000|Overall Study|Protocol Violation|1|||
163389543|NCT00658684|590137858|FG001|Overall Study|Protocol Violation|1|||
163389544|NCT00658684|590137859|FG002|Overall Study|Protocol Violation|0|||
163389545|NCT00658684|590137860|FG003|Overall Study|Protocol Violation|0|||
163389546|NCT00658684|590137857|FG000|Overall Study|Pregnancy|1|||
163389547|NCT00658684|590137858|FG001|Overall Study|Pregnancy|1|||
163389548|NCT00658684|590137859|FG002|Overall Study|Pregnancy|0|||
162950731|NCT00912288|588521789|FG001|Overall Study|Death|1|||
162950732|NCT00912288|588521788|FG000|Overall Study|Adverse Event|1|||
162950733|NCT00912288|588521789|FG001|Overall Study|Adverse Event|1|||
162950734|NCT00912288|588521788|FG000|Overall Study|Lost to Follow-up|1|||
162950735|NCT00912288|588521789|FG001|Overall Study|Lost to Follow-up|0|||
162950736|NCT00912288|588521788|FG000|Overall Study|Protocol Violation|1|||
162950737|NCT00912288|588521789|FG001|Overall Study|Protocol Violation|0|||
162950738|NCT00912288|588521788|FG000|Overall Study|Withdrawal by Subject|3|||
163389549|NCT00658684|590137860|FG003|Overall Study|Pregnancy|0|||
163389550|NCT00688103|590137861|FG000|Overall Study|Adverse Event|4|||
163389551|NCT00688103|590137862|FG001|Overall Study|Adverse Event|1|||
162950739|NCT00912288|588521789|FG001|Overall Study|Withdrawal by Subject|3|||
162950740|NCT00912288|588521788|FG000|Overall Study|Study terminated by sponsor|34|||
162950741|NCT00912288|588521789|FG001|Overall Study|Study terminated by sponsor|35|||
163188228|NCT00313300|589406049|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
163188229|NCT00313300|589406050|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
163188230|NCT00313300|589406046|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
163188231|NCT00313300|589406047|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
163188232|NCT00313300|589406048|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
163188233|NCT00313300|589406049|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
163188234|NCT00313300|589406050|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
163188235|NCT00313300|589406046|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
163188236|NCT00313300|589406047|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
163188237|NCT00313300|589406048|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
163188238|NCT00313300|589406049|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
163188239|NCT00313300|589406050|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
163188240|NCT00313300|589406046|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
163188241|NCT00313300|589406047|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
163188242|NCT00313300|589406048|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
163188243|NCT00313300|589406049|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
162950742|NCT00912288|588521788|FG000|Overall Study|Other|1|||
162950743|NCT00912288|588521789|FG001|Overall Study|Other|0|||
162950744|NCT01449630|588521790|FG000|Period 1|Physician Decision|1|||
162950745|NCT01449630|588521791|FG001|Period 1|Physician Decision|0|||
162950746|NCT01449630|588521792|FG002|Period 1|Physician Decision|0|||
162950747|NCT01449630|588521793|FG003|Period 1|Physician Decision|1|||
162950748|NCT01449630|588521794|FG004|Period 1|Physician Decision|0|||
162950749|NCT01449630|588521795|FG005|Period 1|Physician Decision|0|||
162950750|NCT01449630|588521796|FG006|Period 1|Physician Decision|0|||
162950751|NCT01449630|588521797|FG007|Period 1|Physician Decision|0|||
162950752|NCT01449630|588521798|FG008|Period 1|Physician Decision|0|||
162950753|NCT01449630|588521790|FG000|Period 1|Sponsor Decision|0|||
162950754|NCT01449630|588521791|FG001|Period 1|Sponsor Decision|0|||
162950755|NCT01449630|588521792|FG002|Period 1|Sponsor Decision|0|||
162950756|NCT01449630|588521793|FG003|Period 1|Sponsor Decision|0|||
162950757|NCT01449630|588521794|FG004|Period 1|Sponsor Decision|0|||
162950758|NCT01449630|588521795|FG005|Period 1|Sponsor Decision|1|||
162950759|NCT01449630|588521796|FG006|Period 1|Sponsor Decision|0|||
162950760|NCT01449630|588521797|FG007|Period 1|Sponsor Decision|0|||
162950761|NCT01449630|588521798|FG008|Period 1|Sponsor Decision|0|||
162950762|NCT01449630|588521790|FG000|Period 2|Sponsor Decision|0|||
162950763|NCT01449630|588521791|FG001|Period 2|Sponsor Decision|0|||
162950764|NCT01449630|588521792|FG002|Period 2|Sponsor Decision|0|||
162950765|NCT01449630|588521793|FG003|Period 2|Sponsor Decision|0|||
162950766|NCT01449630|588521794|FG004|Period 2|Sponsor Decision|0|||
162950767|NCT01449630|588521795|FG005|Period 2|Sponsor Decision|0|||
162950768|NCT01449630|588521796|FG006|Period 2|Sponsor Decision|1|||
163188244|NCT00313300|589406050|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
163188245|NCT00313300|589406046|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
162950769|NCT01449630|588521797|FG007|Period 2|Sponsor Decision|0|||
162950770|NCT01449630|588521798|FG008|Period 2|Sponsor Decision|0|||
162950771|NCT00105196|588521799|FG000|Overall Study|Lack of Efficacy|2|||
162950772|NCT00105196|588521800|FG001|Overall Study|Lack of Efficacy|3|||
162950773|NCT00105196|588521799|FG000|Overall Study|Adverse Event|11|||
162950774|NCT00105196|588521800|FG001|Overall Study|Adverse Event|3|||
163188246|NCT00313300|589406047|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
163188247|NCT00313300|589406048|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
163188248|NCT00313300|589406049|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
163188249|NCT00313300|589406050|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
163188250|NCT00313300|589406046|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
163188251|NCT00313300|589406047|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
163188252|NCT00313300|589406048|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
163188253|NCT00313300|589406049|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
163188254|NCT00313300|589406050|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
163188255|NCT00313300|589406046|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
163188256|NCT00313300|589406047|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
163188257|NCT00313300|589406048|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
163188258|NCT00313300|589406049|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
163293618|NCT04707313|589780861|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162950775|NCT00105196|588521799|FG000|Overall Study|Withdrawal by Subject|6|||
162950776|NCT00105196|588521800|FG001|Overall Study|Withdrawal by Subject|6|||
163293619|NCT04707313|589780862|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163188259|NCT00313300|589406050|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
163188260|NCT00313300|589406046|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
163188261|NCT00313300|589406047|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
163188262|NCT00313300|589406048|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
163188263|NCT00313300|589406049|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
163188264|NCT00313300|589406050|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
163188265|NCT00313300|589406046|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
163188266|NCT00313300|589406047|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
163188267|NCT00313300|589406048|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
163188268|NCT00313300|589406049|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
163188269|NCT00313300|589406050|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
163188270|NCT00313300|589406046|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
163188271|NCT00313300|589406047|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
163188272|NCT00313300|589406048|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
163188273|NCT00313300|589406049|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
163188274|NCT00313300|589406050|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
163188275|NCT00313300|589406046|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
163188276|NCT00313300|589406047|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
163188277|NCT00313300|589406048|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
163188278|NCT00313300|589406049|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
163188279|NCT00313300|589406050|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
163188280|NCT00313300|589406046|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
163188281|NCT00313300|589406047|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
163188282|NCT00313300|589406048|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
163188283|NCT00313300|589406049|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
163188284|NCT00313300|589406050|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
163188285|NCT00313300|589406046|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
163188286|NCT00313300|589406047|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
163188287|NCT00313300|589406048|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
163188288|NCT00313300|589406049|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
163188289|NCT00313300|589406050|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
163188290|NCT00313300|589406046|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
163188291|NCT00313300|589406047|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
163188292|NCT00313300|589406048|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
163188293|NCT00313300|589406049|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
163188294|NCT00313300|589406050|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
163188295|NCT00639678|589406053|FG000|Overall Study|Withdrawal by Subject|3|||
163188296|NCT00639678|589406054|FG001|Overall Study|Withdrawal by Subject|0|||
163188297|NCT00639678|589406055|FG002|Overall Study|Withdrawal by Subject|4|||
163188298|NCT00639678|589406056|FG003|Overall Study|Withdrawal by Subject|0|||
163188299|NCT00639678|589406053|FG000|Overall Study|Lost to Follow-up|1|||
163188300|NCT00639678|589406054|FG001|Overall Study|Lost to Follow-up|0|||
163188301|NCT00639678|589406055|FG002|Overall Study|Lost to Follow-up|6|||
163188302|NCT00639678|589406056|FG003|Overall Study|Lost to Follow-up|0|||
163188303|NCT00639678|589406053|FG000|Overall Study|Adverse Event|0|||
163188304|NCT00639678|589406054|FG001|Overall Study|Adverse Event|1|||
163188305|NCT00639678|589406055|FG002|Overall Study|Adverse Event|0|||
163188306|NCT00639678|589406056|FG003|Overall Study|Adverse Event|0|||
163188307|NCT00639678|589406053|FG000|Overall Study|Lack of Compliance|0|||
163188308|NCT00639678|589406054|FG001|Overall Study|Lack of Compliance|0|||
163188309|NCT00639678|589406055|FG002|Overall Study|Lack of Compliance|1|||
163188310|NCT00639678|589406056|FG003|Overall Study|Lack of Compliance|0|||
163188311|NCT04540497|589406059|FG000|Overall Study|Adverse Event|0|||
163188312|NCT04540497|589406060|FG001|Overall Study|Adverse Event|2|||
163188313|NCT04540497|589406059|FG000|Overall Study|Lost to Follow-up|1|||
163188314|NCT04540497|589406060|FG001|Overall Study|Lost to Follow-up|0|||
163188315|NCT04540497|589406059|FG000|Overall Study|Withdrawal by Subject|1|||
163188316|NCT04540497|589406060|FG001|Overall Study|Withdrawal by Subject|1|||
163188317|NCT04540497|589406059|FG000|Overall Study|Miscellaneous|2|||
163188318|NCT04540497|589406060|FG001|Overall Study|Miscellaneous|1|||
163188319|NCT05274815|589406061|FG000|Overall Study|Adverse Event|1|||
163188320|NCT05274815|589406061|FG000|Overall Study|Death|2|||
163389552|NCT00688103|590137861|FG000|Overall Study|Lack of Efficacy|11|||
163389553|NCT00688103|590137862|FG001|Overall Study|Lack of Efficacy|1|||
163389554|NCT00688103|590137861|FG000|Overall Study|Withdrawal by Subject|4|||
163389555|NCT00688103|590137862|FG001|Overall Study|Withdrawal by Subject|2|||
163389556|NCT00688103|590137861|FG000|Overall Study|complex reasons|11|||
163389557|NCT00688103|590137862|FG001|Overall Study|complex reasons|9|||
163389558|NCT06071754|590137864|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
163389559|NCT03226275|590137865|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
163389560|NCT03226275|590137866|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
163389561|NCT03226275|590137867|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
163389562|NCT03226275|590137868|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
163389563|NCT03226275|590137865|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
163389564|NCT03226275|590137866|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
163389565|NCT03226275|590137867|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
163389566|NCT03226275|590137868|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
163389567|NCT05959629|590137871|FG000|Overall Study|partially necrotic/technical issues|2|||
163389568|NCT05959629|590137872|FG001|Overall Study|partially necrotic/technical issues|2|||
163389569|NCT01920594|590139495|FG000|Overall Study|Adverse Event|4|||
163389570|NCT01920594|590139496|FG001|Overall Study|Adverse Event|2|||
163389571|NCT01920594|590139495|FG000|Overall Study|Lost to Follow-up|1|||
163389572|NCT01920594|590139496|FG001|Overall Study|Lost to Follow-up|0|||
163389573|NCT01920594|590139495|FG000|Overall Study|Recovery|2|||
163389574|NCT01920594|590139496|FG001|Overall Study|Recovery|0|||
163389575|NCT01920594|590139495|FG000|Overall Study|Investigator discretion|0|||
163389576|NCT01920594|590139496|FG001|Overall Study|Investigator discretion|1|||
163389577|NCT04906616|590139497|FG000|Overall Study|Divorce|3|||
163389578|NCT04906616|590139498|FG001|Overall Study|Divorce|2|||
163389579|NCT01521897|590139499|FG000|Overall Study|Protocol Violation|18|||
163389580|NCT01521897|590139499|FG000|Overall Study|Lost to Follow-up|5|||
163389581|NCT02194062|590139500|FG000|Overall Study|Lost to Follow-up|2|||
163389582|NCT02194062|590139501|FG001|Overall Study|Lost to Follow-up|2|||
163389583|NCT02194062|590139502|FG002|Overall Study|Lost to Follow-up|5|||
163188321|NCT05274815|589406061|FG000|Overall Study|Lost to Follow-up|4|||
163188322|NCT05274815|589406061|FG000|Overall Study|Withdrawn from study due to investigator's decision|1|||
163188323|NCT05274815|589406061|FG000|Overall Study|Withdrawn from study due to participant's decision to withdraw|1|||
163188324|NCT05274815|589406061|FG000|Overall Study|Withdrawn from study due to severe non-compliance with the protocol|1|||
163188325|NCT05274815|589406061|FG000|Overall Study|Withdrawn from study due to subject decision|1|||
163188326|NCT05274815|589406061|FG000|Overall Study|Withdrawn due to participant's decision not to continue for personal and family reasons|1|||
163188327|NCT05274815|589406061|FG000|Overall Study|Withdrawn from study due to the participant stopped visit; agreed to a telephone contact at Week 52|1|||
163188328|NCT05274815|589406061|FG000|Overall Study|Withdrawn from study due to randomization into closed cohort by mistake|1|||
163188329|NCT05274815|589406061|FG000|Overall Study|Withdrawal by Subject|11|||
163188330|NCT04416633|589406062|FG000|Overall Study|Death|1|||
163188331|NCT04416633|589406062|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
163188332|NCT04416633|589406062|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
163188333|NCT04416633|589406062|FG000|Overall Study|Adverse Event|6|||
163389584|NCT04147234|590139503|FG000|Overall Study|Clinical deterioration|0|||
163389585|NCT04147234|590139504|FG001|Overall Study|Clinical deterioration|0|||
163389586|NCT04147234|590139505|FG002|Overall Study|Clinical deterioration|1|||
163389587|NCT04147234|590139506|FG003|Overall Study|Clinical deterioration|0|||
163389588|NCT04147234|590139507|FG004|Overall Study|Clinical deterioration|0|||
163389589|NCT04147234|590139508|FG005|Overall Study|Clinical deterioration|0|||
163389590|NCT04147234|590139509|FG006|Overall Study|Clinical deterioration|0|||
163389591|NCT04147234|590139503|FG000|Overall Study|Withdrawal by Subject|0|||
163188334|NCT04416633|589406062|FG000|Overall Study|Withdrawal by Subject|6|||
163188335|NCT03914326|589406063|FG000|Overall Study|Withdrawal by Subject|27|||
163188336|NCT03914326|589406064|FG001|Overall Study|Withdrawal by Subject|34|||
163389592|NCT04147234|590139504|FG001|Overall Study|Withdrawal by Subject|1|||
163188337|NCT03914326|589406063|FG000|Overall Study|Lost to Follow-up|43|||
163188338|NCT03914326|589406064|FG001|Overall Study|Lost to Follow-up|51|||
163188339|NCT03914326|589406063|FG000|Overall Study|Randomised more than once|0|||
163188340|NCT03914326|589406064|FG001|Overall Study|Randomised more than once|1|||
163188341|NCT03323502|589406065|FG000|Overall Study|Resident could not be linked to CMS data|594|||
163188342|NCT03323502|589406066|FG001|Overall Study|Resident could not be linked to CMS data|435|||
163188343|NCT03323502|589406065|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
163188344|NCT03323502|589406066|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
163188345|NCT03323502|589406065|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
163188346|NCT03323502|589406066|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
163389593|NCT04147234|590139505|FG002|Overall Study|Withdrawal by Subject|1|||
163389594|NCT04147234|590139506|FG003|Overall Study|Withdrawal by Subject|0|||
163389595|NCT04147234|590139507|FG004|Overall Study|Withdrawal by Subject|0|||
163389596|NCT04147234|590139508|FG005|Overall Study|Withdrawal by Subject|0|||
163389597|NCT04147234|590139509|FG006|Overall Study|Withdrawal by Subject|0|||
163389598|NCT04147234|590139503|FG000|Overall Study|Clinical disease progression|1|||
163389599|NCT04147234|590139504|FG001|Overall Study|Clinical disease progression|3|||
163389600|NCT04147234|590139505|FG002|Overall Study|Clinical disease progression|1|||
163389601|NCT04147234|590139506|FG003|Overall Study|Clinical disease progression|1|||
163389602|NCT04147234|590139507|FG004|Overall Study|Clinical disease progression|0|||
163188347|NCT03323502|589406065|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
163188348|NCT03323502|589406066|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
163188349|NCT03323502|589406065|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
163188350|NCT03323502|589406066|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
163188351|NCT01675427|589406070|FG000|Overall Study|Withdrawal by Subject|7|||
163188352|NCT01675427|589406070|FG000|Overall Study|Participant Refused Sample Collection|18|||
163188353|NCT01675427|589406070|FG000|Overall Study|Sample not Collected by Mistake|2|||
163188354|NCT01675427|589406070|FG000|Overall Study|Lost to Follow-up|5|||
163389603|NCT04147234|590139508|FG005|Overall Study|Clinical disease progression|1|||
163389604|NCT04147234|590139509|FG006|Overall Study|Clinical disease progression|0|||
163389605|NCT04147234|590139503|FG000|Overall Study|Objective disease progression|6|||
163389606|NCT04147234|590139504|FG001|Overall Study|Objective disease progression|4|||
163389607|NCT04147234|590139505|FG002|Overall Study|Objective disease progression|3|||
163389608|NCT04147234|590139506|FG003|Overall Study|Objective disease progression|3|||
163389609|NCT04147234|590139507|FG004|Overall Study|Objective disease progression|5|||
163389610|NCT04147234|590139508|FG005|Overall Study|Objective disease progression|2|||
163389611|NCT04147234|590139509|FG006|Overall Study|Objective disease progression|3|||
163389612|NCT04147234|590139503|FG000|Overall Study|Adverse Event|0|||
163389613|NCT04147234|590139504|FG001|Overall Study|Adverse Event|0|||
163389614|NCT04147234|590139505|FG002|Overall Study|Adverse Event|0|||
163389615|NCT04147234|590139506|FG003|Overall Study|Adverse Event|0|||
163389616|NCT04147234|590139507|FG004|Overall Study|Adverse Event|1|||
163389617|NCT04147234|590139508|FG005|Overall Study|Adverse Event|0|||
163389618|NCT04147234|590139509|FG006|Overall Study|Adverse Event|0|||
163389619|NCT04498169|590139514|FG000|Study Completion|Adverse Event|1|||
163389620|NCT04498169|590139515|FG001|Study Completion|Adverse Event|1|||
163389621|NCT01754857|590139516|FG000|Overall Study|Adverse Event|7|||
163389622|NCT01754857|590139516|FG000|Overall Study|Disease progression|3|||
163389623|NCT01754857|590139516|FG000|Overall Study|Physician Decision|2|||
163389624|NCT01754857|590139516|FG000|Overall Study|Withdrawal by Subject|3|||
163389625|NCT01754857|590139516|FG000|Overall Study|other complicating disease|1|||
163389626|NCT01754857|590139516|FG000|Overall Study|ineligible to continue onto maintenance|1|||
163389627|NCT01754857|590139516|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
163389628|NCT01754857|590139516|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
163389629|NCT04964960|590139517|FG000|Overall Study|Withdrawal by Subject|1|||
162950777|NCT00105196|588521799|FG000|Overall Study|Lost to Follow-up|3|||
162950778|NCT00105196|588521800|FG001|Overall Study|Lost to Follow-up|2|||
162950779|NCT00105196|588521799|FG000|Overall Study|Poor/noncompliance|3|||
163389630|NCT04964960|590139517|FG000|Overall Study|Did not complete cycles|1|||
163389631|NCT02960854|590139520|FG000|Overall Study|Not Disclosed|2|||
163389632|NCT02960854|590139521|FG001|Overall Study|Not Disclosed|2|||
163389633|NCT02960854|590139520|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
162950780|NCT00105196|588521800|FG001|Overall Study|Poor/noncompliance|4|||
162950781|NCT00105196|588521799|FG000|Overall Study|Protocol Violation|5|||
162950782|NCT00105196|588521800|FG001|Overall Study|Protocol Violation|2|||
162950783|NCT00105196|588521799|FG000|Overall Study|pending surgery|0|||
162950784|NCT00105196|588521800|FG001|Overall Study|pending surgery|1|||
162950785|NCT00105196|588521799|FG000|Overall Study|marijuana use|0|||
162950786|NCT00105196|588521800|FG001|Overall Study|marijuana use|1|||
162950787|NCT00105196|588521799|FG000|Overall Study|Subject became unblinded|0|||
162950788|NCT00105196|588521800|FG001|Overall Study|Subject became unblinded|1|||
162950789|NCT03340727|588521801|FG000|Overall Study|Death|1|||
162950790|NCT03340727|588521802|FG001|Overall Study|Death|0|||
162950791|NCT03340727|588521801|FG000|Overall Study|Lost to Follow-up|31|||
162950792|NCT03340727|588521802|FG001|Overall Study|Lost to Follow-up|35|||
162950793|NCT03340727|588521801|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
162950794|NCT03340727|588521802|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
162950795|NCT03340727|588521801|FG000|Overall Study|Transferred to another facility|10|||
162950796|NCT03340727|588521802|FG001|Overall Study|Transferred to another facility|7|||
162950797|NCT03340727|588521801|FG000|Overall Study|Withdrawal by Subject|28|||
162950798|NCT03340727|588521802|FG001|Overall Study|Withdrawal by Subject|17|||
162950799|NCT00874237|588521803|FG000|Overall Study|Physician Decision|0|||
162950800|NCT00874237|588521804|FG001|Overall Study|Physician Decision|1|||
162950801|NCT00874237|588521805|FG002|Overall Study|Physician Decision|0|||
162950802|NCT00874237|588521806|FG003|Overall Study|Physician Decision|0|||
162950803|NCT00874237|588521807|FG004|Overall Study|Physician Decision|0|||
162950804|NCT00874237|588521808|FG005|Overall Study|Physician Decision|0|||
162950805|NCT00874237|588521803|FG000|Overall Study|Withdrawal by Subject|0|||
162950806|NCT00874237|588521804|FG001|Overall Study|Withdrawal by Subject|0|||
162950807|NCT00874237|588521805|FG002|Overall Study|Withdrawal by Subject|1|||
162950808|NCT00874237|588521806|FG003|Overall Study|Withdrawal by Subject|0|||
162950809|NCT00874237|588521807|FG004|Overall Study|Withdrawal by Subject|0|||
162950810|NCT00874237|588521808|FG005|Overall Study|Withdrawal by Subject|0|||
162950811|NCT00522457|588521813|FG000|Overall Study|Due to disease progression|16|||
162950812|NCT00522457|588521813|FG000|Overall Study|Adverse Event|2|||
162950813|NCT03447262|588523563|FG000|Overall Study|Adverse Event|7|||
162950814|NCT03447262|588523563|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
162950815|NCT03447262|588523563|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
162950816|NCT03447262|588523563|FG000|Overall Study|Death|2|||
162950817|NCT03447262|588523563|FG000|Overall Study|Study Termination by Sponsor|455|||
162950818|NCT03447262|588523563|FG000|Overall Study|Other|4|||
162950819|NCT03478397|588523566|FG000|Overall Study|Refused to participate|31|||
162950820|NCT03478397|588523567|FG001|Overall Study|Refused to participate|7|||
162950821|NCT05327491|588523568|FG000|Periods 1 & 2|Miscellaneous|0|||
162950822|NCT05327491|588523569|FG001|Periods 1 & 2|Miscellaneous|1|||
162950823|NCT05327491|588523570|FG002|Periods 1 & 2|Miscellaneous|0|||
162950824|NCT05327491|588523571|FG003|Periods 1 & 2|Miscellaneous|0|||
163293620|NCT04707313|589780863|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
163293621|NCT04707313|589780864|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
163293622|NCT04707313|589780865|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
163293623|NCT04707313|589780866|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163293624|NCT04707313|589780867|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163293625|NCT04707313|589780868|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163293626|NCT04707313|589780869|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163293627|NCT04707313|589780870|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163293628|NCT04707313|589780858|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
163293629|NCT04707313|589780859|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
163293630|NCT04707313|589780860|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
163293631|NCT04707313|589780861|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
163293632|NCT04707313|589780862|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
163293633|NCT04707313|589780863|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
163293634|NCT04707313|589780864|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
163293635|NCT04707313|589780865|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
163293636|NCT04707313|589780866|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
163293637|NCT04707313|589780867|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
163293638|NCT04707313|589780868|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
162950825|NCT05327491|588523568|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
162950826|NCT05327491|588523569|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
162950827|NCT05327491|588523570|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
162950828|NCT05327491|588523571|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
162950829|NCT00096447|588523572|FG000|Overall Study|Never treated|1|||
162950830|NCT00569374|588523575|FG000|Overall Study|Withdrawal by Subject|4|||
162950831|NCT01126736|588523576|FG000|Overall Study|Death|2|||
162950832|NCT01126736|588523577|FG001|Overall Study|Death|2|||
162950833|NCT01126736|588523578|FG002|Overall Study|Death|1|||
162950834|NCT01126736|588523579|FG003|Overall Study|Death|19|||
162950835|NCT01126736|588523580|FG004|Overall Study|Death|19|||
163188355|NCT01675427|589406070|FG000|Overall Study|Other|2|||
163389634|NCT02960854|590139521|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
163188356|NCT00902668|589406078|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
163188357|NCT01914757|589406079|FG000|Overall Study|Severe non-compliance to protocol|3|||
163188358|NCT01914757|589406080|FG001|Overall Study|Severe non-compliance to protocol|1|||
163188359|NCT01914757|589406081|FG002|Overall Study|Severe non-compliance to protocol|2|||
163188360|NCT01914757|589406079|FG000|Overall Study|Lost to Follow-up|5|||
163188361|NCT01914757|589406080|FG001|Overall Study|Lost to Follow-up|8|||
163188362|NCT01914757|589406081|FG002|Overall Study|Lost to Follow-up|6|||
163188363|NCT01914757|589406079|FG000|Overall Study|Withdrawal by Subject|15|||
163188364|NCT01914757|589406080|FG001|Overall Study|Withdrawal by Subject|27|||
163188365|NCT01914757|589406081|FG002|Overall Study|Withdrawal by Subject|19|||
163188366|NCT01914757|589406079|FG000|Overall Study|Death|2|||
163188367|NCT01914757|589406080|FG001|Overall Study|Death|2|||
163188368|NCT01914757|589406081|FG002|Overall Study|Death|1|||
163188369|NCT01914757|589406079|FG000|Overall Study|Adverse Event|4|||
163188370|NCT01914757|589406080|FG001|Overall Study|Adverse Event|3|||
163188371|NCT01914757|589406081|FG002|Overall Study|Adverse Event|4|||
163188372|NCT01914757|589406079|FG000|Overall Study|Study specific withdrawal criteria|0|||
163188373|NCT01914757|589406080|FG001|Overall Study|Study specific withdrawal criteria|1|||
163188374|NCT01914757|589406081|FG002|Overall Study|Study specific withdrawal criteria|0|||
163188375|NCT01914757|589406079|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
163188376|NCT01914757|589406080|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
163188377|NCT01914757|589406081|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
163188378|NCT01914757|589406079|FG000|Overall Study|Other reasons|5|||
163188379|NCT01914757|589406080|FG001|Overall Study|Other reasons|9|||
163188380|NCT01914757|589406081|FG002|Overall Study|Other reasons|4|||
163188381|NCT00408629|589406084|FG000|Overall Study|Adverse Event|13|||
163188382|NCT00408629|589406085|FG001|Overall Study|Adverse Event|27|||
163188383|NCT00408629|589406084|FG000|Overall Study|Withdrawal by Subject|8|||
163188384|NCT00408629|589406085|FG001|Overall Study|Withdrawal by Subject|4|||
163188385|NCT00408629|589406084|FG000|Overall Study|Lost to Follow-up|1|||
163188386|NCT00408629|589406085|FG001|Overall Study|Lost to Follow-up|1|||
163188387|NCT00408629|589406084|FG000|Overall Study|Lack of Efficacy|63|||
163188388|NCT00408629|589406085|FG001|Overall Study|Lack of Efficacy|73|||
163188389|NCT00408629|589406084|FG000|Overall Study|Protocol Violation|1|||
163188390|NCT00408629|589406085|FG001|Overall Study|Protocol Violation|5|||
163188391|NCT00408629|589406084|FG000|Overall Study|Miscellaneous|11|||
163188392|NCT00408629|589406085|FG001|Overall Study|Miscellaneous|15|||
163188393|NCT01461980|589406086|FG000|Overall Study|Other|9|||
163188394|NCT01461980|589406087|FG001|Overall Study|Other|8|||
163188395|NCT01461980|589406088|FG002|Overall Study|Other|6|||
163188396|NCT01461980|589406086|FG000|Overall Study|Medication error|7|||
163188397|NCT01461980|589406087|FG001|Overall Study|Medication error|5|||
163188398|NCT01461980|589406088|FG002|Overall Study|Medication error|6|||
163188399|NCT01461980|589406086|FG000|Overall Study|Adverse Event|12|||
163188400|NCT01461980|589406087|FG001|Overall Study|Adverse Event|5|||
163188401|NCT01461980|589406088|FG002|Overall Study|Adverse Event|6|||
163188402|NCT01461980|589406086|FG000|Overall Study|Protocol Violation|12|||
163188403|NCT01461980|589406087|FG001|Overall Study|Protocol Violation|19|||
163188404|NCT01461980|589406088|FG002|Overall Study|Protocol Violation|16|||
163188405|NCT01461980|589406086|FG000|Overall Study|No longer meets eligibility criteria|18|||
163188406|NCT01461980|589406087|FG001|Overall Study|No longer meets eligibility criteria|9|||
163293639|NCT04707313|589780869|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
163293640|NCT04707313|589780870|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
163293641|NCT04707313|589780858|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163293642|NCT04707313|589780859|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163293643|NCT04707313|589780860|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
163293644|NCT04707313|589780861|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163293645|NCT04707313|589780862|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163293646|NCT04707313|589780863|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163293647|NCT04707313|589780864|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163293648|NCT04707313|589780865|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
163293649|NCT04707313|589780866|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163293650|NCT04707313|589780867|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163389635|NCT02960854|590139520|FG000|Overall Study|Subject Withdrew Consent|0|||
162950836|NCT01126736|588523576|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
163188407|NCT01461980|589406088|FG002|Overall Study|No longer meets eligibility criteria|19|||
163188408|NCT01461980|589406086|FG000|Overall Study|Lost to Follow-up|52|||
163188409|NCT01461980|589406087|FG001|Overall Study|Lost to Follow-up|53|||
163188410|NCT01461980|589406088|FG002|Overall Study|Lost to Follow-up|51|||
163188411|NCT01461980|589406086|FG000|Overall Study|No longer willing to participate|52|||
163188412|NCT01461980|589406087|FG001|Overall Study|No longer willing to participate|38|||
163188413|NCT01461980|589406088|FG002|Overall Study|No longer willing to participate|54|||
163188414|NCT01461980|589406086|FG000|Overall Study|Randomized but not vaccinated|4|||
162950837|NCT01126736|588523577|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
162950838|NCT01126736|588523578|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
162950839|NCT01126736|588523579|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
162950840|NCT01126736|588523580|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
162950841|NCT01126736|588523576|FG000|Overall Study|Lost to Follow-up|0|||
162950842|NCT01126736|588523577|FG001|Overall Study|Lost to Follow-up|0|||
162950843|NCT01126736|588523578|FG002|Overall Study|Lost to Follow-up|0|||
162950844|NCT01126736|588523579|FG003|Overall Study|Lost to Follow-up|1|||
162950845|NCT01126736|588523580|FG004|Overall Study|Lost to Follow-up|1|||
162950846|NCT01126736|588523576|FG000|Overall Study|Administrative reasons|0|||
162950847|NCT01126736|588523577|FG001|Overall Study|Administrative reasons|0|||
162950848|NCT01126736|588523578|FG002|Overall Study|Administrative reasons|0|||
162950849|NCT01126736|588523579|FG003|Overall Study|Administrative reasons|0|||
162950850|NCT01126736|588523580|FG004|Overall Study|Administrative reasons|1|||
162950851|NCT01126736|588523576|FG000|Overall Study|Progressive disease|0|||
162950852|NCT01126736|588523577|FG001|Overall Study|Progressive disease|0|||
162950853|NCT01126736|588523578|FG002|Overall Study|Progressive disease|0|||
162950854|NCT01126736|588523579|FG003|Overall Study|Progressive disease|2|||
162950855|NCT01126736|588523580|FG004|Overall Study|Progressive disease|1|||
163389636|NCT02960854|590139521|FG001|Overall Study|Subject Withdrew Consent|1|||
163389637|NCT02960854|590139520|FG000|Overall Study|Death|4|||
163389638|NCT02960854|590139521|FG001|Overall Study|Death|6|||
163389639|NCT00221195|590139522|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
163389640|NCT00221195|590139523|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
163389641|NCT00221195|590139522|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
163389642|NCT00221195|590139523|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
163389643|NCT00221195|590139522|FG000|Washout Period (Months 7-9)|Death|0|||
163389644|NCT00221195|590139523|FG001|Washout Period (Months 7-9)|Death|1|||
163389645|NCT00221195|590139522|FG000|Therapy 2 (Months 10-15)|Death|1|||
163389646|NCT00221195|590139523|FG001|Therapy 2 (Months 10-15)|Death|0|||
163389647|NCT00221195|590139522|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
163389648|NCT00221195|590139523|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
163389649|NCT01383161|590139525|FG000|Overall Study|Adverse Event|5|||
163389650|NCT01383161|590139526|FG001|Overall Study|Adverse Event|1|||
163389651|NCT01383161|590139525|FG000|Overall Study|Withdrawal by Subject|0|||
163389652|NCT01383161|590139526|FG001|Overall Study|Withdrawal by Subject|2|||
163389653|NCT01383161|590139525|FG000|Overall Study|Lack of Efficacy|0|||
163389654|NCT01383161|590139526|FG001|Overall Study|Lack of Efficacy|1|||
163389655|NCT00833911|590139527|FG000|Titration|Adverse Event|18|||
163389656|NCT00833911|590139527|FG000|Titration|Withdrawal by Subject|3|||
163389657|NCT00833911|590139527|FG000|Maintenance Phase I|Adverse Event|73|||
163389658|NCT00833911|590139527|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
163389659|NCT00833911|590139527|FG000|Maintenance Phase I|Physician Decision|10|||
163389660|NCT00833911|590139527|FG000|Maintenance Phase I|Lack of Efficacy|4|||
163389661|NCT00833911|590139527|FG000|Maintenance Phase II|Adverse Event|6|||
163389662|NCT00833911|590139527|FG000|Maintenance Phase II|Physician Decision|2|||
163389663|NCT00833911|590139527|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
163389664|NCT00833911|590139527|FG000|Maintenance Phase II|Lack of Efficacy|1|||
163389665|NCT01423812|590139528|FG000|Overall Study|Lost to Follow-up|2|||
163389666|NCT01423812|590139529|FG001|Overall Study|Lost to Follow-up|2|||
163389667|NCT01423812|590139528|FG000|Overall Study|Withdrawal by Subject|1|||
163389668|NCT01423812|590139529|FG001|Overall Study|Withdrawal by Subject|2|||
163389669|NCT02616614|590139530|FG000|Overall Study|Withdrawal by Subject|10|||
163389670|NCT02616614|590139531|FG001|Overall Study|Withdrawal by Subject|5|||
163389671|NCT02616614|590139532|FG002|Overall Study|Withdrawal by Subject|6|||
163389672|NCT02616614|590139530|FG000|Overall Study|Physician Decision|2|||
163389673|NCT02616614|590139531|FG001|Overall Study|Physician Decision|1|||
163389674|NCT02616614|590139532|FG002|Overall Study|Physician Decision|0|||
163389675|NCT02616614|590139530|FG000|Overall Study|Adverse Event|1|||
163389676|NCT02616614|590139531|FG001|Overall Study|Adverse Event|4|||
163389677|NCT02616614|590139532|FG002|Overall Study|Adverse Event|1|||
163389678|NCT02616614|590139530|FG000|Overall Study|Protocol Violation|0|||
163389679|NCT02616614|590139531|FG001|Overall Study|Protocol Violation|3|||
163389680|NCT02616614|590139532|FG002|Overall Study|Protocol Violation|1|||
163389681|NCT02616614|590139530|FG000|Overall Study|Prohibited Medication|12|||
163389682|NCT02616614|590139531|FG001|Overall Study|Prohibited Medication|9|||
162950856|NCT01126736|588523576|FG000|Overall Study|Withdrawal by Subject|0|||
162950857|NCT01126736|588523577|FG001|Overall Study|Withdrawal by Subject|0|||
162950858|NCT01126736|588523578|FG002|Overall Study|Withdrawal by Subject|0|||
162950859|NCT01126736|588523579|FG003|Overall Study|Withdrawal by Subject|1|||
163389683|NCT02616614|590139532|FG002|Overall Study|Prohibited Medication|5|||
163389684|NCT02616614|590139530|FG000|Overall Study|More than 3 applications missed|6|||
162950860|NCT01126736|588523580|FG004|Overall Study|Withdrawal by Subject|1|||
162950861|NCT01126736|588523576|FG000|Overall Study|Other|2|||
163389685|NCT02616614|590139531|FG001|Overall Study|More than 3 applications missed|8|||
163389686|NCT02616614|590139532|FG002|Overall Study|More than 3 applications missed|1|||
163389687|NCT02616614|590139530|FG000|Overall Study|Lost to Follow-up|31|||
163188415|NCT01461980|589406087|FG001|Overall Study|Randomized but not vaccinated|8|||
163188416|NCT01461980|589406088|FG002|Overall Study|Randomized but not vaccinated|7|||
163188417|NCT00122109|589406089|FG000|Overall Study|Did not meet criteria|6|||
163188418|NCT00122109|589406090|FG001|Overall Study|Did not meet criteria|7|||
163188419|NCT01890746|589406091|FG000|Overall Study|Death|39|||
163188420|NCT01890746|589406092|FG001|Overall Study|Death|30|||
163188421|NCT01890746|589406091|FG000|Overall Study|Adverse Event|1|||
163188422|NCT01890746|589406092|FG001|Overall Study|Adverse Event|0|||
163188423|NCT01890746|589406091|FG000|Overall Study|Lost to Follow-up|4|||
163188424|NCT01890746|589406092|FG001|Overall Study|Lost to Follow-up|1|||
163188425|NCT01890746|589406091|FG000|Overall Study|Physician Decision|3|||
163188426|NCT01890746|589406092|FG001|Overall Study|Physician Decision|2|||
163188427|NCT01890746|589406091|FG000|Overall Study|Withdrawal by Subject|5|||
163188428|NCT01890746|589406092|FG001|Overall Study|Withdrawal by Subject|8|||
163188429|NCT00100178|589406093|FG000|Overall Study|Lost to Follow-up|0|||
163188430|NCT00100178|589406094|FG001|Overall Study|Lost to Follow-up|6|||
163188431|NCT00100178|589406095|FG002|Overall Study|Lost to Follow-up|5|||
163188432|NCT00100178|589406093|FG000|Overall Study|Adverse Event|2|||
163188433|NCT00100178|589406094|FG001|Overall Study|Adverse Event|2|||
163188434|NCT00100178|589406095|FG002|Overall Study|Adverse Event|1|||
163188435|NCT00100178|589406093|FG000|Overall Study|Withdrawal by Subject|1|||
163188436|NCT00100178|589406094|FG001|Overall Study|Withdrawal by Subject|1|||
163188437|NCT00100178|589406095|FG002|Overall Study|Withdrawal by Subject|1|||
163188438|NCT00100178|589406093|FG000|Overall Study|Physician Decision|6|||
163188439|NCT00100178|589406094|FG001|Overall Study|Physician Decision|1|||
163188440|NCT00100178|589406095|FG002|Overall Study|Physician Decision|3|||
163188441|NCT00631696|589406096|FG000|Overall Study|Entered, not randomized to treatment|1|||
163188442|NCT00631696|589406097|FG001|Overall Study|Entered, not randomized to treatment|1|||
163188443|NCT00631696|589406096|FG000|Overall Study|Discontinued after database release date|1|||
163188444|NCT00631696|589406097|FG001|Overall Study|Discontinued after database release date|0|||
163188445|NCT00631696|589406096|FG000|Overall Study|Follow up after database release date|1|||
163188446|NCT00631696|589406097|FG001|Overall Study|Follow up after database release date|0|||
163188447|NCT00631696|589406096|FG000|Overall Study|Lost to Follow-up|7|||
163188448|NCT00631696|589406097|FG001|Overall Study|Lost to Follow-up|10|||
163188449|NCT00631696|589406096|FG000|Overall Study|Withdrawal by Subject|2|||
163188450|NCT00631696|589406097|FG001|Overall Study|Withdrawal by Subject|9|||
163188451|NCT00631696|589406096|FG000|Overall Study|Other|8|||
163188452|NCT00631696|589406097|FG001|Overall Study|Other|8|||
163188453|NCT00631696|589406096|FG000|Overall Study|Protocol Violation|9|||
163188454|NCT00631696|589406097|FG001|Overall Study|Protocol Violation|9|||
163188455|NCT00631696|589406096|FG000|Overall Study|Study terminated by sponsor|3|||
163188456|NCT00631696|589406097|FG001|Overall Study|Study terminated by sponsor|3|||
163188457|NCT00631696|589406096|FG000|Overall Study|Adverse Event|5|||
163188458|NCT00631696|589406097|FG001|Overall Study|Adverse Event|0|||
163188459|NCT02607930|589406101|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
163188460|NCT02607930|589406102|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
163188461|NCT02607930|589406103|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
163188462|NCT02607930|589406104|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
163188463|NCT02607930|589406101|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
163188464|NCT02607930|589406102|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
163188465|NCT02607930|589406103|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
163188466|NCT02607930|589406104|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
163188467|NCT02607930|589406101|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
163188468|NCT02607930|589406102|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
163188469|NCT02607930|589406103|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
163188470|NCT02607930|589406104|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
163188471|NCT02607930|589406101|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
163188472|NCT02607930|589406102|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
163188473|NCT02607930|589406103|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
163188474|NCT02607930|589406104|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
163188475|NCT02607930|589406101|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
163188476|NCT02607930|589406102|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
163188477|NCT02607930|589406103|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
163188478|NCT02607930|589406104|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
163188479|NCT02607930|589406101|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
163188480|NCT02607930|589406102|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
163188481|NCT02607930|589406103|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
163188482|NCT02607930|589406104|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
163188483|NCT02607930|589406101|FG000|Double-Blinded Treatment Phase|Death|2|||
163188484|NCT02607930|589406102|FG001|Double-Blinded Treatment Phase|Death|1|||
163188485|NCT02607930|589406103|FG002|Double-Blinded Treatment Phase|Death|0|||
163188486|NCT02607930|589406104|FG003|Double-Blinded Treatment Phase|Death|0|||
163389688|NCT02616614|590139531|FG001|Overall Study|Lost to Follow-up|28|||
162950862|NCT01126736|588523577|FG001|Overall Study|Other|4|||
162950863|NCT01126736|588523578|FG002|Overall Study|Other|4|||
162950864|NCT01126736|588523579|FG003|Overall Study|Other|16|||
162950865|NCT01126736|588523580|FG004|Overall Study|Other|15|||
162950866|NCT02202850|588523582|FG000|Overall Study|Other|2|||
162950867|NCT02202850|588523583|FG001|Overall Study|Other|2|||
162950868|NCT02202850|588523582|FG000|Overall Study|Enbrel treatment discontinued|15|||
162950869|NCT02202850|588523583|FG001|Overall Study|Enbrel treatment discontinued|3|||
162950870|NCT02202850|588523582|FG000|Overall Study|Lost to Follow-up|7|||
162950871|NCT02202850|588523583|FG001|Overall Study|Lost to Follow-up|1|||
162950872|NCT01873586|588523584|FG000|Overall Study|Lost to Follow-up|3|||
162950873|NCT00615069|588523585|FG000|Overall Study|Death|10|||
162950874|NCT00615069|588523585|FG000|Overall Study|Physician Decision|2|||
162950875|NCT00615069|588523585|FG000|Overall Study|Withdrawal by Subject|4|||
162950876|NCT00669942|588523586|FG000|Parts 2 and 3|Adverse Event|0|||
162950877|NCT00669942|588523587|FG001|Parts 2 and 3|Adverse Event|0|||
162950878|NCT00669942|588523588|FG002|Parts 2 and 3|Adverse Event|0|||
162950879|NCT00669942|588523589|FG003|Parts 2 and 3|Adverse Event|0|||
162950880|NCT00669942|588523590|FG004|Parts 2 and 3|Adverse Event|0|||
162950881|NCT00669942|588523591|FG005|Parts 2 and 3|Adverse Event|0|||
162950882|NCT00669942|588523592|FG006|Parts 2 and 3|Adverse Event|0|||
162950883|NCT00669942|588523593|FG007|Parts 2 and 3|Adverse Event|2|||
162950884|NCT00669942|588523594|FG008|Parts 2 and 3|Adverse Event|1|||
162950885|NCT00669942|588523595|FG009|Parts 2 and 3|Adverse Event|0|||
162950886|NCT00669942|588523596|FG010|Parts 2 and 3|Adverse Event|0|||
162950887|NCT00669942|588523597|FG011|Parts 2 and 3|Adverse Event|0|||
162950888|NCT00669942|588523586|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
162950889|NCT00669942|588523587|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
162950890|NCT00669942|588523588|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
162950891|NCT00669942|588523589|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
162950892|NCT00669942|588523590|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
162950893|NCT00669942|588523591|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
163389689|NCT02616614|590139532|FG002|Overall Study|Lost to Follow-up|13|||
163389690|NCT02616614|590139530|FG000|Overall Study|Pregnancy|2|||
163389691|NCT02616614|590139531|FG001|Overall Study|Pregnancy|0|||
163389692|NCT02616614|590139532|FG002|Overall Study|Pregnancy|1|||
162950894|NCT00669942|588523592|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
162950895|NCT00669942|588523593|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
162950896|NCT00669942|588523594|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
162950897|NCT00669942|588523595|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
162950898|NCT00669942|588523596|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
162950899|NCT00669942|588523597|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
162950900|NCT00669942|588523586|FG000|Parts 2 and 3|Protocol Violation|0|||
162950901|NCT00669942|588523587|FG001|Parts 2 and 3|Protocol Violation|0|||
162950902|NCT00669942|588523588|FG002|Parts 2 and 3|Protocol Violation|0|||
162950903|NCT00669942|588523589|FG003|Parts 2 and 3|Protocol Violation|0|||
162950904|NCT00669942|588523590|FG004|Parts 2 and 3|Protocol Violation|0|||
162950905|NCT00669942|588523591|FG005|Parts 2 and 3|Protocol Violation|1|||
162950906|NCT00669942|588523592|FG006|Parts 2 and 3|Protocol Violation|0|||
162950907|NCT00669942|588523593|FG007|Parts 2 and 3|Protocol Violation|0|||
162950908|NCT00669942|588523594|FG008|Parts 2 and 3|Protocol Violation|0|||
162950909|NCT00669942|588523595|FG009|Parts 2 and 3|Protocol Violation|0|||
162950910|NCT00669942|588523596|FG010|Parts 2 and 3|Protocol Violation|0|||
162950911|NCT00669942|588523597|FG011|Parts 2 and 3|Protocol Violation|0|||
162950912|NCT00282048|588523598|FG000|Overall Study|Lack of Efficacy|30|||
163188487|NCT02607930|589406101|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
163188488|NCT02607930|589406102|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
163188489|NCT02607930|589406103|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
163188490|NCT02607930|589406104|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
163188491|NCT02607930|589406101|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
163188492|NCT02607930|589406102|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
163188493|NCT02607930|589406103|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
163188494|NCT02607930|589406104|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
163188495|NCT02607930|589406101|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
163188496|NCT02607930|589406102|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
163188497|NCT02607930|589406103|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
163389693|NCT02616614|590139530|FG000|Overall Study|Other|1|||
163389694|NCT02616614|590139531|FG001|Overall Study|Other|2|||
162950913|NCT00282048|588523598|FG000|Overall Study|Adverse Event|22|||
162950914|NCT00282048|588523598|FG000|Overall Study|Withdrawal by Subject|1|||
162950915|NCT00282048|588523598|FG000|Overall Study|Other|8|||
162950916|NCT00282048|588523598|FG000|Overall Study|Ongoing|1|||
163188498|NCT02607930|589406104|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
163188499|NCT02607930|589406101|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
162950917|NCT00259012|588523600|FG000|Overall Study|Adverse Event|0|||
162950918|NCT00259012|588523601|FG001|Overall Study|Adverse Event|1|||
162950919|NCT00259012|588523600|FG000|Overall Study|Withdrawal by Subject|1|||
163389695|NCT02616614|590139532|FG002|Overall Study|Other|1|||
163389696|NCT02748018|590139533|FG000|Study Period|Adverse Event|1|||
163389697|NCT02748018|590139534|FG001|Study Period|Adverse Event|3|||
163389698|NCT02748018|590139535|FG002|Study Period|Adverse Event|4|||
163389699|NCT02748018|590139536|FG003|Study Period|Adverse Event|0|||
163389700|NCT02748018|590139537|FG004|Study Period|Adverse Event|3|||
163389701|NCT02748018|590139538|FG005|Study Period|Adverse Event|3|||
163389702|NCT02748018|590139533|FG000|Study Period|Withdrawal by Subject|7|||
163389703|NCT02748018|590139534|FG001|Study Period|Withdrawal by Subject|4|||
163389704|NCT02748018|590139535|FG002|Study Period|Withdrawal by Subject|4|||
163389705|NCT02748018|590139536|FG003|Study Period|Withdrawal by Subject|11|||
163389706|NCT02748018|590139537|FG004|Study Period|Withdrawal by Subject|12|||
163389707|NCT02748018|590139538|FG005|Study Period|Withdrawal by Subject|10|||
163389708|NCT02748018|590139533|FG000|Study Period|Pregnancy|0|||
163389709|NCT02748018|590139534|FG001|Study Period|Pregnancy|1|||
163389710|NCT02748018|590139535|FG002|Study Period|Pregnancy|0|||
163389711|NCT02748018|590139536|FG003|Study Period|Pregnancy|0|||
163389712|NCT02748018|590139537|FG004|Study Period|Pregnancy|1|||
163389713|NCT02748018|590139538|FG005|Study Period|Pregnancy|0|||
163389714|NCT02748018|590139533|FG000|Study Period|Physician Decision|2|||
163389715|NCT02748018|590139534|FG001|Study Period|Physician Decision|2|||
163389716|NCT02748018|590139535|FG002|Study Period|Physician Decision|1|||
163389717|NCT02748018|590139536|FG003|Study Period|Physician Decision|0|||
163389718|NCT02748018|590139537|FG004|Study Period|Physician Decision|2|||
163389719|NCT02748018|590139538|FG005|Study Period|Physician Decision|0|||
163389720|NCT02748018|590139533|FG000|Study Period|Lost to Follow-up|0|||
163389721|NCT02748018|590139534|FG001|Study Period|Lost to Follow-up|0|||
163389722|NCT02748018|590139535|FG002|Study Period|Lost to Follow-up|0|||
163389723|NCT02748018|590139536|FG003|Study Period|Lost to Follow-up|2|||
163389724|NCT02748018|590139537|FG004|Study Period|Lost to Follow-up|0|||
163389725|NCT02748018|590139538|FG005|Study Period|Lost to Follow-up|1|||
163389726|NCT02748018|590139533|FG000|Continuation Period|Adverse Event|2|||
163389727|NCT02748018|590139534|FG001|Continuation Period|Adverse Event|0|||
163389728|NCT02748018|590139535|FG002|Continuation Period|Adverse Event|1|||
163389729|NCT02748018|590139536|FG003|Continuation Period|Adverse Event|1|||
163389730|NCT02748018|590139537|FG004|Continuation Period|Adverse Event|1|||
163389731|NCT02748018|590139538|FG005|Continuation Period|Adverse Event|4|||
163389732|NCT02748018|590139533|FG000|Continuation Period|Withdrawal by Subject|3|||
163389733|NCT02748018|590139534|FG001|Continuation Period|Withdrawal by Subject|5|||
163389734|NCT02748018|590139535|FG002|Continuation Period|Withdrawal by Subject|3|||
163389735|NCT02748018|590139536|FG003|Continuation Period|Withdrawal by Subject|9|||
163389736|NCT02748018|590139537|FG004|Continuation Period|Withdrawal by Subject|11|||
163389737|NCT02748018|590139538|FG005|Continuation Period|Withdrawal by Subject|1|||
163389738|NCT02748018|590139533|FG000|Continuation Period|Lost to Follow-up|0|||
163389739|NCT02748018|590139534|FG001|Continuation Period|Lost to Follow-up|2|||
163389740|NCT02748018|590139535|FG002|Continuation Period|Lost to Follow-up|1|||
163389741|NCT02748018|590139536|FG003|Continuation Period|Lost to Follow-up|0|||
163389742|NCT02748018|590139537|FG004|Continuation Period|Lost to Follow-up|1|||
163389743|NCT02748018|590139538|FG005|Continuation Period|Lost to Follow-up|0|||
163188500|NCT02607930|589406102|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
163188501|NCT02607930|589406103|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
163188502|NCT02607930|589406104|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
163188503|NCT02607930|589406101|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
163188504|NCT02607930|589406102|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
163188505|NCT02607930|589406103|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
163188506|NCT02607930|589406104|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
163188507|NCT02607930|589406101|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
163188508|NCT02607930|589406102|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
163188509|NCT02607930|589406103|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
163188510|NCT02607930|589406104|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
163188511|NCT02607930|589406101|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
163389744|NCT02748018|590139533|FG000|Continuation Period|Pregnancy|1|||
163389745|NCT02748018|590139534|FG001|Continuation Period|Pregnancy|2|||
163389746|NCT02748018|590139535|FG002|Continuation Period|Pregnancy|0|||
163389747|NCT02748018|590139536|FG003|Continuation Period|Pregnancy|0|||
163389748|NCT02748018|590139537|FG004|Continuation Period|Pregnancy|0|||
163188512|NCT02607930|589406102|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
163188513|NCT02607930|589406103|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
163188514|NCT02607930|589406104|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
163188515|NCT02607930|589406101|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
163188516|NCT02607930|589406102|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
163188517|NCT02607930|589406103|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
163389749|NCT02748018|590139538|FG005|Continuation Period|Pregnancy|0|||
163389750|NCT02748018|590139533|FG000|Continuation Period|Physician Decision|0|||
163389751|NCT02748018|590139534|FG001|Continuation Period|Physician Decision|1|||
163389752|NCT02748018|590139535|FG002|Continuation Period|Physician Decision|2|||
163389753|NCT02748018|590139536|FG003|Continuation Period|Physician Decision|0|||
163389754|NCT02748018|590139537|FG004|Continuation Period|Physician Decision|2|||
163389755|NCT02748018|590139538|FG005|Continuation Period|Physician Decision|1|||
163389756|NCT02748018|590139533|FG000|Continuation Period|Protocol Violation|0|||
163389757|NCT02748018|590139534|FG001|Continuation Period|Protocol Violation|1|||
163389758|NCT02748018|590139535|FG002|Continuation Period|Protocol Violation|0|||
163389759|NCT02748018|590139536|FG003|Continuation Period|Protocol Violation|0|||
163389760|NCT02748018|590139537|FG004|Continuation Period|Protocol Violation|0|||
163389761|NCT02748018|590139538|FG005|Continuation Period|Protocol Violation|0|||
163389762|NCT06069778|590139539|FG000|Overall Study|Withdrawal by Subject|1|||
163389763|NCT04704336|590139543|FG000|Overall Study|Death|2|||
163389764|NCT04704336|590139544|FG001|Overall Study|Death|2|||
163389765|NCT04704336|590139543|FG000|Overall Study|Lost to Follow-up|33|||
163389766|NCT04704336|590139544|FG001|Overall Study|Lost to Follow-up|40|||
163389767|NCT02119325|590139545|FG000|Washout Period 1|Adverse Event|0|||
163389768|NCT02119325|590139546|FG001|Washout Period 1|Adverse Event|1|||
163389769|NCT02249767|590139547|FG000|Overall Study|Did not use medication|8|||
163389770|NCT02249767|590139548|FG001|Overall Study|Did not use medication|9|||
163389771|NCT02249767|590139549|FG002|Overall Study|Did not use medication|8|||
163389772|NCT01372410|590139550|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
163389773|NCT01372410|590139551|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
163389774|NCT01372410|590139552|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
163389775|NCT01372410|590139553|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
163389776|NCT01372410|590139554|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
163389777|NCT01372410|590139555|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
163389778|NCT01372410|590139556|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
163389779|NCT01372410|590139557|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
163389780|NCT01372410|590139550|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
163389781|NCT01372410|590139551|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
163389782|NCT01372410|590139552|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
163389783|NCT01372410|590139553|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
163389784|NCT01372410|590139554|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
163389785|NCT01372410|590139555|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
163389786|NCT01372410|590139556|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
163389787|NCT01372410|590139557|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
163389788|NCT01372410|590139550|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163389789|NCT01372410|590139551|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163389790|NCT01372410|590139552|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163389791|NCT01372410|590139553|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163389792|NCT01372410|590139554|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
163389793|NCT01372410|590139555|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163389794|NCT01372410|590139556|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163389795|NCT01372410|590139557|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163389796|NCT01372410|590139550|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
163389797|NCT01372410|590139551|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
163389798|NCT01372410|590139552|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
163389799|NCT01372410|590139553|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
163389800|NCT01372410|590139554|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
163389801|NCT01372410|590139555|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
163389802|NCT01372410|590139556|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
163389803|NCT01372410|590139557|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
163389804|NCT01372410|590139550|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
163389805|NCT01372410|590139551|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
163389806|NCT01372410|590139552|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
163389807|NCT01372410|590139553|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
163389808|NCT01372410|590139554|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
163389809|NCT01372410|590139555|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
163389810|NCT01372410|590139556|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
163389811|NCT01372410|590139557|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
163389812|NCT01372410|590139550|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
163389813|NCT01372410|590139551|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
163389814|NCT01372410|590139552|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
163389815|NCT01372410|590139553|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
163389816|NCT01372410|590139554|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
163389817|NCT01372410|590139555|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
163389818|NCT01372410|590139556|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
163389819|NCT01372410|590139557|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
163389820|NCT01372410|590139550|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
163389821|NCT01372410|590139551|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
163389822|NCT01372410|590139552|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
163188518|NCT02607930|589406104|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
163188519|NCT02607930|589406101|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
163188520|NCT02607930|589406102|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
163188521|NCT02607930|589406103|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
163188522|NCT02607930|589406104|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
163188523|NCT03198078|589406105|FG000|Overall Study|Adverse Event|0|||
163188524|NCT03198078|589406106|FG001|Overall Study|Adverse Event|1|||
163188525|NCT03198078|589406107|FG002|Overall Study|Adverse Event|2|||
163188526|NCT03198078|589406105|FG000|Overall Study|Lack of Efficacy|0|||
163188527|NCT03198078|589406106|FG001|Overall Study|Lack of Efficacy|0|||
163188528|NCT03198078|589406107|FG002|Overall Study|Lack of Efficacy|3|||
163188529|NCT03198078|589406105|FG000|Overall Study|Lost to Follow-up|1|||
163188530|NCT03198078|589406106|FG001|Overall Study|Lost to Follow-up|0|||
163188531|NCT03198078|589406107|FG002|Overall Study|Lost to Follow-up|0|||
163188532|NCT03198078|589406105|FG000|Overall Study|Pregnancy|0|||
163188533|NCT03198078|589406106|FG001|Overall Study|Pregnancy|1|||
163188534|NCT03198078|589406107|FG002|Overall Study|Pregnancy|0|||
163188535|NCT03198078|589406105|FG000|Overall Study|Withdrawal by Subject|1|||
163188536|NCT03198078|589406106|FG001|Overall Study|Withdrawal by Subject|0|||
163188537|NCT03198078|589406107|FG002|Overall Study|Withdrawal by Subject|2|||
163188538|NCT03198078|589406105|FG000|Overall Study|Withdrawal by Caregiver|1|||
163188539|NCT03198078|589406106|FG001|Overall Study|Withdrawal by Caregiver|3|||
163188540|NCT03198078|589406107|FG002|Overall Study|Withdrawal by Caregiver|5|||
163188541|NCT01578330|589406108|FG000|Overall Study|Adverse Event|2|||
163188542|NCT01578330|589406108|FG000|Overall Study|Protocol Violation|5|||
163188543|NCT01676727|589406109|FG000|Overall Study|Death|18|||
163188544|NCT01676727|589406109|FG000|Overall Study|Withdrawal by Subject|6|||
163188545|NCT01676727|589406109|FG000|Overall Study|Screening failure|5|||
163188546|NCT01676727|589406109|FG000|Overall Study|Not willing to attend 1-year visit|2|||
163188547|NCT01676727|589406109|FG000|Overall Study|Valve explanted|1|||
163188548|NCT01134731|589406110|FG000|Overall Study|Adverse Event|3|||
163188549|NCT01134731|589406111|FG001|Overall Study|Adverse Event|2|||
163293651|NCT04707313|589780868|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163293652|NCT04707313|589780869|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163293653|NCT04707313|589780870|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163293654|NCT04707313|589780858|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163293655|NCT04707313|589780859|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163293656|NCT04707313|589780860|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163293657|NCT04707313|589780861|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163293658|NCT04707313|589780862|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163293659|NCT04707313|589780863|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163293660|NCT04707313|589780864|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163293661|NCT04707313|589780865|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163293662|NCT04707313|589780866|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163293663|NCT04707313|589780867|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163293664|NCT04707313|589780868|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
163293665|NCT04707313|589780869|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
163293666|NCT04707313|589780870|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
163293667|NCT04707313|589780858|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163293668|NCT04707313|589780859|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163293669|NCT04707313|589780860|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163293670|NCT04707313|589780861|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163293671|NCT04707313|589780862|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163293672|NCT04707313|589780863|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163293673|NCT04707313|589780864|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163293674|NCT04707313|589780865|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163293675|NCT04707313|589780866|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163293676|NCT04707313|589780867|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
163188550|NCT01134731|589406112|FG002|Overall Study|Adverse Event|1|||
163188551|NCT01134731|589406110|FG000|Overall Study|Physician Decision|2|||
163188552|NCT01134731|589406111|FG001|Overall Study|Physician Decision|2|||
163188553|NCT01134731|589406112|FG002|Overall Study|Physician Decision|2|||
163188554|NCT01134731|589406110|FG000|Overall Study|Lack of Efficacy|0|||
163188555|NCT01134731|589406111|FG001|Overall Study|Lack of Efficacy|0|||
163188556|NCT01134731|589406112|FG002|Overall Study|Lack of Efficacy|1|||
163188557|NCT01134731|589406110|FG000|Overall Study|Withdrawal by Subject|3|||
163188558|NCT01134731|589406111|FG001|Overall Study|Withdrawal by Subject|3|||
163188559|NCT01134731|589406112|FG002|Overall Study|Withdrawal by Subject|1|||
163188560|NCT01134731|589406110|FG000|Overall Study|Lost to Follow-up|5|||
163188561|NCT01134731|589406111|FG001|Overall Study|Lost to Follow-up|4|||
163188562|NCT01134731|589406112|FG002|Overall Study|Lost to Follow-up|3|||
163188563|NCT02517866|589406114|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
163188564|NCT02517866|589406115|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
163188565|NCT02517866|589406116|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
162950920|NCT00259012|588523601|FG001|Overall Study|Withdrawal by Subject|0|||
162950921|NCT00259012|588523600|FG000|Overall Study|Physician Decision|0|||
162950922|NCT00259012|588523601|FG001|Overall Study|Physician Decision|1|||
162950923|NCT00259012|588523600|FG000|Overall Study|Lost to Follow-up|0|||
162950924|NCT00259012|588523601|FG001|Overall Study|Lost to Follow-up|1|||
162950925|NCT00259012|588523600|FG000|Overall Study|Protocol Violation|1|||
162950926|NCT00259012|588523601|FG001|Overall Study|Protocol Violation|1|||
162950927|NCT03522675|588523602|FG000|Overall Study|Screen fail|1|||
162950928|NCT03522675|588523602|FG000|Overall Study|Non-reactive to histamine|1|||
162950929|NCT00707161|588523603|FG000|Overall Study|Physician Decision|6|||
162950930|NCT02674477|588523604|FG000|Overall Study|Protocol Violation|8|||
162950931|NCT02674477|588523605|FG001|Overall Study|Protocol Violation|2|||
162950932|NCT02336165|588523610|FG000|Overall Study|Death|3|||
162950933|NCT02336165|588523611|FG001|Overall Study|Death|0|||
162950934|NCT02336165|588523612|FG002|Overall Study|Death|0|||
162950935|NCT02336165|588523613|FG003|Overall Study|Death|0|||
162950936|NCT02336165|588523614|FG004|Overall Study|Death|1|||
162950937|NCT02336165|588523610|FG000|Overall Study|Physician Decision|2|||
162950938|NCT02336165|588523611|FG001|Overall Study|Physician Decision|2|||
162950939|NCT02336165|588523612|FG002|Overall Study|Physician Decision|1|||
162950940|NCT02336165|588523613|FG003|Overall Study|Physician Decision|1|||
162950941|NCT02336165|588523614|FG004|Overall Study|Physician Decision|0|||
162950942|NCT02336165|588523610|FG000|Overall Study|Withdrawal by Subject|0|||
162950943|NCT02336165|588523611|FG001|Overall Study|Withdrawal by Subject|0|||
162950944|NCT02336165|588523612|FG002|Overall Study|Withdrawal by Subject|1|||
162950945|NCT02336165|588523613|FG003|Overall Study|Withdrawal by Subject|0|||
162950946|NCT02336165|588523614|FG004|Overall Study|Withdrawal by Subject|1|||
162950947|NCT02336165|588523610|FG000|Overall Study|Adverse Event|4|||
162950948|NCT02336165|588523611|FG001|Overall Study|Adverse Event|1|||
162950949|NCT02336165|588523612|FG002|Overall Study|Adverse Event|2|||
162950950|NCT02336165|588523613|FG003|Overall Study|Adverse Event|4|||
162950951|NCT02336165|588523614|FG004|Overall Study|Adverse Event|1|||
162950952|NCT02336165|588523610|FG000|Overall Study|Progressive disease|23|||
162950953|NCT02336165|588523611|FG001|Overall Study|Progressive disease|22|||
162950954|NCT02336165|588523612|FG002|Overall Study|Progressive disease|27|||
162950955|NCT02336165|588523613|FG003|Overall Study|Progressive disease|24|||
162950956|NCT02336165|588523614|FG004|Overall Study|Progressive disease|19|||
162950957|NCT02336165|588523610|FG000|Overall Study|Non-compliance|1|||
162950958|NCT02336165|588523611|FG001|Overall Study|Non-compliance|0|||
162950959|NCT02336165|588523612|FG002|Overall Study|Non-compliance|0|||
162950960|NCT02336165|588523613|FG003|Overall Study|Non-compliance|1|||
162950961|NCT02336165|588523614|FG004|Overall Study|Non-compliance|0|||
162950962|NCT02336165|588523610|FG000|Overall Study|Other|1|||
162950963|NCT02336165|588523611|FG001|Overall Study|Other|0|||
162950964|NCT02336165|588523612|FG002|Overall Study|Other|0|||
162950965|NCT02336165|588523613|FG003|Overall Study|Other|1|||
162950966|NCT02336165|588523614|FG004|Overall Study|Other|0|||
162950967|NCT00450190|588523615|FG000|Overall Study|Withdrawal by Subject|2|||
162950968|NCT03002077|588523618|FG000|Overall Study|Non-compliance with Study Drug|4|||
162950969|NCT03002077|588523618|FG000|Overall Study|Non-compliance w/Background ADT|1|||
162950970|NCT03002077|588523618|FG000|Overall Study|Study Terminated by Sponsor|257|||
162950971|NCT03002077|588523618|FG000|Overall Study|Site Terminated by Sponsor|5|||
162950972|NCT03002077|588523618|FG000|Overall Study|Miscellaneous Reasons|10|||
162950973|NCT03002077|588523618|FG000|Overall Study|Adverse Event|23|||
162950974|NCT03002077|588523618|FG000|Overall Study|Lack of Efficacy|20|||
162950975|NCT03002077|588523618|FG000|Overall Study|Withdrawal by Subject|72|||
162950976|NCT03002077|588523618|FG000|Overall Study|Lost to Follow-up|21|||
162950977|NCT03002077|588523618|FG000|Overall Study|Pregnancy|4|||
162950978|NCT03002077|588523618|FG000|Overall Study|Protocol Violation|21|||
162950979|NCT00834756|588523621|FG000|First Intervention|Adverse Event|1|||
162950980|NCT00834756|588523622|FG001|First Intervention|Adverse Event|0|||
162950981|NCT00834756|588523621|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
162950982|NCT00834756|588523622|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
162950983|NCT04625114|588523634|FG000|Overall Study|Adverse Event|3|||
162950984|NCT04625114|588523635|FG001|Overall Study|Adverse Event|1|||
162950985|NCT04625114|588523634|FG000|Overall Study|Withdrawal by Subject|2|||
162950986|NCT04625114|588523635|FG001|Overall Study|Withdrawal by Subject|0|||
162950987|NCT00986245|588523636|FG000|First Intervention|Poor compliance|8|||
162950988|NCT00986245|588523637|FG001|First Intervention|Poor compliance|4|||
162950989|NCT00986245|588523636|FG000|First Intervention|Lack of Efficacy|1|||
162950990|NCT00986245|588523637|FG001|First Intervention|Lack of Efficacy|2|||
162950991|NCT00986245|588523636|FG000|First Intervention|Withdrawal by Subject|0|||
162950992|NCT00986245|588523637|FG001|First Intervention|Withdrawal by Subject|1|||
162950993|NCT00986245|588523636|FG000|First Intervention|Protocol Violation|0|||
162950994|NCT00986245|588523637|FG001|First Intervention|Protocol Violation|1|||
162950995|NCT00986245|588523636|FG000|First Intervention|Out of indication|1|||
162950996|NCT00986245|588523637|FG001|First Intervention|Out of indication|0|||
162950997|NCT00986245|588523636|FG000|Second Intervention|Poor compliance|1|||
162950998|NCT00986245|588523637|FG001|Second Intervention|Poor compliance|0|||
162950999|NCT00986245|588523636|FG000|Second Intervention|Lost to Follow-up|1|||
162951000|NCT00986245|588523637|FG001|Second Intervention|Lost to Follow-up|0|||
162951001|NCT00986245|588523636|FG000|Second Intervention|Protocol Violation|0|||
162951002|NCT00986245|588523637|FG001|Second Intervention|Protocol Violation|1|||
162951003|NCT00854308|588523641|FG000|Overall Study|Disease progression|42|||
162951004|NCT00854308|588523642|FG001|Overall Study|Disease progression|50|||
162951005|NCT00854308|588523641|FG000|Overall Study|Adverse Event|8|||
162951006|NCT00854308|588523642|FG001|Overall Study|Adverse Event|3|||
162951007|NCT00854308|588523641|FG000|Overall Study|Death|2|||
162951008|NCT00854308|588523642|FG001|Overall Study|Death|5|||
162951009|NCT00854308|588523641|FG000|Overall Study|Physician Decision|6|||
162951010|NCT00854308|588523642|FG001|Overall Study|Physician Decision|6|||
162951011|NCT00854308|588523641|FG000|Overall Study|Withdrawal by Subject|4|||
162951012|NCT00854308|588523642|FG001|Overall Study|Withdrawal by Subject|2|||
162951013|NCT00854308|588523641|FG000|Overall Study|Sponsor's decision to terminate study|0|||
162951014|NCT00854308|588523642|FG001|Overall Study|Sponsor's decision to terminate study|1|||
162951015|NCT01390844|588523643|FG000|Treatment Phase|Adverse Event|12|||
162951016|NCT01390844|588523644|FG001|Treatment Phase|Adverse Event|2|||
162951017|NCT01390844|588523645|FG002|Treatment Phase|Adverse Event|3|||
162951018|NCT01390844|588523646|FG003|Treatment Phase|Adverse Event|2|||
162951019|NCT01390844|588523643|FG000|Treatment Phase|Treatment Failure|23|||
162951020|NCT01390844|588523644|FG001|Treatment Phase|Treatment Failure|25|||
162951021|NCT01390844|588523645|FG002|Treatment Phase|Treatment Failure|10|||
162951022|NCT01390844|588523646|FG003|Treatment Phase|Treatment Failure|13|||
162951023|NCT01390844|588523643|FG000|Treatment Phase|Non-Medical Reasons|5|||
162951024|NCT01390844|588523644|FG001|Treatment Phase|Non-Medical Reasons|1|||
162951025|NCT01390844|588523645|FG002|Treatment Phase|Non-Medical Reasons|8|||
162951026|NCT01390844|588523646|FG003|Treatment Phase|Non-Medical Reasons|1|||
162951027|NCT01390844|588523643|FG000|Treatment Phase|Non-GCP Compliant|0|||
162951028|NCT01390844|588523644|FG001|Treatment Phase|Non-GCP Compliant|0|||
162951029|NCT01390844|588523645|FG002|Treatment Phase|Non-GCP Compliant|10|||
162951030|NCT01390844|588523646|FG003|Treatment Phase|Non-GCP Compliant|3|||
162951031|NCT01390844|588523643|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
162951032|NCT01390844|588523644|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
162951033|NCT01390844|588523645|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
162951034|NCT01390844|588523646|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
162951035|NCT03048500|588523649|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
162951036|NCT03048500|588523649|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
162951037|NCT03048500|588523649|FG000|Reached 1st Response/Continued Treatment|Death|1|||
162951038|NCT03048500|588523649|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
162951039|NCT03048500|588523649|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
162951040|NCT03048500|588523649|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
162951041|NCT03048500|588523649|FG000|Follow up for 3 Years|Death|12|||
162951042|NCT01479439|588523650|FG000|Overall Study|Adverse Event|1|||
162951043|NCT01479439|588523651|FG001|Overall Study|Adverse Event|0|||
162951044|NCT01479439|588523652|FG002|Overall Study|Adverse Event|0|||
162951045|NCT01479439|588523650|FG000|Overall Study|Lost to Follow-up|0|||
162951046|NCT01479439|588523651|FG001|Overall Study|Lost to Follow-up|1|||
162951047|NCT01479439|588523652|FG002|Overall Study|Lost to Follow-up|0|||
162951048|NCT01479439|588523650|FG000|Overall Study|Protocol Violation|0|||
162951049|NCT01479439|588523651|FG001|Overall Study|Protocol Violation|0|||
162951050|NCT01479439|588523652|FG002|Overall Study|Protocol Violation|2|||
162951051|NCT02079766|588523656|FG000|Overall Study|Physician Decision|1|||
162951052|NCT02079766|588523657|FG001|Overall Study|Physician Decision|0|||
162951053|NCT02079766|588523656|FG000|Overall Study|Withdrawal by Subject|1|||
162951054|NCT02079766|588523657|FG001|Overall Study|Withdrawal by Subject|0|||
162951055|NCT03018249|588523664|FG000|Overall Study|Withdrawal by Subject|2|||
162951056|NCT03018249|588523665|FG001|Overall Study|Withdrawal by Subject|2|||
162951057|NCT03929393|588523669|FG000|Overall Study|Death|1|||
162951058|NCT03929393|588523670|FG001|Overall Study|Death|0|||
162951059|NCT03929393|588523669|FG000|Overall Study|Time Commitment|2|||
162951060|NCT03929393|588523670|FG001|Overall Study|Time Commitment|5|||
162951061|NCT03929393|588523669|FG000|Overall Study|Motor Vehicle Accident|0|||
162951062|NCT03929393|588523670|FG001|Overall Study|Motor Vehicle Accident|1|||
162951063|NCT03929393|588523669|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
162951064|NCT03929393|588523670|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
162951065|NCT03929393|588523669|FG000|Overall Study|Other|1|||
162951066|NCT03929393|588523670|FG001|Overall Study|Other|3|||
162951067|NCT00694551|588523683|FG000|Overall Study|Disease Progression|1|||
162951068|NCT00694551|588523684|FG001|Overall Study|Disease Progression|0|||
163389823|NCT01372410|590139553|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
162951069|NCT00694551|588523685|FG002|Overall Study|Disease Progression|1|||
162951070|NCT01937390|588523689|FG000|Overall Study|Death|2|||
162951071|NCT01937390|588523689|FG000|Overall Study|Lost to Follow-up|7|||
162951072|NCT01937390|588523689|FG000|Overall Study|Withdrawal by Subject|5|||
162951073|NCT01937390|588523689|FG000|Overall Study|Fail to return|21|||
162951074|NCT02216071|588523690|FG000|Overall Study|Withdrawal by Subject|7|||
162951075|NCT02216071|588523691|FG001|Overall Study|Withdrawal by Subject|2|||
162951076|NCT02216071|588523690|FG000|Overall Study|Lost to Follow-up|3|||
162951077|NCT02216071|588523691|FG001|Overall Study|Lost to Follow-up|3|||
162951078|NCT02216071|588523690|FG000|Overall Study|Protocol Violation|3|||
162951079|NCT02216071|588523691|FG001|Overall Study|Protocol Violation|5|||
162951080|NCT02216071|588523690|FG000|Overall Study|Other|2|||
162951081|NCT02216071|588523691|FG001|Overall Study|Other|2|||
162951082|NCT03544138|588523692|FG000|Overall Study|Lost to Follow-up|29|||
162951083|NCT01706536|588523693|FG000|Overall Study|Withdrawal by Subject|1|||
162951084|NCT01706536|588523694|FG001|Overall Study|Withdrawal by Subject|0|||
162951085|NCT01706536|588523695|FG002|Overall Study|Withdrawal by Subject|1|||
162951086|NCT01706536|588523696|FG003|Overall Study|Withdrawal by Subject|0|||
162951087|NCT01706536|588523697|FG004|Overall Study|Withdrawal by Subject|0|||
162951088|NCT01706536|588523693|FG000|Overall Study|Adverse Event|2|||
162951089|NCT01706536|588523694|FG001|Overall Study|Adverse Event|3|||
162951090|NCT01706536|588523695|FG002|Overall Study|Adverse Event|4|||
162951091|NCT01706536|588523696|FG003|Overall Study|Adverse Event|3|||
162951092|NCT01706536|588523697|FG004|Overall Study|Adverse Event|2|||
162951093|NCT01706536|588523693|FG000|Overall Study|Lack of Efficacy|1|||
163293677|NCT04707313|589780868|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
163293678|NCT04707313|589780869|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
163293679|NCT04707313|589780870|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163293680|NCT04707313|589780858|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163293681|NCT04707313|589780859|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163293682|NCT04707313|589780860|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162951094|NCT01706536|588523694|FG001|Overall Study|Lack of Efficacy|0|||
162951095|NCT01706536|588523695|FG002|Overall Study|Lack of Efficacy|0|||
162951096|NCT01706536|588523696|FG003|Overall Study|Lack of Efficacy|1|||
162951097|NCT01706536|588523697|FG004|Overall Study|Lack of Efficacy|0|||
162951098|NCT01706536|588523693|FG000|Overall Study|non compliance|0|||
162951099|NCT01706536|588523694|FG001|Overall Study|non compliance|1|||
162951100|NCT01706536|588523695|FG002|Overall Study|non compliance|0|||
162951101|NCT01706536|588523696|FG003|Overall Study|non compliance|0|||
162951102|NCT01706536|588523697|FG004|Overall Study|non compliance|0|||
162951103|NCT04753437|588523700|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
162951104|NCT04753437|588523701|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
162951105|NCT04753437|588523700|FG000|Overall Study|Liver Function Test Abnormalities|2|||
162951106|NCT04753437|588523701|FG001|Overall Study|Liver Function Test Abnormalities|4|||
162951107|NCT00385684|588523704|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
162951108|NCT00385684|588523705|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
162951109|NCT00385684|588523704|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
162951110|NCT00385684|588523705|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
162951111|NCT00385684|588523704|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
162951112|NCT00385684|588523705|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
162951113|NCT00463606|588523706|FG000|Overall Study|Adverse Event|21|||
162951114|NCT00463606|588523707|FG001|Overall Study|Adverse Event|18|||
162951115|NCT00463606|588523708|FG002|Overall Study|Adverse Event|11|||
163293683|NCT04707313|589780861|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163293684|NCT04707313|589780862|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163293685|NCT04707313|589780863|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163293686|NCT04707313|589780864|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163293687|NCT04707313|589780865|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162951116|NCT00463606|588523706|FG000|Overall Study|Withdrawal by Subject|11|||
162951117|NCT00463606|588523707|FG001|Overall Study|Withdrawal by Subject|11|||
162951118|NCT00463606|588523708|FG002|Overall Study|Withdrawal by Subject|5|||
163293688|NCT04707313|589780866|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162951119|NCT00463606|588523706|FG000|Overall Study|Lost to Follow-up|2|||
162951120|NCT00463606|588523707|FG001|Overall Study|Lost to Follow-up|2|||
162951121|NCT00463606|588523708|FG002|Overall Study|Lost to Follow-up|3|||
162951122|NCT00463606|588523706|FG000|Overall Study|Subject noncompliance|1|||
162951123|NCT00463606|588523707|FG001|Overall Study|Subject noncompliance|1|||
163389824|NCT01372410|590139554|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
163389825|NCT01372410|590139555|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
163389826|NCT01372410|590139556|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
163389827|NCT01372410|590139557|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
163389828|NCT01372410|590139550|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
163389829|NCT01372410|590139551|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
163389830|NCT01372410|590139552|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
163389831|NCT01372410|590139553|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
163389832|NCT01372410|590139554|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
163389833|NCT01372410|590139555|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
163389834|NCT01372410|590139556|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
163389835|NCT01372410|590139557|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
163389836|NCT01372410|590139550|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
163389837|NCT01372410|590139551|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
163389838|NCT01372410|590139552|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
163389839|NCT01372410|590139553|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
163389840|NCT01372410|590139554|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
163389841|NCT01372410|590139555|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
163389842|NCT01372410|590139556|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
163389843|NCT01372410|590139557|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
163389844|NCT01372410|590139550|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
163389845|NCT01372410|590139551|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
163389846|NCT01372410|590139552|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
163389847|NCT01372410|590139553|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
163389848|NCT01372410|590139554|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
163389849|NCT01372410|590139555|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
163389850|NCT01372410|590139556|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
163389851|NCT01372410|590139557|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
163389852|NCT04585646|590139558|FG000|First Intervention|Physician Decision|1|||
163389853|NCT04585646|590139559|FG001|First Intervention|Physician Decision|0|||
163389854|NCT04585646|590139558|FG000|First Intervention|Lost to Follow-up|0|||
163389855|NCT04585646|590139559|FG001|First Intervention|Lost to Follow-up|3|||
163389856|NCT04585646|590139558|FG000|First Intervention|Withdrawal by Subject|0|||
163389857|NCT04585646|590139559|FG001|First Intervention|Withdrawal by Subject|1|||
163389858|NCT04614662|590139560|FG000|Overall Study|Withdrawal by Subject|0|||
163389859|NCT04614662|590139561|FG001|Overall Study|Withdrawal by Subject|1|||
163293689|NCT04707313|589780867|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
163293690|NCT04707313|589780868|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
163293691|NCT04707313|589780869|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
163293692|NCT04707313|589780870|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
163293693|NCT04707313|589780858|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
163293694|NCT04707313|589780859|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
163293695|NCT04707313|589780860|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
163293696|NCT04707313|589780861|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
163293697|NCT04707313|589780862|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
163293698|NCT04707313|589780863|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
163293699|NCT04707313|589780864|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
163293700|NCT04707313|589780865|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
163293701|NCT04707313|589780866|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
163293702|NCT04707313|589780867|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
163293703|NCT04707313|589780868|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
163293704|NCT04707313|589780869|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
163293705|NCT04707313|589780870|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
163293706|NCT04707313|589780858|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163293707|NCT04707313|589780859|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163293708|NCT04707313|589780860|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163293709|NCT04707313|589780861|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163293710|NCT04707313|589780862|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163293711|NCT04707313|589780863|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163293712|NCT04707313|589780864|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163293713|NCT04707313|589780865|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163293714|NCT04707313|589780866|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163293715|NCT04707313|589780867|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
163293716|NCT04707313|589780868|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
163293717|NCT04707313|589780869|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163293718|NCT04707313|589780870|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163293719|NCT04707313|589780858|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163293720|NCT04707313|589780859|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163293721|NCT04707313|589780860|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163293722|NCT04707313|589780861|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163293723|NCT04707313|589780862|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163293724|NCT04707313|589780863|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163293725|NCT04707313|589780864|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163293726|NCT04707313|589780865|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163293727|NCT04707313|589780866|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163293728|NCT04707313|589780867|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
163293729|NCT04707313|589780868|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
163293730|NCT04707313|589780869|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
163293731|NCT04707313|589780870|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
163293732|NCT02459899|589780871|FG000|Overall Study|Adverse Event|1|||
163293733|NCT02459899|589780872|FG001|Overall Study|Adverse Event|1|||
163293734|NCT02459899|589780873|FG002|Overall Study|Adverse Event|0|||
163293735|NCT02459899|589780874|FG003|Overall Study|Adverse Event|0|||
163293736|NCT02459899|589780871|FG000|Overall Study|Lost to Follow-up|1|||
163293737|NCT02459899|589780872|FG001|Overall Study|Lost to Follow-up|2|||
163293738|NCT02459899|589780873|FG002|Overall Study|Lost to Follow-up|0|||
163293739|NCT02459899|589780874|FG003|Overall Study|Lost to Follow-up|1|||
163293740|NCT02459899|589780871|FG000|Overall Study|Non-compliance with the treatment|0|||
163293741|NCT02459899|589780872|FG001|Overall Study|Non-compliance with the treatment|0|||
163293742|NCT02459899|589780873|FG002|Overall Study|Non-compliance with the treatment|0|||
163293743|NCT02459899|589780874|FG003|Overall Study|Non-compliance with the treatment|1|||
163293744|NCT02459899|589780871|FG000|Overall Study|Withdrawal by Subject|1|||
163293745|NCT02459899|589780872|FG001|Overall Study|Withdrawal by Subject|3|||
163293746|NCT02459899|589780873|FG002|Overall Study|Withdrawal by Subject|0|||
162951124|NCT00463606|588523708|FG002|Overall Study|Subject noncompliance|0|||
162951125|NCT00463606|588523706|FG000|Overall Study|Subject moved out of town|1|||
162951126|NCT00463606|588523707|FG001|Overall Study|Subject moved out of town|0|||
162951127|NCT00463606|588523708|FG002|Overall Study|Subject moved out of town|0|||
162951128|NCT00463606|588523706|FG000|Overall Study|Physician Decision|0|||
162951129|NCT00463606|588523707|FG001|Overall Study|Physician Decision|1|||
162951130|NCT00463606|588523708|FG002|Overall Study|Physician Decision|0|||
162951131|NCT00463606|588523706|FG000|Overall Study|Sponsor request|0|||
162951132|NCT00463606|588523707|FG001|Overall Study|Sponsor request|1|||
162951133|NCT00463606|588523708|FG002|Overall Study|Sponsor request|0|||
162951134|NCT00463606|588523706|FG000|Overall Study|Exclusion criteria violation|2|||
162951135|NCT00463606|588523707|FG001|Overall Study|Exclusion criteria violation|0|||
162951136|NCT00463606|588523708|FG002|Overall Study|Exclusion criteria violation|0|||
162951137|NCT00463606|588523706|FG000|Overall Study|Coordinator error|1|||
162951138|NCT00463606|588523707|FG001|Overall Study|Coordinator error|0|||
162951139|NCT00463606|588523708|FG002|Overall Study|Coordinator error|0|||
162951140|NCT00463606|588523706|FG000|Overall Study|Patient randomized in error|1|||
162951141|NCT00463606|588523707|FG001|Overall Study|Patient randomized in error|0|||
162951142|NCT00463606|588523708|FG002|Overall Study|Patient randomized in error|0|||
162951143|NCT00463606|588523706|FG000|Overall Study|Participation in another ABT-335 trial|1|||
162951144|NCT00463606|588523707|FG001|Overall Study|Participation in another ABT-335 trial|0|||
162951145|NCT00463606|588523708|FG002|Overall Study|Participation in another ABT-335 trial|0|||
162951146|NCT00463606|588523706|FG000|Overall Study|Protocol Violation|0|||
162951147|NCT00463606|588523707|FG001|Overall Study|Protocol Violation|0|||
162951148|NCT00463606|588523708|FG002|Overall Study|Protocol Violation|1|||
162951149|NCT02682602|588523710|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
162951150|NCT02682602|588523711|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
162951151|NCT02682602|588523710|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
162951152|NCT02682602|588523711|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
162951153|NCT03567174|588523712|FG000|Overall Study|Death|24|||
162951154|NCT03567174|588523713|FG001|Overall Study|Death|31|||
162951155|NCT03567174|588523712|FG000|Overall Study|Lost to Follow-up|165|||
162951156|NCT03567174|588523713|FG001|Overall Study|Lost to Follow-up|174|||
162951157|NCT02140060|588523714|FG000|Overall Study|Adverse Event|0|||
162951158|NCT02140060|588523715|FG001|Overall Study|Adverse Event|0|||
162951159|NCT02140060|588523716|FG002|Overall Study|Adverse Event|0|||
162951160|NCT02140060|588523717|FG003|Overall Study|Adverse Event|1|||
162951161|NCT02140060|588523718|FG004|Overall Study|Adverse Event|1|||
162951162|NCT02140060|588523719|FG005|Overall Study|Adverse Event|1|||
162951163|NCT02140060|588523714|FG000|Overall Study|Lack of Efficacy|0|||
162951164|NCT02140060|588523715|FG001|Overall Study|Lack of Efficacy|0|||
162951165|NCT02140060|588523716|FG002|Overall Study|Lack of Efficacy|0|||
162951166|NCT02140060|588523717|FG003|Overall Study|Lack of Efficacy|1|||
162951167|NCT02140060|588523718|FG004|Overall Study|Lack of Efficacy|0|||
162951168|NCT02140060|588523719|FG005|Overall Study|Lack of Efficacy|0|||
162951169|NCT02158936|588523720|FG000|Overall Study|Study closed/ terminated|57|||
162951170|NCT02158936|588523721|FG001|Overall Study|Study closed/ terminated|77|||
162951171|NCT02158936|588523720|FG000|Overall Study|Azacitidine tx discontinued|53|||
162951172|NCT02158936|588523721|FG001|Overall Study|Azacitidine tx discontinued|46|||
162951173|NCT02158936|588523720|FG000|Overall Study|Adverse Event|39|||
162951174|NCT02158936|588523721|FG001|Overall Study|Adverse Event|24|||
162951175|NCT02158936|588523720|FG000|Overall Study|Withdrawal by Subject|15|||
162951176|NCT02158936|588523721|FG001|Overall Study|Withdrawal by Subject|16|||
162951177|NCT02158936|588523720|FG000|Overall Study|Physician Decision|15|||
162951178|NCT02158936|588523721|FG001|Overall Study|Physician Decision|13|||
162951179|NCT02158936|588523720|FG000|Overall Study|Lost to Follow-up|0|||
162951180|NCT02158936|588523721|FG001|Overall Study|Lost to Follow-up|1|||
162951181|NCT01066143|588525331|FG000|Overall Study|ineligible for the study|8|||
162951182|NCT05376319|588525332|FG000|Overall Study|Funding termination|2|||
163389860|NCT01862640|590139568|FG000|Overall Study|Adverse Event|4|||
163389861|NCT01862640|590139569|FG001|Overall Study|Adverse Event|10|||
163389862|NCT01862640|590139570|FG002|Overall Study|Adverse Event|6|||
163389863|NCT01862640|590139571|FG003|Overall Study|Adverse Event|8|||
163389864|NCT01862640|590139568|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
163389865|NCT01862640|590139569|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
163389866|NCT01862640|590139570|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
163389867|NCT01862640|590139571|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
162951183|NCT05376319|588525333|FG001|Overall Study|Funding termination|4|||
162951184|NCT01340495|588525334|FG000|Overall Study|Withdrawal by Subject|1|||
162951185|NCT03497897|588525335|FG000|Overall Study|Adverse Event|1|||
162951186|NCT03497897|588525336|FG001|Overall Study|Adverse Event|1|||
162951187|NCT03497897|588525337|FG002|Overall Study|Adverse Event|1|||
162951188|NCT03497897|588525335|FG000|Overall Study|Lost to Follow-up|2|||
162951189|NCT03497897|588525336|FG001|Overall Study|Lost to Follow-up|0|||
162951190|NCT03497897|588525337|FG002|Overall Study|Lost to Follow-up|2|||
162951191|NCT03497897|588525335|FG000|Overall Study|Physician Decision|1|||
163389868|NCT01862640|590139568|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
162951192|NCT03497897|588525336|FG001|Overall Study|Physician Decision|0|||
162951193|NCT03497897|588525337|FG002|Overall Study|Physician Decision|0|||
162951194|NCT03497897|588525335|FG000|Overall Study|Subject/Guardian Decision|2|||
162951195|NCT03497897|588525336|FG001|Overall Study|Subject/Guardian Decision|1|||
162951196|NCT03497897|588525337|FG002|Overall Study|Subject/Guardian Decision|3|||
162951197|NCT00723528|588525338|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
162951198|NCT00723528|588525339|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
162951199|NCT00723528|588525340|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
162951200|NCT00723528|588525341|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
162951201|NCT00723528|588525342|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
162951202|NCT00723528|588525343|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
162951203|NCT00723528|588525344|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
162951204|NCT00723528|588525338|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
162951205|NCT00723528|588525339|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
162951206|NCT00723528|588525340|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
162951207|NCT00723528|588525341|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
162951208|NCT00723528|588525342|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
163389869|NCT01862640|590139569|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
163389870|NCT01862640|590139570|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
162951209|NCT00723528|588525343|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
162951210|NCT00723528|588525344|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
162951211|NCT00723528|588525338|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
162951212|NCT00723528|588525339|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
162951213|NCT00723528|588525340|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
162951214|NCT00723528|588525341|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
162951215|NCT00723528|588525342|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
162951216|NCT00723528|588525343|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
162951217|NCT00723528|588525344|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
162951218|NCT00723528|588525338|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
162951219|NCT00723528|588525339|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
162951220|NCT00723528|588525340|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
162951221|NCT00723528|588525341|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
162951222|NCT00723528|588525342|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
162951223|NCT00723528|588525343|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
162951224|NCT00723528|588525344|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
162951225|NCT00723528|588525338|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
162951226|NCT00723528|588525339|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
162951227|NCT00723528|588525340|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
162951228|NCT00723528|588525341|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
162951229|NCT00723528|588525342|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
162951230|NCT00723528|588525343|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
162951231|NCT00723528|588525344|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
162951232|NCT00723528|588525338|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
162951233|NCT00723528|588525339|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
162951234|NCT00723528|588525340|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
162951235|NCT00723528|588525341|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
162951236|NCT00723528|588525342|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
162951237|NCT00723528|588525343|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
162951238|NCT00723528|588525344|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
162951239|NCT00723528|588525338|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
162951240|NCT00723528|588525339|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
162951241|NCT00723528|588525340|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
162951242|NCT00723528|588525341|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
162951243|NCT00723528|588525342|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
162951244|NCT00723528|588525343|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
162951245|NCT00723528|588525344|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
162951246|NCT00723528|588525338|FG000|Period 2: After Controlled Period|Other|0|||
162951247|NCT00723528|588525339|FG001|Period 2: After Controlled Period|Other|0|||
162951248|NCT00723528|588525340|FG002|Period 2: After Controlled Period|Other|0|||
163389871|NCT01862640|590139571|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
162951249|NCT00723528|588525341|FG003|Period 2: After Controlled Period|Other|0|||
162951250|NCT00723528|588525342|FG004|Period 2: After Controlled Period|Other|1|||
162951251|NCT00723528|588525343|FG005|Period 2: After Controlled Period|Other|4|||
162951252|NCT00723528|588525344|FG006|Period 2: After Controlled Period|Other|0|||
162951253|NCT00723528|588525338|FG000|Period 2: After Controlled Period|Adverse Event|0|||
162951254|NCT00723528|588525339|FG001|Period 2: After Controlled Period|Adverse Event|0|||
163188566|NCT02517866|589406114|FG000|Overall Study|Significant Protocol Deviation|4|||
163188567|NCT02517866|589406115|FG001|Overall Study|Significant Protocol Deviation|1|||
163188568|NCT02517866|589406116|FG002|Overall Study|Significant Protocol Deviation|0|||
163188569|NCT02517866|589406114|FG000|Overall Study|Lost to Follow-up|1|||
163188570|NCT02517866|589406115|FG001|Overall Study|Lost to Follow-up|0|||
163188571|NCT02517866|589406116|FG002|Overall Study|Lost to Follow-up|0|||
163188572|NCT02517866|589406114|FG000|Overall Study|Voluntary Withdrawal|2|||
163188573|NCT02517866|589406115|FG001|Overall Study|Voluntary Withdrawal|2|||
163188574|NCT02517866|589406116|FG002|Overall Study|Voluntary Withdrawal|0|||
163188575|NCT02517866|589406114|FG000|Overall Study|Investigator Decision|2|||
163188576|NCT02517866|589406115|FG001|Overall Study|Investigator Decision|1|||
163188577|NCT02517866|589406116|FG002|Overall Study|Investigator Decision|0|||
163188578|NCT02517866|589406114|FG000|Overall Study|Reason not specified|2|||
163188579|NCT02517866|589406115|FG001|Overall Study|Reason not specified|0|||
163188580|NCT02517866|589406116|FG002|Overall Study|Reason not specified|0|||
163188581|NCT03114488|589406117|FG000|Time Period 2|Withdrawal by Subject|1|||
163188582|NCT03114488|589406118|FG001|Time Period 2|Withdrawal by Subject|3|||
163188583|NCT03711266|589406120|FG000|Overall Study|Lost to Follow-up|10|||
163188584|NCT01646073|589406123|FG000|Period A (12 Weeks)|Adverse Event|0|||
163188585|NCT01646073|589406124|FG001|Period A (12 Weeks)|Adverse Event|2|||
163188586|NCT01646073|589406123|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
163188587|NCT01646073|589406124|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
163188588|NCT01646073|589406123|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
163188589|NCT01646073|589406124|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
163188590|NCT01646073|589406123|FG000|Period A (12 Weeks)|Protocol Violation|0|||
163188591|NCT01646073|589406124|FG001|Period A (12 Weeks)|Protocol Violation|1|||
163188592|NCT01646073|589406123|FG000|Period A (12 Weeks)|Other|0|||
163188593|NCT01646073|589406124|FG001|Period A (12 Weeks)|Other|1|||
163188594|NCT01646073|589406123|FG000|Period B (12 Weeks)|Adverse Event|0|||
163188595|NCT01646073|589406124|FG001|Period B (12 Weeks)|Adverse Event|7|||
163188596|NCT01646073|589406123|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
163188597|NCT01646073|589406124|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
163188598|NCT01646073|589406123|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
163188599|NCT01646073|589406124|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
163188600|NCT00679055|589406127|FG000|Overall Study|Adverse Event|0|||
163188601|NCT00679055|589406128|FG001|Overall Study|Adverse Event|1|||
163293747|NCT02459899|589780874|FG003|Overall Study|Withdrawal by Subject|0|||
163293748|NCT00940992|589780875|FG000|Overall Study|Adverse Event|2|||
163293749|NCT00940992|589780876|FG001|Overall Study|Adverse Event|0|||
163293750|NCT00940992|589780877|FG002|Overall Study|Adverse Event|1|||
163293751|NCT00940992|589780875|FG000|Overall Study|subject request|2|||
163293752|NCT00940992|589780876|FG001|Overall Study|subject request|1|||
163293753|NCT00940992|589780877|FG002|Overall Study|subject request|0|||
163293754|NCT00940992|589780875|FG000|Overall Study|Lost to Follow-up|0|||
163293755|NCT00940992|589780876|FG001|Overall Study|Lost to Follow-up|1|||
163293756|NCT00940992|589780877|FG002|Overall Study|Lost to Follow-up|1|||
163293757|NCT03586544|589780878|FG000|First Intervention|Adverse Event|0|||
163293758|NCT03586544|589780879|FG001|First Intervention|Adverse Event|1|||
163293759|NCT03586544|589780878|FG000|Second Intervention|Withdrawal by Subject|0|||
163293760|NCT03586544|589780879|FG001|Second Intervention|Withdrawal by Subject|1|||
163293761|NCT00324038|589780887|FG000|Overall Study|Adverse Event|38|||
163293762|NCT00324038|589780888|FG001|Overall Study|Adverse Event|23|||
163293763|NCT00324038|589780887|FG000|Overall Study|Lack of Efficacy|5|||
163293764|NCT00324038|589780888|FG001|Overall Study|Lack of Efficacy|13|||
163293765|NCT00324038|589780887|FG000|Overall Study|Lost to Follow-up|0|||
163293766|NCT00324038|589780888|FG001|Overall Study|Lost to Follow-up|2|||
163293767|NCT00324038|589780887|FG000|Overall Study|Other|6|||
163293768|NCT00324038|589780888|FG001|Overall Study|Other|13|||
163293769|NCT00361283|589780896|FG000|Overall Study|Lost to Follow-up|27|||
163293770|NCT01837641|589780897|FG000|Overall Study|Sponsor decision|1|||
163293771|NCT01837641|589780898|FG001|Overall Study|Sponsor decision|0|||
163293772|NCT01837641|589780899|FG002|Overall Study|Sponsor decision|0|||
163293773|NCT01837641|589780900|FG003|Overall Study|Sponsor decision|0|||
163293774|NCT01837641|589780901|FG004|Overall Study|Sponsor decision|0|||
163293775|NCT01837641|589780902|FG005|Overall Study|Sponsor decision|1|||
163293776|NCT01837641|589780903|FG006|Overall Study|Sponsor decision|0|||
163293777|NCT01837641|589780904|FG007|Overall Study|Sponsor decision|0|||
163293778|NCT01837641|589780897|FG000|Overall Study|Adverse Event|0|||
163188602|NCT00679055|589406127|FG000|Overall Study|Other|0|||
163188603|NCT00679055|589406128|FG001|Overall Study|Other|3|||
163188604|NCT00679055|589406127|FG000|Overall Study|Study Terminated|2|||
163188605|NCT00679055|589406128|FG001|Overall Study|Study Terminated|1|||
163188606|NCT00629772|589406129|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
163188607|NCT00629772|589406130|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
163293779|NCT01837641|589780898|FG001|Overall Study|Adverse Event|0|||
163293780|NCT01837641|589780899|FG002|Overall Study|Adverse Event|0|||
163293781|NCT01837641|589780900|FG003|Overall Study|Adverse Event|0|||
163293782|NCT01837641|589780901|FG004|Overall Study|Adverse Event|0|||
163293783|NCT01837641|589780902|FG005|Overall Study|Adverse Event|1|||
162951255|NCT00723528|588525340|FG002|Period 2: After Controlled Period|Adverse Event|0|||
162951256|NCT00723528|588525341|FG003|Period 2: After Controlled Period|Adverse Event|0|||
162951257|NCT00723528|588525342|FG004|Period 2: After Controlled Period|Adverse Event|1|||
162951258|NCT00723528|588525343|FG005|Period 2: After Controlled Period|Adverse Event|0|||
162951259|NCT00723528|588525344|FG006|Period 2: After Controlled Period|Adverse Event|1|||
162951260|NCT00723528|588525338|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
162951261|NCT00723528|588525339|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
162951262|NCT00723528|588525340|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
162951263|NCT00723528|588525341|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
162951264|NCT00723528|588525342|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
162951265|NCT00723528|588525343|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
162951266|NCT00723528|588525344|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
163389872|NCT01862640|590139568|FG000|Overall Study|Withdrawal by Subject|2|||
163389873|NCT01862640|590139569|FG001|Overall Study|Withdrawal by Subject|4|||
163389874|NCT01862640|590139570|FG002|Overall Study|Withdrawal by Subject|8|||
163389875|NCT01862640|590139571|FG003|Overall Study|Withdrawal by Subject|5|||
163389876|NCT01862640|590139568|FG000|Overall Study|Protocol Deviation|0|||
163389877|NCT01862640|590139569|FG001|Overall Study|Protocol Deviation|0|||
163389878|NCT01862640|590139570|FG002|Overall Study|Protocol Deviation|1|||
163389879|NCT01862640|590139571|FG003|Overall Study|Protocol Deviation|0|||
163389880|NCT02178553|590139572|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
163389881|NCT02178553|590139573|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
163389882|NCT02178553|590139572|FG000|Overall Study|Physician Decision|0|||
163389883|NCT02178553|590139573|FG001|Overall Study|Physician Decision|4|||
163389884|NCT02178553|590139572|FG000|Overall Study|Technical problem with injection|1|||
163389885|NCT02178553|590139573|FG001|Overall Study|Technical problem with injection|3|||
163389886|NCT05085665|590139574|FG000|Overall Study|Physician Decision|2|||
163389887|NCT03294109|590139575|FG000|Overall Study|Withdrawal by Subject|6|||
163389888|NCT03294109|590139576|FG001|Overall Study|Withdrawal by Subject|5|||
163389889|NCT01717768|590139579|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163389890|NCT01717768|590139580|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
163389891|NCT01717768|590139581|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163389892|NCT01717768|590139582|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163389893|NCT01717768|590139583|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163389894|NCT01717768|590139584|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163389895|NCT01717768|590139585|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163389896|NCT01717768|590139586|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163389897|NCT01717768|590139587|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163389898|NCT01717768|590139588|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163389899|NCT01717768|590139589|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163389900|NCT01717768|590139590|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163389901|NCT01717768|590139579|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163389902|NCT01717768|590139580|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163389903|NCT01717768|590139581|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163389904|NCT01717768|590139582|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163389905|NCT01717768|590139583|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163389906|NCT01717768|590139584|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163389907|NCT01717768|590139585|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163389908|NCT01717768|590139586|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163389909|NCT01717768|590139587|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163188608|NCT00629772|589406129|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
163188609|NCT00629772|589406130|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
163188610|NCT01393301|589406133|FG000|Overall Study|Lost to Follow-up|5|||
163188611|NCT01393301|589406134|FG001|Overall Study|Lost to Follow-up|3|||
163188612|NCT01393301|589406133|FG000|Overall Study|Withdrawal by Subject|2|||
163188613|NCT01393301|589406134|FG001|Overall Study|Withdrawal by Subject|0|||
163188614|NCT01393301|589406133|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
163188615|NCT01393301|589406134|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
163188616|NCT03342963|589406137|FG000|Overall Study|Adverse Event|1|||
163188617|NCT03342963|589406138|FG001|Overall Study|Adverse Event|2|||
163188618|NCT03342963|589406139|FG002|Overall Study|Adverse Event|0|||
163188619|NCT03342963|589406140|FG003|Overall Study|Adverse Event|0|||
163188620|NCT03342963|589406137|FG000|Overall Study|Withdrawal by Subject|1|||
163188621|NCT03342963|589406138|FG001|Overall Study|Withdrawal by Subject|0|||
163188622|NCT03342963|589406139|FG002|Overall Study|Withdrawal by Subject|0|||
163188623|NCT03342963|589406140|FG003|Overall Study|Withdrawal by Subject|0|||
163188624|NCT01309165|589406141|FG000|Overall Study|Lost to Follow-up|4|||
163188625|NCT01309165|589406142|FG001|Overall Study|Lost to Follow-up|3|||
163188626|NCT01309165|589406141|FG000|Overall Study|Return to work|1|||
163188627|NCT01309165|589406142|FG001|Overall Study|Return to work|2|||
163188628|NCT01309165|589406141|FG000|Overall Study|Left country|0|||
163188629|NCT01309165|589406142|FG001|Overall Study|Left country|1|||
163188630|NCT01309165|589406141|FG000|Overall Study|No transportation|0|||
163188631|NCT01309165|589406142|FG001|Overall Study|No transportation|1|||
163188632|NCT01309165|589406141|FG000|Overall Study|Admitted to hospital for second stroke|1|||
163188633|NCT01309165|589406142|FG001|Overall Study|Admitted to hospital for second stroke|0|||
163188634|NCT01739309|589406143|FG000|Overall Study|Adverse Event|1|||
163188635|NCT01739309|589406143|FG000|Overall Study|Withdrawal by Subject|1|||
163188636|NCT00178633|589406144|FG000|Overall Study|Lost to Follow-up|6|||
163188637|NCT04810481|589406146|FG000|Overall Study|Disqualified data sets|10|||
163188638|NCT04810481|589406147|FG001|Overall Study|Disqualified data sets|28|||
163188639|NCT01484132|589406151|FG000|Overall Study|Lost to Follow-up|8|||
163188640|NCT01484132|589406151|FG000|Overall Study|Difficulty with time commitment|2|||
163188641|NCT01484132|589406151|FG000|Overall Study|Ineligible|1|||
163188642|NCT01484132|589406151|FG000|Overall Study|No pre-treatment urine sample collected|1|||
163188643|NCT01484132|589406151|FG000|Overall Study|No post-treatment urine sample collected|10|||
163188644|NCT03538431|589406152|FG000|Overall Study|Physician Decision|0|||
163188645|NCT03538431|589406153|FG001|Overall Study|Physician Decision|1|||
163188646|NCT03538431|589406152|FG000|Overall Study|Withdrawal by Subject|1|||
163188647|NCT03538431|589406153|FG001|Overall Study|Withdrawal by Subject|0|||
163188648|NCT00620464|589406154|FG000|Overall Study|Adverse Event|15|||
163389910|NCT01717768|590139588|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163389911|NCT01717768|590139589|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163389912|NCT01717768|590139590|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
163389913|NCT01717768|590139579|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163389914|NCT01717768|590139580|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163389915|NCT01717768|590139581|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163389916|NCT01717768|590139582|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163389917|NCT01717768|590139583|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163389918|NCT01717768|590139584|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163389919|NCT01717768|590139585|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163389920|NCT01717768|590139586|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
163389921|NCT01717768|590139587|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163188649|NCT00620464|589406155|FG001|Overall Study|Adverse Event|17|||
163389922|NCT01717768|590139588|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163188650|NCT00620464|589406154|FG000|Overall Study|Lost to Follow-up|1|||
163188651|NCT00620464|589406155|FG001|Overall Study|Lost to Follow-up|1|||
163188652|NCT00620464|589406154|FG000|Overall Study|Planning Pregnancy|1|||
163188653|NCT00620464|589406155|FG001|Overall Study|Planning Pregnancy|4|||
163188654|NCT00620464|589406154|FG000|Overall Study|Personal|2|||
163188655|NCT00620464|589406155|FG001|Overall Study|Personal|2|||
163188656|NCT00620464|589406154|FG000|Overall Study|Used prohibited medication|1|||
163188657|NCT00620464|589406155|FG001|Overall Study|Used prohibited medication|0|||
163188658|NCT05394350|589406156|FG000|Overall Study|Death|2|||
163188659|NCT05394350|589406157|FG001|Overall Study|Death|2|||
163188660|NCT05394350|589406158|FG002|Overall Study|Death|4|||
163188661|NCT05394350|589406159|FG003|Overall Study|Death|0|||
163188662|NCT05394350|589406160|FG004|Overall Study|Death|1|||
163188663|NCT05394350|589406161|FG005|Overall Study|Death|0|||
163188664|NCT05394350|589406156|FG000|Overall Study|Study terminated by sponsor|1|||
163188665|NCT05394350|589406157|FG001|Overall Study|Study terminated by sponsor|1|||
163188666|NCT05394350|589406158|FG002|Overall Study|Study terminated by sponsor|7|||
163188667|NCT05394350|589406159|FG003|Overall Study|Study terminated by sponsor|3|||
163188668|NCT05394350|589406160|FG004|Overall Study|Study terminated by sponsor|2|||
163188669|NCT05394350|589406161|FG005|Overall Study|Study terminated by sponsor|4|||
163188670|NCT02024555|589406162|FG000|Overall Study|Lost to Follow-up|1|||
163188671|NCT02024555|589406163|FG001|Overall Study|Lost to Follow-up|1|||
163188672|NCT02024555|589406162|FG000|Overall Study|Withdrawal by Subject|5|||
163188673|NCT02024555|589406163|FG001|Overall Study|Withdrawal by Subject|1|||
163188674|NCT02887859|589406164|FG000|Overall Study|Ongoing|6|||
163188675|NCT02887859|589406164|FG000|Overall Study|Adverse Event|7|||
163188676|NCT02887859|589406164|FG000|Overall Study|Death|1|||
163188677|NCT02887859|589406164|FG000|Overall Study|Physician Decision|1|||
163188678|NCT00492050|589406165|FG000|Overall Study|Adverse Event|1|||
163188679|NCT00492050|589406165|FG000|Overall Study|Lack of Efficacy|1|||
163188680|NCT00492050|589406165|FG000|Overall Study|Withdrawal by Subject|3|||
163188681|NCT00492050|589406165|FG000|Overall Study|Unable to collect SCT|2|||
163188682|NCT00492050|589406165|FG000|Overall Study|Progressive Disease|2|||
163188683|NCT04246372|589407844|FG000|Overall Study|Adverse Event|1|||
163188684|NCT04246372|589407844|FG000|Overall Study|Withdrawal by Subject|1|||
163188685|NCT04246372|589407844|FG000|Overall Study|Protocol Violation|2|||
163188686|NCT04246372|589407844|FG000|Overall Study|Physician Decision|1|||
163188687|NCT00257608|589407846|FG000|Chemotherapy Phase|Adverse Event|138|||
163188688|NCT00257608|589407847|FG001|Chemotherapy Phase|Adverse Event|0|||
163188689|NCT00257608|589407848|FG002|Chemotherapy Phase|Adverse Event|0|||
163188690|NCT00257608|589407846|FG000|Chemotherapy Phase|Disease progression|139|||
163188691|NCT00257608|589407847|FG001|Chemotherapy Phase|Disease progression|0|||
163188692|NCT00257608|589407848|FG002|Chemotherapy Phase|Disease progression|0|||
163188693|NCT00257608|589407846|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
163188694|NCT00257608|589407847|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
163188695|NCT00257608|589407848|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
163188696|NCT00257608|589407846|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
163188697|NCT00257608|589407847|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
163188698|NCT00257608|589407848|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
163188699|NCT00257608|589407846|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
163188700|NCT00257608|589407847|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
163188701|NCT00257608|589407848|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
163188702|NCT00257608|589407846|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
163188703|NCT00257608|589407847|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
163188704|NCT00257608|589407848|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
162951267|NCT00723528|588525338|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
162951268|NCT00723528|588525339|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
162951269|NCT00723528|588525340|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
162951270|NCT00723528|588525341|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
162951271|NCT00723528|588525342|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
162951272|NCT00723528|588525343|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
162951273|NCT00723528|588525344|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
162951274|NCT00667862|588525346|FG000|Overall Study|Adverse Event|9|||
162951275|NCT00667862|588525346|FG000|Overall Study|Death|1|||
162951276|NCT00667862|588525346|FG000|Overall Study|Disease Progression|22|||
162951277|NCT00667862|588525346|FG000|Overall Study|Withdrawal by Subject|3|||
162951278|NCT00667095|588525350|FG000|Overall Study|Withdrawal by Subject|0|||
162951279|NCT00667095|588525351|FG001|Overall Study|Withdrawal by Subject|1|||
162951280|NCT01520909|588525352|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
162951281|NCT01520909|588525353|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
162951282|NCT01520909|588525354|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
162951283|NCT01520909|588525352|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
162951284|NCT01520909|588525353|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
162951285|NCT01520909|588525354|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
162951286|NCT01520909|588525352|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
162951287|NCT01520909|588525353|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
162951288|NCT01520909|588525354|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
162951289|NCT01520909|588525352|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
162951290|NCT01520909|588525353|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
162951291|NCT01520909|588525354|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
162951292|NCT01435265|588525356|FG000|Overall Study|Lost to Follow-up|0|||
162951293|NCT01435265|588525357|FG001|Overall Study|Lost to Follow-up|1|||
162951294|NCT02128997|588525358|FG000|Overall Study|Lost to Follow-up|6|||
162951295|NCT02128997|588525359|FG001|Overall Study|Lost to Follow-up|11|||
162951296|NCT00856388|588525369|FG000|Overall Study|Other|1|||
162951297|NCT05038293|588525370|FG000|Overall Study|device was not operating properly for one subject.|1|||
162951298|NCT05038293|588525371|FG001|Overall Study|device was not operating properly for one subject.|0|||
162951299|NCT05038293|588525370|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
162951300|NCT05038293|588525371|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
162951301|NCT01171989|588525373|FG000|Overall Study|Lost to Follow-up|0|||
162951302|NCT01171989|588525374|FG001|Overall Study|Lost to Follow-up|0|||
162951303|NCT01171989|588525375|FG002|Overall Study|Lost to Follow-up|1|||
162951304|NCT00418184|588525376|FG000|Double-blind Phase|Withdrawal by Subject|22|||
162951305|NCT00418184|588525377|FG001|Double-blind Phase|Withdrawal by Subject|9|||
162951306|NCT00418184|588525376|FG000|Double-blind Phase|Adverse Event|2|||
162951307|NCT00418184|588525377|FG001|Double-blind Phase|Adverse Event|1|||
162951308|NCT00418184|588525376|FG000|Double-blind Phase|Poor compliance|3|||
162951309|NCT00418184|588525377|FG001|Double-blind Phase|Poor compliance|1|||
162951310|NCT00620074|588525379|FG000|Overall Study|Adverse Event|1|||
162951311|NCT04466111|588525384|FG000|Prior to Trial Phase|Physician Decision|1|||
162951312|NCT03553823|588525393|FG000|Overall Study|Physician Decision|0|||
162951313|NCT03553823|588525394|FG001|Overall Study|Physician Decision|1|||
162951314|NCT00893464|588525395|FG000|Overall Study|Did not complete therapy/experience PD|0|||
162951315|NCT00893464|588525396|FG001|Overall Study|Did not complete therapy/experience PD|0|||
163389923|NCT01717768|590139589|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163389924|NCT01717768|590139590|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163389925|NCT01717768|590139579|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
162951316|NCT00893464|588525397|FG002|Overall Study|Did not complete therapy/experience PD|0|||
162951317|NCT00893464|588525398|FG003|Overall Study|Did not complete therapy/experience PD|0|||
162951318|NCT00893464|588525399|FG004|Overall Study|Did not complete therapy/experience PD|0|||
163389926|NCT01717768|590139580|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163188705|NCT00257608|589407846|FG000|Chemotherapy Phase|Physician Decision|28|||
163188706|NCT00257608|589407847|FG001|Chemotherapy Phase|Physician Decision|0|||
163188707|NCT00257608|589407848|FG002|Chemotherapy Phase|Physician Decision|0|||
163188708|NCT00257608|589407846|FG000|Post Chemotherapy Phase|Adverse Event|0|||
163188709|NCT00257608|589407847|FG001|Post Chemotherapy Phase|Adverse Event|34|||
163188710|NCT00257608|589407848|FG002|Post Chemotherapy Phase|Adverse Event|38|||
163188711|NCT00257608|589407846|FG000|Post Chemotherapy Phase|Disease progression|0|||
163188712|NCT00257608|589407847|FG001|Post Chemotherapy Phase|Disease progression|204|||
163188713|NCT00257608|589407848|FG002|Post Chemotherapy Phase|Disease progression|168|||
163188714|NCT00257608|589407846|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
163188715|NCT00257608|589407847|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
163293784|NCT01837641|589780903|FG006|Overall Study|Adverse Event|0|||
163293785|NCT01837641|589780904|FG007|Overall Study|Adverse Event|0|||
163293786|NCT01837641|589780897|FG000|Overall Study|Withdrawal by Subject|0|||
163293787|NCT01837641|589780898|FG001|Overall Study|Withdrawal by Subject|0|||
163293788|NCT01837641|589780899|FG002|Overall Study|Withdrawal by Subject|0|||
163293789|NCT01837641|589780900|FG003|Overall Study|Withdrawal by Subject|0|||
163293790|NCT01837641|589780901|FG004|Overall Study|Withdrawal by Subject|1|||
163293791|NCT01837641|589780902|FG005|Overall Study|Withdrawal by Subject|0|||
163293792|NCT01837641|589780903|FG006|Overall Study|Withdrawal by Subject|1|||
163293793|NCT01837641|589780904|FG007|Overall Study|Withdrawal by Subject|0|||
163293794|NCT01123083|589780911|FG000|Overall Study|Investigator recommendation|1|||
163293795|NCT01123083|589780912|FG001|Overall Study|Investigator recommendation|1|||
163293796|NCT01123083|589780911|FG000|Overall Study|Administrative reasons|0|||
163293797|NCT01123083|589780912|FG001|Overall Study|Administrative reasons|4|||
163293798|NCT01123083|589780911|FG000|Overall Study|Lost to Follow-up|2|||
163293799|NCT01123083|589780912|FG001|Overall Study|Lost to Follow-up|6|||
163293800|NCT01123083|589780911|FG000|Overall Study|Adverse Event|1|||
163293801|NCT01123083|589780912|FG001|Overall Study|Adverse Event|0|||
163293802|NCT01123083|589780911|FG000|Overall Study|Withdrew for another reason not covered|0|||
163293803|NCT01123083|589780912|FG001|Overall Study|Withdrew for another reason not covered|1|||
163293804|NCT01123083|589780911|FG000|Overall Study|Participant/legal representative request|7|||
163293805|NCT01123083|589780912|FG001|Overall Study|Participant/legal representative request|3|||
163293806|NCT00961636|589780913|FG000|Overall Study|Adverse Event|35|||
163293807|NCT00961636|589780914|FG001|Overall Study|Adverse Event|54|||
163293808|NCT00961636|589780915|FG002|Overall Study|Adverse Event|13|||
163293809|NCT00961636|589780913|FG000|Overall Study|Flushing Symptoms|29|||
163293810|NCT00961636|589780914|FG001|Overall Study|Flushing Symptoms|46|||
163293811|NCT00961636|589780915|FG002|Overall Study|Flushing Symptoms|3|||
163293812|NCT00961636|589780913|FG000|Overall Study|Lost to Follow-up|2|||
163293813|NCT00961636|589780914|FG001|Overall Study|Lost to Follow-up|3|||
163293814|NCT00961636|589780915|FG002|Overall Study|Lost to Follow-up|1|||
163293815|NCT00961636|589780913|FG000|Overall Study|Physician Decision|3|||
163293816|NCT00961636|589780914|FG001|Overall Study|Physician Decision|1|||
163293817|NCT00961636|589780915|FG002|Overall Study|Physician Decision|1|||
163293818|NCT00961636|589780913|FG000|Overall Study|Protocol Violation|9|||
163293819|NCT00961636|589780914|FG001|Overall Study|Protocol Violation|5|||
163293820|NCT00961636|589780915|FG002|Overall Study|Protocol Violation|1|||
163293821|NCT00961636|589780913|FG000|Overall Study|Withdrawal by Subject|29|||
163293822|NCT00961636|589780914|FG001|Overall Study|Withdrawal by Subject|22|||
163293823|NCT00961636|589780915|FG002|Overall Study|Withdrawal by Subject|13|||
163293824|NCT00290706|589780916|FG000|Overall Study|Withdrawal by Subject|2|||
163293825|NCT00290706|589780917|FG001|Overall Study|Withdrawal by Subject|0|||
163293826|NCT00290706|589780918|FG002|Overall Study|Withdrawal by Subject|0|||
163293827|NCT00290706|589780919|FG003|Overall Study|Withdrawal by Subject|0|||
163293828|NCT00290706|589780916|FG000|Overall Study|Progressive Disease|3|||
163293829|NCT00290706|589780917|FG001|Overall Study|Progressive Disease|5|||
163293830|NCT00290706|589780918|FG002|Overall Study|Progressive Disease|4|||
163293831|NCT00290706|589780919|FG003|Overall Study|Progressive Disease|10|||
163293832|NCT00290706|589780916|FG000|Overall Study|Adverse Event|0|||
163293833|NCT00290706|589780917|FG001|Overall Study|Adverse Event|1|||
163293834|NCT00290706|589780918|FG002|Overall Study|Adverse Event|2|||
163293835|NCT00290706|589780919|FG003|Overall Study|Adverse Event|0|||
163293836|NCT00290706|589780916|FG000|Overall Study|Receive auto transplant or radiation|0|||
163293837|NCT00290706|589780917|FG001|Overall Study|Receive auto transplant or radiation|0|||
163293838|NCT00290706|589780918|FG002|Overall Study|Receive auto transplant or radiation|0|||
163293839|NCT00290706|589780919|FG003|Overall Study|Receive auto transplant or radiation|1|||
163293840|NCT00290706|589780916|FG000|Overall Study|Physician Decision|0|||
163293841|NCT00290706|589780917|FG001|Overall Study|Physician Decision|0|||
163293842|NCT00290706|589780918|FG002|Overall Study|Physician Decision|0|||
163293843|NCT00290706|589780919|FG003|Overall Study|Physician Decision|1|||
163293844|NCT01196429|589780923|FG000|Overall Study|Ineligible - inadequate pathology|1|||
163293845|NCT01196429|589780924|FG001|Overall Study|Ineligible - inadequate pathology|0|||
163293846|NCT01196429|589780923|FG000|Overall Study|Ineligible - wrong cell type|1|||
163389927|NCT01717768|590139581|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163389928|NCT01717768|590139582|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163389929|NCT01717768|590139583|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163389930|NCT01717768|590139584|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163389931|NCT01717768|590139585|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163389932|NCT01717768|590139586|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163389933|NCT01717768|590139587|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163389934|NCT01717768|590139588|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
163389935|NCT01717768|590139589|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163389936|NCT01717768|590139590|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163389937|NCT00448435|590139591|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
163389938|NCT00448435|590139592|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
163389939|NCT02804178|590139597|FG000|Overall Study|Adverse Event|1|||
163389940|NCT00412971|590139598|FG000|Overall Study|Lost to Follow-up|17|||
163389941|NCT00412971|590139599|FG001|Overall Study|Lost to Follow-up|9|||
163389942|NCT00412971|590139598|FG000|Overall Study|Protocol Violation|13|||
163389943|NCT00412971|590139599|FG001|Overall Study|Protocol Violation|1|||
163389944|NCT01387230|590139600|FG000|Overall Study|Adverse Event|0|||
163389945|NCT01387230|590139601|FG001|Overall Study|Adverse Event|1|||
163389946|NCT01387230|590139602|FG002|Overall Study|Adverse Event|3|||
163389947|NCT01387230|590139600|FG000|Overall Study|Lack of Efficacy|8|||
163389948|NCT01387230|590139601|FG001|Overall Study|Lack of Efficacy|5|||
163389949|NCT01387230|590139602|FG002|Overall Study|Lack of Efficacy|4|||
163389950|NCT01387230|590139600|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
163389951|NCT01387230|590139601|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
163389952|NCT01387230|590139602|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
163389953|NCT01387230|590139600|FG000|Overall Study|Lost to Follow-up|0|||
163389954|NCT01387230|590139601|FG001|Overall Study|Lost to Follow-up|0|||
163389955|NCT01387230|590139602|FG002|Overall Study|Lost to Follow-up|1|||
163389956|NCT01387230|590139600|FG000|Overall Study|Withdrawal by Subject|4|||
163389957|NCT01387230|590139601|FG001|Overall Study|Withdrawal by Subject|1|||
163389958|NCT01387230|590139602|FG002|Overall Study|Withdrawal by Subject|0|||
163389959|NCT01163721|590139603|FG000|Overall Study|Adverse Event|5|||
163389960|NCT01163721|590139604|FG001|Overall Study|Adverse Event|6|||
163389961|NCT01163721|590139603|FG000|Overall Study|Withdrawal by Subject|3|||
163389962|NCT01163721|590139604|FG001|Overall Study|Withdrawal by Subject|4|||
163389963|NCT01163721|590139603|FG000|Overall Study|Lost to Follow-up|0|||
163389964|NCT01163721|590139604|FG001|Overall Study|Lost to Follow-up|1|||
163389965|NCT01163721|590139603|FG000|Overall Study|Physician Decision|0|||
163389966|NCT01163721|590139604|FG001|Overall Study|Physician Decision|1|||
163389967|NCT01050205|590139610|FG000|Overall Study|Lost to Follow-up|7|||
163389968|NCT01050205|590139611|FG001|Overall Study|Lost to Follow-up|1|||
163389969|NCT01050205|590139610|FG000|Overall Study|Withdrawal by Subject|1|||
163389970|NCT01050205|590139611|FG001|Overall Study|Withdrawal by Subject|1|||
163389971|NCT01050205|590139610|FG000|Overall Study|Relocated from area|1|||
163389972|NCT01050205|590139611|FG001|Overall Study|Relocated from area|2|||
163389973|NCT01050205|590139610|FG000|Overall Study|Discontinued Intervention|2|||
163389974|NCT01050205|590139611|FG001|Overall Study|Discontinued Intervention|0|||
163389975|NCT00364156|590139612|FG000|Overall Study|Withdrawal by Subject|73|||
163389976|NCT00364156|590139613|FG001|Overall Study|Withdrawal by Subject|80|||
163389977|NCT00364156|590139612|FG000|Overall Study|Protocol Violation|6|||
163389978|NCT00364156|590139613|FG001|Overall Study|Protocol Violation|1|||
163389979|NCT01472380|590139614|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
163389980|NCT01472380|590139614|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
163389981|NCT01295281|590139615|FG000|First Intervention (7 Days)|Death|0|||
163389982|NCT01295281|590139616|FG001|First Intervention (7 Days)|Death|1|||
163389983|NCT00292461|590139617|FG000|Overall Study|Adverse Event|4|||
163389984|NCT00292461|590139618|FG001|Overall Study|Adverse Event|2|||
163389985|NCT00292461|590139617|FG000|Overall Study|Lack of Efficacy|1|||
162951319|NCT00893464|588525400|FG005|Overall Study|Did not complete therapy/experience PD|0|||
162951320|NCT00893464|588525401|FG006|Overall Study|Did not complete therapy/experience PD|2|||
162951321|NCT00893464|588525402|FG007|Overall Study|Did not complete therapy/experience PD|2|||
162951322|NCT03450070|588525403|FG000|Overall Study|Withdrawal by Subject|8|||
162951323|NCT02910037|588525406|FG000|Overall Study|Withdrawal by Subject|4|||
162951324|NCT02910037|588525406|FG000|Overall Study|Lost to Follow-up|6|||
162951325|NCT00813293|588525409|FG000|Overall Study|Intercurrent illness|1|||
162951326|NCT00813293|588525410|FG001|Overall Study|Intercurrent illness|0|||
162951327|NCT00813293|588525409|FG000|Overall Study|Adverse Event|0|||
162951328|NCT00813293|588525410|FG001|Overall Study|Adverse Event|1|||
162951329|NCT02794974|588525411|FG000|Overall Study|Physician Decision|0|||
162951330|NCT02794974|588525412|FG001|Overall Study|Physician Decision|1|||
162951331|NCT00533273|588525415|FG000|Double-blind|Withdrew consent|0|||
162951332|NCT00533273|588525416|FG001|Double-blind|Withdrew consent|2|||
162951333|NCT00533273|588525415|FG000|Open-label|Withdrawal by Subject|6|||
162951334|NCT00533273|588525416|FG001|Open-label|Withdrawal by Subject|0|||
162951335|NCT00454909|588525417|FG000|Overall Study|Withdrawal by Subject|1|||
162951336|NCT00454909|588525418|FG001|Overall Study|Withdrawal by Subject|0|||
162951337|NCT00454909|588525419|FG002|Overall Study|Withdrawal by Subject|0|||
162951338|NCT00454909|588525417|FG000|Overall Study|Migrated/moved from study area|0|||
162951339|NCT00454909|588525418|FG001|Overall Study|Migrated/moved from study area|0|||
162951340|NCT00454909|588525419|FG002|Overall Study|Migrated/moved from study area|1|||
162951341|NCT00454909|588525417|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
162951342|NCT00454909|588525418|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
162951343|NCT00454909|588525419|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
162951344|NCT00454909|588525417|FG000|Overall Study|Others|1|||
162951345|NCT00454909|588525418|FG001|Overall Study|Others|0|||
162951346|NCT00454909|588525419|FG002|Overall Study|Others|0|||
162951347|NCT03752528|588525420|FG000|Part A|Lost to Follow-up|1|||
162951348|NCT03752528|588525420|FG000|Part A|Protocol Violation|1|||
162951349|NCT03752528|588525420|FG000|Part B|Protocol Violation|1|||
162951350|NCT03752528|588525420|FG000|Part B|Study terminated by sponsor|3|||
163389986|NCT00292461|590139618|FG001|Overall Study|Lack of Efficacy|0|||
163389987|NCT00292461|590139617|FG000|Overall Study|Withdrawal by Subject|0|||
163389988|NCT00292461|590139618|FG001|Overall Study|Withdrawal by Subject|1|||
163389989|NCT00292461|590139617|FG000|Overall Study|Protocol Violation|4|||
163389990|NCT00292461|590139618|FG001|Overall Study|Protocol Violation|3|||
162951351|NCT01981720|588525421|FG000|Overall Study|Adverse Event|1|||
162951352|NCT01981720|588525421|FG000|Overall Study|Withdrawal by Subject|3|||
162951353|NCT01981720|588525421|FG000|Overall Study|Pregnancy|1|||
162951354|NCT02549092|588525423|FG000|Treatment Period|Adverse Event|2|||
162951355|NCT02549092|588525424|FG001|Treatment Period|Adverse Event|2|||
162951356|NCT02549092|588525423|FG000|Treatment Period|Withdrawal by Subject|1|||
162951357|NCT02549092|588525424|FG001|Treatment Period|Withdrawal by Subject|3|||
162951358|NCT02549092|588525423|FG000|Treatment Period|Lack of Efficacy|0|||
162951359|NCT02549092|588525424|FG001|Treatment Period|Lack of Efficacy|2|||
163389991|NCT00292461|590139617|FG000|Overall Study|Lost to Follow-up|1|||
163389992|NCT00292461|590139618|FG001|Overall Study|Lost to Follow-up|0|||
163188716|NCT00257608|589407848|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
163188717|NCT00257608|589407846|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
163188718|NCT00257608|589407847|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
163188719|NCT00257608|589407848|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
163188720|NCT00257608|589407846|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
163188721|NCT00257608|589407847|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
163188722|NCT00257608|589407848|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
163188723|NCT00257608|589407846|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
163188724|NCT00257608|589407847|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
163188725|NCT00257608|589407848|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
163389993|NCT00633061|590139619|FG000|Overall Study|Study closed|86|||
163389994|NCT00633061|590139620|FG001|Overall Study|Study closed|0|||
163389995|NCT02708095|590139621|FG000|Overall Study|Adverse Event|4|||
163389996|NCT02708095|590139622|FG001|Overall Study|Adverse Event|10|||
163389997|NCT02708095|590139623|FG002|Overall Study|Adverse Event|11|||
163389998|NCT02708095|590139621|FG000|Overall Study|Lack of Efficacy|9|||
163389999|NCT02708095|590139622|FG001|Overall Study|Lack of Efficacy|3|||
163390000|NCT02708095|590139623|FG002|Overall Study|Lack of Efficacy|0|||
163390001|NCT02708095|590139621|FG000|Overall Study|Lost to Follow-up|2|||
163390002|NCT02708095|590139622|FG001|Overall Study|Lost to Follow-up|0|||
163390003|NCT02708095|590139623|FG002|Overall Study|Lost to Follow-up|0|||
163390004|NCT02708095|590139621|FG000|Overall Study|Physician Decision|2|||
163390005|NCT02708095|590139622|FG001|Overall Study|Physician Decision|3|||
163390006|NCT02708095|590139623|FG002|Overall Study|Physician Decision|2|||
162951360|NCT02549092|588525423|FG000|Extension/Transition Period|Adverse Event|1|||
163188726|NCT00257608|589407846|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
163188727|NCT00257608|589407847|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
163188728|NCT00257608|589407848|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
163188729|NCT00257608|589407846|FG000|Post Chemotherapy Phase|Physician Decision|0|||
163188730|NCT00257608|589407847|FG001|Post Chemotherapy Phase|Physician Decision|8|||
163188731|NCT00257608|589407848|FG002|Post Chemotherapy Phase|Physician Decision|11|||
163188732|NCT00257608|589407846|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
163188733|NCT00257608|589407847|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
163188734|NCT00257608|589407848|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
163188735|NCT00257608|589407846|FG000|Post Chemotherapy Phase|Not treated|0|||
163188736|NCT00257608|589407847|FG001|Post Chemotherapy Phase|Not treated|4|||
163188737|NCT00257608|589407848|FG002|Post Chemotherapy Phase|Not treated|7|||
163188738|NCT03673046|589407849|FG000|Overall Study|Adverse Event|1|||
163188739|NCT03673046|589407850|FG001|Overall Study|Adverse Event|1|||
163188740|NCT03673046|589407849|FG000|Overall Study|Withdrawal by Subject|8|||
163188741|NCT03673046|589407850|FG001|Overall Study|Withdrawal by Subject|2|||
163188742|NCT01896050|589407851|FG000|Overall Study|Adverse Event|37|||
163188743|NCT01896050|589407852|FG001|Overall Study|Adverse Event|2|||
163188744|NCT01896050|589407851|FG000|Overall Study|Death|1|||
163390007|NCT02708095|590139621|FG000|Overall Study|Protocol Violation|0|||
163390008|NCT02708095|590139622|FG001|Overall Study|Protocol Violation|0|||
163390009|NCT02708095|590139623|FG002|Overall Study|Protocol Violation|1|||
163293847|NCT01196429|589780924|FG001|Overall Study|Ineligible - wrong cell type|0|||
163293848|NCT01196429|589780923|FG000|Overall Study|Refused - Never Treated|1|||
163293849|NCT01196429|589780924|FG001|Overall Study|Refused - Never Treated|0|||
163293850|NCT03768206|589780925|FG000|Overall Study|Lost to Follow-up|2|||
163293851|NCT03768206|589780926|FG001|Overall Study|Lost to Follow-up|1|||
163293852|NCT03768206|589780925|FG000|Overall Study|Withdrawal by Subject|0|||
163293853|NCT03768206|589780926|FG001|Overall Study|Withdrawal by Subject|1|||
163293854|NCT00688519|589780927|FG000|Overall Study|Adverse Event|2|||
163293855|NCT00688519|589780928|FG001|Overall Study|Adverse Event|3|||
163293856|NCT00688519|589780927|FG000|Overall Study|Lost to Follow-up|3|||
163293857|NCT00688519|589780928|FG001|Overall Study|Lost to Follow-up|3|||
163293858|NCT00688519|589780927|FG000|Overall Study|Lack of Efficacy|3|||
163390010|NCT02708095|590139621|FG000|Overall Study|Withdrawal by Subject|5|||
163188745|NCT01896050|589407852|FG001|Overall Study|Death|0|||
163188746|NCT00392015|589407854|FG000|Overall Study|Lost to Follow-up|2|||
163188747|NCT00392015|589407855|FG001|Overall Study|Lost to Follow-up|0|||
163188748|NCT00392015|589407856|FG002|Overall Study|Lost to Follow-up|2|||
163188749|NCT00392015|589407857|FG003|Overall Study|Lost to Follow-up|1|||
163188750|NCT00392015|589407858|FG004|Overall Study|Lost to Follow-up|1|||
163188751|NCT00392015|589407859|FG005|Overall Study|Lost to Follow-up|0|||
163188752|NCT00392015|589407854|FG000|Overall Study|Withdrawal by Subject|0|||
163188753|NCT00392015|589407855|FG001|Overall Study|Withdrawal by Subject|0|||
163188754|NCT00392015|589407856|FG002|Overall Study|Withdrawal by Subject|2|||
163188755|NCT00392015|589407857|FG003|Overall Study|Withdrawal by Subject|0|||
163188756|NCT00392015|589407858|FG004|Overall Study|Withdrawal by Subject|0|||
163188757|NCT00392015|589407859|FG005|Overall Study|Withdrawal by Subject|0|||
163188758|NCT00392015|589407854|FG000|Overall Study|Adverse Event|0|||
163188759|NCT00392015|589407855|FG001|Overall Study|Adverse Event|0|||
163188760|NCT00392015|589407856|FG002|Overall Study|Adverse Event|0|||
163188761|NCT00392015|589407857|FG003|Overall Study|Adverse Event|0|||
163188762|NCT00392015|589407858|FG004|Overall Study|Adverse Event|1|||
163188763|NCT00392015|589407859|FG005|Overall Study|Adverse Event|0|||
163188764|NCT00392015|589407854|FG000|Overall Study|Previous trial recipient|0|||
163188765|NCT00392015|589407855|FG001|Overall Study|Previous trial recipient|0|||
163188766|NCT00392015|589407856|FG002|Overall Study|Previous trial recipient|0|||
163188767|NCT00392015|589407857|FG003|Overall Study|Previous trial recipient|0|||
163188768|NCT00392015|589407858|FG004|Overall Study|Previous trial recipient|1|||
163188769|NCT00392015|589407859|FG005|Overall Study|Previous trial recipient|0|||
163188770|NCT03693300|589407860|FG000|Overall Study|Withdrawal by Subject|6|||
163188771|NCT03693300|589407861|FG001|Overall Study|Withdrawal by Subject|0|||
163188772|NCT03693300|589407860|FG000|Overall Study|Death|50|||
163188773|NCT03693300|589407861|FG001|Overall Study|Death|2|||
163188774|NCT03693300|589407860|FG000|Overall Study|Lost to Follow-up|2|||
163188775|NCT03693300|589407861|FG001|Overall Study|Lost to Follow-up|0|||
163188776|NCT02742441|589407862|FG000|Overall Study|Lost to Follow-up|4|||
163188777|NCT02742441|589407863|FG001|Overall Study|Lost to Follow-up|4|||
163188778|NCT02742441|589407862|FG000|Overall Study|Withdrawal by Subject|2|||
163188779|NCT02742441|589407863|FG001|Overall Study|Withdrawal by Subject|2|||
163188780|NCT02742441|589407862|FG000|Overall Study|Adverse Event|0|||
163188781|NCT02742441|589407863|FG001|Overall Study|Adverse Event|2|||
163188782|NCT00537238|589407864|FG000|Overall Study|Death|1|||
163188783|NCT00537238|589407865|FG001|Overall Study|Death|2|||
163188784|NCT00537238|589407864|FG000|Overall Study|Adverse Event|31|||
163188785|NCT00537238|589407865|FG001|Overall Study|Adverse Event|22|||
163188786|NCT00537238|589407864|FG000|Overall Study|Lack of Efficacy|20|||
163188787|NCT00537238|589407865|FG001|Overall Study|Lack of Efficacy|21|||
163188788|NCT00537238|589407864|FG000|Overall Study|Lost to Follow-up|12|||
163188789|NCT00537238|589407865|FG001|Overall Study|Lost to Follow-up|8|||
163188790|NCT00537238|589407864|FG000|Overall Study|Withdrawal by Subject|51|||
163188791|NCT00537238|589407865|FG001|Overall Study|Withdrawal by Subject|47|||
163188792|NCT00537238|589407864|FG000|Overall Study|Protocol Violation|15|||
163188793|NCT00537238|589407865|FG001|Overall Study|Protocol Violation|19|||
163188794|NCT00537238|589407864|FG000|Overall Study|Does not meet entrance criteria|0|||
163188795|NCT00537238|589407865|FG001|Overall Study|Does not meet entrance criteria|2|||
163188796|NCT00537238|589407864|FG000|Overall Study|Other|44|||
163188797|NCT00537238|589407865|FG001|Overall Study|Other|52|||
163188798|NCT01824342|589407868|FG000|Overall Study|Withdrawal by Subject|0|||
163188799|NCT01824342|589407869|FG001|Overall Study|Withdrawal by Subject|3|||
163293859|NCT00688519|589780928|FG001|Overall Study|Lack of Efficacy|1|||
163293860|NCT00688519|589780927|FG000|Overall Study|Withdrawal by Subject|7|||
163293861|NCT00688519|589780928|FG001|Overall Study|Withdrawal by Subject|6|||
163188800|NCT01824342|589407868|FG000|Overall Study|Adverse Event|1|||
163188801|NCT01824342|589407869|FG001|Overall Study|Adverse Event|1|||
163188802|NCT01824342|589407868|FG000|Overall Study|Disease Progression|1|||
163188803|NCT01824342|589407869|FG001|Overall Study|Disease Progression|1|||
163188804|NCT01824342|589407868|FG000|Overall Study|Physician Decision|5|||
163293862|NCT00688519|589780927|FG000|Overall Study|Prohibited medication|1|||
163293863|NCT00688519|589780928|FG001|Overall Study|Prohibited medication|0|||
163293864|NCT00688519|589780927|FG000|Overall Study|Non-compliance|0|||
163293865|NCT00688519|589780928|FG001|Overall Study|Non-compliance|1|||
163293866|NCT00688519|589780927|FG000|Overall Study|Subject moved out of state|1|||
163293867|NCT00688519|589780928|FG001|Overall Study|Subject moved out of state|0|||
163293868|NCT00688519|589780927|FG000|Overall Study|Investigator decision|1|||
163293869|NCT00688519|589780928|FG001|Overall Study|Investigator decision|0|||
163293870|NCT00688519|589780927|FG000|Overall Study|Subject moved out of area|1|||
163293871|NCT00688519|589780928|FG001|Overall Study|Subject moved out of area|0|||
163293872|NCT00688519|589780927|FG000|Overall Study|Pregnancy|0|||
163293873|NCT00688519|589780928|FG001|Overall Study|Pregnancy|1|||
163293874|NCT02551055|589780931|FG000|Overall Study|Death|2|||
163293875|NCT02551055|589780932|FG001|Overall Study|Death|4|||
163293876|NCT02551055|589780933|FG002|Overall Study|Death|2|||
163293877|NCT02551055|589780934|FG003|Overall Study|Death|2|||
163293878|NCT02551055|589780935|FG004|Overall Study|Death|2|||
163293879|NCT02551055|589780936|FG005|Overall Study|Death|1|||
163293880|NCT02551055|589780937|FG006|Overall Study|Death|2|||
163293881|NCT02551055|589780938|FG007|Overall Study|Death|0|||
163293882|NCT02551055|589780931|FG000|Overall Study|Study Terminated by Sponsor|1|||
163293883|NCT02551055|589780932|FG001|Overall Study|Study Terminated by Sponsor|1|||
163293884|NCT02551055|589780933|FG002|Overall Study|Study Terminated by Sponsor|0|||
163293885|NCT02551055|589780934|FG003|Overall Study|Study Terminated by Sponsor|2|||
163293886|NCT02551055|589780935|FG004|Overall Study|Study Terminated by Sponsor|2|||
163293887|NCT02551055|589780936|FG005|Overall Study|Study Terminated by Sponsor|0|||
163293888|NCT02551055|589780937|FG006|Overall Study|Study Terminated by Sponsor|0|||
163293889|NCT02551055|589780938|FG007|Overall Study|Study Terminated by Sponsor|0|||
163293890|NCT02551055|589780931|FG000|Overall Study|Withdrawal by Subject|1|||
163293891|NCT02551055|589780932|FG001|Overall Study|Withdrawal by Subject|1|||
163293892|NCT02551055|589780933|FG002|Overall Study|Withdrawal by Subject|0|||
163293893|NCT02551055|589780934|FG003|Overall Study|Withdrawal by Subject|1|||
163293894|NCT02551055|589780935|FG004|Overall Study|Withdrawal by Subject|2|||
163293895|NCT02551055|589780936|FG005|Overall Study|Withdrawal by Subject|0|||
163293896|NCT02551055|589780937|FG006|Overall Study|Withdrawal by Subject|0|||
163293897|NCT02551055|589780938|FG007|Overall Study|Withdrawal by Subject|0|||
163293898|NCT02551055|589780931|FG000|Overall Study|Reason not specified|0|||
163293899|NCT02551055|589780932|FG001|Overall Study|Reason not specified|0|||
163293900|NCT02551055|589780933|FG002|Overall Study|Reason not specified|0|||
163293901|NCT02551055|589780934|FG003|Overall Study|Reason not specified|0|||
163293902|NCT02551055|589780935|FG004|Overall Study|Reason not specified|1|||
163293903|NCT02551055|589780936|FG005|Overall Study|Reason not specified|0|||
163293904|NCT02551055|589780937|FG006|Overall Study|Reason not specified|1|||
163293905|NCT02551055|589780938|FG007|Overall Study|Reason not specified|0|||
163293906|NCT02106442|589780942|FG000|Overall Study|Case Report Forms Uncollected|7|||
163293907|NCT02106442|589780942|FG000|Overall Study|Protocol Deviation|30|||
163293908|NCT00423098|589782750|FG000|Overall Study|Adverse Event|1|||
163293909|NCT00423098|589782751|FG001|Overall Study|Adverse Event|2|||
163293910|NCT00423098|589782750|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163293911|NCT00423098|589782751|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163293912|NCT00423098|589782750|FG000|Overall Study|Administrative problems|0|||
163293913|NCT00423098|589782751|FG001|Overall Study|Administrative problems|1|||
163293914|NCT00423098|589782750|FG000|Overall Study|Death|2|||
163293915|NCT00423098|589782751|FG001|Overall Study|Death|0|||
163293916|NCT00711958|589782764|FG000|Overall Study|Withdrawal by Subject|6|||
163293917|NCT00711958|589782765|FG001|Overall Study|Withdrawal by Subject|8|||
163293918|NCT00711958|589782764|FG000|Overall Study|Lack of Efficacy|3|||
163293919|NCT00711958|589782765|FG001|Overall Study|Lack of Efficacy|1|||
163293920|NCT00711958|589782764|FG000|Overall Study|Clinical deterioration|1|||
163293921|NCT00711958|589782765|FG001|Overall Study|Clinical deterioration|0|||
163293922|NCT00711958|589782764|FG000|Overall Study|Adverse Event|9|||
163293923|NCT00711958|589782765|FG001|Overall Study|Adverse Event|7|||
163293924|NCT00711958|589782764|FG000|Overall Study|Protocol Violation|1|||
163293925|NCT00711958|589782765|FG001|Overall Study|Protocol Violation|0|||
163293926|NCT00711958|589782764|FG000|Overall Study|Lost to Follow-up|2|||
163293927|NCT00711958|589782765|FG001|Overall Study|Lost to Follow-up|2|||
163293928|NCT00711958|589782764|FG000|Overall Study|Death|10|||
163293929|NCT00711958|589782765|FG001|Overall Study|Death|5|||
163293930|NCT00711958|589782764|FG000|Overall Study|Progression of disease|1|||
163293931|NCT00711958|589782765|FG001|Overall Study|Progression of disease|0|||
163293932|NCT02383472|589782766|FG000|Overall Study|Withdrawal by Subject|1|||
163293933|NCT02383472|589782767|FG001|Overall Study|Withdrawal by Subject|1|||
163293934|NCT02013830|589782768|FG000|Overall Study|Adverse Event|3|||
163293935|NCT02013830|589782768|FG000|Overall Study|Death|1|||
163293936|NCT02013830|589782768|FG000|Overall Study|Insufficient therapeutic response|25|||
163293937|NCT02013830|589782768|FG000|Overall Study|Refused treatment|1|||
163293938|NCT01111526|589782769|FG000|Overall Study|GVHD Disease Progression|0|||
163293939|NCT01111526|589782770|FG001|Overall Study|GVHD Disease Progression|1|||
163293940|NCT01111526|589782771|FG002|Overall Study|GVHD Disease Progression|2|||
163293941|NCT04424641|589782772|FG000|Overall Study|Death|1|||
163293942|NCT04424641|589782773|FG001|Overall Study|Death|2|||
163293943|NCT04424641|589782774|FG002|Overall Study|Death|3|||
163293944|NCT04424641|589782775|FG003|Overall Study|Death|0|||
163293945|NCT04424641|589782776|FG004|Overall Study|Death|3|||
163293946|NCT04424641|589782777|FG005|Overall Study|Death|0|||
163293947|NCT04424641|589782778|FG006|Overall Study|Death|1|||
163293948|NCT04424641|589782779|FG007|Overall Study|Death|2|||
163293949|NCT04424641|589782772|FG000|Overall Study|Sponsor decision|0|||
163293950|NCT04424641|589782773|FG001|Overall Study|Sponsor decision|2|||
163293951|NCT04424641|589782774|FG002|Overall Study|Sponsor decision|3|||
163293952|NCT04424641|589782775|FG003|Overall Study|Sponsor decision|7|||
163293953|NCT04424641|589782776|FG004|Overall Study|Sponsor decision|2|||
163293954|NCT04424641|589782777|FG005|Overall Study|Sponsor decision|2|||
163293955|NCT04424641|589782778|FG006|Overall Study|Sponsor decision|3|||
163293956|NCT04424641|589782779|FG007|Overall Study|Sponsor decision|4|||
163293957|NCT04424641|589782772|FG000|Overall Study|Withdrawal by Subject|0|||
163293958|NCT04424641|589782773|FG001|Overall Study|Withdrawal by Subject|0|||
163293959|NCT04424641|589782774|FG002|Overall Study|Withdrawal by Subject|0|||
163293960|NCT04424641|589782775|FG003|Overall Study|Withdrawal by Subject|0|||
163293961|NCT04424641|589782776|FG004|Overall Study|Withdrawal by Subject|1|||
163293962|NCT04424641|589782777|FG005|Overall Study|Withdrawal by Subject|0|||
163293963|NCT04424641|589782778|FG006|Overall Study|Withdrawal by Subject|0|||
163293964|NCT04424641|589782779|FG007|Overall Study|Withdrawal by Subject|0|||
163293965|NCT04424641|589782772|FG000|Overall Study|Other|0|||
163293966|NCT04424641|589782773|FG001|Overall Study|Other|0|||
163293967|NCT04424641|589782774|FG002|Overall Study|Other|1|||
163293968|NCT04424641|589782775|FG003|Overall Study|Other|0|||
163293969|NCT04424641|589782776|FG004|Overall Study|Other|0|||
163293970|NCT04424641|589782777|FG005|Overall Study|Other|0|||
163293971|NCT04424641|589782778|FG006|Overall Study|Other|0|||
163293972|NCT04424641|589782779|FG007|Overall Study|Other|0|||
163293973|NCT02015546|589782780|FG000|Overall Study|Withdrawal by Subject|1|||
163293974|NCT02015546|589782781|FG001|Overall Study|Withdrawal by Subject|1|||
163293975|NCT02015546|589782782|FG002|Overall Study|Withdrawal by Subject|1|||
163293976|NCT02015546|589782780|FG000|Overall Study|Screem Failure|2|||
163293977|NCT02015546|589782781|FG001|Overall Study|Screem Failure|1|||
163293978|NCT02015546|589782782|FG002|Overall Study|Screem Failure|3|||
163293979|NCT01171625|589782783|FG000|Overall Study|On-Protocol|67|||
163293980|NCT01171625|589782783|FG000|Overall Study|Death|38|||
163293981|NCT01171625|589782783|FG000|Overall Study|Withdrawal by Subject|31|||
163293982|NCT01171625|589782783|FG000|Overall Study|Explanted|10|||
163293983|NCT01171625|589782783|FG000|Overall Study|Lost to Follow-up|5|||
163293984|NCT01171625|589782783|FG000|Overall Study|Patient received valve-in-valve|3|||
163293985|NCT01171625|589782783|FG000|Overall Study|Other|1|||
163293986|NCT01171625|589782783|FG000|Overall Study|Consented but did not receive device|25|||
163293987|NCT00799396|589782786|FG000|Clopidogrel Treatment|Adverse Event|6|||
163293988|NCT00799396|589782786|FG000|Clopidogrel Treatment|Physician Decision|5|||
163293989|NCT00799396|589782786|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
163293990|NCT00799396|589782786|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
163293991|NCT00799396|589782786|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
163293992|NCT01113931|589782787|FG000|Overall Study|Adverse Event|2|||
163293993|NCT01113931|589782788|FG001|Overall Study|Adverse Event|2|||
163293994|NCT01113931|589782787|FG000|Overall Study|Physician Decision|0|||
163293995|NCT01113931|589782788|FG001|Overall Study|Physician Decision|2|||
163293996|NCT01113931|589782787|FG000|Overall Study|Lost to Follow-up|12|||
163293997|NCT01113931|589782788|FG001|Overall Study|Lost to Follow-up|9|||
163293998|NCT01113931|589782787|FG000|Overall Study|Various|2|||
163293999|NCT01113931|589782788|FG001|Overall Study|Various|4|||
163390011|NCT02708095|590139622|FG001|Overall Study|Withdrawal by Subject|3|||
163390012|NCT02708095|590139623|FG002|Overall Study|Withdrawal by Subject|4|||
163294000|NCT01113931|589782787|FG000|Overall Study|Withdrawal by Subject|3|||
163294001|NCT01113931|589782788|FG001|Overall Study|Withdrawal by Subject|0|||
163390013|NCT06268288|590139628|FG000|Overall Study|Withdrawal by Subject|1|||
163390014|NCT06268288|590139629|FG001|Overall Study|Withdrawal by Subject|2|||
163294002|NCT01307267|589782789|FG000|Overall Study|Death|4|||
163294003|NCT01307267|589782790|FG001|Overall Study|Death|3|||
163294004|NCT01307267|589782791|FG002|Overall Study|Death|5|||
163294005|NCT01307267|589782792|FG003|Overall Study|Death|3|||
163294006|NCT01307267|589782793|FG004|Overall Study|Death|1|||
163294007|NCT01307267|589782794|FG005|Overall Study|Death|26|||
163294008|NCT01307267|589782795|FG006|Overall Study|Death|2|||
163294009|NCT01307267|589782796|FG007|Overall Study|Death|2|||
163294010|NCT01307267|589782797|FG008|Overall Study|Death|21|||
163294011|NCT01307267|589782798|FG009|Overall Study|Death|2|||
163294012|NCT01307267|589782799|FG010|Overall Study|Death|3|||
163294013|NCT01307267|589782800|FG011|Overall Study|Death|9|||
163294014|NCT01307267|589782801|FG012|Overall Study|Death|0|||
163294015|NCT01307267|589782802|FG013|Overall Study|Death|0|||
163294016|NCT01307267|589782803|FG014|Overall Study|Death|0|||
163390015|NCT03049735|590139630|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
163188805|NCT01824342|589407869|FG001|Overall Study|Physician Decision|0|||
163188806|NCT01824342|589407868|FG000|Overall Study|Death|2|||
163188807|NCT01824342|589407869|FG001|Overall Study|Death|0|||
163188808|NCT01926015|589407870|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163188809|NCT01926015|589407871|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163188810|NCT01926015|589407870|FG000|Overall Study|Randomized not treated|2|||
163188811|NCT01926015|589407871|FG001|Overall Study|Randomized not treated|0|||
163188812|NCT01364649|589407872|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
163188813|NCT01364649|589407873|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
163188814|NCT01364649|589407872|FG000|Overall Study|Lack of Efficacy|6|||
163294017|NCT01307267|589782804|FG015|Overall Study|Death|0|||
163294018|NCT01307267|589782805|FG016|Overall Study|Death|1|||
163294019|NCT01307267|589782806|FG017|Overall Study|Death|1|||
163294020|NCT01307267|589782807|FG018|Overall Study|Death|2|||
163294021|NCT01307267|589782808|FG019|Overall Study|Death|8|||
163294022|NCT01307267|589782809|FG020|Overall Study|Death|1|||
163294023|NCT01307267|589782810|FG021|Overall Study|Death|2|||
163294024|NCT01307267|589782811|FG022|Overall Study|Death|2|||
163294025|NCT01307267|589782789|FG000|Overall Study|Lost to Follow-up|0|||
163294026|NCT01307267|589782790|FG001|Overall Study|Lost to Follow-up|0|||
163294027|NCT01307267|589782791|FG002|Overall Study|Lost to Follow-up|0|||
163294028|NCT01307267|589782792|FG003|Overall Study|Lost to Follow-up|0|||
163294029|NCT01307267|589782793|FG004|Overall Study|Lost to Follow-up|0|||
163294030|NCT01307267|589782794|FG005|Overall Study|Lost to Follow-up|7|||
163294031|NCT01307267|589782795|FG006|Overall Study|Lost to Follow-up|0|||
163294032|NCT01307267|589782796|FG007|Overall Study|Lost to Follow-up|0|||
163294033|NCT01307267|589782797|FG008|Overall Study|Lost to Follow-up|1|||
163294034|NCT01307267|589782798|FG009|Overall Study|Lost to Follow-up|2|||
163294035|NCT01307267|589782799|FG010|Overall Study|Lost to Follow-up|1|||
163294036|NCT01307267|589782800|FG011|Overall Study|Lost to Follow-up|0|||
163294037|NCT01307267|589782801|FG012|Overall Study|Lost to Follow-up|0|||
163294038|NCT01307267|589782802|FG013|Overall Study|Lost to Follow-up|0|||
163294039|NCT01307267|589782803|FG014|Overall Study|Lost to Follow-up|0|||
163294040|NCT01307267|589782804|FG015|Overall Study|Lost to Follow-up|0|||
163390016|NCT03049735|590139631|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
163390017|NCT03049735|590139632|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
163390018|NCT03049735|590139630|FG000|Overall Study|Other|5|||
163390019|NCT03049735|590139631|FG001|Overall Study|Other|3|||
163390020|NCT03049735|590139632|FG002|Overall Study|Other|1|||
163188815|NCT01364649|589407873|FG001|Overall Study|Lack of Efficacy|0|||
163188816|NCT01364649|589407872|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
163188817|NCT01364649|589407873|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
163188818|NCT01364649|589407872|FG000|Overall Study|Protocol Deviations|4|||
163188819|NCT01364649|589407873|FG001|Overall Study|Protocol Deviations|8|||
163188820|NCT01364649|589407872|FG000|Overall Study|Withdrawal of Consent|9|||
163188821|NCT01364649|589407873|FG001|Overall Study|Withdrawal of Consent|7|||
163188822|NCT01364649|589407872|FG000|Overall Study|Lost to Follow-up|12|||
163188823|NCT01364649|589407873|FG001|Overall Study|Lost to Follow-up|13|||
163188824|NCT01364649|589407872|FG000|Overall Study|Other|4|||
163188825|NCT01364649|589407873|FG001|Overall Study|Other|1|||
163188826|NCT01826604|589407874|FG000|Overall Study|Lost to Follow-up|8|||
163188827|NCT01826604|589407875|FG001|Overall Study|Lost to Follow-up|9|||
163188828|NCT06132659|589407876|FG000|Overall Study|Lost to Follow-up|0|||
163188829|NCT06132659|589407877|FG001|Overall Study|Lost to Follow-up|1|||
163188830|NCT06132659|589407878|FG002|Overall Study|Lost to Follow-up|0|||
163188831|NCT03615326|589407879|FG000|Overall Study|Death|266|||
163188832|NCT03615326|589407880|FG001|Overall Study|Death|286|||
163188833|NCT03615326|589407881|FG002|Overall Study|Death|14|||
163188834|NCT03615326|589407882|FG003|Overall Study|Death|17|||
163188835|NCT03615326|589407879|FG000|Overall Study|Lost to Follow-up|0|||
163188836|NCT03615326|589407880|FG001|Overall Study|Lost to Follow-up|1|||
163188837|NCT03615326|589407881|FG002|Overall Study|Lost to Follow-up|0|||
163188838|NCT03615326|589407882|FG003|Overall Study|Lost to Follow-up|0|||
163294041|NCT01307267|589782805|FG016|Overall Study|Lost to Follow-up|0|||
163294042|NCT01307267|589782806|FG017|Overall Study|Lost to Follow-up|0|||
163294043|NCT01307267|589782807|FG018|Overall Study|Lost to Follow-up|0|||
163294044|NCT01307267|589782808|FG019|Overall Study|Lost to Follow-up|2|||
163294045|NCT01307267|589782809|FG020|Overall Study|Lost to Follow-up|0|||
163188839|NCT03615326|589407879|FG000|Overall Study|Withdrawal by Subject|1|||
163188840|NCT03615326|589407880|FG001|Overall Study|Withdrawal by Subject|3|||
163188841|NCT03615326|589407881|FG002|Overall Study|Withdrawal by Subject|0|||
163188842|NCT03615326|589407882|FG003|Overall Study|Withdrawal by Subject|0|||
163188843|NCT03615326|589407879|FG000|Overall Study|Participants Ongoing|83|||
163188844|NCT03615326|589407880|FG001|Overall Study|Participants Ongoing|58|||
163188845|NCT03615326|589407881|FG002|Overall Study|Participants Ongoing|6|||
163294046|NCT01307267|589782810|FG021|Overall Study|Lost to Follow-up|0|||
163294047|NCT01307267|589782811|FG022|Overall Study|Lost to Follow-up|0|||
163294048|NCT01307267|589782789|FG000|Overall Study|Withdrawal by Subject|0|||
163188846|NCT03615326|589407882|FG003|Overall Study|Participants Ongoing|3|||
163390021|NCT03049735|590139630|FG000|Overall Study|Lack of Efficacy|4|||
163294049|NCT01307267|589782790|FG001|Overall Study|Withdrawal by Subject|0|||
163294050|NCT01307267|589782791|FG002|Overall Study|Withdrawal by Subject|0|||
163294051|NCT01307267|589782792|FG003|Overall Study|Withdrawal by Subject|0|||
163294052|NCT01307267|589782793|FG004|Overall Study|Withdrawal by Subject|0|||
163294053|NCT01307267|589782794|FG005|Overall Study|Withdrawal by Subject|1|||
163294054|NCT01307267|589782795|FG006|Overall Study|Withdrawal by Subject|0|||
163294055|NCT01307267|589782796|FG007|Overall Study|Withdrawal by Subject|1|||
163294056|NCT01307267|589782797|FG008|Overall Study|Withdrawal by Subject|5|||
163294057|NCT01307267|589782798|FG009|Overall Study|Withdrawal by Subject|1|||
163294058|NCT01307267|589782799|FG010|Overall Study|Withdrawal by Subject|1|||
163294059|NCT01307267|589782800|FG011|Overall Study|Withdrawal by Subject|1|||
163294060|NCT01307267|589782801|FG012|Overall Study|Withdrawal by Subject|0|||
163294061|NCT01307267|589782802|FG013|Overall Study|Withdrawal by Subject|0|||
163294062|NCT01307267|589782803|FG014|Overall Study|Withdrawal by Subject|0|||
163188847|NCT03794583|589407883|FG000|Overall Study|Death|8|||
163188848|NCT03794583|589407883|FG000|Overall Study|Study Terminated by Sponsor|24|||
163188849|NCT03794583|589407883|FG000|Overall Study|Withdrawal by Subject|9|||
163188850|NCT02497612|589407884|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
163188851|NCT02497612|589407885|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
163188852|NCT02497612|589407886|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
163188853|NCT02497612|589407887|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
163188854|NCT02497612|589407884|FG000|Overall Study|Participant's request|2|||
163188855|NCT02497612|589407885|FG001|Overall Study|Participant's request|3|||
163188856|NCT02497612|589407886|FG002|Overall Study|Participant's request|4|||
163188857|NCT02497612|589407887|FG003|Overall Study|Participant's request|1|||
163188858|NCT02497612|589407884|FG000|Overall Study|Investigator's judgement|1|||
163188859|NCT02497612|589407885|FG001|Overall Study|Investigator's judgement|0|||
163188860|NCT02497612|589407886|FG002|Overall Study|Investigator's judgement|0|||
163188861|NCT02497612|589407887|FG003|Overall Study|Investigator's judgement|2|||
163188862|NCT02497612|589407884|FG000|Overall Study|Adverse Event|3|||
163188863|NCT02497612|589407885|FG001|Overall Study|Adverse Event|1|||
163188864|NCT02497612|589407886|FG002|Overall Study|Adverse Event|4|||
163188865|NCT02497612|589407887|FG003|Overall Study|Adverse Event|1|||
163188866|NCT02497612|589407884|FG000|Overall Study|Lost to Follow-up|1|||
163188867|NCT02497612|589407885|FG001|Overall Study|Lost to Follow-up|1|||
163188868|NCT02497612|589407886|FG002|Overall Study|Lost to Follow-up|0|||
163188869|NCT02497612|589407887|FG003|Overall Study|Lost to Follow-up|1|||
163188870|NCT02497612|589407884|FG000|Overall Study|Other unspecified|1|||
163188871|NCT02497612|589407885|FG001|Overall Study|Other unspecified|1|||
163188872|NCT02497612|589407886|FG002|Overall Study|Other unspecified|2|||
163188873|NCT02497612|589407887|FG003|Overall Study|Other unspecified|0|||
163188874|NCT02497612|589407884|FG000|Overall Study|Not eligible|1|||
163188875|NCT02497612|589407885|FG001|Overall Study|Not eligible|0|||
163188876|NCT02497612|589407886|FG002|Overall Study|Not eligible|0|||
163188877|NCT02497612|589407887|FG003|Overall Study|Not eligible|1|||
163188878|NCT02651467|589407888|FG000|Overall Study|Withdrawal by Subject|0|||
163188879|NCT02651467|589407889|FG001|Overall Study|Withdrawal by Subject|0|||
163188880|NCT02651467|589407890|FG002|Overall Study|Withdrawal by Subject|2|||
163188881|NCT02651467|589407888|FG000|Overall Study|Other (Not specified)|1|||
163188882|NCT02651467|589407889|FG001|Overall Study|Other (Not specified)|0|||
163188883|NCT02651467|589407890|FG002|Overall Study|Other (Not specified)|2|||
163188884|NCT02477839|589407893|FG000|Overall Study|Adverse Event|0|||
163188885|NCT02477839|589407894|FG001|Overall Study|Adverse Event|1|||
163188886|NCT02477839|589407893|FG000|Overall Study|Protocol Violation|0|||
163188887|NCT02477839|589407894|FG001|Overall Study|Protocol Violation|2|||
163188888|NCT02477839|589407893|FG000|Overall Study|Withdrawal by Subject|3|||
163188889|NCT02477839|589407894|FG001|Overall Study|Withdrawal by Subject|3|||
163188890|NCT02477839|589407893|FG000|Overall Study|Participant had PGS during V6|0|||
163188891|NCT02477839|589407894|FG001|Overall Study|Participant had PGS during V6|1|||
163188892|NCT02477839|589407893|FG000|Overall Study|Parents decided to stop medication|0|||
163188893|NCT02477839|589407894|FG001|Overall Study|Parents decided to stop medication|1|||
163188894|NCT02477839|589407893|FG000|Overall Study|Lack of tolerability|0|||
163294063|NCT01307267|589782804|FG015|Overall Study|Withdrawal by Subject|0|||
163188895|NCT02477839|589407894|FG001|Overall Study|Lack of tolerability|1|||
163188896|NCT02477839|589407893|FG000|Overall Study|Exclusion criterion|0|||
163188897|NCT02477839|589407894|FG001|Overall Study|Exclusion criterion|1|||
163188898|NCT01439568|589407897|FG000|Overall Study|Lost to Follow-up|1|||
163188899|NCT01439568|589407898|FG001|Overall Study|Lost to Follow-up|0|||
163188900|NCT01439568|589407897|FG000|Overall Study|Withdrawal by Subject|2|||
163188901|NCT01439568|589407898|FG001|Overall Study|Withdrawal by Subject|2|||
163188902|NCT01050543|589407899|FG000|Overall Study|Withdrawal by Subject|0|||
163188903|NCT01050543|589407900|FG001|Overall Study|Withdrawal by Subject|2|||
163188904|NCT01050543|589407899|FG000|Overall Study|Protocol Violation|0|||
163188905|NCT01050543|589407900|FG001|Overall Study|Protocol Violation|1|||
163188906|NCT01050543|589407899|FG000|Overall Study|Administrative|4|||
163188907|NCT01050543|589407900|FG001|Overall Study|Administrative|1|||
163188908|NCT00437320|589407903|FG000|Overall Study|Participant request|2|||
163188909|NCT00437320|589407904|FG001|Overall Study|Participant request|1|||
163188910|NCT00437320|589407905|FG002|Overall Study|Participant request|4|||
163188911|NCT01950169|589407906|FG000|Overall Study|Withdrawal by Subject|2|||
163188912|NCT01950169|589407907|FG001|Overall Study|Withdrawal by Subject|8|||
163188913|NCT01950169|589407908|FG002|Overall Study|Withdrawal by Subject|1|||
163188914|NCT01950169|589407906|FG000|Overall Study|Death|1|||
163188915|NCT01950169|589407907|FG001|Overall Study|Death|0|||
163188916|NCT01950169|589407908|FG002|Overall Study|Death|0|||
163188917|NCT01938573|589407909|FG000|Overall Study|Lack of Efficacy|1|||
163188918|NCT01938573|589407910|FG001|Overall Study|Lack of Efficacy|0|||
163188919|NCT01938573|589407909|FG000|Overall Study|Operation at other hospital|1|||
163188920|NCT01938573|589407910|FG001|Overall Study|Operation at other hospital|0|||
163188921|NCT00737438|589407911|FG000|Overall Study|Withdrawal by Subject|2|||
163188922|NCT00737438|589407911|FG000|Overall Study|Patient ineligible|1|||
163188923|NCT02410551|589407912|FG000|Overall Study|Adverse Event|1|||
163188924|NCT02410551|589407912|FG000|Overall Study|Withdrawal by Subject|1|||
163188925|NCT02410551|589407912|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
163188926|NCT05469113|589407913|FG000|Period 2|Adverse Event|0|||
163188927|NCT05469113|589407914|FG001|Period 2|Adverse Event|3|||
163188928|NCT05447897|589407915|FG000|Overall Study|Did not participate in survey|2|||
163188929|NCT04553679|589407916|FG000|Overall Study|Withdrawal by Subject|2|||
163188930|NCT04553679|589407917|FG001|Overall Study|Withdrawal by Subject|0|||
163188931|NCT04553679|589407916|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
163188932|NCT04553679|589407917|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
163188933|NCT01230710|589407919|FG000|Overall Study|Disease Progression|41|||
163188934|NCT01230710|589407919|FG000|Overall Study|Lost to Follow-up|3|||
163188935|NCT01230710|589407919|FG000|Overall Study|Death|4|||
163188936|NCT01230710|589407919|FG000|Overall Study|Withdrawal of Consent|1|||
163188937|NCT02905149|589407920|FG000|Overall Study|Lost to Follow-up|2|||
163188938|NCT02905149|589407921|FG001|Overall Study|Lost to Follow-up|0|||
163188939|NCT00747812|589407922|FG000|Overall Study|Research Site Staff Relocation|5|||
163188940|NCT00747812|589407923|FG001|Overall Study|Research Site Staff Relocation|3|||
163188941|NCT01708161|589407926|FG000|Overall Study|Adverse Event|1|||
163188942|NCT01708161|589407927|FG001|Overall Study|Adverse Event|3|||
163188943|NCT01708161|589407928|FG002|Overall Study|Adverse Event|4|||
163188944|NCT01708161|589407929|FG003|Overall Study|Adverse Event|2|||
163188945|NCT01708161|589407930|FG004|Overall Study|Adverse Event|3|||
163188946|NCT01708161|589407931|FG005|Overall Study|Adverse Event|0|||
163188947|NCT01708161|589407926|FG000|Overall Study|Death|0|||
163188948|NCT01708161|589407927|FG001|Overall Study|Death|0|||
163188949|NCT01708161|589407928|FG002|Overall Study|Death|0|||
163188950|NCT01708161|589407929|FG003|Overall Study|Death|1|||
163188951|NCT01708161|589407930|FG004|Overall Study|Death|0|||
163188952|NCT01708161|589407931|FG005|Overall Study|Death|1|||
163188953|NCT01708161|589407926|FG000|Overall Study|Withdrawal by Subject|0|||
163188954|NCT01708161|589407927|FG001|Overall Study|Withdrawal by Subject|1|||
163188955|NCT01708161|589407928|FG002|Overall Study|Withdrawal by Subject|1|||
163188956|NCT01708161|589407929|FG003|Overall Study|Withdrawal by Subject|0|||
163188957|NCT01708161|589407930|FG004|Overall Study|Withdrawal by Subject|0|||
163188958|NCT01708161|589407931|FG005|Overall Study|Withdrawal by Subject|0|||
163188959|NCT01708161|589407926|FG000|Overall Study|Administrative problems|0|||
163188960|NCT01708161|589407927|FG001|Overall Study|Administrative problems|1|||
163188961|NCT01708161|589407928|FG002|Overall Study|Administrative problems|0|||
163188962|NCT01708161|589407929|FG003|Overall Study|Administrative problems|0|||
163188963|NCT01708161|589407930|FG004|Overall Study|Administrative problems|0|||
163188964|NCT01708161|589407931|FG005|Overall Study|Administrative problems|0|||
163188965|NCT01708161|589407926|FG000|Overall Study|Disease progression|3|||
163188966|NCT01708161|589407927|FG001|Overall Study|Disease progression|5|||
163188967|NCT01708161|589407928|FG002|Overall Study|Disease progression|5|||
163188968|NCT01708161|589407929|FG003|Overall Study|Disease progression|13|||
163188969|NCT01708161|589407930|FG004|Overall Study|Disease progression|3|||
163294064|NCT01307267|589782805|FG016|Overall Study|Withdrawal by Subject|0|||
163294065|NCT01307267|589782806|FG017|Overall Study|Withdrawal by Subject|0|||
163294066|NCT01307267|589782807|FG018|Overall Study|Withdrawal by Subject|0|||
163294067|NCT01307267|589782808|FG019|Overall Study|Withdrawal by Subject|3|||
163188970|NCT01708161|589407931|FG005|Overall Study|Disease progression|0|||
163188971|NCT01986140|589407933|FG000|Overall Study|Withdrawal by Subject|31|||
163188972|NCT01986140|589407934|FG001|Overall Study|Withdrawal by Subject|25|||
163188973|NCT01986140|589407933|FG000|Overall Study|alternative treatment|1|||
163188974|NCT01986140|589407934|FG001|Overall Study|alternative treatment|1|||
163188975|NCT01986140|589407933|FG000|Overall Study|found not eligible|3|||
163188976|NCT01986140|589407934|FG001|Overall Study|found not eligible|0|||
163188977|NCT01986140|589407933|FG000|Overall Study|Adverse Event|0|||
163188978|NCT01986140|589407934|FG001|Overall Study|Adverse Event|1|||
163188979|NCT01986140|589407933|FG000|Overall Study|progression disease|0|||
163188980|NCT01986140|589407934|FG001|Overall Study|progression disease|1|||
163188981|NCT01069627|589407950|FG000|Overall Study|Disease progression|7|||
163188982|NCT01069627|589407950|FG000|Overall Study|Adverse Event|12|||
163390022|NCT03049735|590139631|FG001|Overall Study|Lack of Efficacy|0|||
163188983|NCT01069627|589407950|FG000|Overall Study|Protocol Violation|1|||
163188984|NCT02963935|589407951|FG000|Overall Study|Adverse Event|12|||
163188985|NCT02963935|589407952|FG001|Overall Study|Adverse Event|6|||
163188986|NCT02963935|589407951|FG000|Overall Study|Protocol Violation|2|||
163188987|NCT02963935|589407952|FG001|Overall Study|Protocol Violation|1|||
163188988|NCT02963935|589407951|FG000|Overall Study|Lack of Efficacy|0|||
163188989|NCT02963935|589407952|FG001|Overall Study|Lack of Efficacy|2|||
163188990|NCT02963935|589407951|FG000|Overall Study|Lost to Follow-up|1|||
163188991|NCT02963935|589407952|FG001|Overall Study|Lost to Follow-up|6|||
163188992|NCT02963935|589407951|FG000|Overall Study|Unclassified|13|||
163188993|NCT02963935|589407952|FG001|Overall Study|Unclassified|22|||
163188994|NCT03911154|589407953|FG000|Overall Study|Withdrawal by Subject|1|||
163188995|NCT00292318|589407954|FG000|Overall Study|Study terminated by officials|2|||
163188996|NCT00292318|589407955|FG001|Overall Study|Study terminated by officials|1|||
163188997|NCT01822496|589407956|FG000|Overall Study|Protocol Violation|2|||
163188998|NCT01822496|589407957|FG001|Overall Study|Protocol Violation|2|||
163188999|NCT01822496|589407958|FG002|Overall Study|Protocol Violation|0|||
163189000|NCT01822496|589407959|FG003|Overall Study|Protocol Violation|1|||
163189001|NCT01822496|589407956|FG000|Overall Study|Withdrawal by Subject|0|||
163189002|NCT01822496|589407957|FG001|Overall Study|Withdrawal by Subject|0|||
163189003|NCT01822496|589407958|FG002|Overall Study|Withdrawal by Subject|0|||
163189004|NCT01822496|589407959|FG003|Overall Study|Withdrawal by Subject|3|||
163189005|NCT01631812|589407960|FG000|Overall Study|Adverse Event|25|||
163189006|NCT01631812|589407960|FG000|Overall Study|Lack of Efficacy|5|||
163189007|NCT01631812|589407960|FG000|Overall Study|Withdrawal by Subject|4|||
163189008|NCT01631812|589407960|FG000|Overall Study|Physician Decision|3|||
163189009|NCT00543543|589407961|FG000|Base Study|Adverse Event|1|||
163189010|NCT00543543|589407962|FG001|Base Study|Adverse Event|11|||
163189011|NCT00543543|589407963|FG002|Base Study|Adverse Event|0|||
163189012|NCT00543543|589407964|FG003|Base Study|Adverse Event|5|||
163189013|NCT00543543|589407961|FG000|Base Study|Lost to Follow-up|12|||
163189014|NCT00543543|589407962|FG001|Base Study|Lost to Follow-up|749|||
163189015|NCT00543543|589407963|FG002|Base Study|Lost to Follow-up|9|||
163189016|NCT00543543|589407964|FG003|Base Study|Lost to Follow-up|701|||
163189017|NCT00543543|589407961|FG000|Base Study|Physician Decision|0|||
163189018|NCT00543543|589407962|FG001|Base Study|Physician Decision|4|||
163189019|NCT00543543|589407963|FG002|Base Study|Physician Decision|0|||
163189020|NCT00543543|589407964|FG003|Base Study|Physician Decision|7|||
163189021|NCT00543543|589407961|FG000|Base Study|Protocol Violation|0|||
163189022|NCT00543543|589407962|FG001|Base Study|Protocol Violation|6|||
163189023|NCT00543543|589407963|FG002|Base Study|Protocol Violation|0|||
163189024|NCT00543543|589407964|FG003|Base Study|Protocol Violation|6|||
163189025|NCT00543543|589407961|FG000|Base Study|Withdrawal by Subject|7|||
163189026|NCT00543543|589407962|FG001|Base Study|Withdrawal by Subject|482|||
163189027|NCT00543543|589407963|FG002|Base Study|Withdrawal by Subject|5|||
163189028|NCT00543543|589407964|FG003|Base Study|Withdrawal by Subject|503|||
163189029|NCT00543543|589407961|FG000|Extension Study|Adverse Event|0|||
163189030|NCT00543543|589407962|FG001|Extension Study|Adverse Event|0|||
163189031|NCT00543543|589407963|FG002|Extension Study|Adverse Event|0|||
163189032|NCT00543543|589407964|FG003|Extension Study|Adverse Event|5|||
163189033|NCT00543543|589407961|FG000|Extension Study|Lost to Follow-up|0|||
163189034|NCT00543543|589407962|FG001|Extension Study|Lost to Follow-up|0|||
163189035|NCT00543543|589407963|FG002|Extension Study|Lost to Follow-up|0|||
163189036|NCT00543543|589407964|FG003|Extension Study|Lost to Follow-up|77|||
163189037|NCT00543543|589407961|FG000|Extension Study|Physician Decision|0|||
163189038|NCT00543543|589407962|FG001|Extension Study|Physician Decision|0|||
163189039|NCT00543543|589407963|FG002|Extension Study|Physician Decision|0|||
163189040|NCT00543543|589407964|FG003|Extension Study|Physician Decision|7|||
163189041|NCT00543543|589407961|FG000|Extension Study|Pregnancy|0|||
163189042|NCT00543543|589407962|FG001|Extension Study|Pregnancy|0|||
163189043|NCT00543543|589407963|FG002|Extension Study|Pregnancy|0|||
163189044|NCT00543543|589407964|FG003|Extension Study|Pregnancy|6|||
163189045|NCT00543543|589407961|FG000|Extension Study|Protocol Violation|0|||
163189046|NCT00543543|589407962|FG001|Extension Study|Protocol Violation|0|||
163189047|NCT00543543|589407963|FG002|Extension Study|Protocol Violation|0|||
163189048|NCT00543543|589407964|FG003|Extension Study|Protocol Violation|11|||
163189049|NCT00543543|589407961|FG000|Extension Study|Withdrawal by Subject|0|||
163189050|NCT00543543|589407962|FG001|Extension Study|Withdrawal by Subject|0|||
163189051|NCT00543543|589407963|FG002|Extension Study|Withdrawal by Subject|0|||
163189052|NCT00543543|589407964|FG003|Extension Study|Withdrawal by Subject|120|||
163189053|NCT00945555|589407965|FG000|Overall Study|Referred to another hospital|5|||
163189054|NCT00945555|589407965|FG000|Overall Study|Worsening condition, intensive care unit|1|||
163189055|NCT00945555|589407965|FG000|Overall Study|Withdrawal by Subject|2|||
163189056|NCT00945555|589407965|FG000|Overall Study|Participant continued treatment at home|1|||
163189057|NCT00945555|589407965|FG000|Overall Study|Death|18|||
163390023|NCT03049735|590139632|FG002|Overall Study|Lack of Efficacy|3|||
163294068|NCT01307267|589782809|FG020|Overall Study|Withdrawal by Subject|0|||
163294069|NCT01307267|589782810|FG021|Overall Study|Withdrawal by Subject|0|||
163294070|NCT01307267|589782811|FG022|Overall Study|Withdrawal by Subject|0|||
163294071|NCT01307267|589782789|FG000|Overall Study|Other|0|||
163294072|NCT01307267|589782790|FG001|Overall Study|Other|0|||
163294073|NCT01307267|589782791|FG002|Overall Study|Other|0|||
163294074|NCT01307267|589782792|FG003|Overall Study|Other|0|||
163294075|NCT01307267|589782793|FG004|Overall Study|Other|0|||
163294076|NCT01307267|589782794|FG005|Overall Study|Other|7|||
163390024|NCT03049735|590139630|FG000|Overall Study|Protocol deviation|1|||
163390025|NCT03049735|590139631|FG001|Overall Study|Protocol deviation|0|||
163390026|NCT03049735|590139632|FG002|Overall Study|Protocol deviation|0|||
163390027|NCT03049735|590139630|FG000|Overall Study|Pregnancy|0|||
163390028|NCT03049735|590139631|FG001|Overall Study|Pregnancy|0|||
163390029|NCT03049735|590139632|FG002|Overall Study|Pregnancy|1|||
163390030|NCT03049735|590139630|FG000|Overall Study|Adverse Event|7|||
163390031|NCT03049735|590139631|FG001|Overall Study|Adverse Event|18|||
163390032|NCT03049735|590139632|FG002|Overall Study|Adverse Event|5|||
163390033|NCT03049735|590139630|FG000|Overall Study|Withdrawal by Subject|10|||
163390034|NCT03049735|590139631|FG001|Overall Study|Withdrawal by Subject|3|||
163390035|NCT03049735|590139632|FG002|Overall Study|Withdrawal by Subject|7|||
163390036|NCT03049735|590139630|FG000|Overall Study|Lost to Follow-up|1|||
163390037|NCT03049735|590139631|FG001|Overall Study|Lost to Follow-up|5|||
163390038|NCT03049735|590139632|FG002|Overall Study|Lost to Follow-up|5|||
163390039|NCT03254485|590139633|FG000|Overall Study|Adverse Event|3|||
163390040|NCT03254485|590139634|FG001|Overall Study|Adverse Event|0|||
163390041|NCT03254485|590139635|FG002|Overall Study|Adverse Event|0|||
163390042|NCT03254485|590139636|FG003|Overall Study|Adverse Event|6|||
163390043|NCT03254485|590139633|FG000|Overall Study|Protocol Violation|6|||
163390044|NCT03254485|590139634|FG001|Overall Study|Protocol Violation|0|||
163390045|NCT03254485|590139635|FG002|Overall Study|Protocol Violation|0|||
163390046|NCT03254485|590139636|FG003|Overall Study|Protocol Violation|2|||
163390047|NCT03254485|590139633|FG000|Overall Study|Withdrawal by Subject|1|||
163390048|NCT03254485|590139634|FG001|Overall Study|Withdrawal by Subject|0|||
163390049|NCT03254485|590139635|FG002|Overall Study|Withdrawal by Subject|0|||
163390050|NCT03254485|590139636|FG003|Overall Study|Withdrawal by Subject|4|||
163390051|NCT03254485|590139633|FG000|Overall Study|Death|0|||
163390052|NCT03254485|590139634|FG001|Overall Study|Death|0|||
163390053|NCT03254485|590139635|FG002|Overall Study|Death|0|||
163390054|NCT03254485|590139636|FG003|Overall Study|Death|1|||
163390055|NCT03254485|590139633|FG000|Overall Study|Lost to Follow-up|1|||
163390056|NCT03254485|590139634|FG001|Overall Study|Lost to Follow-up|0|||
163390057|NCT03254485|590139635|FG002|Overall Study|Lost to Follow-up|0|||
163390058|NCT03254485|590139636|FG003|Overall Study|Lost to Follow-up|0|||
163390059|NCT03254485|590139633|FG000|Overall Study|Other|1|||
163390060|NCT03254485|590139634|FG001|Overall Study|Other|0|||
163390061|NCT03254485|590139635|FG002|Overall Study|Other|0|||
163390062|NCT03254485|590139636|FG003|Overall Study|Other|2|||
163390063|NCT02146326|590139637|FG000|Overall Study|Lost to Follow-up|3|||
163390064|NCT02146326|590139638|FG001|Overall Study|Lost to Follow-up|3|||
163390065|NCT02146326|590139639|FG002|Overall Study|Lost to Follow-up|11|||
163390066|NCT02146326|590139640|FG003|Overall Study|Lost to Follow-up|19|||
163390067|NCT02146326|590139637|FG000|Overall Study|Withdrawal by Subject|2|||
163390068|NCT02146326|590139638|FG001|Overall Study|Withdrawal by Subject|1|||
163390069|NCT02146326|590139639|FG002|Overall Study|Withdrawal by Subject|15|||
163390070|NCT02146326|590139640|FG003|Overall Study|Withdrawal by Subject|11|||
163390071|NCT02146326|590139637|FG000|Overall Study|Separated from mental health center|23|||
163390072|NCT02146326|590139638|FG001|Overall Study|Separated from mental health center|33|||
163390073|NCT02146326|590139639|FG002|Overall Study|Separated from mental health center|0|||
163390074|NCT02146326|590139640|FG003|Overall Study|Separated from mental health center|0|||
163390075|NCT02146326|590139637|FG000|Overall Study|Incarcerated|0|||
163390076|NCT02146326|590139638|FG001|Overall Study|Incarcerated|0|||
163390077|NCT02146326|590139639|FG002|Overall Study|Incarcerated|3|||
163390078|NCT02146326|590139640|FG003|Overall Study|Incarcerated|8|||
163294077|NCT01307267|589782795|FG006|Overall Study|Other|0|||
163294078|NCT01307267|589782796|FG007|Overall Study|Other|1|||
163390079|NCT02146326|590139637|FG000|Overall Study|Death|0|||
163390080|NCT02146326|590139638|FG001|Overall Study|Death|0|||
163390081|NCT02146326|590139639|FG002|Overall Study|Death|4|||
163390082|NCT02146326|590139640|FG003|Overall Study|Death|4|||
163390083|NCT02146326|590139637|FG000|Overall Study|Unable to complete interview|0|||
163390084|NCT02146326|590139638|FG001|Overall Study|Unable to complete interview|0|||
163390085|NCT02146326|590139639|FG002|Overall Study|Unable to complete interview|10|||
163390086|NCT02146326|590139640|FG003|Overall Study|Unable to complete interview|6|||
163294079|NCT01307267|589782797|FG008|Overall Study|Other|3|||
163294080|NCT01307267|589782798|FG009|Overall Study|Other|0|||
163294081|NCT01307267|589782799|FG010|Overall Study|Other|1|||
163294082|NCT01307267|589782800|FG011|Overall Study|Other|1|||
163294083|NCT01307267|589782801|FG012|Overall Study|Other|1|||
163294084|NCT01307267|589782802|FG013|Overall Study|Other|0|||
163294085|NCT01307267|589782803|FG014|Overall Study|Other|2|||
163294086|NCT01307267|589782804|FG015|Overall Study|Other|1|||
163294087|NCT01307267|589782805|FG016|Overall Study|Other|0|||
163294088|NCT01307267|589782806|FG017|Overall Study|Other|0|||
163294089|NCT01307267|589782807|FG018|Overall Study|Other|0|||
163294090|NCT01307267|589782808|FG019|Overall Study|Other|19|||
163294091|NCT01307267|589782809|FG020|Overall Study|Other|2|||
163294092|NCT01307267|589782810|FG021|Overall Study|Other|3|||
163294093|NCT01307267|589782811|FG022|Overall Study|Other|2|||
163294094|NCT04956575|589782814|FG000|Overall Study|Death|1|||
162951361|NCT02549092|588525424|FG001|Extension/Transition Period|Adverse Event|1|||
162951362|NCT02549092|588525423|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
162951363|NCT02549092|588525424|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
162951364|NCT02549092|588525423|FG000|Extension/Transition Period|Other, Not Specified|4|||
162951365|NCT02549092|588525424|FG001|Extension/Transition Period|Other, Not Specified|2|||
162951366|NCT00910663|588525425|FG000|Period 1|Withdrawal by Subject|0|||
162951367|NCT00910663|588525426|FG001|Period 1|Withdrawal by Subject|1|||
162951368|NCT01772537|588525427|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
162951369|NCT01772537|588525428|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
162951370|NCT01772537|588525429|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
163294095|NCT04956575|589782815|FG001|Overall Study|Death|0|||
163294096|NCT04956575|589782816|FG002|Overall Study|Death|0|||
163294097|NCT04956575|589782817|FG003|Overall Study|Death|0|||
163294098|NCT04956575|589782818|FG004|Overall Study|Death|0|||
163294099|NCT04956575|589782819|FG005|Overall Study|Death|0|||
163294100|NCT04956575|589782820|FG006|Overall Study|Death|0|||
163294101|NCT04956575|589782821|FG007|Overall Study|Death|1|||
163294102|NCT04956575|589782822|FG008|Overall Study|Death|0|||
163294103|NCT04956575|589782823|FG009|Overall Study|Death|1|||
163294104|NCT04956575|589782824|FG010|Overall Study|Death|0|||
163294105|NCT04956575|589782825|FG011|Overall Study|Death|0|||
163294106|NCT04956575|589782814|FG000|Overall Study|Lost to Follow-up|3|||
163294107|NCT04956575|589782815|FG001|Overall Study|Lost to Follow-up|4|||
163294108|NCT04956575|589782816|FG002|Overall Study|Lost to Follow-up|2|||
163294109|NCT04956575|589782817|FG003|Overall Study|Lost to Follow-up|3|||
163294110|NCT04956575|589782818|FG004|Overall Study|Lost to Follow-up|1|||
163294111|NCT04956575|589782819|FG005|Overall Study|Lost to Follow-up|10|||
163294112|NCT04956575|589782820|FG006|Overall Study|Lost to Follow-up|11|||
163294113|NCT04956575|589782821|FG007|Overall Study|Lost to Follow-up|7|||
163294114|NCT04956575|589782822|FG008|Overall Study|Lost to Follow-up|4|||
163294115|NCT04956575|589782823|FG009|Overall Study|Lost to Follow-up|2|||
163294116|NCT04956575|589782824|FG010|Overall Study|Lost to Follow-up|3|||
163294117|NCT04956575|589782825|FG011|Overall Study|Lost to Follow-up|8|||
163294118|NCT04956575|589782814|FG000|Overall Study|Withdrawal by Subject|1|||
163294119|NCT04956575|589782815|FG001|Overall Study|Withdrawal by Subject|2|||
163294120|NCT04956575|589782816|FG002|Overall Study|Withdrawal by Subject|1|||
163294121|NCT04956575|589782817|FG003|Overall Study|Withdrawal by Subject|4|||
163294122|NCT04956575|589782818|FG004|Overall Study|Withdrawal by Subject|2|||
163294123|NCT04956575|589782819|FG005|Overall Study|Withdrawal by Subject|8|||
163294124|NCT04956575|589782820|FG006|Overall Study|Withdrawal by Subject|5|||
163390087|NCT03153111|590139641|FG000|Overall Study|Death|2|||
163294125|NCT04956575|589782821|FG007|Overall Study|Withdrawal by Subject|1|||
163294126|NCT04956575|589782822|FG008|Overall Study|Withdrawal by Subject|1|||
163294127|NCT04956575|589782823|FG009|Overall Study|Withdrawal by Subject|0|||
163294128|NCT04956575|589782824|FG010|Overall Study|Withdrawal by Subject|3|||
163294129|NCT04956575|589782825|FG011|Overall Study|Withdrawal by Subject|1|||
163294130|NCT00854906|589782828|FG000|Overall Study|One person had no ocular history|1|||
163294131|NCT05526248|589782829|FG000|Overall Study|Lost to Follow-up|1|||
163294132|NCT05526248|589782829|FG000|Overall Study|Adverse Event|2|||
163294133|NCT05526248|589782829|FG000|Overall Study|Withdrawal by Subject|1|||
163294134|NCT01135511|589782837|FG000|Overall Study|Adverse Event|0|||
163294135|NCT01135511|589782838|FG001|Overall Study|Adverse Event|1|||
163294136|NCT01135511|589782839|FG002|Overall Study|Adverse Event|2|||
163294137|NCT01135511|589782840|FG003|Overall Study|Adverse Event|0|||
163294138|NCT01135511|589782841|FG004|Overall Study|Adverse Event|0|||
163294139|NCT01135511|589782842|FG005|Overall Study|Adverse Event|1|||
163294140|NCT01135511|589782843|FG006|Overall Study|Adverse Event|0|||
163294141|NCT01135511|589782844|FG007|Overall Study|Adverse Event|1|||
163294142|NCT01135511|589782845|FG008|Overall Study|Adverse Event|0|||
163390088|NCT03153111|590139642|FG001|Overall Study|Death|5|||
162951371|NCT01376167|588525433|FG000|Overall Study|Lost to Follow-up|2|||
163294143|NCT01135511|589782837|FG000|Overall Study|Lack of Efficacy|0|||
163294144|NCT01135511|589782838|FG001|Overall Study|Lack of Efficacy|1|||
163294145|NCT01135511|589782839|FG002|Overall Study|Lack of Efficacy|1|||
163294146|NCT01135511|589782840|FG003|Overall Study|Lack of Efficacy|2|||
163189058|NCT00945555|589407965|FG000|Overall Study|Other|1|||
163189059|NCT04502979|589407966|FG000|Overall Study|Lost to Follow-up|1|||
163189060|NCT04502979|589407967|FG001|Overall Study|Lost to Follow-up|3|||
163189061|NCT04502979|589407966|FG000|Overall Study|Withdrawal by Subject|2|||
163189062|NCT04502979|589407967|FG001|Overall Study|Withdrawal by Subject|1|||
163189063|NCT00586625|589407971|FG000|Overall Study|Adverse Event|6|||
163189064|NCT00586625|589407972|FG001|Overall Study|Adverse Event|6|||
163189065|NCT00586625|589407971|FG000|Overall Study|Protocol Violation|3|||
163189066|NCT00586625|589407972|FG001|Overall Study|Protocol Violation|0|||
163189067|NCT00586625|589407971|FG000|Overall Study|Withdrawal by Subject|32|||
163189068|NCT00586625|589407972|FG001|Overall Study|Withdrawal by Subject|10|||
163189069|NCT00586625|589407971|FG000|Overall Study|Subject non-compliance|0|||
163189070|NCT00586625|589407972|FG001|Overall Study|Subject non-compliance|1|||
163189071|NCT00586625|589407971|FG000|Overall Study|Subject unable to return for visit|2|||
163189072|NCT00586625|589407972|FG001|Overall Study|Subject unable to return for visit|0|||
163189073|NCT02906332|589407974|FG000|Overall Study|Withdrawal by Subject|1|||
163189074|NCT00165984|589407975|FG000|Overall Study|Death|15|||
163189075|NCT01686828|589407979|FG000|Overall Study|Physician Decision|1|||
163189076|NCT01686828|589407980|FG001|Overall Study|Physician Decision|0|||
163189077|NCT01686828|589407981|FG002|Overall Study|Physician Decision|0|||
163189078|NCT01686828|589407982|FG003|Overall Study|Physician Decision|0|||
163189079|NCT01686828|589407979|FG000|Overall Study|New Job|0|||
163189080|NCT01686828|589407980|FG001|Overall Study|New Job|1|||
163189081|NCT01686828|589407981|FG002|Overall Study|New Job|0|||
163189082|NCT01686828|589407982|FG003|Overall Study|New Job|0|||
163189083|NCT01686828|589407979|FG000|Overall Study|Weight Loss|0|||
163189084|NCT01686828|589407980|FG001|Overall Study|Weight Loss|0|||
163189085|NCT01686828|589407981|FG002|Overall Study|Weight Loss|1|||
163189086|NCT01686828|589407982|FG003|Overall Study|Weight Loss|0|||
163189087|NCT02734433|589407983|FG000|Overall Study|Disease progression|1|||
163189088|NCT02734433|589407984|FG001|Overall Study|Disease progression|5|||
163189089|NCT02734433|589407983|FG000|Overall Study|Clinical progression|0|||
163189090|NCT02734433|589407984|FG001|Overall Study|Clinical progression|1|||
163189091|NCT02734433|589407983|FG000|Overall Study|Withdrawal by Subject|1|||
163189092|NCT02734433|589407984|FG001|Overall Study|Withdrawal by Subject|2|||
163189093|NCT03698331|589407987|FG000|Overall Study|Adverse Event|2|||
163189094|NCT03698331|589407988|FG001|Overall Study|Adverse Event|3|||
163189095|NCT03698331|589407987|FG000|Overall Study|Withdrawal by Subject|1|||
163189096|NCT03698331|589407988|FG001|Overall Study|Withdrawal by Subject|1|||
163189097|NCT03698331|589407987|FG000|Overall Study|Lost to Follow-up|0|||
163189098|NCT03698331|589407988|FG001|Overall Study|Lost to Follow-up|2|||
163189099|NCT03698331|589407987|FG000|Overall Study|Non-compliance with study drug|1|||
163189100|NCT03698331|589407988|FG001|Overall Study|Non-compliance with study drug|0|||
163189101|NCT04916769|589407990|FG000|Period 1|Physician Decision|0|||
163189102|NCT04916769|589407991|FG001|Period 1|Physician Decision|0|||
163189103|NCT04916769|589407992|FG002|Period 1|Physician Decision|0|||
163189104|NCT04916769|589407993|FG003|Period 1|Physician Decision|0|||
163189105|NCT04916769|589407994|FG004|Period 1|Physician Decision|0|||
163189106|NCT04916769|589407995|FG005|Period 1|Physician Decision|1|||
163189107|NCT04916769|589407990|FG000|Period 2|Physician Decision|0|||
163189108|NCT04916769|589407991|FG001|Period 2|Physician Decision|1|||
163189109|NCT04916769|589407992|FG002|Period 2|Physician Decision|0|||
163189110|NCT04916769|589407993|FG003|Period 2|Physician Decision|0|||
163189111|NCT04916769|589407994|FG004|Period 2|Physician Decision|0|||
163189112|NCT04916769|589407995|FG005|Period 2|Physician Decision|0|||
163189113|NCT04941456|589407996|FG000|Overall Study|Withdrawal by Subject|1|||
163189114|NCT04941456|589407997|FG001|Overall Study|Withdrawal by Subject|0|||
163189115|NCT04941456|589407996|FG000|Overall Study|Protocol Violation|1|||
163189116|NCT04941456|589407997|FG001|Overall Study|Protocol Violation|0|||
163189117|NCT05628103|589408000|FG000|Overall Study|Adverse Event|7|||
163189118|NCT05628103|589408000|FG000|Overall Study|Withdrawal by Subject|3|||
163189119|NCT05628103|589408000|FG000|Overall Study|Lost to Follow-up|3|||
163189120|NCT05628103|589408000|FG000|Overall Study|Lack of Efficacy|1|||
163189121|NCT05628103|589408000|FG000|Overall Study|Non-Compliance With Study Drug|4|||
163189122|NCT04840888|589408001|FG000|Period 1|Withdrawal by Subject|0|||
163189123|NCT04840888|589408002|FG001|Period 1|Withdrawal by Subject|0|||
163189124|NCT04840888|589408003|FG002|Period 1|Withdrawal by Subject|0|||
163189125|NCT04840888|589408004|FG003|Period 1|Withdrawal by Subject|0|||
163189126|NCT04840888|589408005|FG004|Period 1|Withdrawal by Subject|1|||
163189127|NCT04840888|589408006|FG005|Period 1|Withdrawal by Subject|0|||
163189128|NCT04840888|589408001|FG000|Period 1|Adverse Event|0|||
163189129|NCT04840888|589408002|FG001|Period 1|Adverse Event|0|||
163189130|NCT04840888|589408003|FG002|Period 1|Adverse Event|1|||
163294147|NCT01135511|589782841|FG004|Overall Study|Lack of Efficacy|0|||
163189131|NCT04840888|589408004|FG003|Period 1|Adverse Event|1|||
163189132|NCT04840888|589408005|FG004|Period 1|Adverse Event|10|||
163189133|NCT04840888|589408006|FG005|Period 1|Adverse Event|1|||
163189134|NCT02718300|589408007|FG000|Overall Study|Death|4|||
163189135|NCT02718300|589408008|FG001|Overall Study|Death|5|||
163189136|NCT02718300|589408009|FG002|Overall Study|Death|17|||
163189137|NCT02718300|589408007|FG000|Overall Study|Lost to Follow-up|1|||
163294148|NCT01135511|589782842|FG005|Overall Study|Lack of Efficacy|0|||
163294149|NCT01135511|589782843|FG006|Overall Study|Lack of Efficacy|0|||
163294150|NCT01135511|589782844|FG007|Overall Study|Lack of Efficacy|0|||
163294151|NCT01135511|589782845|FG008|Overall Study|Lack of Efficacy|0|||
163294152|NCT01135511|589782837|FG000|Overall Study|Protocol Violation|0|||
163294153|NCT01135511|589782838|FG001|Overall Study|Protocol Violation|0|||
163294154|NCT01135511|589782839|FG002|Overall Study|Protocol Violation|3|||
163294155|NCT01135511|589782840|FG003|Overall Study|Protocol Violation|0|||
163294156|NCT01135511|589782841|FG004|Overall Study|Protocol Violation|0|||
163294157|NCT01135511|589782842|FG005|Overall Study|Protocol Violation|0|||
163294158|NCT01135511|589782843|FG006|Overall Study|Protocol Violation|0|||
163294159|NCT01135511|589782844|FG007|Overall Study|Protocol Violation|0|||
163294160|NCT01135511|589782845|FG008|Overall Study|Protocol Violation|0|||
163294161|NCT01135511|589782837|FG000|Overall Study|Pregnancy|0|||
163294162|NCT01135511|589782838|FG001|Overall Study|Pregnancy|0|||
163294163|NCT01135511|589782839|FG002|Overall Study|Pregnancy|0|||
163294164|NCT01135511|589782840|FG003|Overall Study|Pregnancy|1|||
163294165|NCT01135511|589782841|FG004|Overall Study|Pregnancy|0|||
163294166|NCT01135511|589782842|FG005|Overall Study|Pregnancy|0|||
163294167|NCT01135511|589782843|FG006|Overall Study|Pregnancy|0|||
163294168|NCT01135511|589782844|FG007|Overall Study|Pregnancy|0|||
163294169|NCT01135511|589782845|FG008|Overall Study|Pregnancy|0|||
163294170|NCT01135511|589782837|FG000|Overall Study|could not visit the clinic|0|||
163294171|NCT01135511|589782838|FG001|Overall Study|could not visit the clinic|1|||
163294172|NCT01135511|589782839|FG002|Overall Study|could not visit the clinic|2|||
163294173|NCT01135511|589782840|FG003|Overall Study|could not visit the clinic|0|||
163294174|NCT01135511|589782841|FG004|Overall Study|could not visit the clinic|0|||
163294175|NCT01135511|589782842|FG005|Overall Study|could not visit the clinic|0|||
163294176|NCT01135511|589782843|FG006|Overall Study|could not visit the clinic|0|||
163294177|NCT01135511|589782844|FG007|Overall Study|could not visit the clinic|0|||
163294178|NCT01135511|589782845|FG008|Overall Study|could not visit the clinic|0|||
163294179|NCT01135511|589782837|FG000|Overall Study|noncompliance with study drug taken|0|||
163294180|NCT01135511|589782838|FG001|Overall Study|noncompliance with study drug taken|0|||
163294181|NCT01135511|589782839|FG002|Overall Study|noncompliance with study drug taken|0|||
163294182|NCT01135511|589782840|FG003|Overall Study|noncompliance with study drug taken|0|||
163294183|NCT01135511|589782841|FG004|Overall Study|noncompliance with study drug taken|1|||
163294184|NCT01135511|589782842|FG005|Overall Study|noncompliance with study drug taken|0|||
163294185|NCT01135511|589782843|FG006|Overall Study|noncompliance with study drug taken|0|||
163294186|NCT01135511|589782844|FG007|Overall Study|noncompliance with study drug taken|0|||
163294187|NCT01135511|589782845|FG008|Overall Study|noncompliance with study drug taken|0|||
163294188|NCT01135511|589782837|FG000|Overall Study|Withdrawal by Subject|0|||
163294189|NCT01135511|589782838|FG001|Overall Study|Withdrawal by Subject|0|||
163294190|NCT01135511|589782839|FG002|Overall Study|Withdrawal by Subject|0|||
163294191|NCT01135511|589782840|FG003|Overall Study|Withdrawal by Subject|0|||
163294192|NCT01135511|589782841|FG004|Overall Study|Withdrawal by Subject|0|||
163294193|NCT01135511|589782842|FG005|Overall Study|Withdrawal by Subject|0|||
163294194|NCT01135511|589782843|FG006|Overall Study|Withdrawal by Subject|1|||
163294195|NCT01135511|589782844|FG007|Overall Study|Withdrawal by Subject|0|||
163294196|NCT01135511|589782845|FG008|Overall Study|Withdrawal by Subject|1|||
163294197|NCT02425111|589782849|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
163294198|NCT02425111|589782849|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
163294199|NCT02425111|589782849|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
163294200|NCT02425111|589782849|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
163294201|NCT02425111|589782849|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
163294202|NCT02425111|589782849|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
163294203|NCT00585533|589782850|FG000|Overall Study|objective or symptomatic progression|9|||
163294204|NCT02739035|589782852|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
163294205|NCT02739035|589782853|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
163294206|NCT02739035|589782852|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
163294207|NCT02739035|589782853|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
163294208|NCT02739035|589782852|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
163294209|NCT02739035|589782853|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
163294210|NCT02739035|589782852|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
163294211|NCT02739035|589782853|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
163294212|NCT04446117|589782856|FG000|Overall Study|No Study Treatment Given|4|||
163294213|NCT04446117|589782857|FG001|Overall Study|No Study Treatment Given|3|||
163294214|NCT04446117|589782856|FG000|Overall Study|Radiographic Disease Progression|132|||
163294215|NCT04446117|589782857|FG001|Overall Study|Radiographic Disease Progression|158|||
163294216|NCT04446117|589782856|FG000|Overall Study|Adverse Event|79|||
163294217|NCT04446117|589782857|FG001|Overall Study|Adverse Event|43|||
163294218|NCT04446117|589782856|FG000|Overall Study|Lack of Clinical Benefit|1|||
163294219|NCT04446117|589782857|FG001|Overall Study|Lack of Clinical Benefit|1|||
163294220|NCT04446117|589782856|FG000|Overall Study|Withdrawal by Subject|24|||
163294221|NCT04446117|589782857|FG001|Overall Study|Withdrawal by Subject|22|||
163294222|NCT04446117|589782856|FG000|Overall Study|Lost to Follow-up|0|||
163294223|NCT04446117|589782857|FG001|Overall Study|Lost to Follow-up|3|||
163390089|NCT03153111|590139641|FG000|Overall Study|Lost to Follow-up|1|||
163390090|NCT03153111|590139642|FG001|Overall Study|Lost to Follow-up|0|||
163390091|NCT03153111|590139641|FG000|Overall Study|Physician Decision|5|||
163390092|NCT03153111|590139642|FG001|Overall Study|Physician Decision|1|||
162951372|NCT01376167|588525434|FG001|Overall Study|Lost to Follow-up|4|||
162951373|NCT01376167|588525435|FG002|Overall Study|Lost to Follow-up|2|||
162951374|NCT01376167|588525433|FG000|Overall Study|Physician Decision|1|||
162951375|NCT01376167|588525434|FG001|Overall Study|Physician Decision|1|||
162951376|NCT01376167|588525435|FG002|Overall Study|Physician Decision|0|||
162951377|NCT01376167|588525433|FG000|Overall Study|Withdrawal by Subject|1|||
162951378|NCT01376167|588525434|FG001|Overall Study|Withdrawal by Subject|5|||
162951379|NCT01376167|588525435|FG002|Overall Study|Withdrawal by Subject|4|||
162951380|NCT02193165|588525438|FG000|4 Week Product Use|Lost to Follow-up|1|||
162951381|NCT02193165|588525439|FG001|4 Week Product Use|Lost to Follow-up|1|||
162951382|NCT02193165|588525440|FG002|4 Week Product Use|Lost to Follow-up|1|||
162951383|NCT02193165|588525438|FG000|6 Week Product Use|Lost to Follow-up|0|||
162951384|NCT02193165|588525439|FG001|6 Week Product Use|Lost to Follow-up|1|||
162951385|NCT02193165|588525440|FG002|6 Week Product Use|Lost to Follow-up|0|||
162951386|NCT01546545|588525442|FG000|Overall Study|Withdrawal by Subject|1|||
162951387|NCT01214850|588525443|FG000|Overall Study|Withdrawal by Subject|38|||
162951388|NCT01214850|588525444|FG001|Overall Study|Withdrawal by Subject|31|||
162951389|NCT01214850|588525445|FG002|Overall Study|Withdrawal by Subject|28|||
162951390|NCT01214850|588525443|FG000|Overall Study|Lost to Follow-up|124|||
162951391|NCT01214850|588525444|FG001|Overall Study|Lost to Follow-up|98|||
162951392|NCT01214850|588525445|FG002|Overall Study|Lost to Follow-up|123|||
162951393|NCT01214850|588525443|FG000|Overall Study|Protocol Violation|5|||
162951394|NCT01214850|588525444|FG001|Overall Study|Protocol Violation|5|||
162951395|NCT01214850|588525445|FG002|Overall Study|Protocol Violation|6|||
162951396|NCT01214850|588525443|FG000|Overall Study|Adverse event or death|11|||
162951397|NCT01214850|588525444|FG001|Overall Study|Adverse event or death|8|||
162951398|NCT01214850|588525445|FG002|Overall Study|Adverse event or death|3|||
162951399|NCT01214850|588525443|FG000|Overall Study|Inappropriate enrollment|2|||
162951400|NCT01214850|588525444|FG001|Overall Study|Inappropriate enrollment|1|||
162951401|NCT01214850|588525445|FG002|Overall Study|Inappropriate enrollment|0|||
162951402|NCT01214850|588525443|FG000|Overall Study|Administrative reason|1|||
162951403|NCT01214850|588525444|FG001|Overall Study|Administrative reason|0|||
163189138|NCT02718300|589408008|FG001|Overall Study|Lost to Follow-up|0|||
163189139|NCT02718300|589408009|FG002|Overall Study|Lost to Follow-up|2|||
163189140|NCT02718300|589408007|FG000|Overall Study|Physician Decision|1|||
163189141|NCT02718300|589408008|FG001|Overall Study|Physician Decision|0|||
163189142|NCT02718300|589408009|FG002|Overall Study|Physician Decision|2|||
163189143|NCT02718300|589408007|FG000|Overall Study|Study Terminated by Sponsor|6|||
163189144|NCT02718300|589408008|FG001|Overall Study|Study Terminated by Sponsor|3|||
163189145|NCT02718300|589408009|FG002|Overall Study|Study Terminated by Sponsor|4|||
163189146|NCT02718300|589408007|FG000|Overall Study|Withdrawal by Subject|0|||
163189147|NCT02718300|589408008|FG001|Overall Study|Withdrawal by Subject|4|||
163189148|NCT02718300|589408009|FG002|Overall Study|Withdrawal by Subject|3|||
163189149|NCT02718300|589408007|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
163189150|NCT02718300|589408008|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
163189151|NCT02718300|589408009|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
163189152|NCT05741528|589408010|FG000|Overall Study|Withdrawal by Subject|11|||
163189153|NCT05741528|589408010|FG000|Overall Study|Lost to Follow-up|3|||
163189154|NCT05741528|589408010|FG000|Overall Study|Adverse Event|2|||
163189155|NCT05741528|589408010|FG000|Overall Study|Non-Compliance With Study Drug|2|||
163189156|NCT05741528|589408010|FG000|Overall Study|Reason Not Specified|1|||
163189157|NCT04063384|589409506|FG000|Overall Study|placebo manipulation issue|1|||
163189158|NCT04063384|589409507|FG001|Overall Study|placebo manipulation issue|2|||
163189159|NCT04063384|589409508|FG002|Overall Study|placebo manipulation issue|1|||
163189160|NCT04063384|589409509|FG003|Overall Study|placebo manipulation issue|1|||
163189161|NCT03894046|589409515|FG000|Overall Study|Protocol Violation|1|||
163189162|NCT03894046|589409516|FG001|Overall Study|Protocol Violation|0|||
163189163|NCT03894046|589409517|FG002|Overall Study|Protocol Violation|0|||
163189164|NCT03894046|589409515|FG000|Overall Study|Adverse Event|0|||
163189165|NCT03894046|589409516|FG001|Overall Study|Adverse Event|1|||
163189166|NCT03894046|589409517|FG002|Overall Study|Adverse Event|0|||
163189167|NCT03894046|589409515|FG000|Overall Study|Withdrawal by Subject|2|||
163189168|NCT03894046|589409516|FG001|Overall Study|Withdrawal by Subject|3|||
163189169|NCT03894046|589409517|FG002|Overall Study|Withdrawal by Subject|1|||
163189170|NCT03894046|589409515|FG000|Overall Study|Death|15|||
163189171|NCT03894046|589409516|FG001|Overall Study|Death|21|||
163189172|NCT03894046|589409517|FG002|Overall Study|Death|4|||
163189173|NCT03894046|589409515|FG000|Overall Study|No growth of ABC|2|||
163189174|NCT03894046|589409516|FG001|Overall Study|No growth of ABC|1|||
163189175|NCT03894046|589409517|FG002|Overall Study|No growth of ABC|0|||
163189176|NCT03894046|589409515|FG000|Overall Study|Physician Decision|1|||
162951404|NCT01214850|588525445|FG002|Overall Study|Administrative reason|0|||
162951405|NCT01214850|588525443|FG000|Overall Study|Unable to classify|2|||
162951406|NCT01214850|588525444|FG001|Overall Study|Unable to classify|1|||
162951407|NCT01214850|588525445|FG002|Overall Study|Unable to classify|1|||
162951408|NCT00610363|588525450|FG000|Overall Study|Non-compliance with protocol|0|||
162951409|NCT00610363|588525451|FG001|Overall Study|Non-compliance with protocol|1|||
162951410|NCT00610363|588525450|FG000|Overall Study|Adverse Event|3|||
162951411|NCT00610363|588525451|FG001|Overall Study|Adverse Event|1|||
162951412|NCT00610363|588525450|FG000|Overall Study|Lack of Efficacy|2|||
162951413|NCT00610363|588525451|FG001|Overall Study|Lack of Efficacy|0|||
162951414|NCT00610363|588525450|FG000|Overall Study|Lost to Follow-up|4|||
162951415|NCT00610363|588525451|FG001|Overall Study|Lost to Follow-up|0|||
162951416|NCT00610363|588525450|FG000|Overall Study|Withdrawal by Subject|1|||
162951417|NCT00610363|588525451|FG001|Overall Study|Withdrawal by Subject|0|||
162951418|NCT00610363|588525450|FG000|Overall Study|Other than specified above|1|||
162951419|NCT00610363|588525451|FG001|Overall Study|Other than specified above|1|||
162951420|NCT03361228|588525461|FG000|Overall Study|Other|1|||
162951421|NCT03361228|588525462|FG001|Overall Study|Other|1|||
162951422|NCT03361228|588525461|FG000|Overall Study|Death|3|||
162951423|NCT03361228|588525462|FG001|Overall Study|Death|0|||
162951424|NCT01722877|588525466|FG000|Overall Study|Death|1|||
162951425|NCT01722877|588525466|FG000|Overall Study|Lost to Follow-up|1|||
162951426|NCT03693430|588525467|FG000|Overall Study|Lost to Follow-up|3|||
162951427|NCT03693430|588525468|FG001|Overall Study|Lost to Follow-up|14|||
162951428|NCT03693430|588525467|FG000|Overall Study|Death|1|||
162951429|NCT03693430|588525468|FG001|Overall Study|Death|0|||
162951430|NCT03693430|588525467|FG000|Overall Study|Withdrawal by Subject|0|||
162951431|NCT03693430|588525468|FG001|Overall Study|Withdrawal by Subject|4|||
162951432|NCT00585689|588525470|FG000|Overall Study|Received different ABI-007 schedule|3|||
162951433|NCT00585689|588525470|FG000|Overall Study|Adverse Event|1|||
162951434|NCT00585689|588525470|FG000|Overall Study|Patient Declined Surgery|1|||
162951435|NCT00585689|588525470|FG000|Overall Study|Patient had unresectable disease|1|||
162951436|NCT00585689|588525470|FG000|Overall Study|Death|1|||
162951437|NCT02930005|588525471|FG000|Overall Study|Lost to Follow-up|1|||
162951438|NCT02930005|588525472|FG001|Overall Study|Lost to Follow-up|5|||
162951439|NCT02373098|588525473|FG000|Overall Study|Lost to Follow-up|1|||
162951440|NCT02373098|588525474|FG001|Overall Study|Lost to Follow-up|0|||
162951441|NCT02373098|588525473|FG000|Overall Study|Protocol Violation|3|||
162951442|NCT02373098|588525474|FG001|Overall Study|Protocol Violation|0|||
162951443|NCT02373098|588525473|FG000|Overall Study|Withdrawal by Subject|5|||
162951444|NCT02373098|588525474|FG001|Overall Study|Withdrawal by Subject|0|||
162951445|NCT02373098|588525473|FG000|Overall Study|Adverse Event|3|||
162951446|NCT02373098|588525474|FG001|Overall Study|Adverse Event|0|||
162951447|NCT00870870|588525475|FG000|Overall Study|Withdrawal by Subject|0|||
162951448|NCT00870870|588525476|FG001|Overall Study|Withdrawal by Subject|1|||
162951449|NCT00870870|588525477|FG002|Overall Study|Withdrawal by Subject|1|||
162951450|NCT00870870|588525478|FG003|Overall Study|Withdrawal by Subject|3|||
162951451|NCT00870870|588525475|FG000|Overall Study|Adverse Event|0|||
162951452|NCT00870870|588525476|FG001|Overall Study|Adverse Event|0|||
162951453|NCT00870870|588525477|FG002|Overall Study|Adverse Event|2|||
163189177|NCT03894046|589409516|FG001|Overall Study|Physician Decision|1|||
163189178|NCT03894046|589409517|FG002|Overall Study|Physician Decision|1|||
163189179|NCT03894046|589409515|FG000|Overall Study|Prohibited concomitant medication|1|||
163189180|NCT03894046|589409516|FG001|Overall Study|Prohibited concomitant medication|0|||
163189181|NCT03894046|589409517|FG002|Overall Study|Prohibited concomitant medication|0|||
163189182|NCT03894046|589409515|FG000|Overall Study|Transferred to other arm/group|1|||
163189183|NCT03894046|589409516|FG001|Overall Study|Transferred to other arm/group|1|||
163189184|NCT03894046|589409517|FG002|Overall Study|Transferred to other arm/group|0|||
163189185|NCT03270644|589409518|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
163189186|NCT03270644|589409518|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
163189187|NCT00333801|589409519|FG000|Overall Study|Moved to another state|5|||
163189188|NCT00333801|589409520|FG001|Overall Study|Moved to another state|3|||
163189189|NCT00333801|589409519|FG000|Overall Study|Lost to Follow-up|2|||
163189190|NCT00333801|589409520|FG001|Overall Study|Lost to Follow-up|0|||
163189191|NCT00333801|589409519|FG000|Overall Study|Incarcerated|1|||
163189192|NCT00333801|589409520|FG001|Overall Study|Incarcerated|2|||
163189193|NCT00333801|589409519|FG000|Overall Study|Withdrawal by Subject|0|||
163189194|NCT00333801|589409520|FG001|Overall Study|Withdrawal by Subject|1|||
163189195|NCT02476201|589409521|FG000|Overall Study|Unable to program MPP|9|||
163189196|NCT02476201|589409521|FG000|Overall Study|Study echo not performed|5|||
162951454|NCT00870870|588525478|FG003|Overall Study|Adverse Event|2|||
162951455|NCT00855738|588525483|FG000|Overall Study|Lost to Follow-up|2|||
162951456|NCT00855738|588525483|FG000|Overall Study|Adverse Event|1|||
162951457|NCT00855738|588525483|FG000|Overall Study|Subject Defaulted|1|||
162951458|NCT00855738|588525483|FG000|Overall Study|Death|1|||
162951459|NCT00304083|588525486|FG000|Overall Study|Withdrawal by Subject|4|||
162951460|NCT00304083|588525487|FG001|Overall Study|Withdrawal by Subject|2|||
162951461|NCT00304083|588525486|FG000|Overall Study|Physician Decision|8|||
163294224|NCT04446117|589782856|FG000|Overall Study|Miscellaneous|26|||
163294225|NCT04446117|589782857|FG001|Overall Study|Miscellaneous|36|||
163294226|NCT04446117|589782856|FG000|Overall Study|Missing Data/Data not yet Received|1|||
163294227|NCT04446117|589782857|FG001|Overall Study|Missing Data/Data not yet Received|0|||
163294228|NCT00630786|589782863|FG000|Overall Study|Physician Decision|0|||
163294229|NCT00630786|589782864|FG001|Overall Study|Physician Decision|0|||
163294230|NCT00630786|589782865|FG002|Overall Study|Physician Decision|1|||
163294231|NCT00630786|589782863|FG000|Overall Study|Withdrawal by Subject|0|||
163294232|NCT00630786|589782864|FG001|Overall Study|Withdrawal by Subject|1|||
163294233|NCT00630786|589782865|FG002|Overall Study|Withdrawal by Subject|1|||
163294234|NCT00630786|589782863|FG000|Overall Study|Lost to Follow-up|0|||
163294235|NCT00630786|589782864|FG001|Overall Study|Lost to Follow-up|1|||
163294236|NCT00630786|589782865|FG002|Overall Study|Lost to Follow-up|0|||
163294237|NCT00630786|589782863|FG000|Overall Study|Other|1|||
163294238|NCT00630786|589782864|FG001|Overall Study|Other|0|||
163294239|NCT00630786|589782865|FG002|Overall Study|Other|0|||
163294240|NCT02770248|589782866|FG000|Overall Study|Adverse Event|0|||
163294241|NCT02770248|589782867|FG001|Overall Study|Adverse Event|1|||
163294242|NCT02770248|589782866|FG000|Overall Study|Randomized in error, prior to treatment|0|||
163294243|NCT02770248|589782867|FG001|Overall Study|Randomized in error, prior to treatment|1|||
163294244|NCT01579916|589782868|FG000|Overall Study|Lost to Follow-up|6|||
163294245|NCT01579916|589782869|FG001|Overall Study|Lost to Follow-up|1|||
163294246|NCT01579916|589782868|FG000|Overall Study|Withdrawal by Subject|1|||
163294247|NCT01579916|589782869|FG001|Overall Study|Withdrawal by Subject|1|||
163294248|NCT01579916|589782868|FG000|Overall Study|Death|1|||
163294249|NCT01579916|589782869|FG001|Overall Study|Death|0|||
163294250|NCT03264456|589782870|FG000|Overall Study|Withdrawal by Subject|3|||
163294251|NCT03264456|589782870|FG000|Overall Study|Lost to Follow-up|1|||
163294252|NCT06119113|589784039|FG000|Overall Study|Lost to Follow-up|15|||
163294253|NCT06119113|589784040|FG001|Overall Study|Lost to Follow-up|13|||
163294254|NCT06119113|589784041|FG002|Overall Study|Lost to Follow-up|21|||
163294255|NCT05136443|589784044|FG000|Overall Study|Lost to Follow-up|2|||
163294256|NCT05136443|589784044|FG000|Overall Study|Adverse Event|2|||
163294257|NCT01786564|589784051|FG000|Overall Study|Lost to Follow-up|47|||
163390093|NCT03153111|590139641|FG000|Overall Study|Withdrawal by Subject|3|||
163390094|NCT03153111|590139642|FG001|Overall Study|Withdrawal by Subject|3|||
163390095|NCT00777946|590139645|FG000|Overall Study|Adverse Event|11|||
163390096|NCT00777946|590139646|FG001|Overall Study|Adverse Event|1|||
163390097|NCT00777946|590139647|FG002|Overall Study|Adverse Event|3|||
163390098|NCT00777946|590139645|FG000|Overall Study|Lack of Efficacy|0|||
163390099|NCT00777946|590139646|FG001|Overall Study|Lack of Efficacy|0|||
163390100|NCT00777946|590139647|FG002|Overall Study|Lack of Efficacy|9|||
163390101|NCT00777946|590139645|FG000|Overall Study|Condition no longer required study drug|1|||
163390102|NCT00777946|590139646|FG001|Overall Study|Condition no longer required study drug|0|||
163390103|NCT00777946|590139647|FG002|Overall Study|Condition no longer required study drug|0|||
163390104|NCT00777946|590139645|FG000|Overall Study|Patient withdrew consent|3|||
163390105|NCT00777946|590139646|FG001|Overall Study|Patient withdrew consent|2|||
163390106|NCT00777946|590139647|FG002|Overall Study|Patient withdrew consent|3|||
163390107|NCT00777946|590139645|FG000|Overall Study|Lost to Follow-up|3|||
163294258|NCT01786564|589784051|FG000|Overall Study|Ineligible|17|||
163390108|NCT00777946|590139646|FG001|Overall Study|Lost to Follow-up|1|||
163390109|NCT00777946|590139647|FG002|Overall Study|Lost to Follow-up|0|||
163390110|NCT00777946|590139645|FG000|Overall Study|Protocol deviation|2|||
163390111|NCT00777946|590139646|FG001|Overall Study|Protocol deviation|1|||
163390112|NCT00777946|590139647|FG002|Overall Study|Protocol deviation|1|||
163390113|NCT00777946|590139645|FG000|Overall Study|Randomized in error|1|||
163390114|NCT00777946|590139646|FG001|Overall Study|Randomized in error|1|||
163390115|NCT00777946|590139647|FG002|Overall Study|Randomized in error|0|||
163390116|NCT02684357|590139648|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
163390117|NCT02684357|590139649|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
163390118|NCT02684357|590139650|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
163390119|NCT02684357|590139651|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
163294259|NCT03034915|589784052|FG000|Overall Study|Adverse Event|29|||
163294260|NCT03034915|589784053|FG001|Overall Study|Adverse Event|32|||
163390120|NCT02684357|590139652|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
163294261|NCT03034915|589784054|FG002|Overall Study|Adverse Event|22|||
163294262|NCT03034915|589784052|FG000|Overall Study|Lost to Follow-up|5|||
163390121|NCT02684357|590139653|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
163390122|NCT02684357|590139648|FG000|Part A|Lost to Follow-up|0|||
163189197|NCT02476201|589409521|FG000|Overall Study|Adverse Event|4|||
163189198|NCT02476201|589409521|FG000|Overall Study|Death|2|||
163189199|NCT02476201|589409521|FG000|Overall Study|Lost to Follow-up|2|||
163189200|NCT02476201|589409521|FG000|Overall Study|MPP programmed to OFF|2|||
163189201|NCT02476201|589409521|FG000|Overall Study|Withdrawal by Subject|1|||
163189202|NCT02476201|589409521|FG000|Overall Study|Unsuccessful implant|1|||
163189203|NCT00777205|589409522|FG000|Overall Study|Lost to Follow-up|25|||
163189204|NCT00777205|589409523|FG001|Overall Study|Lost to Follow-up|9|||
163189205|NCT00777205|589409522|FG000|Overall Study|Withdrawal by Subject|6|||
163189206|NCT00777205|589409523|FG001|Overall Study|Withdrawal by Subject|4|||
163189207|NCT00777205|589409522|FG000|Overall Study|Death|0|||
163189208|NCT00777205|589409523|FG001|Overall Study|Death|2|||
163189209|NCT00777205|589409522|FG000|Overall Study|Protocol Violation|0|||
163189210|NCT00777205|589409523|FG001|Overall Study|Protocol Violation|56|||
163189211|NCT02633501|589409527|FG000|Overall Study|Adverse Event|0|||
163189212|NCT02633501|589409528|FG001|Overall Study|Adverse Event|0|||
163189213|NCT02633501|589409529|FG002|Overall Study|Adverse Event|1|||
163189214|NCT02633501|589409530|FG003|Overall Study|Adverse Event|0|||
163189215|NCT02633501|589409531|FG004|Overall Study|Adverse Event|1|||
163189216|NCT02633501|589409532|FG005|Overall Study|Adverse Event|1|||
163189217|NCT02633501|589409527|FG000|Overall Study|Withdrawal by Subject|2|||
163189218|NCT02633501|589409528|FG001|Overall Study|Withdrawal by Subject|1|||
163189219|NCT02633501|589409529|FG002|Overall Study|Withdrawal by Subject|2|||
163189220|NCT02633501|589409530|FG003|Overall Study|Withdrawal by Subject|2|||
163189221|NCT02633501|589409531|FG004|Overall Study|Withdrawal by Subject|1|||
163189222|NCT02633501|589409532|FG005|Overall Study|Withdrawal by Subject|3|||
163189223|NCT02633501|589409527|FG000|Overall Study|Various other reasons|0|||
163189224|NCT02633501|589409528|FG001|Overall Study|Various other reasons|2|||
163189225|NCT02633501|589409529|FG002|Overall Study|Various other reasons|4|||
163189226|NCT02633501|589409530|FG003|Overall Study|Various other reasons|1|||
163189227|NCT02633501|589409531|FG004|Overall Study|Various other reasons|7|||
163189228|NCT02633501|589409532|FG005|Overall Study|Various other reasons|11|||
163189229|NCT02633501|589409527|FG000|Overall Study|Lost to Follow-up|0|||
163189230|NCT02633501|589409528|FG001|Overall Study|Lost to Follow-up|0|||
163189231|NCT02633501|589409529|FG002|Overall Study|Lost to Follow-up|0|||
163189232|NCT02633501|589409530|FG003|Overall Study|Lost to Follow-up|1|||
163189233|NCT02633501|589409531|FG004|Overall Study|Lost to Follow-up|2|||
163189234|NCT02633501|589409532|FG005|Overall Study|Lost to Follow-up|0|||
163189235|NCT01104155|589409534|FG000|Overall Study|Adverse Event|15|||
163189236|NCT01104155|589409535|FG001|Overall Study|Adverse Event|8|||
163189237|NCT01104155|589409534|FG000|Overall Study|Participant choice|6|||
163189238|NCT01104155|589409535|FG001|Overall Study|Participant choice|5|||
163189239|NCT01104155|589409534|FG000|Overall Study|Withdrawal of consent|1|||
163189240|NCT01104155|589409535|FG001|Overall Study|Withdrawal of consent|1|||
163189241|NCT01104155|589409534|FG000|Overall Study|Other|3|||
163189242|NCT01104155|589409535|FG001|Overall Study|Other|4|||
163189243|NCT00464269|589409538|FG000|Overall Study|Lack of Efficacy|1|||
163294263|NCT03034915|589784053|FG001|Overall Study|Lost to Follow-up|13|||
163294264|NCT03034915|589784054|FG002|Overall Study|Lost to Follow-up|3|||
163294265|NCT03034915|589784052|FG000|Overall Study|Withdrawal by Subject|29|||
163294266|NCT03034915|589784053|FG001|Overall Study|Withdrawal by Subject|46|||
163294267|NCT03034915|589784054|FG002|Overall Study|Withdrawal by Subject|41|||
163294268|NCT03034915|589784052|FG000|Overall Study|Protocol Deviation|2|||
163294269|NCT03034915|589784053|FG001|Overall Study|Protocol Deviation|14|||
163294270|NCT03034915|589784054|FG002|Overall Study|Protocol Deviation|7|||
163294271|NCT03034915|589784052|FG000|Overall Study|Lack of Efficacy|8|||
163294272|NCT03034915|589784053|FG001|Overall Study|Lack of Efficacy|16|||
163294273|NCT03034915|589784054|FG002|Overall Study|Lack of Efficacy|18|||
163294274|NCT03034915|589784052|FG000|Overall Study|Site closed|2|||
163294275|NCT03034915|589784053|FG001|Overall Study|Site closed|2|||
163294276|NCT03034915|589784054|FG002|Overall Study|Site closed|4|||
163294277|NCT03034915|589784052|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
163294278|NCT03034915|589784053|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
163294279|NCT03034915|589784054|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
163294280|NCT03034915|589784052|FG000|Overall Study|Physician Decision|1|||
163294281|NCT03034915|589784053|FG001|Overall Study|Physician Decision|5|||
163189244|NCT00464269|589409539|FG001|Overall Study|Lack of Efficacy|0|||
163189245|NCT00464269|589409540|FG002|Overall Study|Lack of Efficacy|0|||
163189246|NCT00464269|589409541|FG003|Overall Study|Lack of Efficacy|0|||
163189247|NCT00464269|589409538|FG000|Overall Study|Lost to Follow-up|0|||
163294282|NCT03034915|589784054|FG002|Overall Study|Physician Decision|2|||
163294283|NCT03861767|589784057|FG000|Overall Study|Withdrawal by Subject|2|||
163294284|NCT03861767|589784058|FG001|Overall Study|Withdrawal by Subject|1|||
163294285|NCT03861767|589784059|FG002|Overall Study|Withdrawal by Subject|0|||
163189248|NCT00464269|589409539|FG001|Overall Study|Lost to Follow-up|4|||
163189249|NCT00464269|589409540|FG002|Overall Study|Lost to Follow-up|0|||
163189250|NCT00464269|589409541|FG003|Overall Study|Lost to Follow-up|1|||
163294286|NCT03861767|589784060|FG003|Overall Study|Withdrawal by Subject|5|||
163294287|NCT03861767|589784061|FG004|Overall Study|Withdrawal by Subject|2|||
162951462|NCT00304083|588525487|FG001|Overall Study|Physician Decision|3|||
162951463|NCT00304083|588525486|FG000|Overall Study|Disease Progression|5|||
162951464|NCT00304083|588525487|FG001|Overall Study|Disease Progression|1|||
162951465|NCT00304083|588525486|FG000|Overall Study|Other|5|||
162951466|NCT00304083|588525487|FG001|Overall Study|Other|2|||
162951467|NCT03966365|588525488|FG000|Overall Study|Protocol Violation|1|||
162951468|NCT03966365|588525489|FG001|Overall Study|Protocol Violation|0|||
162951469|NCT01378975|588525490|FG000|Overall Study|Death|77|||
162951470|NCT01378975|588525491|FG001|Overall Study|Death|46|||
162951471|NCT01378975|588525490|FG000|Overall Study|Investigator Request|1|||
162951472|NCT01378975|588525491|FG001|Overall Study|Investigator Request|0|||
162951473|NCT01378975|588525490|FG000|Overall Study|Lost to Follow-up|4|||
162951474|NCT01378975|588525491|FG001|Overall Study|Lost to Follow-up|1|||
162951475|NCT01378975|588525490|FG000|Overall Study|Withdrew Consent|4|||
162951476|NCT01378975|588525491|FG001|Overall Study|Withdrew Consent|3|||
162951477|NCT00319735|588525492|FG000|Overall Study|Death|2|||
162951478|NCT01149473|588527543|FG000|First Intervention|Adverse Event|1|||
162951479|NCT01149473|588527544|FG001|First Intervention|Adverse Event|1|||
162951480|NCT01149473|588527543|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
162951481|NCT01149473|588527544|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
162951482|NCT01247701|588527545|FG000|Overall Study|Death|2|||
162951483|NCT01247701|588527545|FG000|Overall Study|Relapsed|8|||
162951484|NCT04166630|588527546|FG000|Overall Study|Withdrawal by Subject|0|||
162951485|NCT04166630|588527547|FG001|Overall Study|Withdrawal by Subject|1|||
162951486|NCT01838941|588527548|FG000|Overall Study|Adverse Event|1|||
162951487|NCT01838941|588527548|FG000|Overall Study|Withdrawal by Subject|1|||
162951488|NCT02822235|588527549|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
162951489|NCT02822235|588527550|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
162951490|NCT02822235|588527549|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
162951491|NCT02822235|588527550|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
162951492|NCT02822235|588527549|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
162951493|NCT02822235|588527550|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
162951494|NCT02822235|588527549|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
162951495|NCT02822235|588527550|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
162951496|NCT02822235|588527549|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
162951497|NCT02822235|588527550|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
163042862|NCT00845676|588863980|FG000|Overall Study|Virologic breakthrough at week 20|1|||
163294288|NCT03861767|589784062|FG005|Overall Study|Withdrawal by Subject|1|||
162951498|NCT02822235|588527549|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
162951499|NCT02822235|588527550|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
162951500|NCT00829530|588527551|FG000|First Intervention|Adverse Event|0|||
162951501|NCT00829530|588527552|FG001|First Intervention|Adverse Event|1|||
162951502|NCT00829530|588527551|FG000|First Intervention|Intolerance to Venopuncture|0|||
163390123|NCT02684357|590139649|FG001|Part A|Lost to Follow-up|2|||
163390124|NCT02684357|590139650|FG002|Part A|Lost to Follow-up|2|||
163390125|NCT02684357|590139651|FG003|Part A|Lost to Follow-up|0|||
163390126|NCT02684357|590139652|FG004|Part A|Lost to Follow-up|0|||
163390127|NCT02684357|590139653|FG005|Part A|Lost to Follow-up|0|||
163390128|NCT02684357|590139648|FG000|Part A|Withdrawal by Subject|3|||
163390129|NCT02684357|590139649|FG001|Part A|Withdrawal by Subject|0|||
163390130|NCT02684357|590139650|FG002|Part A|Withdrawal by Subject|0|||
163390131|NCT02684357|590139651|FG003|Part A|Withdrawal by Subject|0|||
163390132|NCT02684357|590139652|FG004|Part A|Withdrawal by Subject|0|||
163390133|NCT02684357|590139653|FG005|Part A|Withdrawal by Subject|0|||
163390134|NCT02684357|590139648|FG000|Part A|Other|0|||
163390135|NCT02684357|590139649|FG001|Part A|Other|1|||
163390136|NCT02684357|590139650|FG002|Part A|Other|0|||
163390137|NCT02684357|590139651|FG003|Part A|Other|0|||
163390138|NCT02684357|590139652|FG004|Part A|Other|0|||
163390139|NCT02684357|590139653|FG005|Part A|Other|0|||
163390140|NCT02684357|590139648|FG000|Part B|Adverse Event (Other)|0|||
163390141|NCT02684357|590139649|FG001|Part B|Adverse Event (Other)|0|||
163390142|NCT02684357|590139650|FG002|Part B|Adverse Event (Other)|0|||
163390143|NCT02684357|590139651|FG003|Part B|Adverse Event (Other)|1|||
163390144|NCT02684357|590139652|FG004|Part B|Adverse Event (Other)|1|||
163390145|NCT02684357|590139653|FG005|Part B|Adverse Event (Other)|1|||
163390146|NCT02684357|590139648|FG000|Part B|Lost to Follow-up|0|||
163390147|NCT02684357|590139649|FG001|Part B|Lost to Follow-up|0|||
163390148|NCT02684357|590139650|FG002|Part B|Lost to Follow-up|0|||
163390149|NCT02684357|590139651|FG003|Part B|Lost to Follow-up|1|||
163390150|NCT02684357|590139652|FG004|Part B|Lost to Follow-up|1|||
163390151|NCT02684357|590139653|FG005|Part B|Lost to Follow-up|7|||
163390152|NCT02684357|590139648|FG000|Part B|Withdrawal by Subject|0|||
163390153|NCT02684357|590139649|FG001|Part B|Withdrawal by Subject|0|||
163390154|NCT02684357|590139650|FG002|Part B|Withdrawal by Subject|0|||
163390155|NCT02684357|590139651|FG003|Part B|Withdrawal by Subject|0|||
163390156|NCT02684357|590139652|FG004|Part B|Withdrawal by Subject|2|||
163390157|NCT02684357|590139653|FG005|Part B|Withdrawal by Subject|4|||
163390158|NCT02684357|590139648|FG000|Part B|Other|0|||
163390159|NCT02684357|590139649|FG001|Part B|Other|0|||
163390160|NCT02684357|590139650|FG002|Part B|Other|0|||
163390161|NCT02684357|590139651|FG003|Part B|Other|1|||
163390162|NCT02684357|590139652|FG004|Part B|Other|0|||
163390163|NCT02684357|590139653|FG005|Part B|Other|1|||
163390164|NCT00390910|590139654|FG000|Overall Study|Adverse Event|1|||
163390165|NCT00390910|590139655|FG001|Overall Study|Adverse Event|0|||
163390166|NCT00390910|590139656|FG002|Overall Study|Adverse Event|0|||
163390167|NCT00390910|590139654|FG000|Overall Study|Lost to Follow-up|0|||
163390168|NCT00390910|590139655|FG001|Overall Study|Lost to Follow-up|1|||
163390169|NCT00390910|590139656|FG002|Overall Study|Lost to Follow-up|5|||
163390170|NCT00390910|590139654|FG000|Overall Study|Withdrawal by Subject|1|||
162951503|NCT00829530|588527552|FG001|First Intervention|Intolerance to Venopuncture|1|||
163294289|NCT03861767|589784063|FG006|Overall Study|Withdrawal by Subject|3|||
163294290|NCT03861767|589784064|FG007|Overall Study|Withdrawal by Subject|1|||
162951504|NCT00829530|588527551|FG000|Second Intervention|Intolerance to Venopuncture|1|||
162951505|NCT00829530|588527552|FG001|Second Intervention|Intolerance to Venopuncture|0|||
162951506|NCT01038856|588527555|FG000|Overall Study|Adverse Event|2|||
162951507|NCT04638153|588527556|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162951508|NCT04638153|588527557|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163294291|NCT03861767|589784065|FG008|Overall Study|Withdrawal by Subject|0|||
163294292|NCT03861767|589784066|FG009|Overall Study|Withdrawal by Subject|5|||
163294293|NCT00424762|589784072|FG000|Overall Study|Withdrawal by Subject|18|||
163294294|NCT00424762|589784073|FG001|Overall Study|Withdrawal by Subject|19|||
163294295|NCT00424762|589784072|FG000|Overall Study|Lost to Follow-up|2|||
163294296|NCT00424762|589784073|FG001|Overall Study|Lost to Follow-up|3|||
163294297|NCT01145885|589784074|FG000|Overall Study|Progressive Disease|7|||
162951509|NCT04638153|588527558|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163294298|NCT05299606|589784075|FG000|Overall Study|Death|1|||
162951510|NCT04638153|588527556|FG000|Overall Study|Study terminated by sponsor|4|||
163294299|NCT03460756|589784077|FG000|Overall Study|Adverse Event|0|||
163294300|NCT03460756|589784078|FG001|Overall Study|Adverse Event|0|||
163294301|NCT03460756|589784079|FG002|Overall Study|Adverse Event|0|||
163294302|NCT03460756|589784080|FG003|Overall Study|Adverse Event|1|||
163390171|NCT00390910|590139655|FG001|Overall Study|Withdrawal by Subject|3|||
163390172|NCT00390910|590139656|FG002|Overall Study|Withdrawal by Subject|2|||
163390173|NCT00390910|590139654|FG000|Overall Study|Migrated/moved from study area|0|||
163390174|NCT00390910|590139655|FG001|Overall Study|Migrated/moved from study area|0|||
163390175|NCT00390910|590139656|FG002|Overall Study|Migrated/moved from study area|3|||
162951511|NCT04638153|588527557|FG001|Overall Study|Study terminated by sponsor|2|||
163294303|NCT03460756|589784077|FG000|Overall Study|Lack of Efficacy|0|||
163294304|NCT03460756|589784078|FG001|Overall Study|Lack of Efficacy|0|||
163390176|NCT04821869|590139669|FG000|Overall Study|Adverse Event|4|||
163390177|NCT04821869|590139669|FG000|Overall Study|Withdrawal by Subject|2|||
163390178|NCT04821869|590139669|FG000|Overall Study|Did not meet FEV1 criteria|1|||
163189251|NCT00464269|589409538|FG000|Overall Study|Withdrawal by Subject|0|||
163189252|NCT00464269|589409539|FG001|Overall Study|Withdrawal by Subject|2|||
163189253|NCT00464269|589409540|FG002|Overall Study|Withdrawal by Subject|1|||
163189254|NCT00464269|589409541|FG003|Overall Study|Withdrawal by Subject|1|||
162951512|NCT04638153|588527558|FG002|Overall Study|Study terminated by sponsor|14|||
162951513|NCT01440283|588527559|FG000|Overall Study|Death|3|||
162951514|NCT01440283|588527559|FG000|Overall Study|Withdrawal by Subject|4|||
162951515|NCT01440283|588527559|FG000|Overall Study|Physician Decision|3|||
162951516|NCT01196052|588527560|FG000|Overall Study|Adverse Event|9|||
162951517|NCT01196052|588527560|FG000|Overall Study|Lost to Follow-up|1|||
162951518|NCT01196052|588527560|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
162951519|NCT01196052|588527560|FG000|Overall Study|Reason not Specified|5|||
162951520|NCT01196052|588527560|FG000|Overall Study|Withdrawal by Subject|6|||
162951521|NCT01389102|588527561|FG000|Overall Study|Adverse Event|1|||
162951522|NCT01389102|588527562|FG001|Overall Study|Adverse Event|3|||
162951523|NCT01389102|588527563|FG002|Overall Study|Adverse Event|2|||
162951524|NCT01389102|588527564|FG003|Overall Study|Adverse Event|2|||
162951525|NCT01389102|588527565|FG004|Overall Study|Adverse Event|2|||
162951526|NCT01389102|588527566|FG005|Overall Study|Adverse Event|2|||
162951527|NCT01389102|588527561|FG000|Overall Study|Hurricane Katrina|4|||
162951528|NCT01389102|588527562|FG001|Overall Study|Hurricane Katrina|2|||
162951529|NCT01389102|588527563|FG002|Overall Study|Hurricane Katrina|3|||
162951530|NCT01389102|588527564|FG003|Overall Study|Hurricane Katrina|0|||
162951531|NCT01389102|588527565|FG004|Overall Study|Hurricane Katrina|3|||
162951532|NCT01389102|588527566|FG005|Overall Study|Hurricane Katrina|1|||
162951533|NCT01389102|588527561|FG000|Overall Study|Lost to Follow-up|4|||
162951534|NCT01389102|588527562|FG001|Overall Study|Lost to Follow-up|1|||
162951535|NCT01389102|588527563|FG002|Overall Study|Lost to Follow-up|1|||
162951536|NCT01389102|588527564|FG003|Overall Study|Lost to Follow-up|2|||
162951537|NCT01389102|588527565|FG004|Overall Study|Lost to Follow-up|4|||
162951538|NCT01389102|588527566|FG005|Overall Study|Lost to Follow-up|1|||
162951539|NCT01389102|588527561|FG000|Overall Study|Protocol Violation|0|||
162951540|NCT01389102|588527562|FG001|Overall Study|Protocol Violation|0|||
162951541|NCT01389102|588527563|FG002|Overall Study|Protocol Violation|3|||
162951542|NCT01389102|588527564|FG003|Overall Study|Protocol Violation|0|||
163189255|NCT00464269|589409538|FG000|Overall Study|Other reason|3|||
163189256|NCT00464269|589409539|FG001|Overall Study|Other reason|3|||
163189257|NCT00464269|589409540|FG002|Overall Study|Other reason|1|||
163189258|NCT00464269|589409541|FG003|Overall Study|Other reason|1|||
163294305|NCT03460756|589784079|FG002|Overall Study|Lack of Efficacy|0|||
163294306|NCT03460756|589784080|FG003|Overall Study|Lack of Efficacy|2|||
163294307|NCT03460756|589784077|FG000|Overall Study|Lost to Follow-up|0|||
163294308|NCT03460756|589784078|FG001|Overall Study|Lost to Follow-up|1|||
163294309|NCT03460756|589784079|FG002|Overall Study|Lost to Follow-up|2|||
163294310|NCT03460756|589784080|FG003|Overall Study|Lost to Follow-up|1|||
163294311|NCT03460756|589784077|FG000|Overall Study|Pregnancy|0|||
163294312|NCT03460756|589784078|FG001|Overall Study|Pregnancy|0|||
163294313|NCT03460756|589784079|FG002|Overall Study|Pregnancy|0|||
163294314|NCT03460756|589784080|FG003|Overall Study|Pregnancy|1|||
163294315|NCT03460756|589784077|FG000|Overall Study|Protocol Violation|0|||
163294316|NCT03460756|589784078|FG001|Overall Study|Protocol Violation|0|||
163294317|NCT03460756|589784079|FG002|Overall Study|Protocol Violation|0|||
163294318|NCT03460756|589784080|FG003|Overall Study|Protocol Violation|1|||
163294319|NCT03460756|589784077|FG000|Overall Study|Withdrawal by Subject|0|||
163294320|NCT03460756|589784078|FG001|Overall Study|Withdrawal by Subject|4|||
163294321|NCT03460756|589784079|FG002|Overall Study|Withdrawal by Subject|7|||
163294322|NCT03460756|589784080|FG003|Overall Study|Withdrawal by Subject|3|||
163294323|NCT00723450|589784082|FG000|Open-Label Phase|Adverse Event|26|||
163294324|NCT00723450|589784083|FG001|Open-Label Phase|Adverse Event|0|||
163390179|NCT01313117|590139673|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
163189259|NCT00464269|589409538|FG000|Overall Study|AE, serious fatal|0|||
163189260|NCT00464269|589409539|FG001|Overall Study|AE, serious fatal|0|||
163189261|NCT00464269|589409540|FG002|Overall Study|AE, serious fatal|1|||
163189262|NCT00464269|589409541|FG003|Overall Study|AE, serious fatal|1|||
163189263|NCT00464269|589409538|FG000|Overall Study|SAE, non-fatal|0|||
163189264|NCT00464269|589409539|FG001|Overall Study|SAE, non-fatal|0|||
163294325|NCT00723450|589784084|FG002|Open-Label Phase|Adverse Event|0|||
163294326|NCT00723450|589784082|FG000|Open-Label Phase|Lack of Efficacy|18|||
163294327|NCT00723450|589784083|FG001|Open-Label Phase|Lack of Efficacy|0|||
163294328|NCT00723450|589784084|FG002|Open-Label Phase|Lack of Efficacy|0|||
163294329|NCT00723450|589784082|FG000|Open-Label Phase|Protocol Violation|35|||
163294330|NCT00723450|589784083|FG001|Open-Label Phase|Protocol Violation|0|||
163294331|NCT00723450|589784084|FG002|Open-Label Phase|Protocol Violation|0|||
163294332|NCT00723450|589784082|FG000|Open-Label Phase|Lost to Follow-up|7|||
162951543|NCT01389102|588527565|FG004|Overall Study|Protocol Violation|1|||
162951544|NCT01389102|588527566|FG005|Overall Study|Protocol Violation|1|||
162951545|NCT01389102|588527561|FG000|Overall Study|Withdrawal by Subject|7|||
162951546|NCT01389102|588527562|FG001|Overall Study|Withdrawal by Subject|4|||
162951547|NCT01389102|588527563|FG002|Overall Study|Withdrawal by Subject|9|||
163189265|NCT00464269|589409540|FG002|Overall Study|SAE, non-fatal|0|||
163294333|NCT00723450|589784083|FG001|Open-Label Phase|Lost to Follow-up|0|||
162951548|NCT01389102|588527564|FG003|Overall Study|Withdrawal by Subject|2|||
162951549|NCT01389102|588527565|FG004|Overall Study|Withdrawal by Subject|3|||
162951550|NCT01389102|588527566|FG005|Overall Study|Withdrawal by Subject|3|||
162951551|NCT01389102|588527561|FG000|Overall Study|Subject Traveling Out of Country|0|||
162951552|NCT01389102|588527562|FG001|Overall Study|Subject Traveling Out of Country|0|||
162951553|NCT01389102|588527563|FG002|Overall Study|Subject Traveling Out of Country|0|||
163189266|NCT00464269|589409541|FG003|Overall Study|SAE, non-fatal|1|||
163189267|NCT00464269|589409538|FG000|Overall Study|AE, non-serious non-fatal|2|||
163189268|NCT00464269|589409539|FG001|Overall Study|AE, non-serious non-fatal|8|||
163189269|NCT00464269|589409540|FG002|Overall Study|AE, non-serious non-fatal|3|||
163189270|NCT00464269|589409541|FG003|Overall Study|AE, non-serious non-fatal|4|||
163189271|NCT00464269|589409538|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
163189272|NCT00464269|589409539|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
163189273|NCT00464269|589409540|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
163189274|NCT00464269|589409541|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
163189275|NCT05055128|589409542|FG000|Overall Study|Adverse Event|0|||
163189276|NCT05055128|589409543|FG001|Overall Study|Adverse Event|0|||
163189277|NCT05055128|589409544|FG002|Overall Study|Adverse Event|0|||
163189278|NCT05055128|589409545|FG003|Overall Study|Adverse Event|1|||
163189279|NCT05055128|589409546|FG004|Overall Study|Adverse Event|1|||
163189280|NCT05055128|589409542|FG000|Overall Study|Protocol Violation|0|||
163189281|NCT05055128|589409543|FG001|Overall Study|Protocol Violation|0|||
163189282|NCT05055128|589409544|FG002|Overall Study|Protocol Violation|0|||
163189283|NCT05055128|589409545|FG003|Overall Study|Protocol Violation|1|||
163189284|NCT05055128|589409546|FG004|Overall Study|Protocol Violation|0|||
163189285|NCT05055128|589409542|FG000|Overall Study|Withdrawal by Subject|5|||
163189286|NCT05055128|589409543|FG001|Overall Study|Withdrawal by Subject|2|||
163189287|NCT05055128|589409544|FG002|Overall Study|Withdrawal by Subject|2|||
163189288|NCT05055128|589409545|FG003|Overall Study|Withdrawal by Subject|4|||
163189289|NCT05055128|589409546|FG004|Overall Study|Withdrawal by Subject|2|||
163189290|NCT05055128|589409542|FG000|Overall Study|Randomized By Mistake|0|||
163390180|NCT01313117|590139673|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
163390181|NCT03602261|590139674|FG000|Overall Study|Adverse Event|5|||
163390182|NCT03602261|590139675|FG001|Overall Study|Adverse Event|1|||
163390183|NCT03602261|590139674|FG000|Overall Study|Physician Decision|1|||
163390184|NCT03602261|590139675|FG001|Overall Study|Physician Decision|0|||
163390185|NCT03602261|590139674|FG000|Overall Study|Withdrawal by Subject|1|||
163390186|NCT03602261|590139675|FG001|Overall Study|Withdrawal by Subject|1|||
163390187|NCT03602261|590139674|FG000|Overall Study|Lack of Efficacy|0|||
163390188|NCT03602261|590139675|FG001|Overall Study|Lack of Efficacy|1|||
163390189|NCT03602261|590139674|FG000|Overall Study|Subject moving out of state|1|||
163390190|NCT03602261|590139675|FG001|Overall Study|Subject moving out of state|0|||
163390191|NCT01436071|590141548|FG000|Overall Study|Adverse Event|1|||
163390192|NCT01436071|590141549|FG001|Overall Study|Adverse Event|0|||
163390193|NCT01436071|590141548|FG000|Overall Study|Lack of Efficacy|16|||
163390194|NCT01436071|590141549|FG001|Overall Study|Lack of Efficacy|7|||
163390195|NCT01436071|590141548|FG000|Overall Study|Protocol Violation|0|||
163390196|NCT01436071|590141549|FG001|Overall Study|Protocol Violation|1|||
163390197|NCT01436071|590141548|FG000|Overall Study|Lost to Follow-up|3|||
163390198|NCT01436071|590141549|FG001|Overall Study|Lost to Follow-up|1|||
163390199|NCT01436071|590141548|FG000|Overall Study|Physician Decision|1|||
163390200|NCT01436071|590141549|FG001|Overall Study|Physician Decision|0|||
163390201|NCT01436071|590141548|FG000|Overall Study|Withdrawal by Subject|2|||
163390202|NCT01436071|590141549|FG001|Overall Study|Withdrawal by Subject|2|||
163390203|NCT01436071|590141548|FG000|Overall Study|Did Not Receive Trial Medication|3|||
163390204|NCT01436071|590141549|FG001|Overall Study|Did Not Receive Trial Medication|3|||
163390205|NCT03808688|590141552|FG000|Overall Study|Adverse Event|13|||
163390206|NCT03808688|590141553|FG001|Overall Study|Adverse Event|17|||
163390207|NCT03808688|590141552|FG000|Overall Study|Lack of Efficacy|2|||
163390208|NCT03808688|590141553|FG001|Overall Study|Lack of Efficacy|0|||
163390209|NCT03808688|590141552|FG000|Overall Study|Lost to Follow-up|0|||
163390210|NCT03808688|590141553|FG001|Overall Study|Lost to Follow-up|2|||
163390211|NCT03808688|590141552|FG000|Overall Study|Withdrawal by Subject|1|||
163390212|NCT03808688|590141553|FG001|Overall Study|Withdrawal by Subject|0|||
163390213|NCT03808688|590141552|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
163390214|NCT03808688|590141553|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
163390215|NCT03808688|590141552|FG000|Overall Study|IOP Too High|1|||
163390216|NCT03808688|590141553|FG001|Overall Study|IOP Too High|1|||
163390217|NCT03808688|590141552|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
163390218|NCT03808688|590141553|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
163390219|NCT03808688|590141552|FG000|Overall Study|Visit Out of Window|0|||
163390220|NCT03808688|590141553|FG001|Overall Study|Visit Out of Window|1|||
163390221|NCT03808688|590141552|FG000|Overall Study|Medication Non-Compliance|0|||
163390222|NCT03808688|590141553|FG001|Overall Study|Medication Non-Compliance|1|||
163390223|NCT03335163|590141557|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
163390224|NCT03335163|590141557|FG000|Overall Study|Withdrawal by Subject|18|||
163390225|NCT01215175|590141559|FG000|Overall Study|Lost to Follow-up|0|||
163390226|NCT01215175|590141560|FG001|Overall Study|Lost to Follow-up|1|||
162951554|NCT01389102|588527564|FG003|Overall Study|Subject Traveling Out of Country|1|||
162951555|NCT01389102|588527565|FG004|Overall Study|Subject Traveling Out of Country|0|||
162951556|NCT01389102|588527566|FG005|Overall Study|Subject Traveling Out of Country|0|||
162951557|NCT01389102|588527561|FG000|Overall Study|Subject Moved|2|||
162951558|NCT01389102|588527562|FG001|Overall Study|Subject Moved|0|||
162951559|NCT01389102|588527563|FG002|Overall Study|Subject Moved|1|||
162951560|NCT01389102|588527564|FG003|Overall Study|Subject Moved|0|||
162951561|NCT01389102|588527565|FG004|Overall Study|Subject Moved|0|||
162951562|NCT01389102|588527566|FG005|Overall Study|Subject Moved|0|||
162951563|NCT01389102|588527561|FG000|Overall Study|Unavailable due to husband's illness|0|||
162951564|NCT01389102|588527562|FG001|Overall Study|Unavailable due to husband's illness|1|||
162951565|NCT01389102|588527563|FG002|Overall Study|Unavailable due to husband's illness|0|||
162951566|NCT01389102|588527564|FG003|Overall Study|Unavailable due to husband's illness|0|||
162951567|NCT01389102|588527565|FG004|Overall Study|Unavailable due to husband's illness|0|||
162951568|NCT01389102|588527566|FG005|Overall Study|Unavailable due to husband's illness|0|||
162951569|NCT01389102|588527561|FG000|Overall Study|Investigator Judgement|0|||
162951570|NCT01389102|588527562|FG001|Overall Study|Investigator Judgement|1|||
162951571|NCT01389102|588527563|FG002|Overall Study|Investigator Judgement|0|||
162951572|NCT01389102|588527564|FG003|Overall Study|Investigator Judgement|0|||
162951573|NCT01389102|588527565|FG004|Overall Study|Investigator Judgement|0|||
162951574|NCT01389102|588527566|FG005|Overall Study|Investigator Judgement|0|||
162951575|NCT00050778|588527567|FG000|Overall Study|Adverse Event|13|||
162951576|NCT00050778|588527568|FG001|Overall Study|Adverse Event|3|||
162951577|NCT00050778|588527569|FG002|Overall Study|Adverse Event|2|||
163390227|NCT01215175|590141561|FG002|Overall Study|Lost to Follow-up|0|||
163390228|NCT01215175|590141562|FG003|Overall Study|Lost to Follow-up|1|||
163390229|NCT01215175|590141563|FG004|Overall Study|Lost to Follow-up|0|||
163390230|NCT01016964|590141564|FG000|Overall Study|Lost to Follow-up|3|||
163390231|NCT01016964|590141565|FG001|Overall Study|Lost to Follow-up|3|||
163390232|NCT03872453|590141566|FG000|Overall Study|Adverse Event|1|||
163189291|NCT05055128|589409543|FG001|Overall Study|Randomized By Mistake|1|||
163189292|NCT05055128|589409544|FG002|Overall Study|Randomized By Mistake|0|||
163189293|NCT05055128|589409545|FG003|Overall Study|Randomized By Mistake|0|||
163189294|NCT05055128|589409546|FG004|Overall Study|Randomized By Mistake|0|||
163390233|NCT03872453|590141567|FG001|Overall Study|Adverse Event|1|||
163390234|NCT03872453|590141568|FG002|Overall Study|Adverse Event|0|||
163390235|NCT03872453|590141569|FG003|Overall Study|Adverse Event|0|||
163390236|NCT03872453|590141566|FG000|Overall Study|Lost to Follow-up|8|||
163390237|NCT03872453|590141567|FG001|Overall Study|Lost to Follow-up|7|||
163390238|NCT03872453|590141568|FG002|Overall Study|Lost to Follow-up|4|||
163390239|NCT03872453|590141569|FG003|Overall Study|Lost to Follow-up|4|||
163390240|NCT03872453|590141566|FG000|Overall Study|Never Treated Migraine|19|||
163390241|NCT03872453|590141567|FG001|Overall Study|Never Treated Migraine|17|||
163390242|NCT03872453|590141568|FG002|Overall Study|Never Treated Migraine|13|||
163390243|NCT03872453|590141569|FG003|Overall Study|Never Treated Migraine|12|||
163390244|NCT03872453|590141566|FG000|Overall Study|Pregnancy|1|||
163390245|NCT03872453|590141567|FG001|Overall Study|Pregnancy|0|||
163390246|NCT03872453|590141568|FG002|Overall Study|Pregnancy|0|||
163390247|NCT03872453|590141569|FG003|Overall Study|Pregnancy|0|||
163390248|NCT03872453|590141566|FG000|Overall Study|Protocol Deviation|2|||
163390249|NCT03872453|590141567|FG001|Overall Study|Protocol Deviation|0|||
163189295|NCT05055128|589409542|FG000|Overall Study|Other|1|||
163189296|NCT05055128|589409543|FG001|Overall Study|Other|0|||
163189297|NCT05055128|589409544|FG002|Overall Study|Other|0|||
163189298|NCT05055128|589409545|FG003|Overall Study|Other|0|||
163189299|NCT05055128|589409546|FG004|Overall Study|Other|0|||
163189300|NCT00747461|589409547|FG000|Overall Study|study terminated by sponsor|5|||
163189301|NCT02149875|589409548|FG000|Overall Study|Lost to Follow-up|3|||
163390250|NCT03872453|590141568|FG002|Overall Study|Protocol Deviation|0|||
163390251|NCT03872453|590141569|FG003|Overall Study|Protocol Deviation|2|||
163189302|NCT02149875|589409549|FG001|Overall Study|Lost to Follow-up|4|||
163189303|NCT02149875|589409550|FG002|Overall Study|Lost to Follow-up|5|||
163189304|NCT02149875|589409548|FG000|Overall Study|Withdrawal by Subject|3|||
163189305|NCT02149875|589409549|FG001|Overall Study|Withdrawal by Subject|2|||
163390252|NCT03872453|590141566|FG000|Overall Study|Withdrawal by Subject|0|||
162951578|NCT00050778|588527567|FG000|Overall Study|Death|0|||
162951579|NCT00050778|588527568|FG001|Overall Study|Death|1|||
162951580|NCT00050778|588527569|FG002|Overall Study|Death|1|||
162951581|NCT00050778|588527567|FG000|Overall Study|Lack of Efficacy|16|||
162951582|NCT00050778|588527568|FG001|Overall Study|Lack of Efficacy|2|||
162951583|NCT00050778|588527569|FG002|Overall Study|Lack of Efficacy|2|||
162951584|NCT00050778|588527567|FG000|Overall Study|Lost to Follow-up|0|||
162951585|NCT00050778|588527568|FG001|Overall Study|Lost to Follow-up|2|||
162951586|NCT00050778|588527569|FG002|Overall Study|Lost to Follow-up|4|||
162951587|NCT00050778|588527567|FG000|Overall Study|Physician Decision|3|||
162951588|NCT00050778|588527568|FG001|Overall Study|Physician Decision|0|||
162951589|NCT00050778|588527569|FG002|Overall Study|Physician Decision|2|||
162951590|NCT00050778|588527567|FG000|Overall Study|Protocol Violation|2|||
162951591|NCT00050778|588527568|FG001|Overall Study|Protocol Violation|0|||
162951592|NCT00050778|588527569|FG002|Overall Study|Protocol Violation|1|||
162951593|NCT00050778|588527567|FG000|Overall Study|Withdrawal by Subject|6|||
162951594|NCT00050778|588527568|FG001|Overall Study|Withdrawal by Subject|8|||
162951595|NCT00050778|588527569|FG002|Overall Study|Withdrawal by Subject|4|||
162951596|NCT00050778|588527567|FG000|Overall Study|Randomized but not treated|4|||
162951597|NCT00050778|588527568|FG001|Overall Study|Randomized but not treated|5|||
162951598|NCT00050778|588527569|FG002|Overall Study|Randomized but not treated|2|||
162951599|NCT00050778|588527567|FG000|Overall Study|Familial and personal reasons|1|||
162951600|NCT00050778|588527568|FG001|Overall Study|Familial and personal reasons|0|||
162951601|NCT00050778|588527569|FG002|Overall Study|Familial and personal reasons|0|||
162951602|NCT01035060|588527570|FG000|Overall Study|Lost to Follow-up|0|||
162951603|NCT01035060|588527571|FG001|Overall Study|Lost to Follow-up|7|||
162951604|NCT01035060|588527570|FG000|Overall Study|Did not quality after 2nd screening|14|||
162951605|NCT01035060|588527571|FG001|Overall Study|Did not quality after 2nd screening|1|||
162951606|NCT01035060|588527570|FG000|Overall Study|Withdrawal by Subject|8|||
162951607|NCT01035060|588527571|FG001|Overall Study|Withdrawal by Subject|6|||
163294334|NCT00723450|589784084|FG002|Open-Label Phase|Lost to Follow-up|0|||
163294335|NCT00723450|589784082|FG000|Open-Label Phase|Physician Decision|2|||
163294336|NCT00723450|589784083|FG001|Open-Label Phase|Physician Decision|0|||
163294337|NCT00723450|589784084|FG002|Open-Label Phase|Physician Decision|0|||
163294338|NCT00723450|589784082|FG000|Open-Label Phase|Withdrawal by Subject|37|||
163294339|NCT00723450|589784083|FG001|Open-Label Phase|Withdrawal by Subject|0|||
163294340|NCT00723450|589784084|FG002|Open-Label Phase|Withdrawal by Subject|0|||
163294341|NCT00723450|589784082|FG000|Randomized Phase|Adverse Event|0|||
163390253|NCT03872453|590141567|FG001|Overall Study|Withdrawal by Subject|1|||
162951608|NCT01035060|588527570|FG000|Overall Study|Physician Decision|2|||
162951609|NCT01035060|588527571|FG001|Overall Study|Physician Decision|0|||
162951610|NCT00625443|588527573|FG000|Overall Study|Adverse Event|1|||
162951611|NCT00625443|588527574|FG001|Overall Study|Adverse Event|4|||
162951612|NCT00625443|588527575|FG002|Overall Study|Adverse Event|0|||
162951613|NCT00625443|588527573|FG000|Overall Study|Non-compliance with protocol|0|||
162951614|NCT00625443|588527574|FG001|Overall Study|Non-compliance with protocol|1|||
162951615|NCT00625443|588527575|FG002|Overall Study|Non-compliance with protocol|0|||
162951616|NCT00625443|588527573|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
162951617|NCT00625443|588527574|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
162951618|NCT00625443|588527575|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
162951619|NCT00625443|588527573|FG000|Overall Study|Withdrawal by Subject|0|||
162951620|NCT00625443|588527574|FG001|Overall Study|Withdrawal by Subject|1|||
162951621|NCT00625443|588527575|FG002|Overall Study|Withdrawal by Subject|2|||
162951622|NCT00625443|588527573|FG000|Overall Study|Physician Decision|0|||
162951623|NCT00625443|588527574|FG001|Overall Study|Physician Decision|4|||
162951624|NCT00625443|588527575|FG002|Overall Study|Physician Decision|2|||
162951625|NCT00625443|588527573|FG000|Overall Study|Other|0|||
162951626|NCT00625443|588527574|FG001|Overall Study|Other|1|||
162951627|NCT00625443|588527575|FG002|Overall Study|Other|1|||
162951628|NCT02015390|588527576|FG000|Overall Study|Lost to Follow-up|1|||
162951629|NCT02015390|588527577|FG001|Overall Study|Lost to Follow-up|0|||
162951630|NCT02015390|588527576|FG000|Overall Study|Adverse Event|0|||
162951631|NCT02015390|588527577|FG001|Overall Study|Adverse Event|3|||
162951632|NCT02015390|588527576|FG000|Overall Study|Physician Decision|0|||
162951633|NCT02015390|588527577|FG001|Overall Study|Physician Decision|1|||
162951634|NCT03136380|588527578|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
162951635|NCT03136380|588527579|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
162951636|NCT03136380|588527580|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
162951637|NCT03136380|588527581|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
162951638|NCT03136380|588527582|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
162951639|NCT01661686|588527583|FG000|Overall Study|Lost to Follow-up|2|||
162951640|NCT01661686|588527584|FG001|Overall Study|Lost to Follow-up|1|||
162951641|NCT01661686|588527583|FG000|Overall Study|did not receive allocated intervention|0|||
162951642|NCT01661686|588527584|FG001|Overall Study|did not receive allocated intervention|1|||
162951643|NCT01720264|588527589|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
162951644|NCT01720264|588527589|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
162951645|NCT01720264|588527589|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
162951646|NCT02728102|588527590|FG000|Overall Study|Death|3|||
162951647|NCT02728102|588527591|FG001|Overall Study|Death|0|||
162951648|NCT02728102|588527592|FG002|Overall Study|Death|1|||
162951649|NCT02728102|588527590|FG000|Overall Study|Withdrawal by Subject|0|||
162951650|NCT02728102|588527591|FG001|Overall Study|Withdrawal by Subject|2|||
162951651|NCT02728102|588527592|FG002|Overall Study|Withdrawal by Subject|3|||
162951652|NCT02728102|588527590|FG000|Overall Study|Physician Decision|1|||
162951653|NCT02728102|588527591|FG001|Overall Study|Physician Decision|1|||
162951654|NCT02728102|588527592|FG002|Overall Study|Physician Decision|0|||
162951655|NCT02728102|588527590|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
162951656|NCT02728102|588527591|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
162951657|NCT02728102|588527592|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
162951658|NCT02728102|588527590|FG000|Overall Study|Covid|0|||
163294342|NCT00723450|589784083|FG001|Randomized Phase|Adverse Event|26|||
162951659|NCT02728102|588527591|FG001|Overall Study|Covid|0|||
162951660|NCT02728102|588527592|FG002|Overall Study|Covid|1|||
162951661|NCT04869787|588527593|FG000|Screening|Physician Decision|1|||
162951662|NCT04869787|588527593|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
163390254|NCT03872453|590141568|FG002|Overall Study|Withdrawal by Subject|2|||
163390255|NCT03872453|590141569|FG003|Overall Study|Withdrawal by Subject|0|||
163390256|NCT03872453|590141566|FG000|Overall Study|Other Than Specified|1|||
163390257|NCT03872453|590141567|FG001|Overall Study|Other Than Specified|0|||
163390258|NCT03872453|590141568|FG002|Overall Study|Other Than Specified|0|||
163390259|NCT03872453|590141569|FG003|Overall Study|Other Than Specified|0|||
163390260|NCT00352885|590141570|FG000|Overall Study|Withdrawal by Subject|0|||
163390261|NCT00352885|590141571|FG001|Overall Study|Withdrawal by Subject|3|||
163390262|NCT00352885|590141570|FG000|Overall Study|Development of major depression|0|||
163390263|NCT00352885|590141571|FG001|Overall Study|Development of major depression|1|||
163390264|NCT00352885|590141570|FG000|Overall Study|Progression of metastatic melanoma|5|||
163390265|NCT00352885|590141571|FG001|Overall Study|Progression of metastatic melanoma|3|||
163390266|NCT00352885|590141570|FG000|Overall Study|Side effects of IL-2 administration|1|||
163390267|NCT00352885|590141571|FG001|Overall Study|Side effects of IL-2 administration|0|||
163390268|NCT01678209|590141572|FG000|Overall Study|could not scan twice|1|||
163390269|NCT01678209|590141573|FG001|Overall Study|could not scan twice|1|||
163390270|NCT01678209|590141574|FG002|Overall Study|could not scan twice|1|||
163390271|NCT01678209|590141572|FG000|Overall Study|scheduling conflicts|0|||
163390272|NCT01678209|590141573|FG001|Overall Study|scheduling conflicts|0|||
163390273|NCT01678209|590141574|FG002|Overall Study|scheduling conflicts|1|||
163390274|NCT01678209|590141572|FG000|Overall Study|screen fail|16|||
163390275|NCT01678209|590141573|FG001|Overall Study|screen fail|17|||
163390276|NCT01678209|590141574|FG002|Overall Study|screen fail|16|||
163390277|NCT03756350|590141579|FG000|Overall Study|Lost to Follow-up|1|||
163390278|NCT00440700|590141582|FG000|Overall Study|Withdrawal by Subject|8|||
163390279|NCT00440700|590141583|FG001|Overall Study|Withdrawal by Subject|8|||
163390280|NCT00440700|590141584|FG002|Overall Study|Withdrawal by Subject|4|||
163390281|NCT01096342|590141585|FG000|Overall Study|Protocol Violation|1|||
163390282|NCT00385203|590141586|FG000|Overall Study|Adverse Event|5|||
163390283|NCT00385203|590141587|FG001|Overall Study|Adverse Event|4|||
163390284|NCT00385203|590141586|FG000|Overall Study|Death|1|||
163390285|NCT00385203|590141587|FG001|Overall Study|Death|0|||
163390286|NCT00385203|590141586|FG000|Overall Study|Condition under investigation worsened|18|||
163390287|NCT00385203|590141587|FG001|Overall Study|Condition under investigation worsened|3|||
162951663|NCT00553280|588527595|FG000|Overall Study|Adverse Event|19|||
162951664|NCT00553280|588527595|FG000|Overall Study|Lack of Efficacy|3|||
162951665|NCT00553280|588527595|FG000|Overall Study|Withdrawal by Subject|3|||
163189306|NCT02149875|589409550|FG002|Overall Study|Withdrawal by Subject|2|||
163189307|NCT02149875|589409548|FG000|Overall Study|Physician Decision|1|||
163189308|NCT02149875|589409549|FG001|Overall Study|Physician Decision|2|||
163189309|NCT02149875|589409550|FG002|Overall Study|Physician Decision|2|||
163189310|NCT00299182|589409551|FG000|Overall Study|Withdrawal by Subject|0|||
163189311|NCT00299182|589409552|FG001|Overall Study|Withdrawal by Subject|0|||
163189312|NCT00299182|589409553|FG002|Overall Study|Withdrawal by Subject|1|||
163189313|NCT00299182|589409554|FG003|Overall Study|Withdrawal by Subject|0|||
163189314|NCT00299182|589409555|FG004|Overall Study|Withdrawal by Subject|1|||
163189315|NCT00299182|589409556|FG005|Overall Study|Withdrawal by Subject|2|||
163189316|NCT00299182|589409557|FG006|Overall Study|Withdrawal by Subject|0|||
163189317|NCT00299182|589409551|FG000|Overall Study|Chemotherapy Changed|0|||
163189318|NCT00299182|589409552|FG001|Overall Study|Chemotherapy Changed|0|||
163189319|NCT00299182|589409553|FG002|Overall Study|Chemotherapy Changed|1|||
163189320|NCT00299182|589409554|FG003|Overall Study|Chemotherapy Changed|0|||
163189321|NCT00299182|589409555|FG004|Overall Study|Chemotherapy Changed|1|||
163189322|NCT00299182|589409556|FG005|Overall Study|Chemotherapy Changed|0|||
163189323|NCT00299182|589409557|FG006|Overall Study|Chemotherapy Changed|1|||
163189324|NCT00299182|589409551|FG000|Overall Study|Adverse Event|0|||
163189325|NCT00299182|589409552|FG001|Overall Study|Adverse Event|0|||
163189326|NCT00299182|589409553|FG002|Overall Study|Adverse Event|0|||
163189327|NCT00299182|589409554|FG003|Overall Study|Adverse Event|0|||
163189328|NCT00299182|589409555|FG004|Overall Study|Adverse Event|0|||
163189329|NCT00299182|589409556|FG005|Overall Study|Adverse Event|1|||
163189330|NCT00299182|589409557|FG006|Overall Study|Adverse Event|0|||
163189331|NCT00299182|589409551|FG000|Overall Study|Not Eligible|0|||
163189332|NCT00299182|589409552|FG001|Overall Study|Not Eligible|0|||
163189333|NCT00299182|589409553|FG002|Overall Study|Not Eligible|0|||
163189334|NCT00299182|589409554|FG003|Overall Study|Not Eligible|0|||
163189335|NCT00299182|589409555|FG004|Overall Study|Not Eligible|1|||
163189336|NCT00299182|589409556|FG005|Overall Study|Not Eligible|0|||
163189337|NCT00299182|589409557|FG006|Overall Study|Not Eligible|0|||
163189338|NCT00771316|589409561|FG000|Overall Study|Adverse Event|0|||
163189339|NCT00771316|589409562|FG001|Overall Study|Adverse Event|1|||
163189340|NCT00771316|589409561|FG000|Overall Study|Patient withdrew consent|1|||
163189341|NCT00771316|589409562|FG001|Overall Study|Patient withdrew consent|0|||
163189342|NCT00771316|589409561|FG000|Overall Study|Discontinued due to early termination|1|||
163189343|NCT00771316|589409562|FG001|Overall Study|Discontinued due to early termination|0|||
163189344|NCT03643159|589409563|FG000|Overall Study|Adverse Event|1|||
163189345|NCT03643159|589409563|FG000|Overall Study|Withdrawal by Subject|1|||
163189346|NCT04308304|589409566|FG000|Overall Study|Withdrawal by Subject|4|||
162951666|NCT00553280|588527595|FG000|Overall Study|Physician Decision|1|||
162951667|NCT01544127|588527596|FG000|Overall Study|Lost to Follow-up|4|||
162951668|NCT01544127|588527597|FG001|Overall Study|Lost to Follow-up|2|||
162951669|NCT01544127|588527598|FG002|Overall Study|Lost to Follow-up|9|||
162951670|NCT01544127|588527596|FG000|Overall Study|Withdrawal by Subject|2|||
162951671|NCT01544127|588527597|FG001|Overall Study|Withdrawal by Subject|2|||
162951672|NCT01544127|588527598|FG002|Overall Study|Withdrawal by Subject|1|||
162951673|NCT01544127|588527596|FG000|Overall Study|Discharged out of catchment area|1|||
162951674|NCT01544127|588527597|FG001|Overall Study|Discharged out of catchment area|1|||
162951675|NCT01544127|588527598|FG002|Overall Study|Discharged out of catchment area|1|||
162951676|NCT01544127|588527596|FG000|Overall Study|Death|1|||
162951677|NCT01544127|588527597|FG001|Overall Study|Death|0|||
162951678|NCT01544127|588527598|FG002|Overall Study|Death|0|||
162951679|NCT01544127|588527596|FG000|Overall Study|Jail or Prison|1|||
162951680|NCT01544127|588527597|FG001|Overall Study|Jail or Prison|1|||
162951681|NCT01544127|588527598|FG002|Overall Study|Jail or Prison|2|||
162951682|NCT01544127|588527596|FG000|Overall Study|Became Psychotic|1|||
162951683|NCT01544127|588527597|FG001|Overall Study|Became Psychotic|0|||
162951684|NCT01544127|588527598|FG002|Overall Study|Became Psychotic|0|||
162951685|NCT01544127|588527596|FG000|Overall Study|Researcher withdrew|1|||
162951686|NCT01544127|588527597|FG001|Overall Study|Researcher withdrew|0|||
162951687|NCT01544127|588527598|FG002|Overall Study|Researcher withdrew|0|||
162951688|NCT01544127|588527596|FG000|Overall Study|Went active duty|0|||
162951689|NCT01544127|588527597|FG001|Overall Study|Went active duty|0|||
162951690|NCT01544127|588527598|FG002|Overall Study|Went active duty|1|||
162951691|NCT02914600|588527601|FG000|Overall Study|Adverse Event|298|||
162951692|NCT02914600|588527602|FG001|Overall Study|Adverse Event|35|||
163189347|NCT04308304|589409567|FG001|Overall Study|Withdrawal by Subject|0|||
163189348|NCT04308304|589409566|FG000|Overall Study|Protocol Violation|1|||
163189349|NCT04308304|589409567|FG001|Overall Study|Protocol Violation|0|||
163189350|NCT03945266|589409572|FG000|Overall Study|Withdrawal by Subject|1|||
163189351|NCT03945266|589409573|FG001|Overall Study|Withdrawal by Subject|0|||
163189352|NCT03945266|589409572|FG000|Overall Study|Miscarriage|0|||
163189353|NCT03945266|589409573|FG001|Overall Study|Miscarriage|2|||
163189354|NCT03945266|589409572|FG000|Overall Study|Lost to Follow-up|1|||
163189355|NCT03945266|589409573|FG001|Overall Study|Lost to Follow-up|0|||
163189356|NCT03805646|589409591|FG000|Overall Study|Death|40|||
163189357|NCT03805646|589409592|FG001|Overall Study|Death|49|||
163189358|NCT03805646|589409591|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
163189359|NCT03805646|589409592|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
163189360|NCT04452344|589409594|FG000|Overall Study|Withdrawal by Subject|3|||
163189361|NCT04452344|589409595|FG001|Overall Study|Withdrawal by Subject|6|||
163189362|NCT04452344|589409594|FG000|Overall Study|Adverse Event|1|||
163189363|NCT04452344|589409595|FG001|Overall Study|Adverse Event|2|||
163189364|NCT04452344|589409594|FG000|Overall Study|Lost to Follow-up|2|||
163189365|NCT04452344|589409595|FG001|Overall Study|Lost to Follow-up|2|||
163189366|NCT04452344|589409594|FG000|Overall Study|No Post-Op Visit|6|||
163189367|NCT04452344|589409595|FG001|Overall Study|No Post-Op Visit|7|||
163189368|NCT05171777|589409596|FG000|Treatment Crossover Period|Adverse Event|9|||
163189369|NCT05171777|589409597|FG001|Treatment Crossover Period|Adverse Event|6|||
163189370|NCT05171777|589409598|FG002|Treatment Crossover Period|Adverse Event|0|||
163189371|NCT05171777|589409599|FG003|Treatment Crossover Period|Adverse Event|0|||
163189372|NCT05171777|589409596|FG000|Treatment Crossover Period|Death|5|||
163189373|NCT05171777|589409597|FG001|Treatment Crossover Period|Death|5|||
163189374|NCT05171777|589409598|FG002|Treatment Crossover Period|Death|0|||
163189375|NCT05171777|589409599|FG003|Treatment Crossover Period|Death|0|||
163189376|NCT05171777|589409596|FG000|Treatment Crossover Period|Disease Relapse|1|||
163189377|NCT05171777|589409597|FG001|Treatment Crossover Period|Disease Relapse|0|||
163189378|NCT05171777|589409598|FG002|Treatment Crossover Period|Disease Relapse|0|||
163189379|NCT05171777|589409599|FG003|Treatment Crossover Period|Disease Relapse|0|||
163189380|NCT05171777|589409596|FG000|Treatment Crossover Period|Reason not Specified|1|||
163189381|NCT05171777|589409597|FG001|Treatment Crossover Period|Reason not Specified|1|||
163189382|NCT05171777|589409598|FG002|Treatment Crossover Period|Reason not Specified|0|||
163189383|NCT05171777|589409599|FG003|Treatment Crossover Period|Reason not Specified|0|||
163189384|NCT05171777|589409596|FG000|Treatment Crossover Period|Physician Decision|0|||
163189385|NCT05171777|589409597|FG001|Treatment Crossover Period|Physician Decision|1|||
163189386|NCT05171777|589409598|FG002|Treatment Crossover Period|Physician Decision|0|||
163189387|NCT05171777|589409599|FG003|Treatment Crossover Period|Physician Decision|0|||
163189388|NCT05171777|589409596|FG000|Treatment Crossover Period|Progressive Disease|14|||
163189389|NCT05171777|589409597|FG001|Treatment Crossover Period|Progressive Disease|10|||
163390288|NCT00385203|590141586|FG000|Overall Study|Incorrect enrollment|2|||
163390289|NCT00385203|590141587|FG001|Overall Study|Incorrect enrollment|0|||
163390290|NCT03422172|590141588|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
163390291|NCT03422172|590141588|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
163390292|NCT03422172|590141588|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
163390293|NCT00293722|590141597|FG000|Overall Study|Other|427|||
163390294|NCT01008696|590141598|FG000|Overall Study|Participant's evasion of hospital visit|5|||
163390295|NCT01008696|590141599|FG001|Overall Study|Participant's evasion of hospital visit|4|||
163390296|NCT01008696|590141598|FG000|Overall Study|Withdrawal by Subject|2|||
163390297|NCT01008696|590141599|FG001|Overall Study|Withdrawal by Subject|4|||
163390298|NCT01008696|590141598|FG000|Overall Study|Physician Decision|5|||
163390299|NCT01008696|590141599|FG001|Overall Study|Physician Decision|1|||
163390300|NCT01008696|590141598|FG000|Overall Study|Adverse Event|1|||
163390301|NCT01008696|590141599|FG001|Overall Study|Adverse Event|0|||
163390302|NCT01008696|590141598|FG000|Overall Study|Participants' non-cooperation|2|||
163390303|NCT01008696|590141599|FG001|Overall Study|Participants' non-cooperation|3|||
163390304|NCT01008696|590141598|FG000|Overall Study|Other|2|||
163390305|NCT01008696|590141599|FG001|Overall Study|Other|3|||
163390306|NCT01008696|590141598|FG000|Overall Study|Other|0|||
163390307|NCT01008696|590141599|FG001|Overall Study|Other|2|||
163390308|NCT02310672|590141606|FG000|Overall Study|Death|1|||
163390309|NCT02310672|590141606|FG000|Overall Study|Lost to Follow-up|1|||
163390310|NCT02310672|590141606|FG000|Overall Study|Withdrawal by Subject|1|||
163390311|NCT02310672|590141606|FG000|Overall Study|Sponsor's decision|12|||
163390312|NCT01214187|590141610|FG000|Overall Study|Adverse Event|6|||
163390313|NCT01214187|590141611|FG001|Overall Study|Adverse Event|2|||
163390314|NCT01214187|590141610|FG000|Overall Study|Death|1|||
163390315|NCT01214187|590141611|FG001|Overall Study|Death|1|||
163390316|NCT01214187|590141610|FG000|Overall Study|Withdrawal by Subject|0|||
163390317|NCT01214187|590141611|FG001|Overall Study|Withdrawal by Subject|3|||
163390318|NCT02308007|590141620|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
163390319|NCT02308007|590141621|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
163390320|NCT02308007|590141622|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
163390321|NCT02308007|590141620|FG000|Overall Study|Positive for STD at Baseline|7|||
163390322|NCT02308007|590141621|FG001|Overall Study|Positive for STD at Baseline|11|||
163390323|NCT02308007|590141622|FG002|Overall Study|Positive for STD at Baseline|7|||
163390324|NCT02308007|590141620|FG000|Overall Study|Lost to Follow-up|3|||
163390325|NCT02308007|590141621|FG001|Overall Study|Lost to Follow-up|0|||
163390326|NCT02308007|590141622|FG002|Overall Study|Lost to Follow-up|1|||
163390327|NCT03118674|590141623|FG000|Overall Study|Lost to Follow-up|2|||
163390328|NCT03118674|590141623|FG000|Overall Study|Screen Faliure|8|||
163390329|NCT03118674|590141623|FG000|Overall Study|Withdrawal by Subject|5|||
163390330|NCT01233869|590141624|FG000|Initial Treatment Period (24 Months)|Death|1|||
163390331|NCT01233869|590141625|FG001|Initial Treatment Period (24 Months)|Death|0|||
163390332|NCT01233869|590141626|FG002|Initial Treatment Period (24 Months)|Death|0|||
163390333|NCT01233869|590141627|FG003|Initial Treatment Period (24 Months)|Death|0|||
162951693|NCT02914600|588527603|FG002|Overall Study|Adverse Event|25|||
163390334|NCT01233869|590141624|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
163390335|NCT01233869|590141625|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
163390336|NCT01233869|590141626|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
163390337|NCT01233869|590141627|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
163390338|NCT01233869|590141624|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
163390339|NCT01233869|590141625|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
163390340|NCT01233869|590141626|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
163390341|NCT01233869|590141627|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
163390342|NCT01233869|590141624|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
163390343|NCT01233869|590141625|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
163390344|NCT01233869|590141626|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
163390345|NCT01233869|590141627|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
163390346|NCT01233869|590141624|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
163390347|NCT01233869|590141625|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
163390348|NCT01233869|590141626|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
163390349|NCT01233869|590141627|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
163390350|NCT01233869|590141624|FG000|Extended Treatment Period (46 Months)|Other|3|||
163390351|NCT01233869|590141625|FG001|Extended Treatment Period (46 Months)|Other|0|||
163390352|NCT01233869|590141626|FG002|Extended Treatment Period (46 Months)|Other|0|||
163390353|NCT01233869|590141627|FG003|Extended Treatment Period (46 Months)|Other|3|||
163390354|NCT01233869|590141624|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
163390355|NCT01233869|590141625|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
163390356|NCT01233869|590141626|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
163390357|NCT01233869|590141627|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
163390358|NCT01324323|590141628|FG000|Overall Study|Withdrawal by Subject|1|||
163390359|NCT00537485|590141629|FG000|Overall Study|Adverse Event|10|||
163390360|NCT00537485|590141630|FG001|Overall Study|Adverse Event|5|||
163390361|NCT00537485|590141629|FG000|Overall Study|Withdrawal by Subject|3|||
163189390|NCT05171777|589409598|FG002|Treatment Crossover Period|Progressive Disease|0|||
163189391|NCT05171777|589409599|FG003|Treatment Crossover Period|Progressive Disease|0|||
163390362|NCT00537485|590141630|FG001|Overall Study|Withdrawal by Subject|2|||
163390363|NCT00537485|590141629|FG000|Overall Study|Withdrawal by Subject|1|||
163390364|NCT00537485|590141630|FG001|Overall Study|Withdrawal by Subject|3|||
163390365|NCT00537485|590141629|FG000|Overall Study|Physician Decision|1|||
163390366|NCT00537485|590141630|FG001|Overall Study|Physician Decision|0|||
163390367|NCT01601847|590141639|FG000|Overall Study|Death|1|||
163390368|NCT01601847|590141640|FG001|Overall Study|Death|0|||
163390369|NCT01601847|590141639|FG000|Overall Study|Withdrawal by Subject|11|||
163390370|NCT01601847|590141640|FG001|Overall Study|Withdrawal by Subject|7|||
163390371|NCT01601847|590141639|FG000|Overall Study|Lost to Follow-up|1|||
163189392|NCT05171777|589409596|FG000|Treatment Crossover Period|Protocol Violation|0|||
163189393|NCT05171777|589409597|FG001|Treatment Crossover Period|Protocol Violation|2|||
163189394|NCT05171777|589409598|FG002|Treatment Crossover Period|Protocol Violation|0|||
163189395|NCT05171777|589409599|FG003|Treatment Crossover Period|Protocol Violation|0|||
163189396|NCT05171777|589409596|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
163189397|NCT05171777|589409597|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
163189398|NCT05171777|589409598|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
163189399|NCT05171777|589409599|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
163189400|NCT05171777|589409596|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
163390372|NCT01601847|590141640|FG001|Overall Study|Lost to Follow-up|3|||
163390373|NCT00631189|590141641|FG000|Initial Phase|Protocol Violation|347|||
163390374|NCT00631189|590141642|FG001|Initial Phase|Protocol Violation|0|||
163390375|NCT00631189|590141643|FG002|Initial Phase|Protocol Violation|0|||
163390376|NCT00631189|590141644|FG003|Initial Phase|Protocol Violation|0|||
163294343|NCT00723450|589784084|FG002|Randomized Phase|Adverse Event|17|||
163294344|NCT00723450|589784082|FG000|Randomized Phase|Lack of Efficacy|0|||
163294345|NCT00723450|589784083|FG001|Randomized Phase|Lack of Efficacy|11|||
163294346|NCT00723450|589784084|FG002|Randomized Phase|Lack of Efficacy|11|||
163294347|NCT00723450|589784082|FG000|Randomized Phase|Protocol Violation|0|||
163294348|NCT00723450|589784083|FG001|Randomized Phase|Protocol Violation|9|||
163294349|NCT00723450|589784084|FG002|Randomized Phase|Protocol Violation|13|||
163294350|NCT00723450|589784082|FG000|Randomized Phase|Lost to Follow-up|0|||
163294351|NCT00723450|589784083|FG001|Randomized Phase|Lost to Follow-up|2|||
163294352|NCT00723450|589784084|FG002|Randomized Phase|Lost to Follow-up|3|||
163294353|NCT00723450|589784082|FG000|Randomized Phase|Physician Decision|0|||
163294354|NCT00723450|589784083|FG001|Randomized Phase|Physician Decision|3|||
163294355|NCT00723450|589784084|FG002|Randomized Phase|Physician Decision|1|||
163294356|NCT00723450|589784082|FG000|Randomized Phase|Withdrawal by Subject|0|||
163294357|NCT00723450|589784083|FG001|Randomized Phase|Withdrawal by Subject|14|||
163294358|NCT00723450|589784084|FG002|Randomized Phase|Withdrawal by Subject|22|||
163294359|NCT00189202|589784085|FG000|Overall Study|Physician Decision|5|||
163294360|NCT02950558|589784089|FG000|Overall Study|Lost to Follow-up|2|||
163294361|NCT02950558|589784090|FG001|Overall Study|Lost to Follow-up|0|||
163294362|NCT02537522|589784096|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
163294363|NCT02537522|589784097|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
163042863|NCT00845676|588863980|FG000|Overall Study|Adverse Event|1|||
163189401|NCT05171777|589409597|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
163189402|NCT05171777|589409598|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
163390377|NCT00631189|590141641|FG000|Initial Phase|Withdrawal by Subject|4|||
163390378|NCT00631189|590141642|FG001|Initial Phase|Withdrawal by Subject|0|||
163189403|NCT05171777|589409599|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
163189404|NCT05171777|589409596|FG000|Treatment Continuation Period|Adverse Event|0|||
163189405|NCT05171777|589409597|FG001|Treatment Continuation Period|Adverse Event|0|||
163189406|NCT05171777|589409598|FG002|Treatment Continuation Period|Adverse Event|3|||
163189407|NCT05171777|589409599|FG003|Treatment Continuation Period|Adverse Event|6|||
163189408|NCT05171777|589409596|FG000|Treatment Continuation Period|Death|0|||
163189409|NCT05171777|589409597|FG001|Treatment Continuation Period|Death|0|||
163189410|NCT05171777|589409598|FG002|Treatment Continuation Period|Death|1|||
163189411|NCT05171777|589409599|FG003|Treatment Continuation Period|Death|3|||
163189412|NCT05171777|589409596|FG000|Treatment Continuation Period|Disease Relapse|0|||
163189413|NCT05171777|589409597|FG001|Treatment Continuation Period|Disease Relapse|0|||
163189414|NCT05171777|589409598|FG002|Treatment Continuation Period|Disease Relapse|1|||
163189415|NCT05171777|589409599|FG003|Treatment Continuation Period|Disease Relapse|0|||
163189416|NCT05171777|589409596|FG000|Treatment Continuation Period|Lack of Efficacy|0|||
163189417|NCT05171777|589409597|FG001|Treatment Continuation Period|Lack of Efficacy|0|||
163189418|NCT05171777|589409598|FG002|Treatment Continuation Period|Lack of Efficacy|0|||
163189419|NCT05171777|589409599|FG003|Treatment Continuation Period|Lack of Efficacy|1|||
163189420|NCT05171777|589409596|FG000|Treatment Continuation Period|Physician Decision|0|||
163189421|NCT05171777|589409597|FG001|Treatment Continuation Period|Physician Decision|0|||
163189422|NCT05171777|589409598|FG002|Treatment Continuation Period|Physician Decision|0|||
163189423|NCT05171777|589409599|FG003|Treatment Continuation Period|Physician Decision|4|||
163189424|NCT05171777|589409596|FG000|Treatment Continuation Period|Progressive Disease|0|||
163189425|NCT05171777|589409597|FG001|Treatment Continuation Period|Progressive Disease|0|||
163189426|NCT05171777|589409598|FG002|Treatment Continuation Period|Progressive Disease|6|||
163189427|NCT05171777|589409599|FG003|Treatment Continuation Period|Progressive Disease|20|||
163189428|NCT05171777|589409596|FG000|Treatment Continuation Period|Study Ended by Sponsor|0|||
163189429|NCT05171777|589409597|FG001|Treatment Continuation Period|Study Ended by Sponsor|0|||
163189430|NCT05171777|589409598|FG002|Treatment Continuation Period|Study Ended by Sponsor|4|||
163189431|NCT05171777|589409599|FG003|Treatment Continuation Period|Study Ended by Sponsor|15|||
163189432|NCT05171777|589409596|FG000|Treatment Continuation Period|Symptomatic Deterioration|0|||
163189433|NCT05171777|589409597|FG001|Treatment Continuation Period|Symptomatic Deterioration|0|||
163189434|NCT05171777|589409598|FG002|Treatment Continuation Period|Symptomatic Deterioration|0|||
163189435|NCT05171777|589409599|FG003|Treatment Continuation Period|Symptomatic Deterioration|2|||
163189436|NCT05171777|589409596|FG000|Treatment Continuation Period|Withdrawal by Subject|0|||
163189437|NCT05171777|589409597|FG001|Treatment Continuation Period|Withdrawal by Subject|0|||
163189438|NCT05171777|589409598|FG002|Treatment Continuation Period|Withdrawal by Subject|0|||
163189439|NCT05171777|589409599|FG003|Treatment Continuation Period|Withdrawal by Subject|6|||
163189440|NCT02364713|589409600|FG000|Overall Study|Ineligible|2|||
163189441|NCT02364713|589409601|FG001|Overall Study|Ineligible|2|||
163189442|NCT04686786|589409602|FG000|Overall Study|Adverse Event|9|||
163189443|NCT04686786|589409602|FG000|Overall Study|Death|1|||
163189444|NCT04686786|589409602|FG000|Overall Study|Lack of Efficacy|25|||
163189445|NCT04686786|589409602|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
163189446|NCT04686786|589409602|FG000|Overall Study|Study Terminated by Sponsor|14|||
163189447|NCT04686786|589409602|FG000|Overall Study|Withdrawal by Subject|15|||
163189448|NCT04686786|589409602|FG000|Overall Study|Other than specified|1|||
163189449|NCT02719327|589409605|FG000|Overall Study|Withdrawal by Subject|11|||
163189450|NCT02719327|589409606|FG001|Overall Study|Withdrawal by Subject|8|||
163189451|NCT04340193|589409607|FG000|Overall Study|Other reason|0|||
163189452|NCT04340193|589409608|FG001|Overall Study|Other reason|0|||
163189453|NCT04340193|589409609|FG002|Overall Study|Other reason|1|||
163189454|NCT04340193|589409607|FG000|Overall Study|Disease recurrence|0|||
163189455|NCT04340193|589409608|FG001|Overall Study|Disease recurrence|1|||
163189456|NCT04340193|589409609|FG002|Overall Study|Disease recurrence|0|||
163189457|NCT04340193|589409607|FG000|Overall Study|Study drug toxicity|1|||
163189458|NCT04340193|589409608|FG001|Overall Study|Study drug toxicity|0|||
163189459|NCT04340193|589409609|FG002|Overall Study|Study drug toxicity|0|||
163189460|NCT04340193|589409607|FG000|Overall Study|Disease progression|1|||
163189461|NCT04340193|589409608|FG001|Overall Study|Disease progression|2|||
163189462|NCT04340193|589409609|FG002|Overall Study|Disease progression|3|||
163189463|NCT04340193|589409607|FG000|Overall Study|Administrative reasons by sponsor|0|||
163189464|NCT04340193|589409608|FG001|Overall Study|Administrative reasons by sponsor|1|||
163189465|NCT04340193|589409609|FG002|Overall Study|Administrative reasons by sponsor|0|||
163189466|NCT04340193|589409607|FG000|Overall Study|Adverse Event|1|||
163189467|NCT04340193|589409608|FG001|Overall Study|Adverse Event|1|||
163189468|NCT04340193|589409609|FG002|Overall Study|Adverse Event|0|||
163189469|NCT03924869|589409610|FG000|Overall Study|Death|73|||
163189470|NCT03924869|589409611|FG001|Overall Study|Death|62|||
163189471|NCT03924869|589409610|FG000|Overall Study|Lost to Follow-up|3|||
163189472|NCT03924869|589409611|FG001|Overall Study|Lost to Follow-up|0|||
163189473|NCT03924869|589409610|FG000|Overall Study|Physician Decision|0|||
163390379|NCT00631189|590141643|FG002|Initial Phase|Withdrawal by Subject|0|||
162951694|NCT02914600|588527601|FG000|Overall Study|Sponsors decision|287|||
162951695|NCT02914600|588527602|FG001|Overall Study|Sponsors decision|41|||
162951696|NCT02914600|588527603|FG002|Overall Study|Sponsors decision|12|||
162951697|NCT02914600|588527601|FG000|Overall Study|Withdrawal by Subject|158|||
162951698|NCT02914600|588527602|FG001|Overall Study|Withdrawal by Subject|20|||
162951699|NCT02914600|588527603|FG002|Overall Study|Withdrawal by Subject|18|||
163294364|NCT02537522|589784098|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
163294365|NCT02537522|589784099|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
163294366|NCT02537522|589784096|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
163294367|NCT02537522|589784097|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
162951700|NCT02914600|588527601|FG000|Overall Study|Investigators discretion|169|||
162951701|NCT02914600|588527602|FG001|Overall Study|Investigators discretion|14|||
162951702|NCT02914600|588527603|FG002|Overall Study|Investigators discretion|13|||
163042864|NCT00248833|588863983|FG000|Overall Study|Adverse Event|2|||
162951703|NCT02914600|588527601|FG000|Overall Study|Lost to Follow-up|10|||
162951704|NCT02914600|588527602|FG001|Overall Study|Lost to Follow-up|4|||
162951705|NCT02914600|588527603|FG002|Overall Study|Lost to Follow-up|0|||
162951706|NCT02914600|588527601|FG000|Overall Study|Pregnancy|8|||
162951707|NCT02914600|588527602|FG001|Overall Study|Pregnancy|0|||
162951708|NCT02914600|588527603|FG002|Overall Study|Pregnancy|0|||
162951709|NCT02914600|588527601|FG000|Overall Study|Protocol Violation|5|||
162951710|NCT02914600|588527602|FG001|Overall Study|Protocol Violation|3|||
162951711|NCT02914600|588527603|FG002|Overall Study|Protocol Violation|0|||
162951712|NCT02914600|588527601|FG000|Overall Study|Non-compliance with study drug|6|||
162951713|NCT02914600|588527602|FG001|Overall Study|Non-compliance with study drug|1|||
162951714|NCT02914600|588527603|FG002|Overall Study|Non-compliance with study drug|0|||
162951715|NCT02914600|588527601|FG000|Overall Study|Death|3|||
162951716|NCT02914600|588527602|FG001|Overall Study|Death|1|||
162951717|NCT02914600|588527603|FG002|Overall Study|Death|1|||
162951718|NCT02914600|588527601|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
162951719|NCT02914600|588527602|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
162951720|NCT02914600|588527603|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
162951721|NCT02914600|588527601|FG000|Overall Study|Enrolled but not treated|1|||
162951722|NCT02914600|588527602|FG001|Overall Study|Enrolled but not treated|0|||
162951723|NCT02914600|588527603|FG002|Overall Study|Enrolled but not treated|0|||
162951724|NCT02996682|588527605|FG000|Overall Study|Death|0|||
162951725|NCT02996682|588527606|FG001|Overall Study|Death|3|||
162951726|NCT02457520|588527607|FG000|Active Treatment Phase|Adverse Event|10|||
162951727|NCT02457520|588527607|FG000|Active Treatment Phase|Lost to Follow-up|8|||
162951728|NCT02457520|588527607|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
162951729|NCT02457520|588527607|FG000|Active Treatment Phase|other|4|||
162951730|NCT02457520|588527607|FG000|Active Treatment Phase|Physician Decision|1|||
162951731|NCT02457520|588527607|FG000|Active Treatment Phase|Protocol Violation|1|||
163390380|NCT00631189|590141644|FG003|Initial Phase|Withdrawal by Subject|0|||
163390381|NCT00631189|590141641|FG000|Treatment Phase|Withdrawal by Subject|0|||
162951732|NCT02457520|588527607|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
162951733|NCT02457520|588527607|FG000|Post-treatment Period|Other: Retreatment Required|7|||
162951734|NCT02457520|588527607|FG000|Post-treatment Period|Lost to Follow-up|23|||
162951735|NCT02457520|588527607|FG000|Post-treatment Period|Other|3|||
162951736|NCT02457520|588527607|FG000|Post-treatment Period|Physician Decision|1|||
162951737|NCT02457520|588527607|FG000|Post-treatment Period|Withdrawal by Subject|14|||
162951738|NCT00696020|588527612|FG000|Overall Study|Adverse Event|3|||
162951739|NCT00696020|588527613|FG001|Overall Study|Adverse Event|1|||
162951740|NCT00696020|588527614|FG002|Overall Study|Adverse Event|2|||
162951741|NCT00696020|588527615|FG003|Overall Study|Adverse Event|1|||
162951742|NCT00696020|588527612|FG000|Overall Study|Lack of Efficacy|1|||
162951743|NCT00696020|588527613|FG001|Overall Study|Lack of Efficacy|0|||
162951744|NCT00696020|588527614|FG002|Overall Study|Lack of Efficacy|0|||
162951745|NCT00696020|588527615|FG003|Overall Study|Lack of Efficacy|0|||
162951746|NCT00696020|588527612|FG000|Overall Study|Protocol Violation|0|||
162951747|NCT00696020|588527613|FG001|Overall Study|Protocol Violation|0|||
162951748|NCT00696020|588527614|FG002|Overall Study|Protocol Violation|0|||
162951749|NCT00696020|588527615|FG003|Overall Study|Protocol Violation|1|||
162951750|NCT00696020|588527612|FG000|Overall Study|Withdrawal by Subject|0|||
162951751|NCT00696020|588527613|FG001|Overall Study|Withdrawal by Subject|1|||
162951752|NCT00696020|588527614|FG002|Overall Study|Withdrawal by Subject|0|||
162951753|NCT00696020|588527615|FG003|Overall Study|Withdrawal by Subject|1|||
162951754|NCT00696020|588527612|FG000|Overall Study|Other not stated above|0|||
162951755|NCT00696020|588527613|FG001|Overall Study|Other not stated above|0|||
162951756|NCT00696020|588527614|FG002|Overall Study|Other not stated above|1|||
162951757|NCT00696020|588527615|FG003|Overall Study|Other not stated above|1|||
162951758|NCT03687736|588527618|FG000|Overall Study|Lost to Follow-up|7|||
162951759|NCT03687736|588527618|FG000|Overall Study|Withdrawal by Subject|3|||
162951760|NCT02511782|588527619|FG000|Overall Study|Withdrawal by Subject|1|||
163390382|NCT00631189|590141642|FG001|Treatment Phase|Withdrawal by Subject|2|||
163390383|NCT00631189|590141643|FG002|Treatment Phase|Withdrawal by Subject|1|||
163390384|NCT00631189|590141644|FG003|Treatment Phase|Withdrawal by Subject|1|||
163390385|NCT00631189|590141641|FG000|Treatment Phase|Protocol Violation|0|||
163390386|NCT00631189|590141642|FG001|Treatment Phase|Protocol Violation|1|||
162951761|NCT02511782|588527620|FG001|Overall Study|Withdrawal by Subject|0|||
162951762|NCT02511782|588527621|FG002|Overall Study|Withdrawal by Subject|0|||
162951763|NCT01536574|588527622|FG000|Overall Study|Adverse Event|4|||
162951764|NCT01536574|588527623|FG001|Overall Study|Adverse Event|5|||
163390387|NCT00631189|590141643|FG002|Treatment Phase|Protocol Violation|6|||
162951765|NCT01536574|588527622|FG000|Overall Study|Withdrawal by Subject|1|||
162951766|NCT01536574|588527623|FG001|Overall Study|Withdrawal by Subject|2|||
163390388|NCT00631189|590141644|FG003|Treatment Phase|Protocol Violation|2|||
163390389|NCT00631189|590141641|FG000|Treatment Phase|Adverse Event|0|||
163390390|NCT00631189|590141642|FG001|Treatment Phase|Adverse Event|3|||
163390391|NCT00631189|590141643|FG002|Treatment Phase|Adverse Event|2|||
163390392|NCT00631189|590141644|FG003|Treatment Phase|Adverse Event|4|||
163390393|NCT00631189|590141641|FG000|Treatment Phase|Lost to Follow-up|0|||
163390394|NCT00631189|590141642|FG001|Treatment Phase|Lost to Follow-up|1|||
163390395|NCT00631189|590141643|FG002|Treatment Phase|Lost to Follow-up|0|||
162951767|NCT01536574|588527622|FG000|Overall Study|Lack of Efficacy|1|||
162951768|NCT01536574|588527623|FG001|Overall Study|Lack of Efficacy|0|||
162951769|NCT02514122|588527624|FG000|Overall Study|Withdrawal by Subject|2|||
163390396|NCT00631189|590141644|FG003|Treatment Phase|Lost to Follow-up|0|||
163390397|NCT00631189|590141641|FG000|Treatment Phase|Pregnancy|0|||
163390398|NCT00631189|590141642|FG001|Treatment Phase|Pregnancy|0|||
163390399|NCT00631189|590141643|FG002|Treatment Phase|Pregnancy|1|||
163042865|NCT00248833|588863984|FG001|Overall Study|Adverse Event|0|||
163042866|NCT00248833|588863985|FG002|Overall Study|Adverse Event|0|||
163042867|NCT00248833|588863983|FG000|Overall Study|Withdrawal by Subject|0|||
163042868|NCT00248833|588863984|FG001|Overall Study|Withdrawal by Subject|1|||
163042869|NCT00248833|588863985|FG002|Overall Study|Withdrawal by Subject|1|||
163042870|NCT00248833|588863983|FG000|Overall Study|Lost to Follow-up|1|||
163042871|NCT00248833|588863984|FG001|Overall Study|Lost to Follow-up|1|||
163042872|NCT00248833|588863985|FG002|Overall Study|Lost to Follow-up|1|||
163189474|NCT03924869|589409611|FG001|Overall Study|Physician Decision|3|||
163189475|NCT03924869|589409610|FG000|Overall Study|Withdrawal by Subject|7|||
163042873|NCT00248833|588863983|FG000|Overall Study|Other|0|||
163042874|NCT00248833|588863984|FG001|Overall Study|Other|1|||
163042875|NCT00248833|588863985|FG002|Overall Study|Other|0|||
163189476|NCT03924869|589409611|FG001|Overall Study|Withdrawal by Subject|3|||
163189477|NCT03924869|589409610|FG000|Overall Study|Study Terminated By Sponsor|144|||
163189478|NCT03924869|589409611|FG001|Overall Study|Study Terminated By Sponsor|153|||
163189479|NCT03001882|589409614|FG000|Overall Study|Death|1|||
163189480|NCT03001882|589409615|FG001|Overall Study|Death|0|||
163189481|NCT03001882|589409616|FG002|Overall Study|Death|0|||
163189482|NCT03001882|589409617|FG003|Overall Study|Death|3|||
163189483|NCT03001882|589409614|FG000|Overall Study|Participant withdrew consent|0|||
163189484|NCT03001882|589409615|FG001|Overall Study|Participant withdrew consent|1|||
163189485|NCT03001882|589409616|FG002|Overall Study|Participant withdrew consent|0|||
163189486|NCT03001882|589409617|FG003|Overall Study|Participant withdrew consent|5|||
163189487|NCT03001882|589409614|FG000|Overall Study|Other reasons|1|||
163189488|NCT03001882|589409615|FG001|Overall Study|Other reasons|2|||
163189489|NCT03001882|589409616|FG002|Overall Study|Other reasons|0|||
163189490|NCT03001882|589409617|FG003|Overall Study|Other reasons|5|||
163189491|NCT03001882|589409614|FG000|Overall Study|Administrative reason by sponsor|0|||
163189492|NCT03001882|589409615|FG001|Overall Study|Administrative reason by sponsor|0|||
163189493|NCT03001882|589409616|FG002|Overall Study|Administrative reason by sponsor|0|||
163189494|NCT03001882|589409617|FG003|Overall Study|Administrative reason by sponsor|1|||
163189495|NCT03001882|589409614|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
163189496|NCT03001882|589409615|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
163189497|NCT03001882|589409616|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
163189498|NCT03001882|589409617|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
163189499|NCT03001882|589409614|FG000|Overall Study|Not reported|0|||
163189500|NCT03001882|589409615|FG001|Overall Study|Not reported|0|||
163189501|NCT03001882|589409616|FG002|Overall Study|Not reported|0|||
163189502|NCT03001882|589409617|FG003|Overall Study|Not reported|6|||
163189503|NCT03001882|589409614|FG000|Overall Study|Maximum clinical benefit|2|||
163189504|NCT03001882|589409615|FG001|Overall Study|Maximum clinical benefit|3|||
163189505|NCT03001882|589409616|FG002|Overall Study|Maximum clinical benefit|0|||
163189506|NCT03001882|589409617|FG003|Overall Study|Maximum clinical benefit|10|||
163189507|NCT03001882|589409614|FG000|Overall Study|AE unrelated to study drug|3|||
163189508|NCT03001882|589409615|FG001|Overall Study|AE unrelated to study drug|3|||
163189509|NCT03001882|589409616|FG002|Overall Study|AE unrelated to study drug|0|||
163189510|NCT03001882|589409617|FG003|Overall Study|AE unrelated to study drug|11|||
163189511|NCT03001882|589409614|FG000|Overall Study|Study Drug Toxicity|8|||
163189512|NCT03001882|589409615|FG001|Overall Study|Study Drug Toxicity|5|||
163189513|NCT03001882|589409616|FG002|Overall Study|Study Drug Toxicity|0|||
163189514|NCT03001882|589409617|FG003|Overall Study|Study Drug Toxicity|37|||
163189515|NCT03001882|589409614|FG000|Overall Study|Disease progression|16|||
163189516|NCT03001882|589409615|FG001|Overall Study|Disease progression|14|||
163189517|NCT03001882|589409616|FG002|Overall Study|Disease progression|1|||
163189518|NCT03001882|589409617|FG003|Overall Study|Disease progression|90|||
163189519|NCT05268055|589409619|FG000|Overall Study|Lost to Follow-up|68|||
163189520|NCT05268055|589409620|FG001|Overall Study|Lost to Follow-up|68|||
163189521|NCT05268055|589409619|FG000|Overall Study|Withdrawal by Subject|12|||
163189522|NCT05268055|589409620|FG001|Overall Study|Withdrawal by Subject|8|||
163189523|NCT03507400|589409621|FG000|Overall Study|discontinued|5|||
163189524|NCT03507400|589409622|FG001|Overall Study|discontinued|1|||
163189525|NCT03507400|589409621|FG000|Overall Study|Lost to Follow-up|8|||
163189526|NCT03507400|589409622|FG001|Overall Study|Lost to Follow-up|6|||
163189527|NCT03507400|589409621|FG000|Overall Study|Protocol Violation|0|||
163189528|NCT03507400|589409622|FG001|Overall Study|Protocol Violation|1|||
163042876|NCT01554163|588863986|FG000|Overall Study|Adverse Event|3|||
163042877|NCT01554163|588863987|FG001|Overall Study|Adverse Event|0|||
163189529|NCT01555983|589409623|FG000|Overall Study|Withdrawal by Subject|1|||
163189530|NCT01555983|589409624|FG001|Overall Study|Withdrawal by Subject|0|||
163189531|NCT01555983|589409625|FG002|Overall Study|Withdrawal by Subject|0|||
163189532|NCT01555983|589409626|FG003|Overall Study|Withdrawal by Subject|0|||
163294368|NCT02537522|589784098|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
163294369|NCT02537522|589784099|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
163294370|NCT02537522|589784096|FG000|Phase I - Contralateral|incorrect randomization|0|||
163189533|NCT01555983|589409627|FG004|Overall Study|Withdrawal by Subject|1|||
163042878|NCT01554163|588863986|FG000|Overall Study|Lack of Efficacy|1|||
162951770|NCT02514122|588527625|FG001|Overall Study|Withdrawal by Subject|0|||
162951771|NCT01472341|588527629|FG000|Overall Study|Started insulin therapy|55|||
162951772|NCT01472341|588527629|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
162951773|NCT01472341|588527629|FG000|Overall Study|Withdrawal by Subject|39|||
162951774|NCT01472341|588527629|FG000|Overall Study|Lost to Follow-up|52|||
162951775|NCT01472341|588527629|FG000|Overall Study|Laboratory parameters unavailable|25|||
162951776|NCT01472341|588527629|FG000|Overall Study|Death|9|||
162951777|NCT00112463|588527632|FG000|Overall Study|Physician Decision|1|||
162951778|NCT00112463|588527632|FG000|Overall Study|Progression|30|||
162951779|NCT00112463|588527632|FG000|Overall Study|Second Primary|1|||
162951780|NCT00112463|588527632|FG000|Overall Study|Toxicity|3|||
163042879|NCT01554163|588863987|FG001|Overall Study|Lack of Efficacy|0|||
163042880|NCT01554163|588863986|FG000|Overall Study|Lost to Follow-up|1|||
163042881|NCT01554163|588863987|FG001|Overall Study|Lost to Follow-up|0|||
163042882|NCT01554163|588863986|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163042883|NCT01554163|588863987|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163042884|NCT01554163|588863986|FG000|Overall Study|Protocol Violation|0|||
163189534|NCT01555983|589409628|FG005|Overall Study|Withdrawal by Subject|1|||
163189535|NCT04026711|589409632|FG000|Overall Study|Withdrawal by Subject|1|||
163042885|NCT01554163|588863987|FG001|Overall Study|Protocol Violation|4|||
163042886|NCT01554163|588863986|FG000|Overall Study|Withdrawal by Subject|1|||
163042887|NCT01554163|588863987|FG001|Overall Study|Withdrawal by Subject|5|||
163042888|NCT01554163|588863986|FG000|Overall Study|Not Treated|1|||
163042889|NCT01554163|588863987|FG001|Overall Study|Not Treated|0|||
163042890|NCT01941537|588863988|FG000|Overall Study|Lack of Efficacy|1|||
163042891|NCT01941537|588863989|FG001|Overall Study|Lack of Efficacy|2|||
163042892|NCT01941537|588863988|FG000|Overall Study|Lost to Follow-up|1|||
163042893|NCT01941537|588863989|FG001|Overall Study|Lost to Follow-up|0|||
163042894|NCT01941537|588863988|FG000|Overall Study|Pregnancy|1|||
163042895|NCT01941537|588863989|FG001|Overall Study|Pregnancy|0|||
163042896|NCT01941537|588863988|FG000|Overall Study|Adverse Event|1|||
163042897|NCT01941537|588863989|FG001|Overall Study|Adverse Event|0|||
163042898|NCT01941537|588863988|FG000|Overall Study|Withdrawal by Subject|0|||
163042899|NCT01941537|588863989|FG001|Overall Study|Withdrawal by Subject|1|||
163042900|NCT02634983|588863990|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
163042901|NCT02634983|588863991|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
163042902|NCT00463801|588865665|FG000|Overall Study|Protocol Violation|1|||
163042903|NCT00463801|588865665|FG000|Overall Study|Lack of Efficacy|2|||
163042904|NCT00463801|588865665|FG000|Overall Study|Adverse Event|4|||
163042905|NCT00463801|588865665|FG000|Overall Study|Lost to Follow-up|5|||
163042906|NCT00463801|588865665|FG000|Overall Study|No longer require therapy|1|||
163042907|NCT00669318|588865666|FG000|Overall Study|Withdrawal by Subject|2|||
163042908|NCT04441788|588865669|FG000|Overall Study|Voluntary Withdrawl|0|||
163042909|NCT04441788|588865670|FG001|Overall Study|Voluntary Withdrawl|1|||
163042910|NCT04441788|588865671|FG002|Overall Study|Voluntary Withdrawl|0|||
163042911|NCT04441788|588865669|FG000|Overall Study|Ineligibility|1|||
163042912|NCT04441788|588865670|FG001|Overall Study|Ineligibility|0|||
163042913|NCT04441788|588865671|FG002|Overall Study|Ineligibility|0|||
163042914|NCT04441788|588865669|FG000|Overall Study|Adverse Event|0|||
163042915|NCT04441788|588865670|FG001|Overall Study|Adverse Event|0|||
163042916|NCT04441788|588865671|FG002|Overall Study|Adverse Event|4|||
163294371|NCT02537522|589784097|FG001|Phase I - Contralateral|incorrect randomization|1|||
163042917|NCT04441788|588865669|FG000|Overall Study|Study Terminated by Sponsor|16|||
163042918|NCT04441788|588865670|FG001|Overall Study|Study Terminated by Sponsor|16|||
163042919|NCT04441788|588865671|FG002|Overall Study|Study Terminated by Sponsor|12|||
163042920|NCT02315664|588865674|FG000|Overall Study|Lost to Follow-up|1|||
163042921|NCT02315664|588865675|FG001|Overall Study|Lost to Follow-up|1|||
163042922|NCT02315664|588865674|FG000|Overall Study|Withdrawal by Subject|0|||
163042923|NCT02315664|588865675|FG001|Overall Study|Withdrawal by Subject|3|||
163042924|NCT01677182|588865676|FG000|Overall Study|Adverse Event|2|||
163042925|NCT01677182|588865677|FG001|Overall Study|Adverse Event|1|||
163390400|NCT00631189|590141644|FG003|Treatment Phase|Pregnancy|0|||
163390401|NCT00631189|590141641|FG000|Treatment Phase|patient did not take pravastatin|0|||
163390402|NCT00631189|590141642|FG001|Treatment Phase|patient did not take pravastatin|0|||
163390403|NCT00631189|590141643|FG002|Treatment Phase|patient did not take pravastatin|1|||
163390404|NCT00631189|590141644|FG003|Treatment Phase|patient did not take pravastatin|0|||
163390405|NCT04464265|590141645|FG000|Overall Study|Physician Decision|2|||
163390406|NCT00954174|590141652|FG000|Overall Study|Adverse Event|28|||
163390407|NCT00954174|590141653|FG001|Overall Study|Adverse Event|23|||
163390408|NCT00954174|590141654|FG002|Overall Study|Adverse Event|4|||
163390409|NCT00954174|590141655|FG003|Overall Study|Adverse Event|9|||
163390410|NCT00954174|590141652|FG000|Overall Study|Death|4|||
163390411|NCT00954174|590141653|FG001|Overall Study|Death|2|||
163390412|NCT00954174|590141654|FG002|Overall Study|Death|0|||
163390413|NCT00954174|590141655|FG003|Overall Study|Death|0|||
163390414|NCT00954174|590141652|FG000|Overall Study|Lack of Efficacy|32|||
162951781|NCT00112463|588527632|FG000|Overall Study|Withdrawal by Subject|2|||
162951782|NCT00112463|588527632|FG000|Overall Study|Never started treatment|2|||
162951783|NCT00678639|588527633|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
162951784|NCT00678639|588527634|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
162951785|NCT00296647|588527636|FG000|Overall Study|Death|4|||
162951786|NCT00296647|588527637|FG001|Overall Study|Death|1|||
162951787|NCT00296647|588527638|FG002|Overall Study|Death|2|||
162951788|NCT00296647|588527639|FG003|Overall Study|Death|1|||
162951789|NCT00296647|588527640|FG004|Overall Study|Death|1|||
162951790|NCT00296647|588527636|FG000|Overall Study|Withdrawal by Subject|28|||
162951791|NCT00296647|588527637|FG001|Overall Study|Withdrawal by Subject|27|||
162951792|NCT00296647|588527638|FG002|Overall Study|Withdrawal by Subject|32|||
162951793|NCT00296647|588527639|FG003|Overall Study|Withdrawal by Subject|16|||
162951794|NCT00296647|588527640|FG004|Overall Study|Withdrawal by Subject|19|||
162951795|NCT05615935|588527641|FG000|Overall Study|Lost to Follow-up|1|||
162951796|NCT05615935|588527642|FG001|Overall Study|Lost to Follow-up|1|||
162951797|NCT00735904|588527643|FG000|Overall Study|Adverse Event|3|||
162951798|NCT00735904|588527643|FG000|Overall Study|Death|20|||
162951799|NCT00735904|588527643|FG000|Overall Study|Protocol Violation|1|||
162951800|NCT00735904|588527643|FG000|Overall Study|Withdrawal by Subject|1|||
162951801|NCT00735904|588527643|FG000|Overall Study|Study Terminated by Sponsor|5|||
162951802|NCT00735904|588527643|FG000|Overall Study|Other|8|||
162951803|NCT04510285|588527646|FG000|Overall Study|Death|1|||
162951804|NCT00048581|588527647|FG000|Double-Blind Period|Adverse Event|9|||
162951805|NCT00048581|588527648|FG001|Double-Blind Period|Adverse Event|5|||
162951806|NCT00048581|588527649|FG002|Double-Blind Period|Adverse Event|0|||
162951807|NCT00048581|588527647|FG000|Double-Blind Period|Lack of Efficacy|14|||
162951808|NCT00048581|588527648|FG001|Double-Blind Period|Lack of Efficacy|27|||
162951809|NCT00048581|588527649|FG002|Double-Blind Period|Lack of Efficacy|0|||
162951810|NCT00048581|588527647|FG000|Double-Blind Period|Lost to Follow-up|5|||
162951811|NCT00048581|588527648|FG001|Double-Blind Period|Lost to Follow-up|0|||
162951812|NCT00048581|588527649|FG002|Double-Blind Period|Lost to Follow-up|0|||
162951813|NCT00048581|588527647|FG000|Double-Blind Period|Withdrawal by Subject|5|||
162951814|NCT00048581|588527648|FG001|Double-Blind Period|Withdrawal by Subject|2|||
162951815|NCT00048581|588527649|FG002|Double-Blind Period|Withdrawal by Subject|0|||
162951816|NCT00048581|588527647|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
162951817|NCT00048581|588527648|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
162951818|NCT00048581|588527649|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
162951819|NCT00048581|588527647|FG000|Double-Blind Period|Investigator Decision|1|||
162951820|NCT00048581|588527648|FG001|Double-Blind Period|Investigator Decision|0|||
162951821|NCT00048581|588527649|FG002|Double-Blind Period|Investigator Decision|0|||
162951822|NCT00048581|588527647|FG000|Open-Label Period|Death|0|||
162951823|NCT00048581|588527648|FG001|Open-Label Period|Death|0|||
162951824|NCT00048581|588527649|FG002|Open-Label Period|Death|4|||
162951825|NCT00048581|588527647|FG000|Open-Label Period|Adverse Event|0|||
162951826|NCT00048581|588527648|FG001|Open-Label Period|Adverse Event|0|||
162951827|NCT00048581|588527649|FG002|Open-Label Period|Adverse Event|37|||
162951828|NCT00048581|588527647|FG000|Open-Label Period|Lack of Efficacy|0|||
162951829|NCT00048581|588527648|FG001|Open-Label Period|Lack of Efficacy|0|||
162951830|NCT00048581|588527649|FG002|Open-Label Period|Lack of Efficacy|69|||
162951831|NCT00048581|588527647|FG000|Open-Label Period|Lost to Follow-up|0|||
162951832|NCT00048581|588527648|FG001|Open-Label Period|Lost to Follow-up|0|||
162951833|NCT00048581|588527649|FG002|Open-Label Period|Lost to Follow-up|14|||
162951834|NCT00048581|588527647|FG000|Open-Label Period|Withdrawal by Subject|0|||
162951835|NCT00048581|588527648|FG001|Open-Label Period|Withdrawal by Subject|0|||
162951836|NCT00048581|588527649|FG002|Open-Label Period|Withdrawal by Subject|20|||
162951837|NCT00048581|588527647|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
162951838|NCT00048581|588527648|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
162951839|NCT00048581|588527649|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
162951840|NCT00048581|588527647|FG000|Open-Label Period|Poor/Non-compliance|0|||
163390415|NCT00954174|590141653|FG001|Overall Study|Lack of Efficacy|22|||
162951841|NCT00048581|588527648|FG001|Open-Label Period|Poor/Non-compliance|0|||
162951842|NCT00048581|588527649|FG002|Open-Label Period|Poor/Non-compliance|5|||
162951843|NCT00048581|588527647|FG000|Open-Label Period|Pregnancy|0|||
162951844|NCT00048581|588527648|FG001|Open-Label Period|Pregnancy|0|||
162951845|NCT00048581|588527649|FG002|Open-Label Period|Pregnancy|7|||
162951846|NCT00048581|588527647|FG000|Open-Label Period|Study Site Closure|0|||
162951847|NCT00048581|588527648|FG001|Open-Label Period|Study Site Closure|0|||
162951848|NCT00048581|588527649|FG002|Open-Label Period|Study Site Closure|2|||
162951849|NCT00048581|588527647|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
163189536|NCT04026711|589409633|FG001|Overall Study|Withdrawal by Subject|0|||
163189537|NCT04026711|589409632|FG000|Overall Study|mental health crisis|1|||
163189538|NCT04026711|589409633|FG001|Overall Study|mental health crisis|0|||
163189539|NCT05985395|589409634|FG000|Overall Study|Physician Decision|2|||
163189540|NCT05985395|589409635|FG001|Overall Study|Physician Decision|1|||
163189541|NCT05985395|589409634|FG000|Overall Study|Withdrawal by Subject|1|||
163189542|NCT05985395|589409635|FG001|Overall Study|Withdrawal by Subject|0|||
163189543|NCT04823650|589409636|FG000|Overall Study|Withdrawal by Subject|0|||
163189544|NCT04823650|589409637|FG001|Overall Study|Withdrawal by Subject|0|||
163189545|NCT04823650|589409638|FG002|Overall Study|Withdrawal by Subject|0|||
163189546|NCT04823650|589409639|FG003|Overall Study|Withdrawal by Subject|0|||
163189547|NCT04823650|589409640|FG004|Overall Study|Withdrawal by Subject|1|||
163189548|NCT04823650|589409641|FG005|Overall Study|Withdrawal by Subject|0|||
163189549|NCT02699697|589410564|FG000|Overall Study|Death|18|||
163189550|NCT02699697|589410565|FG001|Overall Study|Death|15|||
163189551|NCT02699697|589410564|FG000|Overall Study|Physician Decision|0|||
163042926|NCT01677182|588865678|FG002|Overall Study|Adverse Event|8|||
163189552|NCT02699697|589410565|FG001|Overall Study|Physician Decision|1|||
163042927|NCT01677182|588865676|FG000|Overall Study|Protocol Violation|5|||
163294372|NCT02537522|589784098|FG002|Phase I - Contralateral|incorrect randomization|0|||
163042928|NCT01677182|588865677|FG001|Overall Study|Protocol Violation|1|||
163042929|NCT01677182|588865678|FG002|Overall Study|Protocol Violation|4|||
163042930|NCT01677182|588865676|FG000|Overall Study|Lost to Follow-up|4|||
163042931|NCT01677182|588865677|FG001|Overall Study|Lost to Follow-up|0|||
163042932|NCT01677182|588865678|FG002|Overall Study|Lost to Follow-up|3|||
163042933|NCT01677182|588865676|FG000|Overall Study|Withdrawal by Subject|7|||
163042934|NCT01677182|588865677|FG001|Overall Study|Withdrawal by Subject|12|||
163042935|NCT01677182|588865678|FG002|Overall Study|Withdrawal by Subject|10|||
163042936|NCT01677182|588865676|FG000|Overall Study|Study termination|12|||
163042937|NCT01677182|588865677|FG001|Overall Study|Study termination|9|||
163042938|NCT01677182|588865678|FG002|Overall Study|Study termination|11|||
163042939|NCT01677182|588865676|FG000|Overall Study|Lack of Efficacy|3|||
163294373|NCT02537522|589784099|FG003|Phase I - Contralateral|incorrect randomization|0|||
163294374|NCT02537522|589784096|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
163294375|NCT02537522|589784097|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
163294376|NCT02537522|589784098|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
163294377|NCT02537522|589784099|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
163294378|NCT02537522|589784096|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
163294379|NCT02537522|589784097|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
163294380|NCT02537522|589784098|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
163294381|NCT02537522|589784099|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
163294382|NCT03920215|589784101|FG000|Overall Study|Lost to Follow-up|1|||
163294383|NCT03920215|589784102|FG001|Overall Study|Lost to Follow-up|2|||
163294384|NCT03920215|589784103|FG002|Overall Study|Lost to Follow-up|0|||
163294385|NCT03920215|589784104|FG003|Overall Study|Lost to Follow-up|0|||
163294386|NCT03920215|589784101|FG000|Overall Study|Death|0|||
163294387|NCT03920215|589784102|FG001|Overall Study|Death|0|||
163294388|NCT03920215|589784103|FG002|Overall Study|Death|0|||
163294389|NCT03920215|589784104|FG003|Overall Study|Death|1|||
163294390|NCT02547922|589784114|FG000|Overall Study|Withdrawal by Subject|9|||
163294391|NCT02547922|589784115|FG001|Overall Study|Withdrawal by Subject|6|||
163294392|NCT02547922|589784116|FG002|Overall Study|Withdrawal by Subject|10|||
163294393|NCT02547922|589784114|FG000|Overall Study|Adverse Event|3|||
163294394|NCT02547922|589784115|FG001|Overall Study|Adverse Event|1|||
163294395|NCT02547922|589784116|FG002|Overall Study|Adverse Event|2|||
163294396|NCT02547922|589784114|FG000|Overall Study|Lost to Follow-up|1|||
163294397|NCT02547922|589784115|FG001|Overall Study|Lost to Follow-up|0|||
163294398|NCT02547922|589784116|FG002|Overall Study|Lost to Follow-up|0|||
163294399|NCT02547922|589784114|FG000|Overall Study|Lack of Efficacy|5|||
163294400|NCT02547922|589784115|FG001|Overall Study|Lack of Efficacy|7|||
163294401|NCT02547922|589784116|FG002|Overall Study|Lack of Efficacy|4|||
163294402|NCT02547922|589784114|FG000|Overall Study|Death|1|||
163294403|NCT02547922|589784115|FG001|Overall Study|Death|0|||
163294404|NCT02547922|589784116|FG002|Overall Study|Death|0|||
163294405|NCT02547922|589784114|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
163294406|NCT02547922|589784115|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
163294407|NCT02547922|589784116|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
163294408|NCT02547922|589784114|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
163294409|NCT02547922|589784115|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
163294410|NCT02547922|589784116|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
163294411|NCT02547922|589784114|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
163294412|NCT02547922|589784115|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
163294413|NCT02547922|589784116|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
163294414|NCT02547922|589784114|FG000|Overall Study|Physician Decision|2|||
163294415|NCT02547922|589784115|FG001|Overall Study|Physician Decision|1|||
163294416|NCT02547922|589784116|FG002|Overall Study|Physician Decision|2|||
163294417|NCT02547922|589784114|FG000|Overall Study|Patients did not receive IP|1|||
163294418|NCT02547922|589784115|FG001|Overall Study|Patients did not receive IP|1|||
163294419|NCT02547922|589784116|FG002|Overall Study|Patients did not receive IP|0|||
163294420|NCT02709655|589784117|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
163294421|NCT02709655|589784118|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
163294422|NCT02709655|589784119|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
163294423|NCT02709655|589784120|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
163294424|NCT02709655|589784121|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
163294425|NCT02709655|589784117|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
163294426|NCT02709655|589784118|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
163294427|NCT02709655|589784119|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
163294428|NCT02709655|589784120|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
163042940|NCT01677182|588865677|FG001|Overall Study|Lack of Efficacy|0|||
163042941|NCT01677182|588865678|FG002|Overall Study|Lack of Efficacy|1|||
163042942|NCT01677182|588865676|FG000|Overall Study|Other reasons|1|||
163042943|NCT01677182|588865677|FG001|Overall Study|Other reasons|5|||
163042944|NCT01677182|588865678|FG002|Overall Study|Other reasons|2|||
163042945|NCT00667992|588865681|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
163189553|NCT02699697|589410564|FG000|Overall Study|Lost to Follow-up|2|||
163189554|NCT02699697|589410565|FG001|Overall Study|Lost to Follow-up|3|||
163390416|NCT00954174|590141654|FG002|Overall Study|Lack of Efficacy|8|||
163390417|NCT00954174|590141655|FG003|Overall Study|Lack of Efficacy|6|||
163390418|NCT00954174|590141652|FG000|Overall Study|Withdrawal by Subject|14|||
163390419|NCT00954174|590141653|FG001|Overall Study|Withdrawal by Subject|10|||
163390420|NCT00954174|590141654|FG002|Overall Study|Withdrawal by Subject|4|||
163390421|NCT00954174|590141655|FG003|Overall Study|Withdrawal by Subject|3|||
162951850|NCT00048581|588527648|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
162951851|NCT00048581|588527649|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
162951852|NCT00048581|588527647|FG000|Open-Label Period|Problem With Transportation To Site|0|||
162951853|NCT00048581|588527648|FG001|Open-Label Period|Problem With Transportation To Site|0|||
162951854|NCT00048581|588527649|FG002|Open-Label Period|Problem With Transportation To Site|1|||
162951855|NCT00048581|588527647|FG000|Open-Label Period|Primary Investigator Retired|0|||
162951856|NCT00048581|588527648|FG001|Open-Label Period|Primary Investigator Retired|0|||
162951857|NCT00048581|588527649|FG002|Open-Label Period|Primary Investigator Retired|2|||
162951858|NCT00048581|588527647|FG000|Open-Label Period|Study Ended By Sponsor|0|||
162951859|NCT00048581|588527648|FG001|Open-Label Period|Study Ended By Sponsor|0|||
162951860|NCT00048581|588527649|FG002|Open-Label Period|Study Ended By Sponsor|1|||
162951861|NCT03639311|588527653|FG000|Maintenance Phase|Lost to Follow-up|1|||
162951862|NCT03639311|588527654|FG001|Maintenance Phase|Lost to Follow-up|0|||
162951863|NCT03639311|588527655|FG002|Maintenance Phase|Lost to Follow-up|0|||
162951864|NCT03639311|588527653|FG000|Maintenance Phase|Adverse Event|1|||
162951865|NCT03639311|588527654|FG001|Maintenance Phase|Adverse Event|0|||
162951866|NCT03639311|588527655|FG002|Maintenance Phase|Adverse Event|0|||
162951867|NCT03639311|588527653|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
162951868|NCT03639311|588527654|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
162951869|NCT03639311|588527655|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
162951870|NCT03639311|588527653|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
162951871|NCT03639311|588527654|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
162951872|NCT03639311|588527655|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
162951873|NCT03639311|588527653|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
162951874|NCT03639311|588527654|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
163390422|NCT00954174|590141652|FG000|Overall Study|Medical Reason|4|||
163390423|NCT00954174|590141653|FG001|Overall Study|Medical Reason|2|||
163390424|NCT00954174|590141654|FG002|Overall Study|Medical Reason|1|||
163390425|NCT00954174|590141655|FG003|Overall Study|Medical Reason|0|||
163390426|NCT00954174|590141652|FG000|Overall Study|Ineligible|40|||
163189555|NCT02699697|589410564|FG000|Overall Study|Refused to follow up|1|||
163189556|NCT02699697|589410565|FG001|Overall Study|Refused to follow up|1|||
163189557|NCT02699697|589410564|FG000|Overall Study|Entered hospice care|5|||
163189558|NCT02699697|589410565|FG001|Overall Study|Entered hospice care|2|||
163189559|NCT02699697|589410564|FG000|Overall Study|Missing reason for discontinuation|6|||
163189560|NCT02699697|589410565|FG001|Overall Study|Missing reason for discontinuation|5|||
163189561|NCT02362035|589410566|FG000|Overall Study|Death|67|||
163189562|NCT02362035|589410566|FG000|Overall Study|Lost to Follow-up|3|||
163189563|NCT02362035|589410566|FG000|Overall Study|Adverse Event|1|||
163189564|NCT02362035|589410566|FG000|Overall Study|Physician Decision|1|||
163189565|NCT02362035|589410566|FG000|Overall Study|Subject started another cancer therapy|10|||
163189566|NCT02362035|589410566|FG000|Overall Study|Study terminated by sponsor|45|||
163189567|NCT02362035|589410566|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
163189568|NCT02362035|589410566|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
163189569|NCT02362035|589410566|FG000|Overall Study|Disease progression|11|||
163189570|NCT02362035|589410566|FG000|Overall Study|Withdrawal by Subject|20|||
163189571|NCT00004635|589410567|FG000|Period One|refused|2|||
163189572|NCT00004635|589410568|FG001|Period One|refused|1|||
163189573|NCT00004635|589410567|FG000|Period One|Withdrawal by Subject|1|||
163189574|NCT00004635|589410568|FG001|Period One|Withdrawal by Subject|1|||
163189575|NCT00004635|589410567|FG000|Period One|Protocol Violation|1|||
163189576|NCT00004635|589410568|FG001|Period One|Protocol Violation|0|||
163189577|NCT00004635|589410567|FG000|Period One|PSA did not go <5 ng/mL|1|||
163189578|NCT00004635|589410568|FG001|Period One|PSA did not go <5 ng/mL|0|||
163390427|NCT00954174|590141653|FG001|Overall Study|Ineligible|47|||
163390428|NCT00954174|590141654|FG002|Overall Study|Ineligible|7|||
163390429|NCT00954174|590141655|FG003|Overall Study|Ineligible|4|||
163390430|NCT00954174|590141652|FG000|Overall Study|Never Treated|4|||
163390431|NCT00954174|590141653|FG001|Overall Study|Never Treated|17|||
163390432|NCT00954174|590141654|FG002|Overall Study|Never Treated|0|||
163390433|NCT00954174|590141655|FG003|Overall Study|Never Treated|3|||
163390434|NCT02234323|590141656|FG000|All Enrolled|Not Treated: Completed study in database|2|||
163390435|NCT02234323|590141656|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
163390436|NCT02234323|590141656|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
163390437|NCT02234323|590141656|FG000|All Treated|Death|1|||
163390438|NCT02234323|590141656|FG000|All Treated|Physician Decision|5|||
163390439|NCT02234323|590141656|FG000|All Treated|Lack of Efficacy|3|||
163294429|NCT02709655|589784121|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
163294430|NCT02709655|589784117|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
163294431|NCT02709655|589784118|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
163294432|NCT02709655|589784119|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
163294433|NCT02709655|589784120|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
163294434|NCT02709655|589784121|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
163294435|NCT02709655|589784117|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
163294436|NCT02709655|589784118|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
163294437|NCT02709655|589784119|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
162978985|NCT01660022|588623542|FG004|First Sequence (7 Days)|Adverse Event|1|||
163390440|NCT02234323|590141656|FG000|All Treated|Exceeded lab value limit|2|||
163390441|NCT02234323|590141656|FG000|All Treated|Other|7|||
163401994|NCT01840579|590182956|FG003|Overall Study|Follow-up ended by Sponsor|0|||
162951875|NCT03639311|588527655|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
162951876|NCT03639311|588527653|FG000|Maintenance Phase|Lack of Efficacy|1|||
162951877|NCT03639311|588527654|FG001|Maintenance Phase|Lack of Efficacy|0|||
162951878|NCT03639311|588527655|FG002|Maintenance Phase|Lack of Efficacy|0|||
162951879|NCT00822926|588527658|FG000|Second Injection Visit|Lost to Follow-up|1|||
162951880|NCT00822926|588527659|FG001|Second Injection Visit|Lost to Follow-up|0|||
162951881|NCT00822926|588527658|FG000|Second Injection Visit|Withdrawal by Subject|0|||
162951882|NCT00822926|588527659|FG001|Second Injection Visit|Withdrawal by Subject|1|||
162951883|NCT04320849|588527670|FG000|Overall Study|Withdrawal by Subject|4|||
162951884|NCT04320849|588527670|FG000|Overall Study|Imaging data unavailable|2|||
162951885|NCT04320849|588527670|FG000|Overall Study|Incomplete imaging|2|||
162951886|NCT03135834|588527673|FG000|Stage 1|Adverse Event|1|||
162951887|NCT03135834|588527674|FG001|Stage 1|Adverse Event|2|||
162951888|NCT03135834|588527675|FG002|Stage 1|Adverse Event|2|||
162951889|NCT03135834|588527676|FG003|Stage 1|Adverse Event|1|||
162951890|NCT03135834|588527673|FG000|Stage 1|Death|1|||
162951891|NCT03135834|588527674|FG001|Stage 1|Death|0|||
162951892|NCT03135834|588527675|FG002|Stage 1|Death|0|||
162951893|NCT03135834|588527676|FG003|Stage 1|Death|0|||
162951894|NCT03135834|588527673|FG000|Stage 1|Lost to Follow-up|17|||
162951895|NCT03135834|588527674|FG001|Stage 1|Lost to Follow-up|24|||
162951896|NCT03135834|588527675|FG002|Stage 1|Lost to Follow-up|21|||
162951897|NCT03135834|588527676|FG003|Stage 1|Lost to Follow-up|38|||
162951898|NCT03135834|588527673|FG000|Stage 1|No longer met eligibility criteria|1|||
162951899|NCT03135834|588527674|FG001|Stage 1|No longer met eligibility criteria|6|||
162951900|NCT03135834|588527675|FG002|Stage 1|No longer met eligibility criteria|2|||
162951901|NCT03135834|588527676|FG003|Stage 1|No longer met eligibility criteria|5|||
162951902|NCT03135834|588527673|FG000|Stage 1|Other|0|||
162951903|NCT03135834|588527674|FG001|Stage 1|Other|2|||
162951904|NCT03135834|588527675|FG002|Stage 1|Other|1|||
162951905|NCT03135834|588527676|FG003|Stage 1|Other|0|||
162951906|NCT03135834|588527673|FG000|Stage 1|Physician Decision|0|||
162951907|NCT03135834|588527674|FG001|Stage 1|Physician Decision|1|||
162951908|NCT03135834|588527675|FG002|Stage 1|Physician Decision|0|||
162951909|NCT03135834|588527676|FG003|Stage 1|Physician Decision|0|||
162951910|NCT03135834|588527673|FG000|Stage 1|Pregnancy|0|||
162951911|NCT03135834|588527674|FG001|Stage 1|Pregnancy|4|||
162951912|NCT03135834|588527675|FG002|Stage 1|Pregnancy|2|||
162951913|NCT03135834|588527676|FG003|Stage 1|Pregnancy|4|||
162951914|NCT03135834|588527673|FG000|Stage 1|Protocol Violation|1|||
162951915|NCT03135834|588527674|FG001|Stage 1|Protocol Violation|1|||
162951916|NCT03135834|588527675|FG002|Stage 1|Protocol Violation|2|||
162951917|NCT03135834|588527676|FG003|Stage 1|Protocol Violation|1|||
162951918|NCT03135834|588527673|FG000|Stage 1|Withdrawal by parent/guardian|2|||
162951919|NCT03135834|588527674|FG001|Stage 1|Withdrawal by parent/guardian|10|||
162951920|NCT03135834|588527675|FG002|Stage 1|Withdrawal by parent/guardian|2|||
162951921|NCT03135834|588527676|FG003|Stage 1|Withdrawal by parent/guardian|1|||
162951922|NCT03135834|588527673|FG000|Stage 1|Withdrawal by Subject|16|||
162951923|NCT03135834|588527674|FG001|Stage 1|Withdrawal by Subject|22|||
162951924|NCT03135834|588527675|FG002|Stage 1|Withdrawal by Subject|7|||
162951925|NCT03135834|588527676|FG003|Stage 1|Withdrawal by Subject|10|||
162951926|NCT03135834|588527673|FG000|Stage 1|Randomized but not Vaccinated|0|||
162951927|NCT03135834|588527674|FG001|Stage 1|Randomized but not Vaccinated|3|||
162951928|NCT03135834|588527675|FG002|Stage 1|Randomized but not Vaccinated|1|||
163042946|NCT00667992|588865682|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
163042947|NCT00667992|588865681|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
163042948|NCT00667992|588865682|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
163042949|NCT00667992|588865681|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
163042950|NCT00667992|588865682|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
163042951|NCT00667992|588865681|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
163042952|NCT00667992|588865682|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
163042953|NCT00667992|588865681|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
163042954|NCT00667992|588865682|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
163042955|NCT00667992|588865681|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
163042956|NCT00667992|588865682|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
163042957|NCT00667992|588865681|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
163042958|NCT00667992|588865682|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
163042959|NCT00667992|588865681|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
163042960|NCT00667992|588865682|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
163042961|NCT00667992|588865681|FG000|Wash-out|Not within one doubling dilution|4|||
163042962|NCT00667992|588865682|FG001|Wash-out|Not within one doubling dilution|3|||
163042963|NCT00667992|588865681|FG000|Wash-out|Failure to wash-out|2|||
163042964|NCT00667992|588865682|FG001|Wash-out|Failure to wash-out|2|||
163042965|NCT00667992|588865681|FG000|Wash-out|Withdrawal by Subject|1|||
163042966|NCT00667992|588865682|FG001|Wash-out|Withdrawal by Subject|0|||
163042967|NCT00667992|588865681|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
163042968|NCT00667992|588865682|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
163294438|NCT02709655|589784120|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
163294439|NCT02709655|589784121|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
163294440|NCT02709655|589784117|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
163294441|NCT02709655|589784118|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
163294442|NCT02709655|589784119|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
163294443|NCT02709655|589784120|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
163294444|NCT02709655|589784121|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
163294445|NCT02709655|589784117|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
163042969|NCT00667992|588865681|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
163042970|NCT00667992|588865682|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
163042971|NCT00762762|588865686|FG000|Overall Study|Did not return for appointments|6|||
163042972|NCT00762762|588865687|FG001|Overall Study|Did not return for appointments|8|||
163042973|NCT02489448|588865688|FG000|Overall Study|Death|3|||
163042974|NCT02489448|588865688|FG000|Overall Study|Withdrawal by Subject|2|||
163042975|NCT02748057|588865689|FG000|Overall Study|Adverse Event|1|||
163042976|NCT02748057|588865690|FG001|Overall Study|Adverse Event|0|||
163042977|NCT02748057|588865689|FG000|Overall Study|Physician Decision|0|||
163042978|NCT02748057|588865690|FG001|Overall Study|Physician Decision|1|||
163042979|NCT02748057|588865689|FG000|Overall Study|Protocol Violation|2|||
163042980|NCT02748057|588865690|FG001|Overall Study|Protocol Violation|1|||
163042981|NCT02748057|588865689|FG000|Overall Study|Participant Moved|1|||
163042982|NCT02748057|588865690|FG001|Overall Study|Participant Moved|0|||
163042983|NCT02748057|588865689|FG000|Overall Study|Withdrawal by Subject|1|||
163042984|NCT02748057|588865690|FG001|Overall Study|Withdrawal by Subject|0|||
163042985|NCT02793947|588865693|FG000|Overall Study|Death|1|||
163042986|NCT02793947|588865694|FG001|Overall Study|Death|0|||
163042987|NCT02793947|588865693|FG000|Overall Study|Physician Decision|1|||
163042988|NCT02793947|588865694|FG001|Overall Study|Physician Decision|5|||
163042989|NCT02542397|588865695|FG000|Overall Study|Death|2|||
163042990|NCT02542397|588865695|FG000|Overall Study|Physician Decision|6|||
163042991|NCT02542397|588865695|FG000|Overall Study|Withdrawal by Subject|6|||
163042992|NCT02542397|588865695|FG000|Overall Study|Lost to Follow-up|2|||
163042993|NCT02090283|588865696|FG000|Overall Study|Withdrawal by Subject|6|||
163042994|NCT02090283|588865697|FG001|Overall Study|Withdrawal by Subject|6|||
163042995|NCT02090283|588865698|FG002|Overall Study|Withdrawal by Subject|6|||
163042996|NCT02090283|588865696|FG000|Overall Study|Sponsor Terminated Study|6|||
163042997|NCT02090283|588865697|FG001|Overall Study|Sponsor Terminated Study|6|||
163042998|NCT02090283|588865698|FG002|Overall Study|Sponsor Terminated Study|1|||
163042999|NCT02090283|588865696|FG000|Overall Study|Lost to Follow-up|2|||
163043000|NCT02090283|588865697|FG001|Overall Study|Lost to Follow-up|2|||
163294446|NCT02709655|589784118|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
163294447|NCT02709655|589784119|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
163043001|NCT02090283|588865698|FG002|Overall Study|Lost to Follow-up|3|||
163043002|NCT02090283|588865696|FG000|Overall Study|Adverse Event|1|||
163043003|NCT02090283|588865697|FG001|Overall Study|Adverse Event|1|||
163043004|NCT02090283|588865698|FG002|Overall Study|Adverse Event|0|||
163043005|NCT02090283|588865696|FG000|Overall Study|Protocol Violation|2|||
163043006|NCT02090283|588865697|FG001|Overall Study|Protocol Violation|0|||
163043007|NCT02090283|588865698|FG002|Overall Study|Protocol Violation|0|||
163189579|NCT00004635|589410567|FG000|Period One|second malignancy|1|||
163189580|NCT00004635|589410568|FG001|Period One|second malignancy|0|||
163189581|NCT00004635|589410567|FG000|Period One|progressed|0|||
163189582|NCT00004635|589410568|FG001|Period One|progressed|2|||
163189583|NCT00004635|589410567|FG000|Period One|health problem|0|||
163189584|NCT00004635|589410568|FG001|Period One|health problem|1|||
163189585|NCT00004635|589410567|FG000|Period One|discrepancy in data entry|0|||
163189586|NCT00004635|589410568|FG001|Period One|discrepancy in data entry|1|||
163189587|NCT00004635|589410567|FG000|Period Two|progression|2|||
163189588|NCT00004635|589410568|FG001|Period Two|progression|3|||
163189589|NCT00004635|589410567|FG000|Period Two|Adverse Event|1|||
163189590|NCT00004635|589410568|FG001|Period Two|Adverse Event|0|||
163189591|NCT00004635|589410567|FG000|Period Two|refused|0|||
163189592|NCT00004635|589410568|FG001|Period Two|refused|2|||
163189593|NCT00004635|589410567|FG000|Period Two|health problem|1|||
163189594|NCT00004635|589410568|FG001|Period Two|health problem|1|||
163189595|NCT00004635|589410567|FG000|Period Two|travel issues|0|||
163189596|NCT00004635|589410568|FG001|Period Two|travel issues|1|||
163189597|NCT00004635|589410567|FG000|Period Two|secondary malignancy|1|||
163189598|NCT00004635|589410568|FG001|Period Two|secondary malignancy|1|||
163189599|NCT00004635|589410567|FG000|Period Two|Lost to Follow-up|1|||
163189600|NCT00004635|589410568|FG001|Period Two|Lost to Follow-up|0|||
163189601|NCT00004635|589410567|FG000|Period Two|discrepancy in data entry|0|||
163189602|NCT00004635|589410568|FG001|Period Two|discrepancy in data entry|1|||
163189603|NCT00191906|589410569|FG000|Study Period II|Adverse Event|0|||
163189604|NCT00191906|589410570|FG001|Study Period II|Adverse Event|1|||
163189605|NCT00191906|589410571|FG002|Study Period II|Adverse Event|0|||
163189606|NCT00191906|589410572|FG003|Study Period II|Adverse Event|0|||
163189607|NCT00191906|589410569|FG000|Study Period II|Withdrawal by Subject|0|||
163189608|NCT00191906|589410570|FG001|Study Period II|Withdrawal by Subject|3|||
163189609|NCT00191906|589410571|FG002|Study Period II|Withdrawal by Subject|0|||
163189610|NCT00191906|589410572|FG003|Study Period II|Withdrawal by Subject|0|||
163189611|NCT00191906|589410569|FG000|Study Period II|Parent/Caregiver Decision|0|||
163189612|NCT00191906|589410570|FG001|Study Period II|Parent/Caregiver Decision|1|||
163189613|NCT00191906|589410571|FG002|Study Period II|Parent/Caregiver Decision|0|||
163189614|NCT00191906|589410572|FG003|Study Period II|Parent/Caregiver Decision|0|||
163189615|NCT00191906|589410569|FG000|Study Period II|Entry Criteria Exclusion|0|||
163189616|NCT00191906|589410570|FG001|Study Period II|Entry Criteria Exclusion|0|||
163189617|NCT00191906|589410571|FG002|Study Period II|Entry Criteria Exclusion|1|||
163189618|NCT00191906|589410572|FG003|Study Period II|Entry Criteria Exclusion|0|||
163189619|NCT00191906|589410569|FG000|Study Period III|Adverse Event|1|||
163189620|NCT00191906|589410570|FG001|Study Period III|Adverse Event|0|||
163189621|NCT00191906|589410571|FG002|Study Period III|Adverse Event|0|||
163189622|NCT00191906|589410572|FG003|Study Period III|Adverse Event|0|||
163189623|NCT00191906|589410569|FG000|Study Period III|Lost to Follow-up|0|||
163189624|NCT00191906|589410570|FG001|Study Period III|Lost to Follow-up|1|||
163189625|NCT00191906|589410571|FG002|Study Period III|Lost to Follow-up|0|||
163189626|NCT00191906|589410572|FG003|Study Period III|Lost to Follow-up|0|||
163189627|NCT00191906|589410569|FG000|Study Period III|Parent/Caregiver Decision|1|||
163189628|NCT00191906|589410570|FG001|Study Period III|Parent/Caregiver Decision|0|||
163189629|NCT00191906|589410571|FG002|Study Period III|Parent/Caregiver Decision|0|||
163189630|NCT00191906|589410572|FG003|Study Period III|Parent/Caregiver Decision|0|||
163189631|NCT00191906|589410569|FG000|Study Period III|Lack of Efficacy|3|||
163189632|NCT00191906|589410570|FG001|Study Period III|Lack of Efficacy|3|||
163189633|NCT00191906|589410571|FG002|Study Period III|Lack of Efficacy|0|||
163189634|NCT00191906|589410572|FG003|Study Period III|Lack of Efficacy|0|||
163189635|NCT00354614|589410573|FG000|Overall Study|Lack of Efficacy|28|||
163189636|NCT00573937|589410574|FG000|Overall Study|Study Terminated|0|||
163189637|NCT00573937|589410575|FG001|Overall Study|Study Terminated|1|||
163189638|NCT01797731|589410581|FG000|Overall Study|Didn't have proper radiographs required|3|||
163189639|NCT01797731|589410582|FG001|Overall Study|Didn't have proper radiographs required|3|||
163189640|NCT01604408|589410583|FG000|Treatment Period 1|Protocol Violation|0|||
163189641|NCT01604408|589410584|FG001|Treatment Period 1|Protocol Violation|1|||
163189642|NCT01604408|589410583|FG000|Treatment Period 2|Withdrawal by Subject|1|||
163189643|NCT01604408|589410584|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163189644|NCT01604408|589410583|FG000|Treatment Period 2|Protocol Violation|1|||
163043008|NCT00281697|588865700|FG000|Overall Study|> 60 days since last dose of study drug|4|||
163043009|NCT00281697|588865701|FG001|Overall Study|> 60 days since last dose of study drug|4|||
163189645|NCT01604408|589410584|FG001|Treatment Period 2|Protocol Violation|0|||
163189646|NCT01604408|589410583|FG000|Treatment Period 2|Adverse Event|0|||
163189647|NCT01604408|589410584|FG001|Treatment Period 2|Adverse Event|1|||
163189648|NCT01604408|589410583|FG000|Treatment Period 3|Protocol Violation|1|||
163189649|NCT01604408|589410584|FG001|Treatment Period 3|Protocol Violation|1|||
163189650|NCT01604408|589410583|FG000|Treatment Period 3|Adverse Event|0|||
163189651|NCT01604408|589410584|FG001|Treatment Period 3|Adverse Event|3|||
163189652|NCT01604408|589410583|FG000|Treatment Period 3|Withdrawal by Subject|3|||
163189653|NCT01604408|589410584|FG001|Treatment Period 3|Withdrawal by Subject|1|||
163189654|NCT01604408|589410583|FG000|Treatment Period 3|Sponsor Decision|1|||
163043010|NCT00281697|588865700|FG000|Overall Study|Adverse Event|54|||
163043011|NCT00281697|588865701|FG001|Overall Study|Adverse Event|15|||
163043012|NCT00281697|588865700|FG000|Overall Study|Death|8|||
163043013|NCT00281697|588865701|FG001|Overall Study|Death|3|||
163043014|NCT00281697|588865700|FG000|Overall Study|Disease progression|279|||
163043015|NCT00281697|588865701|FG001|Overall Study|Disease progression|149|||
163043016|NCT00281697|588865700|FG000|Overall Study|Other|5|||
163043017|NCT00281697|588865701|FG001|Overall Study|Other|6|||
163043018|NCT00281697|588865700|FG000|Overall Study|Physician's decision to withdraw|15|||
163043019|NCT00281697|588865701|FG001|Overall Study|Physician's decision to withdraw|12|||
163043020|NCT00281697|588865700|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
163043021|NCT00281697|588865701|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
163043022|NCT00281697|588865700|FG000|Overall Study|Did not receive study drug|3|||
163043023|NCT00281697|588865701|FG001|Overall Study|Did not receive study drug|2|||
163043024|NCT00632125|588865702|FG000|Overall Study|Death|82|||
163043025|NCT00632125|588865702|FG000|Overall Study|Withdrawal by Subject|44|||
163043026|NCT00632125|588865702|FG000|Overall Study|Adverse Event|36|||
163043027|NCT00632125|588865702|FG000|Overall Study|Renal transplantation|17|||
163043028|NCT00632125|588865702|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
163043029|NCT00632125|588865702|FG000|Overall Study|Non-compliance|8|||
163043030|NCT00632125|588865702|FG000|Overall Study|Development of uncontrolled hypertension|5|||
163043031|NCT00632125|588865702|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
163043032|NCT00577772|588865705|FG000|Overall Study|Lost to Follow-up|0|||
163043033|NCT00577772|588865706|FG001|Overall Study|Lost to Follow-up|1|||
163189655|NCT01604408|589410584|FG001|Treatment Period 3|Sponsor Decision|0|||
163189656|NCT01604408|589410583|FG000|Treatment Period 4|Death|1|||
163189657|NCT01604408|589410584|FG001|Treatment Period 4|Death|0|||
163189658|NCT01604408|589410583|FG000|Treatment Period 4|Withdrawal by Subject|2|||
163189659|NCT01604408|589410584|FG001|Treatment Period 4|Withdrawal by Subject|1|||
163189660|NCT01604408|589410583|FG000|Treatment Period 4|Adverse Event|0|||
163189661|NCT01604408|589410584|FG001|Treatment Period 4|Adverse Event|1|||
163189662|NCT01604408|589410583|FG000|Treatment Period 5|Adverse Event|4|||
163189663|NCT01604408|589410584|FG001|Treatment Period 5|Adverse Event|0|||
163189664|NCT01604408|589410583|FG000|Treatment Period 6|Lost to Follow-up|0|||
163189665|NCT01604408|589410584|FG001|Treatment Period 6|Lost to Follow-up|1|||
163043034|NCT00540644|588865710|FG000|Overall Study|Adverse Event|3|||
163043035|NCT00540644|588865711|FG001|Overall Study|Adverse Event|1|||
163043036|NCT00540644|588865710|FG000|Overall Study|Disease Progression|3|||
163043037|NCT00540644|588865711|FG001|Overall Study|Disease Progression|1|||
163189666|NCT01604408|589410583|FG000|Treatment Period 6|Adverse Event|2|||
163189667|NCT01604408|589410584|FG001|Treatment Period 6|Adverse Event|0|||
163189668|NCT01604408|589410583|FG000|Treatment Period 6|Sponsor decision|0|||
163189669|NCT01604408|589410584|FG001|Treatment Period 6|Sponsor decision|1|||
163189670|NCT01604408|589410583|FG000|Observation Period|Adverse Event|1|||
163189671|NCT01604408|589410584|FG001|Observation Period|Adverse Event|1|||
163189672|NCT01604408|589410583|FG000|Observation Period|Withdrawal by Subject|0|||
163189673|NCT01604408|589410584|FG001|Observation Period|Withdrawal by Subject|2|||
163189674|NCT00722423|589410588|FG000|Overall Study|Protocol Violation|0|||
163189675|NCT00722423|589410589|FG001|Overall Study|Protocol Violation|1|||
163189676|NCT01189604|589410591|FG000|Overall Study|Impossible to visit|0|||
163189677|NCT01189604|589410592|FG001|Overall Study|Impossible to visit|0|||
163189678|NCT01189604|589410593|FG002|Overall Study|Impossible to visit|0|||
163294448|NCT02709655|589784120|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
163294449|NCT02709655|589784121|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
163294450|NCT02709655|589784117|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
163294451|NCT02709655|589784118|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
163294452|NCT02709655|589784119|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
163294453|NCT02709655|589784120|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
163294454|NCT02709655|589784121|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
163189679|NCT01189604|589410594|FG003|Overall Study|Impossible to visit|0|||
163189680|NCT01189604|589410595|FG004|Overall Study|Impossible to visit|0|||
163189681|NCT01189604|589410596|FG005|Overall Study|Impossible to visit|1|||
163189682|NCT01189604|589410597|FG006|Overall Study|Impossible to visit|0|||
163189683|NCT01189604|589410591|FG000|Overall Study|Adverse Event|0|||
163189684|NCT01189604|589410592|FG001|Overall Study|Adverse Event|1|||
163189685|NCT01189604|589410593|FG002|Overall Study|Adverse Event|0|||
163189686|NCT01189604|589410594|FG003|Overall Study|Adverse Event|0|||
163189687|NCT01189604|589410595|FG004|Overall Study|Adverse Event|2|||
163189688|NCT01189604|589410596|FG005|Overall Study|Adverse Event|0|||
163189689|NCT01189604|589410597|FG006|Overall Study|Adverse Event|1|||
163189690|NCT01189604|589410591|FG000|Overall Study|Withdrawal by Subject|1|||
163189691|NCT01189604|589410592|FG001|Overall Study|Withdrawal by Subject|0|||
163189692|NCT01189604|589410593|FG002|Overall Study|Withdrawal by Subject|0|||
163189693|NCT01189604|589410594|FG003|Overall Study|Withdrawal by Subject|0|||
163189694|NCT01189604|589410595|FG004|Overall Study|Withdrawal by Subject|0|||
163189695|NCT01189604|589410596|FG005|Overall Study|Withdrawal by Subject|0|||
163189696|NCT01189604|589410597|FG006|Overall Study|Withdrawal by Subject|0|||
163189697|NCT03945214|589410598|FG000|Overall Study|Lost to Follow-up|3|||
163189698|NCT03945214|589410599|FG001|Overall Study|Lost to Follow-up|4|||
163189699|NCT03945214|589410600|FG002|Overall Study|Lost to Follow-up|7|||
163189700|NCT03945214|589410601|FG003|Overall Study|Lost to Follow-up|4|||
163189701|NCT04102098|589410612|FG000|Main Study Period|Ongoing in study|302|||
163189702|NCT04102098|589410613|FG001|Main Study Period|Ongoing in study|291|||
163189703|NCT04102098|589410612|FG000|Main Study Period|Death|20|||
163189704|NCT04102098|589410613|FG001|Main Study Period|Death|27|||
163189705|NCT04102098|589410612|FG000|Main Study Period|Lost to Follow-up|1|||
163189706|NCT04102098|589410613|FG001|Main Study Period|Lost to Follow-up|1|||
163189707|NCT04102098|589410612|FG000|Main Study Period|Physician Decision|0|||
163189708|NCT04102098|589410613|FG001|Main Study Period|Physician Decision|1|||
163189709|NCT04102098|589410612|FG000|Main Study Period|Withdrawal by Subject|11|||
163189710|NCT04102098|589410613|FG001|Main Study Period|Withdrawal by Subject|14|||
163189711|NCT04102098|589410612|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
163189712|NCT04102098|589410613|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
163189713|NCT04102098|589410612|FG000|Crossover: AS Who Crossed Over|Death|11|||
163189714|NCT04102098|589410613|FG001|Crossover: AS Who Crossed Over|Death|0|||
163189715|NCT04102098|589410612|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
163189716|NCT04102098|589410613|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
163189717|NCT03150173|589410616|FG000|Overall Study|Lost to Follow-up|13|||
163189718|NCT03150173|589410617|FG001|Overall Study|Lost to Follow-up|5|||
163189719|NCT01756053|589410619|FG000|Period 1 (10 Days)|Protocol Violation|1|||
163189720|NCT01756053|589410620|FG001|Period 1 (10 Days)|Protocol Violation|1|||
163189721|NCT01756053|589410619|FG000|Period 2 (10 Days)|Protocol Violation|0|||
163189722|NCT01756053|589410620|FG001|Period 2 (10 Days)|Protocol Violation|2|||
163189723|NCT03277690|589410621|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
163189724|NCT03277690|589410622|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
163189725|NCT03277690|589410621|FG000|Dose Titration and Maintenance|Physician Decision|1|||
163189726|NCT03277690|589410622|FG001|Dose Titration and Maintenance|Physician Decision|0|||
163189727|NCT03277690|589410621|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
163189728|NCT03277690|589410622|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
163189729|NCT03277690|589410621|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
163189730|NCT03277690|589410622|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
163189731|NCT03277690|589410621|FG000|Dose Titration and Maintenance|Adverse Event|15|||
163189732|NCT03277690|589410622|FG001|Dose Titration and Maintenance|Adverse Event|0|||
163189733|NCT03277690|589410621|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
163189734|NCT03277690|589410622|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
163189735|NCT03277690|589410621|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
163189736|NCT03277690|589410622|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
163189737|NCT02853344|589410625|FG000|Overall Study|Lost to Follow-up|1|||
163189738|NCT02853344|589410626|FG001|Overall Study|Lost to Follow-up|1|||
163189739|NCT02853344|589410625|FG000|Overall Study|Withdrawal by Subject|2|||
163189740|NCT02853344|589410626|FG001|Overall Study|Withdrawal by Subject|4|||
163189741|NCT02853344|589410625|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
163189742|NCT02853344|589410626|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
163294455|NCT02709655|589784117|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
163189743|NCT02853344|589410625|FG000|Overall Study|Death|70|||
163189744|NCT02853344|589410626|FG001|Overall Study|Death|112|||
163189745|NCT02955797|589410636|FG000|Overall Study|Protocol Violation|1|||
163189746|NCT02955797|589410637|FG001|Overall Study|Protocol Violation|0|||
163189747|NCT02955797|589410638|FG002|Overall Study|Protocol Violation|0|||
163189748|NCT02955797|589410639|FG003|Overall Study|Protocol Violation|1|||
163189749|NCT02955797|589410636|FG000|Overall Study|Withdrawal by Subject|2|||
163189750|NCT02955797|589410637|FG001|Overall Study|Withdrawal by Subject|2|||
163189751|NCT02955797|589410638|FG002|Overall Study|Withdrawal by Subject|0|||
163189752|NCT02955797|589410639|FG003|Overall Study|Withdrawal by Subject|1|||
163189753|NCT02955797|589410636|FG000|Overall Study|Lost to Follow-up|0|||
163189754|NCT02955797|589410637|FG001|Overall Study|Lost to Follow-up|1|||
163189755|NCT02955797|589410638|FG002|Overall Study|Lost to Follow-up|0|||
163189756|NCT02955797|589410639|FG003|Overall Study|Lost to Follow-up|0|||
163189757|NCT03131453|589410641|FG000|Overall Study|Study terminated by Sponsor|424|||
163189758|NCT03131453|589410642|FG001|Overall Study|Study terminated by Sponsor|222|||
163189759|NCT03131453|589410643|FG002|Overall Study|Study terminated by Sponsor|438|||
163189760|NCT03131453|589410641|FG000|Overall Study|Withdrawal by Subject|18|||
163390442|NCT02644941|590141657|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
163390443|NCT02644941|590141658|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
163390444|NCT00867113|590141659|FG000|Treatment Period|Adverse Event|15|||
163390445|NCT00867113|590141659|FG000|Treatment Period|Death|2|||
163390446|NCT00867113|590141659|FG000|Treatment Period|Withdrawal by Subject|19|||
163390447|NCT00867113|590141659|FG000|Treatment Period|Lost to Follow-up|3|||
163390448|NCT00867113|590141659|FG000|Treatment Period|Administrative problems|1|||
163390449|NCT00867113|590141659|FG000|Treatment Period|Disease progression/relapse|1|||
163390450|NCT00867113|590141659|FG000|Treatment Period|Protocol Violation|4|||
163390451|NCT00867113|590141659|FG000|Post Treatment After Survival Follow-up|Death|1|||
163390452|NCT00867113|590141659|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
163390453|NCT00867113|590141659|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
163390454|NCT00867113|590141659|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
163390455|NCT01145495|590141660|FG000|Overall Study|Adverse Event|6|||
163390456|NCT01145495|590141660|FG000|Overall Study|Withdrawal by Subject|6|||
163390457|NCT01145495|590141660|FG000|Overall Study|Disease progression after respone|2|||
163390458|NCT01886313|590141663|FG000|Overall Study|Adverse Event|1|||
163390459|NCT01886313|590141664|FG001|Overall Study|Adverse Event|1|||
163390460|NCT01603082|590141665|FG000|Overall Study|Adverse Event|0|||
163390461|NCT01603082|590141666|FG001|Overall Study|Adverse Event|1|||
163390462|NCT01603082|590141665|FG000|Overall Study|Withdrawal by Subject|1|||
163390463|NCT01603082|590141666|FG001|Overall Study|Withdrawal by Subject|0|||
163390464|NCT01603082|590141665|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
163390465|NCT01603082|590141666|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
163390466|NCT01641809|590141672|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
163390467|NCT01641809|590141673|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
163390468|NCT01641809|590141674|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
163390469|NCT01641809|590141675|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
163390470|NCT01641809|590141672|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
163390471|NCT01641809|590141673|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
163390472|NCT01641809|590141674|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
163189761|NCT03131453|589410642|FG001|Overall Study|Withdrawal by Subject|7|||
163189762|NCT03131453|589410643|FG002|Overall Study|Withdrawal by Subject|13|||
163390473|NCT01641809|590141675|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
163390474|NCT01641809|590141672|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
163390475|NCT01641809|590141673|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
163390476|NCT01641809|590141674|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
163390477|NCT01641809|590141675|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
163390478|NCT01641809|590141672|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
163390479|NCT01641809|590141673|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
162951929|NCT03135834|588527676|FG003|Stage 1|Randomized but not Vaccinated|6|||
163390480|NCT01641809|590141674|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
163390481|NCT01641809|590141675|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
163390482|NCT01641809|590141672|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
163390483|NCT01641809|590141673|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
163390484|NCT01641809|590141674|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
163390485|NCT01641809|590141675|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
163390486|NCT01641809|590141672|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
163390487|NCT01641809|590141673|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
163390488|NCT01641809|590141674|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
163390489|NCT01641809|590141675|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
163390490|NCT01641809|590141672|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
163390491|NCT01641809|590141673|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
163390492|NCT01641809|590141674|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
163390493|NCT01641809|590141675|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
163390494|NCT01641809|590141672|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
163390495|NCT01641809|590141673|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
163390496|NCT01641809|590141674|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
162951930|NCT03135834|588527673|FG000|Stage 2|Lost to Follow-up|0|||
163043038|NCT00540644|588865710|FG000|Overall Study|Physician Decision|0|||
163043039|NCT00540644|588865711|FG001|Overall Study|Physician Decision|5|||
163043040|NCT00540644|588865710|FG000|Overall Study|Withdrawal by Subject|2|||
163043041|NCT00540644|588865711|FG001|Overall Study|Withdrawal by Subject|2|||
163043042|NCT00540644|588865710|FG000|Overall Study|Noncomplilance|1|||
163043043|NCT00540644|588865711|FG001|Overall Study|Noncomplilance|0|||
163043044|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
163043045|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
163043046|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
163043047|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
163043048|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
163043049|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
163294456|NCT02709655|589784118|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
163043050|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
163043051|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
163189763|NCT03131453|589410641|FG000|Overall Study|Adverse Event|10|||
163189764|NCT03131453|589410642|FG001|Overall Study|Adverse Event|3|||
163189765|NCT03131453|589410643|FG002|Overall Study|Adverse Event|3|||
163189766|NCT03131453|589410641|FG000|Overall Study|Lost to Follow-up|1|||
163189767|NCT03131453|589410642|FG001|Overall Study|Lost to Follow-up|0|||
163189768|NCT03131453|589410643|FG002|Overall Study|Lost to Follow-up|1|||
163189769|NCT03131453|589410641|FG000|Overall Study|Physician Decision|1|||
163189770|NCT03131453|589410642|FG001|Overall Study|Physician Decision|0|||
163189771|NCT03131453|589410643|FG002|Overall Study|Physician Decision|1|||
163189772|NCT03131453|589410641|FG000|Overall Study|Non-compliance with study treatment|1|||
163189773|NCT03131453|589410642|FG001|Overall Study|Non-compliance with study treatment|0|||
163189774|NCT03131453|589410643|FG002|Overall Study|Non-compliance with study treatment|0|||
163189775|NCT03131453|589410641|FG000|Overall Study|Technical problems|1|||
163189776|NCT03131453|589410642|FG001|Overall Study|Technical problems|0|||
163189777|NCT03131453|589410643|FG002|Overall Study|Technical problems|0|||
163189778|NCT03131453|589410641|FG000|Overall Study|Protocol deviation|0|||
163189779|NCT03131453|589410642|FG001|Overall Study|Protocol deviation|1|||
163189780|NCT03131453|589410643|FG002|Overall Study|Protocol deviation|0|||
163189781|NCT02081183|589410644|FG000|Overall Study|Lost to Follow-up|0|||
163189782|NCT02081183|589410645|FG001|Overall Study|Lost to Follow-up|1|||
163189783|NCT02081183|589410644|FG000|Overall Study|Protocol Violation|1|||
163189784|NCT02081183|589410645|FG001|Overall Study|Protocol Violation|0|||
163189785|NCT02081183|589410644|FG000|Overall Study|Other|3|||
163189786|NCT02081183|589410645|FG001|Overall Study|Other|3|||
163189787|NCT04043728|589410646|FG000|Overall Study|Lost to Follow-up|1|||
163189788|NCT04043728|589410647|FG001|Overall Study|Lost to Follow-up|2|||
163189789|NCT04043728|589410648|FG002|Overall Study|Lost to Follow-up|0|||
163189790|NCT02840721|589410649|FG000|Treatment Period|Adverse Event|1|||
163189791|NCT02840721|589410649|FG000|Follow-Up|Lack of Efficacy|1|||
163189792|NCT02840721|589410649|FG000|Follow-Up|Withdrawal by Subject|4|||
163189793|NCT02840721|589410649|FG000|Follow-Up|Withdrawal of Consent|2|||
163189794|NCT05535972|589410653|FG000|Overall Study|Withdrawal by Subject|31|||
163189795|NCT05535972|589410653|FG000|Overall Study|Lost to Follow-up|5|||
163189796|NCT05535972|589410653|FG000|Overall Study|Adverse Event|6|||
163189797|NCT05535972|589410653|FG000|Overall Study|Protocol Deviation|2|||
163189798|NCT02649894|589410654|FG000|Overall Study|Adverse Event|1|||
163189799|NCT02649894|589410655|FG001|Overall Study|Adverse Event|0|||
163189800|NCT02649894|589410654|FG000|Overall Study|Physician Decision|0|||
163189801|NCT02649894|589410655|FG001|Overall Study|Physician Decision|1|||
162951931|NCT03135834|588527674|FG001|Stage 2|Lost to Follow-up|1|||
162951932|NCT03135834|588527675|FG002|Stage 2|Lost to Follow-up|0|||
162951933|NCT03135834|588527676|FG003|Stage 2|Lost to Follow-up|0|||
162951934|NCT03135834|588527673|FG000|Stage 2|Withdrawal by Subject|0|||
162951935|NCT03135834|588527674|FG001|Stage 2|Withdrawal by Subject|1|||
162951936|NCT03135834|588527675|FG002|Stage 2|Withdrawal by Subject|0|||
162951937|NCT03135834|588527676|FG003|Stage 2|Withdrawal by Subject|0|||
162951938|NCT03135834|588527673|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
162951939|NCT03135834|588527674|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
162951940|NCT03135834|588527675|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
162951941|NCT03135834|588527676|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
162951942|NCT03135834|588527673|FG000|Stage 2|Did not receive Booster Vaccination|1|||
162951943|NCT03135834|588527674|FG001|Stage 2|Did not receive Booster Vaccination|1|||
162951944|NCT03135834|588527675|FG002|Stage 2|Did not receive Booster Vaccination|0|||
162951945|NCT03135834|588527676|FG003|Stage 2|Did not receive Booster Vaccination|0|||
162951946|NCT00119379|588527679|FG000|Overall Study|Adverse Event|4|||
162951947|NCT00119379|588527680|FG001|Overall Study|Adverse Event|1|||
162951948|NCT02421952|588527687|FG000|Overall Study|Diary Not Returned|93|||
162951949|NCT02421952|588527687|FG000|Overall Study|Failed seriation task|13|||
162951950|NCT02421952|588527687|FG000|Overall Study|Subject uncooperative for baseline test|2|||
162951951|NCT02421952|588527687|FG000|Overall Study|Surgery cancelled|1|||
162951952|NCT03262012|588527698|FG000|Overall Study|Withdrawal by Subject|15|||
162951953|NCT03262012|588527699|FG001|Overall Study|Withdrawal by Subject|13|||
162951954|NCT03262012|588527700|FG002|Overall Study|Withdrawal by Subject|8|||
162951955|NCT03262012|588527701|FG003|Overall Study|Withdrawal by Subject|7|||
162951956|NCT03262012|588527698|FG000|Overall Study|Adverse Event|10|||
162951957|NCT03262012|588527699|FG001|Overall Study|Adverse Event|12|||
162951958|NCT03262012|588527700|FG002|Overall Study|Adverse Event|4|||
162951959|NCT03262012|588527701|FG003|Overall Study|Adverse Event|6|||
162951960|NCT03262012|588527698|FG000|Overall Study|Physician Decision|2|||
162951961|NCT03262012|588527699|FG001|Overall Study|Physician Decision|5|||
163189802|NCT02649894|589410654|FG000|Overall Study|Withdrawal by Subject|5|||
163189803|NCT02649894|589410655|FG001|Overall Study|Withdrawal by Subject|2|||
163189804|NCT02649894|589410654|FG000|Overall Study|Lost to Follow-up|2|||
163189805|NCT02649894|589410655|FG001|Overall Study|Lost to Follow-up|1|||
163189806|NCT02649894|589410654|FG000|Overall Study|Death|30|||
163189807|NCT02649894|589410655|FG001|Overall Study|Death|7|||
163189808|NCT02649894|589410654|FG000|Overall Study|Other, not specified|6|||
163189809|NCT02649894|589410655|FG001|Overall Study|Other, not specified|0|||
163189810|NCT04590963|589410656|FG000|Overall Study|Death|118|||
163189811|NCT04590963|589410657|FG001|Overall Study|Death|59|||
163189812|NCT04590963|589410656|FG000|Overall Study|Lost to Follow-up|1|||
163189813|NCT04590963|589410657|FG001|Overall Study|Lost to Follow-up|1|||
163189814|NCT04590963|589410656|FG000|Overall Study|Progressive disease|0|||
163189815|NCT04590963|589410657|FG001|Overall Study|Progressive disease|1|||
163189816|NCT04590963|589410656|FG000|Overall Study|Study terminated by sponsor|103|||
163189817|NCT04590963|589410657|FG001|Overall Study|Study terminated by sponsor|50|||
163189818|NCT04590963|589410656|FG000|Overall Study|Withdrawal by Subject|15|||
163189819|NCT04590963|589410657|FG001|Overall Study|Withdrawal by Subject|8|||
163294457|NCT02709655|589784119|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
163294458|NCT02709655|589784120|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
162951962|NCT03262012|588527700|FG002|Overall Study|Physician Decision|1|||
163189820|NCT04590963|589410656|FG000|Overall Study|Ongoing at data cut-off|9|||
162951963|NCT03262012|588527701|FG003|Overall Study|Physician Decision|0|||
162951964|NCT03262012|588527698|FG000|Overall Study|Lack of Efficacy|0|||
162951965|NCT03262012|588527699|FG001|Overall Study|Lack of Efficacy|5|||
162951966|NCT03262012|588527700|FG002|Overall Study|Lack of Efficacy|1|||
163189821|NCT04590963|589410657|FG001|Overall Study|Ongoing at data cut-off|4|||
163189822|NCT04590963|589410656|FG000|Overall Study|Screen failure|1|||
163189823|NCT04590963|589410657|FG001|Overall Study|Screen failure|0|||
163189824|NCT01736124|589410658|FG000|Post-intervention Assessment|Death|2|||
162951967|NCT03262012|588527701|FG003|Overall Study|Lack of Efficacy|2|||
163294459|NCT02709655|589784121|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
163189825|NCT01736124|589410659|FG001|Post-intervention Assessment|Death|2|||
163189826|NCT01736124|589410658|FG000|Post-intervention Assessment|lost computer access|1|||
163189827|NCT01736124|589410659|FG001|Post-intervention Assessment|lost computer access|1|||
163189828|NCT01736124|589410658|FG000|Post-intervention Assessment|Moved away|3|||
163189829|NCT01736124|589410659|FG001|Post-intervention Assessment|Moved away|1|||
163189830|NCT01736124|589410658|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
163189831|NCT01736124|589410659|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
163189832|NCT01736124|589410658|FG000|Post-intervention Assessment|Illness|3|||
163189833|NCT01736124|589410659|FG001|Post-intervention Assessment|Illness|2|||
163189834|NCT01736124|589410658|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
163189835|NCT01736124|589410659|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
163189836|NCT01736124|589410658|FG000|Post-intervention Assessment|Temporarily away|3|||
163189837|NCT01736124|589410659|FG001|Post-intervention Assessment|Temporarily away|1|||
163189838|NCT01736124|589410658|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
163189839|NCT01736124|589410659|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
163189840|NCT01736124|589410658|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
163189841|NCT01736124|589410659|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
163189842|NCT01736124|589410658|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
163390497|NCT01641809|590141675|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
163390498|NCT01641809|590141672|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
163189843|NCT01736124|589410659|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
163189844|NCT01736124|589410658|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
163189845|NCT01736124|589410659|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
163189846|NCT01736124|589410658|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
163390499|NCT01641809|590141673|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
163390500|NCT01641809|590141674|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
163390501|NCT01641809|590141675|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
163390502|NCT01641809|590141672|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
163390503|NCT01641809|590141673|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
163390504|NCT01641809|590141674|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
163390505|NCT01641809|590141675|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
163390506|NCT01641809|590141672|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
163390507|NCT01641809|590141673|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
163390508|NCT01641809|590141674|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
163390509|NCT01641809|590141675|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
163390510|NCT01641809|590141672|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
163390511|NCT01641809|590141673|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
163390512|NCT01641809|590141674|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
163390513|NCT01641809|590141675|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
163390514|NCT01641809|590141672|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
163390515|NCT01641809|590141673|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
163390516|NCT01641809|590141674|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
163390517|NCT01641809|590141675|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
163390518|NCT01641809|590141672|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
163390519|NCT01641809|590141673|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
163390520|NCT01641809|590141674|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
163390521|NCT01641809|590141675|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
163390522|NCT01641809|590141672|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
163390523|NCT01641809|590141673|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
163390524|NCT01641809|590141674|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
163390525|NCT01641809|590141675|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
163390526|NCT01641809|590141672|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
163390527|NCT01641809|590141673|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
163390528|NCT01641809|590141674|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
163390529|NCT01641809|590141675|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
163390530|NCT01641809|590141672|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
163390531|NCT01641809|590141673|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
163390532|NCT01641809|590141674|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
163390533|NCT01641809|590141675|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
163390534|NCT01641809|590141672|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
163390535|NCT01641809|590141673|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
163390536|NCT01641809|590141674|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
163390537|NCT01641809|590141675|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
163189847|NCT01736124|589410659|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
163390538|NCT04195581|590141676|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
163390539|NCT04195581|590141676|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
163189848|NCT01736124|589410658|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
163189849|NCT01736124|589410659|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
163189850|NCT01736124|589410658|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
163189851|NCT01736124|589410659|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
163189852|NCT01736124|589410658|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
163189853|NCT01736124|589410659|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
163189854|NCT01736124|589410658|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
163189855|NCT01736124|589410659|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
163189856|NCT04176705|589410661|FG000|Overall Study|Withdrawal by Subject|4|||
163390540|NCT04195581|590141676|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
163189857|NCT04176705|589410662|FG001|Overall Study|Withdrawal by Subject|4|||
163189858|NCT04176705|589410661|FG000|Overall Study|Death|1|||
163390541|NCT04195581|590141676|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
162951968|NCT03262012|588527698|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
162951969|NCT03262012|588527699|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
163189859|NCT04176705|589410662|FG001|Overall Study|Death|1|||
163189860|NCT04176705|589410661|FG000|Overall Study|Lost to Follow-up|3|||
163189861|NCT04176705|589410662|FG001|Overall Study|Lost to Follow-up|3|||
163189862|NCT02628769|589410663|FG000|First Intervention|Adverse Event|1|||
163189863|NCT02628769|589410664|FG001|First Intervention|Adverse Event|0|||
163189864|NCT02628769|589410663|FG000|First Intervention|Withdrawal by Subject|0|||
163189865|NCT02628769|589410664|FG001|First Intervention|Withdrawal by Subject|1|||
163189866|NCT02628769|589410663|FG000|Second Intervention|Adverse Event|2|||
163189867|NCT02628769|589410664|FG001|Second Intervention|Adverse Event|0|||
163189868|NCT02628769|589410663|FG000|Second Intervention|Physician Decision|0|||
163189869|NCT02628769|589410664|FG001|Second Intervention|Physician Decision|1|||
163189870|NCT01467583|589410665|FG000|Overall Study|Death|1|||
163189871|NCT01467583|589410666|FG001|Overall Study|Death|1|||
163189872|NCT01467583|589410667|FG002|Overall Study|Death|0|||
163189873|NCT01467583|589410665|FG000|Overall Study|Withdrawal by Subject|1|||
163189874|NCT01467583|589410666|FG001|Overall Study|Withdrawal by Subject|0|||
163189875|NCT01467583|589410667|FG002|Overall Study|Withdrawal by Subject|0|||
163189876|NCT01467583|589410665|FG000|Overall Study|Protocol Violation|0|||
163189877|NCT01467583|589410666|FG001|Overall Study|Protocol Violation|0|||
163189878|NCT01467583|589410667|FG002|Overall Study|Protocol Violation|2|||
163189879|NCT05274165|589410669|FG000|Overall Study|Withdrawal by Subject|3|||
163189880|NCT05274165|589410670|FG001|Overall Study|Withdrawal by Subject|3|||
163189881|NCT00717093|589412153|FG000|Overall Study|Adverse Event|19|||
163189882|NCT00717093|589412154|FG001|Overall Study|Adverse Event|9|||
163189883|NCT00717093|589412153|FG000|Overall Study|Lack of Efficacy|3|||
163189884|NCT00717093|589412154|FG001|Overall Study|Lack of Efficacy|13|||
163189885|NCT00717093|589412153|FG000|Overall Study|Lost to Follow-up|9|||
163189886|NCT00717093|589412154|FG001|Overall Study|Lost to Follow-up|6|||
163189887|NCT00717093|589412153|FG000|Overall Study|Withdrawal by Subject|12|||
163189888|NCT00717093|589412154|FG001|Overall Study|Withdrawal by Subject|19|||
163189889|NCT00717093|589412153|FG000|Overall Study|Other|0|||
163189890|NCT00717093|589412154|FG001|Overall Study|Other|1|||
163189891|NCT00717093|589412153|FG000|Overall Study|Randomized but not treated|1|||
163189892|NCT00717093|589412154|FG001|Overall Study|Randomized but not treated|0|||
163189893|NCT00217620|589412155|FG000|Overall Study|Adverse Event|2|||
163189894|NCT00217620|589412155|FG000|Overall Study|Progression|31|||
163189895|NCT00217620|589412155|FG000|Overall Study|Not Protocol Specified|4|||
163189896|NCT00217620|589412155|FG000|Overall Study|Ineligible|13|||
163189897|NCT00217620|589412155|FG000|Overall Study|Never received treatment|1|||
163189898|NCT01314703|589412171|FG000|Overall Study|screen failure and closed enrollment|8|||
163189899|NCT04195906|589412175|FG000|Part 1|Adverse Event|3|||
163189900|NCT04195906|589412176|FG001|Part 1|Adverse Event|7|||
163189901|NCT04195906|589412175|FG000|Part 1|Withdrawal by Subject|0|||
163189902|NCT04195906|589412176|FG001|Part 1|Withdrawal by Subject|1|||
163189903|NCT04195906|589412175|FG000|Part 2|Adverse Event|1|||
163189904|NCT04195906|589412176|FG001|Part 2|Adverse Event|1|||
163189905|NCT04195906|589412175|FG000|Part 2|Withdrawal by Subject|0|||
163189906|NCT04195906|589412176|FG001|Part 2|Withdrawal by Subject|3|||
163189907|NCT04195906|589412175|FG000|Part 2|Other|1|||
163189908|NCT04195906|589412176|FG001|Part 2|Other|3|||
163189909|NCT00691301|589412178|FG000|Overall Study|Adverse Event|10|||
163189910|NCT00691301|589412178|FG000|Overall Study|Death|2|||
163189911|NCT00691301|589412178|FG000|Overall Study|Lack of Efficacy|32|||
163189912|NCT00691301|589412178|FG000|Overall Study|Withdrawal by Subject|4|||
163189913|NCT00691301|589412178|FG000|Overall Study|Concurrent illness|2|||
163189914|NCT00691301|589412178|FG000|Overall Study|other reason|3|||
163189915|NCT00691301|589412178|FG000|Overall Study|Did not initiate study treatment|1|||
163189916|NCT02642029|589412179|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
163189917|NCT02642029|589412180|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
163189918|NCT02642029|589412181|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
163189919|NCT02642029|589412182|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
163189920|NCT02642029|589412183|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
163189921|NCT02642029|589412184|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
163189922|NCT02642029|589412179|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
163189923|NCT02642029|589412180|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
163390542|NCT04195581|590141676|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
162951970|NCT03262012|588527700|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
162951971|NCT03262012|588527701|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
162951972|NCT02801877|588527704|FG000|Overall Study|Lost to Follow-up|1|||
162951973|NCT02801877|588527705|FG001|Overall Study|Lost to Follow-up|1|||
162951974|NCT02801877|588527706|FG002|Overall Study|Lost to Follow-up|2|||
162951975|NCT02801877|588527707|FG003|Overall Study|Lost to Follow-up|0|||
162951976|NCT02801877|588527704|FG000|Overall Study|Never Started Treatment|2|||
162951977|NCT02801877|588527705|FG001|Overall Study|Never Started Treatment|0|||
162951978|NCT02801877|588527706|FG002|Overall Study|Never Started Treatment|4|||
163189924|NCT02642029|589412181|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
163189925|NCT02642029|589412182|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
163189926|NCT02642029|589412183|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
163189927|NCT02642029|589412184|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
163390543|NCT04195581|590141676|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
163390544|NCT00821431|590141677|FG000|Overall Study|Adverse Event|6|||
163390545|NCT00821431|590141678|FG001|Overall Study|Adverse Event|3|||
163390546|NCT00821431|590141677|FG000|Overall Study|Withdrawal by Subject|5|||
163189928|NCT02642029|589412179|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
163189929|NCT02642029|589412180|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
163189930|NCT02642029|589412181|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
163390547|NCT00821431|590141678|FG001|Overall Study|Withdrawal by Subject|0|||
163390548|NCT00821431|590141677|FG000|Overall Study|Lost to Follow-up|1|||
163390549|NCT00821431|590141678|FG001|Overall Study|Lost to Follow-up|0|||
163390550|NCT00821431|590141677|FG000|Overall Study|Protocol Violation|3|||
163390551|NCT00821431|590141678|FG001|Overall Study|Protocol Violation|1|||
163390552|NCT00821431|590141677|FG000|Overall Study|Physician Decision|0|||
163390553|NCT00821431|590141678|FG001|Overall Study|Physician Decision|1|||
163390554|NCT01699789|590141682|FG000|Overall Study|Withdrawal by Subject|18|||
163390555|NCT01699789|590141683|FG001|Overall Study|Withdrawal by Subject|23|||
163390556|NCT01699789|590141682|FG000|Overall Study|Death|1|||
163390557|NCT01699789|590141683|FG001|Overall Study|Death|2|||
163390558|NCT01699789|590141682|FG000|Overall Study|Lost to Follow-up|83|||
163390559|NCT01699789|590141683|FG001|Overall Study|Lost to Follow-up|101|||
163390560|NCT00639223|590141684|FG000|Overall Study|Lost to Follow-up|0|||
163390561|NCT00639223|590141685|FG001|Overall Study|Lost to Follow-up|2|||
163390562|NCT02511678|590141686|FG000|Overall Study|Withdrawal by Subject|2|||
163390563|NCT02511678|590141686|FG000|Overall Study|Lost to Follow-up|4|||
163390564|NCT02511678|590141686|FG000|Overall Study|Death|19|||
163390565|NCT02511678|590141686|FG000|Overall Study|Adverse Event|1|||
163390566|NCT02511678|590141686|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
163390567|NCT02511678|590141686|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
163390568|NCT02511678|590141686|FG000|Overall Study|Required Radiofrequency Ablation|1|||
163390569|NCT02511678|590141686|FG000|Overall Study|Biopsy was Negative|1|||
163390570|NCT02511678|590141686|FG000|Overall Study|Protocol Violation|1|||
163390571|NCT02511678|590141686|FG000|Overall Study|Received Radiation Treatment|1|||
163390572|NCT02000427|590141696|FG000|Overall Study|Death|22|||
163390573|NCT05125679|590141699|FG000|Overall Study|Study Terminated by Sponsor|2|||
163390574|NCT05125679|590141700|FG001|Overall Study|Study Terminated by Sponsor|5|||
163390575|NCT03442114|590141701|FG000|Overall Study|Lost to Follow-up|13|||
163390576|NCT03442114|590141702|FG001|Overall Study|Lost to Follow-up|13|||
163390577|NCT03442114|590141701|FG000|Overall Study|Physician Decision|2|||
163390578|NCT03442114|590141702|FG001|Overall Study|Physician Decision|2|||
163390579|NCT03442114|590141701|FG000|Overall Study|Protocol Violation|0|||
163390580|NCT03442114|590141702|FG001|Overall Study|Protocol Violation|2|||
163390581|NCT03442114|590141701|FG000|Overall Study|Withdrawal by Subject|1|||
163390582|NCT03442114|590141702|FG001|Overall Study|Withdrawal by Subject|3|||
163390583|NCT03442114|590141701|FG000|Overall Study|Guardianship Change|0|||
163390584|NCT03442114|590141702|FG001|Overall Study|Guardianship Change|1|||
163390585|NCT04890054|590143247|FG000|Overall Study|Lost to Follow-up|202|||
163390586|NCT04890054|590143248|FG001|Overall Study|Lost to Follow-up|219|||
163390587|NCT04313153|590143249|FG000|Overall Study|Adverse Event (includes Death)|14|||
163390588|NCT04313153|590143250|FG001|Overall Study|Adverse Event (includes Death)|19|||
163390589|NCT04313153|590143251|FG002|Overall Study|Adverse Event (includes Death)|10|||
163390590|NCT04313153|590143249|FG000|Overall Study|Physician Decision|4|||
163390591|NCT04313153|590143250|FG001|Overall Study|Physician Decision|2|||
163390592|NCT04313153|590143251|FG002|Overall Study|Physician Decision|1|||
163390593|NCT04313153|590143249|FG000|Overall Study|Withdrawal by Subject|7|||
163390594|NCT04313153|590143250|FG001|Overall Study|Withdrawal by Subject|6|||
163390595|NCT04313153|590143251|FG002|Overall Study|Withdrawal by Subject|2|||
163390596|NCT04313153|590143249|FG000|Overall Study|Lack of Efficacy|3|||
163390597|NCT04313153|590143250|FG001|Overall Study|Lack of Efficacy|3|||
163390598|NCT04313153|590143251|FG002|Overall Study|Lack of Efficacy|0|||
163390599|NCT04313153|590143249|FG000|Overall Study|Lost to Follow-up|1|||
163390600|NCT04313153|590143250|FG001|Overall Study|Lost to Follow-up|0|||
163390601|NCT04313153|590143251|FG002|Overall Study|Lost to Follow-up|2|||
163390602|NCT04313153|590143249|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
163390603|NCT04313153|590143250|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
163390604|NCT04313153|590143251|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
163390605|NCT04313153|590143249|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
163390606|NCT04313153|590143250|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
163390607|NCT04313153|590143251|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
163390608|NCT04313153|590143249|FG000|Overall Study|Change in Dialysis Modality|0|||
163390609|NCT04313153|590143250|FG001|Overall Study|Change in Dialysis Modality|1|||
163390610|NCT04313153|590143251|FG002|Overall Study|Change in Dialysis Modality|2|||
163390611|NCT04313153|590143249|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
163390612|NCT04313153|590143250|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
163390613|NCT04313153|590143251|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
163390614|NCT04313153|590143249|FG000|Overall Study|Other|5|||
163390615|NCT04313153|590143250|FG001|Overall Study|Other|3|||
163390616|NCT04313153|590143251|FG002|Overall Study|Other|2|||
163390617|NCT05586269|590143252|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
163390618|NCT05586269|590143253|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
163390619|NCT05586269|590143254|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
163390620|NCT05586269|590143255|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
163390621|NCT05586269|590143252|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
163189931|NCT02642029|589412182|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
163189932|NCT02642029|589412183|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
163189933|NCT02642029|589412184|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
163189934|NCT02642029|589412179|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
163189935|NCT02642029|589412180|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
163189936|NCT02642029|589412181|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
163189937|NCT02642029|589412182|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
163189938|NCT02642029|589412183|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
163189939|NCT02642029|589412184|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
163189940|NCT02642029|589412179|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
163189941|NCT02642029|589412180|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
163189942|NCT02642029|589412181|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
163189943|NCT02642029|589412182|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
163189944|NCT02642029|589412183|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
163189945|NCT02642029|589412184|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
163189946|NCT02642029|589412179|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
163189947|NCT02642029|589412180|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
163189948|NCT02642029|589412181|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
163189949|NCT02642029|589412182|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
162951979|NCT02801877|588527707|FG003|Overall Study|Never Started Treatment|0|||
163189950|NCT02642029|589412183|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
163189951|NCT02642029|589412184|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
163189952|NCT01823146|589412185|FG000|Overall Study|Withdrawal by Subject|0|||
163189953|NCT01823146|589412186|FG001|Overall Study|Withdrawal by Subject|1|||
163390622|NCT05586269|590143253|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
163390623|NCT05586269|590143254|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
163390624|NCT05586269|590143255|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
163390625|NCT00702845|590143260|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
163390626|NCT00702845|590143261|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
163390627|NCT00702845|590143260|FG000|Overall Study|Too high ovarian response|5|||
163390628|NCT00702845|590143261|FG001|Overall Study|Too high ovarian response|1|||
163390629|NCT00702845|590143260|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
163390630|NCT00702845|590143261|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
163390631|NCT00702845|590143260|FG000|Overall Study|Insufficient ovarian response|1|||
163390632|NCT00702845|590143261|FG001|Overall Study|Insufficient ovarian response|0|||
163390633|NCT00702845|590143260|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
163390634|NCT00702845|590143261|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
163390635|NCT00702845|590143260|FG000|Overall Study|No or abnormal fertilization|4|||
163390636|NCT00702845|590143261|FG001|Overall Study|No or abnormal fertilization|2|||
163390637|NCT00702845|590143260|FG000|Overall Study|Patient's decision|2|||
163390638|NCT00702845|590143261|FG001|Overall Study|Patient's decision|1|||
163390639|NCT00702845|590143260|FG000|Overall Study|Not randomized|0|||
163390640|NCT00702845|590143261|FG001|Overall Study|Not randomized|1|||
163390641|NCT00928564|590143262|FG000|Overall Study|Lost to Follow-up|6|||
163390642|NCT00928564|590143263|FG001|Overall Study|Lost to Follow-up|0|||
163390643|NCT03434353|590143270|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
163390644|NCT03434353|590143271|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
163390645|NCT03434353|590143272|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
163390646|NCT03434353|590143273|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
163390647|NCT03434353|590143274|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
163390648|NCT03434353|590143270|FG000|Overall Study|Withdrew consent|1|||
163390649|NCT03434353|590143271|FG001|Overall Study|Withdrew consent|0|||
163390650|NCT03434353|590143272|FG002|Overall Study|Withdrew consent|3|||
163390651|NCT03434353|590143273|FG003|Overall Study|Withdrew consent|0|||
163390652|NCT03434353|590143274|FG004|Overall Study|Withdrew consent|0|||
163390653|NCT03434353|590143270|FG000|Overall Study|Adverse Event|1|||
163390654|NCT03434353|590143271|FG001|Overall Study|Adverse Event|0|||
163390655|NCT03434353|590143272|FG002|Overall Study|Adverse Event|0|||
163390656|NCT03434353|590143273|FG003|Overall Study|Adverse Event|0|||
163390657|NCT03434353|590143274|FG004|Overall Study|Adverse Event|1|||
163390658|NCT03434353|590143270|FG000|Overall Study|Lost to Follow-up|2|||
163390659|NCT03434353|590143271|FG001|Overall Study|Lost to Follow-up|0|||
163390660|NCT03434353|590143272|FG002|Overall Study|Lost to Follow-up|0|||
163390661|NCT03434353|590143273|FG003|Overall Study|Lost to Follow-up|0|||
163390662|NCT03434353|590143274|FG004|Overall Study|Lost to Follow-up|0|||
163390663|NCT03739762|590143275|FG000|Overall Study|Lost to Follow-up|1|||
163390664|NCT03739762|590143276|FG001|Overall Study|Lost to Follow-up|1|||
163390665|NCT03739762|590143275|FG000|Overall Study|Withdrawal by Subject|2|||
163390666|NCT03739762|590143276|FG001|Overall Study|Withdrawal by Subject|6|||
163390667|NCT00929656|590143277|FG000|Overall Study|Lost to Follow-up|0|||
163390668|NCT00929656|590143278|FG001|Overall Study|Lost to Follow-up|1|||
163390669|NCT00607880|590143279|FG000|Overall Study|Unable to place port due to occlusion|1|||
163390670|NCT00607880|590143280|FG001|Overall Study|Unable to place port due to occlusion|0|||
163390671|NCT01131351|590143283|FG000|Overall Study|Adverse Event|0|||
163390672|NCT01131351|590143284|FG001|Overall Study|Adverse Event|2|||
163390673|NCT01131351|590143283|FG000|Overall Study|Protocol Deviation|0|||
163390674|NCT01131351|590143284|FG001|Overall Study|Protocol Deviation|1|||
163390675|NCT04606771|590143289|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
163390676|NCT04606771|590143290|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
163390677|NCT04606771|590143289|FG000|Overall Study|Death|5|||
163390678|NCT04606771|590143290|FG001|Overall Study|Death|6|||
163390679|NCT04606771|590143289|FG000|Overall Study|Wrong randomisation|0|||
163390680|NCT04606771|590143290|FG001|Overall Study|Wrong randomisation|1|||
163390681|NCT01207596|590143292|FG000|Overall Study|Physician Decision|4|||
163390682|NCT01207596|590143292|FG000|Overall Study|Lack of Efficacy|1|||
163390683|NCT01207596|590143292|FG000|Overall Study|Adverse Event|3|||
163390684|NCT01207596|590143292|FG000|Overall Study|Withdrawal by Subject|1|||
163390685|NCT03083847|590143293|FG000|Main|Physician Decision|0|||
163390686|NCT03083847|590143294|FG001|Main|Physician Decision|0|||
163390687|NCT03083847|590143295|FG002|Main|Physician Decision|0|||
163390688|NCT03083847|590143296|FG003|Main|Physician Decision|0|||
163390689|NCT03083847|590143297|FG004|Main|Physician Decision|0|||
163390690|NCT03083847|590143298|FG005|Main|Physician Decision|1|||
163390691|NCT03083847|590143299|FG006|Main|Physician Decision|0|||
163390692|NCT03083847|590143300|FG007|Main|Physician Decision|0|||
163390693|NCT03083847|590143301|FG008|Main|Physician Decision|0|||
163390694|NCT03083847|590143302|FG009|Main|Physician Decision|0|||
162951980|NCT00154102|588527708|FG000|Overall Study|investigational study phase ongoing|7|||
162951981|NCT00154102|588527709|FG001|Overall Study|investigational study phase ongoing|2|||
162951982|NCT04934722|588529503|FG000|Overall Study|Death|4|||
162951983|NCT04934722|588529504|FG001|Overall Study|Death|3|||
162951984|NCT04934722|588529503|FG000|Overall Study|Participants Ongoing|88|||
162951985|NCT04934722|588529504|FG001|Overall Study|Participants Ongoing|91|||
162951986|NCT06358820|588529505|FG000|Overall Study|Adverse Event|11|||
162951987|NCT06358820|588529505|FG000|Overall Study|kidney transplantation|3|||
162951988|NCT06358820|588529505|FG000|Overall Study|patient voluntary withdrawal|6|||
162951989|NCT06358820|588529505|FG000|Overall Study|Physician Decision|1|||
162951990|NCT01294787|588529506|FG000|Period 1|Adverse Event|0|||
162951991|NCT01294787|588529507|FG001|Period 1|Adverse Event|0|||
162951992|NCT01294787|588529508|FG002|Period 1|Adverse Event|0|||
162951993|NCT01294787|588529509|FG003|Period 1|Adverse Event|0|||
162951994|NCT01294787|588529510|FG004|Period 1|Adverse Event|1|||
162951995|NCT01294787|588529511|FG005|Period 1|Adverse Event|0|||
162951996|NCT01294787|588529506|FG000|Period 1|Withdrawal by Subject|0|||
163043052|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
163043053|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
163043054|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
163043055|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
163043056|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
163043057|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
163043058|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Death|1|||
163043059|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Death|0|||
163043060|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
163043061|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
163390695|NCT03083847|590143293|FG000|Main|Pregnancy|0|||
163390696|NCT03083847|590143294|FG001|Main|Pregnancy|0|||
163390697|NCT03083847|590143295|FG002|Main|Pregnancy|0|||
163390698|NCT03083847|590143296|FG003|Main|Pregnancy|0|||
163390699|NCT03083847|590143297|FG004|Main|Pregnancy|0|||
163390700|NCT03083847|590143298|FG005|Main|Pregnancy|0|||
163390701|NCT03083847|590143299|FG006|Main|Pregnancy|0|||
163390702|NCT03083847|590143300|FG007|Main|Pregnancy|1|||
163390703|NCT03083847|590143301|FG008|Main|Pregnancy|0|||
163390704|NCT03083847|590143302|FG009|Main|Pregnancy|0|||
163390705|NCT03083847|590143293|FG000|Main|Adverse Event|0|||
163390706|NCT03083847|590143294|FG001|Main|Adverse Event|0|||
163390707|NCT03083847|590143295|FG002|Main|Adverse Event|0|||
163390708|NCT03083847|590143296|FG003|Main|Adverse Event|0|||
163390709|NCT03083847|590143297|FG004|Main|Adverse Event|0|||
163390710|NCT03083847|590143298|FG005|Main|Adverse Event|0|||
162951997|NCT01294787|588529507|FG001|Period 1|Withdrawal by Subject|0|||
162951998|NCT01294787|588529508|FG002|Period 1|Withdrawal by Subject|0|||
162951999|NCT01294787|588529509|FG003|Period 1|Withdrawal by Subject|1|||
162952000|NCT01294787|588529510|FG004|Period 1|Withdrawal by Subject|1|||
162952001|NCT01294787|588529511|FG005|Period 1|Withdrawal by Subject|1|||
162952002|NCT01294787|588529506|FG000|Period 1|Administrative problem|0|||
162952003|NCT01294787|588529507|FG001|Period 1|Administrative problem|0|||
162952004|NCT01294787|588529508|FG002|Period 1|Administrative problem|1|||
162952005|NCT01294787|588529509|FG003|Period 1|Administrative problem|0|||
162952006|NCT01294787|588529510|FG004|Period 1|Administrative problem|0|||
163043062|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
163043063|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
163043064|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
163043065|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
163043066|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
163043067|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
163043068|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
163043069|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
163043070|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
163043071|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
163043072|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
163043073|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
163043074|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
163043075|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
163043076|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
163390711|NCT03083847|590143299|FG006|Main|Adverse Event|0|||
163390712|NCT03083847|590143300|FG007|Main|Adverse Event|2|||
163390713|NCT03083847|590143301|FG008|Main|Adverse Event|0|||
162952007|NCT01294787|588529511|FG005|Period 1|Administrative problem|1|||
162952008|NCT01294787|588529506|FG000|Period 2|Adverse Event|0|||
162952009|NCT01294787|588529507|FG001|Period 2|Adverse Event|3|||
163043077|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
163390714|NCT03083847|590143302|FG009|Main|Adverse Event|0|||
163390715|NCT03083847|590143293|FG000|Main|Withdrawal by Subject|0|||
163390716|NCT03083847|590143294|FG001|Main|Withdrawal by Subject|0|||
163390717|NCT03083847|590143295|FG002|Main|Withdrawal by Subject|0|||
163390718|NCT03083847|590143296|FG003|Main|Withdrawal by Subject|0|||
163390719|NCT03083847|590143297|FG004|Main|Withdrawal by Subject|0|||
163390720|NCT03083847|590143298|FG005|Main|Withdrawal by Subject|0|||
163390721|NCT03083847|590143299|FG006|Main|Withdrawal by Subject|1|||
163390722|NCT03083847|590143300|FG007|Main|Withdrawal by Subject|1|||
163390723|NCT03083847|590143301|FG008|Main|Withdrawal by Subject|0|||
163189954|NCT01823146|589412185|FG000|Overall Study|Lost to Follow-up|2|||
163189955|NCT01823146|589412186|FG001|Overall Study|Lost to Follow-up|1|||
163189956|NCT00463580|589412187|FG000|Overall Study|Lost to Follow-up|1|||
163189957|NCT00463580|589412188|FG001|Overall Study|Lost to Follow-up|0|||
163189958|NCT00463580|589412187|FG000|Overall Study|Schedule conflict|2|||
163189959|NCT00463580|589412188|FG001|Overall Study|Schedule conflict|0|||
163189960|NCT00463580|589412187|FG000|Overall Study|Medical/psychiatric complications|0|||
163189961|NCT00463580|589412188|FG001|Overall Study|Medical/psychiatric complications|2|||
163189962|NCT01426438|589412189|FG000|Overall Study|Lost to Follow-up|1|||
163189963|NCT01426438|589412190|FG001|Overall Study|Lost to Follow-up|3|||
163189964|NCT01426438|589412189|FG000|Overall Study|Off study Treatment|9|||
163189965|NCT01426438|589412190|FG001|Overall Study|Off study Treatment|3|||
163189966|NCT01426438|589412189|FG000|Overall Study|Poor scan quality|3|||
163189967|NCT01426438|589412190|FG001|Overall Study|Poor scan quality|2|||
163189968|NCT01426438|589412189|FG000|Overall Study|Missed Scan|2|||
163189969|NCT01426438|589412190|FG001|Overall Study|Missed Scan|2|||
163189970|NCT01788046|589412191|FG000|Overall Study|Withdrawal by Subject|12|||
163189971|NCT01788046|589412192|FG001|Overall Study|Withdrawal by Subject|12|||
163189972|NCT01788046|589412191|FG000|Overall Study|Lost to Follow-up|12|||
163189973|NCT01788046|589412192|FG001|Overall Study|Lost to Follow-up|19|||
163189974|NCT01788046|589412191|FG000|Overall Study|Death|7|||
163189975|NCT01788046|589412192|FG001|Overall Study|Death|5|||
163189976|NCT01788046|589412191|FG000|Overall Study|Protocol Specified Criteria|25|||
163189977|NCT01788046|589412192|FG001|Overall Study|Protocol Specified Criteria|1|||
163189978|NCT01495975|589412196|FG000|Overall Study|Lost to Follow-up|1|||
163189979|NCT01495975|589412197|FG001|Overall Study|Lost to Follow-up|0|||
163189980|NCT00808483|589412200|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
163189981|NCT00808483|589412201|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
163189982|NCT00808483|589412200|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
163189983|NCT00808483|589412201|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
163189984|NCT00808483|589412200|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
163189985|NCT00808483|589412201|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
163189986|NCT02038881|589412202|FG000|Overall Study|Withdrawal by Subject|0|||
163189987|NCT02038881|589412203|FG001|Overall Study|Withdrawal by Subject|0|||
163189988|NCT02038881|589412204|FG002|Overall Study|Withdrawal by Subject|1|||
163189989|NCT02038881|589412202|FG000|Overall Study|Lost to Follow-up|2|||
163189990|NCT02038881|589412203|FG001|Overall Study|Lost to Follow-up|0|||
163189991|NCT02038881|589412204|FG002|Overall Study|Lost to Follow-up|0|||
163189992|NCT02038881|589412202|FG000|Overall Study|incarcerated|1|||
163189993|NCT02038881|589412203|FG001|Overall Study|incarcerated|0|||
163189994|NCT02038881|589412204|FG002|Overall Study|incarcerated|0|||
163189995|NCT00333840|589412205|FG000|First-line Treatment Period|Adverse Event|38|||
163189996|NCT00333840|589412206|FG001|First-line Treatment Period|Adverse Event|37|||
163189997|NCT00333840|589412207|FG002|First-line Treatment Period|Adverse Event|0|||
163189998|NCT00333840|589412208|FG003|First-line Treatment Period|Adverse Event|0|||
163189999|NCT00333840|589412205|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
163190000|NCT00333840|589412206|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
163190001|NCT00333840|589412207|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
163190002|NCT00333840|589412208|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
163190003|NCT00333840|589412205|FG000|First-line Treatment Period|Abnormal procedure|2|||
163190004|NCT00333840|589412206|FG001|First-line Treatment Period|Abnormal procedure|0|||
163190005|NCT00333840|589412207|FG002|First-line Treatment Period|Abnormal procedure|0|||
163190006|NCT00333840|589412208|FG003|First-line Treatment Period|Abnormal procedure|0|||
163190007|NCT00333840|589412205|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
163190008|NCT00333840|589412206|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
163190009|NCT00333840|589412207|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
163190010|NCT00333840|589412208|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
163190011|NCT00333840|589412205|FG000|First-line Treatment Period|No longer required study drug|21|||
163190012|NCT00333840|589412206|FG001|First-line Treatment Period|No longer required study drug|8|||
163190013|NCT00333840|589412207|FG002|First-line Treatment Period|No longer required study drug|0|||
163190014|NCT00333840|589412208|FG003|First-line Treatment Period|No longer required study drug|0|||
163190015|NCT00333840|589412205|FG000|First-line Treatment Period|Protocol Violation|17|||
163190016|NCT00333840|589412206|FG001|First-line Treatment Period|Protocol Violation|17|||
163190017|NCT00333840|589412207|FG002|First-line Treatment Period|Protocol Violation|0|||
163190018|NCT00333840|589412208|FG003|First-line Treatment Period|Protocol Violation|0|||
163190019|NCT00333840|589412205|FG000|First-line Treatment Period|Subject withdrew consent|57|||
163190020|NCT00333840|589412206|FG001|First-line Treatment Period|Subject withdrew consent|77|||
163190021|NCT00333840|589412207|FG002|First-line Treatment Period|Subject withdrew consent|0|||
163190022|NCT00333840|589412208|FG003|First-line Treatment Period|Subject withdrew consent|0|||
163043078|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Death|0|||
163043079|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Death|0|||
163043080|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
163043081|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
163043082|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
163043083|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
163043084|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
163043085|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
163043086|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
163043087|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
163043088|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
163043089|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
163043090|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
163390724|NCT03083847|590143302|FG009|Main|Withdrawal by Subject|0|||
163390725|NCT00216203|590143303|FG000|Overall Study|Withdrawal by Subject|2|||
163390726|NCT02596620|590143306|FG000|Overall Study|Lost to Follow-up|1|||
163390727|NCT02596620|590143307|FG001|Overall Study|Lost to Follow-up|1|||
163390728|NCT03155373|590143317|FG000|Overall Study|No longer required surgery|1|||
163390729|NCT03155373|590143317|FG000|Overall Study|Protocol Violation|1|||
163390730|NCT03155373|590143317|FG000|Overall Study|Death|2|||
163390731|NCT03155373|590143317|FG000|Overall Study|Withdrawal by Subject|3|||
163390732|NCT01054144|590143318|FG000|Overall Study|Death|2|||
163390733|NCT02856893|590143319|FG000|Overall Study|Lack of Efficacy|27|||
163390734|NCT02856893|590143320|FG001|Overall Study|Lack of Efficacy|15|||
163390735|NCT02856893|590143321|FG002|Overall Study|Lack of Efficacy|19|||
163390736|NCT02856893|590143319|FG000|Overall Study|Death|1|||
163390737|NCT02856893|590143320|FG001|Overall Study|Death|0|||
163390738|NCT02856893|590143321|FG002|Overall Study|Death|0|||
163390739|NCT02856893|590143319|FG000|Overall Study|Adverse Event|2|||
163390740|NCT02856893|590143320|FG001|Overall Study|Adverse Event|0|||
163390741|NCT02856893|590143321|FG002|Overall Study|Adverse Event|0|||
163390742|NCT02856893|590143319|FG000|Overall Study|Physician Decision|0|||
163390743|NCT02856893|590143320|FG001|Overall Study|Physician Decision|2|||
163390744|NCT02856893|590143321|FG002|Overall Study|Physician Decision|3|||
163390745|NCT02856893|590143319|FG000|Overall Study|Withdrawal by Subject|1|||
163390746|NCT02856893|590143320|FG001|Overall Study|Withdrawal by Subject|1|||
163390747|NCT02856893|590143321|FG002|Overall Study|Withdrawal by Subject|0|||
163390748|NCT02856893|590143319|FG000|Overall Study|Other reasons|2|||
163390749|NCT02856893|590143320|FG001|Overall Study|Other reasons|1|||
163390750|NCT02856893|590143321|FG002|Overall Study|Other reasons|2|||
163390751|NCT01284062|590143322|FG000|Overall Study|Adverse Event|4|||
163390752|NCT01284062|590143323|FG001|Overall Study|Adverse Event|5|||
163390753|NCT01284062|590143324|FG002|Overall Study|Adverse Event|0|||
163390754|NCT01284062|590143325|FG003|Overall Study|Adverse Event|5|||
163390755|NCT01284062|590143322|FG000|Overall Study|Lack of Efficacy|3|||
163390756|NCT01284062|590143323|FG001|Overall Study|Lack of Efficacy|2|||
163390757|NCT01284062|590143324|FG002|Overall Study|Lack of Efficacy|2|||
163390758|NCT01284062|590143325|FG003|Overall Study|Lack of Efficacy|1|||
163390759|NCT01284062|590143322|FG000|Overall Study|Medication error without adverse event|0|||
163390760|NCT01284062|590143323|FG001|Overall Study|Medication error without adverse event|0|||
163390761|NCT01284062|590143324|FG002|Overall Study|Medication error without adverse event|1|||
163390762|NCT01284062|590143325|FG003|Overall Study|Medication error without adverse event|0|||
163390763|NCT01284062|590143322|FG000|Overall Study|Protocol Violation|1|||
163390764|NCT01284062|590143323|FG001|Overall Study|Protocol Violation|0|||
163390765|NCT01284062|590143324|FG002|Overall Study|Protocol Violation|0|||
163390766|NCT01284062|590143325|FG003|Overall Study|Protocol Violation|2|||
163390767|NCT01284062|590143322|FG000|Overall Study|Withdrawal by Subject|3|||
163390768|NCT01284062|590143323|FG001|Overall Study|Withdrawal by Subject|1|||
163390769|NCT01284062|590143324|FG002|Overall Study|Withdrawal by Subject|2|||
163390770|NCT01284062|590143325|FG003|Overall Study|Withdrawal by Subject|5|||
163390771|NCT01284062|590143322|FG000|Overall Study|Other|0|||
163390772|NCT01284062|590143323|FG001|Overall Study|Other|0|||
163390773|NCT01284062|590143324|FG002|Overall Study|Other|0|||
163390774|NCT01284062|590143325|FG003|Overall Study|Other|1|||
163390775|NCT01284062|590143322|FG000|Overall Study|Site Closed|0|||
163390776|NCT01284062|590143323|FG001|Overall Study|Site Closed|0|||
163390777|NCT01284062|590143324|FG002|Overall Study|Site Closed|1|||
163390778|NCT01284062|590143325|FG003|Overall Study|Site Closed|0|||
163390779|NCT03189862|590143326|FG000|Overall Study|Withdrawal by Subject|1|||
163390780|NCT03189862|590143327|FG001|Overall Study|Withdrawal by Subject|0|||
163390781|NCT03189862|590143326|FG000|Overall Study|Lost to Follow-up|54|||
163390782|NCT03189862|590143327|FG001|Overall Study|Lost to Follow-up|62|||
163390783|NCT00931944|590143329|FG000|Overall Study|Adverse Event|4|||
163390784|NCT00931944|590143329|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
163390785|NCT00931944|590143329|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
163390786|NCT00931944|590143329|FG000|Overall Study|Death|28|||
163043091|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
163043092|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
163043093|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
163190023|NCT00333840|589412205|FG000|First-line Treatment Period|Lost to Follow-up|15|||
163190024|NCT00333840|589412206|FG001|First-line Treatment Period|Lost to Follow-up|6|||
163190025|NCT00333840|589412207|FG002|First-line Treatment Period|Lost to Follow-up|0|||
163390787|NCT00931944|590143329|FG000|Overall Study|Other|2|||
163390788|NCT00634010|590143338|FG000|Overall Study|Adverse Event|2|||
163390789|NCT00634010|590143339|FG001|Overall Study|Adverse Event|5|||
163190026|NCT00333840|589412208|FG003|First-line Treatment Period|Lost to Follow-up|0|||
163190027|NCT00333840|589412205|FG000|First-line Treatment Period|Administrative problems|12|||
163390790|NCT00634010|590143338|FG000|Overall Study|Withdrawal by Subject|5|||
163390791|NCT00634010|590143339|FG001|Overall Study|Withdrawal by Subject|6|||
163043094|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
163043095|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
163043096|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
163043097|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
163043098|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
163043099|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
163043100|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
163043101|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
163043102|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
163043103|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
163390792|NCT00634010|590143338|FG000|Overall Study|Physician Decision|1|||
163390793|NCT00634010|590143339|FG001|Overall Study|Physician Decision|1|||
163390794|NCT00634010|590143338|FG000|Overall Study|Disease Progression|1|||
163390795|NCT00634010|590143339|FG001|Overall Study|Disease Progression|1|||
163390796|NCT00634010|590143338|FG000|Overall Study|Non-Compliant|1|||
163390797|NCT00634010|590143339|FG001|Overall Study|Non-Compliant|1|||
163390798|NCT00882310|590143340|FG000|Overall Study|Screen Failure|10|||
163043104|NCT01716663|588865714|FG000|Overall Study|Withdrawn prior to procedure|4|||
163043105|NCT01716663|588865714|FG000|Overall Study|Treated with non-study catheter|2|||
163043106|NCT01059773|588865715|FG000|Overall Study|Adverse Event|2|||
163043107|NCT01059773|588865716|FG001|Overall Study|Adverse Event|2|||
163043108|NCT01059773|588865715|FG000|Overall Study|Withdrawal by Subject|1|||
163043109|NCT01059773|588865716|FG001|Overall Study|Withdrawal by Subject|5|||
163294460|NCT02709655|589784117|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
163294461|NCT02709655|589784118|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
163294462|NCT02709655|589784119|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
163294463|NCT02709655|589784120|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
163294464|NCT02709655|589784121|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
163294465|NCT02709655|589784117|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
163294466|NCT02709655|589784118|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
163294467|NCT02709655|589784119|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
163294468|NCT02709655|589784120|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
163294469|NCT02709655|589784121|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
163294470|NCT02709655|589784117|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
163294471|NCT02709655|589784118|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
163294472|NCT02709655|589784119|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
163294473|NCT02709655|589784120|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
163294474|NCT02709655|589784121|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
163294475|NCT02709655|589784117|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
163294476|NCT02709655|589784118|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
163294477|NCT02709655|589784119|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
163294478|NCT02709655|589784120|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
163294479|NCT02709655|589784121|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
163294480|NCT02709655|589784117|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
163294481|NCT02709655|589784118|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
163294482|NCT02709655|589784119|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
163294483|NCT02709655|589784120|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
163294484|NCT02709655|589784121|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
163294485|NCT02709655|589784117|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
163294486|NCT02709655|589784118|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
163294487|NCT02709655|589784119|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
163294488|NCT02709655|589784120|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
163294489|NCT02709655|589784121|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
163294490|NCT02709655|589784117|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
163294491|NCT02709655|589784118|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
163294492|NCT02709655|589784119|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
163294493|NCT02709655|589784120|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
163294494|NCT02709655|589784121|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
163294495|NCT02709655|589784117|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
163294496|NCT02709655|589784118|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
163294497|NCT02709655|589784119|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
163294498|NCT02709655|589784120|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
163294499|NCT02709655|589784121|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
163294500|NCT00102063|589784122|FG000|Overall Study|Lack of Efficacy|5|||
163294501|NCT00102063|589784123|FG001|Overall Study|Lack of Efficacy|1|||
163294502|NCT00102063|589784124|FG002|Overall Study|Lack of Efficacy|1|||
163294503|NCT00102063|589784122|FG000|Overall Study|Adverse Event|7|||
163294504|NCT00102063|589784123|FG001|Overall Study|Adverse Event|4|||
163294505|NCT00102063|589784124|FG002|Overall Study|Adverse Event|2|||
163294506|NCT00102063|589784122|FG000|Overall Study|Withdrawal by Subject|4|||
163294507|NCT00102063|589784123|FG001|Overall Study|Withdrawal by Subject|12|||
163294508|NCT00102063|589784124|FG002|Overall Study|Withdrawal by Subject|5|||
163294509|NCT00102063|589784122|FG000|Overall Study|Lost to Follow-up|0|||
163294510|NCT00102063|589784123|FG001|Overall Study|Lost to Follow-up|0|||
163294511|NCT00102063|589784124|FG002|Overall Study|Lost to Follow-up|1|||
163294512|NCT00102063|589784122|FG000|Overall Study|Protocol Violation|0|||
163294513|NCT00102063|589784123|FG001|Overall Study|Protocol Violation|1|||
163294514|NCT00102063|589784124|FG002|Overall Study|Protocol Violation|1|||
163294515|NCT00857649|589784125|FG000|Overall Study|Adverse Event|15|||
163294516|NCT00857649|589784126|FG001|Overall Study|Adverse Event|10|||
163294517|NCT00857649|589784125|FG000|Overall Study|Non-compliance|1|||
163294518|NCT00857649|589784126|FG001|Overall Study|Non-compliance|1|||
163294519|NCT00857649|589784125|FG000|Overall Study|Protocol Violation|2|||
163294520|NCT00857649|589784126|FG001|Overall Study|Protocol Violation|2|||
163294521|NCT00857649|589784125|FG000|Overall Study|Withdrawal of Consent|10|||
163294522|NCT00857649|589784126|FG001|Overall Study|Withdrawal of Consent|7|||
163294523|NCT00857649|589784125|FG000|Overall Study|Nursing Home Placement|2|||
163294524|NCT00857649|589784126|FG001|Overall Study|Nursing Home Placement|9|||
163190028|NCT00333840|589412206|FG001|First-line Treatment Period|Administrative problems|6|||
163190029|NCT00333840|589412207|FG002|First-line Treatment Period|Administrative problems|0|||
163190030|NCT00333840|589412208|FG003|First-line Treatment Period|Administrative problems|0|||
163190031|NCT00333840|589412205|FG000|First-line Treatment Period|Death|19|||
163190032|NCT00333840|589412206|FG001|First-line Treatment Period|Death|2|||
163190033|NCT00333840|589412207|FG002|First-line Treatment Period|Death|0|||
163190034|NCT00333840|589412208|FG003|First-line Treatment Period|Death|0|||
163190035|NCT00333840|589412205|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
163190036|NCT00333840|589412206|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
163190037|NCT00333840|589412207|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
163190038|NCT00333840|589412208|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
163190039|NCT00333840|589412205|FG000|Second-line Treatment Period|Adverse Event|0|||
163190040|NCT00333840|589412206|FG001|Second-line Treatment Period|Adverse Event|0|||
163190041|NCT00333840|589412207|FG002|Second-line Treatment Period|Adverse Event|3|||
163190042|NCT00333840|589412208|FG003|Second-line Treatment Period|Adverse Event|34|||
163190043|NCT00333840|589412205|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
163190044|NCT00333840|589412206|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
163190045|NCT00333840|589412207|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
163190046|NCT00333840|589412208|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
163190047|NCT00333840|589412205|FG000|Second-line Treatment Period|Abnormal procedure|0|||
163190048|NCT00333840|589412206|FG001|Second-line Treatment Period|Abnormal procedure|0|||
163190049|NCT00333840|589412207|FG002|Second-line Treatment Period|Abnormal procedure|0|||
163190050|NCT00333840|589412208|FG003|Second-line Treatment Period|Abnormal procedure|1|||
163190051|NCT00333840|589412205|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
163190052|NCT00333840|589412206|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
163294525|NCT00857649|589784125|FG000|Overall Study|Other Reasons|1|||
163294526|NCT00857649|589784126|FG001|Overall Study|Other Reasons|3|||
163294527|NCT02517307|589784131|FG000|Overall Study|Withdrawal by Subject|1|||
163294528|NCT02517307|589784132|FG001|Overall Study|Withdrawal by Subject|0|||
163294529|NCT02517307|589784133|FG002|Overall Study|Withdrawal by Subject|1|||
163294530|NCT02517307|589784134|FG003|Overall Study|Withdrawal by Subject|0|||
163294531|NCT02517307|589784131|FG000|Overall Study|Protocol Violation|0|||
163294532|NCT02517307|589784132|FG001|Overall Study|Protocol Violation|0|||
163294533|NCT02517307|589784133|FG002|Overall Study|Protocol Violation|1|||
163294534|NCT02517307|589784134|FG003|Overall Study|Protocol Violation|1|||
163294535|NCT00843882|589784135|FG000|Step 1|Lack of Efficacy|14|||
163294536|NCT00843882|589784136|FG001|Step 1|Lack of Efficacy|10|||
163294537|NCT00843882|589784137|FG002|Step 1|Lack of Efficacy|21|||
163294538|NCT00843882|589784135|FG000|Step 1|Adverse Event|8|||
163294539|NCT00843882|589784136|FG001|Step 1|Adverse Event|17|||
163294540|NCT00843882|589784137|FG002|Step 1|Adverse Event|20|||
163294541|NCT00843882|589784135|FG000|Step 1|Death|1|||
163294542|NCT00843882|589784136|FG001|Step 1|Death|2|||
163294543|NCT00843882|589784137|FG002|Step 1|Death|4|||
163294544|NCT00843882|589784135|FG000|Step 1|Withdrawal by Subject|6|||
163294545|NCT00843882|589784136|FG001|Step 1|Withdrawal by Subject|12|||
163294546|NCT00843882|589784137|FG002|Step 1|Withdrawal by Subject|9|||
163294547|NCT00843882|589784135|FG000|Step 1|Physician Decision|0|||
163294548|NCT00843882|589784136|FG001|Step 1|Physician Decision|5|||
163294549|NCT00843882|589784137|FG002|Step 1|Physician Decision|1|||
163294550|NCT00843882|589784135|FG000|Step 1|Patient and physician's decision|0|||
163294551|NCT00843882|589784136|FG001|Step 1|Patient and physician's decision|0|||
163294552|NCT00843882|589784137|FG002|Step 1|Patient and physician's decision|1|||
163294553|NCT00843882|589784135|FG000|Step 1|Other complicating disease|1|||
163294554|NCT00843882|589784136|FG001|Step 1|Other complicating disease|3|||
163294555|NCT00843882|589784137|FG002|Step 1|Other complicating disease|4|||
163294556|NCT00843882|589784135|FG000|Step 1|Alternative therapy|0|||
163294557|NCT00843882|589784136|FG001|Step 1|Alternative therapy|1|||
163294558|NCT00843882|589784137|FG002|Step 1|Alternative therapy|1|||
163294559|NCT00843882|589784135|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
163294560|NCT00843882|589784136|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
163294561|NCT00843882|589784137|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
163294562|NCT00843882|589784135|FG000|Step 1|Off treatment reason unknown|0|||
163294563|NCT00843882|589784136|FG001|Step 1|Off treatment reason unknown|1|||
163294564|NCT00843882|589784137|FG002|Step 1|Off treatment reason unknown|4|||
163294565|NCT00843882|589784135|FG000|Step 1|Never started treatment|2|||
163294566|NCT00843882|589784136|FG001|Step 1|Never started treatment|0|||
163294567|NCT00843882|589784137|FG002|Step 1|Never started treatment|0|||
163294568|NCT00843882|589784135|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
163294569|NCT00843882|589784136|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
162952010|NCT01294787|588529508|FG002|Period 2|Adverse Event|0|||
162952011|NCT01294787|588529509|FG003|Period 2|Adverse Event|1|||
162952012|NCT01294787|588529510|FG004|Period 2|Adverse Event|0|||
162952013|NCT01294787|588529511|FG005|Period 2|Adverse Event|0|||
162952014|NCT01294787|588529506|FG000|Period 2|No longer needs study drug|0|||
162952015|NCT01294787|588529507|FG001|Period 2|No longer needs study drug|0|||
163190053|NCT00333840|589412207|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
163190054|NCT00333840|589412208|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
163190055|NCT00333840|589412205|FG000|Second-line Treatment Period|No longer required study drug|0|||
163390799|NCT00882310|590143340|FG000|Overall Study|Never received treatment|1|||
163390800|NCT00882310|590143340|FG000|Overall Study|Death|6|||
163390801|NCT00882310|590143340|FG000|Overall Study|Progression of disease|4|||
163390802|NCT00882310|590143340|FG000|Overall Study|Adverse Event|1|||
163390803|NCT04233164|590143343|FG000|Overall Study|Unable to obtain specimen|0|||
163390804|NCT04233164|590143344|FG001|Overall Study|Unable to obtain specimen|1|||
163390805|NCT04201821|590143345|FG000|Overall Study|Withdrawal by Subject|2|||
163390806|NCT00651157|590143346|FG000|Overall Study|Death|1|||
163390807|NCT00651157|590143346|FG000|Overall Study|Protocol Violation|1|||
163390808|NCT03829319|590143348|FG000|Overall Study|Sponsor's Decision|4|||
163390809|NCT03829319|590143349|FG001|Overall Study|Sponsor's Decision|90|||
163390810|NCT03829319|590143350|FG002|Overall Study|Sponsor's Decision|102|||
163390811|NCT03829319|590143348|FG000|Overall Study|Withdrawal by Subject|1|||
163390812|NCT03829319|590143349|FG001|Overall Study|Withdrawal by Subject|5|||
163390813|NCT03829319|590143350|FG002|Overall Study|Withdrawal by Subject|4|||
163390814|NCT03829319|590143348|FG000|Overall Study|Physician Decision|0|||
163390815|NCT03829319|590143349|FG001|Overall Study|Physician Decision|3|||
163390816|NCT03829319|590143350|FG002|Overall Study|Physician Decision|0|||
163390817|NCT03829319|590143348|FG000|Overall Study|Lost to Follow-up|0|||
163390818|NCT03829319|590143349|FG001|Overall Study|Lost to Follow-up|0|||
163390819|NCT03829319|590143350|FG002|Overall Study|Lost to Follow-up|1|||
163390820|NCT03829319|590143348|FG000|Overall Study|Death|8|||
163390821|NCT03829319|590143349|FG001|Overall Study|Death|277|||
163390822|NCT03829319|590143350|FG002|Overall Study|Death|266|||
163390823|NCT04484259|590143351|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
163390824|NCT04484259|590143352|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
163390825|NCT04484259|590143353|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
163390826|NCT04484259|590143354|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
163390827|NCT04484259|590143355|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
163390828|NCT04484259|590143351|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
163390829|NCT04484259|590143352|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
163390830|NCT04484259|590143353|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
163390831|NCT04484259|590143354|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
163390832|NCT04484259|590143355|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
163390833|NCT04484259|590143351|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
163390834|NCT04484259|590143352|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
163390835|NCT04484259|590143353|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
163390836|NCT04484259|590143354|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
163390837|NCT04484259|590143355|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
163390838|NCT04484259|590143351|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
163390839|NCT04484259|590143352|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
163390840|NCT04484259|590143353|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
163390841|NCT04484259|590143354|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
163390842|NCT04484259|590143355|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
163390843|NCT04484259|590143351|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
163390844|NCT04484259|590143352|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
163390845|NCT04484259|590143353|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
163390846|NCT04484259|590143354|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
163390847|NCT04484259|590143355|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
163390848|NCT04484259|590143351|FG000|Randomized Treatment|Withdrawal by Subject|1|||
163390849|NCT04484259|590143352|FG001|Randomized Treatment|Withdrawal by Subject|0|||
163390850|NCT04484259|590143353|FG002|Randomized Treatment|Withdrawal by Subject|0|||
163390851|NCT04484259|590143354|FG003|Randomized Treatment|Withdrawal by Subject|0|||
163390852|NCT04484259|590143355|FG004|Randomized Treatment|Withdrawal by Subject|0|||
163390853|NCT04498832|590143356|FG000|Overall Study|Adverse Event|1|||
163390854|NCT04498832|590143357|FG001|Overall Study|Adverse Event|3|||
163390855|NCT04498832|590143356|FG000|Overall Study|Withdrawal by Subject|0|||
163390856|NCT04498832|590143357|FG001|Overall Study|Withdrawal by Subject|1|||
163190056|NCT00333840|589412206|FG001|Second-line Treatment Period|No longer required study drug|0|||
163190057|NCT00333840|589412207|FG002|Second-line Treatment Period|No longer required study drug|1|||
163190058|NCT00333840|589412208|FG003|Second-line Treatment Period|No longer required study drug|14|||
163190059|NCT00333840|589412205|FG000|Second-line Treatment Period|Protocol Violation|0|||
163190060|NCT00333840|589412206|FG001|Second-line Treatment Period|Protocol Violation|0|||
163190061|NCT00333840|589412207|FG002|Second-line Treatment Period|Protocol Violation|1|||
163190062|NCT00333840|589412208|FG003|Second-line Treatment Period|Protocol Violation|10|||
163390857|NCT01313650|590143359|FG000|Overall Study|Adverse Event|9|||
163390858|NCT01313650|590143360|FG001|Overall Study|Adverse Event|34|||
163390859|NCT01313650|590143361|FG002|Overall Study|Adverse Event|24|||
163390860|NCT01313650|590143362|FG003|Overall Study|Adverse Event|23|||
163390861|NCT01313650|590143359|FG000|Overall Study|Lack of Efficacy|37|||
163390862|NCT01313650|590143360|FG001|Overall Study|Lack of Efficacy|20|||
163390863|NCT01313650|590143361|FG002|Overall Study|Lack of Efficacy|32|||
163390864|NCT01313650|590143362|FG003|Overall Study|Lack of Efficacy|20|||
163390865|NCT01313650|590143359|FG000|Overall Study|Lost to Follow-up|1|||
163390866|NCT01313650|590143360|FG001|Overall Study|Lost to Follow-up|0|||
163390867|NCT01313650|590143361|FG002|Overall Study|Lost to Follow-up|3|||
163390868|NCT01313650|590143362|FG003|Overall Study|Lost to Follow-up|2|||
163390869|NCT01313650|590143359|FG000|Overall Study|Withdrawal by Subject|16|||
163390870|NCT01313650|590143360|FG001|Overall Study|Withdrawal by Subject|20|||
163390871|NCT01313650|590143361|FG002|Overall Study|Withdrawal by Subject|15|||
163390872|NCT01313650|590143362|FG003|Overall Study|Withdrawal by Subject|15|||
163390873|NCT01313650|590143359|FG000|Overall Study|Protocol Violation|4|||
163390874|NCT01313650|590143360|FG001|Overall Study|Protocol Violation|7|||
163390875|NCT01313650|590143361|FG002|Overall Study|Protocol Violation|5|||
163390876|NCT01313650|590143362|FG003|Overall Study|Protocol Violation|6|||
163390877|NCT01313650|590143359|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
163390878|NCT01313650|590143360|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
163390879|NCT01313650|590143361|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
163390880|NCT01313650|590143362|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
163390881|NCT04029480|590143363|FG000|Overall Study|Physician Decision|0|||
163390882|NCT04029480|590143364|FG001|Overall Study|Physician Decision|0|||
163390883|NCT04029480|590143365|FG002|Overall Study|Physician Decision|2|||
163390884|NCT04029480|590143366|FG003|Overall Study|Physician Decision|1|||
163390885|NCT04029480|590143363|FG000|Overall Study|Withdrawal by Subject|2|||
163390886|NCT04029480|590143364|FG001|Overall Study|Withdrawal by Subject|0|||
163390887|NCT04029480|590143365|FG002|Overall Study|Withdrawal by Subject|1|||
163390888|NCT04029480|590143366|FG003|Overall Study|Withdrawal by Subject|1|||
163390889|NCT02593786|590143369|FG000|Overall Study|Disease progression|12|||
163390890|NCT02593786|590143370|FG001|Overall Study|Disease progression|16|||
163390891|NCT02593786|590143371|FG002|Overall Study|Disease progression|10|||
163390892|NCT02593786|590143372|FG003|Overall Study|Disease progression|7|||
163390893|NCT02593786|590143369|FG000|Overall Study|Study drug toxicity|1|||
163390894|NCT02593786|590143370|FG001|Overall Study|Study drug toxicity|0|||
163390895|NCT02593786|590143371|FG002|Overall Study|Study drug toxicity|0|||
163390896|NCT02593786|590143372|FG003|Overall Study|Study drug toxicity|0|||
163390897|NCT02593786|590143369|FG000|Overall Study|Adverse event unrelated to study drug|1|||
163390898|NCT02593786|590143370|FG001|Overall Study|Adverse event unrelated to study drug|1|||
163390899|NCT02593786|590143371|FG002|Overall Study|Adverse event unrelated to study drug|1|||
163390900|NCT02593786|590143372|FG003|Overall Study|Adverse event unrelated to study drug|0|||
163390901|NCT02593786|590143369|FG000|Overall Study|Participant request to discontinue study therapy|0|||
163390902|NCT02593786|590143370|FG001|Overall Study|Participant request to discontinue study therapy|2|||
163390903|NCT02593786|590143371|FG002|Overall Study|Participant request to discontinue study therapy|0|||
163043110|NCT01059773|588865715|FG000|Overall Study|Lost to Follow-up|1|||
162952016|NCT01294787|588529508|FG002|Period 2|No longer needs study drug|0|||
162952017|NCT01294787|588529509|FG003|Period 2|No longer needs study drug|1|||
162952018|NCT01294787|588529510|FG004|Period 2|No longer needs study drug|0|||
162952019|NCT01294787|588529511|FG005|Period 2|No longer needs study drug|0|||
162952020|NCT01294787|588529506|FG000|Period 3|Adverse Event|0|||
162952021|NCT01294787|588529507|FG001|Period 3|Adverse Event|0|||
162952022|NCT01294787|588529508|FG002|Period 3|Adverse Event|0|||
162952023|NCT01294787|588529509|FG003|Period 3|Adverse Event|0|||
162952024|NCT01294787|588529510|FG004|Period 3|Adverse Event|1|||
162952025|NCT01294787|588529511|FG005|Period 3|Adverse Event|0|||
162952026|NCT01124175|588529512|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
162952027|NCT01124175|588529513|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
162952028|NCT00942968|588529514|FG000|Overall Study|Adverse Event|60|||
162952029|NCT00942968|588529514|FG000|Overall Study|Death|76|||
162952030|NCT00942968|588529514|FG000|Overall Study|Protocol Violation|9|||
162952031|NCT00942968|588529514|FG000|Overall Study|Lost to Follow-up|4|||
162952032|NCT00942968|588529514|FG000|Overall Study|Withdrawal by Subject|44|||
162952033|NCT00942968|588529514|FG000|Overall Study|Sponsor request|5|||
162952034|NCT00942968|588529514|FG000|Overall Study|Physician Decision|11|||
162952035|NCT00942968|588529514|FG000|Overall Study|Progression of disease|12|||
162952036|NCT00942968|588529514|FG000|Overall Study|Inferior vena cava filter placement|4|||
162952037|NCT00942968|588529514|FG000|Overall Study|Pulmonary embolism (PE)|1|||
162952038|NCT00942968|588529514|FG000|Overall Study|Participant required pancreatic biopsy|1|||
162952039|NCT00942968|588529514|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
162952040|NCT01948258|588529515|FG000|Overall Study|Pregnancy|41|||
162952041|NCT01948258|588529515|FG000|Overall Study|Did not complete by cut-off date|35|||
162952042|NCT01948258|588529515|FG000|Overall Study|Lost to Follow-up|27|||
162952043|NCT01948258|588529515|FG000|Overall Study|Withdrawal by SPD|8|||
162952044|NCT01948258|588529515|FG000|Overall Study|Withdrawal by Subject|6|||
162952045|NCT01948258|588529515|FG000|Overall Study|Health Care Professional|43|||
162952046|NCT01948258|588529515|FG000|Overall Study|Removed from statistical analysis|2|||
162952047|NCT00520130|588529522|FG000|Overall Study|Disease progression on study|4|||
162952048|NCT00520130|588529523|FG001|Overall Study|Disease progression on study|0|||
162952049|NCT00520130|588529522|FG000|Overall Study|Physician Decision|1|||
162952050|NCT00520130|588529523|FG001|Overall Study|Physician Decision|1|||
162952051|NCT01045096|588529526|FG000|Overall Study|Withdrawal by Subject|2|||
162952052|NCT01045096|588529527|FG001|Overall Study|Withdrawal by Subject|0|||
162952053|NCT01045096|588529528|FG002|Overall Study|Withdrawal by Subject|0|||
162952054|NCT01045096|588529526|FG000|Overall Study|Other|1|||
162952055|NCT01045096|588529527|FG001|Overall Study|Other|0|||
162952056|NCT01045096|588529528|FG002|Overall Study|Other|0|||
162952057|NCT01900691|588529529|FG000|Overall Study|Death|7|||
162952058|NCT01900691|588529529|FG000|Overall Study|Lost to Follow-up|4|||
162952059|NCT01900691|588529529|FG000|Overall Study|Study Device Not Placed|3|||
162952060|NCT01900691|588529529|FG000|Overall Study|Non study stent placed|2|||
162952061|NCT01900691|588529529|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
162952062|NCT01900691|588529529|FG000|Overall Study|Complete stent migration through digestive tract|1|||
162952063|NCT01954394|588529530|FG000|Overall Study|Enrolled but not treated|1|||
162952064|NCT01954394|588529531|FG001|Overall Study|Enrolled but not treated|0|||
162952065|NCT01954394|588529530|FG000|Overall Study|Adverse Event|10|||
162952066|NCT01954394|588529531|FG001|Overall Study|Adverse Event|23|||
162952067|NCT01954394|588529530|FG000|Overall Study|Poor compliance to protocol|7|||
162952068|NCT01954394|588529531|FG001|Overall Study|Poor compliance to protocol|7|||
163190063|NCT00333840|589412205|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
163190064|NCT00333840|589412206|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
162952069|NCT01954394|588529530|FG000|Overall Study|Participant Moved|0|||
163190065|NCT00333840|589412207|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
163190066|NCT00333840|589412208|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
162952070|NCT01954394|588529531|FG001|Overall Study|Participant Moved|4|||
162952071|NCT01954394|588529530|FG000|Overall Study|Related to Study Drug administration|2|||
163043111|NCT01059773|588865716|FG001|Overall Study|Lost to Follow-up|1|||
163043112|NCT01059773|588865715|FG000|Overall Study|Pregnancy|1|||
163043113|NCT01059773|588865716|FG001|Overall Study|Pregnancy|1|||
163043114|NCT01059773|588865715|FG000|Overall Study|Protocol Violation|6|||
163043115|NCT01059773|588865716|FG001|Overall Study|Protocol Violation|2|||
163043116|NCT01059773|588865715|FG000|Overall Study|Physician Decision|5|||
163043117|NCT01059773|588865716|FG001|Overall Study|Physician Decision|4|||
163294570|NCT00843882|589784137|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
163043118|NCT01059773|588865715|FG000|Overall Study|Lack of Efficacy|3|||
163043119|NCT01059773|588865716|FG001|Overall Study|Lack of Efficacy|3|||
163294571|NCT00843882|589784135|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
163043120|NCT01059773|588865715|FG000|Overall Study|Death|0|||
163190067|NCT00333840|589412205|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
163190068|NCT00333840|589412206|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
163190069|NCT00333840|589412207|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
163190070|NCT00333840|589412208|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
163190071|NCT00333840|589412205|FG000|Second-line Treatment Period|Administrative problems|0|||
163190072|NCT00333840|589412206|FG001|Second-line Treatment Period|Administrative problems|0|||
163190073|NCT00333840|589412207|FG002|Second-line Treatment Period|Administrative problems|0|||
163190074|NCT00333840|589412208|FG003|Second-line Treatment Period|Administrative problems|7|||
163190075|NCT00333840|589412205|FG000|Second-line Treatment Period|Death|0|||
163390904|NCT02593786|590143372|FG003|Overall Study|Participant request to discontinue study therapy|0|||
163390905|NCT02593786|590143369|FG000|Overall Study|Other reasons|1|||
163390906|NCT02593786|590143370|FG001|Overall Study|Other reasons|1|||
163390907|NCT02593786|590143371|FG002|Overall Study|Other reasons|0|||
163390908|NCT02593786|590143372|FG003|Overall Study|Other reasons|5|||
163390909|NCT01839487|590143373|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
163390910|NCT01839487|590143374|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
163390911|NCT01839487|590143375|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
163390912|NCT01839487|590143376|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
163390913|NCT01839487|590143377|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
163390914|NCT01839487|590143378|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
163390915|NCT01839487|590143373|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
163390916|NCT01839487|590143374|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
163390917|NCT01839487|590143375|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
163390918|NCT01839487|590143376|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
163390919|NCT01839487|590143377|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
163390920|NCT01839487|590143378|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
163390921|NCT01839487|590143373|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
163390922|NCT01839487|590143374|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
163390923|NCT01839487|590143375|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
163390924|NCT01839487|590143376|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
163390925|NCT01839487|590143377|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
163390926|NCT01839487|590143378|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
163390927|NCT01839487|590143373|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
163390928|NCT01839487|590143374|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
163390929|NCT01839487|590143375|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
163390930|NCT01839487|590143376|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
163390931|NCT01839487|590143377|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
163390932|NCT01839487|590143378|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
163390933|NCT01839487|590143373|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
163390934|NCT01839487|590143374|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
163390935|NCT01839487|590143375|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
163390936|NCT01839487|590143376|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
163390937|NCT01839487|590143377|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
163390938|NCT01839487|590143378|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
163390939|NCT01839487|590143373|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
163390940|NCT01839487|590143374|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
163390941|NCT01839487|590143375|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
163390942|NCT01839487|590143376|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
163390943|NCT01839487|590143377|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
163390944|NCT01839487|590143378|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
163390945|NCT01839487|590143373|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
163390946|NCT01839487|590143374|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
163390947|NCT01839487|590143375|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
163390948|NCT01839487|590143376|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
163390949|NCT01839487|590143377|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
163390950|NCT01839487|590143378|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
163390951|NCT01839487|590143373|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
163390952|NCT01839487|590143374|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
163390953|NCT01839487|590143375|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
163390954|NCT01839487|590143376|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
163390955|NCT01839487|590143377|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
163390956|NCT01839487|590143378|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
163390957|NCT01839487|590143373|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
163390958|NCT01839487|590143374|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
163390959|NCT01839487|590143375|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
163390960|NCT01839487|590143376|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
163390961|NCT01839487|590143377|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
163390962|NCT01839487|590143378|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
163390963|NCT01019980|590143383|FG000|Overall Study|Drug not available.|2|||
163390964|NCT01019980|590143384|FG001|Overall Study|Drug not available.|0|||
163390965|NCT02038920|590143394|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
163390966|NCT02038920|590143395|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
163390967|NCT02038920|590143396|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
163390968|NCT02038920|590143397|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
163390969|NCT02038920|590143398|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
163390970|NCT02038920|590143399|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
163043121|NCT01059773|588865716|FG001|Overall Study|Death|1|||
163043122|NCT01059773|588865715|FG000|Overall Study|Malignancy including squamous cell skin|0|||
163043123|NCT01059773|588865716|FG001|Overall Study|Malignancy including squamous cell skin|1|||
163043124|NCT01059773|588865715|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
163043125|NCT01059773|588865716|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
163043126|NCT01059773|588865715|FG000|Overall Study|Other|1|||
163043127|NCT01059773|588865716|FG001|Overall Study|Other|3|||
163043128|NCT01806168|588865719|FG000|Overall Study|Adverse Event|1|||
163043129|NCT01806168|588865720|FG001|Overall Study|Adverse Event|0|||
163043130|NCT01806168|588865721|FG002|Overall Study|Adverse Event|0|||
163043131|NCT01806168|588865719|FG000|Overall Study|Withdrawal by Subject|0|||
163043132|NCT01806168|588865720|FG001|Overall Study|Withdrawal by Subject|1|||
163043133|NCT01806168|588865721|FG002|Overall Study|Withdrawal by Subject|2|||
163043134|NCT01806168|588865719|FG000|Overall Study|Protocol Violation|0|||
163043135|NCT01806168|588865720|FG001|Overall Study|Protocol Violation|0|||
163043136|NCT01806168|588865721|FG002|Overall Study|Protocol Violation|1|||
163043137|NCT02620787|588865724|FG000|Overall Study|Adverse Event|1|||
163043138|NCT02620787|588865725|FG001|Overall Study|Adverse Event|0|||
163043139|NCT02620787|588865724|FG000|Overall Study|Eligibility Criteria Not Met|1|||
163043140|NCT02620787|588865725|FG001|Overall Study|Eligibility Criteria Not Met|0|||
163043141|NCT01462630|588865728|FG000|Overall Study|Did not initiate therapy|3|||
163043142|NCT01462630|588865728|FG000|Overall Study|Death|1|||
163043143|NCT01462630|588865728|FG000|Overall Study|Protocol Violation|2|||
163043144|NCT01462630|588865728|FG000|Overall Study|Adverse Event|1|||
163043145|NCT03665077|588865729|FG000|Overall Study|Lost to Follow-up|2|||
163043146|NCT03665077|588865729|FG000|Overall Study|Physician Decision|2|||
163043147|NCT02364388|588865730|FG000|Overall Study|Protocol Violation|1|||
163043148|NCT02364388|588865730|FG000|Overall Study|Technical Failure|3|||
163043149|NCT02364388|588865730|FG000|Overall Study|No OA/US data|2|||
163043150|NCT02364388|588865730|FG000|Overall Study|No Biopsy|2|||
163043151|NCT00837967|588865731|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
163043152|NCT00837967|588865732|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
163043153|NCT02504320|588865736|FG000|Treatment Period 1|Positive Drug Screen|0|||
163043154|NCT02504320|588865737|FG001|Treatment Period 1|Positive Drug Screen|0|||
163043155|NCT02504320|588865738|FG002|Treatment Period 1|Positive Drug Screen|1|||
163043156|NCT02504320|588865739|FG003|Treatment Period 1|Positive Drug Screen|0|||
163043157|NCT02504320|588865736|FG000|Treatment Period 2|Positive Drug Screen|0|||
163043158|NCT02504320|588865737|FG001|Treatment Period 2|Positive Drug Screen|1|||
163043159|NCT02504320|588865738|FG002|Treatment Period 2|Positive Drug Screen|0|||
163043160|NCT02504320|588865739|FG003|Treatment Period 2|Positive Drug Screen|0|||
163043161|NCT02504320|588865736|FG000|Treatment Period 3|Positive Drug Screen|0|||
163043162|NCT02504320|588865737|FG001|Treatment Period 3|Positive Drug Screen|0|||
163043163|NCT02504320|588865738|FG002|Treatment Period 3|Positive Drug Screen|0|||
163043164|NCT02504320|588865739|FG003|Treatment Period 3|Positive Drug Screen|1|||
163043165|NCT02504320|588865736|FG000|Treatment Period 3|Adverse Event|0|||
163043166|NCT02504320|588865737|FG001|Treatment Period 3|Adverse Event|0|||
163043167|NCT02504320|588865738|FG002|Treatment Period 3|Adverse Event|1|||
163043168|NCT02504320|588865739|FG003|Treatment Period 3|Adverse Event|0|||
163043169|NCT02497404|588865742|FG000|Overall Study|Adverse Event|1|||
163043170|NCT01408901|588865743|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
163043171|NCT01408901|588865744|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
163043172|NCT01408901|588865745|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
163043173|NCT01408901|588865746|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
163043174|NCT01408901|588865743|FG000|6-Week Follow-Up|Death|1|||
163043175|NCT01408901|588865744|FG001|6-Week Follow-Up|Death|0|||
163043176|NCT01408901|588865745|FG002|6-Week Follow-Up|Death|0|||
163043177|NCT01408901|588865746|FG003|6-Week Follow-Up|Death|0|||
163043178|NCT01408901|588865743|FG000|6-Week Follow-Up|Cancelled visit|0|||
163043179|NCT01408901|588865744|FG001|6-Week Follow-Up|Cancelled visit|1|||
163043180|NCT01408901|588865745|FG002|6-Week Follow-Up|Cancelled visit|0|||
163043181|NCT01408901|588865746|FG003|6-Week Follow-Up|Cancelled visit|2|||
163043182|NCT01408901|588865743|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
163043183|NCT01408901|588865744|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
163043184|NCT01408901|588865745|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
163043185|NCT01408901|588865746|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
163043186|NCT01408901|588865743|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
163043187|NCT01408901|588865744|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
163043188|NCT01408901|588865745|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
163043189|NCT01408901|588865746|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
163043190|NCT01408901|588865743|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
163043191|NCT01408901|588865744|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
163043192|NCT01408901|588865745|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
163043193|NCT01408901|588865746|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
163043194|NCT01408901|588865743|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
163043195|NCT01408901|588865744|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
163043196|NCT01408901|588865745|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
163043197|NCT01408901|588865746|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
163043198|NCT01408901|588865743|FG000|26-Week Follow-Up|Death|0|||
163043199|NCT01408901|588865744|FG001|26-Week Follow-Up|Death|1|||
163043200|NCT01408901|588865745|FG002|26-Week Follow-Up|Death|0|||
163043201|NCT01408901|588865746|FG003|26-Week Follow-Up|Death|0|||
163043202|NCT02098395|588865749|FG000|Overall Study|Protocol Violation|2|||
163043203|NCT02098395|588865750|FG001|Overall Study|Protocol Violation|2|||
163043204|NCT02098395|588865751|FG002|Overall Study|Protocol Violation|0|||
163043205|NCT02098395|588865752|FG003|Overall Study|Protocol Violation|7|||
163043206|NCT02098395|588865749|FG000|Overall Study|Withdrawal by Subject|10|||
163043207|NCT02098395|588865750|FG001|Overall Study|Withdrawal by Subject|10|||
163043208|NCT02098395|588865751|FG002|Overall Study|Withdrawal by Subject|5|||
163043209|NCT02098395|588865752|FG003|Overall Study|Withdrawal by Subject|13|||
163043210|NCT02098395|588865749|FG000|Overall Study|Adverse Event|12|||
163043211|NCT02098395|588865750|FG001|Overall Study|Adverse Event|19|||
163043212|NCT02098395|588865751|FG002|Overall Study|Adverse Event|34|||
163043213|NCT02098395|588865752|FG003|Overall Study|Adverse Event|2|||
163043214|NCT02098395|588865749|FG000|Overall Study|Lost to Follow-up|2|||
163043215|NCT02098395|588865750|FG001|Overall Study|Lost to Follow-up|1|||
163043216|NCT02098395|588865751|FG002|Overall Study|Lost to Follow-up|0|||
163043217|NCT02098395|588865752|FG003|Overall Study|Lost to Follow-up|3|||
163190076|NCT00333840|589412206|FG001|Second-line Treatment Period|Death|0|||
163390971|NCT02038920|590143394|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
163390972|NCT02038920|590143395|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
163390973|NCT02038920|590143396|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
163390974|NCT02038920|590143397|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
163390975|NCT02038920|590143398|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
163390976|NCT02038920|590143399|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
163390977|NCT02038920|590143394|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
163390978|NCT02038920|590143395|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
163390979|NCT02038920|590143396|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
163390980|NCT02038920|590143397|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
163390981|NCT02038920|590143398|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
163390982|NCT02038920|590143399|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
163390983|NCT02038920|590143394|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
163390984|NCT02038920|590143395|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
163390985|NCT02038920|590143396|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
163390986|NCT02038920|590143397|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
163390987|NCT02038920|590143398|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
163390988|NCT02038920|590143399|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
163390989|NCT02038920|590143394|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
163390990|NCT02038920|590143395|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
163390991|NCT02038920|590143396|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
163390992|NCT02038920|590143397|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
163390993|NCT02038920|590143398|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
163390994|NCT02038920|590143399|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
163390995|NCT02038920|590143394|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
163390996|NCT02038920|590143395|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
163390997|NCT02038920|590143396|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
163390998|NCT02038920|590143397|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
163390999|NCT02038920|590143398|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
163391000|NCT02038920|590143399|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
163391001|NCT02038920|590143394|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
163391002|NCT02038920|590143395|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
163391003|NCT02038920|590143396|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
163391004|NCT02038920|590143397|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
163391005|NCT02038920|590143398|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
163391006|NCT02038920|590143399|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
163391007|NCT02038920|590143394|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
163391008|NCT02038920|590143395|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
163391009|NCT02038920|590143396|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
163391010|NCT02038920|590143397|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
163391011|NCT02038920|590143398|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
163391012|NCT02038920|590143399|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
163391013|NCT02038920|590143394|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
163391014|NCT02038920|590143395|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
163391015|NCT02038920|590143396|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
163391016|NCT02038920|590143397|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
163391017|NCT02038920|590143398|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
163391018|NCT02038920|590143399|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
163391019|NCT02038920|590143394|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
163391020|NCT02038920|590143395|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
163190077|NCT00333840|589412207|FG002|Second-line Treatment Period|Death|0|||
163190078|NCT00333840|589412208|FG003|Second-line Treatment Period|Death|9|||
163190079|NCT02357979|589412209|FG000|Overall Study|Lost to Follow-up|5|||
163190080|NCT02357979|589412210|FG001|Overall Study|Lost to Follow-up|5|||
163190081|NCT01453725|589412211|FG000|Overall Study|Adverse Event|3|||
163190082|NCT01453725|589412212|FG001|Overall Study|Adverse Event|3|||
163190083|NCT01453725|589412211|FG000|Overall Study|Lost to Follow-up|4|||
163190084|NCT01453725|589412212|FG001|Overall Study|Lost to Follow-up|0|||
163391021|NCT02038920|590143396|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
163391022|NCT02038920|590143397|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
163391023|NCT02038920|590143398|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
163190085|NCT01453725|589412211|FG000|Overall Study|Non-compliance With Protocol|1|||
163190086|NCT01453725|589412212|FG001|Overall Study|Non-compliance With Protocol|2|||
163190087|NCT01453725|589412211|FG000|Overall Study|Protocol Violation|1|||
163190088|NCT01453725|589412212|FG001|Overall Study|Protocol Violation|0|||
163294572|NCT00843882|589784136|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
163294573|NCT00843882|589784137|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
163294574|NCT00843882|589784135|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
163294575|NCT00843882|589784136|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
163294576|NCT00843882|589784137|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
163294577|NCT00843882|589784135|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
163294578|NCT00843882|589784136|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
163294579|NCT00843882|589784137|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
163294580|NCT00843882|589784135|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
163294581|NCT00843882|589784136|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
163294582|NCT00843882|589784137|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
163294583|NCT00843882|589784135|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
163294584|NCT00843882|589784136|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
163294585|NCT00843882|589784137|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
163294586|NCT00843882|589784135|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
163294587|NCT00843882|589784136|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
163294588|NCT00843882|589784137|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
163294589|NCT02248480|589784138|FG000|Overall Study|Lack of Efficacy|4|||
163294590|NCT02248480|589784139|FG001|Overall Study|Lack of Efficacy|6|||
163294591|NCT02248480|589784138|FG000|Overall Study|Adverse Event|11|||
163294592|NCT02248480|589784139|FG001|Overall Study|Adverse Event|2|||
163294593|NCT02248480|589784138|FG000|Overall Study|Withdrawal by Subject|2|||
163294594|NCT02248480|589784139|FG001|Overall Study|Withdrawal by Subject|4|||
163294595|NCT02248480|589784138|FG000|Overall Study|Entry Criteria Not Met|0|||
163294596|NCT02248480|589784139|FG001|Overall Study|Entry Criteria Not Met|1|||
163294597|NCT02248480|589784138|FG000|Overall Study|Other:Physician Decision|0|||
163294598|NCT02248480|589784139|FG001|Overall Study|Other:Physician Decision|1|||
163294599|NCT01582269|589784140|FG000|Overall Study|Withdrawal by Subject|1|||
163294600|NCT01582269|589784141|FG001|Overall Study|Withdrawal by Subject|0|||
163294601|NCT01582269|589784142|FG002|Overall Study|Withdrawal by Subject|0|||
163294602|NCT02486588|589784145|FG000|Overall Study|Randomized in error- ineligible|738|||
163294603|NCT02486588|589784146|FG001|Overall Study|Randomized in error- ineligible|750|||
163294604|NCT02486588|589784147|FG002|Overall Study|Randomized in error- ineligible|755|||
163294605|NCT02486588|589784148|FG003|Overall Study|Randomized in error- ineligible|738|||
163294606|NCT02486588|589784149|FG004|Overall Study|Randomized in error- ineligible|746|||
163294607|NCT02486588|589784150|FG005|Overall Study|Randomized in error- ineligible|746|||
163294608|NCT00546871|589784151|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
163294609|NCT00546871|589784152|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
163294610|NCT00546871|589784151|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
163294611|NCT00546871|589784152|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
163294612|NCT00546871|589784151|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
163294613|NCT00546871|589784152|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
163294614|NCT00546871|589784151|FG000|Study Extension Period|Protocol Violation|1|||
163294615|NCT00546871|589784152|FG001|Study Extension Period|Protocol Violation|0|||
163294616|NCT00546871|589784151|FG000|Study Extension Period|Withdrawal by Subject|0|||
163294617|NCT00546871|589784152|FG001|Study Extension Period|Withdrawal by Subject|1|||
163294618|NCT06001177|589785023|FG000|Treatment Phase|Adverse Event|1|||
163294619|NCT06001177|589785024|FG001|Treatment Phase|Adverse Event|0|||
163294620|NCT06001177|589785023|FG000|Treatment Phase|Withdrawal by Subject|1|||
163294621|NCT06001177|589785024|FG001|Treatment Phase|Withdrawal by Subject|0|||
163294622|NCT06001177|589785023|FG000|Observation Phase|Adverse Event|1|||
162952072|NCT01954394|588529531|FG001|Overall Study|Related to Study Drug administration|2|||
163294623|NCT06001177|589785024|FG001|Observation Phase|Adverse Event|1|||
163294624|NCT06001177|589785023|FG000|Observation Phase|Withdrawal by Subject|0|||
163294625|NCT06001177|589785024|FG001|Observation Phase|Withdrawal by Subject|1|||
163294626|NCT03593876|589785025|FG000|Overall Study|Withdrawal by Subject|1|||
163294627|NCT03593876|589785025|FG000|Overall Study|Discharged home before intervention completion|2|||
163294628|NCT05309668|589785026|FG000|Overall Study|Ongoing at data cut-off|14|||
163294629|NCT05309668|589785027|FG001|Overall Study|Ongoing at data cut-off|17|||
163294630|NCT05309668|589785028|FG002|Overall Study|Ongoing at data cut-off|4|||
163294631|NCT02696707|589785029|FG000|Per Protocol Population|Physician Decision|2|||
163294632|NCT02696707|589785030|FG001|Per Protocol Population|Physician Decision|1|||
163294633|NCT02696707|589785029|FG000|Per Protocol Population|Participant Decision|0|||
163294634|NCT02696707|589785030|FG001|Per Protocol Population|Participant Decision|2|||
163294635|NCT02696707|589785029|FG000|Completed Study as Planned|Reason = LVEF|2|||
163294636|NCT02696707|589785030|FG001|Completed Study as Planned|Reason = LVEF|2|||
163294637|NCT02696707|589785029|FG000|Completed Study as Planned|Protocol Violation|2|||
163294638|NCT02696707|589785030|FG001|Completed Study as Planned|Protocol Violation|6|||
163294639|NCT02696707|589785029|FG000|Completed Study as Planned|Metastatic disease|3|||
163294640|NCT02696707|589785030|FG001|Completed Study as Planned|Metastatic disease|0|||
163294641|NCT02696707|589785029|FG000|Completed Study as Planned|Location|1|||
163294642|NCT02696707|589785030|FG001|Completed Study as Planned|Location|1|||
163391024|NCT02038920|590143399|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
163294643|NCT00071799|589785031|FG000|Overall Study|Adverse Event|19|||
163294644|NCT00071799|589785032|FG001|Overall Study|Adverse Event|10|||
163294645|NCT00071799|589785031|FG000|Overall Study|Protocol Violation|1|||
163294646|NCT00071799|589785032|FG001|Overall Study|Protocol Violation|7|||
163294647|NCT00071799|589785031|FG000|Overall Study|Lost to Follow-up|1|||
163294648|NCT00071799|589785032|FG001|Overall Study|Lost to Follow-up|1|||
163294649|NCT00071799|589785031|FG000|Overall Study|Withdrawal by Subject|15|||
163294650|NCT00071799|589785032|FG001|Overall Study|Withdrawal by Subject|37|||
163294651|NCT00071799|589785031|FG000|Overall Study|Physician Decision|0|||
163294652|NCT00071799|589785032|FG001|Overall Study|Physician Decision|2|||
163294653|NCT00071799|589785031|FG000|Overall Study|Lack of Efficacy|11|||
163294654|NCT00071799|589785032|FG001|Overall Study|Lack of Efficacy|18|||
163294655|NCT00071799|589785031|FG000|Overall Study|Disease Progression|23|||
163294656|NCT00071799|589785032|FG001|Overall Study|Disease Progression|20|||
163294657|NCT00071799|589785031|FG000|Overall Study|Different Central+Local Pathology Review|0|||
163294658|NCT00071799|589785032|FG001|Overall Study|Different Central+Local Pathology Review|1|||
163294659|NCT00071799|589785031|FG000|Overall Study|Not Documented|0|||
163294660|NCT00071799|589785032|FG001|Overall Study|Not Documented|2|||
163294661|NCT00814346|589785033|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
163294662|NCT00814346|589785034|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
163294663|NCT00814346|589785033|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
163391025|NCT02038920|590143394|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
163391026|NCT02038920|590143395|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
163391027|NCT02038920|590143396|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
163190089|NCT01453725|589412211|FG000|Overall Study|Withdrawal by Subject|2|||
163190090|NCT01453725|589412212|FG001|Overall Study|Withdrawal by Subject|3|||
163190091|NCT01453725|589412211|FG000|Overall Study|Pregnancy Wish|0|||
163190092|NCT01453725|589412212|FG001|Overall Study|Pregnancy Wish|2|||
163190093|NCT01453725|589412211|FG000|Overall Study|Pregnancy|1|||
163190094|NCT01453725|589412212|FG001|Overall Study|Pregnancy|0|||
163190095|NCT01453725|589412211|FG000|Overall Study|Physician Decision|1|||
163190096|NCT01453725|589412212|FG001|Overall Study|Physician Decision|1|||
163190097|NCT03449901|589412220|FG000|Overall Study|Progression|57|||
163190098|NCT03449901|589412221|FG001|Overall Study|Progression|12|||
163190099|NCT03449901|589412220|FG000|Overall Study|Adverse Event|3|||
163294664|NCT00814346|589785034|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
163294665|NCT00814346|589785033|FG000|Open Phase (17 Months)|Adverse Event|5|||
163294666|NCT00814346|589785034|FG001|Open Phase (17 Months)|Adverse Event|0|||
163294667|NCT00814346|589785033|FG000|Open Phase (17 Months)|Consent|2|||
163190100|NCT03449901|589412221|FG001|Overall Study|Adverse Event|0|||
163294668|NCT00814346|589785034|FG001|Open Phase (17 Months)|Consent|0|||
163190101|NCT03449901|589412220|FG000|Overall Study|Death|6|||
163190102|NCT03449901|589412221|FG001|Overall Study|Death|2|||
163190103|NCT03449901|589412220|FG000|Overall Study|Withdrawal by Subject|12|||
163190104|NCT03449901|589412221|FG001|Overall Study|Withdrawal by Subject|1|||
163190105|NCT03449901|589412220|FG000|Overall Study|Physician Decision|1|||
163190106|NCT03449901|589412221|FG001|Overall Study|Physician Decision|0|||
163190107|NCT03449901|589412220|FG000|Overall Study|Patient elected for surgical intervention|1|||
163190108|NCT03449901|589412221|FG001|Overall Study|Patient elected for surgical intervention|0|||
163190109|NCT03449901|589412220|FG000|Overall Study|Patient off for other complicating disease|1|||
163190110|NCT03449901|589412221|FG001|Overall Study|Patient off for other complicating disease|0|||
163190111|NCT03755791|589412224|FG000|Overall Study|Did not receive any study treatment|3|||
163190112|NCT03755791|589412225|FG001|Overall Study|Did not receive any study treatment|0|||
163190113|NCT03755791|589412226|FG002|Overall Study|Did not receive any study treatment|10|||
163190114|NCT03755791|589412224|FG000|Overall Study|Radiographic progression|204|||
163190115|NCT03755791|589412225|FG001|Overall Study|Radiographic progression|92|||
163190116|NCT03755791|589412226|FG002|Overall Study|Radiographic progression|115|||
163190117|NCT03755791|589412224|FG000|Overall Study|Adverse Event|140|||
163190118|NCT03755791|589412225|FG001|Overall Study|Adverse Event|60|||
163190119|NCT03755791|589412226|FG002|Overall Study|Adverse Event|51|||
163190120|NCT03755791|589412224|FG000|Overall Study|Lack of Efficacy|12|||
163190121|NCT03755791|589412225|FG001|Overall Study|Lack of Efficacy|6|||
163190122|NCT03755791|589412226|FG002|Overall Study|Lack of Efficacy|6|||
163190123|NCT03755791|589412224|FG000|Overall Study|Withdrawal by Subject|26|||
163190124|NCT03755791|589412225|FG001|Overall Study|Withdrawal by Subject|23|||
163190125|NCT03755791|589412226|FG002|Overall Study|Withdrawal by Subject|24|||
163190126|NCT03755791|589412224|FG000|Overall Study|Sponsor decision,|41|||
163190127|NCT03755791|589412225|FG001|Overall Study|Sponsor decision,|5|||
163190128|NCT03755791|589412226|FG002|Overall Study|Sponsor decision,|7|||
163190129|NCT03755791|589412224|FG000|Overall Study|Lost to Follow-up|1|||
163190130|NCT03755791|589412225|FG001|Overall Study|Lost to Follow-up|0|||
163190131|NCT03755791|589412226|FG002|Overall Study|Lost to Follow-up|2|||
163190132|NCT03755791|589412224|FG000|Overall Study|Protocol Violation|0|||
163190133|NCT03755791|589412225|FG001|Overall Study|Protocol Violation|0|||
163190134|NCT03755791|589412226|FG002|Overall Study|Protocol Violation|2|||
163190135|NCT03755791|589412224|FG000|Overall Study|Other than specified|5|||
163190136|NCT03755791|589412225|FG001|Overall Study|Other than specified|2|||
163190137|NCT03755791|589412226|FG002|Overall Study|Other than specified|0|||
163190138|NCT03605212|589412232|FG000|Treatment Period|Adverse Event|1|||
163190139|NCT03605212|589412233|FG001|Treatment Period|Adverse Event|0|||
163190140|NCT03605212|589412234|FG002|Treatment Period|Adverse Event|0|||
163190141|NCT03605212|589412235|FG003|Treatment Period|Adverse Event|0|||
163190142|NCT03605212|589412236|FG004|Treatment Period|Adverse Event|0|||
163190143|NCT03605212|589412232|FG000|Treatment Period|Physician Decision|0|||
163190144|NCT03605212|589412233|FG001|Treatment Period|Physician Decision|0|||
163190145|NCT03605212|589412234|FG002|Treatment Period|Physician Decision|0|||
163190146|NCT03605212|589412235|FG003|Treatment Period|Physician Decision|0|||
163190147|NCT03605212|589412236|FG004|Treatment Period|Physician Decision|1|||
163190148|NCT01254292|589412237|FG000|Comparative Phase|Adverse Event|25|||
163190149|NCT01254292|589412238|FG001|Comparative Phase|Adverse Event|25|||
163190150|NCT01254292|589412237|FG000|Comparative Phase|Lost to Follow-up|3|||
163190151|NCT01254292|589412238|FG001|Comparative Phase|Lost to Follow-up|21|||
163190152|NCT01254292|589412237|FG000|Comparative Phase|Pregnancy|2|||
163190153|NCT01254292|589412238|FG001|Comparative Phase|Pregnancy|6|||
163190154|NCT01254292|589412237|FG000|Comparative Phase|Withdrawal by Subject|20|||
163190155|NCT01254292|589412238|FG001|Comparative Phase|Withdrawal by Subject|21|||
163190156|NCT01254292|589412237|FG000|Comparative Phase|Protocol Violation|1|||
163190157|NCT01254292|589412238|FG001|Comparative Phase|Protocol Violation|2|||
163190158|NCT01254292|589412237|FG000|Comparative Phase|Wish for pregnancy|4|||
163190159|NCT01254292|589412238|FG001|Comparative Phase|Wish for pregnancy|6|||
163190160|NCT01254292|589412237|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
163190161|NCT01254292|589412238|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
163190162|NCT01254292|589412237|FG000|LCS12 Extension Phase|Adverse Event|9|||
163190163|NCT01254292|589412238|FG001|LCS12 Extension Phase|Adverse Event|0|||
163190164|NCT01254292|589412237|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
163190165|NCT01254292|589412238|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
163190166|NCT01254292|589412237|FG000|LCS12 Extension Phase|Other unknown|4|||
163190167|NCT01254292|589412238|FG001|LCS12 Extension Phase|Other unknown|0|||
163190168|NCT01254292|589412237|FG000|LCS12 Extension Phase|Pregnancy|2|||
163190169|NCT01254292|589412238|FG001|LCS12 Extension Phase|Pregnancy|0|||
163190170|NCT01254292|589412237|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
163190171|NCT01254292|589412238|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
163190172|NCT00285818|589412239|FG000|Overall Study|Withdrawal by Subject|3|||
163190173|NCT00285818|589412240|FG001|Overall Study|Withdrawal by Subject|2|||
163190174|NCT00285818|589412239|FG000|Overall Study|Lost to Follow-up|1|||
163190175|NCT00285818|589412240|FG001|Overall Study|Lost to Follow-up|0|||
163190176|NCT02083081|589412241|FG000|Overall Study|Lost to Follow-up|31|||
163190177|NCT02083081|589412242|FG001|Overall Study|Lost to Follow-up|9|||
163294669|NCT00814346|589785033|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
163294670|NCT00814346|589785034|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
163294671|NCT00814346|589785033|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
163294672|NCT00814346|589785034|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
163294673|NCT05764161|589785036|FG000|12-week DBVC Period|Lack of Efficacy|2|||
163294674|NCT05764161|589785037|FG001|12-week DBVC Period|Lack of Efficacy|1|||
163294675|NCT05764161|589785036|FG000|12-week DBVC Period|Lost to Follow-up|0|||
163043218|NCT02098395|588865749|FG000|Overall Study|Unclassified|0|||
163043219|NCT02098395|588865750|FG001|Overall Study|Unclassified|0|||
163294676|NCT05764161|589785037|FG001|12-week DBVC Period|Lost to Follow-up|2|||
163294677|NCT05764161|589785036|FG000|12-week DBVC Period|Protocol Violation|2|||
163294678|NCT05764161|589785037|FG001|12-week DBVC Period|Protocol Violation|4|||
163294679|NCT05764161|589785036|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
163294680|NCT05764161|589785037|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
163294681|NCT05764161|589785036|FG000|40-week OLE Period|Lack of Efficacy|0|||
163294682|NCT05764161|589785037|FG001|40-week OLE Period|Lack of Efficacy|1|||
163294683|NCT05764161|589785036|FG000|40-week OLE Period|Lost to Follow-up|1|||
163294684|NCT05764161|589785037|FG001|40-week OLE Period|Lost to Follow-up|4|||
163294685|NCT05764161|589785036|FG000|40-week OLE Period|Withdrawal by Subject|2|||
163294686|NCT05764161|589785037|FG001|40-week OLE Period|Withdrawal by Subject|7|||
163294687|NCT05764161|589785036|FG000|40-week OLE Period|Extended Travel|0|||
163294688|NCT05764161|589785037|FG001|40-week OLE Period|Extended Travel|1|||
163294689|NCT05764161|589785036|FG000|40-week OLE Period|Ongoing|66|||
163294690|NCT05764161|589785037|FG001|40-week OLE Period|Ongoing|59|||
163294691|NCT00507689|589785042|FG000|Pre-Randomization Period|Adverse Event|1|||
163294692|NCT00507689|589785043|FG001|Pre-Randomization Period|Adverse Event|0|||
163294693|NCT00507689|589785042|FG000|Pre-Randomization Period|Physician Decision|1|||
163294694|NCT00507689|589785043|FG001|Pre-Randomization Period|Physician Decision|0|||
163294695|NCT00507689|589785042|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
163294696|NCT00507689|589785043|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
163294697|NCT00507689|589785042|FG000|Randomized Period|Adverse Event|1|||
163294698|NCT00507689|589785043|FG001|Randomized Period|Adverse Event|1|||
163294699|NCT00507689|589785042|FG000|Randomized Period|Withdrawal by Subject|0|||
163294700|NCT00507689|589785043|FG001|Randomized Period|Withdrawal by Subject|1|||
163294701|NCT01241292|589785044|FG000|Overall Study|Administrative Reason by Sponsor|1|||
163294702|NCT01241292|589785045|FG001|Overall Study|Administrative Reason by Sponsor|0|||
163294703|NCT01241292|589785044|FG000|Overall Study|Disease Progression|2|||
163294704|NCT01241292|589785045|FG001|Overall Study|Disease Progression|0|||
163294705|NCT01241292|589785044|FG000|Overall Study|Study Drug Toxicity|0|||
163294706|NCT01241292|589785045|FG001|Overall Study|Study Drug Toxicity|1|||
163294707|NCT01241292|589785044|FG000|Overall Study|Participant Discontinued Treatment|0|||
163294708|NCT01241292|589785045|FG001|Overall Study|Participant Discontinued Treatment|2|||
163294709|NCT00346333|589785048|FG000|Overall Study|Death|1|||
163294710|NCT00346333|589785049|FG001|Overall Study|Death|0|||
163294711|NCT00346333|589785048|FG000|Overall Study|unwilling or unable to continue|4|||
163294712|NCT00346333|589785049|FG001|Overall Study|unwilling or unable to continue|8|||
163294713|NCT00117286|589785050|FG000|Overall Study|Adverse Event|12|||
163294714|NCT00117286|589785051|FG001|Overall Study|Adverse Event|6|||
163294715|NCT00117286|589785050|FG000|Overall Study|Lost to Follow-up|2|||
163294716|NCT00117286|589785051|FG001|Overall Study|Lost to Follow-up|0|||
163294717|NCT00117286|589785050|FG000|Overall Study|Protocol Violation|3|||
163294718|NCT00117286|589785051|FG001|Overall Study|Protocol Violation|3|||
163294719|NCT00117286|589785050|FG000|Overall Study|Withdrawal by Subject|6|||
163294720|NCT00117286|589785051|FG001|Overall Study|Withdrawal by Subject|2|||
163294721|NCT00117286|589785050|FG000|Overall Study|Physician Decision|3|||
163294722|NCT00117286|589785051|FG001|Overall Study|Physician Decision|7|||
163294723|NCT00117286|589785050|FG000|Overall Study|Lack of Efficacy|2|||
163294724|NCT00117286|589785051|FG001|Overall Study|Lack of Efficacy|1|||
163294725|NCT00117286|589785050|FG000|Overall Study|Research site closing|0|||
163294726|NCT00117286|589785051|FG001|Overall Study|Research site closing|2|||
163294727|NCT02798835|589785056|FG000|Overall Study|Protocol Violation|0|||
163294728|NCT02798835|589785057|FG001|Overall Study|Protocol Violation|0|||
163294729|NCT02798835|589785058|FG002|Overall Study|Protocol Violation|3|||
163294730|NCT03024606|589785063|FG000|Overall Study|Withdrawal by Subject|9|||
163294731|NCT03024606|589785064|FG001|Overall Study|Withdrawal by Subject|10|||
163294732|NCT01595061|589785066|FG000|Overall Study|Never Treated|3|||
163294733|NCT01595061|589785066|FG000|Overall Study|Inadequate Pathology|1|||
163294734|NCT03194958|589785069|FG000|Overall Study|Death|0|||
163294735|NCT03194958|589785070|FG001|Overall Study|Death|1|||
163294736|NCT03194958|589785071|FG002|Overall Study|Death|1|||
163294737|NCT03194958|589785072|FG003|Overall Study|Death|1|||
163294738|NCT03194958|589785069|FG000|Overall Study|Withdrawal by Subject|24|||
163294739|NCT03194958|589785070|FG001|Overall Study|Withdrawal by Subject|27|||
163294740|NCT03194958|589785071|FG002|Overall Study|Withdrawal by Subject|7|||
163294741|NCT03194958|589785072|FG003|Overall Study|Withdrawal by Subject|22|||
163294742|NCT03194958|589785069|FG000|Overall Study|Lost to Follow-up|168|||
163294743|NCT03194958|589785070|FG001|Overall Study|Lost to Follow-up|196|||
163294744|NCT03194958|589785071|FG002|Overall Study|Lost to Follow-up|174|||
163294745|NCT03194958|589785072|FG003|Overall Study|Lost to Follow-up|186|||
163294746|NCT00356265|589785073|FG000|Overall Study|Withdrawal by Subject|0|||
163294747|NCT00356265|589785074|FG001|Overall Study|Withdrawal by Subject|0|||
163294748|NCT00356265|589785075|FG002|Overall Study|Withdrawal by Subject|1|||
163294749|NCT00588770|589785081|FG000|Overall Study|Disease progression|85|||
163294750|NCT00588770|589785082|FG001|Overall Study|Disease progression|68|||
163294751|NCT00588770|589785081|FG000|Overall Study|Adverse Event|29|||
163294752|NCT00588770|589785082|FG001|Overall Study|Adverse Event|58|||
163391028|NCT02038920|590143397|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
163294753|NCT00588770|589785081|FG000|Overall Study|Death|13|||
163294754|NCT00588770|589785082|FG001|Overall Study|Death|22|||
163294755|NCT00588770|589785081|FG000|Overall Study|Withdrawal by Subject|15|||
163294756|NCT00588770|589785082|FG001|Overall Study|Withdrawal by Subject|25|||
163294757|NCT00588770|589785081|FG000|Overall Study|Alternative therapy|2|||
163294758|NCT00588770|589785082|FG001|Overall Study|Alternative therapy|4|||
163391029|NCT02038920|590143398|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
163391030|NCT02038920|590143399|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
163391031|NCT02038920|590143394|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
163391032|NCT02038920|590143395|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
162952073|NCT01954394|588529530|FG000|Overall Study|Other than specified above|10|||
163190178|NCT03109847|589412250|FG000|Overall Study|Withdrawal by Subject|1|||
163190179|NCT03109847|589412251|FG001|Overall Study|Withdrawal by Subject|0|||
163190180|NCT01268150|589412252|FG000|Treatment Phase|Progression of disease|18|||
163190181|NCT01268150|589412252|FG000|Treatment Phase|Adverse Event|3|||
163190182|NCT01268150|589412252|FG000|Treatment Phase|Withdrawal by Subject|3|||
163190183|NCT01268150|589412252|FG000|Treatment Phase|Other|4|||
163190184|NCT01268150|589412252|FG000|Extension Phase|Adverse Event|3|||
163190185|NCT01268150|589412252|FG000|Extension Phase|Disease progression|18|||
163190186|NCT01268150|589412252|FG000|Extension Phase|Other|6|||
163190187|NCT01672736|589412253|FG000|Overall Study|Available drug expired on 31 May 16|3|||
163190188|NCT04209348|589412254|FG000|Overall Study|Lost to Follow-up|1|||
163190189|NCT04209348|589412255|FG001|Overall Study|Lost to Follow-up|0|||
163190190|NCT02927262|589412256|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
163190191|NCT02927262|589412257|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
163190192|NCT02927262|589412256|FG000|Treatment Period (Up to 744 Days)|Death|1|||
163190193|NCT02927262|589412257|FG001|Treatment Period (Up to 744 Days)|Death|0|||
163190194|NCT02927262|589412256|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
163190195|NCT02927262|589412257|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
163190196|NCT02927262|589412256|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
163190197|NCT02927262|589412257|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
163190198|NCT02927262|589412256|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
163190199|NCT02927262|589412257|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
163190200|NCT02927262|589412256|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
163190201|NCT02927262|589412257|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
163190202|NCT02927262|589412256|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
163190203|NCT02927262|589412257|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
163190204|NCT02927262|589412256|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
163190205|NCT02927262|589412257|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
163190206|NCT02927262|589412256|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
163294759|NCT00588770|589785081|FG000|Overall Study|Other complicating disease|3|||
163294760|NCT00588770|589785082|FG001|Overall Study|Other complicating disease|2|||
163294761|NCT00588770|589785081|FG000|Overall Study|Not start protocol therapy|0|||
163294762|NCT00588770|589785082|FG001|Overall Study|Not start protocol therapy|9|||
163294763|NCT00588770|589785081|FG000|Overall Study|Lack of Efficacy|8|||
163294764|NCT00588770|589785082|FG001|Overall Study|Lack of Efficacy|10|||
163294765|NCT00588770|589785081|FG000|Overall Study|Physician discretion|2|||
163294766|NCT00588770|589785082|FG001|Overall Study|Physician discretion|0|||
163294767|NCT00588770|589785081|FG000|Overall Study|Patient non-compliance|2|||
163294768|NCT00588770|589785082|FG001|Overall Study|Patient non-compliance|2|||
163294769|NCT04697628|589785083|FG000|Overall Study|Withdrawal by Subject|17|||
163294770|NCT04697628|589785084|FG001|Overall Study|Withdrawal by Subject|23|||
163294771|NCT04697628|589785083|FG000|Overall Study|Lost to Follow-up|0|||
163294772|NCT04697628|589785084|FG001|Overall Study|Lost to Follow-up|4|||
163294773|NCT04697628|589785083|FG000|Overall Study|On-going in study|122|||
163294774|NCT04697628|589785084|FG001|Overall Study|On-going in study|91|||
163294775|NCT03388632|589785085|FG000|Triplet C|Clinical progression|0|||
163294776|NCT03388632|589785086|FG001|Triplet C|Clinical progression|0|||
163294777|NCT03388632|589785087|FG002|Triplet C|Clinical progression|0|||
163391033|NCT02038920|590143396|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
163294778|NCT03388632|589785088|FG003|Triplet C|Clinical progression|0|||
163294779|NCT03388632|589785089|FG004|Triplet C|Clinical progression|1|||
163294780|NCT03388632|589785090|FG005|Triplet C|Clinical progression|0|||
163294781|NCT03388632|589785091|FG006|Triplet C|Clinical progression|0|||
163294782|NCT03388632|589785092|FG007|Triplet C|Clinical progression|0|||
163294783|NCT03388632|589785093|FG008|Triplet C|Clinical progression|0|||
163294784|NCT03388632|589785085|FG000|Triplet C|42-day lapse in tx|0|||
163294785|NCT03388632|589785086|FG001|Triplet C|42-day lapse in tx|0|||
163294786|NCT03388632|589785087|FG002|Triplet C|42-day lapse in tx|0|||
163294787|NCT03388632|589785088|FG003|Triplet C|42-day lapse in tx|0|||
163294788|NCT03388632|589785089|FG004|Triplet C|42-day lapse in tx|1|||
163294789|NCT03388632|589785090|FG005|Triplet C|42-day lapse in tx|0|||
163294790|NCT03388632|589785091|FG006|Triplet C|42-day lapse in tx|0|||
163294791|NCT03388632|589785092|FG007|Triplet C|42-day lapse in tx|0|||
163391034|NCT02038920|590143397|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
163391035|NCT02038920|590143398|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
163391036|NCT02038920|590143399|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
163391037|NCT00866697|590143400|FG000|Overall Study|Study closed/terminated|156|||
163391038|NCT00866697|590143401|FG001|Overall Study|Study closed/terminated|138|||
163294792|NCT03388632|589785093|FG008|Triplet C|42-day lapse in tx|0|||
163294793|NCT03388632|589785085|FG000|Triplet C|Adverse Event|0|||
163294794|NCT03388632|589785086|FG001|Triplet C|Adverse Event|0|||
163294795|NCT03388632|589785087|FG002|Triplet C|Adverse Event|0|||
163294796|NCT03388632|589785088|FG003|Triplet C|Adverse Event|0|||
163294797|NCT03388632|589785089|FG004|Triplet C|Adverse Event|0|||
163294798|NCT03388632|589785090|FG005|Triplet C|Adverse Event|0|||
163294799|NCT03388632|589785091|FG006|Triplet C|Adverse Event|0|||
163294800|NCT03388632|589785092|FG007|Triplet C|Adverse Event|0|||
163294801|NCT03388632|589785093|FG008|Triplet C|Adverse Event|1|||
163294802|NCT03388632|589785085|FG000|Triplet C|Switched to alternative treatment|0|||
163294803|NCT03388632|589785086|FG001|Triplet C|Switched to alternative treatment|0|||
163294804|NCT03388632|589785087|FG002|Triplet C|Switched to alternative treatment|0|||
163294805|NCT03388632|589785088|FG003|Triplet C|Switched to alternative treatment|0|||
163294806|NCT03388632|589785089|FG004|Triplet C|Switched to alternative treatment|0|||
163294807|NCT03388632|589785090|FG005|Triplet C|Switched to alternative treatment|0|||
163294808|NCT03388632|589785091|FG006|Triplet C|Switched to alternative treatment|0|||
163391039|NCT00866697|590143400|FG000|Overall Study|Lost to Follow-up|22|||
163391040|NCT00866697|590143401|FG001|Overall Study|Lost to Follow-up|28|||
163043220|NCT02098395|588865751|FG002|Overall Study|Unclassified|3|||
163294809|NCT03388632|589785092|FG007|Triplet C|Switched to alternative treatment|1|||
163294810|NCT03388632|589785093|FG008|Triplet C|Switched to alternative treatment|0|||
163391041|NCT00866697|590143400|FG000|Overall Study|Physician Decision|3|||
163391042|NCT00866697|590143401|FG001|Overall Study|Physician Decision|5|||
163294811|NCT03388632|589785085|FG000|Triplet C|Participant choice|0|||
163294812|NCT03388632|589785086|FG001|Triplet C|Participant choice|0|||
163294813|NCT03388632|589785087|FG002|Triplet C|Participant choice|0|||
163294814|NCT03388632|589785088|FG003|Triplet C|Participant choice|0|||
163294815|NCT03388632|589785089|FG004|Triplet C|Participant choice|0|||
163294816|NCT03388632|589785090|FG005|Triplet C|Participant choice|1|||
163391043|NCT00866697|590143400|FG000|Overall Study|Withdrawal by Subject|33|||
163294817|NCT03388632|589785091|FG006|Triplet C|Participant choice|0|||
163294818|NCT03388632|589785092|FG007|Triplet C|Participant choice|0|||
163294819|NCT03388632|589785093|FG008|Triplet C|Participant choice|0|||
163294820|NCT06218251|589785096|FG000|Overall Study|Lost to Follow-up|4|||
163294821|NCT00997386|589785099|FG000|Overall Study|Death|7|||
163294822|NCT03492177|589785100|FG000|Overall Study|Adverse Event|1|||
163294823|NCT03492177|589785101|FG001|Overall Study|Adverse Event|0|||
163294824|NCT03492177|589785102|FG002|Overall Study|Adverse Event|0|||
162952074|NCT01954394|588529531|FG001|Overall Study|Other than specified above|21|||
162952075|NCT00909610|588529532|FG000|Period: First Intervention|Adverse Event|0|||
162952076|NCT00909610|588529533|FG001|Period: First Intervention|Adverse Event|1|||
163391044|NCT00866697|590143401|FG001|Overall Study|Withdrawal by Subject|57|||
163391045|NCT02906787|590143404|FG000|Overall Study|Withdrawal by Subject|12|||
163391046|NCT02906787|590143405|FG001|Overall Study|Withdrawal by Subject|10|||
163391047|NCT02906787|590143404|FG000|Overall Study|Missed|24|||
163391048|NCT02906787|590143405|FG001|Overall Study|Missed|22|||
163391049|NCT03901053|590143410|FG000|Overall Study|Lost to Follow-up|6|||
163391050|NCT03901053|590143411|FG001|Overall Study|Lost to Follow-up|2|||
162952077|NCT00909610|588529532|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
163391051|NCT03901053|590143410|FG000|Overall Study|Withdrawal by Subject|4|||
163391052|NCT03901053|590143411|FG001|Overall Study|Withdrawal by Subject|3|||
163391053|NCT03901053|590143410|FG000|Overall Study|Unsatisfactory Device|1|||
163391054|NCT03901053|590143411|FG001|Overall Study|Unsatisfactory Device|2|||
163391055|NCT03901053|590143410|FG000|Overall Study|No longer meets study criteria|1|||
163391056|NCT03901053|590143411|FG001|Overall Study|No longer meets study criteria|3|||
163391057|NCT03901053|590143410|FG000|Overall Study|Subject's Medical Status|0|||
163391058|NCT03901053|590143411|FG001|Overall Study|Subject's Medical Status|1|||
163294825|NCT03492177|589785100|FG000|Overall Study|Death|3|||
163294826|NCT03492177|589785101|FG001|Overall Study|Death|0|||
163294827|NCT03492177|589785102|FG002|Overall Study|Death|3|||
163294828|NCT03492177|589785100|FG000|Overall Study|Lack of Efficacy|1|||
163294829|NCT03492177|589785101|FG001|Overall Study|Lack of Efficacy|2|||
163294830|NCT03492177|589785102|FG002|Overall Study|Lack of Efficacy|0|||
163294831|NCT03492177|589785100|FG000|Overall Study|Other|1|||
163391059|NCT03901053|590143410|FG000|Overall Study|Screening Failure|1|||
163294832|NCT03492177|589785101|FG001|Overall Study|Other|0|||
163294833|NCT03492177|589785102|FG002|Overall Study|Other|0|||
163294834|NCT03492177|589785100|FG000|Overall Study|Ongoing|16|||
163391060|NCT03901053|590143411|FG001|Overall Study|Screening Failure|0|||
163294835|NCT03492177|589785101|FG001|Overall Study|Ongoing|19|||
163294836|NCT03492177|589785102|FG002|Overall Study|Ongoing|17|||
163294837|NCT01713946|589785103|FG000|Overall Study|Death|0|||
163190207|NCT02927262|589412257|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
163190208|NCT02927262|589412256|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
163190209|NCT02927262|589412257|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
163190210|NCT02927262|589412256|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
163190211|NCT02927262|589412257|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
163190212|NCT02927262|589412256|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
163190213|NCT02927262|589412257|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
163190214|NCT02927262|589412256|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
163190215|NCT02927262|589412257|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
163190216|NCT02927262|589412256|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
163190217|NCT02927262|589412257|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
163294838|NCT01713946|589785104|FG001|Overall Study|Death|2|||
163190218|NCT02927262|589412256|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
163190219|NCT02927262|589412257|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
163190220|NCT02927262|589412256|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
163190221|NCT02927262|589412257|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
163190222|NCT02913612|589412258|FG000|Overall Study|Lost to Follow-up|6|||
163190223|NCT02913612|589412259|FG001|Overall Study|Lost to Follow-up|5|||
163190224|NCT02913612|589412260|FG002|Overall Study|Lost to Follow-up|2|||
163190225|NCT02913612|589412261|FG003|Overall Study|Lost to Follow-up|0|||
163190226|NCT02913612|589412258|FG000|Overall Study|Physician Decision|1|||
163294839|NCT01713946|589785105|FG002|Overall Study|Death|2|||
163294840|NCT01713946|589785103|FG000|Overall Study|Adverse Event|19|||
163294841|NCT01713946|589785104|FG001|Overall Study|Adverse Event|14|||
163294842|NCT01713946|589785105|FG002|Overall Study|Adverse Event|13|||
163294843|NCT01713946|589785103|FG000|Overall Study|Withdrawal by Subject|12|||
163294844|NCT01713946|589785104|FG001|Overall Study|Withdrawal by Subject|12|||
163294845|NCT01713946|589785105|FG002|Overall Study|Withdrawal by Subject|8|||
163294846|NCT01713946|589785103|FG000|Overall Study|Lack of Efficacy|8|||
163294847|NCT01713946|589785104|FG001|Overall Study|Lack of Efficacy|8|||
163294848|NCT01713946|589785105|FG002|Overall Study|Lack of Efficacy|14|||
163294849|NCT01713946|589785103|FG000|Overall Study|Protocol Violation|2|||
163294850|NCT01713946|589785104|FG001|Overall Study|Protocol Violation|4|||
163294851|NCT01713946|589785105|FG002|Overall Study|Protocol Violation|1|||
163294852|NCT01713946|589785103|FG000|Overall Study|Lost to Follow-up|0|||
163294853|NCT01713946|589785104|FG001|Overall Study|Lost to Follow-up|0|||
163294854|NCT01713946|589785105|FG002|Overall Study|Lost to Follow-up|1|||
163294855|NCT01713946|589785103|FG000|Overall Study|Administrative problems|1|||
163294856|NCT01713946|589785104|FG001|Overall Study|Administrative problems|0|||
163294857|NCT01713946|589785105|FG002|Overall Study|Administrative problems|0|||
163294858|NCT01713946|589785103|FG000|Overall Study|Did not continue in Ext|0|||
163294859|NCT01713946|589785104|FG001|Overall Study|Did not continue in Ext|3|||
163294860|NCT01713946|589785105|FG002|Overall Study|Did not continue in Ext|0|||
163294861|NCT01713946|589785103|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
163294862|NCT01713946|589785104|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
163294863|NCT01713946|589785105|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
163294864|NCT01713946|589785103|FG000|Overall Study|Patients never switched to everolimus|0|||
163294865|NCT01713946|589785104|FG001|Overall Study|Patients never switched to everolimus|0|||
163294866|NCT01713946|589785105|FG002|Overall Study|Patients never switched to everolimus|5|||
163294867|NCT05644444|589786269|FG000|Tolerance Phase|Adverse Event|0|||
163294868|NCT05644444|589786270|FG001|Tolerance Phase|Adverse Event|2|||
163294869|NCT05644444|589786269|FG000|Treatment Phase|Adverse Event|0|||
163294870|NCT05644444|589786270|FG001|Treatment Phase|Adverse Event|2|||
163294871|NCT03723616|589786272|FG000|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|17|||
163294872|NCT03723616|589786273|FG001|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|16|||
163294873|NCT03723616|589786274|FG002|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|20|||
163294874|NCT03723616|589786275|FG003|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|6|||
163294875|NCT03723616|589786276|FG004|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
163294876|NCT03723616|589786277|FG005|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
163294877|NCT00493649|589786280|FG000|Overall Study|Adverse Event|44|||
163294878|NCT00493649|589786280|FG000|Overall Study|Patient Request|21|||
163294879|NCT00493649|589786280|FG000|Overall Study|Investigator Request|2|||
163294880|NCT00493649|589786280|FG000|Overall Study|Disease Progression|1|||
163294881|NCT00493649|589786280|FG000|Overall Study|Lost to Follow-up|1|||
163294882|NCT00493649|589786280|FG000|Overall Study|Other|13|||
163294883|NCT00925899|589786283|FG000|Part 1|Death|1|||
163294884|NCT00925899|589786284|FG001|Part 1|Death|2|||
163294885|NCT00925899|589786283|FG000|Part 1|Withdrawal by Subject|10|||
163294886|NCT00925899|589786284|FG001|Part 1|Withdrawal by Subject|9|||
163294887|NCT00683696|589786285|FG000|Overall Study|Withdrawn due to study closure|337|||
163294888|NCT00683696|589786286|FG001|Overall Study|Withdrawn due to study closure|338|||
163294889|NCT00683696|589786285|FG000|Overall Study|Withdrawn prior to study closure|13|||
163190227|NCT02913612|589412259|FG001|Overall Study|Physician Decision|4|||
163190228|NCT02913612|589412260|FG002|Overall Study|Physician Decision|1|||
163391117|NCT03047551|590144628|FG000|Overall Study|Did not receive TAS|1|||
163391118|NCT03047551|590144629|FG001|Overall Study|Did not receive TAS|0|||
163391119|NCT03047551|590144628|FG000|Overall Study|Physician Decision|1|||
163391120|NCT03047551|590144629|FG001|Overall Study|Physician Decision|0|||
163391121|NCT03047551|590144628|FG000|Overall Study|Withdrawal by Subject|0|||
163391122|NCT03047551|590144629|FG001|Overall Study|Withdrawal by Subject|1|||
163391123|NCT03047551|590144628|FG000|Overall Study|Probe malfunction|0|||
163391124|NCT03047551|590144629|FG001|Overall Study|Probe malfunction|1|||
163391125|NCT03047551|590144628|FG000|Overall Study|Ineligible|0|||
163391126|NCT03047551|590144629|FG001|Overall Study|Ineligible|1|||
163391127|NCT00726622|590144630|FG000|Overall Study|Withdrawal by Subject|16|||
163190229|NCT02913612|589412261|FG003|Overall Study|Physician Decision|0|||
163391128|NCT00726622|590144631|FG001|Overall Study|Withdrawal by Subject|2|||
163391129|NCT00726622|590144630|FG000|Overall Study|Physician Decision|0|||
163190230|NCT02913612|589412258|FG000|Overall Study|Withdrawal by Subject|2|||
163190231|NCT02913612|589412259|FG001|Overall Study|Withdrawal by Subject|4|||
163190232|NCT02913612|589412260|FG002|Overall Study|Withdrawal by Subject|0|||
163190233|NCT02913612|589412261|FG003|Overall Study|Withdrawal by Subject|0|||
163294890|NCT00683696|589786286|FG001|Overall Study|Withdrawn prior to study closure|28|||
163294891|NCT00683696|589786285|FG000|Overall Study|Lost to Follow-up|5|||
163294892|NCT00683696|589786286|FG001|Overall Study|Lost to Follow-up|6|||
163294893|NCT00683696|589786285|FG000|Overall Study|Vital status follow-up only|3|||
163294894|NCT00683696|589786286|FG001|Overall Study|Vital status follow-up only|3|||
163294895|NCT00683696|589786285|FG000|Overall Study|Death|46|||
163294896|NCT00683696|589786286|FG001|Overall Study|Death|30|||
163294897|NCT03648762|589786289|FG000|Overall Study|Lost to Follow-up|1|||
163294898|NCT03648762|589786290|FG001|Overall Study|Lost to Follow-up|2|||
163294899|NCT03648762|589786291|FG002|Overall Study|Lost to Follow-up|0|||
163294900|NCT03648762|589786289|FG000|Overall Study|Withdrawal by Subject|5|||
163294901|NCT03648762|589786290|FG001|Overall Study|Withdrawal by Subject|2|||
163294902|NCT03648762|589786291|FG002|Overall Study|Withdrawal by Subject|1|||
163294903|NCT01662336|589786301|FG000|Overall Study|Adverse Event|1|||
163294904|NCT01662336|589786301|FG000|Overall Study|No longer on LPV/r|30|||
163294905|NCT01662336|589786301|FG000|Overall Study|Other|29|||
163294906|NCT01662336|589786301|FG000|Overall Study|Withdrawal by Subject|6|||
163294907|NCT02189252|589786302|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
163294908|NCT02189252|589786303|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
163294909|NCT02189252|589786304|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
163294910|NCT02189252|589786305|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
163294911|NCT02189252|589786302|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
163294912|NCT02189252|589786303|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
163294913|NCT02189252|589786304|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
163294914|NCT02189252|589786305|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
163294915|NCT03454529|589786308|FG000|Overall Study|Did not receive treatment|6|||
163294916|NCT03454529|589786308|FG000|Overall Study|Received < 80% doses|1|||
163294917|NCT01040689|589786310|FG000|Overall Study|Adverse Event|0|||
163294918|NCT01040689|589786311|FG001|Overall Study|Adverse Event|0|||
163294919|NCT01040689|589786312|FG002|Overall Study|Adverse Event|2|||
163294920|NCT01040689|589786313|FG003|Overall Study|Adverse Event|4|||
163294921|NCT01040689|589786310|FG000|Overall Study|Lack of Efficacy|0|||
163294922|NCT01040689|589786311|FG001|Overall Study|Lack of Efficacy|0|||
163294923|NCT01040689|589786312|FG002|Overall Study|Lack of Efficacy|1|||
163294924|NCT01040689|589786313|FG003|Overall Study|Lack of Efficacy|0|||
163294925|NCT01040689|589786310|FG000|Overall Study|Lost to Follow-up|1|||
163043221|NCT02098395|588865752|FG003|Overall Study|Unclassified|2|||
163190234|NCT02913612|589412258|FG000|Overall Study|Hemangioma resolved|1|||
163190235|NCT02913612|589412259|FG001|Overall Study|Hemangioma resolved|0|||
163190236|NCT02913612|589412260|FG002|Overall Study|Hemangioma resolved|0|||
163190237|NCT02913612|589412261|FG003|Overall Study|Hemangioma resolved|0|||
163190238|NCT02913612|589412258|FG000|Overall Study|Local IRB decision|1|||
163190239|NCT02913612|589412259|FG001|Overall Study|Local IRB decision|0|||
163190240|NCT02913612|589412260|FG002|Overall Study|Local IRB decision|0|||
163190241|NCT02913612|589412261|FG003|Overall Study|Local IRB decision|0|||
163190242|NCT02913612|589412258|FG000|Overall Study|Study drug non-compliance|1|||
163190243|NCT02913612|589412259|FG001|Overall Study|Study drug non-compliance|1|||
163190244|NCT02913612|589412260|FG002|Overall Study|Study drug non-compliance|0|||
163190245|NCT02913612|589412261|FG003|Overall Study|Study drug non-compliance|0|||
163190246|NCT02913612|589412258|FG000|Overall Study|Insurance issues|0|||
163190247|NCT02913612|589412259|FG001|Overall Study|Insurance issues|1|||
163190248|NCT02913612|589412260|FG002|Overall Study|Insurance issues|0|||
163190249|NCT02913612|589412261|FG003|Overall Study|Insurance issues|0|||
163190250|NCT02913612|589412258|FG000|Overall Study|Needed to treat second hemangioma|0|||
163190251|NCT02913612|589412259|FG001|Overall Study|Needed to treat second hemangioma|1|||
163190252|NCT02913612|589412260|FG002|Overall Study|Needed to treat second hemangioma|0|||
163190253|NCT02913612|589412261|FG003|Overall Study|Needed to treat second hemangioma|0|||
163190254|NCT02913612|589412258|FG000|Overall Study|Study completion criteria not met|0|||
163190255|NCT02913612|589412259|FG001|Overall Study|Study completion criteria not met|1|||
163190256|NCT02913612|589412260|FG002|Overall Study|Study completion criteria not met|0|||
163190257|NCT02913612|589412261|FG003|Overall Study|Study completion criteria not met|0|||
163190258|NCT02913612|589412258|FG000|Overall Study|Ineligible|0|||
163190259|NCT02913612|589412259|FG001|Overall Study|Ineligible|1|||
163190260|NCT02913612|589412260|FG002|Overall Study|Ineligible|0|||
163190261|NCT02913612|589412261|FG003|Overall Study|Ineligible|0|||
163190262|NCT04251273|589412262|FG000|Overall Study|Lost to Follow-up|331|||
163190263|NCT04251273|589412263|FG001|Overall Study|Lost to Follow-up|290|||
163190264|NCT04402060|589412264|FG000|Overall Study|Death|1|||
163190265|NCT04402060|589412265|FG001|Overall Study|Death|12|||
163190266|NCT04402060|589412266|FG002|Overall Study|Death|7|||
163190267|NCT04402060|589412264|FG000|Overall Study|Adverse Event|0|||
163190268|NCT04402060|589412265|FG001|Overall Study|Adverse Event|0|||
163190269|NCT04402060|589412266|FG002|Overall Study|Adverse Event|1|||
163190270|NCT04402060|589412264|FG000|Overall Study|Withdrawal by Subject|0|||
163190271|NCT04402060|589412265|FG001|Overall Study|Withdrawal by Subject|1|||
163190272|NCT04402060|589412266|FG002|Overall Study|Withdrawal by Subject|2|||
163190273|NCT04402060|589412264|FG000|Overall Study|Sponsor Request|0|||
163190274|NCT04402060|589412265|FG001|Overall Study|Sponsor Request|2|||
163190275|NCT04402060|589412266|FG002|Overall Study|Sponsor Request|0|||
163190276|NCT04402060|589412264|FG000|Overall Study|Physician Decision|0|||
163190277|NCT04402060|589412265|FG001|Overall Study|Physician Decision|0|||
163190278|NCT04402060|589412266|FG002|Overall Study|Physician Decision|1|||
163190279|NCT04402060|589412264|FG000|Overall Study|Other|0|||
163190280|NCT04402060|589412265|FG001|Overall Study|Other|1|||
163190281|NCT04402060|589412266|FG002|Overall Study|Other|0|||
163190282|NCT00936611|589412267|FG000|Overall Study|Progressive Disease|3|||
163190283|NCT00936611|589412267|FG000|Overall Study|New Systemic Therapy|22|||
163190284|NCT00936611|589412267|FG000|Overall Study|Lost to Follow-up|1|||
163190285|NCT00936611|589412267|FG000|Overall Study|Withdrawal by Subject|2|||
163190286|NCT00936611|589412267|FG000|Overall Study|Still on Follow-up|1|||
163190287|NCT00936611|589412267|FG000|Overall Study|Still on Active Therapy|7|||
163190288|NCT00936611|589412267|FG000|Overall Study|Ineligible for Study Drug|3|||
163190289|NCT02282358|589412276|FG000|Overall Study|Nonevaluable|1|||
163190290|NCT01898208|589412277|FG000|Overall Study|Positive blood culture|17|||
163190291|NCT01898208|589412278|FG001|Overall Study|Positive blood culture|23|||
163190292|NCT01898208|589412279|FG002|Overall Study|Positive blood culture|15|||
163190293|NCT01898208|589412277|FG000|Overall Study|Death/comfort care within 24 hours|10|||
163190294|NCT01898208|589412278|FG001|Overall Study|Death/comfort care within 24 hours|9|||
163190295|NCT01898208|589412279|FG002|Overall Study|Death/comfort care within 24 hours|8|||
163190296|NCT01898208|589412277|FG000|Overall Study|Negative Gram Stain|6|||
163190297|NCT01898208|589412278|FG001|Overall Study|Negative Gram Stain|9|||
163190298|NCT01898208|589412279|FG002|Overall Study|Negative Gram Stain|6|||
163190299|NCT01898208|589412277|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
163190300|NCT01898208|589412278|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
163190301|NCT01898208|589412279|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
163043222|NCT00110357|588865758|FG000|Overall Study|Deterioration without progression|2|||
163043223|NCT00110357|588865759|FG001|Overall Study|Deterioration without progression|0|||
163190302|NCT01898208|589412277|FG000|Overall Study|System/Technical Error|1|||
163190303|NCT01898208|589412278|FG001|Overall Study|System/Technical Error|2|||
163190304|NCT01898208|589412279|FG002|Overall Study|System/Technical Error|3|||
163190305|NCT01898208|589412277|FG000|Overall Study|Lost to Follow-up|3|||
163190306|NCT01898208|589412278|FG001|Overall Study|Lost to Follow-up|1|||
163190307|NCT01898208|589412279|FG002|Overall Study|Lost to Follow-up|1|||
163190308|NCT03780543|589412281|FG000|Overall Study|Adverse Event|1|||
163190309|NCT03780543|589412282|FG001|Overall Study|Adverse Event|0|||
163190310|NCT03780543|589412283|FG002|Overall Study|Adverse Event|2|||
163190311|NCT03780543|589412281|FG000|Overall Study|Lost to Follow-up|2|||
163190312|NCT03780543|589412282|FG001|Overall Study|Lost to Follow-up|0|||
163391130|NCT00726622|590144631|FG001|Overall Study|Physician Decision|1|||
163391131|NCT00726622|590144630|FG000|Overall Study|Metastasis|2|||
163391132|NCT00726622|590144631|FG001|Overall Study|Metastasis|0|||
163391133|NCT02462928|590144633|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
163391134|NCT02462928|590144634|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
163391135|NCT02462928|590144635|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
163391136|NCT02462928|590144633|FG000|Overall Study|Adverse Event|47|||
163391137|NCT02462928|590144634|FG001|Overall Study|Adverse Event|51|||
163391138|NCT02462928|590144635|FG002|Overall Study|Adverse Event|25|||
163190313|NCT03780543|589412283|FG002|Overall Study|Lost to Follow-up|1|||
163190314|NCT03780543|589412281|FG000|Overall Study|Study terminated by Sponsor|8|||
163190315|NCT03780543|589412282|FG001|Overall Study|Study terminated by Sponsor|7|||
163190316|NCT03780543|589412283|FG002|Overall Study|Study terminated by Sponsor|13|||
163190317|NCT03780543|589412281|FG000|Overall Study|Withdrawal by Subject|1|||
163190318|NCT03780543|589412282|FG001|Overall Study|Withdrawal by Subject|8|||
163190319|NCT03780543|589412283|FG002|Overall Study|Withdrawal by Subject|1|||
163190320|NCT03780543|589412281|FG000|Overall Study|Noncompliance with study drug|1|||
163190321|NCT03780543|589412282|FG001|Overall Study|Noncompliance with study drug|0|||
163190322|NCT03780543|589412283|FG002|Overall Study|Noncompliance with study drug|0|||
163190323|NCT01033851|589412284|FG000|Overall Study|Withdrawal by Subject|3|||
163190324|NCT01033851|589412285|FG001|Overall Study|Withdrawal by Subject|7|||
163190325|NCT02158975|589412286|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
163190326|NCT02728596|589412289|FG000|Overall Study|Refusal unrelated to adverse event|3|||
163190327|NCT02728596|589412290|FG001|Overall Study|Refusal unrelated to adverse event|6|||
163190328|NCT02728596|589412291|FG002|Overall Study|Refusal unrelated to adverse event|7|||
163190329|NCT02728596|589412292|FG003|Overall Study|Refusal unrelated to adverse event|7|||
163190330|NCT02728596|589412289|FG000|Overall Study|Death|44|||
163190331|NCT02728596|589412290|FG001|Overall Study|Death|42|||
163190332|NCT02728596|589412291|FG002|Overall Study|Death|123|||
163190333|NCT02728596|589412292|FG003|Overall Study|Death|68|||
163190334|NCT04430738|589412293|FG000|Phase 1: Dose Escalation|Death|1|||
163190335|NCT04430738|589412294|FG001|Phase 1: Dose Escalation|Death|4|||
163190336|NCT04430738|589412295|FG002|Phase 1: Dose Escalation|Death|4|||
163190337|NCT04430738|589412296|FG003|Phase 1: Dose Escalation|Death|1|||
163190338|NCT04430738|589412297|FG004|Phase 1: Dose Escalation|Death|6|||
163190339|NCT04430738|589412298|FG005|Phase 1: Dose Escalation|Death|0|||
163190340|NCT04430738|589412293|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
163190341|NCT04430738|589412294|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
163190342|NCT04430738|589412295|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
163190343|NCT04430738|589412296|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
163190344|NCT04430738|589412297|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
163190345|NCT04430738|589412298|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
163190346|NCT04430738|589412293|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
163190347|NCT04430738|589412294|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
163190348|NCT04430738|589412295|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
163190349|NCT04430738|589412296|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
163190350|NCT04430738|589412297|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
163190351|NCT04430738|589412298|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
163190352|NCT04430738|589412293|FG000|Phase 1: Dose Escalation|Other|1|||
163190353|NCT04430738|589412294|FG001|Phase 1: Dose Escalation|Other|0|||
163190354|NCT04430738|589412295|FG002|Phase 1: Dose Escalation|Other|0|||
163190355|NCT04430738|589412296|FG003|Phase 1: Dose Escalation|Other|0|||
163190356|NCT04430738|589412297|FG004|Phase 1: Dose Escalation|Other|0|||
163190357|NCT04430738|589412298|FG005|Phase 1: Dose Escalation|Other|0|||
163190358|NCT04430738|589412293|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
163190359|NCT04430738|589412294|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
163190360|NCT04430738|589412295|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
163190361|NCT04430738|589412296|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
163190362|NCT04430738|589412297|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
163190363|NCT04430738|589412298|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
163190364|NCT04430738|589412293|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
163190365|NCT04430738|589412294|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
163190366|NCT04430738|589412295|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
163190367|NCT04430738|589412296|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
163190368|NCT04430738|589412297|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
163190369|NCT04430738|589412298|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
163190370|NCT04102189|589412300|FG000|Overall Study|Withdrawal by Subject|1|||
163190371|NCT04102189|589412301|FG001|Overall Study|Withdrawal by Subject|2|||
163190372|NCT04102189|589412300|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163190373|NCT04102189|589412301|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163391139|NCT02462928|590144633|FG000|Overall Study|Lack of Efficacy|3|||
163391140|NCT02462928|590144634|FG001|Overall Study|Lack of Efficacy|8|||
163391141|NCT02462928|590144635|FG002|Overall Study|Lack of Efficacy|3|||
163190374|NCT04102189|589412300|FG000|Overall Study|Lost to Follow-up|1|||
163190375|NCT04102189|589412301|FG001|Overall Study|Lost to Follow-up|0|||
163190376|NCT01543698|589414124|FG000|Phase 1b|Disease progression|2|||
163190377|NCT01543698|589414125|FG001|Phase 1b|Disease progression|4|||
163190378|NCT01543698|589414126|FG002|Phase 1b|Disease progression|3|||
163190379|NCT01543698|589414127|FG003|Phase 1b|Disease progression|2|||
163190380|NCT01543698|589414128|FG004|Phase 1b|Disease progression|10|||
163190381|NCT01543698|589414129|FG005|Phase 1b|Disease progression|6|||
163190382|NCT01543698|589414130|FG006|Phase 1b|Disease progression|5|||
163190383|NCT01543698|589414131|FG007|Phase 1b|Disease progression|3|||
163190384|NCT01543698|589414132|FG008|Phase 1b|Disease progression|4|||
163190385|NCT01543698|589414133|FG009|Phase 1b|Disease progression|5|||
163190386|NCT01543698|589414134|FG010|Phase 1b|Disease progression|1|||
163190387|NCT01543698|589414135|FG011|Phase 1b|Disease progression|0|||
163190388|NCT01543698|589414136|FG012|Phase 1b|Disease progression|0|||
163190389|NCT01543698|589414137|FG013|Phase 1b|Disease progression|0|||
163190390|NCT01543698|589414138|FG014|Phase 1b|Disease progression|0|||
163190391|NCT01543698|589414124|FG000|Phase 1b|Death|0|||
163190392|NCT01543698|589414125|FG001|Phase 1b|Death|0|||
163190393|NCT01543698|589414126|FG002|Phase 1b|Death|1|||
163190394|NCT01543698|589414127|FG003|Phase 1b|Death|1|||
163190395|NCT01543698|589414128|FG004|Phase 1b|Death|0|||
163190396|NCT01543698|589414129|FG005|Phase 1b|Death|0|||
163190397|NCT01543698|589414130|FG006|Phase 1b|Death|0|||
163190398|NCT01543698|589414131|FG007|Phase 1b|Death|0|||
163190399|NCT01543698|589414132|FG008|Phase 1b|Death|0|||
163190400|NCT01543698|589414133|FG009|Phase 1b|Death|0|||
163190401|NCT01543698|589414134|FG010|Phase 1b|Death|1|||
163190402|NCT01543698|589414135|FG011|Phase 1b|Death|0|||
163190403|NCT01543698|589414136|FG012|Phase 1b|Death|0|||
163190404|NCT01543698|589414137|FG013|Phase 1b|Death|0|||
163190405|NCT01543698|589414138|FG014|Phase 1b|Death|0|||
163190406|NCT01543698|589414124|FG000|Phase 1b|Withdrawal by Subject|0|||
163190407|NCT01543698|589414125|FG001|Phase 1b|Withdrawal by Subject|1|||
163190408|NCT01543698|589414126|FG002|Phase 1b|Withdrawal by Subject|0|||
163190409|NCT01543698|589414127|FG003|Phase 1b|Withdrawal by Subject|1|||
163190410|NCT01543698|589414128|FG004|Phase 1b|Withdrawal by Subject|0|||
163190411|NCT01543698|589414129|FG005|Phase 1b|Withdrawal by Subject|0|||
163190412|NCT01543698|589414130|FG006|Phase 1b|Withdrawal by Subject|1|||
163190413|NCT01543698|589414131|FG007|Phase 1b|Withdrawal by Subject|0|||
163190414|NCT01543698|589414132|FG008|Phase 1b|Withdrawal by Subject|0|||
163190415|NCT01543698|589414133|FG009|Phase 1b|Withdrawal by Subject|0|||
163190416|NCT01543698|589414134|FG010|Phase 1b|Withdrawal by Subject|0|||
163190417|NCT01543698|589414135|FG011|Phase 1b|Withdrawal by Subject|0|||
163190418|NCT01543698|589414136|FG012|Phase 1b|Withdrawal by Subject|0|||
163190419|NCT01543698|589414137|FG013|Phase 1b|Withdrawal by Subject|0|||
163190420|NCT01543698|589414138|FG014|Phase 1b|Withdrawal by Subject|0|||
163190421|NCT01543698|589414124|FG000|Phase 1b|Adverse Event|1|||
163190422|NCT01543698|589414125|FG001|Phase 1b|Adverse Event|0|||
163190423|NCT01543698|589414126|FG002|Phase 1b|Adverse Event|0|||
163190424|NCT01543698|589414127|FG003|Phase 1b|Adverse Event|1|||
163190425|NCT01543698|589414128|FG004|Phase 1b|Adverse Event|2|||
163190426|NCT01543698|589414129|FG005|Phase 1b|Adverse Event|2|||
163190427|NCT01543698|589414130|FG006|Phase 1b|Adverse Event|0|||
163190428|NCT01543698|589414131|FG007|Phase 1b|Adverse Event|0|||
163190429|NCT01543698|589414132|FG008|Phase 1b|Adverse Event|1|||
163190430|NCT01543698|589414133|FG009|Phase 1b|Adverse Event|1|||
163190431|NCT01543698|589414134|FG010|Phase 1b|Adverse Event|2|||
163190432|NCT01543698|589414135|FG011|Phase 1b|Adverse Event|0|||
163190433|NCT01543698|589414136|FG012|Phase 1b|Adverse Event|0|||
163190434|NCT01543698|589414137|FG013|Phase 1b|Adverse Event|0|||
163190435|NCT01543698|589414138|FG014|Phase 1b|Adverse Event|0|||
163190436|NCT01543698|589414124|FG000|Phase 1b|Administrative problems|1|||
163190437|NCT01543698|589414125|FG001|Phase 1b|Administrative problems|0|||
163391142|NCT02462928|590144633|FG000|Overall Study|Lost to Follow-up|4|||
163391143|NCT02462928|590144634|FG001|Overall Study|Lost to Follow-up|4|||
163391144|NCT02462928|590144635|FG002|Overall Study|Lost to Follow-up|1|||
163391145|NCT02462928|590144633|FG000|Overall Study|Withdrawal by Patient|31|||
163391146|NCT02462928|590144634|FG001|Overall Study|Withdrawal by Patient|21|||
163391147|NCT02462928|590144635|FG002|Overall Study|Withdrawal by Patient|21|||
163391148|NCT02462928|590144633|FG000|Overall Study|Protocol Violation|0|||
163391149|NCT02462928|590144634|FG001|Overall Study|Protocol Violation|1|||
163391150|NCT02462928|590144635|FG002|Overall Study|Protocol Violation|0|||
163391151|NCT02462928|590144633|FG000|Overall Study|Reason not Specified|4|||
163391152|NCT02462928|590144634|FG001|Overall Study|Reason not Specified|6|||
163391153|NCT02462928|590144635|FG002|Overall Study|Reason not Specified|5|||
163391154|NCT00395863|590144636|FG000|Overall Study|Patients did not complete both exams|2|||
163190438|NCT01543698|589414126|FG002|Phase 1b|Administrative problems|0|||
163190439|NCT01543698|589414127|FG003|Phase 1b|Administrative problems|0|||
163190440|NCT01543698|589414128|FG004|Phase 1b|Administrative problems|1|||
163190441|NCT01543698|589414129|FG005|Phase 1b|Administrative problems|0|||
163190442|NCT01543698|589414130|FG006|Phase 1b|Administrative problems|0|||
163190443|NCT01543698|589414131|FG007|Phase 1b|Administrative problems|1|||
163190444|NCT01543698|589414132|FG008|Phase 1b|Administrative problems|0|||
163190445|NCT01543698|589414133|FG009|Phase 1b|Administrative problems|0|||
163190446|NCT01543698|589414134|FG010|Phase 1b|Administrative problems|2|||
163190447|NCT01543698|589414135|FG011|Phase 1b|Administrative problems|0|||
163190448|NCT01543698|589414136|FG012|Phase 1b|Administrative problems|0|||
163190449|NCT01543698|589414137|FG013|Phase 1b|Administrative problems|0|||
163190450|NCT01543698|589414138|FG014|Phase 1b|Administrative problems|0|||
163190451|NCT01543698|589414124|FG000|Phase 1b|Protocol Violation|2|||
163190452|NCT01543698|589414125|FG001|Phase 1b|Protocol Violation|0|||
163190453|NCT01543698|589414126|FG002|Phase 1b|Protocol Violation|0|||
163294926|NCT01040689|589786311|FG001|Overall Study|Lost to Follow-up|0|||
163294927|NCT01040689|589786312|FG002|Overall Study|Lost to Follow-up|0|||
163294928|NCT01040689|589786313|FG003|Overall Study|Lost to Follow-up|0|||
163294929|NCT01040689|589786310|FG000|Overall Study|Withdrawal by Subject|2|||
163294930|NCT01040689|589786311|FG001|Overall Study|Withdrawal by Subject|1|||
163294931|NCT01040689|589786312|FG002|Overall Study|Withdrawal by Subject|1|||
163294932|NCT01040689|589786313|FG003|Overall Study|Withdrawal by Subject|0|||
163294933|NCT01040689|589786310|FG000|Overall Study|Other reasons not listed above|0|||
163294934|NCT01040689|589786311|FG001|Overall Study|Other reasons not listed above|1|||
163294935|NCT01040689|589786312|FG002|Overall Study|Other reasons not listed above|0|||
163294936|NCT01040689|589786313|FG003|Overall Study|Other reasons not listed above|0|||
163294937|NCT04177394|589786318|FG000|Overall Study|Death|16|||
163294938|NCT04177394|589786318|FG000|Overall Study|Withdrawal by Subject|19|||
163294939|NCT04177394|589786318|FG000|Overall Study|Missed visits|61|||
163294940|NCT04177394|589786318|FG000|Overall Study|Expected Visits|15|||
163294941|NCT02115282|589786319|FG000|Overall Study|Disease progression during treatment|216|||
163294942|NCT02115282|589786320|FG001|Overall Study|Disease progression during treatment|229|||
163294943|NCT02115282|589786319|FG000|Overall Study|Adverse Event|49|||
163294944|NCT02115282|589786320|FG001|Overall Study|Adverse Event|23|||
163294945|NCT02115282|589786319|FG000|Overall Study|Death|1|||
163294946|NCT02115282|589786320|FG001|Overall Study|Death|3|||
163294947|NCT02115282|589786319|FG000|Overall Study|Alternative therapy|1|||
163294948|NCT02115282|589786320|FG001|Overall Study|Alternative therapy|1|||
163294949|NCT02115282|589786319|FG000|Overall Study|Complicating disease|0|||
163294950|NCT02115282|589786320|FG001|Overall Study|Complicating disease|3|||
163294951|NCT02115282|589786319|FG000|Overall Study|Withdrawal by Subject|12|||
163294952|NCT02115282|589786320|FG001|Overall Study|Withdrawal by Subject|10|||
163391155|NCT00395863|590144637|FG001|Overall Study|Patients did not complete both exams|3|||
163391156|NCT01940354|590144638|FG000|Overall Study|Withdrawal by Subject|4|||
163391157|NCT01940354|590144639|FG001|Overall Study|Withdrawal by Subject|2|||
163391158|NCT02020863|590144640|FG000|Overall Study|Discovery of Metastatic disease|4|||
163391159|NCT02020863|590144640|FG000|Overall Study|Team chose not to place an a line|1|||
163391160|NCT03873493|590144641|FG000|Overall Study|Withdrawal by Subject|1|||
163391161|NCT03873493|590144641|FG000|Overall Study|Death|9|||
163391162|NCT03873493|590144641|FG000|Overall Study|Lost to Follow-up|1|||
163391163|NCT03873493|590144641|FG000|Overall Study|Study Terminated by Sponsor|1|||
163391164|NCT03873493|590144641|FG000|Overall Study|Other|2|||
163391165|NCT01170039|590144647|FG000|Overall Study|Withdrawal by Subject|5|||
163391166|NCT01170039|590144648|FG001|Overall Study|Withdrawal by Subject|3|||
163391167|NCT01170039|590144647|FG000|Overall Study|Lack of funding, drug not available|3|||
163391168|NCT01170039|590144648|FG001|Overall Study|Lack of funding, drug not available|3|||
163391169|NCT01990534|590144649|FG000|Overall Study|Death|22|||
163391170|NCT01990534|590144649|FG000|Overall Study|Progressive disease|3|||
163391171|NCT01990534|590144649|FG000|Overall Study|Protocol Violation|1|||
163391172|NCT01990534|590144649|FG000|Overall Study|Withdrawal of Informed Consent|2|||
163391173|NCT01990534|590144649|FG000|Overall Study|Symptomatic Deterioration|1|||
163391174|NCT01990534|590144649|FG000|Overall Study|Withdrawal by Subject|3|||
163391175|NCT01990534|590144649|FG000|Overall Study|Reason not Specified|2|||
163391176|NCT01990534|590144649|FG000|Overall Study|Lost to Follow-up|1|||
163391177|NCT01831544|590144650|FG000|Overall Study|Death|1|||
163391178|NCT01831544|590144650|FG000|Overall Study|Still on original MVAD device|2|||
163391179|NCT03308942|590144651|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
163391180|NCT03308942|590144652|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
163391181|NCT03308942|590144653|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
163391182|NCT03308942|590144654|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
163391183|NCT03308942|590144655|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
163391184|NCT03308942|590144651|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
163391185|NCT03308942|590144652|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
163391186|NCT03308942|590144653|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
163391187|NCT03308942|590144654|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
163391188|NCT03308942|590144655|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
163391189|NCT03308942|590144651|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
163391190|NCT03308942|590144652|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
163391191|NCT03308942|590144653|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
163391192|NCT03308942|590144654|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
163190454|NCT01543698|589414127|FG003|Phase 1b|Protocol Violation|0|||
163190455|NCT01543698|589414128|FG004|Phase 1b|Protocol Violation|0|||
163190456|NCT01543698|589414129|FG005|Phase 1b|Protocol Violation|0|||
163190457|NCT01543698|589414130|FG006|Phase 1b|Protocol Violation|0|||
163294953|NCT02115282|589786319|FG000|Overall Study|Symptomatic progression/deterioration|7|||
163294954|NCT02115282|589786320|FG001|Overall Study|Symptomatic progression/deterioration|18|||
163294955|NCT02115282|589786319|FG000|Overall Study|Non-compliance|5|||
163294956|NCT02115282|589786320|FG001|Overall Study|Non-compliance|1|||
163294957|NCT02115282|589786319|FG000|Overall Study|Protocol Violation|2|||
163294958|NCT02115282|589786320|FG001|Overall Study|Protocol Violation|2|||
163294959|NCT02115282|589786319|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
163294960|NCT02115282|589786320|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
163294961|NCT02115282|589786319|FG000|Overall Study|Not start protocol therapy|9|||
163294962|NCT02115282|589786320|FG001|Overall Study|Not start protocol therapy|10|||
163294963|NCT00256243|589786321|FG000|Overall Study|Lost to Follow-up|2|||
163294964|NCT00256243|589786321|FG000|Overall Study|Death|7|||
163043224|NCT00110357|588865758|FG000|Overall Study|Disease progression/relapse|20|||
163043225|NCT00110357|588865759|FG001|Overall Study|Disease progression/relapse|15|||
163190458|NCT01543698|589414131|FG007|Phase 1b|Protocol Violation|0|||
163190459|NCT01543698|589414132|FG008|Phase 1b|Protocol Violation|0|||
163190460|NCT01543698|589414133|FG009|Phase 1b|Protocol Violation|0|||
163190461|NCT01543698|589414134|FG010|Phase 1b|Protocol Violation|0|||
163190462|NCT01543698|589414135|FG011|Phase 1b|Protocol Violation|0|||
163190463|NCT01543698|589414136|FG012|Phase 1b|Protocol Violation|0|||
163190464|NCT01543698|589414137|FG013|Phase 1b|Protocol Violation|0|||
163190465|NCT01543698|589414138|FG014|Phase 1b|Protocol Violation|0|||
163190466|NCT01543698|589414124|FG000|Phase 2|Protocol Violation|0|||
163190467|NCT01543698|589414125|FG001|Phase 2|Protocol Violation|0|||
163391193|NCT03308942|590144655|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
163391194|NCT03308942|590144651|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
163391195|NCT03308942|590144652|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
163391196|NCT03308942|590144653|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
163391197|NCT03308942|590144654|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
163043226|NCT00110357|588865758|FG000|Overall Study|Study Closure|1|||
163391198|NCT03308942|590144655|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
163391199|NCT03308942|590144651|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
163391200|NCT03308942|590144652|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
163391201|NCT03308942|590144653|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
163391202|NCT03308942|590144654|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
163391203|NCT03308942|590144655|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
163391204|NCT03308942|590144651|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
163391205|NCT03308942|590144652|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
163391206|NCT03308942|590144653|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
163043227|NCT00110357|588865759|FG001|Overall Study|Study Closure|0|||
163391207|NCT03308942|590144654|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
163391208|NCT03308942|590144655|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
163190468|NCT01543698|589414126|FG002|Phase 2|Protocol Violation|0|||
163190469|NCT01543698|589414127|FG003|Phase 2|Protocol Violation|0|||
163190470|NCT01543698|589414128|FG004|Phase 2|Protocol Violation|0|||
163190471|NCT01543698|589414129|FG005|Phase 2|Protocol Violation|0|||
163190472|NCT01543698|589414130|FG006|Phase 2|Protocol Violation|0|||
163190473|NCT01543698|589414131|FG007|Phase 2|Protocol Violation|0|||
163190474|NCT01543698|589414132|FG008|Phase 2|Protocol Violation|0|||
163190475|NCT01543698|589414133|FG009|Phase 2|Protocol Violation|0|||
163190476|NCT01543698|589414134|FG010|Phase 2|Protocol Violation|0|||
163190477|NCT01543698|589414135|FG011|Phase 2|Protocol Violation|0|||
163190478|NCT01543698|589414136|FG012|Phase 2|Protocol Violation|1|||
163190479|NCT01543698|589414137|FG013|Phase 2|Protocol Violation|0|||
163190480|NCT01543698|589414138|FG014|Phase 2|Protocol Violation|0|||
163190481|NCT01543698|589414124|FG000|Phase 2|Disease progression|0|||
163190482|NCT01543698|589414125|FG001|Phase 2|Disease progression|0|||
163190483|NCT01543698|589414126|FG002|Phase 2|Disease progression|0|||
163190484|NCT01543698|589414127|FG003|Phase 2|Disease progression|0|||
163190485|NCT01543698|589414128|FG004|Phase 2|Disease progression|0|||
163190486|NCT01543698|589414129|FG005|Phase 2|Disease progression|0|||
163294965|NCT00256243|589786321|FG000|Overall Study|Not treated|1|||
163294966|NCT06129045|589786322|FG000|Overall Study|Lost to Follow-up|1|||
163294967|NCT06129045|589786323|FG001|Overall Study|Lost to Follow-up|1|||
163294968|NCT06129045|589786324|FG002|Overall Study|Lost to Follow-up|4|||
163294969|NCT02031471|589786325|FG000|24 Week Treatment Period|Adverse Event|6|||
163294970|NCT02031471|589786325|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
163294971|NCT02031471|589786325|FG000|24 Week Treatment Period|Protocol Violation|1|||
163294972|NCT02031471|589786325|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
163294973|NCT02031471|589786325|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
163294974|NCT02031471|589786325|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
163294975|NCT02031471|589786325|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
163294976|NCT05797155|589786332|FG000|Overall Study|Lost to Follow-up|33|||
163294977|NCT05797155|589786333|FG001|Overall Study|Lost to Follow-up|12|||
163294978|NCT00617201|589786339|FG000|Overall Study|Lost to Follow-up|9|||
163190487|NCT01543698|589414130|FG006|Phase 2|Disease progression|0|||
163294979|NCT00617201|589786340|FG001|Overall Study|Lost to Follow-up|13|||
163294980|NCT01350804|589786341|FG000|Core Study|Withdrawal by Subject|11|||
163190488|NCT01543698|589414131|FG007|Phase 2|Disease progression|0|||
163190489|NCT01543698|589414132|FG008|Phase 2|Disease progression|0|||
163190490|NCT01543698|589414133|FG009|Phase 2|Disease progression|0|||
163190491|NCT01543698|589414134|FG010|Phase 2|Disease progression|0|||
163190492|NCT01543698|589414135|FG011|Phase 2|Disease progression|10|||
163043228|NCT00110357|588865758|FG000|Overall Study|Study Drug Toxicity|1|||
163190493|NCT01543698|589414136|FG012|Phase 2|Disease progression|21|||
163190494|NCT01543698|589414137|FG013|Phase 2|Disease progression|30|||
163190495|NCT01543698|589414138|FG014|Phase 2|Disease progression|25|||
163190496|NCT01543698|589414124|FG000|Phase 2|Death|0|||
163190497|NCT01543698|589414125|FG001|Phase 2|Death|0|||
163190498|NCT01543698|589414126|FG002|Phase 2|Death|0|||
163190499|NCT01543698|589414127|FG003|Phase 2|Death|0|||
163190500|NCT01543698|589414128|FG004|Phase 2|Death|0|||
163190501|NCT01543698|589414129|FG005|Phase 2|Death|0|||
163190502|NCT01543698|589414130|FG006|Phase 2|Death|0|||
163190503|NCT01543698|589414131|FG007|Phase 2|Death|0|||
163190504|NCT01543698|589414132|FG008|Phase 2|Death|0|||
163190505|NCT01543698|589414133|FG009|Phase 2|Death|0|||
163190506|NCT01543698|589414134|FG010|Phase 2|Death|0|||
163190507|NCT01543698|589414135|FG011|Phase 2|Death|0|||
163190508|NCT01543698|589414136|FG012|Phase 2|Death|1|||
163190509|NCT01543698|589414137|FG013|Phase 2|Death|1|||
163190510|NCT01543698|589414138|FG014|Phase 2|Death|1|||
163190511|NCT01543698|589414124|FG000|Phase 2|Administrative problems|0|||
163190512|NCT01543698|589414125|FG001|Phase 2|Administrative problems|0|||
163190513|NCT01543698|589414126|FG002|Phase 2|Administrative problems|0|||
163190514|NCT01543698|589414127|FG003|Phase 2|Administrative problems|0|||
163190515|NCT01543698|589414128|FG004|Phase 2|Administrative problems|0|||
163190516|NCT01543698|589414129|FG005|Phase 2|Administrative problems|0|||
163190517|NCT01543698|589414130|FG006|Phase 2|Administrative problems|0|||
163190518|NCT01543698|589414131|FG007|Phase 2|Administrative problems|0|||
163190519|NCT01543698|589414132|FG008|Phase 2|Administrative problems|0|||
163190520|NCT01543698|589414133|FG009|Phase 2|Administrative problems|0|||
163190521|NCT01543698|589414134|FG010|Phase 2|Administrative problems|0|||
163190522|NCT01543698|589414135|FG011|Phase 2|Administrative problems|0|||
163190523|NCT01543698|589414136|FG012|Phase 2|Administrative problems|0|||
163190524|NCT01543698|589414137|FG013|Phase 2|Administrative problems|3|||
163190525|NCT01543698|589414138|FG014|Phase 2|Administrative problems|1|||
163190526|NCT01543698|589414124|FG000|Phase 2|Withdrawal by Subject|0|||
163190527|NCT01543698|589414125|FG001|Phase 2|Withdrawal by Subject|0|||
163294981|NCT01350804|589786342|FG001|Core Study|Withdrawal by Subject|17|||
163190528|NCT01543698|589414126|FG002|Phase 2|Withdrawal by Subject|0|||
163190529|NCT01543698|589414127|FG003|Phase 2|Withdrawal by Subject|0|||
163190530|NCT01543698|589414128|FG004|Phase 2|Withdrawal by Subject|0|||
163043229|NCT00110357|588865759|FG001|Overall Study|Study Drug Toxicity|3|||
163190531|NCT01543698|589414129|FG005|Phase 2|Withdrawal by Subject|0|||
163190532|NCT01543698|589414130|FG006|Phase 2|Withdrawal by Subject|0|||
163391209|NCT03308942|590144651|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
163391210|NCT03308942|590144652|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
163391211|NCT03308942|590144653|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
163391212|NCT03308942|590144654|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
163391213|NCT03308942|590144655|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
163391214|NCT01205438|590144658|FG000|Overall Study|Adverse Event|19|||
163391215|NCT01205438|590144659|FG001|Overall Study|Adverse Event|17|||
163391216|NCT01205438|590144660|FG002|Overall Study|Adverse Event|24|||
163391217|NCT01205438|590144658|FG000|Overall Study|Death|1|||
163391218|NCT01205438|590144659|FG001|Overall Study|Death|1|||
163391219|NCT01205438|590144660|FG002|Overall Study|Death|3|||
163391220|NCT01205438|590144658|FG000|Overall Study|Entry Criteria Not Met|16|||
163391221|NCT01205438|590144659|FG001|Overall Study|Entry Criteria Not Met|15|||
163391222|NCT01205438|590144660|FG002|Overall Study|Entry Criteria Not Met|13|||
163391223|NCT01205438|590144658|FG000|Overall Study|Lack of Efficacy|14|||
163391224|NCT01205438|590144659|FG001|Overall Study|Lack of Efficacy|11|||
163391225|NCT01205438|590144660|FG002|Overall Study|Lack of Efficacy|14|||
163391226|NCT01205438|590144658|FG000|Overall Study|Lost to Follow-up|6|||
163391227|NCT01205438|590144659|FG001|Overall Study|Lost to Follow-up|7|||
163391228|NCT01205438|590144660|FG002|Overall Study|Lost to Follow-up|8|||
163391229|NCT01205438|590144658|FG000|Overall Study|Withdrawal by Subject|19|||
163190533|NCT01543698|589414131|FG007|Phase 2|Withdrawal by Subject|0|||
163190534|NCT01543698|589414132|FG008|Phase 2|Withdrawal by Subject|0|||
163190535|NCT01543698|589414133|FG009|Phase 2|Withdrawal by Subject|0|||
163190536|NCT01543698|589414134|FG010|Phase 2|Withdrawal by Subject|0|||
163190537|NCT01543698|589414135|FG011|Phase 2|Withdrawal by Subject|0|||
163190538|NCT01543698|589414136|FG012|Phase 2|Withdrawal by Subject|0|||
163190539|NCT01543698|589414137|FG013|Phase 2|Withdrawal by Subject|3|||
163190540|NCT01543698|589414138|FG014|Phase 2|Withdrawal by Subject|1|||
163190541|NCT01543698|589414124|FG000|Phase 2|Adverse Event|0|||
163190542|NCT01543698|589414125|FG001|Phase 2|Adverse Event|0|||
163190543|NCT01543698|589414126|FG002|Phase 2|Adverse Event|0|||
163190544|NCT01543698|589414127|FG003|Phase 2|Adverse Event|0|||
163190545|NCT01543698|589414128|FG004|Phase 2|Adverse Event|0|||
163190546|NCT01543698|589414129|FG005|Phase 2|Adverse Event|0|||
163190547|NCT01543698|589414130|FG006|Phase 2|Adverse Event|0|||
163190548|NCT01543698|589414131|FG007|Phase 2|Adverse Event|0|||
163190549|NCT01543698|589414132|FG008|Phase 2|Adverse Event|0|||
163190550|NCT01543698|589414133|FG009|Phase 2|Adverse Event|0|||
163190551|NCT01543698|589414134|FG010|Phase 2|Adverse Event|0|||
163190552|NCT01543698|589414135|FG011|Phase 2|Adverse Event|1|||
163190553|NCT01543698|589414136|FG012|Phase 2|Adverse Event|3|||
163190554|NCT01543698|589414137|FG013|Phase 2|Adverse Event|5|||
163190555|NCT01543698|589414138|FG014|Phase 2|Adverse Event|14|||
163190556|NCT00316719|589414139|FG000|Overall Study|Adverse Event|0|||
163294982|NCT01350804|589786343|FG002|Core Study|Withdrawal by Subject|16|||
163294983|NCT01350804|589786344|FG003|Core Study|Withdrawal by Subject|7|||
163294984|NCT01350804|589786341|FG000|Core Study|Study terminated by Sponsor|0|||
163294985|NCT01350804|589786342|FG001|Core Study|Study terminated by Sponsor|0|||
163294986|NCT01350804|589786343|FG002|Core Study|Study terminated by Sponsor|0|||
163294987|NCT01350804|589786344|FG003|Core Study|Study terminated by Sponsor|2|||
163294988|NCT01350804|589786341|FG000|Core Study|Protocol deviation|1|||
163294989|NCT01350804|589786342|FG001|Core Study|Protocol deviation|0|||
163294990|NCT01350804|589786343|FG002|Core Study|Protocol deviation|1|||
163294991|NCT01350804|589786344|FG003|Core Study|Protocol deviation|0|||
163294992|NCT01350804|589786341|FG000|Core Study|Physician Decision|1|||
163190557|NCT00316719|589414140|FG001|Overall Study|Adverse Event|6|||
163190558|NCT00316719|589414139|FG000|Overall Study|Consent withdrawn|2|||
163190559|NCT00316719|589414140|FG001|Overall Study|Consent withdrawn|0|||
163190560|NCT01863953|589414141|FG000|Overall Study|Adverse Event|0|||
163190561|NCT01863953|589414142|FG001|Overall Study|Adverse Event|0|||
163190562|NCT01863953|589414143|FG002|Overall Study|Adverse Event|1|||
163190563|NCT05439941|589414144|FG000|Overall Study|Lack of Efficacy|8|||
163190564|NCT05439941|589414145|FG001|Overall Study|Lack of Efficacy|5|||
163190565|NCT05439941|589414146|FG002|Overall Study|Lack of Efficacy|3|||
163190566|NCT05439941|589414144|FG000|Overall Study|Treatment Failure|0|||
163190567|NCT05439941|589414145|FG001|Overall Study|Treatment Failure|1|||
163190568|NCT05439941|589414146|FG002|Overall Study|Treatment Failure|0|||
163190569|NCT05439941|589414144|FG000|Overall Study|Adverse Event|1|||
163190570|NCT05439941|589414145|FG001|Overall Study|Adverse Event|3|||
163190571|NCT05439941|589414146|FG002|Overall Study|Adverse Event|0|||
163190572|NCT05439941|589414144|FG000|Overall Study|Adverse Event - Parent Study|1|||
163190573|NCT05439941|589414145|FG001|Overall Study|Adverse Event - Parent Study|0|||
163190574|NCT05439941|589414146|FG002|Overall Study|Adverse Event - Parent Study|0|||
163190575|NCT05439941|589414144|FG000|Overall Study|Pregnancy|1|||
163190576|NCT05439941|589414145|FG001|Overall Study|Pregnancy|0|||
163190577|NCT05439941|589414146|FG002|Overall Study|Pregnancy|0|||
163190578|NCT05439941|589414144|FG000|Overall Study|Withdrawal by Subject|9|||
163190579|NCT05439941|589414145|FG001|Overall Study|Withdrawal by Subject|6|||
163190580|NCT05439941|589414146|FG002|Overall Study|Withdrawal by Subject|10|||
163190581|NCT05439941|589414144|FG000|Overall Study|Non-Compliance|1|||
163190582|NCT05439941|589414145|FG001|Overall Study|Non-Compliance|1|||
163190583|NCT05439941|589414146|FG002|Overall Study|Non-Compliance|1|||
163190584|NCT05439941|589414144|FG000|Overall Study|Lost to Follow-up|2|||
163190585|NCT05439941|589414145|FG001|Overall Study|Lost to Follow-up|2|||
163190586|NCT05439941|589414146|FG002|Overall Study|Lost to Follow-up|0|||
163190587|NCT05439941|589414144|FG000|Overall Study|Physician Decision|1|||
163190588|NCT05439941|589414145|FG001|Overall Study|Physician Decision|0|||
163190589|NCT05439941|589414146|FG002|Overall Study|Physician Decision|0|||
163190590|NCT05439941|589414144|FG000|Overall Study|Trial Termination by Sponsor|78|||
163190591|NCT05439941|589414145|FG001|Overall Study|Trial Termination by Sponsor|83|||
163190592|NCT05439941|589414146|FG002|Overall Study|Trial Termination by Sponsor|65|||
163190593|NCT05439941|589414144|FG000|Overall Study|Other than Reasons Listed|2|||
163190594|NCT05439941|589414145|FG001|Overall Study|Other than Reasons Listed|1|||
163190595|NCT05439941|589414146|FG002|Overall Study|Other than Reasons Listed|0|||
163190596|NCT00573183|589414147|FG000|Overall Study|Lost to Follow-up|52|||
163190597|NCT00573183|589414148|FG001|Overall Study|Lost to Follow-up|50|||
163190598|NCT00573183|589414147|FG000|Overall Study|Withdrawal by Subject|8|||
163190599|NCT00573183|589414148|FG001|Overall Study|Withdrawal by Subject|2|||
163190600|NCT00573183|589414147|FG000|Overall Study|Death|0|||
163190601|NCT00573183|589414148|FG001|Overall Study|Death|1|||
163190602|NCT00573183|589414147|FG000|Overall Study|Adverse Event|2|||
163190603|NCT00573183|589414148|FG001|Overall Study|Adverse Event|0|||
163190604|NCT00573183|589414147|FG000|Overall Study|Incarceration|5|||
163190605|NCT00573183|589414148|FG001|Overall Study|Incarceration|8|||
163190606|NCT00573183|589414147|FG000|Overall Study|Other|5|||
163190607|NCT00573183|589414148|FG001|Overall Study|Other|2|||
163190608|NCT02336373|589414151|FG000|Overall Study|Protocol closed early|4|||
163190609|NCT02336373|589414151|FG000|Overall Study|Physician Decision|14|||
163190610|NCT04798781|589414154|FG000|Overall Study|Withdrawal by Subject|1|||
163190611|NCT00615108|589414157|FG000|Overall Study|Adverse Event|122|||
163190612|NCT00615108|589414157|FG000|Overall Study|Other|370|||
163190613|NCT00615108|589414157|FG000|Overall Study|Lost to Follow-up|15|||
163190614|NCT02024529|589414158|FG000|Overall Study|Withdrawal by Subject|11|||
163190615|NCT02024529|589414159|FG001|Overall Study|Withdrawal by Subject|21|||
163190616|NCT02024529|589414158|FG000|Overall Study|Lost to Follow-up|2|||
163190617|NCT02024529|589414159|FG001|Overall Study|Lost to Follow-up|4|||
163190618|NCT00676338|589414160|FG000|Overall Study|Adverse Event|6|||
163190619|NCT00676338|589414161|FG001|Overall Study|Adverse Event|6|||
163190620|NCT00676338|589414162|FG002|Overall Study|Adverse Event|5|||
163190621|NCT00676338|589414163|FG003|Overall Study|Adverse Event|1|||
163190622|NCT00676338|589414160|FG000|Overall Study|Lost to Follow-up|4|||
163190623|NCT00676338|589414161|FG001|Overall Study|Lost to Follow-up|1|||
163190624|NCT00676338|589414162|FG002|Overall Study|Lost to Follow-up|3|||
163190625|NCT00676338|589414163|FG003|Overall Study|Lost to Follow-up|4|||
163190626|NCT00676338|589414160|FG000|Overall Study|Physician Decision|3|||
163190627|NCT00676338|589414161|FG001|Overall Study|Physician Decision|3|||
163190628|NCT00676338|589414162|FG002|Overall Study|Physician Decision|2|||
163190629|NCT00676338|589414163|FG003|Overall Study|Physician Decision|3|||
163190630|NCT00676338|589414160|FG000|Overall Study|Protocol Violation|5|||
163190631|NCT00676338|589414161|FG001|Overall Study|Protocol Violation|9|||
163190632|NCT00676338|589414162|FG002|Overall Study|Protocol Violation|2|||
163190633|NCT00676338|589414163|FG003|Overall Study|Protocol Violation|5|||
163190634|NCT00676338|589414160|FG000|Overall Study|Withdrawal by Subject|17|||
163294993|NCT01350804|589786342|FG001|Core Study|Physician Decision|0|||
163190635|NCT00676338|589414161|FG001|Overall Study|Withdrawal by Subject|9|||
163190636|NCT00676338|589414162|FG002|Overall Study|Withdrawal by Subject|12|||
163294994|NCT01350804|589786343|FG002|Core Study|Physician Decision|1|||
162952078|NCT00909610|588529533|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
163294995|NCT01350804|589786344|FG003|Core Study|Physician Decision|3|||
163294996|NCT01350804|589786341|FG000|Core Study|Lost to Follow-up|3|||
163294997|NCT01350804|589786342|FG001|Core Study|Lost to Follow-up|0|||
163294998|NCT01350804|589786343|FG002|Core Study|Lost to Follow-up|2|||
163294999|NCT01350804|589786344|FG003|Core Study|Lost to Follow-up|1|||
163295000|NCT01350804|589786341|FG000|Core Study|Lack of Efficacy|16|||
163295001|NCT01350804|589786342|FG001|Core Study|Lack of Efficacy|19|||
163295002|NCT01350804|589786343|FG002|Core Study|Lack of Efficacy|18|||
163295003|NCT01350804|589786344|FG003|Core Study|Lack of Efficacy|5|||
163295004|NCT01350804|589786341|FG000|Core Study|Death|1|||
163295005|NCT01350804|589786342|FG001|Core Study|Death|1|||
163295006|NCT01350804|589786343|FG002|Core Study|Death|1|||
163295007|NCT01350804|589786344|FG003|Core Study|Death|0|||
163295008|NCT01350804|589786341|FG000|Core Study|Adverse Event|8|||
163391230|NCT01205438|590144659|FG001|Overall Study|Withdrawal by Subject|25|||
163391231|NCT01205438|590144660|FG002|Overall Study|Withdrawal by Subject|19|||
163391232|NCT01205438|590144658|FG000|Overall Study|Physician Decision|0|||
163391233|NCT01205438|590144659|FG001|Overall Study|Physician Decision|3|||
163391234|NCT01205438|590144660|FG002|Overall Study|Physician Decision|2|||
163391235|NCT01205438|590144658|FG000|Overall Study|Protocol Violation|2|||
163391236|NCT01205438|590144659|FG001|Overall Study|Protocol Violation|7|||
163391237|NCT01205438|590144660|FG002|Overall Study|Protocol Violation|4|||
163391238|NCT01205438|590144658|FG000|Overall Study|Sponsor Decision|0|||
163391239|NCT01205438|590144659|FG001|Overall Study|Sponsor Decision|1|||
163391240|NCT01205438|590144660|FG002|Overall Study|Sponsor Decision|1|||
163391241|NCT00733304|590144664|FG000|Overall Study|Adverse Event|3|||
163190637|NCT00676338|589414163|FG003|Overall Study|Withdrawal by Subject|6|||
163190638|NCT00676338|589414160|FG000|Overall Study|Entry Criteria Not Met|0|||
163391242|NCT00733304|590144665|FG001|Overall Study|Adverse Event|0|||
163391243|NCT00733304|590144666|FG002|Overall Study|Adverse Event|0|||
163190639|NCT00676338|589414161|FG001|Overall Study|Entry Criteria Not Met|2|||
163190640|NCT00676338|589414162|FG002|Overall Study|Entry Criteria Not Met|1|||
163190641|NCT00676338|589414163|FG003|Overall Study|Entry Criteria Not Met|1|||
163190642|NCT00676338|589414160|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
163190643|NCT00676338|589414161|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
163190644|NCT00676338|589414162|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
163190645|NCT00676338|589414163|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
163190646|NCT02122458|589414164|FG000|Overall Study|Withdrawal by Subject|0|||
163190647|NCT02122458|589414165|FG001|Overall Study|Withdrawal by Subject|0|||
163190648|NCT02122458|589414166|FG002|Overall Study|Withdrawal by Subject|0|||
163190649|NCT02122458|589414167|FG003|Overall Study|Withdrawal by Subject|4|||
163190650|NCT02122458|589414168|FG004|Overall Study|Withdrawal by Subject|4|||
163190651|NCT02122458|589414169|FG005|Overall Study|Withdrawal by Subject|4|||
163190652|NCT02122458|589414170|FG006|Overall Study|Withdrawal by Subject|0|||
163190653|NCT02122458|589414164|FG000|Overall Study|Lost to Follow-up|1|||
163190654|NCT02122458|589414165|FG001|Overall Study|Lost to Follow-up|3|||
163190655|NCT02122458|589414166|FG002|Overall Study|Lost to Follow-up|0|||
163190656|NCT02122458|589414167|FG003|Overall Study|Lost to Follow-up|7|||
163190657|NCT02122458|589414168|FG004|Overall Study|Lost to Follow-up|5|||
163190658|NCT02122458|589414169|FG005|Overall Study|Lost to Follow-up|15|||
163190659|NCT02122458|589414170|FG006|Overall Study|Lost to Follow-up|1|||
163190660|NCT02122458|589414164|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
163190661|NCT02122458|589414165|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
163190662|NCT02122458|589414166|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
163190663|NCT02122458|589414167|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
163190664|NCT02122458|589414168|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
163190665|NCT02122458|589414169|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
163190666|NCT02122458|589414170|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
163190667|NCT02122458|589414164|FG000|Overall Study|Adverse Event|1|||
163190668|NCT02122458|589414165|FG001|Overall Study|Adverse Event|0|||
163190669|NCT02122458|589414166|FG002|Overall Study|Adverse Event|0|||
163190670|NCT02122458|589414167|FG003|Overall Study|Adverse Event|0|||
163190671|NCT02122458|589414168|FG004|Overall Study|Adverse Event|0|||
163190672|NCT02122458|589414169|FG005|Overall Study|Adverse Event|0|||
163190673|NCT02122458|589414170|FG006|Overall Study|Adverse Event|0|||
163190674|NCT02122458|589414164|FG000|Overall Study|Experimental Error|0|||
163190675|NCT02122458|589414165|FG001|Overall Study|Experimental Error|0|||
163190676|NCT02122458|589414166|FG002|Overall Study|Experimental Error|0|||
163190677|NCT02122458|589414167|FG003|Overall Study|Experimental Error|0|||
163190678|NCT02122458|589414168|FG004|Overall Study|Experimental Error|3|||
163190679|NCT02122458|589414169|FG005|Overall Study|Experimental Error|0|||
163190680|NCT02122458|589414170|FG006|Overall Study|Experimental Error|0|||
163190681|NCT02122458|589414164|FG000|Overall Study|Deployed or Moved|0|||
163190682|NCT02122458|589414165|FG001|Overall Study|Deployed or Moved|0|||
163190683|NCT02122458|589414166|FG002|Overall Study|Deployed or Moved|0|||
163190684|NCT02122458|589414167|FG003|Overall Study|Deployed or Moved|0|||
163190685|NCT02122458|589414168|FG004|Overall Study|Deployed or Moved|1|||
163190686|NCT02122458|589414169|FG005|Overall Study|Deployed or Moved|0|||
163391244|NCT00733304|590144664|FG000|Overall Study|Lack of Efficacy|0|||
163391245|NCT00733304|590144665|FG001|Overall Study|Lack of Efficacy|0|||
163391246|NCT00733304|590144666|FG002|Overall Study|Lack of Efficacy|2|||
163190687|NCT02122458|589414170|FG006|Overall Study|Deployed or Moved|0|||
163190688|NCT02122458|589414164|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
163190689|NCT02122458|589414165|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
163190690|NCT02122458|589414166|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
163391247|NCT00733304|590144664|FG000|Overall Study|Lost to Follow-up|0|||
163391248|NCT00733304|590144665|FG001|Overall Study|Lost to Follow-up|1|||
163190691|NCT02122458|589414167|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
163190692|NCT02122458|589414168|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
163391249|NCT00733304|590144666|FG002|Overall Study|Lost to Follow-up|0|||
163391250|NCT00733304|590144664|FG000|Overall Study|Physician Decision|3|||
163391251|NCT00733304|590144665|FG001|Overall Study|Physician Decision|1|||
163391252|NCT00733304|590144666|FG002|Overall Study|Physician Decision|3|||
163391253|NCT00733304|590144664|FG000|Overall Study|Withdrawal by Subject|1|||
163391254|NCT00733304|590144665|FG001|Overall Study|Withdrawal by Subject|1|||
163391255|NCT00733304|590144666|FG002|Overall Study|Withdrawal by Subject|0|||
163391256|NCT00528567|590144667|FG000|Overall Study|Death|4|||
163391257|NCT00528567|590144668|FG001|Overall Study|Death|5|||
163391258|NCT00528567|590144667|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
163391259|NCT00528567|590144668|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
163391260|NCT00528567|590144667|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
163391261|NCT00528567|590144668|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
163391262|NCT00528567|590144667|FG000|Overall Study|Violation Criteria at Entry|3|||
163391263|NCT00528567|590144668|FG001|Overall Study|Violation Criteria at Entry|17|||
163391264|NCT00528567|590144667|FG000|Overall Study|Withdrew Consent|59|||
163391265|NCT00528567|590144668|FG001|Overall Study|Withdrew Consent|55|||
163391266|NCT00528567|590144667|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
163391267|NCT00528567|590144668|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
163391268|NCT00528567|590144667|FG000|Overall Study|Failure to Return|1|||
163391269|NCT00528567|590144668|FG001|Overall Study|Failure to Return|4|||
163391270|NCT00528567|590144667|FG000|Overall Study|Other Protocol Violation|5|||
163391271|NCT00528567|590144668|FG001|Overall Study|Other Protocol Violation|21|||
163391272|NCT00528567|590144667|FG000|Overall Study|Administrative/Other|22|||
163391273|NCT00528567|590144668|FG001|Overall Study|Administrative/Other|75|||
163391274|NCT01122576|590144671|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
163391275|NCT01122576|590144672|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
163391276|NCT01122576|590144673|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
163043230|NCT00110357|588865758|FG000|Overall Study|Withdrawal by Subject|3|||
163190693|NCT02122458|589414169|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
163190694|NCT02122458|589414170|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
163190695|NCT02122458|589414164|FG000|Overall Study|Noncompliance|0|||
163190696|NCT02122458|589414165|FG001|Overall Study|Noncompliance|1|||
163190697|NCT02122458|589414166|FG002|Overall Study|Noncompliance|0|||
163190698|NCT02122458|589414167|FG003|Overall Study|Noncompliance|0|||
163190699|NCT02122458|589414168|FG004|Overall Study|Noncompliance|0|||
163190700|NCT02122458|589414169|FG005|Overall Study|Noncompliance|0|||
163190701|NCT02122458|589414170|FG006|Overall Study|Noncompliance|0|||
163190702|NCT00412542|589414171|FG000|Overall Study|Withdrawal by Subject|0|||
163190703|NCT00412542|589414172|FG001|Overall Study|Withdrawal by Subject|2|||
163190704|NCT00412542|589414171|FG000|Overall Study|Not Eligible|0|||
163190705|NCT00412542|589414172|FG001|Overall Study|Not Eligible|1|||
163190706|NCT02833350|589414173|FG000|Overall Study|Adverse Event|0|||
163190707|NCT02833350|589414174|FG001|Overall Study|Adverse Event|3|||
163190708|NCT02833350|589414175|FG002|Overall Study|Adverse Event|4|||
163190709|NCT02833350|589414176|FG003|Overall Study|Adverse Event|4|||
163190710|NCT02833350|589414177|FG004|Overall Study|Adverse Event|1|||
163190711|NCT02833350|589414178|FG005|Overall Study|Adverse Event|0|||
163190712|NCT02833350|589414179|FG006|Overall Study|Adverse Event|1|||
163190713|NCT02833350|589414173|FG000|Overall Study|Death|0|||
163190714|NCT02833350|589414174|FG001|Overall Study|Death|0|||
163190715|NCT02833350|589414175|FG002|Overall Study|Death|1|||
163190716|NCT02833350|589414176|FG003|Overall Study|Death|0|||
163190717|NCT02833350|589414177|FG004|Overall Study|Death|0|||
163190718|NCT02833350|589414178|FG005|Overall Study|Death|0|||
162952079|NCT00909610|588529532|FG000|Period: Second Intervention|Adverse Event|1|||
163295009|NCT01350804|589786342|FG001|Core Study|Adverse Event|10|||
163295010|NCT01350804|589786343|FG002|Core Study|Adverse Event|8|||
163295011|NCT01350804|589786344|FG003|Core Study|Adverse Event|8|||
163295012|NCT01350804|589786341|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
163295013|NCT01350804|589786342|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
163295014|NCT01350804|589786343|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
163295015|NCT01350804|589786344|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
163295016|NCT01350804|589786341|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
163295017|NCT01350804|589786342|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
163295018|NCT01350804|589786343|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
163295019|NCT01350804|589786344|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
163190719|NCT02833350|589414179|FG006|Overall Study|Death|0|||
163190720|NCT02833350|589414173|FG000|Overall Study|Lack of Efficacy|0|||
163190721|NCT02833350|589414174|FG001|Overall Study|Lack of Efficacy|2|||
163391277|NCT01122576|590144671|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
163391278|NCT01122576|590144672|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
163190722|NCT02833350|589414175|FG002|Overall Study|Lack of Efficacy|1|||
163190723|NCT02833350|589414176|FG003|Overall Study|Lack of Efficacy|4|||
163190724|NCT02833350|589414177|FG004|Overall Study|Lack of Efficacy|0|||
163190725|NCT02833350|589414178|FG005|Overall Study|Lack of Efficacy|1|||
163190726|NCT02833350|589414179|FG006|Overall Study|Lack of Efficacy|1|||
163190727|NCT02833350|589414173|FG000|Overall Study|Lost to Follow-up|0|||
163190728|NCT02833350|589414174|FG001|Overall Study|Lost to Follow-up|1|||
163190729|NCT02833350|589414175|FG002|Overall Study|Lost to Follow-up|0|||
163190730|NCT02833350|589414176|FG003|Overall Study|Lost to Follow-up|0|||
163391279|NCT01122576|590144673|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
163391280|NCT01122576|590144671|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
163391281|NCT01122576|590144672|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
163391282|NCT01122576|590144673|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
163190731|NCT02833350|589414177|FG004|Overall Study|Lost to Follow-up|0|||
163190732|NCT02833350|589414178|FG005|Overall Study|Lost to Follow-up|0|||
163190733|NCT02833350|589414179|FG006|Overall Study|Lost to Follow-up|1|||
163391283|NCT05696236|590144674|FG000|Overall Study|Lost to Follow-up|1|||
163190734|NCT02833350|589414173|FG000|Overall Study|Withdrawal by Subject|3|||
163190735|NCT02833350|589414174|FG001|Overall Study|Withdrawal by Subject|3|||
163190736|NCT02833350|589414175|FG002|Overall Study|Withdrawal by Subject|2|||
163391284|NCT05696236|590144675|FG001|Overall Study|Lost to Follow-up|0|||
163295020|NCT01350804|589786341|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
163295021|NCT01350804|589786342|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
163295022|NCT01350804|589786343|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
163295023|NCT01350804|589786344|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
163295024|NCT01350804|589786341|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
163295025|NCT01350804|589786342|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
163295026|NCT01350804|589786343|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
163295027|NCT01350804|589786344|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
163295028|NCT01350804|589786341|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
163295029|NCT01350804|589786342|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
163295030|NCT01350804|589786343|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
163295031|NCT01350804|589786344|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
163295032|NCT01350804|589786341|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
163295033|NCT01350804|589786342|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
163295034|NCT01350804|589786343|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
163295035|NCT01350804|589786344|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
163295036|NCT05850520|589786347|FG000|Overall Study|Withdrawal by Subject|8|||
163295037|NCT05850520|589786348|FG001|Overall Study|Withdrawal by Subject|8|||
163295038|NCT05850520|589786349|FG002|Overall Study|Withdrawal by Subject|16|||
163295039|NCT05850520|589786347|FG000|Overall Study|Lost to Follow-up|2|||
163295040|NCT05850520|589786348|FG001|Overall Study|Lost to Follow-up|2|||
163295041|NCT05850520|589786349|FG002|Overall Study|Lost to Follow-up|2|||
163295042|NCT05850520|589786347|FG000|Overall Study|Death|2|||
163295043|NCT05850520|589786348|FG001|Overall Study|Death|2|||
163295044|NCT05850520|589786349|FG002|Overall Study|Death|3|||
163295045|NCT05850520|589786347|FG000|Overall Study|Adverse Event|2|||
163295046|NCT05850520|589786348|FG001|Overall Study|Adverse Event|0|||
163295047|NCT05850520|589786349|FG002|Overall Study|Adverse Event|1|||
163295048|NCT05850520|589786347|FG000|Overall Study|Physician Decision|0|||
163295049|NCT05850520|589786348|FG001|Overall Study|Physician Decision|1|||
163295050|NCT05850520|589786349|FG002|Overall Study|Physician Decision|0|||
163295051|NCT05850520|589786347|FG000|Overall Study|Protocol deviation|0|||
163295052|NCT05850520|589786348|FG001|Overall Study|Protocol deviation|0|||
163295053|NCT05850520|589786349|FG002|Overall Study|Protocol deviation|1|||
163295054|NCT05850520|589786347|FG000|Overall Study|No information was available on whether follow-up was completed or not|0|||
163295055|NCT05850520|589786348|FG001|Overall Study|No information was available on whether follow-up was completed or not|2|||
163295056|NCT05850520|589786349|FG002|Overall Study|No information was available on whether follow-up was completed or not|2|||
163295057|NCT01170026|589787108|FG000|Overall Study|Lost to Follow-up|4|||
163295058|NCT01170026|589787109|FG001|Overall Study|Lost to Follow-up|2|||
163295059|NCT03889925|589787110|FG000|Overall Study|Lost to Follow-up|11|||
163295060|NCT03889925|589787111|FG001|Overall Study|Lost to Follow-up|10|||
163295061|NCT05777785|589787112|FG000|Overall Study|Withdrawal by Subject|5|||
163295062|NCT05777785|589787112|FG000|Overall Study|Lost to Follow-up|1|||
163295063|NCT00304031|589787113|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
163295064|NCT00304031|589787114|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
163295065|NCT00304031|589787115|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
163295066|NCT00304031|589787113|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
163295067|NCT00304031|589787114|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
163295068|NCT00304031|589787115|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
163190737|NCT02833350|589414176|FG003|Overall Study|Withdrawal by Subject|0|||
163190738|NCT02833350|589414177|FG004|Overall Study|Withdrawal by Subject|2|||
163190739|NCT02833350|589414178|FG005|Overall Study|Withdrawal by Subject|0|||
163190740|NCT02833350|589414179|FG006|Overall Study|Withdrawal by Subject|2|||
163190741|NCT00075218|589414180|FG000|Double-Blind Treatment|Adverse Event|23|||
163190742|NCT00075218|589414181|FG001|Double-Blind Treatment|Adverse Event|4|||
163190743|NCT00075218|589414182|FG002|Double-Blind Treatment|Adverse Event|0|||
163190744|NCT00075218|589414180|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
163190745|NCT00075218|589414181|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
163190746|NCT00075218|589414182|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
163190747|NCT00075218|589414180|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
163190748|NCT00075218|589414181|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
163190749|NCT00075218|589414182|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
163190750|NCT00075218|589414180|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
163190751|NCT00075218|589414181|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
163190752|NCT00075218|589414182|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
163190753|NCT00075218|589414180|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
163190754|NCT00075218|589414181|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
163190755|NCT00075218|589414182|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
163190756|NCT00075218|589414180|FG000|Double-Blind Treatment|No study medication taken|2|||
163190757|NCT00075218|589414181|FG001|Double-Blind Treatment|No study medication taken|0|||
163190758|NCT00075218|589414182|FG002|Double-Blind Treatment|No study medication taken|0|||
163190759|NCT00075218|589414180|FG000|Open-Label Treatment|Lack of Efficacy|0|||
163190760|NCT00075218|589414181|FG001|Open-Label Treatment|Lack of Efficacy|0|||
163190761|NCT00075218|589414182|FG002|Open-Label Treatment|Lack of Efficacy|174|||
163190762|NCT00075218|589414180|FG000|Open-Label Treatment|Adverse Event|0|||
163190763|NCT00075218|589414181|FG001|Open-Label Treatment|Adverse Event|0|||
163190764|NCT00075218|589414182|FG002|Open-Label Treatment|Adverse Event|51|||
163190765|NCT00075218|589414180|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
163190766|NCT00075218|589414181|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
163190767|NCT00075218|589414182|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
163190768|NCT00075218|589414180|FG000|Open-Label Treatment|Decision of Sponsor|0|||
163190769|NCT00075218|589414181|FG001|Open-Label Treatment|Decision of Sponsor|0|||
163190770|NCT00075218|589414182|FG002|Open-Label Treatment|Decision of Sponsor|8|||
163190771|NCT00075218|589414180|FG000|Open-Label Treatment|Protocol Violation|0|||
163190772|NCT00075218|589414181|FG001|Open-Label Treatment|Protocol Violation|0|||
163190773|NCT00075218|589414182|FG002|Open-Label Treatment|Protocol Violation|1|||
163190774|NCT00075218|589414180|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
163190775|NCT00075218|589414181|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
163190776|NCT00075218|589414182|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
163190777|NCT03643575|589414183|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
163190778|NCT03643575|589414184|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
163190779|NCT03643575|589414185|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
163190780|NCT03643575|589414186|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
163190781|NCT03643575|589414187|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
163190782|NCT03643575|589414188|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
163190783|NCT03643575|589414183|FG000|Washout: 7 Days|Adverse Event|1|||
163190784|NCT03643575|589414184|FG001|Washout: 7 Days|Adverse Event|0|||
163190785|NCT03643575|589414185|FG002|Washout: 7 Days|Adverse Event|0|||
163190786|NCT03643575|589414186|FG003|Washout: 7 Days|Adverse Event|0|||
163190787|NCT03643575|589414187|FG004|Washout: 7 Days|Adverse Event|0|||
163190788|NCT03643575|589414188|FG005|Washout: 7 Days|Adverse Event|0|||
163190789|NCT03643575|589414183|FG000|Washout: 7 Days|Non compliance check in|0|||
163190790|NCT03643575|589414184|FG001|Washout: 7 Days|Non compliance check in|1|||
163190791|NCT03643575|589414185|FG002|Washout: 7 Days|Non compliance check in|0|||
163190792|NCT03643575|589414186|FG003|Washout: 7 Days|Non compliance check in|0|||
163190793|NCT03643575|589414187|FG004|Washout: 7 Days|Non compliance check in|0|||
163190794|NCT03643575|589414188|FG005|Washout: 7 Days|Non compliance check in|0|||
163190795|NCT00131508|589414189|FG000|Overall Study|Disease progression|0|||
163190796|NCT00131508|589414190|FG001|Overall Study|Disease progression|2|||
163190797|NCT00131508|589414189|FG000|Overall Study|Non-Compliance|2|||
163190798|NCT00131508|589414190|FG001|Overall Study|Non-Compliance|4|||
163190799|NCT00131508|589414189|FG000|Overall Study|Withdrawal by Subject|1|||
163190800|NCT00131508|589414190|FG001|Overall Study|Withdrawal by Subject|2|||
163391285|NCT05696236|590144674|FG000|Overall Study|Later determined to not be eligible for participation|0|||
163391286|NCT05696236|590144675|FG001|Overall Study|Later determined to not be eligible for participation|1|||
163391287|NCT05696236|590144674|FG000|Overall Study|Withdrawal by Subject|2|||
163391288|NCT05696236|590144675|FG001|Overall Study|Withdrawal by Subject|2|||
163391289|NCT01829360|590144678|FG000|Overall Study|Protocol Violation|0|||
163391290|NCT01829360|590144679|FG001|Overall Study|Protocol Violation|0|||
163391291|NCT01829360|590144680|FG002|Overall Study|Protocol Violation|1|||
163391292|NCT01829360|590144681|FG003|Overall Study|Protocol Violation|0|||
163391293|NCT01026142|590144682|FG000|Overall Study|Death|136|||
163391294|NCT01026142|590144683|FG001|Overall Study|Death|134|||
163391295|NCT01026142|590144682|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
163391296|NCT01026142|590144683|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
163391297|NCT02545322|590144684|FG000|Overall Study|Withdrawal by Subject|3|||
163391298|NCT00041067|590144685|FG000|Overall Study|Adverse Event|20|||
163391299|NCT00041067|590144685|FG000|Overall Study|Progression|19|||
163391300|NCT00041067|590144685|FG000|Overall Study|Patient refusal|12|||
163391301|NCT00041067|590144685|FG000|Overall Study|Other reasons|23|||
163391302|NCT00041067|590144685|FG000|Overall Study|Ineligible|2|||
163391303|NCT01395316|590144690|FG000|Overall Study|Lost to Follow-up|2|||
163391304|NCT01395316|590144690|FG000|Overall Study|poor MRI quality|1|||
163391305|NCT00688181|590144691|FG000|Overall Study|Lost to Follow-up|17|||
163391306|NCT00688181|590144691|FG000|Overall Study|Unknown Reason|4|||
163391307|NCT00688181|590144691|FG000|Overall Study|Non-clinical Reason|2|||
163391308|NCT01891721|590144692|FG000|Overall Study|Lost to Follow-up|10|||
163391309|NCT01891721|590144693|FG001|Overall Study|Lost to Follow-up|5|||
163391310|NCT01891721|590144694|FG002|Overall Study|Lost to Follow-up|1|||
163391311|NCT02846532|590144695|FG000|Overall Study|Lost to Follow-up|0|||
163391312|NCT02846532|590144696|FG001|Overall Study|Lost to Follow-up|1|||
163391313|NCT02846532|590144697|FG002|Overall Study|Lost to Follow-up|1|||
163391314|NCT02846532|590144695|FG000|Overall Study|Withdrawal by Subject|1|||
163391315|NCT02846532|590144696|FG001|Overall Study|Withdrawal by Subject|2|||
163391316|NCT02846532|590144697|FG002|Overall Study|Withdrawal by Subject|0|||
163391317|NCT04908189|590144699|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
163391318|NCT04908189|590144700|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
163391319|NCT04908189|590144701|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
163391320|NCT04908189|590144699|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
163391321|NCT04908189|590144700|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
163391322|NCT04908189|590144701|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
163391323|NCT04908189|590144699|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
163391324|NCT04908189|590144700|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
163391325|NCT04908189|590144701|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
163295069|NCT00304031|589787113|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
163295070|NCT00304031|589787114|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
163295071|NCT00304031|589787115|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
163295072|NCT00304031|589787113|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
163295073|NCT00304031|589787114|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
163295074|NCT00304031|589787115|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
163295075|NCT00304031|589787113|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
163295076|NCT00304031|589787114|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
163295077|NCT00304031|589787115|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
163295078|NCT00304031|589787113|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
163295079|NCT00304031|589787114|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
163295080|NCT00304031|589787115|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
163295081|NCT00304031|589787113|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
163295082|NCT00304031|589787114|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
163295083|NCT00304031|589787115|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
163295084|NCT00304031|589787113|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
163295085|NCT00304031|589787114|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
163295086|NCT00304031|589787115|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
163295087|NCT00304031|589787113|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
163295088|NCT00304031|589787114|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
163295089|NCT00304031|589787115|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
163295090|NCT00089544|589787116|FG000|Overall Study|Ineligible|1|||
163295091|NCT00089544|589787117|FG001|Overall Study|Ineligible|0|||
163295092|NCT01823536|589787118|FG000|Overall Study|Lost to Follow-up|1|||
163295093|NCT01823536|589787119|FG001|Overall Study|Lost to Follow-up|0|||
163295094|NCT01823536|589787120|FG002|Overall Study|Lost to Follow-up|0|||
163295095|NCT01823536|589787121|FG003|Overall Study|Lost to Follow-up|1|||
163295096|NCT01823536|589787122|FG004|Overall Study|Lost to Follow-up|1|||
163295097|NCT01823536|589787123|FG005|Overall Study|Lost to Follow-up|0|||
163295098|NCT01823536|589787118|FG000|Overall Study|Protocol Violation|0|||
163295099|NCT01823536|589787119|FG001|Overall Study|Protocol Violation|1|||
163295100|NCT01823536|589787120|FG002|Overall Study|Protocol Violation|0|||
163295101|NCT01823536|589787121|FG003|Overall Study|Protocol Violation|0|||
163295102|NCT01823536|589787122|FG004|Overall Study|Protocol Violation|0|||
163295103|NCT01823536|589787123|FG005|Overall Study|Protocol Violation|0|||
163295104|NCT01823536|589787118|FG000|Overall Study|Withdrawal by Subject|1|||
163295105|NCT01823536|589787119|FG001|Overall Study|Withdrawal by Subject|1|||
163295106|NCT01823536|589787120|FG002|Overall Study|Withdrawal by Subject|0|||
163295107|NCT01823536|589787121|FG003|Overall Study|Withdrawal by Subject|0|||
163295108|NCT01823536|589787122|FG004|Overall Study|Withdrawal by Subject|0|||
163295109|NCT01823536|589787123|FG005|Overall Study|Withdrawal by Subject|0|||
163295110|NCT01823536|589787118|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
163295111|NCT01823536|589787119|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
163391326|NCT04908189|590144699|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
163295112|NCT01823536|589787120|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
163295113|NCT01823536|589787121|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
163295114|NCT01823536|589787122|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
163295115|NCT01823536|589787123|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
163295116|NCT01823536|589787118|FG000|Overall Study|Met exclusion criterion No 6|0|||
163295117|NCT01823536|589787119|FG001|Overall Study|Met exclusion criterion No 6|0|||
163295118|NCT01823536|589787120|FG002|Overall Study|Met exclusion criterion No 6|0|||
163295119|NCT01823536|589787121|FG003|Overall Study|Met exclusion criterion No 6|1|||
163295120|NCT01823536|589787122|FG004|Overall Study|Met exclusion criterion No 6|0|||
163295121|NCT01823536|589787123|FG005|Overall Study|Met exclusion criterion No 6|0|||
163391327|NCT04908189|590144700|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
163295122|NCT01823536|589787118|FG000|Overall Study|Subject moved out of the state|0|||
163295123|NCT01823536|589787119|FG001|Overall Study|Subject moved out of the state|0|||
163295124|NCT01823536|589787120|FG002|Overall Study|Subject moved out of the state|0|||
163391328|NCT04908189|590144701|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
163190801|NCT00875979|589414191|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
163190802|NCT00875979|589414192|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
163190803|NCT00875979|589414191|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
163190804|NCT00875979|589414192|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
163190805|NCT00875979|589414191|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
163190806|NCT00875979|589414192|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
163190807|NCT00875979|589414191|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
163190808|NCT00875979|589414192|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
163295125|NCT01823536|589787121|FG003|Overall Study|Subject moved out of the state|0|||
163295126|NCT01823536|589787122|FG004|Overall Study|Subject moved out of the state|1|||
163295127|NCT01823536|589787123|FG005|Overall Study|Subject moved out of the state|0|||
163295128|NCT00566735|589787127|FG000|Overall Study|Withdrawal by Subject|0|||
163295129|NCT00566735|589787128|FG001|Overall Study|Withdrawal by Subject|1|||
163295130|NCT00566735|589787127|FG000|Overall Study|Refused neuropsychological testing|2|||
163295131|NCT00566735|589787128|FG001|Overall Study|Refused neuropsychological testing|5|||
163295132|NCT00566735|589787127|FG000|Overall Study|Switched into a manic episode|0|||
163295133|NCT00566735|589787128|FG001|Overall Study|Switched into a manic episode|1|||
163295134|NCT04603924|589787129|FG000|Overall Study|Not Dosed|2|||
163295135|NCT04603924|589787130|FG001|Overall Study|Not Dosed|1|||
163295136|NCT04603924|589787129|FG000|Overall Study|Withdrawal by Subject|6|||
163295137|NCT04603924|589787130|FG001|Overall Study|Withdrawal by Subject|6|||
163295138|NCT04603924|589787129|FG000|Overall Study|Adverse Event|2|||
163295139|NCT04603924|589787130|FG001|Overall Study|Adverse Event|2|||
163295140|NCT03762668|589787131|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
163295141|NCT03762668|589787132|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
163295142|NCT00768664|589787136|FG000|Overall Study|Death|57|||
163295143|NCT00768664|589787136|FG000|Overall Study|Lost to Follow-up|2|||
163295144|NCT00768664|589787136|FG000|Overall Study|Other|9|||
163295145|NCT00768664|589787136|FG000|Overall Study|Participant refused|1|||
163295146|NCT02544152|589787137|FG000|Overall Study|Adverse Event|0|||
163295147|NCT02544152|589787138|FG001|Overall Study|Adverse Event|4|||
163295148|NCT02544152|589787137|FG000|Overall Study|Withdrawal by Subject|0|||
163295149|NCT02544152|589787138|FG001|Overall Study|Withdrawal by Subject|3|||
163295150|NCT02544152|589787137|FG000|Overall Study|Other|1|||
163295151|NCT02544152|589787138|FG001|Overall Study|Other|0|||
163295152|NCT00465816|589787141|FG000|Overall Study|Lost to Follow-up|0|||
163295153|NCT00465816|589787142|FG001|Overall Study|Lost to Follow-up|0|||
163295154|NCT00465816|589787143|FG002|Overall Study|Lost to Follow-up|2|||
163295155|NCT02139046|589787144|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
163295156|NCT02139046|589787145|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
163295157|NCT02139046|589787146|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
163295158|NCT02139046|589787147|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
163295159|NCT02139046|589787148|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
163295160|NCT02139046|589787144|FG000|Overall Study|Major Protocol Deviation|9|||
163295161|NCT02139046|589787145|FG001|Overall Study|Major Protocol Deviation|10|||
163295162|NCT02139046|589787146|FG002|Overall Study|Major Protocol Deviation|16|||
163295163|NCT02139046|589787147|FG003|Overall Study|Major Protocol Deviation|12|||
163391329|NCT04908189|590144699|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
163190809|NCT00875979|589414191|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
163190810|NCT00875979|589414192|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
163190811|NCT00875979|589414191|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
163190812|NCT00875979|589414192|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
163190813|NCT00875979|589414191|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
163190814|NCT00875979|589414192|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
163190815|NCT00875979|589414191|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
163190816|NCT00875979|589414192|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
163190817|NCT00875979|589414191|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
163190818|NCT00875979|589414192|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
163190819|NCT01696695|589414194|FG000|Overall Study|Disease progression|373|||
163190820|NCT01696695|589414194|FG000|Overall Study|Death|29|||
163190821|NCT01696695|589414194|FG000|Overall Study|Adverse Event|74|||
163295164|NCT02139046|589787148|FG004|Overall Study|Major Protocol Deviation|6|||
163295165|NCT02139046|589787144|FG000|Overall Study|Lost to Follow-up|13|||
163295166|NCT02139046|589787145|FG001|Overall Study|Lost to Follow-up|16|||
163295167|NCT02139046|589787146|FG002|Overall Study|Lost to Follow-up|16|||
163295168|NCT02139046|589787147|FG003|Overall Study|Lost to Follow-up|18|||
163295169|NCT02139046|589787148|FG004|Overall Study|Lost to Follow-up|13|||
163295170|NCT02139046|589787144|FG000|Overall Study|Voluntary Withdrawal|20|||
163295171|NCT02139046|589787145|FG001|Overall Study|Voluntary Withdrawal|8|||
163295172|NCT02139046|589787146|FG002|Overall Study|Voluntary Withdrawal|10|||
163295173|NCT02139046|589787147|FG003|Overall Study|Voluntary Withdrawal|15|||
163295174|NCT02139046|589787148|FG004|Overall Study|Voluntary Withdrawal|16|||
163295175|NCT02139046|589787144|FG000|Overall Study|Lack of Efficacy|0|||
163295176|NCT02139046|589787145|FG001|Overall Study|Lack of Efficacy|1|||
163295177|NCT02139046|589787146|FG002|Overall Study|Lack of Efficacy|2|||
163295178|NCT02139046|589787147|FG003|Overall Study|Lack of Efficacy|1|||
163295179|NCT02139046|589787148|FG004|Overall Study|Lack of Efficacy|2|||
163295180|NCT02139046|589787144|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
163295181|NCT02139046|589787145|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
163295182|NCT02139046|589787146|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
163295183|NCT02139046|589787147|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
163295184|NCT02139046|589787148|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
163295185|NCT02139046|589787144|FG000|Overall Study|Other Miscellaneous Reasons|10|||
163295186|NCT02139046|589787145|FG001|Overall Study|Other Miscellaneous Reasons|9|||
163295187|NCT02139046|589787146|FG002|Overall Study|Other Miscellaneous Reasons|4|||
163295188|NCT02139046|589787147|FG003|Overall Study|Other Miscellaneous Reasons|9|||
163295189|NCT02139046|589787148|FG004|Overall Study|Other Miscellaneous Reasons|12|||
163295190|NCT00818454|589787149|FG000|Treatment Period 1|Adverse Event|0|||
163295191|NCT00818454|589787150|FG001|Treatment Period 1|Adverse Event|1|||
163295192|NCT00818454|589787151|FG002|Treatment Period 1|Adverse Event|0|||
163295193|NCT00818454|589787152|FG003|Treatment Period 1|Adverse Event|0|||
163295194|NCT00818454|589787149|FG000|Treatment Period 1|Other|3|||
163295195|NCT00818454|589787150|FG001|Treatment Period 1|Other|0|||
163295196|NCT00818454|589787151|FG002|Treatment Period 1|Other|0|||
163295197|NCT00818454|589787152|FG003|Treatment Period 1|Other|0|||
163295198|NCT00818454|589787149|FG000|Washout Period of 1 Week|Adverse Event|1|||
163295199|NCT00818454|589787150|FG001|Washout Period of 1 Week|Adverse Event|1|||
163295200|NCT00818454|589787151|FG002|Washout Period of 1 Week|Adverse Event|0|||
163295201|NCT00818454|589787152|FG003|Washout Period of 1 Week|Adverse Event|0|||
163295202|NCT00818454|589787149|FG000|Washout Period of 1 Week|Protocol Violation|2|||
163295203|NCT00818454|589787150|FG001|Washout Period of 1 Week|Protocol Violation|0|||
163295204|NCT00818454|589787151|FG002|Washout Period of 1 Week|Protocol Violation|0|||
163295205|NCT00818454|589787152|FG003|Washout Period of 1 Week|Protocol Violation|0|||
163295206|NCT00818454|589787149|FG000|Washout Period of 1 Week|Other|1|||
163295207|NCT00818454|589787150|FG001|Washout Period of 1 Week|Other|2|||
163295208|NCT00818454|589787151|FG002|Washout Period of 1 Week|Other|0|||
163295209|NCT00818454|589787152|FG003|Washout Period of 1 Week|Other|0|||
163295210|NCT00818454|589787149|FG000|Treatment Period 2|Other|2|||
163295211|NCT00818454|589787150|FG001|Treatment Period 2|Other|1|||
163295212|NCT00818454|589787151|FG002|Treatment Period 2|Other|0|||
163295213|NCT00818454|589787152|FG003|Treatment Period 2|Other|0|||
163295214|NCT00818454|589787149|FG000|Treatment Period 3|Adverse Event|0|||
163295215|NCT00818454|589787150|FG001|Treatment Period 3|Adverse Event|0|||
163295216|NCT00818454|589787151|FG002|Treatment Period 3|Adverse Event|0|||
163295217|NCT00818454|589787152|FG003|Treatment Period 3|Adverse Event|1|||
163295218|NCT00494442|589787166|FG000|Overall Study|Death|1|||
163295219|NCT00494442|589787167|FG001|Overall Study|Death|1|||
163295220|NCT00494442|589787166|FG000|Overall Study|Lack of Efficacy|16|||
163295221|NCT00494442|589787167|FG001|Overall Study|Lack of Efficacy|10|||
163295222|NCT00494442|589787166|FG000|Overall Study|Adverse Event|0|||
163295223|NCT00494442|589787167|FG001|Overall Study|Adverse Event|2|||
163295224|NCT00494442|589787166|FG000|Overall Study|Physician Decision|0|||
163295225|NCT00494442|589787167|FG001|Overall Study|Physician Decision|1|||
163295226|NCT00494442|589787166|FG000|Overall Study|Non-compliance|0|||
163295227|NCT00494442|589787167|FG001|Overall Study|Non-compliance|1|||
163295228|NCT00494442|589787166|FG000|Overall Study|Intercurrent illness|0|||
163295229|NCT00494442|589787167|FG001|Overall Study|Intercurrent illness|1|||
163295230|NCT03593213|589787170|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
163295231|NCT03593213|589787171|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
163295232|NCT03593213|589787172|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
163295233|NCT03593213|589787173|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
163295234|NCT03593213|589787170|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
163295235|NCT03593213|589787171|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
163295236|NCT03593213|589787172|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
163295237|NCT03593213|589787173|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
163295238|NCT03593213|589787170|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
163295239|NCT03593213|589787171|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
163295240|NCT03593213|589787172|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
163295241|NCT03593213|589787173|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
163295242|NCT03593213|589787170|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
163295243|NCT03593213|589787171|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
163295244|NCT03593213|589787172|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
163295245|NCT03593213|589787173|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
163295246|NCT03593213|589787170|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
163295247|NCT03593213|589787171|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
163295248|NCT03593213|589787172|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
163295249|NCT03593213|589787173|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
163295250|NCT03593213|589787170|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
163295251|NCT03593213|589787171|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
163295252|NCT03593213|589787172|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
163295253|NCT03593213|589787173|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
163295254|NCT03593213|589787170|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
163295255|NCT03593213|589787171|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
163295256|NCT03593213|589787172|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
163295257|NCT03593213|589787173|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
163391330|NCT04908189|590144700|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
163295258|NCT03593213|589787170|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
163295259|NCT03593213|589787171|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
163295260|NCT03593213|589787172|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
163295261|NCT03593213|589787173|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
163295262|NCT03593213|589787170|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
163295263|NCT03593213|589787171|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
163295264|NCT03593213|589787172|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
163295265|NCT03593213|589787173|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
163295266|NCT03593213|589787170|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
163295267|NCT03593213|589787171|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
163295268|NCT03593213|589787172|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
163295269|NCT03593213|589787173|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
163295270|NCT03593213|589787170|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
163295271|NCT03593213|589787171|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
163295272|NCT03593213|589787172|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
163295273|NCT03593213|589787173|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
163295274|NCT03593213|589787170|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
163295275|NCT03593213|589787171|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
163295276|NCT03593213|589787172|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
163295277|NCT03593213|589787173|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
163295278|NCT03593213|589787170|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
163295279|NCT03593213|589787171|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
163295280|NCT03593213|589787172|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
163295281|NCT03593213|589787173|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
163295282|NCT03593213|589787170|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
163295283|NCT03593213|589787171|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
163295284|NCT03593213|589787172|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
163295285|NCT03593213|589787173|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
163295286|NCT03593213|589787170|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
163295287|NCT03593213|589787171|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
163295288|NCT03593213|589787172|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
163295289|NCT03593213|589787173|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
163391331|NCT04908189|590144701|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
163391332|NCT04908189|590144699|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
163391333|NCT04908189|590144700|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
163391334|NCT04908189|590144701|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
163391335|NCT04908189|590144699|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
163391336|NCT04908189|590144700|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
163391337|NCT04908189|590144701|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
163391338|NCT04908189|590144699|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
163391339|NCT04908189|590144700|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
163391340|NCT04908189|590144701|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
163391341|NCT04908189|590144699|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
163391342|NCT04908189|590144700|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
163391343|NCT04908189|590144701|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
163391344|NCT04908189|590144699|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
163391345|NCT04908189|590144700|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
163391346|NCT04908189|590144701|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
163391347|NCT04908189|590144699|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
163391348|NCT04908189|590144700|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
163391349|NCT04908189|590144701|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
163391350|NCT04908189|590144699|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
163391351|NCT04908189|590144700|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
163391352|NCT04908189|590144701|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
163391353|NCT00607022|590144702|FG000|Overall Study|Withdrawal by Subject|1|||
163391354|NCT00607022|590144703|FG001|Overall Study|Withdrawal by Subject|0|||
163391355|NCT00607022|590144704|FG002|Overall Study|Withdrawal by Subject|0|||
163295290|NCT03593213|589787170|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
163295291|NCT03593213|589787171|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
163295292|NCT03593213|589787172|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
163295293|NCT03593213|589787173|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
163295294|NCT03593213|589787170|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
163190822|NCT01696695|589414194|FG000|Overall Study|Withdrawal by Subject|92|||
163190823|NCT01696695|589414194|FG000|Overall Study|Lost to Follow-up|48|||
163190824|NCT01696695|589414194|FG000|Overall Study|Other|74|||
163190825|NCT01696695|589414194|FG000|Overall Study|Major Protocol Violation|192|||
163190826|NCT01904058|589414203|FG000|Overall Study|Adverse Event|2|||
163190827|NCT01904058|589414204|FG001|Overall Study|Adverse Event|0|||
163190828|NCT01904058|589414205|FG002|Overall Study|Adverse Event|0|||
163190829|NCT01904058|589414206|FG003|Overall Study|Adverse Event|0|||
163190830|NCT01904058|589414203|FG000|Overall Study|Withdrawal by Subject|1|||
163190831|NCT01904058|589414204|FG001|Overall Study|Withdrawal by Subject|0|||
163190832|NCT01904058|589414205|FG002|Overall Study|Withdrawal by Subject|1|||
163190833|NCT01904058|589414206|FG003|Overall Study|Withdrawal by Subject|0|||
163190834|NCT01904058|589414203|FG000|Overall Study|Pregnancy|0|||
163190835|NCT01904058|589414204|FG001|Overall Study|Pregnancy|0|||
163190836|NCT01904058|589414205|FG002|Overall Study|Pregnancy|0|||
163190837|NCT01904058|589414206|FG003|Overall Study|Pregnancy|1|||
163190838|NCT04041375|589414207|FG000|Intervention Phase|Withdrawal by Subject|2|||
163190839|NCT04041375|589414208|FG001|Intervention Phase|Withdrawal by Subject|2|||
163190840|NCT04041375|589414207|FG000|Follow-up Phase|Death|2|||
163190841|NCT04041375|589414208|FG001|Follow-up Phase|Death|0|||
163190842|NCT04041375|589414207|FG000|Follow-up Phase|Lost to Follow-up|2|||
163190843|NCT04041375|589414208|FG001|Follow-up Phase|Lost to Follow-up|1|||
163190844|NCT04041375|589414207|FG000|Follow-up Phase|Too ill|3|||
163190845|NCT04041375|589414208|FG001|Follow-up Phase|Too ill|0|||
163190846|NCT02404220|589414214|FG000|Overall Study|Adverse Event|0|||
163190847|NCT02404220|589414215|FG001|Overall Study|Adverse Event|0|||
163190848|NCT02404220|589414216|FG002|Overall Study|Adverse Event|1|||
163190849|NCT02404220|589414217|FG003|Overall Study|Adverse Event|0|||
163190850|NCT02404220|589414214|FG000|Overall Study|Death|5|||
163190851|NCT02404220|589414215|FG001|Overall Study|Death|5|||
163190852|NCT02404220|589414216|FG002|Overall Study|Death|3|||
163190853|NCT02404220|589414217|FG003|Overall Study|Death|8|||
163190854|NCT02404220|589414214|FG000|Overall Study|Progressive Disease|0|||
163190855|NCT02404220|589414215|FG001|Overall Study|Progressive Disease|0|||
163190856|NCT02404220|589414216|FG002|Overall Study|Progressive Disease|1|||
163190857|NCT02404220|589414217|FG003|Overall Study|Progressive Disease|1|||
163190858|NCT02404220|589414214|FG000|Overall Study|Study Terminated by Sponsor|0|||
163190859|NCT02404220|589414215|FG001|Overall Study|Study Terminated by Sponsor|0|||
163190860|NCT02404220|589414216|FG002|Overall Study|Study Terminated by Sponsor|2|||
163190861|NCT02404220|589414217|FG003|Overall Study|Study Terminated by Sponsor|1|||
163190862|NCT02404220|589414214|FG000|Overall Study|Withdrawal by Subject|0|||
163190863|NCT02404220|589414215|FG001|Overall Study|Withdrawal by Subject|1|||
163190864|NCT02404220|589414216|FG002|Overall Study|Withdrawal by Subject|0|||
163190865|NCT02404220|589414217|FG003|Overall Study|Withdrawal by Subject|0|||
163190866|NCT02404220|589414214|FG000|Overall Study|Enrolled but Never Treated|0|||
163190867|NCT02404220|589414215|FG001|Overall Study|Enrolled but Never Treated|2|||
163190868|NCT02404220|589414216|FG002|Overall Study|Enrolled but Never Treated|0|||
163190869|NCT02404220|589414217|FG003|Overall Study|Enrolled but Never Treated|0|||
163190870|NCT00395733|589414218|FG000|Period 2|Withdrawal by Subject|1|||
163190871|NCT00395733|589414219|FG001|Period 2|Withdrawal by Subject|2|||
163190872|NCT00395733|589414218|FG000|Period 2|Protocol Violation|0|||
163190873|NCT00395733|589414219|FG001|Period 2|Protocol Violation|1|||
163190874|NCT00395733|589414218|FG000|Period 2|Adverse Event|0|||
163190875|NCT00395733|589414219|FG001|Period 2|Adverse Event|2|||
163190876|NCT00395733|589414218|FG000|Period 2|Technical problems|1|||
163190877|NCT00395733|589414219|FG001|Period 2|Technical problems|0|||
163190878|NCT01147172|589414225|FG000|Overall Study|Withdrawal by Subject|2|||
163190879|NCT01147172|589414225|FG000|Overall Study|Lost to Follow-up|2|||
163190880|NCT01697358|589414226|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
163190881|NCT01697358|589414227|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
163190882|NCT01697358|589414226|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
163190883|NCT01697358|589414227|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
163190884|NCT01697358|589414226|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
163190885|NCT01697358|589414227|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
163190886|NCT01697358|589414226|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
163190887|NCT01697358|589414227|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
163190888|NCT01697358|589414226|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
163190889|NCT01697358|589414227|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
163190890|NCT01697358|589414226|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
163190891|NCT01697358|589414227|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
163190892|NCT01697358|589414226|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
163190893|NCT01697358|589414227|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
163190894|NCT01697358|589414226|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
163190895|NCT01697358|589414227|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
163190896|NCT01697358|589414226|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
163190897|NCT01697358|589414227|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
163190898|NCT01697358|589414226|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
163190899|NCT01697358|589414227|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
163190900|NCT02507973|589414230|FG000|Overall Study|Adverse Event|1|||
163190901|NCT02711345|589414231|FG000|Overall Study|Adverse Event|0|||
163190902|NCT02711345|589414232|FG001|Overall Study|Adverse Event|0|||
163190903|NCT02711345|589414233|FG002|Overall Study|Adverse Event|0|||
163190904|NCT02711345|589414234|FG003|Overall Study|Adverse Event|1|||
163190905|NCT02711345|589414235|FG004|Overall Study|Adverse Event|1|||
163190906|NCT02711345|589414236|FG005|Overall Study|Adverse Event|2|||
163190907|NCT02711345|589414237|FG006|Overall Study|Adverse Event|1|||
163190908|NCT02711345|589414238|FG007|Overall Study|Adverse Event|0|||
163190909|NCT02711345|589414239|FG008|Overall Study|Adverse Event|0|||
163190910|NCT02711345|589414240|FG009|Overall Study|Adverse Event|2|||
163190911|NCT02711345|589414231|FG000|Overall Study|Physician Decision|0|||
163190912|NCT02711345|589414232|FG001|Overall Study|Physician Decision|0|||
163190913|NCT02711345|589414233|FG002|Overall Study|Physician Decision|1|||
163190914|NCT02711345|589414234|FG003|Overall Study|Physician Decision|0|||
163190915|NCT02711345|589414235|FG004|Overall Study|Physician Decision|0|||
163190916|NCT02711345|589414236|FG005|Overall Study|Physician Decision|0|||
163190917|NCT02711345|589414237|FG006|Overall Study|Physician Decision|0|||
163190918|NCT02711345|589414238|FG007|Overall Study|Physician Decision|0|||
163190919|NCT02711345|589414239|FG008|Overall Study|Physician Decision|1|||
163190920|NCT02711345|589414240|FG009|Overall Study|Physician Decision|0|||
163190921|NCT02711345|589414231|FG000|Overall Study|Progressive disease|1|||
163190922|NCT02711345|589414232|FG001|Overall Study|Progressive disease|3|||
163190923|NCT02711345|589414233|FG002|Overall Study|Progressive disease|5|||
163190924|NCT02711345|589414234|FG003|Overall Study|Progressive disease|3|||
163190925|NCT02711345|589414235|FG004|Overall Study|Progressive disease|7|||
163190926|NCT02711345|589414236|FG005|Overall Study|Progressive disease|2|||
163190927|NCT02711345|589414237|FG006|Overall Study|Progressive disease|8|||
163190928|NCT02711345|589414238|FG007|Overall Study|Progressive disease|4|||
163190929|NCT02711345|589414239|FG008|Overall Study|Progressive disease|5|||
163190930|NCT02711345|589414240|FG009|Overall Study|Progressive disease|6|||
163190931|NCT02711345|589414231|FG000|Overall Study|Subject/guardian decision|0|||
163190932|NCT02711345|589414232|FG001|Overall Study|Subject/guardian decision|0|||
163190933|NCT02711345|589414233|FG002|Overall Study|Subject/guardian decision|0|||
163190934|NCT02711345|589414234|FG003|Overall Study|Subject/guardian decision|0|||
163190935|NCT02711345|589414235|FG004|Overall Study|Subject/guardian decision|0|||
163190936|NCT02711345|589414236|FG005|Overall Study|Subject/guardian decision|2|||
163190937|NCT02711345|589414237|FG006|Overall Study|Subject/guardian decision|3|||
163190938|NCT02711345|589414238|FG007|Overall Study|Subject/guardian decision|1|||
163190939|NCT02711345|589414239|FG008|Overall Study|Subject/guardian decision|0|||
163190940|NCT02711345|589414240|FG009|Overall Study|Subject/guardian decision|4|||
163190941|NCT02711345|589414231|FG000|Overall Study|Death|1|||
163190942|NCT02711345|589414232|FG001|Overall Study|Death|0|||
163190943|NCT02711345|589414233|FG002|Overall Study|Death|0|||
163190944|NCT02711345|589414234|FG003|Overall Study|Death|0|||
163190945|NCT02711345|589414235|FG004|Overall Study|Death|0|||
163190946|NCT02711345|589414236|FG005|Overall Study|Death|0|||
163190947|NCT02711345|589414237|FG006|Overall Study|Death|0|||
163190948|NCT02711345|589414238|FG007|Overall Study|Death|1|||
163190949|NCT02711345|589414239|FG008|Overall Study|Death|0|||
163190950|NCT02711345|589414240|FG009|Overall Study|Death|0|||
163190951|NCT00961649|589414241|FG000|Overall Study|Adverse Event|4|||
163190952|NCT00961649|589414242|FG001|Overall Study|Adverse Event|0|||
163190953|NCT00961649|589414243|FG002|Overall Study|Adverse Event|0|||
163190954|NCT00961649|589414244|FG003|Overall Study|Adverse Event|2|||
163190955|NCT00961649|589414241|FG000|Overall Study|Inadequate control of IOP|0|||
163190956|NCT00961649|589414242|FG001|Overall Study|Inadequate control of IOP|0|||
163190957|NCT00961649|589414243|FG002|Overall Study|Inadequate control of IOP|0|||
163190958|NCT00961649|589414244|FG003|Overall Study|Inadequate control of IOP|1|||
163190959|NCT00961649|589414241|FG000|Overall Study|Patient has travel plans during holidays|0|||
163190960|NCT00961649|589414242|FG001|Overall Study|Patient has travel plans during holidays|0|||
163190961|NCT00961649|589414243|FG002|Overall Study|Patient has travel plans during holidays|1|||
163190962|NCT00961649|589414244|FG003|Overall Study|Patient has travel plans during holidays|0|||
163190963|NCT00961649|589414241|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
163190964|NCT00961649|589414242|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
163190965|NCT00961649|589414243|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
163190966|NCT00961649|589414244|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
163190967|NCT00961649|589414241|FG000|Overall Study|Study terminated by sponsor|4|||
163190968|NCT00961649|589414242|FG001|Overall Study|Study terminated by sponsor|4|||
163190969|NCT00961649|589414243|FG002|Overall Study|Study terminated by sponsor|4|||
163190970|NCT00961649|589414244|FG003|Overall Study|Study terminated by sponsor|1|||
163190971|NCT02155881|589414245|FG000|Overall Study|Withdrawal by Subject|0|||
163190972|NCT02155881|589414246|FG001|Overall Study|Withdrawal by Subject|2|||
163190973|NCT02155881|589414245|FG000|Overall Study|Inappropriately randomized|2|||
163190974|NCT02155881|589414246|FG001|Overall Study|Inappropriately randomized|2|||
163190975|NCT04357782|589414247|FG000|Overall Study|Discharged from hospital|1|||
163190976|NCT04357782|589414248|FG001|Overall Study|Discharged from hospital|0|||
163190977|NCT04357782|589414247|FG000|Overall Study|Death|0|||
163190978|NCT04357782|589414248|FG001|Overall Study|Death|2|||
163190979|NCT01786148|589414249|FG000|Overall Study|Lost to Follow-up|21|||
163190980|NCT01786148|589414250|FG001|Overall Study|Lost to Follow-up|13|||
163190981|NCT01786148|589414249|FG000|Overall Study|Death|0|||
163190982|NCT01786148|589414250|FG001|Overall Study|Death|1|||
163190983|NCT01786148|589414249|FG000|Overall Study|Withdrawal by Subject|0|||
163190984|NCT01786148|589414250|FG001|Overall Study|Withdrawal by Subject|7|||
163190985|NCT01786148|589414249|FG000|Overall Study|Incarceration|1|||
163190986|NCT01786148|589414250|FG001|Overall Study|Incarceration|1|||
163190987|NCT00338104|589414251|FG000|Overall Study|Protocol Violation|2|||
163190988|NCT00338104|589414252|FG001|Overall Study|Protocol Violation|1|||
163190989|NCT00338104|589414253|FG002|Overall Study|Protocol Violation|3|||
163190990|NCT02362269|589414256|FG000|Overall Study|Moved|1|||
163190991|NCT02362269|589414257|FG001|Overall Study|Moved|0|||
163190992|NCT02362269|589414256|FG000|Overall Study|Lost to Follow-up|0|||
163190993|NCT02362269|589414257|FG001|Overall Study|Lost to Follow-up|6|||
163190994|NCT03841448|589414258|FG000|Double-blind Treatment (DBT) Period|Death|1|||
163190995|NCT03841448|589414259|FG001|Double-blind Treatment (DBT) Period|Death|1|||
163190996|NCT03841448|589414260|FG002|Double-blind Treatment (DBT) Period|Death|0|||
163190997|NCT03841448|589414261|FG003|Double-blind Treatment (DBT) Period|Death|0|||
163190998|NCT03841448|589414258|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
163190999|NCT03841448|589414259|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
163191000|NCT03841448|589414260|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
163191001|NCT03841448|589414261|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
163191002|NCT03841448|589414258|FG000|Open-Label Extension (OLE) Period|Death|0|||
163191003|NCT03841448|589414259|FG001|Open-Label Extension (OLE) Period|Death|0|||
163191004|NCT03841448|589414260|FG002|Open-Label Extension (OLE) Period|Death|0|||
163191005|NCT03841448|589414261|FG003|Open-Label Extension (OLE) Period|Death|1|||
163191006|NCT03841448|589414258|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
163191007|NCT03841448|589414259|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
163191008|NCT03841448|589414260|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
163191009|NCT03841448|589414261|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
163191010|NCT03841448|589414258|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
163191011|NCT03841448|589414259|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
163191012|NCT03841448|589414260|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
163191013|NCT03841448|589414261|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
163191014|NCT03841448|589414258|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
163191015|NCT03841448|589414259|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
163191016|NCT03841448|589414260|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
163191017|NCT03841448|589414261|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
163191018|NCT04068610|589414262|FG000|Overall Study|Death|4|||
163191019|NCT04068610|589414263|FG001|Overall Study|Death|8|||
163191020|NCT04068610|589414264|FG002|Overall Study|Death|13|||
163191021|NCT04068610|589414262|FG000|Overall Study|Lost to Follow-up|0|||
163191022|NCT04068610|589414263|FG001|Overall Study|Lost to Follow-up|2|||
163191023|NCT04068610|589414264|FG002|Overall Study|Lost to Follow-up|0|||
163191024|NCT04068610|589414262|FG000|Overall Study|Withdrawal by Subject|0|||
163191025|NCT04068610|589414263|FG001|Overall Study|Withdrawal by Subject|4|||
163191026|NCT04068610|589414264|FG002|Overall Study|Withdrawal by Subject|2|||
163191027|NCT04068610|589414262|FG000|Overall Study|Other|3|||
163191028|NCT04068610|589414263|FG001|Overall Study|Other|12|||
163191029|NCT04068610|589414264|FG002|Overall Study|Other|11|||
163191030|NCT00072176|589414265|FG000|Overall Study|Withdrawal by Subject|1|||
163191031|NCT00072176|589414266|FG001|Overall Study|Withdrawal by Subject|0|||
163191032|NCT00072176|589414265|FG000|Overall Study|Protocol Violation|0|||
163191033|NCT00072176|589414266|FG001|Overall Study|Protocol Violation|1|||
163191034|NCT02586064|589414267|FG000|Overall Study|Other Obligations|6|||
163191035|NCT02586064|589414268|FG001|Overall Study|Other Obligations|6|||
163191036|NCT02586064|589414267|FG000|Overall Study|Other|3|||
163191037|NCT02586064|589414268|FG001|Overall Study|Other|7|||
163191038|NCT02586064|589414267|FG000|Overall Study|Never Started|3|||
163191039|NCT02586064|589414268|FG001|Overall Study|Never Started|3|||
163191040|NCT02586064|589414267|FG000|Overall Study|Lost Interest|1|||
163295295|NCT03593213|589787171|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
163295296|NCT03593213|589787172|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
163295297|NCT03593213|589787173|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
163295298|NCT03593213|589787170|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
163295299|NCT03593213|589787171|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
163295300|NCT03593213|589787172|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
163295301|NCT03593213|589787173|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
163295302|NCT03593213|589787170|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
163295303|NCT03593213|589787171|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
163295304|NCT03593213|589787172|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
163295305|NCT03593213|589787173|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
163295306|NCT03184558|589787174|FG000|Overall Study|Withdrawal by Subject|2|||
163295307|NCT03184558|589787174|FG000|Overall Study|Death|16|||
163295308|NCT03184558|589787174|FG000|Overall Study|Lost to Follow-up|2|||
163295309|NCT03184558|589787174|FG000|Overall Study|Other|9|||
163295310|NCT00566527|589787178|FG000|Overall Study|Reason not provided|3|||
163295311|NCT00566527|589787179|FG001|Overall Study|Reason not provided|11|||
163295312|NCT00566527|589787180|FG002|Overall Study|Reason not provided|10|||
163295313|NCT00566527|589787178|FG000|Overall Study|Adverse Event|2|||
163295314|NCT00566527|589787179|FG001|Overall Study|Adverse Event|0|||
163295315|NCT00566527|589787180|FG002|Overall Study|Adverse Event|1|||
163295316|NCT00566527|589787178|FG000|Overall Study|Physician Decision|3|||
163295317|NCT00566527|589787179|FG001|Overall Study|Physician Decision|8|||
163295318|NCT00566527|589787180|FG002|Overall Study|Physician Decision|20|||
163295319|NCT00566527|589787178|FG000|Overall Study|Lost to Follow-up|3|||
163295320|NCT00566527|589787179|FG001|Overall Study|Lost to Follow-up|4|||
163295321|NCT00566527|589787180|FG002|Overall Study|Lost to Follow-up|4|||
163295322|NCT00566527|589787178|FG000|Overall Study|Withdrawal by Subject|6|||
163295323|NCT00566527|589787179|FG001|Overall Study|Withdrawal by Subject|43|||
163295324|NCT00566527|589787180|FG002|Overall Study|Withdrawal by Subject|43|||
163295325|NCT01179334|589787185|FG000|Treatment Period|Adverse Event|1|||
163295326|NCT01179334|589787186|FG001|Treatment Period|Adverse Event|0|||
163295327|NCT01179334|589787185|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
163295328|NCT01179334|589787186|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
163295329|NCT01179334|589787185|FG000|Long-term Extension (LTE) Period|Death|3|||
163295330|NCT01179334|589787186|FG001|Long-term Extension (LTE) Period|Death|0|||
163295331|NCT01179334|589787185|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
163295332|NCT01179334|589787186|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
163295333|NCT01152190|589787190|FG000|Overall Study|Adverse Event|2|||
163295334|NCT01152190|589787191|FG001|Overall Study|Adverse Event|4|||
163295335|NCT01152190|589787190|FG000|Overall Study|Death|1|||
163295336|NCT01152190|589787191|FG001|Overall Study|Death|0|||
163295337|NCT01152190|589787190|FG000|Overall Study|Protocol Violation|1|||
163295338|NCT01152190|589787191|FG001|Overall Study|Protocol Violation|1|||
163295339|NCT01152190|589787190|FG000|Overall Study|Withdrawal by Subject|1|||
163295340|NCT01152190|589787191|FG001|Overall Study|Withdrawal by Subject|3|||
163295341|NCT03070483|589787192|FG000|Overall Study|Lost to Follow-up|2|||
163295342|NCT01390402|589787195|FG000|Overall Study|Death|1|||
163295343|NCT01390402|589787195|FG000|Overall Study|Disease Progression|4|||
163391356|NCT04786119|590144705|FG000|Overall Study|Withdrawal by Subject|4|||
163391357|NCT04786119|590144706|FG001|Overall Study|Withdrawal by Subject|5|||
163391358|NCT04786119|590144705|FG000|Overall Study|Lost to Follow-up|5|||
163391359|NCT04786119|590144706|FG001|Overall Study|Lost to Follow-up|5|||
163391360|NCT04786119|590144705|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
163391361|NCT04786119|590144706|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
163391362|NCT01130051|590144711|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
163391363|NCT01130051|590144712|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
163391364|NCT01130051|590144711|FG000|Washout Period of 14 Days|Protocol Violation|1|||
163391365|NCT01130051|590144712|FG001|Washout Period of 14 Days|Protocol Violation|1|||
163391366|NCT00835120|590144717|FG000|Overall Study|Lack of Efficacy|1|||
163295344|NCT00026312|589787198|FG000|Overall Study|Adverse Event|0|||
163295345|NCT00026312|589787199|FG001|Overall Study|Adverse Event|32|||
163295346|NCT00026312|589787198|FG000|Overall Study|Death|1|||
163295347|NCT00026312|589787199|FG001|Overall Study|Death|7|||
163295348|NCT00026312|589787198|FG000|Overall Study|Lack of Efficacy|19|||
163295349|NCT00026312|589787199|FG001|Overall Study|Lack of Efficacy|114|||
163295350|NCT00026312|589787198|FG000|Overall Study|Lost to Follow-up|0|||
163295351|NCT00026312|589787199|FG001|Overall Study|Lost to Follow-up|5|||
163295352|NCT00026312|589787198|FG000|Overall Study|Physician Decision|1|||
163295353|NCT00026312|589787199|FG001|Overall Study|Physician Decision|37|||
163295354|NCT00026312|589787198|FG000|Overall Study|Protocol Violation|0|||
163295355|NCT00026312|589787199|FG001|Overall Study|Protocol Violation|3|||
163295356|NCT00026312|589787198|FG000|Overall Study|Withdrawal by Subject|1|||
163295357|NCT00026312|589787199|FG001|Overall Study|Withdrawal by Subject|6|||
163391367|NCT00835120|590144717|FG000|Overall Study|Lost to Follow-up|3|||
163295358|NCT00026312|589787198|FG000|Overall Study|Ineligible|4|||
163295359|NCT00026312|589787199|FG001|Overall Study|Ineligible|5|||
163295360|NCT00026312|589787198|FG000|Overall Study|Entry onto another COG study|0|||
163295361|NCT00026312|589787199|FG001|Overall Study|Entry onto another COG study|1|||
163295362|NCT00026312|589787198|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
163295363|NCT00026312|589787199|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
163295364|NCT02611037|589787200|FG000|Overall Study|Withdrawal prior to treatment|2|||
163295365|NCT02611037|589787201|FG001|Overall Study|Withdrawal prior to treatment|0|||
163295366|NCT03785782|589788536|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
163295367|NCT03785782|589788537|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
163295368|NCT03785782|589788536|FG000|Overall Study|Withdrawal by Subject|1|||
163295369|NCT03785782|589788537|FG001|Overall Study|Withdrawal by Subject|1|||
163295370|NCT03785782|589788536|FG000|Overall Study|insufficient image quality.|3|||
163295371|NCT03785782|589788537|FG001|Overall Study|insufficient image quality.|0|||
163295372|NCT04817670|589788538|FG000|Overall Study|Withdrawal by Subject|1|||
163295373|NCT04817670|589788539|FG001|Overall Study|Withdrawal by Subject|0|||
163295374|NCT04817670|589788540|FG002|Overall Study|Withdrawal by Subject|0|||
163295375|NCT04817670|589788541|FG003|Overall Study|Withdrawal by Subject|0|||
163295376|NCT04817670|589788542|FG004|Overall Study|Withdrawal by Subject|0|||
163295377|NCT04817670|589788538|FG000|Overall Study|Lost to Follow-up|0|||
163295378|NCT04817670|589788539|FG001|Overall Study|Lost to Follow-up|0|||
163295379|NCT04817670|589788540|FG002|Overall Study|Lost to Follow-up|1|||
163295380|NCT04817670|589788541|FG003|Overall Study|Lost to Follow-up|0|||
163295381|NCT04817670|589788542|FG004|Overall Study|Lost to Follow-up|0|||
163295382|NCT01188655|589788546|FG000|Overall Study|Lack of Efficacy|1|||
163295383|NCT01188655|589788546|FG000|Overall Study|Lost to Follow-up|1|||
163295384|NCT01188655|589788546|FG000|Overall Study|Other|11|||
163295385|NCT02396316|589788547|FG000|Overall Study|Physician Decision|1|||
163295386|NCT02396316|589788548|FG001|Overall Study|Physician Decision|0|||
163295387|NCT02396316|589788547|FG000|Overall Study|Progressive disease|6|||
163295388|NCT02396316|589788548|FG001|Overall Study|Progressive disease|3|||
163295389|NCT02396316|589788547|FG000|Overall Study|Protocol Violation|0|||
163295390|NCT02396316|589788548|FG001|Overall Study|Protocol Violation|1|||
163295391|NCT02396316|589788547|FG000|Overall Study|Treatment unblinded|0|||
163295392|NCT02396316|589788548|FG001|Overall Study|Treatment unblinded|1|||
163295393|NCT00686855|589788551|FG000|Overall Study|Lost to Follow-up|1|||
163295394|NCT00686855|589788552|FG001|Overall Study|Lost to Follow-up|0|||
163295395|NCT00686855|589788551|FG000|Overall Study|Progressive GVHD|0|||
163295396|NCT00686855|589788552|FG001|Overall Study|Progressive GVHD|1|||
163295397|NCT02731755|589788553|FG000|First Intervention|Withdrawal by Subject|0|||
163295398|NCT02731755|589788554|FG001|First Intervention|Withdrawal by Subject|2|||
163295399|NCT02320123|589788555|FG000|Overall Study|Lost to Follow-up|4|||
163295400|NCT02320123|589788556|FG001|Overall Study|Lost to Follow-up|6|||
163391368|NCT00835120|590144717|FG000|Overall Study|Adverse Event|2|||
163391369|NCT00835120|590144717|FG000|Overall Study|Withdrawal by Subject|2|||
163391370|NCT01658826|590144718|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
163391371|NCT01658826|590144719|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
163391372|NCT01658826|590144718|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
163391373|NCT01658826|590144719|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
163391374|NCT01658826|590144718|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
163391375|NCT01658826|590144719|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
163391376|NCT01658826|590144718|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
163391377|NCT01658826|590144719|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
163391378|NCT01658826|590144718|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
163391379|NCT01658826|590144719|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
163391380|NCT01658826|590144718|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
163391381|NCT01658826|590144719|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
163391382|NCT01658826|590144718|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
163391383|NCT01658826|590144719|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
163295401|NCT02320123|589788555|FG000|Overall Study|Death|6|||
163295402|NCT02320123|589788556|FG001|Overall Study|Death|5|||
163295403|NCT04480827|589788557|FG000|Overall Study|Adverse Event|0|||
163295404|NCT04480827|589788558|FG001|Overall Study|Adverse Event|0|||
163295405|NCT04480827|589788559|FG002|Overall Study|Adverse Event|0|||
163295406|NCT04480827|589788560|FG003|Overall Study|Adverse Event|0|||
163295407|NCT04480827|589788561|FG004|Overall Study|Adverse Event|0|||
163295408|NCT04480827|589788562|FG005|Overall Study|Adverse Event|1|||
163295409|NCT04480827|589788563|FG006|Overall Study|Adverse Event|0|||
163295410|NCT01765543|589788570|FG000|Overall Study|Death|1|||
163295411|NCT01765543|589788570|FG000|Overall Study|Withdrawal by Subject|2|||
163295412|NCT01185561|589788571|FG000|Overall Study|Lost to Follow-up|0|||
163295413|NCT01185561|589788572|FG001|Overall Study|Lost to Follow-up|4|||
163295414|NCT01185561|589788571|FG000|Overall Study|Withdrawal by Subject|2|||
163295415|NCT01185561|589788572|FG001|Overall Study|Withdrawal by Subject|8|||
163295416|NCT05876949|589788575|FG000|Overall Study|Withdrawal by Subject|1|||
163295417|NCT05876949|589788576|FG001|Overall Study|Withdrawal by Subject|3|||
163295418|NCT05876949|589788575|FG000|Overall Study|Physician Decision|0|||
163295419|NCT05876949|589788576|FG001|Overall Study|Physician Decision|2|||
163295420|NCT05876949|589788575|FG000|Overall Study|Death|0|||
163295421|NCT05876949|589788576|FG001|Overall Study|Death|1|||
163295422|NCT02755805|589788577|FG000|Overall Study|Lost to Follow-up|1|||
163295423|NCT02755805|589788578|FG001|Overall Study|Lost to Follow-up|2|||
163295424|NCT02755805|589788577|FG000|Overall Study|Refused assessments|1|||
163295425|NCT02755805|589788578|FG001|Overall Study|Refused assessments|0|||
163295426|NCT02755805|589788577|FG000|Overall Study|Withdrawal by Subject|0|||
163295427|NCT02755805|589788578|FG001|Overall Study|Withdrawal by Subject|2|||
163295428|NCT03718767|589788582|FG000|Overall Study|Declined to participate (before treatment started)|0|||
163295429|NCT03718767|589788583|FG001|Overall Study|Declined to participate (before treatment started)|0|||
163295430|NCT03718767|589788584|FG002|Overall Study|Declined to participate (before treatment started)|7|||
163295431|NCT03718767|589788582|FG000|Overall Study|Ineligible|0|||
163295432|NCT03718767|589788583|FG001|Overall Study|Ineligible|0|||
163295433|NCT03718767|589788584|FG002|Overall Study|Ineligible|17|||
163295434|NCT03691428|589788587|FG000|Overall Study|Withdrawal by Subject|6|||
163295435|NCT03691428|589788588|FG001|Overall Study|Withdrawal by Subject|8|||
163295436|NCT01460290|589788589|FG000|Overall Study|Adverse Event|3|||
163295437|NCT01460290|589788589|FG000|Overall Study|Elevated liver function|1|||
163295438|NCT01831791|589788590|FG000|Overall Study|Withdrawal by Subject|10|||
163295439|NCT01190007|589788591|FG000|Overall Study|Withdrawal by Subject|4|||
163295440|NCT01190007|589788591|FG000|Overall Study|Adverse Event|8|||
163295441|NCT01190007|589788591|FG000|Overall Study|Difficulty of visit for complications|1|||
163295442|NCT01190007|589788591|FG000|Overall Study|Participant was arrested|1|||
163295443|NCT01254019|589788597|FG000|Overall Study|Adverse Event|0|||
163295444|NCT01254019|589788598|FG001|Overall Study|Adverse Event|2|||
163295445|NCT01254019|589788597|FG000|Overall Study|Protocol Violation|1|||
163295446|NCT01254019|589788598|FG001|Overall Study|Protocol Violation|0|||
163295447|NCT01254019|589788597|FG000|Overall Study|Withdrawal by Subject|0|||
163295448|NCT01254019|589788598|FG001|Overall Study|Withdrawal by Subject|2|||
163295449|NCT03061474|589788599|FG000|Overall Study|Adverse Event|2|||
163295450|NCT03061474|589788600|FG001|Overall Study|Adverse Event|0|||
163295451|NCT03061474|589788599|FG000|Overall Study|Safety Risk|0|||
163295452|NCT03061474|589788600|FG001|Overall Study|Safety Risk|1|||
163295453|NCT03061474|589788599|FG000|Overall Study|Participant unwilling or unable to participate|0|||
163295454|NCT03061474|589788600|FG001|Overall Study|Participant unwilling or unable to participate|2|||
163295455|NCT03061474|589788599|FG000|Overall Study|Lost to Follow-up|0|||
163295456|NCT03061474|589788600|FG001|Overall Study|Lost to Follow-up|1|||
163295457|NCT00845832|589788603|FG000|Treatment Period|Adverse Event|0|||
163295458|NCT00845832|589788604|FG001|Treatment Period|Adverse Event|2|||
163295459|NCT00845832|589788605|FG002|Treatment Period|Adverse Event|0|||
163295460|NCT00845832|589788603|FG000|Treatment Period|Protocol Violation|1|||
163295461|NCT00845832|589788604|FG001|Treatment Period|Protocol Violation|1|||
163295462|NCT00845832|589788605|FG002|Treatment Period|Protocol Violation|0|||
163295463|NCT00845832|589788603|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
163295464|NCT00845832|589788604|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
163295465|NCT00845832|589788605|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
163295466|NCT00845832|589788603|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
162952080|NCT00909610|588529533|FG001|Period: Second Intervention|Adverse Event|0|||
163295467|NCT00845832|589788604|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
163295468|NCT00845832|589788605|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
163295469|NCT01391130|589788606|FG000|Overall Study|Withdrawal by Subject|3|||
163295470|NCT01391130|589788607|FG001|Overall Study|Withdrawal by Subject|2|||
163295471|NCT01391130|589788606|FG000|Overall Study|Physician Decision|2|||
163295472|NCT01391130|589788607|FG001|Overall Study|Physician Decision|3|||
163295473|NCT01391130|589788606|FG000|Overall Study|Did not Receive Drug|1|||
163295474|NCT01391130|589788607|FG001|Overall Study|Did not Receive Drug|1|||
163295475|NCT03520413|589788614|FG000|Overall Study|Lost to Follow-up|1|||
163295476|NCT03520413|589788615|FG001|Overall Study|Lost to Follow-up|1|||
163295477|NCT03520413|589788614|FG000|Overall Study|Withdrawal by Subject|1|||
163295478|NCT03520413|589788615|FG001|Overall Study|Withdrawal by Subject|2|||
163295479|NCT03520413|589788614|FG000|Overall Study|Death|0|||
163295480|NCT03520413|589788615|FG001|Overall Study|Death|1|||
163191041|NCT02586064|589414268|FG001|Overall Study|Lost Interest|4|||
163191042|NCT02586064|589414267|FG000|Overall Study|Miscellaneous Life Issues|0|||
163191043|NCT02586064|589414268|FG001|Overall Study|Miscellaneous Life Issues|5|||
163191044|NCT02586064|589414267|FG000|Overall Study|Infrequent Attendance|2|||
163191045|NCT02586064|589414268|FG001|Overall Study|Infrequent Attendance|1|||
163191046|NCT02586064|589414267|FG000|Overall Study|Timed Out|2|||
163191047|NCT02586064|589414268|FG001|Overall Study|Timed Out|0|||
163191048|NCT02586064|589414267|FG000|Overall Study|AUD relapse|0|||
163191049|NCT02586064|589414268|FG001|Overall Study|AUD relapse|2|||
163191050|NCT02586064|589414267|FG000|Overall Study|Legal Issue|1|||
163191051|NCT02586064|589414268|FG001|Overall Study|Legal Issue|0|||
163191052|NCT04815031|589414269|FG000|Overall Study|No adverse event information (missing information)|33|||
163191053|NCT00484094|589414270|FG000|Overall Study|Discontinued|39|||
163191054|NCT00484094|589414270|FG000|Overall Study|Other|3|||
163191055|NCT03594994|589414271|FG000|Overall Study|Adverse Event|1|||
163191056|NCT03594994|589414272|FG001|Overall Study|Adverse Event|0|||
163191057|NCT03594994|589414271|FG000|Overall Study|Withdrawal by Subject|0|||
163191058|NCT03594994|589414272|FG001|Overall Study|Withdrawal by Subject|1|||
163191059|NCT00309985|589414274|FG000|Overall Study|Disease progression|12|||
163191060|NCT00309985|589414275|FG001|Overall Study|Disease progression|0|||
163191061|NCT00309985|589414274|FG000|Overall Study|Adverse Event|30|||
163191062|NCT00309985|589414275|FG001|Overall Study|Adverse Event|0|||
163191063|NCT00309985|589414274|FG000|Overall Study|Death|2|||
163191064|NCT00309985|589414275|FG001|Overall Study|Death|0|||
163191065|NCT00309985|589414274|FG000|Overall Study|Withdrawal by Subject|5|||
163191066|NCT00309985|589414275|FG001|Overall Study|Withdrawal by Subject|1|||
163191067|NCT00309985|589414274|FG000|Overall Study|Physician Decision|3|||
163191068|NCT00309985|589414275|FG001|Overall Study|Physician Decision|0|||
163191069|NCT00309985|589414274|FG000|Overall Study|Never started treatment|7|||
163191070|NCT00309985|589414275|FG001|Overall Study|Never started treatment|0|||
163191071|NCT00309985|589414274|FG000|Overall Study|Complicating disease|1|||
163191072|NCT00309985|589414275|FG001|Overall Study|Complicating disease|0|||
163191073|NCT00309985|589414274|FG000|Overall Study|Non-compliance|1|||
163191074|NCT00309985|589414275|FG001|Overall Study|Non-compliance|0|||
163191075|NCT00309985|589414274|FG000|Overall Study|Chemotherapy discontinued only|1|||
163191076|NCT00309985|589414275|FG001|Overall Study|Chemotherapy discontinued only|0|||
163191077|NCT03672643|589414276|FG000|Overall Study|Adverse Event|3|||
163191078|NCT03672643|589414276|FG000|Overall Study|Death|2|||
163191079|NCT03672643|589414276|FG000|Overall Study|Withdrawal by Subject|1|||
163191080|NCT03672643|589414276|FG000|Overall Study|Progressive disease|11|||
163191081|NCT03672643|589414276|FG000|Overall Study|Global deterioration of health status|1|||
163191082|NCT03672643|589414276|FG000|Overall Study|Refused further treatment|7|||
163191083|NCT03672643|589414276|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
163191084|NCT01950390|589414279|FG000|Overall Study|Never started treatment|3|||
163191085|NCT01950390|589414280|FG001|Overall Study|Never started treatment|2|||
163191086|NCT01950390|589414279|FG000|Overall Study|Disease progression|45|||
163191087|NCT01950390|589414280|FG001|Overall Study|Disease progression|52|||
163191088|NCT01950390|589414279|FG000|Overall Study|Adverse Event|22|||
163191089|NCT01950390|589414280|FG001|Overall Study|Adverse Event|16|||
163191090|NCT01950390|589414279|FG000|Overall Study|Death|5|||
163191091|NCT01950390|589414280|FG001|Overall Study|Death|3|||
163191092|NCT01950390|589414279|FG000|Overall Study|Withdrawal by Subject|5|||
163191093|NCT01950390|589414280|FG001|Overall Study|Withdrawal by Subject|1|||
163191094|NCT01950390|589414279|FG000|Overall Study|Alternative therapy|0|||
163191095|NCT01950390|589414280|FG001|Overall Study|Alternative therapy|3|||
163191096|NCT01950390|589414279|FG000|Overall Study|Complicating disease|1|||
163191097|NCT01950390|589414280|FG001|Overall Study|Complicating disease|0|||
163191098|NCT01950390|589414279|FG000|Overall Study|On treatment|1|||
163191099|NCT01950390|589414280|FG001|Overall Study|On treatment|0|||
163191100|NCT01950390|589414279|FG000|Overall Study|Symptomatic deterioration|2|||
163191101|NCT01950390|589414280|FG001|Overall Study|Symptomatic deterioration|1|||
163191102|NCT01950390|589414279|FG000|Overall Study|Physician Decision|0|||
163191103|NCT01950390|589414280|FG001|Overall Study|Physician Decision|4|||
163191104|NCT01950390|589414279|FG000|Overall Study|Lack of clinical benefit|0|||
163191105|NCT01950390|589414280|FG001|Overall Study|Lack of clinical benefit|1|||
163191106|NCT01950390|589414279|FG000|Overall Study|Maintained PR and moved to observation only|0|||
163191107|NCT01950390|589414280|FG001|Overall Study|Maintained PR and moved to observation only|1|||
163191108|NCT02975336|589415842|FG000|DBPC (52 Weeks)|Adverse Event|16|||
163191109|NCT02975336|589415843|FG001|DBPC (52 Weeks)|Adverse Event|17|||
163191110|NCT02975336|589415844|FG002|DBPC (52 Weeks)|Adverse Event|13|||
163191111|NCT02975336|589415845|FG003|DBPC (52 Weeks)|Adverse Event|18|||
163191112|NCT02975336|589415846|FG004|DBPC (52 Weeks)|Adverse Event|0|||
163191113|NCT02975336|589415847|FG005|DBPC (52 Weeks)|Adverse Event|0|||
163191114|NCT02975336|589415848|FG006|DBPC (52 Weeks)|Adverse Event|0|||
163191115|NCT02975336|589415849|FG007|DBPC (52 Weeks)|Adverse Event|0|||
163191116|NCT02975336|589415842|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
163191117|NCT02975336|589415843|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
163191118|NCT02975336|589415844|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
163191119|NCT02975336|589415845|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
163191120|NCT02975336|589415846|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
163191121|NCT02975336|589415847|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
163191122|NCT02975336|589415848|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
163191123|NCT02975336|589415849|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
163191124|NCT02975336|589415842|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
163191125|NCT02975336|589415843|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
163191126|NCT02975336|589415844|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
163191127|NCT02975336|589415845|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
163191128|NCT02975336|589415846|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
163191129|NCT02975336|589415847|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
163191130|NCT02975336|589415848|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
163191131|NCT02975336|589415849|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
163191132|NCT02975336|589415842|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
163191133|NCT02975336|589415843|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
163191134|NCT02975336|589415844|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
163191135|NCT02975336|589415845|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
163295481|NCT03520413|589788614|FG000|Overall Study|Physician Decision|3|||
163295482|NCT03520413|589788615|FG001|Overall Study|Physician Decision|3|||
163295483|NCT03520413|589788614|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
163295484|NCT03520413|589788615|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
163295485|NCT00869323|589788616|FG000|Maintenance Therapy|concurrent illness|1|||
163295486|NCT02880241|589788617|FG000|Overall Study|Lack of Efficacy|1|||
163295487|NCT02880241|589788618|FG001|Overall Study|Lack of Efficacy|0|||
163295488|NCT02880241|589788619|FG002|Overall Study|Lack of Efficacy|0|||
163295489|NCT02880241|589788620|FG003|Overall Study|Lack of Efficacy|0|||
163295490|NCT02880241|589788621|FG004|Overall Study|Lack of Efficacy|0|||
163295491|NCT02880241|589788622|FG005|Overall Study|Lack of Efficacy|0|||
163295492|NCT00638963|589788623|FG000|Overall Study|Withdrawal by Subject|1|||
163295493|NCT00638963|589788624|FG001|Overall Study|Withdrawal by Subject|0|||
163295494|NCT05283395|589788625|FG000|Overall Study|Adverse Event|4|||
163295495|NCT05283395|589788626|FG001|Overall Study|Adverse Event|4|||
163295496|NCT05283395|589788627|FG002|Overall Study|Adverse Event|0|||
163295497|NCT05283395|589788625|FG000|Overall Study|Patient Lost to Follow-Up|0|||
163295498|NCT05283395|589788626|FG001|Overall Study|Patient Lost to Follow-Up|0|||
163295499|NCT05283395|589788627|FG002|Overall Study|Patient Lost to Follow-Up|1|||
163295500|NCT05283395|589788625|FG000|Overall Study|Patient Withdrawal|2|||
163295501|NCT05283395|589788626|FG001|Overall Study|Patient Withdrawal|4|||
163295502|NCT05283395|589788627|FG002|Overall Study|Patient Withdrawal|2|||
163295503|NCT05283395|589788625|FG000|Overall Study|Investigator Decision|1|||
163295504|NCT05283395|589788626|FG001|Overall Study|Investigator Decision|0|||
163295505|NCT05283395|589788627|FG002|Overall Study|Investigator Decision|1|||
163295506|NCT05283395|589788625|FG000|Overall Study|Enrolled in error|0|||
163295507|NCT05283395|589788626|FG001|Overall Study|Enrolled in error|0|||
163295508|NCT05283395|589788627|FG002|Overall Study|Enrolled in error|1|||
163295509|NCT00712335|589788628|FG000|Overall Study|Withdrawal by Subject|0|||
163295510|NCT00712335|589788629|FG001|Overall Study|Withdrawal by Subject|7|||
163295511|NCT00712335|589788630|FG002|Overall Study|Withdrawal by Subject|2|||
163295512|NCT00712335|589788631|FG003|Overall Study|Withdrawal by Subject|3|||
163295513|NCT00712335|589788632|FG004|Overall Study|Withdrawal by Subject|0|||
163295514|NCT00712335|589788628|FG000|Overall Study|Lost to Follow-up|2|||
163295515|NCT00712335|589788629|FG001|Overall Study|Lost to Follow-up|5|||
163295516|NCT00712335|589788630|FG002|Overall Study|Lost to Follow-up|0|||
163295517|NCT00712335|589788631|FG003|Overall Study|Lost to Follow-up|1|||
163295518|NCT00712335|589788632|FG004|Overall Study|Lost to Follow-up|0|||
163295519|NCT00712335|589788628|FG000|Overall Study|Protocol Violation|1|||
163295520|NCT00712335|589788629|FG001|Overall Study|Protocol Violation|2|||
163295521|NCT00712335|589788630|FG002|Overall Study|Protocol Violation|1|||
163295522|NCT00712335|589788631|FG003|Overall Study|Protocol Violation|0|||
163295523|NCT00712335|589788632|FG004|Overall Study|Protocol Violation|0|||
163295524|NCT00712335|589788628|FG000|Overall Study|Lack of Efficacy|0|||
163295525|NCT00712335|589788629|FG001|Overall Study|Lack of Efficacy|0|||
163295526|NCT00712335|589788630|FG002|Overall Study|Lack of Efficacy|1|||
163295527|NCT00712335|589788631|FG003|Overall Study|Lack of Efficacy|1|||
163295528|NCT00712335|589788632|FG004|Overall Study|Lack of Efficacy|0|||
163295529|NCT00712335|589788628|FG000|Overall Study|Other Reason|0|||
163295530|NCT00712335|589788629|FG001|Overall Study|Other Reason|3|||
163295531|NCT00712335|589788630|FG002|Overall Study|Other Reason|1|||
163295532|NCT00712335|589788631|FG003|Overall Study|Other Reason|0|||
163295533|NCT00712335|589788632|FG004|Overall Study|Other Reason|0|||
163295534|NCT03401112|589788633|FG000|Overall Study|Adverse Event|1|||
163295535|NCT03401112|589788634|FG001|Overall Study|Adverse Event|2|||
163295536|NCT03401112|589788635|FG002|Overall Study|Adverse Event|3|||
163295537|NCT03401112|589788636|FG003|Overall Study|Adverse Event|2|||
163295538|NCT03401112|589788637|FG004|Overall Study|Adverse Event|0|||
163295539|NCT03401112|589788633|FG000|Overall Study|Lost to Follow-up|1|||
163295540|NCT03401112|589788634|FG001|Overall Study|Lost to Follow-up|0|||
163295541|NCT03401112|589788635|FG002|Overall Study|Lost to Follow-up|0|||
163295542|NCT03401112|589788636|FG003|Overall Study|Lost to Follow-up|0|||
163295543|NCT03401112|589788637|FG004|Overall Study|Lost to Follow-up|0|||
163295544|NCT03401112|589788633|FG000|Overall Study|Noncompliance|1|||
163295545|NCT03401112|589788634|FG001|Overall Study|Noncompliance|2|||
163295546|NCT03401112|589788635|FG002|Overall Study|Noncompliance|3|||
163295547|NCT03401112|589788636|FG003|Overall Study|Noncompliance|0|||
163295548|NCT03401112|589788637|FG004|Overall Study|Noncompliance|0|||
163295549|NCT03401112|589788633|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
163295550|NCT03401112|589788634|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
163295551|NCT03401112|589788635|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
163295552|NCT03401112|589788636|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
163295553|NCT03401112|589788637|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
163295554|NCT03401112|589788633|FG000|Overall Study|Withdrawal by Subject|0|||
163295555|NCT03401112|589788634|FG001|Overall Study|Withdrawal by Subject|3|||
163295556|NCT03401112|589788635|FG002|Overall Study|Withdrawal by Subject|2|||
163295557|NCT03401112|589788636|FG003|Overall Study|Withdrawal by Subject|1|||
163295558|NCT03401112|589788637|FG004|Overall Study|Withdrawal by Subject|0|||
163295559|NCT03401112|589788633|FG000|Overall Study|Physician Decision|0|||
163295560|NCT03401112|589788634|FG001|Overall Study|Physician Decision|0|||
163295561|NCT03401112|589788635|FG002|Overall Study|Physician Decision|0|||
163295562|NCT03401112|589788636|FG003|Overall Study|Physician Decision|2|||
163191136|NCT02975336|589415846|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
163191137|NCT02975336|589415847|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
163191138|NCT02975336|589415848|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
163191139|NCT02975336|589415849|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
163191140|NCT02975336|589415842|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
163191141|NCT02975336|589415843|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
163191142|NCT02975336|589415844|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
163191143|NCT02975336|589415845|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
163191144|NCT02975336|589415846|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
163191145|NCT02975336|589415847|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
163191146|NCT02975336|589415848|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
163191147|NCT02975336|589415849|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
163191148|NCT02975336|589415842|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
163191149|NCT02975336|589415843|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
163191150|NCT02975336|589415844|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
163191151|NCT02975336|589415845|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
163191152|NCT02975336|589415846|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
163191153|NCT02975336|589415847|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
163191154|NCT02975336|589415848|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
163191155|NCT02975336|589415849|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
163191156|NCT02975336|589415842|FG000|LTE (104 Weeks)|Adverse Event|0|||
163191157|NCT02975336|589415843|FG001|LTE (104 Weeks)|Adverse Event|0|||
163191158|NCT02975336|589415844|FG002|LTE (104 Weeks)|Adverse Event|0|||
163191159|NCT02975336|589415845|FG003|LTE (104 Weeks)|Adverse Event|0|||
163191160|NCT02975336|589415846|FG004|LTE (104 Weeks)|Adverse Event|7|||
163191161|NCT02975336|589415847|FG005|LTE (104 Weeks)|Adverse Event|4|||
163191162|NCT02975336|589415848|FG006|LTE (104 Weeks)|Adverse Event|2|||
163191163|NCT02975336|589415849|FG007|LTE (104 Weeks)|Adverse Event|0|||
163191164|NCT02975336|589415842|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
163191165|NCT02975336|589415843|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
163191166|NCT02975336|589415844|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
163191167|NCT02975336|589415845|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
163191168|NCT02975336|589415846|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
163191169|NCT02975336|589415847|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
163191170|NCT02975336|589415848|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
163191171|NCT02975336|589415849|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
163295563|NCT03401112|589788637|FG004|Overall Study|Physician Decision|0|||
163295564|NCT03401112|589788633|FG000|Overall Study|Study was Terminated by Sponsor|0|||
163295565|NCT03401112|589788634|FG001|Overall Study|Study was Terminated by Sponsor|0|||
163295566|NCT03401112|589788635|FG002|Overall Study|Study was Terminated by Sponsor|0|||
163295567|NCT03401112|589788636|FG003|Overall Study|Study was Terminated by Sponsor|1|||
163295568|NCT03401112|589788637|FG004|Overall Study|Study was Terminated by Sponsor|0|||
163295569|NCT03401112|589788633|FG000|Overall Study|Day 1 Assessment not Done|1|||
163295570|NCT03401112|589788634|FG001|Overall Study|Day 1 Assessment not Done|0|||
163295571|NCT03401112|589788635|FG002|Overall Study|Day 1 Assessment not Done|0|||
163295572|NCT03401112|589788636|FG003|Overall Study|Day 1 Assessment not Done|0|||
163295573|NCT03401112|589788637|FG004|Overall Study|Day 1 Assessment not Done|0|||
163295574|NCT03401112|589788633|FG000|Overall Study|Not Dosed|0|||
163295575|NCT03401112|589788634|FG001|Overall Study|Not Dosed|0|||
163295576|NCT03401112|589788635|FG002|Overall Study|Not Dosed|1|||
163295577|NCT03401112|589788636|FG003|Overall Study|Not Dosed|0|||
163295578|NCT03401112|589788637|FG004|Overall Study|Not Dosed|0|||
163295579|NCT03401112|589788633|FG000|Overall Study|Missed Clinical Visit|0|||
163295580|NCT03401112|589788634|FG001|Overall Study|Missed Clinical Visit|0|||
163295581|NCT03401112|589788635|FG002|Overall Study|Missed Clinical Visit|1|||
163295582|NCT03401112|589788636|FG003|Overall Study|Missed Clinical Visit|0|||
163295583|NCT03401112|589788637|FG004|Overall Study|Missed Clinical Visit|0|||
163295584|NCT03401112|589788633|FG000|Overall Study|Missed Doses|0|||
163295585|NCT03401112|589788634|FG001|Overall Study|Missed Doses|0|||
163295586|NCT03401112|589788635|FG002|Overall Study|Missed Doses|1|||
163295587|NCT03401112|589788636|FG003|Overall Study|Missed Doses|0|||
163295588|NCT03401112|589788637|FG004|Overall Study|Missed Doses|0|||
163295589|NCT01264679|589788638|FG000|Overall Study|Participation in Another Clinical Trial|1|||
163295590|NCT01264679|589788638|FG000|Overall Study|Physician Decision|1|||
163295591|NCT01264679|589788638|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
163295592|NCT01264679|589788638|FG000|Overall Study|Withdrawal by Subject|1|||
163295593|NCT03475316|589788639|FG000|6 Month Intervention|Adverse Event|2|||
163295594|NCT03475316|589788640|FG001|6 Month Intervention|Adverse Event|1|||
163295595|NCT03475316|589788639|FG000|6 Month Intervention|Withdrawal by Subject|2|||
163191172|NCT02975336|589415842|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
163191173|NCT02975336|589415843|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
163191174|NCT02975336|589415844|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
163295596|NCT03475316|589788640|FG001|6 Month Intervention|Withdrawal by Subject|0|||
163295597|NCT03475316|589788639|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
163295598|NCT03475316|589788640|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
163295599|NCT03475316|589788639|FG000|9 Months|Study stopped due to COVID pandemic|3|||
163295600|NCT03475316|589788640|FG001|9 Months|Study stopped due to COVID pandemic|4|||
163295601|NCT01837966|589788647|FG000|Overall Study|Withdrawal by Subject|2|||
163295602|NCT01837966|589788648|FG001|Overall Study|Withdrawal by Subject|1|||
163295603|NCT04975308|589788652|FG000|Overall Study|Withdrawal by Subject|6|||
163295604|NCT04975308|589788653|FG001|Overall Study|Withdrawal by Subject|16|||
163295605|NCT04975308|589788654|FG002|Overall Study|Withdrawal by Subject|6|||
163295606|NCT04975308|589788652|FG000|Overall Study|Physician Decision|0|||
163295607|NCT04975308|589788653|FG001|Overall Study|Physician Decision|3|||
163295608|NCT04975308|589788654|FG002|Overall Study|Physician Decision|1|||
163295609|NCT04975308|589788652|FG000|Overall Study|Adverse Event|10|||
163295610|NCT04975308|589788653|FG001|Overall Study|Adverse Event|1|||
163295611|NCT04975308|589788654|FG002|Overall Study|Adverse Event|12|||
163295612|NCT04975308|589788652|FG000|Overall Study|On study treatment (Ongoing)|65|||
163295613|NCT04975308|589788653|FG001|Overall Study|On study treatment (Ongoing)|43|||
163295614|NCT04975308|589788654|FG002|Overall Study|On study treatment (Ongoing)|75|||
163295615|NCT04975308|589788652|FG000|Overall Study|Protocol Deviation|4|||
163295616|NCT04975308|589788653|FG001|Overall Study|Protocol Deviation|3|||
163295617|NCT04975308|589788654|FG002|Overall Study|Protocol Deviation|2|||
163295618|NCT03654768|589788655|FG000|Overall Study|Adverse Event|1|||
163295619|NCT03654768|589788656|FG001|Overall Study|Adverse Event|6|||
163295620|NCT03654768|589788655|FG000|Overall Study|Loss of response|2|||
163295621|NCT03654768|589788656|FG001|Overall Study|Loss of response|2|||
163295622|NCT03654768|589788655|FG000|Overall Study|Non-compliance|0|||
163295623|NCT03654768|589788656|FG001|Overall Study|Non-compliance|1|||
163295624|NCT03654768|589788655|FG000|Overall Study|Refusal not related to toxicity|1|||
163295625|NCT03654768|589788656|FG001|Overall Study|Refusal not related to toxicity|5|||
163295626|NCT03654768|589788655|FG000|Overall Study|Did not receive protocol therapy|1|||
163295627|NCT03654768|589788656|FG001|Overall Study|Did not receive protocol therapy|1|||
163295628|NCT00547118|589788659|FG000|Overall Study|Did not qualify prior to starting drug|1|||
163295629|NCT00547118|589788660|FG001|Overall Study|Did not qualify prior to starting drug|1|||
163295630|NCT00547118|589788659|FG000|Overall Study|Study suspended|7|||
163295631|NCT00547118|589788660|FG001|Overall Study|Study suspended|8|||
163295632|NCT01585558|589788664|FG000|Overall Study|Withdrawal by Subject|4|||
163295633|NCT01585558|589788665|FG001|Overall Study|Withdrawal by Subject|5|||
163295634|NCT01585558|589788666|FG002|Overall Study|Withdrawal by Subject|8|||
163295635|NCT01585558|589788664|FG000|Overall Study|Lost to Follow-up|2|||
163295636|NCT01585558|589788665|FG001|Overall Study|Lost to Follow-up|0|||
163295637|NCT01585558|589788666|FG002|Overall Study|Lost to Follow-up|3|||
163295638|NCT01585558|589788664|FG000|Overall Study|Adverse Event|3|||
163295639|NCT01585558|589788665|FG001|Overall Study|Adverse Event|4|||
163295640|NCT01585558|589788666|FG002|Overall Study|Adverse Event|1|||
163295641|NCT01585558|589788664|FG000|Overall Study|Protocol Violation|4|||
163295642|NCT01585558|589788665|FG001|Overall Study|Protocol Violation|3|||
163295643|NCT01585558|589788666|FG002|Overall Study|Protocol Violation|2|||
163295644|NCT01585558|589788664|FG000|Overall Study|Lack of Efficacy|0|||
163295645|NCT01585558|589788665|FG001|Overall Study|Lack of Efficacy|0|||
163295646|NCT01585558|589788666|FG002|Overall Study|Lack of Efficacy|1|||
163295647|NCT02994654|589788669|FG000|Overall Study|Lost to Follow-up|1|||
163295648|NCT00732381|589788674|FG000|Overall Study|Adverse Event|1|||
163295649|NCT00732381|589788675|FG001|Overall Study|Adverse Event|0|||
163295650|NCT00732381|589788674|FG000|Overall Study|Treatment Failure|1|||
163295651|NCT00732381|589788675|FG001|Overall Study|Treatment Failure|1|||
163295652|NCT00414544|589789651|FG000|Overall Study|Lost to Follow-up|14|||
163295653|NCT01599104|589789652|FG000|Overall Study|Withdrawal by Subject|1|||
163295654|NCT01599104|589789653|FG001|Overall Study|Withdrawal by Subject|1|||
163295655|NCT01599104|589789654|FG002|Overall Study|Withdrawal by Subject|2|||
163295656|NCT01599104|589789652|FG000|Overall Study|Technical Problems|1|||
163295657|NCT01599104|589789653|FG001|Overall Study|Technical Problems|0|||
163295658|NCT01599104|589789654|FG002|Overall Study|Technical Problems|0|||
163295659|NCT01599104|589789652|FG000|Overall Study|Physician Decision|3|||
163295660|NCT01599104|589789653|FG001|Overall Study|Physician Decision|2|||
163295661|NCT01599104|589789654|FG002|Overall Study|Physician Decision|2|||
163295662|NCT01599104|589789652|FG000|Overall Study|Non-compliance with study treatment|0|||
163295663|NCT01599104|589789653|FG001|Overall Study|Non-compliance with study treatment|1|||
163295664|NCT01599104|589789654|FG002|Overall Study|Non-compliance with study treatment|0|||
163295665|NCT01599104|589789652|FG000|Overall Study|Lack of Efficacy|4|||
163295666|NCT01599104|589789653|FG001|Overall Study|Lack of Efficacy|4|||
163295667|NCT01599104|589789654|FG002|Overall Study|Lack of Efficacy|10|||
163295668|NCT01599104|589789652|FG000|Overall Study|Adverse Event|7|||
163295669|NCT01599104|589789653|FG001|Overall Study|Adverse Event|6|||
163295670|NCT01599104|589789654|FG002|Overall Study|Adverse Event|12|||
163295671|NCT00714714|589789657|FG000|Overall Study|Adverse Event|1|||
163295672|NCT02616900|589789658|FG000|Overall Study|Lack of Efficacy|7|||
163295673|NCT02616900|589789658|FG000|Overall Study|Lost to Follow-up|2|||
163295674|NCT02616900|589789658|FG000|Overall Study|Protocol Violation|5|||
163295675|NCT02616900|589789658|FG000|Overall Study|Withdrawal by Subject|3|||
163295676|NCT02616900|589789658|FG000|Overall Study|Incomplete data|6|||
163295677|NCT04425863|589789659|FG000|Overall Study|Death|0|||
163295678|NCT04425863|589789660|FG001|Overall Study|Death|0|||
163295679|NCT04425863|589789661|FG002|Overall Study|Death|1|||
163295680|NCT02448446|589789663|FG000|Overall Study|Withdrawal by Subject|1|||
163295681|NCT02448446|589789664|FG001|Overall Study|Withdrawal by Subject|0|||
163295682|NCT00463788|589789665|FG000|Overall Study|Progressive Disease|86|||
163295683|NCT00463788|589789666|FG001|Overall Study|Progressive Disease|42|||
163295684|NCT00463788|589789665|FG000|Overall Study|Adverse Event|6|||
163295685|NCT00463788|589789666|FG001|Overall Study|Adverse Event|2|||
163295686|NCT00463788|589789665|FG000|Overall Study|Withdrawal by Subject|6|||
163295687|NCT00463788|589789666|FG001|Overall Study|Withdrawal by Subject|2|||
163295688|NCT00463788|589789665|FG000|Overall Study|Death|4|||
163295689|NCT00463788|589789666|FG001|Overall Study|Death|3|||
163295690|NCT00463788|589789665|FG000|Overall Study|Symptomatic Deterioration|2|||
163295691|NCT00463788|589789666|FG001|Overall Study|Symptomatic Deterioration|3|||
163295692|NCT00463788|589789665|FG000|Overall Study|Lost to Follow-up|1|||
163295693|NCT00463788|589789666|FG001|Overall Study|Lost to Follow-up|0|||
163295694|NCT00463788|589789665|FG000|Overall Study|Protocol Violation|0|||
163295695|NCT00463788|589789666|FG001|Overall Study|Protocol Violation|1|||
163295696|NCT00463788|589789665|FG000|Overall Study|Other|3|||
163295697|NCT00463788|589789666|FG001|Overall Study|Other|0|||
163295698|NCT00463788|589789665|FG000|Overall Study|Randomized but not treated|1|||
163295699|NCT00463788|589789666|FG001|Overall Study|Randomized but not treated|1|||
163295700|NCT00360698|589789667|FG000|Run-In|Physician Decision|0|||
163295701|NCT00360698|589789668|FG001|Run-In|Physician Decision|1|||
163295702|NCT00360698|589789667|FG000|Run-In|Withdrawal by Subject|0|||
163295703|NCT00360698|589789668|FG001|Run-In|Withdrawal by Subject|2|||
163295704|NCT00360698|589789667|FG000|Run-In|Non compliance with treatment procedure|0|||
163295705|NCT00360698|589789668|FG001|Run-In|Non compliance with treatment procedure|1|||
163295706|NCT00360698|589789667|FG000|Run-In|Sponsor request|0|||
163295707|NCT00360698|589789668|FG001|Run-In|Sponsor request|2|||
163295708|NCT00360698|589789667|FG000|Run-In|Patient did not meet inclusion criteria|0|||
163295709|NCT00360698|589789668|FG001|Run-In|Patient did not meet inclusion criteria|1|||
163295710|NCT00360698|589789667|FG000|Run-In|Patient personal reasons|0|||
163295711|NCT00360698|589789668|FG001|Run-In|Patient personal reasons|2|||
163295712|NCT00360698|589789667|FG000|Run-In|Need of insulin with meals|0|||
163295713|NCT00360698|589789668|FG001|Run-In|Need of insulin with meals|1|||
163295714|NCT00360698|589789667|FG000|Treatment Period|Non compliance with treatment procedure|1|||
163295715|NCT00360698|589789668|FG001|Treatment Period|Non compliance with treatment procedure|0|||
163391384|NCT01658826|590144718|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
163295716|NCT00360698|589789667|FG000|Treatment Period|Early termination by error|0|||
163391385|NCT01658826|590144719|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
163391386|NCT01658826|590144718|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
163401995|NCT01840579|590182957|FG004|Overall Study|Follow-up ended by Sponsor|0|||
162952081|NCT02422264|588529537|FG000|Overall Study|Serious Adverse Event|1|||
163295717|NCT00360698|589789668|FG001|Treatment Period|Early termination by error|1|||
163295718|NCT01692938|589789671|FG000|Overall Study|Protocol Deviation|1|||
163295719|NCT01692938|589789672|FG001|Overall Study|Protocol Deviation|1|||
163295720|NCT01692938|589789671|FG000|Overall Study|Study completed prior to site completion|3|||
163191175|NCT02975336|589415845|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
163191176|NCT02975336|589415846|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
163191177|NCT02975336|589415847|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
163191178|NCT02975336|589415848|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
163191179|NCT02975336|589415849|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
163191180|NCT02975336|589415842|FG000|LTE (104 Weeks)|Other|0|||
163191181|NCT02975336|589415843|FG001|LTE (104 Weeks)|Other|0|||
163191182|NCT02975336|589415844|FG002|LTE (104 Weeks)|Other|0|||
163191183|NCT02975336|589415845|FG003|LTE (104 Weeks)|Other|0|||
163191184|NCT02975336|589415846|FG004|LTE (104 Weeks)|Other|55|||
163191185|NCT02975336|589415847|FG005|LTE (104 Weeks)|Other|63|||
163191186|NCT02975336|589415848|FG006|LTE (104 Weeks)|Other|76|||
163191187|NCT02975336|589415849|FG007|LTE (104 Weeks)|Other|72|||
163191188|NCT02008318|589415852|FG000|Overall Study|Adverse Event|4|||
163191189|NCT02008318|589415853|FG001|Overall Study|Adverse Event|0|||
163191190|NCT02008318|589415852|FG000|Overall Study|Physician Decision|2|||
163191191|NCT02008318|589415853|FG001|Overall Study|Physician Decision|0|||
163191192|NCT02008318|589415852|FG000|Overall Study|Progressive Disease|2|||
163191193|NCT02008318|589415853|FG001|Overall Study|Progressive Disease|0|||
163191194|NCT02008318|589415852|FG000|Overall Study|Protocol Violation|1|||
163191195|NCT02008318|589415853|FG001|Overall Study|Protocol Violation|1|||
163191196|NCT02008318|589415852|FG000|Overall Study|Withdrawal by Subject|3|||
163191197|NCT02008318|589415853|FG001|Overall Study|Withdrawal by Subject|0|||
163191198|NCT02281773|589415854|FG000|Overall Study|Adverse Event|6|||
163191199|NCT02281773|589415855|FG001|Overall Study|Adverse Event|1|||
163191200|NCT02281773|589415856|FG002|Overall Study|Adverse Event|4|||
163191201|NCT02281773|589415857|FG003|Overall Study|Adverse Event|8|||
163191202|NCT02281773|589415858|FG004|Overall Study|Adverse Event|9|||
163191203|NCT02281773|589415854|FG000|Overall Study|Protocol Violation|1|||
163191204|NCT02281773|589415855|FG001|Overall Study|Protocol Violation|0|||
163191205|NCT02281773|589415856|FG002|Overall Study|Protocol Violation|0|||
163191206|NCT02281773|589415857|FG003|Overall Study|Protocol Violation|2|||
163191207|NCT02281773|589415858|FG004|Overall Study|Protocol Violation|2|||
163191208|NCT02281773|589415854|FG000|Overall Study|Lost to Follow-up|2|||
163191209|NCT02281773|589415855|FG001|Overall Study|Lost to Follow-up|2|||
163191210|NCT02281773|589415856|FG002|Overall Study|Lost to Follow-up|6|||
163191211|NCT02281773|589415857|FG003|Overall Study|Lost to Follow-up|2|||
163191212|NCT02281773|589415858|FG004|Overall Study|Lost to Follow-up|10|||
163191213|NCT02281773|589415854|FG000|Overall Study|Withdrawal by Subject|2|||
163191214|NCT02281773|589415855|FG001|Overall Study|Withdrawal by Subject|8|||
163295721|NCT01692938|589789672|FG001|Overall Study|Study completed prior to site completion|3|||
163295722|NCT02200770|589789673|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
163295723|NCT02200770|589789674|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
163191215|NCT02281773|589415856|FG002|Overall Study|Withdrawal by Subject|6|||
163191216|NCT02281773|589415857|FG003|Overall Study|Withdrawal by Subject|6|||
163191217|NCT02281773|589415858|FG004|Overall Study|Withdrawal by Subject|8|||
163191218|NCT02281773|589415854|FG000|Overall Study|Other Reason|0|||
163191219|NCT02281773|589415855|FG001|Overall Study|Other Reason|4|||
163191220|NCT02281773|589415856|FG002|Overall Study|Other Reason|2|||
163191221|NCT02281773|589415857|FG003|Overall Study|Other Reason|3|||
163191222|NCT02281773|589415858|FG004|Overall Study|Other Reason|1|||
163391387|NCT01658826|590144719|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
163391388|NCT03610165|590144721|FG000|Overall Study|Device didn't work|0|||
163391389|NCT03610165|590144722|FG001|Overall Study|Device didn't work|1|||
163391390|NCT02383589|590144724|FG000|Treatment Period|Adverse Event|1|||
163391391|NCT02383589|590144725|FG001|Treatment Period|Adverse Event|3|||
163391392|NCT02383589|590144724|FG000|Treatment Period|Lost to Follow-up|0|||
163391393|NCT02383589|590144725|FG001|Treatment Period|Lost to Follow-up|1|||
163391394|NCT02383589|590144724|FG000|Treatment Period|Withdrawal by Subject|0|||
163391395|NCT02383589|590144725|FG001|Treatment Period|Withdrawal by Subject|5|||
163391396|NCT02383589|590144724|FG000|Treatment Period|Non-compliance with study drug|0|||
163391397|NCT02383589|590144725|FG001|Treatment Period|Non-compliance with study drug|1|||
163391398|NCT02383589|590144724|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
163391399|NCT02383589|590144725|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
163391400|NCT02383589|590144724|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
163391401|NCT02383589|590144725|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
163391402|NCT02383589|590144724|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
163391403|NCT02383589|590144725|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
163391404|NCT04752475|590146065|FG000|Overall Study|Withdrawal by Subject|1|||
163391405|NCT04752475|590146066|FG001|Overall Study|Withdrawal by Subject|1|||
163391406|NCT01310803|590146072|FG000|Overall Study|Subject terminated by Sponsor|1|||
163191223|NCT00385762|589415859|FG000|Overall Study|Adverse Event|1|||
163391407|NCT01310803|590146073|FG001|Overall Study|Subject terminated by Sponsor|0|||
163391408|NCT02113579|590146076|FG000|Overall Study|Adverse Event|1|||
163391409|NCT02113579|590146077|FG001|Overall Study|Adverse Event|0|||
163391410|NCT02113579|590146076|FG000|Overall Study|Withdrawal by Subject|3|||
163191224|NCT00385762|589415859|FG000|Overall Study|Lost to Follow-up|1|||
163191225|NCT01856907|589415867|FG000|Overall Study|Pregnancy|0|||
163191226|NCT01856907|589415868|FG001|Overall Study|Pregnancy|1|||
163191227|NCT01856907|589415869|FG002|Overall Study|Pregnancy|0|||
163191228|NCT01856907|589415867|FG000|Overall Study|Pregnancy|0|||
163191229|NCT01856907|589415868|FG001|Overall Study|Pregnancy|1|||
163191230|NCT01856907|589415869|FG002|Overall Study|Pregnancy|0|||
163191231|NCT01856907|589415867|FG000|Overall Study|Withdrawal by Subject|0|||
163191232|NCT01856907|589415868|FG001|Overall Study|Withdrawal by Subject|1|||
163191233|NCT01856907|589415869|FG002|Overall Study|Withdrawal by Subject|0|||
163191234|NCT01436396|589415870|FG000|Overall Study|Protocol Violation|7|||
163191235|NCT01436396|589415871|FG001|Overall Study|Protocol Violation|5|||
163191236|NCT01436396|589415870|FG000|Overall Study|Adverse Event|1|||
163191237|NCT01436396|589415871|FG001|Overall Study|Adverse Event|2|||
163191238|NCT01436396|589415870|FG000|Overall Study|Withdrawal by Subject|19|||
163191239|NCT01436396|589415871|FG001|Overall Study|Withdrawal by Subject|29|||
163191240|NCT01436396|589415870|FG000|Overall Study|Serious adverse event|2|||
163191241|NCT01436396|589415871|FG001|Overall Study|Serious adverse event|3|||
163191242|NCT01436396|589415870|FG000|Overall Study|Lost to Follow-up|3|||
163191243|NCT01436396|589415871|FG001|Overall Study|Lost to Follow-up|3|||
163191244|NCT04674644|589415873|FG000|Overall Study|with missing data|37|||
163191245|NCT03469934|589415874|FG000|Overall Study|Withdrawal by Subject|0|||
163191246|NCT03469934|589415875|FG001|Overall Study|Withdrawal by Subject|1|||
163191247|NCT01024231|589415877|FG000|Overall Study|Other Reasons|1|||
163191248|NCT01024231|589415878|FG001|Overall Study|Other Reasons|2|||
163191249|NCT01024231|589415879|FG002|Overall Study|Other Reasons|0|||
163191250|NCT01024231|589415880|FG003|Overall Study|Other Reasons|0|||
163191251|NCT01024231|589415881|FG004|Overall Study|Other Reasons|2|||
163191252|NCT01024231|589415882|FG005|Overall Study|Other Reasons|0|||
163191253|NCT01024231|589415883|FG006|Overall Study|Other Reasons|1|||
163191254|NCT01024231|589415877|FG000|Overall Study|Maximum Clinical Benefit|1|||
163191255|NCT01024231|589415878|FG001|Overall Study|Maximum Clinical Benefit|2|||
163191256|NCT01024231|589415879|FG002|Overall Study|Maximum Clinical Benefit|0|||
163191257|NCT01024231|589415880|FG003|Overall Study|Maximum Clinical Benefit|1|||
163391411|NCT02113579|590146077|FG001|Overall Study|Withdrawal by Subject|2|||
163391412|NCT02113579|590146076|FG000|Overall Study|Lost to Follow-up|6|||
163191258|NCT01024231|589415881|FG004|Overall Study|Maximum Clinical Benefit|1|||
163191259|NCT01024231|589415882|FG005|Overall Study|Maximum Clinical Benefit|0|||
163191260|NCT01024231|589415883|FG006|Overall Study|Maximum Clinical Benefit|0|||
163295724|NCT02200770|589789673|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
163295725|NCT02200770|589789674|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
163295726|NCT02200770|589789673|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
163295727|NCT02200770|589789674|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
163295728|NCT02200770|589789673|FG000|Randomized-controlled Period (RCP)|Other|1|||
163295729|NCT02200770|589789674|FG001|Randomized-controlled Period (RCP)|Other|2|||
163295730|NCT02200770|589789673|FG000|Open-label Period (OLP)|Adverse Event|1|||
163295731|NCT02200770|589789674|FG001|Open-label Period (OLP)|Adverse Event|2|||
163295732|NCT02200770|589789673|FG000|Open-label Period (OLP)|Death|1|||
163295733|NCT02200770|589789674|FG001|Open-label Period (OLP)|Death|2|||
163295734|NCT02200770|589789673|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
163295735|NCT02200770|589789674|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
163295736|NCT02200770|589789673|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
163295737|NCT02200770|589789674|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
163295738|NCT02200770|589789673|FG000|Open-label Period (OLP)|Other|6|||
163295739|NCT02200770|589789674|FG001|Open-label Period (OLP)|Other|15|||
163295740|NCT00424645|589789678|FG000|Overall Study|Death|1|||
163295741|NCT00424645|589789679|FG001|Overall Study|Death|0|||
163295742|NCT02555215|589789680|FG000|Overall Study|Other|1|||
163295743|NCT02555215|589789680|FG000|Overall Study|Investigator Decision|2|||
163295744|NCT00529789|589789681|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
163295745|NCT00529789|589789681|FG000|Study Period II/III|Adverse Event|3|||
163295746|NCT00529789|589789681|FG000|Study Period II/III|Lack of Efficacy|2|||
163295747|NCT00529789|589789681|FG000|Study Period II/III|Withdrawal by Subject|1|||
163295748|NCT00529789|589789681|FG000|Study Period II/III|Protocol Violation|3|||
163295749|NCT00529789|589789681|FG000|Study Period II/III|Physician Decision|3|||
163295750|NCT00529789|589789681|FG000|Study Period II/III|Lost to Follow-up|3|||
163295751|NCT00529789|589789681|FG000|Study Period IV|Parent/Caregiver Decision|1|||
163295752|NCT00529789|589789681|FG000|Study Period IV|Adverse Event|1|||
163295753|NCT00529789|589789681|FG000|Study Period IV|Lack of Efficacy|1|||
163295754|NCT00529789|589789681|FG000|Study Period IV|Lost to Follow-up|3|||
163295755|NCT02204982|589789682|FG000|Overall Study|Patient ineligible-medical monitor|1|||
163295756|NCT02204982|589789683|FG001|Overall Study|Patient ineligible-medical monitor|0|||
163295757|NCT02204982|589789682|FG000|Overall Study|Withdrawal by Subject|1|||
163295758|NCT02204982|589789683|FG001|Overall Study|Withdrawal by Subject|0|||
163295759|NCT02204982|589789682|FG000|Overall Study|Adverse Event|1|||
163295760|NCT02204982|589789683|FG001|Overall Study|Adverse Event|0|||
163295761|NCT02204982|589789682|FG000|Overall Study|Adverse Event and Investigator decision|1|||
163295762|NCT02204982|589789683|FG001|Overall Study|Adverse Event and Investigator decision|0|||
163295763|NCT02204982|589789682|FG000|Overall Study|Physician Decision|0|||
163295764|NCT02204982|589789683|FG001|Overall Study|Physician Decision|2|||
163295765|NCT02204982|589789682|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
163295766|NCT02204982|589789683|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
163295767|NCT02204982|589789682|FG000|Overall Study|Termination of Study bySponsor|0|||
163295768|NCT02204982|589789683|FG001|Overall Study|Termination of Study bySponsor|1|||
163295769|NCT01968226|589789684|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
163295770|NCT00959946|589789687|FG000|Overall Study|Adverse Event|0|||
163295771|NCT00959946|589789688|FG001|Overall Study|Adverse Event|0|||
163295772|NCT00959946|589789689|FG002|Overall Study|Adverse Event|2|||
163295773|NCT00959946|589789690|FG003|Overall Study|Adverse Event|1|||
163295774|NCT00959946|589789691|FG004|Overall Study|Adverse Event|0|||
163295775|NCT00959946|589789692|FG005|Overall Study|Adverse Event|1|||
163295776|NCT00959946|589789693|FG006|Overall Study|Adverse Event|0|||
163295777|NCT00959946|589789694|FG007|Overall Study|Adverse Event|0|||
163295778|NCT00959946|589789687|FG000|Overall Study|Death|0|||
163295779|NCT00959946|589789688|FG001|Overall Study|Death|0|||
163295780|NCT00959946|589789689|FG002|Overall Study|Death|0|||
163295781|NCT00959946|589789690|FG003|Overall Study|Death|0|||
163295782|NCT00959946|589789691|FG004|Overall Study|Death|0|||
163295783|NCT00959946|589789692|FG005|Overall Study|Death|1|||
163295784|NCT00959946|589789693|FG006|Overall Study|Death|0|||
163295785|NCT00959946|589789694|FG007|Overall Study|Death|0|||
163295786|NCT00959946|589789687|FG000|Overall Study|Disease Progression|2|||
163295787|NCT00959946|589789688|FG001|Overall Study|Disease Progression|4|||
163295788|NCT00959946|589789689|FG002|Overall Study|Disease Progression|2|||
163295789|NCT00959946|589789690|FG003|Overall Study|Disease Progression|4|||
163295790|NCT00959946|589789691|FG004|Overall Study|Disease Progression|4|||
163295791|NCT00959946|589789692|FG005|Overall Study|Disease Progression|6|||
163295792|NCT00959946|589789693|FG006|Overall Study|Disease Progression|2|||
163295793|NCT00959946|589789694|FG007|Overall Study|Disease Progression|2|||
163295794|NCT00959946|589789687|FG000|Overall Study|Withdrawal by Subject|0|||
163295795|NCT00959946|589789688|FG001|Overall Study|Withdrawal by Subject|0|||
163391413|NCT02113579|590146077|FG001|Overall Study|Lost to Follow-up|2|||
163295796|NCT00959946|589789689|FG002|Overall Study|Withdrawal by Subject|0|||
163295797|NCT00959946|589789690|FG003|Overall Study|Withdrawal by Subject|0|||
163295798|NCT00959946|589789691|FG004|Overall Study|Withdrawal by Subject|0|||
163295799|NCT00959946|589789692|FG005|Overall Study|Withdrawal by Subject|1|||
163295800|NCT00959946|589789693|FG006|Overall Study|Withdrawal by Subject|0|||
163295801|NCT00959946|589789694|FG007|Overall Study|Withdrawal by Subject|0|||
163295802|NCT00457743|589789695|FG000|Overall Study|Adverse Event|0|||
163295803|NCT00457743|589789696|FG001|Overall Study|Adverse Event|4|||
163295804|NCT00457743|589789697|FG002|Overall Study|Adverse Event|0|||
163295805|NCT00457743|589789695|FG000|Overall Study|Lack of Efficacy|3|||
163295806|NCT00457743|589789696|FG001|Overall Study|Lack of Efficacy|23|||
163295807|NCT00457743|589789697|FG002|Overall Study|Lack of Efficacy|3|||
163295808|NCT00468910|589789698|FG000|Overall Study|Lost to Follow-up|2|||
163295809|NCT00468910|589789699|FG001|Overall Study|Lost to Follow-up|1|||
163295810|NCT00468910|589789698|FG000|Overall Study|Withdrawal by Subject|2|||
163295811|NCT00468910|589789699|FG001|Overall Study|Withdrawal by Subject|1|||
163295812|NCT00468910|589789698|FG000|Overall Study|Medical Contraindication|0|||
163295813|NCT00468910|589789699|FG001|Overall Study|Medical Contraindication|1|||
163295814|NCT01909778|589789700|FG000|Overall Study|failed screening|1|||
163295815|NCT01943916|589789701|FG000|Overall Study|Technically invalid images|10|||
163295816|NCT01943916|589789701|FG000|Overall Study|Enrollment Failure|23|||
163295817|NCT01943916|589789701|FG000|Overall Study|Pilot Phase exclusion|100|||
163295818|NCT01943916|589789701|FG000|Overall Study|Quality Assurance Reader Fail|130|||
163295819|NCT01943916|589789701|FG000|Overall Study|Technical Failure|39|||
163295820|NCT01943916|589789701|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
163295821|NCT01943916|589789701|FG000|Overall Study|No Truth Panel Review|38|||
163295822|NCT01943916|589789701|FG000|Overall Study|Protocol Deviation|1|||
163295823|NCT00919763|589789702|FG000|Overall Study|Adverse Event|7|||
163295824|NCT00919763|589789703|FG001|Overall Study|Adverse Event|1|||
163295825|NCT00919763|589789702|FG000|Overall Study|Lost to Follow-up|1|||
163295826|NCT00919763|589789703|FG001|Overall Study|Lost to Follow-up|0|||
163295827|NCT00919763|589789702|FG000|Overall Study|Protocol Violation|1|||
163295828|NCT00919763|589789703|FG001|Overall Study|Protocol Violation|1|||
163295829|NCT00919763|589789702|FG000|Overall Study|Withdrawal by Subject|3|||
163295830|NCT00919763|589789703|FG001|Overall Study|Withdrawal by Subject|1|||
163295831|NCT00919763|589789702|FG000|Overall Study|Non-compliance|0|||
163295832|NCT00919763|589789703|FG001|Overall Study|Non-compliance|1|||
163295833|NCT05323734|589789704|FG000|Overall Study|Adverse Event|5|||
163295834|NCT05323734|589789705|FG001|Overall Study|Adverse Event|2|||
163295835|NCT05323734|589789704|FG000|Overall Study|Physician Decision|1|||
163295836|NCT05323734|589789705|FG001|Overall Study|Physician Decision|0|||
163295837|NCT05323734|589789704|FG000|Overall Study|Lack of Efficacy|1|||
163295838|NCT05323734|589789705|FG001|Overall Study|Lack of Efficacy|2|||
163295839|NCT05323734|589789704|FG000|Overall Study|Withdrawal by Subject|2|||
163295840|NCT05323734|589789705|FG001|Overall Study|Withdrawal by Subject|0|||
163295841|NCT05323734|589789704|FG000|Overall Study|Participant Withdrawn Due|0|||
163295842|NCT05323734|589789705|FG001|Overall Study|Participant Withdrawn Due|1|||
163295843|NCT01595321|589789706|FG000|Overall Study|Adverse Event|1|||
163295844|NCT01595321|589789707|FG001|Overall Study|Adverse Event|1|||
163295845|NCT01595321|589789708|FG002|Overall Study|Adverse Event|1|||
163295846|NCT01595321|589789706|FG000|Overall Study|Lack of Efficacy|0|||
163295847|NCT01595321|589789707|FG001|Overall Study|Lack of Efficacy|0|||
163295848|NCT01595321|589789708|FG002|Overall Study|Lack of Efficacy|4|||
163295849|NCT00834834|589789709|FG000|Overall Study|Withdrawal by Subject|4|||
163295850|NCT00834834|589789710|FG001|Overall Study|Withdrawal by Subject|3|||
163295851|NCT00373529|589789711|FG000|Overall Study|Physician Decision|19|||
163295852|NCT00373529|589789711|FG000|Overall Study|Withdrawal by Subject|7|||
163295853|NCT00373529|589789711|FG000|Overall Study|Adverse Event|7|||
163295854|NCT00373529|589789711|FG000|Overall Study|Treatment failure|36|||
163295855|NCT00373529|589789711|FG000|Overall Study|Disease recurrence|10|||
163295856|NCT00373529|589789711|FG000|Overall Study|Death|16|||
163295857|NCT00373529|589789711|FG000|Overall Study|Need for treatment prohibited by study|1|||
163295858|NCT00373529|589789711|FG000|Overall Study|Other|8|||
163295859|NCT00373529|589789711|FG000|Overall Study|Failed independent confirmation of AML|3|||
163295860|NCT00373529|589789711|FG000|Overall Study|Consent violation|1|||
163391414|NCT00594516|590146081|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
163295861|NCT04795752|589789712|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
163295862|NCT04795752|589789713|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
163295863|NCT04795752|589789712|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
163391415|NCT00594516|590146082|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
163295864|NCT04795752|589789713|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
163295865|NCT04795752|589789712|FG000|Primary Endpoint Phase|Physician Decision|2|||
163295866|NCT04795752|589789713|FG001|Primary Endpoint Phase|Physician Decision|0|||
163295867|NCT04795752|589789712|FG000|Primary Endpoint Phase|Other|4|||
163295868|NCT04795752|589789713|FG001|Primary Endpoint Phase|Other|1|||
163295869|NCT04795752|589789712|FG000|Primary Endpoint Phase|Protocol Violation|1|||
163295870|NCT04795752|589789713|FG001|Primary Endpoint Phase|Protocol Violation|0|||
163295871|NCT04795752|589789712|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
163295872|NCT04795752|589789713|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
163391416|NCT00594516|590146083|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
163295873|NCT04795752|589789712|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
163295874|NCT04795752|589789713|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
163295875|NCT04795752|589789712|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
163295876|NCT04795752|589789713|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
163295877|NCT04795752|589789712|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
163295878|NCT04795752|589789713|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
163295879|NCT04795752|589789712|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
163295880|NCT04795752|589789713|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
163295881|NCT00792948|589789714|FG000|Overall Study|Adverse Event|6|||
163295882|NCT00792948|589789714|FG000|Overall Study|Death|4|||
163295883|NCT00792948|589789714|FG000|Overall Study|Withdrawal by Subject|3|||
163295884|NCT00792948|589789714|FG000|Overall Study|Ineligible|2|||
163295885|NCT00792948|589789714|FG000|Overall Study|Insurance denial - not treated|1|||
163295886|NCT00792948|589789714|FG000|Overall Study|Physician Decision|11|||
163295887|NCT00792948|589789714|FG000|Overall Study|Protocol Violation|1|||
163295888|NCT00841035|589789723|FG000|Phase 1 Overall Study|Physician Decision|13|||
163295889|NCT00433199|589789728|FG000|Double-Blind Period|Adverse Event|0|||
163295890|NCT00433199|589789729|FG001|Double-Blind Period|Adverse Event|25|||
163295891|NCT00433199|589789728|FG000|Double-Blind Period|Lack of Efficacy|0|||
163295892|NCT00433199|589789729|FG001|Double-Blind Period|Lack of Efficacy|2|||
163295893|NCT00433199|589789728|FG000|Double-Blind Period|Lost to Follow-up|2|||
163295894|NCT00433199|589789729|FG001|Double-Blind Period|Lost to Follow-up|5|||
163295895|NCT00433199|589789728|FG000|Double-Blind Period|Withdrawal by Subject|8|||
163295896|NCT00433199|589789729|FG001|Double-Blind Period|Withdrawal by Subject|19|||
163295897|NCT00433199|589789728|FG000|Double-Blind Period|Protocol Violation|1|||
163295898|NCT00433199|589789729|FG001|Double-Blind Period|Protocol Violation|10|||
163295899|NCT00433199|589789728|FG000|Double-Blind Period|Administrative|1|||
163295900|NCT00433199|589789729|FG001|Double-Blind Period|Administrative|5|||
163295901|NCT00433199|589789728|FG000|Open-Label Period|Adverse Event|0|||
163295902|NCT00433199|589789729|FG001|Open-Label Period|Adverse Event|19|||
163295903|NCT00433199|589789728|FG000|Open-Label Period|Lack of Efficacy|0|||
163295904|NCT00433199|589789729|FG001|Open-Label Period|Lack of Efficacy|2|||
163295905|NCT00433199|589789728|FG000|Open-Label Period|Lost to Follow-up|0|||
163295906|NCT00433199|589789729|FG001|Open-Label Period|Lost to Follow-up|3|||
163295907|NCT00433199|589789728|FG000|Open-Label Period|Withdrawal by Subject|0|||
163191261|NCT01024231|589415877|FG000|Overall Study|Disease Progression|3|||
163191262|NCT01024231|589415878|FG001|Overall Study|Disease Progression|1|||
163191263|NCT01024231|589415879|FG002|Overall Study|Disease Progression|3|||
163191264|NCT01024231|589415880|FG003|Overall Study|Disease Progression|0|||
163191265|NCT01024231|589415881|FG004|Overall Study|Disease Progression|4|||
163191266|NCT01024231|589415882|FG005|Overall Study|Disease Progression|11|||
163191267|NCT01024231|589415883|FG006|Overall Study|Disease Progression|6|||
163191268|NCT01024231|589415877|FG000|Overall Study|AE unrelated to Study Drug|0|||
163191269|NCT01024231|589415878|FG001|Overall Study|AE unrelated to Study Drug|1|||
163191270|NCT01024231|589415879|FG002|Overall Study|AE unrelated to Study Drug|0|||
163191271|NCT01024231|589415880|FG003|Overall Study|AE unrelated to Study Drug|0|||
163191272|NCT01024231|589415881|FG004|Overall Study|AE unrelated to Study Drug|0|||
163191273|NCT01024231|589415882|FG005|Overall Study|AE unrelated to Study Drug|0|||
163191274|NCT01024231|589415883|FG006|Overall Study|AE unrelated to Study Drug|0|||
163191275|NCT01024231|589415877|FG000|Overall Study|No longer meets criteria|0|||
163191276|NCT01024231|589415878|FG001|Overall Study|No longer meets criteria|0|||
163191277|NCT01024231|589415879|FG002|Overall Study|No longer meets criteria|0|||
163191278|NCT01024231|589415880|FG003|Overall Study|No longer meets criteria|0|||
163191279|NCT01024231|589415881|FG004|Overall Study|No longer meets criteria|1|||
163191280|NCT01024231|589415882|FG005|Overall Study|No longer meets criteria|0|||
163191281|NCT01024231|589415883|FG006|Overall Study|No longer meets criteria|1|||
163191282|NCT01024231|589415877|FG000|Overall Study|Study Drug Toxicity|1|||
163191283|NCT01024231|589415878|FG001|Overall Study|Study Drug Toxicity|6|||
163191284|NCT01024231|589415879|FG002|Overall Study|Study Drug Toxicity|6|||
163191285|NCT01024231|589415880|FG003|Overall Study|Study Drug Toxicity|4|||
163191286|NCT01024231|589415881|FG004|Overall Study|Study Drug Toxicity|2|||
163191287|NCT01024231|589415882|FG005|Overall Study|Study Drug Toxicity|0|||
163295908|NCT00433199|589789729|FG001|Open-Label Period|Withdrawal by Subject|7|||
163295909|NCT00433199|589789728|FG000|Open-Label Period|Protocol Violation|0|||
163295910|NCT00433199|589789729|FG001|Open-Label Period|Protocol Violation|2|||
163191288|NCT01024231|589415883|FG006|Overall Study|Study Drug Toxicity|7|||
163191289|NCT01024231|589415877|FG000|Overall Study|Death|6|||
163191290|NCT01024231|589415878|FG001|Overall Study|Death|2|||
163191291|NCT01024231|589415879|FG002|Overall Study|Death|1|||
163191292|NCT01024231|589415880|FG003|Overall Study|Death|0|||
163295911|NCT00433199|589789728|FG000|Open-Label Period|Administrative|0|||
163295912|NCT00433199|589789729|FG001|Open-Label Period|Administrative|1|||
163295913|NCT00357097|589789730|FG000|Overall Study|Did not meet inclusion criteria|5|||
163295914|NCT00357097|589789731|FG001|Overall Study|Did not meet inclusion criteria|3|||
163295915|NCT00357097|589789730|FG000|Overall Study|Adverse Event|34|||
163295916|NCT00357097|589789731|FG001|Overall Study|Adverse Event|6|||
163295917|NCT00357097|589789730|FG000|Overall Study|Withdrawal by Subject|8|||
163295918|NCT00357097|589789731|FG001|Overall Study|Withdrawal by Subject|7|||
163295919|NCT00357097|589789730|FG000|Overall Study|Non-compliance|1|||
163391417|NCT00594516|590146081|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
163391418|NCT00594516|590146082|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
163191293|NCT01024231|589415881|FG004|Overall Study|Death|4|||
163295920|NCT00357097|589789731|FG001|Overall Study|Non-compliance|2|||
163295921|NCT00357097|589789730|FG000|Overall Study|Lack of Efficacy|2|||
163295922|NCT00357097|589789731|FG001|Overall Study|Lack of Efficacy|8|||
163295923|NCT00357097|589789730|FG000|Overall Study|Met Exclusion Criteria|3|||
163295924|NCT00357097|589789731|FG001|Overall Study|Met Exclusion Criteria|1|||
163295925|NCT00357097|589789730|FG000|Overall Study|Other|1|||
163295926|NCT00357097|589789731|FG001|Overall Study|Other|1|||
163295927|NCT00357097|589789730|FG000|Overall Study|Increase of RLS Symptoms|0|||
163295928|NCT00357097|589789731|FG001|Overall Study|Increase of RLS Symptoms|1|||
163295929|NCT00658996|589789732|FG000|First Intervention|Positive slit lamp finding|1|||
163295930|NCT00658996|589789733|FG001|First Intervention|Positive slit lamp finding|0|||
163295931|NCT00658996|589789732|FG000|First Intervention|Lack of lenses|0|||
163295932|NCT00658996|589789733|FG001|First Intervention|Lack of lenses|1|||
163295933|NCT00658996|589789732|FG000|Crossover Period|Physician Decision|1|||
163295934|NCT00658996|589789733|FG001|Crossover Period|Physician Decision|0|||
163295935|NCT00658996|589789732|FG000|Crossover Period|Ineligible|1|||
163295936|NCT00658996|589789733|FG001|Crossover Period|Ineligible|1|||
163295937|NCT00658996|589789732|FG000|Second Intervention|Developed a stye on upper lid|1|||
163295938|NCT00658996|589789733|FG001|Second Intervention|Developed a stye on upper lid|0|||
163295939|NCT00658996|589789732|FG000|Second Intervention|Positive slit lamp finding|0|||
163295940|NCT00658996|589789733|FG001|Second Intervention|Positive slit lamp finding|1|||
163295941|NCT03603717|589789738|FG000|Overall Study|Lost to Follow-up|20|||
163295942|NCT03603717|589789739|FG001|Overall Study|Lost to Follow-up|20|||
163295943|NCT03603717|589789738|FG000|Overall Study|Withdrawal by Subject|16|||
163391419|NCT00594516|590146083|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
163391420|NCT00594516|590146081|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
163391421|NCT00594516|590146082|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
163391422|NCT00594516|590146083|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
163391423|NCT00594516|590146081|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
163391424|NCT00594516|590146082|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
163391425|NCT00594516|590146083|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
163391426|NCT00594516|590146081|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
163391427|NCT00594516|590146082|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
163391428|NCT00594516|590146083|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
163391429|NCT00594516|590146081|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
163391430|NCT00594516|590146082|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
163391431|NCT00594516|590146083|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
163191294|NCT01024231|589415882|FG005|Overall Study|Death|3|||
163191295|NCT01024231|589415883|FG006|Overall Study|Death|5|||
163191296|NCT01024231|589415877|FG000|Overall Study|Lost to Follow-up|0|||
163191297|NCT01024231|589415878|FG001|Overall Study|Lost to Follow-up|0|||
163191298|NCT01024231|589415879|FG002|Overall Study|Lost to Follow-up|0|||
163191299|NCT01024231|589415880|FG003|Overall Study|Lost to Follow-up|0|||
163191300|NCT01024231|589415881|FG004|Overall Study|Lost to Follow-up|0|||
163191301|NCT01024231|589415882|FG005|Overall Study|Lost to Follow-up|0|||
163191302|NCT01024231|589415883|FG006|Overall Study|Lost to Follow-up|1|||
163191303|NCT01024231|589415877|FG000|Overall Study|Withdrew Consent|0|||
163191304|NCT01024231|589415878|FG001|Overall Study|Withdrew Consent|1|||
163191305|NCT01024231|589415879|FG002|Overall Study|Withdrew Consent|0|||
163191306|NCT01024231|589415880|FG003|Overall Study|Withdrew Consent|0|||
163191307|NCT01024231|589415881|FG004|Overall Study|Withdrew Consent|0|||
163191308|NCT01024231|589415882|FG005|Overall Study|Withdrew Consent|0|||
163295944|NCT03603717|589789739|FG001|Overall Study|Withdrawal by Subject|10|||
163295945|NCT01810263|589789742|FG000|Overall Study|Lost to Follow-up|8|||
163295946|NCT01810263|589789743|FG001|Overall Study|Lost to Follow-up|7|||
163391432|NCT00594516|590146081|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
163391433|NCT00594516|590146082|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
163191309|NCT01024231|589415883|FG006|Overall Study|Withdrew Consent|0|||
163191310|NCT01024231|589415877|FG000|Overall Study|Continuing on Treatment|0|||
163191311|NCT01024231|589415878|FG001|Overall Study|Continuing on Treatment|0|||
163295947|NCT00457691|589789744|FG000|Overall Study|Adverse Event|4|||
163295948|NCT00457691|589789745|FG001|Overall Study|Adverse Event|1|||
163295949|NCT00457691|589789744|FG000|Overall Study|Death|163|||
163295950|NCT00457691|589789745|FG001|Overall Study|Death|148|||
163295951|NCT00457691|589789744|FG000|Overall Study|Protocol Violation|1|||
163295952|NCT00457691|589789745|FG001|Overall Study|Protocol Violation|3|||
163295953|NCT00457691|589789744|FG000|Overall Study|Lost to Follow-up|23|||
163295954|NCT00457691|589789745|FG001|Overall Study|Lost to Follow-up|14|||
163295955|NCT00457691|589789744|FG000|Overall Study|Study terminated by Sponsor|1|||
163295956|NCT00457691|589789745|FG001|Overall Study|Study terminated by Sponsor|1|||
163295957|NCT00457691|589789744|FG000|Overall Study|Subject refused (reason other than AE)|14|||
163295958|NCT00457691|589789745|FG001|Overall Study|Subject refused (reason other than AE)|19|||
163295959|NCT00457691|589789744|FG000|Overall Study|Disease progression, study terminated|180|||
163295960|NCT00457691|589789745|FG001|Overall Study|Disease progression, study terminated|196|||
163295961|NCT00585052|589790855|FG000|Overall Study|Withdrawal by Subject|1|||
163295962|NCT02613871|589790857|FG000|Overall Study|Death|2|||
163295963|NCT02613871|589790857|FG000|Overall Study|Withdrew Consent|1|||
163295964|NCT02527148|589790858|FG000|Overall Study|Did not receive study intervention|1|||
163295965|NCT02527148|589790859|FG001|Overall Study|Did not receive study intervention|0|||
163295966|NCT02918279|589790860|FG000|Overall Study|Lost to Follow-up|3|||
163295967|NCT02918279|589790861|FG001|Overall Study|Lost to Follow-up|6|||
163295968|NCT02918279|589790860|FG000|Overall Study|Withdrawal by Subject|5|||
163295969|NCT02918279|589790861|FG001|Overall Study|Withdrawal by Subject|15|||
163295970|NCT02918279|589790860|FG000|Overall Study|Withdrawal by parent/guardian|2|||
163295971|NCT02918279|589790861|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163295972|NCT02918279|589790860|FG000|Overall Study|Other|3|||
163295973|NCT02918279|589790861|FG001|Overall Study|Other|1|||
163295974|NCT00309907|589790862|FG000|Overall Study|Death|4|||
163295975|NCT00309907|589790862|FG000|Overall Study|Physician Decision|1|||
163295976|NCT00309907|589790862|FG000|Overall Study|Ineligible|11|||
163295977|NCT00309907|589790862|FG000|Overall Study|Major infectious event|4|||
163295978|NCT00494780|589790863|FG000|Overall Study|Adverse Event|1|||
163295979|NCT00494780|589790864|FG001|Overall Study|Adverse Event|0|||
163295980|NCT00494780|589790863|FG000|Overall Study|Withdrew before Dosed|0|||
163295981|NCT00494780|589790864|FG001|Overall Study|Withdrew before Dosed|1|||
163295982|NCT00494780|589790863|FG000|Overall Study|Progression of Study Disease|7|||
163295983|NCT00494780|589790864|FG001|Overall Study|Progression of Study Disease|8|||
163295984|NCT00494780|589790863|FG000|Overall Study|New Treatment|2|||
163295985|NCT00494780|589790864|FG001|Overall Study|New Treatment|2|||
163295986|NCT00494780|589790863|FG000|Overall Study|Non-compliance|1|||
163295987|NCT00494780|589790864|FG001|Overall Study|Non-compliance|0|||
163295988|NCT00494780|589790863|FG000|Overall Study|Residual Tumour Mass|0|||
163295989|NCT00494780|589790864|FG001|Overall Study|Residual Tumour Mass|1|||
163295990|NCT00494780|589790863|FG000|Overall Study|Insurance Issues|0|||
163295991|NCT00494780|589790864|FG001|Overall Study|Insurance Issues|1|||
163295992|NCT00869258|589790865|FG000|Overall Study|Physician Decision|1|||
163295993|NCT01641198|589790866|FG000|After 12 Months of Function|Lost to Follow-up|3|||
163295994|NCT01641198|589790867|FG001|After 12 Months of Function|Lost to Follow-up|2|||
163295995|NCT01641198|589790868|FG002|After 12 Months of Function|Lost to Follow-up|2|||
163295996|NCT01641198|589790866|FG000|After 12 Months of Function|Protocol Violation|1|||
163295997|NCT01641198|589790867|FG001|After 12 Months of Function|Protocol Violation|0|||
163295998|NCT01641198|589790868|FG002|After 12 Months of Function|Protocol Violation|0|||
163295999|NCT01641198|589790866|FG000|After 12 Months of Function|Adverse Event|0|||
163296000|NCT01641198|589790867|FG001|After 12 Months of Function|Adverse Event|1|||
163296001|NCT01641198|589790868|FG002|After 12 Months of Function|Adverse Event|0|||
163296002|NCT01641198|589790866|FG000|After 24 Months of Function|Lost to Follow-up|4|||
163296003|NCT01641198|589790867|FG001|After 24 Months of Function|Lost to Follow-up|9|||
163296004|NCT01641198|589790868|FG002|After 24 Months of Function|Lost to Follow-up|6|||
163296005|NCT01641198|589790866|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
163296006|NCT01641198|589790867|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
163296007|NCT01641198|589790868|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
163296008|NCT01641198|589790866|FG000|At 15-20 Years of Function|Death|1|||
163296009|NCT01641198|589790867|FG001|At 15-20 Years of Function|Death|0|||
163296010|NCT01641198|589790868|FG002|At 15-20 Years of Function|Death|1|||
163296011|NCT00980330|589790870|FG000|Overall Study|Adverse Event|0|||
163296012|NCT00980330|589790871|FG001|Overall Study|Adverse Event|0|||
163296013|NCT00980330|589790872|FG002|Overall Study|Adverse Event|0|||
163296014|NCT00980330|589790873|FG003|Overall Study|Adverse Event|1|||
163296015|NCT00980330|589790874|FG004|Overall Study|Adverse Event|0|||
163296016|NCT00980330|589790875|FG005|Overall Study|Adverse Event|0|||
163296017|NCT00980330|589790876|FG006|Overall Study|Adverse Event|0|||
163296018|NCT00980330|589790870|FG000|Overall Study|Lost to Follow-up|1|||
163296019|NCT00980330|589790871|FG001|Overall Study|Lost to Follow-up|1|||
163296020|NCT00980330|589790872|FG002|Overall Study|Lost to Follow-up|4|||
163296021|NCT00980330|589790873|FG003|Overall Study|Lost to Follow-up|2|||
163296022|NCT00980330|589790874|FG004|Overall Study|Lost to Follow-up|1|||
163296023|NCT00980330|589790875|FG005|Overall Study|Lost to Follow-up|1|||
163296024|NCT00980330|589790876|FG006|Overall Study|Lost to Follow-up|2|||
163296025|NCT00980330|589790870|FG000|Overall Study|Withdrawal by Subject|2|||
163296026|NCT00980330|589790871|FG001|Overall Study|Withdrawal by Subject|4|||
163296027|NCT00980330|589790872|FG002|Overall Study|Withdrawal by Subject|4|||
163296028|NCT00980330|589790873|FG003|Overall Study|Withdrawal by Subject|1|||
163296029|NCT00980330|589790874|FG004|Overall Study|Withdrawal by Subject|3|||
163296030|NCT00980330|589790875|FG005|Overall Study|Withdrawal by Subject|2|||
163296031|NCT00980330|589790876|FG006|Overall Study|Withdrawal by Subject|5|||
163296032|NCT00980330|589790870|FG000|Overall Study|(not specified)|2|||
163296033|NCT00980330|589790871|FG001|Overall Study|(not specified)|0|||
163296034|NCT00980330|589790872|FG002|Overall Study|(not specified)|0|||
163296035|NCT00980330|589790873|FG003|Overall Study|(not specified)|1|||
163296036|NCT00980330|589790874|FG004|Overall Study|(not specified)|1|||
163296037|NCT00980330|589790875|FG005|Overall Study|(not specified)|1|||
163296038|NCT00980330|589790876|FG006|Overall Study|(not specified)|0|||
163296039|NCT00346151|589790877|FG000|Overall Study|Withdrawal by Subject|3|||
163296040|NCT01075217|589790878|FG000|Overall Study|Adverse Event|1|||
163296041|NCT01075217|589790879|FG001|Overall Study|Adverse Event|1|||
163296042|NCT01075217|589790878|FG000|Overall Study|Physician Decision|1|||
163296043|NCT01075217|589790879|FG001|Overall Study|Physician Decision|0|||
163296044|NCT03260140|589790880|FG000|Overall Study|Death|4|||
163296045|NCT03260140|589790881|FG001|Overall Study|Death|1|||
163296046|NCT03260140|589790880|FG000|Overall Study|Withdrawal by Subject|1|||
163296047|NCT03260140|589790881|FG001|Overall Study|Withdrawal by Subject|4|||
163296048|NCT02957136|589790892|FG000|Overall Study|Withdrawal by Subject|2|||
163296049|NCT02957136|589790893|FG001|Overall Study|Withdrawal by Subject|1|||
163296050|NCT01444417|589790897|FG000|Overall Study|Ineligibility Determined|0|||
163296051|NCT01444417|589790898|FG001|Overall Study|Ineligibility Determined|1|||
163296052|NCT01444417|589790897|FG000|Overall Study|Withdrawal by Subject|2|||
163296053|NCT01444417|589790898|FG001|Overall Study|Withdrawal by Subject|0|||
163296054|NCT02423291|589790900|FG000|Overall Study|Lack of Efficacy|14|||
163296055|NCT02423291|589790900|FG000|Overall Study|Adverse Event|1|||
163296056|NCT01124734|589790902|FG000|Overall Study|Disease progression|13|||
163296057|NCT01124734|589790902|FG000|Overall Study|Adverse Event|1|||
163296058|NCT01124734|589790902|FG000|Overall Study|Withdrawal by Subject|1|||
163296059|NCT01124734|589790902|FG000|Overall Study|Elected for alternative treatment|2|||
163296060|NCT02214160|589790904|FG000|Overall Study|Withdrawal by Subject|1|||
163296061|NCT02214160|589790905|FG001|Overall Study|Withdrawal by Subject|0|||
163296062|NCT02214160|589790906|FG002|Overall Study|Withdrawal by Subject|6|||
163296063|NCT02214160|589790904|FG000|Overall Study|Death|2|||
163296064|NCT02214160|589790905|FG001|Overall Study|Death|2|||
163296065|NCT02214160|589790906|FG002|Overall Study|Death|1|||
163296066|NCT02214160|589790904|FG000|Overall Study|Subject Non-Compliance|0|||
163296067|NCT02214160|589790905|FG001|Overall Study|Subject Non-Compliance|3|||
163296068|NCT02214160|589790906|FG002|Overall Study|Subject Non-Compliance|1|||
163296069|NCT02214160|589790904|FG000|Overall Study|Adverse Event|0|||
163296070|NCT02214160|589790905|FG001|Overall Study|Adverse Event|1|||
163296071|NCT02214160|589790906|FG002|Overall Study|Adverse Event|1|||
163296072|NCT02214160|589790904|FG000|Overall Study|Sponsor Decision|0|||
163296073|NCT02214160|589790905|FG001|Overall Study|Sponsor Decision|2|||
163296074|NCT02214160|589790906|FG002|Overall Study|Sponsor Decision|0|||
163296075|NCT02214160|589790904|FG000|Overall Study|Protocol Violation|1|||
163296076|NCT02214160|589790905|FG001|Overall Study|Protocol Violation|0|||
163296077|NCT02214160|589790906|FG002|Overall Study|Protocol Violation|0|||
163296078|NCT02214160|589790904|FG000|Overall Study|Physician Decision|0|||
163296079|NCT02214160|589790905|FG001|Overall Study|Physician Decision|0|||
163296080|NCT02214160|589790906|FG002|Overall Study|Physician Decision|1|||
163296081|NCT02423798|589790907|FG000|Overall Study|Withdrawal by Subject|3|||
163296082|NCT01063972|589790908|FG000|Overall Study|Death|12|||
163296083|NCT01063972|589790909|FG001|Overall Study|Death|11|||
163296084|NCT01063972|589790908|FG000|Overall Study|Incarcerated|2|||
163296085|NCT01063972|589790909|FG001|Overall Study|Incarcerated|1|||
163296086|NCT01510717|589790911|FG000|Overall Study|Adverse Event|1|||
163296087|NCT01510717|589790912|FG001|Overall Study|Adverse Event|2|||
163296088|NCT01510717|589790911|FG000|Overall Study|Death|1|||
163296089|NCT01510717|589790912|FG001|Overall Study|Death|0|||
163296090|NCT01510717|589790911|FG000|Overall Study|Lost to Follow-up|0|||
163296091|NCT01510717|589790912|FG001|Overall Study|Lost to Follow-up|1|||
163296092|NCT01510717|589790911|FG000|Overall Study|Withdrawal by Subject|0|||
163391434|NCT00594516|590146083|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
163296093|NCT01510717|589790912|FG001|Overall Study|Withdrawal by Subject|2|||
163296094|NCT01430611|589790914|FG000|Overall Study|Adverse Event|0|||
163296095|NCT01430611|589790915|FG001|Overall Study|Adverse Event|1|||
163296096|NCT01430611|589790914|FG000|Overall Study|Protocol Violation|1|||
163296097|NCT01430611|589790915|FG001|Overall Study|Protocol Violation|0|||
163296098|NCT01430611|589790914|FG000|Overall Study|Lost to Follow-up|1|||
163296099|NCT01430611|589790915|FG001|Overall Study|Lost to Follow-up|0|||
163296100|NCT01430611|589790914|FG000|Overall Study|Withdrawal by Subject|15|||
163296101|NCT01430611|589790915|FG001|Overall Study|Withdrawal by Subject|14|||
163296102|NCT00939510|589790916|FG000|Overall Study|Withdrawal by Subject|1|||
163296103|NCT01202955|589790917|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
163296104|NCT01202955|589790918|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
163296105|NCT00159783|589790923|FG000|Overall Study|Adverse Event|5|||
163296106|NCT00159783|589790924|FG001|Overall Study|Adverse Event|7|||
163296107|NCT00159783|589790925|FG002|Overall Study|Adverse Event|9|||
163296108|NCT00159783|589790923|FG000|Overall Study|Lack of Efficacy|1|||
163296109|NCT00159783|589790924|FG001|Overall Study|Lack of Efficacy|2|||
163296110|NCT00159783|589790925|FG002|Overall Study|Lack of Efficacy|3|||
163296111|NCT00159783|589790923|FG000|Overall Study|Withdrawal by Subject|7|||
163296112|NCT00159783|589790924|FG001|Overall Study|Withdrawal by Subject|11|||
163296113|NCT00159783|589790925|FG002|Overall Study|Withdrawal by Subject|12|||
163296114|NCT00159783|589790923|FG000|Overall Study|Lost to Follow-up|6|||
163296115|NCT00159783|589790924|FG001|Overall Study|Lost to Follow-up|5|||
163296116|NCT00159783|589790925|FG002|Overall Study|Lost to Follow-up|11|||
163296117|NCT00159783|589790923|FG000|Overall Study|Other|0|||
163296118|NCT00159783|589790924|FG001|Overall Study|Other|2|||
163296119|NCT00159783|589790925|FG002|Overall Study|Other|4|||
163296120|NCT02115139|589790926|FG000|Overall Study|Protocol Violation|1|||
163296121|NCT02115139|589790926|FG000|Overall Study|treatment discontinuation|6|||
163296122|NCT04740164|589790927|FG000|Overall Study|Lack of Efficacy|4|||
163296123|NCT04740164|589790928|FG001|Overall Study|Lack of Efficacy|0|||
163296124|NCT04740164|589790927|FG000|Overall Study|Physician Decision|3|||
163296125|NCT04740164|589790928|FG001|Overall Study|Physician Decision|3|||
163296126|NCT00258895|589790934|FG000|Overall Study|Lost to Follow-up|3|||
163296127|NCT00258895|589790935|FG001|Overall Study|Lost to Follow-up|1|||
163296128|NCT00258895|589790934|FG000|Overall Study|Protocol Violation|6|||
163296129|NCT00258895|589790935|FG001|Overall Study|Protocol Violation|2|||
163296130|NCT00258895|589790934|FG000|Overall Study|Withdrawal by Subject|1|||
163296131|NCT00258895|589790935|FG001|Overall Study|Withdrawal by Subject|0|||
163296132|NCT00442117|589790936|FG000|Overall Study|Adverse Event|3|||
163296133|NCT00442117|589790937|FG001|Overall Study|Adverse Event|2|||
163296134|NCT00442117|589790936|FG000|Overall Study|Lack of Efficacy|2|||
163296135|NCT00442117|589790937|FG001|Overall Study|Lack of Efficacy|6|||
163296136|NCT00442117|589790936|FG000|Overall Study|Lost to Follow-up|1|||
163296137|NCT00442117|589790937|FG001|Overall Study|Lost to Follow-up|2|||
163296138|NCT00442117|589790936|FG000|Overall Study|Withdrawal by Subject|2|||
163296139|NCT00442117|589790937|FG001|Overall Study|Withdrawal by Subject|2|||
163296140|NCT00442117|589790936|FG000|Overall Study|Major Deviation|25|||
163296141|NCT00442117|589790937|FG001|Overall Study|Major Deviation|20|||
163296142|NCT00442117|589790936|FG000|Overall Study|Non compliance with protocol|3|||
163296143|NCT00442117|589790937|FG001|Overall Study|Non compliance with protocol|5|||
163296144|NCT00442117|589790936|FG000|Overall Study|Met Withdrawal Criteria|2|||
163296145|NCT00442117|589790937|FG001|Overall Study|Met Withdrawal Criteria|1|||
163296146|NCT00305695|589790945|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
163296147|NCT00305695|589790946|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
163296148|NCT00305695|589790945|FG000|Overall Study|Did not have baseline scan|1|||
163296149|NCT00305695|589790946|FG001|Overall Study|Did not have baseline scan|1|||
163296150|NCT01121549|589790948|FG000|Overall Study|Adverse Event|10|||
163296151|NCT01121549|589790948|FG000|Overall Study|Lack of Efficacy|11|||
163296152|NCT01121549|589790948|FG000|Overall Study|Lost to Follow-up|12|||
163296153|NCT01121549|589790948|FG000|Overall Study|Did not meet entrance criteria|9|||
163296154|NCT01121549|589790948|FG000|Overall Study|Study terminated by sponsor|197|||
163296155|NCT01121549|589790948|FG000|Overall Study|Pregnancy|1|||
163296156|NCT01121549|589790948|FG000|Overall Study|Protocol Violation|33|||
163296157|NCT01121549|589790948|FG000|Overall Study|Withdrawal by Subject|16|||
163296158|NCT01121549|589790948|FG000|Overall Study|Other|58|||
163296159|NCT02763319|589792239|FG000|Overall Study|Adverse Event|12|||
163296160|NCT02763319|589792240|FG001|Overall Study|Adverse Event|3|||
163296161|NCT02763319|589792239|FG000|Overall Study|Death|123|||
163296162|NCT02763319|589792240|FG001|Overall Study|Death|123|||
163296163|NCT02763319|589792239|FG000|Overall Study|Lost to Follow-up|6|||
163296164|NCT02763319|589792240|FG001|Overall Study|Lost to Follow-up|7|||
163296165|NCT02763319|589792239|FG000|Overall Study|Noncompliance with Study Drug|2|||
163296166|NCT02763319|589792240|FG001|Overall Study|Noncompliance with Study Drug|0|||
163296167|NCT02763319|589792239|FG000|Overall Study|"Captured as Other in Database"|29|||
163296168|NCT02763319|589792240|FG001|Overall Study|"Captured as Other in Database"|34|||
163296169|NCT02763319|589792239|FG000|Overall Study|Physician Decision|1|||
163296170|NCT02763319|589792240|FG001|Overall Study|Physician Decision|7|||
163296171|NCT02763319|589792239|FG000|Overall Study|Progressive Disease|24|||
163296172|NCT02763319|589792240|FG001|Overall Study|Progressive Disease|27|||
163296173|NCT02763319|589792239|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
163296174|NCT02763319|589792240|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
163296175|NCT02763319|589792239|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
163296176|NCT02763319|589792240|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
163296177|NCT02763319|589792239|FG000|Overall Study|Withdrawal by Subject|26|||
163296178|NCT02763319|589792240|FG001|Overall Study|Withdrawal by Subject|25|||
163296179|NCT00840177|589792242|FG000|Overall Study|Adverse Event|5|||
163296180|NCT00840177|589792243|FG001|Overall Study|Adverse Event|1|||
163296181|NCT00840177|589792244|FG002|Overall Study|Adverse Event|1|||
163296182|NCT00840177|589792242|FG000|Overall Study|Refusal unrelated to adverse events|1|||
163296183|NCT00840177|589792243|FG001|Overall Study|Refusal unrelated to adverse events|0|||
163296184|NCT00840177|589792244|FG002|Overall Study|Refusal unrelated to adverse events|1|||
163296185|NCT00840177|589792242|FG000|Overall Study|Progression/relapse|2|||
163296186|NCT00840177|589792243|FG001|Overall Study|Progression/relapse|0|||
163296187|NCT00840177|589792244|FG002|Overall Study|Progression/relapse|0|||
163296188|NCT00840177|589792242|FG000|Overall Study|Death|4|||
163296189|NCT00840177|589792243|FG001|Overall Study|Death|5|||
163296190|NCT00840177|589792244|FG002|Overall Study|Death|5|||
163296191|NCT00840177|589792242|FG000|Overall Study|not protocol specified|6|||
163296192|NCT00840177|589792243|FG001|Overall Study|not protocol specified|3|||
163296193|NCT00840177|589792244|FG002|Overall Study|not protocol specified|0|||
163296194|NCT00840177|589792242|FG000|Overall Study|Ineligible|0|||
163296195|NCT00840177|589792243|FG001|Overall Study|Ineligible|0|||
163296196|NCT00840177|589792244|FG002|Overall Study|Ineligible|3|||
163296197|NCT00840177|589792242|FG000|Overall Study|Did not start treatment|0|||
163296198|NCT00840177|589792243|FG001|Overall Study|Did not start treatment|0|||
163296199|NCT00840177|589792244|FG002|Overall Study|Did not start treatment|1|||
163296200|NCT00722046|589792247|FG000|Overall Study|Adverse Event|0|||
163296201|NCT00722046|589792248|FG001|Overall Study|Adverse Event|1|||
163296202|NCT00722046|589792249|FG002|Overall Study|Adverse Event|2|||
163296203|NCT00722046|589792250|FG003|Overall Study|Adverse Event|1|||
163296204|NCT00722046|589792251|FG004|Overall Study|Adverse Event|2|||
163296205|NCT00722046|589792252|FG005|Overall Study|Adverse Event|1|||
163296206|NCT00722046|589792253|FG006|Overall Study|Adverse Event|0|||
163296207|NCT00722046|589792247|FG000|Overall Study|Death|0|||
163296208|NCT00722046|589792248|FG001|Overall Study|Death|1|||
163296209|NCT00722046|589792249|FG002|Overall Study|Death|0|||
163296210|NCT00722046|589792250|FG003|Overall Study|Death|0|||
163391435|NCT00594516|590146081|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
163296211|NCT00722046|589792251|FG004|Overall Study|Death|0|||
163296212|NCT00722046|589792252|FG005|Overall Study|Death|0|||
163296213|NCT00722046|589792253|FG006|Overall Study|Death|2|||
163296214|NCT00722046|589792247|FG000|Overall Study|Protocol Violation|1|||
163296215|NCT00722046|589792248|FG001|Overall Study|Protocol Violation|0|||
163296216|NCT00722046|589792249|FG002|Overall Study|Protocol Violation|0|||
163296217|NCT00722046|589792250|FG003|Overall Study|Protocol Violation|0|||
163296218|NCT00722046|589792251|FG004|Overall Study|Protocol Violation|0|||
163391436|NCT00594516|590146082|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
163391437|NCT00594516|590146083|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
163391438|NCT00594516|590146081|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
163391439|NCT00594516|590146082|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
163391440|NCT00594516|590146083|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
163391441|NCT01493557|590146084|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
163391442|NCT01493557|590146085|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
163296219|NCT00722046|589792252|FG005|Overall Study|Protocol Violation|1|||
163296220|NCT00722046|589792253|FG006|Overall Study|Protocol Violation|0|||
163296221|NCT00722046|589792247|FG000|Overall Study|Withdrawal by Subject|3|||
163296222|NCT00722046|589792248|FG001|Overall Study|Withdrawal by Subject|3|||
163296223|NCT00722046|589792249|FG002|Overall Study|Withdrawal by Subject|4|||
163296224|NCT00722046|589792250|FG003|Overall Study|Withdrawal by Subject|4|||
163296225|NCT00722046|589792251|FG004|Overall Study|Withdrawal by Subject|4|||
163296226|NCT00722046|589792252|FG005|Overall Study|Withdrawal by Subject|7|||
163296227|NCT00722046|589792253|FG006|Overall Study|Withdrawal by Subject|3|||
163296228|NCT00722046|589792247|FG000|Overall Study|Randomized, but not treated|1|||
163296229|NCT00722046|589792248|FG001|Overall Study|Randomized, but not treated|1|||
163296230|NCT00722046|589792249|FG002|Overall Study|Randomized, but not treated|0|||
163296231|NCT00722046|589792250|FG003|Overall Study|Randomized, but not treated|2|||
163191312|NCT01024231|589415879|FG002|Overall Study|Continuing on Treatment|0|||
163391443|NCT01493557|590146086|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
163391444|NCT01493557|590146084|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
163391445|NCT01493557|590146085|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
163391446|NCT01493557|590146086|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
163391447|NCT01493557|590146084|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
163391448|NCT01493557|590146085|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
163391449|NCT01493557|590146086|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
163391450|NCT01493557|590146084|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
163391451|NCT01493557|590146085|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
163391452|NCT01493557|590146086|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
163391453|NCT01493557|590146084|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
163391454|NCT01493557|590146085|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
163391455|NCT01493557|590146086|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
163391456|NCT01493557|590146084|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
163191313|NCT01024231|589415880|FG003|Overall Study|Continuing on Treatment|0|||
163191314|NCT01024231|589415881|FG004|Overall Study|Continuing on Treatment|3|||
163191315|NCT01024231|589415882|FG005|Overall Study|Continuing on Treatment|2|||
163191316|NCT01024231|589415883|FG006|Overall Study|Continuing on Treatment|0|||
163191317|NCT02761733|589415885|FG000|Overall Study|Death|3|||
163191318|NCT02761733|589415886|FG001|Overall Study|Death|5|||
163191319|NCT02761733|589415887|FG002|Overall Study|Death|1|||
163191320|NCT02761733|589415888|FG003|Overall Study|Death|1|||
163191321|NCT02761733|589415885|FG000|Overall Study|Lost to Follow-up|6|||
163191322|NCT02761733|589415886|FG001|Overall Study|Lost to Follow-up|7|||
163191323|NCT02761733|589415887|FG002|Overall Study|Lost to Follow-up|0|||
163191324|NCT02761733|589415888|FG003|Overall Study|Lost to Follow-up|3|||
163191325|NCT02761733|589415885|FG000|Overall Study|Physician Decision|4|||
163191326|NCT02761733|589415886|FG001|Overall Study|Physician Decision|0|||
163191327|NCT02761733|589415887|FG002|Overall Study|Physician Decision|0|||
163191328|NCT02761733|589415888|FG003|Overall Study|Physician Decision|0|||
163191329|NCT02761733|589415885|FG000|Overall Study|Withdrawal by Subject|2|||
163191330|NCT02761733|589415886|FG001|Overall Study|Withdrawal by Subject|0|||
163191331|NCT02761733|589415887|FG002|Overall Study|Withdrawal by Subject|0|||
163191332|NCT02761733|589415888|FG003|Overall Study|Withdrawal by Subject|0|||
163191333|NCT02761733|589415885|FG000|Overall Study|Discharged from Study Site|10|||
163191334|NCT02761733|589415886|FG001|Overall Study|Discharged from Study Site|9|||
163191335|NCT02761733|589415887|FG002|Overall Study|Discharged from Study Site|25|||
163191336|NCT02761733|589415888|FG003|Overall Study|Discharged from Study Site|11|||
163191337|NCT02761733|589415885|FG000|Overall Study|Cognitive Impairment|5|||
163191338|NCT02761733|589415886|FG001|Overall Study|Cognitive Impairment|0|||
163191339|NCT02761733|589415887|FG002|Overall Study|Cognitive Impairment|1|||
163191340|NCT02761733|589415888|FG003|Overall Study|Cognitive Impairment|0|||
163191341|NCT00669396|589415889|FG000|Overall Study|Lost to Follow-up|10|||
163191342|NCT00669396|589415890|FG001|Overall Study|Lost to Follow-up|12|||
163191343|NCT01262573|589415891|FG000|Overall Study|Withdrawal by Subject|0|||
163191344|NCT01262573|589415892|FG001|Overall Study|Withdrawal by Subject|1|||
163296232|NCT00722046|589792251|FG004|Overall Study|Randomized, but not treated|0|||
163296233|NCT00722046|589792252|FG005|Overall Study|Randomized, but not treated|0|||
163296234|NCT00722046|589792253|FG006|Overall Study|Randomized, but not treated|0|||
163296235|NCT00722046|589792247|FG000|Overall Study|Other|0|||
163296236|NCT00722046|589792248|FG001|Overall Study|Other|0|||
163296237|NCT00722046|589792249|FG002|Overall Study|Other|1|||
163296238|NCT00722046|589792250|FG003|Overall Study|Other|1|||
163296239|NCT00722046|589792251|FG004|Overall Study|Other|3|||
163296240|NCT00722046|589792252|FG005|Overall Study|Other|2|||
163296241|NCT00722046|589792253|FG006|Overall Study|Other|1|||
163296242|NCT01460446|589792261|FG000|Overall Study|Non-compliance|2|||
163296243|NCT01460446|589792262|FG001|Overall Study|Non-compliance|9|||
163391457|NCT01493557|590146085|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
163391458|NCT01493557|590146086|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
163391459|NCT01493557|590146084|FG000|Not Randomized to Management Strategies|Early termination|0|||
163191345|NCT00810693|589415893|FG000|Treatment Period|Adverse Event|8|||
163296244|NCT01460446|589792261|FG000|Overall Study|Consent Withdrawn|0|||
163296245|NCT01460446|589792262|FG001|Overall Study|Consent Withdrawn|4|||
163296246|NCT01460446|589792261|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
163296247|NCT01460446|589792262|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
163296248|NCT01460446|589792261|FG000|Overall Study|Surgery/Illness|1|||
163296249|NCT01460446|589792262|FG001|Overall Study|Surgery/Illness|1|||
163296250|NCT01460446|589792261|FG000|Overall Study|Pregnancy|1|||
163296251|NCT01460446|589792262|FG001|Overall Study|Pregnancy|0|||
163391460|NCT01493557|590146085|FG001|Not Randomized to Management Strategies|Early termination|0|||
163391461|NCT01493557|590146086|FG002|Not Randomized to Management Strategies|Early termination|34|||
163391462|NCT01493557|590146084|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
163391463|NCT01493557|590146085|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
163391464|NCT01493557|590146086|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
163391465|NCT01493557|590146084|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
163391466|NCT01493557|590146085|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
163391467|NCT01493557|590146086|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
163391468|NCT01493557|590146084|FG000|Randomized to Management Strategies|Other adverse event|8|||
163391469|NCT01493557|590146085|FG001|Randomized to Management Strategies|Other adverse event|5|||
163391470|NCT01493557|590146086|FG002|Randomized to Management Strategies|Other adverse event|0|||
163391471|NCT01493557|590146084|FG000|Randomized to Management Strategies|Protocol Violation|3|||
163391472|NCT01493557|590146085|FG001|Randomized to Management Strategies|Protocol Violation|0|||
163191346|NCT00810693|589415894|FG001|Treatment Period|Adverse Event|1|||
163191347|NCT00810693|589415895|FG002|Treatment Period|Adverse Event|7|||
163191348|NCT00810693|589415893|FG000|Treatment Period|Death|0|||
163191349|NCT00810693|589415894|FG001|Treatment Period|Death|1|||
163191350|NCT00810693|589415895|FG002|Treatment Period|Death|2|||
163191351|NCT00810693|589415893|FG000|Treatment Period|Lack of Efficacy|0|||
163191352|NCT00810693|589415894|FG001|Treatment Period|Lack of Efficacy|0|||
163191353|NCT00810693|589415895|FG002|Treatment Period|Lack of Efficacy|1|||
163191354|NCT00810693|589415893|FG000|Treatment Period|Lost to Follow-up|1|||
163191355|NCT00810693|589415894|FG001|Treatment Period|Lost to Follow-up|0|||
163191356|NCT00810693|589415895|FG002|Treatment Period|Lost to Follow-up|0|||
163191357|NCT00810693|589415893|FG000|Treatment Period|Non-compliance|1|||
163191358|NCT00810693|589415894|FG001|Treatment Period|Non-compliance|0|||
163191359|NCT00810693|589415895|FG002|Treatment Period|Non-compliance|0|||
163191360|NCT00810693|589415893|FG000|Treatment Period|Protocol Violation|1|||
163191361|NCT00810693|589415894|FG001|Treatment Period|Protocol Violation|2|||
163191362|NCT00810693|589415895|FG002|Treatment Period|Protocol Violation|2|||
163191363|NCT00810693|589415893|FG000|Treatment Period|Withdrawal by Subject|6|||
163191364|NCT00810693|589415894|FG001|Treatment Period|Withdrawal by Subject|2|||
163191365|NCT00810693|589415895|FG002|Treatment Period|Withdrawal by Subject|3|||
163191366|NCT00810693|589415893|FG000|Treatment Period|Not treated|0|||
163191367|NCT00810693|589415894|FG001|Treatment Period|Not treated|1|||
163191368|NCT00810693|589415895|FG002|Treatment Period|Not treated|1|||
163191369|NCT00810693|589415893|FG000|Follow-up Period (FUP)|Adverse Event|3|||
163191370|NCT00810693|589415894|FG001|Follow-up Period (FUP)|Adverse Event|1|||
163191371|NCT00810693|589415895|FG002|Follow-up Period (FUP)|Adverse Event|1|||
163191372|NCT00810693|589415893|FG000|Follow-up Period (FUP)|Death|2|||
163191373|NCT00810693|589415894|FG001|Follow-up Period (FUP)|Death|0|||
163191374|NCT00810693|589415895|FG002|Follow-up Period (FUP)|Death|1|||
163191375|NCT00810693|589415893|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
163191376|NCT00810693|589415894|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
163191377|NCT00810693|589415895|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
163191378|NCT00810693|589415893|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
163191379|NCT00810693|589415894|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
163191380|NCT00810693|589415895|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
163191381|NCT00810693|589415893|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
163191382|NCT00810693|589415894|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
163191383|NCT00810693|589415895|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
163191384|NCT04295772|589415898|FG000|Overall Study|Protocol Violation|1|||
163191385|NCT04295772|589415899|FG001|Overall Study|Protocol Violation|0|||
163191386|NCT04295772|589415898|FG000|Overall Study|Ongoing for safety monitoring|14|||
163191387|NCT04295772|589415899|FG001|Overall Study|Ongoing for safety monitoring|1|||
163191388|NCT04295772|589415898|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
163191389|NCT04295772|589415899|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
163191390|NCT00331422|589415900|FG000|Overall Study|Did not receive entire study regimen|5|||
163191391|NCT02345226|589415901|FG000|Double-Blind Phase|Adverse Event|5|||
163191392|NCT02345226|589415902|FG001|Double-Blind Phase|Adverse Event|6|||
163191393|NCT02345226|589415901|FG000|Double-Blind Phase|Death|3|||
163191394|NCT02345226|589415902|FG001|Double-Blind Phase|Death|0|||
163191395|NCT02345226|589415901|FG000|Double-Blind Phase|Pregnancy|0|||
163296252|NCT01460446|589792261|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
163296253|NCT01460446|589792262|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
163296254|NCT00516321|589792263|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
163296255|NCT00516321|589792264|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
163296256|NCT00516321|589792265|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
163296257|NCT00516321|589792263|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
163296258|NCT00516321|589792264|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
163296259|NCT00516321|589792265|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
163296260|NCT00516321|589792263|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
163296261|NCT00516321|589792264|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
163296262|NCT00516321|589792265|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
163296263|NCT00516321|589792263|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
163296264|NCT00516321|589792264|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
163296265|NCT00516321|589792265|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
163296266|NCT00516321|589792263|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
163296267|NCT00516321|589792264|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
163296268|NCT00516321|589792265|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
163296269|NCT00516321|589792263|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
163296270|NCT00516321|589792264|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
163296271|NCT00516321|589792265|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
163296272|NCT00516321|589792263|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
163296273|NCT00516321|589792264|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
163296274|NCT00516321|589792265|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
163296275|NCT00516321|589792263|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
163296276|NCT00516321|589792264|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
163296277|NCT00516321|589792265|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
163296278|NCT00516321|589792263|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
163296279|NCT00516321|589792264|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
163296280|NCT00516321|589792265|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
163296281|NCT00516321|589792263|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
163296282|NCT00516321|589792264|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
163296283|NCT00516321|589792265|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
163296284|NCT00516321|589792263|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
163296285|NCT00516321|589792264|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
163296286|NCT00516321|589792265|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
163296287|NCT01318382|589792267|FG000|Overall Study|Physician Decision|2|||
163296288|NCT01318382|589792267|FG000|Overall Study|Device Malfunction|10|||
163296289|NCT01318382|589792267|FG000|Overall Study|Protocol Violation|1|||
163296290|NCT02271854|589792272|FG000|Overall Study|Withdrawal by Subject|2|||
163296291|NCT02271854|589792272|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
163296292|NCT02271854|589792272|FG000|Overall Study|Lost to Follow-up|1|||
163296293|NCT01308567|589792273|FG000|Overall Study|Lost to Follow-up|2|||
163296294|NCT01308567|589792274|FG001|Overall Study|Lost to Follow-up|4|||
163296295|NCT01308567|589792275|FG002|Overall Study|Lost to Follow-up|4|||
163296296|NCT01571596|589792276|FG000|Overall Study|Adverse Event|2|||
163296297|NCT01571596|589792277|FG001|Overall Study|Adverse Event|0|||
163296298|NCT01571596|589792278|FG002|Overall Study|Adverse Event|0|||
163296299|NCT01571596|589792276|FG000|Overall Study|Study Terminated by the Sponsor|0|||
163296300|NCT01571596|589792277|FG001|Overall Study|Study Terminated by the Sponsor|1|||
163296301|NCT01571596|589792278|FG002|Overall Study|Study Terminated by the Sponsor|1|||
163296302|NCT01582100|589792283|FG000|Overall Study|Adverse Event|1|||
163191396|NCT02345226|589415902|FG001|Double-Blind Phase|Pregnancy|1|||
163191397|NCT02345226|589415901|FG000|Double-Blind Phase|Lack of Efficacy|1|||
163191398|NCT02345226|589415902|FG001|Double-Blind Phase|Lack of Efficacy|0|||
163191399|NCT02345226|589415901|FG000|Double-Blind Phase|Investigator's Discretion|4|||
163191400|NCT02345226|589415902|FG001|Double-Blind Phase|Investigator's Discretion|3|||
163191401|NCT02345226|589415901|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
163191402|NCT02345226|589415902|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
163191403|NCT02345226|589415901|FG000|Double-Blind Phase|Withdrew Consent|41|||
163191404|NCT02345226|589415902|FG001|Double-Blind Phase|Withdrew Consent|39|||
163191405|NCT02345226|589415901|FG000|Double-Blind Phase|Lost to Follow-up|12|||
163191406|NCT02345226|589415902|FG001|Double-Blind Phase|Lost to Follow-up|16|||
163191407|NCT02345226|589415901|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
163191408|NCT02345226|589415902|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
163191409|NCT02345226|589415901|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
163191410|NCT02345226|589415902|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
163191411|NCT03386474|589415910|FG000|Overall Study|Death|1|||
163191412|NCT03386474|589415911|FG001|Overall Study|Death|0|||
163191413|NCT03386474|589415910|FG000|Overall Study|Adverse Event|0|||
163296303|NCT01582100|589792283|FG000|Overall Study|Withdrawal by Subject|1|||
163296304|NCT01078116|589792290|FG000|Overall Study|Lost to Follow-up|17|||
163296305|NCT01078116|589792290|FG000|Overall Study|Adverse Event|5|||
163296306|NCT01078116|589792290|FG000|Overall Study|Withdrawal by Subject|8|||
163296307|NCT01078116|589792290|FG000|Overall Study|Lack of effectiveness|15|||
163296308|NCT01078116|589792290|FG000|Overall Study|Case report form not completed|3|||
163296309|NCT02499159|589792291|FG000|Randomization|Protocol Violation|1|||
163296310|NCT02499159|589792292|FG001|Randomization|Protocol Violation|1|||
163296311|NCT02499159|589792291|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
163296312|NCT02499159|589792292|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
163296313|NCT02499159|589792291|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
163296314|NCT02499159|589792292|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
163296315|NCT02499159|589792291|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
163296316|NCT02499159|589792292|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
163296317|NCT02499159|589792291|FG000|30-Day Follow-Up Phone Call|Other|1|||
163296318|NCT02499159|589792292|FG001|30-Day Follow-Up Phone Call|Other|0|||
163296319|NCT02242487|589792293|FG000|Overall Study|Adverse Event|13|||
163296320|NCT02242487|589792294|FG001|Overall Study|Adverse Event|15|||
163296321|NCT02242487|589792293|FG000|Overall Study|Lack of Efficacy|4|||
163296322|NCT02242487|589792294|FG001|Overall Study|Lack of Efficacy|6|||
163296323|NCT02242487|589792293|FG000|Overall Study|Protocol Violation|2|||
163296324|NCT02242487|589792294|FG001|Overall Study|Protocol Violation|0|||
163296325|NCT02242487|589792293|FG000|Overall Study|Lost to Follow-up|2|||
163296326|NCT02242487|589792294|FG001|Overall Study|Lost to Follow-up|1|||
163296327|NCT02242487|589792293|FG000|Overall Study|Other - Miscellaneous|4|||
163296328|NCT02242487|589792294|FG001|Overall Study|Other - Miscellaneous|6|||
163391473|NCT01493557|590146086|FG002|Randomized to Management Strategies|Protocol Violation|0|||
163296329|NCT02242487|589792293|FG000|Overall Study|Withdrawal by Subject|37|||
163296330|NCT02242487|589792294|FG001|Overall Study|Withdrawal by Subject|19|||
163296331|NCT03644849|589792295|FG000|Overall Study|Lost to Follow-up|1|||
163296332|NCT03644849|589792296|FG001|Overall Study|Lost to Follow-up|3|||
163296333|NCT02564744|589792297|FG000|Overall Study|Investigator decision|0|||
163296334|NCT02564744|589792298|FG001|Overall Study|Investigator decision|0|||
163296335|NCT02564744|589792299|FG002|Overall Study|Investigator decision|0|||
163296336|NCT02564744|589792300|FG003|Overall Study|Investigator decision|0|||
163296337|NCT02564744|589792301|FG004|Overall Study|Investigator decision|1|||
163296338|NCT02564744|589792297|FG000|Overall Study|Death|10|||
163296339|NCT02564744|589792298|FG001|Overall Study|Death|5|||
163296340|NCT02564744|589792299|FG002|Overall Study|Death|4|||
163296341|NCT02564744|589792300|FG003|Overall Study|Death|16|||
163296342|NCT02564744|589792301|FG004|Overall Study|Death|16|||
163296343|NCT02564744|589792297|FG000|Overall Study|End of study Page Missing|0|||
163296344|NCT02564744|589792298|FG001|Overall Study|End of study Page Missing|0|||
163296345|NCT02564744|589792299|FG002|Overall Study|End of study Page Missing|3|||
163296346|NCT02564744|589792300|FG003|Overall Study|End of study Page Missing|3|||
163296347|NCT02564744|589792301|FG004|Overall Study|End of study Page Missing|0|||
163296348|NCT02564744|589792297|FG000|Overall Study|Subject Withdrew Consent|1|||
163296349|NCT02564744|589792298|FG001|Overall Study|Subject Withdrew Consent|1|||
163296350|NCT02564744|589792299|FG002|Overall Study|Subject Withdrew Consent|1|||
163296351|NCT02564744|589792300|FG003|Overall Study|Subject Withdrew Consent|0|||
163296352|NCT02564744|589792301|FG004|Overall Study|Subject Withdrew Consent|2|||
163296353|NCT02564744|589792297|FG000|Overall Study|Lost to Follow-up|0|||
163296354|NCT02564744|589792298|FG001|Overall Study|Lost to Follow-up|1|||
163296355|NCT02564744|589792299|FG002|Overall Study|Lost to Follow-up|0|||
163296356|NCT02564744|589792300|FG003|Overall Study|Lost to Follow-up|0|||
163296357|NCT02564744|589792301|FG004|Overall Study|Lost to Follow-up|1|||
163296358|NCT02564744|589792297|FG000|Overall Study|Reason not specified|1|||
163296359|NCT02564744|589792298|FG001|Overall Study|Reason not specified|0|||
163296360|NCT02564744|589792299|FG002|Overall Study|Reason not specified|0|||
163296361|NCT02564744|589792300|FG003|Overall Study|Reason not specified|0|||
163296362|NCT02564744|589792301|FG004|Overall Study|Reason not specified|0|||
163296363|NCT00979992|589792303|FG000|Overall Study|Ineligible - inadequate pathology|1|||
163296364|NCT00979992|589792303|FG000|Overall Study|Ineligible - wrong cell type|2|||
163296365|NCT00979992|589792303|FG000|Overall Study|Refused - Never Treated|2|||
163296366|NCT01140048|589792309|FG000|Overall Study|Physician Decision|1|||
163296367|NCT01140048|589792309|FG000|Overall Study|Withdrawal by Subject|13|||
163296368|NCT01140048|589792309|FG000|Overall Study|Lost to Follow-up|31|||
163296369|NCT02888080|589792310|FG000|Overall Study|Subject / Guardian decision|1|||
163296370|NCT02888080|589792311|FG001|Overall Study|Subject / Guardian decision|3|||
163296371|NCT02888080|589792310|FG000|Overall Study|New Therapy for study indication|1|||
163296372|NCT02888080|589792311|FG001|Overall Study|New Therapy for study indication|0|||
163296373|NCT02888080|589792310|FG000|Overall Study|Lack of Efficacy|0|||
163296374|NCT02888080|589792311|FG001|Overall Study|Lack of Efficacy|1|||
163296375|NCT02888080|589792310|FG000|Overall Study|Adverse Event|0|||
163296376|NCT02888080|589792311|FG001|Overall Study|Adverse Event|1|||
163296377|NCT03737240|589792316|FG000|Overall Study|Lost to Follow-up|16|||
163296378|NCT03737240|589792317|FG001|Overall Study|Lost to Follow-up|15|||
163391474|NCT01493557|590146084|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
163391475|NCT01493557|590146085|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
163391476|NCT01493557|590146086|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
163391477|NCT01493557|590146084|FG000|Randomized to Management Strategies|Other than stated above|1|||
163391478|NCT01493557|590146085|FG001|Randomized to Management Strategies|Other than stated above|3|||
163391479|NCT01493557|590146086|FG002|Randomized to Management Strategies|Other than stated above|0|||
163391480|NCT01493557|590146084|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
163391481|NCT01493557|590146085|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
163391482|NCT01493557|590146086|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
163391483|NCT01493557|590146084|FG000|Adding the Second Strategy|Other adverse event|1|||
163391484|NCT01493557|590146085|FG001|Adding the Second Strategy|Other adverse event|2|||
163391485|NCT01493557|590146086|FG002|Adding the Second Strategy|Other adverse event|0|||
163391486|NCT01493557|590146084|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
163391487|NCT01493557|590146085|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
163391488|NCT01493557|590146086|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
163391489|NCT02973425|590146088|FG000|Overall Study|Lost to Follow-up|49|||
163391490|NCT02973425|590146089|FG001|Overall Study|Lost to Follow-up|53|||
163391491|NCT00909792|590146090|FG000|Period 1|Did not meet inclusion criteria|0|||
163391492|NCT00909792|590146091|FG001|Period 1|Did not meet inclusion criteria|1|||
163391493|NCT00909792|590146090|FG000|Period 2|Biomicroscopy|1|||
163391494|NCT00909792|590146091|FG001|Period 2|Biomicroscopy|0|||
163391495|NCT00909792|590146090|FG000|Period 2|Lost to Follow-up|0|||
163391496|NCT00909792|590146091|FG001|Period 2|Lost to Follow-up|1|||
163391497|NCT01448213|590146092|FG000|Overall Study|Lost to Follow-up|12|||
163391498|NCT01448213|590146093|FG001|Overall Study|Lost to Follow-up|10|||
163391499|NCT01448213|590146092|FG000|Overall Study|Adverse Event|4|||
163191414|NCT03386474|589415911|FG001|Overall Study|Adverse Event|1|||
163191415|NCT00066729|589415915|FG000|Overall Study|Lost to Follow-up|1|||
163191416|NCT00066729|589415915|FG000|Overall Study|Disease progression|1|||
163191417|NCT02349542|589415916|FG000|Overall Study|Withdrawal by Subject|5|||
163191418|NCT03896165|589415919|FG000|Overall Study|Withdrawal by Subject|2|||
163191419|NCT01163266|589415920|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
163191420|NCT01163266|589415921|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
163191421|NCT01163266|589415922|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
163191422|NCT01163266|589415920|FG000|Overall Study|Lack of Efficacy|1|||
163191423|NCT01163266|589415921|FG001|Overall Study|Lack of Efficacy|3|||
163191424|NCT01163266|589415922|FG002|Overall Study|Lack of Efficacy|1|||
163191425|NCT01163266|589415920|FG000|Overall Study|Noncompliance with Study Drug|0|||
163191426|NCT01163266|589415921|FG001|Overall Study|Noncompliance with Study Drug|2|||
163191427|NCT01163266|589415922|FG002|Overall Study|Noncompliance with Study Drug|0|||
163191428|NCT01163266|589415920|FG000|Overall Study|Protocol Deviations|2|||
163191429|NCT01163266|589415921|FG001|Overall Study|Protocol Deviations|2|||
163191430|NCT01163266|589415922|FG002|Overall Study|Protocol Deviations|5|||
163191431|NCT01163266|589415920|FG000|Overall Study|Withdrawal of Consent|5|||
163191432|NCT01163266|589415921|FG001|Overall Study|Withdrawal of Consent|7|||
163191433|NCT01163266|589415922|FG002|Overall Study|Withdrawal of Consent|3|||
163191434|NCT01163266|589415920|FG000|Overall Study|Lost to Follow-up|7|||
163191435|NCT01163266|589415921|FG001|Overall Study|Lost to Follow-up|7|||
163191436|NCT01163266|589415922|FG002|Overall Study|Lost to Follow-up|10|||
163191437|NCT01163266|589415920|FG000|Overall Study|Other|1|||
163191438|NCT01163266|589415921|FG001|Overall Study|Other|1|||
163191439|NCT01163266|589415922|FG002|Overall Study|Other|2|||
163191440|NCT02919696|589415923|FG000|Overall Study|Adverse Event|1|||
163191441|NCT02919696|589415924|FG001|Overall Study|Adverse Event|2|||
163191442|NCT02919696|589415923|FG000|Overall Study|Withdrawal by Subject|2|||
163191443|NCT02919696|589415924|FG001|Overall Study|Withdrawal by Subject|1|||
163191444|NCT02919696|589415923|FG000|Overall Study|Sponsor Decision|1|||
163191445|NCT02919696|589415924|FG001|Overall Study|Sponsor Decision|1|||
163191446|NCT02919696|589415923|FG000|Overall Study|Never Treated|0|||
163191447|NCT02919696|589415924|FG001|Overall Study|Never Treated|1|||
163191448|NCT03181893|589415925|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
163191449|NCT03181893|589415926|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
163191450|NCT03181893|589415927|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
163191451|NCT03181893|589415928|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
163391500|NCT01448213|590146093|FG001|Overall Study|Adverse Event|10|||
163191452|NCT03181893|589415929|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
163191453|NCT03181893|589415930|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
163191454|NCT03181893|589415931|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
163191455|NCT03181893|589415932|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
163191456|NCT03181893|589415933|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
163191457|NCT03181893|589415934|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
163191458|NCT03181893|589415935|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
163191459|NCT03181893|589415925|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
163391501|NCT01448213|590146092|FG000|Overall Study|Protocol Violation|1|||
163391502|NCT01448213|590146093|FG001|Overall Study|Protocol Violation|2|||
163391503|NCT03503513|590146094|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
163296379|NCT02512965|589792320|FG000|Overall Study|Withdrawal by Subject|0|||
163296380|NCT02512965|589792321|FG001|Overall Study|Withdrawal by Subject|4|||
163296381|NCT05001945|589792325|FG000|Overall Study|Adverse Event|0|||
163296382|NCT05001945|589792326|FG001|Overall Study|Adverse Event|0|||
163391504|NCT03503513|590146094|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
163391505|NCT03503513|590146094|FG000|Overall Study|Physician Decision|3|||
163296383|NCT05001945|589792327|FG002|Overall Study|Adverse Event|0|||
163296384|NCT05001945|589792328|FG003|Overall Study|Adverse Event|1|||
163296385|NCT05001945|589792329|FG004|Overall Study|Adverse Event|0|||
163296386|NCT05001945|589792330|FG005|Overall Study|Adverse Event|0|||
163391506|NCT03503513|590146094|FG000|Overall Study|Withdrawal by Subject|2|||
163391507|NCT03503513|590146094|FG000|Overall Study|Lost to Follow-up|1|||
163296387|NCT05001945|589792331|FG006|Overall Study|Adverse Event|0|||
163296388|NCT05001945|589792332|FG007|Overall Study|Adverse Event|0|||
163296389|NCT05001945|589792325|FG000|Overall Study|Lost to Follow-up|0|||
163296390|NCT05001945|589792326|FG001|Overall Study|Lost to Follow-up|1|||
163296391|NCT05001945|589792327|FG002|Overall Study|Lost to Follow-up|1|||
163296392|NCT05001945|589792328|FG003|Overall Study|Lost to Follow-up|2|||
163391508|NCT03823404|590146099|FG000|Overall Study|Lost to Follow-up|1|||
163391509|NCT03823404|590146100|FG001|Overall Study|Lost to Follow-up|2|||
163391510|NCT03823404|590146101|FG002|Overall Study|Lost to Follow-up|3|||
163391511|NCT03823404|590146099|FG000|Overall Study|Protocol Violation|2|||
163391512|NCT03823404|590146100|FG001|Overall Study|Protocol Violation|0|||
163391513|NCT03823404|590146101|FG002|Overall Study|Protocol Violation|2|||
163391514|NCT03823404|590146099|FG000|Overall Study|Adverse Event|35|||
163391515|NCT03823404|590146100|FG001|Overall Study|Adverse Event|38|||
163391516|NCT03823404|590146101|FG002|Overall Study|Adverse Event|8|||
163391517|NCT03823404|590146099|FG000|Overall Study|Withdrawal by Subject|38|||
163391518|NCT03823404|590146100|FG001|Overall Study|Withdrawal by Subject|40|||
163391519|NCT03823404|590146101|FG002|Overall Study|Withdrawal by Subject|35|||
163391520|NCT03823404|590146099|FG000|Overall Study|Death|4|||
163391521|NCT03823404|590146100|FG001|Overall Study|Death|0|||
163391522|NCT03823404|590146101|FG002|Overall Study|Death|0|||
163391523|NCT03823404|590146099|FG000|Overall Study|Other: Various reasons provided|5|||
163391524|NCT03823404|590146100|FG001|Overall Study|Other: Various reasons provided|5|||
163391525|NCT03823404|590146101|FG002|Overall Study|Other: Various reasons provided|6|||
163391526|NCT01524133|590146104|FG000|Treatment Phase|Withdrawal by Subject|13|||
163391527|NCT01524133|590146105|FG001|Treatment Phase|Withdrawal by Subject|28|||
163391528|NCT01524133|590146106|FG002|Treatment Phase|Withdrawal by Subject|31|||
163391529|NCT01524133|590146104|FG000|Treatment Phase|Physician Decision|6|||
163391530|NCT01524133|590146105|FG001|Treatment Phase|Physician Decision|3|||
163391531|NCT01524133|590146106|FG002|Treatment Phase|Physician Decision|3|||
163391532|NCT01524133|590146104|FG000|Treatment Phase|Lost to Follow-up|0|||
163391533|NCT01524133|590146105|FG001|Treatment Phase|Lost to Follow-up|1|||
163391534|NCT01524133|590146106|FG002|Treatment Phase|Lost to Follow-up|2|||
163391535|NCT01524133|590146104|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
163391536|NCT01524133|590146105|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
163391537|NCT01524133|590146106|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
163391538|NCT01524133|590146104|FG000|Overall Study 52 Weeks|Physician Decision|1|||
163391539|NCT01524133|590146105|FG001|Overall Study 52 Weeks|Physician Decision|0|||
163391540|NCT01524133|590146106|FG002|Overall Study 52 Weeks|Physician Decision|2|||
163391541|NCT01524133|590146104|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
163391542|NCT01524133|590146105|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
163391543|NCT01524133|590146106|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
163296393|NCT05001945|589792329|FG004|Overall Study|Lost to Follow-up|0|||
163296394|NCT05001945|589792330|FG005|Overall Study|Lost to Follow-up|1|||
163296395|NCT05001945|589792331|FG006|Overall Study|Lost to Follow-up|0|||
163296396|NCT05001945|589792332|FG007|Overall Study|Lost to Follow-up|0|||
163296397|NCT05001945|589792325|FG000|Overall Study|Protocol Violation|1|||
163296398|NCT05001945|589792326|FG001|Overall Study|Protocol Violation|0|||
163296399|NCT05001945|589792327|FG002|Overall Study|Protocol Violation|1|||
163296400|NCT05001945|589792328|FG003|Overall Study|Protocol Violation|1|||
163296401|NCT05001945|589792329|FG004|Overall Study|Protocol Violation|0|||
163296402|NCT05001945|589792330|FG005|Overall Study|Protocol Violation|1|||
163296403|NCT05001945|589792331|FG006|Overall Study|Protocol Violation|0|||
163296404|NCT05001945|589792332|FG007|Overall Study|Protocol Violation|0|||
163391544|NCT01087957|590146107|FG000|Overall Study|Death|2|||
163391545|NCT01087957|590146108|FG001|Overall Study|Death|2|||
163391546|NCT01087957|590146107|FG000|Overall Study|Lost to Follow-up|3|||
163296405|NCT05001945|589792325|FG000|Overall Study|Withdrawal by Subject|0|||
163296406|NCT05001945|589792326|FG001|Overall Study|Withdrawal by Subject|0|||
163391547|NCT01087957|590146108|FG001|Overall Study|Lost to Follow-up|4|||
163391548|NCT01087957|590146107|FG000|Overall Study|Protocol Violation|13|||
163391549|NCT01087957|590146108|FG001|Overall Study|Protocol Violation|25|||
163391550|NCT01087957|590146107|FG000|Overall Study|Withdrawal by Subject|18|||
163296407|NCT05001945|589792327|FG002|Overall Study|Withdrawal by Subject|0|||
163296408|NCT05001945|589792328|FG003|Overall Study|Withdrawal by Subject|1|||
163296409|NCT05001945|589792329|FG004|Overall Study|Withdrawal by Subject|1|||
163296410|NCT05001945|589792330|FG005|Overall Study|Withdrawal by Subject|1|||
163296411|NCT05001945|589792331|FG006|Overall Study|Withdrawal by Subject|0|||
163296412|NCT05001945|589792332|FG007|Overall Study|Withdrawal by Subject|1|||
163296413|NCT05001945|589792325|FG000|Overall Study|Not specified by Investigator|0|||
163296414|NCT05001945|589792326|FG001|Overall Study|Not specified by Investigator|3|||
163296415|NCT05001945|589792327|FG002|Overall Study|Not specified by Investigator|0|||
163296416|NCT05001945|589792328|FG003|Overall Study|Not specified by Investigator|0|||
163296417|NCT05001945|589792329|FG004|Overall Study|Not specified by Investigator|1|||
163296418|NCT05001945|589792330|FG005|Overall Study|Not specified by Investigator|0|||
163296419|NCT05001945|589792331|FG006|Overall Study|Not specified by Investigator|0|||
163296420|NCT05001945|589792332|FG007|Overall Study|Not specified by Investigator|0|||
163296421|NCT02570711|589792333|FG000|Overall Study|Death|1|||
163296422|NCT02570711|589792334|FG001|Overall Study|Death|0|||
163296423|NCT02570711|589792333|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
163296424|NCT02570711|589792334|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
163296425|NCT01369498|589792336|FG000|Overall Study|Lack of Efficacy|9|||
163296426|NCT01369498|589792337|FG001|Overall Study|Lack of Efficacy|9|||
163296427|NCT01369498|589792338|FG002|Overall Study|Lack of Efficacy|1|||
163296428|NCT01369498|589792339|FG003|Overall Study|Lack of Efficacy|3|||
163296429|NCT01369498|589792336|FG000|Overall Study|Adverse Event|1|||
163296430|NCT01369498|589792337|FG001|Overall Study|Adverse Event|2|||
163296431|NCT01369498|589792338|FG002|Overall Study|Adverse Event|0|||
163296432|NCT01369498|589792339|FG003|Overall Study|Adverse Event|1|||
163296433|NCT01369498|589792336|FG000|Overall Study|Withdrawal of Consent|0|||
163296434|NCT01369498|589792337|FG001|Overall Study|Withdrawal of Consent|1|||
163296435|NCT01369498|589792338|FG002|Overall Study|Withdrawal of Consent|1|||
163296436|NCT01369498|589792339|FG003|Overall Study|Withdrawal of Consent|1|||
163296437|NCT01369498|589792336|FG000|Overall Study|Death|0|||
163296438|NCT01369498|589792337|FG001|Overall Study|Death|0|||
163296439|NCT01369498|589792338|FG002|Overall Study|Death|1|||
163296440|NCT01369498|589792339|FG003|Overall Study|Death|0|||
163296441|NCT01369498|589792336|FG000|Overall Study|Investigator's Discretion|1|||
163296442|NCT01369498|589792337|FG001|Overall Study|Investigator's Discretion|0|||
163296443|NCT01369498|589792338|FG002|Overall Study|Investigator's Discretion|1|||
163296444|NCT01369498|589792339|FG003|Overall Study|Investigator's Discretion|3|||
163296445|NCT01369498|589792336|FG000|Overall Study|Unknown Reason|1|||
163296446|NCT01369498|589792337|FG001|Overall Study|Unknown Reason|0|||
163296447|NCT01369498|589792338|FG002|Overall Study|Unknown Reason|11|||
163296448|NCT01369498|589792339|FG003|Overall Study|Unknown Reason|6|||
163296449|NCT01369498|589792336|FG000|Overall Study|Disease Progression|0|||
163296450|NCT01369498|589792337|FG001|Overall Study|Disease Progression|0|||
163296451|NCT01369498|589792338|FG002|Overall Study|Disease Progression|0|||
163296452|NCT01369498|589792339|FG003|Overall Study|Disease Progression|1|||
163296453|NCT00545077|589792340|FG000|Overall Study|Treatment not received|5|||
163296454|NCT00545077|589792341|FG001|Overall Study|Treatment not received|1|||
163296455|NCT00545077|589792340|FG000|Overall Study|Disease Progression|131|||
163296456|NCT00545077|589792341|FG001|Overall Study|Disease Progression|98|||
163296457|NCT00545077|589792340|FG000|Overall Study|Withdrawal by Subject|3|||
163296458|NCT00545077|589792341|FG001|Overall Study|Withdrawal by Subject|14|||
163296459|NCT00545077|589792340|FG000|Overall Study|Physician Decision|6|||
163296460|NCT00545077|589792341|FG001|Overall Study|Physician Decision|3|||
163296461|NCT00545077|589792340|FG000|Overall Study|Lost to Follow-up|2|||
163391551|NCT01087957|590146108|FG001|Overall Study|Withdrawal by Subject|15|||
163391552|NCT01087957|590146107|FG000|Overall Study|Physician Decision|5|||
163391553|NCT01087957|590146108|FG001|Overall Study|Physician Decision|9|||
163391554|NCT00059839|590146110|FG000|Overall Study|Death|1|||
163391555|NCT00059839|590146111|FG001|Overall Study|Death|1|||
163391556|NCT00059839|590146110|FG000|Overall Study|Lack of Efficacy|6|||
163296462|NCT00545077|589792341|FG001|Overall Study|Lost to Follow-up|0|||
163296463|NCT00545077|589792340|FG000|Overall Study|Protocol Violation|1|||
163296464|NCT00545077|589792341|FG001|Overall Study|Protocol Violation|0|||
163296465|NCT00545077|589792340|FG000|Overall Study|Adverse Event|0|||
163296466|NCT00545077|589792341|FG001|Overall Study|Adverse Event|31|||
163296467|NCT00545077|589792340|FG000|Overall Study|Death|0|||
163296468|NCT00545077|589792341|FG001|Overall Study|Death|8|||
163296469|NCT00439569|589792346|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
163296470|NCT00439569|589792346|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
163296471|NCT00439569|589792346|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
163296472|NCT02755116|589792347|FG000|Overall Study|surgery converted to open, pt admitted|3|||
163296473|NCT02755116|589792348|FG001|Overall Study|surgery converted to open, pt admitted|1|||
163296474|NCT00958633|589792349|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
163296475|NCT00958633|589792350|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
163391557|NCT00059839|590146111|FG001|Overall Study|Lack of Efficacy|5|||
163391558|NCT00059839|590146110|FG000|Overall Study|Lost to Follow-up|2|||
163391559|NCT00059839|590146111|FG001|Overall Study|Lost to Follow-up|0|||
163391560|NCT00059839|590146110|FG000|Overall Study|Physician Decision|1|||
163391561|NCT00059839|590146111|FG001|Overall Study|Physician Decision|2|||
163391562|NCT00059839|590146110|FG000|Overall Study|Withdrawal by Subject|1|||
163391563|NCT00059839|590146111|FG001|Overall Study|Withdrawal by Subject|6|||
163391564|NCT00059839|590146110|FG000|Overall Study|Ineligible|1|||
163391565|NCT00059839|590146111|FG001|Overall Study|Ineligible|3|||
163391566|NCT00698451|590146112|FG000|Overall Study|Adverse Event|22|||
163391567|NCT00698451|590146112|FG000|Overall Study|Physician Decision|2|||
163391568|NCT00698451|590146112|FG000|Overall Study|Protocol Violation|6|||
163391569|NCT00698451|590146112|FG000|Overall Study|Withdrawal by Subject|6|||
163391570|NCT00698451|590146112|FG000|Overall Study|Disease progression|3|||
163391571|NCT03085758|590146117|FG000|Overall Study|Death|26|||
163391572|NCT03085758|590146118|FG001|Overall Study|Death|24|||
163391573|NCT03085758|590146119|FG002|Overall Study|Death|53|||
163391574|NCT03085758|590146117|FG000|Overall Study|Lost to Follow-up|1|||
163391575|NCT03085758|590146118|FG001|Overall Study|Lost to Follow-up|1|||
163391576|NCT03085758|590146119|FG002|Overall Study|Lost to Follow-up|1|||
163391577|NCT03085758|590146117|FG000|Overall Study|Withdrawal by Subject|2|||
163391578|NCT03085758|590146118|FG001|Overall Study|Withdrawal by Subject|2|||
163391579|NCT03085758|590146119|FG002|Overall Study|Withdrawal by Subject|1|||
163391580|NCT03085758|590146117|FG000|Overall Study|Refusal to recall it up to day 90|0|||
163391581|NCT03085758|590146118|FG001|Overall Study|Refusal to recall it up to day 90|0|||
163391582|NCT03085758|590146119|FG002|Overall Study|Refusal to recall it up to day 90|1|||
163391583|NCT03085758|590146117|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
163391584|NCT03085758|590146118|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
163391585|NCT03085758|590146119|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
163391586|NCT03974334|590146120|FG000|Overall Study|Lost to Follow-up|1|||
163391587|NCT01019317|590146121|FG000|Overall Study|Not Eligible|4|||
163391588|NCT00778622|590146122|FG000|Overall Study|Adverse Event|5|||
163391589|NCT00778622|590146123|FG001|Overall Study|Adverse Event|4|||
163391590|NCT00778622|590146124|FG002|Overall Study|Adverse Event|7|||
163391591|NCT00778622|590146122|FG000|Overall Study|Withdrawal by Subject|4|||
163391592|NCT00778622|590146123|FG001|Overall Study|Withdrawal by Subject|5|||
163391593|NCT00778622|590146124|FG002|Overall Study|Withdrawal by Subject|5|||
163391594|NCT00778622|590146122|FG000|Overall Study|Lost to Follow-up|3|||
163391595|NCT00778622|590146123|FG001|Overall Study|Lost to Follow-up|3|||
163391596|NCT00778622|590146124|FG002|Overall Study|Lost to Follow-up|2|||
163391597|NCT00778622|590146122|FG000|Overall Study|Protocol Violation|0|||
163391598|NCT00778622|590146123|FG001|Overall Study|Protocol Violation|3|||
163391599|NCT00778622|590146124|FG002|Overall Study|Protocol Violation|0|||
163391600|NCT00778622|590146122|FG000|Overall Study|Lack of Efficacy|2|||
163391601|NCT00778622|590146123|FG001|Overall Study|Lack of Efficacy|0|||
163391602|NCT00778622|590146124|FG002|Overall Study|Lack of Efficacy|0|||
163391603|NCT00778622|590146122|FG000|Overall Study|immigration|1|||
163391604|NCT00778622|590146123|FG001|Overall Study|immigration|0|||
163391605|NCT00778622|590146124|FG002|Overall Study|immigration|0|||
163391606|NCT00778622|590146122|FG000|Overall Study|Other|1|||
163391607|NCT00778622|590146123|FG001|Overall Study|Other|0|||
163391608|NCT00778622|590146124|FG002|Overall Study|Other|1|||
163391609|NCT01251120|590146126|FG000|Overall Study|Lack of Efficacy|0|||
163391610|NCT01251120|590146127|FG001|Overall Study|Lack of Efficacy|1|||
163391611|NCT01968070|590146128|FG000|Period 1|Withdrawal by Subject|0|||
163391612|NCT01968070|590146129|FG001|Period 1|Withdrawal by Subject|1|||
163391613|NCT01968070|590146130|FG002|Period 1|Withdrawal by Subject|0|||
163391614|NCT01968070|590146131|FG003|Period 1|Withdrawal by Subject|0|||
163391615|NCT01968070|590146132|FG004|Period 1|Withdrawal by Subject|0|||
163391616|NCT01968070|590146133|FG005|Period 1|Withdrawal by Subject|0|||
163391617|NCT01968070|590146134|FG006|Period 1|Withdrawal by Subject|1|||
163391618|NCT01968070|590146135|FG007|Period 1|Withdrawal by Subject|0|||
163391619|NCT01968070|590146136|FG008|Period 1|Withdrawal by Subject|0|||
163391620|NCT01968070|590146137|FG009|Period 1|Withdrawal by Subject|0|||
163391621|NCT01968070|590146138|FG010|Period 1|Withdrawal by Subject|0|||
163391622|NCT01968070|590146139|FG011|Period 1|Withdrawal by Subject|0|||
163391623|NCT01968070|590146140|FG012|Period 1|Withdrawal by Subject|0|||
163391624|NCT01968070|590146141|FG013|Period 1|Withdrawal by Subject|0|||
163391625|NCT01968070|590146142|FG014|Period 1|Withdrawal by Subject|0|||
163391626|NCT01968070|590146143|FG015|Period 1|Withdrawal by Subject|1|||
163391627|NCT01968070|590146144|FG016|Period 1|Withdrawal by Subject|0|||
163391628|NCT01968070|590146145|FG017|Period 1|Withdrawal by Subject|0|||
163391629|NCT01968070|590146128|FG000|Period 1|Protocol Violation|0|||
163391630|NCT01968070|590146129|FG001|Period 1|Protocol Violation|0|||
163391631|NCT01968070|590146130|FG002|Period 1|Protocol Violation|0|||
163391632|NCT01968070|590146131|FG003|Period 1|Protocol Violation|1|||
163391633|NCT01968070|590146132|FG004|Period 1|Protocol Violation|1|||
163391634|NCT01968070|590146133|FG005|Period 1|Protocol Violation|0|||
163391635|NCT01968070|590146134|FG006|Period 1|Protocol Violation|0|||
163391636|NCT01968070|590146135|FG007|Period 1|Protocol Violation|0|||
163391637|NCT01968070|590146136|FG008|Period 1|Protocol Violation|0|||
163391638|NCT01968070|590146137|FG009|Period 1|Protocol Violation|0|||
163296476|NCT00958633|589792351|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
163296477|NCT00958633|589792349|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
163296478|NCT00958633|589792350|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
163296479|NCT00958633|589792351|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
163296480|NCT00958633|589792349|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
163296481|NCT00958633|589792350|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
163296482|NCT00958633|589792351|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
163296483|NCT00958633|589792349|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
163296484|NCT00958633|589792350|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
163296485|NCT00958633|589792351|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
163296486|NCT00958633|589792349|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
163296487|NCT00958633|589792350|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
163296488|NCT00958633|589792351|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
163296489|NCT00958633|589792349|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
163296490|NCT00958633|589792350|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
163296491|NCT00958633|589792351|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
163296492|NCT00958633|589792349|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
163296493|NCT00958633|589792350|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
163296494|NCT00958633|589792351|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
163296495|NCT01597258|589792358|FG000|Overall Study|No Drug Administration|1|||
163296496|NCT04789408|589792359|FG000|Overall Study|Death|4|||
163296497|NCT04789408|589792360|FG001|Overall Study|Death|3|||
163296498|NCT04789408|589792361|FG002|Overall Study|Death|6|||
163296499|NCT04789408|589792359|FG000|Overall Study|Did not meet eligibility criteria|1|||
163296500|NCT04789408|589792360|FG001|Overall Study|Did not meet eligibility criteria|0|||
163296501|NCT04789408|589792361|FG002|Overall Study|Did not meet eligibility criteria|0|||
163296502|NCT04789408|589792359|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
163296503|NCT04789408|589792360|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
163296504|NCT04789408|589792361|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
163296505|NCT03073941|589794423|FG000|Overall Study|Received non-study device intraoperatively|0|||
163296506|NCT03073941|589794424|FG001|Overall Study|Received non-study device intraoperatively|2|||
163296507|NCT03073941|589794423|FG000|Overall Study|Death|1|||
163296508|NCT03073941|589794424|FG001|Overall Study|Death|0|||
163296509|NCT03073941|589794423|FG000|Overall Study|Withdrawal by Subject|1|||
163296510|NCT03073941|589794424|FG001|Overall Study|Withdrawal by Subject|3|||
163296511|NCT03073941|589794423|FG000|Overall Study|Lost to Follow-up|5|||
163296512|NCT03073941|589794424|FG001|Overall Study|Lost to Follow-up|4|||
163296513|NCT03073941|589794423|FG000|Overall Study|Adverse Event|4|||
163296514|NCT03073941|589794424|FG001|Overall Study|Adverse Event|2|||
163296515|NCT03073941|589794423|FG000|Overall Study|Met an exclusion criterion|0|||
163296516|NCT03073941|589794424|FG001|Overall Study|Met an exclusion criterion|1|||
163296517|NCT04250883|589794425|FG000|Overall Study|Lost to Follow-up|1|||
163296518|NCT04250883|589794426|FG001|Overall Study|Lost to Follow-up|0|||
163296519|NCT03936660|589794427|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
163391639|NCT01968070|590146138|FG010|Period 1|Protocol Violation|0|||
163391640|NCT01968070|590146139|FG011|Period 1|Protocol Violation|0|||
163391641|NCT01968070|590146140|FG012|Period 1|Protocol Violation|0|||
163391642|NCT01968070|590146141|FG013|Period 1|Protocol Violation|0|||
163391643|NCT01968070|590146142|FG014|Period 1|Protocol Violation|0|||
163391644|NCT01968070|590146143|FG015|Period 1|Protocol Violation|0|||
163391645|NCT01968070|590146144|FG016|Period 1|Protocol Violation|0|||
163391646|NCT01968070|590146145|FG017|Period 1|Protocol Violation|0|||
163391647|NCT01968070|590146128|FG000|Period 1|Lost to Follow-up|0|||
163391648|NCT01968070|590146129|FG001|Period 1|Lost to Follow-up|0|||
163391649|NCT01968070|590146130|FG002|Period 1|Lost to Follow-up|0|||
163391650|NCT01968070|590146131|FG003|Period 1|Lost to Follow-up|1|||
163391651|NCT01968070|590146132|FG004|Period 1|Lost to Follow-up|0|||
163391652|NCT01968070|590146133|FG005|Period 1|Lost to Follow-up|0|||
163391653|NCT01968070|590146134|FG006|Period 1|Lost to Follow-up|0|||
163391654|NCT01968070|590146135|FG007|Period 1|Lost to Follow-up|0|||
163391655|NCT01968070|590146136|FG008|Period 1|Lost to Follow-up|0|||
163391656|NCT01968070|590146137|FG009|Period 1|Lost to Follow-up|0|||
163391657|NCT01968070|590146138|FG010|Period 1|Lost to Follow-up|0|||
163391658|NCT01968070|590146139|FG011|Period 1|Lost to Follow-up|0|||
163391659|NCT01968070|590146140|FG012|Period 1|Lost to Follow-up|0|||
163391660|NCT01968070|590146141|FG013|Period 1|Lost to Follow-up|0|||
163391661|NCT01968070|590146142|FG014|Period 1|Lost to Follow-up|0|||
163296520|NCT03936660|589794428|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
163296521|NCT00925587|589794429|FG000|Overall Study|Protocol Specified Criteria|6|||
163296522|NCT00925587|589794430|FG001|Overall Study|Protocol Specified Criteria|6|||
163296523|NCT00925587|589794429|FG000|Overall Study|Physician Decision|4|||
163296524|NCT00925587|589794430|FG001|Overall Study|Physician Decision|1|||
163296525|NCT00925587|589794429|FG000|Overall Study|Protocol Violation|6|||
163296526|NCT00925587|589794430|FG001|Overall Study|Protocol Violation|4|||
163296527|NCT00925587|589794429|FG000|Overall Study|Withdrawal by Subject|9|||
163296528|NCT00925587|589794430|FG001|Overall Study|Withdrawal by Subject|6|||
163296529|NCT00925587|589794429|FG000|Overall Study|Death|5|||
163296530|NCT00925587|589794430|FG001|Overall Study|Death|5|||
163296531|NCT00925587|589794429|FG000|Overall Study|Adverse Event|6|||
163296532|NCT00925587|589794430|FG001|Overall Study|Adverse Event|2|||
163296533|NCT00925587|589794429|FG000|Overall Study|Lost to Follow-up|0|||
163296534|NCT00925587|589794430|FG001|Overall Study|Lost to Follow-up|1|||
163296535|NCT00774397|589794431|FG000|Overall Study|Adverse Event|1|||
163296536|NCT00774397|589794432|FG001|Overall Study|Adverse Event|3|||
163296537|NCT00774397|589794433|FG002|Overall Study|Adverse Event|16|||
163296538|NCT00774397|589794434|FG003|Overall Study|Adverse Event|8|||
163296539|NCT00774397|589794435|FG004|Overall Study|Adverse Event|8|||
163296540|NCT00774397|589794436|FG005|Overall Study|Adverse Event|3|||
163296541|NCT00774397|589794437|FG006|Overall Study|Adverse Event|16|||
163296542|NCT00774397|589794431|FG000|Overall Study|Lack of Efficacy|11|||
163296543|NCT00774397|589794432|FG001|Overall Study|Lack of Efficacy|4|||
163296544|NCT00774397|589794433|FG002|Overall Study|Lack of Efficacy|5|||
163296545|NCT00774397|589794434|FG003|Overall Study|Lack of Efficacy|3|||
163296546|NCT00774397|589794435|FG004|Overall Study|Lack of Efficacy|27|||
163296547|NCT00774397|589794436|FG005|Overall Study|Lack of Efficacy|15|||
163296548|NCT00774397|589794437|FG006|Overall Study|Lack of Efficacy|9|||
163296549|NCT00774397|589794431|FG000|Overall Study|Protocol Violation|0|||
163296550|NCT00774397|589794432|FG001|Overall Study|Protocol Violation|1|||
163296551|NCT00774397|589794433|FG002|Overall Study|Protocol Violation|3|||
163296552|NCT00774397|589794434|FG003|Overall Study|Protocol Violation|1|||
163296553|NCT00774397|589794435|FG004|Overall Study|Protocol Violation|2|||
163296554|NCT00774397|589794436|FG005|Overall Study|Protocol Violation|1|||
163296555|NCT00774397|589794437|FG006|Overall Study|Protocol Violation|0|||
163296556|NCT00774397|589794431|FG000|Overall Study|Lost to Follow-up|0|||
163296557|NCT00774397|589794432|FG001|Overall Study|Lost to Follow-up|1|||
163296558|NCT00774397|589794433|FG002|Overall Study|Lost to Follow-up|1|||
163296559|NCT00774397|589794434|FG003|Overall Study|Lost to Follow-up|1|||
163296560|NCT00774397|589794435|FG004|Overall Study|Lost to Follow-up|0|||
163296561|NCT00774397|589794436|FG005|Overall Study|Lost to Follow-up|1|||
163296562|NCT00774397|589794437|FG006|Overall Study|Lost to Follow-up|0|||
163296563|NCT00774397|589794431|FG000|Overall Study|Refused to continue trial medication|1|||
163296564|NCT00774397|589794432|FG001|Overall Study|Refused to continue trial medication|3|||
163296565|NCT00774397|589794433|FG002|Overall Study|Refused to continue trial medication|2|||
163296566|NCT00774397|589794434|FG003|Overall Study|Refused to continue trial medication|2|||
163296567|NCT00774397|589794435|FG004|Overall Study|Refused to continue trial medication|6|||
163296568|NCT00774397|589794436|FG005|Overall Study|Refused to continue trial medication|2|||
163296569|NCT00774397|589794437|FG006|Overall Study|Refused to continue trial medication|3|||
163296570|NCT00774397|589794431|FG000|Overall Study|Not treated|0|||
163296571|NCT00774397|589794432|FG001|Overall Study|Not treated|0|||
163296572|NCT00774397|589794433|FG002|Overall Study|Not treated|0|||
163296573|NCT00774397|589794434|FG003|Overall Study|Not treated|0|||
163296574|NCT00774397|589794435|FG004|Overall Study|Not treated|1|||
163296575|NCT00774397|589794436|FG005|Overall Study|Not treated|0|||
163296576|NCT00774397|589794437|FG006|Overall Study|Not treated|1|||
163296577|NCT00774397|589794431|FG000|Overall Study|Other than those stated above|1|||
163296578|NCT00774397|589794432|FG001|Overall Study|Other than those stated above|1|||
163296579|NCT00774397|589794433|FG002|Overall Study|Other than those stated above|3|||
163296580|NCT00774397|589794434|FG003|Overall Study|Other than those stated above|2|||
163296581|NCT00774397|589794435|FG004|Overall Study|Other than those stated above|2|||
163296582|NCT00774397|589794436|FG005|Overall Study|Other than those stated above|0|||
163296583|NCT00774397|589794437|FG006|Overall Study|Other than those stated above|1|||
163296584|NCT01599793|589794438|FG000|Overall Study|Adverse Event|2|||
163296585|NCT02675244|589794448|FG000|Overall Study|Death|9|||
163296586|NCT02675244|589794449|FG001|Overall Study|Death|6|||
163296587|NCT02675244|589794448|FG000|Overall Study|Withdrawal by Subject|3|||
163296588|NCT02675244|589794449|FG001|Overall Study|Withdrawal by Subject|6|||
163296589|NCT02675244|589794448|FG000|Overall Study|Lost to Follow-up|1|||
163296590|NCT02675244|589794449|FG001|Overall Study|Lost to Follow-up|1|||
163296591|NCT02675244|589794448|FG000|Overall Study|Ongoing at 2 Years|190|||
163296592|NCT02675244|589794449|FG001|Overall Study|Ongoing at 2 Years|185|||
163296593|NCT02652442|589794453|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
163296594|NCT02252042|589794454|FG000|Overall Study|Adverse Event|9|||
163296595|NCT02252042|589794455|FG001|Overall Study|Adverse Event|6|||
163296596|NCT02252042|589794454|FG000|Overall Study|Death|209|||
163296597|NCT02252042|589794455|FG001|Overall Study|Death|217|||
163296598|NCT02252042|589794454|FG000|Overall Study|Physician Decision|0|||
163296599|NCT02252042|589794455|FG001|Overall Study|Physician Decision|2|||
163296600|NCT02252042|589794454|FG000|Overall Study|Transferred to Extension Study|7|||
163296601|NCT02252042|589794455|FG001|Overall Study|Transferred to Extension Study|1|||
163296602|NCT02252042|589794454|FG000|Overall Study|Did Not Continue on Extension Study|7|||
163296603|NCT02252042|589794455|FG001|Overall Study|Did Not Continue on Extension Study|2|||
163296604|NCT02252042|589794454|FG000|Overall Study|Withdrawal by Subject|15|||
163296605|NCT02252042|589794455|FG001|Overall Study|Withdrawal by Subject|20|||
163296606|NCT02593149|589794458|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
163296607|NCT02593149|589794459|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
163296608|NCT02593149|589794458|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
163296609|NCT02593149|589794459|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
163296610|NCT01177670|589794460|FG000|Overall Study|Study Terminated|115|||
163296611|NCT01177670|589794460|FG000|Overall Study|Physician Decision|50|||
163296612|NCT01177670|589794460|FG000|Overall Study|Withdrawal by Subject|4|||
163296613|NCT01636687|589794466|FG000|Induction Period|Withdrawal by Subject|1|||
163296614|NCT01636687|589794467|FG001|Induction Period|Withdrawal by Subject|0|||
163296615|NCT01636687|589794468|FG002|Induction Period|Withdrawal by Subject|0|||
163296616|NCT01636687|589794469|FG003|Induction Period|Withdrawal by Subject|0|||
163296617|NCT01636687|589794470|FG004|Induction Period|Withdrawal by Subject|0|||
163296618|NCT01636687|589794466|FG000|Induction Period|Adverse Event|1|||
163296619|NCT01636687|589794467|FG001|Induction Period|Adverse Event|0|||
163296620|NCT01636687|589794468|FG002|Induction Period|Adverse Event|0|||
163296621|NCT01636687|589794469|FG003|Induction Period|Adverse Event|0|||
163296622|NCT01636687|589794470|FG004|Induction Period|Adverse Event|1|||
163296623|NCT01636687|589794466|FG000|Induction Period|Lack of Efficacy|0|||
163296624|NCT01636687|589794467|FG001|Induction Period|Lack of Efficacy|0|||
163296625|NCT01636687|589794468|FG002|Induction Period|Lack of Efficacy|0|||
163296626|NCT01636687|589794469|FG003|Induction Period|Lack of Efficacy|0|||
163296627|NCT01636687|589794470|FG004|Induction Period|Lack of Efficacy|1|||
163296628|NCT01636687|589794466|FG000|Induction Period|Physician Decision|1|||
163296629|NCT01636687|589794467|FG001|Induction Period|Physician Decision|0|||
163296630|NCT01636687|589794468|FG002|Induction Period|Physician Decision|0|||
163296631|NCT01636687|589794469|FG003|Induction Period|Physician Decision|0|||
163296632|NCT01636687|589794470|FG004|Induction Period|Physician Decision|0|||
163296633|NCT01636687|589794466|FG000|Maintenance Period|Withdrawal by Subject|2|||
163296634|NCT01636687|589794467|FG001|Maintenance Period|Withdrawal by Subject|0|||
163391662|NCT01968070|590146143|FG015|Period 1|Lost to Follow-up|0|||
163391663|NCT01968070|590146144|FG016|Period 1|Lost to Follow-up|0|||
163391664|NCT01968070|590146145|FG017|Period 1|Lost to Follow-up|0|||
163296635|NCT01636687|589794468|FG002|Maintenance Period|Withdrawal by Subject|2|||
163391665|NCT01968070|590146128|FG000|Period 1|Adverse Event|0|||
163391666|NCT01968070|590146129|FG001|Period 1|Adverse Event|0|||
163391667|NCT01968070|590146130|FG002|Period 1|Adverse Event|0|||
163391668|NCT01968070|590146131|FG003|Period 1|Adverse Event|0|||
163391669|NCT01968070|590146132|FG004|Period 1|Adverse Event|0|||
163391670|NCT01968070|590146133|FG005|Period 1|Adverse Event|0|||
163391671|NCT01968070|590146134|FG006|Period 1|Adverse Event|1|||
163296636|NCT01636687|589794469|FG003|Maintenance Period|Withdrawal by Subject|0|||
163296637|NCT01636687|589794470|FG004|Maintenance Period|Withdrawal by Subject|0|||
163296638|NCT01636687|589794466|FG000|Maintenance Period|Adverse Event|1|||
163296639|NCT01636687|589794467|FG001|Maintenance Period|Adverse Event|0|||
163296640|NCT01636687|589794468|FG002|Maintenance Period|Adverse Event|0|||
163296641|NCT01636687|589794469|FG003|Maintenance Period|Adverse Event|0|||
163296642|NCT01636687|589794470|FG004|Maintenance Period|Adverse Event|0|||
163296643|NCT01636687|589794466|FG000|Maintenance Period|Lack of Efficacy|4|||
163296644|NCT01636687|589794467|FG001|Maintenance Period|Lack of Efficacy|1|||
163296645|NCT01636687|589794468|FG002|Maintenance Period|Lack of Efficacy|0|||
163296646|NCT01636687|589794469|FG003|Maintenance Period|Lack of Efficacy|0|||
163296647|NCT01636687|589794470|FG004|Maintenance Period|Lack of Efficacy|0|||
163296648|NCT01636687|589794466|FG000|Maintenance Period|Lost to Follow-up|1|||
163296649|NCT01636687|589794467|FG001|Maintenance Period|Lost to Follow-up|1|||
163296650|NCT01636687|589794468|FG002|Maintenance Period|Lost to Follow-up|0|||
163296651|NCT01636687|589794469|FG003|Maintenance Period|Lost to Follow-up|0|||
163296652|NCT01636687|589794470|FG004|Maintenance Period|Lost to Follow-up|1|||
163296653|NCT01636687|589794466|FG000|Maintenance Period|Physician Decision|0|||
163296654|NCT01636687|589794467|FG001|Maintenance Period|Physician Decision|0|||
163296655|NCT01636687|589794468|FG002|Maintenance Period|Physician Decision|0|||
163296656|NCT01636687|589794469|FG003|Maintenance Period|Physician Decision|0|||
163296657|NCT01636687|589794470|FG004|Maintenance Period|Physician Decision|1|||
163296658|NCT01636687|589794466|FG000|Extension Period|technical problems|0|||
163296659|NCT01636687|589794467|FG001|Extension Period|technical problems|1|||
163296660|NCT01636687|589794468|FG002|Extension Period|technical problems|2|||
163296661|NCT01636687|589794469|FG003|Extension Period|technical problems|1|||
163296662|NCT01636687|589794470|FG004|Extension Period|technical problems|0|||
163296663|NCT01636687|589794466|FG000|Extension Period|Adverse Event|4|||
163296664|NCT01636687|589794467|FG001|Extension Period|Adverse Event|3|||
163296665|NCT01636687|589794468|FG002|Extension Period|Adverse Event|2|||
163391672|NCT01968070|590146135|FG007|Period 1|Adverse Event|0|||
163391673|NCT01968070|590146136|FG008|Period 1|Adverse Event|0|||
163296666|NCT01636687|589794469|FG003|Extension Period|Adverse Event|1|||
163296667|NCT01636687|589794470|FG004|Extension Period|Adverse Event|0|||
163296668|NCT01636687|589794466|FG000|Extension Period|Lack of Efficacy|7|||
163391674|NCT01968070|590146137|FG009|Period 1|Adverse Event|0|||
163391675|NCT01968070|590146138|FG010|Period 1|Adverse Event|0|||
163391676|NCT01968070|590146139|FG011|Period 1|Adverse Event|0|||
163296669|NCT01636687|589794467|FG001|Extension Period|Lack of Efficacy|0|||
163296670|NCT01636687|589794468|FG002|Extension Period|Lack of Efficacy|2|||
163296671|NCT01636687|589794469|FG003|Extension Period|Lack of Efficacy|1|||
163296672|NCT01636687|589794470|FG004|Extension Period|Lack of Efficacy|0|||
163296673|NCT01636687|589794466|FG000|Extension Period|Lost to Follow-up|1|||
163296674|NCT01636687|589794467|FG001|Extension Period|Lost to Follow-up|0|||
163296675|NCT01636687|589794468|FG002|Extension Period|Lost to Follow-up|1|||
163296676|NCT01636687|589794469|FG003|Extension Period|Lost to Follow-up|0|||
163296677|NCT01636687|589794470|FG004|Extension Period|Lost to Follow-up|0|||
163296678|NCT01636687|589794466|FG000|Extension Period|Physician Decision|1|||
163296679|NCT01636687|589794467|FG001|Extension Period|Physician Decision|0|||
163296680|NCT01636687|589794468|FG002|Extension Period|Physician Decision|0|||
163296681|NCT01636687|589794469|FG003|Extension Period|Physician Decision|1|||
163296682|NCT01636687|589794470|FG004|Extension Period|Physician Decision|0|||
163296683|NCT01636687|589794466|FG000|Extension Period|study terminated by sponsor|33|||
163296684|NCT01636687|589794467|FG001|Extension Period|study terminated by sponsor|50|||
163296685|NCT01636687|589794468|FG002|Extension Period|study terminated by sponsor|17|||
163296686|NCT01636687|589794469|FG003|Extension Period|study terminated by sponsor|23|||
163296687|NCT01636687|589794470|FG004|Extension Period|study terminated by sponsor|0|||
163296688|NCT01636687|589794466|FG000|Extension Period|Withdrawal by Subject|1|||
163296689|NCT01636687|589794467|FG001|Extension Period|Withdrawal by Subject|0|||
163296690|NCT01636687|589794468|FG002|Extension Period|Withdrawal by Subject|1|||
163296691|NCT01636687|589794469|FG003|Extension Period|Withdrawal by Subject|1|||
163296692|NCT01636687|589794470|FG004|Extension Period|Withdrawal by Subject|0|||
163296693|NCT01636687|589794466|FG000|Follow-up Period|Withdrawal by Subject|1|||
163296694|NCT01636687|589794467|FG001|Follow-up Period|Withdrawal by Subject|0|||
163296695|NCT01636687|589794468|FG002|Follow-up Period|Withdrawal by Subject|0|||
163296696|NCT01636687|589794469|FG003|Follow-up Period|Withdrawal by Subject|0|||
163296697|NCT01636687|589794470|FG004|Follow-up Period|Withdrawal by Subject|1|||
163296698|NCT00636207|589794473|FG000|Overall Study|Adverse Event|1|||
163296699|NCT00636207|589794474|FG001|Overall Study|Adverse Event|0|||
163296700|NCT00636207|589794475|FG002|Overall Study|Adverse Event|0|||
163296701|NCT00636207|589794476|FG003|Overall Study|Adverse Event|0|||
163296702|NCT00636207|589794477|FG004|Overall Study|Adverse Event|0|||
163296703|NCT00636207|589794478|FG005|Overall Study|Adverse Event|0|||
163296704|NCT00636207|589794479|FG006|Overall Study|Adverse Event|0|||
163296705|NCT00636207|589794473|FG000|Overall Study|Withdrawal by Subject|0|||
163296706|NCT00636207|589794474|FG001|Overall Study|Withdrawal by Subject|1|||
163296707|NCT00636207|589794475|FG002|Overall Study|Withdrawal by Subject|0|||
163296708|NCT00636207|589794476|FG003|Overall Study|Withdrawal by Subject|0|||
163296709|NCT00636207|589794477|FG004|Overall Study|Withdrawal by Subject|1|||
163296710|NCT00636207|589794478|FG005|Overall Study|Withdrawal by Subject|0|||
163296711|NCT00636207|589794479|FG006|Overall Study|Withdrawal by Subject|0|||
163296712|NCT00666276|589794482|FG000|Overall Study|Protocol Violation|34|||
163296713|NCT01039688|589794483|FG000|Overall Study|Adverse Event|38|||
163296714|NCT01039688|589794484|FG001|Overall Study|Adverse Event|39|||
163296715|NCT01039688|589794485|FG002|Overall Study|Adverse Event|24|||
163296716|NCT01039688|589794483|FG000|Overall Study|Lack of Efficacy|20|||
163296717|NCT01039688|589794484|FG001|Overall Study|Lack of Efficacy|11|||
163296718|NCT01039688|589794485|FG002|Overall Study|Lack of Efficacy|26|||
163296719|NCT01039688|589794483|FG000|Overall Study|Lost to Follow-up|11|||
163296720|NCT01039688|589794484|FG001|Overall Study|Lost to Follow-up|9|||
163296721|NCT01039688|589794485|FG002|Overall Study|Lost to Follow-up|5|||
163296722|NCT01039688|589794483|FG000|Overall Study|Other|13|||
163296723|NCT01039688|589794484|FG001|Overall Study|Other|25|||
163296724|NCT01039688|589794485|FG002|Overall Study|Other|12|||
163296725|NCT01039688|589794483|FG000|Overall Study|Withdrawal by Subject|23|||
163296726|NCT01039688|589794484|FG001|Overall Study|Withdrawal by Subject|27|||
163296727|NCT01039688|589794485|FG002|Overall Study|Withdrawal by Subject|13|||
163296728|NCT01039688|589794483|FG000|Overall Study|Death|2|||
163296729|NCT01039688|589794484|FG001|Overall Study|Death|0|||
163296730|NCT01039688|589794485|FG002|Overall Study|Death|0|||
163296731|NCT02594735|589794486|FG000|Overall Study|Adverse Event|1|||
163296732|NCT03844269|589794488|FG000|Overall Study|Withdrawal pre-intervention|1|||
163296733|NCT03844269|589794488|FG000|Overall Study|Did not complete the intervention|2|||
163296734|NCT00101010|589794494|FG000|Overall Study|Physician Decision|1|||
163296735|NCT04054635|589794503|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
163296736|NCT04054635|589794504|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
163296737|NCT04054635|589794505|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
163296738|NCT04054635|589794503|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
163296739|NCT04054635|589794504|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
163296740|NCT04054635|589794505|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
163296741|NCT00364013|589794506|FG000|Overall Study|Ineligibility determined|4|||
163296742|NCT00364013|589794507|FG001|Overall Study|Ineligibility determined|2|||
163296743|NCT00364013|589794506|FG000|Overall Study|Adverse Event|4|||
163296744|NCT00364013|589794507|FG001|Overall Study|Adverse Event|3|||
163296745|NCT00364013|589794506|FG000|Overall Study|Withdrawal by Subject|13|||
163296746|NCT00364013|589794507|FG001|Overall Study|Withdrawal by Subject|18|||
163296747|NCT00364013|589794506|FG000|Overall Study|Physician Decision|3|||
163296748|NCT00364013|589794507|FG001|Overall Study|Physician Decision|3|||
163296749|NCT00364013|589794506|FG000|Overall Study|Lost to Follow-up|10|||
163296750|NCT00364013|589794507|FG001|Overall Study|Lost to Follow-up|3|||
163296751|NCT00364013|589794506|FG000|Overall Study|Protocol-specified criteria|6|||
163296752|NCT00364013|589794507|FG001|Overall Study|Protocol-specified criteria|6|||
163296753|NCT00364013|589794506|FG000|Overall Study|Other|41|||
163296754|NCT00364013|589794507|FG001|Overall Study|Other|47|||
163296755|NCT00364013|589794506|FG000|Overall Study|Ongoing|20|||
163296756|NCT00364013|589794507|FG001|Overall Study|Ongoing|13|||
163296757|NCT00891930|589794508|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
163296758|NCT00891930|589794508|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
163296759|NCT00891930|589794508|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
163296760|NCT00891930|589794508|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
163296761|NCT00891930|589794508|FG000|Part 2 Panitumumab + AMG479|Death|30|||
163296762|NCT00835770|589794515|FG000|Overall Study|MS Relapse|17|||
163296763|NCT00835770|589794516|FG001|Overall Study|MS Relapse|23|||
163296764|NCT00835770|589794515|FG000|Overall Study|MS Progression|14|||
163296765|NCT00835770|589794516|FG001|Overall Study|MS Progression|9|||
163296766|NCT00835770|589794515|FG000|Overall Study|Adverse Event|113|||
163296767|NCT00835770|589794516|FG001|Overall Study|Adverse Event|124|||
163296768|NCT00835770|589794515|FG000|Overall Study|Lost to Follow-up|22|||
163296769|NCT00835770|589794516|FG001|Overall Study|Lost to Follow-up|19|||
163296770|NCT00835770|589794515|FG000|Overall Study|Consent Withdrawn|144|||
163296771|NCT00835770|589794516|FG001|Overall Study|Consent Withdrawn|156|||
163296772|NCT00835770|589794515|FG000|Overall Study|Investigator Decision|42|||
163296773|NCT00835770|589794516|FG001|Overall Study|Investigator Decision|42|||
163296774|NCT00835770|589794515|FG000|Overall Study|Participant Non-Compliance|11|||
163296775|NCT00835770|589794516|FG001|Overall Study|Participant Non-Compliance|9|||
163296776|NCT00835770|589794515|FG000|Overall Study|Death|4|||
163296777|NCT00835770|589794516|FG001|Overall Study|Death|6|||
163296778|NCT00835770|589794515|FG000|Overall Study|Other|115|||
163296779|NCT00835770|589794516|FG001|Overall Study|Other|104|||
163296780|NCT00835770|589794515|FG000|Overall Study|Other|2|||
163296781|NCT00835770|589794516|FG001|Overall Study|Other|1|||
163296782|NCT01185782|589794517|FG000|Overall Study|Adverse Event|0|||
163296783|NCT01185782|589794518|FG001|Overall Study|Adverse Event|1|||
163296784|NCT01185782|589794517|FG000|Overall Study|Protocol Violation|1|||
163296785|NCT01185782|589794518|FG001|Overall Study|Protocol Violation|0|||
163296786|NCT01185782|589794517|FG000|Overall Study|Poor Response to Treatment|3|||
163296787|NCT01185782|589794518|FG001|Overall Study|Poor Response to Treatment|1|||
163296788|NCT01185782|589794517|FG000|Overall Study|Other|2|||
163296789|NCT01185782|589794518|FG001|Overall Study|Other|5|||
163296790|NCT01185782|589794517|FG000|Overall Study|Randomized but not treated|0|||
163296791|NCT01185782|589794518|FG001|Overall Study|Randomized but not treated|4|||
163296792|NCT02507752|589794519|FG000|Overall Study|Adverse Event|1|||
163296793|NCT02507752|589794519|FG000|Overall Study|Protocol Violation|6|||
163296794|NCT02507752|589794519|FG000|Overall Study|Lost to Follow-up|7|||
163296795|NCT02507752|589794519|FG000|Overall Study|Infusion reaction at first infusion|1|||
163296796|NCT02507752|589794519|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
163296797|NCT02507752|589794519|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
163296798|NCT01254188|589794525|FG000|Overall Study|Disease Progression|6|||
163296799|NCT01254188|589794525|FG000|Overall Study|Protocol Violation|6|||
163296800|NCT01254188|589794525|FG000|Overall Study|Pregnancy|2|||
163296801|NCT01254188|589794525|FG000|Overall Study|Death|4|||
163296802|NCT01254188|589794525|FG000|Overall Study|Lost to Follow-up|5|||
163296803|NCT01254188|589794525|FG000|Overall Study|Withdrawal by Subject|7|||
163296804|NCT01254188|589794525|FG000|Overall Study|Adverse Event|43|||
163296805|NCT01254188|589794525|FG000|Overall Study|per investigator discretion|20|||
163296806|NCT02202499|589794529|FG000|Overall Study|Cancer diagnosis|0|||
163296807|NCT02202499|589794530|FG001|Overall Study|Cancer diagnosis|0|||
163296808|NCT02202499|589794531|FG002|Overall Study|Cancer diagnosis|1|||
163296809|NCT02202499|589794529|FG000|Overall Study|Moved from area|0|||
163296810|NCT02202499|589794530|FG001|Overall Study|Moved from area|0|||
163296811|NCT02202499|589794531|FG002|Overall Study|Moved from area|1|||
163296812|NCT02202499|589794529|FG000|Overall Study|Declined before randomization|1|||
163296813|NCT02202499|589794530|FG001|Overall Study|Declined before randomization|0|||
163296814|NCT02202499|589794531|FG002|Overall Study|Declined before randomization|0|||
163296815|NCT02202499|589794529|FG000|Overall Study|Auto accident|1|||
163296816|NCT02202499|589794530|FG001|Overall Study|Auto accident|0|||
163296817|NCT02202499|589794531|FG002|Overall Study|Auto accident|0|||
163296818|NCT00535145|589794533|FG000|Phase I|Adverse Event|3|||
163296819|NCT00535145|589794533|FG000|Phase I|Lost to Follow-up|7|||
163296820|NCT00535145|589794533|FG000|Phase I|Withdrawal by Subject|6|||
163296821|NCT00535145|589794533|FG000|Phase I|(eligibility)|8|||
163296822|NCT00535145|589794533|FG000|Phase I|(protocol violation)|1|||
163296823|NCT00535145|589794533|FG000|Phase I|(PI decision)|1|||
163296824|NCT00535145|589794533|FG000|Phase I|(diagnosis)|3|||
163296825|NCT00535145|589794533|FG000|Phase II|Adverse Event|2|||
163296826|NCT00535145|589794533|FG000|Phase II|Lack of Efficacy|1|||
163296827|NCT00535145|589794533|FG000|Phase II|Lost to Follow-up|5|||
163296828|NCT00535145|589794533|FG000|Phase II|Withdrawal by Subject|5|||
163296829|NCT00535145|589794533|FG000|Phase II|Subject non-compliance|2|||
163296830|NCT05082935|589794536|FG000|Overall Study|Lost to Follow-up|549|||
163296831|NCT05082935|589794537|FG001|Overall Study|Lost to Follow-up|631|||
163296832|NCT05082935|589794536|FG000|Overall Study|Withdrawal by Subject|27|||
163296833|NCT05082935|589794537|FG001|Overall Study|Withdrawal by Subject|58|||
163296834|NCT04530747|589794539|FG000|Overall Study|Withdrawal by Subject|1|||
163296835|NCT04530747|589794540|FG001|Overall Study|Withdrawal by Subject|0|||
163296836|NCT03292913|589794541|FG000|Overall Study|Death|9|||
163296837|NCT03292913|589794542|FG001|Overall Study|Death|3|||
163296838|NCT03292913|589794541|FG000|Overall Study|Lost to Follow-up|49|||
163296839|NCT03292913|589794542|FG001|Overall Study|Lost to Follow-up|49|||
163296840|NCT03292913|589794541|FG000|Overall Study|Withdrawal by Subject|2|||
163296841|NCT03292913|589794542|FG001|Overall Study|Withdrawal by Subject|0|||
163296842|NCT03292913|589794541|FG000|Overall Study|Clinic closed due to COVID|22|||
163296843|NCT03292913|589794542|FG001|Overall Study|Clinic closed due to COVID|36|||
163296844|NCT03950622|589794543|FG000|Overall Study|Withdrawal by Subject|1|||
163296845|NCT03950622|589794544|FG001|Overall Study|Withdrawal by Subject|0|||
163296846|NCT03950622|589794543|FG000|Overall Study|Protocol Deviation|0|||
163296847|NCT03950622|589794544|FG001|Overall Study|Protocol Deviation|1|||
163296848|NCT03950622|589794543|FG000|Overall Study|Physician Decision|1|||
163296849|NCT03950622|589794544|FG001|Overall Study|Physician Decision|0|||
163296850|NCT03950622|589794543|FG000|Overall Study|Lost to Follow-up|5|||
163296851|NCT03950622|589794544|FG001|Overall Study|Lost to Follow-up|5|||
163296852|NCT03950622|589794543|FG000|Overall Study|Death|1|||
163296853|NCT03950622|589794544|FG001|Overall Study|Death|1|||
163296854|NCT03531840|589794551|FG000|Overall Study|Death on study|3|||
163296855|NCT03531840|589794552|FG001|Overall Study|Death on study|2|||
163296856|NCT03531840|589794553|FG002|Overall Study|Death on study|1|||
163296857|NCT03531840|589794554|FG003|Overall Study|Death on study|2|||
163296858|NCT03531840|589794551|FG000|Overall Study|Death during follow up|2|||
163296859|NCT03531840|589794552|FG001|Overall Study|Death during follow up|3|||
163296860|NCT03531840|589794553|FG002|Overall Study|Death during follow up|4|||
163296861|NCT03531840|589794554|FG003|Overall Study|Death during follow up|1|||
163296862|NCT02267824|589794556|FG000|Overall Study|Pregnancy|1|||
163296863|NCT02267824|589794557|FG001|Overall Study|Pregnancy|1|||
163296864|NCT02267824|589794556|FG000|Overall Study|Lost to Follow-up|4|||
163296865|NCT02267824|589794557|FG001|Overall Study|Lost to Follow-up|0|||
163296866|NCT02267824|589794556|FG000|Overall Study|Protocol Violation|3|||
163296867|NCT02267824|589794557|FG001|Overall Study|Protocol Violation|0|||
163296868|NCT02267824|589794556|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
163296869|NCT02267824|589794557|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
163296870|NCT02928224|589794558|FG000|Overall Study|Lost to Follow-up|1|||
163296871|NCT02928224|589794559|FG001|Overall Study|Lost to Follow-up|1|||
163296872|NCT02928224|589794560|FG002|Overall Study|Lost to Follow-up|3|||
163296873|NCT02928224|589794561|FG003|Overall Study|Lost to Follow-up|0|||
163296874|NCT02928224|589794558|FG000|Overall Study|Death|30|||
163296875|NCT02928224|589794559|FG001|Overall Study|Death|209|||
163191460|NCT03181893|589415926|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
163191461|NCT03181893|589415927|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
163191462|NCT03181893|589415928|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
163191463|NCT03181893|589415929|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
163191464|NCT03181893|589415930|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
163191465|NCT03181893|589415931|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
163191466|NCT03181893|589415932|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
163191467|NCT03181893|589415933|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
163191468|NCT03181893|589415934|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
163191469|NCT03181893|589415935|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
163191470|NCT03181893|589415925|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
163191471|NCT03181893|589415926|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
163191472|NCT03181893|589415927|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
163191473|NCT03181893|589415928|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
163191474|NCT03181893|589415929|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
163191475|NCT03181893|589415930|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
163296876|NCT02928224|589794560|FG002|Overall Study|Death|193|||
163296877|NCT02928224|589794561|FG003|Overall Study|Death|198|||
163296878|NCT02928224|589794558|FG000|Overall Study|Withdrawal by Subject|0|||
163296879|NCT02928224|589794559|FG001|Overall Study|Withdrawal by Subject|3|||
163296880|NCT02928224|589794560|FG002|Overall Study|Withdrawal by Subject|7|||
163296881|NCT02928224|589794561|FG003|Overall Study|Withdrawal by Subject|20|||
163296882|NCT02928224|589794558|FG000|Overall Study|Study participation terminated by sponsor|3|||
163296883|NCT02928224|589794559|FG001|Overall Study|Study participation terminated by sponsor|8|||
163296884|NCT02928224|589794560|FG002|Overall Study|Study participation terminated by sponsor|12|||
163191476|NCT03181893|589415931|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
163391677|NCT01968070|590146140|FG012|Period 1|Adverse Event|0|||
163296885|NCT02928224|589794561|FG003|Overall Study|Study participation terminated by sponsor|3|||
163391678|NCT01968070|590146141|FG013|Period 1|Adverse Event|0|||
163391679|NCT01968070|590146142|FG014|Period 1|Adverse Event|0|||
163391680|NCT01968070|590146143|FG015|Period 1|Adverse Event|0|||
163391681|NCT01968070|590146144|FG016|Period 1|Adverse Event|0|||
163391682|NCT01968070|590146145|FG017|Period 1|Adverse Event|0|||
163391683|NCT01968070|590146128|FG000|Period 1|Physician Decision|0|||
163391684|NCT01968070|590146129|FG001|Period 1|Physician Decision|0|||
163391685|NCT01968070|590146130|FG002|Period 1|Physician Decision|0|||
163391686|NCT01968070|590146131|FG003|Period 1|Physician Decision|0|||
163391687|NCT01968070|590146132|FG004|Period 1|Physician Decision|0|||
163391688|NCT01968070|590146133|FG005|Period 1|Physician Decision|0|||
163391689|NCT01968070|590146134|FG006|Period 1|Physician Decision|0|||
163391690|NCT01968070|590146135|FG007|Period 1|Physician Decision|0|||
163391691|NCT01968070|590146136|FG008|Period 1|Physician Decision|0|||
163391692|NCT01968070|590146137|FG009|Period 1|Physician Decision|0|||
163391693|NCT01968070|590146138|FG010|Period 1|Physician Decision|0|||
163391694|NCT01968070|590146139|FG011|Period 1|Physician Decision|1|||
163391695|NCT01968070|590146140|FG012|Period 1|Physician Decision|0|||
163391696|NCT01968070|590146141|FG013|Period 1|Physician Decision|0|||
163391697|NCT01968070|590146142|FG014|Period 1|Physician Decision|0|||
163391698|NCT01968070|590146143|FG015|Period 1|Physician Decision|0|||
163391699|NCT01968070|590146144|FG016|Period 1|Physician Decision|0|||
163391700|NCT01968070|590146145|FG017|Period 1|Physician Decision|0|||
163391701|NCT01968070|590146128|FG000|Period 2|Withdrawal by Subject|0|||
163391702|NCT01968070|590146129|FG001|Period 2|Withdrawal by Subject|0|||
163391703|NCT01968070|590146130|FG002|Period 2|Withdrawal by Subject|0|||
163296886|NCT02928224|589794558|FG000|Overall Study|Other|3|||
163296887|NCT02928224|589794559|FG001|Overall Study|Other|3|||
163296888|NCT02928224|589794560|FG002|Overall Study|Other|5|||
163296889|NCT02928224|589794561|FG003|Overall Study|Other|0|||
163296890|NCT02538107|589794562|FG000|Overall Study|Did not receive any Mircera dose|11|||
163296891|NCT02538107|589794562|FG000|Overall Study|Missing|5|||
163296892|NCT02538107|589794562|FG000|Overall Study|Necessity of dialysis|20|||
163296893|NCT02538107|589794562|FG000|Overall Study|Administration of other ESA|11|||
163391704|NCT01968070|590146131|FG003|Period 2|Withdrawal by Subject|0|||
163391705|NCT01968070|590146132|FG004|Period 2|Withdrawal by Subject|1|||
163391706|NCT01968070|590146133|FG005|Period 2|Withdrawal by Subject|0|||
163391707|NCT01968070|590146134|FG006|Period 2|Withdrawal by Subject|0|||
163391708|NCT01968070|590146135|FG007|Period 2|Withdrawal by Subject|0|||
163391709|NCT01968070|590146136|FG008|Period 2|Withdrawal by Subject|0|||
163391710|NCT01968070|590146137|FG009|Period 2|Withdrawal by Subject|0|||
163391711|NCT01968070|590146138|FG010|Period 2|Withdrawal by Subject|0|||
163391712|NCT01968070|590146139|FG011|Period 2|Withdrawal by Subject|0|||
163391713|NCT01968070|590146140|FG012|Period 2|Withdrawal by Subject|0|||
163391714|NCT01968070|590146141|FG013|Period 2|Withdrawal by Subject|0|||
163391715|NCT01968070|590146142|FG014|Period 2|Withdrawal by Subject|0|||
163391716|NCT01968070|590146143|FG015|Period 2|Withdrawal by Subject|0|||
163391717|NCT01968070|590146144|FG016|Period 2|Withdrawal by Subject|0|||
163391718|NCT01968070|590146145|FG017|Period 2|Withdrawal by Subject|0|||
163391719|NCT01822522|590146148|FG000|Overall Study|Adverse Event|1|||
163391720|NCT01822522|590146149|FG001|Overall Study|Adverse Event|1|||
163391721|NCT01822522|590146150|FG002|Overall Study|Adverse Event|1|||
163391722|NCT01822522|590146151|FG003|Overall Study|Adverse Event|0|||
163391723|NCT01822522|590146152|FG004|Overall Study|Adverse Event|0|||
163391724|NCT01822522|590146153|FG005|Overall Study|Adverse Event|1|||
163391725|NCT01822522|590146148|FG000|Overall Study|Death|3|||
163391726|NCT01822522|590146149|FG001|Overall Study|Death|0|||
163391727|NCT01822522|590146150|FG002|Overall Study|Death|2|||
163391728|NCT01822522|590146151|FG003|Overall Study|Death|0|||
163391729|NCT01822522|590146152|FG004|Overall Study|Death|0|||
163391730|NCT01822522|590146153|FG005|Overall Study|Death|0|||
163391731|NCT01822522|590146148|FG000|Overall Study|Lost to Follow-up|0|||
163391732|NCT01822522|590146149|FG001|Overall Study|Lost to Follow-up|0|||
163296894|NCT02538107|589794562|FG000|Overall Study|No further treatment necessary|18|||
163296895|NCT02538107|589794562|FG000|Overall Study|Withdrawal by Subject|17|||
163296896|NCT02538107|589794562|FG000|Overall Study|Death|4|||
163296897|NCT02538107|589794562|FG000|Overall Study|Administrative reason|5|||
163391733|NCT01822522|590146150|FG002|Overall Study|Lost to Follow-up|1|||
163296898|NCT02538107|589794562|FG000|Overall Study|Adverse Event|4|||
163391734|NCT01822522|590146151|FG003|Overall Study|Lost to Follow-up|1|||
163391735|NCT01822522|590146152|FG004|Overall Study|Lost to Follow-up|0|||
163391736|NCT01822522|590146153|FG005|Overall Study|Lost to Follow-up|1|||
163391737|NCT01822522|590146148|FG000|Overall Study|Withdrawal by Subject|0|||
163391738|NCT01822522|590146149|FG001|Overall Study|Withdrawal by Subject|0|||
163391739|NCT01822522|590146150|FG002|Overall Study|Withdrawal by Subject|0|||
163391740|NCT01822522|590146151|FG003|Overall Study|Withdrawal by Subject|1|||
163391741|NCT01822522|590146152|FG004|Overall Study|Withdrawal by Subject|0|||
163391742|NCT01822522|590146153|FG005|Overall Study|Withdrawal by Subject|0|||
163391743|NCT01822522|590146148|FG000|Overall Study|Lack of Efficacy|0|||
163391744|NCT01822522|590146149|FG001|Overall Study|Lack of Efficacy|0|||
163296899|NCT02538107|589794562|FG000|Overall Study|Surgery|1|||
163296900|NCT02538107|589794562|FG000|Overall Study|Other|7|||
163296901|NCT02538107|589794562|FG000|Overall Study|Not recorded|7|||
163296902|NCT01278394|589794563|FG000|Overall Study|Lost to Follow-up|1|||
163296903|NCT02471755|589794564|FG000|Overall Study|Withdrawal by Subject|1|||
163296904|NCT02471755|589794565|FG001|Overall Study|Withdrawal by Subject|0|||
163296905|NCT02471755|589794564|FG000|Overall Study|Lost to Follow-up|0|||
163296906|NCT02471755|589794565|FG001|Overall Study|Lost to Follow-up|1|||
163296907|NCT00094575|589794568|FG000|Overall Study|Death|146|||
163296908|NCT00094575|589794569|FG001|Overall Study|Death|146|||
163296909|NCT00794118|589794570|FG000|Overall Study|Lost to Follow-up|16|||
163296910|NCT00794118|589794570|FG000|Overall Study|Withdrawal by Subject|9|||
163296911|NCT00794118|589794570|FG000|Overall Study|Changed hospital center|2|||
163296912|NCT04411056|589796223|FG000|Overall Study|surgery cancelled|1|||
163296913|NCT04411056|589796224|FG001|Overall Study|surgery cancelled|0|||
163296914|NCT04411056|589796223|FG000|Overall Study|Equipment problem during intubation|0|||
163296915|NCT04411056|589796224|FG001|Overall Study|Equipment problem during intubation|1|||
163296916|NCT04623008|589796225|FG000|Baseline to T2|Withdrawal by Subject|4|||
163296917|NCT04623008|589796226|FG001|Baseline to T2|Withdrawal by Subject|2|||
163296918|NCT04623008|589796225|FG000|Baseline to T3|Withdrawal by Subject|4|||
163296919|NCT04623008|589796226|FG001|Baseline to T3|Withdrawal by Subject|2|||
163296920|NCT03122886|589796238|FG000|Overall Study|Withdrawal by Subject|1|||
163296921|NCT03122886|589796239|FG001|Overall Study|Withdrawal by Subject|2|||
163296922|NCT05985044|589796244|FG000|Overall Study|Death|6|||
163296923|NCT05985044|589796244|FG000|Overall Study|Lost to Follow-up|4|||
163296924|NCT05985044|589796244|FG000|Overall Study|Incapacitation|3|||
163296925|NCT05985044|589796244|FG000|Overall Study|Withdrawal by Subject|2|||
163296926|NCT02279095|589796248|FG000|Overall Study|Non-Compliance|1|||
163296927|NCT02279095|589796248|FG000|Overall Study|Withdrawal by Subject|8|||
163296928|NCT02279095|589796248|FG000|Overall Study|Adverse Event|2|||
163296929|NCT02279095|589796248|FG000|Overall Study|Other|7|||
163296930|NCT02279095|589796248|FG000|Overall Study|Lost to Follow-up|1|||
163296931|NCT05938413|589796249|FG000|Overall Study|Lost to Follow-up|1|||
163296932|NCT05938413|589796250|FG001|Overall Study|Lost to Follow-up|7|||
163296933|NCT05938413|589796249|FG000|Overall Study|Withdrawal by Subject|1|||
163296934|NCT05938413|589796250|FG001|Overall Study|Withdrawal by Subject|1|||
163296935|NCT03312907|589796251|FG000|Overall Study|Adverse Event|1|||
163296936|NCT03312907|589796252|FG001|Overall Study|Adverse Event|6|||
163296937|NCT03312907|589796253|FG002|Overall Study|Adverse Event|1|||
163296938|NCT03312907|589796251|FG000|Overall Study|Protocol Violation|2|||
163296939|NCT03312907|589796252|FG001|Overall Study|Protocol Violation|3|||
163296940|NCT03312907|589796253|FG002|Overall Study|Protocol Violation|4|||
163296941|NCT03312907|589796251|FG000|Overall Study|Lost to Follow-up|2|||
163296942|NCT03312907|589796252|FG001|Overall Study|Lost to Follow-up|3|||
163296943|NCT03312907|589796253|FG002|Overall Study|Lost to Follow-up|2|||
163296944|NCT03312907|589796251|FG000|Overall Study|Physician Decision|3|||
163296945|NCT03312907|589796252|FG001|Overall Study|Physician Decision|4|||
163296946|NCT03312907|589796253|FG002|Overall Study|Physician Decision|2|||
163296947|NCT03312907|589796251|FG000|Overall Study|Withdrawal by Subject|9|||
163296948|NCT03312907|589796252|FG001|Overall Study|Withdrawal by Subject|14|||
163296949|NCT03312907|589796253|FG002|Overall Study|Withdrawal by Subject|10|||
163296950|NCT04688450|589796254|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
163296951|NCT04688450|589796254|FG000|Overall Study|Withdrawal by Subject|1|||
163296952|NCT03481777|589796259|FG000|Overall Study|Withdrawal by Subject|36|||
163296953|NCT03481777|589796260|FG001|Overall Study|Withdrawal by Subject|31|||
163296954|NCT03481777|589796259|FG000|Overall Study|Non stroke = non target population|277|||
163296955|NCT03481777|589796260|FG001|Overall Study|Non stroke = non target population|254|||
163296956|NCT03189524|589796261|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
163296957|NCT03189524|589796262|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
163296958|NCT03189524|589796263|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
163296959|NCT03189524|589796261|FG000|Overall Study|Death|2|||
163296960|NCT03189524|589796262|FG001|Overall Study|Death|2|||
163296961|NCT03189524|589796263|FG002|Overall Study|Death|1|||
163296962|NCT03189524|589796261|FG000|Overall Study|Lost to Follow-up|1|||
163296963|NCT03189524|589796262|FG001|Overall Study|Lost to Follow-up|0|||
163296964|NCT03189524|589796263|FG002|Overall Study|Lost to Follow-up|8|||
163296965|NCT03189524|589796261|FG000|Overall Study|Withdrawal by Subject|1|||
163296966|NCT03189524|589796262|FG001|Overall Study|Withdrawal by Subject|1|||
163296967|NCT03189524|589796263|FG002|Overall Study|Withdrawal by Subject|3|||
163296968|NCT03189524|589796261|FG000|Overall Study|Progressive Disease|0|||
163296969|NCT03189524|589796262|FG001|Overall Study|Progressive Disease|2|||
163296970|NCT03189524|589796263|FG002|Overall Study|Progressive Disease|0|||
163296971|NCT01780298|589796265|FG000|Overall Study|Physician Decision|1|||
163296972|NCT01780298|589796266|FG001|Overall Study|Physician Decision|5|||
163296973|NCT01780298|589796267|FG002|Overall Study|Physician Decision|1|||
163296974|NCT01780298|589796268|FG003|Overall Study|Physician Decision|1|||
163296975|NCT01780298|589796265|FG000|Overall Study|Subject not matched|1|||
163296976|NCT01780298|589796266|FG001|Overall Study|Subject not matched|0|||
163296977|NCT01780298|589796267|FG002|Overall Study|Subject not matched|1|||
163296978|NCT01780298|589796268|FG003|Overall Study|Subject not matched|0|||
163296979|NCT01780298|589796265|FG000|Overall Study|Adverse Event|0|||
163296980|NCT01780298|589796266|FG001|Overall Study|Adverse Event|0|||
163296981|NCT01780298|589796267|FG002|Overall Study|Adverse Event|2|||
163296982|NCT01780298|589796268|FG003|Overall Study|Adverse Event|0|||
163296983|NCT03613740|589796284|FG000|Overall Study|Lost to Follow-up|1|||
163296984|NCT03613740|589796285|FG001|Overall Study|Lost to Follow-up|1|||
163296985|NCT01693120|589796286|FG000|Enrollment|Lost to Follow-up|1|||
163296986|NCT01693120|589796286|FG000|Enrollment|Withdrawal by Subject|10|||
163296987|NCT01693120|589796286|FG000|Enrollment|Protocol Violation|46|||
163296988|NCT01693120|589796286|FG000|Enrollment|Physician Decision|3|||
163296989|NCT01693120|589796286|FG000|Enrollment|Adverse Event|1|||
163296990|NCT01693120|589796286|FG000|Enrollment|Study closed|8|||
163296991|NCT01693120|589796286|FG000|Enrollment|Other|1|||
163296992|NCT01693120|589796286|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
163296993|NCT01693120|589796286|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
163296994|NCT01693120|589796286|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
163296995|NCT01693120|589796286|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
163296996|NCT01693120|589796286|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
163296997|NCT02300298|589796294|FG000|Disposition for Nintedanib|Progressive disease|10|||
163296998|NCT02300298|589796295|FG001|Disposition for Nintedanib|Progressive disease|0|||
163296999|NCT02300298|589796294|FG000|Disposition for Docetaxel|Progressive disease|0|||
163297000|NCT02300298|589796295|FG001|Disposition for Docetaxel|Progressive disease|6|||
163297001|NCT02300298|589796294|FG000|Disposition for Docetaxel|other adverse event|0|||
163297002|NCT02300298|589796295|FG001|Disposition for Docetaxel|other adverse event|4|||
163297003|NCT02407249|589796296|FG000|Overall Study|Did not complete 12-month follow-up|13|||
163297004|NCT02407249|589796296|FG000|Overall Study|Not treated|13|||
163297005|NCT01391832|589796297|FG000|Overall Study|Withdrawal by Subject|21|||
163297006|NCT01391832|589796298|FG001|Overall Study|Withdrawal by Subject|22|||
163297007|NCT01391832|589796297|FG000|Overall Study|Lost to Follow-up|0|||
163297008|NCT01391832|589796298|FG001|Overall Study|Lost to Follow-up|1|||
163297009|NCT03345901|589796302|FG000|Overall Study|The study was terminated|18|||
163297010|NCT04252586|589796303|FG000|Overall Study|Withdrawal by parent/guardian|3|||
163297011|NCT04252586|589796303|FG000|Overall Study|Adverse Event|1|||
163297012|NCT04252586|589796303|FG000|Overall Study|Death|2|||
163297013|NCT04252586|589796303|FG000|Overall Study|Study terminated by sponsor|4|||
163297014|NCT04252586|589796303|FG000|Overall Study|Sponsor request|10|||
163297015|NCT04252586|589796303|FG000|Overall Study|Did not complete treatment period|1|||
163297016|NCT00232180|589796304|FG000|Double-blind (DB) Phase|Death|186|||
163297017|NCT00232180|589796305|FG001|Double-blind (DB) Phase|Death|222|||
163297018|NCT00232180|589796306|FG002|Double-blind (DB) Phase|Death|0|||
163297019|NCT00232180|589796304|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
163297020|NCT00232180|589796305|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
163297021|NCT00232180|589796306|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
163297022|NCT00232180|589796304|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
163297023|NCT00232180|589796305|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
163297024|NCT00232180|589796306|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
163297025|NCT00232180|589796304|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
163297026|NCT00232180|589796305|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
163297027|NCT00232180|589796306|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
163297028|NCT00232180|589796304|FG000|Double-blind (DB) Phase|Adverse Event|83|||
163297029|NCT00232180|589796305|FG001|Double-blind (DB) Phase|Adverse Event|100|||
163297030|NCT00232180|589796306|FG002|Double-blind (DB) Phase|Adverse Event|0|||
163297031|NCT00232180|589796304|FG000|Double-blind (DB) Phase|Other|70|||
163297032|NCT00232180|589796305|FG001|Double-blind (DB) Phase|Other|75|||
163297033|NCT00232180|589796306|FG002|Double-blind (DB) Phase|Other|0|||
163297034|NCT00232180|589796304|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
163297035|NCT00232180|589796305|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
163297036|NCT00232180|589796306|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
163297037|NCT00232180|589796304|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
163297038|NCT00232180|589796305|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
163391745|NCT01822522|590146150|FG002|Overall Study|Lack of Efficacy|0|||
163391746|NCT01822522|590146151|FG003|Overall Study|Lack of Efficacy|0|||
163391747|NCT01822522|590146152|FG004|Overall Study|Lack of Efficacy|0|||
163391748|NCT01822522|590146153|FG005|Overall Study|Lack of Efficacy|2|||
163297039|NCT00232180|589796306|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
163297040|NCT00232180|589796304|FG000|Open Label Phase|Death|0|||
163297041|NCT00232180|589796305|FG001|Open Label Phase|Death|0|||
163297042|NCT00232180|589796306|FG002|Open Label Phase|Death|48|||
163297043|NCT00232180|589796304|FG000|Open Label Phase|Lost to Follow-up|0|||
163297044|NCT00232180|589796305|FG001|Open Label Phase|Lost to Follow-up|0|||
163297045|NCT00232180|589796306|FG002|Open Label Phase|Lost to Follow-up|5|||
163297046|NCT00232180|589796304|FG000|Open Label Phase|Protocol Violation|0|||
163391749|NCT00890929|590146154|FG000|Overall Study|Death before treatment|2|||
163297047|NCT00232180|589796305|FG001|Open Label Phase|Protocol Violation|0|||
163297048|NCT00232180|589796306|FG002|Open Label Phase|Protocol Violation|3|||
163297049|NCT00232180|589796304|FG000|Open Label Phase|Study terminated by sponsor|0|||
163297050|NCT00232180|589796305|FG001|Open Label Phase|Study terminated by sponsor|0|||
163297051|NCT00232180|589796306|FG002|Open Label Phase|Study terminated by sponsor|3|||
163297052|NCT00232180|589796304|FG000|Open Label Phase|Withdrawal by Subject|0|||
163297053|NCT00232180|589796305|FG001|Open Label Phase|Withdrawal by Subject|0|||
163297054|NCT00232180|589796306|FG002|Open Label Phase|Withdrawal by Subject|37|||
163297055|NCT00232180|589796304|FG000|Open Label Phase|Other|0|||
163297056|NCT00232180|589796305|FG001|Open Label Phase|Other|0|||
163297057|NCT00232180|589796306|FG002|Open Label Phase|Other|16|||
163297058|NCT00232180|589796304|FG000|Open Label Phase|Adverse Event|0|||
163297059|NCT00232180|589796305|FG001|Open Label Phase|Adverse Event|0|||
163297060|NCT00232180|589796306|FG002|Open Label Phase|Adverse Event|25|||
163297061|NCT00232180|589796304|FG000|Open Label Phase|Laboratory abnormality|0|||
163297062|NCT00232180|589796305|FG001|Open Label Phase|Laboratory abnormality|0|||
163297063|NCT00232180|589796306|FG002|Open Label Phase|Laboratory abnormality|10|||
163297064|NCT00232180|589796304|FG000|Open Label Phase|Randomized but not treated|0|||
163297065|NCT00232180|589796305|FG001|Open Label Phase|Randomized but not treated|0|||
163297066|NCT00232180|589796306|FG002|Open Label Phase|Randomized but not treated|1|||
163297067|NCT02748317|589796307|FG000|Overall Study|Withdrawal by Subject|14|||
163297068|NCT02748317|589796307|FG000|Overall Study|Lost to Follow-up|8|||
163297069|NCT02748317|589796307|FG000|Overall Study|Death|1|||
163297070|NCT03452189|589796308|FG000|First Intervention (3 Months)|Adverse Event|1|||
163297071|NCT03452189|589796309|FG001|First Intervention (3 Months)|Adverse Event|0|||
163297072|NCT03452189|589796308|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
163297073|NCT03452189|589796309|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
163297074|NCT02724592|589796310|FG000|Overall Study|Lost to Follow-up|4|||
163297075|NCT02724592|589796311|FG001|Overall Study|Lost to Follow-up|1|||
163297076|NCT00434304|589796312|FG000|Overall Study|Adverse Event|14|||
163297077|NCT00434304|589796312|FG000|Overall Study|Lack of Efficacy|2|||
163297078|NCT00434304|589796312|FG000|Overall Study|Withdrawal by Subject|4|||
163297079|NCT05262738|589796313|FG000|Overall Study|Withdrawal by Subject|1|||
163297080|NCT05262738|589796314|FG001|Overall Study|Withdrawal by Subject|0|||
163297081|NCT01424397|589796318|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
163297082|NCT01424397|589796319|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
163297083|NCT01424397|589796320|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
163297084|NCT01424397|589796321|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
163297085|NCT01424397|589796322|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
163297086|NCT01424397|589796323|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
163297087|NCT01424397|589796324|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
163297088|NCT01424397|589796325|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
163297089|NCT01424397|589796326|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
163297090|NCT01424397|589796327|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
163297091|NCT01424397|589796328|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
163391750|NCT00890929|590146154|FG000|Overall Study|Withdrawal by Subject|3|||
163391751|NCT00890929|590146154|FG000|Overall Study|Physician Decision|1|||
163391752|NCT00108069|590146155|FG000|Overall Study|Never rec'd study drug|0|||
163391753|NCT00108069|590146156|FG001|Overall Study|Never rec'd study drug|1|||
163391754|NCT00108069|590146155|FG000|Overall Study|Adverse Event|1|||
163391755|NCT00108069|590146156|FG001|Overall Study|Adverse Event|1|||
163391756|NCT00108069|590146155|FG000|Overall Study|Withdrawal by Subject|1|||
163391757|NCT00108069|590146156|FG001|Overall Study|Withdrawal by Subject|0|||
163391758|NCT00108069|590146155|FG000|Overall Study|Death|1|||
163391759|NCT00108069|590146156|FG001|Overall Study|Death|0|||
163391760|NCT00108069|590146155|FG000|Overall Study|Progessive disease|27|||
163391761|NCT00108069|590146156|FG001|Overall Study|Progessive disease|11|||
163391762|NCT04029116|590146157|FG000|Overall Study|Adverse Event|0|||
163391763|NCT04029116|590146158|FG001|Overall Study|Adverse Event|2|||
163391764|NCT04029116|590146157|FG000|Overall Study|Lost to Follow-up|3|||
163391765|NCT04029116|590146158|FG001|Overall Study|Lost to Follow-up|5|||
163391766|NCT04029116|590146157|FG000|Overall Study|Physician Decision|2|||
163391767|NCT04029116|590146158|FG001|Overall Study|Physician Decision|0|||
163391768|NCT04029116|590146157|FG000|Overall Study|Pregnancy|1|||
163391769|NCT04029116|590146158|FG001|Overall Study|Pregnancy|2|||
163391770|NCT04029116|590146157|FG000|Overall Study|Withdrawal by Subject|4|||
163391771|NCT04029116|590146158|FG001|Overall Study|Withdrawal by Subject|6|||
163391772|NCT04029116|590146157|FG000|Overall Study|Other|2|||
163391773|NCT04029116|590146158|FG001|Overall Study|Other|1|||
163297092|NCT01424397|589796329|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
163297093|NCT01149369|589796330|FG000|Overall Study|Adverse Event|6|||
163297094|NCT01149369|589796331|FG001|Overall Study|Adverse Event|3|||
163297095|NCT02767765|589796332|FG000|Overall Study|Adverse Event|4|||
163297096|NCT02767765|589796332|FG000|Overall Study|Death|1|||
163297097|NCT02767765|589796332|FG000|Overall Study|Insufficient response|1|||
163391774|NCT01272947|590146159|FG000|Overall Study|Abnormal Laboratory Value|2|||
163391775|NCT01272947|590146160|FG001|Overall Study|Abnormal Laboratory Value|2|||
163391776|NCT02469896|590146161|FG000|Overall Study|Withdrawal by Subject|2|||
163391777|NCT02469896|590146162|FG001|Overall Study|Withdrawal by Subject|0|||
163391778|NCT02019420|590146163|FG000|Overall Study|Did not receive study drug|2|||
163391779|NCT02019420|590146164|FG001|Overall Study|Did not receive study drug|2|||
163297098|NCT02767765|589796332|FG000|Overall Study|Lost to Follow-up|2|||
163297099|NCT02767765|589796332|FG000|Overall Study|Investigator decision|1|||
163297100|NCT02767765|589796332|FG000|Overall Study|Non-Compliance|1|||
163297101|NCT02767765|589796332|FG000|Overall Study|Withdrawal by Subject|1|||
163297102|NCT01951170|589796333|FG000|Overall Study|Investigator decision|1|||
163297103|NCT01972724|589796338|FG000|Double-Blind|Rescue Criteria Met|1|||
163297104|NCT01972724|589796339|FG001|Double-Blind|Rescue Criteria Met|0|||
163297105|NCT01972724|589796340|FG002|Double-Blind|Rescue Criteria Met|0|||
163297106|NCT01972724|589796338|FG000|Double-Blind|Adverse Event|1|||
163297107|NCT01972724|589796339|FG001|Double-Blind|Adverse Event|0|||
163297108|NCT01972724|589796340|FG002|Double-Blind|Adverse Event|0|||
163297109|NCT01972724|589796338|FG000|Double-Blind|Withdrawal of Consent|2|||
163297110|NCT01972724|589796339|FG001|Double-Blind|Withdrawal of Consent|1|||
163297111|NCT01972724|589796340|FG002|Double-Blind|Withdrawal of Consent|0|||
163297112|NCT01972724|589796338|FG000|Double-Blind|Significant Protocol Deviation|5|||
163297113|NCT01972724|589796339|FG001|Double-Blind|Significant Protocol Deviation|8|||
163297114|NCT01972724|589796340|FG002|Double-Blind|Significant Protocol Deviation|0|||
163297115|NCT01972724|589796338|FG000|Open-Label|Withdrew Consent|0|||
163297116|NCT01972724|589796339|FG001|Open-Label|Withdrew Consent|0|||
163297117|NCT01972724|589796340|FG002|Open-Label|Withdrew Consent|3|||
163297118|NCT01972724|589796338|FG000|Open-Label|Significant Protocol Deviation|0|||
163297119|NCT01972724|589796339|FG001|Open-Label|Significant Protocol Deviation|0|||
163297120|NCT01972724|589796340|FG002|Open-Label|Significant Protocol Deviation|2|||
163297121|NCT00277355|589796341|FG000|Overall Study|Withdrawal by Subject|3|||
163297122|NCT00277355|589796342|FG001|Overall Study|Withdrawal by Subject|3|||
163297123|NCT00277355|589796341|FG000|Overall Study|Lost to Follow-up|2|||
163297124|NCT00277355|589796342|FG001|Overall Study|Lost to Follow-up|2|||
163297125|NCT00277355|589796341|FG000|Overall Study|Adverse Event|5|||
163297126|NCT00277355|589796342|FG001|Overall Study|Adverse Event|0|||
163297127|NCT00277355|589796341|FG000|Overall Study|Death|3|||
163297128|NCT00277355|589796342|FG001|Overall Study|Death|0|||
163297129|NCT00277355|589796341|FG000|Overall Study|Physician Decision|1|||
163297130|NCT00277355|589796342|FG001|Overall Study|Physician Decision|0|||
163297131|NCT01546753|589796345|FG000|Overall Study|anxiety|1|||
163297132|NCT01546753|589796346|FG001|Overall Study|anxiety|1|||
163391780|NCT02019420|590146163|FG000|Overall Study|Withdrawal by Subject|1|||
163391781|NCT02019420|590146164|FG001|Overall Study|Withdrawal by Subject|3|||
163391782|NCT02019420|590146163|FG000|Overall Study|At request of sponsor or investigator|0|||
163191477|NCT03181893|589415932|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
163191478|NCT03181893|589415933|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
163191479|NCT03181893|589415934|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
163191480|NCT03181893|589415935|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
163191481|NCT03181893|589415925|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
163191482|NCT03181893|589415926|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
163191483|NCT03181893|589415927|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
163191484|NCT03181893|589415928|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
163191485|NCT03181893|589415929|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
163191486|NCT03181893|589415930|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
163191487|NCT03181893|589415931|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
163191488|NCT03181893|589415932|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
163191489|NCT03181893|589415933|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
163191490|NCT03181893|589415934|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
163191491|NCT03181893|589415935|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
163191492|NCT03181893|589415925|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
163191493|NCT03181893|589415926|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
163191494|NCT03181893|589415927|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
163191495|NCT03181893|589415928|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
163191496|NCT03181893|589415929|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
163191497|NCT03181893|589415930|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
163191498|NCT03181893|589415931|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
163191499|NCT03181893|589415932|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
163191500|NCT03181893|589415933|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
163191501|NCT03181893|589415934|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
163191502|NCT03181893|589415935|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
163297133|NCT01546753|589796345|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
163297134|NCT01546753|589796346|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
163297135|NCT01102231|589796348|FG000|Overall Study|Protocol Violation|3|||
163297136|NCT01102231|589796348|FG000|Overall Study|Lack of Efficacy|2|||
162952082|NCT02422264|588529538|FG001|Overall Study|Serious Adverse Event|0|||
162952083|NCT02422264|588529537|FG000|Overall Study|Withdrawal by Subject|1|||
163191503|NCT04128371|589415936|FG000|Overall Study|Lack of Efficacy|1|||
163191504|NCT03021304|589415938|FG000|Overall Study|Lack of Efficacy|1|||
163191505|NCT01361568|589415941|FG000|Overall Study|Adverse Event|0|||
163191506|NCT01361568|589415942|FG001|Overall Study|Adverse Event|0|||
163191507|NCT01361568|589415943|FG002|Overall Study|Adverse Event|0|||
163191508|NCT01361568|589415944|FG003|Overall Study|Adverse Event|0|||
163191509|NCT01361568|589415945|FG004|Overall Study|Adverse Event|1|||
163191510|NCT01361568|589415946|FG005|Overall Study|Adverse Event|0|||
163191511|NCT01361568|589415941|FG000|Overall Study|Physician Decision|0|||
163191512|NCT01361568|589415942|FG001|Overall Study|Physician Decision|0|||
163191513|NCT01361568|589415943|FG002|Overall Study|Physician Decision|0|||
163191514|NCT01361568|589415944|FG003|Overall Study|Physician Decision|0|||
163191515|NCT01361568|589415945|FG004|Overall Study|Physician Decision|0|||
163191516|NCT01361568|589415946|FG005|Overall Study|Physician Decision|1|||
163191517|NCT01361568|589415941|FG000|Overall Study|Withdrawal by Subject|2|||
163191518|NCT01361568|589415942|FG001|Overall Study|Withdrawal by Subject|1|||
163191519|NCT01361568|589415943|FG002|Overall Study|Withdrawal by Subject|0|||
163191520|NCT01361568|589415944|FG003|Overall Study|Withdrawal by Subject|0|||
163191521|NCT01361568|589415945|FG004|Overall Study|Withdrawal by Subject|0|||
163191522|NCT01361568|589415946|FG005|Overall Study|Withdrawal by Subject|1|||
163191523|NCT03308786|589415947|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
163191524|NCT00761631|589415948|FG000|Overall Study|Parent/legal guardian request|8|||
163191525|NCT00761631|589415949|FG001|Overall Study|Parent/legal guardian request|3|||
163191526|NCT00761631|589415950|FG002|Overall Study|Parent/legal guardian request|8|||
163191527|NCT00761631|589415951|FG003|Overall Study|Parent/legal guardian request|0|||
163191528|NCT00761631|589415952|FG004|Overall Study|Parent/legal guardian request|5|||
163191529|NCT00761631|589415953|FG005|Overall Study|Parent/legal guardian request|0|||
163191530|NCT00761631|589415948|FG000|Overall Study|Lost to Follow-up|2|||
163191531|NCT00761631|589415949|FG001|Overall Study|Lost to Follow-up|4|||
163191532|NCT00761631|589415950|FG002|Overall Study|Lost to Follow-up|7|||
163191533|NCT00761631|589415951|FG003|Overall Study|Lost to Follow-up|1|||
163191534|NCT00761631|589415952|FG004|Overall Study|Lost to Follow-up|6|||
163191535|NCT00761631|589415953|FG005|Overall Study|Lost to Follow-up|1|||
163191536|NCT00761631|589415948|FG000|Overall Study|Protocol Violation|2|||
163191537|NCT00761631|589415949|FG001|Overall Study|Protocol Violation|0|||
163191538|NCT00761631|589415950|FG002|Overall Study|Protocol Violation|0|||
163191539|NCT00761631|589415951|FG003|Overall Study|Protocol Violation|1|||
163191540|NCT00761631|589415952|FG004|Overall Study|Protocol Violation|5|||
163191541|NCT00761631|589415953|FG005|Overall Study|Protocol Violation|1|||
163191542|NCT00761631|589415948|FG000|Overall Study|Randomized, not treated|1|||
163191543|NCT00761631|589415949|FG001|Overall Study|Randomized, not treated|0|||
163191544|NCT00761631|589415950|FG002|Overall Study|Randomized, not treated|0|||
163191545|NCT00761631|589415951|FG003|Overall Study|Randomized, not treated|0|||
163191546|NCT00761631|589415952|FG004|Overall Study|Randomized, not treated|0|||
163191547|NCT00761631|589415953|FG005|Overall Study|Randomized, not treated|0|||
163191548|NCT00761631|589415948|FG000|Overall Study|Failed to return|1|||
163191549|NCT00761631|589415949|FG001|Overall Study|Failed to return|0|||
163191550|NCT00761631|589415950|FG002|Overall Study|Failed to return|1|||
163191551|NCT00761631|589415951|FG003|Overall Study|Failed to return|1|||
163191552|NCT00761631|589415952|FG004|Overall Study|Failed to return|5|||
163191553|NCT00761631|589415953|FG005|Overall Study|Failed to return|2|||
163191554|NCT00761631|589415948|FG000|Overall Study|Physician Decision|1|||
163191555|NCT00761631|589415949|FG001|Overall Study|Physician Decision|0|||
163191556|NCT00761631|589415950|FG002|Overall Study|Physician Decision|0|||
163191557|NCT00761631|589415951|FG003|Overall Study|Physician Decision|0|||
163191558|NCT00761631|589415952|FG004|Overall Study|Physician Decision|0|||
163191559|NCT00761631|589415953|FG005|Overall Study|Physician Decision|0|||
163191560|NCT00761631|589415948|FG000|Overall Study|Other|0|||
163191561|NCT00761631|589415949|FG001|Overall Study|Other|0|||
163191562|NCT00761631|589415950|FG002|Overall Study|Other|0|||
163191563|NCT00761631|589415951|FG003|Overall Study|Other|0|||
163191564|NCT00761631|589415952|FG004|Overall Study|Other|1|||
163191565|NCT00761631|589415953|FG005|Overall Study|Other|1|||
163191566|NCT01999868|589415954|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
163191567|NCT01999868|589415955|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
163191568|NCT01999868|589415956|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
163191569|NCT01999868|589415954|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
163191570|NCT01999868|589415955|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
163191571|NCT01999868|589415956|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
163191572|NCT01999868|589415954|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
163191573|NCT01999868|589415955|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
163191574|NCT01999868|589415956|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
163191575|NCT01999868|589415954|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
162952084|NCT02422264|588529538|FG001|Overall Study|Withdrawal by Subject|2|||
163191576|NCT01999868|589415955|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
163297137|NCT01102231|589796348|FG000|Overall Study|Death|2|||
163297138|NCT01102231|589796348|FG000|Overall Study|Adverse Event|3|||
163297139|NCT01102231|589796348|FG000|Overall Study|Withdrawal by Subject|1|||
163297140|NCT01102231|589796348|FG000|Overall Study|Did not received the treatment|4|||
163297141|NCT01236560|589796355|FG000|Overall Study|Adverse Event|0|||
163297142|NCT01236560|589796356|FG001|Overall Study|Adverse Event|2|||
163297143|NCT01236560|589796357|FG002|Overall Study|Adverse Event|1|||
163297144|NCT01236560|589796358|FG003|Overall Study|Adverse Event|3|||
163297145|NCT01236560|589796359|FG004|Overall Study|Adverse Event|0|||
163297146|NCT01236560|589796360|FG005|Overall Study|Adverse Event|0|||
163297147|NCT01236560|589796355|FG000|Overall Study|Death|0|||
163297148|NCT01236560|589796356|FG001|Overall Study|Death|1|||
163297149|NCT01236560|589796357|FG002|Overall Study|Death|0|||
163297150|NCT01236560|589796358|FG003|Overall Study|Death|1|||
163297151|NCT01236560|589796359|FG004|Overall Study|Death|0|||
163297152|NCT01236560|589796360|FG005|Overall Study|Death|0|||
163297153|NCT01236560|589796355|FG000|Overall Study|Lost to Follow-up|0|||
163297154|NCT01236560|589796356|FG001|Overall Study|Lost to Follow-up|1|||
163297155|NCT01236560|589796357|FG002|Overall Study|Lost to Follow-up|1|||
163297156|NCT01236560|589796358|FG003|Overall Study|Lost to Follow-up|0|||
163297157|NCT01236560|589796359|FG004|Overall Study|Lost to Follow-up|0|||
163297158|NCT01236560|589796360|FG005|Overall Study|Lost to Follow-up|0|||
163297159|NCT01236560|589796355|FG000|Overall Study|Physician Decision|0|||
163297160|NCT01236560|589796356|FG001|Overall Study|Physician Decision|1|||
163297161|NCT01236560|589796357|FG002|Overall Study|Physician Decision|8|||
163297162|NCT01236560|589796358|FG003|Overall Study|Physician Decision|0|||
163297163|NCT01236560|589796359|FG004|Overall Study|Physician Decision|0|||
163297164|NCT01236560|589796360|FG005|Overall Study|Physician Decision|0|||
163297165|NCT01236560|589796355|FG000|Overall Study|Withdrawal by Subject|0|||
163297166|NCT01236560|589796356|FG001|Overall Study|Withdrawal by Subject|0|||
163297167|NCT01236560|589796357|FG002|Overall Study|Withdrawal by Subject|1|||
163297168|NCT01236560|589796358|FG003|Overall Study|Withdrawal by Subject|2|||
163297169|NCT01236560|589796359|FG004|Overall Study|Withdrawal by Subject|0|||
163297170|NCT01236560|589796360|FG005|Overall Study|Withdrawal by Subject|0|||
163297171|NCT01236560|589796355|FG000|Overall Study|Progressive disease|5|||
163297172|NCT01236560|589796356|FG001|Overall Study|Progressive disease|19|||
163297173|NCT01236560|589796357|FG002|Overall Study|Progressive disease|9|||
163297174|NCT01236560|589796358|FG003|Overall Study|Progressive disease|16|||
163297175|NCT01236560|589796359|FG004|Overall Study|Progressive disease|0|||
163297176|NCT01236560|589796360|FG005|Overall Study|Progressive disease|0|||
163297177|NCT01576484|589796363|FG000|Overall Study|Adverse Event|1|||
163297178|NCT01576484|589796364|FG001|Overall Study|Adverse Event|1|||
163297179|NCT01576484|589796363|FG000|Overall Study|Protocol Violation|0|||
163297180|NCT01576484|589796364|FG001|Overall Study|Protocol Violation|2|||
162952085|NCT02422264|588529537|FG000|Overall Study|Migrated/moved from study area|3|||
163297181|NCT01576484|589796363|FG000|Overall Study|Sponsor Decision|2|||
163297182|NCT01576484|589796364|FG001|Overall Study|Sponsor Decision|8|||
163297183|NCT01576484|589796363|FG000|Overall Study|Withdrawal by Subject|0|||
163297184|NCT01576484|589796364|FG001|Overall Study|Withdrawal by Subject|3|||
163297185|NCT01576484|589796363|FG000|Overall Study|Other|2|||
163297186|NCT01576484|589796364|FG001|Overall Study|Other|5|||
163297187|NCT00837616|589796369|FG000|Overall Study|Withdrawal by Subject|0|||
163297188|NCT00837616|589796370|FG001|Overall Study|Withdrawal by Subject|1|||
163297189|NCT03512756|589796376|FG000|Part 1|Death|23|||
163297190|NCT03512756|589796377|FG001|Part 1|Death|18|||
163297191|NCT03512756|589796378|FG002|Part 1|Death|0|||
163297192|NCT03512756|589796379|FG003|Part 1|Death|0|||
163297193|NCT03512756|589796376|FG000|Part 1|Lost to Follow-up|0|||
163297194|NCT03512756|589796377|FG001|Part 1|Lost to Follow-up|3|||
163297195|NCT03512756|589796378|FG002|Part 1|Lost to Follow-up|0|||
163297196|NCT03512756|589796379|FG003|Part 1|Lost to Follow-up|0|||
163297197|NCT03512756|589796376|FG000|Part 1|Physician Decision|0|||
163297198|NCT03512756|589796377|FG001|Part 1|Physician Decision|1|||
163297199|NCT03512756|589796378|FG002|Part 1|Physician Decision|0|||
163297200|NCT03512756|589796379|FG003|Part 1|Physician Decision|0|||
163297201|NCT03512756|589796376|FG000|Part 1|Withdrawal by Subject|2|||
163297202|NCT03512756|589796377|FG001|Part 1|Withdrawal by Subject|2|||
163297203|NCT03512756|589796378|FG002|Part 1|Withdrawal by Subject|0|||
163297204|NCT03512756|589796379|FG003|Part 1|Withdrawal by Subject|0|||
163297205|NCT03512756|589796376|FG000|Part 2|Death|0|||
163297206|NCT03512756|589796377|FG001|Part 2|Death|0|||
163297207|NCT03512756|589796378|FG002|Part 2|Death|32|||
163297208|NCT03512756|589796379|FG003|Part 2|Death|21|||
163297209|NCT03512756|589796376|FG000|Part 2|Lost to Follow-up|0|||
163297210|NCT03512756|589796377|FG001|Part 2|Lost to Follow-up|0|||
163297211|NCT03512756|589796378|FG002|Part 2|Lost to Follow-up|1|||
162952086|NCT02422264|588529538|FG001|Overall Study|Migrated/moved from study area|1|||
163297212|NCT03512756|589796379|FG003|Part 2|Lost to Follow-up|0|||
163297213|NCT03512756|589796376|FG000|Part 2|Physician Decision|0|||
163297214|NCT03512756|589796377|FG001|Part 2|Physician Decision|0|||
163297215|NCT03512756|589796378|FG002|Part 2|Physician Decision|2|||
163297216|NCT03512756|589796379|FG003|Part 2|Physician Decision|4|||
163297217|NCT03512756|589796376|FG000|Part 2|Study Terminated by Sponsor|0|||
163297218|NCT03512756|589796377|FG001|Part 2|Study Terminated by Sponsor|0|||
163297219|NCT03512756|589796378|FG002|Part 2|Study Terminated by Sponsor|2|||
163297220|NCT03512756|589796379|FG003|Part 2|Study Terminated by Sponsor|6|||
163297221|NCT03512756|589796376|FG000|Part 2|Protocol Violation|0|||
163297222|NCT03512756|589796377|FG001|Part 2|Protocol Violation|0|||
163297223|NCT03512756|589796378|FG002|Part 2|Protocol Violation|1|||
163297224|NCT03512756|589796379|FG003|Part 2|Protocol Violation|0|||
163297225|NCT03512756|589796376|FG000|Part 2|Withdrawal by Subject|0|||
163297226|NCT03512756|589796377|FG001|Part 2|Withdrawal by Subject|0|||
163297227|NCT03512756|589796378|FG002|Part 2|Withdrawal by Subject|3|||
163297228|NCT03512756|589796379|FG003|Part 2|Withdrawal by Subject|9|||
163297229|NCT01212991|589796380|FG000|Double-blind|Lost to Follow-up|8|||
163297230|NCT01212991|589796381|FG001|Double-blind|Lost to Follow-up|4|||
163297231|NCT01212991|589796382|FG002|Double-blind|Lost to Follow-up|0|||
163297232|NCT01212991|589796380|FG000|Double-blind|Death|699|||
163297233|NCT01212991|589796381|FG001|Double-blind|Death|550|||
163297234|NCT01212991|589796382|FG002|Double-blind|Death|0|||
163297235|NCT01212991|589796380|FG000|Double-blind|Withdrawal by Subject|16|||
163297236|NCT01212991|589796381|FG001|Double-blind|Withdrawal by Subject|19|||
163297237|NCT01212991|589796382|FG002|Double-blind|Withdrawal by Subject|0|||
163297238|NCT01212991|589796380|FG000|Double-blind|Other|7|||
163297239|NCT01212991|589796381|FG001|Double-blind|Other|0|||
163297240|NCT01212991|589796382|FG002|Double-blind|Other|0|||
163297241|NCT01212991|589796380|FG000|Double-blind|Sponsor decision|142|||
163297242|NCT01212991|589796381|FG001|Double-blind|Sponsor decision|38|||
163297243|NCT01212991|589796382|FG002|Double-blind|Sponsor decision|0|||
163297244|NCT01212991|589796380|FG000|Open-label|Death|0|||
163297245|NCT01212991|589796381|FG001|Open-label|Death|0|||
163297246|NCT01212991|589796382|FG002|Open-label|Death|166|||
163297247|NCT01212991|589796380|FG000|Open-label|Lost to Follow-up|0|||
163297248|NCT01212991|589796381|FG001|Open-label|Lost to Follow-up|0|||
163297249|NCT01212991|589796382|FG002|Open-label|Lost to Follow-up|5|||
163297250|NCT01212991|589796380|FG000|Open-label|Withdrawal by Subject|0|||
163297251|NCT01212991|589796381|FG001|Open-label|Withdrawal by Subject|0|||
163297252|NCT01212991|589796382|FG002|Open-label|Withdrawal by Subject|7|||
163297253|NCT01212991|589796380|FG000|Open-label|Sponsor decision|0|||
163297254|NCT01212991|589796381|FG001|Open-label|Sponsor decision|0|||
163297255|NCT01212991|589796382|FG002|Open-label|Sponsor decision|53|||
163297256|NCT01212991|589796380|FG000|Open-label|Other|0|||
163297257|NCT01212991|589796381|FG001|Open-label|Other|0|||
163297258|NCT01212991|589796382|FG002|Open-label|Other|3|||
163297259|NCT02544074|589797666|FG000|Overall Study|Withdrawal by Subject|0|||
163297260|NCT02544074|589797667|FG001|Overall Study|Withdrawal by Subject|1|||
163297261|NCT02544074|589797668|FG002|Overall Study|Withdrawal by Subject|0|||
163297262|NCT02544074|589797669|FG003|Overall Study|Withdrawal by Subject|0|||
163297263|NCT02544074|589797670|FG004|Overall Study|Withdrawal by Subject|0|||
163297264|NCT02544074|589797671|FG005|Overall Study|Withdrawal by Subject|0|||
163297265|NCT02544074|589797672|FG006|Overall Study|Withdrawal by Subject|0|||
163297266|NCT02544074|589797673|FG007|Overall Study|Withdrawal by Subject|0|||
163297267|NCT02544074|589797674|FG008|Overall Study|Withdrawal by Subject|0|||
163191577|NCT01999868|589415956|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
163191578|NCT01999868|589415954|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
163191579|NCT01999868|589415955|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
163191580|NCT01999868|589415956|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
163191581|NCT01999868|589415954|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
163191582|NCT01999868|589415955|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
163191583|NCT01999868|589415956|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
163191584|NCT01999868|589415954|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
163191585|NCT01999868|589415955|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
163191586|NCT01999868|589415956|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
163297268|NCT02544074|589797675|FG009|Overall Study|Withdrawal by Subject|0|||
163297269|NCT02544074|589797676|FG010|Overall Study|Withdrawal by Subject|0|||
163297270|NCT02544074|589797677|FG011|Overall Study|Withdrawal by Subject|0|||
163297271|NCT02544074|589797678|FG012|Overall Study|Withdrawal by Subject|0|||
163297272|NCT02544074|589797679|FG013|Overall Study|Withdrawal by Subject|0|||
163297273|NCT02544074|589797680|FG014|Overall Study|Withdrawal by Subject|0|||
163297274|NCT02544074|589797681|FG015|Overall Study|Withdrawal by Subject|0|||
163297275|NCT02544074|589797682|FG016|Overall Study|Withdrawal by Subject|0|||
163297276|NCT02544074|589797683|FG017|Overall Study|Withdrawal by Subject|0|||
163297277|NCT02544074|589797684|FG018|Overall Study|Withdrawal by Subject|0|||
163297278|NCT02544074|589797685|FG019|Overall Study|Withdrawal by Subject|0|||
163297279|NCT02544074|589797686|FG020|Overall Study|Withdrawal by Subject|0|||
163297280|NCT02544074|589797666|FG000|Overall Study|Tablet error|0|||
163297281|NCT02544074|589797667|FG001|Overall Study|Tablet error|0|||
163297282|NCT02544074|589797668|FG002|Overall Study|Tablet error|0|||
163297283|NCT02544074|589797669|FG003|Overall Study|Tablet error|0|||
163297284|NCT02544074|589797670|FG004|Overall Study|Tablet error|0|||
163297285|NCT02544074|589797671|FG005|Overall Study|Tablet error|1|||
163297286|NCT02544074|589797672|FG006|Overall Study|Tablet error|0|||
163297287|NCT02544074|589797673|FG007|Overall Study|Tablet error|0|||
163297288|NCT02544074|589797674|FG008|Overall Study|Tablet error|0|||
163297289|NCT02544074|589797675|FG009|Overall Study|Tablet error|1|||
163297290|NCT02544074|589797676|FG010|Overall Study|Tablet error|0|||
163297291|NCT02544074|589797677|FG011|Overall Study|Tablet error|0|||
163297292|NCT02544074|589797678|FG012|Overall Study|Tablet error|0|||
163297293|NCT02544074|589797679|FG013|Overall Study|Tablet error|0|||
163297294|NCT02544074|589797680|FG014|Overall Study|Tablet error|0|||
163297295|NCT02544074|589797681|FG015|Overall Study|Tablet error|0|||
163297296|NCT02544074|589797682|FG016|Overall Study|Tablet error|0|||
163297297|NCT02544074|589797683|FG017|Overall Study|Tablet error|0|||
163297298|NCT02544074|589797684|FG018|Overall Study|Tablet error|0|||
163297299|NCT02544074|589797685|FG019|Overall Study|Tablet error|0|||
163297300|NCT02544074|589797686|FG020|Overall Study|Tablet error|0|||
163297301|NCT04714320|589797691|FG000|Overall Study|Voluntary Withdrawal|4|||
163297302|NCT04714320|589797692|FG001|Overall Study|Voluntary Withdrawal|1|||
163297303|NCT04714320|589797693|FG002|Overall Study|Voluntary Withdrawal|2|||
163297304|NCT04714320|589797691|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
163297305|NCT04714320|589797692|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
163297306|NCT04714320|589797693|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
163297307|NCT04714320|589797691|FG000|Overall Study|Reason Not Specified|1|||
163297308|NCT04714320|589797692|FG001|Overall Study|Reason Not Specified|3|||
163297309|NCT04714320|589797693|FG002|Overall Study|Reason Not Specified|3|||
163297310|NCT04755660|589797694|FG000|Overall Study|Lost to Follow-up|1|||
163297311|NCT04755660|589797695|FG001|Overall Study|Lost to Follow-up|1|||
163297312|NCT04755660|589797696|FG002|Overall Study|Lost to Follow-up|0|||
163297313|NCT04755660|589797694|FG000|Overall Study|Withdrawal by Subject|0|||
163297314|NCT04755660|589797695|FG001|Overall Study|Withdrawal by Subject|1|||
163297315|NCT04755660|589797696|FG002|Overall Study|Withdrawal by Subject|1|||
163297316|NCT04755660|589797694|FG000|Overall Study|Physician Decision|0|||
163297317|NCT04755660|589797695|FG001|Overall Study|Physician Decision|0|||
163297318|NCT04755660|589797696|FG002|Overall Study|Physician Decision|1|||
163297319|NCT05672667|589797698|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
163297320|NCT04524390|589797699|FG000|Double Blind|Consent Withdrawal by subject|2|||
163297321|NCT04524390|589797700|FG001|Double Blind|Consent Withdrawal by subject|1|||
163297322|NCT04524390|589797701|FG002|Double Blind|Consent Withdrawal by subject|0|||
163297323|NCT04524390|589797699|FG000|Double Blind|Adverse Event|5|||
163297324|NCT04524390|589797700|FG001|Double Blind|Adverse Event|3|||
163297325|NCT04524390|589797701|FG002|Double Blind|Adverse Event|0|||
163297326|NCT04524390|589797699|FG000|Double Blind|Liver Transplant|5|||
163297327|NCT04524390|589797700|FG001|Double Blind|Liver Transplant|6|||
163297328|NCT04524390|589797701|FG002|Double Blind|Liver Transplant|0|||
163297329|NCT04524390|589797699|FG000|Double Blind|Disease Progression|0|||
163297330|NCT04524390|589797700|FG001|Double Blind|Disease Progression|1|||
163297331|NCT04524390|589797701|FG002|Double Blind|Disease Progression|0|||
163391783|NCT02019420|590146164|FG001|Overall Study|At request of sponsor or investigator|1|||
163391784|NCT02019420|590146163|FG000|Overall Study|Death|104|||
163391785|NCT02019420|590146164|FG001|Overall Study|Death|99|||
163391786|NCT02019420|590146163|FG000|Overall Study|Transferred to other care facility|1|||
163391787|NCT02019420|590146164|FG001|Overall Study|Transferred to other care facility|1|||
163391788|NCT02510560|590146165|FG000|Overall Study|Discontinued from Treatment|27|||
163391789|NCT02510560|590146166|FG001|Overall Study|Discontinued from Treatment|18|||
163391790|NCT02510560|590146167|FG002|Overall Study|Discontinued from Treatment|19|||
163391791|NCT02510560|590146165|FG000|Overall Study|Other|4|||
163391792|NCT02510560|590146166|FG001|Overall Study|Other|4|||
163391793|NCT02510560|590146167|FG002|Overall Study|Other|3|||
163391794|NCT02401412|590146168|FG000|Overall Study|Lost to Follow-up|1|||
163297332|NCT04524390|589797699|FG000|Open-Label|Drug interruption criteria|0|||
163391795|NCT02401412|590146169|FG001|Overall Study|Lost to Follow-up|0|||
163391796|NCT02401412|590146168|FG000|Overall Study|Discontinued Intervention|15|||
163391797|NCT02401412|590146169|FG001|Overall Study|Discontinued Intervention|21|||
163391798|NCT02401412|590146168|FG000|Overall Study|Withdrawal by Subject|4|||
163391799|NCT02401412|590146169|FG001|Overall Study|Withdrawal by Subject|4|||
163297333|NCT04524390|589797700|FG001|Open-Label|Drug interruption criteria|0|||
163297334|NCT04524390|589797701|FG002|Open-Label|Drug interruption criteria|1|||
163297335|NCT04524390|589797699|FG000|Open-Label|Liver Transplant|0|||
163391800|NCT02401412|590146168|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
163391801|NCT02401412|590146169|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
163391802|NCT02401412|590146168|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
163297336|NCT04524390|589797700|FG001|Open-Label|Liver Transplant|0|||
163297337|NCT04524390|589797701|FG002|Open-Label|Liver Transplant|1|||
163297338|NCT04524390|589797699|FG000|Open-Label|Disease Progression|0|||
163297339|NCT04524390|589797700|FG001|Open-Label|Disease Progression|0|||
163297340|NCT04524390|589797701|FG002|Open-Label|Disease Progression|1|||
163297341|NCT04524390|589797699|FG000|Open-Label|Adverse Event|0|||
163297342|NCT04524390|589797700|FG001|Open-Label|Adverse Event|0|||
163297343|NCT04524390|589797701|FG002|Open-Label|Adverse Event|3|||
163297344|NCT04524390|589797699|FG000|Open-Label|Study Termination by sponsor|0|||
163297345|NCT04524390|589797700|FG001|Open-Label|Study Termination by sponsor|0|||
163297346|NCT04524390|589797701|FG002|Open-Label|Study Termination by sponsor|45|||
163297347|NCT03873779|589797702|FG000|Overall Study|Withdrawal by Subject|1|||
163297348|NCT02581215|589797703|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
163297349|NCT02581215|589797704|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
163297350|NCT02581215|589797703|FG000|Overall Study|Eligibility Criteria Not Met|0|||
163297351|NCT02581215|589797704|FG001|Overall Study|Eligibility Criteria Not Met|1|||
163297352|NCT04279574|589797707|FG000|Overall Study|Death|1|||
163297353|NCT04279574|589797708|FG001|Overall Study|Death|0|||
163297354|NCT04279574|589797707|FG000|Overall Study|lost restoration, tooth fracture|1|||
163297355|NCT04279574|589797708|FG001|Overall Study|lost restoration, tooth fracture|0|||
163297356|NCT04279574|589797707|FG000|Overall Study|Lost to Follow-up|0|||
163297357|NCT04279574|589797708|FG001|Overall Study|Lost to Follow-up|1|||
163297358|NCT02597920|589797714|FG000|Overall Study|Worsening of other pre-existing disease|0|||
163297359|NCT02597920|589797715|FG001|Overall Study|Worsening of other pre-existing disease|1|||
163297360|NCT02597920|589797716|FG002|Overall Study|Worsening of other pre-existing disease|0|||
163297361|NCT02597920|589797714|FG000|Overall Study|Other adverse event|20|||
163297362|NCT02597920|589797715|FG001|Overall Study|Other adverse event|30|||
163297363|NCT02597920|589797716|FG002|Overall Study|Other adverse event|0|||
163297364|NCT02597920|589797714|FG000|Overall Study|Lost to Follow-up|7|||
163297365|NCT02597920|589797715|FG001|Overall Study|Lost to Follow-up|9|||
163297366|NCT02597920|589797716|FG002|Overall Study|Lost to Follow-up|0|||
163297367|NCT02597920|589797714|FG000|Overall Study|Refuse to continue in the study|3|||
163297368|NCT02597920|589797715|FG001|Overall Study|Refuse to continue in the study|13|||
163297369|NCT02597920|589797716|FG002|Overall Study|Refuse to continue in the study|1|||
163297370|NCT02597920|589797714|FG000|Overall Study|Other than specified|10|||
163297371|NCT02597920|589797715|FG001|Overall Study|Other than specified|31|||
163297372|NCT02597920|589797716|FG002|Overall Study|Other than specified|5|||
163297373|NCT02597920|589797714|FG000|Overall Study|Other|1|||
163297374|NCT02597920|589797715|FG001|Overall Study|Other|0|||
163297375|NCT02597920|589797716|FG002|Overall Study|Other|0|||
163297376|NCT00668863|589797717|FG000|Overall Study|Objective Progression or Relapse|42|||
163297377|NCT00668863|589797717|FG000|Overall Study|Adverse Event|13|||
163297378|NCT00668863|589797717|FG000|Overall Study|Study Terminated by Sponsor|8|||
163297379|NCT00668863|589797717|FG000|Overall Study|Global Deterioration of Health Status|4|||
163297380|NCT00668863|589797717|FG000|Overall Study|Withdrawal by Subject|1|||
163297381|NCT00668863|589797717|FG000|Overall Study|Surgery|1|||
163297382|NCT00668863|589797717|FG000|Overall Study|Subject's work scheduling problem|1|||
163297383|NCT00668863|589797717|FG000|Overall Study|Physician Decision|1|||
163297384|NCT00960141|589797723|FG000|Overall Study|Adverse Event|4|||
163297385|NCT00960141|589797724|FG001|Overall Study|Adverse Event|8|||
163297386|NCT00960141|589797725|FG002|Overall Study|Adverse Event|2|||
163297387|NCT00960141|589797723|FG000|Overall Study|Lack of Efficacy|3|||
163297388|NCT00960141|589797724|FG001|Overall Study|Lack of Efficacy|4|||
163297389|NCT00960141|589797725|FG002|Overall Study|Lack of Efficacy|2|||
163297390|NCT00960141|589797723|FG000|Overall Study|Lost to Follow-up|1|||
163297391|NCT00960141|589797724|FG001|Overall Study|Lost to Follow-up|0|||
163297392|NCT00960141|589797725|FG002|Overall Study|Lost to Follow-up|0|||
163297393|NCT00960141|589797723|FG000|Overall Study|Protocol Violation|1|||
163297394|NCT00960141|589797724|FG001|Overall Study|Protocol Violation|3|||
163297395|NCT00960141|589797725|FG002|Overall Study|Protocol Violation|2|||
163297396|NCT00960141|589797723|FG000|Overall Study|Withdrawal by Subject|1|||
163297397|NCT00960141|589797724|FG001|Overall Study|Withdrawal by Subject|2|||
163297398|NCT00960141|589797725|FG002|Overall Study|Withdrawal by Subject|1|||
163297399|NCT03036813|589797726|FG000|Overall Study|Adverse Event|6|||
163297400|NCT03036813|589797727|FG001|Overall Study|Adverse Event|11|||
163297401|NCT03036813|589797728|FG002|Overall Study|Adverse Event|6|||
163297402|NCT03036813|589797726|FG000|Overall Study|Withdrawal by Subject|12|||
163297403|NCT03036813|589797727|FG001|Overall Study|Withdrawal by Subject|6|||
163297404|NCT03036813|589797728|FG002|Overall Study|Withdrawal by Subject|10|||
163297405|NCT03036813|589797726|FG000|Overall Study|Lost to Follow-up|1|||
163297406|NCT03036813|589797727|FG001|Overall Study|Lost to Follow-up|1|||
163297407|NCT03036813|589797728|FG002|Overall Study|Lost to Follow-up|0|||
163297408|NCT03036813|589797726|FG000|Overall Study|Physician Decision|2|||
163297409|NCT03036813|589797727|FG001|Overall Study|Physician Decision|1|||
163297410|NCT03036813|589797728|FG002|Overall Study|Physician Decision|1|||
163297411|NCT03036813|589797726|FG000|Overall Study|Non-Compliance|1|||
163297412|NCT03036813|589797727|FG001|Overall Study|Non-Compliance|5|||
163297413|NCT03036813|589797728|FG002|Overall Study|Non-Compliance|3|||
163297414|NCT03036813|589797726|FG000|Overall Study|Pregnancy|0|||
163297415|NCT03036813|589797727|FG001|Overall Study|Pregnancy|0|||
163297416|NCT03036813|589797728|FG002|Overall Study|Pregnancy|1|||
163297417|NCT03036813|589797726|FG000|Overall Study|Other|0|||
163297418|NCT03036813|589797727|FG001|Overall Study|Other|3|||
163297419|NCT03036813|589797728|FG002|Overall Study|Other|5|||
163297420|NCT00546754|589797729|FG000|Overall Study|Serious Adverse Event|1|||
163297421|NCT00546754|589797730|FG001|Overall Study|Serious Adverse Event|1|||
163297422|NCT00546754|589797729|FG000|Overall Study|Adverse Event|11|||
163297423|NCT00546754|589797730|FG001|Overall Study|Adverse Event|16|||
163297424|NCT00546754|589797729|FG000|Overall Study|Lack of Efficacy|1|||
163297425|NCT00546754|589797730|FG001|Overall Study|Lack of Efficacy|1|||
163297426|NCT00546754|589797729|FG000|Overall Study|Lost to Follow-up|9|||
163297427|NCT00546754|589797730|FG001|Overall Study|Lost to Follow-up|15|||
163297428|NCT00546754|589797729|FG000|Overall Study|Protocol Violation|3|||
163297429|NCT00546754|589797730|FG001|Overall Study|Protocol Violation|0|||
163297430|NCT00546754|589797729|FG000|Overall Study|Withdrawal by Subject|6|||
163297431|NCT00546754|589797730|FG001|Overall Study|Withdrawal by Subject|7|||
163297432|NCT00546754|589797729|FG000|Overall Study|Dyspnea|1|||
163297433|NCT00546754|589797730|FG001|Overall Study|Dyspnea|0|||
163297434|NCT00546754|589797729|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
163297435|NCT00546754|589797730|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
163297436|NCT00546754|589797729|FG000|Overall Study|Hip Replacement|1|||
163297437|NCT00546754|589797730|FG001|Overall Study|Hip Replacement|0|||
163297438|NCT00546754|589797729|FG000|Overall Study|Suicide|1|||
163297439|NCT00546754|589797730|FG001|Overall Study|Suicide|0|||
163297440|NCT00546754|589797729|FG000|Overall Study|Missing Cooperation|1|||
163297441|NCT00546754|589797730|FG001|Overall Study|Missing Cooperation|0|||
163297442|NCT00546754|589797729|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
163297443|NCT00546754|589797730|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
163297444|NCT00546754|589797729|FG000|Overall Study|Patient's Decision|0|||
163297445|NCT00546754|589797730|FG001|Overall Study|Patient's Decision|1|||
163297446|NCT00546754|589797729|FG000|Overall Study|Missing|14|||
163297447|NCT00546754|589797730|FG001|Overall Study|Missing|7|||
163297448|NCT05061693|589797737|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
163297449|NCT05061693|589797738|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
163297450|NCT05061693|589797739|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
163297451|NCT05061693|589797740|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163297452|NCT05061693|589797741|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163297453|NCT05061693|589797742|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163297454|NCT05061693|589797743|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163297455|NCT05061693|589797744|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163297456|NCT05061693|589797745|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163297457|NCT05061693|589797746|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163297458|NCT05061693|589797747|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163297459|NCT05061693|589797748|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163297460|NCT05061693|589797737|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
163297461|NCT05061693|589797738|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
163297462|NCT05061693|589797739|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
163297463|NCT05061693|589797740|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
163297464|NCT05061693|589797741|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
163297465|NCT05061693|589797742|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
163297466|NCT05061693|589797743|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
163297467|NCT05061693|589797744|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
163297468|NCT05061693|589797745|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
163297469|NCT05061693|589797746|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
163297470|NCT05061693|589797747|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
163391803|NCT02401412|590146169|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
163391804|NCT03684642|590146176|FG000|Overall Study|Adverse Event|6|||
163391805|NCT03684642|590146177|FG001|Overall Study|Adverse Event|15|||
163391806|NCT03684642|590146178|FG002|Overall Study|Adverse Event|11|||
163391807|NCT03684642|590146176|FG000|Overall Study|Withdrawal by Subject|35|||
163391808|NCT03684642|590146177|FG001|Overall Study|Withdrawal by Subject|53|||
163391809|NCT03684642|590146178|FG002|Overall Study|Withdrawal by Subject|23|||
163391810|NCT03684642|590146176|FG000|Overall Study|Lack of Efficacy|0|||
163391811|NCT03684642|590146177|FG001|Overall Study|Lack of Efficacy|0|||
163391812|NCT03684642|590146178|FG002|Overall Study|Lack of Efficacy|1|||
162952087|NCT02422264|588529537|FG000|Overall Study|Subject vaccinated outside of the study|0|||
163191587|NCT01999868|589415954|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
163191588|NCT01999868|589415955|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
163191589|NCT01999868|589415956|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
163191590|NCT01999868|589415954|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
163191591|NCT01999868|589415955|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
163191592|NCT01999868|589415956|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
163191593|NCT01999868|589415954|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
163191594|NCT01999868|589415955|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
163391813|NCT03684642|590146176|FG000|Overall Study|Poor compliance to protocol|0|||
163391814|NCT03684642|590146177|FG001|Overall Study|Poor compliance to protocol|4|||
163297471|NCT05061693|589797748|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
163297472|NCT05061693|589797737|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
163297473|NCT05061693|589797738|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163297474|NCT05061693|589797739|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163297475|NCT05061693|589797740|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163297476|NCT05061693|589797741|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163297477|NCT05061693|589797742|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163297478|NCT05061693|589797743|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163297479|NCT05061693|589797744|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163297480|NCT05061693|589797745|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163297481|NCT05061693|589797746|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163297482|NCT05061693|589797747|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163297483|NCT05061693|589797748|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163297484|NCT05061693|589797737|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163297485|NCT05061693|589797738|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163297486|NCT05061693|589797739|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
163297487|NCT05061693|589797740|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163297488|NCT05061693|589797741|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163297489|NCT05061693|589797742|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163297490|NCT05061693|589797743|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163297491|NCT05061693|589797744|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163297492|NCT05061693|589797745|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163297493|NCT05061693|589797746|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163297494|NCT05061693|589797747|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163297495|NCT05061693|589797748|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163297496|NCT05061693|589797737|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
163297497|NCT05061693|589797738|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
163297498|NCT05061693|589797739|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
163297499|NCT05061693|589797740|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
163297500|NCT05061693|589797741|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163297501|NCT05061693|589797742|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163297502|NCT05061693|589797743|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163297503|NCT05061693|589797744|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163297504|NCT05061693|589797745|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163297505|NCT05061693|589797746|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163297506|NCT05061693|589797747|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163297507|NCT05061693|589797748|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163297508|NCT05061693|589797737|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
163297509|NCT05061693|589797738|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
163297510|NCT05061693|589797739|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
163297511|NCT05061693|589797740|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
163297512|NCT05061693|589797741|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163297513|NCT05061693|589797742|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163297514|NCT05061693|589797743|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163297515|NCT05061693|589797744|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163297516|NCT05061693|589797745|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163297517|NCT05061693|589797746|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163297518|NCT05061693|589797747|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163297519|NCT05061693|589797748|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163297520|NCT05061693|589797737|FG000|24-week Extension Period|Adverse Event|0|||
163297521|NCT05061693|589797738|FG001|24-week Extension Period|Adverse Event|0|||
163297522|NCT05061693|589797739|FG002|24-week Extension Period|Adverse Event|0|||
163297523|NCT05061693|589797740|FG003|24-week Extension Period|Adverse Event|0|||
163297524|NCT05061693|589797741|FG004|24-week Extension Period|Adverse Event|0|||
163297525|NCT05061693|589797742|FG005|24-week Extension Period|Adverse Event|0|||
163297526|NCT05061693|589797743|FG006|24-week Extension Period|Adverse Event|0|||
163297527|NCT05061693|589797744|FG007|24-week Extension Period|Adverse Event|2|||
163297528|NCT05061693|589797745|FG008|24-week Extension Period|Adverse Event|2|||
163297529|NCT05061693|589797746|FG009|24-week Extension Period|Adverse Event|0|||
163297530|NCT05061693|589797747|FG010|24-week Extension Period|Adverse Event|1|||
163297531|NCT05061693|589797748|FG011|24-week Extension Period|Adverse Event|3|||
163297532|NCT05061693|589797737|FG000|24-week Extension Period|Lack of Efficacy|0|||
163297533|NCT05061693|589797738|FG001|24-week Extension Period|Lack of Efficacy|0|||
163297534|NCT05061693|589797739|FG002|24-week Extension Period|Lack of Efficacy|0|||
163297535|NCT05061693|589797740|FG003|24-week Extension Period|Lack of Efficacy|0|||
163297536|NCT05061693|589797741|FG004|24-week Extension Period|Lack of Efficacy|0|||
163297537|NCT05061693|589797742|FG005|24-week Extension Period|Lack of Efficacy|0|||
163297538|NCT05061693|589797743|FG006|24-week Extension Period|Lack of Efficacy|0|||
163297539|NCT05061693|589797744|FG007|24-week Extension Period|Lack of Efficacy|0|||
163297540|NCT05061693|589797745|FG008|24-week Extension Period|Lack of Efficacy|0|||
163297541|NCT05061693|589797746|FG009|24-week Extension Period|Lack of Efficacy|0|||
163297542|NCT05061693|589797747|FG010|24-week Extension Period|Lack of Efficacy|2|||
163297543|NCT05061693|589797748|FG011|24-week Extension Period|Lack of Efficacy|0|||
163297544|NCT05061693|589797737|FG000|24-week Extension Period|Lost to Follow-up|0|||
163297545|NCT05061693|589797738|FG001|24-week Extension Period|Lost to Follow-up|0|||
163297546|NCT05061693|589797739|FG002|24-week Extension Period|Lost to Follow-up|0|||
163297547|NCT05061693|589797740|FG003|24-week Extension Period|Lost to Follow-up|0|||
163297548|NCT05061693|589797741|FG004|24-week Extension Period|Lost to Follow-up|0|||
163297549|NCT05061693|589797742|FG005|24-week Extension Period|Lost to Follow-up|0|||
163297550|NCT05061693|589797743|FG006|24-week Extension Period|Lost to Follow-up|1|||
163297551|NCT05061693|589797744|FG007|24-week Extension Period|Lost to Follow-up|0|||
163297552|NCT05061693|589797745|FG008|24-week Extension Period|Lost to Follow-up|1|||
163297553|NCT05061693|589797746|FG009|24-week Extension Period|Lost to Follow-up|1|||
163297554|NCT05061693|589797747|FG010|24-week Extension Period|Lost to Follow-up|0|||
163297555|NCT05061693|589797748|FG011|24-week Extension Period|Lost to Follow-up|0|||
163297556|NCT05061693|589797737|FG000|24-week Extension Period|Withdrawal by Subject|0|||
163297557|NCT05061693|589797738|FG001|24-week Extension Period|Withdrawal by Subject|0|||
163297558|NCT05061693|589797739|FG002|24-week Extension Period|Withdrawal by Subject|0|||
163297559|NCT05061693|589797740|FG003|24-week Extension Period|Withdrawal by Subject|0|||
163297560|NCT05061693|589797741|FG004|24-week Extension Period|Withdrawal by Subject|0|||
163297561|NCT05061693|589797742|FG005|24-week Extension Period|Withdrawal by Subject|0|||
163297562|NCT05061693|589797743|FG006|24-week Extension Period|Withdrawal by Subject|0|||
163297563|NCT05061693|589797744|FG007|24-week Extension Period|Withdrawal by Subject|0|||
163297564|NCT05061693|589797745|FG008|24-week Extension Period|Withdrawal by Subject|1|||
163297565|NCT05061693|589797746|FG009|24-week Extension Period|Withdrawal by Subject|2|||
163297566|NCT05061693|589797747|FG010|24-week Extension Period|Withdrawal by Subject|2|||
163297567|NCT05061693|589797748|FG011|24-week Extension Period|Withdrawal by Subject|1|||
163297568|NCT05061693|589797737|FG000|24-week Extension Period|Sponsor Decision|0|||
163297569|NCT05061693|589797738|FG001|24-week Extension Period|Sponsor Decision|0|||
163297570|NCT05061693|589797739|FG002|24-week Extension Period|Sponsor Decision|0|||
163297571|NCT05061693|589797740|FG003|24-week Extension Period|Sponsor Decision|0|||
163297572|NCT05061693|589797741|FG004|24-week Extension Period|Sponsor Decision|0|||
163297573|NCT05061693|589797742|FG005|24-week Extension Period|Sponsor Decision|0|||
163297574|NCT05061693|589797743|FG006|24-week Extension Period|Sponsor Decision|0|||
163297575|NCT05061693|589797744|FG007|24-week Extension Period|Sponsor Decision|1|||
163297576|NCT05061693|589797745|FG008|24-week Extension Period|Sponsor Decision|0|||
163297577|NCT05061693|589797746|FG009|24-week Extension Period|Sponsor Decision|0|||
163297578|NCT05061693|589797747|FG010|24-week Extension Period|Sponsor Decision|0|||
163297579|NCT05061693|589797748|FG011|24-week Extension Period|Sponsor Decision|0|||
163297580|NCT05061693|589797737|FG000|24-week Extension Period|Site Closure|0|||
163297581|NCT05061693|589797738|FG001|24-week Extension Period|Site Closure|0|||
163297582|NCT05061693|589797739|FG002|24-week Extension Period|Site Closure|0|||
163297583|NCT05061693|589797740|FG003|24-week Extension Period|Site Closure|0|||
163297584|NCT05061693|589797741|FG004|24-week Extension Period|Site Closure|0|||
163297585|NCT05061693|589797742|FG005|24-week Extension Period|Site Closure|0|||
163297586|NCT05061693|589797743|FG006|24-week Extension Period|Site Closure|0|||
163297587|NCT05061693|589797744|FG007|24-week Extension Period|Site Closure|0|||
163297588|NCT05061693|589797745|FG008|24-week Extension Period|Site Closure|1|||
163297589|NCT05061693|589797746|FG009|24-week Extension Period|Site Closure|0|||
163297590|NCT05061693|589797747|FG010|24-week Extension Period|Site Closure|0|||
163297591|NCT05061693|589797748|FG011|24-week Extension Period|Site Closure|1|||
163297592|NCT03823911|589797749|FG000|Overall Study|Lost to Follow-up|1|||
163297593|NCT03823911|589797750|FG001|Overall Study|Lost to Follow-up|5|||
163297594|NCT03823911|589797751|FG002|Overall Study|Lost to Follow-up|2|||
163191595|NCT01999868|589415956|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
163191596|NCT01999868|589415954|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
163191597|NCT01999868|589415955|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
163191598|NCT01999868|589415956|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
163191599|NCT01999868|589415954|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
163191600|NCT01999868|589415955|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
163191601|NCT01999868|589415956|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
163191602|NCT01999868|589415954|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
163297595|NCT03823911|589797749|FG000|Overall Study|Did not meet eligibility criteria|13|||
163297596|NCT03823911|589797750|FG001|Overall Study|Did not meet eligibility criteria|7|||
163297597|NCT03823911|589797751|FG002|Overall Study|Did not meet eligibility criteria|4|||
163297598|NCT03823911|589797749|FG000|Overall Study|Death|0|||
163297599|NCT03823911|589797750|FG001|Overall Study|Death|1|||
163043231|NCT00110357|588865759|FG001|Overall Study|Withdrawal by Subject|1|||
163043232|NCT05285787|588865760|FG000|Overall Study|Withdrawal by Subject|1|||
163191603|NCT01999868|589415955|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
163191604|NCT01999868|589415956|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
163191605|NCT01999868|589415954|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
163191606|NCT01999868|589415955|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
163191607|NCT01999868|589415956|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
163191608|NCT01999868|589415954|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
163191609|NCT01999868|589415955|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
163191610|NCT01999868|589415956|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
163191611|NCT00289016|589415957|FG000|Overall Study|Disease Progression|29|||
163191612|NCT00289016|589415957|FG000|Overall Study|Death|2|||
163191613|NCT00289016|589415957|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
163191614|NCT00289016|589415957|FG000|Overall Study|Withdrawal by Subject|2|||
163191615|NCT00289016|589415957|FG000|Overall Study|Adverse Event|1|||
163191616|NCT00289016|589415957|FG000|Overall Study|Other|1|||
163191617|NCT03553927|589415958|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
163191618|NCT03553927|589415959|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
163191619|NCT03553927|589415958|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
163191620|NCT03553927|589415959|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
163191621|NCT03350620|589415963|FG000|Stage 2|Adverse Event|0|||
163191622|NCT03350620|589415964|FG001|Stage 2|Adverse Event|1|||
163191623|NCT03350620|589415965|FG002|Stage 2|Adverse Event|1|||
163191624|NCT03350620|589415963|FG000|Stage 2|Lack of Efficacy|0|||
163191625|NCT03350620|589415964|FG001|Stage 2|Lack of Efficacy|2|||
163191626|NCT03350620|589415965|FG002|Stage 2|Lack of Efficacy|0|||
163191627|NCT03350620|589415963|FG000|Stage 2|Lost to Follow-up|1|||
163191628|NCT03350620|589415964|FG001|Stage 2|Lost to Follow-up|2|||
163191629|NCT03350620|589415965|FG002|Stage 2|Lost to Follow-up|2|||
163191630|NCT03350620|589415963|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
163191631|NCT03350620|589415964|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
163191632|NCT03350620|589415965|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
163191633|NCT00566111|589415966|FG000|Overall Study|Adverse Event|0|||
163191634|NCT00566111|589415967|FG001|Overall Study|Adverse Event|2|||
163191635|NCT03774082|589415969|FG000|Overall Study|Death|6|||
163191636|NCT03774082|589415970|FG001|Overall Study|Death|3|||
163191637|NCT03774082|589415971|FG002|Overall Study|Death|2|||
163191638|NCT03774082|589415969|FG000|Overall Study|Subject decision|0|||
163191639|NCT03774082|589415970|FG001|Overall Study|Subject decision|3|||
163191640|NCT03774082|589415971|FG002|Overall Study|Subject decision|0|||
163191641|NCT03774082|589415969|FG000|Overall Study|Lost to Follow-up|2|||
163191642|NCT03774082|589415970|FG001|Overall Study|Lost to Follow-up|0|||
163191643|NCT03774082|589415971|FG002|Overall Study|Lost to Follow-up|0|||
163191644|NCT03774082|589415969|FG000|Overall Study|Guardian decision|0|||
163191645|NCT03774082|589415970|FG001|Overall Study|Guardian decision|0|||
163191646|NCT03774082|589415971|FG002|Overall Study|Guardian decision|1|||
163191647|NCT03774082|589415969|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
163191648|NCT03774082|589415970|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
163191649|NCT03774082|589415971|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
163191650|NCT05938920|589415972|FG000|Overall Study|Adverse Event|1|||
163191651|NCT05938920|589415973|FG001|Overall Study|Adverse Event|3|||
163191652|NCT05938920|589415974|FG002|Overall Study|Adverse Event|2|||
163191653|NCT05938920|589415975|FG003|Overall Study|Adverse Event|1|||
163191654|NCT05938920|589415972|FG000|Overall Study|Death|0|||
163191655|NCT05938920|589415973|FG001|Overall Study|Death|1|||
163191656|NCT05938920|589415974|FG002|Overall Study|Death|0|||
163191657|NCT05938920|589415975|FG003|Overall Study|Death|0|||
163191658|NCT05938920|589415972|FG000|Overall Study|Lost to Follow-up|0|||
163191659|NCT05938920|589415973|FG001|Overall Study|Lost to Follow-up|0|||
163191660|NCT05938920|589415974|FG002|Overall Study|Lost to Follow-up|1|||
163191661|NCT05938920|589415975|FG003|Overall Study|Lost to Follow-up|0|||
163191662|NCT05938920|589415972|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
163191663|NCT05938920|589415973|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
163191664|NCT05938920|589415974|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
163191665|NCT05938920|589415975|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
163191666|NCT05938920|589415972|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
163191667|NCT05938920|589415973|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
163191668|NCT05938920|589415974|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
163191669|NCT05938920|589415975|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
163191670|NCT05938920|589415972|FG000|Overall Study|Participant Refused to Come In|0|||
163191671|NCT05938920|589415973|FG001|Overall Study|Participant Refused to Come In|0|||
163191672|NCT05938920|589415974|FG002|Overall Study|Participant Refused to Come In|1|||
163043233|NCT04004260|588865764|FG000|Overall Study|Withdrawal by Subject|7|||
163297600|NCT03823911|589797751|FG002|Overall Study|Death|0|||
163297601|NCT00311363|589797752|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
163297602|NCT00311363|589797753|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
163297603|NCT00311363|589797754|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
163297604|NCT00311363|589797752|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
163297605|NCT00311363|589797753|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
163297606|NCT00311363|589797754|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
163297607|NCT00311363|589797752|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
163297608|NCT00311363|589797753|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
163297609|NCT00311363|589797754|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
163297610|NCT00311363|589797752|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
163297611|NCT00311363|589797753|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
163297612|NCT00311363|589797754|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
163297613|NCT00311363|589797752|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
163297614|NCT00311363|589797753|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
163297615|NCT00311363|589797754|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
163297616|NCT00311363|589797752|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
163297617|NCT00311363|589797753|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
163297618|NCT00311363|589797754|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
163297619|NCT00311363|589797752|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
163297620|NCT00311363|589797753|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
163297621|NCT00311363|589797754|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
163297622|NCT00311363|589797752|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
163297623|NCT00311363|589797753|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
163297624|NCT00311363|589797754|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
163297625|NCT00311363|589797752|FG000|24-Week Single-Blind Treatment Period|Death|1|||
163297626|NCT00311363|589797753|FG001|24-Week Single-Blind Treatment Period|Death|0|||
163297627|NCT00311363|589797754|FG002|24-Week Single-Blind Treatment Period|Death|0|||
163297628|NCT00311363|589797752|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
163297629|NCT00311363|589797753|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
163297630|NCT00311363|589797754|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
163297631|NCT00311363|589797752|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
163297632|NCT00311363|589797753|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
163297633|NCT00311363|589797754|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
163297634|NCT00311363|589797752|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
163297635|NCT00311363|589797753|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
163297636|NCT00311363|589797754|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
163297637|NCT00311363|589797752|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
163297638|NCT00311363|589797753|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
163297639|NCT00311363|589797754|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
163297640|NCT00311363|589797752|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
163297641|NCT00311363|589797753|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
163297642|NCT00311363|589797754|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
163297643|NCT00311363|589797752|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
163297644|NCT00311363|589797753|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
163297645|NCT00311363|589797754|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
163297646|NCT00396084|589797757|FG000|Overall Study|Adverse Event|0|||
163297647|NCT00396084|589797758|FG001|Overall Study|Adverse Event|0|||
163297648|NCT00396084|589797759|FG002|Overall Study|Adverse Event|0|||
163297649|NCT00396084|589797760|FG003|Overall Study|Adverse Event|0|||
163297650|NCT00396084|589797761|FG004|Overall Study|Adverse Event|1|||
163297651|NCT00396084|589797762|FG005|Overall Study|Adverse Event|2|||
163297652|NCT00396084|589797757|FG000|Overall Study|Withdrawal by Subject|0|||
163297653|NCT00396084|589797758|FG001|Overall Study|Withdrawal by Subject|0|||
163297654|NCT00396084|589797759|FG002|Overall Study|Withdrawal by Subject|0|||
163297655|NCT00396084|589797760|FG003|Overall Study|Withdrawal by Subject|1|||
163297656|NCT00396084|589797761|FG004|Overall Study|Withdrawal by Subject|0|||
163297657|NCT00396084|589797762|FG005|Overall Study|Withdrawal by Subject|0|||
163297658|NCT04009577|589797763|FG000|Core Study|Adverse Event|1|||
163297659|NCT04009577|589797764|FG001|Core Study|Adverse Event|0|||
163297660|NCT04009577|589797765|FG002|Core Study|Adverse Event|2|||
163297661|NCT04009577|589797766|FG003|Core Study|Adverse Event|4|||
163297662|NCT04009577|589797763|FG000|Core Study|Withdrawal by Subject|0|||
163297663|NCT04009577|589797764|FG001|Core Study|Withdrawal by Subject|0|||
163297664|NCT04009577|589797765|FG002|Core Study|Withdrawal by Subject|2|||
163297665|NCT04009577|589797766|FG003|Core Study|Withdrawal by Subject|0|||
163297666|NCT04009577|589797763|FG000|Core Study|Other|0|||
163297667|NCT04009577|589797764|FG001|Core Study|Other|0|||
163297668|NCT04009577|589797765|FG002|Core Study|Other|0|||
163297669|NCT04009577|589797766|FG003|Core Study|Other|1|||
163297670|NCT04009577|589797763|FG000|Extension Phase|Adverse Event|0|||
163297671|NCT04009577|589797764|FG001|Extension Phase|Adverse Event|0|||
163297672|NCT04009577|589797765|FG002|Extension Phase|Adverse Event|0|||
163297673|NCT04009577|589797766|FG003|Extension Phase|Adverse Event|1|||
163297674|NCT04009577|589797763|FG000|Extension Phase|Inadequate therapeutic effect|0|||
163297675|NCT04009577|589797764|FG001|Extension Phase|Inadequate therapeutic effect|0|||
163297676|NCT04009577|589797765|FG002|Extension Phase|Inadequate therapeutic effect|1|||
163297677|NCT04009577|589797766|FG003|Extension Phase|Inadequate therapeutic effect|0|||
163297678|NCT04009577|589797763|FG000|Extension Phase|Withdrawal by Subject|0|||
163297679|NCT04009577|589797764|FG001|Extension Phase|Withdrawal by Subject|0|||
163297680|NCT04009577|589797765|FG002|Extension Phase|Withdrawal by Subject|1|||
163297681|NCT04009577|589797766|FG003|Extension Phase|Withdrawal by Subject|0|||
163297682|NCT04009577|589797763|FG000|Extension Phase|Not Treated|0|||
163391815|NCT03684642|590146178|FG002|Overall Study|Poor compliance to protocol|1|||
163391816|NCT03684642|590146176|FG000|Overall Study|Other than specified|62|||
163297683|NCT04009577|589797764|FG001|Extension Phase|Not Treated|0|||
163297684|NCT04009577|589797765|FG002|Extension Phase|Not Treated|2|||
163297685|NCT04009577|589797766|FG003|Extension Phase|Not Treated|0|||
163297686|NCT01832480|589797767|FG000|Overall Study|Lost to Follow-up|33|||
163391817|NCT03684642|590146177|FG001|Overall Study|Other than specified|60|||
163391818|NCT03684642|590146178|FG002|Overall Study|Other than specified|67|||
163391819|NCT03684642|590146176|FG000|Overall Study|Randomized and not treated|0|||
163391820|NCT03684642|590146177|FG001|Overall Study|Randomized and not treated|0|||
163391821|NCT03684642|590146178|FG002|Overall Study|Randomized and not treated|1|||
163391822|NCT03684642|590146176|FG000|Overall Study|Missing completion status but alive at last contact|0|||
163391823|NCT03684642|590146177|FG001|Overall Study|Missing completion status but alive at last contact|1|||
163391824|NCT03684642|590146178|FG002|Overall Study|Missing completion status but alive at last contact|2|||
163391825|NCT01843218|590146181|FG000|Overall Study|Withdrawal by Subject|5|||
163391826|NCT01431534|590146182|FG000|Treatment Phase|Adverse Event|0|||
163391827|NCT01431534|590146183|FG001|Treatment Phase|Adverse Event|0|||
163391828|NCT01431534|590146184|FG002|Treatment Phase|Adverse Event|1|||
163391829|NCT01431534|590146182|FG000|Treatment Phase|Progressive Disease|4|||
163391830|NCT01431534|590146183|FG001|Treatment Phase|Progressive Disease|3|||
163391831|NCT01431534|590146184|FG002|Treatment Phase|Progressive Disease|10|||
163391832|NCT05118204|590146188|FG000|Overall Study|Lost to Follow-up|3|||
163391833|NCT05118204|590146189|FG001|Overall Study|Lost to Follow-up|2|||
163391834|NCT05118204|590146188|FG000|Overall Study|Withdrawal by Subject|0|||
163391835|NCT05118204|590146189|FG001|Overall Study|Withdrawal by Subject|2|||
163391836|NCT05393037|590146191|FG000|Part A|Death|1|||
163391837|NCT05393037|590146192|FG001|Part A|Death|0|||
163391838|NCT05393037|590146191|FG000|Part A|Lost to Follow-up|1|||
163391839|NCT05393037|590146192|FG001|Part A|Lost to Follow-up|1|||
163391840|NCT05393037|590146191|FG000|Part A|Withdrawal by Subject|2|||
163391841|NCT05393037|590146192|FG001|Part A|Withdrawal by Subject|4|||
163391842|NCT05393037|590146191|FG000|Part B|Lost to Follow-up|1|||
163391843|NCT05393037|590146192|FG001|Part B|Lost to Follow-up|0|||
163391844|NCT04409353|590146193|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
163391845|NCT04409353|590146194|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
163391846|NCT04409353|590146195|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
163391847|NCT04409353|590146193|FG000|Overall Study|Lost to Follow-up|6|||
163391848|NCT04409353|590146194|FG001|Overall Study|Lost to Follow-up|8|||
163391849|NCT04409353|590146195|FG002|Overall Study|Lost to Follow-up|7|||
163391850|NCT04409353|590146193|FG000|Overall Study|Major surgery during participation window|4|||
163391851|NCT04409353|590146194|FG001|Overall Study|Major surgery during participation window|3|||
163391852|NCT04409353|590146195|FG002|Overall Study|Major surgery during participation window|3|||
163391853|NCT04409353|590146193|FG000|Overall Study|Life event occurred during participation window|3|||
163391854|NCT04409353|590146194|FG001|Overall Study|Life event occurred during participation window|2|||
163391855|NCT04409353|590146195|FG002|Overall Study|Life event occurred during participation window|4|||
163391856|NCT04409353|590146193|FG000|Overall Study|Lack of Efficacy|4|||
163391857|NCT04409353|590146194|FG001|Overall Study|Lack of Efficacy|1|||
163391858|NCT04409353|590146195|FG002|Overall Study|Lack of Efficacy|3|||
163391859|NCT04409353|590146193|FG000|Overall Study|Adverse Event|2|||
163391860|NCT04409353|590146194|FG001|Overall Study|Adverse Event|1|||
163391861|NCT04409353|590146195|FG002|Overall Study|Adverse Event|1|||
163391862|NCT04409353|590146193|FG000|Overall Study|Disease burden - unable to participate|0|||
163297687|NCT01832480|589797768|FG001|Overall Study|Lost to Follow-up|30|||
163297688|NCT01832480|589797767|FG000|Overall Study|Withdrawal by Subject|0|||
163297689|NCT01832480|589797768|FG001|Overall Study|Withdrawal by Subject|2|||
163391863|NCT04409353|590146194|FG001|Overall Study|Disease burden - unable to participate|1|||
163391864|NCT04409353|590146195|FG002|Overall Study|Disease burden - unable to participate|1|||
163391865|NCT04409353|590146193|FG000|Overall Study|Intervention too complicated|1|||
163391866|NCT04409353|590146194|FG001|Overall Study|Intervention too complicated|0|||
163297690|NCT01832480|589797767|FG000|Overall Study|post randomization ineligible|8|||
163297691|NCT01832480|589797768|FG001|Overall Study|post randomization ineligible|10|||
163297692|NCT02261467|589797770|FG000|Overall Study|Enrolled in Error|1|||
163297693|NCT02261467|589797771|FG001|Overall Study|Enrolled in Error|0|||
163297694|NCT02261467|589797770|FG000|Overall Study|Protocol Violation|0|||
163297695|NCT02261467|589797771|FG001|Overall Study|Protocol Violation|1|||
163297696|NCT02261467|589797770|FG000|Overall Study|Personal Reasons|17|||
163297697|NCT02261467|589797771|FG001|Overall Study|Personal Reasons|22|||
163297698|NCT02261467|589797770|FG000|Overall Study|Lost to Follow-up|2|||
163297699|NCT02261467|589797771|FG001|Overall Study|Lost to Follow-up|13|||
163297700|NCT02261467|589797770|FG000|Overall Study|Adverse Event|1|||
163297701|NCT02261467|589797771|FG001|Overall Study|Adverse Event|1|||
163297702|NCT04305405|589797774|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163297703|NCT04305405|589797775|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163391867|NCT04409353|590146195|FG002|Overall Study|Intervention too complicated|1|||
163391868|NCT01012739|590146196|FG000|Treatment Period 1|Adverse Event|0|||
163297704|NCT00206375|589797776|FG000|Overall Study|Lost to Follow-up|1|||
163297705|NCT00206375|589797777|FG001|Overall Study|Lost to Follow-up|0|||
163297706|NCT00206375|589797778|FG002|Overall Study|Lost to Follow-up|0|||
163297707|NCT00206375|589797776|FG000|Overall Study|Withdrawal by Subject|2|||
163297708|NCT00206375|589797777|FG001|Overall Study|Withdrawal by Subject|1|||
163297709|NCT00206375|589797778|FG002|Overall Study|Withdrawal by Subject|3|||
163297710|NCT00206375|589797776|FG000|Overall Study|Study terminated due to lack of funds|0|||
163297711|NCT00206375|589797777|FG001|Overall Study|Study terminated due to lack of funds|1|||
163297712|NCT00206375|589797778|FG002|Overall Study|Study terminated due to lack of funds|1|||
163297713|NCT01685606|589797784|FG000|Overall Study|Withdrawal by Subject|1|||
163297714|NCT01787760|589797785|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
163297715|NCT01787760|589797786|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
163297716|NCT01787760|589797787|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
163297717|NCT01787760|589797785|FG000|Overall Study|Decompensated on left exotropia|0|||
163297718|NCT01787760|589797786|FG001|Overall Study|Decompensated on left exotropia|0|||
163297719|NCT01787760|589797787|FG002|Overall Study|Decompensated on left exotropia|1|||
163297720|NCT01787760|589797785|FG000|Overall Study|Dryness|0|||
163297721|NCT01787760|589797786|FG001|Overall Study|Dryness|1|||
163297722|NCT01787760|589797787|FG002|Overall Study|Dryness|0|||
163297723|NCT01787760|589797785|FG000|Overall Study|Relocation|1|||
163297724|NCT01787760|589797786|FG001|Overall Study|Relocation|1|||
163297725|NCT01787760|589797787|FG002|Overall Study|Relocation|0|||
163297726|NCT01787760|589797785|FG000|Overall Study|Lens discomfort|3|||
163297727|NCT01787760|589797786|FG001|Overall Study|Lens discomfort|0|||
163297728|NCT01787760|589797787|FG002|Overall Study|Lens discomfort|0|||
163297729|NCT01787760|589797785|FG000|Overall Study|Lens handling difficulty|1|||
163297730|NCT01787760|589797786|FG001|Overall Study|Lens handling difficulty|2|||
163297731|NCT01787760|589797787|FG002|Overall Study|Lens handling difficulty|0|||
163297732|NCT01787760|589797785|FG000|Overall Study|Protocol Violation|6|||
163297733|NCT01787760|589797786|FG001|Overall Study|Protocol Violation|0|||
163297734|NCT01787760|589797787|FG002|Overall Study|Protocol Violation|1|||
163297735|NCT01787760|589797785|FG000|Overall Study|Withdrawal by Subject|5|||
163297736|NCT01787760|589797786|FG001|Overall Study|Withdrawal by Subject|1|||
163297737|NCT01787760|589797787|FG002|Overall Study|Withdrawal by Subject|2|||
163297738|NCT01787760|589797785|FG000|Overall Study|Lost to Follow-up|1|||
163297739|NCT01787760|589797786|FG001|Overall Study|Lost to Follow-up|0|||
163297740|NCT01787760|589797787|FG002|Overall Study|Lost to Follow-up|1|||
163297741|NCT01787760|589797785|FG000|Overall Study|Stroke|1|||
163297742|NCT01787760|589797786|FG001|Overall Study|Stroke|0|||
163297743|NCT01787760|589797787|FG002|Overall Study|Stroke|0|||
163297744|NCT01787760|589797785|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
163297745|NCT01787760|589797786|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
163297746|NCT01787760|589797787|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
163297747|NCT01787760|589797785|FG000|Overall Study|Unsatisfactory physiological response|2|||
163297748|NCT01787760|589797786|FG001|Overall Study|Unsatisfactory physiological response|4|||
163297749|NCT01787760|589797787|FG002|Overall Study|Unsatisfactory physiological response|0|||
163297750|NCT01787760|589797785|FG000|Overall Study|Unsatisfactory visual response|1|||
163297751|NCT01787760|589797786|FG001|Overall Study|Unsatisfactory visual response|1|||
163297752|NCT01787760|589797787|FG002|Overall Study|Unsatisfactory visual response|0|||
163297753|NCT01787760|589797785|FG000|Overall Study|Near vision blur|1|||
163391869|NCT01012739|590146197|FG001|Treatment Period 1|Adverse Event|0|||
163391870|NCT01012739|590146198|FG002|Treatment Period 1|Adverse Event|0|||
163391871|NCT01012739|590146199|FG003|Treatment Period 1|Adverse Event|1|||
163297754|NCT01787760|589797786|FG001|Overall Study|Near vision blur|0|||
163297755|NCT01787760|589797787|FG002|Overall Study|Near vision blur|0|||
163297756|NCT01353963|589797788|FG000|Overall Study|Adverse Event|2|||
163297757|NCT03473340|589797789|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
163297758|NCT03473340|589797790|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
163297759|NCT03473340|589797789|FG000|Overall Study|Withdrawal by Subject|1|||
163297760|NCT03473340|589797790|FG001|Overall Study|Withdrawal by Subject|0|||
163297761|NCT03473340|589797789|FG000|Overall Study|Lost to Follow-up|1|||
163297762|NCT03473340|589797790|FG001|Overall Study|Lost to Follow-up|2|||
163391872|NCT01012739|590146196|FG000|Treatment Period 2|Abnormal test procedure results|0|||
163191673|NCT05938920|589415975|FG003|Overall Study|Participant Refused to Come In|0|||
163191674|NCT01251861|589415976|FG000|Overall Study|Disease progression|6|||
163191675|NCT01251861|589415977|FG001|Overall Study|Disease progression|6|||
163191676|NCT01251861|589415976|FG000|Overall Study|Adverse Event|2|||
163191677|NCT01251861|589415977|FG001|Overall Study|Adverse Event|17|||
163191678|NCT01251861|589415976|FG000|Overall Study|Withdrawal by Subject|2|||
163191679|NCT01251861|589415977|FG001|Overall Study|Withdrawal by Subject|2|||
163191680|NCT01251861|589415976|FG000|Overall Study|Alternative therapy|1|||
163191681|NCT01251861|589415977|FG001|Overall Study|Alternative therapy|0|||
163191682|NCT01251861|589415976|FG000|Overall Study|Other complicating disease|0|||
163191683|NCT01251861|589415977|FG001|Overall Study|Other complicating disease|1|||
163191684|NCT01251861|589415976|FG000|Overall Study|Physician Decision|1|||
163191685|NCT01251861|589415977|FG001|Overall Study|Physician Decision|0|||
163191686|NCT01251861|589415976|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
163191687|NCT01251861|589415977|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
163191688|NCT01251861|589415976|FG000|Overall Study|Other|1|||
163191689|NCT01251861|589415977|FG001|Overall Study|Other|0|||
163191690|NCT01251861|589415976|FG000|Overall Study|Never started therapy|4|||
163191691|NCT01251861|589415977|FG001|Overall Study|Never started therapy|1|||
163191692|NCT01251861|589415976|FG000|Overall Study|Potential interaction of drugs|0|||
163191693|NCT01251861|589415977|FG001|Overall Study|Potential interaction of drugs|1|||
163191694|NCT01816074|589417225|FG000|Phase 1|Time commitment issues|0|||
163191695|NCT01816074|589417226|FG001|Phase 1|Time commitment issues|0|||
163191696|NCT01816074|589417227|FG002|Phase 1|Time commitment issues|1|||
163191697|NCT01816074|589417228|FG003|Phase 1|Time commitment issues|0|||
163191698|NCT01816074|589417225|FG000|Phase 2|Time commitment Issues|0|||
163191699|NCT01816074|589417226|FG001|Phase 2|Time commitment Issues|2|||
163191700|NCT01816074|589417227|FG002|Phase 2|Time commitment Issues|0|||
163191701|NCT01816074|589417228|FG003|Phase 2|Time commitment Issues|0|||
163191702|NCT01816074|589417225|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
163191703|NCT01816074|589417226|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
163191704|NCT01816074|589417227|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
163191705|NCT01816074|589417228|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
163191706|NCT01816074|589417225|FG000|Phase 2|Physician Decision|0|||
163191707|NCT01816074|589417226|FG001|Phase 2|Physician Decision|0|||
163191708|NCT01816074|589417227|FG002|Phase 2|Physician Decision|0|||
163191709|NCT01816074|589417228|FG003|Phase 2|Physician Decision|1|||
163191710|NCT01816074|589417225|FG000|Phase 2|Withdrawal by Subject|1|||
163191711|NCT01816074|589417226|FG001|Phase 2|Withdrawal by Subject|0|||
163191712|NCT01816074|589417227|FG002|Phase 2|Withdrawal by Subject|0|||
163191713|NCT01816074|589417228|FG003|Phase 2|Withdrawal by Subject|0|||
163191714|NCT03355365|589417232|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
163191715|NCT03355365|589417233|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
163191716|NCT03355365|589417232|FG000|Year 1, First Intervention|Protocol Violation|1|||
163191717|NCT03355365|589417233|FG001|Year 1, First Intervention|Protocol Violation|0|||
163191718|NCT03355365|589417232|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
163191719|NCT03355365|589417233|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
163191720|NCT03355365|589417232|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
163191721|NCT03355365|589417233|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
163191722|NCT03355365|589417232|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
163191723|NCT03355365|589417233|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
163191724|NCT03355365|589417232|FG000|Year 2, Crossover Intervention|severe COVID|0|||
163191725|NCT03355365|589417233|FG001|Year 2, Crossover Intervention|severe COVID|1|||
163191726|NCT03355365|589417232|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
163191727|NCT03355365|589417233|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
163191728|NCT01303861|589417245|FG000|Overall Study|Lost to Follow-up|34|||
163191729|NCT01303861|589417246|FG001|Overall Study|Lost to Follow-up|14|||
163191730|NCT01303861|589417247|FG002|Overall Study|Lost to Follow-up|27|||
163191731|NCT01303861|589417248|FG003|Overall Study|Lost to Follow-up|31|||
163191732|NCT01303861|589417245|FG000|Overall Study|Lack of Efficacy|3|||
163191733|NCT01303861|589417246|FG001|Overall Study|Lack of Efficacy|2|||
163191734|NCT01303861|589417247|FG002|Overall Study|Lack of Efficacy|1|||
163191735|NCT01303861|589417248|FG003|Overall Study|Lack of Efficacy|0|||
163191736|NCT01303861|589417245|FG000|Overall Study|Withdrawal by Subject|16|||
163191737|NCT01303861|589417246|FG001|Overall Study|Withdrawal by Subject|8|||
163191738|NCT01303861|589417247|FG002|Overall Study|Withdrawal by Subject|8|||
163191739|NCT01303861|589417248|FG003|Overall Study|Withdrawal by Subject|23|||
163191740|NCT01303861|589417245|FG000|Overall Study|Adverse Event|4|||
163191741|NCT01303861|589417246|FG001|Overall Study|Adverse Event|1|||
163191742|NCT01303861|589417247|FG002|Overall Study|Adverse Event|0|||
163191743|NCT01303861|589417248|FG003|Overall Study|Adverse Event|5|||
163191744|NCT01303861|589417245|FG000|Overall Study|Pregnancy|1|||
163191745|NCT01303861|589417246|FG001|Overall Study|Pregnancy|0|||
163191746|NCT01303861|589417247|FG002|Overall Study|Pregnancy|0|||
163297763|NCT02079844|589797791|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
163297764|NCT02079844|589797792|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
163297765|NCT02079844|589797793|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
163297766|NCT02079844|589797791|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
163297767|NCT02079844|589797792|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
163297768|NCT02079844|589797793|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
163297769|NCT01420549|589797794|FG000|Overall Study|Adverse Event|1|||
163297770|NCT01420549|589797795|FG001|Overall Study|Adverse Event|1|||
163297771|NCT01420549|589797794|FG000|Overall Study|Lost to Follow-up|2|||
163297772|NCT01420549|589797795|FG001|Overall Study|Lost to Follow-up|2|||
163297773|NCT01420549|589797794|FG000|Overall Study|Protocol Violation|0|||
163297774|NCT01420549|589797795|FG001|Overall Study|Protocol Violation|1|||
163297775|NCT01420549|589797794|FG000|Overall Study|Non-adherence to medication|4|||
163297776|NCT01420549|589797795|FG001|Overall Study|Non-adherence to medication|1|||
163297777|NCT03394885|589797796|FG000|Overall Study|Adverse Event|4|||
163297778|NCT03394885|589797796|FG000|Overall Study|Lack of Efficacy|1|||
163297779|NCT03394885|589797796|FG000|Overall Study|Physician Decision|1|||
163297780|NCT03394885|589797796|FG000|Overall Study|Withdrawal by Subject|8|||
163297781|NCT03394885|589797796|FG000|Overall Study|Alternative Therapy|1|||
163297782|NCT00203411|589797797|FG000|Follow-up|Progressive Disease|4|||
163297783|NCT04980755|589797798|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
163297784|NCT04980755|589797798|FG000|Body Reprogramming Courses|Work commitment|2|||
163297785|NCT04980755|589797798|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
163297786|NCT04980755|589797798|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
163297787|NCT00632424|589797805|FG000|Overall Study|Disease Progression|17|||
163297788|NCT00632424|589797805|FG000|Overall Study|Study Drug Toxicity|1|||
163297789|NCT02531113|589797806|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
163297790|NCT02531113|589797806|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
163297791|NCT02531113|589797806|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
163297792|NCT02531113|589797806|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
163297793|NCT02531113|589797806|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
163297794|NCT02531113|589797806|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
163297795|NCT02531113|589797806|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
163297796|NCT02531113|589797806|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
163297797|NCT00801983|589797807|FG000|Period 1|Lost to Follow-up|2|||
163297798|NCT00801983|589797808|FG001|Period 1|Lost to Follow-up|0|||
163297799|NCT00801983|589797807|FG000|Period 1|Withdrawal by Subject|2|||
163297800|NCT00801983|589797808|FG001|Period 1|Withdrawal by Subject|8|||
163297801|NCT00801983|589797807|FG000|Period 2|Withdrawal by Subject|2|||
163297802|NCT00801983|589797808|FG001|Period 2|Withdrawal by Subject|1|||
163297803|NCT04153565|589799454|FG000|Overall Study|Death|13|||
163297804|NCT00446459|589799459|FG000|8 Months|Protocol Violation|12|||
163297805|NCT00446459|589799459|FG000|12 Months|Protocol Violation|4|||
163297806|NCT00446459|589799459|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
163297807|NCT00858117|589799461|FG000|Treatment on Study|Adverse Event|2|||
163297808|NCT00858117|589799461|FG000|Follow up for 5 Years|Death|4|||
163297809|NCT00858117|589799461|FG000|Follow up for 5 Years|No further data collected for study|9|||
163297810|NCT02647905|589799462|FG000|Overall Study|Lost to Follow-up|1|||
163297811|NCT02647905|589799462|FG000|Overall Study|Withdrawal by Subject|2|||
163297812|NCT00371787|589799463|FG000|Overall Study|Withdrawal by Subject|3|||
163297813|NCT00371787|589799464|FG001|Overall Study|Withdrawal by Subject|1|||
163297814|NCT00077675|589799465|FG000|Overall Study|Adverse Event|1|||
163297815|NCT00077675|589799466|FG001|Overall Study|Adverse Event|2|||
163297816|NCT00077675|589799465|FG000|Overall Study|Lost to Follow-up|6|||
163297817|NCT00077675|589799466|FG001|Overall Study|Lost to Follow-up|3|||
163297818|NCT00077675|589799465|FG000|Overall Study|Withdrawal by Subject|1|||
163297819|NCT00077675|589799466|FG001|Overall Study|Withdrawal by Subject|0|||
163297820|NCT00077675|589799465|FG000|Overall Study|Other|0|||
163297821|NCT00077675|589799466|FG001|Overall Study|Other|1|||
163297822|NCT00077675|589799465|FG000|Overall Study|Never received study treatment|3|||
163297823|NCT00077675|589799466|FG001|Overall Study|Never received study treatment|3|||
163297824|NCT02601820|589799467|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
163297825|NCT02601820|589799467|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
163297826|NCT02601820|589799467|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
163297827|NCT02601820|589799467|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
163297828|NCT02765100|589799468|FG000|Overall Study|subject found ineligible after baseline|1|||
163297829|NCT02765100|589799469|FG001|Overall Study|subject found ineligible after baseline|1|||
163297830|NCT02765100|589799468|FG000|Overall Study|Lost to Follow-up|0|||
163297831|NCT02765100|589799469|FG001|Overall Study|Lost to Follow-up|1|||
163297832|NCT04532528|589799475|FG000|Overall Study|Adverse Event|12|||
163297833|NCT04532528|589799476|FG001|Overall Study|Adverse Event|17|||
163297834|NCT04532528|589799475|FG000|Overall Study|Withdrawal of consent|16|||
163191747|NCT01303861|589417248|FG003|Overall Study|Pregnancy|0|||
163191748|NCT03650556|589417254|FG000|Overall Study|Death|2|||
163191749|NCT03650556|589417254|FG000|Overall Study|Withdrawal by Subject|20|||
163191750|NCT03650556|589417254|FG000|Overall Study|Physician Decision|2|||
163191751|NCT03650556|589417254|FG000|Overall Study|Lost to Follow-up|8|||
163191752|NCT03650556|589417254|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
163191753|NCT03650556|589417254|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
163191754|NCT01500031|589417258|FG000|Overall Study|Death|1|||
163191755|NCT01500031|589417258|FG000|Overall Study|Withdrawal by Subject|4|||
163191756|NCT01147640|589417259|FG000|Overall Study|Adverse Event|2|||
163191757|NCT01147640|589417260|FG001|Overall Study|Adverse Event|0|||
163191758|NCT01147640|589417259|FG000|Overall Study|Physician Decision|1|||
163191759|NCT01147640|589417260|FG001|Overall Study|Physician Decision|0|||
163191760|NCT01147640|589417259|FG000|Overall Study|Withdrawal by Subject|1|||
163191761|NCT01147640|589417260|FG001|Overall Study|Withdrawal by Subject|0|||
163191762|NCT01147640|589417259|FG000|Overall Study|Lost to Follow-up|0|||
163191763|NCT01147640|589417260|FG001|Overall Study|Lost to Follow-up|1|||
163191764|NCT01147640|589417259|FG000|Overall Study|Didn't meet eligibility criteria|1|||
163191765|NCT01147640|589417260|FG001|Overall Study|Didn't meet eligibility criteria|0|||
163191766|NCT00091442|589417261|FG000|Overall Study|Progressive Disease|220|||
163191767|NCT00091442|589417262|FG001|Overall Study|Progressive Disease|189|||
163191768|NCT00091442|589417261|FG000|Overall Study|Physician Decision|61|||
163191769|NCT00091442|589417262|FG001|Overall Study|Physician Decision|58|||
163191770|NCT00091442|589417261|FG000|Overall Study|Withdrawal by Subject|38|||
163191771|NCT00091442|589417262|FG001|Overall Study|Withdrawal by Subject|46|||
163191772|NCT00091442|589417261|FG000|Overall Study|Adverse Event|29|||
163191773|NCT00091442|589417262|FG001|Overall Study|Adverse Event|48|||
163191774|NCT00091442|589417261|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
163191775|NCT00091442|589417262|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
163191776|NCT00091442|589417261|FG000|Overall Study|Death|9|||
163191777|NCT00091442|589417262|FG001|Overall Study|Death|7|||
163191778|NCT00091442|589417261|FG000|Overall Study|Lost to Follow-up|1|||
163191779|NCT00091442|589417262|FG001|Overall Study|Lost to Follow-up|3|||
163191780|NCT00091442|589417261|FG000|Overall Study|Other|2|||
163191781|NCT00091442|589417262|FG001|Overall Study|Other|6|||
163191782|NCT00917501|589417263|FG000|Overall Study|Lost to Follow-up|4|||
163191783|NCT00917501|589417264|FG001|Overall Study|Lost to Follow-up|1|||
163191784|NCT00917501|589417263|FG000|Overall Study|Withdrawal by Subject|3|||
163191785|NCT00917501|589417264|FG001|Overall Study|Withdrawal by Subject|1|||
163191786|NCT00917501|589417263|FG000|Overall Study|Lack of Efficacy|1|||
163191787|NCT00917501|589417264|FG001|Overall Study|Lack of Efficacy|2|||
163191788|NCT00917501|589417263|FG000|Overall Study|trouble swollowing capsules|0|||
163191789|NCT00917501|589417264|FG001|Overall Study|trouble swollowing capsules|1|||
163191790|NCT00986830|589417269|FG000|Overall Study|Death|1|||
163191791|NCT00986830|589417269|FG000|Overall Study|Lost to Follow-up|1|||
163191792|NCT00986830|589417269|FG000|Overall Study|Lack of Efficacy|1|||
163191793|NCT00986830|589417269|FG000|Overall Study|Unable to access sinus with device|5|||
163191794|NCT00845858|589417270|FG000|Overall Study|Withdrawal by Subject|5|||
163191795|NCT00845858|589417271|FG001|Overall Study|Withdrawal by Subject|1|||
163191796|NCT00845858|589417272|FG002|Overall Study|Withdrawal by Subject|1|||
163191797|NCT00845858|589417270|FG000|Overall Study|Adverse Event|3|||
163191798|NCT00845858|589417271|FG001|Overall Study|Adverse Event|8|||
163191799|NCT00845858|589417272|FG002|Overall Study|Adverse Event|4|||
163191800|NCT00845858|589417270|FG000|Overall Study|Protocol Violation|0|||
163191801|NCT00845858|589417271|FG001|Overall Study|Protocol Violation|0|||
163191802|NCT00845858|589417272|FG002|Overall Study|Protocol Violation|1|||
163191803|NCT00845858|589417270|FG000|Overall Study|not eligible|0|||
163191804|NCT00845858|589417271|FG001|Overall Study|not eligible|3|||
163191805|NCT00845858|589417272|FG002|Overall Study|not eligible|2|||
163191806|NCT00850070|589417273|FG000|Overall Study|Lack of Efficacy|1|||
163191807|NCT00850070|589417274|FG001|Overall Study|Lack of Efficacy|1|||
163191808|NCT00850070|589417273|FG000|Overall Study|Adverse Event|2|||
163191809|NCT00850070|589417274|FG001|Overall Study|Adverse Event|0|||
163191810|NCT00216476|589417279|FG000|Overall Study|Withdrawal by Subject|59|||
163191811|NCT00216476|589417280|FG001|Overall Study|Withdrawal by Subject|72|||
163391873|NCT01012739|590146197|FG001|Treatment Period 2|Abnormal test procedure results|0|||
163391874|NCT01012739|590146198|FG002|Treatment Period 2|Abnormal test procedure results|0|||
163391875|NCT01012739|590146199|FG003|Treatment Period 2|Abnormal test procedure results|1|||
163297835|NCT04532528|589799476|FG001|Overall Study|Withdrawal of consent|17|||
163297836|NCT04532528|589799475|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
163297837|NCT04532528|589799476|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
163297838|NCT04532528|589799475|FG000|Overall Study|Lost to Follow-up|69|||
163297839|NCT04532528|589799476|FG001|Overall Study|Lost to Follow-up|68|||
163297840|NCT04532528|589799475|FG000|Overall Study|Administrative problems|12|||
163297841|NCT04532528|589799476|FG001|Overall Study|Administrative problems|14|||
163297842|NCT04532528|589799475|FG000|Overall Study|Death|3|||
163297843|NCT04532528|589799476|FG001|Overall Study|Death|3|||
163297844|NCT04532528|589799475|FG000|Overall Study|Other|38|||
163297845|NCT04532528|589799476|FG001|Overall Study|Other|46|||
163297846|NCT00244855|589799481|FG000|Overall Study|Withdrawal by Subject|0|||
163297847|NCT00244855|589799482|FG001|Overall Study|Withdrawal by Subject|1|||
163297848|NCT00665444|589799483|FG000|Overall Study|Physician Decision|1|||
163297849|NCT00665444|589799483|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
163297850|NCT01068743|589799484|FG000|Period 3|Adverse Event|0|||
163297851|NCT01068743|589799485|FG001|Period 3|Adverse Event|1|||
163297852|NCT01068743|589799486|FG002|Period 3|Adverse Event|0|||
163297853|NCT01068743|589799487|FG003|Period 3|Adverse Event|0|||
163297854|NCT00293293|589799488|FG000|Overall Study|Withdrawal by Subject|1|||
163297855|NCT00293293|589799489|FG001|Overall Study|Withdrawal by Subject|1|||
163297856|NCT00293293|589799488|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
163297857|NCT00293293|589799489|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
163297858|NCT00293293|589799488|FG000|Overall Study|Patient discontinued chemotherapy|0|||
163297859|NCT00293293|589799489|FG001|Overall Study|Patient discontinued chemotherapy|1|||
163297860|NCT01061151|589799493|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
163297861|NCT01061151|589799494|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
163191812|NCT00216476|589417281|FG002|Overall Study|Withdrawal by Subject|9|||
163191813|NCT00216476|589417279|FG000|Overall Study|Lost to Follow-up|10|||
163191814|NCT00216476|589417280|FG001|Overall Study|Lost to Follow-up|9|||
163191815|NCT00216476|589417281|FG002|Overall Study|Lost to Follow-up|1|||
163191816|NCT00216476|589417279|FG000|Overall Study|Adverse Event|6|||
163191817|NCT00216476|589417280|FG001|Overall Study|Adverse Event|10|||
163191818|NCT00216476|589417281|FG002|Overall Study|Adverse Event|1|||
163191819|NCT00216476|589417279|FG000|Overall Study|Lack of Efficacy|4|||
163191820|NCT00216476|589417280|FG001|Overall Study|Lack of Efficacy|3|||
163191821|NCT00216476|589417281|FG002|Overall Study|Lack of Efficacy|0|||
163191822|NCT00216476|589417279|FG000|Overall Study|Death|2|||
163191823|NCT00216476|589417280|FG001|Overall Study|Death|0|||
163191824|NCT00216476|589417281|FG002|Overall Study|Death|0|||
163191825|NCT00216476|589417279|FG000|Overall Study|Pregnancy|0|||
163191826|NCT00216476|589417280|FG001|Overall Study|Pregnancy|1|||
163191827|NCT00216476|589417281|FG002|Overall Study|Pregnancy|1|||
163191828|NCT00216476|589417279|FG000|Overall Study|Other|0|||
163191829|NCT00216476|589417280|FG001|Overall Study|Other|0|||
163191830|NCT00216476|589417281|FG002|Overall Study|Other|1|||
163191831|NCT00216476|589417279|FG000|Overall Study|Refuses Injection|11|||
163191832|NCT00216476|589417280|FG001|Overall Study|Refuses Injection|0|||
163191833|NCT00216476|589417281|FG002|Overall Study|Refuses Injection|0|||
163191834|NCT00216476|589417279|FG000|Overall Study|No Further Need for Treatment|3|||
163191835|NCT00216476|589417280|FG001|Overall Study|No Further Need for Treatment|4|||
163191836|NCT00216476|589417281|FG002|Overall Study|No Further Need for Treatment|1|||
163191837|NCT00216476|589417279|FG000|Overall Study|Non-compliance|0|||
163191838|NCT00216476|589417280|FG001|Overall Study|Non-compliance|4|||
163191839|NCT00216476|589417281|FG002|Overall Study|Non-compliance|1|||
163191840|NCT00216476|589417279|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
163191841|NCT00216476|589417280|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
163191842|NCT00216476|589417281|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
163191843|NCT00216476|589417279|FG000|Overall Study|Administrative Reasons|1|||
163191844|NCT00216476|589417280|FG001|Overall Study|Administrative Reasons|1|||
163191845|NCT00216476|589417281|FG002|Overall Study|Administrative Reasons|0|||
163297862|NCT01061151|589799495|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
163297863|NCT01061151|589799496|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
163297864|NCT01061151|589799493|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
163297865|NCT01061151|589799494|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
163297866|NCT01061151|589799495|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
163297867|NCT01061151|589799496|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
163297868|NCT01061151|589799493|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
163297869|NCT01061151|589799494|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
163297870|NCT01061151|589799495|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
163297871|NCT01061151|589799496|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
163297872|NCT01061151|589799493|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
163297873|NCT01061151|589799494|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
163297874|NCT01061151|589799495|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
163297875|NCT01061151|589799496|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
163297876|NCT01061151|589799493|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
163297877|NCT01061151|589799494|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
163297878|NCT01061151|589799495|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
163297879|NCT01061151|589799496|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
163297880|NCT01061151|589799493|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
163297881|NCT01061151|589799494|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
163297882|NCT01061151|589799495|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
163297883|NCT01061151|589799496|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
163191846|NCT00216476|589417279|FG000|Overall Study|Protocol Deviation|5|||
163191847|NCT00216476|589417280|FG001|Overall Study|Protocol Deviation|1|||
163191848|NCT00216476|589417281|FG002|Overall Study|Protocol Deviation|0|||
163191849|NCT00216476|589417279|FG000|Overall Study|Patient Moved|2|||
163191850|NCT00216476|589417280|FG001|Overall Study|Patient Moved|2|||
163191851|NCT00216476|589417281|FG002|Overall Study|Patient Moved|0|||
163191852|NCT01522248|589417284|FG000|Overall Study|Lost to Follow-up|1|||
163191853|NCT01522248|589417285|FG001|Overall Study|Lost to Follow-up|0|||
163391876|NCT04540133|590146200|FG000|Overall Study|Lost to Follow-up|1|||
163391877|NCT04540133|590146201|FG001|Overall Study|Lost to Follow-up|0|||
163391878|NCT04014361|590146202|FG000|Period 2|Physician Decision|0|||
163391879|NCT04014361|590146203|FG001|Period 2|Physician Decision|0|||
163391880|NCT04014361|590146204|FG002|Period 2|Physician Decision|0|||
163391881|NCT04014361|590146205|FG003|Period 2|Physician Decision|1|||
163391882|NCT04014361|590146206|FG004|Period 2|Physician Decision|0|||
163391883|NCT04014361|590146207|FG005|Period 2|Physician Decision|0|||
163391884|NCT04014361|590146208|FG006|Period 2|Physician Decision|0|||
163391885|NCT04014361|590146209|FG007|Period 2|Physician Decision|0|||
163391886|NCT06308666|590146210|FG000|Overall Study|Withdrawal by Subject|1|||
163391887|NCT06308666|590146210|FG000|Overall Study|Protocol Violation|2|||
163391888|NCT04252287|590146212|FG000|Overall Study|Death|5|||
163391889|NCT04252287|590146213|FG001|Overall Study|Death|3|||
163391890|NCT04252287|590146212|FG000|Overall Study|Lost to Follow-up|4|||
163391891|NCT04252287|590146213|FG001|Overall Study|Lost to Follow-up|6|||
163391892|NCT04252287|590146212|FG000|Overall Study|Withdrawal by Subject|19|||
163391893|NCT04252287|590146213|FG001|Overall Study|Withdrawal by Subject|16|||
163391894|NCT04252287|590146212|FG000|Overall Study|Protocol Violation|3|||
163391895|NCT04252287|590146213|FG001|Overall Study|Protocol Violation|4|||
163391896|NCT00671554|590146221|FG000|Overall Study|Disease progression|3|||
163391897|NCT00447382|590146231|FG000|Overall Study|Adverse Event|1|||
163391898|NCT00447382|590146232|FG001|Overall Study|Adverse Event|1|||
163391899|NCT00447382|590146231|FG000|Overall Study|Lack of Efficacy|1|||
163391900|NCT00447382|590146232|FG001|Overall Study|Lack of Efficacy|0|||
163391901|NCT00447382|590146231|FG000|Overall Study|Protocol Violation|2|||
163391902|NCT00447382|590146232|FG001|Overall Study|Protocol Violation|0|||
163391903|NCT00447382|590146231|FG000|Overall Study|Unclassified|2|||
163391904|NCT00447382|590146232|FG001|Overall Study|Unclassified|5|||
163391905|NCT04600336|590146233|FG000|Initial Treatment|Withdrawal by Subject|1|||
163391906|NCT04600336|590146234|FG001|Initial Treatment|Withdrawal by Subject|2|||
163391907|NCT04600336|590146235|FG002|Initial Treatment|Withdrawal by Subject|0|||
163391908|NCT04600336|590146236|FG003|Initial Treatment|Withdrawal by Subject|0|||
163391909|NCT04600336|590146233|FG000|Initial Treatment|Adverse Event|0|||
163391910|NCT04600336|590146234|FG001|Initial Treatment|Adverse Event|2|||
163391911|NCT04600336|590146235|FG002|Initial Treatment|Adverse Event|0|||
163391912|NCT04600336|590146236|FG003|Initial Treatment|Adverse Event|0|||
163391913|NCT04600336|590146233|FG000|Initial Treatment|Other complicating disease|0|||
163391914|NCT04600336|590146234|FG001|Initial Treatment|Other complicating disease|0|||
163391915|NCT04600336|590146235|FG002|Initial Treatment|Other complicating disease|1|||
163391916|NCT04600336|590146236|FG003|Initial Treatment|Other complicating disease|0|||
163391917|NCT04600336|590146233|FG000|Crossover Treatment|Withdrawal by Subject|0|||
163391918|NCT04600336|590146234|FG001|Crossover Treatment|Withdrawal by Subject|0|||
163391919|NCT04600336|590146235|FG002|Crossover Treatment|Withdrawal by Subject|2|||
163391920|NCT04600336|590146236|FG003|Crossover Treatment|Withdrawal by Subject|1|||
163391921|NCT04600336|590146233|FG000|Crossover Treatment|Adverse Event|0|||
163391922|NCT04600336|590146234|FG001|Crossover Treatment|Adverse Event|0|||
163391923|NCT04600336|590146235|FG002|Crossover Treatment|Adverse Event|1|||
163391924|NCT04600336|590146236|FG003|Crossover Treatment|Adverse Event|1|||
163391925|NCT00977574|590146237|FG000|Overall Study|Never Treated|4|||
163391926|NCT00977574|590146238|FG001|Overall Study|Never Treated|2|||
163391927|NCT00977574|590146239|FG002|Overall Study|Never Treated|4|||
163391928|NCT04223791|590146240|FG000|Overall Study|Lost to Follow-up|0|||
163391929|NCT04223791|590146241|FG001|Overall Study|Lost to Follow-up|4|||
163391930|NCT04223791|590146240|FG000|Overall Study|Physician Decision|5|||
163391931|NCT04223791|590146241|FG001|Overall Study|Physician Decision|1|||
163391932|NCT04223791|590146240|FG000|Overall Study|Protocol Violation|1|||
163391933|NCT04223791|590146241|FG001|Overall Study|Protocol Violation|1|||
163391934|NCT04223791|590146240|FG000|Overall Study|Withdrawal by Subject|10|||
163391935|NCT04223791|590146241|FG001|Overall Study|Withdrawal by Subject|12|||
163391936|NCT04223791|590146240|FG000|Overall Study|Pregnancy|1|||
163391937|NCT04223791|590146241|FG001|Overall Study|Pregnancy|1|||
163391938|NCT04223791|590146240|FG000|Overall Study|Ongoing in Study|305|||
163391939|NCT04223791|590146241|FG001|Overall Study|Ongoing in Study|302|||
163391940|NCT03829241|590148067|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
163391941|NCT03829241|590148068|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
163391942|NCT03829241|590148067|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
163391943|NCT03829241|590148068|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
163391944|NCT03829241|590148067|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
163391945|NCT03829241|590148068|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
163391946|NCT03829241|590148067|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
163391947|NCT03829241|590148068|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
163391948|NCT03829241|590148067|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
163391949|NCT03829241|590148068|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
163391950|NCT03829241|590148067|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
163391951|NCT03829241|590148068|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
163391952|NCT03829241|590148067|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
163391953|NCT03829241|590148068|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
163391954|NCT03829241|590148067|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
163391955|NCT03829241|590148068|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
163391956|NCT03829241|590148067|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
163391957|NCT03829241|590148068|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
163391958|NCT03829241|590148067|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
163391959|NCT03829241|590148068|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
163391960|NCT03829241|590148067|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
163391961|NCT03829241|590148068|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
163391962|NCT03829241|590148067|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
163391963|NCT03829241|590148068|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
163391964|NCT03829241|590148067|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
163191854|NCT02191137|589417287|FG000|Treatment|Death|4|||
163191855|NCT02191137|589417287|FG000|Treatment|Withdrawal by Subject|3|||
163191856|NCT02191137|589417287|FG000|Treatment|Adverse Event|2|||
163191857|NCT02191137|589417287|FG000|Treatment|Other|1|||
163191858|NCT02191137|589417287|FG000|Follow-up|Lost to Follow-up|2|||
163191859|NCT02191137|589417287|FG000|Follow-up|Ongoing/unknown|2|||
163191860|NCT02191137|589417287|FG000|Follow-up|Adverse Event|1|||
163191861|NCT01332331|589417288|FG000|Overall Study|Lost to Follow-up|0|||
163191862|NCT01332331|589417289|FG001|Overall Study|Lost to Follow-up|1|||
163191863|NCT01332331|589417288|FG000|Overall Study|Adverse Event|1|||
163191864|NCT01332331|589417289|FG001|Overall Study|Adverse Event|1|||
163191865|NCT01332331|589417288|FG000|Overall Study|Physician Decision|1|||
163191866|NCT01332331|589417289|FG001|Overall Study|Physician Decision|0|||
163191867|NCT00538291|589417290|FG000|Overall Study|Adverse Event|2|||
163191868|NCT00538291|589417290|FG000|Overall Study|Withdrawal by Subject|1|||
163191869|NCT00694707|589417291|FG000|Overall Study|Did Not Receive Treatment|0|||
163191870|NCT00694707|589417292|FG001|Overall Study|Did Not Receive Treatment|0|||
163191871|NCT00694707|589417293|FG002|Overall Study|Did Not Receive Treatment|1|||
163191872|NCT00694707|589417294|FG003|Overall Study|Did Not Receive Treatment|1|||
163191873|NCT00694707|589417295|FG004|Overall Study|Did Not Receive Treatment|1|||
163191874|NCT00694707|589417291|FG000|Overall Study|Adverse Event|22|||
163191875|NCT00694707|589417292|FG001|Overall Study|Adverse Event|14|||
163191876|NCT00694707|589417293|FG002|Overall Study|Adverse Event|8|||
163191877|NCT00694707|589417294|FG003|Overall Study|Adverse Event|12|||
163191878|NCT00694707|589417295|FG004|Overall Study|Adverse Event|13|||
163191879|NCT00694707|589417291|FG000|Overall Study|Insufficient Therapeutic Response|33|||
163191880|NCT00694707|589417292|FG001|Overall Study|Insufficient Therapeutic Response|18|||
163191881|NCT00694707|589417293|FG002|Overall Study|Insufficient Therapeutic Response|17|||
163191882|NCT00694707|589417294|FG003|Overall Study|Insufficient Therapeutic Response|15|||
163191883|NCT00694707|589417295|FG004|Overall Study|Insufficient Therapeutic Response|10|||
163191884|NCT00694707|589417291|FG000|Overall Study|Protocol Violation|1|||
163191885|NCT00694707|589417292|FG001|Overall Study|Protocol Violation|2|||
163191886|NCT00694707|589417293|FG002|Overall Study|Protocol Violation|1|||
163191887|NCT00694707|589417294|FG003|Overall Study|Protocol Violation|3|||
163191888|NCT00694707|589417295|FG004|Overall Study|Protocol Violation|1|||
163191889|NCT00694707|589417291|FG000|Overall Study|Withdrawal of Consent|14|||
163191890|NCT00694707|589417292|FG001|Overall Study|Withdrawal of Consent|18|||
163191891|NCT00694707|589417293|FG002|Overall Study|Withdrawal of Consent|22|||
163191892|NCT00694707|589417294|FG003|Overall Study|Withdrawal of Consent|16|||
163191893|NCT00694707|589417295|FG004|Overall Study|Withdrawal of Consent|15|||
163191894|NCT00694707|589417291|FG000|Overall Study|Lost to Follow-up|0|||
163191895|NCT00694707|589417292|FG001|Overall Study|Lost to Follow-up|1|||
163191896|NCT00694707|589417293|FG002|Overall Study|Lost to Follow-up|2|||
163191897|NCT00694707|589417294|FG003|Overall Study|Lost to Follow-up|0|||
163191898|NCT00694707|589417295|FG004|Overall Study|Lost to Follow-up|0|||
163191899|NCT00694707|589417291|FG000|Overall Study|Jeopardizing Parole Status|1|||
163191900|NCT00694707|589417292|FG001|Overall Study|Jeopardizing Parole Status|0|||
163191901|NCT00694707|589417293|FG002|Overall Study|Jeopardizing Parole Status|0|||
163191902|NCT00694707|589417294|FG003|Overall Study|Jeopardizing Parole Status|0|||
163191903|NCT00694707|589417295|FG004|Overall Study|Jeopardizing Parole Status|0|||
163191904|NCT00694707|589417291|FG000|Overall Study|Death in the Family|1|||
163191905|NCT00694707|589417292|FG001|Overall Study|Death in the Family|0|||
163191906|NCT00694707|589417293|FG002|Overall Study|Death in the Family|0|||
163191907|NCT00694707|589417294|FG003|Overall Study|Death in the Family|0|||
163191908|NCT00694707|589417295|FG004|Overall Study|Death in the Family|0|||
163191909|NCT00694707|589417291|FG000|Overall Study|Arrest by Police|0|||
163191910|NCT00694707|589417292|FG001|Overall Study|Arrest by Police|1|||
163191911|NCT00694707|589417293|FG002|Overall Study|Arrest by Police|0|||
163191912|NCT00694707|589417294|FG003|Overall Study|Arrest by Police|0|||
163191913|NCT00694707|589417295|FG004|Overall Study|Arrest by Police|0|||
163191914|NCT00694707|589417291|FG000|Overall Study|Administrative Reasons|0|||
163191915|NCT00694707|589417292|FG001|Overall Study|Administrative Reasons|1|||
163191916|NCT00694707|589417293|FG002|Overall Study|Administrative Reasons|0|||
163191917|NCT00694707|589417294|FG003|Overall Study|Administrative Reasons|2|||
163191918|NCT00694707|589417295|FG004|Overall Study|Administrative Reasons|0|||
163391965|NCT03829241|590148068|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
163391966|NCT03829241|590148067|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
163391967|NCT03829241|590148068|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
163391968|NCT02224599|590148069|FG000|Overall Study|Physician Decision|1|||
163297884|NCT01061151|589799493|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
163297885|NCT01061151|589799494|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
163297886|NCT01061151|589799495|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
163297887|NCT01061151|589799496|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
163297888|NCT01061151|589799493|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
163297889|NCT01061151|589799494|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
163391969|NCT02224599|590148069|FG000|Overall Study|Progression of Disease|1|||
163391970|NCT02315898|590148072|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
163391971|NCT02315898|590148073|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
163391972|NCT02315898|590148074|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
163391973|NCT02315898|590148075|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
163391974|NCT01330914|590148076|FG000|Overall Study|Withdrawal by Subject|4|||
163391975|NCT01330914|590148076|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
163391976|NCT02445755|590148079|FG000|Overall Study|Withdrawal by Subject|2|||
163391977|NCT02445755|590148079|FG000|Overall Study|Protocol Violation|6|||
163391978|NCT02445755|590148079|FG000|Overall Study|Screen Failure|5|||
163297890|NCT01061151|589799495|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
163297891|NCT01061151|589799496|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
163391979|NCT03239483|590148080|FG000|Overall Study|Lost to Follow-up|1|||
163391980|NCT03239483|590148081|FG001|Overall Study|Lost to Follow-up|0|||
163391981|NCT03239483|590148080|FG000|Overall Study|Withdrawal by Subject|1|||
163391982|NCT03239483|590148081|FG001|Overall Study|Withdrawal by Subject|0|||
163391983|NCT05352048|590148082|FG000|Overall Study|Lost to Follow-up|1|||
163391984|NCT05352048|590148082|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
163391985|NCT03678103|590148092|FG000|Overall Study|Withdrawn prior to completion|4|||
163391986|NCT01674712|590148096|FG000|Overall Study|Adverse Event|5|||
163391987|NCT01674712|590148097|FG001|Overall Study|Adverse Event|6|||
163391988|NCT01674712|590148098|FG002|Overall Study|Adverse Event|3|||
163391989|NCT01674712|590148099|FG003|Overall Study|Adverse Event|4|||
163391990|NCT01674712|590148100|FG004|Overall Study|Adverse Event|6|||
163391991|NCT01674712|590148096|FG000|Overall Study|Lost to Follow-up|1|||
163391992|NCT01674712|590148097|FG001|Overall Study|Lost to Follow-up|0|||
163391993|NCT01674712|590148098|FG002|Overall Study|Lost to Follow-up|0|||
163391994|NCT01674712|590148099|FG003|Overall Study|Lost to Follow-up|0|||
163391995|NCT01674712|590148100|FG004|Overall Study|Lost to Follow-up|0|||
163391996|NCT01674712|590148096|FG000|Overall Study|Protocol Violation|2|||
163391997|NCT01674712|590148097|FG001|Overall Study|Protocol Violation|0|||
163391998|NCT01674712|590148098|FG002|Overall Study|Protocol Violation|0|||
163391999|NCT01674712|590148099|FG003|Overall Study|Protocol Violation|0|||
163392000|NCT01674712|590148100|FG004|Overall Study|Protocol Violation|0|||
163392001|NCT01674712|590148096|FG000|Overall Study|Withdrawal by Subject|2|||
163392002|NCT01674712|590148097|FG001|Overall Study|Withdrawal by Subject|2|||
163392003|NCT01674712|590148098|FG002|Overall Study|Withdrawal by Subject|5|||
163392004|NCT01674712|590148099|FG003|Overall Study|Withdrawal by Subject|4|||
163392005|NCT01674712|590148100|FG004|Overall Study|Withdrawal by Subject|3|||
163392006|NCT01674712|590148096|FG000|Overall Study|Administrative|0|||
163392007|NCT01674712|590148097|FG001|Overall Study|Administrative|1|||
163392008|NCT01674712|590148098|FG002|Overall Study|Administrative|0|||
163392009|NCT01674712|590148099|FG003|Overall Study|Administrative|0|||
163392010|NCT01674712|590148100|FG004|Overall Study|Administrative|1|||
163392011|NCT01674712|590148096|FG000|Overall Study|Lack of Efficacy|0|||
163392012|NCT01674712|590148097|FG001|Overall Study|Lack of Efficacy|0|||
163392013|NCT01674712|590148098|FG002|Overall Study|Lack of Efficacy|1|||
163392014|NCT01674712|590148099|FG003|Overall Study|Lack of Efficacy|0|||
163392015|NCT01674712|590148100|FG004|Overall Study|Lack of Efficacy|1|||
163392016|NCT00056862|590148101|FG000|Overall Study|Protocol Violation|1|||
163392017|NCT00056862|590148102|FG001|Overall Study|Protocol Violation|0|||
163392018|NCT00381563|590148107|FG000|Overall Study|Withdrawal by Subject|5|||
163392019|NCT00381563|590148108|FG001|Overall Study|Withdrawal by Subject|5|||
163297892|NCT01061151|589799493|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
163297893|NCT01061151|589799494|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
163297894|NCT01061151|589799495|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
163297895|NCT01061151|589799496|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
163297896|NCT01061151|589799493|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
163297897|NCT01061151|589799494|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
163297898|NCT01061151|589799495|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
163297899|NCT01061151|589799496|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
163297900|NCT01061151|589799493|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
163297901|NCT01061151|589799494|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
163297902|NCT01061151|589799495|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
163297903|NCT01061151|589799496|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
163297904|NCT01061151|589799493|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
163297905|NCT01061151|589799494|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
163297906|NCT01061151|589799495|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
163297907|NCT01061151|589799496|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
163297908|NCT01061151|589799493|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
163297909|NCT01061151|589799494|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
163297910|NCT01061151|589799495|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
163297911|NCT01061151|589799496|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
163392020|NCT00381563|590148107|FG000|Overall Study|Lost to Follow-up|2|||
163392021|NCT00381563|590148108|FG001|Overall Study|Lost to Follow-up|0|||
163392022|NCT00381563|590148107|FG000|Overall Study|Protocol Violation|0|||
163392023|NCT00381563|590148108|FG001|Overall Study|Protocol Violation|1|||
163392024|NCT00024167|590148109|FG000|Overall Study|Death|53|||
163392025|NCT00024167|590148110|FG001|Overall Study|Death|47|||
163392026|NCT01109173|590148111|FG000|Overall Study|Adverse Event|15|||
163392027|NCT01109173|590148112|FG001|Overall Study|Adverse Event|17|||
163392028|NCT01109173|590148113|FG002|Overall Study|Adverse Event|9|||
163392029|NCT01109173|590148114|FG003|Overall Study|Adverse Event|6|||
163392030|NCT01109173|590148111|FG000|Overall Study|Lost to Follow-up|0|||
163392031|NCT01109173|590148112|FG001|Overall Study|Lost to Follow-up|1|||
163392032|NCT01109173|590148113|FG002|Overall Study|Lost to Follow-up|0|||
163392033|NCT01109173|590148114|FG003|Overall Study|Lost to Follow-up|0|||
163392034|NCT01109173|590148111|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
163392035|NCT01109173|590148112|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
163392036|NCT01109173|590148113|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
163392037|NCT01109173|590148114|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
163392038|NCT01109173|590148111|FG000|Overall Study|Noncompliance|0|||
163392039|NCT01109173|590148112|FG001|Overall Study|Noncompliance|1|||
163392040|NCT01109173|590148113|FG002|Overall Study|Noncompliance|0|||
163392041|NCT01109173|590148114|FG003|Overall Study|Noncompliance|0|||
163392042|NCT01109173|590148111|FG000|Overall Study|Treatment Failure|25|||
163392043|NCT01109173|590148112|FG001|Overall Study|Treatment Failure|32|||
163392044|NCT01109173|590148113|FG002|Overall Study|Treatment Failure|69|||
163392045|NCT01109173|590148114|FG003|Overall Study|Treatment Failure|64|||
163297912|NCT01061151|589799493|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
163297913|NCT01061151|589799494|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
163297914|NCT01061151|589799495|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
163297915|NCT01061151|589799496|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
163297916|NCT01061151|589799493|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
163297917|NCT01061151|589799494|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
163392046|NCT01109173|590148111|FG000|Overall Study|Protocol Violation|4|||
163392047|NCT01109173|590148112|FG001|Overall Study|Protocol Violation|5|||
163392048|NCT01109173|590148113|FG002|Overall Study|Protocol Violation|1|||
163392049|NCT01109173|590148114|FG003|Overall Study|Protocol Violation|2|||
163392050|NCT01109173|590148111|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
163392051|NCT01109173|590148112|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
163297918|NCT01061151|589799495|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
163297919|NCT01061151|589799496|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
163297920|NCT03740009|589799497|FG000|Overall Study|Physician Decision|9|||
163297921|NCT03740009|589799497|FG000|Overall Study|Lost to Follow-up|1|||
163297922|NCT01236001|589799498|FG000|Overall Study|Adverse Event|5|||
163297923|NCT01236001|589799499|FG001|Overall Study|Adverse Event|14|||
163297924|NCT01236001|589799498|FG000|Overall Study|Lack of Efficacy|6|||
163297925|NCT01236001|589799499|FG001|Overall Study|Lack of Efficacy|6|||
163297926|NCT01236001|589799498|FG000|Overall Study|Lost to Follow-up|6|||
163297927|NCT01236001|589799499|FG001|Overall Study|Lost to Follow-up|1|||
163297928|NCT01236001|589799498|FG000|Overall Study|Incompliance|1|||
163297929|NCT01236001|589799499|FG001|Overall Study|Incompliance|0|||
163297930|NCT01236001|589799498|FG000|Overall Study|Planned Visit After End of Study|0|||
163297931|NCT01236001|589799499|FG001|Overall Study|Planned Visit After End of Study|1|||
163297932|NCT01414738|589799508|FG000|Overall Study|Death|26|||
163297933|NCT01414738|589799508|FG000|Overall Study|Refused testing|5|||
163297934|NCT01414738|589799508|FG000|Overall Study|Lost to Follow-up|2|||
163297935|NCT01414738|589799508|FG000|Overall Study|Refused, disease progression|8|||
163297936|NCT01414738|589799508|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
163297937|NCT01266122|589799509|FG000|Overall Study|Lost to Follow-up|6|||
163297938|NCT01266122|589799510|FG001|Overall Study|Lost to Follow-up|6|||
163297939|NCT03756571|589799511|FG000|Overall Study|Lost to Follow-up|1|||
163297940|NCT03756571|589799512|FG001|Overall Study|Lost to Follow-up|1|||
163297941|NCT02379819|589799513|FG000|Overall Study|Withdrawal by Subject|10|||
163297942|NCT02379819|589799513|FG000|Overall Study|Death|2|||
163297943|NCT02379819|589799513|FG000|Overall Study|Lack of Efficacy|1|||
163297944|NCT02379819|589799513|FG000|Overall Study|Lost to Follow-up|1|||
163297945|NCT00529516|589799514|FG000|Overall Study|Adverse Event|2|||
163297946|NCT00529516|589799515|FG001|Overall Study|Adverse Event|1|||
163297947|NCT00529516|589799516|FG002|Overall Study|Adverse Event|0|||
163297948|NCT00529516|589799514|FG000|Overall Study|Withdrawal by Subject|1|||
163297949|NCT00529516|589799515|FG001|Overall Study|Withdrawal by Subject|1|||
163297950|NCT00529516|589799516|FG002|Overall Study|Withdrawal by Subject|0|||
163297951|NCT00529516|589799514|FG000|Overall Study|Lost to Follow-up|0|||
163297952|NCT00529516|589799515|FG001|Overall Study|Lost to Follow-up|0|||
163297953|NCT00529516|589799516|FG002|Overall Study|Lost to Follow-up|1|||
163297954|NCT03752151|589799517|FG000|Overall Study|Withdrawal by Subject|1|||
163297955|NCT03752151|589799517|FG000|Overall Study|Protocol Violation|1|||
163297956|NCT04056624|589799518|FG000|Overall Study|Withdrawal by Subject|0|||
163297957|NCT04056624|589799519|FG001|Overall Study|Withdrawal by Subject|0|||
163297958|NCT04056624|589799520|FG002|Overall Study|Withdrawal by Subject|1|||
163297959|NCT04056624|589799518|FG000|Overall Study|Protocol Violation|1|||
163297960|NCT04056624|589799519|FG001|Overall Study|Protocol Violation|2|||
163297961|NCT04056624|589799520|FG002|Overall Study|Protocol Violation|0|||
163297962|NCT00703820|589799524|FG000|Overall Study|Adverse Event|12|||
163297963|NCT00703820|589799525|FG001|Overall Study|Adverse Event|17|||
163297964|NCT00703820|589799524|FG000|Overall Study|Death|5|||
163191919|NCT00694707|589417291|FG000|Overall Study|Notification of Past Head Injury|0|||
163191920|NCT00694707|589417292|FG001|Overall Study|Notification of Past Head Injury|0|||
163191921|NCT00694707|589417293|FG002|Overall Study|Notification of Past Head Injury|0|||
163191922|NCT00694707|589417294|FG003|Overall Study|Notification of Past Head Injury|1|||
163191923|NCT00694707|589417295|FG004|Overall Study|Notification of Past Head Injury|0|||
163191924|NCT03096483|589417296|FG000|Overall Study|Withdrawal by site|1|||
163191925|NCT00369707|589417298|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
163191926|NCT00369707|589417298|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
163191927|NCT00369707|589417298|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
163191928|NCT00369707|589417298|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
163191929|NCT00369707|589417298|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
163191930|NCT00369707|589417298|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
163191931|NCT00369707|589417298|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
163191932|NCT00369707|589417298|FG000|Follow up for 2 Years After Treatment|Death|1|||
163191933|NCT00369707|589417298|FG000|Follow up for 2 Years After Treatment|Other|2|||
163191934|NCT05224141|589417299|FG000|Overall Study|Ongoing|75|||
163191935|NCT05224141|589417300|FG001|Overall Study|Ongoing|88|||
163191936|NCT05224141|589417299|FG000|Overall Study|Withdrawal by Subject|2|||
163191937|NCT05224141|589417300|FG001|Overall Study|Withdrawal by Subject|4|||
163191938|NCT05224141|589417299|FG000|Overall Study|Death|153|||
163191939|NCT05224141|589417300|FG001|Overall Study|Death|138|||
163191940|NCT02046733|589417301|FG000|Overall Study|never initiated 'treatment visits'|6|||
163191941|NCT02046733|589417302|FG001|Overall Study|never initiated 'treatment visits'|0|||
163191942|NCT04515394|589417313|FG000|Overall Study|Participant did not receive treatment|1|||
163191943|NCT00199875|589417314|FG000|Overall Study|Withdrawal by Subject|0|||
163191944|NCT00199875|589417315|FG001|Overall Study|Withdrawal by Subject|0|||
163191945|NCT00199875|589417316|FG002|Overall Study|Withdrawal by Subject|0|||
163191946|NCT00199875|589417317|FG003|Overall Study|Withdrawal by Subject|0|||
163297965|NCT00703820|589799525|FG001|Overall Study|Death|0|||
163191947|NCT00199875|589417318|FG004|Overall Study|Withdrawal by Subject|1|||
163191948|NCT01691898|589417320|FG000|Overall Study|Death|34|||
163191949|NCT01691898|589417321|FG001|Overall Study|Death|32|||
163191950|NCT01691898|589417322|FG002|Overall Study|Death|6|||
163191951|NCT01691898|589417323|FG003|Overall Study|Death|3|||
163191952|NCT01691898|589417324|FG004|Overall Study|Death|8|||
163191953|NCT01691898|589417325|FG005|Overall Study|Death|31|||
163191954|NCT01691898|589417320|FG000|Overall Study|Adverse Event|0|||
163191955|NCT01691898|589417321|FG001|Overall Study|Adverse Event|1|||
163191956|NCT01691898|589417322|FG002|Overall Study|Adverse Event|0|||
163191957|NCT01691898|589417323|FG003|Overall Study|Adverse Event|1|||
163191958|NCT01691898|589417324|FG004|Overall Study|Adverse Event|1|||
163191959|NCT01691898|589417325|FG005|Overall Study|Adverse Event|0|||
163297966|NCT00703820|589799524|FG000|Overall Study|Lack of Efficacy|11|||
163392052|NCT01109173|590148113|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
163392053|NCT01109173|590148114|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
163392054|NCT01109173|590148111|FG000|Overall Study|Not Specifiied|5|||
163392055|NCT01109173|590148112|FG001|Overall Study|Not Specifiied|4|||
163392056|NCT01109173|590148113|FG002|Overall Study|Not Specifiied|9|||
163392057|NCT01109173|590148114|FG003|Overall Study|Not Specifiied|14|||
163392058|NCT01132612|590148118|FG000|Overall Study|Death|0|||
163392059|NCT01132612|590148119|FG001|Overall Study|Death|0|||
163392060|NCT01132612|590148120|FG002|Overall Study|Death|1|||
163392061|NCT01132612|590148118|FG000|Overall Study|Protocol deviation|0|||
163392062|NCT01132612|590148119|FG001|Overall Study|Protocol deviation|0|||
163392063|NCT01132612|590148120|FG002|Overall Study|Protocol deviation|3|||
163392064|NCT01132612|590148118|FG000|Overall Study|Lost to Follow-up|2|||
163392065|NCT01132612|590148119|FG001|Overall Study|Lost to Follow-up|2|||
163392066|NCT01132612|590148120|FG002|Overall Study|Lost to Follow-up|7|||
163392067|NCT01132612|590148118|FG000|Overall Study|Adverse Event|5|||
163392068|NCT01132612|590148119|FG001|Overall Study|Adverse Event|2|||
163392069|NCT01132612|590148120|FG002|Overall Study|Adverse Event|15|||
163392070|NCT01132612|590148118|FG000|Overall Study|Withdrawal by Subject|5|||
163392071|NCT01132612|590148119|FG001|Overall Study|Withdrawal by Subject|8|||
163392072|NCT01132612|590148120|FG002|Overall Study|Withdrawal by Subject|19|||
163392073|NCT01132612|590148118|FG000|Overall Study|Administrative problems|5|||
163392074|NCT01132612|590148119|FG001|Overall Study|Administrative problems|1|||
163392075|NCT01132612|590148120|FG002|Overall Study|Administrative problems|52|||
163392076|NCT01132612|590148118|FG000|Overall Study|Lack of Efficacy|23|||
163392077|NCT01132612|590148119|FG001|Overall Study|Lack of Efficacy|22|||
163392078|NCT01132612|590148120|FG002|Overall Study|Lack of Efficacy|73|||
163392079|NCT02252536|590148122|FG000|Overall Study|Lost to Follow-up|5|||
163392080|NCT02252536|590148123|FG001|Overall Study|Lost to Follow-up|3|||
163392081|NCT01438151|590148124|FG000|Overall Study|study terminated|8|||
163392082|NCT00006392|590148133|FG000|Overall Study|Ineligible|11|||
163392083|NCT00006392|590148134|FG001|Overall Study|Ineligible|3|||
163392084|NCT00006392|590148135|FG002|Overall Study|Ineligible|5|||
163392085|NCT00006392|590148136|FG003|Overall Study|Ineligible|5|||
163392086|NCT00006392|590148133|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
163392087|NCT00006392|590148134|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
163392088|NCT00006392|590148135|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
163392089|NCT00006392|590148136|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
163392090|NCT02459769|590148138|FG000|Overall Study|Withdrawal by Subject|7|||
163392091|NCT02459769|590148139|FG001|Overall Study|Withdrawal by Subject|4|||
163392092|NCT02459769|590148140|FG002|Overall Study|Withdrawal by Subject|8|||
163392093|NCT02459769|590148141|FG003|Overall Study|Withdrawal by Subject|5|||
163392094|NCT02459769|590148138|FG000|Overall Study|Lost to Follow-up|1|||
163392095|NCT02459769|590148139|FG001|Overall Study|Lost to Follow-up|0|||
163392096|NCT02459769|590148140|FG002|Overall Study|Lost to Follow-up|1|||
163392097|NCT02459769|590148141|FG003|Overall Study|Lost to Follow-up|0|||
163392098|NCT01186796|590148142|FG000|Overall Study|Adverse Event|3|||
163392099|NCT01186796|590148143|FG001|Overall Study|Adverse Event|0|||
163392100|NCT01186796|590148142|FG000|Overall Study|Withdrawal by Subject|1|||
163392101|NCT01186796|590148143|FG001|Overall Study|Withdrawal by Subject|1|||
163392102|NCT01186796|590148142|FG000|Overall Study|Protocol Violation|0|||
163392103|NCT01186796|590148143|FG001|Overall Study|Protocol Violation|1|||
163392104|NCT03838198|590148145|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
163392105|NCT03838198|590148146|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
163392106|NCT03838198|590148147|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
163392107|NCT03838198|590148148|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
163392108|NCT03838198|590148145|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
163392109|NCT03838198|590148146|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
163392110|NCT03838198|590148147|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
163392111|NCT03838198|590148148|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
163392112|NCT02378220|590148152|FG000|Overall Study|Death|6|||
163392113|NCT02378220|590148153|FG001|Overall Study|Death|1|||
163392114|NCT00578786|590148154|FG000|Overall Study|Adverse Event|27|||
163392115|NCT00578786|590148155|FG001|Overall Study|Adverse Event|37|||
163392116|NCT00578786|590148156|FG002|Overall Study|Adverse Event|17|||
163392117|NCT00578786|590148154|FG000|Overall Study|Lack of Efficacy|2|||
163392118|NCT00578786|590148155|FG001|Overall Study|Lack of Efficacy|5|||
163392119|NCT00578786|590148156|FG002|Overall Study|Lack of Efficacy|2|||
163392120|NCT00578786|590148154|FG000|Overall Study|Early Escape from Prior Study|2|||
163392121|NCT00578786|590148155|FG001|Overall Study|Early Escape from Prior Study|1|||
163392122|NCT00578786|590148156|FG002|Overall Study|Early Escape from Prior Study|2|||
163392123|NCT00578786|590148154|FG000|Overall Study|Withdrawal by Subject|7|||
163392124|NCT00578786|590148155|FG001|Overall Study|Withdrawal by Subject|8|||
163392125|NCT00578786|590148156|FG002|Overall Study|Withdrawal by Subject|5|||
163392126|NCT00578786|590148154|FG000|Overall Study|Protocol Violation|0|||
163392127|NCT00578786|590148155|FG001|Overall Study|Protocol Violation|3|||
163392128|NCT00578786|590148156|FG002|Overall Study|Protocol Violation|1|||
163392129|NCT00578786|590148154|FG000|Overall Study|Physician Decision|1|||
163392130|NCT00578786|590148155|FG001|Overall Study|Physician Decision|0|||
163392131|NCT00578786|590148156|FG002|Overall Study|Physician Decision|1|||
163191960|NCT01691898|589417320|FG000|Overall Study|Progression of Disease|1|||
163191961|NCT01691898|589417321|FG001|Overall Study|Progression of Disease|2|||
163191962|NCT01691898|589417322|FG002|Overall Study|Progression of Disease|1|||
163191963|NCT01691898|589417323|FG003|Overall Study|Progression of Disease|0|||
163392132|NCT00578786|590148154|FG000|Overall Study|Sponsor Decision|0|||
163392133|NCT00578786|590148155|FG001|Overall Study|Sponsor Decision|0|||
163392134|NCT00578786|590148156|FG002|Overall Study|Sponsor Decision|1|||
163392135|NCT00578786|590148154|FG000|Overall Study|Lost to Follow-up|0|||
163392136|NCT00578786|590148155|FG001|Overall Study|Lost to Follow-up|4|||
163392137|NCT00578786|590148156|FG002|Overall Study|Lost to Follow-up|0|||
163392138|NCT00578786|590148154|FG000|Overall Study|Pregnancy|0|||
163392139|NCT00578786|590148155|FG001|Overall Study|Pregnancy|1|||
163392140|NCT00578786|590148156|FG002|Overall Study|Pregnancy|0|||
163392141|NCT00578786|590148154|FG000|Overall Study|Not Otherwise Specified|0|||
163392142|NCT00578786|590148155|FG001|Overall Study|Not Otherwise Specified|4|||
163392143|NCT00578786|590148156|FG002|Overall Study|Not Otherwise Specified|1|||
163392144|NCT00578786|590148154|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
163392145|NCT00578786|590148155|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
163392146|NCT00578786|590148156|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
163392147|NCT00312221|590148157|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
163392148|NCT00312221|590148158|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
163392149|NCT00312221|590148159|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
163392150|NCT00312221|590148160|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
163392151|NCT00312221|590148157|FG000|Open-label Run-in Period|Adverse Event|74|||
163392152|NCT00312221|590148158|FG001|Open-label Run-in Period|Adverse Event|0|||
163392153|NCT00312221|590148159|FG002|Open-label Run-in Period|Adverse Event|0|||
163392154|NCT00312221|590148160|FG003|Open-label Run-in Period|Adverse Event|0|||
163392155|NCT00312221|590148157|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
163392156|NCT00312221|590148158|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
163392157|NCT00312221|590148159|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
163191964|NCT01691898|589417324|FG004|Overall Study|Progression of Disease|0|||
163191965|NCT01691898|589417325|FG005|Overall Study|Progression of Disease|1|||
163191966|NCT01691898|589417320|FG000|Overall Study|Lost to Follow-up|3|||
163191967|NCT01691898|589417321|FG001|Overall Study|Lost to Follow-up|1|||
163191968|NCT01691898|589417322|FG002|Overall Study|Lost to Follow-up|0|||
163191969|NCT01691898|589417323|FG003|Overall Study|Lost to Follow-up|0|||
163191970|NCT01691898|589417324|FG004|Overall Study|Lost to Follow-up|1|||
163191971|NCT01691898|589417325|FG005|Overall Study|Lost to Follow-up|0|||
163191972|NCT01691898|589417320|FG000|Overall Study|Withdrawal by Subject|9|||
163191973|NCT01691898|589417321|FG001|Overall Study|Withdrawal by Subject|8|||
163191974|NCT01691898|589417322|FG002|Overall Study|Withdrawal by Subject|2|||
163191975|NCT01691898|589417323|FG003|Overall Study|Withdrawal by Subject|1|||
163191976|NCT01691898|589417324|FG004|Overall Study|Withdrawal by Subject|3|||
163191977|NCT01691898|589417325|FG005|Overall Study|Withdrawal by Subject|3|||
163392158|NCT00312221|590148160|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
163392159|NCT00312221|590148157|FG000|Open-label Run-in Period|Administrative|42|||
163392160|NCT00312221|590148158|FG001|Open-label Run-in Period|Administrative|0|||
163392161|NCT00312221|590148159|FG002|Open-label Run-in Period|Administrative|0|||
163392162|NCT00312221|590148160|FG003|Open-label Run-in Period|Administrative|0|||
163191978|NCT01691898|589417320|FG000|Overall Study|Non-Compliance|0|||
163191979|NCT01691898|589417321|FG001|Overall Study|Non-Compliance|0|||
163392163|NCT00312221|590148157|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
163392164|NCT00312221|590148158|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
163392165|NCT00312221|590148159|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
163392166|NCT00312221|590148160|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
163392167|NCT00312221|590148157|FG000|Open-label Run-in Period|Did not qualify|5|||
163392168|NCT00312221|590148158|FG001|Open-label Run-in Period|Did not qualify|0|||
163191980|NCT01691898|589417322|FG002|Overall Study|Non-Compliance|0|||
163392169|NCT00312221|590148159|FG002|Open-label Run-in Period|Did not qualify|0|||
163392170|NCT00312221|590148160|FG003|Open-label Run-in Period|Did not qualify|0|||
163392171|NCT00312221|590148157|FG000|Double-blind Phase|Withdrawal by Subject|0|||
163392172|NCT00312221|590148158|FG001|Double-blind Phase|Withdrawal by Subject|6|||
163392173|NCT00312221|590148159|FG002|Double-blind Phase|Withdrawal by Subject|8|||
163392174|NCT00312221|590148160|FG003|Double-blind Phase|Withdrawal by Subject|7|||
163392175|NCT00312221|590148157|FG000|Double-blind Phase|Adverse Event|0|||
163392176|NCT00312221|590148158|FG001|Double-blind Phase|Adverse Event|10|||
163392177|NCT00312221|590148159|FG002|Double-blind Phase|Adverse Event|19|||
163392178|NCT00312221|590148160|FG003|Double-blind Phase|Adverse Event|18|||
163392179|NCT00312221|590148157|FG000|Double-blind Phase|Lost to Follow-up|0|||
163392180|NCT00312221|590148158|FG001|Double-blind Phase|Lost to Follow-up|0|||
163392181|NCT00312221|590148159|FG002|Double-blind Phase|Lost to Follow-up|2|||
163392182|NCT00312221|590148160|FG003|Double-blind Phase|Lost to Follow-up|2|||
163392183|NCT00312221|590148157|FG000|Double-blind Phase|Administrative|0|||
163392184|NCT00312221|590148158|FG001|Double-blind Phase|Administrative|26|||
163392185|NCT00312221|590148159|FG002|Double-blind Phase|Administrative|37|||
163392186|NCT00312221|590148160|FG003|Double-blind Phase|Administrative|33|||
163392187|NCT00312221|590148157|FG000|Double-blind Phase|Lack of Efficacy|0|||
163392188|NCT00312221|590148158|FG001|Double-blind Phase|Lack of Efficacy|17|||
163392189|NCT00312221|590148159|FG002|Double-blind Phase|Lack of Efficacy|6|||
163392190|NCT00312221|590148160|FG003|Double-blind Phase|Lack of Efficacy|10|||
163392191|NCT02060721|590148162|FG000|Overall Study|Lost to Follow-up|1|||
163392192|NCT02060721|590148162|FG000|Overall Study|Physician Decision|2|||
163392193|NCT02060721|590148162|FG000|Overall Study|Death|14|||
163392194|NCT02060721|590148162|FG000|Overall Study|Withdrawal by Subject|2|||
163392195|NCT02060721|590148162|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
163392196|NCT05105789|590148163|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
163392197|NCT00728481|590148164|FG000|Overall Study|Withdrawal by Subject|0|||
163392198|NCT00728481|590148165|FG001|Overall Study|Withdrawal by Subject|1|||
163392199|NCT00728481|590148164|FG000|Overall Study|Adverse Event|0|||
163392200|NCT00728481|590148165|FG001|Overall Study|Adverse Event|1|||
163392201|NCT00728481|590148164|FG000|Overall Study|Study medication non-compliance|0|||
163392202|NCT00728481|590148165|FG001|Overall Study|Study medication non-compliance|2|||
163392203|NCT00728481|590148164|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
163392204|NCT00728481|590148165|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
163392205|NCT03690141|590148166|FG000|Overall Study|Adverse Event|5|||
163392206|NCT03690141|590148166|FG000|Overall Study|Withdrawal by Subject|3|||
163392207|NCT03690141|590148166|FG000|Overall Study|Physician Decision|4|||
163392208|NCT03690141|590148166|FG000|Overall Study|Disease progression|4|||
163392209|NCT01505010|590148167|FG000|Overall Study|Protocol Violation|0|||
163392210|NCT01505010|590148168|FG001|Overall Study|Protocol Violation|1|||
163392211|NCT01505010|590148167|FG000|Overall Study|Lost to Follow-up|0|||
163191981|NCT01691898|589417323|FG003|Overall Study|Non-Compliance|0|||
163191982|NCT01691898|589417324|FG004|Overall Study|Non-Compliance|1|||
163191983|NCT01691898|589417325|FG005|Overall Study|Non-Compliance|0|||
163191984|NCT01013350|589417326|FG000|Overall Study|Lost to Follow-up|15|||
163191985|NCT01013350|589417327|FG001|Overall Study|Lost to Follow-up|95|||
163191986|NCT01013350|589417326|FG000|Overall Study|Adverse Event|0|||
163191987|NCT01013350|589417327|FG001|Overall Study|Adverse Event|1|||
163191988|NCT01013350|589417326|FG000|Overall Study|Physician Decision|4|||
163191989|NCT01013350|589417327|FG001|Overall Study|Physician Decision|20|||
163191990|NCT01013350|589417326|FG000|Overall Study|Withdrawal by Subject|15|||
163191991|NCT01013350|589417327|FG001|Overall Study|Withdrawal by Subject|38|||
163191992|NCT01013350|589417326|FG000|Overall Study|Death|3|||
163191993|NCT01013350|589417327|FG001|Overall Study|Death|5|||
163392212|NCT01505010|590148168|FG001|Overall Study|Lost to Follow-up|1|||
163392213|NCT04744285|590148169|FG000|Overall Study|Withdrawal by Subject|1|||
163191994|NCT01013350|589417326|FG000|Overall Study|Participant entered interventional study|0|||
163191995|NCT01013350|589417327|FG001|Overall Study|Participant entered interventional study|8|||
163191996|NCT01013350|589417326|FG000|Overall Study|Other|1|||
163392214|NCT04744285|590148170|FG001|Overall Study|Withdrawal by Subject|1|||
163392215|NCT04744285|590148171|FG002|Overall Study|Withdrawal by Subject|2|||
163392216|NCT04744285|590148172|FG003|Overall Study|Withdrawal by Subject|1|||
163392217|NCT01807923|590148179|FG000|Overall Study|Adverse Event|2|||
163392218|NCT01807923|590148180|FG001|Overall Study|Adverse Event|1|||
163392219|NCT01807923|590148181|FG002|Overall Study|Adverse Event|2|||
163392220|NCT01807923|590148179|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
163191997|NCT01013350|589417327|FG001|Overall Study|Other|25|||
163191998|NCT02019277|589417328|FG000|Overall Study|Withdrawal by Subject|3|||
163392221|NCT01807923|590148180|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
163392222|NCT01807923|590148181|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
163392223|NCT01807923|590148179|FG000|Overall Study|Physician Decision|0|||
163392224|NCT01807923|590148180|FG001|Overall Study|Physician Decision|0|||
163392225|NCT01807923|590148181|FG002|Overall Study|Physician Decision|1|||
163392226|NCT01807923|590148179|FG000|Overall Study|Not Eligible (Genotype)|0|||
163392227|NCT01807923|590148180|FG001|Overall Study|Not Eligible (Genotype)|0|||
163392228|NCT01807923|590148181|FG002|Overall Study|Not Eligible (Genotype)|1|||
163392229|NCT01807923|590148179|FG000|Overall Study|Randomized But Not Treated|3|||
163392230|NCT01807923|590148180|FG001|Overall Study|Randomized But Not Treated|2|||
163392231|NCT01807923|590148181|FG002|Overall Study|Randomized But Not Treated|5|||
163392232|NCT02558231|590148183|FG000|Overall Study|Death|4|||
163392233|NCT02558231|590148184|FG001|Overall Study|Death|12|||
163392234|NCT02558231|590148183|FG000|Overall Study|Lost to Follow-up|7|||
163392235|NCT02558231|590148184|FG001|Overall Study|Lost to Follow-up|4|||
163392236|NCT02558231|590148183|FG000|Overall Study|Withdrawal by Subject|7|||
163392237|NCT02558231|590148184|FG001|Overall Study|Withdrawal by Subject|4|||
163392238|NCT02558231|590148183|FG000|Overall Study|Physician Decision|7|||
163191999|NCT02019277|589417328|FG000|Overall Study|Death|7|||
163192000|NCT02019277|589417328|FG000|Overall Study|Did no Cooperate|1|||
163192001|NCT02019277|589417328|FG000|Overall Study|Adverse Event|1|||
163192002|NCT03725852|589417329|FG000|Overall Study|Death|1|||
163192003|NCT03725852|589417330|FG001|Overall Study|Death|0|||
163192004|NCT03725852|589417329|FG000|Overall Study|Withdrawal by Subject|1|||
163192005|NCT03725852|589417330|FG001|Overall Study|Withdrawal by Subject|0|||
163192006|NCT03725852|589417329|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
163192007|NCT03725852|589417330|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
163192008|NCT01297920|589417336|FG000|Overall Study|Adverse Event|42|||
163192009|NCT01297920|589417337|FG001|Overall Study|Adverse Event|10|||
163192010|NCT01297920|589417338|FG002|Overall Study|Adverse Event|38|||
163192011|NCT01297920|589417336|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
163192012|NCT01297920|589417337|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
163192013|NCT01297920|589417338|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
163192014|NCT01297920|589417336|FG000|Overall Study|Noncompliance|1|||
163192015|NCT01297920|589417337|FG001|Overall Study|Noncompliance|0|||
163192016|NCT01297920|589417338|FG002|Overall Study|Noncompliance|0|||
163192017|NCT01297920|589417336|FG000|Overall Study|Protocol Violation|1|||
163192018|NCT01297920|589417337|FG001|Overall Study|Protocol Violation|3|||
163192019|NCT01297920|589417338|FG002|Overall Study|Protocol Violation|0|||
163192020|NCT01297920|589417336|FG000|Overall Study|Inadequate Control of IOP|7|||
163192021|NCT01297920|589417337|FG001|Overall Study|Inadequate Control of IOP|9|||
163192022|NCT01297920|589417338|FG002|Overall Study|Inadequate Control of IOP|17|||
163192023|NCT01297920|589417336|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
163192024|NCT01297920|589417337|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
163192025|NCT01297920|589417338|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
163192026|NCT01710046|589417339|FG000|Overall Study|Lost to Follow-up|1|||
163192027|NCT01710046|589417340|FG001|Overall Study|Lost to Follow-up|0|||
163192028|NCT02215096|589417341|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
163192029|NCT02215096|589417342|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
163192030|NCT02215096|589417343|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
163192031|NCT02215096|589417344|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
163192032|NCT02215096|589417345|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
163192033|NCT02215096|589417341|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
163192034|NCT02215096|589417342|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
163192035|NCT02215096|589417343|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
163192036|NCT02215096|589417344|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
163192037|NCT02215096|589417345|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
163192038|NCT02215096|589417341|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
163192039|NCT02215096|589417342|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
163192040|NCT02215096|589417343|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
163192041|NCT02215096|589417344|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
163192042|NCT02215096|589417345|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
163192043|NCT02215096|589417341|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
163192044|NCT02215096|589417342|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
163192045|NCT02215096|589417343|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
163192046|NCT02215096|589417344|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
163192047|NCT02215096|589417345|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
163192048|NCT00370071|589417346|FG000|Overall Study|Withdrawal by Subject|2|||
163392239|NCT02558231|590148184|FG001|Overall Study|Physician Decision|5|||
163392240|NCT02558231|590148183|FG000|Overall Study|Sponsor Decision|0|||
163392241|NCT02558231|590148184|FG001|Overall Study|Sponsor Decision|1|||
163392242|NCT00995007|590148185|FG000|Overall Study|Withdrew consent|1|||
163392243|NCT00995007|590148186|FG001|Overall Study|Withdrew consent|0|||
163392244|NCT00995007|590148185|FG000|Overall Study|Refused further treatment|8|||
163392245|NCT00995007|590148186|FG001|Overall Study|Refused further treatment|2|||
163392246|NCT00995007|590148185|FG000|Overall Study|Toxicity|8|||
163392247|NCT00995007|590148186|FG001|Overall Study|Toxicity|0|||
163392248|NCT03933397|590148187|FG000|Overall Study|No emergency department visit|65|||
163392249|NCT03933397|590148188|FG001|Overall Study|No emergency department visit|71|||
163392250|NCT03933397|590148187|FG000|Overall Study|Missed emergency department visit|25|||
163392251|NCT03933397|590148188|FG001|Overall Study|Missed emergency department visit|30|||
163392252|NCT03933397|590148187|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
163392253|NCT03933397|590148188|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
163392254|NCT03933397|590148187|FG000|Overall Study|Withdrawal by Subject|1|||
163392255|NCT03933397|590148188|FG001|Overall Study|Withdrawal by Subject|0|||
163392256|NCT03933397|590148187|FG000|Overall Study|Physician Decision|1|||
163392257|NCT03933397|590148188|FG001|Overall Study|Physician Decision|1|||
163392258|NCT03933397|590148187|FG000|Overall Study|missing pain score|1|||
163392259|NCT03933397|590148188|FG001|Overall Study|missing pain score|1|||
163392260|NCT03933397|590148187|FG000|Overall Study|Confirmed COVID-19|1|||
163392261|NCT03933397|590148188|FG001|Overall Study|Confirmed COVID-19|2|||
163392262|NCT02066051|590148192|FG000|Overall Study|Subject developed active GVHD|1|||
163392263|NCT01237340|590148197|FG000|Overall Study|Adverse Event|3|||
163392264|NCT01237340|590148197|FG000|Overall Study|Withdrawal by Subject|1|||
163392265|NCT01237340|590148197|FG000|Overall Study|Early termination of the trial|36|||
163392266|NCT01610687|590148198|FG000|Overall Study|Lack of Efficacy|26|||
163392267|NCT01610687|590148198|FG000|Overall Study|Adverse Event|18|||
163392268|NCT01610687|590148198|FG000|Overall Study|Moved out of area|6|||
163392269|NCT01610687|590148198|FG000|Overall Study|Withdrawal by Subject|7|||
163192049|NCT01787331|589417347|FG000|Overall Study|Physician Decision|1|||
163192050|NCT01787331|589417347|FG000|Overall Study|Withdrawal by Subject|1|||
163192051|NCT00319501|589417350|FG000|Double-blind Period|Withdrawal by Subject|0|||
163192052|NCT00319501|589417351|FG001|Double-blind Period|Withdrawal by Subject|3|||
163192053|NCT00319501|589417350|FG000|Double-blind Period|Sponsor Request|1|||
163192054|NCT00319501|589417351|FG001|Double-blind Period|Sponsor Request|0|||
163192055|NCT00319501|589417350|FG000|Double-blind Period|Did not receive treatment|42|||
163192056|NCT00319501|589417351|FG001|Double-blind Period|Did not receive treatment|29|||
163192057|NCT00319501|589417350|FG000|Open-label Period|Adverse Event|5|||
163192058|NCT00319501|589417351|FG001|Open-label Period|Adverse Event|0|||
163192059|NCT00319501|589417350|FG000|Open-label Period|Protocol Violation|6|||
163192060|NCT00319501|589417351|FG001|Open-label Period|Protocol Violation|0|||
163192061|NCT00319501|589417350|FG000|Open-label Period|Withdrawal by Subject|38|||
163192062|NCT00319501|589417351|FG001|Open-label Period|Withdrawal by Subject|0|||
163192063|NCT00319501|589417350|FG000|Open-label Period|Principal Investigator decision|6|||
163192064|NCT00319501|589417351|FG001|Open-label Period|Principal Investigator decision|0|||
163192065|NCT00319501|589417350|FG000|Open-label Period|Sponsor request|12|||
163192066|NCT00319501|589417351|FG001|Open-label Period|Sponsor request|0|||
163392270|NCT01610687|590148198|FG000|Overall Study|Lost to Follow-up|4|||
163392271|NCT01610687|590148198|FG000|Overall Study|Symptom control without study medication|2|||
163192067|NCT00319501|589417350|FG000|Open-label Period|Lost to Follow-up|5|||
163192068|NCT00319501|589417351|FG001|Open-label Period|Lost to Follow-up|0|||
163192069|NCT00319501|589417350|FG000|Open-label Period|Did not receive treatment|33|||
163392272|NCT01610687|590148198|FG000|Overall Study|Unable to make journey|1|||
163392273|NCT01610687|590148198|FG000|Overall Study|Death|1|||
163392274|NCT01610687|590148198|FG000|Overall Study|Cannabis affecting job|1|||
163392275|NCT01610687|590148198|FG000|Overall Study|Felt more alter without study medication|1|||
163392276|NCT03836807|590148199|FG000|Overall Study|Physician Decision|1|||
163392277|NCT03836807|590148200|FG001|Overall Study|Physician Decision|0|||
163392278|NCT00685685|590148201|FG000|Washout Period of 7 Days|Adverse Event|2|||
163392279|NCT00685685|590148202|FG001|Washout Period of 7 Days|Adverse Event|0|||
163392280|NCT00685685|590148201|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
163392281|NCT00685685|590148202|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
163392282|NCT01294150|590148207|FG000|Overall Study|Physician Decision|2|||
163392283|NCT01294150|590148208|FG001|Overall Study|Physician Decision|2|||
163392284|NCT03675776|590148209|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
163392285|NCT03675776|590148210|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
163392286|NCT03675776|590148211|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
163392287|NCT03675776|590148209|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
163392288|NCT03675776|590148210|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
163392289|NCT03675776|590148211|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
163392290|NCT01093625|590148212|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
163392291|NCT01093625|590148213|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
163392292|NCT01093625|590148212|FG000|2-Week Visit|Withdrawal by Subject|1|||
163392293|NCT01093625|590148213|FG001|2-Week Visit|Withdrawal by Subject|0|||
163392294|NCT01093625|590148212|FG000|1-Month Visit|Lost to Follow-up|2|||
163392295|NCT01093625|590148213|FG001|1-Month Visit|Lost to Follow-up|0|||
163392296|NCT01093625|590148212|FG000|3-Month Visit|Lost to Follow-up|2|||
163392297|NCT01093625|590148213|FG001|3-Month Visit|Lost to Follow-up|0|||
163392298|NCT01093625|590148212|FG000|6-Month Visit|Withdrawal by Subject|6|||
163392299|NCT01093625|590148213|FG001|6-Month Visit|Withdrawal by Subject|7|||
163392300|NCT01093625|590148212|FG000|6-Month Visit|Lost to Follow-up|2|||
163392301|NCT01093625|590148213|FG001|6-Month Visit|Lost to Follow-up|2|||
163392302|NCT01093625|590148212|FG000|1-Year Visit|Lost to Follow-up|5|||
163392303|NCT01093625|590148213|FG001|1-Year Visit|Lost to Follow-up|3|||
163392304|NCT00698932|590148214|FG000|Overall Study|Adverse Event|0|||
163392305|NCT00698932|590148215|FG001|Overall Study|Adverse Event|2|||
163392306|NCT00698932|590148214|FG000|Overall Study|Incorrect enrollment|0|||
163392307|NCT00698932|590148215|FG001|Overall Study|Incorrect enrollment|2|||
163392308|NCT00698932|590148214|FG000|Overall Study|Study specific discontinuation criteria|3|||
163392309|NCT00698932|590148215|FG001|Overall Study|Study specific discontinuation criteria|4|||
163392310|NCT00698932|590148214|FG000|Overall Study|Withdrawal by Subject|11|||
163392311|NCT00698932|590148215|FG001|Overall Study|Withdrawal by Subject|23|||
163392312|NCT00698932|590148214|FG000|Overall Study|Lost to Follow-up|6|||
163392313|NCT00698932|590148215|FG001|Overall Study|Lost to Follow-up|1|||
163392314|NCT00698932|590148214|FG000|Overall Study|Severe non-compliance to protocol|1|||
163392315|NCT00698932|590148215|FG001|Overall Study|Severe non-compliance to protocol|2|||
163392316|NCT00698932|590148214|FG000|Overall Study|Safety reasons|0|||
163392317|NCT00698932|590148215|FG001|Overall Study|Safety reasons|2|||
163392318|NCT00698932|590148214|FG000|Overall Study|Death|1|||
163392319|NCT00698932|590148215|FG001|Overall Study|Death|0|||
163392320|NCT02014740|590148216|FG000|Overall Study|Lost to Follow-up|4|||
163392321|NCT02014740|590148217|FG001|Overall Study|Lost to Follow-up|4|||
163392322|NCT02014740|590148216|FG000|Overall Study|Withdrawal by Subject|2|||
163392323|NCT02014740|590148217|FG001|Overall Study|Withdrawal by Subject|1|||
163392324|NCT01621542|590148218|FG000|Overall Study|Adverse Event|0|||
163392325|NCT01621542|590148219|FG001|Overall Study|Adverse Event|0|||
163392326|NCT01621542|590148220|FG002|Overall Study|Adverse Event|1|||
163392327|NCT01621542|590148221|FG003|Overall Study|Adverse Event|3|||
163392328|NCT01621542|590148222|FG004|Overall Study|Adverse Event|0|||
163392329|NCT01621542|590148223|FG005|Overall Study|Adverse Event|0|||
163392330|NCT01621542|590148218|FG000|Overall Study|Death|0|||
163392331|NCT01621542|590148219|FG001|Overall Study|Death|1|||
163392332|NCT01621542|590148220|FG002|Overall Study|Death|0|||
163392333|NCT01621542|590148221|FG003|Overall Study|Death|0|||
163392334|NCT01621542|590148222|FG004|Overall Study|Death|0|||
163392335|NCT01621542|590148223|FG005|Overall Study|Death|0|||
163392336|NCT01621542|590148218|FG000|Overall Study|Physician Decision|1|||
163392337|NCT01621542|590148219|FG001|Overall Study|Physician Decision|0|||
163392338|NCT01621542|590148220|FG002|Overall Study|Physician Decision|1|||
163392339|NCT01621542|590148221|FG003|Overall Study|Physician Decision|13|||
163392340|NCT01621542|590148222|FG004|Overall Study|Physician Decision|3|||
163392341|NCT01621542|590148223|FG005|Overall Study|Physician Decision|1|||
163392342|NCT01621542|590148218|FG000|Overall Study|Withdrawal by Subject|2|||
163392343|NCT01621542|590148219|FG001|Overall Study|Withdrawal by Subject|0|||
163392344|NCT01621542|590148220|FG002|Overall Study|Withdrawal by Subject|1|||
163392345|NCT01621542|590148221|FG003|Overall Study|Withdrawal by Subject|3|||
163392346|NCT01621542|590148222|FG004|Overall Study|Withdrawal by Subject|3|||
163392347|NCT01621542|590148223|FG005|Overall Study|Withdrawal by Subject|3|||
163392348|NCT01621542|590148218|FG000|Overall Study|progression/treatment failure|2|||
163392349|NCT01621542|590148219|FG001|Overall Study|progression/treatment failure|4|||
163392350|NCT01621542|590148220|FG002|Overall Study|progression/treatment failure|3|||
163392351|NCT01621542|590148221|FG003|Overall Study|progression/treatment failure|7|||
163392352|NCT01621542|590148222|FG004|Overall Study|progression/treatment failure|3|||
163392353|NCT01621542|590148223|FG005|Overall Study|progression/treatment failure|5|||
163392354|NCT01621542|590148218|FG000|Overall Study|Protocol Violation|0|||
163392355|NCT01621542|590148219|FG001|Overall Study|Protocol Violation|0|||
163392356|NCT01621542|590148220|FG002|Overall Study|Protocol Violation|0|||
163392357|NCT01621542|590148221|FG003|Overall Study|Protocol Violation|1|||
163392358|NCT01621542|590148222|FG004|Overall Study|Protocol Violation|0|||
163392359|NCT01621542|590148223|FG005|Overall Study|Protocol Violation|0|||
163392360|NCT01621542|590148218|FG000|Overall Study|study stopped by sponsor|0|||
163392361|NCT01621542|590148219|FG001|Overall Study|study stopped by sponsor|0|||
163392362|NCT01621542|590148220|FG002|Overall Study|study stopped by sponsor|0|||
163392363|NCT01621542|590148221|FG003|Overall Study|study stopped by sponsor|1|||
163392364|NCT01621542|590148222|FG004|Overall Study|study stopped by sponsor|0|||
163392365|NCT01621542|590148223|FG005|Overall Study|study stopped by sponsor|0|||
163392366|NCT02742766|590148224|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392367|NCT02742766|590148225|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392368|NCT02742766|590148226|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392369|NCT02742766|590148227|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392370|NCT02742766|590148228|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392371|NCT02742766|590148229|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392372|NCT02742766|590148230|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392373|NCT02742766|590148231|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392374|NCT02742766|590148232|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392375|NCT02742766|590148233|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392376|NCT02742766|590148234|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392377|NCT02742766|590148235|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392378|NCT02742766|590148236|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392379|NCT02742766|590148237|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
163392380|NCT02742766|590148238|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392381|NCT02742766|590148239|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392382|NCT02742766|590148240|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392383|NCT02742766|590148241|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392384|NCT02742766|590148242|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163392385|NCT02742766|590148224|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392386|NCT02742766|590148225|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392387|NCT02742766|590148226|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392388|NCT02742766|590148227|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392389|NCT02742766|590148228|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392390|NCT02742766|590148229|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392391|NCT02742766|590148230|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392392|NCT02742766|590148231|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392393|NCT02742766|590148232|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392394|NCT02742766|590148233|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392395|NCT02742766|590148234|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392396|NCT02742766|590148235|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392397|NCT02742766|590148236|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
163392398|NCT02742766|590148237|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
163392399|NCT02742766|590148238|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392400|NCT02742766|590148239|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
163392401|NCT02742766|590148240|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392402|NCT02742766|590148241|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392403|NCT02742766|590148242|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
163392404|NCT03739437|590148243|FG000|Overall Study|Lost to Follow-up|2|||
163392405|NCT03739437|590148244|FG001|Overall Study|Lost to Follow-up|5|||
163392406|NCT01130974|590148246|FG000|Overall Study|Protocol Violation|10|||
163392407|NCT01130974|590148247|FG001|Overall Study|Protocol Violation|10|||
163392408|NCT01130974|590148246|FG000|Overall Study|Withdrawal by Subject|0|||
163392409|NCT01130974|590148247|FG001|Overall Study|Withdrawal by Subject|1|||
163392410|NCT01130974|590148246|FG000|Overall Study|Ineligibility criteria|5|||
163392411|NCT01130974|590148247|FG001|Overall Study|Ineligibility criteria|2|||
163392412|NCT03359590|590148249|FG000|First Intervention|Withdrawal by Subject|1|||
163392413|NCT03359590|590148250|FG001|First Intervention|Withdrawal by Subject|1|||
163392414|NCT03359590|590148249|FG000|First Intervention|Protocol Violation|0|||
163392415|NCT03359590|590148250|FG001|First Intervention|Protocol Violation|1|||
163392416|NCT02540538|590148251|FG000|Overall Study|Pregnancy|0|||
163392417|NCT02540538|590148252|FG001|Overall Study|Pregnancy|1|||
163392418|NCT02540538|590148253|FG002|Overall Study|Pregnancy|0|||
163392419|NCT04598477|590148255|FG000|Overall Study|Adverse Event|2|||
163392420|NCT04598477|590148256|FG001|Overall Study|Adverse Event|0|||
163392421|NCT04598477|590148255|FG000|Overall Study|Death|0|||
163392422|NCT04598477|590148256|FG001|Overall Study|Death|1|||
163392423|NCT04598477|590148255|FG000|Overall Study|Lost to Follow-up|1|||
163392424|NCT04598477|590148256|FG001|Overall Study|Lost to Follow-up|0|||
163392425|NCT04598477|590148255|FG000|Overall Study|Physician Decision|7|||
163392426|NCT04598477|590148256|FG001|Overall Study|Physician Decision|2|||
163392427|NCT04598477|590148255|FG000|Overall Study|Pregnancy|0|||
163392428|NCT04598477|590148256|FG001|Overall Study|Pregnancy|1|||
163392429|NCT04598477|590148255|FG000|Overall Study|Requires Prohibited Medication|0|||
163392430|NCT04598477|590148256|FG001|Overall Study|Requires Prohibited Medication|1|||
163392431|NCT04598477|590148255|FG000|Overall Study|Study Terminated by Sponsor|18|||
163392432|NCT04598477|590148256|FG001|Overall Study|Study Terminated by Sponsor|12|||
163392433|NCT04598477|590148255|FG000|Overall Study|Withdrawal by Subject|16|||
163392434|NCT04598477|590148256|FG001|Overall Study|Withdrawal by Subject|12|||
163392435|NCT04598477|590148255|FG000|Overall Study|Other|15|||
163392436|NCT04598477|590148256|FG001|Overall Study|Other|8|||
163392437|NCT05579990|590148266|FG000|Overall Study|Lost to Follow-up|3|||
163392438|NCT00332839|590150255|FG000|Core (Months 0 - 12)|Administrative problems|1|||
163392439|NCT00332839|590150256|FG001|Core (Months 0 - 12)|Administrative problems|1|||
163392440|NCT00332839|590150255|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
163392441|NCT00332839|590150256|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
163392442|NCT00332839|590150255|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
163392443|NCT00332839|590150256|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
163392444|NCT00332839|590150255|FG000|Core (Months 0 - 12)|Adverse Event|5|||
163392445|NCT00332839|590150256|FG001|Core (Months 0 - 12)|Adverse Event|15|||
163392446|NCT00332839|590150255|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
163392447|NCT00332839|590150256|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
163392448|NCT00332839|590150255|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
163392449|NCT00332839|590150256|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
163392450|NCT00332839|590150255|FG000|Follow-up (Months 12 - 60)|Death|1|||
163392451|NCT00332839|590150256|FG001|Follow-up (Months 12 - 60)|Death|1|||
163392452|NCT01876251|590150257|FG000|Overall Study|Clinical progression|1|||
163392453|NCT01876251|590150258|FG001|Overall Study|Clinical progression|0|||
163392454|NCT01876251|590150259|FG002|Overall Study|Clinical progression|0|||
163392455|NCT01876251|590150257|FG000|Overall Study|Death|2|||
163392456|NCT01876251|590150258|FG001|Overall Study|Death|0|||
163392457|NCT01876251|590150259|FG002|Overall Study|Death|1|||
163392458|NCT01876251|590150257|FG000|Overall Study|Participant started new treatment|1|||
163392459|NCT01876251|590150258|FG001|Overall Study|Participant started new treatment|0|||
163392460|NCT01876251|590150259|FG002|Overall Study|Participant started new treatment|1|||
163392461|NCT01876251|590150257|FG000|Overall Study|Participant refused further follow-up|0|||
163392462|NCT01876251|590150258|FG001|Overall Study|Participant refused further follow-up|0|||
163392463|NCT01876251|590150259|FG002|Overall Study|Participant refused further follow-up|1|||
163392464|NCT01876251|590150257|FG000|Overall Study|Study terminated|1|||
163392465|NCT01876251|590150258|FG001|Overall Study|Study terminated|0|||
163392466|NCT01876251|590150259|FG002|Overall Study|Study terminated|0|||
163392467|NCT01876251|590150257|FG000|Overall Study|Objective progression or relapse|10|||
163392468|NCT01876251|590150258|FG001|Overall Study|Objective progression or relapse|3|||
163392469|NCT01876251|590150259|FG002|Overall Study|Objective progression or relapse|8|||
163392470|NCT02012296|590150268|FG000|Overall Study|Lack of Efficacy|0|||
163392471|NCT02012296|590150269|FG001|Overall Study|Lack of Efficacy|0|||
163392472|NCT02012296|590150270|FG002|Overall Study|Lack of Efficacy|15|||
163392473|NCT02012296|590150268|FG000|Overall Study|Adverse Event|0|||
163392474|NCT02012296|590150269|FG001|Overall Study|Adverse Event|0|||
163392475|NCT02012296|590150270|FG002|Overall Study|Adverse Event|2|||
163392476|NCT02012296|590150268|FG000|Overall Study|Early study closure|0|||
163392477|NCT02012296|590150269|FG001|Overall Study|Early study closure|0|||
163392478|NCT02012296|590150270|FG002|Overall Study|Early study closure|5|||
163392479|NCT02012296|590150268|FG000|Overall Study|Protocol Violation|0|||
163392480|NCT02012296|590150269|FG001|Overall Study|Protocol Violation|1|||
163392481|NCT02012296|590150270|FG002|Overall Study|Protocol Violation|0|||
163392482|NCT03876171|590150271|FG000|Overall Study|Withdrawal by Subject|3|||
163392483|NCT03876171|590150272|FG001|Overall Study|Withdrawal by Subject|3|||
163392484|NCT03876171|590150271|FG000|Overall Study|Re-arrest|0|||
163392485|NCT03876171|590150272|FG001|Overall Study|Re-arrest|4|||
163392486|NCT00727649|590150275|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
163392487|NCT00727649|590150276|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
163392488|NCT00727649|590150275|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
163392489|NCT00727649|590150276|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
163392490|NCT00727649|590150275|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
163392491|NCT00727649|590150276|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
163392492|NCT00727649|590150275|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
163392493|NCT00727649|590150276|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
163392494|NCT00727649|590150275|FG000|Second Intervention (4-weeks)|Death|1|||
163392495|NCT00727649|590150276|FG001|Second Intervention (4-weeks)|Death|0|||
163392496|NCT00727649|590150275|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
163392497|NCT00727649|590150276|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
163392498|NCT00727649|590150275|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
163392499|NCT00727649|590150276|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
163392500|NCT03627767|590150280|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
163392501|NCT03627767|590150281|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
163392502|NCT03627767|590150282|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
163392503|NCT03627767|590150283|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
163392504|NCT03627767|590150284|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
163392505|NCT03627767|590150280|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
163392506|NCT03627767|590150281|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
163392507|NCT03627767|590150282|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
163392508|NCT03627767|590150283|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
163392509|NCT03627767|590150284|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
163392510|NCT03627767|590150280|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
163392511|NCT03627767|590150281|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
163392512|NCT03627767|590150282|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
163392513|NCT03627767|590150283|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
163392514|NCT03627767|590150284|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
163392515|NCT03627767|590150280|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
163392516|NCT03627767|590150281|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
163392517|NCT03627767|590150282|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
163392518|NCT03627767|590150283|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
163392519|NCT03627767|590150284|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
163392520|NCT03627767|590150280|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
163392521|NCT03627767|590150281|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
163392522|NCT03627767|590150282|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
163392523|NCT03627767|590150283|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
163392524|NCT03627767|590150284|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
163392525|NCT03627767|590150280|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
163392526|NCT03627767|590150281|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
163392527|NCT03627767|590150282|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
163392528|NCT03627767|590150283|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
163392529|NCT03627767|590150284|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
163392530|NCT03627767|590150280|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
163392531|NCT03627767|590150281|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
163392532|NCT03627767|590150282|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
163392533|NCT03627767|590150283|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
163392534|NCT03627767|590150284|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
163392535|NCT03627767|590150280|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
163392536|NCT03627767|590150281|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
163392537|NCT03627767|590150282|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
163392538|NCT03627767|590150283|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
163392539|NCT03627767|590150284|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
163392540|NCT03627767|590150280|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
163392541|NCT03627767|590150281|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
163392542|NCT03627767|590150282|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
163392543|NCT03627767|590150283|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
163392544|NCT03627767|590150284|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
163392545|NCT03627767|590150280|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
163392546|NCT03627767|590150281|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
163392547|NCT03627767|590150282|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
163392548|NCT03627767|590150283|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
163392549|NCT03627767|590150284|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
163392550|NCT03627767|590150280|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
163392551|NCT03627767|590150281|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
163392552|NCT03627767|590150282|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
163392553|NCT03627767|590150283|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
163392554|NCT03627767|590150284|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
163392555|NCT03627767|590150280|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
163392556|NCT03627767|590150281|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
163392557|NCT03627767|590150282|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
163392558|NCT03627767|590150283|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
163392559|NCT03627767|590150284|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
163392560|NCT03627767|590150280|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
163392561|NCT03627767|590150281|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
163392562|NCT03627767|590150282|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
163192070|NCT00319501|589417351|FG001|Open-label Period|Did not receive treatment|0|||
163192071|NCT00319501|589417350|FG000|Open-label Period|Other|11|||
163192072|NCT00319501|589417351|FG001|Open-label Period|Other|0|||
163192073|NCT00319501|589417350|FG000|Open-label Extension Period|Adverse Event|2|||
163192074|NCT00319501|589417351|FG001|Open-label Extension Period|Adverse Event|0|||
163192075|NCT00319501|589417350|FG000|Open-label Extension Period|Did not receive treatment|18|||
163192076|NCT00319501|589417351|FG001|Open-label Extension Period|Did not receive treatment|0|||
163192077|NCT00319501|589417350|FG000|Open-label Extension Period|Other|1|||
163192078|NCT00319501|589417351|FG001|Open-label Extension Period|Other|0|||
163192079|NCT00319501|589417350|FG000|Open-label Extension Period|Principal investigator decision|2|||
163192080|NCT00319501|589417351|FG001|Open-label Extension Period|Principal investigator decision|0|||
163192081|NCT00319501|589417350|FG000|Open-label Extension Period|Sponsor request|26|||
163192082|NCT00319501|589417351|FG001|Open-label Extension Period|Sponsor request|0|||
163192083|NCT00319501|589417350|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
163192084|NCT00319501|589417351|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
163192085|NCT00667875|589417353|FG000|Overall Study|Adverse Event|0|||
163192086|NCT00667875|589417354|FG001|Overall Study|Adverse Event|2|||
163192087|NCT00667875|589417355|FG002|Overall Study|Adverse Event|6|||
163192088|NCT00667875|589417353|FG000|Overall Study|Withdrawal by Subject|10|||
163192089|NCT00667875|589417354|FG001|Overall Study|Withdrawal by Subject|9|||
163192090|NCT00667875|589417355|FG002|Overall Study|Withdrawal by Subject|7|||
163192091|NCT00450255|589417356|FG000|Overall Study|Prior RFA ablation of liver|1|||
163192092|NCT00531934|589419280|FG000|Overall Study|Adverse Event|4|||
163192093|NCT00531934|589419281|FG001|Overall Study|Adverse Event|8|||
163192094|NCT00531934|589419280|FG000|Overall Study|Progression|52|||
163192095|NCT00531934|589419281|FG001|Overall Study|Progression|42|||
163192096|NCT00531934|589419280|FG000|Overall Study|Death|7|||
163192097|NCT00531934|589419281|FG001|Overall Study|Death|10|||
163192098|NCT00531934|589419280|FG000|Overall Study|Withdrawal by Subject|1|||
163192099|NCT00531934|589419281|FG001|Overall Study|Withdrawal by Subject|1|||
163192100|NCT00531934|589419280|FG000|Overall Study|Other|2|||
163192101|NCT00531934|589419281|FG001|Overall Study|Other|2|||
163192102|NCT00150709|589419282|FG000|Overall Study|Protocol Violation|7|||
163192103|NCT00150709|589419283|FG001|Overall Study|Protocol Violation|8|||
163192104|NCT00150709|589419284|FG002|Overall Study|Protocol Violation|3|||
163192105|NCT00150709|589419285|FG003|Overall Study|Protocol Violation|1|||
163192106|NCT00150709|589419282|FG000|Overall Study|Adverse Event|8|||
163192107|NCT00150709|589419283|FG001|Overall Study|Adverse Event|2|||
163192108|NCT00150709|589419284|FG002|Overall Study|Adverse Event|2|||
163192109|NCT00150709|589419285|FG003|Overall Study|Adverse Event|3|||
163192110|NCT00150709|589419282|FG000|Overall Study|Lack of Efficacy|6|||
163192111|NCT00150709|589419283|FG001|Overall Study|Lack of Efficacy|11|||
163192112|NCT00150709|589419284|FG002|Overall Study|Lack of Efficacy|9|||
163192113|NCT00150709|589419285|FG003|Overall Study|Lack of Efficacy|0|||
163192114|NCT00150709|589419282|FG000|Overall Study|Withdrawal by Subject|7|||
163192115|NCT00150709|589419283|FG001|Overall Study|Withdrawal by Subject|10|||
163192116|NCT00150709|589419284|FG002|Overall Study|Withdrawal by Subject|5|||
163192117|NCT00150709|589419285|FG003|Overall Study|Withdrawal by Subject|0|||
163192118|NCT00150709|589419282|FG000|Overall Study|Lost to Follow-up|3|||
163192119|NCT00150709|589419283|FG001|Overall Study|Lost to Follow-up|2|||
163192120|NCT00150709|589419284|FG002|Overall Study|Lost to Follow-up|0|||
163192121|NCT00150709|589419285|FG003|Overall Study|Lost to Follow-up|0|||
163192122|NCT00150709|589419282|FG000|Overall Study|Sponsor decision|0|||
163192123|NCT00150709|589419283|FG001|Overall Study|Sponsor decision|0|||
163192124|NCT00150709|589419284|FG002|Overall Study|Sponsor decision|0|||
163192125|NCT00150709|589419285|FG003|Overall Study|Sponsor decision|1|||
163192126|NCT00150709|589419282|FG000|Overall Study|Site/Investigator discontinued the study|5|||
163192127|NCT00150709|589419283|FG001|Overall Study|Site/Investigator discontinued the study|5|||
163192128|NCT00150709|589419284|FG002|Overall Study|Site/Investigator discontinued the study|2|||
163192129|NCT00150709|589419285|FG003|Overall Study|Site/Investigator discontinued the study|0|||
163192130|NCT00150709|589419282|FG000|Overall Study|Decision of parent(s)|1|||
163192131|NCT00150709|589419283|FG001|Overall Study|Decision of parent(s)|2|||
163192132|NCT00150709|589419284|FG002|Overall Study|Decision of parent(s)|0|||
163192133|NCT00150709|589419285|FG003|Overall Study|Decision of parent(s)|0|||
163192134|NCT00150709|589419282|FG000|Overall Study|Decision of parent(s) and investigator|3|||
163192135|NCT00150709|589419283|FG001|Overall Study|Decision of parent(s) and investigator|0|||
163192136|NCT00150709|589419284|FG002|Overall Study|Decision of parent(s) and investigator|0|||
163192137|NCT00150709|589419285|FG003|Overall Study|Decision of parent(s) and investigator|0|||
163192138|NCT00150709|589419282|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
163192139|NCT00150709|589419283|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
163192140|NCT00150709|589419284|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
163192141|NCT00150709|589419285|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
163192142|NCT00150709|589419282|FG000|Overall Study|Investigator decision|1|||
163192143|NCT00150709|589419283|FG001|Overall Study|Investigator decision|0|||
163192144|NCT00150709|589419284|FG002|Overall Study|Investigator decision|0|||
163192145|NCT00150709|589419285|FG003|Overall Study|Investigator decision|1|||
163392563|NCT03627767|590150283|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
163392564|NCT03627767|590150284|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
163392565|NCT03627767|590150280|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
163392566|NCT03627767|590150281|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
163392567|NCT03627767|590150282|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
163392568|NCT03627767|590150283|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
163392569|NCT03627767|590150284|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
163392570|NCT03627767|590150280|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
163392571|NCT03627767|590150281|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
163392572|NCT03627767|590150282|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
163392573|NCT03627767|590150283|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
163392574|NCT03627767|590150284|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
163392575|NCT03627767|590150280|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
163392576|NCT03627767|590150281|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
163392577|NCT03627767|590150282|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
163392578|NCT03627767|590150283|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
163392579|NCT03627767|590150284|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
163392580|NCT03627767|590150280|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
163392581|NCT03627767|590150281|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
163392582|NCT03627767|590150282|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
163392583|NCT03627767|590150283|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
163392584|NCT03627767|590150284|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
163392585|NCT03627767|590150280|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
163392586|NCT03627767|590150281|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
163392587|NCT03627767|590150282|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
163392588|NCT03627767|590150283|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
163392589|NCT03627767|590150284|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
163392590|NCT03627767|590150280|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
163392591|NCT03627767|590150281|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
163392592|NCT03627767|590150282|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
163392593|NCT03627767|590150283|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
163392594|NCT03627767|590150284|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
163392595|NCT03627767|590150280|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
163392596|NCT03627767|590150281|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
163392597|NCT03627767|590150282|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
163392598|NCT03627767|590150283|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
163392599|NCT03627767|590150284|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
163392600|NCT00283049|590150285|FG000|Overall Study|Adverse Event|6|||
163392601|NCT00283049|590150286|FG001|Overall Study|Adverse Event|1|||
163392602|NCT00283049|590150287|FG002|Overall Study|Adverse Event|4|||
163392603|NCT00283049|590150285|FG000|Overall Study|Protocol Violation|3|||
163392604|NCT00283049|590150286|FG001|Overall Study|Protocol Violation|0|||
163392605|NCT00283049|590150287|FG002|Overall Study|Protocol Violation|3|||
163392606|NCT00283049|590150285|FG000|Overall Study|Death|1|||
163392607|NCT00283049|590150286|FG001|Overall Study|Death|1|||
163392608|NCT00283049|590150287|FG002|Overall Study|Death|1|||
163392609|NCT00283049|590150285|FG000|Overall Study|Lack of Efficacy|0|||
163392610|NCT00283049|590150286|FG001|Overall Study|Lack of Efficacy|1|||
163392611|NCT00283049|590150287|FG002|Overall Study|Lack of Efficacy|1|||
163392612|NCT00283049|590150285|FG000|Overall Study|Lost to Follow-up|4|||
163392613|NCT00283049|590150286|FG001|Overall Study|Lost to Follow-up|2|||
163392614|NCT00283049|590150287|FG002|Overall Study|Lost to Follow-up|5|||
163392615|NCT00283049|590150285|FG000|Overall Study|Withdrawal by Subject|26|||
163392616|NCT00283049|590150286|FG001|Overall Study|Withdrawal by Subject|24|||
163392617|NCT00283049|590150287|FG002|Overall Study|Withdrawal by Subject|19|||
163392618|NCT00283049|590150285|FG000|Overall Study|Discontinuation of Study|18|||
163392619|NCT00283049|590150286|FG001|Overall Study|Discontinuation of Study|16|||
163392620|NCT00283049|590150287|FG002|Overall Study|Discontinuation of Study|20|||
163392621|NCT00283049|590150285|FG000|Overall Study|No longer requires study treatment|0|||
163392622|NCT00283049|590150286|FG001|Overall Study|No longer requires study treatment|0|||
163392623|NCT00283049|590150287|FG002|Overall Study|No longer requires study treatment|1|||
163392624|NCT02953639|590150288|FG000|Overall Study|Adverse Event|2|||
163392625|NCT02953639|590150289|FG001|Overall Study|Adverse Event|0|||
163392626|NCT02953639|590150290|FG002|Overall Study|Adverse Event|1|||
163392627|NCT02953639|590150288|FG000|Overall Study|Lost to Follow-up|8|||
163392628|NCT02953639|590150289|FG001|Overall Study|Lost to Follow-up|4|||
163392629|NCT02953639|590150290|FG002|Overall Study|Lost to Follow-up|3|||
163392630|NCT02953639|590150288|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163392631|NCT02953639|590150289|FG001|Overall Study|Non-Compliance With Study Drug|2|||
163392632|NCT02953639|590150290|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163392633|NCT02953639|590150288|FG000|Overall Study|Multiple Reasons|1|||
163297967|NCT00703820|589799525|FG001|Overall Study|Lack of Efficacy|11|||
163297968|NCT00703820|589799524|FG000|Overall Study|Received non-protocol therapy|1|||
163297969|NCT00703820|589799525|FG001|Overall Study|Received non-protocol therapy|0|||
163297970|NCT00703820|589799524|FG000|Overall Study|Physician Decision|4|||
163297971|NCT00703820|589799525|FG001|Overall Study|Physician Decision|5|||
163297972|NCT00703820|589799524|FG000|Overall Study|Withdrawal by Subject|2|||
163297973|NCT00703820|589799525|FG001|Overall Study|Withdrawal by Subject|1|||
163297974|NCT02092116|589799529|FG000|Overall Study|Withdrawal by Subject|0|||
163297975|NCT02092116|589799530|FG001|Overall Study|Withdrawal by Subject|3|||
163297976|NCT02092116|589799529|FG000|Overall Study|Adverse Event|0|||
163297977|NCT02092116|589799530|FG001|Overall Study|Adverse Event|1|||
163297978|NCT01007396|589799531|FG000|Overall Study|Lost to Follow-up|47|||
163297979|NCT03451721|589799532|FG000|Overall Study|Death|1|||
163297980|NCT03903822|589799535|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
163297981|NCT03903822|589799536|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
163297982|NCT03903822|589799537|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
163297983|NCT03903822|589799538|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
163297984|NCT03903822|589799539|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
163297985|NCT03903822|589799540|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
163297986|NCT03903822|589799541|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
163297987|NCT03903822|589799542|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
163297988|NCT03903822|589799535|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
163297989|NCT03903822|589799536|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
163297990|NCT03903822|589799537|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
163297991|NCT03903822|589799538|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
163297992|NCT03903822|589799539|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
163297993|NCT03903822|589799540|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
163297994|NCT03903822|589799541|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
163297995|NCT03903822|589799542|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
163297996|NCT03903822|589799535|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
163297997|NCT03903822|589799536|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
163297998|NCT03903822|589799537|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
163297999|NCT03903822|589799538|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
163298000|NCT03903822|589799539|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
163298001|NCT03903822|589799540|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
163298002|NCT03903822|589799541|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
163298003|NCT03903822|589799542|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
163298004|NCT03903822|589799535|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
163298005|NCT03903822|589799536|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
163298006|NCT03903822|589799537|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
163298007|NCT03903822|589799538|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
163298008|NCT03903822|589799539|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
163298009|NCT03903822|589799540|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
163298010|NCT03903822|589799541|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
163298011|NCT03903822|589799542|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
163298012|NCT03903822|589799535|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
163298013|NCT03903822|589799536|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
163298014|NCT03903822|589799537|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
163298015|NCT03903822|589799538|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
163298016|NCT03903822|589799539|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
163298017|NCT03903822|589799540|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
163298018|NCT03903822|589799541|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
163298019|NCT03903822|589799542|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
163298020|NCT03903822|589799535|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
163298021|NCT03903822|589799536|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
163298022|NCT03903822|589799537|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
163298023|NCT03903822|589799538|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
163298024|NCT03903822|589799539|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
163298025|NCT03903822|589799540|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
163298026|NCT03903822|589799541|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
163298027|NCT03903822|589799542|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
163298028|NCT03903822|589799535|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
163298029|NCT03903822|589799536|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
163298030|NCT03903822|589799537|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
163298031|NCT03903822|589799538|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
163298032|NCT03903822|589799539|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
163298033|NCT03903822|589799540|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
163298034|NCT03903822|589799541|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
163298035|NCT03903822|589799542|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
163298036|NCT03903822|589799535|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
163298037|NCT03903822|589799536|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
163298038|NCT03903822|589799537|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
163392634|NCT02953639|590150289|FG001|Overall Study|Multiple Reasons|0|||
163392635|NCT02953639|590150290|FG002|Overall Study|Multiple Reasons|1|||
163392636|NCT02953639|590150288|FG000|Overall Study|Physician Decision|1|||
163392637|NCT02953639|590150289|FG001|Overall Study|Physician Decision|0|||
163392638|NCT02953639|590150290|FG002|Overall Study|Physician Decision|0|||
163392639|NCT02953639|590150288|FG000|Overall Study|Withdrawal by Subject|7|||
163392640|NCT02953639|590150289|FG001|Overall Study|Withdrawal by Subject|8|||
163392641|NCT02953639|590150290|FG002|Overall Study|Withdrawal by Subject|10|||
163392642|NCT02953639|590150288|FG000|Overall Study|Completed or Discontinued information is missing|1|||
163392643|NCT02953639|590150289|FG001|Overall Study|Completed or Discontinued information is missing|0|||
163392644|NCT02953639|590150290|FG002|Overall Study|Completed or Discontinued information is missing|0|||
163392645|NCT01667081|590150291|FG000|Overall Study|Death|43|||
163392646|NCT01667081|590150292|FG001|Overall Study|Death|3|||
163392647|NCT01667081|590150291|FG000|Overall Study|Lost to Follow-up|99|||
163392648|NCT01667081|590150292|FG001|Overall Study|Lost to Follow-up|48|||
163392649|NCT01667081|590150291|FG000|Overall Study|Physician Decision|16|||
163392650|NCT01667081|590150292|FG001|Overall Study|Physician Decision|2|||
163392651|NCT01667081|590150291|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
163392652|NCT01667081|590150292|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
163392653|NCT01667081|590150291|FG000|Overall Study|Withdrawal by Subject|90|||
163392654|NCT01667081|590150292|FG001|Overall Study|Withdrawal by Subject|35|||
163392655|NCT03034460|590150293|FG000|Overall Study|Adverse Event|0|||
163392656|NCT03034460|590150294|FG001|Overall Study|Adverse Event|1|||
163392657|NCT03034460|590150293|FG000|Overall Study|Withdrawal by Subject|2|||
163392658|NCT03034460|590150294|FG001|Overall Study|Withdrawal by Subject|2|||
163392659|NCT03034460|590150293|FG000|Overall Study|Personal Reasons|1|||
163392660|NCT03034460|590150294|FG001|Overall Study|Personal Reasons|0|||
163392661|NCT02294682|590150295|FG000|Overall Study|Could not swallow pills|1|||
163392662|NCT02294682|590150296|FG001|Overall Study|Could not swallow pills|0|||
163392663|NCT01516970|590150297|FG000|Overall Study|Lost to Follow-up|7|||
163392664|NCT01516970|590150298|FG001|Overall Study|Lost to Follow-up|8|||
163392665|NCT01516970|590150297|FG000|Overall Study|Adverse Event|1|||
163392666|NCT01516970|590150298|FG001|Overall Study|Adverse Event|5|||
163392667|NCT01516970|590150297|FG000|Overall Study|Withdrawal by Subject|1|||
163392668|NCT01516970|590150298|FG001|Overall Study|Withdrawal by Subject|1|||
163392669|NCT01516970|590150297|FG000|Overall Study|Other|9|||
163392670|NCT01516970|590150298|FG001|Overall Study|Other|7|||
163392671|NCT00434421|590150299|FG000|Overall Study|Withdrawal by Subject|1|||
163392672|NCT00434421|590150299|FG000|Overall Study|Non-compliance with study treatment|1|||
163392673|NCT02366728|590150300|FG000|Overall Study|Death|0|||
163192146|NCT00150709|589419282|FG000|Overall Study|Subject relocated|2|||
163192147|NCT00150709|589419283|FG001|Overall Study|Subject relocated|2|||
163192148|NCT00150709|589419284|FG002|Overall Study|Subject relocated|1|||
163192149|NCT00150709|589419285|FG003|Overall Study|Subject relocated|0|||
163192150|NCT00150709|589419282|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
163192151|NCT00150709|589419283|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
163192152|NCT00150709|589419284|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
163192153|NCT00150709|589419285|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
163192154|NCT00150709|589419282|FG000|Overall Study|Convenience|0|||
163192155|NCT00150709|589419283|FG001|Overall Study|Convenience|1|||
163192156|NCT00150709|589419284|FG002|Overall Study|Convenience|0|||
163192157|NCT00150709|589419285|FG003|Overall Study|Convenience|0|||
163192158|NCT00150709|589419282|FG000|Overall Study|Subject entered new drug study|0|||
163192159|NCT00150709|589419283|FG001|Overall Study|Subject entered new drug study|1|||
163192160|NCT00150709|589419284|FG002|Overall Study|Subject entered new drug study|0|||
163192161|NCT00150709|589419285|FG003|Overall Study|Subject entered new drug study|0|||
163192162|NCT00150709|589419282|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
163192163|NCT00150709|589419283|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
163192164|NCT00150709|589419284|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
163192165|NCT00150709|589419285|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
163192166|NCT00150709|589419282|FG000|Overall Study|Lack of ease of swallowing|0|||
163392674|NCT02366728|590150301|FG001|Overall Study|Death|0|||
163392675|NCT02366728|590150302|FG002|Overall Study|Death|1|||
163392676|NCT02366728|590150300|FG000|Overall Study|Adverse Event|1|||
163392677|NCT02366728|590150301|FG001|Overall Study|Adverse Event|0|||
163392678|NCT02366728|590150302|FG002|Overall Study|Adverse Event|0|||
163392679|NCT02366728|590150300|FG000|Overall Study|Screen Failure|2|||
163392680|NCT02366728|590150301|FG001|Overall Study|Screen Failure|1|||
162952088|NCT02422264|588529538|FG001|Overall Study|Subject vaccinated outside of the study|1|||
163192167|NCT00150709|589419283|FG001|Overall Study|Lack of ease of swallowing|1|||
163192168|NCT00150709|589419284|FG002|Overall Study|Lack of ease of swallowing|0|||
163192169|NCT00150709|589419285|FG003|Overall Study|Lack of ease of swallowing|0|||
163392681|NCT02366728|590150302|FG002|Overall Study|Screen Failure|0|||
163392682|NCT02366728|590150300|FG000|Overall Study|Only yielded 2 vaccines|1|||
163392683|NCT02366728|590150301|FG001|Overall Study|Only yielded 2 vaccines|0|||
163392684|NCT02366728|590150302|FG002|Overall Study|Only yielded 2 vaccines|0|||
163392685|NCT01399190|590150305|FG000|Overall Study|Not Eligible for Final Analysis|5|||
163392686|NCT01399190|590150305|FG000|Overall Study|Adverse Event|8|||
163392687|NCT01399190|590150305|FG000|Overall Study|Participant's Request|5|||
163392688|NCT01399190|590150305|FG000|Overall Study|Physician Decision|2|||
163392689|NCT03842163|590150306|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
163392690|NCT03842163|590150306|FG000|Overall Study|Scintigraphy was not performed|44|||
163392691|NCT01187550|590150308|FG000|Overall Study|Protocol Violation|3|||
163392692|NCT01187550|590150309|FG001|Overall Study|Protocol Violation|1|||
163392693|NCT01187550|590150308|FG000|Overall Study|Other|3|||
163392694|NCT01187550|590150309|FG001|Overall Study|Other|0|||
163392695|NCT01187550|590150308|FG000|Overall Study|Randomized but not treated|8|||
163392696|NCT01187550|590150309|FG001|Overall Study|Randomized but not treated|0|||
163392697|NCT00129623|590150310|FG000|Overall Study|Adverse Event|3|||
163392698|NCT00129623|590150311|FG001|Overall Study|Adverse Event|7|||
163392699|NCT00129623|590150310|FG000|Overall Study|Refused Treatment|5|||
163392700|NCT00129623|590150311|FG001|Overall Study|Refused Treatment|3|||
163392701|NCT00129623|590150310|FG000|Overall Study|Failure to Return|1|||
163392702|NCT00129623|590150311|FG001|Overall Study|Failure to Return|1|||
163392703|NCT00129623|590150310|FG000|Overall Study|Relocated job out of state|1|||
163392704|NCT00129623|590150311|FG001|Overall Study|Relocated job out of state|0|||
163392705|NCT00129623|590150310|FG000|Overall Study|Uncertainty to return|0|||
163392706|NCT00129623|590150311|FG001|Overall Study|Uncertainty to return|1|||
163392707|NCT00596934|590150312|FG000|Overall Study|Protocol Violation|1|||
163392708|NCT00596934|590150312|FG000|Overall Study|Withdrawal by Subject|1|||
163392709|NCT01296035|590150313|FG000|Overall Study|Withdrawal by Subject|1|||
163392710|NCT00117507|590150324|FG000|Overall Study|Adverse Event|4|||
163392711|NCT00117507|590150324|FG000|Overall Study|Abnormal laboratory values|3|||
163392712|NCT00117507|590150324|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163392713|NCT00117507|590150324|FG000|Overall Study|Patient withdrew consent|4|||
163392714|NCT00117507|590150324|FG000|Overall Study|Death|3|||
163392715|NCT00866723|590150325|FG000|Overall Study|Withdrawal by Subject|1|||
163392716|NCT00866723|590150325|FG000|Overall Study|Disease Progression|4|||
163392717|NCT01003990|590150331|FG000|Overall Study|Adverse Event|8|||
163392718|NCT01003990|590150332|FG001|Overall Study|Adverse Event|5|||
163392719|NCT01003990|590150333|FG002|Overall Study|Adverse Event|11|||
163392720|NCT01003990|590150331|FG000|Overall Study|Death|0|||
163392721|NCT01003990|590150332|FG001|Overall Study|Death|8|||
163392722|NCT01003990|590150333|FG002|Overall Study|Death|1|||
163392723|NCT01003990|590150331|FG000|Overall Study|Lack of Efficacy|10|||
163192170|NCT04092582|589419286|FG000|Overall Study|Death|1|||
163192171|NCT04092582|589419287|FG001|Overall Study|Death|1|||
163192172|NCT04092582|589419286|FG000|Overall Study|Withdrawal by Subject|4|||
163192173|NCT04092582|589419287|FG001|Overall Study|Withdrawal by Subject|1|||
163192174|NCT04092582|589419286|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
163192175|NCT04092582|589419287|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
163192176|NCT03019185|589419292|FG000|Overall Study|Lost to Follow-up|3|||
163192177|NCT03019185|589419293|FG001|Overall Study|Lost to Follow-up|0|||
163192178|NCT03019185|589419294|FG002|Overall Study|Lost to Follow-up|2|||
163192179|NCT03019185|589419292|FG000|Overall Study|Withdrawal by Subject|1|||
163192180|NCT03019185|589419293|FG001|Overall Study|Withdrawal by Subject|1|||
163192181|NCT03019185|589419294|FG002|Overall Study|Withdrawal by Subject|0|||
163192182|NCT03019185|589419292|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
163192183|NCT03019185|589419293|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
163192184|NCT03019185|589419294|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
163192185|NCT03019185|589419292|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
163192186|NCT03019185|589419293|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
163192187|NCT03019185|589419294|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
163392724|NCT01003990|590150332|FG001|Overall Study|Lack of Efficacy|2|||
163392725|NCT01003990|590150333|FG002|Overall Study|Lack of Efficacy|3|||
162952089|NCT03021018|588529539|FG000|Overall Study|Adverse Event|1|||
162952090|NCT03021018|588529540|FG001|Overall Study|Adverse Event|0|||
162952091|NCT03021018|588529541|FG002|Overall Study|Adverse Event|0|||
162952092|NCT03021018|588529539|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
162952093|NCT03021018|588529540|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
162952094|NCT03021018|588529541|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
162952095|NCT00328926|588529544|FG000|Overall Study|Pregnancy|2|||
162952096|NCT00328926|588529545|FG001|Overall Study|Pregnancy|1|||
163192188|NCT02764333|589419300|FG000|Overall Study|Ineligible|1|||
163192189|NCT01200524|589419303|FG000|Overall Study|Withdrawal by Subject|1|||
163192190|NCT01200524|589419304|FG001|Overall Study|Withdrawal by Subject|1|||
163192191|NCT01200524|589419305|FG002|Overall Study|Withdrawal by Subject|3|||
163192192|NCT01200524|589419303|FG000|Overall Study|Adverse Event|1|||
163192193|NCT01200524|589419304|FG001|Overall Study|Adverse Event|0|||
163192194|NCT01200524|589419305|FG002|Overall Study|Adverse Event|0|||
163192195|NCT01200524|589419303|FG000|Overall Study|Non availability of study nurse|0|||
163192196|NCT01200524|589419304|FG001|Overall Study|Non availability of study nurse|0|||
163192197|NCT01200524|589419305|FG002|Overall Study|Non availability of study nurse|1|||
163192198|NCT01868503|589419306|FG000|Overall Study|Withdrawal by Subject|1|||
163192199|NCT01868503|589419306|FG000|Overall Study|Protocol Violation|1|||
163192200|NCT03917459|589419313|FG000|Overall Study|Adverse Event|1|||
163192201|NCT03917459|589419314|FG001|Overall Study|Adverse Event|0|||
163192202|NCT03917459|589419313|FG000|Overall Study|Withdrawal by Subject|0|||
163192203|NCT03917459|589419314|FG001|Overall Study|Withdrawal by Subject|1|||
163192204|NCT00736944|589419315|FG000|Induction|Death|1|||
163192205|NCT00736944|589419315|FG000|Definitive Treatment|Physician Decision|1|||
163192206|NCT00491764|589419316|FG000|Overall Study|Adverse Event|1|||
163192207|NCT00491764|589419317|FG001|Overall Study|Adverse Event|2|||
163192208|NCT00491764|589419318|FG002|Overall Study|Adverse Event|4|||
163192209|NCT00491764|589419319|FG003|Overall Study|Adverse Event|4|||
163192210|NCT00491764|589419320|FG004|Overall Study|Adverse Event|0|||
163192211|NCT00491764|589419321|FG005|Overall Study|Adverse Event|1|||
163192212|NCT00491764|589419316|FG000|Overall Study|Lost to Follow-up|0|||
163192213|NCT00491764|589419317|FG001|Overall Study|Lost to Follow-up|1|||
163192214|NCT00491764|589419318|FG002|Overall Study|Lost to Follow-up|0|||
163192215|NCT00491764|589419319|FG003|Overall Study|Lost to Follow-up|1|||
163192216|NCT00491764|589419320|FG004|Overall Study|Lost to Follow-up|0|||
163192217|NCT00491764|589419321|FG005|Overall Study|Lost to Follow-up|3|||
163192218|NCT00491764|589419316|FG000|Overall Study|Withdrawal by Subject|2|||
163192219|NCT00491764|589419317|FG001|Overall Study|Withdrawal by Subject|3|||
163192220|NCT00491764|589419318|FG002|Overall Study|Withdrawal by Subject|1|||
163192221|NCT00491764|589419319|FG003|Overall Study|Withdrawal by Subject|2|||
163192222|NCT00491764|589419320|FG004|Overall Study|Withdrawal by Subject|2|||
163192223|NCT00491764|589419321|FG005|Overall Study|Withdrawal by Subject|4|||
163192224|NCT00491764|589419316|FG000|Overall Study|Non Compliance with the Protocol|1|||
163192225|NCT00491764|589419317|FG001|Overall Study|Non Compliance with the Protocol|0|||
163192226|NCT00491764|589419318|FG002|Overall Study|Non Compliance with the Protocol|0|||
163192227|NCT00491764|589419319|FG003|Overall Study|Non Compliance with the Protocol|0|||
163192228|NCT00491764|589419320|FG004|Overall Study|Non Compliance with the Protocol|0|||
163192229|NCT00491764|589419321|FG005|Overall Study|Non Compliance with the Protocol|0|||
163192230|NCT00491764|589419316|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
163192231|NCT00491764|589419317|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
163192232|NCT00491764|589419318|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
163192233|NCT00491764|589419319|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
163192234|NCT00491764|589419320|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
163192235|NCT00491764|589419321|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
163192236|NCT00491764|589419316|FG000|Overall Study|Administrative|1|||
163192237|NCT00491764|589419317|FG001|Overall Study|Administrative|0|||
163192238|NCT00491764|589419318|FG002|Overall Study|Administrative|2|||
163192239|NCT00491764|589419319|FG003|Overall Study|Administrative|1|||
163192240|NCT00491764|589419320|FG004|Overall Study|Administrative|0|||
163192241|NCT00491764|589419321|FG005|Overall Study|Administrative|0|||
163192242|NCT00894166|589419322|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
163192243|NCT00894166|589419323|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
163192244|NCT00894166|589419324|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
163192245|NCT00894166|589419325|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
163192246|NCT00894166|589419326|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
163192247|NCT00894166|589419327|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
163192248|NCT00894166|589419328|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
163192249|NCT00894166|589419329|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
163192250|NCT00894166|589419322|FG000|Overall Study|Death|0|||
163192251|NCT00894166|589419323|FG001|Overall Study|Death|0|||
163192252|NCT00894166|589419324|FG002|Overall Study|Death|0|||
163192253|NCT00894166|589419325|FG003|Overall Study|Death|1|||
163192254|NCT00894166|589419326|FG004|Overall Study|Death|0|||
163192255|NCT00894166|589419327|FG005|Overall Study|Death|0|||
163192256|NCT00894166|589419328|FG006|Overall Study|Death|0|||
163298039|NCT03903822|589799538|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
163298040|NCT03903822|589799539|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
163298041|NCT03903822|589799540|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
163298042|NCT03903822|589799541|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
163298043|NCT03903822|589799542|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
163298044|NCT03903822|589799535|FG000|Treatment Phase (6 Weeks)|Other|2|||
163298045|NCT03903822|589799536|FG001|Treatment Phase (6 Weeks)|Other|1|||
163298046|NCT03903822|589799537|FG002|Treatment Phase (6 Weeks)|Other|0|||
163298047|NCT03903822|589799538|FG003|Treatment Phase (6 Weeks)|Other|0|||
163298048|NCT03903822|589799539|FG004|Treatment Phase (6 Weeks)|Other|1|||
163298049|NCT03903822|589799540|FG005|Treatment Phase (6 Weeks)|Other|1|||
163298050|NCT03903822|589799541|FG006|Treatment Phase (6 Weeks)|Other|0|||
163298051|NCT03903822|589799542|FG007|Treatment Phase (6 Weeks)|Other|0|||
163298052|NCT03903822|589799535|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
163298053|NCT03903822|589799536|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
163298054|NCT03903822|589799537|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
163298055|NCT03903822|589799538|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
163298056|NCT03903822|589799539|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
163298057|NCT03903822|589799540|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
163298058|NCT03903822|589799541|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
163298059|NCT03903822|589799542|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
163298060|NCT03903822|589799535|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
163298061|NCT03903822|589799536|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
163298062|NCT03903822|589799537|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
163298063|NCT03903822|589799538|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
163298064|NCT03903822|589799539|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
163298065|NCT03903822|589799540|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
162952097|NCT00328926|588529546|FG002|Overall Study|Pregnancy|0|||
162952098|NCT00328926|588529544|FG000|Overall Study|Lost to Follow-up|0|||
162952099|NCT00328926|588529545|FG001|Overall Study|Lost to Follow-up|1|||
162952100|NCT00328926|588529546|FG002|Overall Study|Lost to Follow-up|0|||
162952101|NCT00328926|588529544|FG000|Overall Study|Death|0|||
162952102|NCT00328926|588529545|FG001|Overall Study|Death|0|||
162952103|NCT00328926|588529546|FG002|Overall Study|Death|1|||
162952104|NCT00328926|588529544|FG000|Overall Study|In vitro fertilization treatment|0|||
162952105|NCT00328926|588529545|FG001|Overall Study|In vitro fertilization treatment|0|||
162952106|NCT00328926|588529546|FG002|Overall Study|In vitro fertilization treatment|1|||
162952107|NCT00328926|588529544|FG000|Overall Study|Lack of ovarian response|0|||
162952108|NCT00328926|588529545|FG001|Overall Study|Lack of ovarian response|1|||
162952109|NCT00328926|588529546|FG002|Overall Study|Lack of ovarian response|0|||
162952110|NCT02269657|588529547|FG000|Overall Study|Protocol Violation|3|||
162952111|NCT00834249|588529554|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
162952112|NCT00834249|588529555|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
162952113|NCT00834249|588529554|FG000|Second Intervention|Adverse Event|1|||
162952114|NCT00834249|588529555|FG001|Second Intervention|Adverse Event|0|||
162952115|NCT00834743|588529556|FG000|Second Intervention|Withdrawal by Subject|1|||
162952116|NCT00834743|588529557|FG001|Second Intervention|Withdrawal by Subject|0|||
162952117|NCT01534663|588529558|FG000|Overall Study|Lost to Follow-up|0|||
162952118|NCT01534663|588529559|FG001|Overall Study|Lost to Follow-up|2|||
162952119|NCT01534663|588529558|FG000|Overall Study|Adverse Event|2|||
162952120|NCT01534663|588529559|FG001|Overall Study|Adverse Event|1|||
162952121|NCT04112823|588529562|FG000|Overall Study|Lost to Follow-up|2|||
162952122|NCT04112823|588529563|FG001|Overall Study|Lost to Follow-up|3|||
162952123|NCT01693523|588529564|FG000|Overall Study|Adverse Event|2|||
162952124|NCT01693523|588529565|FG001|Overall Study|Adverse Event|1|||
162952125|NCT01693523|588529566|FG002|Overall Study|Adverse Event|0|||
162952126|NCT01693523|588529564|FG000|Overall Study|Death|0|||
162952127|NCT01693523|588529565|FG001|Overall Study|Death|1|||
162952128|NCT01693523|588529566|FG002|Overall Study|Death|1|||
162952129|NCT01693523|588529564|FG000|Overall Study|Lost to Follow-up|0|||
162952130|NCT01693523|588529565|FG001|Overall Study|Lost to Follow-up|0|||
162952131|NCT01693523|588529566|FG002|Overall Study|Lost to Follow-up|4|||
162952132|NCT01693523|588529564|FG000|Overall Study|Physician Decision|0|||
162952133|NCT01693523|588529565|FG001|Overall Study|Physician Decision|0|||
162952134|NCT01693523|588529566|FG002|Overall Study|Physician Decision|1|||
162952135|NCT01693523|588529564|FG000|Overall Study|Withdrawal by Subject|1|||
162952136|NCT01693523|588529565|FG001|Overall Study|Withdrawal by Subject|2|||
162952137|NCT01693523|588529566|FG002|Overall Study|Withdrawal by Subject|2|||
162952138|NCT01693523|588529564|FG000|Overall Study|Lack of compliance study medication|1|||
162952139|NCT01693523|588529565|FG001|Overall Study|Lack of compliance study medication|2|||
162952140|NCT01693523|588529566|FG002|Overall Study|Lack of compliance study medication|0|||
162952141|NCT01693523|588529564|FG000|Overall Study|Chemotherapy was held|1|||
162952142|NCT01693523|588529565|FG001|Overall Study|Chemotherapy was held|2|||
162952143|NCT01693523|588529566|FG002|Overall Study|Chemotherapy was held|0|||
162952144|NCT03603314|588529569|FG000|Overall Study|Lost to Follow-up|0|||
162952145|NCT03603314|588529570|FG001|Overall Study|Lost to Follow-up|3|||
162952146|NCT03603314|588529571|FG002|Overall Study|Lost to Follow-up|0|||
162952147|NCT03603314|588529569|FG000|Overall Study|Protocol Violation|0|||
162952148|NCT03603314|588529570|FG001|Overall Study|Protocol Violation|1|||
162952149|NCT03603314|588529571|FG002|Overall Study|Protocol Violation|0|||
162952150|NCT03603314|588529569|FG000|Overall Study|Adverse Event|2|||
162952151|NCT03603314|588529570|FG001|Overall Study|Adverse Event|0|||
162952152|NCT03603314|588529571|FG002|Overall Study|Adverse Event|0|||
162952153|NCT03603314|588529569|FG000|Overall Study|Physician Decision|1|||
162952154|NCT03603314|588529570|FG001|Overall Study|Physician Decision|1|||
162952155|NCT03603314|588529571|FG002|Overall Study|Physician Decision|0|||
162952156|NCT03603314|588529569|FG000|Overall Study|Withdrawal by Subject|4|||
162952157|NCT03603314|588529570|FG001|Overall Study|Withdrawal by Subject|5|||
162952158|NCT03603314|588529571|FG002|Overall Study|Withdrawal by Subject|3|||
162952159|NCT03603314|588529569|FG000|Overall Study|Other|0|||
162952160|NCT03603314|588529570|FG001|Overall Study|Other|1|||
162952161|NCT03603314|588529571|FG002|Overall Study|Other|0|||
162952162|NCT00436553|588529572|FG000|Overall Study|Adverse Event|4|||
162952163|NCT00436553|588529573|FG001|Overall Study|Adverse Event|3|||
162952164|NCT00436553|588529574|FG002|Overall Study|Adverse Event|4|||
162952165|NCT00436553|588529572|FG000|Overall Study|Death|3|||
162952166|NCT00436553|588529573|FG001|Overall Study|Death|1|||
162952167|NCT00436553|588529574|FG002|Overall Study|Death|3|||
162952168|NCT00436553|588529572|FG000|Overall Study|Lost to Follow-up|0|||
162952169|NCT00436553|588529573|FG001|Overall Study|Lost to Follow-up|2|||
162952170|NCT00436553|588529574|FG002|Overall Study|Lost to Follow-up|0|||
162952171|NCT00436553|588529572|FG000|Overall Study|Protocol Violation|1|||
162952172|NCT00436553|588529573|FG001|Overall Study|Protocol Violation|0|||
162952173|NCT00436553|588529574|FG002|Overall Study|Protocol Violation|0|||
162952174|NCT00436553|588529572|FG000|Overall Study|Withdrawal by Subject|5|||
162952175|NCT00436553|588529573|FG001|Overall Study|Withdrawal by Subject|6|||
162952176|NCT00436553|588529574|FG002|Overall Study|Withdrawal by Subject|3|||
162952177|NCT00064753|588529585|FG000|Overall Study|Death|251|||
162952178|NCT00064753|588529586|FG001|Overall Study|Death|242|||
162952179|NCT00064753|588529585|FG000|Overall Study|Withdrawal by Subject|198|||
162952180|NCT00064753|588529586|FG001|Overall Study|Withdrawal by Subject|171|||
162952181|NCT00064753|588529585|FG000|Overall Study|Lost to Follow-up|225|||
162952182|NCT00064753|588529586|FG001|Overall Study|Lost to Follow-up|235|||
162952183|NCT02193880|588529587|FG000|Overall Study|patients did not collect enough HPC|3|||
162952184|NCT02419937|588529594|FG000|Overall Study|Lost to Follow-up|1|||
162952185|NCT02419937|588529595|FG001|Overall Study|Lost to Follow-up|0|||
162952186|NCT01182415|588529596|FG000|Overall Study|Lost to Follow-up|1|||
162952187|NCT01256684|588529597|FG000|Overall Study|Adverse Event|1|||
162952188|NCT01256684|588529598|FG001|Overall Study|Adverse Event|4|||
162952189|NCT01256684|588529599|FG002|Overall Study|Adverse Event|2|||
162952190|NCT01256684|588529597|FG000|Overall Study|Withdrawal by Subject|4|||
162952191|NCT01256684|588529598|FG001|Overall Study|Withdrawal by Subject|0|||
162952192|NCT01256684|588529599|FG002|Overall Study|Withdrawal by Subject|2|||
162952193|NCT01256684|588529597|FG000|Overall Study|Physician Decision|0|||
162952194|NCT01256684|588529598|FG001|Overall Study|Physician Decision|1|||
162952195|NCT01256684|588529599|FG002|Overall Study|Physician Decision|0|||
162952196|NCT01256684|588529597|FG000|Overall Study|Lack of Efficacy|0|||
162952197|NCT01256684|588529598|FG001|Overall Study|Lack of Efficacy|1|||
162952198|NCT01256684|588529599|FG002|Overall Study|Lack of Efficacy|1|||
162952199|NCT01256684|588529597|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
162952200|NCT01256684|588529598|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
162952201|NCT01256684|588529599|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
162952202|NCT02587962|588529602|FG000|Overall Study|Adverse Event|0|||
162952203|NCT02587962|588529603|FG001|Overall Study|Adverse Event|0|||
162952204|NCT02587962|588529604|FG002|Overall Study|Adverse Event|1|||
162952205|NCT02587962|588529605|FG003|Overall Study|Adverse Event|0|||
162952206|NCT02587962|588529606|FG004|Overall Study|Adverse Event|0|||
162952207|NCT02587962|588529602|FG000|Overall Study|Withdrawal by Subject|0|||
162952208|NCT02587962|588529603|FG001|Overall Study|Withdrawal by Subject|0|||
162952209|NCT02587962|588529604|FG002|Overall Study|Withdrawal by Subject|1|||
162952210|NCT02587962|588529605|FG003|Overall Study|Withdrawal by Subject|1|||
162952211|NCT02587962|588529606|FG004|Overall Study|Withdrawal by Subject|4|||
162952212|NCT02587962|588529602|FG000|Overall Study|Radiological progression|2|||
162952213|NCT02587962|588529603|FG001|Overall Study|Radiological progression|2|||
162952214|NCT02587962|588529604|FG002|Overall Study|Radiological progression|2|||
162952215|NCT02587962|588529605|FG003|Overall Study|Radiological progression|5|||
162952216|NCT02587962|588529606|FG004|Overall Study|Radiological progression|10|||
162952217|NCT02587962|588529602|FG000|Overall Study|Clinical progression|0|||
162952218|NCT02587962|588529603|FG001|Overall Study|Clinical progression|1|||
162952219|NCT02587962|588529604|FG002|Overall Study|Clinical progression|2|||
162952220|NCT02587962|588529605|FG003|Overall Study|Clinical progression|0|||
162952221|NCT02587962|588529606|FG004|Overall Study|Clinical progression|1|||
162952222|NCT00184600|588529607|FG000|Overall Study|Adverse Event|9|||
162952223|NCT00184600|588529608|FG001|Overall Study|Adverse Event|0|||
162952224|NCT00184600|588529609|FG002|Overall Study|Adverse Event|5|||
162952225|NCT00184600|588529607|FG000|Overall Study|Death|3|||
162952226|NCT00184600|588529608|FG001|Overall Study|Death|9|||
162952227|NCT00184600|588529609|FG002|Overall Study|Death|7|||
162952228|NCT00184600|588529607|FG000|Overall Study|Lack of Efficacy|3|||
162952229|NCT00184600|588529608|FG001|Overall Study|Lack of Efficacy|1|||
162952230|NCT00184600|588529609|FG002|Overall Study|Lack of Efficacy|3|||
162952231|NCT00184600|588529607|FG000|Overall Study|Lost to Follow-up|4|||
162952232|NCT00184600|588529608|FG001|Overall Study|Lost to Follow-up|6|||
162952233|NCT00184600|588529609|FG002|Overall Study|Lost to Follow-up|1|||
162952234|NCT00184600|588529607|FG000|Overall Study|Protocol Violation|2|||
162952235|NCT00184600|588529608|FG001|Overall Study|Protocol Violation|2|||
162952236|NCT00184600|588529609|FG002|Overall Study|Protocol Violation|3|||
162952237|NCT00184600|588529607|FG000|Overall Study|Withdrawal by Subject|20|||
162952238|NCT00184600|588529608|FG001|Overall Study|Withdrawal by Subject|28|||
162952239|NCT00184600|588529609|FG002|Overall Study|Withdrawal by Subject|12|||
162952240|NCT00184600|588529607|FG000|Overall Study|Unclassified|4|||
163192257|NCT00894166|589419329|FG007|Overall Study|Death|0|||
163192258|NCT01601132|589419330|FG000|Overall Study|Patient withdrew consent|1|||
163192259|NCT01601132|589419330|FG000|Overall Study|Protocol deviation|1|||
163192260|NCT02110238|589419331|FG000|12 Week Pivotal Phase|Adverse Event|3|||
162952241|NCT00184600|588529608|FG001|Overall Study|Unclassified|5|||
162952242|NCT00184600|588529609|FG002|Overall Study|Unclassified|3|||
162952243|NCT00624065|588529610|FG000|Overall Study|Adverse Event|5|||
163192261|NCT02110238|589419332|FG001|12 Week Pivotal Phase|Adverse Event|0|||
162952244|NCT00624065|588529611|FG001|Overall Study|Adverse Event|6|||
162952245|NCT00624065|588529610|FG000|Overall Study|Lost to Follow-up|4|||
162952246|NCT00624065|588529611|FG001|Overall Study|Lost to Follow-up|1|||
162952247|NCT00624065|588529610|FG000|Overall Study|Consent withdrawn|6|||
162952248|NCT00624065|588529611|FG001|Overall Study|Consent withdrawn|5|||
162952249|NCT00624065|588529610|FG000|Overall Study|Lack of Efficacy|0|||
163192262|NCT02110238|589419331|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
162952250|NCT00624065|588529611|FG001|Overall Study|Lack of Efficacy|3|||
163392726|NCT01003990|590150331|FG000|Overall Study|Lost to Follow-up|30|||
162952251|NCT00624065|588529610|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
162952252|NCT00624065|588529611|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
162952253|NCT01387022|588529612|FG000|Overall Study|Death|1|||
162952254|NCT01387022|588529613|FG001|Overall Study|Death|1|||
163392727|NCT01003990|590150332|FG001|Overall Study|Lost to Follow-up|12|||
163392728|NCT01003990|590150333|FG002|Overall Study|Lost to Follow-up|7|||
163392729|NCT01003990|590150331|FG000|Overall Study|Reasons Not Identified|14|||
163392730|NCT01003990|590150332|FG001|Overall Study|Reasons Not Identified|13|||
163392731|NCT01003990|590150333|FG002|Overall Study|Reasons Not Identified|8|||
163392732|NCT01003990|590150331|FG000|Overall Study|Poor/Non-compliance|4|||
163392733|NCT01003990|590150332|FG001|Overall Study|Poor/Non-compliance|3|||
163392734|NCT01003990|590150333|FG002|Overall Study|Poor/Non-compliance|2|||
163392735|NCT01003990|590150331|FG000|Overall Study|Pregnancy|10|||
163392736|NCT01003990|590150332|FG001|Overall Study|Pregnancy|2|||
163392737|NCT01003990|590150333|FG002|Overall Study|Pregnancy|4|||
163392738|NCT01003990|590150331|FG000|Overall Study|No Longer Met Study Criteria|4|||
163392739|NCT01003990|590150332|FG001|Overall Study|No Longer Met Study Criteria|1|||
163392740|NCT01003990|590150333|FG002|Overall Study|No Longer Met Study Criteria|0|||
163392741|NCT01003990|590150331|FG000|Overall Study|Subject Withdrew Consent|12|||
163392742|NCT01003990|590150332|FG001|Overall Study|Subject Withdrew Consent|5|||
163392743|NCT01003990|590150333|FG002|Overall Study|Subject Withdrew Consent|7|||
163392744|NCT01271803|590150334|FG000|Overall Study|Progressive disease|0|||
163392745|NCT01271803|590150335|FG001|Overall Study|Progressive disease|0|||
163392746|NCT01271803|590150336|FG002|Overall Study|Progressive disease|2|||
163392747|NCT01271803|590150334|FG000|Overall Study|Death|53|||
163392748|NCT01271803|590150335|FG001|Overall Study|Death|34|||
163392749|NCT01271803|590150336|FG002|Overall Study|Death|0|||
163392750|NCT01271803|590150334|FG000|Overall Study|Withdrawal by Subject|1|||
163392751|NCT01271803|590150335|FG001|Overall Study|Withdrawal by Subject|5|||
163392752|NCT01271803|590150336|FG002|Overall Study|Withdrawal by Subject|0|||
162952255|NCT01387022|588529612|FG000|Overall Study|Lost to Follow-up|0|||
163192263|NCT02110238|589419332|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
163392753|NCT01271803|590150334|FG000|Overall Study|Lost to Follow-up|1|||
163392754|NCT01271803|590150335|FG001|Overall Study|Lost to Follow-up|0|||
163298066|NCT03903822|589799541|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
163298067|NCT03903822|589799542|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
163298068|NCT03903822|589799535|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
163298069|NCT03903822|589799536|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
163298070|NCT03903822|589799537|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
163298071|NCT03903822|589799538|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
163298072|NCT03903822|589799539|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
163298073|NCT03903822|589799540|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
163298074|NCT03903822|589799541|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
163298075|NCT03903822|589799542|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
163298076|NCT03903822|589799535|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
163298077|NCT03903822|589799536|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
163298078|NCT03903822|589799537|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
163298079|NCT03903822|589799538|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
163298080|NCT03903822|589799539|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
163298081|NCT03903822|589799540|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
163298082|NCT03903822|589799541|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
163298083|NCT03903822|589799542|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
163298084|NCT03903822|589799535|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
163298085|NCT03903822|589799536|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
163298086|NCT03903822|589799537|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
163298087|NCT03903822|589799538|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
163298088|NCT03903822|589799539|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
163298089|NCT03903822|589799540|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
163298090|NCT03903822|589799541|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
163298091|NCT03903822|589799542|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
163298092|NCT03903822|589799535|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162952256|NCT01387022|588529613|FG001|Overall Study|Lost to Follow-up|3|||
162952257|NCT02076022|588529614|FG000|Overall Study|Withdrawal by Subject|2|||
162952258|NCT02076022|588529615|FG001|Overall Study|Withdrawal by Subject|0|||
162952259|NCT01536405|588529618|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
162952260|NCT01536405|588529619|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
162952261|NCT01536405|588529618|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
162952262|NCT01536405|588529619|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
162952263|NCT01536405|588529618|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
162952264|NCT01536405|588529619|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
162952265|NCT01536405|588529618|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
162952266|NCT01536405|588529619|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
162952267|NCT01536405|588529618|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
162952268|NCT01536405|588529619|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
162952269|NCT01536405|588529618|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
162952270|NCT01536405|588529619|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
162952271|NCT01536405|588529618|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
162952272|NCT01536405|588529619|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
162952273|NCT01536405|588529618|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
162952274|NCT01536405|588529619|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
162952275|NCT01536405|588529618|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
162952276|NCT01536405|588529619|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
162952277|NCT01536405|588529618|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
162952278|NCT01536405|588529619|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
162952279|NCT01536405|588529618|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
162952280|NCT01536405|588529619|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
162952281|NCT01536405|588529618|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
162952282|NCT01536405|588529619|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
162952283|NCT01536405|588529618|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
162952284|NCT01536405|588529619|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
162952285|NCT01844375|588529623|FG000|Overall Study|Protocol Violation|1|||
162952286|NCT01844375|588529624|FG001|Overall Study|Protocol Violation|1|||
162952287|NCT03627091|588529625|FG000|Overall Study|Adverse Event|0|||
162952288|NCT03627091|588529626|FG001|Overall Study|Adverse Event|0|||
162952289|NCT03627091|588529627|FG002|Overall Study|Adverse Event|2|||
162952290|NCT03627091|588529625|FG000|Overall Study|Withdrawal by Subject|2|||
162952291|NCT03627091|588529626|FG001|Overall Study|Withdrawal by Subject|0|||
162952292|NCT03627091|588529627|FG002|Overall Study|Withdrawal by Subject|2|||
162952293|NCT03627091|588529625|FG000|Overall Study|Physician Decision|2|||
162952294|NCT03627091|588529626|FG001|Overall Study|Physician Decision|0|||
162952295|NCT03627091|588529627|FG002|Overall Study|Physician Decision|0|||
162952296|NCT03627091|588529625|FG000|Overall Study|Site terminated by sponsor|0|||
162952297|NCT03627091|588529626|FG001|Overall Study|Site terminated by sponsor|1|||
163192264|NCT02110238|589419331|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
163192265|NCT02110238|589419332|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
163192266|NCT02110238|589419331|FG000|12 Week Pivotal Phase|Physician Decision|0|||
163192267|NCT02110238|589419332|FG001|12 Week Pivotal Phase|Physician Decision|2|||
163192268|NCT02110238|589419331|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
163192269|NCT02110238|589419332|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
163192270|NCT02110238|589419331|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
163192271|NCT02110238|589419332|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
163192272|NCT02110238|589419331|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
163192273|NCT02110238|589419332|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
163192274|NCT02110238|589419331|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
163192275|NCT02110238|589419332|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
163192276|NCT02110238|589419331|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
163192277|NCT02110238|589419332|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
163192278|NCT02110238|589419331|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
163192279|NCT02110238|589419332|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
163192280|NCT02110238|589419331|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
163192281|NCT02110238|589419332|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
163192282|NCT03228433|589419337|FG000|Overall Study|Lost to Follow-up|1|||
163192283|NCT03228433|589419338|FG001|Overall Study|Lost to Follow-up|0|||
162952298|NCT03627091|588529627|FG002|Overall Study|Site terminated by sponsor|0|||
162952299|NCT03627091|588529625|FG000|Overall Study|Disease relapse|7|||
162952300|NCT03627091|588529626|FG001|Overall Study|Disease relapse|5|||
162952301|NCT03627091|588529627|FG002|Overall Study|Disease relapse|1|||
163192284|NCT03228433|589419339|FG002|Overall Study|Lost to Follow-up|0|||
163192285|NCT03228433|589419340|FG003|Overall Study|Lost to Follow-up|0|||
163192286|NCT03228433|589419341|FG004|Overall Study|Lost to Follow-up|0|||
162952302|NCT03627091|588529625|FG000|Overall Study|Other|1|||
162952303|NCT03627091|588529626|FG001|Overall Study|Other|0|||
162952304|NCT03627091|588529627|FG002|Overall Study|Other|0|||
162952305|NCT00579670|588529628|FG000|Overall Study|Death|1|||
162952306|NCT00579670|588529629|FG001|Overall Study|Death|0|||
162952307|NCT00579670|588529630|FG002|Overall Study|Death|0|||
162952308|NCT00579670|588529631|FG003|Overall Study|Death|0|||
162952309|NCT00579670|588529632|FG004|Overall Study|Death|0|||
162952310|NCT00579670|588529628|FG000|Overall Study|Adverse Event|1|||
162952311|NCT00579670|588529629|FG001|Overall Study|Adverse Event|0|||
162952312|NCT00579670|588529630|FG002|Overall Study|Adverse Event|1|||
162952313|NCT00579670|588529631|FG003|Overall Study|Adverse Event|2|||
162952314|NCT00579670|588529632|FG004|Overall Study|Adverse Event|0|||
162952315|NCT00579670|588529628|FG000|Overall Study|Lack of Efficacy|0|||
162952316|NCT00579670|588529629|FG001|Overall Study|Lack of Efficacy|0|||
162952317|NCT00579670|588529630|FG002|Overall Study|Lack of Efficacy|1|||
162952318|NCT00579670|588529631|FG003|Overall Study|Lack of Efficacy|14|||
162952319|NCT00579670|588529632|FG004|Overall Study|Lack of Efficacy|0|||
162952320|NCT00579670|588529628|FG000|Overall Study|Lost to Follow-up|0|||
162952321|NCT00579670|588529629|FG001|Overall Study|Lost to Follow-up|1|||
162952322|NCT00579670|588529630|FG002|Overall Study|Lost to Follow-up|0|||
162952323|NCT00579670|588529631|FG003|Overall Study|Lost to Follow-up|4|||
162952324|NCT00579670|588529632|FG004|Overall Study|Lost to Follow-up|0|||
162952325|NCT00579670|588529628|FG000|Overall Study|Other|0|||
162952326|NCT00579670|588529629|FG001|Overall Study|Other|0|||
162952327|NCT00579670|588529630|FG002|Overall Study|Other|1|||
162952328|NCT00579670|588529631|FG003|Overall Study|Other|2|||
162952329|NCT00579670|588529632|FG004|Overall Study|Other|0|||
162952330|NCT00579670|588529628|FG000|Overall Study|Withdrawal by Subject|0|||
162952331|NCT00579670|588529629|FG001|Overall Study|Withdrawal by Subject|0|||
162952332|NCT00579670|588529630|FG002|Overall Study|Withdrawal by Subject|1|||
162952333|NCT00579670|588529631|FG003|Overall Study|Withdrawal by Subject|0|||
162952334|NCT00579670|588529632|FG004|Overall Study|Withdrawal by Subject|0|||
162952335|NCT01863745|588529635|FG000|Overall Study|Disease Progression|9|||
162952336|NCT01863745|588529635|FG000|Overall Study|Adverse Event|2|||
162952337|NCT01863745|588529635|FG000|Overall Study|Death|1|||
162952338|NCT01863745|588529635|FG000|Overall Study|Withdrawal by Subject|1|||
162952339|NCT01171963|588529638|FG000|Overall Study|Adverse Event|10|||
162952340|NCT01171963|588529639|FG001|Overall Study|Adverse Event|15|||
162952341|NCT01171963|588529638|FG000|Overall Study|Lost to Follow-up|23|||
162952342|NCT01171963|588529639|FG001|Overall Study|Lost to Follow-up|24|||
162952343|NCT01171963|588529638|FG000|Overall Study|Other - diarrhoea|1|||
162952344|NCT01171963|588529639|FG001|Overall Study|Other - diarrhoea|0|||
162952345|NCT01171963|588529638|FG000|Overall Study|Withdrawal by Subject|114|||
162952346|NCT01171963|588529639|FG001|Overall Study|Withdrawal by Subject|129|||
162952347|NCT05093205|588529640|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
162952348|NCT05093205|588529641|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
162952349|NCT05093205|588529642|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
162952350|NCT05093205|588529643|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
162952351|NCT05093205|588529644|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
162952352|NCT05093205|588529645|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
162952353|NCT05093205|588529646|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
162952354|NCT05093205|588529647|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
163192287|NCT03228433|589419342|FG005|Overall Study|Lost to Follow-up|0|||
163192288|NCT03228433|589419337|FG000|Overall Study|Positive alcohol test|0|||
163192289|NCT03228433|589419338|FG001|Overall Study|Positive alcohol test|0|||
163192290|NCT03228433|589419339|FG002|Overall Study|Positive alcohol test|0|||
163192291|NCT03228433|589419340|FG003|Overall Study|Positive alcohol test|1|||
163192292|NCT03228433|589419341|FG004|Overall Study|Positive alcohol test|0|||
163192293|NCT03228433|589419342|FG005|Overall Study|Positive alcohol test|0|||
163192294|NCT03626168|589419345|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163192295|NCT03626168|589419346|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
162952355|NCT05093205|588529648|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
162952356|NCT05093205|588529649|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
162952357|NCT05093205|588529650|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
162952358|NCT05093205|588529651|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
162952359|NCT05093205|588529652|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
162952360|NCT05093205|588529640|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952361|NCT05093205|588529641|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952362|NCT05093205|588529642|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
163298093|NCT03903822|589799536|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
163298094|NCT03903822|589799537|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
163298095|NCT03903822|589799538|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
163298096|NCT03903822|589799539|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
163298097|NCT03903822|589799540|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
163298098|NCT03903822|589799541|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162952363|NCT05093205|588529643|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952364|NCT05093205|588529644|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952365|NCT05093205|588529645|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952366|NCT05093205|588529646|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952367|NCT05093205|588529647|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952368|NCT05093205|588529648|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952369|NCT05093205|588529649|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952370|NCT05093205|588529650|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952371|NCT05093205|588529651|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952372|NCT05093205|588529652|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952373|NCT05093205|588529640|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
162952374|NCT05093205|588529641|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
162952375|NCT05093205|588529642|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
162952376|NCT05093205|588529643|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
162952377|NCT05093205|588529644|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
162952378|NCT05093205|588529645|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
162952379|NCT05093205|588529646|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
162952380|NCT05093205|588529647|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
162952381|NCT05093205|588529648|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
162952382|NCT05093205|588529649|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
162952383|NCT05093205|588529650|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
162952384|NCT05093205|588529651|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
162952385|NCT05093205|588529652|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
162952386|NCT05093205|588529640|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
162952387|NCT05093205|588529641|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
162952388|NCT05093205|588529642|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
162952389|NCT05093205|588529643|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
162952390|NCT05093205|588529644|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
162952391|NCT05093205|588529645|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
162952392|NCT05093205|588529646|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
162952393|NCT05093205|588529647|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
162952394|NCT05093205|588529648|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
162952395|NCT05093205|588529649|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
162952396|NCT05093205|588529650|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
162952397|NCT05093205|588529651|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
162952398|NCT05093205|588529652|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
162952399|NCT05093205|588529640|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
162952400|NCT05093205|588529641|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
162952401|NCT05093205|588529642|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
162952402|NCT05093205|588529643|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
162952403|NCT05093205|588529644|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
162952404|NCT05093205|588529645|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
162952405|NCT05093205|588529646|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
162952406|NCT05093205|588529647|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
162952407|NCT05093205|588529648|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
162952408|NCT05093205|588529649|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
162952409|NCT05093205|588529650|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
162952410|NCT05093205|588529651|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
162952411|NCT05093205|588529652|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
162952412|NCT05093205|588529640|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
162952413|NCT05093205|588529641|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
162952414|NCT05093205|588529642|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
162952415|NCT05093205|588529643|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
162952416|NCT05093205|588529644|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
162952417|NCT05093205|588529645|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
162952418|NCT05093205|588529646|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
162952419|NCT05093205|588529647|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
162952420|NCT05093205|588529648|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
162952421|NCT05093205|588529649|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
162952422|NCT05093205|588529650|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
162952423|NCT05093205|588529651|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
162952424|NCT05093205|588529652|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
162952425|NCT05093205|588529640|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
162952426|NCT05093205|588529641|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
162952427|NCT05093205|588529642|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
163298099|NCT03903822|589799542|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162952428|NCT05093205|588529643|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
162952429|NCT05093205|588529644|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
162952430|NCT05093205|588529645|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
162952431|NCT05093205|588529646|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
162952432|NCT05093205|588529647|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
162952433|NCT05093205|588529648|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
162952434|NCT05093205|588529649|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
162952435|NCT05093205|588529650|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
162952436|NCT05093205|588529651|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
162952437|NCT05093205|588529652|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
162952438|NCT05093205|588529640|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
162952439|NCT05093205|588529641|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
162952440|NCT05093205|588529642|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
162952441|NCT05093205|588529643|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
162952442|NCT05093205|588529644|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
162952443|NCT05093205|588529645|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
162952444|NCT05093205|588529646|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
162952445|NCT05093205|588529647|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
162952446|NCT05093205|588529648|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
162952447|NCT05093205|588529649|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
162952448|NCT05093205|588529650|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
162952449|NCT05093205|588529651|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
162952450|NCT05093205|588529652|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
162952451|NCT05093205|588529640|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952452|NCT05093205|588529641|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952453|NCT05093205|588529642|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952454|NCT05093205|588529643|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952455|NCT05093205|588529644|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952456|NCT05093205|588529645|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952457|NCT05093205|588529646|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952458|NCT05093205|588529647|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952459|NCT05093205|588529648|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952460|NCT05093205|588529649|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
162952461|NCT05093205|588529650|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952462|NCT05093205|588529651|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952463|NCT05093205|588529652|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952464|NCT05093205|588529640|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
162952465|NCT05093205|588529641|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
162952466|NCT05093205|588529642|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
162952467|NCT05093205|588529643|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
162952468|NCT05093205|588529644|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
162952469|NCT05093205|588529645|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
162952470|NCT05093205|588529646|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
162952471|NCT05093205|588529647|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
162952472|NCT05093205|588529648|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
162952473|NCT05093205|588529649|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
162952474|NCT05093205|588529650|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
162952475|NCT05093205|588529651|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
162952476|NCT05093205|588529652|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
162952477|NCT05093205|588529640|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952478|NCT05093205|588529641|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952479|NCT05093205|588529642|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952480|NCT05093205|588529643|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952481|NCT05093205|588529644|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952482|NCT05093205|588529645|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952483|NCT05093205|588529646|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952484|NCT05093205|588529647|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952485|NCT05093205|588529648|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952486|NCT05093205|588529649|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952487|NCT05093205|588529650|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
162952488|NCT05093205|588529651|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952489|NCT05093205|588529652|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952490|NCT05093205|588529640|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952491|NCT05093205|588529641|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952492|NCT05093205|588529642|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952493|NCT05093205|588529643|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952494|NCT05093205|588529644|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
163192296|NCT03626168|589419345|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
162952495|NCT05093205|588529645|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
163298100|NCT03903822|589799535|FG000|Follow up Phase (4 Weeks)|Other|1|||
162952496|NCT05093205|588529646|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952497|NCT05093205|588529647|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952498|NCT05093205|588529648|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952499|NCT05093205|588529649|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952500|NCT05093205|588529650|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952501|NCT05093205|588529651|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
162952502|NCT05093205|588529652|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952503|NCT05093205|588529640|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
162952504|NCT05093205|588529641|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
162952505|NCT05093205|588529642|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
162952506|NCT05093205|588529643|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
162952507|NCT05093205|588529644|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
162952508|NCT05093205|588529645|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
162952509|NCT05093205|588529646|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
162952510|NCT05093205|588529647|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
162952511|NCT05093205|588529648|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
162952512|NCT05093205|588529649|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
162952513|NCT05093205|588529650|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
162952514|NCT05093205|588529651|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
162952515|NCT05093205|588529652|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
162952516|NCT05093205|588529640|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952517|NCT05093205|588529641|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952518|NCT05093205|588529642|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952519|NCT05093205|588529643|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952520|NCT05093205|588529644|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952521|NCT05093205|588529645|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952522|NCT05093205|588529646|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952523|NCT05093205|588529647|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952524|NCT05093205|588529648|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952525|NCT05093205|588529649|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952526|NCT05093205|588529650|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952527|NCT05093205|588529651|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
162952528|NCT05093205|588529652|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952529|NCT00268905|588529660|FG000|Overall Study|Adverse Event|3|||
162952530|NCT00268905|588529661|FG001|Overall Study|Adverse Event|0|||
162952531|NCT00268905|588529662|FG002|Overall Study|Adverse Event|4|||
162952532|NCT00268905|588529660|FG000|Overall Study|Lost to Follow-up|0|||
162952533|NCT00268905|588529661|FG001|Overall Study|Lost to Follow-up|1|||
162952534|NCT00268905|588529662|FG002|Overall Study|Lost to Follow-up|0|||
162952535|NCT00268905|588529660|FG000|Overall Study|Withdrawal by Subject|0|||
162952536|NCT00268905|588529661|FG001|Overall Study|Withdrawal by Subject|0|||
162952537|NCT00268905|588529662|FG002|Overall Study|Withdrawal by Subject|3|||
162952538|NCT00268905|588529660|FG000|Overall Study|Progressive Disease|28|||
162952539|NCT00268905|588529661|FG001|Overall Study|Progressive Disease|4|||
162952540|NCT00268905|588529662|FG002|Overall Study|Progressive Disease|3|||
162952541|NCT00268905|588529660|FG000|Overall Study|Physician Decision|3|||
162952542|NCT00268905|588529661|FG001|Overall Study|Physician Decision|0|||
162952543|NCT00268905|588529662|FG002|Overall Study|Physician Decision|1|||
162952544|NCT00268905|588529660|FG000|Overall Study|Clinical Progression|9|||
162952545|NCT00268905|588529661|FG001|Overall Study|Clinical Progression|4|||
162952546|NCT00268905|588529662|FG002|Overall Study|Clinical Progression|1|||
162952547|NCT01406795|588529663|FG000|Overall Study|Withdrawal by Subject|1|||
162952548|NCT03897088|588529664|FG000|Overall Study|Withdrawal by Subject|12|||
162952549|NCT03897088|588529665|FG001|Overall Study|Withdrawal by Subject|12|||
162952550|NCT03897088|588529664|FG000|Overall Study|Lost to Follow-up|7|||
162952551|NCT03897088|588529665|FG001|Overall Study|Lost to Follow-up|15|||
162952552|NCT03897088|588529664|FG000|Overall Study|Sponsor Decision|1|||
162952553|NCT03897088|588529665|FG001|Overall Study|Sponsor Decision|2|||
162952554|NCT03897088|588529664|FG000|Overall Study|COVID-19|2|||
162952555|NCT03897088|588529665|FG001|Overall Study|COVID-19|0|||
162952556|NCT03897088|588529664|FG000|Overall Study|Other|3|||
162952557|NCT03897088|588529665|FG001|Overall Study|Other|0|||
162952558|NCT03897088|588529664|FG000|Overall Study|Non-compliance with Study Drug|1|||
162952559|NCT03897088|588529665|FG001|Overall Study|Non-compliance with Study Drug|1|||
162952560|NCT03897088|588529664|FG000|Overall Study|Pregnancy|0|||
162952561|NCT03897088|588529665|FG001|Overall Study|Pregnancy|1|||
162952562|NCT01469546|588529666|FG000|Received 5 mg Dose|Adverse Event|13|||
162952563|NCT01469546|588529666|FG000|Received 5 mg Dose|Death|2|||
163192297|NCT03626168|589419346|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
163192298|NCT03626168|589419345|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
162952564|NCT01469546|588529666|FG000|Received 5 mg Dose|Protocol Violation|2|||
162952565|NCT01469546|588529666|FG000|Received 5 mg Dose|Progressive Disease|3|||
162952566|NCT01469546|588529666|FG000|Received 5 mg Dose|Physician Decision|3|||
162952567|NCT02865122|588529667|FG000|Overall Study|Adverse Event|1|||
162952568|NCT02865122|588529668|FG001|Overall Study|Adverse Event|0|||
162952569|NCT02865122|588529669|FG002|Overall Study|Adverse Event|0|||
163192299|NCT03626168|589419346|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
162952570|NCT01811953|588531592|FG000|Overall Study|Adverse Event|0|||
162952571|NCT01811953|588531593|FG001|Overall Study|Adverse Event|0|||
162952572|NCT01811953|588531594|FG002|Overall Study|Adverse Event|0|||
162952573|NCT01811953|588531595|FG003|Overall Study|Adverse Event|1|||
162952574|NCT01811953|588531596|FG004|Overall Study|Adverse Event|0|||
162952575|NCT01811953|588531597|FG005|Overall Study|Adverse Event|1|||
162952576|NCT01811953|588531592|FG000|Overall Study|Protocol Violation|0|||
162952577|NCT01811953|588531593|FG001|Overall Study|Protocol Violation|0|||
162952578|NCT01811953|588531594|FG002|Overall Study|Protocol Violation|0|||
162952579|NCT01811953|588531595|FG003|Overall Study|Protocol Violation|0|||
162952580|NCT01811953|588531596|FG004|Overall Study|Protocol Violation|1|||
162952581|NCT01811953|588531597|FG005|Overall Study|Protocol Violation|0|||
162952582|NCT04089735|588531606|FG000|Overall Study|Adverse Event|1|||
162952583|NCT04089735|588531607|FG001|Overall Study|Adverse Event|0|||
162952584|NCT04089735|588531608|FG002|Overall Study|Adverse Event|1|||
162952585|NCT04089735|588531609|FG003|Overall Study|Adverse Event|1|||
162952586|NCT04089735|588531610|FG004|Overall Study|Adverse Event|0|||
162952587|NCT04089735|588531611|FG005|Overall Study|Adverse Event|0|||
162952588|NCT04089735|588531606|FG000|Overall Study|Physician Decision|0|||
162952589|NCT04089735|588531607|FG001|Overall Study|Physician Decision|3|||
162952590|NCT04089735|588531608|FG002|Overall Study|Physician Decision|0|||
162952591|NCT04089735|588531609|FG003|Overall Study|Physician Decision|0|||
162952592|NCT04089735|588531610|FG004|Overall Study|Physician Decision|0|||
162952593|NCT04089735|588531611|FG005|Overall Study|Physician Decision|0|||
162952594|NCT04089735|588531606|FG000|Overall Study|Withdrawal by Subject|0|||
162952595|NCT04089735|588531607|FG001|Overall Study|Withdrawal by Subject|0|||
162952596|NCT04089735|588531608|FG002|Overall Study|Withdrawal by Subject|1|||
162952597|NCT04089735|588531609|FG003|Overall Study|Withdrawal by Subject|0|||
162952598|NCT04089735|588531610|FG004|Overall Study|Withdrawal by Subject|0|||
162952599|NCT04089735|588531611|FG005|Overall Study|Withdrawal by Subject|0|||
162952600|NCT04089735|588531606|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
162952601|NCT04089735|588531607|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
162952602|NCT04089735|588531608|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
162952603|NCT04089735|588531609|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
162952604|NCT04089735|588531610|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
162952605|NCT04089735|588531611|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
162952606|NCT04123548|588531614|FG000|Overall Study|Withdrawal by Subject|1|||
162952607|NCT04123548|588531614|FG000|Overall Study|Lost to Follow-up|8|||
162952608|NCT04123548|588531614|FG000|Overall Study|Death|4|||
162952609|NCT04123548|588531614|FG000|Overall Study|Reason Not Specified|1|||
162952610|NCT00851877|588531615|FG000|Phase I-1|Death|1|||
162952611|NCT00851877|588531616|FG001|Phase I-1|Death|0|||
162952612|NCT00851877|588531617|FG002|Phase I-1|Death|0|||
162952613|NCT00851877|588531615|FG000|Phase II|Withdrawal by Subject|0|||
162952614|NCT00851877|588531616|FG001|Phase II|Withdrawal by Subject|0|||
162952615|NCT00851877|588531617|FG002|Phase II|Withdrawal by Subject|3|||
162952616|NCT02440711|588531618|FG000|Second Intervention|Lost to Follow-up|1|||
162952617|NCT02440711|588531619|FG001|Second Intervention|Lost to Follow-up|0|||
162952618|NCT04129346|588531620|FG000|Overall Study|Death|1|||
162952619|NCT04129346|588531621|FG001|Overall Study|Death|0|||
162952620|NCT05755282|588531622|FG000|Overall Study|Protocol Violation|0|||
162952621|NCT05755282|588531623|FG001|Overall Study|Protocol Violation|1|||
162952622|NCT00573066|588531624|FG000|Overall Study|Exclusion criteria|18|||
162952623|NCT00573066|588531624|FG000|Overall Study|IV malfunction|1|||
162952624|NCT00573066|588531624|FG000|Overall Study|Postoperative bleeding|1|||
162952625|NCT00627016|588531625|FG000|Overall Study|Adverse Event|1|||
162952626|NCT00627016|588531626|FG001|Overall Study|Adverse Event|1|||
162952627|NCT00627016|588531625|FG000|Overall Study|Protocol Violation|0|||
162952628|NCT00627016|588531626|FG001|Overall Study|Protocol Violation|2|||
162952629|NCT00627016|588531625|FG000|Overall Study|Lost to Follow-up|0|||
162952630|NCT00627016|588531626|FG001|Overall Study|Lost to Follow-up|1|||
162952631|NCT00627016|588531625|FG000|Overall Study|Withdrawal by Subject|2|||
162952632|NCT00627016|588531626|FG001|Overall Study|Withdrawal by Subject|1|||
162952633|NCT00627016|588531625|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
162952634|NCT00627016|588531626|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
162952635|NCT00627016|588531625|FG000|Overall Study|Lack of Efficacy|1|||
162952636|NCT00627016|588531626|FG001|Overall Study|Lack of Efficacy|0|||
162952637|NCT00627016|588531625|FG000|Overall Study|Placed on Excluded Drugs|1|||
162952638|NCT00627016|588531626|FG001|Overall Study|Placed on Excluded Drugs|0|||
162952639|NCT00627016|588531625|FG000|Overall Study|Pregnancy|1|||
162952640|NCT00627016|588531626|FG001|Overall Study|Pregnancy|0|||
162952641|NCT03025880|588531627|FG000|Overall Study|Adverse Event|1|||
162952642|NCT03025880|588531628|FG001|Overall Study|Adverse Event|0|||
162952643|NCT03025880|588531627|FG000|Overall Study|Death|1|||
162952644|NCT03025880|588531628|FG001|Overall Study|Death|1|||
162952645|NCT03025880|588531627|FG000|Overall Study|Withdrawal by Subject|0|||
162952646|NCT03025880|588531628|FG001|Overall Study|Withdrawal by Subject|1|||
162952647|NCT03025880|588531627|FG000|Overall Study|Physician Decision|0|||
162952648|NCT03025880|588531628|FG001|Overall Study|Physician Decision|1|||
162952649|NCT03025880|588531627|FG000|Overall Study|Progressive Disease|12|||
162952650|NCT03025880|588531628|FG001|Overall Study|Progressive Disease|19|||
162952651|NCT01185548|588531630|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
162952652|NCT00086996|588531631|FG000|Overall Study|Adverse Event|29|||
162952653|NCT00086996|588531631|FG000|Overall Study|Death|4|||
162952654|NCT00086996|588531631|FG000|Overall Study|progression/relapse|7|||
162952655|NCT00086996|588531631|FG000|Overall Study|Withdrawal by Subject|13|||
162952656|NCT00086996|588531631|FG000|Overall Study|Other|6|||
162952657|NCT00086996|588531631|FG000|Overall Study|not eligible|5|||
162952658|NCT01422538|588531633|FG000|Overall Study|Lost to Follow-up|0|||
162952659|NCT01422538|588531634|FG001|Overall Study|Lost to Follow-up|1|||
162952660|NCT01422538|588531635|FG002|Overall Study|Lost to Follow-up|1|||
162952661|NCT01422538|588531633|FG000|Overall Study|Missed visit|0|||
162952662|NCT01422538|588531634|FG001|Overall Study|Missed visit|1|||
162952663|NCT01422538|588531635|FG002|Overall Study|Missed visit|1|||
162952664|NCT02770820|588531636|FG000|Overall Study|Death|1|||
162952665|NCT02770820|588531636|FG000|Overall Study|Physician Decision|2|||
162952666|NCT00312663|588531637|FG000|Immunization Phase|Adverse Event|0|||
162952667|NCT00312663|588531638|FG001|Immunization Phase|Adverse Event|1|||
162952668|NCT00312663|588531639|FG002|Immunization Phase|Adverse Event|0|||
162952669|NCT00286754|588531642|FG000|Overall Study|Adverse Event|2|||
162952670|NCT00286754|588531643|FG001|Overall Study|Adverse Event|2|||
162952671|NCT00286754|588531644|FG002|Overall Study|Adverse Event|3|||
162952672|NCT00286754|588531642|FG000|Overall Study|Withdrawal by Subject|6|||
162952673|NCT00286754|588531643|FG001|Overall Study|Withdrawal by Subject|2|||
162952674|NCT00286754|588531644|FG002|Overall Study|Withdrawal by Subject|0|||
162952675|NCT00286754|588531642|FG000|Overall Study|Lost to Follow-up|12|||
162952676|NCT00286754|588531643|FG001|Overall Study|Lost to Follow-up|14|||
162952677|NCT00286754|588531644|FG002|Overall Study|Lost to Follow-up|6|||
162952678|NCT00286754|588531642|FG000|Overall Study|Moved out of state|0|||
162952679|NCT00286754|588531643|FG001|Overall Study|Moved out of state|0|||
162952680|NCT00286754|588531644|FG002|Overall Study|Moved out of state|1|||
163192300|NCT01419626|589419347|FG000|Overall Study|Protocol Violation|3|||
162952681|NCT02661295|588531645|FG000|Overall Study|Death|1|||
162952682|NCT02661295|588531645|FG000|Overall Study|Transferred Out|1|||
163192301|NCT01419626|589419348|FG001|Overall Study|Protocol Violation|2|||
162952683|NCT02661295|588531645|FG000|Overall Study|Kidney Transplant|1|||
162952684|NCT02661295|588531645|FG000|Overall Study|Withdrawn due to side effects|8|||
162952685|NCT02661295|588531645|FG000|Overall Study|Withdrawn due to access type|1|||
163192302|NCT01419626|589419349|FG002|Overall Study|Protocol Violation|2|||
162952686|NCT02661295|588531645|FG000|Overall Study|Withdrawn due to allergies|1|||
162952687|NCT02661295|588531645|FG000|Overall Study|Withdrawn due to non-compliance|1|||
162952688|NCT02661295|588531645|FG000|Overall Study|Withdrawal by Subject|3|||
162952689|NCT02661295|588531645|FG000|Overall Study|Failed screening|2|||
162952690|NCT00301366|588531646|FG000|Overall Study|Adverse Event|1|||
162952691|NCT01313273|588531647|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
162952692|NCT01313273|588531648|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
162952693|NCT01313273|588531647|FG000|Overall Study|Withdrawal by Subject|1|||
162952694|NCT01313273|588531648|FG001|Overall Study|Withdrawal by Subject|0|||
162952695|NCT01313273|588531647|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
162952696|NCT01313273|588531648|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
162952697|NCT02726581|588531653|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
162952698|NCT02726581|588531654|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
162952699|NCT02726581|588531655|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
162952700|NCT02726581|588531653|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
162952701|NCT02726581|588531654|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
162952702|NCT02726581|588531655|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
162952703|NCT02726581|588531653|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
162952704|NCT02726581|588531654|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162952705|NCT02726581|588531655|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162952706|NCT02726581|588531653|FG000|Treatment Period|Disease progression|47|||
162952707|NCT02726581|588531654|FG001|Treatment Period|Disease progression|50|||
162952708|NCT02726581|588531655|FG002|Treatment Period|Disease progression|16|||
162952709|NCT02726581|588531653|FG000|Treatment Period|Other reasons|9|||
162952710|NCT02726581|588531654|FG001|Treatment Period|Other reasons|8|||
162952711|NCT02726581|588531655|FG002|Treatment Period|Other reasons|2|||
162952712|NCT02726581|588531653|FG000|Treatment Period|Study drug toxicity|6|||
162952713|NCT02726581|588531654|FG001|Treatment Period|Study drug toxicity|3|||
162952714|NCT02726581|588531655|FG002|Treatment Period|Study drug toxicity|2|||
162952715|NCT02726581|588531653|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
162952716|NCT02726581|588531654|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
162952717|NCT02726581|588531655|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
162952718|NCT02726581|588531653|FG000|Treatment Period|Participant withdrew consent|3|||
162952719|NCT02726581|588531654|FG001|Treatment Period|Participant withdrew consent|1|||
162952720|NCT02726581|588531655|FG002|Treatment Period|Participant withdrew consent|1|||
162952721|NCT02726581|588531653|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
162952722|NCT02726581|588531654|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
162952723|NCT02726581|588531655|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
162952724|NCT02726581|588531653|FG000|Treatment Period|Maximum clinical benefit|0|||
162952725|NCT02726581|588531654|FG001|Treatment Period|Maximum clinical benefit|2|||
162952726|NCT02726581|588531655|FG002|Treatment Period|Maximum clinical benefit|0|||
162952727|NCT02726581|588531653|FG000|Treatment Period|Death|1|||
162952728|NCT02726581|588531654|FG001|Treatment Period|Death|0|||
162952729|NCT02726581|588531655|FG002|Treatment Period|Death|0|||
162952730|NCT02726581|588531653|FG000|Treatment Period|Poor/non-compliance|1|||
162952731|NCT02726581|588531654|FG001|Treatment Period|Poor/non-compliance|0|||
162952732|NCT02726581|588531655|FG002|Treatment Period|Poor/non-compliance|0|||
162952733|NCT02726581|588531653|FG000|Treatment Period|Participant no longer meets study criteria|0|||
162952734|NCT02726581|588531654|FG001|Treatment Period|Participant no longer meets study criteria|1|||
162952735|NCT02726581|588531655|FG002|Treatment Period|Participant no longer meets study criteria|0|||
162952736|NCT03195491|588531657|FG000|Overall Study|Study drug toxicity|25|||
162952737|NCT03195491|588531658|FG001|Overall Study|Study drug toxicity|3|||
162952738|NCT03195491|588531657|FG000|Overall Study|Maximum clinical benefit|5|||
162952739|NCT03195491|588531658|FG001|Overall Study|Maximum clinical benefit|0|||
162952740|NCT03195491|588531657|FG000|Overall Study|Lost to Follow-up|1|||
162952741|NCT03195491|588531658|FG001|Overall Study|Lost to Follow-up|0|||
162952742|NCT03195491|588531657|FG000|Overall Study|Death|3|||
162952743|NCT03195491|588531658|FG001|Overall Study|Death|0|||
162952744|NCT03195491|588531657|FG000|Overall Study|Adverse event unrelated to study drug|19|||
162952745|NCT03195491|588531658|FG001|Overall Study|Adverse event unrelated to study drug|2|||
162952746|NCT03195491|588531657|FG000|Overall Study|Disease progression|266|||
162952747|NCT03195491|588531658|FG001|Overall Study|Disease progression|8|||
162952748|NCT03195491|588531657|FG000|Overall Study|Other reasons|10|||
162952749|NCT03195491|588531658|FG001|Overall Study|Other reasons|0|||
162952750|NCT03195491|588531657|FG000|Overall Study|Participant withdrew consent|8|||
162952751|NCT03195491|588531658|FG001|Overall Study|Participant withdrew consent|1|||
162952752|NCT03195491|588531657|FG000|Overall Study|Participant no longer meets study criteria|0|||
162952753|NCT03195491|588531658|FG001|Overall Study|Participant no longer meets study criteria|1|||
162952754|NCT03195491|588531657|FG000|Overall Study|Participant request to discontinue study treatment|10|||
162952755|NCT03195491|588531658|FG001|Overall Study|Participant request to discontinue study treatment|0|||
162952756|NCT03496623|588531659|FG000|Run-In Period (2 Weeks)|Death|1|||
162952757|NCT03496623|588531660|FG001|Run-In Period (2 Weeks)|Death|0|||
162952758|NCT03496623|588531661|FG002|Run-In Period (2 Weeks)|Death|0|||
162952759|NCT03496623|588531662|FG003|Run-In Period (2 Weeks)|Death|0|||
162952760|NCT03496623|588531663|FG004|Run-In Period (2 Weeks)|Death|0|||
162952761|NCT03496623|588531659|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
162952762|NCT03496623|588531660|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
162952763|NCT03496623|588531661|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
162952764|NCT03496623|588531662|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
163298101|NCT03903822|589799536|FG001|Follow up Phase (4 Weeks)|Other|1|||
162952765|NCT03496623|588531663|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
162952766|NCT03496623|588531659|FG000|Period 1 (12 Weeks)|Death|0|||
162952767|NCT03496623|588531660|FG001|Period 1 (12 Weeks)|Death|3|||
162952768|NCT03496623|588531661|FG002|Period 1 (12 Weeks)|Death|0|||
162952769|NCT03496623|588531662|FG003|Period 1 (12 Weeks)|Death|0|||
162952770|NCT03496623|588531663|FG004|Period 1 (12 Weeks)|Death|0|||
162952771|NCT03496623|588531659|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
162952772|NCT03496623|588531660|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
162952773|NCT03496623|588531661|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
162952774|NCT03496623|588531662|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
162952775|NCT03496623|588531663|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
162952776|NCT03496623|588531659|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162952777|NCT03496623|588531660|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
162952778|NCT03496623|588531661|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
162952779|NCT03496623|588531662|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162952780|NCT03496623|588531663|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162952781|NCT03496623|588531659|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
162952782|NCT03496623|588531660|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
162952783|NCT03496623|588531661|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
162952784|NCT03496623|588531662|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
162952785|NCT03496623|588531663|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
162952786|NCT03496623|588531659|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162952787|NCT03496623|588531660|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162952788|NCT03496623|588531661|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
162952789|NCT03496623|588531662|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162952790|NCT03496623|588531663|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162952791|NCT03496623|588531659|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
162952792|NCT03496623|588531660|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
163192303|NCT01419626|589419347|FG000|Overall Study|Withdrawal by Subject|1|||
163192304|NCT01419626|589419348|FG001|Overall Study|Withdrawal by Subject|0|||
163192305|NCT01419626|589419349|FG002|Overall Study|Withdrawal by Subject|0|||
163192306|NCT01419626|589419347|FG000|Overall Study|Lost to Follow-up|0|||
163192307|NCT01419626|589419348|FG001|Overall Study|Lost to Follow-up|1|||
163192308|NCT01419626|589419349|FG002|Overall Study|Lost to Follow-up|1|||
163192309|NCT04738734|589419359|FG000|Overall Study|Withdrawal by Subject|2|||
163192310|NCT04738734|589419360|FG001|Overall Study|Withdrawal by Subject|4|||
163192311|NCT04738734|589419359|FG000|Overall Study|Lost to Follow-up|5|||
163192312|NCT04738734|589419360|FG001|Overall Study|Lost to Follow-up|2|||
162952793|NCT03496623|588531661|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
162952794|NCT03496623|588531662|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
162952795|NCT03496623|588531663|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
162952796|NCT03496623|588531659|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163192313|NCT04738734|589419359|FG000|Overall Study|Physician Decision|0|||
163192314|NCT04738734|589419360|FG001|Overall Study|Physician Decision|1|||
163192315|NCT04738734|589419359|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
163192316|NCT04738734|589419360|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
163192317|NCT04093414|589419361|FG000|3 Month Follow up|Physician Decision|0|||
163192318|NCT04093414|589419362|FG001|3 Month Follow up|Physician Decision|1|||
163192319|NCT04093414|589419361|FG000|6month Follow up|Physician Decision|1|||
163192320|NCT04093414|589419362|FG001|6month Follow up|Physician Decision|3|||
163192321|NCT03452228|589419363|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
163192322|NCT03452228|589419364|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
163192323|NCT03452228|589419365|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
163192324|NCT03452228|589419363|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
163192325|NCT03452228|589419364|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
163192326|NCT03452228|589419365|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163192327|NCT03452228|589419363|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
163192328|NCT03452228|589419364|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
163192329|NCT03452228|589419365|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
163192330|NCT03452228|589419363|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163192331|NCT03452228|589419364|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163192332|NCT03452228|589419365|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
163192333|NCT03212690|589419366|FG000|Overall Study|Protocol Violation|1|||
163192334|NCT03208127|589419368|FG000|Overall Study|Death|1|||
163192335|NCT01254331|589419373|FG000|Initial Phase|Adverse Event|3|||
163192336|NCT01254331|589419373|FG000|Initial Phase|Withdrawal by Subject|1|||
163192337|NCT01254331|589419373|FG000|Initial Phase|Pregnancy|1|||
163192338|NCT01254331|589419373|FG000|Extension Phase|Lack of Efficacy|1|||
163192339|NCT01254331|589419373|FG000|Extension Phase|Lost to Follow-up|3|||
163192340|NCT01011738|589419374|FG000|Overall Study|Death|12|||
163192341|NCT01011738|589419375|FG001|Overall Study|Death|3|||
163192342|NCT01011738|589419376|FG002|Overall Study|Death|0|||
163192343|NCT01011738|589419374|FG000|Overall Study|Unknown reasons|312|||
163192344|NCT01011738|589419375|FG001|Overall Study|Unknown reasons|291|||
163192345|NCT01011738|589419376|FG002|Overall Study|Unknown reasons|17|||
163192346|NCT00287365|589419377|FG000|Overall Study|sample not acquired|13|||
163192347|NCT00968864|589419378|FG000|Overall Study|Protocol exception/ not evaluable|1|||
163192348|NCT01346969|589419379|FG000|Overall Study|Withdrawal by Subject|0|||
163192349|NCT01346969|589419380|FG001|Overall Study|Withdrawal by Subject|0|||
163192350|NCT01346969|589419381|FG002|Overall Study|Withdrawal by Subject|1|||
163192351|NCT01346969|589419382|FG003|Overall Study|Withdrawal by Subject|0|||
163192352|NCT01346969|589419379|FG000|Overall Study|Lost to Follow-up|1|||
163192353|NCT01346969|589419380|FG001|Overall Study|Lost to Follow-up|0|||
163192354|NCT01346969|589419381|FG002|Overall Study|Lost to Follow-up|2|||
163192355|NCT01346969|589419382|FG003|Overall Study|Lost to Follow-up|0|||
163192356|NCT01346969|589419379|FG000|Overall Study|Physician Decision|0|||
163192357|NCT01346969|589419380|FG001|Overall Study|Physician Decision|0|||
163192358|NCT01346969|589419381|FG002|Overall Study|Physician Decision|0|||
163192359|NCT01346969|589419382|FG003|Overall Study|Physician Decision|1|||
163192360|NCT01346969|589419379|FG000|Overall Study|Randomized but not treated|1|||
163192361|NCT01346969|589419380|FG001|Overall Study|Randomized but not treated|0|||
163192362|NCT01346969|589419381|FG002|Overall Study|Randomized but not treated|0|||
163192363|NCT01346969|589419382|FG003|Overall Study|Randomized but not treated|0|||
163192364|NCT01967173|589419383|FG000|Overall Study|Lost to Follow-up|5|||
163192365|NCT01967173|589419384|FG001|Overall Study|Lost to Follow-up|3|||
163192366|NCT01967173|589419385|FG002|Overall Study|Lost to Follow-up|2|||
163192367|NCT01967173|589419386|FG003|Overall Study|Lost to Follow-up|4|||
163192368|NCT01967173|589419387|FG004|Overall Study|Lost to Follow-up|8|||
163192369|NCT01967173|589419388|FG005|Overall Study|Lost to Follow-up|12|||
163192370|NCT01967173|589419389|FG006|Overall Study|Lost to Follow-up|6|||
163192371|NCT01967173|589419390|FG007|Overall Study|Lost to Follow-up|8|||
163192372|NCT01967173|589419383|FG000|Overall Study|Physician Decision|2|||
163192373|NCT01967173|589419384|FG001|Overall Study|Physician Decision|0|||
163192374|NCT01967173|589419385|FG002|Overall Study|Physician Decision|2|||
163298102|NCT03903822|589799537|FG002|Follow up Phase (4 Weeks)|Other|0|||
163298103|NCT03903822|589799538|FG003|Follow up Phase (4 Weeks)|Other|0|||
163192375|NCT01967173|589419386|FG003|Overall Study|Physician Decision|1|||
163298104|NCT03903822|589799539|FG004|Follow up Phase (4 Weeks)|Other|0|||
163192376|NCT01967173|589419387|FG004|Overall Study|Physician Decision|1|||
163192377|NCT01967173|589419388|FG005|Overall Study|Physician Decision|1|||
163192378|NCT01967173|589419389|FG006|Overall Study|Physician Decision|1|||
163192379|NCT01967173|589419390|FG007|Overall Study|Physician Decision|0|||
163192380|NCT01967173|589419383|FG000|Overall Study|Lack of Efficacy|2|||
163192381|NCT01967173|589419384|FG001|Overall Study|Lack of Efficacy|0|||
163192382|NCT01967173|589419385|FG002|Overall Study|Lack of Efficacy|2|||
163192383|NCT01967173|589419386|FG003|Overall Study|Lack of Efficacy|2|||
163192384|NCT01967173|589419387|FG004|Overall Study|Lack of Efficacy|0|||
163192385|NCT01967173|589419388|FG005|Overall Study|Lack of Efficacy|1|||
163192386|NCT01967173|589419389|FG006|Overall Study|Lack of Efficacy|0|||
163192387|NCT01967173|589419390|FG007|Overall Study|Lack of Efficacy|2|||
163192388|NCT01967173|589419383|FG000|Overall Study|Pregnancy|0|||
163192389|NCT01967173|589419384|FG001|Overall Study|Pregnancy|0|||
163192390|NCT01967173|589419385|FG002|Overall Study|Pregnancy|0|||
163192391|NCT01967173|589419386|FG003|Overall Study|Pregnancy|0|||
163298105|NCT03903822|589799540|FG005|Follow up Phase (4 Weeks)|Other|0|||
163298106|NCT03903822|589799541|FG006|Follow up Phase (4 Weeks)|Other|0|||
163298107|NCT03903822|589799542|FG007|Follow up Phase (4 Weeks)|Other|0|||
163298108|NCT00296036|589799543|FG000|Overall Study|Withdrawal by Subject|1|||
163298109|NCT00296036|589799544|FG001|Overall Study|Withdrawal by Subject|0|||
163298110|NCT00296036|589799545|FG002|Overall Study|Withdrawal by Subject|2|||
163298111|NCT00296036|589799546|FG003|Overall Study|Withdrawal by Subject|1|||
163298112|NCT00296036|589799547|FG004|Overall Study|Withdrawal by Subject|2|||
163298113|NCT00296036|589799548|FG005|Overall Study|Withdrawal by Subject|1|||
163298114|NCT00296036|589799543|FG000|Overall Study|Protocol Violation|0|||
163298115|NCT00296036|589799544|FG001|Overall Study|Protocol Violation|0|||
163298116|NCT00296036|589799545|FG002|Overall Study|Protocol Violation|0|||
163298117|NCT00296036|589799546|FG003|Overall Study|Protocol Violation|0|||
163298118|NCT00296036|589799547|FG004|Overall Study|Protocol Violation|0|||
163298119|NCT00296036|589799548|FG005|Overall Study|Protocol Violation|3|||
163298120|NCT00785512|589799551|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
163298121|NCT00785512|589799552|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
163298122|NCT00785512|589799551|FG000|Overall Study|Adverse Event|0|||
163298123|NCT00785512|589799552|FG001|Overall Study|Adverse Event|0|||
163298124|NCT00785512|589799551|FG000|Overall Study|Lack of Efficacy|0|||
163298125|NCT00785512|589799552|FG001|Overall Study|Lack of Efficacy|2|||
163298126|NCT00785512|589799551|FG000|Overall Study|Withdrawal by Subject|0|||
163298127|NCT00785512|589799552|FG001|Overall Study|Withdrawal by Subject|1|||
163298128|NCT00785512|589799551|FG000|Overall Study|Lost to Follow-up|3|||
163298129|NCT00785512|589799552|FG001|Overall Study|Lost to Follow-up|0|||
163298130|NCT00785512|589799551|FG000|Overall Study|Precedure Refused|0|||
163298131|NCT00785512|589799552|FG001|Overall Study|Precedure Refused|0|||
163298132|NCT00785512|589799551|FG000|Overall Study|IVRS Programing Error|0|||
163298133|NCT00785512|589799552|FG001|Overall Study|IVRS Programing Error|0|||
163298134|NCT00785512|589799551|FG000|Overall Study|Physician Decision|0|||
163298135|NCT00785512|589799552|FG001|Overall Study|Physician Decision|0|||
163298136|NCT00785512|589799551|FG000|Overall Study|Lack of compliance|0|||
163298137|NCT00785512|589799552|FG001|Overall Study|Lack of compliance|1|||
163298138|NCT01792830|589799553|FG000|Overall Study|Withdrawal by Subject|22|||
163298139|NCT01792830|589799554|FG001|Overall Study|Withdrawal by Subject|0|||
163298140|NCT01792830|589799555|FG002|Overall Study|Withdrawal by Subject|0|||
163298141|NCT01792830|589799556|FG003|Overall Study|Withdrawal by Subject|2|||
163298142|NCT01792830|589799557|FG004|Overall Study|Withdrawal by Subject|1|||
163298143|NCT01792830|589799558|FG005|Overall Study|Withdrawal by Subject|1|||
163298144|NCT01792830|589799559|FG006|Overall Study|Withdrawal by Subject|1|||
163298145|NCT01792830|589799560|FG007|Overall Study|Withdrawal by Subject|1|||
163298146|NCT01792830|589799561|FG008|Overall Study|Withdrawal by Subject|7|||
163298147|NCT01792830|589799562|FG009|Overall Study|Withdrawal by Subject|0|||
163298148|NCT01792830|589799563|FG010|Overall Study|Withdrawal by Subject|2|||
163298149|NCT01792830|589799553|FG000|Overall Study|Death|3|||
163298150|NCT01792830|589799554|FG001|Overall Study|Death|0|||
163298151|NCT01792830|589799555|FG002|Overall Study|Death|0|||
163298152|NCT01792830|589799556|FG003|Overall Study|Death|1|||
163298153|NCT01792830|589799557|FG004|Overall Study|Death|0|||
163298154|NCT01792830|589799558|FG005|Overall Study|Death|0|||
163298155|NCT01792830|589799559|FG006|Overall Study|Death|1|||
163298156|NCT01792830|589799560|FG007|Overall Study|Death|0|||
163298157|NCT01792830|589799561|FG008|Overall Study|Death|1|||
163298158|NCT01792830|589799562|FG009|Overall Study|Death|0|||
163298159|NCT01792830|589799563|FG010|Overall Study|Death|1|||
163298160|NCT01792830|589799553|FG000|Overall Study|Adverse Event|0|||
163298161|NCT01792830|589799554|FG001|Overall Study|Adverse Event|0|||
163298162|NCT01792830|589799555|FG002|Overall Study|Adverse Event|0|||
163298163|NCT01792830|589799556|FG003|Overall Study|Adverse Event|0|||
163298164|NCT01792830|589799557|FG004|Overall Study|Adverse Event|0|||
163298165|NCT01792830|589799558|FG005|Overall Study|Adverse Event|0|||
163298166|NCT01792830|589799559|FG006|Overall Study|Adverse Event|0|||
163298167|NCT01792830|589799560|FG007|Overall Study|Adverse Event|0|||
163298168|NCT01792830|589799561|FG008|Overall Study|Adverse Event|1|||
163298169|NCT01792830|589799562|FG009|Overall Study|Adverse Event|0|||
163298170|NCT01792830|589799563|FG010|Overall Study|Adverse Event|0|||
163298171|NCT05274217|589799579|FG000|Overall Study|Study terminated.|11|||
163298172|NCT05274217|589799580|FG001|Overall Study|Study terminated.|0|||
163298173|NCT01697969|589799583|FG000|Overall Study|Did not meet inc/exc criteria|3|||
163298174|NCT02674750|589799587|FG000|Overall Study|Death|4|||
163298175|NCT02674750|589799588|FG001|Overall Study|Death|5|||
163298176|NCT02674750|589799589|FG002|Overall Study|Death|8|||
163298177|NCT02674750|589799587|FG000|Overall Study|Lost to Follow-up|0|||
163298178|NCT02674750|589799588|FG001|Overall Study|Lost to Follow-up|8|||
163298179|NCT02674750|589799589|FG002|Overall Study|Lost to Follow-up|0|||
163298180|NCT02674750|589799587|FG000|Overall Study|Lack of Efficacy|1|||
163298181|NCT02674750|589799588|FG001|Overall Study|Lack of Efficacy|17|||
163298182|NCT02674750|589799589|FG002|Overall Study|Lack of Efficacy|3|||
163298183|NCT02674750|589799587|FG000|Overall Study|Withdrawal by Subject|0|||
163298184|NCT02674750|589799588|FG001|Overall Study|Withdrawal by Subject|7|||
163298185|NCT02674750|589799589|FG002|Overall Study|Withdrawal by Subject|1|||
163298186|NCT02674750|589799587|FG000|Overall Study|Other|0|||
163298187|NCT02674750|589799588|FG001|Overall Study|Other|8|||
163298188|NCT02674750|589799589|FG002|Overall Study|Other|0|||
163298189|NCT00736853|589799590|FG000|Open-Label Period|Physician Decision|2|||
163298190|NCT00736853|589799591|FG001|Open-Label Period|Physician Decision|0|||
163298191|NCT00736853|589799592|FG002|Open-Label Period|Physician Decision|0|||
163298192|NCT00736853|589799590|FG000|Open-Label Period|Adverse Event|31|||
163298193|NCT00736853|589799591|FG001|Open-Label Period|Adverse Event|0|||
163298194|NCT00736853|589799592|FG002|Open-Label Period|Adverse Event|0|||
163298195|NCT00736853|589799590|FG000|Open-Label Period|Withdrawal by Subject|16|||
163298196|NCT00736853|589799591|FG001|Open-Label Period|Withdrawal by Subject|0|||
163298197|NCT00736853|589799592|FG002|Open-Label Period|Withdrawal by Subject|0|||
163298198|NCT00736853|589799590|FG000|Open-Label Period|Started but not treated|42|||
163298199|NCT00736853|589799591|FG001|Open-Label Period|Started but not treated|0|||
163298200|NCT00736853|589799592|FG002|Open-Label Period|Started but not treated|0|||
163298201|NCT00736853|589799590|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
163298202|NCT00736853|589799591|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
163298203|NCT00736853|589799592|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
163298204|NCT00736853|589799590|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
163298205|NCT00736853|589799591|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
163298206|NCT00736853|589799592|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
163298207|NCT00736853|589799590|FG000|Double-Blind Period|Lack of Efficacy|0|||
163298208|NCT00736853|589799591|FG001|Double-Blind Period|Lack of Efficacy|19|||
163298209|NCT00736853|589799592|FG002|Double-Blind Period|Lack of Efficacy|42|||
163298210|NCT00736853|589799590|FG000|Double-Blind Period|Adverse Event|0|||
163298211|NCT00736853|589799591|FG001|Double-Blind Period|Adverse Event|3|||
163298212|NCT00736853|589799592|FG002|Double-Blind Period|Adverse Event|2|||
163298213|NCT00736853|589799590|FG000|Double-Blind Period|Withdrawal by Subject|0|||
163298214|NCT00736853|589799591|FG001|Double-Blind Period|Withdrawal by Subject|1|||
163298215|NCT00736853|589799592|FG002|Double-Blind Period|Withdrawal by Subject|4|||
163298216|NCT00736853|589799590|FG000|Double-Blind Period|Ineligible to participate the study|0|||
163298217|NCT00736853|589799591|FG001|Double-Blind Period|Ineligible to participate the study|1|||
163298218|NCT00736853|589799592|FG002|Double-Blind Period|Ineligible to participate the study|0|||
163298219|NCT01764464|589799593|FG000|First Intervention|Withdrawal by Subject|1|||
163298220|NCT01764464|589799594|FG001|First Intervention|Withdrawal by Subject|0|||
163298221|NCT01764464|589799593|FG000|First Intervention|Lost to Follow-up|1|||
163298222|NCT01764464|589799594|FG001|First Intervention|Lost to Follow-up|0|||
163298223|NCT01764464|589799593|FG000|First Intervention|Adverse Event|0|||
163298224|NCT01764464|589799594|FG001|First Intervention|Adverse Event|2|||
163298225|NCT01764464|589799593|FG000|First Intervention|did not receive study drug|0|||
163298226|NCT01764464|589799594|FG001|First Intervention|did not receive study drug|1|||
163298227|NCT01764464|589799593|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
163298228|NCT01764464|589799594|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
163298229|NCT01616459|589799596|FG000|Overall Study|Adverse Event|1|||
163298230|NCT01616459|589799597|FG001|Overall Study|Adverse Event|1|||
163298231|NCT01616459|589799598|FG002|Overall Study|Adverse Event|2|||
163298232|NCT01616459|589799599|FG003|Overall Study|Adverse Event|0|||
163298233|NCT01616459|589799596|FG000|Overall Study|Lost to Follow-up|1|||
163298234|NCT01616459|589799597|FG001|Overall Study|Lost to Follow-up|11|||
163298235|NCT01616459|589799598|FG002|Overall Study|Lost to Follow-up|3|||
163298236|NCT01616459|589799599|FG003|Overall Study|Lost to Follow-up|2|||
163298237|NCT01616459|589799596|FG000|Overall Study|Protocol Violation|0|||
163298238|NCT01616459|589799597|FG001|Overall Study|Protocol Violation|0|||
163298239|NCT01616459|589799598|FG002|Overall Study|Protocol Violation|0|||
163298240|NCT01616459|589799599|FG003|Overall Study|Protocol Violation|2|||
163298241|NCT01616459|589799596|FG000|Overall Study|Withdrawal by Subject|2|||
163298242|NCT01616459|589799597|FG001|Overall Study|Withdrawal by Subject|4|||
163298243|NCT01616459|589799598|FG002|Overall Study|Withdrawal by Subject|4|||
163298244|NCT01616459|589799599|FG003|Overall Study|Withdrawal by Subject|4|||
163298245|NCT01616459|589799596|FG000|Overall Study|Other reason|0|||
163298246|NCT01616459|589799597|FG001|Overall Study|Other reason|1|||
163298247|NCT01616459|589799598|FG002|Overall Study|Other reason|1|||
163298248|NCT01616459|589799599|FG003|Overall Study|Other reason|0|||
163298249|NCT03237481|589800707|FG000|Overall Study|Lost to Follow-up|1|||
163192392|NCT01967173|589419387|FG004|Overall Study|Pregnancy|0|||
163192393|NCT01967173|589419388|FG005|Overall Study|Pregnancy|0|||
163192394|NCT01967173|589419389|FG006|Overall Study|Pregnancy|1|||
163192395|NCT01967173|589419390|FG007|Overall Study|Pregnancy|1|||
163192396|NCT01967173|589419383|FG000|Overall Study|Adverse Event|0|||
163192397|NCT01967173|589419384|FG001|Overall Study|Adverse Event|0|||
163192398|NCT01967173|589419385|FG002|Overall Study|Adverse Event|0|||
163192399|NCT01967173|589419386|FG003|Overall Study|Adverse Event|0|||
163192400|NCT01967173|589419387|FG004|Overall Study|Adverse Event|0|||
163192401|NCT01967173|589419388|FG005|Overall Study|Adverse Event|0|||
163192402|NCT01967173|589419389|FG006|Overall Study|Adverse Event|0|||
163192403|NCT01967173|589419390|FG007|Overall Study|Adverse Event|1|||
163192404|NCT01967173|589419383|FG000|Overall Study|Withdrawal by Subject|15|||
163192405|NCT01967173|589419384|FG001|Overall Study|Withdrawal by Subject|14|||
163192406|NCT01967173|589419385|FG002|Overall Study|Withdrawal by Subject|10|||
163192407|NCT01967173|589419386|FG003|Overall Study|Withdrawal by Subject|7|||
163192408|NCT01967173|589419387|FG004|Overall Study|Withdrawal by Subject|8|||
163192409|NCT01967173|589419388|FG005|Overall Study|Withdrawal by Subject|9|||
163192410|NCT01967173|589419389|FG006|Overall Study|Withdrawal by Subject|10|||
163192411|NCT01967173|589419390|FG007|Overall Study|Withdrawal by Subject|12|||
163192412|NCT03666624|589419393|FG000|Overall Study|participant grieving over recent death of parent|1|||
163192413|NCT03666624|589419394|FG001|Overall Study|participant grieving over recent death of parent|0|||
163192414|NCT05213481|589419395|FG000|Overall Study|Adverse Event|3|||
163192415|NCT05213481|589419395|FG000|Overall Study|Lost to Follow-up|1|||
163192416|NCT00447005|589419397|FG000|Overall Study|Adverse Event|1|||
163192417|NCT00447005|589419397|FG000|Overall Study|Lack of Efficacy|11|||
163192418|NCT00423514|589419398|FG000|Overall Study|Ineligible|1|||
163192419|NCT00423514|589419399|FG001|Overall Study|Ineligible|0|||
163192420|NCT00397215|589419400|FG000|Month 0 (Day 0)|Adverse Event|0|||
163192421|NCT00397215|589419401|FG001|Month 0 (Day 0)|Adverse Event|1|||
163192422|NCT00397215|589419402|FG002|Month 0 (Day 0)|Adverse Event|0|||
163192423|NCT00397215|589419403|FG003|Month 0 (Day 0)|Adverse Event|0|||
163192424|NCT00397215|589419400|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
163192425|NCT00397215|589419401|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
163192426|NCT00397215|589419402|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
163192427|NCT00397215|589419403|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
163192428|NCT00397215|589419400|FG000|Month 0 (Day 0)|Other|4|||
163192429|NCT00397215|589419401|FG001|Month 0 (Day 0)|Other|1|||
163192430|NCT00397215|589419402|FG002|Month 0 (Day 0)|Other|3|||
163192431|NCT00397215|589419403|FG003|Month 0 (Day 0)|Other|3|||
163192432|NCT00397215|589419400|FG000|Month 6 (Day 180)|Adverse Event|0|||
163192433|NCT00397215|589419401|FG001|Month 6 (Day 180)|Adverse Event|3|||
163192434|NCT00397215|589419402|FG002|Month 6 (Day 180)|Adverse Event|2|||
163192435|NCT00397215|589419403|FG003|Month 6 (Day 180)|Adverse Event|0|||
163192436|NCT00397215|589419400|FG000|Month 6 (Day 180)|Other|2|||
163192437|NCT00397215|589419401|FG001|Month 6 (Day 180)|Other|0|||
163192438|NCT00397215|589419402|FG002|Month 6 (Day 180)|Other|3|||
163192439|NCT00397215|589419403|FG003|Month 6 (Day 180)|Other|0|||
163192440|NCT02128932|589419404|FG000|Overall Study|Withdrawal by Subject|11|||
163192441|NCT02128932|589419405|FG001|Overall Study|Withdrawal by Subject|7|||
163192442|NCT02128932|589419406|FG002|Overall Study|Withdrawal by Subject|8|||
163192443|NCT02128932|589419404|FG000|Overall Study|Death|2|||
163192444|NCT02128932|589419405|FG001|Overall Study|Death|0|||
163192445|NCT02128932|589419406|FG002|Overall Study|Death|2|||
163192446|NCT02128932|589419404|FG000|Overall Study|Lost to Follow-up|2|||
163192447|NCT02128932|589419405|FG001|Overall Study|Lost to Follow-up|1|||
163192448|NCT02128932|589419406|FG002|Overall Study|Lost to Follow-up|1|||
163192449|NCT02128932|589419404|FG000|Overall Study|No reason for withdrawal|12|||
163192450|NCT02128932|589419405|FG001|Overall Study|No reason for withdrawal|11|||
163192451|NCT02128932|589419406|FG002|Overall Study|No reason for withdrawal|7|||
163192452|NCT03685123|589419411|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
163192453|NCT03685123|589419412|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
163192454|NCT03685123|589419413|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
163192455|NCT03685123|589419411|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
163192456|NCT03685123|589419412|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
163192457|NCT03685123|589419413|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
163192458|NCT03685123|589419411|FG000|Weight Loss Phase|Lost to Follow-up|1|||
163192459|NCT03685123|589419412|FG001|Weight Loss Phase|Lost to Follow-up|0|||
163192460|NCT03685123|589419413|FG002|Weight Loss Phase|Lost to Follow-up|0|||
163192461|NCT03685123|589419411|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
163192462|NCT03685123|589419412|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
163192463|NCT03685123|589419413|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
163192464|NCT03685123|589419411|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
163192465|NCT03685123|589419412|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
163192466|NCT03685123|589419413|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
163192467|NCT03685123|589419411|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
163192468|NCT03685123|589419412|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
163192469|NCT03685123|589419413|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
163192470|NCT01254630|589419414|FG000|Overall Study|Adverse Event|36|||
163192471|NCT01254630|589419415|FG001|Overall Study|Adverse Event|15|||
163192472|NCT01254630|589419416|FG002|Overall Study|Adverse Event|40|||
163192473|NCT01254630|589419417|FG003|Overall Study|Adverse Event|8|||
163192474|NCT01254630|589419414|FG000|Overall Study|Death|461|||
163192475|NCT01254630|589419415|FG001|Overall Study|Death|151|||
163192476|NCT01254630|589419416|FG002|Overall Study|Death|478|||
163192477|NCT01254630|589419417|FG003|Overall Study|Death|139|||
163192478|NCT01254630|589419414|FG000|Overall Study|Lost to Follow-up|80|||
163192479|NCT01254630|589419415|FG001|Overall Study|Lost to Follow-up|26|||
163192480|NCT01254630|589419416|FG002|Overall Study|Lost to Follow-up|89|||
163192481|NCT01254630|589419417|FG003|Overall Study|Lost to Follow-up|32|||
163192482|NCT01254630|589419414|FG000|Overall Study|Physician Decision|24|||
163192483|NCT01254630|589419415|FG001|Overall Study|Physician Decision|8|||
163192484|NCT01254630|589419416|FG002|Overall Study|Physician Decision|16|||
163192485|NCT01254630|589419417|FG003|Overall Study|Physician Decision|7|||
163192486|NCT01254630|589419414|FG000|Overall Study|Withdrawal by Subject|201|||
163192487|NCT01254630|589419415|FG001|Overall Study|Withdrawal by Subject|94|||
163192488|NCT01254630|589419416|FG002|Overall Study|Withdrawal by Subject|188|||
163192489|NCT01254630|589419417|FG003|Overall Study|Withdrawal by Subject|89|||
163192490|NCT01254630|589419414|FG000|Overall Study|Study terminated by sponsor|0|||
163192491|NCT01254630|589419415|FG001|Overall Study|Study terminated by sponsor|994|||
163192492|NCT01254630|589419416|FG002|Overall Study|Study terminated by sponsor|0|||
163192493|NCT01254630|589419417|FG003|Overall Study|Study terminated by sponsor|1010|||
163192494|NCT01254630|589419414|FG000|Overall Study|Status not recorded|0|||
163192495|NCT01254630|589419415|FG001|Overall Study|Status not recorded|0|||
163192496|NCT01254630|589419416|FG002|Overall Study|Status not recorded|1|||
163192497|NCT01254630|589419417|FG003|Overall Study|Status not recorded|0|||
163192498|NCT02959983|589419418|FG000|Overall Study|Protocol Violation|0|||
163192499|NCT02959983|589419419|FG001|Overall Study|Protocol Violation|1|||
163192500|NCT02959983|589419418|FG000|Overall Study|Lack of Efficacy|0|||
163192501|NCT02959983|589419419|FG001|Overall Study|Lack of Efficacy|1|||
163192502|NCT02959983|589419418|FG000|Overall Study|Lost to Follow-up|12|||
163192503|NCT02959983|589419419|FG001|Overall Study|Lost to Follow-up|9|||
163192504|NCT02959983|589419418|FG000|Overall Study|Other|1|||
163192505|NCT02959983|589419419|FG001|Overall Study|Other|1|||
163192506|NCT02959983|589419418|FG000|Overall Study|Physician Decision|1|||
163192507|NCT02959983|589419419|FG001|Overall Study|Physician Decision|0|||
163192508|NCT02959983|589419418|FG000|Overall Study|Adverse Event|5|||
163192509|NCT02959983|589419419|FG001|Overall Study|Adverse Event|1|||
163192510|NCT02959983|589419418|FG000|Overall Study|Withdrawal by Subject|7|||
163192511|NCT02959983|589419419|FG001|Overall Study|Withdrawal by Subject|12|||
163192512|NCT03439657|589419424|FG000|Overall Study|Adverse Event|2|||
163192513|NCT03439657|589419425|FG001|Overall Study|Adverse Event|3|||
163192514|NCT03439657|589419424|FG000|Overall Study|Lost to Follow-up|1|||
163192515|NCT03439657|589419425|FG001|Overall Study|Lost to Follow-up|0|||
163192516|NCT03439657|589419424|FG000|Overall Study|Protocol Violation|1|||
163192517|NCT03439657|589419425|FG001|Overall Study|Protocol Violation|1|||
163192518|NCT03439657|589419424|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
163298250|NCT03237481|589800708|FG001|Overall Study|Lost to Follow-up|0|||
163298251|NCT03237481|589800709|FG002|Overall Study|Lost to Follow-up|0|||
163298252|NCT03237481|589800707|FG000|Overall Study|Protocol Violation|1|||
163298253|NCT03237481|589800708|FG001|Overall Study|Protocol Violation|0|||
163298254|NCT03237481|589800709|FG002|Overall Study|Protocol Violation|0|||
163298255|NCT03237481|589800707|FG000|Overall Study|Withdrawal by Subject|3|||
163298256|NCT03237481|589800708|FG001|Overall Study|Withdrawal by Subject|2|||
163298257|NCT03237481|589800709|FG002|Overall Study|Withdrawal by Subject|1|||
163298258|NCT02991807|589800710|FG000|Overall Study|Withdrawal by Subject|2|||
163298259|NCT02991807|589800711|FG001|Overall Study|Withdrawal by Subject|1|||
163298260|NCT02991807|589800710|FG000|Overall Study|Physician Decision|0|||
163298261|NCT02991807|589800711|FG001|Overall Study|Physician Decision|1|||
163298262|NCT02991807|589800710|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
163298263|NCT02991807|589800711|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
163298264|NCT02566902|589800712|FG000|Overall Study|Protocol Violation|2|||
163298265|NCT02566902|589800713|FG001|Overall Study|Protocol Violation|1|||
163298266|NCT01875848|589800714|FG000|Overall Study|Withdrawal by Subject|2|||
163298267|NCT01875848|589800715|FG001|Overall Study|Withdrawal by Subject|0|||
163298268|NCT02411084|589800716|FG000|Overall Study|Lack of Efficacy|6|||
163298269|NCT02411084|589800717|FG001|Overall Study|Lack of Efficacy|3|||
163298270|NCT02411084|589800716|FG000|Overall Study|Death|5|||
163298271|NCT02411084|589800717|FG001|Overall Study|Death|4|||
163298272|NCT02411084|589800716|FG000|Overall Study|Adverse Event|2|||
163298273|NCT02411084|589800717|FG001|Overall Study|Adverse Event|1|||
163298274|NCT02411084|589800716|FG000|Overall Study|Other reasons|0|||
163298275|NCT02411084|589800717|FG001|Overall Study|Other reasons|5|||
163298276|NCT02374463|589800718|FG000|Overall Study|Withdrawal by Subject|3|||
163298277|NCT02374463|589800719|FG001|Overall Study|Withdrawal by Subject|3|||
163298278|NCT04723394|589800729|FG000|Overall Study|Adverse Event|0|||
163298279|NCT04723394|589800730|FG001|Overall Study|Adverse Event|3|||
163298280|NCT04723394|589800729|FG000|Overall Study|Death|8|||
163298281|NCT04723394|589800730|FG001|Overall Study|Death|8|||
163298282|NCT04723394|589800729|FG000|Overall Study|Lost to Follow-up|20|||
163298283|NCT04723394|589800730|FG001|Overall Study|Lost to Follow-up|17|||
163298284|NCT04723394|589800729|FG000|Overall Study|Physician Decision|1|||
163298285|NCT04723394|589800730|FG001|Overall Study|Physician Decision|0|||
163298286|NCT04723394|589800729|FG000|Overall Study|Withdrawal by Subject|20|||
163298287|NCT04723394|589800730|FG001|Overall Study|Withdrawal by Subject|34|||
163298288|NCT04723394|589800729|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
163298289|NCT04723394|589800730|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
163298290|NCT00642850|589800738|FG000|Overall Study|Death|7|||
163298291|NCT00642850|589800738|FG000|Overall Study|Adverse Event|2|||
163298292|NCT00642850|589800738|FG000|Overall Study|Lack of Efficacy|1|||
163298293|NCT00642850|589800738|FG000|Overall Study|Protocol Violation|2|||
163298294|NCT00642850|589800738|FG000|Overall Study|Kidney transplantation|8|||
163392755|NCT01271803|590150336|FG002|Overall Study|Lost to Follow-up|0|||
163392756|NCT05211739|590150337|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
163298295|NCT00642850|589800738|FG000|Overall Study|Blood transfusion|6|||
163298296|NCT00642850|589800738|FG000|Overall Study|Other reasons|7|||
163298297|NCT01839331|589800739|FG000|Overall Study|Early Termination|3|||
163298298|NCT01839331|589800740|FG001|Overall Study|Early Termination|0|||
163298299|NCT01839331|589800741|FG002|Overall Study|Early Termination|1|||
163298300|NCT01839331|589800742|FG003|Overall Study|Early Termination|2|||
163298301|NCT01839331|589800739|FG000|Overall Study|Protocol Violation|1|||
163298302|NCT01839331|589800740|FG001|Overall Study|Protocol Violation|6|||
163298303|NCT01839331|589800741|FG002|Overall Study|Protocol Violation|4|||
163298304|NCT01839331|589800742|FG003|Overall Study|Protocol Violation|3|||
163298305|NCT03076515|589800743|FG000|Overall Study|DMC decision based on interim analysis|25|||
163298306|NCT03076515|589800744|FG001|Overall Study|DMC decision based on interim analysis|29|||
163392757|NCT05211739|590150338|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
163298307|NCT00174382|589800745|FG000|Overall Study|Death|2|||
163298308|NCT00174382|589800745|FG000|Overall Study|Adverse Event|19|||
163298309|NCT00174382|589800745|FG000|Overall Study|Withdrawal by Subject|6|||
163298310|NCT00174382|589800745|FG000|Overall Study|Protocol Violation|3|||
163298311|NCT00174382|589800745|FG000|Overall Study|Arrived early for last visit in error|1|||
163298312|NCT00174382|589800745|FG000|Overall Study|Subject felt pill not effective enough|1|||
163192519|NCT03439657|589419425|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
163192520|NCT02925117|589419427|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
163192521|NCT02925117|589419428|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
163192522|NCT02925117|589419429|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
163192523|NCT02925117|589419430|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
163192524|NCT02925117|589419431|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
163192525|NCT02925117|589419432|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
163192526|NCT02925117|589419433|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
163192527|NCT02925117|589419434|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
163192528|NCT02925117|589419435|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
163192529|NCT02925117|589419436|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
163192530|NCT02925117|589419437|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
163192531|NCT02925117|589419438|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
163192532|NCT02925117|589419427|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
163192533|NCT02925117|589419428|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
163192534|NCT02925117|589419429|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
163192535|NCT02925117|589419430|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
163192536|NCT02925117|589419431|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
163192537|NCT02925117|589419432|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
163192538|NCT02925117|589419433|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
163192539|NCT02925117|589419434|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
163192540|NCT02925117|589419435|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
163192541|NCT02925117|589419436|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
163192542|NCT02925117|589419437|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
163192543|NCT02925117|589419438|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
163192544|NCT02925117|589419427|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
163192545|NCT02925117|589419428|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
163192546|NCT02925117|589419429|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
163192547|NCT02925117|589419430|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
163192548|NCT02925117|589419431|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
163192549|NCT02925117|589419432|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
163192550|NCT02925117|589419433|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
163192551|NCT02925117|589419434|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
163192552|NCT02925117|589419435|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
163192553|NCT02925117|589419436|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
163192554|NCT02925117|589419437|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
163192555|NCT02925117|589419438|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
163192556|NCT02925117|589419427|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
163192557|NCT02925117|589419428|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
163192558|NCT02925117|589419429|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
163192559|NCT02925117|589419430|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
163192560|NCT02925117|589419431|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
163192561|NCT02925117|589419432|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
163192562|NCT02925117|589419433|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
163192563|NCT02925117|589419434|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
163192564|NCT02925117|589419435|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
163192565|NCT02925117|589419436|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
163192566|NCT02925117|589419437|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
163192567|NCT02925117|589419438|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
163192568|NCT02925117|589419427|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
163192569|NCT02925117|589419428|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
163192570|NCT02925117|589419429|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
163192571|NCT02925117|589419430|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
163192572|NCT02925117|589419431|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
163192573|NCT02925117|589419432|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
163192574|NCT02925117|589419433|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
163192575|NCT02925117|589419434|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
163192576|NCT02925117|589419435|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
163192577|NCT02925117|589419436|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
163192578|NCT02925117|589419437|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
163192579|NCT02925117|589419438|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
163192580|NCT02925117|589419427|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
163192581|NCT02925117|589419428|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
163192582|NCT02925117|589419429|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
163392758|NCT05211739|590150337|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
163392759|NCT05211739|590150338|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
163392760|NCT05211739|590150337|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
163392761|NCT05211739|590150338|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
163392762|NCT05211739|590150337|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
163392763|NCT05211739|590150338|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
163392764|NCT04178967|590150339|FG000|Induction Period|Adverse Event|4|||
163392765|NCT04178967|590150340|FG001|Induction Period|Adverse Event|6|||
163392766|NCT04178967|590150341|FG002|Induction Period|Adverse Event|0|||
163392767|NCT04178967|590150342|FG003|Induction Period|Adverse Event|0|||
163392768|NCT04178967|590150343|FG004|Induction Period|Adverse Event|0|||
163392769|NCT04178967|590150344|FG005|Induction Period|Adverse Event|0|||
163392770|NCT04178967|590150345|FG006|Induction Period|Adverse Event|0|||
162952797|NCT03496623|588531660|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
163192583|NCT02925117|589419430|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
163192584|NCT02925117|589419431|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
163192585|NCT02925117|589419432|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
163192586|NCT02925117|589419433|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
163192587|NCT02925117|589419434|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
163192588|NCT02925117|589419435|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
163192589|NCT02925117|589419436|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
163192590|NCT02925117|589419437|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
163192591|NCT02925117|589419438|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
163192592|NCT02925117|589419427|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
163192593|NCT02925117|589419428|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
163192594|NCT02925117|589419429|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
163192595|NCT02925117|589419430|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
163192596|NCT02925117|589419431|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
163192597|NCT02925117|589419432|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
163192598|NCT02925117|589419433|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
163192599|NCT02925117|589419434|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
163192600|NCT02925117|589419435|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
163192601|NCT02925117|589419436|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
163192602|NCT02925117|589419437|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
163192603|NCT02925117|589419438|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
163192604|NCT02925117|589419427|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
163192605|NCT02925117|589419428|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
163192606|NCT02925117|589419429|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
163192607|NCT02925117|589419430|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
163192608|NCT02925117|589419431|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
163192609|NCT02925117|589419432|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
163192610|NCT02925117|589419433|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
163192611|NCT02925117|589419434|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
163192612|NCT02925117|589419435|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
163192613|NCT02925117|589419436|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
163192614|NCT02925117|589419437|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
163192615|NCT02925117|589419438|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
163192616|NCT04032652|589419439|FG000|Overall Study|The study was terminated and the PI has|1|||
163192617|NCT04032652|589419440|FG001|Overall Study|The study was terminated and the PI has|1|||
163192618|NCT02663908|589419441|FG000|Overall Study|Withdrawal by Subject|8|||
163192619|NCT02663908|589419442|FG001|Overall Study|Withdrawal by Subject|5|||
163192620|NCT02663908|589419441|FG000|Overall Study|Lost to Follow-up|1|||
163192621|NCT02663908|589419442|FG001|Overall Study|Lost to Follow-up|5|||
163192622|NCT02663908|589419441|FG000|Overall Study|Adverse Event|13|||
163192623|NCT02663908|589419442|FG001|Overall Study|Adverse Event|11|||
163192624|NCT02663908|589419441|FG000|Overall Study|Protocol Violation|1|||
163192625|NCT02663908|589419442|FG001|Overall Study|Protocol Violation|2|||
163192626|NCT02663908|589419441|FG000|Overall Study|Lack of therapeutic response|2|||
163192627|NCT02663908|589419442|FG001|Overall Study|Lack of therapeutic response|0|||
163192628|NCT02663908|589419441|FG000|Overall Study|COVID-19|1|||
163192629|NCT02663908|589419442|FG001|Overall Study|COVID-19|0|||
163192630|NCT02663908|589419441|FG000|Overall Study|Site closed|1|||
163192631|NCT02663908|589419442|FG001|Overall Study|Site closed|0|||
163192632|NCT02663908|589419441|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
163192633|NCT02663908|589419442|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
163192634|NCT02663908|589419441|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
163192635|NCT02663908|589419442|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
163192636|NCT02663908|589419441|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
163192637|NCT02663908|589419442|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
163192638|NCT02663908|589419441|FG000|Overall Study|Death|1|||
163192639|NCT02663908|589419442|FG001|Overall Study|Death|0|||
163192640|NCT02663908|589419441|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
163392771|NCT04178967|590150346|FG007|Induction Period|Adverse Event|0|||
163298313|NCT00174382|589800745|FG000|Overall Study|Lost to Follow-up|1|||
163298314|NCT01943799|589800746|FG000|Overall Study|Lost to Follow-up|0|||
163298315|NCT01943799|589800747|FG001|Overall Study|Lost to Follow-up|1|||
163298316|NCT01943799|589800748|FG002|Overall Study|Lost to Follow-up|1|||
163298317|NCT01943799|589800749|FG003|Overall Study|Lost to Follow-up|0|||
163298318|NCT01943799|589800746|FG000|Overall Study|Protocol Violation|1|||
163298319|NCT01943799|589800747|FG001|Overall Study|Protocol Violation|0|||
163298320|NCT01943799|589800748|FG002|Overall Study|Protocol Violation|0|||
163298321|NCT01943799|589800749|FG003|Overall Study|Protocol Violation|0|||
163298322|NCT01943799|589800746|FG000|Overall Study|Withdrawal by Subject|4|||
163298323|NCT01943799|589800747|FG001|Overall Study|Withdrawal by Subject|2|||
163298324|NCT01943799|589800748|FG002|Overall Study|Withdrawal by Subject|1|||
163298325|NCT01943799|589800749|FG003|Overall Study|Withdrawal by Subject|0|||
163298326|NCT04594759|589800750|FG000|Overall Study|Lost to Follow-up|3|||
163298327|NCT03811574|589800751|FG000|Overall Study|Withdrawal by Subject|2|||
163298328|NCT03811574|589800752|FG001|Overall Study|Withdrawal by Subject|4|||
163298329|NCT03811574|589800753|FG002|Overall Study|Withdrawal by Subject|0|||
163298330|NCT03485950|589800756|FG000|Overall Study|Adverse Event|1|||
163298331|NCT03485950|589800757|FG001|Overall Study|Adverse Event|0|||
163298332|NCT03485950|589800756|FG000|Overall Study|Death|3|||
163298333|NCT03485950|589800757|FG001|Overall Study|Death|2|||
163298334|NCT03485950|589800756|FG000|Overall Study|Withdrawal by Subject|3|||
163298335|NCT03485950|589800757|FG001|Overall Study|Withdrawal by Subject|0|||
163298336|NCT03764475|589800758|FG000|Overall Study|Adverse Event|11|||
163298337|NCT03764475|589800759|FG001|Overall Study|Adverse Event|2|||
163298338|NCT03764475|589800758|FG000|Overall Study|Lost to Follow-up|24|||
163298339|NCT03764475|589800759|FG001|Overall Study|Lost to Follow-up|10|||
163298340|NCT03764475|589800758|FG000|Overall Study|Withdrawal by Subject|26|||
163298341|NCT03764475|589800759|FG001|Overall Study|Withdrawal by Subject|10|||
163298342|NCT03764475|589800758|FG000|Overall Study|Lack of Efficacy|3|||
163298343|NCT03764475|589800759|FG001|Overall Study|Lack of Efficacy|0|||
163298344|NCT03764475|589800758|FG000|Overall Study|COVID-19 Disruption|2|||
162952798|NCT03496623|588531661|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
162952799|NCT03496623|588531662|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162952800|NCT03496623|588531663|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162952801|NCT02543203|588531664|FG000|Overall Study|Unpalatable Fragrance|2|||
162952802|NCT02543203|588531665|FG001|Overall Study|Unpalatable Fragrance|2|||
162952803|NCT02543203|588531664|FG000|Overall Study|Lost to Follow-up|1|||
162952804|NCT02543203|588531665|FG001|Overall Study|Lost to Follow-up|0|||
162952805|NCT02543203|588531664|FG000|Overall Study|Increased Irritability|1|||
162952806|NCT02543203|588531665|FG001|Overall Study|Increased Irritability|0|||
162952807|NCT02543203|588531664|FG000|Overall Study|Family|1|||
162952808|NCT02543203|588531665|FG001|Overall Study|Family|2|||
163298345|NCT03764475|589800759|FG001|Overall Study|COVID-19 Disruption|0|||
163298346|NCT03144674|589800768|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
163298347|NCT03144674|589800769|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
163298348|NCT03144674|589800770|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
163298349|NCT03144674|589800771|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
163298350|NCT03144674|589800768|FG000|Overall Study|Death|3|||
163298351|NCT03144674|589800769|FG001|Overall Study|Death|2|||
163298352|NCT03144674|589800770|FG002|Overall Study|Death|6|||
163298353|NCT03144674|589800771|FG003|Overall Study|Death|24|||
163298354|NCT03144674|589800768|FG000|Overall Study|Lost to Follow-up|0|||
163298355|NCT03144674|589800769|FG001|Overall Study|Lost to Follow-up|1|||
163298356|NCT03144674|589800770|FG002|Overall Study|Lost to Follow-up|0|||
163298357|NCT03144674|589800771|FG003|Overall Study|Lost to Follow-up|4|||
163298358|NCT03144674|589800768|FG000|Overall Study|Withdrawal by Participant|0|||
163392772|NCT04178967|590150347|FG008|Induction Period|Adverse Event|0|||
163392773|NCT04178967|590150348|FG009|Induction Period|Adverse Event|0|||
163392774|NCT04178967|590150349|FG010|Induction Period|Adverse Event|0|||
163392775|NCT04178967|590150339|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
163392776|NCT04178967|590150340|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
163392777|NCT04178967|590150341|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
163392778|NCT04178967|590150342|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
163392779|NCT04178967|590150343|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
162952809|NCT02543203|588531664|FG000|Overall Study|Negative Behavior|1|||
162952810|NCT02543203|588531665|FG001|Overall Study|Negative Behavior|0|||
162952811|NCT02543203|588531664|FG000|Overall Study|Withdrawal by Subject|0|||
162952812|NCT02543203|588531665|FG001|Overall Study|Withdrawal by Subject|1|||
162952813|NCT04786184|588531666|FG000|Overall Study|Adverse Event|4|||
163298359|NCT03144674|589800769|FG001|Overall Study|Withdrawal by Participant|0|||
163298360|NCT03144674|589800770|FG002|Overall Study|Withdrawal by Participant|2|||
163298361|NCT03144674|589800771|FG003|Overall Study|Withdrawal by Participant|6|||
163298362|NCT03144674|589800768|FG000|Overall Study|Discharged from the Trust|0|||
163298363|NCT03144674|589800769|FG001|Overall Study|Discharged from the Trust|0|||
163298364|NCT03144674|589800770|FG002|Overall Study|Discharged from the Trust|1|||
163392780|NCT04178967|590150344|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
163298365|NCT03144674|589800771|FG003|Overall Study|Discharged from the Trust|0|||
163392781|NCT04178967|590150345|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
163392782|NCT04178967|590150346|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
163392783|NCT04178967|590150347|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
162952814|NCT04786184|588531667|FG001|Overall Study|Adverse Event|0|||
163392784|NCT04178967|590150348|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
163392785|NCT04178967|590150349|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
163392786|NCT04178967|590150339|FG000|Induction Period|Lack of Efficacy|4|||
163392787|NCT04178967|590150340|FG001|Induction Period|Lack of Efficacy|1|||
163392788|NCT04178967|590150341|FG002|Induction Period|Lack of Efficacy|0|||
163392789|NCT04178967|590150342|FG003|Induction Period|Lack of Efficacy|0|||
163392790|NCT04178967|590150343|FG004|Induction Period|Lack of Efficacy|0|||
163392791|NCT04178967|590150344|FG005|Induction Period|Lack of Efficacy|0|||
163392792|NCT04178967|590150345|FG006|Induction Period|Lack of Efficacy|0|||
163392793|NCT04178967|590150346|FG007|Induction Period|Lack of Efficacy|0|||
163392794|NCT04178967|590150347|FG008|Induction Period|Lack of Efficacy|0|||
163392795|NCT04178967|590150348|FG009|Induction Period|Lack of Efficacy|0|||
163392796|NCT04178967|590150349|FG010|Induction Period|Lack of Efficacy|0|||
163392797|NCT04178967|590150339|FG000|Induction Period|Protocol Violation|0|||
163392798|NCT04178967|590150340|FG001|Induction Period|Protocol Violation|6|||
163392799|NCT04178967|590150341|FG002|Induction Period|Protocol Violation|0|||
163392800|NCT04178967|590150342|FG003|Induction Period|Protocol Violation|0|||
163392801|NCT04178967|590150343|FG004|Induction Period|Protocol Violation|0|||
163392802|NCT04178967|590150344|FG005|Induction Period|Protocol Violation|0|||
162952815|NCT04786184|588531666|FG000|Overall Study|Withdrawal by Subject|3|||
162952816|NCT04786184|588531667|FG001|Overall Study|Withdrawal by Subject|1|||
163192641|NCT02663908|589419442|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
163192642|NCT02663908|589419441|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
163192643|NCT02663908|589419442|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
163192644|NCT02004522|589419443|FG000|Overall Study|Adverse Event|55|||
163192645|NCT02004522|589419444|FG001|Overall Study|Adverse Event|6|||
163192646|NCT02004522|589419443|FG000|Overall Study|Withdrawal by Subject|13|||
163192647|NCT02004522|589419444|FG001|Overall Study|Withdrawal by Subject|7|||
163192648|NCT02004522|589419443|FG000|Overall Study|Death|12|||
163192649|NCT02004522|589419444|FG001|Overall Study|Death|3|||
163192650|NCT02004522|589419443|FG000|Overall Study|Physician Decision|3|||
163192651|NCT02004522|589419444|FG001|Overall Study|Physician Decision|4|||
163192652|NCT02004522|589419443|FG000|Overall Study|Protocol Violation|1|||
163192653|NCT02004522|589419444|FG001|Overall Study|Protocol Violation|0|||
163192654|NCT02004522|589419443|FG000|Overall Study|Other is reason listed by PI|4|||
163192655|NCT02004522|589419444|FG001|Overall Study|Other is reason listed by PI|1|||
163192656|NCT02004522|589419443|FG000|Overall Study|Never Dosed|2|||
163192657|NCT02004522|589419444|FG001|Overall Study|Never Dosed|4|||
163192658|NCT02004522|589419443|FG000|Overall Study|Disease Progression|35|||
163192659|NCT02004522|589419444|FG001|Overall Study|Disease Progression|31|||
163192660|NCT02004522|589419443|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
163192661|NCT02004522|589419444|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
163192662|NCT02764697|589419448|FG000|Overall Study|Lack of Efficacy|3|||
163192663|NCT00302107|589419451|FG000|Overall Study|Lost to Follow-up|6|||
163192664|NCT00302107|589419452|FG001|Overall Study|Lost to Follow-up|5|||
163192665|NCT00302107|589419451|FG000|Overall Study|Protocol Violation|1|||
163192666|NCT00302107|589419452|FG001|Overall Study|Protocol Violation|0|||
163192667|NCT00302107|589419451|FG000|Overall Study|Relocation|0|||
163192668|NCT00302107|589419452|FG001|Overall Study|Relocation|1|||
163192669|NCT00302107|589419451|FG000|Overall Study|Withdrawal by Subject|0|||
163192670|NCT00302107|589419452|FG001|Overall Study|Withdrawal by Subject|3|||
163192671|NCT00302107|589419451|FG000|Overall Study|Adverse Event|1|||
163192672|NCT00302107|589419452|FG001|Overall Study|Adverse Event|0|||
163192673|NCT00437983|589419453|FG000|Overall Study|Adverse Event|6|||
163192674|NCT00437983|589419454|FG001|Overall Study|Adverse Event|6|||
163192675|NCT00437983|589419453|FG000|Overall Study|Protocol Violation|2|||
163192676|NCT00437983|589419454|FG001|Overall Study|Protocol Violation|1|||
163192677|NCT00437983|589419453|FG000|Overall Study|Withdrawal by Subject|5|||
163192678|NCT00437983|589419454|FG001|Overall Study|Withdrawal by Subject|6|||
163192679|NCT01798004|589421600|FG000|Overall Study|Death|2|||
163192680|NCT01798004|589421600|FG000|Overall Study|Lack of Efficacy|8|||
163192681|NCT01798004|589421600|FG000|Overall Study|Physician Decision|25|||
163192682|NCT01798004|589421600|FG000|Overall Study|Withdrawal by Subject|4|||
162952817|NCT04786184|588531666|FG000|Overall Study|Lost to Follow-up|4|||
163192683|NCT01798004|589421600|FG000|Overall Study|Ineligible|4|||
163192684|NCT01798004|589421600|FG000|Overall Study|Patient/parent refusal|7|||
163192685|NCT01798004|589421600|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
163192686|NCT01798004|589421600|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
163392803|NCT04178967|590150345|FG006|Induction Period|Protocol Violation|0|||
163392804|NCT04178967|590150346|FG007|Induction Period|Protocol Violation|0|||
163392805|NCT04178967|590150347|FG008|Induction Period|Protocol Violation|0|||
163392806|NCT04178967|590150348|FG009|Induction Period|Protocol Violation|0|||
163298366|NCT03144674|589800768|FG000|Overall Study|Exclusion Criteria Met|0|||
163298367|NCT03144674|589800769|FG001|Overall Study|Exclusion Criteria Met|0|||
163298368|NCT03144674|589800770|FG002|Overall Study|Exclusion Criteria Met|1|||
163298369|NCT03144674|589800771|FG003|Overall Study|Exclusion Criteria Met|0|||
163298370|NCT03144674|589800768|FG000|Overall Study|Changed Physicians|0|||
163298371|NCT03144674|589800769|FG001|Overall Study|Changed Physicians|0|||
163298372|NCT03144674|589800770|FG002|Overall Study|Changed Physicians|0|||
163298373|NCT03144674|589800771|FG003|Overall Study|Changed Physicians|1|||
163298374|NCT03144674|589800768|FG000|Overall Study|Removed for Safety|0|||
163298375|NCT03144674|589800769|FG001|Overall Study|Removed for Safety|0|||
163298376|NCT03144674|589800770|FG002|Overall Study|Removed for Safety|0|||
163298377|NCT03144674|589800771|FG003|Overall Study|Removed for Safety|1|||
163298378|NCT03144674|589800768|FG000|Overall Study|Site Closed|0|||
163298379|NCT03144674|589800769|FG001|Overall Study|Site Closed|0|||
163298380|NCT03144674|589800770|FG002|Overall Study|Site Closed|0|||
163298381|NCT03144674|589800771|FG003|Overall Study|Site Closed|1|||
163298382|NCT03144674|589800768|FG000|Overall Study|Histological Criteria Not Met|0|||
163298383|NCT03144674|589800769|FG001|Overall Study|Histological Criteria Not Met|0|||
163298384|NCT03144674|589800770|FG002|Overall Study|Histological Criteria Not Met|0|||
163298385|NCT03144674|589800771|FG003|Overall Study|Histological Criteria Not Met|1|||
163298386|NCT03144674|589800768|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
163298387|NCT03144674|589800769|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
163298388|NCT03144674|589800770|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
163298389|NCT03144674|589800771|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
163298390|NCT03144674|589800768|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
163298391|NCT03144674|589800769|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
163298392|NCT03144674|589800770|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
163298393|NCT03144674|589800771|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
163298394|NCT05510245|589800772|FG000|Overall Study|Withdrawal by Subject|1|||
163298395|NCT05510245|589800773|FG001|Overall Study|Withdrawal by Subject|0|||
163298396|NCT05510245|589800774|FG002|Overall Study|Withdrawal by Subject|0|||
163298397|NCT01373346|589800775|FG000|Overall Study|Death|1|||
163298398|NCT01198028|589800776|FG000|Overall Study|Adverse Event|5|||
163298399|NCT01198028|589800776|FG000|Overall Study|Death|3|||
163298400|NCT01198028|589800776|FG000|Overall Study|Physician Decision|2|||
163298401|NCT01395758|589800778|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
163298402|NCT01395758|589800779|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
163298403|NCT01395758|589800780|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
163298404|NCT01565148|589800781|FG000|Overall Study|Withdrawal by Subject|1|||
163298405|NCT01565148|589800782|FG001|Overall Study|Withdrawal by Subject|1|||
163298406|NCT01565148|589800783|FG002|Overall Study|Withdrawal by Subject|1|||
163298407|NCT01565148|589800784|FG003|Overall Study|Withdrawal by Subject|2|||
163298408|NCT01565148|589800781|FG000|Overall Study|Lost to Follow-up|4|||
163298409|NCT01565148|589800782|FG001|Overall Study|Lost to Follow-up|4|||
163298410|NCT01565148|589800783|FG002|Overall Study|Lost to Follow-up|0|||
163298411|NCT01565148|589800784|FG003|Overall Study|Lost to Follow-up|3|||
162952818|NCT04786184|588531667|FG001|Overall Study|Lost to Follow-up|2|||
163298412|NCT01565148|589800781|FG000|Overall Study|Rescue Therapy|8|||
163298413|NCT01565148|589800782|FG001|Overall Study|Rescue Therapy|5|||
163298414|NCT01565148|589800783|FG002|Overall Study|Rescue Therapy|5|||
163298415|NCT01565148|589800784|FG003|Overall Study|Rescue Therapy|8|||
163298416|NCT01565148|589800781|FG000|Overall Study|Death|0|||
163298417|NCT01565148|589800782|FG001|Overall Study|Death|0|||
163298418|NCT01565148|589800783|FG002|Overall Study|Death|1|||
163298419|NCT01565148|589800784|FG003|Overall Study|Death|0|||
163298420|NCT01565148|589800781|FG000|Overall Study|Physician Decision|2|||
163298421|NCT01565148|589800782|FG001|Overall Study|Physician Decision|5|||
163298422|NCT01565148|589800783|FG002|Overall Study|Physician Decision|0|||
163298423|NCT01565148|589800784|FG003|Overall Study|Physician Decision|0|||
163298424|NCT01759771|589800785|FG000|Overall Study|Withdrawal by Subject|1|||
163298425|NCT01759771|589800786|FG001|Overall Study|Withdrawal by Subject|1|||
163298426|NCT00529659|589800789|FG000|Overall Study|Adverse Event|8|||
163298427|NCT00529659|589800790|FG001|Overall Study|Adverse Event|7|||
163298428|NCT00529659|589800789|FG000|Overall Study|Lost to Follow-up|0|||
163298429|NCT00529659|589800790|FG001|Overall Study|Lost to Follow-up|2|||
163298430|NCT00529659|589800789|FG000|Overall Study|Physician Decision|0|||
162952819|NCT02255097|588531668|FG000|Overall Study|Death|151|||
162952820|NCT02255097|588531668|FG000|Overall Study|Lost to Follow-up|5|||
163298431|NCT00529659|589800790|FG001|Overall Study|Physician Decision|2|||
163298432|NCT00529659|589800789|FG000|Overall Study|Protocol Violation|2|||
163298433|NCT00529659|589800790|FG001|Overall Study|Protocol Violation|6|||
163298434|NCT00529659|589800789|FG000|Overall Study|Withdrawal by Subject|1|||
163298435|NCT00529659|589800790|FG001|Overall Study|Withdrawal by Subject|6|||
163298436|NCT01692730|589800793|FG000|Overall Study|Lost to Follow-up|225|||
163298437|NCT01692730|589800794|FG001|Overall Study|Lost to Follow-up|227|||
163298438|NCT01415349|589800795|FG000|Treatment Period 1|Adverse Event|0|||
163298439|NCT01415349|589800796|FG001|Treatment Period 1|Adverse Event|1|||
163298440|NCT01415349|589800795|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163298441|NCT01415349|589800796|FG001|Treatment Period 1|Withdrawal by Subject|1|||
163298442|NCT02139943|589800797|FG000|Overall Study|Adverse Event|0|||
163298443|NCT02139943|589800798|FG001|Overall Study|Adverse Event|1|||
163298444|NCT02139943|589800799|FG002|Overall Study|Adverse Event|2|||
163298445|NCT02139943|589800797|FG000|Overall Study|Lost to Follow-up|3|||
163298446|NCT02139943|589800798|FG001|Overall Study|Lost to Follow-up|2|||
163298447|NCT02139943|589800799|FG002|Overall Study|Lost to Follow-up|2|||
163298448|NCT02139943|589800797|FG000|Overall Study|Withdrawal by Subject|4|||
163298449|NCT02139943|589800798|FG001|Overall Study|Withdrawal by Subject|3|||
163298450|NCT02139943|589800799|FG002|Overall Study|Withdrawal by Subject|0|||
163298451|NCT02139943|589800797|FG000|Overall Study|Other|0|||
163298452|NCT02139943|589800798|FG001|Overall Study|Other|0|||
163298453|NCT02139943|589800799|FG002|Overall Study|Other|1|||
163298454|NCT02139943|589800797|FG000|Overall Study|Participant wishes to discontinue|2|||
163298455|NCT02139943|589800798|FG001|Overall Study|Participant wishes to discontinue|0|||
163298456|NCT02139943|589800799|FG002|Overall Study|Participant wishes to discontinue|0|||
163298457|NCT02139943|589800797|FG000|Overall Study|Participant in Poor Compliance|1|||
163298458|NCT02139943|589800798|FG001|Overall Study|Participant in Poor Compliance|0|||
163298459|NCT02139943|589800799|FG002|Overall Study|Participant in Poor Compliance|1|||
163298460|NCT02139943|589800797|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
163298461|NCT02139943|589800798|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
163298462|NCT02139943|589800799|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
163298463|NCT01041417|589800800|FG000|Overall Study|Adverse Event|5|||
163298464|NCT01041417|589800801|FG001|Overall Study|Adverse Event|2|||
163298465|NCT01041417|589800800|FG000|Overall Study|Lost to Follow-up|1|||
163298466|NCT01041417|589800801|FG001|Overall Study|Lost to Follow-up|1|||
163298467|NCT01041417|589800800|FG000|Overall Study|Death|1|||
163298468|NCT01041417|589800801|FG001|Overall Study|Death|0|||
163298469|NCT02918071|589800809|FG000|Overall Study|Withdrawal by Subject|2|||
163298470|NCT02918071|589800809|FG000|Overall Study|Lost to Follow-up|1|||
163298471|NCT03783026|589802829|FG000|Treatment Phase|Adverse Event|15|||
163298472|NCT03783026|589802829|FG000|Treatment Phase|Lack of Efficacy|11|||
163298473|NCT03783026|589802829|FG000|Treatment Phase|Withdrawal by Subject|6|||
163298474|NCT03783026|589802829|FG000|Treatment Phase|Lost to Follow-up|2|||
163298475|NCT03783026|589802829|FG000|Treatment Phase|Protocol Deviation|8|||
163298476|NCT03783026|589802829|FG000|Treatment Phase|Did Not Receive Treatment|1|||
163298477|NCT03783026|589802829|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
163298478|NCT04814186|589802830|FG000|Treatment Phase|Adverse Event|1|||
163298479|NCT04814186|589802830|FG000|Treatment Phase|Death|6|||
163298480|NCT04814186|589802830|FG000|Treatment Phase|Withdrawal by Subject|2|||
163298481|NCT04814186|589802830|FG000|Treatment Phase|Other|1|||
163298482|NCT04814186|589802830|FG000|Follow-Up Phase|Adverse Event|1|||
163298483|NCT04814186|589802830|FG000|Follow-Up Phase|Death|6|||
162952821|NCT02255097|588531668|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
163298484|NCT04814186|589802830|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
163298485|NCT04814186|589802830|FG000|Follow-Up Phase|Other|1|||
163298486|NCT03960463|589802846|FG000|Overall Study|Withdrawal by Subject|2|||
163298487|NCT03960463|589802847|FG001|Overall Study|Withdrawal by Subject|0|||
163298488|NCT04043455|589802848|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
163298489|NCT04043455|589802849|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
163298490|NCT04043455|589802850|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
163298491|NCT04043455|589802851|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
163298492|NCT04043455|589802852|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
163298493|NCT04043455|589802853|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
163298494|NCT04043455|589802848|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
163298495|NCT04043455|589802849|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
163298496|NCT04043455|589802850|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
163298497|NCT04043455|589802851|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
163298498|NCT04043455|589802852|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
163298499|NCT04043455|589802853|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
163298500|NCT04043455|589802848|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
163298501|NCT04043455|589802849|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
163298502|NCT04043455|589802850|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
163298503|NCT04043455|589802851|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
163298504|NCT04043455|589802852|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
163298505|NCT04043455|589802853|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
163298506|NCT04043455|589802848|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
163298507|NCT04043455|589802849|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
163298508|NCT04043455|589802850|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
163298509|NCT04043455|589802851|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
163298510|NCT04043455|589802852|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
163298511|NCT04043455|589802853|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
163298512|NCT04043455|589802848|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
163298513|NCT04043455|589802849|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
163298514|NCT04043455|589802850|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
163298515|NCT04043455|589802851|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
163298516|NCT04043455|589802852|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
163298517|NCT04043455|589802853|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
163298518|NCT04043455|589802848|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
163298519|NCT04043455|589802849|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
163298520|NCT04043455|589802850|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
163298521|NCT04043455|589802851|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
163298522|NCT04043455|589802852|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
163298523|NCT04043455|589802853|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
163298524|NCT04043455|589802848|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
163298525|NCT04043455|589802849|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
163298526|NCT04043455|589802850|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
163298527|NCT04043455|589802851|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
163392807|NCT04178967|590150349|FG010|Induction Period|Protocol Violation|0|||
163392808|NCT04178967|590150339|FG000|Induction Period|Withdrawal by Subject|6|||
163392809|NCT04178967|590150340|FG001|Induction Period|Withdrawal by Subject|4|||
163392810|NCT04178967|590150341|FG002|Induction Period|Withdrawal by Subject|0|||
163392811|NCT04178967|590150342|FG003|Induction Period|Withdrawal by Subject|0|||
163392812|NCT04178967|590150343|FG004|Induction Period|Withdrawal by Subject|0|||
163392813|NCT04178967|590150344|FG005|Induction Period|Withdrawal by Subject|0|||
163392814|NCT04178967|590150345|FG006|Induction Period|Withdrawal by Subject|0|||
163392815|NCT04178967|590150346|FG007|Induction Period|Withdrawal by Subject|0|||
163392816|NCT04178967|590150347|FG008|Induction Period|Withdrawal by Subject|0|||
163392817|NCT04178967|590150348|FG009|Induction Period|Withdrawal by Subject|0|||
163392818|NCT04178967|590150349|FG010|Induction Period|Withdrawal by Subject|0|||
163392819|NCT04178967|590150339|FG000|Induction Period|Lost to Follow-up|2|||
163392820|NCT04178967|590150340|FG001|Induction Period|Lost to Follow-up|0|||
163392821|NCT04178967|590150341|FG002|Induction Period|Lost to Follow-up|0|||
163392822|NCT04178967|590150342|FG003|Induction Period|Lost to Follow-up|0|||
163392823|NCT04178967|590150343|FG004|Induction Period|Lost to Follow-up|0|||
163392824|NCT04178967|590150344|FG005|Induction Period|Lost to Follow-up|0|||
163392825|NCT04178967|590150345|FG006|Induction Period|Lost to Follow-up|0|||
163392826|NCT04178967|590150346|FG007|Induction Period|Lost to Follow-up|0|||
163392827|NCT04178967|590150347|FG008|Induction Period|Lost to Follow-up|0|||
163392828|NCT04178967|590150348|FG009|Induction Period|Lost to Follow-up|0|||
163392829|NCT04178967|590150349|FG010|Induction Period|Lost to Follow-up|0|||
163392830|NCT04178967|590150339|FG000|Induction Period|Participant Missed Study Visits|0|||
163392831|NCT04178967|590150340|FG001|Induction Period|Participant Missed Study Visits|1|||
163192687|NCT03320057|589421601|FG000|Overall Study|Lost to Follow-up|4|||
163192688|NCT03320057|589421602|FG001|Overall Study|Lost to Follow-up|17|||
163192689|NCT03320057|589421601|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
163192690|NCT03320057|589421602|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
163192691|NCT06956170|589421603|FG000|Overall Study|Death|2|||
163192692|NCT06956170|589421604|FG001|Overall Study|Death|1|||
163192693|NCT06956170|589421603|FG000|Overall Study|Withdrawal by Subject|1|||
163192694|NCT06956170|589421604|FG001|Overall Study|Withdrawal by Subject|0|||
163192695|NCT06956170|589421603|FG000|Overall Study|Ongoing|7|||
163192696|NCT06956170|589421604|FG001|Overall Study|Ongoing|10|||
163192697|NCT02323113|589421605|FG000|Overall Study|Adverse Event|3|||
163192698|NCT02323113|589421606|FG001|Overall Study|Adverse Event|3|||
163192699|NCT02323113|589421607|FG002|Overall Study|Adverse Event|2|||
163192700|NCT02323113|589421608|FG003|Overall Study|Adverse Event|5|||
163192701|NCT02323113|589421609|FG004|Overall Study|Adverse Event|8|||
163192702|NCT02323113|589421610|FG005|Overall Study|Adverse Event|3|||
163192703|NCT02323113|589421611|FG006|Overall Study|Adverse Event|6|||
163192704|NCT02323113|589421612|FG007|Overall Study|Adverse Event|0|||
163192705|NCT02323113|589421605|FG000|Overall Study|Progressive Disease|0|||
163192706|NCT02323113|589421606|FG001|Overall Study|Progressive Disease|1|||
163192707|NCT02323113|589421607|FG002|Overall Study|Progressive Disease|1|||
163192708|NCT02323113|589421608|FG003|Overall Study|Progressive Disease|0|||
163192709|NCT02323113|589421609|FG004|Overall Study|Progressive Disease|0|||
163192710|NCT02323113|589421610|FG005|Overall Study|Progressive Disease|3|||
163192711|NCT02323113|589421611|FG006|Overall Study|Progressive Disease|0|||
163192712|NCT02323113|589421612|FG007|Overall Study|Progressive Disease|0|||
163192713|NCT02323113|589421605|FG000|Overall Study|Symptomatic Deterioration|0|||
163192714|NCT02323113|589421606|FG001|Overall Study|Symptomatic Deterioration|0|||
163192715|NCT02323113|589421607|FG002|Overall Study|Symptomatic Deterioration|1|||
163192716|NCT02323113|589421608|FG003|Overall Study|Symptomatic Deterioration|0|||
163192717|NCT02323113|589421609|FG004|Overall Study|Symptomatic Deterioration|1|||
163192718|NCT02323113|589421610|FG005|Overall Study|Symptomatic Deterioration|0|||
163192719|NCT02323113|589421611|FG006|Overall Study|Symptomatic Deterioration|0|||
163192720|NCT02323113|589421612|FG007|Overall Study|Symptomatic Deterioration|0|||
163192721|NCT02323113|589421605|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
163192722|NCT02323113|589421606|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
163192723|NCT02323113|589421607|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
163192724|NCT02323113|589421608|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
163192725|NCT02323113|589421609|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
163192726|NCT02323113|589421610|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
163192727|NCT02323113|589421611|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
163192728|NCT02323113|589421612|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
163192729|NCT02323113|589421605|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
163192730|NCT02323113|589421606|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
163192731|NCT02323113|589421607|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
163192732|NCT02323113|589421608|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
163192733|NCT02323113|589421609|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
163192734|NCT02323113|589421610|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
163192735|NCT02323113|589421611|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
163192736|NCT02323113|589421612|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
163192737|NCT02280304|589421617|FG000|Overall Study|Lost to Follow-up|7|||
163298528|NCT04043455|589802852|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
163298529|NCT04043455|589802853|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
163298530|NCT04043455|589802848|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
163298531|NCT04043455|589802849|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
163298532|NCT04043455|589802850|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
163298533|NCT04043455|589802851|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
163298534|NCT04043455|589802852|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
163298535|NCT04043455|589802853|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
163298536|NCT04043455|589802848|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
163298537|NCT04043455|589802849|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
163298538|NCT04043455|589802850|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
163298539|NCT04043455|589802851|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
163298540|NCT04043455|589802852|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
163298541|NCT04043455|589802853|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
163298542|NCT04043455|589802848|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
163298543|NCT04043455|589802849|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
163298544|NCT04043455|589802850|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
163298545|NCT04043455|589802851|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
163298546|NCT04043455|589802852|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
163298547|NCT04043455|589802853|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
163298548|NCT04043455|589802848|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
163298549|NCT04043455|589802849|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
163298550|NCT04043455|589802850|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
163298551|NCT04043455|589802851|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
163298552|NCT04043455|589802852|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
163298553|NCT04043455|589802853|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
163298554|NCT03422276|589802854|FG000|Overall Study|Withdrawal by Subject|21|||
163298555|NCT03422276|589802855|FG001|Overall Study|Withdrawal by Subject|25|||
163298556|NCT03422276|589802856|FG002|Overall Study|Withdrawal by Subject|14|||
163298557|NCT03422276|589802857|FG003|Overall Study|Withdrawal by Subject|16|||
163298558|NCT03422276|589802854|FG000|Overall Study|Death|14|||
163298559|NCT03422276|589802855|FG001|Overall Study|Death|21|||
163298560|NCT03422276|589802856|FG002|Overall Study|Death|3|||
163298561|NCT03422276|589802857|FG003|Overall Study|Death|1|||
163298562|NCT03422276|589802854|FG000|Overall Study|Discontinued, ineligible|4|||
163298563|NCT03422276|589802855|FG001|Overall Study|Discontinued, ineligible|3|||
163298564|NCT03422276|589802856|FG002|Overall Study|Discontinued, ineligible|0|||
163298565|NCT03422276|589802857|FG003|Overall Study|Discontinued, ineligible|0|||
163298566|NCT03422276|589802854|FG000|Overall Study|Lost to Follow-up|15|||
163298567|NCT03422276|589802855|FG001|Overall Study|Lost to Follow-up|8|||
163298568|NCT03422276|589802856|FG002|Overall Study|Lost to Follow-up|13|||
163298569|NCT03422276|589802857|FG003|Overall Study|Lost to Follow-up|4|||
163298570|NCT03422276|589802854|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
163298571|NCT03422276|589802855|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
163298572|NCT03422276|589802856|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
163298573|NCT03422276|589802857|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
163298574|NCT03422276|589802854|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
163298575|NCT03422276|589802855|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
163298576|NCT03422276|589802856|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
163298577|NCT03422276|589802857|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
163298578|NCT03422276|589802854|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
163298579|NCT03422276|589802855|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
163298580|NCT03422276|589802856|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
163298581|NCT03422276|589802857|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
163298582|NCT03422276|589802854|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
163298583|NCT03422276|589802855|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
163298584|NCT03422276|589802856|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
163298585|NCT03422276|589802857|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
163318865|NCT01208662|589878795|FG001|Induction and Consolidation|Adverse Event|18|||
163298586|NCT03422276|589802854|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
163298587|NCT03422276|589802855|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
163298588|NCT03422276|589802856|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
163298589|NCT03422276|589802857|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
163298590|NCT05194917|589802858|FG000|Overall Study|Lost to Follow-up|7|||
163298591|NCT05194917|589802859|FG001|Overall Study|Lost to Follow-up|5|||
163298592|NCT05194917|589802860|FG002|Overall Study|Lost to Follow-up|6|||
163298593|NCT05194917|589802861|FG003|Overall Study|Lost to Follow-up|5|||
163298594|NCT04922021|589802862|FG000|Overall Study|Withdrawal by Subject|4|||
163298595|NCT04922021|589802863|FG001|Overall Study|Withdrawal by Subject|10|||
163298596|NCT04922021|589802862|FG000|Overall Study|Adverse Event|2|||
163298597|NCT04922021|589802863|FG001|Overall Study|Adverse Event|2|||
163298598|NCT04922021|589802862|FG000|Overall Study|Lack of Efficacy|0|||
163298599|NCT04922021|589802863|FG001|Overall Study|Lack of Efficacy|1|||
163298600|NCT04922021|589802862|FG000|Overall Study|Multiple reasons|1|||
163298601|NCT04922021|589802863|FG001|Overall Study|Multiple reasons|0|||
163298602|NCT04201834|589802874|FG000|Overall Study|Screen fail|1|||
163298603|NCT04941287|589802875|FG000|Overall Study|Rapid decline before starting treatment|3|||
163298604|NCT04941287|589802876|FG001|Overall Study|Rapid decline before starting treatment|1|||
163298605|NCT01998984|589802881|FG000|Overall Study|Adverse Event|0|||
163298606|NCT01998984|589802882|FG001|Overall Study|Adverse Event|0|||
163298607|NCT01998984|589802883|FG002|Overall Study|Adverse Event|0|||
163298608|NCT01998984|589802884|FG003|Overall Study|Adverse Event|1|||
163298609|NCT01998984|589802881|FG000|Overall Study|Lost to Follow-up|0|||
163298610|NCT01998984|589802882|FG001|Overall Study|Lost to Follow-up|1|||
163298611|NCT01998984|589802883|FG002|Overall Study|Lost to Follow-up|0|||
163298612|NCT01998984|589802884|FG003|Overall Study|Lost to Follow-up|1|||
163298613|NCT01998984|589802881|FG000|Overall Study|Withdrawal by Subject|0|||
163298614|NCT01998984|589802882|FG001|Overall Study|Withdrawal by Subject|0|||
163298615|NCT01998984|589802883|FG002|Overall Study|Withdrawal by Subject|1|||
163298616|NCT01998984|589802884|FG003|Overall Study|Withdrawal by Subject|0|||
163298617|NCT01998984|589802881|FG000|Overall Study|Other|0|||
163298618|NCT01998984|589802882|FG001|Overall Study|Other|0|||
163298619|NCT01998984|589802883|FG002|Overall Study|Other|0|||
163298620|NCT01998984|589802884|FG003|Overall Study|Other|1|||
163298621|NCT02652260|589802885|FG000|Base Study|Pregnancy|0|||
163298622|NCT02652260|589802886|FG001|Base Study|Pregnancy|1|||
163298623|NCT02652260|589802885|FG000|Base Study|Withdrawal by Subject|0|||
163298624|NCT02652260|589802886|FG001|Base Study|Withdrawal by Subject|1|||
163298625|NCT02652260|589802885|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
163298626|NCT02652260|589802886|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
163298627|NCT02652260|589802885|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
163298628|NCT02652260|589802886|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
163298629|NCT02652260|589802885|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
163298630|NCT02652260|589802886|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
163298631|NCT02652260|589802885|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
163298632|NCT02652260|589802886|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
163298633|NCT02652260|589802885|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
163298634|NCT02652260|589802886|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
163298635|NCT02652260|589802885|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
163298636|NCT02652260|589802886|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
163298637|NCT02652260|589802885|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
163298638|NCT02652260|589802886|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
163298639|NCT02652260|589802885|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
163298640|NCT02652260|589802886|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
163298641|NCT02652260|589802885|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
163298642|NCT02652260|589802886|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
163298643|NCT02652260|589802885|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
163298644|NCT02652260|589802886|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
163298645|NCT02652260|589802885|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
163298646|NCT02652260|589802886|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
163298647|NCT02652260|589802885|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
163298648|NCT02652260|589802886|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
163298649|NCT04300647|589802887|FG000|Pre-Crossover|Death|19|||
163298650|NCT04300647|589802888|FG001|Pre-Crossover|Death|58|||
163298651|NCT04300647|589802889|FG002|Pre-Crossover|Death|0|||
163298652|NCT04300647|589802887|FG000|Pre-Crossover|Lost to Follow-up|0|||
163298653|NCT04300647|589802888|FG001|Pre-Crossover|Lost to Follow-up|3|||
163298654|NCT04300647|589802889|FG002|Pre-Crossover|Lost to Follow-up|0|||
163298655|NCT04300647|589802887|FG000|Pre-Crossover|Withdrawal by Subject|2|||
163298656|NCT04300647|589802888|FG001|Pre-Crossover|Withdrawal by Subject|4|||
163298657|NCT04300647|589802889|FG002|Pre-Crossover|Withdrawal by Subject|0|||
163298658|NCT04300647|589802887|FG000|Pre-Crossover|On-going in Study|24|||
163298659|NCT04300647|589802888|FG001|Pre-Crossover|On-going in Study|61|||
163298660|NCT04300647|589802889|FG002|Pre-Crossover|On-going in Study|0|||
163298661|NCT04300647|589802887|FG000|Post-Crossover|Death|0|||
163298662|NCT04300647|589802888|FG001|Post-Crossover|Death|0|||
163298663|NCT04300647|589802889|FG002|Post-Crossover|Death|3|||
163298664|NCT04300647|589802887|FG000|Post-Crossover|Lost to Follow-up|0|||
163298665|NCT04300647|589802888|FG001|Post-Crossover|Lost to Follow-up|0|||
163298666|NCT04300647|589802889|FG002|Post-Crossover|Lost to Follow-up|1|||
163298667|NCT04300647|589802887|FG000|Post-Crossover|Withdrawal by Subject|0|||
163298668|NCT04300647|589802888|FG001|Post-Crossover|Withdrawal by Subject|0|||
163298669|NCT04300647|589802889|FG002|Post-Crossover|Withdrawal by Subject|1|||
163298670|NCT04300647|589802887|FG000|Post-Crossover|On-going in Study|0|||
163298671|NCT04300647|589802888|FG001|Post-Crossover|On-going in Study|0|||
163298672|NCT04300647|589802889|FG002|Post-Crossover|On-going in Study|8|||
163298673|NCT05056246|589802890|FG000|Overall Study|Adverse Event|0|||
163298674|NCT05056246|589802891|FG001|Overall Study|Adverse Event|0|||
163298675|NCT05056246|589802892|FG002|Overall Study|Adverse Event|0|||
163298676|NCT05056246|589802893|FG003|Overall Study|Adverse Event|0|||
163298677|NCT05056246|589802894|FG004|Overall Study|Adverse Event|1|||
162952822|NCT02255097|588531668|FG000|Overall Study|Withdrawal by Subject|7|||
162952823|NCT02255097|588531668|FG000|Overall Study|Allocated but not treated|1|||
162952824|NCT03956862|588531669|FG000|Overall Study|Lost to Follow-up|1|||
162952825|NCT03956862|588531670|FG001|Overall Study|Lost to Follow-up|1|||
162952826|NCT03956862|588531669|FG000|Overall Study|Withdrawal by Subject|1|||
162952827|NCT03956862|588531670|FG001|Overall Study|Withdrawal by Subject|1|||
162952828|NCT01498120|588531671|FG000|Overall Study|Lost to Follow-up|1|||
162952829|NCT01498120|588531671|FG000|Overall Study|Withdrawal by Subject|5|||
162952830|NCT01498120|588531671|FG000|Overall Study|AE, non-serious non-fatal|3|||
162952831|NCT01498120|588531671|FG000|Overall Study|Other|4|||
162952832|NCT02294604|588531672|FG000|Overall Study|Did not provide samples for culture|0|||
162952833|NCT02294604|588531673|FG001|Overall Study|Did not provide samples for culture|1|||
162952834|NCT02294604|588531674|FG002|Overall Study|Did not provide samples for culture|0|||
162952835|NCT02294604|588531672|FG000|Overall Study|Culture contamination|1|||
162952836|NCT02294604|588531673|FG001|Overall Study|Culture contamination|2|||
162952837|NCT02294604|588531674|FG002|Overall Study|Culture contamination|0|||
162952838|NCT01118312|588531675|FG000|Overall Study|Lost to Follow-up|33|||
162952839|NCT01118312|588531676|FG001|Overall Study|Lost to Follow-up|32|||
162952840|NCT01118312|588531675|FG000|Overall Study|Withdrawal by Subject|1|||
162952841|NCT01118312|588531676|FG001|Overall Study|Withdrawal by Subject|3|||
162952842|NCT03965091|588531677|FG000|Overall Study|Adverse Event|0|||
162952843|NCT03965091|588531678|FG001|Overall Study|Adverse Event|2|||
162952844|NCT03965091|588531679|FG002|Overall Study|Adverse Event|3|||
162952845|NCT03965091|588531677|FG000|Overall Study|Withdrawal by Subject|11|||
162952846|NCT03965091|588531678|FG001|Overall Study|Withdrawal by Subject|3|||
162952847|NCT03965091|588531679|FG002|Overall Study|Withdrawal by Subject|5|||
162952848|NCT03965091|588531677|FG000|Overall Study|Non-compliance with study drug|0|||
162952849|NCT03965091|588531678|FG001|Overall Study|Non-compliance with study drug|0|||
162952850|NCT03965091|588531679|FG002|Overall Study|Non-compliance with study drug|1|||
162952851|NCT03965091|588531677|FG000|Overall Study|Lost to Follow-up|1|||
162952852|NCT03965091|588531678|FG001|Overall Study|Lost to Follow-up|1|||
162952853|NCT03965091|588531679|FG002|Overall Study|Lost to Follow-up|1|||
162952854|NCT03965091|588531677|FG000|Overall Study|Lack of Efficacy|2|||
162952855|NCT03965091|588531678|FG001|Overall Study|Lack of Efficacy|0|||
162952856|NCT03965091|588531679|FG002|Overall Study|Lack of Efficacy|0|||
162952857|NCT03965091|588531677|FG000|Overall Study|Other than specified|9|||
162952858|NCT03965091|588531678|FG001|Overall Study|Other than specified|11|||
162952859|NCT03965091|588531679|FG002|Overall Study|Other than specified|8|||
163298678|NCT05056246|589802890|FG000|Overall Study|Lost to Follow-up|0|||
163298679|NCT05056246|589802891|FG001|Overall Study|Lost to Follow-up|0|||
163298680|NCT05056246|589802892|FG002|Overall Study|Lost to Follow-up|0|||
163298681|NCT05056246|589802893|FG003|Overall Study|Lost to Follow-up|2|||
163298682|NCT05056246|589802894|FG004|Overall Study|Lost to Follow-up|0|||
163298683|NCT05056246|589802890|FG000|Overall Study|Withdrawal by Subject|0|||
163298684|NCT05056246|589802891|FG001|Overall Study|Withdrawal by Subject|1|||
163298685|NCT05056246|589802892|FG002|Overall Study|Withdrawal by Subject|0|||
163298686|NCT05056246|589802893|FG003|Overall Study|Withdrawal by Subject|0|||
163298687|NCT05056246|589802894|FG004|Overall Study|Withdrawal by Subject|0|||
163298688|NCT05386238|589802895|FG000|Overall Study|Lost to Follow-up|3|||
163298689|NCT05386238|589802896|FG001|Overall Study|Lost to Follow-up|2|||
163298690|NCT05386238|589802895|FG000|Overall Study|Withdrawal by Subject|0|||
163298691|NCT05386238|589802896|FG001|Overall Study|Withdrawal by Subject|1|||
163298692|NCT04907474|589802897|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
163298693|NCT04907474|589802898|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
163298694|NCT01353313|589802905|FG000|Overall Study|Lost to Follow-up|22|||
163298695|NCT01353313|589802906|FG001|Overall Study|Lost to Follow-up|23|||
163298696|NCT01353313|589802905|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
163298697|NCT01353313|589802906|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
162952860|NCT00565448|588531680|FG000|Overall Study|Adverse Event|1|||
163298698|NCT01631214|589802910|FG000|Overall Study|Withdrawal by Subject|276|||
163298699|NCT01631214|589802911|FG001|Overall Study|Withdrawal by Subject|290|||
163298700|NCT01631214|589802910|FG000|Overall Study|Death|113|||
163298701|NCT01631214|589802911|FG001|Overall Study|Death|106|||
163298702|NCT01631214|589802910|FG000|Overall Study|Lost to Follow-up|54|||
163298703|NCT01631214|589802911|FG001|Overall Study|Lost to Follow-up|40|||
163298704|NCT01631214|589802910|FG000|Overall Study|Adverse Event|45|||
163298705|NCT01631214|589802911|FG001|Overall Study|Adverse Event|45|||
163298706|NCT01631214|589802910|FG000|Overall Study|Other|22|||
163298707|NCT01631214|589802911|FG001|Overall Study|Other|19|||
163298708|NCT01631214|589802910|FG000|Overall Study|Noncompliance|16|||
163298709|NCT01631214|589802911|FG001|Overall Study|Noncompliance|15|||
163298710|NCT01631214|589802910|FG000|Overall Study|Requirement for Alternative Therapy|8|||
163298711|NCT01631214|589802911|FG001|Overall Study|Requirement for Alternative Therapy|3|||
163298712|NCT01631214|589802910|FG000|Overall Study|Protocol Deviation|4|||
163298713|NCT01631214|589802911|FG001|Overall Study|Protocol Deviation|3|||
163298714|NCT01631214|589802910|FG000|Overall Study|Ineligibility determined|5|||
163298715|NCT01631214|589802911|FG001|Overall Study|Ineligibility determined|2|||
163298716|NCT01631214|589802910|FG000|Overall Study|Administrative Decision|1|||
163298717|NCT01631214|589802911|FG001|Overall Study|Administrative Decision|0|||
163298718|NCT03575052|589802912|FG000|Overall Study|Adverse Event|6|||
163298719|NCT03575052|589802913|FG001|Overall Study|Adverse Event|10|||
163298720|NCT03575052|589802912|FG000|Overall Study|Not further specified|5|||
163298721|NCT03575052|589802913|FG001|Overall Study|Not further specified|7|||
163298722|NCT03575052|589802912|FG000|Overall Study|Withdrawal by Subject|5|||
163298723|NCT03575052|589802913|FG001|Overall Study|Withdrawal by Subject|6|||
163298724|NCT03575052|589802912|FG000|Overall Study|Lost to Follow-up|3|||
163298725|NCT03575052|589802913|FG001|Overall Study|Lost to Follow-up|0|||
163298726|NCT03575052|589802912|FG000|Overall Study|Death|2|||
163298727|NCT03575052|589802913|FG001|Overall Study|Death|1|||
163298728|NCT03575052|589802912|FG000|Overall Study|Lack of Efficacy|2|||
163298729|NCT03575052|589802913|FG001|Overall Study|Lack of Efficacy|1|||
163298730|NCT03575052|589802912|FG000|Overall Study|Study drug noncompliance|1|||
163298731|NCT03575052|589802913|FG001|Overall Study|Study drug noncompliance|2|||
163298732|NCT03575052|589802912|FG000|Overall Study|Protocol Violation|0|||
163298733|NCT03575052|589802913|FG001|Overall Study|Protocol Violation|2|||
163298734|NCT03575052|589802912|FG000|Overall Study|Physician Decision|1|||
163298735|NCT03575052|589802913|FG001|Overall Study|Physician Decision|0|||
163298736|NCT01622868|589802923|FG000|Overall Study|Protocol Violation|7|||
163298737|NCT01622868|589802924|FG001|Overall Study|Protocol Violation|0|||
163298738|NCT03285763|589802926|FG000|Overall Study|Death|470|||
163298739|NCT03285763|589802926|FG000|Overall Study|Lost to Follow-up|18|||
163298740|NCT03285763|589802926|FG000|Overall Study|Physician Decision|2|||
163298741|NCT03285763|589802926|FG000|Overall Study|Study Terminated By Sponsor|79|||
163298742|NCT03285763|589802926|FG000|Overall Study|Withdrawal by Subject|33|||
163298743|NCT03624972|589802927|FG000|Overall Study|Lost to Follow-up|2|||
163298744|NCT03624972|589802928|FG001|Overall Study|Lost to Follow-up|0|||
163298745|NCT03624972|589802929|FG002|Overall Study|Lost to Follow-up|0|||
163298746|NCT03624972|589802927|FG000|Overall Study|Withdrawal by Subject|0|||
163298747|NCT03624972|589802928|FG001|Overall Study|Withdrawal by Subject|2|||
163298748|NCT03624972|589802929|FG002|Overall Study|Withdrawal by Subject|0|||
163298749|NCT03112174|589802930|FG000|Overall Study|Withdrawal by Subject|3|||
163298750|NCT03112174|589802931|FG001|Overall Study|Withdrawal by Subject|0|||
163298751|NCT03112174|589802932|FG002|Overall Study|Withdrawal by Subject|11|||
163298752|NCT03112174|589802933|FG003|Overall Study|Withdrawal by Subject|9|||
163298753|NCT03112174|589802934|FG004|Overall Study|Withdrawal by Subject|7|||
163298754|NCT03112174|589802930|FG000|Overall Study|Lost to Follow-up|1|||
163298755|NCT03112174|589802931|FG001|Overall Study|Lost to Follow-up|1|||
163298756|NCT03112174|589802932|FG002|Overall Study|Lost to Follow-up|2|||
163298757|NCT03112174|589802933|FG003|Overall Study|Lost to Follow-up|3|||
163298758|NCT03112174|589802934|FG004|Overall Study|Lost to Follow-up|2|||
163298759|NCT03112174|589802930|FG000|Overall Study|Death|8|||
163298760|NCT03112174|589802931|FG001|Overall Study|Death|3|||
163298761|NCT03112174|589802932|FG002|Overall Study|Death|67|||
163298762|NCT03112174|589802933|FG003|Overall Study|Death|73|||
163298763|NCT03112174|589802934|FG004|Overall Study|Death|18|||
163298764|NCT03112174|589802930|FG000|Overall Study|Other, Not Specified|1|||
163298765|NCT03112174|589802931|FG001|Overall Study|Other, Not Specified|0|||
163298766|NCT03112174|589802932|FG002|Overall Study|Other, Not Specified|1|||
163298767|NCT03112174|589802933|FG003|Overall Study|Other, Not Specified|2|||
163298768|NCT03112174|589802934|FG004|Overall Study|Other, Not Specified|0|||
163298769|NCT04425629|589802935|FG000|Overall Study|Adverse Event|0|||
163298770|NCT04425629|589802936|FG001|Overall Study|Adverse Event|0|||
163298771|NCT04425629|589802937|FG002|Overall Study|Adverse Event|0|||
163298772|NCT04425629|589802938|FG003|Overall Study|Adverse Event|0|||
163298773|NCT04425629|589802939|FG004|Overall Study|Adverse Event|1|||
163298774|NCT04425629|589802940|FG005|Overall Study|Adverse Event|0|||
163298775|NCT04425629|589802941|FG006|Overall Study|Adverse Event|0|||
163298776|NCT04425629|589802942|FG007|Overall Study|Adverse Event|0|||
163298777|NCT04425629|589802943|FG008|Overall Study|Adverse Event|0|||
163192738|NCT02280304|589421618|FG001|Overall Study|Lost to Follow-up|8|||
163192739|NCT04805541|589421619|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
163192740|NCT00713323|589421630|FG000|Overall Study|Adverse Event|75|||
163192741|NCT00713323|589421630|FG000|Overall Study|Withdrawal by Subject|15|||
163192742|NCT00713323|589421630|FG000|Overall Study|Lost to Follow-up|11|||
163192743|NCT00713323|589421630|FG000|Overall Study|Lack of Efficacy|36|||
163192744|NCT00713323|589421630|FG000|Overall Study|Low creatine clearance at screening|1|||
163192745|NCT00713323|589421630|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
163192746|NCT00713323|589421630|FG000|Overall Study|Surgery cured allodynic pain|1|||
163192747|NCT00713323|589421630|FG000|Overall Study|Pain free|1|||
163192748|NCT00713323|589421630|FG000|Overall Study|Non-compliance|1|||
163192749|NCT00713323|589421630|FG000|Overall Study|Pain resolved|1|||
163192750|NCT00713323|589421630|FG000|Overall Study|Subject travelling to USA|1|||
163192751|NCT00713323|589421630|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
163192752|NCT00713323|589421630|FG000|Overall Study|Treatment that may interact with Sativex|1|||
163192753|NCT05154578|589421631|FG000|Overall Study|Withdrawal by Subject|2|||
163192754|NCT05154578|589421632|FG001|Overall Study|Withdrawal by Subject|3|||
163192755|NCT05154578|589421633|FG002|Overall Study|Withdrawal by Subject|2|||
163192756|NCT05154578|589421634|FG003|Overall Study|Withdrawal by Subject|4|||
163192757|NCT05154578|589421635|FG004|Overall Study|Withdrawal by Subject|0|||
163192758|NCT05154578|589421631|FG000|Overall Study|Lost to Follow-up|0|||
163192759|NCT05154578|589421632|FG001|Overall Study|Lost to Follow-up|1|||
163192760|NCT05154578|589421633|FG002|Overall Study|Lost to Follow-up|0|||
163192761|NCT05154578|589421634|FG003|Overall Study|Lost to Follow-up|3|||
163192762|NCT05154578|589421635|FG004|Overall Study|Lost to Follow-up|0|||
163192763|NCT05154578|589421631|FG000|Overall Study|Adverse Event|0|||
163192764|NCT05154578|589421632|FG001|Overall Study|Adverse Event|0|||
163192765|NCT05154578|589421633|FG002|Overall Study|Adverse Event|0|||
163192766|NCT05154578|589421634|FG003|Overall Study|Adverse Event|1|||
163192767|NCT05154578|589421635|FG004|Overall Study|Adverse Event|0|||
163192768|NCT05154578|589421631|FG000|Overall Study|Relocated to another province|0|||
163192769|NCT05154578|589421632|FG001|Overall Study|Relocated to another province|0|||
163192770|NCT05154578|589421633|FG002|Overall Study|Relocated to another province|1|||
163192771|NCT05154578|589421634|FG003|Overall Study|Relocated to another province|0|||
163192772|NCT05154578|589421635|FG004|Overall Study|Relocated to another province|1|||
163192773|NCT05154578|589421631|FG000|Overall Study|Baby loss|0|||
163192774|NCT05154578|589421632|FG001|Overall Study|Baby loss|1|||
163192775|NCT05154578|589421633|FG002|Overall Study|Baby loss|0|||
163192776|NCT05154578|589421634|FG003|Overall Study|Baby loss|0|||
163192777|NCT05154578|589421635|FG004|Overall Study|Baby loss|0|||
163192778|NCT01146912|589421636|FG000|Overall Study|Already received influenza vaccination|817|||
163192779|NCT01146912|589421637|FG001|Overall Study|Already received influenza vaccination|822|||
163192780|NCT01146912|589421638|FG002|Overall Study|Already received influenza vaccination|13|||
163192781|NCT01146912|589421639|FG003|Overall Study|Already received influenza vaccination|15|||
163192782|NCT01146912|589421640|FG004|Overall Study|Already received influenza vaccination|41|||
163192783|NCT01146912|589421641|FG005|Overall Study|Already received influenza vaccination|61|||
163192784|NCT01146912|589421642|FG006|Overall Study|Already received influenza vaccination|56|||
163192785|NCT01146912|589421643|FG007|Overall Study|Already received influenza vaccination|0|||
163192786|NCT01146912|589421636|FG000|Overall Study|< 14 weeks gestational age|0|||
163192787|NCT01146912|589421637|FG001|Overall Study|< 14 weeks gestational age|0|||
163192788|NCT01146912|589421638|FG002|Overall Study|< 14 weeks gestational age|3|||
163192789|NCT01146912|589421639|FG003|Overall Study|< 14 weeks gestational age|2|||
163192790|NCT01146912|589421640|FG004|Overall Study|< 14 weeks gestational age|0|||
163192791|NCT01146912|589421641|FG005|Overall Study|< 14 weeks gestational age|0|||
163192792|NCT01146912|589421642|FG006|Overall Study|< 14 weeks gestational age|0|||
163192793|NCT01146912|589421643|FG007|Overall Study|< 14 weeks gestational age|0|||
163192794|NCT01146912|589421636|FG000|Overall Study|Duplicate patient|0|||
163192795|NCT01146912|589421637|FG001|Overall Study|Duplicate patient|0|||
163192796|NCT01146912|589421638|FG002|Overall Study|Duplicate patient|1|||
163192797|NCT01146912|589421639|FG003|Overall Study|Duplicate patient|0|||
163192798|NCT01146912|589421640|FG004|Overall Study|Duplicate patient|0|||
163192799|NCT01146912|589421641|FG005|Overall Study|Duplicate patient|0|||
163192800|NCT01146912|589421642|FG006|Overall Study|Duplicate patient|0|||
163192801|NCT01146912|589421643|FG007|Overall Study|Duplicate patient|0|||
163192802|NCT02980783|589421644|FG000|Overall Study|Lost to Follow-up|1|||
163192803|NCT00880542|589421645|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
163192804|NCT00880542|589421645|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
163192805|NCT00880542|589421645|FG000|REP: Surgical Resection|progressive disease|1|||
163192806|NCT05047770|589421646|FG000|Overall Study|Withdrawal by Subject|15|||
163192807|NCT05047770|589421647|FG001|Overall Study|Withdrawal by Subject|10|||
163192808|NCT05047770|589421648|FG002|Overall Study|Withdrawal by Subject|6|||
163192809|NCT05047770|589421649|FG003|Overall Study|Withdrawal by Subject|12|||
163192810|NCT05047770|589421646|FG000|Overall Study|Lost to Follow-up|7|||
163192811|NCT05047770|589421647|FG001|Overall Study|Lost to Follow-up|5|||
163192812|NCT05047770|589421648|FG002|Overall Study|Lost to Follow-up|12|||
163298778|NCT04425629|589802944|FG009|Overall Study|Adverse Event|3|||
163298779|NCT04425629|589802945|FG010|Overall Study|Adverse Event|2|||
163298780|NCT04425629|589802946|FG011|Overall Study|Adverse Event|1|||
163298781|NCT04425629|589802947|FG012|Overall Study|Adverse Event|1|||
163298782|NCT04425629|589802948|FG013|Overall Study|Adverse Event|0|||
163298783|NCT04425629|589802949|FG014|Overall Study|Adverse Event|0|||
163298784|NCT04425629|589802950|FG015|Overall Study|Adverse Event|0|||
163298785|NCT04425629|589802951|FG016|Overall Study|Adverse Event|0|||
163298786|NCT04425629|589802952|FG017|Overall Study|Adverse Event|0|||
163298787|NCT04425629|589802953|FG018|Overall Study|Adverse Event|0|||
163298788|NCT04425629|589802935|FG000|Overall Study|Lost to Follow-up|1|||
163298789|NCT04425629|589802936|FG001|Overall Study|Lost to Follow-up|3|||
163298790|NCT04425629|589802937|FG002|Overall Study|Lost to Follow-up|1|||
163298791|NCT04425629|589802938|FG003|Overall Study|Lost to Follow-up|7|||
163298792|NCT04425629|589802939|FG004|Overall Study|Lost to Follow-up|1|||
163298793|NCT04425629|589802940|FG005|Overall Study|Lost to Follow-up|2|||
163298794|NCT04425629|589802941|FG006|Overall Study|Lost to Follow-up|1|||
163298795|NCT04425629|589802942|FG007|Overall Study|Lost to Follow-up|0|||
163298796|NCT04425629|589802943|FG008|Overall Study|Lost to Follow-up|1|||
163298797|NCT04425629|589802944|FG009|Overall Study|Lost to Follow-up|64|||
163298798|NCT04425629|589802945|FG010|Overall Study|Lost to Follow-up|70|||
163298799|NCT04425629|589802946|FG011|Overall Study|Lost to Follow-up|98|||
163298800|NCT04425629|589802947|FG012|Overall Study|Lost to Follow-up|30|||
163298801|NCT04425629|589802948|FG013|Overall Study|Lost to Follow-up|0|||
163298802|NCT04425629|589802949|FG014|Overall Study|Lost to Follow-up|5|||
163298803|NCT04425629|589802950|FG015|Overall Study|Lost to Follow-up|4|||
163298804|NCT04425629|589802951|FG016|Overall Study|Lost to Follow-up|0|||
163298805|NCT04425629|589802952|FG017|Overall Study|Lost to Follow-up|3|||
163298806|NCT04425629|589802953|FG018|Overall Study|Lost to Follow-up|1|||
163298807|NCT04425629|589802935|FG000|Overall Study|Subject Decision|0|||
163298808|NCT04425629|589802936|FG001|Overall Study|Subject Decision|2|||
163298809|NCT04425629|589802937|FG002|Overall Study|Subject Decision|1|||
163298810|NCT04425629|589802938|FG003|Overall Study|Subject Decision|3|||
163298811|NCT04425629|589802939|FG004|Overall Study|Subject Decision|6|||
163298812|NCT04425629|589802940|FG005|Overall Study|Subject Decision|6|||
163298813|NCT04425629|589802941|FG006|Overall Study|Subject Decision|3|||
163298814|NCT04425629|589802942|FG007|Overall Study|Subject Decision|3|||
163298815|NCT04425629|589802943|FG008|Overall Study|Subject Decision|1|||
163298816|NCT04425629|589802944|FG009|Overall Study|Subject Decision|70|||
163298817|NCT04425629|589802945|FG010|Overall Study|Subject Decision|95|||
163298818|NCT04425629|589802946|FG011|Overall Study|Subject Decision|124|||
163298819|NCT04425629|589802947|FG012|Overall Study|Subject Decision|25|||
163298820|NCT04425629|589802948|FG013|Overall Study|Subject Decision|0|||
163298821|NCT04425629|589802949|FG014|Overall Study|Subject Decision|1|||
163298822|NCT04425629|589802950|FG015|Overall Study|Subject Decision|4|||
163298823|NCT04425629|589802951|FG016|Overall Study|Subject Decision|1|||
163298824|NCT04425629|589802952|FG017|Overall Study|Subject Decision|0|||
163298825|NCT04425629|589802953|FG018|Overall Study|Subject Decision|2|||
163298826|NCT04425629|589802935|FG000|Overall Study|Death|0|||
163392832|NCT04178967|590150341|FG002|Induction Period|Participant Missed Study Visits|0|||
163392833|NCT04178967|590150342|FG003|Induction Period|Participant Missed Study Visits|0|||
163392834|NCT04178967|590150343|FG004|Induction Period|Participant Missed Study Visits|0|||
163392835|NCT04178967|590150344|FG005|Induction Period|Participant Missed Study Visits|0|||
163392836|NCT04178967|590150345|FG006|Induction Period|Participant Missed Study Visits|0|||
163392837|NCT04178967|590150346|FG007|Induction Period|Participant Missed Study Visits|0|||
163392838|NCT04178967|590150347|FG008|Induction Period|Participant Missed Study Visits|0|||
163392839|NCT04178967|590150348|FG009|Induction Period|Participant Missed Study Visits|0|||
163392840|NCT04178967|590150349|FG010|Induction Period|Participant Missed Study Visits|0|||
163392841|NCT04178967|590150339|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
163392842|NCT04178967|590150340|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
163392843|NCT04178967|590150341|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
163392844|NCT04178967|590150342|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
163392845|NCT04178967|590150343|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
163392846|NCT04178967|590150344|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
163392847|NCT04178967|590150345|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
163298827|NCT04425629|589802936|FG001|Overall Study|Death|0|||
163298828|NCT04425629|589802937|FG002|Overall Study|Death|0|||
163298829|NCT04425629|589802938|FG003|Overall Study|Death|0|||
163298830|NCT04425629|589802939|FG004|Overall Study|Death|0|||
163298831|NCT04425629|589802940|FG005|Overall Study|Death|0|||
163298832|NCT04425629|589802941|FG006|Overall Study|Death|0|||
163298833|NCT04425629|589802942|FG007|Overall Study|Death|0|||
163298834|NCT04425629|589802943|FG008|Overall Study|Death|0|||
162952861|NCT00565448|588531681|FG001|Overall Study|Adverse Event|2|||
162952862|NCT00565448|588531680|FG000|Overall Study|Disease progression|1|||
162952863|NCT00565448|588531681|FG001|Overall Study|Disease progression|0|||
162952864|NCT00565448|588531680|FG000|Overall Study|Withdrawal by Subject|1|||
162952865|NCT00565448|588531681|FG001|Overall Study|Withdrawal by Subject|0|||
162952866|NCT00193609|588531682|FG000|Overall Study|Lack of Efficacy|2|||
162952867|NCT00193609|588531682|FG000|Overall Study|Adverse Event|2|||
162952868|NCT00302952|588531683|FG000|Overall Study|Physician Decision|1|||
162952869|NCT00302952|588531684|FG001|Overall Study|Physician Decision|1|||
162952870|NCT00302952|588531683|FG000|Overall Study|Withdrawal by Subject|2|||
162952871|NCT00302952|588531684|FG001|Overall Study|Withdrawal by Subject|3|||
162952872|NCT00302952|588531683|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
162952873|NCT00302952|588531684|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
162952874|NCT02979353|588531685|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
162952875|NCT02979353|588531686|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
162952876|NCT02979353|588531685|FG000|Overall Study|Withdrawal by Subject|16|||
162952877|NCT02979353|588531686|FG001|Overall Study|Withdrawal by Subject|12|||
162952878|NCT02979353|588531685|FG000|Overall Study|Death|10|||
162952879|NCT02979353|588531686|FG001|Overall Study|Death|11|||
162952880|NCT02979353|588531685|FG000|Overall Study|Transfer to Hospice Care|19|||
162952881|NCT02979353|588531686|FG001|Overall Study|Transfer to Hospice Care|14|||
162952882|NCT02979353|588531685|FG000|Overall Study|Lost to Follow-up|1|||
162952883|NCT02979353|588531686|FG001|Overall Study|Lost to Follow-up|5|||
162952884|NCT00857623|588531687|FG000|Overall Study|Adverse Event|5|||
162952885|NCT00857623|588531688|FG001|Overall Study|Adverse Event|2|||
162952886|NCT00857623|588531687|FG000|Overall Study|Study-specific discontinuation criteria|5|||
162952887|NCT00857623|588531688|FG001|Overall Study|Study-specific discontinuation criteria|3|||
162952888|NCT00857623|588531687|FG000|Overall Study|Withdrawal by Subject|2|||
162952889|NCT00857623|588531688|FG001|Overall Study|Withdrawal by Subject|1|||
162952890|NCT00857623|588531687|FG000|Overall Study|Lack of Efficacy|1|||
162952891|NCT00857623|588531688|FG001|Overall Study|Lack of Efficacy|1|||
162952892|NCT00857623|588531687|FG000|Overall Study|Severe non-compliance to protocol|1|||
162952893|NCT00857623|588531688|FG001|Overall Study|Severe non-compliance to protocol|1|||
162952894|NCT00857623|588531687|FG000|Overall Study|Intake of prohibited medication|0|||
163192813|NCT05047770|589421649|FG003|Overall Study|Lost to Follow-up|13|||
163192814|NCT05047770|589421646|FG000|Overall Study|Other|1|||
163192815|NCT05047770|589421647|FG001|Overall Study|Other|0|||
163192816|NCT05047770|589421648|FG002|Overall Study|Other|1|||
163192817|NCT05047770|589421649|FG003|Overall Study|Other|0|||
163192818|NCT01772160|589421650|FG000|Overall Study|Death|3|||
163192819|NCT01772160|589421650|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
163192820|NCT01772160|589421650|FG000|Overall Study|Consent withdrawal|3|||
163192821|NCT01772160|589421650|FG000|Overall Study|Migrated / moved from the study area|4|||
163192822|NCT01772160|589421650|FG000|Overall Study|Lost to Follow-up|30|||
163192823|NCT01772160|589421650|FG000|Overall Study|Other|5|||
163192824|NCT02202980|589421651|FG000|Overall Study|Lack of Efficacy|1|||
163192825|NCT02202980|589421652|FG001|Overall Study|Lack of Efficacy|0|||
163192826|NCT02202980|589421653|FG002|Overall Study|Lack of Efficacy|7|||
163192827|NCT02202980|589421654|FG003|Overall Study|Lack of Efficacy|0|||
163192828|NCT02202980|589421655|FG004|Overall Study|Lack of Efficacy|3|||
163192829|NCT02202980|589421656|FG005|Overall Study|Lack of Efficacy|1|||
163192830|NCT02202980|589421657|FG006|Overall Study|Lack of Efficacy|11|||
163192831|NCT02202980|589421658|FG007|Overall Study|Lack of Efficacy|2|||
163192832|NCT02202980|589421659|FG008|Overall Study|Lack of Efficacy|2|||
163192833|NCT02202980|589421660|FG009|Overall Study|Lack of Efficacy|0|||
163192834|NCT02202980|589421661|FG010|Overall Study|Lack of Efficacy|0|||
163192835|NCT02202980|589421662|FG011|Overall Study|Lack of Efficacy|3|||
163192836|NCT02202980|589421663|FG012|Overall Study|Lack of Efficacy|10|||
163192837|NCT02202980|589421664|FG013|Overall Study|Lack of Efficacy|0|||
163192838|NCT02202980|589421651|FG000|Overall Study|Protocol Violation|0|||
163192839|NCT02202980|589421652|FG001|Overall Study|Protocol Violation|0|||
163192840|NCT02202980|589421653|FG002|Overall Study|Protocol Violation|0|||
163192841|NCT02202980|589421654|FG003|Overall Study|Protocol Violation|3|||
163192842|NCT02202980|589421655|FG004|Overall Study|Protocol Violation|3|||
163192843|NCT02202980|589421656|FG005|Overall Study|Protocol Violation|0|||
163192844|NCT02202980|589421657|FG006|Overall Study|Protocol Violation|0|||
163192845|NCT02202980|589421658|FG007|Overall Study|Protocol Violation|0|||
163192846|NCT02202980|589421659|FG008|Overall Study|Protocol Violation|0|||
163192847|NCT02202980|589421660|FG009|Overall Study|Protocol Violation|0|||
163192848|NCT02202980|589421661|FG010|Overall Study|Protocol Violation|0|||
163192849|NCT02202980|589421662|FG011|Overall Study|Protocol Violation|0|||
163192850|NCT02202980|589421663|FG012|Overall Study|Protocol Violation|0|||
163192851|NCT02202980|589421664|FG013|Overall Study|Protocol Violation|0|||
163192852|NCT02202980|589421651|FG000|Overall Study|Lost to Follow-up|0|||
163192853|NCT02202980|589421652|FG001|Overall Study|Lost to Follow-up|1|||
163192854|NCT02202980|589421653|FG002|Overall Study|Lost to Follow-up|1|||
163192855|NCT02202980|589421654|FG003|Overall Study|Lost to Follow-up|1|||
163192856|NCT02202980|589421655|FG004|Overall Study|Lost to Follow-up|0|||
163192857|NCT02202980|589421656|FG005|Overall Study|Lost to Follow-up|0|||
163298835|NCT04425629|589802944|FG009|Overall Study|Death|11|||
163298836|NCT04425629|589802945|FG010|Overall Study|Death|2|||
163298837|NCT04425629|589802946|FG011|Overall Study|Death|4|||
163298838|NCT04425629|589802947|FG012|Overall Study|Death|0|||
163298839|NCT04425629|589802948|FG013|Overall Study|Death|0|||
163298840|NCT04425629|589802949|FG014|Overall Study|Death|0|||
163298841|NCT04425629|589802950|FG015|Overall Study|Death|0|||
163298842|NCT04425629|589802951|FG016|Overall Study|Death|0|||
163298843|NCT04425629|589802952|FG017|Overall Study|Death|0|||
163298844|NCT04425629|589802953|FG018|Overall Study|Death|0|||
163298845|NCT04425629|589802935|FG000|Overall Study|Sponsor Request|0|||
163298846|NCT04425629|589802936|FG001|Overall Study|Sponsor Request|0|||
163298847|NCT04425629|589802937|FG002|Overall Study|Sponsor Request|0|||
163298848|NCT04425629|589802938|FG003|Overall Study|Sponsor Request|2|||
163298849|NCT04425629|589802939|FG004|Overall Study|Sponsor Request|2|||
163298850|NCT04425629|589802940|FG005|Overall Study|Sponsor Request|2|||
163298851|NCT04425629|589802941|FG006|Overall Study|Sponsor Request|1|||
163298852|NCT04425629|589802942|FG007|Overall Study|Sponsor Request|0|||
163298853|NCT04425629|589802943|FG008|Overall Study|Sponsor Request|0|||
163298854|NCT04425629|589802944|FG009|Overall Study|Sponsor Request|9|||
163298855|NCT04425629|589802945|FG010|Overall Study|Sponsor Request|9|||
163298856|NCT04425629|589802946|FG011|Overall Study|Sponsor Request|10|||
163298857|NCT04425629|589802947|FG012|Overall Study|Sponsor Request|8|||
163298858|NCT04425629|589802948|FG013|Overall Study|Sponsor Request|0|||
163298859|NCT04425629|589802949|FG014|Overall Study|Sponsor Request|0|||
163298860|NCT04425629|589802950|FG015|Overall Study|Sponsor Request|1|||
163298861|NCT04425629|589802951|FG016|Overall Study|Sponsor Request|0|||
163298862|NCT04425629|589802952|FG017|Overall Study|Sponsor Request|0|||
163298863|NCT04425629|589802953|FG018|Overall Study|Sponsor Request|0|||
163298864|NCT04425629|589802935|FG000|Overall Study|Physician Decision|0|||
163298865|NCT04425629|589802936|FG001|Overall Study|Physician Decision|0|||
163298866|NCT04425629|589802937|FG002|Overall Study|Physician Decision|0|||
163298867|NCT04425629|589802938|FG003|Overall Study|Physician Decision|0|||
163298868|NCT04425629|589802939|FG004|Overall Study|Physician Decision|0|||
163298869|NCT04425629|589802940|FG005|Overall Study|Physician Decision|0|||
163298870|NCT04425629|589802941|FG006|Overall Study|Physician Decision|0|||
163298871|NCT04425629|589802942|FG007|Overall Study|Physician Decision|0|||
163298872|NCT04425629|589802943|FG008|Overall Study|Physician Decision|0|||
163298873|NCT04425629|589802944|FG009|Overall Study|Physician Decision|4|||
163298874|NCT04425629|589802945|FG010|Overall Study|Physician Decision|3|||
163298875|NCT04425629|589802946|FG011|Overall Study|Physician Decision|5|||
163298876|NCT04425629|589802947|FG012|Overall Study|Physician Decision|1|||
163298877|NCT04425629|589802948|FG013|Overall Study|Physician Decision|0|||
163298878|NCT04425629|589802949|FG014|Overall Study|Physician Decision|0|||
163298879|NCT04425629|589802950|FG015|Overall Study|Physician Decision|1|||
163298880|NCT04425629|589802951|FG016|Overall Study|Physician Decision|0|||
163298881|NCT04425629|589802952|FG017|Overall Study|Physician Decision|0|||
163298882|NCT04425629|589802953|FG018|Overall Study|Physician Decision|0|||
163298883|NCT04425629|589802935|FG000|Overall Study|Lack of Efficacy|0|||
163298884|NCT04425629|589802936|FG001|Overall Study|Lack of Efficacy|0|||
163298885|NCT04425629|589802937|FG002|Overall Study|Lack of Efficacy|0|||
163298886|NCT04425629|589802938|FG003|Overall Study|Lack of Efficacy|0|||
163298887|NCT04425629|589802939|FG004|Overall Study|Lack of Efficacy|0|||
163298888|NCT04425629|589802940|FG005|Overall Study|Lack of Efficacy|0|||
163298889|NCT04425629|589802941|FG006|Overall Study|Lack of Efficacy|0|||
163298890|NCT04425629|589802942|FG007|Overall Study|Lack of Efficacy|0|||
163298891|NCT04425629|589802943|FG008|Overall Study|Lack of Efficacy|0|||
163298892|NCT04425629|589802944|FG009|Overall Study|Lack of Efficacy|0|||
163298893|NCT04425629|589802945|FG010|Overall Study|Lack of Efficacy|1|||
163298894|NCT04425629|589802946|FG011|Overall Study|Lack of Efficacy|0|||
163298895|NCT04425629|589802947|FG012|Overall Study|Lack of Efficacy|0|||
163298896|NCT04425629|589802948|FG013|Overall Study|Lack of Efficacy|0|||
163298897|NCT04425629|589802949|FG014|Overall Study|Lack of Efficacy|0|||
163298898|NCT04425629|589802950|FG015|Overall Study|Lack of Efficacy|0|||
163298899|NCT04425629|589802951|FG016|Overall Study|Lack of Efficacy|0|||
163298900|NCT04425629|589802952|FG017|Overall Study|Lack of Efficacy|0|||
163298901|NCT04425629|589802953|FG018|Overall Study|Lack of Efficacy|0|||
163298902|NCT00610649|589802956|FG000|Overall Study|Adverse Event|1|||
163298903|NCT00610649|589802957|FG001|Overall Study|Adverse Event|0|||
163298904|NCT00610649|589802958|FG002|Overall Study|Adverse Event|0|||
163298905|NCT00610649|589802959|FG003|Overall Study|Adverse Event|0|||
163298906|NCT00610649|589802960|FG004|Overall Study|Adverse Event|0|||
163298907|NCT00610649|589802961|FG005|Overall Study|Adverse Event|0|||
163298908|NCT00610649|589802962|FG006|Overall Study|Adverse Event|0|||
163298909|NCT00610649|589802963|FG007|Overall Study|Adverse Event|0|||
163298910|NCT00610649|589802964|FG008|Overall Study|Adverse Event|0|||
163298911|NCT00610649|589802965|FG009|Overall Study|Adverse Event|0|||
163298912|NCT00610649|589802966|FG010|Overall Study|Adverse Event|1|||
163298913|NCT00610649|589802956|FG000|Overall Study|Family Emergency|0|||
163298914|NCT00610649|589802957|FG001|Overall Study|Family Emergency|1|||
163298915|NCT00610649|589802958|FG002|Overall Study|Family Emergency|0|||
163298916|NCT00610649|589802959|FG003|Overall Study|Family Emergency|0|||
163298917|NCT00610649|589802960|FG004|Overall Study|Family Emergency|0|||
163298918|NCT00610649|589802961|FG005|Overall Study|Family Emergency|0|||
163298919|NCT00610649|589802962|FG006|Overall Study|Family Emergency|0|||
163298920|NCT00610649|589802963|FG007|Overall Study|Family Emergency|0|||
163298921|NCT00610649|589802964|FG008|Overall Study|Family Emergency|0|||
163298922|NCT00610649|589802965|FG009|Overall Study|Family Emergency|0|||
163298923|NCT00610649|589802966|FG010|Overall Study|Family Emergency|0|||
163298924|NCT00610649|589802956|FG000|Overall Study|Withdrawal by Subject|0|||
163298925|NCT00610649|589802957|FG001|Overall Study|Withdrawal by Subject|0|||
163298926|NCT00610649|589802958|FG002|Overall Study|Withdrawal by Subject|0|||
163298927|NCT00610649|589802959|FG003|Overall Study|Withdrawal by Subject|0|||
163298928|NCT00610649|589802960|FG004|Overall Study|Withdrawal by Subject|0|||
163298929|NCT00610649|589802961|FG005|Overall Study|Withdrawal by Subject|0|||
163298930|NCT00610649|589802962|FG006|Overall Study|Withdrawal by Subject|0|||
163298931|NCT00610649|589802963|FG007|Overall Study|Withdrawal by Subject|0|||
163298932|NCT00610649|589802964|FG008|Overall Study|Withdrawal by Subject|0|||
163298933|NCT00610649|589802965|FG009|Overall Study|Withdrawal by Subject|1|||
163298934|NCT00610649|589802966|FG010|Overall Study|Withdrawal by Subject|0|||
163298935|NCT04259450|589802970|FG000|Overall Study|Adverse event/ Toxicity|0|||
163298936|NCT04259450|589802971|FG001|Overall Study|Adverse event/ Toxicity|3|||
163298937|NCT04259450|589802972|FG002|Overall Study|Adverse event/ Toxicity|0|||
163298938|NCT04259450|589802973|FG003|Overall Study|Adverse event/ Toxicity|1|||
163298939|NCT04259450|589802974|FG004|Overall Study|Adverse event/ Toxicity|0|||
163298940|NCT04259450|589802975|FG005|Overall Study|Adverse event/ Toxicity|0|||
163298941|NCT04259450|589802976|FG006|Overall Study|Adverse event/ Toxicity|0|||
163298942|NCT04259450|589802977|FG007|Overall Study|Adverse event/ Toxicity|1|||
163298943|NCT04259450|589802978|FG008|Overall Study|Adverse event/ Toxicity|0|||
163298944|NCT04259450|589802979|FG009|Overall Study|Adverse event/ Toxicity|3|||
163298945|NCT04259450|589802970|FG000|Overall Study|Disease progression|2|||
163298946|NCT04259450|589802971|FG001|Overall Study|Disease progression|3|||
163298947|NCT04259450|589802972|FG002|Overall Study|Disease progression|4|||
163298948|NCT04259450|589802973|FG003|Overall Study|Disease progression|4|||
163298949|NCT04259450|589802974|FG004|Overall Study|Disease progression|6|||
163392848|NCT04178967|590150346|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
163392849|NCT04178967|590150347|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
163392850|NCT04178967|590150348|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
163392851|NCT04178967|590150349|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
163392852|NCT04178967|590150339|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163392853|NCT04178967|590150340|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163392854|NCT04178967|590150341|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163392855|NCT04178967|590150342|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163392856|NCT04178967|590150343|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163392857|NCT04178967|590150344|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
163392858|NCT04178967|590150345|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163392859|NCT04178967|590150346|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163392860|NCT04178967|590150347|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162952895|NCT00857623|588531688|FG001|Overall Study|Intake of prohibited medication|1|||
162952896|NCT00857623|588531687|FG000|Overall Study|Positive for HEP C|0|||
162952897|NCT00857623|588531688|FG001|Overall Study|Positive for HEP C|1|||
163392861|NCT04178967|590150348|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163392862|NCT04178967|590150349|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163392863|NCT04178967|590150339|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163392864|NCT04178967|590150340|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163392865|NCT04178967|590150341|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163392866|NCT04178967|590150342|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
163298950|NCT04259450|589802975|FG005|Overall Study|Disease progression|6|||
163298951|NCT04259450|589802976|FG006|Overall Study|Disease progression|6|||
163298952|NCT04259450|589802977|FG007|Overall Study|Disease progression|15|||
163298953|NCT04259450|589802978|FG008|Overall Study|Disease progression|6|||
163298954|NCT04259450|589802979|FG009|Overall Study|Disease progression|18|||
163298955|NCT04259450|589802970|FG000|Overall Study|Death|0|||
163298956|NCT04259450|589802971|FG001|Overall Study|Death|0|||
163298957|NCT04259450|589802972|FG002|Overall Study|Death|0|||
163392867|NCT04178967|590150343|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163298958|NCT04259450|589802973|FG003|Overall Study|Death|0|||
163298959|NCT04259450|589802974|FG004|Overall Study|Death|0|||
163298960|NCT04259450|589802975|FG005|Overall Study|Death|0|||
163298961|NCT04259450|589802976|FG006|Overall Study|Death|0|||
163298962|NCT04259450|589802977|FG007|Overall Study|Death|1|||
163298963|NCT04259450|589802978|FG008|Overall Study|Death|1|||
163298964|NCT04259450|589802979|FG009|Overall Study|Death|0|||
163298965|NCT04259450|589802970|FG000|Overall Study|Withdrawal by Subject|0|||
163298966|NCT04259450|589802971|FG001|Overall Study|Withdrawal by Subject|0|||
162952898|NCT04185909|588531689|FG000|Overall Study|Lost to Follow-up|1|||
162952899|NCT02193178|588531690|FG000|Overall Study|Lost to Follow-up|1|||
162952900|NCT02193178|588531690|FG000|Overall Study|Dry eyes|1|||
162952901|NCT03435081|588531691|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
162952902|NCT03435081|588531692|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
162952903|NCT03435081|588531693|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
162952904|NCT03435081|588531691|FG000|Week 0 to Week 16|Adverse Event|2|||
162952905|NCT03435081|588531692|FG001|Week 0 to Week 16|Adverse Event|2|||
162952906|NCT03435081|588531693|FG002|Week 0 to Week 16|Adverse Event|2|||
162952907|NCT03435081|588531691|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
162952908|NCT03435081|588531692|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
162952909|NCT03435081|588531693|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
162952910|NCT03435081|588531691|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
162952911|NCT03435081|588531692|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
162952912|NCT03435081|588531693|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
162952913|NCT03435081|588531691|FG000|Week 0 to Week 16|Pregnancy|1|||
162952914|NCT03435081|588531692|FG001|Week 0 to Week 16|Pregnancy|0|||
162952915|NCT03435081|588531693|FG002|Week 0 to Week 16|Pregnancy|0|||
162952916|NCT03435081|588531691|FG000|Week 0 to Week 16|Non-compliance|1|||
162952917|NCT03435081|588531692|FG001|Week 0 to Week 16|Non-compliance|0|||
162952918|NCT03435081|588531693|FG002|Week 0 to Week 16|Non-compliance|2|||
162952919|NCT03435081|588531691|FG000|Week 0 to Week 16|Inadequate Response|0|||
162952920|NCT03435081|588531692|FG001|Week 0 to Week 16|Inadequate Response|1|||
162952921|NCT03435081|588531693|FG002|Week 0 to Week 16|Inadequate Response|0|||
162952922|NCT03435081|588531691|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
162952923|NCT03435081|588531692|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
162952924|NCT03435081|588531693|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
162952925|NCT03435081|588531691|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
162952926|NCT03435081|588531692|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
162952927|NCT03435081|588531693|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
162952928|NCT03435081|588531691|FG000|Week 16 to Week 104|Adverse Event|1|||
162952929|NCT03435081|588531692|FG001|Week 16 to Week 104|Adverse Event|0|||
162952930|NCT03435081|588531693|FG002|Week 16 to Week 104|Adverse Event|2|||
162952931|NCT03435081|588531691|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
162952932|NCT03435081|588531692|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
162952933|NCT03435081|588531693|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
162952934|NCT03435081|588531691|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
162952935|NCT03435081|588531692|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
162952936|NCT03435081|588531693|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
162952937|NCT03435081|588531691|FG000|Week 16 to Week 104|Non--Compliance|0|||
162952938|NCT03435081|588531692|FG001|Week 16 to Week 104|Non--Compliance|0|||
162952939|NCT03435081|588531693|FG002|Week 16 to Week 104|Non--Compliance|1|||
162952940|NCT02601560|588531694|FG000|Overall Study|Other|0|||
162952941|NCT02601560|588531695|FG001|Overall Study|Other|0|||
162952942|NCT02601560|588531696|FG002|Overall Study|Other|0|||
162952943|NCT02601560|588531697|FG003|Overall Study|Other|0|||
162952944|NCT02601560|588531698|FG004|Overall Study|Other|0|||
162952945|NCT02601560|588531699|FG005|Overall Study|Other|0|||
162952946|NCT02601560|588531700|FG006|Overall Study|Other|1|||
162952947|NCT02601560|588531701|FG007|Overall Study|Other|0|||
162952948|NCT00420238|588531704|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
162952949|NCT00420238|588531705|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
162952950|NCT00420238|588531704|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
162952951|NCT00420238|588531705|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
162952952|NCT00420238|588531704|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
162952953|NCT00420238|588531705|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
162952954|NCT00420238|588531704|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
162952955|NCT00420238|588531705|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
162952956|NCT00420238|588531704|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
162952957|NCT00420238|588531705|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
163192858|NCT02202980|589421657|FG006|Overall Study|Lost to Follow-up|0|||
163192859|NCT02202980|589421658|FG007|Overall Study|Lost to Follow-up|1|||
163192860|NCT02202980|589421659|FG008|Overall Study|Lost to Follow-up|1|||
163192861|NCT02202980|589421660|FG009|Overall Study|Lost to Follow-up|0|||
163192862|NCT02202980|589421661|FG010|Overall Study|Lost to Follow-up|0|||
163192863|NCT02202980|589421662|FG011|Overall Study|Lost to Follow-up|0|||
163192864|NCT02202980|589421663|FG012|Overall Study|Lost to Follow-up|1|||
163192865|NCT02202980|589421664|FG013|Overall Study|Lost to Follow-up|0|||
163192866|NCT02202980|589421651|FG000|Overall Study|Withdrew Consent|0|||
163192867|NCT02202980|589421652|FG001|Overall Study|Withdrew Consent|1|||
163192868|NCT02202980|589421653|FG002|Overall Study|Withdrew Consent|2|||
163192869|NCT02202980|589421654|FG003|Overall Study|Withdrew Consent|0|||
163192870|NCT02202980|589421655|FG004|Overall Study|Withdrew Consent|0|||
162952958|NCT00420238|588531704|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
163192871|NCT02202980|589421656|FG005|Overall Study|Withdrew Consent|0|||
163192872|NCT02202980|589421657|FG006|Overall Study|Withdrew Consent|0|||
162952959|NCT00420238|588531705|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
162952960|NCT00626548|588531706|FG000|Overall Study|Adverse Event|164|||
162952961|NCT00626548|588531707|FG001|Overall Study|Adverse Event|44|||
162952962|NCT00626548|588531706|FG000|Overall Study|Withdrawal by Subject|42|||
162952963|NCT00626548|588531707|FG001|Overall Study|Withdrawal by Subject|46|||
162952964|NCT00626548|588531706|FG000|Overall Study|Protocol Violation|4|||
162952965|NCT00626548|588531707|FG001|Overall Study|Protocol Violation|11|||
162952966|NCT00626548|588531706|FG000|Overall Study|Lost to Follow-up|2|||
162952967|NCT00626548|588531707|FG001|Overall Study|Lost to Follow-up|2|||
162952968|NCT00626548|588531706|FG000|Overall Study|Other termination reason|493|||
162952969|NCT00626548|588531707|FG001|Overall Study|Other termination reason|613|||
162952970|NCT04384978|588531708|FG000|Overall Study|Withdrawal by Subject|4|||
162952971|NCT04384978|588531709|FG001|Overall Study|Withdrawal by Subject|0|||
162952972|NCT00385593|588531710|FG000|Overall Study|Adverse Event|3|||
162952973|NCT00385593|588531711|FG001|Overall Study|Adverse Event|2|||
162952974|NCT00385593|588531710|FG000|Overall Study|Withdrawal by Subject|17|||
162952975|NCT00385593|588531711|FG001|Overall Study|Withdrawal by Subject|7|||
162952976|NCT00385593|588531710|FG000|Overall Study|Lost to Follow-up|12|||
162952977|NCT00385593|588531711|FG001|Overall Study|Lost to Follow-up|8|||
162952978|NCT00385593|588531710|FG000|Overall Study|Protocol Violation|7|||
162952979|NCT00385593|588531711|FG001|Overall Study|Protocol Violation|4|||
162952980|NCT00385593|588531710|FG000|Overall Study|Several reasons|17|||
162952981|NCT00385593|588531711|FG001|Overall Study|Several reasons|15|||
162952982|NCT00385593|588531710|FG000|Overall Study|Incorrect inclusion|2|||
162952983|NCT00385593|588531711|FG001|Overall Study|Incorrect inclusion|0|||
162952984|NCT00385593|588531710|FG000|Overall Study|Incorrect randomization|0|||
162952985|NCT00385593|588531711|FG001|Overall Study|Incorrect randomization|1|||
162952986|NCT03125200|588531714|FG000|Overall Study|Study Termination|0|||
162952987|NCT03125200|588531715|FG001|Overall Study|Study Termination|0|||
163298967|NCT04259450|589802972|FG002|Overall Study|Withdrawal by Subject|0|||
162952988|NCT03125200|588531716|FG002|Overall Study|Study Termination|0|||
162952989|NCT03125200|588531717|FG003|Overall Study|Study Termination|1|||
162952990|NCT03125200|588531718|FG004|Overall Study|Study Termination|1|||
162952991|NCT03125200|588531719|FG005|Overall Study|Study Termination|2|||
162952992|NCT03125200|588531720|FG006|Overall Study|Study Termination|1|||
162952993|NCT03125200|588531714|FG000|Overall Study|Clinical Progression|0|||
162952994|NCT03125200|588531715|FG001|Overall Study|Clinical Progression|0|||
162952995|NCT03125200|588531716|FG002|Overall Study|Clinical Progression|0|||
162952996|NCT03125200|588531717|FG003|Overall Study|Clinical Progression|1|||
162952997|NCT03125200|588531718|FG004|Overall Study|Clinical Progression|0|||
162952998|NCT03125200|588531719|FG005|Overall Study|Clinical Progression|1|||
162952999|NCT03125200|588531720|FG006|Overall Study|Clinical Progression|0|||
162953000|NCT03125200|588531714|FG000|Overall Study|Progressive Disease|2|||
162953001|NCT03125200|588531715|FG001|Overall Study|Progressive Disease|1|||
163298968|NCT04259450|589802973|FG003|Overall Study|Withdrawal by Subject|0|||
163298969|NCT04259450|589802974|FG004|Overall Study|Withdrawal by Subject|0|||
163298970|NCT04259450|589802975|FG005|Overall Study|Withdrawal by Subject|0|||
163298971|NCT04259450|589802976|FG006|Overall Study|Withdrawal by Subject|0|||
163298972|NCT04259450|589802977|FG007|Overall Study|Withdrawal by Subject|1|||
163298973|NCT04259450|589802978|FG008|Overall Study|Withdrawal by Subject|0|||
163298974|NCT04259450|589802979|FG009|Overall Study|Withdrawal by Subject|0|||
162953002|NCT03125200|588531716|FG002|Overall Study|Progressive Disease|2|||
162953003|NCT03125200|588531717|FG003|Overall Study|Progressive Disease|1|||
162953004|NCT03125200|588531718|FG004|Overall Study|Progressive Disease|2|||
163298975|NCT04259450|589802970|FG000|Overall Study|Other than listed|0|||
162953005|NCT03125200|588531719|FG005|Overall Study|Progressive Disease|0|||
162953006|NCT03125200|588531720|FG006|Overall Study|Progressive Disease|1|||
162953007|NCT03125200|588531714|FG000|Overall Study|Lack of Efficacy|0|||
162953008|NCT03125200|588531715|FG001|Overall Study|Lack of Efficacy|0|||
162953009|NCT03125200|588531716|FG002|Overall Study|Lack of Efficacy|0|||
162953010|NCT03125200|588531717|FG003|Overall Study|Lack of Efficacy|1|||
162953011|NCT03125200|588531718|FG004|Overall Study|Lack of Efficacy|0|||
162953012|NCT03125200|588531719|FG005|Overall Study|Lack of Efficacy|0|||
162953013|NCT03125200|588531720|FG006|Overall Study|Lack of Efficacy|0|||
162953014|NCT03125200|588531714|FG000|Overall Study|Toxicity|0|||
162953015|NCT03125200|588531715|FG001|Overall Study|Toxicity|0|||
162953016|NCT03125200|588531716|FG002|Overall Study|Toxicity|0|||
162953017|NCT03125200|588531717|FG003|Overall Study|Toxicity|1|||
162953018|NCT03125200|588531718|FG004|Overall Study|Toxicity|0|||
162953019|NCT03125200|588531719|FG005|Overall Study|Toxicity|0|||
162953020|NCT03125200|588531720|FG006|Overall Study|Toxicity|0|||
162953021|NCT03125200|588531714|FG000|Overall Study|Consent Withdrawn by Subject|0|||
162953022|NCT03125200|588531715|FG001|Overall Study|Consent Withdrawn by Subject|1|||
162953023|NCT03125200|588531716|FG002|Overall Study|Consent Withdrawn by Subject|0|||
162953024|NCT03125200|588531717|FG003|Overall Study|Consent Withdrawn by Subject|0|||
162953025|NCT03125200|588531718|FG004|Overall Study|Consent Withdrawn by Subject|1|||
162953026|NCT03125200|588531719|FG005|Overall Study|Consent Withdrawn by Subject|0|||
162953027|NCT03125200|588531720|FG006|Overall Study|Consent Withdrawn by Subject|1|||
162953028|NCT03041025|588531724|FG000|Overall Study|Adverse Event|0|||
162953029|NCT03041025|588531725|FG001|Overall Study|Adverse Event|0|||
162953030|NCT03041025|588531726|FG002|Overall Study|Adverse Event|1|||
162953031|NCT03041025|588531724|FG000|Overall Study|Lost to Follow-up|1|||
162953032|NCT03041025|588531725|FG001|Overall Study|Lost to Follow-up|0|||
162953033|NCT03041025|588531726|FG002|Overall Study|Lost to Follow-up|0|||
162953034|NCT03041025|588531724|FG000|Overall Study|Withdrawal by Subject|0|||
162953035|NCT03041025|588531725|FG001|Overall Study|Withdrawal by Subject|0|||
162953036|NCT03041025|588531726|FG002|Overall Study|Withdrawal by Subject|1|||
162953037|NCT02963259|588531727|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
162953038|NCT02963259|588531727|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
162953039|NCT02963259|588531727|FG000|Overall Study|Death|1|||
162953040|NCT02963259|588531727|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
162953041|NCT02131129|588531728|FG000|Overall Study|Withdrawal by Subject|1|||
162953042|NCT02131129|588531729|FG001|Overall Study|Withdrawal by Subject|0|||
162953043|NCT00396279|588533314|FG000|Overall Study|Ongoing in study|26|||
162953044|NCT00396279|588533314|FG000|Overall Study|Disease progression|2|||
162953045|NCT00396279|588533314|FG000|Overall Study|Withdrawal by Subject|1|||
162953046|NCT00396279|588533314|FG000|Overall Study|Physician Decision|1|||
162953047|NCT01882257|588533315|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
162953048|NCT01882257|588533316|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
162953049|NCT01882257|588533317|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
162953050|NCT01882257|588533315|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
162953051|NCT01882257|588533316|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
162953052|NCT01882257|588533317|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
162953053|NCT00830206|588533318|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
162953054|NCT00830206|588533319|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
162953055|NCT00905346|588533320|FG000|Period 1|Withdrawal by Subject|1|||
162953056|NCT00905346|588533321|FG001|Period 1|Withdrawal by Subject|0|||
162953057|NCT02736721|588533328|FG000|Overall Study|Adverse Event|8|||
162953058|NCT02736721|588533328|FG000|Overall Study|Lost to Follow-up|3|||
162953059|NCT02736721|588533328|FG000|Overall Study|Other|5|||
162953060|NCT02956460|588533329|FG000|Lens 1|Lost to Follow-up|1|||
162953061|NCT02956460|588533330|FG001|Lens 1|Lost to Follow-up|0|||
162953062|NCT00829673|588533331|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
162953063|NCT00829673|588533332|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
162953064|NCT00272779|588533333|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
162953065|NCT00272779|588533334|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
162953066|NCT00272779|588533333|FG000|Baseline Through Week 48|Death before Week 48|4|||
162953067|NCT00272779|588533334|FG001|Baseline Through Week 48|Death before Week 48|4|||
162953068|NCT00272779|588533333|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
162953069|NCT00272779|588533334|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
162953070|NCT00272779|588533333|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
162953071|NCT00272779|588533334|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
162953072|NCT00272779|588533333|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
162953073|NCT00272779|588533334|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
162953074|NCT00272779|588533333|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
162953075|NCT00272779|588533334|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
162953076|NCT00272779|588533333|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
162953077|NCT00272779|588533334|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
162953078|NCT00272779|588533333|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
162953079|NCT00272779|588533334|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
162953080|NCT00272779|588533333|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
162953081|NCT00272779|588533334|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
162953082|NCT00272779|588533333|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
162953083|NCT00272779|588533334|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
162953084|NCT00272779|588533333|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
162953085|NCT00272779|588533334|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
162953086|NCT00272779|588533333|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
162953087|NCT00272779|588533334|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
162953088|NCT00272779|588533333|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
162953089|NCT00272779|588533334|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
162953090|NCT00272779|588533333|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
162953091|NCT00272779|588533334|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
162953092|NCT00272779|588533333|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
162953093|NCT00272779|588533334|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
162953094|NCT00272779|588533333|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
162953095|NCT00272779|588533334|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
162953096|NCT00272779|588533333|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
162953097|NCT00272779|588533334|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
162953098|NCT00272779|588533333|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
162953099|NCT00272779|588533334|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
162953100|NCT00272779|588533333|FG000|Baseline Through Week 48|Continuing treatment|385|||
162953101|NCT00272779|588533334|FG001|Baseline Through Week 48|Continuing treatment|368|||
162953102|NCT00272779|588533333|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
162953103|NCT00272779|588533334|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
162953104|NCT00272779|588533333|FG000|Baseline Through Week 48|Never treated|2|||
162953105|NCT00272779|588533334|FG001|Baseline Through Week 48|Never treated|3|||
162953106|NCT00272779|588533333|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
162953107|NCT00272779|588533334|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
162953108|NCT00272779|588533333|FG000|Baseline Through Week 96|Death before Week 96|6|||
162953109|NCT00272779|588533334|FG001|Baseline Through Week 96|Death before Week 96|5|||
162953110|NCT00272779|588533333|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
162953111|NCT00272779|588533334|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
162953112|NCT00272779|588533333|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
162953113|NCT00272779|588533334|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
162953114|NCT00272779|588533333|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
162953115|NCT00272779|588533334|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
162953116|NCT00272779|588533333|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
162953117|NCT00272779|588533334|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
162953118|NCT00272779|588533333|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
162953119|NCT00272779|588533334|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
162953120|NCT00272779|588533333|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
162953121|NCT00272779|588533334|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
162953122|NCT00272779|588533333|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
162953123|NCT00272779|588533334|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
162953124|NCT00272779|588533333|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
162953125|NCT00272779|588533334|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
162953126|NCT00272779|588533333|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
162953127|NCT00272779|588533334|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
162953128|NCT00272779|588533333|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
162953129|NCT00272779|588533334|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
163392868|NCT04178967|590150344|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163392869|NCT04178967|590150345|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163392870|NCT04178967|590150346|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163392871|NCT04178967|590150347|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163392872|NCT04178967|590150348|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163192873|NCT02202980|589421658|FG007|Overall Study|Withdrew Consent|0|||
163192874|NCT02202980|589421659|FG008|Overall Study|Withdrew Consent|1|||
163192875|NCT02202980|589421660|FG009|Overall Study|Withdrew Consent|0|||
163192876|NCT02202980|589421661|FG010|Overall Study|Withdrew Consent|0|||
163192877|NCT02202980|589421662|FG011|Overall Study|Withdrew Consent|0|||
163192878|NCT02202980|589421663|FG012|Overall Study|Withdrew Consent|0|||
163192879|NCT02202980|589421664|FG013|Overall Study|Withdrew Consent|0|||
163192880|NCT01952145|589421665|FG000|Overall Study|Protocol Violation|2|||
163192881|NCT01952145|589421666|FG001|Overall Study|Protocol Violation|1|||
163192882|NCT01952145|589421665|FG000|Overall Study|Death|0|||
163192883|NCT01952145|589421666|FG001|Overall Study|Death|1|||
163192884|NCT01952145|589421665|FG000|Overall Study|Adverse Event|9|||
163192885|NCT01952145|589421666|FG001|Overall Study|Adverse Event|0|||
163192886|NCT01952145|589421665|FG000|Overall Study|Withdrawal Criteria|16|||
163192887|NCT01952145|589421666|FG001|Overall Study|Withdrawal Criteria|11|||
163192888|NCT01952145|589421665|FG000|Overall Study|Unclassified|1|||
163192889|NCT01952145|589421666|FG001|Overall Study|Unclassified|1|||
163192890|NCT01540838|589421670|FG000|Overall Study|Open nasogastric tube|9|||
163192891|NCT01540838|589421671|FG001|Overall Study|Open nasogastric tube|7|||
163192892|NCT01540838|589421670|FG000|Overall Study|Treatment doses missing|8|||
163192893|NCT01540838|589421671|FG001|Overall Study|Treatment doses missing|12|||
163192894|NCT01540838|589421670|FG000|Overall Study|Additional antibiotic treatment|1|||
163192895|NCT01540838|589421671|FG001|Overall Study|Additional antibiotic treatment|2|||
163192896|NCT01540838|589421670|FG000|Overall Study|Died before treatment initiation|1|||
163192897|NCT01540838|589421671|FG001|Overall Study|Died before treatment initiation|1|||
163192898|NCT01540838|589421670|FG000|Overall Study|Not BM. Other treatment|3|||
163192899|NCT01540838|589421671|FG001|Overall Study|Not BM. Other treatment|1|||
163192900|NCT02130570|589421672|FG000|Overall Study|Death|3|||
163192901|NCT02130570|589421673|FG001|Overall Study|Death|5|||
163192902|NCT02130570|589421672|FG000|Overall Study|Withdrawal by Subject|6|||
163192903|NCT02130570|589421673|FG001|Overall Study|Withdrawal by Subject|3|||
163192904|NCT02130570|589421672|FG000|Overall Study|Part of practice that discontinued study|0|||
163298976|NCT04259450|589802971|FG001|Overall Study|Other than listed|0|||
163298977|NCT04259450|589802972|FG002|Overall Study|Other than listed|0|||
163298978|NCT04259450|589802973|FG003|Overall Study|Other than listed|0|||
163298979|NCT04259450|589802974|FG004|Overall Study|Other than listed|0|||
163298980|NCT04259450|589802975|FG005|Overall Study|Other than listed|0|||
163298981|NCT04259450|589802976|FG006|Overall Study|Other than listed|0|||
163298982|NCT04259450|589802977|FG007|Overall Study|Other than listed|1|||
163298983|NCT04259450|589802978|FG008|Overall Study|Other than listed|1|||
163298984|NCT04259450|589802979|FG009|Overall Study|Other than listed|2|||
163298985|NCT00332241|589802980|FG000|Overall Study|Lack of Efficacy|6|||
163298986|NCT00332241|589802981|FG001|Overall Study|Lack of Efficacy|1|||
163298987|NCT00332241|589802980|FG000|Overall Study|Adverse Event|3|||
163298988|NCT00332241|589802981|FG001|Overall Study|Adverse Event|5|||
163298989|NCT00332241|589802980|FG000|Overall Study|Withdrawal by Subject|2|||
163298990|NCT00332241|589802981|FG001|Overall Study|Withdrawal by Subject|1|||
163298991|NCT00332241|589802980|FG000|Overall Study|Lost to Follow-up|4|||
163298992|NCT00332241|589802981|FG001|Overall Study|Lost to Follow-up|1|||
163298993|NCT00542789|589802989|FG000|Overall Study|Adverse Event|18|||
163298994|NCT00542789|589802990|FG001|Overall Study|Adverse Event|17|||
162953130|NCT00272779|588533333|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
162953131|NCT00272779|588533334|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
162953132|NCT00272779|588533333|FG000|Baseline Through Week 96|Never treated|2|||
162953133|NCT00272779|588533334|FG001|Baseline Through Week 96|Never treated|3|||
162953134|NCT00272779|588533333|FG000|Baseline Through Week 96|Continuing on treatment|61|||
162953135|NCT00272779|588533334|FG001|Baseline Through Week 96|Continuing on treatment|38|||
162953136|NCT04088760|588533338|FG000|Overall Study|Physician Decision|1|||
162953137|NCT00376623|588533340|FG000|Overall Study|Progressive disease|35|||
162953138|NCT00376623|588533341|FG001|Overall Study|Progressive disease|22|||
162953139|NCT00376623|588533342|FG002|Overall Study|Progressive disease|17|||
162953140|NCT00376623|588533340|FG000|Overall Study|Lost to Follow-up|0|||
162953141|NCT00376623|588533341|FG001|Overall Study|Lost to Follow-up|1|||
162953142|NCT00376623|588533342|FG002|Overall Study|Lost to Follow-up|0|||
162953143|NCT00376623|588533340|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
162953144|NCT00376623|588533341|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
162953145|NCT00376623|588533342|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
162953146|NCT00376623|588533340|FG000|Overall Study|Not treated with BI 2536|1|||
162953147|NCT00376623|588533341|FG001|Overall Study|Not treated with BI 2536|0|||
162953148|NCT00376623|588533342|FG002|Overall Study|Not treated with BI 2536|0|||
162953149|NCT00376623|588533340|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
162953150|NCT00376623|588533341|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
162953151|NCT00376623|588533342|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
162953152|NCT00376623|588533340|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
162953153|NCT00376623|588533341|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
162953154|NCT00376623|588533342|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
162953155|NCT00376623|588533340|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
163298995|NCT00542789|589802989|FG000|Overall Study|Withdrawal by Subject|7|||
163298996|NCT00542789|589802990|FG001|Overall Study|Withdrawal by Subject|3|||
163298997|NCT00542789|589802989|FG000|Overall Study|Protocol Violation|8|||
163298998|NCT00542789|589802990|FG001|Overall Study|Protocol Violation|1|||
162953156|NCT00376623|588533341|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
162953157|NCT00376623|588533342|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
162953158|NCT00376623|588533340|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
162953159|NCT00376623|588533341|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
162953160|NCT00376623|588533342|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
162953161|NCT00376623|588533340|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
162953162|NCT00376623|588533341|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
162953163|NCT00376623|588533342|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
162953164|NCT00376623|588533340|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
162953165|NCT00376623|588533341|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
162953166|NCT00376623|588533342|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
162953167|NCT00376623|588533340|FG000|Overall Study|Increase of tumour markers|0|||
162953168|NCT00376623|588533341|FG001|Overall Study|Increase of tumour markers|1|||
162953169|NCT00376623|588533342|FG002|Overall Study|Increase of tumour markers|0|||
162953170|NCT00376623|588533340|FG000|Overall Study|Bone metastasis|1|||
162953171|NCT00376623|588533341|FG001|Overall Study|Bone metastasis|0|||
163298999|NCT00542789|589802989|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
163299000|NCT00542789|589802990|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
163299001|NCT02584829|589802992|FG000|Overall Study|Physician Decision|1|||
163299002|NCT02584829|589802993|FG001|Overall Study|Physician Decision|0|||
162953172|NCT00376623|588533342|FG002|Overall Study|Bone metastasis|0|||
162953173|NCT02331394|588533343|FG000|Overall Study|Disease progression|1|||
162953174|NCT02098876|588533347|FG000|Overall Study|Withdrawal by Subject|5|||
162953175|NCT02098876|588533348|FG001|Overall Study|Withdrawal by Subject|5|||
163192905|NCT02130570|589421673|FG001|Overall Study|Part of practice that discontinued study|5|||
163192906|NCT02808650|589421679|FG000|Overall Study|Death|0|||
163192907|NCT02808650|589421680|FG001|Overall Study|Death|0|||
163192908|NCT02808650|589421681|FG002|Overall Study|Death|0|||
163192909|NCT02808650|589421682|FG003|Overall Study|Death|0|||
163192910|NCT02808650|589421683|FG004|Overall Study|Death|1|||
163192911|NCT02808650|589421679|FG000|Overall Study|Lack of Efficacy|5|||
163192912|NCT02808650|589421680|FG001|Overall Study|Lack of Efficacy|5|||
163192913|NCT02808650|589421681|FG002|Overall Study|Lack of Efficacy|6|||
163192914|NCT02808650|589421682|FG003|Overall Study|Lack of Efficacy|5|||
163192915|NCT02808650|589421683|FG004|Overall Study|Lack of Efficacy|4|||
163192916|NCT02808650|589421679|FG000|Overall Study|Physician Decision|1|||
163192917|NCT02808650|589421680|FG001|Overall Study|Physician Decision|1|||
163192918|NCT02808650|589421681|FG002|Overall Study|Physician Decision|0|||
163192919|NCT02808650|589421682|FG003|Overall Study|Physician Decision|0|||
162953176|NCT01061866|588533351|FG000|Overall Study|Adverse Event|2|||
162953177|NCT01270503|588533352|FG000|Overall Study|Lost to Follow-up|1|||
162953178|NCT02459951|588533353|FG000|Overall Study|Unable to meet holding requirement|1|||
162953179|NCT04239872|588533355|FG000|Overall Study|Lost to Follow-up|0|||
162953180|NCT04239872|588533356|FG001|Overall Study|Lost to Follow-up|1|||
162953181|NCT01010542|588533359|FG000|Overall Study|Adverse Event|0|||
162953182|NCT01010542|588533360|FG001|Overall Study|Adverse Event|1|||
162953183|NCT01010542|588533361|FG002|Overall Study|Adverse Event|0|||
162953184|NCT01010542|588533359|FG000|Overall Study|Lost to Follow-up|0|||
162953185|NCT01010542|588533360|FG001|Overall Study|Lost to Follow-up|1|||
162953186|NCT01010542|588533361|FG002|Overall Study|Lost to Follow-up|0|||
162953187|NCT01010542|588533359|FG000|Overall Study|Withdrawal by Subject|0|||
162953188|NCT01010542|588533360|FG001|Overall Study|Withdrawal by Subject|3|||
162953189|NCT01010542|588533361|FG002|Overall Study|Withdrawal by Subject|2|||
162953190|NCT01975948|588533371|FG000|Overall Study|Withdrawal by Subject|17|||
162953191|NCT01975948|588533372|FG001|Overall Study|Withdrawal by Subject|21|||
162953192|NCT01975948|588533373|FG002|Overall Study|Withdrawal by Subject|7|||
162953193|NCT01975948|588533374|FG003|Overall Study|Withdrawal by Subject|6|||
162953194|NCT01675765|588533375|FG000|Overall Study|Progressive disease|4|||
162953195|NCT01675765|588533376|FG001|Overall Study|Progressive disease|4|||
162953196|NCT01675765|588533375|FG000|Overall Study|Adverse Event|1|||
162953197|NCT01675765|588533376|FG001|Overall Study|Adverse Event|2|||
162953198|NCT01675765|588533375|FG000|Overall Study|Withdrawal by Subject|2|||
162953199|NCT01675765|588533376|FG001|Overall Study|Withdrawal by Subject|0|||
162953200|NCT01675765|588533375|FG000|Overall Study|Death|1|||
162953201|NCT01675765|588533376|FG001|Overall Study|Death|0|||
162953202|NCT01675765|588533375|FG000|Overall Study|Clinical progression|3|||
162953203|NCT01675765|588533376|FG001|Overall Study|Clinical progression|2|||
162953204|NCT04060147|588533378|FG000|Overall Study|Withdrew consent|1|||
162953205|NCT01534520|588533379|FG000|Overall Study|Adverse Event|0|||
162953206|NCT01534520|588533380|FG001|Overall Study|Adverse Event|1|||
162953207|NCT03204539|588533383|FG000|Overall Study|Loss of funding|0|||
162953208|NCT03204539|588533384|FG001|Overall Study|Loss of funding|1|||
162953209|NCT00550537|588533387|FG000|Overall Study|Death|18|||
162953210|NCT00550537|588533387|FG000|Overall Study|Adverse Event|20|||
162953211|NCT00550537|588533387|FG000|Overall Study|Disease progression before|46|||
162953212|NCT00550537|588533387|FG000|Overall Study|Withdrawal by Subject|7|||
162953213|NCT00550537|588533387|FG000|Overall Study|Change in treatment plan|4|||
162953214|NCT00550537|588533387|FG000|Overall Study|Other complicating ilness|3|||
162953215|NCT00550537|588533387|FG000|Overall Study|Declining performance status|2|||
162953216|NCT00550537|588533387|FG000|Overall Study|Treated closer to home|4|||
162953217|NCT02008565|588533388|FG000|Overall Study|Protocol Violation|1|||
162953218|NCT02008565|588533389|FG001|Overall Study|Protocol Violation|1|||
162953219|NCT02008565|588533390|FG002|Overall Study|Protocol Violation|2|||
162953220|NCT02008565|588533391|FG003|Overall Study|Protocol Violation|0|||
162953221|NCT00617305|588533392|FG000|Overall Study|Adverse Event|4|||
162953222|NCT00617305|588533393|FG001|Overall Study|Adverse Event|0|||
162953223|NCT00617305|588533394|FG002|Overall Study|Adverse Event|0|||
162953224|NCT00617305|588533392|FG000|Overall Study|Death|1|||
162953225|NCT00617305|588533393|FG001|Overall Study|Death|0|||
162953226|NCT00617305|588533394|FG002|Overall Study|Death|0|||
162953227|NCT00617305|588533392|FG000|Overall Study|Physician Decision|1|||
162953228|NCT00617305|588533393|FG001|Overall Study|Physician Decision|0|||
162953229|NCT00617305|588533394|FG002|Overall Study|Physician Decision|0|||
162953230|NCT00617305|588533392|FG000|Overall Study|Protocol Violation|1|||
162953231|NCT00617305|588533393|FG001|Overall Study|Protocol Violation|0|||
162953232|NCT00617305|588533394|FG002|Overall Study|Protocol Violation|1|||
162953233|NCT00617305|588533392|FG000|Overall Study|Withdrawal by Subject|1|||
162953234|NCT00617305|588533393|FG001|Overall Study|Withdrawal by Subject|0|||
162953235|NCT00617305|588533394|FG002|Overall Study|Withdrawal by Subject|0|||
162953236|NCT00537979|588533396|FG000|Overall Study|Adverse Event|2|||
162953237|NCT00537979|588533397|FG001|Overall Study|Adverse Event|2|||
162953238|NCT00537979|588533396|FG000|Overall Study|Withdrawal by Subject|1|||
162953239|NCT00537979|588533397|FG001|Overall Study|Withdrawal by Subject|4|||
162953240|NCT00537979|588533396|FG000|Overall Study|Lost to Follow-up|1|||
162953241|NCT00537979|588533397|FG001|Overall Study|Lost to Follow-up|4|||
162953242|NCT00537979|588533396|FG000|Overall Study|Lack of Efficacy|0|||
162953243|NCT00537979|588533397|FG001|Overall Study|Lack of Efficacy|1|||
162953244|NCT00537979|588533396|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
162953245|NCT00537979|588533397|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
163392873|NCT04178967|590150349|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162953246|NCT00537979|588533396|FG000|Overall Study|Death|0|||
162953247|NCT00537979|588533397|FG001|Overall Study|Death|3|||
162953248|NCT00537979|588533396|FG000|Overall Study|Kidney transplant|0|||
162953249|NCT00537979|588533397|FG001|Overall Study|Kidney transplant|3|||
162953250|NCT00537979|588533396|FG000|Overall Study|Heart failure|0|||
162953251|NCT00537979|588533397|FG001|Overall Study|Heart failure|1|||
162953252|NCT01059903|588533399|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
162953253|NCT01059903|588533400|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
163299003|NCT02584829|589802992|FG000|Overall Study|Withdrawal by Subject|0|||
163299004|NCT02584829|589802993|FG001|Overall Study|Withdrawal by Subject|1|||
163299005|NCT02584829|589802992|FG000|Overall Study|Progressive Disease|0|||
163299006|NCT02584829|589802993|FG001|Overall Study|Progressive Disease|3|||
163299007|NCT00106080|589803000|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
163299008|NCT00106080|589803001|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
163299009|NCT00761605|589803004|FG000|Overall Study|Adverse Event|26|||
163299010|NCT00761605|589803004|FG000|Overall Study|Death|2|||
163299011|NCT00761605|589803004|FG000|Overall Study|Lack of Efficacy|26|||
163299012|NCT00761605|589803004|FG000|Overall Study|Lost to Follow-up|29|||
163299013|NCT00761605|589803004|FG000|Overall Study|Withdrawal by Subject|37|||
163299014|NCT00761605|589803004|FG000|Overall Study|Other|21|||
163299015|NCT03074331|589803005|FG000|Overall Study|Enrolled but Not Treated|1|||
163299016|NCT03074331|589803005|FG000|Overall Study|Lost to Follow-up|5|||
163299017|NCT03074331|589803005|FG000|Overall Study|Withdrew Consent|1|||
162953254|NCT03555305|588533401|FG000|Period 1|Physician Decision|0|||
162953255|NCT03555305|588533402|FG001|Period 1|Physician Decision|1|||
163299018|NCT00350792|589803007|FG000|Overall Study|Adverse Event|11|||
163299019|NCT00350792|589803007|FG000|Overall Study|Death from Study Disease|1|||
163299020|NCT00350792|589803007|FG000|Overall Study|Death from Study Drug Toxicity|1|||
162953256|NCT03555305|588533401|FG000|Period 1|Adverse Event|0|||
163299021|NCT00350792|589803007|FG000|Overall Study|Death Not Study Drug Related|2|||
163299022|NCT00350792|589803007|FG000|Overall Study|Protocol Violation|1|||
163299023|NCT00350792|589803007|FG000|Overall Study|Withdrawal by Subject|4|||
163299024|NCT00350792|589803007|FG000|Overall Study|Physician Decision|2|||
163299025|NCT00350792|589803007|FG000|Overall Study|Lack of Efficacy|11|||
162953257|NCT03555305|588533402|FG001|Period 1|Adverse Event|1|||
162953258|NCT00858845|588533415|FG000|Overall Study|Patient underwent heart transplant.|0|||
162953259|NCT00858845|588533416|FG001|Overall Study|Patient underwent heart transplant.|1|||
162953260|NCT03031847|588533417|FG000|Overall Study|Death|1|||
162953261|NCT03031847|588533418|FG001|Overall Study|Death|1|||
162953262|NCT03031847|588533419|FG002|Overall Study|Death|2|||
162953263|NCT03031847|588533420|FG003|Overall Study|Death|3|||
162953264|NCT03031847|588533417|FG000|Overall Study|Lost to Follow-up|1|||
162953265|NCT03031847|588533418|FG001|Overall Study|Lost to Follow-up|1|||
162953266|NCT03031847|588533419|FG002|Overall Study|Lost to Follow-up|2|||
162953267|NCT03031847|588533420|FG003|Overall Study|Lost to Follow-up|3|||
162953268|NCT02100228|588533423|FG000|Overall Study|Other|19|||
162953269|NCT02100228|588533424|FG001|Overall Study|Other|19|||
162953270|NCT02100228|588533423|FG000|Overall Study|Administrative reason|0|||
162953271|NCT02100228|588533424|FG001|Overall Study|Administrative reason|1|||
162953272|NCT02100228|588533423|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
162953273|NCT02100228|588533424|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
162953274|NCT02100228|588533423|FG000|Overall Study|Non-compliance|0|||
162953275|NCT02100228|588533424|FG001|Overall Study|Non-compliance|3|||
162953276|NCT02100228|588533423|FG000|Overall Study|Lost to Follow-up|0|||
162953277|NCT02100228|588533424|FG001|Overall Study|Lost to Follow-up|1|||
162953278|NCT02100228|588533423|FG000|Overall Study|Withdrawal by Subject|27|||
162953279|NCT02100228|588533424|FG001|Overall Study|Withdrawal by Subject|37|||
162953280|NCT02100228|588533423|FG000|Overall Study|Adverse Event|16|||
162953281|NCT02100228|588533424|FG001|Overall Study|Adverse Event|12|||
162953282|NCT02100228|588533423|FG000|Overall Study|Death|1|||
162953283|NCT02100228|588533424|FG001|Overall Study|Death|1|||
162953284|NCT00214422|588533425|FG000|Overall Study|Physician Decision|2|||
162953285|NCT00214422|588533426|FG001|Overall Study|Physician Decision|0|||
162953286|NCT00214422|588533427|FG002|Overall Study|Physician Decision|0|||
162953287|NCT00214422|588533425|FG000|Overall Study|Developed esophageal ca|1|||
162953288|NCT00214422|588533426|FG001|Overall Study|Developed esophageal ca|0|||
162953289|NCT00214422|588533427|FG002|Overall Study|Developed esophageal ca|0|||
162953290|NCT00214422|588533425|FG000|Overall Study|Pt taken off study|1|||
162953291|NCT00214422|588533426|FG001|Overall Study|Pt taken off study|1|||
162953292|NCT00214422|588533427|FG002|Overall Study|Pt taken off study|0|||
162953293|NCT00214422|588533425|FG000|Overall Study|Disease progression on study|1|||
162953294|NCT00214422|588533426|FG001|Overall Study|Disease progression on study|0|||
162953295|NCT00214422|588533427|FG002|Overall Study|Disease progression on study|0|||
162953296|NCT00214422|588533425|FG000|Overall Study|Unable to make a radiation treatment|0|||
162953297|NCT00214422|588533426|FG001|Overall Study|Unable to make a radiation treatment|0|||
162953298|NCT00214422|588533427|FG002|Overall Study|Unable to make a radiation treatment|1|||
162953299|NCT00854100|588533436|FG000|Overall Study|Inability to complete the study visits|0|||
162953300|NCT00854100|588533437|FG001|Overall Study|Inability to complete the study visits|0|||
163299026|NCT03283371|589803008|FG000|Placebo-controlled|Adverse Event|1|||
163299027|NCT03283371|589803009|FG001|Placebo-controlled|Adverse Event|1|||
163299028|NCT03283371|589803010|FG002|Placebo-controlled|Adverse Event|0|||
162953301|NCT00854100|588533438|FG002|Overall Study|Inability to complete the study visits|1|||
162953302|NCT00854100|588533436|FG000|Overall Study|Lost to Follow-up|2|||
162953303|NCT00854100|588533437|FG001|Overall Study|Lost to Follow-up|0|||
162953304|NCT00854100|588533438|FG002|Overall Study|Lost to Follow-up|3|||
162953305|NCT00854100|588533436|FG000|Overall Study|Withdrawal by Subject|3|||
163299029|NCT03283371|589803011|FG003|Placebo-controlled|Adverse Event|0|||
163299030|NCT03283371|589803008|FG000|Placebo-controlled|Lack of Efficacy|1|||
163299031|NCT03283371|589803009|FG001|Placebo-controlled|Lack of Efficacy|0|||
163299032|NCT03283371|589803010|FG002|Placebo-controlled|Lack of Efficacy|0|||
163299033|NCT03283371|589803011|FG003|Placebo-controlled|Lack of Efficacy|0|||
163299034|NCT03283371|589803008|FG000|Placebo-controlled|Withdrawal by Subject|1|||
163299035|NCT03283371|589803009|FG001|Placebo-controlled|Withdrawal by Subject|1|||
163299036|NCT03283371|589803010|FG002|Placebo-controlled|Withdrawal by Subject|0|||
163299037|NCT03283371|589803011|FG003|Placebo-controlled|Withdrawal by Subject|0|||
163299038|NCT03283371|589803008|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
163299039|NCT03283371|589803009|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
163299040|NCT03283371|589803010|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
163299041|NCT03283371|589803011|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
163299042|NCT03283371|589803008|FG000|Open-label Phase|Adverse Event|0|||
162953306|NCT00854100|588533437|FG001|Overall Study|Withdrawal by Subject|1|||
162953307|NCT00854100|588533438|FG002|Overall Study|Withdrawal by Subject|2|||
162953308|NCT00854100|588533436|FG000|Overall Study|Protocol Violation|2|||
162953309|NCT00854100|588533437|FG001|Overall Study|Protocol Violation|4|||
162953310|NCT00854100|588533438|FG002|Overall Study|Protocol Violation|3|||
162953311|NCT00854100|588533436|FG000|Overall Study|Adverse Event|2|||
162953312|NCT00854100|588533437|FG001|Overall Study|Adverse Event|1|||
162953313|NCT00854100|588533438|FG002|Overall Study|Adverse Event|2|||
162953314|NCT02242201|588533442|FG000|Overall Study|preoperative identified neuropathy|2|||
162953315|NCT02242201|588533443|FG001|Overall Study|preoperative identified neuropathy|0|||
162953316|NCT02242201|588533444|FG002|Overall Study|preoperative identified neuropathy|0|||
162953317|NCT02242201|588533442|FG000|Overall Study|planned post-op anticoagulation|1|||
162953318|NCT02242201|588533443|FG001|Overall Study|planned post-op anticoagulation|0|||
162953319|NCT02242201|588533444|FG002|Overall Study|planned post-op anticoagulation|0|||
162953320|NCT02242201|588533442|FG000|Overall Study|changed surgical procedure|1|||
162953321|NCT02242201|588533443|FG001|Overall Study|changed surgical procedure|0|||
162953322|NCT02242201|588533444|FG002|Overall Study|changed surgical procedure|0|||
162953323|NCT02242201|588533442|FG000|Overall Study|postponed surgery|0|||
162953324|NCT02242201|588533443|FG001|Overall Study|postponed surgery|0|||
162953325|NCT02242201|588533444|FG002|Overall Study|postponed surgery|1|||
162953326|NCT02242201|588533442|FG000|Overall Study|preoperative opioid consumption|0|||
162953327|NCT02242201|588533443|FG001|Overall Study|preoperative opioid consumption|1|||
162953328|NCT02242201|588533444|FG002|Overall Study|preoperative opioid consumption|0|||
162953329|NCT00389064|588533445|FG000|Overall Study|Adverse Event|11|||
162953330|NCT00389064|588533446|FG001|Overall Study|Adverse Event|3|||
162953331|NCT00389064|588533445|FG000|Overall Study|Lack of Efficacy|3|||
162953332|NCT00389064|588533446|FG001|Overall Study|Lack of Efficacy|14|||
162953333|NCT00389064|588533445|FG000|Overall Study|Withdrawal by Subject|17|||
162953334|NCT00389064|588533446|FG001|Overall Study|Withdrawal by Subject|27|||
162953335|NCT00389064|588533445|FG000|Overall Study|Physician Decision|2|||
162953336|NCT00389064|588533446|FG001|Overall Study|Physician Decision|2|||
162953337|NCT00389064|588533445|FG000|Overall Study|Lost to Follow-up|1|||
162953338|NCT00389064|588533446|FG001|Overall Study|Lost to Follow-up|2|||
162953339|NCT00389064|588533445|FG000|Overall Study|Protocol Violation|2|||
162953340|NCT00389064|588533446|FG001|Overall Study|Protocol Violation|0|||
162953341|NCT00389064|588533445|FG000|Overall Study|Multiple Reasons|9|||
162953342|NCT00389064|588533446|FG001|Overall Study|Multiple Reasons|11|||
162953343|NCT01223365|588533450|FG000|Open-label Titration Period|Enrolled but not treated|1|||
162953344|NCT01223365|588533450|FG000|Open-label Titration Period|Adverse Event|23|||
162953345|NCT01223365|588533450|FG000|Open-label Titration Period|Lack of Efficacy|3|||
162953346|NCT01223365|588533450|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
162953347|NCT01223365|588533450|FG000|Open-label Titration Period|Protocol Violation|1|||
162953348|NCT01223365|588533450|FG000|Open-label Titration Period|Lost to Follow-up|2|||
162953349|NCT01223365|588533450|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
162953350|NCT01223365|588533450|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
162953351|NCT01223365|588533450|FG000|Open-label Titration Period|Starting physical therapy|1|||
162953352|NCT01223365|588533450|FG000|Open-label Treatment Period|Adverse Event|39|||
162953353|NCT01223365|588533450|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
162953354|NCT01223365|588533450|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
162953355|NCT01223365|588533450|FG000|Open-label Treatment Period|Protocol Violation|15|||
162953356|NCT01223365|588533450|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
162953357|NCT01223365|588533450|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
162953358|NCT01223365|588533450|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
162953359|NCT01223365|588533450|FG000|Open-label Treatment Period|Moved out of area|2|||
162953360|NCT01223365|588533450|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
162953361|NCT01223365|588533450|FG000|Open-label Treatment Period|"Out of window"|1|||
162953362|NCT01223365|588533450|FG000|Open-label Treatment Period|Starting physical therapy|1|||
162953363|NCT01223365|588533450|FG000|Open-label Treatment Period|Physician Decision|2|||
162953364|NCT03880266|588533451|FG000|Overall Study|Withdrawal by Subject|0|||
163043234|NCT04004260|588865765|FG001|Overall Study|Withdrawal by Subject|3|||
163043235|NCT04004260|588865764|FG000|Overall Study|Lost to Follow-up|22|||
163299043|NCT03283371|589803009|FG001|Open-label Phase|Adverse Event|0|||
163299044|NCT03283371|589803010|FG002|Open-label Phase|Adverse Event|2|||
163299045|NCT03283371|589803011|FG003|Open-label Phase|Adverse Event|0|||
163299046|NCT03283371|589803008|FG000|Open-label Phase|Withdrawal by Subject|0|||
162953365|NCT03880266|588533452|FG001|Overall Study|Withdrawal by Subject|1|||
162953366|NCT03880266|588533453|FG002|Overall Study|Withdrawal by Subject|1|||
162953367|NCT03880266|588533454|FG003|Overall Study|Withdrawal by Subject|0|||
162953368|NCT03880266|588533455|FG004|Overall Study|Withdrawal by Subject|0|||
163192920|NCT02808650|589421683|FG004|Overall Study|Physician Decision|0|||
163192921|NCT02808650|589421679|FG000|Overall Study|Withdrawal by Subject|0|||
163192922|NCT02808650|589421680|FG001|Overall Study|Withdrawal by Subject|0|||
163192923|NCT02808650|589421681|FG002|Overall Study|Withdrawal by Subject|0|||
163192924|NCT02808650|589421682|FG003|Overall Study|Withdrawal by Subject|1|||
163392874|NCT04178967|590150339|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
162953369|NCT03880266|588533456|FG005|Overall Study|Withdrawal by Subject|0|||
162953370|NCT03880266|588533457|FG006|Overall Study|Withdrawal by Subject|0|||
162953371|NCT03880266|588533458|FG007|Overall Study|Withdrawal by Subject|0|||
162953372|NCT02186821|588533459|FG000|Overall Study|Adverse Event|9|||
162953373|NCT02186821|588533459|FG000|Overall Study|Death|2|||
162953374|NCT02186821|588533459|FG000|Overall Study|Disease progression|32|||
162953375|NCT02186821|588533459|FG000|Overall Study|Protocol Violation|1|||
162953376|NCT02186821|588533459|FG000|Overall Study|Physician Decision|1|||
162953377|NCT02186821|588533459|FG000|Overall Study|Study terminated by sponsor|2|||
162953378|NCT05472038|588534835|FG000|Overall Study|Adverse Event|0|||
162953379|NCT05472038|588534836|FG001|Overall Study|Adverse Event|0|||
162953380|NCT05472038|588534837|FG002|Overall Study|Adverse Event|1|||
162953381|NCT05472038|588534838|FG003|Overall Study|Adverse Event|0|||
162953382|NCT05472038|588534839|FG004|Overall Study|Adverse Event|0|||
162953383|NCT05472038|588534840|FG005|Overall Study|Adverse Event|0|||
162953384|NCT05472038|588534841|FG006|Overall Study|Adverse Event|0|||
162953385|NCT05472038|588534842|FG007|Overall Study|Adverse Event|0|||
162953386|NCT05472038|588534843|FG008|Overall Study|Adverse Event|0|||
162953387|NCT05472038|588534844|FG009|Overall Study|Adverse Event|0|||
163392875|NCT04178967|590150340|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
163392876|NCT04178967|590150341|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
163392877|NCT04178967|590150342|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
163392878|NCT04178967|590150343|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
163392879|NCT04178967|590150344|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
163392880|NCT04178967|590150345|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
163392881|NCT04178967|590150346|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
163392882|NCT04178967|590150347|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
163392883|NCT04178967|590150348|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
163392884|NCT04178967|590150349|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
163392885|NCT04178967|590150339|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163392886|NCT04178967|590150340|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163392887|NCT04178967|590150341|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163392888|NCT04178967|590150342|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163392889|NCT04178967|590150343|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
163392890|NCT04178967|590150344|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
163392891|NCT04178967|590150345|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163392892|NCT04178967|590150346|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
163392893|NCT04178967|590150347|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163392894|NCT04178967|590150348|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163392895|NCT04178967|590150349|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163392896|NCT04178967|590150339|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
163392897|NCT04178967|590150340|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
163392898|NCT04178967|590150341|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
163392899|NCT04178967|590150342|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
163392900|NCT04178967|590150343|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
163392901|NCT04178967|590150344|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
163392902|NCT04178967|590150345|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
163392903|NCT04178967|590150346|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
163392904|NCT04178967|590150347|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
163392905|NCT04178967|590150348|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
163392906|NCT04178967|590150349|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
162953388|NCT05472038|588534845|FG010|Overall Study|Adverse Event|0|||
162953389|NCT05472038|588534846|FG011|Overall Study|Adverse Event|0|||
162953390|NCT05472038|588534835|FG000|Overall Study|Death|0|||
162953391|NCT05472038|588534836|FG001|Overall Study|Death|0|||
162953392|NCT05472038|588534837|FG002|Overall Study|Death|0|||
162953393|NCT05472038|588534838|FG003|Overall Study|Death|0|||
162953394|NCT05472038|588534839|FG004|Overall Study|Death|0|||
162953395|NCT05472038|588534840|FG005|Overall Study|Death|1|||
162953396|NCT05472038|588534841|FG006|Overall Study|Death|0|||
162953397|NCT05472038|588534842|FG007|Overall Study|Death|0|||
162953398|NCT05472038|588534843|FG008|Overall Study|Death|0|||
162953399|NCT05472038|588534844|FG009|Overall Study|Death|0|||
162953400|NCT05472038|588534845|FG010|Overall Study|Death|0|||
163299047|NCT03283371|589803009|FG001|Open-label Phase|Withdrawal by Subject|0|||
163299048|NCT03283371|589803010|FG002|Open-label Phase|Withdrawal by Subject|1|||
163299049|NCT03283371|589803011|FG003|Open-label Phase|Withdrawal by Subject|0|||
163299050|NCT03283371|589803008|FG000|Open-label Phase|Other|0|||
162953401|NCT05472038|588534846|FG011|Overall Study|Death|0|||
162953402|NCT05472038|588534835|FG000|Overall Study|Lost to Follow-up|1|||
162953403|NCT05472038|588534836|FG001|Overall Study|Lost to Follow-up|3|||
162953404|NCT05472038|588534837|FG002|Overall Study|Lost to Follow-up|3|||
162953405|NCT05472038|588534838|FG003|Overall Study|Lost to Follow-up|9|||
162953406|NCT05472038|588534839|FG004|Overall Study|Lost to Follow-up|2|||
162953407|NCT05472038|588534840|FG005|Overall Study|Lost to Follow-up|2|||
162953408|NCT05472038|588534841|FG006|Overall Study|Lost to Follow-up|1|||
162953409|NCT05472038|588534842|FG007|Overall Study|Lost to Follow-up|0|||
162953410|NCT05472038|588534843|FG008|Overall Study|Lost to Follow-up|1|||
162953411|NCT05472038|588534844|FG009|Overall Study|Lost to Follow-up|0|||
162953412|NCT05472038|588534845|FG010|Overall Study|Lost to Follow-up|2|||
162953413|NCT05472038|588534846|FG011|Overall Study|Lost to Follow-up|1|||
162953414|NCT05472038|588534835|FG000|Overall Study|Physician Decision|0|||
162953415|NCT05472038|588534836|FG001|Overall Study|Physician Decision|0|||
162953416|NCT05472038|588534837|FG002|Overall Study|Physician Decision|0|||
162953417|NCT05472038|588534838|FG003|Overall Study|Physician Decision|0|||
162953418|NCT05472038|588534839|FG004|Overall Study|Physician Decision|1|||
162953419|NCT05472038|588534840|FG005|Overall Study|Physician Decision|0|||
162953420|NCT05472038|588534841|FG006|Overall Study|Physician Decision|0|||
162953421|NCT05472038|588534842|FG007|Overall Study|Physician Decision|0|||
162953422|NCT05472038|588534843|FG008|Overall Study|Physician Decision|0|||
162953423|NCT05472038|588534844|FG009|Overall Study|Physician Decision|0|||
162953424|NCT05472038|588534845|FG010|Overall Study|Physician Decision|0|||
162953425|NCT05472038|588534846|FG011|Overall Study|Physician Decision|0|||
162953426|NCT05472038|588534835|FG000|Overall Study|Withdrawal by Subject|1|||
162953427|NCT05472038|588534836|FG001|Overall Study|Withdrawal by Subject|3|||
162953428|NCT05472038|588534837|FG002|Overall Study|Withdrawal by Subject|1|||
162953429|NCT05472038|588534838|FG003|Overall Study|Withdrawal by Subject|6|||
162953430|NCT05472038|588534839|FG004|Overall Study|Withdrawal by Subject|1|||
162953431|NCT05472038|588534840|FG005|Overall Study|Withdrawal by Subject|3|||
162953432|NCT05472038|588534841|FG006|Overall Study|Withdrawal by Subject|0|||
162953433|NCT05472038|588534842|FG007|Overall Study|Withdrawal by Subject|2|||
162953434|NCT05472038|588534843|FG008|Overall Study|Withdrawal by Subject|3|||
162953435|NCT05472038|588534844|FG009|Overall Study|Withdrawal by Subject|1|||
162953436|NCT05472038|588534845|FG010|Overall Study|Withdrawal by Subject|2|||
162953437|NCT05472038|588534846|FG011|Overall Study|Withdrawal by Subject|2|||
162953438|NCT05472038|588534835|FG000|Overall Study|Protocol Violation|0|||
162953439|NCT05472038|588534836|FG001|Overall Study|Protocol Violation|0|||
162953440|NCT05472038|588534837|FG002|Overall Study|Protocol Violation|0|||
162953441|NCT05472038|588534838|FG003|Overall Study|Protocol Violation|0|||
162953442|NCT05472038|588534839|FG004|Overall Study|Protocol Violation|0|||
162953443|NCT05472038|588534840|FG005|Overall Study|Protocol Violation|0|||
162953444|NCT05472038|588534841|FG006|Overall Study|Protocol Violation|0|||
162953445|NCT05472038|588534842|FG007|Overall Study|Protocol Violation|1|||
162953446|NCT05472038|588534843|FG008|Overall Study|Protocol Violation|1|||
162953447|NCT05472038|588534844|FG009|Overall Study|Protocol Violation|1|||
162953448|NCT05472038|588534845|FG010|Overall Study|Protocol Violation|1|||
162953449|NCT05472038|588534846|FG011|Overall Study|Protocol Violation|1|||
162953450|NCT05472038|588534835|FG000|Overall Study|Not vaccinated|0|||
162953451|NCT05472038|588534836|FG001|Overall Study|Not vaccinated|0|||
162953452|NCT05472038|588534837|FG002|Overall Study|Not vaccinated|0|||
162953453|NCT05472038|588534838|FG003|Overall Study|Not vaccinated|1|||
162953454|NCT05472038|588534839|FG004|Overall Study|Not vaccinated|0|||
162953455|NCT05472038|588534840|FG005|Overall Study|Not vaccinated|0|||
162953456|NCT05472038|588534841|FG006|Overall Study|Not vaccinated|0|||
162953457|NCT05472038|588534842|FG007|Overall Study|Not vaccinated|0|||
162953458|NCT05472038|588534843|FG008|Overall Study|Not vaccinated|0|||
162953459|NCT05472038|588534844|FG009|Overall Study|Not vaccinated|0|||
162953460|NCT05472038|588534845|FG010|Overall Study|Not vaccinated|0|||
162953461|NCT05472038|588534846|FG011|Overall Study|Not vaccinated|0|||
162953462|NCT03785548|588534850|FG000|Overall Study|age > 80|1|||
162953463|NCT03785548|588534851|FG001|Overall Study|age > 80|0|||
162953464|NCT03785548|588534850|FG000|Overall Study|no Postop queries|1|||
162953465|NCT03785548|588534851|FG001|Overall Study|no Postop queries|0|||
162953466|NCT01993030|588534852|FG000|Overall Study|Adverse Event|0|||
163299051|NCT03283371|589803009|FG001|Open-label Phase|Other|0|||
162953467|NCT01993030|588534853|FG001|Overall Study|Adverse Event|4|||
162953468|NCT03351335|588534859|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
162953469|NCT03351335|588534860|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
162953470|NCT03351335|588534861|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
162953471|NCT01439880|588534865|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
162953472|NCT01439880|588534866|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
162953473|NCT01439880|588534865|FG000|SOC-controlled Period (Year 1)|Death|2|||
163299052|NCT03283371|589803010|FG002|Open-label Phase|Other|1|||
163299053|NCT03283371|589803011|FG003|Open-label Phase|Other|1|||
163299054|NCT01290341|589803012|FG000|Overall Study|Protocol Violation|7|||
163299055|NCT01290341|589803013|FG001|Overall Study|Protocol Violation|3|||
163299056|NCT01290341|589803012|FG000|Overall Study|Adverse Event|1|||
163299057|NCT01290341|589803013|FG001|Overall Study|Adverse Event|0|||
163299058|NCT01290341|589803012|FG000|Overall Study|Lost to Follow-up|21|||
163299059|NCT01290341|589803013|FG001|Overall Study|Lost to Follow-up|10|||
163299060|NCT01290341|589803012|FG000|Overall Study|Withdrawal by Subject|19|||
163299061|NCT01290341|589803013|FG001|Overall Study|Withdrawal by Subject|5|||
163299062|NCT01290341|589803012|FG000|Overall Study|Negative baseline culture and others|44|||
163299063|NCT01290341|589803013|FG001|Overall Study|Negative baseline culture and others|11|||
163299064|NCT03233633|589803021|FG000|Overall Study|Adverse Event|2|||
163299065|NCT03233633|589803021|FG000|Overall Study|Less Than 3 Days of Data|6|||
163299066|NCT02708108|589803022|FG000|Overall Study|Death|1|||
163299067|NCT02708108|589803023|FG001|Overall Study|Death|2|||
163299068|NCT02708108|589803022|FG000|Overall Study|Regimen change|1|||
163299069|NCT02708108|589803023|FG001|Overall Study|Regimen change|0|||
163299070|NCT02708108|589803022|FG000|Overall Study|No MRD and no imaging available|0|||
163299071|NCT02708108|589803023|FG001|Overall Study|No MRD and no imaging available|1|||
163299072|NCT04556981|589803025|FG000|Overall Study|Death|0|||
163299073|NCT04556981|589803026|FG001|Overall Study|Death|1|||
163299074|NCT04556981|589803025|FG000|Overall Study|Lost to Follow-up|2|||
163299075|NCT04556981|589803026|FG001|Overall Study|Lost to Follow-up|11|||
163299076|NCT04556981|589803025|FG000|Overall Study|Moved from the study area|1|||
163299077|NCT04556981|589803026|FG001|Overall Study|Moved from the study area|4|||
163299078|NCT04556981|589803025|FG000|Overall Study|Withdrawal by Subject|2|||
163299079|NCT04556981|589803026|FG001|Overall Study|Withdrawal by Subject|2|||
163299080|NCT04556981|589803025|FG000|Overall Study|Other|2|||
163299081|NCT04556981|589803026|FG001|Overall Study|Other|1|||
163299082|NCT00580866|589803027|FG000|Overall Study|Lost to Follow-up|2|||
163299083|NCT00580866|589803028|FG001|Overall Study|Lost to Follow-up|2|||
163299084|NCT02574455|589803032|FG000|Overall Study|Death|197|||
163299085|NCT02574455|589803033|FG001|Overall Study|Death|210|||
163299086|NCT02574455|589803032|FG000|Overall Study|Withdrawal of Consent|11|||
163299087|NCT02574455|589803033|FG001|Overall Study|Withdrawal of Consent|28|||
163299088|NCT02574455|589803032|FG000|Overall Study|Lost to Follow-up|4|||
163299089|NCT02574455|589803033|FG001|Overall Study|Lost to Follow-up|4|||
163299090|NCT02574455|589803032|FG000|Overall Study|Sponsor's Decision|55|||
163299091|NCT02574455|589803033|FG001|Overall Study|Sponsor's Decision|20|||
163318866|NCT01208662|589878796|FG002|Induction and Consolidation|Adverse Event|2|||
163318867|NCT01208662|589878794|FG000|Induction and Consolidation|MD or Participant Decision|16|||
163318868|NCT01208662|589878795|FG001|Induction and Consolidation|MD or Participant Decision|34|||
163318869|NCT01208662|589878796|FG002|Induction and Consolidation|MD or Participant Decision|4|||
163318870|NCT01208662|589878794|FG000|Induction and Consolidation|Death|1|||
163318871|NCT01208662|589878795|FG001|Induction and Consolidation|Death|3|||
163318872|NCT01208662|589878796|FG002|Induction and Consolidation|Death|1|||
163318873|NCT01208662|589878794|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
163318874|NCT01208662|589878795|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
163318875|NCT01208662|589878796|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
163318876|NCT01208662|589878794|FG000|Maintenance|Disease Progression|156|||
163318877|NCT01208662|589878795|FG001|Maintenance|Disease Progression|102|||
163318878|NCT01208662|589878796|FG002|Maintenance|Disease Progression|0|||
163318879|NCT01208662|589878794|FG000|Maintenance|Adverse Event|12|||
163318880|NCT01208662|589878795|FG001|Maintenance|Adverse Event|28|||
163318881|NCT01208662|589878796|FG002|Maintenance|Adverse Event|0|||
163318882|NCT01208662|589878794|FG000|Maintenance|MD or Participant Decision|24|||
163318883|NCT01208662|589878795|FG001|Maintenance|MD or Participant Decision|36|||
163318884|NCT01208662|589878796|FG002|Maintenance|MD or Participant Decision|0|||
163318885|NCT01208662|589878794|FG000|Maintenance|Death|0|||
163318886|NCT01208662|589878795|FG001|Maintenance|Death|3|||
163318887|NCT01208662|589878796|FG002|Maintenance|Death|0|||
163318888|NCT01208662|589878794|FG000|Maintenance|Discontinued for other reasons|21|||
163318889|NCT01208662|589878795|FG001|Maintenance|Discontinued for other reasons|31|||
163318890|NCT01208662|589878796|FG002|Maintenance|Discontinued for other reasons|0|||
163318891|NCT01208662|589878794|FG000|Maintenance|Still on Treatment|78|||
163318892|NCT01208662|589878795|FG001|Maintenance|Still on Treatment|89|||
163318893|NCT01208662|589878796|FG002|Maintenance|Still on Treatment|0|||
163318894|NCT04433208|589878797|FG000|Overall Study|Withdrawal by Subject|0|||
163318895|NCT04433208|589878798|FG001|Overall Study|Withdrawal by Subject|1|||
163318896|NCT04433208|589878799|FG002|Overall Study|Withdrawal by Subject|1|||
163318897|NCT04433208|589878800|FG003|Overall Study|Withdrawal by Subject|0|||
163318898|NCT04433208|589878801|FG004|Overall Study|Withdrawal by Subject|2|||
163318899|NCT04433208|589878802|FG005|Overall Study|Withdrawal by Subject|1|||
163318900|NCT04433208|589878797|FG000|Overall Study|Lost to Follow-up|0|||
163318901|NCT04433208|589878798|FG001|Overall Study|Lost to Follow-up|0|||
163318902|NCT04433208|589878799|FG002|Overall Study|Lost to Follow-up|0|||
163318903|NCT04433208|589878800|FG003|Overall Study|Lost to Follow-up|0|||
163318904|NCT04433208|589878801|FG004|Overall Study|Lost to Follow-up|0|||
163299092|NCT05505045|589805060|FG000|Overall Study|Withdrawal by Subject|2|||
163299093|NCT05505045|589805061|FG001|Overall Study|Withdrawal by Subject|1|||
163299094|NCT01643070|589805062|FG000|Overall Study|Withdrawal by Subject|3|||
163299095|NCT01643070|589805063|FG001|Overall Study|Withdrawal by Subject|1|||
163299096|NCT01643070|589805062|FG000|Overall Study|Death|1|||
163299097|NCT01643070|589805063|FG001|Overall Study|Death|0|||
163299098|NCT01643070|589805062|FG000|Overall Study|Pregressive disease|0|||
163299099|NCT01643070|589805063|FG001|Overall Study|Pregressive disease|2|||
163299100|NCT04104321|589805069|FG000|Overall Study|didn't take the study drug|3|||
163299101|NCT04842500|589805070|FG000|Overall Study|Withdrawal by Subject|4|||
163299102|NCT04842500|589805071|FG001|Overall Study|Withdrawal by Subject|1|||
163299103|NCT04842500|589805072|FG002|Overall Study|Withdrawal by Subject|2|||
163299104|NCT04842500|589805073|FG003|Overall Study|Withdrawal by Subject|3|||
163299105|NCT04842500|589805070|FG000|Overall Study|Protocol Violation|1|||
163299106|NCT04842500|589805071|FG001|Overall Study|Protocol Violation|0|||
163299107|NCT04842500|589805072|FG002|Overall Study|Protocol Violation|0|||
163299108|NCT04842500|589805073|FG003|Overall Study|Protocol Violation|1|||
163392907|NCT04178967|590150339|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
163392908|NCT04178967|590150340|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
163392909|NCT04178967|590150341|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
163392910|NCT04178967|590150342|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
163392911|NCT04178967|590150343|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
163392912|NCT04178967|590150344|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
163392913|NCT04178967|590150345|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
163392914|NCT04178967|590150346|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
163392915|NCT04178967|590150347|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
163299109|NCT02980276|589805074|FG000|Overall Study|Withdrawal by Subject|4|||
163299110|NCT02980276|589805075|FG001|Overall Study|Withdrawal by Subject|4|||
163299111|NCT02980276|589805074|FG000|Overall Study|Physician Decision|0|||
163299112|NCT02980276|589805075|FG001|Overall Study|Physician Decision|1|||
163299113|NCT02980276|589805074|FG000|Overall Study|Lost to Follow-up|18|||
163299114|NCT02980276|589805075|FG001|Overall Study|Lost to Follow-up|18|||
163299115|NCT02980276|589805074|FG000|Overall Study|Death|1|||
163299116|NCT02980276|589805075|FG001|Overall Study|Death|0|||
163299117|NCT02980276|589805074|FG000|Overall Study|Miscellaneous other|10|||
163299118|NCT02980276|589805075|FG001|Overall Study|Miscellaneous other|4|||
163299119|NCT04139668|589805077|FG000|Overall Study|Withdrawal by Subject|1|||
163299120|NCT02824029|589805078|FG000|Overall Study|Didn't receive treatment|2|||
163299121|NCT02824029|589805078|FG000|Overall Study|Patient decision to discontinue treatment|3|||
163299122|NCT02824029|589805078|FG000|Overall Study|Non-compliant|5|||
163299123|NCT02824029|589805078|FG000|Overall Study|Progression of disease|15|||
163299124|NCT02824029|589805078|FG000|Overall Study|Inadequate response to therapy|2|||
163299125|NCT02824029|589805078|FG000|Overall Study|Possible progression per treating physician|1|||
163299126|NCT04512482|589805081|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
163299127|NCT04512482|589805082|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
163299128|NCT05119855|589805083|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
163299129|NCT05119855|589805084|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
163299130|NCT05119855|589805083|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
163299131|NCT05119855|589805084|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
163299132|NCT05119855|589805083|FG000|Overall Study|Lost to Follow-up|6|||
163299133|NCT05119855|589805084|FG001|Overall Study|Lost to Follow-up|8|||
163299134|NCT00391898|589805089|FG000|Overall Study|Adverse Event|3|||
163299135|NCT00391898|589805090|FG001|Overall Study|Adverse Event|0|||
163299136|NCT00391898|589805089|FG000|Overall Study|Other|8|||
163299137|NCT00391898|589805090|FG001|Overall Study|Other|10|||
163299138|NCT05489484|589805091|FG000|Overall Study|withdrawn|1|||
163299139|NCT02529995|589805092|FG000|Part A|Ongoing Study at Data Cut-off|14|||
163392916|NCT04178967|590150348|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
163299140|NCT02529995|589805093|FG001|Part A|Ongoing Study at Data Cut-off|16|||
163299141|NCT02529995|589805092|FG000|Part A|Discontinued Study|1|||
163299142|NCT02529995|589805093|FG001|Part A|Discontinued Study|0|||
163299143|NCT02529995|589805092|FG000|Part B|Ongoing Study at Data Cut-off|0|||
163299144|NCT02529995|589805093|FG001|Part B|Ongoing Study at Data Cut-off|7|||
163299145|NCT02529995|589805092|FG000|Part B|Discontinued Study|6|||
163299146|NCT02529995|589805093|FG001|Part B|Discontinued Study|5|||
163299147|NCT00444600|589805094|FG000|Overall Study|Death|7|||
163299148|NCT00444600|589805095|FG001|Overall Study|Death|5|||
163299149|NCT00444600|589805096|FG002|Overall Study|Death|3|||
163299150|NCT00444600|589805097|FG003|Overall Study|Death|2|||
163299151|NCT00444600|589805094|FG000|Overall Study|Dropped|11|||
163299152|NCT00444600|589805095|FG001|Overall Study|Dropped|11|||
163299153|NCT00444600|589805096|FG002|Overall Study|Dropped|7|||
163392917|NCT04178967|590150349|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
163299154|NCT00444600|589805097|FG003|Overall Study|Dropped|7|||
163299155|NCT00444600|589805094|FG000|Overall Study|Missed visit|1|||
163299156|NCT00444600|589805095|FG001|Overall Study|Missed visit|0|||
163299157|NCT00444600|589805096|FG002|Overall Study|Missed visit|0|||
162953474|NCT01439880|588534866|FG001|SOC-controlled Period (Year 1)|Death|1|||
162953475|NCT01439880|588534865|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
162953476|NCT01439880|588534866|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
162953477|NCT01439880|588534865|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
162953478|NCT01439880|588534866|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
162953479|NCT01439880|588534865|FG000|SOC-controlled Period (Year 1)|Other|8|||
162953480|NCT01439880|588534866|FG001|SOC-controlled Period (Year 1)|Other|13|||
162953481|NCT01439880|588534865|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
162953482|NCT01439880|588534866|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
162953483|NCT01439880|588534865|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
162953484|NCT01439880|588534866|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
162953485|NCT01439880|588534865|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
162953486|NCT01439880|588534866|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
162953487|NCT01439880|588534865|FG000|All-IP Period (Years 2 to 5)|Death|3|||
162953488|NCT01439880|588534866|FG001|All-IP Period (Years 2 to 5)|Death|13|||
162953489|NCT01439880|588534865|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
162953490|NCT01439880|588534866|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
162953491|NCT01439880|588534865|FG000|All-IP Period (Years 2 to 5)|Other|14|||
162953492|NCT01439880|588534866|FG001|All-IP Period (Years 2 to 5)|Other|31|||
162953493|NCT01439880|588534865|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
162953494|NCT01439880|588534866|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
162953495|NCT02378935|588534869|FG000|Overall Study|Lack of Efficacy|10|||
162953496|NCT02378935|588534870|FG001|Overall Study|Lack of Efficacy|0|||
162953497|NCT02378935|588534871|FG002|Overall Study|Lack of Efficacy|2|||
162953498|NCT02378935|588534872|FG003|Overall Study|Lack of Efficacy|6|||
162953499|NCT02378935|588534873|FG004|Overall Study|Lack of Efficacy|0|||
162953500|NCT02378935|588534874|FG005|Overall Study|Lack of Efficacy|0|||
162953501|NCT02378935|588534875|FG006|Overall Study|Lack of Efficacy|0|||
162953502|NCT02378935|588534869|FG000|Overall Study|Death|0|||
162953503|NCT02378935|588534870|FG001|Overall Study|Death|0|||
162953504|NCT02378935|588534871|FG002|Overall Study|Death|1|||
162953505|NCT02378935|588534872|FG003|Overall Study|Death|0|||
162953506|NCT02378935|588534873|FG004|Overall Study|Death|0|||
162953507|NCT02378935|588534874|FG005|Overall Study|Death|0|||
162953508|NCT02378935|588534875|FG006|Overall Study|Death|0|||
162953509|NCT03450057|588534879|FG000|Overall Study|Death|17|||
162953510|NCT03450057|588534879|FG000|Overall Study|ICF withdrawal|4|||
162953511|NCT03450057|588534879|FG000|Overall Study|Lost to Follow-up|2|||
163192925|NCT02808650|589421683|FG004|Overall Study|Withdrawal by Subject|1|||
163192926|NCT04889222|589421689|FG000|Overall Study|Did not meet eligibility criteria|8|||
163192927|NCT04889222|589421689|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
163192928|NCT04889222|589421689|FG000|Overall Study|Did not proceed due to time constraints|5|||
163192929|NCT01180647|589421690|FG000|Overall Study|Lost to Follow-up|5|||
163192930|NCT01180647|589421691|FG001|Overall Study|Lost to Follow-up|6|||
163192931|NCT00071396|589421698|FG000|Overall Study|Withdrawal by Subject|1|||
163192932|NCT00071396|589421698|FG000|Overall Study|Physician Decision|2|||
163192933|NCT04545554|589421699|FG000|Overall Study|Withdrawal by Subject|0|||
163192934|NCT04545554|589421700|FG001|Overall Study|Withdrawal by Subject|0|||
163192935|NCT04545554|589421701|FG002|Overall Study|Withdrawal by Subject|0|||
163192936|NCT04545554|589421702|FG003|Overall Study|Withdrawal by Subject|1|||
163192937|NCT04545554|589421703|FG004|Overall Study|Withdrawal by Subject|0|||
163192938|NCT04545554|589421704|FG005|Overall Study|Withdrawal by Subject|0|||
163192939|NCT02639546|589421705|FG000|Overall Study|Death|2|||
163192940|NCT02639546|589421706|FG001|Overall Study|Death|2|||
163192941|NCT02639546|589421707|FG002|Overall Study|Death|1|||
163192942|NCT02639546|589421708|FG003|Overall Study|Death|2|||
163192943|NCT02639546|589421709|FG004|Overall Study|Death|2|||
163192944|NCT02639546|589421710|FG005|Overall Study|Death|2|||
163192945|NCT02639546|589421711|FG006|Overall Study|Death|0|||
163192946|NCT02639546|589421712|FG007|Overall Study|Death|0|||
163192947|NCT02639546|589421705|FG000|Overall Study|Lost to Follow-up|0|||
163192948|NCT02639546|589421706|FG001|Overall Study|Lost to Follow-up|0|||
163192949|NCT02639546|589421707|FG002|Overall Study|Lost to Follow-up|1|||
163192950|NCT02639546|589421708|FG003|Overall Study|Lost to Follow-up|0|||
163192951|NCT02639546|589421709|FG004|Overall Study|Lost to Follow-up|1|||
163192952|NCT02639546|589421710|FG005|Overall Study|Lost to Follow-up|1|||
163192953|NCT02639546|589421711|FG006|Overall Study|Lost to Follow-up|0|||
163192954|NCT02639546|589421712|FG007|Overall Study|Lost to Follow-up|1|||
163192955|NCT02639546|589421705|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
163192956|NCT02639546|589421706|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
163192957|NCT02639546|589421707|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
162953512|NCT03214952|588534882|FG000|Overall Study|Protocol Deviation|45|||
162953513|NCT03214952|588534882|FG000|Overall Study|Case Report Forms Uncollected|13|||
162953514|NCT00829790|588534883|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
162953515|NCT00829790|588534884|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
163192958|NCT02639546|589421708|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
163192959|NCT02639546|589421709|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
162953516|NCT03935880|588534885|FG000|Overall Study|Lost to Follow-up|0|||
162953517|NCT03935880|588534886|FG001|Overall Study|Lost to Follow-up|1|||
162953518|NCT00004562|588534887|FG000|Overall Study|Lost to Follow-up|102|||
162953519|NCT00004562|588534888|FG001|Overall Study|Lost to Follow-up|91|||
162953520|NCT04247282|588534889|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
162953521|NCT04247282|588534890|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
162953522|NCT04247282|588534891|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
162953523|NCT04247282|588534892|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
162953524|NCT04247282|588534889|FG000|Overall Study|Refused further treatment|0|||
162953525|NCT04247282|588534890|FG001|Overall Study|Refused further treatment|1|||
162953526|NCT04247282|588534891|FG002|Overall Study|Refused further treatment|0|||
162953527|NCT04247282|588534892|FG003|Overall Study|Refused further treatment|0|||
162953528|NCT02865850|588534893|FG000|Overall Study|Death|15|||
162953529|NCT02865850|588534894|FG001|Overall Study|Death|19|||
162953530|NCT02865850|588534893|FG000|Overall Study|Withdrawal by Subject|3|||
162953531|NCT02865850|588534894|FG001|Overall Study|Withdrawal by Subject|2|||
162953532|NCT02865850|588534893|FG000|Overall Study|Lost to Follow-up|3|||
162953533|NCT02865850|588534894|FG001|Overall Study|Lost to Follow-up|2|||
162953534|NCT00552669|588534895|FG000|Overall Study|Death|3|||
162953535|NCT00552669|588534896|FG001|Overall Study|Death|7|||
162953536|NCT01263704|588534898|FG000|Overall Study|Progressive disease|18|||
162953537|NCT01263704|588534898|FG000|Overall Study|Adverse Event|3|||
163299158|NCT00444600|589805097|FG003|Overall Study|Missed visit|1|||
163299159|NCT05132478|589805098|FG000|Overall Study|did not complete survey after consent|1|||
163299160|NCT05132478|589805099|FG001|Overall Study|did not complete survey after consent|1|||
163299161|NCT05132478|589805098|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
163299162|NCT05132478|589805099|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
163299163|NCT02549170|589805100|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
163299164|NCT02549170|589805101|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
163299165|NCT02549170|589805102|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
163299166|NCT02549170|589805103|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
163299167|NCT02549170|589805104|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
163299168|NCT02549170|589805100|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
163299169|NCT02549170|589805101|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
163299170|NCT02549170|589805102|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
163299171|NCT02549170|589805103|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
163392918|NCT04178967|590150339|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
163392919|NCT04178967|590150340|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
162953538|NCT01263704|588534898|FG000|Overall Study|Death|2|||
162953539|NCT01263704|588534898|FG000|Overall Study|Patient withdrew consent|2|||
162953540|NCT01263704|588534898|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
162953541|NCT01263704|588534898|FG000|Overall Study|Lost to Follow-up|1|||
162953542|NCT01263704|588534898|FG000|Overall Study|Colon metastases|1|||
162953543|NCT01263704|588534898|FG000|Overall Study|Principal Investigator (PI) decision|1|||
162953544|NCT00252720|588534900|FG000|Overall Study|Withdrawal by Subject|95|||
162953545|NCT00252720|588534901|FG001|Overall Study|Withdrawal by Subject|97|||
162953546|NCT00252720|588534900|FG000|Overall Study|Death|7|||
162953547|NCT00252720|588534901|FG001|Overall Study|Death|8|||
162953548|NCT00252720|588534900|FG000|Overall Study|Moving|23|||
162953549|NCT00252720|588534901|FG001|Overall Study|Moving|42|||
162953550|NCT00252720|588534900|FG000|Overall Study|Mainly patients lost to follow-up|7|||
162953551|NCT00252720|588534901|FG001|Overall Study|Mainly patients lost to follow-up|18|||
163392920|NCT04178967|590150341|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
163392921|NCT04178967|590150342|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
163392922|NCT04178967|590150343|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
163392923|NCT04178967|590150344|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
163392924|NCT04178967|590150345|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
163392925|NCT04178967|590150346|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
163392926|NCT04178967|590150347|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
162953552|NCT00102440|588534904|FG000|Overall Study|Lost to Follow-up|25|||
162953553|NCT00102440|588534905|FG001|Overall Study|Lost to Follow-up|18|||
162953554|NCT00102440|588534906|FG002|Overall Study|Lost to Follow-up|21|||
162953555|NCT00102440|588534904|FG000|Overall Study|Adverse Event|16|||
162953556|NCT00102440|588534905|FG001|Overall Study|Adverse Event|23|||
162953557|NCT00102440|588534906|FG002|Overall Study|Adverse Event|8|||
162953558|NCT00102440|588534904|FG000|Overall Study|Gout Flare|10|||
162953559|NCT00102440|588534905|FG001|Overall Study|Gout Flare|28|||
162953560|NCT00102440|588534906|FG002|Overall Study|Gout Flare|9|||
162953561|NCT00102440|588534904|FG000|Overall Study|Personal Reason(s)|19|||
162953562|NCT00102440|588534905|FG001|Overall Study|Personal Reason(s)|13|||
162953563|NCT00102440|588534906|FG002|Overall Study|Personal Reason(s)|13|||
162953564|NCT00102440|588534904|FG000|Overall Study|Other|11|||
162953565|NCT00102440|588534905|FG001|Overall Study|Other|14|||
162953566|NCT00102440|588534906|FG002|Overall Study|Other|14|||
162953567|NCT00102440|588534904|FG000|Overall Study|Protocol Violation|7|||
163192960|NCT02639546|589421710|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
163192961|NCT02639546|589421711|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
163192962|NCT02639546|589421712|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
163192963|NCT02639546|589421705|FG000|Overall Study|Study Terminated By Sponsor|0|||
163192964|NCT02639546|589421706|FG001|Overall Study|Study Terminated By Sponsor|2|||
163192965|NCT02639546|589421707|FG002|Overall Study|Study Terminated By Sponsor|3|||
163192966|NCT02639546|589421708|FG003|Overall Study|Study Terminated By Sponsor|4|||
163192967|NCT02639546|589421709|FG004|Overall Study|Study Terminated By Sponsor|4|||
163192968|NCT02639546|589421710|FG005|Overall Study|Study Terminated By Sponsor|3|||
163192969|NCT02639546|589421711|FG006|Overall Study|Study Terminated By Sponsor|3|||
163192970|NCT02639546|589421712|FG007|Overall Study|Study Terminated By Sponsor|9|||
163192971|NCT02639546|589421705|FG000|Overall Study|Withdrawal by Subject|2|||
163192972|NCT02639546|589421706|FG001|Overall Study|Withdrawal by Subject|2|||
163192973|NCT02639546|589421707|FG002|Overall Study|Withdrawal by Subject|1|||
163192974|NCT02639546|589421708|FG003|Overall Study|Withdrawal by Subject|0|||
163192975|NCT02639546|589421709|FG004|Overall Study|Withdrawal by Subject|0|||
163192976|NCT02639546|589421710|FG005|Overall Study|Withdrawal by Subject|1|||
163192977|NCT02639546|589421711|FG006|Overall Study|Withdrawal by Subject|2|||
163192978|NCT02639546|589421712|FG007|Overall Study|Withdrawal by Subject|1|||
163192979|NCT02478372|589421713|FG000|Overall Study|Protocol Violation|12|||
163192980|NCT02478372|589421714|FG001|Overall Study|Protocol Violation|8|||
163192981|NCT02478372|589421713|FG000|Overall Study|Lost to Follow-up|1|||
163192982|NCT02478372|589421714|FG001|Overall Study|Lost to Follow-up|4|||
163192983|NCT02478372|589421713|FG000|Overall Study|Death|0|||
163192984|NCT02478372|589421714|FG001|Overall Study|Death|2|||
163192985|NCT00116428|589421715|FG000|Overall Study|Withdrawal by Subject|2|||
163192986|NCT00116428|589421716|FG001|Overall Study|Withdrawal by Subject|5|||
163192987|NCT00116428|589421715|FG000|Overall Study|Did not meet inclusion criteria|1|||
163192988|NCT00116428|589421716|FG001|Overall Study|Did not meet inclusion criteria|0|||
163192989|NCT01032174|589421717|FG000|Overall Study|Adverse Event|0|||
163192990|NCT01032174|589421718|FG001|Overall Study|Adverse Event|1|||
163192991|NCT00113087|589421719|FG000|Overall Study|Death or Transplant|14|||
163192992|NCT00113087|589421720|FG001|Overall Study|Death or Transplant|16|||
163192993|NCT00113087|589421719|FG000|Overall Study|Family or MD withdrew subject|10|||
163192994|NCT00113087|589421720|FG001|Overall Study|Family or MD withdrew subject|5|||
163192995|NCT00386607|589421721|FG000|Core|Adverse Event|40|||
163192996|NCT00386607|589421722|FG001|Core|Adverse Event|0|||
163192997|NCT00386607|589421721|FG000|Core|Abnormal laboratory value(s)|3|||
163192998|NCT00386607|589421722|FG001|Core|Abnormal laboratory value(s)|0|||
163192999|NCT00386607|589421721|FG000|Core|Unsatisfactory therapeutic effect|23|||
163193000|NCT00386607|589421722|FG001|Core|Unsatisfactory therapeutic effect|0|||
163193001|NCT00386607|589421721|FG000|Core|Condition no longer requires study drug|4|||
163193002|NCT00386607|589421722|FG001|Core|Condition no longer requires study drug|0|||
163193003|NCT00386607|589421721|FG000|Core|Patient withdrew consent|15|||
163193004|NCT00386607|589421722|FG001|Core|Patient withdrew consent|0|||
163193005|NCT00386607|589421721|FG000|Core|Lost to Follow-up|23|||
163193006|NCT00386607|589421722|FG001|Core|Lost to Follow-up|0|||
163193007|NCT00386607|589421721|FG000|Core|Administrative problems|1|||
163193008|NCT00386607|589421722|FG001|Core|Administrative problems|0|||
163193009|NCT00386607|589421721|FG000|Core|Protocol Deviation|6|||
163193010|NCT00386607|589421722|FG001|Core|Protocol Deviation|0|||
163193011|NCT00386607|589421721|FG000|Extension|Adverse Event|0|||
163193012|NCT00386607|589421722|FG001|Extension|Adverse Event|6|||
163193013|NCT00386607|589421721|FG000|Extension|Abnormal laboratory value(s)|0|||
163193014|NCT00386607|589421722|FG001|Extension|Abnormal laboratory value(s)|1|||
163193015|NCT00386607|589421721|FG000|Extension|Administrative problems|0|||
163193016|NCT00386607|589421722|FG001|Extension|Administrative problems|1|||
163193017|NCT00386607|589421721|FG000|Extension|Lost to Follow-up|0|||
163193018|NCT00386607|589421722|FG001|Extension|Lost to Follow-up|3|||
163193019|NCT00386607|589421721|FG000|Extension|Patient withdrew consent|0|||
163193020|NCT00386607|589421722|FG001|Extension|Patient withdrew consent|5|||
163193021|NCT00386607|589421721|FG000|Extension|Unsatisfactory therapeutic effect|0|||
163193022|NCT00386607|589421722|FG001|Extension|Unsatisfactory therapeutic effect|1|||
163193023|NCT02713204|589421723|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
163193024|NCT02713204|589421724|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
163193025|NCT02713204|589421725|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
163193026|NCT02713204|589421726|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
163193027|NCT02713204|589421727|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
163193028|NCT02713204|589421728|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
163193029|NCT02713204|589421729|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
163193030|NCT02713204|589421730|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
163193031|NCT02713204|589421723|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162953568|NCT00102440|588534905|FG001|Overall Study|Protocol Violation|2|||
163193032|NCT02713204|589421724|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162953569|NCT00102440|588534906|FG002|Overall Study|Protocol Violation|1|||
162953570|NCT04627038|588534907|FG000|Overall Study|Adverse Event|36|||
162953571|NCT04627038|588534908|FG001|Overall Study|Adverse Event|8|||
162953572|NCT04627038|588534907|FG000|Overall Study|Lost to Follow-up|1|||
162953573|NCT04627038|588534908|FG001|Overall Study|Lost to Follow-up|0|||
162953574|NCT04627038|588534907|FG000|Overall Study|Physician Decision|0|||
162953575|NCT04627038|588534908|FG001|Overall Study|Physician Decision|1|||
162953576|NCT04627038|588534907|FG000|Overall Study|Protocol Violation|3|||
162953577|NCT04627038|588534908|FG001|Overall Study|Protocol Violation|1|||
162953578|NCT04627038|588534907|FG000|Overall Study|Withdrawal by Subject|13|||
162953579|NCT04627038|588534908|FG001|Overall Study|Withdrawal by Subject|3|||
162953580|NCT04627038|588534907|FG000|Overall Study|Non-compliance with study drug|0|||
162953581|NCT04627038|588534908|FG001|Overall Study|Non-compliance with study drug|1|||
162953582|NCT04627038|588534907|FG000|Overall Study|Prohibited Concomitant Medication|1|||
162953583|NCT04627038|588534908|FG001|Overall Study|Prohibited Concomitant Medication|0|||
162953584|NCT01792635|588534913|FG000|Part B|Adverse Event|0|||
162953585|NCT01792635|588534914|FG001|Part B|Adverse Event|0|||
163193033|NCT02713204|589421725|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
163193034|NCT02713204|589421726|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
163193035|NCT02713204|589421727|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
163193036|NCT02713204|589421728|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
163193037|NCT02713204|589421729|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
163193038|NCT02713204|589421730|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
163193039|NCT02713204|589421723|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
163193040|NCT02713204|589421724|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
163299172|NCT02549170|589805104|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
162953586|NCT01792635|588534915|FG002|Part B|Adverse Event|1|||
162953587|NCT01792635|588534913|FG000|Part B|Study terminated|0|||
162953588|NCT01792635|588534914|FG001|Part B|Study terminated|4|||
162953589|NCT01792635|588534915|FG002|Part B|Study terminated|3|||
162953590|NCT01401647|588534920|FG000|Overall Study|Withdrawal by Subject|1|||
162953591|NCT01401647|588534921|FG001|Overall Study|Withdrawal by Subject|5|||
162953592|NCT01401647|588534922|FG002|Overall Study|Withdrawal by Subject|2|||
162953593|NCT01401647|588534920|FG000|Overall Study|Lost to Follow-up|3|||
162953594|NCT01401647|588534921|FG001|Overall Study|Lost to Follow-up|3|||
162953595|NCT01401647|588534922|FG002|Overall Study|Lost to Follow-up|1|||
162953596|NCT00473330|588534926|FG000|Core Study|Adverse Event|4|||
162953597|NCT00473330|588534927|FG001|Core Study|Adverse Event|4|||
162953598|NCT00473330|588534928|FG002|Core Study|Adverse Event|1|||
162953599|NCT00473330|588534926|FG000|Core Study|Death|6|||
162953600|NCT00473330|588534927|FG001|Core Study|Death|4|||
162953601|NCT00473330|588534928|FG002|Core Study|Death|4|||
162953602|NCT00473330|588534926|FG000|Core Study|Lost to Follow-up|5|||
162953603|NCT00473330|588534927|FG001|Core Study|Lost to Follow-up|5|||
162953604|NCT00473330|588534928|FG002|Core Study|Lost to Follow-up|10|||
162953605|NCT00473330|588534926|FG000|Core Study|Physician Decision|2|||
162953606|NCT00473330|588534927|FG001|Core Study|Physician Decision|1|||
162953607|NCT00473330|588534928|FG002|Core Study|Physician Decision|3|||
162953608|NCT00473330|588534926|FG000|Core Study|Subject Non-compliance|1|||
162953609|NCT00473330|588534927|FG001|Core Study|Subject Non-compliance|2|||
162953610|NCT00473330|588534928|FG002|Core Study|Subject Non-compliance|1|||
162953611|NCT00473330|588534926|FG000|Core Study|Subject Required Other Therapy|0|||
162953612|NCT00473330|588534927|FG001|Core Study|Subject Required Other Therapy|1|||
162953613|NCT00473330|588534928|FG002|Core Study|Subject Required Other Therapy|3|||
162953614|NCT00473330|588534926|FG000|Core Study|Subject's Decision|9|||
162953615|NCT00473330|588534927|FG001|Core Study|Subject's Decision|8|||
162953616|NCT00473330|588534928|FG002|Core Study|Subject's Decision|19|||
162953617|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
162953618|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
162953619|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
162953620|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Death|2|||
162953621|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Death|0|||
163193041|NCT02713204|589421725|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162953622|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Death|0|||
162953623|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
163193042|NCT02713204|589421726|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
163193043|NCT02713204|589421727|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
163193044|NCT02713204|589421728|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
163193045|NCT02713204|589421729|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
163193046|NCT02713204|589421730|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162953624|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
162953625|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
162953626|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
162953627|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
163043236|NCT04004260|588865765|FG001|Overall Study|Lost to Follow-up|12|||
163392927|NCT04178967|590150348|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
163392928|NCT04178967|590150349|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
163392929|NCT04178967|590150339|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163392930|NCT04178967|590150340|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163392931|NCT04178967|590150341|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163392932|NCT04178967|590150342|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163392933|NCT04178967|590150343|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163392934|NCT04178967|590150344|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163392935|NCT04178967|590150345|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163193047|NCT02713204|589421723|FG000|From Week 12 up to Week 36|Adverse Event|1|||
163193048|NCT02713204|589421724|FG001|From Week 12 up to Week 36|Adverse Event|0|||
163193049|NCT02713204|589421725|FG002|From Week 12 up to Week 36|Adverse Event|0|||
163193050|NCT02713204|589421726|FG003|From Week 12 up to Week 36|Adverse Event|1|||
163193051|NCT02713204|589421727|FG004|From Week 12 up to Week 36|Adverse Event|1|||
163193052|NCT02713204|589421728|FG005|From Week 12 up to Week 36|Adverse Event|0|||
163193053|NCT02713204|589421729|FG006|From Week 12 up to Week 36|Adverse Event|2|||
163193054|NCT02713204|589421730|FG007|From Week 12 up to Week 36|Adverse Event|1|||
163193055|NCT02713204|589421723|FG000|From Week 12 up to Week 36|Death|0|||
163193056|NCT02713204|589421724|FG001|From Week 12 up to Week 36|Death|0|||
163193057|NCT02713204|589421725|FG002|From Week 12 up to Week 36|Death|0|||
163193058|NCT02713204|589421726|FG003|From Week 12 up to Week 36|Death|1|||
163193059|NCT02713204|589421727|FG004|From Week 12 up to Week 36|Death|0|||
163193060|NCT02713204|589421728|FG005|From Week 12 up to Week 36|Death|1|||
163193061|NCT02713204|589421729|FG006|From Week 12 up to Week 36|Death|0|||
163193062|NCT02713204|589421730|FG007|From Week 12 up to Week 36|Death|3|||
163193063|NCT02713204|589421723|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
163193064|NCT02713204|589421724|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
163193065|NCT02713204|589421725|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
163193066|NCT02713204|589421726|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
163193067|NCT02713204|589421727|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
163193068|NCT02713204|589421728|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
163193069|NCT02713204|589421729|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
163193070|NCT02713204|589421730|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
163193071|NCT02713204|589421723|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
163193072|NCT02713204|589421724|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
163193073|NCT02713204|589421725|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
163392936|NCT04178967|590150346|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163392937|NCT04178967|590150347|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
163392938|NCT04178967|590150348|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
163392939|NCT04178967|590150349|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
162953628|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
162953629|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
162953630|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
162953631|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
162953632|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
162953633|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
163193074|NCT02713204|589421726|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
163193075|NCT02713204|589421727|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
163193076|NCT02713204|589421728|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
163193077|NCT02713204|589421729|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
163193078|NCT02713204|589421730|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
163193079|NCT00474760|589421734|FG000|Overall Study|Death|0|||
163193080|NCT00474760|589421735|FG001|Overall Study|Death|0|||
163193081|NCT00474760|589421736|FG002|Overall Study|Death|0|||
163193082|NCT00474760|589421737|FG003|Overall Study|Death|0|||
163193083|NCT00474760|589421738|FG004|Overall Study|Death|2|||
163193084|NCT00474760|589421739|FG005|Overall Study|Death|0|||
163193085|NCT00474760|589421740|FG006|Overall Study|Death|0|||
163193086|NCT00474760|589421734|FG000|Overall Study|Adverse Event|0|||
163193087|NCT00474760|589421735|FG001|Overall Study|Adverse Event|0|||
163193088|NCT00474760|589421736|FG002|Overall Study|Adverse Event|0|||
163193089|NCT00474760|589421737|FG003|Overall Study|Adverse Event|0|||
163193090|NCT00474760|589421738|FG004|Overall Study|Adverse Event|1|||
163193091|NCT00474760|589421739|FG005|Overall Study|Adverse Event|7|||
163193092|NCT00474760|589421740|FG006|Overall Study|Adverse Event|0|||
163193093|NCT00474760|589421734|FG000|Overall Study|Laboratory abnormality|0|||
163193094|NCT00474760|589421735|FG001|Overall Study|Laboratory abnormality|0|||
163193095|NCT00474760|589421736|FG002|Overall Study|Laboratory abnormality|0|||
163193096|NCT00474760|589421737|FG003|Overall Study|Laboratory abnormality|0|||
163193097|NCT00474760|589421738|FG004|Overall Study|Laboratory abnormality|0|||
163193098|NCT00474760|589421739|FG005|Overall Study|Laboratory abnormality|1|||
163193099|NCT00474760|589421740|FG006|Overall Study|Laboratory abnormality|0|||
163193100|NCT00474760|589421734|FG000|Overall Study|Withdrawal by Subject|0|||
163193101|NCT00474760|589421735|FG001|Overall Study|Withdrawal by Subject|0|||
163193102|NCT00474760|589421736|FG002|Overall Study|Withdrawal by Subject|0|||
163193103|NCT00474760|589421737|FG003|Overall Study|Withdrawal by Subject|1|||
163193104|NCT00474760|589421738|FG004|Overall Study|Withdrawal by Subject|0|||
163193105|NCT00474760|589421739|FG005|Overall Study|Withdrawal by Subject|1|||
163193106|NCT00474760|589421740|FG006|Overall Study|Withdrawal by Subject|1|||
163193107|NCT00474760|589421734|FG000|Overall Study|Other|0|||
163193108|NCT00474760|589421735|FG001|Overall Study|Other|1|||
163193109|NCT00474760|589421736|FG002|Overall Study|Other|0|||
163193110|NCT00474760|589421737|FG003|Overall Study|Other|0|||
163193111|NCT00474760|589421738|FG004|Overall Study|Other|1|||
163193112|NCT00474760|589421739|FG005|Overall Study|Other|0|||
163193113|NCT00474760|589421740|FG006|Overall Study|Other|0|||
163193114|NCT00474760|589421734|FG000|Overall Study|Progressive disease|3|||
163193115|NCT00474760|589421735|FG001|Overall Study|Progressive disease|2|||
163193116|NCT00474760|589421736|FG002|Overall Study|Progressive disease|3|||
163193117|NCT00474760|589421737|FG003|Overall Study|Progressive disease|2|||
163193118|NCT00474760|589421738|FG004|Overall Study|Progressive disease|8|||
163193119|NCT00474760|589421739|FG005|Overall Study|Progressive disease|20|||
163193120|NCT00474760|589421740|FG006|Overall Study|Progressive disease|7|||
163193121|NCT00474760|589421734|FG000|Overall Study|Terminated by sponsor|0|||
163193122|NCT00474760|589421735|FG001|Overall Study|Terminated by sponsor|0|||
163193123|NCT00474760|589421736|FG002|Overall Study|Terminated by sponsor|0|||
163193124|NCT00474760|589421737|FG003|Overall Study|Terminated by sponsor|0|||
163193125|NCT00474760|589421738|FG004|Overall Study|Terminated by sponsor|0|||
163193126|NCT00474760|589421739|FG005|Overall Study|Terminated by sponsor|0|||
163193127|NCT00474760|589421740|FG006|Overall Study|Terminated by sponsor|2|||
163193128|NCT01927627|589421742|FG000|Overall Study|Adverse Event|3|||
163193129|NCT01927627|589421742|FG000|Overall Study|Lack of Efficacy|1|||
163193130|NCT01927627|589421742|FG000|Overall Study|Financial Concerns|1|||
163193131|NCT02635776|589421743|FG000|Overall Study|Physician Decision|1|||
163193132|NCT02635776|589421744|FG001|Overall Study|Physician Decision|0|||
163193133|NCT02635776|589421743|FG000|Overall Study|Adverse Event|51|||
163193134|NCT02635776|589421744|FG001|Overall Study|Adverse Event|3|||
163193135|NCT02635776|589421743|FG000|Overall Study|Withdrawal by Subject|41|||
163193136|NCT02635776|589421744|FG001|Overall Study|Withdrawal by Subject|7|||
163193137|NCT02635776|589421743|FG000|Overall Study|Lost to Follow-up|4|||
163193138|NCT02635776|589421744|FG001|Overall Study|Lost to Follow-up|0|||
163193139|NCT02635776|589421743|FG000|Overall Study|Other reasons|5|||
163193140|NCT02635776|589421744|FG001|Overall Study|Other reasons|1|||
163193141|NCT00660673|589421745|FG000|Overall Study|Adverse Event|84|||
163193142|NCT00660673|589421745|FG000|Overall Study|Lack of Efficacy|7|||
163193143|NCT00660673|589421745|FG000|Overall Study|Withdrawal by Subject|22|||
163193144|NCT00660673|589421745|FG000|Overall Study|Administrative|2|||
163193145|NCT00660673|589421745|FG000|Overall Study|Protocol Violation|2|||
163193146|NCT00579098|589421746|FG000|Overall Study|Lost to Follow-up|2|||
163193147|NCT00579098|589421747|FG001|Overall Study|Lost to Follow-up|0|||
163193148|NCT00579098|589421746|FG000|Overall Study|Adverse Event|2|||
163193149|NCT00579098|589421747|FG001|Overall Study|Adverse Event|3|||
163193150|NCT00579098|589421746|FG000|Overall Study|Withdrawal by Subject|2|||
163193151|NCT00579098|589421747|FG001|Overall Study|Withdrawal by Subject|3|||
163193152|NCT00579098|589421746|FG000|Overall Study|AF returned after ablation|3|||
163193153|NCT00579098|589421747|FG001|Overall Study|AF returned after ablation|2|||
163299173|NCT02549170|589805100|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
163299174|NCT02549170|589805101|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
163299175|NCT02549170|589805102|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
163299176|NCT02549170|589805103|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
163299177|NCT02549170|589805104|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
163299178|NCT02988817|589805105|FG000|Overall Study|Withdrawal by Subject|1|||
163299179|NCT02988817|589805106|FG001|Overall Study|Withdrawal by Subject|0|||
163299180|NCT02988817|589805107|FG002|Overall Study|Withdrawal by Subject|0|||
163299181|NCT02988817|589805108|FG003|Overall Study|Withdrawal by Subject|1|||
163299182|NCT02988817|589805109|FG004|Overall Study|Withdrawal by Subject|3|||
163299183|NCT02988817|589805110|FG005|Overall Study|Withdrawal by Subject|1|||
163299184|NCT02988817|589805111|FG006|Overall Study|Withdrawal by Subject|2|||
163299185|NCT02988817|589805112|FG007|Overall Study|Withdrawal by Subject|1|||
163299186|NCT02988817|589805113|FG008|Overall Study|Withdrawal by Subject|1|||
163299187|NCT02988817|589805114|FG009|Overall Study|Withdrawal by Subject|1|||
163299188|NCT02988817|589805115|FG010|Overall Study|Withdrawal by Subject|1|||
163299189|NCT02988817|589805116|FG011|Overall Study|Withdrawal by Subject|12|||
163043237|NCT04004260|588865764|FG000|Overall Study|Did not engage in intervention|13|||
163043238|NCT04004260|588865765|FG001|Overall Study|Did not engage in intervention|17|||
163043239|NCT02360280|588865769|FG000|Overall Study|Withdrawal by Subject|2|||
163299190|NCT02988817|589805117|FG012|Overall Study|Withdrawal by Subject|6|||
163299191|NCT02988817|589805118|FG013|Overall Study|Withdrawal by Subject|6|||
163299192|NCT02988817|589805119|FG014|Overall Study|Withdrawal by Subject|4|||
162953634|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
162953635|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
162953636|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
162953637|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
162953638|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
162953639|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
162953640|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
162953641|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
162953642|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
162953643|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
162953644|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Death|2|||
162953645|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Death|2|||
162953646|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Death|1|||
162953647|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
162953648|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
162953649|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
162953650|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
162953651|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
162953652|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
162953653|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
162953654|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
162953655|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
162953656|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
162953657|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
162953658|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
163043240|NCT02360280|588865770|FG001|Overall Study|Withdrawal by Subject|0|||
163043241|NCT02360280|588865769|FG000|Overall Study|Adverse Event|0|||
163043242|NCT02360280|588865770|FG001|Overall Study|Adverse Event|1|||
163043243|NCT02360280|588865769|FG000|Overall Study|Lost to Follow-up|1|||
163043244|NCT02360280|588865770|FG001|Overall Study|Lost to Follow-up|0|||
163043245|NCT00320788|588865771|FG000|Overall Study|Adverse Event|0|||
163043246|NCT00320788|588865772|FG001|Overall Study|Adverse Event|0|||
163043247|NCT00320788|588865773|FG002|Overall Study|Adverse Event|0|||
163043248|NCT00320788|588865774|FG003|Overall Study|Adverse Event|1|||
163043249|NCT00320788|588865775|FG004|Overall Study|Adverse Event|0|||
163043250|NCT00320788|588865771|FG000|Overall Study|Death|0|||
163043251|NCT00320788|588865772|FG001|Overall Study|Death|0|||
163043252|NCT00320788|588865773|FG002|Overall Study|Death|1|||
163043253|NCT00320788|588865774|FG003|Overall Study|Death|0|||
163043254|NCT00320788|588865775|FG004|Overall Study|Death|1|||
163193154|NCT00633750|589421754|FG000|Overall Study|Adverse Event|2|||
163392940|NCT04178967|590150339|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163043255|NCT00320788|588865771|FG000|Overall Study|Lost to Follow-up|0|||
163043256|NCT00320788|588865772|FG001|Overall Study|Lost to Follow-up|2|||
163193155|NCT00633750|589421754|FG000|Overall Study|Withdrawal by Subject|3|||
163193156|NCT01903031|589421755|FG000|Overall Study|Not Able to Attend Clinic|1|||
163193157|NCT01903031|589421756|FG001|Overall Study|Not Able to Attend Clinic|1|||
163193158|NCT01903031|589421757|FG002|Overall Study|Not Able to Attend Clinic|0|||
163193159|NCT01903031|589421755|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
163193160|NCT01903031|589421756|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
163193161|NCT01903031|589421757|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
163193162|NCT01903031|589421755|FG000|Overall Study|Adverse Event|0|||
163193163|NCT01903031|589421756|FG001|Overall Study|Adverse Event|1|||
163193164|NCT01903031|589421757|FG002|Overall Study|Adverse Event|0|||
163193165|NCT01903031|589421755|FG000|Overall Study|Withdrawal by Subject|0|||
163193166|NCT01903031|589421756|FG001|Overall Study|Withdrawal by Subject|1|||
163193167|NCT01903031|589421757|FG002|Overall Study|Withdrawal by Subject|1|||
163193168|NCT01903031|589421755|FG000|Overall Study|Protocol Violation|0|||
163193169|NCT01903031|589421756|FG001|Overall Study|Protocol Violation|0|||
163193170|NCT01903031|589421757|FG002|Overall Study|Protocol Violation|2|||
163193171|NCT01903031|589421755|FG000|Overall Study|Lost to Follow-up|0|||
163193172|NCT01903031|589421756|FG001|Overall Study|Lost to Follow-up|0|||
163193173|NCT01903031|589421757|FG002|Overall Study|Lost to Follow-up|1|||
163193174|NCT01903031|589421755|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
163193175|NCT01903031|589421756|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
163193176|NCT01903031|589421757|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
163193177|NCT01811225|589421758|FG000|Treatment Period 1|Adverse Event|2|||
163193178|NCT01811225|589421759|FG001|Treatment Period 1|Adverse Event|3|||
163193179|NCT01811225|589421758|FG000|Treatment Period 1|Lost to Follow-up|12|||
163193180|NCT01811225|589421759|FG001|Treatment Period 1|Lost to Follow-up|8|||
163193181|NCT01811225|589421758|FG000|Treatment Period 1|transporation|1|||
163193182|NCT01811225|589421759|FG001|Treatment Period 1|transporation|0|||
163193183|NCT01811225|589421758|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
163193184|NCT01811225|589421759|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
163193185|NCT01811225|589421758|FG000|Treatment Period 2|Lost to Follow-up|1|||
163193186|NCT01811225|589421759|FG001|Treatment Period 2|Lost to Follow-up|2|||
163193187|NCT01811225|589421758|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
163193188|NCT01811225|589421759|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
163193189|NCT03000569|589421760|FG000|Overall Study|Withdrawal by Subject|1|||
163193190|NCT03000569|589421761|FG001|Overall Study|Withdrawal by Subject|0|||
163193191|NCT02298023|589421762|FG000|Overall Study|Withdrawal by Subject|1|||
163193192|NCT02298023|589421763|FG001|Overall Study|Withdrawal by Subject|0|||
163193193|NCT02298023|589421764|FG002|Overall Study|Withdrawal by Subject|0|||
163193194|NCT00492531|589421772|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
163193195|NCT00492531|589421773|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
163193196|NCT04122534|589421774|FG000|Overall Study|Lost to Follow-up|4|||
163193197|NCT01790932|589421780|FG000|Overall Study|Disease Progression|41|||
163193198|NCT01790932|589421780|FG000|Overall Study|Adverse Event|7|||
163193199|NCT01790932|589421780|FG000|Overall Study|Physician Decision|1|||
163193200|NCT01790932|589421780|FG000|Overall Study|Withdrawal by Subject|1|||
163193201|NCT01441180|589421786|FG000|Overall Study|Lost to Follow-up|1|||
163193202|NCT01441180|589421787|FG001|Overall Study|Lost to Follow-up|1|||
163193203|NCT01441180|589421788|FG002|Overall Study|Lost to Follow-up|1|||
163193204|NCT01441180|589421786|FG000|Overall Study|Discontinued|0|||
163193205|NCT01441180|589421787|FG001|Overall Study|Discontinued|0|||
163193206|NCT01441180|589421788|FG002|Overall Study|Discontinued|2|||
163193207|NCT01558739|589421791|FG000|Overall Study|Adverse Event|7|||
163193208|NCT01558739|589421791|FG000|Overall Study|Withdrawal by Subject|2|||
163193209|NCT01558739|589421791|FG000|Overall Study|Death|3|||
163193210|NCT01558739|589421791|FG000|Overall Study|Disease Progression|4|||
163193211|NCT01558739|589421791|FG000|Overall Study|Protocol Violation|1|||
163193212|NCT01402011|589421796|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
163193213|NCT01402011|589421797|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
163193214|NCT01402011|589421798|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
163193215|NCT01402011|589421796|FG000|Active Treatment Period|Withdrawal by Subject|1|||
163193216|NCT01402011|589421797|FG001|Active Treatment Period|Withdrawal by Subject|3|||
163193217|NCT01402011|589421798|FG002|Active Treatment Period|Withdrawal by Subject|0|||
163193218|NCT01402011|589421796|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
163193219|NCT01402011|589421797|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
163193220|NCT01402011|589421798|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
163193221|NCT02612129|589421799|FG000|Single Dose Treatment Period|Screening Failure|1|||
163193222|NCT02612129|589421800|FG001|Single Dose Treatment Period|Screening Failure|0|||
163193223|NCT02612129|589421801|FG002|Single Dose Treatment Period|Screening Failure|0|||
163193224|NCT02612129|589421799|FG000|Continuous Treatment Period|Early Escape|0|||
163193225|NCT02612129|589421800|FG001|Continuous Treatment Period|Early Escape|2|||
163193226|NCT02612129|589421801|FG002|Continuous Treatment Period|Early Escape|0|||
163193227|NCT02612129|589421799|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
163193228|NCT02612129|589421800|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
163193229|NCT02612129|589421801|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
163193230|NCT02612129|589421799|FG000|Continuous Treatment Period|Safety Reasons|0|||
163193231|NCT02612129|589421800|FG001|Continuous Treatment Period|Safety Reasons|3|||
163193232|NCT02612129|589421801|FG002|Continuous Treatment Period|Safety Reasons|0|||
163193233|NCT02612129|589421799|FG000|Continuous Treatment Period|Death|0|||
163193234|NCT02612129|589421800|FG001|Continuous Treatment Period|Death|1|||
163193235|NCT02612129|589421801|FG002|Continuous Treatment Period|Death|0|||
163193236|NCT02612129|589421799|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
163193237|NCT02612129|589421800|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
163193238|NCT02612129|589421801|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
163193239|NCT02557295|589421802|FG000|Overall Study|Withdrawal by Subject|9|||
163193240|NCT02557295|589421803|FG001|Overall Study|Withdrawal by Subject|2|||
163193241|NCT02557295|589421804|FG002|Overall Study|Withdrawal by Subject|4|||
163193242|NCT02557295|589421805|FG003|Overall Study|Withdrawal by Subject|0|||
163193243|NCT02557295|589421806|FG004|Overall Study|Withdrawal by Subject|0|||
163193244|NCT02557295|589421807|FG005|Overall Study|Withdrawal by Subject|0|||
163193245|NCT02557295|589421808|FG006|Overall Study|Withdrawal by Subject|15|||
163193246|NCT02557295|589421809|FG007|Overall Study|Withdrawal by Subject|1|||
163193247|NCT02557295|589421810|FG008|Overall Study|Withdrawal by Subject|3|||
163193248|NCT02557295|589421802|FG000|Overall Study|Disease Progression|0|||
163193249|NCT02557295|589421803|FG001|Overall Study|Disease Progression|0|||
163193250|NCT02557295|589421804|FG002|Overall Study|Disease Progression|0|||
163193251|NCT02557295|589421805|FG003|Overall Study|Disease Progression|0|||
163193252|NCT02557295|589421806|FG004|Overall Study|Disease Progression|0|||
163193253|NCT02557295|589421807|FG005|Overall Study|Disease Progression|0|||
163193254|NCT02557295|589421808|FG006|Overall Study|Disease Progression|1|||
163193255|NCT02557295|589421809|FG007|Overall Study|Disease Progression|0|||
163193256|NCT02557295|589421810|FG008|Overall Study|Disease Progression|0|||
163193257|NCT02557295|589421802|FG000|Overall Study|Lack of Efficacy|24|||
163193258|NCT02557295|589421803|FG001|Overall Study|Lack of Efficacy|1|||
163193259|NCT02557295|589421804|FG002|Overall Study|Lack of Efficacy|3|||
163193260|NCT02557295|589421805|FG003|Overall Study|Lack of Efficacy|0|||
163193261|NCT02557295|589421806|FG004|Overall Study|Lack of Efficacy|0|||
163193262|NCT02557295|589421807|FG005|Overall Study|Lack of Efficacy|0|||
163193263|NCT02557295|589421808|FG006|Overall Study|Lack of Efficacy|12|||
163193264|NCT02557295|589421809|FG007|Overall Study|Lack of Efficacy|1|||
163193265|NCT02557295|589421810|FG008|Overall Study|Lack of Efficacy|0|||
163193266|NCT02557295|589421802|FG000|Overall Study|Adverse Event|16|||
163193267|NCT02557295|589421803|FG001|Overall Study|Adverse Event|2|||
163193268|NCT02557295|589421804|FG002|Overall Study|Adverse Event|3|||
163193269|NCT02557295|589421805|FG003|Overall Study|Adverse Event|0|||
163193270|NCT02557295|589421806|FG004|Overall Study|Adverse Event|0|||
163193271|NCT02557295|589421807|FG005|Overall Study|Adverse Event|0|||
163193272|NCT02557295|589421808|FG006|Overall Study|Adverse Event|2|||
163193273|NCT02557295|589421809|FG007|Overall Study|Adverse Event|1|||
163193274|NCT02557295|589421810|FG008|Overall Study|Adverse Event|1|||
163318905|NCT04433208|589878802|FG005|Overall Study|Lost to Follow-up|1|||
162953659|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
163193275|NCT02557295|589421802|FG000|Overall Study|Lost to Follow-up|4|||
163193276|NCT02557295|589421803|FG001|Overall Study|Lost to Follow-up|0|||
163193277|NCT02557295|589421804|FG002|Overall Study|Lost to Follow-up|0|||
163193278|NCT02557295|589421805|FG003|Overall Study|Lost to Follow-up|0|||
163193279|NCT02557295|589421806|FG004|Overall Study|Lost to Follow-up|0|||
162953660|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
162953661|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
162953662|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
162953663|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
162953664|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
162953665|NCT00336479|588534933|FG000|Overall Study|Adverse Event|8|||
162953666|NCT00336479|588534934|FG001|Overall Study|Adverse Event|11|||
162953667|NCT00336479|588534935|FG002|Overall Study|Adverse Event|18|||
162953668|NCT00336479|588534936|FG003|Overall Study|Adverse Event|4|||
162953669|NCT00336479|588534933|FG000|Overall Study|Noncompliant|1|||
162953670|NCT00336479|588534934|FG001|Overall Study|Noncompliant|7|||
162953671|NCT00336479|588534935|FG002|Overall Study|Noncompliant|3|||
162953672|NCT00336479|588534936|FG003|Overall Study|Noncompliant|0|||
162953673|NCT00336479|588534933|FG000|Overall Study|Physician Decision|2|||
162953674|NCT00336479|588534934|FG001|Overall Study|Physician Decision|3|||
162953675|NCT00336479|588534935|FG002|Overall Study|Physician Decision|1|||
162953676|NCT00336479|588534936|FG003|Overall Study|Physician Decision|0|||
162953677|NCT00336479|588534933|FG000|Overall Study|Lost to Follow-up|3|||
162953678|NCT00336479|588534934|FG001|Overall Study|Lost to Follow-up|2|||
162953679|NCT00336479|588534935|FG002|Overall Study|Lost to Follow-up|0|||
162953680|NCT00336479|588534936|FG003|Overall Study|Lost to Follow-up|0|||
162953681|NCT00336479|588534933|FG000|Overall Study|Withdrawal by Subject|3|||
162953682|NCT00336479|588534934|FG001|Overall Study|Withdrawal by Subject|2|||
162953683|NCT00336479|588534935|FG002|Overall Study|Withdrawal by Subject|3|||
162953684|NCT00336479|588534936|FG003|Overall Study|Withdrawal by Subject|0|||
162953685|NCT00336479|588534933|FG000|Overall Study|Other|0|||
162953686|NCT00336479|588534934|FG001|Overall Study|Other|0|||
162953687|NCT00336479|588534935|FG002|Overall Study|Other|1|||
162953688|NCT00336479|588534936|FG003|Overall Study|Other|0|||
162953689|NCT00336479|588534933|FG000|Overall Study|Virologic Stopping Rule|20|||
162953690|NCT00336479|588534934|FG001|Overall Study|Virologic Stopping Rule|0|||
162953691|NCT00336479|588534935|FG002|Overall Study|Virologic Stopping Rule|0|||
162953692|NCT00336479|588534936|FG003|Overall Study|Virologic Stopping Rule|0|||
162953693|NCT00846495|588534937|FG000|Overall Study|Lost to Follow-up|1|||
162953694|NCT00846495|588534938|FG001|Overall Study|Lost to Follow-up|0|||
162953695|NCT00846495|588534937|FG000|Overall Study|Adverse Event|5|||
162953696|NCT00846495|588534938|FG001|Overall Study|Adverse Event|1|||
162953697|NCT00846495|588534937|FG000|Overall Study|Lack of Efficacy|1|||
162953698|NCT00846495|588534938|FG001|Overall Study|Lack of Efficacy|2|||
162953699|NCT00846495|588534937|FG000|Overall Study|Physician Decision|1|||
162953700|NCT00846495|588534938|FG001|Overall Study|Physician Decision|0|||
162953701|NCT01265056|588534939|FG000|Initial Study Period|Withdrawal by Subject|1|||
162953702|NCT01265056|588534940|FG001|Initial Study Period|Withdrawal by Subject|1|||
162953703|NCT01265056|588534939|FG000|Initial Study Period|Withdrawal by Subject|1|||
162953704|NCT01265056|588534940|FG001|Initial Study Period|Withdrawal by Subject|1|||
162953705|NCT01265056|588534939|FG000|Follow up|Lost to Follow-up|7|||
162953706|NCT01265056|588534940|FG001|Follow up|Lost to Follow-up|3|||
162953707|NCT02711852|588534945|FG000|Overall Study|Death|5|||
162953708|NCT02711852|588534945|FG000|Overall Study|Lost to Follow-up|1|||
162953709|NCT02711852|588534945|FG000|Overall Study|Completed follow-up|3|||
163043257|NCT00320788|588865773|FG002|Overall Study|Lost to Follow-up|1|||
162924266|NCT02575807|588423847|FG001|Overall Study|Terminated due to physician decision|0|||
162924267|NCT02575807|588423848|FG002|Overall Study|Terminated due to physician decision|1|||
163392941|NCT04178967|590150340|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162924268|NCT02575807|588423849|FG003|Overall Study|Terminated due to physician decision|0|||
162953710|NCT02711852|588534945|FG000|Overall Study|Withdrawal by Subject|1|||
162953711|NCT01417078|588534949|FG000|Overall Study|Withdrawal by Subject|1|||
162953712|NCT02612337|588534952|FG000|Overall Study|Lack of Efficacy|1|||
162953713|NCT02612337|588534953|FG001|Overall Study|Lack of Efficacy|0|||
162953714|NCT02612337|588534952|FG000|Overall Study|Withdrawal by Subject|2|||
162953715|NCT02612337|588534953|FG001|Overall Study|Withdrawal by Subject|2|||
162953716|NCT02612337|588534952|FG000|Overall Study|Did not receive study drug|0|||
162953717|NCT02612337|588534953|FG001|Overall Study|Did not receive study drug|1|||
162953718|NCT01697696|588534954|FG000|Overall Study|Study terminated by sponsor|0|||
162953719|NCT01697696|588534955|FG001|Overall Study|Study terminated by sponsor|3|||
162953720|NCT01697696|588534954|FG000|Overall Study|Protocol deviation|1|||
162953721|NCT01697696|588534955|FG001|Overall Study|Protocol deviation|0|||
162953722|NCT01697696|588534954|FG000|Overall Study|Physician Decision|1|||
162953723|NCT01697696|588534955|FG001|Overall Study|Physician Decision|0|||
162953724|NCT01697696|588534954|FG000|Overall Study|Death|4|||
162953725|NCT01697696|588534955|FG001|Overall Study|Death|2|||
162953726|NCT01697696|588534954|FG000|Overall Study|Lost to Follow-up|10|||
162953727|NCT01697696|588534955|FG001|Overall Study|Lost to Follow-up|7|||
162953728|NCT01697696|588534954|FG000|Overall Study|Subject/guardian decision|31|||
163193280|NCT02557295|589421807|FG005|Overall Study|Lost to Follow-up|0|||
163193281|NCT02557295|589421808|FG006|Overall Study|Lost to Follow-up|9|||
163193282|NCT02557295|589421809|FG007|Overall Study|Lost to Follow-up|0|||
163193283|NCT02557295|589421810|FG008|Overall Study|Lost to Follow-up|0|||
163193284|NCT02557295|589421802|FG000|Overall Study|Study Close|54|||
163193285|NCT02557295|589421803|FG001|Overall Study|Study Close|3|||
162953729|NCT01697696|588534955|FG001|Overall Study|Subject/guardian decision|35|||
162953730|NCT03616106|588534956|FG000|Overall Study|Removed by PI|6|||
162953731|NCT03616106|588534957|FG001|Overall Study|Removed by PI|0|||
162953732|NCT03616106|588534956|FG000|Overall Study|Withdrawal by Subject|1|||
162953733|NCT03616106|588534957|FG001|Overall Study|Withdrawal by Subject|1|||
162953734|NCT03616106|588534956|FG000|Overall Study|Lost to Follow-up|7|||
162953735|NCT03616106|588534957|FG001|Overall Study|Lost to Follow-up|0|||
162953736|NCT01880593|588534958|FG000|Overall Study|Adverse Event|1|||
163193286|NCT02557295|589421804|FG002|Overall Study|Study Close|5|||
163193287|NCT02557295|589421805|FG003|Overall Study|Study Close|3|||
163193288|NCT02557295|589421806|FG004|Overall Study|Study Close|0|||
163193289|NCT02557295|589421807|FG005|Overall Study|Study Close|0|||
163193290|NCT02557295|589421808|FG006|Overall Study|Study Close|37|||
163193291|NCT02557295|589421809|FG007|Overall Study|Study Close|3|||
163193292|NCT02557295|589421810|FG008|Overall Study|Study Close|19|||
163193293|NCT02557295|589421802|FG000|Overall Study|except for study close|4|||
163193294|NCT02557295|589421803|FG001|Overall Study|except for study close|0|||
163193295|NCT02557295|589421804|FG002|Overall Study|except for study close|0|||
163193296|NCT02557295|589421805|FG003|Overall Study|except for study close|0|||
163193297|NCT02557295|589421806|FG004|Overall Study|except for study close|0|||
163193298|NCT02557295|589421807|FG005|Overall Study|except for study close|0|||
163193299|NCT02557295|589421808|FG006|Overall Study|except for study close|5|||
163193300|NCT02557295|589421809|FG007|Overall Study|except for study close|1|||
163193301|NCT02557295|589421810|FG008|Overall Study|except for study close|0|||
163193302|NCT01066000|589421811|FG000|Overall Study|Protocol Violation|4|||
163193303|NCT01066000|589421811|FG000|Overall Study|Death|3|||
163193304|NCT01066000|589421811|FG000|Overall Study|Withdrawal by Subject|1|||
163193305|NCT01066000|589421811|FG000|Overall Study|Adverse Event|1|||
163193306|NCT01386008|589421812|FG000|Overall Study|exited w/o incident /study discontinued|17|||
163193307|NCT01386008|589421812|FG000|Overall Study|Adverse Event|3|||
163299193|NCT02988817|589805120|FG015|Overall Study|Withdrawal by Subject|5|||
163299194|NCT02988817|589805121|FG016|Overall Study|Withdrawal by Subject|4|||
163299195|NCT02988817|589805122|FG017|Overall Study|Withdrawal by Subject|11|||
163193308|NCT01067976|589421813|FG000|Overall Study|Study drug never administered|20|||
163193309|NCT01067976|589421813|FG000|Overall Study|Study prematurely discontinued|2|||
163193310|NCT04449861|589421814|FG000|Overall Study|Withdrawal by Subject|4|||
163193311|NCT04449861|589421814|FG000|Overall Study|Lost to Follow-up|5|||
163193312|NCT04449861|589421814|FG000|Overall Study|Death|112|||
162953737|NCT01880593|588534959|FG001|Overall Study|Adverse Event|0|||
162953738|NCT01880593|588534958|FG000|Overall Study|Lack of Efficacy|1|||
162953739|NCT01880593|588534959|FG001|Overall Study|Lack of Efficacy|5|||
162953740|NCT01880593|588534958|FG000|Overall Study|Withdrawal by Subject|6|||
162953741|NCT01880593|588534959|FG001|Overall Study|Withdrawal by Subject|1|||
162953742|NCT05275205|588534964|FG000|Overall Study|Adverse Event|1|||
162953743|NCT05275205|588534965|FG001|Overall Study|Adverse Event|2|||
163043258|NCT00320788|588865774|FG003|Overall Study|Lost to Follow-up|0|||
162953744|NCT05275205|588534964|FG000|Overall Study|Physician Decision|1|||
162953745|NCT05275205|588534965|FG001|Overall Study|Physician Decision|1|||
162953746|NCT05275205|588534964|FG000|Overall Study|Withdrawal by Subject|2|||
163392942|NCT04178967|590150341|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163392943|NCT04178967|590150342|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162953747|NCT05275205|588534965|FG001|Overall Study|Withdrawal by Subject|3|||
163392944|NCT04178967|590150343|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163392945|NCT04178967|590150344|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163392946|NCT04178967|590150345|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163392947|NCT04178967|590150346|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163392948|NCT04178967|590150347|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163392949|NCT04178967|590150348|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
163392950|NCT04178967|590150349|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163392951|NCT04178967|590150339|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163193313|NCT00976677|589421815|FG000|Overall Study|Adverse Event|1|||
163193314|NCT00976677|589421816|FG001|Overall Study|Adverse Event|0|||
163193315|NCT00976677|589421815|FG000|Overall Study|Withdrawal by Subject|0|||
163193316|NCT00976677|589421816|FG001|Overall Study|Withdrawal by Subject|2|||
163193317|NCT00976677|589421815|FG000|Overall Study|Disease progression|1|||
163193318|NCT00976677|589421816|FG001|Overall Study|Disease progression|1|||
163193319|NCT00976677|589421815|FG000|Overall Study|Trial unblinded|2|||
163193320|NCT00976677|589421816|FG001|Overall Study|Trial unblinded|2|||
163193321|NCT00976677|589421815|FG000|Overall Study|Unknown/Missing|1|||
163193322|NCT00976677|589421816|FG001|Overall Study|Unknown/Missing|0|||
163193323|NCT03487549|589421821|FG000|Overall Study|Protocol Violation|0|||
163193324|NCT03487549|589421822|FG001|Overall Study|Protocol Violation|1|||
163193325|NCT03487549|589421821|FG000|Overall Study|Lost to Follow-up|2|||
162953748|NCT05275205|588534964|FG000|Overall Study|Death|1|||
163193326|NCT03487549|589421822|FG001|Overall Study|Lost to Follow-up|1|||
163193327|NCT03487549|589421821|FG000|Overall Study|Withdrawal by Subject|2|||
163392952|NCT04178967|590150340|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163392953|NCT04178967|590150341|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163392954|NCT04178967|590150342|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163392955|NCT04178967|590150343|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163392956|NCT04178967|590150344|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163392957|NCT04178967|590150345|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163392958|NCT04178967|590150346|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163392959|NCT04178967|590150347|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
163392960|NCT04178967|590150348|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
162953749|NCT05275205|588534965|FG001|Overall Study|Death|0|||
162953750|NCT05275205|588534964|FG000|Overall Study|Patient unable to attend visits|1|||
162953751|NCT05275205|588534965|FG001|Overall Study|Patient unable to attend visits|0|||
162953752|NCT03243630|588534967|FG000|Overall Study|Protocol Violation|1|||
162953753|NCT03243630|588534967|FG000|Overall Study|Physician Decision|1|||
162953754|NCT00939003|588534969|FG000|Double-blind Treatment Period|Adverse Event|1|||
162953755|NCT00939003|588534970|FG001|Double-blind Treatment Period|Adverse Event|1|||
162953756|NCT00939003|588534969|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
162953757|NCT00939003|588534970|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
162953758|NCT00939003|588534969|FG000|Double-blind Treatment Period|Pregnancy|0|||
162953759|NCT00939003|588534970|FG001|Double-blind Treatment Period|Pregnancy|1|||
162953760|NCT00939003|588534969|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
162953761|NCT00939003|588534970|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
162953762|NCT00939003|588534969|FG000|Open-label Treatment Period|Adverse Event|4|||
162953763|NCT00939003|588534970|FG001|Open-label Treatment Period|Adverse Event|8|||
162953764|NCT00939003|588534969|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
162953765|NCT00939003|588534970|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
162953766|NCT00939003|588534969|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
162953767|NCT00939003|588534970|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
162953768|NCT00939003|588534969|FG000|Open-label Treatment Period|Pregnancy|1|||
162953769|NCT00939003|588534970|FG001|Open-label Treatment Period|Pregnancy|1|||
162953770|NCT00939003|588534969|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
163193328|NCT03487549|589421822|FG001|Overall Study|Withdrawal by Subject|0|||
162953771|NCT00939003|588534970|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
162953772|NCT00939003|588534969|FG000|Open-label Treatment Period|Site Closure|3|||
162953773|NCT00939003|588534970|FG001|Open-label Treatment Period|Site Closure|4|||
163193329|NCT01313858|589423142|FG000|Overall Study|Premature Treatment Termination|251|||
163193330|NCT01313858|589423143|FG001|Overall Study|Premature Treatment Termination|219|||
163193331|NCT01313858|589423144|FG002|Overall Study|Premature Treatment Termination|191|||
163043259|NCT00320788|588865775|FG004|Overall Study|Lost to Follow-up|0|||
162953774|NCT03707912|588534972|FG000|Overall Study|Violation of inclusion criteria|1|||
162953775|NCT03707912|588534973|FG001|Overall Study|Violation of inclusion criteria|0|||
162953776|NCT01313780|588534982|FG000|Overall Study|Lack of Efficacy|4|||
162953777|NCT01313780|588534983|FG001|Overall Study|Lack of Efficacy|2|||
162953778|NCT01313780|588534982|FG000|Overall Study|Adverse Event|6|||
162953779|NCT01313780|588534983|FG001|Overall Study|Adverse Event|11|||
162953780|NCT01313780|588534982|FG000|Overall Study|Withdrawal by Subject|2|||
162953781|NCT01313780|588534983|FG001|Overall Study|Withdrawal by Subject|8|||
162953782|NCT01313780|588534982|FG000|Overall Study|Protocol Violation|10|||
162953783|NCT01313780|588534983|FG001|Overall Study|Protocol Violation|4|||
162953784|NCT01313780|588534982|FG000|Overall Study|missing data|3|||
162953785|NCT01313780|588534983|FG001|Overall Study|missing data|3|||
162953786|NCT03235739|588536159|FG000|Overall Study|Withdrawal by Subject|2|||
162953787|NCT03235739|588536160|FG001|Overall Study|Withdrawal by Subject|2|||
162953788|NCT03235739|588536159|FG000|Overall Study|Physician Decision|0|||
162953789|NCT03235739|588536160|FG001|Overall Study|Physician Decision|1|||
163193332|NCT01313858|589423142|FG000|Overall Study|Lost to Follow-up|35|||
163193333|NCT01313858|589423143|FG001|Overall Study|Lost to Follow-up|51|||
163193334|NCT01313858|589423144|FG002|Overall Study|Lost to Follow-up|47|||
163193335|NCT03689530|589423148|FG000|Overall Study|Withdrawal by Subject|53|||
163193336|NCT03689530|589423149|FG001|Overall Study|Withdrawal by Subject|16|||
163193337|NCT01392443|589423150|FG000|Overall Study|Disease progression|30|||
163193338|NCT01392443|589423150|FG000|Overall Study|Adverse Event|24|||
163193339|NCT01392443|589423150|FG000|Overall Study|Death|7|||
163193340|NCT01392443|589423150|FG000|Overall Study|Withdrawal by Subject|5|||
163193341|NCT01392443|589423150|FG000|Overall Study|Lost to Follow-up|1|||
163193342|NCT01392443|589423150|FG000|Overall Study|Protocol Violation|1|||
162953790|NCT02847650|588536161|FG000|Overall Study|Adverse Event|2|||
162953791|NCT02847650|588536162|FG001|Overall Study|Adverse Event|4|||
163193343|NCT01977794|589423151|FG000|Overall Study|Adverse Event|2|||
163193344|NCT01977794|589423152|FG001|Overall Study|Adverse Event|2|||
163193345|NCT01977794|589423151|FG000|Overall Study|Lost to Follow-up|2|||
163193346|NCT01977794|589423152|FG001|Overall Study|Lost to Follow-up|1|||
162953792|NCT02847650|588536161|FG000|Overall Study|Lost to Follow-up|1|||
162953793|NCT02847650|588536162|FG001|Overall Study|Lost to Follow-up|0|||
162953794|NCT02847650|588536161|FG000|Overall Study|Protocol Violation|0|||
163193347|NCT01977794|589423151|FG000|Overall Study|Protocol Violation|1|||
163193348|NCT01977794|589423152|FG001|Overall Study|Protocol Violation|0|||
162953795|NCT02847650|588536162|FG001|Overall Study|Protocol Violation|1|||
162953796|NCT02847650|588536161|FG000|Overall Study|Withdrawal by Subject|1|||
162953797|NCT02847650|588536162|FG001|Overall Study|Withdrawal by Subject|1|||
162953798|NCT00467896|588536163|FG000|Overall Study|Consent Withdrawal|18|||
162953799|NCT00467896|588536163|FG000|Overall Study|Adverse Event|7|||
162953800|NCT00467896|588536163|FG000|Overall Study|Serious Adverse Event|13|||
162953801|NCT00467896|588536163|FG000|Overall Study|Non-compliance|3|||
162953802|NCT00467896|588536163|FG000|Overall Study|Changed therapy|2|||
163193349|NCT01977794|589423151|FG000|Overall Study|Death|1|||
163193350|NCT01977794|589423152|FG001|Overall Study|Death|1|||
162953803|NCT00467896|588536163|FG000|Overall Study|Patient received transplant|2|||
162953804|NCT00467896|588536163|FG000|Overall Study|Patient had atrial septostomy|1|||
163193351|NCT01977794|589423151|FG000|Overall Study|Withdrew consent|2|||
162953805|NCT00467896|588536163|FG000|Overall Study|Patient weaned off iloprost|1|||
162953806|NCT00467896|588536163|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
162953807|NCT00467896|588536163|FG000|Overall Study|Started intravenous prostacyclin|1|||
162953808|NCT00467896|588536163|FG000|Overall Study|Started inhaled Remodulin|1|||
162953809|NCT00467896|588536163|FG000|Overall Study|Patient had no improvement|1|||
162953810|NCT03818581|588536166|FG000|Overall Study|Adverse Event|1|||
162953811|NCT03818581|588536167|FG001|Overall Study|Adverse Event|0|||
162953812|NCT03818581|588536168|FG002|Overall Study|Adverse Event|0|||
163043260|NCT00320788|588865771|FG000|Overall Study|Decision by the Sponsor|1|||
163193352|NCT01977794|589423152|FG001|Overall Study|Withdrew consent|1|||
162953813|NCT03818581|588536169|FG003|Overall Study|Adverse Event|0|||
162953814|NCT03818581|588536170|FG004|Overall Study|Adverse Event|0|||
162953815|NCT03818581|588536166|FG000|Overall Study|Covid-19|2|||
162953816|NCT03818581|588536167|FG001|Overall Study|Covid-19|0|||
162953817|NCT03818581|588536168|FG002|Overall Study|Covid-19|0|||
162953818|NCT03818581|588536169|FG003|Overall Study|Covid-19|0|||
162953819|NCT03818581|588536170|FG004|Overall Study|Covid-19|1|||
162953820|NCT03818581|588536166|FG000|Overall Study|Withdrawal by Subject|0|||
162953821|NCT03818581|588536167|FG001|Overall Study|Withdrawal by Subject|0|||
162953822|NCT03818581|588536168|FG002|Overall Study|Withdrawal by Subject|0|||
162953823|NCT03818581|588536169|FG003|Overall Study|Withdrawal by Subject|0|||
162953824|NCT03818581|588536170|FG004|Overall Study|Withdrawal by Subject|1|||
162953825|NCT03818581|588536166|FG000|Overall Study|No longer met study criteria|0|||
162953826|NCT03818581|588536167|FG001|Overall Study|No longer met study criteria|0|||
162953827|NCT03818581|588536168|FG002|Overall Study|No longer met study criteria|0|||
163043261|NCT00320788|588865772|FG001|Overall Study|Decision by the Sponsor|1|||
163193353|NCT01977794|589423151|FG000|Overall Study|Other|0|||
163043262|NCT00320788|588865773|FG002|Overall Study|Decision by the Sponsor|0|||
162953828|NCT03818581|588536169|FG003|Overall Study|No longer met study criteria|0|||
162953829|NCT03818581|588536170|FG004|Overall Study|No longer met study criteria|1|||
162953830|NCT01466166|588536176|FG000|Overall Study|Death|1|||
162953831|NCT01466166|588536176|FG000|Overall Study|Lost to Follow-up|7|||
163193354|NCT01977794|589423152|FG001|Overall Study|Other|1|||
162953832|NCT01466166|588536176|FG000|Overall Study|Infusion Reaction (IR)|27|||
162953833|NCT01466166|588536176|FG000|Overall Study|Adverse Event (Other than IR)|11|||
163193355|NCT00533897|589423155|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
163193356|NCT00533897|589423156|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
162953834|NCT01466166|588536176|FG000|Overall Study|Elevated Serum Uric Acid|78|||
162953835|NCT01466166|588536176|FG000|Overall Study|Withdrawal by Subject|13|||
162953836|NCT01466166|588536176|FG000|Overall Study|Sponsor Decision|4|||
162953837|NCT01466166|588536176|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
162953838|NCT01466166|588536176|FG000|Overall Study|Other|20|||
162953839|NCT02262377|588536177|FG000|Overall Study|Lost to Follow-up|5|||
163392961|NCT04178967|590150349|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
163392962|NCT04178967|590150339|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163392963|NCT04178967|590150340|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
162953840|NCT02262377|588536178|FG001|Overall Study|Lost to Follow-up|6|||
162953841|NCT02262377|588536177|FG000|Overall Study|Found ineligible after enrollment|3|||
162953842|NCT02262377|588536178|FG001|Overall Study|Found ineligible after enrollment|0|||
162953843|NCT02262377|588536177|FG000|Overall Study|Withdrawal by Subject|4|||
162953844|NCT02262377|588536178|FG001|Overall Study|Withdrawal by Subject|0|||
162953845|NCT00371839|588536179|FG000|Overall Study|Death|4|||
162953846|NCT00371839|588536180|FG001|Overall Study|Death|0|||
162953847|NCT00371839|588536181|FG002|Overall Study|Death|0|||
162953848|NCT00371839|588536179|FG000|Overall Study|Withdrawal by Subject|7|||
162953849|NCT00371839|588536180|FG001|Overall Study|Withdrawal by Subject|4|||
162953850|NCT00371839|588536181|FG002|Overall Study|Withdrawal by Subject|0|||
162953851|NCT00371839|588536179|FG000|Overall Study|Lost to Follow-up|6|||
163392964|NCT04178967|590150341|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163392965|NCT04178967|590150342|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
162953852|NCT00371839|588536180|FG001|Overall Study|Lost to Follow-up|3|||
162953853|NCT00371839|588536181|FG002|Overall Study|Lost to Follow-up|2|||
162953854|NCT01511939|588536182|FG000|Overall Study|Withdrawal by Subject|2|||
162953855|NCT01511939|588536183|FG001|Overall Study|Withdrawal by Subject|1|||
162953856|NCT01511939|588536184|FG002|Overall Study|Withdrawal by Subject|0|||
162953857|NCT01591785|588536185|FG000|Overall Study|worsening condition|1|||
162953858|NCT01591785|588536186|FG001|Overall Study|worsening condition|2|||
162953859|NCT01591785|588536185|FG000|Overall Study|Protocol Violation|2|||
163392966|NCT04178967|590150343|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163392967|NCT04178967|590150344|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163392968|NCT04178967|590150345|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163392969|NCT04178967|590150346|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163392970|NCT04178967|590150347|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163392971|NCT04178967|590150348|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
163392972|NCT04178967|590150349|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163392973|NCT04178967|590150339|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163392974|NCT04178967|590150340|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163392975|NCT04178967|590150341|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163392976|NCT04178967|590150342|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163392977|NCT04178967|590150343|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163392978|NCT04178967|590150344|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163392979|NCT04178967|590150345|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163392980|NCT04178967|590150346|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163392981|NCT04178967|590150347|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163392982|NCT04178967|590150348|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
163392983|NCT04178967|590150349|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163392984|NCT01975428|590150353|FG000|Overall Study|Lost to Follow-up|17|||
163392985|NCT01975428|590150354|FG001|Overall Study|Lost to Follow-up|4|||
163392986|NCT01975428|590150353|FG000|Overall Study|Withdrawal by Subject|3|||
163392987|NCT01975428|590150354|FG001|Overall Study|Withdrawal by Subject|10|||
163392988|NCT02187809|590150355|FG000|Overall Study|The study was terminated|3|||
163392989|NCT00628251|590150356|FG000|Randomised Part|Withdrawal by Subject|0|||
163392990|NCT00628251|590150357|FG001|Randomised Part|Withdrawal by Subject|0|||
163392991|NCT00628251|590150358|FG002|Randomised Part|Withdrawal by Subject|1|||
163392992|NCT00628251|590150356|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
163392993|NCT00628251|590150357|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
163392994|NCT00628251|590150358|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
163392995|NCT00628251|590150356|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
163392996|NCT00628251|590150357|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
163392997|NCT00628251|590150358|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
163392998|NCT00628251|590150356|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
163392999|NCT00628251|590150357|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
163393000|NCT00628251|590150358|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
163393001|NCT00628251|590150356|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
163393002|NCT00628251|590150357|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
163393003|NCT00628251|590150358|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
163393004|NCT00628251|590150356|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
163393005|NCT00628251|590150357|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
163393006|NCT00628251|590150358|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
163393007|NCT04513665|590150360|FG000|Overall Study|Adverse Event|2|||
163393008|NCT04513665|590150361|FG001|Overall Study|Adverse Event|0|||
163393009|NCT04513665|590150360|FG000|Overall Study|Lack of Efficacy|14|||
163393010|NCT04513665|590150361|FG001|Overall Study|Lack of Efficacy|0|||
163393011|NCT02608879|590150363|FG000|Overall Study|Lost to Follow-up|1|||
163393012|NCT02608879|590150364|FG001|Overall Study|Lost to Follow-up|0|||
163393013|NCT02608879|590150365|FG002|Overall Study|Lost to Follow-up|0|||
163393014|NCT02608879|590150363|FG000|Overall Study|Did not meet continuation criteria|0|||
163393015|NCT02608879|590150364|FG001|Overall Study|Did not meet continuation criteria|0|||
163393016|NCT02608879|590150365|FG002|Overall Study|Did not meet continuation criteria|3|||
163393017|NCT00544648|590150366|FG000|Overall Study|Withdrawal by Subject|1|||
163393018|NCT00544648|590150367|FG001|Overall Study|Withdrawal by Subject|0|||
163393019|NCT00544648|590150366|FG000|Overall Study|Adverse Event|1|||
163393020|NCT00544648|590150367|FG001|Overall Study|Adverse Event|1|||
163393021|NCT00544648|590150366|FG000|Overall Study|progression of disease|1|||
163393022|NCT00544648|590150367|FG001|Overall Study|progression of disease|0|||
163393023|NCT01351623|590150368|FG000|Overall Study|Protocol Violation|2|||
163393024|NCT01351623|590150368|FG000|Overall Study|Adverse Event|4|||
163393025|NCT01351623|590150368|FG000|Overall Study|Withdrawal by Subject|1|||
163393026|NCT01351623|590150368|FG000|Overall Study|Death|2|||
163393027|NCT02536755|590150369|FG000|Overall Study|Adverse Event|4|||
162953860|NCT01591785|588536186|FG001|Overall Study|Protocol Violation|0|||
162953861|NCT01591785|588536185|FG000|Overall Study|Lost to Follow-up|1|||
162953862|NCT01591785|588536186|FG001|Overall Study|Lost to Follow-up|0|||
162953863|NCT01049334|588536187|FG000|Overall Study|Withdrawal by Subject|5|||
162953864|NCT01049334|588536188|FG001|Overall Study|Withdrawal by Subject|3|||
162953865|NCT01049334|588536187|FG000|Overall Study|Adverse Event|2|||
162953866|NCT01049334|588536188|FG001|Overall Study|Adverse Event|3|||
162953867|NCT01049334|588536187|FG000|Overall Study|Physician Decision|2|||
162953868|NCT01049334|588536188|FG001|Overall Study|Physician Decision|0|||
162953869|NCT01049334|588536187|FG000|Overall Study|Protocol Violation|0|||
162953870|NCT01049334|588536188|FG001|Overall Study|Protocol Violation|1|||
162953871|NCT02476994|588536195|FG000|Overall Study|Based on feedback from FDA|1|||
162953872|NCT02476994|588536196|FG001|Overall Study|Based on feedback from FDA|0|||
163393028|NCT06132425|590150370|FG000|Overall Study|Withdrawal by Subject|3|||
163393029|NCT06132425|590150371|FG001|Overall Study|Withdrawal by Subject|0|||
163393030|NCT06132425|590150370|FG000|Overall Study|Did not follow study instructions|0|||
163393031|NCT06132425|590150371|FG001|Overall Study|Did not follow study instructions|2|||
163393032|NCT06132425|590150370|FG000|Overall Study|Lost to Follow-up|3|||
163393033|NCT06132425|590150371|FG001|Overall Study|Lost to Follow-up|5|||
163393034|NCT04448756|590150372|FG000|Overall Study|Adverse Event|0|||
163393035|NCT04448756|590150373|FG001|Overall Study|Adverse Event|1|||
163393036|NCT04448756|590150374|FG002|Overall Study|Adverse Event|0|||
163393037|NCT04448756|590150372|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
163393038|NCT04448756|590150373|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
163393039|NCT04448756|590150374|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
163393040|NCT04448756|590150372|FG000|Overall Study|Withdrawal by Subject|0|||
163393041|NCT04448756|590150373|FG001|Overall Study|Withdrawal by Subject|3|||
163393042|NCT04448756|590150374|FG002|Overall Study|Withdrawal by Subject|1|||
163393043|NCT04448756|590150372|FG000|Overall Study|Death|2|||
163393044|NCT04448756|590150373|FG001|Overall Study|Death|1|||
163393045|NCT04448756|590150374|FG002|Overall Study|Death|0|||
163393046|NCT02733185|590150375|FG000|Overall Study|Withdrawal by Subject|12|||
163393047|NCT02733185|590150376|FG001|Overall Study|Withdrawal by Subject|10|||
163393048|NCT02733185|590150377|FG002|Overall Study|Withdrawal by Subject|17|||
163393049|NCT02733185|590150378|FG003|Overall Study|Withdrawal by Subject|21|||
162953873|NCT02246166|588536197|FG000|Overall Study|Protocol Violation|1|||
162953874|NCT02246166|588536198|FG001|Overall Study|Protocol Violation|0|||
162953875|NCT02563561|588536199|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
163393050|NCT02733185|590150375|FG000|Overall Study|Death|46|||
163393051|NCT02733185|590150376|FG001|Overall Study|Death|34|||
163393052|NCT02733185|590150377|FG002|Overall Study|Death|35|||
163393053|NCT02733185|590150378|FG003|Overall Study|Death|43|||
163393054|NCT02733185|590150375|FG000|Overall Study|Lost to Follow-up|17|||
163393055|NCT02733185|590150376|FG001|Overall Study|Lost to Follow-up|18|||
163393056|NCT02733185|590150377|FG002|Overall Study|Lost to Follow-up|16|||
163393057|NCT02733185|590150378|FG003|Overall Study|Lost to Follow-up|11|||
163393058|NCT00708175|590150381|FG000|Overall Study|Adverse Event|4|||
163393059|NCT00708175|590150382|FG001|Overall Study|Adverse Event|5|||
163393060|NCT00708175|590150381|FG000|Overall Study|Protocol Violation|2|||
163393061|NCT00708175|590150382|FG001|Overall Study|Protocol Violation|3|||
163393062|NCT00708175|590150381|FG000|Overall Study|Lost to Follow-up|5|||
163393063|NCT00708175|590150382|FG001|Overall Study|Lost to Follow-up|3|||
163393064|NCT00708175|590150381|FG000|Overall Study|Withdrawal by Subject|5|||
163393065|NCT00708175|590150382|FG001|Overall Study|Withdrawal by Subject|7|||
163393066|NCT00708175|590150381|FG000|Overall Study|BMD loss >7%|2|||
163393067|NCT00708175|590150382|FG001|Overall Study|BMD loss >7%|3|||
163393068|NCT01093326|590150384|FG000|Overall Study|Death|0|||
163393069|NCT01093326|590150385|FG001|Overall Study|Death|1|||
163393070|NCT01093326|590150386|FG002|Overall Study|Death|0|||
163393071|NCT01093326|590150384|FG000|Overall Study|Lack of Efficacy|7|||
163393072|NCT01093326|590150385|FG001|Overall Study|Lack of Efficacy|6|||
163393073|NCT01093326|590150386|FG002|Overall Study|Lack of Efficacy|3|||
163393074|NCT01093326|590150384|FG000|Overall Study|Lost to Follow-up|2|||
163393075|NCT01093326|590150385|FG001|Overall Study|Lost to Follow-up|5|||
163393076|NCT01093326|590150386|FG002|Overall Study|Lost to Follow-up|4|||
163393077|NCT01093326|590150384|FG000|Overall Study|Physician Decision|3|||
163393078|NCT01093326|590150385|FG001|Overall Study|Physician Decision|1|||
163393079|NCT01093326|590150386|FG002|Overall Study|Physician Decision|3|||
163393080|NCT01093326|590150384|FG000|Overall Study|Withdrawal by Subject|30|||
163393081|NCT01093326|590150385|FG001|Overall Study|Withdrawal by Subject|27|||
163393082|NCT01093326|590150386|FG002|Overall Study|Withdrawal by Subject|26|||
163393083|NCT01093326|590150384|FG000|Overall Study|Adverse Event|2|||
163393084|NCT01093326|590150385|FG001|Overall Study|Adverse Event|1|||
163393085|NCT01093326|590150386|FG002|Overall Study|Adverse Event|4|||
163393086|NCT01093326|590150384|FG000|Overall Study|Other|0|||
163393087|NCT01093326|590150385|FG001|Overall Study|Other|0|||
163393088|NCT01093326|590150386|FG002|Overall Study|Other|1|||
163393089|NCT04435782|590150387|FG000|Overall Study|Study terminated by sponsor|4|||
163393090|NCT03672461|590150388|FG000|Overall Study|COVID Related|4|||
162953876|NCT02563561|588536200|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
163393091|NCT03672461|590150389|FG001|Overall Study|COVID Related|2|||
163393092|NCT03672461|590150388|FG000|Overall Study|Adverse Event|2|||
163393093|NCT03672461|590150389|FG001|Overall Study|Adverse Event|0|||
163393094|NCT03672461|590150388|FG000|Overall Study|Serious Adverse Event|0|||
163393095|NCT03672461|590150389|FG001|Overall Study|Serious Adverse Event|1|||
163393096|NCT03672461|590150388|FG000|Overall Study|Too Busy|3|||
163393097|NCT03672461|590150389|FG001|Overall Study|Too Busy|1|||
163393098|NCT03672461|590150388|FG000|Overall Study|Lost to Follow-up|1|||
163393099|NCT03672461|590150389|FG001|Overall Study|Lost to Follow-up|2|||
163393100|NCT03672461|590150388|FG000|Overall Study|Family|2|||
163393101|NCT03672461|590150389|FG001|Overall Study|Family|2|||
163393102|NCT03672461|590150388|FG000|Overall Study|No remote technology access|0|||
163393103|NCT03672461|590150389|FG001|Overall Study|No remote technology access|1|||
163393104|NCT03672461|590150388|FG000|Overall Study|Withdrawal by Subject|1|||
162953877|NCT02563561|588536201|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
163393105|NCT03672461|590150389|FG001|Overall Study|Withdrawal by Subject|0|||
163393106|NCT03672461|590150388|FG000|Overall Study|Cannot tolerate intervention|1|||
163393107|NCT03672461|590150389|FG001|Overall Study|Cannot tolerate intervention|0|||
163393108|NCT03672461|590150388|FG000|Overall Study|Incomplete outcome data|6|||
163393109|NCT03672461|590150389|FG001|Overall Study|Incomplete outcome data|1|||
163393110|NCT04225806|590150390|FG000|Overall Study|Trial termination|15|||
163393111|NCT04667247|590150393|FG000|Overall Study|Withdrawal by Subject|0|||
163393112|NCT04667247|590150394|FG001|Overall Study|Withdrawal by Subject|1|||
163393113|NCT05460273|590150395|FG000|Overall Study|Death|43|||
163393114|NCT05460273|590150396|FG001|Overall Study|Death|9|||
163393115|NCT05460273|590150395|FG000|Overall Study|Lost to Follow-up|7|||
163393116|NCT05460273|590150396|FG001|Overall Study|Lost to Follow-up|0|||
163393117|NCT05460273|590150395|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
163393118|NCT05460273|590150396|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
163393119|NCT04124614|590150397|FG000|Placebo Run-in Period|Not Randomized|34|||
163393120|NCT04124614|590150398|FG001|Placebo Run-in Period|Not Randomized|0|||
163393121|NCT04124614|590150399|FG002|Placebo Run-in Period|Not Randomized|0|||
163393122|NCT04124614|590150397|FG000|Double Blind Treatment Period|Adverse Event|0|||
162953878|NCT02563561|588536199|FG000|Overall Study|Withdrew of Consent|1|||
162953879|NCT02563561|588536200|FG001|Overall Study|Withdrew of Consent|1|||
163393123|NCT04124614|590150398|FG001|Double Blind Treatment Period|Adverse Event|7|||
163393124|NCT04124614|590150399|FG002|Double Blind Treatment Period|Adverse Event|22|||
163393125|NCT04124614|590150397|FG000|Double Blind Treatment Period|Death|0|||
162953880|NCT02563561|588536201|FG002|Overall Study|Withdrew of Consent|2|||
162953881|NCT02563561|588536199|FG000|Overall Study|Lost to Follow-up|1|||
162953882|NCT02563561|588536200|FG001|Overall Study|Lost to Follow-up|1|||
162953883|NCT02563561|588536201|FG002|Overall Study|Lost to Follow-up|0|||
162953884|NCT02563561|588536199|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
162953885|NCT02563561|588536200|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
162953886|NCT02563561|588536201|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
162953887|NCT02563561|588536199|FG000|Overall Study|Investigator Decision|3|||
162953888|NCT02563561|588536200|FG001|Overall Study|Investigator Decision|4|||
162953889|NCT02563561|588536201|FG002|Overall Study|Investigator Decision|2|||
162953890|NCT02563561|588536199|FG000|Overall Study|Sponsor Decision|5|||
162953891|NCT02563561|588536200|FG001|Overall Study|Sponsor Decision|2|||
162953892|NCT02563561|588536201|FG002|Overall Study|Sponsor Decision|4|||
162953893|NCT02563561|588536199|FG000|Overall Study|Other|1|||
163393126|NCT04124614|590150398|FG001|Double Blind Treatment Period|Death|0|||
163393127|NCT04124614|590150399|FG002|Double Blind Treatment Period|Death|1|||
163393128|NCT04124614|590150397|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
162953894|NCT02563561|588536200|FG001|Overall Study|Other|5|||
162953895|NCT02563561|588536201|FG002|Overall Study|Other|2|||
162953896|NCT03769896|588536202|FG000|Open-label Phase|Lack of Efficacy|5|||
162953897|NCT03769896|588536203|FG001|Open-label Phase|Lack of Efficacy|0|||
163393129|NCT04124614|590150398|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
163393130|NCT04124614|590150399|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
163393131|NCT04124614|590150397|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
163393132|NCT04124614|590150398|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
163393133|NCT04124614|590150399|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
163393134|NCT04124614|590150397|FG000|Double Blind Treatment Period|Physician Decision|0|||
163393135|NCT04124614|590150398|FG001|Double Blind Treatment Period|Physician Decision|0|||
163393136|NCT04124614|590150399|FG002|Double Blind Treatment Period|Physician Decision|3|||
163393137|NCT04124614|590150397|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
163393138|NCT04124614|590150398|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
163393139|NCT04124614|590150399|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
163393140|NCT04124614|590150397|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
163393141|NCT04124614|590150398|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
163393142|NCT04124614|590150399|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
163393143|NCT04124614|590150397|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
163393144|NCT04124614|590150398|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
163393145|NCT04124614|590150399|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
163393146|NCT05749952|590150400|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
163393147|NCT01650285|590152041|FG000|Overall Study|Adverse Event|1|||
163393148|NCT04163900|590152042|FG000|Overall Study|Radiological disease progression|112|||
163393149|NCT04163900|590152043|FG001|Overall Study|Radiological disease progression|127|||
163393150|NCT04163900|590152042|FG000|Overall Study|Study closure|98|||
163393151|NCT04163900|590152043|FG001|Overall Study|Study closure|133|||
163393152|NCT04163900|590152042|FG000|Overall Study|Adverse Event|78|||
163393153|NCT04163900|590152043|FG001|Overall Study|Adverse Event|32|||
163393154|NCT04163900|590152042|FG000|Overall Study|Withdrawal by Subject|37|||
163393155|NCT04163900|590152043|FG001|Overall Study|Withdrawal by Subject|34|||
163393156|NCT04163900|590152042|FG000|Overall Study|Death|29|||
163393157|NCT04163900|590152043|FG001|Overall Study|Death|16|||
163393158|NCT04163900|590152042|FG000|Overall Study|Physician Decision|17|||
163393159|NCT04163900|590152043|FG001|Overall Study|Physician Decision|25|||
163393160|NCT04163900|590152042|FG000|Overall Study|Clinical disease progression|14|||
163393161|NCT04163900|590152043|FG001|Overall Study|Clinical disease progression|13|||
163393162|NCT04163900|590152042|FG000|Overall Study|Protocol Violation|3|||
163393163|NCT04163900|590152043|FG001|Overall Study|Protocol Violation|4|||
163393164|NCT04163900|590152042|FG000|Overall Study|Lost to Follow-up|0|||
163393165|NCT04163900|590152043|FG001|Overall Study|Lost to Follow-up|1|||
163393166|NCT01830855|590152044|FG000|Overall Study|Other|7|||
163393167|NCT01830855|590152045|FG001|Overall Study|Other|1|||
163393168|NCT01830855|590152046|FG002|Overall Study|Other|4|||
163393169|NCT01830855|590152047|FG003|Overall Study|Other|4|||
163393170|NCT01830855|590152044|FG000|Overall Study|Medication error without associated AE|1|||
163393171|NCT01830855|590152045|FG001|Overall Study|Medication error without associated AE|0|||
163393172|NCT01830855|590152046|FG002|Overall Study|Medication error without associated AE|0|||
163393173|NCT01830855|590152047|FG003|Overall Study|Medication error without associated AE|1|||
163393174|NCT01830855|590152044|FG000|Overall Study|Pregnancy|3|||
163393175|NCT01830855|590152045|FG001|Overall Study|Pregnancy|1|||
163393176|NCT01830855|590152046|FG002|Overall Study|Pregnancy|2|||
162953898|NCT03769896|588536202|FG000|Open-label Phase|Adverse Event|3|||
163393177|NCT01830855|590152047|FG003|Overall Study|Pregnancy|1|||
163393178|NCT01830855|590152044|FG000|Overall Study|No longer meets eligibility criteria|11|||
163393179|NCT01830855|590152045|FG001|Overall Study|No longer meets eligibility criteria|2|||
163393180|NCT01830855|590152046|FG002|Overall Study|No longer meets eligibility criteria|3|||
163193357|NCT00533897|589423157|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
163193358|NCT00533897|589423158|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
163193359|NCT00533897|589423159|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
163193360|NCT00533897|589423160|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
163193361|NCT00533897|589423161|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
163193362|NCT00533897|589423162|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
163193363|NCT00533897|589423155|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
163393181|NCT01830855|590152047|FG003|Overall Study|No longer meets eligibility criteria|5|||
163393182|NCT01830855|590152044|FG000|Overall Study|Adverse Event|11|||
163393183|NCT01830855|590152045|FG001|Overall Study|Adverse Event|5|||
163393184|NCT01830855|590152046|FG002|Overall Study|Adverse Event|6|||
163193364|NCT00533897|589423156|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
163193365|NCT00533897|589423157|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
163393185|NCT01830855|590152047|FG003|Overall Study|Adverse Event|3|||
163193366|NCT00533897|589423158|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
163393186|NCT01830855|590152044|FG000|Overall Study|Protocol deviation|10|||
163393187|NCT01830855|590152045|FG001|Overall Study|Protocol deviation|5|||
163393188|NCT01830855|590152046|FG002|Overall Study|Protocol deviation|6|||
163393189|NCT01830855|590152047|FG003|Overall Study|Protocol deviation|6|||
163393190|NCT01830855|590152044|FG000|Overall Study|Withdrawal by Subject|33|||
163393191|NCT01830855|590152045|FG001|Overall Study|Withdrawal by Subject|14|||
163393192|NCT01830855|590152046|FG002|Overall Study|Withdrawal by Subject|10|||
163393193|NCT01830855|590152047|FG003|Overall Study|Withdrawal by Subject|12|||
163393194|NCT01830855|590152044|FG000|Overall Study|No longer willing to participate|32|||
163393195|NCT01830855|590152045|FG001|Overall Study|No longer willing to participate|13|||
163393196|NCT01830855|590152046|FG002|Overall Study|No longer willing to participate|12|||
163393197|NCT01830855|590152047|FG003|Overall Study|No longer willing to participate|17|||
163393198|NCT01830855|590152044|FG000|Overall Study|Lost to Follow-up|47|||
163393199|NCT01830855|590152045|FG001|Overall Study|Lost to Follow-up|20|||
163393200|NCT01830855|590152046|FG002|Overall Study|Lost to Follow-up|23|||
163393201|NCT01830855|590152047|FG003|Overall Study|Lost to Follow-up|33|||
163393202|NCT01950247|590152051|FG000|Overall Study|Withdrawal by Subject|28|||
163393203|NCT01950247|590152052|FG001|Overall Study|Withdrawal by Subject|13|||
163393204|NCT01950247|590152051|FG000|Overall Study|Lost to Follow-up|18|||
163393205|NCT01950247|590152052|FG001|Overall Study|Lost to Follow-up|16|||
162953899|NCT03769896|588536203|FG001|Open-label Phase|Adverse Event|0|||
163193367|NCT00533897|589423159|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
163393206|NCT01950247|590152051|FG000|Overall Study|Physician Decision|3|||
163393207|NCT01950247|590152052|FG001|Overall Study|Physician Decision|4|||
163393208|NCT01950247|590152051|FG000|Overall Study|Adverse Event|3|||
163393209|NCT01950247|590152052|FG001|Overall Study|Adverse Event|2|||
163393210|NCT01950247|590152051|FG000|Overall Study|Death|1|||
163393211|NCT01950247|590152052|FG001|Overall Study|Death|1|||
163193368|NCT00533897|589423160|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
163193369|NCT00533897|589423161|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
163193370|NCT00533897|589423162|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
163193371|NCT00533897|589423155|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
163193372|NCT00533897|589423156|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
163193373|NCT00533897|589423157|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
163193374|NCT00533897|589423158|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
163193375|NCT00533897|589423159|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
163193376|NCT00533897|589423160|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
163193377|NCT00533897|589423161|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
163193378|NCT00533897|589423162|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
163193379|NCT00533897|589423155|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
163193380|NCT00533897|589423156|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
163193381|NCT00533897|589423157|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
163193382|NCT00533897|589423158|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
163193383|NCT00533897|589423159|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
163193384|NCT00533897|589423160|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
163193385|NCT00533897|589423161|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
163193386|NCT00533897|589423162|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
163193387|NCT00533897|589423155|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
163193388|NCT00533897|589423156|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
163193389|NCT00533897|589423157|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
163193390|NCT00533897|589423158|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
163193391|NCT00533897|589423159|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
163193392|NCT00533897|589423160|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
163193393|NCT00533897|589423161|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
163193394|NCT00533897|589423162|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
163193395|NCT00533897|589423155|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
163193396|NCT00533897|589423156|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
163193397|NCT00533897|589423157|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
163193398|NCT00533897|589423158|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
163193399|NCT00533897|589423159|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
163193400|NCT00533897|589423160|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
163193401|NCT00533897|589423161|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
163193402|NCT00533897|589423162|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
163193403|NCT00533897|589423155|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
163193404|NCT00533897|589423156|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
163193405|NCT00533897|589423157|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
163193406|NCT00533897|589423158|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
163193407|NCT00533897|589423159|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
163193408|NCT00533897|589423160|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
163193409|NCT00533897|589423161|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
163193410|NCT00533897|589423162|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
163193411|NCT00533897|589423155|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
163193412|NCT00533897|589423156|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
163193413|NCT00533897|589423157|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
163193414|NCT00533897|589423158|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
163193415|NCT00533897|589423159|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
163193416|NCT00533897|589423160|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
163193417|NCT00533897|589423161|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
163193418|NCT00533897|589423162|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
163193419|NCT00533897|589423155|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
163393212|NCT01950247|590152051|FG000|Overall Study|Not Defined|4|||
163193420|NCT00533897|589423156|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
163193421|NCT00533897|589423157|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
163193422|NCT00533897|589423158|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
163393213|NCT01950247|590152052|FG001|Overall Study|Not Defined|10|||
163393214|NCT01798992|590152055|FG000|Overall Study|Administrative withdrawal|0|||
163393215|NCT01798992|590152056|FG001|Overall Study|Administrative withdrawal|1|||
163193423|NCT00533897|589423159|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
163193424|NCT00533897|589423160|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
163193425|NCT00533897|589423161|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
163193426|NCT00533897|589423162|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
163193427|NCT00533897|589423155|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
163193428|NCT00533897|589423156|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
163193429|NCT00533897|589423157|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
163193430|NCT00533897|589423158|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
163193431|NCT00533897|589423159|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
163193432|NCT00533897|589423160|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
162953900|NCT03769896|588536202|FG000|Open-label Phase|Withdrawal by Subject|1|||
162953901|NCT03769896|588536203|FG001|Open-label Phase|Withdrawal by Subject|0|||
162953902|NCT01015703|588536204|FG000|Overall Study|Withdrawal by Subject|0|||
162953903|NCT01015703|588536205|FG001|Overall Study|Withdrawal by Subject|1|||
162953904|NCT01015703|588536206|FG002|Overall Study|Withdrawal by Subject|0|||
162953905|NCT01015703|588536207|FG003|Overall Study|Withdrawal by Subject|0|||
162953906|NCT01015703|588536208|FG004|Overall Study|Withdrawal by Subject|0|||
162953907|NCT01015703|588536204|FG000|Overall Study|Adverse Event|1|||
162953908|NCT01015703|588536205|FG001|Overall Study|Adverse Event|0|||
162953909|NCT01015703|588536206|FG002|Overall Study|Adverse Event|0|||
162953910|NCT01015703|588536207|FG003|Overall Study|Adverse Event|0|||
162953911|NCT01015703|588536208|FG004|Overall Study|Adverse Event|0|||
162953912|NCT01015703|588536204|FG000|Overall Study|Protocol Violation|1|||
162953913|NCT01015703|588536205|FG001|Overall Study|Protocol Violation|0|||
162953914|NCT01015703|588536206|FG002|Overall Study|Protocol Violation|0|||
162953915|NCT01015703|588536207|FG003|Overall Study|Protocol Violation|0|||
162953916|NCT01015703|588536208|FG004|Overall Study|Protocol Violation|0|||
162953917|NCT03122535|588536209|FG000|Overall Study|Lost to Follow-up|68|||
162953918|NCT03122535|588536210|FG001|Overall Study|Lost to Follow-up|68|||
162953919|NCT03122535|588536209|FG000|Overall Study|Physician Decision|3|||
163193433|NCT00533897|589423161|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
162953920|NCT03122535|588536210|FG001|Overall Study|Physician Decision|3|||
162953921|NCT03122535|588536209|FG000|Overall Study|Withdrawal by Subject|2|||
162953922|NCT03122535|588536210|FG001|Overall Study|Withdrawal by Subject|2|||
162953923|NCT02646124|588536211|FG000|Overall Study|Lost to Follow-up|0|||
162953924|NCT02646124|588536212|FG001|Overall Study|Lost to Follow-up|2|||
162953925|NCT00857454|588536215|FG000|Overall Study|Withdrawal by Subject|2|||
162953926|NCT00857454|588536215|FG000|Overall Study|Lost to Follow-up|1|||
162953927|NCT00857454|588536215|FG000|Overall Study|Adverse Event|2|||
162953928|NCT00857454|588536215|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
163193434|NCT00533897|589423162|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
163193435|NCT00533897|589423155|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
163193436|NCT00533897|589423156|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
163193437|NCT00533897|589423157|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
163393216|NCT01798992|590152057|FG002|Overall Study|Administrative withdrawal|0|||
163393217|NCT01798992|590152058|FG003|Overall Study|Administrative withdrawal|1|||
163393218|NCT01798992|590152055|FG000|Overall Study|Lost to Follow-up|0|||
163393219|NCT01798992|590152056|FG001|Overall Study|Lost to Follow-up|1|||
162953929|NCT00857454|588536215|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
162953930|NCT00857454|588536215|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
163193438|NCT00533897|589423158|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
163193439|NCT00533897|589423159|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
163193440|NCT00533897|589423160|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
163193441|NCT00533897|589423161|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
163193442|NCT00533897|589423162|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
163193443|NCT00533897|589423155|FG000|Long Term Extension (LTE)|Death|0|||
163193444|NCT00533897|589423156|FG001|Long Term Extension (LTE)|Death|0|||
163193445|NCT00533897|589423157|FG002|Long Term Extension (LTE)|Death|0|||
163193446|NCT00533897|589423158|FG003|Long Term Extension (LTE)|Death|0|||
163193447|NCT00533897|589423159|FG004|Long Term Extension (LTE)|Death|0|||
163193448|NCT00533897|589423160|FG005|Long Term Extension (LTE)|Death|0|||
163193449|NCT00533897|589423161|FG006|Long Term Extension (LTE)|Death|1|||
163193450|NCT00533897|589423162|FG007|Long Term Extension (LTE)|Death|3|||
163193451|NCT00533897|589423155|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
163193452|NCT00533897|589423156|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
163193453|NCT00533897|589423157|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
163193454|NCT00533897|589423158|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
163193455|NCT00533897|589423159|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
162953931|NCT03154047|588536216|FG000|Overall Study|Death|1|||
162953932|NCT03154047|588536216|FG000|Overall Study|Study terminated by sponsor|76|||
162953933|NCT03154047|588536216|FG000|Overall Study|Withdrawal by Subject|3|||
162953934|NCT00365365|588536217|FG000|Overall Study|Randomized but not treated|0|||
162953935|NCT00365365|588536218|FG001|Overall Study|Randomized but not treated|2|||
162953936|NCT00365365|588536219|FG002|Overall Study|Randomized but not treated|0|||
163193456|NCT00533897|589423160|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
163193457|NCT00533897|589423161|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
163193458|NCT00533897|589423162|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
163193459|NCT00533897|589423155|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
163193460|NCT00533897|589423156|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
163193461|NCT00533897|589423157|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
163193462|NCT00533897|589423158|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
163193463|NCT00533897|589423159|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
163193464|NCT00533897|589423160|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
163193465|NCT00533897|589423161|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
163299196|NCT02988817|589805123|FG018|Overall Study|Withdrawal by Subject|4|||
163299197|NCT02988817|589805124|FG019|Overall Study|Withdrawal by Subject|2|||
163299198|NCT02988817|589805105|FG000|Overall Study|Death|0|||
163299199|NCT02988817|589805106|FG001|Overall Study|Death|1|||
163299200|NCT02988817|589805107|FG002|Overall Study|Death|3|||
163299201|NCT02988817|589805108|FG003|Overall Study|Death|1|||
163299202|NCT02988817|589805109|FG004|Overall Study|Death|6|||
163299203|NCT02988817|589805110|FG005|Overall Study|Death|10|||
163299204|NCT02988817|589805111|FG006|Overall Study|Death|1|||
163299205|NCT02988817|589805112|FG007|Overall Study|Death|2|||
163299206|NCT02988817|589805113|FG008|Overall Study|Death|1|||
163299207|NCT02988817|589805114|FG009|Overall Study|Death|5|||
163299208|NCT02988817|589805115|FG010|Overall Study|Death|1|||
163299209|NCT02988817|589805116|FG011|Overall Study|Death|8|||
163299210|NCT02988817|589805117|FG012|Overall Study|Death|9|||
163299211|NCT02988817|589805118|FG013|Overall Study|Death|17|||
163299212|NCT02988817|589805119|FG014|Overall Study|Death|18|||
163299213|NCT02988817|589805120|FG015|Overall Study|Death|30|||
163299214|NCT02988817|589805121|FG016|Overall Study|Death|17|||
163299215|NCT02988817|589805122|FG017|Overall Study|Death|38|||
163299216|NCT02988817|589805123|FG018|Overall Study|Death|14|||
163299217|NCT02988817|589805124|FG019|Overall Study|Death|16|||
163299218|NCT02988817|589805105|FG000|Overall Study|Other|0|||
163299219|NCT02988817|589805106|FG001|Overall Study|Other|0|||
163299220|NCT02988817|589805107|FG002|Overall Study|Other|0|||
163299221|NCT02988817|589805108|FG003|Overall Study|Other|1|||
163299222|NCT02988817|589805109|FG004|Overall Study|Other|1|||
163299223|NCT02988817|589805110|FG005|Overall Study|Other|0|||
163299224|NCT02988817|589805111|FG006|Overall Study|Other|0|||
163299225|NCT02988817|589805112|FG007|Overall Study|Other|0|||
163299226|NCT02988817|589805113|FG008|Overall Study|Other|0|||
163299227|NCT02988817|589805114|FG009|Overall Study|Other|0|||
163299228|NCT02988817|589805115|FG010|Overall Study|Other|0|||
163299229|NCT02988817|589805116|FG011|Overall Study|Other|0|||
163299230|NCT02988817|589805117|FG012|Overall Study|Other|0|||
163299231|NCT02988817|589805118|FG013|Overall Study|Other|0|||
163299232|NCT02988817|589805119|FG014|Overall Study|Other|0|||
163299233|NCT02988817|589805120|FG015|Overall Study|Other|1|||
163299234|NCT02988817|589805121|FG016|Overall Study|Other|0|||
163299235|NCT02988817|589805122|FG017|Overall Study|Other|0|||
163299236|NCT02988817|589805123|FG018|Overall Study|Other|0|||
163299237|NCT02988817|589805124|FG019|Overall Study|Other|0|||
163299238|NCT02988817|589805105|FG000|Overall Study|Lost to Follow-up|0|||
163299239|NCT02988817|589805106|FG001|Overall Study|Lost to Follow-up|0|||
163299240|NCT02988817|589805107|FG002|Overall Study|Lost to Follow-up|0|||
163299241|NCT02988817|589805108|FG003|Overall Study|Lost to Follow-up|0|||
163299242|NCT02988817|589805109|FG004|Overall Study|Lost to Follow-up|0|||
163299243|NCT02988817|589805110|FG005|Overall Study|Lost to Follow-up|0|||
163299244|NCT02988817|589805111|FG006|Overall Study|Lost to Follow-up|0|||
163299245|NCT02988817|589805112|FG007|Overall Study|Lost to Follow-up|0|||
163299246|NCT02988817|589805113|FG008|Overall Study|Lost to Follow-up|1|||
163299247|NCT02988817|589805114|FG009|Overall Study|Lost to Follow-up|0|||
163299248|NCT02988817|589805115|FG010|Overall Study|Lost to Follow-up|1|||
163299249|NCT02988817|589805116|FG011|Overall Study|Lost to Follow-up|1|||
163299250|NCT02988817|589805117|FG012|Overall Study|Lost to Follow-up|0|||
163299251|NCT02988817|589805118|FG013|Overall Study|Lost to Follow-up|0|||
163299252|NCT02988817|589805119|FG014|Overall Study|Lost to Follow-up|1|||
163299253|NCT02988817|589805120|FG015|Overall Study|Lost to Follow-up|1|||
163299254|NCT02988817|589805121|FG016|Overall Study|Lost to Follow-up|2|||
163299255|NCT02988817|589805122|FG017|Overall Study|Lost to Follow-up|3|||
163299256|NCT02988817|589805123|FG018|Overall Study|Lost to Follow-up|0|||
163299257|NCT02988817|589805124|FG019|Overall Study|Lost to Follow-up|0|||
163299258|NCT02988817|589805105|FG000|Overall Study|Sponsor decision|0|||
163299259|NCT02988817|589805106|FG001|Overall Study|Sponsor decision|0|||
163299260|NCT02988817|589805107|FG002|Overall Study|Sponsor decision|0|||
163299261|NCT02988817|589805108|FG003|Overall Study|Sponsor decision|0|||
163299262|NCT02988817|589805109|FG004|Overall Study|Sponsor decision|0|||
163299263|NCT02988817|589805110|FG005|Overall Study|Sponsor decision|0|||
163299264|NCT02988817|589805111|FG006|Overall Study|Sponsor decision|0|||
163299265|NCT02988817|589805112|FG007|Overall Study|Sponsor decision|0|||
163299266|NCT02988817|589805113|FG008|Overall Study|Sponsor decision|0|||
163299267|NCT02988817|589805114|FG009|Overall Study|Sponsor decision|0|||
163299268|NCT02988817|589805115|FG010|Overall Study|Sponsor decision|0|||
163299269|NCT02988817|589805116|FG011|Overall Study|Sponsor decision|1|||
163193466|NCT00533897|589423162|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
163193467|NCT00533897|589423155|FG000|Long Term Extension (LTE)|Adverse Event|0|||
163193468|NCT00533897|589423156|FG001|Long Term Extension (LTE)|Adverse Event|0|||
163193469|NCT00533897|589423157|FG002|Long Term Extension (LTE)|Adverse Event|0|||
163193470|NCT00533897|589423158|FG003|Long Term Extension (LTE)|Adverse Event|0|||
163193471|NCT00533897|589423159|FG004|Long Term Extension (LTE)|Adverse Event|0|||
163193472|NCT00533897|589423160|FG005|Long Term Extension (LTE)|Adverse Event|0|||
163193473|NCT00533897|589423161|FG006|Long Term Extension (LTE)|Adverse Event|2|||
162953937|NCT00365365|588536217|FG000|Overall Study|Poor compliance to protocol|0|||
162953938|NCT00365365|588536218|FG001|Overall Study|Poor compliance to protocol|1|||
162953939|NCT00365365|588536219|FG002|Overall Study|Poor compliance to protocol|0|||
162953940|NCT00365365|588536217|FG000|Overall Study|Lost to Follow-up|3|||
162953941|NCT00365365|588536218|FG001|Overall Study|Lost to Follow-up|3|||
162953942|NCT00365365|588536219|FG002|Overall Study|Lost to Follow-up|3|||
162953943|NCT00365365|588536217|FG000|Overall Study|Death|1|||
162953944|NCT00365365|588536218|FG001|Overall Study|Death|3|||
162953945|NCT00365365|588536219|FG002|Overall Study|Death|0|||
162953946|NCT00365365|588536217|FG000|Overall Study|Subject's request|11|||
162953947|NCT00365365|588536218|FG001|Overall Study|Subject's request|13|||
162953948|NCT00365365|588536219|FG002|Overall Study|Subject's request|1|||
162953949|NCT00365365|588536217|FG000|Overall Study|Disease progression/relapse|9|||
162953950|NCT00365365|588536218|FG001|Overall Study|Disease progression/relapse|6|||
162953951|NCT00365365|588536219|FG002|Overall Study|Disease progression/relapse|7|||
163193474|NCT00533897|589423162|FG007|Long Term Extension (LTE)|Adverse Event|5|||
163193475|NCT00533897|589423155|FG000|Long Term Extension (LTE)|Pregnancy|0|||
163193476|NCT00533897|589423156|FG001|Long Term Extension (LTE)|Pregnancy|0|||
163193477|NCT00533897|589423157|FG002|Long Term Extension (LTE)|Pregnancy|0|||
163193478|NCT00533897|589423158|FG003|Long Term Extension (LTE)|Pregnancy|0|||
163193479|NCT00533897|589423159|FG004|Long Term Extension (LTE)|Pregnancy|0|||
163193480|NCT00533897|589423160|FG005|Long Term Extension (LTE)|Pregnancy|0|||
163193481|NCT00533897|589423161|FG006|Long Term Extension (LTE)|Pregnancy|0|||
163193482|NCT00533897|589423162|FG007|Long Term Extension (LTE)|Pregnancy|2|||
163193483|NCT00533897|589423155|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
163193484|NCT00533897|589423156|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
163193485|NCT00533897|589423157|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
163193486|NCT00533897|589423158|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
163193487|NCT00533897|589423159|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
163193488|NCT00533897|589423160|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
163193489|NCT00533897|589423161|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
163193490|NCT00533897|589423162|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
163193491|NCT00533897|589423155|FG000|Long Term Extension (LTE)|Other|0|||
162953952|NCT00365365|588536217|FG000|Overall Study|Adverse Event|6|||
163193492|NCT00533897|589423156|FG001|Long Term Extension (LTE)|Other|0|||
163193493|NCT00533897|589423157|FG002|Long Term Extension (LTE)|Other|0|||
163193494|NCT00533897|589423158|FG003|Long Term Extension (LTE)|Other|0|||
163193495|NCT00533897|589423159|FG004|Long Term Extension (LTE)|Other|0|||
163193496|NCT00533897|589423160|FG005|Long Term Extension (LTE)|Other|0|||
163193497|NCT00533897|589423161|FG006|Long Term Extension (LTE)|Other|1|||
163193498|NCT00533897|589423162|FG007|Long Term Extension (LTE)|Other|6|||
163193499|NCT01546207|589423165|FG000|Overall Study|Death|1|||
163193500|NCT01626456|589423166|FG000|Overall Study|Withdrawal by Subject|21|||
163193501|NCT01626456|589423167|FG001|Overall Study|Withdrawal by Subject|46|||
163193502|NCT01626456|589423166|FG000|Overall Study|Adverse Event|2|||
163193503|NCT01626456|589423167|FG001|Overall Study|Adverse Event|27|||
163193504|NCT01626456|589423166|FG000|Overall Study|Lost to Follow-up|2|||
163193505|NCT01626456|589423167|FG001|Overall Study|Lost to Follow-up|27|||
163193506|NCT01626456|589423166|FG000|Overall Study|Lack of Efficacy|6|||
163193507|NCT01626456|589423167|FG001|Overall Study|Lack of Efficacy|7|||
163193508|NCT01626456|589423166|FG000|Overall Study|Physician Decision|1|||
163193509|NCT01626456|589423167|FG001|Overall Study|Physician Decision|4|||
163393220|NCT01798992|590152057|FG002|Overall Study|Lost to Follow-up|1|||
163393221|NCT01798992|590152058|FG003|Overall Study|Lost to Follow-up|0|||
163393222|NCT01798992|590152055|FG000|Overall Study|Insufficient biopsy tissue|0|||
163393223|NCT01798992|590152056|FG001|Overall Study|Insufficient biopsy tissue|0|||
163393224|NCT01798992|590152057|FG002|Overall Study|Insufficient biopsy tissue|1|||
163393225|NCT01798992|590152058|FG003|Overall Study|Insufficient biopsy tissue|0|||
163393226|NCT01069120|590152059|FG000|Overall Study|Study prematurely terminated|27|||
162953953|NCT00365365|588536218|FG001|Overall Study|Adverse Event|6|||
163393227|NCT00763971|590152060|FG000|Overall Study|Adverse Event|5|||
163393228|NCT00763971|590152061|FG001|Overall Study|Adverse Event|2|||
163393229|NCT00763971|590152062|FG002|Overall Study|Adverse Event|4|||
163393230|NCT00763971|590152060|FG000|Overall Study|Protocol Violation|3|||
163393231|NCT00763971|590152061|FG001|Overall Study|Protocol Violation|3|||
163393232|NCT00763971|590152062|FG002|Overall Study|Protocol Violation|2|||
163393233|NCT00763971|590152060|FG000|Overall Study|Withdrawal by Subject|4|||
163393234|NCT00763971|590152061|FG001|Overall Study|Withdrawal by Subject|5|||
163393235|NCT00763971|590152062|FG002|Overall Study|Withdrawal by Subject|5|||
163393236|NCT00763971|590152060|FG000|Overall Study|Lost to Follow-up|0|||
163393237|NCT00763971|590152061|FG001|Overall Study|Lost to Follow-up|1|||
163393238|NCT00763971|590152062|FG002|Overall Study|Lost to Follow-up|0|||
163393239|NCT00763971|590152060|FG000|Overall Study|Lack of Efficacy|11|||
163393240|NCT00763971|590152061|FG001|Overall Study|Lack of Efficacy|22|||
163393241|NCT00763971|590152062|FG002|Overall Study|Lack of Efficacy|54|||
163393242|NCT00763971|590152060|FG000|Overall Study|Unable to swallow capsule|2|||
163393243|NCT00763971|590152061|FG001|Overall Study|Unable to swallow capsule|1|||
163393244|NCT00763971|590152062|FG002|Overall Study|Unable to swallow capsule|1|||
163393245|NCT00763971|590152060|FG000|Overall Study|Personal reason|3|||
163393246|NCT00763971|590152061|FG001|Overall Study|Personal reason|0|||
162953954|NCT00365365|588536219|FG002|Overall Study|Adverse Event|3|||
162953955|NCT00365365|588536217|FG000|Overall Study|Moved|2|||
162953956|NCT00365365|588536218|FG001|Overall Study|Moved|0|||
163193510|NCT01626456|589423166|FG000|Overall Study|Protocol Violation|1|||
163193511|NCT01626456|589423167|FG001|Overall Study|Protocol Violation|1|||
163193512|NCT01626456|589423166|FG000|Overall Study|Site Closure|2|||
163193513|NCT01626456|589423167|FG001|Overall Study|Site Closure|3|||
163193514|NCT01626456|589423166|FG000|Overall Study|Incarceration|0|||
163393247|NCT00763971|590152062|FG002|Overall Study|Personal reason|0|||
163393248|NCT00763971|590152060|FG000|Overall Study|Exclusion criteria met|1|||
163393249|NCT00763971|590152061|FG001|Overall Study|Exclusion criteria met|0|||
163393250|NCT00763971|590152062|FG002|Overall Study|Exclusion criteria met|0|||
163393251|NCT00763971|590152060|FG000|Overall Study|Sponsor decision|1|||
163299270|NCT02988817|589805117|FG012|Overall Study|Sponsor decision|1|||
163299271|NCT02988817|589805118|FG013|Overall Study|Sponsor decision|2|||
163299272|NCT02988817|589805119|FG014|Overall Study|Sponsor decision|2|||
163299273|NCT02988817|589805120|FG015|Overall Study|Sponsor decision|6|||
163299274|NCT02988817|589805121|FG016|Overall Study|Sponsor decision|2|||
163299275|NCT02988817|589805122|FG017|Overall Study|Sponsor decision|3|||
163299276|NCT02988817|589805123|FG018|Overall Study|Sponsor decision|2|||
163299277|NCT02988817|589805124|FG019|Overall Study|Sponsor decision|7|||
163299278|NCT02988817|589805105|FG000|Overall Study|Physician Decision|0|||
163299279|NCT02988817|589805106|FG001|Overall Study|Physician Decision|0|||
163299280|NCT02988817|589805107|FG002|Overall Study|Physician Decision|0|||
163299281|NCT02988817|589805108|FG003|Overall Study|Physician Decision|0|||
163299282|NCT02988817|589805109|FG004|Overall Study|Physician Decision|0|||
163299283|NCT02988817|589805110|FG005|Overall Study|Physician Decision|0|||
163299284|NCT02988817|589805111|FG006|Overall Study|Physician Decision|0|||
163299285|NCT02988817|589805112|FG007|Overall Study|Physician Decision|0|||
163299286|NCT02988817|589805113|FG008|Overall Study|Physician Decision|0|||
163299287|NCT02988817|589805114|FG009|Overall Study|Physician Decision|0|||
163299288|NCT02988817|589805115|FG010|Overall Study|Physician Decision|0|||
163299289|NCT02988817|589805116|FG011|Overall Study|Physician Decision|0|||
163299290|NCT02988817|589805117|FG012|Overall Study|Physician Decision|0|||
163299291|NCT02988817|589805118|FG013|Overall Study|Physician Decision|0|||
163299292|NCT02988817|589805119|FG014|Overall Study|Physician Decision|0|||
163299293|NCT02988817|589805120|FG015|Overall Study|Physician Decision|1|||
163299294|NCT02988817|589805121|FG016|Overall Study|Physician Decision|0|||
163299295|NCT02988817|589805122|FG017|Overall Study|Physician Decision|0|||
163299296|NCT02988817|589805123|FG018|Overall Study|Physician Decision|1|||
163299297|NCT02988817|589805124|FG019|Overall Study|Physician Decision|1|||
163299298|NCT00421889|589805126|FG000|Overall Study|Adverse Event|1|||
163299299|NCT00421889|589805127|FG001|Overall Study|Adverse Event|0|||
163299300|NCT00421889|589805128|FG002|Overall Study|Adverse Event|1|||
163299301|NCT00421889|589805129|FG003|Overall Study|Adverse Event|1|||
163299302|NCT00421889|589805130|FG004|Overall Study|Adverse Event|1|||
163299303|NCT00421889|589805131|FG005|Overall Study|Adverse Event|4|||
163299304|NCT00421889|589805132|FG006|Overall Study|Adverse Event|1|||
163299305|NCT00421889|589805133|FG007|Overall Study|Adverse Event|0|||
163299306|NCT00421889|589805134|FG008|Overall Study|Adverse Event|2|||
163299307|NCT00421889|589805126|FG000|Overall Study|Withdrawal by Subject|1|||
163299308|NCT00421889|589805127|FG001|Overall Study|Withdrawal by Subject|3|||
163299309|NCT00421889|589805128|FG002|Overall Study|Withdrawal by Subject|0|||
163299310|NCT00421889|589805129|FG003|Overall Study|Withdrawal by Subject|0|||
163299311|NCT00421889|589805130|FG004|Overall Study|Withdrawal by Subject|2|||
163299312|NCT00421889|589805131|FG005|Overall Study|Withdrawal by Subject|0|||
163299313|NCT00421889|589805132|FG006|Overall Study|Withdrawal by Subject|0|||
163299314|NCT00421889|589805133|FG007|Overall Study|Withdrawal by Subject|0|||
163299315|NCT00421889|589805134|FG008|Overall Study|Withdrawal by Subject|0|||
163299316|NCT00421889|589805126|FG000|Overall Study|Death|0|||
163299317|NCT00421889|589805127|FG001|Overall Study|Death|0|||
163299318|NCT00421889|589805128|FG002|Overall Study|Death|0|||
163299319|NCT00421889|589805129|FG003|Overall Study|Death|0|||
163299320|NCT00421889|589805130|FG004|Overall Study|Death|1|||
163299321|NCT00421889|589805131|FG005|Overall Study|Death|1|||
163299322|NCT00421889|589805132|FG006|Overall Study|Death|0|||
163299323|NCT00421889|589805133|FG007|Overall Study|Death|0|||
163299324|NCT00421889|589805134|FG008|Overall Study|Death|0|||
163299325|NCT00421889|589805126|FG000|Overall Study|Progressive disease|3|||
163299326|NCT00421889|589805127|FG001|Overall Study|Progressive disease|2|||
163299327|NCT00421889|589805128|FG002|Overall Study|Progressive disease|2|||
163299328|NCT00421889|589805129|FG003|Overall Study|Progressive disease|3|||
163299329|NCT00421889|589805130|FG004|Overall Study|Progressive disease|2|||
163299330|NCT00421889|589805131|FG005|Overall Study|Progressive disease|21|||
163299331|NCT00421889|589805132|FG006|Overall Study|Progressive disease|3|||
163299332|NCT00421889|589805133|FG007|Overall Study|Progressive disease|1|||
163299333|NCT00421889|589805134|FG008|Overall Study|Progressive disease|5|||
163193515|NCT01626456|589423167|FG001|Overall Study|Incarceration|2|||
163193516|NCT00506662|589423169|FG000|Overall Study|Adverse Event|0|||
163193517|NCT00506662|589423170|FG001|Overall Study|Adverse Event|2|||
163193518|NCT00506662|589423169|FG000|Overall Study|Lack of Efficacy|1|||
163193519|NCT00506662|589423170|FG001|Overall Study|Lack of Efficacy|0|||
163193520|NCT00506662|589423169|FG000|Overall Study|Protocol Violation|2|||
163193521|NCT00506662|589423170|FG001|Overall Study|Protocol Violation|4|||
163193522|NCT00506662|589423169|FG000|Overall Study|Trial terminated|10|||
163193523|NCT00506662|589423170|FG001|Overall Study|Trial terminated|16|||
163193524|NCT00506662|589423169|FG000|Overall Study|Not recorded|4|||
163193525|NCT00506662|589423170|FG001|Overall Study|Not recorded|6|||
163193526|NCT04015336|589423171|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
163193527|NCT00491075|589423172|FG000|Overall Study|Withdrawal by Subject|1|||
163193528|NCT00491075|589423172|FG000|Overall Study|Physician Decision|1|||
163193529|NCT01603355|589423173|FG000|Overall Study|Lack of Efficacy|2|||
163193530|NCT00246753|589423174|FG000|Overall Study|Withdrawal by Subject|2|||
163193531|NCT00246753|589423174|FG000|Overall Study|Physician Decision|2|||
163193532|NCT00246753|589423174|FG000|Overall Study|Adverse Event|2|||
163193533|NCT00246753|589423174|FG000|Overall Study|Unacceptable toxicity|2|||
163193534|NCT01065597|589423181|FG000|Overall Study|Adverse Event|1|||
163193535|NCT00619177|589423183|FG000|Overall Study|Adverse Event|18|||
163193536|NCT00619177|589423183|FG000|Overall Study|Lost to Follow-up|2|||
163193537|NCT00619177|589423183|FG000|Overall Study|Lack of Efficacy|1|||
163193538|NCT00619177|589423183|FG000|Overall Study|Missing termination information|481|||
163193539|NCT00619177|589423183|FG000|Overall Study|Not specified reasons|6|||
162953957|NCT00365365|588536219|FG002|Overall Study|Moved|0|||
162953958|NCT00365365|588536217|FG000|Overall Study|New cancer|1|||
162953959|NCT00365365|588536218|FG001|Overall Study|New cancer|0|||
162953960|NCT00365365|588536219|FG002|Overall Study|New cancer|0|||
162953961|NCT00365365|588536217|FG000|Overall Study|Withdrew consent|1|||
162953962|NCT00365365|588536218|FG001|Overall Study|Withdrew consent|1|||
162953963|NCT00365365|588536219|FG002|Overall Study|Withdrew consent|0|||
162953964|NCT00365365|588536217|FG000|Overall Study|Second malignancy|0|||
162953965|NCT00365365|588536218|FG001|Overall Study|Second malignancy|1|||
162953966|NCT00365365|588536219|FG002|Overall Study|Second malignancy|0|||
162953967|NCT00365365|588536217|FG000|Overall Study|Patient/physician decision|0|||
162953968|NCT00365365|588536218|FG001|Overall Study|Patient/physician decision|0|||
162953969|NCT00365365|588536219|FG002|Overall Study|Patient/physician decision|1|||
162953970|NCT00984022|588536220|FG000|Overall Study|Lost to Follow-up|10|||
162953971|NCT00984022|588536221|FG001|Overall Study|Lost to Follow-up|14|||
162953972|NCT00573443|588536222|FG000|Double-Blind Phase|Lost to Follow-up|1|||
162953973|NCT00573443|588536223|FG001|Double-Blind Phase|Lost to Follow-up|3|||
162953974|NCT00573443|588536224|FG002|Double-Blind Phase|Lost to Follow-up|2|||
162953975|NCT00573443|588536222|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
162953976|NCT00573443|588536223|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
162953977|NCT00573443|588536224|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
162953978|NCT00573443|588536222|FG000|Double-Blind Phase|Adverse Event|1|||
162953979|NCT00573443|588536223|FG001|Double-Blind Phase|Adverse Event|5|||
162953980|NCT00573443|588536224|FG002|Double-Blind Phase|Adverse Event|0|||
162953981|NCT00573443|588536222|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
162953982|NCT00573443|588536223|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
162953983|NCT00573443|588536224|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
162953984|NCT00573443|588536222|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
162953985|NCT00573443|588536223|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
162953986|NCT00573443|588536224|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
162953987|NCT00573443|588536222|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
162953988|NCT00573443|588536223|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
162953989|NCT00573443|588536224|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
162953990|NCT00573443|588536222|FG000|Double-Blind Phase|Protocol Violation|0|||
162953991|NCT00573443|588536223|FG001|Double-Blind Phase|Protocol Violation|2|||
162953992|NCT00573443|588536224|FG002|Double-Blind Phase|Protocol Violation|1|||
162953993|NCT00573443|588536222|FG000|Double-Blind Phase|Other|0|||
162953994|NCT00573443|588536223|FG001|Double-Blind Phase|Other|2|||
162953995|NCT00573443|588536224|FG002|Double-Blind Phase|Other|3|||
162953996|NCT00573443|588536222|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
162953997|NCT00573443|588536223|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
162953998|NCT00573443|588536224|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
162953999|NCT00573443|588536222|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
162954000|NCT00573443|588536223|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
162954001|NCT00573443|588536224|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
162954002|NCT00573443|588536222|FG000|Open-Label Extension Phase|Adverse Event|3|||
163299334|NCT00421889|589805126|FG000|Overall Study|Patient/Investigator request|0|||
163299335|NCT00421889|589805127|FG001|Overall Study|Patient/Investigator request|0|||
162954003|NCT00573443|588536223|FG001|Open-Label Extension Phase|Adverse Event|0|||
162954004|NCT00573443|588536224|FG002|Open-Label Extension Phase|Adverse Event|0|||
162954005|NCT00573443|588536222|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
163193540|NCT01281137|589423188|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
163393252|NCT00763971|590152061|FG001|Overall Study|Sponsor decision|0|||
163193541|NCT01281137|589423189|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
163193542|NCT01281137|589423188|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
163193543|NCT01281137|589423189|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
163193544|NCT01281137|589423188|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
163193545|NCT01281137|589423189|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
163193546|NCT01281137|589423188|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
163193547|NCT01281137|589423189|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
163193548|NCT01281137|589423188|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
163193549|NCT01281137|589423189|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
163193550|NCT00788073|589423190|FG000|STX209 Then Placebo|Adverse Event|1|||
163193551|NCT00788073|589423191|FG001|STX209 Then Placebo|Adverse Event|0|||
163193552|NCT00788073|589423190|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
163193553|NCT00788073|589423191|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
163193554|NCT00788073|589423190|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
163193555|NCT00788073|589423191|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
163193556|NCT00788073|589423190|FG000|STX209 Then Placebo|unable to return due to travel|0|||
163193557|NCT00788073|589423191|FG001|STX209 Then Placebo|unable to return due to travel|1|||
163193558|NCT00788073|589423190|FG000|Placebo Then STX209|Adverse Event|2|||
163193559|NCT00788073|589423191|FG001|Placebo Then STX209|Adverse Event|0|||
163193560|NCT00788073|589423190|FG000|Placebo Then STX209|Protocol Violation|0|||
163193561|NCT00788073|589423191|FG001|Placebo Then STX209|Protocol Violation|1|||
163193562|NCT03608254|589423192|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
163193563|NCT03608254|589423192|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
163193564|NCT00910273|589423193|FG000|Overall Study|Lack of Efficacy|6|||
163193565|NCT00910273|589423194|FG001|Overall Study|Lack of Efficacy|9|||
163193566|NCT00910273|589423193|FG000|Overall Study|Adverse Event|1|||
163193567|NCT00910273|589423194|FG001|Overall Study|Adverse Event|1|||
163193568|NCT00910273|589423193|FG000|Overall Study|Withdrawal by Subject|1|||
163193569|NCT00910273|589423194|FG001|Overall Study|Withdrawal by Subject|0|||
163193570|NCT00910273|589423193|FG000|Overall Study|Discontinuation of study by sponsor|8|||
163193571|NCT00910273|589423194|FG001|Overall Study|Discontinuation of study by sponsor|2|||
163193572|NCT00910273|589423193|FG000|Overall Study|Protocol Violation|1|||
163193573|NCT00910273|589423194|FG001|Overall Study|Protocol Violation|0|||
163193574|NCT00910273|589423193|FG000|Overall Study|Lost to Follow-up|1|||
163193575|NCT00910273|589423194|FG001|Overall Study|Lost to Follow-up|1|||
163193576|NCT03540030|589423195|FG000|Overall Study|Withdrawal by Subject|2|||
163193577|NCT03540030|589423196|FG001|Overall Study|Withdrawal by Subject|1|||
163193578|NCT03540030|589423195|FG000|Overall Study|screen fail|7|||
163193579|NCT03540030|589423196|FG001|Overall Study|screen fail|1|||
163193580|NCT03540030|589423195|FG000|Overall Study|never had surgery after signing consent|9|||
163193581|NCT03540030|589423196|FG001|Overall Study|never had surgery after signing consent|1|||
163193582|NCT00569270|589423197|FG000|Period: First Intervention|Protocol Violation|0|||
163193583|NCT00569270|589423198|FG001|Period: First Intervention|Protocol Violation|1|||
163193584|NCT04729621|589423203|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
163193585|NCT04729621|589423204|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
163193586|NCT04729621|589423205|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
163193587|NCT04729621|589423206|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
163193588|NCT04729621|589423207|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
163193589|NCT04729621|589423203|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
163193590|NCT04729621|589423204|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
163193591|NCT04729621|589423205|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
163193592|NCT04729621|589423206|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
163193593|NCT04729621|589423207|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
163193594|NCT04729621|589423203|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
163193595|NCT04729621|589423204|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
163193596|NCT04729621|589423205|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
163193597|NCT04729621|589423206|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
163193598|NCT04729621|589423207|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
163193599|NCT04729621|589423203|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
163193600|NCT04729621|589423204|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
163193601|NCT04729621|589423205|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
163193602|NCT04729621|589423206|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
163193603|NCT04729621|589423207|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
163193604|NCT04729621|589423203|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
163193605|NCT04729621|589423204|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
163193606|NCT04729621|589423205|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
163193607|NCT04729621|589423206|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
163193608|NCT04729621|589423207|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
163193609|NCT04729621|589423203|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
163299336|NCT00421889|589805128|FG002|Overall Study|Patient/Investigator request|0|||
163299337|NCT00421889|589805129|FG003|Overall Study|Patient/Investigator request|0|||
163299338|NCT00421889|589805130|FG004|Overall Study|Patient/Investigator request|0|||
163299339|NCT00421889|589805131|FG005|Overall Study|Patient/Investigator request|9|||
163299340|NCT00421889|589805132|FG006|Overall Study|Patient/Investigator request|0|||
163299341|NCT00421889|589805133|FG007|Overall Study|Patient/Investigator request|1|||
163299342|NCT00421889|589805134|FG008|Overall Study|Patient/Investigator request|3|||
163299343|NCT00421889|589805126|FG000|Overall Study|Lost to Follow-up|0|||
163299344|NCT00421889|589805127|FG001|Overall Study|Lost to Follow-up|0|||
163299345|NCT00421889|589805128|FG002|Overall Study|Lost to Follow-up|0|||
163299346|NCT00421889|589805129|FG003|Overall Study|Lost to Follow-up|0|||
163299347|NCT00421889|589805130|FG004|Overall Study|Lost to Follow-up|0|||
163193610|NCT04729621|589423204|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
163193611|NCT04729621|589423205|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
163193612|NCT04729621|589423206|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
163193613|NCT04729621|589423207|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
163193614|NCT01449539|589423211|FG000|Overall Study|Withdrawal by Subject|3|||
163193615|NCT01449539|589423211|FG000|Overall Study|Toxicity not study related|1|||
163193616|NCT01387789|589423212|FG000|Overall Study|Adverse Event|5|||
163193617|NCT01387789|589423212|FG000|Overall Study|Lack of Efficacy|2|||
163193618|NCT01387789|589423212|FG000|Overall Study|Lost to Follow-up|1|||
163193619|NCT00913380|589423215|FG000|Clinical Outcomes|Lost to Follow-up|6|||
163193620|NCT00913380|589423216|FG001|Clinical Outcomes|Lost to Follow-up|6|||
163193621|NCT02187744|589423217|FG000|Study|Participant refused further follow-up|1|||
163193622|NCT02187744|589423218|FG001|Study|Participant refused further follow-up|0|||
163193623|NCT02187744|589423217|FG000|Study|Other|2|||
163193624|NCT02187744|589423218|FG001|Study|Other|1|||
163193625|NCT02187744|589423217|FG000|Study|Lost to Follow-up|0|||
163193626|NCT02187744|589423218|FG001|Study|Lost to Follow-up|2|||
163193627|NCT02187744|589423217|FG000|Study|Related adverse event, not serious|0|||
163193628|NCT02187744|589423218|FG001|Study|Related adverse event, not serious|2|||
163193629|NCT02187744|589423217|FG000|Study|Death|1|||
163193630|NCT02187744|589423218|FG001|Study|Death|0|||
163193631|NCT02187744|589423217|FG000|Study|Related adverse event, serious non-fatal|0|||
163193632|NCT02187744|589423218|FG001|Study|Related adverse event, serious non-fatal|1|||
163193633|NCT02187744|589423217|FG000|Treatment|Death|1|||
163193634|NCT02187744|589423218|FG001|Treatment|Death|0|||
163193635|NCT02187744|589423217|FG000|Treatment|Related adverse event, serious non-fatal|0|||
163193636|NCT02187744|589423218|FG001|Treatment|Related adverse event, serious non-fatal|1|||
163193637|NCT02187744|589423217|FG000|Treatment|Related adverse event, not serious|0|||
163193638|NCT02187744|589423218|FG001|Treatment|Related adverse event, not serious|2|||
163193639|NCT02187744|589423217|FG000|Treatment|Lost to Follow-up|0|||
163193640|NCT02187744|589423218|FG001|Treatment|Lost to Follow-up|1|||
163193641|NCT02187744|589423217|FG000|Treatment|Other|2|||
163193642|NCT02187744|589423218|FG001|Treatment|Other|0|||
163193643|NCT02187744|589423217|FG000|Treatment|Participant refused continued treatment|1|||
163193644|NCT02187744|589423218|FG001|Treatment|Participant refused continued treatment|1|||
163193645|NCT01788228|589423223|FG000|Overall Study|Migrated/moved from study area|1|||
163193646|NCT01788228|589423224|FG001|Overall Study|Migrated/moved from study area|0|||
163193647|NCT01972568|589423225|FG000|Overall Study|Other events|3|||
163193648|NCT01972568|589423226|FG001|Overall Study|Other events|0|||
163193649|NCT01972568|589423227|FG002|Overall Study|Other events|0|||
163193650|NCT01972568|589423225|FG000|Overall Study|Lack of Efficacy|0|||
163193651|NCT01972568|589423226|FG001|Overall Study|Lack of Efficacy|1|||
163193652|NCT01972568|589423227|FG002|Overall Study|Lack of Efficacy|2|||
163193653|NCT01972568|589423225|FG000|Overall Study|Protocol Violation|1|||
163193654|NCT01972568|589423226|FG001|Overall Study|Protocol Violation|2|||
163193655|NCT01972568|589423227|FG002|Overall Study|Protocol Violation|2|||
163193656|NCT01972568|589423225|FG000|Overall Study|Withdrawal by Subject|6|||
163193657|NCT01972568|589423226|FG001|Overall Study|Withdrawal by Subject|3|||
163193658|NCT01972568|589423227|FG002|Overall Study|Withdrawal by Subject|7|||
163193659|NCT01972568|589423225|FG000|Overall Study|Lost to Follow-up|1|||
163193660|NCT01972568|589423226|FG001|Overall Study|Lost to Follow-up|0|||
163193661|NCT01972568|589423227|FG002|Overall Study|Lost to Follow-up|0|||
163193662|NCT01972568|589423225|FG000|Overall Study|Adverse Event|5|||
163193663|NCT01972568|589423226|FG001|Overall Study|Adverse Event|6|||
163193664|NCT01972568|589423227|FG002|Overall Study|Adverse Event|5|||
163193665|NCT02059408|589423231|FG000|Overall Study|Did not get tested|0|||
163193666|NCT02059408|589423232|FG001|Overall Study|Did not get tested|330|||
163193667|NCT02059408|589423233|FG002|Overall Study|Did not get tested|358|||
163193668|NCT04223973|589423239|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
163193669|NCT04223973|589423240|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
163193670|NCT04223973|589423239|FG000|Overall Study|Adverse Event|4|||
163193671|NCT04223973|589423240|FG001|Overall Study|Adverse Event|0|||
163193672|NCT04223973|589423239|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
163193673|NCT04223973|589423240|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
163193674|NCT04223973|589423239|FG000|Overall Study|Physician Decision|1|||
163193675|NCT04223973|589423240|FG001|Overall Study|Physician Decision|1|||
163193676|NCT04223973|589423239|FG000|Overall Study|Withdrawal by Subject|0|||
163193677|NCT04223973|589423240|FG001|Overall Study|Withdrawal by Subject|1|||
163193678|NCT00594659|589423241|FG000|Overall Study|Lost to Follow-up|13|||
163193679|NCT00594659|589423242|FG001|Overall Study|Lost to Follow-up|9|||
163193680|NCT00594659|589423243|FG002|Overall Study|Lost to Follow-up|7|||
163193681|NCT00142298|589423245|FG000|Overall Study|Adverse Event|10|||
163193682|NCT00142298|589423246|FG001|Overall Study|Adverse Event|10|||
163193683|NCT00142298|589423247|FG002|Overall Study|Adverse Event|1|||
163193684|NCT00142298|589423248|FG003|Overall Study|Adverse Event|5|||
163193685|NCT00142298|589423249|FG004|Overall Study|Adverse Event|2|||
163193686|NCT00142298|589423250|FG005|Overall Study|Adverse Event|2|||
163193687|NCT00142298|589423251|FG006|Overall Study|Adverse Event|0|||
163299348|NCT00421889|589805131|FG005|Overall Study|Lost to Follow-up|0|||
163299349|NCT00421889|589805132|FG006|Overall Study|Lost to Follow-up|0|||
163299350|NCT00421889|589805133|FG007|Overall Study|Lost to Follow-up|0|||
163299351|NCT00421889|589805134|FG008|Overall Study|Lost to Follow-up|1|||
163299352|NCT00978042|589805135|FG000|Initial Treatment Period|Treated in Error|0|||
163299353|NCT00978042|589805136|FG001|Initial Treatment Period|Treated in Error|3|||
163299354|NCT00978042|589805135|FG000|Initial Treatment Period|Ineligibility|1|||
163299355|NCT00978042|589805136|FG001|Initial Treatment Period|Ineligibility|0|||
163299356|NCT00978042|589805135|FG000|Initial Treatment Period|Lost to Follow-up|21|||
163299357|NCT00978042|589805136|FG001|Initial Treatment Period|Lost to Follow-up|3|||
163299358|NCT00978042|589805135|FG000|Initial Treatment Period|Adverse Event|2|||
163299359|NCT00978042|589805136|FG001|Initial Treatment Period|Adverse Event|0|||
163299360|NCT00978042|589805135|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
162954006|NCT00573443|588536223|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
162954007|NCT00573443|588536224|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
162954008|NCT00573443|588536222|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
162954009|NCT00573443|588536223|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
162954010|NCT00573443|588536224|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
162954011|NCT00573443|588536222|FG000|Open-Label Extension Phase|Protocol Violation|2|||
162954012|NCT00573443|588536223|FG001|Open-Label Extension Phase|Protocol Violation|0|||
162954013|NCT00573443|588536224|FG002|Open-Label Extension Phase|Protocol Violation|0|||
162954014|NCT00573443|588536222|FG000|Open-Label Extension Phase|Other|2|||
162954015|NCT00573443|588536223|FG001|Open-Label Extension Phase|Other|0|||
163193688|NCT00142298|589423252|FG007|Overall Study|Adverse Event|0|||
163299361|NCT00978042|589805136|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
163299362|NCT00978042|589805135|FG000|Initial Treatment Period|Consent withdrawn|22|||
163299363|NCT00978042|589805136|FG001|Initial Treatment Period|Consent withdrawn|9|||
163299364|NCT00978042|589805135|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
163299365|NCT00978042|589805136|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
163299366|NCT00111813|589805137|FG000|Overall Study|Adverse Event|1|||
163299367|NCT00111813|589805138|FG001|Overall Study|Adverse Event|2|||
163299368|NCT00111813|589805139|FG002|Overall Study|Adverse Event|4|||
163299369|NCT00111813|589805140|FG003|Overall Study|Adverse Event|2|||
163299370|NCT00111813|589805141|FG004|Overall Study|Adverse Event|2|||
163299371|NCT00111813|589805142|FG005|Overall Study|Adverse Event|2|||
163299372|NCT00111813|589805137|FG000|Overall Study|Progressive disease|2|||
163299373|NCT00111813|589805138|FG001|Overall Study|Progressive disease|1|||
163299374|NCT00111813|589805139|FG002|Overall Study|Progressive disease|5|||
163299375|NCT00111813|589805140|FG003|Overall Study|Progressive disease|3|||
163299376|NCT00111813|589805141|FG004|Overall Study|Progressive disease|4|||
162954016|NCT00573443|588536224|FG002|Open-Label Extension Phase|Other|0|||
162954017|NCT04567186|588536230|FG000|Period 1|COVID-19 related|1|||
163193689|NCT00142298|589423253|FG008|Overall Study|Adverse Event|0|||
163193690|NCT00142298|589423254|FG009|Overall Study|Adverse Event|0|||
163193691|NCT00142298|589423245|FG000|Overall Study|Clinical disease progression|1|||
163193692|NCT00142298|589423246|FG001|Overall Study|Clinical disease progression|0|||
163193693|NCT00142298|589423247|FG002|Overall Study|Clinical disease progression|0|||
163193694|NCT00142298|589423248|FG003|Overall Study|Clinical disease progression|0|||
163193695|NCT00142298|589423249|FG004|Overall Study|Clinical disease progression|0|||
163193696|NCT00142298|589423250|FG005|Overall Study|Clinical disease progression|0|||
163193697|NCT00142298|589423251|FG006|Overall Study|Clinical disease progression|0|||
163193698|NCT00142298|589423252|FG007|Overall Study|Clinical disease progression|0|||
163193699|NCT00142298|589423253|FG008|Overall Study|Clinical disease progression|0|||
163193700|NCT00142298|589423254|FG009|Overall Study|Clinical disease progression|0|||
163193701|NCT00142298|589423245|FG000|Overall Study|Death|1|||
163193702|NCT00142298|589423246|FG001|Overall Study|Death|1|||
163193703|NCT00142298|589423247|FG002|Overall Study|Death|1|||
163193704|NCT00142298|589423248|FG003|Overall Study|Death|0|||
163193705|NCT00142298|589423249|FG004|Overall Study|Death|0|||
163193706|NCT00142298|589423250|FG005|Overall Study|Death|6|||
163193707|NCT00142298|589423251|FG006|Overall Study|Death|0|||
163193708|NCT00142298|589423252|FG007|Overall Study|Death|0|||
163193709|NCT00142298|589423253|FG008|Overall Study|Death|0|||
163193710|NCT00142298|589423254|FG009|Overall Study|Death|0|||
163193711|NCT00142298|589423245|FG000|Overall Study|Lack of Efficacy|44|||
163193712|NCT00142298|589423246|FG001|Overall Study|Lack of Efficacy|62|||
163193713|NCT00142298|589423247|FG002|Overall Study|Lack of Efficacy|9|||
163193714|NCT00142298|589423248|FG003|Overall Study|Lack of Efficacy|12|||
163193715|NCT00142298|589423249|FG004|Overall Study|Lack of Efficacy|1|||
163193716|NCT00142298|589423250|FG005|Overall Study|Lack of Efficacy|0|||
163193717|NCT00142298|589423251|FG006|Overall Study|Lack of Efficacy|0|||
163193718|NCT00142298|589423252|FG007|Overall Study|Lack of Efficacy|1|||
163299377|NCT00111813|589805142|FG005|Overall Study|Progressive disease|3|||
163193719|NCT00142298|589423253|FG008|Overall Study|Lack of Efficacy|0|||
163193720|NCT00142298|589423254|FG009|Overall Study|Lack of Efficacy|0|||
163193721|NCT00142298|589423245|FG000|Overall Study|Non-compliance|15|||
163193722|NCT00142298|589423246|FG001|Overall Study|Non-compliance|13|||
163193723|NCT00142298|589423247|FG002|Overall Study|Non-compliance|0|||
163193724|NCT00142298|589423248|FG003|Overall Study|Non-compliance|6|||
163193725|NCT00142298|589423249|FG004|Overall Study|Non-compliance|1|||
163193726|NCT00142298|589423250|FG005|Overall Study|Non-compliance|0|||
163193727|NCT00142298|589423251|FG006|Overall Study|Non-compliance|0|||
163193728|NCT00142298|589423252|FG007|Overall Study|Non-compliance|3|||
163193729|NCT00142298|589423253|FG008|Overall Study|Non-compliance|3|||
163193730|NCT00142298|589423254|FG009|Overall Study|Non-compliance|0|||
163193731|NCT00142298|589423245|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
163193732|NCT00142298|589423246|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
163193733|NCT00142298|589423247|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
163193734|NCT00142298|589423248|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
163193735|NCT00142298|589423249|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
163193736|NCT00142298|589423250|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
163193737|NCT00142298|589423251|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
163193738|NCT00142298|589423252|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
163193739|NCT00142298|589423253|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
163193740|NCT00142298|589423254|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
163193741|NCT00142298|589423245|FG000|Overall Study|Pregnancy|4|||
163193742|NCT00142298|589423246|FG001|Overall Study|Pregnancy|4|||
163193743|NCT00142298|589423247|FG002|Overall Study|Pregnancy|2|||
163193744|NCT00142298|589423248|FG003|Overall Study|Pregnancy|3|||
163193745|NCT00142298|589423249|FG004|Overall Study|Pregnancy|0|||
163193746|NCT00142298|589423250|FG005|Overall Study|Pregnancy|0|||
163193747|NCT00142298|589423251|FG006|Overall Study|Pregnancy|0|||
163193748|NCT00142298|589423252|FG007|Overall Study|Pregnancy|0|||
163193749|NCT00142298|589423253|FG008|Overall Study|Pregnancy|1|||
163193750|NCT00142298|589423254|FG009|Overall Study|Pregnancy|0|||
163193751|NCT00142298|589423245|FG000|Overall Study|Virologic breakthrough|19|||
163193752|NCT00142298|589423246|FG001|Overall Study|Virologic breakthrough|23|||
163193753|NCT00142298|589423247|FG002|Overall Study|Virologic breakthrough|9|||
163193754|NCT00142298|589423248|FG003|Overall Study|Virologic breakthrough|7|||
163193755|NCT00142298|589423249|FG004|Overall Study|Virologic breakthrough|2|||
163193756|NCT00142298|589423250|FG005|Overall Study|Virologic breakthrough|3|||
163193757|NCT00142298|589423251|FG006|Overall Study|Virologic breakthrough|3|||
163193758|NCT00142298|589423252|FG007|Overall Study|Virologic breakthrough|0|||
163193759|NCT00142298|589423253|FG008|Overall Study|Virologic breakthrough|0|||
163193760|NCT00142298|589423254|FG009|Overall Study|Virologic breakthrough|0|||
163193761|NCT00142298|589423245|FG000|Overall Study|Other- not specified|0|||
163193762|NCT00142298|589423246|FG001|Overall Study|Other- not specified|3|||
163193763|NCT00142298|589423247|FG002|Overall Study|Other- not specified|0|||
163193764|NCT00142298|589423248|FG003|Overall Study|Other- not specified|1|||
163193765|NCT00142298|589423249|FG004|Overall Study|Other- not specified|0|||
163193766|NCT00142298|589423250|FG005|Overall Study|Other- not specified|0|||
163193767|NCT00142298|589423251|FG006|Overall Study|Other- not specified|0|||
163193768|NCT00142298|589423252|FG007|Overall Study|Other- not specified|0|||
163193769|NCT00142298|589423253|FG008|Overall Study|Other- not specified|0|||
163193770|NCT00142298|589423254|FG009|Overall Study|Other- not specified|0|||
163193771|NCT00142298|589423245|FG000|Overall Study|Lost to Follow-up|0|||
163193772|NCT00142298|589423246|FG001|Overall Study|Lost to Follow-up|0|||
163193773|NCT00142298|589423247|FG002|Overall Study|Lost to Follow-up|0|||
163193774|NCT00142298|589423248|FG003|Overall Study|Lost to Follow-up|0|||
163193775|NCT00142298|589423249|FG004|Overall Study|Lost to Follow-up|0|||
163193776|NCT00142298|589423250|FG005|Overall Study|Lost to Follow-up|0|||
163193777|NCT00142298|589423251|FG006|Overall Study|Lost to Follow-up|2|||
163193778|NCT00142298|589423252|FG007|Overall Study|Lost to Follow-up|0|||
163193779|NCT00142298|589423253|FG008|Overall Study|Lost to Follow-up|0|||
163193780|NCT00142298|589423254|FG009|Overall Study|Lost to Follow-up|0|||
163193781|NCT00142298|589423245|FG000|Overall Study|Treatment Failure|0|||
163193782|NCT00142298|589423246|FG001|Overall Study|Treatment Failure|0|||
163193783|NCT00142298|589423247|FG002|Overall Study|Treatment Failure|0|||
163193784|NCT00142298|589423248|FG003|Overall Study|Treatment Failure|0|||
163193785|NCT00142298|589423249|FG004|Overall Study|Treatment Failure|0|||
163193786|NCT00142298|589423250|FG005|Overall Study|Treatment Failure|2|||
163193787|NCT00142298|589423251|FG006|Overall Study|Treatment Failure|2|||
163193788|NCT00142298|589423252|FG007|Overall Study|Treatment Failure|0|||
163193789|NCT00142298|589423253|FG008|Overall Study|Treatment Failure|0|||
163193790|NCT00142298|589423254|FG009|Overall Study|Treatment Failure|0|||
163193791|NCT02423772|589423257|FG000|Overall Study|Lost to Follow-up|3|||
163193792|NCT02423772|589423258|FG001|Overall Study|Lost to Follow-up|3|||
163193793|NCT02423772|589423257|FG000|Overall Study|Did not begin intervention|2|||
163193794|NCT02423772|589423258|FG001|Overall Study|Did not begin intervention|5|||
163193795|NCT01193842|589423259|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
163193796|NCT01193842|589423260|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
163193797|NCT01193842|589423261|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
163193798|NCT01193842|589423262|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
163193799|NCT01193842|589423263|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
163193800|NCT01193842|589423259|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
163193801|NCT01193842|589423260|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
163193802|NCT01193842|589423261|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
163193803|NCT01193842|589423262|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
163193804|NCT01193842|589423263|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
163193805|NCT01193842|589423259|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
163193806|NCT01193842|589423260|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
163193807|NCT01193842|589423261|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
163299378|NCT00111813|589805137|FG000|Overall Study|Lack of Efficacy|0|||
163299379|NCT00111813|589805138|FG001|Overall Study|Lack of Efficacy|0|||
163299380|NCT00111813|589805139|FG002|Overall Study|Lack of Efficacy|0|||
163299381|NCT00111813|589805140|FG003|Overall Study|Lack of Efficacy|0|||
163299382|NCT00111813|589805141|FG004|Overall Study|Lack of Efficacy|0|||
163299383|NCT00111813|589805142|FG005|Overall Study|Lack of Efficacy|1|||
163299384|NCT00111813|589805137|FG000|Overall Study|Other|0|||
163299385|NCT00111813|589805138|FG001|Overall Study|Other|0|||
163299386|NCT00111813|589805139|FG002|Overall Study|Other|1|||
163299387|NCT00111813|589805140|FG003|Overall Study|Other|0|||
163299388|NCT00111813|589805141|FG004|Overall Study|Other|0|||
163299389|NCT00111813|589805142|FG005|Overall Study|Other|0|||
163299390|NCT01610297|589805144|FG000|Overall Study|Lost to Follow-up|1|||
163299391|NCT03051165|589805145|FG000|Overall Study|Withdrawal by Subject|1|||
163299392|NCT03051165|589805145|FG000|Overall Study|Early termination of study|12|||
163299393|NCT00818246|589805146|FG000|Overall Study|Impossible to match pictures|5|||
163299394|NCT03684044|589805151|FG000|Overall Study|Adverse Event|3|||
163299395|NCT03684044|589805152|FG001|Overall Study|Adverse Event|0|||
163299396|NCT03684044|589805151|FG000|Overall Study|Death|4|||
163299397|NCT03684044|589805152|FG001|Overall Study|Death|7|||
163299398|NCT03684044|589805151|FG000|Overall Study|Lost to Follow-up|3|||
163299399|NCT03684044|589805152|FG001|Overall Study|Lost to Follow-up|2|||
163299400|NCT03684044|589805151|FG000|Overall Study|Patient Not Available|0|||
163299401|NCT03684044|589805152|FG001|Overall Study|Patient Not Available|2|||
163299402|NCT03684044|589805151|FG000|Overall Study|Physician Decision|1|||
163299403|NCT03684044|589805152|FG001|Overall Study|Physician Decision|0|||
163299404|NCT03684044|589805151|FG000|Overall Study|Withdrawal by Subject|11|||
163299405|NCT03684044|589805152|FG001|Overall Study|Withdrawal by Subject|9|||
162954018|NCT04567186|588536231|FG001|Period 1|COVID-19 related|0|||
162954019|NCT04567186|588536230|FG000|Period 1|Protocol Violation|0|||
162954020|NCT04567186|588536231|FG001|Period 1|Protocol Violation|1|||
162954021|NCT04567186|588536230|FG000|Period 1|Adverse Event|0|||
162954022|NCT04567186|588536231|FG001|Period 1|Adverse Event|2|||
162954023|NCT04567186|588536230|FG000|Period 2|COVID-19 Related|0|||
162954024|NCT04567186|588536231|FG001|Period 2|COVID-19 Related|1|||
162954025|NCT04567186|588536230|FG000|Period 2|Protocol Violation|0|||
162954026|NCT04567186|588536231|FG001|Period 2|Protocol Violation|1|||
162954027|NCT04567186|588536230|FG000|Period 2|Lost to Follow-up|0|||
162954028|NCT04567186|588536231|FG001|Period 2|Lost to Follow-up|1|||
162954029|NCT04567186|588536230|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
162954030|NCT04567186|588536231|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
162954031|NCT02924883|588536232|FG000|Overall Study|Death|39|||
162954032|NCT02924883|588536233|FG001|Overall Study|Death|20|||
162954033|NCT02924883|588536232|FG000|Overall Study|Lost to Follow-up|1|||
163193808|NCT01193842|589423262|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
163193809|NCT01193842|589423263|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
163193810|NCT01193842|589423259|FG000|Phase II: Randomized Groups|Death|0|||
163193811|NCT01193842|589423260|FG001|Phase II: Randomized Groups|Death|0|||
163193812|NCT01193842|589423261|FG002|Phase II: Randomized Groups|Death|0|||
163193813|NCT01193842|589423262|FG003|Phase II: Randomized Groups|Death|1|||
163193814|NCT01193842|589423263|FG004|Phase II: Randomized Groups|Death|1|||
163193815|NCT01193842|589423259|FG000|Phase II: Randomized Groups|Adverse Event|0|||
163193816|NCT01193842|589423260|FG001|Phase II: Randomized Groups|Adverse Event|0|||
163193817|NCT01193842|589423261|FG002|Phase II: Randomized Groups|Adverse Event|0|||
163193818|NCT01193842|589423262|FG003|Phase II: Randomized Groups|Adverse Event|5|||
163193819|NCT01193842|589423263|FG004|Phase II: Randomized Groups|Adverse Event|3|||
163193820|NCT01193842|589423259|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
163193821|NCT01193842|589423260|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
163193822|NCT01193842|589423261|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
163193823|NCT01193842|589423262|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
163193824|NCT01193842|589423263|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
163193825|NCT01193842|589423259|FG000|Phase II: Randomized Groups|Ineligible|0|||
163193826|NCT01193842|589423260|FG001|Phase II: Randomized Groups|Ineligible|0|||
163193827|NCT01193842|589423261|FG002|Phase II: Randomized Groups|Ineligible|0|||
163193828|NCT01193842|589423262|FG003|Phase II: Randomized Groups|Ineligible|0|||
163193829|NCT01193842|589423263|FG004|Phase II: Randomized Groups|Ineligible|1|||
163193830|NCT01193842|589423259|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
163193831|NCT01193842|589423260|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
163193832|NCT01193842|589423261|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
163193833|NCT01193842|589423262|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
163193834|NCT01193842|589423263|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
163193835|NCT06238362|589423265|FG000|Overall Study|Insufficient total sleep time|1|||
163193836|NCT06238362|589423266|FG001|Overall Study|Insufficient total sleep time|0|||
163193837|NCT06238362|589423265|FG000|Overall Study|Inadequate signal quality|1|||
163193838|NCT06238362|589423266|FG001|Overall Study|Inadequate signal quality|0|||
163193839|NCT01995825|589424954|FG000|Overall Study|Withdrawal by Subject|1|||
163193840|NCT01995825|589424955|FG001|Overall Study|Withdrawal by Subject|0|||
163193841|NCT01367002|589424956|FG000|Overall Study|Withdrawal by Subject|1|||
163193842|NCT01367002|589424957|FG001|Overall Study|Withdrawal by Subject|0|||
163193843|NCT01367002|589424956|FG000|Overall Study|Physician Decision|0|||
163193844|NCT01367002|589424957|FG001|Overall Study|Physician Decision|2|||
163193845|NCT00354744|589424960|FG000|Overall Study|Adverse Event|2|||
163193846|NCT00354744|589424960|FG000|Overall Study|Death|2|||
163193847|NCT00354744|589424960|FG000|Overall Study|Lack of Efficacy|11|||
163193848|NCT00354744|589424960|FG000|Overall Study|Lost to Follow-up|2|||
163193849|NCT00354744|589424960|FG000|Overall Study|Physician Decision|11|||
163193850|NCT00354744|589424960|FG000|Overall Study|Withdrawal by Subject|14|||
163193851|NCT00541931|589424961|FG000|Overall Study|Adverse Event|1|||
163193852|NCT00541931|589424962|FG001|Overall Study|Adverse Event|0|||
163193853|NCT00541931|589424961|FG000|Overall Study|Lost to Follow-up|3|||
163193854|NCT00541931|589424962|FG001|Overall Study|Lost to Follow-up|3|||
163193855|NCT00541931|589424961|FG000|Overall Study|Withdrawal by Subject|1|||
163193856|NCT00541931|589424962|FG001|Overall Study|Withdrawal by Subject|0|||
163193857|NCT00541931|589424961|FG000|Overall Study|Transportation Issue|0|||
163193858|NCT00541931|589424962|FG001|Overall Study|Transportation Issue|1|||
163193859|NCT03094169|589424966|FG000|Overall Study|Lack of Efficacy|0|||
163193860|NCT03094169|589424967|FG001|Overall Study|Lack of Efficacy|0|||
163193861|NCT03094169|589424968|FG002|Overall Study|Lack of Efficacy|0|||
163193862|NCT03094169|589424969|FG003|Overall Study|Lack of Efficacy|0|||
162954034|NCT02924883|588536233|FG001|Overall Study|Lost to Follow-up|0|||
162954035|NCT02924883|588536232|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
162954036|NCT02924883|588536233|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
162954037|NCT02924883|588536232|FG000|Overall Study|Protocol Violation|1|||
162954038|NCT02924883|588536233|FG001|Overall Study|Protocol Violation|0|||
162954039|NCT02924883|588536232|FG000|Overall Study|Withdrawal by Subject|22|||
162954040|NCT02924883|588536233|FG001|Overall Study|Withdrawal by Subject|16|||
162954041|NCT02924883|588536232|FG000|Overall Study|Progressive Disease|1|||
162954042|NCT02924883|588536233|FG001|Overall Study|Progressive Disease|0|||
162954043|NCT02924883|588536232|FG000|Overall Study|Study Terminated by Sponsor|69|||
162954044|NCT02924883|588536233|FG001|Overall Study|Study Terminated by Sponsor|32|||
162954045|NCT02481830|588536235|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
162954046|NCT02481830|588536236|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
163193863|NCT03094169|589424970|FG004|Overall Study|Lack of Efficacy|0|||
163193864|NCT03094169|589424971|FG005|Overall Study|Lack of Efficacy|0|||
162954047|NCT02481830|588536235|FG000|Pre-treatment|Withdrawal by Subject|0|||
162954048|NCT02481830|588536236|FG001|Pre-treatment|Withdrawal by Subject|10|||
162954049|NCT02481830|588536235|FG000|Pre-treatment|Disease Progression|1|||
162954050|NCT02481830|588536236|FG001|Pre-treatment|Disease Progression|1|||
162954051|NCT02481830|588536235|FG000|Pre-treatment|Other reasons|0|||
162954052|NCT02481830|588536236|FG001|Pre-treatment|Other reasons|1|||
162954053|NCT02481830|588536235|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
162954054|NCT02481830|588536236|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
162954055|NCT02481830|588536235|FG000|Treatment|Disease Progression|233|||
162954056|NCT02481830|588536236|FG001|Treatment|Disease Progression|171|||
162954057|NCT02481830|588536235|FG000|Treatment|Study drug toxicity|18|||
162954058|NCT02481830|588536236|FG001|Treatment|Study drug toxicity|38|||
162954059|NCT02481830|588536235|FG000|Treatment|Death|1|||
162954060|NCT02481830|588536236|FG001|Treatment|Death|1|||
162954061|NCT02481830|588536235|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
162954062|NCT02481830|588536236|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
162954063|NCT02481830|588536235|FG000|Treatment|Participants request to discontinue Study treatment|6|||
162954064|NCT02481830|588536236|FG001|Treatment|Participants request to discontinue Study treatment|34|||
162954065|NCT02481830|588536235|FG000|Treatment|Withdrawal by Subject|2|||
162954066|NCT02481830|588536236|FG001|Treatment|Withdrawal by Subject|3|||
162954067|NCT02481830|588536235|FG000|Treatment|Lost to Follow-up|1|||
162954068|NCT02481830|588536236|FG001|Treatment|Lost to Follow-up|0|||
162954069|NCT02481830|588536235|FG000|Treatment|Maximum Clinical Benefit|0|||
162954070|NCT02481830|588536236|FG001|Treatment|Maximum Clinical Benefit|5|||
163043263|NCT00320788|588865774|FG003|Overall Study|Decision by the Sponsor|0|||
163043264|NCT00320788|588865775|FG004|Overall Study|Decision by the Sponsor|1|||
163043265|NCT00320788|588865771|FG000|Overall Study|Other|1|||
163043266|NCT00320788|588865772|FG001|Overall Study|Other|2|||
163043267|NCT00320788|588865773|FG002|Overall Study|Other|1|||
163043268|NCT00320788|588865774|FG003|Overall Study|Other|1|||
163043269|NCT00320788|588865775|FG004|Overall Study|Other|1|||
163043270|NCT00320788|588865771|FG000|Overall Study|Physician Decision|1|||
163043271|NCT00320788|588865772|FG001|Overall Study|Physician Decision|1|||
163043272|NCT00320788|588865773|FG002|Overall Study|Physician Decision|0|||
163043273|NCT00320788|588865774|FG003|Overall Study|Physician Decision|0|||
163043274|NCT00320788|588865775|FG004|Overall Study|Physician Decision|0|||
163043275|NCT00320788|588865771|FG000|Overall Study|Protocol Violation|0|||
163043276|NCT00320788|588865772|FG001|Overall Study|Protocol Violation|0|||
163043277|NCT00320788|588865773|FG002|Overall Study|Protocol Violation|0|||
163043278|NCT00320788|588865774|FG003|Overall Study|Protocol Violation|0|||
163043279|NCT00320788|588865775|FG004|Overall Study|Protocol Violation|1|||
163043280|NCT00320788|588865771|FG000|Overall Study|Withdrawal by Subject|3|||
163043281|NCT00320788|588865772|FG001|Overall Study|Withdrawal by Subject|0|||
163043282|NCT00320788|588865773|FG002|Overall Study|Withdrawal by Subject|0|||
163043283|NCT00320788|588865774|FG003|Overall Study|Withdrawal by Subject|3|||
163043284|NCT00320788|588865775|FG004|Overall Study|Withdrawal by Subject|1|||
163043285|NCT04633226|588865777|FG000|Overall Study|Withdrawal by parent/guardian|4|||
163043286|NCT04633226|588865777|FG000|Overall Study|Randomized by mistake without study treatment|1|||
163043287|NCT01765569|588865780|FG000|Period B|Withdrawal by Subject|1|||
163043288|NCT01765569|588865780|FG000|Period C|Death|1|||
163043289|NCT05415462|588865784|FG000|Overall Study|Death|18|||
163043290|NCT05415462|588865785|FG001|Overall Study|Death|10|||
162954071|NCT02481830|588536235|FG000|Treatment|Administrative reason by sponsor|1|||
162954072|NCT02481830|588536236|FG001|Treatment|Administrative reason by sponsor|1|||
162954073|NCT02481830|588536235|FG000|Treatment|Other reasons|6|||
162954074|NCT02481830|588536236|FG001|Treatment|Other reasons|1|||
162954075|NCT00772941|588536237|FG000|Overall Study|CRFs not available|195|||
163043291|NCT05415462|588865784|FG000|Overall Study|Lost to Follow-up|72|||
163043292|NCT05415462|588865785|FG001|Overall Study|Lost to Follow-up|64|||
163043293|NCT05415462|588865784|FG000|Overall Study|Physician Decision|5|||
163043294|NCT05415462|588865785|FG001|Overall Study|Physician Decision|5|||
163043295|NCT05415462|588865784|FG000|Overall Study|Protocol Deviation|1|||
163043296|NCT05415462|588865785|FG001|Overall Study|Protocol Deviation|0|||
163043297|NCT05415462|588865784|FG000|Overall Study|Withdrawal by Subject|129|||
163043298|NCT05415462|588865785|FG001|Overall Study|Withdrawal by Subject|101|||
162954076|NCT00772941|588536237|FG000|Overall Study|Study not completed|16|||
163043299|NCT05415462|588865784|FG000|Overall Study|Other Than Specified|8|||
162954077|NCT00772941|588536237|FG000|Overall Study|Missed Visits|374|||
162954078|NCT00772941|588536237|FG000|Overall Study|Poor Compliance|7|||
162954079|NCT00772941|588536237|FG000|Overall Study|GPSP Violation|90|||
162954080|NCT02714062|588536239|FG000|Overall Study|Adverse Event|0|||
162954081|NCT02714062|588536240|FG001|Overall Study|Adverse Event|0|||
162954082|NCT02714062|588536241|FG002|Overall Study|Adverse Event|2|||
162954083|NCT02714062|588536239|FG000|Overall Study|Withdrawal by Subject|1|||
162954084|NCT02714062|588536240|FG001|Overall Study|Withdrawal by Subject|0|||
162954085|NCT02714062|588536241|FG002|Overall Study|Withdrawal by Subject|1|||
162954086|NCT02714062|588536239|FG000|Overall Study|Protocol Violation|0|||
162954087|NCT02714062|588536240|FG001|Overall Study|Protocol Violation|1|||
162954088|NCT02714062|588536241|FG002|Overall Study|Protocol Violation|0|||
162954089|NCT02682784|588536242|FG000|Overall Study|Withdrawal by Subject|0|||
162954090|NCT02682784|588536243|FG001|Overall Study|Withdrawal by Subject|2|||
162954091|NCT02682784|588536244|FG002|Overall Study|Withdrawal by Subject|1|||
162954092|NCT02682784|588536245|FG003|Overall Study|Withdrawal by Subject|2|||
162954093|NCT02682784|588536242|FG000|Overall Study|Physician Decision|1|||
162954094|NCT02682784|588536243|FG001|Overall Study|Physician Decision|0|||
162954095|NCT02682784|588536244|FG002|Overall Study|Physician Decision|1|||
162954096|NCT02682784|588536245|FG003|Overall Study|Physician Decision|1|||
162954097|NCT01702987|588536246|FG000|Overall Study|Withdrawal by Subject|1|||
162954098|NCT01702987|588536247|FG001|Overall Study|Withdrawal by Subject|0|||
162954099|NCT00467363|588536248|FG000|Overall Study|Lost to Follow-up|80|||
162954100|NCT00467363|588536249|FG001|Overall Study|Lost to Follow-up|70|||
162954101|NCT03181594|588536250|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
162954102|NCT03181594|588536250|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
162954103|NCT03181594|588536250|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
162954104|NCT03181594|588536250|FG000|Initial Study Protocol (12-month FU)|Death|1|||
162954105|NCT03181594|588536250|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
162954106|NCT03181594|588536250|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
162954107|NCT02017223|588536251|FG000|Overall Study|Algorithm problems|2|||
162954108|NCT00365846|588536253|FG000|Overall Study|Lost to Follow-up|1|||
162954109|NCT00904215|588536254|FG000|Overall Study|Adverse Event|25|||
162954110|NCT00904215|588536254|FG000|Overall Study|Protocol Violation|10|||
162954111|NCT00904215|588536254|FG000|Overall Study|Lost to Follow-up|63|||
162954112|NCT00904215|588536254|FG000|Overall Study|Withdrawal by Subject|9|||
162954113|NCT00904215|588536254|FG000|Overall Study|Other|28|||
162954114|NCT00838630|588536258|FG000|First Intervention|Adverse Event|1|||
162954115|NCT00838630|588536259|FG001|First Intervention|Adverse Event|0|||
162954116|NCT00838630|588536258|FG000|Washout: 7 Days|Protocol Violation|1|||
162954117|NCT00838630|588536259|FG001|Washout: 7 Days|Protocol Violation|0|||
162954118|NCT01185821|588536261|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162954119|NCT01185821|588536262|FG001|Overall Study|Abnormal laboratory value(s)|2|||
162954120|NCT01185821|588536263|FG002|Overall Study|Abnormal laboratory value(s)|1|||
162954121|NCT01185821|588536264|FG003|Overall Study|Abnormal laboratory value(s)|0|||
162954122|NCT01185821|588536265|FG004|Overall Study|Abnormal laboratory value(s)|0|||
162954123|NCT01185821|588536261|FG000|Overall Study|Protocol Violation|0|||
162954124|NCT01185821|588536262|FG001|Overall Study|Protocol Violation|0|||
162954125|NCT01185821|588536263|FG002|Overall Study|Protocol Violation|0|||
162954126|NCT01185821|588536264|FG003|Overall Study|Protocol Violation|1|||
162954127|NCT01185821|588536265|FG004|Overall Study|Protocol Violation|1|||
162954128|NCT01185821|588536261|FG000|Overall Study|Abnormal test procedure result|0|||
162954129|NCT01185821|588536262|FG001|Overall Study|Abnormal test procedure result|0|||
162954130|NCT01185821|588536263|FG002|Overall Study|Abnormal test procedure result|0|||
163193865|NCT03094169|589424972|FG006|Overall Study|Lack of Efficacy|0|||
162954131|NCT01185821|588536264|FG003|Overall Study|Abnormal test procedure result|0|||
162954132|NCT01185821|588536265|FG004|Overall Study|Abnormal test procedure result|1|||
162954133|NCT01185821|588536261|FG000|Overall Study|Death|0|||
162954134|NCT01185821|588536262|FG001|Overall Study|Death|1|||
162954135|NCT01185821|588536263|FG002|Overall Study|Death|0|||
162954136|NCT01185821|588536264|FG003|Overall Study|Death|0|||
163193866|NCT03094169|589424973|FG007|Overall Study|Lack of Efficacy|21|||
163393253|NCT00763971|590152062|FG002|Overall Study|Sponsor decision|0|||
162954137|NCT01185821|588536265|FG004|Overall Study|Death|0|||
162954138|NCT01185821|588536261|FG000|Overall Study|Condition no longer required study drug|0|||
162954139|NCT01185821|588536262|FG001|Overall Study|Condition no longer required study drug|0|||
162954140|NCT01185821|588536263|FG002|Overall Study|Condition no longer required study drug|0|||
162954141|NCT01185821|588536264|FG003|Overall Study|Condition no longer required study drug|0|||
162954142|NCT01185821|588536265|FG004|Overall Study|Condition no longer required study drug|1|||
162954143|NCT01185821|588536261|FG000|Overall Study|Adverse Event|2|||
162954144|NCT01185821|588536262|FG001|Overall Study|Adverse Event|3|||
162954145|NCT01185821|588536263|FG002|Overall Study|Adverse Event|1|||
162954146|NCT01185821|588536264|FG003|Overall Study|Adverse Event|2|||
162954147|NCT01185821|588536265|FG004|Overall Study|Adverse Event|5|||
162954148|NCT01185821|588536261|FG000|Overall Study|Lack of Efficacy|0|||
162954149|NCT01185821|588536262|FG001|Overall Study|Lack of Efficacy|0|||
162954150|NCT01185821|588536263|FG002|Overall Study|Lack of Efficacy|3|||
162954151|NCT01185821|588536264|FG003|Overall Study|Lack of Efficacy|0|||
162954152|NCT01185821|588536265|FG004|Overall Study|Lack of Efficacy|9|||
162954153|NCT01185821|588536261|FG000|Overall Study|Withdrawal by Subject|3|||
162954154|NCT01185821|588536262|FG001|Overall Study|Withdrawal by Subject|2|||
162954155|NCT01185821|588536263|FG002|Overall Study|Withdrawal by Subject|2|||
162954156|NCT01185821|588536264|FG003|Overall Study|Withdrawal by Subject|1|||
162954157|NCT01185821|588536265|FG004|Overall Study|Withdrawal by Subject|3|||
162954158|NCT01185821|588536261|FG000|Overall Study|Lost to Follow-up|1|||
162954159|NCT01185821|588536262|FG001|Overall Study|Lost to Follow-up|1|||
162954160|NCT01185821|588536263|FG002|Overall Study|Lost to Follow-up|2|||
162954161|NCT01185821|588536264|FG003|Overall Study|Lost to Follow-up|1|||
162954162|NCT01185821|588536265|FG004|Overall Study|Lost to Follow-up|2|||
162954163|NCT01185821|588536261|FG000|Overall Study|Administrative problems|0|||
162954164|NCT01185821|588536262|FG001|Overall Study|Administrative problems|0|||
162954165|NCT01185821|588536263|FG002|Overall Study|Administrative problems|1|||
162954166|NCT01185821|588536264|FG003|Overall Study|Administrative problems|1|||
162954167|NCT01185821|588536265|FG004|Overall Study|Administrative problems|2|||
162954168|NCT04263649|588536269|FG000|Overall Study|Adverse Event|53|||
162954169|NCT04263649|588536269|FG000|Overall Study|Lost to Follow-up|3|||
162954170|NCT04263649|588536269|FG000|Overall Study|Death|29|||
162954171|NCT04263649|588536269|FG000|Overall Study|Device deficiency|19|||
162954172|NCT04263649|588536269|FG000|Overall Study|other reasons|11|||
162954173|NCT02057458|588536270|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
162954174|NCT02057458|588536271|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
162954175|NCT02057458|588536272|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
162954176|NCT02057458|588536270|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
162954177|NCT02057458|588536271|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
162954178|NCT02057458|588536272|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
162954179|NCT02057458|588536270|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
162954180|NCT02057458|588536271|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
162954181|NCT02057458|588536272|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
162954182|NCT00723710|588536277|FG000|Overall Study|Disease progression|48|||
162954183|NCT00723710|588536277|FG000|Overall Study|Adverse Event|88|||
162954184|NCT00723710|588536277|FG000|Overall Study|Withdrawal by Subject|36|||
162954185|NCT00723710|588536277|FG000|Overall Study|Physician Decision|2|||
162954186|NCT01079988|588536278|FG000|Overall Study|Lost to Follow-up|0|||
162954187|NCT01079988|588536279|FG001|Overall Study|Lost to Follow-up|0|||
162954188|NCT01079988|588536280|FG002|Overall Study|Lost to Follow-up|0|||
162954189|NCT01079988|588536281|FG003|Overall Study|Lost to Follow-up|1|||
162954190|NCT01079988|588536282|FG004|Overall Study|Lost to Follow-up|0|||
162954191|NCT01079988|588536278|FG000|Overall Study|Lack of Efficacy|1|||
162954192|NCT01079988|588536279|FG001|Overall Study|Lack of Efficacy|0|||
162954193|NCT01079988|588536280|FG002|Overall Study|Lack of Efficacy|0|||
162954194|NCT01079988|588536281|FG003|Overall Study|Lack of Efficacy|0|||
162954195|NCT01079988|588536282|FG004|Overall Study|Lack of Efficacy|0|||
162954196|NCT01079988|588536278|FG000|Overall Study|Other|0|||
162954197|NCT01079988|588536279|FG001|Overall Study|Other|0|||
162954198|NCT01079988|588536280|FG002|Overall Study|Other|0|||
162954199|NCT01079988|588536281|FG003|Overall Study|Other|2|||
162954200|NCT01079988|588536282|FG004|Overall Study|Other|1|||
162954201|NCT00468286|588536283|FG000|Overall Study|Adverse Event|1|||
162954202|NCT00468286|588536284|FG001|Overall Study|Adverse Event|6|||
162954203|NCT00468286|588536283|FG000|Overall Study|Protocol Violation|2|||
162954204|NCT00468286|588536284|FG001|Overall Study|Protocol Violation|2|||
162954205|NCT00468286|588536283|FG000|Overall Study|Withdrawal by Subject|4|||
162954206|NCT00468286|588536284|FG001|Overall Study|Withdrawal by Subject|3|||
162954207|NCT00468286|588536283|FG000|Overall Study|Physician Decision|0|||
162954208|NCT00468286|588536284|FG001|Overall Study|Physician Decision|1|||
162954209|NCT02196675|588536286|FG000|Overall Study|Withdrawal by Subject|1|||
162954210|NCT02196675|588536287|FG001|Overall Study|Withdrawal by Subject|0|||
162954211|NCT02196675|588536288|FG002|Overall Study|Withdrawal by Subject|0|||
163193867|NCT03094169|589424966|FG000|Overall Study|Adverse Event|0|||
163043300|NCT05415462|588865785|FG001|Overall Study|Other Than Specified|8|||
163043301|NCT01030718|588865786|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
163043302|NCT01030718|588865787|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
163043303|NCT01030718|588865788|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
162954212|NCT02196675|588536286|FG000|Overall Study|Intra-operative surgical exclusion|1|||
162954213|NCT02196675|588536287|FG001|Overall Study|Intra-operative surgical exclusion|1|||
162954214|NCT02196675|588536288|FG002|Overall Study|Intra-operative surgical exclusion|0|||
162954215|NCT02196675|588536286|FG000|Overall Study|Protocol Violation|0|||
162954216|NCT02196675|588536287|FG001|Overall Study|Protocol Violation|1|||
162954217|NCT02196675|588536288|FG002|Overall Study|Protocol Violation|0|||
162954218|NCT02196675|588536286|FG000|Overall Study|Death|0|||
162954219|NCT02196675|588536287|FG001|Overall Study|Death|0|||
162954220|NCT02196675|588536288|FG002|Overall Study|Death|1|||
162954221|NCT03459807|588536289|FG000|Overall Study|Withdrawal due to transplant|0|||
162954222|NCT03459807|588536290|FG001|Overall Study|Withdrawal due to transplant|1|||
163393254|NCT00763971|590152060|FG000|Overall Study|Due to holiday season|2|||
162954223|NCT02392000|588536295|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
162954224|NCT02392000|588536295|FG000|Overall Study|Withdrawal by Subject|1|||
162954225|NCT02392000|588536295|FG000|Overall Study|Lost to Follow-up|8|||
162954226|NCT00833937|588536296|FG000|Washout|Withdrawal by Subject|1|||
162954227|NCT00833937|588536297|FG001|Washout|Withdrawal by Subject|0|||
163393255|NCT00763971|590152061|FG001|Overall Study|Due to holiday season|0|||
163393256|NCT00763971|590152062|FG002|Overall Study|Due to holiday season|1|||
163393257|NCT00763971|590152060|FG000|Overall Study|Randomization error|0|||
163393258|NCT00763971|590152061|FG001|Overall Study|Randomization error|0|||
163393259|NCT00763971|590152062|FG002|Overall Study|Randomization error|1|||
163393260|NCT00763971|590152060|FG000|Overall Study|Medical monitor decision|0|||
163393261|NCT00763971|590152061|FG001|Overall Study|Medical monitor decision|0|||
163393262|NCT00763971|590152062|FG002|Overall Study|Medical monitor decision|1|||
163393263|NCT00763971|590152060|FG000|Overall Study|Moved to another country|0|||
163393264|NCT00763971|590152061|FG001|Overall Study|Moved to another country|1|||
163393265|NCT00763971|590152062|FG002|Overall Study|Moved to another country|0|||
163393266|NCT00763971|590152060|FG000|Overall Study|Subject wanted dose reduction|0|||
163393267|NCT00763971|590152061|FG001|Overall Study|Subject wanted dose reduction|1|||
163393268|NCT00763971|590152062|FG002|Overall Study|Subject wanted dose reduction|0|||
163393269|NCT00763971|590152060|FG000|Overall Study|Lack of availability|0|||
163393270|NCT00763971|590152061|FG001|Overall Study|Lack of availability|1|||
163393271|NCT00763971|590152062|FG002|Overall Study|Lack of availability|0|||
163393272|NCT00763971|590152060|FG000|Overall Study|Performed final visit on phone|0|||
163393273|NCT00763971|590152061|FG001|Overall Study|Performed final visit on phone|1|||
163393274|NCT00763971|590152062|FG002|Overall Study|Performed final visit on phone|0|||
163393275|NCT00763971|590152060|FG000|Overall Study|Participation in 489-326 required|1|||
163393276|NCT00763971|590152061|FG001|Overall Study|Participation in 489-326 required|0|||
163393277|NCT00763971|590152062|FG002|Overall Study|Participation in 489-326 required|0|||
163393278|NCT02713542|590152063|FG000|Overall Study|Use of prohibited medication|14|||
163393279|NCT02713542|590152064|FG001|Overall Study|Use of prohibited medication|5|||
163393280|NCT02713542|590152063|FG000|Overall Study|Withdrawal by Subject|4|||
163393281|NCT02713542|590152064|FG001|Overall Study|Withdrawal by Subject|1|||
163393282|NCT03631667|590152065|FG000|Overall Study|Withdrawal by Subject|3|||
163393283|NCT00884325|590152077|FG000|Overall Study|Lost to Follow-up|1|||
163393284|NCT00884325|590152078|FG001|Overall Study|Lost to Follow-up|2|||
163393285|NCT00884325|590152077|FG000|Overall Study|Lack of Efficacy|0|||
163393286|NCT00884325|590152078|FG001|Overall Study|Lack of Efficacy|1|||
163393287|NCT00884325|590152077|FG000|Overall Study|Withdrawal by Subject|1|||
162978986|NCT01660022|588623543|FG005|First Sequence (7 Days)|Adverse Event|3|||
162978987|NCT01660022|588623538|FG000|First Sequence (7 Days)|Protocol Violation|0|||
162978988|NCT01660022|588623539|FG001|First Sequence (7 Days)|Protocol Violation|0|||
162978989|NCT01660022|588623540|FG002|First Sequence (7 Days)|Protocol Violation|0|||
163393288|NCT00884325|590152078|FG001|Overall Study|Withdrawal by Subject|1|||
163393289|NCT00884325|590152077|FG000|Overall Study|Not provided|1|||
163393290|NCT00884325|590152078|FG001|Overall Study|Not provided|0|||
163393291|NCT01446016|590152079|FG000|Overall Study|Lost to Follow-up|3|||
163393292|NCT01446016|590152079|FG000|Overall Study|Withdrawal by Subject|1|||
163393293|NCT01446016|590152079|FG000|Overall Study|Toxicity|3|||
163393294|NCT01949155|590152086|FG000|Overall Study|Lost to Follow-up|1|||
163043304|NCT01030718|588865786|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
163043305|NCT01030718|588865787|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
163043306|NCT01030718|588865788|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
163043307|NCT01030718|588865786|FG000|Studies CA180-031 and -036 Combined|Death|0|||
163043308|NCT01030718|588865787|FG001|Studies CA180-031 and -036 Combined|Death|1|||
163043309|NCT01030718|588865788|FG002|Studies CA180-031 and -036 Combined|Death|0|||
163043310|NCT01030718|588865786|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
163043311|NCT01030718|588865787|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
163043312|NCT01030718|588865788|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
163043313|NCT01030718|588865786|FG000|Study CA180-036 Only|insufficient effect|1|||
163043314|NCT01030718|588865787|FG001|Study CA180-036 Only|insufficient effect|1|||
163043315|NCT01030718|588865788|FG002|Study CA180-036 Only|insufficient effect|5|||
163043316|NCT01030718|588865786|FG000|Study CA180-036 Only|Adverse Event|2|||
163043317|NCT01030718|588865787|FG001|Study CA180-036 Only|Adverse Event|3|||
163043318|NCT01030718|588865788|FG002|Study CA180-036 Only|Adverse Event|0|||
163043319|NCT01030718|588865786|FG000|Study CA180-036 Only|Death|0|||
163043320|NCT01030718|588865787|FG001|Study CA180-036 Only|Death|1|||
163043321|NCT01030718|588865788|FG002|Study CA180-036 Only|Death|0|||
163193868|NCT03094169|589424967|FG001|Overall Study|Adverse Event|0|||
163193869|NCT03094169|589424968|FG002|Overall Study|Adverse Event|0|||
163043322|NCT01030718|588865786|FG000|Study CA180-036 Only|Other Reasons|0|||
163043323|NCT01030718|588865787|FG001|Study CA180-036 Only|Other Reasons|2|||
163043324|NCT01030718|588865788|FG002|Study CA180-036 Only|Other Reasons|0|||
163043325|NCT00423813|588865789|FG000|Overall Study|Adverse Event|11|||
163043326|NCT00423813|588865790|FG001|Overall Study|Adverse Event|30|||
163043327|NCT00423813|588865791|FG002|Overall Study|Adverse Event|40|||
163193870|NCT03094169|589424969|FG003|Overall Study|Adverse Event|0|||
163043328|NCT00423813|588865789|FG000|Overall Study|Withdrawal by Subject|6|||
163043329|NCT00423813|588865790|FG001|Overall Study|Withdrawal by Subject|8|||
163299406|NCT03703336|589805153|FG000|Overall Study|Parent withdrew consent|29|||
163299407|NCT03703336|589805154|FG001|Overall Study|Parent withdrew consent|8|||
163043330|NCT00423813|588865791|FG002|Overall Study|Withdrawal by Subject|5|||
163299408|NCT03703336|589805153|FG000|Overall Study|Migration|3|||
163299409|NCT03703336|589805154|FG001|Overall Study|Migration|3|||
163043331|NCT00423813|588865789|FG000|Overall Study|Lost to Follow-up|5|||
163043332|NCT00423813|588865790|FG001|Overall Study|Lost to Follow-up|4|||
163299410|NCT03703336|589805153|FG000|Overall Study|Protocol Violation|3|||
163299411|NCT03703336|589805154|FG001|Overall Study|Protocol Violation|1|||
163299412|NCT03703336|589805153|FG000|Overall Study|Physician Decision|2|||
163043333|NCT00423813|588865791|FG002|Overall Study|Lost to Follow-up|4|||
163043334|NCT00423813|588865789|FG000|Overall Study|Lack of Efficacy|23|||
163043335|NCT00423813|588865790|FG001|Overall Study|Lack of Efficacy|18|||
163043336|NCT00423813|588865791|FG002|Overall Study|Lack of Efficacy|19|||
163043337|NCT00423813|588865789|FG000|Overall Study|Physician Decision|2|||
163043338|NCT00423813|588865790|FG001|Overall Study|Physician Decision|0|||
163043339|NCT00423813|588865791|FG002|Overall Study|Physician Decision|0|||
163299413|NCT03703336|589805154|FG001|Overall Study|Physician Decision|0|||
163043340|NCT00423813|588865789|FG000|Overall Study|Sponsor Decision|0|||
163043341|NCT00423813|588865790|FG001|Overall Study|Sponsor Decision|1|||
163043342|NCT00423813|588865791|FG002|Overall Study|Sponsor Decision|0|||
163043343|NCT00423813|588865789|FG000|Overall Study|Protocol Violation|9|||
163043344|NCT00423813|588865790|FG001|Overall Study|Protocol Violation|4|||
163043345|NCT00423813|588865791|FG002|Overall Study|Protocol Violation|4|||
163043346|NCT00423813|588865789|FG000|Overall Study|Pregnancy|0|||
163043347|NCT00423813|588865790|FG001|Overall Study|Pregnancy|0|||
163043348|NCT00423813|588865791|FG002|Overall Study|Pregnancy|1|||
163043349|NCT00423813|588865789|FG000|Overall Study|Subject started night shift work|1|||
163043350|NCT00423813|588865790|FG001|Overall Study|Subject started night shift work|0|||
163043351|NCT00423813|588865791|FG002|Overall Study|Subject started night shift work|0|||
163043352|NCT00423813|588865789|FG000|Overall Study|Will start exclusionary medications|0|||
163043353|NCT00423813|588865790|FG001|Overall Study|Will start exclusionary medications|1|||
163043354|NCT00423813|588865791|FG002|Overall Study|Will start exclusionary medications|0|||
163043355|NCT00423813|588865789|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
163043356|NCT00423813|588865790|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
163043357|NCT00423813|588865791|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
163043358|NCT01904032|588865794|FG000|Overall Study|Adverse Event|3|||
163043359|NCT01904032|588865795|FG001|Overall Study|Adverse Event|1|||
163043360|NCT01904032|588865794|FG000|Overall Study|Lost to Follow-up|4|||
163043361|NCT01904032|588865795|FG001|Overall Study|Lost to Follow-up|2|||
163043362|NCT02998996|588865802|FG000|Overall Study|Lost to Follow-up|0|||
163043363|NCT02998996|588865803|FG001|Overall Study|Lost to Follow-up|0|||
163043364|NCT02998996|588865804|FG002|Overall Study|Lost to Follow-up|1|||
163043365|NCT02998996|588865805|FG003|Overall Study|Lost to Follow-up|0|||
163299414|NCT03703336|589805153|FG000|Overall Study|Adverse Event|0|||
163299415|NCT03703336|589805154|FG001|Overall Study|Adverse Event|2|||
163299416|NCT03703336|589805153|FG000|Overall Study|Lost to Follow-up|1|||
163299417|NCT03703336|589805154|FG001|Overall Study|Lost to Follow-up|0|||
163299418|NCT00595413|589805155|FG000|Overall Study|Adverse Event|0|||
163299419|NCT00595413|589805156|FG001|Overall Study|Adverse Event|2|||
163043366|NCT02998996|588865806|FG004|Overall Study|Lost to Follow-up|0|||
163043367|NCT02998996|588865807|FG005|Overall Study|Lost to Follow-up|0|||
163043368|NCT02998996|588865802|FG000|Overall Study|Pregnancy|0|||
163043369|NCT02998996|588865803|FG001|Overall Study|Pregnancy|1|||
163043370|NCT02998996|588865804|FG002|Overall Study|Pregnancy|0|||
163043371|NCT02998996|588865805|FG003|Overall Study|Pregnancy|0|||
163043372|NCT02998996|588865806|FG004|Overall Study|Pregnancy|0|||
163043373|NCT02998996|588865807|FG005|Overall Study|Pregnancy|0|||
163299420|NCT00595413|589805157|FG002|Overall Study|Adverse Event|1|||
163393295|NCT01949155|590152087|FG001|Overall Study|Lost to Follow-up|0|||
163393296|NCT01949155|590152086|FG000|Overall Study|Protocol Violation|1|||
163393297|NCT01949155|590152087|FG001|Overall Study|Protocol Violation|0|||
163393298|NCT02448225|590152088|FG000|Overall Study|Withdrawal by Subject|1|||
163393299|NCT02448225|590152088|FG000|Overall Study|Did not get FSPG scan|18|||
163393300|NCT02448225|590152088|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
163393301|NCT01287364|590152091|FG000|Overall Study|Adverse Event|0|||
163393302|NCT01287364|590152092|FG001|Overall Study|Adverse Event|3|||
163393303|NCT01287364|590152091|FG000|Overall Study|Protocol Violation|5|||
163393304|NCT01287364|590152092|FG001|Overall Study|Protocol Violation|5|||
163393305|NCT01287364|590152091|FG000|Overall Study|Other Reason|4|||
163043374|NCT02998996|588865802|FG000|Overall Study|Family reasons|0|||
163043375|NCT02998996|588865803|FG001|Overall Study|Family reasons|0|||
163043376|NCT02998996|588865804|FG002|Overall Study|Family reasons|0|||
163043377|NCT02998996|588865805|FG003|Overall Study|Family reasons|0|||
163043378|NCT02998996|588865806|FG004|Overall Study|Family reasons|1|||
163043379|NCT02998996|588865807|FG005|Overall Study|Family reasons|0|||
163043380|NCT01398358|588865812|FG000|Overall Study|Lost to Follow-up|11|||
163299421|NCT00595413|589805158|FG003|Overall Study|Adverse Event|1|||
163299422|NCT00595413|589805155|FG000|Overall Study|Lost to Follow-up|2|||
163393306|NCT01287364|590152092|FG001|Overall Study|Other Reason|2|||
163393307|NCT01245387|590152094|FG000|Overall Study|Lost to Follow-up|106|||
163043381|NCT01398358|588865813|FG001|Overall Study|Lost to Follow-up|21|||
163043382|NCT01398358|588865814|FG002|Overall Study|Lost to Follow-up|18|||
163299423|NCT00595413|589805156|FG001|Overall Study|Lost to Follow-up|2|||
163043383|NCT01398358|588865812|FG000|Overall Study|Withdrawal by Subject|3|||
163043384|NCT01398358|588865813|FG001|Overall Study|Withdrawal by Subject|2|||
163043385|NCT01398358|588865814|FG002|Overall Study|Withdrawal by Subject|2|||
162954228|NCT04115293|588537511|FG000|Overall Study|Adverse Event|0|||
162954229|NCT04115293|588537512|FG001|Overall Study|Adverse Event|2|||
162954230|NCT04115293|588537511|FG000|Overall Study|Withdrawal by Subject|2|||
162954231|NCT04115293|588537512|FG001|Overall Study|Withdrawal by Subject|1|||
162954232|NCT04115293|588537511|FG000|Overall Study|Physician Decision|1|||
163043386|NCT01398358|588865812|FG000|Overall Study|no longer eligible|1|||
162954233|NCT04115293|588537512|FG001|Overall Study|Physician Decision|0|||
162954234|NCT04115293|588537511|FG000|Overall Study|Death|1|||
162954235|NCT04115293|588537512|FG001|Overall Study|Death|1|||
162954236|NCT02674152|588537513|FG000|Overall Study|Personal Reasons|1|||
162954237|NCT02674152|588537514|FG001|Overall Study|Personal Reasons|0|||
162954238|NCT02674152|588537515|FG002|Overall Study|Personal Reasons|0|||
162954239|NCT02674152|588537516|FG003|Overall Study|Personal Reasons|1|||
162954240|NCT02674152|588537517|FG004|Overall Study|Personal Reasons|1|||
162954241|NCT02674152|588537513|FG000|Overall Study|Other adverse event or clinical progression|0|||
162954242|NCT02674152|588537514|FG001|Overall Study|Other adverse event or clinical progression|1|||
162954243|NCT02674152|588537515|FG002|Overall Study|Other adverse event or clinical progression|0|||
162954244|NCT02674152|588537516|FG003|Overall Study|Other adverse event or clinical progression|3|||
162954245|NCT02674152|588537517|FG004|Overall Study|Other adverse event or clinical progression|0|||
162954246|NCT02674152|588537513|FG000|Overall Study|Dose-limiting toxicity|0|||
162954247|NCT02674152|588537514|FG001|Overall Study|Dose-limiting toxicity|0|||
162954248|NCT02674152|588537515|FG002|Overall Study|Dose-limiting toxicity|0|||
162954249|NCT02674152|588537516|FG003|Overall Study|Dose-limiting toxicity|0|||
162954250|NCT02674152|588537517|FG004|Overall Study|Dose-limiting toxicity|1|||
162954251|NCT02674152|588537513|FG000|Overall Study|Progressive Disease|2|||
162954252|NCT02674152|588537514|FG001|Overall Study|Progressive Disease|1|||
162954253|NCT02674152|588537515|FG002|Overall Study|Progressive Disease|1|||
162954254|NCT02674152|588537516|FG003|Overall Study|Progressive Disease|13|||
163043387|NCT01398358|588865813|FG001|Overall Study|no longer eligible|0|||
163043388|NCT01398358|588865814|FG002|Overall Study|no longer eligible|1|||
163043389|NCT00003896|588865815|FG000|Overall Study|Adverse Event|16|||
162954255|NCT02674152|588537517|FG004|Overall Study|Progressive Disease|2|||
162954256|NCT02674152|588537513|FG000|Overall Study|Adverse Event|0|||
162954257|NCT02674152|588537514|FG001|Overall Study|Adverse Event|0|||
162954258|NCT02674152|588537515|FG002|Overall Study|Adverse Event|1|||
162954259|NCT02674152|588537516|FG003|Overall Study|Adverse Event|0|||
163043390|NCT00003896|588865815|FG000|Overall Study|Withdrawal by Subject|1|||
162954260|NCT02674152|588537517|FG004|Overall Study|Adverse Event|1|||
162954261|NCT03772522|588537518|FG000|Pre-intervention|Withdrawal by Subject|3|||
162954262|NCT03772522|588537519|FG001|Pre-intervention|Withdrawal by Subject|4|||
162954263|NCT03772522|588537518|FG000|Intervention|Withdrawal by Subject|1|||
162954264|NCT03772522|588537519|FG001|Intervention|Withdrawal by Subject|0|||
162954265|NCT03772522|588537518|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
162954266|NCT03772522|588537519|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
163193871|NCT03094169|589424970|FG004|Overall Study|Adverse Event|0|||
163043391|NCT00003896|588865815|FG000|Overall Study|Lack of Efficacy|1|||
163043392|NCT00003896|588865815|FG000|Overall Study|Death|3|||
163043393|NCT00003896|588865815|FG000|Overall Study|not protocol specified|3|||
163043394|NCT00003896|588865815|FG000|Overall Study|ineligible|5|||
163043395|NCT02559570|588865819|FG000|Overall Study|Adverse Event|0|||
163043396|NCT02559570|588865820|FG001|Overall Study|Adverse Event|2|||
163043397|NCT02559570|588865821|FG002|Overall Study|Adverse Event|0|||
163043398|NCT02559570|588865822|FG003|Overall Study|Adverse Event|1|||
163043399|NCT02559570|588865823|FG004|Overall Study|Adverse Event|0|||
163043400|NCT02559570|588865819|FG000|Overall Study|Withdrawal of Consent|0|||
163043401|NCT02559570|588865820|FG001|Overall Study|Withdrawal of Consent|0|||
163299424|NCT00595413|589805157|FG002|Overall Study|Lost to Follow-up|1|||
163299425|NCT00595413|589805158|FG003|Overall Study|Lost to Follow-up|3|||
163299426|NCT00595413|589805155|FG000|Overall Study|Death|0|||
163299427|NCT00595413|589805156|FG001|Overall Study|Death|0|||
163299428|NCT00595413|589805157|FG002|Overall Study|Death|1|||
163299429|NCT00595413|589805158|FG003|Overall Study|Death|0|||
163299430|NCT00595413|589805155|FG000|Overall Study|Other|5|||
163299431|NCT00595413|589805156|FG001|Overall Study|Other|1|||
163299432|NCT00595413|589805157|FG002|Overall Study|Other|5|||
163299433|NCT00595413|589805158|FG003|Overall Study|Other|0|||
163299434|NCT00807937|589805159|FG000|Overall Study|Adverse Event|12|||
163299435|NCT00807937|589805160|FG001|Overall Study|Adverse Event|12|||
163299436|NCT00807937|589805161|FG002|Overall Study|Adverse Event|5|||
163299437|NCT00807937|589805162|FG003|Overall Study|Adverse Event|4|||
163299438|NCT00807937|589805159|FG000|Overall Study|Protocol Violation|4|||
163393308|NCT01245387|590152094|FG000|Overall Study|Lack of Efficacy|195|||
163043402|NCT02559570|588865821|FG002|Overall Study|Withdrawal of Consent|1|||
163043403|NCT02559570|588865822|FG003|Overall Study|Withdrawal of Consent|2|||
163043404|NCT02559570|588865823|FG004|Overall Study|Withdrawal of Consent|1|||
163043405|NCT02559570|588865819|FG000|Overall Study|Lost to Follow-up|1|||
163043406|NCT02559570|588865820|FG001|Overall Study|Lost to Follow-up|0|||
163043407|NCT02559570|588865821|FG002|Overall Study|Lost to Follow-up|0|||
163393309|NCT01245387|590152094|FG000|Overall Study|Adverse Event|9|||
163393310|NCT01245387|590152094|FG000|Overall Study|Death|3|||
163043408|NCT02559570|588865822|FG003|Overall Study|Lost to Follow-up|0|||
163393311|NCT01245387|590152094|FG000|Overall Study|Other|131|||
163393312|NCT01245387|590152094|FG000|Overall Study|Missing discontinuation status|369|||
163393313|NCT00601705|590152095|FG000|Overall Study|Withdrawal by Subject|1|||
163393314|NCT02146599|590152098|FG000|Overall Study|Failed to meet inclusion criteria|5|||
163393315|NCT04246801|590152099|FG000|Overall Study|Adverse Event|1|||
163393316|NCT04246801|590152100|FG001|Overall Study|Adverse Event|1|||
163393317|NCT04246801|590152099|FG000|Overall Study|Protocol Violation|1|||
163393318|NCT04246801|590152100|FG001|Overall Study|Protocol Violation|1|||
163393319|NCT04246801|590152099|FG000|Overall Study|Lack of Efficacy|0|||
163393320|NCT04246801|590152100|FG001|Overall Study|Lack of Efficacy|2|||
163393321|NCT04246801|590152099|FG000|Overall Study|Lost to Follow-up|1|||
163393322|NCT04246801|590152100|FG001|Overall Study|Lost to Follow-up|1|||
163393323|NCT04246801|590152099|FG000|Overall Study|Withdrawal by Subject|2|||
163393324|NCT04246801|590152100|FG001|Overall Study|Withdrawal by Subject|1|||
163393325|NCT02101021|590152104|FG000|Overall Study|Death|4|||
163393326|NCT02101021|590152105|FG001|Overall Study|Death|3|||
163393327|NCT02101021|590152106|FG002|Overall Study|Death|6|||
163393328|NCT02101021|590152107|FG003|Overall Study|Death|0|||
163393329|NCT02101021|590152108|FG004|Overall Study|Death|3|||
163393330|NCT02101021|590152104|FG000|Overall Study|Withdrew Consent from study|1|||
163393331|NCT02101021|590152105|FG001|Overall Study|Withdrew Consent from study|1|||
163393332|NCT02101021|590152106|FG002|Overall Study|Withdrew Consent from study|0|||
163393333|NCT02101021|590152107|FG003|Overall Study|Withdrew Consent from study|2|||
163393334|NCT02101021|590152108|FG004|Overall Study|Withdrew Consent from study|0|||
163393335|NCT02101021|590152104|FG000|Overall Study|Lost to Follow-up|1|||
163393336|NCT02101021|590152105|FG001|Overall Study|Lost to Follow-up|0|||
163393337|NCT02101021|590152106|FG002|Overall Study|Lost to Follow-up|0|||
163393338|NCT02101021|590152107|FG003|Overall Study|Lost to Follow-up|0|||
163043409|NCT02559570|588865823|FG004|Overall Study|Lost to Follow-up|0|||
163043410|NCT02559570|588865819|FG000|Overall Study|Protocol Violation|1|||
163299439|NCT00807937|589805160|FG001|Overall Study|Protocol Violation|5|||
163299440|NCT00807937|589805161|FG002|Overall Study|Protocol Violation|3|||
163299441|NCT00807937|589805162|FG003|Overall Study|Protocol Violation|3|||
163299442|NCT00807937|589805159|FG000|Overall Study|Withdrawal by Subject|5|||
163393339|NCT02101021|590152108|FG004|Overall Study|Lost to Follow-up|0|||
163393340|NCT02101021|590152104|FG000|Overall Study|Study Terminated by Sponsor|1|||
163393341|NCT02101021|590152105|FG001|Overall Study|Study Terminated by Sponsor|0|||
163393342|NCT02101021|590152106|FG002|Overall Study|Study Terminated by Sponsor|1|||
163393343|NCT02101021|590152107|FG003|Overall Study|Study Terminated by Sponsor|1|||
163393344|NCT02101021|590152108|FG004|Overall Study|Study Terminated by Sponsor|1|||
163393345|NCT01368042|590152109|FG000|Overall Study|Death|14|||
163299443|NCT00807937|589805160|FG001|Overall Study|Withdrawal by Subject|4|||
163299444|NCT00807937|589805161|FG002|Overall Study|Withdrawal by Subject|1|||
163299445|NCT00807937|589805162|FG003|Overall Study|Withdrawal by Subject|4|||
163299446|NCT00807937|589805159|FG000|Overall Study|Lost to Follow-up|4|||
163299447|NCT00807937|589805160|FG001|Overall Study|Lost to Follow-up|0|||
163299448|NCT00807937|589805161|FG002|Overall Study|Lost to Follow-up|2|||
163299449|NCT00807937|589805162|FG003|Overall Study|Lost to Follow-up|1|||
163299450|NCT00807937|589805159|FG000|Overall Study|Lack of Efficacy|0|||
163299451|NCT00807937|589805160|FG001|Overall Study|Lack of Efficacy|0|||
163299452|NCT00807937|589805161|FG002|Overall Study|Lack of Efficacy|1|||
163299453|NCT00807937|589805162|FG003|Overall Study|Lack of Efficacy|2|||
163299454|NCT00807937|589805159|FG000|Overall Study|Intake of prohibited medicine|0|||
163299455|NCT00807937|589805160|FG001|Overall Study|Intake of prohibited medicine|0|||
163299456|NCT00807937|589805161|FG002|Overall Study|Intake of prohibited medicine|2|||
163299457|NCT00807937|589805162|FG003|Overall Study|Intake of prohibited medicine|0|||
163299458|NCT00807937|589805159|FG000|Overall Study|All other reasons (not provided)|2|||
163299459|NCT00807937|589805160|FG001|Overall Study|All other reasons (not provided)|4|||
163299460|NCT00807937|589805161|FG002|Overall Study|All other reasons (not provided)|0|||
163299461|NCT00807937|589805162|FG003|Overall Study|All other reasons (not provided)|1|||
163299462|NCT04629950|589805165|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
163299463|NCT04629950|589805166|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
163299464|NCT04629950|589805167|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
163299465|NCT04629950|589805168|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
163299466|NCT04629950|589805165|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
163299467|NCT04629950|589805166|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
163299468|NCT04629950|589805167|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
163299469|NCT04629950|589805168|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
163299470|NCT04629950|589805165|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
163299471|NCT04629950|589805166|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
163299472|NCT04629950|589805167|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
163299473|NCT04629950|589805168|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
163299474|NCT04629950|589805165|FG000|Extension Study|Withdrawal by Subject|0|||
163299475|NCT04629950|589805166|FG001|Extension Study|Withdrawal by Subject|0|||
163393346|NCT01368042|590152109|FG000|Overall Study|Protocol Violation|11|||
163393347|NCT01368042|590152109|FG000|Overall Study|Lost to Follow-up|4|||
163393348|NCT01368042|590152109|FG000|Overall Study|Transplanted|1|||
163393349|NCT02632721|590152111|FG000|Overall Study|Adverse Event|0|||
163393350|NCT02632721|590152112|FG001|Overall Study|Adverse Event|0|||
163393351|NCT02632721|590152113|FG002|Overall Study|Adverse Event|2|||
163393352|NCT02632721|590152114|FG003|Overall Study|Adverse Event|5|||
163393353|NCT02632721|590152115|FG004|Overall Study|Adverse Event|3|||
163393354|NCT02632721|590152111|FG000|Overall Study|Dose limiting toxicity|0|||
163393355|NCT02632721|590152112|FG001|Overall Study|Dose limiting toxicity|0|||
163393356|NCT02632721|590152113|FG002|Overall Study|Dose limiting toxicity|0|||
163393357|NCT02632721|590152114|FG003|Overall Study|Dose limiting toxicity|1|||
163393358|NCT02632721|590152115|FG004|Overall Study|Dose limiting toxicity|0|||
163393359|NCT02632721|590152111|FG000|Overall Study|Progressive disease|3|||
162954267|NCT00070291|588537523|FG000|Step 1|Withdrawal by Subject|1|||
162954268|NCT00070291|588537523|FG000|Step 1|Adverse Event|1|||
162954269|NCT00070291|588537523|FG000|Step 2|Adverse Event|1|||
162954270|NCT03255733|588537524|FG000|Overall Study|Lost to Follow-up|4|||
162954271|NCT02533258|588537526|FG000|Overall Study|Adverse Event|1|||
162954272|NCT02533258|588537526|FG000|Overall Study|Death|2|||
163393360|NCT02632721|590152112|FG001|Overall Study|Progressive disease|0|||
162954273|NCT02533258|588537526|FG000|Overall Study|Other|1|||
162954274|NCT02533258|588537526|FG000|Overall Study|Economic factor|1|||
162954275|NCT02533258|588537526|FG000|Overall Study|Progression of pleural effusion|1|||
162954276|NCT02533258|588537526|FG000|Overall Study|Lack of Efficacy|2|||
162954277|NCT02096211|588537527|FG000|Overall Study|Death|2|||
162954278|NCT02096211|588537527|FG000|Overall Study|Withdrawal by Subject|8|||
162954279|NCT02096211|588537527|FG000|Overall Study|Revision of implant|7|||
162954280|NCT02096211|588537527|FG000|Overall Study|Lost to Follow-up|43|||
162954281|NCT02883452|588537531|FG000|Overall Study|Withdrawal by Subject|1|||
162954282|NCT02883452|588537532|FG001|Overall Study|Withdrawal by Subject|1|||
162954283|NCT02883452|588537533|FG002|Overall Study|Withdrawal by Subject|3|||
162954284|NCT02883452|588537534|FG003|Overall Study|Withdrawal by Subject|0|||
162954285|NCT02883452|588537535|FG004|Overall Study|Withdrawal by Subject|2|||
162954286|NCT02883452|588537536|FG005|Overall Study|Withdrawal by Subject|5|||
162954287|NCT02883452|588537531|FG000|Overall Study|Disease progression|1|||
162954288|NCT02883452|588537532|FG001|Overall Study|Disease progression|0|||
162954289|NCT02883452|588537533|FG002|Overall Study|Disease progression|0|||
162954290|NCT02883452|588537534|FG003|Overall Study|Disease progression|1|||
163299476|NCT04629950|589805167|FG002|Extension Study|Withdrawal by Subject|1|||
163393361|NCT02632721|590152113|FG002|Overall Study|Progressive disease|4|||
163393362|NCT02632721|590152114|FG003|Overall Study|Progressive disease|6|||
163393363|NCT02632721|590152115|FG004|Overall Study|Progressive disease|5|||
163193872|NCT03094169|589424971|FG005|Overall Study|Adverse Event|0|||
163193873|NCT03094169|589424972|FG006|Overall Study|Adverse Event|0|||
163193874|NCT03094169|589424973|FG007|Overall Study|Adverse Event|2|||
163193875|NCT03094169|589424966|FG000|Overall Study|Withdrawal by Subject|0|||
163193876|NCT03094169|589424967|FG001|Overall Study|Withdrawal by Subject|0|||
163193877|NCT03094169|589424968|FG002|Overall Study|Withdrawal by Subject|0|||
163193878|NCT03094169|589424969|FG003|Overall Study|Withdrawal by Subject|0|||
163193879|NCT03094169|589424970|FG004|Overall Study|Withdrawal by Subject|0|||
163193880|NCT03094169|589424971|FG005|Overall Study|Withdrawal by Subject|0|||
163193881|NCT03094169|589424972|FG006|Overall Study|Withdrawal by Subject|1|||
163193882|NCT03094169|589424973|FG007|Overall Study|Withdrawal by Subject|1|||
163193883|NCT03094169|589424966|FG000|Overall Study|Trial Termination|0|||
163193884|NCT03094169|589424967|FG001|Overall Study|Trial Termination|0|||
163193885|NCT03094169|589424968|FG002|Overall Study|Trial Termination|0|||
163193886|NCT03094169|589424969|FG003|Overall Study|Trial Termination|0|||
163193887|NCT03094169|589424970|FG004|Overall Study|Trial Termination|0|||
163193888|NCT03094169|589424971|FG005|Overall Study|Trial Termination|0|||
163193889|NCT03094169|589424972|FG006|Overall Study|Trial Termination|0|||
163193890|NCT03094169|589424973|FG007|Overall Study|Trial Termination|1|||
163193891|NCT00617851|589424974|FG000|Overall Study|Death|0|||
163193892|NCT00617851|589424975|FG001|Overall Study|Death|0|||
163193893|NCT00617851|589424976|FG002|Overall Study|Death|0|||
163193894|NCT00617851|589424977|FG003|Overall Study|Death|1|||
163193895|NCT00617851|589424974|FG000|Overall Study|Withdrawal by Subject|14|||
163193896|NCT00617851|589424975|FG001|Overall Study|Withdrawal by Subject|7|||
162954291|NCT02883452|588537535|FG004|Overall Study|Disease progression|4|||
162954292|NCT02883452|588537536|FG005|Overall Study|Disease progression|5|||
163193897|NCT00617851|589424976|FG002|Overall Study|Withdrawal by Subject|12|||
163193898|NCT00617851|589424977|FG003|Overall Study|Withdrawal by Subject|4|||
163193899|NCT00617851|589424974|FG000|Overall Study|Lost to Follow-up|27|||
163193900|NCT00617851|589424975|FG001|Overall Study|Lost to Follow-up|29|||
163193901|NCT00617851|589424976|FG002|Overall Study|Lost to Follow-up|31|||
162954293|NCT02883452|588537531|FG000|Overall Study|Adverse Event|2|||
163193902|NCT00617851|589424977|FG003|Overall Study|Lost to Follow-up|19|||
163193903|NCT00617851|589424974|FG000|Overall Study|Inappropriate Enrollment|5|||
163299477|NCT04629950|589805168|FG003|Extension Study|Withdrawal by Subject|0|||
163299478|NCT04629950|589805165|FG000|Extension Study|Adverse Event|0|||
163299479|NCT04629950|589805166|FG001|Extension Study|Adverse Event|0|||
163299480|NCT04629950|589805167|FG002|Extension Study|Adverse Event|0|||
163299481|NCT04629950|589805168|FG003|Extension Study|Adverse Event|1|||
163299482|NCT02568683|589805172|FG000|Overall Study|Death|0|||
163299483|NCT02568683|589805173|FG001|Overall Study|Death|2|||
163299484|NCT02568683|589805172|FG000|Overall Study|Withdrew Consent|1|||
163299485|NCT02568683|589805173|FG001|Overall Study|Withdrew Consent|0|||
163393364|NCT02632721|590152111|FG000|Overall Study|Refused to continue taking trial medication|0|||
163299486|NCT02568683|589805172|FG000|Overall Study|Study Terminated By Sponsor|5|||
162954294|NCT02883452|588537532|FG001|Overall Study|Adverse Event|1|||
162954295|NCT02883452|588537533|FG002|Overall Study|Adverse Event|1|||
162954296|NCT02883452|588537534|FG003|Overall Study|Adverse Event|1|||
162954297|NCT02883452|588537535|FG004|Overall Study|Adverse Event|1|||
162954298|NCT02883452|588537536|FG005|Overall Study|Adverse Event|3|||
162954299|NCT02883452|588537531|FG000|Overall Study|Physician Decision|0|||
162954300|NCT02883452|588537532|FG001|Overall Study|Physician Decision|0|||
162954301|NCT02883452|588537533|FG002|Overall Study|Physician Decision|0|||
162954302|NCT02883452|588537534|FG003|Overall Study|Physician Decision|0|||
162954303|NCT02883452|588537535|FG004|Overall Study|Physician Decision|4|||
162954304|NCT02883452|588537536|FG005|Overall Study|Physician Decision|1|||
162954305|NCT02883452|588537531|FG000|Overall Study|Death|1|||
162954306|NCT02883452|588537532|FG001|Overall Study|Death|0|||
162954307|NCT02883452|588537533|FG002|Overall Study|Death|1|||
163043411|NCT02559570|588865820|FG001|Overall Study|Protocol Violation|0|||
163043412|NCT02559570|588865821|FG002|Overall Study|Protocol Violation|0|||
163043413|NCT02559570|588865822|FG003|Overall Study|Protocol Violation|0|||
163043414|NCT02559570|588865823|FG004|Overall Study|Protocol Violation|1|||
163043415|NCT02559570|588865819|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163043416|NCT02559570|588865820|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163043417|NCT02559570|588865821|FG002|Overall Study|Other Miscellaneous Reasons|1|||
163043418|NCT02559570|588865822|FG003|Overall Study|Other Miscellaneous Reasons|0|||
163043419|NCT02559570|588865823|FG004|Overall Study|Other Miscellaneous Reasons|0|||
163043420|NCT03373461|588865831|FG000|Part 2|Adverse Event|0|||
163043421|NCT03373461|588865832|FG001|Part 2|Adverse Event|1|||
163043422|NCT03373461|588865833|FG002|Part 2|Adverse Event|0|||
163043423|NCT03373461|588865834|FG003|Part 2|Adverse Event|0|||
163043424|NCT03373461|588865835|FG004|Part 2|Adverse Event|1|||
163043425|NCT01366638|588865836|FG000|Overall Study|Withdrawal by Subject|0|||
163043426|NCT01366638|588865837|FG001|Overall Study|Withdrawal by Subject|0|||
163043427|NCT01366638|588865838|FG002|Overall Study|Withdrawal by Subject|6|||
163043428|NCT01366638|588865836|FG000|Overall Study|Other|1|||
163043429|NCT01366638|588865837|FG001|Overall Study|Other|0|||
163043430|NCT01366638|588865838|FG002|Overall Study|Other|0|||
163043431|NCT00215644|588868035|FG000|Overall Study|Disease Progression|28|||
163043432|NCT00215644|588868036|FG001|Overall Study|Disease Progression|10|||
162954308|NCT02883452|588537534|FG003|Overall Study|Death|0|||
162954309|NCT02883452|588537535|FG004|Overall Study|Death|0|||
162954310|NCT02883452|588537536|FG005|Overall Study|Death|0|||
163043433|NCT00215644|588868035|FG000|Overall Study|Adverse Event|2|||
163043434|NCT00215644|588868036|FG001|Overall Study|Adverse Event|9|||
163043435|NCT00215644|588868035|FG000|Overall Study|Death|1|||
163043436|NCT00215644|588868036|FG001|Overall Study|Death|2|||
162954311|NCT02883452|588537531|FG000|Overall Study|Other|0|||
162954312|NCT02883452|588537532|FG001|Overall Study|Other|0|||
162954313|NCT02883452|588537533|FG002|Overall Study|Other|0|||
162954314|NCT02883452|588537534|FG003|Overall Study|Other|0|||
162954315|NCT02883452|588537535|FG004|Overall Study|Other|0|||
162954316|NCT02883452|588537536|FG005|Overall Study|Other|1|||
162954317|NCT00905840|588537542|FG000|Overall Study|Lost to Follow-up|11|||
162954318|NCT00905840|588537542|FG000|Overall Study|Death|3|||
162954319|NCT00905840|588537542|FG000|Overall Study|Withdrawal by Subject|1|||
162954320|NCT00905840|588537542|FG000|Overall Study|Adverse Event|1|||
162954321|NCT00448019|588537543|FG000|Overall Study|Withdrawal by Subject|3|||
162954322|NCT00448019|588537543|FG000|Overall Study|Disease progression|1|||
162954323|NCT00448019|588537543|FG000|Overall Study|Death|2|||
162954324|NCT00448019|588537543|FG000|Overall Study|Insurance Issues|1|||
162954325|NCT02699866|588537551|FG000|Overall Study|Withdrawal by Subject|3|||
162954326|NCT02699866|588537551|FG000|Overall Study|Physician Decision|2|||
162954327|NCT02699866|588537551|FG000|Overall Study|Adverse Event|3|||
162954328|NCT05169710|588537554|FG000|Overall Study|Adverse Event|1|||
162954329|NCT05169710|588537555|FG001|Overall Study|Adverse Event|2|||
162954330|NCT05169710|588537556|FG002|Overall Study|Adverse Event|2|||
162954331|NCT05169710|588537554|FG000|Overall Study|Lost to Follow-up|0|||
162954332|NCT05169710|588537555|FG001|Overall Study|Lost to Follow-up|0|||
162954333|NCT05169710|588537556|FG002|Overall Study|Lost to Follow-up|1|||
162954334|NCT05169710|588537554|FG000|Overall Study|Withdrawal by Subject|2|||
162954335|NCT05169710|588537555|FG001|Overall Study|Withdrawal by Subject|1|||
162954336|NCT05169710|588537556|FG002|Overall Study|Withdrawal by Subject|0|||
162954337|NCT05169710|588537554|FG000|Overall Study|Other Study Discontinuation Reason|0|||
162954338|NCT05169710|588537555|FG001|Overall Study|Other Study Discontinuation Reason|2|||
162954339|NCT05169710|588537556|FG002|Overall Study|Other Study Discontinuation Reason|0|||
162954340|NCT01208337|588537560|FG000|Overall Study|Death|3|||
162954341|NCT01864174|588537564|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
162954342|NCT01864174|588537565|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
162954343|NCT01864174|588537564|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
162954344|NCT01864174|588537565|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
162954345|NCT01864174|588537564|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
162954346|NCT01864174|588537565|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
162954347|NCT01864174|588537564|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
163043437|NCT00215644|588868035|FG000|Overall Study|Withdrawal by Subject|1|||
163043438|NCT00215644|588868036|FG001|Overall Study|Withdrawal by Subject|0|||
163043439|NCT00215644|588868035|FG000|Overall Study|Other|3|||
162954348|NCT01864174|588537565|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
162954349|NCT01864174|588537564|FG000|Double Blind - Compliant Randomized|Death|1|||
162954350|NCT01864174|588537565|FG001|Double Blind - Compliant Randomized|Death|0|||
162954351|NCT01864174|588537564|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
162954352|NCT01864174|588537565|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
162954353|NCT01864174|588537564|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
163043440|NCT00215644|588868036|FG001|Overall Study|Other|15|||
163043441|NCT00215644|588868035|FG000|Overall Study|Randomized but Not Treated|1|||
163043442|NCT00215644|588868036|FG001|Overall Study|Randomized but Not Treated|0|||
163043443|NCT02861664|588868039|FG000|Overall Study|Withdrawal of Consent|0|||
163043444|NCT02861664|588868040|FG001|Overall Study|Withdrawal of Consent|1|||
163043445|NCT03512353|588868041|FG000|Overall Study|Sponsor Decision|3|||
163043446|NCT03512353|588868041|FG000|Overall Study|Death|1|||
163043447|NCT01000974|588868042|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
163043448|NCT01000974|588868043|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
163043449|NCT01000974|588868044|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
163043450|NCT01000974|588868042|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
163043451|NCT01000974|588868043|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
163043452|NCT01000974|588868044|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
163043453|NCT01000974|588868042|FG000|Primary Vaccination Phase|Protocol Violation|40|||
163043454|NCT01000974|588868043|FG001|Primary Vaccination Phase|Protocol Violation|3|||
163043455|NCT01000974|588868044|FG002|Primary Vaccination Phase|Protocol Violation|2|||
163043456|NCT01000974|588868042|FG000|Primary Vaccination Phase|Adverse Event|14|||
163043457|NCT01000974|588868043|FG001|Primary Vaccination Phase|Adverse Event|2|||
163043458|NCT01000974|588868044|FG002|Primary Vaccination Phase|Adverse Event|2|||
163043459|NCT01000974|588868042|FG000|Primary Vaccination Phase|Other|4|||
163043460|NCT01000974|588868043|FG001|Primary Vaccination Phase|Other|9|||
163043461|NCT01000974|588868044|FG002|Primary Vaccination Phase|Other|12|||
163043462|NCT01000974|588868042|FG000|Booster Vaccination Phase|Protocol Violation|0|||
163043463|NCT01000974|588868043|FG001|Booster Vaccination Phase|Protocol Violation|0|||
163393365|NCT02632721|590152112|FG001|Overall Study|Refused to continue taking trial medication|1|||
163043464|NCT01000974|588868044|FG002|Booster Vaccination Phase|Protocol Violation|2|||
163043465|NCT01000974|588868042|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
162954354|NCT01864174|588537565|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
163043466|NCT01000974|588868043|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
163043467|NCT01000974|588868044|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
163043468|NCT01000974|588868042|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
162954355|NCT01864174|588537564|FG000|Double Blind - Compliant Randomized|Other|6|||
162954356|NCT01864174|588537565|FG001|Double Blind - Compliant Randomized|Other|10|||
162954357|NCT01864174|588537564|FG000|Off Treatment Follow-Up|Other|2|||
162954358|NCT01864174|588537565|FG001|Off Treatment Follow-Up|Other|0|||
162954359|NCT01864174|588537564|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
162954360|NCT01864174|588537565|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
162954361|NCT02158663|588537568|FG000|Overall Study|Withdrawal by Subject|5|||
162954362|NCT02158663|588537569|FG001|Overall Study|Withdrawal by Subject|4|||
162954363|NCT00576056|588537570|FG000|Overall Study|Adverse Event|1|||
162954364|NCT00576056|588537570|FG000|Overall Study|Death|1|||
162954365|NCT00576056|588537570|FG000|Overall Study|Lack of Efficacy|1|||
162954366|NCT00576056|588537570|FG000|Overall Study|Withdrawal by Subject|2|||
162954367|NCT00576056|588537570|FG000|Overall Study|did not meet eligibility criteria|8|||
162954368|NCT00576056|588537570|FG000|Overall Study|Physician Decision|1|||
162954369|NCT03197883|588537571|FG000|Overall Study|Adverse Event|1|||
162954370|NCT03197883|588537572|FG001|Overall Study|Adverse Event|1|||
162954371|NCT03197883|588537571|FG000|Overall Study|Lost to Follow-up|1|||
162954372|NCT03197883|588537572|FG001|Overall Study|Lost to Follow-up|0|||
162954373|NCT03197883|588537571|FG000|Overall Study|Protocol Violation|1|||
162954374|NCT03197883|588537572|FG001|Overall Study|Protocol Violation|0|||
162954375|NCT03197883|588537571|FG000|Overall Study|Other (Not Specified)|0|||
162954376|NCT03197883|588537572|FG001|Overall Study|Other (Not Specified)|5|||
162954377|NCT01353664|588537573|FG000|Overall Study|Other|3|||
162954378|NCT01353664|588537573|FG000|Overall Study|Disease Progression|16|||
162954379|NCT03273153|588537574|FG000|Overall Study|Adverse Event|1|||
162954380|NCT03273153|588537575|FG001|Overall Study|Adverse Event|2|||
162954381|NCT03273153|588537574|FG000|Overall Study|Missing|0|||
162954382|NCT03273153|588537575|FG001|Overall Study|Missing|2|||
162954383|NCT03273153|588537574|FG000|Overall Study|Other|3|||
162954384|NCT03273153|588537575|FG001|Overall Study|Other|2|||
162954385|NCT03273153|588537574|FG000|Overall Study|Symptomatic Deterioration|0|||
162954386|NCT03273153|588537575|FG001|Overall Study|Symptomatic Deterioration|1|||
162954387|NCT03273153|588537574|FG000|Overall Study|Progressive Disease|6|||
162954388|NCT03273153|588537575|FG001|Overall Study|Progressive Disease|5|||
162954389|NCT03273153|588537574|FG000|Overall Study|Physician Decision|1|||
162954390|NCT03273153|588537575|FG001|Overall Study|Physician Decision|3|||
162954391|NCT03273153|588537574|FG000|Overall Study|Study Terminated by Sponsor|112|||
162954392|NCT03273153|588537575|FG001|Overall Study|Study Terminated by Sponsor|102|||
162954393|NCT03273153|588537574|FG000|Overall Study|Withdrawal by Subject|26|||
162954394|NCT03273153|588537575|FG001|Overall Study|Withdrawal by Subject|25|||
163043469|NCT01000974|588868043|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
162954395|NCT03273153|588537574|FG000|Overall Study|Protocol Deviation|3|||
163043470|NCT01000974|588868044|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
162954396|NCT03273153|588537575|FG001|Overall Study|Protocol Deviation|0|||
162954397|NCT03273153|588537574|FG000|Overall Study|Lost to Follow-up|6|||
162954398|NCT03273153|588537575|FG001|Overall Study|Lost to Follow-up|11|||
162954399|NCT03273153|588537574|FG000|Overall Study|Death|66|||
162954400|NCT03273153|588537575|FG001|Overall Study|Death|69|||
162954401|NCT02409355|588537576|FG000|Overall Study|Withdrawal by Subject|1|||
162954402|NCT02409355|588537577|FG001|Overall Study|Withdrawal by Subject|0|||
162954403|NCT02409355|588537576|FG000|Overall Study|Death|1|||
162954404|NCT02409355|588537577|FG001|Overall Study|Death|1|||
163043471|NCT01000974|588868042|FG000|Booster Vaccination Phase|Other|24|||
162954405|NCT02409355|588537576|FG000|Overall Study|Study terminated by Sponsor|2|||
163193904|NCT00617851|589424975|FG001|Overall Study|Inappropriate Enrollment|4|||
163193905|NCT00617851|589424976|FG002|Overall Study|Inappropriate Enrollment|1|||
163193906|NCT00617851|589424977|FG003|Overall Study|Inappropriate Enrollment|1|||
163193907|NCT00617851|589424974|FG000|Overall Study|Unable to classify|1|||
163193908|NCT00617851|589424975|FG001|Overall Study|Unable to classify|0|||
163193909|NCT00617851|589424976|FG002|Overall Study|Unable to classify|1|||
163193910|NCT00617851|589424977|FG003|Overall Study|Unable to classify|0|||
163193911|NCT05350410|589424980|FG000|Overall Study|Withdrawal by Subject|1|||
163299487|NCT02568683|589805173|FG001|Overall Study|Study Terminated By Sponsor|2|||
163193912|NCT03750955|589424987|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
163043472|NCT01000974|588868043|FG001|Booster Vaccination Phase|Other|6|||
163193913|NCT03750955|589424988|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
163193914|NCT03750955|589424987|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
163193915|NCT03750955|589424988|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
163193916|NCT00697788|589424994|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
163193917|NCT00697788|589424995|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
163193918|NCT00697788|589424996|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
163193919|NCT00697788|589424997|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
163393366|NCT02632721|590152113|FG002|Overall Study|Refused to continue taking trial medication|1|||
162954406|NCT02409355|588537577|FG001|Overall Study|Study terminated by Sponsor|3|||
162954407|NCT01237054|588537578|FG000|Overall Study|imaging 10C0096|1|||
162954408|NCT00838539|588537579|FG000|Overall Study|Disease Progression|2|||
162954409|NCT00838539|588537580|FG001|Overall Study|Disease Progression|4|||
162954410|NCT00838539|588537581|FG002|Overall Study|Disease Progression|3|||
162954411|NCT00838539|588537582|FG003|Overall Study|Disease Progression|2|||
162954412|NCT00838539|588537583|FG004|Overall Study|Disease Progression|4|||
162954413|NCT00838539|588537584|FG005|Overall Study|Disease Progression|2|||
162954414|NCT00838539|588537585|FG006|Overall Study|Disease Progression|3|||
162954415|NCT00838539|588537586|FG007|Overall Study|Disease Progression|4|||
162954416|NCT00838539|588537587|FG008|Overall Study|Disease Progression|4|||
162954417|NCT00838539|588537588|FG009|Overall Study|Disease Progression|5|||
163393367|NCT02632721|590152114|FG003|Overall Study|Refused to continue taking trial medication|1|||
162954418|NCT00838539|588537589|FG010|Overall Study|Disease Progression|1|||
162954419|NCT00838539|588537590|FG011|Overall Study|Disease Progression|4|||
162954420|NCT00838539|588537579|FG000|Overall Study|Adverse Event|1|||
162954421|NCT00838539|588537580|FG001|Overall Study|Adverse Event|1|||
162954422|NCT00838539|588537581|FG002|Overall Study|Adverse Event|1|||
162954423|NCT00838539|588537582|FG003|Overall Study|Adverse Event|1|||
162954424|NCT00838539|588537583|FG004|Overall Study|Adverse Event|2|||
162954425|NCT00838539|588537584|FG005|Overall Study|Adverse Event|1|||
162954426|NCT00838539|588537585|FG006|Overall Study|Adverse Event|0|||
162954427|NCT00838539|588537586|FG007|Overall Study|Adverse Event|2|||
162954428|NCT00838539|588537587|FG008|Overall Study|Adverse Event|0|||
162954429|NCT00838539|588537588|FG009|Overall Study|Adverse Event|1|||
162954430|NCT00838539|588537589|FG010|Overall Study|Adverse Event|2|||
162954431|NCT00838539|588537590|FG011|Overall Study|Adverse Event|0|||
162954432|NCT00838539|588537579|FG000|Overall Study|Withdrawal by Subject|0|||
162954433|NCT00838539|588537580|FG001|Overall Study|Withdrawal by Subject|1|||
162954434|NCT00838539|588537581|FG002|Overall Study|Withdrawal by Subject|0|||
162954435|NCT00838539|588537582|FG003|Overall Study|Withdrawal by Subject|0|||
162954436|NCT00838539|588537583|FG004|Overall Study|Withdrawal by Subject|0|||
162954437|NCT00838539|588537584|FG005|Overall Study|Withdrawal by Subject|0|||
162954438|NCT00838539|588537585|FG006|Overall Study|Withdrawal by Subject|0|||
162954439|NCT00838539|588537586|FG007|Overall Study|Withdrawal by Subject|0|||
162954440|NCT00838539|588537587|FG008|Overall Study|Withdrawal by Subject|0|||
162954441|NCT00838539|588537588|FG009|Overall Study|Withdrawal by Subject|1|||
162954442|NCT00838539|588537589|FG010|Overall Study|Withdrawal by Subject|2|||
162954443|NCT00838539|588537590|FG011|Overall Study|Withdrawal by Subject|0|||
162954444|NCT00838539|588537579|FG000|Overall Study|Death|0|||
162954445|NCT00838539|588537580|FG001|Overall Study|Death|0|||
162954446|NCT00838539|588537581|FG002|Overall Study|Death|0|||
162954447|NCT00838539|588537582|FG003|Overall Study|Death|0|||
162954448|NCT00838539|588537583|FG004|Overall Study|Death|0|||
162954449|NCT00838539|588537584|FG005|Overall Study|Death|0|||
162954450|NCT00838539|588537585|FG006|Overall Study|Death|1|||
162954451|NCT00838539|588537586|FG007|Overall Study|Death|0|||
162954452|NCT00838539|588537587|FG008|Overall Study|Death|0|||
162954453|NCT00838539|588537588|FG009|Overall Study|Death|0|||
162954454|NCT00838539|588537589|FG010|Overall Study|Death|0|||
162954455|NCT00838539|588537590|FG011|Overall Study|Death|0|||
162954456|NCT00838539|588537579|FG000|Overall Study|Physician Decision|0|||
162954457|NCT00838539|588537580|FG001|Overall Study|Physician Decision|0|||
162954458|NCT00838539|588537581|FG002|Overall Study|Physician Decision|0|||
162954459|NCT00838539|588537582|FG003|Overall Study|Physician Decision|0|||
162954460|NCT00838539|588537583|FG004|Overall Study|Physician Decision|0|||
162954461|NCT00838539|588537584|FG005|Overall Study|Physician Decision|0|||
163043473|NCT01000974|588868044|FG002|Booster Vaccination Phase|Other|4|||
163043474|NCT01639144|588868047|FG000|Overall Study|Withdrawal by Subject|4|||
163043475|NCT01639144|588868048|FG001|Overall Study|Withdrawal by Subject|2|||
163043476|NCT01639144|588868047|FG000|Overall Study|Physician Decision|2|||
163043477|NCT01639144|588868048|FG001|Overall Study|Physician Decision|0|||
163043478|NCT01639144|588868047|FG000|Overall Study|Met postoperative exclusion criteria|4|||
163043479|NCT01639144|588868048|FG001|Overall Study|Met postoperative exclusion criteria|3|||
163043480|NCT01307891|588868050|FG000|Overall Study|Progressive Disease|3|||
163043481|NCT01307891|588868051|FG001|Overall Study|Progressive Disease|1|||
163043482|NCT03365934|588868052|FG000|Overall Study|Adverse Event|1|||
163043483|NCT03365934|588868052|FG000|Overall Study|Withdrawal by Subject|1|||
163043484|NCT02937740|588868053|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
163043485|NCT02937740|588868054|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
163043486|NCT02937740|588868053|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
163043487|NCT02937740|588868054|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
163043488|NCT02937740|588868053|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
163043489|NCT02937740|588868054|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
163043490|NCT02937740|588868053|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
163043491|NCT02937740|588868054|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
163043492|NCT02937740|588868053|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
163043493|NCT02937740|588868054|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
163043494|NCT02937740|588868053|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
163043495|NCT02937740|588868054|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
163043496|NCT02964338|588868057|FG000|Overall Study|Sponsor terminated study for futility|12|||
163043497|NCT02964338|588868058|FG001|Overall Study|Sponsor terminated study for futility|15|||
163043498|NCT02964338|588868059|FG002|Overall Study|Sponsor terminated study for futility|14|||
163043499|NCT02964338|588868057|FG000|Overall Study|Lack of Efficacy|0|||
162954462|NCT00838539|588537585|FG006|Overall Study|Physician Decision|0|||
162954463|NCT00838539|588537586|FG007|Overall Study|Physician Decision|0|||
162954464|NCT00838539|588537587|FG008|Overall Study|Physician Decision|1|||
162954465|NCT00838539|588537588|FG009|Overall Study|Physician Decision|0|||
163043500|NCT02964338|588868058|FG001|Overall Study|Lack of Efficacy|3|||
163193920|NCT00697788|589424998|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
163193921|NCT00697788|589424999|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
163193922|NCT00697788|589425000|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162954466|NCT00838539|588537589|FG010|Overall Study|Physician Decision|0|||
162954467|NCT00838539|588537590|FG011|Overall Study|Physician Decision|0|||
162954468|NCT00838539|588537579|FG000|Overall Study|Clinical Progression|0|||
162954469|NCT00838539|588537580|FG001|Overall Study|Clinical Progression|0|||
162954470|NCT00838539|588537581|FG002|Overall Study|Clinical Progression|0|||
162954471|NCT00838539|588537582|FG003|Overall Study|Clinical Progression|0|||
162954472|NCT00838539|588537583|FG004|Overall Study|Clinical Progression|0|||
162954473|NCT00838539|588537584|FG005|Overall Study|Clinical Progression|0|||
162954474|NCT00838539|588537585|FG006|Overall Study|Clinical Progression|1|||
162954475|NCT00838539|588537586|FG007|Overall Study|Clinical Progression|0|||
163043501|NCT02964338|588868059|FG002|Overall Study|Lack of Efficacy|0|||
163043502|NCT02964338|588868057|FG000|Overall Study|Lost to Follow-up|1|||
163043503|NCT02964338|588868058|FG001|Overall Study|Lost to Follow-up|0|||
163043504|NCT02964338|588868059|FG002|Overall Study|Lost to Follow-up|3|||
163043505|NCT02964338|588868057|FG000|Overall Study|Protocol Violation|0|||
163193923|NCT00697788|589425001|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162954476|NCT00838539|588537587|FG008|Overall Study|Clinical Progression|0|||
163299488|NCT01561989|589805176|FG000|Overall Study|accural target not met.|5|||
163299489|NCT01561989|589805177|FG001|Overall Study|accural target not met.|6|||
163299490|NCT02477605|589805181|FG000|Overall Study|Discontinued prior to treatment|1|||
163299491|NCT02477605|589805182|FG001|Overall Study|Discontinued prior to treatment|0|||
163299492|NCT02477605|589805181|FG000|Overall Study|Lost to Follow-up|0|||
163299493|NCT02477605|589805182|FG001|Overall Study|Lost to Follow-up|2|||
163299494|NCT02477605|589805181|FG000|Overall Study|Withdrawal by Subject|0|||
163299495|NCT02477605|589805182|FG001|Overall Study|Withdrawal by Subject|1|||
163299496|NCT02477605|589805181|FG000|Overall Study|Administered gas during surgery|0|||
163299497|NCT02477605|589805182|FG001|Overall Study|Administered gas during surgery|1|||
163299498|NCT00970359|589805186|FG000|Overall Study|Not Treated|4|||
163299499|NCT01388361|589805187|FG000|Overall Study|Adverse Event|0|||
163299500|NCT01388361|589805188|FG001|Overall Study|Adverse Event|5|||
163299501|NCT01388361|589805189|FG002|Overall Study|Adverse Event|1|||
163299502|NCT01388361|589805187|FG000|Overall Study|Protocol Violation|0|||
163299503|NCT01388361|589805188|FG001|Overall Study|Protocol Violation|0|||
163299504|NCT01388361|589805189|FG002|Overall Study|Protocol Violation|2|||
163299505|NCT01388361|589805187|FG000|Overall Study|Withdrawal criteria|12|||
163043506|NCT02964338|588868058|FG001|Overall Study|Protocol Violation|1|||
163043507|NCT02964338|588868059|FG002|Overall Study|Protocol Violation|0|||
163043508|NCT02964338|588868057|FG000|Overall Study|Withdrawal by Subject|1|||
163043509|NCT02964338|588868058|FG001|Overall Study|Withdrawal by Subject|3|||
163043510|NCT02964338|588868059|FG002|Overall Study|Withdrawal by Subject|1|||
163043511|NCT02964338|588868057|FG000|Overall Study|Adverse Event|2|||
163043512|NCT02964338|588868058|FG001|Overall Study|Adverse Event|1|||
163043513|NCT02964338|588868059|FG002|Overall Study|Adverse Event|1|||
163043514|NCT02964338|588868057|FG000|Overall Study|Non-compliant with e-diary|0|||
163043515|NCT02964338|588868058|FG001|Overall Study|Non-compliant with e-diary|1|||
163043516|NCT02964338|588868059|FG002|Overall Study|Non-compliant with e-diary|0|||
163043517|NCT02964338|588868057|FG000|Overall Study|Did not meet criteria|1|||
163043518|NCT02964338|588868058|FG001|Overall Study|Did not meet criteria|0|||
163043519|NCT02964338|588868059|FG002|Overall Study|Did not meet criteria|0|||
163043520|NCT02291029|588868064|FG000|Overall Study|Withdrawal by Subject|0|||
163043521|NCT02291029|588868065|FG001|Overall Study|Withdrawal by Subject|0|||
163043522|NCT02291029|588868066|FG002|Overall Study|Withdrawal by Subject|1|||
163043523|NCT02291029|588868067|FG003|Overall Study|Withdrawal by Subject|0|||
162954477|NCT00838539|588537588|FG009|Overall Study|Clinical Progression|0|||
162954478|NCT00838539|588537589|FG010|Overall Study|Clinical Progression|0|||
162954479|NCT00838539|588537590|FG011|Overall Study|Clinical Progression|0|||
162954480|NCT00838539|588537579|FG000|Overall Study|Symptomatic Deterioration|0|||
162954481|NCT00838539|588537580|FG001|Overall Study|Symptomatic Deterioration|0|||
162954482|NCT00838539|588537581|FG002|Overall Study|Symptomatic Deterioration|1|||
162954483|NCT00838539|588537582|FG003|Overall Study|Symptomatic Deterioration|1|||
162954484|NCT00838539|588537583|FG004|Overall Study|Symptomatic Deterioration|0|||
162954485|NCT00838539|588537584|FG005|Overall Study|Symptomatic Deterioration|1|||
162954486|NCT00838539|588537585|FG006|Overall Study|Symptomatic Deterioration|0|||
162954487|NCT00838539|588537586|FG007|Overall Study|Symptomatic Deterioration|0|||
162954488|NCT00838539|588537587|FG008|Overall Study|Symptomatic Deterioration|0|||
162954489|NCT00838539|588537588|FG009|Overall Study|Symptomatic Deterioration|1|||
162954490|NCT00838539|588537589|FG010|Overall Study|Symptomatic Deterioration|0|||
162954491|NCT00838539|588537590|FG011|Overall Study|Symptomatic Deterioration|0|||
162954492|NCT01908205|588537591|FG000|Overall Study|Lost to Follow-up|2|||
162954493|NCT01908205|588537592|FG001|Overall Study|Lost to Follow-up|0|||
162954494|NCT01908205|588537591|FG000|Overall Study|Withdrawal by Subject|3|||
162954495|NCT01908205|588537592|FG001|Overall Study|Withdrawal by Subject|1|||
162954496|NCT05323396|588537593|FG000|Overall Study|Lost to Follow-up|1|||
162954497|NCT05323396|588537594|FG001|Overall Study|Lost to Follow-up|35|||
162954498|NCT05323396|588537593|FG000|Overall Study|Pregnancy|1|||
162954499|NCT05323396|588537594|FG001|Overall Study|Pregnancy|0|||
162954500|NCT03420300|588537601|FG000|Overall Study|Death|2|||
162954501|NCT03500692|588537609|FG000|Overall Study|Death|163|||
162954502|NCT03500692|588537609|FG000|Overall Study|Lost to Follow-up|75|||
162954503|NCT03500692|588537609|FG000|Overall Study|Termination Reasons|3|||
162954504|NCT02305758|588537610|FG000|Overall Study|Death|27|||
162954505|NCT02305758|588537611|FG001|Overall Study|Death|27|||
162954506|NCT02305758|588537610|FG000|Overall Study|Withdrew consent|9|||
162954507|NCT02305758|588537611|FG001|Overall Study|Withdrew consent|2|||
162954508|NCT02305758|588537610|FG000|Overall Study|Lost to Follow-up|6|||
162954509|NCT02305758|588537611|FG001|Overall Study|Lost to Follow-up|1|||
162954510|NCT02305758|588537610|FG000|Overall Study|Study Terminated by Sponsor|21|||
162954511|NCT02305758|588537611|FG001|Overall Study|Study Terminated by Sponsor|34|||
162954512|NCT02305758|588537610|FG000|Overall Study|Other, not specified|2|||
162954513|NCT02305758|588537611|FG001|Overall Study|Other, not specified|1|||
162954514|NCT02032888|588537613|FG000|Treatment Period|Poor compliance/noncompliance|1|||
162954515|NCT02032888|588537614|FG001|Treatment Period|Poor compliance/noncompliance|1|||
162954516|NCT02032888|588537615|FG002|Treatment Period|Poor compliance/noncompliance|0|||
162954517|NCT02032888|588537613|FG000|Treatment Period|Other|1|||
163043524|NCT02291029|588868068|FG004|Overall Study|Withdrawal by Subject|0|||
162954518|NCT02032888|588537614|FG001|Treatment Period|Other|1|||
162954519|NCT02032888|588537615|FG002|Treatment Period|Other|0|||
162954520|NCT02032888|588537613|FG000|Follow-up Period|Lost to Follow-up|1|||
163043525|NCT02291029|588868069|FG005|Overall Study|Withdrawal by Subject|0|||
163393368|NCT02632721|590152115|FG004|Overall Study|Refused to continue taking trial medication|2|||
162954521|NCT02032888|588537614|FG001|Follow-up Period|Lost to Follow-up|1|||
163043526|NCT02291029|588868064|FG000|Overall Study|Adverse Event|0|||
162954522|NCT02032888|588537615|FG002|Follow-up Period|Lost to Follow-up|0|||
162954523|NCT02032888|588537613|FG000|Follow-up Period|Death|1|||
162954524|NCT02032888|588537614|FG001|Follow-up Period|Death|1|||
162954525|NCT02032888|588537615|FG002|Follow-up Period|Death|0|||
162954526|NCT02032888|588537613|FG000|Follow-up Period|Other|1|||
162954527|NCT02032888|588537614|FG001|Follow-up Period|Other|0|||
163043527|NCT02291029|588868065|FG001|Overall Study|Adverse Event|1|||
163043528|NCT02291029|588868066|FG002|Overall Study|Adverse Event|0|||
163043529|NCT02291029|588868067|FG003|Overall Study|Adverse Event|0|||
163043530|NCT02291029|588868068|FG004|Overall Study|Adverse Event|0|||
163043531|NCT02291029|588868069|FG005|Overall Study|Adverse Event|0|||
162954528|NCT02032888|588537615|FG002|Follow-up Period|Other|0|||
162954529|NCT01424644|588537616|FG000|Overall Study|Adverse Event|2|||
162954530|NCT01424644|588537617|FG001|Overall Study|Adverse Event|0|||
162954531|NCT01424644|588537616|FG000|Overall Study|Withdrawal by Subject|9|||
162954532|NCT01424644|588537617|FG001|Overall Study|Withdrawal by Subject|12|||
162954533|NCT01424644|588537616|FG000|Overall Study|Lost to Follow-up|16|||
162954534|NCT01424644|588537617|FG001|Overall Study|Lost to Follow-up|12|||
162954535|NCT01424644|588537616|FG000|Overall Study|Protocol Violation|4|||
162954536|NCT01424644|588537617|FG001|Overall Study|Protocol Violation|3|||
162954537|NCT01424644|588537616|FG000|Overall Study|Administrative Reason|1|||
162954538|NCT01424644|588537617|FG001|Overall Study|Administrative Reason|0|||
162954539|NCT01424644|588537616|FG000|Overall Study|Unable to Classify|1|||
162954540|NCT01424644|588537617|FG001|Overall Study|Unable to Classify|0|||
162954541|NCT05593965|588537618|FG000|1st Intervention (1 Day)|Technical error|1|||
162954542|NCT05593965|588537619|FG001|1st Intervention (1 Day)|Technical error|0|||
162954543|NCT02272777|588537620|FG000|Overall Study|Adverse Event|0|||
162954544|NCT02272777|588537621|FG001|Overall Study|Adverse Event|1|||
162954545|NCT02272777|588537620|FG000|Overall Study|Withdrawal by Subject|0|||
162954546|NCT02272777|588537621|FG001|Overall Study|Withdrawal by Subject|3|||
162954547|NCT02272777|588537620|FG000|Overall Study|Lost to Follow-up|2|||
162954548|NCT02272777|588537621|FG001|Overall Study|Lost to Follow-up|0|||
162954549|NCT02272777|588537620|FG000|Overall Study|Other|2|||
162954550|NCT02272777|588537621|FG001|Overall Study|Other|0|||
162954551|NCT02066922|588537624|FG000|Overall Study|Adverse Event|1|||
162954552|NCT00440297|588537625|FG000|Overall Study|Adverse Event|8|||
162954553|NCT00440297|588537626|FG001|Overall Study|Adverse Event|5|||
162954554|NCT00440297|588537625|FG000|Overall Study|Lost to Follow-up|1|||
162954555|NCT00440297|588537626|FG001|Overall Study|Lost to Follow-up|0|||
162954556|NCT00440297|588537625|FG000|Overall Study|Physician Decision|1|||
162954557|NCT00440297|588537626|FG001|Overall Study|Physician Decision|0|||
162954558|NCT00440297|588537625|FG000|Overall Study|Protocol Violation|11|||
162954559|NCT00440297|588537626|FG001|Overall Study|Protocol Violation|7|||
162954560|NCT00440297|588537625|FG000|Overall Study|Withdrawal by Subject|1|||
162954561|NCT00440297|588537626|FG001|Overall Study|Withdrawal by Subject|6|||
162954562|NCT00440297|588537625|FG000|Overall Study|Randomized by mistake|1|||
162954563|NCT00440297|588537626|FG001|Overall Study|Randomized by mistake|0|||
162954564|NCT02445339|588537627|FG000|Overall Study|Physician Decision|1|||
162954565|NCT02445339|588537628|FG001|Overall Study|Physician Decision|0|||
162954566|NCT02445339|588537627|FG000|Overall Study|Lost to Follow-up|11|||
162954567|NCT02445339|588537628|FG001|Overall Study|Lost to Follow-up|15|||
162954568|NCT02024932|588537629|FG000|Overall Study|Adverse Event|2|||
162954569|NCT02024932|588537630|FG001|Overall Study|Adverse Event|3|||
162954570|NCT02024932|588537631|FG002|Overall Study|Adverse Event|0|||
162954571|NCT02024932|588537632|FG003|Overall Study|Adverse Event|0|||
162954572|NCT02024932|588537633|FG004|Overall Study|Adverse Event|2|||
163043532|NCT02171429|588868070|FG000|Overall Study|Other|0|||
163043533|NCT02171429|588868071|FG001|Overall Study|Other|1|||
162954573|NCT02024932|588537634|FG005|Overall Study|Adverse Event|0|||
162954574|NCT02024932|588537629|FG000|Overall Study|Abnormal laboratory value|0|||
162954575|NCT02024932|588537630|FG001|Overall Study|Abnormal laboratory value|0|||
162954576|NCT02024932|588537631|FG002|Overall Study|Abnormal laboratory value|0|||
162954577|NCT02024932|588537632|FG003|Overall Study|Abnormal laboratory value|2|||
162954578|NCT02024932|588537633|FG004|Overall Study|Abnormal laboratory value|0|||
162954579|NCT02024932|588537634|FG005|Overall Study|Abnormal laboratory value|0|||
162954580|NCT03206177|588537635|FG000|Overall Study|Withdrawal by Subject|1|||
162954581|NCT03020641|588537636|FG000|Overall Study|Lost to Follow-up|0|||
162954582|NCT03020641|588537637|FG001|Overall Study|Lost to Follow-up|1|||
162954583|NCT03020641|588537636|FG000|Overall Study|Converted to open surgery|2|||
162954584|NCT03020641|588537637|FG001|Overall Study|Converted to open surgery|1|||
162954585|NCT03020641|588537636|FG000|Overall Study|for surgery not performed|0|||
163043534|NCT02171429|588868072|FG002|Overall Study|Other|1|||
162954586|NCT03020641|588537637|FG001|Overall Study|for surgery not performed|1|||
162954587|NCT00727961|588537638|FG000|Overall Study|Lost to Follow-up|1|||
162954588|NCT00727961|588537638|FG000|Overall Study|Adverse Event|4|||
162954589|NCT00727961|588537638|FG000|Overall Study|Patient's refusal|2|||
162954590|NCT00727961|588537638|FG000|Overall Study|Progression|30|||
162954591|NCT03238781|588537639|FG000|Overall Study|Adverse Event|1|||
162954592|NCT03238781|588537640|FG001|Overall Study|Adverse Event|1|||
162954593|NCT03238781|588537641|FG002|Overall Study|Adverse Event|2|||
162954594|NCT03238781|588537639|FG000|Overall Study|Lost to Follow-up|2|||
162954595|NCT03238781|588537640|FG001|Overall Study|Lost to Follow-up|1|||
162954596|NCT03238781|588537641|FG002|Overall Study|Lost to Follow-up|2|||
163043535|NCT02171429|588868070|FG000|Overall Study|Non-Compliance|0|||
163043536|NCT02171429|588868071|FG001|Overall Study|Non-Compliance|0|||
163043537|NCT02171429|588868072|FG002|Overall Study|Non-Compliance|1|||
163043538|NCT02171429|588868070|FG000|Overall Study|Physician Decision|0|||
163043539|NCT02171429|588868071|FG001|Overall Study|Physician Decision|0|||
163043540|NCT02171429|588868072|FG002|Overall Study|Physician Decision|1|||
163043541|NCT02171429|588868070|FG000|Overall Study|Withdrawal by Subject|1|||
163043542|NCT02171429|588868071|FG001|Overall Study|Withdrawal by Subject|1|||
163299506|NCT01388361|589805188|FG001|Overall Study|Withdrawal criteria|7|||
163299507|NCT01388361|589805189|FG002|Overall Study|Withdrawal criteria|10|||
163299508|NCT01388361|589805187|FG000|Overall Study|Unclassified|0|||
163043543|NCT02171429|588868072|FG002|Overall Study|Withdrawal by Subject|1|||
163299509|NCT01388361|589805188|FG001|Overall Study|Unclassified|0|||
163043544|NCT02171429|588868070|FG000|Overall Study|Lost to Follow-up|0|||
163043545|NCT02171429|588868071|FG001|Overall Study|Lost to Follow-up|1|||
163043546|NCT02171429|588868072|FG002|Overall Study|Lost to Follow-up|0|||
163043547|NCT02171429|588868070|FG000|Overall Study|Death|0|||
163043548|NCT02171429|588868071|FG001|Overall Study|Death|0|||
163043549|NCT02171429|588868072|FG002|Overall Study|Death|1|||
163043550|NCT00493012|588868073|FG000|Overall Study|Lost to Follow-up|18|||
163043551|NCT00493012|588868074|FG001|Overall Study|Lost to Follow-up|17|||
163043552|NCT04147247|588868076|FG000|Overall Study|Progressive disease|3|||
163043553|NCT04147247|588868077|FG001|Overall Study|Progressive disease|3|||
163043554|NCT04147247|588868078|FG002|Overall Study|Progressive disease|4|||
163043555|NCT04147247|588868079|FG003|Overall Study|Progressive disease|4|||
163043556|NCT04147247|588868080|FG004|Overall Study|Progressive disease|3|||
163043557|NCT04147247|588868076|FG000|Overall Study|Physician Decision|0|||
163043558|NCT04147247|588868077|FG001|Overall Study|Physician Decision|1|||
163193924|NCT00697788|589424994|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
163193925|NCT00697788|589424995|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
163193926|NCT00697788|589424996|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
163193927|NCT00697788|589424997|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
163193928|NCT00697788|589424998|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
163193929|NCT00697788|589424999|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
163193930|NCT00697788|589425000|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
163193931|NCT00697788|589425001|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
163193932|NCT00142935|589425003|FG000|Overall Study|Other reason|1|||
163193933|NCT00142935|589425004|FG001|Overall Study|Other reason|1|||
163043559|NCT04147247|588868078|FG002|Overall Study|Physician Decision|0|||
163043560|NCT04147247|588868079|FG003|Overall Study|Physician Decision|0|||
163043561|NCT04147247|588868080|FG004|Overall Study|Physician Decision|0|||
163043562|NCT04147247|588868076|FG000|Overall Study|Clinical Disease Progression|0|||
163299510|NCT01388361|589805189|FG002|Overall Study|Unclassified|1|||
163299511|NCT05368831|589805192|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
163299512|NCT03565315|589805194|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
163299513|NCT03565315|589805195|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
163043563|NCT04147247|588868077|FG001|Overall Study|Clinical Disease Progression|0|||
163043564|NCT04147247|588868078|FG002|Overall Study|Clinical Disease Progression|0|||
163043565|NCT04147247|588868079|FG003|Overall Study|Clinical Disease Progression|0|||
163043566|NCT04147247|588868080|FG004|Overall Study|Clinical Disease Progression|1|||
163043567|NCT04147247|588868076|FG000|Overall Study|Adverse Event|0|||
163043568|NCT04147247|588868077|FG001|Overall Study|Adverse Event|0|||
163299514|NCT03565315|589805196|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
162954597|NCT03238781|588537639|FG000|Overall Study|Withdrawal by Subject|23|||
162954598|NCT03238781|588537640|FG001|Overall Study|Withdrawal by Subject|14|||
162954599|NCT03238781|588537641|FG002|Overall Study|Withdrawal by Subject|16|||
162954600|NCT03238781|588537639|FG000|Overall Study|Decision by sponsor|0|||
162954601|NCT03238781|588537640|FG001|Overall Study|Decision by sponsor|1|||
162954602|NCT03238781|588537641|FG002|Overall Study|Decision by sponsor|0|||
162954603|NCT03161405|588537642|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
162954604|NCT01421277|588537643|FG000|Overall Study|Lack of qualifying event|0|||
162954605|NCT01421277|588537644|FG001|Overall Study|Lack of qualifying event|61|||
162954606|NCT01421277|588537643|FG000|Overall Study|Incomplete baseline data|0|||
162954607|NCT01421277|588537644|FG001|Overall Study|Incomplete baseline data|31|||
162954608|NCT02039908|588537645|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
162954609|NCT02039908|588537646|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
162954610|NCT02039908|588537647|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
162954611|NCT02039908|588537648|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
162954612|NCT02039908|588537645|FG000|Phase 1-Summer|Protocol Violation|6|||
162954613|NCT02039908|588537646|FG001|Phase 1-Summer|Protocol Violation|0|||
162954614|NCT02039908|588537647|FG002|Phase 1-Summer|Protocol Violation|0|||
162954615|NCT02039908|588537648|FG003|Phase 1-Summer|Protocol Violation|0|||
162954616|NCT02039908|588537645|FG000|Phase 2-School Year|Lost to Follow-up|0|||
162954617|NCT02039908|588537646|FG001|Phase 2-School Year|Lost to Follow-up|0|||
162954618|NCT02039908|588537647|FG002|Phase 2-School Year|Lost to Follow-up|1|||
162954619|NCT02039908|588537648|FG003|Phase 2-School Year|Lost to Follow-up|3|||
162954620|NCT02039908|588537645|FG000|Phase 2-School Year|Protocol Violation|0|||
162954621|NCT02039908|588537646|FG001|Phase 2-School Year|Protocol Violation|0|||
162954622|NCT02039908|588537647|FG002|Phase 2-School Year|Protocol Violation|3|||
162954623|NCT02039908|588537648|FG003|Phase 2-School Year|Protocol Violation|0|||
162954624|NCT02039908|588537645|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
162954625|NCT02039908|588537646|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
162954626|NCT02039908|588537647|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
162954627|NCT02039908|588537648|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
162954628|NCT01597245|588537649|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
162954629|NCT01597245|588537650|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
162954630|NCT01597245|588537651|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
162954631|NCT01597245|588537652|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
162954632|NCT01597245|588537653|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954633|NCT01597245|588537654|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954634|NCT01597245|588537655|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954635|NCT01597245|588537656|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954636|NCT01597245|588537657|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954637|NCT01597245|588537658|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954638|NCT01597245|588537659|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954639|NCT01597245|588537660|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954640|NCT01597245|588537661|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954641|NCT01597245|588537662|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954642|NCT01597245|588537663|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954643|NCT01597245|588537664|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954644|NCT01597245|588537665|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954645|NCT01597245|588537666|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954646|NCT01597245|588537667|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954647|NCT01597245|588537668|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954648|NCT01597245|588537669|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954649|NCT01597245|588537649|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
162954650|NCT01597245|588537650|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
162954651|NCT01597245|588537651|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
162954652|NCT01597245|588537652|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
162954653|NCT01597245|588537653|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954654|NCT01597245|588537654|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
163193934|NCT00142935|589425005|FG002|Overall Study|Other reason|1|||
163193935|NCT00142935|589425003|FG000|Overall Study|Lost to Follow-up|2|||
163193936|NCT00142935|589425004|FG001|Overall Study|Lost to Follow-up|5|||
163193937|NCT00142935|589425005|FG002|Overall Study|Lost to Follow-up|5|||
163193938|NCT00142935|589425003|FG000|Overall Study|Death|0|||
163193939|NCT00142935|589425004|FG001|Overall Study|Death|2|||
163193940|NCT00142935|589425005|FG002|Overall Study|Death|1|||
163193941|NCT01180985|589425010|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
163193942|NCT01180985|589425011|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
163193943|NCT00705289|589425012|FG000|Overall Study|Subject or treating physician's choice|131|||
163193944|NCT01030536|589425013|FG000|Overall Study|Withdrawal by Subject|0|||
163193945|NCT01030536|589425014|FG001|Overall Study|Withdrawal by Subject|0|||
163193946|NCT01030536|589425015|FG002|Overall Study|Withdrawal by Subject|1|||
163193947|NCT01030536|589425016|FG003|Overall Study|Withdrawal by Subject|0|||
163193948|NCT01030536|589425017|FG004|Overall Study|Withdrawal by Subject|0|||
163193949|NCT01030536|589425013|FG000|Overall Study|undefined|1|||
163193950|NCT01030536|589425014|FG001|Overall Study|undefined|0|||
163193951|NCT01030536|589425015|FG002|Overall Study|undefined|1|||
163193952|NCT01030536|589425016|FG003|Overall Study|undefined|1|||
163193953|NCT01030536|589425017|FG004|Overall Study|undefined|0|||
163193954|NCT01030536|589425013|FG000|Overall Study|Adverse Event|0|||
163193955|NCT01030536|589425014|FG001|Overall Study|Adverse Event|3|||
163193956|NCT01030536|589425015|FG002|Overall Study|Adverse Event|1|||
163193957|NCT01030536|589425016|FG003|Overall Study|Adverse Event|0|||
163193958|NCT01030536|589425017|FG004|Overall Study|Adverse Event|1|||
163193959|NCT01030536|589425013|FG000|Overall Study|Progressive disease|6|||
163193960|NCT01030536|589425014|FG001|Overall Study|Progressive disease|2|||
163193961|NCT01030536|589425015|FG002|Overall Study|Progressive disease|3|||
163193962|NCT01030536|589425016|FG003|Overall Study|Progressive disease|2|||
163193963|NCT01030536|589425017|FG004|Overall Study|Progressive disease|0|||
163193964|NCT01030536|589425013|FG000|Overall Study|Death|0|||
163193965|NCT01030536|589425014|FG001|Overall Study|Death|1|||
163193966|NCT01030536|589425015|FG002|Overall Study|Death|0|||
163193967|NCT01030536|589425016|FG003|Overall Study|Death|0|||
163193968|NCT01030536|589425017|FG004|Overall Study|Death|0|||
163193969|NCT03345914|589425022|FG000|Overall Study|Transition to another study at week 16|80|||
163193970|NCT03345914|589425023|FG001|Overall Study|Transition to another study at week 16|86|||
163193971|NCT03345914|589425024|FG002|Overall Study|Transition to another study at week 16|78|||
163193972|NCT03345914|589425022|FG000|Overall Study|Transition to OLE during follow-up|37|||
163043569|NCT04147247|588868078|FG002|Overall Study|Adverse Event|1|||
163193973|NCT03345914|589425023|FG001|Overall Study|Transition to OLE during follow-up|33|||
163193974|NCT03345914|589425024|FG002|Overall Study|Transition to OLE during follow-up|39|||
163193975|NCT03345914|589425022|FG000|Overall Study|Physician Decision|0|||
163193976|NCT03345914|589425023|FG001|Overall Study|Physician Decision|1|||
163193977|NCT03345914|589425024|FG002|Overall Study|Physician Decision|1|||
163193978|NCT03345914|589425022|FG000|Overall Study|Withdrawal by Subject|5|||
163193979|NCT03345914|589425023|FG001|Overall Study|Withdrawal by Subject|1|||
163043570|NCT04147247|588868079|FG003|Overall Study|Adverse Event|0|||
163043571|NCT04147247|588868080|FG004|Overall Study|Adverse Event|1|||
163043572|NCT01724177|588868081|FG000|Overall Study|Adverse Event|8|||
163043573|NCT01724177|588868081|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
163043574|NCT01724177|588868081|FG000|Overall Study|Nervous participant|1|||
163043575|NCT01724177|588868081|FG000|Overall Study|Serious Adverse Event Related|1|||
163043576|NCT00327340|588868084|FG000|Overall Study|Withdrawal by Subject|1|||
163043577|NCT00327340|588868085|FG001|Overall Study|Withdrawal by Subject|5|||
163043578|NCT00327340|588868084|FG000|Overall Study|Physician Decision|1|||
163043579|NCT00327340|588868085|FG001|Overall Study|Physician Decision|1|||
163043580|NCT00327340|588868084|FG000|Overall Study|Disease Progression|10|||
163043581|NCT00327340|588868085|FG001|Overall Study|Disease Progression|19|||
163043582|NCT00327340|588868084|FG000|Overall Study|Symptomatic Disease|0|||
163043583|NCT00327340|588868085|FG001|Overall Study|Symptomatic Disease|2|||
163043584|NCT00327340|588868084|FG000|Overall Study|Adverse Event|3|||
163043585|NCT00327340|588868085|FG001|Overall Study|Adverse Event|3|||
163043586|NCT04085601|588868086|FG000|Overall Study|Lost to Follow-up|1|||
163043587|NCT04085601|588868087|FG001|Overall Study|Lost to Follow-up|0|||
163043588|NCT04085601|588868086|FG000|Overall Study|Death|1|||
163043589|NCT04085601|588868087|FG001|Overall Study|Death|1|||
163043590|NCT03492437|588868088|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163043591|NCT03492437|588868089|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163043592|NCT01914393|588868090|FG000|Overall Study|Protocol Violation|11|||
163043593|NCT01914393|588868091|FG001|Overall Study|Protocol Violation|3|||
163043594|NCT01914393|588868092|FG002|Overall Study|Protocol Violation|19|||
163043595|NCT01914393|588868090|FG000|Overall Study|Lack of Efficacy|11|||
163043596|NCT01914393|588868091|FG001|Overall Study|Lack of Efficacy|16|||
163043597|NCT01914393|588868092|FG002|Overall Study|Lack of Efficacy|5|||
163043598|NCT01914393|588868090|FG000|Overall Study|no reason given|14|||
163043599|NCT01914393|588868091|FG001|Overall Study|no reason given|8|||
163043600|NCT01914393|588868092|FG002|Overall Study|no reason given|16|||
163043601|NCT01914393|588868090|FG000|Overall Study|Adverse Event|29|||
163043602|NCT01914393|588868091|FG001|Overall Study|Adverse Event|18|||
163043603|NCT01914393|588868092|FG002|Overall Study|Adverse Event|31|||
163043604|NCT01914393|588868090|FG000|Overall Study|Withdrawal by Subject|38|||
163043605|NCT01914393|588868091|FG001|Overall Study|Withdrawal by Subject|20|||
163043606|NCT01914393|588868092|FG002|Overall Study|Withdrawal by Subject|47|||
163193980|NCT03345914|589425024|FG002|Overall Study|Withdrawal by Subject|2|||
163193981|NCT03345914|589425022|FG000|Overall Study|Other|1|||
163193982|NCT03345914|589425023|FG001|Overall Study|Other|1|||
163193983|NCT03345914|589425024|FG002|Overall Study|Other|1|||
163193984|NCT03345914|589425022|FG000|Overall Study|Ongoing|0|||
163193985|NCT03345914|589425023|FG001|Overall Study|Ongoing|0|||
163193986|NCT03345914|589425024|FG002|Overall Study|Ongoing|1|||
163193987|NCT02601027|589425027|FG000|Registration to Surgery|Withdrawal by Subject|20|||
163193988|NCT02601027|589425028|FG001|Registration to Surgery|Withdrawal by Subject|10|||
163193989|NCT01330030|589425029|FG000|Overall Study|Lost to Follow-up|16|||
163193990|NCT01330030|589425030|FG001|Overall Study|Lost to Follow-up|17|||
163193991|NCT01365052|589425031|FG000|Overall Study|Adverse Event|4|||
163043607|NCT01914393|588868090|FG000|Overall Study|Lost to Follow-up|12|||
163043608|NCT01914393|588868091|FG001|Overall Study|Lost to Follow-up|6|||
163043609|NCT01914393|588868092|FG002|Overall Study|Lost to Follow-up|19|||
163043610|NCT01914393|588868090|FG000|Overall Study|subject never dosed|0|||
163043611|NCT01914393|588868091|FG001|Overall Study|subject never dosed|0|||
163043612|NCT01914393|588868092|FG002|Overall Study|subject never dosed|1|||
163043613|NCT00572455|588868093|FG000|Stage I (14 Days)|Adverse Event|0|||
163193992|NCT01365052|589425032|FG001|Overall Study|Adverse Event|4|||
163043614|NCT00572455|588868094|FG001|Stage I (14 Days)|Adverse Event|0|||
163193993|NCT02248701|589425035|FG000|Overall Study|Withdrawal by Subject|2|||
163193994|NCT02248701|589425036|FG001|Overall Study|Withdrawal by Subject|1|||
163193995|NCT02248701|589425035|FG000|Overall Study|Physician Decision|0|||
163043615|NCT00572455|588868095|FG002|Stage I (14 Days)|Adverse Event|0|||
163043616|NCT00572455|588868096|FG003|Stage I (14 Days)|Adverse Event|0|||
163043617|NCT00572455|588868097|FG004|Stage I (14 Days)|Adverse Event|0|||
163043618|NCT00572455|588868098|FG005|Stage I (14 Days)|Adverse Event|3|||
163043619|NCT00572455|588868099|FG006|Stage I (14 Days)|Adverse Event|0|||
163043620|NCT00572455|588868100|FG007|Stage I (14 Days)|Adverse Event|0|||
163043621|NCT00572455|588868101|FG008|Stage I (14 Days)|Adverse Event|0|||
163043622|NCT00572455|588868102|FG009|Stage I (14 Days)|Adverse Event|0|||
163043623|NCT00572455|588868103|FG010|Stage I (14 Days)|Adverse Event|0|||
163043624|NCT00572455|588868104|FG011|Stage I (14 Days)|Adverse Event|0|||
163043625|NCT00572455|588868105|FG012|Stage I (14 Days)|Adverse Event|0|||
163043626|NCT00572455|588868106|FG013|Stage I (14 Days)|Adverse Event|0|||
163043627|NCT00572455|588868093|FG000|Stage I (14 Days)|Other|0|||
163043628|NCT00572455|588868094|FG001|Stage I (14 Days)|Other|0|||
163043629|NCT00572455|588868095|FG002|Stage I (14 Days)|Other|0|||
163043630|NCT00572455|588868096|FG003|Stage I (14 Days)|Other|0|||
163043631|NCT00572455|588868097|FG004|Stage I (14 Days)|Other|1|||
163043632|NCT00572455|588868098|FG005|Stage I (14 Days)|Other|0|||
163043633|NCT00572455|588868099|FG006|Stage I (14 Days)|Other|0|||
163043634|NCT00572455|588868100|FG007|Stage I (14 Days)|Other|0|||
163043635|NCT00572455|588868101|FG008|Stage I (14 Days)|Other|0|||
163043636|NCT00572455|588868102|FG009|Stage I (14 Days)|Other|0|||
163043637|NCT00572455|588868103|FG010|Stage I (14 Days)|Other|0|||
163043638|NCT00572455|588868104|FG011|Stage I (14 Days)|Other|0|||
163043639|NCT00572455|588868105|FG012|Stage I (14 Days)|Other|0|||
163043640|NCT00572455|588868106|FG013|Stage I (14 Days)|Other|0|||
163043641|NCT00572455|588868093|FG000|Stage II (28 Days)|Adverse Event|0|||
163043642|NCT00572455|588868094|FG001|Stage II (28 Days)|Adverse Event|0|||
163043643|NCT00572455|588868095|FG002|Stage II (28 Days)|Adverse Event|0|||
163043644|NCT00572455|588868096|FG003|Stage II (28 Days)|Adverse Event|0|||
163043645|NCT00572455|588868097|FG004|Stage II (28 Days)|Adverse Event|0|||
163043646|NCT00572455|588868098|FG005|Stage II (28 Days)|Adverse Event|0|||
163043647|NCT00572455|588868099|FG006|Stage II (28 Days)|Adverse Event|0|||
163193996|NCT02248701|589425036|FG001|Overall Study|Physician Decision|1|||
163193997|NCT02248701|589425035|FG000|Overall Study|Adverse Event|1|||
163193998|NCT02248701|589425036|FG001|Overall Study|Adverse Event|0|||
163193999|NCT02248701|589425035|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
163194000|NCT02248701|589425036|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
163194001|NCT00885846|589425039|FG000|Overall Study|Withdrawal by Subject|2|||
163194002|NCT00885846|589425040|FG001|Overall Study|Withdrawal by Subject|5|||
163194003|NCT00885846|589425041|FG002|Overall Study|Withdrawal by Subject|2|||
163194004|NCT00074984|589425042|FG000|Overall Study|Death|1|||
163194005|NCT00074984|589425043|FG001|Overall Study|Death|2|||
163043648|NCT00572455|588868100|FG007|Stage II (28 Days)|Adverse Event|0|||
163043649|NCT00572455|588868101|FG008|Stage II (28 Days)|Adverse Event|1|||
163043650|NCT00572455|588868102|FG009|Stage II (28 Days)|Adverse Event|3|||
163043651|NCT00572455|588868103|FG010|Stage II (28 Days)|Adverse Event|3|||
163043652|NCT00572455|588868104|FG011|Stage II (28 Days)|Adverse Event|4|||
163043653|NCT00572455|588868105|FG012|Stage II (28 Days)|Adverse Event|5|||
163043654|NCT00572455|588868106|FG013|Stage II (28 Days)|Adverse Event|1|||
163043655|NCT00572455|588868093|FG000|Stage II (28 Days)|Death|0|||
163194006|NCT00074984|589425042|FG000|Overall Study|Withdrawal by Subject|2|||
163043656|NCT00572455|588868094|FG001|Stage II (28 Days)|Death|0|||
163043657|NCT00572455|588868095|FG002|Stage II (28 Days)|Death|0|||
163043658|NCT00572455|588868096|FG003|Stage II (28 Days)|Death|0|||
163043659|NCT00572455|588868097|FG004|Stage II (28 Days)|Death|0|||
163043660|NCT00572455|588868098|FG005|Stage II (28 Days)|Death|0|||
163043661|NCT00572455|588868099|FG006|Stage II (28 Days)|Death|0|||
163194007|NCT00074984|589425043|FG001|Overall Study|Withdrawal by Subject|3|||
162954655|NCT01597245|588537655|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954656|NCT01597245|588537656|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
163194008|NCT00074984|589425042|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
163194009|NCT00074984|589425043|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
163194010|NCT03758443|589425044|FG000|Induction Period|Adverse Event|2|||
163393369|NCT02632721|590152111|FG000|Overall Study|Inadequate clinical condition|0|||
163393370|NCT02632721|590152112|FG001|Overall Study|Inadequate clinical condition|0|||
162954657|NCT01597245|588537657|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954658|NCT01597245|588537658|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954659|NCT01597245|588537659|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954660|NCT01597245|588537660|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
163043662|NCT00572455|588868100|FG007|Stage II (28 Days)|Death|0|||
163043663|NCT00572455|588868101|FG008|Stage II (28 Days)|Death|1|||
163043664|NCT00572455|588868102|FG009|Stage II (28 Days)|Death|0|||
163043665|NCT00572455|588868103|FG010|Stage II (28 Days)|Death|0|||
163043666|NCT00572455|588868104|FG011|Stage II (28 Days)|Death|0|||
163043667|NCT00572455|588868105|FG012|Stage II (28 Days)|Death|0|||
163043668|NCT00572455|588868106|FG013|Stage II (28 Days)|Death|0|||
163043669|NCT00572455|588868093|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
163043670|NCT00572455|588868094|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
163043671|NCT00572455|588868095|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
163043672|NCT00572455|588868096|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
163043673|NCT00572455|588868097|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
163043674|NCT00572455|588868098|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
163043675|NCT00572455|588868099|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
163043676|NCT00572455|588868100|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
163043677|NCT00572455|588868101|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
163043678|NCT00572455|588868102|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
163043679|NCT00572455|588868103|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
163043680|NCT00572455|588868104|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
163043681|NCT00572455|588868105|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
163043682|NCT00572455|588868106|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
163043683|NCT00572455|588868093|FG000|Stage II (28 Days)|Other|0|||
163043684|NCT00572455|588868094|FG001|Stage II (28 Days)|Other|0|||
163194011|NCT03758443|589425045|FG001|Induction Period|Adverse Event|4|||
163194012|NCT03758443|589425046|FG002|Induction Period|Adverse Event|2|||
163194013|NCT03758443|589425047|FG003|Induction Period|Adverse Event|3|||
163194014|NCT03758443|589425044|FG000|Induction Period|Physician Decision|1|||
163194015|NCT03758443|589425045|FG001|Induction Period|Physician Decision|1|||
163194016|NCT03758443|589425046|FG002|Induction Period|Physician Decision|3|||
163194017|NCT03758443|589425047|FG003|Induction Period|Physician Decision|0|||
163194018|NCT03758443|589425044|FG000|Induction Period|Protocol Violation|0|||
163194019|NCT03758443|589425045|FG001|Induction Period|Protocol Violation|0|||
163194020|NCT03758443|589425046|FG002|Induction Period|Protocol Violation|0|||
163194021|NCT03758443|589425047|FG003|Induction Period|Protocol Violation|1|||
163194022|NCT03758443|589425044|FG000|Induction Period|Withdrawal by Subject|3|||
163194023|NCT03758443|589425045|FG001|Induction Period|Withdrawal by Subject|2|||
163194024|NCT03758443|589425046|FG002|Induction Period|Withdrawal by Subject|2|||
163194025|NCT03758443|589425047|FG003|Induction Period|Withdrawal by Subject|4|||
163194026|NCT03758443|589425044|FG000|Extended Induction Period|Adverse Event|1|||
163194027|NCT03758443|589425045|FG001|Extended Induction Period|Adverse Event|1|||
163194028|NCT03758443|589425046|FG002|Extended Induction Period|Adverse Event|0|||
163194029|NCT03758443|589425047|FG003|Extended Induction Period|Adverse Event|1|||
163194030|NCT03758443|589425044|FG000|Extended Induction Period|Lost to Follow-up|1|||
163043685|NCT00572455|588868095|FG002|Stage II (28 Days)|Other|0|||
163043686|NCT00572455|588868096|FG003|Stage II (28 Days)|Other|0|||
163043687|NCT00572455|588868097|FG004|Stage II (28 Days)|Other|0|||
163043688|NCT00572455|588868098|FG005|Stage II (28 Days)|Other|0|||
163194031|NCT03758443|589425045|FG001|Extended Induction Period|Lost to Follow-up|0|||
163194032|NCT03758443|589425046|FG002|Extended Induction Period|Lost to Follow-up|0|||
163043689|NCT00572455|588868099|FG006|Stage II (28 Days)|Other|0|||
163043690|NCT00572455|588868100|FG007|Stage II (28 Days)|Other|0|||
163043691|NCT00572455|588868101|FG008|Stage II (28 Days)|Other|1|||
163194033|NCT03758443|589425047|FG003|Extended Induction Period|Lost to Follow-up|0|||
163194034|NCT03758443|589425044|FG000|Extended Induction Period|Physician Decision|2|||
163043692|NCT00572455|588868102|FG009|Stage II (28 Days)|Other|0|||
163043693|NCT00572455|588868103|FG010|Stage II (28 Days)|Other|0|||
163043694|NCT00572455|588868104|FG011|Stage II (28 Days)|Other|0|||
163043695|NCT00572455|588868105|FG012|Stage II (28 Days)|Other|0|||
163043696|NCT00572455|588868106|FG013|Stage II (28 Days)|Other|0|||
163043697|NCT00572455|588868093|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
163043698|NCT00572455|588868094|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
163043699|NCT00572455|588868095|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
163043700|NCT00572455|588868096|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
163043701|NCT00572455|588868097|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
163043702|NCT00572455|588868098|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
163043703|NCT00572455|588868099|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
163043704|NCT00572455|588868100|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
163043705|NCT00572455|588868101|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
163043706|NCT00572455|588868102|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
163043707|NCT00572455|588868103|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
163043708|NCT00572455|588868104|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
163043709|NCT00572455|588868105|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
163043710|NCT00572455|588868106|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
163043711|NCT02609386|588868107|FG000|Overall Study|Withdrawal by Subject|6|||
163043712|NCT02609386|588868108|FG001|Overall Study|Withdrawal by Subject|1|||
163043713|NCT02609386|588868107|FG000|Overall Study|Lost to Follow-up|3|||
163043714|NCT02609386|588868108|FG001|Overall Study|Lost to Follow-up|5|||
163043715|NCT02609386|588868107|FG000|Overall Study|Death|19|||
163043716|NCT02609386|588868108|FG001|Overall Study|Death|9|||
163043717|NCT02609386|588868107|FG000|Overall Study|Physician Decision|0|||
163043718|NCT02609386|588868108|FG001|Overall Study|Physician Decision|2|||
163043719|NCT03280056|588868109|FG000|Overall Study|Withdrawal by Subject|12|||
163043720|NCT03280056|588868110|FG001|Overall Study|Withdrawal by Subject|14|||
163043721|NCT03280056|588868109|FG000|Overall Study|Death|9|||
163043722|NCT03280056|588868110|FG001|Overall Study|Death|2|||
163043723|NCT03280056|588868109|FG000|Overall Study|Adverse Event|1|||
163043724|NCT03280056|588868110|FG001|Overall Study|Adverse Event|3|||
163043725|NCT03280056|588868109|FG000|Overall Study|Lost to Follow-up|1|||
163043726|NCT03280056|588868110|FG001|Overall Study|Lost to Follow-up|1|||
163043727|NCT03280056|588868109|FG000|Overall Study|Physician Decision|0|||
163043728|NCT03280056|588868110|FG001|Overall Study|Physician Decision|1|||
163043729|NCT03280056|588868109|FG000|Overall Study|Early Discontinuation|1|||
163043730|NCT03280056|588868110|FG001|Overall Study|Early Discontinuation|0|||
163043731|NCT00610168|588868111|FG000|Overall Study|Withdrawal by Subject|2|||
163043732|NCT00610168|588868112|FG001|Overall Study|Withdrawal by Subject|0|||
163043733|NCT01135524|588868118|FG000|Overall Study|Withdrawal by Subject|14|||
163043734|NCT01135524|588868118|FG000|Overall Study|Adverse Event|20|||
163043735|NCT01135524|588868118|FG000|Overall Study|Lost to Follow-up|3|||
163043736|NCT01135524|588868118|FG000|Overall Study|Administrative|151|||
163043737|NCT01135524|588868118|FG000|Overall Study|Lack of Efficacy|8|||
163043738|NCT00613821|588868119|FG000|Overall Study|Withdrawal by Subject|1|||
163043739|NCT00613821|588868120|FG001|Overall Study|Withdrawal by Subject|0|||
163043740|NCT00613821|588868119|FG000|Overall Study|Physician Decision|1|||
163043741|NCT00613821|588868120|FG001|Overall Study|Physician Decision|1|||
163043742|NCT02907463|588868121|FG000|Overall Study|Lost to Follow-up|17|||
163043743|NCT02907463|588868121|FG000|Overall Study|Death|10|||
163043744|NCT02907463|588868121|FG000|Overall Study|Withdrawal by Subject|4|||
163043745|NCT02907463|588868121|FG000|Overall Study|MIS Approach was not used|2|||
163043746|NCT02907463|588868121|FG000|Overall Study|Not Implanted with Study Device|2|||
163043747|NCT02907463|588868121|FG000|Overall Study|Device Explanted|1|||
163043748|NCT02907463|588868121|FG000|Overall Study|Missing Exit Form|1|||
163194035|NCT03758443|589425045|FG001|Extended Induction Period|Physician Decision|1|||
163194036|NCT03758443|589425046|FG002|Extended Induction Period|Physician Decision|2|||
163194037|NCT03758443|589425047|FG003|Extended Induction Period|Physician Decision|2|||
163194038|NCT03758443|589425044|FG000|Extended Induction Period|Protocol Violation|0|||
163194039|NCT03758443|589425045|FG001|Extended Induction Period|Protocol Violation|0|||
163194040|NCT03758443|589425046|FG002|Extended Induction Period|Protocol Violation|0|||
162954661|NCT01597245|588537661|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954662|NCT01597245|588537662|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954663|NCT01597245|588537663|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954664|NCT01597245|588537664|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954665|NCT01597245|588537665|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954666|NCT01597245|588537666|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954667|NCT01597245|588537667|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954668|NCT01597245|588537668|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954669|NCT01597245|588537669|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954670|NCT01597245|588537649|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
162954671|NCT01597245|588537650|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
162954672|NCT01597245|588537651|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
162954673|NCT01597245|588537652|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
162954674|NCT01597245|588537653|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954675|NCT01597245|588537654|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954676|NCT01597245|588537655|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954677|NCT01597245|588537656|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
163299515|NCT03565315|589805197|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
163299516|NCT03887650|589805198|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
163299517|NCT03887650|589805199|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
163043749|NCT01266824|588868122|FG000|Overall Study|Study terminated prior to completion|2|||
163043750|NCT01266824|588868123|FG001|Overall Study|Study terminated prior to completion|3|||
163043751|NCT00397189|588868124|FG000|3 Weeks Period|Lost to Follow-up|5|||
163043752|NCT00397189|588868125|FG001|3 Weeks Period|Lost to Follow-up|4|||
163043753|NCT00397189|588868124|FG000|3 Weeks Period|Adverse Event|3|||
163043754|NCT00397189|588868125|FG001|3 Weeks Period|Adverse Event|2|||
163043755|NCT00397189|588868124|FG000|3 Weeks Period|Withdrawal by Subject|13|||
163043756|NCT00397189|588868125|FG001|3 Weeks Period|Withdrawal by Subject|9|||
163043757|NCT00397189|588868124|FG000|3 Weeks Period|Physician Decision|0|||
163043758|NCT00397189|588868125|FG001|3 Weeks Period|Physician Decision|2|||
163043759|NCT00397189|588868124|FG000|3 Weeks Period|Protocol Violation|0|||
163043760|NCT00397189|588868125|FG001|3 Weeks Period|Protocol Violation|3|||
163043761|NCT00397189|588868124|FG000|3 Weeks Period|Other|0|||
163043762|NCT00397189|588868125|FG001|3 Weeks Period|Other|2|||
163043763|NCT01447407|588868128|FG000|Overall Study|Withdrawal by Subject|2|||
163043764|NCT01447407|588868129|FG001|Overall Study|Withdrawal by Subject|0|||
163043765|NCT01447407|588868130|FG002|Overall Study|Withdrawal by Subject|0|||
163043766|NCT01447407|588868131|FG003|Overall Study|Withdrawal by Subject|1|||
163043767|NCT01447407|588868128|FG000|Overall Study|Physician Decision|0|||
163043768|NCT01447407|588868129|FG001|Overall Study|Physician Decision|0|||
163043769|NCT01447407|588868130|FG002|Overall Study|Physician Decision|1|||
163043770|NCT01447407|588868131|FG003|Overall Study|Physician Decision|1|||
163043771|NCT00141518|588868134|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
163043772|NCT00141518|588868135|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
163043773|NCT00141518|588868136|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
163043774|NCT00141518|588868134|FG000|Overall Study|Adverse Event|7|||
163043775|NCT00141518|588868135|FG001|Overall Study|Adverse Event|5|||
163043776|NCT00141518|588868136|FG002|Overall Study|Adverse Event|2|||
163043777|NCT00141518|588868134|FG000|Overall Study|Withdrawal by Subject|2|||
163043778|NCT00141518|588868135|FG001|Overall Study|Withdrawal by Subject|0|||
163043779|NCT00141518|588868136|FG002|Overall Study|Withdrawal by Subject|2|||
163043780|NCT00141518|588868134|FG000|Overall Study|Protocol Violation|1|||
163043781|NCT00141518|588868135|FG001|Overall Study|Protocol Violation|1|||
163043782|NCT00141518|588868136|FG002|Overall Study|Protocol Violation|2|||
163043783|NCT00141518|588868134|FG000|Overall Study|Lack of Efficacy|5|||
163043784|NCT00141518|588868135|FG001|Overall Study|Lack of Efficacy|0|||
163043785|NCT00141518|588868136|FG002|Overall Study|Lack of Efficacy|0|||
163043786|NCT01029262|588868140|FG000|Overall Study|Adverse Event|9|||
163043787|NCT01029262|588868141|FG001|Overall Study|Adverse Event|52|||
163043788|NCT01029262|588868140|FG000|Overall Study|Lack of therapeutic effect|57|||
163043789|NCT01029262|588868141|FG001|Overall Study|Lack of therapeutic effect|76|||
163043790|NCT01029262|588868140|FG000|Overall Study|Withdrawal by Subject|10|||
163043791|NCT01029262|588868141|FG001|Overall Study|Withdrawal by Subject|17|||
163043792|NCT01029262|588868140|FG000|Overall Study|Protocol Violation|2|||
163043793|NCT01029262|588868141|FG001|Overall Study|Protocol Violation|3|||
163043794|NCT01029262|588868140|FG000|Overall Study|Miscellaneous|1|||
163043795|NCT01029262|588868141|FG001|Overall Study|Miscellaneous|9|||
163043796|NCT01029262|588868140|FG000|Overall Study|Death|0|||
163043797|NCT01029262|588868141|FG001|Overall Study|Death|3|||
163043798|NCT01001910|588868142|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
163043799|NCT01468454|588868143|FG000|Overall Study|Did not have surgery after PET|9|||
163043800|NCT02896569|588868144|FG000|Overall Study|Lost to Follow-up|2|||
163393371|NCT02632721|590152113|FG002|Overall Study|Inadequate clinical condition|0|||
163393372|NCT02632721|590152114|FG003|Overall Study|Inadequate clinical condition|0|||
163393373|NCT02632721|590152115|FG004|Overall Study|Inadequate clinical condition|1|||
163393374|NCT02632721|590152111|FG000|Overall Study|No meet eligibility|0|||
163393375|NCT02632721|590152112|FG001|Overall Study|No meet eligibility|0|||
163393376|NCT02632721|590152113|FG002|Overall Study|No meet eligibility|0|||
163393377|NCT02632721|590152114|FG003|Overall Study|No meet eligibility|0|||
163393378|NCT02632721|590152115|FG004|Overall Study|No meet eligibility|1|||
163393379|NCT02632721|590152111|FG000|Overall Study|Allergic reaction|0|||
163393380|NCT02632721|590152112|FG001|Overall Study|Allergic reaction|0|||
163393381|NCT02632721|590152113|FG002|Overall Study|Allergic reaction|0|||
163393382|NCT02632721|590152114|FG003|Overall Study|Allergic reaction|1|||
163393383|NCT02632721|590152115|FG004|Overall Study|Allergic reaction|0|||
163043801|NCT02896569|588868145|FG001|Overall Study|Lost to Follow-up|1|||
163043802|NCT02896569|588868144|FG000|Overall Study|Physician Decision|1|||
163043803|NCT02896569|588868145|FG001|Overall Study|Physician Decision|3|||
163043804|NCT02896569|588868144|FG000|Overall Study|Adverse Event|0|||
163043805|NCT02896569|588868145|FG001|Overall Study|Adverse Event|1|||
163043806|NCT02896569|588868144|FG000|Overall Study|Withdrawal by Subject|1|||
163393384|NCT02632721|590152111|FG000|Overall Study|Receiving Decitabine locally|0|||
163043807|NCT02896569|588868145|FG001|Overall Study|Withdrawal by Subject|0|||
163043808|NCT03060291|588868148|FG000|3-month Follow-up|Declined to respond|8|||
163043809|NCT03060291|588868149|FG001|3-month Follow-up|Declined to respond|10|||
163043810|NCT03060291|588868150|FG002|3-month Follow-up|Declined to respond|2|||
163043811|NCT03060291|588868148|FG000|6-month Follow-up|Declined to respond|7|||
163043812|NCT03060291|588868149|FG001|6-month Follow-up|Declined to respond|13|||
163043813|NCT03060291|588868150|FG002|6-month Follow-up|Declined to respond|4|||
163043814|NCT03060291|588868148|FG000|12-month Follow-up|Declined to respond|7|||
163043815|NCT03060291|588868149|FG001|12-month Follow-up|Declined to respond|16|||
163043816|NCT03060291|588868150|FG002|12-month Follow-up|Declined to respond|6|||
163043817|NCT01509664|588868153|FG000|Overall Study|Lost to Follow-up|15|||
163043818|NCT01509664|588868154|FG001|Overall Study|Lost to Follow-up|21|||
163043819|NCT02306850|588868159|FG000|Overall Study|Lack of Efficacy|2|||
163043820|NCT02420262|588868160|FG000|Overall Study|Adverse Event|1|||
163043821|NCT02420262|588868161|FG001|Overall Study|Adverse Event|0|||
163043822|NCT02420262|588868160|FG000|Overall Study|Withdrawal by Subject|1|||
163043823|NCT02420262|588868161|FG001|Overall Study|Withdrawal by Subject|4|||
163043824|NCT02420262|588868160|FG000|Overall Study|Unclassified|0|||
163043825|NCT02420262|588868161|FG001|Overall Study|Unclassified|1|||
163043826|NCT01210222|588868162|FG000|Overall Study|Ineligible|2|||
163043827|NCT01210222|588868162|FG000|Overall Study|Never treated|1|||
163043828|NCT00941304|588868163|FG000|Overall Study|Lost to Follow-up|1|||
163043829|NCT00941304|588868164|FG001|Overall Study|Lost to Follow-up|0|||
163043830|NCT00941304|588868165|FG002|Overall Study|Lost to Follow-up|0|||
163043831|NCT00941304|588868166|FG003|Overall Study|Lost to Follow-up|0|||
163043832|NCT00941304|588868167|FG004|Overall Study|Lost to Follow-up|0|||
163043833|NCT03293394|588868168|FG000|Follow-up (6 Months)|Adverse Event|4|||
163043834|NCT03293394|588868169|FG001|Follow-up (6 Months)|Adverse Event|2|||
163043835|NCT01903993|588868174|FG000|Overall Study|Death|118|||
163043836|NCT01903993|588868175|FG001|Overall Study|Death|121|||
163043837|NCT01903993|588868174|FG000|Overall Study|Withdrawal by Subject|15|||
163043838|NCT01903993|588868175|FG001|Overall Study|Withdrawal by Subject|4|||
163043839|NCT01903993|588868174|FG000|Overall Study|Lost to Follow-up|2|||
163043840|NCT01903993|588868175|FG001|Overall Study|Lost to Follow-up|3|||
163043841|NCT01903993|588868174|FG000|Overall Study|Study Terminated by Sponsor|8|||
163043842|NCT01903993|588868175|FG001|Overall Study|Study Terminated by Sponsor|14|||
163043843|NCT01903993|588868174|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
163043844|NCT01903993|588868175|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
163043845|NCT00184093|588868178|FG000|Overall Study|Adverse Event|3|||
163043846|NCT00184093|588868178|FG000|Overall Study|Lost to Follow-up|3|||
163043847|NCT00184093|588868178|FG000|Overall Study|Physician Decision|1|||
163043848|NCT00184093|588868178|FG000|Overall Study|Withdrawal by Subject|2|||
163043849|NCT03283930|588868183|FG000|Overall Study|Scheduling conflict|8|||
163043850|NCT03283930|588868184|FG001|Overall Study|Scheduling conflict|10|||
162954678|NCT01597245|588537657|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954679|NCT01597245|588537658|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954680|NCT01597245|588537659|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954681|NCT01597245|588537660|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954682|NCT01597245|588537661|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954683|NCT01597245|588537662|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954684|NCT01597245|588537663|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954685|NCT01597245|588537664|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954686|NCT01597245|588537665|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954687|NCT01597245|588537666|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954688|NCT01597245|588537667|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954689|NCT01597245|588537668|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954690|NCT01597245|588537669|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954691|NCT01597245|588537649|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
162954692|NCT01597245|588537650|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
162954693|NCT01597245|588537651|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
162954694|NCT01597245|588537652|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954695|NCT01597245|588537653|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954696|NCT01597245|588537654|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954697|NCT01597245|588537655|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954698|NCT01597245|588537656|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
163194041|NCT03758443|589425047|FG003|Extended Induction Period|Protocol Violation|1|||
162954699|NCT01597245|588537657|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954700|NCT01597245|588537658|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954701|NCT01597245|588537659|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954702|NCT01597245|588537660|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954703|NCT01597245|588537661|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954704|NCT01597245|588537662|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954705|NCT01597245|588537663|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954706|NCT01597245|588537664|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954707|NCT01597245|588537665|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954708|NCT01597245|588537666|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954709|NCT01597245|588537667|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954710|NCT01597245|588537668|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954711|NCT01597245|588537669|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954712|NCT01597245|588537649|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
162954713|NCT01597245|588537650|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954714|NCT01597245|588537651|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954715|NCT01597245|588537652|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
162954716|NCT01597245|588537653|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954717|NCT01597245|588537654|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954718|NCT01597245|588537655|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954719|NCT01597245|588537656|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954720|NCT01597245|588537657|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954721|NCT01597245|588537658|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954722|NCT01597245|588537659|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954723|NCT01597245|588537660|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954724|NCT01597245|588537661|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954725|NCT01597245|588537662|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954726|NCT01597245|588537663|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954727|NCT01597245|588537664|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954728|NCT01597245|588537665|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954729|NCT01597245|588537666|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954730|NCT01597245|588537667|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954731|NCT01597245|588537668|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954732|NCT01597245|588537669|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954733|NCT01597245|588537649|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
162954734|NCT01597245|588537650|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
162954735|NCT01597245|588537651|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
162954736|NCT01597245|588537652|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954737|NCT01597245|588537653|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954738|NCT01597245|588537654|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954739|NCT01597245|588537655|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954740|NCT01597245|588537656|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954741|NCT01597245|588537657|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954742|NCT01597245|588537658|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954743|NCT01597245|588537659|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954744|NCT01597245|588537660|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954745|NCT01597245|588537661|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954746|NCT01597245|588537662|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954747|NCT01597245|588537663|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954748|NCT01597245|588537664|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954749|NCT01597245|588537665|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954750|NCT01597245|588537666|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954751|NCT01597245|588537667|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954752|NCT01597245|588537668|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954753|NCT01597245|588537669|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954754|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954755|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954756|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954757|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954758|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
163194042|NCT03758443|589425044|FG000|Extended Induction Period|Withdrawal by Subject|8|||
163194043|NCT03758443|589425045|FG001|Extended Induction Period|Withdrawal by Subject|1|||
163194044|NCT03758443|589425046|FG002|Extended Induction Period|Withdrawal by Subject|7|||
163194045|NCT03758443|589425047|FG003|Extended Induction Period|Withdrawal by Subject|3|||
163194046|NCT03758443|589425044|FG000|Extended Induction Period|Miscellaneous|1|||
163194047|NCT03758443|589425045|FG001|Extended Induction Period|Miscellaneous|0|||
163393385|NCT02632721|590152112|FG001|Overall Study|Receiving Decitabine locally|0|||
162954759|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
162954760|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
162954761|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954762|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954763|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954764|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954765|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954766|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954767|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954768|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954769|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954770|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954771|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954772|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954773|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954774|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954775|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954776|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954777|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954778|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954779|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
162954780|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
162954781|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
162954782|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
162954783|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954784|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
162954785|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954786|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954787|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954788|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954789|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954790|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954791|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954792|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954793|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954794|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954795|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954796|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954797|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954798|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954799|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954800|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954801|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
162954802|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954803|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954804|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
162954805|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
163194048|NCT03758443|589425046|FG002|Extended Induction Period|Miscellaneous|0|||
163194049|NCT03758443|589425047|FG003|Extended Induction Period|Miscellaneous|0|||
163194050|NCT03758443|589425044|FG000|Maintenance Period|Adverse Event|1|||
163194051|NCT03758443|589425045|FG001|Maintenance Period|Adverse Event|2|||
163194052|NCT03758443|589425046|FG002|Maintenance Period|Adverse Event|0|||
163194053|NCT03758443|589425047|FG003|Maintenance Period|Adverse Event|0|||
163194054|NCT03758443|589425044|FG000|Maintenance Period|Lost to Follow-up|0|||
163194055|NCT03758443|589425045|FG001|Maintenance Period|Lost to Follow-up|0|||
163393386|NCT02632721|590152113|FG002|Overall Study|Receiving Decitabine locally|1|||
162954806|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
162954807|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
162954808|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
162954809|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954810|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954811|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
163194056|NCT03758443|589425046|FG002|Maintenance Period|Lost to Follow-up|0|||
163194057|NCT03758443|589425047|FG003|Maintenance Period|Lost to Follow-up|1|||
163393387|NCT02632721|590152114|FG003|Overall Study|Receiving Decitabine locally|0|||
163194058|NCT03758443|589425044|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
163043851|NCT03283930|588868183|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
163043852|NCT03283930|588868184|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
163194059|NCT03758443|589425045|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
163194060|NCT03758443|589425046|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
163194061|NCT03758443|589425047|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
163194062|NCT03758443|589425044|FG000|Maintenance Period|Protocol Violation|0|||
163194063|NCT03758443|589425045|FG001|Maintenance Period|Protocol Violation|1|||
163194064|NCT03758443|589425046|FG002|Maintenance Period|Protocol Violation|0|||
163194065|NCT03758443|589425047|FG003|Maintenance Period|Protocol Violation|0|||
163194066|NCT03758443|589425044|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
163194067|NCT03758443|589425045|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
163194068|NCT03758443|589425046|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
163194069|NCT03758443|589425047|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
163194070|NCT03758443|589425044|FG000|Maintenance Period|Withdrawal by Subject|1|||
163194071|NCT03758443|589425045|FG001|Maintenance Period|Withdrawal by Subject|0|||
163194072|NCT03758443|589425046|FG002|Maintenance Period|Withdrawal by Subject|1|||
163194073|NCT03758443|589425047|FG003|Maintenance Period|Withdrawal by Subject|1|||
163194074|NCT03758443|589425044|FG000|Maintenance Period|Miscellaneous|0|||
163194075|NCT03758443|589425045|FG001|Maintenance Period|Miscellaneous|0|||
163194076|NCT03758443|589425046|FG002|Maintenance Period|Miscellaneous|1|||
163194077|NCT03758443|589425047|FG003|Maintenance Period|Miscellaneous|0|||
163194078|NCT03080454|589425048|FG000|Baseline|Adverse Event|2|||
163194079|NCT03080454|589425048|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
163194080|NCT03080454|589425048|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
163194081|NCT02747875|589425049|FG000|Overall Study|Physician Decision|1|||
163194082|NCT02747875|589425050|FG001|Overall Study|Physician Decision|0|||
163194083|NCT02747875|589425049|FG000|Overall Study|Adverse Event|0|||
163194084|NCT02747875|589425050|FG001|Overall Study|Adverse Event|1|||
163194085|NCT03863197|589425051|FG000|Overall Study|Lost to Follow-up|2|||
163194086|NCT03863197|589425052|FG001|Overall Study|Lost to Follow-up|3|||
163194087|NCT03863197|589425051|FG000|Overall Study|Withdrawal by Subject|4|||
163194088|NCT03863197|589425052|FG001|Overall Study|Withdrawal by Subject|0|||
163194089|NCT03863197|589425051|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
163194090|NCT03863197|589425052|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
163194091|NCT01781975|589425053|FG000|Overall Study|Death|1|||
163194092|NCT01781975|589425054|FG001|Overall Study|Death|0|||
163194093|NCT01781975|589425053|FG000|Overall Study|Withdrawal by Subject|1|||
163194094|NCT01781975|589425054|FG001|Overall Study|Withdrawal by Subject|1|||
163194095|NCT01622231|589425055|FG000|Overall Study|Physician Decision|1|||
163194096|NCT01622231|589425055|FG000|Overall Study|Withdrawal by Subject|1|||
163194097|NCT01058655|589425056|FG000|Overall Study|Withdrawal by Subject|1|||
163194098|NCT01058655|589425057|FG001|Overall Study|Withdrawal by Subject|0|||
163194099|NCT01058655|589425058|FG002|Overall Study|Withdrawal by Subject|3|||
163194100|NCT01058655|589425059|FG003|Overall Study|Withdrawal by Subject|4|||
163194101|NCT01058655|589425056|FG000|Overall Study|Prolonged Treatment Delay|0|||
163194102|NCT01058655|589425057|FG001|Overall Study|Prolonged Treatment Delay|0|||
163194103|NCT01058655|589425058|FG002|Overall Study|Prolonged Treatment Delay|0|||
163393388|NCT02632721|590152115|FG004|Overall Study|Receiving Decitabine locally|0|||
163194104|NCT01058655|589425059|FG003|Overall Study|Prolonged Treatment Delay|2|||
162954812|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
163194105|NCT01058655|589425056|FG000|Overall Study|Symptomatic Deterioration|0|||
163194106|NCT01058655|589425057|FG001|Overall Study|Symptomatic Deterioration|0|||
162954813|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954814|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954815|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954816|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954817|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954818|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954819|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954820|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954821|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
162954822|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
162954823|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
162954824|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
162954825|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
162954826|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
162954827|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
162954828|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
162954829|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
162954830|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954831|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954832|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
163299518|NCT03887650|589805198|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
162954833|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954834|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
163299519|NCT03887650|589805199|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
163299520|NCT03887650|589805198|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
163299521|NCT03887650|589805199|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
162954835|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954836|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954837|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954838|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954839|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954840|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954841|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954842|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
162954843|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
162954844|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
162954845|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954846|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
162954847|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
162954848|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
162954849|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
162954850|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
162954851|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954852|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954853|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954854|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954855|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954856|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954857|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954858|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954859|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954860|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954861|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954862|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954863|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
162954864|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954865|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954866|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954867|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
162954868|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
162954869|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
162954870|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954871|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
162954872|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954873|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954874|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954875|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954876|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954877|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954878|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954879|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954880|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
163194107|NCT01058655|589425058|FG002|Overall Study|Symptomatic Deterioration|0|||
163194108|NCT01058655|589425059|FG003|Overall Study|Symptomatic Deterioration|1|||
163194109|NCT01058655|589425056|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
163194110|NCT01058655|589425057|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
163194111|NCT01058655|589425058|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
162954881|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
163194112|NCT01058655|589425059|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
163194113|NCT01058655|589425056|FG000|Overall Study|Death|0|||
163194114|NCT01058655|589425057|FG001|Overall Study|Death|1|||
163194115|NCT01058655|589425058|FG002|Overall Study|Death|1|||
163194116|NCT01058655|589425059|FG003|Overall Study|Death|0|||
163194117|NCT01058655|589425056|FG000|Overall Study|Disease Progression|1|||
163194118|NCT01058655|589425057|FG001|Overall Study|Disease Progression|2|||
163194119|NCT01058655|589425058|FG002|Overall Study|Disease Progression|4|||
163194120|NCT01058655|589425059|FG003|Overall Study|Disease Progression|24|||
163194121|NCT01058655|589425056|FG000|Overall Study|Other|0|||
163194122|NCT01058655|589425057|FG001|Overall Study|Other|0|||
163194123|NCT01058655|589425058|FG002|Overall Study|Other|0|||
163194124|NCT01058655|589425059|FG003|Overall Study|Other|4|||
163194125|NCT04545060|589425060|FG000|Overall Study|Adverse Event|0|||
163194126|NCT04545060|589425061|FG001|Overall Study|Adverse Event|1|||
163194127|NCT04545060|589425060|FG000|Overall Study|Death|0|||
163194128|NCT04545060|589425061|FG001|Overall Study|Death|5|||
163194129|NCT04545060|589425060|FG000|Overall Study|Lost to Follow-up|10|||
163194130|NCT04545060|589425061|FG001|Overall Study|Lost to Follow-up|13|||
163194131|NCT04545060|589425060|FG000|Overall Study|Physician Decision|3|||
163194132|NCT04545060|589425061|FG001|Overall Study|Physician Decision|0|||
163194133|NCT04545060|589425060|FG000|Overall Study|Withdrawal by Subject|17|||
163194134|NCT04545060|589425061|FG001|Overall Study|Withdrawal by Subject|22|||
163194135|NCT02846324|589425062|FG000|Overall Study|Other|1|||
163194136|NCT02846324|589425063|FG001|Overall Study|Other|0|||
163194137|NCT02846324|589425064|FG002|Overall Study|Other|0|||
163194138|NCT02846324|589425065|FG003|Overall Study|Other|0|||
163299522|NCT01170962|589805200|FG000|Treatment Period|Lack of Efficacy|96|||
163194139|NCT02846324|589425062|FG000|Overall Study|Withdrawal by Subject|1|||
163194140|NCT02846324|589425063|FG001|Overall Study|Withdrawal by Subject|0|||
163194141|NCT02846324|589425064|FG002|Overall Study|Withdrawal by Subject|4|||
163194142|NCT02846324|589425065|FG003|Overall Study|Withdrawal by Subject|0|||
163194143|NCT00810355|589425075|FG000|Overall Study|Lost to Follow-up|13|||
163194144|NCT00810355|589425076|FG001|Overall Study|Lost to Follow-up|17|||
163194145|NCT00810355|589425077|FG002|Overall Study|Lost to Follow-up|11|||
163194146|NCT00810355|589425075|FG000|Overall Study|Withdrawal by Subject|1|||
163194147|NCT00810355|589425076|FG001|Overall Study|Withdrawal by Subject|0|||
163194148|NCT00810355|589425077|FG002|Overall Study|Withdrawal by Subject|0|||
163194149|NCT00657358|589425078|FG000|Overall Study|Lack of Efficacy|6|||
163194150|NCT00400764|589425079|FG000|Phase Ib|Adverse Event|1|||
162954882|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954883|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954884|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
162954885|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
162954886|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
162954887|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954888|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
162954889|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
162954890|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
162954891|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
162954892|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
162954893|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954894|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954895|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954896|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954897|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954898|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954899|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954900|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954901|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954902|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954903|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954904|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954905|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954906|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
162954907|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954908|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954909|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
162954910|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
162954911|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
162954912|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
162954913|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954914|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954915|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954916|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954917|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954918|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954919|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954920|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954921|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954922|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954923|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954924|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954925|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954926|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954927|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954928|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954929|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954930|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954931|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954932|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
163194151|NCT00400764|589425080|FG001|Phase Ib|Adverse Event|0|||
163194152|NCT00400764|589425081|FG002|Phase Ib|Adverse Event|0|||
163194153|NCT00400764|589425082|FG003|Phase Ib|Adverse Event|0|||
163194154|NCT00400764|589425083|FG004|Phase Ib|Adverse Event|0|||
163194155|NCT00400764|589425079|FG000|Phase Ib|Death|1|||
163194156|NCT00400764|589425080|FG001|Phase Ib|Death|0|||
163194157|NCT00400764|589425081|FG002|Phase Ib|Death|0|||
163194158|NCT00400764|589425082|FG003|Phase Ib|Death|0|||
163194159|NCT00400764|589425083|FG004|Phase Ib|Death|0|||
163194160|NCT00400764|589425079|FG000|Phase Ib|Disease Progression|4|||
163299523|NCT01170962|589805201|FG001|Treatment Period|Lack of Efficacy|91|||
163299524|NCT01170962|589805202|FG002|Treatment Period|Lack of Efficacy|7|||
162954933|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
163194161|NCT00400764|589425080|FG001|Phase Ib|Disease Progression|4|||
163194162|NCT00400764|589425081|FG002|Phase Ib|Disease Progression|0|||
163194163|NCT00400764|589425082|FG003|Phase Ib|Disease Progression|0|||
163194164|NCT00400764|589425083|FG004|Phase Ib|Disease Progression|0|||
163043853|NCT03283930|588868183|FG000|Overall Study|Technical software issue|2|||
163043854|NCT03283930|588868184|FG001|Overall Study|Technical software issue|2|||
163043855|NCT00805129|588868185|FG000|Overall Study|Not treated|1|||
163043856|NCT00571662|588868186|FG000|Overall Study|Withdrawal by Subject|2|||
163043857|NCT00571662|588868186|FG000|Overall Study|psychiatric instability|1|||
163043858|NCT00571662|588868186|FG000|Overall Study|Adverse Event|5|||
163043859|NCT03681184|588868189|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
163043860|NCT03681184|588868190|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
163043861|NCT02787083|588868195|FG000|Overall Study|Adverse Event|1|||
163043862|NCT02787083|588868196|FG001|Overall Study|Adverse Event|0|||
163043863|NCT02787083|588868195|FG000|Overall Study|Withdrawal by Subject|2|||
163043864|NCT02787083|588868196|FG001|Overall Study|Withdrawal by Subject|2|||
163043865|NCT02710084|588868197|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
163043866|NCT02710084|588868198|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
163043867|NCT02453256|588868203|FG000|Double Blind Period|Death|1|||
163043868|NCT02453256|588868204|FG001|Double Blind Period|Death|1|||
163043869|NCT02453256|588868203|FG000|Double Blind Period|Adverse Event|3|||
163043870|NCT02453256|588868204|FG001|Double Blind Period|Adverse Event|2|||
163043871|NCT02453256|588868203|FG000|Double Blind Period|Withdrawal by Subject|9|||
163043872|NCT02453256|588868204|FG001|Double Blind Period|Withdrawal by Subject|5|||
163043873|NCT02453256|588868203|FG000|Double Blind Period|Other|0|||
163043874|NCT02453256|588868204|FG001|Double Blind Period|Other|1|||
163043875|NCT02453256|588868203|FG000|Open Label Period|Adverse Event|1|||
163043876|NCT02453256|588868204|FG001|Open Label Period|Adverse Event|3|||
163043877|NCT02453256|588868203|FG000|Open Label Period|Death|0|||
163043878|NCT02453256|588868204|FG001|Open Label Period|Death|1|||
163043879|NCT02453256|588868203|FG000|Open Label Period|Lost to Follow-up|1|||
163043880|NCT02453256|588868204|FG001|Open Label Period|Lost to Follow-up|0|||
163043881|NCT02453256|588868203|FG000|Open Label Period|Other|0|||
163043882|NCT02453256|588868204|FG001|Open Label Period|Other|2|||
162954934|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954935|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954936|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954937|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954938|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954939|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954940|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954941|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954942|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954943|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954944|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954945|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954946|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954947|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954948|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954949|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954950|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954951|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954952|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954953|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954954|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954955|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954956|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
162954957|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
162954958|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
162954959|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954960|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954961|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954962|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954963|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954964|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954965|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954966|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954967|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954968|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954969|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954970|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954971|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954972|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954973|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954974|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954975|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954976|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954977|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
162954978|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
162954979|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
162954980|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954981|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954982|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954983|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954984|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954985|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954986|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954987|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954988|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954989|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954990|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954991|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954992|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954993|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954994|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954995|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954996|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
163043883|NCT02453256|588868203|FG000|Open Label Period|Withdrawal by Subject|5|||
163299525|NCT01170962|589805200|FG000|Treatment Period|Adverse Event|11|||
163299526|NCT01170962|589805201|FG001|Treatment Period|Adverse Event|12|||
163299527|NCT01170962|589805202|FG002|Treatment Period|Adverse Event|3|||
163299528|NCT01170962|589805200|FG000|Treatment Period|Withdrawal by Subject|2|||
163299529|NCT01170962|589805201|FG001|Treatment Period|Withdrawal by Subject|1|||
163299530|NCT01170962|589805202|FG002|Treatment Period|Withdrawal by Subject|0|||
163299531|NCT01170962|589805200|FG000|Treatment Period|Lost to Follow-up|1|||
163299532|NCT01170962|589805201|FG001|Treatment Period|Lost to Follow-up|1|||
163299533|NCT01170962|589805202|FG002|Treatment Period|Lost to Follow-up|1|||
163299534|NCT01170962|589805200|FG000|Treatment Period|Participant no longer meets criteria|0|||
163299535|NCT01170962|589805201|FG001|Treatment Period|Participant no longer meets criteria|1|||
163299536|NCT01170962|589805202|FG002|Treatment Period|Participant no longer meets criteria|0|||
163299537|NCT01170962|589805200|FG000|Treatment Period|Request to discontinue treatment|7|||
163299538|NCT01170962|589805201|FG001|Treatment Period|Request to discontinue treatment|3|||
163299539|NCT01170962|589805202|FG002|Treatment Period|Request to discontinue treatment|1|||
163393389|NCT02632721|590152111|FG000|Overall Study|No benefit from study treatment|1|||
162954997|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954998|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954999|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
162955000|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
162955001|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162955002|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162955003|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162955004|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162955005|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162955006|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955007|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955008|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955009|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955010|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955011|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955012|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955013|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955014|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955015|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955016|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955017|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955018|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955019|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955020|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
162955021|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
162955022|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955023|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955024|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955025|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955026|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955027|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955028|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955029|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955030|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955031|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955032|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955033|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955034|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955035|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955036|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955037|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955038|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955039|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955040|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
162955041|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
162955042|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
162955043|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955044|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
163393390|NCT02632721|590152112|FG001|Overall Study|No benefit from study treatment|1|||
163043884|NCT02453256|588868204|FG001|Open Label Period|Withdrawal by Subject|1|||
163043885|NCT01243177|588868206|FG000|Overall Study|Lack of Efficacy|47|||
163043886|NCT01243177|588868207|FG001|Overall Study|Lack of Efficacy|31|||
163043887|NCT01243177|588868206|FG000|Overall Study|Protocol Violation|11|||
163043888|NCT01243177|588868207|FG001|Overall Study|Protocol Violation|10|||
163043889|NCT01243177|588868206|FG000|Overall Study|Lost to Follow-up|15|||
163043890|NCT01243177|588868207|FG001|Overall Study|Lost to Follow-up|18|||
163043891|NCT01243177|588868206|FG000|Overall Study|Withdrawal by Subject|46|||
163043892|NCT01243177|588868207|FG001|Overall Study|Withdrawal by Subject|38|||
163043893|NCT01243177|588868206|FG000|Overall Study|AE, serious fatal|0|||
163043894|NCT01243177|588868207|FG001|Overall Study|AE, serious fatal|1|||
163043895|NCT01243177|588868206|FG000|Overall Study|SAE, non-fatal|7|||
163043896|NCT01243177|588868207|FG001|Overall Study|SAE, non-fatal|9|||
163043897|NCT01243177|588868206|FG000|Overall Study|AE, non-serious non-fatal|40|||
163043898|NCT01243177|588868207|FG001|Overall Study|AE, non-serious non-fatal|58|||
162955045|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955046|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955047|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955048|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955049|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955050|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955051|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955052|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955053|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955054|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955055|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
163043899|NCT01243177|588868206|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
163194165|NCT00400764|589425079|FG000|Phase II|Death|0|||
163194166|NCT00400764|589425080|FG001|Phase II|Death|0|||
163194167|NCT00400764|589425081|FG002|Phase II|Death|1|||
163194168|NCT00400764|589425082|FG003|Phase II|Death|2|||
163194169|NCT00400764|589425083|FG004|Phase II|Death|0|||
163194170|NCT00400764|589425079|FG000|Phase II|Lost to Follow-up|0|||
163194171|NCT00400764|589425080|FG001|Phase II|Lost to Follow-up|0|||
163043900|NCT01243177|588868207|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
163043901|NCT01243177|588868206|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
163043902|NCT01243177|588868207|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
163043903|NCT01243177|588868206|FG000|Overall Study|Other Reason|11|||
163194172|NCT00400764|589425081|FG002|Phase II|Lost to Follow-up|1|||
163194173|NCT00400764|589425082|FG003|Phase II|Lost to Follow-up|0|||
163393391|NCT02632721|590152113|FG002|Overall Study|No benefit from study treatment|0|||
163393392|NCT02632721|590152114|FG003|Overall Study|No benefit from study treatment|0|||
163194174|NCT00400764|589425083|FG004|Phase II|Lost to Follow-up|0|||
163194175|NCT00400764|589425079|FG000|Phase II|Physician Decision|0|||
163194176|NCT00400764|589425080|FG001|Phase II|Physician Decision|0|||
163393393|NCT02632721|590152115|FG004|Overall Study|No benefit from study treatment|1|||
163393394|NCT02632721|590152111|FG000|Overall Study|Patient wish for other treatment|0|||
162955056|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955057|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955058|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955059|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955060|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955061|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955062|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
162955063|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
162955064|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955065|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955066|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955067|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955068|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955069|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
163393395|NCT02632721|590152112|FG001|Overall Study|Patient wish for other treatment|1|||
162955070|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
163043904|NCT01243177|588868207|FG001|Overall Study|Other Reason|12|||
163043905|NCT05259163|588869363|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
163043906|NCT05259163|588869364|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
163043907|NCT05251233|588869365|FG000|Overall Study|Disease progression - did not start treatment|0|||
163043908|NCT05251233|588869366|FG001|Overall Study|Disease progression - did not start treatment|0|||
163043909|NCT05251233|588869367|FG002|Overall Study|Disease progression - did not start treatment|5|||
163043910|NCT05251233|588869365|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
163043911|NCT05251233|588869366|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
163194177|NCT00400764|589425081|FG002|Phase II|Physician Decision|1|||
163194178|NCT00400764|589425082|FG003|Phase II|Physician Decision|1|||
163393396|NCT02632721|590152113|FG002|Overall Study|Patient wish for other treatment|0|||
163194179|NCT00400764|589425083|FG004|Phase II|Physician Decision|0|||
162955071|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955072|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955073|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955074|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955075|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955076|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955077|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955078|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955079|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955080|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955081|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955082|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955083|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
162955084|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
162955085|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955086|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955087|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955088|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955089|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955090|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955091|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955092|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955093|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955094|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955095|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955096|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955097|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955098|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955099|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955100|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955101|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955102|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955103|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955104|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
162955105|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
162955106|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955107|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955108|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955109|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955110|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955111|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955112|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955113|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955114|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955115|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955116|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955117|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955118|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955119|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955120|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955121|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955122|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955123|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955124|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955125|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
162955126|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
162955127|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955128|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955129|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955130|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955131|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
163194180|NCT00400764|589425079|FG000|Phase II|Sponsor's decision to terminate|0|||
163194181|NCT00400764|589425080|FG001|Phase II|Sponsor's decision to terminate|0|||
163393397|NCT02632721|590152114|FG003|Overall Study|Patient wish for other treatment|0|||
163393398|NCT02632721|590152115|FG004|Overall Study|Patient wish for other treatment|0|||
163194182|NCT00400764|589425081|FG002|Phase II|Sponsor's decision to terminate|18|||
163194183|NCT00400764|589425082|FG003|Phase II|Sponsor's decision to terminate|22|||
163194184|NCT00400764|589425083|FG004|Phase II|Sponsor's decision to terminate|11|||
163194185|NCT00400764|589425079|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
163194186|NCT00400764|589425080|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
163194187|NCT00400764|589425081|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
163194188|NCT00400764|589425082|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
163194189|NCT00400764|589425083|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
163194190|NCT00400764|589425079|FG000|Phase II|Withdrawal by Subject|0|||
163194191|NCT00400764|589425080|FG001|Phase II|Withdrawal by Subject|0|||
163194192|NCT00400764|589425081|FG002|Phase II|Withdrawal by Subject|1|||
163194193|NCT00400764|589425082|FG003|Phase II|Withdrawal by Subject|1|||
163194194|NCT00400764|589425083|FG004|Phase II|Withdrawal by Subject|0|||
163194195|NCT00347360|589425086|FG000|Overall Study|Adverse Event|1|||
163194196|NCT00347360|589425087|FG001|Overall Study|Adverse Event|2|||
163194197|NCT00347360|589425088|FG002|Overall Study|Adverse Event|0|||
163393399|NCT02632721|590152111|FG000|Overall Study|Relapsed Pneumonia|0|||
163393400|NCT02632721|590152112|FG001|Overall Study|Relapsed Pneumonia|0|||
163194198|NCT00347360|589425089|FG003|Overall Study|Adverse Event|4|||
163194199|NCT00347360|589425090|FG004|Overall Study|Adverse Event|1|||
163194200|NCT00347360|589425091|FG005|Overall Study|Adverse Event|2|||
163194201|NCT00347360|589425092|FG006|Overall Study|Adverse Event|2|||
163194202|NCT00347360|589425093|FG007|Overall Study|Adverse Event|0|||
163194203|NCT00347360|589425094|FG008|Overall Study|Adverse Event|2|||
163194204|NCT00347360|589425095|FG009|Overall Study|Adverse Event|3|||
163393401|NCT02632721|590152113|FG002|Overall Study|Relapsed Pneumonia|0|||
163393402|NCT02632721|590152114|FG003|Overall Study|Relapsed Pneumonia|0|||
162955132|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955133|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955134|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955135|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955136|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955137|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955138|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955139|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955140|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955141|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955142|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955143|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955144|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955145|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
162955146|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955147|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955148|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955149|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955150|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955151|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955152|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955153|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955154|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955155|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955156|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955157|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955158|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955159|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955160|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955161|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955162|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955163|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955164|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955165|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955166|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955167|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955168|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955169|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
162955170|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
162955171|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
162955172|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
162955173|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
162955174|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955175|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955176|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955177|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955178|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955179|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955180|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955181|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955182|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955183|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955184|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
163194205|NCT00347360|589425096|FG010|Overall Study|Adverse Event|3|||
163194206|NCT00347360|589425097|FG011|Overall Study|Adverse Event|1|||
163194207|NCT00347360|589425098|FG012|Overall Study|Adverse Event|3|||
163194208|NCT00347360|589425099|FG013|Overall Study|Adverse Event|2|||
163194209|NCT00347360|589425100|FG014|Overall Study|Adverse Event|2|||
163194210|NCT00347360|589425086|FG000|Overall Study|Lost to Follow-up|0|||
163194211|NCT00347360|589425087|FG001|Overall Study|Lost to Follow-up|0|||
163194212|NCT00347360|589425088|FG002|Overall Study|Lost to Follow-up|0|||
163194213|NCT00347360|589425089|FG003|Overall Study|Lost to Follow-up|2|||
163194214|NCT00347360|589425090|FG004|Overall Study|Lost to Follow-up|1|||
163194215|NCT00347360|589425091|FG005|Overall Study|Lost to Follow-up|1|||
163043912|NCT05251233|588869367|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
163043913|NCT05251233|588869365|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
163043914|NCT05251233|588869366|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
163043915|NCT05251233|588869367|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
163043916|NCT05251233|588869365|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
163043917|NCT05251233|588869366|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
163043918|NCT05251233|588869367|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
163043919|NCT05251233|588869365|FG000|Overall Study|Death - did not start treatment|3|||
163043920|NCT05251233|588869366|FG001|Overall Study|Death - did not start treatment|0|||
163043921|NCT05251233|588869367|FG002|Overall Study|Death - did not start treatment|0|||
163043922|NCT05251233|588869365|FG000|Overall Study|Withdrawal by Subject|2|||
163043923|NCT05251233|588869366|FG001|Overall Study|Withdrawal by Subject|2|||
163043924|NCT05251233|588869367|FG002|Overall Study|Withdrawal by Subject|0|||
163043925|NCT05251233|588869365|FG000|Overall Study|Other complicating disease|2|||
163043926|NCT05251233|588869366|FG001|Overall Study|Other complicating disease|1|||
163043927|NCT05251233|588869367|FG002|Overall Study|Other complicating disease|0|||
163194216|NCT00347360|589425092|FG006|Overall Study|Lost to Follow-up|0|||
162955185|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955186|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955187|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955188|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955189|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955190|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955191|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
162955192|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
162955193|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
162955194|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
162955195|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955196|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955197|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955198|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955199|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955200|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955201|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955202|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955203|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955204|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955205|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955206|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955207|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955208|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955209|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955210|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955211|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
162955212|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955213|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955214|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
162955215|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
162955216|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955217|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955218|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955219|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955220|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955221|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955222|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955223|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955224|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955225|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955226|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955227|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955228|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955229|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955230|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955231|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955232|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955233|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955234|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
162955235|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
162955236|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
162955237|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955238|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955239|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955240|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955241|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955242|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955243|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955244|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955245|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955246|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
163393403|NCT02632721|590152115|FG004|Overall Study|Relapsed Pneumonia|1|||
163393404|NCT02632721|590152111|FG000|Overall Study|Therapy refractory AML|0|||
163393405|NCT02632721|590152112|FG001|Overall Study|Therapy refractory AML|0|||
163393406|NCT02632721|590152113|FG002|Overall Study|Therapy refractory AML|0|||
163393407|NCT02632721|590152114|FG003|Overall Study|Therapy refractory AML|0|||
163393408|NCT02632721|590152115|FG004|Overall Study|Therapy refractory AML|1|||
163393409|NCT02632721|590152111|FG000|Overall Study|Increase of white blood cell count|0|||
163393410|NCT02632721|590152112|FG001|Overall Study|Increase of white blood cell count|0|||
163393411|NCT02632721|590152113|FG002|Overall Study|Increase of white blood cell count|0|||
163393412|NCT02632721|590152114|FG003|Overall Study|Increase of white blood cell count|0|||
163393413|NCT02632721|590152115|FG004|Overall Study|Increase of white blood cell count|1|||
163043928|NCT05251233|588869365|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
163043929|NCT05251233|588869366|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
163043930|NCT05251233|588869367|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
163043931|NCT05251233|588869365|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
163043932|NCT05251233|588869366|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
163043933|NCT05251233|588869367|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
163043934|NCT00588146|588869381|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
163043935|NCT00588146|588869382|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
163043936|NCT02100839|588869383|FG000|Multiple Ascending Dose|Adverse Event|2|||
163043937|NCT02100839|588869384|FG001|Multiple Ascending Dose|Adverse Event|0|||
163043938|NCT02100839|588869383|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
163393414|NCT02632721|590152111|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
162955247|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955248|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955249|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955250|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955251|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
163194217|NCT00347360|589425093|FG007|Overall Study|Lost to Follow-up|1|||
162955252|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955253|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
163299540|NCT01170962|589805200|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
162955254|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955255|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955256|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
162955257|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
162955258|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955259|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955260|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955261|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
163299541|NCT01170962|589805201|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
163299542|NCT01170962|589805202|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
163299543|NCT01170962|589805200|FG000|Follow up Period|Withdrawal by Subject|14|||
163299544|NCT01170962|589805201|FG001|Follow up Period|Withdrawal by Subject|10|||
163299545|NCT01170962|589805202|FG002|Follow up Period|Withdrawal by Subject|2|||
162955262|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
163299546|NCT01170962|589805200|FG000|Follow up Period|Lost to Follow-up|13|||
163299547|NCT01170962|589805201|FG001|Follow up Period|Lost to Follow-up|8|||
163299548|NCT01170962|589805202|FG002|Follow up Period|Lost to Follow-up|1|||
163299549|NCT01170962|589805200|FG000|Follow up Period|Death|2|||
163299550|NCT01170962|589805201|FG001|Follow up Period|Death|2|||
163299551|NCT01170962|589805202|FG002|Follow up Period|Death|0|||
163299552|NCT01170962|589805200|FG000|Follow up Period|Others|10|||
163393415|NCT02632721|590152112|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
163393416|NCT02632721|590152113|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
163393417|NCT02632721|590152114|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
162955263|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955264|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955265|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955266|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955267|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955268|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955269|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955270|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955271|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955272|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955273|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955274|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
162955275|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955276|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955277|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
162955278|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
162955279|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955280|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955281|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955282|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955283|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955284|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955285|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955286|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955287|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955288|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955289|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955290|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955291|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955292|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955293|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955294|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955295|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
162955296|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955297|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955298|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
162955299|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955300|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955301|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955302|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955303|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955304|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955305|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955306|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955307|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955308|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955309|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955310|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955311|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955312|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955313|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955314|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955315|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955316|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
162955317|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955318|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955319|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
162955320|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955321|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955322|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955323|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
163194218|NCT00347360|589425094|FG008|Overall Study|Lost to Follow-up|1|||
163194219|NCT00347360|589425095|FG009|Overall Study|Lost to Follow-up|2|||
163194220|NCT00347360|589425096|FG010|Overall Study|Lost to Follow-up|0|||
163194221|NCT00347360|589425097|FG011|Overall Study|Lost to Follow-up|0|||
162955324|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955325|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955326|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955327|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955328|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955329|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955330|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955331|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955332|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955333|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955334|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955335|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955336|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955337|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
163393418|NCT02632721|590152115|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
163393419|NCT02663271|590152119|FG000|Overall Study|Withdrawal by Subject|5|||
162955338|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955339|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
163194222|NCT00347360|589425098|FG012|Overall Study|Lost to Follow-up|1|||
163194223|NCT00347360|589425099|FG013|Overall Study|Lost to Follow-up|0|||
163194224|NCT00347360|589425100|FG014|Overall Study|Lost to Follow-up|0|||
163194225|NCT00347360|589425086|FG000|Overall Study|Protocol Violation|2|||
163194226|NCT00347360|589425087|FG001|Overall Study|Protocol Violation|3|||
163194227|NCT00347360|589425088|FG002|Overall Study|Protocol Violation|1|||
163194228|NCT00347360|589425089|FG003|Overall Study|Protocol Violation|2|||
163194229|NCT00347360|589425090|FG004|Overall Study|Protocol Violation|1|||
163194230|NCT00347360|589425091|FG005|Overall Study|Protocol Violation|2|||
163194231|NCT00347360|589425092|FG006|Overall Study|Protocol Violation|0|||
163194232|NCT00347360|589425093|FG007|Overall Study|Protocol Violation|0|||
163194233|NCT00347360|589425094|FG008|Overall Study|Protocol Violation|1|||
163194234|NCT00347360|589425095|FG009|Overall Study|Protocol Violation|2|||
163194235|NCT00347360|589425096|FG010|Overall Study|Protocol Violation|0|||
163194236|NCT00347360|589425097|FG011|Overall Study|Protocol Violation|0|||
163194237|NCT00347360|589425098|FG012|Overall Study|Protocol Violation|0|||
163194238|NCT00347360|589425099|FG013|Overall Study|Protocol Violation|1|||
163194239|NCT00347360|589425100|FG014|Overall Study|Protocol Violation|0|||
163194240|NCT00347360|589425086|FG000|Overall Study|Withdrawal by Subject|0|||
163194241|NCT00347360|589425087|FG001|Overall Study|Withdrawal by Subject|1|||
163194242|NCT00347360|589425088|FG002|Overall Study|Withdrawal by Subject|2|||
163194243|NCT00347360|589425089|FG003|Overall Study|Withdrawal by Subject|4|||
163194244|NCT00347360|589425090|FG004|Overall Study|Withdrawal by Subject|1|||
163194245|NCT00347360|589425091|FG005|Overall Study|Withdrawal by Subject|2|||
163194246|NCT00347360|589425092|FG006|Overall Study|Withdrawal by Subject|1|||
163194247|NCT00347360|589425093|FG007|Overall Study|Withdrawal by Subject|1|||
163194248|NCT00347360|589425094|FG008|Overall Study|Withdrawal by Subject|1|||
163194249|NCT00347360|589425095|FG009|Overall Study|Withdrawal by Subject|1|||
163194250|NCT00347360|589425096|FG010|Overall Study|Withdrawal by Subject|0|||
163194251|NCT00347360|589425097|FG011|Overall Study|Withdrawal by Subject|3|||
163194252|NCT00347360|589425098|FG012|Overall Study|Withdrawal by Subject|4|||
163194253|NCT00347360|589425099|FG013|Overall Study|Withdrawal by Subject|2|||
163194254|NCT00347360|589425100|FG014|Overall Study|Withdrawal by Subject|1|||
163194255|NCT00347360|589425086|FG000|Overall Study|Lack of Efficacy|1|||
163194256|NCT00347360|589425087|FG001|Overall Study|Lack of Efficacy|1|||
163194257|NCT00347360|589425088|FG002|Overall Study|Lack of Efficacy|3|||
163194258|NCT00347360|589425089|FG003|Overall Study|Lack of Efficacy|1|||
163194259|NCT00347360|589425090|FG004|Overall Study|Lack of Efficacy|0|||
163194260|NCT00347360|589425091|FG005|Overall Study|Lack of Efficacy|1|||
163194261|NCT00347360|589425092|FG006|Overall Study|Lack of Efficacy|0|||
163194262|NCT00347360|589425093|FG007|Overall Study|Lack of Efficacy|1|||
163194263|NCT00347360|589425094|FG008|Overall Study|Lack of Efficacy|1|||
162955340|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
162955341|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955342|NCT00731783|588537670|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
162955343|NCT00731783|588537671|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
162955344|NCT00731783|588537670|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
162955345|NCT00731783|588537671|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
162955346|NCT00731783|588537670|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
163194264|NCT00347360|589425095|FG009|Overall Study|Lack of Efficacy|0|||
163194265|NCT00347360|589425096|FG010|Overall Study|Lack of Efficacy|0|||
163194266|NCT00347360|589425097|FG011|Overall Study|Lack of Efficacy|0|||
163194267|NCT00347360|589425098|FG012|Overall Study|Lack of Efficacy|0|||
163194268|NCT00347360|589425099|FG013|Overall Study|Lack of Efficacy|0|||
163194269|NCT00347360|589425100|FG014|Overall Study|Lack of Efficacy|0|||
163194270|NCT00347360|589425086|FG000|Overall Study|Reason not listed/blank|1|||
163194271|NCT00347360|589425087|FG001|Overall Study|Reason not listed/blank|0|||
163194272|NCT00347360|589425088|FG002|Overall Study|Reason not listed/blank|0|||
163194273|NCT00347360|589425089|FG003|Overall Study|Reason not listed/blank|0|||
163194274|NCT00347360|589425090|FG004|Overall Study|Reason not listed/blank|0|||
163194275|NCT00347360|589425091|FG005|Overall Study|Reason not listed/blank|0|||
163194276|NCT00347360|589425092|FG006|Overall Study|Reason not listed/blank|1|||
163194277|NCT00347360|589425093|FG007|Overall Study|Reason not listed/blank|0|||
163194278|NCT00347360|589425094|FG008|Overall Study|Reason not listed/blank|0|||
163194279|NCT00347360|589425095|FG009|Overall Study|Reason not listed/blank|0|||
163194280|NCT00347360|589425096|FG010|Overall Study|Reason not listed/blank|0|||
163194281|NCT00347360|589425097|FG011|Overall Study|Reason not listed/blank|0|||
163194282|NCT00347360|589425098|FG012|Overall Study|Reason not listed/blank|0|||
163194283|NCT00347360|589425099|FG013|Overall Study|Reason not listed/blank|1|||
163194284|NCT00347360|589425100|FG014|Overall Study|Reason not listed/blank|0|||
163194285|NCT00347360|589425086|FG000|Overall Study|Per sponsors instruction|0|||
163194286|NCT00347360|589425087|FG001|Overall Study|Per sponsors instruction|1|||
163194287|NCT00347360|589425088|FG002|Overall Study|Per sponsors instruction|0|||
163194288|NCT00347360|589425089|FG003|Overall Study|Per sponsors instruction|0|||
163194289|NCT00347360|589425090|FG004|Overall Study|Per sponsors instruction|0|||
163194290|NCT00347360|589425091|FG005|Overall Study|Per sponsors instruction|0|||
163194291|NCT00347360|589425092|FG006|Overall Study|Per sponsors instruction|0|||
163194292|NCT00347360|589425093|FG007|Overall Study|Per sponsors instruction|0|||
163194293|NCT00347360|589425094|FG008|Overall Study|Per sponsors instruction|0|||
163194294|NCT00347360|589425095|FG009|Overall Study|Per sponsors instruction|0|||
163194295|NCT00347360|589425096|FG010|Overall Study|Per sponsors instruction|0|||
162955347|NCT00731783|588537671|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
162955348|NCT00731783|588537670|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
162955349|NCT00731783|588537671|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
162955350|NCT02571907|588539234|FG000|Overall Study|Death|4|||
163194296|NCT00347360|589425097|FG011|Overall Study|Per sponsors instruction|0|||
163194297|NCT00347360|589425098|FG012|Overall Study|Per sponsors instruction|0|||
163194298|NCT00347360|589425099|FG013|Overall Study|Per sponsors instruction|0|||
163194299|NCT00347360|589425100|FG014|Overall Study|Per sponsors instruction|0|||
163194300|NCT00347360|589425086|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
163299553|NCT01170962|589805201|FG001|Follow up Period|Others|7|||
163299554|NCT01170962|589805202|FG002|Follow up Period|Others|3|||
163299555|NCT01083316|589805203|FG000|Overall Study|Adverse Event|2|||
163299556|NCT01083316|589805203|FG000|Overall Study|Withdrawal by Subject|1|||
163299557|NCT04200365|589805204|FG000|Overall Study|Adverse Event|2|||
163299558|NCT04200365|589805204|FG000|Overall Study|Progressive Disease|4|||
163299559|NCT04200365|589805204|FG000|Overall Study|Lack of Efficacy|1|||
163299560|NCT04200365|589805204|FG000|Overall Study|Study Closure|4|||
163299561|NCT03942042|589805205|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
163299562|NCT03942042|589805206|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
163299563|NCT03942042|589805205|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
163299564|NCT03942042|589805206|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
163299565|NCT01499199|589805209|FG000|Overall Study|Adverse Event|1|||
163299566|NCT01499199|589805209|FG000|Overall Study|Lack of Efficacy|1|||
163299567|NCT01199705|589805210|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
163299568|NCT01849055|589805216|FG000|Overall Study|Withdrawal by Subject|0|||
163299569|NCT01849055|589805217|FG001|Overall Study|Withdrawal by Subject|0|||
163299570|NCT01849055|589805218|FG002|Overall Study|Withdrawal by Subject|1|||
163299571|NCT01849055|589805219|FG003|Overall Study|Withdrawal by Subject|0|||
163299572|NCT01849055|589805220|FG004|Overall Study|Withdrawal by Subject|0|||
163299573|NCT01849055|589805221|FG005|Overall Study|Withdrawal by Subject|0|||
163299574|NCT01199575|589805222|FG000|Overall Study|Withdrawal by Subject|5|||
163299575|NCT00933400|589805223|FG000|Overall Study|Withdrawal by Subject|21|||
163299576|NCT00933400|589805224|FG001|Overall Study|Withdrawal by Subject|1|||
163299577|NCT00223795|589805225|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
163299578|NCT00223795|589805226|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
163299579|NCT00223795|589805225|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
163299580|NCT00223795|589805226|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
163299581|NCT01239316|589805232|FG000|Overall Study|Progression/Relapse|11|||
163299582|NCT01239316|589805232|FG000|Overall Study|Adverse Event|1|||
163299583|NCT02409667|589805235|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
163299584|NCT02409667|589805236|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
163299585|NCT02409667|589805237|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
163299586|NCT02409667|589805238|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
163299587|NCT02409667|589805239|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
163299588|NCT02409667|589805235|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
163299589|NCT02409667|589805236|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
163299590|NCT02409667|589805237|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
163299591|NCT02409667|589805238|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
163299592|NCT02409667|589805239|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
163299593|NCT02409667|589805235|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
163299594|NCT02409667|589805236|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
163299595|NCT02409667|589805237|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
163299596|NCT02409667|589805238|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
163299597|NCT02409667|589805239|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
163299598|NCT02409667|589805235|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
163299599|NCT02409667|589805236|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
163299600|NCT02409667|589805237|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
163299601|NCT02409667|589805238|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
163299602|NCT02409667|589805239|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
163299603|NCT02409667|589805235|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
163299604|NCT02409667|589805236|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
163299605|NCT02409667|589805237|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
163299606|NCT02409667|589805238|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
163299607|NCT02409667|589805239|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
163299608|NCT02409667|589805235|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
163299609|NCT02409667|589805236|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
163299610|NCT02409667|589805237|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
163299611|NCT02409667|589805238|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
163299612|NCT02409667|589805239|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
163299613|NCT02409667|589805235|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
163299614|NCT02409667|589805236|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
163299615|NCT02409667|589805237|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
163299616|NCT02409667|589805238|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
163299617|NCT02409667|589805239|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
163299618|NCT02409667|589805235|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
163299619|NCT02409667|589805236|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
163299620|NCT02409667|589805237|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
163299621|NCT02409667|589805238|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
163299622|NCT02409667|589805239|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
163299623|NCT02409667|589805235|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
163299624|NCT02409667|589805236|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
163299625|NCT02409667|589805237|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
163299626|NCT02409667|589805238|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
163299627|NCT02409667|589805239|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
162955351|NCT02571907|588539234|FG000|Overall Study|Lost to Follow-up|3|||
162955352|NCT02571907|588539234|FG000|Overall Study|Withdrawal by Subject|3|||
162955353|NCT03071575|588539235|FG000|Overall Study|Death|0|||
162955354|NCT03071575|588539236|FG001|Overall Study|Death|1|||
162955355|NCT03071575|588539235|FG000|Overall Study|Lost to Follow-up|5|||
162955356|NCT03071575|588539236|FG001|Overall Study|Lost to Follow-up|11|||
162955357|NCT03071575|588539235|FG000|Overall Study|Withdrawal by Subject|4|||
162955358|NCT03071575|588539236|FG001|Overall Study|Withdrawal by Subject|2|||
162955359|NCT00218257|588539241|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
162955360|NCT00218257|588539242|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
162955361|NCT00579345|588539243|FG000|Overall Study|Withdrawal by Subject|2|||
162955362|NCT00579345|588539244|FG001|Overall Study|Withdrawal by Subject|0|||
162955363|NCT00579345|588539245|FG002|Overall Study|Withdrawal by Subject|0|||
162955364|NCT00579345|588539246|FG003|Overall Study|Withdrawal by Subject|0|||
162955365|NCT00579345|588539247|FG004|Overall Study|Withdrawal by Subject|0|||
162955366|NCT00579345|588539248|FG005|Overall Study|Withdrawal by Subject|0|||
163043939|NCT02100839|588869384|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
163043940|NCT03272347|588869386|FG000|Overall Study|Death|0|||
163043941|NCT03272347|588869387|FG001|Overall Study|Death|0|||
163043942|NCT03272347|588869388|FG002|Overall Study|Death|0|||
163393420|NCT02663271|590152119|FG000|Overall Study|Lack of Efficacy|1|||
163393421|NCT01572675|590152120|FG000|Overall Study|End of prescribed treatment|140|||
163393422|NCT01572675|590152121|FG001|Overall Study|End of prescribed treatment|118|||
163393423|NCT01572675|590152120|FG000|Overall Study|Recovery|16|||
163393424|NCT01572675|590152121|FG001|Overall Study|Recovery|23|||
163393425|NCT01572675|590152120|FG000|Overall Study|Lack of Efficacy|31|||
163393426|NCT01572675|590152121|FG001|Overall Study|Lack of Efficacy|31|||
163393427|NCT01572675|590152120|FG000|Overall Study|Intolerance|6|||
163393428|NCT01572675|590152121|FG001|Overall Study|Intolerance|5|||
163393429|NCT01572675|590152120|FG000|Overall Study|Improved symptoms|8|||
163393430|NCT01572675|590152121|FG001|Overall Study|Improved symptoms|2|||
163393431|NCT01572675|590152120|FG000|Overall Study|Surgical intervention|3|||
163393432|NCT01572675|590152121|FG001|Overall Study|Surgical intervention|6|||
163393433|NCT01572675|590152120|FG000|Overall Study|Withdrawal by Subject|5|||
163393434|NCT01572675|590152121|FG001|Overall Study|Withdrawal by Subject|1|||
163393435|NCT01572675|590152120|FG000|Overall Study|Physician Decision|2|||
163393436|NCT01572675|590152121|FG001|Overall Study|Physician Decision|2|||
163393437|NCT01572675|590152120|FG000|Overall Study|Death unrelated to coxibs|1|||
163393438|NCT01572675|590152121|FG001|Overall Study|Death unrelated to coxibs|1|||
163393439|NCT01572675|590152120|FG000|Overall Study|Other disease detected|1|||
163393440|NCT01572675|590152121|FG001|Overall Study|Other disease detected|1|||
163393441|NCT01572675|590152120|FG000|Overall Study|Unknown reason|1|||
163393442|NCT01572675|590152121|FG001|Overall Study|Unknown reason|1|||
163393443|NCT01572675|590152120|FG000|Overall Study|Rheumatologist new evaluation|0|||
163393444|NCT01572675|590152121|FG001|Overall Study|Rheumatologist new evaluation|1|||
163393445|NCT01572675|590152120|FG000|Overall Study|Missing data|1|||
163393446|NCT01572675|590152121|FG001|Overall Study|Missing data|4|||
163393447|NCT01572675|590152120|FG000|Overall Study|Lost to Follow-up|22|||
163393448|NCT01572675|590152121|FG001|Overall Study|Lost to Follow-up|27|||
163393449|NCT01326728|590152127|FG000|Overall Study|Death|13|||
163393450|NCT01326728|590152128|FG001|Overall Study|Death|0|||
163393451|NCT01326728|590152127|FG000|Overall Study|Early closure of study|34|||
163393452|NCT01326728|590152128|FG001|Overall Study|Early closure of study|9|||
163393453|NCT02966223|590152129|FG000|Overall Study|Physician Decision|3|||
163393454|NCT02966223|590152129|FG000|Overall Study|Withdrawal by Subject|11|||
163393455|NCT02966223|590152129|FG000|Overall Study|Lost to Follow-up|1|||
163393456|NCT04399122|590152132|FG000|Overall Study|Lost to Follow-up|2|||
163393457|NCT04399122|590152133|FG001|Overall Study|Lost to Follow-up|0|||
163393458|NCT04399122|590152132|FG000|Overall Study|Withdrawal by Subject|1|||
162955367|NCT00579345|588539249|FG006|Overall Study|Withdrawal by Subject|0|||
162955368|NCT00579345|588539250|FG007|Overall Study|Withdrawal by Subject|1|||
162955369|NCT00579345|588539243|FG000|Overall Study|Lost to Follow-up|1|||
162955370|NCT00579345|588539244|FG001|Overall Study|Lost to Follow-up|0|||
162955371|NCT00579345|588539245|FG002|Overall Study|Lost to Follow-up|0|||
162955372|NCT00579345|588539246|FG003|Overall Study|Lost to Follow-up|0|||
162955373|NCT00579345|588539247|FG004|Overall Study|Lost to Follow-up|0|||
163043943|NCT03272347|588869389|FG003|Overall Study|Death|1|||
163043944|NCT03272347|588869386|FG000|Overall Study|Lost to Follow-up|1|||
163043945|NCT03272347|588869387|FG001|Overall Study|Lost to Follow-up|3|||
163043946|NCT03272347|588869388|FG002|Overall Study|Lost to Follow-up|5|||
163393459|NCT04399122|590152133|FG001|Overall Study|Withdrawal by Subject|0|||
163393460|NCT02322229|590152136|FG000|Overall Study|Physician Decision|2|||
163393461|NCT03065023|590152137|FG000|Overall Study|Progressive Disease|0|||
163393462|NCT03065023|590152138|FG001|Overall Study|Progressive Disease|1|||
162955374|NCT00579345|588539248|FG005|Overall Study|Lost to Follow-up|0|||
162955375|NCT00579345|588539249|FG006|Overall Study|Lost to Follow-up|0|||
162955376|NCT00579345|588539250|FG007|Overall Study|Lost to Follow-up|0|||
162955377|NCT00579345|588539243|FG000|Overall Study|Adverse Event|0|||
162955378|NCT00579345|588539244|FG001|Overall Study|Adverse Event|0|||
162955379|NCT00579345|588539245|FG002|Overall Study|Adverse Event|1|||
162955380|NCT00579345|588539246|FG003|Overall Study|Adverse Event|0|||
162955381|NCT00579345|588539247|FG004|Overall Study|Adverse Event|0|||
162955382|NCT00579345|588539248|FG005|Overall Study|Adverse Event|0|||
162955383|NCT00579345|588539249|FG006|Overall Study|Adverse Event|0|||
162955384|NCT00579345|588539250|FG007|Overall Study|Adverse Event|0|||
162955385|NCT00579345|588539243|FG000|Overall Study|Protocol Violation|1|||
163393463|NCT03065023|590152139|FG002|Overall Study|Progressive Disease|0|||
163393464|NCT03065023|590152140|FG003|Overall Study|Progressive Disease|0|||
162955386|NCT00579345|588539244|FG001|Overall Study|Protocol Violation|0|||
162955387|NCT00579345|588539245|FG002|Overall Study|Protocol Violation|0|||
162955388|NCT00579345|588539246|FG003|Overall Study|Protocol Violation|0|||
162955389|NCT00579345|588539247|FG004|Overall Study|Protocol Violation|0|||
162955390|NCT00579345|588539248|FG005|Overall Study|Protocol Violation|0|||
162955391|NCT00579345|588539249|FG006|Overall Study|Protocol Violation|0|||
163043947|NCT03272347|588869389|FG003|Overall Study|Lost to Follow-up|1|||
163043948|NCT03272347|588869386|FG000|Overall Study|Physician Decision|4|||
162955392|NCT00579345|588539250|FG007|Overall Study|Protocol Violation|1|||
162955393|NCT00579345|588539243|FG000|Overall Study|Death|1|||
162955394|NCT00579345|588539244|FG001|Overall Study|Death|1|||
162955395|NCT00579345|588539245|FG002|Overall Study|Death|1|||
162955396|NCT00579345|588539246|FG003|Overall Study|Death|1|||
162955397|NCT00579345|588539247|FG004|Overall Study|Death|0|||
162955398|NCT00579345|588539248|FG005|Overall Study|Death|0|||
162955399|NCT00579345|588539249|FG006|Overall Study|Death|0|||
162955400|NCT00579345|588539250|FG007|Overall Study|Death|0|||
162955401|NCT02267187|588539256|FG000|Overall Study|Physician Decision|2|||
162955402|NCT02267187|588539256|FG000|Overall Study|Screen fail|3|||
162955403|NCT00712959|588539261|FG000|Overall Study|Protocol Violation|3|||
162955404|NCT00712959|588539262|FG001|Overall Study|Protocol Violation|1|||
162955405|NCT00712959|588539261|FG000|Overall Study|Lost to Follow-up|13|||
162955406|NCT00712959|588539262|FG001|Overall Study|Lost to Follow-up|2|||
162955407|NCT00712959|588539261|FG000|Overall Study|Withdrawal by Subject|3|||
162955408|NCT00712959|588539262|FG001|Overall Study|Withdrawal by Subject|0|||
162955409|NCT00834067|588539263|FG000|Washout of 21 Days|Protocol Violation|0|||
162955410|NCT00834067|588539264|FG001|Washout of 21 Days|Protocol Violation|1|||
162955411|NCT00418561|588539265|FG000|Overall Study|Participant's (guardian's) decision|0|||
162955412|NCT00418561|588539266|FG001|Overall Study|Participant's (guardian's) decision|1|||
162955413|NCT00418561|588539267|FG002|Overall Study|Participant's (guardian's) decision|0|||
162955414|NCT01796171|588539268|FG000|Enrolled|Death|0|||
162955415|NCT01796171|588539269|FG001|Enrolled|Death|0|||
162955416|NCT01796171|588539270|FG002|Enrolled|Death|0|||
162955417|NCT01796171|588539271|FG003|Enrolled|Death|0|||
162955418|NCT01796171|588539272|FG004|Enrolled|Death|0|||
162955419|NCT01796171|588539273|FG005|Enrolled|Death|0|||
162955420|NCT01796171|588539274|FG006|Enrolled|Death|0|||
162955421|NCT01796171|588539275|FG007|Enrolled|Death|0|||
162955422|NCT01796171|588539276|FG008|Enrolled|Death|0|||
162955423|NCT01796171|588539277|FG009|Enrolled|Death|0|||
162955424|NCT01796171|588539278|FG010|Enrolled|Death|0|||
162955425|NCT01796171|588539279|FG011|Enrolled|Death|0|||
162955426|NCT01796171|588539280|FG012|Enrolled|Death|0|||
162955427|NCT01796171|588539281|FG013|Enrolled|Death|0|||
162955428|NCT01796171|588539282|FG014|Enrolled|Death|1|||
162955429|NCT01796171|588539268|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
162955430|NCT01796171|588539269|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
162955431|NCT01796171|588539270|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
162955432|NCT01796171|588539271|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
163043949|NCT03272347|588869387|FG001|Overall Study|Physician Decision|2|||
162955433|NCT01796171|588539272|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
163194301|NCT00347360|589425087|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
163194302|NCT00347360|589425088|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
163194303|NCT00347360|589425089|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
163194304|NCT00347360|589425090|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
163194305|NCT00347360|589425091|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
163194306|NCT00347360|589425092|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
162955434|NCT01796171|588539273|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
162955435|NCT01796171|588539274|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
162955436|NCT01796171|588539275|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
162955437|NCT01796171|588539276|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
162955438|NCT01796171|588539277|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
162955439|NCT01796171|588539278|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
162955440|NCT01796171|588539279|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
162955441|NCT01796171|588539280|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
163043950|NCT03272347|588869388|FG002|Overall Study|Physician Decision|5|||
163043951|NCT03272347|588869389|FG003|Overall Study|Physician Decision|4|||
163043952|NCT03272347|588869386|FG000|Overall Study|Screen Failure|1|||
163043953|NCT03272347|588869387|FG001|Overall Study|Screen Failure|0|||
163043954|NCT03272347|588869388|FG002|Overall Study|Screen Failure|0|||
163043955|NCT03272347|588869389|FG003|Overall Study|Screen Failure|0|||
163043956|NCT03272347|588869386|FG000|Overall Study|Withdrawal by Subject|5|||
163043957|NCT03272347|588869387|FG001|Overall Study|Withdrawal by Subject|1|||
163043958|NCT03272347|588869388|FG002|Overall Study|Withdrawal by Subject|2|||
163043959|NCT03272347|588869389|FG003|Overall Study|Withdrawal by Subject|1|||
163043960|NCT01971567|588869390|FG000|Overall Study|Withdrawal by Subject|3|||
163043961|NCT01971567|588869391|FG001|Overall Study|Withdrawal by Subject|2|||
163043962|NCT01971567|588869390|FG000|Overall Study|Lost to Follow-up|1|||
163043963|NCT01971567|588869391|FG001|Overall Study|Lost to Follow-up|0|||
163043964|NCT04826484|588869392|FG000|Overall Study|Lost to Follow-up|2|||
163043965|NCT04826484|588869393|FG001|Overall Study|Lost to Follow-up|0|||
163043966|NCT02239640|588869396|FG000|Overall Study|Withdrawal by Subject|3|||
163043967|NCT02239640|588869396|FG000|Overall Study|Lost to Follow-up|72|||
163043968|NCT02239640|588869396|FG000|Overall Study|Death|142|||
163043969|NCT00206427|588869406|FG000|Overall Study|Adverse Event|2|||
163043970|NCT02915159|588869407|FG000|Overall Study|Participant no longer meets criteria|2|||
163043971|NCT02915159|588869408|FG001|Overall Study|Participant no longer meets criteria|0|||
163043972|NCT02915159|588869407|FG000|Overall Study|poor/non-compliance|1|||
163043973|NCT02915159|588869408|FG001|Overall Study|poor/non-compliance|0|||
163043974|NCT02915159|588869407|FG000|Overall Study|Participant withdrew consent|5|||
163043975|NCT02915159|588869408|FG001|Overall Study|Participant withdrew consent|1|||
163043976|NCT02915159|588869407|FG000|Overall Study|Request to discontinue treatment|1|||
163043977|NCT02915159|588869408|FG001|Overall Study|Request to discontinue treatment|2|||
163043978|NCT02915159|588869407|FG000|Overall Study|Adverse Event|2|||
163043979|NCT02915159|588869408|FG001|Overall Study|Adverse Event|2|||
163043980|NCT02915159|588869407|FG000|Overall Study|Lack of Efficacy|0|||
163043981|NCT02915159|588869408|FG001|Overall Study|Lack of Efficacy|3|||
163043982|NCT04534517|588869410|FG000|Overall Study|Adverse Event|1|||
163043983|NCT04534517|588869410|FG000|Overall Study|Withdrawal by Subject|1|||
163043984|NCT04534517|588869410|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
163043985|NCT04534517|588869410|FG000|Overall Study|COVID-19 Related|1|||
163043986|NCT03872843|588869411|FG000|Overall Study|Lost to Follow-up|5|||
163043987|NCT03872843|588869412|FG001|Overall Study|Lost to Follow-up|7|||
163043988|NCT02121795|588869413|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
163194307|NCT00347360|589425093|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
163194308|NCT00347360|589425094|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
163194309|NCT00347360|589425095|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
163194310|NCT00347360|589425096|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
163194311|NCT00347360|589425097|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
163194312|NCT00347360|589425098|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
163194313|NCT00347360|589425099|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
163194314|NCT00347360|589425100|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
163194315|NCT00347360|589425086|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
163194316|NCT00347360|589425087|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
163194317|NCT00347360|589425088|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
163194318|NCT00347360|589425089|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
163194319|NCT00347360|589425090|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
163194320|NCT00347360|589425091|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
163194321|NCT00347360|589425092|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
163194322|NCT00347360|589425093|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
163194323|NCT00347360|589425094|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
163194324|NCT00347360|589425095|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
163194325|NCT00347360|589425096|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
163194326|NCT00347360|589425097|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
163194327|NCT00347360|589425098|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
163194328|NCT00347360|589425099|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
163043989|NCT02121795|588869414|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
163043990|NCT02121795|588869413|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
163043991|NCT02121795|588869414|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
163043992|NCT02121795|588869413|FG000|Double-Blind Phase|Lost to Follow-up|7|||
163043993|NCT02121795|588869414|FG001|Double-Blind Phase|Lost to Follow-up|4|||
163043994|NCT02121795|588869413|FG000|Double-Blind Phase|Physician Decision|2|||
163043995|NCT02121795|588869414|FG001|Double-Blind Phase|Physician Decision|5|||
163043996|NCT02121795|588869413|FG000|Double-Blind Phase|Adverse Event|5|||
163043997|NCT02121795|588869414|FG001|Double-Blind Phase|Adverse Event|0|||
163043998|NCT02121795|588869413|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
163043999|NCT02121795|588869414|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
163044000|NCT02121795|588869413|FG000|Double-Blind Phase|Protocol Violation|0|||
163044001|NCT02121795|588869414|FG001|Double-Blind Phase|Protocol Violation|3|||
163044002|NCT02121795|588869413|FG000|Double-Blind Phase|Death|1|||
163044003|NCT02121795|588869414|FG001|Double-Blind Phase|Death|1|||
163044004|NCT02121795|588869413|FG000|Open-Label Phase|Physician Decision|8|||
163044005|NCT02121795|588869414|FG001|Open-Label Phase|Physician Decision|8|||
163044006|NCT02121795|588869413|FG000|Open-Label Phase|Withdrawal by Subject|3|||
163044007|NCT02121795|588869414|FG001|Open-Label Phase|Withdrawal by Subject|2|||
163044008|NCT02121795|588869413|FG000|Open-Label Phase|Lost to Follow-up|1|||
163044009|NCT02121795|588869414|FG001|Open-Label Phase|Lost to Follow-up|0|||
163044010|NCT00823264|588869415|FG000|Overall Study|Protocol Violation|2|||
163044011|NCT00823264|588869416|FG001|Overall Study|Protocol Violation|0|||
163044012|NCT00856999|588869417|FG000|Overall Study|Withdrawal by Subject|5|||
163044013|NCT02465437|588869418|FG000|Overall Study|Physician Decision|0|||
163044014|NCT02465437|588869419|FG001|Overall Study|Physician Decision|0|||
163044015|NCT02465437|588869420|FG002|Overall Study|Physician Decision|1|||
163044016|NCT02465437|588869421|FG003|Overall Study|Physician Decision|0|||
163044017|NCT02465437|588869418|FG000|Overall Study|Withdrawal by Subject|1|||
163044018|NCT02465437|588869419|FG001|Overall Study|Withdrawal by Subject|0|||
163044019|NCT02465437|588869420|FG002|Overall Study|Withdrawal by Subject|0|||
163044020|NCT02465437|588869421|FG003|Overall Study|Withdrawal by Subject|1|||
163044021|NCT02465437|588869418|FG000|Overall Study|Adverse Event|0|||
163044022|NCT02465437|588869419|FG001|Overall Study|Adverse Event|1|||
163044023|NCT02465437|588869420|FG002|Overall Study|Adverse Event|0|||
163044024|NCT02465437|588869421|FG003|Overall Study|Adverse Event|0|||
163044025|NCT00003483|588869422|FG000|Overall Study|Not evaluable|1|||
163044026|NCT01308463|588869423|FG000|Overall Study|Study Discontinued|23|||
163044027|NCT01308463|588869423|FG000|Overall Study|Death|4|||
163044028|NCT01308463|588869423|FG000|Overall Study|Revision|2|||
163044029|NCT00103662|588869426|FG000|Overall Study|Entered Rescue Procedure|0|||
163044030|NCT00103662|588869427|FG001|Overall Study|Entered Rescue Procedure|7|||
163044031|NCT00103662|588869426|FG000|Overall Study|Death|7|||
163044032|NCT00103662|588869427|FG001|Overall Study|Death|7|||
163044033|NCT00103662|588869426|FG000|Overall Study|Elective Withdrawal|5|||
163044034|NCT00103662|588869427|FG001|Overall Study|Elective Withdrawal|5|||
163044035|NCT00103662|588869426|FG000|Overall Study|Lost to Follow-up|0|||
163044036|NCT00103662|588869427|FG001|Overall Study|Lost to Follow-up|1|||
163044037|NCT00103662|588869426|FG000|Overall Study|Other|6|||
163044038|NCT00103662|588869427|FG001|Overall Study|Other|9|||
163044039|NCT00103662|588869426|FG000|Overall Study|Failed mobilization|0|||
163044040|NCT00103662|588869427|FG001|Overall Study|Failed mobilization|4|||
163044041|NCT00103662|588869426|FG000|Overall Study|Intercurrent illness|1|||
163044042|NCT00103662|588869427|FG001|Overall Study|Intercurrent illness|0|||
163044043|NCT03373760|588869430|FG000|Overall Study|Adverse Event|8|||
163044044|NCT03373760|588869430|FG000|Overall Study|Disease Progression|46|||
163044045|NCT03373760|588869430|FG000|Overall Study|Death|4|||
163044046|NCT02302846|588869435|FG000|Overall Study|Withdrawal by Subject|1|||
163044047|NCT00872521|588869438|FG000|Completed PAD Induction|Patient choice|0|||
163044048|NCT00872521|588869439|FG001|Completed PAD Induction|Patient choice|1|||
163044049|NCT00872521|588869440|FG002|Completed PAD Induction|Patient choice|0|||
163044050|NCT00872521|588869438|FG000|Completed PAD Induction|Disease progression|0|||
163044051|NCT00872521|588869439|FG001|Completed PAD Induction|Disease progression|2|||
163044052|NCT00872521|588869440|FG002|Completed PAD Induction|Disease progression|0|||
163044053|NCT00872521|588869438|FG000|Completed PAD Induction|Adverse Event|4|||
163044054|NCT00872521|588869439|FG001|Completed PAD Induction|Adverse Event|0|||
163044055|NCT00872521|588869440|FG002|Completed PAD Induction|Adverse Event|0|||
163044056|NCT00872521|588869438|FG000|Completed PAD Induction|Death|1|||
163044057|NCT00872521|588869439|FG001|Completed PAD Induction|Death|1|||
163044058|NCT00872521|588869440|FG002|Completed PAD Induction|Death|0|||
163044059|NCT00872521|588869438|FG000|Primary Endpoint Analysis|Other|1|||
163044060|NCT00872521|588869439|FG001|Primary Endpoint Analysis|Other|2|||
163044061|NCT00872521|588869440|FG002|Primary Endpoint Analysis|Other|0|||
163044062|NCT00872521|588869438|FG000|Primary Endpoint Analysis|Patient choice|0|||
163044063|NCT00872521|588869439|FG001|Primary Endpoint Analysis|Patient choice|1|||
163044064|NCT00872521|588869440|FG002|Primary Endpoint Analysis|Patient choice|0|||
163044065|NCT00872521|588869438|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
163044066|NCT00872521|588869439|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
163044067|NCT00872521|588869440|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
163044068|NCT00872521|588869438|FG000|Primary Endpoint Analysis|Patient response missing|0|||
163044069|NCT00872521|588869439|FG001|Primary Endpoint Analysis|Patient response missing|0|||
163044070|NCT00872521|588869440|FG002|Primary Endpoint Analysis|Patient response missing|1|||
163044071|NCT00872521|588869438|FG000|Completed 3-month Follow up|Other|0|||
163044072|NCT00872521|588869439|FG001|Completed 3-month Follow up|Other|2|||
163044073|NCT00872521|588869440|FG002|Completed 3-month Follow up|Other|0|||
163044074|NCT00872521|588869438|FG000|Completed 3-month Follow up|Physician Decision|0|||
163044075|NCT00872521|588869439|FG001|Completed 3-month Follow up|Physician Decision|1|||
163044076|NCT00872521|588869440|FG002|Completed 3-month Follow up|Physician Decision|0|||
163044077|NCT00872521|588869438|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
163044078|NCT00872521|588869439|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
163044079|NCT00872521|588869440|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
163044080|NCT03200548|588869441|FG000|Overall Study|Withdrawal by Subject|5|||
163044081|NCT03200548|588869442|FG001|Overall Study|Withdrawal by Subject|11|||
163044082|NCT03200548|588869443|FG002|Overall Study|Withdrawal by Subject|7|||
163044083|NCT03200548|588869444|FG003|Overall Study|Withdrawal by Subject|6|||
163044084|NCT01048541|588869449|FG000|Overall Study|Withdrawal by Subject|1|||
163044085|NCT01048541|588869450|FG001|Overall Study|Withdrawal by Subject|0|||
163044086|NCT00922116|588869451|FG000|Overall Study|Adverse Event|4|||
163044087|NCT00922116|588869451|FG000|Overall Study|Death|1|||
163044088|NCT00922116|588869451|FG000|Overall Study|Lost to Follow-up|1|||
163044089|NCT00922116|588869451|FG000|Overall Study|Withdrawal by Subject|4|||
163044090|NCT00922116|588869451|FG000|Overall Study|Other|5|||
163044091|NCT02258659|588869453|FG000|Overall Study|Withdrawal by Subject|1|||
163044092|NCT01411852|588869454|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
163044093|NCT01411852|588869455|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
163044094|NCT01411852|588869454|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
163044095|NCT01411852|588869455|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
163044096|NCT01411852|588869454|FG000|Prehospital Intervention Phase|Found to be under age|0|||
163044097|NCT01411852|588869455|FG001|Prehospital Intervention Phase|Found to be under age|1|||
163044098|NCT01411852|588869454|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
163044099|NCT01411852|588869455|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
163044100|NCT01411852|588869454|FG000|Hospital Intervention Phase|Severe head injury|5|||
163044101|NCT01411852|588869455|FG001|Hospital Intervention Phase|Severe head injury|4|||
163044102|NCT01411852|588869454|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
163044103|NCT01411852|588869455|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
163044104|NCT01411852|588869454|FG000|Hospital Intervention Phase|Miscommunication error|1|||
163044105|NCT01411852|588869455|FG001|Hospital Intervention Phase|Miscommunication error|2|||
163044106|NCT01411852|588869454|FG000|Hospital Intervention Phase|CPR administered|3|||
163044107|NCT01411852|588869455|FG001|Hospital Intervention Phase|CPR administered|1|||
163044108|NCT01411852|588869454|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
163044109|NCT01411852|588869455|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
163044110|NCT01411852|588869454|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
163044111|NCT01411852|588869455|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
163044112|NCT01411852|588869454|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
163044113|NCT01411852|588869455|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
163044114|NCT01411852|588869454|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
163044115|NCT01411852|588869455|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
163044116|NCT01411852|588869454|FG000|Hospital Intervention Phase|Other ineligible|2|||
163044117|NCT01411852|588869455|FG001|Hospital Intervention Phase|Other ineligible|2|||
162955442|NCT01796171|588539281|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
162955443|NCT01796171|588539282|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
162955444|NCT01796171|588539268|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955445|NCT01796171|588539269|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955446|NCT01796171|588539270|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955447|NCT01796171|588539271|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955448|NCT01796171|588539272|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955449|NCT01796171|588539273|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955450|NCT01796171|588539274|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955451|NCT01796171|588539275|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955452|NCT01796171|588539276|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955453|NCT01796171|588539277|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955454|NCT01796171|588539278|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955455|NCT01796171|588539279|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955456|NCT01796171|588539280|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955457|NCT01796171|588539281|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
162955458|NCT01796171|588539282|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955459|NCT01796171|588539268|FG000|Treatment Period With Betalutin|Progressive disease|0|||
162955460|NCT01796171|588539269|FG001|Treatment Period With Betalutin|Progressive disease|1|||
162955461|NCT01796171|588539270|FG002|Treatment Period With Betalutin|Progressive disease|0|||
162955462|NCT01796171|588539271|FG003|Treatment Period With Betalutin|Progressive disease|0|||
162955463|NCT01796171|588539272|FG004|Treatment Period With Betalutin|Progressive disease|0|||
162955464|NCT01796171|588539273|FG005|Treatment Period With Betalutin|Progressive disease|0|||
162955465|NCT01796171|588539274|FG006|Treatment Period With Betalutin|Progressive disease|0|||
162955466|NCT01796171|588539275|FG007|Treatment Period With Betalutin|Progressive disease|0|||
162955467|NCT01796171|588539276|FG008|Treatment Period With Betalutin|Progressive disease|0|||
162955468|NCT01796171|588539277|FG009|Treatment Period With Betalutin|Progressive disease|0|||
163044118|NCT01411852|588869454|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
163044119|NCT01411852|588869455|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
163044120|NCT01411852|588869454|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
163044121|NCT01411852|588869455|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
163044122|NCT01411852|588869454|FG000|Hospital Intervention Phase|Vascular access failed|1|||
163044123|NCT01411852|588869455|FG001|Hospital Intervention Phase|Vascular access failed|0|||
163044124|NCT00272844|588869456|FG000|Overall Study|Withdrawal by Subject|5|||
163044125|NCT03193047|588869457|FG000|Overall Study|Physician Decision|1|||
163044126|NCT03193047|588869458|FG001|Overall Study|Physician Decision|0|||
163044127|NCT03193047|588869457|FG000|Overall Study|Participant Left State|1|||
163044128|NCT03193047|588869458|FG001|Overall Study|Participant Left State|0|||
163044129|NCT03743025|588869462|FG000|Overall Study|Surgery was cancelled|2|||
163044130|NCT03743025|588869463|FG001|Overall Study|Surgery was cancelled|1|||
163044131|NCT00791700|588869464|FG000|Overall Study|Insufficient clinical response|1|||
163044132|NCT00791700|588869465|FG001|Overall Study|Insufficient clinical response|4|||
163044133|NCT00791700|588869466|FG002|Overall Study|Insufficient clinical response|1|||
163044134|NCT00791700|588869467|FG003|Overall Study|Insufficient clinical response|8|||
163044135|NCT00791700|588869464|FG000|Overall Study|No longer willing to participate|1|||
163044136|NCT00791700|588869465|FG001|Overall Study|No longer willing to participate|1|||
163044137|NCT00791700|588869466|FG002|Overall Study|No longer willing to participate|0|||
163044138|NCT00791700|588869467|FG003|Overall Study|No longer willing to participate|8|||
163044139|NCT00791700|588869464|FG000|Overall Study|Non-compliance with study treatment|0|||
163044140|NCT00791700|588869465|FG001|Overall Study|Non-compliance with study treatment|2|||
163044141|NCT00791700|588869466|FG002|Overall Study|Non-compliance with study treatment|0|||
163044142|NCT00791700|588869467|FG003|Overall Study|Non-compliance with study treatment|4|||
163044143|NCT00791700|588869464|FG000|Overall Study|Withdrawn due to pregnancy|0|||
163044144|NCT00791700|588869465|FG001|Overall Study|Withdrawn due to pregnancy|0|||
163044145|NCT00791700|588869466|FG002|Overall Study|Withdrawn due to pregnancy|0|||
163044146|NCT00791700|588869467|FG003|Overall Study|Withdrawn due to pregnancy|1|||
163044147|NCT00791700|588869464|FG000|Overall Study|Other|0|||
163044148|NCT00791700|588869465|FG001|Overall Study|Other|1|||
163044149|NCT00791700|588869466|FG002|Overall Study|Other|0|||
163044150|NCT00791700|588869467|FG003|Overall Study|Other|1|||
163044151|NCT00791700|588869464|FG000|Overall Study|Death|0|||
163044152|NCT00791700|588869465|FG001|Overall Study|Death|0|||
163044153|NCT00791700|588869466|FG002|Overall Study|Death|0|||
163044154|NCT00791700|588869467|FG003|Overall Study|Death|1|||
163044155|NCT00791700|588869464|FG000|Overall Study|Lost to Follow-up|4|||
163044156|NCT00791700|588869465|FG001|Overall Study|Lost to Follow-up|3|||
163044157|NCT00791700|588869466|FG002|Overall Study|Lost to Follow-up|4|||
163044158|NCT00791700|588869467|FG003|Overall Study|Lost to Follow-up|6|||
163044159|NCT00791700|588869464|FG000|Overall Study|Adverse Event|0|||
163044160|NCT00791700|588869465|FG001|Overall Study|Adverse Event|0|||
163044161|NCT00791700|588869466|FG002|Overall Study|Adverse Event|1|||
163044162|NCT00791700|588869467|FG003|Overall Study|Adverse Event|1|||
163194329|NCT00347360|589425100|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
163194330|NCT00347360|589425086|FG000|Overall Study|Abnormal lab values|0|||
163194331|NCT00347360|589425087|FG001|Overall Study|Abnormal lab values|0|||
163194332|NCT00347360|589425088|FG002|Overall Study|Abnormal lab values|0|||
163194333|NCT00347360|589425089|FG003|Overall Study|Abnormal lab values|0|||
163194334|NCT00347360|589425090|FG004|Overall Study|Abnormal lab values|0|||
163194335|NCT00347360|589425091|FG005|Overall Study|Abnormal lab values|0|||
163194336|NCT00347360|589425092|FG006|Overall Study|Abnormal lab values|1|||
163194337|NCT00347360|589425093|FG007|Overall Study|Abnormal lab values|0|||
163194338|NCT00347360|589425094|FG008|Overall Study|Abnormal lab values|0|||
163194339|NCT00347360|589425095|FG009|Overall Study|Abnormal lab values|0|||
163194340|NCT00347360|589425096|FG010|Overall Study|Abnormal lab values|0|||
163194341|NCT00347360|589425097|FG011|Overall Study|Abnormal lab values|0|||
163194342|NCT00347360|589425098|FG012|Overall Study|Abnormal lab values|0|||
163194343|NCT00347360|589425099|FG013|Overall Study|Abnormal lab values|0|||
163194344|NCT00347360|589425100|FG014|Overall Study|Abnormal lab values|0|||
163299628|NCT02409667|589805235|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
163299629|NCT02409667|589805236|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
163044163|NCT00996034|588869468|FG000|Overall Study|Lost to Follow-up|2|||
163044164|NCT00996034|588869468|FG000|Overall Study|withdrawn by PI|1|||
163194345|NCT00347360|589425086|FG000|Overall Study|PI recommended early withdrawal|0|||
163194346|NCT00347360|589425087|FG001|Overall Study|PI recommended early withdrawal|0|||
163194347|NCT00347360|589425088|FG002|Overall Study|PI recommended early withdrawal|0|||
163194348|NCT00347360|589425089|FG003|Overall Study|PI recommended early withdrawal|0|||
163044165|NCT05095311|588869469|FG000|Overall Study|Lost to Follow-up|7|||
163044166|NCT05095311|588869470|FG001|Overall Study|Lost to Follow-up|0|||
163044167|NCT05095311|588869471|FG002|Overall Study|Lost to Follow-up|0|||
163044168|NCT02588664|588869472|FG000|Overall Study|Death|56|||
163044169|NCT02588664|588869473|FG001|Overall Study|Death|55|||
163044170|NCT02588664|588869472|FG000|Overall Study|Lost to Follow-up|1305|||
163044171|NCT02588664|588869473|FG001|Overall Study|Lost to Follow-up|990|||
163044172|NCT02500719|588869474|FG000|Overall Study|Lost to Follow-up|2|||
163044173|NCT02500719|588869475|FG001|Overall Study|Lost to Follow-up|3|||
163044174|NCT02500719|588869474|FG000|Overall Study|Trauma history|1|||
163194349|NCT00347360|589425090|FG004|Overall Study|PI recommended early withdrawal|0|||
162955469|NCT01796171|588539278|FG010|Treatment Period With Betalutin|Progressive disease|0|||
162955470|NCT01796171|588539279|FG011|Treatment Period With Betalutin|Progressive disease|0|||
162955471|NCT01796171|588539280|FG012|Treatment Period With Betalutin|Progressive disease|0|||
162955472|NCT01796171|588539281|FG013|Treatment Period With Betalutin|Progressive disease|0|||
162955473|NCT01796171|588539282|FG014|Treatment Period With Betalutin|Progressive disease|0|||
162955474|NCT01796171|588539268|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955475|NCT01796171|588539269|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955476|NCT01796171|588539270|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955477|NCT01796171|588539271|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955478|NCT01796171|588539272|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955479|NCT01796171|588539273|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955480|NCT01796171|588539274|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955481|NCT01796171|588539275|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955482|NCT01796171|588539276|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
162955483|NCT01796171|588539277|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955484|NCT01796171|588539278|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
162955485|NCT01796171|588539279|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
162955486|NCT01796171|588539280|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955487|NCT01796171|588539281|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955488|NCT01796171|588539282|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955489|NCT01796171|588539268|FG000|Treatment Period With Betalutin|Physician Decision|0|||
162955490|NCT01796171|588539269|FG001|Treatment Period With Betalutin|Physician Decision|0|||
162955491|NCT01796171|588539270|FG002|Treatment Period With Betalutin|Physician Decision|0|||
162955492|NCT01796171|588539271|FG003|Treatment Period With Betalutin|Physician Decision|0|||
162955493|NCT01796171|588539272|FG004|Treatment Period With Betalutin|Physician Decision|0|||
162955494|NCT01796171|588539273|FG005|Treatment Period With Betalutin|Physician Decision|0|||
162955495|NCT01796171|588539274|FG006|Treatment Period With Betalutin|Physician Decision|0|||
162955496|NCT01796171|588539275|FG007|Treatment Period With Betalutin|Physician Decision|0|||
162955497|NCT01796171|588539276|FG008|Treatment Period With Betalutin|Physician Decision|0|||
162955498|NCT01796171|588539277|FG009|Treatment Period With Betalutin|Physician Decision|0|||
162955499|NCT01796171|588539278|FG010|Treatment Period With Betalutin|Physician Decision|5|||
162955500|NCT01796171|588539279|FG011|Treatment Period With Betalutin|Physician Decision|1|||
162955501|NCT01796171|588539280|FG012|Treatment Period With Betalutin|Physician Decision|1|||
162955502|NCT01796171|588539281|FG013|Treatment Period With Betalutin|Physician Decision|0|||
162955503|NCT01796171|588539282|FG014|Treatment Period With Betalutin|Physician Decision|0|||
162955504|NCT01796171|588539268|FG000|Treatment Period With Betalutin|Death|0|||
163044175|NCT02500719|588869475|FG001|Overall Study|Trauma history|0|||
163194350|NCT00347360|589425091|FG005|Overall Study|PI recommended early withdrawal|0|||
163194351|NCT00347360|589425092|FG006|Overall Study|PI recommended early withdrawal|0|||
163194352|NCT00347360|589425093|FG007|Overall Study|PI recommended early withdrawal|0|||
163194353|NCT00347360|589425094|FG008|Overall Study|PI recommended early withdrawal|0|||
163194354|NCT00347360|589425095|FG009|Overall Study|PI recommended early withdrawal|1|||
163194355|NCT00347360|589425096|FG010|Overall Study|PI recommended early withdrawal|0|||
163194356|NCT00347360|589425097|FG011|Overall Study|PI recommended early withdrawal|0|||
163194357|NCT00347360|589425098|FG012|Overall Study|PI recommended early withdrawal|0|||
163194358|NCT00347360|589425099|FG013|Overall Study|PI recommended early withdrawal|0|||
163194359|NCT00347360|589425100|FG014|Overall Study|PI recommended early withdrawal|0|||
163194360|NCT00347360|589425086|FG000|Overall Study|Did not meet criteria before ABPM|0|||
163194361|NCT00347360|589425087|FG001|Overall Study|Did not meet criteria before ABPM|0|||
163299630|NCT02409667|589805237|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
163393465|NCT03065023|590152141|FG004|Overall Study|Progressive Disease|0|||
162955505|NCT01796171|588539269|FG001|Treatment Period With Betalutin|Death|0|||
162955506|NCT01796171|588539270|FG002|Treatment Period With Betalutin|Death|0|||
162955507|NCT01796171|588539271|FG003|Treatment Period With Betalutin|Death|0|||
162955508|NCT01796171|588539272|FG004|Treatment Period With Betalutin|Death|0|||
162955509|NCT01796171|588539273|FG005|Treatment Period With Betalutin|Death|0|||
162955510|NCT01796171|588539274|FG006|Treatment Period With Betalutin|Death|0|||
162955511|NCT01796171|588539275|FG007|Treatment Period With Betalutin|Death|0|||
162955512|NCT01796171|588539276|FG008|Treatment Period With Betalutin|Death|0|||
162955513|NCT01796171|588539277|FG009|Treatment Period With Betalutin|Death|0|||
162955514|NCT01796171|588539278|FG010|Treatment Period With Betalutin|Death|2|||
162955515|NCT01796171|588539279|FG011|Treatment Period With Betalutin|Death|0|||
162955516|NCT01796171|588539280|FG012|Treatment Period With Betalutin|Death|0|||
162955517|NCT01796171|588539281|FG013|Treatment Period With Betalutin|Death|0|||
162955518|NCT01796171|588539282|FG014|Treatment Period With Betalutin|Death|0|||
162955519|NCT01796171|588539268|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
162955520|NCT01796171|588539269|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
162955521|NCT01796171|588539270|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
162955522|NCT01796171|588539271|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
162955523|NCT01796171|588539272|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
162955524|NCT01796171|588539273|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
162955525|NCT01796171|588539274|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
162955526|NCT01796171|588539275|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
162955527|NCT01796171|588539276|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
162955528|NCT01796171|588539277|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
162955529|NCT01796171|588539278|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
162955530|NCT01796171|588539279|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
162955531|NCT01796171|588539280|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
162955532|NCT01796171|588539281|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
162955533|NCT01796171|588539282|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
162955534|NCT01796171|588539268|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955535|NCT01796171|588539269|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955536|NCT01796171|588539270|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955537|NCT01796171|588539271|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955538|NCT01796171|588539272|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955539|NCT01796171|588539273|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955540|NCT01796171|588539274|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955541|NCT01796171|588539275|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955542|NCT01796171|588539276|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955543|NCT01796171|588539277|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955544|NCT01796171|588539278|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
162955545|NCT01796171|588539279|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
162955546|NCT01796171|588539280|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955547|NCT01796171|588539281|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955548|NCT01796171|588539282|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955549|NCT01796171|588539268|FG000|Follow-up Period|Start of further anticancer therapy|4|||
162955550|NCT01796171|588539269|FG001|Follow-up Period|Start of further anticancer therapy|25|||
162955551|NCT01796171|588539270|FG002|Follow-up Period|Start of further anticancer therapy|2|||
162955552|NCT01796171|588539271|FG003|Follow-up Period|Start of further anticancer therapy|1|||
162955553|NCT01796171|588539272|FG004|Follow-up Period|Start of further anticancer therapy|2|||
162955554|NCT01796171|588539273|FG005|Follow-up Period|Start of further anticancer therapy|2|||
162955555|NCT01796171|588539274|FG006|Follow-up Period|Start of further anticancer therapy|1|||
162955556|NCT01796171|588539275|FG007|Follow-up Period|Start of further anticancer therapy|15|||
162955557|NCT01796171|588539276|FG008|Follow-up Period|Start of further anticancer therapy|2|||
162955558|NCT01796171|588539277|FG009|Follow-up Period|Start of further anticancer therapy|0|||
162955559|NCT01796171|588539278|FG010|Follow-up Period|Start of further anticancer therapy|0|||
162955560|NCT01796171|588539279|FG011|Follow-up Period|Start of further anticancer therapy|0|||
162955561|NCT01796171|588539280|FG012|Follow-up Period|Start of further anticancer therapy|0|||
162955562|NCT01796171|588539281|FG013|Follow-up Period|Start of further anticancer therapy|0|||
162955563|NCT01796171|588539282|FG014|Follow-up Period|Start of further anticancer therapy|0|||
162955564|NCT01796171|588539268|FG000|Follow-up Period|Progressive disease|0|||
162955565|NCT01796171|588539269|FG001|Follow-up Period|Progressive disease|1|||
162955566|NCT01796171|588539270|FG002|Follow-up Period|Progressive disease|0|||
162955567|NCT01796171|588539271|FG003|Follow-up Period|Progressive disease|0|||
162955568|NCT01796171|588539272|FG004|Follow-up Period|Progressive disease|0|||
163044176|NCT02500719|588869474|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
163044177|NCT02500719|588869475|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
162955569|NCT01796171|588539273|FG005|Follow-up Period|Progressive disease|0|||
162955570|NCT01796171|588539274|FG006|Follow-up Period|Progressive disease|0|||
162955571|NCT01796171|588539275|FG007|Follow-up Period|Progressive disease|3|||
163194362|NCT00347360|589425088|FG002|Overall Study|Did not meet criteria before ABPM|0|||
163194363|NCT00347360|589425089|FG003|Overall Study|Did not meet criteria before ABPM|0|||
163194364|NCT00347360|589425090|FG004|Overall Study|Did not meet criteria before ABPM|0|||
163194365|NCT00347360|589425091|FG005|Overall Study|Did not meet criteria before ABPM|0|||
163194366|NCT00347360|589425092|FG006|Overall Study|Did not meet criteria before ABPM|0|||
163194367|NCT00347360|589425093|FG007|Overall Study|Did not meet criteria before ABPM|0|||
163194368|NCT00347360|589425094|FG008|Overall Study|Did not meet criteria before ABPM|0|||
163194369|NCT00347360|589425095|FG009|Overall Study|Did not meet criteria before ABPM|0|||
163194370|NCT00347360|589425096|FG010|Overall Study|Did not meet criteria before ABPM|1|||
163194371|NCT00347360|589425097|FG011|Overall Study|Did not meet criteria before ABPM|0|||
163194372|NCT00347360|589425098|FG012|Overall Study|Did not meet criteria before ABPM|0|||
163194373|NCT00347360|589425099|FG013|Overall Study|Did not meet criteria before ABPM|0|||
163194374|NCT00347360|589425100|FG014|Overall Study|Did not meet criteria before ABPM|0|||
163044178|NCT02500719|588869474|FG000|Overall Study|Did not meet criteria for PTSD|0|||
163044179|NCT02500719|588869475|FG001|Overall Study|Did not meet criteria for PTSD|1|||
163044180|NCT02500719|588869474|FG000|Overall Study|Claustrophobia|0|||
163044181|NCT02500719|588869475|FG001|Overall Study|Claustrophobia|1|||
163044182|NCT02500719|588869474|FG000|Overall Study|History of head trauma|0|||
163044183|NCT02500719|588869475|FG001|Overall Study|History of head trauma|1|||
163044184|NCT00154375|588869476|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
163044185|NCT00154375|588869477|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
163044186|NCT00154375|588869476|FG000|Overall Study|Adverse Event|18|||
163044187|NCT00154375|588869477|FG001|Overall Study|Adverse Event|20|||
163044188|NCT00154375|588869476|FG000|Overall Study|Withdrawal by Subject|14|||
163044189|NCT00154375|588869477|FG001|Overall Study|Withdrawal by Subject|10|||
163044190|NCT00154375|588869476|FG000|Overall Study|Death|5|||
163044191|NCT00154375|588869477|FG001|Overall Study|Death|13|||
163044192|NCT00154375|588869476|FG000|Overall Study|Study drug no longer required|5|||
163044193|NCT00154375|588869477|FG001|Overall Study|Study drug no longer required|3|||
163044194|NCT00154375|588869476|FG000|Overall Study|Lost to Follow-up|2|||
163044195|NCT00154375|588869477|FG001|Overall Study|Lost to Follow-up|1|||
163044196|NCT00154375|588869476|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163044197|NCT00154375|588869477|FG001|Overall Study|Abnormal laboratory value(s)|2|||
163044198|NCT00154375|588869476|FG000|Overall Study|Protocol Violation|0|||
163044199|NCT00154375|588869477|FG001|Overall Study|Protocol Violation|1|||
163044200|NCT00154375|588869476|FG000|Overall Study|Suspected progression of disease|44|||
163044201|NCT00154375|588869477|FG001|Overall Study|Suspected progression of disease|30|||
163044202|NCT00792116|588869478|FG000|Overall Study|Lost to Follow-up|0|||
163044203|NCT00792116|588869479|FG001|Overall Study|Lost to Follow-up|1|||
163044204|NCT00792116|588869478|FG000|Overall Study|Discontnued intervention|1|||
163044205|NCT00792116|588869479|FG001|Overall Study|Discontnued intervention|0|||
163044206|NCT00103285|588871410|FG000|Induction|Adverse Event|14|||
163044207|NCT00103285|588871411|FG001|Induction|Adverse Event|0|||
163044208|NCT00103285|588871412|FG002|Induction|Adverse Event|0|||
163044209|NCT00103285|588871413|FG003|Induction|Adverse Event|0|||
163044210|NCT00103285|588871414|FG004|Induction|Adverse Event|0|||
163044211|NCT00103285|588871415|FG005|Induction|Adverse Event|0|||
163044212|NCT00103285|588871416|FG006|Induction|Adverse Event|0|||
163044213|NCT00103285|588871417|FG007|Induction|Adverse Event|0|||
163044214|NCT00103285|588871410|FG000|Induction|Death|24|||
163044215|NCT00103285|588871411|FG001|Induction|Death|0|||
163044216|NCT00103285|588871412|FG002|Induction|Death|0|||
163044217|NCT00103285|588871413|FG003|Induction|Death|0|||
163044218|NCT00103285|588871414|FG004|Induction|Death|0|||
163044219|NCT00103285|588871415|FG005|Induction|Death|0|||
163044220|NCT00103285|588871416|FG006|Induction|Death|0|||
163044221|NCT00103285|588871417|FG007|Induction|Death|0|||
163044222|NCT00103285|588871410|FG000|Induction|Physician Decision|103|||
163044223|NCT00103285|588871411|FG001|Induction|Physician Decision|0|||
163044224|NCT00103285|588871412|FG002|Induction|Physician Decision|0|||
163044225|NCT00103285|588871413|FG003|Induction|Physician Decision|0|||
163044226|NCT00103285|588871414|FG004|Induction|Physician Decision|0|||
163044227|NCT00103285|588871415|FG005|Induction|Physician Decision|0|||
163194375|NCT00347360|589425086|FG000|Overall Study|Randomized in error|0|||
163194376|NCT00347360|589425087|FG001|Overall Study|Randomized in error|0|||
163194377|NCT00347360|589425088|FG002|Overall Study|Randomized in error|0|||
163299631|NCT02409667|589805238|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
163044228|NCT00103285|588871416|FG006|Induction|Physician Decision|0|||
163044229|NCT00103285|588871417|FG007|Induction|Physician Decision|0|||
163044230|NCT00103285|588871410|FG000|Induction|Withdrawal by Subject|1|||
163044231|NCT00103285|588871411|FG001|Induction|Withdrawal by Subject|0|||
163044232|NCT00103285|588871412|FG002|Induction|Withdrawal by Subject|0|||
163044233|NCT00103285|588871413|FG003|Induction|Withdrawal by Subject|0|||
163044234|NCT00103285|588871414|FG004|Induction|Withdrawal by Subject|0|||
163044235|NCT00103285|588871415|FG005|Induction|Withdrawal by Subject|0|||
163044236|NCT00103285|588871416|FG006|Induction|Withdrawal by Subject|0|||
163044237|NCT00103285|588871417|FG007|Induction|Withdrawal by Subject|0|||
163299632|NCT02409667|589805239|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
163299633|NCT02409667|589805235|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
163299634|NCT02409667|589805236|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
163299635|NCT02409667|589805237|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
163299636|NCT02409667|589805238|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
163299637|NCT02409667|589805239|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
163299638|NCT02409667|589805235|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
163299639|NCT02409667|589805236|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
162955572|NCT01796171|588539276|FG008|Follow-up Period|Progressive disease|0|||
162955573|NCT01796171|588539277|FG009|Follow-up Period|Progressive disease|0|||
162955574|NCT01796171|588539278|FG010|Follow-up Period|Progressive disease|0|||
162955575|NCT01796171|588539279|FG011|Follow-up Period|Progressive disease|0|||
162955576|NCT01796171|588539280|FG012|Follow-up Period|Progressive disease|0|||
162955577|NCT01796171|588539281|FG013|Follow-up Period|Progressive disease|0|||
162955578|NCT01796171|588539282|FG014|Follow-up Period|Progressive disease|0|||
162955579|NCT01796171|588539268|FG000|Follow-up Period|Physician Decision|0|||
162955580|NCT01796171|588539269|FG001|Follow-up Period|Physician Decision|2|||
162955581|NCT01796171|588539270|FG002|Follow-up Period|Physician Decision|0|||
162955582|NCT01796171|588539271|FG003|Follow-up Period|Physician Decision|0|||
162955583|NCT01796171|588539272|FG004|Follow-up Period|Physician Decision|0|||
162955584|NCT01796171|588539273|FG005|Follow-up Period|Physician Decision|0|||
162955585|NCT01796171|588539274|FG006|Follow-up Period|Physician Decision|0|||
162955586|NCT01796171|588539275|FG007|Follow-up Period|Physician Decision|0|||
162955587|NCT01796171|588539276|FG008|Follow-up Period|Physician Decision|0|||
162955588|NCT01796171|588539277|FG009|Follow-up Period|Physician Decision|0|||
162955589|NCT01796171|588539278|FG010|Follow-up Period|Physician Decision|5|||
162955590|NCT01796171|588539279|FG011|Follow-up Period|Physician Decision|0|||
162955591|NCT01796171|588539280|FG012|Follow-up Period|Physician Decision|0|||
162955592|NCT01796171|588539281|FG013|Follow-up Period|Physician Decision|0|||
162955593|NCT01796171|588539282|FG014|Follow-up Period|Physician Decision|0|||
162955594|NCT01796171|588539268|FG000|Follow-up Period|Withdrawal by Subject|0|||
162955595|NCT01796171|588539269|FG001|Follow-up Period|Withdrawal by Subject|1|||
162955596|NCT01796171|588539270|FG002|Follow-up Period|Withdrawal by Subject|0|||
162955597|NCT01796171|588539271|FG003|Follow-up Period|Withdrawal by Subject|0|||
162955598|NCT01796171|588539272|FG004|Follow-up Period|Withdrawal by Subject|0|||
162955599|NCT01796171|588539273|FG005|Follow-up Period|Withdrawal by Subject|1|||
162955600|NCT01796171|588539274|FG006|Follow-up Period|Withdrawal by Subject|0|||
162955601|NCT01796171|588539275|FG007|Follow-up Period|Withdrawal by Subject|0|||
162955602|NCT01796171|588539276|FG008|Follow-up Period|Withdrawal by Subject|0|||
162955603|NCT01796171|588539277|FG009|Follow-up Period|Withdrawal by Subject|0|||
162955604|NCT01796171|588539278|FG010|Follow-up Period|Withdrawal by Subject|3|||
162955605|NCT01796171|588539279|FG011|Follow-up Period|Withdrawal by Subject|1|||
163299640|NCT02409667|589805237|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
163393466|NCT03065023|590152137|FG000|Overall Study|Death|2|||
163044238|NCT00103285|588871410|FG000|Induction|Ineligible|43|||
163044239|NCT00103285|588871411|FG001|Induction|Ineligible|0|||
163044240|NCT00103285|588871412|FG002|Induction|Ineligible|0|||
163044241|NCT00103285|588871413|FG003|Induction|Ineligible|0|||
163044242|NCT00103285|588871414|FG004|Induction|Ineligible|0|||
163044243|NCT00103285|588871415|FG005|Induction|Ineligible|0|||
163044244|NCT00103285|588871416|FG006|Induction|Ineligible|0|||
163044245|NCT00103285|588871417|FG007|Induction|Ineligible|0|||
163044246|NCT00103285|588871410|FG000|Induction|Refusal|906|||
163044247|NCT00103285|588871411|FG001|Induction|Refusal|0|||
163044248|NCT00103285|588871412|FG002|Induction|Refusal|0|||
163044249|NCT00103285|588871413|FG003|Induction|Refusal|0|||
163194378|NCT00347360|589425089|FG003|Overall Study|Randomized in error|0|||
163194379|NCT00347360|589425090|FG004|Overall Study|Randomized in error|0|||
163194380|NCT00347360|589425091|FG005|Overall Study|Randomized in error|0|||
163194381|NCT00347360|589425092|FG006|Overall Study|Randomized in error|0|||
163194382|NCT00347360|589425093|FG007|Overall Study|Randomized in error|0|||
163194383|NCT00347360|589425094|FG008|Overall Study|Randomized in error|0|||
163194384|NCT00347360|589425095|FG009|Overall Study|Randomized in error|0|||
163194385|NCT00347360|589425096|FG010|Overall Study|Randomized in error|0|||
163194386|NCT00347360|589425097|FG011|Overall Study|Randomized in error|1|||
163194387|NCT00347360|589425098|FG012|Overall Study|Randomized in error|0|||
163194388|NCT00347360|589425099|FG013|Overall Study|Randomized in error|0|||
163194389|NCT00347360|589425100|FG014|Overall Study|Randomized in error|0|||
163194390|NCT00347360|589425086|FG000|Overall Study|Failed inclusion criteria #4|0|||
163194391|NCT00347360|589425087|FG001|Overall Study|Failed inclusion criteria #4|0|||
163194392|NCT00347360|589425088|FG002|Overall Study|Failed inclusion criteria #4|0|||
163194393|NCT00347360|589425089|FG003|Overall Study|Failed inclusion criteria #4|0|||
163194394|NCT00347360|589425090|FG004|Overall Study|Failed inclusion criteria #4|0|||
163194395|NCT00347360|589425091|FG005|Overall Study|Failed inclusion criteria #4|0|||
163194396|NCT00347360|589425092|FG006|Overall Study|Failed inclusion criteria #4|0|||
163194397|NCT00347360|589425093|FG007|Overall Study|Failed inclusion criteria #4|0|||
163194398|NCT00347360|589425094|FG008|Overall Study|Failed inclusion criteria #4|0|||
163194399|NCT00347360|589425095|FG009|Overall Study|Failed inclusion criteria #4|0|||
163194400|NCT00347360|589425096|FG010|Overall Study|Failed inclusion criteria #4|0|||
163194401|NCT00347360|589425097|FG011|Overall Study|Failed inclusion criteria #4|1|||
163194402|NCT00347360|589425098|FG012|Overall Study|Failed inclusion criteria #4|0|||
163194403|NCT00347360|589425099|FG013|Overall Study|Failed inclusion criteria #4|0|||
163194404|NCT00347360|589425100|FG014|Overall Study|Failed inclusion criteria #4|0|||
163194405|NCT00347360|589425086|FG000|Overall Study|Prolonged duration between visits|0|||
163194406|NCT00347360|589425087|FG001|Overall Study|Prolonged duration between visits|0|||
163194407|NCT00347360|589425088|FG002|Overall Study|Prolonged duration between visits|0|||
163194408|NCT00347360|589425089|FG003|Overall Study|Prolonged duration between visits|0|||
163194409|NCT00347360|589425090|FG004|Overall Study|Prolonged duration between visits|0|||
163194410|NCT00347360|589425091|FG005|Overall Study|Prolonged duration between visits|0|||
163194411|NCT00347360|589425092|FG006|Overall Study|Prolonged duration between visits|0|||
163194412|NCT00347360|589425093|FG007|Overall Study|Prolonged duration between visits|0|||
163194413|NCT00347360|589425094|FG008|Overall Study|Prolonged duration between visits|0|||
163194414|NCT00347360|589425095|FG009|Overall Study|Prolonged duration between visits|0|||
163194415|NCT00347360|589425096|FG010|Overall Study|Prolonged duration between visits|0|||
163194416|NCT00347360|589425097|FG011|Overall Study|Prolonged duration between visits|0|||
163194417|NCT00347360|589425098|FG012|Overall Study|Prolonged duration between visits|1|||
163194418|NCT00347360|589425099|FG013|Overall Study|Prolonged duration between visits|0|||
163194419|NCT00347360|589425100|FG014|Overall Study|Prolonged duration between visits|0|||
163194420|NCT00347360|589425086|FG000|Overall Study|Subject left town, ran out of study drug|0|||
163194421|NCT00347360|589425087|FG001|Overall Study|Subject left town, ran out of study drug|0|||
163194422|NCT00347360|589425088|FG002|Overall Study|Subject left town, ran out of study drug|0|||
163194423|NCT00347360|589425089|FG003|Overall Study|Subject left town, ran out of study drug|0|||
163194424|NCT00347360|589425090|FG004|Overall Study|Subject left town, ran out of study drug|0|||
163194425|NCT00347360|589425091|FG005|Overall Study|Subject left town, ran out of study drug|0|||
163194426|NCT00347360|589425092|FG006|Overall Study|Subject left town, ran out of study drug|0|||
163194427|NCT00347360|589425093|FG007|Overall Study|Subject left town, ran out of study drug|0|||
163194428|NCT00347360|589425094|FG008|Overall Study|Subject left town, ran out of study drug|0|||
163194429|NCT00347360|589425095|FG009|Overall Study|Subject left town, ran out of study drug|0|||
163194430|NCT00347360|589425096|FG010|Overall Study|Subject left town, ran out of study drug|0|||
163194431|NCT00347360|589425097|FG011|Overall Study|Subject left town, ran out of study drug|0|||
163194432|NCT00347360|589425098|FG012|Overall Study|Subject left town, ran out of study drug|0|||
163194433|NCT00347360|589425099|FG013|Overall Study|Subject left town, ran out of study drug|1|||
163393467|NCT03065023|590152138|FG001|Overall Study|Death|0|||
163393468|NCT03065023|590152139|FG002|Overall Study|Death|1|||
163044250|NCT00103285|588871414|FG004|Induction|Refusal|0|||
163044251|NCT00103285|588871415|FG005|Induction|Refusal|0|||
163044252|NCT00103285|588871416|FG006|Induction|Refusal|0|||
163044253|NCT00103285|588871417|FG007|Induction|Refusal|0|||
163044254|NCT00103285|588871410|FG000|Induction|Other|258|||
163194434|NCT00347360|589425100|FG014|Overall Study|Subject left town, ran out of study drug|0|||
163194435|NCT00347360|589425086|FG000|Overall Study|Subject refuse to sign updated consent|0|||
163194436|NCT00347360|589425087|FG001|Overall Study|Subject refuse to sign updated consent|0|||
163194437|NCT00347360|589425088|FG002|Overall Study|Subject refuse to sign updated consent|0|||
163194438|NCT00347360|589425089|FG003|Overall Study|Subject refuse to sign updated consent|0|||
163194439|NCT00347360|589425090|FG004|Overall Study|Subject refuse to sign updated consent|0|||
163194440|NCT00347360|589425091|FG005|Overall Study|Subject refuse to sign updated consent|0|||
163194441|NCT00347360|589425092|FG006|Overall Study|Subject refuse to sign updated consent|0|||
163194442|NCT00347360|589425093|FG007|Overall Study|Subject refuse to sign updated consent|0|||
163194443|NCT00347360|589425094|FG008|Overall Study|Subject refuse to sign updated consent|0|||
163194444|NCT00347360|589425095|FG009|Overall Study|Subject refuse to sign updated consent|0|||
163194445|NCT00347360|589425096|FG010|Overall Study|Subject refuse to sign updated consent|0|||
163194446|NCT00347360|589425097|FG011|Overall Study|Subject refuse to sign updated consent|0|||
163194447|NCT00347360|589425098|FG012|Overall Study|Subject refuse to sign updated consent|0|||
163194448|NCT00347360|589425099|FG013|Overall Study|Subject refuse to sign updated consent|0|||
163194449|NCT00347360|589425100|FG014|Overall Study|Subject refuse to sign updated consent|1|||
163194450|NCT00347360|589425086|FG000|Overall Study|Visits conflicted with new job|0|||
163194451|NCT00347360|589425087|FG001|Overall Study|Visits conflicted with new job|0|||
163194452|NCT00347360|589425088|FG002|Overall Study|Visits conflicted with new job|0|||
163194453|NCT00347360|589425089|FG003|Overall Study|Visits conflicted with new job|0|||
163194454|NCT00347360|589425090|FG004|Overall Study|Visits conflicted with new job|0|||
163194455|NCT00347360|589425091|FG005|Overall Study|Visits conflicted with new job|0|||
163194456|NCT00347360|589425092|FG006|Overall Study|Visits conflicted with new job|1|||
163194457|NCT00347360|589425093|FG007|Overall Study|Visits conflicted with new job|0|||
163194458|NCT00347360|589425094|FG008|Overall Study|Visits conflicted with new job|0|||
163194459|NCT00347360|589425095|FG009|Overall Study|Visits conflicted with new job|0|||
163194460|NCT00347360|589425096|FG010|Overall Study|Visits conflicted with new job|0|||
163194461|NCT00347360|589425097|FG011|Overall Study|Visits conflicted with new job|0|||
163194462|NCT00347360|589425098|FG012|Overall Study|Visits conflicted with new job|0|||
162955606|NCT01796171|588539280|FG012|Follow-up Period|Withdrawal by Subject|0|||
162955607|NCT01796171|588539281|FG013|Follow-up Period|Withdrawal by Subject|0|||
162955608|NCT01796171|588539282|FG014|Follow-up Period|Withdrawal by Subject|0|||
162955609|NCT01796171|588539268|FG000|Follow-up Period|Death|0|||
162955610|NCT01796171|588539269|FG001|Follow-up Period|Death|0|||
162955611|NCT01796171|588539270|FG002|Follow-up Period|Death|0|||
162955612|NCT01796171|588539271|FG003|Follow-up Period|Death|0|||
162955613|NCT01796171|588539272|FG004|Follow-up Period|Death|0|||
162955614|NCT01796171|588539273|FG005|Follow-up Period|Death|0|||
162955615|NCT01796171|588539274|FG006|Follow-up Period|Death|1|||
162955616|NCT01796171|588539275|FG007|Follow-up Period|Death|0|||
162955617|NCT01796171|588539276|FG008|Follow-up Period|Death|0|||
162955618|NCT01796171|588539277|FG009|Follow-up Period|Death|0|||
163044255|NCT00103285|588871411|FG001|Induction|Other|0|||
163044256|NCT00103285|588871412|FG002|Induction|Other|0|||
163044257|NCT00103285|588871413|FG003|Induction|Other|0|||
163044258|NCT00103285|588871414|FG004|Induction|Other|0|||
163044259|NCT00103285|588871415|FG005|Induction|Other|0|||
163044260|NCT00103285|588871416|FG006|Induction|Other|0|||
163044261|NCT00103285|588871417|FG007|Induction|Other|0|||
163044262|NCT00103285|588871410|FG000|Response Assignment|Adverse Event|0|||
163044263|NCT00103285|588871411|FG001|Response Assignment|Adverse Event|8|||
163044264|NCT00103285|588871412|FG002|Response Assignment|Adverse Event|3|||
163044265|NCT00103285|588871413|FG003|Response Assignment|Adverse Event|2|||
163044266|NCT00103285|588871414|FG004|Response Assignment|Adverse Event|3|||
163044267|NCT00103285|588871415|FG005|Response Assignment|Adverse Event|1|||
163044268|NCT00103285|588871416|FG006|Response Assignment|Adverse Event|1|||
163044269|NCT00103285|588871417|FG007|Response Assignment|Adverse Event|2|||
163044270|NCT00103285|588871410|FG000|Response Assignment|Death|0|||
163194463|NCT00347360|589425099|FG013|Overall Study|Visits conflicted with new job|0|||
163194464|NCT00347360|589425100|FG014|Overall Study|Visits conflicted with new job|0|||
163194465|NCT03113071|589425101|FG000|Overall Study|Withdrawal by Subject|1|||
163194466|NCT03113071|589425102|FG001|Overall Study|Withdrawal by Subject|0|||
163194467|NCT02369016|589425105|FG000|Overall Study|AE associated with clinical disease progression|2|||
163194468|NCT02369016|589425106|FG001|Overall Study|AE associated with clinical disease progression|1|||
163393469|NCT03065023|590152140|FG003|Overall Study|Death|1|||
162955619|NCT01796171|588539278|FG010|Follow-up Period|Death|17|||
162955620|NCT01796171|588539279|FG011|Follow-up Period|Death|9|||
162955621|NCT01796171|588539280|FG012|Follow-up Period|Death|1|||
162955622|NCT01796171|588539281|FG013|Follow-up Period|Death|0|||
162955623|NCT01796171|588539282|FG014|Follow-up Period|Death|0|||
163044271|NCT00103285|588871411|FG001|Response Assignment|Death|5|||
163044272|NCT00103285|588871412|FG002|Response Assignment|Death|2|||
162955624|NCT01796171|588539268|FG000|Follow-up Period|Patient transferred to other hospital|0|||
162955625|NCT01796171|588539269|FG001|Follow-up Period|Patient transferred to other hospital|1|||
163044273|NCT00103285|588871413|FG003|Response Assignment|Death|2|||
163044274|NCT00103285|588871414|FG004|Response Assignment|Death|3|||
163393470|NCT03065023|590152141|FG004|Overall Study|Death|0|||
163393471|NCT03065023|590152137|FG000|Overall Study|Lost to Follow-up|0|||
163393472|NCT03065023|590152138|FG001|Overall Study|Lost to Follow-up|1|||
163393473|NCT03065023|590152139|FG002|Overall Study|Lost to Follow-up|0|||
163393474|NCT03065023|590152140|FG003|Overall Study|Lost to Follow-up|0|||
163393475|NCT03065023|590152141|FG004|Overall Study|Lost to Follow-up|0|||
163393476|NCT03065023|590152137|FG000|Overall Study|Participant Decision|0|||
163393477|NCT03065023|590152138|FG001|Overall Study|Participant Decision|0|||
162955626|NCT01796171|588539270|FG002|Follow-up Period|Patient transferred to other hospital|0|||
162955627|NCT01796171|588539271|FG003|Follow-up Period|Patient transferred to other hospital|0|||
162955628|NCT01796171|588539272|FG004|Follow-up Period|Patient transferred to other hospital|0|||
162955629|NCT01796171|588539273|FG005|Follow-up Period|Patient transferred to other hospital|0|||
162955630|NCT01796171|588539274|FG006|Follow-up Period|Patient transferred to other hospital|0|||
162955631|NCT01796171|588539275|FG007|Follow-up Period|Patient transferred to other hospital|0|||
162955632|NCT01796171|588539276|FG008|Follow-up Period|Patient transferred to other hospital|0|||
162955633|NCT01796171|588539277|FG009|Follow-up Period|Patient transferred to other hospital|0|||
162955634|NCT01796171|588539278|FG010|Follow-up Period|Patient transferred to other hospital|0|||
162955635|NCT01796171|588539279|FG011|Follow-up Period|Patient transferred to other hospital|0|||
162955636|NCT01796171|588539280|FG012|Follow-up Period|Patient transferred to other hospital|0|||
162955637|NCT01796171|588539281|FG013|Follow-up Period|Patient transferred to other hospital|0|||
162955638|NCT01796171|588539282|FG014|Follow-up Period|Patient transferred to other hospital|0|||
162955639|NCT01796171|588539268|FG000|Follow-up Period|Sponsor Decision|0|||
162955640|NCT01796171|588539269|FG001|Follow-up Period|Sponsor Decision|0|||
162955641|NCT01796171|588539270|FG002|Follow-up Period|Sponsor Decision|0|||
162955642|NCT01796171|588539271|FG003|Follow-up Period|Sponsor Decision|0|||
162955643|NCT01796171|588539272|FG004|Follow-up Period|Sponsor Decision|0|||
162955644|NCT01796171|588539273|FG005|Follow-up Period|Sponsor Decision|0|||
162955645|NCT01796171|588539274|FG006|Follow-up Period|Sponsor Decision|0|||
162955646|NCT01796171|588539275|FG007|Follow-up Period|Sponsor Decision|0|||
162955647|NCT01796171|588539276|FG008|Follow-up Period|Sponsor Decision|0|||
162955648|NCT01796171|588539277|FG009|Follow-up Period|Sponsor Decision|0|||
162955649|NCT01796171|588539278|FG010|Follow-up Period|Sponsor Decision|40|||
162955650|NCT01796171|588539279|FG011|Follow-up Period|Sponsor Decision|15|||
162955651|NCT01796171|588539280|FG012|Follow-up Period|Sponsor Decision|7|||
162955652|NCT01796171|588539281|FG013|Follow-up Period|Sponsor Decision|0|||
162955653|NCT01796171|588539282|FG014|Follow-up Period|Sponsor Decision|0|||
162955654|NCT00829309|588539283|FG000|Washout: 7 Days|Protocol Violation|1|||
162955655|NCT00829309|588539284|FG001|Washout: 7 Days|Protocol Violation|0|||
162955656|NCT01083693|588539285|FG000|Overall Study|Adverse Event|1|||
162955657|NCT01083693|588539286|FG001|Overall Study|Adverse Event|1|||
162955658|NCT01083693|588539287|FG002|Overall Study|Adverse Event|0|||
162955659|NCT01083693|588539285|FG000|Overall Study|Lost to Follow-up|2|||
162955660|NCT01083693|588539286|FG001|Overall Study|Lost to Follow-up|0|||
162955661|NCT01083693|588539287|FG002|Overall Study|Lost to Follow-up|2|||
162955662|NCT01083693|588539285|FG000|Overall Study|Lack of effectiveness|13|||
162955663|NCT01083693|588539286|FG001|Overall Study|Lack of effectiveness|2|||
162955664|NCT01083693|588539287|FG002|Overall Study|Lack of effectiveness|2|||
162955665|NCT01083693|588539285|FG000|Overall Study|Patient Moved|0|||
163044275|NCT00103285|588871415|FG005|Response Assignment|Death|1|||
163044276|NCT00103285|588871416|FG006|Response Assignment|Death|0|||
163044277|NCT00103285|588871417|FG007|Response Assignment|Death|8|||
163044278|NCT00103285|588871410|FG000|Response Assignment|Lost to Follow-up|0|||
163044279|NCT00103285|588871411|FG001|Response Assignment|Lost to Follow-up|9|||
162955666|NCT01083693|588539286|FG001|Overall Study|Patient Moved|1|||
162955667|NCT01083693|588539287|FG002|Overall Study|Patient Moved|0|||
162955668|NCT01083693|588539285|FG000|Overall Study|Complete remission|0|||
163044280|NCT00103285|588871412|FG002|Response Assignment|Lost to Follow-up|5|||
163194469|NCT02369016|589425105|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
162955669|NCT01083693|588539286|FG001|Overall Study|Complete remission|1|||
162955670|NCT01083693|588539287|FG002|Overall Study|Complete remission|0|||
162955671|NCT01083693|588539285|FG000|Overall Study|Other medical condition/surgery|1|||
162955672|NCT01083693|588539286|FG001|Overall Study|Other medical condition/surgery|1|||
162955673|NCT01083693|588539287|FG002|Overall Study|Other medical condition/surgery|0|||
163194470|NCT02369016|589425106|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
162955674|NCT01083693|588539285|FG000|Overall Study|Withdrawal by Subject|3|||
163194471|NCT02369016|589425105|FG000|Overall Study|Progressive disease - clinical progression|1|||
163044281|NCT00103285|588871413|FG003|Response Assignment|Lost to Follow-up|5|||
163044282|NCT00103285|588871414|FG004|Response Assignment|Lost to Follow-up|1|||
163044283|NCT00103285|588871415|FG005|Response Assignment|Lost to Follow-up|2|||
163044284|NCT00103285|588871416|FG006|Response Assignment|Lost to Follow-up|2|||
163044285|NCT00103285|588871417|FG007|Response Assignment|Lost to Follow-up|5|||
163044286|NCT00103285|588871410|FG000|Response Assignment|Physician Decision|0|||
163044287|NCT00103285|588871411|FG001|Response Assignment|Physician Decision|13|||
163044288|NCT00103285|588871412|FG002|Response Assignment|Physician Decision|14|||
163044289|NCT00103285|588871413|FG003|Response Assignment|Physician Decision|9|||
163044290|NCT00103285|588871414|FG004|Response Assignment|Physician Decision|13|||
163044291|NCT00103285|588871415|FG005|Response Assignment|Physician Decision|7|||
163044292|NCT00103285|588871416|FG006|Response Assignment|Physician Decision|4|||
163044293|NCT00103285|588871417|FG007|Response Assignment|Physician Decision|35|||
162955675|NCT01083693|588539286|FG001|Overall Study|Withdrawal by Subject|0|||
162955676|NCT01083693|588539287|FG002|Overall Study|Withdrawal by Subject|2|||
163044294|NCT00103285|588871410|FG000|Response Assignment|Protocol Violation|0|||
163044295|NCT00103285|588871411|FG001|Response Assignment|Protocol Violation|2|||
163044296|NCT00103285|588871412|FG002|Response Assignment|Protocol Violation|0|||
162955677|NCT01083693|588539285|FG000|Overall Study|Reason unknown|0|||
162955678|NCT01083693|588539286|FG001|Overall Study|Reason unknown|0|||
162955679|NCT01083693|588539287|FG002|Overall Study|Reason unknown|1|||
162955680|NCT03699020|588539291|FG000|Overall Study|Withdrawal by Subject|3|||
163044297|NCT00103285|588871413|FG003|Response Assignment|Protocol Violation|0|||
163044298|NCT00103285|588871414|FG004|Response Assignment|Protocol Violation|0|||
163044299|NCT00103285|588871415|FG005|Response Assignment|Protocol Violation|0|||
163044300|NCT00103285|588871416|FG006|Response Assignment|Protocol Violation|0|||
163044301|NCT00103285|588871417|FG007|Response Assignment|Protocol Violation|0|||
163044302|NCT00103285|588871410|FG000|Response Assignment|Withdrawal by Subject|0|||
163044303|NCT00103285|588871411|FG001|Response Assignment|Withdrawal by Subject|4|||
163044304|NCT00103285|588871412|FG002|Response Assignment|Withdrawal by Subject|1|||
162955681|NCT03699020|588539292|FG001|Overall Study|Withdrawal by Subject|2|||
162955682|NCT03020615|588539296|FG000|Overall Study|Physician Decision|3|||
162955683|NCT03020615|588539297|FG001|Overall Study|Physician Decision|1|||
162955684|NCT03020615|588539298|FG002|Overall Study|Physician Decision|2|||
162955685|NCT03020615|588539296|FG000|Overall Study|Parent/guardian/patient choice|3|||
162955686|NCT03020615|588539297|FG001|Overall Study|Parent/guardian/patient choice|0|||
162955687|NCT03020615|588539298|FG002|Overall Study|Parent/guardian/patient choice|4|||
162955688|NCT03020615|588539296|FG000|Overall Study|Screen failure|0|||
162955689|NCT03020615|588539297|FG001|Overall Study|Screen failure|0|||
162955690|NCT03020615|588539298|FG002|Overall Study|Screen failure|1|||
162955691|NCT03020615|588539296|FG000|Overall Study|Death|1|||
162955692|NCT03020615|588539297|FG001|Overall Study|Death|0|||
162955693|NCT03020615|588539298|FG002|Overall Study|Death|0|||
162955694|NCT03020615|588539296|FG000|Overall Study|Lost to Follow-up|0|||
162955695|NCT03020615|588539297|FG001|Overall Study|Lost to Follow-up|1|||
162955696|NCT03020615|588539298|FG002|Overall Study|Lost to Follow-up|0|||
162955697|NCT00089661|588539299|FG000|Overall Study|Adverse Event|0|||
162955698|NCT00089661|588539300|FG001|Overall Study|Adverse Event|2|||
162955699|NCT00089661|588539299|FG000|Overall Study|Death|1|||
162955700|NCT00089661|588539300|FG001|Overall Study|Death|0|||
162955701|NCT00089661|588539299|FG000|Overall Study|Lost to Follow-up|0|||
162955702|NCT00089661|588539300|FG001|Overall Study|Lost to Follow-up|3|||
162955703|NCT00089661|588539299|FG000|Overall Study|Withdrawal by Subject|11|||
162955704|NCT00089661|588539300|FG001|Overall Study|Withdrawal by Subject|9|||
162955705|NCT00089661|588539299|FG000|Overall Study|Disease progression|1|||
162955706|NCT00089661|588539300|FG001|Overall Study|Disease progression|3|||
163044305|NCT00103285|588871413|FG003|Response Assignment|Withdrawal by Subject|1|||
163044306|NCT00103285|588871414|FG004|Response Assignment|Withdrawal by Subject|2|||
163044307|NCT00103285|588871415|FG005|Response Assignment|Withdrawal by Subject|2|||
163044308|NCT00103285|588871416|FG006|Response Assignment|Withdrawal by Subject|0|||
163044309|NCT00103285|588871417|FG007|Response Assignment|Withdrawal by Subject|2|||
163044310|NCT00103285|588871410|FG000|Response Assignment|Ineligible|0|||
163044311|NCT00103285|588871411|FG001|Response Assignment|Ineligible|8|||
163044312|NCT00103285|588871412|FG002|Response Assignment|Ineligible|6|||
163044313|NCT00103285|588871413|FG003|Response Assignment|Ineligible|2|||
163044314|NCT00103285|588871414|FG004|Response Assignment|Ineligible|0|||
163194472|NCT02369016|589425106|FG001|Overall Study|Progressive disease - clinical progression|4|||
163194473|NCT02369016|589425105|FG000|Overall Study|withdrawal by patient|4|||
163194474|NCT02369016|589425106|FG001|Overall Study|withdrawal by patient|0|||
163194475|NCT02369016|589425105|FG000|Overall Study|Progressive disease - radiological progression|6|||
163044315|NCT00103285|588871415|FG005|Response Assignment|Ineligible|3|||
162955707|NCT00089661|588539299|FG000|Overall Study|Ineligibility determined|4|||
162955708|NCT00089661|588539300|FG001|Overall Study|Ineligibility determined|4|||
162955709|NCT00089661|588539299|FG000|Overall Study|Noncompliance|2|||
163044316|NCT00103285|588871416|FG006|Response Assignment|Ineligible|1|||
163044317|NCT00103285|588871417|FG007|Response Assignment|Ineligible|5|||
162955710|NCT00089661|588539300|FG001|Overall Study|Noncompliance|4|||
162955711|NCT00089661|588539299|FG000|Overall Study|Other|2|||
163194476|NCT02369016|589425106|FG001|Overall Study|Progressive disease - radiological progression|2|||
163194477|NCT01187433|589425107|FG000|Overall Study|Protocol Violation|6|||
163194478|NCT01187433|589425108|FG001|Overall Study|Protocol Violation|2|||
163194479|NCT01187433|589425107|FG000|Overall Study|Withdrawal by Subject|5|||
163194480|NCT01187433|589425108|FG001|Overall Study|Withdrawal by Subject|2|||
163194481|NCT04203797|589425109|FG000|Overall Study|Adverse Event|1|||
163194482|NCT04203797|589425110|FG001|Overall Study|Adverse Event|0|||
163194483|NCT04203797|589425109|FG000|Overall Study|Did not complete End of Study follow-up|1|||
163194484|NCT04203797|589425110|FG001|Overall Study|Did not complete End of Study follow-up|0|||
163194485|NCT00621959|589425111|FG000|Overall Study|Adverse Event|4|||
163194486|NCT00621959|589425112|FG001|Overall Study|Adverse Event|2|||
163194487|NCT00621959|589425111|FG000|Overall Study|Lack of Efficacy|1|||
163194488|NCT00621959|589425112|FG001|Overall Study|Lack of Efficacy|1|||
163194489|NCT00621959|589425111|FG000|Overall Study|Lost to Follow-up|0|||
163194490|NCT00621959|589425112|FG001|Overall Study|Lost to Follow-up|2|||
163194491|NCT00621959|589425111|FG000|Overall Study|Withdrawal by Subject|1|||
163194492|NCT00621959|589425112|FG001|Overall Study|Withdrawal by Subject|1|||
163194493|NCT00621959|589425111|FG000|Overall Study|Other|1|||
163194494|NCT00621959|589425112|FG001|Overall Study|Other|3|||
163194495|NCT00242216|589425113|FG000|Overall Study|Lost to Follow-up|12|||
163194496|NCT00242216|589425114|FG001|Overall Study|Lost to Follow-up|17|||
163194497|NCT00242216|589425113|FG000|Overall Study|Death|4|||
163194498|NCT00242216|589425114|FG001|Overall Study|Death|2|||
163194499|NCT00242216|589425113|FG000|Overall Study|Lack of Efficacy|1|||
163194500|NCT00242216|589425114|FG001|Overall Study|Lack of Efficacy|2|||
163194501|NCT00242216|589425113|FG000|Overall Study|no medicaiton dispensed|1|||
163194502|NCT00242216|589425114|FG001|Overall Study|no medicaiton dispensed|1|||
163194503|NCT03360747|589425115|FG000|Overall Study|Voluntary Withdrawal|1|||
163194504|NCT02484690|589425116|FG000|Overall Study|Adverse Event|1|||
163194505|NCT02484690|589425117|FG001|Overall Study|Adverse Event|3|||
163194506|NCT02484690|589425118|FG002|Overall Study|Adverse Event|0|||
163194507|NCT02484690|589425119|FG003|Overall Study|Adverse Event|0|||
163194508|NCT02484690|589425120|FG004|Overall Study|Adverse Event|5|||
163194509|NCT02484690|589425116|FG000|Overall Study|Death|0|||
163194510|NCT02484690|589425117|FG001|Overall Study|Death|0|||
163194511|NCT02484690|589425118|FG002|Overall Study|Death|0|||
163194512|NCT02484690|589425119|FG003|Overall Study|Death|0|||
163194513|NCT02484690|589425120|FG004|Overall Study|Death|1|||
163194514|NCT02484690|589425116|FG000|Overall Study|Withdrawal by Subject|1|||
163194515|NCT02484690|589425117|FG001|Overall Study|Withdrawal by Subject|3|||
163194516|NCT02484690|589425118|FG002|Overall Study|Withdrawal by Subject|1|||
163194517|NCT02484690|589425119|FG003|Overall Study|Withdrawal by Subject|2|||
163194518|NCT02484690|589425120|FG004|Overall Study|Withdrawal by Subject|0|||
163194519|NCT02484690|589425116|FG000|Overall Study|Physician Decision|2|||
163194520|NCT02484690|589425117|FG001|Overall Study|Physician Decision|0|||
163194521|NCT02484690|589425118|FG002|Overall Study|Physician Decision|1|||
163194522|NCT02484690|589425119|FG003|Overall Study|Physician Decision|0|||
163194523|NCT02484690|589425120|FG004|Overall Study|Physician Decision|0|||
163194524|NCT02484690|589425116|FG000|Overall Study|Lost to Follow-up|0|||
163194525|NCT02484690|589425117|FG001|Overall Study|Lost to Follow-up|0|||
163194526|NCT02484690|589425118|FG002|Overall Study|Lost to Follow-up|1|||
163194527|NCT02484690|589425119|FG003|Overall Study|Lost to Follow-up|0|||
163194528|NCT02484690|589425120|FG004|Overall Study|Lost to Follow-up|0|||
163194529|NCT01759511|589425121|FG000|Overall Study|Adverse Event|4|||
163194530|NCT01759511|589425121|FG000|Overall Study|Death|2|||
163194531|NCT01759511|589425121|FG000|Overall Study|Lack of Efficacy|2|||
163194532|NCT01759511|589425121|FG000|Overall Study|Physician Decision|1|||
163194533|NCT01759511|589425121|FG000|Overall Study|Progressive Disease|5|||
163194534|NCT01759511|589425121|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
163194535|NCT01759511|589425121|FG000|Overall Study|Study Terminated by Sponsor|13|||
163194536|NCT01759511|589425121|FG000|Overall Study|Withdrawal by Subject|3|||
163194537|NCT02569671|589425129|FG000|Overall Study|Lost to Follow-up|2|||
163194538|NCT02569671|589425130|FG001|Overall Study|Lost to Follow-up|1|||
163194539|NCT02569671|589425129|FG000|Overall Study|Withdrawal by Subject|1|||
163194540|NCT02569671|589425130|FG001|Overall Study|Withdrawal by Subject|3|||
163194541|NCT01757535|589425131|FG000|Overall Study|Disease Relapse|151|||
163194542|NCT01757535|589425132|FG001|Overall Study|Disease Relapse|181|||
163194543|NCT01757535|589425131|FG000|Overall Study|Other Reasons|28|||
163044318|NCT00103285|588871410|FG000|Response Assignment|Refusal|0|||
163194544|NCT01757535|589425132|FG001|Overall Study|Other Reasons|27|||
163194545|NCT01757535|589425131|FG000|Overall Study|Adverse Event|31|||
163194546|NCT01757535|589425132|FG001|Overall Study|Adverse Event|11|||
163194547|NCT01757535|589425131|FG000|Overall Study|Withdrew Consent|19|||
163194548|NCT01757535|589425132|FG001|Overall Study|Withdrew Consent|13|||
163194549|NCT01757535|589425131|FG000|Overall Study|Physician Decision|7|||
163194550|NCT01757535|589425132|FG001|Overall Study|Physician Decision|0|||
163194551|NCT01757535|589425131|FG000|Overall Study|Death|2|||
163194552|NCT01757535|589425132|FG001|Overall Study|Death|2|||
163194553|NCT00589290|589425133|FG000|Overall Study|Withdrawal by Subject|1|||
163194554|NCT03730012|589425135|FG000|Overall Study|Adverse Event|0|||
163044319|NCT00103285|588871411|FG001|Response Assignment|Refusal|53|||
163044320|NCT00103285|588871412|FG002|Response Assignment|Refusal|5|||
163044321|NCT00103285|588871413|FG003|Response Assignment|Refusal|3|||
163044322|NCT00103285|588871414|FG004|Response Assignment|Refusal|25|||
163044323|NCT00103285|588871415|FG005|Response Assignment|Refusal|15|||
163044324|NCT00103285|588871416|FG006|Response Assignment|Refusal|30|||
163044325|NCT00103285|588871417|FG007|Response Assignment|Refusal|10|||
163044326|NCT00103285|588871410|FG000|Response Assignment|Other|0|||
163044327|NCT00103285|588871411|FG001|Response Assignment|Other|30|||
163044328|NCT00103285|588871412|FG002|Response Assignment|Other|48|||
163044329|NCT00103285|588871413|FG003|Response Assignment|Other|38|||
163044330|NCT00103285|588871414|FG004|Response Assignment|Other|37|||
163044331|NCT00103285|588871415|FG005|Response Assignment|Other|17|||
163044332|NCT00103285|588871416|FG006|Response Assignment|Other|11|||
163044333|NCT00103285|588871417|FG007|Response Assignment|Other|53|||
163044334|NCT00452439|588871418|FG000|Overall Study|Lost to Follow-up|1|||
163044335|NCT00452439|588871419|FG001|Overall Study|Lost to Follow-up|1|||
163044336|NCT00452439|588871418|FG000|Overall Study|Refused Treatment|4|||
163044337|NCT00452439|588871419|FG001|Overall Study|Refused Treatment|3|||
163044338|NCT00452439|588871418|FG000|Overall Study|Death|3|||
163044339|NCT00452439|588871419|FG001|Overall Study|Death|1|||
163044340|NCT00452439|588871418|FG000|Overall Study|Bone Marrow Transplant|0|||
163044341|NCT00452439|588871419|FG001|Overall Study|Bone Marrow Transplant|1|||
163044342|NCT00452439|588871418|FG000|Overall Study|Too Ill to Continue|0|||
163044343|NCT00452439|588871419|FG001|Overall Study|Too Ill to Continue|1|||
163044344|NCT00452439|588871418|FG000|Overall Study|Failed to achieve complete response|2|||
163044345|NCT00452439|588871419|FG001|Overall Study|Failed to achieve complete response|0|||
163044346|NCT00452439|588871418|FG000|Overall Study|Relapse|3|||
163044347|NCT00452439|588871419|FG001|Overall Study|Relapse|0|||
163044348|NCT00452439|588871418|FG000|Overall Study|Fracture|1|||
163044349|NCT00452439|588871419|FG001|Overall Study|Fracture|0|||
163044350|NCT01381926|588871422|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
163044351|NCT01381926|588871423|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
163044352|NCT01381926|588871422|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
163044353|NCT01381926|588871423|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
163044354|NCT02624947|588871428|FG000|Maternal Participants|Adverse Event|5|||
163044355|NCT02624947|588871429|FG001|Maternal Participants|Adverse Event|0|||
163044356|NCT02624947|588871428|FG000|Maternal Participants|Investigator Decision|5|||
163044357|NCT02624947|588871429|FG001|Maternal Participants|Investigator Decision|3|||
163044358|NCT02624947|588871428|FG000|Maternal Participants|Lost to Follow-up|54|||
163044359|NCT02624947|588871429|FG001|Maternal Participants|Lost to Follow-up|24|||
163044360|NCT02624947|588871428|FG000|Maternal Participants|Non Compliance|8|||
163044361|NCT02624947|588871429|FG001|Maternal Participants|Non Compliance|5|||
163044362|NCT02624947|588871428|FG000|Maternal Participants|Sponsor Request|1|||
163044363|NCT02624947|588871429|FG001|Maternal Participants|Sponsor Request|1|||
163044364|NCT02624947|588871428|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
163044365|NCT02624947|588871429|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
163044366|NCT02624947|588871428|FG000|Maternal Participants|Miscellaneous|23|||
163044367|NCT02624947|588871429|FG001|Maternal Participants|Miscellaneous|15|||
163044368|NCT02624947|588871428|FG000|Infant Participants|Adverse Event|18|||
163044369|NCT02624947|588871429|FG001|Infant Participants|Adverse Event|11|||
163044370|NCT02624947|588871428|FG000|Infant Participants|Investigator Decision|5|||
163044371|NCT02624947|588871429|FG001|Infant Participants|Investigator Decision|4|||
163044372|NCT02624947|588871428|FG000|Infant Participants|Lost to Follow-up|93|||
163044373|NCT02624947|588871429|FG001|Infant Participants|Lost to Follow-up|58|||
163044374|NCT02624947|588871428|FG000|Infant Participants|Non Compliance|17|||
163044375|NCT02624947|588871429|FG001|Infant Participants|Non Compliance|7|||
163044376|NCT02624947|588871428|FG000|Infant Participants|Sponsor Request|0|||
163044377|NCT02624947|588871429|FG001|Infant Participants|Sponsor Request|1|||
163044378|NCT02624947|588871428|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
163044379|NCT02624947|588871429|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
163044380|NCT02624947|588871428|FG000|Infant Participants|Miscellaneous|50|||
163044381|NCT02624947|588871429|FG001|Infant Participants|Miscellaneous|26|||
163044382|NCT03654729|588871438|FG000|Overall Study|Death|9|||
163044383|NCT03654729|588871439|FG001|Overall Study|Death|9|||
163044384|NCT03654729|588871440|FG002|Overall Study|Death|16|||
163044385|NCT03654729|588871438|FG000|Overall Study|Withdrawal by Subject|8|||
163044386|NCT03654729|588871439|FG001|Overall Study|Withdrawal by Subject|6|||
163044387|NCT03654729|588871440|FG002|Overall Study|Withdrawal by Subject|4|||
163044388|NCT03654729|588871438|FG000|Overall Study|Study terminated by Sponsor|3|||
163044389|NCT03654729|588871439|FG001|Overall Study|Study terminated by Sponsor|5|||
163044390|NCT03654729|588871440|FG002|Overall Study|Study terminated by Sponsor|4|||
163044391|NCT03654729|588871438|FG000|Overall Study|Not reported|2|||
163044392|NCT03654729|588871439|FG001|Overall Study|Not reported|4|||
163044393|NCT03654729|588871440|FG002|Overall Study|Not reported|5|||
163044394|NCT03654729|588871438|FG000|Overall Study|Progressive disease|3|||
163044395|NCT03654729|588871439|FG001|Overall Study|Progressive disease|0|||
163194555|NCT03730012|589425136|FG001|Overall Study|Adverse Event|1|||
163194556|NCT03730012|589425135|FG000|Overall Study|Lack of Efficacy|1|||
163194557|NCT03730012|589425136|FG001|Overall Study|Lack of Efficacy|5|||
163194558|NCT03730012|589425135|FG000|Overall Study|Withdrawal by Subject|0|||
163194559|NCT03730012|589425136|FG001|Overall Study|Withdrawal by Subject|1|||
163194560|NCT03730012|589425135|FG000|Overall Study|Miscellaneous|2|||
163194561|NCT03730012|589425136|FG001|Overall Study|Miscellaneous|1|||
163194562|NCT00403234|589426803|FG000|Overall Study|Withdrawal by Subject|0|||
163194563|NCT00403234|589426804|FG001|Overall Study|Withdrawal by Subject|1|||
163194564|NCT00403234|589426805|FG002|Overall Study|Withdrawal by Subject|0|||
163194565|NCT00403234|589426806|FG003|Overall Study|Withdrawal by Subject|0|||
163194566|NCT00403234|589426803|FG000|Overall Study|Adverse Event|1|||
163194567|NCT00403234|589426804|FG001|Overall Study|Adverse Event|0|||
163194568|NCT00403234|589426805|FG002|Overall Study|Adverse Event|1|||
162955712|NCT00089661|588539300|FG001|Overall Study|Other|1|||
162955713|NCT02760368|588539301|FG000|Overall Study|Withdrawal by Subject|8|||
162955714|NCT02760368|588539302|FG001|Overall Study|Withdrawal by Subject|12|||
162955715|NCT02760368|588539303|FG002|Overall Study|Withdrawal by Subject|9|||
162955716|NCT02760368|588539301|FG000|Overall Study|Screen Failure|0|||
162955717|NCT02760368|588539302|FG001|Overall Study|Screen Failure|0|||
163194569|NCT00403234|589426806|FG003|Overall Study|Adverse Event|0|||
162955718|NCT02760368|588539303|FG002|Overall Study|Screen Failure|1|||
162955719|NCT02760368|588539301|FG000|Overall Study|Death|0|||
163194570|NCT00560105|589426809|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
162955720|NCT02760368|588539302|FG001|Overall Study|Death|1|||
163194571|NCT00560105|589426810|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
163194572|NCT03539081|589426811|FG000|Overall Study|Withdrawal by Subject|2|||
163194573|NCT03539081|589426812|FG001|Overall Study|Withdrawal by Subject|3|||
163194574|NCT03539081|589426813|FG002|Overall Study|Withdrawal by Subject|0|||
162955721|NCT02760368|588539303|FG002|Overall Study|Death|0|||
162955722|NCT02760368|588539301|FG000|Overall Study|Withdrawal by Sponsor|0|||
162955723|NCT02760368|588539302|FG001|Overall Study|Withdrawal by Sponsor|0|||
162955724|NCT02760368|588539303|FG002|Overall Study|Withdrawal by Sponsor|1|||
162955725|NCT00794963|588539304|FG000|Overall Study|Withdrawal by Subject|1|||
162955726|NCT00794963|588539305|FG001|Overall Study|Withdrawal by Subject|4|||
162955727|NCT01037114|588539306|FG000|Year 20|Others|1|||
162955728|NCT01602419|588539307|FG000|Overall Study|Not treated with Wilate|9|||
162955729|NCT01602419|588539307|FG000|Overall Study|Adverse Drug Reaction|4|||
162955730|NCT01602419|588539307|FG000|Overall Study|Insurance issues|3|||
162955731|NCT01602419|588539307|FG000|Overall Study|Changed treatment centre|1|||
162955732|NCT01602419|588539307|FG000|Overall Study|Treatment centre closed|1|||
162955733|NCT01602419|588539307|FG000|Overall Study|Withdrawal by Subject|5|||
162955734|NCT01602419|588539307|FG000|Overall Study|Lost to Follow-up|6|||
162955735|NCT03620747|588539313|FG000|Overall Study|Participant decision|7|||
162955736|NCT03620747|588539313|FG000|Overall Study|Adverse Event|6|||
162955737|NCT03620747|588539313|FG000|Overall Study|Lack of Efficacy|1|||
162955738|NCT03620747|588539313|FG000|Overall Study|Poor compliance to protocol|2|||
162955739|NCT03620747|588539313|FG000|Overall Study|Other-unspecified|3|||
162955740|NCT00850174|588539316|FG000|Washout: One Week|Withdrawal by Subject|0|||
162955741|NCT00850174|588539317|FG001|Washout: One Week|Withdrawal by Subject|2|||
162955742|NCT00850174|588539316|FG000|Second Intervention|Withdrawal by Subject|1|||
162955743|NCT00850174|588539317|FG001|Second Intervention|Withdrawal by Subject|0|||
162955744|NCT00635492|588539318|FG000|Overall Study|Death|12|||
162955745|NCT00635492|588539319|FG001|Overall Study|Death|40|||
162955746|NCT00635492|588539318|FG000|Overall Study|Lost to Follow-up|151|||
162955747|NCT00635492|588539319|FG001|Overall Study|Lost to Follow-up|172|||
162955748|NCT00635492|588539318|FG000|Overall Study|Physician Decision|32|||
162955749|NCT00635492|588539319|FG001|Overall Study|Physician Decision|22|||
162955750|NCT00635492|588539318|FG000|Overall Study|Sponsor decision|2|||
162955751|NCT00635492|588539319|FG001|Overall Study|Sponsor decision|3|||
162955752|NCT00635492|588539318|FG000|Overall Study|Withdrawal by Subject|82|||
162955753|NCT00635492|588539319|FG001|Overall Study|Withdrawal by Subject|45|||
162955754|NCT04533594|588539320|FG000|Overall Study|Death|26|||
162955755|NCT03500341|588539325|FG000|Overall Study|Withdrawn prior to Completion|2|||
162955756|NCT02937870|588539326|FG000|Overall Study|Adverse Event|1|||
162955757|NCT02937870|588539326|FG000|Overall Study|Protocol Deviation|2|||
162955758|NCT01294917|588539327|FG000|Overall Study|Relocation|5|||
162955759|NCT01294917|588539327|FG000|Overall Study|Inconvenience|1|||
162955760|NCT03017885|588539328|FG000|Overall Study|Adverse Event|2|||
162955761|NCT03017885|588539329|FG001|Overall Study|Adverse Event|0|||
162955762|NCT03017885|588539330|FG002|Overall Study|Adverse Event|0|||
162955763|NCT03017885|588539331|FG003|Overall Study|Adverse Event|0|||
162955764|NCT03017885|588539332|FG004|Overall Study|Adverse Event|0|||
162955765|NCT03017885|588539333|FG005|Overall Study|Adverse Event|0|||
162955766|NCT03017885|588539328|FG000|Overall Study|Progression of disease|4|||
162955767|NCT03017885|588539329|FG001|Overall Study|Progression of disease|3|||
162955768|NCT03017885|588539330|FG002|Overall Study|Progression of disease|4|||
162955769|NCT03017885|588539331|FG003|Overall Study|Progression of disease|0|||
162955770|NCT03017885|588539332|FG004|Overall Study|Progression of disease|0|||
162955771|NCT03017885|588539333|FG005|Overall Study|Progression of disease|0|||
162955772|NCT03017885|588539328|FG000|Overall Study|Other than listed|1|||
162955773|NCT03017885|588539329|FG001|Overall Study|Other than listed|2|||
162955774|NCT03017885|588539330|FG002|Overall Study|Other than listed|1|||
162955775|NCT03017885|588539331|FG003|Overall Study|Other than listed|0|||
162955776|NCT03017885|588539332|FG004|Overall Study|Other than listed|0|||
162955777|NCT03017885|588539333|FG005|Overall Study|Other than listed|0|||
162955778|NCT03017885|588539328|FG000|Overall Study|Lost to Follow-up|2|||
163044396|NCT03654729|588871440|FG002|Overall Study|Progressive disease|0|||
163044397|NCT03654729|588871438|FG000|Overall Study|Lost to Follow-up|2|||
163044398|NCT03654729|588871439|FG001|Overall Study|Lost to Follow-up|0|||
163044399|NCT03654729|588871440|FG002|Overall Study|Lost to Follow-up|0|||
163194575|NCT03539081|589426811|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
162955779|NCT03017885|588539329|FG001|Overall Study|Lost to Follow-up|0|||
162955780|NCT03017885|588539330|FG002|Overall Study|Lost to Follow-up|3|||
162955781|NCT03017885|588539331|FG003|Overall Study|Lost to Follow-up|0|||
162955782|NCT03017885|588539332|FG004|Overall Study|Lost to Follow-up|0|||
162955783|NCT03017885|588539333|FG005|Overall Study|Lost to Follow-up|0|||
162955784|NCT03017885|588539328|FG000|Overall Study|Change to other anti-cancer therapy|0|||
162955785|NCT03017885|588539329|FG001|Overall Study|Change to other anti-cancer therapy|0|||
162955786|NCT03017885|588539330|FG002|Overall Study|Change to other anti-cancer therapy|1|||
163044400|NCT03654729|588871438|FG000|Overall Study|Physician Decision|2|||
162955787|NCT03017885|588539331|FG003|Overall Study|Change to other anti-cancer therapy|0|||
162955788|NCT03017885|588539332|FG004|Overall Study|Change to other anti-cancer therapy|0|||
163194576|NCT03539081|589426812|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
162955789|NCT03017885|588539333|FG005|Overall Study|Change to other anti-cancer therapy|0|||
163194577|NCT03539081|589426813|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
163194578|NCT02555683|589426817|FG000|Overall Study|Physician Decision|1|||
163194579|NCT02555683|589426818|FG001|Overall Study|Physician Decision|0|||
163194580|NCT02555683|589426819|FG002|Overall Study|Physician Decision|2|||
163194581|NCT02555683|589426817|FG000|Overall Study|Lost to Follow-up|2|||
163194582|NCT02555683|589426818|FG001|Overall Study|Lost to Follow-up|1|||
163393478|NCT03065023|590152139|FG002|Overall Study|Participant Decision|0|||
162955790|NCT00836056|588539343|FG000|First Intervention|Adverse Event|1|||
162955791|NCT00836056|588539344|FG001|First Intervention|Adverse Event|0|||
162955792|NCT01001208|588539348|FG000|Overall Study|Adverse Event|10|||
163194583|NCT02555683|589426819|FG002|Overall Study|Lost to Follow-up|2|||
163194584|NCT02555683|589426817|FG000|Overall Study|Technical Problems|1|||
163194585|NCT02555683|589426818|FG001|Overall Study|Technical Problems|1|||
163194586|NCT02555683|589426819|FG002|Overall Study|Technical Problems|0|||
163194587|NCT02555683|589426817|FG000|Overall Study|Protocol deviation|0|||
163194588|NCT02555683|589426818|FG001|Overall Study|Protocol deviation|1|||
163194589|NCT02555683|589426819|FG002|Overall Study|Protocol deviation|0|||
163194590|NCT02555683|589426817|FG000|Overall Study|Lack of Efficacy|2|||
163393479|NCT03065023|590152140|FG003|Overall Study|Participant Decision|1|||
163194591|NCT02555683|589426818|FG001|Overall Study|Lack of Efficacy|0|||
162955793|NCT01001208|588539349|FG001|Overall Study|Adverse Event|5|||
162955794|NCT01001208|588539348|FG000|Overall Study|Lost to Follow-up|5|||
162955795|NCT01001208|588539349|FG001|Overall Study|Lost to Follow-up|9|||
162955796|NCT01001208|588539348|FG000|Overall Study|Physician Decision|1|||
162955797|NCT01001208|588539349|FG001|Overall Study|Physician Decision|0|||
162955798|NCT01001208|588539348|FG000|Overall Study|Withdrawal by Subject|4|||
162955799|NCT01001208|588539349|FG001|Overall Study|Withdrawal by Subject|5|||
162955800|NCT01001208|588539348|FG000|Overall Study|Ineligibility Determined|4|||
163044401|NCT03654729|588871439|FG001|Overall Study|Physician Decision|0|||
163044402|NCT03654729|588871440|FG002|Overall Study|Physician Decision|0|||
163044403|NCT03654729|588871438|FG000|Overall Study|Protocol Violation|1|||
163044404|NCT03654729|588871439|FG001|Overall Study|Protocol Violation|1|||
163044405|NCT03654729|588871440|FG002|Overall Study|Protocol Violation|0|||
163393480|NCT03065023|590152141|FG004|Overall Study|Participant Decision|0|||
163393481|NCT03065023|590152137|FG000|Overall Study|Withdrawal by Subject|0|||
163393482|NCT03065023|590152138|FG001|Overall Study|Withdrawal by Subject|0|||
163393483|NCT03065023|590152139|FG002|Overall Study|Withdrawal by Subject|0|||
163393484|NCT03065023|590152140|FG003|Overall Study|Withdrawal by Subject|1|||
163393485|NCT03065023|590152141|FG004|Overall Study|Withdrawal by Subject|0|||
163393486|NCT00705432|590152142|FG000|Treatment Period|Adverse Event|45|||
163393487|NCT00705432|590152143|FG001|Treatment Period|Adverse Event|37|||
163393488|NCT00705432|590152144|FG002|Treatment Period|Adverse Event|51|||
163393489|NCT00705432|590152145|FG003|Treatment Period|Adverse Event|12|||
163393490|NCT00705432|590152146|FG004|Treatment Period|Adverse Event|8|||
163393491|NCT00705432|590152147|FG005|Treatment Period|Adverse Event|9|||
163393492|NCT00705432|590152142|FG000|Treatment Period|Treatment failure|92|||
163393493|NCT00705432|590152143|FG001|Treatment Period|Treatment failure|42|||
163393494|NCT00705432|590152144|FG002|Treatment Period|Treatment failure|33|||
163393495|NCT00705432|590152145|FG003|Treatment Period|Treatment failure|25|||
163393496|NCT00705432|590152146|FG004|Treatment Period|Treatment failure|13|||
163393497|NCT00705432|590152147|FG005|Treatment Period|Treatment failure|14|||
163393498|NCT00705432|590152142|FG000|Treatment Period|Non medical reason|26|||
163393499|NCT00705432|590152143|FG001|Treatment Period|Non medical reason|32|||
163393500|NCT00705432|590152144|FG002|Treatment Period|Non medical reason|37|||
163393501|NCT00705432|590152145|FG003|Treatment Period|Non medical reason|4|||
163393502|NCT00705432|590152146|FG004|Treatment Period|Non medical reason|7|||
163393503|NCT00705432|590152147|FG005|Treatment Period|Non medical reason|7|||
163393504|NCT00705432|590152142|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
163393505|NCT00705432|590152143|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
162955801|NCT01001208|588539349|FG001|Overall Study|Ineligibility Determined|2|||
163044406|NCT03654729|588871438|FG000|Overall Study|Non-compliance with study drug|0|||
163044407|NCT03654729|588871439|FG001|Overall Study|Non-compliance with study drug|1|||
163044408|NCT03654729|588871440|FG002|Overall Study|Non-compliance with study drug|0|||
163044409|NCT03654729|588871438|FG000|Overall Study|Site terminated by Sponsor|1|||
163044410|NCT03654729|588871439|FG001|Overall Study|Site terminated by Sponsor|0|||
163044411|NCT03654729|588871440|FG002|Overall Study|Site terminated by Sponsor|0|||
163044412|NCT00391872|588871441|FG000|Overall Study|Protocol Violation|7|||
163044413|NCT00391872|588871442|FG001|Overall Study|Protocol Violation|2|||
163044414|NCT00391872|588871441|FG000|Overall Study|Withdrawal by Subject|296|||
163044415|NCT00391872|588871442|FG001|Overall Study|Withdrawal by Subject|249|||
163044416|NCT00391872|588871441|FG000|Overall Study|Reason unknown|2|||
163044417|NCT00391872|588871442|FG001|Overall Study|Reason unknown|4|||
163044418|NCT00391872|588871441|FG000|Overall Study|Lost to Follow-up|2|||
163044419|NCT00391872|588871442|FG001|Overall Study|Lost to Follow-up|0|||
163044420|NCT01239394|588871443|FG000|Overall Study|Adverse Event|1|||
163299641|NCT02409667|589805238|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
163299642|NCT02409667|589805239|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
163299643|NCT02409667|589805235|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
163299644|NCT02409667|589805236|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
163299645|NCT02409667|589805237|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
163299646|NCT02409667|589805238|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
163299647|NCT02409667|589805239|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
163393506|NCT00705432|590152144|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
162955802|NCT01001208|588539348|FG000|Overall Study|Noncompliance|4|||
162955803|NCT01001208|588539349|FG001|Overall Study|Noncompliance|7|||
162955804|NCT01001208|588539348|FG000|Overall Study|Disease Progression|0|||
162955805|NCT01001208|588539349|FG001|Overall Study|Disease Progression|3|||
163044421|NCT00905632|588871445|FG000|Overall Study|Adverse Event|0|||
163044422|NCT00905632|588871446|FG001|Overall Study|Adverse Event|0|||
163044423|NCT00905632|588871447|FG002|Overall Study|Adverse Event|0|||
163044424|NCT00905632|588871448|FG003|Overall Study|Adverse Event|0|||
163044425|NCT00905632|588871449|FG004|Overall Study|Adverse Event|0|||
163393507|NCT00705432|590152145|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
163393508|NCT00705432|590152146|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
163393509|NCT00705432|590152147|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
163044426|NCT00905632|588871450|FG005|Overall Study|Adverse Event|1|||
163044427|NCT00905632|588871451|FG006|Overall Study|Adverse Event|4|||
163044428|NCT03569098|588871452|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
163044429|NCT03569098|588871453|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
163044430|NCT03569098|588871454|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
163044431|NCT03569098|588871452|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
163044432|NCT03569098|588871453|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
163044433|NCT03569098|588871454|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
163044434|NCT03569098|588871452|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
163044435|NCT03569098|588871453|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
163044436|NCT03569098|588871454|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
163044437|NCT03569098|588871452|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
163044438|NCT03569098|588871453|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
163044439|NCT03569098|588871454|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
163044440|NCT03569098|588871452|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
163044441|NCT03569098|588871453|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
163044442|NCT03569098|588871454|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
163044443|NCT03569098|588871452|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
163044444|NCT03569098|588871453|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
163044445|NCT03569098|588871454|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
163044446|NCT03569098|588871452|FG000|Double-Blind Treatment Cycle 1|Other|1|||
163044447|NCT03569098|588871453|FG001|Double-Blind Treatment Cycle 1|Other|0|||
163044448|NCT03569098|588871454|FG002|Double-Blind Treatment Cycle 1|Other|1|||
163044449|NCT03569098|588871452|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
163044450|NCT03569098|588871453|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
163044451|NCT03569098|588871454|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
163044452|NCT03569098|588871452|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
163044453|NCT03569098|588871453|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
163044454|NCT03569098|588871454|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
163044455|NCT03569098|588871452|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
163044456|NCT03569098|588871453|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
163044457|NCT03569098|588871454|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
163194592|NCT02555683|589426819|FG002|Overall Study|Lack of Efficacy|0|||
163194593|NCT02555683|589426817|FG000|Overall Study|Death|0|||
163194594|NCT02555683|589426818|FG001|Overall Study|Death|1|||
163044458|NCT03569098|588871452|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
163044459|NCT03569098|588871453|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
163194595|NCT02555683|589426819|FG002|Overall Study|Death|2|||
163194596|NCT02555683|589426817|FG000|Overall Study|Adverse Event|1|||
162955806|NCT01001208|588539348|FG000|Overall Study|Other|0|||
162955807|NCT01001208|588539349|FG001|Overall Study|Other|2|||
162955808|NCT02648347|588539350|FG000|Overall Study|Death|174|||
162955809|NCT02648347|588539351|FG001|Overall Study|Death|167|||
162955810|NCT02648347|588539350|FG000|Overall Study|Withdrawal by Subject|16|||
162955811|NCT02648347|588539351|FG001|Overall Study|Withdrawal by Subject|9|||
162955812|NCT02648347|588539350|FG000|Overall Study|Lost to Follow-up|18|||
162955813|NCT02648347|588539351|FG001|Overall Study|Lost to Follow-up|21|||
162955814|NCT02648347|588539350|FG000|Overall Study|Missing|1|||
162955815|NCT02648347|588539351|FG001|Overall Study|Missing|0|||
162955816|NCT03546842|588539353|FG000|Overall Study|Protocol Violation|1|||
163194597|NCT02555683|589426818|FG001|Overall Study|Adverse Event|0|||
163194598|NCT02555683|589426819|FG002|Overall Study|Adverse Event|1|||
163194599|NCT02555683|589426817|FG000|Overall Study|Subject/guardian decision|12|||
163194600|NCT02555683|589426818|FG001|Overall Study|Subject/guardian decision|12|||
163194601|NCT02555683|589426819|FG002|Overall Study|Subject/guardian decision|22|||
163194602|NCT02555683|589426817|FG000|Overall Study|Death post Treatment/safety period|0|||
163194603|NCT02555683|589426818|FG001|Overall Study|Death post Treatment/safety period|1|||
162955817|NCT03546842|588539353|FG000|Overall Study|Withdrawal by Subject|2|||
162955818|NCT01723397|588539354|FG000|Study Period 1|Protocol Violation|0|||
162955819|NCT01723397|588539355|FG001|Study Period 1|Protocol Violation|1|||
163044460|NCT03569098|588871454|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
163194604|NCT02555683|589426819|FG002|Overall Study|Death post Treatment/safety period|0|||
163194605|NCT04622306|589426823|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
163299648|NCT02409667|589805235|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
163299649|NCT02409667|589805236|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
163299650|NCT02409667|589805237|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
163299651|NCT02409667|589805238|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
163299652|NCT02409667|589805239|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
163299653|NCT02409667|589805235|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
163299654|NCT02409667|589805236|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
163299655|NCT02409667|589805237|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
163299656|NCT02409667|589805238|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
163299657|NCT02409667|589805239|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
163194606|NCT04622306|589426824|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
163299658|NCT02409667|589805235|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
162955820|NCT01723397|588539354|FG000|Study Period 2|Protocol Violation|0|||
162955821|NCT01723397|588539355|FG001|Study Period 2|Protocol Violation|1|||
162955822|NCT02739997|588539356|FG000|Overall Study|Death|1|||
162955823|NCT02739997|588539356|FG000|Overall Study|Withdrawal by Subject|1|||
162955824|NCT04419311|588539360|FG000|Overall Study|Lost to Follow-up|1|||
162955825|NCT04419311|588539361|FG001|Overall Study|Lost to Follow-up|0|||
162955826|NCT01921062|588539362|FG000|Overall Study|Withdrawal by Subject|0|||
162955827|NCT01921062|588539363|FG001|Overall Study|Withdrawal by Subject|7|||
162955828|NCT01921062|588539362|FG000|Overall Study|Adverse Event|5|||
162955829|NCT01921062|588539363|FG001|Overall Study|Adverse Event|6|||
162955830|NCT01921062|588539362|FG000|Overall Study|Protocol Violation|0|||
162955831|NCT01921062|588539363|FG001|Overall Study|Protocol Violation|1|||
162955832|NCT01921062|588539362|FG000|Overall Study|VMIQ score > 72|4|||
163194607|NCT04622306|589426825|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
163194608|NCT04622306|589426826|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
163194609|NCT04622306|589426827|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
163194610|NCT04622306|589426828|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
163194611|NCT04622306|589426823|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
163194612|NCT04622306|589426824|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
163194613|NCT04622306|589426825|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
163194614|NCT04622306|589426826|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
163194615|NCT04622306|589426827|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
163194616|NCT04622306|589426828|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
163194617|NCT01145625|589426832|FG000|Overall Study|Lost to Follow-up|8|||
163194618|NCT01145625|589426833|FG001|Overall Study|Lost to Follow-up|9|||
163194619|NCT01145625|589426832|FG000|Overall Study|Adverse Event|6|||
163194620|NCT01145625|589426833|FG001|Overall Study|Adverse Event|4|||
163194621|NCT01145625|589426832|FG000|Overall Study|Protocol Violation|3|||
163194622|NCT01145625|589426833|FG001|Overall Study|Protocol Violation|1|||
163194623|NCT01145625|589426832|FG000|Overall Study|Withdrawal by Subject|7|||
163194624|NCT01145625|589426833|FG001|Overall Study|Withdrawal by Subject|16|||
163194625|NCT01145625|589426832|FG000|Overall Study|Pregnancy|0|||
163194626|NCT01145625|589426833|FG001|Overall Study|Pregnancy|1|||
163194627|NCT01896102|589426834|FG000|Overall Study|Death|1|||
163194628|NCT01896102|589426834|FG000|Overall Study|Participant to receive allogenic transplant|2|||
163194629|NCT04289623|589426836|FG000|Wave 1 Emails|Email was not delivered|268|||
163194630|NCT04289623|589426837|FG001|Wave 1 Emails|Email was not delivered|257|||
163194631|NCT04289623|589426838|FG002|Wave 1 Emails|Email was not delivered|0|||
163194632|NCT04289623|589426839|FG003|Wave 1 Emails|Email was not delivered|0|||
163194633|NCT04289623|589426840|FG004|Wave 1 Emails|Email was not delivered|0|||
163194634|NCT04289623|589426841|FG005|Wave 1 Emails|Email was not delivered|0|||
163194635|NCT00696800|589426848|FG000|Overall Study|Adverse Event|16|||
163194636|NCT00696800|589426849|FG001|Overall Study|Adverse Event|3|||
163194637|NCT00696800|589426848|FG000|Overall Study|Insufficient compliance with medication|2|||
163194638|NCT00696800|589426849|FG001|Overall Study|Insufficient compliance with medication|1|||
163194639|NCT00696800|589426848|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
163194640|NCT00696800|589426849|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
163194641|NCT00696800|589426848|FG000|Overall Study|Insufficient ovarian response|4|||
163194642|NCT00696800|589426849|FG001|Overall Study|Insufficient ovarian response|1|||
163194643|NCT00696800|589426848|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
163194644|NCT00696800|589426849|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
163299659|NCT02409667|589805236|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
162955833|NCT01921062|588539363|FG001|Overall Study|VMIQ score > 72|1|||
163194645|NCT00696800|589426848|FG000|Overall Study|Too high ovarian response|6|||
163194646|NCT00696800|589426849|FG001|Overall Study|Too high ovarian response|1|||
163194647|NCT00696800|589426848|FG000|Overall Study|No/too few/bad quality oocytes|4|||
163194648|NCT00696800|589426849|FG001|Overall Study|No/too few/bad quality oocytes|3|||
162955834|NCT01921062|588539362|FG000|Overall Study|Logistic error|0|||
162955835|NCT01921062|588539363|FG001|Overall Study|Logistic error|1|||
162955836|NCT00965185|588539364|FG000|Overall Study|Lost to Follow-up|2|||
162955837|NCT00965185|588539365|FG001|Overall Study|Lost to Follow-up|0|||
162955838|NCT00965185|588539364|FG000|Overall Study|Withdrawal by Subject|0|||
162955839|NCT00965185|588539365|FG001|Overall Study|Withdrawal by Subject|1|||
162955840|NCT03686033|588539366|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
162955841|NCT03686033|588539367|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
162955842|NCT03686033|588539368|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
162955843|NCT03686033|588539369|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
162955844|NCT03686033|588539370|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
162955845|NCT03686033|588539371|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
162955846|NCT01302548|588539373|FG000|Overall Study|Lost to Follow-up|2|||
162955847|NCT01302548|588539374|FG001|Overall Study|Lost to Follow-up|1|||
162955848|NCT02089997|588539385|FG000|Overall Study|Case report forms uncollected|99|||
162955849|NCT02089997|588539385|FG000|Overall Study|Protocol Violation|147|||
162955850|NCT00095212|588539386|FG000|Overall Study|Withdrawal by Subject|1|||
162955851|NCT00095212|588539387|FG001|Overall Study|Withdrawal by Subject|3|||
162955852|NCT02374853|588539390|FG000|Overall Study|Surgery Cancelled|5|||
162955853|NCT02374853|588539391|FG001|Overall Study|Surgery Cancelled|11|||
162955854|NCT03681470|588539393|FG000|Overall Study|Lack of Efficacy|3|||
162955855|NCT03681470|588539393|FG000|Overall Study|Lost to Follow-up|1|||
162955856|NCT03681470|588539393|FG000|Overall Study|Protocol Violation|3|||
162955857|NCT03681470|588539393|FG000|Overall Study|Withdrawal by Subject|1|||
162955858|NCT02335658|588539398|FG000|Overall Study|Adverse Event|18|||
162955859|NCT02335658|588539399|FG001|Overall Study|Adverse Event|12|||
162955860|NCT02335658|588539398|FG000|Overall Study|Lack of Efficacy|4|||
162955861|NCT02335658|588539399|FG001|Overall Study|Lack of Efficacy|5|||
162955862|NCT02335658|588539398|FG000|Overall Study|Pregnancy|1|||
162955863|NCT02335658|588539399|FG001|Overall Study|Pregnancy|0|||
162955864|NCT02335658|588539398|FG000|Overall Study|Withdrawal by Subject|13|||
162955865|NCT02335658|588539399|FG001|Overall Study|Withdrawal by Subject|21|||
162955866|NCT02335658|588539398|FG000|Overall Study|non-compliance|2|||
162955867|NCT02335658|588539399|FG001|Overall Study|non-compliance|3|||
162955868|NCT02335658|588539398|FG000|Overall Study|other reason|2|||
162955869|NCT02335658|588539399|FG001|Overall Study|other reason|3|||
162955870|NCT04149964|588539404|FG000|Overall Study|Lost to Follow-up|19|||
162955871|NCT04149964|588539405|FG001|Overall Study|Lost to Follow-up|18|||
162955872|NCT00837486|588539407|FG000|Blinded-treatment Phase|Physician Decision|1|||
162955873|NCT00837486|588539408|FG001|Blinded-treatment Phase|Physician Decision|0|||
162955874|NCT00837486|588539407|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
162955875|NCT00837486|588539408|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
162955876|NCT00837486|588539407|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
162955877|NCT00837486|588539408|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
162955878|NCT00837486|588539407|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
162955879|NCT00837486|588539408|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
162955880|NCT01577381|588539409|FG000|Overall Study|Discontinued|2|||
162955881|NCT01577381|588539410|FG001|Overall Study|Discontinued|1|||
162955882|NCT01577381|588539411|FG002|Overall Study|Discontinued|2|||
162955883|NCT01577381|588539412|FG003|Overall Study|Discontinued|2|||
162955884|NCT01577381|588539409|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
162955885|NCT01577381|588539410|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
162955886|NCT01577381|588539411|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
163194649|NCT00696800|589426848|FG000|Overall Study|No/abnormal fertilization|11|||
163194650|NCT00696800|589426849|FG001|Overall Study|No/abnormal fertilization|13|||
162955887|NCT01577381|588539412|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
162955888|NCT01754597|588539413|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
162955889|NCT01754597|588539414|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
162955890|NCT03447353|588541305|FG000|Overall Study|Failure at Screening Visit|2|||
162955891|NCT03447353|588541305|FG000|Overall Study|Lost to Follow-up|4|||
162955892|NCT03447353|588541305|FG000|Overall Study|Scheduling Conflicts|3|||
162955893|NCT03447353|588541305|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
162955894|NCT02175095|588541306|FG000|Overall Study|Withdrawal by Subject|3|||
163393510|NCT00705432|590152142|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
163393511|NCT00705432|590152143|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
163393512|NCT00705432|590152144|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
163393513|NCT00705432|590152145|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
163393514|NCT00705432|590152146|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
163393515|NCT00705432|590152147|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
163393516|NCT01102803|590152148|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
163393517|NCT01102803|590152149|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
163393518|NCT01102803|590152148|FG000|Post to Follow-Up|Lost to Follow-up|1|||
163393519|NCT01102803|590152149|FG001|Post to Follow-Up|Lost to Follow-up|3|||
163393520|NCT00521053|590152150|FG000|Observation Phase|Disease Progression|55|||
163393521|NCT00521053|590152150|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
162955895|NCT02635750|588541307|FG000|Part 1, Period 2|Adverse Event|1|||
162955896|NCT02635750|588541308|FG001|Part 1, Period 2|Adverse Event|0|||
163299660|NCT02409667|589805237|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
163299661|NCT02409667|589805238|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
163299662|NCT02409667|589805239|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
163299663|NCT01925339|589805240|FG000|Overall Study|Adverse Event|2|||
162955897|NCT02635750|588541309|FG002|Part 1, Period 2|Adverse Event|0|||
163299664|NCT01925339|589805241|FG001|Overall Study|Adverse Event|0|||
163299665|NCT03025789|589807758|FG000|Overall Study|Lack of Efficacy|6|||
162955898|NCT00462345|588541312|FG000|Overall Study|Withdrawal by Subject|2|||
163299666|NCT03025789|589807759|FG001|Overall Study|Lack of Efficacy|1|||
163299667|NCT03025789|589807758|FG000|Overall Study|Death|1|||
162955899|NCT00462345|588541312|FG000|Overall Study|Did not complete second course|1|||
162955900|NCT02642653|588541314|FG000|Overall Study|Adverse Event|2|||
162955901|NCT02642653|588541315|FG001|Overall Study|Adverse Event|0|||
162955902|NCT02875392|588541319|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
162955903|NCT02875392|588541320|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
162955904|NCT00508651|588541324|FG000|Overall Study|Lost to Follow-up|3|||
163194651|NCT00696800|589426848|FG000|Overall Study|No/too few/bad quality embryos|24|||
163194652|NCT00696800|589426849|FG001|Overall Study|No/too few/bad quality embryos|18|||
163194653|NCT00696800|589426848|FG000|Overall Study|Other Reasons|5|||
163194654|NCT00696800|589426849|FG001|Overall Study|Other Reasons|3|||
163194655|NCT00696800|589426848|FG000|Overall Study|Not treated|1|||
163194656|NCT00696800|589426849|FG001|Overall Study|Not treated|2|||
163194657|NCT00762385|589426851|FG000|First Intervention|Lens Issue|1|||
163194658|NCT00762385|589426852|FG001|First Intervention|Lens Issue|1|||
163194659|NCT00762385|589426851|FG000|First Intervention|Lost to Follow-up|0|||
162955905|NCT00508651|588541325|FG001|Overall Study|Lost to Follow-up|1|||
163044461|NCT03569098|588871452|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
163044462|NCT03569098|588871453|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
163194660|NCT00762385|589426852|FG001|First Intervention|Lost to Follow-up|2|||
163194661|NCT00762385|589426851|FG000|First Intervention|Ineligible|1|||
162955906|NCT00508651|588541324|FG000|Overall Study|Withdrawal by Subject|1|||
162955907|NCT00508651|588541325|FG001|Overall Study|Withdrawal by Subject|1|||
162955908|NCT03874715|588541328|FG000|Overall Study|Adverse Event|2|||
162955909|NCT03874715|588541329|FG001|Overall Study|Adverse Event|0|||
162955910|NCT03874715|588541328|FG000|Overall Study|Poor compliance to protocol|5|||
162955911|NCT03874715|588541329|FG001|Overall Study|Poor compliance to protocol|1|||
162955912|NCT03874715|588541328|FG000|Overall Study|Withdrawal by Subject|1|||
162955913|NCT03874715|588541329|FG001|Overall Study|Withdrawal by Subject|0|||
162955914|NCT03874715|588541328|FG000|Overall Study|Other-unspecified|1|||
162955915|NCT03874715|588541329|FG001|Overall Study|Other-unspecified|0|||
162955916|NCT00461786|588541332|FG000|Overall Study|Entry Criteria Not Met|2|||
162955917|NCT00461786|588541332|FG000|Overall Study|Inevaluable (Never Treated)|1|||
162955918|NCT00934050|588541333|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
162955919|NCT00934050|588541334|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
162955920|NCT00934050|588541335|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
162955921|NCT00934050|588541336|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
162955922|NCT00934050|588541337|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
162955923|NCT00934050|588541338|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
162955924|NCT00934050|588541333|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
162955925|NCT00934050|588541334|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
162955926|NCT00934050|588541335|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
162955927|NCT00934050|588541336|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
163299668|NCT03025789|589807759|FG001|Overall Study|Death|0|||
163299669|NCT03025789|589807758|FG000|Overall Study|Withdrawal by Subject|0|||
162955928|NCT00934050|588541337|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
162955929|NCT00934050|588541338|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
162955930|NCT00934050|588541333|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
162955931|NCT00934050|588541334|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
162955932|NCT00934050|588541335|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
162955933|NCT00934050|588541336|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
162955934|NCT00934050|588541337|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
162955935|NCT00934050|588541338|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
162955936|NCT00934050|588541333|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
163044463|NCT03569098|588871454|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
163044464|NCT03569098|588871452|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
163044465|NCT03569098|588871453|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
163044466|NCT03569098|588871454|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
163044467|NCT02581488|588871459|FG000|Overall Study|Adverse Event|6|||
163044468|NCT02581488|588871460|FG001|Overall Study|Adverse Event|7|||
163044469|NCT02581488|588871459|FG000|Overall Study|Lost to Follow-up|1|||
163044470|NCT02581488|588871460|FG001|Overall Study|Lost to Follow-up|0|||
163044471|NCT02581488|588871459|FG000|Overall Study|Withdrawal by Subject|1|||
163044472|NCT02581488|588871460|FG001|Overall Study|Withdrawal by Subject|0|||
163044473|NCT02581488|588871459|FG000|Overall Study|Non-Compliance|1|||
163044474|NCT02581488|588871460|FG001|Overall Study|Non-Compliance|0|||
163044475|NCT02581488|588871459|FG000|Overall Study|Protocol Violation|0|||
163044476|NCT02581488|588871460|FG001|Overall Study|Protocol Violation|4|||
163044477|NCT04194489|588871461|FG000|Overall Study|Withdrawal by Subject|5|||
163044478|NCT04194489|588871461|FG000|Overall Study|Lost to Follow-up|48|||
163044479|NCT02485483|588871462|FG000|Overall Study|Depression at baseline|15|||
163044480|NCT02485483|588871463|FG001|Overall Study|Depression at baseline|0|||
163044481|NCT02485483|588871462|FG000|Overall Study|Discontinued after baseline|39|||
163044482|NCT02485483|588871463|FG001|Overall Study|Discontinued after baseline|0|||
163044483|NCT00377637|588871464|FG000|Induction Phase|Adverse Event|12|||
163044484|NCT00377637|588871465|FG001|Induction Phase|Adverse Event|21|||
163044485|NCT00377637|588871466|FG002|Induction Phase|Adverse Event|0|||
163044486|NCT00377637|588871467|FG003|Induction Phase|Adverse Event|0|||
163044487|NCT00377637|588871464|FG000|Induction Phase|Deterioration/serum creatinine|2|||
163044488|NCT00377637|588871465|FG001|Induction Phase|Deterioration/serum creatinine|0|||
163044489|NCT00377637|588871466|FG002|Induction Phase|Deterioration/serum creatinine|0|||
163044490|NCT00377637|588871467|FG003|Induction Phase|Deterioration/serum creatinine|0|||
163044491|NCT00377637|588871464|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
163044492|NCT00377637|588871465|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
163044493|NCT00377637|588871466|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
163044494|NCT00377637|588871467|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
163044495|NCT00377637|588871464|FG000|Induction Phase|Lost to Follow-up|2|||
163044496|NCT00377637|588871465|FG001|Induction Phase|Lost to Follow-up|1|||
163044497|NCT00377637|588871466|FG002|Induction Phase|Lost to Follow-up|0|||
163044498|NCT00377637|588871467|FG003|Induction Phase|Lost to Follow-up|0|||
163044499|NCT00377637|588871464|FG000|Induction Phase|Death|1|||
163044500|NCT00377637|588871465|FG001|Induction Phase|Death|3|||
163044501|NCT00377637|588871466|FG002|Induction Phase|Death|0|||
163044502|NCT00377637|588871467|FG003|Induction Phase|Death|0|||
163044503|NCT00377637|588871464|FG000|Induction Phase|Withdrawal by Subject|5|||
163044504|NCT00377637|588871465|FG001|Induction Phase|Withdrawal by Subject|6|||
163044505|NCT00377637|588871466|FG002|Induction Phase|Withdrawal by Subject|0|||
163044506|NCT00377637|588871467|FG003|Induction Phase|Withdrawal by Subject|0|||
163044507|NCT00377637|588871464|FG000|Induction Phase|Physician Decision|3|||
163044508|NCT00377637|588871465|FG001|Induction Phase|Physician Decision|1|||
163044509|NCT00377637|588871466|FG002|Induction Phase|Physician Decision|0|||
163044510|NCT00377637|588871467|FG003|Induction Phase|Physician Decision|0|||
163044511|NCT00377637|588871464|FG000|Induction Phase|Sponsor decision|1|||
163044512|NCT00377637|588871465|FG001|Induction Phase|Sponsor decision|2|||
163044513|NCT00377637|588871466|FG002|Induction Phase|Sponsor decision|0|||
163044514|NCT00377637|588871467|FG003|Induction Phase|Sponsor decision|0|||
163044515|NCT00377637|588871464|FG000|Induction Phase|Non-Compliance|1|||
163044516|NCT00377637|588871465|FG001|Induction Phase|Non-Compliance|0|||
163044517|NCT00377637|588871466|FG002|Induction Phase|Non-Compliance|0|||
163044518|NCT00377637|588871467|FG003|Induction Phase|Non-Compliance|0|||
163044519|NCT00377637|588871464|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
163044520|NCT00377637|588871465|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
163044521|NCT00377637|588871466|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
163044522|NCT00377637|588871467|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
163044523|NCT00377637|588871464|FG000|Maintenance Phase|Adverse Event|0|||
163044524|NCT00377637|588871465|FG001|Maintenance Phase|Adverse Event|0|||
163044525|NCT00377637|588871466|FG002|Maintenance Phase|Adverse Event|29|||
163044526|NCT00377637|588871467|FG003|Maintenance Phase|Adverse Event|43|||
163044527|NCT00377637|588871464|FG000|Maintenance Phase|Physician Decision|0|||
163044528|NCT00377637|588871465|FG001|Maintenance Phase|Physician Decision|0|||
163044529|NCT00377637|588871466|FG002|Maintenance Phase|Physician Decision|5|||
163044530|NCT00377637|588871467|FG003|Maintenance Phase|Physician Decision|4|||
163044531|NCT00377637|588871464|FG000|Maintenance Phase|Lost to Follow-up|0|||
163044532|NCT00377637|588871465|FG001|Maintenance Phase|Lost to Follow-up|0|||
163044533|NCT00377637|588871466|FG002|Maintenance Phase|Lost to Follow-up|3|||
163044534|NCT00377637|588871467|FG003|Maintenance Phase|Lost to Follow-up|1|||
163044535|NCT00377637|588871464|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163044536|NCT00377637|588871465|FG001|Maintenance Phase|Withdrawal by Subject|0|||
163044537|NCT00377637|588871466|FG002|Maintenance Phase|Withdrawal by Subject|3|||
163044538|NCT00377637|588871467|FG003|Maintenance Phase|Withdrawal by Subject|3|||
162955937|NCT00934050|588541334|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
162955938|NCT00934050|588541335|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
162955939|NCT00934050|588541336|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
162955940|NCT00934050|588541337|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
162955941|NCT00934050|588541338|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
162955942|NCT00934050|588541333|FG000|Enrolled After 15 Dec 2009|Death|0|||
162955943|NCT00934050|588541334|FG001|Enrolled After 15 Dec 2009|Death|0|||
162955944|NCT00934050|588541335|FG002|Enrolled After 15 Dec 2009|Death|0|||
162955945|NCT00934050|588541336|FG003|Enrolled After 15 Dec 2009|Death|0|||
162955946|NCT00934050|588541337|FG004|Enrolled After 15 Dec 2009|Death|0|||
162955947|NCT00934050|588541338|FG005|Enrolled After 15 Dec 2009|Death|1|||
162955948|NCT00934050|588541333|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
162955949|NCT00934050|588541334|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
162955950|NCT00934050|588541335|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
162955951|NCT00934050|588541336|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
162955952|NCT00934050|588541337|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
162955953|NCT00934050|588541338|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
162955954|NCT00934050|588541333|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
162955955|NCT00934050|588541334|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
162955956|NCT00934050|588541335|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
162955957|NCT00934050|588541336|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
162955958|NCT00934050|588541337|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
162955959|NCT00934050|588541338|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
162955960|NCT03616535|588541342|FG000|Overall Study|Death|2|||
162955961|NCT03616535|588541343|FG001|Overall Study|Death|0|||
162955962|NCT03616535|588541344|FG002|Overall Study|Death|0|||
162955963|NCT03616535|588541345|FG003|Overall Study|Death|1|||
162955964|NCT03616535|588541342|FG000|Overall Study|Lost to Follow-up|2|||
162955965|NCT03616535|588541343|FG001|Overall Study|Lost to Follow-up|1|||
162955966|NCT03616535|588541344|FG002|Overall Study|Lost to Follow-up|0|||
162955967|NCT03616535|588541345|FG003|Overall Study|Lost to Follow-up|2|||
162955968|NCT03616535|588541342|FG000|Overall Study|Withdrawal by Subject|1|||
162955969|NCT03616535|588541343|FG001|Overall Study|Withdrawal by Subject|2|||
162955970|NCT03616535|588541344|FG002|Overall Study|Withdrawal by Subject|5|||
162955971|NCT03616535|588541345|FG003|Overall Study|Withdrawal by Subject|1|||
162955972|NCT03616535|588541342|FG000|Overall Study|Not specified or change in eligibility|2|||
162955973|NCT03616535|588541343|FG001|Overall Study|Not specified or change in eligibility|3|||
162955974|NCT03616535|588541344|FG002|Overall Study|Not specified or change in eligibility|3|||
162955975|NCT03616535|588541345|FG003|Overall Study|Not specified or change in eligibility|1|||
163194662|NCT00762385|589426852|FG001|First Intervention|Ineligible|0|||
163194663|NCT00762385|589426851|FG000|First Intervention|Protocol Violation|0|||
163194664|NCT00762385|589426852|FG001|First Intervention|Protocol Violation|1|||
163194665|NCT00762385|589426851|FG000|Second Intervention|Protocol Violation|3|||
163194666|NCT00762385|589426852|FG001|Second Intervention|Protocol Violation|3|||
163194667|NCT00591344|589426855|FG000|Overall Study|Transportation issues|1|||
163194668|NCT00591344|589426856|FG001|Overall Study|Transportation issues|0|||
163194669|NCT00591344|589426855|FG000|Overall Study|Moved out of state|1|||
163194670|NCT00591344|589426856|FG001|Overall Study|Moved out of state|0|||
163194671|NCT00591344|589426855|FG000|Overall Study|Medical complications|1|||
163194672|NCT00591344|589426856|FG001|Overall Study|Medical complications|3|||
163194673|NCT00591344|589426855|FG000|Overall Study|Underwent DBS|2|||
163194674|NCT00591344|589426856|FG001|Overall Study|Underwent DBS|2|||
163194675|NCT00591344|589426855|FG000|Overall Study|Death|0|||
163194676|NCT00591344|589426856|FG001|Overall Study|Death|1|||
163194677|NCT00591344|589426855|FG000|Overall Study|Lost to Follow-up|0|||
163194678|NCT00591344|589426856|FG001|Overall Study|Lost to Follow-up|1|||
163194679|NCT00591344|589426855|FG000|Overall Study|Did not want to come off medication|0|||
163194680|NCT00591344|589426856|FG001|Overall Study|Did not want to come off medication|1|||
163194681|NCT00493025|589426857|FG000|Overall Study|Physician Decision|19|||
163194682|NCT02939079|589426864|FG000|Overall Study|Adverse Event|2|||
163393522|NCT00521053|590152150|FG000|Observation Phase|Death|2|||
163194683|NCT02939079|589426865|FG001|Overall Study|Adverse Event|1|||
163194684|NCT02939079|589426864|FG000|Overall Study|Lost to Follow-up|0|||
163194685|NCT02939079|589426865|FG001|Overall Study|Lost to Follow-up|2|||
163299670|NCT03025789|589807759|FG001|Overall Study|Withdrawal by Subject|2|||
163299671|NCT03554265|589807760|FG000|Overall Study|Withdrawal by Subject|2|||
163299672|NCT03554265|589807761|FG001|Overall Study|Withdrawal by Subject|2|||
163299673|NCT03554265|589807762|FG002|Overall Study|Withdrawal by Subject|3|||
163299674|NCT03554265|589807760|FG000|Overall Study|Physician Decision|0|||
163299675|NCT03554265|589807761|FG001|Overall Study|Physician Decision|0|||
163299676|NCT03554265|589807762|FG002|Overall Study|Physician Decision|1|||
163299677|NCT02723955|589807763|FG000|Escalation Phase|Death|1|||
163299678|NCT02723955|589807764|FG001|Escalation Phase|Death|1|||
163299679|NCT02723955|589807765|FG002|Escalation Phase|Death|2|||
163299680|NCT02723955|589807766|FG003|Escalation Phase|Death|7|||
163299681|NCT02723955|589807767|FG004|Escalation Phase|Death|18|||
163299682|NCT02723955|589807768|FG005|Escalation Phase|Death|17|||
163299683|NCT02723955|589807769|FG006|Escalation Phase|Death|11|||
163299684|NCT02723955|589807770|FG007|Escalation Phase|Death|21|||
163299685|NCT02723955|589807771|FG008|Escalation Phase|Death|3|||
163299686|NCT02723955|589807772|FG009|Escalation Phase|Death|0|||
163299687|NCT02723955|589807773|FG010|Escalation Phase|Death|0|||
163299688|NCT02723955|589807774|FG011|Escalation Phase|Death|0|||
163299689|NCT02723955|589807775|FG012|Escalation Phase|Death|2|||
163299690|NCT02723955|589807776|FG013|Escalation Phase|Death|4|||
163393523|NCT00521053|590152150|FG000|Observation Phase|Adverse Event|1|||
163299691|NCT02723955|589807777|FG014|Escalation Phase|Death|5|||
163299692|NCT02723955|589807778|FG015|Escalation Phase|Death|6|||
163299693|NCT02723955|589807779|FG016|Escalation Phase|Death|6|||
162955976|NCT00834418|588541348|FG000|Overall Study|Adverse Event|0|||
162955977|NCT00834418|588541349|FG001|Overall Study|Adverse Event|2|||
162955978|NCT01705574|588541350|FG000|Double-Blind Phase|Lost to Follow-up|12|||
162955979|NCT01705574|588541351|FG001|Double-Blind Phase|Lost to Follow-up|16|||
162955980|NCT01705574|588541352|FG002|Double-Blind Phase|Lost to Follow-up|0|||
162955981|NCT01705574|588541353|FG003|Double-Blind Phase|Lost to Follow-up|0|||
162955982|NCT01705574|588541350|FG000|Double-Blind Phase|Adverse Event|3|||
162955983|NCT01705574|588541351|FG001|Double-Blind Phase|Adverse Event|10|||
162955984|NCT01705574|588541352|FG002|Double-Blind Phase|Adverse Event|0|||
162955985|NCT01705574|588541353|FG003|Double-Blind Phase|Adverse Event|0|||
162955986|NCT01705574|588541350|FG000|Double-Blind Phase|Withdrew Consent|8|||
163194686|NCT02939079|589426864|FG000|Overall Study|Protocol Violation|1|||
162955987|NCT01705574|588541351|FG001|Double-Blind Phase|Withdrew Consent|5|||
163299694|NCT02723955|589807780|FG017|Escalation Phase|Death|7|||
163299695|NCT02723955|589807781|FG018|Escalation Phase|Death|1|||
163299696|NCT02723955|589807782|FG019|Escalation Phase|Death|3|||
163299697|NCT02723955|589807783|FG020|Escalation Phase|Death|13|||
163299698|NCT02723955|589807784|FG021|Escalation Phase|Death|3|||
163299699|NCT02723955|589807785|FG022|Escalation Phase|Death|2|||
163299700|NCT02723955|589807786|FG023|Escalation Phase|Death|4|||
163299701|NCT02723955|589807787|FG024|Escalation Phase|Death|31|||
163299702|NCT02723955|589807788|FG025|Escalation Phase|Death|7|||
163299703|NCT02723955|589807789|FG026|Escalation Phase|Death|13|||
163299704|NCT02723955|589807790|FG027|Escalation Phase|Death|0|||
163299705|NCT02723955|589807791|FG028|Escalation Phase|Death|1|||
163299706|NCT02723955|589807792|FG029|Escalation Phase|Death|0|||
163299707|NCT02723955|589807793|FG030|Escalation Phase|Death|0|||
163299708|NCT02723955|589807794|FG031|Escalation Phase|Death|0|||
163299709|NCT02723955|589807795|FG032|Escalation Phase|Death|0|||
163299710|NCT02723955|589807796|FG033|Escalation Phase|Death|0|||
163299711|NCT02723955|589807797|FG034|Escalation Phase|Death|0|||
163299712|NCT02723955|589807798|FG035|Escalation Phase|Death|0|||
163299713|NCT02723955|589807799|FG036|Escalation Phase|Death|0|||
163299714|NCT02723955|589807800|FG037|Escalation Phase|Death|0|||
163299715|NCT02723955|589807801|FG038|Escalation Phase|Death|0|||
163299716|NCT02723955|589807802|FG039|Escalation Phase|Death|0|||
163299717|NCT02723955|589807803|FG040|Escalation Phase|Death|0|||
163299718|NCT02723955|589807804|FG041|Escalation Phase|Death|0|||
163299719|NCT02723955|589807805|FG042|Escalation Phase|Death|0|||
163299720|NCT02723955|589807763|FG000|Escalation Phase|Lost to Follow-up|0|||
163299721|NCT02723955|589807764|FG001|Escalation Phase|Lost to Follow-up|0|||
163299722|NCT02723955|589807765|FG002|Escalation Phase|Lost to Follow-up|0|||
163299723|NCT02723955|589807766|FG003|Escalation Phase|Lost to Follow-up|0|||
163299724|NCT02723955|589807767|FG004|Escalation Phase|Lost to Follow-up|0|||
163299725|NCT02723955|589807768|FG005|Escalation Phase|Lost to Follow-up|2|||
163299726|NCT02723955|589807769|FG006|Escalation Phase|Lost to Follow-up|1|||
163299727|NCT02723955|589807770|FG007|Escalation Phase|Lost to Follow-up|1|||
163299728|NCT02723955|589807771|FG008|Escalation Phase|Lost to Follow-up|1|||
163299729|NCT02723955|589807772|FG009|Escalation Phase|Lost to Follow-up|0|||
163299730|NCT02723955|589807773|FG010|Escalation Phase|Lost to Follow-up|0|||
163299731|NCT02723955|589807774|FG011|Escalation Phase|Lost to Follow-up|0|||
163299732|NCT02723955|589807775|FG012|Escalation Phase|Lost to Follow-up|1|||
163299733|NCT02723955|589807776|FG013|Escalation Phase|Lost to Follow-up|0|||
163299734|NCT02723955|589807777|FG014|Escalation Phase|Lost to Follow-up|0|||
163299735|NCT02723955|589807778|FG015|Escalation Phase|Lost to Follow-up|0|||
163299736|NCT02723955|589807779|FG016|Escalation Phase|Lost to Follow-up|1|||
163299737|NCT02723955|589807780|FG017|Escalation Phase|Lost to Follow-up|2|||
163299738|NCT02723955|589807781|FG018|Escalation Phase|Lost to Follow-up|0|||
163299739|NCT02723955|589807782|FG019|Escalation Phase|Lost to Follow-up|1|||
163299740|NCT02723955|589807783|FG020|Escalation Phase|Lost to Follow-up|2|||
162955988|NCT01705574|588541352|FG002|Double-Blind Phase|Withdrew Consent|0|||
162955989|NCT01705574|588541353|FG003|Double-Blind Phase|Withdrew Consent|0|||
162955990|NCT01705574|588541350|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
162955991|NCT01705574|588541351|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
162955992|NCT01705574|588541352|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
163299741|NCT02723955|589807784|FG021|Escalation Phase|Lost to Follow-up|1|||
163299742|NCT02723955|589807785|FG022|Escalation Phase|Lost to Follow-up|0|||
163299743|NCT02723955|589807786|FG023|Escalation Phase|Lost to Follow-up|0|||
163299744|NCT02723955|589807787|FG024|Escalation Phase|Lost to Follow-up|1|||
163299745|NCT02723955|589807788|FG025|Escalation Phase|Lost to Follow-up|1|||
162955993|NCT01705574|588541353|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
162955994|NCT01705574|588541350|FG000|Double-Blind Phase|Pregnancy|1|||
162955995|NCT01705574|588541351|FG001|Double-Blind Phase|Pregnancy|1|||
162955996|NCT01705574|588541352|FG002|Double-Blind Phase|Pregnancy|0|||
162955997|NCT01705574|588541353|FG003|Double-Blind Phase|Pregnancy|0|||
162955998|NCT01705574|588541350|FG000|Double-Blind Phase|Protocol Violation|1|||
162955999|NCT01705574|588541351|FG001|Double-Blind Phase|Protocol Violation|0|||
162956000|NCT01705574|588541352|FG002|Double-Blind Phase|Protocol Violation|0|||
162956001|NCT01705574|588541353|FG003|Double-Blind Phase|Protocol Violation|0|||
163299746|NCT02723955|589807789|FG026|Escalation Phase|Lost to Follow-up|3|||
163299747|NCT02723955|589807790|FG027|Escalation Phase|Lost to Follow-up|0|||
163299748|NCT02723955|589807791|FG028|Escalation Phase|Lost to Follow-up|1|||
163299749|NCT02723955|589807792|FG029|Escalation Phase|Lost to Follow-up|0|||
163299750|NCT02723955|589807793|FG030|Escalation Phase|Lost to Follow-up|0|||
163299751|NCT02723955|589807794|FG031|Escalation Phase|Lost to Follow-up|0|||
163299752|NCT02723955|589807795|FG032|Escalation Phase|Lost to Follow-up|0|||
163299753|NCT02723955|589807796|FG033|Escalation Phase|Lost to Follow-up|0|||
163299754|NCT02723955|589807797|FG034|Escalation Phase|Lost to Follow-up|0|||
163299755|NCT02723955|589807798|FG035|Escalation Phase|Lost to Follow-up|0|||
163299756|NCT02723955|589807799|FG036|Escalation Phase|Lost to Follow-up|0|||
163299757|NCT02723955|589807800|FG037|Escalation Phase|Lost to Follow-up|0|||
163299758|NCT02723955|589807801|FG038|Escalation Phase|Lost to Follow-up|0|||
162956002|NCT01705574|588541350|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
162956003|NCT01705574|588541351|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
162956004|NCT01705574|588541352|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
162956005|NCT01705574|588541353|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
162956006|NCT01705574|588541350|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
162956007|NCT01705574|588541351|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
162956008|NCT01705574|588541352|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
162956009|NCT01705574|588541353|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
162956010|NCT01705574|588541350|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
162956011|NCT01705574|588541351|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
162956012|NCT01705574|588541352|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
162956013|NCT01705574|588541353|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
162956014|NCT01705574|588541350|FG000|Open-Label Extension Phase|Adverse Event|3|||
162956015|NCT01705574|588541351|FG001|Open-Label Extension Phase|Adverse Event|0|||
162956016|NCT01705574|588541352|FG002|Open-Label Extension Phase|Adverse Event|0|||
162956017|NCT01705574|588541353|FG003|Open-Label Extension Phase|Adverse Event|1|||
162956018|NCT01705574|588541350|FG000|Open-Label Extension Phase|Death|2|||
162956019|NCT01705574|588541351|FG001|Open-Label Extension Phase|Death|0|||
162956020|NCT01705574|588541352|FG002|Open-Label Extension Phase|Death|1|||
162956021|NCT01705574|588541353|FG003|Open-Label Extension Phase|Death|0|||
162956022|NCT01705574|588541350|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
162956023|NCT01705574|588541351|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
162956024|NCT01705574|588541352|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
162956025|NCT01705574|588541353|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
162956026|NCT01705574|588541350|FG000|Open-Label Extension Phase|Physician Decision|0|||
163299759|NCT02723955|589807802|FG039|Escalation Phase|Lost to Follow-up|0|||
162956027|NCT01705574|588541351|FG001|Open-Label Extension Phase|Physician Decision|0|||
163299760|NCT02723955|589807803|FG040|Escalation Phase|Lost to Follow-up|0|||
163299761|NCT02723955|589807804|FG041|Escalation Phase|Lost to Follow-up|0|||
163299762|NCT02723955|589807805|FG042|Escalation Phase|Lost to Follow-up|0|||
163299763|NCT02723955|589807763|FG000|Escalation Phase|Physician Decision|0|||
163299764|NCT02723955|589807764|FG001|Escalation Phase|Physician Decision|0|||
163299765|NCT02723955|589807765|FG002|Escalation Phase|Physician Decision|0|||
163299766|NCT02723955|589807766|FG003|Escalation Phase|Physician Decision|0|||
163299767|NCT02723955|589807767|FG004|Escalation Phase|Physician Decision|0|||
163299768|NCT02723955|589807768|FG005|Escalation Phase|Physician Decision|2|||
163299769|NCT02723955|589807769|FG006|Escalation Phase|Physician Decision|0|||
163299770|NCT02723955|589807770|FG007|Escalation Phase|Physician Decision|0|||
163299771|NCT02723955|589807771|FG008|Escalation Phase|Physician Decision|0|||
163299772|NCT02723955|589807772|FG009|Escalation Phase|Physician Decision|0|||
163299773|NCT02723955|589807773|FG010|Escalation Phase|Physician Decision|0|||
163299774|NCT02723955|589807774|FG011|Escalation Phase|Physician Decision|0|||
163299775|NCT02723955|589807775|FG012|Escalation Phase|Physician Decision|0|||
163299776|NCT02723955|589807776|FG013|Escalation Phase|Physician Decision|0|||
163299777|NCT02723955|589807777|FG014|Escalation Phase|Physician Decision|0|||
163299778|NCT02723955|589807778|FG015|Escalation Phase|Physician Decision|0|||
163299779|NCT02723955|589807779|FG016|Escalation Phase|Physician Decision|0|||
163299780|NCT02723955|589807780|FG017|Escalation Phase|Physician Decision|0|||
163299781|NCT02723955|589807781|FG018|Escalation Phase|Physician Decision|0|||
163299782|NCT02723955|589807782|FG019|Escalation Phase|Physician Decision|0|||
163299783|NCT02723955|589807783|FG020|Escalation Phase|Physician Decision|0|||
163299784|NCT02723955|589807784|FG021|Escalation Phase|Physician Decision|0|||
163299785|NCT02723955|589807785|FG022|Escalation Phase|Physician Decision|0|||
163299786|NCT02723955|589807786|FG023|Escalation Phase|Physician Decision|0|||
163299787|NCT02723955|589807787|FG024|Escalation Phase|Physician Decision|0|||
163299788|NCT02723955|589807788|FG025|Escalation Phase|Physician Decision|0|||
163299789|NCT02723955|589807789|FG026|Escalation Phase|Physician Decision|2|||
163299790|NCT02723955|589807790|FG027|Escalation Phase|Physician Decision|0|||
163299791|NCT02723955|589807791|FG028|Escalation Phase|Physician Decision|0|||
163299792|NCT02723955|589807792|FG029|Escalation Phase|Physician Decision|0|||
163299793|NCT02723955|589807793|FG030|Escalation Phase|Physician Decision|0|||
163299794|NCT02723955|589807794|FG031|Escalation Phase|Physician Decision|0|||
163299795|NCT02723955|589807795|FG032|Escalation Phase|Physician Decision|0|||
163299796|NCT02723955|589807796|FG033|Escalation Phase|Physician Decision|0|||
162956028|NCT01705574|588541352|FG002|Open-Label Extension Phase|Physician Decision|2|||
162956029|NCT01705574|588541353|FG003|Open-Label Extension Phase|Physician Decision|0|||
162956030|NCT01705574|588541350|FG000|Open-Label Extension Phase|Pregnancy|0|||
163299797|NCT02723955|589807797|FG034|Escalation Phase|Physician Decision|0|||
163299798|NCT02723955|589807798|FG035|Escalation Phase|Physician Decision|0|||
163299799|NCT02723955|589807799|FG036|Escalation Phase|Physician Decision|0|||
163299800|NCT02723955|589807800|FG037|Escalation Phase|Physician Decision|0|||
163299801|NCT02723955|589807801|FG038|Escalation Phase|Physician Decision|0|||
163299802|NCT02723955|589807802|FG039|Escalation Phase|Physician Decision|0|||
163299803|NCT02723955|589807803|FG040|Escalation Phase|Physician Decision|0|||
163194687|NCT02939079|589426865|FG001|Overall Study|Protocol Violation|0|||
163194688|NCT02939079|589426864|FG000|Overall Study|Withdrawal by Subject|0|||
163194689|NCT02939079|589426865|FG001|Overall Study|Withdrawal by Subject|1|||
163194690|NCT02939079|589426864|FG000|Overall Study|relapse during the study|1|||
163194691|NCT02939079|589426865|FG001|Overall Study|relapse during the study|1|||
163194692|NCT01609231|589426866|FG000|Overall Study|Adverse Event|1|||
163194693|NCT01609231|589426867|FG001|Overall Study|Adverse Event|3|||
163194694|NCT01609231|589426866|FG000|Overall Study|Physician Decision|1|||
163194695|NCT01609231|589426867|FG001|Overall Study|Physician Decision|0|||
163194696|NCT01609231|589426866|FG000|Overall Study|Withdrawal by Subject|1|||
163194697|NCT01609231|589426867|FG001|Overall Study|Withdrawal by Subject|0|||
163194698|NCT00973674|589426868|FG000|Overall Study|Protocol Violation|2|||
163194699|NCT00973674|589426869|FG001|Overall Study|Protocol Violation|0|||
163194700|NCT00494299|589426876|FG000|Overall Study|Adverse Event|93|||
163194701|NCT00494299|589426877|FG001|Overall Study|Adverse Event|13|||
163194702|NCT00494299|589426876|FG000|Overall Study|Lost to Follow-up|1|||
163194703|NCT00494299|589426877|FG001|Overall Study|Lost to Follow-up|0|||
163194704|NCT00494299|589426876|FG000|Overall Study|Physician Decision|0|||
163194705|NCT00494299|589426877|FG001|Overall Study|Physician Decision|2|||
163194706|NCT00494299|589426876|FG000|Overall Study|Protocol Violation|1|||
163194707|NCT00494299|589426877|FG001|Overall Study|Protocol Violation|2|||
163194708|NCT00494299|589426876|FG000|Overall Study|Withdrawal by Subject|8|||
163194709|NCT00494299|589426877|FG001|Overall Study|Withdrawal by Subject|3|||
163194710|NCT00494299|589426876|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
163194711|NCT00494299|589426877|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
163194712|NCT00494299|589426876|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
163194713|NCT00494299|589426877|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
163299804|NCT02723955|589807804|FG041|Escalation Phase|Physician Decision|0|||
163299805|NCT02723955|589807805|FG042|Escalation Phase|Physician Decision|0|||
163299806|NCT02723955|589807763|FG000|Escalation Phase|Withdrawal by Subject|0|||
163299807|NCT02723955|589807764|FG001|Escalation Phase|Withdrawal by Subject|0|||
163299808|NCT02723955|589807765|FG002|Escalation Phase|Withdrawal by Subject|0|||
163393524|NCT00521053|590152150|FG000|Observation Phase|Other non-study melanoma treatment|1|||
163393525|NCT00521053|590152150|FG000|Observation Phase|Physician Decision|1|||
163393526|NCT01667107|590152151|FG000|Overall Study|Adverse Event|4|||
163393527|NCT01667107|590152152|FG001|Overall Study|Adverse Event|3|||
163393528|NCT01667107|590152151|FG000|Overall Study|Tolerability issues|0|||
163393529|NCT01667107|590152152|FG001|Overall Study|Tolerability issues|2|||
163393530|NCT01667107|590152151|FG000|Overall Study|Protocol Violation|0|||
163393531|NCT01667107|590152152|FG001|Overall Study|Protocol Violation|1|||
163393532|NCT01667107|590152151|FG000|Overall Study|Lack of Efficacy|0|||
163393533|NCT01667107|590152152|FG001|Overall Study|Lack of Efficacy|1|||
163393534|NCT01557348|590152153|FG000|Overall Study|Adverse Event|6|||
163299809|NCT02723955|589807766|FG003|Escalation Phase|Withdrawal by Subject|0|||
163299810|NCT02723955|589807767|FG004|Escalation Phase|Withdrawal by Subject|1|||
163299811|NCT02723955|589807768|FG005|Escalation Phase|Withdrawal by Subject|1|||
163299812|NCT02723955|589807769|FG006|Escalation Phase|Withdrawal by Subject|1|||
163393535|NCT01557348|590152154|FG001|Overall Study|Adverse Event|16|||
163299813|NCT02723955|589807770|FG007|Escalation Phase|Withdrawal by Subject|1|||
163393536|NCT01557348|590152153|FG000|Overall Study|Infusion reaction event|5|||
163393537|NCT01557348|590152154|FG001|Overall Study|Infusion reaction event|5|||
163393538|NCT01557348|590152153|FG000|Overall Study|Death|7|||
163393539|NCT01557348|590152154|FG001|Overall Study|Death|4|||
163393540|NCT01557348|590152153|FG000|Overall Study|Insufficient Therapeutic Response|13|||
163393541|NCT01557348|590152154|FG001|Overall Study|Insufficient Therapeutic Response|28|||
163393542|NCT01557348|590152153|FG000|Overall Study|Withdrawal by Subject|5|||
163393543|NCT01557348|590152154|FG001|Overall Study|Withdrawal by Subject|4|||
163393544|NCT01557348|590152153|FG000|Overall Study|Lost to Follow-up|26|||
163393545|NCT01557348|590152154|FG001|Overall Study|Lost to Follow-up|22|||
163393546|NCT01557348|590152153|FG000|Overall Study|Administrative|18|||
163393547|NCT01557348|590152154|FG001|Overall Study|Administrative|11|||
163393548|NCT03427125|590152155|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
163393549|NCT03427125|590152156|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
163393550|NCT03427125|590152157|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
163393551|NCT02281357|590152158|FG000|Overall Study|Adverse Event|2|||
163393552|NCT02281357|590152159|FG001|Overall Study|Adverse Event|1|||
163393553|NCT02281357|590152158|FG000|Overall Study|Lost to Follow-up|1|||
163393554|NCT02281357|590152159|FG001|Overall Study|Lost to Follow-up|0|||
163393555|NCT02281357|590152158|FG000|Overall Study|Withdrawal by Subject|4|||
163393556|NCT02281357|590152159|FG001|Overall Study|Withdrawal by Subject|3|||
163393557|NCT01162239|590152160|FG000|Treatment Phase|Withdrawal by Subject|1|||
163393558|NCT01162239|590152161|FG001|Treatment Phase|Withdrawal by Subject|3|||
163393559|NCT01162239|590152162|FG002|Treatment Phase|Withdrawal by Subject|2|||
163393560|NCT01162239|590152163|FG003|Treatment Phase|Withdrawal by Subject|3|||
163393561|NCT01162239|590152160|FG000|Treatment Phase|Death|0|||
163393562|NCT01162239|590152161|FG001|Treatment Phase|Death|0|||
163393563|NCT01162239|590152162|FG002|Treatment Phase|Death|0|||
163393564|NCT01162239|590152163|FG003|Treatment Phase|Death|1|||
163393565|NCT01162239|590152160|FG000|Treatment Phase|Lost to Follow-up|5|||
163393566|NCT01162239|590152161|FG001|Treatment Phase|Lost to Follow-up|4|||
163393567|NCT01162239|590152162|FG002|Treatment Phase|Lost to Follow-up|2|||
163393568|NCT01162239|590152163|FG003|Treatment Phase|Lost to Follow-up|1|||
163393569|NCT01162239|590152160|FG000|Extended Follow-up|Lost to Follow-up|8|||
163393570|NCT01162239|590152161|FG001|Extended Follow-up|Lost to Follow-up|13|||
163393571|NCT01162239|590152162|FG002|Extended Follow-up|Lost to Follow-up|8|||
163393572|NCT01162239|590152163|FG003|Extended Follow-up|Lost to Follow-up|6|||
163393573|NCT05390580|590152166|FG000|Overall Study|Physician Decision|3|||
163393574|NCT05390580|590152167|FG001|Overall Study|Physician Decision|2|||
163393575|NCT02499770|590152169|FG000|Overall Study|Death|17|||
163393576|NCT02499770|590152170|FG001|Overall Study|Death|56|||
163393577|NCT02499770|590152169|FG000|Overall Study|Study completion|1|||
163393578|NCT02499770|590152170|FG001|Overall Study|Study completion|10|||
163393579|NCT02499770|590152169|FG000|Overall Study|Withdrawal by Subject|0|||
163393580|NCT02499770|590152170|FG001|Overall Study|Withdrawal by Subject|7|||
163393581|NCT02499770|590152169|FG000|Overall Study|Lost to Follow-up|0|||
163393582|NCT02499770|590152170|FG001|Overall Study|Lost to Follow-up|2|||
163393583|NCT02499770|590152169|FG000|Overall Study|Subject declined further treatment|1|||
163393584|NCT02499770|590152170|FG001|Overall Study|Subject declined further treatment|0|||
163299814|NCT02723955|589807771|FG008|Escalation Phase|Withdrawal by Subject|0|||
163299815|NCT02723955|589807772|FG009|Escalation Phase|Withdrawal by Subject|0|||
163393585|NCT02499770|590152169|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
163393586|NCT02499770|590152170|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
163393587|NCT02499770|590152169|FG000|Overall Study|Randomized but not enrolled|0|||
163393588|NCT02499770|590152170|FG001|Overall Study|Randomized but not enrolled|1|||
163299816|NCT02723955|589807773|FG010|Escalation Phase|Withdrawal by Subject|0|||
163299817|NCT02723955|589807774|FG011|Escalation Phase|Withdrawal by Subject|0|||
163299818|NCT02723955|589807775|FG012|Escalation Phase|Withdrawal by Subject|1|||
163299819|NCT02723955|589807776|FG013|Escalation Phase|Withdrawal by Subject|0|||
163299820|NCT02723955|589807777|FG014|Escalation Phase|Withdrawal by Subject|0|||
163044539|NCT00377637|588871464|FG000|Maintenance Phase|Sponsor decision|0|||
163044540|NCT00377637|588871465|FG001|Maintenance Phase|Sponsor decision|0|||
163044541|NCT00377637|588871466|FG002|Maintenance Phase|Sponsor decision|2|||
163044542|NCT00377637|588871467|FG003|Maintenance Phase|Sponsor decision|3|||
163044543|NCT00377637|588871464|FG000|Maintenance Phase|Non-compliance|0|||
163044544|NCT00377637|588871465|FG001|Maintenance Phase|Non-compliance|0|||
163044545|NCT00377637|588871466|FG002|Maintenance Phase|Non-compliance|1|||
163044546|NCT00377637|588871467|FG003|Maintenance Phase|Non-compliance|1|||
163044547|NCT00377637|588871464|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
163044548|NCT00377637|588871465|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
163044549|NCT00377637|588871466|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
163044550|NCT00377637|588871467|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
163044551|NCT00377637|588871464|FG000|Maintenance Phase|Death|0|||
163044552|NCT00377637|588871465|FG001|Maintenance Phase|Death|0|||
163044553|NCT00377637|588871466|FG002|Maintenance Phase|Death|0|||
163044554|NCT00377637|588871467|FG003|Maintenance Phase|Death|1|||
163044555|NCT00522548|588871468|FG000|Overall Study|Adverse Event|2|||
163044556|NCT00522548|588871469|FG001|Overall Study|Adverse Event|2|||
163044557|NCT00522548|588871468|FG000|Overall Study|Withdrawal by Subject|0|||
163044558|NCT00522548|588871469|FG001|Overall Study|Withdrawal by Subject|2|||
163299821|NCT02723955|589807778|FG015|Escalation Phase|Withdrawal by Subject|0|||
163299822|NCT02723955|589807779|FG016|Escalation Phase|Withdrawal by Subject|1|||
163299823|NCT02723955|589807780|FG017|Escalation Phase|Withdrawal by Subject|0|||
163044559|NCT05225558|588871476|FG000|Overall Study|Withdrawal by Subject|4|||
163044560|NCT05225558|588871477|FG001|Overall Study|Withdrawal by Subject|3|||
163044561|NCT05225558|588871476|FG000|Overall Study|Adverse Event|1|||
163044562|NCT05225558|588871477|FG001|Overall Study|Adverse Event|0|||
163044563|NCT05225558|588871476|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
163044564|NCT05225558|588871477|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
163044565|NCT05225558|588871476|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
163044566|NCT05225558|588871477|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
163044567|NCT00313846|588871478|FG000|Overall Study|Withdrawal by Subject|2|||
163044568|NCT00313846|588871479|FG001|Overall Study|Withdrawal by Subject|0|||
163044569|NCT00313846|588871478|FG000|Overall Study|Adverse Event|1|||
163044570|NCT00313846|588871479|FG001|Overall Study|Adverse Event|8|||
163044571|NCT00313846|588871478|FG000|Overall Study|Administrative|2|||
163044572|NCT00313846|588871479|FG001|Overall Study|Administrative|3|||
163044573|NCT01896193|588871480|FG000|Overall Study|Lack of Efficacy|20|||
163044574|NCT01896193|588871481|FG001|Overall Study|Lack of Efficacy|11|||
163044575|NCT01896193|588871480|FG000|Overall Study|Protocol Violation|0|||
163044576|NCT01896193|588871481|FG001|Overall Study|Protocol Violation|1|||
163044577|NCT01896193|588871480|FG000|Overall Study|Withdrew Consent|1|||
163044578|NCT01896193|588871481|FG001|Overall Study|Withdrew Consent|0|||
163044579|NCT02592447|588871484|FG000|Overall Study|Lost to Follow-up|1|||
163044580|NCT02592447|588871485|FG001|Overall Study|Lost to Follow-up|0|||
163044581|NCT02592447|588871484|FG000|Overall Study|Ineligible after randomization|1|||
163044582|NCT02592447|588871485|FG001|Overall Study|Ineligible after randomization|0|||
163044583|NCT02592447|588871484|FG000|Overall Study|Withdrawal by Subject|0|||
163044584|NCT02592447|588871485|FG001|Overall Study|Withdrawal by Subject|1|||
163044585|NCT03428100|588871486|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
163044586|NCT03428100|588871487|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163299824|NCT02723955|589807781|FG018|Escalation Phase|Withdrawal by Subject|0|||
163299825|NCT02723955|589807782|FG019|Escalation Phase|Withdrawal by Subject|0|||
163299826|NCT02723955|589807783|FG020|Escalation Phase|Withdrawal by Subject|0|||
163299827|NCT02723955|589807784|FG021|Escalation Phase|Withdrawal by Subject|0|||
163299828|NCT02723955|589807785|FG022|Escalation Phase|Withdrawal by Subject|0|||
163044587|NCT03428100|588871488|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
163044588|NCT03428100|588871489|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
163044589|NCT03428100|588871490|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044590|NCT03428100|588871491|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044591|NCT03428100|588871492|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044592|NCT03428100|588871493|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163299829|NCT02723955|589807786|FG023|Escalation Phase|Withdrawal by Subject|2|||
163299830|NCT02723955|589807787|FG024|Escalation Phase|Withdrawal by Subject|0|||
163299831|NCT02723955|589807788|FG025|Escalation Phase|Withdrawal by Subject|1|||
163044593|NCT03428100|588871494|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044594|NCT03428100|588871495|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044595|NCT03428100|588871496|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044596|NCT03428100|588871497|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044597|NCT03428100|588871498|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044598|NCT03428100|588871499|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044599|NCT03428100|588871500|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044600|NCT03428100|588871501|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044601|NCT03428100|588871502|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044602|NCT03428100|588871503|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044603|NCT03428100|588871504|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044604|NCT03428100|588871486|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
163044605|NCT03428100|588871487|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
163044606|NCT03428100|588871488|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
163044607|NCT03428100|588871489|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
163044608|NCT03428100|588871490|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044609|NCT03428100|588871491|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044610|NCT03428100|588871492|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044611|NCT03428100|588871493|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044612|NCT03428100|588871494|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044613|NCT03428100|588871495|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044614|NCT03428100|588871496|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044615|NCT03428100|588871497|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044616|NCT03428100|588871498|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044617|NCT03428100|588871499|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044618|NCT03428100|588871500|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044619|NCT03428100|588871501|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044620|NCT03428100|588871502|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044621|NCT03428100|588871503|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044622|NCT03428100|588871504|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044623|NCT03428100|588871486|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044624|NCT03428100|588871487|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
163044625|NCT03428100|588871488|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
163044626|NCT03428100|588871489|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044627|NCT03428100|588871490|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044628|NCT03428100|588871491|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044629|NCT03428100|588871492|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044630|NCT03428100|588871493|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044631|NCT03428100|588871494|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044632|NCT03428100|588871495|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044633|NCT03428100|588871496|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044634|NCT03428100|588871497|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044635|NCT03428100|588871498|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044636|NCT03428100|588871499|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044637|NCT03428100|588871500|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044638|NCT03428100|588871501|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044639|NCT03428100|588871502|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044640|NCT03428100|588871503|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044641|NCT03428100|588871504|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044642|NCT03428100|588871486|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
163044643|NCT03428100|588871487|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044644|NCT03428100|588871488|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044645|NCT03428100|588871489|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044646|NCT03428100|588871490|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044647|NCT03428100|588871491|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044648|NCT03428100|588871492|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163299832|NCT02723955|589807789|FG026|Escalation Phase|Withdrawal by Subject|0|||
163299833|NCT02723955|589807790|FG027|Escalation Phase|Withdrawal by Subject|0|||
163299834|NCT02723955|589807791|FG028|Escalation Phase|Withdrawal by Subject|1|||
163299835|NCT02723955|589807792|FG029|Escalation Phase|Withdrawal by Subject|0|||
163299836|NCT02723955|589807793|FG030|Escalation Phase|Withdrawal by Subject|0|||
163299837|NCT02723955|589807794|FG031|Escalation Phase|Withdrawal by Subject|0|||
163299838|NCT02723955|589807795|FG032|Escalation Phase|Withdrawal by Subject|0|||
163299839|NCT02723955|589807796|FG033|Escalation Phase|Withdrawal by Subject|0|||
163299840|NCT02723955|589807797|FG034|Escalation Phase|Withdrawal by Subject|0|||
162956031|NCT01705574|588541351|FG001|Open-Label Extension Phase|Pregnancy|0|||
162956032|NCT01705574|588541352|FG002|Open-Label Extension Phase|Pregnancy|1|||
162956033|NCT01705574|588541353|FG003|Open-Label Extension Phase|Pregnancy|1|||
162956034|NCT00777023|588541354|FG000|Overall Study|Adverse Event|15|||
162956035|NCT00777023|588541355|FG001|Overall Study|Adverse Event|21|||
162956036|NCT00777023|588541356|FG002|Overall Study|Adverse Event|8|||
162956037|NCT00777023|588541354|FG000|Overall Study|Lack of Efficacy|1|||
162956038|NCT00777023|588541355|FG001|Overall Study|Lack of Efficacy|0|||
162956039|NCT00777023|588541356|FG002|Overall Study|Lack of Efficacy|14|||
162956040|NCT00777023|588541354|FG000|Overall Study|Protocol Violation|2|||
162956041|NCT00777023|588541355|FG001|Overall Study|Protocol Violation|1|||
162956042|NCT00777023|588541356|FG002|Overall Study|Protocol Violation|1|||
162956043|NCT00777023|588541354|FG000|Overall Study|Lost to Follow-up|2|||
162956044|NCT00777023|588541355|FG001|Overall Study|Lost to Follow-up|3|||
162956045|NCT00777023|588541356|FG002|Overall Study|Lost to Follow-up|3|||
162956046|NCT00777023|588541354|FG000|Overall Study|Death|0|||
162956047|NCT00777023|588541355|FG001|Overall Study|Death|1|||
162956048|NCT00777023|588541356|FG002|Overall Study|Death|0|||
162956049|NCT00777023|588541354|FG000|Overall Study|Withdrawal by Subject|7|||
162956050|NCT00777023|588541355|FG001|Overall Study|Withdrawal by Subject|7|||
162956051|NCT00777023|588541356|FG002|Overall Study|Withdrawal by Subject|8|||
162956052|NCT00777023|588541354|FG000|Overall Study|Missing data|1|||
162956053|NCT00777023|588541355|FG001|Overall Study|Missing data|1|||
162956054|NCT00777023|588541356|FG002|Overall Study|Missing data|0|||
162956055|NCT00777023|588541354|FG000|Overall Study|Reasons not specified|4|||
163044649|NCT03428100|588871493|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044650|NCT03428100|588871494|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044651|NCT03428100|588871495|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
162956056|NCT00777023|588541355|FG001|Overall Study|Reasons not specified|4|||
163044652|NCT03428100|588871496|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
162956057|NCT00777023|588541356|FG002|Overall Study|Reasons not specified|2|||
162956058|NCT00777023|588541354|FG000|Overall Study|Last dose date unknown|3|||
162956059|NCT00777023|588541355|FG001|Overall Study|Last dose date unknown|3|||
163299841|NCT02723955|589807798|FG035|Escalation Phase|Withdrawal by Subject|0|||
163299842|NCT02723955|589807799|FG036|Escalation Phase|Withdrawal by Subject|0|||
163299843|NCT02723955|589807800|FG037|Escalation Phase|Withdrawal by Subject|0|||
163299844|NCT02723955|589807801|FG038|Escalation Phase|Withdrawal by Subject|0|||
163299845|NCT02723955|589807802|FG039|Escalation Phase|Withdrawal by Subject|0|||
163299846|NCT02723955|589807803|FG040|Escalation Phase|Withdrawal by Subject|0|||
163299847|NCT02723955|589807804|FG041|Escalation Phase|Withdrawal by Subject|0|||
163299848|NCT02723955|589807805|FG042|Escalation Phase|Withdrawal by Subject|0|||
163044653|NCT03428100|588871497|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044654|NCT03428100|588871498|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044655|NCT03428100|588871499|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044656|NCT03428100|588871500|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044657|NCT03428100|588871501|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044658|NCT03428100|588871502|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044659|NCT03428100|588871503|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044660|NCT03428100|588871504|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044661|NCT03428100|588871486|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044662|NCT03428100|588871487|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
163044663|NCT03428100|588871488|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044664|NCT03428100|588871489|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044665|NCT03428100|588871490|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044666|NCT03428100|588871491|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044667|NCT03428100|588871492|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044668|NCT03428100|588871493|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044669|NCT03428100|588871494|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044670|NCT03428100|588871495|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044671|NCT03428100|588871496|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044672|NCT03428100|588871497|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044673|NCT03428100|588871498|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044674|NCT03428100|588871499|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044675|NCT03428100|588871500|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044676|NCT03428100|588871501|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044677|NCT03428100|588871502|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044678|NCT03428100|588871503|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044679|NCT03428100|588871504|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044680|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044681|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044682|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044683|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044684|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044685|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
163044686|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
163044687|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
163044688|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
163044689|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044690|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
163044691|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044692|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
163044693|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
163044694|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
163044695|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
163044696|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
163044697|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044698|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044699|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
163044700|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
163044701|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
163044702|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
163044703|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
163044704|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
163044705|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
163044706|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
163044707|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
163044708|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
163044709|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
163044710|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
163044711|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
163044712|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
163044713|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
163044714|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
163044715|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
163194714|NCT00494299|589426876|FG000|Overall Study|Site Closed by Sponsor|6|||
163393589|NCT02129205|590152173|FG000|Overall Study|Withdrawal by Subject|0|||
163393590|NCT02129205|590152174|FG001|Overall Study|Withdrawal by Subject|0|||
163393591|NCT02129205|590152175|FG002|Overall Study|Withdrawal by Subject|0|||
162956060|NCT00777023|588541356|FG002|Overall Study|Last dose date unknown|1|||
162956061|NCT02472366|588541357|FG000|Overall Study|Lost to Follow-up|1|||
162956062|NCT02472366|588541358|FG001|Overall Study|Lost to Follow-up|0|||
162956063|NCT02678286|588541359|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
162956064|NCT02678286|588541360|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
163393592|NCT02129205|590152176|FG003|Overall Study|Withdrawal by Subject|0|||
162956065|NCT02678286|588541359|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
163393593|NCT02129205|590152177|FG004|Overall Study|Withdrawal by Subject|1|||
163393594|NCT02129205|590152178|FG005|Overall Study|Withdrawal by Subject|1|||
162956066|NCT02678286|588541360|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
163194715|NCT00494299|589426877|FG001|Overall Study|Site Closed by Sponsor|0|||
163194716|NCT00494299|589426876|FG000|Overall Study|Protocol Driven Decision Point|11|||
163194717|NCT00494299|589426877|FG001|Overall Study|Protocol Driven Decision Point|22|||
163194718|NCT00516074|589426886|FG000|Overall Study|Adverse Event|0|||
163194719|NCT00516074|589426887|FG001|Overall Study|Adverse Event|1|||
163194720|NCT00516074|589426886|FG000|Overall Study|Subject Decision|4|||
163194721|NCT00516074|589426887|FG001|Overall Study|Subject Decision|2|||
163194722|NCT00516074|589426886|FG000|Overall Study|Loss of Glucose Control|2|||
163194723|NCT00516074|589426887|FG001|Overall Study|Loss of Glucose Control|0|||
163194724|NCT03822182|589426890|FG000|Overall Study|Protocol Violation|0|||
163194725|NCT03822182|589426891|FG001|Overall Study|Protocol Violation|1|||
163194726|NCT03822182|589426892|FG002|Overall Study|Protocol Violation|1|||
163194727|NCT01484275|589426893|FG000|Overall Study|Study terminated by sponsor|28|||
163194728|NCT01484275|589426894|FG001|Overall Study|Study terminated by sponsor|32|||
163194729|NCT01484275|589426893|FG000|Overall Study|Other|10|||
163194730|NCT01484275|589426894|FG001|Overall Study|Other|0|||
163194731|NCT01484275|589426893|FG000|Overall Study|Death|3|||
163194732|NCT01484275|589426894|FG001|Overall Study|Death|4|||
163194733|NCT01484275|589426893|FG000|Overall Study|Withdrawal by Subject|1|||
163194734|NCT01484275|589426894|FG001|Overall Study|Withdrawal by Subject|5|||
163194735|NCT01484275|589426893|FG000|Overall Study|Lost to Follow-up|1|||
163194736|NCT01484275|589426894|FG001|Overall Study|Lost to Follow-up|1|||
163194737|NCT04154930|589426895|FG000|Overall Study|Withdrawal by Subject|15|||
163194738|NCT04154930|589426896|FG001|Overall Study|Withdrawal by Subject|6|||
163194739|NCT04154930|589426895|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
163194740|NCT04154930|589426896|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
163194741|NCT04154930|589426895|FG000|Overall Study|Lost to Follow-up|14|||
163194742|NCT04154930|589426896|FG001|Overall Study|Lost to Follow-up|6|||
163194743|NCT04154930|589426895|FG000|Overall Study|Other|6|||
163194744|NCT04154930|589426896|FG001|Overall Study|Other|0|||
163194745|NCT03113916|589426902|FG000|Overall Study|Withdrawal by Subject|9|||
163194746|NCT03113916|589426903|FG001|Overall Study|Withdrawal by Subject|7|||
163194747|NCT03113916|589426902|FG000|Overall Study|Pregnancy|1|||
163194748|NCT03113916|589426903|FG001|Overall Study|Pregnancy|3|||
163194749|NCT03113916|589426902|FG000|Overall Study|Lost to Follow-up|1|||
163194750|NCT03113916|589426903|FG001|Overall Study|Lost to Follow-up|2|||
163194751|NCT01893203|589426905|FG000|Overall Study|Withdrawal by Subject|1|||
163194752|NCT01758523|589426906|FG000|Overall Study|Adverse Event|2|||
163194753|NCT01758523|589426907|FG001|Overall Study|Adverse Event|1|||
163194754|NCT01758523|589426906|FG000|Overall Study|Lack of Efficacy|4|||
163194755|NCT01758523|589426907|FG001|Overall Study|Lack of Efficacy|2|||
163194756|NCT01758523|589426906|FG000|Overall Study|Lost to Follow-up|3|||
163194757|NCT01758523|589426907|FG001|Overall Study|Lost to Follow-up|4|||
163194758|NCT01758523|589426906|FG000|Overall Study|Withdrawal by Subject|12|||
163194759|NCT01758523|589426907|FG001|Overall Study|Withdrawal by Subject|7|||
163194760|NCT00722800|589426908|FG000|Overall Study|Withdrawal by Subject|1|||
163194761|NCT00722800|589426909|FG001|Overall Study|Withdrawal by Subject|0|||
163194762|NCT00722800|589426908|FG000|Overall Study|Physician Decision|1|||
163194763|NCT00722800|589426909|FG001|Overall Study|Physician Decision|0|||
163194764|NCT02130297|589426914|FG000|Overall Study|Lost to Follow-up|4|||
163194765|NCT00508755|589426923|FG000|Overall Study|Withdrawal by Subject|1|||
163194766|NCT00957580|589426924|FG000|Overall Study|Ongoing at data cut-off|0|||
163194767|NCT00957580|589426925|FG001|Overall Study|Ongoing at data cut-off|1|||
163194768|NCT00957580|589426926|FG002|Overall Study|Ongoing at data cut-off|0|||
163194769|NCT00957580|589426924|FG000|Overall Study|Enrolled but not treated|0|||
163194770|NCT00957580|589426925|FG001|Overall Study|Enrolled but not treated|1|||
163194771|NCT00957580|589426926|FG002|Overall Study|Enrolled but not treated|0|||
163194772|NCT00945893|589426927|FG000|Overall Study|Lost to Follow-up|2|||
162956067|NCT02678286|588541359|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
162956068|NCT02678286|588541360|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
162956069|NCT02678286|588541359|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
162956070|NCT02678286|588541360|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
162956071|NCT02678286|588541359|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
162956072|NCT02678286|588541360|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
162956073|NCT04274686|588541361|FG000|Overall Study|Physician Decision|1|||
162956074|NCT04274686|588541362|FG001|Overall Study|Physician Decision|0|||
162956075|NCT01273805|588541365|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
163393595|NCT02129205|590152179|FG006|Overall Study|Withdrawal by Subject|1|||
163393596|NCT02129205|590152180|FG007|Overall Study|Withdrawal by Subject|0|||
163393597|NCT02129205|590152181|FG008|Overall Study|Withdrawal by Subject|1|||
163393598|NCT02129205|590152182|FG009|Overall Study|Withdrawal by Subject|0|||
163393599|NCT02129205|590152173|FG000|Overall Study|Other|1|||
163393600|NCT02129205|590152174|FG001|Overall Study|Other|0|||
163393601|NCT02129205|590152175|FG002|Overall Study|Other|0|||
163393602|NCT02129205|590152176|FG003|Overall Study|Other|0|||
163393603|NCT02129205|590152177|FG004|Overall Study|Other|2|||
163393604|NCT02129205|590152178|FG005|Overall Study|Other|3|||
163393605|NCT02129205|590152179|FG006|Overall Study|Other|3|||
163393606|NCT02129205|590152180|FG007|Overall Study|Other|2|||
163393607|NCT02129205|590152181|FG008|Overall Study|Other|1|||
163393608|NCT02129205|590152182|FG009|Overall Study|Other|0|||
163393609|NCT02877927|590152183|FG000|Overall Study|Adverse Event|1|||
163393610|NCT02877927|590152184|FG001|Overall Study|Adverse Event|0|||
163393611|NCT02877927|590152183|FG000|Overall Study|Lost to Follow-up|37|||
163393612|NCT02877927|590152184|FG001|Overall Study|Lost to Follow-up|38|||
163393613|NCT02877927|590152183|FG000|Overall Study|Withdrawal by Subject|11|||
163393614|NCT02877927|590152184|FG001|Overall Study|Withdrawal by Subject|12|||
163393615|NCT02877927|590152183|FG000|Overall Study|Physician Decision|0|||
163393616|NCT02877927|590152184|FG001|Overall Study|Physician Decision|1|||
163393617|NCT02877927|590152183|FG000|Overall Study|Missed EOT/PTE Visit|5|||
163393618|NCT02877927|590152184|FG001|Overall Study|Missed EOT/PTE Visit|6|||
163393619|NCT04376060|590152186|FG000|Overall Study|Physician Decision|1|||
163393620|NCT04275297|590152187|FG000|Overall Study|Lost to Follow-up|1|||
163393621|NCT04275297|590152188|FG001|Overall Study|Lost to Follow-up|1|||
163393622|NCT01791803|590152189|FG000|Overall Study|Withdrawal by Subject|0|||
163393623|NCT01791803|590152190|FG001|Overall Study|Withdrawal by Subject|0|||
163393624|NCT01791803|590152191|FG002|Overall Study|Withdrawal by Subject|0|||
163393625|NCT01791803|590152192|FG003|Overall Study|Withdrawal by Subject|2|||
163393626|NCT01791803|590152189|FG000|Overall Study|Physician Decision|0|||
163393627|NCT01791803|590152190|FG001|Overall Study|Physician Decision|2|||
163393628|NCT01791803|590152191|FG002|Overall Study|Physician Decision|0|||
163393629|NCT01791803|590152192|FG003|Overall Study|Physician Decision|1|||
163393630|NCT01791803|590152189|FG000|Overall Study|Death|0|||
163393631|NCT01791803|590152190|FG001|Overall Study|Death|0|||
163393632|NCT01791803|590152191|FG002|Overall Study|Death|2|||
163393633|NCT01791803|590152192|FG003|Overall Study|Death|2|||
163393634|NCT04572854|590152193|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
163393635|NCT04572854|590152194|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
163393636|NCT04572854|590152195|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
163393637|NCT04572854|590152196|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
163393638|NCT04572854|590152193|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
163393639|NCT04572854|590152194|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
163393640|NCT04572854|590152195|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
163393641|NCT04572854|590152196|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
163393642|NCT07052682|590152201|FG000|Overall Study|Withdrawal by Subject|4|||
163393643|NCT02246582|590153880|FG000|Overall Study|Withdrawal by Subject|3|||
163393644|NCT02246582|590153881|FG001|Overall Study|Withdrawal by Subject|4|||
163393645|NCT02060383|590153883|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
163393646|NCT02060383|590153884|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
163393647|NCT02060383|590153885|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
163393648|NCT02060383|590153886|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
163393649|NCT02060383|590153887|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
163393650|NCT02060383|590153883|FG000|Core Phase|Adverse Event|2|||
163393651|NCT02060383|590153884|FG001|Core Phase|Adverse Event|0|||
163393652|NCT02060383|590153885|FG002|Core Phase|Adverse Event|0|||
163393653|NCT02060383|590153886|FG003|Core Phase|Adverse Event|2|||
163393654|NCT02060383|590153887|FG004|Core Phase|Adverse Event|6|||
163393655|NCT02060383|590153883|FG000|Core Phase|Administrative problems|0|||
163393656|NCT02060383|590153884|FG001|Core Phase|Administrative problems|1|||
163393657|NCT02060383|590153885|FG002|Core Phase|Administrative problems|0|||
163393658|NCT02060383|590153886|FG003|Core Phase|Administrative problems|0|||
163393659|NCT02060383|590153887|FG004|Core Phase|Administrative problems|0|||
163393660|NCT02060383|590153883|FG000|Core Phase|Protocol Violation|0|||
163393661|NCT02060383|590153884|FG001|Core Phase|Protocol Violation|0|||
163393662|NCT02060383|590153885|FG002|Core Phase|Protocol Violation|0|||
163393663|NCT02060383|590153886|FG003|Core Phase|Protocol Violation|1|||
163393664|NCT02060383|590153887|FG004|Core Phase|Protocol Violation|0|||
163393665|NCT02060383|590153883|FG000|Core Phase|Withdrawal by Subject|0|||
163393666|NCT02060383|590153884|FG001|Core Phase|Withdrawal by Subject|0|||
163393667|NCT02060383|590153885|FG002|Core Phase|Withdrawal by Subject|0|||
163393668|NCT02060383|590153886|FG003|Core Phase|Withdrawal by Subject|4|||
163393669|NCT02060383|590153887|FG004|Core Phase|Withdrawal by Subject|2|||
163393670|NCT02060383|590153883|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
163393671|NCT02060383|590153884|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
163393672|NCT02060383|590153885|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
163393673|NCT02060383|590153886|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
163393674|NCT02060383|590153887|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
163393675|NCT02060383|590153883|FG000|Extension Phase|Adverse Event|1|||
163393676|NCT02060383|590153884|FG001|Extension Phase|Adverse Event|1|||
163393677|NCT02060383|590153885|FG002|Extension Phase|Adverse Event|2|||
163393678|NCT02060383|590153886|FG003|Extension Phase|Adverse Event|0|||
163393679|NCT02060383|590153887|FG004|Extension Phase|Adverse Event|1|||
163393680|NCT02060383|590153883|FG000|Extension Phase|Withdrawal by Subject|0|||
163393681|NCT02060383|590153884|FG001|Extension Phase|Withdrawal by Subject|1|||
163393682|NCT02060383|590153885|FG002|Extension Phase|Withdrawal by Subject|0|||
163393683|NCT02060383|590153886|FG003|Extension Phase|Withdrawal by Subject|0|||
163393684|NCT02060383|590153887|FG004|Extension Phase|Withdrawal by Subject|2|||
163393685|NCT02060383|590153883|FG000|Extension Phase|Administrative problems|1|||
163393686|NCT02060383|590153884|FG001|Extension Phase|Administrative problems|0|||
163393687|NCT02060383|590153885|FG002|Extension Phase|Administrative problems|0|||
163393688|NCT02060383|590153886|FG003|Extension Phase|Administrative problems|0|||
163393689|NCT02060383|590153887|FG004|Extension Phase|Administrative problems|0|||
163393690|NCT02060383|590153883|FG000|Extension Phase|Death|0|||
163393691|NCT02060383|590153884|FG001|Extension Phase|Death|0|||
163393692|NCT02060383|590153885|FG002|Extension Phase|Death|1|||
163393693|NCT02060383|590153886|FG003|Extension Phase|Death|0|||
163393694|NCT02060383|590153887|FG004|Extension Phase|Death|1|||
163393695|NCT02060383|590153883|FG000|Extension Phase|Protocol Violation|0|||
163393696|NCT02060383|590153884|FG001|Extension Phase|Protocol Violation|0|||
163393697|NCT02060383|590153885|FG002|Extension Phase|Protocol Violation|0|||
163393698|NCT02060383|590153886|FG003|Extension Phase|Protocol Violation|0|||
163393699|NCT02060383|590153887|FG004|Extension Phase|Protocol Violation|1|||
163393700|NCT03426787|590153888|FG000|Overall Study|Withdrawal by Subject|6|||
163393701|NCT03426787|590153888|FG000|Overall Study|Lost to Follow-up|7|||
163393702|NCT03426787|590153888|FG000|Overall Study|Unrelated to intervention death|1|||
163393703|NCT00257166|590153894|FG000|Overall Study|Adverse Event|18|||
163393704|NCT00257166|590153895|FG001|Overall Study|Adverse Event|13|||
163393705|NCT00257166|590153894|FG000|Overall Study|Laboratory abnormality|1|||
163393706|NCT00257166|590153895|FG001|Overall Study|Laboratory abnormality|0|||
163393707|NCT00257166|590153894|FG000|Overall Study|Lost to Follow-up|8|||
163393708|NCT00257166|590153895|FG001|Overall Study|Lost to Follow-up|1|||
163393709|NCT00257166|590153894|FG000|Overall Study|Withdrawal by Subject|9|||
163393710|NCT00257166|590153895|FG001|Overall Study|Withdrawal by Subject|2|||
163393711|NCT00257166|590153894|FG000|Overall Study|Other|16|||
163393712|NCT00257166|590153895|FG001|Overall Study|Other|21|||
163393713|NCT00257166|590153894|FG000|Overall Study|Randomized, but not treated|1|||
163393714|NCT00257166|590153895|FG001|Overall Study|Randomized, but not treated|0|||
163393715|NCT02592551|590153896|FG000|Overall Study|Not evaluable|1|||
163393716|NCT02592551|590153897|FG001|Overall Study|Not evaluable|3|||
163393717|NCT02592551|590153898|FG002|Overall Study|Not evaluable|0|||
163393718|NCT00761306|590153899|FG000|Overall Study|Adverse Event|5|||
163393719|NCT00761306|590153899|FG000|Overall Study|Lack of Efficacy|4|||
163393720|NCT00761306|590153899|FG000|Overall Study|Protocol Violation|2|||
163393721|NCT00761306|590153899|FG000|Overall Study|Withdrawal of Consent|3|||
163393722|NCT00761306|590153899|FG000|Overall Study|Lost to Follow-up|1|||
163393723|NCT00761306|590153899|FG000|Overall Study|Administrative or Other Reasons|5|||
162956076|NCT01273805|588541366|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
162956077|NCT02647944|588541367|FG000|Overall Study|Withdrawal by Subject|0|||
162956078|NCT02647944|588541368|FG001|Overall Study|Withdrawal by Subject|3|||
162956079|NCT02647944|588541367|FG000|Overall Study|Adverse Event|2|||
162956080|NCT02647944|588541368|FG001|Overall Study|Adverse Event|0|||
162956081|NCT02077465|588541370|FG000|Overall Study|Withdrew Consent|0|||
162956082|NCT02077465|588541371|FG001|Overall Study|Withdrew Consent|1|||
162956083|NCT02077465|588541370|FG000|Overall Study|Lost to Follow-up|1|||
162956084|NCT02077465|588541371|FG001|Overall Study|Lost to Follow-up|0|||
162956085|NCT01827163|588541373|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
162956086|NCT01827163|588541373|FG000|Overall Study|Adverse Event|9|||
162956087|NCT03375463|588541374|FG000|Period 1|Lost to Follow-up|0|||
162956088|NCT03375463|588541375|FG001|Period 1|Lost to Follow-up|0|||
162956089|NCT03375463|588541376|FG002|Period 1|Lost to Follow-up|1|||
162956090|NCT03375463|588541377|FG003|Period 1|Lost to Follow-up|0|||
163194773|NCT00945893|589426928|FG001|Overall Study|Lost to Follow-up|8|||
163194774|NCT00945893|589426927|FG000|Overall Study|Withdrawal of consent|1|||
163393724|NCT05162027|590153900|FG000|Overall Study|Adverse Event|1|||
163393725|NCT05162027|590153901|FG001|Overall Study|Adverse Event|0|||
163393726|NCT00993954|590153903|FG000|Overall Study|Protocol Violation|21|||
163393727|NCT00993954|590153904|FG001|Overall Study|Protocol Violation|2|||
163393728|NCT00907257|590153910|FG000|Overall Study|Adverse Event|0|||
163393729|NCT00907257|590153911|FG001|Overall Study|Adverse Event|4|||
163393730|NCT00907257|590153910|FG000|Overall Study|Protocol Violation|1|||
163393731|NCT00907257|590153911|FG001|Overall Study|Protocol Violation|2|||
163393732|NCT00907257|590153910|FG000|Overall Study|Lost to Follow-up|3|||
163393733|NCT00907257|590153911|FG001|Overall Study|Lost to Follow-up|3|||
163393734|NCT00907257|590153910|FG000|Overall Study|Withdrawal by Subject|1|||
163393735|NCT00907257|590153911|FG001|Overall Study|Withdrawal by Subject|2|||
163393736|NCT00907257|590153910|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
163393737|NCT00907257|590153911|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
163393738|NCT00907257|590153910|FG000|Overall Study|Moved|1|||
163393739|NCT00907257|590153911|FG001|Overall Study|Moved|0|||
163393740|NCT00907257|590153910|FG000|Overall Study|Personal Reasons|6|||
163393741|NCT00907257|590153911|FG001|Overall Study|Personal Reasons|1|||
163393742|NCT01873417|590153913|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
163393743|NCT01873417|590153913|FG000|Overall Study|Adverse Event|24|||
163393744|NCT01873417|590153913|FG000|Overall Study|Lost to Follow-up|2|||
163393745|NCT01873417|590153913|FG000|Overall Study|Withdrawal by Subject|2|||
163393746|NCT01873417|590153913|FG000|Overall Study|Physician Decision|3|||
163393747|NCT00785044|590153914|FG000|Overall Study|Dosed at non-participating sites|152|||
163393748|NCT00785044|590153914|FG000|Overall Study|Death|77|||
163393749|NCT00785044|590153914|FG000|Overall Study|Lost to Follow-up|266|||
163393750|NCT00785044|590153914|FG000|Overall Study|Withdrawal by Subject|1|||
163393751|NCT01628107|590153915|FG000|Overall Study|Withdrawal by Subject|17|||
163393752|NCT01628107|590153915|FG000|Overall Study|Lost to Follow-up|4|||
163393753|NCT01628107|590153915|FG000|Overall Study|Adverse Event|33|||
163393754|NCT01628107|590153915|FG000|Overall Study|Physician Decision|2|||
163393755|NCT01628107|590153915|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
163393756|NCT01628107|590153915|FG000|Overall Study|Non-compliant with Study Procedures|10|||
163393757|NCT01628107|590153915|FG000|Overall Study|Not Treated|8|||
163393758|NCT01628107|590153915|FG000|Overall Study|Sponsor Decision|11|||
163393759|NCT01628107|590153915|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
163393760|NCT01628107|590153915|FG000|Overall Study|Relocated|8|||
163393761|NCT01628107|590153915|FG000|Overall Study|Kidney Transplant|9|||
163393762|NCT01628107|590153915|FG000|Overall Study|Use of Standard of Care|9|||
163393763|NCT00295633|590153916|FG000|Overall Study|Lack of Efficacy|19|||
163393764|NCT00295633|590153917|FG001|Overall Study|Lack of Efficacy|7|||
163393765|NCT00295633|590153918|FG002|Overall Study|Lack of Efficacy|16|||
163393766|NCT00295633|590153916|FG000|Overall Study|Withdrawal of consent by subject|16|||
163393767|NCT00295633|590153917|FG001|Overall Study|Withdrawal of consent by subject|16|||
163393768|NCT00295633|590153918|FG002|Overall Study|Withdrawal of consent by subject|26|||
163393769|NCT00295633|590153916|FG000|Overall Study|Adverse Event|9|||
163393770|NCT00295633|590153917|FG001|Overall Study|Adverse Event|17|||
163393771|NCT00295633|590153918|FG002|Overall Study|Adverse Event|9|||
163393772|NCT00295633|590153916|FG000|Overall Study|Lost to Follow-up|6|||
163393773|NCT00295633|590153917|FG001|Overall Study|Lost to Follow-up|11|||
163393774|NCT00295633|590153918|FG002|Overall Study|Lost to Follow-up|7|||
163393775|NCT00295633|590153916|FG000|Overall Study|Physician Decision|9|||
163393776|NCT00295633|590153917|FG001|Overall Study|Physician Decision|10|||
163393777|NCT00295633|590153918|FG002|Overall Study|Physician Decision|8|||
162956091|NCT03375463|588541378|FG004|Period 1|Lost to Follow-up|0|||
162956092|NCT03375463|588541379|FG005|Period 1|Lost to Follow-up|0|||
162956093|NCT03375463|588541374|FG000|Period 1|Adverse Event|0|||
162956094|NCT03375463|588541375|FG001|Period 1|Adverse Event|0|||
162956095|NCT03375463|588541376|FG002|Period 1|Adverse Event|0|||
162956096|NCT03375463|588541377|FG003|Period 1|Adverse Event|0|||
162956097|NCT03375463|588541378|FG004|Period 1|Adverse Event|1|||
163393778|NCT00295633|590153916|FG000|Overall Study|Poor/Noncompliance|2|||
163393779|NCT00295633|590153917|FG001|Overall Study|Poor/Noncompliance|2|||
163393780|NCT00295633|590153918|FG002|Overall Study|Poor/Noncompliance|6|||
163393781|NCT00295633|590153916|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
163393782|NCT00295633|590153917|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
163393783|NCT00295633|590153918|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
163393784|NCT00295633|590153916|FG000|Overall Study|Death|1|||
163393785|NCT00295633|590153917|FG001|Overall Study|Death|1|||
163393786|NCT00295633|590153918|FG002|Overall Study|Death|0|||
163393787|NCT00295633|590153916|FG000|Overall Study|Administrative reason by sponsor|0|||
162956098|NCT03375463|588541379|FG005|Period 1|Adverse Event|0|||
162956099|NCT03375463|588541374|FG000|Period 2|Lost to Follow-up|1|||
162956100|NCT03375463|588541375|FG001|Period 2|Lost to Follow-up|1|||
163393788|NCT00295633|590153917|FG001|Overall Study|Administrative reason by sponsor|0|||
163393789|NCT00295633|590153918|FG002|Overall Study|Administrative reason by sponsor|1|||
163393790|NCT01641237|590153925|FG000|Period II|Withdrawal by Subject|1|||
163299849|NCT02723955|589807763|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299850|NCT02723955|589807764|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299851|NCT02723955|589807765|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299852|NCT02723955|589807766|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299853|NCT02723955|589807767|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
163299854|NCT02723955|589807768|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
163299855|NCT02723955|589807769|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
163299856|NCT02723955|589807770|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
163299857|NCT02723955|589807771|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
163299858|NCT02723955|589807772|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299859|NCT02723955|589807773|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299860|NCT02723955|589807774|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299861|NCT02723955|589807775|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299862|NCT02723955|589807776|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299863|NCT02723955|589807777|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299864|NCT02723955|589807778|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299865|NCT02723955|589807779|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299866|NCT02723955|589807780|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299867|NCT02723955|589807781|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299868|NCT02723955|589807782|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299869|NCT02723955|589807783|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299870|NCT02723955|589807784|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299871|NCT02723955|589807785|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299872|NCT02723955|589807786|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299873|NCT02723955|589807787|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299874|NCT02723955|589807788|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299875|NCT02723955|589807789|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299876|NCT02723955|589807790|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299877|NCT02723955|589807791|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299878|NCT02723955|589807792|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299879|NCT02723955|589807793|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299880|NCT02723955|589807794|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299881|NCT02723955|589807795|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299882|NCT02723955|589807796|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299883|NCT02723955|589807797|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299884|NCT02723955|589807798|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299885|NCT02723955|589807799|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299886|NCT02723955|589807800|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299887|NCT02723955|589807801|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299888|NCT02723955|589807802|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299889|NCT02723955|589807803|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299890|NCT02723955|589807804|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299891|NCT02723955|589807805|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163299892|NCT02723955|589807763|FG000|Escalation Phase|Site Closed|0|||
163299893|NCT02723955|589807764|FG001|Escalation Phase|Site Closed|0|||
163299894|NCT02723955|589807765|FG002|Escalation Phase|Site Closed|0|||
163299895|NCT02723955|589807766|FG003|Escalation Phase|Site Closed|0|||
163299896|NCT02723955|589807767|FG004|Escalation Phase|Site Closed|0|||
163299897|NCT02723955|589807768|FG005|Escalation Phase|Site Closed|0|||
163299898|NCT02723955|589807769|FG006|Escalation Phase|Site Closed|0|||
163299899|NCT02723955|589807770|FG007|Escalation Phase|Site Closed|0|||
163299900|NCT02723955|589807771|FG008|Escalation Phase|Site Closed|0|||
163299901|NCT02723955|589807772|FG009|Escalation Phase|Site Closed|0|||
163299902|NCT02723955|589807773|FG010|Escalation Phase|Site Closed|0|||
163299903|NCT02723955|589807774|FG011|Escalation Phase|Site Closed|0|||
162956101|NCT03375463|588541376|FG002|Period 2|Lost to Follow-up|0|||
162956102|NCT03375463|588541377|FG003|Period 2|Lost to Follow-up|0|||
162956103|NCT03375463|588541378|FG004|Period 2|Lost to Follow-up|0|||
162956104|NCT03375463|588541379|FG005|Period 2|Lost to Follow-up|0|||
162956105|NCT01745120|588541383|FG000|Overall Study|Investigator decision|1|||
162956106|NCT01745120|588541384|FG001|Overall Study|Investigator decision|0|||
162956107|NCT02909907|588541392|FG000|Overall Study|Withdrawal by Subject|0|||
162956108|NCT02909907|588541393|FG001|Overall Study|Withdrawal by Subject|1|||
162956109|NCT01513174|588541394|FG000|Overall Study|Inclusion Error|1|||
162956110|NCT01513174|588541395|FG001|Overall Study|Inclusion Error|7|||
162956111|NCT01513174|588541394|FG000|Overall Study|Not receive study treatment|3|||
162956112|NCT01513174|588541395|FG001|Overall Study|Not receive study treatment|1|||
162956113|NCT01900626|588541398|FG000|Overall Study|study was closed due to low enrollment|1|||
162956114|NCT01900626|588541399|FG001|Overall Study|study was closed due to low enrollment|1|||
162956115|NCT01200810|588541405|FG000|Overall Study|Physician Decision|1|||
162956116|NCT01200810|588541406|FG001|Overall Study|Physician Decision|0|||
162956117|NCT01200810|588541405|FG000|Overall Study|Withdrawal by Subject|1|||
162956118|NCT01200810|588541406|FG001|Overall Study|Withdrawal by Subject|2|||
162956119|NCT01200810|588541405|FG000|Overall Study|Sponsor stopped making study drug|3|||
162956120|NCT01200810|588541406|FG001|Overall Study|Sponsor stopped making study drug|3|||
162956121|NCT02576938|588541411|FG000|Overall Study|Adverse Event|5|||
162956122|NCT02576938|588541412|FG001|Overall Study|Adverse Event|3|||
162956123|NCT02576938|588541413|FG002|Overall Study|Adverse Event|6|||
162956124|NCT02576938|588541411|FG000|Overall Study|Protocol Violation|1|||
163044716|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
163044717|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
163299904|NCT02723955|589807775|FG012|Escalation Phase|Site Closed|0|||
163299905|NCT02723955|589807776|FG013|Escalation Phase|Site Closed|0|||
162956125|NCT02576938|588541412|FG001|Overall Study|Protocol Violation|1|||
162956126|NCT02576938|588541413|FG002|Overall Study|Protocol Violation|1|||
163299906|NCT02723955|589807777|FG014|Escalation Phase|Site Closed|0|||
162956127|NCT02576938|588541411|FG000|Overall Study|Withdrawal by Subject|3|||
162956128|NCT02576938|588541412|FG001|Overall Study|Withdrawal by Subject|2|||
162956129|NCT02576938|588541413|FG002|Overall Study|Withdrawal by Subject|4|||
162956130|NCT02576938|588541411|FG000|Overall Study|Lack of Efficacy|9|||
162956131|NCT02576938|588541412|FG001|Overall Study|Lack of Efficacy|4|||
162956132|NCT02576938|588541413|FG002|Overall Study|Lack of Efficacy|0|||
162956133|NCT02576938|588541411|FG000|Overall Study|Lost to Follow-up|2|||
162956134|NCT02576938|588541412|FG001|Overall Study|Lost to Follow-up|0|||
162956135|NCT02576938|588541413|FG002|Overall Study|Lost to Follow-up|1|||
162956136|NCT02576938|588541411|FG000|Overall Study|Physician Decision|0|||
162956137|NCT02576938|588541412|FG001|Overall Study|Physician Decision|1|||
162956138|NCT02576938|588541413|FG002|Overall Study|Physician Decision|0|||
162956139|NCT02576938|588541411|FG000|Overall Study|Met Exclusion Criteria|0|||
162956140|NCT02576938|588541412|FG001|Overall Study|Met Exclusion Criteria|1|||
162956141|NCT02576938|588541413|FG002|Overall Study|Met Exclusion Criteria|0|||
162956142|NCT00448591|588541414|FG000|Overall Study|Withdrawal by Subject|178|||
162956143|NCT00448591|588541414|FG000|Overall Study|Progressive Disease|1382|||
162956144|NCT00448591|588541414|FG000|Overall Study|Adverse Event|382|||
162956145|NCT00448591|588541414|FG000|Overall Study|Protocol Violation|41|||
162956146|NCT00448591|588541414|FG000|Overall Study|Lost to Follow-up|19|||
162956147|NCT00448591|588541414|FG000|Overall Study|Treatment Regimen Completed|70|||
162956148|NCT00448591|588541414|FG000|Overall Study|Other|154|||
162956149|NCT00448591|588541414|FG000|Overall Study|Termination of Study|70|||
162956150|NCT00640562|588541415|FG000|Overall Study|Adverse Event|8|||
162956151|NCT00640562|588541416|FG001|Overall Study|Adverse Event|5|||
162956152|NCT00640562|588541415|FG000|Overall Study|Lack of Efficacy|1|||
162956153|NCT00640562|588541416|FG001|Overall Study|Lack of Efficacy|4|||
162956154|NCT00640562|588541415|FG000|Overall Study|Protocol Violation|2|||
162956155|NCT00640562|588541416|FG001|Overall Study|Protocol Violation|4|||
162956156|NCT00640562|588541415|FG000|Overall Study|Withdrawal by Subject|6|||
162956157|NCT00640562|588541416|FG001|Overall Study|Withdrawal by Subject|10|||
162956158|NCT00640562|588541415|FG000|Overall Study|Known risperidone intolerance|0|||
162956159|NCT00640562|588541416|FG001|Overall Study|Known risperidone intolerance|1|||
162956160|NCT00640562|588541415|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
162956161|NCT00640562|588541416|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
162956162|NCT00640562|588541415|FG000|Overall Study|Low study drug dose|0|||
162956163|NCT00640562|588541416|FG001|Overall Study|Low study drug dose|1|||
162956164|NCT00640562|588541415|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
162956165|NCT00640562|588541416|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
162956166|NCT03098394|588541420|FG000|Overall Study|Pregnancy|0|||
163194775|NCT00945893|589426928|FG001|Overall Study|Withdrawal of consent|2|||
163194776|NCT01602120|589426929|FG000|Overall Study|Adverse Event|3|||
163194777|NCT01602120|589426930|FG001|Overall Study|Adverse Event|6|||
163194778|NCT01602120|589426931|FG002|Overall Study|Adverse Event|0|||
163194779|NCT01602120|589426932|FG003|Overall Study|Adverse Event|2|||
163194780|NCT01602120|589426929|FG000|Overall Study|Death|0|||
163194781|NCT01602120|589426930|FG001|Overall Study|Death|4|||
163194782|NCT01602120|589426931|FG002|Overall Study|Death|0|||
163194783|NCT01602120|589426932|FG003|Overall Study|Death|0|||
163194784|NCT01602120|589426929|FG000|Overall Study|Lost to Follow-up|0|||
163299907|NCT02723955|589807778|FG015|Escalation Phase|Site Closed|1|||
163299908|NCT02723955|589807779|FG016|Escalation Phase|Site Closed|0|||
163299909|NCT02723955|589807780|FG017|Escalation Phase|Site Closed|2|||
163299910|NCT02723955|589807781|FG018|Escalation Phase|Site Closed|0|||
163299911|NCT02723955|589807782|FG019|Escalation Phase|Site Closed|0|||
163299912|NCT02723955|589807783|FG020|Escalation Phase|Site Closed|1|||
163299913|NCT02723955|589807784|FG021|Escalation Phase|Site Closed|0|||
163299914|NCT02723955|589807785|FG022|Escalation Phase|Site Closed|0|||
163299915|NCT02723955|589807786|FG023|Escalation Phase|Site Closed|0|||
163299916|NCT02723955|589807787|FG024|Escalation Phase|Site Closed|3|||
163299917|NCT02723955|589807788|FG025|Escalation Phase|Site Closed|1|||
163299918|NCT02723955|589807789|FG026|Escalation Phase|Site Closed|3|||
163299919|NCT02723955|589807790|FG027|Escalation Phase|Site Closed|1|||
163299920|NCT02723955|589807791|FG028|Escalation Phase|Site Closed|1|||
163299921|NCT02723955|589807792|FG029|Escalation Phase|Site Closed|0|||
163299922|NCT02723955|589807793|FG030|Escalation Phase|Site Closed|0|||
163299923|NCT02723955|589807794|FG031|Escalation Phase|Site Closed|0|||
163299924|NCT02723955|589807795|FG032|Escalation Phase|Site Closed|0|||
163299925|NCT02723955|589807796|FG033|Escalation Phase|Site Closed|0|||
163299926|NCT02723955|589807797|FG034|Escalation Phase|Site Closed|0|||
163299927|NCT02723955|589807798|FG035|Escalation Phase|Site Closed|0|||
163299928|NCT02723955|589807799|FG036|Escalation Phase|Site Closed|0|||
162956167|NCT03098394|588541421|FG001|Overall Study|Pregnancy|1|||
162956168|NCT04408794|588541422|FG000|Overall Study|Adverse Event|43|||
163194785|NCT01602120|589426930|FG001|Overall Study|Lost to Follow-up|1|||
163299929|NCT02723955|589807800|FG037|Escalation Phase|Site Closed|0|||
163299930|NCT02723955|589807801|FG038|Escalation Phase|Site Closed|0|||
163299931|NCT02723955|589807802|FG039|Escalation Phase|Site Closed|0|||
163299932|NCT02723955|589807803|FG040|Escalation Phase|Site Closed|0|||
163299933|NCT02723955|589807804|FG041|Escalation Phase|Site Closed|0|||
163299934|NCT02723955|589807805|FG042|Escalation Phase|Site Closed|0|||
162956169|NCT04408794|588541422|FG000|Overall Study|Infrequent study drug usage|43|||
162956170|NCT04408794|588541422|FG000|Overall Study|Lack of Efficacy|61|||
162956171|NCT04408794|588541422|FG000|Overall Study|Lost to Follow-up|33|||
162956172|NCT04408794|588541422|FG000|Overall Study|Non-compliance|6|||
162956173|NCT04408794|588541422|FG000|Overall Study|Physician Decision|1|||
162956174|NCT04408794|588541422|FG000|Overall Study|Pregnancy|6|||
162956175|NCT04408794|588541422|FG000|Overall Study|Protocol Deviation|9|||
162956176|NCT04408794|588541422|FG000|Overall Study|Sheehan-STS Result|1|||
163299935|NCT02723955|589807763|FG000|Expansion Phase|Death|0|||
163299936|NCT02723955|589807764|FG001|Expansion Phase|Death|0|||
163299937|NCT02723955|589807765|FG002|Expansion Phase|Death|0|||
163299938|NCT02723955|589807766|FG003|Expansion Phase|Death|0|||
163299939|NCT02723955|589807767|FG004|Expansion Phase|Death|0|||
163299940|NCT02723955|589807768|FG005|Expansion Phase|Death|0|||
163299941|NCT02723955|589807769|FG006|Expansion Phase|Death|0|||
163299942|NCT02723955|589807770|FG007|Expansion Phase|Death|0|||
163299943|NCT02723955|589807771|FG008|Expansion Phase|Death|0|||
163299944|NCT02723955|589807772|FG009|Expansion Phase|Death|25|||
163299945|NCT02723955|589807773|FG010|Expansion Phase|Death|69|||
163299946|NCT02723955|589807774|FG011|Expansion Phase|Death|48|||
163299947|NCT02723955|589807775|FG012|Expansion Phase|Death|0|||
163299948|NCT02723955|589807776|FG013|Expansion Phase|Death|0|||
163299949|NCT02723955|589807777|FG014|Expansion Phase|Death|0|||
163299950|NCT02723955|589807778|FG015|Expansion Phase|Death|0|||
163299951|NCT02723955|589807779|FG016|Expansion Phase|Death|0|||
163299952|NCT02723955|589807780|FG017|Expansion Phase|Death|0|||
163299953|NCT02723955|589807781|FG018|Expansion Phase|Death|0|||
163299954|NCT02723955|589807782|FG019|Expansion Phase|Death|0|||
163299955|NCT02723955|589807783|FG020|Expansion Phase|Death|0|||
163299956|NCT02723955|589807784|FG021|Expansion Phase|Death|0|||
163299957|NCT02723955|589807785|FG022|Expansion Phase|Death|0|||
163299958|NCT02723955|589807786|FG023|Expansion Phase|Death|0|||
163299959|NCT02723955|589807787|FG024|Expansion Phase|Death|0|||
163299960|NCT02723955|589807788|FG025|Expansion Phase|Death|0|||
163299961|NCT02723955|589807789|FG026|Expansion Phase|Death|0|||
163299962|NCT02723955|589807790|FG027|Expansion Phase|Death|0|||
163299963|NCT02723955|589807791|FG028|Expansion Phase|Death|0|||
163299964|NCT02723955|589807792|FG029|Expansion Phase|Death|12|||
163299965|NCT02723955|589807793|FG030|Expansion Phase|Death|202|||
163299966|NCT02723955|589807794|FG031|Expansion Phase|Death|31|||
163299967|NCT02723955|589807795|FG032|Expansion Phase|Death|17|||
163299968|NCT02723955|589807796|FG033|Expansion Phase|Death|2|||
163299969|NCT02723955|589807797|FG034|Expansion Phase|Death|3|||
163299970|NCT02723955|589807798|FG035|Expansion Phase|Death|3|||
163299971|NCT02723955|589807799|FG036|Expansion Phase|Death|1|||
163299972|NCT02723955|589807800|FG037|Expansion Phase|Death|0|||
163299973|NCT02723955|589807801|FG038|Expansion Phase|Death|0|||
163299974|NCT02723955|589807802|FG039|Expansion Phase|Death|0|||
163299975|NCT02723955|589807803|FG040|Expansion Phase|Death|0|||
163299976|NCT02723955|589807804|FG041|Expansion Phase|Death|0|||
163299977|NCT02723955|589807805|FG042|Expansion Phase|Death|0|||
163393791|NCT01641237|590153926|FG001|Period II|Withdrawal by Subject|0|||
163299978|NCT02723955|589807763|FG000|Expansion Phase|Lost to Follow-up|0|||
163299979|NCT02723955|589807764|FG001|Expansion Phase|Lost to Follow-up|0|||
163299980|NCT02723955|589807765|FG002|Expansion Phase|Lost to Follow-up|0|||
163299981|NCT02723955|589807766|FG003|Expansion Phase|Lost to Follow-up|0|||
163299982|NCT02723955|589807767|FG004|Expansion Phase|Lost to Follow-up|0|||
163299983|NCT02723955|589807768|FG005|Expansion Phase|Lost to Follow-up|0|||
163299984|NCT02723955|589807769|FG006|Expansion Phase|Lost to Follow-up|0|||
163299985|NCT02723955|589807770|FG007|Expansion Phase|Lost to Follow-up|0|||
163299986|NCT02723955|589807771|FG008|Expansion Phase|Lost to Follow-up|0|||
163299987|NCT02723955|589807772|FG009|Expansion Phase|Lost to Follow-up|0|||
162956177|NCT04408794|588541422|FG000|Overall Study|Withdrawal by Subject|57|||
162978990|NCT01660022|588623541|FG003|First Sequence (7 Days)|Protocol Violation|0|||
163299988|NCT02723955|589807773|FG010|Expansion Phase|Lost to Follow-up|4|||
163299989|NCT02723955|589807774|FG011|Expansion Phase|Lost to Follow-up|1|||
163299990|NCT02723955|589807775|FG012|Expansion Phase|Lost to Follow-up|0|||
163299991|NCT02723955|589807776|FG013|Expansion Phase|Lost to Follow-up|0|||
163299992|NCT02723955|589807777|FG014|Expansion Phase|Lost to Follow-up|0|||
163299993|NCT02723955|589807778|FG015|Expansion Phase|Lost to Follow-up|0|||
163299994|NCT02723955|589807779|FG016|Expansion Phase|Lost to Follow-up|0|||
163299995|NCT02723955|589807780|FG017|Expansion Phase|Lost to Follow-up|0|||
163299996|NCT02723955|589807781|FG018|Expansion Phase|Lost to Follow-up|0|||
162956178|NCT04408794|588541422|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
162956179|NCT04408794|588541422|FG000|Overall Study|Never Treated Migraine|5|||
162956180|NCT00244764|588541423|FG000|Overall Study|Adverse Event|37|||
162956181|NCT00244764|588541423|FG000|Overall Study|Lost to Follow-up|23|||
163299997|NCT02723955|589807782|FG019|Expansion Phase|Lost to Follow-up|0|||
163299998|NCT02723955|589807783|FG020|Expansion Phase|Lost to Follow-up|0|||
163194786|NCT01602120|589426931|FG002|Overall Study|Lost to Follow-up|0|||
163194787|NCT01602120|589426932|FG003|Overall Study|Lost to Follow-up|1|||
163194788|NCT01602120|589426929|FG000|Overall Study|Protocol Violation|1|||
163194789|NCT01602120|589426930|FG001|Overall Study|Protocol Violation|1|||
163194790|NCT01602120|589426931|FG002|Overall Study|Protocol Violation|0|||
163194791|NCT01602120|589426932|FG003|Overall Study|Protocol Violation|0|||
163194792|NCT01602120|589426929|FG000|Overall Study|Non-compliance|0|||
163044718|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
163044719|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
163044720|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
162956182|NCT00244764|588541423|FG000|Overall Study|Withdrawal by Subject|12|||
162956183|NCT00244764|588541423|FG000|Overall Study|Disease Progression|13|||
162956184|NCT00244764|588541423|FG000|Overall Study|Protocol Violation|2|||
162956185|NCT00244764|588541423|FG000|Overall Study|Death|1|||
162956186|NCT00244764|588541423|FG000|Overall Study|Off Study Medication for >21 Days|1|||
162956187|NCT00244764|588541423|FG000|Overall Study|Declining Performance Status|1|||
162956188|NCT00244764|588541423|FG000|Overall Study|Participant was Hospitalized until Death|1|||
162956189|NCT00244764|588541423|FG000|Overall Study|Primary Investigator Discretion|2|||
162956190|NCT00244764|588541423|FG000|Overall Study|Sponsor Terminated Study|2|||
162956191|NCT00244764|588541423|FG000|Overall Study|Developed Secondary Malignancy|1|||
162956192|NCT01518972|588541424|FG000|Overall Study|Lost to Follow-up|2|||
162956193|NCT01518972|588541425|FG001|Overall Study|Lost to Follow-up|1|||
162956194|NCT01518972|588541424|FG000|Overall Study|Withdrawal by Subject|1|||
162956195|NCT01518972|588541425|FG001|Overall Study|Withdrawal by Subject|0|||
162956196|NCT01518972|588541424|FG000|Overall Study|Moved from area|1|||
162956197|NCT01518972|588541425|FG001|Overall Study|Moved from area|0|||
162956198|NCT01518972|588541424|FG000|Overall Study|Transportation problems|1|||
162956199|NCT01518972|588541425|FG001|Overall Study|Transportation problems|0|||
162956200|NCT01518972|588541424|FG000|Overall Study|Exclusionary medical condition|1|||
162956201|NCT01518972|588541425|FG001|Overall Study|Exclusionary medical condition|0|||
162956202|NCT01518972|588541424|FG000|Overall Study|Missed safety visits|0|||
162956203|NCT01518972|588541425|FG001|Overall Study|Missed safety visits|1|||
162956204|NCT01518972|588541424|FG000|Overall Study|Exclusionary medication|0|||
162956205|NCT01518972|588541425|FG001|Overall Study|Exclusionary medication|1|||
162956206|NCT01518972|588541424|FG000|Overall Study|Declined medication starting on day 12|0|||
162956207|NCT01518972|588541425|FG001|Overall Study|Declined medication starting on day 12|1|||
162956208|NCT04022954|588541427|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
162956209|NCT04022954|588541427|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
162956210|NCT04022954|588541427|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
162956211|NCT03637764|588541428|FG000|Overall Study|Adverse Event|2|||
162956212|NCT03637764|588541429|FG001|Overall Study|Adverse Event|0|||
162956213|NCT03637764|588541430|FG002|Overall Study|Adverse Event|0|||
162956214|NCT03637764|588541431|FG003|Overall Study|Adverse Event|1|||
162956215|NCT03637764|588541428|FG000|Overall Study|Progressive Disease|23|||
162956216|NCT03637764|588541429|FG001|Overall Study|Progressive Disease|23|||
162956217|NCT03637764|588541430|FG002|Overall Study|Progressive Disease|18|||
162956218|NCT03637764|588541431|FG003|Overall Study|Progressive Disease|31|||
162956219|NCT03637764|588541428|FG000|Overall Study|Withdrawal by Subject|1|||
162956220|NCT03637764|588541429|FG001|Overall Study|Withdrawal by Subject|3|||
162956221|NCT03637764|588541430|FG002|Overall Study|Withdrawal by Subject|0|||
162956222|NCT03637764|588541431|FG003|Overall Study|Withdrawal by Subject|1|||
163194793|NCT01602120|589426930|FG001|Overall Study|Non-compliance|3|||
163194794|NCT01602120|589426931|FG002|Overall Study|Non-compliance|0|||
162956223|NCT02648438|588541432|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162956224|NCT02648438|588541433|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
162956225|NCT02648438|588541434|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
162956226|NCT02648438|588541432|FG000|Overall Study|Protocol Violation|2|||
162956227|NCT02648438|588541433|FG001|Overall Study|Protocol Violation|0|||
162956228|NCT02648438|588541434|FG002|Overall Study|Protocol Violation|0|||
162956229|NCT02648438|588541432|FG000|Overall Study|Withdrawal by Subject|1|||
163194795|NCT01602120|589426932|FG003|Overall Study|Non-compliance|1|||
163044721|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
163044722|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
163044723|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
163044724|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
163044725|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
163044726|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
163044727|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
163044728|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
163044729|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
163044730|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
163044731|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
163044732|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
163044733|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
163044734|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
163044735|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
163194796|NCT01602120|589426929|FG000|Overall Study|Withdrawal by Subject|8|||
163194797|NCT01602120|589426930|FG001|Overall Study|Withdrawal by Subject|17|||
163393792|NCT01641237|590153927|FG002|Period II|Withdrawal by Subject|0|||
163194798|NCT01602120|589426931|FG002|Overall Study|Withdrawal by Subject|0|||
163194799|NCT01602120|589426932|FG003|Overall Study|Withdrawal by Subject|3|||
163393793|NCT01641237|590153928|FG003|Period II|Withdrawal by Subject|0|||
163044736|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
163393794|NCT01641237|590153925|FG000|Period III|Lost to Follow-up|1|||
163194800|NCT01602120|589426929|FG000|Overall Study|Study Terminated by Sponsor|12|||
163194801|NCT01602120|589426930|FG001|Overall Study|Study Terminated by Sponsor|24|||
163194802|NCT01602120|589426931|FG002|Overall Study|Study Terminated by Sponsor|17|||
163194803|NCT01602120|589426932|FG003|Overall Study|Study Terminated by Sponsor|44|||
163194804|NCT01602120|589426929|FG000|Overall Study|Physician Decision|2|||
163194805|NCT01602120|589426930|FG001|Overall Study|Physician Decision|3|||
163194806|NCT01602120|589426931|FG002|Overall Study|Physician Decision|0|||
163393795|NCT01641237|590153926|FG001|Period III|Lost to Follow-up|0|||
163393796|NCT01641237|590153927|FG002|Period III|Lost to Follow-up|0|||
163393797|NCT01641237|590153928|FG003|Period III|Lost to Follow-up|0|||
163393798|NCT01301456|590153929|FG000|Stage 1|Withdrawal by Subject|0|||
163393799|NCT01301456|590153930|FG001|Stage 1|Withdrawal by Subject|0|||
163393800|NCT01301456|590153931|FG002|Stage 1|Withdrawal by Subject|1|||
163393801|NCT01301456|590153932|FG003|Stage 1|Withdrawal by Subject|0|||
163393802|NCT01301456|590153933|FG004|Stage 1|Withdrawal by Subject|1|||
163393803|NCT01301456|590153934|FG005|Stage 1|Withdrawal by Subject|0|||
163194807|NCT01602120|589426932|FG003|Overall Study|Physician Decision|0|||
163194808|NCT01602120|589426929|FG000|Overall Study|Unspecified Reason|3|||
163194809|NCT01602120|589426930|FG001|Overall Study|Unspecified Reason|1|||
163393804|NCT01301456|590153935|FG006|Stage 1|Withdrawal by Subject|0|||
163393805|NCT01301456|590153936|FG007|Stage 1|Withdrawal by Subject|0|||
163393806|NCT01301456|590153937|FG008|Stage 1|Withdrawal by Subject|0|||
163194810|NCT01602120|589426931|FG002|Overall Study|Unspecified Reason|0|||
163194811|NCT01602120|589426932|FG003|Overall Study|Unspecified Reason|2|||
163194812|NCT01611155|589426935|FG000|Overall Study|Adverse Event|1|||
163194813|NCT01611155|589426936|FG001|Overall Study|Adverse Event|1|||
163194814|NCT01611155|589426935|FG000|Overall Study|Refused further treatment|6|||
163194815|NCT01611155|589426936|FG001|Overall Study|Refused further treatment|4|||
163194816|NCT01611155|589426935|FG000|Overall Study|Disease progression|1|||
163194817|NCT01611155|589426936|FG001|Overall Study|Disease progression|0|||
163194818|NCT01611155|589426935|FG000|Overall Study|Withdrawal by Subject|1|||
163194819|NCT01611155|589426936|FG001|Overall Study|Withdrawal by Subject|0|||
163194820|NCT01611155|589426935|FG000|Overall Study|Alternative treatment|0|||
163194821|NCT01611155|589426936|FG001|Overall Study|Alternative treatment|1|||
163194822|NCT01611155|589426935|FG000|Overall Study|Ineligible patient|0|||
163194823|NCT01611155|589426936|FG001|Overall Study|Ineligible patient|1|||
163194824|NCT04502433|589426937|FG000|Overall Study|Death|2|||
163194825|NCT04502433|589426938|FG001|Overall Study|Death|4|||
163194826|NCT04502433|589426937|FG000|Overall Study|Lost to Follow-up|1|||
163194827|NCT04502433|589426938|FG001|Overall Study|Lost to Follow-up|0|||
163194828|NCT04502433|589426937|FG000|Overall Study|Physician Decision|0|||
163194829|NCT04502433|589426938|FG001|Overall Study|Physician Decision|1|||
163194830|NCT01681472|589426941|FG000|Overall Study|Adverse Event|0|||
163194831|NCT01681472|589426942|FG001|Overall Study|Adverse Event|1|||
163194832|NCT01681472|589426943|FG002|Overall Study|Adverse Event|0|||
163194833|NCT01681472|589426944|FG003|Overall Study|Adverse Event|0|||
163194834|NCT01696071|589426957|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
163194835|NCT01696071|589426958|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
163194836|NCT00678080|589426962|FG000|Overall Study|Physician Decision|2|||
162956230|NCT02648438|588541433|FG001|Overall Study|Withdrawal by Subject|1|||
163194837|NCT00678080|589426963|FG001|Overall Study|Physician Decision|0|||
163194838|NCT00678080|589426962|FG000|Overall Study|Lost to Follow-up|1|||
163194839|NCT00678080|589426963|FG001|Overall Study|Lost to Follow-up|0|||
163393807|NCT01301456|590153938|FG009|Stage 1|Withdrawal by Subject|0|||
163393808|NCT01301456|590153939|FG010|Stage 1|Withdrawal by Subject|0|||
163393809|NCT01301456|590153940|FG011|Stage 1|Withdrawal by Subject|0|||
163393810|NCT01301456|590153929|FG000|Stage 1|Randomized but not treated|0|||
163393811|NCT01301456|590153930|FG001|Stage 1|Randomized but not treated|0|||
163393812|NCT01301456|590153931|FG002|Stage 1|Randomized but not treated|0|||
163194840|NCT00678080|589426962|FG000|Overall Study|Withdrawal by Subject|0|||
163194841|NCT00678080|589426963|FG001|Overall Study|Withdrawal by Subject|1|||
163194842|NCT04439201|589426966|FG000|Overall Study|Ineligible|2|||
163194843|NCT04439201|589426966|FG000|Overall Study|Never start protocol therapy|1|||
163194844|NCT04439201|589426966|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
163194845|NCT04439201|589426966|FG000|Overall Study|Mutation status not confirmed|4|||
163194846|NCT04439201|589426966|FG000|Overall Study|Adverse Event|1|||
163393813|NCT01301456|590153932|FG003|Stage 1|Randomized but not treated|0|||
163194847|NCT04439201|589426966|FG000|Overall Study|Death|7|||
163194848|NCT04439201|589426966|FG000|Overall Study|Withdrawal by Subject|2|||
163194849|NCT04439201|589426966|FG000|Overall Study|Disease progression|20|||
163393814|NCT01301456|590153933|FG004|Stage 1|Randomized but not treated|0|||
163393815|NCT01301456|590153934|FG005|Stage 1|Randomized but not treated|0|||
163299999|NCT02723955|589807784|FG021|Expansion Phase|Lost to Follow-up|0|||
163300000|NCT02723955|589807785|FG022|Expansion Phase|Lost to Follow-up|0|||
163300001|NCT02723955|589807786|FG023|Expansion Phase|Lost to Follow-up|0|||
163300002|NCT02723955|589807787|FG024|Expansion Phase|Lost to Follow-up|0|||
163300003|NCT02723955|589807788|FG025|Expansion Phase|Lost to Follow-up|0|||
163300004|NCT02723955|589807789|FG026|Expansion Phase|Lost to Follow-up|0|||
163300005|NCT02723955|589807790|FG027|Expansion Phase|Lost to Follow-up|0|||
163300006|NCT02723955|589807791|FG028|Expansion Phase|Lost to Follow-up|0|||
163300007|NCT02723955|589807792|FG029|Expansion Phase|Lost to Follow-up|1|||
163300008|NCT02723955|589807793|FG030|Expansion Phase|Lost to Follow-up|19|||
163300009|NCT02723955|589807794|FG031|Expansion Phase|Lost to Follow-up|2|||
163300010|NCT02723955|589807795|FG032|Expansion Phase|Lost to Follow-up|1|||
163044737|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044738|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044739|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044740|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044741|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044742|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044743|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044744|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
163044745|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163300011|NCT02723955|589807796|FG033|Expansion Phase|Lost to Follow-up|0|||
163044746|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044747|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044748|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
163300012|NCT02723955|589807797|FG034|Expansion Phase|Lost to Follow-up|0|||
163300013|NCT02723955|589807798|FG035|Expansion Phase|Lost to Follow-up|0|||
163300014|NCT02723955|589807799|FG036|Expansion Phase|Lost to Follow-up|0|||
163300015|NCT02723955|589807800|FG037|Expansion Phase|Lost to Follow-up|0|||
163300016|NCT02723955|589807801|FG038|Expansion Phase|Lost to Follow-up|0|||
163300017|NCT02723955|589807802|FG039|Expansion Phase|Lost to Follow-up|0|||
163044749|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
163300018|NCT02723955|589807803|FG040|Expansion Phase|Lost to Follow-up|0|||
163300019|NCT02723955|589807804|FG041|Expansion Phase|Lost to Follow-up|0|||
163194850|NCT04439201|589426966|FG000|Overall Study|Alternative therapy|1|||
163194851|NCT04439201|589426966|FG000|Overall Study|Physician Decision|1|||
163194852|NCT05136690|589426967|FG000|Period 1|Withdrawal by Subject|0|||
163194853|NCT05136690|589426968|FG001|Period 1|Withdrawal by Subject|1|||
163393816|NCT01301456|590153935|FG006|Stage 1|Randomized but not treated|1|||
163393817|NCT01301456|590153936|FG007|Stage 1|Randomized but not treated|0|||
163393818|NCT01301456|590153937|FG008|Stage 1|Randomized but not treated|0|||
163393819|NCT01301456|590153938|FG009|Stage 1|Randomized but not treated|0|||
163393820|NCT01301456|590153939|FG010|Stage 1|Randomized but not treated|0|||
163393821|NCT01301456|590153940|FG011|Stage 1|Randomized but not treated|0|||
163393822|NCT01301456|590153929|FG000|Stage 2|Adverse Event|0|||
163300020|NCT02723955|589807805|FG042|Expansion Phase|Lost to Follow-up|0|||
163300021|NCT02723955|589807763|FG000|Expansion Phase|Physician Decision|0|||
163300022|NCT02723955|589807764|FG001|Expansion Phase|Physician Decision|0|||
163300023|NCT02723955|589807765|FG002|Expansion Phase|Physician Decision|0|||
163300024|NCT02723955|589807766|FG003|Expansion Phase|Physician Decision|0|||
163300025|NCT02723955|589807767|FG004|Expansion Phase|Physician Decision|0|||
163300026|NCT02723955|589807768|FG005|Expansion Phase|Physician Decision|0|||
163300027|NCT02723955|589807769|FG006|Expansion Phase|Physician Decision|0|||
163300028|NCT02723955|589807770|FG007|Expansion Phase|Physician Decision|0|||
163393823|NCT01301456|590153930|FG001|Stage 2|Adverse Event|0|||
163393824|NCT01301456|590153931|FG002|Stage 2|Adverse Event|0|||
163393825|NCT01301456|590153932|FG003|Stage 2|Adverse Event|0|||
163300029|NCT02723955|589807771|FG008|Expansion Phase|Physician Decision|0|||
163300030|NCT02723955|589807772|FG009|Expansion Phase|Physician Decision|0|||
163393826|NCT01301456|590153933|FG004|Stage 2|Adverse Event|0|||
163393827|NCT01301456|590153934|FG005|Stage 2|Adverse Event|0|||
163393828|NCT01301456|590153935|FG006|Stage 2|Adverse Event|0|||
162956231|NCT02648438|588541434|FG002|Overall Study|Withdrawal by Subject|0|||
162956232|NCT03138967|588541437|FG000|Overall Study|Death|0|||
163194854|NCT05136690|589426967|FG000|Period 2|Lost to Follow-up|0|||
163194855|NCT05136690|589426968|FG001|Period 2|Lost to Follow-up|3|||
163194856|NCT05136690|589426967|FG000|Period 2|Withdrawal by Subject|0|||
163194857|NCT05136690|589426968|FG001|Period 2|Withdrawal by Subject|1|||
163194858|NCT02020577|589426969|FG000|Overall Study|Progressive disease|3|||
163194859|NCT02020577|589426970|FG001|Overall Study|Progressive disease|38|||
163194860|NCT02020577|589426969|FG000|Overall Study|Other AE or clinical progression|0|||
163194861|NCT02020577|589426970|FG001|Overall Study|Other AE or clinical progression|15|||
163194862|NCT02020577|589426969|FG000|Overall Study|Withdrawal by Subject|0|||
163194863|NCT02020577|589426970|FG001|Overall Study|Withdrawal by Subject|1|||
163194864|NCT02020577|589426969|FG000|Overall Study|Other than stated above|0|||
163194865|NCT02020577|589426970|FG001|Overall Study|Other than stated above|1|||
163194866|NCT01453361|589426971|FG000|Overall Study|Disease Progression|6|||
163194867|NCT01453361|589426971|FG000|Overall Study|Screen-Failures|10|||
163194868|NCT01752985|589426972|FG000|Treatment Period|Subject request to discontinue treatment|1|||
163194869|NCT01752985|589426973|FG001|Treatment Period|Subject request to discontinue treatment|0|||
163194870|NCT01752985|589426974|FG002|Treatment Period|Subject request to discontinue treatment|1|||
163194871|NCT01752985|589426972|FG000|Treatment Period|Subject no longer meets study criteria|0|||
163194872|NCT01752985|589426973|FG001|Treatment Period|Subject no longer meets study criteria|1|||
163194873|NCT01752985|589426974|FG002|Treatment Period|Subject no longer meets study criteria|1|||
163194874|NCT01752985|589426972|FG000|Treatment Period|Adverse Event|2|||
163194875|NCT01752985|589426973|FG001|Treatment Period|Adverse Event|1|||
163194876|NCT01752985|589426974|FG002|Treatment Period|Adverse Event|2|||
163194877|NCT01752985|589426972|FG000|Treatment Period|Withdrawal by Subject|1|||
163194878|NCT01752985|589426973|FG001|Treatment Period|Withdrawal by Subject|1|||
163194879|NCT01752985|589426974|FG002|Treatment Period|Withdrawal by Subject|0|||
163194880|NCT01752985|589426972|FG000|Treatment Period|Lost to Follow-up|0|||
163194881|NCT01752985|589426973|FG001|Treatment Period|Lost to Follow-up|0|||
163194882|NCT01752985|589426974|FG002|Treatment Period|Lost to Follow-up|1|||
163194883|NCT01516437|589428346|FG000|Overall Study|Reason not specified|0|||
163194884|NCT01516437|589428347|FG001|Overall Study|Reason not specified|0|||
163194885|NCT01516437|589428348|FG002|Overall Study|Reason not specified|1|||
163194886|NCT01516437|589428349|FG003|Overall Study|Reason not specified|1|||
162956233|NCT03138967|588541438|FG001|Overall Study|Death|1|||
163194887|NCT01550289|589428350|FG000|Overall Study|Protocol Violation|1|||
163194888|NCT01550289|589428351|FG001|Overall Study|Protocol Violation|0|||
163194889|NCT01550289|589428350|FG000|Overall Study|Lost to Follow-up|1|||
163194890|NCT01550289|589428351|FG001|Overall Study|Lost to Follow-up|1|||
162956234|NCT03138967|588541437|FG000|Overall Study|Physician Decision|1|||
162956235|NCT03138967|588541438|FG001|Overall Study|Physician Decision|3|||
162956236|NCT04604275|588541439|FG000|Washout-1 Week|Withdrawal by Subject|1|||
163194891|NCT01550289|589428350|FG000|Overall Study|Withdrawal by Subject|11|||
163194892|NCT01550289|589428351|FG001|Overall Study|Withdrawal by Subject|3|||
163194893|NCT02025621|589428352|FG000|Overall Study|Withdrawal by Subject|1|||
163194894|NCT02025621|589428353|FG001|Overall Study|Withdrawal by Subject|0|||
163194895|NCT02025621|589428352|FG000|Overall Study|Death|0|||
163194896|NCT02025621|589428353|FG001|Overall Study|Death|1|||
163194897|NCT02025621|589428352|FG000|Overall Study|No longer eligible|10|||
163194898|NCT02025621|589428353|FG001|Overall Study|No longer eligible|15|||
163194899|NCT02025621|589428352|FG000|Overall Study|Surgery initiated before infusion|3|||
163194900|NCT02025621|589428353|FG001|Overall Study|Surgery initiated before infusion|3|||
163194901|NCT00739674|589428354|FG000|Overall Study|Screening failures|19|||
163194902|NCT00739674|589428355|FG001|Overall Study|Screening failures|17|||
163194903|NCT00739674|589428354|FG000|Overall Study|Site 212 removal|19|||
163194904|NCT00739674|589428355|FG001|Overall Study|Site 212 removal|13|||
163194905|NCT00739674|589428354|FG000|Overall Study|No follow-up data|33|||
163194906|NCT00739674|589428355|FG001|Overall Study|No follow-up data|18|||
163194907|NCT00739674|589428354|FG000|Overall Study|Dietician consultation >30 days|1|||
163393829|NCT01301456|590153936|FG007|Stage 2|Adverse Event|0|||
163194908|NCT00739674|589428355|FG001|Overall Study|Dietician consultation >30 days|9|||
163194909|NCT00739674|589428354|FG000|Overall Study|Adverse Event|22|||
163194910|NCT00739674|589428355|FG001|Overall Study|Adverse Event|13|||
163194911|NCT00739674|589428354|FG000|Overall Study|Death|1|||
163194912|NCT00739674|589428355|FG001|Overall Study|Death|0|||
163194913|NCT00739674|589428354|FG000|Overall Study|Lack of Efficacy|1|||
163194914|NCT00739674|589428355|FG001|Overall Study|Lack of Efficacy|0|||
163393830|NCT01301456|590153937|FG008|Stage 2|Adverse Event|0|||
162956237|NCT04604275|588541440|FG001|Washout-1 Week|Withdrawal by Subject|0|||
162956238|NCT04405570|588541441|FG000|Overall Study|Adverse Event|0|||
162956239|NCT04405570|588541442|FG001|Overall Study|Adverse Event|1|||
162956240|NCT04405570|588541443|FG002|Overall Study|Adverse Event|1|||
162956241|NCT04405570|588541444|FG003|Overall Study|Adverse Event|1|||
162956242|NCT04405570|588541441|FG000|Overall Study|Lost to Follow-up|0|||
162956243|NCT04405570|588541442|FG001|Overall Study|Lost to Follow-up|1|||
162956244|NCT04405570|588541443|FG002|Overall Study|Lost to Follow-up|0|||
162956245|NCT04405570|588541444|FG003|Overall Study|Lost to Follow-up|0|||
162956246|NCT04405570|588541441|FG000|Overall Study|Physician Decision|0|||
162956247|NCT04405570|588541442|FG001|Overall Study|Physician Decision|0|||
162956248|NCT04405570|588541443|FG002|Overall Study|Physician Decision|1|||
162956249|NCT04405570|588541444|FG003|Overall Study|Physician Decision|0|||
162956250|NCT04405570|588541441|FG000|Overall Study|Withdrawal by Subject|0|||
162956251|NCT04405570|588541442|FG001|Overall Study|Withdrawal by Subject|1|||
162956252|NCT04405570|588541443|FG002|Overall Study|Withdrawal by Subject|1|||
162956253|NCT04405570|588541444|FG003|Overall Study|Withdrawal by Subject|0|||
162956254|NCT04405570|588541441|FG000|Overall Study|Randomized not dosed|0|||
162956255|NCT04405570|588541442|FG001|Overall Study|Randomized not dosed|2|||
162956256|NCT04405570|588541443|FG002|Overall Study|Randomized not dosed|0|||
162956257|NCT04405570|588541444|FG003|Overall Study|Randomized not dosed|0|||
162956258|NCT04499963|588541445|FG000|Overall Study|Adverse Event|3|||
162956259|NCT04499963|588541446|FG001|Overall Study|Adverse Event|0|||
162956260|NCT04499963|588541445|FG000|Overall Study|Death|3|||
162956261|NCT04499963|588541446|FG001|Overall Study|Death|0|||
162956262|NCT04499963|588541445|FG000|Overall Study|Lack of Efficacy|7|||
162956263|NCT04499963|588541446|FG001|Overall Study|Lack of Efficacy|0|||
162956264|NCT04499963|588541445|FG000|Overall Study|Lost to Follow-up|2|||
162956265|NCT04499963|588541446|FG001|Overall Study|Lost to Follow-up|0|||
162956266|NCT02601625|588541450|FG000|Overall Study|Lost to Follow-up|0|||
162956267|NCT02601625|588541451|FG001|Overall Study|Lost to Follow-up|0|||
162956268|NCT02601625|588541452|FG002|Overall Study|Lost to Follow-up|1|||
162956269|NCT02601625|588541453|FG003|Overall Study|Lost to Follow-up|1|||
162956270|NCT00838279|588541454|FG000|Washout|Protocol Violation|1|||
162956271|NCT00838279|588541455|FG001|Washout|Protocol Violation|0|||
162956272|NCT00838279|588541454|FG000|Washout|Withdrawal by Subject|0|||
162956273|NCT00838279|588541455|FG001|Washout|Withdrawal by Subject|1|||
162956274|NCT04608188|588541456|FG000|Overall Study|Withdrawal by Subject|4|||
162956275|NCT04608188|588541457|FG001|Overall Study|Withdrawal by Subject|8|||
162956276|NCT03586726|588541460|FG000|Overall Study|Withdrawal by Subject|1|||
162956277|NCT01045161|588541461|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
162956278|NCT01045161|588541462|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
162956279|NCT01045161|588541463|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
162956280|NCT01045161|588541461|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
162956281|NCT01045161|588541462|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
162956282|NCT01045161|588541463|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
162956283|NCT01045161|588541461|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
162956284|NCT01045161|588541462|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
162956285|NCT01045161|588541463|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
162956286|NCT01045161|588541461|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
162956287|NCT01045161|588541462|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
162956288|NCT01045161|588541463|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
162956289|NCT01045161|588541461|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
162956290|NCT01045161|588541462|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
163194915|NCT00739674|589428354|FG000|Overall Study|Lost to Follow-up|52|||
163194916|NCT00739674|589428355|FG001|Overall Study|Lost to Follow-up|30|||
163194917|NCT00739674|589428354|FG000|Overall Study|Protocol Violation|5|||
163194918|NCT00739674|589428355|FG001|Overall Study|Protocol Violation|5|||
163194919|NCT00739674|589428354|FG000|Overall Study|Withdrawal by Subject|9|||
163194920|NCT00739674|589428355|FG001|Overall Study|Withdrawal by Subject|9|||
163194921|NCT00739674|589428354|FG000|Overall Study|Reason missing|2|||
163194922|NCT00739674|589428355|FG001|Overall Study|Reason missing|0|||
163194923|NCT00739674|589428354|FG000|Overall Study|Clinic closed|6|||
163194924|NCT00739674|589428355|FG001|Overall Study|Clinic closed|4|||
163194925|NCT00739674|589428354|FG000|Overall Study|Patient moved|3|||
163194926|NCT00739674|589428355|FG001|Overall Study|Patient moved|2|||
163194927|NCT00739674|589428354|FG000|Overall Study|Non compliant|4|||
163194928|NCT00739674|589428355|FG001|Overall Study|Non compliant|0|||
163194929|NCT00739674|589428354|FG000|Overall Study|Unable to attend visit|3|||
163194930|NCT00739674|589428355|FG001|Overall Study|Unable to attend visit|1|||
163194931|NCT00739674|589428354|FG000|Overall Study|Home monitoring off meds|1|||
163194932|NCT00739674|589428355|FG001|Overall Study|Home monitoring off meds|0|||
163194933|NCT00739674|589428354|FG000|Overall Study|Erectile dysfunction|0|||
163194934|NCT00739674|589428355|FG001|Overall Study|Erectile dysfunction|1|||
162956291|NCT01045161|588541463|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
162956292|NCT01045161|588541461|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
162956293|NCT01045161|588541462|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
162956294|NCT01045161|588541463|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
162956295|NCT01045161|588541461|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
162956296|NCT01045161|588541462|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
162956297|NCT01045161|588541463|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
162956298|NCT01045161|588541461|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
162956299|NCT01045161|588541462|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
162956300|NCT01045161|588541463|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
162956301|NCT01045161|588541461|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
162956302|NCT01045161|588541462|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
162956303|NCT01045161|588541463|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
162956304|NCT01045161|588541461|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
162956305|NCT01045161|588541462|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
162956306|NCT01045161|588541463|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
163044750|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163300031|NCT02723955|589807773|FG010|Expansion Phase|Physician Decision|0|||
163300032|NCT02723955|589807774|FG011|Expansion Phase|Physician Decision|0|||
163300033|NCT02723955|589807775|FG012|Expansion Phase|Physician Decision|0|||
163300034|NCT02723955|589807776|FG013|Expansion Phase|Physician Decision|0|||
163300035|NCT02723955|589807777|FG014|Expansion Phase|Physician Decision|0|||
163300036|NCT02723955|589807778|FG015|Expansion Phase|Physician Decision|0|||
163300037|NCT02723955|589807779|FG016|Expansion Phase|Physician Decision|0|||
163300038|NCT02723955|589807780|FG017|Expansion Phase|Physician Decision|0|||
162956307|NCT01045161|588541461|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
162956308|NCT01045161|588541462|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
162956309|NCT01045161|588541463|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
162956310|NCT01045161|588541461|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
162956311|NCT01045161|588541462|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
162956312|NCT01045161|588541463|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
162956313|NCT01045161|588541461|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
162956314|NCT01045161|588541462|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
162956315|NCT01045161|588541463|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
162956316|NCT01045161|588541461|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
162956317|NCT01045161|588541462|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
162956318|NCT01045161|588541463|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
162956319|NCT01854047|588541464|FG000|Overall Study|Lack of Efficacy|1|||
162956320|NCT01854047|588541465|FG001|Overall Study|Lack of Efficacy|0|||
162956321|NCT01854047|588541466|FG002|Overall Study|Lack of Efficacy|0|||
162956322|NCT01854047|588541467|FG003|Overall Study|Lack of Efficacy|0|||
162956323|NCT01854047|588541468|FG004|Overall Study|Lack of Efficacy|0|||
162956324|NCT01854047|588541464|FG000|Overall Study|Poor compliance to protocol|3|||
162956325|NCT01854047|588541465|FG001|Overall Study|Poor compliance to protocol|0|||
162956326|NCT01854047|588541466|FG002|Overall Study|Poor compliance to protocol|2|||
162956327|NCT01854047|588541467|FG003|Overall Study|Poor compliance to protocol|0|||
162956328|NCT01854047|588541468|FG004|Overall Study|Poor compliance to protocol|0|||
162956329|NCT01854047|588541464|FG000|Overall Study|Adverse Event|5|||
162956330|NCT01854047|588541465|FG001|Overall Study|Adverse Event|4|||
162956331|NCT01854047|588541466|FG002|Overall Study|Adverse Event|6|||
162956332|NCT01854047|588541467|FG003|Overall Study|Adverse Event|10|||
162956333|NCT01854047|588541468|FG004|Overall Study|Adverse Event|7|||
163194935|NCT01897454|589428357|FG000|Overall Study|Withdrawal by Subject|1|||
163194936|NCT02195583|589428359|FG000|Overall Study|Lost to Follow-up|1|||
163194937|NCT02195583|589428359|FG000|Overall Study|Withdrawal by Subject|4|||
163194938|NCT02195583|589428359|FG000|Overall Study|Adverse Event|2|||
163194939|NCT02195583|589428359|FG000|Overall Study|Other Reason|2|||
163194940|NCT01560403|589428360|FG000|Overall Study|Lost to Follow-up|0|||
163194941|NCT01560403|589428361|FG001|Overall Study|Lost to Follow-up|1|||
163194942|NCT00983437|589428363|FG000|Overall Study|Adverse Event|9|||
163194943|NCT00983437|589428363|FG000|Overall Study|Lack of Efficacy|1|||
163194944|NCT00983437|589428363|FG000|Overall Study|Withdrawal by Subject|8|||
163194945|NCT00983437|589428363|FG000|Overall Study|Noncompliance to Study Procedures|1|||
163194946|NCT00983437|589428363|FG000|Overall Study|Lost to Follow-up|2|||
163194947|NCT00983437|589428363|FG000|Overall Study|Other Reason|26|||
163194948|NCT04019288|589428364|FG000|Overall Study|Death|1|||
163194949|NCT04019288|589428365|FG001|Overall Study|Death|0|||
163194950|NCT04019288|589428366|FG002|Overall Study|Death|0|||
163194951|NCT00094172|589428367|FG000|Overall Study|Adverse Event|0|||
163194952|NCT00094172|589428368|FG001|Overall Study|Adverse Event|1|||
163194953|NCT00094172|589428367|FG000|Overall Study|Lost to Follow-up|2|||
163194954|NCT00094172|589428368|FG001|Overall Study|Lost to Follow-up|0|||
163194955|NCT00094172|589428367|FG000|Overall Study|Protocol Violation|0|||
163194956|NCT00094172|589428368|FG001|Overall Study|Protocol Violation|1|||
163194957|NCT00094172|589428367|FG000|Overall Study|Withdrawal by Subject|10|||
163194958|NCT00094172|589428368|FG001|Overall Study|Withdrawal by Subject|5|||
163194959|NCT00094172|589428367|FG000|Overall Study|Primary endpoint met.|1|||
163194960|NCT00094172|589428368|FG001|Overall Study|Primary endpoint met.|0|||
163194961|NCT00094172|589428367|FG000|Overall Study|Started other MS therapy due to disease|1|||
163194962|NCT00094172|589428368|FG001|Overall Study|Started other MS therapy due to disease|0|||
163194963|NCT00289133|589428376|FG000|Overall Study|Non-study device implanted|12|||
163194964|NCT00289133|589428377|FG001|Overall Study|Non-study device implanted|0|||
163194965|NCT00289133|589428376|FG000|Overall Study|Protocol Violation|32|||
163194966|NCT00289133|589428377|FG001|Overall Study|Protocol Violation|38|||
163194967|NCT00289133|589428376|FG000|Overall Study|Withdrawal by Subject|9|||
163194968|NCT00289133|589428377|FG001|Overall Study|Withdrawal by Subject|10|||
163194969|NCT00289133|589428376|FG000|Overall Study|Death|5|||
163194970|NCT00289133|589428377|FG001|Overall Study|Death|10|||
163194971|NCT00289133|589428376|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
163194972|NCT00289133|589428377|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
163194973|NCT00289133|589428376|FG000|Overall Study|Physician Decision|41|||
163194974|NCT00289133|589428377|FG001|Overall Study|Physician Decision|45|||
163194975|NCT00289133|589428376|FG000|Overall Study|Revision|8|||
163194976|NCT00289133|589428377|FG001|Overall Study|Revision|6|||
163194977|NCT00289133|589428376|FG000|Overall Study|Lost to Follow-up|92|||
163194978|NCT00289133|589428377|FG001|Overall Study|Lost to Follow-up|115|||
163300039|NCT02723955|589807781|FG018|Expansion Phase|Physician Decision|0|||
163300040|NCT02723955|589807782|FG019|Expansion Phase|Physician Decision|0|||
163300041|NCT02723955|589807783|FG020|Expansion Phase|Physician Decision|0|||
163300042|NCT02723955|589807784|FG021|Expansion Phase|Physician Decision|0|||
163300043|NCT02723955|589807785|FG022|Expansion Phase|Physician Decision|0|||
163300044|NCT02723955|589807786|FG023|Expansion Phase|Physician Decision|0|||
163300045|NCT02723955|589807787|FG024|Expansion Phase|Physician Decision|0|||
163300046|NCT02723955|589807788|FG025|Expansion Phase|Physician Decision|0|||
163300047|NCT02723955|589807789|FG026|Expansion Phase|Physician Decision|0|||
163300048|NCT02723955|589807790|FG027|Expansion Phase|Physician Decision|0|||
163300049|NCT02723955|589807791|FG028|Expansion Phase|Physician Decision|0|||
163300050|NCT02723955|589807792|FG029|Expansion Phase|Physician Decision|0|||
163300051|NCT02723955|589807793|FG030|Expansion Phase|Physician Decision|1|||
163300052|NCT02723955|589807794|FG031|Expansion Phase|Physician Decision|1|||
163300053|NCT02723955|589807795|FG032|Expansion Phase|Physician Decision|0|||
163300054|NCT02723955|589807796|FG033|Expansion Phase|Physician Decision|0|||
163300055|NCT02723955|589807797|FG034|Expansion Phase|Physician Decision|0|||
163300056|NCT02723955|589807798|FG035|Expansion Phase|Physician Decision|0|||
163300057|NCT02723955|589807799|FG036|Expansion Phase|Physician Decision|0|||
163300058|NCT02723955|589807800|FG037|Expansion Phase|Physician Decision|0|||
163300059|NCT02723955|589807801|FG038|Expansion Phase|Physician Decision|0|||
163300060|NCT02723955|589807802|FG039|Expansion Phase|Physician Decision|0|||
163300061|NCT02723955|589807803|FG040|Expansion Phase|Physician Decision|0|||
163300062|NCT02723955|589807804|FG041|Expansion Phase|Physician Decision|0|||
163300063|NCT02723955|589807805|FG042|Expansion Phase|Physician Decision|0|||
163300064|NCT02723955|589807763|FG000|Expansion Phase|Withdrawal by Subject|0|||
163300065|NCT02723955|589807764|FG001|Expansion Phase|Withdrawal by Subject|0|||
163300066|NCT02723955|589807765|FG002|Expansion Phase|Withdrawal by Subject|0|||
163300067|NCT02723955|589807766|FG003|Expansion Phase|Withdrawal by Subject|0|||
163300068|NCT02723955|589807767|FG004|Expansion Phase|Withdrawal by Subject|0|||
163300069|NCT02723955|589807768|FG005|Expansion Phase|Withdrawal by Subject|0|||
163300070|NCT02723955|589807769|FG006|Expansion Phase|Withdrawal by Subject|0|||
163300071|NCT02723955|589807770|FG007|Expansion Phase|Withdrawal by Subject|0|||
163300072|NCT02723955|589807771|FG008|Expansion Phase|Withdrawal by Subject|0|||
163300073|NCT02723955|589807772|FG009|Expansion Phase|Withdrawal by Subject|2|||
163300074|NCT02723955|589807773|FG010|Expansion Phase|Withdrawal by Subject|1|||
163300075|NCT02723955|589807774|FG011|Expansion Phase|Withdrawal by Subject|0|||
163300076|NCT02723955|589807775|FG012|Expansion Phase|Withdrawal by Subject|0|||
163300077|NCT02723955|589807776|FG013|Expansion Phase|Withdrawal by Subject|0|||
163300078|NCT02723955|589807777|FG014|Expansion Phase|Withdrawal by Subject|0|||
163300079|NCT02723955|589807778|FG015|Expansion Phase|Withdrawal by Subject|0|||
163300080|NCT02723955|589807779|FG016|Expansion Phase|Withdrawal by Subject|0|||
163300081|NCT02723955|589807780|FG017|Expansion Phase|Withdrawal by Subject|0|||
163300082|NCT02723955|589807781|FG018|Expansion Phase|Withdrawal by Subject|0|||
163300083|NCT02723955|589807782|FG019|Expansion Phase|Withdrawal by Subject|0|||
163300084|NCT02723955|589807783|FG020|Expansion Phase|Withdrawal by Subject|0|||
163300085|NCT02723955|589807784|FG021|Expansion Phase|Withdrawal by Subject|0|||
163300086|NCT02723955|589807785|FG022|Expansion Phase|Withdrawal by Subject|0|||
163300087|NCT02723955|589807786|FG023|Expansion Phase|Withdrawal by Subject|0|||
163300088|NCT02723955|589807787|FG024|Expansion Phase|Withdrawal by Subject|0|||
163300089|NCT02723955|589807788|FG025|Expansion Phase|Withdrawal by Subject|0|||
163300090|NCT02723955|589807789|FG026|Expansion Phase|Withdrawal by Subject|0|||
163300091|NCT02723955|589807790|FG027|Expansion Phase|Withdrawal by Subject|0|||
163300092|NCT02723955|589807791|FG028|Expansion Phase|Withdrawal by Subject|0|||
163300093|NCT02723955|589807792|FG029|Expansion Phase|Withdrawal by Subject|0|||
163300094|NCT02723955|589807793|FG030|Expansion Phase|Withdrawal by Subject|8|||
163300095|NCT02723955|589807794|FG031|Expansion Phase|Withdrawal by Subject|4|||
163300096|NCT02723955|589807795|FG032|Expansion Phase|Withdrawal by Subject|0|||
163300097|NCT02723955|589807796|FG033|Expansion Phase|Withdrawal by Subject|0|||
163300098|NCT02723955|589807797|FG034|Expansion Phase|Withdrawal by Subject|0|||
163300099|NCT02723955|589807798|FG035|Expansion Phase|Withdrawal by Subject|1|||
163300100|NCT02723955|589807799|FG036|Expansion Phase|Withdrawal by Subject|0|||
163300101|NCT02723955|589807800|FG037|Expansion Phase|Withdrawal by Subject|0|||
163300102|NCT02723955|589807801|FG038|Expansion Phase|Withdrawal by Subject|0|||
163300103|NCT02723955|589807802|FG039|Expansion Phase|Withdrawal by Subject|0|||
163300104|NCT02723955|589807803|FG040|Expansion Phase|Withdrawal by Subject|0|||
163300105|NCT02723955|589807804|FG041|Expansion Phase|Withdrawal by Subject|0|||
163300106|NCT02723955|589807805|FG042|Expansion Phase|Withdrawal by Subject|0|||
163300107|NCT02723955|589807763|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300108|NCT02723955|589807764|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300109|NCT02723955|589807765|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300110|NCT02723955|589807766|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300111|NCT02723955|589807767|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300112|NCT02723955|589807768|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300113|NCT02723955|589807769|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300114|NCT02723955|589807770|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163393831|NCT01301456|590153938|FG009|Stage 2|Adverse Event|0|||
163300115|NCT02723955|589807771|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300116|NCT02723955|589807772|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
163300117|NCT02723955|589807773|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
163300118|NCT02723955|589807774|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
163300119|NCT02723955|589807775|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300120|NCT02723955|589807776|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300121|NCT02723955|589807777|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300122|NCT02723955|589807778|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300123|NCT02723955|589807779|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300124|NCT02723955|589807780|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300125|NCT02723955|589807781|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300126|NCT02723955|589807782|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300127|NCT02723955|589807783|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300128|NCT02723955|589807784|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300129|NCT02723955|589807785|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300130|NCT02723955|589807786|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300131|NCT02723955|589807787|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300132|NCT02723955|589807788|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300133|NCT02723955|589807789|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300134|NCT02723955|589807790|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163393832|NCT01301456|590153939|FG010|Stage 2|Adverse Event|1|||
162956334|NCT01854047|588541464|FG000|Overall Study|Randomized but not treated|0|||
162956335|NCT01854047|588541465|FG001|Overall Study|Randomized but not treated|1|||
162956336|NCT01854047|588541466|FG002|Overall Study|Randomized but not treated|2|||
162956337|NCT01854047|588541467|FG003|Overall Study|Randomized but not treated|0|||
162956338|NCT01854047|588541468|FG004|Overall Study|Randomized but not treated|4|||
162956339|NCT01854047|588541464|FG000|Overall Study|Other than specified above|3|||
163300135|NCT02723955|589807791|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300136|NCT02723955|589807792|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300137|NCT02723955|589807793|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
163300138|NCT02723955|589807794|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300139|NCT02723955|589807795|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300140|NCT02723955|589807796|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300141|NCT02723955|589807797|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300142|NCT02723955|589807798|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300143|NCT02723955|589807799|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300144|NCT02723955|589807800|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300145|NCT02723955|589807801|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300146|NCT02723955|589807802|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300147|NCT02723955|589807803|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300148|NCT02723955|589807804|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300149|NCT02723955|589807805|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163300150|NCT02723955|589807763|FG000|Expansion Phase|Site Closed|0|||
163300151|NCT02723955|589807764|FG001|Expansion Phase|Site Closed|0|||
163300152|NCT02723955|589807765|FG002|Expansion Phase|Site Closed|0|||
163300153|NCT02723955|589807766|FG003|Expansion Phase|Site Closed|0|||
163300154|NCT02723955|589807767|FG004|Expansion Phase|Site Closed|0|||
163300155|NCT02723955|589807768|FG005|Expansion Phase|Site Closed|0|||
163300156|NCT02723955|589807769|FG006|Expansion Phase|Site Closed|0|||
163300157|NCT02723955|589807770|FG007|Expansion Phase|Site Closed|0|||
163300158|NCT02723955|589807771|FG008|Expansion Phase|Site Closed|0|||
163300159|NCT02723955|589807772|FG009|Expansion Phase|Site Closed|1|||
163300160|NCT02723955|589807773|FG010|Expansion Phase|Site Closed|2|||
163300161|NCT02723955|589807774|FG011|Expansion Phase|Site Closed|6|||
163300162|NCT02723955|589807775|FG012|Expansion Phase|Site Closed|0|||
163300163|NCT02723955|589807776|FG013|Expansion Phase|Site Closed|0|||
163300164|NCT02723955|589807777|FG014|Expansion Phase|Site Closed|0|||
163300165|NCT02723955|589807778|FG015|Expansion Phase|Site Closed|0|||
163300166|NCT02723955|589807779|FG016|Expansion Phase|Site Closed|0|||
163300167|NCT02723955|589807780|FG017|Expansion Phase|Site Closed|0|||
163300168|NCT02723955|589807781|FG018|Expansion Phase|Site Closed|0|||
163300169|NCT02723955|589807782|FG019|Expansion Phase|Site Closed|0|||
163300170|NCT02723955|589807783|FG020|Expansion Phase|Site Closed|0|||
163300171|NCT02723955|589807784|FG021|Expansion Phase|Site Closed|0|||
163300172|NCT02723955|589807785|FG022|Expansion Phase|Site Closed|0|||
163300173|NCT02723955|589807786|FG023|Expansion Phase|Site Closed|0|||
163300174|NCT02723955|589807787|FG024|Expansion Phase|Site Closed|0|||
162956340|NCT01854047|588541465|FG001|Overall Study|Other than specified above|3|||
162956341|NCT01854047|588541466|FG002|Overall Study|Other than specified above|3|||
163300175|NCT02723955|589807788|FG025|Expansion Phase|Site Closed|0|||
163044751|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
163044752|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044753|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044754|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
163044755|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044756|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
163044757|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
163044758|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
163044759|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
163044760|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
163044761|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
163044762|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
163044763|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
163044764|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
163044765|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
163044766|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
163044767|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
163044768|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
163044769|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
163044770|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
163044771|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
163044772|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
163044773|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
163044774|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
163044775|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044776|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044777|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044778|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163393833|NCT01301456|590153940|FG011|Stage 2|Adverse Event|0|||
163393834|NCT03583450|590153941|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
163393835|NCT03583450|590153942|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
163393836|NCT00404066|590153943|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
163393837|NCT00404066|590153943|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
163393838|NCT01186939|590153944|FG000|Overall Study|Death|7|||
163393839|NCT01186939|590153944|FG000|Overall Study|Withdrawal by Subject|2|||
163044779|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044780|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044781|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
163044782|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044783|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044784|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044785|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044786|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044787|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044788|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044789|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044790|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044791|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163194979|NCT03372096|589428382|FG000|Overall Study|Study Closed|8|||
163393840|NCT01186939|590153944|FG000|Overall Study|No longer receiving clinical benefit|17|||
163393841|NCT01186939|590153944|FG000|Overall Study|Program closed|5|||
163393842|NCT01186939|590153944|FG000|Overall Study|Sponsor decision|4|||
163393843|NCT01186939|590153944|FG000|Overall Study|Started additional treatment|1|||
163393844|NCT01186939|590153944|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
162956342|NCT01854047|588541467|FG003|Overall Study|Other than specified above|5|||
162956343|NCT01854047|588541468|FG004|Overall Study|Other than specified above|8|||
162956344|NCT02281084|588541472|FG000|Overall Study|Death|21|||
162956345|NCT02281084|588541473|FG001|Overall Study|Death|18|||
162956346|NCT02281084|588541474|FG002|Overall Study|Death|3|||
162956347|NCT02281084|588541475|FG003|Overall Study|Death|5|||
162956348|NCT02281084|588541472|FG000|Overall Study|Adverse Event|1|||
162956349|NCT02281084|588541473|FG001|Overall Study|Adverse Event|0|||
162956350|NCT02281084|588541474|FG002|Overall Study|Adverse Event|0|||
162956351|NCT02281084|588541475|FG003|Overall Study|Adverse Event|0|||
162956352|NCT02281084|588541472|FG000|Overall Study|Withdrawal by Subject|2|||
162956353|NCT02281084|588541473|FG001|Overall Study|Withdrawal by Subject|2|||
162956354|NCT02281084|588541474|FG002|Overall Study|Withdrawal by Subject|0|||
162956355|NCT02281084|588541475|FG003|Overall Study|Withdrawal by Subject|0|||
162956356|NCT02281084|588541472|FG000|Overall Study|Site Closure by Sponsor|5|||
162956357|NCT02281084|588541473|FG001|Overall Study|Site Closure by Sponsor|1|||
162956358|NCT02281084|588541474|FG002|Overall Study|Site Closure by Sponsor|2|||
162956359|NCT02281084|588541475|FG003|Overall Study|Site Closure by Sponsor|0|||
162956360|NCT02957942|588541476|FG000|Overall Study|Withdrawal by Subject|0|||
162956361|NCT02957942|588541477|FG001|Overall Study|Withdrawal by Subject|1|||
162956362|NCT02957942|588541476|FG000|Overall Study|Practicing experiment protocol|0|||
162956363|NCT02957942|588541477|FG001|Overall Study|Practicing experiment protocol|6|||
162956364|NCT02655679|588541480|FG000|Overall Study|Adverse Event|0|||
162956365|NCT02655679|588541481|FG001|Overall Study|Adverse Event|1|||
163300176|NCT02723955|589807789|FG026|Expansion Phase|Site Closed|0|||
163300177|NCT02723955|589807790|FG027|Expansion Phase|Site Closed|0|||
163300178|NCT02723955|589807791|FG028|Expansion Phase|Site Closed|0|||
163300179|NCT02723955|589807792|FG029|Expansion Phase|Site Closed|0|||
163300180|NCT02723955|589807793|FG030|Expansion Phase|Site Closed|8|||
163300181|NCT02723955|589807794|FG031|Expansion Phase|Site Closed|4|||
163300182|NCT02723955|589807795|FG032|Expansion Phase|Site Closed|2|||
163300183|NCT02723955|589807796|FG033|Expansion Phase|Site Closed|2|||
163300184|NCT02723955|589807797|FG034|Expansion Phase|Site Closed|0|||
163300185|NCT02723955|589807798|FG035|Expansion Phase|Site Closed|0|||
163300186|NCT02723955|589807799|FG036|Expansion Phase|Site Closed|0|||
163300187|NCT02723955|589807800|FG037|Expansion Phase|Site Closed|0|||
163300188|NCT02723955|589807801|FG038|Expansion Phase|Site Closed|0|||
163300189|NCT02723955|589807802|FG039|Expansion Phase|Site Closed|0|||
163300190|NCT02723955|589807803|FG040|Expansion Phase|Site Closed|0|||
163300191|NCT02723955|589807804|FG041|Expansion Phase|Site Closed|0|||
163300192|NCT02723955|589807805|FG042|Expansion Phase|Site Closed|0|||
163300193|NCT02723955|589807763|FG000|Crossover/ Re-treatment Phase|Death|0|||
163300194|NCT02723955|589807764|FG001|Crossover/ Re-treatment Phase|Death|0|||
163300195|NCT02723955|589807765|FG002|Crossover/ Re-treatment Phase|Death|0|||
163300196|NCT02723955|589807766|FG003|Crossover/ Re-treatment Phase|Death|0|||
163300197|NCT02723955|589807767|FG004|Crossover/ Re-treatment Phase|Death|0|||
163300198|NCT02723955|589807768|FG005|Crossover/ Re-treatment Phase|Death|0|||
163300199|NCT02723955|589807769|FG006|Crossover/ Re-treatment Phase|Death|0|||
163300200|NCT02723955|589807770|FG007|Crossover/ Re-treatment Phase|Death|0|||
163300201|NCT02723955|589807771|FG008|Crossover/ Re-treatment Phase|Death|0|||
163300202|NCT02723955|589807772|FG009|Crossover/ Re-treatment Phase|Death|0|||
163300203|NCT02723955|589807773|FG010|Crossover/ Re-treatment Phase|Death|0|||
163300204|NCT02723955|589807774|FG011|Crossover/ Re-treatment Phase|Death|0|||
163300205|NCT02723955|589807775|FG012|Crossover/ Re-treatment Phase|Death|0|||
163300206|NCT02723955|589807776|FG013|Crossover/ Re-treatment Phase|Death|0|||
163300207|NCT02723955|589807777|FG014|Crossover/ Re-treatment Phase|Death|0|||
163300208|NCT02723955|589807778|FG015|Crossover/ Re-treatment Phase|Death|0|||
163300209|NCT02723955|589807779|FG016|Crossover/ Re-treatment Phase|Death|0|||
163300210|NCT02723955|589807780|FG017|Crossover/ Re-treatment Phase|Death|0|||
163300211|NCT02723955|589807781|FG018|Crossover/ Re-treatment Phase|Death|0|||
163300212|NCT02723955|589807782|FG019|Crossover/ Re-treatment Phase|Death|0|||
163300213|NCT02723955|589807783|FG020|Crossover/ Re-treatment Phase|Death|0|||
163300214|NCT02723955|589807784|FG021|Crossover/ Re-treatment Phase|Death|0|||
163300215|NCT02723955|589807785|FG022|Crossover/ Re-treatment Phase|Death|0|||
163300216|NCT02723955|589807786|FG023|Crossover/ Re-treatment Phase|Death|0|||
163300217|NCT02723955|589807787|FG024|Crossover/ Re-treatment Phase|Death|0|||
163300218|NCT02723955|589807788|FG025|Crossover/ Re-treatment Phase|Death|0|||
163300219|NCT02723955|589807789|FG026|Crossover/ Re-treatment Phase|Death|0|||
163300220|NCT02723955|589807790|FG027|Crossover/ Re-treatment Phase|Death|0|||
163300221|NCT02723955|589807791|FG028|Crossover/ Re-treatment Phase|Death|0|||
162956366|NCT02655679|588541482|FG002|Overall Study|Adverse Event|0|||
162956367|NCT02655679|588541483|FG003|Overall Study|Adverse Event|0|||
162956368|NCT02655679|588541484|FG004|Overall Study|Adverse Event|0|||
162956369|NCT02655679|588541480|FG000|Overall Study|Withdrawal by Subject|1|||
162956370|NCT02655679|588541481|FG001|Overall Study|Withdrawal by Subject|1|||
162956371|NCT02655679|588541482|FG002|Overall Study|Withdrawal by Subject|0|||
163300222|NCT02723955|589807792|FG029|Crossover/ Re-treatment Phase|Death|0|||
163300223|NCT02723955|589807793|FG030|Crossover/ Re-treatment Phase|Death|0|||
162956372|NCT02655679|588541483|FG003|Overall Study|Withdrawal by Subject|3|||
162956373|NCT02655679|588541484|FG004|Overall Study|Withdrawal by Subject|1|||
162956374|NCT02655679|588541480|FG000|Overall Study|Inability to Comply with the Protocol|1|||
162956375|NCT02655679|588541481|FG001|Overall Study|Inability to Comply with the Protocol|0|||
162956376|NCT02655679|588541482|FG002|Overall Study|Inability to Comply with the Protocol|0|||
162956377|NCT02655679|588541483|FG003|Overall Study|Inability to Comply with the Protocol|0|||
162956378|NCT02655679|588541484|FG004|Overall Study|Inability to Comply with the Protocol|0|||
162956379|NCT02655679|588541480|FG000|Overall Study|Lost to Follow-up|0|||
162956380|NCT02655679|588541481|FG001|Overall Study|Lost to Follow-up|1|||
162956381|NCT02655679|588541482|FG002|Overall Study|Lost to Follow-up|1|||
162956382|NCT02655679|588541483|FG003|Overall Study|Lost to Follow-up|1|||
162956383|NCT02655679|588541484|FG004|Overall Study|Lost to Follow-up|0|||
162956384|NCT02655679|588541480|FG000|Overall Study|Other Miscellaneous Reasons|1|||
162956385|NCT02655679|588541481|FG001|Overall Study|Other Miscellaneous Reasons|0|||
162956386|NCT02655679|588541482|FG002|Overall Study|Other Miscellaneous Reasons|0|||
162956387|NCT02655679|588541483|FG003|Overall Study|Other Miscellaneous Reasons|0|||
162956388|NCT02655679|588541484|FG004|Overall Study|Other Miscellaneous Reasons|0|||
163300224|NCT02723955|589807794|FG031|Crossover/ Re-treatment Phase|Death|0|||
162956389|NCT03801707|588541485|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
163044792|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163300225|NCT02723955|589807795|FG032|Crossover/ Re-treatment Phase|Death|0|||
163300226|NCT02723955|589807796|FG033|Crossover/ Re-treatment Phase|Death|0|||
163300227|NCT02723955|589807797|FG034|Crossover/ Re-treatment Phase|Death|0|||
163300228|NCT02723955|589807798|FG035|Crossover/ Re-treatment Phase|Death|0|||
163300229|NCT02723955|589807799|FG036|Crossover/ Re-treatment Phase|Death|0|||
163300230|NCT02723955|589807800|FG037|Crossover/ Re-treatment Phase|Death|1|||
162956390|NCT00819741|588541486|FG000|Overall Study|Adverse Event|5|||
162956391|NCT00819741|588541487|FG001|Overall Study|Adverse Event|2|||
163393845|NCT01186939|590153944|FG000|Overall Study|Myocardial infarction|1|||
163393846|NCT01186939|590153944|FG000|Overall Study|Bone marrow transplant|1|||
163393847|NCT01186939|590153944|FG000|Overall Study|Transformation to AML|1|||
163393848|NCT00791258|590153947|FG000|Overall Study|Adverse Event|87|||
163393849|NCT00791258|590153947|FG000|Overall Study|Lost to Follow-up|18|||
163393850|NCT00791258|590153947|FG000|Overall Study|Protocol Violation|109|||
163393851|NCT00791258|590153947|FG000|Overall Study|Withdrawal by Subject|40|||
163393852|NCT00791258|590153947|FG000|Overall Study|Did not take medication for >3 days|1|||
163393853|NCT00791258|590153947|FG000|Overall Study|subject left area|2|||
163393854|NCT00791258|590153947|FG000|Overall Study|non-compliance|3|||
163393855|NCT00791258|590153947|FG000|Overall Study|Subject incarcerated|1|||
163393856|NCT00791258|590153947|FG000|Overall Study|Subject required restricted medication|1|||
163393857|NCT00791258|590153947|FG000|Overall Study|Lack of Efficacy|1|||
163393858|NCT00436618|590153948|FG000|Overall Study|Withdrawal by Subject|5|||
163393859|NCT00436618|590153949|FG001|Overall Study|Withdrawal by Subject|8|||
163393860|NCT00436618|590153950|FG002|Overall Study|Withdrawal by Subject|11|||
163393861|NCT00436618|590153948|FG000|Overall Study|Adverse Event|8|||
163393862|NCT00436618|590153949|FG001|Overall Study|Adverse Event|8|||
163393863|NCT00436618|590153950|FG002|Overall Study|Adverse Event|9|||
163393864|NCT00436618|590153948|FG000|Overall Study|Alternate Treatment|3|||
163393865|NCT00436618|590153949|FG001|Overall Study|Alternate Treatment|4|||
163393866|NCT00436618|590153950|FG002|Overall Study|Alternate Treatment|12|||
163393867|NCT00436618|590153948|FG000|Overall Study|Other Medical Problems|3|||
163393868|NCT00436618|590153949|FG001|Overall Study|Other Medical Problems|1|||
163393869|NCT00436618|590153950|FG002|Overall Study|Other Medical Problems|7|||
163393870|NCT00436618|590153948|FG000|Overall Study|Death|4|||
163393871|NCT00436618|590153949|FG001|Overall Study|Death|2|||
163393872|NCT00436618|590153950|FG002|Overall Study|Death|3|||
163393873|NCT00436618|590153948|FG000|Overall Study|New Primary or Other Reasons|6|||
163393874|NCT00436618|590153949|FG001|Overall Study|New Primary or Other Reasons|2|||
163393875|NCT00436618|590153950|FG002|Overall Study|New Primary or Other Reasons|12|||
163393876|NCT00436618|590153948|FG000|Overall Study|Still on treatment|1|||
163393877|NCT00436618|590153949|FG001|Overall Study|Still on treatment|2|||
163393878|NCT00436618|590153950|FG002|Overall Study|Still on treatment|7|||
163393879|NCT00698204|590153951|FG000|Overall Study|Withdrawal by Subject|1|||
163393880|NCT00698204|590153952|FG001|Overall Study|Withdrawal by Subject|0|||
163393881|NCT00314249|590153953|FG000|Overall Study|Adverse Event|73|||
163393882|NCT00314249|590153954|FG001|Overall Study|Adverse Event|94|||
163393883|NCT00314249|590153953|FG000|Overall Study|Lack of Efficacy|33|||
163393884|NCT00314249|590153954|FG001|Overall Study|Lack of Efficacy|24|||
163393885|NCT00314249|590153953|FG000|Overall Study|Withdrawal by Subject|21|||
163393886|NCT00314249|590153954|FG001|Overall Study|Withdrawal by Subject|28|||
163393887|NCT00314249|590153953|FG000|Overall Study|Lost to Follow-up|15|||
163393888|NCT00314249|590153954|FG001|Overall Study|Lost to Follow-up|9|||
163393889|NCT00314249|590153953|FG000|Overall Study|Physician Decision|1|||
163393890|NCT00314249|590153954|FG001|Overall Study|Physician Decision|1|||
163393891|NCT00314249|590153953|FG000|Overall Study|Withdrawn for other reasons|4|||
163393892|NCT00314249|590153954|FG001|Overall Study|Withdrawn for other reasons|1|||
163393893|NCT00314249|590153953|FG000|Overall Study|Non-Compliant|5|||
163393894|NCT00314249|590153954|FG001|Overall Study|Non-Compliant|6|||
163393895|NCT05395104|590153955|FG000|Overall Study|Met Liver Stopping Criteria|1|||
163393896|NCT05395104|590153955|FG000|Overall Study|Withdrawal by Subject|1|||
163393897|NCT04422990|590153958|FG000|Overall Study|Withdrawal by Subject|0|||
163393898|NCT04422990|590153959|FG001|Overall Study|Withdrawal by Subject|1|||
163393899|NCT04422990|590153958|FG000|Overall Study|Travel|3|||
163393900|NCT04422990|590153959|FG001|Overall Study|Travel|0|||
163393901|NCT05372653|590153963|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
163393902|NCT05372653|590153964|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
163393903|NCT05372653|590153963|FG000|Overall Study|Adverse Event|0|||
163393904|NCT05372653|590153964|FG001|Overall Study|Adverse Event|1|||
163393905|NCT00711529|590153965|FG000|Overall Study|Protocol Violation|2|||
163393906|NCT00711529|590153966|FG001|Overall Study|Protocol Violation|0|||
163393907|NCT00711529|590153965|FG000|Overall Study|Withdrawal by Subject|2|||
163393908|NCT00711529|590153966|FG001|Overall Study|Withdrawal by Subject|6|||
163393909|NCT03740997|590153967|FG000|Overall Study|Withdrawal by Subject|1|||
163393910|NCT03740997|590153968|FG001|Overall Study|Withdrawal by Subject|0|||
163393911|NCT03740997|590153967|FG000|Overall Study|Participant was unable to complete study procedures|1|||
163393912|NCT03740997|590153968|FG001|Overall Study|Participant was unable to complete study procedures|0|||
163393913|NCT01849497|590153970|FG000|Overall Study|Withdrawal by Subject|1|||
163393914|NCT01849497|590153971|FG001|Overall Study|Withdrawal by Subject|2|||
163393915|NCT01849497|590153970|FG000|Overall Study|Sponsor Decision|0|||
163393916|NCT01849497|590153971|FG001|Overall Study|Sponsor Decision|1|||
163393917|NCT01849497|590153970|FG000|Overall Study|Lost to Follow-up|0|||
163393918|NCT01849497|590153971|FG001|Overall Study|Lost to Follow-up|1|||
163393919|NCT00955279|590153972|FG000|Overall Study|Other|0|||
163393920|NCT00955279|590153973|FG001|Overall Study|Other|0|||
163393921|NCT00955279|590153974|FG002|Overall Study|Other|3|||
163393922|NCT00955279|590153972|FG000|Overall Study|Death|1|||
163393923|NCT00955279|590153973|FG001|Overall Study|Death|1|||
163393924|NCT00955279|590153974|FG002|Overall Study|Death|1|||
163393925|NCT00955279|590153972|FG000|Overall Study|Lost to Follow-up|0|||
163393926|NCT00955279|590153973|FG001|Overall Study|Lost to Follow-up|3|||
163393927|NCT00955279|590153974|FG002|Overall Study|Lost to Follow-up|1|||
163393928|NCT00955279|590153972|FG000|Overall Study|Withdrawal by Subject|2|||
163393929|NCT00955279|590153973|FG001|Overall Study|Withdrawal by Subject|0|||
163393930|NCT00955279|590153974|FG002|Overall Study|Withdrawal by Subject|3|||
163393931|NCT00999713|590153977|FG000|Overall Study|Physician Decision|2|||
163393932|NCT00999713|590153978|FG001|Overall Study|Physician Decision|0|||
163393933|NCT03346057|590153979|FG000|Overall Study|Death|1|||
163393934|NCT03346057|590153980|FG001|Overall Study|Death|2|||
163393935|NCT03346057|590153981|FG002|Overall Study|Death|0|||
163393936|NCT03346057|590153982|FG003|Overall Study|Death|0|||
163393937|NCT03346057|590153979|FG000|Overall Study|Lost to Follow-up|0|||
163393938|NCT03346057|590153980|FG001|Overall Study|Lost to Follow-up|2|||
163393939|NCT03346057|590153981|FG002|Overall Study|Lost to Follow-up|1|||
163393940|NCT03346057|590153982|FG003|Overall Study|Lost to Follow-up|0|||
163393941|NCT03346057|590153979|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
163393942|NCT03346057|590153980|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
163393943|NCT03346057|590153981|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
163393944|NCT03346057|590153982|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
163393945|NCT03346057|590153979|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
163393946|NCT03346057|590153980|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
163393947|NCT03346057|590153981|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
163393948|NCT03346057|590153982|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
163393949|NCT03346057|590153979|FG000|Overall Study|Physician Decision|3|||
163393950|NCT03346057|590153980|FG001|Overall Study|Physician Decision|2|||
163393951|NCT03346057|590153981|FG002|Overall Study|Physician Decision|0|||
163393952|NCT03346057|590153982|FG003|Overall Study|Physician Decision|2|||
163393953|NCT03346057|590153979|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
163393954|NCT03346057|590153980|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
163393955|NCT03346057|590153981|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
163393956|NCT03346057|590153982|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
163393957|NCT03346057|590153979|FG000|Overall Study|Withdrawal by Subject|1|||
163393958|NCT03346057|590153980|FG001|Overall Study|Withdrawal by Subject|0|||
163393959|NCT03346057|590153981|FG002|Overall Study|Withdrawal by Subject|0|||
163393960|NCT03346057|590153982|FG003|Overall Study|Withdrawal by Subject|0|||
163393961|NCT02921269|590153983|FG000|Overall Study|Did not complete DLT period|1|||
163393962|NCT00387764|590153994|FG000|Overall Study|Adverse Event|12|||
163393963|NCT00387764|590153994|FG000|Overall Study|Withdrawal by Subject|8|||
163393964|NCT00387764|590153994|FG000|Overall Study|Sponsor Terminated Study|1|||
163393965|NCT00387764|590153994|FG000|Overall Study|Physician Decision|1|||
163393966|NCT00387764|590153994|FG000|Overall Study|Other|2|||
163393967|NCT00387764|590153994|FG000|Overall Study|Death|7|||
163393968|NCT01184053|590153995|FG000|Overall Study|progression while on treatment|3|||
163393969|NCT01174238|590153998|FG000|Overall Study|Lost to Follow-up|2|||
163393970|NCT05975840|590154003|FG000|Overall Study|Other|1|||
163300231|NCT02723955|589807801|FG038|Crossover/ Re-treatment Phase|Death|14|||
163300232|NCT02723955|589807802|FG039|Crossover/ Re-treatment Phase|Death|32|||
163300233|NCT02723955|589807803|FG040|Crossover/ Re-treatment Phase|Death|2|||
163300234|NCT02723955|589807804|FG041|Crossover/ Re-treatment Phase|Death|1|||
163300235|NCT02723955|589807805|FG042|Crossover/ Re-treatment Phase|Death|0|||
163300236|NCT02723955|589807763|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300237|NCT02723955|589807764|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300238|NCT02723955|589807765|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300239|NCT02723955|589807766|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300240|NCT02723955|589807767|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300241|NCT02723955|589807768|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300242|NCT02723955|589807769|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300243|NCT02723955|589807770|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300244|NCT02723955|589807771|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300245|NCT02723955|589807772|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300246|NCT02723955|589807773|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300247|NCT02723955|589807774|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300248|NCT02723955|589807775|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300249|NCT02723955|589807776|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300250|NCT02723955|589807777|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300251|NCT02723955|589807778|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300252|NCT02723955|589807779|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300253|NCT02723955|589807780|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300254|NCT02723955|589807781|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300255|NCT02723955|589807782|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300256|NCT02723955|589807783|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300257|NCT02723955|589807784|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300258|NCT02723955|589807785|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300259|NCT02723955|589807786|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300260|NCT02723955|589807787|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300261|NCT02723955|589807788|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300262|NCT02723955|589807789|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300263|NCT02723955|589807790|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300264|NCT02723955|589807791|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300265|NCT02723955|589807792|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300266|NCT02723955|589807793|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300267|NCT02723955|589807794|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300268|NCT02723955|589807795|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300269|NCT02723955|589807796|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300270|NCT02723955|589807797|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300271|NCT02723955|589807798|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162956392|NCT00819741|588541486|FG000|Overall Study|Lack of Efficacy|0|||
162956393|NCT00819741|588541487|FG001|Overall Study|Lack of Efficacy|2|||
162956394|NCT00819741|588541486|FG000|Overall Study|Lost to Follow-up|3|||
162956395|NCT00819741|588541487|FG001|Overall Study|Lost to Follow-up|1|||
162956396|NCT00819741|588541486|FG000|Overall Study|Protocol Violation|3|||
162956397|NCT00819741|588541487|FG001|Overall Study|Protocol Violation|4|||
162956398|NCT00819741|588541486|FG000|Overall Study|Withdrawal by Subject|2|||
162956399|NCT00819741|588541487|FG001|Overall Study|Withdrawal by Subject|2|||
163300272|NCT02723955|589807799|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300273|NCT02723955|589807800|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300274|NCT02723955|589807801|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300275|NCT02723955|589807802|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
163300276|NCT02723955|589807803|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300277|NCT02723955|589807804|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300278|NCT02723955|589807805|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163300279|NCT02723955|589807763|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300280|NCT02723955|589807764|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300281|NCT02723955|589807765|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300282|NCT02723955|589807766|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300283|NCT02723955|589807767|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300284|NCT02723955|589807768|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300285|NCT02723955|589807769|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300286|NCT02723955|589807770|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300287|NCT02723955|589807771|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300288|NCT02723955|589807772|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300289|NCT02723955|589807773|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300290|NCT02723955|589807774|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300291|NCT02723955|589807775|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
163393971|NCT05975840|590154004|FG001|Overall Study|Other|0|||
162956400|NCT00819741|588541486|FG000|Overall Study|Unclassified|6|||
162956401|NCT00819741|588541487|FG001|Overall Study|Unclassified|0|||
163194980|NCT00040365|589428383|FG000|Overall Study|Death|1|||
162956402|NCT00819741|588541486|FG000|Overall Study|Reasons unknown|3|||
162956403|NCT00819741|588541487|FG001|Overall Study|Reasons unknown|3|||
162956404|NCT02222818|588543507|FG000|Period 1|Eligibility criteria not met|0|||
162956405|NCT02222818|588543508|FG001|Period 1|Eligibility criteria not met|3|||
162956406|NCT00834717|588543509|FG000|First Intervention|Adverse Event|1|||
162956407|NCT00834717|588543510|FG001|First Intervention|Adverse Event|0|||
162956408|NCT00834717|588543509|FG000|First Intervention|Withdrawal by Subject|0|||
162956409|NCT00834717|588543510|FG001|First Intervention|Withdrawal by Subject|1|||
162956410|NCT01660243|588543511|FG000|Overall Study|Adverse Event|1|||
162956411|NCT01660243|588543512|FG001|Overall Study|Adverse Event|0|||
162956412|NCT01660243|588543513|FG002|Overall Study|Adverse Event|1|||
162956413|NCT01660243|588543514|FG003|Overall Study|Adverse Event|0|||
162956414|NCT01660243|588543511|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
162956415|NCT01660243|588543512|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
162956416|NCT01660243|588543513|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
162956417|NCT01660243|588543514|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
162956418|NCT01660243|588543511|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
162956419|NCT01660243|588543512|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
162956420|NCT01660243|588543513|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
162956421|NCT01660243|588543514|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
162956422|NCT01660243|588543511|FG000|Overall Study|Randomization error|0|||
162956423|NCT01660243|588543512|FG001|Overall Study|Randomization error|0|||
162956424|NCT01660243|588543513|FG002|Overall Study|Randomization error|0|||
162956425|NCT01660243|588543514|FG003|Overall Study|Randomization error|1|||
162956426|NCT04299087|588543515|FG000|Overall Study|Lost to Follow-up|2|||
162956427|NCT04299087|588543516|FG001|Overall Study|Lost to Follow-up|1|||
162956428|NCT03025087|588543517|FG000|Overall Study|Physician Decision|3|||
162956429|NCT03025087|588543518|FG001|Overall Study|Physician Decision|3|||
162956430|NCT03025087|588543519|FG002|Overall Study|Physician Decision|0|||
162956431|NCT03025087|588543520|FG003|Overall Study|Physician Decision|0|||
162956432|NCT03025087|588543521|FG004|Overall Study|Physician Decision|0|||
162956433|NCT03025087|588543517|FG000|Overall Study|Withdrawal by Subject|1|||
162956434|NCT03025087|588543518|FG001|Overall Study|Withdrawal by Subject|1|||
162956435|NCT03025087|588543519|FG002|Overall Study|Withdrawal by Subject|0|||
162956436|NCT03025087|588543520|FG003|Overall Study|Withdrawal by Subject|0|||
162956437|NCT03025087|588543521|FG004|Overall Study|Withdrawal by Subject|0|||
162956438|NCT03025087|588543517|FG000|Overall Study|Unable to complete MRI|2|||
162956439|NCT03025087|588543518|FG001|Overall Study|Unable to complete MRI|2|||
162956440|NCT03025087|588543519|FG002|Overall Study|Unable to complete MRI|0|||
162956441|NCT03025087|588543520|FG003|Overall Study|Unable to complete MRI|0|||
162956442|NCT03025087|588543521|FG004|Overall Study|Unable to complete MRI|0|||
162956443|NCT00594035|588543522|FG000|Overall Study|Lost to Follow-up|1|||
162956444|NCT00594035|588543523|FG001|Overall Study|Lost to Follow-up|1|||
162956445|NCT00594035|588543522|FG000|Overall Study|Withdrawal by Subject|1|||
162956446|NCT00594035|588543523|FG001|Overall Study|Withdrawal by Subject|0|||
162956447|NCT00594035|588543522|FG000|Overall Study|Subject transferred to nursing home|0|||
162956448|NCT00594035|588543523|FG001|Overall Study|Subject transferred to nursing home|1|||
162956449|NCT00594035|588543522|FG000|Overall Study|Subject couldn't return due to job|0|||
162956450|NCT00594035|588543523|FG001|Overall Study|Subject couldn't return due to job|1|||
162956451|NCT00795821|588543524|FG000|Acute Treatment Phase|Adverse Event|23|||
162956452|NCT00795821|588543525|FG001|Acute Treatment Phase|Adverse Event|4|||
162956453|NCT00795821|588543524|FG000|Acute Treatment Phase|Death|1|||
162956454|NCT00795821|588543525|FG001|Acute Treatment Phase|Death|0|||
162956455|NCT00795821|588543524|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
162956456|NCT00795821|588543525|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
162956457|NCT00795821|588543524|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
163194981|NCT00040365|589428383|FG000|Overall Study|Progressive disease|7|||
163194982|NCT00040365|589428383|FG000|Overall Study|Lost to Follow-up|3|||
163194983|NCT01397890|589428392|FG000|Overall Study|Withdrawal by Subject|7|||
163194984|NCT01397890|589428393|FG001|Overall Study|Withdrawal by Subject|11|||
163194985|NCT01397890|589428392|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
163194986|NCT01397890|589428393|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
163194987|NCT01397890|589428392|FG000|Overall Study|Death|2|||
162956458|NCT00795821|588543525|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
162956459|NCT00795821|588543524|FG000|Acute Treatment Phase|Physician Decision|1|||
162956460|NCT00795821|588543525|FG001|Acute Treatment Phase|Physician Decision|1|||
162956461|NCT00795821|588543524|FG000|Acute Treatment Phase|Protocol Violation|1|||
163044793|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
163044794|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
163194988|NCT01397890|589428393|FG001|Overall Study|Death|3|||
163194989|NCT01397890|589428392|FG000|Overall Study|Lost to Follow-up|1|||
163194990|NCT01397890|589428393|FG001|Overall Study|Lost to Follow-up|4|||
163194991|NCT01397890|589428392|FG000|Overall Study|Condition under Investigation Worsened|1|||
162956462|NCT00795821|588543525|FG001|Acute Treatment Phase|Protocol Violation|2|||
163393972|NCT05975840|590154005|FG002|Overall Study|Other|0|||
162956463|NCT00795821|588543524|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
162956464|NCT00795821|588543525|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
162956465|NCT00795821|588543524|FG000|Long-term Extension Phase|Adverse Event|25|||
162956466|NCT00795821|588543525|FG001|Long-term Extension Phase|Adverse Event|32|||
162956467|NCT00795821|588543524|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
162956468|NCT00795821|588543525|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
162956469|NCT00795821|588543524|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
162956470|NCT00795821|588543525|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
162956471|NCT00795821|588543524|FG000|Long-term Extension Phase|Physician Decision|1|||
162956472|NCT00795821|588543525|FG001|Long-term Extension Phase|Physician Decision|2|||
162956473|NCT00795821|588543524|FG000|Long-term Extension Phase|Protocol Violation|3|||
162956474|NCT00795821|588543525|FG001|Long-term Extension Phase|Protocol Violation|5|||
162956475|NCT00795821|588543524|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
162956476|NCT00795821|588543525|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
162956477|NCT00795821|588543524|FG000|Taper Phase|Adverse Event|2|||
162956478|NCT00795821|588543525|FG001|Taper Phase|Adverse Event|0|||
162956479|NCT00795821|588543524|FG000|Taper Phase|Lost to Follow-up|1|||
162956480|NCT00795821|588543525|FG001|Taper Phase|Lost to Follow-up|0|||
162956481|NCT00795821|588543524|FG000|Taper Phase|Physician Decision|2|||
162956482|NCT00795821|588543525|FG001|Taper Phase|Physician Decision|0|||
162956483|NCT00795821|588543524|FG000|Taper Phase|Withdrawal by Subject|4|||
162956484|NCT00795821|588543525|FG001|Taper Phase|Withdrawal by Subject|0|||
162956485|NCT00440518|588543531|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
162956486|NCT00440518|588543532|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
162956487|NCT00440518|588543533|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
162956488|NCT00440518|588543531|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
162956489|NCT00440518|588543532|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
162956490|NCT00440518|588543533|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
162956491|NCT00440518|588543531|FG000|Randomized /Titration Period|Protocol Deviation|1|||
162956492|NCT00440518|588543532|FG001|Randomized /Titration Period|Protocol Deviation|0|||
162956493|NCT00440518|588543533|FG002|Randomized /Titration Period|Protocol Deviation|0|||
162956494|NCT00440518|588543531|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
162956495|NCT00440518|588543532|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
162956496|NCT00440518|588543533|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
162956497|NCT00440518|588543531|FG000|Randomized /Titration Period|Other|1|||
162956498|NCT00440518|588543532|FG001|Randomized /Titration Period|Other|0|||
162956499|NCT00440518|588543533|FG002|Randomized /Titration Period|Other|0|||
162956500|NCT00440518|588543531|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
162956501|NCT00440518|588543532|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
162956502|NCT00440518|588543533|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
162956503|NCT00440518|588543531|FG000|Randomized /Titration Period|Adverse Event|2|||
162956504|NCT00440518|588543532|FG001|Randomized /Titration Period|Adverse Event|3|||
162956505|NCT00440518|588543533|FG002|Randomized /Titration Period|Adverse Event|0|||
162956506|NCT00440518|588543531|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
162956507|NCT00440518|588543532|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
162956508|NCT00440518|588543533|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
162956509|NCT00440518|588543531|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
162956510|NCT00440518|588543532|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
162956511|NCT00440518|588543533|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
162956512|NCT00440518|588543531|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
162956513|NCT00440518|588543532|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
162956514|NCT00440518|588543533|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
162956515|NCT00440518|588543531|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
162956516|NCT00440518|588543532|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
163300292|NCT02723955|589807776|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300293|NCT02723955|589807777|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300294|NCT02723955|589807778|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300295|NCT02723955|589807779|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300296|NCT02723955|589807780|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300297|NCT02723955|589807781|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300298|NCT02723955|589807782|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300299|NCT02723955|589807783|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300300|NCT02723955|589807784|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300301|NCT02723955|589807785|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300302|NCT02723955|589807786|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300303|NCT02723955|589807787|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300304|NCT02723955|589807788|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
162956517|NCT00440518|588543533|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
162956518|NCT00440518|588543531|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
162956519|NCT00440518|588543532|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
163300305|NCT02723955|589807789|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300306|NCT02723955|589807790|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300307|NCT02723955|589807791|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300308|NCT02723955|589807792|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300309|NCT02723955|589807793|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300310|NCT02723955|589807794|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300311|NCT02723955|589807795|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300312|NCT02723955|589807796|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300313|NCT02723955|589807797|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300314|NCT02723955|589807798|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300315|NCT02723955|589807799|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300316|NCT02723955|589807800|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300317|NCT02723955|589807801|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
163300318|NCT02723955|589807802|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
163300319|NCT02723955|589807803|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
163300320|NCT02723955|589807804|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
162956520|NCT00440518|588543533|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
162956521|NCT00440518|588543531|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
163300321|NCT02723955|589807805|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
163300322|NCT02723955|589807763|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
163300323|NCT02723955|589807764|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
163044795|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
163044796|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
163044797|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
163044798|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
163044799|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
163044800|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
163044801|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
163044802|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
163044803|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
163044804|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
163044805|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
163044806|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
163044807|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
163044808|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
163044809|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
163044810|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
163044811|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
163044812|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
163044813|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044814|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044815|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044816|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044817|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
163044818|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044819|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
163044820|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
163044821|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044822|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
163044823|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
163044824|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
163044825|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
163044826|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
163044827|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
163044828|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044829|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
163044830|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
163044831|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044832|NCT01300247|588871505|FG000|Overall Study|Death|1|||
163044833|NCT01300247|588871506|FG001|Overall Study|Death|1|||
163044834|NCT01300247|588871505|FG000|Overall Study|Lost to Follow-up|2|||
163044835|NCT01300247|588871506|FG001|Overall Study|Lost to Follow-up|0|||
163044836|NCT01300247|588871505|FG000|Overall Study|Withdrawal by Subject|1|||
163044837|NCT01300247|588871506|FG001|Overall Study|Withdrawal by Subject|0|||
163044838|NCT01300247|588871505|FG000|Overall Study|Non-Compliance|0|||
163044839|NCT01300247|588871506|FG001|Overall Study|Non-Compliance|1|||
163044840|NCT03990051|588871507|FG000|Masked Period|Lost to Follow-up|1|||
163044841|NCT03990051|588871508|FG001|Masked Period|Lost to Follow-up|0|||
163044842|NCT03990051|588871507|FG000|Long Term Period|Death|1|||
163044843|NCT03990051|588871508|FG001|Long Term Period|Death|1|||
163044844|NCT03990051|588871507|FG000|Long Term Period|Lost to Follow-up|7|||
163044845|NCT03990051|588871508|FG001|Long Term Period|Lost to Follow-up|2|||
163044846|NCT01720524|588871509|FG000|Part A|Insufficient Clinical Response|2|||
163044847|NCT01720524|588871510|FG001|Part A|Insufficient Clinical Response|4|||
163044848|NCT01720524|588871509|FG000|Part A|Adverse Event|2|||
163044849|NCT01720524|588871510|FG001|Part A|Adverse Event|2|||
163044850|NCT01720524|588871509|FG000|Part A|Death|2|||
163044851|NCT01720524|588871510|FG001|Part A|Death|1|||
163044852|NCT01720524|588871509|FG000|Part A|Lost to Follow-up|0|||
163044853|NCT01720524|588871510|FG001|Part A|Lost to Follow-up|1|||
163300324|NCT02723955|589807765|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
163300325|NCT02723955|589807766|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
163300326|NCT02723955|589807767|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
163300327|NCT02723955|589807768|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
163300328|NCT02723955|589807769|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
163300329|NCT02723955|589807770|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
163300330|NCT02723955|589807771|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
163300331|NCT02723955|589807772|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
163300332|NCT02723955|589807773|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
163393973|NCT05975840|590154006|FG003|Overall Study|Other|0|||
163393974|NCT05975840|590154007|FG004|Overall Study|Other|1|||
163393975|NCT05975840|590154008|FG005|Overall Study|Other|0|||
163393976|NCT05975840|590154009|FG006|Overall Study|Other|0|||
163393977|NCT05975840|590154010|FG007|Overall Study|Other|0|||
163393978|NCT05975840|590154003|FG000|Overall Study|Lost to Follow-up|3|||
163393979|NCT05975840|590154004|FG001|Overall Study|Lost to Follow-up|6|||
163393980|NCT05975840|590154005|FG002|Overall Study|Lost to Follow-up|3|||
163393981|NCT05975840|590154006|FG003|Overall Study|Lost to Follow-up|1|||
163393982|NCT05975840|590154007|FG004|Overall Study|Lost to Follow-up|4|||
162956522|NCT00440518|588543532|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
162956523|NCT00440518|588543533|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
163393983|NCT05975840|590154008|FG005|Overall Study|Lost to Follow-up|1|||
163393984|NCT05975840|590154009|FG006|Overall Study|Lost to Follow-up|2|||
163393985|NCT05975840|590154010|FG007|Overall Study|Lost to Follow-up|4|||
163393986|NCT05975840|590154003|FG000|Overall Study|Migrated/moved from the study area|1|||
163393987|NCT05975840|590154004|FG001|Overall Study|Migrated/moved from the study area|0|||
163393988|NCT05975840|590154005|FG002|Overall Study|Migrated/moved from the study area|0|||
163393989|NCT05975840|590154006|FG003|Overall Study|Migrated/moved from the study area|0|||
163393990|NCT05975840|590154007|FG004|Overall Study|Migrated/moved from the study area|0|||
163393991|NCT05975840|590154008|FG005|Overall Study|Migrated/moved from the study area|0|||
163393992|NCT05975840|590154009|FG006|Overall Study|Migrated/moved from the study area|0|||
163393993|NCT05975840|590154010|FG007|Overall Study|Migrated/moved from the study area|0|||
163393994|NCT05975840|590154003|FG000|Overall Study|Withdrawal by Subject|0|||
163393995|NCT05975840|590154004|FG001|Overall Study|Withdrawal by Subject|5|||
163393996|NCT05975840|590154005|FG002|Overall Study|Withdrawal by Subject|2|||
163393997|NCT05975840|590154006|FG003|Overall Study|Withdrawal by Subject|2|||
163393998|NCT05975840|590154007|FG004|Overall Study|Withdrawal by Subject|0|||
163393999|NCT05975840|590154008|FG005|Overall Study|Withdrawal by Subject|2|||
163394000|NCT05975840|590154009|FG006|Overall Study|Withdrawal by Subject|2|||
163394001|NCT05975840|590154010|FG007|Overall Study|Withdrawal by Subject|1|||
163394002|NCT05975840|590154003|FG000|Overall Study|Protocol Violation|0|||
163394003|NCT05975840|590154004|FG001|Overall Study|Protocol Violation|1|||
163394004|NCT05975840|590154005|FG002|Overall Study|Protocol Violation|0|||
163394005|NCT05975840|590154006|FG003|Overall Study|Protocol Violation|0|||
163394006|NCT05975840|590154007|FG004|Overall Study|Protocol Violation|0|||
163394007|NCT05975840|590154008|FG005|Overall Study|Protocol Violation|0|||
163394008|NCT05975840|590154009|FG006|Overall Study|Protocol Violation|0|||
163394009|NCT05975840|590154010|FG007|Overall Study|Protocol Violation|0|||
163394010|NCT05975840|590154003|FG000|Overall Study|Adverse Event|0|||
163394011|NCT05975840|590154004|FG001|Overall Study|Adverse Event|0|||
163394012|NCT05975840|590154005|FG002|Overall Study|Adverse Event|0|||
163394013|NCT05975840|590154006|FG003|Overall Study|Adverse Event|1|||
163394014|NCT05975840|590154007|FG004|Overall Study|Adverse Event|0|||
163394015|NCT05975840|590154008|FG005|Overall Study|Adverse Event|0|||
163394016|NCT05975840|590154009|FG006|Overall Study|Adverse Event|0|||
163394017|NCT05975840|590154010|FG007|Overall Study|Adverse Event|0|||
163394018|NCT05975840|590154003|FG000|Overall Study|Death|0|||
163394019|NCT05975840|590154004|FG001|Overall Study|Death|1|||
163394020|NCT05975840|590154005|FG002|Overall Study|Death|0|||
163394021|NCT05975840|590154006|FG003|Overall Study|Death|0|||
163394022|NCT05975840|590154007|FG004|Overall Study|Death|0|||
163394023|NCT05975840|590154008|FG005|Overall Study|Death|0|||
163394024|NCT05975840|590154009|FG006|Overall Study|Death|0|||
163394025|NCT05975840|590154010|FG007|Overall Study|Death|1|||
163394026|NCT00232141|590154013|FG000|Overall Study|Adverse Event|9|||
163394027|NCT00232141|590154014|FG001|Overall Study|Adverse Event|4|||
163394028|NCT00232141|590154013|FG000|Overall Study|Lack of Efficacy|0|||
163394029|NCT00232141|590154014|FG001|Overall Study|Lack of Efficacy|3|||
163394030|NCT00232141|590154013|FG000|Overall Study|Lost to Follow-up|9|||
163394031|NCT00232141|590154014|FG001|Overall Study|Lost to Follow-up|6|||
162956524|NCT03570749|588543534|FG000|Overall Study|Ongoing|26|||
162956525|NCT03570749|588543535|FG001|Overall Study|Ongoing|25|||
162956526|NCT03570749|588543536|FG002|Overall Study|Ongoing|25|||
162956527|NCT03570749|588543537|FG003|Overall Study|Ongoing|26|||
163194992|NCT01397890|589428393|FG001|Overall Study|Condition under Investigation Worsened|3|||
163194993|NCT01397890|589428392|FG000|Overall Study|Adverse Event|1|||
163194994|NCT01397890|589428393|FG001|Overall Study|Adverse Event|2|||
163194995|NCT01397890|589428392|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
163194996|NCT01397890|589428393|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
163394032|NCT00232141|590154013|FG000|Overall Study|Other|8|||
163394033|NCT00232141|590154014|FG001|Overall Study|Other|10|||
163394034|NCT00232141|590154013|FG000|Overall Study|Withdrawal by Subject|5|||
163394035|NCT00232141|590154014|FG001|Overall Study|Withdrawal by Subject|3|||
163394036|NCT00972777|590154017|FG000|Overall Study|Adverse Event|3|||
163394037|NCT00972777|590154018|FG001|Overall Study|Adverse Event|2|||
163394038|NCT00972777|590154017|FG000|Overall Study|Lost to Follow-up|0|||
163394039|NCT00972777|590154018|FG001|Overall Study|Lost to Follow-up|4|||
163394040|NCT00972777|590154017|FG000|Overall Study|Withdrawal by Subject|4|||
163394041|NCT00972777|590154018|FG001|Overall Study|Withdrawal by Subject|5|||
163394042|NCT00972777|590154017|FG000|Overall Study|Physician Decision|4|||
162956528|NCT03570749|588543538|FG004|Overall Study|Ongoing|140|||
162956529|NCT03570749|588543539|FG005|Overall Study|Ongoing|142|||
163194997|NCT01397890|589428392|FG000|Overall Study|Others|2|||
163394043|NCT00972777|590154018|FG001|Overall Study|Physician Decision|0|||
163394044|NCT00972777|590154017|FG000|Overall Study|Protocol Violation|0|||
163394045|NCT00972777|590154018|FG001|Overall Study|Protocol Violation|2|||
163394046|NCT00972777|590154017|FG000|Overall Study|Screening Failure|2|||
163394047|NCT00972777|590154018|FG001|Overall Study|Screening Failure|1|||
163394048|NCT00972777|590154017|FG000|Overall Study|Missed visit|1|||
163394049|NCT00972777|590154018|FG001|Overall Study|Missed visit|0|||
163394050|NCT06950879|590154019|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
163394051|NCT00525044|590155624|FG000|Overall Study|Lost to Follow-up|0|||
163394052|NCT00525044|590155625|FG001|Overall Study|Lost to Follow-up|1|||
163394053|NCT02460497|590155630|FG000|Overall Study|Participant Requested Withdrawal|4|||
163394054|NCT02460497|590155630|FG000|Overall Study|Non-Compliance|1|||
163394055|NCT02460497|590155630|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
162956530|NCT03570749|588543540|FG006|Overall Study|Ongoing|220|||
162956531|NCT03570749|588543534|FG000|Overall Study|Adverse Event|0|||
162956532|NCT03570749|588543535|FG001|Overall Study|Adverse Event|0|||
162956533|NCT03570749|588543536|FG002|Overall Study|Adverse Event|0|||
162956534|NCT03570749|588543537|FG003|Overall Study|Adverse Event|0|||
162956535|NCT03570749|588543538|FG004|Overall Study|Adverse Event|2|||
162956536|NCT03570749|588543539|FG005|Overall Study|Adverse Event|3|||
162956537|NCT03570749|588543540|FG006|Overall Study|Adverse Event|6|||
162956538|NCT03570749|588543534|FG000|Overall Study|Lack of Efficacy|0|||
162956539|NCT03570749|588543535|FG001|Overall Study|Lack of Efficacy|0|||
162956540|NCT03570749|588543536|FG002|Overall Study|Lack of Efficacy|0|||
162956541|NCT03570749|588543537|FG003|Overall Study|Lack of Efficacy|0|||
162956542|NCT03570749|588543538|FG004|Overall Study|Lack of Efficacy|8|||
162956543|NCT03570749|588543539|FG005|Overall Study|Lack of Efficacy|2|||
162956544|NCT03570749|588543540|FG006|Overall Study|Lack of Efficacy|7|||
162956545|NCT03570749|588543534|FG000|Overall Study|Lost to Follow-up|0|||
162956546|NCT03570749|588543535|FG001|Overall Study|Lost to Follow-up|0|||
162956547|NCT03570749|588543536|FG002|Overall Study|Lost to Follow-up|0|||
162956548|NCT03570749|588543537|FG003|Overall Study|Lost to Follow-up|0|||
162956549|NCT03570749|588543538|FG004|Overall Study|Lost to Follow-up|5|||
162956550|NCT03570749|588543539|FG005|Overall Study|Lost to Follow-up|10|||
162956551|NCT03570749|588543540|FG006|Overall Study|Lost to Follow-up|10|||
162956552|NCT03570749|588543534|FG000|Overall Study|Pregnancy|0|||
162956553|NCT03570749|588543535|FG001|Overall Study|Pregnancy|0|||
162956554|NCT03570749|588543536|FG002|Overall Study|Pregnancy|0|||
162956555|NCT03570749|588543537|FG003|Overall Study|Pregnancy|0|||
162956556|NCT03570749|588543538|FG004|Overall Study|Pregnancy|0|||
163194998|NCT01397890|589428393|FG001|Overall Study|Others|1|||
163194999|NCT02763462|589428397|FG000|Overall Study|Protocol Violation|6|||
163195000|NCT00129272|589428398|FG000|Overall Study|Lost to Follow-up|12|||
163195001|NCT00129272|589428399|FG001|Overall Study|Lost to Follow-up|11|||
163195002|NCT00129272|589428398|FG000|Overall Study|Withdrawal by Subject|5|||
163195003|NCT00129272|589428399|FG001|Overall Study|Withdrawal by Subject|11|||
163195004|NCT00675948|589428401|FG000|Overall Study|Adverse Event|23|||
163195005|NCT00675948|589428402|FG001|Overall Study|Adverse Event|1|||
163195006|NCT00675948|589428401|FG000|Overall Study|Lack of Efficacy|3|||
163195007|NCT00675948|589428402|FG001|Overall Study|Lack of Efficacy|0|||
163195008|NCT00675948|589428401|FG000|Overall Study|Withdrawal by Subject|7|||
163195009|NCT00675948|589428402|FG001|Overall Study|Withdrawal by Subject|0|||
163195010|NCT00675948|589428401|FG000|Overall Study|Lost to Follow-up|2|||
163300333|NCT02723955|589807774|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
163300334|NCT02723955|589807775|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
163300335|NCT02723955|589807776|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
163300336|NCT02723955|589807777|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
163300337|NCT02723955|589807778|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
163300338|NCT02723955|589807779|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
163300339|NCT02723955|589807780|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
163300340|NCT02723955|589807781|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
163300341|NCT02723955|589807782|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
163300342|NCT02723955|589807783|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
163300343|NCT02723955|589807784|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
163300344|NCT02723955|589807785|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
163300345|NCT02723955|589807786|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
163300346|NCT02723955|589807787|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
163300347|NCT02723955|589807788|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
163300348|NCT02723955|589807789|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
163300349|NCT02723955|589807790|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
163300350|NCT02723955|589807791|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
163300351|NCT02723955|589807792|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
163300352|NCT02723955|589807793|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
163300353|NCT02723955|589807794|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
163300354|NCT02723955|589807795|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
163300355|NCT02723955|589807796|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
163300356|NCT02723955|589807797|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
163300357|NCT02723955|589807798|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
163300358|NCT02723955|589807799|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
162956557|NCT03570749|588543539|FG005|Overall Study|Pregnancy|1|||
162956558|NCT03570749|588543540|FG006|Overall Study|Pregnancy|1|||
163300359|NCT02723955|589807800|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
163300360|NCT02723955|589807801|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
163394056|NCT02460497|590155630|FG000|Overall Study|Lost to Follow-up|2|||
163300361|NCT02723955|589807802|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
163300362|NCT02723955|589807803|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
163300363|NCT02723955|589807804|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
163300364|NCT02723955|589807805|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
163300365|NCT04999085|589807808|FG000|Overall Study|Death|1|||
163300366|NCT05057897|589807809|FG000|Overall Study|Site closure|2|||
163300367|NCT05057897|589807810|FG001|Overall Study|Site closure|2|||
163300368|NCT05057897|589807809|FG000|Overall Study|Death|1|||
162956559|NCT03570749|588543534|FG000|Overall Study|Screen Fail|0|||
162956560|NCT03570749|588543535|FG001|Overall Study|Screen Fail|0|||
162956561|NCT03570749|588543536|FG002|Overall Study|Screen Fail|0|||
162956562|NCT03570749|588543537|FG003|Overall Study|Screen Fail|0|||
162956563|NCT03570749|588543538|FG004|Overall Study|Screen Fail|0|||
162956564|NCT03570749|588543539|FG005|Overall Study|Screen Fail|0|||
162956565|NCT03570749|588543540|FG006|Overall Study|Screen Fail|1|||
162956566|NCT03570749|588543534|FG000|Overall Study|Withdrawal by Subject|2|||
162956567|NCT03570749|588543535|FG001|Overall Study|Withdrawal by Subject|3|||
162956568|NCT03570749|588543536|FG002|Overall Study|Withdrawal by Subject|2|||
162956569|NCT03570749|588543537|FG003|Overall Study|Withdrawal by Subject|1|||
162956570|NCT03570749|588543538|FG004|Overall Study|Withdrawal by Subject|17|||
162956571|NCT03570749|588543539|FG005|Overall Study|Withdrawal by Subject|12|||
162956572|NCT03570749|588543540|FG006|Overall Study|Withdrawal by Subject|15|||
162956573|NCT03570749|588543534|FG000|Overall Study|Other|0|||
162956574|NCT03570749|588543535|FG001|Overall Study|Other|0|||
162956575|NCT03570749|588543536|FG002|Overall Study|Other|0|||
162956576|NCT03570749|588543537|FG003|Overall Study|Other|0|||
162956577|NCT03570749|588543538|FG004|Overall Study|Other|17|||
162956578|NCT03570749|588543539|FG005|Overall Study|Other|14|||
162956579|NCT03570749|588543540|FG006|Overall Study|Other|21|||
162956580|NCT00561015|588543541|FG000|Overall Study|Adverse Event|0|||
162956581|NCT00561015|588543542|FG001|Overall Study|Adverse Event|0|||
162956582|NCT00561015|588543543|FG002|Overall Study|Adverse Event|0|||
162956583|NCT00561015|588543544|FG003|Overall Study|Adverse Event|0|||
162956584|NCT00561015|588543545|FG004|Overall Study|Adverse Event|1|||
162956585|NCT00561015|588543546|FG005|Overall Study|Adverse Event|0|||
162956586|NCT00561015|588543541|FG000|Overall Study|Lost to Follow-up|2|||
162956587|NCT00561015|588543542|FG001|Overall Study|Lost to Follow-up|0|||
162956588|NCT00561015|588543543|FG002|Overall Study|Lost to Follow-up|0|||
162956589|NCT00561015|588543544|FG003|Overall Study|Lost to Follow-up|1|||
162956590|NCT00561015|588543545|FG004|Overall Study|Lost to Follow-up|0|||
162956591|NCT00561015|588543546|FG005|Overall Study|Lost to Follow-up|3|||
163300369|NCT05057897|589807810|FG001|Overall Study|Death|0|||
163300370|NCT04540913|589807816|FG000|Overall Study|Withdrawal by Subject|14|||
163300371|NCT04540913|589807817|FG001|Overall Study|Withdrawal by Subject|3|||
163300372|NCT04440176|589807818|FG000|Overall Study|Withdrawal by Subject|5|||
163300373|NCT04440176|589807819|FG001|Overall Study|Withdrawal by Subject|3|||
163300374|NCT04440176|589807818|FG000|Overall Study|Withdrawal by parent/guardian|4|||
163300375|NCT04440176|589807819|FG001|Overall Study|Withdrawal by parent/guardian|5|||
163300376|NCT04440176|589807818|FG000|Overall Study|Adverse Event|2|||
163300377|NCT04440176|589807819|FG001|Overall Study|Adverse Event|6|||
163300378|NCT04440176|589807818|FG000|Overall Study|Lost to Follow-up|22|||
163300379|NCT04440176|589807819|FG001|Overall Study|Lost to Follow-up|23|||
163300380|NCT04440176|589807818|FG000|Overall Study|Medication error without associated adverse event|0|||
163300381|NCT04440176|589807819|FG001|Overall Study|Medication error without associated adverse event|1|||
163300382|NCT04440176|589807818|FG000|Overall Study|No longer met eligibility criteria|7|||
163300383|NCT04440176|589807819|FG001|Overall Study|No longer met eligibility criteria|1|||
163300384|NCT04440176|589807818|FG000|Overall Study|Other|1|||
163300385|NCT04440176|589807819|FG001|Overall Study|Other|2|||
163300386|NCT04440176|589807818|FG000|Overall Study|Protocol deviation|6|||
163300387|NCT04440176|589807819|FG001|Overall Study|Protocol deviation|8|||
163300388|NCT04440176|589807818|FG000|Overall Study|Randomized but not vaccinated|6|||
163300389|NCT04440176|589807819|FG001|Overall Study|Randomized but not vaccinated|3|||
163300390|NCT04188379|589807820|FG000|Overall Study|Withdrawal by Subject|10|||
163300391|NCT04188379|589807821|FG001|Overall Study|Withdrawal by Subject|3|||
163300392|NCT04188379|589807820|FG000|Overall Study|Physician Decision|0|||
163300393|NCT04188379|589807821|FG001|Overall Study|Physician Decision|1|||
163300394|NCT04188379|589807820|FG000|Overall Study|Adverse Event|3|||
163300395|NCT04188379|589807821|FG001|Overall Study|Adverse Event|1|||
163300396|NCT04188379|589807820|FG000|Overall Study|Pregnancy|1|||
163300397|NCT04188379|589807821|FG001|Overall Study|Pregnancy|0|||
163300398|NCT04188379|589807820|FG000|Overall Study|Lack of Efficacy|8|||
163300399|NCT04188379|589807821|FG001|Overall Study|Lack of Efficacy|5|||
162956592|NCT00561015|588543541|FG000|Overall Study|Participant non-compliance|2|||
162956593|NCT00561015|588543542|FG001|Overall Study|Participant non-compliance|0|||
162956594|NCT00561015|588543543|FG002|Overall Study|Participant non-compliance|0|||
163300400|NCT04188379|589807820|FG000|Overall Study|Other|0|||
163300401|NCT04188379|589807821|FG001|Overall Study|Other|3|||
162956595|NCT00561015|588543544|FG003|Overall Study|Participant non-compliance|0|||
162956596|NCT00561015|588543545|FG004|Overall Study|Participant non-compliance|0|||
162956597|NCT00561015|588543546|FG005|Overall Study|Participant non-compliance|0|||
162956598|NCT02146105|588543547|FG000|Overall Study|Adverse Event|1|||
162956599|NCT02146105|588543547|FG000|Overall Study|Withdrawal by Subject|5|||
162956600|NCT03086460|588543548|FG000|Study Participants|Lost to Follow-up|2|||
162956601|NCT03086460|588543548|FG000|Study Participants|Protocol Violation|1|||
162956602|NCT03086460|588543548|FG000|Study Participants|Withdrawal by Subject|6|||
162956603|NCT03086460|588543548|FG000|Treatment A|Lost to Follow-up|1|||
162956604|NCT03086460|588543548|FG000|Treatment A|Protocol Violation|1|||
162956605|NCT03086460|588543548|FG000|Treatment A|Withdrawal by Subject|2|||
162956606|NCT03086460|588543548|FG000|Treatment C|Withdrawal by Subject|2|||
162956607|NCT03086460|588543548|FG000|Treatment E|Lost to Follow-up|1|||
162956608|NCT03086460|588543548|FG000|Treatment E|Withdrawal by Subject|3|||
162956609|NCT02545283|588543549|FG000|Overall Study|Lost to Follow-up|2|||
162956610|NCT02545283|588543550|FG001|Overall Study|Lost to Follow-up|4|||
162956611|NCT02545283|588543549|FG000|Overall Study|Withdrawal by Subject|5|||
162956612|NCT02545283|588543550|FG001|Overall Study|Withdrawal by Subject|9|||
162956613|NCT02545283|588543549|FG000|Overall Study|Death|109|||
162956614|NCT02545283|588543550|FG001|Overall Study|Death|211|||
162956615|NCT02545283|588543549|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
162956616|NCT02545283|588543550|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
162956617|NCT02545283|588543549|FG000|Overall Study|Study Terminated By Sponsor|33|||
162956618|NCT02545283|588543550|FG001|Overall Study|Study Terminated By Sponsor|71|||
162956619|NCT02436005|588543551|FG000|Second Intervention|Adverse Event|0|||
162956620|NCT02436005|588543552|FG001|Second Intervention|Adverse Event|1|||
162956621|NCT00583453|588543553|FG000|Overall Study|discontinued intervention|0|||
162956622|NCT00583453|588543554|FG001|Overall Study|discontinued intervention|2|||
162956623|NCT00905606|588543555|FG000|Period 1|Adverse Event|0|||
162956624|NCT00905606|588543556|FG001|Period 1|Adverse Event|1|||
162956625|NCT00905606|588543555|FG000|Washout|Withdrawal by Subject|1|||
162956626|NCT00905606|588543556|FG001|Washout|Withdrawal by Subject|0|||
162956627|NCT00455312|588543557|FG000|Overall Study|Death|0|||
162956628|NCT00455312|588543558|FG001|Overall Study|Death|1|||
162956629|NCT02659150|588543559|FG000|Subject Enrollment|Physician Decision|3|||
162956630|NCT02659150|588543559|FG000|Subject Enrollment|Withdrawal by Subject|2|||
162956631|NCT02659150|588543559|FG000|Baseline Imaging|Withdrawal by Subject|1|||
162956632|NCT02659150|588543559|FG000|Baseline Imaging|Physician Decision|1|||
162956633|NCT02659150|588543559|FG000|Study Drug Dosing|Adverse Event|1|||
162956634|NCT02902211|588543562|FG000|First Three Months|Withdrawal by Subject|7|||
162956635|NCT02902211|588543563|FG001|First Three Months|Withdrawal by Subject|3|||
162956636|NCT01363765|588543564|FG000|Overall Study|non-diagnostic|2621|||
162956637|NCT01363765|588543565|FG001|Overall Study|non-diagnostic|1124|||
162956638|NCT01363765|588543564|FG000|Overall Study|duplicate records|736|||
163044854|NCT01720524|588871509|FG000|Part A|Missed 28 day follow-up visit|1|||
163044855|NCT01720524|588871510|FG001|Part A|Missed 28 day follow-up visit|1|||
163195011|NCT00675948|589428402|FG001|Overall Study|Lost to Follow-up|0|||
163195012|NCT00675948|589428401|FG000|Overall Study|Protocol Violation|1|||
162956639|NCT01363765|588543565|FG001|Overall Study|duplicate records|3177|||
162956640|NCT01363765|588543564|FG000|Overall Study|non-resident|156|||
162956641|NCT01363765|588543565|FG001|Overall Study|non-resident|76|||
162956642|NCT01363765|588543564|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
162956643|NCT01363765|588543565|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
162956644|NCT01363765|588543564|FG000|Overall Study|smear during intervention|2170|||
162956645|NCT01363765|588543565|FG001|Overall Study|smear during intervention|0|||
162956646|NCT00609674|588543566|FG000|Overall Study|Adverse Event|1|||
162956647|NCT00609674|588543567|FG001|Overall Study|Adverse Event|1|||
162956648|NCT00609674|588543566|FG000|Overall Study|Protocol Violation|3|||
162956649|NCT00609674|588543567|FG001|Overall Study|Protocol Violation|5|||
162956650|NCT00609674|588543566|FG000|Overall Study|Lost to Follow-up|1|||
162956651|NCT00609674|588543567|FG001|Overall Study|Lost to Follow-up|0|||
162956652|NCT00609674|588543566|FG000|Overall Study|Withdrew consent|2|||
162956653|NCT00609674|588543567|FG001|Overall Study|Withdrew consent|1|||
162956654|NCT00571064|588543570|FG000|Overall Study|Adverse Event|13|||
162956655|NCT00571064|588543570|FG000|Overall Study|Protocol Violation|4|||
162956656|NCT00571064|588543570|FG000|Overall Study|Withdrawal by Subject|2|||
162956657|NCT00571064|588543570|FG000|Overall Study|Other|2|||
163195013|NCT00675948|589428402|FG001|Overall Study|Protocol Violation|0|||
163195014|NCT00675948|589428401|FG000|Overall Study|Pain under control|1|||
163195015|NCT00675948|589428402|FG001|Overall Study|Pain under control|0|||
162956658|NCT02159950|588543580|FG000|Overall Study|Adverse Event|0|||
162956659|NCT02159950|588543581|FG001|Overall Study|Adverse Event|1|||
162956660|NCT02159950|588543580|FG000|Overall Study|Progression|0|||
162956661|NCT02159950|588543581|FG001|Overall Study|Progression|1|||
162956662|NCT00003659|588543582|FG000|Overall Study|Withdrawal by Subject|3|||
162956663|NCT03872128|588543585|FG000|Overall Study|Dropped out before treatment|1|||
162956664|NCT03872128|588543586|FG001|Overall Study|Dropped out before treatment|0|||
162956665|NCT03872128|588543587|FG002|Overall Study|Dropped out before treatment|4|||
162956666|NCT03872128|588543585|FG000|Overall Study|Lost to Follow-up|2|||
162956667|NCT03872128|588543586|FG001|Overall Study|Lost to Follow-up|5|||
163394057|NCT02460497|590155630|FG000|Overall Study|Investigator Decision|1|||
163394058|NCT00908583|590155631|FG000|Phase 1|Withdrawal by Subject|1|||
163394059|NCT00908583|590155631|FG000|Phase 1|Adverse Event|4|||
162956668|NCT03872128|588543587|FG002|Overall Study|Lost to Follow-up|8|||
162956669|NCT03285594|588543592|FG000|Overall Study|At the Participant's Own Request|10|||
162956670|NCT03285594|588543593|FG001|Overall Study|At the Participant's Own Request|5|||
162956671|NCT03285594|588543594|FG002|Overall Study|At the Participant's Own Request|21|||
162956672|NCT03285594|588543592|FG000|Overall Study|Adverse Event|2|||
162956673|NCT03285594|588543593|FG001|Overall Study|Adverse Event|2|||
162956674|NCT03285594|588543594|FG002|Overall Study|Adverse Event|6|||
162956675|NCT03285594|588543592|FG000|Overall Study|Poor Compliance to Protocol|0|||
162956676|NCT03285594|588543593|FG001|Overall Study|Poor Compliance to Protocol|0|||
162956677|NCT03285594|588543594|FG002|Overall Study|Poor Compliance to Protocol|1|||
162956678|NCT03285594|588543592|FG000|Overall Study|Lost to Follow-up|0|||
162956679|NCT03285594|588543593|FG001|Overall Study|Lost to Follow-up|0|||
162956680|NCT03285594|588543594|FG002|Overall Study|Lost to Follow-up|1|||
162956681|NCT03285594|588543592|FG000|Overall Study|Reason Not Specified|3|||
163394060|NCT00908583|590155631|FG000|Phase 2|Physician Decision|1|||
163394061|NCT00908583|590155631|FG000|Phase 2|Adverse Event|1|||
162956682|NCT03285594|588543593|FG001|Overall Study|Reason Not Specified|4|||
162956683|NCT03285594|588543594|FG002|Overall Study|Reason Not Specified|8|||
162956684|NCT00834431|588543595|FG000|First Intervention|Adverse Event|0|||
163300402|NCT05288283|589807822|FG000|Overall Study|Study Terminated Early|1|||
162956685|NCT00834431|588543596|FG001|First Intervention|Adverse Event|1|||
162956686|NCT00834431|588543595|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
163300403|NCT05288283|589807823|FG001|Overall Study|Study Terminated Early|1|||
163300404|NCT03990649|589807828|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
163300405|NCT03990649|589807829|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
162956687|NCT00834431|588543596|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
163300406|NCT03990649|589807830|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
163300407|NCT03990649|589807828|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
163300408|NCT03990649|589807829|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
163044856|NCT01720524|588871509|FG000|Part A|Withdrawal by Subject|0|||
163044857|NCT01720524|588871510|FG001|Part A|Withdrawal by Subject|1|||
163044858|NCT01720524|588871509|FG000|Part A|Other|0|||
163044859|NCT01720524|588871510|FG001|Part A|Other|1|||
163044860|NCT01720524|588871509|FG000|Part A|Lost to Follow-up|0|||
163044861|NCT01720524|588871510|FG001|Part A|Lost to Follow-up|1|||
163044862|NCT01720524|588871509|FG000|Part B|No longer willing to participate in study|1|||
163044863|NCT01720524|588871510|FG001|Part B|No longer willing to participate in study|4|||
163044864|NCT01720524|588871509|FG000|Part B|Other|2|||
163044865|NCT01720524|588871510|FG001|Part B|Other|0|||
163044866|NCT01720524|588871509|FG000|Part B|Lost to Follow-up|2|||
163044867|NCT01720524|588871510|FG001|Part B|Lost to Follow-up|3|||
163044868|NCT01720524|588871509|FG000|Part B|Death|0|||
163044869|NCT01720524|588871510|FG001|Part B|Death|2|||
163044870|NCT00158262|588871514|FG000|Overall Study|Lost to Follow-up|1|||
163044871|NCT00158262|588871515|FG001|Overall Study|Lost to Follow-up|1|||
163044872|NCT00527826|588871516|FG000|Overall Study|Adverse Event|10|||
163044873|NCT00527826|588871517|FG001|Overall Study|Adverse Event|10|||
163044874|NCT00527826|588871516|FG000|Overall Study|Lost to Follow-up|3|||
163044875|NCT00527826|588871517|FG001|Overall Study|Lost to Follow-up|2|||
163044876|NCT00527826|588871516|FG000|Overall Study|Withdrawal by Subject|5|||
163044877|NCT00527826|588871517|FG001|Overall Study|Withdrawal by Subject|8|||
163044878|NCT00527826|588871516|FG000|Overall Study|Inclusion Criteria Not Met|3|||
163044879|NCT00527826|588871517|FG001|Overall Study|Inclusion Criteria Not Met|3|||
163044880|NCT00527826|588871516|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
163044881|NCT00527826|588871517|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
163044882|NCT00527826|588871516|FG000|Overall Study|Additional Intake of Viani forte|0|||
163044883|NCT00527826|588871517|FG001|Overall Study|Additional Intake of Viani forte|1|||
163044884|NCT00527826|588871516|FG000|Overall Study|Participant moved away|0|||
163044885|NCT00527826|588871517|FG001|Overall Study|Participant moved away|1|||
163044886|NCT04501952|588871525|FG000|Overall Study|Adverse Event|0|||
163044887|NCT04501952|588871526|FG001|Overall Study|Adverse Event|3|||
163044888|NCT04501952|588871525|FG000|Overall Study|Investigator's Discretion|0|||
163044889|NCT04501952|588871526|FG001|Overall Study|Investigator's Discretion|1|||
163044890|NCT04501952|588871525|FG000|Overall Study|Protocol Violation|1|||
163044891|NCT04501952|588871526|FG001|Overall Study|Protocol Violation|1|||
163044892|NCT04501952|588871525|FG000|Overall Study|Withdrew Consent|5|||
163044893|NCT04501952|588871526|FG001|Overall Study|Withdrew Consent|4|||
163044894|NCT04501952|588871525|FG000|Overall Study|Lost to Follow-up|7|||
162956688|NCT00556322|588543601|FG000|Overall Study|Insufficient therapeutic response|158|||
162956689|NCT00556322|588543602|FG001|Overall Study|Insufficient therapeutic response|168|||
162956690|NCT00556322|588543601|FG000|Overall Study|Adverse Event|7|||
163044895|NCT04501952|588871526|FG001|Overall Study|Lost to Follow-up|2|||
163044896|NCT04501952|588871525|FG000|Overall Study|Randomized and Never Treated|13|||
163044897|NCT04501952|588871526|FG001|Overall Study|Randomized and Never Treated|9|||
162956691|NCT00556322|588543602|FG001|Overall Study|Adverse Event|4|||
162956692|NCT00556322|588543601|FG000|Overall Study|Other|4|||
162956693|NCT00556322|588543602|FG001|Overall Study|Other|1|||
162956694|NCT00556322|588543601|FG000|Overall Study|Lost to Follow-up|5|||
162956695|NCT00556322|588543602|FG001|Overall Study|Lost to Follow-up|3|||
163044898|NCT03382418|588871533|FG000|Overall Study|Withdrawal by Subject|1|||
163044899|NCT03382418|588871534|FG001|Overall Study|Withdrawal by Subject|0|||
162956696|NCT00556322|588543601|FG000|Overall Study|Withdrawal by Subject|19|||
163044900|NCT03382418|588871535|FG002|Overall Study|Withdrawal by Subject|0|||
163044901|NCT03382418|588871533|FG000|Overall Study|Lost to Follow-up|2|||
163044902|NCT03382418|588871534|FG001|Overall Study|Lost to Follow-up|3|||
162956697|NCT00556322|588543602|FG001|Overall Study|Withdrawal by Subject|7|||
162956698|NCT00556322|588543601|FG000|Overall Study|Protocol Violation|5|||
162956699|NCT00556322|588543602|FG001|Overall Study|Protocol Violation|1|||
162956700|NCT00556322|588543601|FG000|Overall Study|Ongoing at data cutoff|3|||
163044903|NCT03382418|588871535|FG002|Overall Study|Lost to Follow-up|0|||
163044904|NCT01189461|588871544|FG000|Overall Study|Lack of Efficacy|13|||
163044905|NCT01189461|588871544|FG000|Overall Study|Lost to Follow-up|1|||
163044906|NCT01189461|588871544|FG000|Overall Study|Withdrawal by Subject|6|||
163044907|NCT01189461|588871544|FG000|Overall Study|Protocol Violation|1|||
162956701|NCT00556322|588543602|FG001|Overall Study|Ongoing at data cutoff|5|||
162956702|NCT00556322|588543601|FG000|Overall Study|Death|20|||
162956703|NCT00556322|588543602|FG001|Overall Study|Death|14|||
163044908|NCT01189461|588871544|FG000|Overall Study|Adverse Event|2|||
163195016|NCT00675948|589428401|FG000|Overall Study|Sponsor decision|0|||
163300409|NCT03990649|589807830|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
163300410|NCT03990649|589807828|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
163394062|NCT00908583|590155631|FG000|Phase 3|Adverse Event|2|||
163300411|NCT03990649|589807829|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
163300412|NCT03990649|589807830|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
163300413|NCT03990649|589807828|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
163300414|NCT03990649|589807829|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
163300415|NCT03990649|589807830|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
163300416|NCT03990649|589807828|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
163300417|NCT03990649|589807829|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
163300418|NCT03990649|589807830|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
163300419|NCT03990649|589807828|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
163300420|NCT03990649|589807829|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
163300421|NCT03990649|589807830|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
162956704|NCT03733444|588543603|FG000|Overall Study|Adverse Event|8|||
162956705|NCT03733444|588543604|FG001|Overall Study|Adverse Event|10|||
162956706|NCT03733444|588543605|FG002|Overall Study|Adverse Event|5|||
162956707|NCT03733444|588543603|FG000|Overall Study|Death|20|||
162956708|NCT03733444|588543604|FG001|Overall Study|Death|19|||
162956709|NCT03733444|588543605|FG002|Overall Study|Death|11|||
162956710|NCT03733444|588543603|FG000|Overall Study|Lost to Follow-up|3|||
162956711|NCT03733444|588543604|FG001|Overall Study|Lost to Follow-up|0|||
163044909|NCT01189461|588871544|FG000|Overall Study|Did not meet entrance criteria|3|||
162956712|NCT03733444|588543605|FG002|Overall Study|Lost to Follow-up|1|||
162956713|NCT03733444|588543603|FG000|Overall Study|Lack of Efficacy|0|||
163300422|NCT03990649|589807828|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
163300423|NCT03990649|589807829|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
163300424|NCT03990649|589807830|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
163300425|NCT03050814|589807831|FG000|Overall Study|Screen failures|0|||
163300426|NCT03050814|589807832|FG001|Overall Study|Screen failures|0|||
163300427|NCT03050814|589807833|FG002|Overall Study|Screen failures|4|||
163044910|NCT01189461|588871544|FG000|Overall Study|Other|8|||
163300428|NCT04759833|589807834|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
163300429|NCT04759833|589807835|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
163300430|NCT04759833|589807836|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
163300431|NCT04759833|589807837|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
163300432|NCT04759833|589807838|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
163300433|NCT04759833|589807834|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
163300434|NCT04759833|589807835|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
163300435|NCT04759833|589807836|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
163300436|NCT04759833|589807837|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
163300437|NCT04759833|589807838|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
163300438|NCT04759833|589807834|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
163300439|NCT04759833|589807835|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
163300440|NCT04759833|589807836|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
163300441|NCT04759833|589807837|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
163300442|NCT04759833|589807838|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
163300443|NCT04759833|589807834|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
162956714|NCT03733444|588543604|FG001|Overall Study|Lack of Efficacy|1|||
162956715|NCT03733444|588543605|FG002|Overall Study|Lack of Efficacy|1|||
162956716|NCT03733444|588543603|FG000|Overall Study|Physician Decision|2|||
162956717|NCT03733444|588543604|FG001|Overall Study|Physician Decision|1|||
162956718|NCT03733444|588543605|FG002|Overall Study|Physician Decision|0|||
162956719|NCT03733444|588543603|FG000|Overall Study|Protocol Violation|2|||
162956720|NCT03733444|588543604|FG001|Overall Study|Protocol Violation|1|||
162956721|NCT03733444|588543605|FG002|Overall Study|Protocol Violation|0|||
162956722|NCT03733444|588543603|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
162956723|NCT03733444|588543604|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
162956724|NCT03733444|588543605|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
162956725|NCT03733444|588543603|FG000|Overall Study|Study Terminated by Sponsor|203|||
162956726|NCT03733444|588543604|FG001|Overall Study|Study Terminated by Sponsor|209|||
162956727|NCT03733444|588543605|FG002|Overall Study|Study Terminated by Sponsor|221|||
162956728|NCT03733444|588543603|FG000|Overall Study|Withdrawal by Subject|19|||
162956729|NCT03733444|588543604|FG001|Overall Study|Withdrawal by Subject|18|||
162956730|NCT03733444|588543605|FG002|Overall Study|Withdrawal by Subject|16|||
163300444|NCT04759833|589807835|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
163394063|NCT00908583|590155631|FG000|Phase 4|Adverse Event|1|||
162956731|NCT03733444|588543603|FG000|Overall Study|Miscellaneous|1|||
162956732|NCT03733444|588543604|FG001|Overall Study|Miscellaneous|0|||
162956733|NCT03733444|588543605|FG002|Overall Study|Miscellaneous|1|||
162956734|NCT03733444|588543603|FG000|Overall Study|Not Treated|1|||
163300445|NCT04759833|589807836|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
163300446|NCT04759833|589807837|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
163300447|NCT04759833|589807838|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
163300448|NCT04759833|589807834|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
163300449|NCT04759833|589807835|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
163300450|NCT04759833|589807836|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
163300451|NCT04759833|589807837|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
163300452|NCT04759833|589807838|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
163300453|NCT04759833|589807834|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
163300454|NCT04759833|589807835|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
163300455|NCT04759833|589807836|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
163300456|NCT04759833|589807837|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
163300457|NCT04759833|589807838|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
163300458|NCT04759833|589807834|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
163300459|NCT04759833|589807835|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
163300460|NCT04759833|589807836|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
163300461|NCT04759833|589807837|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
163300462|NCT04759833|589807838|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
163300463|NCT04759833|589807834|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
163300464|NCT04759833|589807835|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
163300465|NCT04759833|589807836|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
163300466|NCT04759833|589807837|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
163300467|NCT04759833|589807838|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
163300468|NCT04759833|589807834|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
163300469|NCT04759833|589807835|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
163300470|NCT04759833|589807836|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
163300471|NCT04759833|589807837|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
163394064|NCT00908583|590155631|FG000|Phase 4|Physician Decision|1|||
163394065|NCT00908583|590155631|FG000|Phase 5|Adverse Event|3|||
163394066|NCT00860951|590155634|FG000|Overall Study|Withdrawal by Subject|2|||
162956735|NCT03733444|588543604|FG001|Overall Study|Not Treated|2|||
162956736|NCT03733444|588543605|FG002|Overall Study|Not Treated|1|||
162956737|NCT01913405|588543606|FG000|Overall Study|Withdrawal by Subject|1|||
162956738|NCT01913405|588543606|FG000|Overall Study|Adverse Event|1|||
162956739|NCT04400890|588543607|FG000|Overall Study|Withdrawal by Subject|3|||
162956740|NCT04400890|588543608|FG001|Overall Study|Withdrawal by Subject|2|||
162956741|NCT03925532|588543609|FG000|Overall Study|Lost to Follow-up|1|||
162956742|NCT02258074|588543610|FG000|Overall Study|Withdrawal by Subject|1|||
162956743|NCT02258074|588543611|FG001|Overall Study|Withdrawal by Subject|0|||
162956744|NCT02258074|588543612|FG002|Overall Study|Withdrawal by Subject|0|||
162956745|NCT02258074|588543613|FG003|Overall Study|Withdrawal by Subject|0|||
162956746|NCT05446870|588543614|FG000|Overall Study|Death|6|||
162956747|NCT05446870|588543615|FG001|Overall Study|Death|5|||
162956748|NCT05446870|588543614|FG000|Overall Study|Lost to Follow-up|0|||
162956749|NCT05446870|588543615|FG001|Overall Study|Lost to Follow-up|1|||
162956750|NCT05446870|588543614|FG000|Overall Study|Physician Decision|52|||
162956751|NCT05446870|588543615|FG001|Overall Study|Physician Decision|53|||
162956752|NCT05446870|588543614|FG000|Overall Study|Withdrawal by Subject|3|||
162956753|NCT05446870|588543615|FG001|Overall Study|Withdrawal by Subject|3|||
162956754|NCT01615198|588543618|FG000|Overall Study|Withdrawal by Subject|5|||
162956755|NCT01615198|588543619|FG001|Overall Study|Withdrawal by Subject|5|||
162956756|NCT01615198|588543618|FG000|Overall Study|Protocol deviation|1|||
162956757|NCT01615198|588543619|FG001|Overall Study|Protocol deviation|1|||
162956758|NCT01615198|588543618|FG000|Overall Study|Physician Decision|5|||
162956759|NCT01615198|588543619|FG001|Overall Study|Physician Decision|1|||
162956760|NCT01615198|588543618|FG000|Overall Study|Lost to Follow-up|1|||
162956761|NCT01615198|588543619|FG001|Overall Study|Lost to Follow-up|1|||
162956762|NCT01615198|588543618|FG000|Overall Study|Lack of Efficacy|1|||
162956763|NCT01615198|588543619|FG001|Overall Study|Lack of Efficacy|6|||
162956764|NCT01615198|588543618|FG000|Overall Study|Adverse Event|11|||
162956765|NCT01615198|588543619|FG001|Overall Study|Adverse Event|5|||
162956766|NCT01686438|588543620|FG000|Overall Study|Lost to Follow-up|8|||
162956767|NCT01686438|588543621|FG001|Overall Study|Lost to Follow-up|9|||
162956768|NCT01686438|588543622|FG002|Overall Study|Lost to Follow-up|10|||
162956769|NCT01686438|588543620|FG000|Overall Study|Adverse Event|0|||
162956770|NCT01686438|588543621|FG001|Overall Study|Adverse Event|0|||
162956771|NCT01686438|588543622|FG002|Overall Study|Adverse Event|1|||
162956772|NCT01686438|588543620|FG000|Overall Study|Protocol Violation|0|||
162956773|NCT01686438|588543621|FG001|Overall Study|Protocol Violation|0|||
162956774|NCT01686438|588543622|FG002|Overall Study|Protocol Violation|1|||
162956775|NCT01686438|588543620|FG000|Overall Study|Withdrawal by Subject|0|||
163300472|NCT04759833|589807838|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
163300473|NCT04759833|589807834|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
163300474|NCT04759833|589807835|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
163300475|NCT04759833|589807836|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
163300476|NCT04759833|589807837|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
163300477|NCT04759833|589807838|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
163300478|NCT04759833|589807834|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
163300479|NCT04759833|589807835|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
163300480|NCT04759833|589807836|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
163300481|NCT04759833|589807837|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
163300482|NCT04759833|589807838|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
163300483|NCT04759833|589807834|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
163300484|NCT04759833|589807835|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
163300485|NCT04759833|589807836|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
163300486|NCT04759833|589807837|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
163300487|NCT04759833|589807838|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
163300488|NCT04759833|589807834|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
163300489|NCT04759833|589807835|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
163300490|NCT04759833|589807836|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
163300491|NCT04759833|589807837|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
163300492|NCT04759833|589807838|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
163300493|NCT00508924|589807839|FG000|Overall Study|Protocol Violation|0|||
163300494|NCT00508924|589807840|FG001|Overall Study|Protocol Violation|0|||
163300495|NCT00508924|589807841|FG002|Overall Study|Protocol Violation|1|||
163300496|NCT00508924|589807842|FG003|Overall Study|Protocol Violation|1|||
163300497|NCT00630058|589807843|FG000|Overall Study|Adverse Event|1|||
163300498|NCT00630058|589807844|FG001|Overall Study|Adverse Event|1|||
163195017|NCT00675948|589428402|FG001|Overall Study|Sponsor decision|1|||
163195018|NCT00675948|589428401|FG000|Overall Study|Patient died|1|||
163195019|NCT00675948|589428402|FG001|Overall Study|Patient died|0|||
163195020|NCT00675948|589428401|FG000|Overall Study|Patient unable to comply with diaries|1|||
163195021|NCT00675948|589428402|FG001|Overall Study|Patient unable to comply with diaries|0|||
163195022|NCT00675948|589428401|FG000|Overall Study|Patient feels unable to take medication|0|||
163195023|NCT00675948|589428402|FG001|Overall Study|Patient feels unable to take medication|1|||
163195024|NCT02100514|589428403|FG000|Treatment Period|Adverse Event|0|||
163195025|NCT02100514|589428404|FG001|Treatment Period|Adverse Event|5|||
163195026|NCT02100514|589428405|FG002|Treatment Period|Adverse Event|0|||
163195027|NCT02100514|589428406|FG003|Treatment Period|Adverse Event|0|||
163195028|NCT02100514|589428407|FG004|Treatment Period|Adverse Event|0|||
163195029|NCT02100514|589428403|FG000|Treatment Period|Death|2|||
163195030|NCT02100514|589428404|FG001|Treatment Period|Death|2|||
162956776|NCT01686438|588543621|FG001|Overall Study|Withdrawal by Subject|0|||
162956777|NCT01686438|588543622|FG002|Overall Study|Withdrawal by Subject|1|||
162956778|NCT00984126|588543623|FG000|Overall Study|Protocol Violation|0|||
162956779|NCT00984126|588543624|FG001|Overall Study|Protocol Violation|0|||
162956780|NCT00984126|588543625|FG002|Overall Study|Protocol Violation|1|||
163195031|NCT02100514|589428405|FG002|Treatment Period|Death|0|||
163195032|NCT02100514|589428406|FG003|Treatment Period|Death|0|||
163195033|NCT02100514|589428407|FG004|Treatment Period|Death|0|||
163195034|NCT02100514|589428403|FG000|Treatment Period|Lost to Follow-up|5|||
162956781|NCT00984126|588543626|FG003|Overall Study|Protocol Violation|2|||
163300499|NCT00630058|589807843|FG000|Overall Study|Withdrawal by Subject|0|||
163300500|NCT00630058|589807844|FG001|Overall Study|Withdrawal by Subject|1|||
163300501|NCT00630058|589807843|FG000|Overall Study|stopping criteria|3|||
163300502|NCT00630058|589807844|FG001|Overall Study|stopping criteria|2|||
163300503|NCT02706717|589807849|FG000|Overall Study|Withdrawal by Subject|1|||
163300504|NCT02706717|589807850|FG001|Overall Study|Withdrawal by Subject|8|||
163300505|NCT02706717|589807849|FG000|Overall Study|Lost to Follow-up|0|||
163300506|NCT02706717|589807850|FG001|Overall Study|Lost to Follow-up|1|||
163300507|NCT02706717|589807849|FG000|Overall Study|Physician Decision|0|||
163300508|NCT02706717|589807850|FG001|Overall Study|Physician Decision|1|||
163300509|NCT02706717|589807849|FG000|Overall Study|Death|0|||
163300510|NCT02706717|589807850|FG001|Overall Study|Death|1|||
163300511|NCT02121002|589807852|FG000|Overall Study|Physician Decision|2|||
163300512|NCT02121002|589807853|FG001|Overall Study|Physician Decision|0|||
163300513|NCT02121002|589807854|FG002|Overall Study|Physician Decision|0|||
163300514|NCT02121002|589807852|FG000|Overall Study|Withdrawal by Subject|3|||
163300515|NCT02121002|589807853|FG001|Overall Study|Withdrawal by Subject|1|||
163300516|NCT02121002|589807854|FG002|Overall Study|Withdrawal by Subject|4|||
163300517|NCT02121002|589807852|FG000|Overall Study|Protocol Violation|1|||
163300518|NCT02121002|589807853|FG001|Overall Study|Protocol Violation|2|||
163394067|NCT00860951|590155634|FG000|Overall Study|Lost to Follow-up|5|||
163394068|NCT02982239|590155637|FG000|Overall Study|Lost to Follow-up|3|||
163394069|NCT02982239|590155638|FG001|Overall Study|Lost to Follow-up|2|||
163394070|NCT01086410|590155639|FG000|Overall Study|Adverse Event|1|||
163394071|NCT01086410|590155640|FG001|Overall Study|Adverse Event|0|||
163394072|NCT01086410|590155641|FG002|Overall Study|Adverse Event|0|||
163394073|NCT01086410|590155642|FG003|Overall Study|Adverse Event|2|||
163394074|NCT01086410|590155639|FG000|Overall Study|Lack of Efficacy|1|||
163394075|NCT01086410|590155640|FG001|Overall Study|Lack of Efficacy|1|||
163394076|NCT01086410|590155641|FG002|Overall Study|Lack of Efficacy|0|||
163394077|NCT01086410|590155642|FG003|Overall Study|Lack of Efficacy|0|||
163394078|NCT01086410|590155639|FG000|Overall Study|Protocol Violation|1|||
163394079|NCT01086410|590155640|FG001|Overall Study|Protocol Violation|1|||
163394080|NCT01086410|590155641|FG002|Overall Study|Protocol Violation|0|||
163394081|NCT01086410|590155642|FG003|Overall Study|Protocol Violation|0|||
163394082|NCT01086410|590155639|FG000|Overall Study|Lost to Follow-up|0|||
163394083|NCT01086410|590155640|FG001|Overall Study|Lost to Follow-up|0|||
163394084|NCT01086410|590155641|FG002|Overall Study|Lost to Follow-up|1|||
163394085|NCT01086410|590155642|FG003|Overall Study|Lost to Follow-up|0|||
163394086|NCT02230254|590155643|FG000|Overall Study|Lost to Follow-up|3|||
163394087|NCT00621751|590155644|FG000|Overall Study|Adverse Event|0|||
163394088|NCT00621751|590155645|FG001|Overall Study|Adverse Event|1|||
163394089|NCT03383289|590155656|FG000|Overall Study|Death|83|||
163394090|NCT03383289|590155657|FG001|Overall Study|Death|78|||
163394091|NCT03383289|590155656|FG000|Overall Study|discharge from facility|84|||
163394092|NCT03383289|590155657|FG001|Overall Study|discharge from facility|84|||
163394093|NCT03383289|590155656|FG000|Overall Study|Withdrawal by Subject|4|||
163394094|NCT03383289|590155657|FG001|Overall Study|Withdrawal by Subject|1|||
163394095|NCT00832117|590155658|FG000|Overall Study|Death|1|||
163394096|NCT00832117|590155658|FG000|Overall Study|Disease Progression|11|||
163394097|NCT04439071|590155659|FG000|Overall Study|Lost to Follow-up|0|||
163394098|NCT04439071|590155660|FG001|Overall Study|Lost to Follow-up|3|||
163300519|NCT02121002|589807854|FG002|Overall Study|Protocol Violation|4|||
163394099|NCT04439071|590155659|FG000|Overall Study|Withdrawal by Subject|3|||
163394100|NCT04439071|590155660|FG001|Overall Study|Withdrawal by Subject|8|||
163394101|NCT04439071|590155659|FG000|Overall Study|Death|6|||
162956782|NCT00984126|588543623|FG000|Overall Study|Adverse Event|0|||
163300520|NCT02121002|589807852|FG000|Overall Study|Concomitant therapy|0|||
163300521|NCT02121002|589807853|FG001|Overall Study|Concomitant therapy|1|||
163300522|NCT02121002|589807854|FG002|Overall Study|Concomitant therapy|1|||
163300523|NCT02121002|589807852|FG000|Overall Study|Others|1|||
163394102|NCT04439071|590155660|FG001|Overall Study|Death|4|||
162956783|NCT00984126|588543624|FG001|Overall Study|Adverse Event|0|||
163394103|NCT04439071|590155659|FG000|Overall Study|Other than specified|3|||
163394104|NCT04439071|590155660|FG001|Overall Study|Other than specified|3|||
163394105|NCT04439071|590155659|FG000|Overall Study|Randomized but not treated|2|||
163195035|NCT02100514|589428404|FG001|Treatment Period|Lost to Follow-up|17|||
162956784|NCT00984126|588543625|FG002|Overall Study|Adverse Event|0|||
162956785|NCT00984126|588543626|FG003|Overall Study|Adverse Event|2|||
162956786|NCT00984126|588543623|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
162956787|NCT00984126|588543624|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
163195036|NCT02100514|589428405|FG002|Treatment Period|Lost to Follow-up|0|||
162956788|NCT00984126|588543625|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
162956789|NCT00984126|588543626|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
162956790|NCT00984126|588543623|FG000|Overall Study|Withdrawal criteria|0|||
162956791|NCT00984126|588543624|FG001|Overall Study|Withdrawal criteria|1|||
162956792|NCT00984126|588543625|FG002|Overall Study|Withdrawal criteria|3|||
162956793|NCT00984126|588543626|FG003|Overall Study|Withdrawal criteria|9|||
162956794|NCT01029340|588543629|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
163195037|NCT02100514|589428406|FG003|Treatment Period|Lost to Follow-up|0|||
163195038|NCT02100514|589428407|FG004|Treatment Period|Lost to Follow-up|0|||
163195039|NCT02100514|589428403|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
163195040|NCT02100514|589428404|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
163195041|NCT02100514|589428405|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
163195042|NCT02100514|589428406|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
163195043|NCT02100514|589428407|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
163195044|NCT02100514|589428403|FG000|Treatment Period|Protocol Violation|1|||
163195045|NCT02100514|589428404|FG001|Treatment Period|Protocol Violation|1|||
163195046|NCT02100514|589428405|FG002|Treatment Period|Protocol Violation|0|||
163195047|NCT02100514|589428406|FG003|Treatment Period|Protocol Violation|0|||
163195048|NCT02100514|589428407|FG004|Treatment Period|Protocol Violation|0|||
163195049|NCT02100514|589428403|FG000|Treatment Period|Withdrawal by Subject|12|||
163195050|NCT02100514|589428404|FG001|Treatment Period|Withdrawal by Subject|37|||
163195051|NCT02100514|589428405|FG002|Treatment Period|Withdrawal by Subject|0|||
163195052|NCT02100514|589428406|FG003|Treatment Period|Withdrawal by Subject|0|||
163195053|NCT02100514|589428407|FG004|Treatment Period|Withdrawal by Subject|0|||
163195054|NCT02100514|589428403|FG000|Treatment Period|Other|9|||
163195055|NCT02100514|589428404|FG001|Treatment Period|Other|11|||
163195056|NCT02100514|589428405|FG002|Treatment Period|Other|0|||
163195057|NCT02100514|589428406|FG003|Treatment Period|Other|0|||
163195058|NCT02100514|589428407|FG004|Treatment Period|Other|0|||
163195059|NCT02100514|589428403|FG000|Extension Period|Withdrew consent|0|||
163195060|NCT02100514|589428404|FG001|Extension Period|Withdrew consent|0|||
163195061|NCT02100514|589428405|FG002|Extension Period|Withdrew consent|2|||
163195062|NCT02100514|589428406|FG003|Extension Period|Withdrew consent|0|||
163195063|NCT02100514|589428407|FG004|Extension Period|Withdrew consent|0|||
163195064|NCT00319553|589428408|FG000|Overall Study|Protocol Violation|1|||
163195065|NCT00319553|589428409|FG001|Overall Study|Protocol Violation|2|||
163195066|NCT00319553|589428408|FG000|Overall Study|Lost to Follow-up|2|||
163195067|NCT00319553|589428409|FG001|Overall Study|Lost to Follow-up|1|||
163195068|NCT00319553|589428408|FG000|Overall Study|Withdrawal by Subject|1|||
163195069|NCT00319553|589428409|FG001|Overall Study|Withdrawal by Subject|1|||
163195070|NCT01751178|589428410|FG000|Overall Study|Adverse Event|2|||
163195071|NCT01751178|589428411|FG001|Overall Study|Adverse Event|0|||
163195072|NCT01751178|589428412|FG002|Overall Study|Adverse Event|0|||
163195073|NCT01751178|589428410|FG000|Overall Study|Other Reason (unknown)|1|||
163195074|NCT01751178|589428411|FG001|Overall Study|Other Reason (unknown)|0|||
163195075|NCT01751178|589428412|FG002|Overall Study|Other Reason (unknown)|2|||
163195076|NCT04138810|589428413|FG000|Overall Study|Withdrawal by Subject|0|||
163195077|NCT04138810|589428414|FG001|Overall Study|Withdrawal by Subject|1|||
163195078|NCT04138810|589428413|FG000|Overall Study|Subject cancelled surgery|1|||
163195079|NCT04138810|589428414|FG001|Overall Study|Subject cancelled surgery|0|||
163195080|NCT03641339|589428417|FG000|Overall Study|Physician Decision|1|||
163195081|NCT03641339|589428418|FG001|Overall Study|Physician Decision|0|||
163195082|NCT03641339|589428419|FG002|Overall Study|Physician Decision|0|||
163195083|NCT03641339|589428420|FG003|Overall Study|Physician Decision|0|||
163195084|NCT03641339|589428421|FG004|Overall Study|Physician Decision|0|||
163195085|NCT03641339|589428422|FG005|Overall Study|Physician Decision|0|||
163195086|NCT03641339|589428417|FG000|Overall Study|Withdrawal by Subject|0|||
163300524|NCT02121002|589807853|FG001|Overall Study|Others|0|||
163195087|NCT03641339|589428418|FG001|Overall Study|Withdrawal by Subject|2|||
163195088|NCT03641339|589428419|FG002|Overall Study|Withdrawal by Subject|0|||
163195089|NCT03641339|589428420|FG003|Overall Study|Withdrawal by Subject|2|||
163195090|NCT03641339|589428421|FG004|Overall Study|Withdrawal by Subject|0|||
163195091|NCT03641339|589428422|FG005|Overall Study|Withdrawal by Subject|1|||
163195092|NCT02329080|589428423|FG000|Overall Study|Adverse Event|1|||
163195093|NCT02329080|589428423|FG000|Overall Study|Death|4|||
163195094|NCT02329080|589428423|FG000|Overall Study|Lack of Efficacy|22|||
163195095|NCT02329080|589428423|FG000|Overall Study|Lost to Follow-up|1|||
162956795|NCT01029340|588543630|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
163195096|NCT02329080|589428423|FG000|Overall Study|Physician Decision|2|||
163195097|NCT02329080|589428423|FG000|Overall Study|Partial response|4|||
163195098|NCT02329080|589428423|FG000|Overall Study|Complete response|4|||
163300525|NCT02121002|589807854|FG002|Overall Study|Others|1|||
163300526|NCT02590432|589807855|FG000|Open-label Treatment Period|Adverse Event|97|||
163300527|NCT02590432|589807856|FG001|Open-label Treatment Period|Adverse Event|79|||
163300528|NCT02590432|589807857|FG002|Open-label Treatment Period|Adverse Event|0|||
163300529|NCT02590432|589807858|FG003|Open-label Treatment Period|Adverse Event|0|||
163300530|NCT02590432|589807859|FG004|Open-label Treatment Period|Adverse Event|0|||
163300531|NCT02590432|589807860|FG005|Open-label Treatment Period|Adverse Event|0|||
163300532|NCT02590432|589807861|FG006|Open-label Treatment Period|Adverse Event|0|||
163300533|NCT02590432|589807862|FG007|Open-label Treatment Period|Adverse Event|0|||
163300534|NCT02590432|589807863|FG008|Open-label Treatment Period|Adverse Event|0|||
162956796|NCT01029340|588543631|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
162956797|NCT01029340|588543632|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
162956798|NCT01029340|588543633|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
162956799|NCT01029340|588543634|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
162956800|NCT01029340|588543629|FG000|Part B Treatment Period|Protocol Violation|0|||
162956801|NCT01029340|588543630|FG001|Part B Treatment Period|Protocol Violation|0|||
162956802|NCT01029340|588543631|FG002|Part B Treatment Period|Protocol Violation|1|||
162956803|NCT01029340|588543632|FG003|Part B Treatment Period|Protocol Violation|0|||
162956804|NCT01029340|588543633|FG004|Part B Treatment Period|Protocol Violation|0|||
162956805|NCT01029340|588543634|FG005|Part B Treatment Period|Protocol Violation|0|||
162956806|NCT01029340|588543629|FG000|Extension Period|Adverse Event|0|||
162956807|NCT01029340|588543630|FG001|Extension Period|Adverse Event|0|||
162956808|NCT01029340|588543631|FG002|Extension Period|Adverse Event|0|||
162956809|NCT01029340|588543632|FG003|Extension Period|Adverse Event|0|||
162956810|NCT01029340|588543633|FG004|Extension Period|Adverse Event|0|||
162956811|NCT01029340|588543634|FG005|Extension Period|Adverse Event|1|||
162956812|NCT01029340|588543629|FG000|Extension Period|starting another study|0|||
162956813|NCT01029340|588543630|FG001|Extension Period|starting another study|0|||
162956814|NCT01029340|588543631|FG002|Extension Period|starting another study|0|||
162956815|NCT01029340|588543632|FG003|Extension Period|starting another study|0|||
162956816|NCT01029340|588543633|FG004|Extension Period|starting another study|0|||
162956817|NCT01029340|588543634|FG005|Extension Period|starting another study|8|||
162956818|NCT01029340|588543629|FG000|Extension Period|non-compliance|0|||
162956819|NCT01029340|588543630|FG001|Extension Period|non-compliance|0|||
162956820|NCT01029340|588543631|FG002|Extension Period|non-compliance|0|||
162956821|NCT01029340|588543632|FG003|Extension Period|non-compliance|0|||
162956822|NCT01029340|588543633|FG004|Extension Period|non-compliance|0|||
162956823|NCT01029340|588543634|FG005|Extension Period|non-compliance|1|||
162956824|NCT01029340|588543629|FG000|Extension Period|Withdrawal by Subject|0|||
162956825|NCT01029340|588543630|FG001|Extension Period|Withdrawal by Subject|0|||
162956826|NCT01029340|588543631|FG002|Extension Period|Withdrawal by Subject|0|||
162956827|NCT01029340|588543632|FG003|Extension Period|Withdrawal by Subject|0|||
162956828|NCT01029340|588543633|FG004|Extension Period|Withdrawal by Subject|0|||
163300535|NCT02590432|589807855|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
163300536|NCT02590432|589807856|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
162956829|NCT01029340|588543634|FG005|Extension Period|Withdrawal by Subject|1|||
162956830|NCT01029340|588543629|FG000|Extension Period|Physician Decision|0|||
163300537|NCT02590432|589807857|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
163300538|NCT02590432|589807858|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
163300539|NCT02590432|589807859|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
163300540|NCT02590432|589807860|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
163300541|NCT02590432|589807861|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
163300542|NCT02590432|589807862|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
163300543|NCT02590432|589807863|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
163300544|NCT02590432|589807855|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
163300545|NCT02590432|589807856|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
163300546|NCT02590432|589807857|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
163300547|NCT02590432|589807858|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
163300548|NCT02590432|589807859|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
163300549|NCT02590432|589807860|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
163300550|NCT02590432|589807861|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
163300551|NCT02590432|589807862|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
163300552|NCT02590432|589807863|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
163300553|NCT02590432|589807855|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
163300554|NCT02590432|589807856|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
163300555|NCT02590432|589807857|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
163300556|NCT02590432|589807858|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
163300557|NCT02590432|589807859|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
163300558|NCT02590432|589807860|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
163300559|NCT02590432|589807861|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
163300560|NCT02590432|589807862|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
163300561|NCT02590432|589807863|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
163300562|NCT02590432|589807855|FG000|Open-label Treatment Period|Protocol Violation|10|||
163300563|NCT02590432|589807856|FG001|Open-label Treatment Period|Protocol Violation|4|||
163300564|NCT02590432|589807857|FG002|Open-label Treatment Period|Protocol Violation|0|||
163300565|NCT02590432|589807858|FG003|Open-label Treatment Period|Protocol Violation|0|||
163300566|NCT02590432|589807859|FG004|Open-label Treatment Period|Protocol Violation|0|||
163300567|NCT02590432|589807860|FG005|Open-label Treatment Period|Protocol Violation|0|||
163300568|NCT02590432|589807861|FG006|Open-label Treatment Period|Protocol Violation|0|||
163300569|NCT02590432|589807862|FG007|Open-label Treatment Period|Protocol Violation|0|||
163300570|NCT02590432|589807863|FG008|Open-label Treatment Period|Protocol Violation|0|||
163300571|NCT02590432|589807855|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
163300572|NCT02590432|589807856|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
163300573|NCT02590432|589807857|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
163300574|NCT02590432|589807858|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
163300575|NCT02590432|589807859|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
163300576|NCT02590432|589807860|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
163300577|NCT02590432|589807861|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
163300578|NCT02590432|589807862|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
163300579|NCT02590432|589807863|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
163300580|NCT02590432|589807855|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
163394106|NCT04439071|590155660|FG001|Overall Study|Randomized but not treated|0|||
163394107|NCT00892177|590155661|FG000|Phase II|Ineligible|0|||
163300581|NCT02590432|589807856|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
163300582|NCT02590432|589807857|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
163300583|NCT02590432|589807858|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
163044911|NCT00420628|588871546|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
163044912|NCT00420628|588871547|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
163044913|NCT00420628|588871546|FG000|Overall Study|Lost to Follow-up|3|||
163044914|NCT00420628|588871547|FG001|Overall Study|Lost to Follow-up|2|||
163044915|NCT00420628|588871546|FG000|Overall Study|Adverse Event|1|||
163044916|NCT00420628|588871547|FG001|Overall Study|Adverse Event|0|||
163044917|NCT02716584|588871548|FG000|Overall Study|Lost to Follow-up|8|||
163044918|NCT02716584|588871549|FG001|Overall Study|Lost to Follow-up|5|||
163044919|NCT03301831|588871555|FG000|Overall Study|Lost to Follow-up|5|||
163044920|NCT03301831|588871556|FG001|Overall Study|Lost to Follow-up|3|||
163044921|NCT03301831|588871555|FG000|Overall Study|Protocol Violation|4|||
163044922|NCT03301831|588871556|FG001|Overall Study|Protocol Violation|0|||
163044923|NCT03301831|588871555|FG000|Overall Study|Withdrawal by Subject|11|||
163300584|NCT02590432|589807859|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
163300585|NCT02590432|589807860|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
163300586|NCT02590432|589807861|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
163300587|NCT02590432|589807862|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
163300588|NCT02590432|589807863|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
163300589|NCT02590432|589807855|FG000|Double-blind Treatment Period|Adverse Event|0|||
163300590|NCT02590432|589807856|FG001|Double-blind Treatment Period|Adverse Event|0|||
163300591|NCT02590432|589807857|FG002|Double-blind Treatment Period|Adverse Event|14|||
163300592|NCT02590432|589807858|FG003|Double-blind Treatment Period|Adverse Event|12|||
163300593|NCT02590432|589807859|FG004|Double-blind Treatment Period|Adverse Event|6|||
163300594|NCT02590432|589807860|FG005|Double-blind Treatment Period|Adverse Event|22|||
163300595|NCT02590432|589807861|FG006|Double-blind Treatment Period|Adverse Event|20|||
163300596|NCT02590432|589807862|FG007|Double-blind Treatment Period|Adverse Event|0|||
163300597|NCT02590432|589807863|FG008|Double-blind Treatment Period|Adverse Event|0|||
163300598|NCT02590432|589807855|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
163300599|NCT02590432|589807856|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
163300600|NCT02590432|589807857|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
163300601|NCT02590432|589807858|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
163300602|NCT02590432|589807859|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
163300603|NCT02590432|589807860|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
163300604|NCT02590432|589807861|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
163300605|NCT02590432|589807862|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
163300606|NCT02590432|589807863|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
163300607|NCT02590432|589807855|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
163300608|NCT02590432|589807856|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
163300609|NCT02590432|589807857|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
163300610|NCT02590432|589807858|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
163300611|NCT02590432|589807859|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
163300612|NCT02590432|589807860|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
163300613|NCT02590432|589807861|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
163300614|NCT02590432|589807862|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
163300615|NCT02590432|589807863|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
163300616|NCT02590432|589807855|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
163300617|NCT02590432|589807856|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
163300618|NCT02590432|589807857|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
163300619|NCT02590432|589807858|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
163300620|NCT02590432|589807859|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
163300621|NCT02590432|589807860|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
163300622|NCT02590432|589807861|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
163300623|NCT02590432|589807862|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
163300624|NCT02590432|589807863|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
163300625|NCT02590432|589807855|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163300626|NCT02590432|589807856|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163300627|NCT02590432|589807857|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163300628|NCT02590432|589807858|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163300629|NCT02590432|589807859|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163394108|NCT00892177|590155662|FG001|Phase II|Ineligible|0|||
163394109|NCT00892177|590155663|FG002|Phase II|Ineligible|0|||
163044924|NCT03301831|588871556|FG001|Overall Study|Withdrawal by Subject|0|||
163300630|NCT02590432|589807860|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
163300631|NCT02590432|589807861|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163300632|NCT02590432|589807862|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163300633|NCT02590432|589807863|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163300634|NCT02590432|589807855|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
163300635|NCT02590432|589807856|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
163300636|NCT02590432|589807857|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
163300637|NCT02590432|589807858|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
163300638|NCT02590432|589807859|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
163300639|NCT02590432|589807860|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
163300640|NCT02590432|589807861|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
163300641|NCT02590432|589807862|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
163300642|NCT02590432|589807863|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
163300643|NCT02590432|589807855|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
163300644|NCT02590432|589807856|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
163300645|NCT02590432|589807857|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
163300646|NCT02590432|589807858|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
163300647|NCT02590432|589807859|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
163300648|NCT02590432|589807860|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
163300649|NCT02590432|589807861|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
163300650|NCT02590432|589807862|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
163300651|NCT02590432|589807863|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
163300652|NCT02590432|589807855|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
163300653|NCT02590432|589807856|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
163394110|NCT00892177|590155664|FG003|Phase II|Ineligible|0|||
163394111|NCT00892177|590155665|FG004|Phase II|Ineligible|1|||
163394112|NCT00892177|590155666|FG005|Phase II|Ineligible|1|||
163394113|NCT00892177|590155661|FG000|Phase II|Withdrawal by Subject|0|||
163394114|NCT00892177|590155662|FG001|Phase II|Withdrawal by Subject|0|||
163394115|NCT00892177|590155663|FG002|Phase II|Withdrawal by Subject|0|||
163394116|NCT00892177|590155664|FG003|Phase II|Withdrawal by Subject|0|||
163394117|NCT00892177|590155665|FG004|Phase II|Withdrawal by Subject|4|||
163394118|NCT00892177|590155666|FG005|Phase II|Withdrawal by Subject|1|||
163394119|NCT05097716|590155667|FG000|Period 1|Adverse Event|1|||
163394120|NCT05097716|590155667|FG000|Period 1|Close contact with highly-transmissible infection|1|||
163394121|NCT01011439|590155668|FG000|Overall Study|Death|37|||
163394122|NCT01011439|590155668|FG000|Overall Study|Lost to Follow-up|4|||
163394123|NCT01011439|590155668|FG000|Overall Study|Withdrawal by Subject|1|||
163394124|NCT01011439|590155668|FG000|Overall Study|Sponsor's decision|15|||
163394125|NCT00058552|590155669|FG000|Overall Study|Died prior to receiving treatment|4|||
163394126|NCT00058552|590155670|FG001|Overall Study|Died prior to receiving treatment|2|||
163394127|NCT00058552|590155669|FG000|Overall Study|Disease progression|52|||
163394128|NCT00058552|590155670|FG001|Overall Study|Disease progression|44|||
163394129|NCT00058552|590155669|FG000|Overall Study|Adverse Event|4|||
163394130|NCT00058552|590155670|FG001|Overall Study|Adverse Event|2|||
163394131|NCT00058552|590155669|FG000|Overall Study|Withdrawal by Subject|3|||
163394132|NCT00058552|590155670|FG001|Overall Study|Withdrawal by Subject|5|||
163394133|NCT00058552|590155669|FG000|Overall Study|Physician Decision|2|||
163394134|NCT00058552|590155670|FG001|Overall Study|Physician Decision|5|||
163394135|NCT00058552|590155669|FG000|Overall Study|Clinical disease progression|0|||
163394136|NCT00058552|590155670|FG001|Overall Study|Clinical disease progression|4|||
163394137|NCT02066311|590155671|FG000|Overall Study|Adverse Event|4|||
163394138|NCT02066311|590155671|FG000|Overall Study|Withdrawal by Subject|1|||
163394139|NCT01372150|590155674|FG000|Overall Study|Lack of Efficacy|3|||
163394140|NCT01372150|590155675|FG001|Overall Study|Lack of Efficacy|0|||
163394141|NCT01372150|590155676|FG002|Overall Study|Lack of Efficacy|1|||
163394142|NCT01372150|590155674|FG000|Overall Study|Lost to Follow-up|4|||
163394143|NCT01372150|590155675|FG001|Overall Study|Lost to Follow-up|5|||
163394144|NCT01372150|590155676|FG002|Overall Study|Lost to Follow-up|6|||
163394145|NCT01372150|590155674|FG000|Overall Study|Protocol Violation|1|||
163394146|NCT01372150|590155675|FG001|Overall Study|Protocol Violation|0|||
163394147|NCT01372150|590155676|FG002|Overall Study|Protocol Violation|3|||
163394148|NCT01372150|590155674|FG000|Overall Study|Withdrawal by Subject|2|||
163394149|NCT01372150|590155675|FG001|Overall Study|Withdrawal by Subject|7|||
163394150|NCT01372150|590155676|FG002|Overall Study|Withdrawal by Subject|2|||
163394151|NCT01372150|590155674|FG000|Overall Study|Other|1|||
163394152|NCT01372150|590155675|FG001|Overall Study|Other|0|||
163394153|NCT01372150|590155676|FG002|Overall Study|Other|2|||
163394154|NCT01372150|590155674|FG000|Overall Study|Adverse Event|2|||
163394155|NCT01372150|590155675|FG001|Overall Study|Adverse Event|1|||
163394156|NCT01372150|590155676|FG002|Overall Study|Adverse Event|2|||
163394157|NCT01372150|590155674|FG000|Overall Study|Randomized but not treated|0|||
163394158|NCT01372150|590155675|FG001|Overall Study|Randomized but not treated|1|||
163394159|NCT01372150|590155676|FG002|Overall Study|Randomized but not treated|0|||
163300654|NCT02590432|589807857|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
163300655|NCT02590432|589807858|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
163300656|NCT02590432|589807859|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
163300657|NCT02590432|589807860|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
163300658|NCT02590432|589807861|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
163300659|NCT02590432|589807862|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
163300660|NCT02590432|589807863|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
163300661|NCT02590432|589807855|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163300662|NCT02590432|589807856|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163300663|NCT02590432|589807857|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163300664|NCT02590432|589807858|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163300665|NCT02590432|589807859|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163300666|NCT02590432|589807860|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163300667|NCT02590432|589807861|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163300668|NCT02590432|589807862|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163300669|NCT02590432|589807863|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
163300670|NCT02590432|589807855|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163300671|NCT02590432|589807856|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163300672|NCT02590432|589807857|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163300673|NCT02590432|589807858|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163300674|NCT02590432|589807859|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163300675|NCT02590432|589807860|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163300676|NCT02590432|589807861|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163300677|NCT02590432|589807862|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163300678|NCT02590432|589807863|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
163300679|NCT02590432|589807855|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163300680|NCT02590432|589807856|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163300681|NCT02590432|589807857|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163300682|NCT02590432|589807858|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163300683|NCT02590432|589807859|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163300684|NCT02590432|589807860|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163300685|NCT02590432|589807861|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163300686|NCT02590432|589807862|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
163300687|NCT02590432|589807863|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163300688|NCT02590432|589807855|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163300689|NCT02590432|589807856|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163300690|NCT02590432|589807857|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163300691|NCT02590432|589807858|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163300692|NCT02590432|589807859|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163300693|NCT02590432|589807860|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163300694|NCT02590432|589807861|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163300695|NCT02590432|589807862|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
163300696|NCT02590432|589807863|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163300697|NCT00409838|589807864|FG000|Short-term Period|Adverse Event|0|||
163300698|NCT00409838|589807865|FG001|Short-term Period|Adverse Event|1|||
163300699|NCT00409838|589807864|FG000|Short-term Period|Lost to Follow-up|0|||
163300700|NCT00409838|589807865|FG001|Short-term Period|Lost to Follow-up|1|||
163300701|NCT00409838|589807864|FG000|Short-term Period|Withdrawal by Subject|2|||
163300702|NCT00409838|589807865|FG001|Short-term Period|Withdrawal by Subject|3|||
163300703|NCT00409838|589807864|FG000|Short-term Period|Never Treated|1|||
163300704|NCT00409838|589807865|FG001|Short-term Period|Never Treated|0|||
163300705|NCT00409838|589807864|FG000|Long-term Extension Period|Adverse Event|10|||
163300706|NCT00409838|589807865|FG001|Long-term Extension Period|Adverse Event|0|||
163300707|NCT00409838|589807864|FG000|Long-term Extension Period|Death|1|||
163300708|NCT00409838|589807865|FG001|Long-term Extension Period|Death|0|||
163300709|NCT00409838|589807864|FG000|Long-term Extension Period|Lack of Efficacy|2|||
163300710|NCT00409838|589807865|FG001|Long-term Extension Period|Lack of Efficacy|0|||
163300711|NCT00409838|589807864|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
163300712|NCT00409838|589807865|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
163300713|NCT00409838|589807864|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
163300714|NCT00409838|589807865|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
163300715|NCT00409838|589807864|FG000|Long-term Extension Period|Pregnancy|1|||
163300716|NCT00409838|589807865|FG001|Long-term Extension Period|Pregnancy|0|||
163300717|NCT04788641|589807867|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
163300718|NCT04788641|589807868|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
163300719|NCT04788641|589807869|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
163300720|NCT04788641|589807870|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
163300721|NCT04788641|589807867|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
163300722|NCT04788641|589807868|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
163300723|NCT04788641|589807869|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
163300724|NCT04788641|589807870|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
163300725|NCT04788641|589807867|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
163300726|NCT04788641|589807868|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
163300727|NCT04788641|589807869|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
163300728|NCT04788641|589807870|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
163300729|NCT01250769|589807871|FG000|Overall Study|Withdrawal by Subject|0|||
163300730|NCT01250769|589807872|FG001|Overall Study|Withdrawal by Subject|1|||
163300731|NCT01250769|589807873|FG002|Overall Study|Withdrawal by Subject|1|||
163300732|NCT01250769|589807874|FG003|Overall Study|Withdrawal by Subject|0|||
163300733|NCT01250769|589807871|FG000|Overall Study|Adverse Event|0|||
162956831|NCT01029340|588543630|FG001|Extension Period|Physician Decision|0|||
162956832|NCT01029340|588543631|FG002|Extension Period|Physician Decision|0|||
162956833|NCT01029340|588543632|FG003|Extension Period|Physician Decision|0|||
163300734|NCT01250769|589807872|FG001|Overall Study|Adverse Event|0|||
163300735|NCT01250769|589807873|FG002|Overall Study|Adverse Event|1|||
162956834|NCT01029340|588543633|FG004|Extension Period|Physician Decision|0|||
162956835|NCT01029340|588543634|FG005|Extension Period|Physician Decision|1|||
162956836|NCT02009163|588543642|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
162956837|NCT02009163|588543643|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
162956838|NCT02009163|588543644|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
162956839|NCT02009163|588543642|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
162956840|NCT02009163|588543643|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
162956841|NCT02009163|588543644|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
163300736|NCT01250769|589807874|FG003|Overall Study|Adverse Event|0|||
163300737|NCT03951805|589807879|FG000|Overall Study|Adverse Event|1|||
163300738|NCT03951805|589807880|FG001|Overall Study|Adverse Event|0|||
163300739|NCT03951805|589807881|FG002|Overall Study|Adverse Event|0|||
163300740|NCT03951805|589807882|FG003|Overall Study|Adverse Event|0|||
163300741|NCT01198145|589807885|FG000|Overall Study|Withdrawal by Subject|1|||
163300742|NCT01198145|589807886|FG001|Overall Study|Withdrawal by Subject|1|||
163300743|NCT02528188|589807887|FG000|Overall Study|Adverse Event|23|||
163300744|NCT02528188|589807888|FG001|Overall Study|Adverse Event|22|||
163300745|NCT02528188|589807889|FG002|Overall Study|Adverse Event|8|||
163300746|NCT02528188|589807887|FG000|Overall Study|Protocol Violation|4|||
163300747|NCT02528188|589807888|FG001|Overall Study|Protocol Violation|6|||
163300748|NCT02528188|589807889|FG002|Overall Study|Protocol Violation|4|||
163300749|NCT02528188|589807887|FG000|Overall Study|Lack of Efficacy|19|||
163300750|NCT02528188|589807888|FG001|Overall Study|Lack of Efficacy|21|||
163300751|NCT02528188|589807889|FG002|Overall Study|Lack of Efficacy|22|||
163300752|NCT02528188|589807887|FG000|Overall Study|Withdrawal by Subject|97|||
163300753|NCT02528188|589807888|FG001|Overall Study|Withdrawal by Subject|104|||
163300754|NCT02528188|589807889|FG002|Overall Study|Withdrawal by Subject|100|||
163300755|NCT02528188|589807887|FG000|Overall Study|Lost to Follow-up|25|||
163300756|NCT02528188|589807888|FG001|Overall Study|Lost to Follow-up|21|||
163300757|NCT02528188|589807889|FG002|Overall Study|Lost to Follow-up|31|||
163300758|NCT02528188|589807887|FG000|Overall Study|Death|4|||
163394160|NCT02316340|590155677|FG000|First Progression|Clinical progression|2|||
163394161|NCT02316340|590155678|FG001|First Progression|Clinical progression|1|||
163394162|NCT02316340|590155677|FG000|First Progression|Withdrawal by Subject|1|||
163394163|NCT02316340|590155678|FG001|First Progression|Withdrawal by Subject|0|||
163394164|NCT01835015|590155679|FG000|Overall Study|Adverse Event|0|||
163394165|NCT01835015|590155680|FG001|Overall Study|Adverse Event|0|||
163394166|NCT01835015|590155681|FG002|Overall Study|Adverse Event|1|||
163394167|NCT01835015|590155682|FG003|Overall Study|Adverse Event|0|||
163394168|NCT01835015|590155683|FG004|Overall Study|Adverse Event|0|||
163394169|NCT03781323|590155684|FG000|Overall Study|Withdrawal by Subject|1|||
163394170|NCT00975715|590155688|FG000|Titration Period|Adverse Event|6|||
163394171|NCT00975715|590155689|FG001|Titration Period|Adverse Event|0|||
163394172|NCT00975715|590155688|FG000|Titration Period|Protocol Violation|1|||
163394173|NCT00975715|590155689|FG001|Titration Period|Protocol Violation|0|||
163394174|NCT00975715|590155688|FG000|Maintenance Period|Adverse Event|2|||
162956842|NCT02009163|588543642|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
162956843|NCT02009163|588543643|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
162956844|NCT02009163|588543644|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
162956845|NCT02009163|588543642|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
162956846|NCT02009163|588543643|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
162956847|NCT02009163|588543644|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
162956848|NCT02009163|588543642|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
162956849|NCT02009163|588543643|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
162956850|NCT02009163|588543644|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
162956851|NCT02009163|588543642|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
162956852|NCT02009163|588543643|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
162956853|NCT02009163|588543644|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
163300759|NCT02528188|589807888|FG001|Overall Study|Death|4|||
163300760|NCT02528188|589807889|FG002|Overall Study|Death|0|||
163300761|NCT02528188|589807887|FG000|Overall Study|Other|89|||
163394175|NCT00975715|590155689|FG001|Maintenance Period|Adverse Event|1|||
162956854|NCT02009163|588543642|FG000|Open-label Period (Non-randomized)|Other|13|||
162956855|NCT02009163|588543643|FG001|Open-label Period (Non-randomized)|Other|0|||
163300762|NCT02528188|589807888|FG001|Overall Study|Other|91|||
163300763|NCT02528188|589807889|FG002|Overall Study|Other|74|||
163300764|NCT02528188|589807887|FG000|Overall Study|Randomized but not treated|6|||
162956856|NCT02009163|588543644|FG002|Open-label Period (Non-randomized)|Other|0|||
163394176|NCT01241552|590155693|FG000|Overall Study|Lack of Efficacy|1|||
163394177|NCT01241552|590155694|FG001|Overall Study|Lack of Efficacy|0|||
163394178|NCT01241552|590155695|FG002|Overall Study|Lack of Efficacy|0|||
162956857|NCT02009163|588543642|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
163044925|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
163300765|NCT02528188|589807888|FG001|Overall Study|Randomized but not treated|7|||
163394179|NCT01241552|590155696|FG003|Overall Study|Lack of Efficacy|0|||
163300766|NCT02528188|589807889|FG002|Overall Study|Randomized but not treated|12|||
163300767|NCT02299375|589807890|FG000|Overall Study|Adverse Event, serious fatal|1|||
163300768|NCT02299375|589807891|FG001|Overall Study|Adverse Event, serious fatal|3|||
163300769|NCT02299375|589807890|FG000|Overall Study|Adverse Event, non-fatal|8|||
163300770|NCT02299375|589807891|FG001|Overall Study|Adverse Event, non-fatal|9|||
163300771|NCT02299375|589807890|FG000|Overall Study|Lack of Efficacy|1|||
163300772|NCT02299375|589807891|FG001|Overall Study|Lack of Efficacy|3|||
163300773|NCT02299375|589807890|FG000|Overall Study|Protocol Violation|1|||
163300774|NCT02299375|589807891|FG001|Overall Study|Protocol Violation|3|||
163300775|NCT02299375|589807890|FG000|Overall Study|Other: Met stopping criteria|1|||
163300776|NCT02299375|589807891|FG001|Overall Study|Other: Met stopping criteria|0|||
163300777|NCT02299375|589807890|FG000|Overall Study|Other: Study closed/terminated|66|||
163300778|NCT02299375|589807891|FG001|Overall Study|Other: Study closed/terminated|55|||
163300779|NCT02299375|589807890|FG000|Overall Study|Lost to Follow-up|0|||
163300780|NCT02299375|589807891|FG001|Overall Study|Lost to Follow-up|2|||
163300781|NCT02299375|589807890|FG000|Overall Study|Physician Decision|1|||
163300782|NCT02299375|589807891|FG001|Overall Study|Physician Decision|1|||
163300783|NCT02299375|589807890|FG000|Overall Study|Withdrawal by Subject|1|||
163300784|NCT02299375|589807891|FG001|Overall Study|Withdrawal by Subject|4|||
163300785|NCT00704184|589807897|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
163300786|NCT00704184|589807898|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
163300787|NCT00704184|589807899|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
163300788|NCT00704184|589807900|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
163300789|NCT00704184|589807901|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
163300790|NCT00704184|589807897|FG000|Open-Label Treatment|Adverse Event|0|||
163394180|NCT01241552|590155693|FG000|Overall Study|Death|26|||
163394181|NCT01241552|590155694|FG001|Overall Study|Death|30|||
163394182|NCT01241552|590155695|FG002|Overall Study|Death|20|||
163394183|NCT01241552|590155696|FG003|Overall Study|Death|25|||
163394184|NCT01241552|590155693|FG000|Overall Study|Adverse Event|1|||
163394185|NCT01241552|590155694|FG001|Overall Study|Adverse Event|1|||
163394186|NCT01241552|590155695|FG002|Overall Study|Adverse Event|0|||
163394187|NCT01241552|590155696|FG003|Overall Study|Adverse Event|0|||
163394188|NCT01241552|590155693|FG000|Overall Study|Technical Problems|2|||
163394189|NCT01241552|590155694|FG001|Overall Study|Technical Problems|0|||
163394190|NCT01241552|590155695|FG002|Overall Study|Technical Problems|2|||
163394191|NCT01241552|590155696|FG003|Overall Study|Technical Problems|2|||
163394192|NCT01241552|590155693|FG000|Overall Study|Progressive Disease|0|||
163394193|NCT01241552|590155694|FG001|Overall Study|Progressive Disease|0|||
163394194|NCT01241552|590155695|FG002|Overall Study|Progressive Disease|1|||
163394195|NCT01241552|590155696|FG003|Overall Study|Progressive Disease|2|||
163394196|NCT01241552|590155693|FG000|Overall Study|Protocol Violation|0|||
163394197|NCT01241552|590155694|FG001|Overall Study|Protocol Violation|2|||
163394198|NCT01241552|590155695|FG002|Overall Study|Protocol Violation|6|||
163394199|NCT01241552|590155696|FG003|Overall Study|Protocol Violation|1|||
163394200|NCT01241552|590155693|FG000|Overall Study|Withdrawal by Subject|7|||
163394201|NCT01241552|590155694|FG001|Overall Study|Withdrawal by Subject|15|||
163394202|NCT01241552|590155695|FG002|Overall Study|Withdrawal by Subject|14|||
163394203|NCT01241552|590155696|FG003|Overall Study|Withdrawal by Subject|15|||
163394204|NCT01241552|590155693|FG000|Overall Study|Physician Decision|2|||
163394205|NCT01241552|590155694|FG001|Overall Study|Physician Decision|4|||
163394206|NCT01241552|590155695|FG002|Overall Study|Physician Decision|2|||
163394207|NCT01241552|590155696|FG003|Overall Study|Physician Decision|3|||
163394208|NCT01241552|590155693|FG000|Overall Study|Lost to Follow-up|2|||
163394209|NCT01241552|590155694|FG001|Overall Study|Lost to Follow-up|11|||
163394210|NCT01241552|590155695|FG002|Overall Study|Lost to Follow-up|15|||
163394211|NCT01241552|590155696|FG003|Overall Study|Lost to Follow-up|16|||
163394212|NCT04004429|590155697|FG000|Overall Study|Protocol Violation|1|||
163394213|NCT04004429|590155698|FG001|Overall Study|Protocol Violation|0|||
163394214|NCT04004429|590155699|FG002|Overall Study|Protocol Violation|0|||
163394215|NCT04004429|590155697|FG000|Overall Study|Physician Decision|0|||
163394216|NCT04004429|590155698|FG001|Overall Study|Physician Decision|1|||
163394217|NCT04004429|590155699|FG002|Overall Study|Physician Decision|1|||
163394218|NCT04004429|590155697|FG000|Overall Study|Withdrawal by Subject|1|||
163044926|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
163044927|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
163300791|NCT00704184|589807898|FG001|Open-Label Treatment|Adverse Event|0|||
163300792|NCT00704184|589807899|FG002|Open-Label Treatment|Adverse Event|2|||
163300793|NCT00704184|589807900|FG003|Open-Label Treatment|Adverse Event|0|||
163300794|NCT00704184|589807901|FG004|Open-Label Treatment|Adverse Event|1|||
163300795|NCT00704184|589807897|FG000|Open-Label Treatment|Lack of Efficacy|0|||
163300796|NCT00704184|589807898|FG001|Open-Label Treatment|Lack of Efficacy|2|||
163300797|NCT00704184|589807899|FG002|Open-Label Treatment|Lack of Efficacy|2|||
163300798|NCT00704184|589807900|FG003|Open-Label Treatment|Lack of Efficacy|2|||
163300799|NCT00704184|589807901|FG004|Open-Label Treatment|Lack of Efficacy|1|||
163300800|NCT00704184|589807897|FG000|Open-Label Treatment|Physician Decision|0|||
163300801|NCT00704184|589807898|FG001|Open-Label Treatment|Physician Decision|0|||
163300802|NCT00704184|589807899|FG002|Open-Label Treatment|Physician Decision|0|||
163300803|NCT00704184|589807900|FG003|Open-Label Treatment|Physician Decision|0|||
163300804|NCT00704184|589807901|FG004|Open-Label Treatment|Physician Decision|1|||
163300805|NCT00704184|589807897|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
163300806|NCT00704184|589807898|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
163300807|NCT00704184|589807899|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
163300808|NCT00704184|589807900|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
163300809|NCT00704184|589807901|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
163300810|NCT00716859|589807904|FG000|Overall Study|Adverse Event|4|||
163394219|NCT04004429|590155698|FG001|Overall Study|Withdrawal by Subject|1|||
163394220|NCT04004429|590155699|FG002|Overall Study|Withdrawal by Subject|1|||
163394221|NCT02606461|590155700|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
163394222|NCT02606461|590155701|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
163394223|NCT02606461|590155702|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
163394224|NCT02606461|590155703|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
163394225|NCT02606461|590155704|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
163394226|NCT02606461|590155705|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
163044928|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
163300811|NCT00716859|589807905|FG001|Overall Study|Adverse Event|1|||
163300812|NCT00716859|589807904|FG000|Overall Study|Lack of Efficacy|3|||
163300813|NCT00716859|589807905|FG001|Overall Study|Lack of Efficacy|0|||
163300814|NCT00716859|589807904|FG000|Overall Study|Withdrawal by Subject|1|||
163394227|NCT00239226|590155706|FG000|Overall Study|permAF during stabilization period|0|||
163394228|NCT00239226|590155707|FG001|Overall Study|permAF during stabilization period|0|||
163394229|NCT00239226|590155708|FG002|Overall Study|permAF during stabilization period|0|||
163300815|NCT00716859|589807905|FG001|Overall Study|Withdrawal by Subject|3|||
163300816|NCT00716859|589807904|FG000|Overall Study|Not treated|1|||
163300817|NCT00716859|589807905|FG001|Overall Study|Not treated|1|||
163300818|NCT02178098|589807906|FG000|Overall Study|Withdrawal by Subject|0|||
163300819|NCT02178098|589807907|FG001|Overall Study|Withdrawal by Subject|6|||
163300820|NCT02178098|589807906|FG000|Overall Study|Adverse Event|1|||
163300821|NCT02178098|589807907|FG001|Overall Study|Adverse Event|2|||
163300822|NCT02178098|589807906|FG000|Overall Study|Protocol Violation|1|||
163394230|NCT00239226|590155709|FG003|Overall Study|permAF during stabilization period|3|||
163394231|NCT00239226|590155706|FG000|Overall Study|Lost to Follow-up|1|||
163300823|NCT02178098|589807907|FG001|Overall Study|Protocol Violation|1|||
163394232|NCT00239226|590155707|FG001|Overall Study|Lost to Follow-up|0|||
163300824|NCT02178098|589807906|FG000|Overall Study|Lost to Follow-up|0|||
163300825|NCT02178098|589807907|FG001|Overall Study|Lost to Follow-up|1|||
163300826|NCT02178098|589807906|FG000|Overall Study|Sponsor Request|1|||
163300827|NCT02178098|589807907|FG001|Overall Study|Sponsor Request|0|||
163300828|NCT02178098|589807906|FG000|Overall Study|Other|2|||
163300829|NCT02178098|589807907|FG001|Overall Study|Other|2|||
163300830|NCT01109524|589807913|FG000|Overall Study|Disease Progression|29|||
163300831|NCT01109524|589807913|FG000|Overall Study|Study Drug toxicity|6|||
163300832|NCT01109524|589807913|FG000|Overall Study|Adverse Event|4|||
163300833|NCT01109524|589807913|FG000|Overall Study|Withdrawal by Subject|2|||
163300834|NCT01109524|589807913|FG000|Overall Study|Maximum clinical benefit|3|||
163300835|NCT01109524|589807913|FG000|Overall Study|Death|2|||
163300836|NCT01109524|589807913|FG000|Overall Study|No longer meets criteria|2|||
163300837|NCT01109524|589807913|FG000|Overall Study|Participant requested to end treatment|4|||
163300838|NCT01109524|589807913|FG000|Overall Study|Other|5|||
163300839|NCT00411216|589807914|FG000|Overall Study|Ten participants were entered into the c|0|||
163300840|NCT00411216|589807915|FG001|Overall Study|Ten participants were entered into the c|2|||
163195099|NCT00413244|589428425|FG000|Overall Study|Withdrawal by Subject|10|||
163195100|NCT00413244|589428426|FG001|Overall Study|Withdrawal by Subject|1|||
163195101|NCT02319837|589428429|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
163195102|NCT02319837|589428430|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
163195103|NCT02319837|589428431|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
163195104|NCT02319837|589428429|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
163195105|NCT02319837|589428430|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
163195106|NCT02319837|589428431|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
163195107|NCT02319837|589428429|FG000|Study Treatment Phase|Adverse Event|73|||
163195108|NCT02319837|589428430|FG001|Study Treatment Phase|Adverse Event|36|||
163195109|NCT02319837|589428431|FG002|Study Treatment Phase|Adverse Event|63|||
163195110|NCT02319837|589428429|FG000|Study Treatment Phase|Development of castration resistance|0|||
163195111|NCT02319837|589428430|FG001|Study Treatment Phase|Development of castration resistance|2|||
163195112|NCT02319837|589428431|FG002|Study Treatment Phase|Development of castration resistance|0|||
163195113|NCT02319837|589428429|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
163195114|NCT02319837|589428430|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
163195115|NCT02319837|589428431|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
163195116|NCT02319837|589428429|FG000|Study Treatment Phase|Protocol Violation|2|||
163195117|NCT02319837|589428430|FG001|Study Treatment Phase|Protocol Violation|2|||
163195118|NCT02319837|589428431|FG002|Study Treatment Phase|Protocol Violation|1|||
163195119|NCT02319837|589428429|FG000|Study Treatment Phase|Lost to Follow-up|0|||
163195120|NCT02319837|589428430|FG001|Study Treatment Phase|Lost to Follow-up|1|||
163195121|NCT02319837|589428431|FG002|Study Treatment Phase|Lost to Follow-up|0|||
163195122|NCT02319837|589428429|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
163195123|NCT02319837|589428430|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
163195124|NCT02319837|589428431|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
163195125|NCT02319837|589428429|FG000|Study Treatment Phase|Other|0|||
163195126|NCT02319837|589428430|FG001|Study Treatment Phase|Other|1|||
163195127|NCT02319837|589428431|FG002|Study Treatment Phase|Other|0|||
163195128|NCT02319837|589428429|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
163195129|NCT02319837|589428430|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
163195130|NCT02319837|589428431|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
163195131|NCT02319837|589428429|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
163195132|NCT02319837|589428430|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
163195133|NCT02319837|589428431|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
163195134|NCT02319837|589428429|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
163195135|NCT02319837|589428430|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
163195136|NCT02319837|589428431|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
163195137|NCT02319837|589428429|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
163195138|NCT02319837|589428430|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
163195139|NCT02319837|589428431|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
163195140|NCT02319837|589428429|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
163195141|NCT02319837|589428430|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
163195142|NCT02319837|589428431|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
163195143|NCT02319837|589428429|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
163195144|NCT02319837|589428430|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
163195145|NCT02319837|589428431|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
163195146|NCT02319837|589428429|FG000|Long-Term Follow-Up Phase|Death|33|||
163195147|NCT02319837|589428430|FG001|Long-Term Follow-Up Phase|Death|54|||
163195148|NCT02319837|589428431|FG002|Long-Term Follow-Up Phase|Death|42|||
163195149|NCT02435147|589428432|FG000|Overall Study|non-evaluable DXA scan|11|||
163195150|NCT00839852|589428435|FG000|Overall Study|Adverse Event|10|||
163195151|NCT00839852|589428435|FG000|Overall Study|Insufficient Therapeutic Response|3|||
163195152|NCT00839852|589428435|FG000|Overall Study|Protocol Violation|9|||
163195153|NCT00839852|589428435|FG000|Overall Study|Withdrawal of Consent|16|||
163195154|NCT00839852|589428435|FG000|Overall Study|Lost to Follow-up|7|||
163195155|NCT00839852|589428435|FG000|Overall Study|Lack of Compliance While in Jail|1|||
163195156|NCT00839852|589428435|FG000|Overall Study|Pregnancy|1|||
163195157|NCT03082261|589428436|FG000|Overall Study|Death|4|||
163195158|NCT03082261|589428436|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
163195159|NCT03082261|589428436|FG000|Overall Study|Insurance denial|1|||
163195160|NCT03082261|589428436|FG000|Overall Study|Peripheral lead added|1|||
162956858|NCT02009163|588543643|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
162956859|NCT02009163|588543644|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
162956860|NCT02009163|588543642|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
162956861|NCT02009163|588543643|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
162956862|NCT02009163|588543644|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
162956863|NCT02009163|588543642|FG000|Randomized-withdrawal Period|Adverse Event|0|||
163195161|NCT03082261|589428436|FG000|Overall Study|Withdrawal by Subject|40|||
163195162|NCT03082261|589428436|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
163195163|NCT03082261|589428436|FG000|Overall Study|Subject implanted with device other than study device|1|||
163195164|NCT03082261|589428436|FG000|Overall Study|Lost to Follow-up|14|||
163195165|NCT03082261|589428436|FG000|Overall Study|Subject moved to a different state|1|||
163195166|NCT03082261|589428436|FG000|Overall Study|Subject non-compliance|2|||
163195167|NCT03082261|589428436|FG000|Overall Study|Subject participation terminated by investigator|9|||
163195168|NCT03082261|589428436|FG000|Overall Study|Subject participation terminated by sponsor|4|||
163195169|NCT03082261|589428436|FG000|Overall Study|System explant|19|||
163195170|NCT03082261|589428436|FG000|Overall Study|Unable to place lead(s)|2|||
163195171|NCT03082261|589428436|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
163195172|NCT01313312|589428440|FG000|Overall Study|Adverse Event|5|||
163195173|NCT01313312|589428440|FG000|Overall Study|Withdrawal by Subject|18|||
163195174|NCT01313312|589428440|FG000|Overall Study|Lack of Efficacy|3|||
163195175|NCT01313312|589428440|FG000|Overall Study|Investigator Decision|1|||
163195176|NCT01313312|589428440|FG000|Overall Study|Observational Phase|1|||
163195177|NCT01313312|589428440|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
163195178|NCT01313312|589428440|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
163195179|NCT01206166|589428448|FG000|Overall Study|No evaluable data|2|||
163195180|NCT01206166|589428449|FG001|Overall Study|No evaluable data|3|||
163195181|NCT02716805|589428450|FG000|Overall Study|Progressive disease|2|||
163195182|NCT02716805|589428451|FG001|Overall Study|Progressive disease|0|||
163300841|NCT01205048|589807916|FG000|Overall Study|Withdrawal by Subject|14|||
162956864|NCT02009163|588543643|FG001|Randomized-withdrawal Period|Adverse Event|0|||
162956865|NCT02009163|588543644|FG002|Randomized-withdrawal Period|Adverse Event|6|||
162956866|NCT02009163|588543642|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
163195183|NCT02716805|589428452|FG002|Overall Study|Progressive disease|0|||
163300842|NCT01205048|589807916|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
163195184|NCT02716805|589428453|FG003|Overall Study|Progressive disease|0|||
163300843|NCT01205048|589807916|FG000|Overall Study|Lost to Follow-up|4|||
163300844|NCT01205048|589807916|FG000|Overall Study|Other|2|||
162956867|NCT02009163|588543643|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
162956868|NCT02009163|588543644|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
162956869|NCT02009163|588543642|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
162956870|NCT02009163|588543643|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
162956871|NCT02009163|588543644|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
162956872|NCT02009163|588543642|FG000|Randomized-withdrawal Period|Pregnancy|0|||
162956873|NCT02009163|588543643|FG001|Randomized-withdrawal Period|Pregnancy|0|||
162956874|NCT02009163|588543644|FG002|Randomized-withdrawal Period|Pregnancy|2|||
162956875|NCT02009163|588543642|FG000|Randomized-withdrawal Period|Other|0|||
162956876|NCT02009163|588543643|FG001|Randomized-withdrawal Period|Other|9|||
162956877|NCT02009163|588543644|FG002|Randomized-withdrawal Period|Other|5|||
162956878|NCT02453386|588543645|FG000|Overall Study|Adverse Event|22|||
162956879|NCT02453386|588543646|FG001|Overall Study|Adverse Event|30|||
162956880|NCT02453386|588543647|FG002|Overall Study|Adverse Event|15|||
162956881|NCT02453386|588543645|FG000|Overall Study|Protocol Violation|1|||
162956882|NCT02453386|588543646|FG001|Overall Study|Protocol Violation|0|||
162956883|NCT02453386|588543647|FG002|Overall Study|Protocol Violation|1|||
162956884|NCT02453386|588543645|FG000|Overall Study|Withdrawal by Subject|10|||
162956885|NCT02453386|588543646|FG001|Overall Study|Withdrawal by Subject|9|||
162956886|NCT02453386|588543647|FG002|Overall Study|Withdrawal by Subject|9|||
162956887|NCT02453386|588543645|FG000|Overall Study|Sponsor Terminated Study|14|||
162956888|NCT02453386|588543646|FG001|Overall Study|Sponsor Terminated Study|8|||
162956889|NCT02453386|588543647|FG002|Overall Study|Sponsor Terminated Study|11|||
162956890|NCT02453386|588543645|FG000|Overall Study|Subject Terminated by Sponsor|1|||
162956891|NCT02453386|588543646|FG001|Overall Study|Subject Terminated by Sponsor|1|||
162956892|NCT02453386|588543647|FG002|Overall Study|Subject Terminated by Sponsor|1|||
162956893|NCT02453386|588543645|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
162956894|NCT02453386|588543646|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
163300845|NCT00823472|589807917|FG000|Overall Study|Physician Decision|24|||
163300846|NCT00823472|589807918|FG001|Overall Study|Physician Decision|28|||
163300847|NCT02769858|589807932|FG000|Overall Study|Withdrawal by Subject|2|||
162956895|NCT02453386|588543647|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
162956896|NCT02453386|588543645|FG000|Overall Study|Lost to Follow-up|0|||
162956897|NCT02453386|588543646|FG001|Overall Study|Lost to Follow-up|0|||
162956898|NCT02453386|588543647|FG002|Overall Study|Lost to Follow-up|1|||
163300848|NCT04939246|589807933|FG000|After Treatment|Death|4|||
163300849|NCT04939246|589807933|FG000|After Treatment|Lost to Follow-up|1|||
163394233|NCT00239226|590155708|FG002|Overall Study|Lost to Follow-up|1|||
163300850|NCT04939246|589807933|FG000|After Treatment|Discharged to hospice|2|||
163300851|NCT01853748|589809873|FG000|Allocation|Withdrawal by Subject|1|||
163300852|NCT01853748|589809874|FG001|Allocation|Withdrawal by Subject|13|||
163300853|NCT01853748|589809873|FG000|Allocation|not sufficient to receive intervention|0|||
163300854|NCT01853748|589809874|FG001|Allocation|not sufficient to receive intervention|1|||
163300855|NCT01853748|589809873|FG000|Follow-Up|Withdrawal by Subject|7|||
163300856|NCT01853748|589809874|FG001|Follow-Up|Withdrawal by Subject|6|||
163300857|NCT01853748|589809873|FG000|Follow-Up|Adverse Event|67|||
163300858|NCT01853748|589809874|FG001|Follow-Up|Adverse Event|7|||
163300859|NCT01853748|589809873|FG000|Follow-Up|not available for data collection|16|||
163300860|NCT01853748|589809874|FG001|Follow-Up|not available for data collection|4|||
163300861|NCT00780416|589809879|FG000|Overall Study|Physician Decision|3|||
163300862|NCT00780416|589809880|FG001|Overall Study|Physician Decision|3|||
163300863|NCT00780416|589809879|FG000|Overall Study|Protocol Violation|1|||
163300864|NCT00780416|589809880|FG001|Overall Study|Protocol Violation|0|||
163300865|NCT00780416|589809879|FG000|Overall Study|Withdrawal by Subject|8|||
163300866|NCT00780416|589809880|FG001|Overall Study|Withdrawal by Subject|6|||
163300867|NCT02916706|589809881|FG000|Overall Study|Adverse Event|0|||
163300868|NCT02916706|589809882|FG001|Overall Study|Adverse Event|1|||
163300869|NCT02916706|589809881|FG000|Overall Study|Lost to Follow-up|0|||
163300870|NCT02916706|589809882|FG001|Overall Study|Lost to Follow-up|1|||
163300871|NCT02916706|589809881|FG000|Overall Study|Physician Decision|1|||
163300872|NCT02916706|589809882|FG001|Overall Study|Physician Decision|0|||
163300873|NCT02916706|589809881|FG000|Overall Study|Protocol Violation|3|||
163300874|NCT02916706|589809882|FG001|Overall Study|Protocol Violation|1|||
163300875|NCT02916706|589809881|FG000|Overall Study|Withdrawal by Subject|6|||
163300876|NCT02916706|589809882|FG001|Overall Study|Withdrawal by Subject|9|||
163300877|NCT02916706|589809881|FG000|Overall Study|Other|5|||
163300878|NCT02916706|589809882|FG001|Overall Study|Other|19|||
163300879|NCT03088813|589809884|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
163300880|NCT03088813|589809885|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
163300881|NCT03088813|589809886|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
163300882|NCT03088813|589809887|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
163300883|NCT03088813|589809884|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
163300884|NCT03088813|589809885|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
163300885|NCT03088813|589809886|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
163300886|NCT03088813|589809887|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
162956899|NCT02453386|588543645|FG000|Overall Study|Other|1|||
162956900|NCT02453386|588543646|FG001|Overall Study|Other|0|||
162956901|NCT02453386|588543647|FG002|Overall Study|Other|1|||
162956902|NCT00359281|588543648|FG000|Overall Study|Adverse Event|1|||
162956903|NCT00359281|588543649|FG001|Overall Study|Adverse Event|0|||
162956904|NCT00359281|588543650|FG002|Overall Study|Adverse Event|0|||
162956905|NCT00359281|588543651|FG003|Overall Study|Adverse Event|0|||
162956906|NCT00359281|588543652|FG004|Overall Study|Adverse Event|0|||
162956907|NCT00359281|588543653|FG005|Overall Study|Adverse Event|0|||
163300887|NCT03088813|589809884|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
163300888|NCT03088813|589809885|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
163300889|NCT03088813|589809886|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
163300890|NCT03088813|589809887|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
163300891|NCT03088813|589809884|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
162956908|NCT00359281|588543654|FG006|Overall Study|Adverse Event|1|||
162956909|NCT00359281|588543655|FG007|Overall Study|Adverse Event|0|||
162956910|NCT00359281|588543656|FG008|Overall Study|Adverse Event|0|||
162956911|NCT00359281|588543648|FG000|Overall Study|Withdrawal by Subject|0|||
162956912|NCT00359281|588543649|FG001|Overall Study|Withdrawal by Subject|0|||
162956913|NCT00359281|588543650|FG002|Overall Study|Withdrawal by Subject|0|||
162956914|NCT00359281|588543651|FG003|Overall Study|Withdrawal by Subject|0|||
162956915|NCT00359281|588543652|FG004|Overall Study|Withdrawal by Subject|0|||
163195185|NCT00066365|589428454|FG000|Overall Study|Adverse Event|1|||
163195186|NCT00066365|589428455|FG001|Overall Study|Adverse Event|0|||
163195187|NCT00066365|589428454|FG000|Overall Study|Lack of Efficacy|15|||
163195188|NCT00066365|589428455|FG001|Overall Study|Lack of Efficacy|12|||
163195189|NCT00066365|589428454|FG000|Overall Study|Physician Decision|1|||
163195190|NCT00066365|589428455|FG001|Overall Study|Physician Decision|0|||
163195191|NCT00066365|589428454|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
163195192|NCT00066365|589428455|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
163195193|NCT00066365|589428454|FG000|Overall Study|Ineligible|4|||
163195194|NCT00066365|589428455|FG001|Overall Study|Ineligible|2|||
163195195|NCT00467857|589428458|FG000|Overall Study|Adverse Event|1|||
163195196|NCT00467857|589428459|FG001|Overall Study|Adverse Event|0|||
163195197|NCT00467857|589428458|FG000|Overall Study|Withdrew consent|2|||
163195198|NCT00467857|589428459|FG001|Overall Study|Withdrew consent|0|||
163195199|NCT00467857|589428458|FG000|Overall Study|Death|0|||
163195200|NCT00467857|589428459|FG001|Overall Study|Death|1|||
163195201|NCT00467857|589428458|FG000|Overall Study|Discharged from court service|0|||
163195202|NCT00467857|589428459|FG001|Overall Study|Discharged from court service|1|||
163195203|NCT00467857|589428458|FG000|Overall Study|Emergency care required|0|||
163195204|NCT00467857|589428459|FG001|Overall Study|Emergency care required|1|||
163195205|NCT00467857|589428458|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
163195206|NCT00467857|589428459|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
163195207|NCT00467857|589428458|FG000|Overall Study|Discontinuation reason missing|0|||
163195208|NCT00467857|589428459|FG001|Overall Study|Discontinuation reason missing|3|||
163195209|NCT03576495|589428461|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
163195210|NCT03576495|589428462|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
163195211|NCT05306977|589428464|FG000|Overall Study|Withdrawal by Subject|1|||
163195212|NCT02628938|589428468|FG000|Overall Study|Did not attend the follow up recall|2|||
163195213|NCT02628938|589428469|FG001|Overall Study|Did not attend the follow up recall|2|||
163195214|NCT02628938|589428470|FG002|Overall Study|Did not attend the follow up recall|1|||
163195215|NCT02628938|589428468|FG000|Overall Study|Failure to comply with the instructions|3|||
163195216|NCT02628938|589428469|FG001|Overall Study|Failure to comply with the instructions|0|||
163195217|NCT02628938|589428470|FG002|Overall Study|Failure to comply with the instructions|3|||
163195218|NCT02058693|589428471|FG000|Phase 1|Withdrawal by Subject|3|||
163195219|NCT02058693|589428472|FG001|Phase 1|Withdrawal by Subject|2|||
163195220|NCT02058693|589428471|FG000|Phase 1|Adverse Event|0|||
163195221|NCT02058693|589428472|FG001|Phase 1|Adverse Event|1|||
163195222|NCT02058693|589428471|FG000|Phase 1|Lack of Efficacy|1|||
163195223|NCT02058693|589428472|FG001|Phase 1|Lack of Efficacy|0|||
163195224|NCT02058693|589428471|FG000|Phase 1|Physician Decision|1|||
163195225|NCT02058693|589428472|FG001|Phase 1|Physician Decision|1|||
163195226|NCT02058693|589428471|FG000|Phase 2|Withdrawal by Subject|0|||
163195227|NCT02058693|589428472|FG001|Phase 2|Withdrawal by Subject|2|||
163195228|NCT00241358|589428474|FG000|Overall Study|Determined to be not ineligible|0|||
163300892|NCT03088813|589809885|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
163300893|NCT03088813|589809886|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
163300894|NCT03088813|589809887|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
163300895|NCT03088813|589809884|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
163300896|NCT03088813|589809885|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
163300897|NCT03088813|589809886|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
163300898|NCT03088813|589809887|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
163300899|NCT03088813|589809884|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
163300900|NCT03088813|589809885|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
163300901|NCT03088813|589809886|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
163300902|NCT03088813|589809887|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
163300903|NCT03088813|589809884|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
163300904|NCT03088813|589809885|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
163300905|NCT03088813|589809886|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
163300906|NCT03088813|589809887|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
163300907|NCT02152137|589809888|FG000|Overall Study|Withdrawal by Subject|1|||
163300908|NCT02152137|589809888|FG000|Overall Study|Originally assigned to Arm B|3|||
163300909|NCT04878354|589809889|FG000|Overall Study|Adverse Event|4|||
163300910|NCT04878354|589809890|FG001|Overall Study|Adverse Event|13|||
163300911|NCT04878354|589809889|FG000|Overall Study|Withdrawal by Subject|14|||
163300912|NCT04878354|589809890|FG001|Overall Study|Withdrawal by Subject|12|||
163300913|NCT04878354|589809889|FG000|Overall Study|Lost to Follow-up|4|||
163300914|NCT04878354|589809890|FG001|Overall Study|Lost to Follow-up|1|||
163300915|NCT04878354|589809889|FG000|Overall Study|Lack of Efficacy|1|||
163300916|NCT04878354|589809890|FG001|Overall Study|Lack of Efficacy|0|||
163300917|NCT04878354|589809889|FG000|Overall Study|Protocol Violation|0|||
163300918|NCT04878354|589809890|FG001|Overall Study|Protocol Violation|1|||
163300919|NCT04878354|589809889|FG000|Overall Study|"Reason stated as other in CRF"|2|||
163300920|NCT04878354|589809890|FG001|Overall Study|"Reason stated as other in CRF"|3|||
163300921|NCT01903811|589809912|FG000|Overall Study|No measurable disease|1|||
163300922|NCT01903811|589809913|FG001|Overall Study|No measurable disease|1|||
163300923|NCT01903811|589809912|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
163300924|NCT01903811|589809913|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
163300925|NCT01903811|589809912|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
163300926|NCT01903811|589809913|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
163300927|NCT01903811|589809912|FG000|Overall Study|Withdrawal by Subject|0|||
163300928|NCT01903811|589809913|FG001|Overall Study|Withdrawal by Subject|1|||
163300929|NCT05613205|589809914|FG000|Overall Study|Lost to Follow-up|0|||
163300930|NCT05613205|589809915|FG001|Overall Study|Lost to Follow-up|0|||
163300931|NCT05613205|589809916|FG002|Overall Study|Lost to Follow-up|1|||
162956916|NCT00359281|588543653|FG005|Overall Study|Withdrawal by Subject|0|||
163300932|NCT05613205|589809917|FG003|Overall Study|Lost to Follow-up|1|||
163300933|NCT05613205|589809918|FG004|Overall Study|Lost to Follow-up|0|||
162956917|NCT00359281|588543654|FG006|Overall Study|Withdrawal by Subject|1|||
162956918|NCT00359281|588543655|FG007|Overall Study|Withdrawal by Subject|0|||
163300934|NCT05613205|589809914|FG000|Overall Study|Withdrawal by Subject|0|||
163300935|NCT05613205|589809915|FG001|Overall Study|Withdrawal by Subject|0|||
163300936|NCT05613205|589809916|FG002|Overall Study|Withdrawal by Subject|1|||
163394234|NCT00239226|590155709|FG003|Overall Study|Lost to Follow-up|0|||
163394235|NCT00851682|590155711|FG000|Overall Study|screen failure|5|||
163394236|NCT00851682|590155712|FG001|Overall Study|screen failure|0|||
163394237|NCT04060563|590155713|FG000|Overall Study|Lost to Follow-up|1|||
163394238|NCT04060563|590155714|FG001|Overall Study|Lost to Follow-up|1|||
163394239|NCT04060563|590155713|FG000|Overall Study|Physician Decision|0|||
163394240|NCT04060563|590155714|FG001|Overall Study|Physician Decision|1|||
163394241|NCT01379573|590155720|FG000|Overall Study|Lost to Follow-up|1|||
163394242|NCT01379573|590155720|FG000|Overall Study|Screen Failure|10|||
163394243|NCT00770770|590155723|FG000|Overall Study|Lost to Follow-up|1|||
163394244|NCT00770770|590155724|FG001|Overall Study|Lost to Follow-up|0|||
163394245|NCT00770770|590155723|FG000|Overall Study|Withdrawal by Subject|1|||
163394246|NCT00770770|590155724|FG001|Overall Study|Withdrawal by Subject|0|||
163394247|NCT00770770|590155723|FG000|Overall Study|Death|0|||
163394248|NCT00770770|590155724|FG001|Overall Study|Death|1|||
162956919|NCT00359281|588543656|FG008|Overall Study|Withdrawal by Subject|0|||
162956920|NCT01415986|588543659|FG000|Overall Study|Lost to Follow-up|1|||
162956921|NCT01474551|588543662|FG000|Overall Study|Death|1|||
162956922|NCT03122457|588543671|FG000|Overall Study|Withdrawal by Subject|6|||
162956923|NCT03769025|588543675|FG000|Overall Study|Withdrawal by Subject|1|||
162956924|NCT03769025|588543676|FG001|Overall Study|Withdrawal by Subject|1|||
162956925|NCT03769025|588543675|FG000|Overall Study|Lost to Follow-up|4|||
162956926|NCT03769025|588543676|FG001|Overall Study|Lost to Follow-up|3|||
162956927|NCT02911701|588543679|FG000|Overall Study|Withdrawal by Subject|2|||
162956928|NCT02911701|588543680|FG001|Overall Study|Withdrawal by Subject|4|||
162956929|NCT02911701|588543679|FG000|Overall Study|Adverse Event|1|||
162956930|NCT02911701|588543680|FG001|Overall Study|Adverse Event|0|||
162956931|NCT04659603|588543683|FG000|Overall Study|Study terminated by sponsor|0|||
162956932|NCT04659603|588543684|FG001|Overall Study|Study terminated by sponsor|0|||
163195229|NCT00241358|589428475|FG001|Overall Study|Determined to be not ineligible|1|||
163195230|NCT00241358|589428476|FG002|Overall Study|Determined to be not ineligible|1|||
163195231|NCT03855228|589428477|FG000|Overall Study|Adverse Event|2|||
163195232|NCT03855228|589428478|FG001|Overall Study|Adverse Event|4|||
163195233|NCT03855228|589428479|FG002|Overall Study|Adverse Event|4|||
163195234|NCT03855228|589428480|FG003|Overall Study|Adverse Event|8|||
163195235|NCT03855228|589428477|FG000|Overall Study|Treatment Failure|1|||
163195236|NCT03855228|589428478|FG001|Overall Study|Treatment Failure|2|||
163195237|NCT03855228|589428479|FG002|Overall Study|Treatment Failure|1|||
163195238|NCT03855228|589428480|FG003|Overall Study|Treatment Failure|8|||
163195239|NCT03855228|589428477|FG000|Overall Study|Lost to Follow-up|0|||
163195240|NCT03855228|589428478|FG001|Overall Study|Lost to Follow-up|0|||
163195241|NCT03855228|589428479|FG002|Overall Study|Lost to Follow-up|0|||
163195242|NCT03855228|589428480|FG003|Overall Study|Lost to Follow-up|1|||
163195243|NCT03855228|589428477|FG000|Overall Study|Protocol Violation|0|||
163195244|NCT03855228|589428478|FG001|Overall Study|Protocol Violation|1|||
163195245|NCT03855228|589428479|FG002|Overall Study|Protocol Violation|2|||
163195246|NCT03855228|589428480|FG003|Overall Study|Protocol Violation|1|||
163195247|NCT03855228|589428477|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
163195248|NCT03855228|589428478|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
163195249|NCT03855228|589428479|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
163195250|NCT03855228|589428480|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
163195251|NCT00590135|589428481|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
163195252|NCT00300274|589428482|FG000|Overall Study|Withdrawal by Subject|12|||
163195253|NCT00300274|589428483|FG001|Overall Study|Withdrawal by Subject|3|||
163195254|NCT00300274|589428484|FG002|Overall Study|Withdrawal by Subject|14|||
163195255|NCT00300274|589428482|FG000|Overall Study|Lost to Follow-up|3|||
163195256|NCT00300274|589428483|FG001|Overall Study|Lost to Follow-up|4|||
163195257|NCT00300274|589428484|FG002|Overall Study|Lost to Follow-up|5|||
163195258|NCT00300274|589428482|FG000|Overall Study|Death|31|||
163195259|NCT00300274|589428483|FG001|Overall Study|Death|20|||
163195260|NCT00300274|589428484|FG002|Overall Study|Death|25|||
163195261|NCT00300274|589428482|FG000|Overall Study|Re-transplant|0|||
163195262|NCT00300274|589428483|FG001|Overall Study|Re-transplant|0|||
163195263|NCT00300274|589428484|FG002|Overall Study|Re-transplant|1|||
163195264|NCT02400333|589429791|FG000|Overall Study|Withdrawal by Subject|0|||
163394249|NCT00770770|590155723|FG000|Overall Study|Study Terminated|8|||
163394250|NCT00770770|590155724|FG001|Overall Study|Study Terminated|0|||
163394251|NCT02486653|590155725|FG000|Overall Study|Withdrawal by Subject|1|||
162956933|NCT04659603|588543685|FG002|Overall Study|Study terminated by sponsor|2|||
162956934|NCT04659603|588543683|FG000|Overall Study|Withdrawal by Subject|0|||
163195265|NCT02400333|589429792|FG001|Overall Study|Withdrawal by Subject|1|||
163195266|NCT02400333|589429793|FG002|Overall Study|Withdrawal by Subject|0|||
163195267|NCT02400333|589429794|FG003|Overall Study|Withdrawal by Subject|1|||
163195268|NCT02400333|589429791|FG000|Overall Study|Protocol Violation|1|||
163195269|NCT02400333|589429792|FG001|Overall Study|Protocol Violation|0|||
163195270|NCT02400333|589429793|FG002|Overall Study|Protocol Violation|2|||
163195271|NCT02400333|589429794|FG003|Overall Study|Protocol Violation|1|||
163195272|NCT02468674|589429795|FG000|Overall Study|Adverse Event|0|||
162956935|NCT04659603|588543684|FG001|Overall Study|Withdrawal by Subject|5|||
163394252|NCT02486653|590155726|FG001|Overall Study|Withdrawal by Subject|3|||
163300937|NCT05613205|589809917|FG003|Overall Study|Withdrawal by Subject|1|||
163300938|NCT05613205|589809918|FG004|Overall Study|Withdrawal by Subject|0|||
163300939|NCT02118961|589809919|FG000|Overall Study|Withdrawal by Subject|1|||
163300940|NCT02118961|589809920|FG001|Overall Study|Withdrawal by Subject|0|||
162956936|NCT04659603|588543685|FG002|Overall Study|Withdrawal by Subject|0|||
162956937|NCT04659603|588543683|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
162956938|NCT04659603|588543684|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
162956939|NCT04659603|588543685|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
162956940|NCT01110005|588543686|FG000|Overall Study|ineligible|1|||
163044929|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
163044930|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
163044931|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
163044932|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
163044933|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
163044934|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
163044935|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
163044936|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
163044937|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
163044938|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
163044939|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
163044940|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
163044941|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
163195273|NCT02468674|589429796|FG001|Overall Study|Adverse Event|0|||
163195274|NCT02468674|589429797|FG002|Overall Study|Adverse Event|0|||
163195275|NCT02468674|589429798|FG003|Overall Study|Adverse Event|1|||
163195276|NCT02468674|589429799|FG004|Overall Study|Adverse Event|0|||
163195277|NCT02468674|589429800|FG005|Overall Study|Adverse Event|1|||
162956941|NCT01110005|588543687|FG001|Overall Study|ineligible|2|||
162956942|NCT01110005|588543686|FG000|Overall Study|missing consent|3|||
162956943|NCT01110005|588543687|FG001|Overall Study|missing consent|2|||
162956944|NCT01110005|588543686|FG000|Overall Study|Withdrawal by Subject|0|||
162956945|NCT01110005|588543687|FG001|Overall Study|Withdrawal by Subject|1|||
162956946|NCT04646213|588543688|FG000|Overall Study|Physician Decision|3|||
162956947|NCT04646213|588543688|FG000|Overall Study|Withdrawal by Subject|2|||
162956948|NCT02441309|588543689|FG000|Overall Study|Disease progression|2|||
162956949|NCT02441309|588543690|FG001|Overall Study|Disease progression|1|||
162956950|NCT02441309|588543691|FG002|Overall Study|Disease progression|2|||
162956951|NCT02441309|588543689|FG000|Overall Study|Adverse Event|0|||
162956952|NCT02441309|588543690|FG001|Overall Study|Adverse Event|1|||
162956953|NCT02441309|588543691|FG002|Overall Study|Adverse Event|0|||
162956954|NCT02441309|588543689|FG000|Overall Study|Withdrawal by Subject|1|||
162956955|NCT02441309|588543690|FG001|Overall Study|Withdrawal by Subject|0|||
163195278|NCT02468674|589429801|FG006|Overall Study|Adverse Event|0|||
163195279|NCT02468674|589429802|FG007|Overall Study|Adverse Event|0|||
163195280|NCT02468674|589429803|FG008|Overall Study|Adverse Event|0|||
163195281|NCT02468674|589429795|FG000|Overall Study|Lost to Follow-up|1|||
163195282|NCT02468674|589429796|FG001|Overall Study|Lost to Follow-up|0|||
163195283|NCT02468674|589429797|FG002|Overall Study|Lost to Follow-up|0|||
163195284|NCT02468674|589429798|FG003|Overall Study|Lost to Follow-up|0|||
163195285|NCT02468674|589429799|FG004|Overall Study|Lost to Follow-up|0|||
163195286|NCT02468674|589429800|FG005|Overall Study|Lost to Follow-up|0|||
163195287|NCT02468674|589429801|FG006|Overall Study|Lost to Follow-up|0|||
163195288|NCT02468674|589429802|FG007|Overall Study|Lost to Follow-up|1|||
163195289|NCT02468674|589429803|FG008|Overall Study|Lost to Follow-up|1|||
163195290|NCT02468674|589429795|FG000|Overall Study|Physician Decision|0|||
163195291|NCT02468674|589429796|FG001|Overall Study|Physician Decision|0|||
163195292|NCT02468674|589429797|FG002|Overall Study|Physician Decision|0|||
163195293|NCT02468674|589429798|FG003|Overall Study|Physician Decision|0|||
163195294|NCT02468674|589429799|FG004|Overall Study|Physician Decision|0|||
163300941|NCT03103321|589809921|FG000|Overall Study|Protocol Violation|1|||
163195295|NCT02468674|589429800|FG005|Overall Study|Physician Decision|0|||
162956956|NCT02441309|588543691|FG002|Overall Study|Withdrawal by Subject|1|||
162956957|NCT02658084|588543692|FG000|Overall Study|Withdrawal by Subject|1|||
162956958|NCT02658084|588543693|FG001|Overall Study|Withdrawal by Subject|0|||
162956959|NCT02658084|588543692|FG000|Overall Study|Study Termination|1|||
162956960|NCT02658084|588543693|FG001|Overall Study|Study Termination|0|||
162956961|NCT03290781|588543694|FG000|Overall Study|Adverse Event|5|||
162956962|NCT03290781|588543695|FG001|Overall Study|Adverse Event|7|||
162956963|NCT03290781|588543696|FG002|Overall Study|Adverse Event|4|||
162956964|NCT03290781|588543697|FG003|Overall Study|Adverse Event|1|||
162956965|NCT03290781|588543698|FG004|Overall Study|Adverse Event|0|||
162956966|NCT03290781|588543699|FG005|Overall Study|Adverse Event|0|||
162956967|NCT03290781|588543700|FG006|Overall Study|Adverse Event|0|||
162956968|NCT03290781|588543694|FG000|Overall Study|Death|0|||
162956969|NCT03290781|588543695|FG001|Overall Study|Death|0|||
162956970|NCT03290781|588543696|FG002|Overall Study|Death|1|||
162956971|NCT03290781|588543697|FG003|Overall Study|Death|0|||
162956972|NCT03290781|588543698|FG004|Overall Study|Death|1|||
162956973|NCT03290781|588543699|FG005|Overall Study|Death|0|||
162956974|NCT03290781|588543700|FG006|Overall Study|Death|0|||
162956975|NCT03290781|588543694|FG000|Overall Study|Withdrawal by Subject|6|||
162956976|NCT03290781|588543695|FG001|Overall Study|Withdrawal by Subject|5|||
162956977|NCT03290781|588543696|FG002|Overall Study|Withdrawal by Subject|9|||
162956978|NCT03290781|588543697|FG003|Overall Study|Withdrawal by Subject|10|||
162956979|NCT03290781|588543698|FG004|Overall Study|Withdrawal by Subject|1|||
162956980|NCT03290781|588543699|FG005|Overall Study|Withdrawal by Subject|2|||
162956981|NCT03290781|588543700|FG006|Overall Study|Withdrawal by Subject|0|||
162956982|NCT03290781|588543694|FG000|Overall Study|Physician Decision|0|||
162956983|NCT03290781|588543695|FG001|Overall Study|Physician Decision|1|||
162956984|NCT03290781|588543696|FG002|Overall Study|Physician Decision|0|||
162956985|NCT03290781|588543697|FG003|Overall Study|Physician Decision|0|||
162956986|NCT03290781|588543698|FG004|Overall Study|Physician Decision|0|||
162956987|NCT03290781|588543699|FG005|Overall Study|Physician Decision|0|||
162956988|NCT03290781|588543700|FG006|Overall Study|Physician Decision|0|||
162956989|NCT03290781|588543694|FG000|Overall Study|Site Terminated by Sponsor|1|||
162956990|NCT03290781|588543695|FG001|Overall Study|Site Terminated by Sponsor|0|||
162956991|NCT03290781|588543696|FG002|Overall Study|Site Terminated by Sponsor|2|||
162956992|NCT03290781|588543697|FG003|Overall Study|Site Terminated by Sponsor|1|||
162956993|NCT03290781|588543698|FG004|Overall Study|Site Terminated by Sponsor|0|||
162956994|NCT03290781|588543699|FG005|Overall Study|Site Terminated by Sponsor|0|||
162956995|NCT03290781|588543700|FG006|Overall Study|Site Terminated by Sponsor|0|||
162956996|NCT03290781|588543694|FG000|Overall Study|Lost to Follow-up|0|||
162956997|NCT03290781|588543695|FG001|Overall Study|Lost to Follow-up|0|||
162956998|NCT03290781|588543696|FG002|Overall Study|Lost to Follow-up|0|||
162956999|NCT03290781|588543697|FG003|Overall Study|Lost to Follow-up|1|||
162957000|NCT03290781|588543698|FG004|Overall Study|Lost to Follow-up|0|||
162957001|NCT03290781|588543699|FG005|Overall Study|Lost to Follow-up|0|||
162957002|NCT03290781|588543700|FG006|Overall Study|Lost to Follow-up|0|||
162957003|NCT03290781|588543694|FG000|Overall Study|Protocol Deviation|2|||
162957004|NCT03290781|588543695|FG001|Overall Study|Protocol Deviation|0|||
162957005|NCT03290781|588543696|FG002|Overall Study|Protocol Deviation|0|||
162957006|NCT03290781|588543697|FG003|Overall Study|Protocol Deviation|1|||
162957007|NCT03290781|588543698|FG004|Overall Study|Protocol Deviation|0|||
162957008|NCT03290781|588543699|FG005|Overall Study|Protocol Deviation|0|||
162957009|NCT03290781|588543700|FG006|Overall Study|Protocol Deviation|0|||
162957010|NCT03290781|588543694|FG000|Overall Study|Disease Relapse|32|||
162957011|NCT03290781|588543695|FG001|Overall Study|Disease Relapse|5|||
162957012|NCT03290781|588543696|FG002|Overall Study|Disease Relapse|38|||
162957013|NCT03290781|588543697|FG003|Overall Study|Disease Relapse|7|||
162957014|NCT03290781|588543698|FG004|Overall Study|Disease Relapse|3|||
162957015|NCT03290781|588543699|FG005|Overall Study|Disease Relapse|1|||
162957016|NCT03290781|588543700|FG006|Overall Study|Disease Relapse|4|||
162957017|NCT03290781|588543694|FG000|Overall Study|Other|3|||
162957018|NCT03290781|588543695|FG001|Overall Study|Other|0|||
162957019|NCT03290781|588543696|FG002|Overall Study|Other|2|||
162957020|NCT03290781|588543697|FG003|Overall Study|Other|2|||
162957021|NCT03290781|588543698|FG004|Overall Study|Other|0|||
162957022|NCT03290781|588543699|FG005|Overall Study|Other|0|||
162957023|NCT03290781|588543700|FG006|Overall Study|Other|0|||
162957024|NCT02820350|588543717|FG000|Overall Study|Withdrawal by Subject|3|||
163195296|NCT02468674|589429801|FG006|Overall Study|Physician Decision|1|||
163195297|NCT02468674|589429802|FG007|Overall Study|Physician Decision|0|||
163195298|NCT02468674|589429803|FG008|Overall Study|Physician Decision|0|||
163044942|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
163044943|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
163044944|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
163044945|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
163044946|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
163044947|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
163044948|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
163044949|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
163044950|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
163044951|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
163044952|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
163044953|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
163044954|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
163044955|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
163044956|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
163044957|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
163044958|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
163044959|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
163044960|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
163195299|NCT02468674|589429795|FG000|Overall Study|Patient/Guardian Decision|0|||
163195300|NCT02468674|589429796|FG001|Overall Study|Patient/Guardian Decision|0|||
163195301|NCT02468674|589429797|FG002|Overall Study|Patient/Guardian Decision|0|||
162957025|NCT02820350|588543717|FG000|Overall Study|Death|4|||
162957026|NCT02057835|588544879|FG000|Overall Study|Withdrawal by Subject|0|||
162957027|NCT02057835|588544880|FG001|Overall Study|Withdrawal by Subject|2|||
162957028|NCT02057835|588544881|FG002|Overall Study|Withdrawal by Subject|0|||
162957029|NCT02057835|588544882|FG003|Overall Study|Withdrawal by Subject|0|||
162957030|NCT02057835|588544883|FG004|Overall Study|Withdrawal by Subject|0|||
162957031|NCT02057835|588544884|FG005|Overall Study|Withdrawal by Subject|0|||
162957032|NCT02057835|588544885|FG006|Overall Study|Withdrawal by Subject|0|||
162957033|NCT02057835|588544886|FG007|Overall Study|Withdrawal by Subject|0|||
162957034|NCT02057835|588544887|FG008|Overall Study|Withdrawal by Subject|0|||
162957035|NCT02057835|588544888|FG009|Overall Study|Withdrawal by Subject|0|||
162957036|NCT01376037|588544889|FG000|Overall Study|Lost to Follow-up|0|||
162957037|NCT01376037|588544890|FG001|Overall Study|Lost to Follow-up|2|||
162957038|NCT02328040|588544891|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
162957039|NCT02328040|588544892|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
162957040|NCT03697109|588544893|FG000|Open-label (OL) Phase|Adverse Event|24|||
162957041|NCT03697109|588544894|FG001|Open-label (OL) Phase|Adverse Event|0|||
162957042|NCT03697109|588544895|FG002|Open-label (OL) Phase|Adverse Event|0|||
162957043|NCT03697109|588544893|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
162957044|NCT03697109|588544894|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
162957045|NCT03697109|588544895|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
162957046|NCT03697109|588544893|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
162957047|NCT03697109|588544894|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
162957048|NCT03697109|588544895|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
162957049|NCT03697109|588544893|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
162957050|NCT03697109|588544894|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
162957051|NCT03697109|588544895|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
162957052|NCT03697109|588544893|FG000|Open-label (OL) Phase|Physician Decision|2|||
162957053|NCT03697109|588544894|FG001|Open-label (OL) Phase|Physician Decision|0|||
162957054|NCT03697109|588544895|FG002|Open-label (OL) Phase|Physician Decision|0|||
162957055|NCT03697109|588544893|FG000|Open-label (OL) Phase|Death|2|||
162957056|NCT03697109|588544894|FG001|Open-label (OL) Phase|Death|0|||
162957057|NCT03697109|588544895|FG002|Open-label (OL) Phase|Death|0|||
162957058|NCT03697109|588544893|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
162957059|NCT03697109|588544894|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
162957060|NCT03697109|588544895|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
162957061|NCT03697109|588544893|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
162957062|NCT03697109|588544894|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
162957063|NCT03697109|588544895|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
162957064|NCT03697109|588544893|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
162957065|NCT03697109|588544894|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
162957066|NCT03697109|588544895|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
162957067|NCT02301975|588544899|FG000|Overall Study|Adverse Event|8|||
162957068|NCT02301975|588544900|FG001|Overall Study|Adverse Event|3|||
162957069|NCT02301975|588544901|FG002|Overall Study|Adverse Event|2|||
162957070|NCT02301975|588544899|FG000|Overall Study|Lack of Efficacy|1|||
162957071|NCT02301975|588544900|FG001|Overall Study|Lack of Efficacy|1|||
162957072|NCT02301975|588544901|FG002|Overall Study|Lack of Efficacy|1|||
162957073|NCT02301975|588544899|FG000|Overall Study|Protocol Violation|3|||
162957074|NCT02301975|588544900|FG001|Overall Study|Protocol Violation|5|||
162957075|NCT02301975|588544901|FG002|Overall Study|Protocol Violation|3|||
162957076|NCT02301975|588544899|FG000|Overall Study|Lost to Follow-up|0|||
162957077|NCT02301975|588544900|FG001|Overall Study|Lost to Follow-up|2|||
162957078|NCT02301975|588544901|FG002|Overall Study|Lost to Follow-up|2|||
162957079|NCT02301975|588544899|FG000|Overall Study|Physician Decision|4|||
162957080|NCT02301975|588544900|FG001|Overall Study|Physician Decision|2|||
162957081|NCT02301975|588544901|FG002|Overall Study|Physician Decision|3|||
162957082|NCT02301975|588544899|FG000|Overall Study|Withdrawal by Subject|15|||
162957083|NCT02301975|588544900|FG001|Overall Study|Withdrawal by Subject|12|||
162957084|NCT02301975|588544901|FG002|Overall Study|Withdrawal by Subject|11|||
162957085|NCT00835991|588544902|FG000|First Intervention|Adverse Event|0|||
162957086|NCT00835991|588544903|FG001|First Intervention|Adverse Event|1|||
162957087|NCT00835991|588544902|FG000|Washout|Protocol Violation|0|||
162957088|NCT00835991|588544903|FG001|Washout|Protocol Violation|2|||
162957089|NCT00835991|588544902|FG000|Washout|Withdrawal by Subject|3|||
162957090|NCT00835991|588544903|FG001|Washout|Withdrawal by Subject|1|||
162957091|NCT02149420|588544904|FG000|Core Study|Administrative problems|0|||
162957092|NCT02149420|588544905|FG001|Core Study|Administrative problems|1|||
162957093|NCT02149420|588544906|FG002|Core Study|Administrative problems|2|||
162957094|NCT02149420|588544904|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
162957095|NCT02149420|588544905|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
162957096|NCT02149420|588544906|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
162957097|NCT04278560|588544907|FG000|Overall Study|Adverse Event|1|||
162957098|NCT04278560|588544908|FG001|Overall Study|Adverse Event|2|||
162957099|NCT04278560|588544907|FG000|Overall Study|Withdrawal by Subject|0|||
163300942|NCT03103321|589809922|FG001|Overall Study|Protocol Violation|1|||
163044961|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
163044962|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
163044963|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
163044964|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
163044965|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
163044966|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
163044967|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
163044968|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
163044969|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
163044970|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
163044971|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
163044972|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
163044973|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
163044974|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
163044975|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
163044976|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
163044977|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
163044978|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
163044979|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
163044980|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
163044981|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
163044982|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
163044983|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
163044984|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
163044985|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
163044986|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
163044987|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
163044988|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
163044989|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
163044990|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
163044991|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
163044992|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
163044993|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
163044994|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
163044995|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
163044996|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
163044997|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
163044998|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
163044999|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
163045000|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
163045001|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
163045002|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
163045003|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
163045004|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
163045005|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
163045006|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
163045007|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
163195302|NCT02468674|589429798|FG003|Overall Study|Patient/Guardian Decision|0|||
163195303|NCT02468674|589429799|FG004|Overall Study|Patient/Guardian Decision|1|||
162957100|NCT04278560|588544908|FG001|Overall Study|Withdrawal by Subject|1|||
162957101|NCT00163657|588544909|FG000|Overall Study|Death|12|||
162957102|NCT00163657|588544910|FG001|Overall Study|Death|14|||
162957103|NCT00163657|588544911|FG002|Overall Study|Death|19|||
162957104|NCT00163657|588544909|FG000|Overall Study|graft loss|4|||
162957105|NCT00163657|588544910|FG001|Overall Study|graft loss|1|||
162957106|NCT00163657|588544911|FG002|Overall Study|graft loss|2|||
162957107|NCT00163657|588544909|FG000|Overall Study|Withdrawal by Subject|2|||
162957108|NCT00163657|588544910|FG001|Overall Study|Withdrawal by Subject|3|||
162957109|NCT00163657|588544911|FG002|Overall Study|Withdrawal by Subject|2|||
162957110|NCT00163657|588544909|FG000|Overall Study|Physician Decision|0|||
162957111|NCT00163657|588544910|FG001|Overall Study|Physician Decision|1|||
162957112|NCT00163657|588544911|FG002|Overall Study|Physician Decision|1|||
162957113|NCT00163657|588544909|FG000|Overall Study|Non Compliance|1|||
162957114|NCT00163657|588544910|FG001|Overall Study|Non Compliance|0|||
162957115|NCT00163657|588544911|FG002|Overall Study|Non Compliance|0|||
162957116|NCT00163657|588544909|FG000|Overall Study|Lost to Follow-up|1|||
162957117|NCT00163657|588544910|FG001|Overall Study|Lost to Follow-up|3|||
162957118|NCT00163657|588544911|FG002|Overall Study|Lost to Follow-up|10|||
162957119|NCT00163657|588544909|FG000|Overall Study|Other reason|0|||
162957120|NCT00163657|588544910|FG001|Overall Study|Other reason|1|||
163300943|NCT03103321|589809923|FG002|Overall Study|Protocol Violation|1|||
163394253|NCT02486653|590155725|FG000|Overall Study|Protocol Violation|1|||
163394254|NCT02486653|590155726|FG001|Overall Study|Protocol Violation|0|||
163394255|NCT02486653|590155725|FG000|Overall Study|surgery cancelled|4|||
163394256|NCT02486653|590155726|FG001|Overall Study|surgery cancelled|1|||
163394257|NCT00800436|590155727|FG000|Overall Study|Withdrawal by Subject|0|||
163394258|NCT00800436|590155728|FG001|Overall Study|Withdrawal by Subject|0|||
163394259|NCT00800436|590155729|FG002|Overall Study|Withdrawal by Subject|1|||
163394260|NCT00800436|590155730|FG003|Overall Study|Withdrawal by Subject|1|||
163394261|NCT00800436|590155731|FG004|Overall Study|Withdrawal by Subject|0|||
163394262|NCT00800436|590155732|FG005|Overall Study|Withdrawal by Subject|0|||
163394263|NCT00800436|590155733|FG006|Overall Study|Withdrawal by Subject|0|||
163394264|NCT01829425|590155746|FG000|Overall Study|Withdrawal by Subject|4|||
163394265|NCT01829425|590155747|FG001|Overall Study|Withdrawal by Subject|3|||
163394266|NCT01829425|590155746|FG000|Overall Study|Lost to Follow-up|2|||
163394267|NCT01829425|590155747|FG001|Overall Study|Lost to Follow-up|1|||
163394268|NCT03681951|590155748|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
163394269|NCT03681951|590155749|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
163394270|NCT03681951|590155750|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
163394271|NCT03681951|590155751|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
163394272|NCT03681951|590155752|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
163394273|NCT03681951|590155753|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
163394274|NCT03681951|590155754|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
163394275|NCT03681951|590155755|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
163394276|NCT03681951|590155748|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
163394277|NCT03681951|590155749|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
163394278|NCT03681951|590155750|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
163394279|NCT03681951|590155751|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
163394280|NCT03681951|590155752|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
163394281|NCT03681951|590155753|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
163394282|NCT03681951|590155754|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
163394283|NCT03681951|590155755|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
163394284|NCT03681951|590155748|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
162957121|NCT00163657|588544911|FG002|Overall Study|Other reason|3|||
162957122|NCT01319383|588544912|FG000|Overall Study|No ex vivo or in vivo response|4|||
162957123|NCT01319383|588544913|FG001|Overall Study|No ex vivo or in vivo response|0|||
162957124|NCT01319383|588544912|FG000|Overall Study|Physician Decision|3|||
162957125|NCT01319383|588544913|FG001|Overall Study|Physician Decision|0|||
163300944|NCT03103321|589809924|FG003|Overall Study|Protocol Violation|0|||
163300945|NCT03602014|589809927|FG000|Overall Study|Lost to Follow-up|2|||
163300946|NCT03602014|589809928|FG001|Overall Study|Lost to Follow-up|0|||
163300947|NCT03602014|589809929|FG002|Overall Study|Lost to Follow-up|0|||
163300948|NCT02992925|589809932|FG000|Cohort 2|Physician Decision|0|||
163300949|NCT02992925|589809933|FG001|Cohort 2|Physician Decision|0|||
163300950|NCT02992925|589809934|FG002|Cohort 2|Physician Decision|1|||
163300951|NCT02992925|589809935|FG003|Cohort 2|Physician Decision|0|||
163300952|NCT02992925|589809932|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
163300953|NCT02992925|589809933|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
163300954|NCT02992925|589809934|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
163300955|NCT02992925|589809935|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
163300956|NCT05678998|589809936|FG000|Overall Study|Withdrawal by Subject|1|||
163300957|NCT05678998|589809937|FG001|Overall Study|Withdrawal by Subject|1|||
163300958|NCT05678998|589809938|FG002|Overall Study|Withdrawal by Subject|3|||
163300959|NCT05678998|589809939|FG003|Overall Study|Withdrawal by Subject|0|||
163195304|NCT02468674|589429800|FG005|Overall Study|Patient/Guardian Decision|0|||
163195305|NCT02468674|589429801|FG006|Overall Study|Patient/Guardian Decision|0|||
163195306|NCT02468674|589429802|FG007|Overall Study|Patient/Guardian Decision|2|||
163045008|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
163045009|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
163045010|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
163045011|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
163045012|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
163045013|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
163045014|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
163045015|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
163045016|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
163045017|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
163045018|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
163045019|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
163045020|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
163045021|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
163045022|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
163045023|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
163045024|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
163045025|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
163045026|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
163045027|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
163045028|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
163045029|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
163045030|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
163045031|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
163045032|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
163045033|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
163045034|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
163045035|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
163045036|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
163045037|NCT00481767|588871562|FG000|Overall Study|Withdrawal by Subject|16|||
163045038|NCT00481767|588871563|FG001|Overall Study|Withdrawal by Subject|11|||
163045039|NCT00481767|588871562|FG000|Overall Study|Lost to Follow-up|16|||
163045040|NCT00481767|588871563|FG001|Overall Study|Lost to Follow-up|10|||
163045041|NCT00636636|588871564|FG000|Overall Study|Other reason|4|||
163045042|NCT00636636|588871565|FG001|Overall Study|Other reason|6|||
163045043|NCT00636636|588871564|FG000|Overall Study|Adverse Event|19|||
163045044|NCT00636636|588871565|FG001|Overall Study|Adverse Event|8|||
163045045|NCT00636636|588871564|FG000|Overall Study|Lack of Efficacy|7|||
163045046|NCT00636636|588871565|FG001|Overall Study|Lack of Efficacy|12|||
163045047|NCT00636636|588871564|FG000|Overall Study|Protocol Violation|2|||
163045048|NCT00636636|588871565|FG001|Overall Study|Protocol Violation|2|||
163045049|NCT00636636|588871564|FG000|Overall Study|Lost to Follow-up|0|||
163045050|NCT00636636|588871565|FG001|Overall Study|Lost to Follow-up|1|||
163045051|NCT00636636|588871564|FG000|Overall Study|Death|0|||
163045052|NCT00636636|588871565|FG001|Overall Study|Death|1|||
163045053|NCT00636636|588871564|FG000|Overall Study|Withdrawal by Subject|4|||
163045054|NCT00636636|588871565|FG001|Overall Study|Withdrawal by Subject|9|||
163045055|NCT00524173|588871566|FG000|Overall Study|Lost to Follow-up|0|||
163045056|NCT00524173|588871567|FG001|Overall Study|Lost to Follow-up|1|||
163045057|NCT00524173|588871566|FG000|Overall Study|Death|1|||
163045058|NCT00524173|588871567|FG001|Overall Study|Death|0|||
163045059|NCT00524173|588871566|FG000|Overall Study|Had not reached endpoint at study close|4|||
163045060|NCT00524173|588871567|FG001|Overall Study|Had not reached endpoint at study close|1|||
163045061|NCT03300180|588871568|FG000|Baseline|Withdrawal by Subject|4|||
163045062|NCT03300180|588871569|FG001|Baseline|Withdrawal by Subject|6|||
163045063|NCT03300180|588871570|FG002|Baseline|Withdrawal by Subject|4|||
163045064|NCT03300180|588871568|FG000|6 Month Outcome|Withdrawal by Subject|12|||
163045065|NCT03300180|588871569|FG001|6 Month Outcome|Withdrawal by Subject|12|||
163045066|NCT03300180|588871570|FG002|6 Month Outcome|Withdrawal by Subject|19|||
163045067|NCT03300180|588871568|FG000|6 Month Outcome|Death|2|||
163045068|NCT03300180|588871569|FG001|6 Month Outcome|Death|4|||
163045069|NCT03300180|588871570|FG002|6 Month Outcome|Death|3|||
163045070|NCT03300180|588871568|FG000|6 Month Outcome|Missed Assessment|43|||
163045071|NCT03300180|588871569|FG001|6 Month Outcome|Missed Assessment|52|||
163045072|NCT03300180|588871570|FG002|6 Month Outcome|Missed Assessment|46|||
163045073|NCT03300180|588871568|FG000|12 Month Outcome|Withdrawal by Subject|3|||
163045074|NCT03300180|588871569|FG001|12 Month Outcome|Withdrawal by Subject|6|||
163045075|NCT03300180|588871570|FG002|12 Month Outcome|Withdrawal by Subject|6|||
163045076|NCT03300180|588871568|FG000|12 Month Outcome|Death|9|||
163045077|NCT03300180|588871569|FG001|12 Month Outcome|Death|6|||
163045078|NCT03300180|588871570|FG002|12 Month Outcome|Death|6|||
163045079|NCT03300180|588871568|FG000|12 Month Outcome|Missed Assessment|62|||
163045080|NCT03300180|588871569|FG001|12 Month Outcome|Missed Assessment|59|||
163045081|NCT03300180|588871570|FG002|12 Month Outcome|Missed Assessment|58|||
163045082|NCT03300180|588871568|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
163045083|NCT03300180|588871569|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
163045084|NCT03300180|588871570|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
163045085|NCT03300180|588871568|FG000|18 Month Outcome Assessment|Death|8|||
163045086|NCT03300180|588871569|FG001|18 Month Outcome Assessment|Death|5|||
163045087|NCT03300180|588871570|FG002|18 Month Outcome Assessment|Death|5|||
163195307|NCT02468674|589429803|FG008|Overall Study|Patient/Guardian Decision|1|||
163045088|NCT03300180|588871568|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
163045089|NCT03300180|588871569|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
163045090|NCT03300180|588871570|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
163045091|NCT03300180|588871568|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
163045092|NCT03300180|588871569|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
163045093|NCT03300180|588871570|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
163045094|NCT03300180|588871568|FG000|24 Month Outcome Assessment|Death|13|||
163045095|NCT03300180|588871569|FG001|24 Month Outcome Assessment|Death|13|||
163045096|NCT03300180|588871570|FG002|24 Month Outcome Assessment|Death|3|||
163045097|NCT03300180|588871568|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
163045098|NCT03300180|588871569|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
163195308|NCT02468674|589429795|FG000|Overall Study|Protocol Deviation|0|||
163045099|NCT03300180|588871570|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
163045100|NCT01972464|588871573|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
163045101|NCT01972464|588871574|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
163045102|NCT01972464|588871573|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
163045103|NCT01972464|588871574|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
163045104|NCT01972464|588871573|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
163045105|NCT01972464|588871574|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
163045106|NCT01972464|588871573|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
163045107|NCT01972464|588871574|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
163045108|NCT01409915|588873092|FG000|Overall Study|Adverse Event|0|||
163045109|NCT01409915|588873093|FG001|Overall Study|Adverse Event|2|||
163045110|NCT01409915|588873092|FG000|Overall Study|Withdrawal by Subject|0|||
163045111|NCT01409915|588873093|FG001|Overall Study|Withdrawal by Subject|1|||
163045112|NCT01409915|588873092|FG000|Overall Study|Protocol Violation|1|||
163045113|NCT01409915|588873093|FG001|Overall Study|Protocol Violation|0|||
163045114|NCT02922153|588873097|FG000|Overall Study|Death|8|||
163045115|NCT02922153|588873098|FG001|Overall Study|Death|1|||
163045116|NCT02922153|588873097|FG000|Overall Study|Lost to Follow-up|1|||
163045117|NCT02922153|588873098|FG001|Overall Study|Lost to Follow-up|0|||
163045118|NCT02922153|588873097|FG000|Overall Study|Physician Decision|1|||
163045119|NCT02922153|588873098|FG001|Overall Study|Physician Decision|1|||
163045120|NCT03506438|588873099|FG000|Overall Study|Lost to Follow-up|8|||
163045121|NCT03506438|588873100|FG001|Overall Study|Lost to Follow-up|7|||
163045122|NCT03506438|588873101|FG002|Overall Study|Lost to Follow-up|8|||
163045123|NCT03506438|588873102|FG003|Overall Study|Lost to Follow-up|7|||
163045124|NCT03506438|588873103|FG004|Overall Study|Lost to Follow-up|0|||
163045125|NCT03506438|588873104|FG005|Overall Study|Lost to Follow-up|0|||
163045126|NCT01128296|588873105|FG000|Overall Study|Physician Decision|0|||
163045127|NCT01128296|588873106|FG001|Overall Study|Physician Decision|0|||
163045128|NCT01128296|588873107|FG002|Overall Study|Physician Decision|0|||
163045129|NCT01128296|588873108|FG003|Overall Study|Physician Decision|0|||
163045130|NCT01128296|588873109|FG004|Overall Study|Physician Decision|0|||
163045131|NCT01128296|588873110|FG005|Overall Study|Physician Decision|3|||
163045132|NCT01128296|588873105|FG000|Overall Study|Withdrawal by Subject|0|||
163045133|NCT01128296|588873106|FG001|Overall Study|Withdrawal by Subject|0|||
163045134|NCT01128296|588873107|FG002|Overall Study|Withdrawal by Subject|0|||
163045135|NCT01128296|588873108|FG003|Overall Study|Withdrawal by Subject|0|||
163045136|NCT01128296|588873109|FG004|Overall Study|Withdrawal by Subject|0|||
163045137|NCT01128296|588873110|FG005|Overall Study|Withdrawal by Subject|2|||
163045138|NCT01714544|588873111|FG000|Overall Study|Lost to Follow-up|1|||
163045139|NCT01714544|588873111|FG000|Overall Study|Physician Decision|1|||
163045140|NCT01714544|588873111|FG000|Overall Study|Withdrawal by Subject|1|||
163045141|NCT01053741|588873112|FG000|2nd Study Intervention|Physician Decision|0|||
163045142|NCT01053741|588873113|FG001|2nd Study Intervention|Physician Decision|1|||
163045143|NCT00666211|588873114|FG000|Overall Study|Withdrawal by Subject|10|||
163045144|NCT00666211|588873115|FG001|Overall Study|Withdrawal by Subject|13|||
163045145|NCT00666211|588873114|FG000|Overall Study|went off medication, no more pain|1|||
163045146|NCT00666211|588873115|FG001|Overall Study|went off medication, no more pain|0|||
163045147|NCT00666211|588873114|FG000|Overall Study|patient non-compliant|6|||
163045148|NCT00666211|588873115|FG001|Overall Study|patient non-compliant|6|||
163045149|NCT00666211|588873114|FG000|Overall Study|disease progression|1|||
163045150|NCT00666211|588873115|FG001|Overall Study|disease progression|8|||
163045151|NCT00666211|588873114|FG000|Overall Study|Lost to Follow-up|2|||
163045152|NCT00666211|588873115|FG001|Overall Study|Lost to Follow-up|0|||
163045153|NCT00666211|588873114|FG000|Overall Study|toxicity|0|||
163045154|NCT00666211|588873115|FG001|Overall Study|toxicity|2|||
163045155|NCT00666211|588873114|FG000|Overall Study|hospital admission|0|||
163045156|NCT00666211|588873115|FG001|Overall Study|hospital admission|5|||
163045157|NCT00666211|588873114|FG000|Overall Study|Death|0|||
163045158|NCT00666211|588873115|FG001|Overall Study|Death|2|||
163045159|NCT00666211|588873114|FG000|Overall Study|off tx for other complicating disease|0|||
163045160|NCT00666211|588873115|FG001|Overall Study|off tx for other complicating disease|1|||
163045161|NCT00666211|588873114|FG000|Overall Study|Physician Decision|0|||
163045162|NCT00666211|588873115|FG001|Overall Study|Physician Decision|1|||
163045163|NCT00003537|588873124|FG000|Overall Study|Not evalauable|1|||
163045164|NCT01001520|588873125|FG000|Medication Period 1|Withdrawal by Subject|2|||
163045165|NCT01001520|588873126|FG001|Medication Period 1|Withdrawal by Subject|2|||
163045166|NCT01001520|588873125|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
163045167|NCT01001520|588873126|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
163045168|NCT01001520|588873125|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
163045169|NCT01001520|588873126|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
163045170|NCT01001520|588873125|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
163045171|NCT01001520|588873126|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
163045172|NCT01001520|588873125|FG000|Washout Period|Withdrawal by Subject|2|||
163045173|NCT01001520|588873126|FG001|Washout Period|Withdrawal by Subject|1|||
163045174|NCT01001520|588873125|FG000|Medication Period 2|Withdrawal by Subject|0|||
163045175|NCT01001520|588873126|FG001|Medication Period 2|Withdrawal by Subject|3|||
163045176|NCT04668209|588873127|FG000|Overall Study|Withdrawal by Subject|2|||
163045177|NCT04668209|588873128|FG001|Overall Study|Withdrawal by Subject|2|||
163045178|NCT04668209|588873127|FG000|Overall Study|Lost to Follow-up|3|||
163045179|NCT04668209|588873128|FG001|Overall Study|Lost to Follow-up|4|||
163045180|NCT04668209|588873127|FG000|Overall Study|Subject Expired|2|||
163045181|NCT04668209|588873128|FG001|Overall Study|Subject Expired|0|||
163045182|NCT04668209|588873127|FG000|Overall Study|Withdrawn from study|0|||
163045183|NCT04668209|588873128|FG001|Overall Study|Withdrawn from study|1|||
163045184|NCT04668209|588873127|FG000|Overall Study|Adverse Event|0|||
163045185|NCT04668209|588873128|FG001|Overall Study|Adverse Event|1|||
163045186|NCT01089127|588873130|FG000|Overall Study|Adverse Event|5|||
163045187|NCT01089127|588873131|FG001|Overall Study|Adverse Event|1|||
163045188|NCT01089127|588873132|FG002|Overall Study|Adverse Event|1|||
163045189|NCT01089127|588873133|FG003|Overall Study|Adverse Event|0|||
163045190|NCT01089127|588873134|FG004|Overall Study|Adverse Event|0|||
163045191|NCT01089127|588873135|FG005|Overall Study|Adverse Event|1|||
163045192|NCT01089127|588873130|FG000|Overall Study|Subject withdrew consent|0|||
163045193|NCT01089127|588873131|FG001|Overall Study|Subject withdrew consent|1|||
163045194|NCT01089127|588873132|FG002|Overall Study|Subject withdrew consent|1|||
163045195|NCT01089127|588873133|FG003|Overall Study|Subject withdrew consent|1|||
163045196|NCT01089127|588873134|FG004|Overall Study|Subject withdrew consent|0|||
163045197|NCT01089127|588873135|FG005|Overall Study|Subject withdrew consent|2|||
163045198|NCT01089127|588873130|FG000|Overall Study|Abnormal test procedure result(s)|2|||
163045199|NCT01089127|588873131|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163045200|NCT01089127|588873132|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163045201|NCT01089127|588873133|FG003|Overall Study|Abnormal test procedure result(s)|0|||
163045202|NCT01089127|588873134|FG004|Overall Study|Abnormal test procedure result(s)|0|||
163045203|NCT01089127|588873135|FG005|Overall Study|Abnormal test procedure result(s)|0|||
163045204|NCT01089127|588873130|FG000|Overall Study|Lost to Follow-up|1|||
163045205|NCT01089127|588873131|FG001|Overall Study|Lost to Follow-up|1|||
163045206|NCT01089127|588873132|FG002|Overall Study|Lost to Follow-up|0|||
163045207|NCT01089127|588873133|FG003|Overall Study|Lost to Follow-up|0|||
163195309|NCT02468674|589429796|FG001|Overall Study|Protocol Deviation|0|||
163195310|NCT02468674|589429797|FG002|Overall Study|Protocol Deviation|0|||
163195311|NCT02468674|589429798|FG003|Overall Study|Protocol Deviation|0|||
163045208|NCT01089127|588873134|FG004|Overall Study|Lost to Follow-up|1|||
163045209|NCT01089127|588873135|FG005|Overall Study|Lost to Follow-up|0|||
163045210|NCT01089127|588873130|FG000|Overall Study|Protocol deviation|0|||
163195312|NCT02468674|589429799|FG004|Overall Study|Protocol Deviation|0|||
163045211|NCT01089127|588873131|FG001|Overall Study|Protocol deviation|1|||
163045212|NCT01089127|588873132|FG002|Overall Study|Protocol deviation|0|||
163045213|NCT01089127|588873133|FG003|Overall Study|Protocol deviation|0|||
163045214|NCT01089127|588873134|FG004|Overall Study|Protocol deviation|1|||
163195313|NCT02468674|589429800|FG005|Overall Study|Protocol Deviation|0|||
163045215|NCT01089127|588873135|FG005|Overall Study|Protocol deviation|0|||
163045216|NCT00875563|588873137|FG000|Overall Study|Death|4|||
163195314|NCT02468674|589429801|FG006|Overall Study|Protocol Deviation|0|||
163045217|NCT00875563|588873137|FG000|Overall Study|Withdrawal by Subject|7|||
163045218|NCT00875563|588873137|FG000|Overall Study|No long-term (3-5 year) consent|6|||
163045219|NCT00875563|588873137|FG000|Overall Study|Still be eligible for follow-up|7|||
163045220|NCT00511810|588873140|FG000|Overall Study|Lost to Follow-up|1|||
163045221|NCT00511810|588873141|FG001|Overall Study|Lost to Follow-up|2|||
163045222|NCT00511810|588873140|FG000|Overall Study|Lack of Efficacy|0|||
163045223|NCT00511810|588873141|FG001|Overall Study|Lack of Efficacy|2|||
163045224|NCT00511810|588873140|FG000|Overall Study|Refused second scn|0|||
163045225|NCT00511810|588873141|FG001|Overall Study|Refused second scn|1|||
163045226|NCT00618826|588873143|FG000|Overall Study|Adverse Event|1|||
163045227|NCT01421641|588873146|FG000|Overall Study|Protocol Violation|2|||
163045228|NCT01421641|588873147|FG001|Overall Study|Protocol Violation|2|||
163045229|NCT03231306|588873148|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
163045230|NCT03231306|588873148|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
163045231|NCT03231306|588873148|FG000|Overall Study|Treatment delay > 21 days|2|||
163045232|NCT03231306|588873148|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
163045233|NCT03231306|588873148|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
163045234|NCT03231306|588873148|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
163045235|NCT03231306|588873148|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
163045236|NCT03231306|588873148|FG000|Overall Study|More than 1 Reason|2|||
163045237|NCT01502033|588873149|FG000|Overall Study|1 participant had scalp discomfort|1|||
163045238|NCT01502033|588873149|FG000|Overall Study|1 participant had worsening depression|1|||
163045239|NCT01502033|588873149|FG000|Overall Study|1 participant went back to school|1|||
163045240|NCT02983045|588873150|FG000|Overall Study|Withdrawal by Subject|0|||
163045241|NCT02983045|588873151|FG001|Overall Study|Withdrawal by Subject|1|||
163045242|NCT02983045|588873152|FG002|Overall Study|Withdrawal by Subject|0|||
163045243|NCT02983045|588873153|FG003|Overall Study|Withdrawal by Subject|5|||
163045244|NCT02983045|588873154|FG004|Overall Study|Withdrawal by Subject|0|||
163045245|NCT02983045|588873155|FG005|Overall Study|Withdrawal by Subject|72|||
163045246|NCT02983045|588873156|FG006|Overall Study|Withdrawal by Subject|0|||
163045247|NCT02983045|588873157|FG007|Overall Study|Withdrawal by Subject|0|||
163045248|NCT02983045|588873158|FG008|Overall Study|Withdrawal by Subject|0|||
163045249|NCT02983045|588873159|FG009|Overall Study|Withdrawal by Subject|2|||
163045250|NCT02983045|588873150|FG000|Overall Study|Lost to Follow-up|0|||
163045251|NCT02983045|588873151|FG001|Overall Study|Lost to Follow-up|0|||
163045252|NCT02983045|588873152|FG002|Overall Study|Lost to Follow-up|0|||
163045253|NCT02983045|588873153|FG003|Overall Study|Lost to Follow-up|0|||
163045254|NCT02983045|588873154|FG004|Overall Study|Lost to Follow-up|0|||
163045255|NCT02983045|588873155|FG005|Overall Study|Lost to Follow-up|10|||
163394285|NCT03681951|590155749|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
163394286|NCT03681951|590155750|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
163394287|NCT03681951|590155751|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
163394288|NCT03681951|590155752|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
163394289|NCT03681951|590155753|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
163394290|NCT03681951|590155754|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
163394291|NCT03681951|590155755|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
163394292|NCT01020448|590155756|FG000|Pre-assignment|Adverse Event|6|||
163394293|NCT01020448|590155756|FG000|Pre-assignment|Withdrawal by Subject|5|||
163394294|NCT01020448|590155756|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
163394295|NCT01020448|590155756|FG000|Treatment|Adverse Event|11|||
163394296|NCT01020448|590155756|FG000|Treatment|Consent Withdrawn|3|||
163394297|NCT01020448|590155756|FG000|Treatment|Disease Progression|2|||
163394298|NCT01020448|590155756|FG000|Treatment|Lack of Efficacy|8|||
163394299|NCT01020448|590155756|FG000|Treatment|Lost to Follow-up|2|||
163394300|NCT01230554|590155757|FG000|Overall Study|Lost to Follow-up|2|||
163394301|NCT01230554|590155757|FG000|Overall Study|Inability to maintain visit schedule|1|||
163394302|NCT01006265|590155768|FG000|Overall Study|Lost to Follow-up|1|||
163394303|NCT01006265|590155769|FG001|Overall Study|Lost to Follow-up|0|||
163045256|NCT02983045|588873156|FG006|Overall Study|Lost to Follow-up|0|||
163045257|NCT02983045|588873157|FG007|Overall Study|Lost to Follow-up|0|||
163045258|NCT02983045|588873158|FG008|Overall Study|Lost to Follow-up|0|||
163045259|NCT02983045|588873159|FG009|Overall Study|Lost to Follow-up|0|||
163394304|NCT01006265|590155770|FG002|Overall Study|Lost to Follow-up|1|||
163394305|NCT01006265|590155771|FG003|Overall Study|Lost to Follow-up|0|||
163394306|NCT01006265|590155768|FG000|Overall Study|Withdrawal by Subject|4|||
163394307|NCT01006265|590155769|FG001|Overall Study|Withdrawal by Subject|7|||
163045260|NCT01808261|588873160|FG000|Overall Study|Physician Decision|0|||
163045261|NCT01808261|588873161|FG001|Overall Study|Physician Decision|2|||
163394308|NCT01006265|590155770|FG002|Overall Study|Withdrawal by Subject|5|||
163394309|NCT01006265|590155771|FG003|Overall Study|Withdrawal by Subject|5|||
163394310|NCT01006265|590155768|FG000|Overall Study|Administrative reason|1|||
163394311|NCT01006265|590155769|FG001|Overall Study|Administrative reason|2|||
163394312|NCT01006265|590155770|FG002|Overall Study|Administrative reason|3|||
162957126|NCT01319383|588544912|FG000|Overall Study|Lack of Efficacy|5|||
162957127|NCT01319383|588544913|FG001|Overall Study|Lack of Efficacy|9|||
162957128|NCT01319383|588544912|FG000|Overall Study|No in vivo response to interval doses|0|||
162957129|NCT01319383|588544913|FG001|Overall Study|No in vivo response to interval doses|1|||
162957130|NCT01531894|588544916|FG000|Overall Study|Physician Decision|8|||
162957131|NCT01531894|588544916|FG000|Overall Study|Death|1|||
162957132|NCT03635320|588544922|FG000|Overall Study|not implanted the device|1|||
162957133|NCT03635320|588544923|FG001|Overall Study|not implanted the device|2|||
162957134|NCT03635320|588544922|FG000|Overall Study|Withdrawal by Subject|11|||
162957135|NCT03635320|588544923|FG001|Overall Study|Withdrawal by Subject|6|||
162957136|NCT01558635|588544924|FG000|Overall Study|Death|1|||
162957137|NCT01558635|588544924|FG000|Overall Study|Withdrawal by Subject|2|||
162957138|NCT01558635|588544924|FG000|Overall Study|Physician Decision|1|||
162957139|NCT01558635|588544924|FG000|Overall Study|Subject received other treatment|1|||
162957140|NCT01558635|588544924|FG000|Overall Study|Reveal XT was explanted|1|||
162957141|NCT03868891|588544927|FG000|Overall Study|Adverse Event|1|||
162957142|NCT03868891|588544928|FG001|Overall Study|Adverse Event|0|||
162957143|NCT03868891|588544927|FG000|Overall Study|Lost to Follow-up|2|||
162957144|NCT03868891|588544928|FG001|Overall Study|Lost to Follow-up|1|||
162957145|NCT03868891|588544927|FG000|Overall Study|COVID-19 Restrictions|1|||
162957146|NCT03868891|588544928|FG001|Overall Study|COVID-19 Restrictions|2|||
162957147|NCT01158118|588544929|FG000|Overall Study|Screen failure|1|||
162957148|NCT01158118|588544930|FG001|Overall Study|Screen failure|0|||
162957149|NCT01158118|588544929|FG000|Overall Study|Donor match was a screen failure|0|||
162957150|NCT01158118|588544930|FG001|Overall Study|Donor match was a screen failure|1|||
162957151|NCT01158118|588544929|FG000|Overall Study|Suffered stroke prior to transplant|0|||
162957152|NCT01158118|588544930|FG001|Overall Study|Suffered stroke prior to transplant|1|||
162957153|NCT01158118|588544929|FG000|Overall Study|Death|0|||
162957154|NCT01158118|588544930|FG001|Overall Study|Death|1|||
162957155|NCT04994535|588544931|FG000|Overall Study|Lost to Follow-up|7|||
162957156|NCT04994535|588544932|FG001|Overall Study|Lost to Follow-up|7|||
162957157|NCT04994535|588544931|FG000|Overall Study|Withdrawal by Subject|10|||
162957158|NCT04994535|588544932|FG001|Overall Study|Withdrawal by Subject|7|||
162957159|NCT04994535|588544931|FG000|Overall Study|Other|1|||
162957160|NCT04994535|588544932|FG001|Overall Study|Other|1|||
162957161|NCT00604162|588544933|FG000|Overall Study|Physician Decision|3|||
162957162|NCT00604162|588544933|FG000|Overall Study|Withdrawal by Subject|1|||
162957163|NCT02246920|588544935|FG000|Overall Study|Adverse Event|3|||
162957164|NCT02246920|588544936|FG001|Overall Study|Adverse Event|1|||
162957165|NCT02246920|588544937|FG002|Overall Study|Adverse Event|1|||
162957166|NCT02246920|588544935|FG000|Overall Study|Lost to Follow-up|2|||
162957167|NCT02246920|588544936|FG001|Overall Study|Lost to Follow-up|1|||
162957168|NCT02246920|588544937|FG002|Overall Study|Lost to Follow-up|0|||
162957169|NCT02246920|588544935|FG000|Overall Study|Protocol Violation|2|||
162957170|NCT02246920|588544936|FG001|Overall Study|Protocol Violation|5|||
162957171|NCT02246920|588544937|FG002|Overall Study|Protocol Violation|1|||
162957172|NCT02246920|588544935|FG000|Overall Study|Withdrawal by Subject|0|||
162957173|NCT02246920|588544936|FG001|Overall Study|Withdrawal by Subject|0|||
162957174|NCT02246920|588544937|FG002|Overall Study|Withdrawal by Subject|1|||
162957175|NCT00960297|588544941|FG000|Overall Study|Physician Decision|1|||
162957176|NCT00960297|588544941|FG000|Overall Study|Venous port infection|1|||
162957177|NCT00960297|588544941|FG000|Overall Study|Disease progression|1|||
162957178|NCT03247972|588544942|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
162957179|NCT03247972|588544942|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
162957180|NCT00968812|588544943|FG000|Overall Study|Adverse Event|30|||
162957181|NCT00968812|588544944|FG001|Overall Study|Adverse Event|46|||
162957182|NCT00968812|588544945|FG002|Overall Study|Adverse Event|33|||
162957183|NCT00968812|588544943|FG000|Overall Study|Death|2|||
162957184|NCT00968812|588544944|FG001|Overall Study|Death|2|||
162957185|NCT00968812|588544945|FG002|Overall Study|Death|1|||
162957186|NCT00968812|588544943|FG000|Overall Study|Lack of Efficacy|9|||
162957187|NCT00968812|588544944|FG001|Overall Study|Lack of Efficacy|7|||
162957188|NCT00968812|588544945|FG002|Overall Study|Lack of Efficacy|16|||
163195315|NCT02468674|589429802|FG007|Overall Study|Protocol Deviation|1|||
162957189|NCT00968812|588544943|FG000|Overall Study|Lost to Follow-up|17|||
162957190|NCT00968812|588544944|FG001|Overall Study|Lost to Follow-up|12|||
162957191|NCT00968812|588544945|FG002|Overall Study|Lost to Follow-up|11|||
162957192|NCT00968812|588544943|FG000|Overall Study|Physician Decision|8|||
162957193|NCT00968812|588544944|FG001|Overall Study|Physician Decision|5|||
162957194|NCT00968812|588544945|FG002|Overall Study|Physician Decision|9|||
162957195|NCT00968812|588544943|FG000|Overall Study|Protocol Violation|7|||
163195316|NCT02468674|589429803|FG008|Overall Study|Protocol Deviation|1|||
163195317|NCT01687998|589429811|FG000|Overall Study|Withdrawal by Subject|49|||
163195318|NCT01687998|589429812|FG001|Overall Study|Withdrawal by Subject|51|||
162957196|NCT00968812|588544944|FG001|Overall Study|Protocol Violation|4|||
162957197|NCT00968812|588544945|FG002|Overall Study|Protocol Violation|3|||
162957198|NCT00968812|588544943|FG000|Overall Study|Withdrawal by Subject|17|||
162957199|NCT00968812|588544944|FG001|Overall Study|Withdrawal by Subject|23|||
163045262|NCT01808261|588873160|FG000|Overall Study|Study Closed/Terminated|25|||
163045263|NCT01808261|588873161|FG001|Overall Study|Study Closed/Terminated|23|||
163045264|NCT01808261|588873160|FG000|Overall Study|Adverse event, non-fatal|2|||
163045265|NCT01808261|588873161|FG001|Overall Study|Adverse event, non-fatal|0|||
163045266|NCT01808261|588873160|FG000|Overall Study|Consent withdrawn by subject|6|||
163045267|NCT01808261|588873161|FG001|Overall Study|Consent withdrawn by subject|7|||
163045268|NCT01808261|588873160|FG000|Overall Study|Lost to Follow-up|3|||
163045269|NCT01808261|588873161|FG001|Overall Study|Lost to Follow-up|1|||
163045270|NCT02585713|588873162|FG000|Overall Study|Withdrew prior to treatment|2|||
163045271|NCT02585713|588873163|FG001|Overall Study|Withdrew prior to treatment|7|||
163045272|NCT02585713|588873162|FG000|Overall Study|Other|3|||
163045273|NCT02585713|588873163|FG001|Overall Study|Other|1|||
163045274|NCT02609984|588873166|FG000|Overall Study|Death|29|||
163045275|NCT02609984|588873167|FG001|Overall Study|Death|26|||
163045276|NCT02609984|588873166|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
163045277|NCT02609984|588873167|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
163045278|NCT02609984|588873166|FG000|Overall Study|Lost to Follow-up|1|||
163045279|NCT02609984|588873167|FG001|Overall Study|Lost to Follow-up|2|||
163045280|NCT02609984|588873166|FG000|Overall Study|Withdrawal by Subject|0|||
163045281|NCT02609984|588873167|FG001|Overall Study|Withdrawal by Subject|1|||
163045282|NCT02609984|588873166|FG000|Overall Study|Disease Progression|2|||
163045283|NCT02609984|588873167|FG001|Overall Study|Disease Progression|0|||
163045284|NCT02080364|588873168|FG000|Baseline Period|Protocol Violation|2|||
163045285|NCT02080364|588873169|FG001|Baseline Period|Protocol Violation|1|||
163045286|NCT02080364|588873170|FG002|Baseline Period|Protocol Violation|0|||
163045287|NCT02080364|588873171|FG003|Baseline Period|Protocol Violation|0|||
163045288|NCT02080364|588873168|FG000|Baseline Period|Other|0|||
163045289|NCT02080364|588873169|FG001|Baseline Period|Other|1|||
163045290|NCT02080364|588873170|FG002|Baseline Period|Other|1|||
163045291|NCT02080364|588873171|FG003|Baseline Period|Other|0|||
163045292|NCT02080364|588873168|FG000|Treatment Period|Adverse Event|10|||
163045293|NCT02080364|588873169|FG001|Treatment Period|Adverse Event|15|||
163045294|NCT02080364|588873170|FG002|Treatment Period|Adverse Event|11|||
163045295|NCT02080364|588873171|FG003|Treatment Period|Adverse Event|14|||
163045296|NCT02080364|588873168|FG000|Treatment Period|Lost to Follow-up|2|||
163045297|NCT02080364|588873169|FG001|Treatment Period|Lost to Follow-up|3|||
163300960|NCT05678998|589809940|FG004|Overall Study|Withdrawal by Subject|1|||
163300961|NCT05678998|589809936|FG000|Overall Study|Lost to Follow-up|0|||
163045298|NCT02080364|588873170|FG002|Treatment Period|Lost to Follow-up|5|||
163045299|NCT02080364|588873171|FG003|Treatment Period|Lost to Follow-up|0|||
163045300|NCT02080364|588873168|FG000|Treatment Period|Protocol Violation|5|||
163045301|NCT02080364|588873169|FG001|Treatment Period|Protocol Violation|3|||
163045302|NCT02080364|588873170|FG002|Treatment Period|Protocol Violation|5|||
163045303|NCT02080364|588873171|FG003|Treatment Period|Protocol Violation|1|||
163045304|NCT02080364|588873168|FG000|Treatment Period|Withdrawal by Subject|16|||
163045305|NCT02080364|588873169|FG001|Treatment Period|Withdrawal by Subject|16|||
163045306|NCT02080364|588873170|FG002|Treatment Period|Withdrawal by Subject|15|||
163045307|NCT02080364|588873171|FG003|Treatment Period|Withdrawal by Subject|10|||
163045308|NCT02080364|588873168|FG000|Treatment Period|Study Terminated by Sponsor|0|||
163045309|NCT02080364|588873169|FG001|Treatment Period|Study Terminated by Sponsor|0|||
163045310|NCT02080364|588873170|FG002|Treatment Period|Study Terminated by Sponsor|180|||
163045311|NCT02080364|588873171|FG003|Treatment Period|Study Terminated by Sponsor|183|||
163045312|NCT02080364|588873168|FG000|Treatment Period|Other|14|||
163045313|NCT02080364|588873169|FG001|Treatment Period|Other|12|||
163045314|NCT02080364|588873170|FG002|Treatment Period|Other|21|||
163045315|NCT02080364|588873171|FG003|Treatment Period|Other|16|||
163045316|NCT00991289|588873172|FG000|Overall Study|Adverse Event|1|||
163045317|NCT00991289|588873172|FG000|Overall Study|Physician Decision|2|||
163045318|NCT00991289|588873172|FG000|Overall Study|Withdrawal by Subject|3|||
163045319|NCT00991289|588873172|FG000|Overall Study|Lost to Follow-up|4|||
163045320|NCT00991289|588873172|FG000|Overall Study|Protocol Violation|2|||
163045321|NCT02256839|588873174|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
163045322|NCT02256839|588873175|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
163045323|NCT01843803|588873176|FG000|Overall Study|not a Veteran, did not see provider|1|||
163045324|NCT01843803|588873177|FG001|Overall Study|not a Veteran, did not see provider|3|||
163045325|NCT00436826|588873181|FG000|Double Blind Period (DBP)|Adverse Event|2|||
163045326|NCT00436826|588873182|FG001|Double Blind Period (DBP)|Adverse Event|0|||
163045327|NCT00436826|588873183|FG002|Double Blind Period (DBP)|Adverse Event|0|||
163045328|NCT00436826|588873184|FG003|Double Blind Period (DBP)|Adverse Event|0|||
163300962|NCT05678998|589809937|FG001|Overall Study|Lost to Follow-up|0|||
163394313|NCT01006265|590155771|FG003|Overall Study|Administrative reason|0|||
163394314|NCT01390272|590155772|FG000|Overall Study|Death|3|||
163394315|NCT01390272|590155773|FG001|Overall Study|Death|2|||
163394316|NCT01390272|590155772|FG000|Overall Study|Withdrawal by Subject|9|||
163394317|NCT01390272|590155773|FG001|Overall Study|Withdrawal by Subject|5|||
163394318|NCT01390272|590155772|FG000|Overall Study|Patient moved, no longer eligible|5|||
163394319|NCT01390272|590155773|FG001|Overall Study|Patient moved, no longer eligible|8|||
163394320|NCT01177384|590155774|FG000|Overall Study|Adverse Event|6|||
163394321|NCT01177384|590155775|FG001|Overall Study|Adverse Event|4|||
163394322|NCT01177384|590155774|FG000|Overall Study|Lack of Efficacy|0|||
163394323|NCT01177384|590155775|FG001|Overall Study|Lack of Efficacy|1|||
163394324|NCT01177384|590155774|FG000|Overall Study|Lost to Follow-up|3|||
163394325|NCT01177384|590155775|FG001|Overall Study|Lost to Follow-up|4|||
163394326|NCT01177384|590155774|FG000|Overall Study|Physician Decision|0|||
163394327|NCT01177384|590155775|FG001|Overall Study|Physician Decision|3|||
163394328|NCT01177384|590155774|FG000|Overall Study|Protocol Violation|0|||
163394329|NCT01177384|590155775|FG001|Overall Study|Protocol Violation|2|||
163394330|NCT01177384|590155774|FG000|Overall Study|Withdrawal by Subject|5|||
163394331|NCT01177384|590155775|FG001|Overall Study|Withdrawal by Subject|12|||
163394332|NCT00590044|590155776|FG000|Overall Study|Withdrawal by Subject|2|||
163394333|NCT00590044|590155777|FG001|Overall Study|Withdrawal by Subject|2|||
163394334|NCT00590044|590155776|FG000|Overall Study|wrong insulin arm assigned|1|||
163394335|NCT00590044|590155777|FG001|Overall Study|wrong insulin arm assigned|0|||
163394336|NCT00590044|590155776|FG000|Overall Study|Protocol Violation|1|||
163394337|NCT00590044|590155777|FG001|Overall Study|Protocol Violation|0|||
163394338|NCT01514136|590155778|FG000|Test Period 1; Test A|Protocol Violation|1|||
163394339|NCT01514136|590155779|FG001|Test Period 1; Test A|Protocol Violation|0|||
163394340|NCT01514136|590155780|FG002|Test Period 1; Test A|Protocol Violation|0|||
163394341|NCT01514136|590155781|FG003|Test Period 1; Test A|Protocol Violation|0|||
163394342|NCT01514136|590155782|FG004|Test Period 1; Test A|Protocol Violation|0|||
163394343|NCT01514136|590155783|FG005|Test Period 1; Test A|Protocol Violation|0|||
163394344|NCT01514136|590155784|FG006|Test Period 1; Test A|Protocol Violation|0|||
163394345|NCT01514136|590155785|FG007|Test Period 1; Test A|Protocol Violation|0|||
163394346|NCT01514136|590155778|FG000|Test Period 1; Test A|Break from study holiday|2|||
163394347|NCT01514136|590155779|FG001|Test Period 1; Test A|Break from study holiday|0|||
163394348|NCT01514136|590155780|FG002|Test Period 1; Test A|Break from study holiday|0|||
163394349|NCT01514136|590155781|FG003|Test Period 1; Test A|Break from study holiday|0|||
163394350|NCT01514136|590155782|FG004|Test Period 1; Test A|Break from study holiday|0|||
163394351|NCT01514136|590155783|FG005|Test Period 1; Test A|Break from study holiday|0|||
163394352|NCT01514136|590155784|FG006|Test Period 1; Test A|Break from study holiday|0|||
163394353|NCT01514136|590155785|FG007|Test Period 1; Test A|Break from study holiday|0|||
163394354|NCT01514136|590155778|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
163394355|NCT01514136|590155779|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
163394356|NCT01514136|590155780|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
163394357|NCT01514136|590155781|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
163394358|NCT01514136|590155782|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
163394359|NCT01514136|590155783|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
163394360|NCT01514136|590155784|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
163394361|NCT01514136|590155785|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
162957200|NCT00968812|588544945|FG002|Overall Study|Withdrawal by Subject|25|||
162957201|NCT00968812|588544943|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
163300963|NCT05678998|589809938|FG002|Overall Study|Lost to Follow-up|0|||
163300964|NCT05678998|589809939|FG003|Overall Study|Lost to Follow-up|0|||
163300965|NCT05678998|589809940|FG004|Overall Study|Lost to Follow-up|1|||
163300966|NCT05678998|589809936|FG000|Overall Study|Death|0|||
163300967|NCT05678998|589809937|FG001|Overall Study|Death|0|||
163300968|NCT05678998|589809938|FG002|Overall Study|Death|0|||
163300969|NCT05678998|589809939|FG003|Overall Study|Death|3|||
163300970|NCT05678998|589809940|FG004|Overall Study|Death|4|||
163300971|NCT05678998|589809936|FG000|Overall Study|Other|0|||
163300972|NCT05678998|589809937|FG001|Overall Study|Other|0|||
163300973|NCT05678998|589809938|FG002|Overall Study|Other|0|||
163300974|NCT05678998|589809939|FG003|Overall Study|Other|2|||
163300975|NCT05678998|589809940|FG004|Overall Study|Other|1|||
163300976|NCT05773313|589809941|FG000|Overall Study|Lost to Follow-up|3|||
163300977|NCT05137236|589809942|FG000|Part A|Other than Specified|1|||
163300978|NCT05137236|589809943|FG001|Part A|Other than Specified|0|||
163300979|NCT05137236|589809944|FG002|Part A|Other than Specified|0|||
163300980|NCT05137236|589809945|FG003|Part A|Other than Specified|0|||
163300981|NCT05137236|589809946|FG004|Part A|Other than Specified|0|||
163300982|NCT05137236|589809947|FG005|Part A|Other than Specified|0|||
163300983|NCT05137236|589809948|FG006|Part A|Other than Specified|0|||
163300984|NCT05137236|589809949|FG007|Part A|Other than Specified|0|||
163300985|NCT05137236|589809942|FG000|Part A|Withdrawal by Subject|0|||
163300986|NCT05137236|589809943|FG001|Part A|Withdrawal by Subject|4|||
163300987|NCT05137236|589809944|FG002|Part A|Withdrawal by Subject|1|||
163045329|NCT00436826|588873185|FG004|Double Blind Period (DBP)|Adverse Event|0|||
163045330|NCT00436826|588873186|FG005|Double Blind Period (DBP)|Adverse Event|0|||
163045331|NCT00436826|588873181|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
163045332|NCT00436826|588873182|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
163045333|NCT00436826|588873183|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
163045334|NCT00436826|588873184|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
163045335|NCT00436826|588873185|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
163045336|NCT00436826|588873186|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
163045337|NCT00436826|588873181|FG000|Double Blind Period (DBP)|Other|10|||
163045338|NCT00436826|588873182|FG001|Double Blind Period (DBP)|Other|11|||
163045339|NCT00436826|588873183|FG002|Double Blind Period (DBP)|Other|0|||
163045340|NCT00436826|588873184|FG003|Double Blind Period (DBP)|Other|0|||
163045341|NCT00436826|588873185|FG004|Double Blind Period (DBP)|Other|0|||
163045342|NCT00436826|588873186|FG005|Double Blind Period (DBP)|Other|0|||
163045343|NCT00436826|588873181|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
163045344|NCT00436826|588873182|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
163045345|NCT00436826|588873183|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
163045346|NCT00436826|588873184|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
163045347|NCT00436826|588873185|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
163045348|NCT00436826|588873186|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
163045349|NCT00436826|588873181|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
163045350|NCT00436826|588873182|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
163045351|NCT00436826|588873183|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
163045352|NCT00436826|588873184|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
163045353|NCT00436826|588873185|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
163045354|NCT00436826|588873186|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
163045355|NCT00436826|588873181|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
163045356|NCT00436826|588873182|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
163045357|NCT00436826|588873183|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
163045358|NCT00436826|588873184|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
163045359|NCT00436826|588873185|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
163045360|NCT00436826|588873186|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
163045361|NCT00784719|588873201|FG000|Overall Study|Adverse Event|0|||
163045362|NCT00784719|588873202|FG001|Overall Study|Adverse Event|2|||
163045363|NCT00784719|588873203|FG002|Overall Study|Adverse Event|0|||
163045364|NCT00784719|588873204|FG003|Overall Study|Adverse Event|0|||
163045365|NCT00784719|588873205|FG004|Overall Study|Adverse Event|1|||
163045366|NCT00784719|588873206|FG005|Overall Study|Adverse Event|1|||
163045367|NCT00784719|588873207|FG006|Overall Study|Adverse Event|1|||
163045368|NCT00784719|588873201|FG000|Overall Study|Lost to Follow-up|0|||
163045369|NCT00784719|588873202|FG001|Overall Study|Lost to Follow-up|0|||
163045370|NCT00784719|588873203|FG002|Overall Study|Lost to Follow-up|0|||
163045371|NCT00784719|588873204|FG003|Overall Study|Lost to Follow-up|0|||
163045372|NCT00784719|588873205|FG004|Overall Study|Lost to Follow-up|1|||
163045373|NCT00784719|588873206|FG005|Overall Study|Lost to Follow-up|1|||
162957202|NCT00968812|588544944|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
162957203|NCT00968812|588544945|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
162957204|NCT00968812|588544943|FG000|Overall Study|Noncompliance with study drug|4|||
162957205|NCT00968812|588544944|FG001|Overall Study|Noncompliance with study drug|1|||
162957206|NCT00968812|588544945|FG002|Overall Study|Noncompliance with study drug|6|||
162957207|NCT00968812|588544943|FG000|Overall Study|Unable to take rescue therapy|12|||
162957208|NCT00968812|588544944|FG001|Overall Study|Unable to take rescue therapy|12|||
162957209|NCT00968812|588544945|FG002|Overall Study|Unable to take rescue therapy|17|||
162957210|NCT00968812|588544943|FG000|Overall Study|Other|25|||
162957211|NCT00968812|588544944|FG001|Overall Study|Other|37|||
162957212|NCT00968812|588544945|FG002|Overall Study|Other|40|||
162957213|NCT00834340|588544946|FG000|Washout|Adverse Event|1|||
162957214|NCT00834340|588544947|FG001|Washout|Adverse Event|0|||
162957215|NCT00834340|588544946|FG000|Washout|Withdrawal by Subject|1|||
162957216|NCT00834340|588544947|FG001|Washout|Withdrawal by Subject|0|||
162957217|NCT00395694|588544948|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
163045374|NCT00784719|588873207|FG006|Overall Study|Lost to Follow-up|0|||
163045375|NCT00784719|588873201|FG000|Overall Study|Other|2|||
163045376|NCT00784719|588873202|FG001|Overall Study|Other|1|||
163045377|NCT00784719|588873203|FG002|Overall Study|Other|1|||
163045378|NCT00784719|588873204|FG003|Overall Study|Other|0|||
162957218|NCT00395694|588544949|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
162957219|NCT00395694|588544948|FG000|Continuation Phase|Adverse Event|1|||
162957220|NCT00395694|588544949|FG001|Continuation Phase|Adverse Event|0|||
162957221|NCT00395694|588544948|FG000|Continuation Phase|Lack of Efficacy|12|||
162957222|NCT00395694|588544949|FG001|Continuation Phase|Lack of Efficacy|11|||
162957223|NCT00395694|588544948|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
162957224|NCT00395694|588544949|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
162957225|NCT00395694|588544948|FG000|Continuation Phase|Poor Compliance|1|||
162957226|NCT00395694|588544949|FG001|Continuation Phase|Poor Compliance|0|||
162957227|NCT00395694|588544948|FG000|Continuation Phase|Withdrawal by Subject|0|||
162957228|NCT00395694|588544949|FG001|Continuation Phase|Withdrawal by Subject|2|||
162957229|NCT02689505|588544952|FG000|Overall Study|Progressive disease|2|||
162957230|NCT02689505|588544953|FG001|Overall Study|Progressive disease|2|||
162957231|NCT02689505|588544954|FG002|Overall Study|Progressive disease|3|||
162957232|NCT02689505|588544955|FG003|Overall Study|Progressive disease|9|||
162957233|NCT02689505|588544956|FG004|Overall Study|Progressive disease|1|||
162957234|NCT02689505|588544952|FG000|Overall Study|Dose Limiting Toxicity|0|||
162957235|NCT02689505|588544953|FG001|Overall Study|Dose Limiting Toxicity|1|||
162957236|NCT02689505|588544954|FG002|Overall Study|Dose Limiting Toxicity|0|||
162957237|NCT02689505|588544955|FG003|Overall Study|Dose Limiting Toxicity|0|||
162957238|NCT02689505|588544956|FG004|Overall Study|Dose Limiting Toxicity|2|||
162957239|NCT02689505|588544952|FG000|Overall Study|Other AE or clinical progression|0|||
162957240|NCT02689505|588544953|FG001|Overall Study|Other AE or clinical progression|2|||
162957241|NCT02689505|588544954|FG002|Overall Study|Other AE or clinical progression|0|||
162957242|NCT02689505|588544955|FG003|Overall Study|Other AE or clinical progression|2|||
162957243|NCT02689505|588544956|FG004|Overall Study|Other AE or clinical progression|0|||
162957244|NCT04108858|588544957|FG000|Overall Study|Adverse Event|1|||
162957245|NCT03663179|588544958|FG000|Overall Study|Withdrawal by Subject|2|||
162957246|NCT03663179|588544959|FG001|Overall Study|Withdrawal by Subject|0|||
162957247|NCT03663179|588544958|FG000|Overall Study|Lost to Follow-up|1|||
162957248|NCT03663179|588544959|FG001|Overall Study|Lost to Follow-up|1|||
162957249|NCT03663179|588544958|FG000|Overall Study|Revealed exclusionary condition|1|||
162957250|NCT03663179|588544959|FG001|Overall Study|Revealed exclusionary condition|0|||
162957251|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
162957252|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
162957253|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
162957254|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
162957255|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
162957256|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
162957257|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
162957258|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
162957259|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
162957260|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
162957261|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
162957262|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
162957263|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
162957264|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
162957265|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
162957266|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
162957267|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
162957268|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
162957269|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
162957270|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
162957271|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Death|0|||
162957272|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Death|1|||
162957273|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Death|0|||
162957274|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Death|0|||
162957275|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
162957276|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
162957277|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
162957278|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
162957279|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
162957280|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
162957281|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
162957282|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
162957283|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
163045379|NCT00784719|588873205|FG004|Overall Study|Other|2|||
162957284|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
162957285|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
162957286|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
162957287|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
162957288|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
162957289|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
162957290|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
162957291|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
162957292|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
162957293|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
162957294|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
162957295|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
162957296|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
162957297|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
162957298|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
162957299|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
162957300|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
162957301|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
162957302|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
162957303|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
162957304|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
162957305|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
162957306|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
162957307|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
162957308|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
162957309|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
162957310|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
162957311|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
162957312|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
162957313|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
162957314|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
162957315|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
162957316|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
162957317|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
162957318|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
162957319|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
162957320|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
162957321|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
162957322|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
162957323|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
162957324|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
162957325|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
162957326|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
162957327|NCT01289262|588544966|FG000|Overall Study|Lost to Follow-up|29|||
162957328|NCT01289262|588544967|FG001|Overall Study|Lost to Follow-up|16|||
162957329|NCT01289262|588544966|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
162957330|NCT01289262|588544967|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
162957331|NCT03792477|588544970|FG000|Overall Study|Adverse Event|0|||
162957332|NCT03792477|588544971|FG001|Overall Study|Adverse Event|0|||
162957333|NCT03792477|588544972|FG002|Overall Study|Adverse Event|0|||
162957334|NCT03792477|588544973|FG003|Overall Study|Adverse Event|1|||
162957335|NCT03792477|588544974|FG004|Overall Study|Adverse Event|0|||
162957336|NCT03792477|588544970|FG000|Overall Study|Lost to Follow-up|0|||
162957337|NCT03792477|588544971|FG001|Overall Study|Lost to Follow-up|0|||
162957338|NCT03792477|588544972|FG002|Overall Study|Lost to Follow-up|2|||
162957339|NCT03792477|588544973|FG003|Overall Study|Lost to Follow-up|0|||
162957340|NCT03792477|588544974|FG004|Overall Study|Lost to Follow-up|0|||
162957341|NCT03792477|588544970|FG000|Overall Study|Other|0|||
162957342|NCT03792477|588544971|FG001|Overall Study|Other|0|||
162957343|NCT03792477|588544972|FG002|Overall Study|Other|0|||
162957344|NCT03792477|588544973|FG003|Overall Study|Other|0|||
162957345|NCT03792477|588544974|FG004|Overall Study|Other|1|||
162957346|NCT00446563|588544977|FG000|Overall Study|Adverse Event|4|||
162957347|NCT00446563|588544978|FG001|Overall Study|Adverse Event|3|||
162957348|NCT00446563|588544977|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162957349|NCT00446563|588544978|FG001|Overall Study|Abnormal laboratory value(s)|1|||
162957350|NCT00446563|588544977|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162957351|NCT00446563|588544978|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162957352|NCT00446563|588544977|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162957353|NCT00446563|588544978|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
162957354|NCT00446563|588544977|FG000|Overall Study|Withdrawal by Subject|2|||
162957355|NCT00446563|588544978|FG001|Overall Study|Withdrawal by Subject|1|||
162957356|NCT00446563|588544977|FG000|Overall Study|Administrative problems|0|||
162957357|NCT00446563|588544978|FG001|Overall Study|Administrative problems|1|||
162957358|NCT01169558|588544979|FG000|Overall Study|Disease progression|98|||
162957359|NCT01169558|588544979|FG000|Overall Study|Adverse Event|25|||
162957360|NCT01169558|588544979|FG000|Overall Study|Withdrawal of Consent|8|||
162957361|NCT01169558|588544979|FG000|Overall Study|Medical Decision|7|||
163045380|NCT00784719|588873206|FG005|Overall Study|Other|1|||
163045381|NCT00784719|588873207|FG006|Overall Study|Other|3|||
163045382|NCT00784719|588873201|FG000|Overall Study|Withdrawal by Subject|1|||
163045383|NCT00784719|588873202|FG001|Overall Study|Withdrawal by Subject|0|||
163045384|NCT00784719|588873203|FG002|Overall Study|Withdrawal by Subject|0|||
163045385|NCT00784719|588873204|FG003|Overall Study|Withdrawal by Subject|0|||
163045386|NCT00784719|588873205|FG004|Overall Study|Withdrawal by Subject|2|||
163045387|NCT00784719|588873206|FG005|Overall Study|Withdrawal by Subject|0|||
163045388|NCT00784719|588873207|FG006|Overall Study|Withdrawal by Subject|1|||
163045389|NCT04533438|588873208|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
163045390|NCT04533438|588873209|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
163045391|NCT05568797|588873212|FG000|Overall Study|Adverse Event|0|||
163045392|NCT05568797|588873213|FG001|Overall Study|Adverse Event|8|||
163045393|NCT05568797|588873212|FG000|Overall Study|Lost to Follow-up|2|||
163045394|NCT05568797|588873213|FG001|Overall Study|Lost to Follow-up|3|||
163045395|NCT05568797|588873212|FG000|Overall Study|Withdrawal by Subject|1|||
163045396|NCT05568797|588873213|FG001|Overall Study|Withdrawal by Subject|10|||
163045397|NCT05568797|588873212|FG000|Overall Study|Other|2|||
163045398|NCT05568797|588873213|FG001|Overall Study|Other|2|||
163045399|NCT02401035|588873215|FG000|Overall Study|Withdrawal by Subject|1|||
163045400|NCT02401035|588873216|FG001|Overall Study|Withdrawal by Subject|0|||
163045401|NCT00869128|588873217|FG000|Overall Study|lack of Compliance|6|||
163045402|NCT00869128|588873218|FG001|Overall Study|lack of Compliance|6|||
163045403|NCT00985686|588873224|FG000|Overall Study|Lost to Follow-up|1|||
163045404|NCT00985686|588873225|FG001|Overall Study|Lost to Follow-up|1|||
163045405|NCT00985686|588873226|FG002|Overall Study|Lost to Follow-up|0|||
163045406|NCT00985686|588873227|FG003|Overall Study|Lost to Follow-up|2|||
163045407|NCT03046953|588873228|FG000|Overall Study|Relapse/progressive disease|21|||
163045408|NCT03046953|588873228|FG000|Overall Study|Death|2|||
163045409|NCT03046953|588873228|FG000|Overall Study|Withdrawal by Subject|3|||
163045410|NCT04039204|588873230|FG000|Overall Study|Withdrawal by Subject|0|||
163045411|NCT04039204|588873231|FG001|Overall Study|Withdrawal by Subject|2|||
163045412|NCT00396383|588873238|FG000|Overall Study|Death|2|||
163045413|NCT00396383|588873238|FG000|Overall Study|Lost to Follow-up|1|||
163045414|NCT02385110|588873241|FG000|Overall Study|Early Death|1|||
163045415|NCT02385110|588873242|FG001|Overall Study|Early Death|0|||
163045416|NCT00534638|588873243|FG000|Overall Study|Withdrawal by Subject|3|||
163045417|NCT00534638|588873244|FG001|Overall Study|Withdrawal by Subject|4|||
163045418|NCT00534638|588873243|FG000|Overall Study|Migrated/moved from study area|13|||
163045419|NCT00534638|588873244|FG001|Overall Study|Migrated/moved from study area|11|||
163045420|NCT00534638|588873243|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
163045421|NCT00534638|588873244|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
163045422|NCT00534638|588873243|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
163045423|NCT00534638|588873244|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
163045424|NCT00534638|588873243|FG000|Overall Study|Other|1685|||
163045425|NCT00534638|588873244|FG001|Overall Study|Other|902|||
163045426|NCT00282152|588873247|FG000|Overall Study|Withdrawal by Subject|1|||
163045427|NCT00282152|588873248|FG001|Overall Study|Withdrawal by Subject|0|||
163045428|NCT00585325|588873249|FG000|Overall Study|Withdrawal by Subject|1|||
163045429|NCT00585325|588873250|FG001|Overall Study|Withdrawal by Subject|1|||
163045430|NCT01124292|588873251|FG000|Overall Study|Lost to Follow-up|2|||
163045431|NCT01124292|588873252|FG001|Overall Study|Lost to Follow-up|4|||
163045432|NCT01124292|588873253|FG002|Overall Study|Lost to Follow-up|3|||
163045433|NCT01124292|588873251|FG000|Overall Study|Physician Decision|0|||
163045434|NCT01124292|588873252|FG001|Overall Study|Physician Decision|3|||
163045435|NCT01124292|588873253|FG002|Overall Study|Physician Decision|2|||
163045436|NCT01124292|588873251|FG000|Overall Study|Withdrawal by Subject|0|||
163045437|NCT01124292|588873252|FG001|Overall Study|Withdrawal by Subject|6|||
163045438|NCT01124292|588873253|FG002|Overall Study|Withdrawal by Subject|2|||
163045439|NCT01124292|588873251|FG000|Overall Study|medical issue unrelated to the study|0|||
163045440|NCT01124292|588873252|FG001|Overall Study|medical issue unrelated to the study|0|||
163045441|NCT01124292|588873253|FG002|Overall Study|medical issue unrelated to the study|2|||
163045442|NCT01124292|588873251|FG000|Overall Study|piercing track closed|0|||
163045443|NCT01124292|588873252|FG001|Overall Study|piercing track closed|2|||
163045444|NCT01124292|588873253|FG002|Overall Study|piercing track closed|1|||
163045445|NCT01237327|588873254|FG000|Overall Study|Protocol Violation: Core Study|1|||
163045446|NCT01237327|588873255|FG001|Overall Study|Protocol Violation: Core Study|0|||
163045447|NCT01237327|588873254|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
163045448|NCT01237327|588873255|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
163045449|NCT01237327|588873254|FG000|Overall Study|Progression of Disease: Core Study|18|||
163045450|NCT01237327|588873255|FG001|Overall Study|Progression of Disease: Core Study|22|||
163045451|NCT01237327|588873254|FG000|Overall Study|Progression of Disease: Extension Study|15|||
163045452|NCT01237327|588873255|FG001|Overall Study|Progression of Disease: Extension Study|13|||
163045453|NCT01237327|588873254|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
163045454|NCT01237327|588873255|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
162957362|NCT01169558|588544979|FG000|Overall Study|Stable Disease|4|||
162957363|NCT01169558|588544979|FG000|Overall Study|Lost to Follow-up|4|||
162957364|NCT01169558|588544979|FG000|Overall Study|Need for Surgery|4|||
162957365|NCT01169558|588544979|FG000|Overall Study|Non-compliance|2|||
162957366|NCT01169558|588544979|FG000|Overall Study|Protocol Violation|2|||
162957367|NCT01169558|588544979|FG000|Overall Study|Partial response|2|||
162957368|NCT03134222|588544982|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
162957369|NCT03134222|588544983|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
162957370|NCT03134222|588544984|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
162957371|NCT03134222|588544985|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
162957372|NCT03134222|588544986|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
162957373|NCT03134222|588544982|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
162957374|NCT03134222|588544983|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
162957375|NCT03134222|588544984|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
162957376|NCT03134222|588544985|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
162957377|NCT03134222|588544986|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
162957378|NCT03134222|588544982|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
162957379|NCT03134222|588544983|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
162957380|NCT03134222|588544984|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
162957381|NCT03134222|588544985|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
162957382|NCT03134222|588544986|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
162957383|NCT03134222|588544982|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
162957384|NCT03134222|588544983|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
162957385|NCT03134222|588544984|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
162957386|NCT03134222|588544985|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
162957387|NCT03134222|588544986|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
162957388|NCT03134222|588544982|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
162957389|NCT03134222|588544983|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
162957390|NCT03134222|588544984|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
162957391|NCT03134222|588544985|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
162957392|NCT03134222|588544986|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
162957393|NCT03134222|588544982|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
162957394|NCT03134222|588544983|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
162957395|NCT03134222|588544984|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
162957396|NCT03134222|588544985|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
162957397|NCT03134222|588544986|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
162957398|NCT03134222|588544982|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
162957399|NCT03134222|588544983|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
162957400|NCT03134222|588544984|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
162957401|NCT03134222|588544985|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
162957402|NCT03134222|588544986|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
162957403|NCT03134222|588544982|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
162957404|NCT03134222|588544983|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
162957405|NCT03134222|588544984|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
162957406|NCT03134222|588544985|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
162957407|NCT03134222|588544986|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
162957408|NCT02605928|588544987|FG000|Overall Study|Model tuning phase|28|||
162957409|NCT02605928|588544987|FG000|Overall Study|Lack of Efficacy|5|||
162957410|NCT03482882|588544990|FG000|Overall Study|Adverse Event|3|||
162957411|NCT03482882|588544990|FG000|Overall Study|Lost to Follow-up|1|||
162957412|NCT03482882|588544990|FG000|Overall Study|Protocol Violation|2|||
162957413|NCT03482882|588544990|FG000|Overall Study|Not further specified|1|||
162957414|NCT05341622|588544997|FG000|Overall Study|Death|0|||
162957415|NCT05341622|588544998|FG001|Overall Study|Death|0|||
162957416|NCT05341622|588544999|FG002|Overall Study|Death|0|||
162957417|NCT05341622|588545000|FG003|Overall Study|Death|0|||
162957418|NCT05341622|588545001|FG004|Overall Study|Death|1|||
162957419|NCT05341622|588545002|FG005|Overall Study|Death|0|||
162957420|NCT05341622|588545003|FG006|Overall Study|Death|0|||
162957421|NCT05341622|588545004|FG007|Overall Study|Death|1|||
162957422|NCT05341622|588544997|FG000|Overall Study|Invalid Address|0|||
162957423|NCT05341622|588544998|FG001|Overall Study|Invalid Address|1|||
162957424|NCT05341622|588544999|FG002|Overall Study|Invalid Address|0|||
162957425|NCT05341622|588545000|FG003|Overall Study|Invalid Address|0|||
162957426|NCT05341622|588545001|FG004|Overall Study|Invalid Address|0|||
162957427|NCT05341622|588545002|FG005|Overall Study|Invalid Address|0|||
162957428|NCT05341622|588545003|FG006|Overall Study|Invalid Address|0|||
162957429|NCT05341622|588545004|FG007|Overall Study|Invalid Address|0|||
162957430|NCT05341622|588544997|FG000|Overall Study|Ineligible|26|||
162957431|NCT05341622|588544998|FG001|Overall Study|Ineligible|21|||
162957432|NCT05341622|588544999|FG002|Overall Study|Ineligible|28|||
162957433|NCT05341622|588545000|FG003|Overall Study|Ineligible|24|||
162957434|NCT05341622|588545001|FG004|Overall Study|Ineligible|29|||
162957435|NCT05341622|588545002|FG005|Overall Study|Ineligible|31|||
162957436|NCT05341622|588545003|FG006|Overall Study|Ineligible|28|||
162957437|NCT05341622|588545004|FG007|Overall Study|Ineligible|26|||
162957438|NCT04611789|588545005|FG000|Overall Study|Lost to Follow-up|1|||
162957439|NCT04611789|588545006|FG001|Overall Study|Lost to Follow-up|0|||
162957440|NCT04611789|588545007|FG002|Overall Study|Lost to Follow-up|0|||
162957441|NCT05152576|588545008|FG000|Overall Study|Lost to Follow-up|3|||
162957442|NCT05152576|588545009|FG001|Overall Study|Lost to Follow-up|0|||
162957443|NCT05152576|588545010|FG002|Overall Study|Lost to Follow-up|0|||
162957444|NCT05152576|588545011|FG003|Overall Study|Lost to Follow-up|1|||
162957445|NCT05152576|588545008|FG000|Overall Study|Withdrawal by Subject|0|||
162957446|NCT05152576|588545009|FG001|Overall Study|Withdrawal by Subject|1|||
162957447|NCT05152576|588545010|FG002|Overall Study|Withdrawal by Subject|0|||
162957448|NCT05152576|588545011|FG003|Overall Study|Withdrawal by Subject|1|||
162957449|NCT05152576|588545008|FG000|Overall Study|Other|2|||
162957450|NCT05152576|588545009|FG001|Overall Study|Other|0|||
162957451|NCT05152576|588545010|FG002|Overall Study|Other|0|||
162957452|NCT05152576|588545011|FG003|Overall Study|Other|0|||
162957453|NCT00859430|588545012|FG000|First Intervention|Withdrawal by Subject|0|||
162957454|NCT00859430|588545013|FG001|First Intervention|Withdrawal by Subject|1|||
162957455|NCT02286739|588546447|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
162957456|NCT02286739|588546448|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
162957457|NCT02286739|588546447|FG000|Overall Study|No Verasense type documented|0|||
162957458|NCT02286739|588546448|FG001|Overall Study|No Verasense type documented|23|||
162957459|NCT02286739|588546447|FG000|Overall Study|Adverse Event|1|||
162957460|NCT02286739|588546448|FG001|Overall Study|Adverse Event|2|||
162957461|NCT02286739|588546447|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
162957462|NCT02286739|588546448|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
162957463|NCT00834795|588546449|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
162957464|NCT00834795|588546450|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
162957465|NCT00834795|588546449|FG000|Second Intervention|Adverse Event|1|||
162957466|NCT00834795|588546450|FG001|Second Intervention|Adverse Event|0|||
162957467|NCT02718326|588546458|FG000|Overall Study|Adverse Event|4|||
162957468|NCT02718326|588546459|FG001|Overall Study|Adverse Event|9|||
162957469|NCT02718326|588546460|FG002|Overall Study|Adverse Event|0|||
162957470|NCT02718326|588546458|FG000|Overall Study|Death|8|||
162957471|NCT02718326|588546459|FG001|Overall Study|Death|1|||
162957472|NCT02718326|588546460|FG002|Overall Study|Death|2|||
162957473|NCT02718326|588546458|FG000|Overall Study|Withdrawal by Subject|4|||
162957474|NCT02718326|588546459|FG001|Overall Study|Withdrawal by Subject|9|||
162957475|NCT02718326|588546460|FG002|Overall Study|Withdrawal by Subject|6|||
162957476|NCT02718326|588546458|FG000|Overall Study|Lost to Follow-up|18|||
162957477|NCT02718326|588546459|FG001|Overall Study|Lost to Follow-up|5|||
162957478|NCT02718326|588546460|FG002|Overall Study|Lost to Follow-up|14|||
162957479|NCT02718326|588546458|FG000|Overall Study|Protocol Deviation|1|||
163045455|NCT01237327|588873254|FG000|Overall Study|Withdrawal by Subject|1|||
163045456|NCT01237327|588873255|FG001|Overall Study|Withdrawal by Subject|3|||
163045457|NCT01237327|588873254|FG000|Overall Study|Lost to Follow-up|3|||
163045458|NCT01237327|588873255|FG001|Overall Study|Lost to Follow-up|0|||
163045459|NCT02557516|588873256|FG000|Overall Study|Adverse Event|1|||
163045460|NCT02557516|588873257|FG001|Overall Study|Adverse Event|0|||
163045461|NCT02557516|588873258|FG002|Overall Study|Adverse Event|2|||
163045462|NCT02557516|588873259|FG003|Overall Study|Adverse Event|1|||
163045463|NCT02557516|588873256|FG000|Overall Study|Disease progression|0|||
163045464|NCT02557516|588873257|FG001|Overall Study|Disease progression|2|||
163045465|NCT02557516|588873258|FG002|Overall Study|Disease progression|0|||
163045466|NCT02557516|588873259|FG003|Overall Study|Disease progression|0|||
163045467|NCT02557516|588873256|FG000|Overall Study|Physician Decision|0|||
163045468|NCT02557516|588873257|FG001|Overall Study|Physician Decision|2|||
163045469|NCT02557516|588873258|FG002|Overall Study|Physician Decision|0|||
163045470|NCT02557516|588873259|FG003|Overall Study|Physician Decision|0|||
163045471|NCT02557516|588873256|FG000|Overall Study|Sponsor decision|0|||
163045472|NCT02557516|588873257|FG001|Overall Study|Sponsor decision|1|||
163045473|NCT02557516|588873258|FG002|Overall Study|Sponsor decision|2|||
163045474|NCT02557516|588873259|FG003|Overall Study|Sponsor decision|8|||
163045475|NCT01919164|588874994|FG000|Overall Study|Adverse Event|6|||
163045476|NCT01919164|588874995|FG001|Overall Study|Adverse Event|4|||
163045477|NCT01919164|588874996|FG002|Overall Study|Adverse Event|9|||
163045478|NCT01919164|588874997|FG003|Overall Study|Adverse Event|3|||
163045479|NCT01919164|588874998|FG004|Overall Study|Adverse Event|2|||
163045480|NCT01919164|588874994|FG000|Overall Study|Lost to Follow-up|2|||
163045481|NCT01919164|588874995|FG001|Overall Study|Lost to Follow-up|2|||
163045482|NCT01919164|588874996|FG002|Overall Study|Lost to Follow-up|2|||
163045483|NCT01919164|588874997|FG003|Overall Study|Lost to Follow-up|0|||
163045484|NCT01919164|588874998|FG004|Overall Study|Lost to Follow-up|4|||
163045485|NCT01919164|588874994|FG000|Overall Study|Death|1|||
163195319|NCT01687998|589429811|FG000|Overall Study|Known to be Alive at Study End|54|||
163195320|NCT01687998|589429812|FG001|Overall Study|Known to be Alive at Study End|62|||
162957480|NCT02718326|588546459|FG001|Overall Study|Protocol Deviation|0|||
162957481|NCT02718326|588546460|FG002|Overall Study|Protocol Deviation|0|||
162957482|NCT02718326|588546458|FG000|Overall Study|Pregnancy|1|||
162957483|NCT02718326|588546459|FG001|Overall Study|Pregnancy|0|||
162957484|NCT02718326|588546460|FG002|Overall Study|Pregnancy|0|||
162957485|NCT06195579|588546461|FG000|Overall Study|Withdrawal by Subject|1|||
162957486|NCT03049748|588546464|FG000|Overall Study|Lost to Follow-up|1|||
162957487|NCT03049748|588546465|FG001|Overall Study|Lost to Follow-up|0|||
162957488|NCT03049748|588546464|FG000|Overall Study|Death|3|||
162957489|NCT03049748|588546465|FG001|Overall Study|Death|0|||
162957490|NCT03049748|588546464|FG000|Overall Study|Withdrawal by Subject|0|||
162957491|NCT03049748|588546465|FG001|Overall Study|Withdrawal by Subject|3|||
162957492|NCT03049748|588546464|FG000|Overall Study|Protocol Violation|0|||
162957493|NCT03049748|588546465|FG001|Overall Study|Protocol Violation|2|||
162957494|NCT03049748|588546464|FG000|Overall Study|Moved out of state (relocation)|0|||
162957495|NCT03049748|588546465|FG001|Overall Study|Moved out of state (relocation)|1|||
163045486|NCT01919164|588874995|FG001|Overall Study|Death|0|||
163045487|NCT01919164|588874996|FG002|Overall Study|Death|0|||
163195321|NCT01687998|589429811|FG000|Overall Study|Lost to Follow-up|9|||
163195322|NCT01687998|589429812|FG001|Overall Study|Lost to Follow-up|7|||
163195323|NCT00443261|589429815|FG000|Overall Study|Death|1|||
163195324|NCT01663532|589429816|FG000|Overall Study|Lost to Follow-up|9|||
163195325|NCT01663532|589429817|FG001|Overall Study|Lost to Follow-up|10|||
163045488|NCT01919164|588874997|FG003|Overall Study|Death|0|||
163045489|NCT01919164|588874998|FG004|Overall Study|Death|0|||
163195326|NCT01663532|589429816|FG000|Overall Study|Adverse Event|7|||
163195327|NCT01663532|589429817|FG001|Overall Study|Adverse Event|13|||
163195328|NCT01663532|589429816|FG000|Overall Study|Met Withdrawal Criteria|7|||
163195329|NCT01663532|589429817|FG001|Overall Study|Met Withdrawal Criteria|6|||
163195330|NCT01663532|589429816|FG000|Overall Study|Physician Decision|1|||
163195331|NCT01663532|589429817|FG001|Overall Study|Physician Decision|1|||
163195332|NCT01663532|589429816|FG000|Overall Study|Withdrawal by Subject|35|||
163195333|NCT01663532|589429817|FG001|Overall Study|Withdrawal by Subject|17|||
163195334|NCT01663532|589429816|FG000|Overall Study|Lack of Efficacy|15|||
163195335|NCT01663532|589429817|FG001|Overall Study|Lack of Efficacy|60|||
163195336|NCT01871532|589429823|FG000|Overall Study|Withdrawal by Subject|1|||
163195337|NCT01871532|589429824|FG001|Overall Study|Withdrawal by Subject|2|||
163195338|NCT00283400|589429825|FG000|Overall Study|Withdrawal by Subject|1|||
163195339|NCT00283400|589429826|FG001|Overall Study|Withdrawal by Subject|1|||
163195340|NCT00283400|589429827|FG002|Overall Study|Withdrawal by Subject|0|||
163195341|NCT00283400|589429828|FG003|Overall Study|Withdrawal by Subject|0|||
163195342|NCT00283400|589429825|FG000|Overall Study|Death|1|||
163195343|NCT00283400|589429826|FG001|Overall Study|Death|0|||
163195344|NCT00283400|589429827|FG002|Overall Study|Death|1|||
163195345|NCT00283400|589429828|FG003|Overall Study|Death|0|||
163195346|NCT00934089|589429832|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
163195347|NCT00934089|589429833|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
163045490|NCT01919164|588874994|FG000|Overall Study|Protocol Violation|6|||
163045491|NCT01919164|588874995|FG001|Overall Study|Protocol Violation|0|||
163045492|NCT01919164|588874996|FG002|Overall Study|Protocol Violation|3|||
163045493|NCT01919164|588874997|FG003|Overall Study|Protocol Violation|2|||
163045494|NCT01919164|588874998|FG004|Overall Study|Protocol Violation|2|||
163045495|NCT01919164|588874994|FG000|Overall Study|Disease progression|2|||
163045496|NCT01919164|588874995|FG001|Overall Study|Disease progression|2|||
163045497|NCT01919164|588874996|FG002|Overall Study|Disease progression|1|||
163045498|NCT01919164|588874997|FG003|Overall Study|Disease progression|2|||
163045499|NCT01919164|588874998|FG004|Overall Study|Disease progression|1|||
163045500|NCT01919164|588874994|FG000|Overall Study|Withdrew consent|13|||
163045501|NCT01919164|588874995|FG001|Overall Study|Withdrew consent|13|||
163045502|NCT01919164|588874996|FG002|Overall Study|Withdrew consent|14|||
163045503|NCT01919164|588874997|FG003|Overall Study|Withdrew consent|14|||
163045504|NCT01919164|588874998|FG004|Overall Study|Withdrew consent|9|||
163045505|NCT01919164|588874994|FG000|Overall Study|Other Un-specified|13|||
163045506|NCT01919164|588874995|FG001|Overall Study|Other Un-specified|9|||
163045507|NCT01919164|588874996|FG002|Overall Study|Other Un-specified|8|||
163045508|NCT01919164|588874997|FG003|Overall Study|Other Un-specified|7|||
163045509|NCT01919164|588874998|FG004|Overall Study|Other Un-specified|15|||
163045510|NCT01845597|588875002|FG000|Overall Study|Death|8|||
163045511|NCT01845597|588875002|FG000|Overall Study|Lost to Follow-up|22|||
163045512|NCT01957579|588875008|FG000|Overall Study|Withdrawal of concent|0|||
163045513|NCT01957579|588875009|FG001|Overall Study|Withdrawal of concent|1|||
163045514|NCT01957579|588875010|FG002|Overall Study|Withdrawal of concent|0|||
163045515|NCT01957579|588875011|FG003|Overall Study|Withdrawal of concent|0|||
163045516|NCT01957579|588875008|FG000|Overall Study|Death|0|||
163045517|NCT01957579|588875009|FG001|Overall Study|Death|0|||
163045518|NCT01957579|588875010|FG002|Overall Study|Death|2|||
163045519|NCT01957579|588875011|FG003|Overall Study|Death|0|||
163045520|NCT02019550|588875012|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
163045521|NCT02019550|588875013|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
163045522|NCT02750332|588875014|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163045523|NCT02750332|588875015|FG001|Treatment Period 1|Withdrawal by Subject|1|||
163045524|NCT00956839|588875019|FG000|Overall Study|Lost to Follow-up|3|||
163045525|NCT00956839|588875020|FG001|Overall Study|Lost to Follow-up|0|||
163045526|NCT00956839|588875021|FG002|Overall Study|Lost to Follow-up|3|||
163045527|NCT04155463|588875022|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
163045528|NCT04155463|588875023|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
163045529|NCT00113295|588875026|FG000|Overall Study|Adverse Event|4|||
163045530|NCT00113295|588875027|FG001|Overall Study|Adverse Event|1|||
163045531|NCT00113295|588875026|FG000|Overall Study|Unrelated Medical Illness|1|||
163045532|NCT00113295|588875027|FG001|Overall Study|Unrelated Medical Illness|0|||
163045533|NCT02806713|588875028|FG000|Overall Study|Urethral injury during procedure|1|||
163045534|NCT02806713|588875029|FG001|Overall Study|Urethral injury during procedure|0|||
163045535|NCT02806713|588875028|FG000|Overall Study|cancelled surgery|1|||
163045536|NCT02806713|588875029|FG001|Overall Study|cancelled surgery|2|||
162957496|NCT01735994|588546466|FG000|Overall Study|Withdrawal by Subject|6|||
162957497|NCT01735994|588546467|FG001|Overall Study|Withdrawal by Subject|4|||
162957498|NCT01735994|588546466|FG000|Overall Study|Injury|2|||
162957499|NCT01735994|588546467|FG001|Overall Study|Injury|0|||
162957500|NCT01735994|588546466|FG000|Overall Study|Kicked off team|5|||
162957501|NCT01735994|588546467|FG001|Overall Study|Kicked off team|0|||
162957502|NCT01735994|588546466|FG000|Overall Study|Lost to Follow-up|50|||
163300988|NCT05137236|589809945|FG003|Part A|Withdrawal by Subject|1|||
162957503|NCT01735994|588546467|FG001|Overall Study|Lost to Follow-up|62|||
162957504|NCT03437265|588546484|FG000|Overall Study|Protocol Violation|6|||
162957505|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
162957506|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
162957507|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
162957508|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
162957509|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
162957510|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
162957511|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
162957512|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
162957513|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
162957514|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
162957515|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
162957516|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
162957517|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
162957518|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
162957519|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
162957520|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
162957521|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
162957522|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
162957523|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
162957524|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
162957525|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
162957526|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
162957527|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
162957528|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
162957529|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
162957530|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
162957531|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
162957532|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
162957533|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
162957534|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
162957535|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
162957536|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
162957537|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
162957538|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
162957539|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
162957540|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
162957541|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
162957542|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
162957543|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
162957544|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
162957545|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
162957546|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
162957547|NCT01175018|588546498|FG000|Overall Study|Adverse Event|3|||
162957548|NCT01175018|588546499|FG001|Overall Study|Adverse Event|1|||
162957549|NCT02911792|588546500|FG000|Overall Study|Lost to Follow-up|3|||
162957550|NCT02911792|588546501|FG001|Overall Study|Lost to Follow-up|3|||
162957551|NCT02911792|588546502|FG002|Overall Study|Lost to Follow-up|3|||
162957552|NCT02911792|588546503|FG003|Overall Study|Lost to Follow-up|3|||
162957553|NCT00840073|588546510|FG000|Second Intervention|Missed 72 hour blood draw|1|||
162957554|NCT00840073|588546511|FG001|Second Intervention|Missed 72 hour blood draw|1|||
162957555|NCT01788423|588546513|FG000|Overall Study|See Comments in Completed (above)|0|||
162957556|NCT01788423|588546514|FG001|Overall Study|See Comments in Completed (above)|4|||
162957557|NCT01788423|588546515|FG002|Overall Study|See Comments in Completed (above)|5|||
162957558|NCT00835263|588546516|FG000|Second Intervention|Adverse Event|1|||
162957559|NCT00835263|588546517|FG001|Second Intervention|Adverse Event|0|||
162957560|NCT03249454|588546518|FG000|Overall Study|Withdrawal by Subject|0|||
162957561|NCT03249454|588546519|FG001|Overall Study|Withdrawal by Subject|0|||
162957562|NCT03249454|588546520|FG002|Overall Study|Withdrawal by Subject|0|||
162957563|NCT03249454|588546521|FG003|Overall Study|Withdrawal by Subject|0|||
162957564|NCT03249454|588546522|FG004|Overall Study|Withdrawal by Subject|0|||
163195348|NCT00934089|589429832|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
163195349|NCT00934089|589429833|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
163195350|NCT01020981|589429834|FG000|Overall Study|Did not return mailed survey|74|||
162957565|NCT03249454|588546523|FG005|Overall Study|Withdrawal by Subject|0|||
162957566|NCT03249454|588546524|FG006|Overall Study|Withdrawal by Subject|0|||
162957567|NCT03249454|588546525|FG007|Overall Study|Withdrawal by Subject|0|||
162957568|NCT03249454|588546526|FG008|Overall Study|Withdrawal by Subject|0|||
162957569|NCT03249454|588546527|FG009|Overall Study|Withdrawal by Subject|1|||
162957570|NCT03249454|588546528|FG010|Overall Study|Withdrawal by Subject|1|||
162957571|NCT03987191|588546531|FG000|Overall Study|COVID-19 related research disruption|0|||
162957572|NCT03987191|588546532|FG001|Overall Study|COVID-19 related research disruption|2|||
162957573|NCT01020474|588546533|FG000|Overall Study|Adverse Event|4|||
162957574|NCT01020474|588546534|FG001|Overall Study|Adverse Event|4|||
162957575|NCT01020474|588546533|FG000|Overall Study|Protocol Violation|0|||
162957576|NCT01020474|588546534|FG001|Overall Study|Protocol Violation|2|||
162957577|NCT01020474|588546533|FG000|Overall Study|Withdrawal by Subject|5|||
162957578|NCT01020474|588546534|FG001|Overall Study|Withdrawal by Subject|7|||
162957579|NCT01020474|588546533|FG000|Overall Study|Other Reasons|1|||
162957580|NCT01020474|588546534|FG001|Overall Study|Other Reasons|1|||
162957581|NCT01020474|588546533|FG000|Overall Study|Insufficient Clinical Response|0|||
162957582|NCT01020474|588546534|FG001|Overall Study|Insufficient Clinical Response|3|||
162957583|NCT00107991|588546535|FG000|Eligibility Assessment|Disease not severe enough|7|||
162957584|NCT00107991|588546535|FG000|Eligibility Assessment|Unwilling to participate|7|||
162957585|NCT00107991|588546535|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
162957586|NCT00107991|588546535|FG000|Eligibility Assessment|Abnormal labs|2|||
162957587|NCT00107991|588546535|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
162957588|NCT00107991|588546535|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
162957589|NCT00107991|588546535|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
162957590|NCT00107991|588546535|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
162957591|NCT00107991|588546535|FG000|12 Week Treatment Period|Adverse Event|1|||
162957592|NCT00107991|588546535|FG000|12 Week Treatment Period|Protocol Violation|1|||
162957593|NCT00107991|588546535|FG000|12 Week Treatment Period|Incarcerated|1|||
162957594|NCT00107991|588546535|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
162957595|NCT03669861|588546536|FG000|Overall Study|Disease Flare|5|||
162957596|NCT03669861|588546536|FG000|Overall Study|Lack of Efficacy|2|||
162957597|NCT02760927|588546537|FG000|Overall Study|Tube Slippage from Device|1|||
162957598|NCT03256695|588546539|FG000|Overall Study|Adverse Event|8|||
162957599|NCT03256695|588546539|FG000|Overall Study|Death|2|||
162957600|NCT03256695|588546539|FG000|Overall Study|Withdrawal by Subject|14|||
162957601|NCT03256695|588546539|FG000|Overall Study|Non-compliance with study drug|1|||
162957602|NCT03256695|588546539|FG000|Overall Study|Lost to Follow-up|3|||
162957603|NCT03256695|588546539|FG000|Overall Study|Lack of Efficacy|3|||
162957604|NCT03256695|588546539|FG000|Overall Study|Protocol Violation|5|||
162957605|NCT03256695|588546539|FG000|Overall Study|Other than specified|3|||
163045537|NCT02824224|588875030|FG000|Overall Study|Discontinued, IUS expulsion|0|||
163045538|NCT02824224|588875031|FG001|Overall Study|Discontinued, IUS expulsion|1|||
163045539|NCT02824224|588875030|FG000|Overall Study|Did not show up for allocation visit|2|||
163045540|NCT02824224|588875031|FG001|Overall Study|Did not show up for allocation visit|0|||
163045541|NCT04878055|588875038|FG000|Overall Study|Patient transferred in another department|0|||
163045542|NCT04878055|588875039|FG001|Overall Study|Patient transferred in another department|2|||
163045543|NCT04878055|588875038|FG000|Overall Study|Physician Decision|1|||
163045544|NCT04878055|588875039|FG001|Overall Study|Physician Decision|1|||
163045545|NCT04878055|588875038|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
163045546|NCT04878055|588875039|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
163045547|NCT04878055|588875038|FG000|Overall Study|Adverse Event|12|||
163045548|NCT04878055|588875039|FG001|Overall Study|Adverse Event|7|||
163045549|NCT04878055|588875038|FG000|Overall Study|Other|5|||
163045550|NCT04878055|588875039|FG001|Overall Study|Other|0|||
163045551|NCT04878055|588875038|FG000|Overall Study|Withdrawal by Subject|7|||
163045552|NCT04878055|588875039|FG001|Overall Study|Withdrawal by Subject|3|||
163045553|NCT04878055|588875038|FG000|Overall Study|Lost to Follow-up|10|||
163045554|NCT04878055|588875039|FG001|Overall Study|Lost to Follow-up|1|||
163045555|NCT01968811|588875040|FG000|Overall Study|Protocol Violation|4|||
163045556|NCT01968811|588875040|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
163045557|NCT01178125|588875042|FG000|Overall Study|Lost to Follow-up|397|||
163045558|NCT01178125|588875042|FG000|Overall Study|Adverse Event|244|||
163045559|NCT01178125|588875042|FG000|Overall Study|Withdrawal by Subject|209|||
163045560|NCT01178125|588875042|FG000|Overall Study|Noncompliance|184|||
163045561|NCT01178125|588875042|FG000|Overall Study|Pregnancy|55|||
163045562|NCT01178125|588875042|FG000|Overall Study|Other Reason|39|||
163045563|NCT01178125|588875042|FG000|Overall Study|Sponsor Decision|28|||
163045564|NCT01178125|588875042|FG000|Overall Study|Protocol Violation|17|||
163045565|NCT01178125|588875042|FG000|Overall Study|Investigator Decision|5|||
163045566|NCT01004978|588875043|FG000|Overall Study|Disease progression|31|||
163045567|NCT01004978|588875044|FG001|Overall Study|Disease progression|48|||
163045568|NCT01004978|588875043|FG000|Overall Study|Adverse Event|42|||
163045569|NCT01004978|588875044|FG001|Overall Study|Adverse Event|22|||
163045570|NCT01004978|588875043|FG000|Overall Study|Death|3|||
163045571|NCT01004978|588875044|FG001|Overall Study|Death|2|||
163045572|NCT01004978|588875043|FG000|Overall Study|Withdrawal by Subject|16|||
163045573|NCT01004978|588875044|FG001|Overall Study|Withdrawal by Subject|16|||
163045574|NCT01004978|588875043|FG000|Overall Study|Alternative therapy|4|||
163045575|NCT01004978|588875044|FG001|Overall Study|Alternative therapy|8|||
163045576|NCT01004978|588875043|FG000|Overall Study|Physician Decision|6|||
163045577|NCT01004978|588875044|FG001|Overall Study|Physician Decision|3|||
163045578|NCT01004978|588875043|FG000|Overall Study|Other complicating disease|2|||
163045579|NCT01004978|588875044|FG001|Overall Study|Other complicating disease|2|||
163045580|NCT01004978|588875043|FG000|Overall Study|Protocol Violation|2|||
163045581|NCT01004978|588875044|FG001|Overall Study|Protocol Violation|3|||
163045582|NCT01004978|588875043|FG000|Overall Study|Non-compliance|3|||
163045583|NCT01004978|588875044|FG001|Overall Study|Non-compliance|2|||
163045584|NCT01004978|588875043|FG000|Overall Study|Ineligible|1|||
163045585|NCT01004978|588875044|FG001|Overall Study|Ineligible|0|||
163045586|NCT01004978|588875043|FG000|Overall Study|Unblinded|0|||
163045587|NCT01004978|588875044|FG001|Overall Study|Unblinded|1|||
163045588|NCT01004978|588875043|FG000|Overall Study|Performance status worsening|0|||
163045589|NCT01004978|588875044|FG001|Overall Study|Performance status worsening|1|||
163045590|NCT01004978|588875043|FG000|Overall Study|Never started treatment|8|||
163045591|NCT01004978|588875044|FG001|Overall Study|Never started treatment|9|||
163045592|NCT00369915|588875045|FG000|Overall Study|expected side effects|2|||
163045593|NCT00369915|588875046|FG001|Overall Study|expected side effects|1|||
163045594|NCT00369915|588875045|FG000|Overall Study|Withdrawal by Subject|4|||
163045595|NCT00369915|588875046|FG001|Overall Study|Withdrawal by Subject|1|||
163195351|NCT01020981|589429835|FG001|Overall Study|Did not return mailed survey|58|||
163045596|NCT00369915|588875045|FG000|Overall Study|W/drawl by investigators|0|||
163045597|NCT00369915|588875046|FG001|Overall Study|W/drawl by investigators|1|||
163045598|NCT00268983|588875056|FG000|Overall Study|Death|3|||
163045599|NCT00268983|588875057|FG001|Overall Study|Death|0|||
163045600|NCT01719380|588875058|FG000|Overall Study|Adverse Event|0|||
163045601|NCT01719380|588875059|FG001|Overall Study|Adverse Event|0|||
163045602|NCT01719380|588875060|FG002|Overall Study|Adverse Event|1|||
163045603|NCT01719380|588875061|FG003|Overall Study|Adverse Event|2|||
163045604|NCT01719380|588875062|FG004|Overall Study|Adverse Event|0|||
163045605|NCT01719380|588875063|FG005|Overall Study|Adverse Event|1|||
163045606|NCT01719380|588875064|FG006|Overall Study|Adverse Event|0|||
163045607|NCT01719380|588875065|FG007|Overall Study|Adverse Event|1|||
163045608|NCT01719380|588875066|FG008|Overall Study|Adverse Event|4|||
163195352|NCT01020981|589429834|FG000|Overall Study|Survey returned undeliverable|8|||
163045609|NCT01719380|588875067|FG009|Overall Study|Adverse Event|3|||
163045610|NCT01719380|588875058|FG000|Overall Study|Death|0|||
163045611|NCT01719380|588875059|FG001|Overall Study|Death|1|||
163045612|NCT01719380|588875060|FG002|Overall Study|Death|0|||
163045613|NCT01719380|588875061|FG003|Overall Study|Death|0|||
162957606|NCT02964039|588546545|FG000|Overall Study|Medical reason unrelated to study participation|1|||
162957607|NCT02964039|588546546|FG001|Overall Study|Medical reason unrelated to study participation|0|||
162957608|NCT02964039|588546547|FG002|Overall Study|Medical reason unrelated to study participation|3|||
162957609|NCT02964039|588546545|FG000|Overall Study|Research shutdown due to pandemic|2|||
162957610|NCT02964039|588546546|FG001|Overall Study|Research shutdown due to pandemic|0|||
162957611|NCT02964039|588546547|FG002|Overall Study|Research shutdown due to pandemic|1|||
162957612|NCT02964039|588546545|FG000|Overall Study|Withdrawal by Subject|0|||
162957613|NCT02964039|588546546|FG001|Overall Study|Withdrawal by Subject|1|||
162957614|NCT02964039|588546547|FG002|Overall Study|Withdrawal by Subject|0|||
162957615|NCT02964039|588546545|FG000|Overall Study|Lost to Follow-up|1|||
162957616|NCT02964039|588546546|FG001|Overall Study|Lost to Follow-up|0|||
162957617|NCT02964039|588546547|FG002|Overall Study|Lost to Follow-up|1|||
162957618|NCT01103713|588546548|FG000|Overall Study|Lost to Follow-up|2|||
162957619|NCT01103713|588546548|FG000|Overall Study|Withdrawal by Subject|8|||
162957620|NCT01103713|588546548|FG000|Overall Study|Study terminated by sponsor|2|||
162957621|NCT01103713|588546548|FG000|Overall Study|Other|1|||
162957622|NCT02089685|588546549|FG000|Overall Study|Adverse Event|1|||
162957623|NCT02089685|588546550|FG001|Overall Study|Adverse Event|0|||
162957624|NCT02089685|588546551|FG002|Overall Study|Adverse Event|0|||
162957625|NCT02089685|588546552|FG003|Overall Study|Adverse Event|0|||
162957626|NCT02089685|588546553|FG004|Overall Study|Adverse Event|1|||
162957627|NCT02089685|588546554|FG005|Overall Study|Adverse Event|0|||
162957628|NCT02089685|588546549|FG000|Overall Study|Clinical Progression|4|||
162957629|NCT02089685|588546550|FG001|Overall Study|Clinical Progression|0|||
162957630|NCT02089685|588546551|FG002|Overall Study|Clinical Progression|0|||
162957631|NCT02089685|588546552|FG003|Overall Study|Clinical Progression|5|||
162957632|NCT02089685|588546553|FG004|Overall Study|Clinical Progression|1|||
162957633|NCT02089685|588546554|FG005|Overall Study|Clinical Progression|2|||
162957634|NCT02089685|588546549|FG000|Overall Study|Excluded Medication|1|||
162957635|NCT02089685|588546550|FG001|Overall Study|Excluded Medication|0|||
162957636|NCT02089685|588546551|FG002|Overall Study|Excluded Medication|0|||
162957637|NCT02089685|588546552|FG003|Overall Study|Excluded Medication|11|||
162957638|NCT02089685|588546553|FG004|Overall Study|Excluded Medication|2|||
162957639|NCT02089685|588546554|FG005|Overall Study|Excluded Medication|1|||
162957640|NCT02089685|588546549|FG000|Overall Study|Progressive disease|13|||
162957641|NCT02089685|588546550|FG001|Overall Study|Progressive disease|10|||
162957642|NCT02089685|588546551|FG002|Overall Study|Progressive disease|3|||
162957643|NCT02089685|588546552|FG003|Overall Study|Progressive disease|51|||
162957644|NCT02089685|588546553|FG004|Overall Study|Progressive disease|17|||
162957645|NCT02089685|588546554|FG005|Overall Study|Progressive disease|12|||
162957646|NCT02089685|588546549|FG000|Overall Study|Follow up ended by sponsor|2|||
162957647|NCT02089685|588546550|FG001|Overall Study|Follow up ended by sponsor|2|||
162957648|NCT02089685|588546551|FG002|Overall Study|Follow up ended by sponsor|0|||
162957649|NCT02089685|588546552|FG003|Overall Study|Follow up ended by sponsor|70|||
162957650|NCT02089685|588546553|FG004|Overall Study|Follow up ended by sponsor|26|||
162957651|NCT02089685|588546554|FG005|Overall Study|Follow up ended by sponsor|26|||
162957652|NCT02089685|588546549|FG000|Overall Study|Withdrawal by Subject|0|||
162957653|NCT02089685|588546550|FG001|Overall Study|Withdrawal by Subject|2|||
162957654|NCT02089685|588546551|FG002|Overall Study|Withdrawal by Subject|0|||
162957655|NCT02089685|588546552|FG003|Overall Study|Withdrawal by Subject|8|||
162957656|NCT02089685|588546553|FG004|Overall Study|Withdrawal by Subject|1|||
162957657|NCT02089685|588546554|FG005|Overall Study|Withdrawal by Subject|1|||
162957658|NCT02089685|588546549|FG000|Overall Study|Status not recorded|1|||
162957659|NCT02089685|588546550|FG001|Overall Study|Status not recorded|0|||
162957660|NCT02089685|588546551|FG002|Overall Study|Status not recorded|0|||
162957661|NCT02089685|588546552|FG003|Overall Study|Status not recorded|0|||
162957662|NCT02089685|588546553|FG004|Overall Study|Status not recorded|1|||
162957663|NCT02089685|588546554|FG005|Overall Study|Status not recorded|0|||
162957664|NCT02089685|588546549|FG000|Overall Study|Death|0|||
162957665|NCT02089685|588546550|FG001|Overall Study|Death|0|||
162957666|NCT02089685|588546551|FG002|Overall Study|Death|0|||
163195353|NCT01020981|589429835|FG001|Overall Study|Survey returned undeliverable|32|||
162957667|NCT02089685|588546552|FG003|Overall Study|Death|7|||
162957668|NCT02089685|588546553|FG004|Overall Study|Death|2|||
163195354|NCT01020981|589429834|FG000|Overall Study|Participant declined to complete survey|2|||
163195355|NCT01020981|589429835|FG001|Overall Study|Participant declined to complete survey|0|||
162957669|NCT02089685|588546554|FG005|Overall Study|Death|5|||
162957670|NCT02089685|588546549|FG000|Overall Study|Lost to Follow-up|0|||
162957671|NCT02089685|588546550|FG001|Overall Study|Lost to Follow-up|0|||
162957672|NCT02089685|588546551|FG002|Overall Study|Lost to Follow-up|0|||
162957673|NCT02089685|588546552|FG003|Overall Study|Lost to Follow-up|1|||
162957674|NCT02089685|588546553|FG004|Overall Study|Lost to Follow-up|0|||
162957675|NCT02089685|588546554|FG005|Overall Study|Lost to Follow-up|0|||
162957676|NCT02089685|588546549|FG000|Overall Study|Physician Decision|0|||
162957677|NCT02089685|588546550|FG001|Overall Study|Physician Decision|0|||
163045614|NCT01719380|588875062|FG004|Overall Study|Death|0|||
162957678|NCT02089685|588546551|FG002|Overall Study|Physician Decision|0|||
162957679|NCT02089685|588546552|FG003|Overall Study|Physician Decision|0|||
162957680|NCT02089685|588546553|FG004|Overall Study|Physician Decision|0|||
162957681|NCT02089685|588546554|FG005|Overall Study|Physician Decision|4|||
162957682|NCT02089685|588546549|FG000|Overall Study|Screen failure|1|||
162957683|NCT02089685|588546550|FG001|Overall Study|Screen failure|0|||
162957684|NCT02089685|588546551|FG002|Overall Study|Screen failure|0|||
162957685|NCT02089685|588546552|FG003|Overall Study|Screen failure|0|||
162957686|NCT02089685|588546553|FG004|Overall Study|Screen failure|0|||
162957687|NCT02089685|588546554|FG005|Overall Study|Screen failure|0|||
162957688|NCT04887415|588546557|FG000|Overall Study|Lost to Follow-up|2|||
162957689|NCT00840411|588546558|FG000|First Intervention|Adverse Event|1|||
162957690|NCT00840411|588546559|FG001|First Intervention|Adverse Event|0|||
162957691|NCT00840411|588546558|FG000|Washout|Withdrawal by Subject|1|||
162957692|NCT00840411|588546559|FG001|Washout|Withdrawal by Subject|0|||
162957693|NCT01576042|588546561|FG000|Overall Study|Physician Decision|2|||
162957694|NCT01576042|588546562|FG001|Overall Study|Physician Decision|0|||
162957695|NCT03233724|588546563|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
162957696|NCT03233724|588546564|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
162957697|NCT03233724|588546565|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
162957698|NCT03233724|588546566|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
162957699|NCT03233724|588546567|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
162957700|NCT03233724|588546563|FG000|Phase I Dose Escalation|Best interest of participant|1|||
162957701|NCT03233724|588546564|FG001|Phase I Dose Escalation|Best interest of participant|1|||
162957702|NCT03233724|588546565|FG002|Phase I Dose Escalation|Best interest of participant|1|||
162957703|NCT03233724|588546566|FG003|Phase I Dose Escalation|Best interest of participant|0|||
162957704|NCT03233724|588546567|FG004|Phase I Dose Escalation|Best interest of participant|0|||
162957705|NCT03233724|588546563|FG000|Phase I Dose Escalation|Physician Decision|0|||
162957706|NCT03233724|588546564|FG001|Phase I Dose Escalation|Physician Decision|0|||
162957707|NCT03233724|588546565|FG002|Phase I Dose Escalation|Physician Decision|1|||
162957708|NCT03233724|588546566|FG003|Phase I Dose Escalation|Physician Decision|0|||
162957709|NCT03233724|588546567|FG004|Phase I Dose Escalation|Physician Decision|0|||
162957710|NCT03233724|588546563|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
162957711|NCT03233724|588546564|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
162957712|NCT03233724|588546565|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
162957713|NCT03233724|588546566|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
162957714|NCT03233724|588546567|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
162957715|NCT00651820|588546570|FG000|Overall Study|Lost to Follow-up|2|||
162957716|NCT01911676|588546571|FG000|Period 1 of Study|Withdrawal by Subject|4|||
162957717|NCT01911676|588546572|FG001|Period 1 of Study|Withdrawal by Subject|2|||
162957718|NCT01911676|588546573|FG002|Period 1 of Study|Withdrawal by Subject|1|||
162957719|NCT01911676|588546574|FG003|Period 1 of Study|Withdrawal by Subject|2|||
162957720|NCT01911676|588546571|FG000|Period 1 of Study|Physician Decision|2|||
162957721|NCT01911676|588546572|FG001|Period 1 of Study|Physician Decision|0|||
162957722|NCT01911676|588546573|FG002|Period 1 of Study|Physician Decision|0|||
162957723|NCT01911676|588546574|FG003|Period 1 of Study|Physician Decision|1|||
162957724|NCT01911676|588546571|FG000|Period 2 of Study|Physician Decision|2|||
162957725|NCT01911676|588546572|FG001|Period 2 of Study|Physician Decision|0|||
162957726|NCT01911676|588546573|FG002|Period 2 of Study|Physician Decision|0|||
162957727|NCT01911676|588546574|FG003|Period 2 of Study|Physician Decision|1|||
162957728|NCT01911676|588546571|FG000|Period 2 of Study|Lost to Follow-up|0|||
162957729|NCT01911676|588546572|FG001|Period 2 of Study|Lost to Follow-up|0|||
162957730|NCT01911676|588546573|FG002|Period 2 of Study|Lost to Follow-up|0|||
162957731|NCT01911676|588546574|FG003|Period 2 of Study|Lost to Follow-up|1|||
162957732|NCT00773253|588546577|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
162957733|NCT00773253|588546578|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
162957734|NCT00657553|588546580|FG000|Overall Study|low accrual, no analysis run|5|||
162957735|NCT00657553|588546581|FG001|Overall Study|low accrual, no analysis run|5|||
162957736|NCT03173547|588546582|FG000|Overall Study|Adverse Event|2|||
162957737|NCT03173547|588546583|FG001|Overall Study|Adverse Event|0|||
162957738|NCT03173547|588546582|FG000|Overall Study|Withdrawal by Subject|2|||
162957739|NCT03173547|588546583|FG001|Overall Study|Withdrawal by Subject|2|||
162957740|NCT01566721|588546584|FG000|Treatment Period|Withdrawal by Subject|35|||
163045615|NCT01719380|588875063|FG005|Overall Study|Death|0|||
163195356|NCT00680017|589429839|FG000|Overall Study|Adverse Event|13|||
162957741|NCT01566721|588546585|FG001|Treatment Period|Withdrawal by Subject|9|||
162957742|NCT01566721|588546584|FG000|Treatment Period|Disease Progression/Recurrence|37|||
162957743|NCT01566721|588546585|FG001|Treatment Period|Disease Progression/Recurrence|13|||
162957744|NCT01566721|588546584|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
162957745|NCT01566721|588546585|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
162957746|NCT01566721|588546584|FG000|Treatment Period|Other|13|||
162957747|NCT01566721|588546585|FG001|Treatment Period|Other|2|||
162957748|NCT01566721|588546584|FG000|Treatment Period|Lack of Compliance|5|||
162957749|NCT01566721|588546585|FG001|Treatment Period|Lack of Compliance|1|||
162957750|NCT01566721|588546584|FG000|Treatment Period|Adverse Event|100|||
163045616|NCT01719380|588875064|FG006|Overall Study|Death|0|||
163045617|NCT01719380|588875065|FG007|Overall Study|Death|0|||
163045618|NCT01719380|588875066|FG008|Overall Study|Death|3|||
163045619|NCT01719380|588875067|FG009|Overall Study|Death|3|||
163045620|NCT01719380|588875058|FG000|Overall Study|Participant/Guardian Decision|0|||
163045621|NCT01719380|588875059|FG001|Overall Study|Participant/Guardian Decision|0|||
163045622|NCT01719380|588875060|FG002|Overall Study|Participant/Guardian Decision|1|||
163045623|NCT01719380|588875061|FG003|Overall Study|Participant/Guardian Decision|0|||
163045624|NCT01719380|588875062|FG004|Overall Study|Participant/Guardian Decision|0|||
163045625|NCT01719380|588875063|FG005|Overall Study|Participant/Guardian Decision|0|||
163045626|NCT01719380|588875064|FG006|Overall Study|Participant/Guardian Decision|0|||
163045627|NCT01719380|588875065|FG007|Overall Study|Participant/Guardian Decision|0|||
163045628|NCT01719380|588875066|FG008|Overall Study|Participant/Guardian Decision|2|||
163045629|NCT01719380|588875067|FG009|Overall Study|Participant/Guardian Decision|2|||
163300989|NCT05137236|589809946|FG004|Part A|Withdrawal by Subject|3|||
163300990|NCT05137236|589809947|FG005|Part A|Withdrawal by Subject|2|||
163300991|NCT05137236|589809948|FG006|Part A|Withdrawal by Subject|0|||
163300992|NCT05137236|589809949|FG007|Part A|Withdrawal by Subject|0|||
163300993|NCT05137236|589809942|FG000|Part A|Lost to Follow-up|5|||
163300994|NCT05137236|589809943|FG001|Part A|Lost to Follow-up|7|||
163300995|NCT05137236|589809944|FG002|Part A|Lost to Follow-up|1|||
163300996|NCT05137236|589809945|FG003|Part A|Lost to Follow-up|3|||
163300997|NCT05137236|589809946|FG004|Part A|Lost to Follow-up|3|||
163300998|NCT05137236|589809947|FG005|Part A|Lost to Follow-up|8|||
163300999|NCT05137236|589809948|FG006|Part A|Lost to Follow-up|0|||
163301000|NCT05137236|589809949|FG007|Part A|Lost to Follow-up|0|||
163301001|NCT05137236|589809942|FG000|Part B|Withdrawal by Subject|0|||
163301002|NCT05137236|589809943|FG001|Part B|Withdrawal by Subject|0|||
163301003|NCT05137236|589809944|FG002|Part B|Withdrawal by Subject|0|||
163301004|NCT05137236|589809945|FG003|Part B|Withdrawal by Subject|0|||
163301005|NCT05137236|589809946|FG004|Part B|Withdrawal by Subject|0|||
163301006|NCT05137236|589809947|FG005|Part B|Withdrawal by Subject|0|||
163301007|NCT05137236|589809948|FG006|Part B|Withdrawal by Subject|0|||
163301008|NCT05137236|589809949|FG007|Part B|Withdrawal by Subject|2|||
163301009|NCT05137236|589809942|FG000|Part B|Lost to Follow-up|0|||
163301010|NCT05137236|589809943|FG001|Part B|Lost to Follow-up|0|||
163301011|NCT05137236|589809944|FG002|Part B|Lost to Follow-up|0|||
163301012|NCT05137236|589809945|FG003|Part B|Lost to Follow-up|0|||
163301013|NCT05137236|589809946|FG004|Part B|Lost to Follow-up|0|||
163301014|NCT05137236|589809947|FG005|Part B|Lost to Follow-up|0|||
163301015|NCT05137236|589809948|FG006|Part B|Lost to Follow-up|5|||
163301016|NCT05137236|589809949|FG007|Part B|Lost to Follow-up|5|||
163301017|NCT05137236|589809942|FG000|Part B|Death|0|||
163301018|NCT05137236|589809943|FG001|Part B|Death|0|||
163301019|NCT05137236|589809944|FG002|Part B|Death|0|||
163301020|NCT05137236|589809945|FG003|Part B|Death|0|||
163301021|NCT05137236|589809946|FG004|Part B|Death|0|||
163301022|NCT05137236|589809947|FG005|Part B|Death|0|||
163301023|NCT05137236|589809948|FG006|Part B|Death|0|||
163301024|NCT05137236|589809949|FG007|Part B|Death|2|||
163301025|NCT01534494|589809950|FG000|Overall Study|Withdrawal by Subject|1|||
163301026|NCT00802464|589809951|FG000|Month 0 - Month 8|Adverse Event|0|||
163301027|NCT00802464|589809952|FG001|Month 0 - Month 8|Adverse Event|1|||
163301028|NCT00802464|589809953|FG002|Month 0 - Month 8|Adverse Event|1|||
163301029|NCT00802464|589809954|FG003|Month 0 - Month 8|Adverse Event|2|||
163301030|NCT00802464|589809951|FG000|Month 0 - Month 8|Protocol Violation|0|||
163301031|NCT00802464|589809952|FG001|Month 0 - Month 8|Protocol Violation|0|||
163301032|NCT00802464|589809953|FG002|Month 0 - Month 8|Protocol Violation|1|||
163301033|NCT00802464|589809954|FG003|Month 0 - Month 8|Protocol Violation|0|||
163301034|NCT00802464|589809951|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
163301035|NCT00802464|589809952|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
163301036|NCT00802464|589809953|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
163301037|NCT00802464|589809954|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
163301038|NCT00802464|589809951|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
163301039|NCT00802464|589809952|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
163301040|NCT00802464|589809953|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
163301041|NCT00802464|589809954|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
163301042|NCT00802464|589809951|FG000|Month 0 - Month 8|Other|0|||
163301043|NCT00802464|589809952|FG001|Month 0 - Month 8|Other|0|||
163301044|NCT00802464|589809953|FG002|Month 0 - Month 8|Other|1|||
163301045|NCT00802464|589809954|FG003|Month 0 - Month 8|Other|0|||
163301046|NCT00802464|589809951|FG000|Month 8 - Month 14|Adverse Event|0|||
163301047|NCT00802464|589809952|FG001|Month 8 - Month 14|Adverse Event|1|||
163301048|NCT00802464|589809953|FG002|Month 8 - Month 14|Adverse Event|0|||
163301049|NCT00802464|589809954|FG003|Month 8 - Month 14|Adverse Event|0|||
163301050|NCT00802464|589809951|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
163301051|NCT00802464|589809952|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
163301052|NCT00802464|589809953|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
163301053|NCT00802464|589809954|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
163301054|NCT00802464|589809951|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
163301055|NCT00802464|589809952|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
162957751|NCT01566721|588546585|FG001|Treatment Period|Adverse Event|30|||
162957752|NCT01566721|588546584|FG000|Treatment Period|Pregnancy|1|||
162957753|NCT01566721|588546585|FG001|Treatment Period|Pregnancy|0|||
162957754|NCT01566721|588546584|FG000|Safety Follow-up|Physician Decision|6|||
162957755|NCT01566721|588546585|FG001|Safety Follow-up|Physician Decision|4|||
162957756|NCT01566721|588546584|FG000|Safety Follow-up|Lost to Follow-up|101|||
162957757|NCT01566721|588546585|FG001|Safety Follow-up|Lost to Follow-up|48|||
162957758|NCT01566721|588546584|FG000|Safety Follow-up|Withdrawal by Subject|155|||
162957759|NCT01566721|588546585|FG001|Safety Follow-up|Withdrawal by Subject|49|||
162957760|NCT01566721|588546584|FG000|Safety Follow-up|Death|28|||
162957761|NCT01566721|588546585|FG001|Safety Follow-up|Death|4|||
162957762|NCT01566721|588546584|FG000|Safety Follow-up|Non-compliance|7|||
162957763|NCT01566721|588546585|FG001|Safety Follow-up|Non-compliance|3|||
162957764|NCT01566721|588546584|FG000|Safety Follow-up|Protocol Violation|7|||
162957765|NCT01566721|588546585|FG001|Safety Follow-up|Protocol Violation|0|||
162957766|NCT01566721|588546584|FG000|Safety Follow-up|Site closure|2|||
162957767|NCT01566721|588546585|FG001|Safety Follow-up|Site closure|3|||
162957768|NCT01566721|588546584|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
162957769|NCT01566721|588546585|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
162957770|NCT01566721|588546584|FG000|Safety Follow-up|Missing|7|||
162957771|NCT01566721|588546585|FG001|Safety Follow-up|Missing|2|||
162957772|NCT01566721|588546584|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
162957773|NCT01566721|588546585|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
162957774|NCT01566721|588546584|FG000|Safety Follow-up|Sponsor decision|1|||
162957775|NCT01566721|588546585|FG001|Safety Follow-up|Sponsor decision|0|||
162957776|NCT01566721|588546584|FG000|Safety Follow-up|Adverse Event|8|||
162957777|NCT01566721|588546585|FG001|Safety Follow-up|Adverse Event|4|||
162957778|NCT00811655|588546591|FG000|Overall Study|Physician Decision|1|||
162957779|NCT00119015|588546593|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
162957780|NCT00119015|588546594|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
162957781|NCT00119015|588546595|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
162957782|NCT00787254|588546598|FG000|Overall Study|Adverse Event|24|||
162957783|NCT00787254|588546599|FG001|Overall Study|Adverse Event|23|||
162957784|NCT00787254|588546598|FG000|Overall Study|Protocol Violation|26|||
162957785|NCT00787254|588546599|FG001|Overall Study|Protocol Violation|23|||
162957786|NCT00787254|588546598|FG000|Overall Study|Withdrawal by Subject|16|||
163045630|NCT01719380|588875058|FG000|Overall Study|Physician Decision|0|||
163045631|NCT01719380|588875059|FG001|Overall Study|Physician Decision|0|||
163045632|NCT01719380|588875060|FG002|Overall Study|Physician Decision|2|||
163045633|NCT01719380|588875061|FG003|Overall Study|Physician Decision|0|||
163045634|NCT01719380|588875062|FG004|Overall Study|Physician Decision|0|||
163045635|NCT01719380|588875063|FG005|Overall Study|Physician Decision|0|||
163045636|NCT01719380|588875064|FG006|Overall Study|Physician Decision|0|||
163045637|NCT01719380|588875065|FG007|Overall Study|Physician Decision|0|||
163045638|NCT01719380|588875066|FG008|Overall Study|Physician Decision|1|||
163045639|NCT01719380|588875067|FG009|Overall Study|Physician Decision|1|||
163045640|NCT01719380|588875058|FG000|Overall Study|Lack of Efficacy|2|||
163045641|NCT01719380|588875059|FG001|Overall Study|Lack of Efficacy|6|||
163045642|NCT01719380|588875060|FG002|Overall Study|Lack of Efficacy|5|||
163045643|NCT01719380|588875061|FG003|Overall Study|Lack of Efficacy|6|||
163045644|NCT01719380|588875062|FG004|Overall Study|Lack of Efficacy|3|||
163045645|NCT01719380|588875063|FG005|Overall Study|Lack of Efficacy|7|||
163045646|NCT01719380|588875064|FG006|Overall Study|Lack of Efficacy|10|||
163045647|NCT01719380|588875065|FG007|Overall Study|Lack of Efficacy|6|||
163045648|NCT01719380|588875066|FG008|Overall Study|Lack of Efficacy|39|||
163045649|NCT01719380|588875067|FG009|Overall Study|Lack of Efficacy|42|||
163045650|NCT01719380|588875058|FG000|Overall Study|Progressive Disease|0|||
163045651|NCT01719380|588875059|FG001|Overall Study|Progressive Disease|0|||
163045652|NCT01719380|588875060|FG002|Overall Study|Progressive Disease|0|||
163045653|NCT01719380|588875061|FG003|Overall Study|Progressive Disease|0|||
163045654|NCT01719380|588875062|FG004|Overall Study|Progressive Disease|0|||
163045655|NCT01719380|588875063|FG005|Overall Study|Progressive Disease|0|||
163045656|NCT01719380|588875064|FG006|Overall Study|Progressive Disease|0|||
163045657|NCT01719380|588875065|FG007|Overall Study|Progressive Disease|0|||
163045658|NCT01719380|588875066|FG008|Overall Study|Progressive Disease|1|||
163045659|NCT01719380|588875067|FG009|Overall Study|Progressive Disease|0|||
163045660|NCT00249873|588875070|FG000|Overall Study|Not treated|7|||
163045661|NCT00249873|588875071|FG001|Overall Study|Not treated|8|||
163045662|NCT00249873|588875070|FG000|Overall Study|Significant thrombocytopenia|9|||
163045663|NCT00249873|588875071|FG001|Overall Study|Significant thrombocytopenia|8|||
163045664|NCT00249873|588875070|FG000|Overall Study|Severe allergic reaction|8|||
163045665|NCT00249873|588875071|FG001|Overall Study|Severe allergic reaction|1|||
163045666|NCT00249873|588875070|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
163045667|NCT00249873|588875071|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
163045668|NCT00249873|588875070|FG000|Overall Study|Other Serious Adverse Event|86|||
163045669|NCT00249873|588875071|FG001|Overall Study|Other Serious Adverse Event|97|||
163045670|NCT00249873|588875070|FG000|Overall Study|Qualifying condition not present|20|||
163045671|NCT00249873|588875071|FG001|Overall Study|Qualifying condition not present|23|||
163045672|NCT00249873|588875070|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
163045673|NCT00249873|588875071|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
163045674|NCT00249873|588875070|FG000|Overall Study|Withdrawal by Subject|504|||
163045675|NCT00249873|588875071|FG001|Overall Study|Withdrawal by Subject|466|||
163045676|NCT00249873|588875070|FG000|Overall Study|Lost to Follow-up|4|||
163045677|NCT00249873|588875071|FG001|Overall Study|Lost to Follow-up|7|||
163045678|NCT00249873|588875070|FG000|Overall Study|Minor bleeding|99|||
163045679|NCT00249873|588875071|FG001|Overall Study|Minor bleeding|37|||
163045680|NCT00249873|588875070|FG000|Overall Study|Non-compliance|41|||
163045681|NCT00249873|588875071|FG001|Overall Study|Non-compliance|46|||
163045682|NCT00249873|588875070|FG000|Overall Study|Other non serious Adverse Event|112|||
163045683|NCT00249873|588875071|FG001|Overall Study|Other non serious Adverse Event|108|||
163045684|NCT00249873|588875070|FG000|Overall Study|Other contraindicated medication|1|||
163045685|NCT00249873|588875071|FG001|Overall Study|Other contraindicated medication|0|||
163045686|NCT00249873|588875070|FG000|Overall Study|Patient not wish to continue after May08|3|||
163045687|NCT00249873|588875071|FG001|Overall Study|Patient not wish to continue after May08|4|||
163045688|NCT00249873|588875070|FG000|Overall Study|Physician withdrew consent|59|||
163045689|NCT00249873|588875071|FG001|Overall Study|Physician withdrew consent|60|||
163045690|NCT00249873|588875070|FG000|Overall Study|Open label clopidogrel required|31|||
163045691|NCT00249873|588875071|FG001|Overall Study|Open label clopidogrel required|42|||
163045692|NCT00249873|588875070|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
163045693|NCT00249873|588875071|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
163045694|NCT00249873|588875070|FG000|Overall Study|Oral anticoagulant required|159|||
163045695|NCT00249873|588875071|FG001|Overall Study|Oral anticoagulant required|157|||
163045696|NCT00249873|588875070|FG000|Overall Study|Study drug intolerance|5|||
163045697|NCT00249873|588875071|FG001|Overall Study|Study drug intolerance|0|||
163045698|NCT00249873|588875070|FG000|Overall Study|Surgery/ procedure|9|||
163045699|NCT00249873|588875071|FG001|Overall Study|Surgery/ procedure|9|||
163045700|NCT00249873|588875070|FG000|Overall Study|Event related to cardiac condition|12|||
163045701|NCT00249873|588875071|FG001|Overall Study|Event related to cardiac condition|21|||
163045702|NCT00249873|588875070|FG000|Overall Study|Thromboembolic/outcome event|82|||
163045703|NCT00249873|588875071|FG001|Overall Study|Thromboembolic/outcome event|122|||
163045704|NCT02532374|588875072|FG000|Overall Study|Withdrawal by Subject|1|||
163045705|NCT02532374|588875072|FG000|Overall Study|Physician Decision|1|||
162957787|NCT00787254|588546599|FG001|Overall Study|Withdrawal by Subject|11|||
163301056|NCT00802464|589809953|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
162957788|NCT00787254|588546598|FG000|Overall Study|Lack of Efficacy|4|||
163301057|NCT00802464|589809954|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
162957789|NCT00787254|588546599|FG001|Overall Study|Lack of Efficacy|15|||
162957790|NCT00787254|588546598|FG000|Overall Study|NSAIDs discontinuation|1|||
162957791|NCT00787254|588546599|FG001|Overall Study|NSAIDs discontinuation|2|||
162957792|NCT00787254|588546598|FG000|Overall Study|Institution closed|1|||
163394362|NCT01514136|590155778|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
163394363|NCT01514136|590155779|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
163394364|NCT01514136|590155780|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
163394365|NCT01514136|590155781|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
162957793|NCT00787254|588546599|FG001|Overall Study|Institution closed|0|||
163301058|NCT00402246|589809955|FG000|Overall Study|Death|62|||
163394366|NCT01514136|590155782|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
163394367|NCT01514136|590155783|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
163394368|NCT01514136|590155784|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
163394369|NCT01514136|590155785|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
163394370|NCT01514136|590155778|FG000|Test Period 2; Test A*|Adverse Event|0|||
163394371|NCT01514136|590155779|FG001|Test Period 2; Test A*|Adverse Event|0|||
163394372|NCT01514136|590155780|FG002|Test Period 2; Test A*|Adverse Event|0|||
163394373|NCT01514136|590155781|FG003|Test Period 2; Test A*|Adverse Event|0|||
163394374|NCT01514136|590155782|FG004|Test Period 2; Test A*|Adverse Event|1|||
163394375|NCT01514136|590155783|FG005|Test Period 2; Test A*|Adverse Event|0|||
163394376|NCT01514136|590155784|FG006|Test Period 2; Test A*|Adverse Event|0|||
163394377|NCT01514136|590155785|FG007|Test Period 2; Test A*|Adverse Event|0|||
163394378|NCT01514136|590155778|FG000|Test Period 2; Test A*|Holiday|0|||
163394379|NCT01514136|590155779|FG001|Test Period 2; Test A*|Holiday|0|||
163394380|NCT01514136|590155780|FG002|Test Period 2; Test A*|Holiday|0|||
163394381|NCT01514136|590155781|FG003|Test Period 2; Test A*|Holiday|0|||
163394382|NCT01514136|590155782|FG004|Test Period 2; Test A*|Holiday|1|||
163394383|NCT01514136|590155783|FG005|Test Period 2; Test A*|Holiday|0|||
163394384|NCT01514136|590155784|FG006|Test Period 2; Test A*|Holiday|0|||
163394385|NCT01514136|590155785|FG007|Test Period 2; Test A*|Holiday|0|||
163394386|NCT01514136|590155778|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
163394387|NCT01514136|590155779|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
163301059|NCT00402246|589809956|FG001|Overall Study|Death|58|||
163301060|NCT00402246|589809955|FG000|Overall Study|Lost to Follow-up|20|||
163301061|NCT00402246|589809956|FG001|Overall Study|Lost to Follow-up|28|||
163301062|NCT00402246|589809955|FG000|Overall Study|Withdrawal by Subject|72|||
163301063|NCT00402246|589809956|FG001|Overall Study|Withdrawal by Subject|87|||
163301064|NCT00402246|589809955|FG000|Overall Study|Physician Decision|24|||
163301065|NCT00402246|589809956|FG001|Overall Study|Physician Decision|26|||
163301066|NCT00402246|589809955|FG000|Overall Study|Protocol Violation|25|||
163301067|NCT00402246|589809956|FG001|Overall Study|Protocol Violation|24|||
163301068|NCT00402246|589809955|FG000|Overall Study|Missed Final Visit|1|||
163301069|NCT00402246|589809956|FG001|Overall Study|Missed Final Visit|2|||
163301070|NCT00402246|589809955|FG000|Overall Study|Insurance Issues|2|||
163301071|NCT00402246|589809956|FG001|Overall Study|Insurance Issues|1|||
163301072|NCT00402246|589809955|FG000|Overall Study|Heart Transplant|0|||
163301073|NCT00402246|589809956|FG001|Overall Study|Heart Transplant|1|||
163301074|NCT00402246|589809955|FG000|Overall Study|Patient's device explanted|6|||
163301075|NCT00402246|589809956|FG001|Overall Study|Patient's device explanted|2|||
163301076|NCT00402246|589809955|FG000|Overall Study|Center Closure|5|||
163301077|NCT00402246|589809956|FG001|Overall Study|Center Closure|3|||
163301078|NCT00402246|589809955|FG000|Overall Study|Deterioriating Condition|3|||
163301079|NCT00402246|589809956|FG001|Overall Study|Deterioriating Condition|2|||
163301080|NCT00431834|589809962|FG000|Overall Study|Withdrawal by Subject|7|||
163301081|NCT00431834|589809962|FG000|Overall Study|Death|3|||
163301082|NCT00431834|589809962|FG000|Overall Study|Missed Endpoint Visit|2|||
163301083|NCT00431834|589809962|FG000|Overall Study|Lost to Follow-up|1|||
163301084|NCT02622568|589809967|FG000|Overall Study|Lost to Follow-up|5|||
163301085|NCT02622568|589809968|FG001|Overall Study|Lost to Follow-up|5|||
163301086|NCT01939899|589809969|FG000|Lead-in Dose Finding Phase|Death|0|||
163301087|NCT01939899|589809970|FG001|Lead-in Dose Finding Phase|Death|3|||
163301088|NCT01939899|589809971|FG002|Lead-in Dose Finding Phase|Death|1|||
163301089|NCT01939899|589809972|FG003|Lead-in Dose Finding Phase|Death|0|||
163301090|NCT01939899|589809973|FG004|Lead-in Dose Finding Phase|Death|0|||
163301091|NCT01939899|589809969|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
163301092|NCT01939899|589809970|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
163301093|NCT01939899|589809971|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
163301094|NCT01939899|589809972|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
163301095|NCT01939899|589809973|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
163394388|NCT01514136|590155780|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
163394389|NCT01514136|590155781|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
162957794|NCT00787254|588546598|FG000|Overall Study|Physician Decision|4|||
162957795|NCT00787254|588546599|FG001|Overall Study|Physician Decision|8|||
162957796|NCT01952691|588548466|FG000|Overall Study|Lost to Follow-up|2|||
163301096|NCT01939899|589809969|FG000|Lead-in Dose Finding Phase|Other|0|||
163394390|NCT01514136|590155782|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
162957797|NCT05265624|588548467|FG000|Overall Study|Lost to Follow-up|3|||
162957798|NCT05265624|588548468|FG001|Overall Study|Lost to Follow-up|0|||
162957799|NCT05265624|588548467|FG000|Overall Study|Withdrawal by Subject|1|||
162957800|NCT05265624|588548468|FG001|Overall Study|Withdrawal by Subject|0|||
162957801|NCT00001703|588548469|FG000|Overall Study|progressed disease|2|||
162957802|NCT00001703|588548469|FG000|Overall Study|No evidence of disease|1|||
162957803|NCT00001703|588548469|FG000|Overall Study|recurrent disease|2|||
162957804|NCT00665925|588548471|FG000|Overall Study|Lack of Efficacy|10|||
162957805|NCT00665925|588548472|FG001|Overall Study|Lack of Efficacy|8|||
162957806|NCT00665925|588548473|FG002|Overall Study|Lack of Efficacy|9|||
162957807|NCT00665925|588548474|FG003|Overall Study|Lack of Efficacy|8|||
162957808|NCT00665925|588548471|FG000|Overall Study|Lost to Follow-up|1|||
162957809|NCT00665925|588548472|FG001|Overall Study|Lost to Follow-up|2|||
162957810|NCT00665925|588548473|FG002|Overall Study|Lost to Follow-up|2|||
162957811|NCT00665925|588548474|FG003|Overall Study|Lost to Follow-up|2|||
162957812|NCT00665925|588548471|FG000|Overall Study|Withdrawal by Subject|2|||
162957813|NCT00665925|588548472|FG001|Overall Study|Withdrawal by Subject|2|||
162957814|NCT00665925|588548473|FG002|Overall Study|Withdrawal by Subject|3|||
162957815|NCT00665925|588548474|FG003|Overall Study|Withdrawal by Subject|2|||
162957816|NCT00665925|588548471|FG000|Overall Study|Physician Decision|0|||
162957817|NCT00665925|588548472|FG001|Overall Study|Physician Decision|0|||
162957818|NCT00665925|588548473|FG002|Overall Study|Physician Decision|1|||
162957819|NCT00665925|588548474|FG003|Overall Study|Physician Decision|2|||
162957820|NCT00665925|588548471|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
162957821|NCT00665925|588548472|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
162957822|NCT00665925|588548473|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
162957823|NCT00665925|588548474|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
162957824|NCT00665925|588548471|FG000|Overall Study|Adverse Event|1|||
162957825|NCT00665925|588548472|FG001|Overall Study|Adverse Event|5|||
162957826|NCT00665925|588548473|FG002|Overall Study|Adverse Event|10|||
162957827|NCT00665925|588548474|FG003|Overall Study|Adverse Event|5|||
162957828|NCT00665925|588548471|FG000|Overall Study|Enrolled by mistake|0|||
162957829|NCT00665925|588548472|FG001|Overall Study|Enrolled by mistake|0|||
162957830|NCT00665925|588548473|FG002|Overall Study|Enrolled by mistake|0|||
162957831|NCT00665925|588548474|FG003|Overall Study|Enrolled by mistake|1|||
162957832|NCT00665925|588548471|FG000|Overall Study|Due to exclusion criteria|1|||
162957833|NCT00665925|588548472|FG001|Overall Study|Due to exclusion criteria|0|||
162957834|NCT00665925|588548473|FG002|Overall Study|Due to exclusion criteria|0|||
162957835|NCT00665925|588548474|FG003|Overall Study|Due to exclusion criteria|0|||
162957836|NCT04035187|588548477|FG000|Overall Study|Withdrawal by Subject|2|||
162957837|NCT04035187|588548478|FG001|Overall Study|Withdrawal by Subject|1|||
163394391|NCT01514136|590155783|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
163394392|NCT01514136|590155784|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
163394393|NCT01514136|590155785|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
163394394|NCT01514136|590155778|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
163394395|NCT01514136|590155779|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
163394396|NCT01514136|590155780|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
163394397|NCT01514136|590155781|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
163394398|NCT01514136|590155782|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
163394399|NCT01514136|590155783|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
163394400|NCT01514136|590155784|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
163394401|NCT01514136|590155785|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
163394402|NCT01514136|590155778|FG000|Test Period 2; Test C*|holiday|0|||
163394403|NCT01514136|590155779|FG001|Test Period 2; Test C*|holiday|0|||
163394404|NCT01514136|590155780|FG002|Test Period 2; Test C*|holiday|0|||
163394405|NCT01514136|590155781|FG003|Test Period 2; Test C*|holiday|0|||
163394406|NCT01514136|590155782|FG004|Test Period 2; Test C*|holiday|0|||
163394407|NCT01514136|590155783|FG005|Test Period 2; Test C*|holiday|0|||
163394408|NCT01514136|590155784|FG006|Test Period 2; Test C*|holiday|1|||
163394409|NCT01514136|590155785|FG007|Test Period 2; Test C*|holiday|0|||
163394410|NCT01514136|590155778|FG000|Test Period 2; Test C*|Protocol Violation|0|||
163394411|NCT01514136|590155779|FG001|Test Period 2; Test C*|Protocol Violation|0|||
163394412|NCT01514136|590155780|FG002|Test Period 2; Test C*|Protocol Violation|0|||
163394413|NCT01514136|590155781|FG003|Test Period 2; Test C*|Protocol Violation|0|||
163394414|NCT01514136|590155782|FG004|Test Period 2; Test C*|Protocol Violation|0|||
163394415|NCT01514136|590155783|FG005|Test Period 2; Test C*|Protocol Violation|0|||
163394416|NCT01514136|590155784|FG006|Test Period 2; Test C*|Protocol Violation|1|||
163394417|NCT01514136|590155785|FG007|Test Period 2; Test C*|Protocol Violation|0|||
163394418|NCT02729740|590155786|FG000|Overall Study|Early Termination|130|||
163394419|NCT02729740|590155786|FG000|Overall Study|Other|1|||
163394420|NCT00757003|590155790|FG000|Overall Study|Death|33|||
163394421|NCT00757003|590155790|FG000|Overall Study|Lost to Follow-up|9|||
163394422|NCT00757003|590155790|FG000|Overall Study|Withdrawal by Subject|4|||
163394423|NCT00757003|590155790|FG000|Overall Study|Surgically explanted|2|||
163394424|NCT00757003|590155790|FG000|Overall Study|Not implanted|1|||
163394425|NCT03044249|590155793|FG000|Overall Study|Adverse Event|4|||
163394426|NCT03044249|590155794|FG001|Overall Study|Adverse Event|9|||
163394427|NCT03044249|590155793|FG000|Overall Study|Lost to Follow-up|1|||
163394428|NCT03044249|590155794|FG001|Overall Study|Lost to Follow-up|0|||
163394429|NCT03044249|590155793|FG000|Overall Study|Non-compliance with Study Drug|1|||
163394430|NCT03044249|590155794|FG001|Overall Study|Non-compliance with Study Drug|0|||
163394431|NCT03044249|590155793|FG000|Overall Study|Study Terminated by Sponsor|2|||
163394432|NCT03044249|590155794|FG001|Overall Study|Study Terminated by Sponsor|0|||
163394433|NCT03044249|590155793|FG000|Overall Study|Withdrawal by Subject|2|||
163394434|NCT03044249|590155794|FG001|Overall Study|Withdrawal by Subject|5|||
163394435|NCT02301936|590155796|FG000|Overall Study|Lost to Follow-up|1|||
163394436|NCT02301936|590155797|FG001|Overall Study|Lost to Follow-up|0|||
163394437|NCT00601250|590155802|FG000|Overall Study|Adverse Event|3|||
163394438|NCT00601250|590155803|FG001|Overall Study|Adverse Event|9|||
163394439|NCT00601250|590155802|FG000|Overall Study|Protocol Violation|3|||
163394440|NCT00601250|590155803|FG001|Overall Study|Protocol Violation|2|||
163394441|NCT00601250|590155802|FG000|Overall Study|Lost to Follow-up|2|||
163394442|NCT00601250|590155803|FG001|Overall Study|Lost to Follow-up|6|||
163394443|NCT00601250|590155802|FG000|Overall Study|Withdrawal by Subject|4|||
163394444|NCT00601250|590155803|FG001|Overall Study|Withdrawal by Subject|13|||
163394445|NCT00601250|590155802|FG000|Overall Study|Other incl. lack of efficacy|2|||
163394446|NCT00601250|590155803|FG001|Overall Study|Other incl. lack of efficacy|9|||
162957838|NCT04035187|588548479|FG002|Overall Study|Withdrawal by Subject|0|||
162957839|NCT04035187|588548480|FG003|Overall Study|Withdrawal by Subject|0|||
162978991|NCT01660022|588623542|FG004|First Sequence (7 Days)|Protocol Violation|0|||
163394447|NCT01810016|590155804|FG000|Overall Study|Progressive disease|1|||
163394448|NCT01810016|590155805|FG001|Overall Study|Progressive disease|1|||
163394449|NCT01810016|590155806|FG002|Overall Study|Progressive disease|0|||
163394450|NCT01810016|590155804|FG000|Overall Study|Death|0|||
163394451|NCT01810016|590155805|FG001|Overall Study|Death|0|||
163394452|NCT01810016|590155806|FG002|Overall Study|Death|1|||
163394453|NCT04263896|590155808|FG000|Overall Study|Withdrawal by Subject|2|||
163394454|NCT04263896|590155809|FG001|Overall Study|Withdrawal by Subject|4|||
163394455|NCT04263896|590155808|FG000|Overall Study|converted to open procedure|0|||
163394456|NCT04263896|590155809|FG001|Overall Study|converted to open procedure|1|||
163394457|NCT04263896|590155808|FG000|Overall Study|Lost to Follow-up|9|||
163394458|NCT04263896|590155809|FG001|Overall Study|Lost to Follow-up|11|||
163045706|NCT02762084|588875073|FG000|Overall Study|Withdrawal by Subject|1|||
163045707|NCT02762084|588875074|FG001|Overall Study|Withdrawal by Subject|0|||
163045708|NCT02762084|588875075|FG002|Overall Study|Withdrawal by Subject|0|||
163045709|NCT02762084|588875073|FG000|Overall Study|Adverse Event|0|||
163045710|NCT02762084|588875074|FG001|Overall Study|Adverse Event|0|||
163045711|NCT02762084|588875075|FG002|Overall Study|Adverse Event|1|||
163045712|NCT02659943|588875076|FG000|Overall Study|Switched to alternative treatment|1|||
163045713|NCT02659943|588875077|FG001|Overall Study|Switched to alternative treatment|1|||
163045714|NCT02659943|588875078|FG002|Overall Study|Switched to alternative treatment|0|||
163045715|NCT02659943|588875079|FG003|Overall Study|Switched to alternative treatment|2|||
163045716|NCT02659943|588875080|FG004|Overall Study|Switched to alternative treatment|1|||
162957840|NCT04035187|588548477|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
162957841|NCT04035187|588548478|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
162957842|NCT04035187|588548479|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
162957843|NCT04035187|588548480|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
162957844|NCT02255149|588548493|FG000|Overall Study|Lost to Follow-up|2|||
162957845|NCT02255149|588548493|FG000|Overall Study|Withdrawal by Subject|1|||
162957846|NCT02255149|588548493|FG000|Overall Study|Withdrawal by PI|1|||
162957847|NCT02255149|588548493|FG000|Overall Study|Implant Failure|1|||
162957848|NCT00373256|588548494|FG000|Overall Study|Adverse Event (AE)|1|||
162957849|NCT00373256|588548495|FG001|Overall Study|Adverse Event (AE)|5|||
162957850|NCT00373256|588548494|FG000|Overall Study|Lost to Follow-up|2|||
162957851|NCT00373256|588548495|FG001|Overall Study|Lost to Follow-up|1|||
162957852|NCT00373256|588548494|FG000|Overall Study|Death|9|||
162957853|NCT00373256|588548495|FG001|Overall Study|Death|8|||
162957854|NCT00373256|588548494|FG000|Overall Study|Objective Progression or Relapse|111|||
162957855|NCT00373256|588548495|FG001|Overall Study|Objective Progression or Relapse|104|||
162957856|NCT00373256|588548494|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
162957857|NCT00373256|588548495|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
162957858|NCT00373256|588548494|FG000|Overall Study|Other|73|||
162957859|NCT00373256|588548495|FG001|Overall Study|Other|107|||
162957860|NCT00373256|588548494|FG000|Overall Study|Protocol Violation|0|||
162957861|NCT00373256|588548495|FG001|Overall Study|Protocol Violation|2|||
162957862|NCT00373256|588548494|FG000|Overall Study|Study Terminated by Sponsor|41|||
162957863|NCT00373256|588548495|FG001|Overall Study|Study Terminated by Sponsor|13|||
162957864|NCT03032172|588548498|FG000|Treatment Period|Adverse Event|0|||
162957865|NCT03032172|588548499|FG001|Treatment Period|Adverse Event|1|||
162957866|NCT03032172|588548500|FG002|Treatment Period|Adverse Event|0|||
162957867|NCT03032172|588548501|FG003|Treatment Period|Adverse Event|0|||
162957868|NCT03032172|588548502|FG004|Treatment Period|Adverse Event|0|||
162957869|NCT03032172|588548503|FG005|Treatment Period|Adverse Event|0|||
162957870|NCT03032172|588548504|FG006|Treatment Period|Adverse Event|0|||
162957871|NCT03032172|588548505|FG007|Treatment Period|Adverse Event|0|||
162957872|NCT03032172|588548498|FG000|Treatment Period|Lack of Efficacy|0|||
162957873|NCT03032172|588548499|FG001|Treatment Period|Lack of Efficacy|1|||
162957874|NCT03032172|588548500|FG002|Treatment Period|Lack of Efficacy|0|||
162957875|NCT03032172|588548501|FG003|Treatment Period|Lack of Efficacy|0|||
162957876|NCT03032172|588548502|FG004|Treatment Period|Lack of Efficacy|0|||
162957877|NCT03032172|588548503|FG005|Treatment Period|Lack of Efficacy|0|||
162957878|NCT03032172|588548504|FG006|Treatment Period|Lack of Efficacy|0|||
162957879|NCT03032172|588548505|FG007|Treatment Period|Lack of Efficacy|0|||
162957880|NCT03032172|588548498|FG000|Treatment Period|Non-compliance With Study Drug|0|||
162957881|NCT03032172|588548499|FG001|Treatment Period|Non-compliance With Study Drug|1|||
162957882|NCT03032172|588548500|FG002|Treatment Period|Non-compliance With Study Drug|0|||
162957883|NCT03032172|588548501|FG003|Treatment Period|Non-compliance With Study Drug|0|||
162957884|NCT03032172|588548502|FG004|Treatment Period|Non-compliance With Study Drug|0|||
162957885|NCT03032172|588548503|FG005|Treatment Period|Non-compliance With Study Drug|0|||
162957886|NCT03032172|588548504|FG006|Treatment Period|Non-compliance With Study Drug|0|||
162957887|NCT03032172|588548505|FG007|Treatment Period|Non-compliance With Study Drug|0|||
162957888|NCT03032172|588548498|FG000|Treatment Period|Reason Not Specified|0|||
162957889|NCT03032172|588548499|FG001|Treatment Period|Reason Not Specified|4|||
162957890|NCT03032172|588548500|FG002|Treatment Period|Reason Not Specified|1|||
162957891|NCT03032172|588548501|FG003|Treatment Period|Reason Not Specified|0|||
162957892|NCT03032172|588548502|FG004|Treatment Period|Reason Not Specified|0|||
162957893|NCT03032172|588548503|FG005|Treatment Period|Reason Not Specified|0|||
162957894|NCT03032172|588548504|FG006|Treatment Period|Reason Not Specified|0|||
162957895|NCT03032172|588548505|FG007|Treatment Period|Reason Not Specified|0|||
162957896|NCT03032172|588548498|FG000|Treatment Period|Physician Decision|0|||
162957897|NCT03032172|588548499|FG001|Treatment Period|Physician Decision|2|||
163045717|NCT02659943|588875081|FG005|Overall Study|Switched to alternative treatment|0|||
163045718|NCT02659943|588875082|FG006|Overall Study|Switched to alternative treatment|1|||
163301097|NCT01939899|589809970|FG001|Lead-in Dose Finding Phase|Other|0|||
163301098|NCT01939899|589809971|FG002|Lead-in Dose Finding Phase|Other|1|||
163301099|NCT01939899|589809972|FG003|Lead-in Dose Finding Phase|Other|0|||
162957898|NCT03032172|588548500|FG002|Treatment Period|Physician Decision|1|||
162957899|NCT03032172|588548501|FG003|Treatment Period|Physician Decision|0|||
162957900|NCT03032172|588548502|FG004|Treatment Period|Physician Decision|0|||
162957901|NCT03032172|588548503|FG005|Treatment Period|Physician Decision|0|||
162957902|NCT03032172|588548504|FG006|Treatment Period|Physician Decision|0|||
162957903|NCT03032172|588548505|FG007|Treatment Period|Physician Decision|0|||
162957904|NCT03032172|588548498|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
162957905|NCT03032172|588548499|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
162957906|NCT03032172|588548500|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
162957907|NCT03032172|588548501|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
162957908|NCT03032172|588548502|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
162957909|NCT03032172|588548503|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
162957910|NCT03032172|588548504|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
162957911|NCT03032172|588548505|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
162957912|NCT03032172|588548498|FG000|Treatment Period|Withdrawal by Subject|2|||
162957913|NCT03032172|588548499|FG001|Treatment Period|Withdrawal by Subject|0|||
162957914|NCT03032172|588548500|FG002|Treatment Period|Withdrawal by Subject|3|||
162957915|NCT03032172|588548501|FG003|Treatment Period|Withdrawal by Subject|0|||
162957916|NCT03032172|588548502|FG004|Treatment Period|Withdrawal by Subject|0|||
162957917|NCT03032172|588548503|FG005|Treatment Period|Withdrawal by Subject|0|||
162957918|NCT03032172|588548504|FG006|Treatment Period|Withdrawal by Subject|0|||
162957919|NCT03032172|588548505|FG007|Treatment Period|Withdrawal by Subject|0|||
162957920|NCT03032172|588548498|FG000|Open-label Extension Period|Death|0|||
162957921|NCT03032172|588548499|FG001|Open-label Extension Period|Death|0|||
162957922|NCT03032172|588548500|FG002|Open-label Extension Period|Death|0|||
162957923|NCT03032172|588548501|FG003|Open-label Extension Period|Death|0|||
162957924|NCT03032172|588548502|FG004|Open-label Extension Period|Death|0|||
162957925|NCT03032172|588548503|FG005|Open-label Extension Period|Death|0|||
162957926|NCT03032172|588548504|FG006|Open-label Extension Period|Death|0|||
162957927|NCT03032172|588548505|FG007|Open-label Extension Period|Death|2|||
162957928|NCT03032172|588548498|FG000|Open-label Extension Period|Reason Not Specified|0|||
162957929|NCT03032172|588548499|FG001|Open-label Extension Period|Reason Not Specified|0|||
162957930|NCT03032172|588548500|FG002|Open-label Extension Period|Reason Not Specified|0|||
162957931|NCT03032172|588548501|FG003|Open-label Extension Period|Reason Not Specified|0|||
162957932|NCT03032172|588548502|FG004|Open-label Extension Period|Reason Not Specified|0|||
162957933|NCT03032172|588548503|FG005|Open-label Extension Period|Reason Not Specified|5|||
163195357|NCT00680017|589429840|FG001|Overall Study|Adverse Event|7|||
163301100|NCT01939899|589809973|FG004|Lead-in Dose Finding Phase|Other|0|||
162957934|NCT03032172|588548504|FG006|Open-label Extension Period|Reason Not Specified|3|||
162957935|NCT03032172|588548505|FG007|Open-label Extension Period|Reason Not Specified|0|||
162957936|NCT03032172|588548498|FG000|Open-label Extension Period|Pregnancy|0|||
162957937|NCT03032172|588548499|FG001|Open-label Extension Period|Pregnancy|0|||
162957938|NCT03032172|588548500|FG002|Open-label Extension Period|Pregnancy|0|||
162957939|NCT03032172|588548501|FG003|Open-label Extension Period|Pregnancy|0|||
162957940|NCT03032172|588548502|FG004|Open-label Extension Period|Pregnancy|0|||
162957941|NCT03032172|588548503|FG005|Open-label Extension Period|Pregnancy|0|||
162957942|NCT03032172|588548504|FG006|Open-label Extension Period|Pregnancy|1|||
162957943|NCT03032172|588548505|FG007|Open-label Extension Period|Pregnancy|0|||
162957944|NCT03032172|588548498|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
162957945|NCT03032172|588548499|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
162957946|NCT03032172|588548500|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
162957947|NCT03032172|588548501|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
162957948|NCT03032172|588548502|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
162957949|NCT03032172|588548503|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
162957950|NCT03032172|588548504|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
162957951|NCT03032172|588548505|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
162957952|NCT06144424|588548510|FG000|Overall Study|Withdrawal by Subject|2|||
162957953|NCT06144424|588548511|FG001|Overall Study|Withdrawal by Subject|0|||
162957954|NCT06144424|588548510|FG000|Overall Study|Incarceration|1|||
162957955|NCT06144424|588548511|FG001|Overall Study|Incarceration|0|||
162957956|NCT00834522|588548512|FG000|Washout|Adverse Event|1|||
162957957|NCT00834522|588548513|FG001|Washout|Adverse Event|0|||
162957958|NCT00834522|588548512|FG000|Washout|Withdrawal by Subject|2|||
162957959|NCT00834522|588548513|FG001|Washout|Withdrawal by Subject|1|||
162957960|NCT03165994|588548514|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
162957961|NCT03165994|588548514|FG000|Overall Study|Death|2|||
162957962|NCT03165994|588548514|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
162957963|NCT03165994|588548514|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
162957964|NCT03165994|588548514|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
162957965|NCT03165994|588548514|FG000|Overall Study|Miscellaneous|1|||
162957966|NCT01111461|588548515|FG000|Overall Study|Adverse Event|32|||
162957967|NCT01111461|588548515|FG000|Overall Study|Participant choice|11|||
162957968|NCT01111461|588548515|FG000|Overall Study|Lost to Follow-up|1|||
162957969|NCT01111461|588548515|FG000|Overall Study|Withdrawal by Subject|1|||
162957970|NCT01111461|588548515|FG000|Overall Study|Other|6|||
162957971|NCT03600805|588548528|FG000|Overall Study|Adverse Event|2|||
162957972|NCT03600805|588548529|FG001|Overall Study|Adverse Event|1|||
162957973|NCT03600805|588548530|FG002|Overall Study|Adverse Event|1|||
162957974|NCT03600805|588548531|FG003|Overall Study|Adverse Event|7|||
162957975|NCT03600805|588548528|FG000|Overall Study|Lack of Efficacy|2|||
162957976|NCT03600805|588548529|FG001|Overall Study|Lack of Efficacy|1|||
162957977|NCT03600805|588548530|FG002|Overall Study|Lack of Efficacy|0|||
162957978|NCT03600805|588548531|FG003|Overall Study|Lack of Efficacy|0|||
162957979|NCT03600805|588548528|FG000|Overall Study|Withdrawal by Subject|1|||
162957980|NCT03600805|588548529|FG001|Overall Study|Withdrawal by Subject|0|||
162957981|NCT03600805|588548530|FG002|Overall Study|Withdrawal by Subject|0|||
162957982|NCT03600805|588548531|FG003|Overall Study|Withdrawal by Subject|1|||
162957983|NCT03600805|588548528|FG000|Overall Study|Other unspecified|14|||
162957984|NCT03600805|588548529|FG001|Overall Study|Other unspecified|6|||
162957985|NCT03600805|588548530|FG002|Overall Study|Other unspecified|7|||
162957986|NCT03600805|588548531|FG003|Overall Study|Other unspecified|11|||
162957987|NCT00804856|588548536|FG000|Overall Study|Progressive Disease|3|||
162957988|NCT00804856|588548537|FG001|Overall Study|Progressive Disease|2|||
162957989|NCT00804856|588548538|FG002|Overall Study|Progressive Disease|4|||
162957990|NCT00804856|588548539|FG003|Overall Study|Progressive Disease|6|||
162957991|NCT00804856|588548540|FG004|Overall Study|Progressive Disease|4|||
162957992|NCT00804856|588548541|FG005|Overall Study|Progressive Disease|1|||
162957993|NCT00804856|588548542|FG006|Overall Study|Progressive Disease|8|||
162957994|NCT00804856|588548543|FG007|Overall Study|Progressive Disease|2|||
162957995|NCT00804856|588548544|FG008|Overall Study|Progressive Disease|4|||
162957996|NCT00804856|588548545|FG009|Overall Study|Progressive Disease|5|||
162957997|NCT00804856|588548546|FG010|Overall Study|Progressive Disease|12|||
162957998|NCT00804856|588548547|FG011|Overall Study|Progressive Disease|2|||
162957999|NCT00804856|588548548|FG012|Overall Study|Progressive Disease|2|||
162958000|NCT00804856|588548549|FG013|Overall Study|Progressive Disease|26|||
162958001|NCT00804856|588548550|FG014|Overall Study|Progressive Disease|20|||
162958002|NCT00804856|588548536|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958003|NCT00804856|588548537|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958004|NCT00804856|588548538|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958005|NCT00804856|588548539|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958006|NCT00804856|588548540|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
162958007|NCT00804856|588548541|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958008|NCT00804856|588548542|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958009|NCT00804856|588548543|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958010|NCT00804856|588548544|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958011|NCT00804856|588548545|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958012|NCT00804856|588548546|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958013|NCT00804856|588548547|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958014|NCT00804856|588548548|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958015|NCT00804856|588548549|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958016|NCT00804856|588548550|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
162958017|NCT00804856|588548536|FG000|Overall Study|Other Adverse Event|1|||
162958018|NCT00804856|588548537|FG001|Overall Study|Other Adverse Event|1|||
162958019|NCT00804856|588548538|FG002|Overall Study|Other Adverse Event|1|||
162958020|NCT00804856|588548539|FG003|Overall Study|Other Adverse Event|2|||
163195358|NCT00680017|589429839|FG000|Overall Study|Withdrawal by Subject|2|||
163195359|NCT00680017|589429840|FG001|Overall Study|Withdrawal by Subject|5|||
163195360|NCT00680017|589429839|FG000|Overall Study|Lost to Follow-up|2|||
162958021|NCT00804856|588548540|FG004|Overall Study|Other Adverse Event|2|||
162958022|NCT00804856|588548541|FG005|Overall Study|Other Adverse Event|1|||
162958023|NCT00804856|588548542|FG006|Overall Study|Other Adverse Event|3|||
162958024|NCT00804856|588548543|FG007|Overall Study|Other Adverse Event|0|||
162958025|NCT00804856|588548544|FG008|Overall Study|Other Adverse Event|0|||
162958026|NCT00804856|588548545|FG009|Overall Study|Other Adverse Event|1|||
162958027|NCT00804856|588548546|FG010|Overall Study|Other Adverse Event|5|||
162958028|NCT00804856|588548547|FG011|Overall Study|Other Adverse Event|2|||
162958029|NCT00804856|588548548|FG012|Overall Study|Other Adverse Event|0|||
162958030|NCT00804856|588548549|FG013|Overall Study|Other Adverse Event|6|||
162958031|NCT00804856|588548550|FG014|Overall Study|Other Adverse Event|13|||
162958032|NCT00804856|588548536|FG000|Overall Study|Non compliance with protocol|0|||
162958033|NCT00804856|588548537|FG001|Overall Study|Non compliance with protocol|0|||
162958034|NCT00804856|588548538|FG002|Overall Study|Non compliance with protocol|0|||
162958035|NCT00804856|588548539|FG003|Overall Study|Non compliance with protocol|0|||
162958036|NCT00804856|588548540|FG004|Overall Study|Non compliance with protocol|0|||
162958037|NCT00804856|588548541|FG005|Overall Study|Non compliance with protocol|0|||
162958038|NCT00804856|588548542|FG006|Overall Study|Non compliance with protocol|0|||
162958039|NCT00804856|588548543|FG007|Overall Study|Non compliance with protocol|0|||
162958040|NCT00804856|588548544|FG008|Overall Study|Non compliance with protocol|0|||
162958041|NCT00804856|588548545|FG009|Overall Study|Non compliance with protocol|0|||
162958042|NCT00804856|588548546|FG010|Overall Study|Non compliance with protocol|0|||
162958043|NCT00804856|588548547|FG011|Overall Study|Non compliance with protocol|0|||
162958044|NCT00804856|588548548|FG012|Overall Study|Non compliance with protocol|0|||
162958045|NCT00804856|588548549|FG013|Overall Study|Non compliance with protocol|2|||
162958046|NCT00804856|588548550|FG014|Overall Study|Non compliance with protocol|0|||
162958047|NCT00804856|588548536|FG000|Overall Study|Refused to continue medication|0|||
162958048|NCT00804856|588548537|FG001|Overall Study|Refused to continue medication|0|||
162958049|NCT00804856|588548538|FG002|Overall Study|Refused to continue medication|0|||
162958050|NCT00804856|588548539|FG003|Overall Study|Refused to continue medication|1|||
162958051|NCT00804856|588548540|FG004|Overall Study|Refused to continue medication|1|||
162958052|NCT00804856|588548541|FG005|Overall Study|Refused to continue medication|0|||
162958053|NCT00804856|588548542|FG006|Overall Study|Refused to continue medication|0|||
162958054|NCT00804856|588548543|FG007|Overall Study|Refused to continue medication|0|||
162958055|NCT00804856|588548544|FG008|Overall Study|Refused to continue medication|0|||
162958056|NCT00804856|588548545|FG009|Overall Study|Refused to continue medication|0|||
162958057|NCT00804856|588548546|FG010|Overall Study|Refused to continue medication|3|||
162958058|NCT00804856|588548547|FG011|Overall Study|Refused to continue medication|0|||
162958059|NCT00804856|588548548|FG012|Overall Study|Refused to continue medication|1|||
163045719|NCT02659943|588875076|FG000|Overall Study|Disease progression on study|0|||
163394459|NCT04263896|590155808|FG000|Overall Study|surveys lost in mail|5|||
163394460|NCT04263896|590155809|FG001|Overall Study|surveys lost in mail|3|||
162958060|NCT00804856|588548549|FG013|Overall Study|Refused to continue medication|1|||
162958061|NCT00804856|588548550|FG014|Overall Study|Refused to continue medication|5|||
162958062|NCT00804856|588548536|FG000|Overall Study|Other reason than listed above|0|||
162958063|NCT00804856|588548537|FG001|Overall Study|Other reason than listed above|0|||
162958064|NCT00804856|588548538|FG002|Overall Study|Other reason than listed above|0|||
162958065|NCT00804856|588548539|FG003|Overall Study|Other reason than listed above|0|||
162958066|NCT00804856|588548540|FG004|Overall Study|Other reason than listed above|0|||
162958067|NCT00804856|588548541|FG005|Overall Study|Other reason than listed above|1|||
162958068|NCT00804856|588548542|FG006|Overall Study|Other reason than listed above|0|||
162958069|NCT00804856|588548543|FG007|Overall Study|Other reason than listed above|0|||
162958070|NCT00804856|588548544|FG008|Overall Study|Other reason than listed above|1|||
162958071|NCT00804856|588548545|FG009|Overall Study|Other reason than listed above|0|||
162958072|NCT00804856|588548546|FG010|Overall Study|Other reason than listed above|3|||
162958073|NCT00804856|588548547|FG011|Overall Study|Other reason than listed above|1|||
162958074|NCT00804856|588548548|FG012|Overall Study|Other reason than listed above|1|||
162958075|NCT00804856|588548549|FG013|Overall Study|Other reason than listed above|10|||
162958076|NCT00804856|588548550|FG014|Overall Study|Other reason than listed above|3|||
162958077|NCT03343535|588548553|FG000|Overall Study|Lost to Follow-up|1|||
162958078|NCT03343535|588548553|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
162958079|NCT03343535|588548553|FG000|Overall Study|Death|12|||
162958080|NCT03415308|588548556|FG000|Overall Study|Lost to Follow-up|0|||
162958081|NCT03415308|588548557|FG001|Overall Study|Lost to Follow-up|0|||
162958082|NCT03415308|588548558|FG002|Overall Study|Lost to Follow-up|1|||
162958083|NCT03415308|588548556|FG000|Overall Study|Scheduling Conflicts|0|||
162958084|NCT03415308|588548557|FG001|Overall Study|Scheduling Conflicts|0|||
162958085|NCT03415308|588548558|FG002|Overall Study|Scheduling Conflicts|7|||
162958086|NCT01471353|588548561|FG000|Overall Study|remain on study|3|||
162958087|NCT03123094|588548563|FG000|Overall Study|Withdrawal by Subject|0|||
162958088|NCT03123094|588548564|FG001|Overall Study|Withdrawal by Subject|2|||
162958089|NCT03123094|588548565|FG002|Overall Study|Withdrawal by Subject|1|||
162958090|NCT03123094|588548566|FG003|Overall Study|Withdrawal by Subject|0|||
162958091|NCT03123094|588548567|FG004|Overall Study|Withdrawal by Subject|1|||
162958092|NCT04238754|588548572|FG000|Washout - 1 Week|Lost to Follow-up|1|||
162958093|NCT04238754|588548573|FG001|Washout - 1 Week|Lost to Follow-up|0|||
162958094|NCT01444378|588548578|FG000|Overall Study|Lost to Follow-up|1|||
162958095|NCT01444378|588548578|FG000|Overall Study|Withdrawal by Subject|1|||
162958096|NCT01444378|588548578|FG000|Overall Study|Death|3|||
162958097|NCT01444378|588548578|FG000|Overall Study|Administrative Closure Of The Study|2|||
162958098|NCT01444378|588548578|FG000|Overall Study|Missed Visits|10|||
162958099|NCT00705666|588548579|FG000|Overall Study|No post-treatment questionnaire|279|||
162958100|NCT00705666|588548579|FG000|Overall Study|Withdrawal by Subject|21|||
162958101|NCT00705666|588548579|FG000|Overall Study|Physician Decision|7|||
162958102|NCT00705666|588548579|FG000|Overall Study|Lost to Follow-up|5|||
162958103|NCT00705666|588548579|FG000|Overall Study|Death|1|||
162958104|NCT00705666|588548579|FG000|Overall Study|Adverse Event|4|||
162958105|NCT00705666|588548579|FG000|Overall Study|Other|12|||
162958106|NCT00705666|588548579|FG000|Overall Study|Other|2|||
162958107|NCT00705666|588548579|FG000|Overall Study|Lack of data|3|||
162958108|NCT00705666|588548579|FG000|Overall Study|Untreated|5|||
162958109|NCT02645409|588548581|FG000|Overall Study|Withdrawal by Subject|3|||
162958110|NCT02645409|588548582|FG001|Overall Study|Withdrawal by Subject|0|||
162958111|NCT02645409|588548581|FG000|Overall Study|Physician Decision|1|||
162958112|NCT02645409|588548582|FG001|Overall Study|Physician Decision|0|||
162958113|NCT03552393|588548585|FG000|Core Period|Kidney Transplant|1|||
162958114|NCT03552393|588548585|FG000|Core Period|Prohibited Medication|1|||
163045720|NCT02659943|588875077|FG001|Overall Study|Disease progression on study|1|||
163045721|NCT02659943|588875078|FG002|Overall Study|Disease progression on study|1|||
163045722|NCT02659943|588875079|FG003|Overall Study|Disease progression on study|1|||
163045723|NCT02659943|588875080|FG004|Overall Study|Disease progression on study|1|||
163045724|NCT02659943|588875081|FG005|Overall Study|Disease progression on study|4|||
163045725|NCT02659943|588875082|FG006|Overall Study|Disease progression on study|0|||
163045726|NCT02659943|588875076|FG000|Overall Study|Patient's condition per principal investigator|0|||
163045727|NCT02659943|588875077|FG001|Overall Study|Patient's condition per principal investigator|0|||
163045728|NCT02659943|588875078|FG002|Overall Study|Patient's condition per principal investigator|0|||
163045729|NCT02659943|588875079|FG003|Overall Study|Patient's condition per principal investigator|0|||
163045730|NCT02659943|588875080|FG004|Overall Study|Patient's condition per principal investigator|0|||
163045731|NCT02659943|588875081|FG005|Overall Study|Patient's condition per principal investigator|1|||
163045732|NCT02659943|588875082|FG006|Overall Study|Patient's condition per principal investigator|0|||
163045733|NCT02659943|588875076|FG000|Overall Study|Ineligible|0|||
163045734|NCT02659943|588875077|FG001|Overall Study|Ineligible|0|||
163045735|NCT02659943|588875078|FG002|Overall Study|Ineligible|0|||
163045736|NCT02659943|588875079|FG003|Overall Study|Ineligible|0|||
163045737|NCT02659943|588875080|FG004|Overall Study|Ineligible|0|||
163045738|NCT02659943|588875081|FG005|Overall Study|Ineligible|0|||
163045739|NCT02659943|588875082|FG006|Overall Study|Ineligible|1|||
163045740|NCT02659943|588875076|FG000|Overall Study|No longer meets eligibility|0|||
163045741|NCT02659943|588875077|FG001|Overall Study|No longer meets eligibility|0|||
163045742|NCT02659943|588875078|FG002|Overall Study|No longer meets eligibility|0|||
163045743|NCT02659943|588875079|FG003|Overall Study|No longer meets eligibility|0|||
163045744|NCT02659943|588875080|FG004|Overall Study|No longer meets eligibility|0|||
163045745|NCT02659943|588875081|FG005|Overall Study|No longer meets eligibility|0|||
163045746|NCT02659943|588875082|FG006|Overall Study|No longer meets eligibility|1|||
163045747|NCT02659943|588875076|FG000|Overall Study|No treatment, per protocol|0|||
163045748|NCT02659943|588875077|FG001|Overall Study|No treatment, per protocol|0|||
163045749|NCT02659943|588875078|FG002|Overall Study|No treatment, per protocol|0|||
163045750|NCT02659943|588875079|FG003|Overall Study|No treatment, per protocol|0|||
163045751|NCT02659943|588875080|FG004|Overall Study|No treatment, per protocol|0|||
163045752|NCT02659943|588875081|FG005|Overall Study|No treatment, per protocol|0|||
163045753|NCT02659943|588875082|FG006|Overall Study|No treatment, per protocol|3|||
163045754|NCT03478371|588875083|FG000|Overall Study|non-compliance|1|||
163045755|NCT03478371|588875083|FG000|Overall Study|Lost to Follow-up|4|||
163045756|NCT01096160|588875087|FG000|Overall Study|Adverse Event|0|||
163045757|NCT01096160|588875088|FG001|Overall Study|Adverse Event|0|||
163045758|NCT01096160|588875089|FG002|Overall Study|Adverse Event|1|||
163045759|NCT01096160|588875090|FG003|Overall Study|Adverse Event|0|||
163045760|NCT01096160|588875091|FG004|Overall Study|Adverse Event|0|||
163045761|NCT01096160|588875092|FG005|Overall Study|Adverse Event|0|||
163045762|NCT01096160|588875093|FG006|Overall Study|Adverse Event|0|||
163045763|NCT01096160|588875094|FG007|Overall Study|Adverse Event|0|||
163045764|NCT01096160|588875095|FG008|Overall Study|Adverse Event|0|||
163045765|NCT01096160|588875096|FG009|Overall Study|Adverse Event|1|||
163045766|NCT01096160|588875087|FG000|Overall Study|Met stopping criteria per protocol|0|||
163045767|NCT01096160|588875088|FG001|Overall Study|Met stopping criteria per protocol|0|||
163045768|NCT01096160|588875089|FG002|Overall Study|Met stopping criteria per protocol|0|||
163045769|NCT01096160|588875090|FG003|Overall Study|Met stopping criteria per protocol|0|||
163045770|NCT01096160|588875091|FG004|Overall Study|Met stopping criteria per protocol|1|||
163045771|NCT01096160|588875092|FG005|Overall Study|Met stopping criteria per protocol|0|||
163045772|NCT01096160|588875093|FG006|Overall Study|Met stopping criteria per protocol|2|||
163045773|NCT01096160|588875094|FG007|Overall Study|Met stopping criteria per protocol|0|||
163045774|NCT01096160|588875095|FG008|Overall Study|Met stopping criteria per protocol|2|||
163045775|NCT01096160|588875096|FG009|Overall Study|Met stopping criteria per protocol|0|||
163045776|NCT00627497|588875097|FG000|Overall Study|Lost to Follow-up|1|||
163045777|NCT00627497|588875098|FG001|Overall Study|Lost to Follow-up|1|||
163045778|NCT00627497|588875099|FG002|Overall Study|Lost to Follow-up|0|||
163394461|NCT04263896|590155808|FG000|Overall Study|excluded from analysis|1|||
163045779|NCT00627497|588875100|FG003|Overall Study|Lost to Follow-up|0|||
163045780|NCT02028507|588875103|FG000|Overall Study|Progressive Disease|122|||
163045781|NCT02028507|588875104|FG001|Overall Study|Progressive Disease|90|||
163045782|NCT02028507|588875105|FG002|Overall Study|Progressive Disease|102|||
163045783|NCT02028507|588875106|FG003|Overall Study|Progressive Disease|89|||
162958115|NCT03552393|588548585|FG000|Safety Extension Period|Kidney Transplant|4|||
162958116|NCT05646251|588548588|FG000|Overall Study|Physician Decision|1|||
162958117|NCT05646251|588548589|FG001|Overall Study|Physician Decision|0|||
162958118|NCT05646251|588548590|FG002|Overall Study|Physician Decision|2|||
162958119|NCT00465270|588548591|FG000|Overall Study|Death|7|||
162958120|NCT00465270|588548592|FG001|Overall Study|Death|11|||
162958121|NCT00465270|588548591|FG000|Overall Study|Withdrawal by Subject|34|||
162958122|NCT00465270|588548592|FG001|Overall Study|Withdrawal by Subject|78|||
162958123|NCT00465270|588548591|FG000|Overall Study|Lost to Follow-up|60|||
162958124|NCT00465270|588548592|FG001|Overall Study|Lost to Follow-up|67|||
162958125|NCT00465270|588548591|FG000|Overall Study|Investigator request|3|||
162958126|NCT00465270|588548592|FG001|Overall Study|Investigator request|4|||
162958127|NCT02388191|588548593|FG000|Overall Study|Patient did not receive IUD|1|||
162958128|NCT02388191|588548594|FG001|Overall Study|Patient did not receive IUD|0|||
162958129|NCT02530905|588548595|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
162958130|NCT02530905|588548596|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
162958131|NCT02530905|588548597|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
162958132|NCT01231906|588548598|FG000|Overall Study|Lack of Efficacy|75|||
162958133|NCT01231906|588548599|FG001|Overall Study|Lack of Efficacy|68|||
162958134|NCT01231906|588548598|FG000|Overall Study|Lost to Follow-up|1|||
162958135|NCT01231906|588548599|FG001|Overall Study|Lost to Follow-up|0|||
162958136|NCT01231906|588548598|FG000|Overall Study|Physician Decision|34|||
162958137|NCT01231906|588548599|FG001|Overall Study|Physician Decision|24|||
162958138|NCT01231906|588548598|FG000|Overall Study|Withdrawal by Subject|0|||
162958139|NCT01231906|588548599|FG001|Overall Study|Withdrawal by Subject|4|||
162958140|NCT01231906|588548598|FG000|Overall Study|Ineligible|10|||
162958141|NCT01231906|588548599|FG001|Overall Study|Ineligible|3|||
162958142|NCT01231906|588548598|FG000|Overall Study|No treatment|1|||
162958143|NCT01231906|588548599|FG001|Overall Study|No treatment|2|||
162958144|NCT01136174|588548600|FG000|Overall Study|Adverse Event|0|||
162958145|NCT01136174|588548601|FG001|Overall Study|Adverse Event|0|||
162958146|NCT01136174|588548602|FG002|Overall Study|Adverse Event|0|||
162958147|NCT01136174|588548603|FG003|Overall Study|Adverse Event|4|||
162958148|NCT01249651|588548606|FG000|Overall Study|Withdrawal by Subject|4|||
162958149|NCT01249651|588548606|FG000|Overall Study|Adverse Event|1|||
162958150|NCT01249651|588548606|FG000|Overall Study|Protocol Violation|1|||
162958151|NCT01249651|588548606|FG000|Overall Study|Sponsor Decision|1|||
162958152|NCT03873272|588548613|FG000|Overall Study|Withdrawal by Subject|2|||
162958153|NCT03873272|588548614|FG001|Overall Study|Withdrawal by Subject|0|||
162958154|NCT03873272|588548615|FG002|Overall Study|Withdrawal by Subject|1|||
162958155|NCT03873272|588548613|FG000|Overall Study|Death|0|||
162958156|NCT03873272|588548614|FG001|Overall Study|Death|2|||
162958157|NCT03873272|588548615|FG002|Overall Study|Death|1|||
162958158|NCT03761173|588548616|FG000|Overall Study|Lost to Follow-up|93|||
162958159|NCT03761173|588548616|FG000|Overall Study|Withdrawal by Subject|74|||
162958160|NCT03761173|588548616|FG000|Overall Study|Death|45|||
162958161|NCT03761173|588548616|FG000|Overall Study|Withdrawal for Other Reasons|29|||
162958162|NCT03761173|588548616|FG000|Overall Study|Protocol Violation|1|||
162958163|NCT00316186|588548618|FG000|Overall Study|Adverse Event|6|||
162958164|NCT00316186|588548618|FG000|Overall Study|Disease Progression|4|||
162958165|NCT00316186|588548618|FG000|Overall Study|Lost to Follow-up|1|||
162958166|NCT00316186|588548618|FG000|Overall Study|Other|1|||
162958167|NCT01802320|588548620|FG000|Overall Study|Death|1|||
162958168|NCT01802320|588548620|FG000|Overall Study|Withdrawal by Subject|1|||
162958169|NCT00199901|588549586|FG000|Overall Study|Protocol Violation|2|||
162958170|NCT00199901|588549587|FG001|Overall Study|Protocol Violation|0|||
162958171|NCT00199901|588549586|FG000|Overall Study|Withdrawal by Subject|1|||
162958172|NCT00199901|588549587|FG001|Overall Study|Withdrawal by Subject|0|||
163045784|NCT02028507|588875103|FG000|Overall Study|Adverse Event|8|||
162958173|NCT00199901|588549586|FG000|Overall Study|Progressive Disease|24|||
163045785|NCT02028507|588875104|FG001|Overall Study|Adverse Event|25|||
162958174|NCT00199901|588549587|FG001|Overall Study|Progressive Disease|24|||
162958175|NCT05776901|588549590|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
162958176|NCT01958294|588549599|FG000|Overall Study|Clinical Circumstances|2|||
163045786|NCT02028507|588875105|FG002|Overall Study|Adverse Event|3|||
163195361|NCT00680017|589429840|FG001|Overall Study|Lost to Follow-up|0|||
162958177|NCT06137781|588549603|FG000|Baseline measurements|Lost to Follow-up|2|||
162958178|NCT06137781|588549603|FG000|Baseline measurements|Withdrawal by Subject|1|||
162958179|NCT06137781|588549603|FG000|Baseline measurements|Expedited surgery|1|||
162958180|NCT06137781|588549603|FG000|Intervention period|Lost to Follow-up|2|||
162958181|NCT06137781|588549603|FG000|Intervention period|Withdrawal by Subject|3|||
162958182|NCT06137781|588549603|FG000|Intervention period|Expedited surgery|1|||
162958183|NCT06137781|588549603|FG000|Intervention period|Adverse Event|1|||
162958184|NCT06284525|588549609|FG000|Overall Study|Withdrawal by Subject|1|||
162958185|NCT00519194|588549610|FG000|Overall Study|Withdrawal by Subject|9|||
162958186|NCT00519194|588549610|FG000|Overall Study|Death|9|||
162958187|NCT00519194|588549610|FG000|Overall Study|Lost to Follow-up|3|||
162958188|NCT05014828|588549618|FG000|Overall Study|Study Completed by Sponsor|16|||
162958189|NCT05014828|588549619|FG001|Overall Study|Study Completed by Sponsor|16|||
162958190|NCT05014828|588549620|FG002|Overall Study|Study Completed by Sponsor|3|||
162958191|NCT05014828|588549621|FG003|Overall Study|Study Completed by Sponsor|3|||
162958192|NCT05014828|588549618|FG000|Overall Study|Death|11|||
162958193|NCT05014828|588549619|FG001|Overall Study|Death|6|||
162958194|NCT05014828|588549620|FG002|Overall Study|Death|0|||
162958195|NCT05014828|588549621|FG003|Overall Study|Death|0|||
162958196|NCT05014828|588549618|FG000|Overall Study|Lost to Follow-up|0|||
162958197|NCT05014828|588549619|FG001|Overall Study|Lost to Follow-up|0|||
162958198|NCT05014828|588549620|FG002|Overall Study|Lost to Follow-up|2|||
162958199|NCT05014828|588549621|FG003|Overall Study|Lost to Follow-up|0|||
162958200|NCT05014828|588549618|FG000|Overall Study|Miscellaneous.|0|||
162958201|NCT05014828|588549619|FG001|Overall Study|Miscellaneous.|1|||
162958202|NCT05014828|588549620|FG002|Overall Study|Miscellaneous.|0|||
162958203|NCT05014828|588549621|FG003|Overall Study|Miscellaneous.|0|||
162958204|NCT02682238|588549624|FG000|Overall Study|Lost to Follow-up|0|||
162958205|NCT02682238|588549625|FG001|Overall Study|Lost to Follow-up|2|||
163195362|NCT01434667|589429841|FG000|Overall Study|Lost to Follow-up|5|||
163195363|NCT01434667|589429842|FG001|Overall Study|Lost to Follow-up|10|||
162958206|NCT02682238|588549624|FG000|Overall Study|Withdrawal by Subject|1|||
162958207|NCT02682238|588549625|FG001|Overall Study|Withdrawal by Subject|0|||
162958208|NCT02682238|588549624|FG000|Overall Study|Adverse Event|1|||
162958209|NCT02682238|588549625|FG001|Overall Study|Adverse Event|0|||
162958210|NCT02682238|588549624|FG000|Overall Study|Non-compliance with Study Drug|1|||
163195364|NCT02034110|589429845|FG000|Overall Study|Physician Decision|0|||
162958211|NCT02682238|588549625|FG001|Overall Study|Non-compliance with Study Drug|0|||
163195365|NCT02034110|589429846|FG001|Overall Study|Physician Decision|0|||
162958212|NCT02682238|588549624|FG000|Overall Study|Non-compliance with Protocol|0|||
162958213|NCT02682238|588549625|FG001|Overall Study|Non-compliance with Protocol|2|||
162958214|NCT00075478|588549626|FG000|Overall Study|not eligible|1|||
162958215|NCT00075478|588549627|FG001|Overall Study|not eligible|0|||
162958216|NCT00075478|588549626|FG000|Overall Study|Physician Decision|0|||
162958217|NCT00075478|588549627|FG001|Overall Study|Physician Decision|1|||
162958218|NCT00824291|588549632|FG000|Overall Study|Adverse Event|15|||
162958219|NCT00824291|588549633|FG001|Overall Study|Adverse Event|6|||
162958220|NCT00824291|588549632|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
163045787|NCT02028507|588875106|FG003|Overall Study|Adverse Event|16|||
163045788|NCT02028507|588875103|FG000|Overall Study|Withdrawal by Subject|6|||
163045789|NCT02028507|588875104|FG001|Overall Study|Withdrawal by Subject|8|||
163045790|NCT02028507|588875105|FG002|Overall Study|Withdrawal by Subject|5|||
163045791|NCT02028507|588875106|FG003|Overall Study|Withdrawal by Subject|9|||
163045792|NCT02028507|588875103|FG000|Overall Study|Protocol Violation|2|||
162958221|NCT00824291|588549633|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
162958222|NCT00824291|588549632|FG000|Overall Study|Lost to Follow-up|11|||
162958223|NCT00824291|588549633|FG001|Overall Study|Lost to Follow-up|9|||
162958224|NCT00824291|588549632|FG000|Overall Study|Non-compliance|1|||
162958225|NCT00824291|588549633|FG001|Overall Study|Non-compliance|1|||
162958226|NCT00824291|588549632|FG000|Overall Study|Protocol Violation|4|||
162958227|NCT00824291|588549633|FG001|Overall Study|Protocol Violation|1|||
162958228|NCT00824291|588549632|FG000|Overall Study|Withdrawal by Subject|14|||
162958229|NCT00824291|588549633|FG001|Overall Study|Withdrawal by Subject|8|||
162958230|NCT00824291|588549632|FG000|Overall Study|Lack of Efficacy|7|||
162958231|NCT00824291|588549633|FG001|Overall Study|Lack of Efficacy|8|||
162958232|NCT00824291|588549632|FG000|Overall Study|Participant on prohibited medication|1|||
162958233|NCT00824291|588549633|FG001|Overall Study|Participant on prohibited medication|0|||
162958234|NCT00123734|588549638|FG000|Overall Study|Death|3|||
162958235|NCT00123734|588549638|FG000|Overall Study|Lost to Follow-up|3|||
162958236|NCT00123734|588549638|FG000|Overall Study|Dropout|1|||
162958237|NCT00123734|588549638|FG000|Overall Study|Withdrawal by Subject|1|||
162958238|NCT00113386|588549639|FG000|Overall Study|Withdrawal by Subject|1|||
162958239|NCT00113386|588549640|FG001|Overall Study|Withdrawal by Subject|0|||
162958240|NCT00113386|588549639|FG000|Overall Study|Physician Decision|0|||
162958241|NCT00113386|588549640|FG001|Overall Study|Physician Decision|1|||
162958242|NCT00113386|588549639|FG000|Overall Study|Toxicity|3|||
162958243|NCT00113386|588549640|FG001|Overall Study|Toxicity|0|||
162958244|NCT00113386|588549639|FG000|Overall Study|Ineligible|1|||
162958245|NCT00113386|588549640|FG001|Overall Study|Ineligible|2|||
162958246|NCT00113386|588549639|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
162958247|NCT00113386|588549640|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
162958248|NCT02849457|588549641|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
162958249|NCT02849457|588549642|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
162958250|NCT02849457|588549643|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
162958251|NCT02849457|588549644|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
162958252|NCT01778010|588549648|FG000|Overall Study|Withdrawal by Subject|2|||
162958253|NCT01778010|588549648|FG000|Overall Study|abnormal ECG before meds|1|||
162958254|NCT01778010|588549648|FG000|Overall Study|Arrested|1|||
162958255|NCT01778010|588549648|FG000|Overall Study|rash while on placebo|1|||
162958256|NCT02159183|588549651|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
163195366|NCT02034110|589429847|FG002|Overall Study|Physician Decision|0|||
162958257|NCT02159183|588549652|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
162958258|NCT02159183|588549651|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
162958259|NCT02159183|588549652|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
163045793|NCT02028507|588875104|FG001|Overall Study|Protocol Violation|4|||
163045794|NCT02028507|588875105|FG002|Overall Study|Protocol Violation|1|||
162958260|NCT02159183|588549651|FG000|Analysis After the 36 Months Follow-up|Death|0|||
162958261|NCT02159183|588549652|FG001|Analysis After the 36 Months Follow-up|Death|1|||
162958262|NCT02159183|588549651|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
162958263|NCT02159183|588549652|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
162958264|NCT02159183|588549651|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
162958265|NCT02159183|588549652|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
162958266|NCT02558491|588549654|FG000|First Invention|Withdrawal by Subject|3|||
162958267|NCT02558491|588549655|FG001|First Invention|Withdrawal by Subject|1|||
162958268|NCT02558491|588549654|FG000|First Invention|Data collection issues|1|||
162958269|NCT02558491|588549655|FG001|First Invention|Data collection issues|0|||
162958270|NCT02558491|588549654|FG000|First Invention|Stopping criteria|0|||
162958271|NCT02558491|588549655|FG001|First Invention|Stopping criteria|1|||
162958272|NCT02558491|588549654|FG000|First Invention|Changed parameters during trial|1|||
162958273|NCT02558491|588549655|FG001|First Invention|Changed parameters during trial|0|||
162958274|NCT02558491|588549654|FG000|Second Intervention|Withdrawal by Subject|1|||
162958275|NCT02558491|588549655|FG001|Second Intervention|Withdrawal by Subject|0|||
162958276|NCT02558491|588549654|FG000|Second Intervention|Stopping Criteria|1|||
162958277|NCT02558491|588549655|FG001|Second Intervention|Stopping Criteria|0|||
162958278|NCT05630885|588549664|FG000|Study Completion|Took prohibited medications|2|||
162958279|NCT05630885|588549665|FG001|Study Completion|Took prohibited medications|0|||
162958280|NCT05630885|588549664|FG000|Study Completion|Non-compliance with study drug|1|||
162958281|NCT05630885|588549665|FG001|Study Completion|Non-compliance with study drug|0|||
162958282|NCT05630885|588549664|FG000|Study Completion|Adverse Event|1|||
162958283|NCT05630885|588549665|FG001|Study Completion|Adverse Event|0|||
162958284|NCT05630885|588549664|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
162958285|NCT05630885|588549665|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
162958286|NCT05630885|588549664|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
162958287|NCT05630885|588549665|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
162958288|NCT03419403|588549666|FG000|Overall Study|Withdrawal by Subject|5|||
162958289|NCT03419403|588549667|FG001|Overall Study|Withdrawal by Subject|2|||
162958290|NCT03419403|588549668|FG002|Overall Study|Withdrawal by Subject|5|||
162958291|NCT03419403|588549669|FG003|Overall Study|Withdrawal by Subject|1|||
162958292|NCT03419403|588549666|FG000|Overall Study|Progressive disease (per protocol)|0|||
162958293|NCT03419403|588549667|FG001|Overall Study|Progressive disease (per protocol)|2|||
162958294|NCT03419403|588549668|FG002|Overall Study|Progressive disease (per protocol)|2|||
162958295|NCT03419403|588549669|FG003|Overall Study|Progressive disease (per protocol)|0|||
162958296|NCT03419403|588549666|FG000|Overall Study|Other, not specified|6|||
162958297|NCT03419403|588549667|FG001|Overall Study|Other, not specified|4|||
162958298|NCT03419403|588549668|FG002|Overall Study|Other, not specified|5|||
162958299|NCT03419403|588549669|FG003|Overall Study|Other, not specified|1|||
162958300|NCT03419403|588549666|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
162958301|NCT03419403|588549667|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
162958302|NCT03419403|588549668|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
162958303|NCT03419403|588549669|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
162958304|NCT03084471|588549674|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
162958305|NCT03084471|588549674|FG000|Overall Study|Condition under investigation worsened|84|||
162958306|NCT03084471|588549674|FG000|Overall Study|Lack of therapeutic response|2|||
162958307|NCT03084471|588549674|FG000|Overall Study|Protocol Violation|1|||
162958308|NCT03084471|588549674|FG000|Overall Study|Adverse Event|73|||
162958309|NCT03084471|588549674|FG000|Overall Study|Withdrawal by Subject|12|||
162958310|NCT03084471|588549674|FG000|Overall Study|Disease relapse|181|||
162958311|NCT03084471|588549674|FG000|Overall Study|Subjective disease progression|359|||
162958312|NCT03084471|588549674|FG000|Overall Study|Other (as recorded)|33|||
162958313|NCT03084471|588549674|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
162958314|NCT00429416|588549677|FG000|Overall Study|Death|1|||
162958315|NCT00730691|588549679|FG000|Overall Study|Adverse Event|4|||
162958316|NCT00730691|588549680|FG001|Overall Study|Adverse Event|8|||
162958317|NCT00730691|588549681|FG002|Overall Study|Adverse Event|11|||
162958318|NCT00730691|588549682|FG003|Overall Study|Adverse Event|11|||
162958319|NCT00730691|588549683|FG004|Overall Study|Adverse Event|23|||
162958320|NCT00730691|588549679|FG000|Overall Study|Lack of Efficacy|4|||
162958321|NCT00730691|588549680|FG001|Overall Study|Lack of Efficacy|4|||
162958322|NCT00730691|588549681|FG002|Overall Study|Lack of Efficacy|2|||
162958323|NCT00730691|588549682|FG003|Overall Study|Lack of Efficacy|1|||
162958324|NCT00730691|588549683|FG004|Overall Study|Lack of Efficacy|1|||
162958325|NCT00730691|588549679|FG000|Overall Study|Non-compliance with Study Drug|6|||
162958326|NCT00730691|588549680|FG001|Overall Study|Non-compliance with Study Drug|1|||
162958327|NCT00730691|588549681|FG002|Overall Study|Non-compliance with Study Drug|6|||
162958328|NCT00730691|588549682|FG003|Overall Study|Non-compliance with Study Drug|3|||
162958329|NCT00730691|588549683|FG004|Overall Study|Non-compliance with Study Drug|3|||
162958330|NCT00730691|588549679|FG000|Overall Study|Protocol Deviations|3|||
162958331|NCT00730691|588549680|FG001|Overall Study|Protocol Deviations|5|||
163394462|NCT04263896|590155809|FG001|Overall Study|excluded from analysis|0|||
162958332|NCT00730691|588549681|FG002|Overall Study|Protocol Deviations|3|||
162958333|NCT00730691|588549682|FG003|Overall Study|Protocol Deviations|7|||
162958334|NCT00730691|588549683|FG004|Overall Study|Protocol Deviations|5|||
162958335|NCT00730691|588549679|FG000|Overall Study|Withdrawal of Consent|7|||
163045795|NCT02028507|588875106|FG003|Overall Study|Protocol Violation|3|||
163045796|NCT02028507|588875103|FG000|Overall Study|Physician Decision|0|||
163045797|NCT02028507|588875104|FG001|Overall Study|Physician Decision|4|||
163045798|NCT02028507|588875105|FG002|Overall Study|Physician Decision|0|||
163045799|NCT02028507|588875106|FG003|Overall Study|Physician Decision|0|||
163045800|NCT02028507|588875103|FG000|Overall Study|Death|1|||
163045801|NCT02028507|588875104|FG001|Overall Study|Death|0|||
163045802|NCT02028507|588875105|FG002|Overall Study|Death|1|||
163045803|NCT02028507|588875106|FG003|Overall Study|Death|3|||
163045804|NCT02028507|588875103|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
163045805|NCT02028507|588875104|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
163045806|NCT02028507|588875105|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
163045807|NCT02028507|588875106|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
163045808|NCT02028507|588875103|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
163045809|NCT02028507|588875104|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
163045810|NCT02028507|588875105|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
163045811|NCT02028507|588875106|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
163045812|NCT02028507|588875103|FG000|Overall Study|Randomized But Not Treated|3|||
163045813|NCT02028507|588875104|FG001|Overall Study|Randomized But Not Treated|6|||
163045814|NCT02028507|588875105|FG002|Overall Study|Randomized But Not Treated|0|||
163045815|NCT02028507|588875106|FG003|Overall Study|Randomized But Not Treated|4|||
163045816|NCT02028507|588875103|FG000|Overall Study|Enzyme defect|0|||
163045817|NCT02028507|588875104|FG001|Overall Study|Enzyme defect|0|||
163045818|NCT02028507|588875105|FG002|Overall Study|Enzyme defect|0|||
163045819|NCT02028507|588875106|FG003|Overall Study|Enzyme defect|1|||
163045820|NCT02028507|588875103|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
163045821|NCT02028507|588875104|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
163045822|NCT02028507|588875105|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
163045823|NCT02028507|588875106|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
163045824|NCT02028507|588875103|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
163045825|NCT02028507|588875104|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
163045826|NCT02028507|588875105|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
163045827|NCT02028507|588875106|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
163045828|NCT03361306|588875107|FG000|Overall Study|Death|6|||
163045829|NCT01556932|588875108|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
163045830|NCT01556932|588875109|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
163045831|NCT02105285|588875114|FG000|Overall Study|Adverse Event|1|||
163045832|NCT02105285|588875115|FG001|Overall Study|Adverse Event|1|||
163045833|NCT02105285|588875116|FG002|Overall Study|Adverse Event|0|||
163045834|NCT02105285|588875114|FG000|Overall Study|Protocol Violation|0|||
163045835|NCT02105285|588875115|FG001|Overall Study|Protocol Violation|1|||
163045836|NCT02105285|588875116|FG002|Overall Study|Protocol Violation|0|||
163045837|NCT02105285|588875114|FG000|Overall Study|Withdrawal by Subject|1|||
163045838|NCT02105285|588875115|FG001|Overall Study|Withdrawal by Subject|0|||
163045839|NCT02105285|588875116|FG002|Overall Study|Withdrawal by Subject|0|||
163045840|NCT02420119|588875117|FG000|Overall Study|insufficient laboratory data|5|||
163045841|NCT04767373|588875118|FG000|Overall Study|Death|6|||
163045842|NCT04767373|588875119|FG001|Overall Study|Death|3|||
163045843|NCT04767373|588875118|FG000|Overall Study|Lost to Follow-up|67|||
163045844|NCT04767373|588875119|FG001|Overall Study|Lost to Follow-up|35|||
163045845|NCT04767373|588875118|FG000|Overall Study|Physician Decision|15|||
163045846|NCT04767373|588875119|FG001|Overall Study|Physician Decision|4|||
163045847|NCT04767373|588875118|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163045848|NCT04767373|588875119|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
163045849|NCT04767373|588875118|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
163045850|NCT04767373|588875119|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
163045851|NCT04767373|588875118|FG000|Overall Study|Other|1|||
163045852|NCT04767373|588875119|FG001|Overall Study|Other|2|||
163045853|NCT02472886|588875121|FG000|Overall Study|Lack of Efficacy|0|||
163045854|NCT02472886|588875122|FG001|Overall Study|Lack of Efficacy|2|||
163045855|NCT02472886|588875123|FG002|Overall Study|Lack of Efficacy|1|||
163045856|NCT04346199|588875125|FG000|Overall Study|Death|8|||
163045857|NCT04346199|588875126|FG001|Overall Study|Death|9|||
163045858|NCT04346199|588875125|FG000|Overall Study|Lost to Follow-up|0|||
163045859|NCT04346199|588875126|FG001|Overall Study|Lost to Follow-up|1|||
163195367|NCT02034110|589429848|FG003|Overall Study|Physician Decision|0|||
163195368|NCT02034110|589429849|FG004|Overall Study|Physician Decision|2|||
163394463|NCT02229539|590156910|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
163195369|NCT02034110|589429850|FG005|Overall Study|Physician Decision|0|||
163045860|NCT04346199|588875125|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
163045861|NCT04346199|588875126|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
163045862|NCT04346199|588875125|FG000|Overall Study|Withdrawal by Subject|5|||
163045863|NCT04346199|588875126|FG001|Overall Study|Withdrawal by Subject|1|||
163195370|NCT02034110|589429851|FG006|Overall Study|Physician Decision|1|||
163045864|NCT00099632|588875130|FG000|Overall Study|Lost to Follow-up|1|||
163045865|NCT00099632|588875131|FG001|Overall Study|Lost to Follow-up|0|||
163045866|NCT00099632|588875132|FG002|Overall Study|Lost to Follow-up|3|||
163045867|NCT00099632|588875133|FG003|Overall Study|Lost to Follow-up|1|||
163045868|NCT00099632|588875134|FG004|Overall Study|Lost to Follow-up|1|||
163045869|NCT00099632|588875135|FG005|Overall Study|Lost to Follow-up|0|||
163045870|NCT00099632|588875130|FG000|Overall Study|Withdrawal by Subject|0|||
163045871|NCT00099632|588875131|FG001|Overall Study|Withdrawal by Subject|1|||
163045872|NCT00099632|588875132|FG002|Overall Study|Withdrawal by Subject|0|||
163045873|NCT00099632|588875133|FG003|Overall Study|Withdrawal by Subject|0|||
163045874|NCT00099632|588875134|FG004|Overall Study|Withdrawal by Subject|0|||
163045875|NCT00099632|588875135|FG005|Overall Study|Withdrawal by Subject|1|||
163045876|NCT00099632|588875130|FG000|Overall Study|Protocol Violation|0|||
163045877|NCT00099632|588875131|FG001|Overall Study|Protocol Violation|0|||
163045878|NCT00099632|588875132|FG002|Overall Study|Protocol Violation|0|||
163045879|NCT00099632|588875133|FG003|Overall Study|Protocol Violation|0|||
163045880|NCT00099632|588875134|FG004|Overall Study|Protocol Violation|0|||
163045881|NCT00099632|588875135|FG005|Overall Study|Protocol Violation|1|||
163045882|NCT03131687|588875136|FG000|Overall Study|Adverse Event|0|||
163045883|NCT03131687|588875137|FG001|Overall Study|Adverse Event|1|||
163195371|NCT02034110|589429852|FG007|Overall Study|Physician Decision|0|||
163195372|NCT02034110|589429845|FG000|Overall Study|Lost to Follow-up|1|||
163195373|NCT02034110|589429846|FG001|Overall Study|Lost to Follow-up|0|||
162958336|NCT00730691|588549680|FG001|Overall Study|Withdrawal of Consent|9|||
162958337|NCT00730691|588549681|FG002|Overall Study|Withdrawal of Consent|3|||
162958338|NCT00730691|588549682|FG003|Overall Study|Withdrawal of Consent|6|||
162958339|NCT00730691|588549683|FG004|Overall Study|Withdrawal of Consent|3|||
162958340|NCT00730691|588549679|FG000|Overall Study|Lost to Follow-up|11|||
162958341|NCT00730691|588549680|FG001|Overall Study|Lost to Follow-up|8|||
162958342|NCT00730691|588549681|FG002|Overall Study|Lost to Follow-up|13|||
162958343|NCT00730691|588549682|FG003|Overall Study|Lost to Follow-up|15|||
162958344|NCT00730691|588549683|FG004|Overall Study|Lost to Follow-up|13|||
162958345|NCT00730691|588549679|FG000|Overall Study|Other|1|||
162958346|NCT00730691|588549680|FG001|Overall Study|Other|1|||
162958347|NCT00730691|588549681|FG002|Overall Study|Other|1|||
162958348|NCT00730691|588549682|FG003|Overall Study|Other|2|||
162958349|NCT00730691|588549683|FG004|Overall Study|Other|2|||
162958350|NCT00813592|588549684|FG000|Overall Study|Disease assessment was not completed per|2|||
162958351|NCT02566850|588551552|FG000|Overall Study|Protocol Violation|1|||
162958352|NCT00682461|588551553|FG000|Overall Study|Adverse Event|5|||
162958353|NCT00682461|588551554|FG001|Overall Study|Adverse Event|7|||
162958354|NCT00682461|588551553|FG000|Overall Study|Lost to Follow-up|8|||
162958355|NCT00682461|588551554|FG001|Overall Study|Lost to Follow-up|5|||
162958356|NCT00682461|588551553|FG000|Overall Study|Withdrawal by Subject|12|||
162958357|NCT00682461|588551554|FG001|Overall Study|Withdrawal by Subject|19|||
162958358|NCT06298396|588551565|FG000|Default MAP|Protocol Violation|1|||
162958359|NCT01528696|588551568|FG000|Overall Study|See detailed description|18|||
162958360|NCT01528696|588551569|FG001|Overall Study|See detailed description|19|||
162958361|NCT01547286|588551572|FG000|Overall Study|Did not meet all eligibility criteria|1|||
162958362|NCT01547286|588551572|FG000|Overall Study|Physician Decision|1|||
162958363|NCT00836472|588551573|FG000|Washout|Adverse Event|1|||
162958364|NCT00836472|588551574|FG001|Washout|Adverse Event|2|||
162958365|NCT00836472|588551573|FG000|Washout|Withdrawal by Subject|1|||
162958366|NCT00836472|588551574|FG001|Washout|Withdrawal by Subject|1|||
162958367|NCT01695239|588551575|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
163045884|NCT03131687|588875138|FG002|Overall Study|Adverse Event|0|||
163045885|NCT03131687|588875139|FG003|Overall Study|Adverse Event|1|||
163045886|NCT03131687|588875140|FG004|Overall Study|Adverse Event|2|||
163045887|NCT03131687|588875141|FG005|Overall Study|Adverse Event|2|||
163045888|NCT03131687|588875136|FG000|Overall Study|Death|1|||
163045889|NCT03131687|588875137|FG001|Overall Study|Death|0|||
163045890|NCT03131687|588875138|FG002|Overall Study|Death|0|||
163195374|NCT02034110|589429847|FG002|Overall Study|Lost to Follow-up|0|||
163045891|NCT03131687|588875139|FG003|Overall Study|Death|0|||
163045892|NCT03131687|588875140|FG004|Overall Study|Death|0|||
163045893|NCT03131687|588875141|FG005|Overall Study|Death|0|||
163045894|NCT03131687|588875136|FG000|Overall Study|Withdrawal by Subject|3|||
163045895|NCT03131687|588875137|FG001|Overall Study|Withdrawal by Subject|3|||
163045896|NCT03131687|588875138|FG002|Overall Study|Withdrawal by Subject|3|||
163045897|NCT03131687|588875139|FG003|Overall Study|Withdrawal by Subject|1|||
163045898|NCT03131687|588875140|FG004|Overall Study|Withdrawal by Subject|2|||
163045899|NCT03131687|588875141|FG005|Overall Study|Withdrawal by Subject|1|||
163045900|NCT03131687|588875136|FG000|Overall Study|Lost to Follow-up|1|||
163045901|NCT03131687|588875137|FG001|Overall Study|Lost to Follow-up|4|||
163045902|NCT03131687|588875138|FG002|Overall Study|Lost to Follow-up|0|||
163045903|NCT03131687|588875139|FG003|Overall Study|Lost to Follow-up|1|||
163045904|NCT03131687|588875140|FG004|Overall Study|Lost to Follow-up|4|||
163045905|NCT03131687|588875141|FG005|Overall Study|Lost to Follow-up|2|||
163045906|NCT03131687|588875136|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
163045907|NCT03131687|588875137|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
163045908|NCT03131687|588875138|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
163045909|NCT03131687|588875139|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
163045910|NCT03131687|588875140|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
163045911|NCT03131687|588875141|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
163045912|NCT03131687|588875136|FG000|Overall Study|Principle Investigator Decision|0|||
163045913|NCT03131687|588875137|FG001|Overall Study|Principle Investigator Decision|1|||
163045914|NCT03131687|588875138|FG002|Overall Study|Principle Investigator Decision|0|||
163045915|NCT03131687|588875139|FG003|Overall Study|Principle Investigator Decision|0|||
163045916|NCT03131687|588875140|FG004|Overall Study|Principle Investigator Decision|0|||
162958368|NCT01695239|588551576|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
162958369|NCT01695239|588551577|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
162958370|NCT01695239|588551578|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
163195375|NCT02034110|589429848|FG003|Overall Study|Lost to Follow-up|0|||
163045917|NCT03131687|588875141|FG005|Overall Study|Principle Investigator Decision|0|||
163045918|NCT03131687|588875136|FG000|Overall Study|Inadvertent Enrollment|0|||
163045919|NCT03131687|588875137|FG001|Overall Study|Inadvertent Enrollment|0|||
163394464|NCT02229539|590156911|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
163394465|NCT02229539|590156912|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
163394466|NCT02229539|590156910|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
163394467|NCT02229539|590156911|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
163394468|NCT02229539|590156912|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
163394469|NCT02229539|590156910|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
163394470|NCT02229539|590156911|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
163394471|NCT02229539|590156912|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
163394472|NCT02229539|590156910|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
163394473|NCT02229539|590156911|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
163394474|NCT02229539|590156912|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
163394475|NCT02229539|590156910|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
163394476|NCT02229539|590156911|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
163394477|NCT02229539|590156912|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
163394478|NCT02229539|590156910|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
163394479|NCT02229539|590156911|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
163394480|NCT02229539|590156912|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
163394481|NCT03441334|590156913|FG000|Overall Study|Withdrawal by Subject|1|||
163394482|NCT03441334|590156914|FG001|Overall Study|Withdrawal by Subject|0|||
163394483|NCT00088907|590156915|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
163394484|NCT00088907|590156916|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
163394485|NCT00088907|590156915|FG000|Randomized Study (Step 1)|Adverse Event|14|||
163394486|NCT00088907|590156916|FG001|Randomized Study (Step 1)|Adverse Event|19|||
163394487|NCT00088907|590156915|FG000|Randomized Study (Step 1)|Death|11|||
163394488|NCT00088907|590156916|FG001|Randomized Study (Step 1)|Death|12|||
163394489|NCT00088907|590156915|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
163394490|NCT00088907|590156916|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
163394491|NCT00088907|590156915|FG000|Randomized Study (Step 1)|complicating disease|3|||
163394492|NCT00088907|590156916|FG001|Randomized Study (Step 1)|complicating disease|1|||
163394493|NCT00088907|590156915|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
163394494|NCT00088907|590156916|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
163394495|NCT00088907|590156915|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
163394496|NCT00088907|590156916|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
163394497|NCT00088907|590156915|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
163394498|NCT00088907|590156916|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
163394499|NCT00088907|590156915|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
163394500|NCT00088907|590156916|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
163394501|NCT00088907|590156915|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
163394502|NCT00088907|590156916|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
163394503|NCT00088907|590156915|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
163394504|NCT00088907|590156916|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
163394505|NCT00682448|590156921|FG000|Overall Study|Adverse Event|1|||
163394506|NCT00682448|590156922|FG001|Overall Study|Adverse Event|2|||
163394507|NCT00682448|590156921|FG000|Overall Study|Lack of Efficacy|1|||
163394508|NCT00682448|590156922|FG001|Overall Study|Lack of Efficacy|0|||
163394509|NCT00682448|590156921|FG000|Overall Study|Lost to Follow-up|1|||
163394510|NCT00682448|590156922|FG001|Overall Study|Lost to Follow-up|3|||
163394511|NCT00682448|590156921|FG000|Overall Study|Pregnancy|0|||
163394512|NCT00682448|590156922|FG001|Overall Study|Pregnancy|1|||
163394513|NCT00682448|590156921|FG000|Overall Study|Withdrawal by Subject|2|||
163394514|NCT00682448|590156922|FG001|Overall Study|Withdrawal by Subject|0|||
163394515|NCT04050670|590156925|FG000|Period 3|Physician Decision|0|||
163394516|NCT04050670|590156926|FG001|Period 3|Physician Decision|1|||
163394517|NCT04050670|590156927|FG002|Period 3|Physician Decision|0|||
163394518|NCT00268437|590156928|FG000|Overall Study|Ineligible|1|||
163394519|NCT02553265|590156929|FG000|Enrollment|Death|0|||
163394520|NCT02553265|590156930|FG001|Enrollment|Death|0|||
163394521|NCT02553265|590156931|FG002|Enrollment|Death|1|||
163394522|NCT02553265|590156929|FG000|First Intervention (28 Days)|Adverse Event|1|||
163394523|NCT02553265|590156930|FG001|First Intervention (28 Days)|Adverse Event|0|||
163394524|NCT02553265|590156931|FG002|First Intervention (28 Days)|Adverse Event|0|||
163394525|NCT02553265|590156929|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
163394526|NCT02553265|590156930|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
163394527|NCT02553265|590156931|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
163394528|NCT02553265|590156929|FG000|Second Intervention (28 Days)|Adverse Event|1|||
163394529|NCT02553265|590156930|FG001|Second Intervention (28 Days)|Adverse Event|0|||
163394530|NCT02553265|590156931|FG002|Second Intervention (28 Days)|Adverse Event|0|||
163394531|NCT02553265|590156929|FG000|Third Intervention (28 Days)|Adverse Event|1|||
163394532|NCT02553265|590156930|FG001|Third Intervention (28 Days)|Adverse Event|0|||
163394533|NCT02553265|590156931|FG002|Third Intervention (28 Days)|Adverse Event|0|||
162958371|NCT01695239|588551579|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958372|NCT01695239|588551580|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958373|NCT01695239|588551581|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958374|NCT01695239|588551582|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958375|NCT01695239|588551583|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958376|NCT01695239|588551584|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958377|NCT01695239|588551585|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958378|NCT01695239|588551586|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958379|NCT01695239|588551587|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958380|NCT01695239|588551588|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958381|NCT01695239|588551575|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
162958382|NCT01695239|588551576|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
162958383|NCT01695239|588551577|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
162958384|NCT01695239|588551578|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
162958385|NCT01695239|588551579|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958386|NCT01695239|588551580|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958387|NCT01695239|588551581|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958388|NCT01695239|588551582|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958389|NCT01695239|588551583|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958390|NCT01695239|588551584|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958391|NCT01695239|588551585|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958392|NCT01695239|588551586|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958393|NCT01695239|588551587|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958394|NCT01695239|588551588|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958395|NCT01695239|588551575|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
162958396|NCT01695239|588551576|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958397|NCT01695239|588551577|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
162958398|NCT01695239|588551578|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958399|NCT01695239|588551579|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958400|NCT01695239|588551580|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958401|NCT01695239|588551581|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958402|NCT01695239|588551582|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958403|NCT01695239|588551583|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958404|NCT01695239|588551584|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958405|NCT01695239|588551585|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958406|NCT01695239|588551586|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958407|NCT01695239|588551587|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958408|NCT01695239|588551588|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958409|NCT01695239|588551575|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
163394534|NCT02553265|590156929|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
163394535|NCT02553265|590156930|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
163394536|NCT02553265|590156931|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
163394537|NCT00659529|590156932|FG000|Overall Study|Withdrawal by Subject|4|||
163394538|NCT00659529|590156932|FG000|Overall Study|Protocol Violation|3|||
163394539|NCT00659529|590156932|FG000|Overall Study|Screen failure|9|||
163394540|NCT01022996|590156936|FG000|Overall Study|Adverse Event|14|||
163394541|NCT01022996|590156936|FG000|Overall Study|Withdrawal by Subject|3|||
163394542|NCT01022996|590156936|FG000|Overall Study|Lost to Follow-up|1|||
163394543|NCT01022996|590156936|FG000|Overall Study|Administrative problems|6|||
163394544|NCT01022996|590156936|FG000|Overall Study|Disease Progression|32|||
163394545|NCT01022996|590156936|FG000|Overall Study|Protocol Violation|1|||
163394546|NCT02767323|590156937|FG000|Overall Study|Withdrawal by Subject|17|||
163394547|NCT02767323|590156938|FG001|Overall Study|Withdrawal by Subject|5|||
163394548|NCT02767323|590156939|FG002|Overall Study|Withdrawal by Subject|13|||
163394549|NCT02767323|590156940|FG003|Overall Study|Withdrawal by Subject|0|||
163394550|NCT02767323|590156937|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
163394551|NCT02767323|590156938|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
163394552|NCT02767323|590156939|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
163394553|NCT02767323|590156940|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
163394554|NCT00930722|590156941|FG000|Overall Study|Lost to Follow-up|16|||
163394555|NCT00930722|590156941|FG000|Overall Study|No longer willing to participate|9|||
163394556|NCT00930722|590156941|FG000|Overall Study|Study terminated by sponsor|2|||
162958410|NCT01695239|588551576|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
162958411|NCT01695239|588551577|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
163394557|NCT03523728|590156942|FG000|Stage 1 (24 Months)|Adverse Event|2|||
163394558|NCT03523728|590156943|FG001|Stage 1 (24 Months)|Adverse Event|2|||
163394559|NCT03523728|590156944|FG002|Stage 1 (24 Months)|Adverse Event|4|||
163301101|NCT01939899|589809969|FG000|Phase 2|Withdrawal by Subject|0|||
163301102|NCT01939899|589809970|FG001|Phase 2|Withdrawal by Subject|0|||
163301103|NCT01939899|589809971|FG002|Phase 2|Withdrawal by Subject|0|||
163301104|NCT01939899|589809972|FG003|Phase 2|Withdrawal by Subject|2|||
163301105|NCT01939899|589809973|FG004|Phase 2|Withdrawal by Subject|0|||
163301106|NCT01939899|589809969|FG000|Phase 2|Disease Progression|0|||
163301107|NCT01939899|589809970|FG001|Phase 2|Disease Progression|0|||
163301108|NCT01939899|589809971|FG002|Phase 2|Disease Progression|0|||
163301109|NCT01939899|589809972|FG003|Phase 2|Disease Progression|9|||
163301110|NCT01939899|589809973|FG004|Phase 2|Disease Progression|1|||
163301111|NCT02015520|589809978|FG000|Overall Study|Lack of Efficacy|1|||
163301112|NCT02015520|589809979|FG001|Overall Study|Lack of Efficacy|0|||
163301113|NCT02015520|589809980|FG002|Overall Study|Lack of Efficacy|3|||
163301114|NCT02015520|589809981|FG003|Overall Study|Lack of Efficacy|2|||
163301115|NCT02015520|589809978|FG000|Overall Study|Adverse Event|0|||
163301116|NCT02015520|589809979|FG001|Overall Study|Adverse Event|0|||
163301117|NCT02015520|589809980|FG002|Overall Study|Adverse Event|0|||
163301118|NCT02015520|589809981|FG003|Overall Study|Adverse Event|1|||
163301119|NCT02015520|589809978|FG000|Overall Study|Withdrawal by Subject|2|||
163301120|NCT02015520|589809979|FG001|Overall Study|Withdrawal by Subject|2|||
163301121|NCT02015520|589809980|FG002|Overall Study|Withdrawal by Subject|1|||
163301122|NCT02015520|589809981|FG003|Overall Study|Withdrawal by Subject|0|||
163301123|NCT02015520|589809978|FG000|Overall Study|Death|1|||
163301124|NCT02015520|589809979|FG001|Overall Study|Death|0|||
163301125|NCT02015520|589809980|FG002|Overall Study|Death|0|||
163301126|NCT02015520|589809981|FG003|Overall Study|Death|0|||
163301127|NCT02015520|589809978|FG000|Overall Study|Lost to Follow-up|0|||
163301128|NCT02015520|589809979|FG001|Overall Study|Lost to Follow-up|0|||
163301129|NCT02015520|589809980|FG002|Overall Study|Lost to Follow-up|1|||
162958412|NCT01695239|588551578|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958413|NCT01695239|588551579|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958414|NCT01695239|588551580|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958415|NCT01695239|588551581|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958416|NCT01695239|588551582|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958417|NCT01695239|588551583|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958418|NCT01695239|588551584|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958419|NCT01695239|588551585|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958420|NCT01695239|588551586|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958421|NCT01695239|588551587|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958422|NCT01695239|588551588|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958423|NCT01695239|588551575|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
162958424|NCT01695239|588551576|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958425|NCT01695239|588551577|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
162958426|NCT01695239|588551578|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958427|NCT01695239|588551579|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958428|NCT01695239|588551580|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958429|NCT01695239|588551581|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958430|NCT01695239|588551582|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
163301130|NCT02015520|589809981|FG003|Overall Study|Lost to Follow-up|0|||
163301131|NCT02015520|589809978|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
163301132|NCT02015520|589809979|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
163301133|NCT02015520|589809980|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
163301134|NCT02015520|589809981|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
162958431|NCT01695239|588551583|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958432|NCT01695239|588551584|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958433|NCT01695239|588551585|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
163301135|NCT02015520|589809978|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
163394560|NCT03523728|590156945|FG003|Stage 1 (24 Months)|Adverse Event|0|||
162958434|NCT01695239|588551586|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
163195376|NCT02034110|589429849|FG004|Overall Study|Lost to Follow-up|1|||
163195377|NCT02034110|589429850|FG005|Overall Study|Lost to Follow-up|0|||
163195378|NCT02034110|589429851|FG006|Overall Study|Lost to Follow-up|1|||
163195379|NCT02034110|589429852|FG007|Overall Study|Lost to Follow-up|0|||
163195380|NCT02034110|589429845|FG000|Overall Study|Withdrawal by Subject|5|||
163195381|NCT02034110|589429846|FG001|Overall Study|Withdrawal by Subject|7|||
163195382|NCT02034110|589429847|FG002|Overall Study|Withdrawal by Subject|0|||
163195383|NCT02034110|589429848|FG003|Overall Study|Withdrawal by Subject|3|||
163195384|NCT02034110|589429849|FG004|Overall Study|Withdrawal by Subject|7|||
163195385|NCT02034110|589429850|FG005|Overall Study|Withdrawal by Subject|0|||
163195386|NCT02034110|589429851|FG006|Overall Study|Withdrawal by Subject|3|||
163195387|NCT02034110|589429852|FG007|Overall Study|Withdrawal by Subject|1|||
163195388|NCT02034110|589429845|FG000|Overall Study|Study closed by sponsor|6|||
163195389|NCT02034110|589429846|FG001|Overall Study|Study closed by sponsor|2|||
163195390|NCT02034110|589429847|FG002|Overall Study|Study closed by sponsor|0|||
163195391|NCT02034110|589429848|FG003|Overall Study|Study closed by sponsor|6|||
163195392|NCT02034110|589429849|FG004|Overall Study|Study closed by sponsor|7|||
163195393|NCT02034110|589429850|FG005|Overall Study|Study closed by sponsor|0|||
163195394|NCT02034110|589429851|FG006|Overall Study|Study closed by sponsor|42|||
163195395|NCT02034110|589429852|FG007|Overall Study|Study closed by sponsor|0|||
163301136|NCT02015520|589809979|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
163301137|NCT02015520|589809980|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
163301138|NCT02015520|589809981|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
163301139|NCT01854385|589809985|FG000|Pre-Treatment|Withdrawal by Subject|4|||
163301140|NCT01854385|589809985|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
163301141|NCT01854385|589809985|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
163301142|NCT01854385|589809985|FG000|Pre-Treatment|Unable to come for study visits|1|||
163301143|NCT01854385|589809985|FG000|Treatment|Lost to Follow-up|1|||
163301144|NCT02932579|589809986|FG000|Overall Study|Withdrawal by Subject|4|||
163301145|NCT02932579|589809987|FG001|Overall Study|Withdrawal by Subject|1|||
163301146|NCT00415519|589809992|FG000|Overall Study|Adverse Event|1|||
163301147|NCT00415519|589809993|FG001|Overall Study|Adverse Event|0|||
163301148|NCT00415519|589809992|FG000|Overall Study|Withdrawal by Subject|2|||
163301149|NCT00415519|589809993|FG001|Overall Study|Withdrawal by Subject|0|||
163301150|NCT00415519|589809992|FG000|Overall Study|Patient's convenience|1|||
163301151|NCT00415519|589809993|FG001|Overall Study|Patient's convenience|0|||
163301152|NCT04163718|589809994|FG000|Overall Study|Study terminated|12|||
163301153|NCT01985334|589809997|FG000|Overall Study|Administrative problems|1|||
163301154|NCT01985334|589809998|FG001|Overall Study|Administrative problems|1|||
163301155|NCT01985334|589809999|FG002|Overall Study|Administrative problems|0|||
163301156|NCT01985334|589810000|FG003|Overall Study|Administrative problems|2|||
163301157|NCT01985334|589810001|FG004|Overall Study|Administrative problems|0|||
163301158|NCT01985334|589810002|FG005|Overall Study|Administrative problems|1|||
163301159|NCT01985334|589810003|FG006|Overall Study|Administrative problems|1|||
163301160|NCT01985334|589810004|FG007|Overall Study|Administrative problems|3|||
163301161|NCT01985334|589809997|FG000|Overall Study|Death|1|||
163301162|NCT01985334|589809998|FG001|Overall Study|Death|0|||
163301163|NCT01985334|589809999|FG002|Overall Study|Death|0|||
163301164|NCT01985334|589810000|FG003|Overall Study|Death|3|||
163301165|NCT01985334|589810001|FG004|Overall Study|Death|0|||
163301166|NCT01985334|589810002|FG005|Overall Study|Death|0|||
163301167|NCT01985334|589810003|FG006|Overall Study|Death|1|||
163301168|NCT01985334|589810004|FG007|Overall Study|Death|2|||
163301169|NCT01985334|589809997|FG000|Overall Study|Worsening of disease|0|||
163301170|NCT01985334|589809998|FG001|Overall Study|Worsening of disease|0|||
163301171|NCT01985334|589809999|FG002|Overall Study|Worsening of disease|0|||
163301172|NCT01985334|589810000|FG003|Overall Study|Worsening of disease|1|||
163301173|NCT01985334|589810001|FG004|Overall Study|Worsening of disease|0|||
163301174|NCT01985334|589810002|FG005|Overall Study|Worsening of disease|3|||
163301175|NCT01985334|589810003|FG006|Overall Study|Worsening of disease|0|||
163301176|NCT01985334|589810004|FG007|Overall Study|Worsening of disease|1|||
163301177|NCT01985334|589809997|FG000|Overall Study|Other|2|||
163301178|NCT01985334|589809998|FG001|Overall Study|Other|9|||
163301179|NCT01985334|589809999|FG002|Overall Study|Other|7|||
163301180|NCT01985334|589810000|FG003|Overall Study|Other|17|||
163301181|NCT01985334|589810001|FG004|Overall Study|Other|4|||
163301182|NCT01985334|589810002|FG005|Overall Study|Other|8|||
163301183|NCT01985334|589810003|FG006|Overall Study|Other|4|||
163301184|NCT01985334|589810004|FG007|Overall Study|Other|7|||
163301185|NCT01985334|589809997|FG000|Overall Study|Protocol deviation|6|||
163301186|NCT01985334|589809998|FG001|Overall Study|Protocol deviation|31|||
163301187|NCT01985334|589809999|FG002|Overall Study|Protocol deviation|25|||
163301188|NCT01985334|589810000|FG003|Overall Study|Protocol deviation|84|||
163301189|NCT01985334|589810001|FG004|Overall Study|Protocol deviation|17|||
163301190|NCT01985334|589810002|FG005|Overall Study|Protocol deviation|47|||
163301191|NCT01985334|589810003|FG006|Overall Study|Protocol deviation|15|||
163301192|NCT01985334|589810004|FG007|Overall Study|Protocol deviation|42|||
163301193|NCT01985334|589809997|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
163301194|NCT01985334|589809998|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
163301195|NCT01985334|589809999|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
163301196|NCT01985334|589810000|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
163301197|NCT01985334|589810001|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
163301198|NCT01985334|589810002|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
163301199|NCT01985334|589810003|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
163301200|NCT01985334|589810004|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
163301201|NCT01985334|589809997|FG000|Overall Study|Subject withdrawal of consent|3|||
163301202|NCT01985334|589809998|FG001|Overall Study|Subject withdrawal of consent|6|||
163301203|NCT01985334|589809999|FG002|Overall Study|Subject withdrawal of consent|2|||
163301204|NCT01985334|589810000|FG003|Overall Study|Subject withdrawal of consent|28|||
163301205|NCT01985334|589810001|FG004|Overall Study|Subject withdrawal of consent|4|||
163301206|NCT01985334|589810002|FG005|Overall Study|Subject withdrawal of consent|19|||
163301207|NCT01985334|589810003|FG006|Overall Study|Subject withdrawal of consent|0|||
163301208|NCT01985334|589810004|FG007|Overall Study|Subject withdrawal of consent|20|||
163301209|NCT01985334|589809997|FG000|Overall Study|Adverse Event|0|||
163301210|NCT01985334|589809998|FG001|Overall Study|Adverse Event|8|||
163301211|NCT01985334|589809999|FG002|Overall Study|Adverse Event|2|||
163301212|NCT01985334|589810000|FG003|Overall Study|Adverse Event|26|||
163301213|NCT01985334|589810001|FG004|Overall Study|Adverse Event|3|||
163301214|NCT01985334|589810002|FG005|Overall Study|Adverse Event|18|||
163301215|NCT01985334|589810003|FG006|Overall Study|Adverse Event|3|||
163301216|NCT01985334|589810004|FG007|Overall Study|Adverse Event|15|||
163301217|NCT01985334|589809997|FG000|Overall Study|Other|4|||
163301218|NCT01985334|589809998|FG001|Overall Study|Other|2|||
163301219|NCT01985334|589809999|FG002|Overall Study|Other|3|||
163394561|NCT03523728|590156946|FG004|Stage 1 (24 Months)|Adverse Event|0|||
163394562|NCT03523728|590156942|FG000|Stage 1 (24 Months)|Progressive disease|0|||
163394563|NCT03523728|590156943|FG001|Stage 1 (24 Months)|Progressive disease|0|||
163394564|NCT03523728|590156944|FG002|Stage 1 (24 Months)|Progressive disease|1|||
163394565|NCT03523728|590156945|FG003|Stage 1 (24 Months)|Progressive disease|0|||
163394566|NCT03523728|590156946|FG004|Stage 1 (24 Months)|Progressive disease|0|||
163394567|NCT03523728|590156942|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
163394568|NCT03523728|590156943|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
163394569|NCT03523728|590156944|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
163394570|NCT03523728|590156945|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
163394571|NCT03523728|590156946|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
163394572|NCT03523728|590156942|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
163394573|NCT03523728|590156943|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
163394574|NCT03523728|590156944|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
163394575|NCT03523728|590156945|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
163394576|NCT03523728|590156946|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
163394577|NCT03523728|590156942|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
163394578|NCT03523728|590156943|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
163394579|NCT03523728|590156944|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
163301220|NCT01985334|589810000|FG003|Overall Study|Other|10|||
163301221|NCT01985334|589810001|FG004|Overall Study|Other|1|||
163301222|NCT01985334|589810002|FG005|Overall Study|Other|6|||
163301223|NCT01985334|589810003|FG006|Overall Study|Other|2|||
163301224|NCT01985334|589810004|FG007|Overall Study|Other|2|||
163301225|NCT01985334|589809997|FG000|Overall Study|Medication non-compliance|0|||
163301226|NCT01985334|589809998|FG001|Overall Study|Medication non-compliance|4|||
163301227|NCT01985334|589809999|FG002|Overall Study|Medication non-compliance|1|||
163301228|NCT01985334|589810000|FG003|Overall Study|Medication non-compliance|6|||
163301229|NCT01985334|589810001|FG004|Overall Study|Medication non-compliance|2|||
163301230|NCT01985334|589810002|FG005|Overall Study|Medication non-compliance|3|||
163301231|NCT01985334|589810003|FG006|Overall Study|Medication non-compliance|1|||
163045920|NCT03131687|588875138|FG002|Overall Study|Inadvertent Enrollment|0|||
163045921|NCT03131687|588875139|FG003|Overall Study|Inadvertent Enrollment|1|||
163045922|NCT03131687|588875140|FG004|Overall Study|Inadvertent Enrollment|0|||
163045923|NCT03131687|588875141|FG005|Overall Study|Inadvertent Enrollment|0|||
163045924|NCT02137226|588875142|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
163045925|NCT02137226|588875143|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
163045926|NCT02137226|588875144|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
163045927|NCT02137226|588875145|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
163045928|NCT02137226|588875146|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
163045929|NCT02137226|588875142|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
163045930|NCT02137226|588875143|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
163045931|NCT02137226|588875144|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
163045932|NCT02137226|588875145|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
163045933|NCT02137226|588875146|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
163045934|NCT02137226|588875142|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
163045935|NCT02137226|588875143|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
163045936|NCT02137226|588875144|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
163045937|NCT02137226|588875145|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
163045938|NCT02137226|588875146|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
163195396|NCT00064337|589429853|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
163195397|NCT00064337|589429853|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
163195398|NCT00064337|589429853|FG000|PBSCC or Induction/PBSCC|Progression|3|||
163195399|NCT00064337|589429853|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
163195400|NCT00064337|589429853|FG000|PBSCC or Induction/PBSCC|Death|2|||
163195401|NCT00064337|589429853|FG000|Transplant|Adverse Event|9|||
163195402|NCT00064337|589429853|FG000|Transplant|Not protocol-specified|5|||
163195403|NCT00064337|589429853|FG000|Transplant|Death|3|||
163195404|NCT00064337|589429853|FG000|Transplant|Patient Refusal|2|||
163195405|NCT00064337|589429853|FG000|Transplant|Progression|2|||
163195406|NCT00064337|589429853|FG000|Maintenance|Adverse Event|3|||
163195407|NCT00064337|589429853|FG000|Maintenance|Progression|2|||
163195408|NCT00064337|589429853|FG000|Maintenance|On treatment at time of analysis|2|||
163195409|NCT00064337|589429853|FG000|Maintenance|Not protocol-specified|2|||
163195410|NCT00064337|589429853|FG000|Maintenance|Death|1|||
163195411|NCT02279420|589429854|FG000|Overall Study|Lost to Follow-up|23|||
163195412|NCT03535844|589429857|FG000|Overall Study|Withdrawal by Subject|0|||
163195413|NCT03535844|589429858|FG001|Overall Study|Withdrawal by Subject|1|||
163195414|NCT00612040|589429859|FG000|Overall Study|Adverse Event|0|||
163195415|NCT00612040|589429860|FG001|Overall Study|Adverse Event|2|||
163195416|NCT00612040|589429861|FG002|Overall Study|Adverse Event|1|||
163195417|NCT00612040|589429859|FG000|Overall Study|Protocol Violation|1|||
163195418|NCT00612040|589429860|FG001|Overall Study|Protocol Violation|2|||
163195419|NCT00612040|589429861|FG002|Overall Study|Protocol Violation|1|||
163195420|NCT00612040|589429859|FG000|Overall Study|Lack of Efficacy|2|||
163195421|NCT00612040|589429860|FG001|Overall Study|Lack of Efficacy|1|||
163195422|NCT00612040|589429861|FG002|Overall Study|Lack of Efficacy|0|||
163195423|NCT00612040|589429859|FG000|Overall Study|Unclassified|2|||
163195424|NCT00612040|589429860|FG001|Overall Study|Unclassified|2|||
163195425|NCT00612040|589429861|FG002|Overall Study|Unclassified|5|||
163195426|NCT00297830|589429862|FG000|6 Month Visit|Death|1|||
163195427|NCT00297830|589429863|FG001|6 Month Visit|Death|0|||
163195428|NCT00297830|589429864|FG002|6 Month Visit|Death|2|||
163195429|NCT00297830|589429862|FG000|6 Month Visit|Withdrawal by Subject|2|||
163195430|NCT00297830|589429863|FG001|6 Month Visit|Withdrawal by Subject|1|||
163195431|NCT00297830|589429864|FG002|6 Month Visit|Withdrawal by Subject|1|||
163195432|NCT00297830|589429862|FG000|6 Month Visit|Adverse Event|0|||
163195433|NCT00297830|589429863|FG001|6 Month Visit|Adverse Event|1|||
163195434|NCT00297830|589429864|FG002|6 Month Visit|Adverse Event|0|||
163195435|NCT00297830|589429862|FG000|12 Month Visit|Lost to Follow-up|1|||
163195436|NCT00297830|589429863|FG001|12 Month Visit|Lost to Follow-up|0|||
163195437|NCT00297830|589429864|FG002|12 Month Visit|Lost to Follow-up|0|||
163195438|NCT00297830|589429862|FG000|12 Month Visit|Adverse Event|0|||
163195439|NCT00297830|589429863|FG001|12 Month Visit|Adverse Event|3|||
163195440|NCT00297830|589429864|FG002|12 Month Visit|Adverse Event|0|||
163195441|NCT00297830|589429862|FG000|12 Month Visit|Withdrawal by Subject|0|||
163195442|NCT00297830|589429863|FG001|12 Month Visit|Withdrawal by Subject|3|||
163195443|NCT00297830|589429864|FG002|12 Month Visit|Withdrawal by Subject|0|||
163195444|NCT02835820|589429865|FG000|Overall Study|Baseline Screen Failure|0|||
163195445|NCT02835820|589429866|FG001|Overall Study|Baseline Screen Failure|3|||
163195446|NCT00827502|589429867|FG000|Overall Study|randomized but not treated|11|||
163195447|NCT00827502|589429867|FG000|Overall Study|Adverse Event|1|||
163195448|NCT00827502|589429867|FG000|Overall Study|Lost to Follow-up|4|||
163195449|NCT00827502|589429867|FG000|Overall Study|Withdrawal by Subject|5|||
163195450|NCT05096221|589429868|FG000|Part 2|Physician Decision|0|||
163195451|NCT05096221|589429869|FG001|Part 2|Physician Decision|1|||
163301232|NCT01985334|589810004|FG007|Overall Study|Medication non-compliance|3|||
163301233|NCT01985334|589809997|FG000|Overall Study|Use of prohibited treatment|1|||
163301234|NCT01985334|589809998|FG001|Overall Study|Use of prohibited treatment|4|||
163301235|NCT01985334|589809999|FG002|Overall Study|Use of prohibited treatment|1|||
163301236|NCT01985334|589810000|FG003|Overall Study|Use of prohibited treatment|2|||
163301237|NCT01985334|589810001|FG004|Overall Study|Use of prohibited treatment|1|||
163301238|NCT01985334|589810002|FG005|Overall Study|Use of prohibited treatment|6|||
163301239|NCT01985334|589810003|FG006|Overall Study|Use of prohibited treatment|2|||
163301240|NCT01985334|589810004|FG007|Overall Study|Use of prohibited treatment|0|||
163301241|NCT01985334|589809997|FG000|Overall Study|Investigator decision|0|||
163045939|NCT02137226|588875142|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
163045940|NCT02137226|588875143|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
163045941|NCT02137226|588875144|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
163045942|NCT02137226|588875145|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
163045943|NCT02137226|588875146|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
163045944|NCT02137226|588875142|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
163045945|NCT02137226|588875143|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
163045946|NCT02137226|588875144|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
163045947|NCT02137226|588875145|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
163045948|NCT02137226|588875146|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
163045949|NCT02137226|588875142|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
163045950|NCT02137226|588875143|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
163045951|NCT02137226|588875144|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
163045952|NCT02137226|588875145|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
163045953|NCT02137226|588875146|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
163045954|NCT02137226|588875142|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
163045955|NCT02137226|588875143|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
163045956|NCT02137226|588875144|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
163045957|NCT02137226|588875145|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
163301242|NCT01985334|589809998|FG001|Overall Study|Investigator decision|3|||
163301243|NCT01985334|589809999|FG002|Overall Study|Investigator decision|0|||
163301244|NCT01985334|589810000|FG003|Overall Study|Investigator decision|7|||
163301245|NCT01985334|589810001|FG004|Overall Study|Investigator decision|1|||
163301246|NCT01985334|589810002|FG005|Overall Study|Investigator decision|1|||
163301247|NCT01985334|589810003|FG006|Overall Study|Investigator decision|0|||
163301248|NCT01985334|589810004|FG007|Overall Study|Investigator decision|4|||
163301249|NCT01985334|589809997|FG000|Overall Study|Lost to Follow-up|0|||
163301250|NCT01985334|589809998|FG001|Overall Study|Lost to Follow-up|2|||
163301251|NCT01985334|589809999|FG002|Overall Study|Lost to Follow-up|0|||
163301252|NCT01985334|589810000|FG003|Overall Study|Lost to Follow-up|3|||
163301253|NCT01985334|589810001|FG004|Overall Study|Lost to Follow-up|1|||
163301254|NCT01985334|589810002|FG005|Overall Study|Lost to Follow-up|4|||
163301255|NCT01985334|589810003|FG006|Overall Study|Lost to Follow-up|0|||
163301256|NCT01985334|589810004|FG007|Overall Study|Lost to Follow-up|3|||
163301257|NCT00093015|589810005|FG000|Overall Study|Withdrawal by Subject|194|||
163301258|NCT00093015|589810006|FG001|Overall Study|Withdrawal by Subject|171|||
163301259|NCT00093015|589810005|FG000|Overall Study|Lost to Follow-up|96|||
163301260|NCT00093015|589810006|FG001|Overall Study|Lost to Follow-up|108|||
163301261|NCT00093015|589810005|FG000|Overall Study|Death|375|||
163301262|NCT00093015|589810006|FG001|Overall Study|Death|385|||
163301263|NCT04872738|589810007|FG000|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|152|||
163301264|NCT04872738|589810008|FG001|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|15|||
163301265|NCT04191499|589810009|FG000|Overall Study|Adverse Event|1|||
163301266|NCT04191499|589810010|FG001|Overall Study|Adverse Event|0|||
163301267|NCT04191499|589810009|FG000|Overall Study|Death|42|||
163301268|NCT04191499|589810010|FG001|Overall Study|Death|55|||
163301269|NCT04191499|589810009|FG000|Overall Study|Lost to Follow-up|4|||
163301270|NCT04191499|589810010|FG001|Overall Study|Lost to Follow-up|1|||
163301271|NCT04191499|589810009|FG000|Overall Study|Physician Decision|1|||
163301272|NCT04191499|589810010|FG001|Overall Study|Physician Decision|0|||
163301273|NCT04191499|589810009|FG000|Overall Study|Progressive Disease|1|||
163301274|NCT04191499|589810010|FG001|Overall Study|Progressive Disease|0|||
163301275|NCT04191499|589810009|FG000|Overall Study|Symptomatic Deterioration|1|||
163301276|NCT04191499|589810010|FG001|Overall Study|Symptomatic Deterioration|0|||
163045958|NCT02137226|588875146|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
163301277|NCT04191499|589810009|FG000|Overall Study|Withdrawal by Subject|7|||
163301278|NCT04191499|589810010|FG001|Overall Study|Withdrawal by Subject|11|||
163301279|NCT04191499|589810009|FG000|Overall Study|Ongoing in the study|104|||
163301280|NCT04191499|589810010|FG001|Overall Study|Ongoing in the study|97|||
163301281|NCT00529100|589810013|FG000|Overall Study|Adverse Event|0|||
163301282|NCT00529100|589810014|FG001|Overall Study|Adverse Event|5|||
163301283|NCT00529100|589810013|FG000|Overall Study|Protocol Violation|0|||
163301284|NCT00529100|589810014|FG001|Overall Study|Protocol Violation|1|||
163301285|NCT00529100|589810013|FG000|Overall Study|Progressive Disease|0|||
163301286|NCT00529100|589810014|FG001|Overall Study|Progressive Disease|1|||
162958435|NCT01695239|588551587|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958436|NCT01695239|588551588|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958437|NCT01695239|588551575|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
162958438|NCT01695239|588551576|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163195452|NCT03417219|589429876|FG000|Overall Study|Lost to Follow-up|0|||
163195453|NCT03417219|589429877|FG001|Overall Study|Lost to Follow-up|3|||
163195454|NCT02264639|589429882|FG000|Overall Study|Death (after completing single-dose phase)|1|||
163195455|NCT02264639|589429883|FG001|Overall Study|Death (after completing single-dose phase)|0|||
163195456|NCT02264639|589429884|FG002|Overall Study|Death (after completing single-dose phase)|0|||
163195457|NCT02264639|589429885|FG003|Overall Study|Death (after completing single-dose phase)|0|||
163195458|NCT02264639|589429886|FG004|Overall Study|Death (after completing single-dose phase)|0|||
163195459|NCT02264639|589429882|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
163195460|NCT02264639|589429883|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
163195461|NCT02264639|589429884|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
163195462|NCT02264639|589429885|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
163195463|NCT02264639|589429886|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
163195464|NCT02264639|589429882|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
163195465|NCT02264639|589429883|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
163195466|NCT02264639|589429884|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
163195467|NCT02264639|589429885|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
163195468|NCT02264639|589429886|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
163195469|NCT02264639|589429882|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
163195470|NCT02264639|589429883|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
163195471|NCT02264639|589429884|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
163195472|NCT02264639|589429885|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
163195473|NCT02264639|589429886|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
163195474|NCT00369824|589429890|FG000|Overall Study|Adverse Event|0|||
163195475|NCT00369824|589429891|FG001|Overall Study|Adverse Event|2|||
163195476|NCT00369824|589429892|FG002|Overall Study|Adverse Event|0|||
163195477|NCT00369824|589429893|FG003|Overall Study|Adverse Event|0|||
163195478|NCT00369824|589429894|FG004|Overall Study|Adverse Event|1|||
163195479|NCT00369824|589429895|FG005|Overall Study|Adverse Event|0|||
163195480|NCT00369824|589429890|FG000|Overall Study|Protocol Violation|0|||
163195481|NCT00369824|589429891|FG001|Overall Study|Protocol Violation|1|||
163195482|NCT00369824|589429892|FG002|Overall Study|Protocol Violation|0|||
163195483|NCT00369824|589429893|FG003|Overall Study|Protocol Violation|1|||
163195484|NCT00369824|589429894|FG004|Overall Study|Protocol Violation|1|||
163195485|NCT00369824|589429895|FG005|Overall Study|Protocol Violation|0|||
163195486|NCT00369824|589429890|FG000|Overall Study|Withdrawal by Subject|9|||
163195487|NCT00369824|589429891|FG001|Overall Study|Withdrawal by Subject|5|||
163195488|NCT00369824|589429892|FG002|Overall Study|Withdrawal by Subject|5|||
163195489|NCT00369824|589429893|FG003|Overall Study|Withdrawal by Subject|4|||
163195490|NCT00369824|589429894|FG004|Overall Study|Withdrawal by Subject|6|||
163195491|NCT00369824|589429895|FG005|Overall Study|Withdrawal by Subject|2|||
163195492|NCT00369824|589429890|FG000|Overall Study|Lost to Follow-up|6|||
163195493|NCT00369824|589429891|FG001|Overall Study|Lost to Follow-up|11|||
163195494|NCT00369824|589429892|FG002|Overall Study|Lost to Follow-up|7|||
163195495|NCT00369824|589429893|FG003|Overall Study|Lost to Follow-up|8|||
163195496|NCT00369824|589429894|FG004|Overall Study|Lost to Follow-up|9|||
163195497|NCT00369824|589429895|FG005|Overall Study|Lost to Follow-up|6|||
163195498|NCT00369824|589429890|FG000|Overall Study|Other|0|||
163195499|NCT00369824|589429891|FG001|Overall Study|Other|0|||
163195500|NCT00369824|589429892|FG002|Overall Study|Other|0|||
163195501|NCT00369824|589429893|FG003|Overall Study|Other|2|||
163195502|NCT00369824|589429894|FG004|Overall Study|Other|1|||
163195503|NCT00369824|589429895|FG005|Overall Study|Other|3|||
163195504|NCT01443078|589429896|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
163195505|NCT01443078|589429896|FG000|Overall Study|Withdrawal by Subject|1|||
163195506|NCT01443078|589429896|FG000|Overall Study|Patient had brain mets|1|||
163195507|NCT01390649|589429897|FG000|Overall Study|Physician Decision|1|||
163195508|NCT00415168|589429898|FG000|Overall Study|Death|26|||
163195509|NCT00415168|589429898|FG000|Overall Study|Lost to Follow-up|3|||
163195510|NCT00415168|589429898|FG000|Overall Study|Physician Decision|13|||
163195511|NCT00415168|589429898|FG000|Overall Study|Sponsor Decision|4|||
163195512|NCT00415168|589429898|FG000|Overall Study|Withdrawal by Subject|6|||
163195513|NCT01612858|589429900|FG000|Overall Study|Withdrawal by Subject|5|||
163195514|NCT01612858|589429901|FG001|Overall Study|Withdrawal by Subject|1|||
163195515|NCT00003487|589429902|FG000|Overall Study|Not evaluable|2|||
163195516|NCT00005044|589429905|FG000|Overall Study|Protocol Violation|37|||
163195517|NCT00005044|589429906|FG001|Overall Study|Protocol Violation|46|||
163195518|NCT00005044|589429905|FG000|Overall Study|Withdrawal by Subject|1|||
163301287|NCT00529100|589810013|FG000|Overall Study|Withdrawal by Subject|0|||
163301288|NCT00529100|589810014|FG001|Overall Study|Withdrawal by Subject|1|||
163301289|NCT00529100|589810013|FG000|Overall Study|Participant Ineligibility|0|||
163301290|NCT00529100|589810014|FG001|Overall Study|Participant Ineligibility|1|||
163301291|NCT05524454|589810016|FG000|Overall Study|Withdrawal by Subject|1|||
163301292|NCT05999435|589810017|FG000|Overall Study|Adverse Event|1|||
163301293|NCT05999435|589810018|FG001|Overall Study|Adverse Event|0|||
163301294|NCT05999435|589810019|FG002|Overall Study|Adverse Event|0|||
163301295|NCT05999435|589810017|FG000|Overall Study|Withdrawal by Subject|2|||
163301296|NCT05999435|589810018|FG001|Overall Study|Withdrawal by Subject|1|||
163301297|NCT05999435|589810019|FG002|Overall Study|Withdrawal by Subject|0|||
163301298|NCT00781274|589810026|FG000|Overall Study|Withdrawal by Subject|2|||
163301299|NCT00603954|589810028|FG000|Overall Study|Protocol Violation|1|||
163301300|NCT00603954|589810029|FG001|Overall Study|Protocol Violation|2|||
163301301|NCT04705480|589810030|FG000|Overall Study|Withdrawal by Subject|1|||
163301302|NCT04705480|589810031|FG001|Overall Study|Withdrawal by Subject|0|||
163301303|NCT04705480|589810032|FG002|Overall Study|Withdrawal by Subject|1|||
163301304|NCT04705480|589810030|FG000|Overall Study|Protocol Violation|2|||
163301305|NCT04705480|589810031|FG001|Overall Study|Protocol Violation|0|||
163301306|NCT04705480|589810032|FG002|Overall Study|Protocol Violation|2|||
163301307|NCT04705480|589810030|FG000|Overall Study|Decision to discharge before intervention|2|||
163301308|NCT04705480|589810031|FG001|Overall Study|Decision to discharge before intervention|0|||
163301309|NCT04705480|589810032|FG002|Overall Study|Decision to discharge before intervention|0|||
163301310|NCT04970654|589810033|FG000|Overall Study|Withdrawal by parents/guardian|1|||
163301311|NCT04970654|589810034|FG001|Overall Study|Withdrawal by parents/guardian|2|||
163301312|NCT04970654|589810033|FG000|Overall Study|Unclassified|2|||
163301313|NCT04970654|589810034|FG001|Overall Study|Unclassified|1|||
163301314|NCT04970654|589810033|FG000|Overall Study|Lost to Follow-up|1|||
163301315|NCT04970654|589810034|FG001|Overall Study|Lost to Follow-up|0|||
163301316|NCT01251354|589810036|FG000|Overall Study|Adverse Event|1|||
163301317|NCT01251354|589810036|FG000|Overall Study|Investigator's Decision|1|||
163301318|NCT01251354|589810036|FG000|Overall Study|Disease Progression|4|||
163301319|NCT04992390|589810043|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
163301320|NCT04992390|589810044|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
162958439|NCT01695239|588551577|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
162958440|NCT01695239|588551578|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958441|NCT01695239|588551579|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163301321|NCT04992390|589810045|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
163301322|NCT04992390|589810043|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
163301323|NCT04992390|589810044|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
163301324|NCT04992390|589810045|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
163301325|NCT04992390|589810043|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
163301326|NCT04992390|589810044|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
163301327|NCT04992390|589810045|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
162958442|NCT01695239|588551580|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958443|NCT01695239|588551581|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163301328|NCT04992390|589810043|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
163301329|NCT04992390|589810044|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
163301330|NCT04992390|589810045|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
162958444|NCT01695239|588551582|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958445|NCT01695239|588551583|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958446|NCT01695239|588551584|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958447|NCT01695239|588551585|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958448|NCT01695239|588551586|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958449|NCT01695239|588551587|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958450|NCT01695239|588551588|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958451|NCT01695239|588551575|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
162958452|NCT01695239|588551576|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958453|NCT01695239|588551577|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958454|NCT01695239|588551578|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958455|NCT01695239|588551579|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958456|NCT01695239|588551580|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958457|NCT01695239|588551581|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
163301331|NCT04992390|589810043|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
163301332|NCT04992390|589810044|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
163301333|NCT04992390|589810045|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
163301334|NCT04992390|589810043|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
163301335|NCT04992390|589810044|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
163301336|NCT04992390|589810045|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
163301337|NCT04992390|589810043|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
163301338|NCT04992390|589810044|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
163301339|NCT04992390|589810045|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
163301340|NCT04992390|589810043|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
163301341|NCT04992390|589810044|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
163301342|NCT04992390|589810045|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
163301343|NCT04992390|589810043|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
163301344|NCT04992390|589810044|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
163301345|NCT04992390|589810045|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
163301346|NCT04992390|589810043|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
163301347|NCT04992390|589810044|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
163301348|NCT04992390|589810045|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
163301349|NCT04992390|589810043|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
163301350|NCT04992390|589810044|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
163301351|NCT04992390|589810045|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
163301352|NCT04992390|589810043|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
163301353|NCT04992390|589810044|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
163301354|NCT04992390|589810045|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
163301355|NCT04992390|589810043|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
163301356|NCT04992390|589810044|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
163301357|NCT04992390|589810045|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
163301358|NCT04992390|589810043|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
163301359|NCT04992390|589810044|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
163301360|NCT04992390|589810045|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
162958458|NCT01695239|588551582|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958459|NCT01695239|588551583|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958460|NCT01695239|588551584|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958461|NCT01695239|588551585|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958462|NCT01695239|588551586|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958463|NCT01695239|588551587|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958464|NCT01695239|588551588|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958465|NCT01695239|588551575|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958466|NCT01695239|588551576|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958467|NCT01695239|588551577|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958468|NCT01695239|588551578|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958469|NCT01695239|588551579|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958470|NCT01695239|588551580|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958471|NCT01695239|588551581|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958472|NCT01695239|588551582|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
162958473|NCT01695239|588551583|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958474|NCT01695239|588551584|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958475|NCT01695239|588551585|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958476|NCT01695239|588551586|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958477|NCT01695239|588551587|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958478|NCT01695239|588551588|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958479|NCT01695239|588551575|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958480|NCT01695239|588551576|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958481|NCT01695239|588551577|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958482|NCT01695239|588551578|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958483|NCT01695239|588551579|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958484|NCT01695239|588551580|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958485|NCT01695239|588551581|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958486|NCT01695239|588551582|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
162958487|NCT01695239|588551583|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958488|NCT01695239|588551584|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958489|NCT01695239|588551585|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958490|NCT01695239|588551586|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958491|NCT01695239|588551587|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958492|NCT01695239|588551588|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958493|NCT01695239|588551575|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958494|NCT01695239|588551576|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958495|NCT01695239|588551577|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
163045959|NCT02137226|588875142|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
163045960|NCT02137226|588875143|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
163301361|NCT04992390|589810043|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
163301362|NCT04992390|589810044|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
163045961|NCT02137226|588875144|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
163045962|NCT02137226|588875145|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
163045963|NCT02137226|588875146|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
163045964|NCT02137226|588875142|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
163045965|NCT02137226|588875143|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
163045966|NCT02137226|588875144|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
163045967|NCT02137226|588875145|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
163045968|NCT02137226|588875146|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
163045969|NCT02137226|588875142|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
163045970|NCT02137226|588875143|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
163045971|NCT02137226|588875144|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
163045972|NCT02137226|588875145|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
163301363|NCT04992390|589810045|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
163301364|NCT04992390|589810043|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
163301365|NCT04992390|589810044|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
163301366|NCT04992390|589810045|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
163301367|NCT03358875|589811135|FG000|Overall Study|Death|409|||
163301368|NCT03358875|589811136|FG001|Overall Study|Death|223|||
163301369|NCT03358875|589811135|FG000|Overall Study|Study Closed by Sponsor|66|||
163301370|NCT03358875|589811136|FG001|Overall Study|Study Closed by Sponsor|29|||
163301371|NCT03358875|589811135|FG000|Overall Study|Withdrawal by Subject|13|||
163301372|NCT03358875|589811136|FG001|Overall Study|Withdrawal by Subject|16|||
163301373|NCT03358875|589811135|FG000|Overall Study|Lost to Follow-up|13|||
163301374|NCT03358875|589811136|FG001|Overall Study|Lost to Follow-up|2|||
163301375|NCT03358875|589811135|FG000|Overall Study|Miscellaneous|33|||
163301376|NCT03358875|589811136|FG001|Overall Study|Miscellaneous|0|||
163301377|NCT03358875|589811135|FG000|Overall Study|Remained on Study|1|||
163045973|NCT02137226|588875146|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
163045974|NCT02137226|588875142|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
163045975|NCT02137226|588875143|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
163301378|NCT03358875|589811136|FG001|Overall Study|Remained on Study|0|||
163301379|NCT06375421|589811137|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
163301380|NCT06375421|589811138|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
163301381|NCT06375421|589811139|FG002|First Intervention (1 Week)|Withdrawal by Subject|1|||
163301382|NCT06375421|589811140|FG003|First Intervention (1 Week)|Withdrawal by Subject|0|||
163301383|NCT05760313|589811146|FG000|Overall Study|Withdrawal by Subject|0|||
163301384|NCT05760313|589811147|FG001|Overall Study|Withdrawal by Subject|0|||
163301385|NCT05760313|589811148|FG002|Overall Study|Withdrawal by Subject|1|||
163301386|NCT05760313|589811146|FG000|Overall Study|Other|1|||
163301387|NCT05760313|589811147|FG001|Overall Study|Other|0|||
163301388|NCT05760313|589811148|FG002|Overall Study|Other|0|||
163301389|NCT00956007|589811149|FG000|Overall Study|Protocol Violation|27|||
163301390|NCT00956007|589811150|FG001|Overall Study|Protocol Violation|23|||
163301391|NCT05228470|589811151|FG000|Overall Study|Death|6|||
163301392|NCT05228470|589811152|FG001|Overall Study|Death|11|||
163301393|NCT05228470|589811151|FG000|Overall Study|Withdrawal by Subject|1|||
163301394|NCT05228470|589811152|FG001|Overall Study|Withdrawal by Subject|8|||
163301395|NCT05228470|589811151|FG000|Overall Study|Ongoing|1|||
163301396|NCT05228470|589811152|FG001|Overall Study|Ongoing|11|||
163301397|NCT03885037|589811153|FG000|Overall Study|Protocol Violation|16|||
163301398|NCT01492686|589811154|FG000|Double-blind Phase|Adverse Event|0|||
163301399|NCT01492686|589811155|FG001|Double-blind Phase|Adverse Event|2|||
163301400|NCT01492686|589811154|FG000|Double-blind Phase|Physician Decision|0|||
163301401|NCT01492686|589811155|FG001|Double-blind Phase|Physician Decision|1|||
163301402|NCT01492686|589811154|FG000|Double-blind Phase|Withdrawal by Subject|0|||
163301403|NCT01492686|589811155|FG001|Double-blind Phase|Withdrawal by Subject|2|||
163301404|NCT01492686|589811154|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
163301405|NCT01492686|589811155|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
163301406|NCT01492686|589811154|FG000|Open-label Phase|Adverse Event|1|||
163045976|NCT02137226|588875144|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
162958496|NCT01695239|588551578|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958497|NCT01695239|588551579|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958498|NCT01695239|588551580|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958499|NCT01695239|588551581|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958500|NCT01695239|588551582|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
162958501|NCT01695239|588551583|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958502|NCT01695239|588551584|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958503|NCT01695239|588551585|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958504|NCT01695239|588551586|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958505|NCT01695239|588551587|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958506|NCT01695239|588551588|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958507|NCT01695239|588551575|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958508|NCT01695239|588551576|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958509|NCT01695239|588551577|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958510|NCT01695239|588551578|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958511|NCT01695239|588551579|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958512|NCT01695239|588551580|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958513|NCT01695239|588551581|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958514|NCT01695239|588551582|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958515|NCT01695239|588551583|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
162958516|NCT01695239|588551584|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
162958517|NCT01695239|588551585|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958518|NCT01695239|588551586|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958519|NCT01695239|588551587|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958520|NCT01695239|588551588|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958521|NCT01695239|588551575|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
162958522|NCT01695239|588551576|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
162958523|NCT01695239|588551577|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
162958524|NCT01695239|588551578|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
162958525|NCT01695239|588551579|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
162958526|NCT01695239|588551580|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
162958527|NCT01695239|588551581|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
162958528|NCT01695239|588551582|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
162958529|NCT01695239|588551583|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
162958530|NCT01695239|588551584|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
162958531|NCT01695239|588551585|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
162958532|NCT01695239|588551586|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
162958533|NCT01695239|588551587|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
162958534|NCT01695239|588551588|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
162958535|NCT01695239|588551575|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958536|NCT01695239|588551576|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958537|NCT01695239|588551577|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958538|NCT01695239|588551578|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958539|NCT01695239|588551579|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958540|NCT01695239|588551580|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958541|NCT01695239|588551581|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958542|NCT01695239|588551582|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958543|NCT01695239|588551583|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
162958544|NCT01695239|588551584|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
162958545|NCT01695239|588551585|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958546|NCT01695239|588551586|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958547|NCT01695239|588551587|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958548|NCT01695239|588551588|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958549|NCT01695239|588551575|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
162958550|NCT01695239|588551576|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
162958551|NCT01695239|588551577|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
162958552|NCT01695239|588551578|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
162958553|NCT01695239|588551579|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
163045977|NCT02137226|588875145|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
163045978|NCT02137226|588875146|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
163045979|NCT02137226|588875142|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
162958554|NCT01695239|588551580|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
162958555|NCT01695239|588551581|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
163045980|NCT02137226|588875143|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
163195519|NCT00005044|589429906|FG001|Overall Study|Withdrawal by Subject|5|||
162958556|NCT01695239|588551582|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
162958557|NCT01695239|588551583|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
162958558|NCT01695239|588551584|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
162958559|NCT01695239|588551585|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
162958560|NCT01695239|588551586|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
162958561|NCT01695239|588551587|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
162958562|NCT01695239|588551588|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
162958563|NCT01695239|588551575|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958564|NCT01695239|588551576|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958565|NCT01695239|588551577|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958566|NCT01695239|588551578|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958567|NCT01695239|588551579|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958568|NCT01695239|588551580|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958569|NCT01695239|588551581|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958570|NCT01695239|588551582|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958571|NCT01695239|588551583|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
163195520|NCT00005044|589429905|FG000|Overall Study|No protocol treatment|0|||
163195521|NCT00005044|589429906|FG001|Overall Study|No protocol treatment|1|||
163195522|NCT00843856|589429907|FG000|Overall Study|Lost to Follow-up|1|||
163195523|NCT00843856|589429908|FG001|Overall Study|Lost to Follow-up|2|||
163195524|NCT02993757|589429913|FG000|Overall Study|Non compliance with the protocol|155|||
163195525|NCT02993757|589429914|FG001|Overall Study|Non compliance with the protocol|170|||
163195526|NCT02993757|589429913|FG000|Overall Study|Lost to Follow-up|1|||
163195527|NCT02993757|589429914|FG001|Overall Study|Lost to Follow-up|0|||
163195528|NCT02993757|589429913|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
163195529|NCT02993757|589429914|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
163195530|NCT00190671|589429923|FG000|Overall Study|Satisfactory Response|4|||
163195531|NCT00190671|589429924|FG001|Overall Study|Satisfactory Response|7|||
163195532|NCT00190671|589429923|FG000|Overall Study|Lack of Efficacy|19|||
163195533|NCT00190671|589429924|FG001|Overall Study|Lack of Efficacy|24|||
163195534|NCT00190671|589429923|FG000|Overall Study|Death from Study Disease|1|||
163195535|NCT00190671|589429924|FG001|Overall Study|Death from Study Disease|1|||
163195536|NCT00190671|589429923|FG000|Overall Study|Adverse Event|3|||
163195537|NCT00190671|589429924|FG001|Overall Study|Adverse Event|2|||
163195538|NCT00190671|589429923|FG000|Overall Study|Clinical Relapse|0|||
163195539|NCT00190671|589429924|FG001|Overall Study|Clinical Relapse|1|||
163195540|NCT00190671|589429923|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
163195541|NCT00190671|589429924|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
163195542|NCT00190671|589429923|FG000|Overall Study|Death from Other Causes|0|||
163195543|NCT00190671|589429924|FG001|Overall Study|Death from Other Causes|2|||
163195544|NCT00190671|589429923|FG000|Overall Study|Protocol Violation|0|||
163195545|NCT00190671|589429924|FG001|Overall Study|Protocol Violation|1|||
163195546|NCT00190671|589429923|FG000|Overall Study|Withdrawal by Subject|0|||
163301407|NCT01492686|589811155|FG001|Open-label Phase|Adverse Event|2|||
163301408|NCT01492686|589811154|FG000|Open-label Phase|Physician Decision|1|||
163301409|NCT01492686|589811155|FG001|Open-label Phase|Physician Decision|0|||
163301410|NCT01492686|589811154|FG000|Open-label Phase|Withdrawal by Subject|6|||
163301411|NCT01492686|589811155|FG001|Open-label Phase|Withdrawal by Subject|7|||
163301412|NCT01492686|589811154|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
163301413|NCT01492686|589811155|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
163301414|NCT03314987|589811158|FG000|Overall Study|Lost to Follow-up|13|||
163301415|NCT03314987|589811159|FG001|Overall Study|Lost to Follow-up|13|||
163301416|NCT05552963|589811160|FG000|Overall Study|Lost to Follow-up|1|||
163301417|NCT05552963|589811160|FG000|Overall Study|Study catheter was inserted, but PF energy was not delivered due to ECG interference|1|||
163301418|NCT05529979|589811163|FG000|Overall Study|Lost to Follow-up|6|||
163301419|NCT05529979|589811163|FG000|Overall Study|Physician Decision|1|||
163301420|NCT05529979|589811163|FG000|Overall Study|non-feasibility cases|4|||
163301421|NCT05529979|589811163|FG000|Overall Study|Lack of Efficacy|3|||
163301422|NCT05529979|589811163|FG000|Overall Study|ablation not performed|1|||
163301423|NCT03403413|589811166|FG000|Overall Study|Lack of Efficacy|2|||
163301424|NCT02924064|589811167|FG000|Overall Study|Adverse Event|2|||
163301425|NCT02924064|589811168|FG001|Overall Study|Adverse Event|2|||
163301426|NCT02924064|589811167|FG000|Overall Study|Lost to Follow-up|0|||
163301427|NCT02924064|589811168|FG001|Overall Study|Lost to Follow-up|2|||
163301428|NCT02924064|589811167|FG000|Overall Study|Physician Decision|0|||
163301429|NCT02924064|589811168|FG001|Overall Study|Physician Decision|2|||
163301430|NCT02924064|589811167|FG000|Overall Study|Protocol Violation|1|||
163301431|NCT02924064|589811168|FG001|Overall Study|Protocol Violation|3|||
163301432|NCT02924064|589811167|FG000|Overall Study|Withdrawal by Subject|4|||
163301433|NCT02924064|589811168|FG001|Overall Study|Withdrawal by Subject|5|||
163301434|NCT02924064|589811167|FG000|Overall Study|Other|17|||
163301435|NCT02924064|589811168|FG001|Overall Study|Other|29|||
163301436|NCT05054725|589811169|FG000|Overall Study|Withdrawal by Subject|3|||
163301437|NCT05054725|589811170|FG001|Overall Study|Withdrawal by Subject|4|||
163301438|NCT05054725|589811169|FG000|Overall Study|Sponsor's Decision to Terminate the Study|0|||
163301439|NCT05054725|589811170|FG001|Overall Study|Sponsor's Decision to Terminate the Study|3|||
163301440|NCT05054725|589811169|FG000|Overall Study|Death|1|||
163301441|NCT05054725|589811170|FG001|Overall Study|Death|21|||
163301442|NCT05054725|589811169|FG000|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|0|||
163301443|NCT05054725|589811170|FG001|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|3|||
163301444|NCT05054725|589811169|FG000|Overall Study|PI's decision that there is no benefit from LTFU|0|||
162924269|NCT02575807|588423850|FG004|Overall Study|Terminated due to physician decision|0|||
162924270|NCT02575807|588423846|FG000|Overall Study|Subject ineligible - medical implant|0|||
162924271|NCT02575807|588423847|FG001|Overall Study|Subject ineligible - medical implant|0|||
162924272|NCT02575807|588423848|FG002|Overall Study|Subject ineligible - medical implant|0|||
162924273|NCT02575807|588423849|FG003|Overall Study|Subject ineligible - medical implant|1|||
162924274|NCT02575807|588423850|FG004|Overall Study|Subject ineligible - medical implant|0|||
163045981|NCT02137226|588875144|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
162924275|NCT02575807|588423846|FG000|Overall Study|Withdrawal by Subject|0|||
162924276|NCT02575807|588423847|FG001|Overall Study|Withdrawal by Subject|0|||
162924277|NCT02575807|588423848|FG002|Overall Study|Withdrawal by Subject|1|||
162924278|NCT02575807|588423849|FG003|Overall Study|Withdrawal by Subject|1|||
162924279|NCT02575807|588423850|FG004|Overall Study|Withdrawal by Subject|2|||
162924280|NCT03319368|588423851|FG000|Overall Study|Discharge swabs not collected from resident|57|||
162924281|NCT03319368|588423852|FG001|Overall Study|Discharge swabs not collected from resident|46|||
162924282|NCT02180659|588423853|FG000|Overall Study|Adverse Event|1|||
162924283|NCT02180659|588423854|FG001|Overall Study|Adverse Event|0|||
163045982|NCT02137226|588875145|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
163045983|NCT02137226|588875146|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
163045984|NCT03134911|588875147|FG000|Overall Study|Screen failure|31|||
163045985|NCT03134911|588875147|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
163045986|NCT01118663|588875148|FG000|Overall Study|Adverse Event|2|||
163045987|NCT01118663|588875149|FG001|Overall Study|Adverse Event|1|||
163045988|NCT01118663|588875148|FG000|Overall Study|Withdrawal by Subject|0|||
163045989|NCT01118663|588875149|FG001|Overall Study|Withdrawal by Subject|1|||
163045990|NCT00672633|588875156|FG000|Overall Study|Withdrawal by Subject|0|||
163045991|NCT00672633|588875157|FG001|Overall Study|Withdrawal by Subject|1|||
163045992|NCT02824627|588875158|FG000|Overall Study|Adverse Event|1|||
163045993|NCT02824627|588875159|FG001|Overall Study|Adverse Event|2|||
163045994|NCT02824627|588875158|FG000|Overall Study|Lost to Follow-up|2|||
163045995|NCT02824627|588875159|FG001|Overall Study|Lost to Follow-up|1|||
163045996|NCT01868165|588875160|FG000|Overall Study|Withdrawal by Subject|36|||
163045997|NCT01868165|588875160|FG000|Overall Study|Physician Decision|2|||
163045998|NCT01868165|588875160|FG000|Overall Study|Lost to Follow-up|3|||
163045999|NCT01868165|588875160|FG000|Overall Study|Death|4|||
163046000|NCT03472521|588875161|FG000|Overall Study|Lost to Follow-up|3|||
163046001|NCT03472521|588875162|FG001|Overall Study|Lost to Follow-up|2|||
163046002|NCT03472521|588875161|FG000|Overall Study|Discontinued intervention|3|||
163046003|NCT03472521|588875162|FG001|Overall Study|Discontinued intervention|1|||
163046004|NCT01603407|588875163|FG000|Overall Study|Adverse Event|1|||
163046005|NCT01603407|588875164|FG001|Overall Study|Adverse Event|1|||
163046006|NCT01603407|588875165|FG002|Overall Study|Adverse Event|1|||
163394580|NCT03523728|590156945|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
163394581|NCT03523728|590156946|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
163394582|NCT03523728|590156942|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
163394583|NCT03523728|590156943|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
163394584|NCT03523728|590156944|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
163394585|NCT03523728|590156945|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
163394586|NCT03523728|590156946|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
163394587|NCT03523728|590156942|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
163394588|NCT03523728|590156943|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
163394589|NCT03523728|590156944|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
163394590|NCT03523728|590156945|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
163394591|NCT03523728|590156946|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
163394592|NCT03523728|590156942|FG000|Stage 2 (24 Months)|Adverse Event|0|||
163394593|NCT03523728|590156943|FG001|Stage 2 (24 Months)|Adverse Event|0|||
163394594|NCT03523728|590156944|FG002|Stage 2 (24 Months)|Adverse Event|0|||
163394595|NCT03523728|590156945|FG003|Stage 2 (24 Months)|Adverse Event|1|||
163394596|NCT03523728|590156946|FG004|Stage 2 (24 Months)|Adverse Event|2|||
163394597|NCT03523728|590156942|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
163394598|NCT03523728|590156943|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
163394599|NCT03523728|590156944|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
163394600|NCT03523728|590156945|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
163394601|NCT03523728|590156946|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
163394602|NCT03523728|590156942|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
163394603|NCT03523728|590156943|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
163394604|NCT03523728|590156944|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
163394605|NCT03523728|590156945|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
163394606|NCT03523728|590156946|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
163394607|NCT03523728|590156942|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
163394608|NCT03523728|590156943|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
163394609|NCT03523728|590156944|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
163394610|NCT03523728|590156945|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
163394611|NCT03523728|590156946|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
163394612|NCT03523728|590156942|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
163394613|NCT03523728|590156943|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
163394614|NCT03523728|590156944|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
163394615|NCT03523728|590156945|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
163394616|NCT03523728|590156946|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
163394617|NCT02023242|590156947|FG000|Overall Study|Lost to Follow-up|3|||
163394618|NCT02023242|590156948|FG001|Overall Study|Lost to Follow-up|1|||
163394619|NCT02023242|590156947|FG000|Overall Study|Death|0|||
163394620|NCT02023242|590156948|FG001|Overall Study|Death|1|||
163394621|NCT00710879|590156952|FG000|Overall Study|Lost to Follow-up|2|||
163394622|NCT00710879|590156953|FG001|Overall Study|Lost to Follow-up|1|||
163394623|NCT00710879|590156952|FG000|Overall Study|Protocol Violation|0|||
163394624|NCT00710879|590156953|FG001|Overall Study|Protocol Violation|3|||
163394625|NCT01809132|590156954|FG000|Overall Study|Withdrawal by Subject|0|||
163394626|NCT01809132|590156955|FG001|Overall Study|Withdrawal by Subject|0|||
163394627|NCT01809132|590156956|FG002|Overall Study|Withdrawal by Subject|1|||
163046007|NCT01603407|588875163|FG000|Overall Study|Protocol Violation|2|||
163046008|NCT01603407|588875164|FG001|Overall Study|Protocol Violation|2|||
163046009|NCT01603407|588875165|FG002|Overall Study|Protocol Violation|0|||
163394628|NCT04854434|590156957|FG000|Overall Study|Death|1|||
163394629|NCT04854434|590156958|FG001|Overall Study|Death|3|||
163394630|NCT04854434|590156959|FG002|Overall Study|Death|4|||
163394631|NCT04854434|590156957|FG000|Overall Study|Study Terminated by Sponsor|2|||
162958572|NCT01695239|588551584|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
162958573|NCT01695239|588551585|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958574|NCT01695239|588551586|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958575|NCT01695239|588551587|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958576|NCT01695239|588551588|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958577|NCT01695239|588551575|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958578|NCT01695239|588551576|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
163046010|NCT01603407|588875163|FG000|Overall Study|Withdrawal by Subject|8|||
163046011|NCT01603407|588875164|FG001|Overall Study|Withdrawal by Subject|5|||
163046012|NCT01603407|588875165|FG002|Overall Study|Withdrawal by Subject|7|||
163046013|NCT01603407|588875163|FG000|Overall Study|Lost to Follow-up|0|||
163046014|NCT01603407|588875164|FG001|Overall Study|Lost to Follow-up|3|||
163046015|NCT01603407|588875165|FG002|Overall Study|Lost to Follow-up|2|||
163046016|NCT02358031|588877269|FG000|Overall Study|Death|253|||
163046017|NCT02358031|588877270|FG001|Overall Study|Death|237|||
163046018|NCT02358031|588877271|FG002|Overall Study|Death|266|||
163046019|NCT02358031|588877269|FG000|Overall Study|Lost to Follow-up|1|||
163046020|NCT02358031|588877270|FG001|Overall Study|Lost to Follow-up|1|||
163046021|NCT02358031|588877271|FG002|Overall Study|Lost to Follow-up|0|||
163046022|NCT02358031|588877269|FG000|Overall Study|Withdrawal by Subject|19|||
163046023|NCT02358031|588877270|FG001|Overall Study|Withdrawal by Subject|14|||
163046024|NCT02358031|588877271|FG002|Overall Study|Withdrawal by Subject|18|||
163046025|NCT02358031|588877269|FG000|Overall Study|Sponsor Decision|26|||
163046026|NCT02358031|588877270|FG001|Overall Study|Sponsor Decision|28|||
163046027|NCT02358031|588877271|FG002|Overall Study|Sponsor Decision|16|||
163046028|NCT04980014|588877274|FG000|Overall Study|Participants who are Duplicated|1|||
163046029|NCT04980014|588877274|FG000|Overall Study|Follow-up Failure|13|||
163046030|NCT04980014|588877274|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
163046031|NCT04980014|588877274|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
163046032|NCT04980014|588877274|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
163046033|NCT00940888|588877275|FG000|Overall Study|Unsuccessful Implant|4|||
163046034|NCT00940888|588877275|FG000|Overall Study|Death|461|||
163046035|NCT00940888|588877275|FG000|Overall Study|Withdrawn - Non-Death|364|||
163046036|NCT00940888|588877275|FG000|Overall Study|Lost to Follow-up|6|||
163046037|NCT02250300|588877279|FG000|Expansion Phase|Death|6|||
163046038|NCT02250300|588877280|FG001|Expansion Phase|Death|7|||
163046039|NCT02250300|588877281|FG002|Expansion Phase|Death|0|||
163195547|NCT00190671|589429924|FG001|Overall Study|Withdrawal by Subject|2|||
163046040|NCT02250300|588877282|FG003|Expansion Phase|Death|0|||
163046041|NCT00715559|588877284|FG000|Overall Study|medication not tolerated - nausea|1|||
163195548|NCT00087607|589429925|FG000|Overall Study|Adverse Event|14|||
163046042|NCT00758498|588877285|FG000|Overall Study|Adverse Event|2|||
163394632|NCT04854434|590156958|FG001|Overall Study|Study Terminated by Sponsor|0|||
163394633|NCT04854434|590156959|FG002|Overall Study|Study Terminated by Sponsor|0|||
163394634|NCT04854434|590156957|FG000|Overall Study|Other|1|||
163394635|NCT04854434|590156958|FG001|Overall Study|Other|1|||
163394636|NCT04854434|590156959|FG002|Overall Study|Other|0|||
163394637|NCT03349775|590156960|FG000|Overall Study|Side Effects|1|||
163394638|NCT03349775|590156961|FG001|Overall Study|Side Effects|2|||
163394639|NCT03349775|590156960|FG000|Overall Study|Withdrawal by Subject|1|||
163394640|NCT03349775|590156961|FG001|Overall Study|Withdrawal by Subject|1|||
163394641|NCT03349775|590156960|FG000|Overall Study|No primary outcome measurements|0|||
163394642|NCT03349775|590156961|FG001|Overall Study|No primary outcome measurements|1|||
163394643|NCT04479436|590156962|FG000|Overall Study|Progressive disease|26|||
163394644|NCT04479436|590156963|FG001|Overall Study|Progressive disease|1|||
163394645|NCT04479436|590156962|FG000|Overall Study|Adverse Event|6|||
163394646|NCT04479436|590156963|FG001|Overall Study|Adverse Event|0|||
163394647|NCT04479436|590156962|FG000|Overall Study|Withdrawal by Subject|5|||
163394648|NCT04479436|590156963|FG001|Overall Study|Withdrawal by Subject|0|||
163394649|NCT04479436|590156962|FG000|Overall Study|Clinical progression|1|||
163394650|NCT04479436|590156963|FG001|Overall Study|Clinical progression|0|||
163394651|NCT04479436|590156962|FG000|Overall Study|Physician Decision|1|||
163394652|NCT04479436|590156963|FG001|Overall Study|Physician Decision|0|||
163394653|NCT02428855|590156965|FG000|Overall Study|Withdrawal by Subject|2|||
163394654|NCT00823823|590156966|FG000|Overall Study|Lost to Follow-up|3|||
163394655|NCT00823823|590156967|FG001|Overall Study|Lost to Follow-up|1|||
163394656|NCT00823823|590156966|FG000|Overall Study|Protocol Violation|5|||
163394657|NCT00823823|590156967|FG001|Overall Study|Protocol Violation|5|||
163394658|NCT03334409|590156968|FG000|Overall Study|Did not meet inclusion criteria|1|||
163394659|NCT03334409|590156969|FG001|Overall Study|Did not meet inclusion criteria|0|||
163394660|NCT00718549|590156975|FG000|Induction Phase|Disease Progression|1|||
163394661|NCT00718549|590156976|FG001|Induction Phase|Disease Progression|0|||
163394662|NCT00718549|590156977|FG002|Induction Phase|Disease Progression|0|||
163394663|NCT00718549|590156975|FG000|Induction Phase|Eligibility Criteria Violation|2|||
163394664|NCT00718549|590156976|FG001|Induction Phase|Eligibility Criteria Violation|0|||
163394665|NCT00718549|590156977|FG002|Induction Phase|Eligibility Criteria Violation|0|||
163394666|NCT00718549|590156975|FG000|Induction Phase|Early Termination - No Additional Info|59|||
163394667|NCT00718549|590156976|FG001|Induction Phase|Early Termination - No Additional Info|0|||
163394668|NCT00718549|590156977|FG002|Induction Phase|Early Termination - No Additional Info|0|||
163394669|NCT00718549|590156975|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
163394670|NCT00718549|590156976|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
163394671|NCT00718549|590156977|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
163394672|NCT00718549|590156975|FG000|Maintenance/ Observation Phase|Death|0|||
163394673|NCT00718549|590156976|FG001|Maintenance/ Observation Phase|Death|1|||
163394674|NCT00718549|590156977|FG002|Maintenance/ Observation Phase|Death|2|||
163394675|NCT00718549|590156975|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
163394676|NCT00718549|590156976|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
163394677|NCT00718549|590156977|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
163394678|NCT00718549|590156975|FG000|Maintenance/ Observation Phase|Progression|0|||
163394679|NCT00718549|590156976|FG001|Maintenance/ Observation Phase|Progression|5|||
163394680|NCT00718549|590156977|FG002|Maintenance/ Observation Phase|Progression|14|||
163394681|NCT00718549|590156975|FG000|Maintenance/ Observation Phase|Relapse|0|||
163394682|NCT00718549|590156976|FG001|Maintenance/ Observation Phase|Relapse|3|||
163394683|NCT00718549|590156977|FG002|Maintenance/ Observation Phase|Relapse|2|||
163394684|NCT01303965|590156978|FG000|Overall Study|Adverse Event|1|||
163394685|NCT01303965|590156979|FG001|Overall Study|Adverse Event|1|||
163394686|NCT01303965|590156978|FG000|Overall Study|Death|0|||
163394687|NCT01303965|590156979|FG001|Overall Study|Death|3|||
163394688|NCT01303965|590156978|FG000|Overall Study|Withdrawal by Subject|1|||
163394689|NCT01303965|590156979|FG001|Overall Study|Withdrawal by Subject|0|||
163394690|NCT01303965|590156978|FG000|Overall Study|Disease Progression|1|||
163394691|NCT01303965|590156979|FG001|Overall Study|Disease Progression|6|||
163394692|NCT02871778|590156984|FG000|Part A: Treatment Period 1|Adverse Event|1|||
163394693|NCT02871778|590156985|FG001|Part A: Treatment Period 1|Adverse Event|1|||
163394694|NCT02871778|590156986|FG002|Part A: Treatment Period 1|Adverse Event|1|||
163394695|NCT02871778|590156987|FG003|Part A: Treatment Period 1|Adverse Event|0|||
163394696|NCT02871778|590156988|FG004|Part A: Treatment Period 1|Adverse Event|0|||
163394697|NCT02871778|590156989|FG005|Part A: Treatment Period 1|Adverse Event|0|||
163394698|NCT02871778|590156990|FG006|Part A: Treatment Period 1|Adverse Event|0|||
163394699|NCT02871778|590156991|FG007|Part A: Treatment Period 1|Adverse Event|0|||
163394700|NCT02871778|590156984|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
163394701|NCT02871778|590156985|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
163394702|NCT02871778|590156986|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
163394703|NCT02871778|590156987|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
163394704|NCT02871778|590156988|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
163046043|NCT00758498|588877286|FG001|Overall Study|Adverse Event|2|||
163046044|NCT00758498|588877287|FG002|Overall Study|Adverse Event|3|||
163046045|NCT00758498|588877285|FG000|Overall Study|Subject legally detained out of state|1|||
163046046|NCT00758498|588877286|FG001|Overall Study|Subject legally detained out of state|0|||
163046047|NCT00758498|588877287|FG002|Overall Study|Subject legally detained out of state|0|||
162924284|NCT02180659|588423853|FG000|Overall Study|Lost to Follow-up|4|||
162924285|NCT02180659|588423854|FG001|Overall Study|Lost to Follow-up|2|||
162924286|NCT02180659|588423853|FG000|Overall Study|Subject incarcerated during conduct|1|||
162924287|NCT02180659|588423854|FG001|Overall Study|Subject incarcerated during conduct|0|||
162924288|NCT02180659|588423853|FG000|Overall Study|Withdrawal by Subject|0|||
162924289|NCT02180659|588423854|FG001|Overall Study|Withdrawal by Subject|2|||
162924290|NCT02180659|588423853|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
162924291|NCT02180659|588423854|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
162924292|NCT00824993|588423855|FG000|Overall Study|Withdrawal by Subject|1|||
162924293|NCT00824993|588423856|FG001|Overall Study|Withdrawal by Subject|1|||
162924294|NCT00824993|588423855|FG000|Overall Study|Malignancy Relapse|9|||
162924295|NCT00824993|588423856|FG001|Overall Study|Malignancy Relapse|10|||
162924296|NCT00824993|588423855|FG000|Overall Study|Rapid Bone Loss|0|||
162924297|NCT00824993|588423856|FG001|Overall Study|Rapid Bone Loss|1|||
162924298|NCT00824993|588423855|FG000|Overall Study|Non-Compliant|2|||
162924299|NCT00824993|588423856|FG001|Overall Study|Non-Compliant|1|||
162924300|NCT00824993|588423855|FG000|Overall Study|Insurance Issue|2|||
162924301|NCT00824993|588423856|FG001|Overall Study|Insurance Issue|1|||
162924302|NCT00824993|588423855|FG000|Overall Study|Death|0|||
162924303|NCT00824993|588423856|FG001|Overall Study|Death|3|||
162924304|NCT00518011|588423857|FG000|Overall Study|Death|1|||
162958579|NCT01695239|588551577|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958580|NCT01695239|588551578|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958581|NCT01695239|588551579|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958582|NCT01695239|588551580|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958583|NCT01695239|588551581|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958584|NCT01695239|588551582|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958585|NCT01695239|588551583|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
162958586|NCT01695239|588551584|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
163394705|NCT02871778|590156989|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
162958587|NCT01695239|588551585|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958588|NCT01695239|588551586|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958589|NCT01695239|588551587|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958590|NCT01695239|588551588|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958591|NCT01695239|588551575|FG000|Extension Long-Term Extension Periods|Death|0|||
162958592|NCT01695239|588551576|FG001|Extension Long-Term Extension Periods|Death|0|||
162958593|NCT01695239|588551577|FG002|Extension Long-Term Extension Periods|Death|0|||
162958594|NCT01695239|588551578|FG003|Extension Long-Term Extension Periods|Death|0|||
162958595|NCT01695239|588551579|FG004|Extension Long-Term Extension Periods|Death|0|||
162958596|NCT01695239|588551580|FG005|Extension Long-Term Extension Periods|Death|0|||
162958597|NCT01695239|588551581|FG006|Extension Long-Term Extension Periods|Death|0|||
162958598|NCT01695239|588551582|FG007|Extension Long-Term Extension Periods|Death|0|||
163195549|NCT00087607|589429926|FG001|Overall Study|Adverse Event|24|||
163195550|NCT00087607|589429925|FG000|Overall Study|Death|0|||
163195551|NCT00087607|589429926|FG001|Overall Study|Death|1|||
163195552|NCT00087607|589429925|FG000|Overall Study|Insufficient Therapeutic Response|53|||
162924305|NCT00518011|588423858|FG001|Overall Study|Death|1|||
163301445|NCT05054725|589811170|FG001|Overall Study|PI's decision that there is no benefit from LTFU|6|||
163046048|NCT00758498|588877285|FG000|Overall Study|Withdrawal by Subject|0|||
163046049|NCT00758498|588877286|FG001|Overall Study|Withdrawal by Subject|0|||
163046050|NCT00758498|588877287|FG002|Overall Study|Withdrawal by Subject|1|||
163046051|NCT00758498|588877285|FG000|Overall Study|Noncompliance to study procedures|0|||
163046052|NCT00758498|588877286|FG001|Overall Study|Noncompliance to study procedures|0|||
163046053|NCT00758498|588877287|FG002|Overall Study|Noncompliance to study procedures|1|||
163046054|NCT01516736|588877288|FG000|Overall Study|Withdrawal by Subject|10|||
163046055|NCT01516736|588877289|FG001|Overall Study|Withdrawal by Subject|4|||
163046056|NCT01516736|588877288|FG000|Overall Study|Adverse Event|4|||
163046057|NCT01516736|588877289|FG001|Overall Study|Adverse Event|5|||
163046058|NCT01516736|588877288|FG000|Overall Study|Death|3|||
163046059|NCT01516736|588877289|FG001|Overall Study|Death|1|||
163046060|NCT01516736|588877288|FG000|Overall Study|Physician Decision|2|||
163046061|NCT01516736|588877289|FG001|Overall Study|Physician Decision|1|||
163046062|NCT01516736|588877288|FG000|Overall Study|Lack of Efficacy|1|||
163046063|NCT01516736|588877289|FG001|Overall Study|Lack of Efficacy|0|||
163046064|NCT01516736|588877288|FG000|Overall Study|Protocol Violation|0|||
163046065|NCT01516736|588877289|FG001|Overall Study|Protocol Violation|1|||
163046066|NCT01516736|588877288|FG000|Overall Study|Other (not specified)|0|||
163046067|NCT01516736|588877289|FG001|Overall Study|Other (not specified)|1|||
163046068|NCT00524771|588877290|FG000|Overall Study|Protocol Violation|220|||
163046069|NCT00524771|588877291|FG001|Overall Study|Protocol Violation|585|||
163046070|NCT02781818|588877292|FG000|Overall Study|Lost to Follow-up|4|||
163046071|NCT02781818|588877293|FG001|Overall Study|Lost to Follow-up|2|||
163046072|NCT02781818|588877294|FG002|Overall Study|Lost to Follow-up|1|||
163046073|NCT01877668|588877295|FG000|Overall Study|Death|0|||
163046074|NCT01877668|588877296|FG001|Overall Study|Death|0|||
163046075|NCT01877668|588877297|FG002|Overall Study|Death|0|||
163046076|NCT01877668|588877298|FG003|Overall Study|Death|1|||
163046077|NCT01877668|588877299|FG004|Overall Study|Death|0|||
163046078|NCT01877668|588877295|FG000|Overall Study|No longer met study criteria|1|||
163046079|NCT01877668|588877296|FG001|Overall Study|No longer met study criteria|0|||
163046080|NCT01877668|588877297|FG002|Overall Study|No longer met study criteria|1|||
163046081|NCT01877668|588877298|FG003|Overall Study|No longer met study criteria|0|||
163046082|NCT01877668|588877299|FG004|Overall Study|No longer met study criteria|0|||
163046083|NCT01877668|588877295|FG000|Overall Study|Insufficient clinical response|0|||
163046084|NCT01877668|588877296|FG001|Overall Study|Insufficient clinical response|1|||
163046085|NCT01877668|588877297|FG002|Overall Study|Insufficient clinical response|2|||
163046086|NCT01877668|588877298|FG003|Overall Study|Insufficient clinical response|2|||
163046087|NCT01877668|588877299|FG004|Overall Study|Insufficient clinical response|0|||
163046088|NCT01877668|588877295|FG000|Overall Study|Lost to Follow-up|0|||
163046089|NCT01877668|588877296|FG001|Overall Study|Lost to Follow-up|2|||
163046090|NCT01877668|588877297|FG002|Overall Study|Lost to Follow-up|1|||
163046091|NCT01877668|588877298|FG003|Overall Study|Lost to Follow-up|0|||
163046092|NCT01877668|588877299|FG004|Overall Study|Lost to Follow-up|0|||
163046093|NCT01877668|588877295|FG000|Overall Study|Withdrawal by Subject|2|||
163046094|NCT01877668|588877296|FG001|Overall Study|Withdrawal by Subject|0|||
163046095|NCT01877668|588877297|FG002|Overall Study|Withdrawal by Subject|3|||
163046096|NCT01877668|588877298|FG003|Overall Study|Withdrawal by Subject|2|||
163046097|NCT01877668|588877299|FG004|Overall Study|Withdrawal by Subject|2|||
163046098|NCT01877668|588877295|FG000|Overall Study|Other|1|||
163046099|NCT01877668|588877296|FG001|Overall Study|Other|1|||
163046100|NCT01877668|588877297|FG002|Overall Study|Other|1|||
163046101|NCT01877668|588877298|FG003|Overall Study|Other|1|||
163046102|NCT01877668|588877299|FG004|Overall Study|Other|3|||
163046103|NCT01877668|588877295|FG000|Overall Study|Protocol Violation|1|||
163046104|NCT01877668|588877296|FG001|Overall Study|Protocol Violation|1|||
163046105|NCT01877668|588877297|FG002|Overall Study|Protocol Violation|0|||
163046106|NCT01877668|588877298|FG003|Overall Study|Protocol Violation|0|||
163046107|NCT01877668|588877299|FG004|Overall Study|Protocol Violation|3|||
163046108|NCT01877668|588877295|FG000|Overall Study|Adverse event related to study drug|2|||
163046109|NCT01877668|588877296|FG001|Overall Study|Adverse event related to study drug|2|||
163046110|NCT01877668|588877297|FG002|Overall Study|Adverse event related to study drug|2|||
163046111|NCT01877668|588877298|FG003|Overall Study|Adverse event related to study drug|2|||
163046112|NCT01877668|588877299|FG004|Overall Study|Adverse event related to study drug|1|||
163046113|NCT01877668|588877295|FG000|Overall Study|Adverse event unrelated to study drug|4|||
163046114|NCT01877668|588877296|FG001|Overall Study|Adverse event unrelated to study drug|1|||
163394706|NCT02871778|590156990|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
163394707|NCT02871778|590156991|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
163046115|NCT01877668|588877297|FG002|Overall Study|Adverse event unrelated to study drug|2|||
163046116|NCT01877668|588877298|FG003|Overall Study|Adverse event unrelated to study drug|0|||
163046117|NCT01877668|588877299|FG004|Overall Study|Adverse event unrelated to study drug|1|||
163046118|NCT02317991|588877300|FG000|Overall Study|Adverse Event|12|||
163046119|NCT02317991|588877300|FG000|Overall Study|Death|4|||
163046120|NCT02317991|588877300|FG000|Overall Study|Withdrawal by Subject|8|||
163046121|NCT02317991|588877300|FG000|Overall Study|Progressive Disease|41|||
162958599|NCT01695239|588551583|FG008|Extension Long-Term Extension Periods|Death|1|||
162958600|NCT01695239|588551584|FG009|Extension Long-Term Extension Periods|Death|0|||
162958601|NCT01695239|588551585|FG010|Extension Long-Term Extension Periods|Death|0|||
162958602|NCT01695239|588551586|FG011|Extension Long-Term Extension Periods|Death|0|||
162958603|NCT01695239|588551587|FG012|Extension Long-Term Extension Periods|Death|0|||
162958604|NCT01695239|588551588|FG013|Extension Long-Term Extension Periods|Death|0|||
162958605|NCT01695239|588551575|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958606|NCT01695239|588551576|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958607|NCT01695239|588551577|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958608|NCT01695239|588551578|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958609|NCT01695239|588551579|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958610|NCT01695239|588551580|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958611|NCT01695239|588551581|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958612|NCT01695239|588551582|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958613|NCT01695239|588551583|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958614|NCT01695239|588551584|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163046122|NCT01223404|588877301|FG000|First Intervention (1 Day)|Adverse Event|0|||
163046123|NCT01223404|588877302|FG001|First Intervention (1 Day)|Adverse Event|0|||
162958615|NCT01695239|588551585|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958616|NCT01695239|588551586|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
162958617|NCT01695239|588551587|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
162958618|NCT01695239|588551588|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
162958619|NCT01695239|588551575|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958620|NCT01695239|588551576|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958621|NCT01695239|588551577|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958622|NCT01695239|588551578|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958623|NCT01695239|588551579|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958624|NCT01695239|588551580|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958625|NCT01695239|588551581|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958626|NCT01695239|588551582|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958627|NCT01695239|588551583|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958628|NCT01695239|588551584|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958629|NCT01695239|588551585|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958630|NCT01695239|588551586|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958631|NCT01695239|588551587|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
162958632|NCT01695239|588551588|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
162958633|NCT01695239|588551575|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958634|NCT01695239|588551576|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958635|NCT01695239|588551577|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958636|NCT01695239|588551578|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958637|NCT01695239|588551579|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958638|NCT01695239|588551580|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958639|NCT01695239|588551581|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958640|NCT01695239|588551582|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958641|NCT01695239|588551583|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958642|NCT01695239|588551584|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958643|NCT01695239|588551585|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958644|NCT01695239|588551586|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958645|NCT01695239|588551587|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
162958646|NCT01695239|588551588|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958647|NCT01695239|588551575|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958648|NCT01695239|588551576|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958649|NCT01695239|588551577|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958650|NCT01695239|588551578|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958651|NCT01695239|588551579|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958652|NCT01695239|588551580|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958653|NCT01695239|588551581|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958654|NCT01695239|588551582|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958655|NCT01695239|588551583|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958656|NCT01695239|588551584|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958657|NCT01695239|588551585|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958658|NCT01695239|588551586|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958659|NCT01695239|588551587|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958660|NCT01695239|588551588|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
163195553|NCT00087607|589429926|FG001|Overall Study|Insufficient Therapeutic Response|42|||
163195554|NCT00087607|589429925|FG000|Overall Study|Failure to return|21|||
163195555|NCT00087607|589429926|FG001|Overall Study|Failure to return|17|||
163195556|NCT00087607|589429925|FG000|Overall Study|Withdrew Consent|12|||
163195557|NCT00087607|589429926|FG001|Overall Study|Withdrew Consent|16|||
163195558|NCT00087607|589429925|FG000|Overall Study|Administrative|12|||
163301446|NCT05054725|589811169|FG000|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|0|||
162958661|NCT05239195|588551590|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
162958662|NCT05239195|588551591|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
162958663|NCT00081653|588551592|FG000|Overall Study|Adverse Event|23|||
162958664|NCT00081653|588551593|FG001|Overall Study|Adverse Event|17|||
162958665|NCT00081653|588551592|FG000|Overall Study|Lost to Follow-up|2|||
162958666|NCT00081653|588551593|FG001|Overall Study|Lost to Follow-up|4|||
162958667|NCT00081653|588551592|FG000|Overall Study|Refused Treatment|18|||
162958668|NCT00081653|588551593|FG001|Overall Study|Refused Treatment|14|||
163301447|NCT05054725|589811170|FG001|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|1|||
162958669|NCT00081653|588551592|FG000|Overall Study|Low bone mineral density|1|||
163301448|NCT05054725|589811169|FG000|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|0|||
163301449|NCT05054725|589811170|FG001|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|1|||
163301450|NCT05054725|589811169|FG000|Overall Study|Physician discretion due to subject progression|0|||
163394708|NCT02871778|590156984|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
163394709|NCT02871778|590156985|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
163301451|NCT05054725|589811170|FG001|Overall Study|Physician discretion due to subject progression|1|||
163301452|NCT03674411|589811171|FG000|Overall Study|Non-treatment|4|||
163301453|NCT03674411|589811172|FG001|Overall Study|Non-treatment|0|||
163301454|NCT04982315|589811173|FG000|Overall Study|Death|1|||
163301455|NCT04982315|589811174|FG001|Overall Study|Death|0|||
163301456|NCT04982315|589811175|FG002|Overall Study|Death|1|||
163301457|NCT04982315|589811173|FG000|Overall Study|Lack of Efficacy|0|||
163301458|NCT04982315|589811174|FG001|Overall Study|Lack of Efficacy|0|||
163301459|NCT04982315|589811175|FG002|Overall Study|Lack of Efficacy|2|||
163301460|NCT04982315|589811173|FG000|Overall Study|Withdrawal by Subject|24|||
163301461|NCT04982315|589811174|FG001|Overall Study|Withdrawal by Subject|1|||
163301462|NCT04982315|589811175|FG002|Overall Study|Withdrawal by Subject|2|||
163301463|NCT04982315|589811173|FG000|Overall Study|Dealing with health/life issues|3|||
163301464|NCT04982315|589811174|FG001|Overall Study|Dealing with health/life issues|4|||
163301465|NCT04982315|589811175|FG002|Overall Study|Dealing with health/life issues|7|||
163301466|NCT04982315|589811173|FG000|Overall Study|Privacy concerns|1|||
163301467|NCT04982315|589811174|FG001|Overall Study|Privacy concerns|0|||
163301468|NCT04982315|589811175|FG002|Overall Study|Privacy concerns|0|||
163301469|NCT04982315|589811173|FG000|Overall Study|Withdrawal by research team|0|||
163301470|NCT04982315|589811174|FG001|Overall Study|Withdrawal by research team|0|||
163301471|NCT04982315|589811175|FG002|Overall Study|Withdrawal by research team|1|||
163301472|NCT00780910|589811176|FG000|Overall Study|Adverse Event|2|||
163301473|NCT00861692|589811189|FG000|Overall Study|Death|6|||
163301474|NCT06429163|589811190|FG000|Overall Study|uterine fibroid type 7|1|||
163394710|NCT02871778|590156986|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
163394711|NCT02871778|590156987|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
163394712|NCT02871778|590156988|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
163394713|NCT02871778|590156989|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
163394714|NCT02871778|590156990|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
163394715|NCT02871778|590156991|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
163394716|NCT02871778|590156984|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
163394717|NCT02871778|590156985|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
163394718|NCT02871778|590156986|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
163394719|NCT02871778|590156987|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
163394720|NCT02871778|590156988|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
163394721|NCT02871778|590156989|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
163394722|NCT02871778|590156990|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
163394723|NCT02871778|590156991|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
163394724|NCT02871778|590156984|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
163394725|NCT02871778|590156985|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
163394726|NCT02871778|590156986|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
163394727|NCT02871778|590156987|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
163394728|NCT02871778|590156988|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
163394729|NCT02871778|590156989|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
163394730|NCT02871778|590156990|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
163394731|NCT02871778|590156991|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
163394732|NCT02871778|590156984|FG000|Part A: Treatment Period 2|Adverse Event|2|||
163394733|NCT02871778|590156985|FG001|Part A: Treatment Period 2|Adverse Event|2|||
163394734|NCT02871778|590156986|FG002|Part A: Treatment Period 2|Adverse Event|0|||
163394735|NCT02871778|590156987|FG003|Part A: Treatment Period 2|Adverse Event|0|||
163394736|NCT02871778|590156988|FG004|Part A: Treatment Period 2|Adverse Event|0|||
163394737|NCT02871778|590156989|FG005|Part A: Treatment Period 2|Adverse Event|0|||
163394738|NCT02871778|590156990|FG006|Part A: Treatment Period 2|Adverse Event|0|||
163394739|NCT02871778|590156991|FG007|Part A: Treatment Period 2|Adverse Event|0|||
163394740|NCT02871778|590156984|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
163394741|NCT02871778|590156985|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
163394742|NCT02871778|590156986|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
163394743|NCT02871778|590156987|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
163394744|NCT02871778|590156988|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
163394745|NCT02871778|590156989|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
163394746|NCT02871778|590156990|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
163394747|NCT02871778|590156991|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
163301475|NCT06429163|589811191|FG001|Overall Study|uterine fibroid type 7|1|||
163301476|NCT06429163|589811192|FG002|Overall Study|uterine fibroid type 7|1|||
163301477|NCT06429163|589811190|FG000|Overall Study|severe adhesions|1|||
163394748|NCT02871778|590156984|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
162958670|NCT00081653|588551593|FG001|Overall Study|Low bone mineral density|0|||
162958671|NCT00081653|588551592|FG000|Overall Study|Bone loss|2|||
162958672|NCT00081653|588551593|FG001|Overall Study|Bone loss|0|||
162958673|NCT00081653|588551592|FG000|Overall Study|Participant leaving country|1|||
162958674|NCT00081653|588551593|FG001|Overall Study|Participant leaving country|0|||
162958675|NCT00081653|588551592|FG000|Overall Study|Loss of bone mass|0|||
162958676|NCT00081653|588551593|FG001|Overall Study|Loss of bone mass|2|||
162958677|NCT00736190|588551594|FG000|Overall Study|Pregnancy|1|||
162958678|NCT00736190|588551594|FG000|Overall Study|Withdrawal by Subject|1|||
163046124|NCT01223404|588877303|FG002|First Intervention (1 Day)|Adverse Event|0|||
163046125|NCT01223404|588877304|FG003|First Intervention (1 Day)|Adverse Event|1|||
163301478|NCT06429163|589811191|FG001|Overall Study|severe adhesions|2|||
163301479|NCT06429163|589811192|FG002|Overall Study|severe adhesions|1|||
163301480|NCT06429163|589811190|FG000|Overall Study|conversion to laparotomy|0|||
163301481|NCT06429163|589811191|FG001|Overall Study|conversion to laparotomy|1|||
163301482|NCT06429163|589811192|FG002|Overall Study|conversion to laparotomy|0|||
163301483|NCT06429163|589811190|FG000|Overall Study|concomitant procedure|1|||
163301484|NCT06429163|589811191|FG001|Overall Study|concomitant procedure|0|||
163301485|NCT06429163|589811192|FG002|Overall Study|concomitant procedure|0|||
163301486|NCT04929483|589811193|FG000|Main Study (24 Weeks)|Adverse Event|1|||
163301487|NCT04929483|589811194|FG001|Main Study (24 Weeks)|Adverse Event|6|||
163301488|NCT04929483|589811195|FG002|Main Study (24 Weeks)|Adverse Event|2|||
163301489|NCT04929483|589811196|FG003|Main Study (24 Weeks)|Adverse Event|1|||
163301490|NCT04929483|589811197|FG004|Main Study (24 Weeks)|Adverse Event|0|||
163301491|NCT04929483|589811198|FG005|Main Study (24 Weeks)|Adverse Event|0|||
163301492|NCT04929483|589811193|FG000|Main Study (24 Weeks)|Withdrawal by Subject|0|||
163301493|NCT04929483|589811194|FG001|Main Study (24 Weeks)|Withdrawal by Subject|3|||
163301494|NCT04929483|589811195|FG002|Main Study (24 Weeks)|Withdrawal by Subject|3|||
163301495|NCT04929483|589811196|FG003|Main Study (24 Weeks)|Withdrawal by Subject|3|||
163301496|NCT04929483|589811197|FG004|Main Study (24 Weeks)|Withdrawal by Subject|0|||
163301497|NCT04929483|589811198|FG005|Main Study (24 Weeks)|Withdrawal by Subject|0|||
163301498|NCT04929483|589811193|FG000|Main Study (24 Weeks)|Lost to Follow-up|0|||
163301499|NCT04929483|589811194|FG001|Main Study (24 Weeks)|Lost to Follow-up|2|||
163301500|NCT04929483|589811195|FG002|Main Study (24 Weeks)|Lost to Follow-up|0|||
163394749|NCT02871778|590156985|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
163394750|NCT02871778|590156986|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
163394751|NCT02871778|590156987|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
163394752|NCT02871778|590156988|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
163394753|NCT02871778|590156989|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
163394754|NCT02871778|590156990|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
163394755|NCT02871778|590156991|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
163394756|NCT02871778|590156984|FG000|Part B: Treatment Period 3|Adverse Event|0|||
163394757|NCT02871778|590156985|FG001|Part B: Treatment Period 3|Adverse Event|0|||
163394758|NCT02871778|590156986|FG002|Part B: Treatment Period 3|Adverse Event|0|||
163394759|NCT02871778|590156987|FG003|Part B: Treatment Period 3|Adverse Event|0|||
163394760|NCT02871778|590156988|FG004|Part B: Treatment Period 3|Adverse Event|1|||
163394761|NCT02871778|590156989|FG005|Part B: Treatment Period 3|Adverse Event|1|||
163394762|NCT02871778|590156990|FG006|Part B: Treatment Period 3|Adverse Event|1|||
163394763|NCT02871778|590156991|FG007|Part B: Treatment Period 3|Adverse Event|0|||
163394764|NCT02653300|590156992|FG000|Overall Study|Withdrawal by Subject|2|||
163394765|NCT00888381|590156993|FG000|Overall Study|Lost to Follow-up|0|||
163394766|NCT00888381|590156994|FG001|Overall Study|Lost to Follow-up|1|||
163394767|NCT00307333|590156995|FG000|Overall Study|Lost to Follow-up|11|||
163394768|NCT00307333|590156996|FG001|Overall Study|Lost to Follow-up|3|||
163394769|NCT04166383|590156997|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
163394770|NCT04166383|590156997|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
163394771|NCT04166383|590156997|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
163394772|NCT03044886|590156998|FG000|Overall Study|Lost to Follow-up|15|||
163394773|NCT03044886|590156999|FG001|Overall Study|Lost to Follow-up|10|||
163394774|NCT03044886|590157000|FG002|Overall Study|Lost to Follow-up|12|||
163394775|NCT03785678|590157003|FG000|Overall Study|Death|44|||
163394776|NCT03785678|590157004|FG001|Overall Study|Death|42|||
163394777|NCT03785678|590157003|FG000|Overall Study|Lost to Follow-up|4|||
163394778|NCT03785678|590157004|FG001|Overall Study|Lost to Follow-up|2|||
163394779|NCT03785678|590157003|FG000|Overall Study|Physician Decision|0|||
163394780|NCT03785678|590157004|FG001|Overall Study|Physician Decision|2|||
163394781|NCT03785678|590157003|FG000|Overall Study|Withdrawal by Subject|5|||
163394782|NCT03785678|590157004|FG001|Overall Study|Withdrawal by Subject|3|||
163394783|NCT01159912|590157005|FG000|Overall Study|Adverse Event|2|||
163394784|NCT01159912|590157006|FG001|Overall Study|Adverse Event|2|||
163394785|NCT01159912|590157007|FG002|Overall Study|Adverse Event|3|||
163394786|NCT01159912|590157005|FG000|Overall Study|Lack of Efficacy|23|||
163394787|NCT01159912|590157006|FG001|Overall Study|Lack of Efficacy|15|||
163394788|NCT01159912|590157007|FG002|Overall Study|Lack of Efficacy|14|||
163394789|NCT01159912|590157005|FG000|Overall Study|Protocol Violation|1|||
163394790|NCT01159912|590157006|FG001|Overall Study|Protocol Violation|2|||
163394791|NCT01159912|590157007|FG002|Overall Study|Protocol Violation|3|||
163394792|NCT01159912|590157005|FG000|Overall Study|Lost to Follow-up|4|||
163394793|NCT01159912|590157006|FG001|Overall Study|Lost to Follow-up|0|||
163394794|NCT01159912|590157007|FG002|Overall Study|Lost to Follow-up|0|||
163394795|NCT01159912|590157005|FG000|Overall Study|Physician Decision|0|||
163394796|NCT01159912|590157006|FG001|Overall Study|Physician Decision|0|||
163394797|NCT01159912|590157007|FG002|Overall Study|Physician Decision|3|||
163394798|NCT01159912|590157005|FG000|Overall Study|Withdrawal by Subject|10|||
162958679|NCT00736190|588551594|FG000|Overall Study|Adverse Event|1|||
163394799|NCT01159912|590157006|FG001|Overall Study|Withdrawal by Subject|3|||
163046126|NCT01223404|588877305|FG004|First Intervention (1 Day)|Adverse Event|0|||
162958680|NCT03246503|588551595|FG000|Overall Study|Lost to Follow-up|23|||
162958681|NCT03246503|588551595|FG000|Overall Study|Withdrawal by Subject|20|||
162958682|NCT03246503|588551595|FG000|Overall Study|Physician Decision|5|||
162958683|NCT03246503|588551595|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
162958684|NCT01370317|588551596|FG000|Overall Study|Participant withdrew consent|1|||
162958685|NCT01370317|588551597|FG001|Overall Study|Participant withdrew consent|0|||
162958686|NCT01370317|588551596|FG000|Overall Study|Protocol deviation|0|||
162958687|NCT01370317|588551597|FG001|Overall Study|Protocol deviation|1|||
162958688|NCT00392665|588551599|FG000|Overall Study|Death|16|||
162958689|NCT00392665|588551600|FG001|Overall Study|Death|14|||
162958690|NCT00392665|588551599|FG000|Overall Study|Lost to Follow-up|1|||
163301501|NCT04929483|589811196|FG003|Main Study (24 Weeks)|Lost to Follow-up|2|||
163301502|NCT04929483|589811197|FG004|Main Study (24 Weeks)|Lost to Follow-up|0|||
163301503|NCT04929483|589811198|FG005|Main Study (24 Weeks)|Lost to Follow-up|0|||
163301504|NCT04929483|589811193|FG000|Main Study (24 Weeks)|Physician Decision|0|||
163301505|NCT04929483|589811194|FG001|Main Study (24 Weeks)|Physician Decision|2|||
163301506|NCT04929483|589811195|FG002|Main Study (24 Weeks)|Physician Decision|0|||
163301507|NCT04929483|589811196|FG003|Main Study (24 Weeks)|Physician Decision|0|||
163301508|NCT04929483|589811197|FG004|Main Study (24 Weeks)|Physician Decision|0|||
163301509|NCT04929483|589811198|FG005|Main Study (24 Weeks)|Physician Decision|0|||
163301510|NCT04929483|589811193|FG000|Main Study (24 Weeks)|Protocol Violation|0|||
163301511|NCT04929483|589811194|FG001|Main Study (24 Weeks)|Protocol Violation|0|||
163301512|NCT04929483|589811195|FG002|Main Study (24 Weeks)|Protocol Violation|1|||
163301513|NCT04929483|589811196|FG003|Main Study (24 Weeks)|Protocol Violation|0|||
163301514|NCT04929483|589811197|FG004|Main Study (24 Weeks)|Protocol Violation|0|||
163301515|NCT04929483|589811198|FG005|Main Study (24 Weeks)|Protocol Violation|0|||
163301516|NCT04929483|589811193|FG000|Main Study (24 Weeks)|Randomized in error|0|||
163301517|NCT04929483|589811194|FG001|Main Study (24 Weeks)|Randomized in error|1|||
163301518|NCT04929483|589811195|FG002|Main Study (24 Weeks)|Randomized in error|0|||
163301519|NCT04929483|589811196|FG003|Main Study (24 Weeks)|Randomized in error|2|||
163301520|NCT04929483|589811197|FG004|Main Study (24 Weeks)|Randomized in error|0|||
163301521|NCT04929483|589811198|FG005|Main Study (24 Weeks)|Randomized in error|0|||
163301522|NCT04929483|589811193|FG000|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
163301523|NCT04929483|589811194|FG001|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
163301524|NCT04929483|589811195|FG002|Extension Study (24 Weeks)|Withdrawal by Subject|3|||
163301525|NCT04929483|589811196|FG003|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
163046127|NCT01223404|588877306|FG005|First Intervention (1 Day)|Adverse Event|0|||
163046128|NCT01223404|588877301|FG000|Second Intervention (1 Day)|Adverse Event|1|||
163046129|NCT01223404|588877302|FG001|Second Intervention (1 Day)|Adverse Event|0|||
163046130|NCT01223404|588877303|FG002|Second Intervention (1 Day)|Adverse Event|0|||
163046131|NCT01223404|588877304|FG003|Second Intervention (1 Day)|Adverse Event|0|||
163046132|NCT01223404|588877305|FG004|Second Intervention (1 Day)|Adverse Event|0|||
163046133|NCT01223404|588877306|FG005|Second Intervention (1 Day)|Adverse Event|0|||
163046134|NCT01223404|588877301|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
163046135|NCT01223404|588877302|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
163046136|NCT01223404|588877303|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
163195559|NCT00087607|589429926|FG001|Overall Study|Administrative|12|||
163195560|NCT00087607|589429925|FG000|Overall Study|Refused Treatment|5|||
163195561|NCT00087607|589429926|FG001|Overall Study|Refused Treatment|7|||
163195562|NCT00087607|589429925|FG000|Overall Study|Other Protocol Violation|5|||
163394800|NCT01159912|590157007|FG002|Overall Study|Withdrawal by Subject|3|||
163394801|NCT00375219|590157008|FG000|Overall Study|Failure to achieve a response|16|||
163195563|NCT00087607|589429926|FG001|Overall Study|Other Protocol Violation|2|||
163195564|NCT00087607|589429925|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
163046137|NCT01223404|588877304|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
163046138|NCT01223404|588877305|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
162958691|NCT00392665|588551600|FG001|Overall Study|Lost to Follow-up|1|||
162958692|NCT03673670|588551601|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
162958693|NCT03673670|588551602|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
162958694|NCT03673670|588551603|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
162958695|NCT03673670|588551604|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
162958696|NCT03673670|588551605|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
162958697|NCT03673670|588551606|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
163195565|NCT00087607|589429926|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
163195566|NCT02699593|589429927|FG000|Period 1|Unsatisfactory Visual Response|0|||
163195567|NCT02699593|589429928|FG001|Period 1|Unsatisfactory Visual Response|1|||
163195568|NCT02699593|589429927|FG000|Period 1|Torn Contact Len|4|||
162958698|NCT03673670|588551601|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
162958699|NCT03673670|588551602|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
162958700|NCT03673670|588551603|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
162958701|NCT03673670|588551604|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
162958702|NCT03673670|588551605|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
163195569|NCT02699593|589429928|FG001|Period 1|Torn Contact Len|3|||
163046139|NCT01223404|588877306|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
163046140|NCT00707057|588877307|FG000|Overall Study|Withdrawal by Subject|8|||
163046141|NCT00707057|588877308|FG001|Overall Study|Withdrawal by Subject|3|||
163046142|NCT00707057|588877307|FG000|Overall Study|Dosed incorrectly|0|||
163046143|NCT00707057|588877308|FG001|Overall Study|Dosed incorrectly|1|||
163046144|NCT02492165|588877309|FG000|Overall Study|Withdrawal by Subject|0|||
163046145|NCT02492165|588877310|FG001|Overall Study|Withdrawal by Subject|1|||
163046146|NCT02492165|588877311|FG002|Overall Study|Withdrawal by Subject|0|||
163046147|NCT02492165|588877312|FG003|Overall Study|Withdrawal by Subject|0|||
163046148|NCT01697800|588877313|FG000|Overall Study|Death|0|||
163046149|NCT01697800|588877314|FG001|Overall Study|Death|1|||
163046150|NCT00954122|588877315|FG000|Overall Study|Withdrawal by Subject|5|||
163046151|NCT00954122|588877315|FG000|Overall Study|Adverse Event|1|||
163046152|NCT00954122|588877315|FG000|Overall Study|Safety Reason|1|||
163046153|NCT00823134|588877324|FG000|Overall Study|Invalid measurement|1|||
163046154|NCT03316586|588877333|FG000|Overall Study|Adverse Event|2|||
163046155|NCT03316586|588877333|FG000|Overall Study|Physician Decision|3|||
163046156|NCT03316586|588877333|FG000|Overall Study|Lack of Efficacy|10|||
163046157|NCT03316586|588877333|FG000|Overall Study|still on treatment|1|||
163046158|NCT03316586|588877333|FG000|Overall Study|Patient needed radiation therapy|1|||
163046159|NCT03316586|588877333|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
163046160|NCT00994110|588877334|FG000|Overall Study|Withdrawal by Subject|9|||
163046161|NCT00994110|588877335|FG001|Overall Study|Withdrawal by Subject|9|||
163046162|NCT00994110|588877334|FG000|Overall Study|Not Treated|4|||
163046163|NCT00994110|588877335|FG001|Overall Study|Not Treated|8|||
163046164|NCT00994110|588877334|FG000|Overall Study|Adverse Event|1|||
163046165|NCT00994110|588877335|FG001|Overall Study|Adverse Event|0|||
163046166|NCT00994110|588877334|FG000|Overall Study|Patient not resected|41|||
163046167|NCT00994110|588877335|FG001|Overall Study|Patient not resected|52|||
163046168|NCT00994110|588877334|FG000|Overall Study|Pt not eligible|10|||
163046169|NCT00994110|588877335|FG001|Overall Study|Pt not eligible|5|||
163046170|NCT00619827|588877336|FG000|Overall Study|Adverse Event|1|||
163046171|NCT00619827|588877337|FG001|Overall Study|Adverse Event|2|||
163046172|NCT00619827|588877336|FG000|Overall Study|Withdrawal by Subject|2|||
163046173|NCT00619827|588877337|FG001|Overall Study|Withdrawal by Subject|2|||
163046174|NCT02163395|588877338|FG000|Overall Study|Withdrawal by Subject|1|||
163046175|NCT02163395|588877338|FG000|Overall Study|Lost to Follow-up|3|||
163046176|NCT02163395|588877338|FG000|Overall Study|Adverse Event|1|||
163046177|NCT02999789|588877339|FG000|Overall Study|Withdrawal by Subject|0|||
163046178|NCT02999789|588877340|FG001|Overall Study|Withdrawal by Subject|1|||
163046179|NCT02999789|588877339|FG000|Overall Study|Became ineligible|1|||
163046180|NCT02999789|588877340|FG001|Overall Study|Became ineligible|2|||
163046181|NCT01111565|588877341|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
163046182|NCT01111565|588877342|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
163046183|NCT01111565|588877343|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
163046184|NCT01111565|588877344|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
163046185|NCT01111565|588877345|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
163046186|NCT01111565|588877341|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
163046187|NCT01111565|588877342|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
163046188|NCT01111565|588877343|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
163046189|NCT01111565|588877344|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
163046190|NCT01111565|588877345|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
163046191|NCT01111565|588877341|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
163046192|NCT01111565|588877342|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
163046193|NCT01111565|588877343|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
163046194|NCT01111565|588877344|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
163046195|NCT01111565|588877345|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
163046196|NCT01111565|588877341|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
163046197|NCT01111565|588877342|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
163046198|NCT01111565|588877343|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
163046199|NCT01111565|588877344|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
163046200|NCT01111565|588877345|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
163046201|NCT01111565|588877341|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
163195570|NCT02699593|589429927|FG000|Period 1|Protocol Violation|0|||
163195571|NCT02699593|589429928|FG001|Period 1|Protocol Violation|1|||
163195572|NCT02699593|589429927|FG000|Period 1|Withdrawal by Subject|0|||
163046202|NCT01111565|588877342|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
163046203|NCT01111565|588877343|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
163046204|NCT01111565|588877344|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
163046205|NCT01111565|588877345|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
163046206|NCT01111565|588877341|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
163046207|NCT01111565|588877342|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
163195573|NCT02699593|589429928|FG001|Period 1|Withdrawal by Subject|1|||
163195574|NCT02699593|589429927|FG000|Period 1|Adverse Event|1|||
163046208|NCT01111565|588877343|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
163046209|NCT01111565|588877344|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
162924306|NCT00518011|588423857|FG000|Overall Study|Adverse Event|2|||
162924307|NCT00518011|588423858|FG001|Overall Study|Adverse Event|3|||
162924308|NCT00518011|588423857|FG000|Overall Study|Disease Progression|2|||
162924309|NCT00518011|588423858|FG001|Overall Study|Disease Progression|2|||
162924310|NCT00518011|588423857|FG000|Overall Study|Other Reasons|3|||
162924311|NCT00518011|588423858|FG001|Overall Study|Other Reasons|2|||
162924312|NCT00518011|588423857|FG000|Overall Study|Withdrawal by Subject|1|||
162924313|NCT00518011|588423858|FG001|Overall Study|Withdrawal by Subject|0|||
162924314|NCT02998645|588423859|FG000|Treatment Period 1|Adverse Event|6|||
162924315|NCT02998645|588423859|FG000|Treatment Period 1|Death|5|||
162924316|NCT02998645|588423859|FG000|Treatment Period 1|Technical Problems|4|||
162924317|NCT02998645|588423859|FG000|Treatment Period 1|Lack of Efficacy|2|||
162924318|NCT02998645|588423859|FG000|Treatment Period 1|Progressive disease|1|||
162924319|NCT02998645|588423859|FG000|Treatment Period 1|Subject/guardian decision|1|||
162924320|NCT02998645|588423859|FG000|Treatment Period 2|Lack of Efficacy|5|||
162924321|NCT02998645|588423859|FG000|Treatment Period 2|Adverse Event|2|||
162924322|NCT02998645|588423859|FG000|Treatment Period 2|Progressive disease|2|||
162924323|NCT02998645|588423859|FG000|Treatment Period 2|Physician Decision|1|||
162924324|NCT00090259|588423860|FG000|Overall Study|Lost to Follow-up|30|||
162924325|NCT00090259|588423861|FG001|Overall Study|Lost to Follow-up|26|||
162924326|NCT00090259|588423860|FG000|Overall Study|Withdrawal by Subject|21|||
162924327|NCT00090259|588423861|FG001|Overall Study|Withdrawal by Subject|15|||
162924328|NCT00090259|588423860|FG000|Overall Study|Investigator site closed|11|||
162924329|NCT00090259|588423861|FG001|Overall Study|Investigator site closed|7|||
162924330|NCT03701516|588423862|FG000|Period 1|Lost to Follow-up|0|||
162924331|NCT03701516|588423863|FG001|Period 1|Lost to Follow-up|1|||
162924332|NCT03701516|588423862|FG000|Period 1|Adverse Event|0|||
162924333|NCT03701516|588423863|FG001|Period 1|Adverse Event|2|||
162924334|NCT03701516|588423862|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
162924335|NCT03701516|588423863|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
162924336|NCT03701516|588423862|FG000|Period 1|Non Compliance to Protocol|2|||
162924337|NCT03701516|588423863|FG001|Period 1|Non Compliance to Protocol|1|||
162924338|NCT03701516|588423862|FG000|Period 1|Withdrawal by Subject|0|||
162924339|NCT03701516|588423863|FG001|Period 1|Withdrawal by Subject|1|||
162924340|NCT03701516|588423862|FG000|Period 2|failed to meet all eligibility creiteria|1|||
162924341|NCT03701516|588423863|FG001|Period 2|failed to meet all eligibility creiteria|0|||
162924342|NCT03701516|588423862|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
162924343|NCT03701516|588423863|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
162924344|NCT03644927|588423869|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
162924345|NCT03644927|588423870|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
162924346|NCT00956813|588423871|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
162924347|NCT00956813|588423872|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
162924348|NCT00956813|588423871|FG000|Flaxseed and Placebo|Ineligible|3|||
162924349|NCT00956813|588423872|FG001|Flaxseed and Placebo|Ineligible|1|||
162924350|NCT04797637|588423873|FG000|Overall Study|Lost to Follow-up|23|||
162924351|NCT04797637|588423874|FG001|Overall Study|Lost to Follow-up|32|||
162924352|NCT04797637|588423873|FG000|Overall Study|Withdrawal by Subject|0|||
163046210|NCT01111565|588877345|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
162958703|NCT03673670|588551606|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
162958704|NCT03673670|588551601|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
162958705|NCT03673670|588551602|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
162958706|NCT03673670|588551603|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
162958707|NCT03673670|588551604|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
162958708|NCT03673670|588551605|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
162958709|NCT03673670|588551606|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
162958710|NCT03673670|588551601|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
162958711|NCT03673670|588551602|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
162958712|NCT03673670|588551603|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
162958713|NCT03673670|588551604|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
162958714|NCT03673670|588551605|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
162958715|NCT03673670|588551606|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
162958716|NCT03673670|588551601|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
162958717|NCT03673670|588551602|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
162958718|NCT03673670|588551603|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
162958719|NCT03673670|588551604|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
162958720|NCT03673670|588551605|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
162958721|NCT03673670|588551606|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
162958722|NCT03673670|588551601|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
162958723|NCT03673670|588551602|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
162958724|NCT03673670|588551603|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
162958725|NCT03673670|588551604|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
162958726|NCT03673670|588551605|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
162958727|NCT03673670|588551606|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
162958728|NCT03673670|588551601|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
162958729|NCT03673670|588551602|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
162958730|NCT03673670|588551603|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
162958731|NCT03673670|588551604|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
162958732|NCT03673670|588551605|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
162958733|NCT03673670|588551606|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
162958734|NCT01058668|588551607|FG000|Double-blind Treatment Phase|Adverse Event|8|||
162958735|NCT01058668|588551608|FG001|Double-blind Treatment Phase|Adverse Event|15|||
162958736|NCT01058668|588551609|FG002|Double-blind Treatment Phase|Adverse Event|25|||
162958737|NCT01058668|588551607|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
162958738|NCT01058668|588551608|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
162958739|NCT01058668|588551609|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
162958740|NCT01058668|588551607|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
162958741|NCT01058668|588551608|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
162958742|NCT01058668|588551609|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
162958743|NCT01058668|588551607|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
162958744|NCT01058668|588551608|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
162958745|NCT01058668|588551609|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
162958746|NCT01058668|588551607|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
162958747|NCT01058668|588551608|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
162958748|NCT01058668|588551609|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
162958749|NCT01058668|588551607|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
162958750|NCT01058668|588551608|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
162958751|NCT01058668|588551609|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
162958752|NCT02294786|588551612|FG000|Overall Study|Withdrawal by Subject|0|||
162958753|NCT02294786|588551613|FG001|Overall Study|Withdrawal by Subject|1|||
162958754|NCT02294786|588551612|FG000|Overall Study|Physician Decision|6|||
162958755|NCT02294786|588551613|FG001|Overall Study|Physician Decision|7|||
162958756|NCT02294786|588551612|FG000|Overall Study|Lost to Follow-up|1|||
162958757|NCT02294786|588551613|FG001|Overall Study|Lost to Follow-up|2|||
162958758|NCT02294786|588551612|FG000|Overall Study|Protocol Violation|1|||
162958759|NCT02294786|588551613|FG001|Overall Study|Protocol Violation|0|||
162958760|NCT02294786|588551612|FG000|Overall Study|Adverse Event|1|||
162958761|NCT02294786|588551613|FG001|Overall Study|Adverse Event|1|||
162958762|NCT02294786|588551612|FG000|Overall Study|Death|2|||
162958763|NCT02294786|588551613|FG001|Overall Study|Death|3|||
162958764|NCT01663233|588551616|FG000|Overall Study|Withdrawal by Subject|3|||
162958765|NCT01663233|588551617|FG001|Overall Study|Withdrawal by Subject|2|||
162958766|NCT01663233|588551616|FG000|Overall Study|Protocol Deviation|1|||
163058597|NCT00042289|588924237|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
162958767|NCT01663233|588551617|FG001|Overall Study|Protocol Deviation|4|||
162958768|NCT01663233|588551616|FG000|Overall Study|Lost to Follow-up|0|||
162958769|NCT01663233|588551617|FG001|Overall Study|Lost to Follow-up|1|||
162958770|NCT00796328|588551618|FG000|Overall Study|experienced hypotension requiring tx|6|||
162958771|NCT03406156|588551619|FG000|Overall Study|Death|9|||
162958772|NCT03406156|588551620|FG001|Overall Study|Death|3|||
163046211|NCT01111565|588877341|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
163046212|NCT01111565|588877342|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
163046213|NCT01111565|588877343|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
162958773|NCT03406156|588551619|FG000|Overall Study|Withdrawal by Subject|1|||
162958774|NCT03406156|588551620|FG001|Overall Study|Withdrawal by Subject|2|||
162958775|NCT03406156|588551619|FG000|Overall Study|COVID-19 infection|1|||
162958776|NCT03406156|588551620|FG001|Overall Study|COVID-19 infection|0|||
162958777|NCT03406156|588551619|FG000|Overall Study|Non-compliance with study procedures|1|||
162958778|NCT03406156|588551620|FG001|Overall Study|Non-compliance with study procedures|1|||
162958779|NCT03406156|588551619|FG000|Overall Study|Lost to Follow-up|0|||
162958780|NCT03406156|588551620|FG001|Overall Study|Lost to Follow-up|2|||
162958781|NCT03406156|588551619|FG000|Overall Study|Other, not specified|72|||
162958782|NCT03406156|588551620|FG001|Overall Study|Other, not specified|28|||
162958783|NCT05479058|588551621|FG000|Overall Study|Withdrawal by Subject|1|||
162958784|NCT05479058|588551622|FG001|Overall Study|Withdrawal by Subject|1|||
162958785|NCT05479058|588551621|FG000|Overall Study|Study terminated by sponsor|10|||
162958786|NCT05479058|588551622|FG001|Overall Study|Study terminated by sponsor|10|||
162958787|NCT02414152|588551627|FG000|Overall Study|Withdrawal by Subject|1|||
162958788|NCT02414152|588551627|FG000|Overall Study|Lack of Efficacy|1|||
162958789|NCT01757392|588551628|FG000|Overall Study|Withdrawal by Subject|1|||
162958790|NCT01757392|588551628|FG000|Overall Study|Screen Fail|3|||
162958791|NCT00841698|588551635|FG000|First Intervention|Withdrawal by Subject|1|||
162958792|NCT00841698|588551636|FG001|First Intervention|Withdrawal by Subject|0|||
162958793|NCT04078022|588551643|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
162958794|NCT04078022|588551644|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
162958795|NCT01250912|588551645|FG000|Overall Study|Lost to Follow-up|1|||
162958796|NCT00191815|588551646|FG000|Overall Study|Adverse Event|2|||
162958797|NCT00191815|588551646|FG000|Overall Study|Disease progression or relapse|24|||
162958798|NCT00191815|588551646|FG000|Overall Study|Death|2|||
162958799|NCT00191815|588551646|FG000|Overall Study|Protocol Violation|3|||
162958800|NCT00191815|588551646|FG000|Overall Study|Physician Decision|2|||
162958801|NCT00191815|588551646|FG000|Overall Study|Withdrawal by Subject|7|||
162958802|NCT01929863|588551647|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
162958803|NCT01929863|588551648|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
162958804|NCT01929863|588551647|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
162958805|NCT01929863|588551648|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
162958806|NCT01929863|588551647|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
162958807|NCT01929863|588551648|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
162958808|NCT00251979|588551649|FG000|Overall Study|Protocol Violation|3|||
162958809|NCT00251979|588551650|FG001|Overall Study|Protocol Violation|5|||
163046214|NCT01111565|588877344|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
163046215|NCT01111565|588877345|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
162958810|NCT00251979|588551649|FG000|Overall Study|Adverse Event|11|||
162958811|NCT00251979|588551650|FG001|Overall Study|Adverse Event|17|||
162958812|NCT00251979|588551649|FG000|Overall Study|Withdrawal by Subject|13|||
162958813|NCT00251979|588551650|FG001|Overall Study|Withdrawal by Subject|7|||
162958814|NCT00251979|588551649|FG000|Overall Study|Lost to Follow-up|8|||
162958815|NCT00251979|588551650|FG001|Overall Study|Lost to Follow-up|6|||
162958816|NCT00251979|588551649|FG000|Overall Study|Death|3|||
162958817|NCT00251979|588551650|FG001|Overall Study|Death|5|||
162958818|NCT01348789|588551660|FG000|Overall Study|Protocol Violation|2|||
163046216|NCT01111565|588877341|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
162958819|NCT01348789|588551660|FG000|Overall Study|Withdrawal by Subject|2|||
162958820|NCT01878292|588551661|FG000|Randomized|Protocol Violation|1|||
162958821|NCT01878292|588551662|FG001|Randomized|Protocol Violation|0|||
162958822|NCT01878292|588551663|FG002|Randomized|Protocol Violation|0|||
162958823|NCT01878292|588551661|FG000|Randomized|Lost to Follow-up|1|||
162958824|NCT01878292|588551662|FG001|Randomized|Lost to Follow-up|0|||
162958825|NCT01878292|588551663|FG002|Randomized|Lost to Follow-up|0|||
162958826|NCT01878292|588551661|FG000|Randomized|Adverse Event|1|||
162958827|NCT01878292|588551662|FG001|Randomized|Adverse Event|0|||
162958828|NCT01878292|588551663|FG002|Randomized|Adverse Event|0|||
162958829|NCT01878292|588551661|FG000|Double-blind Treatment Period|Other Reasons|2|||
162958830|NCT01878292|588551662|FG001|Double-blind Treatment Period|Other Reasons|0|||
163046217|NCT01111565|588877342|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
163046218|NCT01111565|588877343|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
162958831|NCT01878292|588551663|FG002|Double-blind Treatment Period|Other Reasons|0|||
162958832|NCT01878292|588551661|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
162958833|NCT01878292|588551662|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
162958834|NCT01878292|588551663|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
162958835|NCT01878292|588551661|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
162958836|NCT01878292|588551662|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
162958837|NCT01878292|588551663|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
162958838|NCT01878292|588551661|FG000|Double-blind Treatment Period|Protocol Violation|3|||
162958839|NCT01878292|588551662|FG001|Double-blind Treatment Period|Protocol Violation|4|||
162958840|NCT01878292|588551663|FG002|Double-blind Treatment Period|Protocol Violation|2|||
162958841|NCT01878292|588551661|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
163195575|NCT02699593|589429928|FG001|Period 1|Adverse Event|1|||
163195576|NCT02699593|589429927|FG000|Period 2|Adverse Event|1|||
162958842|NCT01878292|588551662|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
163046219|NCT01111565|588877344|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
163046220|NCT01111565|588877345|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
162958843|NCT01878292|588551663|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
162958844|NCT01878292|588551661|FG000|Double-blind Treatment Period|Adverse Event|4|||
162958845|NCT01878292|588551662|FG001|Double-blind Treatment Period|Adverse Event|9|||
162958846|NCT01878292|588551663|FG002|Double-blind Treatment Period|Adverse Event|8|||
162958847|NCT01878292|588551661|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
162958848|NCT01878292|588551662|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
162958849|NCT01878292|588551663|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
162958850|NCT00323882|588551664|FG000|Overall Study|Adverse Event|2|||
162958851|NCT00323882|588551665|FG001|Overall Study|Adverse Event|1|||
162958852|NCT00323882|588551666|FG002|Overall Study|Adverse Event|1|||
162958853|NCT00323882|588551667|FG003|Overall Study|Adverse Event|1|||
162958854|NCT00323882|588551668|FG004|Overall Study|Adverse Event|3|||
162958855|NCT00323882|588551664|FG000|Overall Study|Disease Progression|6|||
162958856|NCT00323882|588551665|FG001|Overall Study|Disease Progression|4|||
162958857|NCT00323882|588551666|FG002|Overall Study|Disease Progression|10|||
162958858|NCT00323882|588551667|FG003|Overall Study|Disease Progression|5|||
162958859|NCT00323882|588551668|FG004|Overall Study|Disease Progression|22|||
162958860|NCT00323882|588551664|FG000|Overall Study|Death|0|||
162958861|NCT00323882|588551665|FG001|Overall Study|Death|1|||
162958862|NCT00323882|588551666|FG002|Overall Study|Death|1|||
162958863|NCT00323882|588551667|FG003|Overall Study|Death|0|||
162958864|NCT00323882|588551668|FG004|Overall Study|Death|5|||
162958865|NCT00323882|588551664|FG000|Overall Study|Lost to Follow-up|0|||
162958866|NCT00323882|588551665|FG001|Overall Study|Lost to Follow-up|0|||
162958867|NCT00323882|588551666|FG002|Overall Study|Lost to Follow-up|1|||
162958868|NCT00323882|588551667|FG003|Overall Study|Lost to Follow-up|0|||
162958869|NCT00323882|588551668|FG004|Overall Study|Lost to Follow-up|1|||
162958870|NCT00323882|588551664|FG000|Overall Study|Other|0|||
162958871|NCT00323882|588551665|FG001|Overall Study|Other|0|||
162958872|NCT00323882|588551666|FG002|Overall Study|Other|0|||
162958873|NCT00323882|588551667|FG003|Overall Study|Other|1|||
162958874|NCT00323882|588551668|FG004|Overall Study|Other|1|||
162958875|NCT00415363|588551678|FG000|Overall Study|Withdrawal by Subject|4|||
162958876|NCT00415363|588551679|FG001|Overall Study|Withdrawal by Subject|4|||
162958877|NCT00415363|588551678|FG000|Overall Study|Adverse Event|4|||
162958878|NCT00415363|588551679|FG001|Overall Study|Adverse Event|4|||
162958879|NCT00415363|588551678|FG000|Overall Study|Lost to Follow-up|2|||
162958880|NCT00415363|588551679|FG001|Overall Study|Lost to Follow-up|1|||
162958881|NCT00415363|588551678|FG000|Overall Study|Physician Decision|3|||
162958882|NCT00415363|588551679|FG001|Overall Study|Physician Decision|1|||
162958883|NCT00415363|588551678|FG000|Overall Study|Death|16|||
162958884|NCT00415363|588551679|FG001|Overall Study|Death|12|||
162958885|NCT00415363|588551678|FG000|Overall Study|Progressive disease|26|||
162958886|NCT00415363|588551679|FG001|Overall Study|Progressive disease|32|||
162958887|NCT02152163|588551680|FG000|Overall Study|Physician Decision|12|||
162958888|NCT02152163|588551681|FG001|Overall Study|Physician Decision|13|||
162958889|NCT03123471|588551682|FG000|Placebo-controlled Phase|Adverse Event|3|||
162958890|NCT03123471|588551683|FG001|Placebo-controlled Phase|Adverse Event|8|||
162958891|NCT03123471|588551682|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
162958892|NCT03123471|588551683|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
162958893|NCT03123471|588551682|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
162958894|NCT03123471|588551683|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
162958895|NCT03123471|588551682|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
162958896|NCT03123471|588551683|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
162958897|NCT03123471|588551682|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
162958898|NCT03123471|588551683|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
162958899|NCT03123471|588551682|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
163195577|NCT02699593|589429928|FG001|Period 2|Adverse Event|1|||
163195578|NCT02699593|589429927|FG000|Period 2|Lost Contact Lens|0|||
163195579|NCT02699593|589429928|FG001|Period 2|Lost Contact Lens|1|||
163195580|NCT02699593|589429927|FG000|Period 2|Torn Contact Lens|1|||
163195581|NCT02699593|589429928|FG001|Period 2|Torn Contact Lens|0|||
163195582|NCT02015754|589429929|FG000|Overall Study|Disease progression|5|||
163301526|NCT04929483|589811197|FG004|Extension Study (24 Weeks)|Withdrawal by Subject|2|||
163301527|NCT04929483|589811198|FG005|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
163301528|NCT04929483|589811193|FG000|Extension Study (24 Weeks)|Lost to Follow-up|0|||
163301529|NCT04929483|589811194|FG001|Extension Study (24 Weeks)|Lost to Follow-up|1|||
163301530|NCT04929483|589811195|FG002|Extension Study (24 Weeks)|Lost to Follow-up|1|||
163301531|NCT04929483|589811196|FG003|Extension Study (24 Weeks)|Lost to Follow-up|0|||
163301532|NCT04929483|589811197|FG004|Extension Study (24 Weeks)|Lost to Follow-up|1|||
163301533|NCT04929483|589811198|FG005|Extension Study (24 Weeks)|Lost to Follow-up|0|||
163301534|NCT04929483|589811193|FG000|Extension Study (24 Weeks)|Other than specified|1|||
163301535|NCT04929483|589811194|FG001|Extension Study (24 Weeks)|Other than specified|0|||
163301536|NCT04929483|589811195|FG002|Extension Study (24 Weeks)|Other than specified|1|||
163301537|NCT04929483|589811196|FG003|Extension Study (24 Weeks)|Other than specified|0|||
163301538|NCT04929483|589811197|FG004|Extension Study (24 Weeks)|Other than specified|1|||
163301539|NCT04929483|589811198|FG005|Extension Study (24 Weeks)|Other than specified|0|||
163301540|NCT04929483|589811193|FG000|Extension Study (24 Weeks)|Adverse Event|0|||
163301541|NCT04929483|589811194|FG001|Extension Study (24 Weeks)|Adverse Event|2|||
163301542|NCT04929483|589811195|FG002|Extension Study (24 Weeks)|Adverse Event|3|||
163301543|NCT04929483|589811196|FG003|Extension Study (24 Weeks)|Adverse Event|0|||
163301544|NCT04929483|589811197|FG004|Extension Study (24 Weeks)|Adverse Event|0|||
163301545|NCT04929483|589811198|FG005|Extension Study (24 Weeks)|Adverse Event|0|||
163301546|NCT01626885|589811199|FG000|Overall Study|Adverse Event|8|||
163301547|NCT01626885|589811199|FG000|Overall Study|Withdrawal by Subject|4|||
163301548|NCT04083781|589811206|FG000|Main Part|Physician Decision|0|||
163301549|NCT04083781|589811207|FG001|Main Part|Physician Decision|1|||
163301550|NCT04083781|589811208|FG002|Main Part|Physician Decision|2|||
163301551|NCT04083781|589811209|FG003|Main Part|Physician Decision|0|||
163301552|NCT04083781|589811206|FG000|Main Part|Death|1|||
163301553|NCT04083781|589811207|FG001|Main Part|Death|3|||
163301554|NCT04083781|589811208|FG002|Main Part|Death|1|||
163301555|NCT04083781|589811209|FG003|Main Part|Death|0|||
163301556|NCT04083781|589811206|FG000|Main Part|Withdrawal by Subject|5|||
163301557|NCT04083781|589811207|FG001|Main Part|Withdrawal by Subject|2|||
163301558|NCT04083781|589811208|FG002|Main Part|Withdrawal by Subject|3|||
163301559|NCT04083781|589811209|FG003|Main Part|Withdrawal by Subject|7|||
163301560|NCT04083781|589811206|FG000|Extension Part|Physician Decision|0|||
163301561|NCT04083781|589811207|FG001|Extension Part|Physician Decision|0|||
163301562|NCT04083781|589811208|FG002|Extension Part|Physician Decision|0|||
163301563|NCT04083781|589811209|FG003|Extension Part|Physician Decision|1|||
163301564|NCT04083781|589811206|FG000|Extension Part|Death|0|||
163301565|NCT04083781|589811207|FG001|Extension Part|Death|1|||
163301566|NCT04083781|589811208|FG002|Extension Part|Death|0|||
163301567|NCT04083781|589811209|FG003|Extension Part|Death|1|||
163301568|NCT04083781|589811206|FG000|Extension Part|Withdrawal by Subject|0|||
163301569|NCT04083781|589811207|FG001|Extension Part|Withdrawal by Subject|1|||
163301570|NCT04083781|589811208|FG002|Extension Part|Withdrawal by Subject|0|||
163301571|NCT04083781|589811209|FG003|Extension Part|Withdrawal by Subject|0|||
163301572|NCT04083781|589811206|FG000|Extension Part|Ongoing|13|||
163301573|NCT04083781|589811207|FG001|Extension Part|Ongoing|25|||
163301574|NCT04083781|589811208|FG002|Extension Part|Ongoing|15|||
163301575|NCT04083781|589811209|FG003|Extension Part|Ongoing|51|||
163301576|NCT01143337|589811210|FG000|Overall Study|Adverse Event|3|||
163301577|NCT01143337|589811211|FG001|Overall Study|Adverse Event|9|||
163301578|NCT01143337|589811212|FG002|Overall Study|Adverse Event|5|||
163301579|NCT01143337|589811210|FG000|Overall Study|Lack of Efficacy|6|||
163301580|NCT01143337|589811211|FG001|Overall Study|Lack of Efficacy|2|||
163301581|NCT01143337|589811212|FG002|Overall Study|Lack of Efficacy|1|||
163301582|NCT01143337|589811210|FG000|Overall Study|Protocol Violation|1|||
163301583|NCT01143337|589811211|FG001|Overall Study|Protocol Violation|0|||
163301584|NCT01143337|589811212|FG002|Overall Study|Protocol Violation|0|||
163301585|NCT01143337|589811210|FG000|Overall Study|Withdrawal by Subject|0|||
163301586|NCT01143337|589811211|FG001|Overall Study|Withdrawal by Subject|0|||
163301587|NCT01143337|589811212|FG002|Overall Study|Withdrawal by Subject|1|||
163301588|NCT01143337|589811210|FG000|Overall Study|Other reason|0|||
163301589|NCT01143337|589811211|FG001|Overall Study|Other reason|0|||
163301590|NCT01143337|589811212|FG002|Overall Study|Other reason|5|||
163301591|NCT01466192|589811213|FG000|Overall Study|Physician Decision|1|||
163301592|NCT01466192|589811213|FG000|Overall Study|Withdrawal by Subject|3|||
163301593|NCT05600283|589811214|FG000|Overall Study|Withdrawal by Subject|3|||
163301594|NCT05600283|589811215|FG001|Overall Study|Withdrawal by Subject|8|||
163301595|NCT05600283|589811214|FG000|Overall Study|Invalid Vaginal Swab|2|||
163301596|NCT05600283|589811215|FG001|Overall Study|Invalid Vaginal Swab|2|||
163301597|NCT05600283|589811214|FG000|Overall Study|Missing Clinician Collection|3|||
163301598|NCT05600283|589811215|FG001|Overall Study|Missing Clinician Collection|6|||
163301599|NCT05600283|589811214|FG000|Overall Study|Screen Failure|1|||
163301600|NCT05600283|589811215|FG001|Overall Study|Screen Failure|2|||
163301601|NCT05600283|589811214|FG000|Overall Study|Sample Lost in Transit|1|||
163301602|NCT05600283|589811215|FG001|Overall Study|Sample Lost in Transit|0|||
163046221|NCT01111565|588877341|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163046222|NCT01111565|588877342|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163046223|NCT01111565|588877343|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
162958900|NCT03123471|588551683|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
162958901|NCT03123471|588551682|FG000|Placebo-controlled Phase|Miscellaneous|0|||
162958902|NCT03123471|588551683|FG001|Placebo-controlled Phase|Miscellaneous|1|||
162958903|NCT03123471|588551682|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
162958904|NCT03123471|588551683|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
163046224|NCT01111565|588877344|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163046225|NCT01111565|588877345|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163046226|NCT01111565|588877341|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
163046227|NCT01111565|588877342|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
163046228|NCT01111565|588877343|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
163046229|NCT01111565|588877344|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
163046230|NCT01111565|588877345|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
163046231|NCT01111565|588877341|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
163046232|NCT01111565|588877342|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
163046233|NCT01111565|588877343|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
163046234|NCT01111565|588877344|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
163046235|NCT01111565|588877345|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
163046236|NCT01111565|588877341|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
163046237|NCT01111565|588877342|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
163046238|NCT01111565|588877343|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
163046239|NCT01111565|588877344|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
163046240|NCT01111565|588877345|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
163046241|NCT03150082|588877346|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
163301603|NCT00068601|589811216|FG000|Overall Study|Ineligible|11|||
162958905|NCT03123471|588551682|FG000|Apremilast Extension Phase|Adverse Event|1|||
162958906|NCT03123471|588551683|FG001|Apremilast Extension Phase|Adverse Event|5|||
162958907|NCT03123471|588551682|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
162958908|NCT03123471|588551683|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
162958909|NCT03123471|588551682|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
162958910|NCT03123471|588551683|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
162958911|NCT02358538|588551686|FG000|Through Week 26|Adverse Event|0|||
162958912|NCT02358538|588551687|FG001|Through Week 26|Adverse Event|1|||
162958913|NCT02358538|588551688|FG002|Through Week 26|Adverse Event|1|||
162958914|NCT02358538|588551689|FG003|Through Week 26|Adverse Event|2|||
162958915|NCT02358538|588551686|FG000|Through Week 26|Lack of Efficacy|1|||
162958916|NCT02358538|588551687|FG001|Through Week 26|Lack of Efficacy|1|||
162958917|NCT02358538|588551688|FG002|Through Week 26|Lack of Efficacy|3|||
162958918|NCT02358538|588551689|FG003|Through Week 26|Lack of Efficacy|3|||
162958919|NCT02358538|588551686|FG000|Through Week 26|Withdrawal by Subject|1|||
162958920|NCT02358538|588551687|FG001|Through Week 26|Withdrawal by Subject|0|||
162958921|NCT02358538|588551688|FG002|Through Week 26|Withdrawal by Subject|0|||
162958922|NCT02358538|588551689|FG003|Through Week 26|Withdrawal by Subject|0|||
162958923|NCT02358538|588551686|FG000|Through Week 26|Non-Compliance|0|||
162958924|NCT02358538|588551687|FG001|Through Week 26|Non-Compliance|0|||
162958925|NCT02358538|588551688|FG002|Through Week 26|Non-Compliance|1|||
162958926|NCT02358538|588551689|FG003|Through Week 26|Non-Compliance|0|||
162958927|NCT02358538|588551686|FG000|Through Week 26|Family did not see benefit from IP|1|||
162958928|NCT02358538|588551687|FG001|Through Week 26|Family did not see benefit from IP|0|||
162958929|NCT02358538|588551688|FG002|Through Week 26|Family did not see benefit from IP|0|||
162958930|NCT02358538|588551689|FG003|Through Week 26|Family did not see benefit from IP|0|||
162958931|NCT02358538|588551686|FG000|52 Week Extension Period|Lack of Efficacy|0|||
162958932|NCT02358538|588551687|FG001|52 Week Extension Period|Lack of Efficacy|0|||
162958933|NCT02358538|588551688|FG002|52 Week Extension Period|Lack of Efficacy|2|||
162958934|NCT02358538|588551689|FG003|52 Week Extension Period|Lack of Efficacy|4|||
162958935|NCT01686477|588551690|FG000|Feeding Intervention|Death|1|||
162958936|NCT01686477|588551691|FG001|Feeding Intervention|Death|0|||
162958937|NCT01686477|588551692|FG002|Feeding Intervention|Death|1|||
162958938|NCT01686477|588551690|FG000|Feeding Intervention|Withdrawal by Subject|0|||
162958939|NCT01686477|588551691|FG001|Feeding Intervention|Withdrawal by Subject|6|||
162958940|NCT01686477|588551692|FG002|Feeding Intervention|Withdrawal by Subject|0|||
162958941|NCT01686477|588551690|FG000|Feeding Intervention|Physician Decision|1|||
162958942|NCT01686477|588551691|FG001|Feeding Intervention|Physician Decision|2|||
162958943|NCT01686477|588551692|FG002|Feeding Intervention|Physician Decision|0|||
162958944|NCT01686477|588551690|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
162958945|NCT01686477|588551691|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
162958946|NCT01686477|588551692|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
162958947|NCT01686477|588551690|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
162958948|NCT01686477|588551691|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
162958949|NCT01686477|588551692|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
162958950|NCT01686477|588551690|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
162958951|NCT01686477|588551691|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
162958952|NCT01686477|588551692|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
162958953|NCT01686477|588551690|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
163301604|NCT00068601|589811217|FG001|Overall Study|Ineligible|13|||
163301605|NCT00068601|589811216|FG000|Overall Study|Not evaluable: withdrew consent|5|||
163301606|NCT00068601|589811217|FG001|Overall Study|Not evaluable: withdrew consent|4|||
163301607|NCT00068601|589811216|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
163301608|NCT00068601|589811217|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
163301609|NCT00068601|589811216|FG000|Overall Study|Death|11|||
162958954|NCT01686477|588551691|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
163301610|NCT00068601|589811217|FG001|Overall Study|Death|3|||
163301611|NCT00068601|589811216|FG000|Overall Study|Lost to Follow-up|3|||
163301612|NCT00068601|589811217|FG001|Overall Study|Lost to Follow-up|2|||
162958955|NCT01686477|588551692|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
162958956|NCT01686477|588551690|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
163301613|NCT00068601|589811216|FG000|Overall Study|Missing primary outcome data|30|||
162958957|NCT01686477|588551691|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
162958958|NCT01686477|588551692|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
162958959|NCT01686477|588551690|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
162958960|NCT01686477|588551691|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
162958961|NCT01686477|588551692|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
162958962|NCT01686477|588551690|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
163301614|NCT00068601|589811217|FG001|Overall Study|Missing primary outcome data|34|||
163046242|NCT03150082|588877347|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
163046243|NCT04131712|588877350|FG000|Overall Study|COVID related|0|||
162958963|NCT01686477|588551691|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
162958964|NCT01686477|588551692|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
162958965|NCT06999265|588551694|FG000|Overall Study|Lost to Follow-up|1|||
162958966|NCT06999265|588551695|FG001|Overall Study|Lost to Follow-up|1|||
162958967|NCT02178787|588551696|FG000|Overall Study|Lost to Follow-up|1|||
162958968|NCT02178787|588551697|FG001|Overall Study|Lost to Follow-up|0|||
162958969|NCT02178787|588551696|FG000|Overall Study|Withdrawal by Subject|0|||
162958970|NCT02178787|588551697|FG001|Overall Study|Withdrawal by Subject|2|||
162958971|NCT02178787|588551696|FG000|Overall Study|No TCD window|3|||
162958972|NCT02178787|588551697|FG001|Overall Study|No TCD window|7|||
162958973|NCT02178787|588551696|FG000|Overall Study|Physician Decision|1|||
162958974|NCT02178787|588551697|FG001|Overall Study|Physician Decision|0|||
162958975|NCT01588236|588551702|FG000|Overall Study|Adverse Event|5|||
162958976|NCT01588236|588551703|FG001|Overall Study|Adverse Event|4|||
163301615|NCT01061671|589811218|FG000|Overall Study|Withdrawal by Subject|16|||
162958977|NCT01588236|588551704|FG002|Overall Study|Adverse Event|1|||
162958978|NCT01588236|588551702|FG000|Overall Study|Lost to Follow-up|8|||
162958979|NCT01588236|588551703|FG001|Overall Study|Lost to Follow-up|13|||
162958980|NCT01588236|588551704|FG002|Overall Study|Lost to Follow-up|6|||
162958981|NCT01588236|588551702|FG000|Overall Study|Physician Decision|1|||
163301616|NCT01061671|589811219|FG001|Overall Study|Withdrawal by Subject|20|||
162958982|NCT01588236|588551703|FG001|Overall Study|Physician Decision|2|||
162958983|NCT01588236|588551704|FG002|Overall Study|Physician Decision|0|||
162958984|NCT01588236|588551702|FG000|Overall Study|Protocol Violation|0|||
162958985|NCT01588236|588551703|FG001|Overall Study|Protocol Violation|1|||
162958986|NCT01588236|588551704|FG002|Overall Study|Protocol Violation|1|||
162958987|NCT01588236|588551702|FG000|Overall Study|Withdrawal by Subject|14|||
162958988|NCT01588236|588551703|FG001|Overall Study|Withdrawal by Subject|16|||
162958989|NCT01588236|588551704|FG002|Overall Study|Withdrawal by Subject|18|||
162958990|NCT01588236|588551702|FG000|Overall Study|Exclusion Criteria met during study|2|||
162958991|NCT01588236|588551703|FG001|Overall Study|Exclusion Criteria met during study|1|||
163046244|NCT04131712|588877351|FG001|Overall Study|COVID related|0|||
163046245|NCT04131712|588877352|FG002|Overall Study|COVID related|2|||
163046246|NCT04131712|588877353|FG003|Overall Study|COVID related|0|||
162958992|NCT01588236|588551704|FG002|Overall Study|Exclusion Criteria met during study|0|||
163195583|NCT02015754|589429929|FG000|Overall Study|Change in treatment modality|5|||
163195584|NCT02015754|589429929|FG000|Overall Study|Lost to Follow-up|1|||
163195585|NCT02229383|589429930|FG000|Overall Study|Adverse Event|7|||
163195586|NCT02229383|589429931|FG001|Overall Study|Adverse Event|4|||
163195587|NCT02229383|589429930|FG000|Overall Study|Death|0|||
163195588|NCT02229383|589429931|FG001|Overall Study|Death|1|||
163195589|NCT02229383|589429930|FG000|Overall Study|Lost to Follow-up|5|||
163195590|NCT02229383|589429931|FG001|Overall Study|Lost to Follow-up|3|||
162958993|NCT01588236|588551702|FG000|Overall Study|sponsor decision|1|||
162958994|NCT01588236|588551703|FG001|Overall Study|sponsor decision|6|||
162958995|NCT01588236|588551704|FG002|Overall Study|sponsor decision|2|||
162958996|NCT02430480|588551705|FG000|Overall Study|Death|1|||
162958997|NCT02430480|588551705|FG000|Overall Study|Anesthesia concerns|1|||
162958998|NCT02430480|588551705|FG000|Overall Study|Progressed on treatment|1|||
162958999|NCT01030133|588551706|FG000|Overall Study|failed to experience pain at level 7/10|2|||
162959000|NCT01030133|588551707|FG001|Overall Study|failed to experience pain at level 7/10|2|||
162959001|NCT01097577|588551708|FG000|Overall Study|Adverse Event|0|||
163046247|NCT04131712|588877350|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
162959002|NCT01097577|588551709|FG001|Overall Study|Adverse Event|1|||
162959003|NCT04493684|588551717|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
163195591|NCT02229383|589429930|FG000|Overall Study|Withdrawal by Subject|4|||
163046248|NCT04131712|588877351|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
163046249|NCT04131712|588877352|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
163046250|NCT04131712|588877353|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
163046251|NCT02299388|588877354|FG000|Overall Study|Withdrawal by Subject|0|||
163046252|NCT02299388|588877355|FG001|Overall Study|Withdrawal by Subject|1|||
163046253|NCT03334188|588877356|FG000|Overall Study|Withdrawal by Subject|0|||
163046254|NCT03334188|588877357|FG001|Overall Study|Withdrawal by Subject|1|||
163046255|NCT03334188|588877356|FG000|Overall Study|Death|1|||
163046256|NCT03334188|588877357|FG001|Overall Study|Death|0|||
163046257|NCT03334188|588877356|FG000|Overall Study|Never had qualifying clinic visit|7|||
163301617|NCT01061671|589811218|FG000|Overall Study|Lost to Follow-up|3|||
163301618|NCT01061671|589811219|FG001|Overall Study|Lost to Follow-up|5|||
163301619|NCT01061671|589811218|FG000|Overall Study|Death|28|||
163301620|NCT01061671|589811219|FG001|Overall Study|Death|30|||
163301621|NCT02468128|589811220|FG000|Overall Study|Protocol Violation|6|||
163301622|NCT02468128|589811221|FG001|Overall Study|Protocol Violation|6|||
163301623|NCT00440011|589811222|FG000|Overall Study|Adverse Event|2|||
163301624|NCT00440011|589811223|FG001|Overall Study|Adverse Event|0|||
163301625|NCT00440011|589811222|FG000|Overall Study|Lost to Follow-up|0|||
163301626|NCT00440011|589811223|FG001|Overall Study|Lost to Follow-up|2|||
163301627|NCT00440011|589811222|FG000|Overall Study|Protocol Violation|1|||
163301628|NCT00440011|589811223|FG001|Overall Study|Protocol Violation|1|||
163301629|NCT00440011|589811222|FG000|Overall Study|Withdrawal by Subject|1|||
163301630|NCT00440011|589811223|FG001|Overall Study|Withdrawal by Subject|0|||
163301631|NCT02321514|589811232|FG000|Overall Study|Death|15|||
163301632|NCT02321514|589811232|FG000|Overall Study|Missed Visit|7|||
163301633|NCT02321514|589811232|FG000|Overall Study|Study Exit|3|||
163301634|NCT00621296|589811233|FG000|Overall Study|Adverse Event|2|||
163301635|NCT00621296|589811233|FG000|Overall Study|Lack of Efficacy|1|||
163301636|NCT00621296|589811233|FG000|Overall Study|Physician Decision|7|||
163301637|NCT00621296|589811233|FG000|Overall Study|Unmatch Criteria|1|||
163301638|NCT00621296|589811233|FG000|Overall Study|Stopping Criteria|3|||
163301639|NCT04166058|589811234|FG000|Overall Study|Adverse Event|1|||
163301640|NCT04166058|589811235|FG001|Overall Study|Adverse Event|1|||
163301641|NCT04166058|589811236|FG002|Overall Study|Adverse Event|0|||
163301642|NCT04166058|589811237|FG003|Overall Study|Adverse Event|0|||
163301643|NCT04166058|589811234|FG000|Overall Study|Withdrawal by Subject|4|||
163301644|NCT04166058|589811235|FG001|Overall Study|Withdrawal by Subject|4|||
163301645|NCT04166058|589811236|FG002|Overall Study|Withdrawal by Subject|1|||
163301646|NCT04166058|589811237|FG003|Overall Study|Withdrawal by Subject|10|||
163301647|NCT04166058|589811234|FG000|Overall Study|Lost to Follow-up|9|||
163301648|NCT04166058|589811235|FG001|Overall Study|Lost to Follow-up|2|||
163301649|NCT04166058|589811236|FG002|Overall Study|Lost to Follow-up|1|||
163301650|NCT04166058|589811237|FG003|Overall Study|Lost to Follow-up|1|||
163301651|NCT04166058|589811234|FG000|Overall Study|Pregnancy|1|||
163301652|NCT04166058|589811235|FG001|Overall Study|Pregnancy|0|||
163301653|NCT04166058|589811236|FG002|Overall Study|Pregnancy|0|||
163301654|NCT04166058|589811237|FG003|Overall Study|Pregnancy|0|||
163301655|NCT04166058|589811234|FG000|Overall Study|Physician Decision|2|||
163301656|NCT04166058|589811235|FG001|Overall Study|Physician Decision|0|||
163301657|NCT04166058|589811236|FG002|Overall Study|Physician Decision|0|||
163301658|NCT04166058|589811237|FG003|Overall Study|Physician Decision|2|||
163301659|NCT04166058|589811234|FG000|Overall Study|Protocol Violation|1|||
163301660|NCT04166058|589811235|FG001|Overall Study|Protocol Violation|0|||
163301661|NCT04166058|589811236|FG002|Overall Study|Protocol Violation|0|||
163301662|NCT04166058|589811237|FG003|Overall Study|Protocol Violation|0|||
163301663|NCT04166058|589811234|FG000|Overall Study|Lack of Efficacy|2|||
163301664|NCT04166058|589811235|FG001|Overall Study|Lack of Efficacy|0|||
163301665|NCT04166058|589811236|FG002|Overall Study|Lack of Efficacy|0|||
163301666|NCT04166058|589811237|FG003|Overall Study|Lack of Efficacy|0|||
163301667|NCT04166058|589811234|FG000|Overall Study|Other|1|||
163301668|NCT04166058|589811235|FG001|Overall Study|Other|0|||
163301669|NCT04166058|589811236|FG002|Overall Study|Other|0|||
163301670|NCT04166058|589811237|FG003|Overall Study|Other|1|||
163301671|NCT04166058|589811234|FG000|Overall Study|Non-compliance with study drug|0|||
163301672|NCT04166058|589811235|FG001|Overall Study|Non-compliance with study drug|0|||
163301673|NCT04166058|589811236|FG002|Overall Study|Non-compliance with study drug|0|||
163301674|NCT04166058|589811237|FG003|Overall Study|Non-compliance with study drug|2|||
163301675|NCT02998528|589811238|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
163301676|NCT02998528|589811239|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
163301677|NCT02998528|589811240|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
163301678|NCT02998528|589811238|FG000|Randomization Period|Participant withdrew consent|0|||
163301679|NCT02998528|589811239|FG001|Randomization Period|Participant withdrew consent|3|||
163301680|NCT02998528|589811240|FG002|Randomization Period|Participant withdrew consent|0|||
163301681|NCT02998528|589811238|FG000|Randomization Period|Participant no longer meets study criteria|1|||
163301682|NCT02998528|589811239|FG001|Randomization Period|Participant no longer meets study criteria|3|||
163301683|NCT02998528|589811240|FG002|Randomization Period|Participant no longer meets study criteria|2|||
163301684|NCT02998528|589811238|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
163301685|NCT02998528|589811239|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
163301686|NCT02998528|589811240|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
163301687|NCT02998528|589811238|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
163301688|NCT02998528|589811239|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
163301689|NCT02998528|589811240|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
163301690|NCT02998528|589811238|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
163301691|NCT02998528|589811239|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
163301692|NCT02998528|589811240|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
163301693|NCT02998528|589811238|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
163301694|NCT02998528|589811239|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
162959004|NCT04493684|588551718|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959005|NCT04493684|588551719|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
162959006|NCT04493684|588551720|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959007|NCT04493684|588551721|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959008|NCT04493684|588551722|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
162959009|NCT04493684|588551723|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959010|NCT04493684|588551724|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959011|NCT04493684|588551725|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959012|NCT04493684|588551726|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959013|NCT04493684|588551727|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959014|NCT04493684|588551728|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959015|NCT04493684|588551729|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959016|NCT04493684|588551730|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959017|NCT04493684|588551731|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959018|NCT04493684|588551732|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959019|NCT04493684|588551733|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959020|NCT04493684|588551717|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
162959021|NCT04493684|588551718|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959022|NCT04493684|588551719|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959023|NCT04493684|588551720|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959024|NCT04493684|588551721|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959025|NCT04493684|588551722|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959026|NCT04493684|588551723|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959027|NCT04493684|588551724|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959028|NCT04493684|588551725|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959029|NCT04493684|588551726|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959030|NCT04493684|588551727|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959031|NCT04493684|588551728|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959032|NCT04493684|588551729|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959033|NCT04493684|588551730|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959034|NCT04493684|588551731|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959035|NCT04493684|588551732|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
163301695|NCT02998528|589811240|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
163046258|NCT03334188|588877357|FG001|Overall Study|Never had qualifying clinic visit|7|||
163046259|NCT01093586|588877358|FG000|Overall Study|Failed to engraft|3|||
163046260|NCT00357877|588877359|FG000|Overall Study|Death|2|||
163046261|NCT00357877|588877360|FG001|Overall Study|Death|1|||
163046262|NCT00357877|588877359|FG000|Overall Study|Lost to Follow-up|20|||
163046263|NCT00357877|588877360|FG001|Overall Study|Lost to Follow-up|23|||
163046264|NCT00357877|588877359|FG000|Overall Study|Withdrawal by Subject|3|||
163046265|NCT00357877|588877360|FG001|Overall Study|Withdrawal by Subject|3|||
163046266|NCT00357877|588877359|FG000|Overall Study|Administrative withdrawal|1|||
163046267|NCT00357877|588877360|FG001|Overall Study|Administrative withdrawal|1|||
163046268|NCT00357877|588877359|FG000|Overall Study|Other|0|||
163046269|NCT00357877|588877360|FG001|Overall Study|Other|2|||
163046270|NCT00613366|588877370|FG000|Overall Study|Withdrawal by Subject|3|||
163046271|NCT00613366|588877371|FG001|Overall Study|Withdrawal by Subject|2|||
163046272|NCT00943397|588877372|FG000|Overall Study|Adverse Event|0|||
163046273|NCT00943397|588877373|FG001|Overall Study|Adverse Event|6|||
163046274|NCT00943397|588877372|FG000|Overall Study|Lost to Follow-up|0|||
163046275|NCT00943397|588877373|FG001|Overall Study|Lost to Follow-up|4|||
163046276|NCT00943397|588877372|FG000|Overall Study|Protocol Violation|2|||
162959036|NCT04493684|588551733|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959037|NCT04493684|588551717|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959038|NCT04493684|588551718|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959039|NCT04493684|588551719|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959040|NCT04493684|588551720|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959041|NCT04493684|588551721|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959042|NCT04493684|588551722|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
163046277|NCT00943397|588877373|FG001|Overall Study|Protocol Violation|5|||
163046278|NCT00943397|588877372|FG000|Overall Study|Withdrawal by Subject|1|||
163046279|NCT00943397|588877373|FG001|Overall Study|Withdrawal by Subject|1|||
163046280|NCT00943397|588877372|FG000|Overall Study|Site terminated and other|12|||
163046281|NCT00943397|588877373|FG001|Overall Study|Site terminated and other|56|||
163046282|NCT01765296|588877374|FG000|Overall Study|Protocol Violation|0|||
163046283|NCT01765296|588877375|FG001|Overall Study|Protocol Violation|5|||
163046284|NCT01765296|588877376|FG002|Overall Study|Protocol Violation|4|||
163046285|NCT01765296|588877374|FG000|Overall Study|Withdrawal by Subject|4|||
163046286|NCT01765296|588877375|FG001|Overall Study|Withdrawal by Subject|2|||
163046287|NCT01765296|588877376|FG002|Overall Study|Withdrawal by Subject|2|||
163046288|NCT01765296|588877374|FG000|Overall Study|Adverse Event|1|||
163046289|NCT01765296|588877375|FG001|Overall Study|Adverse Event|13|||
163046290|NCT01765296|588877376|FG002|Overall Study|Adverse Event|5|||
163046291|NCT01765296|588877374|FG000|Overall Study|Lack of Efficacy|0|||
163046292|NCT01765296|588877375|FG001|Overall Study|Lack of Efficacy|0|||
163046293|NCT01765296|588877376|FG002|Overall Study|Lack of Efficacy|2|||
163046294|NCT03257436|588877377|FG000|Overall Study|Withdrawal by Subject|76|||
163046295|NCT03257436|588877377|FG000|Overall Study|Death|19|||
163046296|NCT01619852|588877378|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
163046297|NCT01619852|588877379|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
163046298|NCT01619852|588877378|FG000|3 Month Follow up|Lost to Follow-up|31|||
163046299|NCT01619852|588877379|FG001|3 Month Follow up|Lost to Follow-up|34|||
163046300|NCT00970489|588877380|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
163046301|NCT00970489|588877381|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
163046302|NCT03489343|588877385|FG000|Overall Study|Documented progressive disease|1|||
163046303|NCT03489343|588877386|FG001|Overall Study|Documented progressive disease|0|||
163046304|NCT03489343|588877387|FG002|Overall Study|Documented progressive disease|3|||
163046305|NCT03489343|588877388|FG003|Overall Study|Documented progressive disease|1|||
163046306|NCT03489343|588877389|FG004|Overall Study|Documented progressive disease|3|||
163195592|NCT02229383|589429931|FG001|Overall Study|Withdrawal by Subject|6|||
163046307|NCT03489343|588877390|FG005|Overall Study|Documented progressive disease|5|||
163046308|NCT03489343|588877391|FG006|Overall Study|Documented progressive disease|4|||
163046309|NCT03489343|588877385|FG000|Overall Study|Adverse Event|0|||
163046310|NCT03489343|588877386|FG001|Overall Study|Adverse Event|1|||
163046311|NCT03489343|588877387|FG002|Overall Study|Adverse Event|0|||
163046312|NCT03489343|588877388|FG003|Overall Study|Adverse Event|0|||
163195593|NCT02229383|589429930|FG000|Overall Study|Did not receive treatment|1|||
163195594|NCT02229383|589429931|FG001|Overall Study|Did not receive treatment|0|||
163195595|NCT02229383|589429930|FG000|Overall Study|Other|3|||
163195596|NCT02229383|589429931|FG001|Overall Study|Other|8|||
163195597|NCT00873015|589429937|FG000|Overall Study|Withdrawal by Subject|0|||
163195598|NCT00873015|589429938|FG001|Overall Study|Withdrawal by Subject|1|||
163195599|NCT00873015|589429939|FG002|Overall Study|Withdrawal by Subject|0|||
163195600|NCT00873015|589429940|FG003|Overall Study|Withdrawal by Subject|0|||
163195601|NCT06934993|589429947|FG000|Overall Study|Withdrawal by Subject|29|||
163195602|NCT06934993|589429947|FG000|Overall Study|elevated postoperative creatinine level|11|||
163195603|NCT06934993|589429947|FG000|Overall Study|Death|3|||
163195604|NCT01218113|589432000|FG000|Overall Study|Withdrawal by Subject|1|||
163195605|NCT01218113|589432001|FG001|Overall Study|Withdrawal by Subject|0|||
163195606|NCT01218113|589432002|FG002|Overall Study|Withdrawal by Subject|1|||
163195607|NCT01218113|589432000|FG000|Overall Study|Lost to Follow-up|4|||
163195608|NCT01218113|589432001|FG001|Overall Study|Lost to Follow-up|1|||
163195609|NCT01218113|589432002|FG002|Overall Study|Lost to Follow-up|4|||
163301696|NCT02998528|589811238|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
163301697|NCT02998528|589811239|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
163301698|NCT02998528|589811240|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
163301699|NCT02998528|589811238|FG000|Neoadjuvant Treatment Period|Death|1|||
163301700|NCT02998528|589811239|FG001|Neoadjuvant Treatment Period|Death|0|||
163301701|NCT02998528|589811240|FG002|Neoadjuvant Treatment Period|Death|0|||
163301702|NCT02998528|589811238|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
163301703|NCT02998528|589811239|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
163301704|NCT02998528|589811240|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
163301705|NCT02998528|589811238|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
163301706|NCT02998528|589811239|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
163301707|NCT02998528|589811240|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
163301708|NCT02998528|589811238|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
163301709|NCT02998528|589811239|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
163301710|NCT02998528|589811240|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
163301711|NCT02998528|589811238|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
163301712|NCT02998528|589811239|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
163301713|NCT02998528|589811240|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
163301714|NCT02998528|589811238|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
163301715|NCT02998528|589811239|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
163301716|NCT02998528|589811240|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
163195610|NCT01218113|589432000|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
163195611|NCT01218113|589432001|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
163195612|NCT01218113|589432002|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
163301717|NCT02998528|589811238|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
163195613|NCT01385566|589432006|FG000|Overall Study|Lost to Follow-up|1|||
163195614|NCT01385566|589432007|FG001|Overall Study|Lost to Follow-up|0|||
163195615|NCT01385566|589432008|FG002|Overall Study|Lost to Follow-up|0|||
163394802|NCT00375219|590157009|FG001|Overall Study|Failure to achieve a response|2|||
163394803|NCT00375219|590157010|FG002|Overall Study|Failure to achieve a response|0|||
163394804|NCT00375219|590157008|FG000|Overall Study|Adverse Event|8|||
163394805|NCT00375219|590157009|FG001|Overall Study|Adverse Event|2|||
163394806|NCT00375219|590157010|FG002|Overall Study|Adverse Event|1|||
162959043|NCT04493684|588551723|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
162959044|NCT04493684|588551724|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959045|NCT04493684|588551725|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959046|NCT04493684|588551726|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959047|NCT04493684|588551727|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959048|NCT04493684|588551728|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959049|NCT04493684|588551729|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959050|NCT04493684|588551730|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959051|NCT04493684|588551731|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959052|NCT04493684|588551732|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959053|NCT04493684|588551733|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959054|NCT04493684|588551717|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
162959055|NCT04493684|588551718|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959056|NCT04493684|588551719|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959057|NCT04493684|588551720|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959058|NCT04493684|588551721|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959059|NCT04493684|588551722|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959060|NCT04493684|588551723|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959061|NCT04493684|588551724|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959062|NCT04493684|588551725|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959063|NCT04493684|588551726|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959064|NCT04493684|588551727|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959065|NCT04493684|588551728|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959066|NCT04493684|588551729|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959067|NCT04493684|588551730|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959068|NCT04493684|588551731|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959069|NCT04493684|588551732|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959070|NCT04493684|588551733|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959071|NCT04493684|588551717|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959072|NCT04493684|588551718|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
163046313|NCT03489343|588877389|FG004|Overall Study|Adverse Event|0|||
163394807|NCT00375219|590157008|FG000|Overall Study|Protocol Violation|1|||
162959073|NCT04493684|588551719|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959074|NCT04493684|588551720|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959075|NCT04493684|588551721|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959076|NCT04493684|588551722|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
162959077|NCT04493684|588551723|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
163301718|NCT02998528|589811239|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
163301719|NCT02998528|589811240|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
163301720|NCT00591214|589811241|FG000|Overall Study|Physician Decision|7|||
163301721|NCT00591214|589811241|FG000|Overall Study|Withdrawal by Subject|1|||
163301722|NCT01753570|589811245|FG000|Overall Study|Adverse Event|1|||
163301723|NCT01753570|589811246|FG001|Overall Study|Adverse Event|0|||
162959078|NCT04493684|588551724|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
163046314|NCT03489343|588877390|FG005|Overall Study|Adverse Event|1|||
163195616|NCT01385566|589432009|FG003|Overall Study|Lost to Follow-up|0|||
163195617|NCT01385566|589432010|FG004|Overall Study|Lost to Follow-up|0|||
163195618|NCT01385566|589432011|FG005|Overall Study|Lost to Follow-up|0|||
163195619|NCT01385566|589432006|FG000|Overall Study|Withdrawal by Subject|0|||
163195620|NCT01385566|589432007|FG001|Overall Study|Withdrawal by Subject|0|||
163195621|NCT01385566|589432008|FG002|Overall Study|Withdrawal by Subject|0|||
163195622|NCT01385566|589432009|FG003|Overall Study|Withdrawal by Subject|1|||
163195623|NCT01385566|589432010|FG004|Overall Study|Withdrawal by Subject|0|||
163195624|NCT01385566|589432011|FG005|Overall Study|Withdrawal by Subject|0|||
163195625|NCT00967668|589432012|FG000|Overall Study|Withdrawal by Subject|13|||
163195626|NCT00967668|589432013|FG001|Overall Study|Withdrawal by Subject|8|||
163195627|NCT00967668|589432014|FG002|Overall Study|Withdrawal by Subject|8|||
163195628|NCT00967668|589432012|FG000|Overall Study|Death|0|||
163195629|NCT00967668|589432013|FG001|Overall Study|Death|2|||
163195630|NCT00967668|589432014|FG002|Overall Study|Death|4|||
163195631|NCT00967668|589432012|FG000|Overall Study|Removed due to behavior|1|||
163195632|NCT00967668|589432013|FG001|Overall Study|Removed due to behavior|1|||
163195633|NCT00967668|589432014|FG002|Overall Study|Removed due to behavior|2|||
163195634|NCT00967668|589432012|FG000|Overall Study|Refused Year 2|11|||
163195635|NCT00967668|589432013|FG001|Overall Study|Refused Year 2|6|||
163195636|NCT00967668|589432014|FG002|Overall Study|Refused Year 2|4|||
163195637|NCT00967668|589432012|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
163195638|NCT00967668|589432013|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
163195639|NCT00967668|589432014|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
163195640|NCT00967668|589432012|FG000|Overall Study|Lost to Follow-up|15|||
163195641|NCT00967668|589432013|FG001|Overall Study|Lost to Follow-up|9|||
163195642|NCT00967668|589432014|FG002|Overall Study|Lost to Follow-up|16|||
163195643|NCT00967668|589432012|FG000|Overall Study|Refused 12-mo assessment|3|||
163195644|NCT00967668|589432013|FG001|Overall Study|Refused 12-mo assessment|1|||
163195645|NCT00967668|589432014|FG002|Overall Study|Refused 12-mo assessment|9|||
163195646|NCT00967668|589432012|FG000|Overall Study|Pregnancy|1|||
163195647|NCT00967668|589432013|FG001|Overall Study|Pregnancy|0|||
163195648|NCT00967668|589432014|FG002|Overall Study|Pregnancy|0|||
163195649|NCT00825682|589432015|FG000|Overall Study|personal reasons/ inconvenience|13|||
163195650|NCT00825682|589432016|FG001|Overall Study|personal reasons/ inconvenience|5|||
163195651|NCT03281577|589432017|FG000|Overall Study|Adverse Event|0|||
163195652|NCT03281577|589432018|FG001|Overall Study|Adverse Event|0|||
163195653|NCT03281577|589432019|FG002|Overall Study|Adverse Event|0|||
163195654|NCT03281577|589432020|FG003|Overall Study|Adverse Event|1|||
163195655|NCT03281577|589432017|FG000|Overall Study|Withdrawal by Subject|1|||
163195656|NCT03281577|589432018|FG001|Overall Study|Withdrawal by Subject|0|||
163195657|NCT03281577|589432019|FG002|Overall Study|Withdrawal by Subject|0|||
163195658|NCT03281577|589432020|FG003|Overall Study|Withdrawal by Subject|0|||
163195659|NCT01644565|589432021|FG000|Overall Study|Undisclosed Medical History|1|||
163195660|NCT01644565|589432022|FG001|Overall Study|Undisclosed Medical History|0|||
163195661|NCT01644565|589432023|FG002|Overall Study|Undisclosed Medical History|0|||
163195662|NCT01644565|589432024|FG003|Overall Study|Undisclosed Medical History|0|||
163195663|NCT01644565|589432025|FG004|Overall Study|Undisclosed Medical History|0|||
163195664|NCT01644565|589432026|FG005|Overall Study|Undisclosed Medical History|0|||
163195665|NCT01644565|589432027|FG006|Overall Study|Undisclosed Medical History|0|||
163195666|NCT01644565|589432028|FG007|Overall Study|Undisclosed Medical History|0|||
163195667|NCT01644565|589432029|FG008|Overall Study|Undisclosed Medical History|0|||
163195668|NCT01644565|589432021|FG000|Overall Study|Lost to Follow-up|0|||
163195669|NCT01644565|589432022|FG001|Overall Study|Lost to Follow-up|0|||
163195670|NCT01644565|589432023|FG002|Overall Study|Lost to Follow-up|0|||
163195671|NCT01644565|589432024|FG003|Overall Study|Lost to Follow-up|1|||
163195672|NCT01644565|589432025|FG004|Overall Study|Lost to Follow-up|0|||
163195673|NCT01644565|589432026|FG005|Overall Study|Lost to Follow-up|0|||
163195674|NCT01644565|589432027|FG006|Overall Study|Lost to Follow-up|0|||
163394808|NCT00375219|590157009|FG001|Overall Study|Protocol Violation|0|||
163195675|NCT01644565|589432028|FG007|Overall Study|Lost to Follow-up|2|||
163195676|NCT01644565|589432029|FG008|Overall Study|Lost to Follow-up|0|||
163195677|NCT01644565|589432021|FG000|Overall Study|Family emergency|0|||
163195678|NCT01644565|589432022|FG001|Overall Study|Family emergency|0|||
163195679|NCT01644565|589432023|FG002|Overall Study|Family emergency|0|||
163195680|NCT01644565|589432024|FG003|Overall Study|Family emergency|0|||
163195681|NCT01644565|589432025|FG004|Overall Study|Family emergency|1|||
163394809|NCT00375219|590157010|FG002|Overall Study|Protocol Violation|1|||
163195682|NCT01644565|589432026|FG005|Overall Study|Family emergency|0|||
163195683|NCT01644565|589432027|FG006|Overall Study|Family emergency|0|||
163195684|NCT01644565|589432028|FG007|Overall Study|Family emergency|0|||
163195685|NCT01644565|589432029|FG008|Overall Study|Family emergency|0|||
163195686|NCT01644565|589432021|FG000|Overall Study|Relocation|0|||
163394810|NCT00375219|590157008|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
163046315|NCT03489343|588877391|FG006|Overall Study|Adverse Event|0|||
163195687|NCT01644565|589432022|FG001|Overall Study|Relocation|0|||
163195688|NCT01644565|589432023|FG002|Overall Study|Relocation|0|||
163195689|NCT01644565|589432024|FG003|Overall Study|Relocation|0|||
163195690|NCT01644565|589432025|FG004|Overall Study|Relocation|0|||
163195691|NCT01644565|589432026|FG005|Overall Study|Relocation|0|||
163195692|NCT01644565|589432027|FG006|Overall Study|Relocation|0|||
163195693|NCT01644565|589432028|FG007|Overall Study|Relocation|0|||
163195694|NCT01644565|589432029|FG008|Overall Study|Relocation|1|||
163195695|NCT00787891|589432030|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
163195696|NCT00787891|589432031|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
163195697|NCT00787891|589432030|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
163195698|NCT00787891|589432031|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
163195699|NCT00787891|589432030|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
163195700|NCT00787891|589432031|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
163195701|NCT00787891|589432030|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
163195702|NCT00787891|589432031|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
163195703|NCT00787891|589432030|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
163195704|NCT00787891|589432031|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
163195705|NCT00787891|589432030|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
163195706|NCT00787891|589432031|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
163195707|NCT00787891|589432030|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
163195708|NCT00787891|589432031|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
163195709|NCT00787891|589432030|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
163195710|NCT00787891|589432031|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
163195711|NCT00787891|589432030|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
163195712|NCT00787891|589432031|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
163195713|NCT00787891|589432030|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
163195714|NCT00787891|589432031|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
163195715|NCT01594281|589432032|FG000|Interventional Core Phase|Protocol Deviation|1|||
163046316|NCT03489343|588877385|FG000|Overall Study|Withdrawal by Subject|0|||
163046317|NCT03489343|588877386|FG001|Overall Study|Withdrawal by Subject|0|||
163046318|NCT03489343|588877387|FG002|Overall Study|Withdrawal by Subject|0|||
163046319|NCT03489343|588877388|FG003|Overall Study|Withdrawal by Subject|1|||
163046320|NCT03489343|588877389|FG004|Overall Study|Withdrawal by Subject|0|||
163046321|NCT03489343|588877390|FG005|Overall Study|Withdrawal by Subject|1|||
163046322|NCT03489343|588877391|FG006|Overall Study|Withdrawal by Subject|1|||
163046323|NCT03489343|588877385|FG000|Overall Study|Clinical progression|0|||
163046324|NCT03489343|588877386|FG001|Overall Study|Clinical progression|0|||
163046325|NCT03489343|588877387|FG002|Overall Study|Clinical progression|0|||
163046326|NCT03489343|588877388|FG003|Overall Study|Clinical progression|1|||
163046327|NCT03489343|588877389|FG004|Overall Study|Clinical progression|0|||
163046328|NCT03489343|588877390|FG005|Overall Study|Clinical progression|0|||
163195716|NCT01594281|589432033|FG001|Interventional Core Phase|Protocol Deviation|0|||
163195717|NCT01594281|589432034|FG002|Interventional Core Phase|Protocol Deviation|0|||
163195718|NCT01594281|589432032|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
163195719|NCT01594281|589432033|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
163195720|NCT01594281|589432034|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
163195721|NCT01594281|589432032|FG000|Interventional Core Phase|Death|1|||
163301724|NCT01753570|589811247|FG002|Overall Study|Adverse Event|1|||
163195722|NCT01594281|589432033|FG001|Interventional Core Phase|Death|1|||
163195723|NCT01594281|589432034|FG002|Interventional Core Phase|Death|2|||
162959079|NCT04493684|588551725|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959080|NCT04493684|588551726|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959081|NCT04493684|588551727|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959082|NCT04493684|588551728|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959083|NCT04493684|588551729|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959084|NCT04493684|588551730|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959085|NCT04493684|588551731|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959086|NCT04493684|588551732|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959087|NCT04493684|588551733|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959088|NCT04493684|588551717|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959089|NCT04493684|588551718|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959090|NCT04493684|588551719|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959091|NCT04493684|588551720|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959092|NCT04493684|588551721|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959093|NCT04493684|588551722|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959094|NCT04493684|588551723|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959095|NCT04493684|588551724|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959096|NCT04493684|588551725|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959097|NCT04493684|588551726|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959098|NCT04493684|588551727|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959099|NCT04493684|588551728|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
162959100|NCT04493684|588551729|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959101|NCT04493684|588551730|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959102|NCT04493684|588551731|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959103|NCT04493684|588551732|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959104|NCT04493684|588551733|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959105|NCT04493684|588551717|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959106|NCT04493684|588551718|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959107|NCT04493684|588551719|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959108|NCT04493684|588551720|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959109|NCT04493684|588551721|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959110|NCT04493684|588551722|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959111|NCT04493684|588551723|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959112|NCT04493684|588551724|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959113|NCT04493684|588551725|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959114|NCT04493684|588551726|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959115|NCT04493684|588551727|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959116|NCT04493684|588551728|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959117|NCT04493684|588551729|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959118|NCT04493684|588551730|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959119|NCT04493684|588551731|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959120|NCT04493684|588551732|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
162959121|NCT04493684|588551733|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959122|NCT04493684|588551717|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
163195724|NCT01594281|589432032|FG000|Interventional Core Phase|Lost to Follow-up|1|||
163195725|NCT01594281|589432033|FG001|Interventional Core Phase|Lost to Follow-up|4|||
163195726|NCT01594281|589432034|FG002|Interventional Core Phase|Lost to Follow-up|1|||
163195727|NCT01594281|589432032|FG000|Interventional Core Phase|Adverse Event|4|||
163394811|NCT00375219|590157009|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
162959123|NCT04493684|588551718|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959124|NCT04493684|588551719|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959125|NCT04493684|588551720|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959126|NCT04493684|588551721|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959127|NCT04493684|588551722|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959128|NCT04493684|588551723|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959129|NCT04493684|588551724|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959130|NCT04493684|588551725|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959131|NCT04493684|588551726|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959132|NCT04493684|588551727|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959133|NCT04493684|588551728|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959134|NCT04493684|588551729|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959135|NCT04493684|588551730|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959136|NCT04493684|588551731|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959137|NCT04493684|588551732|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
162959138|NCT04493684|588551733|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959139|NCT04825275|588553464|FG000|Overall Study|Withdrawal by Subject|1|||
162959140|NCT04825275|588553465|FG001|Overall Study|Withdrawal by Subject|0|||
162959141|NCT05710718|588553471|FG000|Overall Study|Withdrawal by Subject|5|||
162959142|NCT05710718|588553472|FG001|Overall Study|Withdrawal by Subject|1|||
162959143|NCT05710718|588553471|FG000|Overall Study|Lost to Follow-up|0|||
162959144|NCT05710718|588553472|FG001|Overall Study|Lost to Follow-up|1|||
162959145|NCT05710718|588553471|FG000|Overall Study|Death|0|||
162959146|NCT05710718|588553472|FG001|Overall Study|Death|1|||
162959147|NCT04372238|588553473|FG000|Overall Study|Duplicate|3|||
163301725|NCT01753570|589811245|FG000|Overall Study|Physician Decision|0|||
162959148|NCT04372238|588553474|FG001|Overall Study|Duplicate|3|||
162959149|NCT04372238|588553473|FG000|Overall Study|Did not consent for data linkage|6|||
163301726|NCT01753570|589811246|FG001|Overall Study|Physician Decision|1|||
163301727|NCT01753570|589811247|FG002|Overall Study|Physician Decision|0|||
163301728|NCT01753570|589811245|FG000|Overall Study|Withdrawal by Subject|1|||
162959150|NCT04372238|588553474|FG001|Overall Study|Did not consent for data linkage|10|||
162959151|NCT02591420|588553475|FG000|Overall Study|Lost to Follow-up|0|||
162959152|NCT02591420|588553476|FG001|Overall Study|Lost to Follow-up|1|||
162959153|NCT02591420|588553477|FG002|Overall Study|Lost to Follow-up|2|||
162959154|NCT04241458|588553478|FG000|Overall Study|Withdrawal by Subject|0|||
162959155|NCT04241458|588553479|FG001|Overall Study|Withdrawal by Subject|0|||
162959156|NCT04241458|588553480|FG002|Overall Study|Withdrawal by Subject|0|||
162959157|NCT04241458|588553481|FG003|Overall Study|Withdrawal by Subject|0|||
162959158|NCT04241458|588553482|FG004|Overall Study|Withdrawal by Subject|1|||
162959159|NCT05005442|588553483|FG000|Overall Study|Death|14|||
162959160|NCT05005442|588553484|FG001|Overall Study|Death|10|||
162959161|NCT05005442|588553485|FG002|Overall Study|Death|8|||
162959162|NCT05005442|588553486|FG003|Overall Study|Death|22|||
162959163|NCT05005442|588553487|FG004|Overall Study|Death|13|||
162959164|NCT05005442|588553488|FG005|Overall Study|Death|15|||
162959165|NCT05005442|588553483|FG000|Overall Study|Lost to Follow-up|0|||
162959166|NCT05005442|588553484|FG001|Overall Study|Lost to Follow-up|2|||
162959167|NCT05005442|588553485|FG002|Overall Study|Lost to Follow-up|0|||
162959168|NCT05005442|588553486|FG003|Overall Study|Lost to Follow-up|0|||
162959169|NCT05005442|588553487|FG004|Overall Study|Lost to Follow-up|1|||
162959170|NCT05005442|588553488|FG005|Overall Study|Lost to Follow-up|0|||
162959171|NCT05005442|588553483|FG000|Overall Study|Physician Decision|0|||
162959172|NCT05005442|588553484|FG001|Overall Study|Physician Decision|0|||
162959173|NCT05005442|588553485|FG002|Overall Study|Physician Decision|1|||
162959174|NCT05005442|588553486|FG003|Overall Study|Physician Decision|0|||
162959175|NCT05005442|588553487|FG004|Overall Study|Physician Decision|2|||
162959176|NCT05005442|588553488|FG005|Overall Study|Physician Decision|0|||
162959177|NCT05005442|588553483|FG000|Overall Study|Sponsor decision|26|||
162959178|NCT05005442|588553484|FG001|Overall Study|Sponsor decision|26|||
162959179|NCT05005442|588553485|FG002|Overall Study|Sponsor decision|10|||
162959180|NCT05005442|588553486|FG003|Overall Study|Sponsor decision|5|||
162959181|NCT05005442|588553487|FG004|Overall Study|Sponsor decision|9|||
162959182|NCT05005442|588553488|FG005|Overall Study|Sponsor decision|12|||
162959183|NCT05005442|588553483|FG000|Overall Study|Withdrawal by Subject|2|||
162959184|NCT05005442|588553484|FG001|Overall Study|Withdrawal by Subject|2|||
162959185|NCT05005442|588553485|FG002|Overall Study|Withdrawal by Subject|1|||
162959186|NCT05005442|588553486|FG003|Overall Study|Withdrawal by Subject|3|||
162959187|NCT05005442|588553487|FG004|Overall Study|Withdrawal by Subject|0|||
162959188|NCT05005442|588553488|FG005|Overall Study|Withdrawal by Subject|5|||
162959189|NCT05005442|588553483|FG000|Overall Study|Site terminated by sponsor|0|||
162959190|NCT05005442|588553484|FG001|Overall Study|Site terminated by sponsor|2|||
162959191|NCT05005442|588553485|FG002|Overall Study|Site terminated by sponsor|0|||
162959192|NCT05005442|588553486|FG003|Overall Study|Site terminated by sponsor|0|||
162959193|NCT05005442|588553487|FG004|Overall Study|Site terminated by sponsor|0|||
162959194|NCT05005442|588553488|FG005|Overall Study|Site terminated by sponsor|1|||
162959195|NCT03696160|588553489|FG000|Overall Study|Withdrew before IMP dosing|2|||
162959196|NCT03696160|588553490|FG001|Overall Study|Withdrew before IMP dosing|3|||
162959197|NCT00334815|588553491|FG000|Overall Study|Adverse Event|3|||
162959198|NCT00334815|588553492|FG001|Overall Study|Adverse Event|2|||
162959199|NCT00334815|588553491|FG000|Overall Study|Death|0|||
162959200|NCT00334815|588553492|FG001|Overall Study|Death|2|||
162959201|NCT00334815|588553491|FG000|Overall Study|Progression|1|||
162959202|NCT00334815|588553492|FG001|Overall Study|Progression|0|||
162959203|NCT00334815|588553491|FG000|Overall Study|ineligible|1|||
163301729|NCT01753570|589811246|FG001|Overall Study|Withdrawal by Subject|4|||
162959204|NCT00334815|588553492|FG001|Overall Study|ineligible|1|||
162959205|NCT00334815|588553491|FG000|Overall Study|patient refused treatment|0|||
163195728|NCT01594281|589432033|FG001|Interventional Core Phase|Adverse Event|4|||
163046329|NCT03489343|588877391|FG006|Overall Study|Clinical progression|1|||
163195729|NCT01594281|589432034|FG002|Interventional Core Phase|Adverse Event|4|||
162959206|NCT00334815|588553492|FG001|Overall Study|patient refused treatment|1|||
162959207|NCT00334815|588553491|FG000|Overall Study|Physician Decision|2|||
162959208|NCT00334815|588553492|FG001|Overall Study|Physician Decision|4|||
162959209|NCT05604170|588553493|FG000|Overall Study|Lack of Efficacy|5|||
162959210|NCT05604170|588553493|FG000|Overall Study|Adverse Event|6|||
162959211|NCT05604170|588553493|FG000|Overall Study|Physician Decision|6|||
162959212|NCT05604170|588553493|FG000|Overall Study|Lost to Follow-up|6|||
162959213|NCT05604170|588553493|FG000|Overall Study|Withdrawal by Subject|11|||
162959214|NCT05604170|588553493|FG000|Overall Study|Early study termination by sponsor|77|||
162959215|NCT05604170|588553493|FG000|Overall Study|Other|6|||
162959216|NCT04742491|588553496|FG000|Overall Study|Death|2|||
163394812|NCT00375219|590157010|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
163394813|NCT00375219|590157008|FG000|Overall Study|Lost to Follow-up|1|||
163394814|NCT00375219|590157009|FG001|Overall Study|Lost to Follow-up|1|||
162959217|NCT04742491|588553497|FG001|Overall Study|Death|0|||
162959218|NCT04742491|588553496|FG000|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
162959219|NCT04742491|588553497|FG001|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
162959220|NCT04742491|588553496|FG000|Overall Study|Lost to Follow-up|6|||
162959221|NCT04742491|588553497|FG001|Overall Study|Lost to Follow-up|8|||
162959222|NCT04742491|588553496|FG000|Overall Study|Withdrawal by Subject|4|||
162959223|NCT04742491|588553497|FG001|Overall Study|Withdrawal by Subject|2|||
162959224|NCT04742491|588553496|FG000|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|2|||
162959225|NCT04742491|588553497|FG001|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|1|||
162959226|NCT04742491|588553496|FG000|Overall Study|Participant refused further participation|2|||
162959227|NCT04742491|588553497|FG001|Overall Study|Participant refused further participation|7|||
162959228|NCT04742491|588553496|FG000|Overall Study|Participant unable to adhere to visit schedule|3|||
162959229|NCT04742491|588553497|FG001|Overall Study|Participant unable to adhere to visit schedule|4|||
162959230|NCT04742491|588553496|FG000|Overall Study|Other reasons|3|||
162959231|NCT04742491|588553497|FG001|Overall Study|Other reasons|4|||
163394815|NCT00375219|590157010|FG002|Overall Study|Lost to Follow-up|0|||
163046330|NCT00327717|588877392|FG000|Overall Study|Adverse Event|6|||
163046331|NCT00327717|588877393|FG001|Overall Study|Adverse Event|6|||
163046332|NCT00327717|588877392|FG000|Overall Study|Lack of Efficacy|0|||
163046333|NCT00327717|588877393|FG001|Overall Study|Lack of Efficacy|1|||
163195730|NCT01594281|589432032|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
163195731|NCT01594281|589432033|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
163195732|NCT01594281|589432034|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
163195733|NCT01594281|589432032|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
163195734|NCT01594281|589432033|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
162959232|NCT03317899|588553498|FG000|Overall Study|Death|6|||
162959233|NCT03317899|588553499|FG001|Overall Study|Death|9|||
162959234|NCT00446966|588553500|FG000|Overall Study|Lost to Follow-up|10|||
162959235|NCT00446966|588553501|FG001|Overall Study|Lost to Follow-up|7|||
162959236|NCT01440803|588553502|FG000|Overall Study|Met study stopping rule|2|||
162959237|NCT01440803|588553503|FG001|Overall Study|Met study stopping rule|1|||
162959238|NCT01440803|588553502|FG000|Overall Study|Lost to Follow-up|0|||
162959239|NCT01440803|588553503|FG001|Overall Study|Lost to Follow-up|2|||
162959240|NCT01440803|588553502|FG000|Overall Study|Withdrawal by Subject|0|||
163195735|NCT01594281|589432034|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
163195736|NCT01594281|589432032|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
163195737|NCT01594281|589432033|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
163195738|NCT01594281|589432034|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
163195739|NCT01193530|589432038|FG000|Overall Study|Withdrawal by Subject|2|||
163195740|NCT01193530|589432039|FG001|Overall Study|Withdrawal by Subject|2|||
163195741|NCT01193530|589432038|FG000|Overall Study|Began Contraindicated Therapy|1|||
163195742|NCT01193530|589432039|FG001|Overall Study|Began Contraindicated Therapy|0|||
163195743|NCT01193530|589432038|FG000|Overall Study|Lost Light Box|0|||
163195744|NCT01193530|589432039|FG001|Overall Study|Lost Light Box|1|||
163195745|NCT01193530|589432038|FG000|Overall Study|Returned home - out of state|0|||
163195746|NCT01193530|589432039|FG001|Overall Study|Returned home - out of state|1|||
163195747|NCT01193530|589432038|FG000|Overall Study|Non-Compliance|0|||
163195748|NCT01193530|589432039|FG001|Overall Study|Non-Compliance|1|||
163195749|NCT01890473|589432040|FG000|Overall Study|Lost to Follow-up|1|||
163195750|NCT01890473|589432041|FG001|Overall Study|Lost to Follow-up|0|||
163195751|NCT01890473|589432040|FG000|Overall Study|Poor/non-compliance|1|||
163195752|NCT01890473|589432041|FG001|Overall Study|Poor/non-compliance|0|||
163195753|NCT01945281|589432042|FG000|Overall Study|Adverse Event|1|||
163301730|NCT01753570|589811247|FG002|Overall Study|Withdrawal by Subject|0|||
162959241|NCT01440803|588553503|FG001|Overall Study|Withdrawal by Subject|1|||
162959242|NCT03502811|588553505|FG000|Overall Study|Death|157|||
162959243|NCT03502811|588553505|FG000|Overall Study|Withdrawal by Subject|105|||
162959244|NCT03502811|588553505|FG000|Overall Study|Lost to Follow-up|26|||
162959245|NCT03502811|588553505|FG000|Overall Study|No Visits (Missed)|31|||
162959246|NCT03913377|588553506|FG000|Period 1|Test Article no longer available|0|||
162959247|NCT03913377|588553507|FG001|Period 1|Test Article no longer available|1|||
162959248|NCT03913377|588553508|FG002|Period 1|Test Article no longer available|0|||
162959249|NCT03913377|588553506|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
162959250|NCT03913377|588553507|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
162959251|NCT03913377|588553508|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
162959252|NCT02197416|588553511|FG000|Overall Study|Other reasons|0|||
162959253|NCT02197416|588553512|FG001|Overall Study|Other reasons|2|||
162959254|NCT02197416|588553513|FG002|Overall Study|Other reasons|5|||
162959255|NCT02197416|588553511|FG000|Overall Study|Withdrawal by Subject|0|||
162959256|NCT02197416|588553512|FG001|Overall Study|Withdrawal by Subject|2|||
162959257|NCT02197416|588553513|FG002|Overall Study|Withdrawal by Subject|1|||
162959258|NCT02197416|588553511|FG000|Overall Study|Protocol Violation|1|||
162959259|NCT02197416|588553512|FG001|Overall Study|Protocol Violation|0|||
162959260|NCT02197416|588553513|FG002|Overall Study|Protocol Violation|1|||
162959261|NCT02197416|588553511|FG000|Overall Study|Adverse Event|0|||
162959262|NCT02197416|588553512|FG001|Overall Study|Adverse Event|0|||
162959263|NCT02197416|588553513|FG002|Overall Study|Adverse Event|1|||
162959264|NCT03689400|588553514|FG000|Overall Study|Lost to Follow-up|4|||
162959265|NCT01204294|588553515|FG000|Overall Study|Adverse Event|2|||
162959266|NCT01204294|588553516|FG001|Overall Study|Adverse Event|6|||
162959267|NCT01204294|588553517|FG002|Overall Study|Adverse Event|0|||
162959268|NCT01204294|588553518|FG003|Overall Study|Adverse Event|7|||
162959269|NCT01204294|588553519|FG004|Overall Study|Adverse Event|1|||
162959270|NCT01204294|588553520|FG005|Overall Study|Adverse Event|4|||
162959271|NCT01204294|588553521|FG006|Overall Study|Adverse Event|0|||
162959272|NCT01204294|588553515|FG000|Overall Study|Protocol Violation|1|||
162959273|NCT01204294|588553516|FG001|Overall Study|Protocol Violation|0|||
162959274|NCT01204294|588553517|FG002|Overall Study|Protocol Violation|2|||
162959275|NCT01204294|588553518|FG003|Overall Study|Protocol Violation|1|||
162959276|NCT01204294|588553519|FG004|Overall Study|Protocol Violation|0|||
162959277|NCT01204294|588553520|FG005|Overall Study|Protocol Violation|0|||
162959278|NCT01204294|588553521|FG006|Overall Study|Protocol Violation|0|||
162959279|NCT01204294|588553515|FG000|Overall Study|Withdrawal by Subject|0|||
162959280|NCT01204294|588553516|FG001|Overall Study|Withdrawal by Subject|2|||
162959281|NCT01204294|588553517|FG002|Overall Study|Withdrawal by Subject|2|||
162959282|NCT01204294|588553518|FG003|Overall Study|Withdrawal by Subject|1|||
162959283|NCT01204294|588553519|FG004|Overall Study|Withdrawal by Subject|1|||
162959284|NCT01204294|588553520|FG005|Overall Study|Withdrawal by Subject|1|||
162959285|NCT01204294|588553521|FG006|Overall Study|Withdrawal by Subject|2|||
162959286|NCT01204294|588553515|FG000|Overall Study|Lack of Efficacy|0|||
162959287|NCT01204294|588553516|FG001|Overall Study|Lack of Efficacy|0|||
162959288|NCT01204294|588553517|FG002|Overall Study|Lack of Efficacy|0|||
162959289|NCT01204294|588553518|FG003|Overall Study|Lack of Efficacy|2|||
162959290|NCT01204294|588553519|FG004|Overall Study|Lack of Efficacy|0|||
162959291|NCT01204294|588553520|FG005|Overall Study|Lack of Efficacy|0|||
162959292|NCT01204294|588553521|FG006|Overall Study|Lack of Efficacy|0|||
162959293|NCT01204294|588553515|FG000|Overall Study|Other (house moving)|0|||
162959294|NCT01204294|588553516|FG001|Overall Study|Other (house moving)|0|||
162959295|NCT01204294|588553517|FG002|Overall Study|Other (house moving)|1|||
162959296|NCT01204294|588553518|FG003|Overall Study|Other (house moving)|0|||
163046334|NCT00327717|588877392|FG000|Overall Study|Withdrawal by Subject|3|||
163046335|NCT00327717|588877393|FG001|Overall Study|Withdrawal by Subject|7|||
163046336|NCT01630135|588877395|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
162959297|NCT01204294|588553519|FG004|Overall Study|Other (house moving)|0|||
162959298|NCT01204294|588553520|FG005|Overall Study|Other (house moving)|0|||
162959299|NCT01204294|588553521|FG006|Overall Study|Other (house moving)|0|||
162959300|NCT03128723|588553522|FG000|Overall Study|Withdrawal by Subject|2|||
162959301|NCT02075463|588553523|FG000|Overall Study|Adverse Event|3|||
162959302|NCT02075463|588553523|FG000|Overall Study|Par. reached stopping criteria|4|||
162959303|NCT02075463|588553523|FG000|Overall Study|Withdrawal by Subject|1|||
162959304|NCT00673660|588553524|FG000|Overall Study|Lost to Follow-up|107|||
162959305|NCT01527006|588553525|FG000|Core Study|Adverse Event|0|||
162959306|NCT01527006|588553526|FG001|Core Study|Adverse Event|2|||
162959307|NCT01527006|588553525|FG000|Core Study|Lost to Follow-up|0|||
162959308|NCT01527006|588553526|FG001|Core Study|Lost to Follow-up|1|||
162959309|NCT01527006|588553525|FG000|Core Study|Subject Choice|1|||
162959310|NCT01527006|588553526|FG001|Core Study|Subject Choice|0|||
162959311|NCT01527006|588553525|FG000|Core Study|Inadequate Therapeutic Effect|1|||
162959312|NCT01527006|588553526|FG001|Core Study|Inadequate Therapeutic Effect|0|||
162959313|NCT01527006|588553525|FG000|Core Study|Withdrawal by Subject|0|||
162959314|NCT01527006|588553526|FG001|Core Study|Withdrawal by Subject|1|||
162959315|NCT01527006|588553525|FG000|Core Study|Other|0|||
162959316|NCT01527006|588553526|FG001|Core Study|Other|2|||
162959317|NCT01527006|588553525|FG000|Extension Phase|Adverse Event|4|||
162959318|NCT01527006|588553526|FG001|Extension Phase|Adverse Event|2|||
162959319|NCT01527006|588553525|FG000|Extension Phase|Lost to Follow-up|0|||
162959320|NCT01527006|588553526|FG001|Extension Phase|Lost to Follow-up|1|||
162959321|NCT01527006|588553525|FG000|Extension Phase|Subject Choice|1|||
162959322|NCT01527006|588553526|FG001|Extension Phase|Subject Choice|1|||
162959323|NCT01527006|588553525|FG000|Extension Phase|Inadequate therapeutic effect|1|||
162959324|NCT01527006|588553526|FG001|Extension Phase|Inadequate therapeutic effect|1|||
162959325|NCT01527006|588553525|FG000|Extension Phase|Other|0|||
162959326|NCT01527006|588553526|FG001|Extension Phase|Other|3|||
162959327|NCT00933686|588553527|FG000|Overall Study|Protocol Violation|0|||
162959328|NCT00933686|588553528|FG001|Overall Study|Protocol Violation|1|||
162959329|NCT00933686|588553527|FG000|Overall Study|Lost to Follow-up|2|||
162959330|NCT00933686|588553528|FG001|Overall Study|Lost to Follow-up|2|||
162959331|NCT00933686|588553527|FG000|Overall Study|Withdrawal by Subject|6|||
162959332|NCT00933686|588553528|FG001|Overall Study|Withdrawal by Subject|5|||
162959333|NCT00933686|588553527|FG000|Overall Study|Adverse Event|1|||
162959334|NCT00933686|588553528|FG001|Overall Study|Adverse Event|1|||
162959335|NCT00933686|588553527|FG000|Overall Study|Physician Decision|1|||
162959336|NCT00933686|588553528|FG001|Overall Study|Physician Decision|0|||
162959337|NCT00933686|588553527|FG000|Overall Study|Failure to show up at endpoint visits|0|||
162959338|NCT00933686|588553528|FG001|Overall Study|Failure to show up at endpoint visits|2|||
163046337|NCT01630135|588877396|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
162959339|NCT01383486|588553529|FG000|Overall Study|Lost to Follow-up|10|||
162959340|NCT01383486|588553529|FG000|Overall Study|Incomplete information for analysis|2|||
162959341|NCT01383486|588553529|FG000|Overall Study|Did not take any product|6|||
162959342|NCT00245063|588553530|FG000|Overall Study|Adverse Event|6|||
162959343|NCT00245063|588553531|FG001|Overall Study|Adverse Event|5|||
162959344|NCT00245063|588553530|FG000|Overall Study|Death|1|||
162959345|NCT00245063|588553531|FG001|Overall Study|Death|0|||
162959346|NCT01839279|588553534|FG000|Overall Study|Adverse Event|4|||
162959347|NCT01839279|588553535|FG001|Overall Study|Adverse Event|1|||
162959348|NCT01839279|588553536|FG002|Overall Study|Adverse Event|1|||
162959349|NCT01839279|588553534|FG000|Overall Study|Withdrawal by Subject|4|||
162959350|NCT01839279|588553535|FG001|Overall Study|Withdrawal by Subject|1|||
162959351|NCT01839279|588553536|FG002|Overall Study|Withdrawal by Subject|1|||
162959352|NCT01839279|588553534|FG000|Overall Study|Classified as 'Other'|5|||
162959353|NCT01839279|588553535|FG001|Overall Study|Classified as 'Other'|0|||
162959354|NCT01839279|588553536|FG002|Overall Study|Classified as 'Other'|0|||
162959355|NCT05919823|588553540|FG000|Pre-Treatment Period|Screen failure|1|||
162959356|NCT05919823|588553541|FG001|Pre-Treatment Period|Screen failure|0|||
162959357|NCT05919823|588553542|FG002|Pre-Treatment Period|Screen failure|0|||
162959358|NCT05919823|588553543|FG003|Pre-Treatment Period|Screen failure|0|||
162959359|NCT05919823|588553540|FG000|Pre-Treatment Period|Protocol Violation|0|||
162959360|NCT05919823|588553541|FG001|Pre-Treatment Period|Protocol Violation|1|||
162959361|NCT05919823|588553542|FG002|Pre-Treatment Period|Protocol Violation|0|||
162959362|NCT05919823|588553543|FG003|Pre-Treatment Period|Protocol Violation|0|||
162959363|NCT05919823|588553540|FG000|Double-Blind Period|Adverse Event|8|||
162959364|NCT05919823|588553541|FG001|Double-Blind Period|Adverse Event|9|||
162959365|NCT05919823|588553542|FG002|Double-Blind Period|Adverse Event|0|||
162959366|NCT05919823|588553543|FG003|Double-Blind Period|Adverse Event|0|||
162959367|NCT05919823|588553540|FG000|Double-Blind Period|Protocol Violation|2|||
162959368|NCT05919823|588553541|FG001|Double-Blind Period|Protocol Violation|1|||
162959369|NCT05919823|588553542|FG002|Double-Blind Period|Protocol Violation|0|||
162959370|NCT05919823|588553543|FG003|Double-Blind Period|Protocol Violation|0|||
162959371|NCT05919823|588553540|FG000|Double-Blind Period|Participant withdrew consent|11|||
162959372|NCT05919823|588553541|FG001|Double-Blind Period|Participant withdrew consent|7|||
162959373|NCT05919823|588553542|FG002|Double-Blind Period|Participant withdrew consent|0|||
162959374|NCT05919823|588553543|FG003|Double-Blind Period|Participant withdrew consent|0|||
162959375|NCT05919823|588553540|FG000|Double-Blind Period|Other reasons|2|||
162959376|NCT05919823|588553541|FG001|Double-Blind Period|Other reasons|3|||
162959377|NCT05919823|588553542|FG002|Double-Blind Period|Other reasons|0|||
162959378|NCT05919823|588553543|FG003|Double-Blind Period|Other reasons|0|||
162959379|NCT05919823|588553540|FG000|Open Label Period|Adverse Event|0|||
162959380|NCT05919823|588553541|FG001|Open Label Period|Adverse Event|0|||
162959381|NCT05919823|588553542|FG002|Open Label Period|Adverse Event|2|||
162959382|NCT05919823|588553543|FG003|Open Label Period|Adverse Event|4|||
162959383|NCT05919823|588553540|FG000|Open Label Period|Lost to Follow-up|0|||
162959384|NCT05919823|588553541|FG001|Open Label Period|Lost to Follow-up|0|||
162959385|NCT05919823|588553542|FG002|Open Label Period|Lost to Follow-up|1|||
162959386|NCT05919823|588553543|FG003|Open Label Period|Lost to Follow-up|0|||
162959387|NCT05919823|588553540|FG000|Open Label Period|Protocol Violation|0|||
162959388|NCT05919823|588553541|FG001|Open Label Period|Protocol Violation|0|||
163195754|NCT01945281|589432043|FG001|Overall Study|Adverse Event|0|||
163195755|NCT01945281|589432042|FG000|Overall Study|Death|3|||
163195756|NCT01945281|589432043|FG001|Overall Study|Death|3|||
163195757|NCT01945281|589432042|FG000|Overall Study|Physician Decision|1|||
163195758|NCT01945281|589432043|FG001|Overall Study|Physician Decision|1|||
163195759|NCT01945281|589432042|FG000|Overall Study|Technical Problems|1|||
163195760|NCT01945281|589432043|FG001|Overall Study|Technical Problems|0|||
163195761|NCT05074667|589432046|FG000|Overall Study|Death|1|||
163195762|NCT05074667|589432046|FG000|Overall Study|Withdrawal by Subject|4|||
163195763|NCT05074667|589432046|FG000|Overall Study|Lost to Follow-up|10|||
163195764|NCT02478632|589432048|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
163195765|NCT02478632|589432049|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
163195766|NCT02478632|589432048|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
163195767|NCT02478632|589432049|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
163195768|NCT02478632|589432048|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
163195769|NCT02478632|589432049|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
163195770|NCT01867424|589432050|FG000|Overall Study|Patient noncompliance|2|||
163195771|NCT01867424|589432051|FG001|Overall Study|Patient noncompliance|1|||
163195772|NCT04645953|589432052|FG000|Overall Study|Lost to Follow-up|2|||
163195773|NCT04645953|589432053|FG001|Overall Study|Lost to Follow-up|1|||
163195774|NCT04645953|589432054|FG002|Overall Study|Lost to Follow-up|1|||
163195775|NCT04645953|589432052|FG000|Overall Study|Withdrawal by Subject|0|||
163046338|NCT02658669|588877398|FG000|Overall Study|Lost to Follow-up|7|||
163195776|NCT04645953|589432053|FG001|Overall Study|Withdrawal by Subject|1|||
163195777|NCT04645953|589432054|FG002|Overall Study|Withdrawal by Subject|0|||
163195778|NCT04645953|589432052|FG000|Overall Study|Physician Decision|0|||
163195779|NCT04645953|589432053|FG001|Overall Study|Physician Decision|1|||
163195780|NCT04645953|589432054|FG002|Overall Study|Physician Decision|0|||
163195781|NCT04645953|589432052|FG000|Overall Study|Discontinued Prior to Dosing|0|||
163195782|NCT04645953|589432053|FG001|Overall Study|Discontinued Prior to Dosing|0|||
163195783|NCT04645953|589432054|FG002|Overall Study|Discontinued Prior to Dosing|2|||
163195784|NCT04613375|589432055|FG000|Overall Study|Death|198|||
163195785|NCT04613375|589432055|FG000|Overall Study|Withdrawal by Subject|3|||
163195786|NCT00434954|589432059|FG000|Overall Study|Adverse Event|17|||
163195787|NCT00434954|589432060|FG001|Overall Study|Adverse Event|2|||
163195788|NCT00434954|589432059|FG000|Overall Study|Entry criteria not met|14|||
163195789|NCT00434954|589432060|FG001|Overall Study|Entry criteria not met|16|||
163195790|NCT00434954|589432059|FG000|Overall Study|Lost to Follow-up|0|||
163046339|NCT02658669|588877399|FG001|Overall Study|Lost to Follow-up|5|||
163195791|NCT00434954|589432060|FG001|Overall Study|Lost to Follow-up|1|||
163195792|NCT00434954|589432059|FG000|Overall Study|Physician Decision|6|||
163195793|NCT00434954|589432060|FG001|Overall Study|Physician Decision|3|||
163195794|NCT00434954|589432059|FG000|Overall Study|Protocol Violation|36|||
163195795|NCT00434954|589432060|FG001|Overall Study|Protocol Violation|27|||
163195796|NCT00434954|589432059|FG000|Overall Study|Sponsor decision|1|||
163195797|NCT00434954|589432060|FG001|Overall Study|Sponsor decision|0|||
162959389|NCT05919823|588553542|FG002|Open Label Period|Protocol Violation|0|||
162959390|NCT05919823|588553543|FG003|Open Label Period|Protocol Violation|1|||
162959391|NCT05919823|588553540|FG000|Open Label Period|Participant withdrew consent|0|||
162959392|NCT05919823|588553541|FG001|Open Label Period|Participant withdrew consent|0|||
162959393|NCT05919823|588553542|FG002|Open Label Period|Participant withdrew consent|8|||
162959394|NCT05919823|588553543|FG003|Open Label Period|Participant withdrew consent|6|||
162959395|NCT05919823|588553540|FG000|Open Label Period|Death|0|||
162959396|NCT05919823|588553541|FG001|Open Label Period|Death|0|||
162959397|NCT05919823|588553542|FG002|Open Label Period|Death|0|||
162959398|NCT05919823|588553543|FG003|Open Label Period|Death|1|||
162959399|NCT05919823|588553540|FG000|Open Label Period|Other reasons|0|||
162959400|NCT05919823|588553541|FG001|Open Label Period|Other reasons|0|||
162959401|NCT05919823|588553542|FG002|Open Label Period|Other reasons|9|||
162959402|NCT05919823|588553543|FG003|Open Label Period|Other reasons|5|||
162959403|NCT01648582|588553544|FG000|Overall Study|Adverse Event|6|||
162959404|NCT01648582|588553545|FG001|Overall Study|Adverse Event|11|||
162959405|NCT01648582|588553546|FG002|Overall Study|Adverse Event|2|||
162959406|NCT01648582|588553544|FG000|Overall Study|Lost to Follow-up|9|||
162959407|NCT01648582|588553545|FG001|Overall Study|Lost to Follow-up|6|||
162959408|NCT01648582|588553546|FG002|Overall Study|Lost to Follow-up|8|||
162959409|NCT01648582|588553544|FG000|Overall Study|Protocol Violation|1|||
162959410|NCT01648582|588553545|FG001|Overall Study|Protocol Violation|2|||
162959411|NCT01648582|588553546|FG002|Overall Study|Protocol Violation|1|||
163046340|NCT00838097|588877408|FG000|Overall Study|Ineligibility determined|6|||
163046341|NCT00838097|588877408|FG000|Overall Study|Adverse Event|2|||
163046342|NCT00838097|588877408|FG000|Overall Study|Withdrawal by Subject|3|||
163046343|NCT00838097|588877408|FG000|Overall Study|Requirement for alternative therapy|2|||
163195798|NCT00434954|589432059|FG000|Overall Study|Subject decision|8|||
163195799|NCT00434954|589432060|FG001|Overall Study|Subject decision|22|||
163046344|NCT00838097|588877408|FG000|Overall Study|Physician Decision|4|||
163046345|NCT00838097|588877408|FG000|Overall Study|Lost to Follow-up|11|||
163046346|NCT00838097|588877408|FG000|Overall Study|Death|6|||
163195800|NCT00002651|589432061|FG000|Induction|Adverse Event|44|||
163195801|NCT00002651|589432062|FG001|Induction|Adverse Event|0|||
163195802|NCT00002651|589432063|FG002|Induction|Adverse Event|0|||
163195803|NCT00002651|589432061|FG000|Induction|Refusal unrelated to adverse event|50|||
163195804|NCT00002651|589432062|FG001|Induction|Refusal unrelated to adverse event|0|||
163195805|NCT00002651|589432063|FG002|Induction|Refusal unrelated to adverse event|0|||
163195806|NCT00002651|589432061|FG000|Induction|Progression/relapse|274|||
163195807|NCT00002651|589432062|FG001|Induction|Progression/relapse|0|||
163195808|NCT00002651|589432063|FG002|Induction|Progression/relapse|0|||
163195809|NCT00002651|589432061|FG000|Induction|Death|62|||
163195810|NCT00002651|589432062|FG001|Induction|Death|0|||
163195811|NCT00002651|589432063|FG002|Induction|Death|0|||
163195812|NCT00002651|589432061|FG000|Induction|Other|823|||
163195813|NCT00002651|589432062|FG001|Induction|Other|0|||
163195814|NCT00002651|589432063|FG002|Induction|Other|0|||
163195815|NCT00002651|589432061|FG000|Induction|not eligible|90|||
163195816|NCT00002651|589432062|FG001|Induction|not eligible|0|||
163195817|NCT00002651|589432063|FG002|Induction|not eligible|0|||
163195818|NCT00002651|589432061|FG000|Consolidation and Randomization|Adverse Event|0|||
163195819|NCT00002651|589432062|FG001|Consolidation and Randomization|Adverse Event|36|||
163195820|NCT00002651|589432063|FG002|Consolidation and Randomization|Adverse Event|14|||
163195821|NCT00002651|589432061|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
163195822|NCT00002651|589432062|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
163195823|NCT00002651|589432063|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
163195824|NCT00002651|589432061|FG000|Consolidation and Randomization|Progression/relapse|0|||
163195825|NCT00002651|589432062|FG001|Consolidation and Randomization|Progression/relapse|295|||
163195826|NCT00002651|589432063|FG002|Consolidation and Randomization|Progression/relapse|298|||
163195827|NCT00002651|589432061|FG000|Consolidation and Randomization|Death|0|||
163195828|NCT00002651|589432062|FG001|Consolidation and Randomization|Death|38|||
163195829|NCT00002651|589432063|FG002|Consolidation and Randomization|Death|48|||
163195830|NCT00002651|589432061|FG000|Consolidation and Randomization|Other|0|||
163195831|NCT00002651|589432062|FG001|Consolidation and Randomization|Other|314|||
163195832|NCT00002651|589432063|FG002|Consolidation and Randomization|Other|313|||
162959412|NCT01648582|588553544|FG000|Overall Study|Withdrawal by Subject|15|||
162959413|NCT01648582|588553545|FG001|Overall Study|Withdrawal by Subject|17|||
162959414|NCT01648582|588553546|FG002|Overall Study|Withdrawal by Subject|17|||
162959415|NCT01648582|588553544|FG000|Overall Study|Physician Decision|0|||
162959416|NCT01648582|588553545|FG001|Overall Study|Physician Decision|1|||
162959417|NCT01648582|588553546|FG002|Overall Study|Physician Decision|3|||
162959418|NCT01648582|588553544|FG000|Overall Study|Death|1|||
162959419|NCT01648582|588553545|FG001|Overall Study|Death|0|||
162959420|NCT01648582|588553546|FG002|Overall Study|Death|0|||
162959421|NCT01648582|588553544|FG000|Overall Study|Sponsor Decision|0|||
162959422|NCT01648582|588553545|FG001|Overall Study|Sponsor Decision|1|||
162959423|NCT01648582|588553546|FG002|Overall Study|Sponsor Decision|1|||
162959424|NCT02321098|588553551|FG000|12 Weeks Treament|Lost to Follow-up|1|||
162959425|NCT02321098|588553552|FG001|12 Weeks Treament|Lost to Follow-up|1|||
162959426|NCT02321098|588553553|FG002|12 Weeks Treament|Lost to Follow-up|0|||
162959427|NCT02321098|588553551|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
162959428|NCT02321098|588553552|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
162959429|NCT02321098|588553553|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
162959430|NCT02321098|588553551|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
162959431|NCT02321098|588553552|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
162959432|NCT02321098|588553553|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
162959433|NCT02321098|588553551|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
162959434|NCT02321098|588553552|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
163301731|NCT05308316|589811248|FG000|Overall Study|Withdrawal by Subject|2|||
163301732|NCT05308316|589811248|FG000|Overall Study|Physician Decision|1|||
162959435|NCT02321098|588553553|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
162959436|NCT03261167|588553558|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
162959437|NCT03261167|588553559|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
162959438|NCT03261167|588553558|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
162959439|NCT03261167|588553559|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
162959440|NCT03261167|588553558|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
163301733|NCT03997916|589811252|FG000|Overall Study|Protocol Violation|35|||
162959441|NCT03261167|588553559|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
163318906|NCT05485779|589878805|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
163046347|NCT00838097|588877408|FG000|Overall Study|Protocol-specified criteria|142|||
163046348|NCT03311841|588877409|FG000|14-day Wash-out|Adverse Event|0|||
163046349|NCT03311841|588877410|FG001|14-day Wash-out|Adverse Event|1|||
163046350|NCT03311841|588877411|FG002|14-day Wash-out|Adverse Event|0|||
163046351|NCT03311841|588877412|FG003|14-day Wash-out|Adverse Event|0|||
163046352|NCT03311841|588877413|FG004|14-day Wash-out|Adverse Event|0|||
163046353|NCT03311841|588877409|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
163046354|NCT03311841|588877410|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
163046355|NCT03311841|588877411|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
163046356|NCT03311841|588877412|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
163046357|NCT03311841|588877413|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
163195833|NCT00002651|589432061|FG000|Consolidation and Randomization|not eligible|0|||
163195834|NCT00002651|589432062|FG001|Consolidation and Randomization|not eligible|102|||
163046358|NCT05464420|588877414|FG000|Overall Study|Death|0|||
163046359|NCT05464420|588877415|FG001|Overall Study|Death|0|||
163046360|NCT05464420|588877416|FG002|Overall Study|Death|0|||
162959442|NCT03261167|588553558|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
162959443|NCT03261167|588553559|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
162959444|NCT03261167|588553558|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
162959445|NCT03261167|588553559|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
162959446|NCT03199963|588553565|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
162959447|NCT03199963|588553566|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
162959448|NCT03199963|588553565|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
162959449|NCT03199963|588553566|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
162959450|NCT03199963|588553565|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
162959451|NCT03199963|588553566|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
162959452|NCT03199963|588553565|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
162959453|NCT03199963|588553566|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
162959454|NCT03199963|588553565|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
162959455|NCT03199963|588553566|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
162959456|NCT03199963|588553565|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
162959457|NCT03199963|588553566|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
162959458|NCT02105272|588553573|FG000|Overall Study|Adverse Event|1|||
162959459|NCT02105272|588553574|FG001|Overall Study|Adverse Event|2|||
163046361|NCT05464420|588877417|FG003|Overall Study|Death|1|||
163046362|NCT05464420|588877414|FG000|Overall Study|Lost to Follow-up|16|||
163046363|NCT05464420|588877415|FG001|Overall Study|Lost to Follow-up|11|||
163046364|NCT05464420|588877416|FG002|Overall Study|Lost to Follow-up|11|||
163046365|NCT05464420|588877417|FG003|Overall Study|Lost to Follow-up|11|||
163301734|NCT03671811|589811253|FG000|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|4|||
163301735|NCT03671811|589811254|FG001|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|3|||
163301736|NCT06938230|589811257|FG000|Overall Study|Lost to Follow-up|56|||
163301737|NCT06938230|589811258|FG001|Overall Study|Lost to Follow-up|18|||
163301738|NCT05096819|589812757|FG000|Overall Study|Withdrawal by Subject|3|||
163301739|NCT05096819|589812758|FG001|Overall Study|Withdrawal by Subject|0|||
163301740|NCT03324984|589812759|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
163301741|NCT03324984|589812760|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
163301742|NCT04337372|589812766|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
163301743|NCT04337372|589812767|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
163301744|NCT04337372|589812768|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
163301745|NCT04337372|589812769|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
163301746|NCT04337372|589812766|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
163301747|NCT04337372|589812767|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
163301748|NCT04337372|589812768|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
163301749|NCT04337372|589812769|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
163301750|NCT04337372|589812766|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
163301751|NCT04337372|589812767|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
163301752|NCT04337372|589812768|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
163301753|NCT04337372|589812769|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
163301754|NCT04337372|589812766|FG000|Day 2: EEG Measures|Protocol Violation|6|||
163301755|NCT04337372|589812767|FG001|Day 2: EEG Measures|Protocol Violation|6|||
163301756|NCT04337372|589812768|FG002|Day 2: EEG Measures|Protocol Violation|5|||
163301757|NCT04337372|589812769|FG003|Day 2: EEG Measures|Protocol Violation|17|||
163301758|NCT03584516|589812781|FG000|Part 1|Death|2|||
163301759|NCT03584516|589812782|FG001|Part 1|Death|3|||
163301760|NCT03584516|589812783|FG002|Part 1|Death|0|||
163301761|NCT03584516|589812784|FG003|Part 1|Death|0|||
163301762|NCT03584516|589812785|FG004|Part 1|Death|0|||
163301763|NCT03584516|589812786|FG005|Part 1|Death|0|||
163301764|NCT03584516|589812781|FG000|Part 1|Withdrawal by Subject|2|||
163301765|NCT03584516|589812782|FG001|Part 1|Withdrawal by Subject|0|||
163301766|NCT03584516|589812783|FG002|Part 1|Withdrawal by Subject|0|||
163301767|NCT03584516|589812784|FG003|Part 1|Withdrawal by Subject|0|||
163301768|NCT03584516|589812785|FG004|Part 1|Withdrawal by Subject|0|||
163301769|NCT03584516|589812786|FG005|Part 1|Withdrawal by Subject|0|||
163301770|NCT03584516|589812781|FG000|Part 1|Lost to Follow-up|1|||
163301771|NCT03584516|589812782|FG001|Part 1|Lost to Follow-up|0|||
163301772|NCT03584516|589812783|FG002|Part 1|Lost to Follow-up|0|||
163301773|NCT03584516|589812784|FG003|Part 1|Lost to Follow-up|0|||
163301774|NCT03584516|589812785|FG004|Part 1|Lost to Follow-up|0|||
163301775|NCT03584516|589812786|FG005|Part 1|Lost to Follow-up|0|||
163301776|NCT03584516|589812781|FG000|Part 1|Study Terminated by Sponsor|0|||
163301777|NCT03584516|589812782|FG001|Part 1|Study Terminated by Sponsor|2|||
163301778|NCT03584516|589812783|FG002|Part 1|Study Terminated by Sponsor|0|||
163301779|NCT03584516|589812784|FG003|Part 1|Study Terminated by Sponsor|0|||
163301780|NCT03584516|589812785|FG004|Part 1|Study Terminated by Sponsor|0|||
163301781|NCT03584516|589812786|FG005|Part 1|Study Terminated by Sponsor|0|||
163301782|NCT03584516|589812781|FG000|Part 1 Expansion|Death|0|||
163301783|NCT03584516|589812782|FG001|Part 1 Expansion|Death|0|||
163301784|NCT03584516|589812783|FG002|Part 1 Expansion|Death|9|||
163301785|NCT03584516|589812784|FG003|Part 1 Expansion|Death|8|||
163301786|NCT03584516|589812785|FG004|Part 1 Expansion|Death|4|||
163301787|NCT03584516|589812786|FG005|Part 1 Expansion|Death|5|||
163301788|NCT03584516|589812781|FG000|Part 1 Expansion|Lost to Follow-up|0|||
163394816|NCT00375219|590157008|FG000|Overall Study|Disease progression|18|||
163394817|NCT00375219|590157009|FG001|Overall Study|Disease progression|9|||
163394818|NCT00375219|590157010|FG002|Overall Study|Disease progression|12|||
163394819|NCT00375219|590157008|FG000|Overall Study|Death|4|||
163394820|NCT00375219|590157009|FG001|Overall Study|Death|3|||
163394821|NCT00375219|590157010|FG002|Overall Study|Death|7|||
163301789|NCT03584516|589812782|FG001|Part 1 Expansion|Lost to Follow-up|0|||
163301790|NCT03584516|589812783|FG002|Part 1 Expansion|Lost to Follow-up|0|||
163301791|NCT03584516|589812784|FG003|Part 1 Expansion|Lost to Follow-up|1|||
163301792|NCT03584516|589812785|FG004|Part 1 Expansion|Lost to Follow-up|0|||
163301793|NCT03584516|589812786|FG005|Part 1 Expansion|Lost to Follow-up|0|||
163301794|NCT03584516|589812781|FG000|Part 1 Expansion|Physician Decision|0|||
163301795|NCT03584516|589812782|FG001|Part 1 Expansion|Physician Decision|0|||
163301796|NCT03584516|589812783|FG002|Part 1 Expansion|Physician Decision|4|||
163301797|NCT03584516|589812784|FG003|Part 1 Expansion|Physician Decision|3|||
163301798|NCT03584516|589812785|FG004|Part 1 Expansion|Physician Decision|2|||
163301799|NCT03584516|589812786|FG005|Part 1 Expansion|Physician Decision|3|||
163301800|NCT03584516|589812781|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
163301801|NCT03584516|589812782|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
163301802|NCT03584516|589812783|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
163301803|NCT03584516|589812784|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
163301804|NCT03584516|589812785|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
163301805|NCT03584516|589812786|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
163394822|NCT00375219|590157008|FG000|Overall Study|Hematologic resistance|1|||
163394823|NCT00375219|590157009|FG001|Overall Study|Hematologic resistance|0|||
163301806|NCT03584516|589812781|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
163301807|NCT03584516|589812782|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
163301808|NCT03584516|589812783|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
163301809|NCT03584516|589812784|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
163301810|NCT03584516|589812785|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
163301811|NCT03584516|589812786|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
163301812|NCT03584516|589812781|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
163301813|NCT03584516|589812782|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
163301814|NCT03584516|589812783|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
163301815|NCT03584516|589812784|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
163301816|NCT03584516|589812785|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
163301817|NCT03584516|589812786|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
163301818|NCT03584516|589812781|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
163301819|NCT03584516|589812782|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
162959460|NCT02105272|588553573|FG000|Overall Study|Physician Decision|0|||
162959461|NCT02105272|588553574|FG001|Overall Study|Physician Decision|1|||
163195835|NCT00002651|589432063|FG002|Consolidation and Randomization|not eligible|112|||
163195836|NCT01705730|589432064|FG000|Overall Study|Lack of Efficacy|1|||
163195837|NCT01705730|589432064|FG000|Overall Study|Adverse Event|3|||
163195838|NCT01705730|589432064|FG000|Overall Study|Lost to Follow-up|1|||
163195839|NCT01705730|589432064|FG000|Overall Study|Reason not Specified|4|||
163195840|NCT04891978|589432068|FG000|Baseline|Protocol Violation|2|||
163195841|NCT04891978|589432069|FG001|Baseline|Protocol Violation|1|||
163195842|NCT04891978|589432070|FG002|Baseline|Protocol Violation|0|||
163195843|NCT04891978|589432068|FG000|Baseline|Missing AIRQ|1|||
163195844|NCT04891978|589432069|FG001|Baseline|Missing AIRQ|0|||
163195845|NCT04891978|589432070|FG002|Baseline|Missing AIRQ|0|||
163195846|NCT04891978|589432068|FG000|Baseline|Did not attend a baseline visit|0|||
163195847|NCT04891978|589432069|FG001|Baseline|Did not attend a baseline visit|0|||
163195848|NCT04891978|589432070|FG002|Baseline|Did not attend a baseline visit|9|||
163195849|NCT01776840|589432071|FG000|Overall Study|Lost to Follow-up|12|||
163195850|NCT01776840|589432072|FG001|Overall Study|Lost to Follow-up|7|||
163195851|NCT01776840|589432071|FG000|Overall Study|Withdrawal by Subject|32|||
163195852|NCT01776840|589432072|FG001|Overall Study|Withdrawal by Subject|48|||
163195853|NCT01776840|589432071|FG000|Overall Study|Sponsor decision|89|||
163195854|NCT01776840|589432072|FG001|Overall Study|Sponsor decision|87|||
163195855|NCT05338216|589432073|FG000|Overall Study|Withdrawal by Subject|1|||
163195856|NCT05338216|589432074|FG001|Overall Study|Withdrawal by Subject|1|||
163195857|NCT02589405|589432078|FG000|Overall Study|Adverse Event|3|||
163195858|NCT02589405|589432078|FG000|Overall Study|Withdrawal by Subject|1|||
163195859|NCT02693119|589432081|FG000|Open-Label Period|Withdrawal by Subject|0|||
163195860|NCT02693119|589432082|FG001|Open-Label Period|Withdrawal by Subject|1|||
163195861|NCT01719783|589432083|FG000|Dose 2|Physician Decision|1|||
163195862|NCT01719783|589432084|FG001|Dose 2|Physician Decision|0|||
163195863|NCT01350492|589432085|FG000|Intervention|Lost to Follow-up|2|||
163195864|NCT01350492|589432086|FG001|Intervention|Lost to Follow-up|5|||
163195865|NCT01350492|589432085|FG000|Intervention|Withdrawal by Subject|3|||
163195866|NCT01350492|589432086|FG001|Intervention|Withdrawal by Subject|1|||
163195867|NCT01350492|589432085|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
163195868|NCT01350492|589432086|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
163195869|NCT01350492|589432085|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
163195870|NCT01350492|589432086|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
163195871|NCT00753766|589432087|FG000|Overall Study|Physician Decision|1|||
163195872|NCT00753766|589432088|FG001|Overall Study|Physician Decision|0|||
163195873|NCT03800173|589432091|FG000|Overall Study|Lost to Follow-up|0|||
163195874|NCT03800173|589432092|FG001|Overall Study|Lost to Follow-up|0|||
163195875|NCT03800173|589432093|FG002|Overall Study|Lost to Follow-up|0|||
163195876|NCT03800173|589432094|FG003|Overall Study|Lost to Follow-up|0|||
163195877|NCT03800173|589432095|FG004|Overall Study|Lost to Follow-up|1|||
163195878|NCT00932126|589432098|FG000|Overall Study|Adverse Event|0|||
163195879|NCT00932126|589432099|FG001|Overall Study|Adverse Event|0|||
162959462|NCT02105272|588553573|FG000|Overall Study|Protocol Violation|2|||
162959463|NCT02105272|588553574|FG001|Overall Study|Protocol Violation|0|||
162959464|NCT02105272|588553573|FG000|Overall Study|Withdrawal by Subject|2|||
163195880|NCT00932126|589432100|FG002|Overall Study|Adverse Event|0|||
163195881|NCT00932126|589432101|FG003|Overall Study|Adverse Event|0|||
163195882|NCT00932126|589432102|FG004|Overall Study|Adverse Event|0|||
163195883|NCT00932126|589432103|FG005|Overall Study|Adverse Event|0|||
163195884|NCT00932126|589432104|FG006|Overall Study|Adverse Event|1|||
163195885|NCT00932126|589432105|FG007|Overall Study|Adverse Event|2|||
163195886|NCT00932126|589432098|FG000|Overall Study|Protocol Violation|0|||
163195887|NCT00932126|589432099|FG001|Overall Study|Protocol Violation|0|||
163195888|NCT00932126|589432100|FG002|Overall Study|Protocol Violation|0|||
163195889|NCT00932126|589432101|FG003|Overall Study|Protocol Violation|0|||
163195890|NCT00932126|589432102|FG004|Overall Study|Protocol Violation|1|||
163195891|NCT00932126|589432103|FG005|Overall Study|Protocol Violation|0|||
162959465|NCT02105272|588553574|FG001|Overall Study|Withdrawal by Subject|0|||
162959466|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Adverse Event|11|||
162959467|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Adverse Event|23|||
162959468|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Adverse Event|29|||
162959469|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Adverse Event|2|||
162959470|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Adverse Event|8|||
162959471|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
162959472|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
162959473|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
163195892|NCT00932126|589432104|FG006|Overall Study|Protocol Violation|0|||
162959474|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
162959475|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
162959476|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
162959477|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
162959478|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
162959479|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
162959480|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
162959481|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
162959482|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
162959483|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
162959484|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
162959485|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
163195893|NCT00932126|589432105|FG007|Overall Study|Protocol Violation|0|||
163195894|NCT00932126|589432098|FG000|Overall Study|Withdrawal by Subject|0|||
163195895|NCT00932126|589432099|FG001|Overall Study|Withdrawal by Subject|0|||
163195896|NCT00932126|589432100|FG002|Overall Study|Withdrawal by Subject|1|||
163195897|NCT00932126|589432101|FG003|Overall Study|Withdrawal by Subject|0|||
163195898|NCT00932126|589432102|FG004|Overall Study|Withdrawal by Subject|0|||
163195899|NCT00932126|589432103|FG005|Overall Study|Withdrawal by Subject|0|||
163195900|NCT00932126|589432104|FG006|Overall Study|Withdrawal by Subject|0|||
163195901|NCT00932126|589432105|FG007|Overall Study|Withdrawal by Subject|1|||
163195902|NCT00932126|589432098|FG000|Overall Study|Objective progression or relapse|3|||
163195903|NCT00932126|589432099|FG001|Overall Study|Objective progression or relapse|3|||
163195904|NCT00932126|589432100|FG002|Overall Study|Objective progression or relapse|2|||
163195905|NCT00932126|589432101|FG003|Overall Study|Objective progression or relapse|3|||
163195906|NCT00932126|589432102|FG004|Overall Study|Objective progression or relapse|3|||
163195907|NCT00932126|589432103|FG005|Overall Study|Objective progression or relapse|3|||
163195908|NCT00932126|589432104|FG006|Overall Study|Objective progression or relapse|3|||
163195909|NCT00932126|589432105|FG007|Overall Study|Objective progression or relapse|5|||
163195910|NCT00932126|589432098|FG000|Overall Study|Other|0|||
163195911|NCT00932126|589432099|FG001|Overall Study|Other|0|||
163195912|NCT00932126|589432100|FG002|Overall Study|Other|0|||
163195913|NCT00932126|589432101|FG003|Overall Study|Other|0|||
163195914|NCT00932126|589432102|FG004|Overall Study|Other|1|||
163195915|NCT00932126|589432103|FG005|Overall Study|Other|0|||
163195916|NCT00932126|589432104|FG006|Overall Study|Other|1|||
163195917|NCT00932126|589432105|FG007|Overall Study|Other|2|||
163195918|NCT02121522|589432113|FG000|Overall Study|Adverse Event|1|||
163195919|NCT01235689|589432114|FG000|Overall Study|Adverse Event|12|||
163195920|NCT01235689|589432115|FG001|Overall Study|Adverse Event|16|||
163195921|NCT01235689|589432114|FG000|Overall Study|Lack of Efficacy|12|||
163195922|NCT01235689|589432115|FG001|Overall Study|Lack of Efficacy|5|||
163195923|NCT01235689|589432114|FG000|Overall Study|Withdrawal by Subject|3|||
163195924|NCT01235689|589432115|FG001|Overall Study|Withdrawal by Subject|4|||
163195925|NCT01235689|589432114|FG000|Overall Study|Lost to Follow-up|1|||
163195926|NCT01235689|589432115|FG001|Overall Study|Lost to Follow-up|2|||
163195927|NCT01235689|589432114|FG000|Overall Study|Miscellaneous|1|||
163195928|NCT01235689|589432115|FG001|Overall Study|Miscellaneous|5|||
163195929|NCT00806351|589432116|FG000|Overall Study|Death|5|||
163195930|NCT00806351|589432117|FG001|Overall Study|Death|4|||
163195931|NCT00672646|589432121|FG000|Overall Study|Lost to Follow-up|0|||
162959486|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
162959487|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
162959488|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
163195932|NCT00672646|589432122|FG001|Overall Study|Lost to Follow-up|1|||
163195933|NCT00672646|589432123|FG002|Overall Study|Lost to Follow-up|2|||
163195934|NCT00672646|589432121|FG000|Overall Study|Withdrawal by Subject|0|||
163195935|NCT00672646|589432122|FG001|Overall Study|Withdrawal by Subject|0|||
163195936|NCT00672646|589432123|FG002|Overall Study|Withdrawal by Subject|1|||
163195937|NCT00289783|589432124|FG000|Primary Phase|Adverse Event|10|||
162959489|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
162959490|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
162959491|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
162959492|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
163195938|NCT00289783|589432125|FG001|Primary Phase|Adverse Event|1|||
163195939|NCT00289783|589432124|FG000|Primary Phase|Protocol Violation|27|||
163301820|NCT03584516|589812783|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
163301821|NCT03584516|589812784|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
163301822|NCT03584516|589812785|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
163301823|NCT03584516|589812786|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
163301824|NCT05846646|589812788|FG000|Overall Study|Physician Decision|1|||
163301825|NCT05846646|589812789|FG001|Overall Study|Physician Decision|0|||
163301826|NCT05846646|589812790|FG002|Overall Study|Physician Decision|0|||
163301827|NCT05846646|589812788|FG000|Overall Study|Lack of Efficacy|1|||
163301828|NCT05846646|589812789|FG001|Overall Study|Lack of Efficacy|1|||
163301829|NCT05846646|589812790|FG002|Overall Study|Lack of Efficacy|0|||
163301830|NCT05846646|589812788|FG000|Overall Study|Early Study Termination|1|||
163301831|NCT05846646|589812789|FG001|Overall Study|Early Study Termination|2|||
163301832|NCT05846646|589812790|FG002|Overall Study|Early Study Termination|0|||
163301833|NCT01443845|589812793|FG000|Overall Study|Protocol Violation|43|||
163301834|NCT01443845|589812794|FG001|Overall Study|Protocol Violation|45|||
163301835|NCT01443845|589812793|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
163301836|NCT01443845|589812794|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
163301837|NCT01443845|589812793|FG000|Overall Study|Deterioration in pulmonary function|1|||
163301838|NCT01443845|589812794|FG001|Overall Study|Deterioration in pulmonary function|4|||
163301839|NCT01443845|589812793|FG000|Overall Study|Lack of Efficacy|10|||
163301840|NCT01443845|589812794|FG001|Overall Study|Lack of Efficacy|5|||
163301841|NCT01443845|589812793|FG000|Overall Study|Adverse Event|64|||
163301842|NCT01443845|589812794|FG001|Overall Study|Adverse Event|138|||
163301843|NCT01443845|589812793|FG000|Overall Study|Withdrawal by Subject|63|||
163301844|NCT01443845|589812794|FG001|Overall Study|Withdrawal by Subject|67|||
163301845|NCT01443845|589812793|FG000|Overall Study|Military Conflict - Site Terminated|20|||
163301846|NCT01443845|589812794|FG001|Overall Study|Military Conflict - Site Terminated|21|||
163301847|NCT01443845|589812793|FG000|Overall Study|Lost to Follow-up|9|||
163301848|NCT01443845|589812794|FG001|Overall Study|Lost to Follow-up|13|||
163301849|NCT01471691|589812798|FG000|Overall Study|Lack of Efficacy|0|||
163301850|NCT01471691|589812799|FG001|Overall Study|Lack of Efficacy|1|||
163301851|NCT01808339|589812800|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163301852|NCT01808339|589812801|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163301853|NCT01808339|589812802|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163301854|NCT01808339|589812803|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
163301855|NCT01808339|589812804|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
163301856|NCT01808339|589812805|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
163301857|NCT01808339|589812800|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163301858|NCT01808339|589812801|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163301859|NCT01808339|589812802|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163301860|NCT01808339|589812803|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163301861|NCT01808339|589812804|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163301862|NCT01808339|589812805|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163301863|NCT01808339|589812800|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163301864|NCT01808339|589812801|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163301865|NCT01808339|589812802|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
163301866|NCT01808339|589812803|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163301867|NCT01808339|589812804|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163301868|NCT01808339|589812805|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163301869|NCT02461628|589812806|FG000|Overall Study|Refused to complete survey|4|||
163301870|NCT02461628|589812807|FG001|Overall Study|Refused to complete survey|7|||
163301871|NCT02462759|589812810|FG000|Part 1: Double Blind|Death|1|||
163301872|NCT02462759|589812811|FG001|Part 1: Double Blind|Death|0|||
163301873|NCT02462759|589812812|FG002|Part 1: Double Blind|Death|0|||
163301874|NCT00520546|589812816|FG000|Overall Study|Withdrawal by Subject|1|||
163301875|NCT00520546|589812816|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
163301876|NCT02088853|589812817|FG000|Overall Study|Pregnancy|1|||
163301877|NCT02088853|589812818|FG001|Overall Study|Pregnancy|0|||
163301878|NCT04704284|589812825|FG000|Overall Study|Withdrawal by Subject|1|||
163301879|NCT01248936|589812827|FG000|Overall Study|Sponsor Decision|259|||
163301880|NCT01248936|589812827|FG000|Overall Study|Progression of Disease|50|||
163301881|NCT01248936|589812827|FG000|Overall Study|Death|26|||
163301882|NCT01248936|589812827|FG000|Overall Study|Withdrawal of Consent|20|||
163301883|NCT01248936|589812827|FG000|Overall Study|Adverse Event|8|||
163301884|NCT01248936|589812827|FG000|Overall Study|Lost to Follow-up|7|||
163301885|NCT01248936|589812827|FG000|Overall Study|Refused Treatment|1|||
163301886|NCT01248936|589812827|FG000|Overall Study|Other reason|3|||
163301887|NCT03930420|589812828|FG000|Overall Study|Withdrawal by Subject|7|||
163301888|NCT03930420|589812829|FG001|Overall Study|Withdrawal by Subject|9|||
163301889|NCT05609032|589812830|FG000|Overall Study|Lost to Follow-up|3|||
163301890|NCT05609032|589812831|FG001|Overall Study|Lost to Follow-up|1|||
163301891|NCT05609032|589812830|FG000|Overall Study|Withdrawal by Subject|1|||
163301892|NCT05609032|589812831|FG001|Overall Study|Withdrawal by Subject|0|||
163301893|NCT00609336|589812832|FG000|Overall Study|Protocol Violation|3|||
163301894|NCT00609336|589812832|FG000|Overall Study|Death|1|||
163301895|NCT00609336|589812832|FG000|Overall Study|LA or Met at Surgery|9|||
163301896|NCT00567489|589812833|FG000|Overall Study|Adverse Event|6|||
163301897|NCT00567489|589812834|FG001|Overall Study|Adverse Event|14|||
163301898|NCT00567489|589812833|FG000|Overall Study|Physician Decision|0|||
163301899|NCT00567489|589812834|FG001|Overall Study|Physician Decision|4|||
163301900|NCT00567489|589812833|FG000|Overall Study|Withdrawal by Subject|0|||
163301901|NCT00567489|589812834|FG001|Overall Study|Withdrawal by Subject|2|||
163301902|NCT00567489|589812833|FG000|Overall Study|Renal Transplantation|0|||
163301903|NCT00567489|589812834|FG001|Overall Study|Renal Transplantation|3|||
163301904|NCT00567489|589812833|FG000|Overall Study|Other|1|||
163301905|NCT00567489|589812834|FG001|Overall Study|Other|0|||
163301906|NCT00419341|589812842|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
163301907|NCT00419341|589812842|FG000|Wash in/Wash Out Period|Adverse Event|2|||
163301908|NCT00419341|589812842|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
162959493|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
162959494|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
162959495|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
162959496|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
162959497|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
162959498|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
162959499|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
162959500|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
162959501|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Move|0|||
162959502|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Move|1|||
162959503|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Move|0|||
162959504|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Move|0|||
162959505|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Move|0|||
163301909|NCT00419341|589812842|FG000|Efficacy Period|Withdrawal by Subject|6|||
163301910|NCT00419341|589812842|FG000|Efficacy Period|Protocol Violation|1|||
163301911|NCT00419341|589812842|FG000|Efficacy Period|Lost to Follow-up|1|||
163301912|NCT00419341|589812842|FG000|Efficacy Period|Non-compliance|1|||
163301913|NCT00419341|589812842|FG000|Efficacy Period|Termination of study site|1|||
163301914|NCT00331136|589812843|FG000|Overall Study|Adverse Event|3|||
163301915|NCT00331136|589812844|FG001|Overall Study|Adverse Event|5|||
163301916|NCT00331136|589812845|FG002|Overall Study|Adverse Event|0|||
163301917|NCT00331136|589812846|FG003|Overall Study|Adverse Event|1|||
163301918|NCT00331136|589812843|FG000|Overall Study|Withdrawal by Subject|0|||
163301919|NCT00331136|589812844|FG001|Overall Study|Withdrawal by Subject|1|||
163301920|NCT00331136|589812845|FG002|Overall Study|Withdrawal by Subject|0|||
163301921|NCT00331136|589812846|FG003|Overall Study|Withdrawal by Subject|0|||
163301922|NCT00331136|589812843|FG000|Overall Study|Lost to Follow-up|0|||
163301923|NCT00331136|589812844|FG001|Overall Study|Lost to Follow-up|1|||
163301924|NCT00331136|589812845|FG002|Overall Study|Lost to Follow-up|0|||
163301925|NCT00331136|589812846|FG003|Overall Study|Lost to Follow-up|0|||
163301926|NCT00331136|589812843|FG000|Overall Study|Protocol Violation|1|||
163301927|NCT00331136|589812844|FG001|Overall Study|Protocol Violation|0|||
163301928|NCT00331136|589812845|FG002|Overall Study|Protocol Violation|0|||
163301929|NCT00331136|589812846|FG003|Overall Study|Protocol Violation|0|||
163301930|NCT00331136|589812843|FG000|Overall Study|Not treated|1|||
163301931|NCT00331136|589812844|FG001|Overall Study|Not treated|0|||
163301932|NCT00331136|589812845|FG002|Overall Study|Not treated|0|||
163301933|NCT00331136|589812846|FG003|Overall Study|Not treated|0|||
163301934|NCT02692417|589812847|FG000|Overall Study|Withdrawal by Subject|5|||
163301935|NCT02692417|589812848|FG001|Overall Study|Withdrawal by Subject|1|||
163301936|NCT02692417|589812847|FG000|Overall Study|Adverse Event|1|||
163301937|NCT02692417|589812848|FG001|Overall Study|Adverse Event|0|||
163301938|NCT04578106|589812860|FG000|Follow-up after 1 year|Lost to Follow-up|1|||
163301939|NCT04690556|589812866|FG000|Overall Study|Adverse Event|6|||
163301940|NCT04690556|589812867|FG001|Overall Study|Adverse Event|4|||
163301941|NCT04690556|589812866|FG000|Overall Study|Death|3|||
163301942|NCT04690556|589812867|FG001|Overall Study|Death|4|||
163301943|NCT04690556|589812866|FG000|Overall Study|Lost to Follow-up|3|||
163301944|NCT04690556|589812867|FG001|Overall Study|Lost to Follow-up|2|||
163301945|NCT04690556|589812866|FG000|Overall Study|Protocol Violation|1|||
163301946|NCT04690556|589812867|FG001|Overall Study|Protocol Violation|4|||
163301947|NCT04690556|589812866|FG000|Overall Study|Physician Decision|2|||
163301948|NCT04690556|589812867|FG001|Overall Study|Physician Decision|0|||
163301949|NCT04690556|589812866|FG000|Overall Study|Withdrawal by Subject|25|||
163301950|NCT04690556|589812867|FG001|Overall Study|Withdrawal by Subject|17|||
163301951|NCT04690556|589812866|FG000|Overall Study|Prohibited medications and other reasons|3|||
163301952|NCT04690556|589812867|FG001|Overall Study|Prohibited medications and other reasons|1|||
163301953|NCT03891758|589812870|FG000|Overall Study|Adverse Event|2|||
163301954|NCT03891758|589812871|FG001|Overall Study|Adverse Event|0|||
163301955|NCT03891758|589812870|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163301956|NCT03891758|589812871|FG001|Overall Study|Withdrawal by parent/guardian|2|||
163301957|NCT04434729|589812874|FG000|Overall Study|Adverse Event|1|||
163301958|NCT04434729|589812874|FG000|Overall Study|Physician Decision|1|||
163301959|NCT00975819|589812875|FG000|Overall Study|Lack of Efficacy|8|||
163301960|NCT00975819|589812875|FG000|Overall Study|Adverse Event|2|||
163301961|NCT00975819|589812875|FG000|Overall Study|Physician Decision|2|||
163301962|NCT00975819|589812875|FG000|Overall Study|Withdrawal by Subject|2|||
163301963|NCT00975819|589812875|FG000|Overall Study|Protocol Violation|1|||
163301964|NCT01968109|589812876|FG000|Overall Study|DISEASE PROGRESSION|4|||
163301965|NCT01968109|589812877|FG001|Overall Study|DISEASE PROGRESSION|4|||
162959506|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
162959507|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
162959508|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
162959509|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
162959510|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
163301966|NCT01968109|589812878|FG002|Overall Study|DISEASE PROGRESSION|3|||
163301967|NCT01968109|589812879|FG003|Overall Study|DISEASE PROGRESSION|9|||
163301968|NCT01968109|589812880|FG004|Overall Study|DISEASE PROGRESSION|5|||
162959511|NCT00318461|588553577|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
162959512|NCT00318461|588553578|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
163301969|NCT01968109|589812881|FG005|Overall Study|DISEASE PROGRESSION|6|||
163301970|NCT01968109|589812882|FG006|Overall Study|DISEASE PROGRESSION|6|||
163301971|NCT01968109|589812883|FG007|Overall Study|DISEASE PROGRESSION|6|||
163301972|NCT01968109|589812884|FG008|Overall Study|DISEASE PROGRESSION|4|||
163301973|NCT01968109|589812885|FG009|Overall Study|DISEASE PROGRESSION|5|||
163301974|NCT01968109|589812886|FG010|Overall Study|DISEASE PROGRESSION|8|||
163301975|NCT01968109|589812887|FG011|Overall Study|DISEASE PROGRESSION|4|||
163301976|NCT01968109|589812888|FG012|Overall Study|DISEASE PROGRESSION|7|||
163301977|NCT01968109|589812889|FG013|Overall Study|DISEASE PROGRESSION|14|||
163301978|NCT01968109|589812890|FG014|Overall Study|DISEASE PROGRESSION|14|||
163301979|NCT01968109|589812891|FG015|Overall Study|DISEASE PROGRESSION|13|||
163301980|NCT01968109|589812892|FG016|Overall Study|DISEASE PROGRESSION|34|||
163301981|NCT01968109|589812893|FG017|Overall Study|DISEASE PROGRESSION|20|||
163301982|NCT01968109|589812894|FG018|Overall Study|DISEASE PROGRESSION|54|||
163301983|NCT01968109|589812895|FG019|Overall Study|DISEASE PROGRESSION|46|||
163301984|NCT01968109|589812896|FG020|Overall Study|DISEASE PROGRESSION|77|||
163301985|NCT01968109|589812897|FG021|Overall Study|DISEASE PROGRESSION|25|||
163301986|NCT01968109|589812898|FG022|Overall Study|DISEASE PROGRESSION|47|||
163301987|NCT01968109|589812899|FG023|Overall Study|DISEASE PROGRESSION|125|||
163301988|NCT01968109|589812900|FG024|Overall Study|DISEASE PROGRESSION|155|||
163301989|NCT01968109|589812901|FG025|Overall Study|DISEASE PROGRESSION|63|||
163301990|NCT01968109|589812902|FG026|Overall Study|DISEASE PROGRESSION|65|||
163301991|NCT01968109|589812903|FG027|Overall Study|DISEASE PROGRESSION|137|||
163301992|NCT01968109|589812904|FG028|Overall Study|DISEASE PROGRESSION|35|||
163301993|NCT01968109|589812905|FG029|Overall Study|DISEASE PROGRESSION|23|||
163301994|NCT01968109|589812906|FG030|Overall Study|DISEASE PROGRESSION|71|||
163301995|NCT01968109|589812876|FG000|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163301996|NCT01968109|589812877|FG001|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163301997|NCT01968109|589812878|FG002|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163301998|NCT01968109|589812879|FG003|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163301999|NCT01968109|589812880|FG004|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163302000|NCT01968109|589812881|FG005|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163302001|NCT01968109|589812882|FG006|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163302002|NCT01968109|589812883|FG007|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163302003|NCT01968109|589812884|FG008|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163302004|NCT01968109|589812885|FG009|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163302005|NCT01968109|589812886|FG010|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163302006|NCT01968109|589812887|FG011|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163302007|NCT01968109|589812888|FG012|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163302008|NCT01968109|589812889|FG013|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163302009|NCT01968109|589812890|FG014|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163302010|NCT01968109|589812891|FG015|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163302011|NCT01968109|589812892|FG016|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163302012|NCT01968109|589812893|FG017|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163302013|NCT01968109|589812894|FG018|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163302014|NCT01968109|589812895|FG019|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163302015|NCT01968109|589812896|FG020|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
163302016|NCT01968109|589812897|FG021|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163302017|NCT01968109|589812898|FG022|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
163302018|NCT01968109|589812899|FG023|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|4|||
163302019|NCT01968109|589812900|FG024|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|7|||
163302020|NCT01968109|589812901|FG025|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
163302021|NCT01968109|589812902|FG026|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
163302022|NCT01968109|589812903|FG027|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
163302023|NCT01968109|589812904|FG028|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|8|||
163302024|NCT01968109|589812905|FG029|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|12|||
163302025|NCT01968109|589812906|FG030|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
163302026|NCT01968109|589812876|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
163302027|NCT01968109|589812877|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
163302028|NCT01968109|589812878|FG002|Overall Study|STUDY DRUG TOXICITY|1|||
163302029|NCT01968109|589812879|FG003|Overall Study|STUDY DRUG TOXICITY|2|||
163302030|NCT01968109|589812880|FG004|Overall Study|STUDY DRUG TOXICITY|1|||
163302031|NCT01968109|589812881|FG005|Overall Study|STUDY DRUG TOXICITY|1|||
163302032|NCT01968109|589812882|FG006|Overall Study|STUDY DRUG TOXICITY|1|||
163302033|NCT01968109|589812883|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
163302034|NCT01968109|589812884|FG008|Overall Study|STUDY DRUG TOXICITY|2|||
163302035|NCT01968109|589812885|FG009|Overall Study|STUDY DRUG TOXICITY|1|||
163302036|NCT01968109|589812886|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
163302037|NCT01968109|589812887|FG011|Overall Study|STUDY DRUG TOXICITY|2|||
163302038|NCT01968109|589812888|FG012|Overall Study|STUDY DRUG TOXICITY|0|||
162959513|NCT00318461|588553579|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
163302039|NCT01968109|589812889|FG013|Overall Study|STUDY DRUG TOXICITY|2|||
163302040|NCT01968109|589812890|FG014|Overall Study|STUDY DRUG TOXICITY|2|||
163302041|NCT01968109|589812891|FG015|Overall Study|STUDY DRUG TOXICITY|4|||
163302042|NCT01968109|589812892|FG016|Overall Study|STUDY DRUG TOXICITY|11|||
163302043|NCT01968109|589812893|FG017|Overall Study|STUDY DRUG TOXICITY|3|||
162959514|NCT00318461|588553580|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
162959515|NCT00318461|588553581|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
163302044|NCT01968109|589812894|FG018|Overall Study|STUDY DRUG TOXICITY|4|||
163302045|NCT01968109|589812895|FG019|Overall Study|STUDY DRUG TOXICITY|9|||
163302046|NCT01968109|589812896|FG020|Overall Study|STUDY DRUG TOXICITY|6|||
163302047|NCT01968109|589812897|FG021|Overall Study|STUDY DRUG TOXICITY|4|||
163302048|NCT01968109|589812898|FG022|Overall Study|STUDY DRUG TOXICITY|3|||
163394824|NCT00375219|590157010|FG002|Overall Study|Hematologic resistance|0|||
163394825|NCT00375219|590157008|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
163394826|NCT00375219|590157009|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
163394827|NCT00375219|590157010|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
163394828|NCT00375219|590157008|FG000|Overall Study|Allograft|2|||
163394829|NCT00375219|590157009|FG001|Overall Study|Allograft|0|||
163394830|NCT00375219|590157010|FG002|Overall Study|Allograft|0|||
163394831|NCT00375219|590157008|FG000|Overall Study|Cord blood transplantation|1|||
163302049|NCT01968109|589812899|FG023|Overall Study|STUDY DRUG TOXICITY|8|||
163302050|NCT01968109|589812900|FG024|Overall Study|STUDY DRUG TOXICITY|9|||
163302051|NCT01968109|589812901|FG025|Overall Study|STUDY DRUG TOXICITY|8|||
163302052|NCT01968109|589812902|FG026|Overall Study|STUDY DRUG TOXICITY|3|||
163302053|NCT01968109|589812903|FG027|Overall Study|STUDY DRUG TOXICITY|9|||
163302054|NCT01968109|589812904|FG028|Overall Study|STUDY DRUG TOXICITY|14|||
163302055|NCT01968109|589812905|FG029|Overall Study|STUDY DRUG TOXICITY|21|||
163302056|NCT01968109|589812906|FG030|Overall Study|STUDY DRUG TOXICITY|9|||
163302057|NCT01968109|589812876|FG000|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302058|NCT01968109|589812877|FG001|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302059|NCT01968109|589812878|FG002|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302060|NCT01968109|589812879|FG003|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302061|NCT01968109|589812880|FG004|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163394832|NCT00375219|590157009|FG001|Overall Study|Cord blood transplantation|0|||
163394833|NCT00375219|590157010|FG002|Overall Study|Cord blood transplantation|0|||
163302062|NCT01968109|589812881|FG005|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302063|NCT01968109|589812882|FG006|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302064|NCT01968109|589812883|FG007|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163302065|NCT01968109|589812884|FG008|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302066|NCT01968109|589812885|FG009|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302067|NCT01968109|589812886|FG010|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163394834|NCT00375219|590157008|FG000|Overall Study|Withdrawal by Subject|1|||
163394835|NCT00375219|590157009|FG001|Overall Study|Withdrawal by Subject|0|||
163394836|NCT00375219|590157010|FG002|Overall Study|Withdrawal by Subject|0|||
163302068|NCT01968109|589812887|FG011|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163394837|NCT02684279|590157013|FG000|Overall Study|Adverse Event|87|||
163394838|NCT02684279|590157013|FG000|Overall Study|Lack of Efficacy|4|||
163394839|NCT02684279|590157013|FG000|Overall Study|Lost to Follow-up|61|||
163394840|NCT02684279|590157013|FG000|Overall Study|Protocol Violation|6|||
163302069|NCT01968109|589812888|FG012|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302070|NCT01968109|589812889|FG013|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302071|NCT01968109|589812890|FG014|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302072|NCT01968109|589812891|FG015|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302073|NCT01968109|589812892|FG016|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302074|NCT01968109|589812893|FG017|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302075|NCT01968109|589812894|FG018|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163302076|NCT01968109|589812895|FG019|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163302077|NCT01968109|589812896|FG020|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163394841|NCT02684279|590157013|FG000|Overall Study|Pregnancy|8|||
163394842|NCT02684279|590157013|FG000|Overall Study|Withdrawal by Subject|92|||
163394843|NCT02684279|590157013|FG000|Overall Study|non-compliance with study drug|9|||
163394844|NCT02684279|590157013|FG000|Overall Study|non compliance with study visits|2|||
163394845|NCT02684279|590157013|FG000|Overall Study|subject to have surgery|1|||
163394846|NCT02684279|590157013|FG000|Overall Study|family emergency|1|||
163394847|NCT02684279|590157013|FG000|Overall Study|Site closures|7|||
163394848|NCT02684279|590157013|FG000|Overall Study|Physician Decision|1|||
163394849|NCT00228566|590157014|FG000|Overall Study|Adverse Event|31|||
163394850|NCT00228566|590157014|FG000|Overall Study|Lack of Efficacy|14|||
163394851|NCT00228566|590157014|FG000|Overall Study|Lost to Follow-up|16|||
163394852|NCT00228566|590157014|FG000|Overall Study|Physician Decision|5|||
163394853|NCT00228566|590157014|FG000|Overall Study|Withdrawal by Subject|4|||
163394854|NCT00228566|590157014|FG000|Overall Study|Miscellaneous|1|||
163394855|NCT01479829|590157015|FG000|Overall Study|Withdrawal by Subject|8|||
163394856|NCT01479829|590157016|FG001|Overall Study|Withdrawal by Subject|10|||
163394857|NCT01444456|590157021|FG000|Overall Study|Withdrawal by Subject|21|||
163394858|NCT01444456|590157021|FG000|Overall Study|Physician Decision|9|||
163394859|NCT01444456|590157021|FG000|Overall Study|Lost to Follow-up|37|||
163394860|NCT01444456|590157021|FG000|Overall Study|Death|73|||
163394861|NCT01444456|590157021|FG000|Overall Study|Ineligibility determined|23|||
163394862|NCT01444456|590157021|FG000|Overall Study|Other|18|||
163302078|NCT01968109|589812897|FG021|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163302079|NCT01968109|589812898|FG022|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302080|NCT01968109|589812899|FG023|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302081|NCT01968109|589812900|FG024|Overall Study|SUBJECT WITHDREW CONSENT|3|||
163302082|NCT01968109|589812901|FG025|Overall Study|SUBJECT WITHDREW CONSENT|2|||
163302083|NCT01968109|589812902|FG026|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163302084|NCT01968109|589812903|FG027|Overall Study|SUBJECT WITHDREW CONSENT|4|||
163302085|NCT01968109|589812904|FG028|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163302086|NCT01968109|589812905|FG029|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163302087|NCT01968109|589812906|FG030|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163302088|NCT01968109|589812876|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163302089|NCT01968109|589812877|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163302090|NCT01968109|589812878|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163302091|NCT01968109|589812879|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163302092|NCT01968109|589812880|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163302093|NCT01968109|589812881|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163302094|NCT01968109|589812882|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163302095|NCT01968109|589812883|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163302096|NCT01968109|589812884|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
163302097|NCT01968109|589812885|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
163302098|NCT01968109|589812886|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163394863|NCT01444456|590157021|FG000|Overall Study|Not treated|104|||
163394864|NCT02142738|590158540|FG000|Overall Study|Adverse Event|13|||
163195940|NCT00289783|589432125|FG001|Primary Phase|Protocol Violation|6|||
163195941|NCT00289783|589432124|FG000|Primary Phase|Withdrawal by Subject|93|||
163195942|NCT00289783|589432125|FG001|Primary Phase|Withdrawal by Subject|40|||
163195943|NCT00289783|589432124|FG000|Primary Phase|Lost to Follow-up|60|||
163195944|NCT00289783|589432125|FG001|Primary Phase|Lost to Follow-up|14|||
163195945|NCT00289783|589432124|FG000|Primary Phase|Migration from the study area|26|||
163195946|NCT00289783|589432125|FG001|Primary Phase|Migration from the study area|10|||
163195947|NCT00289783|589432124|FG000|Primary Phase|Other|32|||
163195948|NCT00289783|589432125|FG001|Primary Phase|Other|12|||
163302099|NCT01968109|589812887|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
163302100|NCT01968109|589812888|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163302101|NCT01968109|589812889|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
163302102|NCT01968109|589812890|FG014|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163302103|NCT01968109|589812891|FG015|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
163302104|NCT01968109|589812892|FG016|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
163302105|NCT01968109|589812893|FG017|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163302106|NCT01968109|589812894|FG018|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
163302107|NCT01968109|589812895|FG019|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
163302108|NCT01968109|589812896|FG020|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
163302109|NCT01968109|589812897|FG021|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
163302110|NCT01968109|589812898|FG022|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
163302111|NCT01968109|589812899|FG023|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
163302112|NCT01968109|589812900|FG024|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|5|||
163302113|NCT01968109|589812901|FG025|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|6|||
163302114|NCT01968109|589812902|FG026|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
163302115|NCT01968109|589812903|FG027|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
163302116|NCT01968109|589812904|FG028|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
163302117|NCT01968109|589812905|FG029|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
163302118|NCT01968109|589812906|FG030|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
163302119|NCT01968109|589812876|FG000|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302120|NCT01968109|589812877|FG001|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302121|NCT01968109|589812878|FG002|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302122|NCT01968109|589812879|FG003|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302123|NCT01968109|589812880|FG004|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302124|NCT01968109|589812881|FG005|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163302125|NCT01968109|589812882|FG006|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302126|NCT01968109|589812883|FG007|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302127|NCT01968109|589812884|FG008|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163302128|NCT01968109|589812885|FG009|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302129|NCT01968109|589812886|FG010|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302130|NCT01968109|589812887|FG011|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302131|NCT01968109|589812888|FG012|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302132|NCT01968109|589812889|FG013|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302133|NCT01968109|589812890|FG014|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302134|NCT01968109|589812891|FG015|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
163302135|NCT01968109|589812892|FG016|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
163302136|NCT01968109|589812893|FG017|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163302137|NCT01968109|589812894|FG018|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163302138|NCT01968109|589812895|FG019|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163302139|NCT01968109|589812896|FG020|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
163302140|NCT01968109|589812897|FG021|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163302141|NCT01968109|589812898|FG022|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302142|NCT01968109|589812899|FG023|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
163302143|NCT01968109|589812900|FG024|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|5|||
163302144|NCT01968109|589812901|FG025|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302145|NCT01968109|589812902|FG026|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163302146|NCT01968109|589812903|FG027|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|2|||
163302147|NCT01968109|589812904|FG028|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302148|NCT01968109|589812905|FG029|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163302149|NCT01968109|589812906|FG030|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163302150|NCT01968109|589812876|FG000|Overall Study|OTHER REASONS|0|||
163302151|NCT01968109|589812877|FG001|Overall Study|OTHER REASONS|0|||
163302152|NCT01968109|589812878|FG002|Overall Study|OTHER REASONS|0|||
163302153|NCT01968109|589812879|FG003|Overall Study|OTHER REASONS|1|||
163302154|NCT01968109|589812880|FG004|Overall Study|OTHER REASONS|0|||
163302155|NCT01968109|589812881|FG005|Overall Study|OTHER REASONS|0|||
163302156|NCT01968109|589812882|FG006|Overall Study|OTHER REASONS|0|||
163302157|NCT01968109|589812883|FG007|Overall Study|OTHER REASONS|0|||
163302158|NCT01968109|589812884|FG008|Overall Study|OTHER REASONS|0|||
163302159|NCT01968109|589812885|FG009|Overall Study|OTHER REASONS|0|||
163394865|NCT02142738|590158541|FG001|Overall Study|Adverse Event|9|||
163302160|NCT01968109|589812886|FG010|Overall Study|OTHER REASONS|0|||
163302161|NCT01968109|589812887|FG011|Overall Study|OTHER REASONS|1|||
163302162|NCT01968109|589812888|FG012|Overall Study|OTHER REASONS|0|||
162959516|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Work commitment|0|||
162959517|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Work commitment|0|||
162959518|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Work commitment|0|||
162959519|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Work commitment|0|||
162959520|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Work commitment|1|||
162959521|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Investigator decision|0|||
163195949|NCT00289783|589432124|FG000|Fourth Dose Phase|Adverse Event|1|||
163195950|NCT00289783|589432125|FG001|Fourth Dose Phase|Adverse Event|0|||
163195951|NCT00289783|589432124|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
163195952|NCT00289783|589432125|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
163195953|NCT00289783|589432124|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
163195954|NCT00289783|589432125|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
163195955|NCT00289783|589432124|FG000|Fourth Dose Phase|Migration from the study area|1|||
163195956|NCT00289783|589432125|FG001|Fourth Dose Phase|Migration from the study area|1|||
163195957|NCT00289783|589432124|FG000|Fourth Dose Phase|Other|22|||
163195958|NCT00289783|589432125|FG001|Fourth Dose Phase|Other|10|||
163195959|NCT05248867|589432126|FG000|Double-blind Period|Lost to Follow-up|0|||
163195960|NCT05248867|589432127|FG001|Double-blind Period|Lost to Follow-up|3|||
163195961|NCT05248867|589432128|FG002|Double-blind Period|Lost to Follow-up|0|||
163195962|NCT05248867|589432129|FG003|Double-blind Period|Lost to Follow-up|0|||
163195963|NCT05248867|589432130|FG004|Double-blind Period|Lost to Follow-up|0|||
163195964|NCT05248867|589432131|FG005|Double-blind Period|Lost to Follow-up|0|||
163195965|NCT05248867|589432126|FG000|Double-blind Period|Withdrawal by Subject|5|||
163195966|NCT05248867|589432127|FG001|Double-blind Period|Withdrawal by Subject|14|||
163195967|NCT05248867|589432128|FG002|Double-blind Period|Withdrawal by Subject|0|||
163195968|NCT05248867|589432129|FG003|Double-blind Period|Withdrawal by Subject|0|||
163195969|NCT05248867|589432130|FG004|Double-blind Period|Withdrawal by Subject|0|||
163195970|NCT05248867|589432131|FG005|Double-blind Period|Withdrawal by Subject|0|||
163195971|NCT05248867|589432126|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
163195972|NCT05248867|589432127|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
163195973|NCT05248867|589432128|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
163195974|NCT05248867|589432129|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
163195975|NCT05248867|589432130|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
163195976|NCT05248867|589432131|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
163195977|NCT05248867|589432126|FG000|Double-blind Period|Other, not specified|3|||
163195978|NCT05248867|589432127|FG001|Double-blind Period|Other, not specified|8|||
163195979|NCT05248867|589432128|FG002|Double-blind Period|Other, not specified|0|||
163195980|NCT05248867|589432129|FG003|Double-blind Period|Other, not specified|0|||
163195981|NCT05248867|589432130|FG004|Double-blind Period|Other, not specified|0|||
163195982|NCT05248867|589432131|FG005|Double-blind Period|Other, not specified|0|||
163195983|NCT05248867|589432126|FG000|Open-label Period|Withdrawal by Subject|0|||
163195984|NCT05248867|589432127|FG001|Open-label Period|Withdrawal by Subject|0|||
163195985|NCT05248867|589432128|FG002|Open-label Period|Withdrawal by Subject|3|||
163195986|NCT05248867|589432129|FG003|Open-label Period|Withdrawal by Subject|1|||
163195987|NCT05248867|589432130|FG004|Open-label Period|Withdrawal by Subject|7|||
163195988|NCT05248867|589432131|FG005|Open-label Period|Withdrawal by Subject|9|||
163195989|NCT05248867|589432126|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
163195990|NCT05248867|589432127|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
163195991|NCT05248867|589432128|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
163195992|NCT05248867|589432129|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
163195993|NCT05248867|589432130|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
163195994|NCT05248867|589432131|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
163195995|NCT05248867|589432126|FG000|Open-label Period|Lost to Follow-up|0|||
163195996|NCT05248867|589432127|FG001|Open-label Period|Lost to Follow-up|0|||
163195997|NCT05248867|589432128|FG002|Open-label Period|Lost to Follow-up|0|||
163195998|NCT05248867|589432129|FG003|Open-label Period|Lost to Follow-up|0|||
162959522|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Investigator decision|0|||
162959523|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Investigator decision|0|||
162959524|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Investigator decision|0|||
163195999|NCT05248867|589432130|FG004|Open-label Period|Lost to Follow-up|5|||
163196000|NCT05248867|589432131|FG005|Open-label Period|Lost to Follow-up|2|||
163196001|NCT05248867|589432126|FG000|Open-label Period|COVID-19 Infection|0|||
163196002|NCT05248867|589432127|FG001|Open-label Period|COVID-19 Infection|0|||
163196003|NCT05248867|589432128|FG002|Open-label Period|COVID-19 Infection|0|||
163196004|NCT05248867|589432129|FG003|Open-label Period|COVID-19 Infection|0|||
163196005|NCT05248867|589432130|FG004|Open-label Period|COVID-19 Infection|1|||
163196006|NCT05248867|589432131|FG005|Open-label Period|COVID-19 Infection|0|||
163196007|NCT05248867|589432126|FG000|Open-label Period|Other, not specified|0|||
163196008|NCT05248867|589432127|FG001|Open-label Period|Other, not specified|0|||
163196009|NCT05248867|589432128|FG002|Open-label Period|Other, not specified|0|||
163196010|NCT05248867|589432129|FG003|Open-label Period|Other, not specified|0|||
163196011|NCT05248867|589432130|FG004|Open-label Period|Other, not specified|4|||
163196012|NCT05248867|589432131|FG005|Open-label Period|Other, not specified|0|||
163196013|NCT03128411|589432133|FG000|Treatment Phase|Adverse Event|21|||
163196014|NCT03128411|589432133|FG000|Treatment Phase|Physician Decision|1|||
163196015|NCT03128411|589432133|FG000|Treatment Phase|Other|2|||
163196016|NCT03128411|589432133|FG000|Long Term Follow-up Phase|Death|2|||
163196017|NCT00345839|589432134|FG000|Overall Study|Withdrawal by Subject|91|||
163196018|NCT00345839|589432135|FG001|Overall Study|Withdrawal by Subject|98|||
163196019|NCT00345839|589432134|FG000|Overall Study|Lost to Follow-up|58|||
163196020|NCT00345839|589432135|FG001|Overall Study|Lost to Follow-up|61|||
163196021|NCT03298867|589432153|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
163196022|NCT03298867|589432154|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
163196023|NCT03298867|589432153|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
163196024|NCT03298867|589432154|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
163196025|NCT03298867|589432153|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
163196026|NCT03298867|589432154|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
163196027|NCT03298867|589432153|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
163196028|NCT03298867|589432154|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
163196029|NCT03298867|589432153|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
163196030|NCT03298867|589432154|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
163196031|NCT03298867|589432153|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
163196032|NCT03298867|589432154|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
163196033|NCT03298867|589432153|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
163196034|NCT03298867|589432154|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
163196035|NCT03298867|589432153|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
163196036|NCT03298867|589432154|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
163196037|NCT03298867|589432153|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
163196038|NCT03298867|589432154|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
163196039|NCT03749447|589434026|FG000|Overall Study|Adverse Event|11|||
163196040|NCT03749447|589434027|FG001|Overall Study|Adverse Event|3|||
163196041|NCT03749447|589434026|FG000|Overall Study|Death|1|||
163196042|NCT03749447|589434027|FG001|Overall Study|Death|1|||
163196043|NCT03749447|589434026|FG000|Overall Study|Lost to Follow-up|2|||
163196044|NCT03749447|589434027|FG001|Overall Study|Lost to Follow-up|2|||
163196045|NCT03749447|589434026|FG000|Overall Study|Reason Not Specified|0|||
163196046|NCT03749447|589434027|FG001|Overall Study|Reason Not Specified|3|||
163196047|NCT03749447|589434026|FG000|Overall Study|Physician Decision|4|||
163196048|NCT03749447|589434027|FG001|Overall Study|Physician Decision|3|||
163196049|NCT03749447|589434026|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
163196050|NCT03749447|589434027|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
163196051|NCT03749447|589434026|FG000|Overall Study|Study Terminated By Sponsor|112|||
163196052|NCT03749447|589434027|FG001|Overall Study|Study Terminated By Sponsor|105|||
163196053|NCT03749447|589434026|FG000|Overall Study|Withdrawal by Subject|12|||
163046366|NCT05464420|588877414|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
163046367|NCT05464420|588877415|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
163046368|NCT05464420|588877416|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
163046369|NCT05464420|588877417|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
163046370|NCT05464420|588877414|FG000|Overall Study|Withdrawal by Subject|4|||
163302163|NCT01968109|589812889|FG013|Overall Study|OTHER REASONS|0|||
163302164|NCT01968109|589812890|FG014|Overall Study|OTHER REASONS|1|||
163302165|NCT01968109|589812891|FG015|Overall Study|OTHER REASONS|1|||
163302166|NCT01968109|589812892|FG016|Overall Study|OTHER REASONS|1|||
163302167|NCT01968109|589812893|FG017|Overall Study|OTHER REASONS|0|||
163302168|NCT01968109|589812894|FG018|Overall Study|OTHER REASONS|0|||
163302169|NCT01968109|589812895|FG019|Overall Study|OTHER REASONS|0|||
163302170|NCT01968109|589812896|FG020|Overall Study|OTHER REASONS|0|||
163302171|NCT01968109|589812897|FG021|Overall Study|OTHER REASONS|2|||
163302172|NCT01968109|589812898|FG022|Overall Study|OTHER REASONS|0|||
163302173|NCT01968109|589812899|FG023|Overall Study|OTHER REASONS|0|||
163302174|NCT01968109|589812900|FG024|Overall Study|OTHER REASONS|3|||
163302175|NCT01968109|589812901|FG025|Overall Study|OTHER REASONS|0|||
163302176|NCT01968109|589812902|FG026|Overall Study|OTHER REASONS|3|||
163302177|NCT01968109|589812903|FG027|Overall Study|OTHER REASONS|3|||
163302178|NCT01968109|589812904|FG028|Overall Study|OTHER REASONS|6|||
163302179|NCT01968109|589812905|FG029|Overall Study|OTHER REASONS|7|||
163302180|NCT01968109|589812906|FG030|Overall Study|OTHER REASONS|3|||
163302181|NCT01968109|589812876|FG000|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302182|NCT01968109|589812877|FG001|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302183|NCT01968109|589812878|FG002|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302184|NCT01968109|589812879|FG003|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302185|NCT01968109|589812880|FG004|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302186|NCT01968109|589812881|FG005|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163046371|NCT05464420|588877415|FG001|Overall Study|Withdrawal by Subject|8|||
163302187|NCT01968109|589812882|FG006|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302188|NCT01968109|589812883|FG007|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302189|NCT01968109|589812884|FG008|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302190|NCT01968109|589812885|FG009|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302191|NCT01968109|589812886|FG010|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302192|NCT01968109|589812887|FG011|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163046372|NCT05464420|588877416|FG002|Overall Study|Withdrawal by Subject|3|||
163302193|NCT01968109|589812888|FG012|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302194|NCT01968109|589812889|FG013|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302195|NCT01968109|589812890|FG014|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302196|NCT01968109|589812891|FG015|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302197|NCT01968109|589812892|FG016|Overall Study|MAXIMUM CLINICAL BENEFIT|5|||
163302198|NCT01968109|589812893|FG017|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
163302199|NCT01968109|589812894|FG018|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302200|NCT01968109|589812895|FG019|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
163302201|NCT01968109|589812896|FG020|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
163302202|NCT01968109|589812897|FG021|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302203|NCT01968109|589812898|FG022|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302204|NCT01968109|589812899|FG023|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302205|NCT01968109|589812900|FG024|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
163302206|NCT01968109|589812901|FG025|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163302207|NCT01968109|589812902|FG026|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
163302208|NCT01968109|589812903|FG027|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
163302209|NCT01968109|589812904|FG028|Overall Study|MAXIMUM CLINICAL BENEFIT|3|||
163302210|NCT01968109|589812905|FG029|Overall Study|MAXIMUM CLINICAL BENEFIT|6|||
163302211|NCT01968109|589812906|FG030|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
163302212|NCT01968109|589812876|FG000|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302213|NCT01968109|589812877|FG001|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302214|NCT01968109|589812878|FG002|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302215|NCT01968109|589812879|FG003|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302216|NCT01968109|589812880|FG004|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302217|NCT01968109|589812881|FG005|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302218|NCT01968109|589812882|FG006|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302219|NCT01968109|589812883|FG007|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302220|NCT01968109|589812884|FG008|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302221|NCT01968109|589812885|FG009|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302222|NCT01968109|589812886|FG010|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302223|NCT01968109|589812887|FG011|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302224|NCT01968109|589812888|FG012|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302225|NCT01968109|589812889|FG013|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302226|NCT01968109|589812890|FG014|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302227|NCT01968109|589812891|FG015|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302228|NCT01968109|589812892|FG016|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302229|NCT01968109|589812893|FG017|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302230|NCT01968109|589812894|FG018|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302231|NCT01968109|589812895|FG019|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302232|NCT01968109|589812896|FG020|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|1|||
163302233|NCT01968109|589812897|FG021|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302234|NCT01968109|589812898|FG022|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302235|NCT01968109|589812899|FG023|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|3|||
163302236|NCT01968109|589812900|FG024|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302237|NCT01968109|589812901|FG025|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302238|NCT01968109|589812902|FG026|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302239|NCT01968109|589812903|FG027|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302240|NCT01968109|589812904|FG028|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302241|NCT01968109|589812905|FG029|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302242|NCT01968109|589812906|FG030|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163302243|NCT01968109|589812876|FG000|Overall Study|Death|0|||
163302244|NCT01968109|589812877|FG001|Overall Study|Death|0|||
163302245|NCT01968109|589812878|FG002|Overall Study|Death|0|||
163302246|NCT01968109|589812879|FG003|Overall Study|Death|0|||
163302247|NCT01968109|589812880|FG004|Overall Study|Death|0|||
163302248|NCT01968109|589812881|FG005|Overall Study|Death|0|||
163302249|NCT01968109|589812882|FG006|Overall Study|Death|0|||
163302250|NCT01968109|589812883|FG007|Overall Study|Death|0|||
163302251|NCT01968109|589812884|FG008|Overall Study|Death|0|||
163302252|NCT01968109|589812885|FG009|Overall Study|Death|0|||
163302253|NCT01968109|589812886|FG010|Overall Study|Death|0|||
163302254|NCT01968109|589812887|FG011|Overall Study|Death|0|||
163302255|NCT01968109|589812888|FG012|Overall Study|Death|0|||
163302256|NCT01968109|589812889|FG013|Overall Study|Death|0|||
163302257|NCT01968109|589812890|FG014|Overall Study|Death|0|||
163302258|NCT01968109|589812891|FG015|Overall Study|Death|0|||
163302259|NCT01968109|589812892|FG016|Overall Study|Death|0|||
163302260|NCT01968109|589812893|FG017|Overall Study|Death|0|||
163302261|NCT01968109|589812894|FG018|Overall Study|Death|0|||
163302262|NCT01968109|589812895|FG019|Overall Study|Death|0|||
163302263|NCT01968109|589812896|FG020|Overall Study|Death|0|||
163302264|NCT01968109|589812897|FG021|Overall Study|Death|1|||
163302265|NCT01968109|589812898|FG022|Overall Study|Death|0|||
163302266|NCT01968109|589812899|FG023|Overall Study|Death|0|||
162959525|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Investigator decision|1|||
162959526|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Lack of time|1|||
162959527|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Lack of time|0|||
162959528|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Lack of time|0|||
162959529|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Lack of time|0|||
162959530|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Lack of time|0|||
162959531|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
163196054|NCT03749447|589434027|FG001|Overall Study|Withdrawal by Subject|6|||
163196055|NCT03749447|589434026|FG000|Overall Study|Non-compliance With Study Drug|0|||
163196056|NCT03749447|589434027|FG001|Overall Study|Non-compliance With Study Drug|1|||
163196057|NCT01673867|589434029|FG000|Randomization|Adverse event unrelated to study drug|1|||
163196058|NCT01673867|589434030|FG001|Randomization|Adverse event unrelated to study drug|0|||
163196059|NCT01673867|589434029|FG000|Randomization|Participant request to discontinue study treatment|0|||
163196060|NCT01673867|589434030|FG001|Randomization|Participant request to discontinue study treatment|4|||
163196061|NCT01673867|589434029|FG000|Randomization|Withdrawal by participant|0|||
163196062|NCT01673867|589434030|FG001|Randomization|Withdrawal by participant|12|||
163196063|NCT01673867|589434029|FG000|Randomization|Lost to Follow-up|0|||
163196064|NCT01673867|589434030|FG001|Randomization|Lost to Follow-up|1|||
163196065|NCT01673867|589434029|FG000|Randomization|Participant no longer meets study criteria|4|||
163196066|NCT01673867|589434030|FG001|Randomization|Participant no longer meets study criteria|5|||
163196067|NCT01673867|589434029|FG000|Treatment|Disease Progression|208|||
163196068|NCT01673867|589434030|FG001|Treatment|Disease Progression|178|||
163196069|NCT01673867|589434029|FG000|Treatment|Study Drug Toxicity|23|||
163196070|NCT01673867|589434030|FG001|Treatment|Study Drug Toxicity|43|||
163196071|NCT01673867|589434029|FG000|Treatment|Death|2|||
163196072|NCT01673867|589434030|FG001|Treatment|Death|3|||
163196073|NCT01673867|589434029|FG000|Treatment|Adverse event unrelated to study drug|23|||
163196074|NCT01673867|589434030|FG001|Treatment|Adverse event unrelated to study drug|10|||
163196075|NCT01673867|589434029|FG000|Treatment|Participant request to discontinue study treatment|7|||
163196076|NCT01673867|589434030|FG001|Treatment|Participant request to discontinue study treatment|17|||
163196077|NCT01673867|589434029|FG000|Treatment|Withdrawal by participant|5|||
163196078|NCT01673867|589434030|FG001|Treatment|Withdrawal by participant|5|||
163196079|NCT01673867|589434029|FG000|Treatment|Maximum clinical benefit|1|||
163196080|NCT01673867|589434030|FG001|Treatment|Maximum clinical benefit|10|||
163196081|NCT01673867|589434029|FG000|Treatment|Participant no longer meets study criteria|2|||
163196082|NCT01673867|589434030|FG001|Treatment|Participant no longer meets study criteria|0|||
163196083|NCT01673867|589434029|FG000|Treatment|Administrative reason by sponsor|3|||
163196084|NCT01673867|589434030|FG001|Treatment|Administrative reason by sponsor|0|||
163196085|NCT01673867|589434029|FG000|Treatment|Other reason|11|||
163196086|NCT01673867|589434030|FG001|Treatment|Other reason|2|||
163196087|NCT02550106|589434031|FG000|Overall Study|Adverse Event|1|||
163196088|NCT02550106|589434031|FG000|Overall Study|Lack of Efficacy|3|||
163196089|NCT02550106|589434031|FG000|Overall Study|Protocol Violation|6|||
163196090|NCT02550106|589434031|FG000|Overall Study|Withdrawal by Subject|2|||
163196091|NCT01709513|589434032|FG000|Overall Study|Randomized but not treated|0|||
163196092|NCT01709513|589434033|FG001|Overall Study|Randomized but not treated|1|||
163196093|NCT01709513|589434034|FG002|Overall Study|Randomized but not treated|0|||
163196094|NCT01709513|589434032|FG000|Overall Study|Adverse Event|16|||
163196095|NCT01709513|589434033|FG001|Overall Study|Adverse Event|31|||
163196096|NCT01709513|589434034|FG002|Overall Study|Adverse Event|23|||
163196097|NCT01709513|589434032|FG000|Overall Study|Poor compliance to protocol|2|||
163196098|NCT01709513|589434033|FG001|Overall Study|Poor compliance to protocol|0|||
163196099|NCT01709513|589434034|FG002|Overall Study|Poor compliance to protocol|0|||
163196100|NCT01709513|589434032|FG000|Overall Study|Other|3|||
163196101|NCT01709513|589434033|FG001|Overall Study|Other|11|||
163196102|NCT01709513|589434034|FG002|Overall Study|Other|7|||
163196103|NCT04218695|589434035|FG000|Overall Study|Adverse Event|1|||
163196104|NCT04218695|589434036|FG001|Overall Study|Adverse Event|0|||
163196105|NCT03166735|589434037|FG000|Overall Study|Not Treated|1|||
163196106|NCT03166735|589434038|FG001|Overall Study|Not Treated|0|||
163196107|NCT03166735|589434039|FG002|Overall Study|Not Treated|0|||
163196108|NCT03166735|589434040|FG003|Overall Study|Not Treated|0|||
163196109|NCT03166735|589434041|FG004|Overall Study|Not Treated|0|||
163196110|NCT03166735|589434037|FG000|Overall Study|follow-up not completed as planned|0|||
163196111|NCT03166735|589434038|FG001|Overall Study|follow-up not completed as planned|1|||
163196112|NCT03166735|589434039|FG002|Overall Study|follow-up not completed as planned|1|||
163196113|NCT03166735|589434040|FG003|Overall Study|follow-up not completed as planned|0|||
163196114|NCT03166735|589434041|FG004|Overall Study|follow-up not completed as planned|1|||
163196115|NCT03166735|589434037|FG000|Overall Study|Withdrawal by Subject|0|||
163196116|NCT03166735|589434038|FG001|Overall Study|Withdrawal by Subject|0|||
163302267|NCT01968109|589812900|FG024|Overall Study|Death|0|||
163302268|NCT01968109|589812901|FG025|Overall Study|Death|0|||
163302269|NCT01968109|589812902|FG026|Overall Study|Death|0|||
162959532|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
163302270|NCT01968109|589812903|FG027|Overall Study|Death|0|||
163302271|NCT01968109|589812904|FG028|Overall Study|Death|0|||
163196117|NCT03166735|589434039|FG002|Overall Study|Withdrawal by Subject|1|||
163196118|NCT03166735|589434040|FG003|Overall Study|Withdrawal by Subject|1|||
163196119|NCT03166735|589434041|FG004|Overall Study|Withdrawal by Subject|2|||
163196120|NCT03166735|589434037|FG000|Overall Study|Lost to Follow-up|0|||
163196121|NCT03166735|589434038|FG001|Overall Study|Lost to Follow-up|2|||
163196122|NCT03166735|589434039|FG002|Overall Study|Lost to Follow-up|1|||
163196123|NCT03166735|589434040|FG003|Overall Study|Lost to Follow-up|0|||
163196124|NCT03166735|589434041|FG004|Overall Study|Lost to Follow-up|1|||
163196125|NCT01543958|589434042|FG000|Overall Study|Loss to follow-up|3|||
163196126|NCT01543958|589434042|FG000|Overall Study|ART initiation|1|||
163196127|NCT00926328|589434043|FG000|Overall Study|Lost to Follow-up|12|||
163196128|NCT00926328|589434044|FG001|Overall Study|Lost to Follow-up|14|||
163196129|NCT00726986|589434045|FG000|Induction Phase|Adverse Event|4|||
163196130|NCT00726986|589434045|FG000|Induction Phase|Withdrawal by Subject|2|||
163196131|NCT00726986|589434045|FG000|Induction Phase|Death|2|||
163196132|NCT00726986|589434045|FG000|Induction Phase|Lack of Efficacy|5|||
163196133|NCT00726986|589434045|FG000|Induction Phase|Secondary Disease|2|||
163196134|NCT00726986|589434045|FG000|Maintenance Phase|Adverse Event|1|||
163196135|NCT00726986|589434045|FG000|Maintenance Phase|Lack of Efficacy|2|||
163196136|NCT01819831|589434048|FG000|Overall Study|Withdrawal by Subject|1|||
163196137|NCT01513343|589434049|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
163196138|NCT01513343|589434050|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
163196139|NCT01513343|589434049|FG000|Post Data Collection|Dropped/withdrew from study|7|||
163196140|NCT01513343|589434050|FG001|Post Data Collection|Dropped/withdrew from study|1|||
163196141|NCT01513343|589434049|FG000|Post Data Collection|Lost to Follow-up|10|||
163196142|NCT01513343|589434050|FG001|Post Data Collection|Lost to Follow-up|23|||
163196143|NCT01513343|589434049|FG000|6-month Follow-up|Lost to Follow-up|28|||
163196144|NCT01513343|589434050|FG001|6-month Follow-up|Lost to Follow-up|17|||
163196145|NCT01513343|589434049|FG000|12-month Follow-up|Lost to Follow-up|10|||
163394866|NCT02142738|590158540|FG000|Overall Study|Death|92|||
163394867|NCT02142738|590158541|FG001|Overall Study|Death|112|||
162959533|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
163196146|NCT01513343|589434050|FG001|12-month Follow-up|Lost to Follow-up|3|||
163196147|NCT00599924|589434051|FG000|Overall Study|Lack of Efficacy|3|||
163196148|NCT00599924|589434052|FG001|Overall Study|Lack of Efficacy|5|||
163196149|NCT00599924|589434053|FG002|Overall Study|Lack of Efficacy|1|||
163196150|NCT00599924|589434054|FG003|Overall Study|Lack of Efficacy|2|||
163046373|NCT05464420|588877417|FG003|Overall Study|Withdrawal by Subject|1|||
163046374|NCT05464420|588877414|FG000|Overall Study|Protocol Violation|0|||
163046375|NCT05464420|588877415|FG001|Overall Study|Protocol Violation|0|||
163046376|NCT05464420|588877416|FG002|Overall Study|Protocol Violation|1|||
163046377|NCT05464420|588877417|FG003|Overall Study|Protocol Violation|1|||
163046378|NCT05464420|588877414|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
162959534|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
162959535|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
162959536|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
162959537|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
162959538|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
162959539|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
162959540|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
162959541|NCT00318461|588553577|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
162959542|NCT00318461|588553578|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
162959543|NCT00318461|588553579|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
163046379|NCT05464420|588877415|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
163046380|NCT05464420|588877416|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
163046381|NCT05464420|588877417|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
163046382|NCT01383018|588877418|FG000|Overall Study|Adverse Event|14|||
163046383|NCT01383018|588877418|FG000|Overall Study|Death|10|||
163046384|NCT01383018|588877418|FG000|Overall Study|Lost to Follow-up|5|||
163046385|NCT01383018|588877418|FG000|Overall Study|Physician Decision|5|||
163046386|NCT01383018|588877418|FG000|Overall Study|Withdrawal by Subject|9|||
163046387|NCT01383018|588877418|FG000|Overall Study|Subject not implanted|76|||
163046388|NCT01383018|588877418|FG000|Overall Study|Missed Visit|247|||
163046389|NCT01383018|588877418|FG000|Overall Study|Site closed early-not compliance related|7|||
163046390|NCT01383018|588877418|FG000|Overall Study|Patient moved away from site|1|||
163046391|NCT01383018|588877418|FG000|Overall Study|Subject Incarcerated|1|||
163046392|NCT01051817|588877419|FG000|Overall Study|Adverse Event|0|||
163046393|NCT01051817|588877420|FG001|Overall Study|Adverse Event|2|||
163196151|NCT00599924|589434055|FG004|Overall Study|Lack of Efficacy|3|||
163196152|NCT00599924|589434056|FG005|Overall Study|Lack of Efficacy|2|||
163196153|NCT00599924|589434057|FG006|Overall Study|Lack of Efficacy|0|||
163196154|NCT00599924|589434051|FG000|Overall Study|Adverse Event|0|||
163196155|NCT00599924|589434052|FG001|Overall Study|Adverse Event|0|||
163196156|NCT00599924|589434053|FG002|Overall Study|Adverse Event|0|||
163196157|NCT00599924|589434054|FG003|Overall Study|Adverse Event|2|||
163196158|NCT00599924|589434055|FG004|Overall Study|Adverse Event|0|||
163196159|NCT00599924|589434056|FG005|Overall Study|Adverse Event|0|||
163196160|NCT00599924|589434057|FG006|Overall Study|Adverse Event|2|||
163196161|NCT00599924|589434051|FG000|Overall Study|Death|0|||
163196162|NCT00599924|589434052|FG001|Overall Study|Death|0|||
163196163|NCT00599924|589434053|FG002|Overall Study|Death|0|||
163196164|NCT00599924|589434054|FG003|Overall Study|Death|2|||
163394868|NCT02142738|590158540|FG000|Overall Study|Lost to Follow-up|0|||
162959544|NCT00318461|588553580|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
162959545|NCT00318461|588553581|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
162959546|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
163046394|NCT01051817|588877419|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
163046395|NCT01051817|588877420|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
163196165|NCT00599924|589434055|FG004|Overall Study|Death|0|||
163196166|NCT00599924|589434056|FG005|Overall Study|Death|2|||
163196167|NCT00599924|589434057|FG006|Overall Study|Death|1|||
163196168|NCT00599924|589434051|FG000|Overall Study|Protocol Violation|0|||
163196169|NCT00599924|589434052|FG001|Overall Study|Protocol Violation|0|||
163046396|NCT01051817|588877419|FG000|Overall Study|Withdrawal by Subject|3|||
163046397|NCT01051817|588877420|FG001|Overall Study|Withdrawal by Subject|5|||
163046398|NCT01051817|588877419|FG000|Overall Study|Protocol Violation|0|||
163046399|NCT01051817|588877420|FG001|Overall Study|Protocol Violation|1|||
163046400|NCT00627926|588877421|FG000|Overall Study|Adverse Event|26|||
163046401|NCT00627926|588877422|FG001|Overall Study|Adverse Event|37|||
163302272|NCT01968109|589812905|FG029|Overall Study|Death|0|||
163302273|NCT01968109|589812906|FG030|Overall Study|Death|1|||
163302274|NCT04310735|589813897|FG000|Overall Study|Withdrawal by Subject|1|||
163302275|NCT04310735|589813898|FG001|Overall Study|Withdrawal by Subject|3|||
163302276|NCT04310735|589813899|FG002|Overall Study|Withdrawal by Subject|8|||
163302277|NCT04310735|589813897|FG000|Overall Study|Equipment malfunction|0|||
163302278|NCT04310735|589813898|FG001|Overall Study|Equipment malfunction|1|||
163302279|NCT04310735|589813899|FG002|Overall Study|Equipment malfunction|0|||
163302280|NCT03012841|589813900|FG000|Overall Study|Protocol Violation|0|||
163302281|NCT03012841|589813901|FG001|Overall Study|Protocol Violation|10|||
163302282|NCT03012841|589813900|FG000|Overall Study|Lost to Follow-up|6|||
163302283|NCT03012841|589813901|FG001|Overall Study|Lost to Follow-up|1|||
163302284|NCT03012841|589813900|FG000|Overall Study|Withdrawal by Subject|6|||
163302285|NCT03012841|589813901|FG001|Overall Study|Withdrawal by Subject|0|||
163302286|NCT03012841|589813900|FG000|Overall Study|Unable to complete 12 month visit|6|||
163302287|NCT03012841|589813901|FG001|Overall Study|Unable to complete 12 month visit|0|||
163302288|NCT03012841|589813900|FG000|Overall Study|Subject relocation|1|||
163302289|NCT03012841|589813901|FG001|Overall Study|Subject relocation|0|||
163302290|NCT03012841|589813900|FG000|Overall Study|Seasonal winter travel|1|||
163302291|NCT03012841|589813901|FG001|Overall Study|Seasonal winter travel|0|||
163302292|NCT03012841|589813900|FG000|Overall Study|Physician Decision|0|||
163302293|NCT03012841|589813901|FG001|Overall Study|Physician Decision|2|||
163302294|NCT03012841|589813900|FG000|Overall Study|No ablation performed|0|||
163302295|NCT03012841|589813901|FG001|Overall Study|No ablation performed|2|||
163302296|NCT03012841|589813900|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
163302297|NCT03012841|589813901|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
163302298|NCT03012841|589813900|FG000|Overall Study|Insurance change|0|||
163302299|NCT03012841|589813901|FG001|Overall Study|Insurance change|1|||
163302300|NCT05696080|589813902|FG000|Overall Study|Lost to Follow-up|2|||
163302301|NCT05696080|589813903|FG001|Overall Study|Lost to Follow-up|1|||
163302302|NCT05696080|589813902|FG000|Overall Study|Physician Decision|1|||
163302303|NCT05696080|589813903|FG001|Overall Study|Physician Decision|0|||
163302304|NCT05696080|589813902|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163302305|NCT05696080|589813903|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
163302306|NCT05696080|589813902|FG000|Overall Study|Withdrawal by Subject|12|||
163302307|NCT05696080|589813903|FG001|Overall Study|Withdrawal by Subject|0|||
163302308|NCT03398200|589813904|FG000|Overall Study|Withdrawal by Subject|0|||
163302309|NCT03398200|589813905|FG001|Overall Study|Withdrawal by Subject|1|||
163302310|NCT04065048|589813906|FG000|Overall Study|Withdrawal by Subject|1|||
163302311|NCT04065048|589813907|FG001|Overall Study|Withdrawal by Subject|2|||
163302312|NCT04065048|589813908|FG002|Overall Study|Withdrawal by Subject|1|||
163302313|NCT04065048|589813909|FG003|Overall Study|Withdrawal by Subject|1|||
163302314|NCT04065048|589813906|FG000|Overall Study|Adverse Event|1|||
163302315|NCT04065048|589813907|FG001|Overall Study|Adverse Event|0|||
163302316|NCT04065048|589813908|FG002|Overall Study|Adverse Event|1|||
163302317|NCT04065048|589813909|FG003|Overall Study|Adverse Event|0|||
163302318|NCT03397108|589813910|FG000|Overall Study|Lost to Follow-up|15|||
163302319|NCT03397108|589813911|FG001|Overall Study|Lost to Follow-up|0|||
163302320|NCT03397108|589813910|FG000|Overall Study|Insufficient milk production|3|||
163302321|NCT03397108|589813911|FG001|Overall Study|Insufficient milk production|2|||
163302322|NCT03397108|589813910|FG000|Overall Study|Withdrawal by Subject|2|||
163302323|NCT03397108|589813911|FG001|Overall Study|Withdrawal by Subject|0|||
163302324|NCT04607044|589813914|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
163302325|NCT04607044|589813914|FG000|Overall Study|Adverse Event|1|||
163302326|NCT04607044|589813914|FG000|Overall Study|Did not receive study device|3|||
163302327|NCT04607044|589813914|FG000|Overall Study|Death|1|||
163302328|NCT05403801|589813915|FG000|Overall Study|Withdrawal by Subject|2|||
163302329|NCT05307783|589813916|FG000|Overall Study|Death|7|||
163302330|NCT05307783|589813916|FG000|Overall Study|Lost to Follow-up|4|||
163302331|NCT04883645|589813917|FG000|Overall Study|Death|1|||
163302332|NCT06194214|589813918|FG000|Overall Study|Adverse Event|1|||
163302333|NCT04847999|589813919|FG000|Overall Study|Lost to Follow-up|0|||
163302334|NCT04847999|589813920|FG001|Overall Study|Lost to Follow-up|1|||
163302335|NCT01704079|589813924|FG000|Overall Study|Withdrawal by Subject|5|||
163046402|NCT00627926|588877423|FG002|Overall Study|Adverse Event|36|||
163046403|NCT00627926|588877421|FG000|Overall Study|Death|1|||
163302336|NCT01704079|589813925|FG001|Overall Study|Withdrawal by Subject|7|||
163302337|NCT01704079|589813924|FG000|Overall Study|Lost to Follow-up|2|||
163302338|NCT01704079|589813925|FG001|Overall Study|Lost to Follow-up|5|||
163302339|NCT01704079|589813924|FG000|Overall Study|Adverse Event|4|||
163302340|NCT01704079|589813925|FG001|Overall Study|Adverse Event|7|||
162959547|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
162959548|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
162959549|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
162959550|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
162959551|NCT00318461|588553577|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
162959552|NCT00318461|588553578|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
162959553|NCT00318461|588553579|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
162959554|NCT00318461|588553580|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
162959555|NCT00318461|588553581|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
162959556|NCT00318461|588553577|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
162959557|NCT00318461|588553578|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
162959558|NCT00318461|588553579|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
162959559|NCT00318461|588553580|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
162959560|NCT00318461|588553581|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
162959561|NCT00318461|588553577|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
163046404|NCT00627926|588877422|FG001|Overall Study|Death|0|||
163046405|NCT00627926|588877423|FG002|Overall Study|Death|0|||
163046406|NCT00627926|588877421|FG000|Overall Study|Lost to Follow-up|4|||
163302341|NCT01704079|589813924|FG000|Overall Study|Protocol Violation|1|||
163302342|NCT01704079|589813925|FG001|Overall Study|Protocol Violation|0|||
163302343|NCT01704079|589813924|FG000|Overall Study|Subject noncompliance|2|||
163302344|NCT01704079|589813925|FG001|Overall Study|Subject noncompliance|3|||
163302345|NCT01704079|589813924|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
163046407|NCT00627926|588877422|FG001|Overall Study|Lost to Follow-up|3|||
163302346|NCT01704079|589813925|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
163302347|NCT04300231|589813926|FG000|Overall Study|Protocol Violation|4|||
163196170|NCT00599924|589434053|FG002|Overall Study|Protocol Violation|0|||
163196171|NCT00599924|589434054|FG003|Overall Study|Protocol Violation|1|||
163196172|NCT00599924|589434055|FG004|Overall Study|Protocol Violation|0|||
163196173|NCT00599924|589434056|FG005|Overall Study|Protocol Violation|0|||
163196174|NCT00599924|589434057|FG006|Overall Study|Protocol Violation|0|||
163196175|NCT00599924|589434051|FG000|Overall Study|Withdrawal by Subject|0|||
163196176|NCT00599924|589434052|FG001|Overall Study|Withdrawal by Subject|0|||
163196177|NCT00599924|589434053|FG002|Overall Study|Withdrawal by Subject|1|||
163196178|NCT00599924|589434054|FG003|Overall Study|Withdrawal by Subject|0|||
163196179|NCT00599924|589434055|FG004|Overall Study|Withdrawal by Subject|1|||
163196180|NCT00599924|589434056|FG005|Overall Study|Withdrawal by Subject|0|||
163196181|NCT00599924|589434057|FG006|Overall Study|Withdrawal by Subject|0|||
163196182|NCT00599924|589434051|FG000|Overall Study|Other|0|||
163196183|NCT00599924|589434052|FG001|Overall Study|Other|0|||
163196184|NCT00599924|589434053|FG002|Overall Study|Other|0|||
163196185|NCT00599924|589434054|FG003|Overall Study|Other|1|||
163196186|NCT00599924|589434055|FG004|Overall Study|Other|2|||
163196187|NCT00599924|589434056|FG005|Overall Study|Other|0|||
163196188|NCT00599924|589434057|FG006|Overall Study|Other|2|||
163196189|NCT02587234|589434058|FG000|Overall Study|Withdrawal by Subject|1|||
163302348|NCT04300231|589813927|FG001|Overall Study|Protocol Violation|3|||
163302349|NCT04300231|589813928|FG002|Overall Study|Protocol Violation|0|||
163046408|NCT00627926|588877423|FG002|Overall Study|Lost to Follow-up|4|||
163196190|NCT02587234|589434059|FG001|Overall Study|Withdrawal by Subject|1|||
163196191|NCT02587234|589434058|FG000|Overall Study|Lost to Follow-up|0|||
163196192|NCT02587234|589434059|FG001|Overall Study|Lost to Follow-up|2|||
163046409|NCT00627926|588877421|FG000|Overall Study|Withdrawal by Subject|2|||
163046410|NCT00627926|588877422|FG001|Overall Study|Withdrawal by Subject|1|||
163196193|NCT02165215|589434060|FG000|Induction Phase|Adverse Event|1|||
163196194|NCT02165215|589434061|FG001|Induction Phase|Adverse Event|0|||
163196195|NCT02165215|589434062|FG002|Induction Phase|Adverse Event|0|||
163196196|NCT02165215|589434060|FG000|Induction Phase|Withdrawal by Subject|10|||
163196197|NCT02165215|589434061|FG001|Induction Phase|Withdrawal by Subject|0|||
163196198|NCT02165215|589434062|FG002|Induction Phase|Withdrawal by Subject|0|||
163196199|NCT02165215|589434060|FG000|Induction Phase|Protocol Violation|1|||
163196200|NCT02165215|589434061|FG001|Induction Phase|Protocol Violation|0|||
163196201|NCT02165215|589434062|FG002|Induction Phase|Protocol Violation|0|||
163196202|NCT02165215|589434060|FG000|Induction Phase|Physician Decision|1|||
163196203|NCT02165215|589434061|FG001|Induction Phase|Physician Decision|0|||
163196204|NCT02165215|589434062|FG002|Induction Phase|Physician Decision|0|||
163196205|NCT02165215|589434060|FG000|Induction Phase|Lack of Efficacy|2|||
163196206|NCT02165215|589434061|FG001|Induction Phase|Lack of Efficacy|0|||
163196207|NCT02165215|589434062|FG002|Induction Phase|Lack of Efficacy|0|||
163196208|NCT02165215|589434060|FG000|Induction Phase|Non-Compliance|2|||
163196209|NCT02165215|589434061|FG001|Induction Phase|Non-Compliance|0|||
163196210|NCT02165215|589434062|FG002|Induction Phase|Non-Compliance|0|||
163196211|NCT02165215|589434060|FG000|Induction Phase|Lost to Follow-up|6|||
163196212|NCT02165215|589434061|FG001|Induction Phase|Lost to Follow-up|0|||
163196213|NCT02165215|589434062|FG002|Induction Phase|Lost to Follow-up|0|||
163196214|NCT02165215|589434060|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163196215|NCT02165215|589434061|FG001|Maintenance Phase|Withdrawal by Subject|7|||
163196216|NCT02165215|589434062|FG002|Maintenance Phase|Withdrawal by Subject|3|||
163196217|NCT02165215|589434060|FG000|Maintenance Phase|Multiple reasons|0|||
163196218|NCT02165215|589434061|FG001|Maintenance Phase|Multiple reasons|2|||
163196219|NCT02165215|589434062|FG002|Maintenance Phase|Multiple reasons|1|||
163196220|NCT02165215|589434060|FG000|Maintenance Phase|Lost to Follow-up|0|||
163196221|NCT02165215|589434061|FG001|Maintenance Phase|Lost to Follow-up|2|||
163196222|NCT02165215|589434062|FG002|Maintenance Phase|Lost to Follow-up|0|||
163196223|NCT02165215|589434060|FG000|Maintenance Phase|Adverse Event|0|||
163196224|NCT02165215|589434061|FG001|Maintenance Phase|Adverse Event|1|||
163196225|NCT02165215|589434062|FG002|Maintenance Phase|Adverse Event|1|||
163302350|NCT04300231|589813929|FG003|Overall Study|Protocol Violation|2|||
163302351|NCT02006758|589813940|FG000|Overall Study|Protocol Violation|1|||
163302352|NCT02006758|589813940|FG000|Overall Study|Death|1|||
163302353|NCT02006758|589813940|FG000|Overall Study|Lost to Follow-up|4|||
163302354|NCT02006758|589813940|FG000|Overall Study|Withdrawal by Subject|4|||
163302355|NCT02006758|589813940|FG000|Overall Study|Procedurally excluded|1|||
163302356|NCT02006758|589813940|FG000|Overall Study|Other|2|||
163302357|NCT00914589|589813941|FG000|Overall Study|Adverse Event|1|||
163302358|NCT00914589|589813942|FG001|Overall Study|Adverse Event|0|||
163302359|NCT00914589|589813943|FG002|Overall Study|Adverse Event|1|||
163302360|NCT00914589|589813941|FG000|Overall Study|Protocol Violation|8|||
163302361|NCT00914589|589813942|FG001|Overall Study|Protocol Violation|6|||
163302362|NCT00914589|589813943|FG002|Overall Study|Protocol Violation|3|||
163302363|NCT00914589|589813941|FG000|Overall Study|unclassified|16|||
163302364|NCT00914589|589813942|FG001|Overall Study|unclassified|9|||
163302365|NCT00914589|589813943|FG002|Overall Study|unclassified|7|||
163302366|NCT00914589|589813941|FG000|Overall Study|Death|0|||
163302367|NCT00914589|589813942|FG001|Overall Study|Death|1|||
163302368|NCT00914589|589813943|FG002|Overall Study|Death|1|||
163302369|NCT02101281|589813945|FG000|Overall Study|Adverse Event|0|||
163302370|NCT02101281|589813946|FG001|Overall Study|Adverse Event|1|||
163302371|NCT05052996|589813947|FG000|Overall Study|Still on study|0|||
163302372|NCT05052996|589813948|FG001|Overall Study|Still on study|0|||
163302373|NCT05052996|589813949|FG002|Overall Study|Still on study|47|||
163302374|NCT05052996|589813950|FG003|Overall Study|Still on study|44|||
163302375|NCT05052996|589813947|FG000|Overall Study|Cohort terminated by sponsor|21|||
163302376|NCT05052996|589813948|FG001|Overall Study|Cohort terminated by sponsor|12|||
163302377|NCT05052996|589813949|FG002|Overall Study|Cohort terminated by sponsor|0|||
163302378|NCT05052996|589813950|FG003|Overall Study|Cohort terminated by sponsor|0|||
163302379|NCT05052996|589813947|FG000|Overall Study|Withdrew consent|1|||
163302380|NCT05052996|589813948|FG001|Overall Study|Withdrew consent|0|||
163302381|NCT05052996|589813949|FG002|Overall Study|Withdrew consent|1|||
163302382|NCT05052996|589813950|FG003|Overall Study|Withdrew consent|2|||
163302383|NCT05052996|589813947|FG000|Overall Study|Lost to Follow-up|1|||
163302384|NCT05052996|589813948|FG001|Overall Study|Lost to Follow-up|0|||
163302385|NCT05052996|589813949|FG002|Overall Study|Lost to Follow-up|0|||
163302386|NCT05052996|589813950|FG003|Overall Study|Lost to Follow-up|2|||
163302387|NCT05052996|589813947|FG000|Overall Study|Adverse Event|0|||
163302388|NCT05052996|589813948|FG001|Overall Study|Adverse Event|0|||
163302389|NCT05052996|589813949|FG002|Overall Study|Adverse Event|2|||
163302390|NCT05052996|589813950|FG003|Overall Study|Adverse Event|0|||
163302391|NCT05052996|589813947|FG000|Overall Study|Randomized but never treated|0|||
163302392|NCT05052996|589813948|FG001|Overall Study|Randomized but never treated|0|||
163302393|NCT05052996|589813949|FG002|Overall Study|Randomized but never treated|1|||
163302394|NCT05052996|589813950|FG003|Overall Study|Randomized but never treated|1|||
163302395|NCT05052996|589813947|FG000|Overall Study|Protocol Violation|1|||
163302396|NCT05052996|589813948|FG001|Overall Study|Protocol Violation|0|||
163302397|NCT05052996|589813949|FG002|Overall Study|Protocol Violation|0|||
163302398|NCT05052996|589813950|FG003|Overall Study|Protocol Violation|0|||
163302399|NCT01695954|589813951|FG000|Overall Study|Withdrawal by Subject|4|||
163302400|NCT01695954|589813952|FG001|Overall Study|Withdrawal by Subject|0|||
163302401|NCT01695954|589813951|FG000|Overall Study|Adverse Event|0|||
163302402|NCT01695954|589813952|FG001|Overall Study|Adverse Event|2|||
163302403|NCT02372253|589813955|FG000|Overall Study|Non Compliance|2|||
163302404|NCT02372253|589813956|FG001|Overall Study|Non Compliance|0|||
163302405|NCT03201562|589813957|FG000|Overall Study|Physician Decision|0|||
163302406|NCT03201562|589813958|FG001|Overall Study|Physician Decision|0|||
163302407|NCT03201562|589813959|FG002|Overall Study|Physician Decision|1|||
163302408|NCT03201562|589813957|FG000|Overall Study|Adverse Event|0|||
163302409|NCT03201562|589813958|FG001|Overall Study|Adverse Event|0|||
163302410|NCT03201562|589813959|FG002|Overall Study|Adverse Event|1|||
163302411|NCT03201562|589813957|FG000|Overall Study|Lost to Follow-up|0|||
162959562|NCT00318461|588553578|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
162959563|NCT00318461|588553579|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
162959564|NCT00318461|588553580|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
163196226|NCT01877265|589434063|FG000|Treatment Period 1|Sponsor Decision|0|||
163196227|NCT01877265|589434064|FG001|Treatment Period 1|Sponsor Decision|0|||
163196228|NCT01877265|589434065|FG002|Treatment Period 1|Sponsor Decision|1|||
163196229|NCT01877265|589434066|FG003|Treatment Period 1|Sponsor Decision|0|||
163196230|NCT01877265|589434067|FG004|Treatment Period 1|Sponsor Decision|0|||
163196231|NCT01877265|589434068|FG005|Treatment Period 1|Sponsor Decision|0|||
163196232|NCT01877265|589434063|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
163196233|NCT01877265|589434064|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
163196234|NCT01877265|589434065|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
163196235|NCT01877265|589434066|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
163196236|NCT01877265|589434067|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
163196237|NCT01877265|589434068|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
163196238|NCT01877265|589434063|FG000|Treatment Period 3|Lost to Follow-up|1|||
163196239|NCT01877265|589434064|FG001|Treatment Period 3|Lost to Follow-up|0|||
163196240|NCT01877265|589434065|FG002|Treatment Period 3|Lost to Follow-up|0|||
163196241|NCT01877265|589434066|FG003|Treatment Period 3|Lost to Follow-up|0|||
163196242|NCT01877265|589434067|FG004|Treatment Period 3|Lost to Follow-up|0|||
163196243|NCT01877265|589434068|FG005|Treatment Period 3|Lost to Follow-up|0|||
163196244|NCT01947582|589434069|FG000|Overall Study|Withdrawal by Subject|1|||
163196245|NCT00592384|589434070|FG000|Overall Study|Withdrawal by Subject|5|||
163196246|NCT00592384|589434071|FG001|Overall Study|Withdrawal by Subject|6|||
163196247|NCT01153347|589434075|FG000|Overall Study|Withdrawal by Subject|7|||
163196248|NCT01153347|589434076|FG001|Overall Study|Withdrawal by Subject|7|||
163394869|NCT02142738|590158541|FG001|Overall Study|Lost to Follow-up|3|||
163394870|NCT02142738|590158540|FG000|Overall Study|Withdrawal by Subject|6|||
163394871|NCT02142738|590158541|FG001|Overall Study|Withdrawal by Subject|7|||
163302412|NCT03201562|589813958|FG001|Overall Study|Lost to Follow-up|1|||
163302413|NCT03201562|589813959|FG002|Overall Study|Lost to Follow-up|2|||
163302414|NCT01803555|589813960|FG000|Overall Study|Adverse Event|3|||
163302415|NCT01803555|589813961|FG001|Overall Study|Adverse Event|2|||
163302416|NCT01803555|589813960|FG000|Overall Study|Withdrawal by Subject|3|||
163302417|NCT01803555|589813961|FG001|Overall Study|Withdrawal by Subject|3|||
163302418|NCT01803555|589813960|FG000|Overall Study|Non-compliance|1|||
163302419|NCT01803555|589813961|FG001|Overall Study|Non-compliance|1|||
163302420|NCT01803555|589813960|FG000|Overall Study|Protocol Violation|3|||
163302421|NCT01803555|589813961|FG001|Overall Study|Protocol Violation|5|||
163302422|NCT01803555|589813960|FG000|Overall Study|Lost to Follow-up|0|||
163302423|NCT01803555|589813961|FG001|Overall Study|Lost to Follow-up|2|||
163302424|NCT01803555|589813960|FG000|Overall Study|Other than specified|3|||
163302425|NCT01803555|589813961|FG001|Overall Study|Other than specified|5|||
163302426|NCT03892564|589813966|FG000|Overall Study|Withdrawal by Subject|2|||
163302427|NCT04019444|589813967|FG000|Overall Study|Withdrawal by Subject|0|||
163302428|NCT04019444|589813968|FG001|Overall Study|Withdrawal by Subject|1|||
163302429|NCT04019444|589813969|FG002|Overall Study|Withdrawal by Subject|0|||
163302430|NCT04019444|589813970|FG003|Overall Study|Withdrawal by Subject|1|||
163302431|NCT04019444|589813967|FG000|Overall Study|Solicited Event|0|||
163302432|NCT04019444|589813968|FG001|Overall Study|Solicited Event|0|||
163302433|NCT04019444|589813969|FG002|Overall Study|Solicited Event|2|||
163302434|NCT04019444|589813970|FG003|Overall Study|Solicited Event|0|||
163302435|NCT01207492|589813971|FG000|Overall Study|Still on study|1|||
163302436|NCT01207492|589813971|FG000|Overall Study|Withdrawal by Subject|9|||
163302437|NCT01207492|589813971|FG000|Overall Study|Physician Decision|1|||
163302438|NCT01207492|589813971|FG000|Overall Study|Progressive disease|3|||
163302439|NCT01207492|589813971|FG000|Overall Study|Toxicity|1|||
163302440|NCT00497198|589813972|FG000|Overall Study|Adverse Event|4|||
163302441|NCT00497198|589813973|FG001|Overall Study|Adverse Event|2|||
163302442|NCT00497198|589813972|FG000|Overall Study|Physician Decision|1|||
163302443|NCT00497198|589813973|FG001|Overall Study|Physician Decision|2|||
163302444|NCT00497198|589813972|FG000|Overall Study|Withdrawal by Subject|0|||
163302445|NCT00497198|589813973|FG001|Overall Study|Withdrawal by Subject|1|||
163302446|NCT00424463|589813974|FG000|Overall Study|Adverse Event|2|||
163302447|NCT00424463|589813975|FG001|Overall Study|Adverse Event|3|||
163302448|NCT00424463|589813976|FG002|Overall Study|Adverse Event|2|||
163302449|NCT00424463|589813974|FG000|Overall Study|Physician Decision|0|||
163302450|NCT00424463|589813975|FG001|Overall Study|Physician Decision|2|||
163302451|NCT00424463|589813976|FG002|Overall Study|Physician Decision|2|||
163302452|NCT00424463|589813974|FG000|Overall Study|Withdrawal by Subject|4|||
163302453|NCT00424463|589813975|FG001|Overall Study|Withdrawal by Subject|2|||
163302454|NCT00424463|589813976|FG002|Overall Study|Withdrawal by Subject|5|||
163302455|NCT00424463|589813974|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
163302456|NCT00424463|589813975|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
163302457|NCT00424463|589813976|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
163302458|NCT00424463|589813974|FG000|Overall Study|Patient's convenience|0|||
163302459|NCT00424463|589813975|FG001|Overall Study|Patient's convenience|0|||
163302460|NCT00424463|589813976|FG002|Overall Study|Patient's convenience|1|||
163302461|NCT03570892|589813978|FG000|Overall Study|Death|51|||
163302462|NCT03570892|589813979|FG001|Overall Study|Death|45|||
163302463|NCT03570892|589813978|FG000|Overall Study|Subject decision|5|||
163302464|NCT03570892|589813979|FG001|Overall Study|Subject decision|3|||
163302465|NCT03570892|589813978|FG000|Overall Study|Protocol Violation|1|||
163302466|NCT03570892|589813979|FG001|Overall Study|Protocol Violation|4|||
163302467|NCT03570892|589813978|FG000|Overall Study|Physician Decision|0|||
163302468|NCT03570892|589813979|FG001|Overall Study|Physician Decision|2|||
163302469|NCT05028582|589813980|FG000|Overall Study|Lost to Follow-up|11|||
163302470|NCT05028582|589813981|FG001|Overall Study|Lost to Follow-up|9|||
163302471|NCT05028582|589813980|FG000|Overall Study|Withdrawal by Subject|9|||
163302472|NCT05028582|589813981|FG001|Overall Study|Withdrawal by Subject|10|||
163302473|NCT05028582|589813980|FG000|Overall Study|Adverse Event|5|||
163302474|NCT05028582|589813981|FG001|Overall Study|Adverse Event|2|||
163302475|NCT05028582|589813980|FG000|Overall Study|Miscellaneous|3|||
163302476|NCT05028582|589813981|FG001|Overall Study|Miscellaneous|2|||
163302477|NCT05028582|589813980|FG000|Overall Study|Lack of Efficacy|3|||
163302478|NCT05028582|589813981|FG001|Overall Study|Lack of Efficacy|1|||
163302479|NCT05028582|589813980|FG000|Overall Study|Physician Decision|0|||
163302480|NCT05028582|589813981|FG001|Overall Study|Physician Decision|1|||
163302481|NCT03899792|589813985|FG000|Phase 2|Ongoing Treatment|0|||
163302482|NCT03899792|589813986|FG001|Phase 2|Ongoing Treatment|13|||
163302483|NCT03899792|589813987|FG002|Phase 2|Ongoing Treatment|14|||
163302484|NCT03899792|589813988|FG003|Phase 2|Ongoing Treatment|2|||
163302485|NCT03899792|589813985|FG000|Phase 2|Death|0|||
163302486|NCT03899792|589813986|FG001|Phase 2|Death|0|||
163302487|NCT03899792|589813987|FG002|Phase 2|Death|0|||
163302488|NCT03899792|589813988|FG003|Phase 2|Death|4|||
163302489|NCT03899792|589813985|FG000|Phase 2|Lost to Follow-up|0|||
163302490|NCT03899792|589813986|FG001|Phase 2|Lost to Follow-up|1|||
163302491|NCT03899792|589813987|FG002|Phase 2|Lost to Follow-up|1|||
163302492|NCT03899792|589813988|FG003|Phase 2|Lost to Follow-up|0|||
163302493|NCT03899792|589813985|FG000|Phase 2|Withdrawal by Subject|0|||
162959565|NCT00318461|588553581|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
162959566|NCT00318461|588553577|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
162959567|NCT00318461|588553578|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
162959568|NCT00318461|588553579|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
163046411|NCT00627926|588877423|FG002|Overall Study|Withdrawal by Subject|0|||
163046412|NCT00627926|588877421|FG000|Overall Study|Lack of Efficacy|118|||
163046413|NCT00627926|588877422|FG001|Overall Study|Lack of Efficacy|40|||
163046414|NCT00627926|588877423|FG002|Overall Study|Lack of Efficacy|38|||
163046415|NCT00627926|588877421|FG000|Overall Study|Noncompliance/unspecified|8|||
163046416|NCT00627926|588877422|FG001|Overall Study|Noncompliance/unspecified|23|||
163046417|NCT00627926|588877423|FG002|Overall Study|Noncompliance/unspecified|17|||
163046418|NCT03414229|588877424|FG000|Overall Study|Adverse Event|1|||
163046419|NCT03414229|588877425|FG001|Overall Study|Adverse Event|0|||
163046420|NCT03414229|588877426|FG002|Overall Study|Adverse Event|2|||
163046421|NCT03414229|588877427|FG003|Overall Study|Adverse Event|1|||
162959569|NCT00318461|588553580|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
162959570|NCT00318461|588553581|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
162959571|NCT00505622|588553582|FG000|Overall Study|Adverse Event|5|||
162959572|NCT00505622|588553583|FG001|Overall Study|Adverse Event|6|||
162959573|NCT00505622|588553584|FG002|Overall Study|Adverse Event|4|||
162959574|NCT00505622|588553582|FG000|Overall Study|Protocol Violation|1|||
162959575|NCT00505622|588553583|FG001|Overall Study|Protocol Violation|1|||
162959576|NCT00505622|588553584|FG002|Overall Study|Protocol Violation|0|||
162959577|NCT00505622|588553582|FG000|Overall Study|Withdrawal by Subject|0|||
162959578|NCT00505622|588553583|FG001|Overall Study|Withdrawal by Subject|3|||
162959579|NCT00505622|588553584|FG002|Overall Study|Withdrawal by Subject|2|||
162959580|NCT00505622|588553582|FG000|Overall Study|Study termination by sponsor|115|||
162959581|NCT00505622|588553583|FG001|Overall Study|Study termination by sponsor|98|||
162959582|NCT00505622|588553584|FG002|Overall Study|Study termination by sponsor|90|||
163046422|NCT03414229|588877424|FG000|Overall Study|Lack of Efficacy|7|||
163046423|NCT03414229|588877425|FG001|Overall Study|Lack of Efficacy|4|||
163046424|NCT03414229|588877426|FG002|Overall Study|Lack of Efficacy|1|||
163302494|NCT03899792|589813986|FG001|Phase 2|Withdrawal by Subject|1|||
163302495|NCT03899792|589813987|FG002|Phase 2|Withdrawal by Subject|0|||
163302496|NCT03899792|589813988|FG003|Phase 2|Withdrawal by Subject|0|||
163302497|NCT00330681|589813989|FG000|Overall Study|Adverse Event|3|||
163302498|NCT00330681|589813990|FG001|Overall Study|Adverse Event|6|||
163302499|NCT00330681|589813989|FG000|Overall Study|Protocol Violation|0|||
163302500|NCT00330681|589813990|FG001|Overall Study|Protocol Violation|1|||
163302501|NCT00330681|589813989|FG000|Overall Study|Withdrawal by Subject|5|||
163394872|NCT02142738|590158540|FG000|Overall Study|Follow up ended by sponsor|43|||
163046425|NCT03414229|588877427|FG003|Overall Study|Lack of Efficacy|9|||
163046426|NCT03414229|588877424|FG000|Overall Study|Change in therapy|1|||
163046427|NCT03414229|588877425|FG001|Overall Study|Change in therapy|0|||
163196249|NCT01153347|589434077|FG002|Overall Study|Withdrawal by Subject|7|||
163196250|NCT01153347|589434078|FG003|Overall Study|Withdrawal by Subject|7|||
163196251|NCT01153347|589434075|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163196252|NCT01153347|589434076|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163196253|NCT01153347|589434077|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
163196254|NCT01153347|589434078|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
163196255|NCT01153347|589434075|FG000|Overall Study|Adverse Event|3|||
163196256|NCT01153347|589434076|FG001|Overall Study|Adverse Event|9|||
163196257|NCT01153347|589434077|FG002|Overall Study|Adverse Event|21|||
163196258|NCT01153347|589434078|FG003|Overall Study|Adverse Event|7|||
163196259|NCT01153347|589434075|FG000|Overall Study|Severe non-compliance to protocol|6|||
163196260|NCT01153347|589434076|FG001|Overall Study|Severe non-compliance to protocol|7|||
163196261|NCT01153347|589434077|FG002|Overall Study|Severe non-compliance to protocol|4|||
163196262|NCT01153347|589434078|FG003|Overall Study|Severe non-compliance to protocol|3|||
163196263|NCT01153347|589434075|FG000|Overall Study|Condition under investigation worsened|1|||
163196264|NCT01153347|589434076|FG001|Overall Study|Condition under investigation worsened|1|||
163196265|NCT01153347|589434077|FG002|Overall Study|Condition under investigation worsened|0|||
163196266|NCT01153347|589434078|FG003|Overall Study|Condition under investigation worsened|0|||
163196267|NCT01153347|589434075|FG000|Overall Study|Lack of Efficacy|2|||
163196268|NCT01153347|589434076|FG001|Overall Study|Lack of Efficacy|2|||
163196269|NCT01153347|589434077|FG002|Overall Study|Lack of Efficacy|0|||
163196270|NCT01153347|589434078|FG003|Overall Study|Lack of Efficacy|4|||
163196271|NCT01153347|589434075|FG000|Overall Study|Study-specific withdrawal criteria|4|||
163196272|NCT01153347|589434076|FG001|Overall Study|Study-specific withdrawal criteria|3|||
163196273|NCT01153347|589434077|FG002|Overall Study|Study-specific withdrawal criteria|1|||
163196274|NCT01153347|589434078|FG003|Overall Study|Study-specific withdrawal criteria|2|||
163196275|NCT01153347|589434075|FG000|Overall Study|Lost to Follow-up|4|||
163196276|NCT01153347|589434076|FG001|Overall Study|Lost to Follow-up|9|||
163196277|NCT01153347|589434077|FG002|Overall Study|Lost to Follow-up|11|||
163196278|NCT01153347|589434078|FG003|Overall Study|Lost to Follow-up|8|||
163196279|NCT01153347|589434075|FG000|Overall Study|Other|5|||
163196280|NCT01153347|589434076|FG001|Overall Study|Other|5|||
163196281|NCT01153347|589434077|FG002|Overall Study|Other|4|||
163196282|NCT01153347|589434078|FG003|Overall Study|Other|0|||
163196283|NCT01153347|589434075|FG000|Overall Study|Death|1|||
163196284|NCT01153347|589434076|FG001|Overall Study|Death|0|||
163196285|NCT01153347|589434077|FG002|Overall Study|Death|0|||
163196286|NCT01153347|589434078|FG003|Overall Study|Death|0|||
163196287|NCT04401423|589434081|FG000|Overall Study|Withdrawal by Subject|3|||
163196288|NCT04401423|589434082|FG001|Overall Study|Withdrawal by Subject|1|||
163196289|NCT04401423|589434081|FG000|Overall Study|Physician Decision|2|||
163196290|NCT04401423|589434082|FG001|Overall Study|Physician Decision|1|||
163196291|NCT00003473|589434083|FG000|Overall Study|Three patients were not evaluable.|3|||
163196292|NCT04678661|589434084|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
163196293|NCT04678661|589434085|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
163196294|NCT04678661|589434084|FG000|Overall Study|Protocol Violation|2|||
163196295|NCT04678661|589434085|FG001|Overall Study|Protocol Violation|0|||
163196296|NCT04678661|589434084|FG000|Overall Study|Withdrawal by Subject|1|||
163196297|NCT04678661|589434085|FG001|Overall Study|Withdrawal by Subject|0|||
163196298|NCT04678661|589434084|FG000|Overall Study|Lost to Follow-up|2|||
163196299|NCT04678661|589434085|FG001|Overall Study|Lost to Follow-up|0|||
163196300|NCT04678661|589434084|FG000|Overall Study|Death|2|||
163196301|NCT04678661|589434085|FG001|Overall Study|Death|0|||
163196302|NCT03039283|589434088|FG000|Overall Study|Protocol Violation|2|||
163196303|NCT01086033|589434089|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
163196304|NCT01086033|589434089|FG000|Overall Study|Lost to Follow-up|86|||
163196305|NCT01086033|589434089|FG000|Overall Study|Adverse Event|42|||
163196306|NCT01086033|589434089|FG000|Overall Study|Withdrawal by Subject|41|||
163196307|NCT01086033|589434089|FG000|Overall Study|Other|14|||
163196308|NCT01086033|589434089|FG000|Overall Study|Other|13|||
163196309|NCT01086033|589434089|FG000|Overall Study|AE and Withdrew Consent|5|||
163196310|NCT01086033|589434089|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
163196311|NCT01086033|589434089|FG000|Overall Study|Withdrew consent and Other Reason|4|||
163196312|NCT01086033|589434089|FG000|Overall Study|AE and Lack of Efficacy|4|||
163196313|NCT01086033|589434089|FG000|Overall Study|Death|1|||
163196314|NCT01086033|589434089|FG000|Overall Study|AE and Lost to Follow-up|1|||
163302502|NCT00330681|589813990|FG001|Overall Study|Withdrawal by Subject|5|||
163196315|NCT01086033|589434089|FG000|Overall Study|AE and Other Reason|1|||
163196316|NCT01086033|589434089|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
163196317|NCT02193867|589434090|FG000|Overall Study|Death|2|||
163046428|NCT03414229|588877426|FG002|Overall Study|Change in therapy|0|||
163046429|NCT03414229|588877427|FG003|Overall Study|Change in therapy|0|||
163196318|NCT02193867|589434090|FG000|Overall Study|Sponsor Study Termination|2|||
162959583|NCT00796653|588553585|FG000|Overall Study|Adverse Event|19|||
162959584|NCT00796653|588553586|FG001|Overall Study|Adverse Event|16|||
162959585|NCT00796653|588553587|FG002|Overall Study|Adverse Event|16|||
162959586|NCT00796653|588553588|FG003|Overall Study|Adverse Event|16|||
162959587|NCT00796653|588553585|FG000|Overall Study|Lost to Follow-up|2|||
162959588|NCT00796653|588553586|FG001|Overall Study|Lost to Follow-up|1|||
162959589|NCT00796653|588553587|FG002|Overall Study|Lost to Follow-up|2|||
162959590|NCT00796653|588553588|FG003|Overall Study|Lost to Follow-up|3|||
162959591|NCT00796653|588553585|FG000|Overall Study|Withdrawal by Subject|16|||
162959592|NCT00796653|588553586|FG001|Overall Study|Withdrawal by Subject|8|||
162959593|NCT00796653|588553587|FG002|Overall Study|Withdrawal by Subject|8|||
162959594|NCT00796653|588553588|FG003|Overall Study|Withdrawal by Subject|13|||
162959595|NCT00796653|588553585|FG000|Overall Study|Lack of Efficacy|8|||
162959596|NCT00796653|588553586|FG001|Overall Study|Lack of Efficacy|1|||
162959597|NCT00796653|588553587|FG002|Overall Study|Lack of Efficacy|3|||
162959598|NCT00796653|588553588|FG003|Overall Study|Lack of Efficacy|2|||
162959599|NCT00796653|588553585|FG000|Overall Study|Non compliance with protocol|2|||
162959600|NCT00796653|588553586|FG001|Overall Study|Non compliance with protocol|2|||
162959601|NCT00796653|588553587|FG002|Overall Study|Non compliance with protocol|0|||
162959602|NCT00796653|588553588|FG003|Overall Study|Non compliance with protocol|2|||
162959603|NCT00796653|588553585|FG000|Overall Study|Other reason not described above|4|||
162959604|NCT00796653|588553586|FG001|Overall Study|Other reason not described above|9|||
162959605|NCT00796653|588553587|FG002|Overall Study|Other reason not described above|7|||
162959606|NCT00796653|588553588|FG003|Overall Study|Other reason not described above|4|||
162959607|NCT00835692|588553590|FG000|First Intervention|Withdrawal by Subject|1|||
162959608|NCT00835692|588553591|FG001|First Intervention|Withdrawal by Subject|0|||
162959609|NCT03644550|588553592|FG000|Overall Study|Withdrawal by Subject|3|||
162959610|NCT03644550|588553592|FG000|Overall Study|Progressive disease|15|||
162959611|NCT01218867|588553593|FG000|Overall Study|Death during treatment|0|||
162959612|NCT01218867|588553594|FG001|Overall Study|Death during treatment|0|||
162959613|NCT01218867|588553595|FG002|Overall Study|Death during treatment|0|||
162959614|NCT01218867|588553596|FG003|Overall Study|Death during treatment|0|||
162959615|NCT01218867|588553597|FG004|Overall Study|Death during treatment|0|||
162959616|NCT01218867|588553598|FG005|Overall Study|Death during treatment|0|||
162959617|NCT01218867|588553599|FG006|Overall Study|Death during treatment|1|||
162959618|NCT01218867|588553600|FG007|Overall Study|Death during treatment|0|||
162959619|NCT01218867|588553601|FG008|Overall Study|Death during treatment|0|||
162959620|NCT01218867|588553602|FG009|Overall Study|Death during treatment|0|||
162959621|NCT01218867|588553603|FG010|Overall Study|Death during treatment|0|||
162959622|NCT04970810|588554723|FG000|Overall Study|deemed ineligible after randomization|3|||
162959623|NCT04970810|588554724|FG001|Overall Study|deemed ineligible after randomization|0|||
162959624|NCT04970810|588554725|FG002|Overall Study|deemed ineligible after randomization|4|||
162959625|NCT01056484|588554730|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
162959626|NCT01056484|588554731|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
162959627|NCT01056484|588554730|FG000|Randomized Controlled Trial|Physician Decision|1|||
162959628|NCT01056484|588554731|FG001|Randomized Controlled Trial|Physician Decision|0|||
162959629|NCT01056484|588554730|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
162959630|NCT01056484|588554731|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
162959631|NCT01492439|588554734|FG000|Overall Study|Withdrew from RTE|4|||
162959632|NCT01492439|588554735|FG001|Overall Study|Withdrew from RTE|9|||
162959633|NCT00716625|588554736|FG000|Overall Study|Safety was not Assessable|1|||
162959634|NCT04349267|588554737|FG000|Overall Study|Adverse Event|0|||
162959635|NCT04349267|588554738|FG001|Overall Study|Adverse Event|0|||
162959636|NCT04349267|588554739|FG002|Overall Study|Adverse Event|0|||
162959637|NCT04349267|588554740|FG003|Overall Study|Adverse Event|0|||
162959638|NCT04349267|588554741|FG004|Overall Study|Adverse Event|0|||
162959639|NCT04349267|588554742|FG005|Overall Study|Adverse Event|1|||
162959640|NCT04349267|588554743|FG006|Overall Study|Adverse Event|0|||
162959641|NCT04349267|588554737|FG000|Overall Study|Other reason|0|||
162959642|NCT04349267|588554738|FG001|Overall Study|Other reason|1|||
162959643|NCT04349267|588554739|FG002|Overall Study|Other reason|0|||
162959644|NCT04349267|588554740|FG003|Overall Study|Other reason|0|||
163046430|NCT03414229|588877424|FG000|Overall Study|Pregnancy|0|||
163046431|NCT03414229|588877425|FG001|Overall Study|Pregnancy|0|||
163046432|NCT03414229|588877426|FG002|Overall Study|Pregnancy|1|||
163046433|NCT03414229|588877427|FG003|Overall Study|Pregnancy|0|||
163046434|NCT03414229|588877424|FG000|Overall Study|Withdrawal by Subject|0|||
163046435|NCT03414229|588877425|FG001|Overall Study|Withdrawal by Subject|1|||
163046436|NCT03414229|588877426|FG002|Overall Study|Withdrawal by Subject|1|||
163046437|NCT03414229|588877427|FG003|Overall Study|Withdrawal by Subject|0|||
163046438|NCT02797678|588877449|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
163046439|NCT02797678|588877450|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
163046440|NCT02797678|588877451|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
163302503|NCT00330681|589813989|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
163302504|NCT00330681|589813990|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
163302505|NCT03954184|589815461|FG000|Overall Study|Lost to Follow-up|500|||
163302506|NCT03954184|589815462|FG001|Overall Study|Lost to Follow-up|0|||
163302507|NCT03460236|589815464|FG000|Overall Study|failed radiographic screening|16|||
163302508|NCT03460236|589815464|FG000|Overall Study|Withdrawal by Subject|11|||
163302509|NCT04869982|589815465|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
163302510|NCT04869982|589815466|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
163302511|NCT04869982|589815465|FG000|Overall Study|Migrated / moved from the study area|1|||
163302512|NCT04869982|589815466|FG001|Overall Study|Migrated / moved from the study area|1|||
163302513|NCT04869982|589815465|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
163302514|NCT04869982|589815466|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
163302515|NCT04869982|589815465|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
163302516|NCT04869982|589815466|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
163302517|NCT04869982|589815465|FG000|Overall Study|Solicited adverse event|2|||
163302518|NCT04869982|589815466|FG001|Overall Study|Solicited adverse event|1|||
163302519|NCT04608045|589815467|FG000|Overall Study|Physician Decision|1|||
163302520|NCT02473250|589815469|FG000|Overall Study|Lost to Follow-up|10|||
163302521|NCT02473250|589815469|FG000|Overall Study|Physician Decision|5|||
163302522|NCT02473250|589815469|FG000|Overall Study|Did not tolerate medication washout|3|||
163302523|NCT02473250|589815469|FG000|Overall Study|Antidepressant effect of divalproex|2|||
163302524|NCT05215847|589815470|FG000|Overall Study|Lost to Follow-up|1|||
163302525|NCT06023082|589815481|FG000|Overall Study|Withdrawal by Subject|2|||
163302526|NCT06023082|589815481|FG000|Overall Study|Lost to Follow-up|15|||
163302527|NCT06023082|589815481|FG000|Overall Study|Side effects|5|||
163302528|NCT05986565|589815482|FG000|Overall Study|Lost to Follow-up|8|||
163302529|NCT05986565|589815483|FG001|Overall Study|Lost to Follow-up|3|||
163302530|NCT05986565|589815482|FG000|Overall Study|Withdrawal by Subject|0|||
163302531|NCT05986565|589815483|FG001|Overall Study|Withdrawal by Subject|1|||
163302532|NCT00670046|589815484|FG000|Overall Study|Lost to Follow-up|1|||
163302533|NCT00670046|589815485|FG001|Overall Study|Lost to Follow-up|1|||
163302534|NCT00670046|589815484|FG000|Overall Study|Withdrawal by Subject|0|||
163302535|NCT00670046|589815485|FG001|Overall Study|Withdrawal by Subject|1|||
163302536|NCT02058108|589815490|FG000|Overall Study|Abnormal Laboratory Values|0|||
163302537|NCT02058108|589815491|FG001|Overall Study|Abnormal Laboratory Values|1|||
163302538|NCT02058108|589815490|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
163302539|NCT02058108|589815491|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
163302540|NCT02058108|589815490|FG000|Overall Study|No longer requires study drug|0|||
163302541|NCT02058108|589815491|FG001|Overall Study|No longer requires study drug|1|||
163302542|NCT02058108|589815490|FG000|Overall Study|Withdrawal by Subject|1|||
163302543|NCT02058108|589815491|FG001|Overall Study|Withdrawal by Subject|0|||
163302544|NCT02058108|589815490|FG000|Overall Study|Administrative problems|3|||
163302545|NCT02058108|589815491|FG001|Overall Study|Administrative problems|3|||
163302546|NCT02058108|589815490|FG000|Overall Study|Protocol Violation|0|||
163302547|NCT02058108|589815491|FG001|Overall Study|Protocol Violation|1|||
163302548|NCT01376700|589815495|FG000|Overall Study|Sponsor terminated study early|8|||
163302549|NCT01376700|589815495|FG000|Overall Study|Low or high titer inhibitor|8|||
163302550|NCT00727909|589815496|FG000|Overall Study|Withdrawal by Subject|5|||
163302551|NCT00727909|589815497|FG001|Overall Study|Withdrawal by Subject|11|||
163302552|NCT00727909|589815498|FG002|Overall Study|Withdrawal by Subject|8|||
163302553|NCT00727909|589815499|FG003|Overall Study|Withdrawal by Subject|5|||
163394873|NCT02142738|590158541|FG001|Overall Study|Follow up ended by sponsor|20|||
163046441|NCT02797678|588877452|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
163046442|NCT02797678|588877449|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
163046443|NCT02797678|588877450|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
163046444|NCT02797678|588877451|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
163302554|NCT00727909|589815496|FG000|Overall Study|Death|0|||
163302555|NCT00727909|589815497|FG001|Overall Study|Death|0|||
163302556|NCT00727909|589815498|FG002|Overall Study|Death|1|||
163302557|NCT00727909|589815499|FG003|Overall Study|Death|0|||
163302558|NCT01696773|589815500|FG000|Days 15-27, Washout|Adverse Event|1|||
163302559|NCT01696773|589815501|FG001|Days 15-27, Washout|Adverse Event|0|||
163046445|NCT02797678|588877452|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
163046446|NCT02797678|588877449|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
163046447|NCT02797678|588877450|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
163046448|NCT02797678|588877451|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
163046449|NCT02797678|588877452|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
163046450|NCT00656175|588877458|FG000|Overall Study|Adverse Event|1|||
163046451|NCT00656175|588877459|FG001|Overall Study|Adverse Event|0|||
163046452|NCT00656175|588877458|FG000|Overall Study|Transportation issues|0|||
163046453|NCT00656175|588877459|FG001|Overall Study|Transportation issues|1|||
163046454|NCT02149264|588877465|FG000|Overall Study|Withdrawal by Subject|9|||
163046455|NCT02149264|588877465|FG000|Overall Study|Adverse Event|7|||
163046456|NCT02149264|588877465|FG000|Overall Study|Physician Decision|3|||
163046457|NCT02149264|588877465|FG000|Overall Study|Protocol Violation|1|||
163046458|NCT01938846|588877469|FG000|Overall Study|Progressive disease|26|||
163046459|NCT01938846|588877470|FG001|Overall Study|Progressive disease|18|||
163046460|NCT01938846|588877471|FG002|Overall Study|Progressive disease|16|||
163046461|NCT01938846|588877469|FG000|Overall Study|Adverse Event|8|||
163046462|NCT01938846|588877470|FG001|Overall Study|Adverse Event|4|||
163046463|NCT01938846|588877471|FG002|Overall Study|Adverse Event|3|||
163046464|NCT01938846|588877469|FG000|Overall Study|Withdrawal by Subject|2|||
163046465|NCT01938846|588877470|FG001|Overall Study|Withdrawal by Subject|2|||
163046466|NCT01938846|588877471|FG002|Overall Study|Withdrawal by Subject|1|||
163046467|NCT01938846|588877469|FG000|Overall Study|Other than listed|5|||
163046468|NCT01938846|588877470|FG001|Overall Study|Other than listed|1|||
163046469|NCT01938846|588877471|FG002|Overall Study|Other than listed|4|||
163046470|NCT02499120|588877475|FG000|Overall Study|Death|52|||
163046471|NCT02499120|588877476|FG001|Overall Study|Death|43|||
163046472|NCT02499120|588877475|FG000|Overall Study|Lost to Follow-up|1|||
163046473|NCT02499120|588877476|FG001|Overall Study|Lost to Follow-up|2|||
163046474|NCT02499120|588877475|FG000|Overall Study|Participant refused further follow-up|1|||
163046475|NCT02499120|588877476|FG001|Overall Study|Participant refused further follow-up|0|||
163046476|NCT02499120|588877475|FG000|Overall Study|Withdrawal by Subject|2|||
163046477|NCT02499120|588877476|FG001|Overall Study|Withdrawal by Subject|5|||
163046478|NCT02499120|588877475|FG000|Overall Study|Other|9|||
163046479|NCT02499120|588877476|FG001|Overall Study|Other|10|||
163046480|NCT02282163|588877477|FG000|Overall Study|Protocol Violation|1|||
163046481|NCT01839916|588877478|FG000|Overall Study|Death|9|||
163046482|NCT01839916|588877478|FG000|Overall Study|Physician Decision|17|||
163046483|NCT01839916|588877478|FG000|Overall Study|Relapse|12|||
163046484|NCT01839916|588877478|FG000|Overall Study|GVHD|2|||
163046485|NCT01839916|588877478|FG000|Overall Study|Graft Failure|1|||
163046486|NCT01325350|588879272|FG000|Overall Study|Adverse Event|3|||
163046487|NCT01325350|588879273|FG001|Overall Study|Adverse Event|3|||
163046488|NCT01325350|588879274|FG002|Overall Study|Adverse Event|3|||
163046489|NCT01325350|588879275|FG003|Overall Study|Adverse Event|1|||
163046490|NCT01325350|588879276|FG004|Overall Study|Adverse Event|2|||
163046491|NCT01325350|588879272|FG000|Overall Study|Pregnancy|0|||
163046492|NCT01325350|588879273|FG001|Overall Study|Pregnancy|0|||
163046493|NCT01325350|588879274|FG002|Overall Study|Pregnancy|1|||
163046494|NCT01325350|588879275|FG003|Overall Study|Pregnancy|0|||
163046495|NCT01325350|588879276|FG004|Overall Study|Pregnancy|1|||
163046496|NCT01325350|588879272|FG000|Overall Study|Lost to Follow-up|1|||
163046497|NCT01325350|588879273|FG001|Overall Study|Lost to Follow-up|0|||
163046498|NCT01325350|588879274|FG002|Overall Study|Lost to Follow-up|5|||
163046499|NCT01325350|588879275|FG003|Overall Study|Lost to Follow-up|1|||
163046500|NCT01325350|588879276|FG004|Overall Study|Lost to Follow-up|5|||
163046501|NCT01325350|588879272|FG000|Overall Study|Personal Reasons|2|||
163046502|NCT01325350|588879273|FG001|Overall Study|Personal Reasons|1|||
163046503|NCT01325350|588879274|FG002|Overall Study|Personal Reasons|6|||
163046504|NCT01325350|588879275|FG003|Overall Study|Personal Reasons|5|||
163046505|NCT01325350|588879276|FG004|Overall Study|Personal Reasons|3|||
163046506|NCT01325350|588879272|FG000|Overall Study|Protocol Violation|0|||
163046507|NCT01325350|588879273|FG001|Overall Study|Protocol Violation|0|||
163046508|NCT01325350|588879274|FG002|Overall Study|Protocol Violation|0|||
163046509|NCT01325350|588879275|FG003|Overall Study|Protocol Violation|1|||
163046510|NCT01325350|588879276|FG004|Overall Study|Protocol Violation|0|||
163046511|NCT01325350|588879272|FG000|Overall Study|Withdrawal by Subject|0|||
163046512|NCT01325350|588879273|FG001|Overall Study|Withdrawal by Subject|0|||
163046513|NCT01325350|588879274|FG002|Overall Study|Withdrawal by Subject|1|||
163046514|NCT01325350|588879275|FG003|Overall Study|Withdrawal by Subject|1|||
163046515|NCT01325350|588879276|FG004|Overall Study|Withdrawal by Subject|0|||
163046516|NCT01325350|588879272|FG000|Overall Study|Did Not Receive Treatment|0|||
163046517|NCT01325350|588879273|FG001|Overall Study|Did Not Receive Treatment|1|||
163046518|NCT01325350|588879274|FG002|Overall Study|Did Not Receive Treatment|1|||
163046519|NCT01325350|588879275|FG003|Overall Study|Did Not Receive Treatment|0|||
163046520|NCT01325350|588879276|FG004|Overall Study|Did Not Receive Treatment|1|||
163046521|NCT02692586|588879277|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
163046522|NCT02692586|588879277|FG000|Overall Study|Received adjunctive thrombolytics|2|||
163046523|NCT01396083|588879281|FG000|Overall Study|Adverse Event|2|||
163046524|NCT01396083|588879282|FG001|Overall Study|Adverse Event|28|||
163046525|NCT01396083|588879281|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163046526|NCT01396083|588879282|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
163046527|NCT01396083|588879281|FG000|Overall Study|Consent withdrawn|4|||
163046528|NCT01396083|588879282|FG001|Overall Study|Consent withdrawn|5|||
163046529|NCT01396083|588879281|FG000|Overall Study|Protocol deviation(s)|0|||
163046530|NCT01396083|588879282|FG001|Overall Study|Protocol deviation(s)|1|||
163046531|NCT01396083|588879281|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163046532|NCT01396083|588879282|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163046533|NCT01396083|588879281|FG000|Overall Study|Administrative problems|1|||
163046534|NCT01396083|588879282|FG001|Overall Study|Administrative problems|0|||
163046535|NCT01396083|588879281|FG000|Overall Study|Lost to Follow-up|1|||
163046536|NCT01396083|588879282|FG001|Overall Study|Lost to Follow-up|0|||
163046537|NCT01063855|588879283|FG000|Overall Study|Adverse Event|4|||
163046538|NCT01063855|588879284|FG001|Overall Study|Adverse Event|4|||
163046539|NCT01063855|588879283|FG000|Overall Study|Death|0|||
163046540|NCT01063855|588879284|FG001|Overall Study|Death|1|||
163046541|NCT01063855|588879283|FG000|Overall Study|Lost to Follow-up|8|||
163046542|NCT01063855|588879284|FG001|Overall Study|Lost to Follow-up|4|||
163046543|NCT01063855|588879283|FG000|Overall Study|Pregnancy|1|||
163046544|NCT01063855|588879284|FG001|Overall Study|Pregnancy|0|||
163046545|NCT01063855|588879283|FG000|Overall Study|Lack of Efficacy|0|||
163046546|NCT01063855|588879284|FG001|Overall Study|Lack of Efficacy|1|||
163046547|NCT01063855|588879283|FG000|Overall Study|Withdrawal by Subject|11|||
163046548|NCT01063855|588879284|FG001|Overall Study|Withdrawal by Subject|8|||
163046549|NCT01063855|588879283|FG000|Overall Study|Reason not specified|13|||
163046550|NCT01063855|588879284|FG001|Overall Study|Reason not specified|11|||
163046551|NCT01165307|588879286|FG000|Overall Study|Lost to Follow-up|11|||
163046552|NCT01165307|588879287|FG001|Overall Study|Lost to Follow-up|3|||
163046553|NCT01165307|588879286|FG000|Overall Study|Withdrawal by Subject|2|||
163046554|NCT01165307|588879287|FG001|Overall Study|Withdrawal by Subject|0|||
163046555|NCT01165307|588879286|FG000|Overall Study|Subject not available for contact|1|||
163046556|NCT01165307|588879287|FG001|Overall Study|Subject not available for contact|0|||
163046557|NCT03234036|588879288|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
163046558|NCT03234036|588879289|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
163046559|NCT03234036|588879290|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
163046560|NCT03234036|588879291|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
163046561|NCT02683239|588879311|FG000|Overall Study|Protocol Violation|35|||
163046562|NCT02683239|588879312|FG001|Overall Study|Protocol Violation|23|||
163046563|NCT02683239|588879313|FG002|Overall Study|Protocol Violation|26|||
163046564|NCT02683239|588879314|FG003|Overall Study|Protocol Violation|4|||
163046565|NCT02683239|588879315|FG004|Overall Study|Protocol Violation|35|||
163046566|NCT02683239|588879316|FG005|Overall Study|Protocol Violation|4|||
163046567|NCT02683239|588879317|FG006|Overall Study|Protocol Violation|5|||
163046568|NCT02683239|588879311|FG000|Overall Study|Adverse Event|64|||
163046569|NCT02683239|588879312|FG001|Overall Study|Adverse Event|39|||
163046570|NCT02683239|588879313|FG002|Overall Study|Adverse Event|42|||
163046571|NCT02683239|588879314|FG003|Overall Study|Adverse Event|16|||
163046572|NCT02683239|588879315|FG004|Overall Study|Adverse Event|189|||
163046573|NCT02683239|588879316|FG005|Overall Study|Adverse Event|9|||
163046574|NCT02683239|588879317|FG006|Overall Study|Adverse Event|9|||
163046575|NCT02683239|588879311|FG000|Overall Study|Physician Decision|38|||
163046576|NCT02683239|588879312|FG001|Overall Study|Physician Decision|19|||
163046577|NCT02683239|588879313|FG002|Overall Study|Physician Decision|14|||
163046578|NCT02683239|588879314|FG003|Overall Study|Physician Decision|73|||
163046579|NCT02683239|588879315|FG004|Overall Study|Physician Decision|143|||
163046580|NCT02683239|588879316|FG005|Overall Study|Physician Decision|14|||
163046581|NCT02683239|588879317|FG006|Overall Study|Physician Decision|15|||
163046582|NCT02683239|588879311|FG000|Overall Study|Withdrawal by Subject|187|||
163046583|NCT02683239|588879312|FG001|Overall Study|Withdrawal by Subject|99|||
163046584|NCT02683239|588879313|FG002|Overall Study|Withdrawal by Subject|91|||
163046585|NCT02683239|588879314|FG003|Overall Study|Withdrawal by Subject|18|||
163046586|NCT02683239|588879315|FG004|Overall Study|Withdrawal by Subject|248|||
163046587|NCT02683239|588879316|FG005|Overall Study|Withdrawal by Subject|22|||
162959645|NCT04349267|588554741|FG004|Overall Study|Other reason|1|||
162959646|NCT04349267|588554742|FG005|Overall Study|Other reason|1|||
162959647|NCT04349267|588554743|FG006|Overall Study|Other reason|1|||
162959648|NCT04349267|588554737|FG000|Overall Study|Disease Progression|2|||
162959649|NCT04349267|588554738|FG001|Overall Study|Disease Progression|0|||
162959650|NCT04349267|588554739|FG002|Overall Study|Disease Progression|2|||
162959651|NCT04349267|588554740|FG003|Overall Study|Disease Progression|3|||
162959652|NCT04349267|588554741|FG004|Overall Study|Disease Progression|3|||
162959653|NCT04349267|588554742|FG005|Overall Study|Disease Progression|7|||
162959654|NCT04349267|588554743|FG006|Overall Study|Disease Progression|10|||
162959655|NCT04349267|588554737|FG000|Overall Study|Participant withdrew consent|0|||
162959656|NCT04349267|588554738|FG001|Overall Study|Participant withdrew consent|1|||
162959657|NCT04349267|588554739|FG002|Overall Study|Participant withdrew consent|0|||
162959658|NCT04349267|588554740|FG003|Overall Study|Participant withdrew consent|0|||
162959659|NCT04349267|588554741|FG004|Overall Study|Participant withdrew consent|0|||
162959660|NCT04349267|588554742|FG005|Overall Study|Participant withdrew consent|0|||
162959661|NCT04349267|588554743|FG006|Overall Study|Participant withdrew consent|1|||
162959662|NCT04618211|588554744|FG000|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
162959663|NCT04618211|588554745|FG001|Part I (Non-Attack, Safety)|Withdrawal by Subject|1|||
162959664|NCT04618211|588554746|FG002|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
162959665|NCT04618211|588554744|FG000|Part II (Self-administration, Efficacy)|Withdrawal by Subject|2|||
162959666|NCT04618211|588554745|FG001|Part II (Self-administration, Efficacy)|Withdrawal by Subject|3|||
162959667|NCT04618211|588554746|FG002|Part II (Self-administration, Efficacy)|Withdrawal by Subject|5|||
162959668|NCT04618211|588554744|FG000|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|6|||
162959669|NCT04618211|588554745|FG001|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|9|||
162959670|NCT04618211|588554746|FG002|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|8|||
162959671|NCT01244620|588554749|FG000|Overall Study|Study terminated|4|||
162959672|NCT01244620|588554750|FG001|Overall Study|Study terminated|4|||
162959673|NCT01244620|588554751|FG002|Overall Study|Study terminated|4|||
162959674|NCT01244620|588554752|FG003|Overall Study|Study terminated|4|||
162959675|NCT00466167|588554753|FG000|Overall Study|Adverse Event|8|||
162959676|NCT00466167|588554754|FG001|Overall Study|Adverse Event|8|||
162959677|NCT00466167|588554755|FG002|Overall Study|Adverse Event|7|||
162959678|NCT00466167|588554753|FG000|Overall Study|Lack of Efficacy|2|||
162959679|NCT00466167|588554754|FG001|Overall Study|Lack of Efficacy|0|||
162959680|NCT00466167|588554755|FG002|Overall Study|Lack of Efficacy|3|||
162959681|NCT00466167|588554753|FG000|Overall Study|Protocol Violation|1|||
162959682|NCT00466167|588554754|FG001|Overall Study|Protocol Violation|1|||
162959683|NCT00466167|588554755|FG002|Overall Study|Protocol Violation|2|||
162959684|NCT00466167|588554753|FG000|Overall Study|Lost to Follow-up|3|||
162959685|NCT00466167|588554754|FG001|Overall Study|Lost to Follow-up|2|||
162959686|NCT00466167|588554755|FG002|Overall Study|Lost to Follow-up|2|||
162959687|NCT00466167|588554753|FG000|Overall Study|Withdrawal by Subject|4|||
162959688|NCT00466167|588554754|FG001|Overall Study|Withdrawal by Subject|1|||
162959689|NCT00466167|588554755|FG002|Overall Study|Withdrawal by Subject|6|||
162959690|NCT00466167|588554753|FG000|Overall Study|patient did not meet inclusion criteria|1|||
162959691|NCT00466167|588554754|FG001|Overall Study|patient did not meet inclusion criteria|0|||
162959692|NCT00466167|588554755|FG002|Overall Study|patient did not meet inclusion criteria|1|||
162959693|NCT00466167|588554753|FG000|Overall Study|Not treated|1|||
162959694|NCT00466167|588554754|FG001|Overall Study|Not treated|0|||
162959695|NCT00466167|588554755|FG002|Overall Study|Not treated|0|||
162959696|NCT03930732|588554756|FG000|Overall Study|Adverse Event|9|||
162959697|NCT03930732|588554757|FG001|Overall Study|Adverse Event|7|||
162959698|NCT03930732|588554756|FG000|Overall Study|Poor compliance to protocol|0|||
163046588|NCT02683239|588879317|FG006|Overall Study|Withdrawal by Subject|28|||
163046589|NCT02683239|588879311|FG000|Overall Study|Lost to Follow-up|77|||
163046590|NCT02683239|588879312|FG001|Overall Study|Lost to Follow-up|24|||
163046591|NCT02683239|588879313|FG002|Overall Study|Lost to Follow-up|25|||
163046592|NCT02683239|588879314|FG003|Overall Study|Lost to Follow-up|7|||
163046593|NCT02683239|588879315|FG004|Overall Study|Lost to Follow-up|88|||
163046594|NCT02683239|588879316|FG005|Overall Study|Lost to Follow-up|8|||
163046595|NCT02683239|588879317|FG006|Overall Study|Lost to Follow-up|11|||
163046596|NCT02683239|588879311|FG000|Overall Study|Death|9|||
163046597|NCT02683239|588879312|FG001|Overall Study|Death|5|||
163046598|NCT02683239|588879313|FG002|Overall Study|Death|8|||
163046599|NCT02683239|588879314|FG003|Overall Study|Death|0|||
163046600|NCT02683239|588879315|FG004|Overall Study|Death|12|||
163046601|NCT02683239|588879316|FG005|Overall Study|Death|1|||
163046602|NCT02683239|588879317|FG006|Overall Study|Death|0|||
163046603|NCT02683239|588879311|FG000|Overall Study|Lack of Efficacy|50|||
163046604|NCT02683239|588879312|FG001|Overall Study|Lack of Efficacy|23|||
163046605|NCT02683239|588879313|FG002|Overall Study|Lack of Efficacy|12|||
163394874|NCT02615470|590158542|FG000|Overall Study|Lost to Follow-up|21|||
163046606|NCT02683239|588879314|FG003|Overall Study|Lack of Efficacy|2|||
163046607|NCT02683239|588879315|FG004|Overall Study|Lack of Efficacy|29|||
163046608|NCT02683239|588879316|FG005|Overall Study|Lack of Efficacy|2|||
163046609|NCT02683239|588879317|FG006|Overall Study|Lack of Efficacy|3|||
162959699|NCT03930732|588554757|FG001|Overall Study|Poor compliance to protocol|1|||
162959700|NCT03930732|588554756|FG000|Overall Study|Withdrawal by Subject|23|||
162959701|NCT03930732|588554757|FG001|Overall Study|Withdrawal by Subject|11|||
162959702|NCT03930732|588554756|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
162959703|NCT03930732|588554757|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
162959704|NCT03930732|588554756|FG000|Overall Study|Other reason not related to COVID-19|5|||
162959705|NCT03930732|588554757|FG001|Overall Study|Other reason not related to COVID-19|8|||
162959706|NCT04128761|588554766|FG000|Overall Study|Lost to Follow-up|5|||
162959707|NCT04128761|588554767|FG001|Overall Study|Lost to Follow-up|6|||
162959708|NCT06539676|588554768|FG000|Overall Study|Early study termination|1|||
162959709|NCT06539676|588554769|FG001|Overall Study|Early study termination|0|||
162959710|NCT06539676|588554770|FG002|Overall Study|Early study termination|6|||
162959711|NCT00909038|588554777|FG000|Overall Study|Protocol Violation|187|||
162959712|NCT00909038|588554777|FG000|Overall Study|Non-evaluable Subjects|230|||
162959713|NCT00207090|588554778|FG000|Overall Study|Study drug toxicity|3|||
162959714|NCT00207090|588554778|FG000|Overall Study|Chest wall mass larger|1|||
163196319|NCT03639935|589434091|FG000|Overall Study|Death|3|||
163196320|NCT03639935|589434091|FG000|Overall Study|Adverse Event|1|||
163196321|NCT02924571|589434092|FG000|Overall Study|Lost to Follow-up|1|||
163196322|NCT02924571|589434093|FG001|Overall Study|Lost to Follow-up|1|||
163196323|NCT02924571|589434094|FG002|Overall Study|Lost to Follow-up|0|||
163196324|NCT00864721|589434095|FG000|Overall Study|Patient request|11|||
163196325|NCT00864721|589434095|FG000|Overall Study|Hospitalized|1|||
163196326|NCT00864721|589434095|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
163196327|NCT00864721|589434095|FG000|Overall Study|Adverse Event|21|||
163196328|NCT01921387|589434098|FG000|Overall Study|Adverse Event|1|||
163196329|NCT01773733|589434099|FG000|Overall Study|Adverse Event|3286|||
163196330|NCT01773733|589434100|FG001|Overall Study|Adverse Event|540|||
163196331|NCT01773733|589434099|FG000|Overall Study|Pregnancy|28|||
163196332|NCT01773733|589434100|FG001|Overall Study|Pregnancy|0|||
163196333|NCT01773733|589434099|FG000|Overall Study|Other different categories of not compl|55415|||
163196334|NCT01773733|589434100|FG001|Overall Study|Other different categories of not compl|7781|||
163196335|NCT00261807|589434103|FG000|Overall Study|Lost to Follow-up|2|||
163196336|NCT00261807|589434103|FG000|Overall Study|Adverse Event|2|||
163196337|NCT00261807|589434103|FG000|Overall Study|Death|1|||
163196338|NCT00261807|589434103|FG000|Overall Study|Protocol Violation|2|||
163196339|NCT00762229|589434107|FG000|Overall Study|Lost to Follow-up|1|||
163196340|NCT00762229|589434108|FG001|Overall Study|Lost to Follow-up|1|||
163196341|NCT00762229|589434107|FG000|Overall Study|did not recveive intervention|0|||
163196342|NCT00762229|589434108|FG001|Overall Study|did not recveive intervention|1|||
163196343|NCT01081678|589434110|FG000|Overall Study|Ineligibility Determined|0|||
163196344|NCT01081678|589434111|FG001|Overall Study|Ineligibility Determined|0|||
163196345|NCT01081678|589434112|FG002|Overall Study|Ineligibility Determined|1|||
163196346|NCT01081678|589434113|FG003|Overall Study|Ineligibility Determined|1|||
163196347|NCT01081678|589434110|FG000|Overall Study|Noncompliance|3|||
163196348|NCT01081678|589434111|FG001|Overall Study|Noncompliance|4|||
163196349|NCT01081678|589434112|FG002|Overall Study|Noncompliance|5|||
163196350|NCT01081678|589434113|FG003|Overall Study|Noncompliance|2|||
163196351|NCT01081678|589434110|FG000|Overall Study|Adverse Event|2|||
163196352|NCT01081678|589434111|FG001|Overall Study|Adverse Event|1|||
163196353|NCT01081678|589434112|FG002|Overall Study|Adverse Event|2|||
163196354|NCT01081678|589434113|FG003|Overall Study|Adverse Event|2|||
163196355|NCT01081678|589434110|FG000|Overall Study|Withdrawal by Subject|15|||
163196356|NCT01081678|589434111|FG001|Overall Study|Withdrawal by Subject|7|||
163196357|NCT01081678|589434112|FG002|Overall Study|Withdrawal by Subject|17|||
163196358|NCT01081678|589434113|FG003|Overall Study|Withdrawal by Subject|14|||
163196359|NCT01081678|589434110|FG000|Overall Study|Administrative Decision|1|||
163196360|NCT01081678|589434111|FG001|Overall Study|Administrative Decision|0|||
163196361|NCT01081678|589434112|FG002|Overall Study|Administrative Decision|0|||
163196362|NCT01081678|589434113|FG003|Overall Study|Administrative Decision|1|||
163196363|NCT01081678|589434110|FG000|Overall Study|Lost to Follow-up|4|||
163196364|NCT01081678|589434111|FG001|Overall Study|Lost to Follow-up|1|||
163196365|NCT01081678|589434112|FG002|Overall Study|Lost to Follow-up|4|||
162959715|NCT00207090|588554778|FG000|Overall Study|Disease progression/relapse|2|||
163196366|NCT01081678|589434113|FG003|Overall Study|Lost to Follow-up|3|||
163196367|NCT01081678|589434110|FG000|Overall Study|Death|2|||
163196368|NCT01081678|589434111|FG001|Overall Study|Death|2|||
163196369|NCT01081678|589434112|FG002|Overall Study|Death|2|||
163196370|NCT01081678|589434113|FG003|Overall Study|Death|6|||
163196371|NCT01081678|589434110|FG000|Overall Study|Other|0|||
163196372|NCT01081678|589434111|FG001|Overall Study|Other|1|||
163196373|NCT01081678|589434112|FG002|Overall Study|Other|0|||
163196374|NCT01081678|589434113|FG003|Overall Study|Other|0|||
163196375|NCT01619423|589434118|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
163302560|NCT01121991|589815505|FG000|Overall Study|Lack of Ovarian Response|2|||
163302561|NCT01121991|589815505|FG000|Overall Study|No Oocytes Retrieved|3|||
163196376|NCT01619423|589434119|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
163196377|NCT01619423|589434120|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
163046610|NCT02683239|588879311|FG000|Overall Study|Missing data|0|||
163046611|NCT02683239|588879312|FG001|Overall Study|Missing data|1|||
163046612|NCT02683239|588879313|FG002|Overall Study|Missing data|1|||
163046613|NCT02683239|588879314|FG003|Overall Study|Missing data|0|||
163046614|NCT02683239|588879315|FG004|Overall Study|Missing data|1|||
163046615|NCT02683239|588879316|FG005|Overall Study|Missing data|0|||
163046616|NCT02683239|588879317|FG006|Overall Study|Missing data|0|||
163046617|NCT00521365|588879320|FG000|Overall Study|Adverse Event|3|||
163046618|NCT00521365|588879320|FG000|Overall Study|Lost to Follow-up|6|||
163046619|NCT00521365|588879320|FG000|Overall Study|Protocol deviation|2|||
163046620|NCT00521365|588879320|FG000|Overall Study|Drug compliance|3|||
163046621|NCT00521365|588879320|FG000|Overall Study|Usage of not allowed drugs|6|||
163046622|NCT00368108|588879321|FG000|Overall Study|Adverse Event|38|||
163046623|NCT00368108|588879322|FG001|Overall Study|Adverse Event|26|||
163046624|NCT00368108|588879323|FG002|Overall Study|Adverse Event|44|||
163046625|NCT00368108|588879321|FG000|Overall Study|Abnormal Laboratory Value|0|||
163046626|NCT00368108|588879322|FG001|Overall Study|Abnormal Laboratory Value|0|||
163046627|NCT00368108|588879323|FG002|Overall Study|Abnormal Laboratory Value|3|||
163046628|NCT00368108|588879321|FG000|Overall Study|Protocol Violation|5|||
163046629|NCT00368108|588879322|FG001|Overall Study|Protocol Violation|9|||
163046630|NCT00368108|588879323|FG002|Overall Study|Protocol Violation|9|||
163046631|NCT00368108|588879321|FG000|Overall Study|Withdrawal by Subject|9|||
163046632|NCT00368108|588879322|FG001|Overall Study|Withdrawal by Subject|3|||
163046633|NCT00368108|588879323|FG002|Overall Study|Withdrawal by Subject|5|||
163046634|NCT00368108|588879321|FG000|Overall Study|Lack of Efficacy|7|||
163046635|NCT00368108|588879322|FG001|Overall Study|Lack of Efficacy|8|||
163046636|NCT00368108|588879323|FG002|Overall Study|Lack of Efficacy|5|||
163046637|NCT00368108|588879321|FG000|Overall Study|Physician Decision|2|||
163046638|NCT00368108|588879322|FG001|Overall Study|Physician Decision|0|||
163046639|NCT00368108|588879323|FG002|Overall Study|Physician Decision|1|||
163046640|NCT00368108|588879321|FG000|Overall Study|Other|3|||
163046641|NCT00368108|588879322|FG001|Overall Study|Other|7|||
163046642|NCT00368108|588879323|FG002|Overall Study|Other|1|||
163046643|NCT01718483|588879324|FG000|Overall Study|Withdrawal by Subject|14|||
163046644|NCT01718483|588879325|FG001|Overall Study|Withdrawal by Subject|12|||
163046645|NCT01718483|588879324|FG000|Overall Study|Adverse Event|5|||
163046646|NCT01718483|588879325|FG001|Overall Study|Adverse Event|12|||
163046647|NCT01718483|588879324|FG000|Overall Study|Lost to Follow-up|8|||
163046648|NCT01718483|588879325|FG001|Overall Study|Lost to Follow-up|3|||
163046649|NCT01718483|588879324|FG000|Overall Study|Protocol Violation|4|||
163046650|NCT01718483|588879325|FG001|Overall Study|Protocol Violation|2|||
163046651|NCT01718483|588879324|FG000|Overall Study|Other|1|||
163046652|NCT01718483|588879325|FG001|Overall Study|Other|4|||
163046653|NCT01718483|588879324|FG000|Overall Study|Pregnancy|1|||
163046654|NCT01718483|588879325|FG001|Overall Study|Pregnancy|1|||
163046655|NCT01718483|588879324|FG000|Overall Study|Lack of Efficacy|1|||
163046656|NCT01718483|588879325|FG001|Overall Study|Lack of Efficacy|0|||
163046657|NCT03442088|588879330|FG000|Overall Study|Adverse Event|1|||
163046658|NCT03442088|588879330|FG000|Overall Study|Lack of Efficacy|2|||
163046659|NCT03442088|588879330|FG000|Overall Study|Lost to Follow-up|2|||
163046660|NCT01051557|588879333|FG000|Overall Study|Physician Decision|1|||
163046661|NCT01051557|588879334|FG001|Overall Study|Physician Decision|0|||
163046662|NCT01051557|588879335|FG002|Overall Study|Physician Decision|0|||
163046663|NCT01051557|588879336|FG003|Overall Study|Physician Decision|0|||
163046664|NCT01051557|588879337|FG004|Overall Study|Physician Decision|0|||
163046665|NCT01051557|588879338|FG005|Overall Study|Physician Decision|0|||
163046666|NCT01051557|588879339|FG006|Overall Study|Physician Decision|0|||
163046667|NCT01051557|588879333|FG000|Overall Study|disease progression|3|||
163046668|NCT01051557|588879334|FG001|Overall Study|disease progression|3|||
163394875|NCT02615470|590158543|FG001|Overall Study|Lost to Follow-up|32|||
163394876|NCT03713034|590158544|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
162959716|NCT00207090|588554778|FG000|Overall Study|Physician Decision|1|||
162959717|NCT03480763|588554783|FG000|Overall Study|Withdrawal by Subject|18|||
162959718|NCT03480763|588554784|FG001|Overall Study|Withdrawal by Subject|10|||
162959719|NCT03480763|588554783|FG000|Overall Study|Lost to Follow-up|4|||
162959720|NCT03480763|588554784|FG001|Overall Study|Lost to Follow-up|7|||
162959721|NCT03480763|588554783|FG000|Overall Study|non-study pneumococcal vaccine|1|||
162959722|NCT03480763|588554784|FG001|Overall Study|non-study pneumococcal vaccine|0|||
162959723|NCT03480763|588554783|FG000|Overall Study|oncological treatment|0|||
162959724|NCT03480763|588554784|FG001|Overall Study|oncological treatment|2|||
162959725|NCT03480763|588554783|FG000|Overall Study|pain with vaccination|1|||
162959726|NCT03480763|588554784|FG001|Overall Study|pain with vaccination|0|||
162959727|NCT01895335|588554785|FG000|Overall Study|Adverse Event|106|||
162959728|NCT01895335|588554785|FG000|Overall Study|Lack of Efficacy|53|||
162959729|NCT01895335|588554785|FG000|Overall Study|Poor Compliance to Protocol|11|||
162959730|NCT01895335|588554785|FG000|Overall Study|Included But Not treated|1|||
162959731|NCT01895335|588554785|FG000|Overall Study|Other than Specified Above|44|||
162959732|NCT01647828|588554786|FG000|Overall Study|Death|3|||
162959733|NCT01647828|588554787|FG001|Overall Study|Death|4|||
162959734|NCT01647828|588554788|FG002|Overall Study|Death|4|||
162959735|NCT01647828|588554789|FG003|Overall Study|Death|5|||
162959736|NCT01647828|588554790|FG004|Overall Study|Death|6|||
162959737|NCT01647828|588554791|FG005|Overall Study|Death|3|||
162959738|NCT01647828|588554792|FG006|Overall Study|Death|10|||
162959739|NCT01647828|588554793|FG007|Overall Study|Death|60|||
162959740|NCT01647828|588554794|FG008|Overall Study|Death|71|||
162959741|NCT01647828|588554786|FG000|Overall Study|Withdrawal by Subject|2|||
162959742|NCT01647828|588554787|FG001|Overall Study|Withdrawal by Subject|0|||
162959743|NCT01647828|588554788|FG002|Overall Study|Withdrawal by Subject|0|||
162959744|NCT01647828|588554789|FG003|Overall Study|Withdrawal by Subject|1|||
162959745|NCT01647828|588554790|FG004|Overall Study|Withdrawal by Subject|0|||
162959746|NCT01647828|588554791|FG005|Overall Study|Withdrawal by Subject|0|||
162959747|NCT01647828|588554792|FG006|Overall Study|Withdrawal by Subject|1|||
162959748|NCT01647828|588554793|FG007|Overall Study|Withdrawal by Subject|0|||
162959749|NCT01647828|588554794|FG008|Overall Study|Withdrawal by Subject|2|||
162959750|NCT01647828|588554786|FG000|Overall Study|Study terminated by Sponsor|0|||
162959751|NCT01647828|588554787|FG001|Overall Study|Study terminated by Sponsor|0|||
162959752|NCT01647828|588554788|FG002|Overall Study|Study terminated by Sponsor|0|||
162959753|NCT01647828|588554789|FG003|Overall Study|Study terminated by Sponsor|0|||
162959754|NCT01647828|588554790|FG004|Overall Study|Study terminated by Sponsor|0|||
162959755|NCT01647828|588554791|FG005|Overall Study|Study terminated by Sponsor|0|||
162959756|NCT01647828|588554792|FG006|Overall Study|Study terminated by Sponsor|1|||
162959757|NCT01647828|588554793|FG007|Overall Study|Study terminated by Sponsor|26|||
162959758|NCT01647828|588554794|FG008|Overall Study|Study terminated by Sponsor|16|||
162959759|NCT01647828|588554786|FG000|Overall Study|Lost to Follow-up|0|||
162959760|NCT01647828|588554787|FG001|Overall Study|Lost to Follow-up|0|||
162959761|NCT01647828|588554788|FG002|Overall Study|Lost to Follow-up|0|||
162959762|NCT01647828|588554789|FG003|Overall Study|Lost to Follow-up|0|||
162959763|NCT01647828|588554790|FG004|Overall Study|Lost to Follow-up|0|||
162959764|NCT01647828|588554791|FG005|Overall Study|Lost to Follow-up|0|||
162959765|NCT01647828|588554792|FG006|Overall Study|Lost to Follow-up|0|||
162959766|NCT01647828|588554793|FG007|Overall Study|Lost to Follow-up|2|||
162959767|NCT01647828|588554794|FG008|Overall Study|Lost to Follow-up|0|||
163394877|NCT03713034|590158545|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
163196378|NCT01619423|589434121|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
163196379|NCT01281865|589434128|FG000|Overall Study|Adverse Event|1|||
163196380|NCT01281865|589434129|FG001|Overall Study|Adverse Event|1|||
163196381|NCT01281865|589434128|FG000|Overall Study|Withdrawal by Subject|1|||
163196382|NCT01281865|589434129|FG001|Overall Study|Withdrawal by Subject|0|||
163196383|NCT01281865|589434128|FG000|Overall Study|Lack of Efficacy|1|||
163196384|NCT01281865|589434129|FG001|Overall Study|Lack of Efficacy|0|||
163196385|NCT03478657|589434130|FG000|Overall Study|Withdrawal by Subject|0|||
163196386|NCT03478657|589434131|FG001|Overall Study|Withdrawal by Subject|1|||
163196387|NCT02590003|589434132|FG000|Overall Study|Death|1|||
163196388|NCT02590003|589434133|FG001|Overall Study|Death|2|||
163196389|NCT03733470|589434134|FG000|Overall Study|PI Decision|1|||
163196390|NCT03733470|589434135|FG001|Overall Study|PI Decision|1|||
163196391|NCT04457336|589434138|FG000|Period 2: Part A|Withdrawal by Subject|0|||
163196392|NCT04457336|589434139|FG001|Period 2: Part A|Withdrawal by Subject|1|||
163196393|NCT04457336|589434140|FG002|Period 2: Part A|Withdrawal by Subject|1|||
163196394|NCT04457336|589434141|FG003|Period 2: Part A|Withdrawal by Subject|1|||
163196395|NCT04457336|589434142|FG004|Period 2: Part A|Withdrawal by Subject|0|||
163196396|NCT04457336|589434143|FG005|Period 2: Part A|Withdrawal by Subject|0|||
163196397|NCT04457336|589434144|FG006|Period 2: Part A|Withdrawal by Subject|0|||
163196398|NCT04457336|589434145|FG007|Period 2: Part A|Withdrawal by Subject|0|||
163196399|NCT04457336|589434138|FG000|Period 2: Part A|Adverse Event|0|||
163196400|NCT04457336|589434139|FG001|Period 2: Part A|Adverse Event|0|||
163196401|NCT04457336|589434140|FG002|Period 2: Part A|Adverse Event|1|||
163196402|NCT04457336|589434141|FG003|Period 2: Part A|Adverse Event|1|||
163196403|NCT04457336|589434142|FG004|Period 2: Part A|Adverse Event|0|||
163196404|NCT04457336|589434143|FG005|Period 2: Part A|Adverse Event|0|||
163196405|NCT04457336|589434144|FG006|Period 2: Part A|Adverse Event|0|||
163196406|NCT04457336|589434145|FG007|Period 2: Part A|Adverse Event|0|||
163196407|NCT04457336|589434138|FG000|Period 2: Part A|Study Terminated|0|||
163196408|NCT04457336|589434139|FG001|Period 2: Part A|Study Terminated|0|||
163196409|NCT04457336|589434140|FG002|Period 2: Part A|Study Terminated|1|||
163196410|NCT04457336|589434141|FG003|Period 2: Part A|Study Terminated|0|||
163196411|NCT04457336|589434142|FG004|Period 2: Part A|Study Terminated|0|||
163196412|NCT04457336|589434143|FG005|Period 2: Part A|Study Terminated|0|||
163196413|NCT04457336|589434144|FG006|Period 2: Part A|Study Terminated|0|||
163196414|NCT04457336|589434145|FG007|Period 2: Part A|Study Terminated|0|||
163196415|NCT04457336|589434138|FG000|Period 2: Part A|Protocol Violation|0|||
163196416|NCT04457336|589434139|FG001|Period 2: Part A|Protocol Violation|1|||
162959768|NCT00115063|588554797|FG000|Overall Study|Lost to Follow-up|98|||
163196417|NCT04457336|589434140|FG002|Period 2: Part A|Protocol Violation|0|||
163196418|NCT04457336|589434141|FG003|Period 2: Part A|Protocol Violation|0|||
163196419|NCT04457336|589434142|FG004|Period 2: Part A|Protocol Violation|0|||
163196420|NCT04457336|589434143|FG005|Period 2: Part A|Protocol Violation|0|||
163196421|NCT04457336|589434144|FG006|Period 2: Part A|Protocol Violation|0|||
163196422|NCT04457336|589434145|FG007|Period 2: Part A|Protocol Violation|0|||
163196423|NCT04457336|589434138|FG000|Period 2: Part A|Lost to Follow-up|0|||
163046669|NCT01051557|588879335|FG002|Overall Study|disease progression|5|||
163046670|NCT01051557|588879336|FG003|Overall Study|disease progression|2|||
163046671|NCT01051557|588879337|FG004|Overall Study|disease progression|4|||
163046672|NCT01051557|588879338|FG005|Overall Study|disease progression|3|||
163046673|NCT01051557|588879339|FG006|Overall Study|disease progression|1|||
163046674|NCT01051557|588879333|FG000|Overall Study|Withdrawal by Subject|0|||
163046675|NCT01051557|588879334|FG001|Overall Study|Withdrawal by Subject|0|||
163046676|NCT01051557|588879335|FG002|Overall Study|Withdrawal by Subject|1|||
163046677|NCT01051557|588879336|FG003|Overall Study|Withdrawal by Subject|0|||
163046678|NCT01051557|588879337|FG004|Overall Study|Withdrawal by Subject|2|||
163046679|NCT01051557|588879338|FG005|Overall Study|Withdrawal by Subject|0|||
163046680|NCT01051557|588879339|FG006|Overall Study|Withdrawal by Subject|1|||
163046681|NCT01051557|588879333|FG000|Overall Study|Adverse Event|0|||
163046682|NCT01051557|588879334|FG001|Overall Study|Adverse Event|0|||
163046683|NCT01051557|588879335|FG002|Overall Study|Adverse Event|0|||
163046684|NCT01051557|588879336|FG003|Overall Study|Adverse Event|1|||
163046685|NCT01051557|588879337|FG004|Overall Study|Adverse Event|1|||
163046686|NCT01051557|588879338|FG005|Overall Study|Adverse Event|3|||
163046687|NCT01051557|588879339|FG006|Overall Study|Adverse Event|4|||
163046688|NCT00130689|588879340|FG000|Overall Study|Progressive Disease|29|||
163046689|NCT00130689|588879340|FG000|Overall Study|Death|1|||
163046690|NCT00130689|588879340|FG000|Overall Study|Clinical Deterioration|4|||
163046691|NCT00130689|588879340|FG000|Overall Study|Withdrawal by Subject|3|||
163046692|NCT00130689|588879340|FG000|Overall Study|Ineligible|6|||
163046693|NCT00766597|588879341|FG000|Overall Study|Unexpected closure of study|4|||
163046694|NCT00766597|588879341|FG000|Overall Study|Without CCR5-tropic virus|5|||
163046695|NCT00509899|588879342|FG000|Overall Study|Progressive disease|1|||
163046696|NCT00509899|588879343|FG001|Overall Study|Progressive disease|3|||
163046697|NCT00509899|588879344|FG002|Overall Study|Progressive disease|5|||
163046698|NCT00509899|588879345|FG003|Overall Study|Progressive disease|1|||
163046699|NCT00509899|588879346|FG004|Overall Study|Progressive disease|0|||
163046700|NCT00509899|588879347|FG005|Overall Study|Progressive disease|1|||
163046701|NCT00509899|588879348|FG006|Overall Study|Progressive disease|0|||
163046702|NCT00509899|588879349|FG007|Overall Study|Progressive disease|0|||
163046703|NCT00509899|588879342|FG000|Overall Study|Unacceptable Toxicity|1|||
163046704|NCT00509899|588879343|FG001|Overall Study|Unacceptable Toxicity|0|||
163046705|NCT00509899|588879344|FG002|Overall Study|Unacceptable Toxicity|0|||
163046706|NCT00509899|588879345|FG003|Overall Study|Unacceptable Toxicity|2|||
163196424|NCT04457336|589434139|FG001|Period 2: Part A|Lost to Follow-up|1|||
163196425|NCT04457336|589434140|FG002|Period 2: Part A|Lost to Follow-up|0|||
163046707|NCT00509899|588879346|FG004|Overall Study|Unacceptable Toxicity|0|||
163046708|NCT00509899|588879347|FG005|Overall Study|Unacceptable Toxicity|0|||
163196426|NCT04457336|589434141|FG003|Period 2: Part A|Lost to Follow-up|0|||
163196427|NCT04457336|589434142|FG004|Period 2: Part A|Lost to Follow-up|0|||
163196428|NCT04457336|589434143|FG005|Period 2: Part A|Lost to Follow-up|0|||
163046709|NCT00509899|588879348|FG006|Overall Study|Unacceptable Toxicity|0|||
163046710|NCT00509899|588879349|FG007|Overall Study|Unacceptable Toxicity|0|||
163046711|NCT00509899|588879342|FG000|Overall Study|Withdrawal by Subject|6|||
163046712|NCT00509899|588879343|FG001|Overall Study|Withdrawal by Subject|2|||
163196429|NCT04457336|589434144|FG006|Period 2: Part A|Lost to Follow-up|0|||
162959769|NCT00115063|588554798|FG001|Overall Study|Lost to Follow-up|104|||
162959770|NCT00115063|588554797|FG000|Overall Study|Death|1|||
162959771|NCT00115063|588554798|FG001|Overall Study|Death|0|||
162959772|NCT00185458|588554803|FG000|Contraception Phase|Adverse Event|37|||
162959773|NCT00185458|588554803|FG000|Contraception Phase|Lost to Follow-up|10|||
162959774|NCT00185458|588554803|FG000|Contraception Phase|Protocol Violation|2|||
162959775|NCT00185458|588554803|FG000|Contraception Phase|Physician Decision|2|||
162959776|NCT00185458|588554803|FG000|Contraception Phase|Withdrawal by Subject|7|||
162959777|NCT00185458|588554803|FG000|HRT Phase|Adverse Event|18|||
162959778|NCT00185458|588554803|FG000|HRT Phase|Lost to Follow-up|4|||
162959779|NCT00185458|588554803|FG000|HRT Phase|Protocol Violation|2|||
163394878|NCT00880555|590158550|FG000|Overall Study|Physician Decision|0|||
162959780|NCT00185458|588554803|FG000|HRT Phase|Withdrawal by Subject|3|||
162959781|NCT00830024|588554804|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
162959782|NCT00830024|588554805|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
162959783|NCT02554890|588554806|FG000|Double-blind|Adverse Event|45|||
162959784|NCT02554890|588554807|FG001|Double-blind|Adverse Event|51|||
162959785|NCT02554890|588554806|FG000|Double-blind|Death|6|||
162959786|NCT02554890|588554807|FG001|Double-blind|Death|4|||
162959787|NCT02554890|588554806|FG000|Double-blind|Protocol Violation|1|||
162959788|NCT02554890|588554807|FG001|Double-blind|Protocol Violation|1|||
162959789|NCT02554890|588554806|FG000|Double-blind|Physician Decision|4|||
162959790|NCT02554890|588554807|FG001|Double-blind|Physician Decision|3|||
162959791|NCT02554890|588554806|FG000|Double-blind|Subject/Guardian decision|21|||
162959792|NCT02554890|588554807|FG001|Double-blind|Subject/Guardian decision|16|||
162959793|NCT02554890|588554806|FG000|Double-blind|Lost to Follow-up|7|||
162959794|NCT02554890|588554807|FG001|Double-blind|Lost to Follow-up|5|||
162959795|NCT02554890|588554806|FG000|Double-blind|Technical problems|1|||
162959796|NCT02554890|588554807|FG001|Double-blind|Technical problems|0|||
163046713|NCT00509899|588879344|FG002|Overall Study|Withdrawal by Subject|3|||
163046714|NCT00509899|588879345|FG003|Overall Study|Withdrawal by Subject|0|||
163046715|NCT00509899|588879346|FG004|Overall Study|Withdrawal by Subject|3|||
163046716|NCT00509899|588879347|FG005|Overall Study|Withdrawal by Subject|2|||
163046717|NCT00509899|588879348|FG006|Overall Study|Withdrawal by Subject|0|||
163046718|NCT00509899|588879349|FG007|Overall Study|Withdrawal by Subject|0|||
163046719|NCT00509899|588879342|FG000|Overall Study|Physician Decision|4|||
163046720|NCT00509899|588879343|FG001|Overall Study|Physician Decision|2|||
163046721|NCT00509899|588879344|FG002|Overall Study|Physician Decision|7|||
163046722|NCT00509899|588879345|FG003|Overall Study|Physician Decision|0|||
163046723|NCT00509899|588879346|FG004|Overall Study|Physician Decision|1|||
163046724|NCT00509899|588879347|FG005|Overall Study|Physician Decision|4|||
163046725|NCT00509899|588879348|FG006|Overall Study|Physician Decision|0|||
163046726|NCT00509899|588879349|FG007|Overall Study|Physician Decision|0|||
163046727|NCT00509899|588879342|FG000|Overall Study|Intercurrent Illness|1|||
163046728|NCT00509899|588879343|FG001|Overall Study|Intercurrent Illness|0|||
163046729|NCT00509899|588879344|FG002|Overall Study|Intercurrent Illness|0|||
163046730|NCT00509899|588879345|FG003|Overall Study|Intercurrent Illness|1|||
163046731|NCT00509899|588879346|FG004|Overall Study|Intercurrent Illness|0|||
163046732|NCT00509899|588879347|FG005|Overall Study|Intercurrent Illness|1|||
163046733|NCT00509899|588879348|FG006|Overall Study|Intercurrent Illness|0|||
163394879|NCT00880555|590158551|FG001|Overall Study|Physician Decision|8|||
163394880|NCT00880555|590158552|FG002|Overall Study|Physician Decision|0|||
163394881|NCT00880555|590158553|FG003|Overall Study|Physician Decision|2|||
163394882|NCT00880555|590158554|FG004|Overall Study|Physician Decision|1|||
163394883|NCT00880555|590158555|FG005|Overall Study|Physician Decision|0|||
163394884|NCT00880555|590158550|FG000|Overall Study|Withdrawal by Subject|1|||
163046734|NCT00509899|588879349|FG007|Overall Study|Intercurrent Illness|0|||
163046735|NCT00509899|588879342|FG000|Overall Study|Death|2|||
163046736|NCT00509899|588879343|FG001|Overall Study|Death|2|||
163046737|NCT00509899|588879344|FG002|Overall Study|Death|3|||
163046738|NCT00509899|588879345|FG003|Overall Study|Death|0|||
163046739|NCT00509899|588879346|FG004|Overall Study|Death|1|||
163046740|NCT00509899|588879347|FG005|Overall Study|Death|1|||
163046741|NCT00509899|588879348|FG006|Overall Study|Death|1|||
163046742|NCT00509899|588879349|FG007|Overall Study|Death|1|||
163046743|NCT00509899|588879342|FG000|Overall Study|Lack of Efficacy|1|||
163046744|NCT00509899|588879343|FG001|Overall Study|Lack of Efficacy|0|||
163046745|NCT00509899|588879344|FG002|Overall Study|Lack of Efficacy|2|||
163046746|NCT00509899|588879345|FG003|Overall Study|Lack of Efficacy|0|||
163046747|NCT00509899|588879346|FG004|Overall Study|Lack of Efficacy|0|||
163046748|NCT00509899|588879347|FG005|Overall Study|Lack of Efficacy|1|||
163046749|NCT00509899|588879348|FG006|Overall Study|Lack of Efficacy|0|||
163046750|NCT00509899|588879349|FG007|Overall Study|Lack of Efficacy|0|||
163046751|NCT01254656|588879350|FG000|Overall Study|Discontinued due to termination of study|40|||
163046752|NCT01254656|588879351|FG001|Overall Study|Discontinued due to termination of study|39|||
163046753|NCT01254656|588879352|FG002|Overall Study|Discontinued due to termination of study|13|||
163046754|NCT01254656|588879350|FG000|Overall Study|Lack of Efficacy|3|||
163046755|NCT01254656|588879351|FG001|Overall Study|Lack of Efficacy|0|||
163046756|NCT01254656|588879352|FG002|Overall Study|Lack of Efficacy|0|||
163302562|NCT01121991|589815505|FG000|Overall Study|No Fertilization|1|||
163046757|NCT01254656|588879350|FG000|Overall Study|Lost to Follow-up|1|||
163046758|NCT01254656|588879351|FG001|Overall Study|Lost to Follow-up|0|||
163046759|NCT01254656|588879352|FG002|Overall Study|Lost to Follow-up|2|||
163046760|NCT01254656|588879350|FG000|Overall Study|Withdrawal by Subject|2|||
163046761|NCT01254656|588879351|FG001|Overall Study|Withdrawal by Subject|2|||
163046762|NCT01254656|588879352|FG002|Overall Study|Withdrawal by Subject|1|||
163046763|NCT01254656|588879350|FG000|Overall Study|Pregnancy|0|||
163302563|NCT02740231|589815506|FG000|Overall Study|Withdrawal by Subject|1|||
163302564|NCT02740231|589815507|FG001|Overall Study|Withdrawal by Subject|1|||
163302565|NCT02740231|589815508|FG002|Overall Study|Withdrawal by Subject|1|||
163302566|NCT02740231|589815509|FG003|Overall Study|Withdrawal by Subject|0|||
163302567|NCT02740231|589815506|FG000|Overall Study|Lack of Efficacy|0|||
163302568|NCT02740231|589815507|FG001|Overall Study|Lack of Efficacy|1|||
163302569|NCT02740231|589815508|FG002|Overall Study|Lack of Efficacy|0|||
163302570|NCT02740231|589815509|FG003|Overall Study|Lack of Efficacy|4|||
163302571|NCT02740231|589815506|FG000|Overall Study|Lost to Follow-up|1|||
163394885|NCT00880555|590158551|FG001|Overall Study|Withdrawal by Subject|1|||
163046764|NCT01254656|588879351|FG001|Overall Study|Pregnancy|0|||
163046765|NCT01254656|588879352|FG002|Overall Study|Pregnancy|2|||
163046766|NCT01254656|588879350|FG000|Overall Study|Adverse Event|1|||
163046767|NCT01254656|588879351|FG001|Overall Study|Adverse Event|1|||
163046768|NCT01254656|588879352|FG002|Overall Study|Adverse Event|0|||
163046769|NCT01254656|588879350|FG000|Overall Study|Death|0|||
163046770|NCT01254656|588879351|FG001|Overall Study|Death|1|||
163046771|NCT01254656|588879352|FG002|Overall Study|Death|0|||
163046772|NCT02948829|588879353|FG000|Overall Study|Lost to Follow-up|2|||
163302572|NCT02740231|589815507|FG001|Overall Study|Lost to Follow-up|3|||
163302573|NCT02740231|589815508|FG002|Overall Study|Lost to Follow-up|0|||
163302574|NCT02740231|589815509|FG003|Overall Study|Lost to Follow-up|3|||
163302575|NCT02740231|589815506|FG000|Overall Study|Adverse Event|0|||
163302576|NCT02740231|589815507|FG001|Overall Study|Adverse Event|1|||
163302577|NCT02740231|589815508|FG002|Overall Study|Adverse Event|0|||
163302578|NCT02740231|589815509|FG003|Overall Study|Adverse Event|1|||
163046773|NCT02948829|588879353|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
163046774|NCT02948829|588879353|FG000|Overall Study|Pregnancy|1|||
163046775|NCT02948829|588879353|FG000|Overall Study|Other: Reason not Specified|8|||
163046776|NCT02326272|588879354|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046777|NCT02326272|588879355|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
163302579|NCT00243503|589815510|FG000|Overall Study|Adverse Event|11|||
163302580|NCT00243503|589815510|FG000|Overall Study|Withdrawal by Subject|1|||
163302581|NCT00243503|589815510|FG000|Overall Study|Lack of Efficacy|44|||
163302582|NCT00243503|589815510|FG000|Overall Study|Death|1|||
163302583|NCT00243503|589815510|FG000|Overall Study|Other|1|||
163302584|NCT04110054|589815511|FG000|Overall Study|COVID-19 reason other than AE|0|||
163302585|NCT04110054|589815512|FG001|Overall Study|COVID-19 reason other than AE|0|||
163302586|NCT04110054|589815513|FG002|Overall Study|COVID-19 reason other than AE|2|||
163302587|NCT04110054|589815514|FG003|Overall Study|COVID-19 reason other than AE|0|||
163302588|NCT04110054|589815511|FG000|Overall Study|Withdrawal by Subject|0|||
163302589|NCT04110054|589815512|FG001|Overall Study|Withdrawal by Subject|3|||
163302590|NCT04110054|589815513|FG002|Overall Study|Withdrawal by Subject|2|||
163302591|NCT04110054|589815514|FG003|Overall Study|Withdrawal by Subject|0|||
163302592|NCT04110054|589815511|FG000|Overall Study|Adverse Event|1|||
163302593|NCT04110054|589815512|FG001|Overall Study|Adverse Event|1|||
163302594|NCT04110054|589815513|FG002|Overall Study|Adverse Event|4|||
163302595|NCT04110054|589815514|FG003|Overall Study|Adverse Event|3|||
163302596|NCT01000480|589815516|FG000|Induction Phase|Adverse Event|2|||
163302597|NCT01000480|589815516|FG000|Induction Phase|Lost to Follow-up|1|||
163302598|NCT01000480|589815516|FG000|Induction Phase|Physician Decision|1|||
163302599|NCT01000480|589815516|FG000|Induction Phase|Entry Criteria Not Met|3|||
163302600|NCT01000480|589815516|FG000|Concurrent Therapy Phase|Adverse Event|4|||
163302601|NCT01000480|589815516|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
163302602|NCT01000480|589815516|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
163302603|NCT01000480|589815516|FG000|Concurrent Therapy Phase|Physician Decision|1|||
163302604|NCT03988023|589815517|FG000|Overall Study|Non-compliance|3|||
163302605|NCT03988023|589815518|FG001|Overall Study|Non-compliance|0|||
163302606|NCT03988023|589815517|FG000|Overall Study|Withdrawal by Subject|39|||
163302607|NCT03988023|589815518|FG001|Overall Study|Withdrawal by Subject|37|||
163302608|NCT03988023|589815517|FG000|Overall Study|Adverse Event|0|||
163302609|NCT03988023|589815518|FG001|Overall Study|Adverse Event|2|||
163302610|NCT03988023|589815517|FG000|Overall Study|Physician Decision|0|||
163302611|NCT03988023|589815518|FG001|Overall Study|Physician Decision|1|||
163302612|NCT03988023|589815517|FG000|Overall Study|Lost to Follow-up|5|||
163302613|NCT03988023|589815518|FG001|Overall Study|Lost to Follow-up|8|||
163302614|NCT03988023|589815517|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
163302615|NCT03988023|589815518|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
163302616|NCT03988023|589815517|FG000|Overall Study|Lack of Efficacy|3|||
163302617|NCT03988023|589815518|FG001|Overall Study|Lack of Efficacy|1|||
163302618|NCT03988023|589815517|FG000|Overall Study|COVID-19 pandemic|225|||
163302619|NCT03988023|589815518|FG001|Overall Study|COVID-19 pandemic|227|||
163302620|NCT03655262|589815519|FG000|Overall Study|Withdrawal by Subject|0|||
163302621|NCT03655262|589815520|FG001|Overall Study|Withdrawal by Subject|0|||
163302622|NCT03655262|589815521|FG002|Overall Study|Withdrawal by Subject|1|||
163302623|NCT03733119|589815522|FG000|Overall Study|Physician Decision|2|||
163302624|NCT03733119|589815523|FG001|Overall Study|Physician Decision|1|||
163302625|NCT03733119|589815522|FG000|Overall Study|ineligible to treat per protocol|0|||
163302626|NCT03733119|589815523|FG001|Overall Study|ineligible to treat per protocol|1|||
163302627|NCT02554786|589815526|FG000|Overall Study|Subject/guardian decision|29|||
163302628|NCT02554786|589815527|FG001|Overall Study|Subject/guardian decision|17|||
163302629|NCT02554786|589815528|FG002|Overall Study|Subject/guardian decision|18|||
163302630|NCT02554786|589815529|FG003|Overall Study|Subject/guardian decision|30|||
163302631|NCT02554786|589815530|FG004|Overall Study|Subject/guardian decision|20|||
163302632|NCT02554786|589815526|FG000|Overall Study|Lost to Follow-up|4|||
163302633|NCT02554786|589815527|FG001|Overall Study|Lost to Follow-up|3|||
163302634|NCT02554786|589815528|FG002|Overall Study|Lost to Follow-up|4|||
163302635|NCT02554786|589815529|FG003|Overall Study|Lost to Follow-up|2|||
163302636|NCT02554786|589815530|FG004|Overall Study|Lost to Follow-up|2|||
163302637|NCT02554786|589815526|FG000|Overall Study|Protocol deviation|1|||
163302638|NCT02554786|589815527|FG001|Overall Study|Protocol deviation|3|||
163302639|NCT02554786|589815528|FG002|Overall Study|Protocol deviation|3|||
163302640|NCT02554786|589815529|FG003|Overall Study|Protocol deviation|4|||
163302641|NCT02554786|589815530|FG004|Overall Study|Protocol deviation|2|||
163302642|NCT02554786|589815526|FG000|Overall Study|Technical problems|1|||
163302643|NCT02554786|589815527|FG001|Overall Study|Technical problems|1|||
163302644|NCT02554786|589815528|FG002|Overall Study|Technical problems|0|||
163302645|NCT02554786|589815529|FG003|Overall Study|Technical problems|2|||
163302646|NCT02554786|589815530|FG004|Overall Study|Technical problems|1|||
163302647|NCT02554786|589815526|FG000|Overall Study|Adverse Event|0|||
163196430|NCT04457336|589434145|FG007|Period 2: Part A|Lost to Follow-up|0|||
163196431|NCT04457336|589434138|FG000|Period 2: Part A|Other|0|||
162959797|NCT02554890|588554806|FG000|Double-blind|Withdrawal by Subject|5|||
163196432|NCT04457336|589434139|FG001|Period 2: Part A|Other|1|||
163196433|NCT04457336|589434140|FG002|Period 2: Part A|Other|0|||
163196434|NCT04457336|589434141|FG003|Period 2: Part A|Other|0|||
163196435|NCT04457336|589434142|FG004|Period 2: Part A|Other|0|||
163394886|NCT00880555|590158552|FG002|Overall Study|Withdrawal by Subject|0|||
162959798|NCT02554890|588554807|FG001|Double-blind|Withdrawal by Subject|6|||
162959799|NCT02554890|588554806|FG000|Double-blind|Noncompliance with study treatment|6|||
163196436|NCT04457336|589434143|FG005|Period 2: Part A|Other|0|||
163196437|NCT04457336|589434144|FG006|Period 2: Part A|Other|0|||
162959800|NCT02554890|588554807|FG001|Double-blind|Noncompliance with study treatment|5|||
162959801|NCT02554890|588554806|FG000|Open-label|Adverse Event|0|||
162959802|NCT02554890|588554807|FG001|Open-label|Adverse Event|30|||
162959803|NCT02554890|588554806|FG000|Open-label|Death|0|||
162959804|NCT02554890|588554807|FG001|Open-label|Death|1|||
162959805|NCT02554890|588554806|FG000|Open-label|Physician Decision|0|||
162959806|NCT02554890|588554807|FG001|Open-label|Physician Decision|1|||
162959807|NCT02554890|588554806|FG000|Open-label|Subject/Guardian decision|0|||
162959808|NCT02554890|588554807|FG001|Open-label|Subject/Guardian decision|11|||
162959809|NCT02554890|588554806|FG000|Open-label|Lost to Follow-up|0|||
162959810|NCT02554890|588554807|FG001|Open-label|Lost to Follow-up|7|||
162959811|NCT02554890|588554806|FG000|Open-label|Technical problems|0|||
162959812|NCT02554890|588554807|FG001|Open-label|Technical problems|1|||
162959813|NCT02554890|588554806|FG000|Open-label|Withdrawal by Subject|0|||
162959814|NCT02554890|588554807|FG001|Open-label|Withdrawal by Subject|1|||
163196438|NCT04457336|589434145|FG007|Period 2: Part A|Other|0|||
163196439|NCT04457336|589434138|FG000|Period 2: Part A|Physician Decision|0|||
163196440|NCT04457336|589434139|FG001|Period 2: Part A|Physician Decision|0|||
163196441|NCT04457336|589434140|FG002|Period 2: Part A|Physician Decision|0|||
163196442|NCT04457336|589434141|FG003|Period 2: Part A|Physician Decision|1|||
163196443|NCT04457336|589434142|FG004|Period 2: Part A|Physician Decision|0|||
162959815|NCT03649477|588554810|FG000|Overall Study|Adverse Event|2|||
163196444|NCT04457336|589434143|FG005|Period 2: Part A|Physician Decision|0|||
163302648|NCT02554786|589815527|FG001|Overall Study|Adverse Event|0|||
162959816|NCT03649477|588554811|FG001|Overall Study|Adverse Event|0|||
162959817|NCT03649477|588554812|FG002|Overall Study|Adverse Event|0|||
163302649|NCT02554786|589815528|FG002|Overall Study|Adverse Event|0|||
162959818|NCT04544410|588554813|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
162959819|NCT04544410|588554814|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
162959820|NCT04544410|588554813|FG000|Double-blind Treatment Period|Adverse Event|1|||
162959821|NCT04544410|588554814|FG001|Double-blind Treatment Period|Adverse Event|0|||
162959822|NCT04544410|588554813|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
162959823|NCT04544410|588554814|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
162959824|NCT04544410|588554813|FG000|Double-blind Treatment Period|Protocol Violation|1|||
162959825|NCT04544410|588554814|FG001|Double-blind Treatment Period|Protocol Violation|0|||
162959826|NCT04544410|588554813|FG000|Open-Label Treatment Period|Study Terminated|15|||
162959827|NCT04544410|588554814|FG001|Open-Label Treatment Period|Study Terminated|19|||
162959828|NCT04544410|588554813|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
162959829|NCT04544410|588554814|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
162959830|NCT04544410|588554813|FG000|Open-Label Treatment Period|Adverse Event|0|||
162959831|NCT04544410|588554814|FG001|Open-Label Treatment Period|Adverse Event|1|||
162959832|NCT04544410|588554813|FG000|Open-Label Treatment Period|Physician Decision|1|||
162959833|NCT04544410|588554814|FG001|Open-Label Treatment Period|Physician Decision|0|||
162959834|NCT04544410|588554813|FG000|Open-Label Treatment Period|Other|0|||
162959835|NCT04544410|588554814|FG001|Open-Label Treatment Period|Other|1|||
162959836|NCT01750294|588556173|FG000|Overall Study|Withdrawal by Subject|1|||
162959837|NCT01750294|588556173|FG000|Overall Study|Safety Endpoint|1|||
162959838|NCT01624233|588556174|FG000|Period 2 - Induction|Adverse Event|1|||
162959839|NCT01624233|588556174|FG000|Period 3 - Maintenance|Adverse Event|2|||
162959840|NCT01624233|588556174|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
162959841|NCT01624233|588556174|FG000|Period 3 - Maintenance|Physician Decision|2|||
162959842|NCT01624233|588556174|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
162959843|NCT01624233|588556174|FG000|Period 4 - Drug Free Period|Relapsed|61|||
162959844|NCT01624233|588556174|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
162959845|NCT01624233|588556174|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
162959846|NCT01624233|588556174|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
162959847|NCT01624233|588556174|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
162959848|NCT01624233|588556174|FG000|Period 6: Follow-up|Adverse Event|3|||
162959849|NCT01624233|588556174|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
162959850|NCT01624233|588556174|FG000|Period 6: Follow-up|Physician Decision|1|||
162959851|NCT01624233|588556174|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
162959852|NCT03121586|588556175|FG000|Overall Study|Study terminated by sponsor|0|||
162959853|NCT03121586|588556176|FG001|Overall Study|Study terminated by sponsor|0|||
162959854|NCT03121586|588556177|FG002|Overall Study|Study terminated by sponsor|99|||
162959855|NCT03121586|588556175|FG000|Overall Study|Withdrawal by Subject|37|||
162959856|NCT03121586|588556176|FG001|Overall Study|Withdrawal by Subject|14|||
162959857|NCT03121586|588556177|FG002|Overall Study|Withdrawal by Subject|9|||
162959858|NCT03121586|588556175|FG000|Overall Study|Not further specified|6|||
162959859|NCT03121586|588556176|FG001|Overall Study|Not further specified|11|||
163046778|NCT02326272|588879356|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
163046779|NCT02326272|588879357|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046780|NCT02326272|588879358|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046781|NCT02326272|588879359|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
162959860|NCT03121586|588556177|FG002|Overall Study|Not further specified|10|||
162959861|NCT03121586|588556175|FG000|Overall Study|Adverse Event|16|||
162959862|NCT03121586|588556176|FG001|Overall Study|Adverse Event|5|||
162959863|NCT03121586|588556177|FG002|Overall Study|Adverse Event|6|||
162959864|NCT03121586|588556175|FG000|Overall Study|Protocol Violation|0|||
163046782|NCT02326272|588879360|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163302650|NCT02554786|589815529|FG003|Overall Study|Adverse Event|0|||
162959865|NCT03121586|588556176|FG001|Overall Study|Protocol Violation|5|||
162959866|NCT03121586|588556177|FG002|Overall Study|Protocol Violation|0|||
162959867|NCT03121586|588556175|FG000|Overall Study|Lack of Efficacy|3|||
162959868|NCT03121586|588556176|FG001|Overall Study|Lack of Efficacy|3|||
162959869|NCT03121586|588556177|FG002|Overall Study|Lack of Efficacy|1|||
162959870|NCT03121586|588556175|FG000|Overall Study|Physician Decision|2|||
162959871|NCT03121586|588556176|FG001|Overall Study|Physician Decision|2|||
162959872|NCT03121586|588556177|FG002|Overall Study|Physician Decision|0|||
162959873|NCT03121586|588556175|FG000|Overall Study|Noncompliance with study drug|5|||
162959874|NCT03121586|588556176|FG001|Overall Study|Noncompliance with study drug|3|||
162959875|NCT03121586|588556177|FG002|Overall Study|Noncompliance with study drug|5|||
162959876|NCT03121586|588556175|FG000|Overall Study|Lost to Follow-up|4|||
162959877|NCT03121586|588556176|FG001|Overall Study|Lost to Follow-up|2|||
162959878|NCT03121586|588556177|FG002|Overall Study|Lost to Follow-up|0|||
162959879|NCT03121586|588556175|FG000|Overall Study|Death|2|||
162959880|NCT03121586|588556176|FG001|Overall Study|Death|0|||
162959881|NCT03121586|588556177|FG002|Overall Study|Death|0|||
163196445|NCT04457336|589434144|FG006|Period 2: Part A|Physician Decision|0|||
163196446|NCT04457336|589434145|FG007|Period 2: Part A|Physician Decision|0|||
163394887|NCT00880555|590158553|FG003|Overall Study|Withdrawal by Subject|0|||
163394888|NCT00880555|590158554|FG004|Overall Study|Withdrawal by Subject|0|||
163196447|NCT04457336|589434138|FG000|Period 3: Part B|Study Terminated|0|||
163196448|NCT04457336|589434139|FG001|Period 3: Part B|Study Terminated|0|||
162959882|NCT06381102|588556178|FG000|Washout 5 Days|Withdrawal by Subject|0|||
162959883|NCT06381102|588556179|FG001|Washout 5 Days|Withdrawal by Subject|2|||
162959884|NCT02832063|588556181|FG000|Overall Study|Adverse Event|2|||
162959885|NCT02832063|588556182|FG001|Overall Study|Adverse Event|1|||
163196449|NCT04457336|589434140|FG002|Period 3: Part B|Study Terminated|0|||
163196450|NCT04457336|589434141|FG003|Period 3: Part B|Study Terminated|0|||
163196451|NCT04457336|589434142|FG004|Period 3: Part B|Study Terminated|1|||
163196452|NCT04457336|589434143|FG005|Period 3: Part B|Study Terminated|10|||
163196453|NCT04457336|589434144|FG006|Period 3: Part B|Study Terminated|13|||
163196454|NCT04457336|589434145|FG007|Period 3: Part B|Study Terminated|0|||
163196455|NCT04457336|589434138|FG000|Period 3: Part B|Withdrawal by Subject|0|||
163196456|NCT04457336|589434139|FG001|Period 3: Part B|Withdrawal by Subject|0|||
163196457|NCT04457336|589434140|FG002|Period 3: Part B|Withdrawal by Subject|0|||
163196458|NCT04457336|589434141|FG003|Period 3: Part B|Withdrawal by Subject|0|||
163196459|NCT04457336|589434142|FG004|Period 3: Part B|Withdrawal by Subject|0|||
163394889|NCT00880555|590158555|FG005|Overall Study|Withdrawal by Subject|0|||
163196460|NCT04457336|589434143|FG005|Period 3: Part B|Withdrawal by Subject|1|||
163196461|NCT04457336|589434144|FG006|Period 3: Part B|Withdrawal by Subject|2|||
163196462|NCT04457336|589434145|FG007|Period 3: Part B|Withdrawal by Subject|0|||
163046783|NCT02326272|588879361|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163196463|NCT04457336|589434138|FG000|Period 4: Part C|Study Terminated|0|||
163196464|NCT04457336|589434139|FG001|Period 4: Part C|Study Terminated|0|||
163196465|NCT04457336|589434140|FG002|Period 4: Part C|Study Terminated|0|||
163196466|NCT04457336|589434141|FG003|Period 4: Part C|Study Terminated|0|||
163196467|NCT04457336|589434142|FG004|Period 4: Part C|Study Terminated|0|||
163196468|NCT04457336|589434143|FG005|Period 4: Part C|Study Terminated|0|||
163196469|NCT04457336|589434144|FG006|Period 4: Part C|Study Terminated|0|||
163196470|NCT04457336|589434145|FG007|Period 4: Part C|Study Terminated|30|||
163196471|NCT04457336|589434138|FG000|Period 4: Part C|Adverse Event|0|||
163196472|NCT04457336|589434139|FG001|Period 4: Part C|Adverse Event|0|||
163196473|NCT04457336|589434140|FG002|Period 4: Part C|Adverse Event|0|||
163196474|NCT04457336|589434141|FG003|Period 4: Part C|Adverse Event|0|||
163196475|NCT04457336|589434142|FG004|Period 4: Part C|Adverse Event|0|||
163196476|NCT04457336|589434143|FG005|Period 4: Part C|Adverse Event|0|||
163196477|NCT04457336|589434144|FG006|Period 4: Part C|Adverse Event|0|||
163196478|NCT04457336|589434145|FG007|Period 4: Part C|Adverse Event|2|||
163196479|NCT04457336|589434138|FG000|Period 4: Part C|Site Terminated|0|||
163196480|NCT04457336|589434139|FG001|Period 4: Part C|Site Terminated|0|||
163196481|NCT04457336|589434140|FG002|Period 4: Part C|Site Terminated|0|||
163196482|NCT04457336|589434141|FG003|Period 4: Part C|Site Terminated|0|||
163196483|NCT04457336|589434142|FG004|Period 4: Part C|Site Terminated|0|||
163196484|NCT04457336|589434143|FG005|Period 4: Part C|Site Terminated|0|||
163196485|NCT04457336|589434144|FG006|Period 4: Part C|Site Terminated|0|||
163196486|NCT04457336|589434145|FG007|Period 4: Part C|Site Terminated|1|||
163196487|NCT04457336|589434138|FG000|Period 4: Part C|Other|0|||
163196488|NCT04457336|589434139|FG001|Period 4: Part C|Other|0|||
163196489|NCT04457336|589434140|FG002|Period 4: Part C|Other|0|||
163196490|NCT04457336|589434141|FG003|Period 4: Part C|Other|0|||
163196491|NCT04457336|589434142|FG004|Period 4: Part C|Other|0|||
163196492|NCT04457336|589434143|FG005|Period 4: Part C|Other|0|||
163196493|NCT04457336|589434144|FG006|Period 4: Part C|Other|0|||
163196494|NCT04457336|589434145|FG007|Period 4: Part C|Other|2|||
163196495|NCT04457336|589434138|FG000|Period 4: Part C|Withdrawal by Subject|0|||
163196496|NCT04457336|589434139|FG001|Period 4: Part C|Withdrawal by Subject|0|||
163196497|NCT04457336|589434140|FG002|Period 4: Part C|Withdrawal by Subject|0|||
163196498|NCT04457336|589434141|FG003|Period 4: Part C|Withdrawal by Subject|0|||
163196499|NCT04457336|589434142|FG004|Period 4: Part C|Withdrawal by Subject|0|||
163196500|NCT04457336|589434143|FG005|Period 4: Part C|Withdrawal by Subject|0|||
163196501|NCT04457336|589434144|FG006|Period 4: Part C|Withdrawal by Subject|0|||
163196502|NCT04457336|589434145|FG007|Period 4: Part C|Withdrawal by Subject|3|||
163196503|NCT01416272|589434155|FG000|Overall Study|Unacceptable distance visual acuity|2|||
163196504|NCT01416272|589434155|FG000|Overall Study|Lost to Follow-up|1|||
163196505|NCT01416272|589434155|FG000|Overall Study|Study related complaints|1|||
163196506|NCT00239590|589434160|FG000|Randomized|Lost to Follow-up|0|||
163196507|NCT00239590|589434161|FG001|Randomized|Lost to Follow-up|1|||
163196508|NCT00239590|589434160|FG000|Randomized|Withdrawal by Subject|0|||
163196509|NCT00239590|589434161|FG001|Randomized|Withdrawal by Subject|1|||
163196510|NCT00239590|589434160|FG000|Completed Study Protocol|Adverse Event|1|||
163196511|NCT00239590|589434161|FG001|Completed Study Protocol|Adverse Event|1|||
163196512|NCT00239590|589434160|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
163196513|NCT00239590|589434161|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
163196514|NCT00892047|589434166|FG000|Overall Study|Adverse Event|2|||
163196515|NCT00892047|589434167|FG001|Overall Study|Adverse Event|2|||
163196516|NCT00892047|589434166|FG000|Overall Study|subject burden|2|||
163196517|NCT00892047|589434167|FG001|Overall Study|subject burden|3|||
163196518|NCT00892047|589434166|FG000|Overall Study|Lack of Efficacy|0|||
163196519|NCT00892047|589434167|FG001|Overall Study|Lack of Efficacy|2|||
163196520|NCT02217878|589434168|FG000|Overall Study|required morphine due to chest pain|1|||
163196521|NCT02217878|589434169|FG001|Overall Study|required morphine due to chest pain|2|||
163196522|NCT02217878|589434168|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
163196523|NCT02217878|589434169|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
163196524|NCT01201785|589434173|FG000|Overall Study|Lost to Follow-up|16|||
163196525|NCT02151110|589434174|FG000|Overall Study|Withdrawal by Subject|0|||
163196526|NCT02151110|589434175|FG001|Overall Study|Withdrawal by Subject|0|||
163196527|NCT02151110|589434176|FG002|Overall Study|Withdrawal by Subject|0|||
163196528|NCT02151110|589434177|FG003|Overall Study|Withdrawal by Subject|0|||
163196529|NCT02151110|589434178|FG004|Overall Study|Withdrawal by Subject|0|||
163196530|NCT02151110|589434179|FG005|Overall Study|Withdrawal by Subject|0|||
163196531|NCT02151110|589434180|FG006|Overall Study|Withdrawal by Subject|0|||
163196532|NCT02151110|589434181|FG007|Overall Study|Withdrawal by Subject|1|||
163196533|NCT02151110|589434174|FG000|Overall Study|Lost to Follow-up|0|||
163196534|NCT02151110|589434175|FG001|Overall Study|Lost to Follow-up|0|||
163196535|NCT02151110|589434176|FG002|Overall Study|Lost to Follow-up|0|||
163196536|NCT02151110|589434177|FG003|Overall Study|Lost to Follow-up|0|||
163196537|NCT02151110|589434178|FG004|Overall Study|Lost to Follow-up|0|||
163196538|NCT02151110|589434179|FG005|Overall Study|Lost to Follow-up|0|||
163196539|NCT02151110|589434180|FG006|Overall Study|Lost to Follow-up|0|||
163196540|NCT02151110|589434181|FG007|Overall Study|Lost to Follow-up|2|||
163196541|NCT01999179|589434182|FG000|Overall Study|Adverse Event|1|||
163196542|NCT01999179|589434182|FG000|Overall Study|Lost to Follow-up|1|||
163196543|NCT01999179|589434182|FG000|Overall Study|Change in Therapy|3|||
163196544|NCT01999179|589434182|FG000|Overall Study|New catheter|2|||
163196545|NCT01146665|589434183|FG000|Overall Study|Withdrawal by Subject|10|||
163196546|NCT01146665|589434184|FG001|Overall Study|Withdrawal by Subject|16|||
163196547|NCT01064310|589434187|FG000|Period 1|Adverse Event|7|||
163196548|NCT01064310|589434188|FG001|Period 1|Adverse Event|10|||
163196549|NCT01064310|589434189|FG002|Period 1|Adverse Event|0|||
163196550|NCT01064310|589434187|FG000|Period 1|Physician Decision|1|||
163196551|NCT01064310|589434188|FG001|Period 1|Physician Decision|0|||
163196552|NCT01064310|589434189|FG002|Period 1|Physician Decision|0|||
163196553|NCT01064310|589434187|FG000|Period 1|Withdrawal by Subject|2|||
163196554|NCT01064310|589434188|FG001|Period 1|Withdrawal by Subject|2|||
163196555|NCT01064310|589434189|FG002|Period 1|Withdrawal by Subject|0|||
163196556|NCT01064310|589434187|FG000|Period 1|Lack of Efficacy|3|||
163196557|NCT01064310|589434188|FG001|Period 1|Lack of Efficacy|5|||
163196558|NCT01064310|589434189|FG002|Period 1|Lack of Efficacy|0|||
163196559|NCT01064310|589434187|FG000|Period 1|Entered Open-label Period|1|||
163196560|NCT01064310|589434188|FG001|Period 1|Entered Open-label Period|1|||
163196561|NCT01064310|589434189|FG002|Period 1|Entered Open-label Period|0|||
163196562|NCT01064310|589434187|FG000|Period 2|Adverse Event|2|||
163196563|NCT01064310|589434188|FG001|Period 2|Adverse Event|1|||
163196564|NCT01064310|589434189|FG002|Period 2|Adverse Event|0|||
163196565|NCT01064310|589434187|FG000|Period 2|Physician Decision|0|||
163196566|NCT01064310|589434188|FG001|Period 2|Physician Decision|1|||
163196567|NCT01064310|589434189|FG002|Period 2|Physician Decision|0|||
163196568|NCT01064310|589434187|FG000|Period 2|Entered Open-label Period|1|||
163196569|NCT01064310|589434188|FG001|Period 2|Entered Open-label Period|0|||
163196570|NCT01064310|589434189|FG002|Period 2|Entered Open-label Period|0|||
163196571|NCT01064310|589434187|FG000|Period 2|Lack of Efficacy|1|||
163196572|NCT01064310|589434188|FG001|Period 2|Lack of Efficacy|4|||
163196573|NCT01064310|589434189|FG002|Period 2|Lack of Efficacy|0|||
163196574|NCT01064310|589434187|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
163196575|NCT01064310|589434188|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
163196576|NCT01064310|589434189|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
163196577|NCT01064310|589434187|FG000|Open Label Pazopinib|Adverse Event|0|||
163196578|NCT01064310|589434188|FG001|Open Label Pazopinib|Adverse Event|0|||
163196579|NCT01064310|589434189|FG002|Open Label Pazopinib|Adverse Event|12|||
163196580|NCT01064310|589434187|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
163196581|NCT01064310|589434188|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
163196582|NCT01064310|589434189|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
163196583|NCT01064310|589434187|FG000|Open Label Pazopinib|Physician Decision|0|||
163196584|NCT01064310|589434188|FG001|Open Label Pazopinib|Physician Decision|0|||
163196585|NCT01064310|589434189|FG002|Open Label Pazopinib|Physician Decision|20|||
163196586|NCT00001880|589434190|FG000|Overall Study|Death|14|||
163196587|NCT02639065|589434191|FG000|Study Treatment|Disease Progression|13|||
163196588|NCT02639065|589434191|FG000|Study Treatment|Adverse Event|9|||
163196589|NCT02639065|589434191|FG000|Study Treatment|Withdrawal by Subject|1|||
163196590|NCT02639065|589434191|FG000|Follow up|Subject refused to follow up|1|||
163302651|NCT02554786|589815530|FG004|Overall Study|Adverse Event|2|||
163302652|NCT02554786|589815526|FG000|Overall Study|Death|0|||
163302653|NCT02554786|589815527|FG001|Overall Study|Death|0|||
163302654|NCT02554786|589815528|FG002|Overall Study|Death|0|||
163302655|NCT02554786|589815529|FG003|Overall Study|Death|1|||
163302656|NCT02554786|589815530|FG004|Overall Study|Death|0|||
163302657|NCT02554786|589815526|FG000|Overall Study|Non-compliance with study treatment|0|||
163302658|NCT02554786|589815527|FG001|Overall Study|Non-compliance with study treatment|1|||
163302659|NCT02554786|589815528|FG002|Overall Study|Non-compliance with study treatment|1|||
163302660|NCT02554786|589815529|FG003|Overall Study|Non-compliance with study treatment|0|||
163196591|NCT02639065|589434191|FG000|Follow up|Symptomatic Deterioration|2|||
163196592|NCT02639065|589434191|FG000|Follow up|Death|2|||
163302661|NCT02554786|589815530|FG004|Overall Study|Non-compliance with study treatment|1|||
163302662|NCT02554786|589815526|FG000|Overall Study|Physician Decision|0|||
163302663|NCT02554786|589815527|FG001|Overall Study|Physician Decision|1|||
163302664|NCT02554786|589815528|FG002|Overall Study|Physician Decision|4|||
163302665|NCT02554786|589815529|FG003|Overall Study|Physician Decision|1|||
163302666|NCT02554786|589815530|FG004|Overall Study|Physician Decision|1|||
163302667|NCT02554786|589815526|FG000|Overall Study|Pregnancy|0|||
162959886|NCT02832063|588556181|FG000|Overall Study|Physician Decision|5|||
162959887|NCT02832063|588556182|FG001|Overall Study|Physician Decision|7|||
162959888|NCT02832063|588556181|FG000|Overall Study|Lost to Follow-up|15|||
162959889|NCT02832063|588556182|FG001|Overall Study|Lost to Follow-up|8|||
163302668|NCT02554786|589815527|FG001|Overall Study|Pregnancy|0|||
162959890|NCT02832063|588556181|FG000|Overall Study|Withdrawal by Subject|10|||
163302669|NCT02554786|589815528|FG002|Overall Study|Pregnancy|0|||
163302670|NCT02554786|589815529|FG003|Overall Study|Pregnancy|1|||
163046784|NCT02326272|588879362|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046785|NCT02326272|588879363|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046786|NCT02326272|588879364|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163196593|NCT02639065|589434191|FG000|Follow up|Study Terminated|1|||
163196594|NCT02639065|589434191|FG000|Follow up|Disease Progression|3|||
163196595|NCT00660699|589434192|FG000|Overall Study|Withdrawal by Subject|2|||
163196596|NCT05147428|589434193|FG000|Overall Study|Removed prior to mailing|289|||
163196597|NCT05147428|589434194|FG001|Overall Study|Removed prior to mailing|306|||
163196598|NCT05147428|589434195|FG002|Overall Study|Removed prior to mailing|270|||
163196599|NCT05147428|589434193|FG000|Overall Study|Died or disenrolled during blackout period|239|||
163196600|NCT05147428|589434194|FG001|Overall Study|Died or disenrolled during blackout period|278|||
163196601|NCT05147428|589434195|FG002|Overall Study|Died or disenrolled during blackout period|273|||
163196602|NCT03128047|589434196|FG000|Overall Study|Withdrawal by Subject|1|||
163196603|NCT01713686|589435706|FG000|Overall Study|Lost to Follow-up|9|||
163196604|NCT01713686|589435706|FG000|Overall Study|Withdrawal by Subject|6|||
163196605|NCT02385045|589435707|FG000|Overall Study|Endoscopy could not be completed|4|||
163196606|NCT00381485|589435709|FG000|Open-Label Run-In Period|Adverse Event|9|||
163196607|NCT00381485|589435710|FG001|Open-Label Run-In Period|Adverse Event|0|||
163196608|NCT00381485|589435711|FG002|Open-Label Run-In Period|Adverse Event|0|||
163196609|NCT00381485|589435712|FG003|Open-Label Run-In Period|Adverse Event|0|||
163196610|NCT00381485|589435709|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
163196611|NCT00381485|589435710|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
163196612|NCT00381485|589435711|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
163196613|NCT00381485|589435712|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
163196614|NCT00381485|589435709|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
163196615|NCT00381485|589435710|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
163196616|NCT00381485|589435711|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
163196617|NCT00381485|589435712|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
163302671|NCT02554786|589815530|FG004|Overall Study|Pregnancy|1|||
163302672|NCT04583423|589815541|FG000|Overall Study|Lost to Follow-up|0|||
163302673|NCT04583423|589815542|FG001|Overall Study|Lost to Follow-up|1|||
163302674|NCT04583423|589815543|FG002|Overall Study|Lost to Follow-up|0|||
163302675|NCT04583423|589815544|FG003|Overall Study|Lost to Follow-up|2|||
163302676|NCT04583423|589815541|FG000|Overall Study|Study Terminated by Sponsor|32|||
163302677|NCT04583423|589815542|FG001|Overall Study|Study Terminated by Sponsor|35|||
163302678|NCT04583423|589815543|FG002|Overall Study|Study Terminated by Sponsor|36|||
163302679|NCT04583423|589815544|FG003|Overall Study|Study Terminated by Sponsor|33|||
163302680|NCT04583423|589815541|FG000|Overall Study|Withdrawal by Subject|3|||
163302681|NCT04583423|589815542|FG001|Overall Study|Withdrawal by Subject|1|||
163302682|NCT04583423|589815543|FG002|Overall Study|Withdrawal by Subject|2|||
163302683|NCT04583423|589815544|FG003|Overall Study|Withdrawal by Subject|1|||
163302684|NCT03330795|589815545|FG000|Overall Study|Death|3|||
162959891|NCT02832063|588556182|FG001|Overall Study|Withdrawal by Subject|21|||
162959892|NCT02832063|588556181|FG000|Overall Study|Other|2|||
162959893|NCT02832063|588556182|FG001|Overall Study|Other|1|||
162959894|NCT03733730|588556183|FG000|Overall Study|Lost to Follow-up|1|||
162959895|NCT03733730|588556184|FG001|Overall Study|Lost to Follow-up|32|||
162959896|NCT03733730|588556183|FG000|Overall Study|Other|1|||
162959897|NCT03733730|588556184|FG001|Overall Study|Other|0|||
162959898|NCT03733730|588556183|FG000|Overall Study|Adverse Event|0|||
162959899|NCT03733730|588556184|FG001|Overall Study|Adverse Event|4|||
162959900|NCT03733730|588556183|FG000|Overall Study|Death|0|||
162959901|NCT03733730|588556184|FG001|Overall Study|Death|5|||
162959902|NCT03733730|588556183|FG000|Overall Study|Withdrawal by Subject|0|||
162959903|NCT03733730|588556184|FG001|Overall Study|Withdrawal by Subject|8|||
162959904|NCT00772603|588556185|FG000|Overall Study|Withdrawal by Subject|11|||
162959905|NCT00772603|588556186|FG001|Overall Study|Withdrawal by Subject|10|||
162959906|NCT00772603|588556187|FG002|Overall Study|Withdrawal by Subject|6|||
162959907|NCT00772603|588556185|FG000|Overall Study|Adverse Event|37|||
162959908|NCT00772603|588556186|FG001|Overall Study|Adverse Event|18|||
162959909|NCT00772603|588556187|FG002|Overall Study|Adverse Event|10|||
162959910|NCT00772603|588556185|FG000|Overall Study|Subject Non-compliance|1|||
162959911|NCT00772603|588556186|FG001|Overall Study|Subject Non-compliance|6|||
162959912|NCT00772603|588556187|FG002|Overall Study|Subject Non-compliance|4|||
162959913|NCT00772603|588556185|FG000|Overall Study|Protocol Violation|0|||
162959914|NCT00772603|588556186|FG001|Overall Study|Protocol Violation|1|||
162959915|NCT00772603|588556187|FG002|Overall Study|Protocol Violation|1|||
162959916|NCT00772603|588556185|FG000|Overall Study|Lost to Follow-up|1|||
163302685|NCT03330795|589815545|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
163302686|NCT05575076|589815546|FG000|Overall Study|Adverse Event|24|||
163302687|NCT05575076|589815546|FG000|Overall Study|Death|7|||
162959917|NCT00772603|588556186|FG001|Overall Study|Lost to Follow-up|5|||
162959918|NCT00772603|588556187|FG002|Overall Study|Lost to Follow-up|2|||
162959919|NCT00772603|588556185|FG000|Overall Study|Physician Decision|0|||
162959920|NCT00772603|588556186|FG001|Overall Study|Physician Decision|0|||
162959921|NCT00772603|588556187|FG002|Overall Study|Physician Decision|1|||
162959922|NCT00772603|588556185|FG000|Overall Study|Other|2|||
162959923|NCT00772603|588556186|FG001|Overall Study|Other|0|||
162959924|NCT00772603|588556187|FG002|Overall Study|Other|2|||
162959925|NCT00835575|588556188|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
162959926|NCT00835575|588556189|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
163302688|NCT05575076|589815546|FG000|Overall Study|Lost to Follow-up|16|||
163302689|NCT05575076|589815546|FG000|Overall Study|Non-Compliance|3|||
163302690|NCT05575076|589815546|FG000|Overall Study|Physician Decision|6|||
163302691|NCT05575076|589815546|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
163302692|NCT05575076|589815546|FG000|Overall Study|Withdrawal by Subject|71|||
163302693|NCT05575076|589815546|FG000|Overall Study|Study Terminated by Sponsor|630|||
163302694|NCT05575076|589815546|FG000|Overall Study|Other|17|||
163302695|NCT00510887|589815547|FG000|Overall Study|Lost to Follow-up|1|||
163302696|NCT01736215|589815557|FG000|Overall Study|Early termination of erythropoietin use|1|||
163394890|NCT00880555|590158550|FG000|Overall Study|Lack of resources (hired rater)|9|||
163394891|NCT00880555|590158551|FG001|Overall Study|Lack of resources (hired rater)|7|||
163394892|NCT00880555|590158552|FG002|Overall Study|Lack of resources (hired rater)|5|||
163394893|NCT00880555|590158553|FG003|Overall Study|Lack of resources (hired rater)|0|||
163394894|NCT00880555|590158554|FG004|Overall Study|Lack of resources (hired rater)|0|||
163394895|NCT00880555|590158555|FG005|Overall Study|Lack of resources (hired rater)|0|||
163394896|NCT00880555|590158550|FG000|Overall Study|Death|0|||
163394897|NCT00880555|590158551|FG001|Overall Study|Death|0|||
163394898|NCT00880555|590158552|FG002|Overall Study|Death|0|||
163394899|NCT00880555|590158553|FG003|Overall Study|Death|0|||
163394900|NCT00880555|590158554|FG004|Overall Study|Death|0|||
163394901|NCT00880555|590158555|FG005|Overall Study|Death|1|||
163394902|NCT00880555|590158550|FG000|Overall Study|Lost to Follow-up|0|||
163394903|NCT00880555|590158551|FG001|Overall Study|Lost to Follow-up|1|||
163394904|NCT00880555|590158552|FG002|Overall Study|Lost to Follow-up|0|||
163394905|NCT00880555|590158553|FG003|Overall Study|Lost to Follow-up|0|||
163394906|NCT00880555|590158554|FG004|Overall Study|Lost to Follow-up|0|||
163394907|NCT00880555|590158555|FG005|Overall Study|Lost to Follow-up|0|||
163394908|NCT02982590|590158556|FG000|Overall Study|Lost to Follow-up|0|||
163196618|NCT00381485|589435709|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
163394909|NCT02982590|590158557|FG001|Overall Study|Lost to Follow-up|1|||
162959927|NCT01564394|588556192|FG000|Overall Study|Withdrawal by Subject|6|||
162959928|NCT01564394|588556193|FG001|Overall Study|Withdrawal by Subject|10|||
162959929|NCT00859521|588556194|FG000|Washout|Withdrawal by Subject|0|||
162959930|NCT00859521|588556195|FG001|Washout|Withdrawal by Subject|1|||
162959931|NCT01609257|588556196|FG000|Overall Study|Lost to Follow-up|2|||
162959932|NCT01609257|588556197|FG001|Overall Study|Lost to Follow-up|1|||
162959933|NCT01609257|588556196|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
162959934|NCT01609257|588556197|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
162959935|NCT01609257|588556196|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
162959936|NCT01609257|588556197|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
162959937|NCT02125461|588556198|FG000|Overall Study|Withdrawal by Subject|30|||
162959938|NCT02125461|588556199|FG001|Overall Study|Withdrawal by Subject|16|||
162959939|NCT02125461|588556198|FG000|Overall Study|Lost to Follow-up|8|||
162959940|NCT02125461|588556199|FG001|Overall Study|Lost to Follow-up|3|||
162959941|NCT02125461|588556198|FG000|Overall Study|Death|260|||
162959942|NCT02125461|588556199|FG001|Overall Study|Death|149|||
162959943|NCT02125461|588556198|FG000|Overall Study|Missing Termination Reason|0|||
162959944|NCT02125461|588556199|FG001|Overall Study|Missing Termination Reason|1|||
162959945|NCT03552484|588556208|FG000|Overall Study|Death|6|||
162959946|NCT03552484|588556209|FG001|Overall Study|Death|4|||
162959947|NCT03552484|588556208|FG000|Overall Study|Lost to Follow-up|0|||
162959948|NCT03552484|588556209|FG001|Overall Study|Lost to Follow-up|16|||
162959949|NCT02241551|588556210|FG000|Overall Study|Adverse Event|1|||
162959950|NCT02241551|588556211|FG001|Overall Study|Adverse Event|0|||
162959951|NCT03499353|588556212|FG000|Treatment|Adverse Event|3|||
162959952|NCT03499353|588556212|FG000|Treatment|Progressive Disease|10|||
162959953|NCT03499353|588556212|FG000|Treatment|Other|1|||
162959954|NCT03499353|588556212|FG000|Treatment|Withdrawal by Subject|2|||
162959955|NCT03499353|588556212|FG000|Long-Term Follow-up|Death|2|||
162959956|NCT03499353|588556212|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
162959957|NCT03499353|588556212|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
162959958|NCT00469898|588556219|FG000|Overall Study|Adverse Event|7|||
162959959|NCT00469898|588556219|FG000|Overall Study|Withdrawal by Subject|4|||
162959960|NCT00469898|588556219|FG000|Overall Study|Death|4|||
162959961|NCT00469898|588556219|FG000|Overall Study|Disease progression|9|||
162959962|NCT00469898|588556219|FG000|Overall Study|Decreased performance status|1|||
162959963|NCT02663349|588556222|FG000|Overall Study|Withdrawal by Subject|6|||
162959964|NCT02751424|588556230|FG000|Part 2|Adverse Event|0|||
162959965|NCT02751424|588556231|FG001|Part 2|Adverse Event|0|||
162959966|NCT02751424|588556232|FG002|Part 2|Adverse Event|0|||
162959967|NCT02751424|588556233|FG003|Part 2|Adverse Event|0|||
162959968|NCT02751424|588556234|FG004|Part 2|Adverse Event|0|||
162959969|NCT02751424|588556235|FG005|Part 2|Adverse Event|0|||
162959970|NCT02751424|588556236|FG006|Part 2|Adverse Event|0|||
162959971|NCT02751424|588556237|FG007|Part 2|Adverse Event|5|||
162959972|NCT02751424|588556238|FG008|Part 2|Adverse Event|0|||
162959973|NCT00848536|588556239|FG000|Overall Study|Adverse Event|2|||
162959974|NCT00848536|588556240|FG001|Overall Study|Adverse Event|2|||
162959975|NCT00848536|588556239|FG000|Overall Study|Withdrawal by Subject|0|||
162959976|NCT00848536|588556240|FG001|Overall Study|Withdrawal by Subject|1|||
162959977|NCT00848536|588556239|FG000|Overall Study|Protocol Violation|0|||
162959978|NCT00848536|588556240|FG001|Overall Study|Protocol Violation|1|||
162959979|NCT00848536|588556239|FG000|Overall Study|Noncompliance|1|||
162959980|NCT00848536|588556240|FG001|Overall Study|Noncompliance|0|||
162959981|NCT00848536|588556239|FG000|Overall Study|Inadequate Control of IOP|1|||
162959982|NCT00848536|588556240|FG001|Overall Study|Inadequate Control of IOP|1|||
162959983|NCT00848536|588556239|FG000|Overall Study|Patient Moved|0|||
162959984|NCT00848536|588556240|FG001|Overall Study|Patient Moved|2|||
162959985|NCT01175135|588556241|FG000|Overall Study|Adverse Event|2|||
162959986|NCT01175135|588556242|FG001|Overall Study|Adverse Event|5|||
162959987|NCT01175135|588556243|FG002|Overall Study|Adverse Event|3|||
162959988|NCT01175135|588556244|FG003|Overall Study|Adverse Event|4|||
162959989|NCT01175135|588556241|FG000|Overall Study|Death|1|||
162959990|NCT01175135|588556242|FG001|Overall Study|Death|0|||
162959991|NCT01175135|588556243|FG002|Overall Study|Death|0|||
162959992|NCT01175135|588556244|FG003|Overall Study|Death|0|||
162959993|NCT01175135|588556241|FG000|Overall Study|Lack of Efficacy|4|||
162959994|NCT01175135|588556242|FG001|Overall Study|Lack of Efficacy|5|||
162959995|NCT01175135|588556243|FG002|Overall Study|Lack of Efficacy|0|||
162959996|NCT01175135|588556244|FG003|Overall Study|Lack of Efficacy|5|||
162959997|NCT01175135|588556241|FG000|Overall Study|Lost to Follow-up|1|||
162959998|NCT01175135|588556242|FG001|Overall Study|Lost to Follow-up|2|||
162959999|NCT01175135|588556243|FG002|Overall Study|Lost to Follow-up|0|||
162960000|NCT01175135|588556244|FG003|Overall Study|Lost to Follow-up|0|||
162960001|NCT01175135|588556241|FG000|Overall Study|Protocol Violation|1|||
162960002|NCT01175135|588556242|FG001|Overall Study|Protocol Violation|1|||
162960003|NCT01175135|588556243|FG002|Overall Study|Protocol Violation|0|||
162960004|NCT01175135|588556244|FG003|Overall Study|Protocol Violation|0|||
162960005|NCT01175135|588556241|FG000|Overall Study|Withdrawal by Subject|4|||
162960006|NCT01175135|588556242|FG001|Overall Study|Withdrawal by Subject|8|||
162960007|NCT01175135|588556243|FG002|Overall Study|Withdrawal by Subject|5|||
162960008|NCT01175135|588556244|FG003|Overall Study|Withdrawal by Subject|5|||
162960009|NCT01175135|588556241|FG000|Overall Study|Other|3|||
162960010|NCT01175135|588556242|FG001|Overall Study|Other|1|||
162960011|NCT01175135|588556243|FG002|Overall Study|Other|3|||
162960012|NCT01175135|588556244|FG003|Overall Study|Other|0|||
162960013|NCT01175135|588556241|FG000|Overall Study|Randomized But Not Treated|0|||
162960014|NCT01175135|588556242|FG001|Overall Study|Randomized But Not Treated|0|||
162960015|NCT01175135|588556243|FG002|Overall Study|Randomized But Not Treated|1|||
162960016|NCT01175135|588556244|FG003|Overall Study|Randomized But Not Treated|0|||
162960017|NCT01590563|588556247|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
162960018|NCT03534193|588556250|FG000|Overall Study|Lost to Follow-up|1|||
162960019|NCT03534193|588556251|FG001|Overall Study|Lost to Follow-up|3|||
162960020|NCT02699463|588556252|FG000|Overall Study|Lost to Follow-up|11|||
162960021|NCT02699463|588556253|FG001|Overall Study|Lost to Follow-up|8|||
162960022|NCT02699463|588556252|FG000|Overall Study|Withdrawal by Subject|4|||
162960023|NCT02699463|588556253|FG001|Overall Study|Withdrawal by Subject|1|||
162960024|NCT02488239|588556254|FG000|Overall Study|Death|3|||
162960025|NCT02488239|588556254|FG000|Overall Study|Withdrawal by Subject|3|||
162960026|NCT02488239|588556254|FG000|Overall Study|Physician Decision|2|||
162960027|NCT02488239|588556254|FG000|Overall Study|Consent ineligible|1|||
162960028|NCT02488239|588556254|FG000|Overall Study|Did not undergo implant procedure|1|||
162960029|NCT04414930|588556256|FG000|Overall Study|Withdrawal by Subject|1|||
162960030|NCT04414930|588556257|FG001|Overall Study|Withdrawal by Subject|3|||
162960031|NCT05470699|588556258|FG000|Overall Study|Did not receive intervention|13|||
162960032|NCT05470699|588556258|FG000|Overall Study|Ineligible|1|||
162960033|NCT01370733|588556259|FG000|Overall Study|Withdrawal by Subject|8|||
162960034|NCT01370733|588556260|FG001|Overall Study|Withdrawal by Subject|8|||
162960035|NCT01370733|588556259|FG000|Overall Study|Lost to Follow-up|3|||
162960036|NCT01370733|588556260|FG001|Overall Study|Lost to Follow-up|0|||
162960037|NCT01370733|588556259|FG000|Overall Study|Adverse Event|2|||
162960038|NCT01370733|588556260|FG001|Overall Study|Adverse Event|4|||
162960039|NCT01370733|588556259|FG000|Overall Study|Lack of Efficacy|3|||
162960040|NCT01370733|588556260|FG001|Overall Study|Lack of Efficacy|5|||
162960041|NCT01370733|588556259|FG000|Overall Study|Physician Decision|0|||
162960042|NCT01370733|588556260|FG001|Overall Study|Physician Decision|2|||
162960043|NCT01370733|588556259|FG000|Overall Study|Protocol Violation|1|||
162960044|NCT01370733|588556260|FG001|Overall Study|Protocol Violation|3|||
162960045|NCT03325881|588556261|FG000|Overall Study|Protocol Violation|0|||
162960046|NCT03325881|588556262|FG001|Overall Study|Protocol Violation|1|||
162960047|NCT03325881|588556261|FG000|Overall Study|Withdrawal by Subject|0|||
162960048|NCT03325881|588556262|FG001|Overall Study|Withdrawal by Subject|2|||
163196619|NCT00381485|589435710|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
162960049|NCT03325881|588556261|FG000|Overall Study|Lack of Efficacy|2|||
162960050|NCT03325881|588556262|FG001|Overall Study|Lack of Efficacy|0|||
162960051|NCT03325881|588556261|FG000|Overall Study|Not treated|1|||
163196620|NCT00381485|589435711|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
163196621|NCT00381485|589435712|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
163196622|NCT00381485|589435709|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
162960052|NCT03325881|588556262|FG001|Overall Study|Not treated|0|||
162960053|NCT03676634|588556263|FG000|Overall Study|Red blood cell loss|1|||
162960054|NCT03676634|588556263|FG000|Overall Study|Out-of-limit pulse|2|||
162960055|NCT02294981|588556264|FG000|Overall Study|Lost to Follow-up|1|||
162960056|NCT00829712|588556265|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
162960057|NCT00829712|588556266|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
162960058|NCT01848938|588556278|FG000|Overall Study|Lost to Follow-up|1|||
162960059|NCT01848938|588556279|FG001|Overall Study|Lost to Follow-up|1|||
162960060|NCT00909753|588556282|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
163302697|NCT01736215|589815557|FG000|Overall Study|Adverse Event|4|||
162960061|NCT00909753|588556283|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
163046787|NCT02326272|588879365|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046788|NCT02326272|588879366|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046789|NCT02326272|588879367|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046790|NCT02326272|588879368|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046791|NCT02326272|588879354|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
163046792|NCT02326272|588879355|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
163046793|NCT02326272|588879356|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046794|NCT02326272|588879357|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046795|NCT02326272|588879358|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046796|NCT02326272|588879359|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046797|NCT02326272|588879360|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046798|NCT02326272|588879361|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046799|NCT02326272|588879362|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046800|NCT02326272|588879363|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046801|NCT02326272|588879364|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046802|NCT02326272|588879365|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046803|NCT02326272|588879366|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046804|NCT02326272|588879367|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046805|NCT02326272|588879368|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046806|NCT02326272|588879354|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
163046807|NCT02326272|588879355|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
163046808|NCT02326272|588879356|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
163046809|NCT02326272|588879357|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046810|NCT02326272|588879358|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046811|NCT02326272|588879359|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046812|NCT02326272|588879360|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046813|NCT02326272|588879361|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046814|NCT02326272|588879362|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046815|NCT02326272|588879363|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046816|NCT02326272|588879364|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046817|NCT02326272|588879365|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046818|NCT02326272|588879366|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046819|NCT02326272|588879367|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046820|NCT02326272|588879368|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046821|NCT02326272|588879354|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046822|NCT02326272|588879355|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046823|NCT02326272|588879356|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
163046824|NCT02326272|588879357|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046825|NCT02326272|588879358|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046826|NCT02326272|588879359|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046827|NCT02326272|588879360|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046828|NCT02326272|588879361|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046829|NCT02326272|588879362|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046830|NCT02326272|588879363|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046831|NCT02326272|588879364|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046832|NCT02326272|588879365|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046833|NCT02326272|588879366|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046834|NCT02326272|588879367|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046835|NCT02326272|588879368|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046836|NCT02326272|588879354|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046837|NCT02326272|588879355|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046838|NCT02326272|588879356|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
163046839|NCT02326272|588879357|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046840|NCT02326272|588879358|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046841|NCT02326272|588879359|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046842|NCT02326272|588879360|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046843|NCT02326272|588879361|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046844|NCT02326272|588879362|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046845|NCT02326272|588879363|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046846|NCT02326272|588879364|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046847|NCT02326272|588879365|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046848|NCT02326272|588879366|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046849|NCT02326272|588879367|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163302698|NCT01736215|589815557|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
163302699|NCT01736215|589815557|FG000|Overall Study|Insufficient data to perform analysis|8|||
162960062|NCT00909753|588556282|FG000|Period: Second Intervention|Protocol Violation|1|||
162960063|NCT00909753|588556283|FG001|Period: Second Intervention|Protocol Violation|0|||
162960064|NCT00835536|588556284|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
162960065|NCT00835536|588556285|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
162960066|NCT04827394|588556293|FG000|Overall Study|Physician Decision|0|||
162960067|NCT04827394|588556294|FG001|Overall Study|Physician Decision|2|||
162960068|NCT01154231|588556295|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
162960069|NCT01154231|588556295|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
162960070|NCT06041256|588556296|FG000|Overall Study|Withdrawal by Subject|1|||
162960071|NCT06041256|588556297|FG001|Overall Study|Withdrawal by Subject|0|||
162960072|NCT06041256|588556298|FG002|Overall Study|Withdrawal by Subject|3|||
162960073|NCT06041256|588556299|FG003|Overall Study|Withdrawal by Subject|1|||
162960074|NCT06041256|588556300|FG004|Overall Study|Withdrawal by Subject|1|||
162960075|NCT06041256|588556296|FG000|Overall Study|Rescue|17|||
162960076|NCT06041256|588556297|FG001|Overall Study|Rescue|6|||
162960077|NCT06041256|588556298|FG002|Overall Study|Rescue|9|||
162960078|NCT06041256|588556299|FG003|Overall Study|Rescue|6|||
162960079|NCT06041256|588556300|FG004|Overall Study|Rescue|2|||
162960080|NCT03578809|588557587|FG000|Overall Study|Death|0|||
162960081|NCT03578809|588557588|FG001|Overall Study|Death|2|||
162960082|NCT03578809|588557589|FG002|Overall Study|Death|0|||
162960083|NCT03578809|588557590|FG003|Overall Study|Death|1|||
162960084|NCT03578809|588557587|FG000|Overall Study|Lost to Follow-up|0|||
162960085|NCT03578809|588557588|FG001|Overall Study|Lost to Follow-up|1|||
162960086|NCT03578809|588557589|FG002|Overall Study|Lost to Follow-up|0|||
162960087|NCT03578809|588557590|FG003|Overall Study|Lost to Follow-up|0|||
162960088|NCT03578809|588557587|FG000|Overall Study|Withdrawal by Subject|3|||
162960089|NCT03578809|588557588|FG001|Overall Study|Withdrawal by Subject|5|||
162960090|NCT03578809|588557589|FG002|Overall Study|Withdrawal by Subject|2|||
162960091|NCT03578809|588557590|FG003|Overall Study|Withdrawal by Subject|0|||
162960092|NCT03578809|588557587|FG000|Overall Study|Other|3|||
162960093|NCT03578809|588557588|FG001|Overall Study|Other|6|||
162960094|NCT03578809|588557589|FG002|Overall Study|Other|2|||
162960095|NCT03578809|588557590|FG003|Overall Study|Other|8|||
162960096|NCT03599193|588557591|FG000|Overall Study|Adverse Event|0|||
162960097|NCT03599193|588557592|FG001|Overall Study|Adverse Event|2|||
162960098|NCT03599193|588557591|FG000|Overall Study|Withdrawal by Subject|1|||
162960099|NCT03599193|588557592|FG001|Overall Study|Withdrawal by Subject|0|||
162960100|NCT03599193|588557591|FG000|Overall Study|Protocol Violation|1|||
162960101|NCT03599193|588557592|FG001|Overall Study|Protocol Violation|0|||
162960102|NCT03599193|588557591|FG000|Overall Study|Lost to Follow-up|0|||
162960103|NCT03599193|588557592|FG001|Overall Study|Lost to Follow-up|1|||
162960104|NCT00835705|588557593|FG000|First Intervention|Difficulty with vein|1|||
162960105|NCT00835705|588557594|FG001|First Intervention|Difficulty with vein|0|||
162960106|NCT00835705|588557593|FG000|Second Intervention|Difficulty with vein|1|||
162960107|NCT00835705|588557594|FG001|Second Intervention|Difficulty with vein|0|||
162960108|NCT01116739|588557595|FG000|Overall Study|Child had 2 years of HS|110|||
162960109|NCT01116739|588557596|FG001|Overall Study|Child had 2 years of HS|128|||
162960110|NCT01116739|588557595|FG000|Overall Study|Withdrawal by Subject|6|||
162960111|NCT01116739|588557596|FG001|Overall Study|Withdrawal by Subject|0|||
162960112|NCT01116739|588557595|FG000|Overall Study|child too young|2|||
162960113|NCT01116739|588557596|FG001|Overall Study|child too young|6|||
162960114|NCT01116739|588557595|FG000|Overall Study|child not enrolled in head start|10|||
162960115|NCT01116739|588557596|FG001|Overall Study|child not enrolled in head start|2|||
162960116|NCT01116739|588557595|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
162960117|NCT01116739|588557596|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
162960118|NCT05090839|588557597|FG000|Overall Study|Lost to Follow-up|2|||
162960119|NCT05090839|588557598|FG001|Overall Study|Lost to Follow-up|3|||
163046850|NCT02326272|588879368|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046851|NCT02326272|588879354|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163046852|NCT02326272|588879355|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163046853|NCT02326272|588879356|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
163046854|NCT02326272|588879357|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163046855|NCT02326272|588879358|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163046856|NCT02326272|588879359|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163046857|NCT02326272|588879360|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
162960120|NCT05090839|588557599|FG002|Overall Study|Lost to Follow-up|1|||
162960121|NCT05090839|588557600|FG003|Overall Study|Lost to Follow-up|1|||
162960122|NCT01987765|588557605|FG000|Overall Study|Protocol Violation|65|||
162960123|NCT01987765|588557605|FG000|Overall Study|Lost to Follow-up|37|||
162960124|NCT00443651|588557610|FG000|Overall Study|Death|1|||
162960125|NCT00443651|588557611|FG001|Overall Study|Death|5|||
162960126|NCT00443651|588557610|FG000|Overall Study|Adverse Event|5|||
162960127|NCT00443651|588557611|FG001|Overall Study|Adverse Event|6|||
162960128|NCT00443651|588557610|FG000|Overall Study|Lost to Follow-up|18|||
163302700|NCT03447249|589815558|FG000|Overall Study|Adverse Event|1|||
163302701|NCT03447249|589815559|FG001|Overall Study|Adverse Event|0|||
163302702|NCT03447249|589815558|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
163302703|NCT03447249|589815559|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
163302704|NCT03447249|589815558|FG000|Overall Study|Other|3|||
163302705|NCT03447249|589815559|FG001|Overall Study|Other|0|||
162960129|NCT00443651|588557611|FG001|Overall Study|Lost to Follow-up|12|||
162960130|NCT00443651|588557610|FG000|Overall Study|Patient's/Guardian's Decision|58|||
162960131|NCT00443651|588557611|FG001|Overall Study|Patient's/Guardian's Decision|30|||
162960132|NCT00443651|588557610|FG000|Overall Study|Physician Decision|13|||
162960133|NCT00443651|588557611|FG001|Overall Study|Physician Decision|4|||
162960134|NCT00443651|588557610|FG000|Overall Study|Pregnancy|0|||
162960135|NCT00443651|588557611|FG001|Overall Study|Pregnancy|1|||
162960136|NCT03606174|588557612|FG000|Overall Study|Death|37|||
162960137|NCT03606174|588557613|FG001|Overall Study|Death|15|||
162960138|NCT03606174|588557614|FG002|Overall Study|Death|15|||
162960139|NCT03606174|588557615|FG003|Overall Study|Death|7|||
162960140|NCT03606174|588557616|FG004|Overall Study|Death|35|||
162960141|NCT03606174|588557617|FG005|Overall Study|Death|12|||
162960142|NCT03606174|588557618|FG006|Overall Study|Death|35|||
162960143|NCT03606174|588557619|FG007|Overall Study|Death|8|||
162960144|NCT03606174|588557620|FG008|Overall Study|Death|5|||
162960145|NCT03606174|588557621|FG009|Overall Study|Death|3|||
162960146|NCT03606174|588557622|FG010|Overall Study|Death|0|||
162960147|NCT03606174|588557612|FG000|Overall Study|Lost to Follow-up|0|||
162960148|NCT03606174|588557613|FG001|Overall Study|Lost to Follow-up|0|||
162960149|NCT03606174|588557614|FG002|Overall Study|Lost to Follow-up|0|||
162960150|NCT03606174|588557615|FG003|Overall Study|Lost to Follow-up|0|||
163046858|NCT02326272|588879361|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
162960151|NCT03606174|588557616|FG004|Overall Study|Lost to Follow-up|1|||
162960152|NCT03606174|588557617|FG005|Overall Study|Lost to Follow-up|1|||
162960153|NCT03606174|588557618|FG006|Overall Study|Lost to Follow-up|0|||
162960154|NCT03606174|588557619|FG007|Overall Study|Lost to Follow-up|0|||
163046859|NCT02326272|588879362|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
162960155|NCT03606174|588557620|FG008|Overall Study|Lost to Follow-up|0|||
162960156|NCT03606174|588557621|FG009|Overall Study|Lost to Follow-up|0|||
163046860|NCT02326272|588879363|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163302706|NCT02376790|589815560|FG000|Overall Study|Withdrawal by Subject|43|||
162960157|NCT03606174|588557622|FG010|Overall Study|Lost to Follow-up|0|||
162960158|NCT03606174|588557612|FG000|Overall Study|Withdrawal by Subject|6|||
162960159|NCT03606174|588557613|FG001|Overall Study|Withdrawal by Subject|0|||
163046861|NCT02326272|588879364|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163046862|NCT02326272|588879365|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163394910|NCT02982590|590158556|FG000|Overall Study|Death|4|||
163394911|NCT02982590|590158557|FG001|Overall Study|Death|0|||
163394912|NCT04196803|590158558|FG000|Overall Study|Withdrawal by Subject|1|||
163394913|NCT04196803|590158559|FG001|Overall Study|Withdrawal by Subject|3|||
163394914|NCT04196803|590158558|FG000|Overall Study|Adverse Event|4|||
163394915|NCT04196803|590158559|FG001|Overall Study|Adverse Event|2|||
163394916|NCT04196803|590158558|FG000|Overall Study|Lost to Follow-up|0|||
163394917|NCT04196803|590158559|FG001|Overall Study|Lost to Follow-up|1|||
163394918|NCT01168973|590158560|FG000|Overall Study|Progressive Disease|341|||
163394919|NCT01168973|590158561|FG001|Overall Study|Progressive Disease|429|||
162960160|NCT03606174|588557614|FG002|Overall Study|Withdrawal by Subject|0|||
162960161|NCT03606174|588557615|FG003|Overall Study|Withdrawal by Subject|1|||
162960162|NCT03606174|588557616|FG004|Overall Study|Withdrawal by Subject|2|||
162960163|NCT03606174|588557617|FG005|Overall Study|Withdrawal by Subject|1|||
162960164|NCT03606174|588557618|FG006|Overall Study|Withdrawal by Subject|4|||
162960165|NCT03606174|588557619|FG007|Overall Study|Withdrawal by Subject|0|||
162960166|NCT03606174|588557620|FG008|Overall Study|Withdrawal by Subject|0|||
162960167|NCT03606174|588557621|FG009|Overall Study|Withdrawal by Subject|0|||
162960168|NCT03606174|588557622|FG010|Overall Study|Withdrawal by Subject|1|||
162960169|NCT03606174|588557612|FG000|Overall Study|Study Terminated by Sponsor|5|||
162960170|NCT03606174|588557613|FG001|Overall Study|Study Terminated by Sponsor|7|||
162960171|NCT03606174|588557614|FG002|Overall Study|Study Terminated by Sponsor|3|||
162960172|NCT03606174|588557615|FG003|Overall Study|Study Terminated by Sponsor|0|||
162960173|NCT03606174|588557616|FG004|Overall Study|Study Terminated by Sponsor|11|||
162960174|NCT03606174|588557617|FG005|Overall Study|Study Terminated by Sponsor|6|||
162960175|NCT03606174|588557618|FG006|Overall Study|Study Terminated by Sponsor|12|||
162960176|NCT03606174|588557619|FG007|Overall Study|Study Terminated by Sponsor|1|||
162960177|NCT03606174|588557620|FG008|Overall Study|Study Terminated by Sponsor|3|||
162960178|NCT03606174|588557621|FG009|Overall Study|Study Terminated by Sponsor|1|||
162960179|NCT03606174|588557622|FG010|Overall Study|Study Terminated by Sponsor|2|||
162960180|NCT03606174|588557612|FG000|Overall Study|Miscellaneous|1|||
162960181|NCT03606174|588557613|FG001|Overall Study|Miscellaneous|1|||
162960182|NCT03606174|588557614|FG002|Overall Study|Miscellaneous|0|||
162960183|NCT03606174|588557615|FG003|Overall Study|Miscellaneous|1|||
162960184|NCT03606174|588557616|FG004|Overall Study|Miscellaneous|4|||
162960185|NCT03606174|588557617|FG005|Overall Study|Miscellaneous|7|||
162960186|NCT03606174|588557618|FG006|Overall Study|Miscellaneous|5|||
162960187|NCT03606174|588557619|FG007|Overall Study|Miscellaneous|0|||
162960188|NCT03606174|588557620|FG008|Overall Study|Miscellaneous|0|||
162960189|NCT03606174|588557621|FG009|Overall Study|Miscellaneous|0|||
162960190|NCT03606174|588557622|FG010|Overall Study|Miscellaneous|1|||
162960191|NCT01896934|588557625|FG000|Overall Study|Adverse Event|1|||
162960192|NCT01896934|588557625|FG000|Overall Study|Withdrawal by Subject|1|||
162960193|NCT01572662|588557627|FG000|Overall Study|Withdrawal by Subject|1|||
162960194|NCT01572662|588557628|FG001|Overall Study|Withdrawal by Subject|0|||
162960195|NCT01572662|588557627|FG000|Overall Study|Physician Decision|0|||
162960196|NCT01572662|588557628|FG001|Overall Study|Physician Decision|1|||
162960197|NCT03364192|588557629|FG000|Overall Study|Ineligible|10|||
162960198|NCT03364192|588557629|FG000|Overall Study|Withdrawal by Subject|5|||
162960199|NCT03364192|588557629|FG000|Overall Study|Lost to Follow-up|1|||
162960200|NCT04692155|588557630|FG000|Overall Study|Death|1|||
162960201|NCT04547192|588557631|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
162960202|NCT04547192|588557632|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
162960203|NCT04547192|588557633|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
162960204|NCT04547192|588557634|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
162960205|NCT04547192|588557631|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
162960206|NCT04547192|588557632|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
162960207|NCT04547192|588557633|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
162960208|NCT04547192|588557634|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
162960209|NCT04547192|588557631|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
162960210|NCT04547192|588557632|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
162960211|NCT04547192|588557633|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
162960212|NCT04547192|588557634|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
162960213|NCT04547192|588557631|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
162960214|NCT04547192|588557632|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
162960215|NCT04547192|588557633|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
162960216|NCT04547192|588557634|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
162960217|NCT04547192|588557631|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
162960218|NCT04547192|588557632|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
162960219|NCT04547192|588557633|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
162960220|NCT04547192|588557634|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
162960221|NCT01535222|588557635|FG000|Overall Study|Inclusion/exclusion|0|||
162960222|NCT01535222|588557636|FG001|Overall Study|Inclusion/exclusion|0|||
163394920|NCT01168973|590158560|FG000|Overall Study|Adverse Event|94|||
162960223|NCT01535222|588557637|FG002|Overall Study|Inclusion/exclusion|1|||
162960224|NCT01535222|588557638|FG003|Overall Study|Inclusion/exclusion|0|||
162960225|NCT01535222|588557639|FG004|Overall Study|Inclusion/exclusion|0|||
162960226|NCT01535222|588557640|FG005|Overall Study|Inclusion/exclusion|0|||
162960227|NCT00935012|588557643|FG000|Overall Study|Death|19|||
162960228|NCT00935012|588557643|FG000|Overall Study|Withdrawal by Subject|3|||
162960229|NCT00935012|588557643|FG000|Overall Study|Other|5|||
162960230|NCT00935012|588557643|FG000|Overall Study|Adverse Event|2|||
162960231|NCT01442155|588557644|FG000|Overall Study|Complete remission|35|||
162960232|NCT01442155|588557644|FG000|Overall Study|Recurrence|26|||
162960233|NCT01442155|588557644|FG000|Overall Study|Adverse Event|2|||
162960234|NCT01442155|588557644|FG000|Overall Study|Lost to Follow-up|2|||
162960235|NCT01484912|588557653|FG000|Overall Study|Withdrawal by Subject|1|||
162960236|NCT01484912|588557654|FG001|Overall Study|Withdrawal by Subject|0|||
162960237|NCT01484912|588557653|FG000|Overall Study|Physician Decision|0|||
162960238|NCT01484912|588557654|FG001|Overall Study|Physician Decision|1|||
162960239|NCT01188681|588557655|FG000|Overall Study|bladder cancer|0|||
162960240|NCT01188681|588557656|FG001|Overall Study|bladder cancer|0|||
162960241|NCT01188681|588557657|FG002|Overall Study|bladder cancer|1|||
162960242|NCT01188681|588557658|FG003|Overall Study|bladder cancer|0|||
162960243|NCT01188681|588557655|FG000|Overall Study|Withdrawal by Subject|0|||
162960244|NCT01188681|588557656|FG001|Overall Study|Withdrawal by Subject|0|||
162960245|NCT01188681|588557657|FG002|Overall Study|Withdrawal by Subject|0|||
162960246|NCT01188681|588557658|FG003|Overall Study|Withdrawal by Subject|1|||
162960247|NCT01983969|588557665|FG000|Overall Study|Disease Progression|0|||
162960248|NCT01983969|588557666|FG001|Overall Study|Disease Progression|1|||
162960249|NCT01983969|588557667|FG002|Overall Study|Disease Progression|0|||
162960250|NCT03719040|588557668|FG000|Overall Study|Withdrawal by Subject|177|||
162960251|NCT03719040|588557668|FG000|Overall Study|Lost to Follow-up|26|||
162960252|NCT00268203|588557669|FG000|Overall Study|Lost to Follow-up|92|||
162960253|NCT00268203|588557669|FG000|Overall Study|Withdrawal by Subject|9|||
162960254|NCT00268203|588557669|FG000|Overall Study|Received Other NHL Therapy|7|||
162960255|NCT00268203|588557669|FG000|Overall Study|Progressive Disease|359|||
162960256|NCT00268203|588557669|FG000|Overall Study|Death|84|||
162960257|NCT00268203|588557669|FG000|Overall Study|Reason Not Specified|34|||
162960258|NCT00268203|588557669|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
162960259|NCT04589650|588557672|FG000|Overall Study|Subject decision|6|||
162960260|NCT04589650|588557673|FG001|Overall Study|Subject decision|2|||
162960261|NCT04589650|588557674|FG002|Overall Study|Subject decision|2|||
162960262|NCT04589650|588557675|FG003|Overall Study|Subject decision|0|||
162960263|NCT04589650|588557676|FG004|Overall Study|Subject decision|0|||
162960264|NCT04589650|588557677|FG005|Overall Study|Subject decision|0|||
162960265|NCT04589650|588557672|FG000|Overall Study|Adverse Event|3|||
162960266|NCT04589650|588557673|FG001|Overall Study|Adverse Event|1|||
162960267|NCT04589650|588557674|FG002|Overall Study|Adverse Event|1|||
162960268|NCT04589650|588557675|FG003|Overall Study|Adverse Event|1|||
162960269|NCT04589650|588557676|FG004|Overall Study|Adverse Event|0|||
162960270|NCT04589650|588557677|FG005|Overall Study|Adverse Event|1|||
162960271|NCT04589650|588557672|FG000|Overall Study|Physician Decision|1|||
162960272|NCT04589650|588557673|FG001|Overall Study|Physician Decision|1|||
162960273|NCT04589650|588557674|FG002|Overall Study|Physician Decision|0|||
162960274|NCT04589650|588557675|FG003|Overall Study|Physician Decision|0|||
162960275|NCT04589650|588557676|FG004|Overall Study|Physician Decision|0|||
162960276|NCT04589650|588557677|FG005|Overall Study|Physician Decision|0|||
162960277|NCT04589650|588557672|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162960278|NCT04589650|588557673|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162960279|NCT04589650|588557674|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
162960280|NCT04589650|588557675|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
162960281|NCT04589650|588557676|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
162960282|NCT04589650|588557677|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
162960283|NCT04589650|588557672|FG000|Overall Study|Death|0|||
162960284|NCT04589650|588557673|FG001|Overall Study|Death|0|||
162960285|NCT04589650|588557674|FG002|Overall Study|Death|0|||
162960286|NCT04589650|588557675|FG003|Overall Study|Death|1|||
162960287|NCT04589650|588557676|FG004|Overall Study|Death|0|||
162960288|NCT04589650|588557677|FG005|Overall Study|Death|0|||
162960289|NCT04589650|588557672|FG000|Overall Study|Guardian Decision|0|||
162960290|NCT04589650|588557673|FG001|Overall Study|Guardian Decision|0|||
162960291|NCT04589650|588557674|FG002|Overall Study|Guardian Decision|0|||
162960292|NCT04589650|588557675|FG003|Overall Study|Guardian Decision|1|||
162960293|NCT04589650|588557676|FG004|Overall Study|Guardian Decision|0|||
162960294|NCT04589650|588557677|FG005|Overall Study|Guardian Decision|0|||
162960295|NCT00950989|588557678|FG000|Overall Study|Death|0|||
162960296|NCT00950989|588557679|FG001|Overall Study|Death|0|||
162960297|NCT00950989|588557680|FG002|Overall Study|Death|1|||
162960298|NCT00950989|588557681|FG003|Overall Study|Death|0|||
162960299|NCT00950989|588557678|FG000|Overall Study|Administrative Decision|0|||
162960300|NCT00950989|588557679|FG001|Overall Study|Administrative Decision|1|||
162960301|NCT00950989|588557680|FG002|Overall Study|Administrative Decision|0|||
162960302|NCT00950989|588557681|FG003|Overall Study|Administrative Decision|0|||
162960303|NCT00950989|588557678|FG000|Overall Study|Disease Progression|0|||
162960304|NCT00950989|588557679|FG001|Overall Study|Disease Progression|0|||
162960305|NCT00950989|588557680|FG002|Overall Study|Disease Progression|1|||
162960306|NCT00950989|588557681|FG003|Overall Study|Disease Progression|0|||
162960307|NCT00950989|588557678|FG000|Overall Study|Withdrawal by Subject|2|||
162960308|NCT00950989|588557679|FG001|Overall Study|Withdrawal by Subject|1|||
162960309|NCT00950989|588557680|FG002|Overall Study|Withdrawal by Subject|0|||
162960310|NCT00950989|588557681|FG003|Overall Study|Withdrawal by Subject|0|||
162960311|NCT00950989|588557678|FG000|Overall Study|Adverse Event|2|||
162960312|NCT00950989|588557679|FG001|Overall Study|Adverse Event|1|||
162960313|NCT00950989|588557680|FG002|Overall Study|Adverse Event|1|||
162960314|NCT00950989|588557681|FG003|Overall Study|Adverse Event|0|||
162960315|NCT03804983|588557682|FG000|Overall Study|Adverse Event|0|||
162960316|NCT03804983|588557683|FG001|Overall Study|Adverse Event|1|||
162960317|NCT03804983|588557682|FG000|Overall Study|Family Obligation|1|||
162960318|NCT03804983|588557683|FG001|Overall Study|Family Obligation|0|||
162960319|NCT03600376|588557684|FG000|Overall Study|Adverse Event|1|||
162960320|NCT03600376|588557685|FG001|Overall Study|Adverse Event|1|||
162960321|NCT03600376|588557684|FG000|Overall Study|Transferred to other facility|1|||
162960322|NCT03600376|588557685|FG001|Overall Study|Transferred to other facility|0|||
162960323|NCT03600376|588557684|FG000|Overall Study|Investigator Decision|0|||
162960324|NCT03600376|588557685|FG001|Overall Study|Investigator Decision|4|||
162960325|NCT03600376|588557684|FG000|Overall Study|Determined to be ineligible for study|0|||
162960326|NCT03600376|588557685|FG001|Overall Study|Determined to be ineligible for study|1|||
162960327|NCT00796562|588557689|FG000|Overall Study|Death|49|||
162960328|NCT05655520|588557690|FG000|Overall Study|Adverse Event|2|||
162960329|NCT05655520|588557691|FG001|Overall Study|Adverse Event|3|||
162960330|NCT05655520|588557690|FG000|Overall Study|Physician Decision|2|||
162960331|NCT05655520|588557691|FG001|Overall Study|Physician Decision|0|||
162960332|NCT05655520|588557690|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162960333|NCT05655520|588557691|FG001|Overall Study|Non-Compliance with Study Drug|2|||
162960334|NCT05655520|588557690|FG000|Overall Study|Lost to Follow-up|1|||
162960335|NCT05655520|588557691|FG001|Overall Study|Lost to Follow-up|0|||
162960336|NCT05655520|588557690|FG000|Overall Study|Withdrawal by Subject|4|||
162960337|NCT05655520|588557691|FG001|Overall Study|Withdrawal by Subject|4|||
162960338|NCT05655520|588557690|FG000|Overall Study|Study Terminated by Sponsor|61|||
162960339|NCT05655520|588557691|FG001|Overall Study|Study Terminated by Sponsor|68|||
162960340|NCT00424047|588557692|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
162960341|NCT00424047|588557693|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
162960342|NCT00424047|588557692|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
162960343|NCT00424047|588557693|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
162960344|NCT00424047|588557692|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
162960345|NCT00424047|588557693|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
162960346|NCT00424047|588557692|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
162960347|NCT00424047|588557693|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
162960348|NCT00424047|588557692|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
162960349|NCT00424047|588557693|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
162960350|NCT00424047|588557692|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
162960351|NCT00424047|588557693|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
162960352|NCT00424047|588557692|FG000|On Study at Time of Unblinding|Adverse Event|22|||
162960353|NCT00424047|588557693|FG001|On Study at Time of Unblinding|Adverse Event|12|||
162960354|NCT00424047|588557692|FG000|On Study at Time of Unblinding|Progression of disease|92|||
162960355|NCT00424047|588557693|FG001|On Study at Time of Unblinding|Progression of disease|128|||
162960356|NCT00424047|588557692|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
162960357|NCT00424047|588557693|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
162960358|NCT00424047|588557692|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
162960359|NCT00424047|588557693|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
162960360|NCT00424047|588557692|FG000|On Study at Time of Unblinding|Death|11|||
162960361|NCT00424047|588557693|FG001|On Study at Time of Unblinding|Death|11|||
162960362|NCT00424047|588557692|FG000|On Study at Time of Unblinding|Other|5|||
162960363|NCT00424047|588557693|FG001|On Study at Time of Unblinding|Other|4|||
162960364|NCT00424047|588557692|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
162960365|NCT00424047|588557693|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
162960366|NCT00424047|588557692|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
162960367|NCT00424047|588557693|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
162960368|NCT00424047|588557692|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
162960369|NCT00424047|588557693|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
162960370|NCT00424047|588557692|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
162960371|NCT00424047|588557693|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
162960372|NCT00424047|588557692|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
162960373|NCT00424047|588557693|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
162960374|NCT01229150|588557697|FG000|Overall Study|Toxicity|2|||
162960375|NCT01229150|588557698|FG001|Overall Study|Toxicity|2|||
162960376|NCT01229150|588557699|FG002|Overall Study|Toxicity|0|||
162960377|NCT01229150|588557700|FG003|Overall Study|Toxicity|0|||
162960378|NCT05248204|588557701|FG000|Overall Study|Lost to Follow-up|13|||
162960379|NCT05248204|588557702|FG001|Overall Study|Lost to Follow-up|13|||
163046863|NCT02326272|588879366|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163196623|NCT00381485|589435710|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
162960380|NCT05248204|588557701|FG000|Overall Study|Protocol Violation|1|||
162960381|NCT05248204|588557702|FG001|Overall Study|Protocol Violation|0|||
163046864|NCT02326272|588879367|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
162960382|NCT03100344|588557703|FG000|Overall Study|Adverse Event|0|||
162960383|NCT03100344|588557704|FG001|Overall Study|Adverse Event|3|||
162960384|NCT03100344|588557705|FG002|Overall Study|Adverse Event|2|||
163394921|NCT01168973|590158561|FG001|Overall Study|Adverse Event|55|||
163196624|NCT00381485|589435711|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
163196625|NCT00381485|589435712|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
163196626|NCT00381485|589435709|FG000|Open-Label Run-In Period|Treatment failure|1|||
163196627|NCT00381485|589435710|FG001|Open-Label Run-In Period|Treatment failure|0|||
163196628|NCT00381485|589435711|FG002|Open-Label Run-In Period|Treatment failure|0|||
163196629|NCT00381485|589435712|FG003|Open-Label Run-In Period|Treatment failure|0|||
162960385|NCT03100344|588557706|FG003|Overall Study|Adverse Event|3|||
162960386|NCT03100344|588557703|FG000|Overall Study|Lack of Efficacy|2|||
163196630|NCT00381485|589435709|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162960387|NCT03100344|588557704|FG001|Overall Study|Lack of Efficacy|0|||
162960388|NCT03100344|588557705|FG002|Overall Study|Lack of Efficacy|0|||
162960389|NCT03100344|588557706|FG003|Overall Study|Lack of Efficacy|0|||
162960390|NCT03100344|588557703|FG000|Overall Study|Protocol Violation|1|||
162960391|NCT03100344|588557704|FG001|Overall Study|Protocol Violation|0|||
162960392|NCT03100344|588557705|FG002|Overall Study|Protocol Violation|0|||
162960393|NCT03100344|588557706|FG003|Overall Study|Protocol Violation|0|||
162960394|NCT03100344|588557703|FG000|Overall Study|Withdrawal by Subject|10|||
162960395|NCT03100344|588557704|FG001|Overall Study|Withdrawal by Subject|7|||
162960396|NCT03100344|588557705|FG002|Overall Study|Withdrawal by Subject|4|||
162960397|NCT03100344|588557706|FG003|Overall Study|Withdrawal by Subject|8|||
162960398|NCT03100344|588557703|FG000|Overall Study|Lost to Follow-up|1|||
162960399|NCT03100344|588557704|FG001|Overall Study|Lost to Follow-up|1|||
162960400|NCT03100344|588557705|FG002|Overall Study|Lost to Follow-up|1|||
162960401|NCT03100344|588557706|FG003|Overall Study|Lost to Follow-up|1|||
162960402|NCT01010503|588557707|FG000|Overall Study|Adverse Event|1|||
162960403|NCT01010503|588557707|FG000|Overall Study|Death|1|||
162960404|NCT01963728|588557708|FG000|Overall Study|Study terminated early|0|||
162960405|NCT01963728|588557709|FG001|Overall Study|Study terminated early|1|||
162960406|NCT04406194|588558824|FG000|Period 1|Withdrawal by Subject|0|||
162960407|NCT04406194|588558825|FG001|Period 1|Withdrawal by Subject|1|||
162960408|NCT02888756|588558826|FG000|Analytical Treatment Interruption|Physician Decision|10|||
162960409|NCT02888756|588558827|FG001|Analytical Treatment Interruption|Physician Decision|6|||
162960410|NCT02888756|588558828|FG002|Analytical Treatment Interruption|Physician Decision|5|||
162960411|NCT01205035|588558832|FG000|Overall Study|Withdrawal by Subject|1|||
162960412|NCT01205035|588558833|FG001|Overall Study|Withdrawal by Subject|0|||
162960413|NCT01205035|588558832|FG000|Overall Study|Physician Decision|1|||
162960414|NCT01205035|588558833|FG001|Overall Study|Physician Decision|0|||
162960415|NCT00928057|588558834|FG000|Overall Study|Adverse Event|1|||
162960416|NCT00928057|588558835|FG001|Overall Study|Adverse Event|2|||
162960417|NCT00928057|588558834|FG000|Overall Study|Withdrawal by Subject|1|||
162960418|NCT00928057|588558835|FG001|Overall Study|Withdrawal by Subject|0|||
162960419|NCT00928057|588558834|FG000|Overall Study|Lost to Follow-up|0|||
162960420|NCT00928057|588558835|FG001|Overall Study|Lost to Follow-up|1|||
162960421|NCT00928057|588558834|FG000|Overall Study|Protocol Violation|0|||
162960422|NCT00928057|588558835|FG001|Overall Study|Protocol Violation|1|||
162960423|NCT03206749|588558836|FG000|Overall Study|Withdrawal of consent|5|||
162960424|NCT03206749|588558837|FG001|Overall Study|Withdrawal of consent|3|||
162960425|NCT03206749|588558838|FG002|Overall Study|Withdrawal of consent|6|||
162960426|NCT03206749|588558836|FG000|Overall Study|Lost to Follow-up|0|||
162960427|NCT03206749|588558837|FG001|Overall Study|Lost to Follow-up|0|||
162960428|NCT03206749|588558838|FG002|Overall Study|Lost to Follow-up|1|||
162960429|NCT00316277|588558839|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
162960430|NCT00316277|588558840|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
162960431|NCT00316277|588558839|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
162960432|NCT00316277|588558840|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
162960433|NCT00316277|588558839|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
162960434|NCT00316277|588558840|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
162960435|NCT00316277|588558839|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
162960436|NCT00316277|588558840|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
162960437|NCT00316277|588558839|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
162960438|NCT00316277|588558840|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
162960439|NCT00927069|588558841|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
163196631|NCT00381485|589435710|FG001|Double-Blind Treatment Period|Adverse Event|2|||
163196632|NCT00381485|589435711|FG002|Double-Blind Treatment Period|Adverse Event|2|||
162960440|NCT00927069|588558842|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
162960441|NCT00927069|588558843|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
162960442|NCT00927069|588558844|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
162960443|NCT00927069|588558841|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
162960444|NCT00927069|588558842|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
162960445|NCT00927069|588558843|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
162960446|NCT00927069|588558844|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
162960447|NCT00927069|588558841|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
163196633|NCT00381485|589435712|FG003|Double-Blind Treatment Period|Adverse Event|5|||
162960448|NCT00927069|588558842|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
162960449|NCT00927069|588558843|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
163196634|NCT00381485|589435709|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
163196635|NCT00381485|589435710|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
163196636|NCT00381485|589435711|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
162924353|NCT04797637|588423874|FG001|Overall Study|Withdrawal by Subject|1|||
162924354|NCT02380248|588423875|FG000|Overall Study|Lost to Follow-up|11|||
162924355|NCT02380248|588423875|FG000|Overall Study|Withdrawal by Subject|3|||
162924356|NCT03083639|588423876|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
162924357|NCT03083639|588423877|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
162924358|NCT03083639|588423876|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
162924359|NCT03083639|588423877|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
162924360|NCT00960687|588423878|FG000|Washout Period of 7 Days|Adverse Event|3|||
162924361|NCT00960687|588423879|FG001|Washout Period of 7 Days|Adverse Event|2|||
162924362|NCT00960687|588423878|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
162924363|NCT00960687|588423879|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
162924364|NCT03611751|588423886|FG000|Pre-treatment|Randomized but not treated|1|||
162924365|NCT03611751|588423887|FG001|Pre-treatment|Randomized but not treated|1|||
162924366|NCT03611751|588423888|FG002|Pre-treatment|Randomized but not treated|0|||
162924367|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
162924368|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
162924369|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
162924370|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
162924371|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
162924372|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
162924373|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
162924374|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
162924375|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
162924376|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
162924377|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
162924378|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
162924379|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
162924380|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
162924381|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
162924382|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
162924383|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
162924384|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
162924385|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
162924386|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
162924387|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
162924388|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Death|0|||
162924389|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Death|0|||
162924390|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Death|1|||
162924391|NCT03611751|588423886|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
162924392|NCT03611751|588423887|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
162924393|NCT03611751|588423888|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
162924394|NCT03611751|588423886|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
162924395|NCT03611751|588423887|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
162924396|NCT03611751|588423888|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
162924397|NCT03611751|588423886|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
162924398|NCT03611751|588423887|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
162924399|NCT03611751|588423888|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
162924400|NCT03611751|588423886|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
162924401|NCT03611751|588423887|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
162924402|NCT03611751|588423888|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
162924403|NCT03611751|588423886|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
163196637|NCT00381485|589435712|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
163196638|NCT00381485|589435709|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163196639|NCT00381485|589435710|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
163196640|NCT00381485|589435711|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
162960450|NCT00927069|588558844|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
162960451|NCT00927069|588558841|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
162960452|NCT00927069|588558842|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
162960453|NCT00927069|588558843|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
163196641|NCT00381485|589435712|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
163196642|NCT00381485|589435709|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
163196643|NCT00381485|589435710|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
163196644|NCT00381485|589435711|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
163196645|NCT00381485|589435712|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
163196646|NCT00381485|589435709|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
163196647|NCT00381485|589435710|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
163196648|NCT00381485|589435711|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
163196649|NCT00381485|589435712|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
163196650|NCT00381485|589435709|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
162960454|NCT00927069|588558844|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
162960455|NCT00927069|588558841|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
162960456|NCT00927069|588558842|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
163302707|NCT02376790|589815561|FG001|Overall Study|Withdrawal by Subject|36|||
163302708|NCT02376790|589815562|FG002|Overall Study|Withdrawal by Subject|37|||
162960457|NCT00927069|588558843|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
162960458|NCT00927069|588558844|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
163302709|NCT02376790|589815560|FG000|Overall Study|Decision by Sponsor|2|||
162960459|NCT03497130|588558845|FG000|Overall Study|Lost to Follow-up|1|||
162960460|NCT03497130|588558846|FG001|Overall Study|Lost to Follow-up|1|||
162960461|NCT00418938|588558847|FG000|Overall Study|Reimbursement|1|||
162960462|NCT00418938|588558848|FG001|Overall Study|Reimbursement|0|||
162960463|NCT00418938|588558847|FG000|Overall Study|Administrative decision|3|||
163302710|NCT02376790|589815561|FG001|Overall Study|Decision by Sponsor|1|||
163302711|NCT02376790|589815562|FG002|Overall Study|Decision by Sponsor|4|||
163302712|NCT02376790|589815560|FG000|Overall Study|Lost to Follow-up|15|||
163302713|NCT02376790|589815561|FG001|Overall Study|Lost to Follow-up|10|||
163302714|NCT02376790|589815562|FG002|Overall Study|Lost to Follow-up|12|||
163302715|NCT00988858|589815563|FG000|Overall Study|Adverse Event|7|||
163302716|NCT00988858|589815563|FG000|Overall Study|Death|1|||
163302717|NCT00988858|589815563|FG000|Overall Study|Physician Decision|1|||
163302718|NCT00988858|589815563|FG000|Overall Study|Sponsor Decision|1|||
163302719|NCT02238483|589815564|FG000|Overall Study|Withdrawal by Subject|2|||
163302720|NCT02238483|589815565|FG001|Overall Study|Withdrawal by Subject|7|||
163302721|NCT02238483|589815564|FG000|Overall Study|Lost to Follow-up|1|||
163302722|NCT02238483|589815565|FG001|Overall Study|Lost to Follow-up|1|||
163302723|NCT02238483|589815564|FG000|Overall Study|Protocol Violation|1|||
163302724|NCT02238483|589815565|FG001|Overall Study|Protocol Violation|2|||
163302725|NCT02238483|589815564|FG000|Overall Study|Death|1|||
163302726|NCT02238483|589815565|FG001|Overall Study|Death|0|||
163302727|NCT02238483|589815564|FG000|Overall Study|Adverse Event|7|||
163302728|NCT02238483|589815565|FG001|Overall Study|Adverse Event|3|||
163302729|NCT02238483|589815564|FG000|Overall Study|Withdrawn due to physician decision|1|||
163302730|NCT02238483|589815565|FG001|Overall Study|Withdrawn due to physician decision|0|||
163302731|NCT02238483|589815564|FG000|Overall Study|Completion status not recorded|1|||
163302732|NCT02238483|589815565|FG001|Overall Study|Completion status not recorded|1|||
163302733|NCT02238483|589815564|FG000|Overall Study|Illness in family member|1|||
163302734|NCT02238483|589815565|FG001|Overall Study|Illness in family member|0|||
163302735|NCT02538341|589815566|FG000|Overall Study|Lost to Follow-up|51|||
163302736|NCT02538341|589815567|FG001|Overall Study|Lost to Follow-up|46|||
163302737|NCT02538341|589815566|FG000|Overall Study|Withdrawal by Subject|3|||
163302738|NCT02538341|589815567|FG001|Overall Study|Withdrawal by Subject|1|||
163302739|NCT02538341|589815566|FG000|Overall Study|Death|2|||
163302740|NCT02538341|589815567|FG001|Overall Study|Death|0|||
163302741|NCT00393484|589815568|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
163302742|NCT00393484|589815569|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
163302743|NCT00393484|589815568|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
163302744|NCT00393484|589815569|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
163302745|NCT00393484|589815568|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
163302746|NCT00393484|589815569|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
163302747|NCT00393484|589815568|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
163302748|NCT00393484|589815569|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
163302749|NCT00393484|589815568|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
163302750|NCT00393484|589815569|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
163302751|NCT00393484|589815568|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
163302752|NCT00393484|589815569|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
163302753|NCT00393484|589815568|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
163302754|NCT00393484|589815569|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
163302755|NCT00393484|589815568|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
163302756|NCT00393484|589815569|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
163302757|NCT00393484|589815568|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
163302758|NCT00393484|589815569|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
163302759|NCT00393484|589815568|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
163302760|NCT00393484|589815569|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
163302761|NCT01551355|589815582|FG000|Overall Study|Lost to Follow-up|51|||
163302762|NCT01551355|589815583|FG001|Overall Study|Lost to Follow-up|49|||
163302763|NCT01551355|589815584|FG002|Overall Study|Lost to Follow-up|34|||
163302764|NCT01551355|589815585|FG003|Overall Study|Lost to Follow-up|24|||
163302765|NCT01551355|589815586|FG004|Overall Study|Lost to Follow-up|9|||
163302766|NCT01551355|589815587|FG005|Overall Study|Lost to Follow-up|6|||
163302767|NCT00031694|589815588|FG000|Overall Study|Adverse Event|12|||
163302768|NCT00031694|589815588|FG000|Overall Study|Death|2|||
163302769|NCT00031694|589815588|FG000|Overall Study|Withdrawal by Subject|5|||
163302770|NCT01538719|589815593|FG000|Overall Study|Lost to Follow-up|2|||
163302771|NCT01538719|589815594|FG001|Overall Study|Lost to Follow-up|0|||
163302772|NCT01255670|589815597|FG000|Overall Study|Adverse Event|10|||
163302773|NCT01255670|589815598|FG001|Overall Study|Adverse Event|10|||
163302774|NCT01255670|589815597|FG000|Overall Study|Lost to Follow-up|16|||
163302775|NCT01255670|589815598|FG001|Overall Study|Lost to Follow-up|10|||
163302776|NCT03664960|589815599|FG000|Overall Study|Adverse Event|0|||
163302777|NCT03664960|589815600|FG001|Overall Study|Adverse Event|3|||
163302778|NCT03664960|589815599|FG000|Overall Study|Lost to Follow-up|3|||
163302779|NCT03664960|589815600|FG001|Overall Study|Lost to Follow-up|2|||
162960464|NCT00418938|588558848|FG001|Overall Study|Administrative decision|3|||
162960465|NCT00418938|588558847|FG000|Overall Study|Withdrawal by Subject|16|||
162960466|NCT00418938|588558848|FG001|Overall Study|Withdrawal by Subject|15|||
163046865|NCT02326272|588879368|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163046866|NCT02326272|588879354|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046867|NCT02326272|588879355|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046868|NCT02326272|588879356|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
163046869|NCT02326272|588879357|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046870|NCT02326272|588879358|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046871|NCT02326272|588879359|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046872|NCT02326272|588879360|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163058598|NCT00042289|588924238|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
163196651|NCT00381485|589435710|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
162960467|NCT00418938|588558847|FG000|Overall Study|Lost to Follow-up|1|||
162960468|NCT00418938|588558848|FG001|Overall Study|Lost to Follow-up|3|||
162960469|NCT00418938|588558847|FG000|Overall Study|Adverse Event|1|||
162960470|NCT00418938|588558848|FG001|Overall Study|Adverse Event|1|||
162960471|NCT00418938|588558847|FG000|Overall Study|On-going|1|||
162960472|NCT00418938|588558848|FG001|Overall Study|On-going|1|||
162960473|NCT00418938|588558847|FG000|Overall Study|Ineligibility Determined|1|||
162960474|NCT00418938|588558848|FG001|Overall Study|Ineligibility Determined|0|||
162960475|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
162960476|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
162960477|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
162960478|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
162960479|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
162960480|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
162960481|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Death|9|||
162960482|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Death|7|||
162960483|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Death|14|||
162960484|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Death|7|||
162960485|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Death|0|||
162960486|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Death|0|||
162960487|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
162960488|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
163196652|NCT00381485|589435711|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
163196653|NCT00381485|589435712|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
163394922|NCT01168973|590158560|FG000|Overall Study|Withdrawal by Subject|90|||
162960489|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
162960490|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
162960491|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
162960492|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
162960493|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Other Event|49|||
162960494|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Other Event|52|||
163046873|NCT02326272|588879361|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046874|NCT02326272|588879362|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046875|NCT02326272|588879363|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046876|NCT02326272|588879364|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046877|NCT02326272|588879365|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046878|NCT02326272|588879366|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046879|NCT02326272|588879367|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046880|NCT02326272|588879368|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046881|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046882|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046883|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046884|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046885|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
163046886|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
163046887|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
163046888|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
163046889|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
163046890|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046891|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046892|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046893|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046894|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046895|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046896|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046897|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046898|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046899|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046900|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046901|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
163046902|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
163046903|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046904|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
163046905|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
163046906|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046907|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046908|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046909|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046910|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046911|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046912|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163302780|NCT03664960|589815599|FG000|Overall Study|Physician Decision|1|||
162960495|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Other Event|41|||
162960496|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Other Event|58|||
162960497|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Other Event|0|||
162960498|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Other Event|0|||
162960499|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
162960500|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
162960501|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
162960502|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
162960503|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
162960504|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
162960505|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
162960506|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
162960507|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
162960508|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
162960509|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
162960510|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
162960511|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
163302781|NCT03664960|589815600|FG001|Overall Study|Physician Decision|0|||
163302782|NCT03664960|589815599|FG000|Overall Study|Withdrawal by Subject|3|||
163302783|NCT03664960|589815600|FG001|Overall Study|Withdrawal by Subject|14|||
163302784|NCT03664960|589815599|FG000|Overall Study|Sponsor Decision|1|||
162960512|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
162960513|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
163046913|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163196654|NCT00381485|589435709|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
163196655|NCT00381485|589435710|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
163196656|NCT00381485|589435711|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
163196657|NCT00381485|589435712|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
163196658|NCT00381485|589435709|FG000|Double-Blind Treatment Period|Administrative|0|||
163196659|NCT00381485|589435710|FG001|Double-Blind Treatment Period|Administrative|1|||
163196660|NCT00381485|589435711|FG002|Double-Blind Treatment Period|Administrative|0|||
163196661|NCT00381485|589435712|FG003|Double-Blind Treatment Period|Administrative|1|||
163196662|NCT01235351|589435713|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
163196663|NCT01235351|589435714|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
163196664|NCT00745823|589435715|FG000|Overall Study|Adverse Event|5|||
163302785|NCT03664960|589815600|FG001|Overall Study|Sponsor Decision|1|||
162960514|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
162960515|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
162960516|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
162960517|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
162960518|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
162960519|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
162960520|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
162960521|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
162960522|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
162960523|NCT00205777|588558849|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
162960524|NCT00205777|588558850|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
162960525|NCT00205777|588558851|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
162960526|NCT00205777|588558852|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
162960527|NCT00205777|588558853|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
162960528|NCT00205777|588558854|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
162960529|NCT00205777|588558849|FG000|Completed Core Study, Entered SE I|Other Event|52|||
162960530|NCT00205777|588558850|FG001|Completed Core Study, Entered SE I|Other Event|46|||
162960531|NCT00205777|588558851|FG002|Completed Core Study, Entered SE I|Other Event|47|||
162960532|NCT00205777|588558852|FG003|Completed Core Study, Entered SE I|Other Event|50|||
162960533|NCT00205777|588558853|FG004|Completed Core Study, Entered SE I|Other Event|0|||
162960534|NCT00205777|588558854|FG005|Completed Core Study, Entered SE I|Other Event|0|||
162960535|NCT00205777|588558849|FG000|Study Extension I|Adverse Event|57|||
162960536|NCT00205777|588558850|FG001|Study Extension I|Adverse Event|0|||
162960537|NCT00205777|588558851|FG002|Study Extension I|Adverse Event|0|||
162960538|NCT00205777|588558852|FG003|Study Extension I|Adverse Event|61|||
162960539|NCT00205777|588558853|FG004|Study Extension I|Adverse Event|58|||
162960540|NCT00205777|588558854|FG005|Study Extension I|Adverse Event|0|||
162960541|NCT00205777|588558849|FG000|Study Extension I|Death|5|||
162960542|NCT00205777|588558850|FG001|Study Extension I|Death|0|||
162960543|NCT00205777|588558851|FG002|Study Extension I|Death|0|||
162960544|NCT00205777|588558852|FG003|Study Extension I|Death|1|||
162960545|NCT00205777|588558853|FG004|Study Extension I|Death|2|||
163196665|NCT00745823|589435716|FG001|Overall Study|Adverse Event|3|||
163196666|NCT00745823|589435715|FG000|Overall Study|Lack of Efficacy|20|||
163302786|NCT03664960|589815599|FG000|Overall Study|Other|1|||
163302787|NCT03664960|589815600|FG001|Overall Study|Other|2|||
163302788|NCT03807778|589815603|FG000|Overall Study|Adverse Event|0|||
163302789|NCT03807778|589815604|FG001|Overall Study|Adverse Event|0|||
163302790|NCT03807778|589815605|FG002|Overall Study|Adverse Event|3|||
163302791|NCT03807778|589815606|FG003|Overall Study|Adverse Event|5|||
163302792|NCT03807778|589815603|FG000|Overall Study|Progressive Disease|4|||
163302793|NCT03807778|589815604|FG001|Overall Study|Progressive Disease|2|||
163302794|NCT03807778|589815605|FG002|Overall Study|Progressive Disease|8|||
163302795|NCT03807778|589815606|FG003|Overall Study|Progressive Disease|15|||
163302796|NCT03807778|589815603|FG000|Overall Study|Symptomatic Deterioration|0|||
163196667|NCT00745823|589435716|FG001|Overall Study|Lack of Efficacy|6|||
163196668|NCT00745823|589435715|FG000|Overall Study|Lost to Follow-up|10|||
163196669|NCT00745823|589435716|FG001|Overall Study|Lost to Follow-up|11|||
163196670|NCT00745823|589435715|FG000|Overall Study|Physician Decision|10|||
163196671|NCT00745823|589435716|FG001|Overall Study|Physician Decision|5|||
163196672|NCT00745823|589435715|FG000|Overall Study|Pregnancy|0|||
163196673|NCT00745823|589435716|FG001|Overall Study|Pregnancy|4|||
163196674|NCT00745823|589435715|FG000|Overall Study|Withdrawal by Subject|14|||
163196675|NCT00745823|589435716|FG001|Overall Study|Withdrawal by Subject|8|||
163196676|NCT00745823|589435715|FG000|Overall Study|Study Terminated by Sponsor|326|||
163196677|NCT00745823|589435716|FG001|Overall Study|Study Terminated by Sponsor|349|||
163196678|NCT02980601|589435728|FG000|Overall Study|Lost to Follow-up|2|||
163196679|NCT02980601|589435729|FG001|Overall Study|Lost to Follow-up|2|||
163196680|NCT02980601|589435728|FG000|Overall Study|Death|0|||
163196681|NCT02980601|589435729|FG001|Overall Study|Death|1|||
163196682|NCT02980601|589435728|FG000|Overall Study|Graft loss|1|||
163196683|NCT02980601|589435729|FG001|Overall Study|Graft loss|0|||
163302797|NCT03807778|589815604|FG001|Overall Study|Symptomatic Deterioration|1|||
163302798|NCT03807778|589815605|FG002|Overall Study|Symptomatic Deterioration|0|||
163302799|NCT03807778|589815606|FG003|Overall Study|Symptomatic Deterioration|1|||
163302800|NCT03807778|589815603|FG000|Overall Study|Withdrawal by Subject|0|||
163302801|NCT03807778|589815604|FG001|Overall Study|Withdrawal by Subject|1|||
163302802|NCT03807778|589815605|FG002|Overall Study|Withdrawal by Subject|0|||
163302803|NCT03807778|589815606|FG003|Overall Study|Withdrawal by Subject|1|||
163302804|NCT03807778|589815603|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
163302805|NCT03807778|589815604|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
163302806|NCT03807778|589815605|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
163302807|NCT03807778|589815606|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
163302808|NCT03582722|589815607|FG000|Overall Study|Lost to Follow-up|1|||
163302809|NCT03582722|589815608|FG001|Overall Study|Lost to Follow-up|4|||
163302810|NCT03582722|589815607|FG000|Overall Study|Withdrawal by Subject|3|||
163302811|NCT03582722|589815608|FG001|Overall Study|Withdrawal by Subject|3|||
163302812|NCT02576509|589817551|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
163302813|NCT02576509|589817552|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
163302814|NCT02576509|589817551|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
163302815|NCT02576509|589817552|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
163302816|NCT02576509|589817551|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
163302817|NCT02576509|589817552|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
163196684|NCT02980601|589435728|FG000|Overall Study|Failed to sign consent|2|||
163196685|NCT02980601|589435729|FG001|Overall Study|Failed to sign consent|0|||
163302818|NCT02576509|589817551|FG000|Treatment Period|Disease progression|263|||
163302819|NCT02576509|589817552|FG001|Treatment Period|Disease progression|244|||
163302820|NCT02576509|589817551|FG000|Treatment Period|Study drug toxicity|37|||
163302821|NCT02576509|589817552|FG001|Treatment Period|Study drug toxicity|41|||
163302822|NCT02576509|589817551|FG000|Treatment Period|Death|1|||
163302823|NCT02576509|589817552|FG001|Treatment Period|Death|1|||
163302824|NCT02576509|589817551|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
163302825|NCT02576509|589817552|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
163302826|NCT02576509|589817551|FG000|Treatment Period|Participant request to stop treatment|8|||
163302827|NCT02576509|589817552|FG001|Treatment Period|Participant request to stop treatment|18|||
163302828|NCT02576509|589817551|FG000|Treatment Period|Participant withdrew consent|3|||
163302829|NCT02576509|589817552|FG001|Treatment Period|Participant withdrew consent|7|||
163302830|NCT02576509|589817551|FG000|Treatment Period|Lost to Follow-up|0|||
163302831|NCT02576509|589817552|FG001|Treatment Period|Lost to Follow-up|1|||
163302832|NCT02576509|589817551|FG000|Treatment Period|Maximum clinical benefit|1|||
163302833|NCT02576509|589817552|FG001|Treatment Period|Maximum clinical benefit|0|||
163302834|NCT02576509|589817551|FG000|Treatment Period|Poor/non-compliance|1|||
163302835|NCT02576509|589817552|FG001|Treatment Period|Poor/non-compliance|1|||
163302836|NCT02576509|589817551|FG000|Treatment Period|Participant no longer meets criteria|1|||
163302837|NCT02576509|589817552|FG001|Treatment Period|Participant no longer meets criteria|0|||
163302838|NCT02576509|589817551|FG000|Treatment Period|Other reason|12|||
163302839|NCT02576509|589817552|FG001|Treatment Period|Other reason|8|||
163302840|NCT02576509|589817551|FG000|Treatment Period|NOT REPORTED|1|||
163302841|NCT02576509|589817552|FG001|Treatment Period|NOT REPORTED|0|||
163302842|NCT02576509|589817551|FG000|Treatment Period|Administrative reason by sponsor|0|||
163302843|NCT02576509|589817552|FG001|Treatment Period|Administrative reason by sponsor|1|||
163302844|NCT01216176|589817556|FG000|Overall Study|Adverse Event|0|||
163302845|NCT01216176|589817557|FG001|Overall Study|Adverse Event|8|||
163302846|NCT01216176|589817558|FG002|Overall Study|Adverse Event|0|||
163302847|NCT01216176|589817556|FG000|Overall Study|Physician Decision|0|||
163302848|NCT01216176|589817557|FG001|Overall Study|Physician Decision|0|||
163302849|NCT01216176|589817558|FG002|Overall Study|Physician Decision|1|||
163302850|NCT03725722|589817561|FG000|Overall Study|Lack of Efficacy|2|||
163302851|NCT03725722|589817562|FG001|Overall Study|Lack of Efficacy|1|||
163302852|NCT03725722|589817563|FG002|Overall Study|Lack of Efficacy|2|||
163302853|NCT03725722|589817564|FG003|Overall Study|Lack of Efficacy|0|||
163302854|NCT03725722|589817565|FG004|Overall Study|Lack of Efficacy|2|||
163302855|NCT03725722|589817561|FG000|Overall Study|Adverse Event|2|||
163302856|NCT03725722|589817562|FG001|Overall Study|Adverse Event|2|||
163302857|NCT03725722|589817563|FG002|Overall Study|Adverse Event|1|||
163302858|NCT03725722|589817564|FG003|Overall Study|Adverse Event|0|||
163302859|NCT03725722|589817565|FG004|Overall Study|Adverse Event|6|||
163302860|NCT03725722|589817561|FG000|Overall Study|Withdrawal by Subject|4|||
163302861|NCT03725722|589817562|FG001|Overall Study|Withdrawal by Subject|1|||
163302862|NCT03725722|589817563|FG002|Overall Study|Withdrawal by Subject|0|||
163302863|NCT03725722|589817564|FG003|Overall Study|Withdrawal by Subject|4|||
163302864|NCT03725722|589817565|FG004|Overall Study|Withdrawal by Subject|4|||
163302865|NCT03725722|589817561|FG000|Overall Study|Lost to Follow-up|3|||
163302866|NCT03725722|589817562|FG001|Overall Study|Lost to Follow-up|1|||
163046914|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163302867|NCT03725722|589817563|FG002|Overall Study|Lost to Follow-up|2|||
163046915|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163302868|NCT03725722|589817564|FG003|Overall Study|Lost to Follow-up|2|||
163394923|NCT01168973|590158561|FG001|Overall Study|Withdrawal by Subject|53|||
163394924|NCT01168973|590158560|FG000|Overall Study|Death|42|||
163394925|NCT01168973|590158561|FG001|Overall Study|Death|45|||
163394926|NCT01168973|590158560|FG000|Overall Study|Physician Decision|37|||
163394927|NCT01168973|590158561|FG001|Overall Study|Physician Decision|19|||
163394928|NCT01168973|590158560|FG000|Overall Study|Sponsor Decision|2|||
163394929|NCT01168973|590158561|FG001|Overall Study|Sponsor Decision|1|||
163394930|NCT01168973|590158560|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
163394931|NCT01168973|590158561|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
163394932|NCT00419120|590158562|FG000|Long Term Follow up Period|study ongoing|10|||
163394933|NCT00388505|590158563|FG000|Overall Study|Adverse Event or Death|43|||
163394934|NCT00388505|590158564|FG001|Overall Study|Adverse Event or Death|17|||
163394935|NCT00388505|590158563|FG000|Overall Study|Withdrawal by Subject|24|||
163394936|NCT00388505|590158564|FG001|Overall Study|Withdrawal by Subject|9|||
163394937|NCT00388505|590158563|FG000|Overall Study|Lost to Follow-up|5|||
163394938|NCT00388505|590158564|FG001|Overall Study|Lost to Follow-up|3|||
163394939|NCT00388505|590158563|FG000|Overall Study|Inappropriate Enrollment|0|||
163394940|NCT00388505|590158564|FG001|Overall Study|Inappropriate Enrollment|1|||
163394941|NCT00388505|590158563|FG000|Overall Study|Administrative Reason|1|||
163394942|NCT00388505|590158564|FG001|Overall Study|Administrative Reason|0|||
163394943|NCT00388505|590158563|FG000|Overall Study|Protocol Violation|6|||
163394944|NCT00388505|590158564|FG001|Overall Study|Protocol Violation|5|||
163394945|NCT00388505|590158563|FG000|Overall Study|Unable to classify|4|||
163394946|NCT00388505|590158564|FG001|Overall Study|Unable to classify|3|||
163394947|NCT02667275|590158566|FG000|Overall Study|Protocol Violation|11|||
163394948|NCT02667275|590158567|FG001|Overall Study|Protocol Violation|7|||
163394949|NCT02667275|590158566|FG000|Overall Study|Lost to Follow-up|0|||
163394950|NCT02667275|590158567|FG001|Overall Study|Lost to Follow-up|2|||
163394951|NCT02667275|590158566|FG000|Overall Study|Withdrawal by Subject|0|||
163394952|NCT02667275|590158567|FG001|Overall Study|Withdrawal by Subject|5|||
163394953|NCT02667275|590158566|FG000|Overall Study|Discontinued early without completing|0|||
163394954|NCT02667275|590158567|FG001|Overall Study|Discontinued early without completing|1|||
163394955|NCT01756040|590158568|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
163394956|NCT01756040|590158568|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
163394957|NCT01756040|590158568|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
163394958|NCT01274715|590158569|FG000|Overall Study|Lost to Follow-up|1|||
163394959|NCT01274715|590158569|FG000|Overall Study|After consent, met exclusion criteria.|1|||
163394960|NCT01274715|590158569|FG000|Overall Study|After consent, met exclusion criteria.|1|||
163394961|NCT01274715|590158569|FG000|Overall Study|After consent, met exclusion criteria.|1|||
163394962|NCT00467779|590158582|FG000|Stage 1|Adverse Event|1|||
163394963|NCT00467779|590158583|FG001|Stage 1|Adverse Event|0|||
163394964|NCT00467779|590158584|FG002|Stage 1|Adverse Event|0|||
163394965|NCT00467779|590158585|FG003|Stage 1|Adverse Event|0|||
163394966|NCT00467779|590158586|FG004|Stage 1|Adverse Event|0|||
163394967|NCT00467779|590158587|FG005|Stage 1|Adverse Event|1|||
163394968|NCT00467779|590158588|FG006|Stage 1|Adverse Event|2|||
163394969|NCT00467779|590158589|FG007|Stage 1|Adverse Event|1|||
163394970|NCT00467779|590158590|FG008|Stage 1|Adverse Event|0|||
163394971|NCT00467779|590158591|FG009|Stage 1|Adverse Event|0|||
163394972|NCT00467779|590158592|FG010|Stage 1|Adverse Event|0|||
163394973|NCT00467779|590158593|FG011|Stage 1|Adverse Event|0|||
163394974|NCT00467779|590158594|FG012|Stage 1|Adverse Event|0|||
163394975|NCT00467779|590158595|FG013|Stage 1|Adverse Event|0|||
163394976|NCT00467779|590158596|FG014|Stage 1|Adverse Event|0|||
163394977|NCT00467779|590158582|FG000|Stage 1|Disease Progression|2|||
163394978|NCT00467779|590158583|FG001|Stage 1|Disease Progression|2|||
163394979|NCT00467779|590158584|FG002|Stage 1|Disease Progression|2|||
163394980|NCT00467779|590158585|FG003|Stage 1|Disease Progression|3|||
163394981|NCT00467779|590158586|FG004|Stage 1|Disease Progression|2|||
163394982|NCT00467779|590158587|FG005|Stage 1|Disease Progression|2|||
163394983|NCT00467779|590158588|FG006|Stage 1|Disease Progression|4|||
163394984|NCT00467779|590158589|FG007|Stage 1|Disease Progression|5|||
163394985|NCT00467779|590158590|FG008|Stage 1|Disease Progression|0|||
163394986|NCT00467779|590158591|FG009|Stage 1|Disease Progression|0|||
163394987|NCT00467779|590158592|FG010|Stage 1|Disease Progression|0|||
163394988|NCT00467779|590158593|FG011|Stage 1|Disease Progression|0|||
163394989|NCT00467779|590158594|FG012|Stage 1|Disease Progression|0|||
163394990|NCT00467779|590158595|FG013|Stage 1|Disease Progression|0|||
162960546|NCT00205777|588558854|FG005|Study Extension I|Death|0|||
162960547|NCT00205777|588558849|FG000|Study Extension I|Withdrawal by Subject|99|||
163394991|NCT00467779|590158596|FG014|Stage 1|Disease Progression|0|||
163394992|NCT00467779|590158582|FG000|Stage 1|Unspecified Reason|1|||
163394993|NCT00467779|590158583|FG001|Stage 1|Unspecified Reason|0|||
162960548|NCT00205777|588558850|FG001|Study Extension I|Withdrawal by Subject|0|||
163394994|NCT00467779|590158584|FG002|Stage 1|Unspecified Reason|1|||
163394995|NCT00467779|590158585|FG003|Stage 1|Unspecified Reason|0|||
163394996|NCT00467779|590158586|FG004|Stage 1|Unspecified Reason|1|||
163394997|NCT00467779|590158587|FG005|Stage 1|Unspecified Reason|2|||
163394998|NCT00467779|590158588|FG006|Stage 1|Unspecified Reason|0|||
162924404|NCT03611751|588423887|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
162924405|NCT03611751|588423888|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
162924406|NCT03611751|588423886|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
162924407|NCT03611751|588423887|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
162924408|NCT03611751|588423888|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
162924409|NCT03611751|588423886|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
162924410|NCT03611751|588423887|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
162924411|NCT03611751|588423888|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
162924412|NCT03611751|588423886|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
162924413|NCT03611751|588423887|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
162924414|NCT03611751|588423888|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
162924415|NCT03611751|588423886|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
162924416|NCT03611751|588423887|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
162924417|NCT03611751|588423888|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
162924418|NCT03611751|588423886|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
162924419|NCT03611751|588423887|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
162924420|NCT03611751|588423888|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
162924421|NCT03611751|588423886|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
162924422|NCT03611751|588423887|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
162924423|NCT03611751|588423888|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
162924424|NCT03611751|588423886|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
162924425|NCT03611751|588423887|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
162924426|NCT03611751|588423888|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
162924427|NCT03611751|588423886|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
162924428|NCT03611751|588423887|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
162924429|NCT03611751|588423888|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
162924430|NCT03611751|588423886|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
162924431|NCT03611751|588423887|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
162924432|NCT03611751|588423888|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
162924433|NCT01023022|588423889|FG000|Overall Study|Death|5|||
162924434|NCT01023022|588423889|FG000|Overall Study|Lost to Follow-up|7|||
162924435|NCT01023022|588423889|FG000|Overall Study|due to technical issues|2|||
162924436|NCT03128931|588423891|FG000|Overall Study|Physician Decision|1|||
162924437|NCT03128931|588423891|FG000|Overall Study|Equipment Issues|3|||
162924438|NCT03151226|588423892|FG000|Overall Study|Withdrawal by Subject|2|||
162924439|NCT03151226|588423892|FG000|Overall Study|not wear device correctly|1|||
162924440|NCT00903409|588423893|FG000|Overall Study|Adverse Event|11|||
162924441|NCT00903409|588423894|FG001|Overall Study|Adverse Event|9|||
162924442|NCT00903409|588423893|FG000|Overall Study|Non-compliance with Protocol|1|||
162924443|NCT00903409|588423894|FG001|Overall Study|Non-compliance with Protocol|1|||
162924444|NCT00903409|588423893|FG000|Overall Study|Laboratory Abnormality|2|||
162924445|NCT00903409|588423894|FG001|Overall Study|Laboratory Abnormality|0|||
162924446|NCT00903409|588423893|FG000|Overall Study|Withdrawal by Subject|8|||
162924447|NCT00903409|588423894|FG001|Overall Study|Withdrawal by Subject|8|||
162924448|NCT00903409|588423893|FG000|Overall Study|Other|2|||
162924449|NCT00903409|588423894|FG001|Overall Study|Other|3|||
163302869|NCT03725722|589817565|FG004|Overall Study|Lost to Follow-up|1|||
163302870|NCT03725722|589817561|FG000|Overall Study|Personal reasons|0|||
163302871|NCT03725722|589817562|FG001|Overall Study|Personal reasons|0|||
163302872|NCT03725722|589817563|FG002|Overall Study|Personal reasons|1|||
162924450|NCT00903409|588423893|FG000|Overall Study|Lost to Follow-up|2|||
162924451|NCT00903409|588423894|FG001|Overall Study|Lost to Follow-up|6|||
162924452|NCT03239340|588423895|FG000|Overall Study|Other|26|||
162924453|NCT03239340|588423895|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
162924454|NCT03239340|588423895|FG000|Overall Study|Death|40|||
162924455|NCT03239340|588423895|FG000|Overall Study|Lost to Follow-up|2|||
162924456|NCT03239340|588423895|FG000|Overall Study|Physician Decision|16|||
162924457|NCT03239340|588423895|FG000|Overall Study|Withdrawal by Subject|27|||
162924458|NCT03539952|588423897|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
162924459|NCT03539952|588423898|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
163302873|NCT03725722|589817564|FG003|Overall Study|Personal reasons|0|||
163302874|NCT03725722|589817565|FG004|Overall Study|Personal reasons|1|||
163302875|NCT03725722|589817561|FG000|Overall Study|COVID-19 situation|0|||
163302876|NCT03725722|589817562|FG001|Overall Study|COVID-19 situation|1|||
163302877|NCT03725722|589817563|FG002|Overall Study|COVID-19 situation|0|||
163302878|NCT03725722|589817564|FG003|Overall Study|COVID-19 situation|0|||
163302879|NCT03725722|589817565|FG004|Overall Study|COVID-19 situation|0|||
163302880|NCT01600014|589817566|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
163302881|NCT01600014|589817567|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
163302882|NCT01600014|589817566|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
163302883|NCT01600014|589817567|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
163302884|NCT01600014|589817566|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
163302885|NCT01600014|589817567|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
163302886|NCT01600014|589817566|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
163302887|NCT01600014|589817567|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
163302888|NCT01600014|589817566|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
163302889|NCT01600014|589817567|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
163302890|NCT01600014|589817566|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
163302891|NCT01600014|589817567|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
163302892|NCT01600014|589817566|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
163302893|NCT01600014|589817567|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
163302894|NCT01600014|589817566|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
163302895|NCT01600014|589817567|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
163302896|NCT01600014|589817566|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
163302897|NCT01600014|589817567|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
163302898|NCT01600014|589817566|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
163302899|NCT01600014|589817567|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
163046916|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
163046917|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162960549|NCT00205777|588558851|FG002|Study Extension I|Withdrawal by Subject|0|||
162960550|NCT00205777|588558852|FG003|Study Extension I|Withdrawal by Subject|106|||
162960551|NCT00205777|588558853|FG004|Study Extension I|Withdrawal by Subject|89|||
162960552|NCT00205777|588558854|FG005|Study Extension I|Withdrawal by Subject|0|||
162960553|NCT00205777|588558849|FG000|Study Extension I|Protocol Violation|4|||
162960554|NCT00205777|588558850|FG001|Study Extension I|Protocol Violation|0|||
162960555|NCT00205777|588558851|FG002|Study Extension I|Protocol Violation|0|||
162960556|NCT00205777|588558852|FG003|Study Extension I|Protocol Violation|8|||
162960557|NCT00205777|588558853|FG004|Study Extension I|Protocol Violation|8|||
162960558|NCT00205777|588558854|FG005|Study Extension I|Protocol Violation|0|||
162960559|NCT00205777|588558849|FG000|Study Extension I|Lack of Efficacy|0|||
162960560|NCT00205777|588558850|FG001|Study Extension I|Lack of Efficacy|0|||
162960561|NCT00205777|588558851|FG002|Study Extension I|Lack of Efficacy|0|||
162960562|NCT00205777|588558852|FG003|Study Extension I|Lack of Efficacy|1|||
162960563|NCT00205777|588558853|FG004|Study Extension I|Lack of Efficacy|2|||
162960564|NCT00205777|588558854|FG005|Study Extension I|Lack of Efficacy|0|||
162960565|NCT00205777|588558849|FG000|Study Extension I|Failed to return|15|||
162960566|NCT00205777|588558850|FG001|Study Extension I|Failed to return|0|||
162960567|NCT00205777|588558851|FG002|Study Extension I|Failed to return|0|||
162960568|NCT00205777|588558852|FG003|Study Extension I|Failed to return|17|||
162960569|NCT00205777|588558853|FG004|Study Extension I|Failed to return|13|||
162960570|NCT00205777|588558854|FG005|Study Extension I|Failed to return|0|||
162960571|NCT00205777|588558849|FG000|Study Extension I|Other Event|34|||
162960572|NCT00205777|588558850|FG001|Study Extension I|Other Event|0|||
163302900|NCT01600014|589817566|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
162960573|NCT00205777|588558851|FG002|Study Extension I|Other Event|0|||
163302901|NCT01600014|589817567|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
163394999|NCT00467779|590158589|FG007|Stage 1|Unspecified Reason|0|||
162960574|NCT00205777|588558852|FG003|Study Extension I|Other Event|34|||
162960575|NCT00205777|588558853|FG004|Study Extension I|Other Event|29|||
163395000|NCT00467779|590158590|FG008|Stage 1|Unspecified Reason|0|||
163395001|NCT00467779|590158591|FG009|Stage 1|Unspecified Reason|0|||
163395002|NCT00467779|590158592|FG010|Stage 1|Unspecified Reason|0|||
163395003|NCT00467779|590158593|FG011|Stage 1|Unspecified Reason|0|||
163395004|NCT00467779|590158594|FG012|Stage 1|Unspecified Reason|0|||
163395005|NCT00467779|590158595|FG013|Stage 1|Unspecified Reason|0|||
163395006|NCT00467779|590158596|FG014|Stage 1|Unspecified Reason|0|||
163395007|NCT00467779|590158582|FG000|Stage 1|Physician Decision|0|||
163395008|NCT00467779|590158583|FG001|Stage 1|Physician Decision|1|||
163395009|NCT00467779|590158584|FG002|Stage 1|Physician Decision|0|||
163395010|NCT00467779|590158585|FG003|Stage 1|Physician Decision|0|||
163395011|NCT00467779|590158586|FG004|Stage 1|Physician Decision|0|||
163395012|NCT00467779|590158587|FG005|Stage 1|Physician Decision|0|||
163395013|NCT00467779|590158588|FG006|Stage 1|Physician Decision|0|||
163395014|NCT00467779|590158589|FG007|Stage 1|Physician Decision|0|||
163395015|NCT00467779|590158590|FG008|Stage 1|Physician Decision|0|||
163395016|NCT00467779|590158591|FG009|Stage 1|Physician Decision|0|||
163395017|NCT00467779|590158592|FG010|Stage 1|Physician Decision|0|||
163395018|NCT00467779|590158593|FG011|Stage 1|Physician Decision|0|||
163395019|NCT00467779|590158594|FG012|Stage 1|Physician Decision|0|||
163395020|NCT00467779|590158595|FG013|Stage 1|Physician Decision|0|||
163395021|NCT00467779|590158596|FG014|Stage 1|Physician Decision|0|||
163395022|NCT00467779|590158582|FG000|Stage 1|Withdrawal by Subject|0|||
163395023|NCT00467779|590158583|FG001|Stage 1|Withdrawal by Subject|0|||
163395024|NCT00467779|590158584|FG002|Stage 1|Withdrawal by Subject|0|||
163395025|NCT00467779|590158585|FG003|Stage 1|Withdrawal by Subject|0|||
163395026|NCT00467779|590158586|FG004|Stage 1|Withdrawal by Subject|0|||
163395027|NCT00467779|590158587|FG005|Stage 1|Withdrawal by Subject|0|||
163395028|NCT00467779|590158588|FG006|Stage 1|Withdrawal by Subject|1|||
163395029|NCT00467779|590158589|FG007|Stage 1|Withdrawal by Subject|1|||
163395030|NCT00467779|590158590|FG008|Stage 1|Withdrawal by Subject|0|||
163395031|NCT00467779|590158591|FG009|Stage 1|Withdrawal by Subject|0|||
163395032|NCT00467779|590158592|FG010|Stage 1|Withdrawal by Subject|0|||
163395033|NCT00467779|590158593|FG011|Stage 1|Withdrawal by Subject|0|||
163395034|NCT00467779|590158594|FG012|Stage 1|Withdrawal by Subject|0|||
163395035|NCT00467779|590158595|FG013|Stage 1|Withdrawal by Subject|0|||
163395036|NCT00467779|590158596|FG014|Stage 1|Withdrawal by Subject|0|||
163046918|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
163046919|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046920|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046921|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046922|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046923|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046924|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046925|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046926|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046927|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046928|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046929|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163046930|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046931|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
163046932|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163046933|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163046934|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046935|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163046936|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046937|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046938|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046939|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046940|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046941|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046942|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046943|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046944|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046945|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046946|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046947|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046948|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
163046949|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046950|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046951|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046952|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046953|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046954|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046955|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046956|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046957|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046958|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046959|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046960|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046961|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046962|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
163046963|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046964|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046965|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046966|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046967|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046968|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046969|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163196686|NCT01575769|589435730|FG000|Overall Study|Adverse Event|1|||
163046970|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163196687|NCT01575769|589435730|FG000|Overall Study|Study terminated by sponsor|40|||
163196688|NCT00290888|589435731|FG000|Overall Study|Physician Decision|3|||
163196689|NCT00290888|589435732|FG001|Overall Study|Physician Decision|1|||
163196690|NCT01473836|589435733|FG000|Overall Study|Adverse Event|4|||
163196691|NCT01473836|589435733|FG000|Overall Study|Lack of Efficacy|1|||
163196692|NCT01473836|589435733|FG000|Overall Study|Does not meet entrance criteria|1|||
163046971|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046972|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046973|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046974|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046975|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046976|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046977|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046978|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046979|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
163046980|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046981|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046982|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046983|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046984|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046985|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046986|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163046987|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163046988|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163046989|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163046990|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163046991|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
163046992|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
163046993|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
163046994|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
163046995|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163046996|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163302902|NCT01600014|589817566|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
163302903|NCT01600014|589817567|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
163302904|NCT01600014|589817566|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
163302905|NCT01600014|589817567|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
163302906|NCT01600014|589817566|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
163302907|NCT01600014|589817567|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
163046997|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163046998|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163196693|NCT01034631|589435734|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
163196694|NCT01034631|589435735|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
163196695|NCT01034631|589435736|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
163196696|NCT01034631|589435734|FG000|Phase II|Not Evaluable per protocol|0|||
163196697|NCT01034631|589435735|FG001|Phase II|Not Evaluable per protocol|0|||
163196698|NCT01034631|589435736|FG002|Phase II|Not Evaluable per protocol|2|||
163196699|NCT01034631|589435734|FG000|Phase II|Determined Ineligible per protocol|0|||
163196700|NCT01034631|589435735|FG001|Phase II|Determined Ineligible per protocol|1|||
163196701|NCT01034631|589435736|FG002|Phase II|Determined Ineligible per protocol|0|||
163196702|NCT00799383|589435737|FG000|Overall Study|Protocol Violation|1|||
163196703|NCT00799383|589435738|FG001|Overall Study|Protocol Violation|1|||
163196704|NCT00799383|589435737|FG000|Overall Study|Adverse Event|0|||
163196705|NCT00799383|589435738|FG001|Overall Study|Adverse Event|1|||
163196706|NCT00799383|589435737|FG000|Overall Study|Lost to Follow-up|1|||
163196707|NCT00799383|589435738|FG001|Overall Study|Lost to Follow-up|2|||
163196708|NCT00799383|589435737|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
163196709|NCT00799383|589435738|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
163196710|NCT00799383|589435737|FG000|Overall Study|Withdrawal by Subject|0|||
163196711|NCT00799383|589435738|FG001|Overall Study|Withdrawal by Subject|1|||
163196712|NCT03486223|589435748|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
163196713|NCT03486223|589435749|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
163196714|NCT03068130|589435758|FG000|Overall Study|Adverse Event|19|||
163196715|NCT03068130|589435758|FG000|Overall Study|Death|14|||
163395037|NCT00467779|590158582|FG000|Stage 1A|Adverse Event|0|||
163395038|NCT00467779|590158583|FG001|Stage 1A|Adverse Event|0|||
163395039|NCT00467779|590158584|FG002|Stage 1A|Adverse Event|0|||
163395040|NCT00467779|590158585|FG003|Stage 1A|Adverse Event|0|||
163395041|NCT00467779|590158586|FG004|Stage 1A|Adverse Event|0|||
163395042|NCT00467779|590158587|FG005|Stage 1A|Adverse Event|0|||
163395043|NCT00467779|590158588|FG006|Stage 1A|Adverse Event|0|||
163395044|NCT00467779|590158589|FG007|Stage 1A|Adverse Event|0|||
163395045|NCT00467779|590158590|FG008|Stage 1A|Adverse Event|0|||
163395046|NCT00467779|590158591|FG009|Stage 1A|Adverse Event|0|||
163395047|NCT00467779|590158592|FG010|Stage 1A|Adverse Event|0|||
163395048|NCT00467779|590158593|FG011|Stage 1A|Adverse Event|0|||
163395049|NCT00467779|590158594|FG012|Stage 1A|Adverse Event|1|||
163395050|NCT00467779|590158595|FG013|Stage 1A|Adverse Event|0|||
163395051|NCT00467779|590158596|FG014|Stage 1A|Adverse Event|0|||
163395052|NCT00467779|590158582|FG000|Stage 1A|Death|0|||
163395053|NCT00467779|590158583|FG001|Stage 1A|Death|0|||
163395054|NCT00467779|590158584|FG002|Stage 1A|Death|0|||
163395055|NCT00467779|590158585|FG003|Stage 1A|Death|0|||
163395056|NCT00467779|590158586|FG004|Stage 1A|Death|0|||
163395057|NCT00467779|590158587|FG005|Stage 1A|Death|0|||
163395058|NCT00467779|590158588|FG006|Stage 1A|Death|0|||
163395059|NCT00467779|590158589|FG007|Stage 1A|Death|0|||
163395060|NCT00467779|590158590|FG008|Stage 1A|Death|0|||
163395061|NCT00467779|590158591|FG009|Stage 1A|Death|0|||
163395062|NCT00467779|590158592|FG010|Stage 1A|Death|0|||
163395063|NCT00467779|590158593|FG011|Stage 1A|Death|1|||
163395064|NCT00467779|590158594|FG012|Stage 1A|Death|1|||
163395065|NCT00467779|590158595|FG013|Stage 1A|Death|0|||
163395066|NCT00467779|590158596|FG014|Stage 1A|Death|0|||
163395067|NCT00467779|590158582|FG000|Stage 1A|Disease Progression|0|||
163395068|NCT00467779|590158583|FG001|Stage 1A|Disease Progression|0|||
163395069|NCT00467779|590158584|FG002|Stage 1A|Disease Progression|0|||
163395070|NCT00467779|590158585|FG003|Stage 1A|Disease Progression|0|||
163395071|NCT00467779|590158586|FG004|Stage 1A|Disease Progression|0|||
163395072|NCT00467779|590158587|FG005|Stage 1A|Disease Progression|0|||
163395073|NCT00467779|590158588|FG006|Stage 1A|Disease Progression|0|||
163395074|NCT00467779|590158589|FG007|Stage 1A|Disease Progression|0|||
163395075|NCT00467779|590158590|FG008|Stage 1A|Disease Progression|0|||
163196716|NCT03068130|589435758|FG000|Overall Study|Lost to Follow-up|4|||
163196717|NCT03068130|589435758|FG000|Overall Study|Withdrawal by Subject|26|||
163196718|NCT03068130|589435758|FG000|Overall Study|Administrative Reasons|3|||
163196719|NCT03068130|589435758|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
163395076|NCT00467779|590158591|FG009|Stage 1A|Disease Progression|2|||
163395077|NCT00467779|590158592|FG010|Stage 1A|Disease Progression|2|||
163395078|NCT00467779|590158593|FG011|Stage 1A|Disease Progression|5|||
163395079|NCT00467779|590158594|FG012|Stage 1A|Disease Progression|2|||
163395080|NCT00467779|590158595|FG013|Stage 1A|Disease Progression|0|||
163395081|NCT00467779|590158596|FG014|Stage 1A|Disease Progression|0|||
163395082|NCT00467779|590158582|FG000|Stage 1A|Physician Decision|0|||
163395083|NCT00467779|590158583|FG001|Stage 1A|Physician Decision|0|||
163395084|NCT00467779|590158584|FG002|Stage 1A|Physician Decision|0|||
163395085|NCT00467779|590158585|FG003|Stage 1A|Physician Decision|0|||
163395086|NCT00467779|590158586|FG004|Stage 1A|Physician Decision|0|||
163395087|NCT00467779|590158587|FG005|Stage 1A|Physician Decision|0|||
163395088|NCT00467779|590158588|FG006|Stage 1A|Physician Decision|0|||
163395089|NCT00467779|590158589|FG007|Stage 1A|Physician Decision|0|||
163395090|NCT00467779|590158590|FG008|Stage 1A|Physician Decision|0|||
163302908|NCT01600014|589817566|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
163302909|NCT01600014|589817567|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
163302910|NCT01600014|589817566|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
163302911|NCT01600014|589817567|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
163302912|NCT01600014|589817566|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
163302913|NCT01600014|589817567|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
163302914|NCT03481660|589817571|FG000|Overall Study|Adverse Event|5|||
163302915|NCT03481660|589817572|FG001|Overall Study|Adverse Event|4|||
163302916|NCT03481660|589817571|FG000|Overall Study|Death|13|||
163302917|NCT03481660|589817572|FG001|Overall Study|Death|9|||
163302918|NCT03481660|589817571|FG000|Overall Study|Lost to Follow-up|2|||
163302919|NCT03481660|589817572|FG001|Overall Study|Lost to Follow-up|2|||
163302920|NCT03481660|589817571|FG000|Overall Study|Physician Decision|2|||
163302921|NCT03481660|589817572|FG001|Overall Study|Physician Decision|3|||
163302922|NCT03481660|589817571|FG000|Overall Study|Withdrawal by Subject|14|||
163302923|NCT03481660|589817572|FG001|Overall Study|Withdrawal by Subject|7|||
163302924|NCT04278586|589817573|FG000|Overall Study|Withdrawal by Subject|13|||
163302925|NCT04278586|589817574|FG001|Overall Study|Withdrawal by Subject|6|||
163302926|NCT04278586|589817573|FG000|Overall Study|Lost to Follow-up|37|||
163302927|NCT04278586|589817574|FG001|Overall Study|Lost to Follow-up|24|||
163302928|NCT05075408|589817581|FG000|Overall Study|Withdrawal by Subject|5|||
162960576|NCT00205777|588558854|FG005|Study Extension I|Other Event|0|||
162960577|NCT00205777|588558849|FG000|Study Extension I|Withdrawn as per protocol|0|||
162960578|NCT00205777|588558850|FG001|Study Extension I|Withdrawn as per protocol|0|||
162960579|NCT00205777|588558851|FG002|Study Extension I|Withdrawn as per protocol|1070|||
162960580|NCT00205777|588558852|FG003|Study Extension I|Withdrawn as per protocol|0|||
162960581|NCT00205777|588558853|FG004|Study Extension I|Withdrawn as per protocol|0|||
162960582|NCT00205777|588558854|FG005|Study Extension I|Withdrawn as per protocol|0|||
162960583|NCT00205777|588558849|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
163196720|NCT03068130|589435758|FG000|Overall Study|Study terminated by sponsor|194|||
163395091|NCT00467779|590158591|FG009|Stage 1A|Physician Decision|1|||
163395092|NCT00467779|590158592|FG010|Stage 1A|Physician Decision|0|||
163395093|NCT00467779|590158593|FG011|Stage 1A|Physician Decision|0|||
163395094|NCT00467779|590158594|FG012|Stage 1A|Physician Decision|0|||
163395095|NCT00467779|590158595|FG013|Stage 1A|Physician Decision|0|||
163395096|NCT00467779|590158596|FG014|Stage 1A|Physician Decision|0|||
163395097|NCT00467779|590158582|FG000|Stage 1A|Withdrawal by Subject|0|||
163395098|NCT00467779|590158583|FG001|Stage 1A|Withdrawal by Subject|0|||
163395099|NCT00467779|590158584|FG002|Stage 1A|Withdrawal by Subject|0|||
163395100|NCT00467779|590158585|FG003|Stage 1A|Withdrawal by Subject|0|||
163395101|NCT00467779|590158586|FG004|Stage 1A|Withdrawal by Subject|0|||
163395102|NCT00467779|590158587|FG005|Stage 1A|Withdrawal by Subject|0|||
163395103|NCT00467779|590158588|FG006|Stage 1A|Withdrawal by Subject|0|||
163395104|NCT00467779|590158589|FG007|Stage 1A|Withdrawal by Subject|0|||
163395105|NCT00467779|590158590|FG008|Stage 1A|Withdrawal by Subject|0|||
163395106|NCT00467779|590158591|FG009|Stage 1A|Withdrawal by Subject|0|||
163395107|NCT00467779|590158592|FG010|Stage 1A|Withdrawal by Subject|1|||
163395108|NCT00467779|590158593|FG011|Stage 1A|Withdrawal by Subject|1|||
163395109|NCT00467779|590158594|FG012|Stage 1A|Withdrawal by Subject|1|||
163395110|NCT00467779|590158595|FG013|Stage 1A|Withdrawal by Subject|0|||
163395111|NCT00467779|590158596|FG014|Stage 1A|Withdrawal by Subject|0|||
163395112|NCT00467779|590158582|FG000|Stage 1A|Unspecified Reason|0|||
163395113|NCT00467779|590158583|FG001|Stage 1A|Unspecified Reason|0|||
163395114|NCT00467779|590158584|FG002|Stage 1A|Unspecified Reason|0|||
163395115|NCT00467779|590158585|FG003|Stage 1A|Unspecified Reason|0|||
163395116|NCT00467779|590158586|FG004|Stage 1A|Unspecified Reason|0|||
163395117|NCT00467779|590158587|FG005|Stage 1A|Unspecified Reason|0|||
163395118|NCT00467779|590158588|FG006|Stage 1A|Unspecified Reason|0|||
163395119|NCT00467779|590158589|FG007|Stage 1A|Unspecified Reason|0|||
163395120|NCT00467779|590158590|FG008|Stage 1A|Unspecified Reason|0|||
163395121|NCT00467779|590158591|FG009|Stage 1A|Unspecified Reason|0|||
163395122|NCT00467779|590158592|FG010|Stage 1A|Unspecified Reason|0|||
163395123|NCT00467779|590158593|FG011|Stage 1A|Unspecified Reason|1|||
163395124|NCT00467779|590158594|FG012|Stage 1A|Unspecified Reason|1|||
163395125|NCT00467779|590158595|FG013|Stage 1A|Unspecified Reason|0|||
163395126|NCT00467779|590158596|FG014|Stage 1A|Unspecified Reason|0|||
163395127|NCT00467779|590158582|FG000|Stage 2|Adverse Event|0|||
163395128|NCT00467779|590158583|FG001|Stage 2|Adverse Event|0|||
163395129|NCT00467779|590158584|FG002|Stage 2|Adverse Event|0|||
163395130|NCT00467779|590158585|FG003|Stage 2|Adverse Event|0|||
163395131|NCT00467779|590158586|FG004|Stage 2|Adverse Event|0|||
163395132|NCT00467779|590158587|FG005|Stage 2|Adverse Event|0|||
163395133|NCT00467779|590158588|FG006|Stage 2|Adverse Event|0|||
163395134|NCT00467779|590158589|FG007|Stage 2|Adverse Event|0|||
163395135|NCT00467779|590158590|FG008|Stage 2|Adverse Event|1|||
163395136|NCT00467779|590158591|FG009|Stage 2|Adverse Event|0|||
163395137|NCT00467779|590158592|FG010|Stage 2|Adverse Event|0|||
163395138|NCT00467779|590158593|FG011|Stage 2|Adverse Event|0|||
163395139|NCT00467779|590158594|FG012|Stage 2|Adverse Event|0|||
163395140|NCT00467779|590158595|FG013|Stage 2|Adverse Event|0|||
163395141|NCT00467779|590158596|FG014|Stage 2|Adverse Event|0|||
163395142|NCT00467779|590158582|FG000|Stage 2|Death|0|||
163395143|NCT00467779|590158583|FG001|Stage 2|Death|0|||
163395144|NCT00467779|590158584|FG002|Stage 2|Death|0|||
163395145|NCT00467779|590158585|FG003|Stage 2|Death|0|||
163395146|NCT00467779|590158586|FG004|Stage 2|Death|0|||
163196721|NCT00590720|589435763|FG000|Overall Study|Lost to Follow-up|1|||
163395147|NCT00467779|590158587|FG005|Stage 2|Death|0|||
163395148|NCT00467779|590158588|FG006|Stage 2|Death|0|||
163395149|NCT00467779|590158589|FG007|Stage 2|Death|0|||
163395150|NCT00467779|590158590|FG008|Stage 2|Death|1|||
163395151|NCT00467779|590158591|FG009|Stage 2|Death|0|||
163395152|NCT00467779|590158592|FG010|Stage 2|Death|0|||
163395153|NCT00467779|590158593|FG011|Stage 2|Death|0|||
163395154|NCT00467779|590158594|FG012|Stage 2|Death|0|||
163395155|NCT00467779|590158595|FG013|Stage 2|Death|0|||
163395156|NCT00467779|590158596|FG014|Stage 2|Death|0|||
163395157|NCT00467779|590158582|FG000|Stage 2|Disease Progression|0|||
163395158|NCT00467779|590158583|FG001|Stage 2|Disease Progression|0|||
163395159|NCT00467779|590158584|FG002|Stage 2|Disease Progression|0|||
163395160|NCT00467779|590158585|FG003|Stage 2|Disease Progression|0|||
163395161|NCT00467779|590158586|FG004|Stage 2|Disease Progression|0|||
163395162|NCT00467779|590158587|FG005|Stage 2|Disease Progression|0|||
163395163|NCT00467779|590158588|FG006|Stage 2|Disease Progression|0|||
163196722|NCT00590720|589435764|FG001|Overall Study|Lost to Follow-up|0|||
163046999|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163047000|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163047001|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163196723|NCT00590720|589435763|FG000|Overall Study|Withdrawal by Subject|0|||
163196724|NCT00590720|589435764|FG001|Overall Study|Withdrawal by Subject|1|||
163196725|NCT03741062|589435769|FG000|Overall Study|Protocol Violation|1|||
163196726|NCT03741062|589435770|FG001|Overall Study|Protocol Violation|0|||
163196727|NCT02527161|589435771|FG000|Overall Study|Failed MRI|52|||
163196728|NCT02527161|589435771|FG000|Overall Study|Withdrawal by Subject|19|||
163196729|NCT02527161|589435771|FG000|Overall Study|Delay in or unfit for surgery|16|||
163196730|NCT02527161|589435771|FG000|Overall Study|MRI contraindication|6|||
163196731|NCT02527161|589435771|FG000|Overall Study|Consent violation|4|||
163196732|NCT02527161|589435771|FG000|Overall Study|Only Recruited to Part A|27|||
163196733|NCT02527161|589435771|FG000|Overall Study|Physician Decision|1|||
163196734|NCT02527161|589435771|FG000|Overall Study|Adverse Event|1|||
163196735|NCT02527161|589435771|FG000|Overall Study|Lost to Follow-up|6|||
163196736|NCT02609828|589435772|FG000|Overall Study|Adverse Event|8|||
163047002|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047003|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047004|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047005|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047006|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
163047007|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163196737|NCT02609828|589435773|FG001|Overall Study|Adverse Event|1|||
163196738|NCT02609828|589435774|FG002|Overall Study|Adverse Event|0|||
163196739|NCT02609828|589435775|FG003|Overall Study|Adverse Event|6|||
163196740|NCT02609828|589435772|FG000|Overall Study|Death|15|||
163196741|NCT02609828|589435773|FG001|Overall Study|Death|1|||
163196742|NCT02609828|589435774|FG002|Overall Study|Death|1|||
163196743|NCT02609828|589435775|FG003|Overall Study|Death|19|||
163196744|NCT02609828|589435772|FG000|Overall Study|Insufficient clinical response|2|||
163196745|NCT02609828|589435773|FG001|Overall Study|Insufficient clinical response|1|||
163196746|NCT02609828|589435774|FG002|Overall Study|Insufficient clinical response|0|||
163196747|NCT02609828|589435775|FG003|Overall Study|Insufficient clinical response|0|||
163196748|NCT02609828|589435772|FG000|Overall Study|Lost to Follow-up|0|||
163196749|NCT02609828|589435773|FG001|Overall Study|Lost to Follow-up|0|||
163196750|NCT02609828|589435774|FG002|Overall Study|Lost to Follow-up|0|||
163302929|NCT05075408|589817582|FG001|Overall Study|Withdrawal by Subject|3|||
163302930|NCT05075408|589817583|FG002|Overall Study|Withdrawal by Subject|4|||
163302931|NCT05075408|589817581|FG000|Overall Study|Adverse Event|5|||
163302932|NCT05075408|589817582|FG001|Overall Study|Adverse Event|7|||
163302933|NCT05075408|589817583|FG002|Overall Study|Adverse Event|8|||
163302934|NCT05075408|589817581|FG000|Overall Study|Protocol Violation|0|||
163302935|NCT05075408|589817582|FG001|Overall Study|Protocol Violation|1|||
163302936|NCT05075408|589817583|FG002|Overall Study|Protocol Violation|0|||
163196751|NCT02609828|589435775|FG003|Overall Study|Lost to Follow-up|1|||
163196752|NCT02609828|589435772|FG000|Overall Study|Protocol Violation|2|||
163196753|NCT02609828|589435773|FG001|Overall Study|Protocol Violation|0|||
163302937|NCT05075408|589817581|FG000|Overall Study|Lost to Follow-up|2|||
163302938|NCT05075408|589817582|FG001|Overall Study|Lost to Follow-up|1|||
163302939|NCT05075408|589817583|FG002|Overall Study|Lost to Follow-up|1|||
163302940|NCT05075408|589817581|FG000|Overall Study|Physician Decision|1|||
163302941|NCT05075408|589817582|FG001|Overall Study|Physician Decision|0|||
163302942|NCT05075408|589817583|FG002|Overall Study|Physician Decision|0|||
163302943|NCT05075408|589817581|FG000|Overall Study|Other-unspecified|3|||
163302944|NCT05075408|589817582|FG001|Overall Study|Other-unspecified|2|||
163302945|NCT05075408|589817583|FG002|Overall Study|Other-unspecified|0|||
163302946|NCT03651895|589817584|FG000|First Drug Assignment|Adverse Event|4|||
163302947|NCT03651895|589817585|FG001|First Drug Assignment|Adverse Event|5|||
163302948|NCT03651895|589817584|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
163302949|NCT03651895|589817585|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
163302950|NCT04527146|589817586|FG000|Overall Study|Withdrawal by Subject|12|||
163302951|NCT04527146|589817587|FG001|Overall Study|Withdrawal by Subject|15|||
163302952|NCT04527146|589817588|FG002|Overall Study|Withdrawal by Subject|7|||
163302953|NCT04527146|589817589|FG003|Overall Study|Withdrawal by Subject|16|||
163302954|NCT04527146|589817586|FG000|Overall Study|Lost to Follow-up|13|||
163302955|NCT04527146|589817587|FG001|Overall Study|Lost to Follow-up|9|||
163302956|NCT04527146|589817588|FG002|Overall Study|Lost to Follow-up|16|||
163302957|NCT04527146|589817589|FG003|Overall Study|Lost to Follow-up|13|||
163302958|NCT04527146|589817586|FG000|Overall Study|Death|0|||
163302959|NCT04527146|589817587|FG001|Overall Study|Death|1|||
163302960|NCT04527146|589817588|FG002|Overall Study|Death|1|||
163302961|NCT04527146|589817589|FG003|Overall Study|Death|0|||
163302962|NCT04527146|589817586|FG000|Overall Study|Adverse Event|0|||
163302963|NCT04527146|589817587|FG001|Overall Study|Adverse Event|0|||
163302964|NCT04527146|589817588|FG002|Overall Study|Adverse Event|1|||
163302965|NCT04527146|589817589|FG003|Overall Study|Adverse Event|0|||
163302966|NCT04527146|589817586|FG000|Overall Study|Ineligible after randomization|2|||
163302967|NCT04527146|589817587|FG001|Overall Study|Ineligible after randomization|0|||
163302968|NCT04527146|589817588|FG002|Overall Study|Ineligible after randomization|2|||
163302969|NCT04527146|589817589|FG003|Overall Study|Ineligible after randomization|2|||
163302970|NCT04527146|589817586|FG000|Overall Study|Moved to a different group|6|||
163302971|NCT04527146|589817587|FG001|Overall Study|Moved to a different group|3|||
163302972|NCT04527146|589817588|FG002|Overall Study|Moved to a different group|0|||
163302973|NCT04527146|589817589|FG003|Overall Study|Moved to a different group|2|||
163302974|NCT05510232|589817590|FG000|Overall Study|Withdrawal by Subject|2|||
163302975|NCT05510232|589817591|FG001|Overall Study|Withdrawal by Subject|7|||
163302976|NCT05510232|589817592|FG002|Overall Study|Withdrawal by Subject|6|||
163302977|NCT04468776|589817602|FG000|Overall Study|Lost to Follow-up|4|||
163302978|NCT04468776|589817603|FG001|Overall Study|Lost to Follow-up|3|||
163302979|NCT04468776|589817604|FG002|Overall Study|Lost to Follow-up|4|||
163302980|NCT04468776|589817602|FG000|Overall Study|Withdrawal by Subject|1|||
163302981|NCT04468776|589817603|FG001|Overall Study|Withdrawal by Subject|10|||
163047008|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047009|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047010|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047011|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047012|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163196754|NCT02609828|589435774|FG002|Overall Study|Protocol Violation|0|||
163395164|NCT00467779|590158589|FG007|Stage 2|Disease Progression|0|||
163395165|NCT00467779|590158590|FG008|Stage 2|Disease Progression|16|||
163395166|NCT00467779|590158591|FG009|Stage 2|Disease Progression|0|||
163395167|NCT00467779|590158592|FG010|Stage 2|Disease Progression|0|||
163395168|NCT00467779|590158593|FG011|Stage 2|Disease Progression|0|||
163395169|NCT00467779|590158594|FG012|Stage 2|Disease Progression|0|||
163395170|NCT00467779|590158595|FG013|Stage 2|Disease Progression|0|||
163395171|NCT00467779|590158596|FG014|Stage 2|Disease Progression|0|||
163395172|NCT00467779|590158582|FG000|Stage 2|Unspecified Reason|0|||
163395173|NCT00467779|590158583|FG001|Stage 2|Unspecified Reason|0|||
163395174|NCT00467779|590158584|FG002|Stage 2|Unspecified Reason|0|||
163395175|NCT00467779|590158585|FG003|Stage 2|Unspecified Reason|0|||
163395176|NCT00467779|590158586|FG004|Stage 2|Unspecified Reason|0|||
163395177|NCT00467779|590158587|FG005|Stage 2|Unspecified Reason|0|||
163395178|NCT00467779|590158588|FG006|Stage 2|Unspecified Reason|0|||
163395179|NCT00467779|590158589|FG007|Stage 2|Unspecified Reason|0|||
163395180|NCT00467779|590158590|FG008|Stage 2|Unspecified Reason|3|||
163395181|NCT00467779|590158591|FG009|Stage 2|Unspecified Reason|0|||
163395182|NCT00467779|590158592|FG010|Stage 2|Unspecified Reason|0|||
163395183|NCT00467779|590158593|FG011|Stage 2|Unspecified Reason|0|||
163395184|NCT00467779|590158594|FG012|Stage 2|Unspecified Reason|0|||
163395185|NCT00467779|590158595|FG013|Stage 2|Unspecified Reason|0|||
163395186|NCT00467779|590158596|FG014|Stage 2|Unspecified Reason|0|||
163395187|NCT00467779|590158582|FG000|Stage 2A|Adverse Event|0|||
163395188|NCT00467779|590158583|FG001|Stage 2A|Adverse Event|0|||
163395189|NCT00467779|590158584|FG002|Stage 2A|Adverse Event|0|||
163395190|NCT00467779|590158585|FG003|Stage 2A|Adverse Event|0|||
163395191|NCT00467779|590158586|FG004|Stage 2A|Adverse Event|0|||
163395192|NCT00467779|590158587|FG005|Stage 2A|Adverse Event|0|||
163395193|NCT00467779|590158588|FG006|Stage 2A|Adverse Event|0|||
163395194|NCT00467779|590158589|FG007|Stage 2A|Adverse Event|0|||
163395195|NCT00467779|590158590|FG008|Stage 2A|Adverse Event|0|||
163395196|NCT00467779|590158591|FG009|Stage 2A|Adverse Event|0|||
163395197|NCT00467779|590158592|FG010|Stage 2A|Adverse Event|0|||
163395198|NCT00467779|590158593|FG011|Stage 2A|Adverse Event|0|||
163395199|NCT00467779|590158594|FG012|Stage 2A|Adverse Event|0|||
163395200|NCT00467779|590158595|FG013|Stage 2A|Adverse Event|2|||
163395201|NCT00467779|590158596|FG014|Stage 2A|Adverse Event|0|||
163395202|NCT00467779|590158582|FG000|Stage 2A|Death|0|||
163395203|NCT00467779|590158583|FG001|Stage 2A|Death|0|||
163395204|NCT00467779|590158584|FG002|Stage 2A|Death|0|||
163395205|NCT00467779|590158585|FG003|Stage 2A|Death|0|||
163395206|NCT00467779|590158586|FG004|Stage 2A|Death|0|||
163395207|NCT00467779|590158587|FG005|Stage 2A|Death|0|||
163395208|NCT00467779|590158588|FG006|Stage 2A|Death|0|||
163395209|NCT00467779|590158589|FG007|Stage 2A|Death|0|||
163395210|NCT00467779|590158590|FG008|Stage 2A|Death|0|||
163395211|NCT00467779|590158591|FG009|Stage 2A|Death|0|||
163395212|NCT00467779|590158592|FG010|Stage 2A|Death|0|||
163395213|NCT00467779|590158593|FG011|Stage 2A|Death|0|||
163395214|NCT00467779|590158594|FG012|Stage 2A|Death|0|||
163395215|NCT00467779|590158595|FG013|Stage 2A|Death|1|||
163395216|NCT00467779|590158596|FG014|Stage 2A|Death|0|||
163395217|NCT00467779|590158582|FG000|Stage 2A|Disease Progression|0|||
163395218|NCT00467779|590158583|FG001|Stage 2A|Disease Progression|0|||
163395219|NCT00467779|590158584|FG002|Stage 2A|Disease Progression|0|||
163395220|NCT00467779|590158585|FG003|Stage 2A|Disease Progression|0|||
163395221|NCT00467779|590158586|FG004|Stage 2A|Disease Progression|0|||
163395222|NCT00467779|590158587|FG005|Stage 2A|Disease Progression|0|||
163395223|NCT00467779|590158588|FG006|Stage 2A|Disease Progression|0|||
163395224|NCT00467779|590158589|FG007|Stage 2A|Disease Progression|0|||
163395225|NCT00467779|590158590|FG008|Stage 2A|Disease Progression|0|||
163395226|NCT00467779|590158591|FG009|Stage 2A|Disease Progression|0|||
163395227|NCT00467779|590158592|FG010|Stage 2A|Disease Progression|0|||
163395228|NCT00467779|590158593|FG011|Stage 2A|Disease Progression|0|||
163395229|NCT00467779|590158594|FG012|Stage 2A|Disease Progression|0|||
163395230|NCT00467779|590158595|FG013|Stage 2A|Disease Progression|10|||
163395231|NCT00467779|590158596|FG014|Stage 2A|Disease Progression|0|||
163395232|NCT00467779|590158582|FG000|Stage 2A|Unspecified Reason|0|||
163395233|NCT00467779|590158583|FG001|Stage 2A|Unspecified Reason|0|||
163395234|NCT00467779|590158584|FG002|Stage 2A|Unspecified Reason|0|||
163395235|NCT00467779|590158585|FG003|Stage 2A|Unspecified Reason|0|||
163395236|NCT00467779|590158586|FG004|Stage 2A|Unspecified Reason|0|||
163395237|NCT00467779|590158587|FG005|Stage 2A|Unspecified Reason|0|||
163395238|NCT00467779|590158588|FG006|Stage 2A|Unspecified Reason|0|||
163395239|NCT00467779|590158589|FG007|Stage 2A|Unspecified Reason|0|||
163196755|NCT02609828|589435775|FG003|Overall Study|Protocol Violation|1|||
163196756|NCT02609828|589435772|FG000|Overall Study|Withdrawal by Subject|12|||
163196757|NCT02609828|589435773|FG001|Overall Study|Withdrawal by Subject|1|||
163196758|NCT02609828|589435774|FG002|Overall Study|Withdrawal by Subject|0|||
163196759|NCT02609828|589435775|FG003|Overall Study|Withdrawal by Subject|10|||
163196760|NCT02609828|589435772|FG000|Overall Study|Other|3|||
162960584|NCT00205777|588558850|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
162960585|NCT00205777|588558851|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
162960586|NCT00205777|588558852|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
162960587|NCT00205777|588558853|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
162960588|NCT00205777|588558854|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
162960589|NCT00205777|588558849|FG000|Study Extension II|Adverse Event|0|||
162960590|NCT00205777|588558850|FG001|Study Extension II|Adverse Event|0|||
162960591|NCT00205777|588558851|FG002|Study Extension II|Adverse Event|0|||
162960592|NCT00205777|588558852|FG003|Study Extension II|Adverse Event|14|||
162960593|NCT00205777|588558853|FG004|Study Extension II|Adverse Event|0|||
162960594|NCT00205777|588558854|FG005|Study Extension II|Adverse Event|30|||
162960595|NCT00205777|588558849|FG000|Study Extension II|Death|0|||
162960596|NCT00205777|588558850|FG001|Study Extension II|Death|0|||
162960597|NCT00205777|588558851|FG002|Study Extension II|Death|0|||
162960598|NCT00205777|588558852|FG003|Study Extension II|Death|2|||
162960599|NCT00205777|588558853|FG004|Study Extension II|Death|0|||
162960600|NCT00205777|588558854|FG005|Study Extension II|Death|5|||
162960601|NCT00205777|588558849|FG000|Study Extension II|Withdrawal by Subject|0|||
162960602|NCT00205777|588558850|FG001|Study Extension II|Withdrawal by Subject|0|||
162960603|NCT00205777|588558851|FG002|Study Extension II|Withdrawal by Subject|0|||
162960604|NCT00205777|588558852|FG003|Study Extension II|Withdrawal by Subject|35|||
162960605|NCT00205777|588558853|FG004|Study Extension II|Withdrawal by Subject|0|||
162960606|NCT00205777|588558854|FG005|Study Extension II|Withdrawal by Subject|59|||
162960607|NCT00205777|588558849|FG000|Study Extension II|Protocol Violation|0|||
162960608|NCT00205777|588558850|FG001|Study Extension II|Protocol Violation|0|||
162960609|NCT00205777|588558851|FG002|Study Extension II|Protocol Violation|0|||
162960610|NCT00205777|588558852|FG003|Study Extension II|Protocol Violation|1|||
162960611|NCT00205777|588558853|FG004|Study Extension II|Protocol Violation|0|||
163196761|NCT02609828|589435773|FG001|Overall Study|Other|0|||
163196762|NCT02609828|589435774|FG002|Overall Study|Other|0|||
163196763|NCT02609828|589435775|FG003|Overall Study|Other|6|||
163196764|NCT02609828|589435772|FG000|Overall Study|Randomized but not treated|1|||
163196765|NCT02609828|589435773|FG001|Overall Study|Randomized but not treated|0|||
163196766|NCT02609828|589435774|FG002|Overall Study|Randomized but not treated|0|||
163196767|NCT02609828|589435775|FG003|Overall Study|Randomized but not treated|0|||
163196768|NCT01786668|589435778|FG000|Overall Study|Adverse Event|0|||
163196769|NCT01786668|589435779|FG001|Overall Study|Adverse Event|1|||
163196770|NCT01786668|589435780|FG002|Overall Study|Adverse Event|1|||
163196771|NCT01786668|589435781|FG003|Overall Study|Adverse Event|2|||
163196772|NCT01786668|589435778|FG000|Overall Study|Withdrawal by Subject|0|||
163196773|NCT01786668|589435779|FG001|Overall Study|Withdrawal by Subject|0|||
163196774|NCT01786668|589435780|FG002|Overall Study|Withdrawal by Subject|3|||
163196775|NCT01786668|589435781|FG003|Overall Study|Withdrawal by Subject|1|||
163196776|NCT01786668|589435778|FG000|Overall Study|Pregnancy|0|||
163196777|NCT01786668|589435779|FG001|Overall Study|Pregnancy|0|||
163196778|NCT01786668|589435780|FG002|Overall Study|Pregnancy|0|||
163196779|NCT01786668|589435781|FG003|Overall Study|Pregnancy|1|||
163196780|NCT01786668|589435778|FG000|Overall Study|Lost to Follow-up|1|||
163196781|NCT01786668|589435779|FG001|Overall Study|Lost to Follow-up|0|||
163196782|NCT01786668|589435780|FG002|Overall Study|Lost to Follow-up|1|||
163196783|NCT01786668|589435781|FG003|Overall Study|Lost to Follow-up|0|||
163302982|NCT04468776|589817604|FG002|Overall Study|Withdrawal by Subject|4|||
163302983|NCT04468776|589817602|FG000|Overall Study|Physician Decision|0|||
163302984|NCT04468776|589817603|FG001|Overall Study|Physician Decision|1|||
163302985|NCT04468776|589817604|FG002|Overall Study|Physician Decision|1|||
163302986|NCT05687903|589817605|FG000|Overall Study|Protocol Deviation|1|||
163196784|NCT03068455|589435786|FG000|Pre-treatment Period|Disease progression|0|||
163196785|NCT03068455|589435787|FG001|Pre-treatment Period|Disease progression|1|||
163196786|NCT03068455|589435786|FG000|Pre-treatment Period|Participant withdrew consent|1|||
163196787|NCT03068455|589435787|FG001|Pre-treatment Period|Participant withdrew consent|1|||
163196788|NCT03068455|589435786|FG000|Pre-treatment Period|Poor/non-compliance|0|||
163196789|NCT03068455|589435787|FG001|Pre-treatment Period|Poor/non-compliance|1|||
163196790|NCT03068455|589435786|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
163196791|NCT03068455|589435787|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
163196792|NCT03068455|589435786|FG000|Pre-treatment Period|Not reported|2|||
163196793|NCT03068455|589435787|FG001|Pre-treatment Period|Not reported|1|||
163196794|NCT03068455|589435786|FG000|Treatment Period|Disease progression|166|||
163196795|NCT03068455|589435787|FG001|Treatment Period|Disease progression|208|||
163196796|NCT03068455|589435786|FG000|Treatment Period|Study drug toxicity|317|||
163302987|NCT05687903|589817606|FG001|Overall Study|Protocol Deviation|1|||
163302988|NCT05687903|589817607|FG002|Overall Study|Protocol Deviation|0|||
163302989|NCT05687903|589817608|FG003|Overall Study|Protocol Deviation|1|||
163302990|NCT05687903|589817609|FG004|Overall Study|Protocol Deviation|0|||
163302991|NCT04855760|589817610|FG000|Overall Study|Adverse Event|21|||
163302992|NCT04855760|589817610|FG000|Overall Study|Withdrawal by Subject|116|||
163302993|NCT04855760|589817610|FG000|Overall Study|Lack of Efficacy|21|||
163302994|NCT04855760|589817610|FG000|Overall Study|Lost to Follow-up|49|||
163302995|NCT04855760|589817610|FG000|Overall Study|Protocol Violation|2|||
163302996|NCT04855760|589817610|FG000|Overall Study|Physician Decision|5|||
163196797|NCT03068455|589435787|FG001|Treatment Period|Study drug toxicity|104|||
163196798|NCT03068455|589435786|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
163196799|NCT03068455|589435787|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
163196800|NCT03068455|589435786|FG000|Treatment Period|Participant request to stop therapy|33|||
163196801|NCT03068455|589435787|FG001|Treatment Period|Participant request to stop therapy|20|||
163302997|NCT04855760|589817610|FG000|Overall Study|Pregnancy|1|||
163302998|NCT04855760|589817610|FG000|Overall Study|Non-Compliance with Study Drug|11|||
162960612|NCT00205777|588558854|FG005|Study Extension II|Protocol Violation|10|||
162960613|NCT00205777|588558849|FG000|Study Extension II|Lack of Efficacy|0|||
163395240|NCT00467779|590158590|FG008|Stage 2A|Unspecified Reason|0|||
163395241|NCT00467779|590158591|FG009|Stage 2A|Unspecified Reason|0|||
163395242|NCT00467779|590158592|FG010|Stage 2A|Unspecified Reason|0|||
163395243|NCT00467779|590158593|FG011|Stage 2A|Unspecified Reason|0|||
163395244|NCT00467779|590158594|FG012|Stage 2A|Unspecified Reason|0|||
163395245|NCT00467779|590158595|FG013|Stage 2A|Unspecified Reason|7|||
163395246|NCT00467779|590158596|FG014|Stage 2A|Unspecified Reason|0|||
163395247|NCT00467779|590158582|FG000|Stage 2A|Withdrawal by Subject|0|||
163395248|NCT00467779|590158583|FG001|Stage 2A|Withdrawal by Subject|0|||
163395249|NCT00467779|590158584|FG002|Stage 2A|Withdrawal by Subject|0|||
163395250|NCT00467779|590158585|FG003|Stage 2A|Withdrawal by Subject|0|||
163395251|NCT00467779|590158586|FG004|Stage 2A|Withdrawal by Subject|0|||
163395252|NCT00467779|590158587|FG005|Stage 2A|Withdrawal by Subject|0|||
163395253|NCT00467779|590158588|FG006|Stage 2A|Withdrawal by Subject|0|||
163395254|NCT00467779|590158589|FG007|Stage 2A|Withdrawal by Subject|0|||
163395255|NCT00467779|590158590|FG008|Stage 2A|Withdrawal by Subject|0|||
163395256|NCT00467779|590158591|FG009|Stage 2A|Withdrawal by Subject|0|||
163395257|NCT00467779|590158592|FG010|Stage 2A|Withdrawal by Subject|0|||
163395258|NCT00467779|590158593|FG011|Stage 2A|Withdrawal by Subject|0|||
163395259|NCT00467779|590158594|FG012|Stage 2A|Withdrawal by Subject|0|||
163395260|NCT00467779|590158595|FG013|Stage 2A|Withdrawal by Subject|1|||
163395261|NCT00467779|590158596|FG014|Stage 2A|Withdrawal by Subject|0|||
163395262|NCT00467779|590158582|FG000|Stage 3|Adverse Event|0|||
163395263|NCT00467779|590158583|FG001|Stage 3|Adverse Event|0|||
163395264|NCT00467779|590158584|FG002|Stage 3|Adverse Event|0|||
163395265|NCT00467779|590158585|FG003|Stage 3|Adverse Event|0|||
163395266|NCT00467779|590158586|FG004|Stage 3|Adverse Event|0|||
163395267|NCT00467779|590158587|FG005|Stage 3|Adverse Event|0|||
163395268|NCT00467779|590158588|FG006|Stage 3|Adverse Event|0|||
163395269|NCT00467779|590158589|FG007|Stage 3|Adverse Event|0|||
163395270|NCT00467779|590158590|FG008|Stage 3|Adverse Event|0|||
162960614|NCT00205777|588558850|FG001|Study Extension II|Lack of Efficacy|0|||
163395271|NCT00467779|590158591|FG009|Stage 3|Adverse Event|0|||
163395272|NCT00467779|590158592|FG010|Stage 3|Adverse Event|0|||
163395273|NCT00467779|590158593|FG011|Stage 3|Adverse Event|0|||
163395274|NCT00467779|590158594|FG012|Stage 3|Adverse Event|0|||
163395275|NCT00467779|590158595|FG013|Stage 3|Adverse Event|0|||
163395276|NCT00467779|590158596|FG014|Stage 3|Adverse Event|2|||
163395277|NCT00467779|590158582|FG000|Stage 3|Death|0|||
163395278|NCT00467779|590158583|FG001|Stage 3|Death|0|||
162960615|NCT00205777|588558851|FG002|Study Extension II|Lack of Efficacy|0|||
162960616|NCT00205777|588558852|FG003|Study Extension II|Lack of Efficacy|0|||
162960617|NCT00205777|588558853|FG004|Study Extension II|Lack of Efficacy|0|||
162960618|NCT00205777|588558854|FG005|Study Extension II|Lack of Efficacy|1|||
163196802|NCT03068455|589435786|FG000|Treatment Period|Participant withdrew consent|5|||
163196803|NCT03068455|589435787|FG001|Treatment Period|Participant withdrew consent|10|||
163196804|NCT03068455|589435786|FG000|Treatment Period|Poor/non-compliance|3|||
163196805|NCT03068455|589435787|FG001|Treatment Period|Poor/non-compliance|0|||
163196806|NCT03068455|589435786|FG000|Treatment Period|Participant no longer meets study criteria|1|||
163196807|NCT03068455|589435787|FG001|Treatment Period|Participant no longer meets study criteria|3|||
163196808|NCT03068455|589435786|FG000|Treatment Period|Other reasons|12|||
163196809|NCT03068455|589435787|FG001|Treatment Period|Other reasons|4|||
163196810|NCT05379231|589435788|FG000|Home Visit|Withdrawal by Subject|2|||
163196811|NCT05379231|589435788|FG000|In-lab Visit|Withdrawal by Subject|2|||
163196812|NCT00446251|589435792|FG000|Overall Study|On-study Transplants|2|||
163196813|NCT00446251|589435792|FG000|Overall Study|Rituximab Infusion Reaction|2|||
163196814|NCT00446251|589435792|FG000|Overall Study|Lost to Follow-up|1|||
163196815|NCT00702689|589435793|FG000|Overall Study|Withdrawal by Subject|4|||
163196816|NCT00702689|589435793|FG000|Overall Study|Recurrent malignancy|1|||
162960619|NCT00205777|588558849|FG000|Study Extension II|Failed to return|0|||
163196817|NCT00702689|589435793|FG000|Overall Study|Adverse Event|1|||
163196818|NCT01986907|589435794|FG000|Overall Study|Adverse Event|11|||
163196819|NCT01986907|589435794|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
163196820|NCT01986907|589435794|FG000|Overall Study|Protocol Violation|4|||
163395279|NCT00467779|590158584|FG002|Stage 3|Death|0|||
163395280|NCT00467779|590158585|FG003|Stage 3|Death|0|||
163395281|NCT00467779|590158586|FG004|Stage 3|Death|0|||
163395282|NCT00467779|590158587|FG005|Stage 3|Death|0|||
163395283|NCT00467779|590158588|FG006|Stage 3|Death|0|||
163395284|NCT00467779|590158589|FG007|Stage 3|Death|0|||
163395285|NCT00467779|590158590|FG008|Stage 3|Death|0|||
163395286|NCT00467779|590158591|FG009|Stage 3|Death|0|||
163395287|NCT00467779|590158592|FG010|Stage 3|Death|0|||
163395288|NCT00467779|590158593|FG011|Stage 3|Death|0|||
163395289|NCT00467779|590158594|FG012|Stage 3|Death|0|||
163395290|NCT00467779|590158595|FG013|Stage 3|Death|0|||
163395291|NCT00467779|590158596|FG014|Stage 3|Death|1|||
163395292|NCT00467779|590158582|FG000|Stage 3|Disease Progression|0|||
163395293|NCT00467779|590158583|FG001|Stage 3|Disease Progression|0|||
163395294|NCT00467779|590158584|FG002|Stage 3|Disease Progression|0|||
163395295|NCT00467779|590158585|FG003|Stage 3|Disease Progression|0|||
163395296|NCT00467779|590158586|FG004|Stage 3|Disease Progression|0|||
163395297|NCT00467779|590158587|FG005|Stage 3|Disease Progression|0|||
163395298|NCT00467779|590158588|FG006|Stage 3|Disease Progression|0|||
163395299|NCT00467779|590158589|FG007|Stage 3|Disease Progression|0|||
163395300|NCT00467779|590158590|FG008|Stage 3|Disease Progression|0|||
163395301|NCT00467779|590158591|FG009|Stage 3|Disease Progression|0|||
163395302|NCT00467779|590158592|FG010|Stage 3|Disease Progression|0|||
162960620|NCT00205777|588558850|FG001|Study Extension II|Failed to return|0|||
163395303|NCT00467779|590158593|FG011|Stage 3|Disease Progression|0|||
163395304|NCT00467779|590158594|FG012|Stage 3|Disease Progression|0|||
163395305|NCT00467779|590158595|FG013|Stage 3|Disease Progression|0|||
163395306|NCT00467779|590158596|FG014|Stage 3|Disease Progression|9|||
163395307|NCT00467779|590158582|FG000|Stage 3|Unspecified Reason|0|||
163395308|NCT00467779|590158583|FG001|Stage 3|Unspecified Reason|0|||
163395309|NCT00467779|590158584|FG002|Stage 3|Unspecified Reason|0|||
163395310|NCT00467779|590158585|FG003|Stage 3|Unspecified Reason|0|||
163395311|NCT00467779|590158586|FG004|Stage 3|Unspecified Reason|0|||
163395312|NCT00467779|590158587|FG005|Stage 3|Unspecified Reason|0|||
163395313|NCT00467779|590158588|FG006|Stage 3|Unspecified Reason|0|||
162960621|NCT00205777|588558851|FG002|Study Extension II|Failed to return|0|||
162960622|NCT00205777|588558852|FG003|Study Extension II|Failed to return|14|||
162960623|NCT00205777|588558853|FG004|Study Extension II|Failed to return|0|||
162960624|NCT00205777|588558854|FG005|Study Extension II|Failed to return|26|||
162960625|NCT00205777|588558849|FG000|Study Extension II|Other Event|0|||
162960626|NCT00205777|588558850|FG001|Study Extension II|Other Event|0|||
162960627|NCT00205777|588558851|FG002|Study Extension II|Other Event|0|||
162960628|NCT00205777|588558852|FG003|Study Extension II|Other Event|12|||
162960629|NCT00205777|588558853|FG004|Study Extension II|Other Event|0|||
162960630|NCT00205777|588558854|FG005|Study Extension II|Other Event|20|||
162960631|NCT00205777|588558849|FG000|Study Extension II|Enrolled but not treated|0|||
162960632|NCT00205777|588558850|FG001|Study Extension II|Enrolled but not treated|0|||
162960633|NCT00205777|588558851|FG002|Study Extension II|Enrolled but not treated|0|||
162960634|NCT00205777|588558852|FG003|Study Extension II|Enrolled but not treated|71|||
162960635|NCT00205777|588558853|FG004|Study Extension II|Enrolled but not treated|0|||
162960636|NCT00205777|588558854|FG005|Study Extension II|Enrolled but not treated|131|||
162960637|NCT00700739|588558858|FG000|Overall Study|Lost to Follow-up|4|||
162960638|NCT00700739|588558859|FG001|Overall Study|Lost to Follow-up|4|||
162960639|NCT00003470|588558861|FG000|Overall Study|Not evaluable|6|||
162960640|NCT01794845|588558864|FG000|Overall Study|Withdrawal by Subject|1|||
162960641|NCT01004510|588558868|FG000|Overall Study|Adverse Event|1|||
162960642|NCT02911025|588558870|FG000|Overall Study|Lost to Follow-up|3|||
162960643|NCT00436163|588558871|FG000|Overall Study|Lost to Follow-up|2|||
162960644|NCT00436163|588558871|FG000|Overall Study|Adverse Event|1|||
162960645|NCT02597049|588558872|FG000|Overall Study|Lost to Follow-up|0|||
162960646|NCT02597049|588558873|FG001|Overall Study|Lost to Follow-up|3|||
162960647|NCT02597049|588558874|FG002|Overall Study|Lost to Follow-up|2|||
162960648|NCT02597049|588558872|FG000|Overall Study|Withdrawal by Subject|2|||
162960649|NCT02597049|588558873|FG001|Overall Study|Withdrawal by Subject|2|||
162960650|NCT02597049|588558874|FG002|Overall Study|Withdrawal by Subject|1|||
162960651|NCT02597049|588558872|FG000|Overall Study|Adverse Event|2|||
162960652|NCT02597049|588558873|FG001|Overall Study|Adverse Event|0|||
162960653|NCT02597049|588558874|FG002|Overall Study|Adverse Event|0|||
162960654|NCT02597049|588558872|FG000|Overall Study|Death|2|||
162960655|NCT02597049|588558873|FG001|Overall Study|Death|0|||
162960656|NCT02597049|588558874|FG002|Overall Study|Death|0|||
162960657|NCT02597049|588558872|FG000|Overall Study|Noncompliant with Study Visits|1|||
162960658|NCT02597049|588558873|FG001|Overall Study|Noncompliant with Study Visits|0|||
162960659|NCT02597049|588558874|FG002|Overall Study|Noncompliant with Study Visits|0|||
162960660|NCT06647173|588558880|FG000|Overall Study|Lost to Follow-up|24|||
162960661|NCT02923349|588558881|FG000|Overall Study|Other|1|||
162960662|NCT02923349|588558882|FG001|Overall Study|Other|2|||
162960663|NCT02923349|588558883|FG002|Overall Study|Other|4|||
162960664|NCT02923349|588558884|FG003|Overall Study|Other|1|||
162960665|NCT02923349|588558885|FG004|Overall Study|Other|3|||
162960666|NCT02923349|588558886|FG005|Overall Study|Other|0|||
162960667|NCT02923349|588558887|FG006|Overall Study|Other|1|||
162960668|NCT02923349|588558881|FG000|Overall Study|Withdrawal by Subject|2|||
162960669|NCT02923349|588558882|FG001|Overall Study|Withdrawal by Subject|2|||
162960670|NCT02923349|588558883|FG002|Overall Study|Withdrawal by Subject|8|||
162960671|NCT02923349|588558884|FG003|Overall Study|Withdrawal by Subject|10|||
162960672|NCT02923349|588558885|FG004|Overall Study|Withdrawal by Subject|12|||
162960673|NCT02923349|588558886|FG005|Overall Study|Withdrawal by Subject|3|||
162960674|NCT02923349|588558887|FG006|Overall Study|Withdrawal by Subject|0|||
162960675|NCT02923349|588558881|FG000|Overall Study|Physician Decision|0|||
162960676|NCT02923349|588558882|FG001|Overall Study|Physician Decision|0|||
162960677|NCT02923349|588558883|FG002|Overall Study|Physician Decision|0|||
162960678|NCT02923349|588558884|FG003|Overall Study|Physician Decision|1|||
162960679|NCT02923349|588558885|FG004|Overall Study|Physician Decision|1|||
162960680|NCT02923349|588558886|FG005|Overall Study|Physician Decision|0|||
162960681|NCT02923349|588558887|FG006|Overall Study|Physician Decision|2|||
162960682|NCT02923349|588558881|FG000|Overall Study|Lost to Follow-up|0|||
162960683|NCT02923349|588558882|FG001|Overall Study|Lost to Follow-up|0|||
163395314|NCT00467779|590158589|FG007|Stage 3|Unspecified Reason|0|||
163395315|NCT00467779|590158590|FG008|Stage 3|Unspecified Reason|0|||
163395316|NCT00467779|590158591|FG009|Stage 3|Unspecified Reason|0|||
163395317|NCT00467779|590158592|FG010|Stage 3|Unspecified Reason|0|||
163395318|NCT00467779|590158593|FG011|Stage 3|Unspecified Reason|0|||
163395319|NCT00467779|590158594|FG012|Stage 3|Unspecified Reason|0|||
163395320|NCT00467779|590158595|FG013|Stage 3|Unspecified Reason|0|||
163395321|NCT00467779|590158596|FG014|Stage 3|Unspecified Reason|5|||
163395322|NCT01509079|590158597|FG000|Overall Study|Lack of Efficacy|0|||
163395323|NCT01509079|590158598|FG001|Overall Study|Lack of Efficacy|2|||
163395324|NCT01509079|590158597|FG000|Overall Study|started an excluded medication|0|||
163395325|NCT01509079|590158598|FG001|Overall Study|started an excluded medication|1|||
163395326|NCT01195090|590158599|FG000|Overall Study|Adverse Event|1|||
163395327|NCT01195090|590158600|FG001|Overall Study|Adverse Event|2|||
163395328|NCT01195090|590158599|FG000|Overall Study|Lost to Follow-up|2|||
163395329|NCT01195090|590158600|FG001|Overall Study|Lost to Follow-up|2|||
163395330|NCT01195090|590158599|FG000|Overall Study|Protocol Violation|3|||
163395331|NCT01195090|590158600|FG001|Overall Study|Protocol Violation|4|||
163395332|NCT05111041|590158601|FG000|Overall Study|Lost to Follow-up|6|||
163395333|NCT05111041|590158602|FG001|Overall Study|Lost to Follow-up|7|||
163395334|NCT05111041|590158601|FG000|Overall Study|Withdrawal by Subject|1|||
163196821|NCT01986907|589435794|FG000|Overall Study|Withdrawal by Subject|76|||
163196822|NCT01986907|589435794|FG000|Overall Study|Lost to Follow-up|38|||
163395335|NCT05111041|590158602|FG001|Overall Study|Withdrawal by Subject|0|||
163395336|NCT04912245|590158603|FG000|Overall Study|Withdrawal by Subject|21|||
163395337|NCT04912245|590158604|FG001|Overall Study|Withdrawal by Subject|4|||
163395338|NCT04912245|590158603|FG000|Overall Study|Lost to Follow-up|5|||
162960684|NCT02923349|588558883|FG002|Overall Study|Lost to Follow-up|3|||
162960685|NCT02923349|588558884|FG003|Overall Study|Lost to Follow-up|0|||
162960686|NCT02923349|588558885|FG004|Overall Study|Lost to Follow-up|1|||
162960687|NCT02923349|588558886|FG005|Overall Study|Lost to Follow-up|1|||
162960688|NCT02923349|588558887|FG006|Overall Study|Lost to Follow-up|0|||
163302999|NCT04855760|589817610|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
163047013|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047014|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047015|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047016|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047017|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047018|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047019|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047020|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163196823|NCT01986907|589435794|FG000|Overall Study|Death|9|||
163196824|NCT02805972|589435795|FG000|Washout Period|Lost to Follow-up|3|||
163196825|NCT02805972|589435796|FG001|Washout Period|Lost to Follow-up|0|||
163196826|NCT00939640|589435798|FG000|Overall Study|Physician Decision|1|||
163196827|NCT00389597|589435803|FG000|Overall Study|Lost to Follow-up|8|||
163196828|NCT00389597|589435804|FG001|Overall Study|Lost to Follow-up|6|||
163196829|NCT00389597|589435805|FG002|Overall Study|Lost to Follow-up|4|||
163196830|NCT00389597|589435806|FG003|Overall Study|Lost to Follow-up|6|||
163196831|NCT00306189|589435809|FG000|Overall Study|Physician Decision|0|||
163196832|NCT00306189|589435810|FG001|Overall Study|Physician Decision|0|||
163196833|NCT00306189|589435811|FG002|Overall Study|Physician Decision|0|||
163196834|NCT00306189|589435812|FG003|Overall Study|Physician Decision|1|||
163196835|NCT00306189|589435809|FG000|Overall Study|Adverse Event|3|||
163196836|NCT00306189|589435810|FG001|Overall Study|Adverse Event|3|||
163196837|NCT00306189|589435811|FG002|Overall Study|Adverse Event|2|||
163196838|NCT00306189|589435812|FG003|Overall Study|Adverse Event|2|||
163196839|NCT00306189|589435809|FG000|Overall Study|Withdrawal by Subject|4|||
163196840|NCT00306189|589435810|FG001|Overall Study|Withdrawal by Subject|2|||
163196841|NCT00306189|589435811|FG002|Overall Study|Withdrawal by Subject|8|||
163196842|NCT00306189|589435812|FG003|Overall Study|Withdrawal by Subject|1|||
163196843|NCT00306189|589435809|FG000|Overall Study|Ineligibility determined|1|||
163196844|NCT00306189|589435810|FG001|Overall Study|Ineligibility determined|1|||
163196845|NCT00306189|589435811|FG002|Overall Study|Ineligibility determined|1|||
163196846|NCT00306189|589435812|FG003|Overall Study|Ineligibility determined|1|||
163196847|NCT00306189|589435809|FG000|Overall Study|Other|1|||
163196848|NCT00306189|589435810|FG001|Overall Study|Other|0|||
163196849|NCT00306189|589435811|FG002|Overall Study|Other|0|||
163196850|NCT00306189|589435812|FG003|Overall Study|Other|0|||
163196851|NCT00259610|589435813|FG000|Overall Study|Withdrawal by Subject|33|||
163196852|NCT00259610|589435814|FG001|Overall Study|Withdrawal by Subject|25|||
163196853|NCT00259610|589435815|FG002|Overall Study|Withdrawal by Subject|29|||
163196854|NCT00259610|589435816|FG003|Overall Study|Withdrawal by Subject|19|||
163196855|NCT00259610|589435813|FG000|Overall Study|Lost to Follow-up|19|||
163196856|NCT00259610|589435814|FG001|Overall Study|Lost to Follow-up|8|||
163196857|NCT00259610|589435815|FG002|Overall Study|Lost to Follow-up|18|||
163196858|NCT00259610|589435816|FG003|Overall Study|Lost to Follow-up|15|||
163196859|NCT00259610|589435813|FG000|Overall Study|Physician Decision|6|||
163196860|NCT00259610|589435814|FG001|Overall Study|Physician Decision|4|||
163196861|NCT00259610|589435815|FG002|Overall Study|Physician Decision|7|||
163196862|NCT00259610|589435816|FG003|Overall Study|Physician Decision|2|||
163196863|NCT00259610|589435813|FG000|Overall Study|Death|1|||
163196864|NCT00259610|589435814|FG001|Overall Study|Death|1|||
163196865|NCT00259610|589435815|FG002|Overall Study|Death|2|||
163196866|NCT00259610|589435816|FG003|Overall Study|Death|0|||
163196867|NCT00259610|589435813|FG000|Overall Study|non medical reason|6|||
163196868|NCT00259610|589435814|FG001|Overall Study|non medical reason|2|||
163196869|NCT00259610|589435815|FG002|Overall Study|non medical reason|10|||
163196870|NCT00259610|589435816|FG003|Overall Study|non medical reason|3|||
163196871|NCT00259610|589435813|FG000|Overall Study|Adverse Event|3|||
163196872|NCT00259610|589435814|FG001|Overall Study|Adverse Event|4|||
163196873|NCT00259610|589435815|FG002|Overall Study|Adverse Event|5|||
163196874|NCT00259610|589435816|FG003|Overall Study|Adverse Event|2|||
163196875|NCT00259610|589435813|FG000|Overall Study|Serious Adverse Event|8|||
163196876|NCT00259610|589435814|FG001|Overall Study|Serious Adverse Event|2|||
163196877|NCT00259610|589435815|FG002|Overall Study|Serious Adverse Event|2|||
163196878|NCT00259610|589435816|FG003|Overall Study|Serious Adverse Event|2|||
163196879|NCT00282984|589435819|FG000|Overall Study|Death|2|||
163196880|NCT00282984|589435820|FG001|Overall Study|Death|5|||
163303000|NCT04855760|589817610|FG000|Overall Study|Study Completed by Sponsor|202|||
163303001|NCT04855760|589817610|FG000|Overall Study|Other|13|||
163303002|NCT04840199|589817613|FG000|Overall Study|Study Terminated by Sponsor|8|||
163303003|NCT04840199|589817614|FG001|Overall Study|Study Terminated by Sponsor|9|||
163303004|NCT04840199|589817613|FG000|Overall Study|Lost to Follow-up|0|||
163303005|NCT04840199|589817614|FG001|Overall Study|Lost to Follow-up|2|||
163196881|NCT00282984|589435819|FG000|Overall Study|Adverse Event|8|||
163196882|NCT00282984|589435820|FG001|Overall Study|Adverse Event|5|||
163196883|NCT00282984|589435819|FG000|Overall Study|Lack of Efficacy|0|||
163196884|NCT00282984|589435820|FG001|Overall Study|Lack of Efficacy|2|||
163196885|NCT00282984|589435819|FG000|Overall Study|Lost to Follow-up|14|||
163196886|NCT00282984|589435820|FG001|Overall Study|Lost to Follow-up|10|||
163196887|NCT00282984|589435819|FG000|Overall Study|Withdrawal by Participant|22|||
163196888|NCT00282984|589435820|FG001|Overall Study|Withdrawal by Participant|34|||
163196889|NCT00282984|589435819|FG000|Overall Study|Participant stopped study medication|2|||
163196890|NCT00282984|589435820|FG001|Overall Study|Participant stopped study medication|2|||
163303006|NCT04840199|589817613|FG000|Overall Study|Withdrawal by Subject|2|||
163303007|NCT04840199|589817614|FG001|Overall Study|Withdrawal by Subject|0|||
163196891|NCT00282984|589435819|FG000|Overall Study|Participant only allowed phone follow-up|0|||
163196892|NCT00282984|589435820|FG001|Overall Study|Participant only allowed phone follow-up|1|||
163196893|NCT00282984|589435819|FG000|Overall Study|Participant used antipsychosis meds|0|||
163303008|NCT04840199|589817613|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
163303009|NCT04840199|589817614|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
163303010|NCT02879448|589817615|FG000|Overall Study|Death|251|||
163303011|NCT02879448|589817616|FG001|Overall Study|Death|263|||
163196894|NCT00282984|589435820|FG001|Overall Study|Participant used antipsychosis meds|1|||
163303012|NCT02879448|589817615|FG000|Overall Study|Lost to Follow-up|23|||
163303013|NCT02879448|589817616|FG001|Overall Study|Lost to Follow-up|28|||
163303014|NCT02879448|589817615|FG000|Overall Study|Withdrawal by Subject|42|||
163303015|NCT02879448|589817616|FG001|Overall Study|Withdrawal by Subject|79|||
163303016|NCT02879448|589817615|FG000|Overall Study|Other Reasons|8|||
163303017|NCT02879448|589817616|FG001|Overall Study|Other Reasons|12|||
163303018|NCT03433339|589817617|FG000|Overall Study|Lost to Follow-up|2|||
163303019|NCT03433339|589817618|FG001|Overall Study|Lost to Follow-up|0|||
163303020|NCT03433339|589817617|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
163303021|NCT03433339|589817618|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
163303022|NCT03433339|589817617|FG000|Overall Study|Withdrawal by Subject|0|||
163303023|NCT03433339|589817618|FG001|Overall Study|Withdrawal by Subject|2|||
163196895|NCT00282984|589435819|FG000|Overall Study|lack of motivation|1|||
163196896|NCT00282984|589435820|FG001|Overall Study|lack of motivation|0|||
163196897|NCT00282984|589435819|FG000|Overall Study|in prison|0|||
163196898|NCT00282984|589435820|FG001|Overall Study|in prison|1|||
163196899|NCT00282984|589435819|FG000|Overall Study|Protocol Violation|2|||
163196900|NCT00282984|589435820|FG001|Overall Study|Protocol Violation|0|||
163196901|NCT00674362|589435821|FG000|Double Blind|Adverse Event|6|||
163196902|NCT00674362|589435822|FG001|Double Blind|Adverse Event|6|||
163196903|NCT00674362|589435821|FG000|Double Blind|Lack of Efficacy|2|||
163196904|NCT00674362|589435822|FG001|Double Blind|Lack of Efficacy|6|||
163196905|NCT00674362|589435821|FG000|Double Blind|Loss of efficacy|0|||
163196906|NCT00674362|589435822|FG001|Double Blind|Loss of efficacy|1|||
163196907|NCT00674362|589435821|FG000|Double Blind|Withdrawal by Subject|4|||
163303024|NCT01898494|589817622|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
163196908|NCT00674362|589435822|FG001|Double Blind|Withdrawal by Subject|3|||
163303025|NCT01898494|589817623|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
163047021|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163303026|NCT01898494|589817624|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
163303027|NCT01898494|589817625|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
163303028|NCT01898494|589817626|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
163303029|NCT01898494|589817622|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
163303030|NCT01898494|589817623|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
163303031|NCT01898494|589817624|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
163303032|NCT01898494|589817625|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
163303033|NCT01898494|589817626|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
163303034|NCT01898494|589817622|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
163303035|NCT01898494|589817623|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
163303036|NCT01898494|589817624|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
163303037|NCT01898494|589817625|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
163303038|NCT01898494|589817626|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
163047022|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
163047023|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047024|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047025|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047026|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047027|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047028|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047029|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047030|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047031|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
163047032|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
163047033|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
163047034|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
163047035|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
163047036|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
163047037|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
163047038|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
163047039|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
163047040|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
163047041|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
163047042|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
163047043|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
163047044|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
163047045|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
163303039|NCT01898494|589817622|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
163303040|NCT01898494|589817623|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
162960689|NCT02923349|588558881|FG000|Overall Study|Death|1|||
162960690|NCT02923349|588558882|FG001|Overall Study|Death|0|||
162960691|NCT02923349|588558883|FG002|Overall Study|Death|2|||
162960692|NCT02923349|588558884|FG003|Overall Study|Death|4|||
162960693|NCT02923349|588558885|FG004|Overall Study|Death|2|||
162960694|NCT02923349|588558886|FG005|Overall Study|Death|3|||
162960695|NCT02923349|588558887|FG006|Overall Study|Death|0|||
162960696|NCT02751827|588558890|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
162960697|NCT02751827|588558891|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
162960698|NCT02751827|588558892|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
162960699|NCT01248728|588558893|FG000|Overall Study|Adverse Event|1|||
162960700|NCT01248728|588558894|FG001|Overall Study|Adverse Event|1|||
162960701|NCT01248728|588558893|FG000|Overall Study|Withdrawal by Subject|2|||
162960702|NCT01248728|588558894|FG001|Overall Study|Withdrawal by Subject|1|||
162960703|NCT01248728|588558893|FG000|Overall Study|Lack of Efficacy|1|||
162960704|NCT01248728|588558894|FG001|Overall Study|Lack of Efficacy|0|||
163303041|NCT01898494|589817624|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
163303042|NCT01898494|589817625|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
163303043|NCT01898494|589817626|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
163303044|NCT01898494|589817622|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
163303045|NCT01898494|589817623|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
163303046|NCT01898494|589817624|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
163303047|NCT01898494|589817625|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
163303048|NCT01898494|589817626|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
163303049|NCT01898494|589817622|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
163303050|NCT01898494|589817623|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
163303051|NCT01898494|589817624|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
163303052|NCT01898494|589817625|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
163303053|NCT01898494|589817626|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
163303054|NCT01898494|589817622|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
163303055|NCT01898494|589817623|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
163303056|NCT01898494|589817624|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
163303057|NCT01898494|589817625|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
163303058|NCT01898494|589817626|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
163303059|NCT01898494|589817622|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
163303060|NCT01898494|589817623|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
163303061|NCT01898494|589817624|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
163303062|NCT01898494|589817625|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
162960705|NCT01841554|588558895|FG000|Overall Study|Death|7|||
162960706|NCT01841554|588558895|FG000|Overall Study|No Implantation|1|||
162960707|NCT01841554|588558895|FG000|Overall Study|Discontinued Follow Up|5|||
162960708|NCT01841554|588558895|FG000|Overall Study|Study exit due to secondary intervention|6|||
163047046|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047047|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047048|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047049|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047050|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047051|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047052|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047053|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047054|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
162960709|NCT01838681|588558896|FG000|Period A|Adverse Event|39|||
162960710|NCT01838681|588558897|FG001|Period A|Adverse Event|0|||
162960711|NCT01838681|588558898|FG002|Period A|Adverse Event|0|||
162960712|NCT01838681|588558899|FG003|Period A|Adverse Event|0|||
162960713|NCT01838681|588558896|FG000|Period A|Lack of Efficacy|21|||
163047055|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047056|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
163047057|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
163047058|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
163047059|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047060|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
163047061|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163395339|NCT04912245|590158604|FG001|Overall Study|Lost to Follow-up|11|||
162960714|NCT01838681|588558897|FG001|Period A|Lack of Efficacy|0|||
162960715|NCT01838681|588558898|FG002|Period A|Lack of Efficacy|0|||
162960716|NCT01838681|588558899|FG003|Period A|Lack of Efficacy|0|||
162960717|NCT01838681|588558896|FG000|Period A|Early response|148|||
162960718|NCT01838681|588558897|FG001|Period A|Early response|0|||
162960719|NCT01838681|588558898|FG002|Period A|Early response|0|||
162960720|NCT01838681|588558899|FG003|Period A|Early response|0|||
163196909|NCT00674362|589435821|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
163196910|NCT00674362|589435822|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
163196911|NCT00674362|589435821|FG000|Double Blind|Other: Surgery|0|||
163196912|NCT00674362|589435822|FG001|Double Blind|Other: Surgery|1|||
163196913|NCT00674362|589435821|FG000|Open Label|Adverse Event|1|||
163196914|NCT00674362|589435822|FG001|Open Label|Adverse Event|0|||
163196915|NCT00674362|589435821|FG000|Open Label|Other: Subject moved to extension study|1|||
163196916|NCT00674362|589435822|FG001|Open Label|Other: Subject moved to extension study|0|||
163196917|NCT00939770|589435825|FG000|Overall Study|Adverse Event|1|||
163196918|NCT00939770|589435826|FG001|Overall Study|Adverse Event|1|||
163196919|NCT00939770|589435827|FG002|Overall Study|Adverse Event|0|||
163196920|NCT00939770|589435828|FG003|Overall Study|Adverse Event|0|||
163196921|NCT00939770|589435829|FG004|Overall Study|Adverse Event|6|||
163196922|NCT00939770|589435830|FG005|Overall Study|Adverse Event|2|||
163196923|NCT00939770|589435831|FG006|Overall Study|Adverse Event|1|||
163196924|NCT00939770|589435832|FG007|Overall Study|Adverse Event|1|||
163196925|NCT00939770|589435825|FG000|Overall Study|Lack of Efficacy|4|||
163196926|NCT00939770|589435826|FG001|Overall Study|Lack of Efficacy|6|||
163196927|NCT00939770|589435827|FG002|Overall Study|Lack of Efficacy|13|||
163196928|NCT00939770|589435828|FG003|Overall Study|Lack of Efficacy|9|||
163196929|NCT00939770|589435829|FG004|Overall Study|Lack of Efficacy|16|||
163196930|NCT00939770|589435830|FG005|Overall Study|Lack of Efficacy|8|||
163196931|NCT00939770|589435831|FG006|Overall Study|Lack of Efficacy|11|||
163303063|NCT01898494|589817626|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
163303064|NCT01898494|589817622|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
163303065|NCT01898494|589817623|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
163303066|NCT01898494|589817624|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
163303067|NCT01898494|589817625|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
163303068|NCT01898494|589817626|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
163303069|NCT01898494|589817622|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
163303070|NCT01898494|589817623|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
163303071|NCT01898494|589817624|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
163303072|NCT01898494|589817625|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
163303073|NCT01898494|589817626|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
163303074|NCT01898494|589817622|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
163303075|NCT01898494|589817623|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
163303076|NCT01898494|589817624|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
163303077|NCT01898494|589817625|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
163303078|NCT01898494|589817626|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
163303079|NCT01898494|589817622|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
163303080|NCT01898494|589817623|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
163303081|NCT01898494|589817624|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
163303082|NCT01898494|589817625|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
163303083|NCT01898494|589817626|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
163303084|NCT01898494|589817622|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
163303085|NCT01898494|589817623|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
163303086|NCT01898494|589817624|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
163303087|NCT01898494|589817625|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
163303088|NCT01898494|589817626|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
163303089|NCT01898494|589817622|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
163303090|NCT01898494|589817623|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
163303091|NCT01898494|589817624|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
163303092|NCT01898494|589817625|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
163303093|NCT01898494|589817626|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
163303094|NCT02819843|589817629|FG000|Overall Study|Disease progression before RT|0|||
163303095|NCT02819843|589817630|FG001|Overall Study|Disease progression before RT|1|||
163303096|NCT04732494|589817631|FG000|Overall Study|Death|39|||
163303097|NCT04732494|589817632|FG001|Overall Study|Death|36|||
163303098|NCT04732494|589817631|FG000|Overall Study|Study Closed by Sponsor|20|||
163303099|NCT04732494|589817632|FG001|Overall Study|Study Closed by Sponsor|15|||
163303100|NCT04732494|589817631|FG000|Overall Study|Withdrawal by Subject|2|||
163303101|NCT04732494|589817632|FG001|Overall Study|Withdrawal by Subject|7|||
163303102|NCT04732494|589817631|FG000|Overall Study|Lost to Follow-up|1|||
163303103|NCT04732494|589817632|FG001|Overall Study|Lost to Follow-up|5|||
163303104|NCT03055858|589817633|FG000|Overall Study|Death|9|||
163303105|NCT03055858|589817633|FG000|Overall Study|Withdrawal by Subject|11|||
163303106|NCT03055858|589817633|FG000|Overall Study|Lost to Follow-up|6|||
163303107|NCT03055858|589817633|FG000|Overall Study|Missed Follow-Up Visits|18|||
163303108|NCT02728557|589817634|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
163303109|NCT02728557|589817635|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
163303110|NCT02728557|589817634|FG000|Overall Study|Dissatisfaction with research tasks|0|||
163303111|NCT02728557|589817635|FG001|Overall Study|Dissatisfaction with research tasks|1|||
163303112|NCT02728557|589817634|FG000|Overall Study|Scheduling or change in availability|1|||
163303113|NCT02728557|589817635|FG001|Overall Study|Scheduling or change in availability|1|||
163303114|NCT03416010|589817636|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
163303115|NCT03416010|589817637|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
163303116|NCT03416010|589817636|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
163303117|NCT03416010|589817637|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
163303118|NCT03416010|589817636|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
163303119|NCT03416010|589817637|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
163303120|NCT03416010|589817636|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
163303121|NCT03416010|589817637|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
163303122|NCT03416010|589817636|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
163303123|NCT03416010|589817637|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
163303124|NCT03416010|589817636|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
163303125|NCT03416010|589817637|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
163303126|NCT03416010|589817636|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
163303127|NCT03416010|589817637|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
163303128|NCT03948763|589817638|FG000|Overall Study|Sponsor's decision|0|||
163303129|NCT03948763|589817639|FG001|Overall Study|Sponsor's decision|2|||
163303130|NCT03948763|589817640|FG002|Overall Study|Sponsor's decision|6|||
163303131|NCT03948763|589817641|FG003|Overall Study|Sponsor's decision|4|||
163303132|NCT03948763|589817642|FG004|Overall Study|Sponsor's decision|0|||
163303133|NCT03948763|589817638|FG000|Overall Study|Physician Decision|0|||
163303134|NCT03948763|589817639|FG001|Overall Study|Physician Decision|0|||
163303135|NCT03948763|589817640|FG002|Overall Study|Physician Decision|1|||
163303136|NCT03948763|589817641|FG003|Overall Study|Physician Decision|0|||
163303137|NCT03948763|589817642|FG004|Overall Study|Physician Decision|0|||
163303138|NCT03948763|589817638|FG000|Overall Study|Lost to Follow-up|0|||
163303139|NCT03948763|589817639|FG001|Overall Study|Lost to Follow-up|0|||
163303140|NCT03948763|589817640|FG002|Overall Study|Lost to Follow-up|0|||
163303141|NCT03948763|589817641|FG003|Overall Study|Lost to Follow-up|0|||
163303142|NCT03948763|589817642|FG004|Overall Study|Lost to Follow-up|1|||
163303143|NCT03948763|589817638|FG000|Overall Study|Death|2|||
163303144|NCT03948763|589817639|FG001|Overall Study|Death|12|||
163303145|NCT03948763|589817640|FG002|Overall Study|Death|13|||
163303146|NCT03948763|589817641|FG003|Overall Study|Death|10|||
163303147|NCT03948763|589817642|FG004|Overall Study|Death|11|||
163303148|NCT03948763|589817638|FG000|Overall Study|Withdrawal by Subject|1|||
163303149|NCT03948763|589817639|FG001|Overall Study|Withdrawal by Subject|1|||
163303150|NCT03948763|589817640|FG002|Overall Study|Withdrawal by Subject|0|||
163303151|NCT03948763|589817641|FG003|Overall Study|Withdrawal by Subject|2|||
163303152|NCT03948763|589817642|FG004|Overall Study|Withdrawal by Subject|4|||
163303153|NCT06629454|589817643|FG000|Overall Study|Withdraw by Clinician Decision|1|||
163303154|NCT05136404|589817644|FG000|Period 1|Adverse Event|0|||
163303155|NCT05136404|589817645|FG001|Period 1|Adverse Event|1|||
163303156|NCT05136404|589817646|FG002|Period 1|Adverse Event|1|||
163303157|NCT05136404|589817644|FG000|Period 2|Inappropriate Behavior|0|||
163303158|NCT05136404|589817645|FG001|Period 2|Inappropriate Behavior|0|||
163303159|NCT05136404|589817646|FG002|Period 2|Inappropriate Behavior|1|||
163303160|NCT05136404|589817644|FG000|Period 3|Adverse Event|0|||
163303161|NCT05136404|589817645|FG001|Period 3|Adverse Event|0|||
163303162|NCT05136404|589817646|FG002|Period 3|Adverse Event|1|||
163303163|NCT02553642|589817652|FG000|Overall Study|Withdrawal by Subject|0|||
163303164|NCT02553642|589817653|FG001|Overall Study|Withdrawal by Subject|3|||
163303165|NCT02553642|589817652|FG000|Overall Study|Physician Decision|0|||
163303166|NCT02553642|589817653|FG001|Overall Study|Physician Decision|1|||
163303167|NCT02553642|589817652|FG000|Overall Study|Additional cancer dx|0|||
163303168|NCT02553642|589817653|FG001|Overall Study|Additional cancer dx|1|||
163303169|NCT02553642|589817652|FG000|Overall Study|Never started treatment|0|||
163303170|NCT02553642|589817653|FG001|Overall Study|Never started treatment|1|||
163303171|NCT01820260|589817655|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163303172|NCT01820260|589817656|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163303173|NCT01820260|589817657|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163303174|NCT01820260|589817658|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163303175|NCT01820260|589817659|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163303176|NCT01820260|589817660|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163303177|NCT01820260|589817661|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
163303178|NCT01820260|589817662|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163303179|NCT01820260|589817663|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163303180|NCT01820260|589817664|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163303181|NCT01820260|589817665|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163303182|NCT01820260|589817666|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163303183|NCT01820260|589817667|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163303184|NCT01820260|589817668|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163303185|NCT01820260|589817655|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163303186|NCT01820260|589817656|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163303187|NCT01820260|589817657|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163303188|NCT01820260|589817658|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163303189|NCT01820260|589817659|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163303190|NCT01820260|589817660|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163303191|NCT01820260|589817661|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163196932|NCT00939770|589435832|FG007|Overall Study|Lack of Efficacy|1|||
163196933|NCT00939770|589435825|FG000|Overall Study|Lost to Follow-up|0|||
163196934|NCT00939770|589435826|FG001|Overall Study|Lost to Follow-up|0|||
163196935|NCT00939770|589435827|FG002|Overall Study|Lost to Follow-up|0|||
163196936|NCT00939770|589435828|FG003|Overall Study|Lost to Follow-up|0|||
163196937|NCT00939770|589435829|FG004|Overall Study|Lost to Follow-up|1|||
163196938|NCT00939770|589435830|FG005|Overall Study|Lost to Follow-up|0|||
162960721|NCT01838681|588558896|FG000|Period A|Withdrawal by Subject|70|||
163303192|NCT01820260|589817662|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163303193|NCT01820260|589817663|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163303194|NCT01820260|589817664|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
163303195|NCT01820260|589817665|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163303196|NCT01820260|589817666|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163303197|NCT01820260|589817667|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163303198|NCT01820260|589817668|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163303199|NCT05444192|589817669|FG000|Overall Study|Lost to Follow-up|1|||
163303200|NCT05444192|589817670|FG001|Overall Study|Lost to Follow-up|0|||
163303201|NCT04424927|589817675|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
163303202|NCT04424927|589817676|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
163303203|NCT04424927|589817677|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
163303204|NCT04424927|589817678|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
163303205|NCT04424927|589817679|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
163303206|NCT04424927|589817675|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
163395340|NCT01205230|590158605|FG000|Overall Study|Adverse Event|4|||
163395341|NCT01205230|590158606|FG001|Overall Study|Adverse Event|0|||
163395342|NCT01205230|590158605|FG000|Overall Study|Physician Decision|1|||
163395343|NCT01205230|590158606|FG001|Overall Study|Physician Decision|0|||
163395344|NCT03945591|590158607|FG000|Overall Study|Participant not transplanted|1|||
163395345|NCT03945591|590158607|FG000|Overall Study|Change in treatment plan|3|||
163395346|NCT03945591|590158607|FG000|Overall Study|Adverse Event|1|||
162960722|NCT01838681|588558897|FG001|Period A|Withdrawal by Subject|0|||
162960723|NCT01838681|588558898|FG002|Period A|Withdrawal by Subject|0|||
162960724|NCT01838681|588558899|FG003|Period A|Withdrawal by Subject|0|||
162960725|NCT01838681|588558896|FG000|Period A|Protocol Violation|16|||
162960726|NCT01838681|588558897|FG001|Period A|Protocol Violation|0|||
162960727|NCT01838681|588558898|FG002|Period A|Protocol Violation|0|||
162960728|NCT01838681|588558899|FG003|Period A|Protocol Violation|0|||
162960729|NCT01838681|588558896|FG000|Period A|Non-compliance with IMP|6|||
162960730|NCT01838681|588558897|FG001|Period A|Non-compliance with IMP|0|||
162960731|NCT01838681|588558898|FG002|Period A|Non-compliance with IMP|0|||
162960732|NCT01838681|588558899|FG003|Period A|Non-compliance with IMP|0|||
162960733|NCT01838681|588558896|FG000|Period A|Lost to Follow-up|4|||
162960734|NCT01838681|588558897|FG001|Period A|Lost to Follow-up|0|||
162960735|NCT01838681|588558898|FG002|Period A|Lost to Follow-up|0|||
162960736|NCT01838681|588558899|FG003|Period A|Lost to Follow-up|0|||
162960737|NCT01838681|588558896|FG000|Period A|Withdrawal before treatment|4|||
162960738|NCT01838681|588558897|FG001|Period A|Withdrawal before treatment|0|||
162960739|NCT01838681|588558898|FG002|Period A|Withdrawal before treatment|0|||
162960740|NCT01838681|588558899|FG003|Period A|Withdrawal before treatment|0|||
162960741|NCT01838681|588558896|FG000|Period A|Administrative or other reasons|17|||
162960742|NCT01838681|588558897|FG001|Period A|Administrative or other reasons|0|||
162960743|NCT01838681|588558898|FG002|Period A|Administrative or other reasons|0|||
162960744|NCT01838681|588558899|FG003|Period A|Administrative or other reasons|0|||
162960745|NCT01838681|588558896|FG000|Period B/A+|Adverse Event|0|||
162960746|NCT01838681|588558897|FG001|Period B/A+|Adverse Event|13|||
162960747|NCT01838681|588558898|FG002|Period B/A+|Adverse Event|27|||
162960748|NCT01838681|588558899|FG003|Period B/A+|Adverse Event|16|||
162960749|NCT01838681|588558896|FG000|Period B/A+|Lack of Efficacy|0|||
162960750|NCT01838681|588558897|FG001|Period B/A+|Lack of Efficacy|9|||
162960751|NCT01838681|588558898|FG002|Period B/A+|Lack of Efficacy|11|||
162960752|NCT01838681|588558899|FG003|Period B/A+|Lack of Efficacy|6|||
162960753|NCT01838681|588558896|FG000|Period B/A+|Withdrawal by Subject|0|||
162960754|NCT01838681|588558897|FG001|Period B/A+|Withdrawal by Subject|28|||
162960755|NCT01838681|588558898|FG002|Period B/A+|Withdrawal by Subject|35|||
162960756|NCT01838681|588558899|FG003|Period B/A+|Withdrawal by Subject|47|||
162960757|NCT01838681|588558896|FG000|Period B/A+|Protocol Violation|0|||
162960758|NCT01838681|588558897|FG001|Period B/A+|Protocol Violation|1|||
163303207|NCT04424927|589817676|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
163303208|NCT04424927|589817677|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
163303209|NCT04424927|589817678|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
163303210|NCT04424927|589817679|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
163303211|NCT04424927|589817675|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
163303212|NCT04424927|589817676|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
163303213|NCT04424927|589817677|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
163395347|NCT00041080|590158608|FG000|Overall Study|Adverse Event|21|||
163395348|NCT00041080|590158609|FG001|Overall Study|Adverse Event|1|||
162960759|NCT01838681|588558898|FG002|Period B/A+|Protocol Violation|4|||
162960760|NCT01838681|588558899|FG003|Period B/A+|Protocol Violation|6|||
162960761|NCT01838681|588558896|FG000|Period B/A+|Non-compliance with IMP|0|||
162960762|NCT01838681|588558897|FG001|Period B/A+|Non-compliance with IMP|2|||
162960763|NCT01838681|588558898|FG002|Period B/A+|Non-compliance with IMP|3|||
162960764|NCT01838681|588558899|FG003|Period B/A+|Non-compliance with IMP|3|||
162960765|NCT01838681|588558896|FG000|Period B/A+|Lost to Follow-up|0|||
162960766|NCT01838681|588558897|FG001|Period B/A+|Lost to Follow-up|2|||
162960767|NCT01838681|588558898|FG002|Period B/A+|Lost to Follow-up|5|||
162960768|NCT01838681|588558899|FG003|Period B/A+|Lost to Follow-up|11|||
162960769|NCT01838681|588558896|FG000|Period B/A+|Withdrawal before treatment|0|||
162960770|NCT01838681|588558897|FG001|Period B/A+|Withdrawal before treatment|1|||
162960771|NCT01838681|588558898|FG002|Period B/A+|Withdrawal before treatment|0|||
162960772|NCT01838681|588558899|FG003|Period B/A+|Withdrawal before treatment|0|||
162960773|NCT01838681|588558896|FG000|Period B/A+|Administrative or other reasons|0|||
162960774|NCT01838681|588558897|FG001|Period B/A+|Administrative or other reasons|6|||
162960775|NCT01838681|588558898|FG002|Period B/A+|Administrative or other reasons|10|||
162960776|NCT01838681|588558899|FG003|Period B/A+|Administrative or other reasons|28|||
162960777|NCT01473953|588558900|FG000|Overall Study|Other|1|||
162960778|NCT01473953|588558901|FG001|Overall Study|Other|0|||
162960779|NCT01473953|588558902|FG002|Overall Study|Other|0|||
162960780|NCT01473953|588558903|FG003|Overall Study|Other|0|||
162960781|NCT01473953|588558904|FG004|Overall Study|Other|0|||
162960782|NCT00312897|588558905|FG000|Overall Study|Adverse Event|1|||
162960783|NCT00312897|588558906|FG001|Overall Study|Adverse Event|0|||
162960784|NCT00312897|588558905|FG000|Overall Study|Lost to Follow-up|2|||
162960785|NCT00312897|588558906|FG001|Overall Study|Lost to Follow-up|0|||
162960786|NCT00312897|588558905|FG000|Overall Study|Physician Decision|1|||
162960787|NCT00312897|588558906|FG001|Overall Study|Physician Decision|0|||
162960788|NCT00312897|588558905|FG000|Overall Study|Withdrawal by Subject|1|||
162960789|NCT00312897|588558906|FG001|Overall Study|Withdrawal by Subject|3|||
162960790|NCT00312897|588558905|FG000|Overall Study|Pregnancy|1|||
162960791|NCT00312897|588558906|FG001|Overall Study|Pregnancy|0|||
162960792|NCT00312897|588558905|FG000|Overall Study|discontinued prior to getting treatment|0|||
162960793|NCT00312897|588558906|FG001|Overall Study|discontinued prior to getting treatment|3|||
162960794|NCT00902538|588558909|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
162960795|NCT00902538|588558910|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
162960796|NCT00902538|588558911|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
162960797|NCT00902538|588558912|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
162960798|NCT00902538|588558913|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
162960799|NCT00902538|588558914|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
162960800|NCT00902538|588558909|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
162960801|NCT00902538|588558910|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
162960802|NCT00902538|588558911|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
162960803|NCT00902538|588558912|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
162960804|NCT00902538|588558913|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
162960805|NCT00902538|588558914|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
162960806|NCT00902538|588558909|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
162960807|NCT00902538|588558910|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
162960808|NCT00902538|588558911|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
162960809|NCT00902538|588558912|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
162960810|NCT00902538|588558913|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
162960811|NCT00902538|588558914|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
162960812|NCT00902538|588558909|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
162960813|NCT00902538|588558910|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
162960814|NCT00902538|588558911|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
162960815|NCT00902538|588558912|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
162960816|NCT00902538|588558913|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
162960817|NCT00902538|588558914|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
162960818|NCT00902538|588558909|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
162960819|NCT00902538|588558910|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
162960820|NCT00902538|588558911|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
162960821|NCT00902538|588558912|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
162960822|NCT00902538|588558913|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
162960823|NCT00902538|588558914|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
162960824|NCT00902538|588558909|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
162960825|NCT00902538|588558910|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
162960826|NCT00902538|588558911|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
162960827|NCT00902538|588558912|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
163047062|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047063|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047064|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047065|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047066|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047067|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047068|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047069|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047070|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047071|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
163047072|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047073|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
163047074|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162960828|NCT00902538|588558913|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
162960829|NCT00902538|588558914|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
162960830|NCT00902538|588558909|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
162960831|NCT00902538|588558910|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
162960832|NCT00902538|588558911|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
162960833|NCT00902538|588558912|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
162960834|NCT00902538|588558913|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
162960835|NCT00902538|588558914|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
162960836|NCT00902538|588558909|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
162960837|NCT00902538|588558910|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
162960838|NCT00902538|588558911|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
162960839|NCT00902538|588558912|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
162960840|NCT00902538|588558913|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
163047075|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047076|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047077|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047078|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047079|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
162960841|NCT00902538|588558914|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
163047080|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163196939|NCT00939770|589435831|FG006|Overall Study|Lost to Follow-up|0|||
163196940|NCT00939770|589435832|FG007|Overall Study|Lost to Follow-up|0|||
163196941|NCT00939770|589435825|FG000|Overall Study|Physician Decision|0|||
163196942|NCT00939770|589435826|FG001|Overall Study|Physician Decision|0|||
163196943|NCT00939770|589435827|FG002|Overall Study|Physician Decision|2|||
163196944|NCT00939770|589435828|FG003|Overall Study|Physician Decision|0|||
163196945|NCT00939770|589435829|FG004|Overall Study|Physician Decision|7|||
163196946|NCT00939770|589435830|FG005|Overall Study|Physician Decision|1|||
163196947|NCT00939770|589435831|FG006|Overall Study|Physician Decision|0|||
163196948|NCT00939770|589435832|FG007|Overall Study|Physician Decision|6|||
163196949|NCT00939770|589435825|FG000|Overall Study|Protocol Violation|0|||
163196950|NCT00939770|589435826|FG001|Overall Study|Protocol Violation|0|||
163196951|NCT00939770|589435827|FG002|Overall Study|Protocol Violation|0|||
163196952|NCT00939770|589435828|FG003|Overall Study|Protocol Violation|0|||
163196953|NCT00939770|589435829|FG004|Overall Study|Protocol Violation|1|||
163196954|NCT00939770|589435830|FG005|Overall Study|Protocol Violation|0|||
163303214|NCT04424927|589817678|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
163303215|NCT04424927|589817679|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
163196955|NCT00939770|589435831|FG006|Overall Study|Protocol Violation|0|||
163303216|NCT04424927|589817675|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
163047081|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047082|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047083|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047084|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047085|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047086|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047087|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
163047088|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047089|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047090|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047091|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047092|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047093|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047094|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047095|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047096|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047097|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047098|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047099|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047100|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047101|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
163047102|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047103|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
163047104|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047105|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
163047106|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047107|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047108|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047109|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047110|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047111|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047112|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047113|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047114|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047115|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047116|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047117|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
163047118|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047119|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047120|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
163047121|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047122|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047123|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047124|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047125|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047126|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047127|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047128|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047129|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047130|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047131|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047132|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
163047133|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
163047134|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047135|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
163047136|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047137|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047138|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047139|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047140|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047141|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047142|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047143|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047144|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047145|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047146|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047147|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
163047148|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047149|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047150|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047151|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047152|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047153|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047154|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047155|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047156|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047157|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047158|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047159|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047160|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047161|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047162|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047163|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
163047164|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047165|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047166|NCT01265394|588879386|FG000|Overall Study|Subjects withdrawn|37|||
163047167|NCT01348139|588879392|FG000|Period 1|Adverse Event|1|||
163047168|NCT01348139|588879393|FG001|Period 1|Adverse Event|0|||
163047169|NCT01348139|588879394|FG002|Period 1|Adverse Event|0|||
163047170|NCT01348139|588879395|FG003|Period 1|Adverse Event|0|||
163047171|NCT01348139|588879396|FG004|Period 1|Adverse Event|0|||
163047172|NCT01348139|588879397|FG005|Period 1|Adverse Event|0|||
163047173|NCT02254772|588879398|FG000|Overall Study|Ineligible|1|||
163047174|NCT02254772|588879398|FG000|Overall Study|Withdrawal by Subject|1|||
163047175|NCT00928434|588879399|FG000|Overall Study|Adverse Event|14|||
163047176|NCT00928434|588879400|FG001|Overall Study|Adverse Event|5|||
162960842|NCT00902538|588558909|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
162960843|NCT00902538|588558910|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
162960844|NCT00902538|588558911|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
162960845|NCT00902538|588558912|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
162960846|NCT00902538|588558913|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
162960847|NCT00902538|588558914|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
162960848|NCT00902538|588558909|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
163047177|NCT00928434|588879401|FG002|Overall Study|Adverse Event|18|||
163047178|NCT00928434|588879399|FG000|Overall Study|Protocol Violation|5|||
163047179|NCT00928434|588879400|FG001|Overall Study|Protocol Violation|0|||
163047180|NCT00928434|588879401|FG002|Overall Study|Protocol Violation|8|||
163047181|NCT00928434|588879399|FG000|Overall Study|Physician Decision|2|||
163047182|NCT00928434|588879400|FG001|Overall Study|Physician Decision|0|||
163047183|NCT00928434|588879401|FG002|Overall Study|Physician Decision|3|||
163047184|NCT00928434|588879399|FG000|Overall Study|Lost to Follow-up|1|||
162960849|NCT00902538|588558910|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
162960850|NCT00902538|588558911|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
162960851|NCT00902538|588558912|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
162960852|NCT00902538|588558913|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
162960853|NCT00902538|588558914|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
162960854|NCT00902538|588558909|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
162960855|NCT00902538|588558910|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
162960856|NCT00902538|588558911|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
162960857|NCT00902538|588558912|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
163047185|NCT00928434|588879400|FG001|Overall Study|Lost to Follow-up|0|||
163047186|NCT00928434|588879401|FG002|Overall Study|Lost to Follow-up|3|||
163047187|NCT00928434|588879399|FG000|Overall Study|Withdrawal by Subject|5|||
163047188|NCT00928434|588879400|FG001|Overall Study|Withdrawal by Subject|3|||
163047189|NCT00928434|588879401|FG002|Overall Study|Withdrawal by Subject|2|||
163047190|NCT00928434|588879399|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
162960858|NCT00902538|588558913|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
163047191|NCT00928434|588879400|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
163047192|NCT00928434|588879401|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
163047193|NCT00928434|588879399|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
163047194|NCT00928434|588879400|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
163047195|NCT00928434|588879401|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
163047196|NCT00928434|588879399|FG000|Overall Study|Other (not meeting above criteria)|5|||
163196956|NCT00939770|589435832|FG007|Overall Study|Protocol Violation|0|||
163196957|NCT00939770|589435825|FG000|Overall Study|Withdrawal by Subject|0|||
163196958|NCT00939770|589435826|FG001|Overall Study|Withdrawal by Subject|1|||
163196959|NCT00939770|589435827|FG002|Overall Study|Withdrawal by Subject|5|||
163196960|NCT00939770|589435828|FG003|Overall Study|Withdrawal by Subject|2|||
163196961|NCT00939770|589435829|FG004|Overall Study|Withdrawal by Subject|6|||
163196962|NCT00939770|589435830|FG005|Overall Study|Withdrawal by Subject|0|||
163196963|NCT00939770|589435831|FG006|Overall Study|Withdrawal by Subject|2|||
163196964|NCT00939770|589435832|FG007|Overall Study|Withdrawal by Subject|2|||
163196965|NCT04665856|589435833|FG000|Overall Study|Site Terminated by Sponsor|1|||
163196966|NCT04665856|589435834|FG001|Overall Study|Site Terminated by Sponsor|0|||
163196967|NCT04665856|589435833|FG000|Overall Study|Withdrawal by Subject|2|||
163196968|NCT04665856|589435834|FG001|Overall Study|Withdrawal by Subject|0|||
163196969|NCT04665856|589435833|FG000|Overall Study|Lost to Follow-up|3|||
163196970|NCT04665856|589435834|FG001|Overall Study|Lost to Follow-up|2|||
163196971|NCT04665856|589435833|FG000|Overall Study|Death|39|||
163196972|NCT04665856|589435834|FG001|Overall Study|Death|44|||
163196973|NCT04665856|589435833|FG000|Overall Study|Ongoing in study|17|||
163196974|NCT04665856|589435834|FG001|Overall Study|Ongoing in study|15|||
163196975|NCT03386448|589435835|FG000|Overall Study|Adverse Event|0|||
163196976|NCT03386448|589435836|FG001|Overall Study|Adverse Event|2|||
163047197|NCT00928434|588879400|FG001|Overall Study|Other (not meeting above criteria)|1|||
163047198|NCT00928434|588879401|FG002|Overall Study|Other (not meeting above criteria)|2|||
163047199|NCT03006562|588879402|FG000|Overall Study|Lost to Follow-up|0|||
163047200|NCT03006562|588879403|FG001|Overall Study|Lost to Follow-up|1|||
163047201|NCT00716456|588879404|FG000|Overall Study|Adverse Event|0|||
163047202|NCT00716456|588879405|FG001|Overall Study|Adverse Event|2|||
163047203|NCT00716456|588879406|FG002|Overall Study|Adverse Event|0|||
163047204|NCT00447772|588879407|FG000|Overall Study|Lack of Efficacy|3|||
163047205|NCT00447772|588879407|FG000|Overall Study|Insufficient compliance|6|||
163047206|NCT00447772|588879407|FG000|Overall Study|Discontinuation of drug therapy|1|||
163047207|NCT00447772|588879407|FG000|Overall Study|Lost to Follow-up|9|||
163047208|NCT00447772|588879407|FG000|Overall Study|Withdrawal by Subject|1|||
163047209|NCT00447772|588879407|FG000|Overall Study|Unable to attend all study visits|2|||
163047210|NCT00447772|588879407|FG000|Overall Study|Adverse Event|1|||
163047211|NCT00447772|588879407|FG000|Overall Study|Patient relocated|1|||
163047212|NCT00447772|588879407|FG000|Overall Study|Incomplete documentation at visit 1|1|||
163047213|NCT00447772|588879407|FG000|Overall Study|Chemotherapy for lung cancer|1|||
163047214|NCT00447772|588879407|FG000|Overall Study|Premature re-injection required|1|||
163047215|NCT02427841|588879408|FG000|Overall Study|Lack of Efficacy|5|||
163047216|NCT02427841|588879408|FG000|Overall Study|Physician Decision|2|||
163047217|NCT02427841|588879408|FG000|Overall Study|Withdrawal by Subject|1|||
163047218|NCT05417412|588879409|FG000|Overall Study|Lost to Follow-up|2|||
163047219|NCT01576575|588879410|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
163047220|NCT01576575|588879410|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
163047221|NCT01576575|588879410|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
163047222|NCT01610037|588879414|FG000|All Patients|Adverse Event|27|||
163047223|NCT01610037|588879415|FG001|All Patients|Adverse Event|22|||
163047224|NCT01610037|588879416|FG002|All Patients|Adverse Event|26|||
163047225|NCT01610037|588879414|FG000|All Patients|Withdrawal by Subject|12|||
163047226|NCT01610037|588879415|FG001|All Patients|Withdrawal by Subject|10|||
163047227|NCT01610037|588879416|FG002|All Patients|Withdrawal by Subject|20|||
163047228|NCT01610037|588879414|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
163047229|NCT01610037|588879415|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
163047230|NCT01610037|588879416|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
163047231|NCT01610037|588879414|FG000|All Patients|Death|4|||
163047232|NCT01610037|588879415|FG001|All Patients|Death|2|||
163047233|NCT01610037|588879416|FG002|All Patients|Death|1|||
163047234|NCT01610037|588879414|FG000|All Patients|Protocol deviation|4|||
163047235|NCT01610037|588879415|FG001|All Patients|Protocol deviation|3|||
163047236|NCT01610037|588879416|FG002|All Patients|Protocol deviation|3|||
163047237|NCT01610037|588879414|FG000|All Patients|Abnormal laboratory value|1|||
163196977|NCT02564796|589435837|FG000|Overall Study|Physician Decision|2|||
163196978|NCT02564796|589435838|FG001|Overall Study|Physician Decision|2|||
163196979|NCT00114530|589435839|FG000|Overall Study|Death|3|||
163047238|NCT01610037|588879415|FG001|All Patients|Abnormal laboratory value|1|||
163047239|NCT01610037|588879416|FG002|All Patients|Abnormal laboratory value|0|||
163047240|NCT01610037|588879414|FG000|All Patients|Administrative problems|1|||
163196980|NCT00114530|589435840|FG001|Overall Study|Death|11|||
163196981|NCT00114530|589435839|FG000|Overall Study|Lost to Follow-up|1|||
163196982|NCT00114530|589435840|FG001|Overall Study|Lost to Follow-up|1|||
163196983|NCT00114530|589435839|FG000|Overall Study|Physician Decision|1|||
163196984|NCT00114530|589435840|FG001|Overall Study|Physician Decision|1|||
162960859|NCT00902538|588558914|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
162960860|NCT00902538|588558909|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
162960861|NCT00902538|588558910|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
162960862|NCT00902538|588558911|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
162960863|NCT00902538|588558912|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
162960864|NCT00902538|588558913|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
162960865|NCT00902538|588558914|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
162960866|NCT00902538|588558909|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
162960867|NCT00902538|588558910|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
162960868|NCT00902538|588558911|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
162960869|NCT00902538|588558912|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
162960870|NCT00902538|588558913|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
162960871|NCT00902538|588558914|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
162960872|NCT00902538|588558909|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
162960873|NCT00902538|588558910|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
162960874|NCT00902538|588558911|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
162960875|NCT00902538|588558912|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
162960876|NCT00902538|588558913|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
162960877|NCT00902538|588558914|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
162960878|NCT00902538|588558909|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
162960879|NCT00902538|588558910|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
162960880|NCT00902538|588558911|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
162960881|NCT00902538|588558912|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
162960882|NCT00902538|588558913|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
162960883|NCT00902538|588558914|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
162960884|NCT00902538|588558909|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
162960885|NCT00902538|588558910|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
162960886|NCT00902538|588558911|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
162960887|NCT00902538|588558912|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
162960888|NCT00902538|588558913|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
162960889|NCT00902538|588558914|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
163196985|NCT00114530|589435839|FG000|Overall Study|Withdrawal by Subject|2|||
163196986|NCT00114530|589435840|FG001|Overall Study|Withdrawal by Subject|6|||
163196987|NCT00114530|589435839|FG000|Overall Study|Breast Cancer|1|||
163196988|NCT00114530|589435840|FG001|Overall Study|Breast Cancer|0|||
163196989|NCT00114530|589435839|FG000|Overall Study|Subject decision after endpoint failure|0|||
163196990|NCT00114530|589435840|FG001|Overall Study|Subject decision after endpoint failure|1|||
163196991|NCT00114530|589435839|FG000|Overall Study|Ineligible|1|||
163196992|NCT00114530|589435840|FG001|Overall Study|Ineligible|0|||
163196993|NCT02538029|589435843|FG000|Overall Study|unable to complete cognitive assessments|1|||
163196994|NCT02538029|589435844|FG001|Overall Study|unable to complete cognitive assessments|0|||
163196995|NCT02538029|589435845|FG002|Overall Study|unable to complete cognitive assessments|1|||
163303217|NCT04424927|589817676|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
163303218|NCT04424927|589817677|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
163303219|NCT04424927|589817678|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
163303220|NCT04424927|589817679|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
163196996|NCT01466153|589435846|FG000|Overall Study|Disease Progression|2|||
163196997|NCT01466153|589435847|FG001|Overall Study|Disease Progression|2|||
163196998|NCT01466153|589435848|FG002|Overall Study|Disease Progression|0|||
163196999|NCT01466153|589435846|FG000|Overall Study|Adverse Event|14|||
163197000|NCT01466153|589435847|FG001|Overall Study|Adverse Event|13|||
163197001|NCT01466153|589435848|FG002|Overall Study|Adverse Event|17|||
163197002|NCT01466153|589435846|FG000|Overall Study|Withdrawal of Consent|2|||
163197003|NCT01466153|589435847|FG001|Overall Study|Withdrawal of Consent|0|||
163197004|NCT01466153|589435848|FG002|Overall Study|Withdrawal of Consent|0|||
163197005|NCT01466153|589435846|FG000|Overall Study|Investigator Discretion|3|||
163197006|NCT01466153|589435847|FG001|Overall Study|Investigator Discretion|2|||
163197007|NCT01466153|589435848|FG002|Overall Study|Investigator Discretion|2|||
163303221|NCT04424927|589817675|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
163303222|NCT04424927|589817676|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
163303223|NCT04424927|589817677|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
163303224|NCT04424927|589817678|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
163303225|NCT04424927|589817679|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
163303226|NCT04424927|589817675|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
163303227|NCT04424927|589817676|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
163303228|NCT04424927|589817677|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
163303229|NCT04424927|589817678|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
163303230|NCT04424927|589817679|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
163303231|NCT04424927|589817675|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
163303232|NCT04424927|589817676|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
163303233|NCT04424927|589817677|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
163303234|NCT04424927|589817678|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
163303235|NCT04424927|589817679|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
163303236|NCT04424927|589817675|FG000|Double-blind Period (24 Weeks)|Other|0|||
163303237|NCT04424927|589817676|FG001|Double-blind Period (24 Weeks)|Other|1|||
163303238|NCT04424927|589817677|FG002|Double-blind Period (24 Weeks)|Other|3|||
163303239|NCT04424927|589817678|FG003|Double-blind Period (24 Weeks)|Other|1|||
163303240|NCT04424927|589817679|FG004|Double-blind Period (24 Weeks)|Other|0|||
163303241|NCT00505934|589817684|FG000|Overall Study|Adverse Event|1|||
163303242|NCT00505934|589817684|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
162960890|NCT00902538|588558909|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
163197008|NCT01466153|589435846|FG000|Overall Study|Randomized-Not Treated|2|||
163197009|NCT01466153|589435847|FG001|Overall Study|Randomized-Not Treated|3|||
163197010|NCT01466153|589435848|FG002|Overall Study|Randomized-Not Treated|4|||
163197011|NCT01466153|589435846|FG000|Overall Study|Other-Unspecified|6|||
163197012|NCT01466153|589435847|FG001|Overall Study|Other-Unspecified|4|||
163197013|NCT01466153|589435848|FG002|Overall Study|Other-Unspecified|2|||
163303243|NCT00505934|589817684|FG000|Overall Study|Other: IV dose needed to be changed|1|||
163303244|NCT01046136|589817689|FG000|Overall Study|Withdrawal by Subject|0|||
163303245|NCT01046136|589817690|FG001|Overall Study|Withdrawal by Subject|4|||
163303246|NCT01046136|589817689|FG000|Overall Study|Physician Decision|1|||
163303247|NCT01046136|589817690|FG001|Overall Study|Physician Decision|1|||
163303248|NCT01046136|589817689|FG000|Overall Study|Lost to Follow-up|3|||
163303249|NCT01046136|589817690|FG001|Overall Study|Lost to Follow-up|3|||
163303250|NCT05623345|589817691|FG000|Overall Study|Withdrawal by Subject|14|||
163303251|NCT05623345|589817692|FG001|Overall Study|Withdrawal by Subject|0|||
163303252|NCT05623345|589817693|FG002|Overall Study|Withdrawal by Subject|9|||
163303253|NCT05623345|589817694|FG003|Overall Study|Withdrawal by Subject|20|||
163303254|NCT05623345|589817691|FG000|Overall Study|Lost to Follow-up|3|||
163303255|NCT05623345|589817692|FG001|Overall Study|Lost to Follow-up|0|||
163303256|NCT05623345|589817693|FG002|Overall Study|Lost to Follow-up|7|||
163303257|NCT05623345|589817694|FG003|Overall Study|Lost to Follow-up|2|||
163303258|NCT05623345|589817691|FG000|Overall Study|Termination of Study By Sponsor|37|||
163303259|NCT05623345|589817692|FG001|Overall Study|Termination of Study By Sponsor|4|||
163047241|NCT01610037|588879415|FG001|All Patients|Administrative problems|4|||
163047242|NCT01610037|588879416|FG002|All Patients|Administrative problems|4|||
163047243|NCT01610037|588879414|FG000|All Patients|Lost to Follow-up|1|||
163047244|NCT01610037|588879415|FG001|All Patients|Lost to Follow-up|0|||
163047245|NCT01610037|588879416|FG002|All Patients|Lost to Follow-up|0|||
163047246|NCT01610037|588879414|FG000|All Patients|Abnormal test procedure result(s)|0|||
163047247|NCT01610037|588879415|FG001|All Patients|Abnormal test procedure result(s)|1|||
163047248|NCT01610037|588879416|FG002|All Patients|Abnormal test procedure result(s)|3|||
163047249|NCT01610037|588879414|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
163047250|NCT01610037|588879415|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
163047251|NCT01610037|588879416|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
163303260|NCT05623345|589817693|FG002|Overall Study|Termination of Study By Sponsor|40|||
163303261|NCT05623345|589817694|FG003|Overall Study|Termination of Study By Sponsor|38|||
163303262|NCT04149002|589817698|FG000|Overall Study|Lost to Follow-up|1|||
163303263|NCT04149002|589817699|FG001|Overall Study|Lost to Follow-up|0|||
163303264|NCT04149002|589817698|FG000|Overall Study|Withdrawal by Subject|1|||
163303265|NCT04149002|589817699|FG001|Overall Study|Withdrawal by Subject|0|||
163303266|NCT00262301|589817700|FG000|Double-blind Phase|Lost to Follow-up|1|||
163303267|NCT00262301|589817701|FG001|Double-blind Phase|Lost to Follow-up|0|||
162960891|NCT00902538|588558910|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
162960892|NCT00902538|588558911|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
162960893|NCT00902538|588558912|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
162960894|NCT00902538|588558913|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
162960895|NCT00902538|588558914|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
162960896|NCT06336356|588558915|FG000|Overall Study|Withdrawal by Subject|1|||
162960897|NCT06336356|588558916|FG001|Overall Study|Withdrawal by Subject|0|||
162960898|NCT06336356|588558915|FG000|Overall Study|Lost to Follow Up|1|||
162960899|NCT06336356|588558916|FG001|Overall Study|Lost to Follow Up|0|||
162960900|NCT00725322|588558917|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
162960901|NCT00725322|588558918|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
162960902|NCT00725322|588558917|FG000|Washout (28 Days)|Protocol Violation|0|||
162960903|NCT00725322|588558918|FG001|Washout (28 Days)|Protocol Violation|1|||
162960904|NCT05871151|588558921|FG000|Overall Study|Lost to Follow-up|1|||
162960905|NCT05871151|588558922|FG001|Overall Study|Lost to Follow-up|0|||
162960906|NCT05871151|588558921|FG000|Overall Study|Unrelated illness|0|||
162960907|NCT05871151|588558922|FG001|Overall Study|Unrelated illness|1|||
162960908|NCT03215706|588558923|FG000|Randomization|Adverse Event unrelated to study drug|1|||
162960909|NCT03215706|588558924|FG001|Randomization|Adverse Event unrelated to study drug|0|||
162960910|NCT03215706|588558923|FG000|Randomization|participant withdrew consent|1|||
162960911|NCT03215706|588558924|FG001|Randomization|participant withdrew consent|3|||
162960912|NCT03215706|588558923|FG000|Randomization|no longer meets study criteria|1|||
162960913|NCT03215706|588558924|FG001|Randomization|no longer meets study criteria|4|||
162960914|NCT03215706|588558923|FG000|Randomization|other reasons|0|||
162960915|NCT03215706|588558924|FG001|Randomization|other reasons|2|||
162960916|NCT03215706|588558923|FG000|Treatment Period|Disease Progression|184|||
163303268|NCT00262301|589817702|FG002|Double-blind Phase|Lost to Follow-up|0|||
163303269|NCT00262301|589817700|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
163303270|NCT00262301|589817701|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
162960917|NCT03215706|588558924|FG001|Treatment Period|Disease Progression|174|||
162960918|NCT03215706|588558923|FG000|Treatment Period|Study Drug Toxicity|70|||
162960919|NCT03215706|588558924|FG001|Treatment Period|Study Drug Toxicity|24|||
162960920|NCT03215706|588558923|FG000|Treatment Period|Death|7|||
162960921|NCT03215706|588558924|FG001|Treatment Period|Death|1|||
162960922|NCT03215706|588558923|FG000|Treatment Period|Adverse event unrelated to study drug|31|||
162960923|NCT03215706|588558924|FG001|Treatment Period|Adverse event unrelated to study drug|27|||
163047252|NCT01610037|588879414|FG000|Treatment and Follow up Period|Death|10|||
163047253|NCT01610037|588879415|FG001|Treatment and Follow up Period|Death|5|||
163047254|NCT01610037|588879416|FG002|Treatment and Follow up Period|Death|4|||
163047255|NCT01610037|588879414|FG000|Treatment and Follow up Period|Administrative problems|1|||
163047256|NCT01610037|588879415|FG001|Treatment and Follow up Period|Administrative problems|3|||
163047257|NCT01610037|588879416|FG002|Treatment and Follow up Period|Administrative problems|2|||
163047258|NCT01610037|588879414|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
163047259|NCT01610037|588879415|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
163047260|NCT01610037|588879416|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
163047261|NCT00274742|588879417|FG000|Overall Study|Adverse Event|0|||
163047262|NCT00274742|588879418|FG001|Overall Study|Adverse Event|4|||
163047263|NCT00274742|588879419|FG002|Overall Study|Adverse Event|1|||
163047264|NCT00274742|588879420|FG003|Overall Study|Adverse Event|4|||
163047265|NCT00274742|588879421|FG004|Overall Study|Adverse Event|12|||
163047266|NCT00274742|588879422|FG005|Overall Study|Adverse Event|3|||
163047267|NCT00274742|588879417|FG000|Overall Study|Lost to Follow-up|0|||
163047268|NCT00274742|588879418|FG001|Overall Study|Lost to Follow-up|0|||
163047269|NCT00274742|588879419|FG002|Overall Study|Lost to Follow-up|0|||
163047270|NCT00274742|588879420|FG003|Overall Study|Lost to Follow-up|0|||
163047271|NCT00274742|588879421|FG004|Overall Study|Lost to Follow-up|1|||
163047272|NCT00274742|588879422|FG005|Overall Study|Lost to Follow-up|0|||
163047273|NCT00274742|588879417|FG000|Overall Study|End of Study|0|||
163047274|NCT00274742|588879418|FG001|Overall Study|End of Study|0|||
162960924|NCT03215706|588558923|FG000|Treatment Period|Request to D/C treatment|2|||
162960925|NCT03215706|588558924|FG001|Treatment Period|Request to D/C treatment|10|||
162960926|NCT03215706|588558923|FG000|Treatment Period|Participant withdrew consent|4|||
162960927|NCT03215706|588558924|FG001|Treatment Period|Participant withdrew consent|5|||
162960928|NCT03215706|588558923|FG000|Treatment Period|Lost to Follow-up|0|||
162960929|NCT03215706|588558924|FG001|Treatment Period|Lost to Follow-up|1|||
162960930|NCT03215706|588558923|FG000|Treatment Period|Administrative reason by sponsor|0|||
162960931|NCT03215706|588558924|FG001|Treatment Period|Administrative reason by sponsor|2|||
162960932|NCT03215706|588558923|FG000|Treatment Period|other reasons|10|||
162960933|NCT03215706|588558924|FG001|Treatment Period|other reasons|5|||
162960934|NCT03215706|588558923|FG000|Treatment Period|Not reported|1|||
162960935|NCT03215706|588558924|FG001|Treatment Period|Not reported|0|||
163047275|NCT00274742|588879419|FG002|Overall Study|End of Study|0|||
163047276|NCT00274742|588879420|FG003|Overall Study|End of Study|1|||
162960936|NCT03114891|588558926|FG000|First Treatment Round|Lost to Follow-up|0|||
162960937|NCT03114891|588558927|FG001|First Treatment Round|Lost to Follow-up|1|||
162960938|NCT03114891|588558928|FG002|First Treatment Round|Lost to Follow-up|1|||
163197014|NCT01088997|589435851|FG000|Overall Study|Physician Decision|1|||
163197015|NCT01088997|589435852|FG001|Overall Study|Physician Decision|1|||
163197016|NCT01088997|589435851|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
162960939|NCT03114891|588558929|FG003|First Treatment Round|Lost to Follow-up|0|||
162960940|NCT03114891|588558926|FG000|First Treatment Round|Withdrawal by Subject|0|||
162960941|NCT03114891|588558927|FG001|First Treatment Round|Withdrawal by Subject|2|||
162960942|NCT03114891|588558928|FG002|First Treatment Round|Withdrawal by Subject|0|||
162960943|NCT03114891|588558929|FG003|First Treatment Round|Withdrawal by Subject|1|||
162960944|NCT03114891|588558926|FG000|3 Week Break|Lost to Follow-up|1|||
162960945|NCT03114891|588558927|FG001|3 Week Break|Lost to Follow-up|0|||
162960946|NCT03114891|588558928|FG002|3 Week Break|Lost to Follow-up|0|||
162960947|NCT03114891|588558929|FG003|3 Week Break|Lost to Follow-up|1|||
162960948|NCT03114891|588558926|FG000|3 Week Break|Withdrawal by Subject|0|||
162960949|NCT03114891|588558927|FG001|3 Week Break|Withdrawal by Subject|1|||
162960950|NCT03114891|588558928|FG002|3 Week Break|Withdrawal by Subject|0|||
162960951|NCT03114891|588558929|FG003|3 Week Break|Withdrawal by Subject|0|||
162960952|NCT03114891|588558926|FG000|Second Treatment Round|Lost to Follow-up|1|||
162960953|NCT03114891|588558927|FG001|Second Treatment Round|Lost to Follow-up|0|||
162960954|NCT03114891|588558928|FG002|Second Treatment Round|Lost to Follow-up|0|||
162960955|NCT03114891|588558929|FG003|Second Treatment Round|Lost to Follow-up|0|||
162960956|NCT03114891|588558926|FG000|Second Treatment Round|Physician Decision|1|||
162960957|NCT03114891|588558927|FG001|Second Treatment Round|Physician Decision|0|||
162960958|NCT03114891|588558928|FG002|Second Treatment Round|Physician Decision|0|||
162960959|NCT03114891|588558929|FG003|Second Treatment Round|Physician Decision|0|||
162960960|NCT03506633|588560645|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
162960961|NCT03506633|588560646|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
162960962|NCT03247686|588560651|FG000|Overall Study|Withdrawal by Subject|1|||
162960963|NCT03247686|588560652|FG001|Overall Study|Withdrawal by Subject|2|||
162960964|NCT02302716|588560653|FG000|Overall Study|Adverse Event|1|||
162960965|NCT02302716|588560654|FG001|Overall Study|Adverse Event|1|||
162960966|NCT02302716|588560653|FG000|Overall Study|Death|0|||
162960967|NCT02302716|588560654|FG001|Overall Study|Death|1|||
162960968|NCT02302716|588560653|FG000|Overall Study|Lack of Efficacy|0|||
162960969|NCT02302716|588560654|FG001|Overall Study|Lack of Efficacy|1|||
163047277|NCT00274742|588879421|FG004|Overall Study|End of Study|0|||
163047278|NCT00274742|588879422|FG005|Overall Study|End of Study|0|||
163047279|NCT00274742|588879417|FG000|Overall Study|Disease Progression|0|||
163047280|NCT00274742|588879418|FG001|Overall Study|Disease Progression|1|||
163047281|NCT00274742|588879419|FG002|Overall Study|Disease Progression|1|||
163047282|NCT00274742|588879420|FG003|Overall Study|Disease Progression|0|||
163047283|NCT00274742|588879421|FG004|Overall Study|Disease Progression|1|||
163047284|NCT00274742|588879422|FG005|Overall Study|Disease Progression|0|||
163047285|NCT00274742|588879417|FG000|Overall Study|Other|0|||
163047286|NCT00274742|588879418|FG001|Overall Study|Other|3|||
163047287|NCT00274742|588879419|FG002|Overall Study|Other|0|||
163047288|NCT00274742|588879420|FG003|Overall Study|Other|0|||
163047289|NCT00274742|588879421|FG004|Overall Study|Other|2|||
163047290|NCT00274742|588879422|FG005|Overall Study|Other|0|||
163047291|NCT00977613|588879429|FG000|Overall Study|Lost to Follow-up|16|||
163047292|NCT01598610|588879436|FG000|Overall Study|Adverse Event|1|||
163047293|NCT02989402|588879442|FG000|Overall Study|Adverse event, or serious adverse event|4|||
163197017|NCT01088997|589435852|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
163197018|NCT01088997|589435851|FG000|Overall Study|Excluded prior to receiving drug|1|||
163197019|NCT01088997|589435852|FG001|Overall Study|Excluded prior to receiving drug|1|||
163197020|NCT00688753|589437435|FG000|Overall Study|Disease progression|55|||
163197021|NCT00688753|589437435|FG000|Overall Study|Missing|1|||
163197022|NCT00688753|589437435|FG000|Overall Study|Death|9|||
163197023|NCT00688753|589437435|FG000|Overall Study|Withdrawal by Subject|3|||
163197024|NCT00688753|589437435|FG000|Overall Study|Adverse Event|20|||
163197025|NCT00688753|589437435|FG000|Overall Study|Protocol Violation|1|||
163197026|NCT00688753|589437435|FG000|Overall Study|Lost to Follow-up|3|||
162960970|NCT02302716|588560653|FG000|Overall Study|Lost to Follow-up|2|||
162960971|NCT02302716|588560654|FG001|Overall Study|Lost to Follow-up|4|||
162960972|NCT02302716|588560653|FG000|Overall Study|Physician Decision|3|||
162960973|NCT02302716|588560654|FG001|Overall Study|Physician Decision|4|||
163197027|NCT05996718|589437441|FG000|Overall Study|Lost to Follow-up|3|||
163197028|NCT04840615|589437443|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
162960974|NCT02302716|588560653|FG000|Overall Study|Withdrawal by Subject|13|||
163047294|NCT02989402|588879442|FG000|Overall Study|Death|2|||
163047295|NCT02989402|588879442|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
163047296|NCT02989402|588879442|FG000|Overall Study|Lost to Follow-up|8|||
163047297|NCT02989402|588879442|FG000|Overall Study|Patient no longer on monotherapy|1|||
163047298|NCT02989402|588879442|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
163047299|NCT02989402|588879442|FG000|Overall Study|Withdrawal by Subject|7|||
163047300|NCT02989402|588879442|FG000|Overall Study|Other|2|||
163047301|NCT03066830|588879443|FG000|Overall Study|At the Participant's own Request|16|||
163047302|NCT03066830|588879444|FG001|Overall Study|At the Participant's own Request|17|||
163047303|NCT03066830|588879443|FG000|Overall Study|Other|3|||
163047304|NCT03066830|588879444|FG001|Overall Study|Other|0|||
163047305|NCT03066830|588879443|FG000|Overall Study|Poor Compliance to Protocol|1|||
163047306|NCT03066830|588879444|FG001|Overall Study|Poor Compliance to Protocol|0|||
163047307|NCT03066830|588879443|FG000|Overall Study|Adverse Event|2|||
163047308|NCT03066830|588879444|FG001|Overall Study|Adverse Event|2|||
163047309|NCT03066830|588879443|FG000|Overall Study|Lost to Follow-up|11|||
163047310|NCT03066830|588879444|FG001|Overall Study|Lost to Follow-up|3|||
163047311|NCT02039778|588879446|FG000|Overall Study|Death|2|||
163047312|NCT02039778|588879446|FG000|Overall Study|Withdrawal by Subject|1|||
163047313|NCT02039778|588879446|FG000|Overall Study|Never started the protocol treatment|1|||
163047314|NCT01216332|588879458|FG000|Overall Study|Withdrawal by Subject|4|||
163047315|NCT01216332|588879459|FG001|Overall Study|Withdrawal by Subject|0|||
163047316|NCT03677869|588879460|FG000|Overall Study|Withdrawal by Subject|1|||
163047317|NCT05219968|588879461|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
163047318|NCT05219968|588879462|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
163047319|NCT05219968|588879463|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
163047320|NCT05219968|588879464|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
163047321|NCT05219968|588879465|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
163047322|NCT05219968|588879461|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
163047323|NCT05219968|588879462|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
163047324|NCT05219968|588879463|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
163047325|NCT05219968|588879464|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
163047326|NCT05219968|588879465|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
163047327|NCT05219968|588879461|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
163047328|NCT05219968|588879462|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
163047329|NCT05219968|588879463|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
163047330|NCT05219968|588879464|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
163047331|NCT05219968|588879465|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
163047332|NCT05219968|588879461|FG000|Week 24 Treatment Period|Adverse Event|3|||
163047333|NCT05219968|588879462|FG001|Week 24 Treatment Period|Adverse Event|0|||
163047334|NCT05219968|588879463|FG002|Week 24 Treatment Period|Adverse Event|0|||
163047335|NCT05219968|588879464|FG003|Week 24 Treatment Period|Adverse Event|0|||
163047336|NCT05219968|588879465|FG004|Week 24 Treatment Period|Adverse Event|0|||
163047337|NCT05219968|588879461|FG000|Week 24 Treatment Period|Physician Decision|0|||
163047338|NCT05219968|588879462|FG001|Week 24 Treatment Period|Physician Decision|1|||
163047339|NCT05219968|588879463|FG002|Week 24 Treatment Period|Physician Decision|0|||
162960975|NCT02302716|588560654|FG001|Overall Study|Withdrawal by Subject|7|||
162960976|NCT02302716|588560653|FG000|Overall Study|Protocol Violation|0|||
162960977|NCT02302716|588560654|FG001|Overall Study|Protocol Violation|1|||
162960978|NCT00830258|588560655|FG000|First Intervention|Adverse Event|1|||
162960979|NCT00830258|588560656|FG001|First Intervention|Adverse Event|0|||
162960980|NCT00830258|588560655|FG000|Washout: 7 Days|Protocol Violation|1|||
162960981|NCT00830258|588560656|FG001|Washout: 7 Days|Protocol Violation|0|||
162960982|NCT00798603|588560657|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
162960983|NCT00798603|588560657|FG000|Overall Study|Withdrawal by Subject|10|||
162960984|NCT00798603|588560657|FG000|Overall Study|Adverse Event|22|||
162960985|NCT00798603|588560657|FG000|Overall Study|Physician Decision|1|||
162960986|NCT00798603|588560657|FG000|Overall Study|Lack of insurance coverage|1|||
162960987|NCT02997176|588560662|FG000|Overall Study|Adverse Event|0|||
162960988|NCT02997176|588560663|FG001|Overall Study|Adverse Event|0|||
162960989|NCT02997176|588560664|FG002|Overall Study|Adverse Event|0|||
162960990|NCT02997176|588560665|FG003|Overall Study|Adverse Event|8|||
162960991|NCT02997176|588560662|FG000|Overall Study|Progressive Disease|1|||
162960992|NCT02997176|588560663|FG001|Overall Study|Progressive Disease|0|||
162960993|NCT02997176|588560664|FG002|Overall Study|Progressive Disease|1|||
162960994|NCT02997176|588560665|FG003|Overall Study|Progressive Disease|1|||
162960995|NCT02997176|588560662|FG000|Overall Study|Death|0|||
162960996|NCT02997176|588560663|FG001|Overall Study|Death|0|||
162960997|NCT02997176|588560664|FG002|Overall Study|Death|1|||
162960998|NCT02997176|588560665|FG003|Overall Study|Death|1|||
162960999|NCT02997176|588560662|FG000|Overall Study|Withdrawal by Subject|0|||
162961000|NCT02997176|588560663|FG001|Overall Study|Withdrawal by Subject|2|||
162961001|NCT02997176|588560664|FG002|Overall Study|Withdrawal by Subject|0|||
162961002|NCT02997176|588560665|FG003|Overall Study|Withdrawal by Subject|1|||
162961003|NCT05511935|588560666|FG000|Overall Study|Lost to Follow-up|9|||
162961004|NCT05511935|588560667|FG001|Overall Study|Lost to Follow-up|27|||
162961005|NCT04523480|588560668|FG000|Overall Study|Lost to Follow-up|30|||
162961006|NCT04523480|588560669|FG001|Overall Study|Lost to Follow-up|35|||
162961007|NCT04523480|588560670|FG002|Overall Study|Lost to Follow-up|0|||
162961008|NCT04102345|588560671|FG000|Overall Study|Withdrawal by Subject|1|||
162961009|NCT04102345|588560672|FG001|Overall Study|Withdrawal by Subject|0|||
162961010|NCT01117623|588560675|FG000|Overall Study|Adverse Event|0|||
162961011|NCT01117623|588560676|FG001|Overall Study|Adverse Event|2|||
162961012|NCT01117623|588560677|FG002|Overall Study|Adverse Event|4|||
162961013|NCT01117623|588560678|FG003|Overall Study|Adverse Event|0|||
162961014|NCT01117623|588560679|FG004|Overall Study|Adverse Event|2|||
162961015|NCT01117623|588560680|FG005|Overall Study|Adverse Event|0|||
162961016|NCT01117623|588560681|FG006|Overall Study|Adverse Event|0|||
162961017|NCT01117623|588560682|FG007|Overall Study|Adverse Event|2|||
162961018|NCT01117623|588560675|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
162961019|NCT01117623|588560676|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
162961020|NCT01117623|588560677|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
162961021|NCT01117623|588560678|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
162961022|NCT01117623|588560679|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
162961023|NCT01117623|588560680|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
162961024|NCT01117623|588560681|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
162961025|NCT01117623|588560682|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
162961026|NCT01117623|588560675|FG000|Overall Study|Withdrawal by Subject|0|||
162961027|NCT01117623|588560676|FG001|Overall Study|Withdrawal by Subject|0|||
162961028|NCT01117623|588560677|FG002|Overall Study|Withdrawal by Subject|2|||
162961029|NCT01117623|588560678|FG003|Overall Study|Withdrawal by Subject|0|||
162961030|NCT01117623|588560679|FG004|Overall Study|Withdrawal by Subject|0|||
162961031|NCT01117623|588560680|FG005|Overall Study|Withdrawal by Subject|1|||
162961032|NCT01117623|588560681|FG006|Overall Study|Withdrawal by Subject|1|||
162961033|NCT01117623|588560682|FG007|Overall Study|Withdrawal by Subject|1|||
162961034|NCT01117623|588560675|FG000|Overall Study|Non-compliance with study medication|0|||
162961035|NCT01117623|588560676|FG001|Overall Study|Non-compliance with study medication|0|||
162961036|NCT01117623|588560677|FG002|Overall Study|Non-compliance with study medication|0|||
162961037|NCT01117623|588560678|FG003|Overall Study|Non-compliance with study medication|0|||
162961038|NCT01117623|588560679|FG004|Overall Study|Non-compliance with study medication|0|||
162961039|NCT01117623|588560680|FG005|Overall Study|Non-compliance with study medication|0|||
162961040|NCT01117623|588560681|FG006|Overall Study|Non-compliance with study medication|0|||
162961041|NCT01117623|588560682|FG007|Overall Study|Non-compliance with study medication|1|||
162961042|NCT01117623|588560675|FG000|Overall Study|Invest. text: completed all planned txs|0|||
162961043|NCT01117623|588560676|FG001|Overall Study|Invest. text: completed all planned txs|0|||
162961044|NCT01117623|588560677|FG002|Overall Study|Invest. text: completed all planned txs|0|||
162961045|NCT01117623|588560678|FG003|Overall Study|Invest. text: completed all planned txs|0|||
162961046|NCT01117623|588560679|FG004|Overall Study|Invest. text: completed all planned txs|0|||
162961047|NCT01117623|588560680|FG005|Overall Study|Invest. text: completed all planned txs|1|||
162961048|NCT01117623|588560681|FG006|Overall Study|Invest. text: completed all planned txs|0|||
162961049|NCT01117623|588560682|FG007|Overall Study|Invest. text: completed all planned txs|0|||
162961050|NCT02727192|588560689|FG000|Overall Study|Lost to Follow-up|1|||
162961051|NCT02727192|588560690|FG001|Overall Study|Lost to Follow-up|0|||
162961052|NCT02727192|588560691|FG002|Overall Study|Lost to Follow-up|0|||
162961053|NCT05497557|588560693|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
162961054|NCT05497557|588560694|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
162961055|NCT05497557|588560695|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
162961056|NCT04590027|588560697|FG000|Overall Study|Lost to Follow-up|17|||
162961057|NCT04590027|588560698|FG001|Overall Study|Lost to Follow-up|14|||
162961058|NCT04590027|588560697|FG000|Overall Study|Protocol Violation|0|||
162961059|NCT04590027|588560698|FG001|Overall Study|Protocol Violation|3|||
162961060|NCT01959672|588560702|FG000|Overall Study|Death|1|||
162961061|NCT02392195|588560703|FG000|Overall Study|Lost to Follow-up|4|||
162961062|NCT02392195|588560703|FG000|Overall Study|Withdrawal by Subject|4|||
162961063|NCT04089553|588560706|FG000|Overall Study|Death|1|||
162961064|NCT04089553|588560707|FG001|Overall Study|Death|1|||
162961065|NCT04089553|588560706|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
162961066|NCT04089553|588560707|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
162961067|NCT04089553|588560706|FG000|Overall Study|Withdrawal by Subject|3|||
162961068|NCT04089553|588560707|FG001|Overall Study|Withdrawal by Subject|3|||
162961069|NCT04089553|588560706|FG000|Overall Study|Physician Decision|1|||
162961070|NCT04089553|588560707|FG001|Overall Study|Physician Decision|0|||
162961071|NCT04089553|588560706|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
162961072|NCT04089553|588560707|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
162961073|NCT04089553|588560706|FG000|Overall Study|Other|1|||
162961074|NCT04089553|588560707|FG001|Overall Study|Other|0|||
162961075|NCT04089553|588560706|FG000|Overall Study|Adverse Event|1|||
163197029|NCT04840615|589437444|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
163197030|NCT04840615|589437445|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
163197031|NCT00115739|589437446|FG000|Overall Study|Lost to Follow-up|3|||
163197032|NCT00259649|589437449|FG000|Overall Study|Lost to Follow-up|7|||
163197033|NCT00259649|589437449|FG000|Overall Study|irregular menses|3|||
163197034|NCT02200211|589437450|FG000|Overall Study|Lost to Follow-up|7|||
163197035|NCT02200211|589437451|FG001|Overall Study|Lost to Follow-up|7|||
163197036|NCT02200211|589437452|FG002|Overall Study|Lost to Follow-up|1|||
163197037|NCT02200211|589437453|FG003|Overall Study|Lost to Follow-up|2|||
163197038|NCT02200211|589437450|FG000|Overall Study|Withdrawal by Subject|1|||
163197039|NCT02200211|589437451|FG001|Overall Study|Withdrawal by Subject|0|||
163197040|NCT02200211|589437452|FG002|Overall Study|Withdrawal by Subject|0|||
163197041|NCT02200211|589437453|FG003|Overall Study|Withdrawal by Subject|0|||
163197042|NCT02501473|589437454|FG000|Overall Study|Study Terminated|2|||
163197043|NCT02501473|589437455|FG001|Overall Study|Study Terminated|3|||
163197044|NCT02501473|589437456|FG002|Overall Study|Study Terminated|7|||
163197045|NCT02501473|589437457|FG003|Overall Study|Study Terminated|9|||
163197046|NCT02501473|589437458|FG004|Overall Study|Study Terminated|2|||
163197047|NCT02501473|589437459|FG005|Overall Study|Study Terminated|10|||
163197048|NCT02501473|589437460|FG006|Overall Study|Study Terminated|1|||
163197049|NCT02501473|589437461|FG007|Overall Study|Study Terminated|0|||
163197050|NCT02501473|589437454|FG000|Overall Study|Withdrawal by Subject|0|||
163197051|NCT02501473|589437455|FG001|Overall Study|Withdrawal by Subject|0|||
163197052|NCT02501473|589437456|FG002|Overall Study|Withdrawal by Subject|3|||
163197053|NCT02501473|589437457|FG003|Overall Study|Withdrawal by Subject|3|||
163197054|NCT02501473|589437458|FG004|Overall Study|Withdrawal by Subject|2|||
163197055|NCT02501473|589437459|FG005|Overall Study|Withdrawal by Subject|2|||
163197056|NCT02501473|589437460|FG006|Overall Study|Withdrawal by Subject|0|||
163197057|NCT02501473|589437461|FG007|Overall Study|Withdrawal by Subject|0|||
163197058|NCT02501473|589437454|FG000|Overall Study|Death|0|||
163197059|NCT02501473|589437455|FG001|Overall Study|Death|0|||
163197060|NCT02501473|589437456|FG002|Overall Study|Death|1|||
163197061|NCT02501473|589437457|FG003|Overall Study|Death|1|||
163197062|NCT02501473|589437458|FG004|Overall Study|Death|0|||
163197063|NCT02501473|589437459|FG005|Overall Study|Death|1|||
163197064|NCT02501473|589437460|FG006|Overall Study|Death|0|||
163197065|NCT02501473|589437461|FG007|Overall Study|Death|0|||
163197066|NCT02501473|589437454|FG000|Overall Study|Lost to Follow-up|1|||
163197067|NCT02501473|589437455|FG001|Overall Study|Lost to Follow-up|0|||
163197068|NCT02501473|589437456|FG002|Overall Study|Lost to Follow-up|1|||
163047340|NCT05219968|588879464|FG003|Week 24 Treatment Period|Physician Decision|0|||
163047341|NCT05219968|588879465|FG004|Week 24 Treatment Period|Physician Decision|0|||
163047342|NCT05219968|588879461|FG000|Week 24 Treatment Period|Other, not specified|3|||
163047343|NCT05219968|588879462|FG001|Week 24 Treatment Period|Other, not specified|0|||
163047344|NCT05219968|588879463|FG002|Week 24 Treatment Period|Other, not specified|0|||
163047345|NCT05219968|588879464|FG003|Week 24 Treatment Period|Other, not specified|0|||
163047346|NCT05219968|588879465|FG004|Week 24 Treatment Period|Other, not specified|0|||
163047347|NCT05219968|588879461|FG000|Safety Extension Period|Treatment administration failure|0|||
163047348|NCT05219968|588879462|FG001|Safety Extension Period|Treatment administration failure|0|||
163047349|NCT05219968|588879463|FG002|Safety Extension Period|Treatment administration failure|0|||
163395349|NCT00041080|590158608|FG000|Overall Study|Withdrawal by Subject|6|||
163197069|NCT02501473|589437457|FG003|Overall Study|Lost to Follow-up|0|||
163197070|NCT02501473|589437458|FG004|Overall Study|Lost to Follow-up|0|||
163197071|NCT02501473|589437459|FG005|Overall Study|Lost to Follow-up|1|||
163197072|NCT02501473|589437460|FG006|Overall Study|Lost to Follow-up|0|||
163197073|NCT02501473|589437461|FG007|Overall Study|Lost to Follow-up|0|||
163197074|NCT02501473|589437454|FG000|Overall Study|Reason not specified|0|||
163197075|NCT02501473|589437455|FG001|Overall Study|Reason not specified|0|||
162961076|NCT04089553|588560707|FG001|Overall Study|Adverse Event|1|||
162961077|NCT03366792|588560710|FG000|Overall Study|Withdrawal by Subject|7|||
162961078|NCT03366792|588560710|FG000|Overall Study|Lost to Follow-up|2|||
162961079|NCT03366792|588560710|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
162961080|NCT03366792|588560710|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
162961081|NCT01808651|588560711|FG000|Study Period 1|Lost to Follow-up|1|||
162961082|NCT01808651|588560712|FG001|Study Period 1|Lost to Follow-up|3|||
162961083|NCT01808651|588560713|FG002|Study Period 1|Lost to Follow-up|0|||
162961084|NCT01808651|588560711|FG000|Study Period 1|Protocol Violation|1|||
162961085|NCT01808651|588560712|FG001|Study Period 1|Protocol Violation|0|||
162961086|NCT01808651|588560713|FG002|Study Period 1|Protocol Violation|1|||
163197076|NCT02501473|589437456|FG002|Overall Study|Reason not specified|1|||
162961087|NCT01808651|588560711|FG000|Study Period 1|Physician Decision|3|||
162961088|NCT01808651|588560712|FG001|Study Period 1|Physician Decision|2|||
162961089|NCT01808651|588560713|FG002|Study Period 1|Physician Decision|0|||
163197077|NCT02501473|589437457|FG003|Overall Study|Reason not specified|1|||
163197078|NCT02501473|589437458|FG004|Overall Study|Reason not specified|0|||
162961090|NCT01808651|588560711|FG000|Study Period 1|Lack of Efficacy|2|||
162961091|NCT01808651|588560712|FG001|Study Period 1|Lack of Efficacy|1|||
162961092|NCT01808651|588560713|FG002|Study Period 1|Lack of Efficacy|0|||
162961093|NCT01808651|588560711|FG000|Study Period 1|Adverse Event|10|||
162961094|NCT01808651|588560712|FG001|Study Period 1|Adverse Event|4|||
163197079|NCT02501473|589437459|FG005|Overall Study|Reason not specified|0|||
163197080|NCT02501473|589437460|FG006|Overall Study|Reason not specified|0|||
163197081|NCT02501473|589437461|FG007|Overall Study|Reason not specified|0|||
163197082|NCT02954237|589437462|FG000|Overall Study|Withdrawal by Subject|25|||
163197083|NCT02954237|589437462|FG000|Overall Study|Missed visit|16|||
163197084|NCT02954237|589437462|FG000|Overall Study|Death|2|||
163197085|NCT00621985|589437469|FG000|Dexamethasone Admission|Adverse Event|1|||
163197086|NCT01806298|589437470|FG000|Overall Study|Adverse Event|3|||
163197087|NCT01806298|589437470|FG000|Overall Study|Protocol Non-compliance|1|||
163197088|NCT01806298|589437470|FG000|Overall Study|Withdrawal by Subject|1|||
163197089|NCT01806298|589437470|FG000|Overall Study|Other|5|||
163197090|NCT01001377|589437473|FG000|Overall Study|Ineligibility determined|2|||
163197091|NCT01001377|589437474|FG001|Overall Study|Ineligibility determined|0|||
163047350|NCT05219968|588879464|FG003|Safety Extension Period|Treatment administration failure|1|||
163047351|NCT05219968|588879465|FG004|Safety Extension Period|Treatment administration failure|4|||
163047352|NCT05219968|588879461|FG000|Safety Extension Period|Bilateral dislodgement|0|||
163047353|NCT05219968|588879462|FG001|Safety Extension Period|Bilateral dislodgement|0|||
163047354|NCT05219968|588879463|FG002|Safety Extension Period|Bilateral dislodgement|4|||
163303271|NCT00262301|589817702|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
163303272|NCT02539225|589817704|FG000|Part A|Adverse Event|13|||
163303273|NCT02539225|589817705|FG001|Part A|Adverse Event|4|||
163303274|NCT02539225|589817704|FG000|Part A|Withdrawal by Subject|2|||
163303275|NCT02539225|589817705|FG001|Part A|Withdrawal by Subject|4|||
163303276|NCT02539225|589817704|FG000|Part A|Physician Decision|4|||
163303277|NCT02539225|589817705|FG001|Part A|Physician Decision|7|||
163303278|NCT02539225|589817704|FG000|Part A|Did Not Receive study Drug|1|||
163303279|NCT02539225|589817705|FG001|Part A|Did Not Receive study Drug|1|||
163197092|NCT01001377|589437473|FG000|Overall Study|Withdrawal by Subject|19|||
163197093|NCT01001377|589437474|FG001|Overall Study|Withdrawal by Subject|20|||
163197094|NCT01001377|589437473|FG000|Overall Study|Lost to Follow-up|14|||
163197095|NCT01001377|589437474|FG001|Overall Study|Lost to Follow-up|17|||
163197096|NCT01001377|589437473|FG000|Overall Study|Death|391|||
163197097|NCT01001377|589437474|FG001|Overall Study|Death|384|||
163197098|NCT04343261|589437475|FG000|Overall Study|Adverse Event|1|||
163197099|NCT04343261|589437475|FG000|Overall Study|received inadequate amount of antibodies|7|||
163197100|NCT02849678|589437476|FG000|Overall Study|Protocol Violation|3|||
163197101|NCT02849678|589437477|FG001|Overall Study|Protocol Violation|6|||
163197102|NCT00289991|589437478|FG000|Overall Study|Death|35|||
163197103|NCT00289991|589437479|FG001|Overall Study|Death|38|||
163197104|NCT00289991|589437478|FG000|Overall Study|Adverse Event|15|||
163197105|NCT00289991|589437479|FG001|Overall Study|Adverse Event|13|||
163197106|NCT00289991|589437478|FG000|Overall Study|Failure of prophylaxis|1|||
163197107|NCT00289991|589437479|FG001|Overall Study|Failure of prophylaxis|1|||
163197108|NCT00289991|589437478|FG000|Overall Study|Fungal breakthrough infection|0|||
163197109|NCT00289991|589437479|FG001|Overall Study|Fungal breakthrough infection|1|||
163197110|NCT00289991|589437478|FG000|Overall Study|Lost to Follow-up|0|||
163197111|NCT00289991|589437479|FG001|Overall Study|Lost to Follow-up|1|||
163197112|NCT00289991|589437478|FG000|Overall Study|Withdrawal by Subject|2|||
163197113|NCT00289991|589437479|FG001|Overall Study|Withdrawal by Subject|12|||
163197114|NCT00289991|589437478|FG000|Overall Study|Other|5|||
163197115|NCT00289991|589437479|FG001|Overall Study|Other|14|||
163197116|NCT01496807|589437480|FG000|Overall Study|Progressive Disease|21|||
163197117|NCT01496807|589437480|FG000|Overall Study|Participant preference/toxicity|8|||
163197118|NCT01496807|589437480|FG000|Overall Study|Change in diagnosis|1|||
163197119|NCT03330288|589437483|FG000|Overall Study|Other reason|1|||
163197120|NCT03330288|589437484|FG001|Overall Study|Other reason|1|||
163197121|NCT03330288|589437483|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
163197122|NCT03330288|589437484|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
163197123|NCT03330288|589437483|FG000|Overall Study|Adverse Event|1|||
163197124|NCT03330288|589437484|FG001|Overall Study|Adverse Event|0|||
163197125|NCT03330288|589437483|FG000|Overall Study|Withdrawal by Subject|1|||
163197126|NCT03330288|589437484|FG001|Overall Study|Withdrawal by Subject|0|||
163197127|NCT03330288|589437483|FG000|Overall Study|Lost to Follow-up|26|||
163197128|NCT03330288|589437484|FG001|Overall Study|Lost to Follow-up|7|||
163197129|NCT04447794|589437485|FG000|Overall Study|Lost to Follow-up|2|||
163197130|NCT04447794|589437486|FG001|Overall Study|Lost to Follow-up|3|||
163197131|NCT04447794|589437487|FG002|Overall Study|Lost to Follow-up|8|||
163197132|NCT04447794|589437485|FG000|Overall Study|Withdrawal by Subject|1|||
163197133|NCT04447794|589437486|FG001|Overall Study|Withdrawal by Subject|1|||
163197134|NCT04447794|589437487|FG002|Overall Study|Withdrawal by Subject|0|||
163197135|NCT00205881|589437492|FG000|Overall Study|Withdrawal by Subject|16|||
163197136|NCT04203498|589437495|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
163197137|NCT04203498|589437496|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
163197138|NCT04203498|589437495|FG000|Overall Study|Withdrawal of patient consent|7|||
163197139|NCT04203498|589437496|FG001|Overall Study|Withdrawal of patient consent|2|||
163197140|NCT04203498|589437495|FG000|Overall Study|Adverse Event|4|||
163197141|NCT04203498|589437496|FG001|Overall Study|Adverse Event|1|||
163197142|NCT04203498|589437495|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
163197143|NCT04203498|589437496|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
163197144|NCT04203498|589437495|FG000|Overall Study|Did not receive IMP|2|||
163197145|NCT04203498|589437496|FG001|Overall Study|Did not receive IMP|0|||
163197146|NCT00334958|589437498|FG000|Overall Study|Medication Noncompliance|0|||
163197147|NCT00334958|589437499|FG001|Overall Study|Medication Noncompliance|3|||
163197148|NCT00334958|589437498|FG000|Overall Study|Protocol Violation|2|||
163197149|NCT00334958|589437499|FG001|Overall Study|Protocol Violation|2|||
163303280|NCT02539225|589817704|FG000|Pre Treatment for Part B|Progressive disease|1|||
163197150|NCT00334958|589437498|FG000|Overall Study|Request of the investigator or sponsor|0|||
163197151|NCT00334958|589437499|FG001|Overall Study|Request of the investigator or sponsor|1|||
163197152|NCT00334958|589437498|FG000|Overall Study|Withdrawal by Subject|7|||
163303281|NCT02539225|589817705|FG001|Pre Treatment for Part B|Progressive disease|1|||
163197153|NCT00334958|589437499|FG001|Overall Study|Withdrawal by Subject|4|||
163197154|NCT00334958|589437498|FG000|Overall Study|Adverse Event|27|||
163197155|NCT00334958|589437499|FG001|Overall Study|Adverse Event|12|||
163197156|NCT00334958|589437498|FG000|Overall Study|Other|1|||
163197157|NCT00334958|589437499|FG001|Overall Study|Other|2|||
163197158|NCT01548287|589437500|FG000|Screening|No reason provided|0|||
163197159|NCT01548287|589437501|FG001|Screening|No reason provided|0|||
163303282|NCT02539225|589817704|FG000|Pre Treatment for Part B|Adverse Event|1|||
163303283|NCT02539225|589817705|FG001|Pre Treatment for Part B|Adverse Event|1|||
163303284|NCT02539225|589817704|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
163303285|NCT02539225|589817705|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
163303286|NCT02539225|589817704|FG000|Pre Treatment for Part B|Physician Decision|2|||
163303287|NCT02539225|589817705|FG001|Pre Treatment for Part B|Physician Decision|0|||
163303288|NCT02539225|589817704|FG000|Part B|Adverse Event|4|||
163303289|NCT02539225|589817705|FG001|Part B|Adverse Event|4|||
163303290|NCT02539225|589817704|FG000|Part B|Withdrawal by Subject|0|||
163303291|NCT02539225|589817705|FG001|Part B|Withdrawal by Subject|3|||
163303292|NCT02539225|589817704|FG000|Part B|Physician Decision|0|||
163303293|NCT02539225|589817705|FG001|Part B|Physician Decision|9|||
163303294|NCT03101371|589817710|FG000|Overall Study|Physician Decision|0|||
163303295|NCT03101371|589817711|FG001|Overall Study|Physician Decision|1|||
163303296|NCT03101371|589817710|FG000|Overall Study|Lost to Follow-up|1|||
163303297|NCT03101371|589817711|FG001|Overall Study|Lost to Follow-up|4|||
163303298|NCT03101371|589817710|FG000|Overall Study|Did not meet eligibility criteria|2|||
163303299|NCT03101371|589817711|FG001|Overall Study|Did not meet eligibility criteria|1|||
163303300|NCT01094184|589817715|FG000|Overall Study|Death|35|||
163303301|NCT01094184|589817716|FG001|Overall Study|Death|11|||
163303302|NCT02318134|589817717|FG000|Overall Study|Withdrawal by Subject|2|||
163303303|NCT02318134|589817718|FG001|Overall Study|Withdrawal by Subject|1|||
163303304|NCT03988842|589817719|FG000|Overall Study|Death|1|||
163303305|NCT04766034|589817720|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
163303306|NCT04766034|589817721|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
163303307|NCT04766034|589817722|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
163303308|NCT04766034|589817723|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
163303309|NCT04766034|589817724|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
162961095|NCT01808651|588560713|FG002|Study Period 1|Adverse Event|1|||
162961096|NCT01808651|588560711|FG000|Study Period 1|Participant Decision|9|||
162961097|NCT01808651|588560712|FG001|Study Period 1|Participant Decision|7|||
162961098|NCT01808651|588560713|FG002|Study Period 1|Participant Decision|3|||
162961099|NCT00841542|588560717|FG000|Period 1|Adverse Event|1|||
162961100|NCT00841542|588560718|FG001|Period 1|Adverse Event|0|||
162961101|NCT04345653|588560719|FG000|Overall Study|Withdrawal by Subject|2|||
162961102|NCT03214588|588560720|FG000|Overall Study|Adverse Event|1|||
162961103|NCT03214588|588560721|FG001|Overall Study|Adverse Event|0|||
162961104|NCT03214588|588560722|FG002|Overall Study|Adverse Event|2|||
162961105|NCT03214588|588560720|FG000|Overall Study|Reason Not Specified|0|||
162961106|NCT03214588|588560721|FG001|Overall Study|Reason Not Specified|1|||
162961107|NCT03214588|588560722|FG002|Overall Study|Reason Not Specified|0|||
162961108|NCT04631562|588560725|FG000|Overall Study|Withdrawal by Subject|0|||
162961109|NCT04631562|588560726|FG001|Overall Study|Withdrawal by Subject|0|||
162961110|NCT04631562|588560727|FG002|Overall Study|Withdrawal by Subject|0|||
162961111|NCT04631562|588560728|FG003|Overall Study|Withdrawal by Subject|0|||
162961112|NCT04631562|588560729|FG004|Overall Study|Withdrawal by Subject|0|||
162961113|NCT04631562|588560730|FG005|Overall Study|Withdrawal by Subject|0|||
162961114|NCT04631562|588560731|FG006|Overall Study|Withdrawal by Subject|0|||
162961115|NCT04631562|588560732|FG007|Overall Study|Withdrawal by Subject|1|||
162961116|NCT04631562|588560733|FG008|Overall Study|Withdrawal by Subject|0|||
162961117|NCT04631562|588560725|FG000|Overall Study|Other|0|||
162961118|NCT04631562|588560726|FG001|Overall Study|Other|0|||
162961119|NCT04631562|588560727|FG002|Overall Study|Other|0|||
162961120|NCT04631562|588560728|FG003|Overall Study|Other|0|||
162961121|NCT04631562|588560729|FG004|Overall Study|Other|0|||
162961122|NCT04631562|588560730|FG005|Overall Study|Other|0|||
162961123|NCT04631562|588560731|FG006|Overall Study|Other|0|||
162961124|NCT04631562|588560732|FG007|Overall Study|Other|0|||
162961125|NCT04631562|588560733|FG008|Overall Study|Other|1|||
162961126|NCT04631562|588560725|FG000|Overall Study|Lost to Follow-up|0|||
162961127|NCT04631562|588560726|FG001|Overall Study|Lost to Follow-up|0|||
162961128|NCT04631562|588560727|FG002|Overall Study|Lost to Follow-up|0|||
162961129|NCT04631562|588560728|FG003|Overall Study|Lost to Follow-up|1|||
162961130|NCT04631562|588560729|FG004|Overall Study|Lost to Follow-up|0|||
162961131|NCT04631562|588560730|FG005|Overall Study|Lost to Follow-up|0|||
162961132|NCT04631562|588560731|FG006|Overall Study|Lost to Follow-up|0|||
162961133|NCT04631562|588560732|FG007|Overall Study|Lost to Follow-up|0|||
162961134|NCT04631562|588560733|FG008|Overall Study|Lost to Follow-up|0|||
162961135|NCT04631562|588560725|FG000|Overall Study|Adverse Event|0|||
162961136|NCT04631562|588560726|FG001|Overall Study|Adverse Event|0|||
162961137|NCT04631562|588560727|FG002|Overall Study|Adverse Event|0|||
162961138|NCT04631562|588560728|FG003|Overall Study|Adverse Event|0|||
162961139|NCT04631562|588560729|FG004|Overall Study|Adverse Event|0|||
162961140|NCT04631562|588560730|FG005|Overall Study|Adverse Event|0|||
162961141|NCT04631562|588560731|FG006|Overall Study|Adverse Event|1|||
162961142|NCT04631562|588560732|FG007|Overall Study|Adverse Event|0|||
162961143|NCT04631562|588560733|FG008|Overall Study|Adverse Event|0|||
163197160|NCT01548287|589437502|FG002|Screening|No reason provided|0|||
163197161|NCT01548287|589437503|FG003|Screening|No reason provided|0|||
163197162|NCT01548287|589437504|FG004|Screening|No reason provided|9|||
163197163|NCT01548287|589437500|FG000|Screening|Did not meet eligibility criteria|0|||
162961144|NCT03503318|588560736|FG000|Overall Study|Death|1|||
162961145|NCT03503318|588560737|FG001|Overall Study|Death|0|||
162961146|NCT03503318|588560738|FG002|Overall Study|Death|4|||
162961147|NCT03503318|588560736|FG000|Overall Study|Adverse Event|3|||
162961148|NCT03503318|588560737|FG001|Overall Study|Adverse Event|4|||
162961149|NCT03503318|588560738|FG002|Overall Study|Adverse Event|2|||
162961150|NCT03503318|588560736|FG000|Overall Study|Withdrawal by Subject|12|||
162961151|NCT03503318|588560737|FG001|Overall Study|Withdrawal by Subject|17|||
163197164|NCT01548287|589437501|FG001|Screening|Did not meet eligibility criteria|0|||
163197165|NCT01548287|589437502|FG002|Screening|Did not meet eligibility criteria|0|||
163197166|NCT01548287|589437503|FG003|Screening|Did not meet eligibility criteria|0|||
163197167|NCT01548287|589437504|FG004|Screening|Did not meet eligibility criteria|74|||
162961152|NCT03503318|588560738|FG002|Overall Study|Withdrawal by Subject|16|||
162961153|NCT03503318|588560736|FG000|Overall Study|Protocol Violation|5|||
162961154|NCT03503318|588560737|FG001|Overall Study|Protocol Violation|0|||
162961155|NCT03503318|588560738|FG002|Overall Study|Protocol Violation|3|||
162961156|NCT03503318|588560736|FG000|Overall Study|Lost to Follow-up|17|||
162961157|NCT03503318|588560737|FG001|Overall Study|Lost to Follow-up|15|||
162961158|NCT03503318|588560738|FG002|Overall Study|Lost to Follow-up|12|||
162961159|NCT03503318|588560736|FG000|Overall Study|Other than specified|1|||
162961160|NCT03503318|588560737|FG001|Overall Study|Other than specified|3|||
163197168|NCT01548287|589437500|FG000|Randomized Period|Did not meet inclusion criteria|0|||
163303310|NCT04766034|589817720|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
163303311|NCT04766034|589817721|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
163303312|NCT04766034|589817722|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
163303313|NCT04766034|589817723|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
163303314|NCT04766034|589817724|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
163303315|NCT04766034|589817720|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
163303316|NCT04766034|589817721|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
163395350|NCT00041080|590158609|FG001|Overall Study|Withdrawal by Subject|6|||
163395351|NCT00041080|590158608|FG000|Overall Study|Concommitant Illness/Other|1|||
163395352|NCT00041080|590158609|FG001|Overall Study|Concommitant Illness/Other|2|||
163395353|NCT00041080|590158608|FG000|Overall Study|Did not start therapy|1|||
163395354|NCT00041080|590158609|FG001|Overall Study|Did not start therapy|1|||
163395355|NCT00041080|590158608|FG000|Overall Study|Ineligible|1|||
163395356|NCT00041080|590158609|FG001|Overall Study|Ineligible|0|||
163395357|NCT00210184|590158610|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
163395358|NCT03198520|590158611|FG000|Overall Study|Physician Decision|2|||
163395359|NCT03198520|590158611|FG000|Overall Study|Protocol Violation|2|||
163395360|NCT03198520|590158611|FG000|Overall Study|Withdrawal by Subject|1|||
163395361|NCT03198520|590158611|FG000|Overall Study|Study Ended|1|||
163395362|NCT01338415|590158612|FG000|Core + Extension|Adverse Event|8|||
163395363|NCT01338415|590158613|FG001|Core + Extension|Adverse Event|6|||
163395364|NCT01338415|590158614|FG002|Core + Extension|Adverse Event|0|||
163395365|NCT01338415|590158612|FG000|Core + Extension|Withdrawal by Subject|1|||
163395366|NCT01338415|590158613|FG001|Core + Extension|Withdrawal by Subject|1|||
163395367|NCT01338415|590158614|FG002|Core + Extension|Withdrawal by Subject|0|||
163395368|NCT01338415|590158612|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
163395369|NCT01338415|590158613|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
163395370|NCT01338415|590158614|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
163395371|NCT01338415|590158612|FG000|Core + Extension|Other (administrative reason)|1|||
162961161|NCT03503318|588560738|FG002|Overall Study|Other than specified|3|||
162961162|NCT02139826|588560741|FG000|Overall Study|Adverse Event|1|||
162961163|NCT03498560|588560743|FG000|Overall Study|Found Ineligible|2|||
162961164|NCT03498560|588560743|FG000|Overall Study|Withdrawal by Subject|14|||
162961165|NCT03498560|588560743|FG000|Overall Study|Lost to Follow-up|4|||
162961166|NCT03498560|588560743|FG000|Overall Study|Death|1|||
162961167|NCT00867360|588560744|FG000|Overall Study|Withdrawal by Subject|1|||
162961168|NCT00867360|588560745|FG001|Overall Study|Withdrawal by Subject|0|||
162961169|NCT00867360|588560744|FG000|Overall Study|Physician Decision|0|||
162961170|NCT00867360|588560745|FG001|Overall Study|Physician Decision|1|||
163047355|NCT05219968|588879464|FG003|Safety Extension Period|Bilateral dislodgement|0|||
163047356|NCT05219968|588879465|FG004|Safety Extension Period|Bilateral dislodgement|1|||
163047357|NCT05219968|588879461|FG000|Safety Extension Period|Withdrawal by Subject|0|||
163047358|NCT05219968|588879462|FG001|Safety Extension Period|Withdrawal by Subject|0|||
163047359|NCT05219968|588879463|FG002|Safety Extension Period|Withdrawal by Subject|2|||
163047360|NCT05219968|588879464|FG003|Safety Extension Period|Withdrawal by Subject|0|||
163047361|NCT05219968|588879465|FG004|Safety Extension Period|Withdrawal by Subject|4|||
163047362|NCT05219968|588879461|FG000|Safety Extension Period|Adverse Event|0|||
163047363|NCT05219968|588879462|FG001|Safety Extension Period|Adverse Event|0|||
163047364|NCT05219968|588879463|FG002|Safety Extension Period|Adverse Event|2|||
163047365|NCT05219968|588879464|FG003|Safety Extension Period|Adverse Event|1|||
163047366|NCT05219968|588879465|FG004|Safety Extension Period|Adverse Event|1|||
163047367|NCT05219968|588879461|FG000|Safety Extension Period|Lost to Follow-up|0|||
163047368|NCT05219968|588879462|FG001|Safety Extension Period|Lost to Follow-up|0|||
163047369|NCT05219968|588879463|FG002|Safety Extension Period|Lost to Follow-up|0|||
163047370|NCT05219968|588879464|FG003|Safety Extension Period|Lost to Follow-up|1|||
163047371|NCT05219968|588879465|FG004|Safety Extension Period|Lost to Follow-up|0|||
163047372|NCT03877224|588879466|FG000|Overall Study|Death|3|||
163047373|NCT03877224|588879467|FG001|Overall Study|Death|2|||
163047374|NCT03877224|588879466|FG000|Overall Study|Withdrawal by Subject|1|||
163047375|NCT03877224|588879467|FG001|Overall Study|Withdrawal by Subject|6|||
163047376|NCT03877224|588879466|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
163047377|NCT03877224|588879467|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
163047378|NCT04587336|588879470|FG000|Overall Study|Lost to Follow-up|1|||
163047379|NCT04587336|588879471|FG001|Overall Study|Lost to Follow-up|0|||
163047380|NCT01212094|588881116|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
163047381|NCT01212094|588881117|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
163047382|NCT01212094|588881118|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
163047383|NCT01212094|588881116|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
163197169|NCT01548287|589437501|FG001|Randomized Period|Did not meet inclusion criteria|0|||
163197170|NCT01548287|589437502|FG002|Randomized Period|Did not meet inclusion criteria|2|||
163197171|NCT01548287|589437503|FG003|Randomized Period|Did not meet inclusion criteria|0|||
163197172|NCT01548287|589437504|FG004|Randomized Period|Did not meet inclusion criteria|0|||
163197173|NCT01548287|589437500|FG000|Randomized Period|Adverse Event|0|||
163197174|NCT01548287|589437501|FG001|Randomized Period|Adverse Event|2|||
163197175|NCT01548287|589437502|FG002|Randomized Period|Adverse Event|5|||
163197176|NCT01548287|589437503|FG003|Randomized Period|Adverse Event|0|||
163197177|NCT01548287|589437504|FG004|Randomized Period|Adverse Event|0|||
163197178|NCT02762578|589437509|FG000|Overall Study|Adverse Event|1|||
163197179|NCT02762578|589437510|FG001|Overall Study|Adverse Event|6|||
163197180|NCT02762578|589437509|FG000|Overall Study|Protocol Violation|4|||
163197181|NCT02762578|589437510|FG001|Overall Study|Protocol Violation|2|||
163197182|NCT02762578|589437509|FG000|Overall Study|Withdrawal by Subject|4|||
163197183|NCT02762578|589437510|FG001|Overall Study|Withdrawal by Subject|2|||
163197184|NCT02762578|589437509|FG000|Overall Study|Unclassified|6|||
163197185|NCT02762578|589437510|FG001|Overall Study|Unclassified|0|||
163197186|NCT01090492|589437511|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
163197187|NCT01090492|589437512|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
163197188|NCT01090492|589437513|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
163197189|NCT01090492|589437514|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
163197190|NCT01090492|589437515|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
163197191|NCT01090492|589437516|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
163197192|NCT01090492|589437517|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
163197193|NCT01090492|589437518|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
163197194|NCT01090492|589437511|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
163197195|NCT01090492|589437512|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
163197196|NCT01090492|589437513|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
163197197|NCT01090492|589437514|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
163197198|NCT01090492|589437515|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
163197199|NCT01090492|589437516|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
163197200|NCT01090492|589437517|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
163047384|NCT01212094|588881117|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
163047385|NCT01212094|588881118|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
163047386|NCT01212094|588881116|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
163047387|NCT01212094|588881117|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
163047388|NCT01212094|588881118|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
163047389|NCT01212094|588881116|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
163047390|NCT01212094|588881117|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
163047391|NCT01212094|588881118|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
163047392|NCT01212094|588881116|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
163047393|NCT01212094|588881117|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
163047394|NCT01212094|588881118|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
163047395|NCT01212094|588881116|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
163047396|NCT01212094|588881117|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
163047397|NCT01212094|588881118|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
163047398|NCT05664581|588881122|FG000|Overall Study|Withdrawal by Subject|2|||
163047399|NCT03101150|588881123|FG000|Overall Study|Lost to Follow-up|2|||
163047400|NCT03101150|588881124|FG001|Overall Study|Lost to Follow-up|4|||
163047401|NCT03101150|588881123|FG000|Overall Study|Miscarriage|3|||
163047402|NCT03101150|588881124|FG001|Overall Study|Miscarriage|6|||
163047403|NCT01317641|588881128|FG000|Overall Study|Not treated|0|||
163197201|NCT01090492|589437518|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
163197202|NCT01090492|589437511|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
163197203|NCT01090492|589437512|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
163197204|NCT01090492|589437513|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
163197205|NCT01090492|589437514|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
163197206|NCT01090492|589437515|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
163047404|NCT01317641|588881129|FG001|Overall Study|Not treated|0|||
163047405|NCT01317641|588881130|FG002|Overall Study|Not treated|0|||
163047406|NCT01317641|588881131|FG003|Overall Study|Not treated|0|||
163047407|NCT01317641|588881132|FG004|Overall Study|Not treated|0|||
163047408|NCT01317641|588881133|FG005|Overall Study|Not treated|0|||
163047409|NCT01317641|588881134|FG006|Overall Study|Not treated|0|||
163047410|NCT01317641|588881135|FG007|Overall Study|Not treated|1|||
163047411|NCT01317641|588881136|FG008|Overall Study|Not treated|1|||
163047412|NCT01317641|588881128|FG000|Overall Study|Adverse Event|0|||
163047413|NCT01317641|588881129|FG001|Overall Study|Adverse Event|1|||
163047414|NCT01317641|588881130|FG002|Overall Study|Adverse Event|0|||
163047415|NCT01317641|588881131|FG003|Overall Study|Adverse Event|1|||
163047416|NCT01317641|588881132|FG004|Overall Study|Adverse Event|0|||
163047417|NCT01317641|588881133|FG005|Overall Study|Adverse Event|0|||
163047418|NCT01317641|588881134|FG006|Overall Study|Adverse Event|2|||
163047419|NCT01317641|588881135|FG007|Overall Study|Adverse Event|1|||
163047420|NCT01317641|588881136|FG008|Overall Study|Adverse Event|0|||
163047421|NCT01317641|588881128|FG000|Overall Study|Protocol Violation|1|||
163047422|NCT01317641|588881129|FG001|Overall Study|Protocol Violation|0|||
163047423|NCT01317641|588881130|FG002|Overall Study|Protocol Violation|0|||
163047424|NCT01317641|588881131|FG003|Overall Study|Protocol Violation|0|||
163047425|NCT01317641|588881132|FG004|Overall Study|Protocol Violation|0|||
163047426|NCT01317641|588881133|FG005|Overall Study|Protocol Violation|0|||
163047427|NCT01317641|588881134|FG006|Overall Study|Protocol Violation|0|||
163047428|NCT01317641|588881135|FG007|Overall Study|Protocol Violation|0|||
163047429|NCT01317641|588881136|FG008|Overall Study|Protocol Violation|0|||
162961171|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
162961172|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
162961173|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
162961174|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
162961175|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
162961176|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
163047430|NCT01317641|588881128|FG000|Overall Study|Disease progression|0|||
163047431|NCT01317641|588881129|FG001|Overall Study|Disease progression|0|||
163303317|NCT04766034|589817722|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
162961177|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961178|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961179|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961180|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961181|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
163047432|NCT01317641|588881130|FG002|Overall Study|Disease progression|0|||
163047433|NCT01317641|588881131|FG003|Overall Study|Disease progression|0|||
163047434|NCT01317641|588881132|FG004|Overall Study|Disease progression|0|||
163047435|NCT01317641|588881133|FG005|Overall Study|Disease progression|0|||
163047436|NCT01317641|588881134|FG006|Overall Study|Disease progression|0|||
163047437|NCT01317641|588881135|FG007|Overall Study|Disease progression|3|||
163047438|NCT01317641|588881136|FG008|Overall Study|Disease progression|4|||
163047439|NCT01317641|588881128|FG000|Overall Study|Withdrawal by Subject|0|||
163047440|NCT01317641|588881129|FG001|Overall Study|Withdrawal by Subject|0|||
163047441|NCT01317641|588881130|FG002|Overall Study|Withdrawal by Subject|0|||
163047442|NCT01317641|588881131|FG003|Overall Study|Withdrawal by Subject|0|||
163047443|NCT01317641|588881132|FG004|Overall Study|Withdrawal by Subject|0|||
163047444|NCT01317641|588881133|FG005|Overall Study|Withdrawal by Subject|0|||
163047445|NCT01317641|588881134|FG006|Overall Study|Withdrawal by Subject|1|||
163047446|NCT01317641|588881135|FG007|Overall Study|Withdrawal by Subject|0|||
163047447|NCT01317641|588881136|FG008|Overall Study|Withdrawal by Subject|0|||
163047448|NCT00329108|588881137|FG000|Overall Study|Adverse Event|2|||
163047449|NCT00329108|588881138|FG001|Overall Study|Adverse Event|2|||
163047450|NCT00329108|588881137|FG000|Overall Study|Lack of Efficacy|3|||
163047451|NCT00329108|588881138|FG001|Overall Study|Lack of Efficacy|3|||
163047452|NCT00329108|588881137|FG000|Overall Study|Withdrawal by Subject|0|||
163047453|NCT00329108|588881138|FG001|Overall Study|Withdrawal by Subject|2|||
163047454|NCT00329108|588881137|FG000|Overall Study|symptomatic deterioration|1|||
163047455|NCT00329108|588881138|FG001|Overall Study|symptomatic deterioration|1|||
163047456|NCT00329108|588881137|FG000|Overall Study|Subject no longer willing to participate|2|||
163047457|NCT00329108|588881138|FG001|Overall Study|Subject no longer willing to participate|2|||
163047458|NCT00329108|588881137|FG000|Overall Study|study terminated by sponsor|1|||
163047459|NCT00329108|588881138|FG001|Overall Study|study terminated by sponsor|0|||
163047460|NCT00329108|588881137|FG000|Overall Study|withdrew patient after SAE resolved|1|||
163047461|NCT00329108|588881138|FG001|Overall Study|withdrew patient after SAE resolved|0|||
163047462|NCT00329108|588881137|FG000|Overall Study|Protocol Violation|0|||
163047463|NCT00329108|588881138|FG001|Overall Study|Protocol Violation|2|||
163047464|NCT01302418|588881139|FG000|Overall Study|Protocol Violation|9|||
163047465|NCT01302418|588881139|FG000|Overall Study|Non-evaluable|9|||
163047466|NCT02787304|588881144|FG000|Overall Study|Adverse Event|9|||
163047467|NCT02787304|588881145|FG001|Overall Study|Adverse Event|3|||
163047468|NCT02787304|588881146|FG002|Overall Study|Adverse Event|8|||
163047469|NCT02787304|588881147|FG003|Overall Study|Adverse Event|1|||
163047470|NCT02787304|588881144|FG000|Overall Study|Withdrawal by Subject|1|||
163047471|NCT02787304|588881145|FG001|Overall Study|Withdrawal by Subject|4|||
163047472|NCT02787304|588881146|FG002|Overall Study|Withdrawal by Subject|0|||
163047473|NCT02787304|588881147|FG003|Overall Study|Withdrawal by Subject|0|||
163047474|NCT02787304|588881144|FG000|Overall Study|Lost to Follow-up|1|||
163047475|NCT02787304|588881145|FG001|Overall Study|Lost to Follow-up|0|||
163047476|NCT02787304|588881146|FG002|Overall Study|Lost to Follow-up|0|||
163047477|NCT02787304|588881147|FG003|Overall Study|Lost to Follow-up|1|||
163047478|NCT02787304|588881144|FG000|Overall Study|Noncompliance with study drug|0|||
163047479|NCT02787304|588881145|FG001|Overall Study|Noncompliance with study drug|0|||
163047480|NCT02787304|588881146|FG002|Overall Study|Noncompliance with study drug|1|||
163047481|NCT02787304|588881147|FG003|Overall Study|Noncompliance with study drug|0|||
163047482|NCT02787304|588881144|FG000|Overall Study|Physician Decision|0|||
163047483|NCT02787304|588881145|FG001|Overall Study|Physician Decision|0|||
163047484|NCT02787304|588881146|FG002|Overall Study|Physician Decision|1|||
163047485|NCT02787304|588881147|FG003|Overall Study|Physician Decision|0|||
163047486|NCT02787304|588881144|FG000|Overall Study|Study terminated by sponsor|25|||
163047487|NCT02787304|588881145|FG001|Overall Study|Study terminated by sponsor|31|||
163047488|NCT02787304|588881146|FG002|Overall Study|Study terminated by sponsor|31|||
163047489|NCT02787304|588881147|FG003|Overall Study|Study terminated by sponsor|32|||
163047490|NCT04771013|588881149|FG000|Overall Study|Withdrawal by Subject|2|||
163047491|NCT04771013|588881150|FG001|Overall Study|Withdrawal by Subject|0|||
163047492|NCT04771013|588881149|FG000|Overall Study|Death|0|||
163047493|NCT04771013|588881150|FG001|Overall Study|Death|5|||
163047494|NCT04771013|588881149|FG000|Overall Study|Referred to another hospital before day 20|0|||
163047495|NCT04771013|588881150|FG001|Overall Study|Referred to another hospital before day 20|1|||
163047496|NCT01051921|588881152|FG000|Overall Study|Physician Decision|9|||
163395372|NCT01338415|590158613|FG001|Core + Extension|Other (administrative reason)|0|||
162961182|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961183|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961184|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961185|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961186|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961187|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961188|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961189|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961190|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961191|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961192|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961193|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961194|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
163047497|NCT01051921|588881152|FG000|Overall Study|Adverse Event|8|||
163047498|NCT01051921|588881152|FG000|Overall Study|Withdrawal by Subject|7|||
163047499|NCT01051921|588881152|FG000|Overall Study|Lost to Follow-up|4|||
163047500|NCT01051921|588881152|FG000|Overall Study|virological failure|1|||
163047501|NCT01051921|588881152|FG000|Overall Study|patient moved|1|||
163047502|NCT00379834|588881153|FG000|Overall Study|Time constraints|2|||
163047503|NCT01519817|588881154|FG000|Overall Study|Withdrawal by Subject|1|||
163047504|NCT01519817|588881155|FG001|Overall Study|Withdrawal by Subject|0|||
163303318|NCT04766034|589817723|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
162961195|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961196|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961197|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961198|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
162961199|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961200|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961201|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961202|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961203|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961204|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961205|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961206|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961207|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961208|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961209|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961210|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961211|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961212|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961213|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961214|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961215|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961216|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961217|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961218|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961219|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961220|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961221|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961222|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961223|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961224|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
162961225|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961226|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961227|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961228|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961229|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961230|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961231|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961232|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961233|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961234|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961235|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961236|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961237|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961238|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961239|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961240|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961241|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961242|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961243|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961244|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961245|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961246|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961247|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961248|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
163318907|NCT05485779|589878806|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
163047505|NCT01519817|588881156|FG002|Overall Study|Withdrawal by Subject|0|||
163047506|NCT01519817|588881157|FG003|Overall Study|Withdrawal by Subject|0|||
163047507|NCT01519817|588881154|FG000|Overall Study|Off study due to infection|0|||
163047508|NCT01519817|588881155|FG001|Overall Study|Off study due to infection|0|||
163047509|NCT01519817|588881156|FG002|Overall Study|Off study due to infection|0|||
163047510|NCT01519817|588881157|FG003|Overall Study|Off study due to infection|1|||
163047511|NCT01716806|588881160|FG000|Overall Study|Patient withdrawal of consent|4|||
163047512|NCT01716806|588881161|FG001|Overall Study|Patient withdrawal of consent|2|||
163047513|NCT01716806|588881162|FG002|Overall Study|Patient withdrawal of consent|4|||
163047514|NCT01716806|588881163|FG003|Overall Study|Patient withdrawal of consent|3|||
163047515|NCT01716806|588881164|FG004|Overall Study|Patient withdrawal of consent|2|||
163047516|NCT01716806|588881165|FG005|Overall Study|Patient withdrawal of consent|0|||
163047517|NCT01716806|588881160|FG000|Overall Study|Lost to Follow-up|3|||
163047518|NCT01716806|588881161|FG001|Overall Study|Lost to Follow-up|3|||
163047519|NCT01716806|588881162|FG002|Overall Study|Lost to Follow-up|0|||
163047520|NCT01716806|588881163|FG003|Overall Study|Lost to Follow-up|2|||
163395373|NCT01338415|590158614|FG002|Core + Extension|Other (administrative reason)|0|||
163047521|NCT01716806|588881164|FG004|Overall Study|Lost to Follow-up|1|||
163047522|NCT01716806|588881165|FG005|Overall Study|Lost to Follow-up|0|||
163047523|NCT01716806|588881160|FG000|Overall Study|Death|13|||
163197207|NCT01090492|589437516|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
163197208|NCT01090492|589437517|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
163197209|NCT01090492|589437518|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
163197210|NCT01090492|589437511|FG000|First Intervention Period (4 Weeks)|Other|0|||
163197211|NCT01090492|589437512|FG001|First Intervention Period (4 Weeks)|Other|0|||
163047524|NCT01716806|588881161|FG001|Overall Study|Death|9|||
163047525|NCT01716806|588881162|FG002|Overall Study|Death|12|||
163047526|NCT01716806|588881163|FG003|Overall Study|Death|4|||
163047527|NCT01716806|588881164|FG004|Overall Study|Death|10|||
163047528|NCT01716806|588881165|FG005|Overall Study|Death|5|||
163047529|NCT01716806|588881160|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
163047530|NCT01716806|588881161|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
163047531|NCT01716806|588881162|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
163047532|NCT01716806|588881163|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
163047533|NCT01716806|588881164|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
163197212|NCT01090492|589437513|FG002|First Intervention Period (4 Weeks)|Other|1|||
163395374|NCT01338415|590158612|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
163395375|NCT01338415|590158613|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
163395376|NCT01338415|590158614|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
163395377|NCT01338415|590158612|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
162961249|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
162961250|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961251|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
162961252|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
162961253|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
162961254|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961255|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961256|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961257|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961258|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961259|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961260|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961261|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961262|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961263|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961264|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961265|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961266|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961267|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961268|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961269|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961270|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961271|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961272|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961273|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961274|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
163197213|NCT01090492|589437514|FG003|First Intervention Period (4 Weeks)|Other|1|||
162961275|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
163047534|NCT01716806|588881165|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
163047535|NCT01716806|588881160|FG000|Overall Study|PI decision|0|||
163047536|NCT01716806|588881161|FG001|Overall Study|PI decision|0|||
163047537|NCT01716806|588881162|FG002|Overall Study|PI decision|0|||
163047538|NCT01716806|588881163|FG003|Overall Study|PI decision|0|||
163047539|NCT01716806|588881164|FG004|Overall Study|PI decision|1|||
163047540|NCT01716806|588881165|FG005|Overall Study|PI decision|0|||
163047541|NCT01716806|588881160|FG000|Overall Study|Change in performance status|1|||
163047542|NCT01716806|588881161|FG001|Overall Study|Change in performance status|0|||
163047543|NCT01716806|588881162|FG002|Overall Study|Change in performance status|0|||
163047544|NCT01716806|588881163|FG003|Overall Study|Change in performance status|0|||
163047545|NCT01716806|588881164|FG004|Overall Study|Change in performance status|0|||
163047546|NCT01716806|588881165|FG005|Overall Study|Change in performance status|0|||
163047547|NCT01716806|588881160|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
163047548|NCT01716806|588881161|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
163047549|NCT01716806|588881162|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
163047550|NCT01716806|588881163|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
163047551|NCT01716806|588881164|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
163047552|NCT01716806|588881165|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
163047553|NCT01716806|588881160|FG000|Overall Study|Sponsor direction|7|||
163047554|NCT01716806|588881161|FG001|Overall Study|Sponsor direction|8|||
163047555|NCT01716806|588881162|FG002|Overall Study|Sponsor direction|5|||
163047556|NCT01716806|588881163|FG003|Overall Study|Sponsor direction|12|||
163047557|NCT01716806|588881164|FG004|Overall Study|Sponsor direction|16|||
163047558|NCT01716806|588881165|FG005|Overall Study|Sponsor direction|1|||
163047559|NCT02498678|588881169|FG000|Overall Study|interference from the surgical team|0|||
163047560|NCT02498678|588881170|FG001|Overall Study|interference from the surgical team|2|||
163047561|NCT01145482|588881171|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
163047562|NCT01145482|588881172|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
163047563|NCT04547140|588881173|FG000|Overall Study|Adverse Event|0|||
163047564|NCT04547140|588881174|FG001|Overall Study|Adverse Event|1|||
163047565|NCT04547140|588881173|FG000|Overall Study|Withdrawal by Subject|0|||
163047566|NCT04547140|588881174|FG001|Overall Study|Withdrawal by Subject|1|||
163047567|NCT04547140|588881173|FG000|Overall Study|Lost to Follow-up|3|||
163047568|NCT04547140|588881174|FG001|Overall Study|Lost to Follow-up|1|||
163047569|NCT04547140|588881173|FG000|Overall Study|Death|2|||
163047570|NCT04547140|588881174|FG001|Overall Study|Death|1|||
163047571|NCT04547140|588881173|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
163047572|NCT04547140|588881174|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
163047573|NCT04547140|588881173|FG000|Overall Study|Pregnancy|1|||
163047574|NCT04547140|588881174|FG001|Overall Study|Pregnancy|0|||
163047575|NCT04547140|588881173|FG000|Overall Study|Reason Not Specified|4|||
163197214|NCT01090492|589437515|FG004|First Intervention Period (4 Weeks)|Other|2|||
163047576|NCT04547140|588881174|FG001|Overall Study|Reason Not Specified|1|||
163047577|NCT04613739|588881175|FG000|Overall Study|Lost to Follow-up|6|||
163047578|NCT04613739|588881176|FG001|Overall Study|Lost to Follow-up|9|||
163047579|NCT04613739|588881175|FG000|Overall Study|potentially duplicative/fraudulent|1|||
163047580|NCT04613739|588881176|FG001|Overall Study|potentially duplicative/fraudulent|3|||
163047581|NCT00048035|588881177|FG000|Core Period|Early Withdrawals|4|||
163047582|NCT00048035|588881178|FG001|Core Period|Early Withdrawals|2|||
163047583|NCT00048035|588881179|FG002|Core Period|Early Withdrawals|1|||
163047584|NCT00048035|588881180|FG003|Core Period|Early Withdrawals|1|||
163047585|NCT00048035|588881181|FG004|Core Period|Early Withdrawals|1|||
163047586|NCT00048035|588881182|FG005|Core Period|Early Withdrawals|1|||
163047587|NCT00048035|588881183|FG006|Core Period|Early Withdrawals|0|||
163047588|NCT00048035|588881184|FG007|Core Period|Early Withdrawals|0|||
163047589|NCT00048035|588881177|FG000|Extension Year 1|Early Withdrawals|0|||
163047590|NCT00048035|588881178|FG001|Extension Year 1|Early Withdrawals|0|||
163047591|NCT00048035|588881179|FG002|Extension Year 1|Early Withdrawals|0|||
163047592|NCT00048035|588881180|FG003|Extension Year 1|Early Withdrawals|0|||
163047593|NCT00048035|588881181|FG004|Extension Year 1|Early Withdrawals|0|||
163047594|NCT00048035|588881182|FG005|Extension Year 1|Early Withdrawals|0|||
163047595|NCT00048035|588881183|FG006|Extension Year 1|Early Withdrawals|11|||
163047596|NCT00048035|588881184|FG007|Extension Year 1|Early Withdrawals|11|||
163047597|NCT00048035|588881177|FG000|Extension Year 2|Early Withdrawals|0|||
163047598|NCT00048035|588881178|FG001|Extension Year 2|Early Withdrawals|0|||
163047599|NCT00048035|588881179|FG002|Extension Year 2|Early Withdrawals|0|||
163047600|NCT00048035|588881180|FG003|Extension Year 2|Early Withdrawals|0|||
163047601|NCT00048035|588881181|FG004|Extension Year 2|Early Withdrawals|0|||
163047602|NCT00048035|588881182|FG005|Extension Year 2|Early Withdrawals|0|||
163197215|NCT01090492|589437516|FG005|First Intervention Period (4 Weeks)|Other|0|||
163197216|NCT01090492|589437517|FG006|First Intervention Period (4 Weeks)|Other|0|||
163197217|NCT01090492|589437518|FG007|First Intervention Period (4 Weeks)|Other|0|||
163047603|NCT00048035|588881183|FG006|Extension Year 2|Early Withdrawals|3|||
163047604|NCT00048035|588881184|FG007|Extension Year 2|Early Withdrawals|3|||
163197218|NCT01090492|589437511|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
163197219|NCT01090492|589437512|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
163047605|NCT05137717|588881185|FG000|Overall Study|Death|2|||
163047606|NCT05137717|588881185|FG000|Overall Study|Withdrawal by Subject|6|||
163047607|NCT02619617|588881186|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
163047608|NCT02619617|588881187|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
163197220|NCT01090492|589437513|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
163197221|NCT01090492|589437514|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
163197222|NCT01090492|589437515|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
163197223|NCT01090492|589437516|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
163197224|NCT01090492|589437517|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
163047609|NCT02619617|588881186|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
163047610|NCT02619617|588881187|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
163047611|NCT00483652|588881192|FG000|Double-blind Treatment Period|Protocol Violation|2|||
163047612|NCT00483652|588881193|FG001|Double-blind Treatment Period|Protocol Violation|1|||
163047613|NCT00483652|588881192|FG000|Double-blind Treatment Period|Adverse Event|3|||
163047614|NCT00483652|588881193|FG001|Double-blind Treatment Period|Adverse Event|4|||
163047615|NCT00483652|588881192|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
163303319|NCT04766034|589817724|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
163303320|NCT04766034|589817720|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
163303321|NCT04766034|589817721|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
163303322|NCT04766034|589817722|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
163303323|NCT04766034|589817723|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
163303324|NCT04766034|589817724|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
163303325|NCT01976312|589817725|FG000|Overall Study|Pregnancy|0|||
163303326|NCT01976312|589817726|FG001|Overall Study|Pregnancy|1|||
163303327|NCT01976312|589817725|FG000|Overall Study|Lost to Follow-up|2|||
163303328|NCT01976312|589817726|FG001|Overall Study|Lost to Follow-up|0|||
163303329|NCT01976312|589817725|FG000|Overall Study|Withdrawal by Subject|7|||
163395378|NCT01338415|590158613|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
163395379|NCT01338415|590158614|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
163395380|NCT01338415|590158612|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
163395381|NCT01338415|590158613|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
163395382|NCT01338415|590158614|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
163047616|NCT00483652|588881193|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
163303330|NCT01976312|589817726|FG001|Overall Study|Withdrawal by Subject|2|||
163395383|NCT01338415|590158612|FG000|Exceptional Use Treatment Period|Death|0|||
163395384|NCT01338415|590158613|FG001|Exceptional Use Treatment Period|Death|0|||
163395385|NCT01338415|590158614|FG002|Exceptional Use Treatment Period|Death|1|||
163395386|NCT01118325|590158615|FG000|Overall Study|Adverse Event|1|||
163395387|NCT01118325|590158616|FG001|Overall Study|Adverse Event|0|||
163395388|NCT01118325|590158617|FG002|Overall Study|Adverse Event|1|||
163395389|NCT00536809|590158618|FG000|Phase II|Adverse Event|1|||
163395390|NCT00536809|590158618|FG000|Phase II|Referred for surgical resection|1|||
163395391|NCT00233363|590158626|FG000|Overall Study|Adverse Event|1|||
163395392|NCT00233363|590158627|FG001|Overall Study|Adverse Event|2|||
163395393|NCT00233363|590158626|FG000|Overall Study|Lack of Efficacy|0|||
163395394|NCT00233363|590158627|FG001|Overall Study|Lack of Efficacy|2|||
163395395|NCT00233363|590158626|FG000|Overall Study|Withdrawal by Subject|1|||
163395396|NCT00233363|590158627|FG001|Overall Study|Withdrawal by Subject|1|||
163395397|NCT00233363|590158626|FG000|Overall Study|Aggravation of complication|1|||
163395398|NCT00233363|590158627|FG001|Overall Study|Aggravation of complication|0|||
163395399|NCT01526551|590158630|FG000|Overall Study|Lack of returned parental consent form|424|||
163395400|NCT00874770|590158631|FG000|Overall Study|Lack of Efficacy|2|||
163395401|NCT00874770|590158632|FG001|Overall Study|Lack of Efficacy|0|||
163303331|NCT01976312|589817725|FG000|Overall Study|Adverse Event|6|||
163303332|NCT01976312|589817726|FG001|Overall Study|Adverse Event|6|||
163303333|NCT01976312|589817725|FG000|Overall Study|Protocol Violation|2|||
163395402|NCT00874770|590158633|FG002|Overall Study|Lack of Efficacy|0|||
163197225|NCT01090492|589437518|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
163197226|NCT01090492|589437511|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
163197227|NCT01090492|589437512|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
163197228|NCT01090492|589437513|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
163197229|NCT01090492|589437514|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
163197230|NCT01090492|589437515|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
163197231|NCT01090492|589437516|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
163197232|NCT01090492|589437517|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
163197233|NCT01090492|589437518|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
163197234|NCT01090492|589437511|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
163197235|NCT01090492|589437512|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
163197236|NCT01090492|589437513|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
163197237|NCT01090492|589437514|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
163197238|NCT01090492|589437515|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
163197239|NCT01090492|589437516|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
163197240|NCT01090492|589437517|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
163197241|NCT01090492|589437518|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
163197242|NCT01090492|589437511|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
163197243|NCT01090492|589437512|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
163197244|NCT01090492|589437513|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
163197245|NCT01090492|589437514|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
163197246|NCT01090492|589437515|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
163197247|NCT01090492|589437516|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
163197248|NCT01090492|589437517|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
163197249|NCT01090492|589437518|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
163197250|NCT01090492|589437511|FG000|Second Intervention Period (4 Weeks)|Other|0|||
163197251|NCT01090492|589437512|FG001|Second Intervention Period (4 Weeks)|Other|1|||
163197252|NCT01090492|589437513|FG002|Second Intervention Period (4 Weeks)|Other|1|||
163197253|NCT01090492|589437514|FG003|Second Intervention Period (4 Weeks)|Other|0|||
163197254|NCT01090492|589437515|FG004|Second Intervention Period (4 Weeks)|Other|0|||
163197255|NCT01090492|589437516|FG005|Second Intervention Period (4 Weeks)|Other|0|||
163197256|NCT01090492|589437517|FG006|Second Intervention Period (4 Weeks)|Other|0|||
163197257|NCT01090492|589437518|FG007|Second Intervention Period (4 Weeks)|Other|0|||
163197258|NCT01090492|589437511|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
163197259|NCT01090492|589437512|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
163197260|NCT01090492|589437513|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
163197261|NCT01090492|589437514|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
163197262|NCT01090492|589437515|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
163197263|NCT01090492|589437516|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
163197264|NCT01090492|589437517|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
163197265|NCT01090492|589437518|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
163197266|NCT01090492|589437511|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
163197267|NCT01090492|589437512|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
163197268|NCT01090492|589437513|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
163197269|NCT01090492|589437514|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
163197270|NCT01090492|589437515|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
163197271|NCT01090492|589437516|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
163197272|NCT01090492|589437517|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
163197273|NCT01090492|589437518|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
163197274|NCT02083965|589437519|FG000|Treatment Period|Other|1|||
163197275|NCT02083965|589437520|FG001|Treatment Period|Other|0|||
163197276|NCT00868608|589437523|FG000|Overall Study|Withdrawal by Subject|3|||
163197277|NCT00868608|589437524|FG001|Overall Study|Withdrawal by Subject|1|||
163197278|NCT00868608|589437525|FG002|Overall Study|Withdrawal by Subject|0|||
163197279|NCT00868608|589437523|FG000|Overall Study|Lost to Follow-up|3|||
162961276|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
162961277|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
162961278|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
162961279|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
162961280|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961281|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961282|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961283|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961284|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961285|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
163197280|NCT00868608|589437524|FG001|Overall Study|Lost to Follow-up|0|||
163197281|NCT00868608|589437525|FG002|Overall Study|Lost to Follow-up|1|||
163197282|NCT00868608|589437523|FG000|Overall Study|Death|16|||
162961286|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961287|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961288|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961289|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961290|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961291|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961292|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961293|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961294|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961295|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961296|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961297|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961298|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961299|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961300|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961301|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|moved|0|||
162961302|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|moved|1|||
162961303|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|moved|1|||
162961304|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|moved|0|||
162961305|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|moved|0|||
162961306|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|moved|0|||
162961307|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|moved|0|||
162961308|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|moved|0|||
162961309|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|moved|0|||
162961310|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|moved|0|||
162961311|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|moved|0|||
162961312|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|moved|0|||
162961313|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|moved|0|||
162961314|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|moved|0|||
162961315|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|moved|0|||
162961316|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|moved|0|||
162961317|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|moved|0|||
162961318|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|moved|0|||
162961319|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|moved|0|||
162961320|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|moved|0|||
162961321|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|moved|0|||
162961322|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|moved|0|||
162961323|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|moved|0|||
162961324|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|moved|0|||
162961325|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|moved|0|||
162961326|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|moved|0|||
162961327|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961328|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961329|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961330|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
162961331|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
163047617|NCT00483652|588881192|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
163047618|NCT00483652|588881193|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
163047619|NCT00891813|588881202|FG000|Overall Study|Adverse Event|3|||
163047620|NCT00891813|588881202|FG000|Overall Study|Withdrawal by Subject|1|||
163047621|NCT00891813|588881202|FG000|Overall Study|Patient Noncompliance|6|||
163047622|NCT00891813|588881202|FG000|Overall Study|Protocol Violation|2|||
163047623|NCT01723072|588881205|FG000|Overall Study|Withdrawal by Subject|7|||
163047624|NCT01723072|588881206|FG001|Overall Study|Withdrawal by Subject|13|||
163047625|NCT01723072|588881205|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
163303334|NCT01976312|589817726|FG001|Overall Study|Protocol Violation|0|||
163303335|NCT02556138|589817727|FG000|Overall Study|Withdrawal by Subject|1|||
163303336|NCT03939312|589817728|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
163303337|NCT03939312|589817728|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
163303338|NCT03939312|589817728|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
163303339|NCT03939312|589817728|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
163303340|NCT03939312|589817728|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
163303341|NCT03939312|589817728|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
163303342|NCT03939312|589817728|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
163303343|NCT03939312|589817728|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
163303344|NCT03939312|589817728|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
163303345|NCT03939312|589817728|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
163303346|NCT03939312|589817728|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
163303347|NCT03939312|589817728|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
163047626|NCT01723072|588881206|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
163303348|NCT01609218|589817730|FG000|Period 1|Adverse Event|3|||
163303349|NCT01609218|589817731|FG001|Period 1|Adverse Event|5|||
163303350|NCT01609218|589817730|FG000|Period 1|Sponsor Decision|0|||
163303351|NCT01609218|589817731|FG001|Period 1|Sponsor Decision|1|||
163303352|NCT01609218|589817730|FG000|Period 2|Adverse Event|1|||
163303353|NCT01609218|589817731|FG001|Period 2|Adverse Event|0|||
163395403|NCT00874770|590158634|FG003|Overall Study|Lack of Efficacy|2|||
163047627|NCT01723072|588881205|FG000|Overall Study|Other|4|||
163047628|NCT01723072|588881206|FG001|Overall Study|Other|3|||
163047629|NCT01841970|588881207|FG000|Overall Study|Withdrawal by Subject|1|||
163047630|NCT01841970|588881207|FG000|Overall Study|Physician Decision|2|||
163197283|NCT00868608|589437524|FG001|Overall Study|Death|2|||
163197284|NCT00868608|589437525|FG002|Overall Study|Death|4|||
163197285|NCT00868608|589437523|FG000|Overall Study|Other - Unspecified|1|||
163197286|NCT00868608|589437524|FG001|Overall Study|Other - Unspecified|0|||
163197287|NCT00868608|589437525|FG002|Overall Study|Other - Unspecified|0|||
163197288|NCT00911547|589437526|FG000|Overall Study|Adverse Event|8|||
163197289|NCT00911547|589437527|FG001|Overall Study|Adverse Event|27|||
163197290|NCT00911547|589437528|FG002|Overall Study|Adverse Event|11|||
163197291|NCT00911547|589437529|FG003|Overall Study|Adverse Event|6|||
163197292|NCT00911547|589437526|FG000|Overall Study|Lost to Follow-up|0|||
163197293|NCT00911547|589437527|FG001|Overall Study|Lost to Follow-up|0|||
163197294|NCT00911547|589437528|FG002|Overall Study|Lost to Follow-up|2|||
163197295|NCT00911547|589437529|FG003|Overall Study|Lost to Follow-up|1|||
163197296|NCT00911547|589437526|FG000|Overall Study|Protocol Violation|0|||
163197297|NCT00911547|589437527|FG001|Overall Study|Protocol Violation|5|||
163197298|NCT00911547|589437528|FG002|Overall Study|Protocol Violation|5|||
163197299|NCT00911547|589437529|FG003|Overall Study|Protocol Violation|1|||
163197300|NCT00911547|589437526|FG000|Overall Study|Withdrawal by Subject|3|||
163197301|NCT00911547|589437527|FG001|Overall Study|Withdrawal by Subject|10|||
163197302|NCT00911547|589437528|FG002|Overall Study|Withdrawal by Subject|4|||
163197303|NCT00911547|589437529|FG003|Overall Study|Withdrawal by Subject|8|||
163197304|NCT00457301|589437530|FG000|Overall Study|Withdrawal by Subject|3|||
163197305|NCT00457301|589437531|FG001|Overall Study|Withdrawal by Subject|3|||
163197306|NCT00457301|589437530|FG000|Overall Study|Censored out of the study|15|||
163197307|NCT00457301|589437531|FG001|Overall Study|Censored out of the study|14|||
163395404|NCT00874770|590158631|FG000|Overall Study|Adverse Event|1|||
163047631|NCT01841970|588881207|FG000|Overall Study|Lost to Follow-up|8|||
163047632|NCT03075267|588881220|FG000|Overall Study|Protocol Violation|1|||
163047633|NCT03075267|588881221|FG001|Overall Study|Protocol Violation|0|||
163047634|NCT03075267|588881222|FG002|Overall Study|Protocol Violation|0|||
163047635|NCT03874013|588881223|FG000|Overall Study|Adverse Event|0|||
163197308|NCT00457301|589437530|FG000|Overall Study|Death|5|||
163197309|NCT00457301|589437531|FG001|Overall Study|Death|7|||
163197310|NCT00191269|589437532|FG000|Overall Study|Protocol Violation|0|||
163197311|NCT00191269|589437533|FG001|Overall Study|Protocol Violation|2|||
163197312|NCT00191269|589437532|FG000|Overall Study|Adverse Event|1|||
163197313|NCT00191269|589437533|FG001|Overall Study|Adverse Event|4|||
163197314|NCT00191269|589437532|FG000|Overall Study|Progression of Disease|4|||
163197315|NCT00191269|589437533|FG001|Overall Study|Progression of Disease|42|||
163197316|NCT00191269|589437532|FG000|Overall Study|Lack of Efficacy|1|||
163303354|NCT02807779|589817732|FG000|Overall Study|Lost to Follow-up|1|||
163303355|NCT02807779|589817733|FG001|Overall Study|Lost to Follow-up|0|||
163047636|NCT03874013|588881224|FG001|Overall Study|Adverse Event|1|||
163197317|NCT00191269|589437533|FG001|Overall Study|Lack of Efficacy|5|||
163197318|NCT00191269|589437532|FG000|Overall Study|Withdrawal by Subject|0|||
163197319|NCT00191269|589437533|FG001|Overall Study|Withdrawal by Subject|1|||
163303356|NCT02807779|589817734|FG002|Overall Study|Lost to Follow-up|0|||
163395405|NCT00874770|590158632|FG001|Overall Study|Adverse Event|1|||
163047637|NCT00069823|588881238|FG000|Overall Study|Did not have follow-up diary cards|6|||
163047638|NCT00069823|588881239|FG001|Overall Study|Did not have follow-up diary cards|3|||
163047639|NCT01801111|588881240|FG000|Overall Study|Adverse Event|12|||
163047640|NCT01801111|588881240|FG000|Overall Study|Death|8|||
163047641|NCT01801111|588881240|FG000|Overall Study|Physician Decision|5|||
163047642|NCT01801111|588881240|FG000|Overall Study|Other|1|||
163047643|NCT01801111|588881240|FG000|Overall Study|Withdrawal by Subject|4|||
163047644|NCT01801111|588881240|FG000|Overall Study|Study Terminated by Sponsor|27|||
163047645|NCT01801111|588881240|FG000|Overall Study|Progressive Disease|81|||
163047646|NCT01210482|588881241|FG000|Overall Study|Protocol Violation|1|||
163047647|NCT01210482|588881241|FG000|Overall Study|Case Report Forms were not collected|18|||
163047648|NCT01210482|588881241|FG000|Overall Study|Duplicated|2|||
163047649|NCT01210482|588881241|FG000|Overall Study|No Drug Administration|28|||
163047650|NCT01223937|588881242|FG000|Overall Study|Withdrawal by Subject|3|||
163047651|NCT01223937|588881243|FG001|Overall Study|Withdrawal by Subject|2|||
163047652|NCT01223937|588881242|FG000|Overall Study|Lost to Follow-up|1|||
163047653|NCT01223937|588881243|FG001|Overall Study|Lost to Follow-up|4|||
163047654|NCT01223937|588881242|FG000|Overall Study|Adverse Event|1|||
163047655|NCT01223937|588881243|FG001|Overall Study|Adverse Event|4|||
163047656|NCT01223937|588881242|FG000|Overall Study|Protocol Violation|8|||
163047657|NCT01223937|588881243|FG001|Overall Study|Protocol Violation|7|||
163047658|NCT01223937|588881242|FG000|Overall Study|Other|4|||
163047659|NCT01223937|588881243|FG001|Overall Study|Other|1|||
163047660|NCT03284853|588881244|FG000|Overall Study|Adverse Event|40|||
163197320|NCT00191269|589437532|FG000|Overall Study|Pathologic Aggrevation|0|||
163047661|NCT03284853|588881245|FG001|Overall Study|Adverse Event|4|||
163047662|NCT03284853|588881244|FG000|Overall Study|Withdrawal by Subject|5|||
163047663|NCT03284853|588881245|FG001|Overall Study|Withdrawal by Subject|1|||
163047664|NCT03284853|588881244|FG000|Overall Study|Lost to Follow-up|1|||
163047665|NCT03284853|588881245|FG001|Overall Study|Lost to Follow-up|0|||
162961332|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961333|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961334|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961335|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961336|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961337|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961338|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961339|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961340|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961341|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961342|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961343|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961344|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162978992|NCT01660022|588623543|FG005|First Sequence (7 Days)|Protocol Violation|1|||
163303357|NCT02807779|589817732|FG000|Overall Study|Physician Decision|2|||
163303358|NCT02807779|589817733|FG001|Overall Study|Physician Decision|0|||
163303359|NCT02807779|589817734|FG002|Overall Study|Physician Decision|1|||
163303360|NCT02807779|589817732|FG000|Overall Study|Death|1|||
163303361|NCT02807779|589817733|FG001|Overall Study|Death|1|||
162961345|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961346|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961347|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961348|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961349|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961350|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
163303362|NCT02807779|589817734|FG002|Overall Study|Death|0|||
163303363|NCT02791230|589819659|FG000|Overall Study|Adverse Event|10|||
163303364|NCT02791230|589819660|FG001|Overall Study|Adverse Event|9|||
163303365|NCT02791230|589819661|FG002|Overall Study|Adverse Event|66|||
163303366|NCT02791230|589819659|FG000|Overall Study|Death|38|||
163303367|NCT02791230|589819660|FG001|Overall Study|Death|25|||
163047666|NCT03284853|588881244|FG000|Overall Study|Lack of Efficacy|1|||
163303368|NCT02791230|589819661|FG002|Overall Study|Death|184|||
163303369|NCT02791230|589819659|FG000|Overall Study|Lack of Efficacy|1|||
163303370|NCT02791230|589819660|FG001|Overall Study|Lack of Efficacy|0|||
163303371|NCT02791230|589819661|FG002|Overall Study|Lack of Efficacy|3|||
163303372|NCT02791230|589819659|FG000|Overall Study|Lost to Follow-up|0|||
163303373|NCT02791230|589819660|FG001|Overall Study|Lost to Follow-up|0|||
163303374|NCT02791230|589819661|FG002|Overall Study|Lost to Follow-up|10|||
163303375|NCT02791230|589819659|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
163303376|NCT02791230|589819660|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
163303377|NCT02791230|589819661|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
163047667|NCT03284853|588881245|FG001|Overall Study|Lack of Efficacy|0|||
163047668|NCT03284853|588881244|FG000|Overall Study|Disallowed Concurrent Medication|1|||
163047669|NCT03284853|588881245|FG001|Overall Study|Disallowed Concurrent Medication|1|||
163047670|NCT03284853|588881244|FG000|Overall Study|Protocol Violation|3|||
163047671|NCT03284853|588881245|FG001|Overall Study|Protocol Violation|3|||
163047672|NCT03284853|588881244|FG000|Overall Study|Death|0|||
163047673|NCT03284853|588881245|FG001|Overall Study|Death|1|||
163047674|NCT03284853|588881244|FG000|Overall Study|Other - Reason not reported in CSR|4|||
163047675|NCT03284853|588881245|FG001|Overall Study|Other - Reason not reported in CSR|3|||
163047676|NCT05176717|588881246|FG000|Overall Study|Sponsor Decision|1|||
163047677|NCT05176717|588881247|FG001|Overall Study|Sponsor Decision|2|||
163047678|NCT05176717|588881248|FG002|Overall Study|Sponsor Decision|2|||
163047679|NCT02058589|588881249|FG000|Overall Study|Serious Adverse Event|1|||
163047680|NCT02058589|588881250|FG001|Overall Study|Serious Adverse Event|1|||
163047681|NCT02058589|588881249|FG000|Overall Study|Non-Serious Adverse Event|1|||
163047682|NCT02058589|588881250|FG001|Overall Study|Non-Serious Adverse Event|0|||
163047683|NCT02058589|588881249|FG000|Overall Study|Withdrawal by Subject|0|||
163047684|NCT02058589|588881250|FG001|Overall Study|Withdrawal by Subject|1|||
163303378|NCT02791230|589819659|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
163303379|NCT02791230|589819660|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
163047685|NCT00765817|588881252|FG000|Overall Study|Adverse Event|13|||
163303380|NCT02791230|589819661|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
163047686|NCT00765817|588881253|FG001|Overall Study|Adverse Event|1|||
163047687|NCT00765817|588881252|FG000|Overall Study|Death|0|||
163303381|NCT02791230|589819659|FG000|Overall Study|Study sites terminated by sponsor|1|||
163047688|NCT00765817|588881253|FG001|Overall Study|Death|1|||
163047689|NCT00765817|588881252|FG000|Overall Study|Entry criteria not met|2|||
163047690|NCT00765817|588881253|FG001|Overall Study|Entry criteria not met|2|||
163303382|NCT02791230|589819660|FG001|Overall Study|Study sites terminated by sponsor|0|||
163047691|NCT00765817|588881252|FG000|Overall Study|Loss of glucose control|0|||
163197321|NCT00191269|589437533|FG001|Overall Study|Pathologic Aggrevation|1|||
163197322|NCT00191269|589437532|FG000|Overall Study|Physician Decision|0|||
163197323|NCT00191269|589437533|FG001|Overall Study|Physician Decision|3|||
163197324|NCT03583697|589437536|FG000|Overall Study|Withdrawal by Subject|0|||
163197325|NCT03583697|589437537|FG001|Overall Study|Withdrawal by Subject|0|||
163197326|NCT03583697|589437538|FG002|Overall Study|Withdrawal by Subject|1|||
162961351|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
163197327|NCT03583697|589437536|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
163197328|NCT03583697|589437537|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
163197329|NCT03583697|589437538|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
163303383|NCT02791230|589819661|FG002|Overall Study|Study sites terminated by sponsor|5|||
163303384|NCT02791230|589819659|FG000|Overall Study|Other|9|||
163303385|NCT02791230|589819660|FG001|Overall Study|Other|1|||
163303386|NCT02791230|589819661|FG002|Overall Study|Other|28|||
163303387|NCT02791230|589819659|FG000|Overall Study|Protocol Violation|0|||
163303388|NCT02791230|589819660|FG001|Overall Study|Protocol Violation|0|||
163303389|NCT02791230|589819661|FG002|Overall Study|Protocol Violation|4|||
162961352|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961353|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
163197330|NCT00365508|589437539|FG000|Overall Study|Lost to Follow-up|139|||
163047692|NCT00765817|588881253|FG001|Overall Study|Loss of glucose control|2|||
163047693|NCT00765817|588881252|FG000|Overall Study|Lost to Follow-up|1|||
163047694|NCT00765817|588881253|FG001|Overall Study|Lost to Follow-up|3|||
163047695|NCT00765817|588881252|FG000|Overall Study|Physician Decision|2|||
163047696|NCT00765817|588881253|FG001|Overall Study|Physician Decision|1|||
163047697|NCT00765817|588881252|FG000|Overall Study|Protocol Violation|1|||
163047698|NCT00765817|588881253|FG001|Overall Study|Protocol Violation|1|||
163047699|NCT00765817|588881252|FG000|Overall Study|Subject decision|7|||
163047700|NCT00765817|588881253|FG001|Overall Study|Subject decision|11|||
163047701|NCT02308228|588881254|FG000|Overall Study|Adverse Event|3|||
163047702|NCT02308228|588881255|FG001|Overall Study|Adverse Event|4|||
163047703|NCT02308228|588881254|FG000|Overall Study|Withdrawal by Subject|5|||
163047704|NCT02308228|588881255|FG001|Overall Study|Withdrawal by Subject|3|||
163047705|NCT02143024|588881256|FG000|Overall Study|Lost to Follow-up|1|||
163047706|NCT02143024|588881257|FG001|Overall Study|Lost to Follow-up|1|||
163047707|NCT02143024|588881256|FG000|Overall Study|Withdrawal by Subject|1|||
163047708|NCT02143024|588881257|FG001|Overall Study|Withdrawal by Subject|0|||
163047709|NCT06597084|588881258|FG000|Overall Study|Withdrawal by Subject|4|||
163047710|NCT06597084|588881259|FG001|Overall Study|Withdrawal by Subject|9|||
163047711|NCT06597084|588881258|FG000|Overall Study|Consent was not given by the patient until V2|0|||
163047712|NCT06597084|588881259|FG001|Overall Study|Consent was not given by the patient until V2|3|||
163047713|NCT06597084|588881258|FG000|Overall Study|Physician Decision|1|||
163047714|NCT06597084|588881259|FG001|Overall Study|Physician Decision|0|||
163047715|NCT06597084|588881258|FG000|Overall Study|Adverse Event|3|||
163047716|NCT06597084|588881259|FG001|Overall Study|Adverse Event|2|||
163047717|NCT06597084|588881258|FG000|Overall Study|Death|4|||
163047718|NCT06597084|588881259|FG001|Overall Study|Death|0|||
163047719|NCT06597084|588881258|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
163047720|NCT06597084|588881259|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
163047721|NCT06597084|588881258|FG000|Overall Study|Lost to Follow-up|4|||
163047722|NCT06597084|588881259|FG001|Overall Study|Lost to Follow-up|2|||
163047723|NCT06597084|588881258|FG000|Overall Study|Other. Not specified|1|||
163047724|NCT06597084|588881259|FG001|Overall Study|Other. Not specified|0|||
163303390|NCT02791230|589819659|FG000|Overall Study|Withdrawal by Subject|24|||
163303391|NCT02791230|589819660|FG001|Overall Study|Withdrawal by Subject|13|||
163303392|NCT02791230|589819661|FG002|Overall Study|Withdrawal by Subject|172|||
163303393|NCT02791230|589819659|FG000|Overall Study|Enrolled but not treated|0|||
163303394|NCT02791230|589819660|FG001|Overall Study|Enrolled but not treated|0|||
163303395|NCT02791230|589819661|FG002|Overall Study|Enrolled but not treated|5|||
163303396|NCT05307978|589819666|FG000|Overall Study|Lost to Follow-up|0|||
163303397|NCT05307978|589819667|FG001|Overall Study|Lost to Follow-up|1|||
163303398|NCT05307978|589819668|FG002|Overall Study|Lost to Follow-up|0|||
163303399|NCT05307978|589819669|FG003|Overall Study|Lost to Follow-up|4|||
163303400|NCT05307978|589819670|FG004|Overall Study|Lost to Follow-up|0|||
163303401|NCT05307978|589819671|FG005|Overall Study|Lost to Follow-up|0|||
163303402|NCT05307978|589819672|FG006|Overall Study|Lost to Follow-up|1|||
163303403|NCT03416023|589819673|FG000|Overall Study|Exclusion criteria failure|1|||
163303404|NCT03416023|589819673|FG000|Overall Study|Withdrawal by Subject|6|||
163303405|NCT03416023|589819673|FG000|Overall Study|Explanted|7|||
163303406|NCT03416023|589819673|FG000|Overall Study|Physician Decision|1|||
163303407|NCT03416023|589819673|FG000|Overall Study|Lost to Follow-up|1|||
163303408|NCT03416023|589819673|FG000|Overall Study|Death|1|||
163303409|NCT02837510|589819674|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
163303410|NCT02837510|589819675|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
163303411|NCT02837510|589819674|FG000|Washout (2 Weeks)|Adverse Event|0|||
163047725|NCT00490971|588881264|FG000|Acute/Continuation|Adverse Event|62|||
163047726|NCT00490971|588881265|FG001|Acute/Continuation|Adverse Event|13|||
163047727|NCT00490971|588881266|FG002|Acute/Continuation|Adverse Event|0|||
163047728|NCT00490971|588881267|FG003|Acute/Continuation|Adverse Event|0|||
163303412|NCT02837510|589819675|FG001|Washout (2 Weeks)|Adverse Event|1|||
163303413|NCT02837510|589819674|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
163047729|NCT00490971|588881268|FG004|Acute/Continuation|Adverse Event|0|||
163047730|NCT00490971|588881264|FG000|Acute/Continuation|Death|2|||
163303414|NCT02837510|589819675|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
163395406|NCT00874770|590158633|FG002|Overall Study|Adverse Event|4|||
163047731|NCT00490971|588881265|FG001|Acute/Continuation|Death|0|||
163303415|NCT02837510|589819674|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
163303416|NCT02837510|589819675|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
163303417|NCT02837510|589819674|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
163303418|NCT02837510|589819675|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
163303419|NCT02837510|589819674|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
163395407|NCT00874770|590158634|FG003|Overall Study|Adverse Event|2|||
163303420|NCT02837510|589819675|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
163303421|NCT05419505|589819677|FG000|Overall Study|Adverse Event|0|||
163303422|NCT05419505|589819678|FG001|Overall Study|Adverse Event|0|||
163303423|NCT05419505|589819679|FG002|Overall Study|Adverse Event|0|||
163303424|NCT05419505|589819680|FG003|Overall Study|Adverse Event|1|||
163303425|NCT05419505|589819681|FG004|Overall Study|Adverse Event|0|||
163395408|NCT00874770|590158631|FG000|Overall Study|Lost to Follow-up|1|||
162961354|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961355|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961356|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961357|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
162961358|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961359|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
163303426|NCT05419505|589819682|FG005|Overall Study|Adverse Event|0|||
163395409|NCT00874770|590158632|FG001|Overall Study|Lost to Follow-up|0|||
162961360|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961361|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
163395410|NCT00874770|590158633|FG002|Overall Study|Lost to Follow-up|0|||
163395411|NCT00874770|590158634|FG003|Overall Study|Lost to Follow-up|1|||
163303427|NCT05419505|589819683|FG006|Overall Study|Adverse Event|0|||
163303428|NCT05419505|589819684|FG007|Overall Study|Adverse Event|0|||
163303429|NCT05419505|589819677|FG000|Overall Study|Withdrawal by Subject|1|||
163303430|NCT05419505|589819678|FG001|Overall Study|Withdrawal by Subject|2|||
163303431|NCT05419505|589819679|FG002|Overall Study|Withdrawal by Subject|0|||
163303432|NCT05419505|589819680|FG003|Overall Study|Withdrawal by Subject|0|||
163303433|NCT05419505|589819681|FG004|Overall Study|Withdrawal by Subject|0|||
163303434|NCT05419505|589819682|FG005|Overall Study|Withdrawal by Subject|0|||
163303435|NCT05419505|589819683|FG006|Overall Study|Withdrawal by Subject|1|||
163303436|NCT05419505|589819684|FG007|Overall Study|Withdrawal by Subject|0|||
163303437|NCT05419505|589819677|FG000|Overall Study|Lost to Follow-up|2|||
163303438|NCT05419505|589819678|FG001|Overall Study|Lost to Follow-up|1|||
163303439|NCT05419505|589819679|FG002|Overall Study|Lost to Follow-up|0|||
163303440|NCT05419505|589819680|FG003|Overall Study|Lost to Follow-up|0|||
163303441|NCT05419505|589819681|FG004|Overall Study|Lost to Follow-up|1|||
163303442|NCT05419505|589819682|FG005|Overall Study|Lost to Follow-up|2|||
163303443|NCT05419505|589819683|FG006|Overall Study|Lost to Follow-up|0|||
163303444|NCT05419505|589819684|FG007|Overall Study|Lost to Follow-up|1|||
163303445|NCT02780388|589819687|FG000|Overall Study|Lost to Follow-up|0|||
163303446|NCT02780388|589819688|FG001|Overall Study|Lost to Follow-up|1|||
163303447|NCT02780388|589819689|FG002|Overall Study|Lost to Follow-up|0|||
163303448|NCT02780388|589819690|FG003|Overall Study|Lost to Follow-up|0|||
163303449|NCT02780388|589819691|FG004|Overall Study|Lost to Follow-up|0|||
163303450|NCT02780388|589819687|FG000|Overall Study|Withdrawal by Subject|1|||
163303451|NCT02780388|589819688|FG001|Overall Study|Withdrawal by Subject|1|||
163303452|NCT02780388|589819689|FG002|Overall Study|Withdrawal by Subject|0|||
163303453|NCT02780388|589819690|FG003|Overall Study|Withdrawal by Subject|0|||
163197331|NCT00365508|589437540|FG001|Overall Study|Lost to Follow-up|154|||
163197332|NCT00404235|589437543|FG000|Overall Study|Withdrawal by Subject|1|||
163197333|NCT00404235|589437544|FG001|Overall Study|Withdrawal by Subject|2|||
163197334|NCT00679432|589437545|FG000|Overall Study|Adverse Event|5|||
163197335|NCT00679432|589437546|FG001|Overall Study|Adverse Event|6|||
163197336|NCT00679432|589437547|FG002|Overall Study|Adverse Event|10|||
163197337|NCT00679432|589437548|FG003|Overall Study|Adverse Event|7|||
163197338|NCT00679432|589437545|FG000|Overall Study|Protocol Violation|1|||
163197339|NCT00679432|589437546|FG001|Overall Study|Protocol Violation|1|||
163197340|NCT00679432|589437547|FG002|Overall Study|Protocol Violation|2|||
162961362|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
163197341|NCT00679432|589437548|FG003|Overall Study|Protocol Violation|1|||
162961363|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162978993|NCT03545191|588623546|FG000|Overall Study|Death|1|||
163197342|NCT00679432|589437545|FG000|Overall Study|Withdrawal by Subject|8|||
163303454|NCT02780388|589819691|FG004|Overall Study|Withdrawal by Subject|0|||
163197343|NCT00679432|589437546|FG001|Overall Study|Withdrawal by Subject|11|||
163197344|NCT00679432|589437547|FG002|Overall Study|Withdrawal by Subject|10|||
163197345|NCT00679432|589437548|FG003|Overall Study|Withdrawal by Subject|9|||
163197346|NCT00679432|589437545|FG000|Overall Study|Lost to Follow-up|1|||
163303455|NCT03857620|589819693|FG000|Overall Study|Death|4|||
163303456|NCT03857620|589819694|FG001|Overall Study|Death|5|||
163395412|NCT00874770|590158631|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
163395413|NCT00874770|590158632|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
163395414|NCT00874770|590158633|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
163395415|NCT00874770|590158634|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
163395416|NCT05215262|590158635|FG000|Overall Study|Lost to Follow-up|12|||
163395417|NCT05215262|590158636|FG001|Overall Study|Lost to Follow-up|0|||
163395418|NCT04880447|590158638|FG000|Overall Study|No vaccination information|1|||
163395419|NCT04880447|590158638|FG000|Overall Study|No adverse event information (missing information)|1|||
163395420|NCT04880447|590158638|FG000|Overall Study|Disease not covered in this study|35|||
163395421|NCT01353508|590158639|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
163395422|NCT01353508|590158640|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
163395423|NCT01353508|590158641|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
163395424|NCT01353508|590158642|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
163395425|NCT01353508|590158639|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
163303457|NCT03857620|589819695|FG002|Overall Study|Death|7|||
163303458|NCT03857620|589819693|FG000|Overall Study|Lost to Follow-up|2|||
163303459|NCT03857620|589819694|FG001|Overall Study|Lost to Follow-up|5|||
163303460|NCT03857620|589819695|FG002|Overall Study|Lost to Follow-up|3|||
163303461|NCT03857620|589819693|FG000|Overall Study|Disease progression or relapse after study registration|1|||
163303462|NCT03857620|589819694|FG001|Overall Study|Disease progression or relapse after study registration|5|||
163303463|NCT03857620|589819695|FG002|Overall Study|Disease progression or relapse after study registration|1|||
163303464|NCT03857620|589819693|FG000|Overall Study|Ineligible|5|||
163303465|NCT03857620|589819694|FG001|Overall Study|Ineligible|0|||
163303466|NCT03857620|589819695|FG002|Overall Study|Ineligible|2|||
163303467|NCT03857620|589819693|FG000|Overall Study|No malignancy|1|||
163303468|NCT03857620|589819694|FG001|Overall Study|No malignancy|0|||
163303469|NCT03857620|589819695|FG002|Overall Study|No malignancy|1|||
163303470|NCT03857620|589819693|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
163303471|NCT03857620|589819694|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
163303472|NCT03857620|589819695|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
163303473|NCT03857620|589819693|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
163395426|NCT01353508|590158640|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
163197347|NCT00679432|589437546|FG001|Overall Study|Lost to Follow-up|5|||
163197348|NCT00679432|589437547|FG002|Overall Study|Lost to Follow-up|4|||
163395427|NCT01353508|590158641|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
163395428|NCT01353508|590158642|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
163395429|NCT00646906|590158643|FG000|Crossover Period 1|Withdrawal by Subject|1|||
163197349|NCT00679432|589437548|FG003|Overall Study|Lost to Follow-up|2|||
163197350|NCT00679432|589437545|FG000|Overall Study|Physician Decision|3|||
163197351|NCT00679432|589437546|FG001|Overall Study|Physician Decision|2|||
163197352|NCT00679432|589437547|FG002|Overall Study|Physician Decision|2|||
163303474|NCT03857620|589819694|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
163303475|NCT03857620|589819695|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
163303476|NCT03857620|589819693|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
163395430|NCT00646906|590158644|FG001|Crossover Period 1|Withdrawal by Subject|0|||
163395431|NCT00646906|590158645|FG002|Crossover Period 1|Withdrawal by Subject|0|||
163395432|NCT00646906|590158646|FG003|Crossover Period 1|Withdrawal by Subject|0|||
163395433|NCT00646906|590158647|FG004|Crossover Period 1|Withdrawal by Subject|0|||
163395434|NCT00646906|590158648|FG005|Crossover Period 1|Withdrawal by Subject|1|||
163395435|NCT00646906|590158649|FG006|Crossover Period 1|Withdrawal by Subject|0|||
163395436|NCT00646906|590158643|FG000|Crossover Period 2|Withdrawal by Subject|0|||
163395437|NCT00646906|590158644|FG001|Crossover Period 2|Withdrawal by Subject|1|||
163395438|NCT00646906|590158645|FG002|Crossover Period 2|Withdrawal by Subject|2|||
163395439|NCT00646906|590158646|FG003|Crossover Period 2|Withdrawal by Subject|1|||
163395440|NCT00646906|590158647|FG004|Crossover Period 2|Withdrawal by Subject|0|||
163395441|NCT00646906|590158648|FG005|Crossover Period 2|Withdrawal by Subject|0|||
163395442|NCT00646906|590158649|FG006|Crossover Period 2|Withdrawal by Subject|0|||
163395443|NCT00646906|590158643|FG000|Crossover Period 2|Physician Decision|0|||
163395444|NCT00646906|590158644|FG001|Crossover Period 2|Physician Decision|0|||
163395445|NCT00646906|590158645|FG002|Crossover Period 2|Physician Decision|0|||
163395446|NCT00646906|590158646|FG003|Crossover Period 2|Physician Decision|0|||
163395447|NCT00646906|590158647|FG004|Crossover Period 2|Physician Decision|0|||
163395448|NCT00646906|590158648|FG005|Crossover Period 2|Physician Decision|0|||
163395449|NCT00646906|590158649|FG006|Crossover Period 2|Physician Decision|1|||
163395450|NCT04534491|590158654|FG000|Overall Study|Not completed end-of-study interview|24|||
163395451|NCT04534491|590158654|FG000|Overall Study|Non-users|70|||
163395452|NCT04534491|590158654|FG000|Overall Study|Non-verifiable users|58|||
163395453|NCT00369785|590158660|FG000|Overall Study|Physician Decision|3|||
163395454|NCT00369785|590158661|FG001|Overall Study|Physician Decision|2|||
163395455|NCT00369785|590158660|FG000|Overall Study|Death|1|||
163395456|NCT00369785|590158661|FG001|Overall Study|Death|2|||
163395457|NCT00369785|590158660|FG000|Overall Study|Withdrawal by Subject|7|||
163395458|NCT00369785|590158661|FG001|Overall Study|Withdrawal by Subject|6|||
163395459|NCT00369785|590158660|FG000|Overall Study|Toxicity|6|||
163395460|NCT00369785|590158661|FG001|Overall Study|Toxicity|4|||
163395461|NCT00369785|590158660|FG000|Overall Study|Never started|0|||
163395462|NCT00369785|590158661|FG001|Overall Study|Never started|2|||
163395463|NCT00369785|590158660|FG000|Overall Study|Progression|4|||
163395464|NCT00369785|590158661|FG001|Overall Study|Progression|4|||
163395465|NCT00369785|590158660|FG000|Overall Study|Multiple reasons|6|||
163395466|NCT00369785|590158661|FG001|Overall Study|Multiple reasons|5|||
163395467|NCT00800683|590158662|FG000|Overall Study|Adverse Event|11|||
163395468|NCT00800683|590158663|FG001|Overall Study|Adverse Event|8|||
163395469|NCT00800683|590158662|FG000|Overall Study|Lost to Follow-up|3|||
163395470|NCT00800683|590158663|FG001|Overall Study|Lost to Follow-up|1|||
163395471|NCT00800683|590158662|FG000|Overall Study|Withdrawal by Subject|1|||
163395472|NCT00800683|590158663|FG001|Overall Study|Withdrawal by Subject|7|||
163395473|NCT00800683|590158662|FG000|Overall Study|Lack of Efficacy|1|||
163395474|NCT00800683|590158663|FG001|Overall Study|Lack of Efficacy|1|||
163395475|NCT00800683|590158662|FG000|Overall Study|Other|1|||
163395476|NCT00800683|590158663|FG001|Overall Study|Other|2|||
163395477|NCT02247960|590158665|FG000|Patient Consent and Randomization|Physician Decision|2|||
163395478|NCT02247960|590158666|FG001|Patient Consent and Randomization|Physician Decision|2|||
163395479|NCT02247960|590158665|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
163395480|NCT02247960|590158666|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
163395481|NCT02247960|590158665|FG000|Catheter Removed|Lost to Follow-up|7|||
163395482|NCT02247960|590158666|FG001|Catheter Removed|Lost to Follow-up|10|||
163395483|NCT02678416|590158667|FG000|Part 1|Withdrawal by Subject|1|||
163395484|NCT02678416|590158667|FG000|Part 2|Adverse Event|2|||
163395485|NCT02678416|590158667|FG000|Part 2|Withdrawal by Subject|1|||
163395486|NCT01848353|590158668|FG000|Phase 1|Withdrawal by Subject|3|||
163395487|NCT01848353|590158669|FG001|Phase 1|Withdrawal by Subject|1|||
163395488|NCT01848353|590158670|FG002|Phase 1|Withdrawal by Subject|0|||
163395489|NCT01848353|590158671|FG003|Phase 1|Withdrawal by Subject|0|||
163395490|NCT01848353|590158668|FG000|Phase 2|Withdrawal by Subject|3|||
163395491|NCT01848353|590158669|FG001|Phase 2|Withdrawal by Subject|2|||
163395492|NCT01848353|590158670|FG002|Phase 2|Withdrawal by Subject|0|||
163395493|NCT01848353|590158671|FG003|Phase 2|Withdrawal by Subject|0|||
163395494|NCT01848353|590158668|FG000|Phase 3|Withdrawal by Subject|1|||
163395495|NCT01848353|590158669|FG001|Phase 3|Withdrawal by Subject|1|||
163395496|NCT01848353|590158670|FG002|Phase 3|Withdrawal by Subject|0|||
163395497|NCT01848353|590158671|FG003|Phase 3|Withdrawal by Subject|0|||
163395498|NCT01910116|590158683|FG000|Overall Study|Adverse Event|0|||
163395499|NCT01910116|590158684|FG001|Overall Study|Adverse Event|3|||
163395500|NCT01910116|590158683|FG000|Overall Study|Lack of Efficacy|3|||
163395501|NCT01910116|590158684|FG001|Overall Study|Lack of Efficacy|4|||
163395502|NCT01910116|590158683|FG000|Overall Study|Lost to Follow-up|1|||
163395503|NCT01910116|590158684|FG001|Overall Study|Lost to Follow-up|0|||
163395504|NCT01910116|590158683|FG000|Overall Study|Protocol Violation|1|||
163395505|NCT01910116|590158684|FG001|Overall Study|Protocol Violation|2|||
163395506|NCT01910116|590158683|FG000|Overall Study|Withdrawal by Subject|8|||
163395507|NCT01910116|590158684|FG001|Overall Study|Withdrawal by Subject|3|||
163303477|NCT03857620|589819694|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
163303478|NCT03857620|589819695|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
163303479|NCT03857620|589819693|FG000|Overall Study|Surgery not performed, patient decision|0|||
163303480|NCT03857620|589819694|FG001|Overall Study|Surgery not performed, patient decision|3|||
163303481|NCT03857620|589819695|FG002|Overall Study|Surgery not performed, patient decision|1|||
163303482|NCT03857620|589819693|FG000|Overall Study|Surgery not performed, other reason|3|||
163303483|NCT03857620|589819694|FG001|Overall Study|Surgery not performed, other reason|1|||
163303484|NCT03857620|589819695|FG002|Overall Study|Surgery not performed, other reason|4|||
163303485|NCT03857620|589819693|FG000|Overall Study|Worsening performance status after surgery performed|0|||
163303486|NCT03857620|589819694|FG001|Overall Study|Worsening performance status after surgery performed|1|||
163303487|NCT03857620|589819695|FG002|Overall Study|Worsening performance status after surgery performed|1|||
163303488|NCT04118452|589819696|FG000|Overall Study|Lost to Follow-up|5|||
163303489|NCT04118452|589819697|FG001|Overall Study|Lost to Follow-up|5|||
163303490|NCT04118452|589819696|FG000|Overall Study|Withdrawal by Subject|17|||
163303491|NCT04118452|589819697|FG001|Overall Study|Withdrawal by Subject|17|||
163303492|NCT01718743|589819698|FG000|Overall Study|Physician Decision|7|||
163303493|NCT01718743|589819698|FG000|Overall Study|Withdrawal by Subject|14|||
163303494|NCT01718743|589819698|FG000|Overall Study|Progressive Disease|22|||
163303495|NCT01718743|589819698|FG000|Overall Study|Toxicity|1|||
163303496|NCT01718743|589819698|FG000|Overall Study|Malignancy|1|||
163303497|NCT04868110|589819706|FG000|Overall Study|Withdrawal by Subject|3|||
163303498|NCT04868110|589819707|FG001|Overall Study|Withdrawal by Subject|4|||
163303499|NCT02386553|589819709|FG000|Overall Study|Reason Not Specified|1|||
163303500|NCT02386553|589819710|FG001|Overall Study|Reason Not Specified|1|||
163303501|NCT02386553|589819709|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
163303502|NCT02386553|589819710|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
163303503|NCT05384730|589819719|FG000|Overall Study|Adverse Event|1|||
163303504|NCT05384730|589819720|FG001|Overall Study|Adverse Event|0|||
163303505|NCT05384730|589819719|FG000|Overall Study|Lack of social support|2|||
163303506|NCT05384730|589819720|FG001|Overall Study|Lack of social support|0|||
163303507|NCT05384730|589819719|FG000|Overall Study|Hospital readmission|2|||
163303508|NCT05384730|589819720|FG001|Overall Study|Hospital readmission|0|||
163303509|NCT05384730|589819719|FG000|Overall Study|Disease progression|5|||
163303510|NCT05384730|589819720|FG001|Overall Study|Disease progression|0|||
163303511|NCT05384730|589819719|FG000|Overall Study|Overwhelmed with College commitments|0|||
163303512|NCT05384730|589819720|FG001|Overall Study|Overwhelmed with College commitments|2|||
163303513|NCT01619410|589819723|FG000|Overall Study|Lost to Follow-up|7|||
163303514|NCT01619410|589819724|FG001|Overall Study|Lost to Follow-up|4|||
163303515|NCT06061081|589819737|FG000|Overall Study|Withdrawal by Subject|1|||
163303516|NCT06061081|589819738|FG001|Overall Study|Withdrawal by Subject|0|||
163303517|NCT06061081|589819739|FG002|Overall Study|Withdrawal by Subject|0|||
163303518|NCT06061081|589819740|FG003|Overall Study|Withdrawal by Subject|0|||
163303519|NCT06061081|589819741|FG004|Overall Study|Withdrawal by Subject|0|||
163303520|NCT05782231|589819742|FG000|Overall Study|Withdrawal by Subject|1|||
163303521|NCT02252172|589819743|FG000|Overall Study|Lost to Follow-up|9|||
163303522|NCT02252172|589819744|FG001|Overall Study|Lost to Follow-up|6|||
163303523|NCT02252172|589819743|FG000|Overall Study|Death|218|||
163303524|NCT02252172|589819744|FG001|Overall Study|Death|175|||
163303525|NCT02252172|589819743|FG000|Overall Study|Withdrawal by Subject|20|||
163303526|NCT02252172|589819744|FG001|Overall Study|Withdrawal by Subject|15|||
163303527|NCT02252172|589819743|FG000|Overall Study|Physician Decision|0|||
163303528|NCT02252172|589819744|FG001|Overall Study|Physician Decision|1|||
163303529|NCT02252172|589819743|FG000|Overall Study|End of data collection|122|||
163303530|NCT02252172|589819744|FG001|Overall Study|End of data collection|170|||
163303531|NCT02252172|589819743|FG000|Overall Study|Site closure|0|||
163303532|NCT02252172|589819744|FG001|Overall Study|Site closure|1|||
163303533|NCT03830866|589819745|FG000|Overall Study|Death|90|||
163303534|NCT03830866|589819746|FG001|Overall Study|Death|111|||
163303535|NCT03830866|589819745|FG000|Overall Study|Lost to Follow-up|7|||
163303536|NCT03830866|589819746|FG001|Overall Study|Lost to Follow-up|7|||
163303537|NCT03830866|589819745|FG000|Overall Study|Withdrawal by Subject|19|||
163303538|NCT03830866|589819746|FG001|Overall Study|Withdrawal by Subject|16|||
163303539|NCT03830866|589819745|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
163303540|NCT03830866|589819746|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
163303541|NCT03830866|589819745|FG000|Overall Study|Other|1|||
163303542|NCT03830866|589819746|FG001|Overall Study|Other|1|||
163303543|NCT01426412|589819747|FG000|Overall Study|Withdrawal by Subject|1|||
163303544|NCT01426412|589819748|FG001|Overall Study|Withdrawal by Subject|0|||
163303545|NCT01426412|589819749|FG002|Overall Study|Withdrawal by Subject|0|||
163303546|NCT01426412|589819750|FG003|Overall Study|Withdrawal by Subject|0|||
163303547|NCT01426412|589819751|FG004|Overall Study|Withdrawal by Subject|1|||
163395508|NCT01910116|590158683|FG000|Overall Study|uncertain allocation|1|||
163395509|NCT01910116|590158684|FG001|Overall Study|uncertain allocation|3|||
163395510|NCT01910116|590158683|FG000|Overall Study|incomplete data|0|||
163303548|NCT01426412|589819752|FG005|Overall Study|Withdrawal by Subject|0|||
163303549|NCT01426412|589819753|FG006|Overall Study|Withdrawal by Subject|0|||
163303550|NCT01426412|589819754|FG007|Overall Study|Withdrawal by Subject|3|||
163303551|NCT01426412|589819755|FG008|Overall Study|Withdrawal by Subject|1|||
163303552|NCT03014453|589819756|FG000|Overall Study|Lost to Follow-up|12|||
163303553|NCT03014453|589819756|FG000|Overall Study|Discontinued GER|3|||
163303554|NCT03014453|589819756|FG000|Overall Study|Excluded|19|||
163303555|NCT03014453|589819756|FG000|Overall Study|Refused to take part in|37|||
163303556|NCT01017146|589819759|FG000|Overall Study|Adverse Event|11|||
163303557|NCT01017146|589819760|FG001|Overall Study|Adverse Event|1|||
163303558|NCT01017146|589819759|FG000|Overall Study|Lost to Follow-up|14|||
163303559|NCT01017146|589819760|FG001|Overall Study|Lost to Follow-up|14|||
163303560|NCT01017146|589819759|FG000|Overall Study|Noncompliance with Study Product|1|||
163303561|NCT01017146|589819760|FG001|Overall Study|Noncompliance with Study Product|1|||
163303562|NCT01017146|589819759|FG000|Overall Study|Withdrawal by Subject|32|||
163303563|NCT01017146|589819760|FG001|Overall Study|Withdrawal by Subject|16|||
163303564|NCT01017146|589819759|FG000|Overall Study|Relocation|0|||
163303565|NCT01017146|589819760|FG001|Overall Study|Relocation|4|||
163303566|NCT01017146|589819759|FG000|Overall Study|Pregnancy|2|||
163303567|NCT01017146|589819760|FG001|Overall Study|Pregnancy|1|||
163303568|NCT01017146|589819759|FG000|Overall Study|Protocol Violation|2|||
163303569|NCT01017146|589819760|FG001|Overall Study|Protocol Violation|0|||
163303570|NCT01017146|589819759|FG000|Overall Study|Took Excluded Medication|2|||
163303571|NCT01017146|589819760|FG001|Overall Study|Took Excluded Medication|0|||
163303572|NCT01017146|589819759|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
163303573|NCT01017146|589819760|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
163303574|NCT01017146|589819759|FG000|Overall Study|Change in Work Situation|1|||
163303575|NCT01017146|589819760|FG001|Overall Study|Change in Work Situation|0|||
163303576|NCT00976495|589819771|FG000|Overall Study|Withdrawal by Subject|0|||
163303577|NCT00976495|589819772|FG001|Overall Study|Withdrawal by Subject|1|||
163303578|NCT00976495|589819773|FG002|Overall Study|Withdrawal by Subject|0|||
163303579|NCT04154384|589819774|FG000|Overall Study|Lost to Follow-up|24|||
163303580|NCT04154384|589819775|FG001|Overall Study|Lost to Follow-up|33|||
163303581|NCT04154384|589819776|FG002|Overall Study|Lost to Follow-up|0|||
163303582|NCT04154384|589819774|FG000|Overall Study|Withdrawal by Subject|7|||
163303583|NCT04154384|589819775|FG001|Overall Study|Withdrawal by Subject|18|||
163303584|NCT04154384|589819776|FG002|Overall Study|Withdrawal by Subject|0|||
163303585|NCT04154384|589819774|FG000|Overall Study|Missing outcome data|1|||
163303586|NCT04154384|589819775|FG001|Overall Study|Missing outcome data|0|||
163303587|NCT04154384|589819776|FG002|Overall Study|Missing outcome data|0|||
163303588|NCT04732338|589819779|FG000|Overall Study|Lost to Follow-up|3|||
163303589|NCT04732338|589819780|FG001|Overall Study|Lost to Follow-up|3|||
163303590|NCT00001277|589819781|FG000|Overall Study|Adverse Event|0|||
163303591|NCT00001277|589819782|FG001|Overall Study|Adverse Event|0|||
163303592|NCT00001277|589819783|FG002|Overall Study|Adverse Event|1|||
163303593|NCT00001277|589819781|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
163303594|NCT00001277|589819782|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
163303595|NCT00001277|589819783|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
163303596|NCT03750968|589819785|FG000|Overall Study|Adverse Event|2|||
163303597|NCT03750968|589819786|FG001|Overall Study|Adverse Event|0|||
163303598|NCT03750968|589819785|FG000|Overall Study|Lost to Follow-up|1|||
163303599|NCT03750968|589819786|FG001|Overall Study|Lost to Follow-up|3|||
163303600|NCT04484935|589819787|FG000|Overall Study|Other|0|||
163303601|NCT04484935|589819788|FG001|Overall Study|Other|1|||
163303602|NCT04484935|589819787|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163303603|NCT04484935|589819788|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163303604|NCT04484935|589819787|FG000|Overall Study|Lost to Follow-up|1|||
163303605|NCT04484935|589819788|FG001|Overall Study|Lost to Follow-up|0|||
163303606|NCT04484935|589819787|FG000|Overall Study|Death|2|||
163303607|NCT04484935|589819788|FG001|Overall Study|Death|1|||
163303608|NCT00088413|589819791|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
162978994|NCT03545191|588623547|FG001|Overall Study|Death|0|||
163303609|NCT00088413|589819792|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
163303610|NCT00088413|589819793|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
163303611|NCT00088413|589819794|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
163303612|NCT00088413|589819791|FG000|Overall Study|Adverse Events/Side Effects|0|||
163303613|NCT00088413|589819792|FG001|Overall Study|Adverse Events/Side Effects|1|||
163303614|NCT00088413|589819793|FG002|Overall Study|Adverse Events/Side Effects|1|||
163303615|NCT00088413|589819794|FG003|Overall Study|Adverse Events/Side Effects|0|||
163303616|NCT00088413|589819791|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
163395511|NCT01910116|590158684|FG001|Overall Study|incomplete data|1|||
163303617|NCT00088413|589819792|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
163303618|NCT00088413|589819793|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
163395512|NCT02289352|590158685|FG000|Overall Study|Withdrawal by Subject|1|||
163395513|NCT02289352|590158686|FG001|Overall Study|Withdrawal by Subject|1|||
162978995|NCT03545191|588623548|FG002|Overall Study|Death|0|||
163303619|NCT00088413|589819794|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
163303620|NCT00088413|589819791|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
163303621|NCT00088413|589819792|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
163303622|NCT00088413|589819793|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
163303623|NCT00088413|589819794|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
163303624|NCT00088413|589819791|FG000|Overall Study|Death|0|||
163303625|NCT00088413|589819792|FG001|Overall Study|Death|1|||
163303626|NCT00088413|589819793|FG002|Overall Study|Death|0|||
163303627|NCT00088413|589819794|FG003|Overall Study|Death|0|||
163303628|NCT00088413|589819791|FG000|Overall Study|Progressive disease|9|||
163303629|NCT00088413|589819792|FG001|Overall Study|Progressive disease|11|||
163303630|NCT00088413|589819793|FG002|Overall Study|Progressive disease|8|||
163303631|NCT00088413|589819794|FG003|Overall Study|Progressive disease|14|||
163303632|NCT00088413|589819791|FG000|Overall Study|Other|0|||
163303633|NCT00088413|589819792|FG001|Overall Study|Other|1|||
163303634|NCT00088413|589819793|FG002|Overall Study|Other|0|||
163303635|NCT00088413|589819794|FG003|Overall Study|Other|0|||
163303636|NCT00088413|589819791|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
163303637|NCT00088413|589819792|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
163303638|NCT00088413|589819793|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
163303639|NCT00088413|589819794|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
163303640|NCT02759016|589819795|FG000|Overall Study|Not treated with BI 836826|1|||
163303641|NCT02759016|589819796|FG001|Overall Study|Not treated with BI 836826|0|||
163303642|NCT02759016|589819795|FG000|Overall Study|Progressive disease|1|||
163303643|NCT02759016|589819796|FG001|Overall Study|Progressive disease|0|||
163303644|NCT02759016|589819795|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
163303645|NCT02759016|589819796|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
163303646|NCT02759016|589819795|FG000|Overall Study|Other not defined above|2|||
163303647|NCT02759016|589819796|FG001|Overall Study|Other not defined above|1|||
163303648|NCT04048382|589819799|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
163303649|NCT04048382|589819800|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
163303650|NCT04048382|589819799|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
163303651|NCT04048382|589819800|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
163303652|NCT04048382|589819799|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
163303653|NCT04048382|589819800|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
163303654|NCT02119650|589819805|FG000|Overall Study|Adverse Event|3|||
163303655|NCT02119650|589819806|FG001|Overall Study|Adverse Event|4|||
163303656|NCT02119650|589819805|FG000|Overall Study|Subject decision|2|||
163303657|NCT02119650|589819806|FG001|Overall Study|Subject decision|3|||
163303658|NCT02119650|589819805|FG000|Overall Study|Disease progression|11|||
163303659|NCT02119650|589819806|FG001|Overall Study|Disease progression|14|||
163303660|NCT02119650|589819805|FG000|Overall Study|Death|5|||
163303661|NCT02119650|589819806|FG001|Overall Study|Death|1|||
163303662|NCT02119650|589819805|FG000|Overall Study|Noncompliance with study treatment|1|||
163303663|NCT02119650|589819806|FG001|Overall Study|Noncompliance with study treatment|1|||
163303664|NCT02119650|589819805|FG000|Overall Study|Study terminated by the sponsor|1|||
163303665|NCT02119650|589819806|FG001|Overall Study|Study terminated by the sponsor|0|||
163303666|NCT02119650|589819805|FG000|Overall Study|Physician Decision|0|||
163303667|NCT02119650|589819806|FG001|Overall Study|Physician Decision|2|||
163303668|NCT02119650|589819805|FG000|Overall Study|Multiple reasons for termination|2|||
163303669|NCT02119650|589819806|FG001|Overall Study|Multiple reasons for termination|1|||
163303670|NCT02269475|589819807|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
163303671|NCT02269475|589819808|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
163303672|NCT02269475|589819807|FG000|Overall Study|Withdrawal by Subject|0|||
163303673|NCT02269475|589819808|FG001|Overall Study|Withdrawal by Subject|1|||
163303674|NCT03481816|589819809|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
163303675|NCT03481816|589819810|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
163395514|NCT02289352|590158687|FG002|Overall Study|Withdrawal by Subject|0|||
163303676|NCT03481816|589819809|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
163303677|NCT03481816|589819810|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
163303678|NCT03481816|589819809|FG000|Dose Expansion|Withdrawal by Subject|0|||
163303679|NCT03481816|589819810|FG001|Dose Expansion|Withdrawal by Subject|2|||
163303680|NCT03481816|589819809|FG000|Dose Expansion|Physician Decision|0|||
163303681|NCT03481816|589819810|FG001|Dose Expansion|Physician Decision|5|||
163303682|NCT02730871|589819811|FG000|Overall Study|Adverse Event|6|||
163303683|NCT02730871|589819812|FG001|Overall Study|Adverse Event|0|||
163303684|NCT05368558|589819813|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
163303685|NCT05368558|589819814|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
163303686|NCT05368558|589819815|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
163303687|NCT05368558|589819816|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163303688|NCT05368558|589819817|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163303689|NCT05368558|589819818|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163303690|NCT05368558|589819819|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163303691|NCT05368558|589819820|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163303692|NCT05368558|589819821|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163303693|NCT05368558|589819822|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163303694|NCT05368558|589819823|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163303695|NCT05368558|589819824|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163303696|NCT05368558|589819813|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163395515|NCT03606980|590158688|FG000|Overall Study|Lost to Follow-up|3|||
163197353|NCT00679432|589437548|FG003|Overall Study|Physician Decision|2|||
163197354|NCT00679432|589437545|FG000|Overall Study|Sponsor decision|1|||
163197355|NCT00679432|589437546|FG001|Overall Study|Sponsor decision|0|||
163197356|NCT00679432|589437547|FG002|Overall Study|Sponsor decision|0|||
163197357|NCT00679432|589437548|FG003|Overall Study|Sponsor decision|0|||
163197358|NCT00679432|589437545|FG000|Overall Study|Lack of Efficacy|13|||
163197359|NCT00679432|589437546|FG001|Overall Study|Lack of Efficacy|9|||
163197360|NCT00679432|589437547|FG002|Overall Study|Lack of Efficacy|14|||
162961364|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961365|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961366|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961367|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961368|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961369|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961370|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961371|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961372|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961373|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961374|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961375|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961376|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961377|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961378|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961379|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
162961380|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
162961381|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
162961382|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
162961383|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
162961384|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
162961385|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
163303697|NCT05368558|589819814|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163303698|NCT05368558|589819815|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163303699|NCT05368558|589819816|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
163303700|NCT05368558|589819817|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163303701|NCT05368558|589819818|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
163047732|NCT00490971|588881266|FG002|Acute/Continuation|Death|0|||
163047733|NCT00490971|588881267|FG003|Acute/Continuation|Death|0|||
163197361|NCT00679432|589437548|FG003|Overall Study|Lack of Efficacy|8|||
163197362|NCT00679432|589437545|FG000|Overall Study|Infectious colitis, normal histology|5|||
163197363|NCT00679432|589437546|FG001|Overall Study|Infectious colitis, normal histology|4|||
163197364|NCT00679432|589437547|FG002|Overall Study|Infectious colitis, normal histology|8|||
163197365|NCT00679432|589437548|FG003|Overall Study|Infectious colitis, normal histology|3|||
163197366|NCT00679432|589437545|FG000|Overall Study|Randomization error, return to prior Rx|0|||
163197367|NCT00679432|589437546|FG001|Overall Study|Randomization error, return to prior Rx|0|||
163197368|NCT00679432|589437547|FG002|Overall Study|Randomization error, return to prior Rx|3|||
163197369|NCT00679432|589437548|FG003|Overall Study|Randomization error, return to prior Rx|0|||
163197370|NCT00824720|589437549|FG000|Overall Study|failed plug insertion|3|||
163197371|NCT00824720|589437550|FG001|Overall Study|failed plug insertion|1|||
163197372|NCT00824720|589437551|FG002|Overall Study|failed plug insertion|0|||
163197373|NCT00824720|589437549|FG000|Overall Study|Protocol Violation|0|||
163197374|NCT00824720|589437550|FG001|Overall Study|Protocol Violation|0|||
163197375|NCT00824720|589437551|FG002|Overall Study|Protocol Violation|1|||
163197376|NCT01558271|589437554|FG000|Overall Study|Adverse Event|6|||
163197377|NCT01558271|589437555|FG001|Overall Study|Adverse Event|3|||
163197378|NCT01558271|589437556|FG002|Overall Study|Adverse Event|4|||
163197379|NCT01558271|589437554|FG000|Overall Study|Lost to Follow-up|1|||
163197380|NCT01558271|589437555|FG001|Overall Study|Lost to Follow-up|0|||
163197381|NCT01558271|589437556|FG002|Overall Study|Lost to Follow-up|0|||
163197382|NCT01558271|589437554|FG000|Overall Study|Protocol Violation|1|||
163197383|NCT01558271|589437555|FG001|Overall Study|Protocol Violation|0|||
163197384|NCT01558271|589437556|FG002|Overall Study|Protocol Violation|0|||
163197385|NCT01558271|589437554|FG000|Overall Study|Withdrawal by Subject|10|||
163197386|NCT01558271|589437555|FG001|Overall Study|Withdrawal by Subject|6|||
163197387|NCT01558271|589437556|FG002|Overall Study|Withdrawal by Subject|12|||
163197388|NCT01558271|589437554|FG000|Overall Study|Physician Decision|0|||
163197389|NCT01558271|589437555|FG001|Overall Study|Physician Decision|2|||
163197390|NCT01558271|589437556|FG002|Overall Study|Physician Decision|1|||
163197391|NCT02610725|589437557|FG000|Overall Study|Lost to Follow-up|197|||
163197392|NCT02610725|589437557|FG000|Overall Study|self-reported contraindication|9|||
163197393|NCT04094883|589437558|FG000|Overall Study|Withdrawal by Subject|1|||
163197394|NCT00743483|589437559|FG000|Baseline Period|Physician Decision|1|||
163197395|NCT00743483|589437559|FG000|Treatment Period|Adverse Event|1|||
163197396|NCT01084083|589437560|FG000|Overall Study|Adverse Event|5|||
163197397|NCT01084083|589437560|FG000|Overall Study|Death|1|||
163197398|NCT01084083|589437560|FG000|Overall Study|Withdrawal by Subject|2|||
163197399|NCT01084083|589437560|FG000|Overall Study|Complicating disease|1|||
163197400|NCT01084083|589437560|FG000|Overall Study|Other|2|||
163197401|NCT01084083|589437560|FG000|Overall Study|Never started assigned therapy|1|||
163197402|NCT00873912|589437562|FG000|Overall Study|Withdrawal by Subject|1|||
163197403|NCT00873912|589437563|FG001|Overall Study|Withdrawal by Subject|0|||
163197404|NCT00873912|589437562|FG000|Overall Study|Lost to Follow-up|2|||
163197405|NCT00873912|589437563|FG001|Overall Study|Lost to Follow-up|0|||
163197406|NCT05570500|589437566|FG000|Overall Study|Lost to Follow-up|7|||
163197407|NCT05570500|589437567|FG001|Overall Study|Lost to Follow-up|5|||
163197408|NCT01095731|589437568|FG000|Overall Study|Protocol Violation|1|||
163197409|NCT01095731|589437569|FG001|Overall Study|Protocol Violation|1|||
163197410|NCT01095731|589437568|FG000|Overall Study|Withdrawal by Subject|0|||
163197411|NCT01095731|589437569|FG001|Overall Study|Withdrawal by Subject|1|||
163197412|NCT02302807|589437572|FG000|Overall Study|Withdrawal by Subject|28|||
163197413|NCT02302807|589437573|FG001|Overall Study|Withdrawal by Subject|11|||
163197414|NCT02302807|589437572|FG000|Overall Study|Lost to Follow-up|4|||
163197415|NCT02302807|589437573|FG001|Overall Study|Lost to Follow-up|6|||
163197416|NCT02302807|589437572|FG000|Overall Study|Death|397|||
163197417|NCT02302807|589437573|FG001|Overall Study|Death|385|||
163197418|NCT02302807|589437572|FG000|Overall Study|Study Terminated By Sponsor|35|||
163197419|NCT02302807|589437573|FG001|Overall Study|Study Terminated By Sponsor|64|||
163197420|NCT02302807|589437572|FG000|Overall Study|Physician Decision|0|||
163197421|NCT02302807|589437573|FG001|Overall Study|Physician Decision|1|||
163197422|NCT01980940|589437575|FG000|Overall Study|Protocol Violation|0|||
163197423|NCT01980940|589437576|FG001|Overall Study|Protocol Violation|0|||
163197424|NCT01980940|589437577|FG002|Overall Study|Protocol Violation|0|||
163197425|NCT01980940|589437578|FG003|Overall Study|Protocol Violation|0|||
163197426|NCT01980940|589437579|FG004|Overall Study|Protocol Violation|0|||
163197427|NCT01980940|589437580|FG005|Overall Study|Protocol Violation|2|||
163197428|NCT01980940|589437581|FG006|Overall Study|Protocol Violation|0|||
163197429|NCT01980940|589437582|FG007|Overall Study|Protocol Violation|0|||
163197430|NCT04731363|589437586|FG000|Overall Study|Could not obtain samples|0|||
163047734|NCT00490971|588881268|FG004|Acute/Continuation|Death|0|||
163197431|NCT04731363|589437587|FG001|Overall Study|Could not obtain samples|1|||
163197432|NCT04731363|589437588|FG002|Overall Study|Could not obtain samples|0|||
163197433|NCT04731363|589437589|FG003|Overall Study|Could not obtain samples|0|||
163197434|NCT04731363|589437586|FG000|Overall Study|Physician Decision|0|||
163197435|NCT04731363|589437587|FG001|Overall Study|Physician Decision|1|||
163395516|NCT03606980|590158689|FG001|Overall Study|Lost to Follow-up|2|||
163395517|NCT03606980|590158690|FG002|Overall Study|Lost to Follow-up|3|||
163395518|NCT03606980|590158688|FG000|Overall Study|Withdrawal by Subject|1|||
163197436|NCT04731363|589437588|FG002|Overall Study|Physician Decision|0|||
163197437|NCT04731363|589437589|FG003|Overall Study|Physician Decision|0|||
163395519|NCT03606980|590158689|FG001|Overall Study|Withdrawal by Subject|0|||
163395520|NCT03606980|590158690|FG002|Overall Study|Withdrawal by Subject|4|||
163395521|NCT00911625|590158695|FG000|Overall Study|Lost to Follow-up|7|||
163197438|NCT03192462|589439223|FG000|Overall Study|Death|13|||
163197439|NCT03192462|589439224|FG001|Overall Study|Death|11|||
163197440|NCT03192462|589439225|FG002|Overall Study|Death|10|||
163197441|NCT03192462|589439223|FG000|Overall Study|Lost to Follow-up|0|||
163197442|NCT03192462|589439224|FG001|Overall Study|Lost to Follow-up|1|||
163197443|NCT03192462|589439225|FG002|Overall Study|Lost to Follow-up|0|||
163197444|NCT03187197|589439226|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
163197445|NCT03187197|589439227|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
163197446|NCT03187197|589439228|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
163197447|NCT03187197|589439226|FG000|Overall Study|Withdrawal by Subject|8|||
163197448|NCT03187197|589439227|FG001|Overall Study|Withdrawal by Subject|63|||
163197449|NCT03187197|589439228|FG002|Overall Study|Withdrawal by Subject|4|||
163197450|NCT03187197|589439226|FG000|Overall Study|Lost to Follow-up|1|||
163197451|NCT03187197|589439227|FG001|Overall Study|Lost to Follow-up|60|||
163395522|NCT00911625|590158696|FG001|Overall Study|Lost to Follow-up|0|||
163197452|NCT03187197|589439228|FG002|Overall Study|Lost to Follow-up|7|||
163197453|NCT03187197|589439226|FG000|Overall Study|Adverse Event|6|||
163303702|NCT05368558|589819819|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163303703|NCT05368558|589819820|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163303704|NCT05368558|589819821|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163303705|NCT05368558|589819822|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163303706|NCT05368558|589819823|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163303707|NCT05368558|589819824|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162961386|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
162961387|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
162961388|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
162961389|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
162961390|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
162961391|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
162961392|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
162961393|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
162961394|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
162961395|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
162961396|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
162961397|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
162961398|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
162961399|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
163303708|NCT05368558|589819813|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163395523|NCT02374021|590158701|FG000|Overall Study|Adverse Event|1|||
163395524|NCT02374021|590158702|FG001|Overall Study|Adverse Event|0|||
162978996|NCT03545191|588623546|FG000|Overall Study|Adverse Event|4|||
162961400|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
162961401|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
162961402|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
162961403|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
163047735|NCT00490971|588881264|FG000|Acute/Continuation|Lack of Efficacy|106|||
163047736|NCT00490971|588881265|FG001|Acute/Continuation|Lack of Efficacy|12|||
163047737|NCT00490971|588881266|FG002|Acute/Continuation|Lack of Efficacy|0|||
163047738|NCT00490971|588881267|FG003|Acute/Continuation|Lack of Efficacy|0|||
163047739|NCT00490971|588881268|FG004|Acute/Continuation|Lack of Efficacy|0|||
163047740|NCT00490971|588881264|FG000|Acute/Continuation|Lost to Follow-up|23|||
163047741|NCT00490971|588881265|FG001|Acute/Continuation|Lost to Follow-up|7|||
163047742|NCT00490971|588881266|FG002|Acute/Continuation|Lost to Follow-up|0|||
163047743|NCT00490971|588881267|FG003|Acute/Continuation|Lost to Follow-up|0|||
162961404|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
162961405|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
163047744|NCT00490971|588881268|FG004|Acute/Continuation|Lost to Follow-up|0|||
163047745|NCT00490971|588881264|FG000|Acute/Continuation|Protocol Violation|10|||
163047746|NCT00490971|588881265|FG001|Acute/Continuation|Protocol Violation|2|||
163047747|NCT00490971|588881266|FG002|Acute/Continuation|Protocol Violation|0|||
163047748|NCT00490971|588881267|FG003|Acute/Continuation|Protocol Violation|0|||
163047749|NCT00490971|588881268|FG004|Acute/Continuation|Protocol Violation|0|||
163047750|NCT00490971|588881264|FG000|Acute/Continuation|Withdrawal by Subject|92|||
163047751|NCT00490971|588881265|FG001|Acute/Continuation|Withdrawal by Subject|24|||
163047752|NCT00490971|588881266|FG002|Acute/Continuation|Withdrawal by Subject|0|||
163047753|NCT00490971|588881267|FG003|Acute/Continuation|Withdrawal by Subject|0|||
163197454|NCT03187197|589439227|FG001|Overall Study|Adverse Event|29|||
162961406|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961407|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961408|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961409|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961410|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
162961411|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
162961412|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961413|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961414|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
162961415|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961416|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961417|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961418|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961419|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961420|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961421|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961422|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961423|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961424|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961425|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
163197455|NCT03187197|589439228|FG002|Overall Study|Adverse Event|0|||
163197456|NCT03187197|589439226|FG000|Overall Study|Death|0|||
163197457|NCT03187197|589439227|FG001|Overall Study|Death|11|||
163197458|NCT03187197|589439228|FG002|Overall Study|Death|0|||
163197459|NCT03187197|589439226|FG000|Overall Study|Administrative problem|1|||
163197460|NCT03187197|589439227|FG001|Overall Study|Administrative problem|1|||
163197461|NCT03187197|589439228|FG002|Overall Study|Administrative problem|0|||
163197462|NCT03187197|589439226|FG000|Overall Study|Reason not listed|2|||
163197463|NCT03187197|589439227|FG001|Overall Study|Reason not listed|54|||
163197464|NCT03187197|589439228|FG002|Overall Study|Reason not listed|1|||
163395525|NCT02374021|590158701|FG000|Overall Study|Lost to Follow-up|3|||
162961426|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961427|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961428|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961429|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961430|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961431|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961432|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961433|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961434|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961435|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961436|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961437|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
163047754|NCT00490971|588881268|FG004|Acute/Continuation|Withdrawal by Subject|0|||
163047755|NCT00490971|588881264|FG000|Acute/Continuation|Other|11|||
163047756|NCT00490971|588881265|FG001|Acute/Continuation|Other|4|||
163197465|NCT03187197|589439226|FG000|Overall Study|Missing|1|||
163197466|NCT03187197|589439227|FG001|Overall Study|Missing|32|||
163047757|NCT00490971|588881266|FG002|Acute/Continuation|Other|0|||
163047758|NCT00490971|588881267|FG003|Acute/Continuation|Other|0|||
163047759|NCT00490971|588881268|FG004|Acute/Continuation|Other|0|||
163047760|NCT00490971|588881264|FG000|Maintenance|Adverse Event|0|||
163047761|NCT00490971|588881265|FG001|Maintenance|Adverse Event|0|||
163047762|NCT00490971|588881266|FG002|Maintenance|Adverse Event|4|||
163047763|NCT00490971|588881267|FG003|Maintenance|Adverse Event|5|||
163047764|NCT00490971|588881268|FG004|Maintenance|Adverse Event|7|||
163047765|NCT00490971|588881264|FG000|Maintenance|Death|0|||
163047766|NCT00490971|588881265|FG001|Maintenance|Death|0|||
163047767|NCT00490971|588881266|FG002|Maintenance|Death|0|||
163047768|NCT00490971|588881267|FG003|Maintenance|Death|2|||
163047769|NCT00490971|588881268|FG004|Maintenance|Death|0|||
163047770|NCT00490971|588881264|FG000|Maintenance|Lost to Follow-up|0|||
163047771|NCT00490971|588881265|FG001|Maintenance|Lost to Follow-up|0|||
163047772|NCT00490971|588881266|FG002|Maintenance|Lost to Follow-up|5|||
163047773|NCT00490971|588881267|FG003|Maintenance|Lost to Follow-up|8|||
163047774|NCT00490971|588881268|FG004|Maintenance|Lost to Follow-up|10|||
163047775|NCT00490971|588881264|FG000|Maintenance|Pregnancy|0|||
163047776|NCT00490971|588881265|FG001|Maintenance|Pregnancy|0|||
163047777|NCT00490971|588881266|FG002|Maintenance|Pregnancy|1|||
163047778|NCT00490971|588881267|FG003|Maintenance|Pregnancy|0|||
163047779|NCT00490971|588881268|FG004|Maintenance|Pregnancy|0|||
163047780|NCT00490971|588881264|FG000|Maintenance|Protocol Violation|0|||
163047781|NCT00490971|588881265|FG001|Maintenance|Protocol Violation|0|||
163047782|NCT00490971|588881266|FG002|Maintenance|Protocol Violation|4|||
163047783|NCT00490971|588881267|FG003|Maintenance|Protocol Violation|1|||
163047784|NCT00490971|588881268|FG004|Maintenance|Protocol Violation|1|||
163047785|NCT00490971|588881264|FG000|Maintenance|Withdrawal by Subject|0|||
163047786|NCT00490971|588881265|FG001|Maintenance|Withdrawal by Subject|0|||
163047787|NCT00490971|588881266|FG002|Maintenance|Withdrawal by Subject|26|||
163047788|NCT00490971|588881267|FG003|Maintenance|Withdrawal by Subject|28|||
163047789|NCT00490971|588881268|FG004|Maintenance|Withdrawal by Subject|18|||
163047790|NCT00490971|588881264|FG000|Maintenance|Other|0|||
163047791|NCT00490971|588881265|FG001|Maintenance|Other|0|||
163047792|NCT00490971|588881266|FG002|Maintenance|Other|11|||
163047793|NCT00490971|588881267|FG003|Maintenance|Other|9|||
163047794|NCT00490971|588881268|FG004|Maintenance|Other|3|||
163047795|NCT03999749|588881270|FG000|Overall Study|Toxicity|16|||
163047796|NCT03999749|588881270|FG000|Overall Study|Withdrawal by Subject|3|||
163047797|NCT03999749|588881270|FG000|Overall Study|Disease progression|26|||
163047798|NCT03999749|588881270|FG000|Overall Study|Physician Decision|4|||
163047799|NCT03999749|588881270|FG000|Overall Study|Death|5|||
163047800|NCT03999749|588881270|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
163047801|NCT00255164|588881271|FG000|Overall Study|Adverse Event|10|||
163047802|NCT00255164|588881272|FG001|Overall Study|Adverse Event|6|||
163047803|NCT00255164|588881273|FG002|Overall Study|Adverse Event|9|||
163047804|NCT00255164|588881271|FG000|Overall Study|Lost to Follow-up|4|||
163047805|NCT00255164|588881272|FG001|Overall Study|Lost to Follow-up|3|||
163047806|NCT00255164|588881273|FG002|Overall Study|Lost to Follow-up|4|||
163047807|NCT00255164|588881271|FG000|Overall Study|Withdrawal by Subject|18|||
163047808|NCT00255164|588881272|FG001|Overall Study|Withdrawal by Subject|17|||
163047809|NCT00255164|588881273|FG002|Overall Study|Withdrawal by Subject|8|||
163047810|NCT00255164|588881271|FG000|Overall Study|Noncompliance|0|||
163047811|NCT00255164|588881272|FG001|Overall Study|Noncompliance|1|||
163047812|NCT00255164|588881273|FG002|Overall Study|Noncompliance|2|||
163047813|NCT00255164|588881271|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
163047814|NCT00255164|588881272|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
163047815|NCT00255164|588881273|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
163047816|NCT00255164|588881271|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
163197467|NCT03187197|589439228|FG002|Overall Study|Missing|3|||
163197468|NCT03187197|589439226|FG000|Overall Study|Status missing|2|||
163197469|NCT03187197|589439227|FG001|Overall Study|Status missing|33|||
163197470|NCT03187197|589439228|FG002|Overall Study|Status missing|3|||
163197471|NCT03187197|589439226|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
163197472|NCT03187197|589439227|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
163047817|NCT00255164|588881272|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
163047818|NCT00255164|588881273|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
163047819|NCT00255164|588881271|FG000|Overall Study|Possible Barrett's Esophagus|1|||
163047820|NCT00255164|588881272|FG001|Overall Study|Possible Barrett's Esophagus|3|||
163047821|NCT00255164|588881273|FG002|Overall Study|Possible Barrett's Esophagus|8|||
163047822|NCT00255164|588881271|FG000|Overall Study|Esophageal Stricture|0|||
163047823|NCT00255164|588881272|FG001|Overall Study|Esophageal Stricture|0|||
163047824|NCT00255164|588881273|FG002|Overall Study|Esophageal Stricture|1|||
163047825|NCT00255164|588881271|FG000|Overall Study|Therapeutic Failure|11|||
163197473|NCT03187197|589439228|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
163197474|NCT00982137|589439229|FG000|Overall Study|Lost to Follow-up|0|||
163047826|NCT00255164|588881272|FG001|Overall Study|Therapeutic Failure|2|||
163047827|NCT00255164|588881273|FG002|Overall Study|Therapeutic Failure|3|||
163047828|NCT00419757|588882608|FG000|Overall Study|Adverse Event|1|||
163047829|NCT00419757|588882609|FG001|Overall Study|Adverse Event|4|||
163197475|NCT00982137|589439230|FG001|Overall Study|Lost to Follow-up|0|||
163197476|NCT00982137|589439231|FG002|Overall Study|Lost to Follow-up|0|||
163197477|NCT00982137|589439232|FG003|Overall Study|Lost to Follow-up|1|||
163303709|NCT05368558|589819814|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163303710|NCT05368558|589819815|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163303711|NCT05368558|589819816|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
163303712|NCT05368558|589819817|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163047830|NCT00419757|588882608|FG000|Overall Study|Lost to Follow-up|1|||
163197478|NCT00982137|589439229|FG000|Overall Study|Withdrawal by Subject|0|||
163197479|NCT00982137|589439230|FG001|Overall Study|Withdrawal by Subject|1|||
163197480|NCT00982137|589439231|FG002|Overall Study|Withdrawal by Subject|0|||
163197481|NCT00982137|589439232|FG003|Overall Study|Withdrawal by Subject|0|||
163395526|NCT02374021|590158702|FG001|Overall Study|Lost to Follow-up|2|||
163395527|NCT02374021|590158701|FG000|Overall Study|Physician Decision|0|||
163197482|NCT00126191|589439233|FG000|Overall Study|Physician Decision|0|||
162961438|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961439|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
162961440|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162978997|NCT03545191|588623547|FG001|Overall Study|Adverse Event|2|||
163047831|NCT00419757|588882609|FG001|Overall Study|Lost to Follow-up|4|||
163395528|NCT02374021|590158702|FG001|Overall Study|Physician Decision|3|||
163303713|NCT05368558|589819818|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163303714|NCT05368558|589819819|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163303715|NCT05368558|589819820|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163303716|NCT05368558|589819821|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163303717|NCT05368558|589819822|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163303718|NCT05368558|589819823|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163047832|NCT00419757|588882608|FG000|Overall Study|Withdrawal by Subject|7|||
163047833|NCT00419757|588882609|FG001|Overall Study|Withdrawal by Subject|1|||
163047834|NCT00419757|588882608|FG000|Overall Study|Protocol Violation|2|||
163303719|NCT05368558|589819824|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163303720|NCT05368558|589819813|FG000|Blinded Extension Period (BEP)|other|0|||
163303721|NCT05368558|589819814|FG001|Blinded Extension Period (BEP)|other|0|||
163047835|NCT00419757|588882609|FG001|Overall Study|Protocol Violation|3|||
163047836|NCT00419757|588882608|FG000|Overall Study|Study specific discontinuation criteria|4|||
163047837|NCT00419757|588882609|FG001|Overall Study|Study specific discontinuation criteria|8|||
163047838|NCT00419757|588882608|FG000|Overall Study|Multiple reasons|3|||
163303722|NCT05368558|589819815|FG002|Blinded Extension Period (BEP)|other|0|||
163303723|NCT05368558|589819816|FG003|Blinded Extension Period (BEP)|other|0|||
163303724|NCT05368558|589819817|FG004|Blinded Extension Period (BEP)|other|0|||
163303725|NCT05368558|589819818|FG005|Blinded Extension Period (BEP)|other|1|||
163047839|NCT00419757|588882609|FG001|Overall Study|Multiple reasons|1|||
163303726|NCT05368558|589819819|FG006|Blinded Extension Period (BEP)|other|0|||
163303727|NCT05368558|589819820|FG007|Blinded Extension Period (BEP)|other|0|||
163395529|NCT02374021|590158701|FG000|Overall Study|Withdrawal by Subject|6|||
163395530|NCT02374021|590158702|FG001|Overall Study|Withdrawal by Subject|5|||
163395531|NCT02374021|590158701|FG000|Overall Study|Poor Adherence|0|||
163395532|NCT02374021|590158702|FG001|Overall Study|Poor Adherence|1|||
163395533|NCT02374021|590158701|FG000|Overall Study|Scan protocol not followed|0|||
163395534|NCT02374021|590158702|FG001|Overall Study|Scan protocol not followed|1|||
163395535|NCT02374021|590158701|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
163395536|NCT02374021|590158702|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
163395537|NCT00732251|590158703|FG000|Overall Study|Lost to Follow-up|3|||
163395538|NCT00732251|590158703|FG000|Overall Study|Withdrawal by Subject|3|||
163395539|NCT00732251|590158703|FG000|Overall Study|Early Term due to Site Closure|1|||
163395540|NCT01848288|590160985|FG000|Overall Study|Death|1|||
163395541|NCT01848288|590160985|FG000|Overall Study|Protocol Violation|1|||
163395542|NCT01848288|590160985|FG000|Overall Study|Withdrawal by Subject|1|||
163395543|NCT01007032|590160986|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
163395544|NCT01007032|590160987|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
162961441|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961442|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
163197483|NCT00126191|589439234|FG001|Overall Study|Physician Decision|1|||
163197484|NCT00126191|589439233|FG000|Overall Study|Death|0|||
163197485|NCT00126191|589439234|FG001|Overall Study|Death|1|||
163197486|NCT00674700|589439246|FG000|Year 1|Adverse Event|17|||
163197487|NCT00674700|589439247|FG001|Year 1|Adverse Event|20|||
163197488|NCT00674700|589439248|FG002|Year 1|Adverse Event|5|||
163197489|NCT00674700|589439246|FG000|Year 1|Withdrawal by Subject|7|||
163197490|NCT00674700|589439247|FG001|Year 1|Withdrawal by Subject|7|||
163197491|NCT00674700|589439248|FG002|Year 1|Withdrawal by Subject|6|||
163197492|NCT00674700|589439246|FG000|Year 1|Any other reason not above-mentioned|7|||
163197493|NCT00674700|589439247|FG001|Year 1|Any other reason not above-mentioned|7|||
163197494|NCT00674700|589439248|FG002|Year 1|Any other reason not above-mentioned|6|||
163197495|NCT00674700|589439246|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
163197496|NCT00674700|589439247|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
163197497|NCT00674700|589439248|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
163197498|NCT00674700|589439246|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
163197499|NCT00674700|589439247|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
163197500|NCT00674700|589439248|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
163197501|NCT00674700|589439246|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
163197502|NCT00674700|589439247|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
163197503|NCT00674700|589439248|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
163197504|NCT02732119|589439253|FG000|Phase I|Adverse Event|1|||
163197505|NCT02732119|589439254|FG001|Phase I|Adverse Event|3|||
163197506|NCT02732119|589439255|FG002|Phase I|Adverse Event|1|||
163197507|NCT02732119|589439256|FG003|Phase I|Adverse Event|0|||
163197508|NCT02732119|589439257|FG004|Phase I|Adverse Event|0|||
163197509|NCT02732119|589439253|FG000|Phase I|Progressive disease|7|||
163197510|NCT02732119|589439254|FG001|Phase I|Progressive disease|3|||
163197511|NCT02732119|589439255|FG002|Phase I|Progressive disease|2|||
163197512|NCT02732119|589439256|FG003|Phase I|Progressive disease|0|||
163197513|NCT02732119|589439257|FG004|Phase I|Progressive disease|0|||
163197514|NCT02732119|589439253|FG000|Phase I|Protocol deviation|0|||
163197515|NCT02732119|589439254|FG001|Phase I|Protocol deviation|1|||
163197516|NCT02732119|589439255|FG002|Phase I|Protocol deviation|0|||
163197517|NCT02732119|589439256|FG003|Phase I|Protocol deviation|0|||
163197518|NCT02732119|589439257|FG004|Phase I|Protocol deviation|0|||
163197519|NCT02732119|589439253|FG000|Phase I|Physician Decision|0|||
163197520|NCT02732119|589439254|FG001|Phase I|Physician Decision|3|||
163197521|NCT02732119|589439255|FG002|Phase I|Physician Decision|4|||
163197522|NCT02732119|589439256|FG003|Phase I|Physician Decision|0|||
163197523|NCT02732119|589439257|FG004|Phase I|Physician Decision|0|||
163197524|NCT02732119|589439253|FG000|Phase II|Adverse Event|0|||
163197525|NCT02732119|589439254|FG001|Phase II|Adverse Event|0|||
163197526|NCT02732119|589439255|FG002|Phase II|Adverse Event|0|||
163197527|NCT02732119|589439256|FG003|Phase II|Adverse Event|3|||
163197528|NCT02732119|589439257|FG004|Phase II|Adverse Event|3|||
163197529|NCT02732119|589439253|FG000|Phase II|Death|0|||
163197530|NCT02732119|589439254|FG001|Phase II|Death|0|||
163197531|NCT02732119|589439255|FG002|Phase II|Death|0|||
163197532|NCT02732119|589439256|FG003|Phase II|Death|1|||
163197533|NCT02732119|589439257|FG004|Phase II|Death|0|||
163197534|NCT02732119|589439253|FG000|Phase II|Progressive dissease|0|||
163197535|NCT02732119|589439254|FG001|Phase II|Progressive dissease|0|||
163197536|NCT02732119|589439255|FG002|Phase II|Progressive dissease|0|||
163197537|NCT02732119|589439256|FG003|Phase II|Progressive dissease|30|||
163197538|NCT02732119|589439257|FG004|Phase II|Progressive dissease|23|||
163197539|NCT02732119|589439253|FG000|Phase II|Study terminated by sponsor|0|||
163197540|NCT02732119|589439254|FG001|Phase II|Study terminated by sponsor|0|||
163197541|NCT02732119|589439255|FG002|Phase II|Study terminated by sponsor|0|||
163197542|NCT02732119|589439256|FG003|Phase II|Study terminated by sponsor|2|||
163303728|NCT05368558|589819821|FG008|Blinded Extension Period (BEP)|other|0|||
163303729|NCT05368558|589819822|FG009|Blinded Extension Period (BEP)|other|0|||
163303730|NCT05368558|589819823|FG010|Blinded Extension Period (BEP)|other|0|||
163303731|NCT05368558|589819824|FG011|Blinded Extension Period (BEP)|other|0|||
163303732|NCT01303445|589819825|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
163303733|NCT01303445|589819826|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
163303734|NCT01303445|589819825|FG000|Second Intervention (7 Days)|Adverse Event|0|||
163303735|NCT01303445|589819826|FG001|Second Intervention (7 Days)|Adverse Event|2|||
163303736|NCT01303445|589819825|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
163303737|NCT01303445|589819826|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
163303738|NCT01303445|589819825|FG000|Washout (14 Days)|Protocol Violation|1|||
163303739|NCT01303445|589819826|FG001|Washout (14 Days)|Protocol Violation|0|||
163303740|NCT01303445|589819825|FG000|Washout (14 Days)|Lost to Follow-up|0|||
163303741|NCT01303445|589819826|FG001|Washout (14 Days)|Lost to Follow-up|2|||
163303742|NCT01303445|589819825|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
163303743|NCT01303445|589819826|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
163303744|NCT01303445|589819825|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
163395545|NCT01007032|590160988|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
163395546|NCT01007032|590160989|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
163395547|NCT01007032|590160986|FG000|Overall Study|Withdrawal by Subject|0|||
163303745|NCT01303445|589819826|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
163303746|NCT05094141|589819830|FG000|Overall Study|Death|0|||
163303747|NCT05094141|589819831|FG001|Overall Study|Death|0|||
163303748|NCT05094141|589819832|FG002|Overall Study|Death|1|||
163303749|NCT05094141|589819830|FG000|Overall Study|Withdrawal by Subject|0|||
163395548|NCT01007032|590160987|FG001|Overall Study|Withdrawal by Subject|0|||
163303750|NCT05094141|589819831|FG001|Overall Study|Withdrawal by Subject|0|||
163303751|NCT05094141|589819832|FG002|Overall Study|Withdrawal by Subject|1|||
163303752|NCT05094141|589819830|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
163303753|NCT05094141|589819831|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
163303754|NCT05094141|589819832|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
163303755|NCT05094141|589819830|FG000|Overall Study|Did not participate in randomization|0|||
163303756|NCT05094141|589819831|FG001|Overall Study|Did not participate in randomization|0|||
163303757|NCT05094141|589819832|FG002|Overall Study|Did not participate in randomization|33|||
163303758|NCT05134337|589821719|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
163303759|NCT05134337|589821720|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
163303760|NCT04923347|589821721|FG000|Overall Study|Withdrawal by Subject|14|||
163303761|NCT03398148|589821722|FG000|Substudy 1 Period 1|Adverse Event|5|||
163303762|NCT03398148|589821723|FG001|Substudy 1 Period 1|Adverse Event|2|||
163303763|NCT03398148|589821724|FG002|Substudy 1 Period 1|Adverse Event|2|||
163303764|NCT03398148|589821725|FG003|Substudy 1 Period 1|Adverse Event|0|||
163303765|NCT03398148|589821726|FG004|Substudy 1 Period 1|Adverse Event|8|||
163303766|NCT03398148|589821727|FG005|Substudy 1 Period 1|Adverse Event|0|||
163303767|NCT03398148|589821728|FG006|Substudy 1 Period 1|Adverse Event|0|||
163303768|NCT03398148|589821729|FG007|Substudy 1 Period 1|Adverse Event|0|||
163303769|NCT03398148|589821730|FG008|Substudy 1 Period 1|Adverse Event|0|||
163303770|NCT03398148|589821731|FG009|Substudy 1 Period 1|Adverse Event|0|||
163303771|NCT03398148|589821732|FG010|Substudy 1 Period 1|Adverse Event|0|||
163303772|NCT03398148|589821733|FG011|Substudy 1 Period 1|Adverse Event|0|||
163303773|NCT03398148|589821734|FG012|Substudy 1 Period 1|Adverse Event|0|||
163197543|NCT02732119|589439257|FG004|Phase II|Study terminated by sponsor|2|||
163197544|NCT02732119|589439253|FG000|Phase II|Other|0|||
163197545|NCT02732119|589439254|FG001|Phase II|Other|0|||
163197546|NCT02732119|589439255|FG002|Phase II|Other|0|||
163197547|NCT02732119|589439256|FG003|Phase II|Other|2|||
163197548|NCT02732119|589439257|FG004|Phase II|Other|0|||
163197549|NCT02732119|589439253|FG000|Phase II|Physician Decision|0|||
163197550|NCT02732119|589439254|FG001|Phase II|Physician Decision|0|||
163197551|NCT02732119|589439255|FG002|Phase II|Physician Decision|0|||
163197552|NCT02732119|589439256|FG003|Phase II|Physician Decision|8|||
162961443|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
163197553|NCT02732119|589439257|FG004|Phase II|Physician Decision|5|||
163197554|NCT00964860|589439258|FG000|Overall Study|Withdrawal by Subject|0|||
163197555|NCT00964860|589439259|FG001|Overall Study|Withdrawal by Subject|1|||
163197556|NCT02585960|589439260|FG000|PK/Safety Assessment Period|Physician Decision|0|||
162961444|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961445|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961446|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961447|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961448|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961449|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961450|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961451|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961452|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961453|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961454|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961455|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961456|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961457|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961458|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961459|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961460|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961461|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961462|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961463|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
163047840|NCT03934216|588882617|FG000|Overall Study|Other Reasons|5|||
163047841|NCT03934216|588882618|FG001|Overall Study|Other Reasons|5|||
163197557|NCT02585960|589439261|FG001|PK/Safety Assessment Period|Physician Decision|1|||
163197558|NCT02585960|589439262|FG002|PK/Safety Assessment Period|Physician Decision|0|||
163197559|NCT02585960|589439260|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
163197560|NCT02585960|589439261|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
163197561|NCT02585960|589439262|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
163197562|NCT02585960|589439260|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
163197563|NCT02585960|589439261|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
163197564|NCT02585960|589439262|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
163197565|NCT02585960|589439260|FG000|PK/Safety Assessment Period|Other|4|||
163197566|NCT02585960|589439261|FG001|PK/Safety Assessment Period|Other|4|||
163197567|NCT02585960|589439262|FG002|PK/Safety Assessment Period|Other|0|||
163197568|NCT02585960|589439260|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
163197569|NCT02585960|589439261|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
163197570|NCT02585960|589439262|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
163197571|NCT02585960|589439260|FG000|PK/Safety Assessment Period|Screen Failure|0|||
163197572|NCT02585960|589439261|FG001|PK/Safety Assessment Period|Screen Failure|0|||
163197573|NCT02585960|589439262|FG002|PK/Safety Assessment Period|Screen Failure|1|||
163197574|NCT02585960|589439260|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
163197575|NCT02585960|589439261|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
163197576|NCT02585960|589439262|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
163197577|NCT02585960|589439260|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
163197578|NCT02585960|589439261|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
163197579|NCT02585960|589439262|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
163197580|NCT06333613|589439264|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
163197581|NCT01847274|589439265|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
163197582|NCT01847274|589439266|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
163197583|NCT01847274|589439267|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
163303774|NCT03398148|589821735|FG013|Substudy 1 Period 1|Adverse Event|0|||
163303775|NCT03398148|589821736|FG014|Substudy 1 Period 1|Adverse Event|0|||
163303776|NCT03398148|589821722|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
163047842|NCT03934216|588882617|FG000|Overall Study|Adverse Event|22|||
163197584|NCT01847274|589439268|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
163197585|NCT01847274|589439269|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
163197586|NCT01847274|589439270|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
163197587|NCT01847274|589439271|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
163197588|NCT01847274|589439272|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
163197589|NCT01847274|589439273|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
163197590|NCT01847274|589439274|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
163197591|NCT01847274|589439275|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
163197592|NCT01847274|589439265|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
163197593|NCT01847274|589439266|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
163197594|NCT01847274|589439267|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
162961464|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961465|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
162961466|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961467|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961468|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
163047843|NCT03934216|588882618|FG001|Overall Study|Adverse Event|11|||
163197595|NCT01847274|589439268|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
163197596|NCT01847274|589439269|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
163303777|NCT03398148|589821723|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
163303778|NCT03398148|589821724|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163303779|NCT03398148|589821725|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
163303780|NCT03398148|589821726|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
163303781|NCT03398148|589821727|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163303782|NCT03398148|589821728|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163303783|NCT03398148|589821729|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163303784|NCT03398148|589821730|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163303785|NCT03398148|589821731|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163303786|NCT03398148|589821732|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163303787|NCT03398148|589821733|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163303788|NCT03398148|589821734|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163303789|NCT03398148|589821735|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163303790|NCT03398148|589821736|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163303791|NCT03398148|589821722|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
163303792|NCT03398148|589821723|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
163303793|NCT03398148|589821724|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
163303794|NCT03398148|589821725|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
163303795|NCT03398148|589821726|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
163303796|NCT03398148|589821727|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
163303797|NCT03398148|589821728|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
163303798|NCT03398148|589821729|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
163303799|NCT03398148|589821730|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
163303800|NCT03398148|589821731|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
163303801|NCT03398148|589821732|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
163303802|NCT03398148|589821733|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
163303803|NCT03398148|589821734|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
163303804|NCT03398148|589821735|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
163303805|NCT03398148|589821736|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
163303806|NCT03398148|589821722|FG000|Substudy 1 Period 1|Other|0|||
163303807|NCT03398148|589821723|FG001|Substudy 1 Period 1|Other|1|||
163303808|NCT03398148|589821724|FG002|Substudy 1 Period 1|Other|0|||
163303809|NCT03398148|589821725|FG003|Substudy 1 Period 1|Other|0|||
163303810|NCT03398148|589821726|FG004|Substudy 1 Period 1|Other|3|||
163303811|NCT03398148|589821727|FG005|Substudy 1 Period 1|Other|0|||
163303812|NCT03398148|589821728|FG006|Substudy 1 Period 1|Other|0|||
163303813|NCT03398148|589821729|FG007|Substudy 1 Period 1|Other|0|||
163303814|NCT03398148|589821730|FG008|Substudy 1 Period 1|Other|0|||
163303815|NCT03398148|589821731|FG009|Substudy 1 Period 1|Other|0|||
163303816|NCT03398148|589821732|FG010|Substudy 1 Period 1|Other|0|||
163303817|NCT03398148|589821733|FG011|Substudy 1 Period 1|Other|0|||
163303818|NCT03398148|589821734|FG012|Substudy 1 Period 1|Other|0|||
163303819|NCT03398148|589821735|FG013|Substudy 1 Period 1|Other|0|||
163303820|NCT03398148|589821736|FG014|Substudy 1 Period 1|Other|0|||
163303821|NCT03398148|589821722|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
163303822|NCT03398148|589821723|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
163303823|NCT03398148|589821724|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
163303824|NCT03398148|589821725|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
163303825|NCT03398148|589821726|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
163303826|NCT03398148|589821727|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
163303827|NCT03398148|589821728|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
163303828|NCT03398148|589821729|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
163303829|NCT03398148|589821730|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
163303830|NCT03398148|589821731|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
163303831|NCT03398148|589821732|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
163303832|NCT03398148|589821733|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
163303833|NCT03398148|589821734|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
163303834|NCT03398148|589821735|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
163303835|NCT03398148|589821736|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
163303836|NCT03398148|589821722|FG000|Substudy 1 Period 2|Adverse Event|0|||
163303837|NCT03398148|589821723|FG001|Substudy 1 Period 2|Adverse Event|0|||
163303838|NCT03398148|589821724|FG002|Substudy 1 Period 2|Adverse Event|0|||
163303839|NCT03398148|589821725|FG003|Substudy 1 Period 2|Adverse Event|0|||
163303840|NCT03398148|589821726|FG004|Substudy 1 Period 2|Adverse Event|0|||
163303841|NCT03398148|589821727|FG005|Substudy 1 Period 2|Adverse Event|2|||
163303842|NCT03398148|589821728|FG006|Substudy 1 Period 2|Adverse Event|4|||
163395549|NCT01007032|590160988|FG002|Overall Study|Withdrawal by Subject|0|||
163303843|NCT03398148|589821729|FG007|Substudy 1 Period 2|Adverse Event|0|||
163303844|NCT03398148|589821730|FG008|Substudy 1 Period 2|Adverse Event|0|||
163303845|NCT03398148|589821731|FG009|Substudy 1 Period 2|Adverse Event|0|||
163303846|NCT03398148|589821732|FG010|Substudy 1 Period 2|Adverse Event|0|||
163303847|NCT03398148|589821733|FG011|Substudy 1 Period 2|Adverse Event|0|||
163303848|NCT03398148|589821734|FG012|Substudy 1 Period 2|Adverse Event|0|||
163303849|NCT03398148|589821735|FG013|Substudy 1 Period 2|Adverse Event|0|||
163303850|NCT03398148|589821736|FG014|Substudy 1 Period 2|Adverse Event|0|||
163303851|NCT03398148|589821722|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163303852|NCT03398148|589821723|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163197597|NCT01847274|589439270|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
163197598|NCT01847274|589439271|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
163197599|NCT01847274|589439272|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
163197600|NCT01847274|589439273|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
163197601|NCT01847274|589439274|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
163197602|NCT01847274|589439275|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
163197603|NCT01847274|589439265|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
163197604|NCT01847274|589439266|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
163197605|NCT01847274|589439267|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
163197606|NCT01847274|589439268|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
163197607|NCT01847274|589439269|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
163197608|NCT01847274|589439270|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
163197609|NCT01847274|589439271|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
163197610|NCT01847274|589439272|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
163197611|NCT01847274|589439273|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
163197612|NCT01847274|589439274|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
163197613|NCT01847274|589439275|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
163197614|NCT01847274|589439265|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
163197615|NCT01847274|589439266|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
163197616|NCT01847274|589439267|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
163197617|NCT01847274|589439268|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
163197618|NCT01847274|589439269|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
163197619|NCT01847274|589439270|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
163197620|NCT01847274|589439271|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
163197621|NCT01847274|589439272|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
163197622|NCT01847274|589439273|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
163197623|NCT01847274|589439274|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
163197624|NCT01847274|589439275|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
163197625|NCT01847274|589439265|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
163197626|NCT01847274|589439266|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
163197627|NCT01847274|589439267|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
163197628|NCT01847274|589439268|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
163197629|NCT01847274|589439269|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
163197630|NCT01847274|589439270|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
163197631|NCT01847274|589439271|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
163197632|NCT01847274|589439272|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
163197633|NCT01847274|589439273|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
163197634|NCT01847274|589439274|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
163197635|NCT01847274|589439275|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
163197636|NCT01847274|589439265|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
163197637|NCT01847274|589439266|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
163197638|NCT01847274|589439267|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
163197639|NCT01847274|589439268|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
163197640|NCT01847274|589439269|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
163197641|NCT01847274|589439270|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
163197642|NCT01847274|589439271|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
163197643|NCT01847274|589439272|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
163197644|NCT01847274|589439273|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
163197645|NCT01847274|589439274|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
163197646|NCT01847274|589439275|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
163197647|NCT01847274|589439265|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
163197648|NCT01847274|589439266|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
163197649|NCT01847274|589439267|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
163047844|NCT03934216|588882617|FG000|Overall Study|Lack of Efficacy|8|||
163197650|NCT01847274|589439268|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
163197651|NCT01847274|589439269|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
163197652|NCT01847274|589439270|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
163197653|NCT01847274|589439271|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
163197654|NCT01847274|589439272|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
163197655|NCT01847274|589439273|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
163197656|NCT01847274|589439274|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
163197657|NCT01847274|589439275|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
163197658|NCT01847274|589439265|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
163197659|NCT01847274|589439266|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
163197660|NCT01847274|589439267|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
163197661|NCT01847274|589439268|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
163197662|NCT01847274|589439269|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
163197663|NCT01847274|589439270|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
163197664|NCT01847274|589439271|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
163197665|NCT01847274|589439272|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
163197666|NCT01847274|589439273|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
163197667|NCT01847274|589439274|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
163197668|NCT01847274|589439275|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
163197669|NCT01847274|589439265|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
163197670|NCT01847274|589439266|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
163197671|NCT01847274|589439267|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
163197672|NCT01847274|589439268|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
163197673|NCT01847274|589439269|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
163197674|NCT01847274|589439270|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
163197675|NCT01847274|589439271|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
163197676|NCT01847274|589439272|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
163197677|NCT01847274|589439273|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
163197678|NCT01847274|589439274|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
163197679|NCT01847274|589439275|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
163197680|NCT01847274|589439265|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
163197681|NCT01847274|589439266|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
163197682|NCT01847274|589439267|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
163197683|NCT01847274|589439268|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
163197684|NCT01847274|589439269|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
163395550|NCT01007032|590160989|FG003|Overall Study|Withdrawal by Subject|1|||
163395551|NCT02285920|590160990|FG000|Overall Study|Kidney transplantation|2|||
163197685|NCT01847274|589439270|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
163197686|NCT01847274|589439271|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
163303853|NCT03398148|589821724|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163303854|NCT03398148|589821725|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163303855|NCT03398148|589821726|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163303856|NCT03398148|589821727|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163303857|NCT03398148|589821728|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
163197687|NCT01847274|589439272|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
163197688|NCT01847274|589439273|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
163197689|NCT01847274|589439274|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
163197690|NCT01847274|589439275|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
163197691|NCT01847274|589439265|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
163197692|NCT01847274|589439266|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
163197693|NCT01847274|589439267|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
163197694|NCT01847274|589439268|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
163197695|NCT01847274|589439269|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
163197696|NCT01847274|589439270|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
163197697|NCT01847274|589439271|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
163197698|NCT01847274|589439272|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
163197699|NCT01847274|589439273|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
163197700|NCT01847274|589439274|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
163197701|NCT01847274|589439275|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
163197702|NCT01847274|589439265|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
163197703|NCT01847274|589439266|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
163197704|NCT01847274|589439267|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
163197705|NCT01847274|589439268|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
163197706|NCT01847274|589439269|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
163197707|NCT01847274|589439270|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
163197708|NCT01847274|589439271|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
163197709|NCT01847274|589439272|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
163197710|NCT01847274|589439273|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
163197711|NCT01847274|589439274|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
163197712|NCT01847274|589439275|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
163197713|NCT01847274|589439265|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
163197714|NCT01847274|589439266|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
163197715|NCT01847274|589439267|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
163197716|NCT01847274|589439268|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
163197717|NCT01847274|589439269|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
163197718|NCT01847274|589439270|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
163197719|NCT01847274|589439271|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
163197720|NCT01847274|589439272|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
163197721|NCT01847274|589439273|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
163197722|NCT01847274|589439274|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
163395552|NCT02285920|590160991|FG001|Overall Study|Kidney transplantation|2|||
163395553|NCT02285920|590160992|FG002|Overall Study|Kidney transplantation|2|||
163395554|NCT02285920|590160993|FG003|Overall Study|Kidney transplantation|0|||
163395555|NCT02285920|590160990|FG000|Overall Study|Change to peritoneal dialysis|0|||
163395556|NCT02285920|590160991|FG001|Overall Study|Change to peritoneal dialysis|0|||
163395557|NCT02285920|590160992|FG002|Overall Study|Change to peritoneal dialysis|1|||
163395558|NCT02285920|590160993|FG003|Overall Study|Change to peritoneal dialysis|0|||
163395559|NCT02285920|590160990|FG000|Overall Study|Transfer to non-participating unit|0|||
163395560|NCT02285920|590160991|FG001|Overall Study|Transfer to non-participating unit|1|||
163395561|NCT02285920|590160992|FG002|Overall Study|Transfer to non-participating unit|0|||
163395562|NCT02285920|590160993|FG003|Overall Study|Transfer to non-participating unit|0|||
163395563|NCT02285920|590160990|FG000|Overall Study|Dialysis discontinuation|0|||
163395564|NCT02285920|590160991|FG001|Overall Study|Dialysis discontinuation|1|||
163395565|NCT02285920|590160992|FG002|Overall Study|Dialysis discontinuation|0|||
163395566|NCT02285920|590160993|FG003|Overall Study|Dialysis discontinuation|0|||
163395567|NCT02285920|590160990|FG000|Overall Study|Death|2|||
163395568|NCT02285920|590160991|FG001|Overall Study|Death|0|||
163395569|NCT02285920|590160992|FG002|Overall Study|Death|2|||
163395570|NCT02285920|590160993|FG003|Overall Study|Death|1|||
163395571|NCT02716675|590160999|FG000|Overall Study|Death|2|||
163395572|NCT02716675|590161000|FG001|Overall Study|Death|3|||
163395573|NCT02716675|590161001|FG002|Overall Study|Death|0|||
163395574|NCT02716675|590160999|FG000|Overall Study|Physician Decision|2|||
163395575|NCT02716675|590161000|FG001|Overall Study|Physician Decision|1|||
163395576|NCT02716675|590161001|FG002|Overall Study|Physician Decision|1|||
163395577|NCT02716675|590160999|FG000|Overall Study|Lost to Follow-up|100|||
163395578|NCT02716675|590161000|FG001|Overall Study|Lost to Follow-up|87|||
163395579|NCT02716675|590161001|FG002|Overall Study|Lost to Follow-up|99|||
163395580|NCT02716675|590160999|FG000|Overall Study|Withdrawal by Subject|22|||
163395581|NCT02716675|590161000|FG001|Overall Study|Withdrawal by Subject|25|||
163395582|NCT02716675|590161001|FG002|Overall Study|Withdrawal by Subject|20|||
163395583|NCT02716675|590160999|FG000|Overall Study|Protocol Violation|0|||
163395584|NCT02716675|590161000|FG001|Overall Study|Protocol Violation|3|||
163395585|NCT02716675|590161001|FG002|Overall Study|Protocol Violation|1|||
163395586|NCT02716675|590160999|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
163395587|NCT02716675|590161000|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
163395588|NCT02716675|590161001|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
163395589|NCT02716675|590160999|FG000|Overall Study|Other|38|||
163395590|NCT02716675|590161000|FG001|Overall Study|Other|47|||
163395591|NCT02716675|590161001|FG002|Overall Study|Other|48|||
163395592|NCT00290290|590161002|FG000|Overall Study|Death|3|||
163395593|NCT00290290|590161003|FG001|Overall Study|Death|4|||
163395594|NCT00290290|590161002|FG000|Overall Study|Withdrawal by Subject|2|||
163395595|NCT00290290|590161003|FG001|Overall Study|Withdrawal by Subject|2|||
163395596|NCT00290290|590161002|FG000|Overall Study|Underwent clean surgical procedure|13|||
163395597|NCT00290290|590161003|FG001|Overall Study|Underwent clean surgical procedure|12|||
163197723|NCT01847274|589439275|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
163197724|NCT01847274|589439265|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
163197725|NCT01847274|589439266|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
163197726|NCT01847274|589439267|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
163197727|NCT01847274|589439268|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
163197728|NCT01847274|589439269|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
163197729|NCT01847274|589439270|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
163197730|NCT01847274|589439271|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
163197731|NCT01847274|589439272|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
163197732|NCT01847274|589439273|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
163197733|NCT01847274|589439274|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
163197734|NCT01847274|589439275|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
163197735|NCT01847274|589439265|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
163197736|NCT01847274|589439266|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
163197737|NCT01847274|589439267|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
163197738|NCT01847274|589439268|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
163197739|NCT01847274|589439269|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
163197740|NCT01847274|589439270|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
163197741|NCT01847274|589439271|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
163197742|NCT01847274|589439272|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
163197743|NCT01847274|589439273|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
163197744|NCT01847274|589439274|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
163197745|NCT01847274|589439275|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
163197746|NCT01847274|589439265|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
163197747|NCT01847274|589439266|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
163197748|NCT01847274|589439267|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
163197749|NCT01847274|589439268|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
163197750|NCT01847274|589439269|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
163197751|NCT01847274|589439270|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
163197752|NCT01847274|589439271|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
163197753|NCT01847274|589439272|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
163197754|NCT01847274|589439273|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
163197755|NCT01847274|589439274|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
163197756|NCT01847274|589439275|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
163197757|NCT02059395|589439277|FG000|Overall Study|Lost to Follow-up|2|||
163197758|NCT02059395|589439278|FG001|Overall Study|Lost to Follow-up|4|||
163197759|NCT00134082|589439279|FG000|Overall Study|Adverse Event|2|||
163197760|NCT00134082|589439279|FG000|Overall Study|Death|1|||
163047845|NCT03934216|588882618|FG001|Overall Study|Lack of Efficacy|7|||
163303858|NCT03398148|589821729|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
163303859|NCT03398148|589821730|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163303860|NCT03398148|589821731|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163303861|NCT03398148|589821732|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163303862|NCT03398148|589821733|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163303863|NCT03398148|589821734|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163303864|NCT03398148|589821735|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163303865|NCT03398148|589821736|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163303866|NCT03398148|589821722|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
163303867|NCT03398148|589821723|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
163303868|NCT03398148|589821724|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
163303869|NCT03398148|589821725|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
163303870|NCT03398148|589821726|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
163303871|NCT03398148|589821727|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
163303872|NCT03398148|589821728|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
163303873|NCT03398148|589821729|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
163303874|NCT03398148|589821730|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
163303875|NCT03398148|589821731|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
163303876|NCT03398148|589821732|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
163303877|NCT03398148|589821733|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
163303878|NCT03398148|589821734|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
163303879|NCT03398148|589821735|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
163303880|NCT03398148|589821736|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
163303881|NCT03398148|589821722|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303882|NCT03398148|589821723|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303883|NCT03398148|589821724|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303884|NCT03398148|589821725|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303885|NCT03398148|589821726|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303886|NCT03398148|589821727|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303887|NCT03398148|589821728|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
163303888|NCT03398148|589821729|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303889|NCT03398148|589821730|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303890|NCT03398148|589821731|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303891|NCT03398148|589821732|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303892|NCT03398148|589821733|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303893|NCT03398148|589821734|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303894|NCT03398148|589821735|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303895|NCT03398148|589821736|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303896|NCT03398148|589821722|FG000|Substudy 1 Period 2|Other|0|||
163303897|NCT03398148|589821723|FG001|Substudy 1 Period 2|Other|0|||
163303898|NCT03398148|589821724|FG002|Substudy 1 Period 2|Other|0|||
163303899|NCT03398148|589821725|FG003|Substudy 1 Period 2|Other|0|||
163303900|NCT03398148|589821726|FG004|Substudy 1 Period 2|Other|0|||
163303901|NCT03398148|589821727|FG005|Substudy 1 Period 2|Other|0|||
163047846|NCT03934216|588882617|FG000|Overall Study|Lost to Follow-up|2|||
163303902|NCT03398148|589821728|FG006|Substudy 1 Period 2|Other|1|||
163303903|NCT03398148|589821729|FG007|Substudy 1 Period 2|Other|0|||
163303904|NCT03398148|589821730|FG008|Substudy 1 Period 2|Other|0|||
163303905|NCT03398148|589821731|FG009|Substudy 1 Period 2|Other|0|||
163303906|NCT03398148|589821732|FG010|Substudy 1 Period 2|Other|0|||
163303907|NCT03398148|589821733|FG011|Substudy 1 Period 2|Other|0|||
163395598|NCT00003895|590161008|FG000|Overall Study|Adverse Event|4|||
163395599|NCT00003895|590161009|FG001|Overall Study|Adverse Event|0|||
163395600|NCT00003895|590161008|FG000|Overall Study|Lack of Efficacy|1|||
163395601|NCT00003895|590161009|FG001|Overall Study|Lack of Efficacy|1|||
163395602|NCT00003895|590161008|FG000|Overall Study|Patient Vacation|2|||
163395603|NCT00003895|590161009|FG001|Overall Study|Patient Vacation|0|||
163395604|NCT00003895|590161008|FG000|Overall Study|Withdrawal by Subject|0|||
163395605|NCT00003895|590161009|FG001|Overall Study|Withdrawal by Subject|3|||
163395606|NCT01380730|590161010|FG000|Overall Study|Death|0|||
163395607|NCT01380730|590161011|FG001|Overall Study|Death|0|||
163395608|NCT01380730|590161012|FG002|Overall Study|Death|0|||
163395609|NCT01380730|590161013|FG003|Overall Study|Death|0|||
163395610|NCT01380730|590161014|FG004|Overall Study|Death|1|||
163395611|NCT01380730|590161015|FG005|Overall Study|Death|0|||
163395612|NCT01380730|590161016|FG006|Overall Study|Death|0|||
163395613|NCT01380730|590161017|FG007|Overall Study|Death|0|||
163395614|NCT01179672|590161019|FG000|Overall Study|Adverse Event|17|||
163395615|NCT01179672|590161020|FG001|Overall Study|Adverse Event|8|||
163395616|NCT01179672|590161019|FG000|Overall Study|Withdrawal by Subject|10|||
163395617|NCT01179672|590161020|FG001|Overall Study|Withdrawal by Subject|12|||
163395618|NCT01179672|590161019|FG000|Overall Study|Entry Criteria Not Met|0|||
163395619|NCT01179672|590161020|FG001|Overall Study|Entry Criteria Not Met|2|||
163395620|NCT01179672|590161019|FG000|Overall Study|Lost to Follow-up|0|||
163395621|NCT01179672|590161020|FG001|Overall Study|Lost to Follow-up|1|||
163395622|NCT01179672|590161019|FG000|Overall Study|Protocol Violation|2|||
163395623|NCT01179672|590161020|FG001|Overall Study|Protocol Violation|2|||
163395624|NCT01179672|590161019|FG000|Overall Study|Physician Decision|1|||
163395625|NCT01179672|590161020|FG001|Overall Study|Physician Decision|1|||
163395626|NCT01994382|590161021|FG000|Overall Study|Informed consent withdrawn|0|||
163395627|NCT01994382|590161022|FG001|Overall Study|Informed consent withdrawn|0|||
163395628|NCT01994382|590161023|FG002|Overall Study|Informed consent withdrawn|0|||
163395629|NCT01994382|590161024|FG003|Overall Study|Informed consent withdrawn|0|||
163395630|NCT01994382|590161025|FG004|Overall Study|Informed consent withdrawn|0|||
163395631|NCT01994382|590161026|FG005|Overall Study|Informed consent withdrawn|0|||
163395632|NCT01994382|590161027|FG006|Overall Study|Informed consent withdrawn|1|||
163395633|NCT01994382|590161028|FG007|Overall Study|Informed consent withdrawn|0|||
163395634|NCT01994382|590161029|FG008|Overall Study|Informed consent withdrawn|0|||
163395635|NCT01994382|590161030|FG009|Overall Study|Informed consent withdrawn|0|||
163395636|NCT01994382|590161031|FG010|Overall Study|Informed consent withdrawn|0|||
163395637|NCT01994382|590161032|FG011|Overall Study|Informed consent withdrawn|0|||
163395638|NCT01994382|590161033|FG012|Overall Study|Informed consent withdrawn|0|||
163395639|NCT01994382|590161034|FG013|Overall Study|Informed consent withdrawn|0|||
163047847|NCT03934216|588882618|FG001|Overall Study|Lost to Follow-up|0|||
163395640|NCT01994382|590161035|FG014|Overall Study|Informed consent withdrawn|0|||
163395641|NCT01994382|590161036|FG015|Overall Study|Informed consent withdrawn|0|||
163395642|NCT01994382|590161037|FG016|Overall Study|Informed consent withdrawn|0|||
163395643|NCT01994382|590161021|FG000|Overall Study|Progressive disease|3|||
163395644|NCT01994382|590161022|FG001|Overall Study|Progressive disease|4|||
163395645|NCT01994382|590161023|FG002|Overall Study|Progressive disease|4|||
163395646|NCT01994382|590161024|FG003|Overall Study|Progressive disease|3|||
163395647|NCT01994382|590161025|FG004|Overall Study|Progressive disease|2|||
163395648|NCT01994382|590161026|FG005|Overall Study|Progressive disease|3|||
163395649|NCT01994382|590161027|FG006|Overall Study|Progressive disease|3|||
163395650|NCT01994382|590161028|FG007|Overall Study|Progressive disease|6|||
162961469|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961470|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
163197761|NCT00724932|589439282|FG000|Overall Study|Lost to Follow-up|1|||
163197762|NCT00724932|589439283|FG001|Overall Study|Lost to Follow-up|0|||
163197763|NCT00724932|589439282|FG000|Overall Study|Not treated|4|||
163197764|NCT00724932|589439283|FG001|Overall Study|Not treated|3|||
163197765|NCT02021331|589439284|FG000|Overall Study|Adverse Event|0|||
163197766|NCT02021331|589439285|FG001|Overall Study|Adverse Event|2|||
163197767|NCT01488370|589439286|FG000|Overall Study|Protocol Violation|0|||
163197768|NCT01488370|589439287|FG001|Overall Study|Protocol Violation|1|||
163197769|NCT01488370|589439288|FG002|Overall Study|Protocol Violation|1|||
163197770|NCT00288054|589439294|FG000|Overall Study|Protocol Violation|2|||
163197771|NCT00288054|589439294|FG000|Overall Study|Lack of Efficacy|16|||
163197772|NCT00288054|589439294|FG000|Overall Study|Adverse Event|3|||
163197773|NCT00288054|589439294|FG000|Overall Study|Withdrawal by Subject|1|||
163197774|NCT00288054|589439294|FG000|Overall Study|Not protocol specified|2|||
163197775|NCT02340975|589439308|FG000|Overall Study|Death|6|||
163197776|NCT02340975|589439309|FG001|Overall Study|Death|23|||
163197777|NCT02340975|589439310|FG002|Overall Study|Death|21|||
163197778|NCT02340975|589439311|FG003|Overall Study|Death|7|||
163197779|NCT02340975|589439312|FG004|Overall Study|Death|21|||
163197780|NCT02340975|589439313|FG005|Overall Study|Death|13|||
163197781|NCT02340975|589439308|FG000|Overall Study|Lost to Follow-up|0|||
163197782|NCT02340975|589439309|FG001|Overall Study|Lost to Follow-up|0|||
163197783|NCT02340975|589439310|FG002|Overall Study|Lost to Follow-up|0|||
163197784|NCT02340975|589439311|FG003|Overall Study|Lost to Follow-up|0|||
163197785|NCT02340975|589439312|FG004|Overall Study|Lost to Follow-up|2|||
163197786|NCT02340975|589439313|FG005|Overall Study|Lost to Follow-up|0|||
163197787|NCT02340975|589439308|FG000|Overall Study|Withdrawal by Subject|0|||
163197788|NCT02340975|589439309|FG001|Overall Study|Withdrawal by Subject|0|||
163197789|NCT02340975|589439310|FG002|Overall Study|Withdrawal by Subject|3|||
163197790|NCT02340975|589439311|FG003|Overall Study|Withdrawal by Subject|3|||
163197791|NCT02340975|589439312|FG004|Overall Study|Withdrawal by Subject|2|||
163197792|NCT02340975|589439313|FG005|Overall Study|Withdrawal by Subject|0|||
163197793|NCT02340975|589439308|FG000|Overall Study|Other|0|||
163197794|NCT02340975|589439309|FG001|Overall Study|Other|4|||
163197795|NCT02340975|589439310|FG002|Overall Study|Other|0|||
163197796|NCT02340975|589439311|FG003|Overall Study|Other|2|||
163197797|NCT02340975|589439312|FG004|Overall Study|Other|0|||
163197798|NCT02340975|589439313|FG005|Overall Study|Other|6|||
163197799|NCT01007812|589439316|FG000|Period 1, One Week|Lost to Follow-up|0|||
163197800|NCT01007812|589439317|FG001|Period 1, One Week|Lost to Follow-up|1|||
163197801|NCT01007812|589439316|FG000|Period 1, One Week|Discomfort|1|||
163197802|NCT01007812|589439317|FG001|Period 1, One Week|Discomfort|0|||
163197803|NCT01091974|589439318|FG000|Overall Study|Did not start intervention|3|||
163197804|NCT01091974|589439319|FG001|Overall Study|Did not start intervention|1|||
163197805|NCT01091974|589439320|FG002|Overall Study|Did not start intervention|3|||
163197806|NCT01091974|589439321|FG003|Overall Study|Did not start intervention|1|||
163197807|NCT01091974|589439318|FG000|Overall Study|resumed sleep medication|0|||
163197808|NCT01091974|589439319|FG001|Overall Study|resumed sleep medication|0|||
163197809|NCT01091974|589439320|FG002|Overall Study|resumed sleep medication|1|||
163197810|NCT01091974|589439321|FG003|Overall Study|resumed sleep medication|2|||
163197811|NCT01091974|589439318|FG000|Overall Study|Withdrawal by Subject|1|||
163197812|NCT01091974|589439319|FG001|Overall Study|Withdrawal by Subject|3|||
163303908|NCT03398148|589821734|FG012|Substudy 1 Period 2|Other|0|||
163303909|NCT03398148|589821735|FG013|Substudy 1 Period 2|Other|0|||
163303910|NCT03398148|589821736|FG014|Substudy 1 Period 2|Other|0|||
163303911|NCT03398148|589821722|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
163303912|NCT03398148|589821723|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
163303913|NCT03398148|589821724|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
163303914|NCT03398148|589821725|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
163303915|NCT03398148|589821726|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
163303916|NCT03398148|589821727|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
163303917|NCT03398148|589821728|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
163303918|NCT03398148|589821729|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
163303919|NCT03398148|589821730|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
163303920|NCT03398148|589821731|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
163303921|NCT03398148|589821732|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
163303922|NCT03398148|589821733|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
163303923|NCT03398148|589821734|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
163303924|NCT03398148|589821735|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
163303925|NCT03398148|589821736|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
163303926|NCT03398148|589821722|FG000|Substudy 2 Period 1|Adverse Event|0|||
163303927|NCT03398148|589821723|FG001|Substudy 2 Period 1|Adverse Event|0|||
163303928|NCT03398148|589821724|FG002|Substudy 2 Period 1|Adverse Event|0|||
163303929|NCT03398148|589821725|FG003|Substudy 2 Period 1|Adverse Event|0|||
163303930|NCT03398148|589821726|FG004|Substudy 2 Period 1|Adverse Event|0|||
163303931|NCT03398148|589821727|FG005|Substudy 2 Period 1|Adverse Event|0|||
163303932|NCT03398148|589821728|FG006|Substudy 2 Period 1|Adverse Event|0|||
163303933|NCT03398148|589821729|FG007|Substudy 2 Period 1|Adverse Event|0|||
163303934|NCT03398148|589821730|FG008|Substudy 2 Period 1|Adverse Event|0|||
163303935|NCT03398148|589821731|FG009|Substudy 2 Period 1|Adverse Event|12|||
163303936|NCT03398148|589821732|FG010|Substudy 2 Period 1|Adverse Event|2|||
163303937|NCT03398148|589821733|FG011|Substudy 2 Period 1|Adverse Event|0|||
163395651|NCT01994382|590161029|FG008|Overall Study|Progressive disease|2|||
162978998|NCT03545191|588623548|FG002|Overall Study|Adverse Event|7|||
163303938|NCT03398148|589821734|FG012|Substudy 2 Period 1|Adverse Event|0|||
163303939|NCT03398148|589821735|FG013|Substudy 2 Period 1|Adverse Event|0|||
163303940|NCT03398148|589821736|FG014|Substudy 2 Period 1|Adverse Event|0|||
163395652|NCT01994382|590161030|FG009|Overall Study|Progressive disease|2|||
163395653|NCT01994382|590161031|FG010|Overall Study|Progressive disease|13|||
163197813|NCT01091974|589439320|FG002|Overall Study|Withdrawal by Subject|2|||
163197814|NCT01091974|589439321|FG003|Overall Study|Withdrawal by Subject|2|||
163197815|NCT01091974|589439318|FG000|Overall Study|side-effects|1|||
163197816|NCT01091974|589439319|FG001|Overall Study|side-effects|1|||
163197817|NCT01091974|589439320|FG002|Overall Study|side-effects|0|||
163197818|NCT01091974|589439321|FG003|Overall Study|side-effects|2|||
162961471|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961472|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
162978999|NCT03545191|588623546|FG000|Overall Study|Other reasons|3|||
163197819|NCT03948581|589439322|FG000|Overall Study|Lost to Follow-up|0|||
163395654|NCT01994382|590161032|FG011|Overall Study|Progressive disease|8|||
163197820|NCT03948581|589439323|FG001|Overall Study|Lost to Follow-up|1|||
163197821|NCT03173313|589439324|FG000|Overall Study|Lost to Follow-up|2|||
163197822|NCT03173313|589439325|FG001|Overall Study|Lost to Follow-up|3|||
163197823|NCT03173313|589439324|FG000|Overall Study|Withdrawal by Subject|0|||
163197824|NCT03173313|589439325|FG001|Overall Study|Withdrawal by Subject|1|||
163197825|NCT03173313|589439324|FG000|Overall Study|Death|5|||
163197826|NCT03173313|589439325|FG001|Overall Study|Death|0|||
163197827|NCT03173313|589439324|FG000|Overall Study|Physician Decision|1|||
163197828|NCT03173313|589439325|FG001|Overall Study|Physician Decision|0|||
163197829|NCT03173313|589439324|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
163197830|NCT03173313|589439325|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
163197831|NCT03173313|589439324|FG000|Overall Study|Bone Fracture|1|||
163197832|NCT03173313|589439325|FG001|Overall Study|Bone Fracture|0|||
163197833|NCT01876420|589439326|FG000|Overall Study|Missed 30 day visit|1|||
163197834|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
163197835|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
163197836|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
163197837|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
163197838|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
163197839|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
163197840|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
163197841|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
163197842|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
163197843|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
163395655|NCT01994382|590161033|FG012|Overall Study|Progressive disease|7|||
163395656|NCT01994382|590161034|FG013|Overall Study|Progressive disease|3|||
163395657|NCT01994382|590161035|FG014|Overall Study|Progressive disease|6|||
163395658|NCT01994382|590161036|FG015|Overall Study|Progressive disease|44|||
163395659|NCT01994382|590161037|FG016|Overall Study|Progressive disease|28|||
163395660|NCT01994382|590161021|FG000|Overall Study|Physician Decision|0|||
163395661|NCT01994382|590161022|FG001|Overall Study|Physician Decision|1|||
163395662|NCT01994382|590161023|FG002|Overall Study|Physician Decision|0|||
163395663|NCT01994382|590161024|FG003|Overall Study|Physician Decision|0|||
163395664|NCT01994382|590161025|FG004|Overall Study|Physician Decision|0|||
163395665|NCT01994382|590161026|FG005|Overall Study|Physician Decision|0|||
163395666|NCT01994382|590161027|FG006|Overall Study|Physician Decision|0|||
163395667|NCT01994382|590161028|FG007|Overall Study|Physician Decision|0|||
163395668|NCT01994382|590161029|FG008|Overall Study|Physician Decision|0|||
163395669|NCT01994382|590161030|FG009|Overall Study|Physician Decision|0|||
163395670|NCT01994382|590161031|FG010|Overall Study|Physician Decision|3|||
163395671|NCT01994382|590161032|FG011|Overall Study|Physician Decision|1|||
163395672|NCT01994382|590161033|FG012|Overall Study|Physician Decision|1|||
163395673|NCT01994382|590161034|FG013|Overall Study|Physician Decision|0|||
163395674|NCT01994382|590161035|FG014|Overall Study|Physician Decision|1|||
163395675|NCT01994382|590161036|FG015|Overall Study|Physician Decision|4|||
163395676|NCT01994382|590161037|FG016|Overall Study|Physician Decision|2|||
163395677|NCT01994382|590161021|FG000|Overall Study|Death|0|||
163395678|NCT01994382|590161022|FG001|Overall Study|Death|0|||
163303941|NCT03398148|589821722|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163303942|NCT03398148|589821723|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163303943|NCT03398148|589821724|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163303944|NCT03398148|589821725|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163303945|NCT03398148|589821726|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163303946|NCT03398148|589821727|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163303947|NCT03398148|589821728|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163303948|NCT03398148|589821729|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163303949|NCT03398148|589821730|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163303950|NCT03398148|589821731|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
163303951|NCT03398148|589821732|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
163303952|NCT03398148|589821733|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163303953|NCT03398148|589821734|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163303954|NCT03398148|589821735|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163303955|NCT03398148|589821736|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163303956|NCT03398148|589821722|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
163303957|NCT03398148|589821723|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
163303958|NCT03398148|589821724|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
163303959|NCT03398148|589821725|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
163303960|NCT03398148|589821726|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
163303961|NCT03398148|589821727|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
163303962|NCT03398148|589821728|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
163303963|NCT03398148|589821729|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
163303964|NCT03398148|589821730|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
163303965|NCT03398148|589821731|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
163303966|NCT03398148|589821732|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
163303967|NCT03398148|589821733|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
163303968|NCT03398148|589821734|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
163303969|NCT03398148|589821735|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
163303970|NCT03398148|589821736|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
163395679|NCT01994382|590161023|FG002|Overall Study|Death|0|||
163395680|NCT01994382|590161024|FG003|Overall Study|Death|0|||
163395681|NCT01994382|590161025|FG004|Overall Study|Death|1|||
163303971|NCT03398148|589821722|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163303972|NCT03398148|589821723|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163303973|NCT03398148|589821724|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163303974|NCT03398148|589821725|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163303975|NCT03398148|589821726|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163395682|NCT01994382|590161026|FG005|Overall Study|Death|0|||
163395683|NCT01994382|590161027|FG006|Overall Study|Death|0|||
163303976|NCT03398148|589821727|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163303977|NCT03398148|589821728|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163303978|NCT03398148|589821729|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163303979|NCT03398148|589821730|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163303980|NCT03398148|589821731|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163303981|NCT03398148|589821732|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
163303982|NCT03398148|589821733|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163303983|NCT03398148|589821734|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163303984|NCT03398148|589821735|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163303985|NCT03398148|589821736|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163303986|NCT03398148|589821722|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303987|NCT03398148|589821723|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303988|NCT03398148|589821724|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303989|NCT03398148|589821725|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303990|NCT03398148|589821726|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303991|NCT03398148|589821727|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303992|NCT03398148|589821728|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303993|NCT03398148|589821729|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303994|NCT03398148|589821730|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303995|NCT03398148|589821731|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303996|NCT03398148|589821732|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
163303997|NCT03398148|589821733|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303998|NCT03398148|589821734|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163303999|NCT03398148|589821735|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163304000|NCT03398148|589821736|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163304001|NCT03398148|589821722|FG000|Substudy 2 Period 1|Other|0|||
163304002|NCT03398148|589821723|FG001|Substudy 2 Period 1|Other|0|||
163304003|NCT03398148|589821724|FG002|Substudy 2 Period 1|Other|0|||
163304004|NCT03398148|589821725|FG003|Substudy 2 Period 1|Other|0|||
163304005|NCT03398148|589821726|FG004|Substudy 2 Period 1|Other|0|||
163304006|NCT03398148|589821727|FG005|Substudy 2 Period 1|Other|0|||
163304007|NCT03398148|589821728|FG006|Substudy 2 Period 1|Other|0|||
163395684|NCT01994382|590161028|FG007|Overall Study|Death|0|||
163304008|NCT03398148|589821729|FG007|Substudy 2 Period 1|Other|0|||
163304009|NCT03398148|589821730|FG008|Substudy 2 Period 1|Other|0|||
163304010|NCT03398148|589821731|FG009|Substudy 2 Period 1|Other|4|||
163304011|NCT03398148|589821732|FG010|Substudy 2 Period 1|Other|4|||
162979000|NCT03545191|588623547|FG001|Overall Study|Other reasons|11|||
163304012|NCT03398148|589821733|FG011|Substudy 2 Period 1|Other|0|||
163304013|NCT03398148|589821734|FG012|Substudy 2 Period 1|Other|0|||
163304014|NCT03398148|589821735|FG013|Substudy 2 Period 1|Other|0|||
163304015|NCT03398148|589821736|FG014|Substudy 2 Period 1|Other|0|||
163304016|NCT03398148|589821722|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
163304017|NCT03398148|589821723|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
163304018|NCT03398148|589821724|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
163304019|NCT03398148|589821725|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
163304020|NCT03398148|589821726|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
163304021|NCT03398148|589821727|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
163304022|NCT03398148|589821728|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
163304023|NCT03398148|589821729|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
163304024|NCT03398148|589821730|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
163304025|NCT03398148|589821731|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
163304026|NCT03398148|589821732|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
163304027|NCT03398148|589821733|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
163304028|NCT03398148|589821734|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
163304029|NCT03398148|589821735|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
163304030|NCT03398148|589821736|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
163304031|NCT03398148|589821722|FG000|Substudy 2 Period 2|Adverse Event|0|||
163304032|NCT03398148|589821723|FG001|Substudy 2 Period 2|Adverse Event|0|||
163304033|NCT03398148|589821724|FG002|Substudy 2 Period 2|Adverse Event|0|||
163304034|NCT03398148|589821725|FG003|Substudy 2 Period 2|Adverse Event|0|||
163304035|NCT03398148|589821726|FG004|Substudy 2 Period 2|Adverse Event|0|||
163304036|NCT03398148|589821727|FG005|Substudy 2 Period 2|Adverse Event|0|||
163395685|NCT01994382|590161029|FG008|Overall Study|Death|1|||
163395686|NCT01994382|590161030|FG009|Overall Study|Death|1|||
163395687|NCT01994382|590161031|FG010|Overall Study|Death|0|||
163395688|NCT01994382|590161032|FG011|Overall Study|Death|0|||
163395689|NCT01994382|590161033|FG012|Overall Study|Death|0|||
163395690|NCT01994382|590161034|FG013|Overall Study|Death|0|||
163395691|NCT01994382|590161035|FG014|Overall Study|Death|0|||
163395692|NCT01994382|590161036|FG015|Overall Study|Death|1|||
163395693|NCT01994382|590161037|FG016|Overall Study|Death|0|||
163395694|NCT01994382|590161021|FG000|Overall Study|Adverse Event|0|||
163395695|NCT01994382|590161022|FG001|Overall Study|Adverse Event|1|||
163395696|NCT01994382|590161023|FG002|Overall Study|Adverse Event|2|||
163395697|NCT01994382|590161024|FG003|Overall Study|Adverse Event|0|||
163395698|NCT01994382|590161025|FG004|Overall Study|Adverse Event|0|||
163395699|NCT01994382|590161026|FG005|Overall Study|Adverse Event|0|||
163304037|NCT03398148|589821728|FG006|Substudy 2 Period 2|Adverse Event|0|||
163304038|NCT03398148|589821729|FG007|Substudy 2 Period 2|Adverse Event|0|||
163304039|NCT03398148|589821730|FG008|Substudy 2 Period 2|Adverse Event|0|||
163304040|NCT03398148|589821731|FG009|Substudy 2 Period 2|Adverse Event|0|||
163304041|NCT03398148|589821732|FG010|Substudy 2 Period 2|Adverse Event|0|||
163304042|NCT03398148|589821733|FG011|Substudy 2 Period 2|Adverse Event|0|||
163395700|NCT01994382|590161027|FG006|Overall Study|Adverse Event|0|||
163395701|NCT01994382|590161028|FG007|Overall Study|Adverse Event|0|||
163395702|NCT01994382|590161029|FG008|Overall Study|Adverse Event|0|||
163304043|NCT03398148|589821734|FG012|Substudy 2 Period 2|Adverse Event|0|||
162961473|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961474|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
163304044|NCT03398148|589821735|FG013|Substudy 2 Period 2|Adverse Event|1|||
163304045|NCT03398148|589821736|FG014|Substudy 2 Period 2|Adverse Event|3|||
163304046|NCT03398148|589821722|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
163304047|NCT03398148|589821723|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
163304048|NCT03398148|589821724|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
163304049|NCT03398148|589821725|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
162961475|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961476|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961477|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961478|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961479|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961480|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
163197844|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
163197845|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
163197846|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
163197847|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
163197848|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
163197849|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
163197850|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
163197851|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
163197852|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
163197853|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
163197854|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
163197855|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
163197856|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
163197857|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
163197858|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
163197859|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
163197860|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
163197861|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
163197862|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
163197863|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
163197864|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
163197865|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
163197866|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
163197867|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
163197868|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
163197869|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
163197870|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
163197871|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
163197872|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
163304050|NCT03398148|589821726|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
163304051|NCT03398148|589821727|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
163304052|NCT03398148|589821728|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
162961481|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961482|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
163197873|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
163197874|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
163197875|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
163197876|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
163197877|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
163197878|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
163197879|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
163197880|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
163197881|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
163197882|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
163197883|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
163197884|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
163197885|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
163197886|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
163197887|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
163197888|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
163197889|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
163197890|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
163197891|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
163197892|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
163197893|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
163197894|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
163197895|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
163197896|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
163197897|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
163197898|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
163197899|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
163197900|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
163395703|NCT01994382|590161030|FG009|Overall Study|Adverse Event|0|||
163304053|NCT03398148|589821729|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
163304054|NCT03398148|589821730|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
163304055|NCT03398148|589821731|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
163304056|NCT03398148|589821732|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
163304057|NCT03398148|589821733|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
163304058|NCT03398148|589821734|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
163304059|NCT03398148|589821735|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
163304060|NCT03398148|589821736|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
163304061|NCT03398148|589821722|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163304062|NCT03398148|589821723|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163304063|NCT03398148|589821724|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163304064|NCT03398148|589821725|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163304065|NCT03398148|589821726|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163304066|NCT03398148|589821727|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163304067|NCT03398148|589821728|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163304068|NCT03398148|589821729|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163304069|NCT03398148|589821730|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163304070|NCT03398148|589821731|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163304071|NCT03398148|589821732|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163304072|NCT03398148|589821733|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
163304073|NCT03398148|589821734|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163304074|NCT03398148|589821735|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
163395704|NCT01994382|590161031|FG010|Overall Study|Adverse Event|15|||
163395705|NCT01994382|590161032|FG011|Overall Study|Adverse Event|2|||
163395706|NCT01994382|590161033|FG012|Overall Study|Adverse Event|7|||
162961483|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
163304075|NCT03398148|589821736|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
163304076|NCT03398148|589821722|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
163304077|NCT03398148|589821723|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
163304078|NCT03398148|589821724|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
163304079|NCT03398148|589821725|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
163304080|NCT03398148|589821726|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
163197901|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
162961484|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961485|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961486|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961487|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961488|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
162961489|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
162961490|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
162961491|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
162961492|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
162961493|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961494|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961495|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961496|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961497|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961498|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961499|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961500|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
163197902|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
163197903|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
163197904|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Change of location|0|||
163197905|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Change of location|0|||
163197906|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Change of location|0|||
163197907|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Change of location|1|||
163197908|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Change of location|0|||
163197909|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
163197910|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
163197911|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
163197912|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
163197913|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
163197914|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
163197915|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
163197916|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
163197917|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
163197918|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
163197919|NCT00730405|589439332|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
163197920|NCT00730405|589439333|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
163197921|NCT00730405|589439334|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
163197922|NCT00730405|589439335|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
163197923|NCT00730405|589439336|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
163197924|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
163197925|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
163197926|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
163197927|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
163197928|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
163197929|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
163197930|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
163304081|NCT03398148|589821727|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
162961501|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961502|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961503|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
163304082|NCT03398148|589821728|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
163304083|NCT03398148|589821729|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
163197931|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
163197932|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
163197933|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
163197934|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
163197935|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
163197936|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
163197937|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
163197938|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
163197939|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Death|0|||
163197940|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Death|1|||
163197941|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Death|0|||
163197942|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Death|1|||
163197943|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Death|0|||
163197944|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Change of location|1|||
163197945|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Change of location|1|||
163197946|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Change of location|0|||
163197947|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Change of location|1|||
163197948|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Change of location|0|||
163197949|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
163304084|NCT03398148|589821730|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
163304085|NCT03398148|589821731|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
163304086|NCT03398148|589821732|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
163304087|NCT03398148|589821733|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
163304088|NCT03398148|589821734|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
163304089|NCT03398148|589821735|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
163047848|NCT03934216|588882617|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163304090|NCT03398148|589821736|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
163197950|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
163304091|NCT03398148|589821722|FG000|Substudy 2 Period 2|Other|0|||
163197951|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
163304092|NCT03398148|589821723|FG001|Substudy 2 Period 2|Other|0|||
163304093|NCT03398148|589821724|FG002|Substudy 2 Period 2|Other|0|||
162961504|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961505|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961506|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
163304094|NCT03398148|589821725|FG003|Substudy 2 Period 2|Other|0|||
163304095|NCT03398148|589821726|FG004|Substudy 2 Period 2|Other|0|||
163304096|NCT03398148|589821727|FG005|Substudy 2 Period 2|Other|0|||
163304097|NCT03398148|589821728|FG006|Substudy 2 Period 2|Other|0|||
163304098|NCT03398148|589821729|FG007|Substudy 2 Period 2|Other|0|||
163304099|NCT03398148|589821730|FG008|Substudy 2 Period 2|Other|0|||
163304100|NCT03398148|589821731|FG009|Substudy 2 Period 2|Other|0|||
162979001|NCT03545191|588623548|FG002|Overall Study|Other reasons|8|||
163304101|NCT03398148|589821732|FG010|Substudy 2 Period 2|Other|0|||
163304102|NCT03398148|589821733|FG011|Substudy 2 Period 2|Other|0|||
163304103|NCT03398148|589821734|FG012|Substudy 2 Period 2|Other|0|||
163304104|NCT03398148|589821735|FG013|Substudy 2 Period 2|Other|1|||
163304105|NCT03398148|589821736|FG014|Substudy 2 Period 2|Other|1|||
163304106|NCT03398148|589821722|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
163304107|NCT03398148|589821723|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
163304108|NCT03398148|589821724|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
163304109|NCT03398148|589821725|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
163304110|NCT03398148|589821726|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
163304111|NCT03398148|589821727|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
163304112|NCT03398148|589821728|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
163304113|NCT03398148|589821729|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
163304114|NCT03398148|589821730|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
163304115|NCT03398148|589821731|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
163304116|NCT03398148|589821732|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
163304117|NCT03398148|589821733|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
163304118|NCT03398148|589821734|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
163304119|NCT03398148|589821735|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
163304120|NCT03398148|589821736|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
163304121|NCT01259401|589821737|FG000|4-month Follow-up|Death|0|||
163304122|NCT01259401|589821738|FG001|4-month Follow-up|Death|1|||
163304123|NCT01259401|589821737|FG000|4-month Follow-up|Lost to Follow-up|0|||
163304124|NCT01259401|589821738|FG001|4-month Follow-up|Lost to Follow-up|1|||
163304125|NCT00212355|589821739|FG000|Overall Study|Adverse Event|1|||
163304126|NCT00212355|589821739|FG000|Overall Study|Withdrawal by Subject|1|||
163304127|NCT00212355|589821739|FG000|Overall Study|A change of address|1|||
163304128|NCT00186992|589821745|FG000|Overall Study|Withdrawal by Subject|5|||
163304129|NCT00186992|589821745|FG000|Overall Study|Physician's discretion|13|||
163304130|NCT00186992|589821745|FG000|Overall Study|PI Discretion|4|||
163304131|NCT00186992|589821745|FG000|Overall Study|Ineligible|2|||
163304132|NCT00186992|589821745|FG000|Overall Study|Lost to Follow-up|2|||
163304133|NCT00186992|589821745|FG000|Overall Study|Still on Study|9|||
163304134|NCT03683069|589821746|FG000|Overall Study|see limitations|12|||
163304135|NCT03683069|589821747|FG001|Overall Study|see limitations|13|||
163304136|NCT05644002|589821750|FG000|Overall Study|Lost to Follow-up|1|||
163304137|NCT05644002|589821751|FG001|Overall Study|Lost to Follow-up|2|||
162961507|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961508|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961509|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961510|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961511|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961512|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961513|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
163197952|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
163197953|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
162961514|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961515|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961516|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961517|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961518|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
162961519|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961520|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961521|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961522|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961523|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961524|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961525|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961526|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961527|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961528|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961529|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961530|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
163047849|NCT03934216|588882618|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163047850|NCT03934216|588882617|FG000|Overall Study|Pregnancy|1|||
163047851|NCT03934216|588882618|FG001|Overall Study|Pregnancy|0|||
163197954|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
163197955|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
163304138|NCT05644002|589821750|FG000|Overall Study|Withdrawal by Subject|0|||
163047852|NCT03934216|588882617|FG000|Overall Study|Withdrawal by Subject|18|||
163047853|NCT03934216|588882618|FG001|Overall Study|Withdrawal by Subject|6|||
163047854|NCT03934216|588882617|FG000|Overall Study|Randomized but not treated|1|||
163047855|NCT03934216|588882618|FG001|Overall Study|Randomized but not treated|1|||
163047856|NCT00735709|588882619|FG000|Overall Study|Adverse Event|2|||
163047857|NCT00735709|588882620|FG001|Overall Study|Adverse Event|3|||
163047858|NCT00735709|588882621|FG002|Overall Study|Adverse Event|1|||
163047859|NCT00735709|588882622|FG003|Overall Study|Adverse Event|5|||
163047860|NCT00735709|588882619|FG000|Overall Study|Lack of Efficacy|8|||
163047861|NCT00735709|588882620|FG001|Overall Study|Lack of Efficacy|4|||
163047862|NCT00735709|588882621|FG002|Overall Study|Lack of Efficacy|2|||
163047863|NCT00735709|588882622|FG003|Overall Study|Lack of Efficacy|3|||
163047864|NCT00735709|588882619|FG000|Overall Study|Noncompliance|0|||
163047865|NCT00735709|588882620|FG001|Overall Study|Noncompliance|0|||
163047866|NCT00735709|588882621|FG002|Overall Study|Noncompliance|1|||
163047867|NCT00735709|588882622|FG003|Overall Study|Noncompliance|0|||
163047868|NCT00735709|588882619|FG000|Overall Study|Protocol deviations|1|||
163047869|NCT00735709|588882620|FG001|Overall Study|Protocol deviations|2|||
163047870|NCT00735709|588882621|FG002|Overall Study|Protocol deviations|1|||
163047871|NCT00735709|588882622|FG003|Overall Study|Protocol deviations|1|||
163047872|NCT00735709|588882619|FG000|Overall Study|Voluntary Withdrawal|1|||
163047873|NCT00735709|588882620|FG001|Overall Study|Voluntary Withdrawal|3|||
163047874|NCT00735709|588882621|FG002|Overall Study|Voluntary Withdrawal|5|||
163047875|NCT00735709|588882622|FG003|Overall Study|Voluntary Withdrawal|7|||
163047876|NCT00735709|588882619|FG000|Overall Study|Lost to Follow-up|0|||
163047877|NCT00735709|588882620|FG001|Overall Study|Lost to Follow-up|1|||
163047878|NCT00735709|588882621|FG002|Overall Study|Lost to Follow-up|1|||
163047879|NCT00735709|588882622|FG003|Overall Study|Lost to Follow-up|1|||
163047880|NCT00735709|588882619|FG000|Overall Study|Excluded medication|1|||
163047881|NCT00735709|588882620|FG001|Overall Study|Excluded medication|0|||
163047882|NCT00735709|588882621|FG002|Overall Study|Excluded medication|0|||
163047883|NCT00735709|588882622|FG003|Overall Study|Excluded medication|1|||
163047884|NCT03627832|588882624|FG000|Overall Study|Withdrawal by Subject|10|||
163047885|NCT03627832|588882625|FG001|Overall Study|Withdrawal by Subject|1|||
163047886|NCT02119299|588882629|FG000|Overall Study|Withdrawal by Subject|7|||
163047887|NCT02119299|588882629|FG000|Overall Study|Lack of Efficacy|1|||
163047888|NCT02119299|588882629|FG000|Overall Study|Pregnancy|1|||
163047889|NCT00873730|588882630|FG000|Overall Study|Protocol Deviation|5|||
163047890|NCT00873730|588882631|FG001|Overall Study|Protocol Deviation|2|||
163047891|NCT00873730|588882630|FG000|Overall Study|Adverse Event|0|||
163047892|NCT00873730|588882631|FG001|Overall Study|Adverse Event|2|||
163047893|NCT00873730|588882630|FG000|Overall Study|Withdrawal by Subject|0|||
163047894|NCT00873730|588882631|FG001|Overall Study|Withdrawal by Subject|1|||
163047895|NCT00873730|588882630|FG000|Overall Study|Sponsor decision|1|||
162961531|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961532|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961533|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961534|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
163047896|NCT00873730|588882631|FG001|Overall Study|Sponsor decision|0|||
162961535|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961536|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
163047897|NCT04110314|588882634|FG000|Overall Study|Did not meet inclusion criteria|35255|||
163047898|NCT04110314|588882635|FG001|Overall Study|Did not meet inclusion criteria|35104|||
163047899|NCT04110314|588882636|FG002|Overall Study|Did not meet inclusion criteria|35636|||
163047900|NCT04110314|588882637|FG003|Overall Study|Did not meet inclusion criteria|35135|||
163047901|NCT04110314|588882638|FG004|Overall Study|Did not meet inclusion criteria|35247|||
163047902|NCT04110314|588882639|FG005|Overall Study|Did not meet inclusion criteria|35727|||
163047903|NCT01711983|588882647|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
163047904|NCT01711983|588882647|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
163047905|NCT01711983|588882647|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
163047906|NCT01711983|588882647|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
163047907|NCT00737100|588882648|FG000|Overall Study|Adverse Event|6|||
163047908|NCT00737100|588882649|FG001|Overall Study|Adverse Event|5|||
163047909|NCT00737100|588882650|FG002|Overall Study|Adverse Event|3|||
163047910|NCT00737100|588882648|FG000|Overall Study|Lost to Follow-up|0|||
163047911|NCT00737100|588882649|FG001|Overall Study|Lost to Follow-up|1|||
163047912|NCT00737100|588882650|FG002|Overall Study|Lost to Follow-up|0|||
163047913|NCT00737100|588882648|FG000|Overall Study|Withdrawal by Subject|0|||
163047914|NCT00737100|588882649|FG001|Overall Study|Withdrawal by Subject|0|||
163197956|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
163047915|NCT00737100|588882650|FG002|Overall Study|Withdrawal by Subject|3|||
163047916|NCT00737100|588882648|FG000|Overall Study|Reason discontinued not explained above|1|||
163047917|NCT00737100|588882649|FG001|Overall Study|Reason discontinued not explained above|1|||
163197957|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
163197958|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
163197959|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
163197960|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
163197961|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
163197962|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
163197963|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
163197964|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
163197965|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
163197966|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
163197967|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
163197968|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
163197969|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
163197970|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
163304139|NCT05644002|589821751|FG001|Overall Study|Withdrawal by Subject|1|||
163304140|NCT05756075|589821756|FG000|Overall Study|Withdrawal by Subject|16|||
163304141|NCT05756075|589821757|FG001|Overall Study|Withdrawal by Subject|9|||
163304142|NCT03821844|589821758|FG000|Overall Study|Death|37|||
163304143|NCT03821844|589821759|FG001|Overall Study|Death|31|||
163304144|NCT03821844|589821758|FG000|Overall Study|Discharged|10|||
163304145|NCT03821844|589821759|FG001|Overall Study|Discharged|14|||
163304146|NCT03821844|589821758|FG000|Overall Study|Not present in facility at followup|2|||
163304147|NCT03821844|589821759|FG001|Overall Study|Not present in facility at followup|3|||
163304148|NCT05104697|589821760|FG000|Overall Study|Withdrawal by Subject|0|||
163304149|NCT05104697|589821761|FG001|Overall Study|Withdrawal by Subject|1|||
163304150|NCT03913195|589821762|FG000|Overall Study|Adverse Event|0|||
163304151|NCT03913195|589821763|FG001|Overall Study|Adverse Event|0|||
163304152|NCT03913195|589821764|FG002|Overall Study|Adverse Event|1|||
162961537|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961538|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961539|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961540|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961541|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961542|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961543|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961544|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
162961545|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961546|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961547|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961548|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961549|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961550|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961551|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961552|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961553|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961554|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961555|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961556|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961557|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961558|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961559|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961560|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961561|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|Moved|0|||
162961562|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|Moved|0|||
162961563|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|Moved|0|||
162961564|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|Moved|0|||
162961565|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|Moved|0|||
162961566|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|Moved|0|||
162961567|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|Moved|0|||
162961568|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|Moved|0|||
162961569|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|Moved|0|||
163304153|NCT03913195|589821765|FG003|Overall Study|Adverse Event|1|||
163304154|NCT03913195|589821766|FG004|Overall Study|Adverse Event|0|||
163304155|NCT03913195|589821762|FG000|Overall Study|Withdrawal by Subject|0|||
163304156|NCT03913195|589821763|FG001|Overall Study|Withdrawal by Subject|0|||
163197971|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
163197972|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
163197973|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
163197974|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
163197975|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
163197976|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
163197977|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
163197978|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
163197979|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
163197980|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
163197981|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
163197982|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
163197983|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
163197984|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
163197985|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
163197986|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
163197987|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
163197988|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
163197989|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
163197990|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
163197991|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
163197992|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
163197993|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
163197994|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
163197995|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
163197996|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
163197997|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
163197998|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
163197999|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Missing|0|||
163198000|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Missing|0|||
163198001|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Missing|2|||
163198002|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Missing|0|||
163198003|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Missing|0|||
163198004|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
163198005|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
163198006|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
163198007|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
163198008|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
163198009|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
163198010|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
163198011|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
163198012|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
162961570|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|Moved|1|||
162961571|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|Moved|0|||
162961572|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|Moved|0|||
162961573|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|Moved|0|||
162961574|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|Moved|0|||
162961575|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|Moved|0|||
162961576|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|Moved|0|||
162961577|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|Moved|0|||
162961578|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|Moved|0|||
162961579|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|Moved|0|||
162961580|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|Moved|0|||
162961581|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|Moved|0|||
162961582|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|Moved|0|||
162961583|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|Moved|0|||
162961584|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|Moved|0|||
162961585|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|Moved|0|||
162961586|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|Moved|0|||
163047918|NCT00737100|588882650|FG002|Overall Study|Reason discontinued not explained above|1|||
163047919|NCT01607593|588882655|FG000|Overall Study|Adverse Event|15|||
163047920|NCT01607593|588882655|FG000|Overall Study|Lack of Efficacy|16|||
163047921|NCT01607593|588882655|FG000|Overall Study|Lost to Follow-up|25|||
162961587|NCT00112437|588560746|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
162961588|NCT00112437|588560747|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
162961589|NCT00112437|588560748|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
162961590|NCT00112437|588560749|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
162961591|NCT00112437|588560750|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
163047922|NCT01607593|588882655|FG000|Overall Study|Continuation|33|||
163047923|NCT01607593|588882655|FG000|Overall Study|Other|4|||
163047924|NCT00115778|588882656|FG000|Overall Study|Withdrawal by Subject|0|||
163047925|NCT00115778|588882657|FG001|Overall Study|Withdrawal by Subject|1|||
163047926|NCT02154139|588882660|FG000|Overall Study|Injection not administered|2|||
163047927|NCT02154139|588882660|FG000|Overall Study|Other|2|||
163047928|NCT02154139|588882660|FG000|Overall Study|Investigator transferred|3|||
163047929|NCT06060496|588882661|FG000|Overall Study|Withdrawal by Subject|2|||
163047930|NCT06060496|588882661|FG000|Overall Study|Lost to Follow-up|2|||
163047931|NCT00321906|588882662|FG000|Overall Study|Adverse Event|36|||
163047932|NCT00321906|588882663|FG001|Overall Study|Adverse Event|44|||
163047933|NCT00321906|588882662|FG000|Overall Study|Death|9|||
163047934|NCT00321906|588882663|FG001|Overall Study|Death|6|||
163047935|NCT00321906|588882662|FG000|Overall Study|Lost to Follow-up|1|||
163047936|NCT00321906|588882663|FG001|Overall Study|Lost to Follow-up|2|||
163047937|NCT00321906|588882662|FG000|Overall Study|Withdrawal by Subject|0|||
163047938|NCT00321906|588882663|FG001|Overall Study|Withdrawal by Subject|4|||
163047939|NCT00149396|588882664|FG000|Overall Study|Death|15|||
163047940|NCT00149396|588882664|FG000|Overall Study|Withdrawal by Subject|1|||
163047941|NCT00149396|588882664|FG000|Overall Study|Subject noncompliance|2|||
163047942|NCT00149396|588882664|FG000|Overall Study|other treatment|5|||
163047943|NCT00807885|588882665|FG000|Overall Study|Lost to Follow-up|0|||
163047944|NCT00807885|588882666|FG001|Overall Study|Lost to Follow-up|0|||
163047945|NCT00807885|588882667|FG002|Overall Study|Lost to Follow-up|0|||
163047946|NCT00807885|588882668|FG003|Overall Study|Lost to Follow-up|0|||
163047947|NCT00807885|588882669|FG004|Overall Study|Lost to Follow-up|0|||
163047948|NCT00807885|588882670|FG005|Overall Study|Lost to Follow-up|1|||
163047949|NCT00807885|588882671|FG006|Overall Study|Lost to Follow-up|0|||
163047950|NCT00807885|588882672|FG007|Overall Study|Lost to Follow-up|0|||
163047951|NCT00807885|588882673|FG008|Overall Study|Lost to Follow-up|0|||
163047952|NCT01166750|588882675|FG000|Overall Study|Lost to Follow-up|1|||
163047953|NCT01166750|588882676|FG001|Overall Study|Lost to Follow-up|0|||
163304157|NCT03913195|589821764|FG002|Overall Study|Withdrawal by Subject|1|||
162961592|NCT00112437|588560751|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
162961593|NCT00112437|588560752|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
162961594|NCT00112437|588560753|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
163047954|NCT05225389|588882677|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
163047955|NCT03113968|588882678|FG000|Overall Study|Withdrawal by Subject|31|||
163047956|NCT03113968|588882679|FG001|Overall Study|Withdrawal by Subject|4|||
163047957|NCT04805671|588882680|FG000|Overall Study|Death|2|||
163047958|NCT04805671|588882681|FG001|Overall Study|Death|7|||
163047959|NCT04805671|588882680|FG000|Overall Study|Lost to Follow-up|1|||
163047960|NCT04805671|588882681|FG001|Overall Study|Lost to Follow-up|0|||
163047961|NCT04805671|588882680|FG000|Overall Study|Withdrawal by Subject|9|||
163047962|NCT04805671|588882681|FG001|Overall Study|Withdrawal by Subject|7|||
163395707|NCT01994382|590161034|FG013|Overall Study|Adverse Event|3|||
163395708|NCT01994382|590161035|FG014|Overall Study|Adverse Event|17|||
163395709|NCT01994382|590161036|FG015|Overall Study|Adverse Event|6|||
163395710|NCT01994382|590161037|FG016|Overall Study|Adverse Event|3|||
163395711|NCT01994382|590161021|FG000|Overall Study|Other than specified|0|||
163395712|NCT01994382|590161022|FG001|Overall Study|Other than specified|0|||
163395713|NCT01994382|590161023|FG002|Overall Study|Other than specified|0|||
163395714|NCT01994382|590161024|FG003|Overall Study|Other than specified|0|||
163395715|NCT01994382|590161025|FG004|Overall Study|Other than specified|0|||
163395716|NCT01994382|590161026|FG005|Overall Study|Other than specified|0|||
163395717|NCT01994382|590161027|FG006|Overall Study|Other than specified|0|||
163395718|NCT01994382|590161028|FG007|Overall Study|Other than specified|0|||
163395719|NCT01994382|590161029|FG008|Overall Study|Other than specified|0|||
163395720|NCT01994382|590161030|FG009|Overall Study|Other than specified|0|||
163395721|NCT01994382|590161031|FG010|Overall Study|Other than specified|2|||
163395722|NCT01994382|590161032|FG011|Overall Study|Other than specified|0|||
163395723|NCT01994382|590161033|FG012|Overall Study|Other than specified|2|||
163395724|NCT01994382|590161034|FG013|Overall Study|Other than specified|0|||
163395725|NCT01994382|590161035|FG014|Overall Study|Other than specified|0|||
163395726|NCT01994382|590161036|FG015|Overall Study|Other than specified|4|||
163395727|NCT01994382|590161037|FG016|Overall Study|Other than specified|4|||
163395728|NCT01994382|590161021|FG000|Overall Study|Withdrawal by Subject|0|||
163047963|NCT04805671|588882680|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
163047964|NCT04805671|588882681|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
163047965|NCT00901342|588882682|FG000|Overall Study|Adverse Event|1|||
163047966|NCT00901342|588882682|FG000|Overall Study|Death|4|||
163047967|NCT00901342|588882682|FG000|Overall Study|Disease progression|1|||
163047968|NCT00901342|588882682|FG000|Overall Study|Withdrawal by Subject|9|||
163047969|NCT03804268|588882683|FG000|Overall Study|Adverse Event|2|||
163047970|NCT03804268|588882684|FG001|Overall Study|Adverse Event|2|||
163047971|NCT03804268|588882683|FG000|Overall Study|Withdrawal by Subject|2|||
163047972|NCT03804268|588882684|FG001|Overall Study|Withdrawal by Subject|0|||
163047973|NCT03804268|588882683|FG000|Overall Study|Lost to Follow-up|1|||
163047974|NCT03804268|588882684|FG001|Overall Study|Lost to Follow-up|0|||
163047975|NCT03804268|588882683|FG000|Overall Study|Physician Decision|2|||
163047976|NCT03804268|588882684|FG001|Overall Study|Physician Decision|0|||
163047977|NCT02849587|588882685|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
163047978|NCT02849587|588882686|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
163047979|NCT02849587|588882687|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
163047980|NCT02849587|588882685|FG000|Overall Study|Withdrawal by Subject|0|||
163047981|NCT02849587|588882686|FG001|Overall Study|Withdrawal by Subject|1|||
163047982|NCT02849587|588882687|FG002|Overall Study|Withdrawal by Subject|0|||
163047983|NCT03380377|588882688|FG000|Overall Study|Physician Decision|1|||
163047984|NCT03380377|588882688|FG000|Overall Study|Withdrawal by Subject|1|||
163047985|NCT00385918|588882689|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
163304158|NCT03913195|589821765|FG003|Overall Study|Withdrawal by Subject|0|||
163304159|NCT03913195|589821766|FG004|Overall Study|Withdrawal by Subject|1|||
163304160|NCT03913195|589821762|FG000|Overall Study|non adherence to study|0|||
163047986|NCT00385918|588882690|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
163047987|NCT00385918|588882691|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
163047988|NCT00385918|588882689|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
163047989|NCT00385918|588882690|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
163047990|NCT00385918|588882691|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
163047991|NCT00385918|588882689|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
163047992|NCT00385918|588882690|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
163047993|NCT00385918|588882691|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
163047994|NCT00385918|588882689|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
163047995|NCT00385918|588882690|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
163047996|NCT00385918|588882691|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
163304161|NCT03913195|589821763|FG001|Overall Study|non adherence to study|0|||
163047997|NCT00385918|588882689|FG000|Intervention Phase After Randomization|Physician Decision|1|||
163047998|NCT00385918|588882690|FG001|Intervention Phase After Randomization|Physician Decision|0|||
163198013|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
163047999|NCT00385918|588882691|FG002|Intervention Phase After Randomization|Physician Decision|0|||
163198014|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
163198015|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
163198016|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
163198017|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
163198018|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
163198019|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
163198020|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
163198021|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
163198022|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
163198023|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
163198024|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
163198025|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
163198026|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
163198027|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
163198028|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
163198029|NCT00730405|589439332|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
163198030|NCT00730405|589439333|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
163198031|NCT00730405|589439334|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
163048000|NCT00385918|588882689|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
163048001|NCT00385918|588882690|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
163198032|NCT00730405|589439335|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
163048002|NCT00385918|588882691|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
163048003|NCT00128661|588882692|FG000|Overall Study|Adverse Event|14|||
163048004|NCT00128661|588882693|FG001|Overall Study|Adverse Event|11|||
163048005|NCT00128661|588882692|FG000|Overall Study|Lost to Follow-up|10|||
163048006|NCT00128661|588882693|FG001|Overall Study|Lost to Follow-up|7|||
163048007|NCT00128661|588882692|FG000|Overall Study|Withdrawal by Subject|243|||
163048008|NCT00128661|588882693|FG001|Overall Study|Withdrawal by Subject|232|||
163048009|NCT00128661|588882692|FG000|Overall Study|Other|7|||
163048010|NCT00128661|588882693|FG001|Overall Study|Other|8|||
163048011|NCT03421379|588882694|FG000|Period 1|Withdrawal by Subject|0|||
163304162|NCT03913195|589821764|FG002|Overall Study|non adherence to study|1|||
163304163|NCT03913195|589821765|FG003|Overall Study|non adherence to study|0|||
163304164|NCT03913195|589821766|FG004|Overall Study|non adherence to study|0|||
163304165|NCT03899961|589821767|FG000|Overall Study|-delivery prior to|2|||
163048012|NCT03421379|588882695|FG001|Period 1|Withdrawal by Subject|1|||
163048013|NCT03421379|588882694|FG000|Period 1|Physician Decision|1|||
163048014|NCT03421379|588882695|FG001|Period 1|Physician Decision|1|||
163048015|NCT03421379|588882694|FG000|Period 1|Did not receive treatment|1|||
163048016|NCT03421379|588882695|FG001|Period 1|Did not receive treatment|2|||
163048017|NCT04010461|588882696|FG000|Overall Study|COVID based withdrawal|5|||
163048018|NCT04010461|588882696|FG000|Overall Study|Withdrawal by Subject|5|||
163048019|NCT04010461|588882696|FG000|Overall Study|Adverse Event|1|||
163048020|NCT04010461|588882696|FG000|Overall Study|No Motor Threshold obtainable|1|||
163048021|NCT04010461|588882696|FG000|Overall Study|Physician Decision|1|||
163048022|NCT03771963|588882697|FG000|Overall Study|Lost to Follow-up|22|||
163048023|NCT03771963|588882697|FG000|Overall Study|Withdrawal of Consent|10|||
163048024|NCT01026948|588882698|FG000|Overall Study|Physician Decision|8|||
163048025|NCT00102596|588882699|FG000|Part A|Screen failures|6|||
163048026|NCT00102596|588882700|FG001|Part A|Screen failures|0|||
163048027|NCT00102596|588882699|FG000|Part A|Adverse Event|1|||
163048028|NCT00102596|588882700|FG001|Part A|Adverse Event|0|||
163048029|NCT01670045|588882704|FG000|Overall Study|Withdrawal by Subject|3|||
163198033|NCT00730405|589439336|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
163198034|NCT00963937|589439337|FG000|Overall Study|Protocol Violation|1|||
163198035|NCT00963937|589439338|FG001|Overall Study|Protocol Violation|1|||
163198036|NCT00963937|589439339|FG002|Overall Study|Protocol Violation|0|||
163198037|NCT00963937|589439337|FG000|Overall Study|Physician Decision|18|||
163198038|NCT00963937|589439338|FG001|Overall Study|Physician Decision|10|||
163198039|NCT00963937|589439339|FG002|Overall Study|Physician Decision|4|||
163198040|NCT02106975|589439340|FG000|Overall Study|Death|25|||
163198041|NCT02106975|589439341|FG001|Overall Study|Death|39|||
163198042|NCT00622401|589439342|FG000|Overall Study|Disease progression prior to treatment|3|||
163198043|NCT00622401|589439343|FG001|Overall Study|Disease progression prior to treatment|2|||
163198044|NCT00622401|589439344|FG002|Overall Study|Disease progression prior to treatment|0|||
163198045|NCT03546062|589439345|FG000|Overall Study|Adverse Event|6|||
163048030|NCT01670045|588882704|FG000|Overall Study|Adverse Event|1|||
163048031|NCT01670045|588882704|FG000|Overall Study|Death|1|||
163048032|NCT01670045|588882704|FG000|Overall Study|Lost to Follow-up|11|||
163048033|NCT03360019|588882705|FG000|Overall Study|Withdrawal by Subject|2|||
163048034|NCT03360019|588882706|FG001|Overall Study|Withdrawal by Subject|0|||
163048035|NCT03360019|588882707|FG002|Overall Study|Withdrawal by Subject|0|||
163048036|NCT03360019|588882705|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
163048037|NCT03360019|588882706|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
163048038|NCT03360019|588882707|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
163048039|NCT00753675|588882710|FG000|Overall Study|other reason|11|||
163048040|NCT00753675|588882711|FG001|Overall Study|other reason|12|||
163048041|NCT00753675|588882712|FG002|Overall Study|other reason|13|||
163198046|NCT03546062|589439346|FG001|Overall Study|Adverse Event|5|||
163198047|NCT03546062|589439347|FG002|Overall Study|Adverse Event|8|||
163198048|NCT00181155|589439348|FG000|Overall Study|Physician Decision|1|||
163048042|NCT00753675|588882710|FG000|Overall Study|Death|1|||
163048043|NCT00753675|588882711|FG001|Overall Study|Death|2|||
163048044|NCT00753675|588882712|FG002|Overall Study|Death|4|||
163048045|NCT00753675|588882710|FG000|Overall Study|Adverse Event|11|||
163048046|NCT00753675|588882711|FG001|Overall Study|Adverse Event|9|||
163048047|NCT00753675|588882712|FG002|Overall Study|Adverse Event|4|||
163048048|NCT00753675|588882710|FG000|Overall Study|Objective progression of disease|35|||
163048049|NCT00753675|588882711|FG001|Overall Study|Objective progression of disease|35|||
163048050|NCT00753675|588882712|FG002|Overall Study|Objective progression of disease|35|||
163048051|NCT00753675|588882710|FG000|Overall Study|Withdrawal by Subject|0|||
163048052|NCT00753675|588882711|FG001|Overall Study|Withdrawal by Subject|1|||
163048053|NCT00753675|588882712|FG002|Overall Study|Withdrawal by Subject|0|||
163048054|NCT00753675|588882710|FG000|Overall Study|Lost to Follow-up|1|||
163048055|NCT00753675|588882711|FG001|Overall Study|Lost to Follow-up|0|||
163048056|NCT00753675|588882712|FG002|Overall Study|Lost to Follow-up|0|||
163304166|NCT03899961|589821768|FG001|Overall Study|-delivery prior to|7|||
163304167|NCT03899961|589821767|FG000|Overall Study|req general anesth|1|||
163304168|NCT03899961|589821768|FG001|Overall Study|req general anesth|2|||
163304169|NCT03899961|589821767|FG000|Overall Study|capacity|5|||
163304170|NCT03899961|589821768|FG001|Overall Study|capacity|6|||
163304171|NCT03899961|589821767|FG000|Overall Study|Withdrawal by Subject|1|||
163048057|NCT01462110|588882713|FG000|Overall Study|Adverse Event|1|||
163048058|NCT01462110|588882714|FG001|Overall Study|Adverse Event|0|||
163048059|NCT05279131|588882715|FG000|Overall Study|Lost to Follow-up|1|||
163304172|NCT03899961|589821768|FG001|Overall Study|Withdrawal by Subject|1|||
163048060|NCT05279131|588882715|FG000|Overall Study|Death|1|||
163048061|NCT05279131|588882715|FG000|Overall Study|Physician Decision|1|||
163048062|NCT00964028|588882721|FG000|Overall Study|Withdrawal by Subject|0|||
163304173|NCT05107401|589821769|FG000|Overall Study|Lost to Follow-up|13|||
163304174|NCT05107401|589821770|FG001|Overall Study|Lost to Follow-up|12|||
162961595|NCT00112437|588560754|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
162961596|NCT00112437|588560755|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
162961597|NCT00112437|588560756|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
162961598|NCT00112437|588560757|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
162961599|NCT00112437|588560758|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
162961600|NCT00112437|588560759|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
162961601|NCT00112437|588560760|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
162961602|NCT00112437|588560761|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
162961603|NCT00112437|588560762|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
162961604|NCT00112437|588560763|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
162961605|NCT00112437|588560764|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
162961606|NCT00112437|588560765|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
162961607|NCT00112437|588560766|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
162961608|NCT00112437|588560767|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
162961609|NCT00112437|588560768|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
163198049|NCT00181155|589439349|FG001|Overall Study|Physician Decision|0|||
163198050|NCT00181155|589439348|FG000|Overall Study|Withdrawal by Subject|1|||
163395729|NCT01994382|590161022|FG001|Overall Study|Withdrawal by Subject|0|||
163395730|NCT01994382|590161023|FG002|Overall Study|Withdrawal by Subject|0|||
163395731|NCT01994382|590161024|FG003|Overall Study|Withdrawal by Subject|0|||
163395732|NCT01994382|590161025|FG004|Overall Study|Withdrawal by Subject|0|||
163395733|NCT01994382|590161026|FG005|Overall Study|Withdrawal by Subject|0|||
163395734|NCT01994382|590161027|FG006|Overall Study|Withdrawal by Subject|0|||
163395735|NCT01994382|590161028|FG007|Overall Study|Withdrawal by Subject|0|||
163395736|NCT01994382|590161029|FG008|Overall Study|Withdrawal by Subject|0|||
163395737|NCT01994382|590161030|FG009|Overall Study|Withdrawal by Subject|0|||
163395738|NCT01994382|590161031|FG010|Overall Study|Withdrawal by Subject|6|||
163395739|NCT01994382|590161032|FG011|Overall Study|Withdrawal by Subject|0|||
163395740|NCT01994382|590161033|FG012|Overall Study|Withdrawal by Subject|2|||
163395741|NCT01994382|590161034|FG013|Overall Study|Withdrawal by Subject|0|||
163395742|NCT01994382|590161035|FG014|Overall Study|Withdrawal by Subject|4|||
163395743|NCT01994382|590161036|FG015|Overall Study|Withdrawal by Subject|3|||
163395744|NCT01994382|590161037|FG016|Overall Study|Withdrawal by Subject|0|||
163395745|NCT01994382|590161021|FG000|Overall Study|Lost to Follow-up|0|||
163395746|NCT01994382|590161022|FG001|Overall Study|Lost to Follow-up|0|||
163395747|NCT01994382|590161023|FG002|Overall Study|Lost to Follow-up|0|||
163395748|NCT01994382|590161024|FG003|Overall Study|Lost to Follow-up|0|||
163395749|NCT01994382|590161025|FG004|Overall Study|Lost to Follow-up|0|||
163395750|NCT01994382|590161026|FG005|Overall Study|Lost to Follow-up|0|||
163395751|NCT01994382|590161027|FG006|Overall Study|Lost to Follow-up|0|||
163395752|NCT01994382|590161028|FG007|Overall Study|Lost to Follow-up|0|||
163395753|NCT01994382|590161029|FG008|Overall Study|Lost to Follow-up|0|||
163395754|NCT01994382|590161030|FG009|Overall Study|Lost to Follow-up|0|||
163395755|NCT01994382|590161031|FG010|Overall Study|Lost to Follow-up|1|||
163395756|NCT01994382|590161032|FG011|Overall Study|Lost to Follow-up|0|||
163395757|NCT01994382|590161033|FG012|Overall Study|Lost to Follow-up|0|||
163395758|NCT01994382|590161034|FG013|Overall Study|Lost to Follow-up|0|||
163395759|NCT01994382|590161035|FG014|Overall Study|Lost to Follow-up|0|||
163395760|NCT01994382|590161036|FG015|Overall Study|Lost to Follow-up|0|||
163395761|NCT01994382|590161037|FG016|Overall Study|Lost to Follow-up|0|||
163395762|NCT01994382|590161021|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163395763|NCT01994382|590161022|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163395764|NCT01994382|590161023|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163395765|NCT01994382|590161024|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163395766|NCT01994382|590161025|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163395767|NCT01994382|590161026|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163395768|NCT01994382|590161027|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163395769|NCT01994382|590161028|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163395770|NCT01994382|590161029|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163395771|NCT01994382|590161030|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163395772|NCT01994382|590161031|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
163395773|NCT01994382|590161032|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163395774|NCT01994382|590161033|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
163395775|NCT01994382|590161034|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163395776|NCT01994382|590161035|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163395777|NCT01994382|590161036|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
163395778|NCT01994382|590161037|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
163395779|NCT01994382|590161021|FG000|Overall Study|Protocol violation/noncompliance|0|||
163395780|NCT01994382|590161022|FG001|Overall Study|Protocol violation/noncompliance|0|||
163395781|NCT01994382|590161023|FG002|Overall Study|Protocol violation/noncompliance|0|||
163395782|NCT01994382|590161024|FG003|Overall Study|Protocol violation/noncompliance|0|||
163395783|NCT01994382|590161025|FG004|Overall Study|Protocol violation/noncompliance|0|||
163395784|NCT01994382|590161026|FG005|Overall Study|Protocol violation/noncompliance|0|||
163395785|NCT01994382|590161027|FG006|Overall Study|Protocol violation/noncompliance|0|||
163395786|NCT01994382|590161028|FG007|Overall Study|Protocol violation/noncompliance|0|||
163395787|NCT01994382|590161029|FG008|Overall Study|Protocol violation/noncompliance|0|||
163395788|NCT01994382|590161030|FG009|Overall Study|Protocol violation/noncompliance|0|||
163198051|NCT00181155|589439349|FG001|Overall Study|Withdrawal by Subject|0|||
162961610|NCT00112437|588560769|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
162961611|NCT00112437|588560770|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
162961612|NCT00112437|588560771|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
162961613|NCT00112437|588560746|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961614|NCT00112437|588560747|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961615|NCT00112437|588560748|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961616|NCT00112437|588560749|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961617|NCT00112437|588560750|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961618|NCT00112437|588560751|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961619|NCT00112437|588560752|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961620|NCT00112437|588560753|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961621|NCT00112437|588560754|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961622|NCT00112437|588560755|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961623|NCT00112437|588560756|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961624|NCT00112437|588560757|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
162961625|NCT00112437|588560758|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961626|NCT00112437|588560759|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
162961627|NCT00112437|588560760|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961628|NCT00112437|588560761|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
162961629|NCT00112437|588560762|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961630|NCT00112437|588560763|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
163048063|NCT00964028|588882722|FG001|Overall Study|Withdrawal by Subject|1|||
163048064|NCT02106351|588882723|FG000|Treatment Cycle 1|Adverse Event|2|||
163048065|NCT02106351|588882724|FG001|Treatment Cycle 1|Adverse Event|0|||
163048066|NCT02106351|588882725|FG002|Treatment Cycle 1|Adverse Event|0|||
163048067|NCT02106351|588882723|FG000|Treatment Cycle 1|Consent withdrawn|1|||
163048068|NCT02106351|588882724|FG001|Treatment Cycle 1|Consent withdrawn|0|||
163048069|NCT02106351|588882725|FG002|Treatment Cycle 1|Consent withdrawn|2|||
163198052|NCT02572401|589439350|FG000|Overall Study|Lost to Follow-up|5|||
163198053|NCT02572401|589439351|FG001|Overall Study|Lost to Follow-up|8|||
163198054|NCT02572401|589439352|FG002|Overall Study|Lost to Follow-up|9|||
163198055|NCT02572401|589439353|FG003|Overall Study|Lost to Follow-up|9|||
163198056|NCT02572401|589439350|FG000|Overall Study|Death|0|||
163198057|NCT02572401|589439351|FG001|Overall Study|Death|0|||
163198058|NCT02572401|589439352|FG002|Overall Study|Death|0|||
163198059|NCT02572401|589439353|FG003|Overall Study|Death|1|||
163198060|NCT01768286|589439359|FG000|Overall Study|Randomized But Not Treated|0|||
163198061|NCT01768286|589439360|FG001|Overall Study|Randomized But Not Treated|0|||
163198062|NCT01768286|589439361|FG002|Overall Study|Randomized But Not Treated|1|||
163198063|NCT01768286|589439362|FG003|Overall Study|Randomized But Not Treated|0|||
163198064|NCT01768286|589439359|FG000|Overall Study|Lack of Efficacy|7|||
163198065|NCT01768286|589439360|FG001|Overall Study|Lack of Efficacy|4|||
163198066|NCT01768286|589439361|FG002|Overall Study|Lack of Efficacy|0|||
163198067|NCT01768286|589439362|FG003|Overall Study|Lack of Efficacy|1|||
163198068|NCT01768286|589439359|FG000|Overall Study|Withdrew Consent|0|||
163198069|NCT01768286|589439360|FG001|Overall Study|Withdrew Consent|0|||
163198070|NCT01768286|589439361|FG002|Overall Study|Withdrew Consent|1|||
163198071|NCT01768286|589439362|FG003|Overall Study|Withdrew Consent|0|||
163198072|NCT02243696|589439363|FG000|Overall Study|Death|282|||
163198073|NCT02243696|589439363|FG000|Overall Study|Withdrawal by Subject|79|||
163198074|NCT02243696|589439363|FG000|Overall Study|Lost to Follow-up|57|||
163198075|NCT02243696|589439363|FG000|Overall Study|Subject No Longer has Study System|42|||
163198076|NCT02243696|589439363|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
163198077|NCT02243696|589439363|FG000|Overall Study|Study Terminated for EP PASSION|961|||
163198078|NCT00622284|589439364|FG000|Overall Study|Lack of Efficacy|45|||
163198079|NCT00622284|589439365|FG001|Overall Study|Lack of Efficacy|15|||
163198080|NCT00622284|589439364|FG000|Overall Study|Adverse Event|61|||
163198081|NCT00622284|589439365|FG001|Overall Study|Adverse Event|90|||
163198082|NCT00622284|589439364|FG000|Overall Study|Protocol Violation|12|||
163198083|NCT00622284|589439365|FG001|Overall Study|Protocol Violation|5|||
163198084|NCT00622284|589439364|FG000|Overall Study|Lost to Follow-up|11|||
163198085|NCT00622284|589439365|FG001|Overall Study|Lost to Follow-up|13|||
163198086|NCT00622284|589439364|FG000|Overall Study|Withdrawal by Subject|27|||
163198087|NCT00622284|589439365|FG001|Overall Study|Withdrawal by Subject|24|||
163198088|NCT00622284|589439364|FG000|Overall Study|Other reason (not specified)|33|||
163198089|NCT00622284|589439365|FG001|Overall Study|Other reason (not specified)|24|||
163198090|NCT02935842|589439366|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
163198091|NCT02935842|589439367|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
163198092|NCT02935842|589439368|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
163198093|NCT02935842|589439369|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
163198094|NCT02935842|589439366|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
163198095|NCT02935842|589439367|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
162961631|NCT00112437|588560764|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
163048070|NCT02106351|588882723|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
163048071|NCT02106351|588882724|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
163048072|NCT02106351|588882725|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
163048073|NCT02106351|588882723|FG000|Treatment Cycle 1|Other|0|||
163048074|NCT02106351|588882724|FG001|Treatment Cycle 1|Other|3|||
163048075|NCT02106351|588882725|FG002|Treatment Cycle 1|Other|1|||
163048076|NCT02106351|588882723|FG000|Treatment Cycle 1|Randomised but not treated|1|||
163048077|NCT02106351|588882724|FG001|Treatment Cycle 1|Randomised but not treated|0|||
163048078|NCT02106351|588882725|FG002|Treatment Cycle 1|Randomised but not treated|1|||
163048079|NCT02106351|588882723|FG000|Treatment Cycle 2|Adverse Event|0|||
163048080|NCT02106351|588882724|FG001|Treatment Cycle 2|Adverse Event|2|||
163048081|NCT02106351|588882725|FG002|Treatment Cycle 2|Adverse Event|0|||
163048082|NCT02106351|588882723|FG000|Treatment Cycle 2|Consent withdrawn|0|||
163048083|NCT02106351|588882724|FG001|Treatment Cycle 2|Consent withdrawn|1|||
163048084|NCT02106351|588882725|FG002|Treatment Cycle 2|Consent withdrawn|1|||
163048085|NCT02106351|588882723|FG000|Treatment Cycle 2|Other|0|||
163048086|NCT02106351|588882724|FG001|Treatment Cycle 2|Other|2|||
163048087|NCT02106351|588882725|FG002|Treatment Cycle 2|Other|2|||
163048088|NCT02106351|588882723|FG000|Treatment Cycle 3|Adverse Event|0|||
163048089|NCT02106351|588882724|FG001|Treatment Cycle 3|Adverse Event|1|||
163048090|NCT02106351|588882725|FG002|Treatment Cycle 3|Adverse Event|0|||
163048091|NCT02106351|588882723|FG000|Treatment Cycle 3|Consent withdrawn|0|||
163048092|NCT02106351|588882724|FG001|Treatment Cycle 3|Consent withdrawn|0|||
163048093|NCT02106351|588882725|FG002|Treatment Cycle 3|Consent withdrawn|2|||
163048094|NCT02106351|588882723|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
163048095|NCT02106351|588882724|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
163048096|NCT02106351|588882725|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
163048097|NCT02106351|588882723|FG000|Treatment Cycle 3|Other|0|||
163048098|NCT02106351|588882724|FG001|Treatment Cycle 3|Other|2|||
163048099|NCT02106351|588882725|FG002|Treatment Cycle 3|Other|3|||
163048100|NCT02106351|588882723|FG000|Treatment Cycle 4|Consent withdrawn|0|||
163048101|NCT02106351|588882724|FG001|Treatment Cycle 4|Consent withdrawn|0|||
163048102|NCT02106351|588882725|FG002|Treatment Cycle 4|Consent withdrawn|2|||
163048103|NCT02106351|588882723|FG000|Treatment Cycle 4|Other|0|||
163048104|NCT02106351|588882724|FG001|Treatment Cycle 4|Other|1|||
163048105|NCT02106351|588882725|FG002|Treatment Cycle 4|Other|0|||
163048106|NCT04754542|588882729|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
163048107|NCT04754542|588882730|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
163048108|NCT00735943|588884719|FG000|Overall Study|Lost to Follow-up|1|||
163048109|NCT00735943|588884719|FG000|Overall Study|Adverse Event|1|||
163048110|NCT03713684|588884722|FG000|Overall Study|Adverse Event|1|||
163048111|NCT03713684|588884723|FG001|Overall Study|Adverse Event|3|||
163048112|NCT03713684|588884724|FG002|Overall Study|Adverse Event|1|||
163048113|NCT03713684|588884725|FG003|Overall Study|Adverse Event|0|||
163048114|NCT03713684|588884722|FG000|Overall Study|Poor compliance to protocol|2|||
163048115|NCT03713684|588884723|FG001|Overall Study|Poor compliance to protocol|1|||
163304175|NCT04093362|589821775|FG000|Overall Study|Study Termination|1|||
163304176|NCT04093362|589821776|FG001|Overall Study|Study Termination|1|||
163304177|NCT04093362|589821775|FG000|Overall Study|Withdrawal of Consent|1|||
163304178|NCT04093362|589821776|FG001|Overall Study|Withdrawal of Consent|0|||
163304179|NCT04093362|589821775|FG000|Overall Study|Death|1|||
163304180|NCT04093362|589821776|FG001|Overall Study|Death|3|||
163304181|NCT04093362|589821775|FG000|Overall Study|Reason not Specified|1|||
163304182|NCT04093362|589821776|FG001|Overall Study|Reason not Specified|2|||
163304183|NCT05952076|589821779|FG000|Overall Study|Death|1|||
163304184|NCT05952076|589821780|FG001|Overall Study|Death|1|||
163304185|NCT05952076|589821779|FG000|Overall Study|Lost to Follow-up|0|||
163304186|NCT05952076|589821780|FG001|Overall Study|Lost to Follow-up|1|||
163304187|NCT03289039|589821781|FG000|Overall Study|Withdrawal by Subject|0|||
163304188|NCT03289039|589821782|FG001|Overall Study|Withdrawal by Subject|1|||
163304189|NCT03289039|589821781|FG000|Overall Study|Became ineligible prior to treatment start|0|||
163395789|NCT01994382|590161031|FG010|Overall Study|Protocol violation/noncompliance|0|||
163048116|NCT03713684|588884724|FG002|Overall Study|Poor compliance to protocol|0|||
163048117|NCT03713684|588884725|FG003|Overall Study|Poor compliance to protocol|1|||
163048118|NCT03713684|588884722|FG000|Overall Study|Withdrawal by Subject|14|||
163048119|NCT03713684|588884723|FG001|Overall Study|Withdrawal by Subject|6|||
163048120|NCT03713684|588884724|FG002|Overall Study|Withdrawal by Subject|14|||
163048121|NCT03713684|588884725|FG003|Overall Study|Withdrawal by Subject|16|||
163048122|NCT03713684|588884722|FG000|Overall Study|Other than specified|69|||
163048123|NCT03713684|588884723|FG001|Overall Study|Other than specified|77|||
163048124|NCT03713684|588884724|FG002|Overall Study|Other than specified|73|||
163048125|NCT03713684|588884725|FG003|Overall Study|Other than specified|70|||
163304190|NCT03289039|589821782|FG001|Overall Study|Became ineligible prior to treatment start|1|||
163304191|NCT03289039|589821781|FG000|Overall Study|progressed before treatment start|1|||
163395790|NCT01994382|590161032|FG011|Overall Study|Protocol violation/noncompliance|1|||
163395791|NCT01994382|590161033|FG012|Overall Study|Protocol violation/noncompliance|0|||
163395792|NCT01994382|590161034|FG013|Overall Study|Protocol violation/noncompliance|0|||
163395793|NCT01994382|590161035|FG014|Overall Study|Protocol violation/noncompliance|0|||
163395794|NCT01994382|590161036|FG015|Overall Study|Protocol violation/noncompliance|0|||
163395795|NCT01994382|590161037|FG016|Overall Study|Protocol violation/noncompliance|2|||
163395796|NCT01994382|590161021|FG000|Overall Study|Rolled over to Phase 2a|0|||
163395797|NCT01994382|590161022|FG001|Overall Study|Rolled over to Phase 2a|0|||
163395798|NCT01994382|590161023|FG002|Overall Study|Rolled over to Phase 2a|1|||
163395799|NCT01994382|590161024|FG003|Overall Study|Rolled over to Phase 2a|0|||
163395800|NCT01994382|590161025|FG004|Overall Study|Rolled over to Phase 2a|0|||
163395801|NCT01994382|590161026|FG005|Overall Study|Rolled over to Phase 2a|0|||
163395802|NCT01994382|590161027|FG006|Overall Study|Rolled over to Phase 2a|0|||
163395803|NCT01994382|590161028|FG007|Overall Study|Rolled over to Phase 2a|0|||
163395804|NCT01994382|590161029|FG008|Overall Study|Rolled over to Phase 2a|0|||
163395805|NCT01994382|590161030|FG009|Overall Study|Rolled over to Phase 2a|2|||
163395806|NCT01994382|590161031|FG010|Overall Study|Rolled over to Phase 2a|0|||
163395807|NCT01994382|590161032|FG011|Overall Study|Rolled over to Phase 2a|0|||
163395808|NCT01994382|590161033|FG012|Overall Study|Rolled over to Phase 2a|0|||
163395809|NCT01994382|590161034|FG013|Overall Study|Rolled over to Phase 2a|0|||
163395810|NCT01994382|590161035|FG014|Overall Study|Rolled over to Phase 2a|0|||
163395811|NCT01994382|590161036|FG015|Overall Study|Rolled over to Phase 2a|0|||
163395812|NCT01994382|590161037|FG016|Overall Study|Rolled over to Phase 2a|0|||
163395813|NCT04667377|590161038|FG000|Dose Escalation Period|Other not specified below|3|||
163395814|NCT04667377|590161039|FG001|Dose Escalation Period|Other not specified below|3|||
163395815|NCT04667377|590161040|FG002|Dose Escalation Period|Other not specified below|2|||
163395816|NCT04667377|590161041|FG003|Dose Escalation Period|Other not specified below|1|||
163395817|NCT04667377|590161042|FG004|Dose Escalation Period|Other not specified below|3|||
163395818|NCT04667377|590161038|FG000|Dose Escalation Period|Protocol Violation|2|||
163395819|NCT04667377|590161039|FG001|Dose Escalation Period|Protocol Violation|2|||
163395820|NCT04667377|590161040|FG002|Dose Escalation Period|Protocol Violation|0|||
163395821|NCT04667377|590161041|FG003|Dose Escalation Period|Protocol Violation|2|||
163395822|NCT04667377|590161042|FG004|Dose Escalation Period|Protocol Violation|1|||
163395823|NCT04667377|590161038|FG000|Dose Escalation Period|Burden of study procedures|2|||
163395824|NCT04667377|590161039|FG001|Dose Escalation Period|Burden of study procedures|1|||
163395825|NCT04667377|590161040|FG002|Dose Escalation Period|Burden of study procedures|1|||
163395826|NCT04667377|590161041|FG003|Dose Escalation Period|Burden of study procedures|1|||
163395827|NCT04667377|590161042|FG004|Dose Escalation Period|Burden of study procedures|5|||
163395828|NCT04667377|590161038|FG000|Dose Escalation Period|Change of residence|0|||
163048126|NCT00528424|588884726|FG000|Overall Study|Lost to Follow-up|13|||
163048127|NCT00528424|588884726|FG000|Overall Study|Withdrew consent|2|||
163048128|NCT00528424|588884726|FG000|Overall Study|Administrative reason|2|||
163048129|NCT00528424|588884726|FG000|Overall Study|Other|12|||
163048130|NCT02515630|588884727|FG000|Overall Study|Withdrawal by Subject|5|||
163048131|NCT02515630|588884727|FG000|Overall Study|Adverse Event|4|||
163048132|NCT02515630|588884727|FG000|Overall Study|Physician Decision|4|||
163048133|NCT02515630|588884727|FG000|Overall Study|Death|2|||
163048134|NCT02515630|588884727|FG000|Overall Study|Disease Progression|1|||
163304192|NCT03289039|589821782|FG001|Overall Study|progressed before treatment start|0|||
163304193|NCT04586920|589821783|FG000|Overall Study|Lost to Follow-up|0|||
163048135|NCT01064414|588884730|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
163048136|NCT01064414|588884731|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
163048137|NCT01064414|588884732|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
163048138|NCT01064414|588884730|FG000|Core Period: Baseline to Week 26|Death|0|||
163048139|NCT01064414|588884731|FG001|Core Period: Baseline to Week 26|Death|1|||
163048140|NCT01064414|588884732|FG002|Core Period: Baseline to Week 26|Death|0|||
163048141|NCT01064414|588884730|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
163048142|NCT01064414|588884731|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
163048143|NCT01064414|588884732|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
163304194|NCT04586920|589821784|FG001|Overall Study|Lost to Follow-up|0|||
163304195|NCT04586920|589821785|FG002|Overall Study|Lost to Follow-up|0|||
163304196|NCT04586920|589821786|FG003|Overall Study|Lost to Follow-up|0|||
163304197|NCT04586920|589821787|FG004|Overall Study|Lost to Follow-up|0|||
163304198|NCT04586920|589821788|FG005|Overall Study|Lost to Follow-up|0|||
163304199|NCT04586920|589821789|FG006|Overall Study|Lost to Follow-up|1|||
163304200|NCT04586920|589821790|FG007|Overall Study|Lost to Follow-up|1|||
163304201|NCT04586920|589821791|FG008|Overall Study|Lost to Follow-up|0|||
163304202|NCT04586920|589821792|FG009|Overall Study|Lost to Follow-up|1|||
163304203|NCT04586920|589821793|FG010|Overall Study|Lost to Follow-up|0|||
163304204|NCT04586920|589821794|FG011|Overall Study|Lost to Follow-up|0|||
163304205|NCT04586920|589821795|FG012|Overall Study|Lost to Follow-up|0|||
163304206|NCT04586920|589821796|FG013|Overall Study|Lost to Follow-up|1|||
163304207|NCT04586920|589821797|FG014|Overall Study|Lost to Follow-up|0|||
162961632|NCT00112437|588560765|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961633|NCT00112437|588560766|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961634|NCT00112437|588560767|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
163304208|NCT04586920|589821798|FG015|Overall Study|Lost to Follow-up|0|||
163304209|NCT04586920|589821799|FG016|Overall Study|Lost to Follow-up|0|||
163395829|NCT04667377|590161039|FG001|Dose Escalation Period|Change of residence|0|||
163304210|NCT04586920|589821800|FG017|Overall Study|Lost to Follow-up|0|||
163304211|NCT04586920|589821783|FG000|Overall Study|Withdrawal by Subject|0|||
163304212|NCT04586920|589821784|FG001|Overall Study|Withdrawal by Subject|0|||
163304213|NCT04586920|589821785|FG002|Overall Study|Withdrawal by Subject|0|||
162961635|NCT00112437|588560768|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961636|NCT00112437|588560769|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
163304214|NCT04586920|589821786|FG003|Overall Study|Withdrawal by Subject|0|||
163304215|NCT04586920|589821787|FG004|Overall Study|Withdrawal by Subject|0|||
163304216|NCT04586920|589821788|FG005|Overall Study|Withdrawal by Subject|0|||
163304217|NCT04586920|589821789|FG006|Overall Study|Withdrawal by Subject|0|||
163304218|NCT04586920|589821790|FG007|Overall Study|Withdrawal by Subject|1|||
163304219|NCT04586920|589821791|FG008|Overall Study|Withdrawal by Subject|0|||
162961637|NCT00112437|588560770|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961638|NCT00112437|588560771|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961639|NCT00112437|588560746|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961640|NCT00112437|588560747|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961641|NCT00112437|588560748|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961642|NCT00112437|588560749|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
163304220|NCT04586920|589821792|FG009|Overall Study|Withdrawal by Subject|1|||
163395830|NCT04667377|590161040|FG002|Dose Escalation Period|Change of residence|1|||
163395831|NCT04667377|590161041|FG003|Dose Escalation Period|Change of residence|0|||
163395832|NCT04667377|590161042|FG004|Dose Escalation Period|Change of residence|0|||
163395833|NCT04667377|590161038|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
163395834|NCT04667377|590161039|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
163395835|NCT04667377|590161040|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
163395836|NCT04667377|590161041|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
163395837|NCT04667377|590161042|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
162961643|NCT00112437|588560750|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961644|NCT00112437|588560751|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961645|NCT00112437|588560752|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961646|NCT00112437|588560753|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
163395838|NCT04667377|590161038|FG000|Dose Escalation Period|Adverse Event|9|||
163395839|NCT04667377|590161039|FG001|Dose Escalation Period|Adverse Event|10|||
163395840|NCT04667377|590161040|FG002|Dose Escalation Period|Adverse Event|12|||
163395841|NCT04667377|590161041|FG003|Dose Escalation Period|Adverse Event|17|||
163395842|NCT04667377|590161042|FG004|Dose Escalation Period|Adverse Event|3|||
163395843|NCT04667377|590161038|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
163395844|NCT04667377|590161039|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
163395845|NCT04667377|590161040|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
163395846|NCT04667377|590161041|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
163395847|NCT04667377|590161042|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
163395848|NCT04667377|590161038|FG000|Dose Escalation Period|Not treated|1|||
163395849|NCT04667377|590161039|FG001|Dose Escalation Period|Not treated|0|||
163395850|NCT04667377|590161040|FG002|Dose Escalation Period|Not treated|0|||
162961647|NCT00112437|588560754|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961648|NCT00112437|588560755|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961649|NCT00112437|588560756|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961650|NCT00112437|588560757|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961651|NCT00112437|588560758|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961652|NCT00112437|588560759|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961653|NCT00112437|588560760|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961654|NCT00112437|588560761|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
162961655|NCT00112437|588560762|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961656|NCT00112437|588560763|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961657|NCT00112437|588560764|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961658|NCT00112437|588560765|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961659|NCT00112437|588560766|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961660|NCT00112437|588560767|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961661|NCT00112437|588560768|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961662|NCT00112437|588560769|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961663|NCT00112437|588560770|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961664|NCT00112437|588560771|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961665|NCT00112437|588560746|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961666|NCT00112437|588560747|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961667|NCT00112437|588560748|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961668|NCT00112437|588560749|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961669|NCT00112437|588560750|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961670|NCT00112437|588560751|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961671|NCT00112437|588560752|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961672|NCT00112437|588560753|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961673|NCT00112437|588560754|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961674|NCT00112437|588560755|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961675|NCT00112437|588560756|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961676|NCT00112437|588560757|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961677|NCT00112437|588560758|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961678|NCT00112437|588560759|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961679|NCT00112437|588560760|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961680|NCT00112437|588560761|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
162961681|NCT00112437|588560762|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961682|NCT00112437|588560763|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961683|NCT00112437|588560764|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961684|NCT00112437|588560765|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961685|NCT00112437|588560766|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961686|NCT00112437|588560767|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961687|NCT00112437|588560768|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961688|NCT00112437|588560769|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
163395851|NCT04667377|590161041|FG003|Dose Escalation Period|Not treated|0|||
163395852|NCT04667377|590161042|FG004|Dose Escalation Period|Not treated|0|||
163395853|NCT04667377|590161038|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
163048144|NCT01064414|588884730|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
163048145|NCT01064414|588884731|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
163048146|NCT01064414|588884732|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
163304221|NCT04586920|589821793|FG010|Overall Study|Withdrawal by Subject|0|||
163304222|NCT04586920|589821794|FG011|Overall Study|Withdrawal by Subject|1|||
162961689|NCT00112437|588560770|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961690|NCT00112437|588560771|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961691|NCT00112437|588560746|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961692|NCT00112437|588560747|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961693|NCT00112437|588560748|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961694|NCT00112437|588560749|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961695|NCT00112437|588560750|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961696|NCT00112437|588560751|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961697|NCT00112437|588560752|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961698|NCT00112437|588560753|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961699|NCT00112437|588560754|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961700|NCT00112437|588560755|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
163304223|NCT04586920|589821795|FG012|Overall Study|Withdrawal by Subject|0|||
162961701|NCT00112437|588560756|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961702|NCT00112437|588560757|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
163395854|NCT04667377|590161039|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
163395855|NCT04667377|590161040|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
163395856|NCT04667377|590161041|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
163395857|NCT04667377|590161042|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
163395858|NCT04667377|590161038|FG000|Dose Escalation Period|Lost to Follow-up|0|||
163395859|NCT04667377|590161039|FG001|Dose Escalation Period|Lost to Follow-up|1|||
163395860|NCT04667377|590161040|FG002|Dose Escalation Period|Lost to Follow-up|0|||
163395861|NCT04667377|590161041|FG003|Dose Escalation Period|Lost to Follow-up|0|||
163395862|NCT04667377|590161042|FG004|Dose Escalation Period|Lost to Follow-up|0|||
163395863|NCT04667377|590161038|FG000|Maintenance Period|Perceived lack of efficacy|0|||
163395864|NCT04667377|590161039|FG001|Maintenance Period|Perceived lack of efficacy|2|||
163395865|NCT04667377|590161040|FG002|Maintenance Period|Perceived lack of efficacy|1|||
163395866|NCT04667377|590161041|FG003|Maintenance Period|Perceived lack of efficacy|0|||
163395867|NCT04667377|590161042|FG004|Maintenance Period|Perceived lack of efficacy|1|||
163395868|NCT04667377|590161038|FG000|Maintenance Period|Adverse Event|2|||
163395869|NCT04667377|590161039|FG001|Maintenance Period|Adverse Event|8|||
163395870|NCT04667377|590161040|FG002|Maintenance Period|Adverse Event|5|||
163395871|NCT04667377|590161041|FG003|Maintenance Period|Adverse Event|4|||
163395872|NCT04667377|590161042|FG004|Maintenance Period|Adverse Event|1|||
163395873|NCT04667377|590161038|FG000|Maintenance Period|Adverse event: COVID infection|0|||
163395874|NCT04667377|590161039|FG001|Maintenance Period|Adverse event: COVID infection|1|||
163395875|NCT04667377|590161040|FG002|Maintenance Period|Adverse event: COVID infection|0|||
163395876|NCT04667377|590161041|FG003|Maintenance Period|Adverse event: COVID infection|0|||
163395877|NCT04667377|590161042|FG004|Maintenance Period|Adverse event: COVID infection|0|||
163395878|NCT04667377|590161038|FG000|Maintenance Period|COVID-related|0|||
163395879|NCT04667377|590161039|FG001|Maintenance Period|COVID-related|0|||
163395880|NCT04667377|590161040|FG002|Maintenance Period|COVID-related|1|||
163395881|NCT04667377|590161041|FG003|Maintenance Period|COVID-related|1|||
163395882|NCT04667377|590161042|FG004|Maintenance Period|COVID-related|0|||
163395883|NCT04667377|590161038|FG000|Maintenance Period|Protocol Violation|1|||
163395884|NCT04667377|590161039|FG001|Maintenance Period|Protocol Violation|0|||
163395885|NCT04667377|590161040|FG002|Maintenance Period|Protocol Violation|0|||
163395886|NCT04667377|590161041|FG003|Maintenance Period|Protocol Violation|0|||
163395887|NCT04667377|590161042|FG004|Maintenance Period|Protocol Violation|1|||
163395888|NCT04667377|590161038|FG000|Maintenance Period|Burden of study procedures|1|||
163395889|NCT04667377|590161039|FG001|Maintenance Period|Burden of study procedures|2|||
163395890|NCT04667377|590161040|FG002|Maintenance Period|Burden of study procedures|0|||
163395891|NCT04667377|590161041|FG003|Maintenance Period|Burden of study procedures|1|||
163395892|NCT04667377|590161042|FG004|Maintenance Period|Burden of study procedures|0|||
163395893|NCT04667377|590161038|FG000|Maintenance Period|Change of residence|0|||
163395894|NCT04667377|590161039|FG001|Maintenance Period|Change of residence|1|||
163395895|NCT04667377|590161040|FG002|Maintenance Period|Change of residence|0|||
163395896|NCT04667377|590161041|FG003|Maintenance Period|Change of residence|0|||
163395897|NCT04667377|590161042|FG004|Maintenance Period|Change of residence|1|||
163395898|NCT04667377|590161038|FG000|Maintenance Period|Missing|1|||
163395899|NCT04667377|590161039|FG001|Maintenance Period|Missing|0|||
163395900|NCT04667377|590161040|FG002|Maintenance Period|Missing|0|||
163395901|NCT04667377|590161041|FG003|Maintenance Period|Missing|0|||
163395902|NCT04667377|590161042|FG004|Maintenance Period|Missing|0|||
162961703|NCT00112437|588560758|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961704|NCT00112437|588560759|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
163395903|NCT04667377|590161038|FG000|Maintenance Period|Other than listed above|2|||
163395904|NCT04667377|590161039|FG001|Maintenance Period|Other than listed above|0|||
163395905|NCT04667377|590161040|FG002|Maintenance Period|Other than listed above|3|||
163395906|NCT04667377|590161041|FG003|Maintenance Period|Other than listed above|2|||
163395907|NCT04667377|590161042|FG004|Maintenance Period|Other than listed above|6|||
163395908|NCT04667377|590161038|FG000|Maintenance Period|Withdrawal by Subject|0|||
163395909|NCT04667377|590161039|FG001|Maintenance Period|Withdrawal by Subject|1|||
163395910|NCT04667377|590161040|FG002|Maintenance Period|Withdrawal by Subject|0|||
163395911|NCT04667377|590161041|FG003|Maintenance Period|Withdrawal by Subject|0|||
163395912|NCT04667377|590161042|FG004|Maintenance Period|Withdrawal by Subject|0|||
163395913|NCT04667377|590161038|FG000|Maintenance Period|Lost to Follow-up|1|||
163395914|NCT04667377|590161039|FG001|Maintenance Period|Lost to Follow-up|0|||
163395915|NCT04667377|590161040|FG002|Maintenance Period|Lost to Follow-up|1|||
163395916|NCT04667377|590161041|FG003|Maintenance Period|Lost to Follow-up|0|||
163395917|NCT04667377|590161042|FG004|Maintenance Period|Lost to Follow-up|1|||
163395918|NCT03861936|590161043|FG000|Overall Study|Withdrawal by Subject|4|||
163395919|NCT03861936|590161044|FG001|Overall Study|Withdrawal by Subject|1|||
163395920|NCT03861936|590161045|FG002|Overall Study|Withdrawal by Subject|3|||
163395921|NCT03861936|590161043|FG000|Overall Study|Lost to Follow-up|5|||
163395922|NCT03861936|590161044|FG001|Overall Study|Lost to Follow-up|3|||
163395923|NCT03861936|590161045|FG002|Overall Study|Lost to Follow-up|3|||
163198096|NCT02935842|589439368|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
163198097|NCT02935842|589439369|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
163198098|NCT02935842|589439366|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
163198099|NCT02935842|589439367|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
163198100|NCT02935842|589439368|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
163198101|NCT02935842|589439369|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
163198102|NCT02935842|589439366|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
162961705|NCT00112437|588560760|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
162961706|NCT00112437|588560761|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961707|NCT00112437|588560762|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961708|NCT00112437|588560763|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961709|NCT00112437|588560764|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961710|NCT00112437|588560765|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961711|NCT00112437|588560766|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961712|NCT00112437|588560767|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
163198103|NCT02935842|589439367|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
163198104|NCT02935842|589439368|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
163198105|NCT02935842|589439369|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
163198106|NCT02935842|589439366|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
163198107|NCT02935842|589439367|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
163198108|NCT02935842|589439368|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
163395924|NCT03861936|590161043|FG000|Overall Study|Physician Decision|0|||
163198109|NCT02935842|589439369|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
163198110|NCT01201850|589439372|FG000|Overall Study|Tumor progression|4|||
163198111|NCT04066023|589439373|FG000|Overall Study|Adverse Event|0|||
163198112|NCT04066023|589439374|FG001|Overall Study|Adverse Event|0|||
163395925|NCT03861936|590161044|FG001|Overall Study|Physician Decision|1|||
163395926|NCT03861936|590161045|FG002|Overall Study|Physician Decision|0|||
163395927|NCT03861936|590161043|FG000|Overall Study|Protocol Deviation|0|||
163395928|NCT03861936|590161044|FG001|Overall Study|Protocol Deviation|0|||
163395929|NCT03861936|590161045|FG002|Overall Study|Protocol Deviation|1|||
163395930|NCT03861936|590161043|FG000|Overall Study|Reason not Specified|5|||
163395931|NCT03861936|590161044|FG001|Overall Study|Reason not Specified|5|||
163395932|NCT03861936|590161045|FG002|Overall Study|Reason not Specified|3|||
163395933|NCT00359021|590161046|FG000|Overall Study|Adverse Event|26|||
163395934|NCT00359021|590161047|FG001|Overall Study|Adverse Event|8|||
163395935|NCT00359021|590161046|FG000|Overall Study|Subject Non-Compliant|1|||
163395936|NCT00359021|590161047|FG001|Overall Study|Subject Non-Compliant|2|||
163395937|NCT00359021|590161046|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
163395938|NCT00359021|590161047|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
163395939|NCT00359021|590161046|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
163395940|NCT00359021|590161047|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
163395941|NCT00359021|590161046|FG000|Overall Study|Withdrawal by Subject|2|||
163395942|NCT00359021|590161047|FG001|Overall Study|Withdrawal by Subject|9|||
163395943|NCT00359021|590161046|FG000|Overall Study|Lost to Follow-up|1|||
163395944|NCT00359021|590161047|FG001|Overall Study|Lost to Follow-up|0|||
163395945|NCT00359021|590161046|FG000|Overall Study|Other|4|||
163395946|NCT00359021|590161047|FG001|Overall Study|Other|1|||
163395947|NCT00359021|590161046|FG000|Overall Study|Pregnancy|1|||
163395948|NCT00359021|590161047|FG001|Overall Study|Pregnancy|0|||
163395949|NCT01670539|590161052|FG000|Overall Study|Death|3|||
163395950|NCT01670539|590161053|FG001|Overall Study|Death|5|||
163395951|NCT01670539|590161052|FG000|Overall Study|Withdrawal by Subject|3|||
163395952|NCT01670539|590161053|FG001|Overall Study|Withdrawal by Subject|0|||
163395953|NCT04353596|590161054|FG000|Overall Study|Protocol Violation|4|||
163395954|NCT04353596|590161055|FG001|Overall Study|Protocol Violation|4|||
163395955|NCT04353596|590161054|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
163395956|NCT04353596|590161055|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
163395957|NCT01236573|590161058|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163395958|NCT01236573|590161059|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163395959|NCT01236573|590161060|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163395960|NCT01236573|590161061|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163395961|NCT01236573|590161062|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163395962|NCT01236573|590161063|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163395963|NCT01236573|590161064|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
163395964|NCT01236573|590161065|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163395965|NCT01236573|590161066|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
163395966|NCT01236573|590161067|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
163395967|NCT01236573|590161068|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163395968|NCT01236573|590161058|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163395969|NCT01236573|590161059|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163395970|NCT01236573|590161060|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163395971|NCT01236573|590161061|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163395972|NCT01236573|590161062|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163198113|NCT04066023|589439375|FG002|Overall Study|Adverse Event|1|||
163198114|NCT04066023|589439373|FG000|Overall Study|Sponsor decision|3|||
163198115|NCT04066023|589439374|FG001|Overall Study|Sponsor decision|6|||
163198116|NCT04066023|589439375|FG002|Overall Study|Sponsor decision|2|||
163198117|NCT04066023|589439373|FG000|Overall Study|Physician Decision|0|||
163198118|NCT04066023|589439374|FG001|Overall Study|Physician Decision|0|||
163198119|NCT04066023|589439375|FG002|Overall Study|Physician Decision|1|||
163198120|NCT04066023|589439373|FG000|Overall Study|Lost to Follow-up|0|||
163198121|NCT04066023|589439374|FG001|Overall Study|Lost to Follow-up|1|||
163198122|NCT04066023|589439375|FG002|Overall Study|Lost to Follow-up|1|||
163198123|NCT04066023|589439373|FG000|Overall Study|Noncompliance|0|||
163198124|NCT04066023|589439374|FG001|Overall Study|Noncompliance|1|||
163198125|NCT04066023|589439375|FG002|Overall Study|Noncompliance|1|||
163395973|NCT01236573|590161063|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163395974|NCT01236573|590161064|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163395975|NCT01236573|590161065|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163395976|NCT01236573|590161066|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
163198126|NCT01552694|589439376|FG000|Overall Study|Lost to Follow-up|0|||
163198127|NCT01552694|589439377|FG001|Overall Study|Lost to Follow-up|1|||
163198128|NCT01552694|589439376|FG000|Overall Study|Protocol Violation|0|||
163395977|NCT01236573|590161067|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163048147|NCT01064414|588884730|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
163048148|NCT01064414|588884731|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
163048149|NCT01064414|588884732|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
163048150|NCT01064414|588884730|FG000|Core Period: Baseline to Week 26|Other|4|||
163048151|NCT01064414|588884731|FG001|Core Period: Baseline to Week 26|Other|7|||
163048152|NCT01064414|588884732|FG002|Core Period: Baseline to Week 26|Other|2|||
163048153|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
163048154|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
163048155|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
163048156|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Death|0|||
163048157|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Death|1|||
163048158|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Death|0|||
163048159|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
163048160|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
163048161|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
163048162|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
163048163|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
162961713|NCT00112437|588560768|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961714|NCT00112437|588560769|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961715|NCT00112437|588560770|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961716|NCT00112437|588560771|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
163198129|NCT01552694|589439377|FG001|Overall Study|Protocol Violation|1|||
163198130|NCT03338010|589439378|FG000|Overall Study|Withdrawal by Subject|14|||
162961717|NCT00112437|588560746|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
163048164|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
163048165|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
163048166|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
163048167|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
163048168|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
163304224|NCT04586920|589821796|FG013|Overall Study|Withdrawal by Subject|0|||
163304225|NCT04586920|589821797|FG014|Overall Study|Withdrawal by Subject|0|||
163304226|NCT04586920|589821798|FG015|Overall Study|Withdrawal by Subject|0|||
163304227|NCT04586920|589821799|FG016|Overall Study|Withdrawal by Subject|0|||
163304228|NCT04586920|589821800|FG017|Overall Study|Withdrawal by Subject|0|||
163304229|NCT04905407|589821806|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
163304230|NCT04905407|589821807|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
163304231|NCT04905407|589821808|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
163395978|NCT01236573|590161068|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163395979|NCT01236573|590161058|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163048169|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
163048170|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
163048171|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
163048172|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
163048173|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
163048174|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Other|5|||
163048175|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Other|2|||
163048176|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Other|1|||
163048177|NCT00974311|588884733|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
163048178|NCT00974311|588884734|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
163048179|NCT00974311|588884733|FG000|DB Phase (up to 24 Months)|Death|561|||
163048180|NCT00974311|588884734|FG001|DB Phase (up to 24 Months)|Death|298|||
163048181|NCT00974311|588884733|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
163048182|NCT00974311|588884734|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
163048183|NCT00974311|588884733|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
163304232|NCT04905407|589821809|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
163395980|NCT01236573|590161059|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163395981|NCT01236573|590161060|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163395982|NCT01236573|590161061|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163395983|NCT01236573|590161062|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163395984|NCT01236573|590161063|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163395985|NCT01236573|590161064|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163395986|NCT01236573|590161065|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163395987|NCT01236573|590161066|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163395988|NCT01236573|590161067|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163395989|NCT01236573|590161068|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
163395990|NCT05418673|590161069|FG000|Overall Study|Study Terminated by Sponsor|2|||
163395991|NCT05418673|590161070|FG001|Overall Study|Study Terminated by Sponsor|4|||
163395992|NCT05418673|590161069|FG000|Overall Study|Lost to Follow-up|1|||
163395993|NCT05418673|590161070|FG001|Overall Study|Lost to Follow-up|0|||
163395994|NCT02665052|590161071|FG000|Overall Study|Lost to Follow-up|1|||
163395995|NCT02665052|590161072|FG001|Overall Study|Lost to Follow-up|0|||
163395996|NCT02665052|590161073|FG002|Overall Study|Lost to Follow-up|0|||
163395997|NCT02665052|590161074|FG003|Overall Study|Lost to Follow-up|0|||
163395998|NCT02665052|590161071|FG000|Overall Study|Withdrawal by Subject|1|||
163395999|NCT02665052|590161072|FG001|Overall Study|Withdrawal by Subject|1|||
163396000|NCT02665052|590161073|FG002|Overall Study|Withdrawal by Subject|0|||
163396001|NCT02665052|590161074|FG003|Overall Study|Withdrawal by Subject|5|||
163396002|NCT02665052|590161071|FG000|Overall Study|Adverse Event|1|||
163396003|NCT02665052|590161072|FG001|Overall Study|Adverse Event|1|||
163396004|NCT02665052|590161073|FG002|Overall Study|Adverse Event|0|||
163396005|NCT02665052|590161074|FG003|Overall Study|Adverse Event|0|||
163396006|NCT02234284|590161075|FG000|Overall Study|Death|4|||
163396007|NCT02234284|590161076|FG001|Overall Study|Death|2|||
163396008|NCT02234284|590161075|FG000|Overall Study|Withdrawal by Subject|1|||
163396009|NCT02234284|590161076|FG001|Overall Study|Withdrawal by Subject|0|||
163396010|NCT02234284|590161075|FG000|Overall Study|Lost to Follow-up|20|||
163396011|NCT02234284|590161076|FG001|Overall Study|Lost to Follow-up|7|||
163396012|NCT01986920|590161079|FG000|A- 101 25%|Withdrawal by Subject|1|||
163396013|NCT01986920|590161080|FG001|A- 101 25%|Withdrawal by Subject|0|||
163396014|NCT01986920|590161081|FG002|A- 101 25%|Withdrawal by Subject|0|||
163396015|NCT01986920|590161082|FG003|A- 101 25%|Withdrawal by Subject|0|||
163396016|NCT01986920|590161079|FG000|A-101 32.5%|Withdrawal by Subject|0|||
163396017|NCT01986920|590161080|FG001|A-101 32.5%|Withdrawal by Subject|1|||
163396018|NCT01986920|590161081|FG002|A-101 32.5%|Withdrawal by Subject|0|||
163396019|NCT01986920|590161082|FG003|A-101 32.5%|Withdrawal by Subject|0|||
163396020|NCT01986920|590161079|FG000|A-101 40%|Withdrawal by Subject|0|||
163396021|NCT01986920|590161080|FG001|A-101 40%|Withdrawal by Subject|0|||
163396022|NCT01986920|590161081|FG002|A-101 40%|Withdrawal by Subject|1|||
163396023|NCT01986920|590161082|FG003|A-101 40%|Withdrawal by Subject|0|||
163396024|NCT01986920|590161079|FG000|Placebo|Withdrawal by Subject|0|||
163396025|NCT01986920|590161080|FG001|Placebo|Withdrawal by Subject|0|||
163396026|NCT01986920|590161081|FG002|Placebo|Withdrawal by Subject|0|||
163396027|NCT01986920|590161082|FG003|Placebo|Withdrawal by Subject|1|||
163396028|NCT03023059|590161085|FG000|Overall Study|Withdrawal by Subject|5|||
163396029|NCT00873366|590161088|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
163396030|NCT00873366|590161088|FG000|Overall Study|Off tamoxifen due to side effects|2|||
163396031|NCT00873366|590161088|FG000|Overall Study|Refused to continue DM-BT testing|3|||
163396032|NCT01576172|590161089|FG000|Overall Study|Ineligible|2|||
163396033|NCT01576172|590161090|FG001|Overall Study|Ineligible|1|||
163396034|NCT01576172|590161089|FG000|Overall Study|Withdrawal by Subject|2|||
163396035|NCT01576172|590161090|FG001|Overall Study|Withdrawal by Subject|0|||
163396036|NCT01576172|590161089|FG000|Overall Study|Insurance issue|1|||
163396037|NCT01576172|590161090|FG001|Overall Study|Insurance issue|0|||
163396038|NCT02092350|590161095|FG000|Overall Study|Adverse Event|0|||
163396039|NCT02092350|590161096|FG001|Overall Study|Adverse Event|3|||
163396040|NCT02092350|590161095|FG000|Overall Study|Death|2|||
163396041|NCT02092350|590161096|FG001|Overall Study|Death|5|||
163048184|NCT00974311|588884734|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
163048185|NCT00974311|588884733|FG000|DB Phase (up to 24 Months)|Other|1|||
163048186|NCT00974311|588884734|FG001|DB Phase (up to 24 Months)|Other|0|||
163048187|NCT00974311|588884733|FG000|OLE Phase (up to 77 Months)|Death|14|||
163048188|NCT00974311|588884734|FG001|OLE Phase (up to 77 Months)|Death|21|||
163048189|NCT00974311|588884733|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
163048190|NCT00974311|588884734|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
163048191|NCT00974311|588884733|FG000|OLE Phase (up to 77 Months)|Other|15|||
163048192|NCT00974311|588884734|FG001|OLE Phase (up to 77 Months)|Other|2|||
163048193|NCT00974311|588884733|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
163048194|NCT00974311|588884734|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
163048195|NCT02595502|588884735|FG000|Period 1|Adverse Event|0|||
163048196|NCT02595502|588884736|FG001|Period 1|Adverse Event|1|||
163048197|NCT02595502|588884735|FG000|Period 1|Withdrawal by Subject|1|||
163048198|NCT02595502|588884736|FG001|Period 1|Withdrawal by Subject|0|||
163048199|NCT02595502|588884735|FG000|Period 1|Lost to Follow-up|0|||
163048200|NCT02595502|588884736|FG001|Period 1|Lost to Follow-up|1|||
163048201|NCT02595502|588884735|FG000|Period 2|Adverse Event|1|||
163048202|NCT02595502|588884736|FG001|Period 2|Adverse Event|1|||
163048203|NCT02595502|588884735|FG000|Period 2|Received incorrect lens at Period 1|0|||
163048204|NCT02595502|588884736|FG001|Period 2|Received incorrect lens at Period 1|1|||
163048205|NCT02595502|588884735|FG000|Period 3|Protocol Violation|0|||
163048206|NCT02595502|588884736|FG001|Period 3|Protocol Violation|1|||
163048207|NCT02595502|588884735|FG000|Period 3|Lost to Follow-up|1|||
163048208|NCT02595502|588884736|FG001|Period 3|Lost to Follow-up|0|||
163048209|NCT02595502|588884735|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
163048210|NCT02595502|588884736|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
163048211|NCT00458003|588884737|FG000|Overall Study|Non protocol spinal anesthesia|1|||
163048212|NCT00458003|588884738|FG001|Overall Study|Non protocol spinal anesthesia|1|||
163048213|NCT03286218|588884739|FG000|Qualification Phase Period 1|Adverse Event|1|||
163048214|NCT03286218|588884740|FG001|Qualification Phase Period 1|Adverse Event|0|||
163048215|NCT03286218|588884741|FG002|Qualification Phase Period 1|Adverse Event|0|||
163048216|NCT03286218|588884742|FG003|Qualification Phase Period 1|Adverse Event|0|||
163048217|NCT03286218|588884743|FG004|Qualification Phase Period 1|Adverse Event|0|||
163396042|NCT02092350|590161095|FG000|Overall Study|Lost to Follow-up|3|||
163396043|NCT02092350|590161096|FG001|Overall Study|Lost to Follow-up|1|||
163048218|NCT03286218|588884744|FG005|Qualification Phase Period 1|Adverse Event|0|||
163048219|NCT03286218|588884745|FG006|Qualification Phase Period 1|Adverse Event|0|||
163048220|NCT03286218|588884746|FG007|Qualification Phase Period 1|Adverse Event|0|||
163048221|NCT03286218|588884747|FG008|Qualification Phase Period 1|Adverse Event|0|||
163048222|NCT03286218|588884748|FG009|Qualification Phase Period 1|Adverse Event|0|||
163048223|NCT03286218|588884749|FG010|Qualification Phase Period 1|Adverse Event|0|||
163048224|NCT03286218|588884750|FG011|Qualification Phase Period 1|Adverse Event|0|||
163048225|NCT03286218|588884739|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048226|NCT03286218|588884740|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
163396044|NCT02092350|590161095|FG000|Overall Study|Protocol Violation|1|||
163396045|NCT02092350|590161096|FG001|Overall Study|Protocol Violation|0|||
163048227|NCT03286218|588884741|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
163396046|NCT02092350|590161095|FG000|Overall Study|Physician Decision|1|||
163396047|NCT02092350|590161096|FG001|Overall Study|Physician Decision|1|||
163048228|NCT03286218|588884742|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048229|NCT03286218|588884743|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048230|NCT03286218|588884744|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048231|NCT03286218|588884745|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048232|NCT03286218|588884746|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048233|NCT03286218|588884747|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048234|NCT03286218|588884748|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048235|NCT03286218|588884749|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048236|NCT03286218|588884750|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048237|NCT03286218|588884739|FG000|Qualification Phase Period 2|Adverse Event|0|||
163048238|NCT03286218|588884740|FG001|Qualification Phase Period 2|Adverse Event|1|||
163048239|NCT03286218|588884741|FG002|Qualification Phase Period 2|Adverse Event|0|||
163048240|NCT03286218|588884742|FG003|Qualification Phase Period 2|Adverse Event|0|||
163048241|NCT03286218|588884743|FG004|Qualification Phase Period 2|Adverse Event|0|||
163048242|NCT03286218|588884744|FG005|Qualification Phase Period 2|Adverse Event|0|||
163048243|NCT03286218|588884745|FG006|Qualification Phase Period 2|Adverse Event|0|||
163048244|NCT03286218|588884746|FG007|Qualification Phase Period 2|Adverse Event|0|||
163048245|NCT03286218|588884747|FG008|Qualification Phase Period 2|Adverse Event|0|||
163048246|NCT03286218|588884748|FG009|Qualification Phase Period 2|Adverse Event|0|||
163048247|NCT03286218|588884749|FG010|Qualification Phase Period 2|Adverse Event|0|||
163048248|NCT03286218|588884750|FG011|Qualification Phase Period 2|Adverse Event|0|||
163048249|NCT03286218|588884739|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
163048250|NCT03286218|588884740|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
163048251|NCT03286218|588884741|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163304233|NCT04905407|589821806|FG000|Part 1 and Part 2|Death|7|||
163304234|NCT04905407|589821807|FG001|Part 1 and Part 2|Death|7|||
163304235|NCT04905407|589821808|FG002|Part 1 and Part 2|Death|7|||
163304236|NCT04905407|589821809|FG003|Part 1 and Part 2|Death|0|||
163304237|NCT04905407|589821806|FG000|Part 1 and Part 2|Other than specified|0|||
163304238|NCT04905407|589821807|FG001|Part 1 and Part 2|Other than specified|0|||
163304239|NCT04905407|589821808|FG002|Part 1 and Part 2|Other than specified|1|||
163048252|NCT03286218|588884742|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048253|NCT03286218|588884743|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048254|NCT03286218|588884744|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048255|NCT03286218|588884745|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048256|NCT03286218|588884746|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048257|NCT03286218|588884747|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048258|NCT03286218|588884748|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048259|NCT03286218|588884749|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048260|NCT03286218|588884750|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048261|NCT03286218|588884739|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
163304240|NCT04905407|589821809|FG003|Part 1 and Part 2|Other than specified|0|||
163304241|NCT04905407|589821806|FG000|Part 3|Death|0|||
163304242|NCT04905407|589821807|FG001|Part 3|Death|0|||
163304243|NCT04905407|589821808|FG002|Part 3|Death|0|||
163304244|NCT04905407|589821809|FG003|Part 3|Death|2|||
163304245|NCT00150813|589821812|FG000|Overall Study|Adverse Event|1|||
163304246|NCT00150813|589821812|FG000|Overall Study|Lack of Efficacy|1|||
163304247|NCT00150813|589821812|FG000|Overall Study|Lost to Follow-up|5|||
163304248|NCT00150813|589821812|FG000|Overall Study|Withdrawal by Subject|5|||
163304249|NCT00150813|589821812|FG000|Overall Study|Remission|3|||
163304250|NCT00150813|589821812|FG000|Overall Study|Planned pregancy|1|||
163304251|NCT00150813|589821812|FG000|Overall Study|Switch to commercially available LEV|2|||
163304252|NCT00894543|589821813|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
163304253|NCT00894543|589821814|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
163304254|NCT00894543|589821813|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
163304255|NCT00894543|589821814|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
163304256|NCT03446157|589821815|FG000|Overall Study|Death|11|||
163304257|NCT03446157|589821816|FG001|Overall Study|Death|9|||
163304258|NCT03446157|589821815|FG000|Overall Study|Lost to Follow-up|0|||
163304259|NCT03446157|589821816|FG001|Overall Study|Lost to Follow-up|1|||
163304260|NCT03446157|589821815|FG000|Overall Study|Withdrawal by Subject|2|||
163304261|NCT03446157|589821816|FG001|Overall Study|Withdrawal by Subject|1|||
163304262|NCT00411151|589821817|FG000|Overall Study|Death|38|||
163304263|NCT00411151|589821817|FG000|Overall Study|Withdrawal by Subject|2|||
163304264|NCT00411151|589821817|FG000|Overall Study|Lost to Follow-up|2|||
163304265|NCT00411151|589821817|FG000|Overall Study|Protocol Violation|1|||
163304266|NCT00411151|589821817|FG000|Overall Study|Trial prematurely closed|4|||
163304267|NCT04452318|589821819|FG000|Overall Study|Physician Decision|1|||
163304268|NCT04452318|589821820|FG001|Overall Study|Physician Decision|2|||
163304269|NCT04452318|589821821|FG002|Overall Study|Physician Decision|0|||
163304270|NCT04452318|589821822|FG003|Overall Study|Physician Decision|2|||
163048262|NCT03286218|588884740|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
163048263|NCT03286218|588884741|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
163048264|NCT03286218|588884742|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
163048265|NCT03286218|588884743|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
163048266|NCT03286218|588884744|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
163048267|NCT03286218|588884745|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
163048268|NCT03286218|588884746|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
163396048|NCT02092350|590161095|FG000|Overall Study|Screen Failure|1|||
163396049|NCT02092350|590161096|FG001|Overall Study|Screen Failure|0|||
163396050|NCT02092350|590161095|FG000|Overall Study|Withdrawal by Subject|2|||
163396051|NCT02092350|590161096|FG001|Overall Study|Withdrawal by Subject|2|||
163396052|NCT00962390|590161107|FG000|Overall Study|Adverse Event|0|||
163396053|NCT00962390|590161108|FG001|Overall Study|Adverse Event|0|||
163396054|NCT00962390|590161109|FG002|Overall Study|Adverse Event|3|||
163396055|NCT00962390|590161110|FG003|Overall Study|Adverse Event|1|||
163396056|NCT00962390|590161107|FG000|Overall Study|Lost to Follow-up|2|||
163396057|NCT00962390|590161108|FG001|Overall Study|Lost to Follow-up|2|||
163396058|NCT00962390|590161109|FG002|Overall Study|Lost to Follow-up|0|||
163396059|NCT00962390|590161110|FG003|Overall Study|Lost to Follow-up|0|||
163396060|NCT00962390|590161107|FG000|Overall Study|Protocol Violation|1|||
163396061|NCT00962390|590161108|FG001|Overall Study|Protocol Violation|0|||
163396062|NCT00962390|590161109|FG002|Overall Study|Protocol Violation|0|||
163396063|NCT00962390|590161110|FG003|Overall Study|Protocol Violation|0|||
163396064|NCT00962390|590161107|FG000|Overall Study|Withdrawal by Subject|1|||
163396065|NCT00962390|590161108|FG001|Overall Study|Withdrawal by Subject|1|||
163396066|NCT00962390|590161109|FG002|Overall Study|Withdrawal by Subject|1|||
163396067|NCT00962390|590161110|FG003|Overall Study|Withdrawal by Subject|0|||
163396068|NCT02613884|590161113|FG000|Overall Study|Death|1|||
163396069|NCT02613884|590161113|FG000|Overall Study|Lost to Follow-up|1|||
163396070|NCT00433914|590161117|FG000|Overall Study|Withdrawal by Subject|0|||
163396071|NCT00433914|590161118|FG001|Overall Study|Withdrawal by Subject|2|||
163396072|NCT00433914|590161117|FG000|Overall Study|Lost to Follow-up|0|||
163396073|NCT00433914|590161118|FG001|Overall Study|Lost to Follow-up|1|||
163396074|NCT02844920|590161119|FG000|Overall Study|Lost to Follow-up|2|||
163396075|NCT00766090|590161120|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163396076|NCT00766090|590161121|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163396077|NCT00766090|590161122|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163396078|NCT00766090|590161123|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163396079|NCT00766090|590161124|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163396080|NCT00766090|590161125|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163396081|NCT00766090|590161126|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163396082|NCT00766090|590161127|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163396083|NCT00766090|590161128|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
163396084|NCT00766090|590161129|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163396085|NCT00766090|590161130|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163396086|NCT00766090|590161131|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163396087|NCT00766090|590161120|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
163396088|NCT00766090|590161121|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163396089|NCT00766090|590161122|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163396090|NCT00766090|590161123|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163396091|NCT00766090|590161124|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163396092|NCT00766090|590161125|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163396093|NCT00766090|590161126|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163396094|NCT00766090|590161127|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163396095|NCT00766090|590161128|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163396096|NCT00766090|590161129|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163396097|NCT00766090|590161130|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163396098|NCT00766090|590161131|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163396099|NCT00766090|590161120|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
163396100|NCT00766090|590161121|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163396101|NCT00766090|590161122|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163396102|NCT00766090|590161123|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
163396103|NCT00766090|590161124|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163396104|NCT00766090|590161125|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163396105|NCT00766090|590161126|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163396106|NCT00766090|590161127|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163396107|NCT00766090|590161128|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163396108|NCT00766090|590161129|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163396109|NCT00766090|590161130|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163396110|NCT00766090|590161131|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163048269|NCT03286218|588884747|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
163048270|NCT03286218|588884748|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
163304271|NCT04452318|589821823|FG004|Overall Study|Physician Decision|0|||
163304272|NCT04452318|589821824|FG005|Overall Study|Physician Decision|2|||
163304273|NCT04452318|589821825|FG006|Overall Study|Physician Decision|5|||
163304274|NCT04452318|589821819|FG000|Overall Study|Death|2|||
163304275|NCT04452318|589821820|FG001|Overall Study|Death|3|||
163048271|NCT03286218|588884749|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
163048272|NCT03286218|588884750|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
163304276|NCT04452318|589821821|FG002|Overall Study|Death|0|||
163304277|NCT04452318|589821822|FG003|Overall Study|Death|0|||
163304278|NCT04452318|589821823|FG004|Overall Study|Death|0|||
163304279|NCT04452318|589821824|FG005|Overall Study|Death|0|||
163304280|NCT04452318|589821825|FG006|Overall Study|Death|0|||
163304281|NCT04452318|589821819|FG000|Overall Study|Lost to Follow-up|38|||
163304282|NCT04452318|589821820|FG001|Overall Study|Lost to Follow-up|28|||
163304283|NCT04452318|589821821|FG002|Overall Study|Lost to Follow-up|0|||
163304284|NCT04452318|589821822|FG003|Overall Study|Lost to Follow-up|3|||
163304285|NCT04452318|589821823|FG004|Overall Study|Lost to Follow-up|3|||
163198131|NCT03338010|589439379|FG001|Overall Study|Withdrawal by Subject|8|||
163198132|NCT03338010|589439378|FG000|Overall Study|Lost to Follow-up|4|||
163198133|NCT03338010|589439379|FG001|Overall Study|Lost to Follow-up|2|||
163198134|NCT03338010|589439378|FG000|Overall Study|Adverse Event|3|||
163198135|NCT03338010|589439379|FG001|Overall Study|Adverse Event|2|||
163198136|NCT03338010|589439378|FG000|Overall Study|Physician Decision|2|||
163198137|NCT03338010|589439379|FG001|Overall Study|Physician Decision|2|||
163198138|NCT03338010|589439378|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163198139|NCT03338010|589439379|FG001|Overall Study|Non-Compliance with Study Drug|3|||
163198140|NCT03338010|589439378|FG000|Overall Study|Protocol Violation|0|||
163198141|NCT03338010|589439379|FG001|Overall Study|Protocol Violation|1|||
163198142|NCT00293033|589439384|FG000|Open-label Titration Period|Adverse Event|10|||
163198143|NCT00293033|589439384|FG000|Open-label Titration Period|Death|3|||
163198144|NCT00293033|589439384|FG000|Open-label Titration Period|Lack of Efficacy|5|||
163198145|NCT00293033|589439384|FG000|Open-label Titration Period|Protocol Violation|2|||
163198146|NCT00293033|589439384|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
163198147|NCT00293033|589439384|FG000|Open-label Titration Period|Noncompliance and other|27|||
163198148|NCT00293033|589439384|FG000|Double-blind Treatment Period|Adverse Event|3|||
163198149|NCT00293033|589439384|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
163198150|NCT00293033|589439384|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
163198151|NCT00293033|589439384|FG000|Double-blind Treatment Period|Noncompliance|4|||
163198152|NCT00837811|589439385|FG000|Overall Study|Adverse Event|4|||
163396111|NCT00766090|590161120|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
163396112|NCT00766090|590161121|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
163396113|NCT00766090|590161122|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
163396114|NCT00766090|590161123|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
163396115|NCT00766090|590161124|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
163396116|NCT00766090|590161125|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
163396117|NCT00766090|590161126|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
163396118|NCT00766090|590161127|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
163396119|NCT00766090|590161128|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
163396120|NCT00766090|590161129|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
163396121|NCT00766090|590161130|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
163396122|NCT00766090|590161131|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
163396123|NCT00766090|590161120|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163396124|NCT00766090|590161121|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163396125|NCT00766090|590161122|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163396126|NCT00766090|590161123|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163396127|NCT00766090|590161124|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
163396128|NCT00766090|590161125|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163396129|NCT00766090|590161126|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163396130|NCT00766090|590161127|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163396131|NCT00766090|590161128|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163396132|NCT00766090|590161129|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163048273|NCT03286218|588884739|FG000|Qualification Phase Period 2|Protocol Violation|2|||
163048274|NCT03286218|588884740|FG001|Qualification Phase Period 2|Protocol Violation|0|||
163048275|NCT03286218|588884741|FG002|Qualification Phase Period 2|Protocol Violation|0|||
163048276|NCT03286218|588884742|FG003|Qualification Phase Period 2|Protocol Violation|0|||
163048277|NCT03286218|588884743|FG004|Qualification Phase Period 2|Protocol Violation|0|||
163048278|NCT03286218|588884744|FG005|Qualification Phase Period 2|Protocol Violation|0|||
163048279|NCT03286218|588884745|FG006|Qualification Phase Period 2|Protocol Violation|0|||
163048280|NCT03286218|588884746|FG007|Qualification Phase Period 2|Protocol Violation|0|||
163048281|NCT03286218|588884747|FG008|Qualification Phase Period 2|Protocol Violation|0|||
163048282|NCT03286218|588884748|FG009|Qualification Phase Period 2|Protocol Violation|0|||
163048283|NCT03286218|588884749|FG010|Qualification Phase Period 2|Protocol Violation|0|||
163048284|NCT03286218|588884750|FG011|Qualification Phase Period 2|Protocol Violation|0|||
163048285|NCT03286218|588884739|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
163048286|NCT03286218|588884740|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
163198153|NCT00837811|589439386|FG001|Overall Study|Adverse Event|6|||
163198154|NCT00837811|589439387|FG002|Overall Study|Adverse Event|0|||
163198155|NCT00837811|589439385|FG000|Overall Study|Death|1|||
163198156|NCT00837811|589439386|FG001|Overall Study|Death|1|||
163198157|NCT00837811|589439387|FG002|Overall Study|Death|0|||
163198158|NCT00837811|589439385|FG000|Overall Study|Lack of Efficacy|0|||
163198159|NCT00837811|589439386|FG001|Overall Study|Lack of Efficacy|11|||
163198160|NCT00837811|589439387|FG002|Overall Study|Lack of Efficacy|0|||
163198161|NCT00837811|589439385|FG000|Overall Study|Lost to Follow-up|1|||
163396133|NCT00766090|590161130|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162961718|NCT00112437|588560747|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961719|NCT00112437|588560748|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961720|NCT00112437|588560749|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
163198162|NCT00837811|589439386|FG001|Overall Study|Lost to Follow-up|3|||
163304286|NCT04452318|589821824|FG005|Overall Study|Lost to Follow-up|2|||
163304287|NCT04452318|589821825|FG006|Overall Study|Lost to Follow-up|1|||
163304288|NCT04452318|589821819|FG000|Overall Study|Withdrawal by Subject|46|||
163304289|NCT04452318|589821820|FG001|Overall Study|Withdrawal by Subject|40|||
163304290|NCT04452318|589821821|FG002|Overall Study|Withdrawal by Subject|0|||
163304291|NCT04452318|589821822|FG003|Overall Study|Withdrawal by Subject|18|||
163304292|NCT04452318|589821823|FG004|Overall Study|Withdrawal by Subject|6|||
163304293|NCT04452318|589821824|FG005|Overall Study|Withdrawal by Subject|8|||
163304294|NCT04452318|589821825|FG006|Overall Study|Withdrawal by Subject|6|||
163304295|NCT02638337|589821831|FG000|Overall Study|Adverse Event|6|||
163304296|NCT02638337|589821832|FG001|Overall Study|Adverse Event|10|||
163304297|NCT02638337|589821831|FG000|Overall Study|Protocol Violation|3|||
163304298|NCT02638337|589821832|FG001|Overall Study|Protocol Violation|0|||
163304299|NCT02638337|589821831|FG000|Overall Study|Withdrawal by Subject|13|||
163304300|NCT02638337|589821832|FG001|Overall Study|Withdrawal by Subject|16|||
163304301|NCT02638337|589821831|FG000|Overall Study|Lost to Follow-up|7|||
163304302|NCT02638337|589821832|FG001|Overall Study|Lost to Follow-up|7|||
163304303|NCT02638337|589821831|FG000|Overall Study|Other - Miscellaneous|4|||
163304304|NCT02638337|589821832|FG001|Overall Study|Other - Miscellaneous|3|||
163304305|NCT03771352|589821833|FG000|Overall Study|Screen failure|2|||
162961721|NCT00112437|588560750|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961722|NCT00112437|588560751|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961723|NCT00112437|588560752|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961724|NCT00112437|588560753|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961725|NCT00112437|588560754|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961726|NCT00112437|588560755|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961727|NCT00112437|588560756|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
162961728|NCT00112437|588560757|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
162961729|NCT00112437|588560758|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961730|NCT00112437|588560759|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961731|NCT00112437|588560760|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961732|NCT00112437|588560761|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961733|NCT00112437|588560762|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961734|NCT00112437|588560763|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961735|NCT00112437|588560764|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961736|NCT00112437|588560765|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
163048287|NCT03286218|588884741|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048288|NCT03286218|588884742|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048289|NCT03286218|588884743|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048290|NCT03286218|588884744|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048291|NCT03286218|588884745|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048292|NCT03286218|588884746|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048293|NCT03286218|588884747|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048294|NCT03286218|588884748|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048295|NCT03286218|588884749|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048296|NCT03286218|588884750|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048297|NCT03286218|588884739|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
163396134|NCT00766090|590161131|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163396135|NCT00766090|590161120|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163396136|NCT00766090|590161121|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163396137|NCT00766090|590161122|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
163396138|NCT00766090|590161123|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163396139|NCT00766090|590161124|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163396140|NCT00766090|590161125|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163396141|NCT00766090|590161126|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163396142|NCT00766090|590161127|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163396143|NCT00766090|590161128|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163396144|NCT00766090|590161129|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163396145|NCT00766090|590161130|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163396146|NCT00766090|590161131|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163396147|NCT00766090|590161120|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
163396148|NCT00766090|590161121|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
163396149|NCT00766090|590161122|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
163396150|NCT00766090|590161123|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
163396151|NCT00766090|590161124|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
163396152|NCT00766090|590161125|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
163396153|NCT00766090|590161126|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
163396154|NCT00766090|590161127|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
163396155|NCT00766090|590161128|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
163396156|NCT00766090|590161129|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
163396157|NCT00766090|590161130|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
163396158|NCT00766090|590161131|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
163396159|NCT00766090|590161120|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163396160|NCT00766090|590161121|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163396161|NCT00766090|590161122|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163396162|NCT00766090|590161123|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163396163|NCT00766090|590161124|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163396164|NCT00766090|590161125|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
163396165|NCT00766090|590161126|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163396166|NCT00766090|590161127|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
162961737|NCT00112437|588560766|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961738|NCT00112437|588560767|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961739|NCT00112437|588560768|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
163048298|NCT03286218|588884740|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
163048299|NCT03286218|588884741|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
163048300|NCT03286218|588884742|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
163048301|NCT03286218|588884743|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
163048302|NCT03286218|588884744|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
163048303|NCT03286218|588884745|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
163048304|NCT03286218|588884746|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
163048305|NCT03286218|588884747|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
163048306|NCT03286218|588884748|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
163048307|NCT03286218|588884749|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
163048308|NCT03286218|588884750|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
163048309|NCT03286218|588884739|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048310|NCT03286218|588884740|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048311|NCT03286218|588884741|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048312|NCT03286218|588884742|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048313|NCT03286218|588884743|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048314|NCT03286218|588884744|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048315|NCT03286218|588884745|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
163304306|NCT03771352|589821833|FG000|Overall Study|Withdrawal by Subject|2|||
163304307|NCT03380390|589821838|FG000|Overall Study|Adverse Event|3|||
163304308|NCT05494788|589821841|FG000|Initial Treatment Period|Adverse Event|2|||
163304309|NCT05494788|589821841|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
163304310|NCT05494788|589821841|FG000|Extension Period|Adverse Event|1|||
163304311|NCT05494788|589821841|FG000|Extension Period|Withdrawal by Subject|1|||
163304312|NCT01771731|589821842|FG000|Overall Study|Physician Decision|1|||
163048316|NCT03286218|588884746|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048317|NCT03286218|588884747|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048318|NCT03286218|588884748|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048319|NCT03286218|588884749|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048320|NCT03286218|588884750|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
163048321|NCT00165503|588884753|FG000|Overall Study|Death|1|||
163396167|NCT00766090|590161128|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163396168|NCT00766090|590161129|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163396169|NCT00766090|590161130|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163396170|NCT00766090|590161131|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163396171|NCT00766090|590161120|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163396172|NCT00766090|590161121|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
163396173|NCT00766090|590161122|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163396174|NCT00766090|590161123|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
163048322|NCT00165503|588884753|FG000|Overall Study|Lost to Follow-up|12|||
163048323|NCT00165503|588884753|FG000|Overall Study|Unresectable|3|||
163304313|NCT01771731|589821843|FG001|Overall Study|Physician Decision|0|||
163304314|NCT01771731|589821842|FG000|Overall Study|Protocol Violation|0|||
163304315|NCT01771731|589821843|FG001|Overall Study|Protocol Violation|1|||
163304316|NCT01771731|589821842|FG000|Overall Study|Adverse event: Pain Crisis|1|||
163304317|NCT01771731|589821843|FG001|Overall Study|Adverse event: Pain Crisis|1|||
163304318|NCT00087139|589821844|FG000|Overall Study|Adverse Event|18|||
163304319|NCT00087139|589821845|FG001|Overall Study|Adverse Event|17|||
163304320|NCT00087139|589821846|FG002|Overall Study|Adverse Event|13|||
163304321|NCT00087139|589821844|FG000|Overall Study|Death|2|||
163304322|NCT00087139|589821845|FG001|Overall Study|Death|1|||
163304323|NCT00087139|589821846|FG002|Overall Study|Death|0|||
163304324|NCT00087139|589821844|FG000|Overall Study|Withdrawal by Subject|3|||
163304325|NCT00087139|589821845|FG001|Overall Study|Withdrawal by Subject|2|||
163304326|NCT00087139|589821846|FG002|Overall Study|Withdrawal by Subject|2|||
163304327|NCT00087139|589821844|FG000|Overall Study|Physician Decision|1|||
163304328|NCT00087139|589821845|FG001|Overall Study|Physician Decision|1|||
163304329|NCT00087139|589821846|FG002|Overall Study|Physician Decision|1|||
163304330|NCT00087139|589821844|FG000|Overall Study|Disease progression|9|||
163304331|NCT00087139|589821845|FG001|Overall Study|Disease progression|19|||
163304332|NCT00087139|589821846|FG002|Overall Study|Disease progression|12|||
163304333|NCT00087139|589821844|FG000|Overall Study|Ineligible|4|||
163304334|NCT00087139|589821845|FG001|Overall Study|Ineligible|7|||
163304335|NCT00087139|589821846|FG002|Overall Study|Ineligible|4|||
163304336|NCT00087139|589821844|FG000|Overall Study|Symptomatic deterioration|1|||
163304337|NCT00087139|589821845|FG001|Overall Study|Symptomatic deterioration|1|||
163304338|NCT00087139|589821846|FG002|Overall Study|Symptomatic deterioration|3|||
163304339|NCT00087139|589821844|FG000|Overall Study|Use of coumadin|1|||
163048324|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Death|20|||
163304340|NCT00087139|589821845|FG001|Overall Study|Use of coumadin|0|||
163304341|NCT00087139|589821846|FG002|Overall Study|Use of coumadin|0|||
163304342|NCT00087139|589821844|FG000|Overall Study|Response achieved|0|||
163304343|NCT00087139|589821845|FG001|Overall Study|Response achieved|1|||
163304344|NCT00087139|589821846|FG002|Overall Study|Response achieved|0|||
163048325|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Death|26|||
163048326|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
163048327|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
163048328|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
163048329|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
163048330|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
163048331|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
163048332|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
163048333|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
163048334|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
163048335|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
163048336|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
163048337|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
163048338|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
163048339|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
163198163|NCT00837811|589439387|FG002|Overall Study|Lost to Follow-up|0|||
163198164|NCT00837811|589439385|FG000|Overall Study|Physician Decision|0|||
163198165|NCT00837811|589439386|FG001|Overall Study|Physician Decision|2|||
163198166|NCT00837811|589439387|FG002|Overall Study|Physician Decision|1|||
162961740|NCT00112437|588560769|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961741|NCT00112437|588560770|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961742|NCT00112437|588560771|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961743|NCT00112437|588560746|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961744|NCT00112437|588560747|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961745|NCT00112437|588560748|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961746|NCT00112437|588560749|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961747|NCT00112437|588560750|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961748|NCT00112437|588560751|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961749|NCT00112437|588560752|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961750|NCT00112437|588560753|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
163048340|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Other|107|||
163048341|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Other|107|||
163048342|NCT00643201|588884754|FG000|Completed Study Follow Up|Death|28|||
163048343|NCT00643201|588884755|FG001|Completed Study Follow Up|Death|34|||
163048344|NCT00643201|588884754|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
163048345|NCT00643201|588884755|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
163048346|NCT00643201|588884754|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
163048347|NCT00643201|588884755|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
163048348|NCT00643201|588884754|FG000|Completed Study Follow Up|non-specified|1|||
163048349|NCT00643201|588884755|FG001|Completed Study Follow Up|non-specified|0|||
163048350|NCT02346708|588884756|FG000|Overall Study|Adverse Event|2|||
163048351|NCT02346708|588884757|FG001|Overall Study|Adverse Event|0|||
163048352|NCT02346708|588884756|FG000|Overall Study|Protocol Violation|0|||
163048353|NCT02346708|588884757|FG001|Overall Study|Protocol Violation|1|||
163048354|NCT02976519|588884758|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
163048355|NCT02976519|588884759|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
163048356|NCT02976519|588884760|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
163048357|NCT02976519|588884761|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
163048358|NCT02976519|588884762|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
163048359|NCT02976519|588884763|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
163048360|NCT02976519|588884764|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
163304345|NCT00087139|589821844|FG000|Overall Study|Extradural disease|0|||
163048361|NCT02976519|588884758|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
163048362|NCT02976519|588884759|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
163048363|NCT02976519|588884760|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
163048364|NCT02976519|588884761|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
163048365|NCT02976519|588884762|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
163048366|NCT02976519|588884763|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
163048367|NCT02976519|588884764|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
163048368|NCT02976519|588884758|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
163048369|NCT02976519|588884759|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
163048370|NCT02976519|588884760|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
163048371|NCT02976519|588884761|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
163048372|NCT02976519|588884762|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
163048373|NCT02976519|588884763|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
163048374|NCT02976519|588884764|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
163048375|NCT02976519|588884758|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
163048376|NCT02976519|588884759|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
163304346|NCT00087139|589821845|FG001|Overall Study|Extradural disease|0|||
163304347|NCT00087139|589821846|FG002|Overall Study|Extradural disease|1|||
163304348|NCT00073749|589821847|FG000|Overall Study|Disease Progression|2|||
163304349|NCT00073749|589821848|FG001|Overall Study|Disease Progression|0|||
163304350|NCT00073749|589821849|FG002|Overall Study|Disease Progression|3|||
163304351|NCT00073749|589821850|FG003|Overall Study|Disease Progression|2|||
163304352|NCT00073749|589821851|FG004|Overall Study|Disease Progression|3|||
163304353|NCT00073749|589821852|FG005|Overall Study|Disease Progression|1|||
163304354|NCT00073749|589821853|FG006|Overall Study|Disease Progression|3|||
163048377|NCT02976519|588884760|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
163048378|NCT02976519|588884761|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
163048379|NCT02976519|588884762|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
163048380|NCT02976519|588884763|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
163048381|NCT02976519|588884764|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
163048382|NCT02976519|588884758|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
163048383|NCT02976519|588884759|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
163048384|NCT02976519|588884760|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
163198167|NCT00837811|589439385|FG000|Overall Study|Withdrawal by Subject|1|||
163198168|NCT00837811|589439386|FG001|Overall Study|Withdrawal by Subject|9|||
163198169|NCT00837811|589439387|FG002|Overall Study|Withdrawal by Subject|0|||
163198170|NCT00837811|589439385|FG000|Overall Study|Sponsor Decision|0|||
163198171|NCT00837811|589439386|FG001|Overall Study|Sponsor Decision|2|||
163198172|NCT00837811|589439387|FG002|Overall Study|Sponsor Decision|0|||
163198173|NCT00717197|589441344|FG000|Overall Study|Unable to purchase study drug|5|||
163198174|NCT00717197|589441344|FG000|Overall Study|Tumor Progression|1|||
163198175|NCT00717197|589441344|FG000|Overall Study|Physician Decision|1|||
163198176|NCT01898806|589441347|FG000|Overall Study|Withdrawal by Subject|2|||
163198177|NCT01898806|589441347|FG000|Overall Study|Physician Decision|1|||
163198178|NCT03003390|589441348|FG000|Overall Study|Physician Decision|2|||
163198179|NCT03003390|589441349|FG001|Overall Study|Physician Decision|0|||
163198180|NCT03003390|589441348|FG000|Overall Study|Parent refused intervention|2|||
163198181|NCT03003390|589441349|FG001|Overall Study|Parent refused intervention|0|||
163198182|NCT01648101|589441350|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
163198183|NCT01648101|589441351|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
163198184|NCT01648101|589441352|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
163198185|NCT01648101|589441350|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
163198186|NCT01648101|589441351|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
163198187|NCT01648101|589441352|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
163198188|NCT01648101|589441350|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
163198189|NCT01648101|589441351|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
163198190|NCT01648101|589441352|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
163198191|NCT01648101|589441350|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
163198192|NCT01648101|589441351|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
163198193|NCT01648101|589441352|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
163198194|NCT01648101|589441350|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
163198195|NCT01648101|589441351|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
163198196|NCT01648101|589441352|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
163198197|NCT01648101|589441350|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
163198198|NCT01648101|589441351|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
163198199|NCT01648101|589441352|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
163198200|NCT01648101|589441350|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
163198201|NCT01648101|589441351|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
163198202|NCT01648101|589441352|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
163198203|NCT01648101|589441350|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
163048385|NCT02976519|588884761|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
163048386|NCT02976519|588884762|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
163048387|NCT02976519|588884763|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
163048388|NCT02976519|588884764|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
163048389|NCT01781962|588884767|FG000|Overall Study|Other Miscellaneous Reasons|5|||
163048390|NCT01278342|588884770|FG000|Overall Study|Physician Decision|0|||
163048391|NCT01278342|588884771|FG001|Overall Study|Physician Decision|1|||
163048392|NCT01278342|588884772|FG002|Overall Study|Physician Decision|0|||
163048393|NCT01278342|588884770|FG000|Overall Study|Lost to Follow-up|1|||
163198204|NCT01648101|589441351|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
163198205|NCT01648101|589441352|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
163198206|NCT01648101|589441350|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
163198207|NCT01648101|589441351|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
163198208|NCT01648101|589441352|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
163198209|NCT01648101|589441350|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
163198210|NCT01648101|589441351|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
163198211|NCT01648101|589441352|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
163198212|NCT01648101|589441350|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
163198213|NCT01648101|589441351|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
163198214|NCT01648101|589441352|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
163198215|NCT02469298|589441365|FG000|Overall Study|Protocol Violation|0|||
163198216|NCT02469298|589441366|FG001|Overall Study|Protocol Violation|1|||
163198217|NCT02469298|589441367|FG002|Overall Study|Protocol Violation|1|||
163198218|NCT02469298|589441368|FG003|Overall Study|Protocol Violation|0|||
163198219|NCT02469298|589441365|FG000|Overall Study|Lost to Follow-up|1|||
163198220|NCT02469298|589441366|FG001|Overall Study|Lost to Follow-up|0|||
163198221|NCT02469298|589441367|FG002|Overall Study|Lost to Follow-up|1|||
163198222|NCT02469298|589441368|FG003|Overall Study|Lost to Follow-up|0|||
163198223|NCT02469298|589441365|FG000|Overall Study|Physician Decision|0|||
163198224|NCT02469298|589441366|FG001|Overall Study|Physician Decision|0|||
163198225|NCT02469298|589441367|FG002|Overall Study|Physician Decision|0|||
163198226|NCT02469298|589441368|FG003|Overall Study|Physician Decision|1|||
163198227|NCT02469298|589441365|FG000|Overall Study|Withdrawal by Subject|0|||
163198228|NCT02469298|589441366|FG001|Overall Study|Withdrawal by Subject|0|||
163198229|NCT02469298|589441367|FG002|Overall Study|Withdrawal by Subject|0|||
163198230|NCT02469298|589441368|FG003|Overall Study|Withdrawal by Subject|1|||
163198231|NCT00307294|589441369|FG000|Overall Study|Withdrawal by Subject|1|||
163198232|NCT03311724|589441370|FG000|Overall Study|Physician Decision|0|||
163198233|NCT03311724|589441371|FG001|Overall Study|Physician Decision|0|||
163198234|NCT03311724|589441372|FG002|Overall Study|Physician Decision|0|||
163048394|NCT01278342|588884771|FG001|Overall Study|Lost to Follow-up|0|||
163048395|NCT01278342|588884772|FG002|Overall Study|Lost to Follow-up|0|||
163048396|NCT01278342|588884770|FG000|Overall Study|Administrative problems|2|||
163048397|NCT01278342|588884771|FG001|Overall Study|Administrative problems|0|||
163198235|NCT03311724|589441373|FG003|Overall Study|Physician Decision|1|||
163198236|NCT03311724|589441370|FG000|Overall Study|Protocol Violation|1|||
163198237|NCT03311724|589441371|FG001|Overall Study|Protocol Violation|0|||
163198238|NCT03311724|589441372|FG002|Overall Study|Protocol Violation|1|||
163396175|NCT00766090|590161124|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163198239|NCT03311724|589441373|FG003|Overall Study|Protocol Violation|0|||
163198240|NCT03311724|589441370|FG000|Overall Study|Withdrawal by Subject|1|||
163198241|NCT03311724|589441371|FG001|Overall Study|Withdrawal by Subject|1|||
163198242|NCT03311724|589441372|FG002|Overall Study|Withdrawal by Subject|0|||
163198243|NCT03311724|589441373|FG003|Overall Study|Withdrawal by Subject|0|||
163198244|NCT03311724|589441370|FG000|Overall Study|Lost to Follow-up|1|||
163198245|NCT03311724|589441371|FG001|Overall Study|Lost to Follow-up|0|||
163198246|NCT03311724|589441372|FG002|Overall Study|Lost to Follow-up|0|||
163198247|NCT03311724|589441373|FG003|Overall Study|Lost to Follow-up|0|||
163198248|NCT03311724|589441370|FG000|Overall Study|Sponsor Decision|0|||
163198249|NCT03311724|589441371|FG001|Overall Study|Sponsor Decision|0|||
163198250|NCT03311724|589441372|FG002|Overall Study|Sponsor Decision|1|||
163048398|NCT01278342|588884772|FG002|Overall Study|Administrative problems|0|||
163198251|NCT03311724|589441373|FG003|Overall Study|Sponsor Decision|0|||
163198252|NCT01433991|589441374|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
163198253|NCT01433991|589441375|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
163198254|NCT01433991|589441376|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
163198255|NCT01433991|589441377|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
163198256|NCT01433991|589441374|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
163198257|NCT01433991|589441375|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
163198258|NCT01433991|589441376|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
163198259|NCT01433991|589441377|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
163198260|NCT01433991|589441374|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
163198261|NCT01433991|589441375|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
163048399|NCT01278342|588884770|FG000|Overall Study|Other|1|||
163048400|NCT01278342|588884771|FG001|Overall Study|Other|0|||
163048401|NCT01278342|588884772|FG002|Overall Study|Other|0|||
163048402|NCT00473655|588884780|FG000|Overall Study|Lost to Follow-up|9|||
163048403|NCT00473655|588884781|FG001|Overall Study|Lost to Follow-up|5|||
163048404|NCT00473655|588884782|FG002|Overall Study|Lost to Follow-up|8|||
163048405|NCT04556760|588884790|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
163048406|NCT04556760|588884791|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
163048407|NCT04556760|588884792|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
163048408|NCT04556760|588884793|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
163048409|NCT04556760|588884794|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
163048410|NCT04556760|588884795|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
163048411|NCT04556760|588884790|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
163048412|NCT04556760|588884791|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
163058599|NCT00042289|588924239|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
163198262|NCT01433991|589441376|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
162961751|NCT00112437|588560754|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961752|NCT00112437|588560755|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
163198263|NCT01433991|589441377|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
163198264|NCT01433991|589441374|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
162961753|NCT00112437|588560756|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961754|NCT00112437|588560757|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
163198265|NCT01433991|589441375|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
163198266|NCT01433991|589441376|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
163048413|NCT04556760|588884792|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
163048414|NCT04556760|588884793|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
163198267|NCT01433991|589441377|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
163198268|NCT01433991|589441374|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
163198269|NCT01433991|589441375|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
163198270|NCT01433991|589441376|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
163198271|NCT01433991|589441377|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
163198272|NCT01433991|589441374|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
163198273|NCT01433991|589441375|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
163198274|NCT01433991|589441376|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
163198275|NCT01433991|589441377|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
163198276|NCT01433991|589441374|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
163396176|NCT00766090|590161125|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163396177|NCT00766090|590161126|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163396178|NCT00766090|590161127|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163396179|NCT00766090|590161128|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163396180|NCT00766090|590161129|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163396181|NCT00766090|590161130|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163396182|NCT00766090|590161131|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
163396183|NCT00766090|590161120|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163396184|NCT00766090|590161121|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163396185|NCT00766090|590161122|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163396186|NCT00766090|590161123|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163396187|NCT00766090|590161124|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
163396188|NCT00766090|590161125|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163396189|NCT00766090|590161126|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163396190|NCT00766090|590161127|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163396191|NCT00766090|590161128|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163396192|NCT00766090|590161129|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163396193|NCT00766090|590161130|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163396194|NCT00766090|590161131|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163396195|NCT03024970|590161134|FG000|First Intervention|Adverse Event|1|||
163396196|NCT03024970|590161135|FG001|First Intervention|Adverse Event|0|||
163396197|NCT03024970|590161134|FG000|Second Intervention|Lost to Follow-up|1|||
163396198|NCT03024970|590161135|FG001|Second Intervention|Lost to Follow-up|0|||
163396199|NCT00131469|590161137|FG000|Overall Study|Withdrawal by Subject|3|||
163396200|NCT00131469|590161138|FG001|Overall Study|Withdrawal by Subject|4|||
163396201|NCT00131469|590161137|FG000|Overall Study|Protocol Violation|3|||
163396202|NCT00131469|590161138|FG001|Overall Study|Protocol Violation|1|||
163396203|NCT00131469|590161137|FG000|Overall Study|Death|0|||
163396204|NCT00131469|590161138|FG001|Overall Study|Death|1|||
163396205|NCT00131469|590161137|FG000|Overall Study|Lost to Follow-up|0|||
163396206|NCT00131469|590161138|FG001|Overall Study|Lost to Follow-up|1|||
163396207|NCT00131469|590161137|FG000|Overall Study|scan not analyzable|3|||
163396208|NCT00131469|590161138|FG001|Overall Study|scan not analyzable|6|||
163396209|NCT00574288|590161139|FG000|Overall Study|Adverse Event|2|||
163396210|NCT00574288|590161140|FG001|Overall Study|Adverse Event|0|||
163396211|NCT00574288|590161141|FG002|Overall Study|Adverse Event|0|||
163396212|NCT00574288|590161142|FG003|Overall Study|Adverse Event|0|||
163396213|NCT00574288|590161143|FG004|Overall Study|Adverse Event|1|||
163396214|NCT00574288|590161144|FG005|Overall Study|Adverse Event|0|||
163396215|NCT00574288|590161145|FG006|Overall Study|Adverse Event|0|||
163396216|NCT00574288|590161139|FG000|Overall Study|Death|0|||
163396217|NCT00574288|590161140|FG001|Overall Study|Death|0|||
163396218|NCT00574288|590161141|FG002|Overall Study|Death|0|||
163198277|NCT01433991|589441375|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
163198278|NCT01433991|589441376|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
163396219|NCT00574288|590161142|FG003|Overall Study|Death|0|||
163396220|NCT00574288|590161143|FG004|Overall Study|Death|0|||
163396221|NCT00574288|590161144|FG005|Overall Study|Death|25|||
163396222|NCT00574288|590161145|FG006|Overall Study|Death|21|||
163396223|NCT00574288|590161139|FG000|Overall Study|Lost to Follow-up|0|||
163396224|NCT00574288|590161140|FG001|Overall Study|Lost to Follow-up|0|||
163396225|NCT00574288|590161141|FG002|Overall Study|Lost to Follow-up|0|||
163396226|NCT00574288|590161142|FG003|Overall Study|Lost to Follow-up|0|||
163396227|NCT00574288|590161143|FG004|Overall Study|Lost to Follow-up|0|||
163396228|NCT00574288|590161144|FG005|Overall Study|Lost to Follow-up|1|||
163396229|NCT00574288|590161145|FG006|Overall Study|Lost to Follow-up|2|||
163048415|NCT04556760|588884794|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
163048416|NCT04556760|588884795|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
163048417|NCT02513550|588884796|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
163048418|NCT02513550|588884797|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
163048419|NCT02513550|588884798|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
163048420|NCT02513550|588884799|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
163048421|NCT02513550|588884800|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
163198279|NCT01433991|589441377|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
163198280|NCT02955602|589441378|FG000|Overall Study|Adverse Event|0|||
163198281|NCT02955602|589441379|FG001|Overall Study|Adverse Event|3|||
163198282|NCT02955602|589441380|FG002|Overall Study|Adverse Event|0|||
163198283|NCT02955602|589441378|FG000|Overall Study|Withdrawal of informed consent|1|||
163198284|NCT02955602|589441379|FG001|Overall Study|Withdrawal of informed consent|3|||
163198285|NCT02955602|589441380|FG002|Overall Study|Withdrawal of informed consent|2|||
162961755|NCT00112437|588560758|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961756|NCT00112437|588560759|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961757|NCT00112437|588560760|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961758|NCT00112437|588560761|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961759|NCT00112437|588560762|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961760|NCT00112437|588560763|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961761|NCT00112437|588560764|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961762|NCT00112437|588560765|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961763|NCT00112437|588560766|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
162961764|NCT00112437|588560767|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
163048422|NCT02513550|588884801|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
163198286|NCT02955602|589441378|FG000|Overall Study|Lost to Follow-up|0|||
163198287|NCT02955602|589441379|FG001|Overall Study|Lost to Follow-up|0|||
163198288|NCT02955602|589441380|FG002|Overall Study|Lost to Follow-up|1|||
162961765|NCT00112437|588560768|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961766|NCT00112437|588560769|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
163198289|NCT02955602|589441378|FG000|Overall Study|Other|0|||
163198290|NCT02955602|589441379|FG001|Overall Study|Other|1|||
163198291|NCT02955602|589441380|FG002|Overall Study|Other|3|||
163198292|NCT01581931|589441383|FG000|Washout|Adverse Event|0|||
163198293|NCT01581931|589441384|FG001|Washout|Adverse Event|1|||
163198294|NCT00395304|589441391|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163198295|NCT00395304|589441392|FG001|Treatment Period 1|Withdrawal by Subject|3|||
163198296|NCT00395304|589441393|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163198297|NCT00395304|589441394|FG003|Treatment Period 1|Withdrawal by Subject|2|||
163198298|NCT00395304|589441395|FG004|Treatment Period 1|Withdrawal by Subject|1|||
163198299|NCT00395304|589441396|FG005|Treatment Period 1|Withdrawal by Subject|1|||
163198300|NCT00395304|589441391|FG000|Treatment Period 1|Lost to Follow-up|1|||
163198301|NCT00395304|589441392|FG001|Treatment Period 1|Lost to Follow-up|0|||
163198302|NCT00395304|589441393|FG002|Treatment Period 1|Lost to Follow-up|0|||
163198303|NCT00395304|589441394|FG003|Treatment Period 1|Lost to Follow-up|1|||
163198304|NCT00395304|589441395|FG004|Treatment Period 1|Lost to Follow-up|0|||
163198305|NCT00395304|589441396|FG005|Treatment Period 1|Lost to Follow-up|1|||
163198306|NCT00395304|589441391|FG000|Treatment Period 1|Physician Decision|0|||
163198307|NCT00395304|589441392|FG001|Treatment Period 1|Physician Decision|1|||
163198308|NCT00395304|589441393|FG002|Treatment Period 1|Physician Decision|0|||
163198309|NCT00395304|589441394|FG003|Treatment Period 1|Physician Decision|0|||
163198310|NCT00395304|589441395|FG004|Treatment Period 1|Physician Decision|0|||
163198311|NCT00395304|589441396|FG005|Treatment Period 1|Physician Decision|0|||
163198312|NCT00395304|589441391|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163198313|NCT00395304|589441392|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163198314|NCT00395304|589441393|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163198315|NCT00395304|589441394|FG003|Treatment Period 2|Withdrawal by Subject|1|||
163198316|NCT00395304|589441395|FG004|Treatment Period 2|Withdrawal by Subject|0|||
163198317|NCT00395304|589441396|FG005|Treatment Period 2|Withdrawal by Subject|2|||
163198318|NCT00395304|589441391|FG000|Treatment Period 2|Lost to Follow-up|0|||
163198319|NCT00395304|589441392|FG001|Treatment Period 2|Lost to Follow-up|3|||
163198320|NCT00395304|589441393|FG002|Treatment Period 2|Lost to Follow-up|0|||
163198321|NCT00395304|589441394|FG003|Treatment Period 2|Lost to Follow-up|0|||
163198322|NCT00395304|589441395|FG004|Treatment Period 2|Lost to Follow-up|0|||
163198323|NCT00395304|589441396|FG005|Treatment Period 2|Lost to Follow-up|0|||
163198324|NCT00395304|589441391|FG000|Treatment Period 2|Physician Decision|0|||
163198325|NCT00395304|589441392|FG001|Treatment Period 2|Physician Decision|0|||
163198326|NCT00395304|589441393|FG002|Treatment Period 2|Physician Decision|1|||
163198327|NCT00395304|589441394|FG003|Treatment Period 2|Physician Decision|0|||
163198328|NCT00395304|589441395|FG004|Treatment Period 2|Physician Decision|0|||
163198329|NCT00395304|589441396|FG005|Treatment Period 2|Physician Decision|0|||
163198330|NCT00395304|589441391|FG000|Treatment Period 2|Other|0|||
163198331|NCT00395304|589441392|FG001|Treatment Period 2|Other|1|||
163198332|NCT00395304|589441393|FG002|Treatment Period 2|Other|0|||
163198333|NCT00395304|589441394|FG003|Treatment Period 2|Other|0|||
163198334|NCT00395304|589441395|FG004|Treatment Period 2|Other|0|||
163198335|NCT00395304|589441396|FG005|Treatment Period 2|Other|0|||
163198336|NCT00395304|589441391|FG000|Treatment Period 3|Withdrawal by Subject|0|||
163198337|NCT00395304|589441392|FG001|Treatment Period 3|Withdrawal by Subject|0|||
163198338|NCT00395304|589441393|FG002|Treatment Period 3|Withdrawal by Subject|0|||
163198339|NCT00395304|589441394|FG003|Treatment Period 3|Withdrawal by Subject|1|||
163198340|NCT00395304|589441395|FG004|Treatment Period 3|Withdrawal by Subject|0|||
163198341|NCT00395304|589441396|FG005|Treatment Period 3|Withdrawal by Subject|1|||
163198342|NCT00395304|589441391|FG000|Treatment Period 3|Lost to Follow-up|1|||
163198343|NCT00395304|589441392|FG001|Treatment Period 3|Lost to Follow-up|1|||
163198344|NCT00395304|589441393|FG002|Treatment Period 3|Lost to Follow-up|0|||
163198345|NCT00395304|589441394|FG003|Treatment Period 3|Lost to Follow-up|0|||
163198346|NCT00395304|589441395|FG004|Treatment Period 3|Lost to Follow-up|0|||
163198347|NCT00395304|589441396|FG005|Treatment Period 3|Lost to Follow-up|0|||
163198348|NCT00395304|589441391|FG000|Treatment Period 3|Physician Decision|0|||
163198349|NCT00395304|589441392|FG001|Treatment Period 3|Physician Decision|1|||
163198350|NCT00395304|589441393|FG002|Treatment Period 3|Physician Decision|0|||
163198351|NCT00395304|589441394|FG003|Treatment Period 3|Physician Decision|0|||
163198352|NCT00395304|589441395|FG004|Treatment Period 3|Physician Decision|0|||
163198353|NCT00395304|589441396|FG005|Treatment Period 3|Physician Decision|0|||
163198354|NCT00395304|589441391|FG000|Treatment Period 3|Other|0|||
163198355|NCT00395304|589441392|FG001|Treatment Period 3|Other|0|||
163198356|NCT00395304|589441393|FG002|Treatment Period 3|Other|0|||
163198357|NCT00395304|589441394|FG003|Treatment Period 3|Other|1|||
163198358|NCT00395304|589441395|FG004|Treatment Period 3|Other|0|||
163198359|NCT00395304|589441396|FG005|Treatment Period 3|Other|0|||
163198360|NCT00980057|589441401|FG000|Overall Study|Death|13|||
163198361|NCT00980057|589441402|FG001|Overall Study|Death|3|||
163198362|NCT00980057|589441401|FG000|Overall Study|Adverse Event|0|||
162961767|NCT00112437|588560770|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961768|NCT00112437|588560771|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961769|NCT00112437|588560746|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
163048423|NCT02513550|588884796|FG000|Double Blind Treatment Period|Adverse Event|5|||
163048424|NCT02513550|588884797|FG001|Double Blind Treatment Period|Adverse Event|13|||
163048425|NCT02513550|588884798|FG002|Double Blind Treatment Period|Adverse Event|17|||
163048426|NCT02513550|588884799|FG003|Double Blind Treatment Period|Adverse Event|0|||
163048427|NCT02513550|588884800|FG004|Double Blind Treatment Period|Adverse Event|1|||
163048428|NCT02513550|588884801|FG005|Double Blind Treatment Period|Adverse Event|0|||
163048429|NCT02513550|588884796|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
163048430|NCT02513550|588884797|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
162961770|NCT00112437|588560747|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
163198363|NCT00980057|589441402|FG001|Overall Study|Adverse Event|1|||
162961771|NCT00112437|588560748|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
163198364|NCT00980057|589441401|FG000|Overall Study|Physician Decision|4|||
163198365|NCT00980057|589441402|FG001|Overall Study|Physician Decision|0|||
163198366|NCT00980057|589441401|FG000|Overall Study|Lost to Follow-up|1|||
162961772|NCT00112437|588560749|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961773|NCT00112437|588560750|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961774|NCT00112437|588560751|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961775|NCT00112437|588560752|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961776|NCT00112437|588560753|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961777|NCT00112437|588560754|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961778|NCT00112437|588560755|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961779|NCT00112437|588560756|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961780|NCT00112437|588560757|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961781|NCT00112437|588560758|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961782|NCT00112437|588560759|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961783|NCT00112437|588560760|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961784|NCT00112437|588560761|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961785|NCT00112437|588560762|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961786|NCT00112437|588560763|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961787|NCT00112437|588560764|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961788|NCT00112437|588560765|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961789|NCT00112437|588560766|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
162961790|NCT00112437|588560767|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961791|NCT00112437|588560768|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961792|NCT00112437|588560769|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961793|NCT00112437|588560770|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961794|NCT00112437|588560771|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961795|NCT00112437|588560746|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961796|NCT00112437|588560747|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
163198367|NCT00980057|589441402|FG001|Overall Study|Lost to Follow-up|0|||
163198368|NCT00980057|589441401|FG000|Overall Study|Withdrawal by Subject|1|||
163198369|NCT00980057|589441402|FG001|Overall Study|Withdrawal by Subject|1|||
163198370|NCT00691015|589441406|FG000|Overall Study|Refused further treatment|1|||
163198371|NCT01397084|589441407|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
163198372|NCT01397084|589441407|FG000|Overall Study|Protocol Violation|2|||
163198373|NCT01397084|589441407|FG000|Overall Study|Adverse Event|2|||
163198374|NCT01397084|589441407|FG000|Overall Study|Withdrawal by Subject|1|||
163198375|NCT01397084|589441407|FG000|Overall Study|Lost to Follow-up|1|||
163198376|NCT01397084|589441407|FG000|Overall Study|Used other proton pump inhibitor|1|||
163198377|NCT04160195|589441410|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
163198378|NCT04160195|589441411|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
163198379|NCT03766581|589441414|FG000|Randomization|Other reasons|2|||
163198380|NCT03766581|589441415|FG001|Randomization|Other reasons|1|||
163198381|NCT03766581|589441416|FG002|Randomization|Other reasons|0|||
163198382|NCT03766581|589441417|FG003|Randomization|Other reasons|1|||
163198383|NCT03766581|589441418|FG004|Randomization|Other reasons|0|||
163198384|NCT03766581|589441419|FG005|Randomization|Other reasons|0|||
163198385|NCT03766581|589441420|FG006|Randomization|Other reasons|0|||
163198386|NCT03766581|589441421|FG007|Randomization|Other reasons|0|||
163198387|NCT03766581|589441414|FG000|Randomization|Participant no longer meets study criteria|5|||
162961797|NCT00112437|588560748|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
163198388|NCT03766581|589441415|FG001|Randomization|Participant no longer meets study criteria|3|||
163198389|NCT03766581|589441416|FG002|Randomization|Participant no longer meets study criteria|4|||
163198390|NCT03766581|589441417|FG003|Randomization|Participant no longer meets study criteria|0|||
163048431|NCT02513550|588884798|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
163396230|NCT00574288|590161139|FG000|Overall Study|Study Terminated By Sponsor|0|||
163396231|NCT00574288|590161140|FG001|Overall Study|Study Terminated By Sponsor|0|||
163396232|NCT00574288|590161141|FG002|Overall Study|Study Terminated By Sponsor|0|||
163396233|NCT00574288|590161142|FG003|Overall Study|Study Terminated By Sponsor|0|||
163396234|NCT00574288|590161143|FG004|Overall Study|Study Terminated By Sponsor|0|||
163396235|NCT00574288|590161144|FG005|Overall Study|Study Terminated By Sponsor|0|||
163396236|NCT00574288|590161145|FG006|Overall Study|Study Terminated By Sponsor|5|||
162961798|NCT00112437|588560749|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961799|NCT00112437|588560750|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961800|NCT00112437|588560751|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
163396237|NCT00574288|590161139|FG000|Overall Study|Progressive Disease|17|||
163396238|NCT00574288|590161140|FG001|Overall Study|Progressive Disease|2|||
163396239|NCT00574288|590161141|FG002|Overall Study|Progressive Disease|3|||
163396240|NCT00574288|590161142|FG003|Overall Study|Progressive Disease|2|||
163396241|NCT00574288|590161143|FG004|Overall Study|Progressive Disease|1|||
163396242|NCT00574288|590161144|FG005|Overall Study|Progressive Disease|0|||
163396243|NCT00574288|590161145|FG006|Overall Study|Progressive Disease|0|||
163396244|NCT00574288|590161139|FG000|Overall Study|Other|1|||
163396245|NCT00574288|590161140|FG001|Overall Study|Other|1|||
163396246|NCT00574288|590161141|FG002|Overall Study|Other|0|||
162961801|NCT00112437|588560752|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961802|NCT00112437|588560753|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
163198391|NCT03766581|589441418|FG004|Randomization|Participant no longer meets study criteria|2|||
163396247|NCT00574288|590161142|FG003|Overall Study|Other|0|||
163396248|NCT00574288|590161143|FG004|Overall Study|Other|0|||
162961803|NCT00112437|588560754|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
163396249|NCT00574288|590161144|FG005|Overall Study|Other|0|||
162961804|NCT00112437|588560755|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
163396250|NCT00574288|590161145|FG006|Overall Study|Other|0|||
163396251|NCT01106027|590161146|FG000|Overall Study|Lost graft early, discontinued|1|||
163396252|NCT00356889|590161147|FG000|Overall Study|Protocol Violation|2|||
163396253|NCT00356889|590161147|FG000|Overall Study|Adverse Event|1|||
163396254|NCT02361944|590161148|FG000|Overall Study|surgery cancellation|0|||
163396255|NCT02361944|590161149|FG001|Overall Study|surgery cancellation|1|||
163304355|NCT00073749|589821847|FG000|Overall Study|Death|0|||
163304356|NCT00073749|589821848|FG001|Overall Study|Death|1|||
163304357|NCT00073749|589821849|FG002|Overall Study|Death|1|||
163304358|NCT00073749|589821850|FG003|Overall Study|Death|0|||
163304359|NCT00073749|589821851|FG004|Overall Study|Death|0|||
163304360|NCT00073749|589821852|FG005|Overall Study|Death|0|||
163304361|NCT00073749|589821853|FG006|Overall Study|Death|29|||
163304362|NCT00073749|589821847|FG000|Overall Study|Adverse Event|0|||
163304363|NCT00073749|589821848|FG001|Overall Study|Adverse Event|3|||
163304364|NCT00073749|589821849|FG002|Overall Study|Adverse Event|6|||
163396256|NCT03123250|590161150|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
163396257|NCT02054325|590161201|FG000|Overall Study|Lost to Follow-up|8|||
162961805|NCT00112437|588560756|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961806|NCT00112437|588560757|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961807|NCT00112437|588560758|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961808|NCT00112437|588560759|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961809|NCT00112437|588560760|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961810|NCT00112437|588560761|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961811|NCT00112437|588560762|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961812|NCT00112437|588560763|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961813|NCT00112437|588560764|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961814|NCT00112437|588560765|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961815|NCT00112437|588560766|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961816|NCT00112437|588560767|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
162961817|NCT00112437|588560768|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961818|NCT00112437|588560769|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961819|NCT00112437|588560770|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961820|NCT00112437|588560771|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961821|NCT00112437|588560746|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961822|NCT00112437|588560747|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961823|NCT00112437|588560748|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961824|NCT00112437|588560749|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961825|NCT00112437|588560750|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961826|NCT00112437|588560751|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961827|NCT00112437|588560752|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961828|NCT00112437|588560753|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961829|NCT00112437|588560754|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
163304365|NCT00073749|589821850|FG003|Overall Study|Adverse Event|4|||
163304366|NCT00073749|589821851|FG004|Overall Study|Adverse Event|2|||
163396258|NCT02054325|590161202|FG001|Overall Study|Lost to Follow-up|5|||
163304367|NCT00073749|589821852|FG005|Overall Study|Adverse Event|1|||
163304368|NCT00073749|589821853|FG006|Overall Study|Adverse Event|0|||
163304369|NCT00073749|589821847|FG000|Overall Study|Physician Decision|0|||
163304370|NCT00073749|589821848|FG001|Overall Study|Physician Decision|0|||
163304371|NCT00073749|589821849|FG002|Overall Study|Physician Decision|1|||
163304372|NCT00073749|589821850|FG003|Overall Study|Physician Decision|0|||
163304373|NCT00073749|589821851|FG004|Overall Study|Physician Decision|0|||
163198392|NCT03766581|589441419|FG005|Randomization|Participant no longer meets study criteria|3|||
163198393|NCT03766581|589441420|FG006|Randomization|Participant no longer meets study criteria|0|||
163198394|NCT03766581|589441421|FG007|Randomization|Participant no longer meets study criteria|1|||
163198395|NCT03766581|589441414|FG000|Randomization|Participant request to discontinue study treatment|1|||
163304374|NCT00073749|589821852|FG005|Overall Study|Physician Decision|2|||
163304375|NCT00073749|589821853|FG006|Overall Study|Physician Decision|0|||
163198396|NCT03766581|589441415|FG001|Randomization|Participant request to discontinue study treatment|0|||
163198397|NCT03766581|589441416|FG002|Randomization|Participant request to discontinue study treatment|0|||
163198398|NCT03766581|589441417|FG003|Randomization|Participant request to discontinue study treatment|0|||
163198399|NCT03766581|589441418|FG004|Randomization|Participant request to discontinue study treatment|1|||
163198400|NCT03766581|589441419|FG005|Randomization|Participant request to discontinue study treatment|2|||
163198401|NCT03766581|589441420|FG006|Randomization|Participant request to discontinue study treatment|0|||
163198402|NCT03766581|589441421|FG007|Randomization|Participant request to discontinue study treatment|0|||
163198403|NCT03766581|589441414|FG000|Randomization|Participant withdrew consent|1|||
163198404|NCT03766581|589441415|FG001|Randomization|Participant withdrew consent|0|||
163198405|NCT03766581|589441416|FG002|Randomization|Participant withdrew consent|1|||
163198406|NCT03766581|589441417|FG003|Randomization|Participant withdrew consent|2|||
163198407|NCT03766581|589441418|FG004|Randomization|Participant withdrew consent|1|||
163198408|NCT03766581|589441419|FG005|Randomization|Participant withdrew consent|1|||
163198409|NCT03766581|589441420|FG006|Randomization|Participant withdrew consent|0|||
163198410|NCT03766581|589441421|FG007|Randomization|Participant withdrew consent|0|||
163198411|NCT03766581|589441414|FG000|Treatment|Adverse Event|82|||
163198412|NCT03766581|589441415|FG001|Treatment|Adverse Event|44|||
163198413|NCT03766581|589441416|FG002|Treatment|Adverse Event|47|||
163198414|NCT03766581|589441417|FG003|Treatment|Adverse Event|46|||
163198415|NCT03766581|589441418|FG004|Treatment|Adverse Event|50|||
163198416|NCT03766581|589441419|FG005|Treatment|Adverse Event|77|||
163198417|NCT03766581|589441420|FG006|Treatment|Adverse Event|5|||
163198418|NCT03766581|589441421|FG007|Treatment|Adverse Event|2|||
163198419|NCT03766581|589441414|FG000|Treatment|Participant request to discontinue treatment|34|||
163198420|NCT03766581|589441415|FG001|Treatment|Participant request to discontinue treatment|6|||
163198421|NCT03766581|589441416|FG002|Treatment|Participant request to discontinue treatment|10|||
163198422|NCT03766581|589441417|FG003|Treatment|Participant request to discontinue treatment|10|||
163198423|NCT03766581|589441418|FG004|Treatment|Participant request to discontinue treatment|14|||
163198424|NCT03766581|589441419|FG005|Treatment|Participant request to discontinue treatment|15|||
163198425|NCT03766581|589441420|FG006|Treatment|Participant request to discontinue treatment|0|||
163198426|NCT03766581|589441421|FG007|Treatment|Participant request to discontinue treatment|1|||
163198427|NCT03766581|589441414|FG000|Treatment|Participant withdrew consent|11|||
163198428|NCT03766581|589441415|FG001|Treatment|Participant withdrew consent|4|||
163198429|NCT03766581|589441416|FG002|Treatment|Participant withdrew consent|5|||
163198430|NCT03766581|589441417|FG003|Treatment|Participant withdrew consent|5|||
163198431|NCT03766581|589441418|FG004|Treatment|Participant withdrew consent|4|||
163198432|NCT03766581|589441419|FG005|Treatment|Participant withdrew consent|4|||
163304376|NCT00073749|589821847|FG000|Overall Study|Withdrawal by Subject|0|||
163304377|NCT00073749|589821848|FG001|Overall Study|Withdrawal by Subject|1|||
163304378|NCT00073749|589821849|FG002|Overall Study|Withdrawal by Subject|0|||
163304379|NCT00073749|589821850|FG003|Overall Study|Withdrawal by Subject|0|||
162961830|NCT00112437|588560755|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961831|NCT00112437|588560756|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961832|NCT00112437|588560757|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961833|NCT00112437|588560758|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961834|NCT00112437|588560759|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961835|NCT00112437|588560760|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961836|NCT00112437|588560761|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961837|NCT00112437|588560762|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961838|NCT00112437|588560763|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961839|NCT00112437|588560764|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961840|NCT00112437|588560765|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961841|NCT00112437|588560766|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961842|NCT00112437|588560767|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
162961843|NCT00112437|588560768|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
163048432|NCT02513550|588884799|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
163048433|NCT02513550|588884800|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
163048434|NCT02513550|588884801|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
163048435|NCT02513550|588884796|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
163048436|NCT02513550|588884797|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
163048437|NCT02513550|588884798|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
163048438|NCT02513550|588884799|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
163048439|NCT02513550|588884800|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
163048440|NCT02513550|588884801|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
163048441|NCT02513550|588884796|FG000|Double Blind Treatment Period|Protocol Violation|1|||
163048442|NCT02513550|588884797|FG001|Double Blind Treatment Period|Protocol Violation|1|||
163198433|NCT03766581|589441420|FG006|Treatment|Participant withdrew consent|0|||
162961844|NCT00112437|588560769|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961845|NCT00112437|588560770|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961846|NCT00112437|588560771|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961847|NCT00112437|588560746|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961848|NCT00112437|588560747|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
163048443|NCT02513550|588884798|FG002|Double Blind Treatment Period|Protocol Violation|4|||
162961849|NCT00112437|588560748|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
163048444|NCT02513550|588884799|FG003|Double Blind Treatment Period|Protocol Violation|0|||
163048445|NCT02513550|588884800|FG004|Double Blind Treatment Period|Protocol Violation|0|||
163048446|NCT02513550|588884801|FG005|Double Blind Treatment Period|Protocol Violation|0|||
163048447|NCT02513550|588884796|FG000|Double Blind Treatment Period|Physician Decision|2|||
163048448|NCT02513550|588884797|FG001|Double Blind Treatment Period|Physician Decision|0|||
162961850|NCT00112437|588560749|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961851|NCT00112437|588560750|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
163048449|NCT02513550|588884798|FG002|Double Blind Treatment Period|Physician Decision|4|||
163048450|NCT02513550|588884799|FG003|Double Blind Treatment Period|Physician Decision|0|||
163048451|NCT02513550|588884800|FG004|Double Blind Treatment Period|Physician Decision|0|||
163048452|NCT02513550|588884801|FG005|Double Blind Treatment Period|Physician Decision|0|||
163048453|NCT02513550|588884796|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
163048454|NCT02513550|588884797|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
163048455|NCT02513550|588884798|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
163048456|NCT02513550|588884799|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
163048457|NCT02513550|588884800|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
163048458|NCT02513550|588884801|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
163048459|NCT02513550|588884796|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
163048460|NCT02513550|588884797|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
163048461|NCT02513550|588884798|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
163048462|NCT02513550|588884799|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
163048463|NCT02513550|588884800|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
163048464|NCT02513550|588884801|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
163048465|NCT02513550|588884796|FG000|Double Blind Treatment Period|Due to personal business|2|||
163048466|NCT02513550|588884797|FG001|Double Blind Treatment Period|Due to personal business|0|||
163048467|NCT02513550|588884798|FG002|Double Blind Treatment Period|Due to personal business|1|||
163048468|NCT02513550|588884799|FG003|Double Blind Treatment Period|Due to personal business|0|||
163048469|NCT02513550|588884800|FG004|Double Blind Treatment Period|Due to personal business|0|||
163396259|NCT02003014|590161203|FG000|Overall Study|Case report forms uncollected|9|||
163198434|NCT03766581|589441421|FG007|Treatment|Participant withdrew consent|0|||
163198435|NCT03766581|589441414|FG000|Treatment|Death|1|||
163198436|NCT03766581|589441415|FG001|Treatment|Death|0|||
163198437|NCT03766581|589441416|FG002|Treatment|Death|0|||
163198438|NCT03766581|589441417|FG003|Treatment|Death|0|||
163198439|NCT03766581|589441418|FG004|Treatment|Death|0|||
163198440|NCT03766581|589441419|FG005|Treatment|Death|0|||
163198441|NCT03766581|589441420|FG006|Treatment|Death|0|||
163198442|NCT03766581|589441421|FG007|Treatment|Death|0|||
163198443|NCT03766581|589441414|FG000|Treatment|Lost to Follow-up|1|||
163198444|NCT03766581|589441415|FG001|Treatment|Lost to Follow-up|0|||
163198445|NCT03766581|589441416|FG002|Treatment|Lost to Follow-up|0|||
163198446|NCT03766581|589441417|FG003|Treatment|Lost to Follow-up|1|||
163198447|NCT03766581|589441418|FG004|Treatment|Lost to Follow-up|0|||
163198448|NCT03766581|589441419|FG005|Treatment|Lost to Follow-up|0|||
163198449|NCT03766581|589441420|FG006|Treatment|Lost to Follow-up|0|||
163198450|NCT03766581|589441421|FG007|Treatment|Lost to Follow-up|0|||
163198451|NCT03766581|589441414|FG000|Treatment|Poor/Non compliance|2|||
163198452|NCT03766581|589441415|FG001|Treatment|Poor/Non compliance|2|||
163198453|NCT03766581|589441416|FG002|Treatment|Poor/Non compliance|1|||
163198454|NCT03766581|589441417|FG003|Treatment|Poor/Non compliance|1|||
163198455|NCT03766581|589441418|FG004|Treatment|Poor/Non compliance|1|||
163198456|NCT03766581|589441419|FG005|Treatment|Poor/Non compliance|1|||
163198457|NCT03766581|589441420|FG006|Treatment|Poor/Non compliance|0|||
163198458|NCT03766581|589441421|FG007|Treatment|Poor/Non compliance|0|||
163198459|NCT03766581|589441414|FG000|Treatment|Participant no longer meets study criteria|9|||
163198460|NCT03766581|589441415|FG001|Treatment|Participant no longer meets study criteria|1|||
163198461|NCT03766581|589441416|FG002|Treatment|Participant no longer meets study criteria|5|||
163198462|NCT03766581|589441417|FG003|Treatment|Participant no longer meets study criteria|4|||
163198463|NCT03766581|589441418|FG004|Treatment|Participant no longer meets study criteria|4|||
163198464|NCT03766581|589441419|FG005|Treatment|Participant no longer meets study criteria|4|||
163198465|NCT03766581|589441420|FG006|Treatment|Participant no longer meets study criteria|2|||
163198466|NCT03766581|589441421|FG007|Treatment|Participant no longer meets study criteria|0|||
163198467|NCT03766581|589441414|FG000|Treatment|Other reasons|13|||
163198468|NCT03766581|589441415|FG001|Treatment|Other reasons|8|||
163198469|NCT03766581|589441416|FG002|Treatment|Other reasons|3|||
163198470|NCT03766581|589441417|FG003|Treatment|Other reasons|7|||
163198471|NCT03766581|589441418|FG004|Treatment|Other reasons|3|||
163198472|NCT03766581|589441419|FG005|Treatment|Other reasons|3|||
163198473|NCT03766581|589441420|FG006|Treatment|Other reasons|0|||
163198474|NCT03766581|589441421|FG007|Treatment|Other reasons|0|||
163198475|NCT03716024|589441422|FG000|Overall Study|Randomized, not Treated|7|||
163198476|NCT03716024|589441423|FG001|Overall Study|Randomized, not Treated|8|||
163198477|NCT03716024|589441422|FG000|Overall Study|Adverse Event|1|||
163198478|NCT03716024|589441423|FG001|Overall Study|Adverse Event|2|||
163198479|NCT03716024|589441422|FG000|Overall Study|Treatment Failure|1|||
163198480|NCT03716024|589441423|FG001|Overall Study|Treatment Failure|0|||
163198481|NCT03716024|589441422|FG000|Overall Study|Lost to Follow-up|2|||
163198482|NCT03716024|589441423|FG001|Overall Study|Lost to Follow-up|6|||
163198483|NCT03716024|589441422|FG000|Overall Study|Withdrawal by Subject|0|||
163396260|NCT02003014|590161203|FG000|Overall Study|Treatment started after contract period|1|||
163198484|NCT03716024|589441423|FG001|Overall Study|Withdrawal by Subject|1|||
163048470|NCT02513550|588884801|FG005|Double Blind Treatment Period|Due to personal business|0|||
163048471|NCT02513550|588884796|FG000|Double Blind Treatment Period|Death|1|||
163048472|NCT02513550|588884797|FG001|Double Blind Treatment Period|Death|0|||
163048473|NCT02513550|588884798|FG002|Double Blind Treatment Period|Death|2|||
162961852|NCT00112437|588560751|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961853|NCT00112437|588560752|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961854|NCT00112437|588560753|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961855|NCT00112437|588560754|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961856|NCT00112437|588560755|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
163396261|NCT02003014|590161203|FG000|Overall Study|Patient did not visit the study site|5|||
163396262|NCT02003014|590161203|FG000|Overall Study|Investigator's transfer|4|||
163396263|NCT03007979|590161206|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
163396264|NCT03734016|590161207|FG000|Overall Study|Sponsor Ended Study|225|||
163396265|NCT03734016|590161208|FG001|Overall Study|Sponsor Ended Study|200|||
163396266|NCT03734016|590161207|FG000|Overall Study|Death|69|||
163396267|NCT03734016|590161208|FG001|Overall Study|Death|83|||
163396268|NCT03734016|590161207|FG000|Overall Study|Withdrawal by Subject|21|||
163396269|NCT03734016|590161208|FG001|Overall Study|Withdrawal by Subject|27|||
163396270|NCT03734016|590161207|FG000|Overall Study|Physician Decision|1|||
163396271|NCT03734016|590161208|FG001|Overall Study|Physician Decision|12|||
163396272|NCT03734016|590161207|FG000|Overall Study|Lost to Follow-up|6|||
162961857|NCT00112437|588560756|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
163198485|NCT03716024|589441422|FG000|Overall Study|Missing Reason|0|||
162961858|NCT00112437|588560757|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961859|NCT00112437|588560758|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
163198486|NCT03716024|589441423|FG001|Overall Study|Missing Reason|1|||
163198487|NCT00867568|589441424|FG000|Overall Study|Lack of Efficacy|10|||
163198488|NCT00867568|589441424|FG000|Overall Study|Adverse Event|4|||
163198489|NCT00867568|589441424|FG000|Overall Study|Withdrawal by Subject|1|||
163198490|NCT01056653|589441425|FG000|Overall Study|Lost to Follow-up|0|||
163198491|NCT01056653|589441426|FG001|Overall Study|Lost to Follow-up|0|||
163198492|NCT01056653|589441427|FG002|Overall Study|Lost to Follow-up|2|||
163048474|NCT02513550|588884799|FG003|Double Blind Treatment Period|Death|0|||
163048475|NCT02513550|588884800|FG004|Double Blind Treatment Period|Death|0|||
163048476|NCT02513550|588884801|FG005|Double Blind Treatment Period|Death|0|||
163048477|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
163048478|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
163048479|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
163048480|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163048481|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163048482|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163048483|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
163048484|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
163048485|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
163048486|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
163048487|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
163048488|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
163048489|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
163048490|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
163048491|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
163048492|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163198493|NCT05275400|589441428|FG000|Treatment Period|Adverse Event|7|||
163198494|NCT05275400|589441429|FG001|Treatment Period|Adverse Event|1|||
163198495|NCT05275400|589441428|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
163198496|NCT05275400|589441429|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
163048493|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163048494|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163048495|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
163048496|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
163048497|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
163048498|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
163048499|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
163048500|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
163048501|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
163048502|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
163048503|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
163048504|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
163048505|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
163048506|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
163048507|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Death|0|||
163048508|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Death|0|||
163048509|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Death|1|||
163048510|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Death|0|||
163048511|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Death|0|||
163048512|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Death|0|||
163048513|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
163048514|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
163048515|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
163048516|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
163048517|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
163048518|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
163048519|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
163048520|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
163048521|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
163048522|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
163048523|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
163048524|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
163048525|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
163304380|NCT00073749|589821851|FG004|Overall Study|Withdrawal by Subject|1|||
163304381|NCT00073749|589821852|FG005|Overall Study|Withdrawal by Subject|0|||
163304382|NCT00073749|589821853|FG006|Overall Study|Withdrawal by Subject|2|||
163304383|NCT00073749|589821847|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
163304384|NCT00073749|589821848|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
163304385|NCT00073749|589821849|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
163304386|NCT00073749|589821850|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
163304387|NCT00073749|589821851|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
163304388|NCT00073749|589821852|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
163304389|NCT00073749|589821853|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
163304390|NCT00073749|589821847|FG000|Overall Study|Lost to Follow-up|0|||
163304391|NCT00073749|589821848|FG001|Overall Study|Lost to Follow-up|0|||
163304392|NCT00073749|589821849|FG002|Overall Study|Lost to Follow-up|0|||
163304393|NCT00073749|589821850|FG003|Overall Study|Lost to Follow-up|0|||
163304394|NCT00073749|589821851|FG004|Overall Study|Lost to Follow-up|0|||
163048526|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
163048527|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
163048528|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
163048529|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
163048530|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
163048531|NCT02849743|588884802|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
163048532|NCT02849743|588884803|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
163048533|NCT02849743|588884802|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
163048534|NCT02849743|588884803|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
163048535|NCT02168491|588884806|FG000|Overall Study|Withdrawal by Subject|1|||
163048536|NCT00809445|588884807|FG000|1 Month Follow-up|Lost contact|1|||
163048537|NCT00809445|588884808|FG001|1 Month Follow-up|Lost contact|2|||
163048538|NCT00809445|588884809|FG002|1 Month Follow-up|Lost contact|1|||
163048539|NCT00809445|588884807|FG000|1 Month Follow-up|Withdrew consent|1|||
163048540|NCT00809445|588884808|FG001|1 Month Follow-up|Withdrew consent|1|||
163048541|NCT00809445|588884809|FG002|1 Month Follow-up|Withdrew consent|1|||
163048542|NCT00809445|588884807|FG000|1 Month Follow-up|Death|0|||
163048543|NCT00809445|588884808|FG001|1 Month Follow-up|Death|1|||
163048544|NCT00809445|588884809|FG002|1 Month Follow-up|Death|1|||
163304395|NCT00073749|589821852|FG005|Overall Study|Lost to Follow-up|0|||
163304396|NCT00073749|589821853|FG006|Overall Study|Lost to Follow-up|2|||
163304397|NCT00073749|589821847|FG000|Overall Study|Other|0|||
163304398|NCT00073749|589821848|FG001|Overall Study|Other|0|||
162961860|NCT00112437|588560759|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961861|NCT00112437|588560760|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961862|NCT00112437|588560761|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961863|NCT00112437|588560762|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961864|NCT00112437|588560763|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961865|NCT00112437|588560764|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961866|NCT00112437|588560765|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961867|NCT00112437|588560766|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
162961868|NCT00112437|588560767|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
163198497|NCT05275400|589441428|FG000|Treatment Period|Death|5|||
163396273|NCT03734016|590161208|FG001|Overall Study|Lost to Follow-up|2|||
163396274|NCT03734016|590161207|FG000|Overall Study|Miscellaneous|5|||
163198498|NCT05275400|589441429|FG001|Treatment Period|Death|2|||
162961869|NCT00112437|588560768|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961870|NCT00112437|588560769|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
163048545|NCT00809445|588884807|FG000|1 Month Follow-up|Incarcerated|0|||
163048546|NCT00809445|588884808|FG001|1 Month Follow-up|Incarcerated|0|||
162961871|NCT00112437|588560770|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961872|NCT00112437|588560771|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961873|NCT00112437|588560746|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961874|NCT00112437|588560747|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961875|NCT00112437|588560748|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961876|NCT00112437|588560749|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961877|NCT00112437|588560750|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961878|NCT00112437|588560751|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961879|NCT00112437|588560752|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961880|NCT00112437|588560753|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961881|NCT00112437|588560754|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961882|NCT00112437|588560755|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961883|NCT00112437|588560756|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
163048547|NCT00809445|588884809|FG002|1 Month Follow-up|Incarcerated|1|||
162961884|NCT00112437|588560757|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961885|NCT00112437|588560758|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
163396275|NCT03734016|590161208|FG001|Overall Study|Miscellaneous|1|||
163396276|NCT01624259|590161211|FG000|Overall Study|Adverse Event|18|||
163396277|NCT01624259|590161212|FG001|Overall Study|Adverse Event|18|||
163396278|NCT01624259|590161211|FG000|Overall Study|Protocol Violation|1|||
163198499|NCT05275400|589441428|FG000|Treatment Period|Protocol Violation|1|||
163396279|NCT01624259|590161212|FG001|Overall Study|Protocol Violation|2|||
163396280|NCT01624259|590161211|FG000|Overall Study|Withdrawal by Subject|5|||
163396281|NCT01624259|590161212|FG001|Overall Study|Withdrawal by Subject|7|||
163396282|NCT01624259|590161211|FG000|Overall Study|Physician Decision|1|||
163396283|NCT01624259|590161212|FG001|Overall Study|Physician Decision|1|||
163396284|NCT01624259|590161211|FG000|Overall Study|Lost to Follow-up|2|||
163396285|NCT01624259|590161212|FG001|Overall Study|Lost to Follow-up|3|||
163396286|NCT01624259|590161211|FG000|Overall Study|Abnormal laboratory measure|3|||
163396287|NCT01624259|590161212|FG001|Overall Study|Abnormal laboratory measure|0|||
163396288|NCT01298518|590161213|FG000|Overall Study|Withdrawal by Subject|0|||
163396289|NCT01298518|590161214|FG001|Overall Study|Withdrawal by Subject|0|||
163396290|NCT01298518|590161215|FG002|Overall Study|Withdrawal by Subject|1|||
163396291|NCT02273726|590161216|FG000|Overall Study|Death|70|||
163396292|NCT02273726|590161217|FG001|Overall Study|Death|62|||
163396293|NCT02273726|590161216|FG000|Overall Study|Withdrawal by Subject|41|||
163396294|NCT02273726|590161217|FG001|Overall Study|Withdrawal by Subject|29|||
163396295|NCT02273726|590161216|FG000|Overall Study|Kidney transplant|31|||
163048548|NCT00809445|588884807|FG000|6 Month Follow-up|Lost contact|16|||
163048549|NCT00809445|588884808|FG001|6 Month Follow-up|Lost contact|14|||
163048550|NCT00809445|588884809|FG002|6 Month Follow-up|Lost contact|14|||
163048551|NCT00809445|588884807|FG000|6 Month Follow-up|Death|2|||
163048552|NCT00809445|588884808|FG001|6 Month Follow-up|Death|1|||
163198500|NCT05275400|589441429|FG001|Treatment Period|Protocol Violation|0|||
163198501|NCT05275400|589441428|FG000|Treatment Period|Physician Decision|5|||
163198502|NCT05275400|589441429|FG001|Treatment Period|Physician Decision|4|||
163198503|NCT05275400|589441428|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
163198504|NCT05275400|589441429|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
163198505|NCT05275400|589441428|FG000|Treatment Period|Withdrawal by Subject|30|||
163198506|NCT05275400|589441429|FG001|Treatment Period|Withdrawal by Subject|12|||
163198507|NCT05275400|589441428|FG000|Treatment Period|Lost to Follow-up|1|||
163198508|NCT05275400|589441429|FG001|Treatment Period|Lost to Follow-up|5|||
163198509|NCT05275400|589441428|FG000|Treatment Period|Lack of Efficacy|1|||
163198510|NCT05275400|589441429|FG001|Treatment Period|Lack of Efficacy|0|||
163198511|NCT05275400|589441428|FG000|Treatment Period|Sponsor Decision|1|||
163198512|NCT05275400|589441429|FG001|Treatment Period|Sponsor Decision|0|||
163198513|NCT05275400|589441428|FG000|Follow-Up Period|Death|2|||
163198514|NCT05275400|589441429|FG001|Follow-Up Period|Death|0|||
163198515|NCT05275400|589441428|FG000|Follow-Up Period|Protocol Violation|1|||
163198516|NCT05275400|589441429|FG001|Follow-Up Period|Protocol Violation|0|||
163198517|NCT05275400|589441428|FG000|Follow-Up Period|Withdrawal by Subject|3|||
163048553|NCT00809445|588884809|FG002|6 Month Follow-up|Death|1|||
163048554|NCT00809445|588884807|FG000|6 Month Follow-up|Incarcerated|6|||
163048555|NCT00809445|588884808|FG001|6 Month Follow-up|Incarcerated|8|||
163048556|NCT00809445|588884809|FG002|6 Month Follow-up|Incarcerated|8|||
163048557|NCT00809445|588884807|FG000|6 Month Follow-up|Withdrew consent|0|||
163048558|NCT00809445|588884808|FG001|6 Month Follow-up|Withdrew consent|0|||
163048559|NCT00809445|588884809|FG002|6 Month Follow-up|Withdrew consent|1|||
163048560|NCT04919317|588884810|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
163048561|NCT04919317|588884811|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
163048562|NCT04919317|588884810|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
163048563|NCT04919317|588884811|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
163048564|NCT01566604|588884812|FG000|Overall Study|Patient's inability to use the device|1|||
163048565|NCT01566604|588884813|FG001|Overall Study|Patient's inability to use the device|0|||
163048566|NCT01566604|588884812|FG000|Overall Study|Administrative problems|1|||
163048567|NCT01566604|588884813|FG001|Overall Study|Administrative problems|0|||
163048568|NCT01566604|588884812|FG000|Overall Study|Lack of Efficacy|1|||
163048569|NCT01566604|588884813|FG001|Overall Study|Lack of Efficacy|2|||
163048570|NCT01566604|588884812|FG000|Overall Study|Protocol deviation|2|||
163048571|NCT01566604|588884813|FG001|Overall Study|Protocol deviation|0|||
163048572|NCT01566604|588884812|FG000|Overall Study|Abnormal laboratory value|2|||
163048573|NCT01566604|588884813|FG001|Overall Study|Abnormal laboratory value|0|||
163198518|NCT05275400|589441429|FG001|Follow-Up Period|Withdrawal by Subject|0|||
163198519|NCT01651039|589441431|FG000|Overall Study|Non-evaluables|5|||
163198520|NCT01651039|589441431|FG000|Overall Study|Physician Decision|2|||
163396296|NCT02273726|590161217|FG001|Overall Study|Kidney transplant|39|||
163396297|NCT02273726|590161216|FG000|Overall Study|Physician Decision|30|||
163396298|NCT02273726|590161217|FG001|Overall Study|Physician Decision|15|||
163396299|NCT02273726|590161216|FG000|Overall Study|Adverse Event|27|||
163396300|NCT02273726|590161217|FG001|Overall Study|Adverse Event|9|||
163396301|NCT02273726|590161216|FG000|Overall Study|Lost to Follow-up|6|||
163048574|NCT01566604|588884812|FG000|Overall Study|Death|4|||
163396302|NCT02273726|590161217|FG001|Overall Study|Lost to Follow-up|3|||
163396303|NCT02273726|590161216|FG000|Overall Study|Lack of Efficacy|6|||
163048575|NCT01566604|588884813|FG001|Overall Study|Death|1|||
163048576|NCT01566604|588884812|FG000|Overall Study|Adverse Event|4|||
163048577|NCT01566604|588884813|FG001|Overall Study|Adverse Event|2|||
163048578|NCT01566604|588884812|FG000|Overall Study|Withdrawal by Subject|9|||
163048579|NCT01566604|588884813|FG001|Overall Study|Withdrawal by Subject|6|||
163048580|NCT01443858|588884820|FG000|Overall Study|Withdrawal by Subject|9|||
163198521|NCT01651039|589441431|FG000|Overall Study|Withdrawal by Subject|1|||
163198522|NCT01651039|589441431|FG000|Overall Study|Progressive Disease|22|||
163198523|NCT03727230|589441432|FG000|Overall Study|Lost to Follow-up|12|||
163198524|NCT03600818|589441433|FG000|Overall Study|Adverse Event|4|||
163048581|NCT01443858|588884821|FG001|Overall Study|Withdrawal by Subject|8|||
163048582|NCT01443858|588884822|FG002|Overall Study|Withdrawal by Subject|5|||
163048583|NCT01443858|588884820|FG000|Overall Study|Lack of Efficacy|1|||
163396304|NCT02273726|590161217|FG001|Overall Study|Lack of Efficacy|1|||
163396305|NCT02273726|590161216|FG000|Overall Study|Protocol Violation|4|||
163396306|NCT02273726|590161217|FG001|Overall Study|Protocol Violation|0|||
163396307|NCT02273726|590161216|FG000|Overall Study|Other than specified|28|||
163396308|NCT02273726|590161217|FG001|Overall Study|Other than specified|30|||
163396309|NCT01979835|590161218|FG000|Primary Outcome SA Measurment|failed insertion|18|||
163396310|NCT01979835|590161218|FG000|Follow-up|Lost to Follow-up|32|||
163396311|NCT03697720|590162655|FG000|Overall Study|Lost to Follow-up|7|||
163048584|NCT01443858|588884821|FG001|Overall Study|Lack of Efficacy|0|||
163048585|NCT01443858|588884822|FG002|Overall Study|Lack of Efficacy|0|||
163198525|NCT03600818|589441434|FG001|Overall Study|Adverse Event|7|||
163048586|NCT01443858|588884820|FG000|Overall Study|Lost to Follow-up|5|||
163048587|NCT01443858|588884821|FG001|Overall Study|Lost to Follow-up|5|||
163048588|NCT01443858|588884822|FG002|Overall Study|Lost to Follow-up|2|||
163048589|NCT02221648|588884825|FG000|Overall Study|Withdrawal by Subject|3|||
163048590|NCT02221648|588884826|FG001|Overall Study|Withdrawal by Subject|3|||
163048591|NCT00810069|588884829|FG000|Lead-in Period I|Adverse Event|43|||
163198526|NCT03600818|589441433|FG000|Overall Study|Lack of Efficacy|9|||
163198527|NCT03600818|589441434|FG001|Overall Study|Lack of Efficacy|4|||
163198528|NCT03600818|589441433|FG000|Overall Study|Withdrawal by Subject|4|||
163198529|NCT03600818|589441434|FG001|Overall Study|Withdrawal by Subject|3|||
163198530|NCT03600818|589441433|FG000|Overall Study|Other-unspecified|5|||
163198531|NCT03600818|589441434|FG001|Overall Study|Other-unspecified|3|||
163198532|NCT03600818|589441433|FG000|Overall Study|Randomized and not treated|0|||
163198533|NCT03600818|589441434|FG001|Overall Study|Randomized and not treated|1|||
163198534|NCT01706146|589441435|FG000|Overall Study|Withdrawal by Subject|1|||
163198535|NCT01706146|589441435|FG000|Overall Study|Adverse Event|3|||
163198536|NCT01706146|589441435|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
163198537|NCT02582983|589441439|FG000|Overall Study|Death|3|||
163198538|NCT02582983|589441439|FG000|Overall Study|Withdrawal by Subject|2|||
163198539|NCT02582983|589441439|FG000|Overall Study|Adverse Event|1|||
163198540|NCT04377620|589441440|FG000|Overall Study|Death|42|||
163198541|NCT04377620|589441441|FG001|Overall Study|Death|48|||
163198542|NCT04377620|589441442|FG002|Overall Study|Death|36|||
163198543|NCT04377620|589441440|FG000|Overall Study|Withdrawal by Subject|0|||
163198544|NCT04377620|589441441|FG001|Overall Study|Withdrawal by Subject|2|||
163198545|NCT04377620|589441442|FG002|Overall Study|Withdrawal by Subject|0|||
163198546|NCT04930965|589441443|FG000|Overall Study|Lost to Follow-up|7|||
163198547|NCT04930965|589441444|FG001|Overall Study|Lost to Follow-up|5|||
163198548|NCT05209360|589441445|FG000|Overall Study|Withdrawal by Subject|0|||
163198549|NCT05209360|589441446|FG001|Overall Study|Withdrawal by Subject|0|||
163396312|NCT00382720|590162663|FG000|Overall Study|Adverse Event|21|||
163396313|NCT00382720|590162664|FG001|Overall Study|Adverse Event|23|||
163396314|NCT00382720|590162665|FG002|Overall Study|Adverse Event|15|||
163396315|NCT00382720|590162663|FG000|Overall Study|Protocol Violation|2|||
163048592|NCT00810069|588884830|FG001|Lead-in Period I|Adverse Event|0|||
163048593|NCT00810069|588884831|FG002|Lead-in Period I|Adverse Event|0|||
163048594|NCT00810069|588884829|FG000|Lead-in Period I|Lack of Efficacy|1|||
163048595|NCT00810069|588884830|FG001|Lead-in Period I|Lack of Efficacy|0|||
163048596|NCT00810069|588884831|FG002|Lead-in Period I|Lack of Efficacy|0|||
163304399|NCT00073749|589821849|FG002|Overall Study|Other|0|||
163304400|NCT00073749|589821850|FG003|Overall Study|Other|0|||
163048597|NCT00810069|588884829|FG000|Lead-in Period I|Lost to Follow-up|19|||
163048598|NCT00810069|588884830|FG001|Lead-in Period I|Lost to Follow-up|0|||
163048599|NCT00810069|588884831|FG002|Lead-in Period I|Lost to Follow-up|0|||
163048600|NCT00810069|588884829|FG000|Lead-in Period I|Physician Decision|1|||
163304401|NCT00073749|589821851|FG004|Overall Study|Other|0|||
163198550|NCT05209360|589441447|FG002|Overall Study|Withdrawal by Subject|1|||
163198551|NCT05209360|589441448|FG003|Overall Study|Withdrawal by Subject|0|||
163198552|NCT05209360|589441449|FG004|Overall Study|Withdrawal by Subject|0|||
163198553|NCT05209360|589441450|FG005|Overall Study|Withdrawal by Subject|0|||
163198554|NCT04189081|589441452|FG000|Overall Study|Lost to Follow-up|1|||
163198555|NCT04189081|589441453|FG001|Overall Study|Lost to Follow-up|0|||
163198556|NCT04189081|589441454|FG002|Overall Study|Lost to Follow-up|0|||
163198557|NCT04189081|589441452|FG000|Overall Study|Withdrawal by Subject|0|||
163304402|NCT00073749|589821852|FG005|Overall Study|Other|2|||
163304403|NCT00073749|589821853|FG006|Overall Study|Other|0|||
163304404|NCT02272816|589821854|FG000|Overall Study|Adverse Event|1|||
163304405|NCT04095104|589821863|FG000|Overall Study|Withdrawal by Subject|0|||
163304406|NCT04095104|589821864|FG001|Overall Study|Withdrawal by Subject|1|||
163304407|NCT01136876|589821865|FG000|Overall Study|Lost to Follow-up|0|||
163304408|NCT01136876|589821866|FG001|Overall Study|Lost to Follow-up|1|||
163304409|NCT01136876|589821865|FG000|Overall Study|Physician Decision|3|||
163304410|NCT01136876|589821866|FG001|Overall Study|Physician Decision|5|||
163304411|NCT01136876|589821865|FG000|Overall Study|Missing NGAL measurement|2|||
163304412|NCT01136876|589821866|FG001|Overall Study|Missing NGAL measurement|5|||
163304413|NCT05321069|589821867|FG000|Overall Study|Adverse Event|52|||
163304414|NCT05321069|589821868|FG001|Overall Study|Adverse Event|52|||
162961886|NCT00112437|588560759|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961887|NCT00112437|588560760|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961888|NCT00112437|588560761|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
163396316|NCT00382720|590162664|FG001|Overall Study|Protocol Violation|5|||
162961889|NCT00112437|588560762|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961890|NCT00112437|588560763|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961891|NCT00112437|588560764|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961892|NCT00112437|588560765|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961893|NCT00112437|588560766|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961894|NCT00112437|588560767|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961895|NCT00112437|588560768|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
162961896|NCT00112437|588560769|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
162961897|NCT00112437|588560770|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961898|NCT00112437|588560771|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
162961899|NCT00112437|588560746|FG000|Years 6-10 (60-Month Extension)|Death|0|||
162961900|NCT00112437|588560747|FG001|Years 6-10 (60-Month Extension)|Death|0|||
162961901|NCT00112437|588560748|FG002|Years 6-10 (60-Month Extension)|Death|0|||
162961902|NCT00112437|588560749|FG003|Years 6-10 (60-Month Extension)|Death|0|||
162961903|NCT00112437|588560750|FG004|Years 6-10 (60-Month Extension)|Death|0|||
162961904|NCT00112437|588560751|FG005|Years 6-10 (60-Month Extension)|Death|0|||
162961905|NCT00112437|588560752|FG006|Years 6-10 (60-Month Extension)|Death|0|||
162961906|NCT00112437|588560753|FG007|Years 6-10 (60-Month Extension)|Death|0|||
162961907|NCT00112437|588560754|FG008|Years 6-10 (60-Month Extension)|Death|0|||
162961908|NCT00112437|588560755|FG009|Years 6-10 (60-Month Extension)|Death|0|||
162961909|NCT00112437|588560756|FG010|Years 6-10 (60-Month Extension)|Death|0|||
162961910|NCT00112437|588560757|FG011|Years 6-10 (60-Month Extension)|Death|0|||
162961911|NCT00112437|588560758|FG012|Years 6-10 (60-Month Extension)|Death|0|||
162961912|NCT00112437|588560759|FG013|Years 6-10 (60-Month Extension)|Death|0|||
162961913|NCT00112437|588560760|FG014|Years 6-10 (60-Month Extension)|Death|0|||
162961914|NCT00112437|588560761|FG015|Years 6-10 (60-Month Extension)|Death|0|||
162961915|NCT00112437|588560762|FG016|Years 6-10 (60-Month Extension)|Death|0|||
162961916|NCT00112437|588560763|FG017|Years 6-10 (60-Month Extension)|Death|0|||
162961917|NCT00112437|588560764|FG018|Years 6-10 (60-Month Extension)|Death|0|||
162961918|NCT00112437|588560765|FG019|Years 6-10 (60-Month Extension)|Death|0|||
162961919|NCT00112437|588560766|FG020|Years 6-10 (60-Month Extension)|Death|0|||
162961920|NCT00112437|588560767|FG021|Years 6-10 (60-Month Extension)|Death|0|||
162961921|NCT00112437|588560768|FG022|Years 6-10 (60-Month Extension)|Death|0|||
162961922|NCT00112437|588560769|FG023|Years 6-10 (60-Month Extension)|Death|2|||
162961923|NCT00112437|588560770|FG024|Years 6-10 (60-Month Extension)|Death|0|||
162961924|NCT00112437|588560771|FG025|Years 6-10 (60-Month Extension)|Death|0|||
162961925|NCT00112437|588560746|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961926|NCT00112437|588560747|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961927|NCT00112437|588560748|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961928|NCT00112437|588560749|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961929|NCT00112437|588560750|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961930|NCT00112437|588560751|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961931|NCT00112437|588560752|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961932|NCT00112437|588560753|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961933|NCT00112437|588560754|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961934|NCT00112437|588560755|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961935|NCT00112437|588560756|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961936|NCT00112437|588560757|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961937|NCT00112437|588560758|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
163396317|NCT00382720|590162665|FG002|Overall Study|Protocol Violation|1|||
162961938|NCT00112437|588560759|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961939|NCT00112437|588560760|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961940|NCT00112437|588560761|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961941|NCT00112437|588560762|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961942|NCT00112437|588560763|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961943|NCT00112437|588560764|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
163198558|NCT04189081|589441453|FG001|Overall Study|Withdrawal by Subject|0|||
163198559|NCT04189081|589441454|FG002|Overall Study|Withdrawal by Subject|1|||
163198560|NCT00044083|589441455|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
163198561|NCT00044083|589441456|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
163198562|NCT00044083|589441455|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
163198563|NCT00044083|589441456|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
163198564|NCT00044083|589441455|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
162961944|NCT00112437|588560765|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
163198565|NCT00044083|589441456|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
162961945|NCT00112437|588560766|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
163048601|NCT00810069|588884830|FG001|Lead-in Period I|Physician Decision|0|||
163048602|NCT00810069|588884831|FG002|Lead-in Period I|Physician Decision|0|||
163048603|NCT00810069|588884829|FG000|Lead-in Period I|Protocol Violation|1|||
163048604|NCT00810069|588884830|FG001|Lead-in Period I|Protocol Violation|0|||
163048605|NCT00810069|588884831|FG002|Lead-in Period I|Protocol Violation|0|||
163048606|NCT00810069|588884829|FG000|Lead-in Period I|Withdrawal by Subject|46|||
163048607|NCT00810069|588884830|FG001|Lead-in Period I|Withdrawal by Subject|0|||
163048608|NCT00810069|588884831|FG002|Lead-in Period I|Withdrawal by Subject|0|||
163048609|NCT00810069|588884829|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
162961946|NCT00112437|588560767|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961947|NCT00112437|588560768|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961948|NCT00112437|588560769|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961949|NCT00112437|588560770|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961950|NCT00112437|588560771|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
163048610|NCT00810069|588884830|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
163048611|NCT00810069|588884831|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
163048612|NCT00810069|588884829|FG000|Lead-in Period I|Randomization criteria not met|158|||
163048613|NCT00810069|588884830|FG001|Lead-in Period I|Randomization criteria not met|0|||
163048614|NCT00810069|588884831|FG002|Lead-in Period I|Randomization criteria not met|0|||
163048615|NCT00810069|588884829|FG000|Double-Blind Period II|Adverse Event|0|||
163048616|NCT00810069|588884830|FG001|Double-Blind Period II|Adverse Event|9|||
163048617|NCT00810069|588884831|FG002|Double-Blind Period II|Adverse Event|8|||
163048618|NCT00810069|588884829|FG000|Double-Blind Period II|Lack of Efficacy|0|||
163048619|NCT00810069|588884830|FG001|Double-Blind Period II|Lack of Efficacy|7|||
163048620|NCT00810069|588884831|FG002|Double-Blind Period II|Lack of Efficacy|12|||
163048621|NCT00810069|588884829|FG000|Double-Blind Period II|Lost to Follow-up|0|||
163048622|NCT00810069|588884830|FG001|Double-Blind Period II|Lost to Follow-up|9|||
163048623|NCT00810069|588884831|FG002|Double-Blind Period II|Lost to Follow-up|9|||
163048624|NCT00810069|588884829|FG000|Double-Blind Period II|Physician Decision|0|||
163048625|NCT00810069|588884830|FG001|Double-Blind Period II|Physician Decision|0|||
163048626|NCT00810069|588884831|FG002|Double-Blind Period II|Physician Decision|1|||
163048627|NCT00810069|588884829|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
163048628|NCT00810069|588884830|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
163048629|NCT00810069|588884831|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
163048630|NCT00810069|588884829|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
163048631|NCT00810069|588884830|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
163048632|NCT00810069|588884831|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
163048633|NCT00810069|588884829|FG000|Double-Blind Period II|Clinical relapse|0|||
163048634|NCT00810069|588884830|FG001|Double-Blind Period II|Clinical relapse|3|||
162961951|NCT00112437|588560746|FG000|Years 6-10 (60-Month Extension)|Other|0|||
162961952|NCT00112437|588560747|FG001|Years 6-10 (60-Month Extension)|Other|0|||
162961953|NCT00112437|588560748|FG002|Years 6-10 (60-Month Extension)|Other|0|||
162961954|NCT00112437|588560749|FG003|Years 6-10 (60-Month Extension)|Other|0|||
162961955|NCT00112437|588560750|FG004|Years 6-10 (60-Month Extension)|Other|0|||
162961956|NCT00112437|588560751|FG005|Years 6-10 (60-Month Extension)|Other|0|||
162961957|NCT00112437|588560752|FG006|Years 6-10 (60-Month Extension)|Other|0|||
162961958|NCT00112437|588560753|FG007|Years 6-10 (60-Month Extension)|Other|0|||
163048635|NCT00810069|588884831|FG002|Double-Blind Period II|Clinical relapse|0|||
163198566|NCT00044083|589441455|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
163198567|NCT00044083|589441456|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
163198568|NCT00044083|589441455|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
163198569|NCT00044083|589441456|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
163198570|NCT00044083|589441455|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
163198571|NCT00044083|589441456|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
163198572|NCT00044083|589441455|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
163198573|NCT00044083|589441456|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
163198574|NCT00044083|589441455|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
163198575|NCT00044083|589441456|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
163198576|NCT00044083|589441455|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
163198577|NCT00044083|589441456|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
163198578|NCT00044083|589441455|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
163198579|NCT00044083|589441456|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
163198580|NCT00444912|589441457|FG000|Overall Study|Death|1|||
163198581|NCT00444912|589441458|FG001|Overall Study|Death|2|||
163198582|NCT00444912|589441457|FG000|Overall Study|Lost to Follow-up|1|||
163198583|NCT00444912|589441458|FG001|Overall Study|Lost to Follow-up|0|||
163198584|NCT00444912|589441457|FG000|Overall Study|Participant Failed Mobilization|1|||
163198585|NCT00444912|589441458|FG001|Overall Study|Participant Failed Mobilization|0|||
163198586|NCT03758066|589441459|FG000|Overall Study|Lost to Follow-up|14|||
163198587|NCT03706079|589441465|FG000|Predecessor Study|Death|0|||
163198588|NCT03706079|589441466|FG001|Predecessor Study|Death|2|||
163198589|NCT03706079|589441467|FG002|Predecessor Study|Death|0|||
163198590|NCT03706079|589441468|FG003|Predecessor Study|Death|1|||
163198591|NCT03706079|589441469|FG004|Predecessor Study|Death|0|||
163198592|NCT03706079|589441470|FG005|Predecessor Study|Death|0|||
163198593|NCT03706079|589441465|FG000|Predecessor Study|Lost to Follow-up|5|||
163198594|NCT03706079|589441466|FG001|Predecessor Study|Lost to Follow-up|2|||
163198595|NCT03706079|589441467|FG002|Predecessor Study|Lost to Follow-up|0|||
163198596|NCT03706079|589441468|FG003|Predecessor Study|Lost to Follow-up|0|||
163198597|NCT03706079|589441469|FG004|Predecessor Study|Lost to Follow-up|1|||
163198598|NCT03706079|589441470|FG005|Predecessor Study|Lost to Follow-up|0|||
162961959|NCT00112437|588560754|FG008|Years 6-10 (60-Month Extension)|Other|0|||
162961960|NCT00112437|588560755|FG009|Years 6-10 (60-Month Extension)|Other|0|||
162961961|NCT00112437|588560756|FG010|Years 6-10 (60-Month Extension)|Other|0|||
162961962|NCT00112437|588560757|FG011|Years 6-10 (60-Month Extension)|Other|0|||
162961963|NCT00112437|588560758|FG012|Years 6-10 (60-Month Extension)|Other|0|||
162961964|NCT00112437|588560759|FG013|Years 6-10 (60-Month Extension)|Other|0|||
162961965|NCT00112437|588560760|FG014|Years 6-10 (60-Month Extension)|Other|0|||
162961966|NCT00112437|588560761|FG015|Years 6-10 (60-Month Extension)|Other|0|||
162961967|NCT00112437|588560762|FG016|Years 6-10 (60-Month Extension)|Other|0|||
162961968|NCT00112437|588560763|FG017|Years 6-10 (60-Month Extension)|Other|0|||
162961969|NCT00112437|588560764|FG018|Years 6-10 (60-Month Extension)|Other|0|||
162961970|NCT00112437|588560765|FG019|Years 6-10 (60-Month Extension)|Other|0|||
162961971|NCT00112437|588560766|FG020|Years 6-10 (60-Month Extension)|Other|0|||
162961972|NCT00112437|588560767|FG021|Years 6-10 (60-Month Extension)|Other|0|||
162961973|NCT00112437|588560768|FG022|Years 6-10 (60-Month Extension)|Other|0|||
162961974|NCT00112437|588560769|FG023|Years 6-10 (60-Month Extension)|Other|0|||
162961975|NCT00112437|588560770|FG024|Years 6-10 (60-Month Extension)|Other|1|||
162961976|NCT00112437|588560771|FG025|Years 6-10 (60-Month Extension)|Other|0|||
162961977|NCT00112437|588560746|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961978|NCT00112437|588560747|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961979|NCT00112437|588560748|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961980|NCT00112437|588560749|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961981|NCT00112437|588560750|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961982|NCT00112437|588560751|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961983|NCT00112437|588560752|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961984|NCT00112437|588560753|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961985|NCT00112437|588560754|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961986|NCT00112437|588560755|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961987|NCT00112437|588560756|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961988|NCT00112437|588560757|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961989|NCT00112437|588560758|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
163048636|NCT00810069|588884829|FG000|Double-Blind Period II|Protocol Violation|0|||
162961990|NCT00112437|588560759|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961991|NCT00112437|588560760|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
163048637|NCT00810069|588884830|FG001|Double-Blind Period II|Protocol Violation|7|||
163048638|NCT00810069|588884831|FG002|Double-Blind Period II|Protocol Violation|6|||
163048639|NCT02899065|588884834|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
163048640|NCT02899065|588884835|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
163048641|NCT02899065|588884834|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
163048642|NCT02899065|588884835|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
163048643|NCT02899065|588884834|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
163048644|NCT02899065|588884835|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
163048645|NCT00186485|588884836|FG000|Overall Study|Lost to Follow-up|3|||
163048646|NCT00426764|588884837|FG000|Overall Study|Protocol Violation|1|||
162961992|NCT00112437|588560761|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961993|NCT00112437|588560762|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961994|NCT00112437|588560763|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961995|NCT00112437|588560764|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961996|NCT00112437|588560765|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961997|NCT00112437|588560766|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961998|NCT00112437|588560767|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961999|NCT00112437|588560768|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162962000|NCT00112437|588560769|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
162962001|NCT00112437|588560770|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162962002|NCT00112437|588560771|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162962003|NCT00112437|588560746|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962004|NCT00112437|588560747|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962005|NCT00112437|588560748|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962006|NCT00112437|588560749|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962007|NCT00112437|588560750|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962008|NCT00112437|588560751|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962009|NCT00112437|588560752|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962010|NCT00112437|588560753|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962011|NCT00112437|588560754|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962012|NCT00112437|588560755|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
163048647|NCT00426764|588884837|FG000|Overall Study|Withdrawal by Subject|4|||
163048648|NCT00426764|588884837|FG000|Overall Study|Physician Decision|6|||
163048649|NCT00426764|588884837|FG000|Overall Study|Compassionate Use|1|||
163048650|NCT00426764|588884837|FG000|Overall Study|Progressive Disease|83|||
163048651|NCT00426764|588884837|FG000|Overall Study|Adverse Event|24|||
163048652|NCT00426764|588884837|FG000|Overall Study|Other|1|||
163048653|NCT00426764|588884837|FG000|Overall Study|Death|1|||
163048654|NCT00426764|588884837|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
163048655|NCT01922258|588884838|FG000|Overall Study|Lost to Follow-up|1|||
163048656|NCT01922258|588884839|FG001|Overall Study|Lost to Follow-up|1|||
163048657|NCT01922258|588884838|FG000|Overall Study|Adverse Event|9|||
163048658|NCT01922258|588884839|FG001|Overall Study|Adverse Event|2|||
163048659|NCT01922258|588884838|FG000|Overall Study|Met Withdrawal Criteria|0|||
163048660|NCT01922258|588884839|FG001|Overall Study|Met Withdrawal Criteria|4|||
163048661|NCT01922258|588884838|FG000|Overall Study|Withdrawn by the Investigator|1|||
163048662|NCT01922258|588884839|FG001|Overall Study|Withdrawn by the Investigator|4|||
163048663|NCT01922258|588884838|FG000|Overall Study|Withdrawal by participant|5|||
163048664|NCT01922258|588884839|FG001|Overall Study|Withdrawal by participant|5|||
163048665|NCT02417753|588884840|FG000|Overall Study|Death|1|||
163048666|NCT01261390|588884841|FG000|Overall Study|Significant Concurrent Illness|1|||
163048667|NCT01261390|588884842|FG001|Overall Study|Significant Concurrent Illness|0|||
163048668|NCT01261390|588884843|FG002|Overall Study|Significant Concurrent Illness|1|||
163048669|NCT01261390|588884844|FG003|Overall Study|Significant Concurrent Illness|0|||
163048670|NCT01261390|588884841|FG000|Overall Study|Dissatisfaction with Treatment|2|||
163048671|NCT01261390|588884842|FG001|Overall Study|Dissatisfaction with Treatment|1|||
163048672|NCT01261390|588884843|FG002|Overall Study|Dissatisfaction with Treatment|1|||
163048673|NCT01261390|588884844|FG003|Overall Study|Dissatisfaction with Treatment|2|||
163048674|NCT01261390|588884841|FG000|Overall Study|Relocation|0|||
163048675|NCT01261390|588884842|FG001|Overall Study|Relocation|1|||
163048676|NCT01261390|588884843|FG002|Overall Study|Relocation|0|||
163048677|NCT01261390|588884844|FG003|Overall Study|Relocation|0|||
163048678|NCT01261390|588884841|FG000|Overall Study|Loss of Interest in the Study|3|||
163048679|NCT01261390|588884842|FG001|Overall Study|Loss of Interest in the Study|1|||
163198599|NCT03706079|589441465|FG000|Predecessor Study|Withdrawal by Subject|8|||
163198600|NCT03706079|589441466|FG001|Predecessor Study|Withdrawal by Subject|15|||
163198601|NCT03706079|589441467|FG002|Predecessor Study|Withdrawal by Subject|0|||
163198602|NCT03706079|589441468|FG003|Predecessor Study|Withdrawal by Subject|5|||
162962013|NCT00112437|588560756|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
163198603|NCT03706079|589441469|FG004|Predecessor Study|Withdrawal by Subject|2|||
163048680|NCT01261390|588884843|FG002|Overall Study|Loss of Interest in the Study|0|||
163048681|NCT01261390|588884844|FG003|Overall Study|Loss of Interest in the Study|0|||
163048682|NCT01261390|588884841|FG000|Overall Study|Lost to Follow-up|1|||
163048683|NCT01261390|588884842|FG001|Overall Study|Lost to Follow-up|6|||
163048684|NCT01261390|588884843|FG002|Overall Study|Lost to Follow-up|5|||
163048685|NCT01261390|588884844|FG003|Overall Study|Lost to Follow-up|6|||
163048686|NCT02782741|588884846|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
163048687|NCT02782741|588884847|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
163048688|NCT02782741|588884848|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
163048689|NCT02782741|588884846|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
163048690|NCT02782741|588884847|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
163048691|NCT02782741|588884848|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
163048692|NCT02782741|588884846|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
163048693|NCT02782741|588884847|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
163048694|NCT02782741|588884848|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
163048695|NCT02782741|588884846|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
163304415|NCT05321069|589821869|FG002|Overall Study|Adverse Event|64|||
163304416|NCT05321069|589821867|FG000|Overall Study|Protocol Violation|1|||
163304417|NCT05321069|589821868|FG001|Overall Study|Protocol Violation|1|||
163304418|NCT05321069|589821869|FG002|Overall Study|Protocol Violation|0|||
163304419|NCT05321069|589821867|FG000|Overall Study|Withdrawal by Subject|23|||
163304420|NCT05321069|589821868|FG001|Overall Study|Withdrawal by Subject|18|||
163304421|NCT05321069|589821869|FG002|Overall Study|Withdrawal by Subject|12|||
163304422|NCT05321069|589821867|FG000|Overall Study|Lost to Follow-up|1|||
163304423|NCT05321069|589821868|FG001|Overall Study|Lost to Follow-up|0|||
163304424|NCT05321069|589821869|FG002|Overall Study|Lost to Follow-up|1|||
163396318|NCT00382720|590162663|FG000|Overall Study|Death|0|||
162962014|NCT00112437|588560757|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962015|NCT00112437|588560758|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962016|NCT00112437|588560759|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962017|NCT00112437|588560760|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962018|NCT00112437|588560761|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962019|NCT00112437|588560762|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962020|NCT00112437|588560763|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962021|NCT00112437|588560764|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962022|NCT00112437|588560765|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962023|NCT00112437|588560766|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962024|NCT00112437|588560767|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962025|NCT00112437|588560768|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
162962026|NCT00112437|588560769|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
162962027|NCT00112437|588560770|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962028|NCT00112437|588560771|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
162962029|NCT01824576|588560773|FG000|Overall Study|Device deficiency|2|||
162962030|NCT03218787|588560779|FG000|Overall Study|Lost to Follow-up|12|||
162962031|NCT03218787|588560779|FG000|Overall Study|Withdrawal by Subject|72|||
162962032|NCT03218787|588560779|FG000|Overall Study|Physician Decision|11|||
162962033|NCT03218787|588560779|FG000|Overall Study|Death|111|||
162962034|NCT02896296|588560780|FG000|Overall Study|Adverse Event|1|||
162962035|NCT02896296|588560780|FG000|Overall Study|Lost to Follow-up|19|||
162962036|NCT02896296|588560780|FG000|Overall Study|Pregnancy|1|||
162962037|NCT02896296|588560780|FG000|Overall Study|Physician Decision|2|||
162962038|NCT02896296|588560780|FG000|Overall Study|Withdrawal by Subject|10|||
162962039|NCT02896296|588560780|FG000|Overall Study|Site closing|7|||
162962040|NCT02896296|588560780|FG000|Overall Study|Incarceration|1|||
162962041|NCT02896296|588560780|FG000|Overall Study|Relocation|1|||
162962042|NCT01120028|588560783|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
162962043|NCT01120028|588560784|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
162962044|NCT01120028|588560785|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
162962045|NCT01120028|588560786|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
162962046|NCT01120028|588560783|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
162962047|NCT01120028|588560784|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
162962048|NCT01120028|588560785|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
162962049|NCT01120028|588560786|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
163048696|NCT02782741|588884847|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
163304425|NCT05321069|589821867|FG000|Overall Study|No reason stated by the participants|23|||
163304426|NCT05321069|589821868|FG001|Overall Study|No reason stated by the participants|22|||
163048697|NCT02782741|588884848|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
163048698|NCT02782741|588884846|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
163304427|NCT05321069|589821869|FG002|Overall Study|No reason stated by the participants|16|||
163304428|NCT05321069|589821867|FG000|Overall Study|Lack of Efficacy|1|||
163304429|NCT05321069|589821868|FG001|Overall Study|Lack of Efficacy|1|||
163304430|NCT05321069|589821869|FG002|Overall Study|Lack of Efficacy|0|||
163304431|NCT05048186|589821872|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
163304432|NCT05048186|589821873|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
162962050|NCT03250117|588560787|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
162962051|NCT03250117|588560788|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
162962052|NCT03250117|588560789|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
162962053|NCT03250117|588560790|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
162962054|NCT04063878|588560791|FG000|Overall Study|Withdrawal by Subject|2|||
162962055|NCT04063878|588560791|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
162962056|NCT00147498|588560792|FG000|Overall Study|Adverse Event|1|||
162962057|NCT00147498|588560793|FG001|Overall Study|Adverse Event|6|||
162962058|NCT00147498|588560794|FG002|Overall Study|Adverse Event|7|||
162962059|NCT00147498|588560795|FG003|Overall Study|Adverse Event|3|||
162962060|NCT00147498|588560792|FG000|Overall Study|Lack of Efficacy|1|||
162962061|NCT00147498|588560793|FG001|Overall Study|Lack of Efficacy|1|||
162962062|NCT00147498|588560794|FG002|Overall Study|Lack of Efficacy|1|||
162962063|NCT00147498|588560795|FG003|Overall Study|Lack of Efficacy|8|||
162962064|NCT00147498|588560792|FG000|Overall Study|Laboratory abnormality|0|||
162962065|NCT00147498|588560793|FG001|Overall Study|Laboratory abnormality|0|||
162962066|NCT00147498|588560794|FG002|Overall Study|Laboratory abnormality|2|||
162962067|NCT00147498|588560795|FG003|Overall Study|Laboratory abnormality|0|||
162962068|NCT00147498|588560792|FG000|Overall Study|Participant defaulted|0|||
162962069|NCT00147498|588560793|FG001|Overall Study|Participant defaulted|1|||
162962070|NCT00147498|588560794|FG002|Overall Study|Participant defaulted|4|||
162962071|NCT00147498|588560795|FG003|Overall Study|Participant defaulted|3|||
162962072|NCT00147498|588560792|FG000|Overall Study|Other|1|||
162962073|NCT00147498|588560793|FG001|Overall Study|Other|1|||
162962074|NCT00147498|588560794|FG002|Overall Study|Other|3|||
162962075|NCT00147498|588560795|FG003|Overall Study|Other|3|||
162962076|NCT04633564|588560796|FG000|Period 1|Adverse Event|28|||
162962077|NCT04633564|588560797|FG001|Period 1|Adverse Event|19|||
162962078|NCT04633564|588560796|FG000|Period 1|Death|8|||
162962079|NCT04633564|588560797|FG001|Period 1|Death|7|||
162962080|NCT04633564|588560796|FG000|Period 1|Lost to Follow-up|3|||
162962081|NCT04633564|588560797|FG001|Period 1|Lost to Follow-up|5|||
162962082|NCT04633564|588560796|FG000|Period 1|Physician Decision|4|||
162962083|NCT04633564|588560797|FG001|Period 1|Physician Decision|12|||
162962084|NCT04633564|588560796|FG000|Period 1|Protocol Violation|0|||
162962085|NCT04633564|588560797|FG001|Period 1|Protocol Violation|1|||
162962086|NCT04633564|588560796|FG000|Period 1|Withdrawal by Subject|10|||
162962087|NCT04633564|588560797|FG001|Period 1|Withdrawal by Subject|8|||
162962088|NCT04633564|588560796|FG000|Period 1|Progressive disease|47|||
162962089|NCT04633564|588560797|FG001|Period 1|Progressive disease|51|||
162962090|NCT04633564|588560796|FG000|Period 1|Terminated by Sponsor|8|||
162962091|NCT04633564|588560797|FG001|Period 1|Terminated by Sponsor|6|||
162962092|NCT04633564|588560796|FG000|Period 2|Adverse Event|3|||
162962093|NCT04633564|588560797|FG001|Period 2|Adverse Event|4|||
162962094|NCT04633564|588560796|FG000|Period 2|Death|0|||
162962095|NCT04633564|588560797|FG001|Period 2|Death|2|||
162962096|NCT04633564|588560796|FG000|Period 2|Lost to Follow-up|0|||
162962097|NCT04633564|588560797|FG001|Period 2|Lost to Follow-up|1|||
162962098|NCT04633564|588560796|FG000|Period 2|Physician Decision|2|||
162962099|NCT04633564|588560797|FG001|Period 2|Physician Decision|4|||
162962100|NCT04633564|588560796|FG000|Period 2|Withdrawal by Subject|5|||
162962101|NCT04633564|588560797|FG001|Period 2|Withdrawal by Subject|1|||
163304433|NCT05048186|589821872|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
163396319|NCT00382720|590162664|FG001|Overall Study|Death|1|||
162962102|NCT04633564|588560796|FG000|Period 2|Progressive Disease|74|||
162962103|NCT04633564|588560797|FG001|Period 2|Progressive Disease|82|||
163304434|NCT05048186|589821873|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
163304435|NCT02412748|589821874|FG000|Overall Study|Lost to Follow-up|38|||
163304436|NCT02412748|589821875|FG001|Overall Study|Lost to Follow-up|39|||
163304437|NCT04218266|589821878|FG000|Overall Study|Death|1|||
162962104|NCT04633564|588560796|FG000|Period 2|Terminated by Sponsor|9|||
162962105|NCT04633564|588560797|FG001|Period 2|Terminated by Sponsor|3|||
162962106|NCT01279486|588560798|FG000|Overall Study|Lost to Follow-up|1|||
162962107|NCT04198363|588560799|FG000|Overall Study|Adverse Event|1|||
162962108|NCT04198363|588560800|FG001|Overall Study|Adverse Event|1|||
163048699|NCT02782741|588884847|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
163048700|NCT02782741|588884848|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
163048701|NCT01951417|588884849|FG000|Overall Study|Withdrawal by Subject|1|||
163048702|NCT01951417|588884849|FG000|Overall Study|Protocol Violation|2|||
163048703|NCT01951417|588884849|FG000|Overall Study|Lost to Follow-up|6|||
163048704|NCT01497067|588884851|FG000|Overall Study|Lost to Follow-up|56|||
163048705|NCT01497067|588884851|FG000|Overall Study|Adverse Event|3|||
163048706|NCT01497067|588884851|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
163048707|NCT01497067|588884851|FG000|Overall Study|Other|13|||
163048708|NCT01275144|588884852|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
163048709|NCT01275144|588884853|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
163048710|NCT05116202|588884854|FG000|Overall Study|Study Terminated by Sponsor|21|||
163048711|NCT05116202|588884855|FG001|Overall Study|Study Terminated by Sponsor|38|||
163048712|NCT05116202|588884856|FG002|Overall Study|Study Terminated by Sponsor|17|||
163048713|NCT05116202|588884857|FG003|Overall Study|Study Terminated by Sponsor|18|||
163048714|NCT05116202|588884858|FG004|Overall Study|Study Terminated by Sponsor|0|||
163048715|NCT05116202|588884854|FG000|Overall Study|Withdrawal by Subject|0|||
163048716|NCT05116202|588884855|FG001|Overall Study|Withdrawal by Subject|1|||
163048717|NCT05116202|588884856|FG002|Overall Study|Withdrawal by Subject|1|||
163048718|NCT05116202|588884857|FG003|Overall Study|Withdrawal by Subject|1|||
163048719|NCT05116202|588884858|FG004|Overall Study|Withdrawal by Subject|1|||
163048720|NCT05116202|588884854|FG000|Overall Study|Lost to Follow-up|0|||
163048721|NCT05116202|588884855|FG001|Overall Study|Lost to Follow-up|0|||
163048722|NCT05116202|588884856|FG002|Overall Study|Lost to Follow-up|0|||
163048723|NCT05116202|588884857|FG003|Overall Study|Lost to Follow-up|0|||
163048724|NCT05116202|588884858|FG004|Overall Study|Lost to Follow-up|2|||
163048725|NCT05116202|588884854|FG000|Overall Study|Death|1|||
163048726|NCT05116202|588884855|FG001|Overall Study|Death|1|||
163048727|NCT05116202|588884856|FG002|Overall Study|Death|2|||
163048728|NCT05116202|588884857|FG003|Overall Study|Death|1|||
163048729|NCT05116202|588884858|FG004|Overall Study|Death|5|||
163048730|NCT02864407|588884865|FG000|Overall Study|Protocol Violation|3|||
163048731|NCT02864407|588884865|FG000|Overall Study|Lost to Follow-up|115|||
163048732|NCT02864407|588884865|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
163048733|NCT02864407|588884865|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
163048734|NCT02864407|588884865|FG000|Overall Study|Consent prior to the contract date|1|||
163048735|NCT00096538|588884873|FG000|Overall Study|Withdrawal by Subject|1|||
163048736|NCT02686164|588884874|FG000|Overall Study|Adverse Event|1|||
163048737|NCT02686164|588884874|FG000|Overall Study|Withdrawal of consent|1|||
163048738|NCT02686164|588884874|FG000|Overall Study|Clinical progression|1|||
163048739|NCT01827592|588884882|FG000|Overall Study|Adverse Event|11|||
163048740|NCT01827592|588884883|FG001|Overall Study|Adverse Event|9|||
163048741|NCT01827592|588884884|FG002|Overall Study|Adverse Event|2|||
163048742|NCT01827592|588884882|FG000|Overall Study|Physician Decision|0|||
163048743|NCT01827592|588884883|FG001|Overall Study|Physician Decision|2|||
163048744|NCT01827592|588884884|FG002|Overall Study|Physician Decision|1|||
163048745|NCT01827592|588884882|FG000|Overall Study|Protocol Violation|2|||
163048746|NCT01827592|588884883|FG001|Overall Study|Protocol Violation|1|||
163048747|NCT01827592|588884884|FG002|Overall Study|Protocol Violation|0|||
163048748|NCT01827592|588884882|FG000|Overall Study|Lost to Follow-up|1|||
163198604|NCT03706079|589441470|FG005|Predecessor Study|Withdrawal by Subject|0|||
163198605|NCT03706079|589441465|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
163198606|NCT03706079|589441466|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
163198607|NCT03706079|589441467|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
163304438|NCT04218266|589821879|FG001|Overall Study|Death|2|||
163048749|NCT01827592|588884883|FG001|Overall Study|Lost to Follow-up|2|||
163048750|NCT01827592|588884884|FG002|Overall Study|Lost to Follow-up|2|||
163048751|NCT01827592|588884882|FG000|Overall Study|Withdrawal by Subject|12|||
163048752|NCT01827592|588884883|FG001|Overall Study|Withdrawal by Subject|11|||
163048753|NCT01827592|588884884|FG002|Overall Study|Withdrawal by Subject|11|||
163048754|NCT01827592|588884882|FG000|Overall Study|Patient's substantial non-compliance|1|||
163048755|NCT01827592|588884883|FG001|Overall Study|Patient's substantial non-compliance|1|||
163048756|NCT01827592|588884884|FG002|Overall Study|Patient's substantial non-compliance|6|||
163048757|NCT01827592|588884882|FG000|Overall Study|Trial terminated by Sponsor|47|||
162962109|NCT04198363|588560799|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
162962110|NCT04198363|588560800|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
162962111|NCT04198363|588560799|FG000|Overall Study|Reason not Specified|1|||
162962112|NCT04198363|588560800|FG001|Overall Study|Reason not Specified|0|||
162962113|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Subject request|8|||
162962114|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Subject request|11|||
162962115|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
162962116|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
162962117|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
162962118|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
162962119|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
162962120|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
162962121|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
162962122|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
162962123|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
162962124|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
162962125|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Death|1|||
162962126|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Death|0|||
162962127|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
162962128|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
162962129|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
162962130|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
162962131|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
162962132|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
162962133|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
162962134|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
162962135|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
162962136|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
162962137|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
162962138|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
162962139|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
162962140|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
162962141|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
162962142|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
162962143|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
162962144|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
162962145|NCT00521586|588562582|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
162962146|NCT00521586|588562583|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
162962147|NCT00521586|588562582|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
162962148|NCT00521586|588562583|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
162962149|NCT00521586|588562582|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
162962150|NCT00521586|588562583|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
162962151|NCT00529763|588562584|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
163048758|NCT01827592|588884883|FG001|Overall Study|Trial terminated by Sponsor|53|||
163048759|NCT01827592|588884884|FG002|Overall Study|Trial terminated by Sponsor|51|||
163048760|NCT01827592|588884882|FG000|Overall Study|Others|0|||
163048761|NCT01827592|588884883|FG001|Overall Study|Others|1|||
163048762|NCT01827592|588884884|FG002|Overall Study|Others|3|||
162962152|NCT00529763|588562585|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
162962153|NCT00529763|588562586|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
162962154|NCT00529763|588562584|FG000|Overall Study|Death|1|||
162962155|NCT00529763|588562585|FG001|Overall Study|Death|1|||
162962156|NCT00529763|588562586|FG002|Overall Study|Death|1|||
162962157|NCT00529763|588562584|FG000|Overall Study|Disease Progression|10|||
162962158|NCT00529763|588562585|FG001|Overall Study|Disease Progression|16|||
162962159|NCT00529763|588562586|FG002|Overall Study|Disease Progression|11|||
162962160|NCT00529763|588562584|FG000|Overall Study|Lost to Follow-up|1|||
162962161|NCT00529763|588562585|FG001|Overall Study|Lost to Follow-up|2|||
162962162|NCT00529763|588562586|FG002|Overall Study|Lost to Follow-up|3|||
162962163|NCT00529763|588562584|FG000|Overall Study|Stem Cell Transplant|0|||
162962164|NCT00529763|588562585|FG001|Overall Study|Stem Cell Transplant|3|||
162962165|NCT00529763|588562586|FG002|Overall Study|Stem Cell Transplant|1|||
162962166|NCT00529763|588562584|FG000|Overall Study|Study Drug Toxicity|3|||
162962167|NCT00529763|588562585|FG001|Overall Study|Study Drug Toxicity|6|||
162962168|NCT00529763|588562586|FG002|Overall Study|Study Drug Toxicity|4|||
162962169|NCT00529763|588562584|FG000|Overall Study|Participant Withdrew Consent|2|||
162962170|NCT00529763|588562585|FG001|Overall Study|Participant Withdrew Consent|3|||
162962171|NCT00529763|588562586|FG002|Overall Study|Participant Withdrew Consent|4|||
162962172|NCT00529763|588562584|FG000|Overall Study|Other reasons|2|||
162962173|NCT00529763|588562585|FG001|Overall Study|Other reasons|0|||
162962174|NCT00529763|588562586|FG002|Overall Study|Other reasons|2|||
163048763|NCT02324361|588884885|FG000|Overall Study|Lost to Follow-up|5|||
162962175|NCT00529763|588562584|FG000|Overall Study|Participant request to discontinue treatment|1|||
162962176|NCT00529763|588562585|FG001|Overall Study|Participant request to discontinue treatment|1|||
162962177|NCT00529763|588562586|FG002|Overall Study|Participant request to discontinue treatment|3|||
162962178|NCT03669250|588562587|FG000|Overall Study|Adverse Event|0|||
162962179|NCT03669250|588562588|FG001|Overall Study|Adverse Event|0|||
162962180|NCT03669250|588562589|FG002|Overall Study|Adverse Event|0|||
162962181|NCT03669250|588562590|FG003|Overall Study|Adverse Event|0|||
162962182|NCT03669250|588562591|FG004|Overall Study|Adverse Event|1|||
162962183|NCT03669250|588562592|FG005|Overall Study|Adverse Event|0|||
162962184|NCT03669250|588562587|FG000|Overall Study|Withdrawal by Subject|0|||
162962185|NCT03669250|588562588|FG001|Overall Study|Withdrawal by Subject|1|||
162962186|NCT03669250|588562589|FG002|Overall Study|Withdrawal by Subject|0|||
162962187|NCT03669250|588562590|FG003|Overall Study|Withdrawal by Subject|1|||
162962188|NCT03669250|588562591|FG004|Overall Study|Withdrawal by Subject|0|||
162962189|NCT03669250|588562592|FG005|Overall Study|Withdrawal by Subject|0|||
162962190|NCT00828321|588562593|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
162962191|NCT00828321|588562594|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
162962192|NCT00828321|588562593|FG000|Second Intervention|Protocol Violation|0|||
162962193|NCT00828321|588562594|FG001|Second Intervention|Protocol Violation|1|||
162962194|NCT01015287|588562595|FG000|Overall Study|Death|21|||
162962195|NCT01015287|588562596|FG001|Overall Study|Death|16|||
162962196|NCT01015287|588562595|FG000|Overall Study|Adverse Event|1|||
162962197|NCT01015287|588562596|FG001|Overall Study|Adverse Event|0|||
162962198|NCT01015287|588562595|FG000|Overall Study|Sponsor Decision|3|||
162962199|NCT01015287|588562596|FG001|Overall Study|Sponsor Decision|7|||
162962200|NCT01015287|588562595|FG000|Overall Study|Physician Decision|19|||
162962201|NCT01015287|588562596|FG001|Overall Study|Physician Decision|21|||
162962202|NCT01015287|588562595|FG000|Overall Study|Withdrawal by Subject|14|||
162962203|NCT01015287|588562596|FG001|Overall Study|Withdrawal by Subject|19|||
162962204|NCT01015287|588562595|FG000|Overall Study|Entry Criteria not Met|11|||
162962205|NCT01015287|588562596|FG001|Overall Study|Entry Criteria not Met|14|||
162962206|NCT01015287|588562595|FG000|Overall Study|Lost to Follow-up|2|||
162962207|NCT01015287|588562596|FG001|Overall Study|Lost to Follow-up|1|||
162962208|NCT01015287|588562595|FG000|Overall Study|Protocol Violation|1|||
162962209|NCT01015287|588562596|FG001|Overall Study|Protocol Violation|1|||
162962210|NCT01592240|588562597|FG000|Overall Study|Adverse Event|1|||
162962211|NCT01592240|588562598|FG001|Overall Study|Adverse Event|0|||
162962212|NCT01592240|588562599|FG002|Overall Study|Adverse Event|0|||
162962213|NCT01592240|588562600|FG003|Overall Study|Adverse Event|1|||
162962214|NCT01592240|588562601|FG004|Overall Study|Adverse Event|1|||
162962215|NCT01592240|588562602|FG005|Overall Study|Adverse Event|0|||
162962216|NCT01592240|588562603|FG006|Overall Study|Adverse Event|0|||
162962217|NCT01592240|588562597|FG000|Overall Study|Death|0|||
162962218|NCT01592240|588562598|FG001|Overall Study|Death|1|||
162962219|NCT01592240|588562599|FG002|Overall Study|Death|0|||
162962220|NCT01592240|588562600|FG003|Overall Study|Death|0|||
162962221|NCT01592240|588562601|FG004|Overall Study|Death|0|||
162962222|NCT01592240|588562602|FG005|Overall Study|Death|0|||
162962223|NCT01592240|588562603|FG006|Overall Study|Death|0|||
162962224|NCT01592240|588562597|FG000|Overall Study|Lost to Follow-up|1|||
162962225|NCT01592240|588562598|FG001|Overall Study|Lost to Follow-up|3|||
162962226|NCT01592240|588562599|FG002|Overall Study|Lost to Follow-up|1|||
162962227|NCT01592240|588562600|FG003|Overall Study|Lost to Follow-up|0|||
162962228|NCT01592240|588562601|FG004|Overall Study|Lost to Follow-up|3|||
162962229|NCT01592240|588562602|FG005|Overall Study|Lost to Follow-up|2|||
163048764|NCT02324361|588884886|FG001|Overall Study|Lost to Follow-up|2|||
163048765|NCT00003471|588884897|FG000|Overall Study|Not evaluable|4|||
163048766|NCT00715403|588884902|FG000|Overall Study|Progressive disease|0|||
163048767|NCT00715403|588884903|FG001|Overall Study|Progressive disease|1|||
163048768|NCT00715403|588884904|FG002|Overall Study|Progressive disease|3|||
163048769|NCT00715403|588884905|FG003|Overall Study|Progressive disease|9|||
163048770|NCT00715403|588884906|FG004|Overall Study|Progressive disease|5|||
163048771|NCT00715403|588884907|FG005|Overall Study|Progressive disease|14|||
163048772|NCT00715403|588884908|FG006|Overall Study|Progressive disease|1|||
163048773|NCT00715403|588884902|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
163048774|NCT00715403|588884903|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
163048775|NCT00715403|588884904|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
163396320|NCT00382720|590162665|FG002|Overall Study|Death|2|||
162962230|NCT01592240|588562603|FG006|Overall Study|Lost to Follow-up|0|||
162962231|NCT01592240|588562597|FG000|Overall Study|Protocol Violation|0|||
163048776|NCT00715403|588884905|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
163396321|NCT00382720|590162663|FG000|Overall Study|Progressive disease|37|||
162962232|NCT01592240|588562598|FG001|Overall Study|Protocol Violation|0|||
162962233|NCT01592240|588562599|FG002|Overall Study|Protocol Violation|0|||
162962234|NCT01592240|588562600|FG003|Overall Study|Protocol Violation|0|||
162962235|NCT01592240|588562601|FG004|Overall Study|Protocol Violation|0|||
162962236|NCT01592240|588562602|FG005|Overall Study|Protocol Violation|1|||
162962237|NCT01592240|588562603|FG006|Overall Study|Protocol Violation|0|||
163048777|NCT00715403|588884906|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
163198608|NCT03706079|589441468|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
163198609|NCT03706079|589441469|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
163198610|NCT03706079|589441470|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
163198611|NCT03706079|589441465|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
163198612|NCT03706079|589441466|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
163198613|NCT03706079|589441467|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
163198614|NCT03706079|589441468|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
163198615|NCT03706079|589441469|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
163198616|NCT03706079|589441470|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
163198617|NCT03706079|589441465|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
163198618|NCT03706079|589441466|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
163198619|NCT03706079|589441467|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
163198620|NCT03706079|589441468|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
163198621|NCT03706079|589441469|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
163198622|NCT03706079|589441470|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
163198623|NCT03706079|589441465|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
163198624|NCT03706079|589441466|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
163198625|NCT03706079|589441467|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
163198626|NCT03706079|589441468|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
163198627|NCT03706079|589441469|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
163198628|NCT03706079|589441470|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
163198629|NCT03706079|589441465|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
163198630|NCT03706079|589441466|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
163198631|NCT03706079|589441467|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
163198632|NCT03706079|589441468|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
163198633|NCT03706079|589441469|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
163198634|NCT03706079|589441470|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
163198635|NCT03706079|589441465|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
163198636|NCT03706079|589441466|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
163198637|NCT03706079|589441467|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
163198638|NCT03706079|589441468|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
163198639|NCT03706079|589441469|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
163198640|NCT03706079|589441470|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
163198641|NCT03706079|589441465|FG000|Long Term Extension (DESTINATION)|Death|8|||
163198642|NCT03706079|589441466|FG001|Long Term Extension (DESTINATION)|Death|2|||
163198643|NCT03706079|589441467|FG002|Long Term Extension (DESTINATION)|Death|2|||
163198644|NCT03706079|589441468|FG003|Long Term Extension (DESTINATION)|Death|1|||
163198645|NCT03706079|589441469|FG004|Long Term Extension (DESTINATION)|Death|0|||
163198646|NCT03706079|589441470|FG005|Long Term Extension (DESTINATION)|Death|0|||
163198647|NCT00329238|589441471|FG000|Overall Study|Adverse Event|147|||
163198648|NCT00329238|589441472|FG001|Overall Study|Adverse Event|129|||
163198649|NCT00329238|589441471|FG000|Overall Study|Protocol Violation|23|||
162962238|NCT01592240|588562597|FG000|Overall Study|Withdrawal by Subject|0|||
163198650|NCT00329238|589441472|FG001|Overall Study|Protocol Violation|34|||
163198651|NCT00329238|589441471|FG000|Overall Study|Lost to Follow-up|2|||
163198652|NCT00329238|589441472|FG001|Overall Study|Lost to Follow-up|6|||
163198653|NCT00329238|589441471|FG000|Overall Study|Withdrawal by Subject|64|||
163198654|NCT00329238|589441472|FG001|Overall Study|Withdrawal by Subject|58|||
163198655|NCT00329238|589441471|FG000|Overall Study|Other reason (not specified)|40|||
163198656|NCT00329238|589441472|FG001|Overall Study|Other reason (not specified)|54|||
163198657|NCT01306942|589441483|FG000|Phase I|Adverse Event|2|||
163198658|NCT01306942|589441484|FG001|Phase I|Adverse Event|2|||
163198659|NCT01306942|589441485|FG002|Phase I|Adverse Event|0|||
163198660|NCT01306942|589441486|FG003|Phase I|Adverse Event|0|||
163198661|NCT01306942|589441483|FG000|Phase I|Physician Decision|3|||
163198662|NCT01306942|589441484|FG001|Phase I|Physician Decision|1|||
163396322|NCT00382720|590162664|FG001|Overall Study|Progressive disease|28|||
163396323|NCT00382720|590162665|FG002|Overall Study|Progressive disease|38|||
163048778|NCT00715403|588884907|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
163048779|NCT00715403|588884908|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
163048780|NCT00715403|588884902|FG000|Overall Study|Other Adverse Event than DLT|1|||
163048781|NCT00715403|588884903|FG001|Overall Study|Other Adverse Event than DLT|0|||
163048782|NCT00715403|588884904|FG002|Overall Study|Other Adverse Event than DLT|0|||
163048783|NCT00715403|588884905|FG003|Overall Study|Other Adverse Event than DLT|0|||
163048784|NCT00715403|588884906|FG004|Overall Study|Other Adverse Event than DLT|0|||
162962239|NCT01592240|588562598|FG001|Overall Study|Withdrawal by Subject|4|||
162962240|NCT01592240|588562599|FG002|Overall Study|Withdrawal by Subject|4|||
162962241|NCT01592240|588562600|FG003|Overall Study|Withdrawal by Subject|1|||
162962242|NCT01592240|588562601|FG004|Overall Study|Withdrawal by Subject|3|||
162962243|NCT01592240|588562602|FG005|Overall Study|Withdrawal by Subject|0|||
162962244|NCT01592240|588562603|FG006|Overall Study|Withdrawal by Subject|2|||
162962245|NCT01592240|588562597|FG000|Overall Study|Other|0|||
162962246|NCT01592240|588562598|FG001|Overall Study|Other|3|||
162962247|NCT01592240|588562599|FG002|Overall Study|Other|1|||
162962248|NCT01592240|588562600|FG003|Overall Study|Other|1|||
162962249|NCT01592240|588562601|FG004|Overall Study|Other|0|||
162962250|NCT01592240|588562602|FG005|Overall Study|Other|0|||
162962251|NCT01592240|588562603|FG006|Overall Study|Other|1|||
162962252|NCT01592240|588562597|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
162962253|NCT01592240|588562598|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
162962254|NCT01592240|588562599|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
162962255|NCT01592240|588562600|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
162962256|NCT01592240|588562601|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
162962257|NCT01592240|588562602|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
162962258|NCT01592240|588562603|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
162962259|NCT00488774|588562604|FG000|Overall Study|Withdrawal of consent|2|||
162962260|NCT00488774|588562605|FG001|Overall Study|Withdrawal of consent|2|||
162962261|NCT00488774|588562606|FG002|Overall Study|Withdrawal of consent|2|||
162962262|NCT00488774|588562607|FG003|Overall Study|Withdrawal of consent|0|||
162962263|NCT00488774|588562604|FG000|Overall Study|Other|6|||
162962264|NCT00488774|588562605|FG001|Overall Study|Other|3|||
162962265|NCT00488774|588562606|FG002|Overall Study|Other|2|||
162962266|NCT00488774|588562607|FG003|Overall Study|Other|2|||
162962267|NCT00488774|588562604|FG000|Overall Study|Lost to Follow-up|0|||
162962268|NCT00488774|588562605|FG001|Overall Study|Lost to Follow-up|0|||
162962269|NCT00488774|588562606|FG002|Overall Study|Lost to Follow-up|1|||
162962270|NCT00488774|588562607|FG003|Overall Study|Lost to Follow-up|1|||
162962271|NCT05523895|588562608|FG000|Overall Study|Adverse Event|2|||
162962272|NCT05523895|588562609|FG001|Overall Study|Adverse Event|1|||
162962273|NCT05523895|588562610|FG002|Overall Study|Adverse Event|1|||
162962274|NCT05523895|588562608|FG000|Overall Study|Lost to Follow-up|0|||
162962275|NCT05523895|588562609|FG001|Overall Study|Lost to Follow-up|1|||
162962276|NCT05523895|588562610|FG002|Overall Study|Lost to Follow-up|2|||
162962277|NCT05523895|588562608|FG000|Overall Study|Noncompliance with study drug|1|||
163198663|NCT01306942|589441485|FG002|Phase I|Physician Decision|0|||
162962278|NCT05523895|588562609|FG001|Overall Study|Noncompliance with study drug|1|||
163198664|NCT01306942|589441486|FG003|Phase I|Physician Decision|0|||
162962279|NCT05523895|588562610|FG002|Overall Study|Noncompliance with study drug|1|||
162962280|NCT05523895|588562608|FG000|Overall Study|Protocol Violation|0|||
162962281|NCT05523895|588562609|FG001|Overall Study|Protocol Violation|2|||
162962282|NCT05523895|588562610|FG002|Overall Study|Protocol Violation|0|||
163048785|NCT00715403|588884907|FG005|Overall Study|Other Adverse Event than DLT|2|||
163048786|NCT00715403|588884908|FG006|Overall Study|Other Adverse Event than DLT|0|||
163048787|NCT00715403|588884902|FG000|Overall Study|Protocol Violation|0|||
163048788|NCT00715403|588884903|FG001|Overall Study|Protocol Violation|0|||
163048789|NCT00715403|588884904|FG002|Overall Study|Protocol Violation|0|||
163048790|NCT00715403|588884905|FG003|Overall Study|Protocol Violation|0|||
163048791|NCT00715403|588884906|FG004|Overall Study|Protocol Violation|0|||
163048792|NCT00715403|588884907|FG005|Overall Study|Protocol Violation|1|||
163048793|NCT00715403|588884908|FG006|Overall Study|Protocol Violation|0|||
163048794|NCT00715403|588884902|FG000|Overall Study|Other reason not defined above|0|||
163048795|NCT00715403|588884903|FG001|Overall Study|Other reason not defined above|0|||
163048796|NCT00715403|588884904|FG002|Overall Study|Other reason not defined above|1|||
163048797|NCT00715403|588884905|FG003|Overall Study|Other reason not defined above|0|||
163048798|NCT00715403|588884906|FG004|Overall Study|Other reason not defined above|1|||
163048799|NCT00715403|588884907|FG005|Overall Study|Other reason not defined above|1|||
163048800|NCT00715403|588884908|FG006|Overall Study|Other reason not defined above|0|||
163048801|NCT01386606|588886888|FG000|Overall Study|Adverse Event|0|||
163048802|NCT01386606|588886889|FG001|Overall Study|Adverse Event|1|||
163048803|NCT01386606|588886890|FG002|Overall Study|Adverse Event|0|||
163048804|NCT01386606|588886891|FG003|Overall Study|Adverse Event|0|||
163048805|NCT01386606|588886888|FG000|Overall Study|Withdrawal by Subject|0|||
163048806|NCT01386606|588886889|FG001|Overall Study|Withdrawal by Subject|1|||
163048807|NCT01386606|588886890|FG002|Overall Study|Withdrawal by Subject|1|||
163048808|NCT01386606|588886891|FG003|Overall Study|Withdrawal by Subject|0|||
163048809|NCT01386606|588886888|FG000|Overall Study|Protocol Violation|1|||
163048810|NCT01386606|588886889|FG001|Overall Study|Protocol Violation|0|||
163048811|NCT01386606|588886890|FG002|Overall Study|Protocol Violation|1|||
163048812|NCT01386606|588886891|FG003|Overall Study|Protocol Violation|1|||
163048813|NCT01386606|588886888|FG000|Overall Study|Lost to Follow-up|2|||
163048814|NCT01386606|588886889|FG001|Overall Study|Lost to Follow-up|0|||
163048815|NCT01386606|588886890|FG002|Overall Study|Lost to Follow-up|0|||
163048816|NCT01386606|588886891|FG003|Overall Study|Lost to Follow-up|0|||
163048817|NCT01386606|588886888|FG000|Overall Study|Subject incarcerated|0|||
162962283|NCT05523895|588562608|FG000|Overall Study|Withdrawal by Subject|1|||
162962284|NCT05523895|588562609|FG001|Overall Study|Withdrawal by Subject|3|||
162962285|NCT05523895|588562610|FG002|Overall Study|Withdrawal by Subject|1|||
162962286|NCT05523895|588562608|FG000|Overall Study|Not further specified|0|||
162962287|NCT05523895|588562609|FG001|Overall Study|Not further specified|3|||
162962288|NCT05523895|588562610|FG002|Overall Study|Not further specified|1|||
162962289|NCT03674892|588562611|FG000|Overall Study|Lack of Efficacy|5|||
162962290|NCT03674892|588562611|FG000|Overall Study|Lost to Follow-up|3|||
162962291|NCT03674892|588562611|FG000|Overall Study|Migraine|2|||
162962292|NCT03674892|588562611|FG000|Overall Study|Excessive Tearing|1|||
162962293|NCT03674892|588562611|FG000|Overall Study|Increased Eye Pain|1|||
162962294|NCT03674892|588562611|FG000|Overall Study|Increased Facial Pain|1|||
162962295|NCT03674892|588562611|FG000|Overall Study|Sinus Irritation|1|||
162962296|NCT03674892|588562611|FG000|Overall Study|Sinus Infection|1|||
162962297|NCT05099380|588562612|FG000|Overall Study|Subject enrolled in error|1|||
162962298|NCT05099380|588562613|FG001|Overall Study|Subject enrolled in error|0|||
162962299|NCT05099380|588562612|FG000|Overall Study|Study Procedure|1|||
162962300|NCT05099380|588562613|FG001|Overall Study|Study Procedure|0|||
162962301|NCT05099380|588562612|FG000|Overall Study|Protocol Violation|1|||
162962302|NCT05099380|588562613|FG001|Overall Study|Protocol Violation|0|||
162962303|NCT05099380|588562612|FG000|Overall Study|Adverse Event|1|||
162962304|NCT05099380|588562613|FG001|Overall Study|Adverse Event|1|||
162962305|NCT05099380|588562612|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
162962306|NCT05099380|588562613|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
163048818|NCT01386606|588886889|FG001|Overall Study|Subject incarcerated|1|||
163048819|NCT01386606|588886890|FG002|Overall Study|Subject incarcerated|0|||
163048820|NCT01386606|588886891|FG003|Overall Study|Subject incarcerated|0|||
163048821|NCT01386606|588886888|FG000|Overall Study|Unable to draw PK|1|||
163048822|NCT01386606|588886889|FG001|Overall Study|Unable to draw PK|0|||
163048823|NCT01386606|588886890|FG002|Overall Study|Unable to draw PK|0|||
163048824|NCT01386606|588886891|FG003|Overall Study|Unable to draw PK|0|||
163048825|NCT01386606|588886888|FG000|Overall Study|T levels too high|0|||
163048826|NCT01386606|588886889|FG001|Overall Study|T levels too high|1|||
163048827|NCT01386606|588886890|FG002|Overall Study|T levels too high|1|||
163048828|NCT01386606|588886891|FG003|Overall Study|T levels too high|0|||
163048829|NCT00593814|588886893|FG000|Overall Study|Death|7|||
163048830|NCT00593814|588886894|FG001|Overall Study|Death|0|||
163048831|NCT00593814|588886893|FG000|Overall Study|Withdrawal by Subject|7|||
163048832|NCT00593814|588886894|FG001|Overall Study|Withdrawal by Subject|0|||
163048833|NCT00593814|588886893|FG000|Overall Study|Lost to Follow-up|7|||
163048834|NCT00593814|588886894|FG001|Overall Study|Lost to Follow-up|0|||
163048835|NCT00593814|588886893|FG000|Overall Study|Physician Decision|3|||
163048836|NCT00593814|588886894|FG001|Overall Study|Physician Decision|0|||
163048837|NCT02723188|588886897|FG000|Overall Study|Withdrawal by Subject|1|||
163048838|NCT02723188|588886898|FG001|Overall Study|Withdrawal by Subject|0|||
163048839|NCT02723188|588886899|FG002|Overall Study|Withdrawal by Subject|0|||
163048840|NCT03110354|588886903|FG000|Overall Study|Death|1|||
163048841|NCT03110354|588886904|FG001|Overall Study|Death|0|||
163048842|NCT03110354|588886905|FG002|Overall Study|Death|0|||
163048843|NCT03110354|588886906|FG003|Overall Study|Death|1|||
163048844|NCT03110354|588886907|FG004|Overall Study|Death|0|||
163048845|NCT03110354|588886903|FG000|Overall Study|Start of new therapy|0|||
163048846|NCT03110354|588886904|FG001|Overall Study|Start of new therapy|0|||
163048847|NCT03110354|588886905|FG002|Overall Study|Start of new therapy|0|||
163048848|NCT03110354|588886906|FG003|Overall Study|Start of new therapy|0|||
163048849|NCT03110354|588886907|FG004|Overall Study|Start of new therapy|1|||
163048850|NCT03110354|588886903|FG000|Overall Study|Failure to achieve response|2|||
163048851|NCT03110354|588886904|FG001|Overall Study|Failure to achieve response|3|||
163048852|NCT03110354|588886905|FG002|Overall Study|Failure to achieve response|0|||
163048853|NCT03110354|588886906|FG003|Overall Study|Failure to achieve response|2|||
163048854|NCT03110354|588886907|FG004|Overall Study|Failure to achieve response|1|||
163048855|NCT03110354|588886903|FG000|Overall Study|Progressive disease|1|||
162962307|NCT03276754|588562616|FG000|Overall Study|Withdrawal of informed consent|4|||
163048856|NCT03110354|588886904|FG001|Overall Study|Progressive disease|1|||
162962308|NCT03276754|588562616|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
162962309|NCT03276754|588562616|FG000|Overall Study|Lost to Follow-up|27|||
162962310|NCT03276754|588562616|FG000|Overall Study|No data reported at Month 24|31|||
163048857|NCT03110354|588886905|FG002|Overall Study|Progressive disease|3|||
163048858|NCT03110354|588886906|FG003|Overall Study|Progressive disease|4|||
162962311|NCT03276754|588562616|FG000|Overall Study|Death|39|||
162962312|NCT00545792|588562617|FG000|Overall Study|Withdrawal by Subject|1|||
162962313|NCT05041361|588562618|FG000|Overall Study|Lost to Follow-up|1|||
163048859|NCT03110354|588886907|FG004|Overall Study|Progressive disease|2|||
163048860|NCT03110354|588886903|FG000|Overall Study|Adverse Event|0|||
163048861|NCT03110354|588886904|FG001|Overall Study|Adverse Event|0|||
163048862|NCT03110354|588886905|FG002|Overall Study|Adverse Event|0|||
163048863|NCT03110354|588886906|FG003|Overall Study|Adverse Event|2|||
163048864|NCT03110354|588886907|FG004|Overall Study|Adverse Event|2|||
163048865|NCT03110354|588886903|FG000|Overall Study|Other|0|||
163048866|NCT03110354|588886904|FG001|Overall Study|Other|0|||
163048867|NCT03110354|588886905|FG002|Overall Study|Other|0|||
163048868|NCT03110354|588886906|FG003|Overall Study|Other|1|||
163048869|NCT03110354|588886907|FG004|Overall Study|Other|1|||
163048870|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
163198665|NCT01306942|589441483|FG000|Phase II|Adverse Event|0|||
163198666|NCT01306942|589441484|FG001|Phase II|Adverse Event|0|||
163198667|NCT01306942|589441485|FG002|Phase II|Adverse Event|0|||
163198668|NCT01306942|589441486|FG003|Phase II|Adverse Event|6|||
163198669|NCT01306942|589441483|FG000|Phase II|Physician Decision|2|||
163198670|NCT01306942|589441484|FG001|Phase II|Physician Decision|0|||
163198671|NCT01306942|589441485|FG002|Phase II|Physician Decision|0|||
163198672|NCT01306942|589441486|FG003|Phase II|Physician Decision|5|||
163198673|NCT01306942|589441483|FG000|Phase II|Withdrawal by Subject|0|||
163198674|NCT01306942|589441484|FG001|Phase II|Withdrawal by Subject|0|||
163198675|NCT01306942|589441485|FG002|Phase II|Withdrawal by Subject|0|||
163198676|NCT01306942|589441486|FG003|Phase II|Withdrawal by Subject|2|||
163198677|NCT01306942|589441483|FG000|Phase II|Death|0|||
163198678|NCT01306942|589441484|FG001|Phase II|Death|0|||
163198679|NCT01306942|589441485|FG002|Phase II|Death|0|||
163198680|NCT01306942|589441486|FG003|Phase II|Death|1|||
163198681|NCT01306942|589441483|FG000|Phase II|Not finished treatment|0|||
163198682|NCT01306942|589441484|FG001|Phase II|Not finished treatment|0|||
163198683|NCT01306942|589441485|FG002|Phase II|Not finished treatment|0|||
163198684|NCT01306942|589441486|FG003|Phase II|Not finished treatment|1|||
163198685|NCT01306942|589441483|FG000|Phase II|Protocol Violation|0|||
163198686|NCT01306942|589441484|FG001|Phase II|Protocol Violation|0|||
163198687|NCT01306942|589441485|FG002|Phase II|Protocol Violation|0|||
163198688|NCT01306942|589441486|FG003|Phase II|Protocol Violation|1|||
163198689|NCT03988088|589441487|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
163198690|NCT03988088|589441488|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
163198691|NCT03988088|589441489|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
163198692|NCT03988088|589441490|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
163198693|NCT03988088|589441487|FG000|Open-Label Addendum|Lost to Follow-up|0|||
163198694|NCT03988088|589441488|FG001|Open-Label Addendum|Lost to Follow-up|0|||
163198695|NCT03988088|589441489|FG002|Open-Label Addendum|Lost to Follow-up|1|||
163198696|NCT03988088|589441490|FG003|Open-Label Addendum|Lost to Follow-up|0|||
163048871|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
163048872|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
163048873|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
163048874|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
163048875|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
163048876|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
163048877|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
163048878|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
163048879|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
163048880|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
163048881|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
163048882|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
163048883|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
163048884|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
163048885|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
163048886|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
163048887|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
163048888|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
163048889|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
163048890|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
163198697|NCT03344796|589441491|FG000|Overall Study|Lost to Follow-up|0|||
163198698|NCT03344796|589441492|FG001|Overall Study|Lost to Follow-up|0|||
163198699|NCT03344796|589441493|FG002|Overall Study|Lost to Follow-up|0|||
163198700|NCT03344796|589441494|FG003|Overall Study|Lost to Follow-up|0|||
163198701|NCT03344796|589441495|FG004|Overall Study|Lost to Follow-up|0|||
163198702|NCT03344796|589441496|FG005|Overall Study|Lost to Follow-up|2|||
163198703|NCT00915278|589441497|FG000|Overall Study|Death|1|||
163198704|NCT00915278|589441498|FG001|Overall Study|Death|0|||
163198705|NCT00915278|589441499|FG002|Overall Study|Death|0|||
163198706|NCT00915278|589441500|FG003|Overall Study|Death|0|||
163396324|NCT00382720|590162663|FG000|Overall Study|Withdrew consent|1|||
163198707|NCT00915278|589441501|FG004|Overall Study|Death|0|||
163198708|NCT00915278|589441502|FG005|Overall Study|Death|0|||
163198709|NCT00915278|589441497|FG000|Overall Study|Lost to Follow-up|0|||
163198710|NCT00915278|589441498|FG001|Overall Study|Lost to Follow-up|1|||
163198711|NCT00915278|589441499|FG002|Overall Study|Lost to Follow-up|0|||
163048891|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
163048892|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
163048893|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
163048894|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
163048895|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
163048896|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
163048897|NCT01198002|588886914|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
163048898|NCT01198002|588886915|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
163048899|NCT01198002|588886916|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
163048900|NCT01198002|588886914|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
163048901|NCT01198002|588886915|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
163048902|NCT01198002|588886916|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
163048903|NCT01198002|588886914|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
163048904|NCT01198002|588886915|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
163048905|NCT01198002|588886916|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
163048906|NCT01198002|588886914|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
163048907|NCT01198002|588886915|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
163048908|NCT01198002|588886916|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
163048909|NCT01198002|588886914|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
163048910|NCT01198002|588886915|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
163048911|NCT01198002|588886916|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
163048912|NCT01198002|588886914|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
163048913|NCT01198002|588886915|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
163048914|NCT01198002|588886916|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
163048915|NCT01307787|588886917|FG000|Overall Study|Withdrawal by Subject|2|||
163048916|NCT01307787|588886918|FG001|Overall Study|Withdrawal by Subject|0|||
163048917|NCT03353792|588886922|FG000|Overall Study|Lost to Follow-up|1|||
163048918|NCT03353792|588886923|FG001|Overall Study|Lost to Follow-up|0|||
163048919|NCT03353792|588886922|FG000|Overall Study|Participant Unable to Manage Device|1|||
163048920|NCT03353792|588886923|FG001|Overall Study|Participant Unable to Manage Device|0|||
163048921|NCT01965327|588886924|FG000|Overall Study|Physician Decision|2|||
163048922|NCT02452047|588886926|FG000|Overall Study|Adverse Event|0|||
163048923|NCT02452047|588886927|FG001|Overall Study|Adverse Event|1|||
163048924|NCT02452047|588886928|FG002|Overall Study|Adverse Event|1|||
163048925|NCT02452047|588886926|FG000|Overall Study|Death|1|||
163048926|NCT02452047|588886927|FG001|Overall Study|Death|3|||
163048927|NCT02452047|588886928|FG002|Overall Study|Death|1|||
163048928|NCT02452047|588886926|FG000|Overall Study|Physician Decision|1|||
163198712|NCT00915278|589441500|FG003|Overall Study|Lost to Follow-up|0|||
163198713|NCT00915278|589441501|FG004|Overall Study|Lost to Follow-up|0|||
163198714|NCT00915278|589441502|FG005|Overall Study|Lost to Follow-up|0|||
163198715|NCT00915278|589441497|FG000|Overall Study|Withdrawal by Subject|0|||
163198716|NCT00915278|589441498|FG001|Overall Study|Withdrawal by Subject|1|||
163198717|NCT00915278|589441499|FG002|Overall Study|Withdrawal by Subject|0|||
163198718|NCT00915278|589441500|FG003|Overall Study|Withdrawal by Subject|0|||
163198719|NCT00915278|589441501|FG004|Overall Study|Withdrawal by Subject|1|||
163198720|NCT00915278|589441502|FG005|Overall Study|Withdrawal by Subject|4|||
163198721|NCT00915278|589441497|FG000|Overall Study|Adverse Event|4|||
163198722|NCT00915278|589441498|FG001|Overall Study|Adverse Event|1|||
163198723|NCT00915278|589441499|FG002|Overall Study|Adverse Event|0|||
163198724|NCT00915278|589441500|FG003|Overall Study|Adverse Event|0|||
163198725|NCT00915278|589441501|FG004|Overall Study|Adverse Event|0|||
163198726|NCT00915278|589441502|FG005|Overall Study|Adverse Event|0|||
163198727|NCT00915278|589441497|FG000|Overall Study|Progressive disease/clinical progression|0|||
163198728|NCT00915278|589441498|FG001|Overall Study|Progressive disease/clinical progression|0|||
163198729|NCT00915278|589441499|FG002|Overall Study|Progressive disease/clinical progression|0|||
163198730|NCT00915278|589441500|FG003|Overall Study|Progressive disease/clinical progression|3|||
163198731|NCT00915278|589441501|FG004|Overall Study|Progressive disease/clinical progression|1|||
163198732|NCT00915278|589441502|FG005|Overall Study|Progressive disease/clinical progression|2|||
163198733|NCT00915278|589441497|FG000|Overall Study|Infusion related AEs|0|||
163048929|NCT02452047|588886927|FG001|Overall Study|Physician Decision|0|||
163048930|NCT02452047|588886928|FG002|Overall Study|Physician Decision|0|||
163198734|NCT00915278|589441498|FG001|Overall Study|Infusion related AEs|0|||
163198735|NCT00915278|589441499|FG002|Overall Study|Infusion related AEs|0|||
163198736|NCT00915278|589441500|FG003|Overall Study|Infusion related AEs|0|||
163198737|NCT00915278|589441501|FG004|Overall Study|Infusion related AEs|0|||
163198738|NCT00915278|589441502|FG005|Overall Study|Infusion related AEs|2|||
163198739|NCT00915278|589441497|FG000|Overall Study|Admission to hospice|0|||
163198740|NCT00915278|589441498|FG001|Overall Study|Admission to hospice|0|||
163048931|NCT02452047|588886926|FG000|Overall Study|Lost to Follow-up|1|||
163048932|NCT02452047|588886927|FG001|Overall Study|Lost to Follow-up|1|||
163048933|NCT02452047|588886928|FG002|Overall Study|Lost to Follow-up|0|||
163048934|NCT02452047|588886926|FG000|Overall Study|Withdrawal by Subject|1|||
163048935|NCT02452047|588886927|FG001|Overall Study|Withdrawal by Subject|0|||
163048936|NCT02452047|588886928|FG002|Overall Study|Withdrawal by Subject|0|||
163048937|NCT02185417|588886931|FG000|Overall Study|Death|448|||
163048938|NCT02185417|588886932|FG001|Overall Study|Death|446|||
163048939|NCT02185417|588886933|FG002|Overall Study|Death|0|||
163048940|NCT02185417|588886931|FG000|Overall Study|Withdrawal by Subject|7|||
163048941|NCT02185417|588886932|FG001|Overall Study|Withdrawal by Subject|12|||
163048942|NCT02185417|588886933|FG002|Overall Study|Withdrawal by Subject|0|||
163048943|NCT03131167|588886936|FG000|Overall Study|Other (Unspecified)|0|||
163048944|NCT03131167|588886937|FG001|Overall Study|Other (Unspecified)|0|||
163048945|NCT03131167|588886938|FG002|Overall Study|Other (Unspecified)|0|||
163048946|NCT03131167|588886939|FG003|Overall Study|Other (Unspecified)|0|||
163048947|NCT03131167|588886940|FG004|Overall Study|Other (Unspecified)|0|||
163048948|NCT03131167|588886941|FG005|Overall Study|Other (Unspecified)|1|||
163048949|NCT03131167|588886942|FG006|Overall Study|Other (Unspecified)|0|||
163048950|NCT03131167|588886943|FG007|Overall Study|Other (Unspecified)|0|||
163048951|NCT03131167|588886944|FG008|Overall Study|Other (Unspecified)|0|||
163048952|NCT03131167|588886945|FG009|Overall Study|Other (Unspecified)|0|||
162962314|NCT05041361|588562619|FG001|Overall Study|Lost to Follow-up|3|||
162962315|NCT01642277|588562620|FG000|Overall Study|Adverse Event|10|||
162962316|NCT01642277|588562621|FG001|Overall Study|Adverse Event|0|||
163048953|NCT03131167|588886946|FG010|Overall Study|Other (Unspecified)|0|||
163048954|NCT03131167|588886947|FG011|Overall Study|Other (Unspecified)|0|||
163048955|NCT03131167|588886948|FG012|Overall Study|Other (Unspecified)|0|||
163048956|NCT00243919|588886961|FG000|Overall Study|Death|3|||
163048957|NCT00243919|588886962|FG001|Overall Study|Death|4|||
163048958|NCT00243919|588886963|FG002|Overall Study|Death|6|||
163048959|NCT00243919|588886961|FG000|Overall Study|Withdrawal by Subject|6|||
163048960|NCT00243919|588886962|FG001|Overall Study|Withdrawal by Subject|6|||
163048961|NCT00243919|588886963|FG002|Overall Study|Withdrawal by Subject|2|||
163048962|NCT00243919|588886961|FG000|Overall Study|Lost to Follow-up|6|||
163048963|NCT00243919|588886962|FG001|Overall Study|Lost to Follow-up|7|||
163048964|NCT00243919|588886963|FG002|Overall Study|Lost to Follow-up|3|||
163048965|NCT00243919|588886961|FG000|Overall Study|Administrative Error|1|||
163048966|NCT00243919|588886962|FG001|Overall Study|Administrative Error|0|||
163048967|NCT00243919|588886963|FG002|Overall Study|Administrative Error|0|||
163048968|NCT00243919|588886961|FG000|Overall Study|Physician Decision|1|||
163048969|NCT00243919|588886962|FG001|Overall Study|Physician Decision|1|||
163048970|NCT00243919|588886963|FG002|Overall Study|Physician Decision|0|||
163048971|NCT04176939|588886968|FG000|Overall Study|Withdrawal by Subject|5|||
163048972|NCT04176939|588886968|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
163048973|NCT04176939|588886968|FG000|Overall Study|Lost to Follow-up|2|||
163048974|NCT04176939|588886968|FG000|Overall Study|Unspecified reason|4|||
163048975|NCT04176939|588886968|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
163048976|NCT02157519|588886969|FG000|Overall Study|Death|3|||
163048977|NCT02157519|588886970|FG001|Overall Study|Death|1|||
163048978|NCT02157519|588886969|FG000|Overall Study|Withdrawal by Subject|7|||
163048979|NCT02157519|588886970|FG001|Overall Study|Withdrawal by Subject|0|||
163048980|NCT02157519|588886969|FG000|Overall Study|Lost to Follow-up|1|||
163048981|NCT02157519|588886970|FG001|Overall Study|Lost to Follow-up|0|||
163048982|NCT01656395|588886971|FG000|Overall Study|Adverse Event|1|||
163048983|NCT01656395|588886972|FG001|Overall Study|Adverse Event|14|||
163048984|NCT01656395|588886973|FG002|Overall Study|Adverse Event|5|||
163048985|NCT01656395|588886974|FG003|Overall Study|Adverse Event|4|||
163048986|NCT01656395|588886975|FG004|Overall Study|Adverse Event|5|||
163048987|NCT01656395|588886976|FG005|Overall Study|Adverse Event|7|||
163048988|NCT01656395|588886977|FG006|Overall Study|Adverse Event|0|||
163048989|NCT01656395|588886978|FG007|Overall Study|Adverse Event|0|||
163048990|NCT01656395|588886971|FG000|Overall Study|Lack of Efficacy|1|||
163048991|NCT01656395|588886972|FG001|Overall Study|Lack of Efficacy|8|||
163048992|NCT01656395|588886973|FG002|Overall Study|Lack of Efficacy|6|||
163048993|NCT01656395|588886974|FG003|Overall Study|Lack of Efficacy|1|||
163048994|NCT01656395|588886975|FG004|Overall Study|Lack of Efficacy|1|||
163048995|NCT01656395|588886976|FG005|Overall Study|Lack of Efficacy|6|||
163048996|NCT01656395|588886977|FG006|Overall Study|Lack of Efficacy|0|||
163048997|NCT01656395|588886978|FG007|Overall Study|Lack of Efficacy|0|||
163048998|NCT01656395|588886971|FG000|Overall Study|Lost to Follow-up|1|||
163048999|NCT01656395|588886972|FG001|Overall Study|Lost to Follow-up|0|||
163049000|NCT01656395|588886973|FG002|Overall Study|Lost to Follow-up|0|||
163049001|NCT01656395|588886974|FG003|Overall Study|Lost to Follow-up|0|||
163049002|NCT01656395|588886975|FG004|Overall Study|Lost to Follow-up|0|||
163049003|NCT01656395|588886976|FG005|Overall Study|Lost to Follow-up|0|||
163049004|NCT01656395|588886977|FG006|Overall Study|Lost to Follow-up|0|||
163049005|NCT01656395|588886978|FG007|Overall Study|Lost to Follow-up|0|||
163049006|NCT01656395|588886971|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163049007|NCT01656395|588886972|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163049008|NCT01656395|588886973|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163049009|NCT01656395|588886974|FG003|Overall Study|Non-Compliance with Study Drug|0|||
163049010|NCT01656395|588886975|FG004|Overall Study|Non-Compliance with Study Drug|1|||
163049011|NCT01656395|588886976|FG005|Overall Study|Non-Compliance with Study Drug|1|||
163049012|NCT01656395|588886977|FG006|Overall Study|Non-Compliance with Study Drug|0|||
163049013|NCT01656395|588886978|FG007|Overall Study|Non-Compliance with Study Drug|0|||
163049014|NCT01656395|588886971|FG000|Overall Study|Other|0|||
163049015|NCT01656395|588886972|FG001|Overall Study|Other|0|||
163049016|NCT01656395|588886973|FG002|Overall Study|Other|1|||
163049017|NCT01656395|588886974|FG003|Overall Study|Other|0|||
163049018|NCT01656395|588886975|FG004|Overall Study|Other|0|||
163049019|NCT01656395|588886976|FG005|Overall Study|Other|1|||
163049020|NCT01656395|588886977|FG006|Overall Study|Other|0|||
163049021|NCT01656395|588886978|FG007|Overall Study|Other|0|||
163049022|NCT01656395|588886971|FG000|Overall Study|Physician Decision|2|||
163049023|NCT01656395|588886972|FG001|Overall Study|Physician Decision|3|||
163049024|NCT01656395|588886973|FG002|Overall Study|Physician Decision|3|||
163049025|NCT01656395|588886974|FG003|Overall Study|Physician Decision|2|||
163049026|NCT01656395|588886975|FG004|Overall Study|Physician Decision|3|||
163049027|NCT01656395|588886976|FG005|Overall Study|Physician Decision|3|||
163049028|NCT01656395|588886977|FG006|Overall Study|Physician Decision|0|||
163049029|NCT01656395|588886978|FG007|Overall Study|Physician Decision|0|||
163049030|NCT01656395|588886971|FG000|Overall Study|Pregnancy|0|||
163049031|NCT01656395|588886972|FG001|Overall Study|Pregnancy|0|||
163049032|NCT01656395|588886973|FG002|Overall Study|Pregnancy|1|||
163049033|NCT01656395|588886974|FG003|Overall Study|Pregnancy|0|||
163049034|NCT01656395|588886975|FG004|Overall Study|Pregnancy|0|||
163049035|NCT01656395|588886976|FG005|Overall Study|Pregnancy|0|||
163049036|NCT01656395|588886977|FG006|Overall Study|Pregnancy|0|||
163049037|NCT01656395|588886978|FG007|Overall Study|Pregnancy|0|||
163049038|NCT01656395|588886971|FG000|Overall Study|Progressive Disease|0|||
163049039|NCT01656395|588886972|FG001|Overall Study|Progressive Disease|0|||
163049040|NCT01656395|588886973|FG002|Overall Study|Progressive Disease|0|||
163049041|NCT01656395|588886974|FG003|Overall Study|Progressive Disease|0|||
163049042|NCT01656395|588886975|FG004|Overall Study|Progressive Disease|0|||
163049043|NCT01656395|588886976|FG005|Overall Study|Progressive Disease|1|||
163049044|NCT01656395|588886977|FG006|Overall Study|Progressive Disease|0|||
163049045|NCT01656395|588886978|FG007|Overall Study|Progressive Disease|0|||
163049046|NCT01656395|588886971|FG000|Overall Study|Protocol Violation|6|||
163049047|NCT01656395|588886972|FG001|Overall Study|Protocol Violation|6|||
163049048|NCT01656395|588886973|FG002|Overall Study|Protocol Violation|9|||
163049049|NCT01656395|588886974|FG003|Overall Study|Protocol Violation|2|||
163049050|NCT01656395|588886975|FG004|Overall Study|Protocol Violation|4|||
163049051|NCT01656395|588886976|FG005|Overall Study|Protocol Violation|10|||
163049052|NCT01656395|588886977|FG006|Overall Study|Protocol Violation|0|||
163049053|NCT01656395|588886978|FG007|Overall Study|Protocol Violation|0|||
163049054|NCT01656395|588886971|FG000|Overall Study|Screen Failure|2|||
163049055|NCT01656395|588886972|FG001|Overall Study|Screen Failure|1|||
163049056|NCT01656395|588886973|FG002|Overall Study|Screen Failure|7|||
163049057|NCT01656395|588886974|FG003|Overall Study|Screen Failure|1|||
163049058|NCT01656395|588886975|FG004|Overall Study|Screen Failure|0|||
163049059|NCT01656395|588886976|FG005|Overall Study|Screen Failure|8|||
163049060|NCT01656395|588886977|FG006|Overall Study|Screen Failure|0|||
163049061|NCT01656395|588886978|FG007|Overall Study|Screen Failure|0|||
163049062|NCT01656395|588886971|FG000|Overall Study|Withdrawal by Subject|3|||
163049063|NCT01656395|588886972|FG001|Overall Study|Withdrawal by Subject|1|||
163049064|NCT01656395|588886973|FG002|Overall Study|Withdrawal by Subject|4|||
163049065|NCT01656395|588886974|FG003|Overall Study|Withdrawal by Subject|2|||
163049066|NCT01656395|588886975|FG004|Overall Study|Withdrawal by Subject|0|||
163049067|NCT01656395|588886976|FG005|Overall Study|Withdrawal by Subject|3|||
163049068|NCT01656395|588886977|FG006|Overall Study|Withdrawal by Subject|0|||
163049069|NCT01656395|588886978|FG007|Overall Study|Withdrawal by Subject|0|||
163049070|NCT00230048|588886983|FG000|Overall Study|Lost to Follow-up|13|||
163049071|NCT00230048|588886984|FG001|Overall Study|Lost to Follow-up|18|||
163198741|NCT00915278|589441499|FG002|Overall Study|Admission to hospice|1|||
163198742|NCT00915278|589441500|FG003|Overall Study|Admission to hospice|0|||
163198743|NCT00915278|589441501|FG004|Overall Study|Admission to hospice|0|||
163198744|NCT00915278|589441502|FG005|Overall Study|Admission to hospice|0|||
163198745|NCT02412618|589441503|FG000|Overall Study|Withdrawal by Subject|1|||
163198746|NCT02412618|589441504|FG001|Overall Study|Withdrawal by Subject|1|||
163198747|NCT02412618|589441503|FG000|Overall Study|Expulsion|1|||
163198748|NCT02412618|589441504|FG001|Overall Study|Expulsion|1|||
163198749|NCT00923156|589441506|FG000|Overall Study|Adverse Event|0|||
163198750|NCT00923156|589441507|FG001|Overall Study|Adverse Event|2|||
163198751|NCT00923156|589441508|FG002|Overall Study|Adverse Event|1|||
163198752|NCT00923156|589441506|FG000|Overall Study|Abnormal laboratory values|0|||
163198753|NCT00923156|589441507|FG001|Overall Study|Abnormal laboratory values|0|||
163049072|NCT00676403|588886985|FG000|Overall Study|Adverse Event|1|||
163049073|NCT00676403|588886986|FG001|Overall Study|Adverse Event|2|||
163049074|NCT00676403|588886987|FG002|Overall Study|Adverse Event|0|||
163198754|NCT00923156|589441508|FG002|Overall Study|Abnormal laboratory values|1|||
163049075|NCT00676403|588886988|FG003|Overall Study|Adverse Event|5|||
163198755|NCT00923156|589441506|FG000|Overall Study|Withdrawal by Subject|0|||
163049076|NCT00676403|588886989|FG004|Overall Study|Adverse Event|1|||
163049077|NCT00676403|588886990|FG005|Overall Study|Adverse Event|2|||
163198756|NCT00923156|589441507|FG001|Overall Study|Withdrawal by Subject|1|||
163198757|NCT00923156|589441508|FG002|Overall Study|Withdrawal by Subject|0|||
163049078|NCT00676403|588886985|FG000|Overall Study|Lost to Follow-up|0|||
163049079|NCT00676403|588886986|FG001|Overall Study|Lost to Follow-up|0|||
163049080|NCT00676403|588886987|FG002|Overall Study|Lost to Follow-up|0|||
163049081|NCT00676403|588886988|FG003|Overall Study|Lost to Follow-up|0|||
163049082|NCT00676403|588886989|FG004|Overall Study|Lost to Follow-up|0|||
163049083|NCT00676403|588886990|FG005|Overall Study|Lost to Follow-up|1|||
163304439|NCT04218266|589821880|FG002|Overall Study|Death|3|||
163304440|NCT04218266|589821878|FG000|Overall Study|Adverse Event|13|||
163304441|NCT04218266|589821879|FG001|Overall Study|Adverse Event|14|||
163304442|NCT04218266|589821880|FG002|Overall Study|Adverse Event|11|||
163304443|NCT04218266|589821878|FG000|Overall Study|Other|7|||
163304444|NCT04218266|589821879|FG001|Overall Study|Other|5|||
163304445|NCT04218266|589821880|FG002|Overall Study|Other|14|||
163304446|NCT04218266|589821878|FG000|Overall Study|Physician Decision|1|||
163304447|NCT04218266|589821879|FG001|Overall Study|Physician Decision|3|||
163304448|NCT04218266|589821880|FG002|Overall Study|Physician Decision|2|||
163304449|NCT04218266|589821878|FG000|Overall Study|Non-compliance with study drug|0|||
163304450|NCT04218266|589821879|FG001|Overall Study|Non-compliance with study drug|0|||
163304451|NCT04218266|589821880|FG002|Overall Study|Non-compliance with study drug|1|||
163304452|NCT04218266|589821878|FG000|Overall Study|Withdrawal by Subject|1|||
163304453|NCT04218266|589821879|FG001|Overall Study|Withdrawal by Subject|3|||
163304454|NCT04218266|589821880|FG002|Overall Study|Withdrawal by Subject|1|||
163304455|NCT04218266|589821878|FG000|Overall Study|Study drug never administered|2|||
163304456|NCT04218266|589821879|FG001|Overall Study|Study drug never administered|0|||
163304457|NCT04218266|589821880|FG002|Overall Study|Study drug never administered|0|||
163304458|NCT00065260|589821882|FG000|Overall Study|Death|0|||
163304459|NCT00065260|589821883|FG001|Overall Study|Death|1|||
163304460|NCT04820686|589821887|FG000|Overall Study|Withdrawal by Subject|5|||
163304461|NCT04820686|589821888|FG001|Overall Study|Withdrawal by Subject|2|||
163304462|NCT04820686|589821889|FG002|Overall Study|Withdrawal by Subject|3|||
163304463|NCT04820686|589821887|FG000|Overall Study|Study Termination|25|||
163304464|NCT04820686|589821888|FG001|Overall Study|Study Termination|13|||
163304465|NCT04820686|589821889|FG002|Overall Study|Study Termination|14|||
163304466|NCT04820686|589821887|FG000|Overall Study|Adverse Event|0|||
163304467|NCT04820686|589821888|FG001|Overall Study|Adverse Event|1|||
163304468|NCT04820686|589821889|FG002|Overall Study|Adverse Event|0|||
163304469|NCT01424670|589821890|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
163304470|NCT01424670|589821891|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
163304471|NCT01424670|589821890|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
163304472|NCT01424670|589821891|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
163304473|NCT01424670|589821890|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
163304474|NCT01424670|589821891|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
163304475|NCT01424670|589821890|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
163304476|NCT01424670|589821891|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
163304477|NCT01424670|589821890|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
163304478|NCT01424670|589821891|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
163304479|NCT01424670|589821890|FG000|Continuation Period|Adverse Event|13|||
163304480|NCT01424670|589821891|FG001|Continuation Period|Adverse Event|5|||
163304481|NCT01424670|589821890|FG000|Continuation Period|Lost to Follow-up|2|||
163304482|NCT01424670|589821891|FG001|Continuation Period|Lost to Follow-up|0|||
163304483|NCT01424670|589821890|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
163304484|NCT01424670|589821891|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
163304485|NCT01424670|589821890|FG000|Continuation Period|Physician Decision|5|||
163304486|NCT01424670|589821891|FG001|Continuation Period|Physician Decision|4|||
163304487|NCT01424670|589821890|FG000|Continuation Period|Withdrawal by Subject|13|||
163304488|NCT01424670|589821891|FG001|Continuation Period|Withdrawal by Subject|4|||
163304489|NCT00761189|589821892|FG000|Overall Study|Adverse Event|42|||
163304490|NCT00761189|589821892|FG000|Overall Study|Lack of Efficacy|45|||
163304491|NCT00761189|589821892|FG000|Overall Study|Lost to Follow-up|36|||
163304492|NCT00761189|589821892|FG000|Overall Study|Withdrawal by Subject|49|||
163304493|NCT00761189|589821892|FG000|Overall Study|Other|13|||
163304494|NCT01494922|589821893|FG000|Overall Study|Adverse Event|1|||
163396325|NCT00382720|590162664|FG001|Overall Study|Withdrew consent|1|||
163304495|NCT04377308|589821894|FG000|Overall Study|Withdrawal by Subject|0|||
163396326|NCT00382720|590162665|FG002|Overall Study|Withdrew consent|2|||
163396327|NCT00382720|590162663|FG000|Overall Study|Withdrawal by Subject|11|||
163396328|NCT00382720|590162664|FG001|Overall Study|Withdrawal by Subject|20|||
163396329|NCT00382720|590162665|FG002|Overall Study|Withdrawal by Subject|12|||
163396330|NCT00382720|590162663|FG000|Overall Study|Surgery|1|||
163049084|NCT00676403|588886985|FG000|Overall Study|Reason Unspecified|1|||
163049085|NCT00676403|588886986|FG001|Overall Study|Reason Unspecified|0|||
163304496|NCT04377308|589821895|FG001|Overall Study|Withdrawal by Subject|1|||
163304497|NCT02891915|589821905|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
163304498|NCT02891915|589821906|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
163049086|NCT00676403|588886987|FG002|Overall Study|Reason Unspecified|1|||
163304499|NCT02891915|589821905|FG000|Overall Study|Withdrawal by Subject|3|||
163049087|NCT00676403|588886988|FG003|Overall Study|Reason Unspecified|0|||
163049088|NCT00676403|588886989|FG004|Overall Study|Reason Unspecified|0|||
163049089|NCT00676403|588886990|FG005|Overall Study|Reason Unspecified|1|||
163049090|NCT00676403|588886985|FG000|Overall Study|Withdrawal by Subject|0|||
163049091|NCT00676403|588886986|FG001|Overall Study|Withdrawal by Subject|0|||
163049092|NCT00676403|588886987|FG002|Overall Study|Withdrawal by Subject|0|||
163049093|NCT00676403|588886988|FG003|Overall Study|Withdrawal by Subject|0|||
163049094|NCT00676403|588886989|FG004|Overall Study|Withdrawal by Subject|0|||
163049095|NCT00676403|588886990|FG005|Overall Study|Withdrawal by Subject|1|||
163049096|NCT03225170|588886991|FG000|Overall Study|Lost to Follow-up|4|||
163049097|NCT03225170|588886992|FG001|Overall Study|Lost to Follow-up|4|||
163049098|NCT03225170|588886993|FG002|Overall Study|Lost to Follow-up|0|||
163049099|NCT03225170|588886991|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
163049100|NCT03225170|588886992|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
163049101|NCT03225170|588886993|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
163049102|NCT00661089|588886995|FG000|Overall Study|1 subject withdrawal|0|||
163049103|NCT00661089|588886996|FG001|Overall Study|1 subject withdrawal|1|||
163049104|NCT00661089|588886995|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
163049105|NCT00661089|588886996|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
163049106|NCT01272908|588886999|FG000|Initial Treatment Period|Adverse Event|1|||
163049107|NCT01272908|588886999|FG000|Initial Treatment Period|Lack of Efficacy|5|||
163049108|NCT01272908|588886999|FG000|Initial Treatment Period|Protocol Violation|1|||
163049109|NCT01272908|588886999|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
163049110|NCT01272908|588886999|FG000|Re-Treatment Period|Adverse Event|2|||
163049111|NCT01272908|588886999|FG000|Re-Treatment Period|Lack of Efficacy|3|||
163049112|NCT01272908|588886999|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
163049113|NCT00971867|588887001|FG000|Overall Study|Adverse Event|4|||
163049114|NCT00971867|588887001|FG000|Overall Study|Participant Withdrew Consent|1|||
163049115|NCT00971867|588887001|FG000|Overall Study|Disease Progression|6|||
163049116|NCT00905424|588887008|FG000|Overall Study|Lost to Follow-up|3|||
163049117|NCT00905424|588887009|FG001|Overall Study|Lost to Follow-up|3|||
163049118|NCT00905424|588887008|FG000|Overall Study|Withdrawal by Subject|1|||
163049119|NCT00905424|588887009|FG001|Overall Study|Withdrawal by Subject|2|||
163049120|NCT00905424|588887008|FG000|Overall Study|Adverse Event|4|||
163049121|NCT00905424|588887009|FG001|Overall Study|Adverse Event|2|||
163049122|NCT00905424|588887008|FG000|Overall Study|Non-compliance with study medication|2|||
163049123|NCT00905424|588887009|FG001|Overall Study|Non-compliance with study medication|0|||
163049124|NCT00905424|588887008|FG000|Overall Study|Sponsor decision|1|||
163049125|NCT00905424|588887009|FG001|Overall Study|Sponsor decision|0|||
163049126|NCT00905424|588887008|FG000|Overall Study|Positive urine drug screen|0|||
163049127|NCT00905424|588887009|FG001|Overall Study|Positive urine drug screen|1|||
163049128|NCT00905424|588887008|FG000|Overall Study|Non-adherence to visit schedule|0|||
163049129|NCT00905424|588887009|FG001|Overall Study|Non-adherence to visit schedule|1|||
163049130|NCT00379899|588887011|FG000|Overall Study|Adverse Event|7|||
163049131|NCT00379899|588887012|FG001|Overall Study|Adverse Event|3|||
163049132|NCT00379899|588887011|FG000|Overall Study|Death|10|||
163049133|NCT00379899|588887012|FG001|Overall Study|Death|10|||
163049134|NCT00379899|588887011|FG000|Overall Study|Lost to Follow-up|2|||
163049135|NCT00379899|588887012|FG001|Overall Study|Lost to Follow-up|4|||
163049136|NCT00379899|588887011|FG000|Overall Study|Physician Decision|3|||
163049137|NCT00379899|588887012|FG001|Overall Study|Physician Decision|4|||
163049138|NCT00379899|588887011|FG000|Overall Study|Withdrawal by Subject|5|||
163049139|NCT00379899|588887012|FG001|Overall Study|Withdrawal by Subject|5|||
163049140|NCT00379899|588887011|FG000|Overall Study|Ineligibility determined|0|||
163049141|NCT00379899|588887012|FG001|Overall Study|Ineligibility determined|1|||
163049142|NCT00379899|588887011|FG000|Overall Study|Noncompliance|1|||
163049143|NCT00379899|588887012|FG001|Overall Study|Noncompliance|1|||
163049144|NCT00379899|588887011|FG000|Overall Study|Parathyroidectomy|0|||
163049145|NCT00379899|588887012|FG001|Overall Study|Parathyroidectomy|2|||
163198758|NCT00923156|589441506|FG000|Overall Study|Death|0|||
163198759|NCT00923156|589441507|FG001|Overall Study|Death|1|||
163049146|NCT00379899|588887011|FG000|Overall Study|Renal transplantation|5|||
163049147|NCT00379899|588887012|FG001|Overall Study|Renal transplantation|4|||
163049148|NCT00379899|588887011|FG000|Overall Study|Coronary artery bypass graft|1|||
163049149|NCT00379899|588887012|FG001|Overall Study|Coronary artery bypass graft|1|||
163049150|NCT00379899|588887011|FG000|Overall Study|Other protocol-specified criteria|3|||
163049151|NCT00379899|588887012|FG001|Overall Study|Other protocol-specified criteria|4|||
163049152|NCT00379899|588887011|FG000|Overall Study|Other|3|||
163049153|NCT00379899|588887012|FG001|Overall Study|Other|1|||
163049154|NCT02716779|588887015|FG000|Monotherapy|Adverse Event|0|||
163198760|NCT00923156|589441508|FG002|Overall Study|Death|0|||
163198761|NCT00923156|589441506|FG000|Overall Study|Lack of Efficacy|0|||
162962317|NCT01642277|588562620|FG000|Overall Study|Physician Decision|2|||
162962318|NCT01642277|588562621|FG001|Overall Study|Physician Decision|0|||
162962319|NCT01642277|588562620|FG000|Overall Study|Protocol Violation|1|||
162962320|NCT01642277|588562621|FG001|Overall Study|Protocol Violation|0|||
162962321|NCT01642277|588562620|FG000|Overall Study|Withdrawal by Subject|11|||
162962322|NCT01642277|588562621|FG001|Overall Study|Withdrawal by Subject|0|||
162962323|NCT03679598|588562622|FG000|Overall Study|Adverse Event|2|||
162962324|NCT03679598|588562623|FG001|Overall Study|Adverse Event|0|||
162962325|NCT03605342|588562624|FG000|Overall Study|Withdrawal by Subject|9|||
162962326|NCT03605342|588562625|FG001|Overall Study|Withdrawal by Subject|7|||
162962327|NCT03605342|588562624|FG000|Overall Study|Lost to Follow-up|1|||
162962328|NCT03605342|588562625|FG001|Overall Study|Lost to Follow-up|1|||
162962329|NCT02842853|588562628|FG000|Overall Study|Non-compliance with the protocol|3|||
162962330|NCT02842853|588562629|FG001|Overall Study|Non-compliance with the protocol|7|||
162962331|NCT02842853|588562630|FG002|Overall Study|Non-compliance with the protocol|2|||
162962332|NCT02842853|588562631|FG003|Overall Study|Non-compliance with the protocol|5|||
162962333|NCT02842853|588562628|FG000|Overall Study|Subject met exclusion criteria|0|||
162962334|NCT02842853|588562629|FG001|Overall Study|Subject met exclusion criteria|1|||
162962335|NCT02842853|588562630|FG002|Overall Study|Subject met exclusion criteria|0|||
162962336|NCT02842853|588562631|FG003|Overall Study|Subject met exclusion criteria|0|||
162962337|NCT02842853|588562628|FG000|Overall Study|Withdrawal by Subject|11|||
162962338|NCT02842853|588562629|FG001|Overall Study|Withdrawal by Subject|13|||
162962339|NCT02842853|588562630|FG002|Overall Study|Withdrawal by Subject|9|||
162962340|NCT02842853|588562631|FG003|Overall Study|Withdrawal by Subject|8|||
162962341|NCT02842853|588562628|FG000|Overall Study|Lost to Follow-up|9|||
162962342|NCT02842853|588562629|FG001|Overall Study|Lost to Follow-up|13|||
162962343|NCT02842853|588562630|FG002|Overall Study|Lost to Follow-up|10|||
162962344|NCT02842853|588562631|FG003|Overall Study|Lost to Follow-up|11|||
162962345|NCT00918645|588562642|FG000|Overall Study|Withdrawal by Subject|1|||
162962346|NCT05133180|588562643|FG000|Overall Study|Withdrawal of consent|1|||
162962347|NCT05133180|588562644|FG001|Overall Study|Withdrawal of consent|1|||
162962348|NCT05133180|588562643|FG000|Overall Study|Lost to Follow-up|1|||
163049155|NCT02716779|588887016|FG001|Monotherapy|Adverse Event|1|||
163049156|NCT02716779|588887017|FG002|Monotherapy|Adverse Event|1|||
163049157|NCT02716779|588887015|FG000|Combination Therapy|Adverse Event|0|||
163049158|NCT02716779|588887016|FG001|Combination Therapy|Adverse Event|2|||
163049159|NCT02716779|588887017|FG002|Combination Therapy|Adverse Event|1|||
162962349|NCT05133180|588562644|FG001|Overall Study|Lost to Follow-up|1|||
162962350|NCT05133180|588562643|FG000|Overall Study|Documented disease progression|0|||
162962351|NCT05133180|588562644|FG001|Overall Study|Documented disease progression|1|||
162962352|NCT04723693|588562645|FG000|Overall Study|Withdrawal by Subject|2|||
162962353|NCT02157974|588562646|FG000|Overall Study|Withdrawal by Subject|0|||
162962354|NCT02157974|588562647|FG001|Overall Study|Withdrawal by Subject|1|||
162962355|NCT02157974|588562648|FG002|Overall Study|Withdrawal by Subject|0|||
162962356|NCT02157974|588562649|FG003|Overall Study|Withdrawal by Subject|0|||
162962357|NCT02157974|588562650|FG004|Overall Study|Withdrawal by Subject|0|||
163049160|NCT00101868|588887030|FG000|Overall Study|Death|10|||
163198762|NCT00923156|589441507|FG001|Overall Study|Lack of Efficacy|0|||
163049161|NCT00101868|588887031|FG001|Overall Study|Death|10|||
163049162|NCT00101868|588887030|FG000|Overall Study|Withdrawal by Subject|8|||
163049163|NCT00101868|588887031|FG001|Overall Study|Withdrawal by Subject|9|||
163049164|NCT00101868|588887030|FG000|Overall Study|Protocol Violation|3|||
163049165|NCT00101868|588887031|FG001|Overall Study|Protocol Violation|0|||
163049166|NCT00101868|588887030|FG000|Overall Study|Lost to Follow-up|8|||
163049167|NCT00101868|588887031|FG001|Overall Study|Lost to Follow-up|13|||
163049168|NCT04001803|588887032|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
163049169|NCT04001803|588887032|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
163049170|NCT04001803|588887032|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
163049171|NCT04001803|588887032|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
163049172|NCT04001803|588887032|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
163049173|NCT04001803|588887032|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
163049174|NCT04001803|588887032|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
163049175|NCT04001803|588887032|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
163049176|NCT04001803|588887032|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
163049177|NCT04001803|588887032|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
163049178|NCT01931397|588887035|FG000|Overall Study|Physician Decision|2|||
163304500|NCT02891915|589821906|FG001|Overall Study|Withdrawal by Subject|3|||
163304501|NCT02891915|589821905|FG000|Overall Study|Became Ineligible After Enrollment|2|||
163049179|NCT01931397|588887035|FG000|Overall Study|Withdrawal by Subject|8|||
163049180|NCT01931397|588887035|FG000|Overall Study|moved out of state|1|||
163049181|NCT00520039|588887038|FG000|Overall Study|Exclusion criteria met at first visit|7|||
163049182|NCT00520039|588887039|FG001|Overall Study|Exclusion criteria met at first visit|5|||
163049183|NCT02329327|588887043|FG000|Overall Study|Death|78|||
163049184|NCT02329327|588887044|FG001|Overall Study|Death|0|||
163049185|NCT02329327|588887043|FG000|Overall Study|Withdrawal by Subject|3|||
163049186|NCT02329327|588887044|FG001|Overall Study|Withdrawal by Subject|0|||
163049187|NCT02329327|588887043|FG000|Overall Study|Lost to Follow-up|4|||
163049188|NCT02329327|588887044|FG001|Overall Study|Lost to Follow-up|0|||
163049189|NCT03560869|588887045|FG000|Overall Study|Withdrawal by Subject|3|||
163049190|NCT03560869|588887046|FG001|Overall Study|Withdrawal by Subject|4|||
163049191|NCT03560869|588887045|FG000|Overall Study|Screening failure|4|||
163049192|NCT03560869|588887046|FG001|Overall Study|Screening failure|4|||
163049193|NCT03560869|588887045|FG000|Overall Study|Withdrawal by PI|0|||
163049194|NCT03560869|588887046|FG001|Overall Study|Withdrawal by PI|1|||
163049195|NCT02493517|588887047|FG000|Overall Study|Protocol Violation|1|||
163049196|NCT02493517|588887048|FG001|Overall Study|Protocol Violation|2|||
163049197|NCT02493517|588887047|FG000|Overall Study|Withdrawal by Subject|1|||
163049198|NCT02493517|588887048|FG001|Overall Study|Withdrawal by Subject|2|||
163049199|NCT02493517|588887047|FG000|Overall Study|Adverse Event|0|||
163049200|NCT02493517|588887048|FG001|Overall Study|Adverse Event|2|||
163049201|NCT02493517|588887047|FG000|Overall Study|Missed study visit|0|||
163049202|NCT02493517|588887048|FG001|Overall Study|Missed study visit|1|||
163049203|NCT01367249|588887049|FG000|Overall Study|Withdrawal by Subject|6|||
163049204|NCT01367249|588887050|FG001|Overall Study|Withdrawal by Subject|6|||
163049205|NCT01367249|588887049|FG000|Overall Study|Other|3|||
163049206|NCT01367249|588887050|FG001|Overall Study|Other|10|||
163049207|NCT03718429|588887051|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
163049208|NCT03718429|588887052|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
163049209|NCT03718429|588887053|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
163049210|NCT03718429|588887054|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
163049211|NCT05404711|588887055|FG000|Completed Study Visit|Withdrawal by Subject|1|||
162962358|NCT02157974|588562646|FG000|Overall Study|Screen Failure|0|||
162962359|NCT02157974|588562647|FG001|Overall Study|Screen Failure|1|||
162962360|NCT02157974|588562648|FG002|Overall Study|Screen Failure|0|||
162962361|NCT02157974|588562649|FG003|Overall Study|Screen Failure|0|||
162962362|NCT02157974|588562650|FG004|Overall Study|Screen Failure|0|||
162962363|NCT02157974|588562646|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
162962364|NCT02157974|588562647|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
162962365|NCT02157974|588562648|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
162962366|NCT02157974|588562649|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
163049212|NCT05404711|588887055|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
163049213|NCT05404711|588887055|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
163049214|NCT05404711|588887055|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
163049215|NCT05404711|588887055|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
163049216|NCT05404711|588887055|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
163049217|NCT00325819|588887056|FG000|Overall Study|Study product lost in mail|2|||
163049218|NCT00325819|588887057|FG001|Overall Study|Study product lost in mail|1|||
163304502|NCT02891915|589821906|FG001|Overall Study|Became Ineligible After Enrollment|1|||
163304503|NCT02891915|589821905|FG000|Overall Study|Lost to Follow-up|1|||
163304504|NCT02891915|589821906|FG001|Overall Study|Lost to Follow-up|4|||
163304505|NCT02891915|589821905|FG000|Overall Study|Physician Decision|1|||
163049219|NCT00325819|588887056|FG000|Overall Study|Did not take a dose of study product|4|||
163049220|NCT00325819|588887057|FG001|Overall Study|Did not take a dose of study product|9|||
163049221|NCT00325819|588887056|FG000|Overall Study|Lost to Follow-up|3|||
163049222|NCT00325819|588887057|FG001|Overall Study|Lost to Follow-up|3|||
163049223|NCT02346877|588887058|FG000|Overall Study|Adverse Event|1|||
163049224|NCT02346877|588887059|FG001|Overall Study|Adverse Event|0|||
163049225|NCT02346877|588887058|FG000|Overall Study|Administrative Decision|1|||
163049226|NCT02346877|588887059|FG001|Overall Study|Administrative Decision|0|||
163049227|NCT02346877|588887058|FG000|Overall Study|Sponsor Decision|12|||
163049228|NCT02346877|588887059|FG001|Overall Study|Sponsor Decision|0|||
163049229|NCT02346877|588887058|FG000|Overall Study|Missing|5|||
163396331|NCT00382720|590162664|FG001|Overall Study|Surgery|1|||
163396332|NCT00382720|590162665|FG002|Overall Study|Surgery|4|||
163049230|NCT02346877|588887059|FG001|Overall Study|Missing|0|||
163049231|NCT02481050|588888885|FG000|Overall Study|Adverse Event|1|||
163049232|NCT02481050|588888885|FG000|Overall Study|Disease Progression|47|||
163049233|NCT02481050|588888885|FG000|Overall Study|Withdrawal by Subject|7|||
163049234|NCT02481050|588888885|FG000|Overall Study|Other|3|||
163049235|NCT01548599|588888888|FG000|Overall Study|Lost to Follow-up|0|||
163049236|NCT01548599|588888889|FG001|Overall Study|Lost to Follow-up|1|||
163049237|NCT01548599|588888888|FG000|Overall Study|Withdrawal by Subject|4|||
163049238|NCT01548599|588888889|FG001|Overall Study|Withdrawal by Subject|0|||
163049239|NCT01548599|588888888|FG000|Overall Study|Death|2|||
163049240|NCT01548599|588888889|FG001|Overall Study|Death|1|||
163049241|NCT02188160|588888890|FG000|Overall Study|Adverse Event|1|||
163049242|NCT02188160|588888891|FG001|Overall Study|Adverse Event|0|||
163049243|NCT02188160|588888890|FG000|Overall Study|Use of an excluded medication|0|||
163049244|NCT02188160|588888891|FG001|Overall Study|Use of an excluded medication|1|||
163049245|NCT01022203|588888896|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
163049246|NCT01022203|588888897|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
163049247|NCT01022203|588888896|FG000|Post Treatment Assessment|Physician Decision|2|||
163049248|NCT01022203|588888897|FG001|Post Treatment Assessment|Physician Decision|0|||
163049249|NCT01022203|588888896|FG000|Post Treatment Assessment|Adverse Event|0|||
163049250|NCT01022203|588888897|FG001|Post Treatment Assessment|Adverse Event|2|||
163049251|NCT01022203|588888896|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
163049252|NCT01022203|588888897|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
163049253|NCT03638128|588888898|FG000|Overall Study|Withdrawal by Subject|1|||
163049254|NCT03638128|588888899|FG001|Overall Study|Withdrawal by Subject|7|||
163049255|NCT03638128|588888900|FG002|Overall Study|Withdrawal by Subject|6|||
163049256|NCT03638128|588888898|FG000|Overall Study|Sponsor Decision|15|||
163049257|NCT03638128|588888899|FG001|Overall Study|Sponsor Decision|12|||
162962367|NCT02157974|588562650|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
162962368|NCT00216736|588562652|FG000|Overall Study|Lost to Follow-up|1|||
162962369|NCT00216736|588562653|FG001|Overall Study|Lost to Follow-up|1|||
162962370|NCT00807495|588562654|FG000|Overall Study|Adverse Event|6|||
162962371|NCT00807495|588562655|FG001|Overall Study|Adverse Event|3|||
162962372|NCT00807495|588562656|FG002|Overall Study|Adverse Event|1|||
162962373|NCT00807495|588562657|FG003|Overall Study|Adverse Event|1|||
162962374|NCT00807495|588562658|FG004|Overall Study|Adverse Event|2|||
162962375|NCT00807495|588562654|FG000|Overall Study|Withdrawal by Patient|2|||
162962376|NCT00807495|588562655|FG001|Overall Study|Withdrawal by Patient|0|||
162962377|NCT00807495|588562656|FG002|Overall Study|Withdrawal by Patient|1|||
162962378|NCT00807495|588562657|FG003|Overall Study|Withdrawal by Patient|0|||
162962379|NCT00807495|588562658|FG004|Overall Study|Withdrawal by Patient|0|||
162962380|NCT00807495|588562654|FG000|Overall Study|Reason Not Specified|0|||
162962381|NCT00807495|588562655|FG001|Overall Study|Reason Not Specified|3|||
162962382|NCT00807495|588562656|FG002|Overall Study|Reason Not Specified|2|||
162962383|NCT00807495|588562657|FG003|Overall Study|Reason Not Specified|0|||
162962384|NCT00807495|588562658|FG004|Overall Study|Reason Not Specified|3|||
162962385|NCT00463684|588562663|FG000|Overall Study|Withdrawal by Subject|1|||
162962386|NCT00463684|588562663|FG000|Overall Study|Lost to Follow-up|3|||
162962387|NCT01906372|588562664|FG000|Overall Study|Withdrawal by Subject|2|||
162962388|NCT03629054|588562665|FG000|Period 2 (4 Days)|Not treated|0|||
162962389|NCT03629054|588562666|FG001|Period 2 (4 Days)|Not treated|1|||
162962390|NCT03808376|588562667|FG000|Overall Study|Withdrawal by Subject|10|||
162962391|NCT02462837|588562668|FG000|Overall Study|pt developed hives|1|||
162962392|NCT02462837|588562669|FG001|Overall Study|pt developed hives|0|||
162962393|NCT02462837|588562668|FG000|Overall Study|Withdrawal by Subject|1|||
162962394|NCT02462837|588562669|FG001|Overall Study|Withdrawal by Subject|0|||
162962395|NCT00924638|588562673|FG000|Overall Study|Death|3|||
162962396|NCT00924638|588562674|FG001|Overall Study|Death|2|||
162962397|NCT00924638|588562673|FG000|Overall Study|Lost to Follow-up|1|||
163198763|NCT00923156|589441508|FG002|Overall Study|Lack of Efficacy|1|||
163198764|NCT03137537|589441509|FG000|Overall Study|Adverse Event|0|||
163198765|NCT03137537|589441510|FG001|Overall Study|Adverse Event|1|||
163198766|NCT02465515|589441514|FG000|Overall Study|Investigator site closed|4|||
163198767|NCT02465515|589441515|FG001|Overall Study|Investigator site closed|5|||
163198768|NCT02465515|589441514|FG000|Overall Study|Withdrawal by Subject|74|||
163198769|NCT02465515|589441515|FG001|Overall Study|Withdrawal by Subject|43|||
163198770|NCT02465515|589441514|FG000|Overall Study|Physician Decision|8|||
163198771|NCT02465515|589441515|FG001|Overall Study|Physician Decision|12|||
163198772|NCT02465515|589441514|FG000|Overall Study|Lost to Follow-up|68|||
163198773|NCT02465515|589441515|FG001|Overall Study|Lost to Follow-up|51|||
163198774|NCT00629707|589441516|FG000|Overall Study|Withdrawal by Subject|0|||
163198775|NCT00629707|589441517|FG001|Overall Study|Withdrawal by Subject|1|||
163198776|NCT00629707|589441516|FG000|Overall Study|Physician Decision|0|||
163198777|NCT00629707|589441517|FG001|Overall Study|Physician Decision|1|||
163198778|NCT00453063|589441518|FG000|Overall Study|Adverse Event|1|||
163198779|NCT00453063|589441519|FG001|Overall Study|Adverse Event|2|||
163198780|NCT00453063|589441518|FG000|Overall Study|Withdrawal by Subject|1|||
163198781|NCT00453063|589441519|FG001|Overall Study|Withdrawal by Subject|1|||
163198782|NCT00453063|589441518|FG000|Overall Study|Protocol Violation|1|||
163198783|NCT00453063|589441519|FG001|Overall Study|Protocol Violation|0|||
163198784|NCT01918774|589443146|FG000|Overall Study|Lost prior to first CBTw session|4|||
163198785|NCT01918774|589443146|FG000|Overall Study|Lost to Follow-up|1|||
163198786|NCT03000439|589443149|FG000|Open Label Part 1|Adverse Event|6|||
163198787|NCT03000439|589443150|FG001|Open Label Part 1|Adverse Event|0|||
163198788|NCT03000439|589443151|FG002|Open Label Part 1|Adverse Event|0|||
163198789|NCT03000439|589443152|FG003|Open Label Part 1|Adverse Event|0|||
163198790|NCT03000439|589443149|FG000|Open Label Part 1|Other|2|||
163198791|NCT03000439|589443150|FG001|Open Label Part 1|Other|0|||
163198792|NCT03000439|589443151|FG002|Open Label Part 1|Other|0|||
163198793|NCT03000439|589443152|FG003|Open Label Part 1|Other|0|||
163198794|NCT03000439|589443149|FG000|Open Label Part 1|Insufficient clinical response|16|||
163198795|NCT03000439|589443150|FG001|Open Label Part 1|Insufficient clinical response|0|||
163198796|NCT03000439|589443151|FG002|Open Label Part 1|Insufficient clinical response|0|||
163198797|NCT03000439|589443152|FG003|Open Label Part 1|Insufficient clinical response|0|||
163198798|NCT03000439|589443149|FG000|Open Label Part 2|Other|0|||
163198799|NCT03000439|589443150|FG001|Open Label Part 2|Other|5|||
162962398|NCT00924638|588562674|FG001|Overall Study|Lost to Follow-up|1|||
162962399|NCT00924638|588562673|FG000|Overall Study|Withdrawal by Subject|5|||
162962400|NCT00924638|588562674|FG001|Overall Study|Withdrawal by Subject|7|||
162962401|NCT00924638|588562673|FG000|Overall Study|Physician Decision|3|||
162962402|NCT00924638|588562674|FG001|Overall Study|Physician Decision|3|||
162962403|NCT01316055|588562675|FG000|Overall Study|Lost to Follow-up|1|||
162962404|NCT01316055|588562676|FG001|Overall Study|Lost to Follow-up|0|||
162962405|NCT01316055|588562677|FG002|Overall Study|Lost to Follow-up|0|||
162962406|NCT02679729|588562679|FG000|Overall Study|Lost to Follow-up|0|||
162962407|NCT02679729|588562680|FG001|Overall Study|Lost to Follow-up|1|||
162962408|NCT02679729|588562681|FG002|Overall Study|Lost to Follow-up|0|||
162962409|NCT02679729|588562682|FG003|Overall Study|Lost to Follow-up|0|||
162962410|NCT02679729|588562683|FG004|Overall Study|Lost to Follow-up|1|||
162962411|NCT02679729|588562684|FG005|Overall Study|Lost to Follow-up|0|||
162962412|NCT02679729|588562685|FG006|Overall Study|Lost to Follow-up|0|||
162962413|NCT02679729|588562686|FG007|Overall Study|Lost to Follow-up|0|||
162962414|NCT02679729|588562687|FG008|Overall Study|Lost to Follow-up|0|||
162962415|NCT02679729|588562679|FG000|Overall Study|Participant decision|0|||
162962416|NCT02679729|588562680|FG001|Overall Study|Participant decision|1|||
162962417|NCT02679729|588562681|FG002|Overall Study|Participant decision|0|||
162962418|NCT02679729|588562682|FG003|Overall Study|Participant decision|0|||
162962419|NCT02679729|588562683|FG004|Overall Study|Participant decision|0|||
162962420|NCT02679729|588562684|FG005|Overall Study|Participant decision|0|||
162962421|NCT02679729|588562685|FG006|Overall Study|Participant decision|1|||
162962422|NCT02679729|588562686|FG007|Overall Study|Participant decision|0|||
162962423|NCT02679729|588562687|FG008|Overall Study|Participant decision|0|||
162962424|NCT00748566|588562688|FG000|Overall Study|Adverse Event|49|||
162962425|NCT00748566|588562688|FG000|Overall Study|Death|1|||
162962426|NCT00748566|588562688|FG000|Overall Study|Lack of Efficacy|12|||
162962427|NCT00748566|588562688|FG000|Overall Study|Lost to Follow-up|1|||
162962428|NCT00748566|588562688|FG000|Overall Study|Protocol Violation|13|||
162962429|NCT00748566|588562688|FG000|Overall Study|Withdrawal by Subject|22|||
162962430|NCT00748566|588562688|FG000|Overall Study|Study terminated by sponsor|5|||
162962431|NCT00748566|588562688|FG000|Overall Study|Other|9|||
162962432|NCT00989950|588562689|FG000|Randomized Phase|Protocol Violation|1|||
162962433|NCT00989950|588562690|FG001|Randomized Phase|Protocol Violation|0|||
162962434|NCT00989950|588562691|FG002|Randomized Phase|Protocol Violation|0|||
162962435|NCT00989950|588562692|FG003|Randomized Phase|Protocol Violation|0|||
162962436|NCT00989950|588562689|FG000|Randomized Phase|Adverse Event|0|||
162962437|NCT00989950|588562690|FG001|Randomized Phase|Adverse Event|1|||
162962438|NCT00989950|588562691|FG002|Randomized Phase|Adverse Event|0|||
162962439|NCT00989950|588562692|FG003|Randomized Phase|Adverse Event|0|||
162962440|NCT00624286|588562695|FG000|Overall Study|Protocol Deviation|7|||
162962441|NCT00624286|588562696|FG001|Overall Study|Protocol Deviation|9|||
162962442|NCT00624286|588562695|FG000|Overall Study|Adverse Event|6|||
162962443|NCT00624286|588562696|FG001|Overall Study|Adverse Event|3|||
162962444|NCT00624286|588562695|FG000|Overall Study|Withdrawal by Subject|5|||
162962445|NCT00624286|588562696|FG001|Overall Study|Withdrawal by Subject|4|||
162962446|NCT00624286|588562695|FG000|Overall Study|Lost to Follow-up|3|||
162962447|NCT00624286|588562696|FG001|Overall Study|Lost to Follow-up|2|||
162962448|NCT00624286|588562695|FG000|Overall Study|Administrative problems|3|||
162962449|NCT00624286|588562696|FG001|Overall Study|Administrative problems|0|||
162962450|NCT00624286|588562695|FG000|Overall Study|Lack of Efficacy|1|||
162962451|NCT00624286|588562696|FG001|Overall Study|Lack of Efficacy|6|||
162962452|NCT00624286|588562695|FG000|Overall Study|Not stated|0|||
162962453|NCT00624286|588562696|FG001|Overall Study|Not stated|1|||
162962454|NCT00624286|588562695|FG000|Overall Study|Abnormal test procedure result(s)|0|||
162962455|NCT00624286|588562696|FG001|Overall Study|Abnormal test procedure result(s)|1|||
162962456|NCT00624286|588562695|FG000|Overall Study|Death|0|||
162962457|NCT00624286|588562696|FG001|Overall Study|Death|1|||
162962458|NCT02845336|588562700|FG000|Overall Study|Lost to Follow-up|3|||
162962459|NCT02845336|588562701|FG001|Overall Study|Lost to Follow-up|1|||
162962460|NCT02845336|588562700|FG000|Overall Study|Inability to get medication|2|||
162962461|NCT02845336|588562701|FG001|Overall Study|Inability to get medication|0|||
162962462|NCT03488108|588562702|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
162962463|NCT03488108|588562703|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
162962464|NCT03488108|588562702|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
162962465|NCT03488108|588562703|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
162962466|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Refused|1|||
162962467|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Refused|3|||
163049258|NCT03638128|588888900|FG002|Overall Study|Sponsor Decision|19|||
162962468|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Medical|0|||
162962469|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Medical|1|||
162962470|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
162962471|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
162962472|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
162962473|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
162962474|NCT02054715|588562705|FG000|Baseline/Follow-up 1|No Reason|0|||
163304506|NCT02891915|589821906|FG001|Overall Study|Physician Decision|0|||
163304507|NCT00709098|589821907|FG000|Double-blind Period|Withdrawal of consent|3|||
163304508|NCT00709098|589821908|FG001|Double-blind Period|Withdrawal of consent|3|||
162962475|NCT02054715|588562706|FG001|Baseline/Follow-up 1|No Reason|1|||
162962476|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
163304509|NCT00709098|589821909|FG002|Double-blind Period|Withdrawal of consent|0|||
163304510|NCT00709098|589821907|FG000|Double-blind Period|Administrative reason|1|||
163304511|NCT00709098|589821908|FG001|Double-blind Period|Administrative reason|3|||
163304512|NCT00709098|589821909|FG002|Double-blind Period|Administrative reason|0|||
163304513|NCT00709098|589821907|FG000|Double-blind Period|Death|1|||
163304514|NCT00709098|589821908|FG001|Double-blind Period|Death|1|||
163304515|NCT00709098|589821909|FG002|Double-blind Period|Death|0|||
163304516|NCT00709098|589821907|FG000|Double-blind Period|Lost to Follow-up|1|||
163304517|NCT00709098|589821908|FG001|Double-blind Period|Lost to Follow-up|1|||
163304518|NCT00709098|589821909|FG002|Double-blind Period|Lost to Follow-up|0|||
163304519|NCT00709098|589821907|FG000|Open-label Period|Withdrawal of consent|0|||
163304520|NCT00709098|589821908|FG001|Open-label Period|Withdrawal of consent|0|||
163304521|NCT00709098|589821909|FG002|Open-label Period|Withdrawal of consent|7|||
163304522|NCT00709098|589821907|FG000|Open-label Period|Administrative reason|0|||
163304523|NCT00709098|589821908|FG001|Open-label Period|Administrative reason|0|||
163304524|NCT00709098|589821909|FG002|Open-label Period|Administrative reason|5|||
163304525|NCT00709098|589821907|FG000|Open-label Period|Death|0|||
163304526|NCT00709098|589821908|FG001|Open-label Period|Death|0|||
163304527|NCT00709098|589821909|FG002|Open-label Period|Death|1|||
163304528|NCT00709098|589821907|FG000|Open-label Period|Lost to Follow-up|0|||
163304529|NCT00709098|589821908|FG001|Open-label Period|Lost to Follow-up|0|||
163304530|NCT00709098|589821909|FG002|Open-label Period|Lost to Follow-up|1|||
163304531|NCT01037985|589821910|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
163304532|NCT01037985|589821911|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
163304533|NCT01037985|589821910|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
163304534|NCT01037985|589821911|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
163304535|NCT01037985|589821910|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
162962477|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
162962478|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Ineligible|3|||
162962479|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Ineligible|0|||
162962480|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Hospitalization|1|||
162962481|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Hospitalization|0|||
162962482|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Changed Mind|1|||
162962483|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Changed Mind|0|||
162962484|NCT02054715|588562705|FG000|Follow-up 2|Lost to Followup|3|||
162962485|NCT02054715|588562706|FG001|Follow-up 2|Lost to Followup|1|||
162962486|NCT02054715|588562705|FG000|Follow-up 2|Refused|3|||
162962487|NCT02054715|588562706|FG001|Follow-up 2|Refused|2|||
162962488|NCT02054715|588562705|FG000|Follow-up 2|Followup Not Completed|3|||
163304536|NCT01037985|589821911|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
163304537|NCT01037985|589821910|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
163304538|NCT01037985|589821911|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
163304539|NCT00774852|589821915|FG000|Overall Study|Adverse Event|9|||
163049259|NCT03638128|588888898|FG000|Overall Study|Lost to Follow-up|0|||
163049260|NCT03638128|588888899|FG001|Overall Study|Lost to Follow-up|0|||
163049261|NCT03638128|588888900|FG002|Overall Study|Lost to Follow-up|1|||
163049262|NCT03163446|588888901|FG000|Overall Study|Unable to return for Day 180 visit|2|||
163049263|NCT03163446|588888902|FG001|Overall Study|Unable to return for Day 180 visit|0|||
163049264|NCT03163446|588888901|FG000|Overall Study|Withdrawal by Subject|2|||
163049265|NCT03163446|588888902|FG001|Overall Study|Withdrawal by Subject|6|||
163049266|NCT03163446|588888901|FG000|Overall Study|Death|16|||
163304540|NCT00774852|589821916|FG001|Overall Study|Adverse Event|6|||
163304541|NCT00774852|589821915|FG000|Overall Study|Death|2|||
163049267|NCT03163446|588888902|FG001|Overall Study|Death|5|||
163049268|NCT03163446|588888901|FG000|Overall Study|Lost to Follow-up|6|||
163049269|NCT03163446|588888902|FG001|Overall Study|Lost to Follow-up|5|||
163049270|NCT03163446|588888901|FG000|Overall Study|Physician Decision|1|||
163049271|NCT03163446|588888902|FG001|Overall Study|Physician Decision|1|||
163049272|NCT03163446|588888901|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
163049273|NCT03163446|588888902|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
163049274|NCT00611806|588888904|FG000|Overall Study|Withdrawal by Subject|8|||
163304542|NCT00774852|589821916|FG001|Overall Study|Death|1|||
163049275|NCT00611806|588888905|FG001|Overall Study|Withdrawal by Subject|2|||
163049276|NCT00611806|588888904|FG000|Overall Study|Adverse Event|2|||
163396333|NCT00382720|590162663|FG000|Overall Study|Patient did not receive study medication|1|||
163396334|NCT00382720|590162664|FG001|Overall Study|Patient did not receive study medication|1|||
163396335|NCT00382720|590162665|FG002|Overall Study|Patient did not receive study medication|4|||
163396336|NCT00382720|590162663|FG000|Overall Study|Clinically progressive disease|0|||
163049277|NCT00611806|588888905|FG001|Overall Study|Adverse Event|1|||
162962489|NCT02054715|588562706|FG001|Follow-up 2|Followup Not Completed|4|||
163396337|NCT00382720|590162664|FG001|Overall Study|Clinically progressive disease|1|||
162962490|NCT02054715|588562705|FG000|Follow-up 2|Ineligible|4|||
163396338|NCT00382720|590162665|FG002|Overall Study|Clinically progressive disease|0|||
162962491|NCT02054715|588562706|FG001|Follow-up 2|Ineligible|5|||
163304543|NCT00774852|589821915|FG000|Overall Study|Lack of Efficacy|3|||
163304544|NCT00774852|589821916|FG001|Overall Study|Lack of Efficacy|7|||
163304545|NCT00774852|589821915|FG000|Overall Study|Lost to Follow-up|9|||
163304546|NCT00774852|589821916|FG001|Overall Study|Lost to Follow-up|5|||
163304547|NCT00774852|589821915|FG000|Overall Study|Physician Decision|2|||
163304548|NCT00774852|589821916|FG001|Overall Study|Physician Decision|6|||
163304549|NCT00774852|589821915|FG000|Overall Study|Pregnancy|1|||
163304550|NCT00774852|589821916|FG001|Overall Study|Pregnancy|2|||
163304551|NCT00774852|589821915|FG000|Overall Study|Withdrawal by Subject|2|||
163304552|NCT00774852|589821916|FG001|Overall Study|Withdrawal by Subject|2|||
162962492|NCT02054715|588562705|FG000|Follow-up 2|Death|3|||
162962493|NCT02054715|588562706|FG001|Follow-up 2|Death|3|||
162962494|NCT02054715|588562705|FG000|Follow-up 2|Hospitalization|0|||
162962495|NCT02054715|588562706|FG001|Follow-up 2|Hospitalization|2|||
162962496|NCT02054715|588562705|FG000|Follow-up 2|Changed MD/Facility|0|||
162962497|NCT02054715|588562706|FG001|Follow-up 2|Changed MD/Facility|1|||
162962498|NCT02054715|588562705|FG000|Follow-up 2|Changed Mind|0|||
162962499|NCT02054715|588562706|FG001|Follow-up 2|Changed Mind|1|||
162962500|NCT02054715|588562705|FG000|Follow-up 2|No Reason|2|||
162962501|NCT02054715|588562706|FG001|Follow-up 2|No Reason|0|||
162962502|NCT02054715|588562705|FG000|Follow-up 2|Treatment Change or Delay|1|||
162962503|NCT02054715|588562706|FG001|Follow-up 2|Treatment Change or Delay|0|||
162962504|NCT01442376|588562711|FG000|Overall Study|Adverse Event|0|||
162962505|NCT01442376|588562712|FG001|Overall Study|Adverse Event|3|||
162962506|NCT01442376|588562713|FG002|Overall Study|Adverse Event|2|||
162962507|NCT01442376|588562711|FG000|Overall Study|Death|0|||
162962508|NCT01442376|588562712|FG001|Overall Study|Death|1|||
162962509|NCT01442376|588562713|FG002|Overall Study|Death|1|||
162962510|NCT01442376|588562711|FG000|Overall Study|Withdrawal of consent|0|||
162962511|NCT01442376|588562712|FG001|Overall Study|Withdrawal of consent|0|||
162962512|NCT01442376|588562713|FG002|Overall Study|Withdrawal of consent|1|||
162962513|NCT01442376|588562711|FG000|Overall Study|Patients not treated|2|||
162962514|NCT01442376|588562712|FG001|Overall Study|Patients not treated|3|||
162962515|NCT01442376|588562713|FG002|Overall Study|Patients not treated|1|||
162962516|NCT01442376|588562711|FG000|Overall Study|Not eligible for subsequent cycles|1|||
162962517|NCT01442376|588562712|FG001|Overall Study|Not eligible for subsequent cycles|2|||
162962518|NCT01442376|588562713|FG002|Overall Study|Not eligible for subsequent cycles|0|||
162962519|NCT04404725|588562714|FG000|First Intervention|Withdrawal by Subject|0|||
162962520|NCT04404725|588562715|FG001|First Intervention|Withdrawal by Subject|2|||
163304553|NCT00774852|589821915|FG000|Overall Study|Non-responder|15|||
163304554|NCT00774852|589821916|FG001|Overall Study|Non-responder|11|||
163304555|NCT00774852|589821915|FG000|Overall Study|Subject non-compliance|0|||
162962521|NCT04404725|588562714|FG000|Second Intervention|Adverse Event|1|||
162962522|NCT04404725|588562715|FG001|Second Intervention|Adverse Event|1|||
162962523|NCT04404725|588562714|FG000|Second Intervention|Withdrawal by Subject|0|||
162962524|NCT04404725|588562715|FG001|Second Intervention|Withdrawal by Subject|1|||
162962525|NCT01075516|588562716|FG000|Overall Study|Death|5|||
162962526|NCT01075516|588562717|FG001|Overall Study|Death|9|||
162962527|NCT01075516|588562716|FG000|Overall Study|Lost to Follow-up|10|||
162962528|NCT01075516|588562717|FG001|Overall Study|Lost to Follow-up|2|||
162962529|NCT01075516|588562716|FG000|Overall Study|Withdrawal by Subject|3|||
163049278|NCT00611806|588888904|FG000|Overall Study|Lost to Follow-up|6|||
163049279|NCT00611806|588888905|FG001|Overall Study|Lost to Follow-up|0|||
163049280|NCT00903201|588888906|FG000|Overall Study|Adverse Event|1|||
163049281|NCT00903201|588888907|FG001|Overall Study|Adverse Event|4|||
163049282|NCT00903201|588888908|FG002|Overall Study|Adverse Event|0|||
163049283|NCT00903201|588888906|FG000|Overall Study|Protocol Violation|2|||
163049284|NCT00903201|588888907|FG001|Overall Study|Protocol Violation|1|||
163049285|NCT00903201|588888908|FG002|Overall Study|Protocol Violation|0|||
163049286|NCT00903201|588888906|FG000|Overall Study|Lost to Follow-up|0|||
163049287|NCT00903201|588888907|FG001|Overall Study|Lost to Follow-up|1|||
163049288|NCT00903201|588888908|FG002|Overall Study|Lost to Follow-up|0|||
163049289|NCT00903201|588888906|FG000|Overall Study|Physician Decision|1|||
163049290|NCT00903201|588888907|FG001|Overall Study|Physician Decision|0|||
163049291|NCT00903201|588888908|FG002|Overall Study|Physician Decision|1|||
163049292|NCT00903201|588888906|FG000|Overall Study|Withdrawal by Subject|1|||
163049293|NCT00903201|588888907|FG001|Overall Study|Withdrawal by Subject|0|||
163049294|NCT00903201|588888908|FG002|Overall Study|Withdrawal by Subject|1|||
163049295|NCT01094288|588888911|FG000|Overall Study|Adverse Event|0|||
163049296|NCT01094288|588888912|FG001|Overall Study|Adverse Event|3|||
163049297|NCT01094288|588888913|FG002|Overall Study|Adverse Event|1|||
163049298|NCT01094288|588888914|FG003|Overall Study|Adverse Event|1|||
163049299|NCT01094288|588888915|FG004|Overall Study|Adverse Event|0|||
163049300|NCT01094288|588888916|FG005|Overall Study|Adverse Event|0|||
163049301|NCT01094288|588888917|FG006|Overall Study|Adverse Event|0|||
163049302|NCT01094288|588888918|FG007|Overall Study|Adverse Event|0|||
163049303|NCT01094288|588888911|FG000|Overall Study|Withdrawal by Subject|0|||
163049304|NCT01094288|588888912|FG001|Overall Study|Withdrawal by Subject|1|||
163049305|NCT01094288|588888913|FG002|Overall Study|Withdrawal by Subject|2|||
163049306|NCT01094288|588888914|FG003|Overall Study|Withdrawal by Subject|0|||
163049307|NCT01094288|588888915|FG004|Overall Study|Withdrawal by Subject|0|||
163049308|NCT01094288|588888916|FG005|Overall Study|Withdrawal by Subject|0|||
163049309|NCT01094288|588888917|FG006|Overall Study|Withdrawal by Subject|0|||
163049310|NCT01094288|588888918|FG007|Overall Study|Withdrawal by Subject|2|||
163049311|NCT01094288|588888911|FG000|Overall Study|Initiation of Alternative Therapy|0|||
163049312|NCT01094288|588888912|FG001|Overall Study|Initiation of Alternative Therapy|0|||
163049313|NCT01094288|588888913|FG002|Overall Study|Initiation of Alternative Therapy|1|||
163049314|NCT01094288|588888914|FG003|Overall Study|Initiation of Alternative Therapy|0|||
163049315|NCT01094288|588888915|FG004|Overall Study|Initiation of Alternative Therapy|0|||
163049316|NCT01094288|588888916|FG005|Overall Study|Initiation of Alternative Therapy|0|||
163049317|NCT01094288|588888917|FG006|Overall Study|Initiation of Alternative Therapy|0|||
163049318|NCT01094288|588888918|FG007|Overall Study|Initiation of Alternative Therapy|0|||
163049319|NCT01094288|588888911|FG000|Overall Study|Reason not Specified|2|||
163049320|NCT01094288|588888912|FG001|Overall Study|Reason not Specified|3|||
163049321|NCT01094288|588888913|FG002|Overall Study|Reason not Specified|0|||
163049322|NCT01094288|588888914|FG003|Overall Study|Reason not Specified|1|||
163049323|NCT01094288|588888915|FG004|Overall Study|Reason not Specified|0|||
163049324|NCT01094288|588888916|FG005|Overall Study|Reason not Specified|0|||
163049325|NCT01094288|588888917|FG006|Overall Study|Reason not Specified|0|||
163049326|NCT01094288|588888918|FG007|Overall Study|Reason not Specified|0|||
163049327|NCT01094288|588888911|FG000|Overall Study|Ongoing Participants|0|||
163049328|NCT01094288|588888912|FG001|Overall Study|Ongoing Participants|3|||
163198800|NCT03000439|589443151|FG002|Open Label Part 2|Other|0|||
163198801|NCT03000439|589443152|FG003|Open Label Part 2|Other|0|||
163198802|NCT03000439|589443149|FG000|Open Label Part 2|Insufficient clinical response|0|||
163198803|NCT03000439|589443150|FG001|Open Label Part 2|Insufficient clinical response|12|||
163198804|NCT03000439|589443151|FG002|Open Label Part 2|Insufficient clinical response|0|||
163198805|NCT03000439|589443152|FG003|Open Label Part 2|Insufficient clinical response|0|||
163198806|NCT03000439|589443149|FG000|Double Blind Phase|Adverse Event|0|||
163198807|NCT03000439|589443150|FG001|Double Blind Phase|Adverse Event|0|||
163198808|NCT03000439|589443151|FG002|Double Blind Phase|Adverse Event|2|||
163198809|NCT03000439|589443152|FG003|Double Blind Phase|Adverse Event|1|||
163049329|NCT01094288|588888913|FG002|Overall Study|Ongoing Participants|0|||
163049330|NCT01094288|588888914|FG003|Overall Study|Ongoing Participants|0|||
163198810|NCT03000439|589443149|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
163049331|NCT01094288|588888915|FG004|Overall Study|Ongoing Participants|0|||
163049332|NCT01094288|588888916|FG005|Overall Study|Ongoing Participants|0|||
163198811|NCT03000439|589443150|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
163198812|NCT03000439|589443151|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
163049333|NCT01094288|588888917|FG006|Overall Study|Ongoing Participants|0|||
163049334|NCT01094288|588888918|FG007|Overall Study|Ongoing Participants|0|||
163049335|NCT00945243|588888919|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
163049336|NCT00754741|588888920|FG000|Overall Study|Died or disenrolled|57|||
163049337|NCT00754741|588888921|FG001|Overall Study|Died or disenrolled|69|||
163049338|NCT00754741|588888922|FG002|Overall Study|Died or disenrolled|54|||
163049339|NCT04152200|588888923|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
163049340|NCT04152200|588888924|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
163049341|NCT04969289|588888925|FG000|Overall Study|Lost to Follow-up|13|||
163049342|NCT04969289|588888926|FG001|Overall Study|Lost to Follow-up|9|||
163049343|NCT02699996|588888927|FG000|Overall Study|Withdrawal by Subject|5|||
163049344|NCT02699996|588888928|FG001|Overall Study|Withdrawal by Subject|2|||
163049345|NCT04069715|588888929|FG000|Overall Study|Lost to Follow-up|1|||
163049346|NCT04069715|588888930|FG001|Overall Study|Lost to Follow-up|1|||
163049347|NCT04069715|588888929|FG000|Overall Study|Physician Decision|1|||
163049348|NCT04069715|588888930|FG001|Overall Study|Physician Decision|1|||
163049349|NCT04069715|588888929|FG000|Overall Study|Withdrawal by Subject|3|||
163049350|NCT04069715|588888930|FG001|Overall Study|Withdrawal by Subject|3|||
163049351|NCT02486692|588888933|FG000|Overall Study|did not login for randomization|4|||
163049352|NCT02486692|588888934|FG001|Overall Study|did not login for randomization|7|||
163049353|NCT02063672|588888935|FG000|Overall Study|Ongoing Follow-up|27|||
163049354|NCT02063672|588888936|FG001|Overall Study|Ongoing Follow-up|14|||
163049355|NCT02063672|588888935|FG000|Overall Study|Death|5|||
163049356|NCT02063672|588888936|FG001|Overall Study|Death|3|||
163049357|NCT02063672|588888935|FG000|Overall Study|Lost to Follow-up|1|||
163049358|NCT02063672|588888936|FG001|Overall Study|Lost to Follow-up|3|||
163049359|NCT02063672|588888935|FG000|Overall Study|Withdrawal by Subject|2|||
163049360|NCT02063672|588888936|FG001|Overall Study|Withdrawal by Subject|2|||
163049361|NCT01294423|588888938|FG000|Overall Study|Adverse Event|1|||
163049362|NCT01294423|588888939|FG001|Overall Study|Adverse Event|2|||
163049363|NCT01294423|588888940|FG002|Overall Study|Adverse Event|3|||
163049364|NCT01294423|588888938|FG000|Overall Study|Withdrawal by Subject|1|||
163049365|NCT01294423|588888939|FG001|Overall Study|Withdrawal by Subject|2|||
163049366|NCT01294423|588888940|FG002|Overall Study|Withdrawal by Subject|2|||
163049367|NCT01294423|588888938|FG000|Overall Study|subject no longer meets study criteria|2|||
163049368|NCT01294423|588888939|FG001|Overall Study|subject no longer meets study criteria|5|||
163304556|NCT00774852|589821916|FG001|Overall Study|Subject non-compliance|1|||
163304557|NCT00774852|589821915|FG000|Overall Study|Protocol Violation|1|||
163049369|NCT01294423|588888940|FG002|Overall Study|subject no longer meets study criteria|2|||
163049370|NCT01294423|588888938|FG000|Overall Study|poor/non-compliance|1|||
163049371|NCT01294423|588888939|FG001|Overall Study|poor/non-compliance|0|||
163049372|NCT01294423|588888940|FG002|Overall Study|poor/non-compliance|1|||
163304558|NCT00774852|589821916|FG001|Overall Study|Protocol Violation|0|||
163304559|NCT00774852|589821915|FG000|Overall Study|Subject received prohibited medication|1|||
163049373|NCT01241279|588888941|FG000|Overall Study|Lost to Follow-up|0|||
163049374|NCT01241279|588888942|FG001|Overall Study|Lost to Follow-up|1|||
163049375|NCT01484951|588888943|FG000|Overall Study|Adverse Event|3|||
163049376|NCT01484951|588888943|FG000|Overall Study|Personal Reasons|1|||
163049377|NCT01484951|588888943|FG000|Overall Study|Non-Compliance|1|||
163049378|NCT02026141|588888945|FG000|Overall Study|Protocol Violation|0|||
163049379|NCT02026141|588888946|FG001|Overall Study|Protocol Violation|1|||
163049380|NCT02169505|588888947|FG000|Overall Study|Withdrawal by Subject|1|||
163049381|NCT01248455|588888948|FG000|Overall Study|switched to alternate treatment|1|||
163049382|NCT02735980|588888949|FG000|Overall Study|Adverse Event|0|||
163049383|NCT02735980|588888950|FG001|Overall Study|Adverse Event|4|||
163049384|NCT02735980|588888951|FG002|Overall Study|Adverse Event|1|||
163049385|NCT02735980|588888949|FG000|Overall Study|Death|5|||
163049386|NCT02735980|588888950|FG001|Overall Study|Death|4|||
163304560|NCT00774852|589821916|FG001|Overall Study|Subject received prohibited medication|0|||
163304561|NCT04428112|589821917|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
163304562|NCT04428112|589821918|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
163304563|NCT04428112|589821917|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
163304564|NCT04428112|589821918|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
163304565|NCT04428112|589821917|FG000|Overall Study|Withdrawal by Subject|9|||
163049387|NCT02735980|588888951|FG002|Overall Study|Death|0|||
163049388|NCT02735980|588888949|FG000|Overall Study|Physician Decision|3|||
163049389|NCT02735980|588888950|FG001|Overall Study|Physician Decision|1|||
163049390|NCT02735980|588888951|FG002|Overall Study|Physician Decision|0|||
163049391|NCT02735980|588888949|FG000|Overall Study|Screen failure|1|||
163304566|NCT04428112|589821918|FG001|Overall Study|Withdrawal by Subject|4|||
163304567|NCT04428112|589821917|FG000|Overall Study|Lost to Follow-up|27|||
163304568|NCT04428112|589821918|FG001|Overall Study|Lost to Follow-up|7|||
163304569|NCT04924062|589823782|FG000|Overall Study|Death|49|||
163049392|NCT02735980|588888950|FG001|Overall Study|Screen failure|0|||
163304570|NCT04924062|589823783|FG001|Overall Study|Death|63|||
163304571|NCT04924062|589823782|FG000|Overall Study|Participant On-going|26|||
163304572|NCT04924062|589823783|FG001|Overall Study|Participant On-going|20|||
163304573|NCT05478525|589823786|FG000|Overall Study|Withdrawal by Subject|0|||
163304574|NCT05478525|589823787|FG001|Overall Study|Withdrawal by Subject|1|||
163304575|NCT05478525|589823788|FG002|Overall Study|Withdrawal by Subject|2|||
163304576|NCT05478525|589823789|FG003|Overall Study|Withdrawal by Subject|0|||
163304577|NCT05478525|589823786|FG000|Overall Study|COVID-19 Infection|2|||
163304578|NCT05478525|589823787|FG001|Overall Study|COVID-19 Infection|0|||
163304579|NCT05478525|589823788|FG002|Overall Study|COVID-19 Infection|1|||
163304580|NCT05478525|589823789|FG003|Overall Study|COVID-19 Infection|1|||
163304581|NCT01649271|589823790|FG000|Overall Study|Progressive disease|4|||
163304582|NCT01649271|589823791|FG001|Overall Study|Progressive disease|5|||
163304583|NCT01649271|589823790|FG000|Overall Study|Other Adverse Event|0|||
163304584|NCT01649271|589823791|FG001|Overall Study|Other Adverse Event|2|||
163304585|NCT01649271|589823790|FG000|Overall Study|Withdrawal by Subject|1|||
163304586|NCT01649271|589823791|FG001|Overall Study|Withdrawal by Subject|0|||
163304587|NCT01649271|589823790|FG000|Overall Study|Other than stated above|1|||
163304588|NCT01649271|589823791|FG001|Overall Study|Other than stated above|0|||
163304589|NCT01991977|589823792|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
163304590|NCT01991977|589823792|FG000|Overall Study|Withdrew after start of treatment|5|||
163304591|NCT04038957|589823794|FG000|Overall Study|Withdrawal by Subject|1|||
163304592|NCT04038957|589823794|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
163304593|NCT02605837|589823796|FG000|Overall Study|Adverse Event|3|||
163304594|NCT02605837|589823797|FG001|Overall Study|Adverse Event|1|||
163304595|NCT02605837|589823796|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163304596|NCT02605837|589823797|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163304597|NCT02605837|589823796|FG000|Overall Study|Withdrawal by Subject|8|||
163304598|NCT02605837|589823797|FG001|Overall Study|Withdrawal by Subject|8|||
163304599|NCT02605837|589823796|FG000|Overall Study|Physician Decision|0|||
163304600|NCT02605837|589823797|FG001|Overall Study|Physician Decision|1|||
163304601|NCT03845465|589823798|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
163304602|NCT03845465|589823799|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
163304603|NCT03845465|589823798|FG000|6-month Data Collection|Withdrawal by Subject|0|||
163304604|NCT03845465|589823799|FG001|6-month Data Collection|Withdrawal by Subject|2|||
163304605|NCT03845465|589823798|FG000|12-month Data Collection|Withdrawal by Subject|0|||
163304606|NCT03845465|589823799|FG001|12-month Data Collection|Withdrawal by Subject|2|||
163304607|NCT05656911|589823804|FG000|Treatment Phase|Physician Decision|2|||
163304608|NCT05656911|589823805|FG001|Treatment Phase|Physician Decision|0|||
163304609|NCT05656911|589823804|FG000|Treatment Phase|Lack of Efficacy|6|||
163304610|NCT05656911|589823805|FG001|Treatment Phase|Lack of Efficacy|3|||
163304611|NCT05656911|589823804|FG000|Treatment Phase|Subject Decision|4|||
163304612|NCT05656911|589823805|FG001|Treatment Phase|Subject Decision|2|||
163304613|NCT05656911|589823804|FG000|Treatment Phase|Other Reasons|1|||
163304614|NCT05656911|589823805|FG001|Treatment Phase|Other Reasons|0|||
163304615|NCT05656911|589823804|FG000|Treatment Phase|Adverse Event|3|||
163304616|NCT05656911|589823805|FG001|Treatment Phase|Adverse Event|1|||
163304617|NCT05656911|589823804|FG000|Follow-up Phase|Subject Decision|0|||
163304618|NCT05656911|589823805|FG001|Follow-up Phase|Subject Decision|1|||
163304619|NCT05656911|589823804|FG000|Follow-up Phase|Missing|1|||
163304620|NCT05656911|589823805|FG001|Follow-up Phase|Missing|0|||
163304621|NCT03547908|589823806|FG000|Blinded Phase|Lost to Follow-up|3|||
163304622|NCT03547908|589823807|FG001|Blinded Phase|Lost to Follow-up|3|||
163304623|NCT03547908|589823808|FG002|Blinded Phase|Lost to Follow-up|0|||
163304624|NCT03547908|589823809|FG003|Blinded Phase|Lost to Follow-up|0|||
163304625|NCT03547908|589823806|FG000|Blinded Phase|Withdrew Consent|2|||
163304626|NCT03547908|589823807|FG001|Blinded Phase|Withdrew Consent|3|||
163304627|NCT03547908|589823808|FG002|Blinded Phase|Withdrew Consent|0|||
163304628|NCT03547908|589823809|FG003|Blinded Phase|Withdrew Consent|0|||
163304629|NCT03547908|589823806|FG000|Blinded Phase|Investigator's Discretion|2|||
163304630|NCT03547908|589823807|FG001|Blinded Phase|Investigator's Discretion|1|||
163304631|NCT03547908|589823808|FG002|Blinded Phase|Investigator's Discretion|0|||
163304632|NCT03547908|589823809|FG003|Blinded Phase|Investigator's Discretion|0|||
163304633|NCT03547908|589823806|FG000|Blinded Phase|Death|2|||
163304634|NCT03547908|589823807|FG001|Blinded Phase|Death|0|||
163304635|NCT03547908|589823808|FG002|Blinded Phase|Death|0|||
163304636|NCT03547908|589823809|FG003|Blinded Phase|Death|0|||
163304637|NCT03547908|589823806|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
163304638|NCT03547908|589823807|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
163304639|NCT03547908|589823808|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
163304640|NCT03547908|589823809|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
163049393|NCT02735980|588888951|FG002|Overall Study|Screen failure|0|||
163304641|NCT03547908|589823806|FG000|Blinded Phase|Adverse Event|1|||
163304642|NCT03547908|589823807|FG001|Blinded Phase|Adverse Event|0|||
163304643|NCT03547908|589823808|FG002|Blinded Phase|Adverse Event|0|||
163304644|NCT03547908|589823809|FG003|Blinded Phase|Adverse Event|0|||
163304645|NCT03547908|589823806|FG000|Blinded Phase|Randomized But Never Treated|1|||
163304646|NCT03547908|589823807|FG001|Blinded Phase|Randomized But Never Treated|0|||
163304647|NCT03547908|589823808|FG002|Blinded Phase|Randomized But Never Treated|0|||
163304648|NCT03547908|589823809|FG003|Blinded Phase|Randomized But Never Treated|0|||
163304649|NCT03547908|589823806|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
163304650|NCT03547908|589823807|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
163049394|NCT02735980|588888949|FG000|Overall Study|Withdrawal by Subject|1|||
163049395|NCT02735980|588888950|FG001|Overall Study|Withdrawal by Subject|2|||
163049396|NCT02735980|588888951|FG002|Overall Study|Withdrawal by Subject|0|||
163304651|NCT03547908|589823808|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
163304652|NCT03547908|589823809|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
163304653|NCT03547908|589823806|FG000|Open-label Extension Phase|Death|0|||
163304654|NCT03547908|589823807|FG001|Open-label Extension Phase|Death|0|||
163304655|NCT03547908|589823808|FG002|Open-label Extension Phase|Death|1|||
163304656|NCT03547908|589823809|FG003|Open-label Extension Phase|Death|0|||
163304657|NCT04059354|589823816|FG000|Overall Study|COVID-19 pandemic|3|||
163304658|NCT02349412|589823817|FG000|Overall Study|Withdrawal by Subject|7|||
163304659|NCT02349412|589823818|FG001|Overall Study|Withdrawal by Subject|7|||
163304660|NCT00567398|589823819|FG000|Overall Study|Adverse Event|6|||
163304661|NCT00567398|589823820|FG001|Overall Study|Adverse Event|14|||
163049397|NCT00917124|588888955|FG000|Overall Study|Protocol Violation|4|||
163049398|NCT00917124|588888956|FG001|Overall Study|Protocol Violation|6|||
163049399|NCT01783743|588888957|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
163049400|NCT01783743|588888958|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
163049401|NCT01783743|588888957|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
163049402|NCT01783743|588888958|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
163049403|NCT01783743|588888957|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
163049404|NCT01783743|588888958|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
163049405|NCT00126594|588888973|FG000|Overall Study|Ineligible|2|||
163049406|NCT00126594|588888974|FG001|Overall Study|Ineligible|0|||
163049407|NCT00126594|588888973|FG000|Overall Study|Withdrawal by Subject|0|||
163049408|NCT00126594|588888974|FG001|Overall Study|Withdrawal by Subject|4|||
163049409|NCT00126594|588888973|FG000|Overall Study|Physician Decision|1|||
163049410|NCT00126594|588888974|FG001|Overall Study|Physician Decision|3|||
163049411|NCT00126594|588888973|FG000|Overall Study|Adverse Event|7|||
163049412|NCT00126594|588888974|FG001|Overall Study|Adverse Event|5|||
163049413|NCT00126594|588888973|FG000|Overall Study|Non-compliance|0|||
163049414|NCT00126594|588888974|FG001|Overall Study|Non-compliance|1|||
163049415|NCT00126594|588888973|FG000|Overall Study|Disease Progression|29|||
163049416|NCT00126594|588888974|FG001|Overall Study|Disease Progression|24|||
163049417|NCT00983372|588888975|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
163049418|NCT00983372|588888975|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
163049419|NCT00983372|588888975|FG000|Diltiazem ER Alone|Adverse Event|1|||
163049420|NCT05635045|588888976|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
163049421|NCT05635045|588888977|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
163049422|NCT05635045|588888978|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
163049423|NCT05635045|588888979|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
163049424|NCT01585246|588888995|FG000|Overall Study|Lost to Follow-up|0|||
163049425|NCT01585246|588888996|FG001|Overall Study|Lost to Follow-up|0|||
163049426|NCT01585246|588888997|FG002|Overall Study|Lost to Follow-up|2|||
163049427|NCT01585246|588888998|FG003|Overall Study|Lost to Follow-up|1|||
163049428|NCT01585246|588888999|FG004|Overall Study|Lost to Follow-up|0|||
163049429|NCT01585246|588888995|FG000|Overall Study|Protocol Violation|0|||
163049430|NCT01585246|588888996|FG001|Overall Study|Protocol Violation|0|||
163049431|NCT01585246|588888997|FG002|Overall Study|Protocol Violation|0|||
163049432|NCT01585246|588888998|FG003|Overall Study|Protocol Violation|0|||
163304662|NCT00567398|589823819|FG000|Overall Study|Physician Decision|0|||
163304663|NCT00567398|589823820|FG001|Overall Study|Physician Decision|4|||
163304664|NCT00567398|589823819|FG000|Overall Study|Withdrawal by Subject|0|||
163396339|NCT00382720|590162663|FG000|Overall Study|Good prognosis|0|||
163396340|NCT00382720|590162664|FG001|Overall Study|Good prognosis|1|||
163396341|NCT00382720|590162665|FG002|Overall Study|Good prognosis|0|||
163396342|NCT00382720|590162663|FG000|Overall Study|Investigator/Clinical decision|5|||
163396343|NCT00382720|590162664|FG001|Overall Study|Investigator/Clinical decision|6|||
163396344|NCT00382720|590162665|FG002|Overall Study|Investigator/Clinical decision|6|||
163396345|NCT00382720|590162663|FG000|Overall Study|Discontinued at end of study|0|||
163396346|NCT00382720|590162664|FG001|Overall Study|Discontinued at end of study|1|||
163396347|NCT00382720|590162665|FG002|Overall Study|Discontinued at end of study|2|||
163396348|NCT02737852|590162668|FG000|Overall Study|Withdrawal by Subject|2|||
163049433|NCT01585246|588888999|FG004|Overall Study|Protocol Violation|1|||
163049434|NCT01585246|588888995|FG000|Overall Study|Withdrawal by Subject|0|||
163049435|NCT01585246|588888996|FG001|Overall Study|Withdrawal by Subject|0|||
163049436|NCT01585246|588888997|FG002|Overall Study|Withdrawal by Subject|1|||
163049437|NCT01585246|588888998|FG003|Overall Study|Withdrawal by Subject|2|||
163049438|NCT01585246|588888999|FG004|Overall Study|Withdrawal by Subject|1|||
163049439|NCT01585246|588888995|FG000|Overall Study|Other|0|||
163049440|NCT01585246|588888996|FG001|Overall Study|Other|1|||
163049441|NCT01585246|588888997|FG002|Overall Study|Other|1|||
163049442|NCT01585246|588888998|FG003|Overall Study|Other|1|||
163049443|NCT01585246|588888999|FG004|Overall Study|Other|0|||
163049444|NCT04396626|588889000|FG000|Overall Study|Premature termination of study|975|||
163396349|NCT03688880|590162669|FG000|Overall Study|Withdrawal by Subject|0|||
163396350|NCT03688880|590162670|FG001|Overall Study|Withdrawal by Subject|2|||
163396351|NCT03688880|590162669|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
163396352|NCT03688880|590162670|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
163396353|NCT03688880|590162669|FG000|Overall Study|Lost to Follow-up|4|||
163396354|NCT03688880|590162670|FG001|Overall Study|Lost to Follow-up|7|||
163396355|NCT03688880|590162669|FG000|Overall Study|Adverse Event|0|||
163396356|NCT03688880|590162670|FG001|Overall Study|Adverse Event|2|||
163049445|NCT02111174|588889001|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
163396357|NCT03688880|590162669|FG000|Overall Study|Device deficiencies|0|||
163396358|NCT03688880|590162670|FG001|Overall Study|Device deficiencies|2|||
163396359|NCT03688880|590162669|FG000|Overall Study|Other|10|||
163396360|NCT03688880|590162670|FG001|Overall Study|Other|16|||
163396361|NCT01183143|590162671|FG000|Overall Study|Protocol Violation|115|||
163396362|NCT01183143|590162671|FG000|Overall Study|Withdrawal by Subject|19|||
163396363|NCT01183143|590162671|FG000|Overall Study|Subject Questionnaires not returned|5|||
163396364|NCT01183143|590162671|FG000|Overall Study|Subjects enrolled, but not treated|11|||
163049446|NCT02111174|588889002|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
163049447|NCT02111174|588889001|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
163396365|NCT01704287|590162673|FG000|Initial Treatment Period|Death|139|||
163396366|NCT01704287|590162674|FG001|Initial Treatment Period|Death|129|||
163396367|NCT01704287|590162675|FG002|Initial Treatment Period|Death|71|||
163396368|NCT01704287|590162676|FG003|Initial Treatment Period|Death|0|||
163396369|NCT01704287|590162677|FG004|Initial Treatment Period|Death|0|||
163396370|NCT01704287|590162673|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
163396371|NCT01704287|590162674|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
163396372|NCT01704287|590162675|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
163396373|NCT01704287|590162676|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
163396374|NCT01704287|590162677|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
163396375|NCT01704287|590162673|FG000|Initial Treatment Period|Lost to Follow-up|5|||
163396376|NCT01704287|590162674|FG001|Initial Treatment Period|Lost to Follow-up|3|||
163396377|NCT01704287|590162675|FG002|Initial Treatment Period|Lost to Follow-up|0|||
163396378|NCT01704287|590162676|FG003|Initial Treatment Period|Lost to Follow-up|0|||
163396379|NCT01704287|590162677|FG004|Initial Treatment Period|Lost to Follow-up|0|||
163396380|NCT01704287|590162673|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
163396381|NCT01704287|590162674|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
163396382|NCT01704287|590162675|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
163396383|NCT01704287|590162676|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
163396384|NCT01704287|590162677|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
163396385|NCT01704287|590162673|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
163396386|NCT01704287|590162674|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
163304665|NCT00567398|589823820|FG001|Overall Study|Withdrawal by Subject|2|||
163304666|NCT00567398|589823819|FG000|Overall Study|Renal Transplantation|0|||
162962530|NCT01075516|588562717|FG001|Overall Study|Withdrawal by Subject|5|||
162962531|NCT02252016|588562718|FG000|Overall Study|Lost to Follow-up|2|||
162962532|NCT02252016|588562719|FG001|Overall Study|Lost to Follow-up|1|||
163304667|NCT00567398|589823820|FG001|Overall Study|Renal Transplantation|3|||
163304668|NCT00567398|589823819|FG000|Overall Study|Other|1|||
162962533|NCT02252016|588562718|FG000|Overall Study|Physician Decision|1|||
162962534|NCT02252016|588562719|FG001|Overall Study|Physician Decision|0|||
162962535|NCT02252016|588562718|FG000|Overall Study|Withdrawal by Subject|0|||
162962536|NCT02252016|588562719|FG001|Overall Study|Withdrawal by Subject|2|||
162962537|NCT00674128|588562720|FG000|Overall Study|Withdrawal by Subject|25|||
162962538|NCT00674128|588562721|FG001|Overall Study|Withdrawal by Subject|23|||
162962539|NCT01825798|588562724|FG000|Overall Study|Adverse Event|1|||
162962540|NCT01825798|588562725|FG001|Overall Study|Adverse Event|5|||
162962541|NCT01825798|588562724|FG000|Overall Study|Lost to Follow-up|1|||
162962542|NCT01825798|588562725|FG001|Overall Study|Lost to Follow-up|0|||
162962543|NCT01559363|588562731|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
162962544|NCT01559363|588562732|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
162962545|NCT01559363|588562733|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
162962546|NCT01559363|588562734|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
162962547|NCT01559363|588562735|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
162962548|NCT01559363|588562736|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
162962549|NCT01559363|588562731|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
162962550|NCT01559363|588562732|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
162962551|NCT01559363|588562733|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
162962552|NCT01559363|588562734|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
162962553|NCT01559363|588562735|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
162962554|NCT01559363|588562736|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
162962555|NCT01559363|588562731|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
162962556|NCT01559363|588562732|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
162962557|NCT01559363|588562733|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
162962558|NCT01559363|588562734|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
162962559|NCT01559363|588562735|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
162962560|NCT01559363|588562736|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
162962561|NCT01559363|588562731|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
162962562|NCT01559363|588562732|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
162962563|NCT01559363|588562733|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
162962564|NCT01559363|588562734|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
162962565|NCT01559363|588562735|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
162962566|NCT01559363|588562736|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
162962567|NCT01559363|588562731|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
162962568|NCT01559363|588562732|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
162962569|NCT01559363|588562733|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
163304669|NCT00567398|589823820|FG001|Overall Study|Other|0|||
162962570|NCT01559363|588562734|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
162962571|NCT01559363|588562735|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
162962572|NCT01559363|588562736|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
162962573|NCT01559363|588562731|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
163049448|NCT02111174|588889002|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
163049449|NCT02111174|588889001|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
163049450|NCT02111174|588889002|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
163049451|NCT02111174|588889001|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
163049452|NCT02111174|588889002|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
163049453|NCT01657162|588889003|FG000|Overall Study|Adverse Event|26|||
163049454|NCT01657162|588889004|FG001|Overall Study|Adverse Event|36|||
163049455|NCT01657162|588889003|FG000|Overall Study|Withdrawal by Subject|13|||
163049456|NCT01657162|588889004|FG001|Overall Study|Withdrawal by Subject|13|||
163049457|NCT01657162|588889003|FG000|Overall Study|Continuing Significant Deterioration|9|||
163396387|NCT01704287|590162675|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
163049458|NCT01657162|588889004|FG001|Overall Study|Continuing Significant Deterioration|3|||
163049459|NCT01657162|588889003|FG000|Overall Study|Refusal of Treatment|4|||
163049460|NCT01657162|588889004|FG001|Overall Study|Refusal of Treatment|6|||
163396388|NCT01704287|590162676|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
163198813|NCT03000439|589443152|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
163198814|NCT03000439|589443149|FG000|Double Blind Phase|Other|0|||
163198815|NCT03000439|589443150|FG001|Double Blind Phase|Other|0|||
163198816|NCT03000439|589443151|FG002|Double Blind Phase|Other|10|||
163198817|NCT03000439|589443152|FG003|Double Blind Phase|Other|11|||
163198818|NCT03000439|589443149|FG000|Double Blind Phase|Insufficient clinical response|0|||
163198819|NCT03000439|589443150|FG001|Double Blind Phase|Insufficient clinical response|0|||
163198820|NCT03000439|589443151|FG002|Double Blind Phase|Insufficient clinical response|0|||
163198821|NCT03000439|589443152|FG003|Double Blind Phase|Insufficient clinical response|2|||
163198822|NCT01389817|589443155|FG000|Overall Study|Physician Decision|1|||
163198823|NCT01389817|589443156|FG001|Overall Study|Physician Decision|0|||
163198824|NCT01389817|589443155|FG000|Overall Study|Lost to Follow-up|1|||
163198825|NCT01389817|589443156|FG001|Overall Study|Lost to Follow-up|0|||
163198826|NCT01389817|589443155|FG000|Overall Study|Withdrawal by Subject|2|||
163198827|NCT01389817|589443156|FG001|Overall Study|Withdrawal by Subject|0|||
163198828|NCT01749137|589443157|FG000|Overall Study|Adverse Event|4|||
163198829|NCT01749137|589443158|FG001|Overall Study|Adverse Event|4|||
163198830|NCT01749137|589443157|FG000|Overall Study|Lost to Follow-up|2|||
163198831|NCT01749137|589443158|FG001|Overall Study|Lost to Follow-up|3|||
163198832|NCT01749137|589443157|FG000|Overall Study|Physician Decision|1|||
163198833|NCT01749137|589443158|FG001|Overall Study|Physician Decision|0|||
163198834|NCT01749137|589443157|FG000|Overall Study|Withdrawal by Subject|8|||
163198835|NCT01749137|589443158|FG001|Overall Study|Withdrawal by Subject|4|||
163198836|NCT04980040|589443160|FG000|Overall Study|Violated the Inclusion Criteria|260|||
163198837|NCT04980040|589443160|FG000|Overall Study|Violated the Administration & Dosage|225|||
163049461|NCT01657162|588889003|FG000|Overall Study|Lost to Follow-up|3|||
163049462|NCT01657162|588889004|FG001|Overall Study|Lost to Follow-up|4|||
163198838|NCT04980040|589443160|FG000|Overall Study|Lost to Safety-Follow-up|4|||
163198839|NCT04980040|589443160|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
163198840|NCT03130257|589443161|FG000|Overall Study|Withdrawal by Subject|1|||
163198841|NCT03130257|589443162|FG001|Overall Study|Withdrawal by Subject|0|||
163198842|NCT03130257|589443163|FG002|Overall Study|Withdrawal by Subject|2|||
163198843|NCT01508650|589443164|FG000|Overall Study|Lost to Follow-up|0|||
163049463|NCT01657162|588889003|FG000|Overall Study|Death|2|||
163049464|NCT01657162|588889004|FG001|Overall Study|Death|3|||
163049465|NCT01657162|588889003|FG000|Overall Study|Inability to Complete Study Procedures|1|||
163049466|NCT01657162|588889004|FG001|Overall Study|Inability to Complete Study Procedures|7|||
163049467|NCT01657162|588889003|FG000|Overall Study|Protocol Violation|1|||
163049468|NCT01657162|588889004|FG001|Overall Study|Protocol Violation|0|||
163304670|NCT03517553|589823821|FG000|Overall Study|Withdrawal by Subject|2|||
163304671|NCT03271151|589823822|FG000|Overall Study|Lost to Follow-up|1|||
163304672|NCT03271151|589823823|FG001|Overall Study|Lost to Follow-up|3|||
163304673|NCT03271151|589823822|FG000|Overall Study|Withdrawal by Subject|1|||
163304674|NCT03271151|589823823|FG001|Overall Study|Withdrawal by Subject|0|||
163304675|NCT02201108|589823824|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
163304676|NCT02201108|589823825|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
163304677|NCT02201108|589823826|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
163304678|NCT02201108|589823824|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
163304679|NCT02201108|589823825|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
163304680|NCT02201108|589823826|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
163304681|NCT02201108|589823824|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
163049469|NCT01657162|588889003|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
163049470|NCT01657162|588889004|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
163049471|NCT01657162|588889003|FG000|Overall Study|Other than Specified|0|||
163049472|NCT01657162|588889004|FG001|Overall Study|Other than Specified|2|||
163049473|NCT02600923|588889005|FG000|Overall Study|Death|10|||
163049474|NCT02600923|588889005|FG000|Overall Study|Adverse Event|3|||
163049475|NCT02600923|588889005|FG000|Overall Study|Global deterioration of health status|2|||
163049476|NCT02600923|588889005|FG000|Overall Study|Insufficient clinical response|6|||
163049477|NCT02600923|588889005|FG000|Overall Study|Lost to Follow-up|1|||
163049478|NCT02600923|588889005|FG000|Overall Study|Withdrawal by Subject|5|||
163049479|NCT02600923|588889005|FG000|Overall Study|Objective progression or relapse|50|||
163049480|NCT02600923|588889005|FG000|Overall Study|Study terminated by Sponsor|53|||
163049481|NCT02600923|588889005|FG000|Overall Study|Not treated|1|||
163049482|NCT00792909|588889006|FG000|Overall Study|Withdrawal by Subject|0|||
163049483|NCT00792909|588889007|FG001|Overall Study|Withdrawal by Subject|1|||
163049484|NCT00792909|588889008|FG002|Overall Study|Withdrawal by Subject|0|||
163198844|NCT01508650|589443165|FG001|Overall Study|Lost to Follow-up|3|||
163198845|NCT02064894|589443166|FG000|Overall Study|Withdrawal by Subject|43|||
163198846|NCT02064894|589443167|FG001|Overall Study|Withdrawal by Subject|102|||
163198847|NCT02064894|589443168|FG002|Overall Study|Withdrawal by Subject|115|||
163198848|NCT01976338|589443169|FG000|Overall Study|Physician Decision|0|||
163198849|NCT01976338|589443170|FG001|Overall Study|Physician Decision|1|||
163198850|NCT01976338|589443169|FG000|Overall Study|Lost to Follow-up|3|||
163198851|NCT01976338|589443170|FG001|Overall Study|Lost to Follow-up|0|||
163198852|NCT01976338|589443169|FG000|Overall Study|Withdrawal by Subject|5|||
163198853|NCT01976338|589443170|FG001|Overall Study|Withdrawal by Subject|2|||
163198854|NCT01976338|589443169|FG000|Overall Study|Adverse Event|5|||
163198855|NCT01976338|589443170|FG001|Overall Study|Adverse Event|1|||
163198856|NCT00705484|589443174|FG000|Overall Study|Adverse Event|28|||
163198857|NCT00705484|589443175|FG001|Overall Study|Adverse Event|27|||
163198858|NCT00705484|589443174|FG000|Overall Study|Lost to Follow-up|169|||
163198859|NCT00705484|589443175|FG001|Overall Study|Lost to Follow-up|250|||
163198860|NCT00705484|589443174|FG000|Overall Study|Withdrawal by Subject|96|||
163049485|NCT04157088|588889010|FG000|Overall Study|Study terminated by sponsor|23|||
163198861|NCT00705484|589443175|FG001|Overall Study|Withdrawal by Subject|72|||
163198862|NCT00705484|589443174|FG000|Overall Study|Administrative|89|||
163049486|NCT04157088|588889010|FG000|Overall Study|Withdrawal by Subject|4|||
163049487|NCT04157088|588889010|FG000|Overall Study|Lost to Follow-up|2|||
163049488|NCT04157088|588889010|FG000|Overall Study|Death|1|||
163049489|NCT02421419|588889011|FG000|Overall Study|Physician Decision|0|||
163049490|NCT02421419|588889012|FG001|Overall Study|Physician Decision|0|||
163049491|NCT02421419|588889013|FG002|Overall Study|Physician Decision|1|||
163049492|NCT01747499|588889015|FG000|Overall Study|Steroid refractory aGvHD|1|||
163049493|NCT01747499|588889016|FG001|Overall Study|Steroid refractory aGvHD|0|||
163049494|NCT01747499|588889017|FG002|Overall Study|Steroid refractory aGvHD|0|||
163049495|NCT01747499|588889018|FG003|Overall Study|Steroid refractory aGvHD|1|||
163049496|NCT01747499|588889019|FG004|Overall Study|Steroid refractory aGvHD|4|||
163049497|NCT01747499|588889015|FG000|Overall Study|Physician Decision|0|||
163049498|NCT01747499|588889016|FG001|Overall Study|Physician Decision|1|||
163049499|NCT01747499|588889017|FG002|Overall Study|Physician Decision|0|||
163049500|NCT01747499|588889018|FG003|Overall Study|Physician Decision|0|||
163049501|NCT01747499|588889019|FG004|Overall Study|Physician Decision|2|||
163049502|NCT01747499|588889015|FG000|Overall Study|Death|0|||
163049503|NCT01747499|588889016|FG001|Overall Study|Death|0|||
163049504|NCT01747499|588889017|FG002|Overall Study|Death|0|||
163049505|NCT01747499|588889018|FG003|Overall Study|Death|1|||
163049506|NCT01747499|588889019|FG004|Overall Study|Death|1|||
163304682|NCT02201108|589823825|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
163304683|NCT02201108|589823826|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
163304684|NCT02201108|589823824|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
163304685|NCT02201108|589823825|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
163304686|NCT02201108|589823826|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
163304687|NCT02201108|589823824|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
163304688|NCT02201108|589823825|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
163304689|NCT02201108|589823826|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
163304690|NCT02201108|589823824|FG000|Open Label Period (up to Week 192)|Other reason|4|||
163304691|NCT02201108|589823825|FG001|Open Label Period (up to Week 192)|Other reason|7|||
163304692|NCT02201108|589823826|FG002|Open Label Period (up to Week 192)|Other reason|0|||
163304693|NCT02201108|589823824|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
163304694|NCT02201108|589823825|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
163304695|NCT02201108|589823826|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
163304696|NCT02201108|589823824|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
163304697|NCT02201108|589823825|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
163304698|NCT02201108|589823826|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
163304699|NCT02201108|589823824|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
163304700|NCT02201108|589823825|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
163304701|NCT02201108|589823826|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
163304702|NCT03055377|589823836|FG000|Treatment Phase|Lost to Follow-up|28|||
163304703|NCT03055377|589823837|FG001|Treatment Phase|Lost to Follow-up|24|||
163304704|NCT03055377|589823836|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
163396389|NCT01704287|590162677|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
163396390|NCT01704287|590162673|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
163396391|NCT01704287|590162674|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
163049507|NCT01747499|588889015|FG000|Overall Study|Withdrawal by Subject|0|||
163049508|NCT01747499|588889016|FG001|Overall Study|Withdrawal by Subject|0|||
163049509|NCT01747499|588889017|FG002|Overall Study|Withdrawal by Subject|0|||
163049510|NCT01747499|588889018|FG003|Overall Study|Withdrawal by Subject|0|||
163049511|NCT01747499|588889019|FG004|Overall Study|Withdrawal by Subject|6|||
163049512|NCT01747499|588889015|FG000|Overall Study|Developed AML and death|0|||
163049513|NCT01747499|588889016|FG001|Overall Study|Developed AML and death|0|||
163049514|NCT01747499|588889017|FG002|Overall Study|Developed AML and death|0|||
163304705|NCT03055377|589823837|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
163304706|NCT04143061|589823838|FG000|Overall Study|Protocol Deviation|0|||
163304707|NCT04143061|589823839|FG001|Overall Study|Protocol Deviation|0|||
163049515|NCT01747499|588889018|FG003|Overall Study|Developed AML and death|0|||
163049516|NCT01747499|588889019|FG004|Overall Study|Developed AML and death|1|||
163049517|NCT01747499|588889015|FG000|Overall Study|Determined not to be eligible|0|||
163049518|NCT01747499|588889016|FG001|Overall Study|Determined not to be eligible|0|||
163396392|NCT01704287|590162675|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
163396393|NCT01704287|590162676|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
163396394|NCT01704287|590162677|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
163396395|NCT01704287|590162673|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
163396396|NCT01704287|590162674|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
163396397|NCT01704287|590162675|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
162962574|NCT01559363|588562732|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
162962575|NCT01559363|588562733|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
162962576|NCT01559363|588562734|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
162962577|NCT01559363|588562735|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
162962578|NCT01559363|588562736|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
162962579|NCT01559363|588562731|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
162962580|NCT01559363|588562732|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
162962581|NCT01559363|588562733|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
162962582|NCT01559363|588562734|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
162962583|NCT01559363|588562735|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
162962584|NCT01559363|588562736|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
162962585|NCT00834873|588562737|FG000|First Intervention|Adverse Event|0|||
162962586|NCT00834873|588562738|FG001|First Intervention|Adverse Event|1|||
162962587|NCT01653704|588562742|FG000|Overall Study|Technical failure during recording|1|||
162962588|NCT01653704|588562743|FG001|Overall Study|Technical failure during recording|1|||
162962589|NCT01653704|588562742|FG000|Overall Study|Performance not reflective of training|1|||
162962590|NCT01653704|588562743|FG001|Overall Study|Performance not reflective of training|0|||
162962591|NCT03966911|588562744|FG000|Overall Study|Adverse Event|1|||
162962592|NCT03966911|588562745|FG001|Overall Study|Adverse Event|1|||
162962593|NCT03966911|588562744|FG000|Overall Study|Withdrawal by Subject|8|||
162962594|NCT03966911|588562745|FG001|Overall Study|Withdrawal by Subject|2|||
162962595|NCT03966911|588562744|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
162962596|NCT03966911|588562745|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
162962597|NCT00985751|588562746|FG000|Overall Study|Adverse Event|0|||
162962598|NCT00985751|588562747|FG001|Overall Study|Adverse Event|0|||
162962599|NCT00985751|588562748|FG002|Overall Study|Adverse Event|0|||
162962600|NCT00985751|588562749|FG003|Overall Study|Adverse Event|0|||
162962601|NCT00985751|588562750|FG004|Overall Study|Adverse Event|1|||
162962602|NCT01899053|588562751|FG000|Overall Study|Progressive Disease|4|||
162962603|NCT01899053|588562752|FG001|Overall Study|Progressive Disease|0|||
162962604|NCT01899053|588562753|FG002|Overall Study|Progressive Disease|3|||
162962605|NCT01899053|588562754|FG003|Overall Study|Progressive Disease|0|||
162962606|NCT01899053|588562755|FG004|Overall Study|Progressive Disease|3|||
162962607|NCT01899053|588562756|FG005|Overall Study|Progressive Disease|1|||
162962608|NCT01899053|588562757|FG006|Overall Study|Progressive Disease|1|||
162962609|NCT01899053|588562758|FG007|Overall Study|Progressive Disease|1|||
162962610|NCT01899053|588562759|FG008|Overall Study|Progressive Disease|4|||
162962611|NCT01899053|588562760|FG009|Overall Study|Progressive Disease|3|||
162962612|NCT01899053|588562761|FG010|Overall Study|Progressive Disease|12|||
162962613|NCT01899053|588562762|FG011|Overall Study|Progressive Disease|5|||
162962614|NCT01899053|588562763|FG012|Overall Study|Progressive Disease|8|||
162962615|NCT01899053|588562764|FG013|Overall Study|Progressive Disease|17|||
162962616|NCT01899053|588562751|FG000|Overall Study|Adverse Event|1|||
162962617|NCT01899053|588562752|FG001|Overall Study|Adverse Event|1|||
162962618|NCT01899053|588562753|FG002|Overall Study|Adverse Event|1|||
162962619|NCT01899053|588562754|FG003|Overall Study|Adverse Event|3|||
162962620|NCT01899053|588562755|FG004|Overall Study|Adverse Event|1|||
162962621|NCT01899053|588562756|FG005|Overall Study|Adverse Event|1|||
162962622|NCT01899053|588562757|FG006|Overall Study|Adverse Event|1|||
163198863|NCT00705484|589443175|FG001|Overall Study|Administrative|59|||
163198864|NCT02197247|589443176|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
163198865|NCT02197247|589443176|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
163198866|NCT02197247|589443176|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
163198867|NCT02197247|589443176|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
163198868|NCT02197247|589443176|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
163198869|NCT02197247|589443176|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
163396398|NCT01704287|590162676|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
162962623|NCT01899053|588562758|FG007|Overall Study|Adverse Event|0|||
162962624|NCT01899053|588562759|FG008|Overall Study|Adverse Event|2|||
162962625|NCT01899053|588562760|FG009|Overall Study|Adverse Event|0|||
162962626|NCT01899053|588562761|FG010|Overall Study|Adverse Event|3|||
162962627|NCT01899053|588562762|FG011|Overall Study|Adverse Event|1|||
162962628|NCT01899053|588562763|FG012|Overall Study|Adverse Event|2|||
162962629|NCT01899053|588562764|FG013|Overall Study|Adverse Event|2|||
162962630|NCT01899053|588562751|FG000|Overall Study|Reason Not Specified|0|||
162962631|NCT01899053|588562752|FG001|Overall Study|Reason Not Specified|0|||
162962632|NCT01899053|588562753|FG002|Overall Study|Reason Not Specified|0|||
163198870|NCT02197247|589443176|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
163198871|NCT02197247|589443176|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
163198872|NCT01606007|589443177|FG000|Overall Study|Reason 'Other' in the protocol|0|||
163198873|NCT01606007|589443178|FG001|Overall Study|Reason 'Other' in the protocol|1|||
163198874|NCT01606007|589443179|FG002|Overall Study|Reason 'Other' in the protocol|1|||
163198875|NCT01606007|589443177|FG000|Overall Study|Pregnancy|0|||
163198876|NCT01606007|589443178|FG001|Overall Study|Pregnancy|1|||
163198877|NCT01606007|589443179|FG002|Overall Study|Pregnancy|1|||
163198878|NCT01606007|589443177|FG000|Overall Study|Withdrawal by Subject|8|||
163198879|NCT01606007|589443178|FG001|Overall Study|Withdrawal by Subject|6|||
162962633|NCT01899053|588562754|FG003|Overall Study|Reason Not Specified|0|||
162962634|NCT01899053|588562755|FG004|Overall Study|Reason Not Specified|0|||
162962635|NCT01899053|588562756|FG005|Overall Study|Reason Not Specified|0|||
162962636|NCT01899053|588562757|FG006|Overall Study|Reason Not Specified|1|||
162962637|NCT01899053|588562758|FG007|Overall Study|Reason Not Specified|0|||
162962638|NCT01899053|588562759|FG008|Overall Study|Reason Not Specified|0|||
162962639|NCT01899053|588562760|FG009|Overall Study|Reason Not Specified|0|||
162962640|NCT01899053|588562761|FG010|Overall Study|Reason Not Specified|0|||
162962641|NCT01899053|588562762|FG011|Overall Study|Reason Not Specified|0|||
162962642|NCT01899053|588562763|FG012|Overall Study|Reason Not Specified|1|||
162962643|NCT01899053|588562764|FG013|Overall Study|Reason Not Specified|0|||
162962644|NCT01899053|588562751|FG000|Overall Study|Withdrawal by Subject|1|||
162962645|NCT01899053|588562752|FG001|Overall Study|Withdrawal by Subject|1|||
162962646|NCT01899053|588562753|FG002|Overall Study|Withdrawal by Subject|2|||
162962647|NCT01899053|588562754|FG003|Overall Study|Withdrawal by Subject|0|||
162962648|NCT01899053|588562755|FG004|Overall Study|Withdrawal by Subject|2|||
162962649|NCT01899053|588562756|FG005|Overall Study|Withdrawal by Subject|0|||
162962650|NCT01899053|588562757|FG006|Overall Study|Withdrawal by Subject|0|||
162962651|NCT01899053|588562758|FG007|Overall Study|Withdrawal by Subject|1|||
162962652|NCT01899053|588562759|FG008|Overall Study|Withdrawal by Subject|0|||
162962653|NCT01899053|588562760|FG009|Overall Study|Withdrawal by Subject|0|||
162962654|NCT01899053|588562761|FG010|Overall Study|Withdrawal by Subject|0|||
162962655|NCT01899053|588562762|FG011|Overall Study|Withdrawal by Subject|0|||
162962656|NCT01899053|588562763|FG012|Overall Study|Withdrawal by Subject|1|||
162962657|NCT01899053|588562764|FG013|Overall Study|Withdrawal by Subject|1|||
162962658|NCT01899053|588562751|FG000|Overall Study|Protocol Violation|0|||
162962659|NCT01899053|588562752|FG001|Overall Study|Protocol Violation|0|||
162962660|NCT01899053|588562753|FG002|Overall Study|Protocol Violation|1|||
162962661|NCT01899053|588562754|FG003|Overall Study|Protocol Violation|0|||
162962662|NCT01899053|588562755|FG004|Overall Study|Protocol Violation|0|||
162962663|NCT01899053|588562756|FG005|Overall Study|Protocol Violation|0|||
162962664|NCT01899053|588562757|FG006|Overall Study|Protocol Violation|0|||
162962665|NCT01899053|588562758|FG007|Overall Study|Protocol Violation|0|||
162962666|NCT01899053|588562759|FG008|Overall Study|Protocol Violation|0|||
162962667|NCT01899053|588562760|FG009|Overall Study|Protocol Violation|0|||
163198880|NCT01606007|589443179|FG002|Overall Study|Withdrawal by Subject|1|||
163198881|NCT01606007|589443177|FG000|Overall Study|Adverse Event|0|||
162962668|NCT01899053|588562761|FG010|Overall Study|Protocol Violation|0|||
162962669|NCT01899053|588562762|FG011|Overall Study|Protocol Violation|0|||
162962670|NCT01899053|588562763|FG012|Overall Study|Protocol Violation|0|||
162962671|NCT01899053|588562764|FG013|Overall Study|Protocol Violation|0|||
163198882|NCT01606007|589443178|FG001|Overall Study|Adverse Event|1|||
163198883|NCT01606007|589443179|FG002|Overall Study|Adverse Event|1|||
163198884|NCT01606007|589443177|FG000|Overall Study|discontinue study treatment|0|||
163198885|NCT01606007|589443178|FG001|Overall Study|discontinue study treatment|2|||
163198886|NCT01606007|589443179|FG002|Overall Study|discontinue study treatment|1|||
163198887|NCT01606007|589443177|FG000|Overall Study|Lost to Follow-up|6|||
163198888|NCT01606007|589443178|FG001|Overall Study|Lost to Follow-up|8|||
163198889|NCT01606007|589443179|FG002|Overall Study|Lost to Follow-up|5|||
163198890|NCT01606007|589443177|FG000|Overall Study|Poor/Non-compliance|1|||
163198891|NCT01606007|589443178|FG001|Overall Study|Poor/Non-compliance|0|||
163198892|NCT01606007|589443179|FG002|Overall Study|Poor/Non-compliance|0|||
163198893|NCT00851747|589443181|FG000|Overall Study|Physician Decision|6|||
163198894|NCT00851747|589443182|FG001|Overall Study|Physician Decision|6|||
163198895|NCT00851747|589443183|FG002|Overall Study|Physician Decision|6|||
163198896|NCT02499783|589443186|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
163198897|NCT02499783|589443187|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
163198898|NCT02499783|589443188|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
163198899|NCT02499783|589443186|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
163198900|NCT02499783|589443187|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
163198901|NCT02499783|589443188|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
163198902|NCT02499783|589443186|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
163304708|NCT04143061|589823840|FG002|Overall Study|Protocol Deviation|0|||
163304709|NCT04143061|589823841|FG003|Overall Study|Protocol Deviation|0|||
163304710|NCT04143061|589823842|FG004|Overall Study|Protocol Deviation|0|||
163304711|NCT04143061|589823843|FG005|Overall Study|Protocol Deviation|0|||
163304712|NCT04143061|589823844|FG006|Overall Study|Protocol Deviation|5|||
163304713|NCT04143061|589823845|FG007|Overall Study|Protocol Deviation|5|||
163304714|NCT04143061|589823838|FG000|Overall Study|Withdrawal by Subject|2|||
163304715|NCT04143061|589823839|FG001|Overall Study|Withdrawal by Subject|0|||
163304716|NCT04143061|589823840|FG002|Overall Study|Withdrawal by Subject|0|||
163304717|NCT04143061|589823841|FG003|Overall Study|Withdrawal by Subject|0|||
163304718|NCT04143061|589823842|FG004|Overall Study|Withdrawal by Subject|0|||
163304719|NCT04143061|589823843|FG005|Overall Study|Withdrawal by Subject|1|||
163304720|NCT04143061|589823844|FG006|Overall Study|Withdrawal by Subject|0|||
163304721|NCT04143061|589823845|FG007|Overall Study|Withdrawal by Subject|0|||
163304722|NCT04143061|589823838|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163304723|NCT04143061|589823839|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163304724|NCT04143061|589823840|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163304725|NCT04143061|589823841|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163304726|NCT04143061|589823842|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
163304727|NCT04143061|589823843|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
163304728|NCT04143061|589823844|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
163304729|NCT04143061|589823845|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
163304730|NCT02287311|589823846|FG000|Cohort 1: Dose Level 1|Death|2|||
163304731|NCT02287311|589823847|FG001|Cohort 1: Dose Level 1|Death|0|||
163304732|NCT02287311|589823848|FG002|Cohort 1: Dose Level 1|Death|0|||
163304733|NCT02287311|589823849|FG003|Cohort 1: Dose Level 1|Death|3|||
162962672|NCT01899053|588562751|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
162962673|NCT01899053|588562752|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
162962674|NCT01899053|588562753|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962675|NCT01899053|588562754|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962676|NCT01899053|588562755|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962677|NCT01899053|588562756|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962678|NCT01899053|588562757|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962679|NCT01899053|588562758|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962680|NCT01899053|588562759|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962681|NCT01899053|588562760|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962682|NCT01899053|588562761|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
162962683|NCT01899053|588562762|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962684|NCT01899053|588562763|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962685|NCT01899053|588562764|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962686|NCT01899053|588562751|FG000|Overall Study|Symptomatic Deterioration|0|||
162962687|NCT01899053|588562752|FG001|Overall Study|Symptomatic Deterioration|0|||
162962688|NCT01899053|588562753|FG002|Overall Study|Symptomatic Deterioration|0|||
162962689|NCT01899053|588562754|FG003|Overall Study|Symptomatic Deterioration|0|||
162962690|NCT01899053|588562755|FG004|Overall Study|Symptomatic Deterioration|0|||
162962691|NCT01899053|588562756|FG005|Overall Study|Symptomatic Deterioration|1|||
162962692|NCT01899053|588562757|FG006|Overall Study|Symptomatic Deterioration|0|||
162962693|NCT01899053|588562758|FG007|Overall Study|Symptomatic Deterioration|1|||
162962694|NCT01899053|588562759|FG008|Overall Study|Symptomatic Deterioration|0|||
162962695|NCT01899053|588562760|FG009|Overall Study|Symptomatic Deterioration|0|||
162962696|NCT01899053|588562761|FG010|Overall Study|Symptomatic Deterioration|0|||
162962697|NCT01899053|588562762|FG011|Overall Study|Symptomatic Deterioration|1|||
162962698|NCT01899053|588562763|FG012|Overall Study|Symptomatic Deterioration|2|||
162962699|NCT01899053|588562764|FG013|Overall Study|Symptomatic Deterioration|0|||
162962700|NCT03500094|588562768|FG000|Overall Study|Withdrawal by Subject|1|||
163304734|NCT02287311|589823850|FG004|Cohort 1: Dose Level 1|Death|0|||
163304735|NCT02287311|589823851|FG005|Cohort 1: Dose Level 1|Death|0|||
163304736|NCT02287311|589823852|FG006|Cohort 1: Dose Level 1|Death|1|||
163304737|NCT02287311|589823853|FG007|Cohort 1: Dose Level 1|Death|0|||
163304738|NCT02287311|589823854|FG008|Cohort 1: Dose Level 1|Death|0|||
163304739|NCT02287311|589823846|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
163304740|NCT02287311|589823847|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
163304741|NCT02287311|589823848|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
163304742|NCT02287311|589823849|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
163304743|NCT02287311|589823850|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
163396399|NCT01704287|590162677|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
163396400|NCT04042740|590162678|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
163396401|NCT04042740|590162678|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
163396402|NCT01717287|590162679|FG000|Overall Study|Lost to Follow-up|0|||
163396403|NCT01717287|590162680|FG001|Overall Study|Lost to Follow-up|2|||
163396404|NCT01717287|590162679|FG000|Overall Study|Protocol Violation|0|||
163396405|NCT01717287|590162680|FG001|Overall Study|Protocol Violation|1|||
163396406|NCT04024228|590162681|FG000|Overall Study|Adverse Event|1|||
163396407|NCT04024228|590162682|FG001|Overall Study|Adverse Event|0|||
163396408|NCT04024228|590162681|FG000|Overall Study|Protocol Deviation|0|||
163396409|NCT04024228|590162682|FG001|Overall Study|Protocol Deviation|2|||
163396410|NCT04024228|590162681|FG000|Overall Study|Withdrawal by Subject|3|||
163396411|NCT04024228|590162682|FG001|Overall Study|Withdrawal by Subject|4|||
163396412|NCT04490395|590162686|FG000|Overall Study|Lost to Follow-up|0|||
163396413|NCT04490395|590162687|FG001|Overall Study|Lost to Follow-up|1|||
163396414|NCT00938717|590162688|FG000|Overall Study|Adverse Event|10|||
163396415|NCT00938717|590162689|FG001|Overall Study|Adverse Event|41|||
163396416|NCT00938717|590162688|FG000|Overall Study|Protocol Violation|11|||
163396417|NCT00938717|590162689|FG001|Overall Study|Protocol Violation|8|||
163396418|NCT00938717|590162688|FG000|Overall Study|Withdrawal by Subject|26|||
163396419|NCT00938717|590162689|FG001|Overall Study|Withdrawal by Subject|24|||
163396420|NCT00938717|590162688|FG000|Overall Study|Lost to Follow-up|13|||
163396421|NCT00938717|590162689|FG001|Overall Study|Lost to Follow-up|18|||
163396422|NCT00938717|590162688|FG000|Overall Study|Lack of Efficacy|33|||
163396423|NCT00938717|590162689|FG001|Overall Study|Lack of Efficacy|15|||
163396424|NCT00938717|590162688|FG000|Overall Study|Other reason|5|||
163396425|NCT00938717|590162689|FG001|Overall Study|Other reason|2|||
163396426|NCT01942148|590162697|FG000|Overall Study|Adverse Event|4|||
163396427|NCT01942148|590162697|FG000|Overall Study|Lack of Efficacy|2|||
163396428|NCT01942148|590162697|FG000|Overall Study|Physician Decision|11|||
163396429|NCT01942148|590162697|FG000|Overall Study|Protocol Violation|1|||
163396430|NCT01942148|590162697|FG000|Overall Study|Withdrawal by Subject|8|||
163396431|NCT01942148|590162697|FG000|Overall Study|Use of the prohibition medicine|1|||
163396432|NCT02807480|590162698|FG000|Overall Study|Withdrawal by Subject|14|||
163396433|NCT02807480|590162699|FG001|Overall Study|Withdrawal by Subject|10|||
163304744|NCT02287311|589823851|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
163304745|NCT02287311|589823852|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
163396434|NCT02163187|590162700|FG000|Overall Study|Device removed|1|||
163396435|NCT02163187|590162701|FG001|Overall Study|Device removed|0|||
163396436|NCT02163187|590162700|FG000|Overall Study|Progressive disease|1|||
163396437|NCT02163187|590162701|FG001|Overall Study|Progressive disease|0|||
163396438|NCT02369848|590162702|FG000|Overall Study|Death|1|||
163396439|NCT02369848|590162702|FG000|Overall Study|Withdrawal by Subject|2|||
163396440|NCT02369848|590162702|FG000|Overall Study|Lost to Follow-up|1|||
163049519|NCT01747499|588889017|FG002|Overall Study|Determined not to be eligible|0|||
163049520|NCT01747499|588889018|FG003|Overall Study|Determined not to be eligible|0|||
163049521|NCT01747499|588889019|FG004|Overall Study|Determined not to be eligible|1|||
163049522|NCT01676701|588889020|FG000|Overall Study|Protocol Violation|1|||
163049523|NCT01676701|588889021|FG001|Overall Study|Protocol Violation|0|||
163049524|NCT01676701|588889020|FG000|Overall Study|Sponsor Decision|3|||
163049525|NCT01676701|588889021|FG001|Overall Study|Sponsor Decision|4|||
163049526|NCT00196105|588889022|FG000|Overall Study|Lost to Follow-up|4|||
163049527|NCT00196105|588889023|FG001|Overall Study|Lost to Follow-up|5|||
163049528|NCT00196105|588889024|FG002|Overall Study|Lost to Follow-up|7|||
163049529|NCT02227784|588889028|FG000|Double-Blind Phase|Adverse Event|3|||
163049530|NCT02227784|588889029|FG001|Double-Blind Phase|Adverse Event|2|||
163049531|NCT02227784|588889030|FG002|Double-Blind Phase|Adverse Event|1|||
163049532|NCT02227784|588889031|FG003|Double-Blind Phase|Adverse Event|3|||
163049533|NCT02227784|588889032|FG004|Double-Blind Phase|Adverse Event|0|||
163049534|NCT02227784|588889028|FG000|Double-Blind Phase|Physician Decision|1|||
163049535|NCT02227784|588889029|FG001|Double-Blind Phase|Physician Decision|0|||
163049536|NCT02227784|588889030|FG002|Double-Blind Phase|Physician Decision|0|||
163049537|NCT02227784|588889031|FG003|Double-Blind Phase|Physician Decision|1|||
163049538|NCT02227784|588889032|FG004|Double-Blind Phase|Physician Decision|0|||
163049539|NCT02227784|588889028|FG000|Double-Blind Phase|Protocol Violation|0|||
163049540|NCT02227784|588889029|FG001|Double-Blind Phase|Protocol Violation|0|||
163049541|NCT02227784|588889030|FG002|Double-Blind Phase|Protocol Violation|1|||
163049542|NCT02227784|588889031|FG003|Double-Blind Phase|Protocol Violation|1|||
163049543|NCT02227784|588889032|FG004|Double-Blind Phase|Protocol Violation|0|||
163049544|NCT02227784|588889028|FG000|Double-Blind Phase|Sponsor Decision|34|||
163049545|NCT02227784|588889029|FG001|Double-Blind Phase|Sponsor Decision|15|||
163049546|NCT02227784|588889030|FG002|Double-Blind Phase|Sponsor Decision|14|||
163049547|NCT02227784|588889031|FG003|Double-Blind Phase|Sponsor Decision|32|||
163049548|NCT02227784|588889032|FG004|Double-Blind Phase|Sponsor Decision|0|||
163049549|NCT02227784|588889028|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
163049550|NCT02227784|588889029|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
163049551|NCT02227784|588889030|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
163049552|NCT02227784|588889031|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
163049553|NCT02227784|588889032|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
163049554|NCT02227784|588889028|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
163049555|NCT02227784|588889029|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
163049556|NCT02227784|588889030|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
163049557|NCT02227784|588889031|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
163049558|NCT02227784|588889032|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
163049559|NCT02227784|588889028|FG000|Open-Label Extension Phase (OLE)|Death|0|||
163049560|NCT02227784|588889029|FG001|Open-Label Extension Phase (OLE)|Death|0|||
163049561|NCT02227784|588889030|FG002|Open-Label Extension Phase (OLE)|Death|0|||
163049562|NCT02227784|588889031|FG003|Open-Label Extension Phase (OLE)|Death|0|||
163049563|NCT02227784|588889032|FG004|Open-Label Extension Phase (OLE)|Death|1|||
163049564|NCT02227784|588889028|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
163049565|NCT02227784|588889029|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
163049566|NCT02227784|588889030|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
163049567|NCT02227784|588889031|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
163049568|NCT02227784|588889032|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
163049569|NCT02227784|588889028|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
163049570|NCT02227784|588889029|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
163049571|NCT02227784|588889030|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
163049572|NCT02227784|588889031|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
163049573|NCT02227784|588889032|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
163304746|NCT02287311|589823853|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
163304747|NCT02287311|589823854|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
163304748|NCT02287311|589823846|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
163304749|NCT02287311|589823847|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
163304750|NCT02287311|589823848|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
163304751|NCT02287311|589823849|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
163049574|NCT04058028|588889033|FG000|Overall Study|Withdrawal of Consent from Study|12|||
163049575|NCT04058028|588889034|FG001|Overall Study|Withdrawal of Consent from Study|8|||
163049576|NCT04058028|588889035|FG002|Overall Study|Withdrawal of Consent from Study|6|||
163049577|NCT04058028|588889036|FG003|Overall Study|Withdrawal of Consent from Study|7|||
163049578|NCT04058028|588889033|FG000|Overall Study|Decision by Sponsor|13|||
163049579|NCT04058028|588889034|FG001|Overall Study|Decision by Sponsor|4|||
163049580|NCT04058028|588889035|FG002|Overall Study|Decision by Sponsor|1|||
163049581|NCT04058028|588889036|FG003|Overall Study|Decision by Sponsor|35|||
163049582|NCT04058028|588889033|FG000|Overall Study|Lost to Follow-up|1|||
163049583|NCT04058028|588889034|FG001|Overall Study|Lost to Follow-up|1|||
163304752|NCT02287311|589823850|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
163304753|NCT02287311|589823851|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
163396441|NCT02573870|590162703|FG000|Overall Study|Adverse Event|0|||
163396442|NCT02573870|590162704|FG001|Overall Study|Adverse Event|2|||
163396443|NCT02573870|590162703|FG000|Overall Study|Lack of Efficacy|0|||
163304754|NCT02287311|589823852|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
163304755|NCT02287311|589823853|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
163304756|NCT02287311|589823854|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
163304757|NCT02287311|589823846|FG000|Cohort 2: Dose Level 2|Death|0|||
163304758|NCT02287311|589823847|FG001|Cohort 2: Dose Level 2|Death|2|||
163304759|NCT02287311|589823848|FG002|Cohort 2: Dose Level 2|Death|0|||
163304760|NCT02287311|589823849|FG003|Cohort 2: Dose Level 2|Death|0|||
163304761|NCT02287311|589823850|FG004|Cohort 2: Dose Level 2|Death|2|||
163304762|NCT02287311|589823851|FG005|Cohort 2: Dose Level 2|Death|0|||
163304763|NCT02287311|589823852|FG006|Cohort 2: Dose Level 2|Death|0|||
163304764|NCT02287311|589823853|FG007|Cohort 2: Dose Level 2|Death|2|||
163304765|NCT02287311|589823854|FG008|Cohort 2: Dose Level 2|Death|0|||
163304766|NCT02287311|589823846|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163304767|NCT02287311|589823847|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163304768|NCT02287311|589823848|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163304769|NCT02287311|589823849|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163304770|NCT02287311|589823850|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
163304771|NCT02287311|589823851|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163304772|NCT02287311|589823852|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163304773|NCT02287311|589823853|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163304774|NCT02287311|589823854|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163304775|NCT02287311|589823846|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
163304776|NCT02287311|589823847|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
163304777|NCT02287311|589823848|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
163304778|NCT02287311|589823849|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
163396444|NCT02573870|590162704|FG001|Overall Study|Lack of Efficacy|1|||
163396445|NCT02573870|590162703|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
163396446|NCT02573870|590162704|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
162962701|NCT03500094|588562768|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
162962702|NCT03500094|588562768|FG000|Overall Study|Lost to Follow-up|1|||
162962703|NCT01891357|588562769|FG000|Overall Study|Protocol Violation|3|||
162962704|NCT00640341|588564627|FG000|Overall Study|Adverse Event|0|||
162962705|NCT00640341|588564628|FG001|Overall Study|Adverse Event|0|||
162962706|NCT00640341|588564629|FG002|Overall Study|Adverse Event|1|||
162962707|NCT00640341|588564627|FG000|Overall Study|Positive Slit Lamp Findings|0|||
162962708|NCT00640341|588564628|FG001|Overall Study|Positive Slit Lamp Findings|0|||
162962709|NCT00640341|588564629|FG002|Overall Study|Positive Slit Lamp Findings|1|||
162962710|NCT00640341|588564627|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
162962711|NCT00640341|588564628|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
162962712|NCT00640341|588564629|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
162962713|NCT00640341|588564627|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
162962714|NCT00640341|588564628|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
162962715|NCT00640341|588564629|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
162962716|NCT00640341|588564627|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
162962717|NCT00640341|588564628|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
162962718|NCT00640341|588564629|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
162962719|NCT00640341|588564627|FG000|Overall Study|Lost to Follow-up|2|||
162962720|NCT00640341|588564628|FG001|Overall Study|Lost to Follow-up|0|||
162962721|NCT00640341|588564629|FG002|Overall Study|Lost to Follow-up|0|||
162962722|NCT00640341|588564627|FG000|Overall Study|Withdrawal by Subject|4|||
162962723|NCT00640341|588564628|FG001|Overall Study|Withdrawal by Subject|0|||
162962724|NCT00640341|588564629|FG002|Overall Study|Withdrawal by Subject|1|||
162962725|NCT00640341|588564627|FG000|Overall Study|Unacceptable Lens Movement|1|||
163304779|NCT02287311|589823850|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
163304780|NCT02287311|589823851|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
163396447|NCT02573870|590162703|FG000|Overall Study|Lost to Follow-up|0|||
162962726|NCT00640341|588564628|FG001|Overall Study|Unacceptable Lens Movement|0|||
163396448|NCT02573870|590162704|FG001|Overall Study|Lost to Follow-up|1|||
162962727|NCT00640341|588564629|FG002|Overall Study|Unacceptable Lens Movement|0|||
162962728|NCT00640341|588564627|FG000|Overall Study|Poor fit/Uncomfortable|4|||
163396449|NCT02573870|590162703|FG000|Overall Study|Other: Fail to Meet Visit|0|||
163304781|NCT02287311|589823852|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
163304782|NCT02287311|589823853|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
163304783|NCT02287311|589823854|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
163304784|NCT02287311|589823846|FG000|Cohort 3: Dose Level 3|Death|0|||
163304785|NCT02287311|589823847|FG001|Cohort 3: Dose Level 3|Death|0|||
163304786|NCT02287311|589823848|FG002|Cohort 3: Dose Level 3|Death|4|||
163304787|NCT02287311|589823849|FG003|Cohort 3: Dose Level 3|Death|0|||
163396450|NCT02573870|590162704|FG001|Overall Study|Other: Fail to Meet Visit|2|||
163396451|NCT00257725|590162705|FG000|Overall Study|Adverse Event|3|||
163396452|NCT01858532|590162706|FG000|Overall Study|Adverse Event|58|||
163304788|NCT02287311|589823850|FG004|Cohort 3: Dose Level 3|Death|0|||
163304789|NCT02287311|589823851|FG005|Cohort 3: Dose Level 3|Death|4|||
163304790|NCT02287311|589823852|FG006|Cohort 3: Dose Level 3|Death|0|||
163304791|NCT02287311|589823853|FG007|Cohort 3: Dose Level 3|Death|0|||
163304792|NCT02287311|589823854|FG008|Cohort 3: Dose Level 3|Death|2|||
163304793|NCT02287311|589823846|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
163304794|NCT02287311|589823847|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
163304795|NCT02287311|589823848|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
163304796|NCT02287311|589823849|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
163304797|NCT02287311|589823850|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
163304798|NCT02287311|589823851|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
163304799|NCT02287311|589823852|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
163304800|NCT02287311|589823853|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
163304801|NCT02287311|589823854|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
163304802|NCT02287311|589823846|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
163304803|NCT02287311|589823847|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
163304804|NCT02287311|589823848|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
163304805|NCT02287311|589823849|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
163304806|NCT02287311|589823850|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
163304807|NCT02287311|589823851|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
163304808|NCT02287311|589823852|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
163304809|NCT02287311|589823853|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
163304810|NCT02287311|589823854|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
163304811|NCT04048681|589823858|FG000|Overall Study|family emergency|0|||
163304812|NCT04048681|589823859|FG001|Overall Study|family emergency|0|||
163304813|NCT04048681|589823860|FG002|Overall Study|family emergency|0|||
163304814|NCT04048681|589823861|FG003|Overall Study|family emergency|1|||
163304815|NCT04048681|589823862|FG004|Overall Study|family emergency|0|||
163304816|NCT04579250|589823863|FG000|Overall Study|Withdrawal by Subject|1|||
163304817|NCT04579250|589823864|FG001|Overall Study|Withdrawal by Subject|1|||
163304818|NCT04579250|589823865|FG002|Overall Study|Withdrawal by Subject|0|||
163304819|NCT04579250|589823863|FG000|Overall Study|Lost to Follow-up|1|||
163304820|NCT04579250|589823864|FG001|Overall Study|Lost to Follow-up|1|||
163304821|NCT04579250|589823865|FG002|Overall Study|Lost to Follow-up|0|||
163304822|NCT04579250|589823863|FG000|Overall Study|Moved from area|0|||
163304823|NCT04579250|589823864|FG001|Overall Study|Moved from area|1|||
163304824|NCT04579250|589823865|FG002|Overall Study|Moved from area|2|||
163304825|NCT02919449|589823866|FG000|Overall Study|Withdrawal by Subject|1|||
163304826|NCT02919449|589823866|FG000|Overall Study|Investigator decision|1|||
163304827|NCT02374307|589823871|FG000|3-months Follow-up|Lost to Follow-up|1|||
163304828|NCT02374307|589823872|FG001|3-months Follow-up|Lost to Follow-up|2|||
163304829|NCT02374307|589823871|FG000|3-months Follow-up|Withdrawal by Subject|1|||
163304830|NCT02374307|589823872|FG001|3-months Follow-up|Withdrawal by Subject|4|||
163304831|NCT02374307|589823871|FG000|3-months Follow-up|Death|1|||
163304832|NCT02374307|589823872|FG001|3-months Follow-up|Death|2|||
163304833|NCT02374307|589823871|FG000|3-months Follow-up|Missed first follow-up|5|||
163304834|NCT02374307|589823872|FG001|3-months Follow-up|Missed first follow-up|1|||
163304835|NCT02374307|589823871|FG000|6-months Follow-up|Lost to Follow-up|1|||
163304836|NCT02374307|589823872|FG001|6-months Follow-up|Lost to Follow-up|2|||
163304837|NCT02374307|589823871|FG000|6-months Follow-up|Death|2|||
163304838|NCT02374307|589823872|FG001|6-months Follow-up|Death|1|||
163304839|NCT02374307|589823871|FG000|6-months Follow-up|Withdrawal by Subject|0|||
163304840|NCT02374307|589823872|FG001|6-months Follow-up|Withdrawal by Subject|3|||
163304841|NCT01989455|589823873|FG000|Overall Study|Adverse Event|0|||
163304842|NCT01989455|589823874|FG001|Overall Study|Adverse Event|1|||
163304843|NCT01989455|589823875|FG002|Overall Study|Adverse Event|0|||
163304844|NCT01989455|589823876|FG003|Overall Study|Adverse Event|0|||
163304845|NCT01989455|589823877|FG004|Overall Study|Adverse Event|0|||
163304846|NCT01989455|589823873|FG000|Overall Study|Withdrawal by Subject|0|||
163304847|NCT01989455|589823874|FG001|Overall Study|Withdrawal by Subject|1|||
163304848|NCT01989455|589823875|FG002|Overall Study|Withdrawal by Subject|0|||
163304849|NCT01989455|589823876|FG003|Overall Study|Withdrawal by Subject|0|||
163304850|NCT01989455|589823877|FG004|Overall Study|Withdrawal by Subject|0|||
163304851|NCT01989455|589823873|FG000|Overall Study|Technical problems with infusion|0|||
163304852|NCT01989455|589823874|FG001|Overall Study|Technical problems with infusion|0|||
163396453|NCT01858532|590162707|FG001|Overall Study|Adverse Event|50|||
163396454|NCT01858532|590162708|FG002|Overall Study|Adverse Event|23|||
162962729|NCT00640341|588564628|FG001|Overall Study|Poor fit/Uncomfortable|0|||
162962730|NCT00640341|588564629|FG002|Overall Study|Poor fit/Uncomfortable|0|||
162962731|NCT00640341|588564627|FG000|Overall Study|Ineligable at Baseline|5|||
162962732|NCT00640341|588564628|FG001|Overall Study|Ineligable at Baseline|3|||
162962733|NCT00640341|588564629|FG002|Overall Study|Ineligable at Baseline|2|||
162962734|NCT00640341|588564627|FG000|Overall Study|Adverse event and positive slit lamp|1|||
162962735|NCT00640341|588564628|FG001|Overall Study|Adverse event and positive slit lamp|0|||
162962736|NCT00640341|588564629|FG002|Overall Study|Adverse event and positive slit lamp|0|||
162962737|NCT01541215|588564632|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
162962738|NCT01541215|588564633|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
162962739|NCT01541215|588564632|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
162962740|NCT01541215|588564633|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
162962741|NCT01541215|588564632|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
162962742|NCT01541215|588564633|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
162962743|NCT01541215|588564632|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
162962744|NCT01541215|588564633|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
162962745|NCT01541215|588564632|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
162962746|NCT01541215|588564633|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
162962747|NCT01541215|588564632|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
162962748|NCT01541215|588564633|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
162962749|NCT02316223|588564637|FG000|Overall Study|Lack of Efficacy|0|||
163198903|NCT02499783|589443187|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
163198904|NCT02499783|589443188|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
163198905|NCT02499783|589443186|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
163198906|NCT02499783|589443187|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
163198907|NCT02499783|589443188|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
163198908|NCT02499783|589443186|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
163198909|NCT02499783|589443187|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
163198910|NCT02499783|589443188|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
163198911|NCT02499783|589443186|FG000|DB Period: Weeks 0-8|Other|1|||
163198912|NCT02499783|589443187|FG001|DB Period: Weeks 0-8|Other|1|||
163198913|NCT02499783|589443188|FG002|DB Period: Weeks 0-8|Other|0|||
163198914|NCT02499783|589443186|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
163198915|NCT02499783|589443187|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
163198916|NCT02499783|589443188|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
162962750|NCT02316223|588564638|FG001|Overall Study|Lack of Efficacy|1|||
163198917|NCT02499783|589443186|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
163198918|NCT02499783|589443187|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
163198919|NCT02499783|589443188|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
163396455|NCT01858532|590162709|FG003|Overall Study|Adverse Event|28|||
163304853|NCT01989455|589823875|FG002|Overall Study|Technical problems with infusion|1|||
163304854|NCT01989455|589823876|FG003|Overall Study|Technical problems with infusion|0|||
163304855|NCT01989455|589823877|FG004|Overall Study|Technical problems with infusion|1|||
163304856|NCT00632203|589823878|FG000|Overall Study|Did not start study treatment|1|||
163304857|NCT00632203|589823879|FG001|Overall Study|Did not start study treatment|0|||
163304858|NCT00999167|589823880|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
163304859|NCT00999167|589823881|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
163304860|NCT00999167|589823882|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
163304861|NCT00999167|589823880|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
163304862|NCT00999167|589823881|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
163304863|NCT00999167|589823882|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
163304864|NCT00999167|589823880|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
163304865|NCT00999167|589823881|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
163304866|NCT00999167|589823882|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
163304867|NCT00999167|589823880|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
163304868|NCT00999167|589823881|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
163304869|NCT00999167|589823882|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
163304870|NCT00999167|589823880|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
163304871|NCT00999167|589823881|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
163304872|NCT00999167|589823882|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
163304873|NCT00999167|589823880|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
163304874|NCT00999167|589823881|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
163304875|NCT00999167|589823882|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
162962751|NCT02316223|588564639|FG002|Overall Study|Lack of Efficacy|1|||
162962752|NCT02316223|588564637|FG000|Overall Study|Lost to Follow-up|27|||
162962753|NCT02316223|588564638|FG001|Overall Study|Lost to Follow-up|34|||
162962754|NCT02316223|588564639|FG002|Overall Study|Lost to Follow-up|36|||
162962755|NCT02316223|588564637|FG000|Overall Study|COPD Diagnosis|3|||
162962756|NCT02316223|588564638|FG001|Overall Study|COPD Diagnosis|2|||
162962757|NCT02316223|588564639|FG002|Overall Study|COPD Diagnosis|3|||
162962758|NCT02316223|588564637|FG000|Overall Study|Reside outside study area|1|||
162962759|NCT02316223|588564638|FG001|Overall Study|Reside outside study area|1|||
162962760|NCT02316223|588564639|FG002|Overall Study|Reside outside study area|1|||
162962761|NCT02316223|588564637|FG000|Overall Study|No asthma|2|||
162962762|NCT02316223|588564638|FG001|Overall Study|No asthma|0|||
162962763|NCT02316223|588564639|FG002|Overall Study|No asthma|0|||
162962764|NCT02316223|588564637|FG000|Overall Study|Discontinued by PI|11|||
162962765|NCT02316223|588564638|FG001|Overall Study|Discontinued by PI|19|||
162962766|NCT02316223|588564639|FG002|Overall Study|Discontinued by PI|3|||
162962767|NCT03234907|588564641|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
162962768|NCT03234907|588564642|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
162962769|NCT03234907|588564643|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
162962770|NCT03234907|588564644|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
162962771|NCT03234907|588564645|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
162962772|NCT03234907|588564646|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
162962773|NCT03234907|588564641|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
162962774|NCT03234907|588564642|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
162962775|NCT03234907|588564643|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
162962776|NCT03234907|588564644|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
162962777|NCT03234907|588564645|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
162962778|NCT03234907|588564646|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
162962779|NCT03234907|588564641|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
162962780|NCT03234907|588564642|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
162962781|NCT03234907|588564643|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
162962782|NCT03234907|588564644|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
163304876|NCT00999167|589823880|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
163304877|NCT00999167|589823881|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
162962783|NCT03234907|588564645|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
162962784|NCT03234907|588564646|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
163049584|NCT04058028|588889035|FG002|Overall Study|Lost to Follow-up|1|||
163049585|NCT04058028|588889036|FG003|Overall Study|Lost to Follow-up|0|||
163049586|NCT04058028|588889033|FG000|Overall Study|Death|0|||
163049587|NCT04058028|588889034|FG001|Overall Study|Death|1|||
163049588|NCT04058028|588889035|FG002|Overall Study|Death|0|||
163049589|NCT04058028|588889036|FG003|Overall Study|Death|0|||
163049590|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
163049591|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
163049592|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Adverse Event|57|||
163049593|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Adverse Event|49|||
163049594|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
163049595|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
163049596|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Site closure|3|||
163049597|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Site closure|2|||
163049598|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
163049599|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
163049600|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Physician Decision|48|||
163049601|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Physician Decision|38|||
163049602|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
163049603|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
163049604|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
163049605|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
163049606|NCT01705977|588889037|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
163049607|NCT01705977|588889038|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
163049608|NCT01705977|588889037|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
163049609|NCT01705977|588889038|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
163049610|NCT01705977|588889037|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
163049611|NCT01705977|588889038|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
163049612|NCT01705977|588889037|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
163049613|NCT01705977|588889038|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
163049614|NCT00248651|588889041|FG000|Overall Study|Withdrawal by Subject|28|||
163049615|NCT00248651|588889042|FG001|Overall Study|Withdrawal by Subject|40|||
163049616|NCT00248651|588889043|FG002|Overall Study|Withdrawal by Subject|32|||
163049617|NCT00828113|588889044|FG000|Overall Study|Withdrawal by Subject|27|||
163049618|NCT00828113|588889045|FG001|Overall Study|Withdrawal by Subject|26|||
163049619|NCT00828113|588889044|FG000|Overall Study|Lost to Follow-up|3|||
163049620|NCT00828113|588889045|FG001|Overall Study|Lost to Follow-up|5|||
163049621|NCT01365130|588889046|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
163049622|NCT05607576|588889048|FG000|Overall Study|immediate sensor error|2|||
163049623|NCT05607576|588889048|FG000|Overall Study|Physician Decision|2|||
163049624|NCT01683604|588889055|FG000|Overall Study|Adverse Event|2|||
163049625|NCT01683604|588889055|FG000|Overall Study|Lack of Efficacy|1|||
163049626|NCT01683604|588889055|FG000|Overall Study|Other|2|||
163049627|NCT03430856|588889056|FG000|Overall Study|Adverse Event|0|||
163049628|NCT03430856|588889057|FG001|Overall Study|Adverse Event|1|||
163049629|NCT03430856|588889058|FG002|Overall Study|Adverse Event|0|||
163049630|NCT03430856|588889056|FG000|Overall Study|Rescue criteria|1|||
163049631|NCT03430856|588889057|FG001|Overall Study|Rescue criteria|1|||
163049632|NCT03430856|588889058|FG002|Overall Study|Rescue criteria|0|||
163049633|NCT03430856|588889056|FG000|Overall Study|Voluntary withdrawal of consent|1|||
163049634|NCT03430856|588889057|FG001|Overall Study|Voluntary withdrawal of consent|1|||
163049635|NCT03430856|588889058|FG002|Overall Study|Voluntary withdrawal of consent|1|||
163049636|NCT02357459|588890867|FG000|Overall Study|Adverse Event|0|||
163049637|NCT02357459|588890868|FG001|Overall Study|Adverse Event|1|||
163049638|NCT02357459|588890869|FG002|Overall Study|Adverse Event|1|||
163049639|NCT02357459|588890867|FG000|Overall Study|Withdrawal by Subject|5|||
163049640|NCT02357459|588890868|FG001|Overall Study|Withdrawal by Subject|3|||
163049641|NCT02357459|588890869|FG002|Overall Study|Withdrawal by Subject|3|||
163049642|NCT02357459|588890867|FG000|Overall Study|Physician Decision|0|||
163049643|NCT02357459|588890868|FG001|Overall Study|Physician Decision|2|||
163049644|NCT02357459|588890869|FG002|Overall Study|Physician Decision|0|||
163049645|NCT02357459|588890867|FG000|Overall Study|Protocol Violation|1|||
163049646|NCT02357459|588890868|FG001|Overall Study|Protocol Violation|1|||
163198920|NCT02499783|589443186|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
163198921|NCT02499783|589443187|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
163396456|NCT01858532|590162706|FG000|Overall Study|Withdrew consent|71|||
163049647|NCT02357459|588890869|FG002|Overall Study|Protocol Violation|0|||
163049648|NCT02357459|588890867|FG000|Overall Study|Lost to Follow-up|1|||
163049649|NCT02357459|588890868|FG001|Overall Study|Lost to Follow-up|3|||
163049650|NCT02357459|588890869|FG002|Overall Study|Lost to Follow-up|0|||
163049651|NCT02357459|588890867|FG000|Overall Study|Lack of Efficacy|7|||
163049652|NCT02357459|588890868|FG001|Overall Study|Lack of Efficacy|4|||
163396457|NCT01858532|590162707|FG001|Overall Study|Withdrew consent|93|||
163049653|NCT02357459|588890869|FG002|Overall Study|Lack of Efficacy|4|||
163049654|NCT02357459|588890867|FG000|Overall Study|Patient Relocated|2|||
163049655|NCT02357459|588890868|FG001|Overall Study|Patient Relocated|0|||
163396458|NCT01858532|590162708|FG002|Overall Study|Withdrew consent|46|||
163396459|NCT01858532|590162709|FG003|Overall Study|Withdrew consent|27|||
163396460|NCT01858532|590162706|FG000|Overall Study|Lost to Follow-up|17|||
163396461|NCT01858532|590162707|FG001|Overall Study|Lost to Follow-up|26|||
163396462|NCT01858532|590162708|FG002|Overall Study|Lost to Follow-up|11|||
163396463|NCT01858532|590162709|FG003|Overall Study|Lost to Follow-up|14|||
163396464|NCT01858532|590162706|FG000|Overall Study|Deterioration of medical status|3|||
163396465|NCT01858532|590162707|FG001|Overall Study|Deterioration of medical status|4|||
163396466|NCT01858532|590162708|FG002|Overall Study|Deterioration of medical status|3|||
163396467|NCT01858532|590162709|FG003|Overall Study|Deterioration of medical status|7|||
163396468|NCT01858532|590162706|FG000|Overall Study|Investigator request|3|||
163396469|NCT01858532|590162707|FG001|Overall Study|Investigator request|4|||
163396470|NCT01858532|590162708|FG002|Overall Study|Investigator request|2|||
163396471|NCT01858532|590162709|FG003|Overall Study|Investigator request|6|||
163396472|NCT01858532|590162706|FG000|Overall Study|Other, not specified|29|||
163396473|NCT01858532|590162707|FG001|Overall Study|Other, not specified|15|||
163396474|NCT01858532|590162708|FG002|Overall Study|Other, not specified|13|||
163396475|NCT01858532|590162709|FG003|Overall Study|Other, not specified|11|||
163396476|NCT00514514|590162710|FG000|Pre-phase|Death|10|||
163396477|NCT00514514|590162711|FG001|Pre-phase|Death|0|||
163396478|NCT00514514|590162712|FG002|Pre-phase|Death|0|||
163396479|NCT00514514|590162710|FG000|Pre-phase|administrative problems|2|||
163396480|NCT00514514|590162711|FG001|Pre-phase|administrative problems|0|||
163396481|NCT00514514|590162712|FG002|Pre-phase|administrative problems|0|||
163049656|NCT02357459|588890869|FG002|Overall Study|Patient Relocated|0|||
163049657|NCT02357459|588890867|FG000|Overall Study|Instruction from PCP|1|||
163049658|NCT02357459|588890868|FG001|Overall Study|Instruction from PCP|0|||
163049659|NCT02357459|588890869|FG002|Overall Study|Instruction from PCP|0|||
163049660|NCT02357459|588890867|FG000|Overall Study|Incarceration|0|||
163049661|NCT02357459|588890868|FG001|Overall Study|Incarceration|0|||
163049662|NCT02357459|588890869|FG002|Overall Study|Incarceration|1|||
163049663|NCT02357459|588890867|FG000|Overall Study|Pre-planned Knee surgery|0|||
163049664|NCT02357459|588890868|FG001|Overall Study|Pre-planned Knee surgery|0|||
163049665|NCT02357459|588890869|FG002|Overall Study|Pre-planned Knee surgery|2|||
163049666|NCT02357459|588890867|FG000|Overall Study|Job Commitments|0|||
163049667|NCT02357459|588890868|FG001|Overall Study|Job Commitments|0|||
163049668|NCT02357459|588890869|FG002|Overall Study|Job Commitments|1|||
163049669|NCT03246347|588890870|FG000|Overall Study|On Study|23|||
163049670|NCT00916578|588890871|FG000|Overall Study|Physician Decision|2|||
163049671|NCT00916578|588890871|FG000|Overall Study|Withdrawal by Subject|3|||
163049672|NCT00916578|588890871|FG000|Overall Study|Insurance Denial|2|||
163049673|NCT01228591|588890874|FG000|Baseline|Lack of Efficacy|1|||
163049674|NCT01228591|588890875|FG001|Baseline|Lack of Efficacy|2|||
163049675|NCT02611882|588890876|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
163049676|NCT02611882|588890877|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
163049677|NCT02611882|588890878|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
163049678|NCT01389232|588890879|FG000|Overall Study|Had scaffold removed|15|||
163049679|NCT01389232|588890879|FG000|Overall Study|Personal reasons|2|||
163049680|NCT01389232|588890879|FG000|Overall Study|Adverse Event|1|||
163049681|NCT01389232|588890879|FG000|Overall Study|Death|1|||
163049682|NCT01317940|588890880|FG000|Overall Study|Death|1|||
163049683|NCT01317940|588890881|FG001|Overall Study|Death|0|||
163049684|NCT01317940|588890882|FG002|Overall Study|Death|1|||
163049685|NCT01317940|588890883|FG003|Overall Study|Death|0|||
163049686|NCT01317940|588890884|FG004|Overall Study|Death|0|||
163049687|NCT01317940|588890885|FG005|Overall Study|Death|0|||
163049688|NCT01317940|588890880|FG000|Overall Study|Lost to Follow-up|0|||
163049689|NCT01317940|588890881|FG001|Overall Study|Lost to Follow-up|0|||
163396482|NCT00514514|590162710|FG000|Pre-phase|Protocol Violation|6|||
163396483|NCT00514514|590162711|FG001|Pre-phase|Protocol Violation|0|||
163396484|NCT00514514|590162712|FG002|Pre-phase|Protocol Violation|0|||
163396485|NCT00514514|590162710|FG000|Pre-phase|condition no longer requires study drug|7|||
163396486|NCT00514514|590162711|FG001|Pre-phase|condition no longer requires study drug|0|||
163049690|NCT01317940|588890882|FG002|Overall Study|Lost to Follow-up|1|||
163049691|NCT01317940|588890883|FG003|Overall Study|Lost to Follow-up|1|||
163049692|NCT01317940|588890884|FG004|Overall Study|Lost to Follow-up|1|||
163049693|NCT01317940|588890885|FG005|Overall Study|Lost to Follow-up|0|||
163396487|NCT00514514|590162712|FG002|Pre-phase|condition no longer requires study drug|0|||
163396488|NCT00514514|590162710|FG000|Pre-phase|abnormal test procedure results|15|||
163049694|NCT01317940|588890880|FG000|Overall Study|Change in therapy plan|0|||
163049695|NCT01317940|588890881|FG001|Overall Study|Change in therapy plan|0|||
163049696|NCT01317940|588890882|FG002|Overall Study|Change in therapy plan|3|||
163049697|NCT01317940|588890883|FG003|Overall Study|Change in therapy plan|0|||
163049698|NCT01317940|588890884|FG004|Overall Study|Change in therapy plan|0|||
163049699|NCT01317940|588890885|FG005|Overall Study|Change in therapy plan|0|||
163396489|NCT00514514|590162711|FG001|Pre-phase|abnormal test procedure results|0|||
163396490|NCT00514514|590162712|FG002|Pre-phase|abnormal test procedure results|0|||
163396491|NCT00514514|590162710|FG000|Pre-phase|Lost to Follow-up|2|||
163396492|NCT00514514|590162711|FG001|Pre-phase|Lost to Follow-up|0|||
163396493|NCT00514514|590162712|FG002|Pre-phase|Lost to Follow-up|0|||
163396494|NCT00514514|590162710|FG000|Pre-phase|abnormal lab values|23|||
163396495|NCT00514514|590162711|FG001|Pre-phase|abnormal lab values|0|||
163396496|NCT00514514|590162712|FG002|Pre-phase|abnormal lab values|0|||
163396497|NCT00514514|590162710|FG000|Pre-phase|Lack of Efficacy|35|||
163396498|NCT00514514|590162711|FG001|Pre-phase|Lack of Efficacy|0|||
163396499|NCT00514514|590162712|FG002|Pre-phase|Lack of Efficacy|0|||
163396500|NCT00514514|590162710|FG000|Pre-phase|Adverse Event|137|||
163396501|NCT00514514|590162711|FG001|Pre-phase|Adverse Event|0|||
163396502|NCT00514514|590162712|FG002|Pre-phase|Adverse Event|0|||
163396503|NCT00514514|590162710|FG000|Pre-phase|Withdrawal by Subject|66|||
163396504|NCT00514514|590162711|FG001|Pre-phase|Withdrawal by Subject|0|||
163396505|NCT00514514|590162712|FG002|Pre-phase|Withdrawal by Subject|0|||
163396506|NCT00514514|590162710|FG000|Randomized - 9 Month|Death|3|||
163396507|NCT00514514|590162711|FG001|Randomized - 9 Month|Death|2|||
163396508|NCT00514514|590162712|FG002|Randomized - 9 Month|Death|2|||
163396509|NCT00514514|590162710|FG000|Randomized - 9 Month|Administrative problems|1|||
163396510|NCT00514514|590162711|FG001|Randomized - 9 Month|Administrative problems|1|||
163396511|NCT00514514|590162712|FG002|Randomized - 9 Month|Administrative problems|2|||
163396512|NCT00514514|590162710|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
163396513|NCT00514514|590162711|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
163396514|NCT00514514|590162712|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
163396515|NCT00514514|590162710|FG000|Randomized - 9 Month|Protocol Violation|1|||
163396516|NCT00514514|590162711|FG001|Randomized - 9 Month|Protocol Violation|1|||
163396517|NCT00514514|590162712|FG002|Randomized - 9 Month|Protocol Violation|0|||
163396518|NCT00514514|590162710|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
163396519|NCT00514514|590162711|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
163396520|NCT00514514|590162712|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
163396521|NCT00514514|590162710|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
163396522|NCT00514514|590162711|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
163396523|NCT00514514|590162712|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
163396524|NCT00514514|590162710|FG000|Randomized - 9 Month|Adverse Event|25|||
163396525|NCT00514514|590162711|FG001|Randomized - 9 Month|Adverse Event|44|||
163396526|NCT00514514|590162712|FG002|Randomized - 9 Month|Adverse Event|27|||
163396527|NCT00514514|590162710|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
163396528|NCT00514514|590162711|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
163396529|NCT00514514|590162712|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
163396530|NCT00514514|590162710|FG000|Extension - 4 Years|Lost to Follow-up|12|||
163396531|NCT00514514|590162711|FG001|Extension - 4 Years|Lost to Follow-up|10|||
163396532|NCT00514514|590162712|FG002|Extension - 4 Years|Lost to Follow-up|9|||
163396533|NCT00514514|590162710|FG000|Extension - 4 Years|Administrative problems|3|||
163396534|NCT00514514|590162711|FG001|Extension - 4 Years|Administrative problems|1|||
163396535|NCT00514514|590162712|FG002|Extension - 4 Years|Administrative problems|1|||
163396536|NCT00514514|590162710|FG000|Extension - 4 Years|Death|8|||
163396537|NCT00514514|590162711|FG001|Extension - 4 Years|Death|3|||
163396538|NCT00514514|590162712|FG002|Extension - 4 Years|Death|6|||
163396539|NCT00514514|590162710|FG000|Extension - 4 Years|Adverse Event|9|||
163396540|NCT00514514|590162711|FG001|Extension - 4 Years|Adverse Event|6|||
163396541|NCT00514514|590162712|FG002|Extension - 4 Years|Adverse Event|3|||
163396542|NCT02081534|590162719|FG000|Overall Study|Adverse Event|5|||
163396543|NCT02081534|590162720|FG001|Overall Study|Adverse Event|4|||
163396544|NCT02081534|590162721|FG002|Overall Study|Adverse Event|3|||
163396545|NCT02081534|590162722|FG003|Overall Study|Adverse Event|10|||
163396546|NCT02081534|590162723|FG004|Overall Study|Adverse Event|2|||
163396547|NCT02081534|590162724|FG005|Overall Study|Adverse Event|8|||
163396548|NCT02081534|590162725|FG006|Overall Study|Adverse Event|2|||
163396549|NCT02081534|590162719|FG000|Overall Study|Withdrawal by Subject|0|||
163396550|NCT02081534|590162720|FG001|Overall Study|Withdrawal by Subject|1|||
163396551|NCT02081534|590162721|FG002|Overall Study|Withdrawal by Subject|1|||
163396552|NCT02081534|590162722|FG003|Overall Study|Withdrawal by Subject|1|||
163396553|NCT02081534|590162723|FG004|Overall Study|Withdrawal by Subject|1|||
163396554|NCT02081534|590162724|FG005|Overall Study|Withdrawal by Subject|0|||
163049700|NCT02371616|588890887|FG000|Overall Study|Protocol Violation|2|||
163396555|NCT02081534|590162725|FG006|Overall Study|Withdrawal by Subject|1|||
163396556|NCT02081534|590162719|FG000|Overall Study|Protocol Violation|0|||
163396557|NCT02081534|590162720|FG001|Overall Study|Protocol Violation|3|||
163396558|NCT02081534|590162721|FG002|Overall Study|Protocol Violation|0|||
163396559|NCT02081534|590162722|FG003|Overall Study|Protocol Violation|0|||
163396560|NCT02081534|590162723|FG004|Overall Study|Protocol Violation|0|||
162962785|NCT03234907|588564641|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
162962786|NCT03234907|588564642|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
162962787|NCT03234907|588564643|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
162962788|NCT03234907|588564644|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
162962789|NCT03234907|588564645|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
162962790|NCT03234907|588564646|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
162962791|NCT03234907|588564641|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
162962792|NCT03234907|588564642|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
162962793|NCT03234907|588564643|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
162962794|NCT03234907|588564644|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
163049701|NCT02371616|588890888|FG001|Overall Study|Protocol Violation|1|||
163049702|NCT02371616|588890887|FG000|Overall Study|Adverse Event|0|||
163049703|NCT02371616|588890888|FG001|Overall Study|Adverse Event|1|||
163049704|NCT02371616|588890887|FG000|Overall Study|Withdrawal of Consent|1|||
163049705|NCT02371616|588890888|FG001|Overall Study|Withdrawal of Consent|0|||
163049706|NCT02371616|588890887|FG000|Overall Study|Other (Not specified)|1|||
163304878|NCT00999167|589823882|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
163304879|NCT00999167|589823880|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
163304880|NCT00999167|589823881|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
163304881|NCT00999167|589823882|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
163304882|NCT00448669|589823883|FG000|Overall Study|Lost to Follow-up|52|||
163304883|NCT00448669|589823884|FG001|Overall Study|Lost to Follow-up|63|||
163304884|NCT00448669|589823883|FG000|Overall Study|Withdrawal by Subject|90|||
163304885|NCT00448669|589823884|FG001|Overall Study|Withdrawal by Subject|74|||
163304886|NCT00448669|589823883|FG000|Overall Study|Relocated|49|||
163304887|NCT00448669|589823884|FG001|Overall Study|Relocated|36|||
163304888|NCT00448669|589823883|FG000|Overall Study|Were withdrawn by investigator|10|||
163304889|NCT00448669|589823884|FG001|Overall Study|Were withdrawn by investigator|6|||
163304890|NCT00448669|589823883|FG000|Overall Study|Death|2|||
163304891|NCT00448669|589823884|FG001|Overall Study|Death|4|||
163304892|NCT00448669|589823883|FG000|Overall Study|Had other reasons|5|||
163304893|NCT00448669|589823884|FG001|Overall Study|Had other reasons|6|||
163304894|NCT00448669|589823883|FG000|Overall Study|HIV-infected at enrollment|1|||
163304895|NCT00448669|589823884|FG001|Overall Study|HIV-infected at enrollment|2|||
163304896|NCT00448669|589823883|FG000|Overall Study|Never started drug|9|||
163304897|NCT00448669|589823884|FG001|Overall Study|Never started drug|7|||
163304898|NCT04287985|589823885|FG000|Overall Study|Adverse Event|1|||
163304899|NCT04287985|589823886|FG001|Overall Study|Adverse Event|0|||
163304900|NCT04287985|589823887|FG002|Overall Study|Adverse Event|0|||
163304901|NCT04287985|589823888|FG003|Overall Study|Adverse Event|0|||
163304902|NCT04287985|589823885|FG000|Overall Study|Protocol Violation|0|||
163304903|NCT04287985|589823886|FG001|Overall Study|Protocol Violation|1|||
163304904|NCT04287985|589823887|FG002|Overall Study|Protocol Violation|0|||
163304905|NCT04287985|589823888|FG003|Overall Study|Protocol Violation|0|||
163304906|NCT04287985|589823885|FG000|Overall Study|Physician Decision|0|||
163304907|NCT04287985|589823886|FG001|Overall Study|Physician Decision|0|||
163304908|NCT04287985|589823887|FG002|Overall Study|Physician Decision|0|||
163304909|NCT04287985|589823888|FG003|Overall Study|Physician Decision|1|||
163304910|NCT04287985|589823885|FG000|Overall Study|Withdrawal by Subject|2|||
163304911|NCT04287985|589823886|FG001|Overall Study|Withdrawal by Subject|1|||
163304912|NCT04287985|589823887|FG002|Overall Study|Withdrawal by Subject|1|||
163304913|NCT04287985|589823888|FG003|Overall Study|Withdrawal by Subject|2|||
163304914|NCT01340066|589823889|FG000|Placebo Run in Period|Screen Failures|27|||
163049707|NCT02371616|588890888|FG001|Overall Study|Other (Not specified)|5|||
163049708|NCT01921517|588890891|FG000|Overall Study|Lost to Follow-up|5|||
163049709|NCT01921517|588890892|FG001|Overall Study|Lost to Follow-up|0|||
163049710|NCT01921517|588890891|FG000|Overall Study|Newly diagnosed health concern|2|||
163049711|NCT01921517|588890892|FG001|Overall Study|Newly diagnosed health concern|0|||
163049712|NCT01921517|588890891|FG000|Overall Study|Physician Decision|0|||
163049713|NCT01921517|588890892|FG001|Overall Study|Physician Decision|2|||
163049714|NCT01921517|588890891|FG000|Overall Study|Withdrawal by Subject|7|||
163049715|NCT01921517|588890892|FG001|Overall Study|Withdrawal by Subject|3|||
163049716|NCT01921517|588890891|FG000|Overall Study|Subject missed final imaging|1|||
163049717|NCT01921517|588890892|FG001|Overall Study|Subject missed final imaging|4|||
163049718|NCT03205150|588890893|FG000|Overall Study|Protocol deviation|1|||
163049719|NCT03205150|588890894|FG001|Overall Study|Protocol deviation|3|||
163049720|NCT03205150|588890895|FG002|Overall Study|Protocol deviation|0|||
163049721|NCT03205150|588890893|FG000|Overall Study|Patient/guardian decision|0|||
163049722|NCT03205150|588890894|FG001|Overall Study|Patient/guardian decision|3|||
163049723|NCT03205150|588890895|FG002|Overall Study|Patient/guardian decision|0|||
163049724|NCT03205150|588890893|FG000|Overall Study|Adverse Event|1|||
163049725|NCT03205150|588890894|FG001|Overall Study|Adverse Event|1|||
163049726|NCT03205150|588890895|FG002|Overall Study|Adverse Event|1|||
163049727|NCT03205150|588890893|FG000|Overall Study|Lost to Follow-up|0|||
163049728|NCT03205150|588890894|FG001|Overall Study|Lost to Follow-up|0|||
163049729|NCT03205150|588890895|FG002|Overall Study|Lost to Follow-up|1|||
163049730|NCT01095835|588890896|FG000|Overall Study|Adverse Event|8|||
163049731|NCT01095835|588890897|FG001|Overall Study|Adverse Event|6|||
163049732|NCT01095835|588890898|FG002|Overall Study|Adverse Event|6|||
163049733|NCT01095835|588890896|FG000|Overall Study|Lack of Efficacy|0|||
163049734|NCT01095835|588890897|FG001|Overall Study|Lack of Efficacy|1|||
163049735|NCT01095835|588890898|FG002|Overall Study|Lack of Efficacy|0|||
163049736|NCT01095835|588890896|FG000|Overall Study|Physician Decision|0|||
163049737|NCT01095835|588890897|FG001|Overall Study|Physician Decision|0|||
163049738|NCT01095835|588890898|FG002|Overall Study|Physician Decision|1|||
163049739|NCT01095835|588890896|FG000|Overall Study|Withdrawal by Subject|1|||
163049740|NCT01095835|588890897|FG001|Overall Study|Withdrawal by Subject|3|||
163049741|NCT01095835|588890898|FG002|Overall Study|Withdrawal by Subject|0|||
163049742|NCT01095835|588890896|FG000|Overall Study|Non study compliance|0|||
163049743|NCT01095835|588890897|FG001|Overall Study|Non study compliance|0|||
163049744|NCT01095835|588890898|FG002|Overall Study|Non study compliance|1|||
163049745|NCT01095835|588890896|FG000|Overall Study|Protocol Violation|1|||
163049746|NCT01095835|588890897|FG001|Overall Study|Protocol Violation|2|||
163049747|NCT01095835|588890898|FG002|Overall Study|Protocol Violation|0|||
163049748|NCT03028142|588890899|FG000|Overall Study|Adverse Event|1|||
163049749|NCT03028142|588890900|FG001|Overall Study|Adverse Event|1|||
163049750|NCT03028142|588890901|FG002|Overall Study|Adverse Event|0|||
163049751|NCT03028142|588890902|FG003|Overall Study|Adverse Event|0|||
163049752|NCT03028142|588890903|FG004|Overall Study|Adverse Event|0|||
163049753|NCT03028142|588890904|FG005|Overall Study|Adverse Event|1|||
163049754|NCT03028142|588890899|FG000|Overall Study|Withdrawal by Subject|0|||
163049755|NCT03028142|588890900|FG001|Overall Study|Withdrawal by Subject|0|||
163049756|NCT03028142|588890901|FG002|Overall Study|Withdrawal by Subject|0|||
163049757|NCT03028142|588890902|FG003|Overall Study|Withdrawal by Subject|0|||
163049758|NCT03028142|588890903|FG004|Overall Study|Withdrawal by Subject|1|||
163049759|NCT03028142|588890904|FG005|Overall Study|Withdrawal by Subject|0|||
163049760|NCT00116688|588890908|FG000|Overall Study|Protocol deviation|1|||
163049761|NCT00116688|588890909|FG001|Overall Study|Protocol deviation|0|||
163049762|NCT00116688|588890908|FG000|Overall Study|Noncompliance|3|||
163049763|NCT00116688|588890909|FG001|Overall Study|Noncompliance|1|||
163396561|NCT02081534|590162724|FG005|Overall Study|Protocol Violation|0|||
163049764|NCT00116688|588890908|FG000|Overall Study|Adverse Event|11|||
163049765|NCT00116688|588890909|FG001|Overall Study|Adverse Event|0|||
163049766|NCT00116688|588890908|FG000|Overall Study|Withdrawal by Subject|26|||
163049767|NCT00116688|588890909|FG001|Overall Study|Withdrawal by Subject|2|||
163049768|NCT00116688|588890908|FG000|Overall Study|Requirement for alternative therapy|11|||
163049769|NCT00116688|588890909|FG001|Overall Study|Requirement for alternative therapy|1|||
163049770|NCT00116688|588890908|FG000|Overall Study|Physician Decision|7|||
163049771|NCT00116688|588890909|FG001|Overall Study|Physician Decision|0|||
163049772|NCT00116688|588890908|FG000|Overall Study|Lost to Follow-up|3|||
163049773|NCT00116688|588890909|FG001|Overall Study|Lost to Follow-up|0|||
163049774|NCT00116688|588890908|FG000|Overall Study|Death|15|||
163049775|NCT00116688|588890909|FG001|Overall Study|Death|0|||
163049776|NCT00116688|588890908|FG000|Overall Study|Protocol-specified criteria|3|||
163049777|NCT00116688|588890909|FG001|Overall Study|Protocol-specified criteria|0|||
163049778|NCT00116688|588890908|FG000|Overall Study|Pregnancy|1|||
163049779|NCT00116688|588890909|FG001|Overall Study|Pregnancy|0|||
163049780|NCT00116688|588890908|FG000|Overall Study|Other|11|||
163049781|NCT00116688|588890909|FG001|Overall Study|Other|0|||
163049782|NCT01775670|588890911|FG000|Overall Study|Lost to Follow-up|1|||
163049783|NCT01775670|588890912|FG001|Overall Study|Lost to Follow-up|1|||
163049784|NCT01298700|588890914|FG000|Overall Study|Adverse Event|50|||
163049785|NCT01298700|588890915|FG001|Overall Study|Adverse Event|51|||
163049786|NCT01298700|588890914|FG000|Overall Study|Lack of Efficacy|9|||
163049787|NCT01298700|588890915|FG001|Overall Study|Lack of Efficacy|14|||
163049788|NCT01298700|588890914|FG000|Overall Study|Lost to Follow-up|5|||
163049789|NCT01298700|588890915|FG001|Overall Study|Lost to Follow-up|2|||
163049790|NCT01298700|588890914|FG000|Overall Study|Withdrawal by Subject|12|||
163049791|NCT01298700|588890915|FG001|Overall Study|Withdrawal by Subject|9|||
163049792|NCT01298700|588890914|FG000|Overall Study|Protocol Violation|6|||
163049793|NCT01298700|588890915|FG001|Overall Study|Protocol Violation|4|||
163049794|NCT01298700|588890914|FG000|Overall Study|Other Miscellaneous Reasons|16|||
163049795|NCT01298700|588890915|FG001|Overall Study|Other Miscellaneous Reasons|15|||
163049796|NCT01298700|588890914|FG000|Overall Study|Did not Receive Study Drug|3|||
163049797|NCT01298700|588890915|FG001|Overall Study|Did not Receive Study Drug|5|||
163049798|NCT04006145|588890918|FG000|Overall Study|Lost to Follow-up|0|||
163049799|NCT04006145|588890919|FG001|Overall Study|Lost to Follow-up|1|||
163049800|NCT04006145|588890918|FG000|Overall Study|Other|1|||
163049801|NCT04006145|588890919|FG001|Overall Study|Other|2|||
163049802|NCT01001429|588890920|FG000|Overall Study|surgery cancelled|0|||
163049803|NCT01001429|588890921|FG001|Overall Study|surgery cancelled|1|||
163049804|NCT02812186|588890924|FG000|Period 1|Post randomization screen failure|5|||
163049805|NCT02812186|588890925|FG001|Period 1|Post randomization screen failure|9|||
163049806|NCT02812186|588890924|FG000|Period 1|nonevaluable data sets|6|||
163049807|NCT02812186|588890925|FG001|Period 1|nonevaluable data sets|6|||
163304915|NCT01340066|589823890|FG001|Placebo Run in Period|Screen Failures|0|||
163304916|NCT01340066|589823891|FG002|Placebo Run in Period|Screen Failures|0|||
163304917|NCT01340066|589823889|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
163304918|NCT01340066|589823890|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
163304919|NCT01340066|589823891|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
163304920|NCT01340066|589823889|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
163304921|NCT01340066|589823890|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
163304922|NCT01340066|589823891|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
163304923|NCT01340066|589823889|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
163304924|NCT01340066|589823890|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
163304925|NCT01340066|589823891|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
163304926|NCT02789020|589823892|FG000|Overall Study|Withdrawal by Subject|6|||
163304927|NCT02789020|589823893|FG001|Overall Study|Withdrawal by Subject|5|||
163304928|NCT04238247|589823896|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
163304929|NCT04238247|589823897|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
163304930|NCT04238247|589823898|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
163304931|NCT04238247|589823899|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
163304932|NCT04238247|589823896|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
163304933|NCT04238247|589823897|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
163304934|NCT04238247|589823898|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
163304935|NCT04238247|589823899|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
163304936|NCT04238247|589823896|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
163304937|NCT04238247|589823897|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
163049808|NCT00010257|588890926|FG000|Overall Study|Withdrawal by Subject|1|||
163049809|NCT00010257|588890927|FG001|Overall Study|Withdrawal by Subject|0|||
163049810|NCT00643760|588890930|FG000|Overall Study|Adverse Event|11|||
163049811|NCT00643760|588890931|FG001|Overall Study|Adverse Event|5|||
163049812|NCT00643760|588890932|FG002|Overall Study|Adverse Event|12|||
163049813|NCT00643760|588890933|FG003|Overall Study|Adverse Event|21|||
163049814|NCT00643760|588890934|FG004|Overall Study|Adverse Event|6|||
163396562|NCT02081534|590162725|FG006|Overall Study|Protocol Violation|1|||
163396563|NCT02081534|590162719|FG000|Overall Study|Lost to Follow-up|0|||
163396564|NCT02081534|590162720|FG001|Overall Study|Lost to Follow-up|0|||
163396565|NCT02081534|590162721|FG002|Overall Study|Lost to Follow-up|0|||
163396566|NCT02081534|590162722|FG003|Overall Study|Lost to Follow-up|2|||
163396567|NCT02081534|590162723|FG004|Overall Study|Lost to Follow-up|1|||
163396568|NCT02081534|590162724|FG005|Overall Study|Lost to Follow-up|1|||
163396569|NCT02081534|590162725|FG006|Overall Study|Lost to Follow-up|0|||
163396570|NCT01841749|590162731|FG000|Overall Study|Protocol Violation|1|||
163396571|NCT00677820|590162732|FG000|Overall Study|Lost to Follow-up|1|||
163396572|NCT00677820|590162733|FG001|Overall Study|Lost to Follow-up|0|||
163396573|NCT01480284|590162734|FG000|Overall Study|Withdrawal by Subject|2|||
163396574|NCT01480284|590162735|FG001|Overall Study|Withdrawal by Subject|0|||
163396575|NCT01480284|590162734|FG000|Overall Study|Adverse Event|1|||
163396576|NCT01480284|590162735|FG001|Overall Study|Adverse Event|0|||
163396577|NCT01480284|590162734|FG000|Overall Study|Study closed/terminated|3|||
163396578|NCT01480284|590162735|FG001|Overall Study|Study closed/terminated|0|||
163396579|NCT01480284|590162734|FG000|Overall Study|Lost to Follow-up|1|||
163396580|NCT01480284|590162735|FG001|Overall Study|Lost to Follow-up|0|||
163396581|NCT01480284|590162734|FG000|Overall Study|Physician Decision|1|||
163396582|NCT01480284|590162735|FG001|Overall Study|Physician Decision|0|||
163396583|NCT00066742|590162738|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
163396584|NCT00066742|590162738|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
163396585|NCT00066742|590162738|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
163396586|NCT00066742|590162738|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
163396587|NCT00066742|590162738|FG000|Induction Chemoradiotherapy|Ineligible|3|||
163396588|NCT00066742|590162738|FG000|Consolidation Chemotherapy|not protocol specified|1|||
163396589|NCT00066742|590162738|FG000|Consolidation Chemotherapy|Ineligible|2|||
163396590|NCT02357134|590162739|FG000|Overall Study|Lost to Follow-up|1|||
163396591|NCT02357134|590162740|FG001|Overall Study|Lost to Follow-up|0|||
163396592|NCT02357134|590162741|FG002|Overall Study|Lost to Follow-up|0|||
163396593|NCT02357134|590162742|FG003|Overall Study|Lost to Follow-up|0|||
163396594|NCT03593850|590162748|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
163396595|NCT03593850|590162749|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
163396596|NCT02490475|590162750|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
163396597|NCT02490475|590162751|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
163396598|NCT02490475|590162752|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
163396599|NCT02490475|590162753|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
163396600|NCT02490475|590162750|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
163198922|NCT02499783|589443188|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
163198923|NCT02499783|589443186|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
163198924|NCT02499783|589443187|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
163396601|NCT02490475|590162751|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
163396602|NCT02490475|590162752|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
163396603|NCT02490475|590162753|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
163396604|NCT02490475|590162750|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
163396605|NCT02490475|590162751|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
163396606|NCT02490475|590162752|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
163396607|NCT02490475|590162753|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
163198925|NCT02499783|589443188|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
163198926|NCT02228460|589443189|FG000|Overall Study|Adverse Event|1|||
163198927|NCT02228460|589443189|FG000|Overall Study|Lost to Follow-up|1|||
163198928|NCT01243892|589443190|FG000|Overall Study|Did not meet eligibility criteria|2|||
163198929|NCT01243892|589443191|FG001|Overall Study|Did not meet eligibility criteria|0|||
163198930|NCT00119106|589443196|FG000|Overall Study|HIV infected at baseline|179|||
163198931|NCT00119106|589443197|FG001|Overall Study|HIV infected at baseline|178|||
163198932|NCT01866293|589443198|FG000|Overall Study|Adverse Event|2|||
163198933|NCT01010061|589443199|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
163198934|NCT01010061|589443200|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
163198935|NCT01010061|589443199|FG000|Overall Study|Disease Progression|2|||
163198936|NCT01010061|589443200|FG001|Overall Study|Disease Progression|8|||
163198937|NCT01010061|589443199|FG000|Overall Study|Withdrew Consent|5|||
163198938|NCT01010061|589443200|FG001|Overall Study|Withdrew Consent|1|||
163198939|NCT01010061|589443199|FG000|Overall Study|Death|3|||
163198940|NCT01010061|589443200|FG001|Overall Study|Death|6|||
163198941|NCT01010061|589443199|FG000|Overall Study|Administrative/Other|0|||
163198942|NCT01010061|589443200|FG001|Overall Study|Administrative/Other|1|||
163198943|NCT01010061|589443199|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
163198944|NCT01010061|589443200|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
163198945|NCT01010061|589443199|FG000|Overall Study|Insufficient Therapeutic Response|1|||
163198946|NCT01010061|589443200|FG001|Overall Study|Insufficient Therapeutic Response|5|||
163198947|NCT01010061|589443199|FG000|Overall Study|Violation of Selection Criteria|0|||
163198948|NCT01010061|589443200|FG001|Overall Study|Violation of Selection Criteria|1|||
163198949|NCT01010061|589443199|FG000|Overall Study|Did Not Receive Treatment|2|||
163198950|NCT01010061|589443200|FG001|Overall Study|Did Not Receive Treatment|2|||
163198951|NCT03066804|589443201|FG000|Overall Study|Physician Decision|0|||
163198952|NCT03066804|589443202|FG001|Overall Study|Physician Decision|4|||
163198953|NCT03066804|589443201|FG000|Overall Study|Death|23|||
163198954|NCT03066804|589443202|FG001|Overall Study|Death|17|||
163198955|NCT03066804|589443201|FG000|Overall Study|Withdrawal by Subject|19|||
163198956|NCT03066804|589443202|FG001|Overall Study|Withdrawal by Subject|25|||
163198957|NCT03066804|589443201|FG000|Overall Study|Lost to Follow-up|2|||
163304938|NCT04238247|589823898|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
163304939|NCT04238247|589823899|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
163304940|NCT04238247|589823896|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
163304941|NCT04238247|589823897|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
163304942|NCT04238247|589823898|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
163304943|NCT04238247|589823899|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
163304944|NCT05512962|589823900|FG000|Overall Study|Withdrawal by Subject|1|||
163304945|NCT05512962|589823901|FG001|Overall Study|Withdrawal by Subject|0|||
163304946|NCT04315181|589823902|FG000|Overall Study|Non-responsive to drug conditions.|1|||
163304947|NCT01948661|589823903|FG000|Overall Study|Withdrawal by Subject|2|||
163304948|NCT01948661|589823904|FG001|Overall Study|Withdrawal by Subject|4|||
163304949|NCT02886286|589823905|FG000|Overall Study|pump motor stall|0|||
163304950|NCT02886286|589823906|FG001|Overall Study|pump motor stall|1|||
163304951|NCT01127373|589823907|FG000|Overall Study|Not Treated|3|||
163304952|NCT01127373|589823907|FG000|Overall Study|Lost to Follow-up|7|||
163304953|NCT01127373|589823907|FG000|Overall Study|Withdrawal by Subject|1|||
163304954|NCT01127373|589823907|FG000|Overall Study|Disease progression|1|||
163304955|NCT02140645|589823909|FG000|Overall Study|Not linked|5489|||
163304956|NCT02140645|589823910|FG001|Overall Study|Not linked|61654|||
163304957|NCT02140645|589823911|FG002|Overall Study|Not linked|4236|||
163304958|NCT02140645|589823912|FG003|Overall Study|Not linked|13833|||
163304959|NCT02140645|589823913|FG004|Overall Study|Not linked|3286|||
163304960|NCT02140645|589823914|FG005|Overall Study|Not linked|70896|||
163304961|NCT01101451|589823916|FG000|Overall Study|Eligible and never treated|0|||
163304962|NCT01101451|589823917|FG001|Overall Study|Eligible and never treated|5|||
163304963|NCT01101451|589823916|FG000|Overall Study|Ineligible and treated|12|||
163304964|NCT01101451|589823917|FG001|Overall Study|Ineligible and treated|8|||
163304965|NCT01101451|589823916|FG000|Overall Study|Ineligible and never treated|2|||
163304966|NCT01101451|589823917|FG001|Overall Study|Ineligible and never treated|2|||
163304967|NCT00136435|589823918|FG000|Overall Study|Ineligible|8|||
163304968|NCT00136435|589823918|FG000|Overall Study|Induction Death|1|||
163304969|NCT00136435|589823918|FG000|Overall Study|Induction Failure|10|||
163304970|NCT00136435|589823918|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
163304971|NCT00136435|589823918|FG000|Overall Study|Withdrawal by Subject|3|||
163304972|NCT00136435|589823918|FG000|Overall Study|Adverse Event|19|||
163304973|NCT00136435|589823918|FG000|Overall Study|Relapse|4|||
163304974|NCT00136435|589823918|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
163304975|NCT00390299|589823923|FG000|Overall Study|Cancellation|1|||
163304976|NCT00390299|589823924|FG001|Overall Study|Cancellation|0|||
163304977|NCT00390299|589823925|FG002|Overall Study|Cancellation|0|||
163304978|NCT00390299|589823926|FG003|Overall Study|Cancellation|0|||
163304979|NCT00390299|589823927|FG004|Overall Study|Cancellation|0|||
163396608|NCT02490475|590162750|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
162962795|NCT03234907|588564645|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
162962796|NCT03234907|588564646|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
162962797|NCT03234907|588564641|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
162962798|NCT03234907|588564642|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
162962799|NCT03234907|588564643|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
162962800|NCT03234907|588564644|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
162962801|NCT03234907|588564645|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
162962802|NCT03234907|588564646|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
162962803|NCT03234907|588564641|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
162962804|NCT03234907|588564642|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
162962805|NCT03234907|588564643|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
162962806|NCT03234907|588564644|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
162962807|NCT03234907|588564645|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
163304980|NCT02965846|589823929|FG000|Overall Study|Lost to Follow-up|1|||
163304981|NCT02965846|589823930|FG001|Overall Study|Lost to Follow-up|0|||
163304982|NCT02965846|589823931|FG002|Overall Study|Lost to Follow-up|0|||
163304983|NCT02965846|589823929|FG000|Overall Study|Withdrawal by Subject|0|||
163304984|NCT02965846|589823930|FG001|Overall Study|Withdrawal by Subject|1|||
162962808|NCT03234907|588564646|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
163049815|NCT00643760|588890930|FG000|Overall Study|Lack of Efficacy|3|||
163049816|NCT00643760|588890931|FG001|Overall Study|Lack of Efficacy|1|||
163049817|NCT00643760|588890932|FG002|Overall Study|Lack of Efficacy|0|||
163049818|NCT00643760|588890933|FG003|Overall Study|Lack of Efficacy|4|||
163049819|NCT00643760|588890934|FG004|Overall Study|Lack of Efficacy|3|||
163049820|NCT00643760|588890930|FG000|Overall Study|Protocol Violation|7|||
163049821|NCT00643760|588890931|FG001|Overall Study|Protocol Violation|6|||
163049822|NCT00643760|588890932|FG002|Overall Study|Protocol Violation|4|||
163049823|NCT00643760|588890933|FG003|Overall Study|Protocol Violation|4|||
163049824|NCT00643760|588890934|FG004|Overall Study|Protocol Violation|6|||
163049825|NCT00643760|588890930|FG000|Overall Study|Lost to Follow-up|6|||
163049826|NCT00643760|588890931|FG001|Overall Study|Lost to Follow-up|2|||
163049827|NCT00643760|588890932|FG002|Overall Study|Lost to Follow-up|1|||
163049828|NCT00643760|588890933|FG003|Overall Study|Lost to Follow-up|3|||
163049829|NCT00643760|588890934|FG004|Overall Study|Lost to Follow-up|3|||
163049830|NCT00643760|588890930|FG000|Overall Study|Investigator Discretion|0|||
163049831|NCT00643760|588890931|FG001|Overall Study|Investigator Discretion|0|||
163049832|NCT00643760|588890932|FG002|Overall Study|Investigator Discretion|0|||
163049833|NCT00643760|588890933|FG003|Overall Study|Investigator Discretion|2|||
163049834|NCT00643760|588890934|FG004|Overall Study|Investigator Discretion|0|||
163049835|NCT00643760|588890930|FG000|Overall Study|Withdrawal by Subject|3|||
163049836|NCT00643760|588890931|FG001|Overall Study|Withdrawal by Subject|1|||
163049837|NCT00643760|588890932|FG002|Overall Study|Withdrawal by Subject|2|||
163049838|NCT00643760|588890933|FG003|Overall Study|Withdrawal by Subject|4|||
163049839|NCT00643760|588890934|FG004|Overall Study|Withdrawal by Subject|1|||
163049840|NCT00789321|588890938|FG000|Overall Study|Adverse Event|0|||
163049841|NCT00789321|588890939|FG001|Overall Study|Adverse Event|1|||
163049842|NCT00104052|588890940|FG000|Overall Study|Adverse Event|1|||
163049843|NCT00104052|588890940|FG000|Overall Study|Lack of Efficacy|26|||
163049844|NCT00104052|588890940|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
163049845|NCT01162343|588890941|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
163049846|NCT01162343|588890941|FG000|Overall Study|Refused psychiatrist assessment|12|||
163049847|NCT02771275|588890942|FG000|Overall Study|Reoperation|3|||
163049848|NCT02771275|588890942|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
163049849|NCT05556148|588890943|FG000|Overall Study|Early Termination|29|||
163049850|NCT05556148|588890943|FG000|Overall Study|Baseline Tasks Expired|4|||
163049851|NCT05556148|588890943|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
163049852|NCT05556148|588890943|FG000|Overall Study|No Longer Wished to Participate|1|||
163049853|NCT05556148|588890943|FG000|Overall Study|Bacterial Conjunctivitis|1|||
163049854|NCT03191799|588890944|FG000|Overall Study|Withdrawal by Subject|4|||
163049855|NCT03191799|588890944|FG000|Overall Study|Physician Decision|2|||
163049856|NCT03191799|588890944|FG000|Overall Study|Lost to Follow-up|1|||
163049857|NCT03191799|588890944|FG000|Overall Study|Death|2|||
163049858|NCT01239797|588890945|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
163049859|NCT01239797|588890946|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
163049860|NCT01239797|588890945|FG000|Randomized Participants|Participant withdrew consent|1|||
163049861|NCT01239797|588890946|FG001|Randomized Participants|Participant withdrew consent|7|||
163049862|NCT01239797|588890945|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
163049863|NCT01239797|588890946|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
163049864|NCT01239797|588890945|FG000|Treated Participants|Disease progression|185|||
163049865|NCT01239797|588890946|FG001|Treated Participants|Disease progression|185|||
163049866|NCT01239797|588890945|FG000|Treated Participants|Study drug toxicity|39|||
163049867|NCT01239797|588890946|FG001|Treated Participants|Study drug toxicity|45|||
163049868|NCT01239797|588890945|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
163049869|NCT01239797|588890946|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
163049870|NCT01239797|588890945|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
163049871|NCT01239797|588890946|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
163049872|NCT01239797|588890945|FG000|Treated Participants|Administrative reason by sponsor|13|||
163049873|NCT01239797|588890946|FG001|Treated Participants|Administrative reason by sponsor|4|||
163198958|NCT03066804|589443202|FG001|Overall Study|Lost to Follow-up|0|||
163049874|NCT01239797|588890945|FG000|Treated Participants|Other reasons|14|||
163049875|NCT01239797|588890946|FG001|Treated Participants|Other reasons|14|||
163049876|NCT01239797|588890945|FG000|Treated Participants|Participant withdrew consent|6|||
163049877|NCT01239797|588890946|FG001|Treated Participants|Participant withdrew consent|11|||
163049878|NCT01239797|588890945|FG000|Treated Participants|Death|1|||
163049879|NCT01239797|588890946|FG001|Treated Participants|Death|1|||
163049880|NCT01239797|588890945|FG000|Treated Participants|Participant no longer meets study criteria|1|||
163049881|NCT01239797|588890946|FG001|Treated Participants|Participant no longer meets study criteria|1|||
163049882|NCT01239797|588890945|FG000|Treated Participants|Poor/non-compliance|0|||
163049883|NCT01239797|588890946|FG001|Treated Participants|Poor/non-compliance|1|||
163049884|NCT02631941|588890949|FG000|Overall Study|Physician Decision|0|||
163049885|NCT02631941|588890950|FG001|Overall Study|Physician Decision|1|||
163049886|NCT02631941|588890951|FG002|Overall Study|Physician Decision|0|||
163049887|NCT02631941|588890952|FG003|Overall Study|Physician Decision|0|||
163049888|NCT02631941|588890953|FG004|Overall Study|Physician Decision|0|||
163049889|NCT02631941|588890954|FG005|Overall Study|Physician Decision|0|||
163049890|NCT02631941|588890955|FG006|Overall Study|Physician Decision|0|||
163049891|NCT02631941|588890956|FG007|Overall Study|Physician Decision|0|||
163049892|NCT02631941|588890957|FG008|Overall Study|Physician Decision|0|||
163049893|NCT02631941|588890958|FG009|Overall Study|Physician Decision|0|||
163049894|NCT02631941|588890949|FG000|Overall Study|Adverse Event|0|||
163049895|NCT02631941|588890950|FG001|Overall Study|Adverse Event|1|||
163049896|NCT02631941|588890951|FG002|Overall Study|Adverse Event|0|||
163049897|NCT02631941|588890952|FG003|Overall Study|Adverse Event|0|||
163049898|NCT02631941|588890953|FG004|Overall Study|Adverse Event|0|||
163049899|NCT02631941|588890954|FG005|Overall Study|Adverse Event|0|||
163049900|NCT02631941|588890955|FG006|Overall Study|Adverse Event|0|||
163049901|NCT02631941|588890956|FG007|Overall Study|Adverse Event|0|||
163049902|NCT02631941|588890957|FG008|Overall Study|Adverse Event|0|||
163049903|NCT02631941|588890958|FG009|Overall Study|Adverse Event|0|||
163049904|NCT02631941|588890949|FG000|Overall Study|Withdrawal by Subject|0|||
163049905|NCT02631941|588890950|FG001|Overall Study|Withdrawal by Subject|0|||
163049906|NCT02631941|588890951|FG002|Overall Study|Withdrawal by Subject|0|||
163049907|NCT02631941|588890952|FG003|Overall Study|Withdrawal by Subject|0|||
163049908|NCT02631941|588890953|FG004|Overall Study|Withdrawal by Subject|1|||
163049909|NCT02631941|588890954|FG005|Overall Study|Withdrawal by Subject|0|||
163049910|NCT02631941|588890955|FG006|Overall Study|Withdrawal by Subject|0|||
163049911|NCT02631941|588890956|FG007|Overall Study|Withdrawal by Subject|1|||
163049912|NCT02631941|588890957|FG008|Overall Study|Withdrawal by Subject|0|||
163049913|NCT02631941|588890958|FG009|Overall Study|Withdrawal by Subject|0|||
163049914|NCT02631941|588890949|FG000|Overall Study|Lost to Follow-up|0|||
163049915|NCT02631941|588890950|FG001|Overall Study|Lost to Follow-up|0|||
163049916|NCT02631941|588890951|FG002|Overall Study|Lost to Follow-up|0|||
163049917|NCT02631941|588890952|FG003|Overall Study|Lost to Follow-up|0|||
163049918|NCT02631941|588890953|FG004|Overall Study|Lost to Follow-up|0|||
163049919|NCT02631941|588890954|FG005|Overall Study|Lost to Follow-up|0|||
163049920|NCT02631941|588890955|FG006|Overall Study|Lost to Follow-up|0|||
163049921|NCT02631941|588890956|FG007|Overall Study|Lost to Follow-up|0|||
163049922|NCT02631941|588890957|FG008|Overall Study|Lost to Follow-up|1|||
163049923|NCT02631941|588890958|FG009|Overall Study|Lost to Follow-up|0|||
163049924|NCT02087774|588890959|FG000|Overall Study|Were absent day of data collection|8|||
163049925|NCT02087774|588890960|FG001|Overall Study|Were absent day of data collection|20|||
163049926|NCT00731822|588890962|FG000|Overall Study|Adverse Event|2|||
163049927|NCT00731822|588890963|FG001|Overall Study|Adverse Event|1|||
163049928|NCT00731822|588890962|FG000|Overall Study|Protocol Violation|1|||
163049929|NCT00731822|588890963|FG001|Overall Study|Protocol Violation|0|||
163049930|NCT00731822|588890962|FG000|Overall Study|Lost to Follow-up|1|||
163049931|NCT00731822|588890963|FG001|Overall Study|Lost to Follow-up|0|||
163049932|NCT04073303|588890964|FG000|Overall Study|Adverse Event|0|||
163049933|NCT04073303|588890965|FG001|Overall Study|Adverse Event|2|||
163049934|NCT04073303|588890964|FG000|Overall Study|Withdrawal by Subject|16|||
163049935|NCT04073303|588890965|FG001|Overall Study|Withdrawal by Subject|36|||
163049936|NCT04073303|588890964|FG000|Overall Study|Lost to Follow-up|6|||
163049937|NCT04073303|588890965|FG001|Overall Study|Lost to Follow-up|1|||
163049938|NCT04073303|588890964|FG000|Overall Study|Protocol Deviation|0|||
163198959|NCT03066804|589443201|FG000|Overall Study|Adverse Event|2|||
163198960|NCT03066804|589443202|FG001|Overall Study|Adverse Event|3|||
163198961|NCT03066804|589443201|FG000|Overall Study|Technical problems|5|||
163198962|NCT03066804|589443202|FG001|Overall Study|Technical problems|1|||
163198963|NCT03982368|589443207|FG000|Overall Study|Adverse Event|6|||
163198964|NCT03982368|589443208|FG001|Overall Study|Adverse Event|4|||
163198965|NCT03982368|589443209|FG002|Overall Study|Adverse Event|3|||
163198966|NCT03982368|589443207|FG000|Overall Study|Lost to Follow-up|2|||
163049939|NCT04073303|588890965|FG001|Overall Study|Protocol Deviation|4|||
163049940|NCT04073303|588890964|FG000|Overall Study|Other|1|||
163198967|NCT03982368|589443208|FG001|Overall Study|Lost to Follow-up|1|||
163198968|NCT03982368|589443209|FG002|Overall Study|Lost to Follow-up|0|||
163198969|NCT03982368|589443207|FG000|Overall Study|Withdrawal by Subject|1|||
163049941|NCT04073303|588890965|FG001|Overall Study|Other|1|||
163049942|NCT01867008|588890966|FG000|Overall Study|Withdrawal by Subject|1|||
163049943|NCT01158261|588890967|FG000|Overall Study|Lost to Follow-up|9|||
163049944|NCT01158261|588890967|FG000|Overall Study|Death|7|||
163049945|NCT01158261|588890967|FG000|Overall Study|Withdrawal by Subject|1|||
163049946|NCT03143101|588890968|FG000|Overall Study|Withdrawal by Subject|0|||
163049947|NCT03143101|588890969|FG001|Overall Study|Withdrawal by Subject|1|||
163049948|NCT03143101|588890970|FG002|Overall Study|Withdrawal by Subject|0|||
163049949|NCT03143101|588890968|FG000|Overall Study|Lost to Follow-up|2|||
163049950|NCT03143101|588890969|FG001|Overall Study|Lost to Follow-up|2|||
163049951|NCT03143101|588890970|FG002|Overall Study|Lost to Follow-up|0|||
163049952|NCT05227118|588890971|FG000|Overall Study|Adverse Event|0|||
163198970|NCT03982368|589443208|FG001|Overall Study|Withdrawal by Subject|2|||
162962809|NCT02986139|588564649|FG000|Overall Study|Sponsor Decision|1|||
163049953|NCT05227118|588890972|FG001|Overall Study|Adverse Event|0|||
163049954|NCT05227118|588890973|FG002|Overall Study|Adverse Event|1|||
163049955|NCT05227118|588890974|FG003|Overall Study|Adverse Event|0|||
163049956|NCT05227118|588890971|FG000|Overall Study|Withdrawal by Subject|0|||
163049957|NCT05227118|588890972|FG001|Overall Study|Withdrawal by Subject|0|||
163049958|NCT05227118|588890973|FG002|Overall Study|Withdrawal by Subject|2|||
163049959|NCT05227118|588890974|FG003|Overall Study|Withdrawal by Subject|0|||
163049960|NCT03727841|588890977|FG000|Overall Study|Physician Decision|3|||
163049961|NCT03727841|588890978|FG001|Overall Study|Physician Decision|1|||
163049962|NCT03126786|588890979|FG000|Overall Study|Adverse Event|3|||
163049963|NCT03126786|588890980|FG001|Overall Study|Adverse Event|0|||
163049964|NCT03126786|588890979|FG000|Overall Study|Lost to Follow-up|0|||
163049965|NCT03126786|588890980|FG001|Overall Study|Lost to Follow-up|1|||
163049966|NCT03126786|588890979|FG000|Overall Study|Withdrawal by Subject|3|||
163049967|NCT03126786|588890980|FG001|Overall Study|Withdrawal by Subject|1|||
163049968|NCT01601496|588890981|FG000|Overall Study|Physician Decision|1|||
163049969|NCT01601496|588890981|FG000|Overall Study|Withdrawal by Subject|1|||
163049970|NCT01601496|588890981|FG000|Overall Study|Lost to Follow-up|6|||
163049971|NCT01601496|588890981|FG000|Overall Study|Death|4|||
163049972|NCT01601496|588890981|FG000|Overall Study|Other: patient refusal to continue|3|||
163049973|NCT03243305|588890982|FG000|Overall Study|Lost to Follow-up|250|||
163049974|NCT03243305|588890982|FG000|Overall Study|Withdrawal by Subject|170|||
163049975|NCT03243305|588890982|FG000|Overall Study|Pregnancy|104|||
163049976|NCT03243305|588890982|FG000|Overall Study|Non-Compliance with Study Drug|38|||
162962810|NCT02986139|588564650|FG001|Overall Study|Sponsor Decision|2|||
162962811|NCT02986139|588564649|FG000|Overall Study|Withdrawal by Subject|0|||
162962812|NCT02986139|588564650|FG001|Overall Study|Withdrawal by Subject|1|||
162962813|NCT02986139|588564649|FG000|Overall Study|Lost to Follow-up|0|||
162962814|NCT02986139|588564650|FG001|Overall Study|Lost to Follow-up|1|||
163049977|NCT03243305|588890982|FG000|Overall Study|Adverse Event|23|||
163049978|NCT03243305|588890982|FG000|Overall Study|No sexually active|26|||
163049979|NCT03243305|588890982|FG000|Overall Study|Physician Decision|22|||
163049980|NCT03243305|588890982|FG000|Overall Study|Protocol Violation|22|||
163049981|NCT03243305|588890982|FG000|Overall Study|Study method no longer primary method|12|||
163049982|NCT03243305|588890982|FG000|Overall Study|Study Terminated by Sponsor|1|||
163049983|NCT03243305|588890982|FG000|Overall Study|Early terminations|267|||
163049984|NCT02689804|588890983|FG000|Overall Study|Withdrawal by Subject|2|||
162962815|NCT02583048|588564651|FG000|Overall Study|Withdrawal by Subject|0|||
162962816|NCT02583048|588564652|FG001|Overall Study|Withdrawal by Subject|1|||
162962817|NCT02583048|588564653|FG002|Overall Study|Withdrawal by Subject|0|||
162962818|NCT02583048|588564651|FG000|Overall Study|Failed to meet eligibility criterion|0|||
162962819|NCT02583048|588564652|FG001|Overall Study|Failed to meet eligibility criterion|0|||
162962820|NCT02583048|588564653|FG002|Overall Study|Failed to meet eligibility criterion|1|||
162962821|NCT00414726|588564657|FG000|Overall Study|Withdrawal by Subject|0|||
162962822|NCT00414726|588564658|FG001|Overall Study|Withdrawal by Subject|1|||
162962823|NCT02107196|588564659|FG000|12-week Treatment Period|Adverse Event|6|||
162962824|NCT02107196|588564660|FG001|12-week Treatment Period|Adverse Event|3|||
162962825|NCT02107196|588564659|FG000|12-week Treatment Period|Lack of Efficacy|2|||
162962826|NCT02107196|588564660|FG001|12-week Treatment Period|Lack of Efficacy|1|||
162962827|NCT02107196|588564659|FG000|12-week Treatment Period|Lost to Follow-up|3|||
162962828|NCT02107196|588564660|FG001|12-week Treatment Period|Lost to Follow-up|6|||
162962829|NCT02107196|588564659|FG000|12-week Treatment Period|Physician Decision|0|||
162962830|NCT02107196|588564660|FG001|12-week Treatment Period|Physician Decision|1|||
162962831|NCT02107196|588564659|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
162962832|NCT02107196|588564660|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
163049985|NCT02689804|588890984|FG001|Overall Study|Withdrawal by Subject|0|||
163049986|NCT00227539|588890985|FG000|Overall Study|Protocol Violation|1|||
163049987|NCT00673257|588890986|FG000|Overall Study|Withdrawal by Subject|4|||
163198971|NCT03982368|589443209|FG002|Overall Study|Withdrawal by Subject|0|||
163198972|NCT03982368|589443207|FG000|Overall Study|unknow|4|||
163198973|NCT03982368|589443208|FG001|Overall Study|unknow|0|||
163198974|NCT03982368|589443209|FG002|Overall Study|unknow|2|||
163198975|NCT00518284|589443210|FG000|Overall Study|Adverse Event|0|||
163198976|NCT00518284|589443211|FG001|Overall Study|Adverse Event|1|||
163198977|NCT00518284|589443212|FG002|Overall Study|Adverse Event|0|||
163198978|NCT00518284|589443213|FG003|Overall Study|Adverse Event|0|||
163049988|NCT00673257|588890986|FG000|Overall Study|Unable to obtain specimen|1|||
163049989|NCT04552132|588890989|FG000|Overall Study|Lost to Follow-up|4|||
163049990|NCT04552132|588890990|FG001|Overall Study|Lost to Follow-up|3|||
163049991|NCT04552132|588890989|FG000|Overall Study|Protocol Violation|1|||
163049992|NCT04552132|588890990|FG001|Overall Study|Protocol Violation|0|||
162962833|NCT02107196|588564659|FG000|12-week Treatment Period|Protocol Violation|7|||
162962834|NCT02107196|588564660|FG001|12-week Treatment Period|Protocol Violation|8|||
162962835|NCT02107196|588564659|FG000|12-week Treatment Period|Reason Missing|11|||
162962836|NCT02107196|588564660|FG001|12-week Treatment Period|Reason Missing|8|||
163198979|NCT00518284|589443210|FG000|Overall Study|Study Termination|0|||
163198980|NCT00518284|589443211|FG001|Overall Study|Study Termination|2|||
163396609|NCT02490475|590162751|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
162962837|NCT02107196|588564659|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
162962838|NCT02107196|588564660|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
162962839|NCT02107196|588564659|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
162962840|NCT02107196|588564660|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
162962841|NCT02107196|588564659|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
162962842|NCT02107196|588564660|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
162962843|NCT02107196|588564659|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
162962844|NCT02107196|588564660|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
162962845|NCT00691704|588564663|FG000|Induction Therapy|Disease Progression|1|||
162962846|NCT00691704|588564663|FG000|Induction Therapy|Active Hepatitis|1|||
162962847|NCT00691704|588564663|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
162962848|NCT00691704|588564663|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
162962849|NCT00691704|588564663|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
162962850|NCT01993186|588564664|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
162962851|NCT01993186|588564665|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
162962852|NCT01993186|588564664|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
162962853|NCT01993186|588564665|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
163198981|NCT00518284|589443212|FG002|Overall Study|Study Termination|1|||
163198982|NCT00518284|589443213|FG003|Overall Study|Study Termination|2|||
163198983|NCT03570697|589443214|FG000|Overall Study|Lost to Follow-up|0|||
163198984|NCT03570697|589443215|FG001|Overall Study|Lost to Follow-up|1|||
163198985|NCT03570697|589443214|FG000|Overall Study|Death|2|||
163198986|NCT03570697|589443215|FG001|Overall Study|Death|0|||
163198987|NCT03570697|589443214|FG000|Overall Study|Withdrawal by Subject|4|||
163198988|NCT03570697|589443215|FG001|Overall Study|Withdrawal by Subject|2|||
163198989|NCT01849783|589443216|FG000|Overall Study|Adverse Event|5|||
163198990|NCT01849783|589443216|FG000|Overall Study|Death|2|||
163198991|NCT01849783|589443216|FG000|Overall Study|Physician Decision|1|||
163198992|NCT01849783|589443216|FG000|Overall Study|Withdrawal by Subject|1|||
163198993|NCT01849783|589443216|FG000|Overall Study|Unable to comply|2|||
163198994|NCT01849783|589443216|FG000|Overall Study|Disease progression|11|||
163198995|NCT02571777|589443217|FG000|Overall Study|Subject/guardian decision|34|||
163198996|NCT02571777|589443218|FG001|Overall Study|Subject/guardian decision|26|||
163198997|NCT02571777|589443219|FG002|Overall Study|Subject/guardian decision|26|||
163198998|NCT02571777|589443220|FG003|Overall Study|Subject/guardian decision|25|||
163198999|NCT02571777|589443221|FG004|Overall Study|Subject/guardian decision|27|||
163199000|NCT02571777|589443217|FG000|Overall Study|Protocol Deviation|2|||
163199001|NCT02571777|589443218|FG001|Overall Study|Protocol Deviation|3|||
163199002|NCT02571777|589443219|FG002|Overall Study|Protocol Deviation|4|||
163199003|NCT02571777|589443220|FG003|Overall Study|Protocol Deviation|8|||
163199004|NCT02571777|589443221|FG004|Overall Study|Protocol Deviation|4|||
163199005|NCT02571777|589443217|FG000|Overall Study|Death|1|||
163199006|NCT02571777|589443218|FG001|Overall Study|Death|1|||
163199007|NCT02571777|589443219|FG002|Overall Study|Death|4|||
163199008|NCT02571777|589443220|FG003|Overall Study|Death|0|||
163199009|NCT02571777|589443221|FG004|Overall Study|Death|0|||
163199010|NCT02571777|589443217|FG000|Overall Study|Lost to Follow-up|1|||
163199011|NCT02571777|589443218|FG001|Overall Study|Lost to Follow-up|1|||
163199012|NCT02571777|589443219|FG002|Overall Study|Lost to Follow-up|2|||
163199013|NCT02571777|589443220|FG003|Overall Study|Lost to Follow-up|0|||
163199014|NCT02571777|589443221|FG004|Overall Study|Lost to Follow-up|1|||
163199015|NCT02571777|589443217|FG000|Overall Study|Physician Decision|1|||
163199016|NCT02571777|589443218|FG001|Overall Study|Physician Decision|7|||
163199017|NCT02571777|589443219|FG002|Overall Study|Physician Decision|5|||
163199018|NCT02571777|589443220|FG003|Overall Study|Physician Decision|2|||
163199019|NCT02571777|589443221|FG004|Overall Study|Physician Decision|4|||
163199020|NCT02571777|589443217|FG000|Overall Study|Pregnancy|0|||
163199021|NCT02571777|589443218|FG001|Overall Study|Pregnancy|0|||
163304985|NCT02965846|589823931|FG002|Overall Study|Withdrawal by Subject|0|||
163304986|NCT02965846|589823929|FG000|Overall Study|Study Terminated By Sponsor|4|||
163304987|NCT02965846|589823930|FG001|Overall Study|Study Terminated By Sponsor|4|||
163304988|NCT02965846|589823931|FG002|Overall Study|Study Terminated By Sponsor|0|||
163304989|NCT02965846|589823929|FG000|Overall Study|Participants not randomized|0|||
163304990|NCT02965846|589823930|FG001|Overall Study|Participants not randomized|0|||
163304991|NCT02965846|589823931|FG002|Overall Study|Participants not randomized|33|||
163304992|NCT00539734|589823932|FG000|Overall Study|Protocol Violation|1|||
163304993|NCT02794480|589823933|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
163304994|NCT02794480|589823934|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
163304995|NCT02794480|589823935|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
163304996|NCT02794480|589823936|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
163396610|NCT02490475|590162752|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
162962854|NCT01993186|588564664|FG000|Open-Label Extension Period|Other, Not Specified|0|||
162962855|NCT01993186|588564665|FG001|Open-Label Extension Period|Other, Not Specified|1|||
162962856|NCT01993186|588564664|FG000|Open-Label Extension Period|Adverse Event|1|||
162962857|NCT01993186|588564665|FG001|Open-Label Extension Period|Adverse Event|0|||
162962858|NCT01993186|588564664|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
162962859|NCT01993186|588564665|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
162962860|NCT01993186|588564664|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
162962861|NCT01993186|588564665|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
162962862|NCT01993186|588564664|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
162962863|NCT01993186|588564665|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
162962864|NCT02451696|588564667|FG000|Overall Study|Surgery postponed|1|||
162962865|NCT02451696|588564668|FG001|Overall Study|Surgery postponed|0|||
162962866|NCT00198133|588564669|FG000|Overall Study|Disease progression|2|||
162962867|NCT00198133|588564670|FG001|Overall Study|Disease progression|5|||
162962868|NCT00198133|588564669|FG000|Overall Study|Adverse Event|1|||
162962869|NCT00198133|588564670|FG001|Overall Study|Adverse Event|3|||
162962870|NCT00198133|588564669|FG000|Overall Study|Withdrawal by Subject|1|||
162962871|NCT00198133|588564670|FG001|Overall Study|Withdrawal by Subject|0|||
162962872|NCT00198133|588564669|FG000|Overall Study|Physician Decision|1|||
163304997|NCT02794480|589823933|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
163199022|NCT02571777|589443219|FG002|Overall Study|Pregnancy|0|||
162962873|NCT00198133|588564670|FG001|Overall Study|Physician Decision|0|||
162962874|NCT01557751|588564671|FG000|Overall Study|Physician Decision|3|||
162962875|NCT02752074|588564672|FG000|Overall Study|Lost to Follow-up|1|||
162962876|NCT02752074|588564673|FG001|Overall Study|Lost to Follow-up|4|||
162962877|NCT02752074|588564672|FG000|Overall Study|Death|146|||
162962878|NCT02752074|588564673|FG001|Overall Study|Death|129|||
162962879|NCT02752074|588564672|FG000|Overall Study|Withdrawal by Subject|9|||
162962880|NCT02752074|588564673|FG001|Overall Study|Withdrawal by Subject|10|||
163199023|NCT02571777|589443220|FG003|Overall Study|Pregnancy|2|||
162962881|NCT00840216|588564674|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
162962882|NCT00840216|588564675|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
163199024|NCT02571777|589443221|FG004|Overall Study|Pregnancy|0|||
163199025|NCT05393895|589443225|FG000|Overall Study|Adverse Event|2|||
163199026|NCT05393895|589443226|FG001|Overall Study|Adverse Event|3|||
163199027|NCT05393895|589443225|FG000|Overall Study|Lost to Follow-up|4|||
163396611|NCT02490475|590162753|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
163396612|NCT02490475|590162750|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
163396613|NCT02490475|590162751|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
163396614|NCT02490475|590162752|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
163396615|NCT02490475|590162753|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
163396616|NCT02490475|590162750|FG000|Period 2: Extension Phase|Refused Treatment|0|||
163396617|NCT02490475|590162751|FG001|Period 2: Extension Phase|Refused Treatment|0|||
163396618|NCT02490475|590162752|FG002|Period 2: Extension Phase|Refused Treatment|0|||
163396619|NCT02490475|590162753|FG003|Period 2: Extension Phase|Refused Treatment|1|||
163199028|NCT05393895|589443226|FG001|Overall Study|Lost to Follow-up|3|||
163199029|NCT05393895|589443225|FG000|Overall Study|Protocol Violation|1|||
163199030|NCT05393895|589443226|FG001|Overall Study|Protocol Violation|0|||
163199031|NCT05393895|589443225|FG000|Overall Study|Withdrawal by Subject|1|||
163199032|NCT05393895|589443226|FG001|Overall Study|Withdrawal by Subject|4|||
163199033|NCT03190915|589443227|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
163199034|NCT03190915|589443227|FG000|Overall Study|Progressive Disease|3|||
163199035|NCT01546883|589443241|FG000|Overall Study|Withdrawal by Subject|3|||
163199036|NCT01546883|589443241|FG000|Overall Study|Adverse Event|4|||
163199037|NCT01546883|589443241|FG000|Overall Study|Lost to Follow-up|2|||
163199038|NCT01546883|589443241|FG000|Overall Study|early closure of study|2|||
163199039|NCT01546883|589443241|FG000|Overall Study|other unrelated illness|1|||
163199040|NCT02021773|589443242|FG000|Overall Study|Adverse Event|1|||
163199041|NCT02021773|589443243|FG001|Overall Study|Adverse Event|4|||
163199042|NCT02021773|589443244|FG002|Overall Study|Adverse Event|3|||
163199043|NCT02021773|589443242|FG000|Overall Study|Lack of Efficacy|2|||
163199044|NCT02021773|589443243|FG001|Overall Study|Lack of Efficacy|2|||
163199045|NCT02021773|589443244|FG002|Overall Study|Lack of Efficacy|2|||
163199046|NCT02021773|589443242|FG000|Overall Study|Protocol Violation|2|||
163199047|NCT02021773|589443243|FG001|Overall Study|Protocol Violation|3|||
163049993|NCT00570401|588890991|FG000|Overall Study|Adverse Event|2|||
163049994|NCT05616013|588890997|FG000|Overall Study|Adverse Event|6|||
163049995|NCT05616013|588890998|FG001|Overall Study|Adverse Event|12|||
163049996|NCT05616013|588890999|FG002|Overall Study|Adverse Event|8|||
163049997|NCT05616013|588891000|FG003|Overall Study|Adverse Event|4|||
163049998|NCT05616013|588891001|FG004|Overall Study|Adverse Event|6|||
163049999|NCT05616013|588891002|FG005|Overall Study|Adverse Event|8|||
163050000|NCT05616013|588891003|FG006|Overall Study|Adverse Event|3|||
163050001|NCT05616013|588891004|FG007|Overall Study|Adverse Event|6|||
163050002|NCT05616013|588891005|FG008|Overall Study|Adverse Event|1|||
163050003|NCT05616013|588890997|FG000|Overall Study|Lost to Follow-up|5|||
163050004|NCT05616013|588890998|FG001|Overall Study|Lost to Follow-up|4|||
163050005|NCT05616013|588890999|FG002|Overall Study|Lost to Follow-up|3|||
163050006|NCT05616013|588891000|FG003|Overall Study|Lost to Follow-up|2|||
163050007|NCT05616013|588891001|FG004|Overall Study|Lost to Follow-up|0|||
163050008|NCT05616013|588891002|FG005|Overall Study|Lost to Follow-up|5|||
163050009|NCT05616013|588891003|FG006|Overall Study|Lost to Follow-up|2|||
163050010|NCT05616013|588891004|FG007|Overall Study|Lost to Follow-up|1|||
163050011|NCT05616013|588891005|FG008|Overall Study|Lost to Follow-up|2|||
163050012|NCT05616013|588890997|FG000|Overall Study|Non-compliance with study requirements|2|||
163050013|NCT05616013|588890998|FG001|Overall Study|Non-compliance with study requirements|2|||
163050014|NCT05616013|588890999|FG002|Overall Study|Non-compliance with study requirements|2|||
163050015|NCT05616013|588891000|FG003|Overall Study|Non-compliance with study requirements|3|||
163050016|NCT05616013|588891001|FG004|Overall Study|Non-compliance with study requirements|0|||
163050017|NCT05616013|588891002|FG005|Overall Study|Non-compliance with study requirements|2|||
163050018|NCT05616013|588891003|FG006|Overall Study|Non-compliance with study requirements|1|||
163050019|NCT05616013|588891004|FG007|Overall Study|Non-compliance with study requirements|1|||
163050020|NCT05616013|588891005|FG008|Overall Study|Non-compliance with study requirements|4|||
163050021|NCT05616013|588890997|FG000|Overall Study|Withdrawal by Subject|11|||
163050022|NCT05616013|588890998|FG001|Overall Study|Withdrawal by Subject|9|||
163050023|NCT05616013|588890999|FG002|Overall Study|Withdrawal by Subject|8|||
163050024|NCT05616013|588891000|FG003|Overall Study|Withdrawal by Subject|6|||
163050025|NCT05616013|588891001|FG004|Overall Study|Withdrawal by Subject|3|||
163050026|NCT05616013|588891002|FG005|Overall Study|Withdrawal by Subject|4|||
163050027|NCT05616013|588891003|FG006|Overall Study|Withdrawal by Subject|6|||
163050028|NCT05616013|588891004|FG007|Overall Study|Withdrawal by Subject|5|||
163050029|NCT05616013|588891005|FG008|Overall Study|Withdrawal by Subject|4|||
163050030|NCT05616013|588890997|FG000|Overall Study|Physician Decision|0|||
163050031|NCT05616013|588890998|FG001|Overall Study|Physician Decision|0|||
163050032|NCT05616013|588890999|FG002|Overall Study|Physician Decision|1|||
163050033|NCT05616013|588891000|FG003|Overall Study|Physician Decision|0|||
163050034|NCT05616013|588891001|FG004|Overall Study|Physician Decision|0|||
163199048|NCT02021773|589443244|FG002|Overall Study|Protocol Violation|1|||
163050035|NCT05616013|588891002|FG005|Overall Study|Physician Decision|1|||
163050036|NCT05616013|588891003|FG006|Overall Study|Physician Decision|3|||
163050037|NCT05616013|588891004|FG007|Overall Study|Physician Decision|0|||
163050038|NCT05616013|588891005|FG008|Overall Study|Physician Decision|0|||
163050039|NCT05616013|588890997|FG000|Overall Study|Protocol Violation|0|||
163050040|NCT05616013|588890998|FG001|Overall Study|Protocol Violation|0|||
163050041|NCT05616013|588890999|FG002|Overall Study|Protocol Violation|0|||
163050042|NCT05616013|588891000|FG003|Overall Study|Protocol Violation|0|||
163050043|NCT05616013|588891001|FG004|Overall Study|Protocol Violation|0|||
163050044|NCT05616013|588891002|FG005|Overall Study|Protocol Violation|0|||
163050045|NCT05616013|588891003|FG006|Overall Study|Protocol Violation|1|||
163050046|NCT05616013|588891004|FG007|Overall Study|Protocol Violation|0|||
163050047|NCT05616013|588891005|FG008|Overall Study|Protocol Violation|2|||
163050048|NCT05616013|588890997|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
163050049|NCT05616013|588890998|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050050|NCT05616013|588890999|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050051|NCT05616013|588891000|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050052|NCT05616013|588891001|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050053|NCT05616013|588891002|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050054|NCT05616013|588891003|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050055|NCT05616013|588891004|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050056|NCT05616013|588891005|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050057|NCT05616013|588890997|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
163050058|NCT05616013|588890998|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050059|NCT05616013|588890999|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050060|NCT05616013|588891000|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050061|NCT05616013|588891001|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050062|NCT05616013|588891002|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050063|NCT05616013|588891003|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050064|NCT05616013|588891004|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050065|NCT05616013|588891005|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050066|NCT05616013|588890997|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
163050067|NCT05616013|588890998|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050068|NCT05616013|588890999|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050069|NCT05616013|588891000|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050070|NCT05616013|588891001|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050071|NCT05616013|588891002|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050072|NCT05616013|588891003|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050073|NCT05616013|588891004|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050074|NCT05616013|588891005|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050075|NCT05616013|588890997|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050076|NCT05616013|588890998|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
163050077|NCT05616013|588890999|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050078|NCT05616013|588891000|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050079|NCT05616013|588891001|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050080|NCT05616013|588891002|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050081|NCT05616013|588891003|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050082|NCT05616013|588891004|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050083|NCT05616013|588891005|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050084|NCT05616013|588890997|FG000|Overall Study|Participant Decision, Time Constraints|0|||
163050085|NCT05616013|588890998|FG001|Overall Study|Participant Decision, Time Constraints|1|||
163050086|NCT05616013|588890999|FG002|Overall Study|Participant Decision, Time Constraints|0|||
163050087|NCT05616013|588891000|FG003|Overall Study|Participant Decision, Time Constraints|0|||
163050088|NCT05616013|588891001|FG004|Overall Study|Participant Decision, Time Constraints|0|||
163050089|NCT05616013|588891002|FG005|Overall Study|Participant Decision, Time Constraints|0|||
163050090|NCT05616013|588891003|FG006|Overall Study|Participant Decision, Time Constraints|0|||
163050091|NCT05616013|588891004|FG007|Overall Study|Participant Decision, Time Constraints|0|||
163050092|NCT05616013|588891005|FG008|Overall Study|Participant Decision, Time Constraints|0|||
163050093|NCT05616013|588890997|FG000|Overall Study|Prohibited Concomitant Medication|0|||
163050094|NCT05616013|588890998|FG001|Overall Study|Prohibited Concomitant Medication|0|||
163050095|NCT05616013|588890999|FG002|Overall Study|Prohibited Concomitant Medication|1|||
163050096|NCT05616013|588891000|FG003|Overall Study|Prohibited Concomitant Medication|0|||
163050097|NCT05616013|588891001|FG004|Overall Study|Prohibited Concomitant Medication|0|||
162962883|NCT01380782|588564677|FG000|Overall Study|Adverse Event|0|||
162962884|NCT01380782|588564678|FG001|Overall Study|Adverse Event|1|||
162962885|NCT01380782|588564679|FG002|Overall Study|Adverse Event|0|||
162962886|NCT01380782|588564680|FG003|Overall Study|Adverse Event|0|||
162962887|NCT01380782|588564677|FG000|Overall Study|Death|1|||
162962888|NCT01380782|588564678|FG001|Overall Study|Death|0|||
162962889|NCT01380782|588564679|FG002|Overall Study|Death|0|||
162962890|NCT01380782|588564680|FG003|Overall Study|Death|0|||
162962891|NCT01380782|588564677|FG000|Overall Study|Lack of Efficacy|10|||
162962892|NCT01380782|588564678|FG001|Overall Study|Lack of Efficacy|9|||
162962893|NCT01380782|588564679|FG002|Overall Study|Lack of Efficacy|10|||
162962894|NCT01380782|588564680|FG003|Overall Study|Lack of Efficacy|3|||
162962895|NCT01380782|588564677|FG000|Overall Study|Physician Decision|1|||
162962896|NCT01380782|588564678|FG001|Overall Study|Physician Decision|0|||
162962897|NCT01380782|588564679|FG002|Overall Study|Physician Decision|0|||
162962898|NCT01380782|588564680|FG003|Overall Study|Physician Decision|0|||
162962899|NCT01380782|588564677|FG000|Overall Study|Withdrawal by Subject|0|||
162962900|NCT01380782|588564678|FG001|Overall Study|Withdrawal by Subject|0|||
162962901|NCT01380782|588564679|FG002|Overall Study|Withdrawal by Subject|1|||
162962902|NCT01380782|588564680|FG003|Overall Study|Withdrawal by Subject|1|||
162962903|NCT01403194|588564684|FG000|Overall Study|Screen Failure|2|||
162962904|NCT01403194|588564684|FG000|Overall Study|Lost to Follow-up|8|||
162962905|NCT04474405|588564685|FG000|Overall Study|Withdrawal by Subject|0|||
162962906|NCT04474405|588564686|FG001|Overall Study|Withdrawal by Subject|0|||
162962907|NCT04474405|588564687|FG002|Overall Study|Withdrawal by Subject|1|||
162962908|NCT04474405|588564688|FG003|Overall Study|Withdrawal by Subject|0|||
162962909|NCT04474405|588564689|FG004|Overall Study|Withdrawal by Subject|1|||
162962910|NCT04474405|588564690|FG005|Overall Study|Withdrawal by Subject|0|||
162962911|NCT04474405|588564685|FG000|Overall Study|Other|0|||
162962912|NCT04474405|588564686|FG001|Overall Study|Other|0|||
162962913|NCT04474405|588564687|FG002|Overall Study|Other|0|||
162962914|NCT04474405|588564688|FG003|Overall Study|Other|0|||
162962915|NCT04474405|588564689|FG004|Overall Study|Other|3|||
162962916|NCT04474405|588564690|FG005|Overall Study|Other|0|||
162962917|NCT00274651|588564691|FG000|Overall Study|Adverse Event|6|||
162962918|NCT00274651|588564692|FG001|Overall Study|Adverse Event|3|||
162962919|NCT00274651|588564691|FG000|Overall Study|Lack of Efficacy|13|||
162962920|NCT00274651|588564692|FG001|Overall Study|Lack of Efficacy|6|||
162962921|NCT00274651|588564691|FG000|Overall Study|Death|1|||
162962922|NCT00274651|588564692|FG001|Overall Study|Death|3|||
163304998|NCT02794480|589823934|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
162962923|NCT00274651|588564691|FG000|Overall Study|Withdrawal by Subject|0|||
163199049|NCT02021773|589443242|FG000|Overall Study|Withdrawal by Subject|3|||
163199050|NCT02021773|589443243|FG001|Overall Study|Withdrawal by Subject|4|||
163199051|NCT02021773|589443244|FG002|Overall Study|Withdrawal by Subject|5|||
163199052|NCT02021773|589443242|FG000|Overall Study|Lost to Follow-up|1|||
163199053|NCT02021773|589443243|FG001|Overall Study|Lost to Follow-up|3|||
163199054|NCT02021773|589443244|FG002|Overall Study|Lost to Follow-up|0|||
163199055|NCT02021773|589443242|FG000|Overall Study|Reason not specified|3|||
163199056|NCT02021773|589443243|FG001|Overall Study|Reason not specified|0|||
163199057|NCT02021773|589443244|FG002|Overall Study|Reason not specified|0|||
163199058|NCT01253408|589443248|FG000|Overall Study|Adverse Event|0|||
162962924|NCT00274651|588564692|FG001|Overall Study|Withdrawal by Subject|1|||
162962925|NCT00274651|588564691|FG000|Overall Study|Physician Decision|8|||
162962926|NCT00274651|588564692|FG001|Overall Study|Physician Decision|7|||
162962927|NCT03446768|588564693|FG000|Overall Study|Withdrawal by Subject|0|||
162962928|NCT03446768|588564694|FG001|Overall Study|Withdrawal by Subject|1|||
162962929|NCT01604941|588564698|FG000|Overall Study|Adverse Event|1|||
162962930|NCT01604941|588564699|FG001|Overall Study|Adverse Event|2|||
162962931|NCT01604941|588564700|FG002|Overall Study|Adverse Event|0|||
162962932|NCT01604941|588564701|FG003|Overall Study|Adverse Event|0|||
162962933|NCT01604941|588564702|FG004|Overall Study|Adverse Event|1|||
162962934|NCT01604941|588564703|FG005|Overall Study|Adverse Event|5|||
162962935|NCT01604941|588564698|FG000|Overall Study|Non-compliance|1|||
162962936|NCT01604941|588564699|FG001|Overall Study|Non-compliance|0|||
162962937|NCT01604941|588564700|FG002|Overall Study|Non-compliance|0|||
162962938|NCT01604941|588564701|FG003|Overall Study|Non-compliance|0|||
162962939|NCT01604941|588564702|FG004|Overall Study|Non-compliance|0|||
162962940|NCT01604941|588564703|FG005|Overall Study|Non-compliance|0|||
162962941|NCT01604941|588564698|FG000|Overall Study|Participant Decision|0|||
162962942|NCT01604941|588564699|FG001|Overall Study|Participant Decision|0|||
162962943|NCT01604941|588564700|FG002|Overall Study|Participant Decision|0|||
162962944|NCT01604941|588564701|FG003|Overall Study|Participant Decision|0|||
162962945|NCT01604941|588564702|FG004|Overall Study|Participant Decision|0|||
162962946|NCT01604941|588564703|FG005|Overall Study|Participant Decision|2|||
162962947|NCT01604941|588564698|FG000|Overall Study|Early Study Termination|9|||
162962948|NCT01604941|588564699|FG001|Overall Study|Early Study Termination|2|||
162962949|NCT01604941|588564700|FG002|Overall Study|Early Study Termination|3|||
162962950|NCT01604941|588564701|FG003|Overall Study|Early Study Termination|3|||
162962951|NCT01604941|588564702|FG004|Overall Study|Early Study Termination|0|||
162962952|NCT01604941|588564703|FG005|Overall Study|Early Study Termination|0|||
162962953|NCT01410227|588564704|FG000|Overall Study|Adverse Event|1|||
162962954|NCT01410227|588564705|FG001|Overall Study|Adverse Event|0|||
162962955|NCT01410227|588564706|FG002|Overall Study|Adverse Event|0|||
162962956|NCT01410227|588564707|FG003|Overall Study|Adverse Event|0|||
163050098|NCT05616013|588891002|FG005|Overall Study|Prohibited Concomitant Medication|0|||
163050099|NCT05616013|588891003|FG006|Overall Study|Prohibited Concomitant Medication|0|||
162962957|NCT01410227|588564704|FG000|Overall Study|Withdrawal by Subject|3|||
163050100|NCT05616013|588891004|FG007|Overall Study|Prohibited Concomitant Medication|0|||
163050101|NCT05616013|588891005|FG008|Overall Study|Prohibited Concomitant Medication|0|||
162962958|NCT01410227|588564705|FG001|Overall Study|Withdrawal by Subject|0|||
162962959|NCT01410227|588564706|FG002|Overall Study|Withdrawal by Subject|1|||
163050102|NCT05616013|588890997|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
162962960|NCT01410227|588564707|FG003|Overall Study|Withdrawal by Subject|0|||
162962961|NCT01410227|588564704|FG000|Overall Study|Pregnancy|0|||
162962962|NCT01410227|588564705|FG001|Overall Study|Pregnancy|0|||
162962963|NCT01410227|588564706|FG002|Overall Study|Pregnancy|0|||
162962964|NCT01410227|588564707|FG003|Overall Study|Pregnancy|1|||
162962965|NCT01410227|588564704|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
162962966|NCT01410227|588564705|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
162962967|NCT01410227|588564706|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
162962968|NCT01410227|588564707|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
162962969|NCT00606281|588564708|FG000|Overall Study|Adverse Event|11|||
162962970|NCT00606281|588564709|FG001|Overall Study|Adverse Event|12|||
162962971|NCT00606281|588564708|FG000|Overall Study|Death|1|||
162962972|NCT00606281|588564709|FG001|Overall Study|Death|0|||
162962973|NCT00606281|588564708|FG000|Overall Study|Lack of Efficacy|28|||
162962974|NCT00606281|588564709|FG001|Overall Study|Lack of Efficacy|35|||
162962975|NCT00606281|588564708|FG000|Overall Study|Physician Decision|0|||
162962976|NCT00606281|588564709|FG001|Overall Study|Physician Decision|1|||
162962977|NCT00606281|588564708|FG000|Overall Study|Protocol Violation|3|||
162962978|NCT00606281|588564709|FG001|Overall Study|Protocol Violation|3|||
162962979|NCT00606281|588564708|FG000|Overall Study|Withdrawal by Subject|11|||
162962980|NCT00606281|588564709|FG001|Overall Study|Withdrawal by Subject|13|||
162962981|NCT00606281|588564708|FG000|Overall Study|Progression to depressive phase|1|||
162962982|NCT00606281|588564709|FG001|Overall Study|Progression to depressive phase|1|||
162962983|NCT00606281|588564708|FG000|Overall Study|Change of residence or other commitments|1|||
162962984|NCT00606281|588564709|FG001|Overall Study|Change of residence or other commitments|1|||
162962985|NCT00540423|588564711|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162962986|NCT00540423|588564712|FG001|Double-Blind Treatment Period|Adverse Event|1|||
162962987|NCT00540423|588564713|FG002|Double-Blind Treatment Period|Adverse Event|0|||
162962988|NCT00540423|588564711|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
162962989|NCT00540423|588564712|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
162962990|NCT00540423|588564713|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
162962991|NCT03131895|588564714|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
162962992|NCT03131895|588564715|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
162962993|NCT03131895|588564716|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
162962994|NCT03131895|588564717|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
162962995|NCT03131895|588564714|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
162962996|NCT03131895|588564715|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
162962997|NCT03131895|588564716|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
162962998|NCT03131895|588564717|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
162962999|NCT03131895|588564714|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162963000|NCT03131895|588564715|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
162963001|NCT03131895|588564716|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162963002|NCT03131895|588564717|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
162963003|NCT03131895|588564714|FG000|Washout Period (at Least 5 Days)|Other|0|||
162963004|NCT03131895|588564715|FG001|Washout Period (at Least 5 Days)|Other|0|||
162963005|NCT03131895|588564716|FG002|Washout Period (at Least 5 Days)|Other|2|||
162963006|NCT03131895|588564717|FG003|Washout Period (at Least 5 Days)|Other|0|||
162963007|NCT03131895|588564714|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
162963008|NCT03131895|588564715|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
162963009|NCT03131895|588564716|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
162963010|NCT03131895|588564717|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
162963011|NCT03131895|588564714|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
162963012|NCT03131895|588564715|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
162963013|NCT03131895|588564716|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
162963014|NCT03131895|588564717|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
162963015|NCT02213263|588564722|FG000|Overall Study|Insufficient clinical response|4|||
162963016|NCT02213263|588564723|FG001|Overall Study|Insufficient clinical response|3|||
162963017|NCT02213263|588564722|FG000|Overall Study|Lost to Follow-up|0|||
162963018|NCT02213263|588564723|FG001|Overall Study|Lost to Follow-up|1|||
163199059|NCT01253408|589443249|FG001|Overall Study|Adverse Event|1|||
163199060|NCT01253408|589443250|FG002|Overall Study|Adverse Event|0|||
163199061|NCT03408483|589443251|FG000|Overall Study|Physician Decision|3|||
163199062|NCT03408483|589443252|FG001|Overall Study|Physician Decision|3|||
163199063|NCT03408483|589443251|FG000|Overall Study|Lost to Follow-up|3|||
163199064|NCT03408483|589443252|FG001|Overall Study|Lost to Follow-up|0|||
163199065|NCT00478231|589443253|FG000|Overall Study|Death|7|||
162963019|NCT02213263|588564722|FG000|Overall Study|No longer willing to participate|3|||
163199066|NCT00478231|589443253|FG000|Overall Study|Lack of Efficacy|47|||
163050103|NCT05616013|588890998|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
163050104|NCT05616013|588890999|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
163050105|NCT05616013|588891000|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
163199067|NCT00478231|589443253|FG000|Overall Study|Lost to Follow-up|7|||
163199068|NCT00478231|589443253|FG000|Overall Study|Withdrawal by Subject|6|||
163050106|NCT05616013|588891001|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
163050107|NCT05616013|588891002|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
163050108|NCT05616013|588891003|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
163050109|NCT05616013|588891004|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
163050110|NCT05616013|588891005|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
163050111|NCT05616013|588890997|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163050112|NCT05616013|588890998|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163050113|NCT05616013|588890999|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163050114|NCT05616013|588891000|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
163050115|NCT05616013|588891001|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163058600|NCT00042289|588924240|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
162963020|NCT02213263|588564723|FG001|Overall Study|No longer willing to participate|4|||
162963021|NCT02213263|588564722|FG000|Overall Study|Progressive disease|20|||
162963022|NCT02213263|588564723|FG001|Overall Study|Progressive disease|14|||
162963023|NCT02213263|588564722|FG000|Overall Study|Protocol Violation|0|||
162963024|NCT02213263|588564723|FG001|Overall Study|Protocol Violation|1|||
162963025|NCT02213263|588564722|FG000|Overall Study|Adverse Event|1|||
163199069|NCT00478231|589443253|FG000|Overall Study|Other|9|||
163199070|NCT00478231|589443253|FG000|Overall Study|Adverse Event|5|||
163199071|NCT00478231|589443253|FG000|Overall Study|Randomized, not treated|3|||
163199072|NCT00191139|589443258|FG000|Overall Study|Adverse Event|2|||
163199073|NCT00191139|589443259|FG001|Overall Study|Adverse Event|6|||
163050116|NCT05616013|588891002|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163050117|NCT05616013|588891003|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163050118|NCT05616013|588891004|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163050119|NCT05616013|588891005|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163050120|NCT05616013|588890997|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050121|NCT05616013|588890998|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050122|NCT05616013|588890999|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050123|NCT05616013|588891000|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050124|NCT05616013|588891001|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050125|NCT05616013|588891002|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050126|NCT05616013|588891003|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
163050127|NCT05616013|588891004|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050128|NCT05616013|588891005|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050129|NCT05616013|588890997|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050130|NCT05616013|588890998|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050131|NCT05616013|588890999|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050132|NCT05616013|588891000|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050133|NCT05616013|588891001|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050134|NCT05616013|588891002|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050135|NCT05616013|588891003|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050136|NCT05616013|588891004|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050137|NCT05616013|588891005|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
163050138|NCT05616013|588890997|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
163050139|NCT05616013|588890998|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
163050140|NCT05616013|588890999|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
163050141|NCT05616013|588891000|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
163050142|NCT05616013|588891001|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
163050143|NCT05616013|588891002|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
163050144|NCT05616013|588891003|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
163050145|NCT05616013|588891004|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
163050146|NCT05616013|588891005|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
163050147|NCT05067972|588891006|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
163050148|NCT05067972|588891007|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
163050149|NCT05067972|588891008|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
163050150|NCT05067972|588891009|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
163050151|NCT05067972|588891010|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
163050152|NCT05067972|588891011|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
163050153|NCT05067972|588891012|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
163050154|NCT05067972|588891006|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
163050155|NCT05067972|588891007|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
163050156|NCT05067972|588891008|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
163050157|NCT05067972|588891009|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
163050158|NCT05067972|588891010|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
163050159|NCT05067972|588891011|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
163050160|NCT05067972|588891012|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
163050161|NCT05067972|588891006|FG000|Part 1: Treatment|Progressive Disease|3|||
163050162|NCT05067972|588891007|FG001|Part 1: Treatment|Progressive Disease|3|||
163050163|NCT05067972|588891008|FG002|Part 1: Treatment|Progressive Disease|4|||
163050164|NCT05067972|588891009|FG003|Part 1: Treatment|Progressive Disease|2|||
162963026|NCT02213263|588564723|FG001|Overall Study|Adverse Event|3|||
162963027|NCT00731939|588564724|FG000|Overall Study|Adverse Event|6|||
162963028|NCT00731939|588564724|FG000|Overall Study|Lost to Follow-up|15|||
162963029|NCT00731939|588564724|FG000|Overall Study|Not implanted with study device|9|||
162963030|NCT00731939|588564724|FG000|Overall Study|Withdrawal by Subject|2|||
162963031|NCT00731939|588564724|FG000|Overall Study|Did not meet enrollment criteria|2|||
162963032|NCT05752721|588564725|FG000|Overall Study|Lost to Follow-up|22|||
162963033|NCT05752721|588564726|FG001|Overall Study|Lost to Follow-up|20|||
162963034|NCT05752721|588564725|FG000|Overall Study|Withdrawal by Subject|15|||
162963035|NCT05752721|588564726|FG001|Overall Study|Withdrawal by Subject|12|||
162963036|NCT00263588|588564727|FG000|Overall Study|Death|54|||
162963037|NCT00263588|588564728|FG001|Overall Study|Death|90|||
162963038|NCT00263588|588564727|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
162963039|NCT00263588|588564728|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
162963040|NCT00263588|588564727|FG000|Overall Study|Lost to Follow-up|7|||
162963041|NCT00263588|588564728|FG001|Overall Study|Lost to Follow-up|10|||
163050165|NCT05067972|588891010|FG004|Part 1: Treatment|Progressive Disease|3|||
163050166|NCT05067972|588891011|FG005|Part 1: Treatment|Progressive Disease|0|||
163050167|NCT05067972|588891012|FG006|Part 1: Treatment|Progressive Disease|2|||
163050168|NCT05067972|588891006|FG000|Part 1: Treatment|Physician Decision|0|||
163050169|NCT05067972|588891007|FG001|Part 1: Treatment|Physician Decision|0|||
163050170|NCT05067972|588891008|FG002|Part 1: Treatment|Physician Decision|0|||
163050171|NCT05067972|588891009|FG003|Part 1: Treatment|Physician Decision|1|||
163050172|NCT05067972|588891010|FG004|Part 1: Treatment|Physician Decision|0|||
163050173|NCT05067972|588891011|FG005|Part 1: Treatment|Physician Decision|0|||
163050174|NCT05067972|588891012|FG006|Part 1: Treatment|Physician Decision|0|||
163050175|NCT05067972|588891006|FG000|Part 1: Treatment|Death|0|||
163050176|NCT05067972|588891007|FG001|Part 1: Treatment|Death|0|||
163050177|NCT05067972|588891008|FG002|Part 1: Treatment|Death|0|||
163304999|NCT02794480|589823935|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
163305000|NCT02794480|589823936|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
163050178|NCT05067972|588891009|FG003|Part 1: Treatment|Death|2|||
163050179|NCT05067972|588891010|FG004|Part 1: Treatment|Death|0|||
163050180|NCT05067972|588891011|FG005|Part 1: Treatment|Death|0|||
163050181|NCT05067972|588891012|FG006|Part 1: Treatment|Death|0|||
163305001|NCT02794480|589823933|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162963042|NCT00263588|588564727|FG000|Overall Study|Withdrawal by Subject|3|||
162963043|NCT00263588|588564728|FG001|Overall Study|Withdrawal by Subject|4|||
162963044|NCT00263588|588564727|FG000|Overall Study|Protocol Violation|0|||
162963045|NCT00263588|588564728|FG001|Overall Study|Protocol Violation|1|||
162963046|NCT00263588|588564727|FG000|Overall Study|Investigator decision|7|||
163050182|NCT05067972|588891006|FG000|Part 1: Treatment|Adverse Event|0|||
163050183|NCT05067972|588891007|FG001|Part 1: Treatment|Adverse Event|0|||
163050184|NCT05067972|588891008|FG002|Part 1: Treatment|Adverse Event|0|||
163050185|NCT05067972|588891009|FG003|Part 1: Treatment|Adverse Event|0|||
163050186|NCT05067972|588891010|FG004|Part 1: Treatment|Adverse Event|0|||
163050187|NCT05067972|588891011|FG005|Part 1: Treatment|Adverse Event|2|||
163050188|NCT05067972|588891012|FG006|Part 1: Treatment|Adverse Event|1|||
163050189|NCT05067972|588891006|FG000|Part 1: Follow-up|Adverse Event|0|||
163305002|NCT02794480|589823934|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163305003|NCT02794480|589823935|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163305004|NCT02794480|589823936|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
163305005|NCT02794480|589823933|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163305006|NCT02794480|589823934|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
163305007|NCT02794480|589823935|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163050190|NCT05067972|588891007|FG001|Part 1: Follow-up|Adverse Event|0|||
163050191|NCT05067972|588891008|FG002|Part 1: Follow-up|Adverse Event|0|||
163050192|NCT05067972|588891009|FG003|Part 1: Follow-up|Adverse Event|0|||
163050193|NCT05067972|588891010|FG004|Part 1: Follow-up|Adverse Event|0|||
163050194|NCT05067972|588891011|FG005|Part 1: Follow-up|Adverse Event|1|||
163050195|NCT05067972|588891012|FG006|Part 1: Follow-up|Adverse Event|0|||
163050196|NCT05067972|588891006|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
163050197|NCT05067972|588891007|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
163050198|NCT05067972|588891008|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
163050199|NCT05067972|588891009|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
163050200|NCT05067972|588891010|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
163050201|NCT05067972|588891011|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
163050202|NCT05067972|588891012|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
163050203|NCT05067972|588891006|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
163050204|NCT05067972|588891007|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
163050205|NCT05067972|588891008|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
163050206|NCT05067972|588891009|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
163050207|NCT05067972|588891010|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
163050208|NCT05067972|588891011|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
163050209|NCT05067972|588891012|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
163050210|NCT05067972|588891006|FG000|Part 1: Follow-up|Physician Decision|0|||
163050211|NCT05067972|588891007|FG001|Part 1: Follow-up|Physician Decision|0|||
163050212|NCT05067972|588891008|FG002|Part 1: Follow-up|Physician Decision|0|||
163050213|NCT05067972|588891009|FG003|Part 1: Follow-up|Physician Decision|1|||
163050214|NCT05067972|588891010|FG004|Part 1: Follow-up|Physician Decision|0|||
163050215|NCT05067972|588891011|FG005|Part 1: Follow-up|Physician Decision|0|||
163050216|NCT05067972|588891012|FG006|Part 1: Follow-up|Physician Decision|0|||
163050217|NCT05067972|588891006|FG000|Part 1: Follow-up|Death|1|||
163050218|NCT05067972|588891007|FG001|Part 1: Follow-up|Death|2|||
163050219|NCT05067972|588891008|FG002|Part 1: Follow-up|Death|1|||
163050220|NCT05067972|588891009|FG003|Part 1: Follow-up|Death|0|||
163050221|NCT05067972|588891010|FG004|Part 1: Follow-up|Death|1|||
163050222|NCT05067972|588891011|FG005|Part 1: Follow-up|Death|0|||
163050223|NCT05067972|588891012|FG006|Part 1: Follow-up|Death|1|||
163050224|NCT04391842|588891014|FG000|Overall Study|Withdrawal by Subject|2|||
163050225|NCT00810199|588891015|FG000|Overall Study|Adverse Event|24|||
163050226|NCT00810199|588891016|FG001|Overall Study|Adverse Event|26|||
163050227|NCT00810199|588891015|FG000|Overall Study|Death|4|||
163050228|NCT00810199|588891016|FG001|Overall Study|Death|6|||
163050229|NCT00810199|588891015|FG000|Overall Study|Withdrew consent|9|||
163050230|NCT00810199|588891016|FG001|Overall Study|Withdrew consent|12|||
163050231|NCT00810199|588891015|FG000|Overall Study|Insufficient therapeutic response|5|||
163050232|NCT00810199|588891016|FG001|Overall Study|Insufficient therapeutic response|14|||
163050233|NCT00810199|588891015|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
163050234|NCT00810199|588891016|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
163050235|NCT00810199|588891015|FG000|Overall Study|Administrative/Other|5|||
163050236|NCT00810199|588891016|FG001|Overall Study|Administrative/Other|6|||
163050237|NCT00810199|588891015|FG000|Overall Study|Protocol Violation|2|||
163050238|NCT00810199|588891016|FG001|Overall Study|Protocol Violation|6|||
163050239|NCT00810199|588891015|FG000|Overall Study|Failure to return|1|||
163050240|NCT00810199|588891016|FG001|Overall Study|Failure to return|4|||
163050241|NCT00810199|588891015|FG000|Overall Study|Did not receive study drug|2|||
163305008|NCT02794480|589823936|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
163305009|NCT02794480|589823933|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
163305010|NCT02794480|589823934|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163050242|NCT00810199|588891016|FG001|Overall Study|Did not receive study drug|1|||
163050243|NCT00992017|588891017|FG000|Overall Study|Lost to Follow-up|2|||
163050244|NCT00992017|588891017|FG000|Overall Study|Withdrawal by Subject|2|||
163050245|NCT00992017|588891017|FG000|Overall Study|Unable to get to clinic|5|||
163050246|NCT00992017|588891017|FG000|Overall Study|Not adhere to study requirements|1|||
163050247|NCT01691378|588891018|FG000|Overall Study|Withdrawal by Subject|2|||
163050248|NCT01691378|588891019|FG001|Overall Study|Withdrawal by Subject|0|||
163050249|NCT01691378|588891018|FG000|Overall Study|Lost to Follow-up|5|||
163050250|NCT01691378|588891019|FG001|Overall Study|Lost to Follow-up|2|||
163050251|NCT04877990|588891024|FG000|Treatment|Other reasons|3|||
163050252|NCT04877990|588891025|FG001|Treatment|Other reasons|1|||
163050253|NCT04877990|588891024|FG000|Treatment|Administrative reasons by sponsor|17|||
163050254|NCT04877990|588891025|FG001|Treatment|Administrative reasons by sponsor|33|||
163050255|NCT04877990|588891024|FG000|Treatment|Withdrawal by Subject|2|||
163050256|NCT04877990|588891025|FG001|Treatment|Withdrawal by Subject|6|||
163050257|NCT04877990|588891024|FG000|Treatment|Adverse Event|2|||
163050258|NCT04877990|588891025|FG001|Treatment|Adverse Event|1|||
163050259|NCT04235504|588891026|FG000|Study Phase|Withdrawal by Subject|5|||
163050260|NCT04235504|588891027|FG001|Study Phase|Withdrawal by Subject|2|||
163050261|NCT04235504|588891028|FG002|Study Phase|Withdrawal by Subject|0|||
163050262|NCT04235504|588891029|FG003|Study Phase|Withdrawal by Subject|0|||
163050263|NCT04235504|588891026|FG000|Continuation Phase|Withdrawal by Subject|0|||
163050264|NCT04235504|588891027|FG001|Continuation Phase|Withdrawal by Subject|4|||
163050265|NCT04235504|588891028|FG002|Continuation Phase|Withdrawal by Subject|0|||
163050266|NCT04235504|588891029|FG003|Continuation Phase|Withdrawal by Subject|0|||
163199074|NCT00191139|589443258|FG000|Overall Study|Death|2|||
163199075|NCT00191139|589443259|FG001|Overall Study|Death|0|||
163199076|NCT00191139|589443258|FG000|Overall Study|Withdrawal by Subject|0|||
163199077|NCT00191139|589443259|FG001|Overall Study|Withdrawal by Subject|3|||
163199078|NCT00191139|589443258|FG000|Overall Study|Disease Progression|0|||
163050267|NCT04235504|588891026|FG000|Continuation Phase|Adverse Event|0|||
163050268|NCT04235504|588891027|FG001|Continuation Phase|Adverse Event|1|||
163050269|NCT04235504|588891028|FG002|Continuation Phase|Adverse Event|0|||
163050270|NCT04235504|588891029|FG003|Continuation Phase|Adverse Event|0|||
163199079|NCT00191139|589443259|FG001|Overall Study|Disease Progression|1|||
163199080|NCT00191139|589443258|FG000|Overall Study|Other|1|||
163199081|NCT00191139|589443259|FG001|Overall Study|Other|2|||
163199082|NCT00816595|589443260|FG000|Overall Study|Withdrawal by Subject|2|||
163199083|NCT00816595|589443261|FG001|Overall Study|Withdrawal by Subject|0|||
163199084|NCT01817530|589443262|FG000|Overall Study|Exclusionary Medication Received|0|||
163199085|NCT01817530|589443263|FG001|Overall Study|Exclusionary Medication Received|0|||
163199086|NCT01817530|589443264|FG002|Overall Study|Exclusionary Medication Received|0|||
163199087|NCT01817530|589443265|FG003|Overall Study|Exclusionary Medication Received|0|||
163199088|NCT01817530|589443266|FG004|Overall Study|Exclusionary Medication Received|1|||
163199089|NCT01817530|589443267|FG005|Overall Study|Exclusionary Medication Received|0|||
163199090|NCT01817530|589443268|FG006|Overall Study|Exclusionary Medication Received|0|||
163199091|NCT01817530|589443269|FG007|Overall Study|Exclusionary Medication Received|0|||
163199092|NCT01817530|589443262|FG000|Overall Study|Adverse Event|6|||
163199093|NCT01817530|589443263|FG001|Overall Study|Adverse Event|3|||
163199094|NCT01817530|589443264|FG002|Overall Study|Adverse Event|2|||
163199095|NCT01817530|589443265|FG003|Overall Study|Adverse Event|5|||
163199096|NCT01817530|589443266|FG004|Overall Study|Adverse Event|0|||
163050271|NCT04235504|588891026|FG000|Continuation Phase|Physician Decision|1|||
163199097|NCT01817530|589443267|FG005|Overall Study|Adverse Event|10|||
163199098|NCT01817530|589443268|FG006|Overall Study|Adverse Event|5|||
163199099|NCT01817530|589443269|FG007|Overall Study|Adverse Event|8|||
163199100|NCT01817530|589443262|FG000|Overall Study|Subject Noncompliant|3|||
163199101|NCT01817530|589443263|FG001|Overall Study|Subject Noncompliant|1|||
162963047|NCT00263588|588564728|FG001|Overall Study|Investigator decision|15|||
162963048|NCT00263588|588564727|FG000|Overall Study|Sponsor terminated study|0|||
162963049|NCT00263588|588564728|FG001|Overall Study|Sponsor terminated study|1|||
162963050|NCT02622386|588564735|FG000|First Assignment|Withdrawal by Subject|3|||
162963051|NCT02622386|588564736|FG001|First Assignment|Withdrawal by Subject|2|||
162963052|NCT02622386|588564735|FG000|Washout|Withdrawal by Subject|4|||
162963053|NCT02622386|588564736|FG001|Washout|Withdrawal by Subject|4|||
162963054|NCT02622386|588564735|FG000|Second Assignment|Withdrawal by Subject|0|||
162963055|NCT02622386|588564736|FG001|Second Assignment|Withdrawal by Subject|2|||
162963056|NCT05274763|588564738|FG000|Overall Study|Lost to Follow-up|1|||
162963057|NCT01075282|588564740|FG000|Overall Study|Withdrawal by Subject|11|||
162963058|NCT01075282|588564741|FG001|Overall Study|Withdrawal by Subject|7|||
162963059|NCT01075282|588564742|FG002|Overall Study|Withdrawal by Subject|11|||
162963060|NCT01075282|588564740|FG000|Overall Study|Adverse Event|9|||
162963061|NCT01075282|588564741|FG001|Overall Study|Adverse Event|8|||
162963062|NCT01075282|588564742|FG002|Overall Study|Adverse Event|5|||
162963063|NCT01075282|588564740|FG000|Overall Study|Entry Criteria Not Met|3|||
162963064|NCT01075282|588564741|FG001|Overall Study|Entry Criteria Not Met|2|||
162963065|NCT01075282|588564742|FG002|Overall Study|Entry Criteria Not Met|0|||
162963066|NCT01075282|588564740|FG000|Overall Study|Lost to Follow-up|3|||
162963067|NCT01075282|588564741|FG001|Overall Study|Lost to Follow-up|3|||
162963068|NCT01075282|588564742|FG002|Overall Study|Lost to Follow-up|3|||
162963069|NCT01075282|588564740|FG000|Overall Study|Physician Decision|3|||
162963070|NCT01075282|588564741|FG001|Overall Study|Physician Decision|3|||
162963071|NCT01075282|588564742|FG002|Overall Study|Physician Decision|3|||
162963072|NCT01075282|588564740|FG000|Overall Study|Lack of Efficacy|1|||
162963073|NCT01075282|588564741|FG001|Overall Study|Lack of Efficacy|1|||
162963074|NCT01075282|588564742|FG002|Overall Study|Lack of Efficacy|0|||
162963075|NCT01075282|588564740|FG000|Overall Study|Treatment Non-compliance|1|||
162963076|NCT01075282|588564741|FG001|Overall Study|Treatment Non-compliance|2|||
162963077|NCT01075282|588564742|FG002|Overall Study|Treatment Non-compliance|2|||
162963078|NCT01075282|588564740|FG000|Overall Study|Protocol Violation|0|||
162963079|NCT01075282|588564741|FG001|Overall Study|Protocol Violation|2|||
162963080|NCT01075282|588564742|FG002|Overall Study|Protocol Violation|1|||
162963081|NCT01075282|588564740|FG000|Overall Study|Death|0|||
162963082|NCT01075282|588564741|FG001|Overall Study|Death|1|||
162963083|NCT01075282|588564742|FG002|Overall Study|Death|2|||
162963084|NCT00367133|588564743|FG000|2 Years|Death|20|||
162963085|NCT00367133|588564744|FG001|2 Years|Death|12|||
162963086|NCT00367133|588564745|FG002|2 Years|Death|12|||
162963087|NCT00367133|588564743|FG000|2 Years|Dropped|34|||
162963088|NCT00367133|588564744|FG001|2 Years|Dropped|19|||
162963089|NCT00367133|588564745|FG002|2 Years|Dropped|33|||
162963090|NCT00367133|588564743|FG000|2 Years|Missed visit|4|||
162963091|NCT00367133|588564744|FG001|2 Years|Missed visit|5|||
162963092|NCT00367133|588564745|FG002|2 Years|Missed visit|4|||
162963093|NCT00847535|588564746|FG000|Overall Study|Withdrawal by Subject|2|||
162963094|NCT00847535|588564747|FG001|Overall Study|Withdrawal by Subject|1|||
162963095|NCT00847535|588564748|FG002|Overall Study|Withdrawal by Subject|1|||
162963096|NCT00847535|588564746|FG000|Overall Study|Lost to Follow-up|0|||
162963097|NCT00847535|588564747|FG001|Overall Study|Lost to Follow-up|1|||
162963098|NCT00847535|588564748|FG002|Overall Study|Lost to Follow-up|0|||
162963099|NCT00906399|588564749|FG000|Year 1|Randomized But Not Treated|0|||
163199102|NCT01817530|589443264|FG002|Overall Study|Subject Noncompliant|0|||
163199103|NCT01817530|589443265|FG003|Overall Study|Subject Noncompliant|4|||
163199104|NCT01817530|589443266|FG004|Overall Study|Subject Noncompliant|0|||
162963100|NCT00906399|588564750|FG001|Year 1|Randomized But Not Treated|1|||
162963101|NCT00906399|588564751|FG002|Year 1|Randomized But Not Treated|3|||
162963102|NCT00906399|588564752|FG003|Year 1|Randomized But Not Treated|0|||
162963103|NCT00906399|588564753|FG004|Year 1|Randomized But Not Treated|0|||
162963104|NCT00906399|588564754|FG005|Year 1|Randomized But Not Treated|0|||
162963105|NCT00906399|588564755|FG006|Year 1|Randomized But Not Treated|0|||
163305011|NCT02794480|589823935|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162963106|NCT00906399|588564749|FG000|Year 1|Adverse Event|4|||
162963107|NCT00906399|588564750|FG001|Year 1|Adverse Event|22|||
162963108|NCT00906399|588564751|FG002|Year 1|Adverse Event|24|||
162963109|NCT00906399|588564752|FG003|Year 1|Adverse Event|0|||
163305012|NCT02794480|589823936|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
162963110|NCT00906399|588564753|FG004|Year 1|Adverse Event|0|||
162963111|NCT00906399|588564754|FG005|Year 1|Adverse Event|0|||
163050272|NCT04235504|588891027|FG001|Continuation Phase|Physician Decision|2|||
163050273|NCT04235504|588891028|FG002|Continuation Phase|Physician Decision|1|||
163050274|NCT04235504|588891029|FG003|Continuation Phase|Physician Decision|0|||
163050275|NCT04888494|588891031|FG000|Overall Study|Lost to Follow-up|2|||
163050276|NCT04888494|588891032|FG001|Overall Study|Lost to Follow-up|3|||
163050277|NCT04888494|588891031|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
163050278|NCT04888494|588891032|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
163050279|NCT00565604|588891034|FG000|Overall Study|Failure to treat|2|||
163050280|NCT00565604|588891034|FG000|Overall Study|Lost to Follow-up|2|||
163050281|NCT03652818|588893506|FG000|Overall Study|Adverse Event|1|||
163050282|NCT03652818|588893507|FG001|Overall Study|Adverse Event|0|||
163050283|NCT03652818|588893508|FG002|Overall Study|Adverse Event|0|||
163050284|NCT03652818|588893509|FG003|Overall Study|Adverse Event|0|||
163050285|NCT03652818|588893510|FG004|Overall Study|Adverse Event|0|||
163050286|NCT03652818|588893506|FG000|Overall Study|Physician Decision|1|||
163050287|NCT03652818|588893507|FG001|Overall Study|Physician Decision|0|||
163050288|NCT03652818|588893508|FG002|Overall Study|Physician Decision|0|||
163050289|NCT03652818|588893509|FG003|Overall Study|Physician Decision|0|||
163050290|NCT03652818|588893510|FG004|Overall Study|Physician Decision|0|||
163050291|NCT03652818|588893506|FG000|Overall Study|Lost to Follow-up|0|||
163050292|NCT03652818|588893507|FG001|Overall Study|Lost to Follow-up|1|||
163050293|NCT03652818|588893508|FG002|Overall Study|Lost to Follow-up|2|||
163050294|NCT03652818|588893509|FG003|Overall Study|Lost to Follow-up|1|||
163050295|NCT03652818|588893510|FG004|Overall Study|Lost to Follow-up|1|||
163050296|NCT01699750|588893516|FG000|Overall Study|Withdrew Consent|0|||
163050297|NCT01699750|588893517|FG001|Overall Study|Withdrew Consent|1|||
163050298|NCT01699750|588893516|FG000|Overall Study|Other|0|||
163050299|NCT01699750|588893517|FG001|Overall Study|Other|2|||
163050300|NCT01868646|588893520|FG000|Overall Study|Do not meet inclusion criteria|3|||
163050301|NCT01868646|588893521|FG001|Overall Study|Do not meet inclusion criteria|5|||
163050302|NCT01831427|588893522|FG000|Overall Study|Adverse Event|0|||
163050303|NCT01831427|588893523|FG001|Overall Study|Adverse Event|1|||
163050304|NCT01831427|588893524|FG002|Overall Study|Adverse Event|0|||
163050305|NCT01831427|588893525|FG003|Overall Study|Adverse Event|0|||
163050306|NCT01831427|588893526|FG004|Overall Study|Adverse Event|0|||
163050307|NCT01831427|588893527|FG005|Overall Study|Adverse Event|1|||
163050308|NCT01831427|588893528|FG006|Overall Study|Adverse Event|0|||
163050309|NCT01831427|588893529|FG007|Overall Study|Adverse Event|1|||
163050310|NCT01831427|588893530|FG008|Overall Study|Adverse Event|0|||
163050311|NCT01831427|588893531|FG009|Overall Study|Adverse Event|0|||
163050312|NCT01831427|588893532|FG010|Overall Study|Adverse Event|2|||
163050313|NCT01831427|588893522|FG000|Overall Study|Investigator's Discretion|0|||
163199105|NCT01817530|589443267|FG005|Overall Study|Subject Noncompliant|1|||
163199106|NCT01817530|589443268|FG006|Overall Study|Subject Noncompliant|1|||
163199107|NCT01817530|589443269|FG007|Overall Study|Subject Noncompliant|1|||
163199108|NCT01817530|589443262|FG000|Overall Study|Lack of Efficacy|1|||
163199109|NCT01817530|589443263|FG001|Overall Study|Lack of Efficacy|0|||
163050314|NCT01831427|588893523|FG001|Overall Study|Investigator's Discretion|0|||
163050315|NCT01831427|588893524|FG002|Overall Study|Investigator's Discretion|0|||
163050316|NCT01831427|588893525|FG003|Overall Study|Investigator's Discretion|1|||
163050317|NCT01831427|588893526|FG004|Overall Study|Investigator's Discretion|0|||
163199110|NCT01817530|589443264|FG002|Overall Study|Lack of Efficacy|0|||
163199111|NCT01817530|589443265|FG003|Overall Study|Lack of Efficacy|0|||
163050318|NCT01831427|588893527|FG005|Overall Study|Investigator's Discretion|0|||
163050319|NCT01831427|588893528|FG006|Overall Study|Investigator's Discretion|0|||
163050320|NCT01831427|588893529|FG007|Overall Study|Investigator's Discretion|0|||
163199112|NCT01817530|589443266|FG004|Overall Study|Lack of Efficacy|0|||
163050321|NCT01831427|588893530|FG008|Overall Study|Investigator's Discretion|0|||
163050322|NCT01831427|588893531|FG009|Overall Study|Investigator's Discretion|0|||
163050323|NCT01831427|588893532|FG010|Overall Study|Investigator's Discretion|0|||
163050324|NCT01831427|588893522|FG000|Overall Study|Withdrew Consent|0|||
163050325|NCT01831427|588893523|FG001|Overall Study|Withdrew Consent|0|||
163050326|NCT01831427|588893524|FG002|Overall Study|Withdrew Consent|0|||
163050327|NCT01831427|588893525|FG003|Overall Study|Withdrew Consent|0|||
163199113|NCT01817530|589443267|FG005|Overall Study|Lack of Efficacy|1|||
163050328|NCT01831427|588893526|FG004|Overall Study|Withdrew Consent|0|||
163050329|NCT01831427|588893527|FG005|Overall Study|Withdrew Consent|0|||
163050330|NCT01831427|588893528|FG006|Overall Study|Withdrew Consent|2|||
163050331|NCT01831427|588893529|FG007|Overall Study|Withdrew Consent|0|||
163199114|NCT01817530|589443268|FG006|Overall Study|Lack of Efficacy|0|||
163199115|NCT01817530|589443269|FG007|Overall Study|Lack of Efficacy|1|||
163050332|NCT01831427|588893530|FG008|Overall Study|Withdrew Consent|0|||
163199116|NCT01817530|589443262|FG000|Overall Study|Pregnancy|0|||
162963112|NCT00906399|588564755|FG006|Year 1|Adverse Event|0|||
162963113|NCT00906399|588564749|FG000|Year 1|Lost to Follow-up|4|||
162963114|NCT00906399|588564750|FG001|Year 1|Lost to Follow-up|4|||
162963115|NCT00906399|588564751|FG002|Year 1|Lost to Follow-up|2|||
163199117|NCT01817530|589443263|FG001|Overall Study|Pregnancy|0|||
163199118|NCT01817530|589443264|FG002|Overall Study|Pregnancy|0|||
163199119|NCT01817530|589443265|FG003|Overall Study|Pregnancy|0|||
163199120|NCT01817530|589443266|FG004|Overall Study|Pregnancy|0|||
163199121|NCT01817530|589443267|FG005|Overall Study|Pregnancy|1|||
163199122|NCT01817530|589443268|FG006|Overall Study|Pregnancy|0|||
163199123|NCT01817530|589443269|FG007|Overall Study|Pregnancy|0|||
162963116|NCT00906399|588564752|FG003|Year 1|Lost to Follow-up|0|||
163199124|NCT01817530|589443262|FG000|Overall Study|Other|0|||
162963117|NCT00906399|588564753|FG004|Year 1|Lost to Follow-up|0|||
163396620|NCT02490475|590162750|FG000|Period 2: Extension Phase|Adverse Event|0|||
163050333|NCT01831427|588893531|FG009|Overall Study|Withdrew Consent|1|||
163050334|NCT01831427|588893532|FG010|Overall Study|Withdrew Consent|1|||
163050335|NCT01249417|588893535|FG000|Randomised Population|Study treatment not received|0|||
163050336|NCT01249417|588893536|FG001|Randomised Population|Study treatment not received|0|||
163050337|NCT01249417|588893537|FG002|Randomised Population|Study treatment not received|2|||
163050338|NCT01249417|588893535|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
163050339|NCT01249417|588893536|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
163050340|NCT01249417|588893537|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
163050341|NCT01249417|588893535|FG000|Treatment Phase - ITT Population|Other|0|||
163050342|NCT01249417|588893536|FG001|Treatment Phase - ITT Population|Other|0|||
163050343|NCT01249417|588893537|FG002|Treatment Phase - ITT Population|Other|1|||
163050344|NCT01249417|588893535|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
163050345|NCT01249417|588893536|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
163050346|NCT01249417|588893537|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
163050347|NCT01249417|588893535|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
163050348|NCT01249417|588893536|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
163050349|NCT01249417|588893537|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
163050350|NCT01249417|588893535|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
163050351|NCT01249417|588893536|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
163050352|NCT01249417|588893537|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
163050353|NCT01854697|588893538|FG000|Overall Study|Adverse Event|1|||
163050354|NCT01854697|588893539|FG001|Overall Study|Adverse Event|0|||
163050355|NCT01854697|588893540|FG002|Overall Study|Adverse Event|0|||
163050356|NCT01854697|588893541|FG003|Overall Study|Adverse Event|0|||
163050357|NCT01854697|588893542|FG004|Overall Study|Adverse Event|1|||
163050358|NCT01854697|588893538|FG000|Overall Study|Lost to Follow-up|4|||
163050359|NCT01854697|588893539|FG001|Overall Study|Lost to Follow-up|1|||
163050360|NCT01854697|588893540|FG002|Overall Study|Lost to Follow-up|1|||
163050361|NCT01854697|588893541|FG003|Overall Study|Lost to Follow-up|2|||
163050362|NCT01854697|588893542|FG004|Overall Study|Lost to Follow-up|0|||
163050363|NCT01854697|588893538|FG000|Overall Study|To enter another AbbVie study|1|||
163050364|NCT01854697|588893539|FG001|Overall Study|To enter another AbbVie study|0|||
163050365|NCT01854697|588893540|FG002|Overall Study|To enter another AbbVie study|0|||
163050366|NCT01854697|588893541|FG003|Overall Study|To enter another AbbVie study|0|||
163050367|NCT01854697|588893542|FG004|Overall Study|To enter another AbbVie study|1|||
163050368|NCT01854697|588893538|FG000|Overall Study|Withdrew Consent|0|||
163050369|NCT01854697|588893539|FG001|Overall Study|Withdrew Consent|1|||
163050370|NCT01854697|588893540|FG002|Overall Study|Withdrew Consent|0|||
163050371|NCT01854697|588893541|FG003|Overall Study|Withdrew Consent|1|||
163050372|NCT01854697|588893542|FG004|Overall Study|Withdrew Consent|0|||
163199125|NCT01817530|589443263|FG001|Overall Study|Other|1|||
163199126|NCT01817530|589443264|FG002|Overall Study|Other|0|||
163199127|NCT01817530|589443265|FG003|Overall Study|Other|0|||
163199128|NCT01817530|589443266|FG004|Overall Study|Other|1|||
163199129|NCT01817530|589443267|FG005|Overall Study|Other|0|||
163199130|NCT01817530|589443268|FG006|Overall Study|Other|5|||
163199131|NCT01817530|589443269|FG007|Overall Study|Other|0|||
163199132|NCT01817530|589443262|FG000|Overall Study|Surgery or Invasive Intervention|1|||
163199133|NCT01817530|589443263|FG001|Overall Study|Surgery or Invasive Intervention|0|||
163199134|NCT01817530|589443264|FG002|Overall Study|Surgery or Invasive Intervention|0|||
163199135|NCT01817530|589443265|FG003|Overall Study|Surgery or Invasive Intervention|0|||
163199136|NCT01817530|589443266|FG004|Overall Study|Surgery or Invasive Intervention|1|||
163199137|NCT01817530|589443267|FG005|Overall Study|Surgery or Invasive Intervention|1|||
163199138|NCT01817530|589443268|FG006|Overall Study|Surgery or Invasive Intervention|1|||
163199139|NCT01817530|589443269|FG007|Overall Study|Surgery or Invasive Intervention|0|||
163199140|NCT01817530|589443262|FG000|Overall Study|Consent Withdrawn by Subject|3|||
163199141|NCT01817530|589443263|FG001|Overall Study|Consent Withdrawn by Subject|4|||
163199142|NCT01817530|589443264|FG002|Overall Study|Consent Withdrawn by Subject|7|||
163199143|NCT01817530|589443265|FG003|Overall Study|Consent Withdrawn by Subject|3|||
163199144|NCT01817530|589443266|FG004|Overall Study|Consent Withdrawn by Subject|5|||
163199145|NCT01817530|589443267|FG005|Overall Study|Consent Withdrawn by Subject|3|||
163199146|NCT01817530|589443268|FG006|Overall Study|Consent Withdrawn by Subject|3|||
163199147|NCT01817530|589443269|FG007|Overall Study|Consent Withdrawn by Subject|10|||
163050373|NCT01854697|588893538|FG000|Overall Study|Other|0|||
163050374|NCT01854697|588893539|FG001|Overall Study|Other|1|||
163050375|NCT01854697|588893540|FG002|Overall Study|Other|1|||
163050376|NCT01854697|588893541|FG003|Overall Study|Other|0|||
163050377|NCT01854697|588893542|FG004|Overall Study|Other|0|||
163050378|NCT01171898|588893547|FG000|Overall Study|Death|0|||
163050379|NCT01171898|588893548|FG001|Overall Study|Death|0|||
163050380|NCT01171898|588893549|FG002|Overall Study|Death|2|||
163050381|NCT01171898|588893550|FG003|Overall Study|Death|0|||
163050382|NCT01171898|588893547|FG000|Overall Study|Lost to Follow-up|0|||
163050383|NCT01171898|588893548|FG001|Overall Study|Lost to Follow-up|1|||
163050384|NCT01171898|588893549|FG002|Overall Study|Lost to Follow-up|1|||
163050385|NCT01171898|588893550|FG003|Overall Study|Lost to Follow-up|1|||
163050386|NCT01171898|588893547|FG000|Overall Study|Withdrawal by Subject|1|||
163050387|NCT01171898|588893548|FG001|Overall Study|Withdrawal by Subject|4|||
163050388|NCT01171898|588893549|FG002|Overall Study|Withdrawal by Subject|6|||
163050389|NCT01171898|588893550|FG003|Overall Study|Withdrawal by Subject|3|||
163050390|NCT01171898|588893547|FG000|Overall Study|Terminated by Sponsor|1|||
163050391|NCT01171898|588893548|FG001|Overall Study|Terminated by Sponsor|0|||
163050392|NCT01171898|588893549|FG002|Overall Study|Terminated by Sponsor|0|||
163050393|NCT01171898|588893550|FG003|Overall Study|Terminated by Sponsor|0|||
163050394|NCT01171898|588893547|FG000|Overall Study|Ongoing|1|||
163050395|NCT01171898|588893548|FG001|Overall Study|Ongoing|9|||
163050396|NCT01171898|588893549|FG002|Overall Study|Ongoing|3|||
163050397|NCT01171898|588893550|FG003|Overall Study|Ongoing|0|||
163050398|NCT01171898|588893547|FG000|Overall Study|Other|1|||
163050399|NCT01171898|588893548|FG001|Overall Study|Other|5|||
163050400|NCT01171898|588893549|FG002|Overall Study|Other|0|||
163050401|NCT01171898|588893550|FG003|Overall Study|Other|2|||
163199148|NCT01817530|589443262|FG000|Overall Study|Lost to Follow-up|1|||
163199149|NCT01817530|589443263|FG001|Overall Study|Lost to Follow-up|4|||
163199150|NCT01817530|589443264|FG002|Overall Study|Lost to Follow-up|2|||
163199151|NCT01817530|589443265|FG003|Overall Study|Lost to Follow-up|1|||
163199152|NCT01817530|589443266|FG004|Overall Study|Lost to Follow-up|3|||
163199153|NCT01817530|589443267|FG005|Overall Study|Lost to Follow-up|2|||
163199154|NCT01817530|589443268|FG006|Overall Study|Lost to Follow-up|8|||
163050402|NCT00468585|588893551|FG000|Overall Study|Patient not treated|1|||
163050403|NCT00468585|588893552|FG001|Overall Study|Patient not treated|0|||
163050404|NCT00468585|588893553|FG002|Overall Study|Patient not treated|1|||
163050405|NCT00468585|588893554|FG003|Overall Study|Patient not treated|0|||
163050406|NCT00468585|588893551|FG000|Overall Study|Patient found to be ineligible|0|||
163050407|NCT00468585|588893552|FG001|Overall Study|Patient found to be ineligible|0|||
163050408|NCT00468585|588893553|FG002|Overall Study|Patient found to be ineligible|1|||
163050409|NCT00468585|588893554|FG003|Overall Study|Patient found to be ineligible|0|||
163050410|NCT00468585|588893551|FG000|Overall Study|Adverse Event|0|||
163050411|NCT00468585|588893552|FG001|Overall Study|Adverse Event|0|||
163199155|NCT01817530|589443269|FG007|Overall Study|Lost to Follow-up|4|||
163199156|NCT00566995|589443271|FG000|Overall Study|Toxicity|4|||
163199157|NCT00566995|589443271|FG000|Overall Study|Withdrew consent|3|||
163050412|NCT00468585|588893553|FG002|Overall Study|Adverse Event|1|||
163050413|NCT00468585|588893554|FG003|Overall Study|Adverse Event|0|||
163199158|NCT02657369|589443272|FG000|Overall Study|Death|27|||
163199159|NCT02657369|589443272|FG000|Overall Study|Study terminated by sponsor|7|||
163199160|NCT00481078|589443273|FG000|Overall Study|Progression of disease|11|||
163199161|NCT00481078|589443274|FG001|Overall Study|Progression of disease|11|||
163199162|NCT00481078|589443273|FG000|Overall Study|Adverse Event|15|||
163199163|NCT00481078|589443274|FG001|Overall Study|Adverse Event|3|||
163199164|NCT00481078|589443273|FG000|Overall Study|Death|5|||
163199165|NCT00481078|589443274|FG001|Overall Study|Death|3|||
162963118|NCT00906399|588564754|FG005|Year 1|Lost to Follow-up|0|||
162963119|NCT00906399|588564755|FG006|Year 1|Lost to Follow-up|0|||
163199166|NCT00481078|589443273|FG000|Overall Study|Intercurrent illness|1|||
163199167|NCT00481078|589443274|FG001|Overall Study|Intercurrent illness|0|||
163199168|NCT00481078|589443273|FG000|Overall Study|Withdrawal by Subject|7|||
163199169|NCT00481078|589443274|FG001|Overall Study|Withdrawal by Subject|1|||
163199170|NCT00481078|589443273|FG000|Overall Study|Information not available|1|||
163199171|NCT00481078|589443274|FG001|Overall Study|Information not available|0|||
163199172|NCT00481078|589443273|FG000|Overall Study|Received other treatment|2|||
163199173|NCT00481078|589443274|FG001|Overall Study|Received other treatment|1|||
163199174|NCT00481078|589443273|FG000|Overall Study|Brain metastasis|0|||
163199175|NCT00481078|589443274|FG001|Overall Study|Brain metastasis|1|||
163199176|NCT00074152|589443275|FG000|Overall Study|Death|21|||
163199177|NCT00074152|589443276|FG001|Overall Study|Death|9|||
162963120|NCT00906399|588564749|FG000|Year 1|Withdrawal by Subject|30|||
163050414|NCT00468585|588893551|FG000|Overall Study|Withdrawal by Subject|0|||
163050415|NCT00468585|588893552|FG001|Overall Study|Withdrawal by Subject|0|||
163050416|NCT00468585|588893553|FG002|Overall Study|Withdrawal by Subject|2|||
163050417|NCT00468585|588893554|FG003|Overall Study|Withdrawal by Subject|1|||
163050418|NCT03769649|588893555|FG000|Overall Study|Lost to Follow-up|4|||
163050419|NCT03322293|588893556|FG000|Overall Study|Lost to Follow-up|0|||
163050420|NCT03322293|588893557|FG001|Overall Study|Lost to Follow-up|0|||
163050421|NCT03322293|588893558|FG002|Overall Study|Lost to Follow-up|1|||
163050422|NCT00853762|588893561|FG000|Overall Study|Premature Termination|16|||
163050423|NCT00853762|588893562|FG001|Overall Study|Premature Termination|15|||
163050424|NCT00853762|588893563|FG002|Overall Study|Premature Termination|14|||
163050425|NCT00853762|588893564|FG003|Overall Study|Premature Termination|21|||
163050426|NCT00853762|588893561|FG000|Overall Study|Protocol Violation|0|||
163050427|NCT00853762|588893562|FG001|Overall Study|Protocol Violation|0|||
163050428|NCT00853762|588893563|FG002|Overall Study|Protocol Violation|0|||
163050429|NCT00853762|588893564|FG003|Overall Study|Protocol Violation|1|||
163050430|NCT00853762|588893561|FG000|Overall Study|Withdrawal by Subject|0|||
163050431|NCT00853762|588893562|FG001|Overall Study|Withdrawal by Subject|0|||
163050432|NCT00853762|588893563|FG002|Overall Study|Withdrawal by Subject|1|||
163050433|NCT00853762|588893564|FG003|Overall Study|Withdrawal by Subject|0|||
163050434|NCT00853762|588893561|FG000|Overall Study|Other|0|||
163050435|NCT00853762|588893562|FG001|Overall Study|Other|2|||
163050436|NCT00853762|588893563|FG002|Overall Study|Other|0|||
163050437|NCT00853762|588893564|FG003|Overall Study|Other|0|||
163050438|NCT00853762|588893561|FG000|Overall Study|Randomised but not Treated|0|||
163050439|NCT00853762|588893562|FG001|Overall Study|Randomised but not Treated|2|||
163050440|NCT00853762|588893563|FG002|Overall Study|Randomised but not Treated|2|||
163050441|NCT00853762|588893564|FG003|Overall Study|Randomised but not Treated|0|||
163050442|NCT02000921|588893571|FG000|Overall Study|Withdrawal by Subject|3|||
163050443|NCT02000921|588893572|FG001|Overall Study|Withdrawal by Subject|10|||
163050444|NCT02000921|588893573|FG002|Overall Study|Withdrawal by Subject|5|||
163050445|NCT02000921|588893571|FG000|Overall Study|Lost to Follow-up|2|||
163050446|NCT02000921|588893572|FG001|Overall Study|Lost to Follow-up|4|||
163050447|NCT02000921|588893573|FG002|Overall Study|Lost to Follow-up|5|||
163050448|NCT02000921|588893571|FG000|Overall Study|Physician Decision|0|||
163050449|NCT02000921|588893572|FG001|Overall Study|Physician Decision|2|||
163050450|NCT02000921|588893573|FG002|Overall Study|Physician Decision|0|||
163050451|NCT03933449|588893574|FG000|Overall Study|Adverse Event|6|||
163050452|NCT03933449|588893575|FG001|Overall Study|Adverse Event|4|||
163050453|NCT03933449|588893574|FG000|Overall Study|Death|55|||
163050454|NCT03933449|588893575|FG001|Overall Study|Death|57|||
163050455|NCT03933449|588893574|FG000|Overall Study|Sponsor Decision|1|||
163050456|NCT03933449|588893575|FG001|Overall Study|Sponsor Decision|0|||
163050457|NCT00719901|588893578|FG000|Overall Study|Adverse Event|5|||
163050458|NCT00719901|588893578|FG000|Overall Study|Withdrawal by Subject|1|||
163050459|NCT00719901|588893578|FG000|Overall Study|Alternate Treatment|1|||
163050460|NCT00719901|588893578|FG000|Overall Study|Disease Progression|3|||
163050461|NCT00719901|588893578|FG000|Overall Study|Availability of Study Drug|1|||
163050462|NCT02858401|588893579|FG000|Overall Study|Withdrew Consent|0|||
163050463|NCT02858401|588893580|FG001|Overall Study|Withdrew Consent|0|||
163050464|NCT02858401|588893581|FG002|Overall Study|Withdrew Consent|0|||
163050465|NCT02858401|588893582|FG003|Overall Study|Withdrew Consent|0|||
163050466|NCT02858401|588893583|FG004|Overall Study|Withdrew Consent|0|||
163050467|NCT02858401|588893584|FG005|Overall Study|Withdrew Consent|1|||
163050468|NCT02858401|588893585|FG006|Overall Study|Withdrew Consent|0|||
163050469|NCT02858401|588893579|FG000|Overall Study|Lost to Follow-up|0|||
163050470|NCT02858401|588893580|FG001|Overall Study|Lost to Follow-up|1|||
163050471|NCT02858401|588893581|FG002|Overall Study|Lost to Follow-up|0|||
163050472|NCT02858401|588893582|FG003|Overall Study|Lost to Follow-up|0|||
163050473|NCT02858401|588893583|FG004|Overall Study|Lost to Follow-up|0|||
163050474|NCT02858401|588893584|FG005|Overall Study|Lost to Follow-up|0|||
163050475|NCT02858401|588893585|FG006|Overall Study|Lost to Follow-up|0|||
163050476|NCT01268267|588893586|FG000|Overall Study|Protocol Violation|1|||
163050477|NCT01418339|588893588|FG000|Overall Study|Adverse Event|5|||
163050478|NCT01418339|588893589|FG001|Overall Study|Adverse Event|2|||
163050479|NCT01418339|588893588|FG000|Overall Study|Subject Withdrew Consent|1|||
163050480|NCT01418339|588893589|FG001|Overall Study|Subject Withdrew Consent|2|||
163050481|NCT01418339|588893588|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
163050482|NCT01418339|588893589|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
163050483|NCT02219685|588893590|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
163050484|NCT02219685|588893591|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
163050485|NCT02219685|588893590|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
163050486|NCT02219685|588893591|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
163050487|NCT02869789|588893592|FG000|Overall Study|Disease progression|184|||
163050488|NCT02869789|588893593|FG001|Overall Study|Disease progression|109|||
163050489|NCT02869789|588893594|FG002|Overall Study|Disease progression|260|||
163050490|NCT02869789|588893595|FG003|Overall Study|Disease progression|19|||
163050491|NCT02869789|588893592|FG000|Overall Study|Study drug toxicity|90|||
163050492|NCT02869789|588893593|FG001|Overall Study|Study drug toxicity|32|||
163050493|NCT02869789|588893594|FG002|Overall Study|Study drug toxicity|55|||
163050494|NCT02869789|588893595|FG003|Overall Study|Study drug toxicity|14|||
163050495|NCT02869789|588893592|FG000|Overall Study|Death|7|||
163199178|NCT00074152|589443275|FG000|Overall Study|Lack of Efficacy|34|||
163396621|NCT02490475|590162751|FG001|Period 2: Extension Phase|Adverse Event|0|||
163050496|NCT02869789|588893593|FG001|Overall Study|Death|3|||
163050497|NCT02869789|588893594|FG002|Overall Study|Death|5|||
163050498|NCT02869789|588893595|FG003|Overall Study|Death|1|||
163050499|NCT02869789|588893592|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
163050500|NCT02869789|588893593|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
163050501|NCT02869789|588893594|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
163050502|NCT02869789|588893595|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
163050503|NCT02869789|588893592|FG000|Overall Study|Participant request to discontinue study treatment|10|||
163050504|NCT02869789|588893593|FG001|Overall Study|Participant request to discontinue study treatment|5|||
163199179|NCT00074152|589443276|FG001|Overall Study|Lack of Efficacy|24|||
163199180|NCT00228384|589443277|FG000|Overall Study|Death|9|||
163199181|NCT00228384|589443278|FG001|Overall Study|Death|3|||
162963121|NCT00906399|588564750|FG001|Year 1|Withdrawal by Subject|32|||
162963122|NCT00906399|588564751|FG002|Year 1|Withdrawal by Subject|36|||
162963123|NCT00906399|588564752|FG003|Year 1|Withdrawal by Subject|0|||
162963124|NCT00906399|588564753|FG004|Year 1|Withdrawal by Subject|0|||
162963125|NCT00906399|588564754|FG005|Year 1|Withdrawal by Subject|0|||
162963126|NCT00906399|588564755|FG006|Year 1|Withdrawal by Subject|0|||
162963127|NCT00906399|588564749|FG000|Year 1|Physician Decision|0|||
162963128|NCT00906399|588564750|FG001|Year 1|Physician Decision|1|||
162963129|NCT00906399|588564751|FG002|Year 1|Physician Decision|3|||
162963130|NCT00906399|588564752|FG003|Year 1|Physician Decision|0|||
162963131|NCT00906399|588564753|FG004|Year 1|Physician Decision|0|||
162963132|NCT00906399|588564754|FG005|Year 1|Physician Decision|0|||
162963133|NCT00906399|588564755|FG006|Year 1|Physician Decision|0|||
162963134|NCT00906399|588564749|FG000|Year 1|Death|2|||
162963135|NCT00906399|588564750|FG001|Year 1|Death|1|||
162963136|NCT00906399|588564751|FG002|Year 1|Death|1|||
162963137|NCT00906399|588564752|FG003|Year 1|Death|0|||
162963138|NCT00906399|588564753|FG004|Year 1|Death|0|||
162963139|NCT00906399|588564754|FG005|Year 1|Death|0|||
162963140|NCT00906399|588564755|FG006|Year 1|Death|0|||
162963141|NCT00906399|588564749|FG000|Year 1|Other|4|||
162963142|NCT00906399|588564750|FG001|Year 1|Other|2|||
162963143|NCT00906399|588564751|FG002|Year 1|Other|7|||
162963144|NCT00906399|588564752|FG003|Year 1|Other|0|||
162963145|NCT00906399|588564753|FG004|Year 1|Other|0|||
162963146|NCT00906399|588564754|FG005|Year 1|Other|0|||
162963147|NCT00906399|588564755|FG006|Year 1|Other|0|||
162963148|NCT00906399|588564749|FG000|Year 2|Adverse Event|0|||
162963149|NCT00906399|588564750|FG001|Year 2|Adverse Event|0|||
162963150|NCT00906399|588564751|FG002|Year 2|Adverse Event|0|||
162963151|NCT00906399|588564752|FG003|Year 2|Adverse Event|9|||
162963152|NCT00906399|588564753|FG004|Year 2|Adverse Event|8|||
162963153|NCT00906399|588564754|FG005|Year 2|Adverse Event|11|||
162963154|NCT00906399|588564755|FG006|Year 2|Adverse Event|6|||
162963155|NCT00906399|588564749|FG000|Year 2|Lost to Follow-up|0|||
162963156|NCT00906399|588564750|FG001|Year 2|Lost to Follow-up|0|||
162963157|NCT00906399|588564751|FG002|Year 2|Lost to Follow-up|0|||
162963158|NCT00906399|588564752|FG003|Year 2|Lost to Follow-up|1|||
162963159|NCT00906399|588564753|FG004|Year 2|Lost to Follow-up|4|||
162963160|NCT00906399|588564754|FG005|Year 2|Lost to Follow-up|2|||
162963161|NCT00906399|588564755|FG006|Year 2|Lost to Follow-up|4|||
162963162|NCT00906399|588564749|FG000|Year 2|Withdrawal by Subject|0|||
162963163|NCT00906399|588564750|FG001|Year 2|Withdrawal by Subject|0|||
162963164|NCT00906399|588564751|FG002|Year 2|Withdrawal by Subject|0|||
162963165|NCT00906399|588564752|FG003|Year 2|Withdrawal by Subject|17|||
162963166|NCT00906399|588564753|FG004|Year 2|Withdrawal by Subject|18|||
162963167|NCT00906399|588564754|FG005|Year 2|Withdrawal by Subject|27|||
162963168|NCT00906399|588564755|FG006|Year 2|Withdrawal by Subject|13|||
162963169|NCT00906399|588564749|FG000|Year 2|Physician Decision|0|||
162963170|NCT00906399|588564750|FG001|Year 2|Physician Decision|0|||
162963171|NCT00906399|588564751|FG002|Year 2|Physician Decision|0|||
163199182|NCT00228384|589443277|FG000|Overall Study|Lost to Follow-up|6|||
162963172|NCT00906399|588564752|FG003|Year 2|Physician Decision|0|||
162963173|NCT00906399|588564753|FG004|Year 2|Physician Decision|2|||
162963174|NCT00906399|588564754|FG005|Year 2|Physician Decision|6|||
162963175|NCT00906399|588564755|FG006|Year 2|Physician Decision|3|||
162963176|NCT00906399|588564749|FG000|Year 2|Death|0|||
162963177|NCT00906399|588564750|FG001|Year 2|Death|0|||
162963178|NCT00906399|588564751|FG002|Year 2|Death|0|||
162963179|NCT00906399|588564752|FG003|Year 2|Death|1|||
162963180|NCT00906399|588564753|FG004|Year 2|Death|0|||
162963181|NCT00906399|588564754|FG005|Year 2|Death|0|||
162963182|NCT00906399|588564755|FG006|Year 2|Death|3|||
162963183|NCT00906399|588564749|FG000|Year 2|Other|0|||
162963184|NCT00906399|588564750|FG001|Year 2|Other|0|||
162963185|NCT00906399|588564751|FG002|Year 2|Other|0|||
162963186|NCT00906399|588564752|FG003|Year 2|Other|2|||
162963187|NCT00906399|588564753|FG004|Year 2|Other|3|||
162963188|NCT00906399|588564754|FG005|Year 2|Other|1|||
163199183|NCT00228384|589443278|FG001|Overall Study|Lost to Follow-up|10|||
163199184|NCT00228384|589443277|FG000|Overall Study|Surgical Intervention (bypass)|5|||
163199185|NCT00228384|589443278|FG001|Overall Study|Surgical Intervention (bypass)|5|||
163199186|NCT00228384|589443277|FG000|Overall Study|Withdrawal by Subject|9|||
163199187|NCT00228384|589443278|FG001|Overall Study|Withdrawal by Subject|10|||
163199188|NCT00228384|589443277|FG000|Overall Study|Physician Decision|0|||
163199189|NCT00228384|589443278|FG001|Overall Study|Physician Decision|1|||
162963189|NCT00906399|588564755|FG006|Year 2|Other|0|||
162963190|NCT02471807|588564766|FG000|Overall Study|Death|14|||
162963191|NCT02471807|588564766|FG000|Overall Study|Withdrawal by Subject|2|||
162963192|NCT02471807|588564766|FG000|Overall Study|Explant|5|||
162963193|NCT02471807|588564766|FG000|Overall Study|Lost to Follow-up|1|||
162963194|NCT02055547|588564768|FG000|Overall Study|Protocol Violation|0|||
162963195|NCT02055547|588564769|FG001|Overall Study|Protocol Violation|0|||
162963196|NCT02055547|588564770|FG002|Overall Study|Protocol Violation|1|||
162963197|NCT02055547|588564771|FG003|Overall Study|Protocol Violation|0|||
162963198|NCT02055547|588564772|FG004|Overall Study|Protocol Violation|0|||
162963199|NCT02055547|588564773|FG005|Overall Study|Protocol Violation|0|||
162963200|NCT02055547|588564774|FG006|Overall Study|Protocol Violation|1|||
162963201|NCT02055547|588564775|FG007|Overall Study|Protocol Violation|0|||
163199190|NCT01785069|589443279|FG000|Overall Study|Implanted with nonstudy device|1|||
162963202|NCT02055547|588564776|FG008|Overall Study|Protocol Violation|0|||
162963203|NCT02055547|588564777|FG009|Overall Study|Protocol Violation|0|||
163050505|NCT02869789|588893594|FG002|Overall Study|Participant request to discontinue study treatment|5|||
163050506|NCT02869789|588893595|FG003|Overall Study|Participant request to discontinue study treatment|3|||
163050507|NCT02869789|588893592|FG000|Overall Study|Withdrawal by Subject|5|||
163050508|NCT02869789|588893593|FG001|Overall Study|Withdrawal by Subject|2|||
163050509|NCT02869789|588893594|FG002|Overall Study|Withdrawal by Subject|7|||
163050510|NCT02869789|588893595|FG003|Overall Study|Withdrawal by Subject|2|||
163050511|NCT02869789|588893592|FG000|Overall Study|Lost to Follow-up|0|||
163050512|NCT02869789|588893593|FG001|Overall Study|Lost to Follow-up|0|||
163050513|NCT02869789|588893594|FG002|Overall Study|Lost to Follow-up|2|||
163050514|NCT02869789|588893595|FG003|Overall Study|Lost to Follow-up|0|||
163050515|NCT02869789|588893592|FG000|Overall Study|Maximum clinical benefit|5|||
163050516|NCT02869789|588893593|FG001|Overall Study|Maximum clinical benefit|2|||
163050517|NCT02869789|588893594|FG002|Overall Study|Maximum clinical benefit|1|||
163050518|NCT02869789|588893595|FG003|Overall Study|Maximum clinical benefit|0|||
163050519|NCT02869789|588893592|FG000|Overall Study|Poor/Non-compliance|0|||
163050520|NCT02869789|588893593|FG001|Overall Study|Poor/Non-compliance|2|||
163050521|NCT02869789|588893594|FG002|Overall Study|Poor/Non-compliance|1|||
163050522|NCT02869789|588893595|FG003|Overall Study|Poor/Non-compliance|0|||
163050523|NCT02869789|588893592|FG000|Overall Study|Participant no longer meets study criteria|0|||
163050524|NCT02869789|588893593|FG001|Overall Study|Participant no longer meets study criteria|1|||
163050525|NCT02869789|588893594|FG002|Overall Study|Participant no longer meets study criteria|1|||
163050526|NCT02869789|588893595|FG003|Overall Study|Participant no longer meets study criteria|0|||
163050527|NCT02869789|588893592|FG000|Overall Study|Administrative reason by sponsor|0|||
163050528|NCT02869789|588893593|FG001|Overall Study|Administrative reason by sponsor|0|||
163050529|NCT02869789|588893594|FG002|Overall Study|Administrative reason by sponsor|1|||
163050530|NCT02869789|588893595|FG003|Overall Study|Administrative reason by sponsor|0|||
163050531|NCT02869789|588893592|FG000|Overall Study|Other reasons|4|||
163050532|NCT02869789|588893593|FG001|Overall Study|Other reasons|8|||
163050533|NCT02869789|588893594|FG002|Overall Study|Other reasons|6|||
163050534|NCT02869789|588893595|FG003|Overall Study|Other reasons|0|||
163050535|NCT00297648|588893596|FG000|Overall Study|Adverse Event|13|||
163050536|NCT00297648|588893596|FG000|Overall Study|Lack of Efficacy|18|||
163050537|NCT00297648|588893596|FG000|Overall Study|Lost to Follow-up|1|||
163050538|NCT00297648|588893596|FG000|Overall Study|Withdrawal by Subject|3|||
163050539|NCT00297648|588893596|FG000|Overall Study|Other: Incompliance|1|||
163050540|NCT01529606|588893598|FG000|Overall Study|Lost to Follow-up|21|||
163050541|NCT01529606|588893599|FG001|Overall Study|Lost to Follow-up|18|||
163050542|NCT01746862|588893600|FG000|Overall Study|Withdrawal by Subject|1|||
163050543|NCT01746862|588893601|FG001|Overall Study|Withdrawal by Subject|1|||
163050544|NCT01746862|588893600|FG000|Overall Study|Protocol Violation|1|||
163050545|NCT01746862|588893601|FG001|Overall Study|Protocol Violation|0|||
163050546|NCT01746862|588893600|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
163050547|NCT01746862|588893601|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
163050548|NCT01746862|588893600|FG000|Overall Study|Entered puberty during the study|1|||
163050549|NCT01746862|588893601|FG001|Overall Study|Entered puberty during the study|0|||
163396622|NCT02490475|590162752|FG002|Period 2: Extension Phase|Adverse Event|1|||
163396623|NCT02490475|590162753|FG003|Period 2: Extension Phase|Adverse Event|0|||
163050550|NCT04742673|588893602|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
163050551|NCT04742673|588893603|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
163050552|NCT05209880|588893619|FG000|1-Month Follow-up|Spoke with Doctor|5|||
163050553|NCT05209880|588893620|FG001|1-Month Follow-up|Spoke with Doctor|5|||
163050554|NCT05209880|588893619|FG000|1-Month Follow-up|Lost to Follow-up|7|||
163396624|NCT00616434|590162755|FG000|Overall Study|Adverse Event|5|||
162963204|NCT02055547|588564778|FG010|Overall Study|Protocol Violation|0|||
162963205|NCT02055547|588564779|FG011|Overall Study|Protocol Violation|0|||
162963206|NCT02055547|588564780|FG012|Overall Study|Protocol Violation|0|||
162963207|NCT02055547|588564781|FG013|Overall Study|Protocol Violation|0|||
162963208|NCT02055547|588564782|FG014|Overall Study|Protocol Violation|0|||
162963209|NCT02055547|588564783|FG015|Overall Study|Protocol Violation|0|||
162963210|NCT02055547|588564784|FG016|Overall Study|Protocol Violation|0|||
162963211|NCT02055547|588564785|FG017|Overall Study|Protocol Violation|0|||
162963212|NCT02055547|588564786|FG018|Overall Study|Protocol Violation|0|||
162963213|NCT02055547|588564768|FG000|Overall Study|Physician Decision|0|||
162963214|NCT02055547|588564769|FG001|Overall Study|Physician Decision|1|||
162963215|NCT02055547|588564770|FG002|Overall Study|Physician Decision|1|||
162963216|NCT02055547|588564771|FG003|Overall Study|Physician Decision|0|||
162963217|NCT02055547|588564772|FG004|Overall Study|Physician Decision|1|||
162963218|NCT02055547|588564773|FG005|Overall Study|Physician Decision|0|||
162963219|NCT02055547|588564774|FG006|Overall Study|Physician Decision|0|||
162963220|NCT02055547|588564775|FG007|Overall Study|Physician Decision|0|||
162963221|NCT02055547|588564776|FG008|Overall Study|Physician Decision|0|||
162963222|NCT02055547|588564777|FG009|Overall Study|Physician Decision|1|||
162963223|NCT02055547|588564778|FG010|Overall Study|Physician Decision|1|||
162963224|NCT02055547|588564779|FG011|Overall Study|Physician Decision|0|||
162963225|NCT02055547|588564780|FG012|Overall Study|Physician Decision|0|||
162963226|NCT02055547|588564781|FG013|Overall Study|Physician Decision|0|||
162963227|NCT02055547|588564782|FG014|Overall Study|Physician Decision|0|||
162963228|NCT02055547|588564783|FG015|Overall Study|Physician Decision|0|||
163050555|NCT05209880|588893620|FG001|1-Month Follow-up|Lost to Follow-up|9|||
163050556|NCT05209880|588893619|FG000|1-Month Follow-up|Discontinued|0|||
163050557|NCT05209880|588893620|FG001|1-Month Follow-up|Discontinued|1|||
163050558|NCT05209880|588893619|FG000|3-Month Follow-up|Spoke with Doctor|17|||
163050559|NCT05209880|588893620|FG001|3-Month Follow-up|Spoke with Doctor|7|||
163050560|NCT05209880|588893619|FG000|3-Month Follow-up|Lost to Follow-up|8|||
163050561|NCT05209880|588893620|FG001|3-Month Follow-up|Lost to Follow-up|10|||
163050562|NCT05209880|588893619|FG000|3-Month Follow-up|Discontinued|1|||
163050563|NCT05209880|588893620|FG001|3-Month Follow-up|Discontinued|3|||
163050564|NCT05209880|588893619|FG000|6-Month Follow-up|Spoke with Doctor|25|||
163050565|NCT05209880|588893620|FG001|6-Month Follow-up|Spoke with Doctor|14|||
163050566|NCT05209880|588893619|FG000|6-Month Follow-up|Lost to Follow-up|9|||
163050567|NCT05209880|588893620|FG001|6-Month Follow-up|Lost to Follow-up|14|||
163050568|NCT05209880|588893619|FG000|6-Month Follow-up|Discontinued|1|||
163050569|NCT05209880|588893620|FG001|6-Month Follow-up|Discontinued|3|||
163050570|NCT03834493|588893621|FG000|Overall Study|Participants Ongoing|311|||
163050571|NCT03834493|588893622|FG001|Overall Study|Participants Ongoing|324|||
163050572|NCT03834493|588893621|FG000|Overall Study|Withdrawal by Subject|20|||
163050573|NCT03834493|588893622|FG001|Overall Study|Withdrawal by Subject|17|||
163050574|NCT03834493|588893621|FG000|Overall Study|Physician Decision|1|||
163050575|NCT03834493|588893622|FG001|Overall Study|Physician Decision|0|||
163050576|NCT03834493|588893621|FG000|Overall Study|Death|289|||
163050577|NCT03834493|588893622|FG001|Overall Study|Death|282|||
163050578|NCT04003103|588893623|FG000|Overall Study|Death|1|||
163050579|NCT04003103|588893624|FG001|Overall Study|Death|0|||
163050580|NCT04003103|588893625|FG002|Overall Study|Death|0|||
163396625|NCT00616434|590162756|FG001|Overall Study|Adverse Event|2|||
163050581|NCT04003103|588893623|FG000|Overall Study|Lost to Follow-up|4|||
163050582|NCT04003103|588893624|FG001|Overall Study|Lost to Follow-up|3|||
163050583|NCT04003103|588893625|FG002|Overall Study|Lost to Follow-up|2|||
163050584|NCT04003103|588893623|FG000|Overall Study|Withdrawal by Subject|10|||
163050585|NCT04003103|588893624|FG001|Overall Study|Withdrawal by Subject|1|||
163050586|NCT04003103|588893625|FG002|Overall Study|Withdrawal by Subject|1|||
162963229|NCT02055547|588564784|FG016|Overall Study|Physician Decision|0|||
162963230|NCT02055547|588564785|FG017|Overall Study|Physician Decision|0|||
162963231|NCT02055547|588564786|FG018|Overall Study|Physician Decision|0|||
162963232|NCT02055547|588564768|FG000|Overall Study|Adverse Event|0|||
162963233|NCT02055547|588564769|FG001|Overall Study|Adverse Event|0|||
162963234|NCT02055547|588564770|FG002|Overall Study|Adverse Event|0|||
162963235|NCT02055547|588564771|FG003|Overall Study|Adverse Event|0|||
162963236|NCT02055547|588564772|FG004|Overall Study|Adverse Event|0|||
162963237|NCT02055547|588564773|FG005|Overall Study|Adverse Event|0|||
163050587|NCT04003103|588893623|FG000|Overall Study|Status not recorded|0|||
163050588|NCT04003103|588893624|FG001|Overall Study|Status not recorded|2|||
162963238|NCT02055547|588564774|FG006|Overall Study|Adverse Event|1|||
163050589|NCT04003103|588893625|FG002|Overall Study|Status not recorded|0|||
163050590|NCT04144322|588893632|FG000|Overall Study|Lack of Efficacy|2|||
163050591|NCT04144322|588893633|FG001|Overall Study|Lack of Efficacy|2|||
163050592|NCT02277028|588893634|FG000|Overall Study|Lost to Follow-up|1|||
163050593|NCT02277028|588893635|FG001|Overall Study|Lost to Follow-up|0|||
163050594|NCT02277028|588893634|FG000|Overall Study|Withdrawal by Subject|0|||
163050595|NCT02277028|588893635|FG001|Overall Study|Withdrawal by Subject|1|||
163050596|NCT02718911|588893636|FG000|Overall Study|Adverse Event|0|||
163050597|NCT02718911|588893637|FG001|Overall Study|Adverse Event|0|||
163050598|NCT02718911|588893638|FG002|Overall Study|Adverse Event|0|||
163050599|NCT02718911|588893639|FG003|Overall Study|Adverse Event|0|||
163050600|NCT02718911|588893640|FG004|Overall Study|Adverse Event|0|||
163050601|NCT02718911|588893641|FG005|Overall Study|Adverse Event|0|||
163050602|NCT02718911|588893642|FG006|Overall Study|Adverse Event|0|||
163050603|NCT02718911|588893643|FG007|Overall Study|Adverse Event|0|||
163050604|NCT02718911|588893644|FG008|Overall Study|Adverse Event|0|||
163050605|NCT02718911|588893645|FG009|Overall Study|Adverse Event|2|||
163050606|NCT02718911|588893636|FG000|Overall Study|Death|2|||
163050607|NCT02718911|588893637|FG001|Overall Study|Death|3|||
163050608|NCT02718911|588893638|FG002|Overall Study|Death|1|||
163050609|NCT02718911|588893639|FG003|Overall Study|Death|0|||
163050610|NCT02718911|588893640|FG004|Overall Study|Death|1|||
163050611|NCT02718911|588893641|FG005|Overall Study|Death|3|||
163050612|NCT02718911|588893642|FG006|Overall Study|Death|1|||
163050613|NCT02718911|588893643|FG007|Overall Study|Death|1|||
163050614|NCT02718911|588893644|FG008|Overall Study|Death|4|||
163050615|NCT02718911|588893645|FG009|Overall Study|Death|3|||
163050616|NCT02718911|588893636|FG000|Overall Study|Lost to Follow-up|0|||
163050617|NCT02718911|588893637|FG001|Overall Study|Lost to Follow-up|0|||
163050618|NCT02718911|588893638|FG002|Overall Study|Lost to Follow-up|0|||
163050619|NCT02718911|588893639|FG003|Overall Study|Lost to Follow-up|0|||
163050620|NCT02718911|588893640|FG004|Overall Study|Lost to Follow-up|0|||
163050621|NCT02718911|588893641|FG005|Overall Study|Lost to Follow-up|0|||
163050622|NCT02718911|588893642|FG006|Overall Study|Lost to Follow-up|0|||
163050623|NCT02718911|588893643|FG007|Overall Study|Lost to Follow-up|0|||
163050624|NCT02718911|588893644|FG008|Overall Study|Lost to Follow-up|1|||
163050625|NCT02718911|588893645|FG009|Overall Study|Lost to Follow-up|0|||
163050626|NCT02718911|588893636|FG000|Overall Study|Physician Decision|2|||
163050627|NCT02718911|588893637|FG001|Overall Study|Physician Decision|0|||
163050628|NCT02718911|588893638|FG002|Overall Study|Physician Decision|1|||
163050629|NCT02718911|588893639|FG003|Overall Study|Physician Decision|1|||
163050630|NCT02718911|588893640|FG004|Overall Study|Physician Decision|0|||
162963239|NCT02055547|588564775|FG007|Overall Study|Adverse Event|0|||
162963240|NCT02055547|588564776|FG008|Overall Study|Adverse Event|1|||
162963241|NCT02055547|588564777|FG009|Overall Study|Adverse Event|0|||
162963242|NCT02055547|588564778|FG010|Overall Study|Adverse Event|0|||
162963243|NCT02055547|588564779|FG011|Overall Study|Adverse Event|0|||
162963244|NCT02055547|588564780|FG012|Overall Study|Adverse Event|0|||
162963245|NCT02055547|588564781|FG013|Overall Study|Adverse Event|0|||
162963246|NCT02055547|588564782|FG014|Overall Study|Adverse Event|0|||
162963247|NCT02055547|588564783|FG015|Overall Study|Adverse Event|0|||
162963248|NCT02055547|588564784|FG016|Overall Study|Adverse Event|0|||
162963249|NCT02055547|588564785|FG017|Overall Study|Adverse Event|0|||
162963250|NCT02055547|588564786|FG018|Overall Study|Adverse Event|0|||
162963251|NCT02055547|588564768|FG000|Overall Study|Withdrawal by Subject|0|||
163050631|NCT02718911|588893641|FG005|Overall Study|Physician Decision|0|||
163050632|NCT02718911|588893642|FG006|Overall Study|Physician Decision|0|||
163050633|NCT02718911|588893643|FG007|Overall Study|Physician Decision|1|||
163050634|NCT02718911|588893644|FG008|Overall Study|Physician Decision|2|||
162963252|NCT02055547|588564769|FG001|Overall Study|Withdrawal by Subject|0|||
162963253|NCT02055547|588564770|FG002|Overall Study|Withdrawal by Subject|0|||
163050635|NCT02718911|588893645|FG009|Overall Study|Physician Decision|1|||
163050636|NCT02718911|588893636|FG000|Overall Study|Withdrawal by Subject|0|||
163050637|NCT02718911|588893637|FG001|Overall Study|Withdrawal by Subject|0|||
163050638|NCT02718911|588893638|FG002|Overall Study|Withdrawal by Subject|0|||
163050639|NCT02718911|588893639|FG003|Overall Study|Withdrawal by Subject|0|||
163050640|NCT02718911|588893640|FG004|Overall Study|Withdrawal by Subject|1|||
163050641|NCT02718911|588893641|FG005|Overall Study|Withdrawal by Subject|0|||
163050642|NCT02718911|588893642|FG006|Overall Study|Withdrawal by Subject|0|||
162963254|NCT02055547|588564771|FG003|Overall Study|Withdrawal by Subject|0|||
162963255|NCT02055547|588564772|FG004|Overall Study|Withdrawal by Subject|0|||
163305013|NCT01070069|589823937|FG000|Overall Study|Death|1|||
163305014|NCT01070069|589823938|FG001|Overall Study|Death|0|||
163305015|NCT01070069|589823939|FG002|Overall Study|Death|2|||
163305016|NCT01070069|589823940|FG003|Overall Study|Death|0|||
163305017|NCT01070069|589823941|FG004|Overall Study|Death|1|||
163305018|NCT01070069|589823937|FG000|Overall Study|Withdrawal by Subject|1|||
163305019|NCT01070069|589823938|FG001|Overall Study|Withdrawal by Subject|1|||
163305020|NCT01070069|589823939|FG002|Overall Study|Withdrawal by Subject|4|||
163305021|NCT01070069|589823940|FG003|Overall Study|Withdrawal by Subject|0|||
163305022|NCT01070069|589823941|FG004|Overall Study|Withdrawal by Subject|0|||
163305023|NCT01070069|589823937|FG000|Overall Study|Lost to Follow-up|4|||
163305024|NCT01070069|589823938|FG001|Overall Study|Lost to Follow-up|1|||
163305025|NCT01070069|589823939|FG002|Overall Study|Lost to Follow-up|0|||
163305026|NCT01070069|589823940|FG003|Overall Study|Lost to Follow-up|0|||
163305027|NCT01070069|589823941|FG004|Overall Study|Lost to Follow-up|3|||
163305028|NCT03101930|589823942|FG000|Overall Study|Withdrawal by Subject|2|||
163305029|NCT03101930|589823943|FG001|Overall Study|Withdrawal by Subject|1|||
163305030|NCT03101930|589823944|FG002|Overall Study|Withdrawal by Subject|2|||
163305031|NCT02814838|589823945|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
163305032|NCT02814838|589823946|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
163305033|NCT02814838|589823945|FG000|Overall Study|Consent withdrawal|1|||
163305034|NCT02814838|589823946|FG001|Overall Study|Consent withdrawal|1|||
163305035|NCT01747486|589823947|FG000|Stage 1|Physician Decision|3|||
163305036|NCT01747486|589823948|FG001|Stage 1|Physician Decision|0|||
163199191|NCT01785069|589443280|FG001|Overall Study|Implanted with nonstudy device|2|||
163199192|NCT01785069|589443281|FG002|Overall Study|Implanted with nonstudy device|1|||
163199193|NCT01785069|589443282|FG003|Overall Study|Implanted with nonstudy device|0|||
163199194|NCT01785069|589443279|FG000|Overall Study|Death|0|||
163199195|NCT01785069|589443280|FG001|Overall Study|Death|0|||
163199196|NCT01785069|589443281|FG002|Overall Study|Death|2|||
163199197|NCT01785069|589443282|FG003|Overall Study|Death|0|||
163199198|NCT01785069|589443279|FG000|Overall Study|Subject choice|2|||
163199199|NCT01785069|589443280|FG001|Overall Study|Subject choice|2|||
163199200|NCT01785069|589443281|FG002|Overall Study|Subject choice|0|||
163199201|NCT01785069|589443282|FG003|Overall Study|Subject choice|1|||
163199202|NCT01785069|589443279|FG000|Overall Study|Lost to Follow-up|1|||
163199203|NCT01785069|589443280|FG001|Overall Study|Lost to Follow-up|2|||
163199204|NCT01785069|589443281|FG002|Overall Study|Lost to Follow-up|4|||
163199205|NCT01785069|589443282|FG003|Overall Study|Lost to Follow-up|1|||
163199206|NCT01785069|589443279|FG000|Overall Study|Reason not Specified|1|||
163199207|NCT01785069|589443280|FG001|Overall Study|Reason not Specified|2|||
163199208|NCT01785069|589443281|FG002|Overall Study|Reason not Specified|1|||
163199209|NCT01785069|589443282|FG003|Overall Study|Reason not Specified|4|||
163199210|NCT01785069|589443279|FG000|Overall Study|Not evaluable|7|||
163199211|NCT01785069|589443280|FG001|Overall Study|Not evaluable|4|||
163199212|NCT01785069|589443281|FG002|Overall Study|Not evaluable|5|||
163199213|NCT01785069|589443282|FG003|Overall Study|Not evaluable|8|||
163199214|NCT03288129|589443283|FG000|Overall Study|Adverse Event|10|||
163199215|NCT03288129|589443283|FG000|Overall Study|Lost to Follow-up|3|||
163199216|NCT03288129|589443283|FG000|Overall Study|Withdrawal by Subject|3|||
163199217|NCT03288129|589443283|FG000|Overall Study|Withdrawal of consent/assent|1|||
163199218|NCT03288129|589443283|FG000|Overall Study|Other|5|||
163199219|NCT01744197|589443286|FG000|Overall Study|Received 1 patch|2|||
163199220|NCT01744197|589443287|FG001|Overall Study|Received 1 patch|1|||
163199221|NCT01744197|589443286|FG000|Overall Study|No patch received|2|||
163199222|NCT01744197|589443287|FG001|Overall Study|No patch received|2|||
163199223|NCT02777333|589443288|FG000|Overall Study|Withdrawal by Subject|0|||
163199224|NCT02777333|589443289|FG001|Overall Study|Withdrawal by Subject|1|||
163199225|NCT02777333|589443288|FG000|Overall Study|Lost to Follow-up|0|||
163199226|NCT02777333|589443289|FG001|Overall Study|Lost to Follow-up|1|||
163199227|NCT03305575|589445279|FG000|Overall Study|Physician Decision|1|||
163199228|NCT03305575|589445280|FG001|Overall Study|Physician Decision|0|||
163050643|NCT02718911|588893643|FG007|Overall Study|Withdrawal by Subject|0|||
163050644|NCT02718911|588893644|FG008|Overall Study|Withdrawal by Subject|1|||
163050645|NCT02718911|588893645|FG009|Overall Study|Withdrawal by Subject|4|||
163050646|NCT02718911|588893636|FG000|Overall Study|Reason Not Collected|0|||
163050647|NCT02718911|588893637|FG001|Overall Study|Reason Not Collected|0|||
163050648|NCT02718911|588893638|FG002|Overall Study|Reason Not Collected|1|||
163050649|NCT02718911|588893639|FG003|Overall Study|Reason Not Collected|0|||
163050650|NCT02718911|588893640|FG004|Overall Study|Reason Not Collected|0|||
163050651|NCT02718911|588893641|FG005|Overall Study|Reason Not Collected|0|||
163050652|NCT02718911|588893642|FG006|Overall Study|Reason Not Collected|2|||
163050653|NCT02718911|588893643|FG007|Overall Study|Reason Not Collected|1|||
163050654|NCT02718911|588893644|FG008|Overall Study|Reason Not Collected|4|||
163050655|NCT02718911|588893645|FG009|Overall Study|Reason Not Collected|9|||
163050656|NCT04817332|588893646|FG000|Overall Study|Lost to Follow-up|3|||
163050657|NCT04817332|588893647|FG001|Overall Study|Lost to Follow-up|3|||
163050658|NCT04817332|588893646|FG000|Overall Study|Protocol Violation|2|||
163050659|NCT04817332|588893647|FG001|Overall Study|Protocol Violation|0|||
163050660|NCT01435759|588893654|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
163050661|NCT01435759|588893655|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
163050662|NCT01435759|588893656|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
163050663|NCT01435759|588893657|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
163050664|NCT01435759|588893658|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
163050665|NCT01435759|588893659|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
163050666|NCT01435759|588893654|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
163305037|NCT01747486|589823947|FG000|Stage 1|Withdrawal by Subject|4|||
163050667|NCT01435759|588893655|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
163050668|NCT01435759|588893656|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
163305038|NCT01747486|589823948|FG001|Stage 1|Withdrawal by Subject|3|||
163305039|NCT01747486|589823947|FG000|Stage 1|Disease progression|4|||
163305040|NCT01747486|589823948|FG001|Stage 1|Disease progression|9|||
163305041|NCT01747486|589823947|FG000|Stage 1|Death|1|||
163305042|NCT01747486|589823948|FG001|Stage 1|Death|1|||
163305043|NCT01747486|589823947|FG000|Stage 2|Physician Decision|2|||
163305044|NCT01747486|589823948|FG001|Stage 2|Physician Decision|0|||
163305045|NCT01747486|589823947|FG000|Stage 2|Withdrawal by Subject|1|||
163305046|NCT01747486|589823948|FG001|Stage 2|Withdrawal by Subject|0|||
163305047|NCT01747486|589823947|FG000|Stage 2|New Cancer Therapy|3|||
163305048|NCT01747486|589823948|FG001|Stage 2|New Cancer Therapy|0|||
163305049|NCT01747486|589823947|FG000|Stage 2|Disease Progression|3|||
163305050|NCT01747486|589823948|FG001|Stage 2|Disease Progression|0|||
163305051|NCT00632749|589823949|FG000|Overall Study|Progressive disease|3|||
163305052|NCT00632749|589823950|FG001|Overall Study|Progressive disease|2|||
163305053|NCT00632749|589823951|FG002|Overall Study|Progressive disease|2|||
163305054|NCT00632749|589823952|FG003|Overall Study|Progressive disease|2|||
163305055|NCT00632749|589823953|FG004|Overall Study|Progressive disease|4|||
163305056|NCT00632749|589823954|FG005|Overall Study|Progressive disease|4|||
163305057|NCT00632749|589823955|FG006|Overall Study|Progressive disease|3|||
163305058|NCT00632749|589823956|FG007|Overall Study|Progressive disease|2|||
163305059|NCT00632749|589823957|FG008|Overall Study|Progressive disease|3|||
163305060|NCT00632749|589823958|FG009|Overall Study|Progressive disease|2|||
163305061|NCT00632749|589823959|FG010|Overall Study|Progressive disease|4|||
163305062|NCT00632749|589823960|FG011|Overall Study|Progressive disease|3|||
163305063|NCT00632749|589823961|FG012|Overall Study|Progressive disease|2|||
163305064|NCT00632749|589823962|FG013|Overall Study|Progressive disease|4|||
163305065|NCT00632749|589823949|FG000|Overall Study|Other Adverse event|1|||
163305066|NCT00632749|589823950|FG001|Overall Study|Other Adverse event|1|||
163305067|NCT00632749|589823951|FG002|Overall Study|Other Adverse event|1|||
163305068|NCT00632749|589823952|FG003|Overall Study|Other Adverse event|1|||
163305069|NCT00632749|589823953|FG004|Overall Study|Other Adverse event|2|||
163305070|NCT00632749|589823954|FG005|Overall Study|Other Adverse event|4|||
163305071|NCT00632749|589823955|FG006|Overall Study|Other Adverse event|1|||
163305072|NCT00632749|589823956|FG007|Overall Study|Other Adverse event|2|||
163305073|NCT00632749|589823957|FG008|Overall Study|Other Adverse event|2|||
163305074|NCT00632749|589823958|FG009|Overall Study|Other Adverse event|0|||
163305075|NCT00632749|589823959|FG010|Overall Study|Other Adverse event|1|||
163305076|NCT00632749|589823960|FG011|Overall Study|Other Adverse event|0|||
163305077|NCT00632749|589823961|FG012|Overall Study|Other Adverse event|1|||
163305078|NCT00632749|589823962|FG013|Overall Study|Other Adverse event|0|||
163305079|NCT00632749|589823949|FG000|Overall Study|Refuse to continue medication|0|||
163305080|NCT00632749|589823950|FG001|Overall Study|Refuse to continue medication|0|||
163305081|NCT00632749|589823951|FG002|Overall Study|Refuse to continue medication|0|||
163305082|NCT00632749|589823952|FG003|Overall Study|Refuse to continue medication|1|||
163305083|NCT00632749|589823953|FG004|Overall Study|Refuse to continue medication|0|||
163305084|NCT00632749|589823954|FG005|Overall Study|Refuse to continue medication|0|||
163396626|NCT00616434|590162755|FG000|Overall Study|Physician Decision|0|||
163396627|NCT00616434|590162756|FG001|Overall Study|Physician Decision|4|||
163396628|NCT00616434|590162755|FG000|Overall Study|Withdrawal by Subject|1|||
163396629|NCT00616434|590162756|FG001|Overall Study|Withdrawal by Subject|1|||
163396630|NCT00616434|590162755|FG000|Overall Study|Protocol deviation|0|||
163396631|NCT00616434|590162756|FG001|Overall Study|Protocol deviation|1|||
163396632|NCT02319668|590162762|FG000|Overall Study|Other (Not specified)|0|||
163396633|NCT02319668|590162763|FG001|Overall Study|Other (Not specified)|2|||
163396634|NCT01161043|590162764|FG000|Overall Study|Withdrawal by Subject|3|||
163396635|NCT02164929|590162765|FG000|Overall Study|Converted to open procedure|1|||
163396636|NCT02164929|590162766|FG001|Overall Study|Converted to open procedure|0|||
163396637|NCT02164929|590162767|FG002|Overall Study|Converted to open procedure|0|||
163396638|NCT02164929|590162768|FG003|Overall Study|Converted to open procedure|2|||
162963256|NCT02055547|588564773|FG005|Overall Study|Withdrawal by Subject|1|||
162963257|NCT02055547|588564774|FG006|Overall Study|Withdrawal by Subject|0|||
162963258|NCT02055547|588564775|FG007|Overall Study|Withdrawal by Subject|0|||
163199229|NCT02871297|589445288|FG000|Overall Study|Adverse Event|34|||
163199230|NCT02871297|589445288|FG000|Overall Study|Lack of Efficacy|10|||
163199231|NCT02871297|589445288|FG000|Overall Study|Non-compliance with study drug|15|||
163199232|NCT02871297|589445288|FG000|Overall Study|Protocol Violation|3|||
163199233|NCT02871297|589445288|FG000|Overall Study|Withdrawal by Subject|20|||
163199234|NCT02871297|589445288|FG000|Overall Study|Lost to Follow-up|13|||
163199235|NCT02871297|589445288|FG000|Overall Study|Rolled over to 13546A|2|||
163199236|NCT02871297|589445288|FG000|Overall Study|Other than specified|39|||
163199237|NCT02966028|589445289|FG000|Overall Study|Adverse Event|7|||
163199238|NCT02966028|589445290|FG001|Overall Study|Adverse Event|13|||
163199239|NCT02966028|589445291|FG002|Overall Study|Adverse Event|10|||
163396639|NCT02164929|590162765|FG000|Overall Study|Failed regional block|0|||
163396640|NCT02164929|590162766|FG001|Overall Study|Failed regional block|0|||
163396641|NCT02164929|590162767|FG002|Overall Study|Failed regional block|1|||
162963259|NCT02055547|588564776|FG008|Overall Study|Withdrawal by Subject|1|||
163199240|NCT02966028|589445289|FG000|Overall Study|Physician Decision|1|||
163199241|NCT02966028|589445290|FG001|Overall Study|Physician Decision|0|||
163199242|NCT02966028|589445291|FG002|Overall Study|Physician Decision|2|||
163396642|NCT02164929|590162768|FG003|Overall Study|Failed regional block|0|||
163396643|NCT00365456|590162772|FG000|Trial Period I (12 Months)|Adverse Event|84|||
163396644|NCT00365456|590162773|FG001|Trial Period I (12 Months)|Adverse Event|0|||
163396645|NCT00365456|590162772|FG000|Trial Period I (12 Months)|Non-compliance|3|||
162963260|NCT02055547|588564777|FG009|Overall Study|Withdrawal by Subject|0|||
162963261|NCT02055547|588564778|FG010|Overall Study|Withdrawal by Subject|0|||
162963262|NCT02055547|588564779|FG011|Overall Study|Withdrawal by Subject|0|||
162963263|NCT02055547|588564780|FG012|Overall Study|Withdrawal by Subject|0|||
162963264|NCT02055547|588564781|FG013|Overall Study|Withdrawal by Subject|1|||
162963265|NCT02055547|588564782|FG014|Overall Study|Withdrawal by Subject|0|||
162963266|NCT02055547|588564783|FG015|Overall Study|Withdrawal by Subject|1|||
162963267|NCT02055547|588564784|FG016|Overall Study|Withdrawal by Subject|0|||
162963268|NCT02055547|588564785|FG017|Overall Study|Withdrawal by Subject|0|||
162963269|NCT02055547|588564786|FG018|Overall Study|Withdrawal by Subject|0|||
162963270|NCT02055547|588564768|FG000|Overall Study|Lost to Follow-up|0|||
162963271|NCT02055547|588564769|FG001|Overall Study|Lost to Follow-up|0|||
162963272|NCT02055547|588564770|FG002|Overall Study|Lost to Follow-up|1|||
162963273|NCT02055547|588564771|FG003|Overall Study|Lost to Follow-up|0|||
162963274|NCT02055547|588564772|FG004|Overall Study|Lost to Follow-up|0|||
162963275|NCT02055547|588564773|FG005|Overall Study|Lost to Follow-up|0|||
162963276|NCT02055547|588564774|FG006|Overall Study|Lost to Follow-up|0|||
162963277|NCT02055547|588564775|FG007|Overall Study|Lost to Follow-up|0|||
162963278|NCT02055547|588564776|FG008|Overall Study|Lost to Follow-up|0|||
162963279|NCT02055547|588564777|FG009|Overall Study|Lost to Follow-up|0|||
162963280|NCT02055547|588564778|FG010|Overall Study|Lost to Follow-up|0|||
162963281|NCT02055547|588564779|FG011|Overall Study|Lost to Follow-up|0|||
162963282|NCT02055547|588564780|FG012|Overall Study|Lost to Follow-up|0|||
162963283|NCT02055547|588564781|FG013|Overall Study|Lost to Follow-up|0|||
162963284|NCT02055547|588564782|FG014|Overall Study|Lost to Follow-up|0|||
162963285|NCT02055547|588564783|FG015|Overall Study|Lost to Follow-up|0|||
162963286|NCT02055547|588564784|FG016|Overall Study|Lost to Follow-up|0|||
162963287|NCT02055547|588564785|FG017|Overall Study|Lost to Follow-up|0|||
162963288|NCT02055547|588564786|FG018|Overall Study|Lost to Follow-up|0|||
163396646|NCT00365456|590162773|FG001|Trial Period I (12 Months)|Non-compliance|0|||
163396647|NCT00365456|590162772|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
163396648|NCT00365456|590162773|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
163199243|NCT02966028|589445289|FG000|Overall Study|Withdrawal by Subject|7|||
163396649|NCT00365456|590162772|FG000|Trial Period I (12 Months)|Other|11|||
163396650|NCT00365456|590162773|FG001|Trial Period I (12 Months)|Other|0|||
163396651|NCT00365456|590162772|FG000|Trial Period II (12 Months)|Adverse Event|0|||
163396652|NCT00365456|590162773|FG001|Trial Period II (12 Months)|Adverse Event|6|||
163396653|NCT00365456|590162772|FG000|Trial Period II (12 Months)|Non-compliance|0|||
163396654|NCT00365456|590162773|FG001|Trial Period II (12 Months)|Non-compliance|2|||
162963289|NCT01456221|588564787|FG000|Overall Study|Withdrawal by Subject|56|||
162963290|NCT01456221|588564788|FG001|Overall Study|Withdrawal by Subject|49|||
162963291|NCT01456221|588564787|FG000|Overall Study|Lost to Follow-up|1|||
162963292|NCT01456221|588564788|FG001|Overall Study|Lost to Follow-up|4|||
163305085|NCT00632749|589823955|FG006|Overall Study|Refuse to continue medication|0|||
163305086|NCT00632749|589823956|FG007|Overall Study|Refuse to continue medication|0|||
163305087|NCT00632749|589823957|FG008|Overall Study|Refuse to continue medication|0|||
163305088|NCT00632749|589823958|FG009|Overall Study|Refuse to continue medication|1|||
163305089|NCT00632749|589823959|FG010|Overall Study|Refuse to continue medication|0|||
163305090|NCT00632749|589823960|FG011|Overall Study|Refuse to continue medication|0|||
163305091|NCT00632749|589823961|FG012|Overall Study|Refuse to continue medication|0|||
163305092|NCT00632749|589823962|FG013|Overall Study|Refuse to continue medication|0|||
163305093|NCT00632749|589823949|FG000|Overall Study|Reason other than those specified above|0|||
163305094|NCT00632749|589823950|FG001|Overall Study|Reason other than those specified above|2|||
163305095|NCT00632749|589823951|FG002|Overall Study|Reason other than those specified above|0|||
163305096|NCT00632749|589823952|FG003|Overall Study|Reason other than those specified above|0|||
163305097|NCT00632749|589823953|FG004|Overall Study|Reason other than those specified above|1|||
163305098|NCT00632749|589823954|FG005|Overall Study|Reason other than those specified above|0|||
163305099|NCT00632749|589823955|FG006|Overall Study|Reason other than those specified above|1|||
163305100|NCT00632749|589823956|FG007|Overall Study|Reason other than those specified above|0|||
163305101|NCT00632749|589823957|FG008|Overall Study|Reason other than those specified above|0|||
163305102|NCT00632749|589823958|FG009|Overall Study|Reason other than those specified above|0|||
163305103|NCT00632749|589823959|FG010|Overall Study|Reason other than those specified above|2|||
163396655|NCT00365456|590162772|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
162963293|NCT01456221|588564787|FG000|Overall Study|Received medication|3|||
162963294|NCT01456221|588564788|FG001|Overall Study|Received medication|2|||
162963295|NCT01456221|588564787|FG000|Overall Study|Incomplete data|4|||
163305104|NCT00632749|589823960|FG011|Overall Study|Reason other than those specified above|1|||
163305105|NCT00632749|589823961|FG012|Overall Study|Reason other than those specified above|0|||
163305106|NCT00632749|589823962|FG013|Overall Study|Reason other than those specified above|2|||
163305107|NCT00611559|589823963|FG000|Overall Study|Lost to Follow-up|0|||
163305108|NCT00611559|589823964|FG001|Overall Study|Lost to Follow-up|1|||
163305109|NCT00611559|589823965|FG002|Overall Study|Lost to Follow-up|0|||
163305110|NCT00611559|589823963|FG000|Overall Study|Protocol Violation|1|||
163305111|NCT00611559|589823964|FG001|Overall Study|Protocol Violation|0|||
163305112|NCT00611559|589823965|FG002|Overall Study|Protocol Violation|1|||
163305113|NCT00879333|589823966|FG000|Overall Study|Adverse Event|94|||
163305114|NCT00879333|589823967|FG001|Overall Study|Adverse Event|34|||
163305115|NCT00879333|589823966|FG000|Overall Study|Abnormal Laboratory Value|1|||
163305116|NCT00879333|589823967|FG001|Overall Study|Abnormal Laboratory Value|0|||
163305117|NCT00879333|589823966|FG000|Overall Study|Withdrawal by Subject|20|||
163305118|NCT00879333|589823967|FG001|Overall Study|Withdrawal by Subject|7|||
162963296|NCT01456221|588564788|FG001|Overall Study|Incomplete data|2|||
162963297|NCT01986647|588564790|FG000|Overall Study|Lost to Follow-up|4|||
163305119|NCT00879333|589823966|FG000|Overall Study|Lost to Follow-up|2|||
163305120|NCT00879333|589823967|FG001|Overall Study|Lost to Follow-up|1|||
163305121|NCT00879333|589823966|FG000|Overall Study|Administrative Problems|2|||
163305122|NCT00879333|589823967|FG001|Overall Study|Administrative Problems|0|||
163305123|NCT00879333|589823966|FG000|Overall Study|Death|16|||
163305124|NCT00879333|589823967|FG001|Overall Study|Death|5|||
163305125|NCT00879333|589823966|FG000|Overall Study|Disease Progression|292|||
163305126|NCT00879333|589823967|FG001|Overall Study|Disease Progression|169|||
163305127|NCT00879333|589823966|FG000|Overall Study|Protocol Violation|1|||
163305128|NCT00879333|589823967|FG001|Overall Study|Protocol Violation|1|||
163305129|NCT04402294|589823972|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
163305130|NCT04402294|589823973|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
163305131|NCT04402294|589823972|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
163305132|NCT04402294|589823973|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
163305133|NCT04459416|589826088|FG000|Overall Study|Lost to Follow-up|2|||
163305134|NCT04459416|589826089|FG001|Overall Study|Lost to Follow-up|0|||
163305135|NCT04459416|589826088|FG000|Overall Study|Withdrawal by Subject|8|||
163305136|NCT04459416|589826089|FG001|Overall Study|Withdrawal by Subject|10|||
163305137|NCT04459416|589826088|FG000|Overall Study|Disease progression|0|||
163305138|NCT04459416|589826089|FG001|Overall Study|Disease progression|3|||
163305139|NCT03744312|589826090|FG000|Overall Study|Withdrawal by Subject|0|||
163305140|NCT03744312|589826091|FG001|Overall Study|Withdrawal by Subject|1|||
163305141|NCT03744312|589826090|FG000|Overall Study|Screen fail|0|||
163305142|NCT03744312|589826091|FG001|Overall Study|Screen fail|1|||
163305143|NCT05338086|589826097|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
163305144|NCT05338086|589826098|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
163305145|NCT05338086|589826099|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
163305146|NCT05338086|589826100|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
163305147|NCT05338086|589826101|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
163305148|NCT05338086|589826097|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
163305149|NCT05338086|589826098|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
163305150|NCT05338086|589826099|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
163305151|NCT05338086|589826100|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
163305152|NCT05338086|589826101|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
163305153|NCT05338086|589826097|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
163305154|NCT05338086|589826098|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
163305155|NCT05338086|589826099|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
163305156|NCT05338086|589826100|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
163305157|NCT05338086|589826101|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
163305158|NCT05338086|589826097|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
163305159|NCT05338086|589826098|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
163305160|NCT05338086|589826099|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
163305161|NCT05338086|589826100|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
163305162|NCT05338086|589826101|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
163305163|NCT05338086|589826097|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
163305164|NCT05338086|589826098|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
163305165|NCT05338086|589826099|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
163305166|NCT05338086|589826100|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
163305167|NCT05338086|589826101|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
163305168|NCT05338086|589826097|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
163305169|NCT05338086|589826098|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
163305170|NCT05338086|589826099|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
162963298|NCT01986647|588564791|FG001|Overall Study|Lost to Follow-up|1|||
163305171|NCT05338086|589826100|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
163305172|NCT05338086|589826101|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
163305173|NCT05338086|589826097|FG000|Transition Period (M12 to M18)|Death|0|||
163305174|NCT05338086|589826098|FG001|Transition Period (M12 to M18)|Death|0|||
163305175|NCT05338086|589826099|FG002|Transition Period (M12 to M18)|Death|1|||
163305176|NCT05338086|589826100|FG003|Transition Period (M12 to M18)|Death|0|||
163305177|NCT05338086|589826101|FG004|Transition Period (M12 to M18)|Death|0|||
163050669|NCT01435759|588893657|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
163305178|NCT05338086|589826097|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
163305179|NCT05338086|589826098|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
163305180|NCT05338086|589826099|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
163199244|NCT02966028|589445290|FG001|Overall Study|Withdrawal by Subject|5|||
163199245|NCT02966028|589445291|FG002|Overall Study|Withdrawal by Subject|5|||
163199246|NCT02966028|589445289|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
163199247|NCT02966028|589445290|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
163199248|NCT02966028|589445291|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
163396656|NCT00365456|590162773|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
162963299|NCT01986647|588564792|FG002|Overall Study|Lost to Follow-up|4|||
162963300|NCT01986647|588564793|FG003|Overall Study|Lost to Follow-up|4|||
162963301|NCT01986647|588564790|FG000|Overall Study|Withdrawal by Subject|1|||
162963302|NCT01986647|588564791|FG001|Overall Study|Withdrawal by Subject|3|||
162963303|NCT01986647|588564792|FG002|Overall Study|Withdrawal by Subject|2|||
162963304|NCT01986647|588564793|FG003|Overall Study|Withdrawal by Subject|3|||
162963305|NCT01986647|588564790|FG000|Overall Study|Health|5|||
162963306|NCT01986647|588564791|FG001|Overall Study|Health|3|||
162963307|NCT01986647|588564792|FG002|Overall Study|Health|6|||
162963308|NCT01986647|588564793|FG003|Overall Study|Health|4|||
162963309|NCT01960296|588564794|FG000|Overall Study|Postponed surgery|1|||
162963310|NCT01960296|588564795|FG001|Overall Study|Postponed surgery|0|||
162963311|NCT01960296|588564794|FG000|Overall Study|Received different procedure|1|||
162963312|NCT01960296|588564795|FG001|Overall Study|Received different procedure|3|||
162963313|NCT02003391|588564796|FG000|Overall Study|Withdrawal by Subject|2|||
163305181|NCT05338086|589826100|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
163305182|NCT05338086|589826101|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
163305183|NCT05338086|589826097|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
163305184|NCT05338086|589826098|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
163305185|NCT05338086|589826099|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
163305186|NCT05338086|589826100|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
163305187|NCT05338086|589826101|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
163305188|NCT05338086|589826097|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
163305189|NCT05338086|589826098|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
163305190|NCT05338086|589826099|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
163305191|NCT05338086|589826100|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
163305192|NCT05338086|589826101|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
163305193|NCT03424811|589826102|FG000|Overall Study|Lost to Follow-up|9|||
163305194|NCT03424811|589826103|FG001|Overall Study|Lost to Follow-up|0|||
163305195|NCT05141903|589826109|FG000|Overall Study|Withdrawal by Subject|0|||
163305196|NCT05141903|589826110|FG001|Overall Study|Withdrawal by Subject|1|||
163305197|NCT05141903|589826111|FG002|Overall Study|Withdrawal by Subject|1|||
163305198|NCT05141903|589826112|FG003|Overall Study|Withdrawal by Subject|0|||
163305199|NCT05141903|589826113|FG004|Overall Study|Withdrawal by Subject|0|||
163305200|NCT05141903|589826109|FG000|Overall Study|Other|1|||
163305201|NCT05141903|589826110|FG001|Overall Study|Other|1|||
162963314|NCT02003391|588564797|FG001|Overall Study|Withdrawal by Subject|1|||
163305202|NCT05141903|589826111|FG002|Overall Study|Other|0|||
163396657|NCT00365456|590162772|FG000|Trial Period II (12 Months)|Other|0|||
163305203|NCT05141903|589826112|FG003|Overall Study|Other|0|||
163305204|NCT05141903|589826113|FG004|Overall Study|Other|0|||
163305205|NCT05387447|589826115|FG000|Overall Study|Participants changed their minds about study participation.|3|||
163305206|NCT05387447|589826116|FG001|Overall Study|Participants changed their minds about study participation.|5|||
163305207|NCT01673984|589826117|FG000|Overall Study|Adverse Event|1|||
163305208|NCT01673984|589826118|FG001|Overall Study|Adverse Event|0|||
163305209|NCT01673984|589826117|FG000|Overall Study|Study termination|9|||
163305210|NCT01673984|589826118|FG001|Overall Study|Study termination|6|||
163305211|NCT04178733|589826119|FG000|Overall Study|Investigator Decision|0|||
163305212|NCT04178733|589826120|FG001|Overall Study|Investigator Decision|0|||
163305213|NCT04178733|589826121|FG002|Overall Study|Investigator Decision|0|||
163305214|NCT04178733|589826122|FG003|Overall Study|Investigator Decision|1|||
163305215|NCT04178733|589826123|FG004|Overall Study|Investigator Decision|2|||
163305216|NCT03655132|589826128|FG000|Overall Study|Lost to Follow-up|2|||
163305217|NCT03655132|589826129|FG001|Overall Study|Lost to Follow-up|1|||
163305218|NCT03655132|589826128|FG000|Overall Study|Withdrawal by Subject|0|||
163305219|NCT03655132|589826129|FG001|Overall Study|Withdrawal by Subject|1|||
163305220|NCT03655132|589826128|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
163305221|NCT03655132|589826129|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
163305222|NCT02651324|589826131|FG000|Overall Study|drug not administered, due dispensing issue|1|||
163305223|NCT02651324|589826132|FG001|Overall Study|drug not administered, due dispensing issue|0|||
163305224|NCT05919082|589826135|FG000|Overall Study|Adverse Event|3|||
163305225|NCT05919082|589826136|FG001|Overall Study|Adverse Event|0|||
163305226|NCT05919082|589826135|FG000|Overall Study|Lost to Follow-up|0|||
163305227|NCT05919082|589826136|FG001|Overall Study|Lost to Follow-up|1|||
163305228|NCT05919082|589826135|FG000|Overall Study|Withdrawal by Subject|8|||
163305229|NCT05919082|589826136|FG001|Overall Study|Withdrawal by Subject|9|||
163305230|NCT05919082|589826135|FG000|Overall Study|Lack of Efficacy|0|||
163305231|NCT05919082|589826136|FG001|Overall Study|Lack of Efficacy|1|||
163305232|NCT05919082|589826135|FG000|Overall Study|Investigator Decision|1|||
163305233|NCT05919082|589826136|FG001|Overall Study|Investigator Decision|0|||
163305234|NCT05439603|589826137|FG000|Overall Study|met withdrawal criteria|2|||
163305235|NCT05461131|589826141|FG000|Overall Study|Lost to Follow-up|0|||
163305236|NCT05461131|589826142|FG001|Overall Study|Lost to Follow-up|2|||
163305237|NCT03896516|589826143|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
163305238|NCT03896516|589826144|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
163305239|NCT03896516|589826143|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
163305240|NCT03896516|589826144|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
163305241|NCT03896516|589826143|FG000|Washout Period|Physician Decision|3|||
163305242|NCT03896516|589826144|FG001|Washout Period|Physician Decision|1|||
163305243|NCT03896516|589826143|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
163305244|NCT03896516|589826144|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
163305245|NCT04549168|589826153|FG000|Randomization Phase|Adverse Event|0|||
163305246|NCT04549168|589826154|FG001|Randomization Phase|Adverse Event|0|||
163305247|NCT04549168|589826155|FG002|Randomization Phase|Adverse Event|1|||
163305248|NCT04549168|589826153|FG000|Randomization Phase|Other|0|||
163305249|NCT04549168|589826154|FG001|Randomization Phase|Other|2|||
163305250|NCT04549168|589826155|FG002|Randomization Phase|Other|0|||
163305251|NCT04549168|589826153|FG000|Randomization Phase|Withdrawal by Subject|0|||
163305252|NCT04549168|589826154|FG001|Randomization Phase|Withdrawal by Subject|2|||
163305253|NCT04549168|589826155|FG002|Randomization Phase|Withdrawal by Subject|1|||
163305254|NCT04437433|589826163|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
163305255|NCT04437433|589826164|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
163305256|NCT04437433|589826163|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
163305257|NCT04437433|589826164|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
163305258|NCT04437433|589826163|FG000|Overall Study|Adverse Event|9|||
163305259|NCT04437433|589826164|FG001|Overall Study|Adverse Event|0|||
163305260|NCT04437433|589826163|FG000|Overall Study|Lack of Efficacy|4|||
163305261|NCT04437433|589826164|FG001|Overall Study|Lack of Efficacy|0|||
163305262|NCT04437433|589826163|FG000|Overall Study|Withdrawal by Subject|4|||
163305263|NCT04437433|589826164|FG001|Overall Study|Withdrawal by Subject|1|||
163305264|NCT04437433|589826163|FG000|Overall Study|Protocol Deviation|0|||
163305265|NCT04437433|589826164|FG001|Overall Study|Protocol Deviation|1|||
163305266|NCT04437433|589826163|FG000|Overall Study|Other, not specified|0|||
163305267|NCT04437433|589826164|FG001|Overall Study|Other, not specified|1|||
163305268|NCT04711135|589826173|FG000|Overall Study|Physician Decision|0|||
163305269|NCT04711135|589826174|FG001|Overall Study|Physician Decision|1|||
163305270|NCT04711135|589826173|FG000|Overall Study|Ongoing treatment|0|||
163305271|NCT04711135|589826174|FG001|Overall Study|Ongoing treatment|1|||
163305272|NCT03578536|589826177|FG000|Overall Study|Lost to Follow-up|1|||
163305273|NCT02538900|589826178|FG000|Overall Study|Death|2|||
163305274|NCT02538900|589826179|FG001|Overall Study|Death|2|||
163305275|NCT02538900|589826180|FG002|Overall Study|Death|2|||
163305276|NCT02538900|589826178|FG000|Overall Study|Withdrawal by Subject|18|||
163305277|NCT02538900|589826179|FG001|Overall Study|Withdrawal by Subject|16|||
163305278|NCT02538900|589826180|FG002|Overall Study|Withdrawal by Subject|15|||
163305279|NCT03732820|589826181|FG000|Overall Study|Death|168|||
163305280|NCT03732820|589826182|FG001|Overall Study|Death|203|||
163305281|NCT03732820|589826181|FG000|Overall Study|Other|2|||
163305282|NCT03732820|589826182|FG001|Overall Study|Other|2|||
163305283|NCT03732820|589826181|FG000|Overall Study|Failure to meet randomisation criteria|1|||
163305284|NCT03732820|589826182|FG001|Overall Study|Failure to meet randomisation criteria|1|||
163305285|NCT03732820|589826181|FG000|Overall Study|Patient decision|14|||
163305286|NCT03732820|589826182|FG001|Overall Study|Patient decision|10|||
163305287|NCT03732820|589826181|FG000|Overall Study|Screen failure|0|||
163305288|NCT03732820|589826182|FG001|Overall Study|Screen failure|1|||
163305289|NCT03732820|589826181|FG000|Overall Study|Patients ongoing study at data cut off|210|||
163305290|NCT03732820|589826182|FG001|Overall Study|Patients ongoing study at data cut off|178|||
163305291|NCT03732820|589826181|FG000|Overall Study|Lost to Follow-up|4|||
163305292|NCT03732820|589826182|FG001|Overall Study|Lost to Follow-up|2|||
163305293|NCT04436107|589826183|FG000|Overall Study|Sponsor Ended Study|2|||
163305294|NCT04436107|589826184|FG001|Overall Study|Sponsor Ended Study|4|||
163305295|NCT04436107|589826185|FG002|Overall Study|Sponsor Ended Study|8|||
163305296|NCT04436107|589826186|FG003|Overall Study|Sponsor Ended Study|20|||
163305297|NCT04436107|589826183|FG000|Overall Study|Death|3|||
163305298|NCT04436107|589826184|FG001|Overall Study|Death|5|||
163305299|NCT04436107|589826185|FG002|Overall Study|Death|3|||
163305300|NCT04436107|589826186|FG003|Overall Study|Death|18|||
163305301|NCT04436107|589826183|FG000|Overall Study|Withdrawal by Subject|1|||
163305302|NCT04436107|589826184|FG001|Overall Study|Withdrawal by Subject|1|||
163305303|NCT04436107|589826185|FG002|Overall Study|Withdrawal by Subject|0|||
163305304|NCT04436107|589826186|FG003|Overall Study|Withdrawal by Subject|1|||
163305305|NCT00274469|589826195|FG000|Overall Study|Death|63|||
163305306|NCT00274469|589826196|FG001|Overall Study|Death|74|||
163305307|NCT00274469|589826195|FG000|Overall Study|Did not consent to OS follow-up|16|||
163305308|NCT00274469|589826196|FG001|Overall Study|Did not consent to OS follow-up|19|||
163305309|NCT03338816|589826197|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
163305310|NCT03338816|589826198|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
163305311|NCT03338816|589826199|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
163305312|NCT03338816|589826200|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
163305313|NCT03338816|589826197|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
163305314|NCT03338816|589826198|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
163305315|NCT03338816|589826199|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
163305316|NCT03338816|589826200|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
163305317|NCT03338816|589826197|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
163305318|NCT03338816|589826198|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
163305319|NCT03338816|589826199|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
163305320|NCT03338816|589826200|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
163305321|NCT03338816|589826197|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
163305322|NCT03338816|589826198|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
163305323|NCT03338816|589826199|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
163305324|NCT03338816|589826200|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
163305325|NCT03338816|589826197|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
163305326|NCT03338816|589826198|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
163305327|NCT03338816|589826199|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
163305328|NCT03338816|589826200|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
163305329|NCT03338816|589826197|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
163305330|NCT03338816|589826198|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
163305331|NCT03338816|589826199|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
163305332|NCT03338816|589826200|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
163305333|NCT03338816|589826197|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
163305334|NCT03338816|589826198|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
163305335|NCT03338816|589826199|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
163199249|NCT04115839|589445292|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
163199250|NCT04115839|589445293|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
163396658|NCT00365456|590162773|FG001|Trial Period II (12 Months)|Other|1|||
163396659|NCT00365456|590162772|FG000|Trial Period III (12 Months)|Adverse Event|13|||
162963315|NCT02003391|588564796|FG000|Overall Study|Protocol Violation|0|||
163305336|NCT03338816|589826200|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
162963316|NCT02003391|588564797|FG001|Overall Study|Protocol Violation|1|||
163305337|NCT04950127|589826201|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
163305338|NCT04950127|589826202|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
163305339|NCT04950127|589826203|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
163305340|NCT04950127|589826204|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
162963317|NCT02003391|588564796|FG000|Overall Study|Adverse Event|1|||
163305341|NCT04950127|589826205|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
163305342|NCT04950127|589826206|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
163305343|NCT04950127|589826201|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
163305344|NCT04950127|589826202|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
163305345|NCT04950127|589826203|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
163305346|NCT04950127|589826204|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
162963318|NCT02003391|588564797|FG001|Overall Study|Adverse Event|0|||
163199251|NCT04115839|589445294|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
162924460|NCT03539952|588423897|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
162924461|NCT03539952|588423898|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
162924462|NCT03539952|588423897|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
162924463|NCT03539952|588423898|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
162924464|NCT03539952|588423897|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
162924465|NCT03539952|588423898|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
163305347|NCT04950127|589826205|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
163305348|NCT04950127|589826206|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
163305349|NCT04950127|589826201|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
163305350|NCT04950127|589826202|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
163305351|NCT04950127|589826203|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
163305352|NCT04950127|589826204|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
163305353|NCT04950127|589826205|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
163305354|NCT04950127|589826206|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
163305355|NCT04950127|589826201|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
163396660|NCT00365456|590162773|FG001|Trial Period III (12 Months)|Adverse Event|3|||
163199252|NCT04115839|589445295|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
163199253|NCT04115839|589445296|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
163199254|NCT04115839|589445297|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
163199255|NCT04115839|589445298|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
163199256|NCT04115839|589445292|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
163199257|NCT04115839|589445293|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
163199258|NCT04115839|589445294|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
163199259|NCT04115839|589445295|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
163199260|NCT04115839|589445296|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
163199261|NCT04115839|589445297|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
163199262|NCT04115839|589445298|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
163199263|NCT04115839|589445292|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
163199264|NCT04115839|589445293|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
163199265|NCT04115839|589445294|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
163199266|NCT04115839|589445295|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
163199267|NCT04115839|589445296|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
163199268|NCT04115839|589445297|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
163199269|NCT04115839|589445298|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
163199270|NCT04115839|589445292|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
163199271|NCT04115839|589445293|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
163199272|NCT04115839|589445294|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
163199273|NCT04115839|589445295|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
163199274|NCT04115839|589445296|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
163199275|NCT04115839|589445297|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
163199276|NCT04115839|589445298|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
163199277|NCT04115839|589445292|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
163199278|NCT04115839|589445293|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
163199279|NCT04115839|589445294|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
163199280|NCT04115839|589445295|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
163199281|NCT04115839|589445296|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
163199282|NCT04115839|589445297|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
163199283|NCT04115839|589445298|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
163199284|NCT04115839|589445292|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
163199285|NCT04115839|589445293|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
163199286|NCT04115839|589445294|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
163199287|NCT04115839|589445295|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
163199288|NCT04115839|589445296|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
163199289|NCT04115839|589445297|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
163199290|NCT04115839|589445298|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
163199291|NCT01408485|589445299|FG000|Overall Study|Withdrawal by Subject|21|||
163199292|NCT02151591|589445300|FG000|Overall Study|Lost to Follow-up|6|||
163199293|NCT02151591|589445301|FG001|Overall Study|Lost to Follow-up|3|||
163199294|NCT01342796|589445302|FG000|Overall Study|Withdrawal by Subject|2|||
163199295|NCT01342796|589445303|FG001|Overall Study|Withdrawal by Subject|0|||
163199296|NCT01342796|589445302|FG000|Overall Study|Lost to Follow-up|0|||
163199297|NCT01342796|589445303|FG001|Overall Study|Lost to Follow-up|3|||
163199298|NCT01342796|589445302|FG000|Overall Study|Inappropriate enrollment|1|||
163199299|NCT01342796|589445303|FG001|Overall Study|Inappropriate enrollment|0|||
163199300|NCT01751867|589445304|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
163199301|NCT01751867|589445305|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
163199302|NCT01751867|589445304|FG000|Overall Study|Diease Progression|4|||
163199303|NCT01751867|589445305|FG001|Overall Study|Diease Progression|18|||
163199304|NCT01751867|589445304|FG000|Overall Study|Adverse Event|8|||
163199305|NCT01751867|589445305|FG001|Overall Study|Adverse Event|15|||
163199306|NCT01751867|589445304|FG000|Overall Study|Poor Compliance|0|||
163396661|NCT00365456|590162772|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
163396662|NCT00365456|590162773|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
163396663|NCT00365456|590162772|FG000|Trial Period III (12 Months)|Other|1|||
163396664|NCT00365456|590162773|FG001|Trial Period III (12 Months)|Other|1|||
163396665|NCT04754802|590162775|FG000|Overall Study|Lost to Follow-up|0|||
163396666|NCT04754802|590162776|FG001|Overall Study|Lost to Follow-up|2|||
163396667|NCT04754802|590162775|FG000|Overall Study|Withdrawal by Subject|2|||
163396668|NCT04754802|590162776|FG001|Overall Study|Withdrawal by Subject|0|||
163396669|NCT00701090|590162777|FG000|Overall Study|Adverse Event|11|||
163396670|NCT00701090|590162778|FG001|Overall Study|Adverse Event|2|||
163396671|NCT00701090|590162777|FG000|Overall Study|Death|0|||
163305356|NCT04950127|589826202|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
163305357|NCT04950127|589826203|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
163305358|NCT04950127|589826204|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
163305359|NCT04950127|589826205|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
163305360|NCT04950127|589826206|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
163305361|NCT04950127|589826201|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
163305362|NCT04950127|589826202|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
163305363|NCT04950127|589826203|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
163305364|NCT04950127|589826204|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
163305365|NCT04950127|589826205|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
163305366|NCT04950127|589826206|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
163305367|NCT01711632|589826207|FG000|Overall Study|Adverse Event|4|||
163305368|NCT01711632|589826207|FG000|Overall Study|Death|3|||
163305369|NCT01711632|589826207|FG000|Overall Study|Lost to Follow-up|3|||
163305370|NCT01711632|589826207|FG000|Overall Study|Withdrawal by Subject|4|||
163305371|NCT01711632|589826207|FG000|Overall Study|Progressive disease|2|||
163396672|NCT00701090|590162778|FG001|Overall Study|Death|1|||
163396673|NCT00701090|590162777|FG000|Overall Study|Lack of Efficacy|5|||
163396674|NCT00701090|590162778|FG001|Overall Study|Lack of Efficacy|4|||
163396675|NCT00701090|590162777|FG000|Overall Study|Lost to Follow-up|9|||
163396676|NCT00701090|590162778|FG001|Overall Study|Lost to Follow-up|9|||
162963319|NCT02611323|588564798|FG000|Overall Study|Death|3|||
162963320|NCT02611323|588564799|FG001|Overall Study|Death|1|||
162963321|NCT02611323|588564800|FG002|Overall Study|Death|0|||
162963322|NCT02611323|588564801|FG003|Overall Study|Death|0|||
162963323|NCT02611323|588564802|FG004|Overall Study|Death|1|||
162963324|NCT02611323|588564803|FG005|Overall Study|Death|1|||
163305372|NCT01711632|589826207|FG000|Overall Study|No follow up required in re-treatment|3|||
163305373|NCT01711632|589826207|FG000|Overall Study|No follow up required in re-treatment|3|||
163305374|NCT03517969|589826208|FG000|Overall Study|Never started protocol treatment|3|||
163305375|NCT03517969|589826209|FG001|Overall Study|Never started protocol treatment|5|||
163305376|NCT03517969|589826208|FG000|Overall Study|Disease progression|11|||
163305377|NCT03517969|589826209|FG001|Overall Study|Disease progression|16|||
163305378|NCT03517969|589826208|FG000|Overall Study|PSA progression|8|||
163305379|NCT03517969|589826209|FG001|Overall Study|PSA progression|1|||
162963325|NCT02611323|588564804|FG006|Overall Study|Death|8|||
162963326|NCT02611323|588564805|FG007|Overall Study|Death|0|||
162963327|NCT02611323|588564806|FG008|Overall Study|Death|4|||
162963328|NCT02611323|588564807|FG009|Overall Study|Death|6|||
163199307|NCT01751867|589445305|FG001|Overall Study|Poor Compliance|5|||
163199308|NCT01751867|589445304|FG000|Overall Study|Withdrawal by Subject|3|||
163199309|NCT01751867|589445305|FG001|Overall Study|Withdrawal by Subject|1|||
163199310|NCT01751867|589445304|FG000|Overall Study|Physician Decision|4|||
163199311|NCT01751867|589445305|FG001|Overall Study|Physician Decision|7|||
163199312|NCT01751867|589445304|FG000|Overall Study|Protocol Violation|0|||
163199313|NCT01751867|589445305|FG001|Overall Study|Protocol Violation|2|||
163199314|NCT01751867|589445304|FG000|Overall Study|Death|0|||
163199315|NCT01751867|589445305|FG001|Overall Study|Death|5|||
163199316|NCT01751867|589445304|FG000|Overall Study|Other|11|||
163199317|NCT01751867|589445305|FG001|Overall Study|Other|37|||
163305380|NCT03517969|589826208|FG000|Overall Study|Clinical progression|4|||
163396677|NCT00701090|590162777|FG000|Overall Study|Physician Decision|3|||
163396678|NCT00701090|590162778|FG001|Overall Study|Physician Decision|4|||
162963329|NCT02611323|588564808|FG010|Overall Study|Death|26|||
162963330|NCT02611323|588564798|FG000|Overall Study|Lost to Follow-up|1|||
162963331|NCT02611323|588564799|FG001|Overall Study|Lost to Follow-up|0|||
163199318|NCT01751867|589445304|FG000|Overall Study|Randomized but not treated.|2|||
163396679|NCT00701090|590162777|FG000|Overall Study|Protocol Violation|2|||
163396680|NCT00701090|590162778|FG001|Overall Study|Protocol Violation|3|||
163199319|NCT01751867|589445305|FG001|Overall Study|Randomized but not treated.|1|||
163199320|NCT01396148|589445306|FG000|Overall Study|Patient Decision|1|||
162963332|NCT02611323|588564800|FG002|Overall Study|Lost to Follow-up|0|||
162963333|NCT02611323|588564801|FG003|Overall Study|Lost to Follow-up|0|||
162963334|NCT02611323|588564802|FG004|Overall Study|Lost to Follow-up|0|||
162963335|NCT02611323|588564803|FG005|Overall Study|Lost to Follow-up|0|||
162963336|NCT02611323|588564804|FG006|Overall Study|Lost to Follow-up|3|||
162963337|NCT02611323|588564805|FG007|Overall Study|Lost to Follow-up|0|||
162963338|NCT02611323|588564806|FG008|Overall Study|Lost to Follow-up|0|||
162963339|NCT02611323|588564807|FG009|Overall Study|Lost to Follow-up|0|||
162963340|NCT02611323|588564808|FG010|Overall Study|Lost to Follow-up|2|||
162963341|NCT02611323|588564798|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963342|NCT02611323|588564799|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963343|NCT02611323|588564800|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963344|NCT02611323|588564801|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963345|NCT02611323|588564802|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963346|NCT02611323|588564803|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963347|NCT02611323|588564804|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963348|NCT02611323|588564805|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963349|NCT02611323|588564806|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963350|NCT02611323|588564807|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
162963351|NCT02611323|588564808|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963352|NCT02611323|588564798|FG000|Overall Study|Progressive Disease|0|||
163396681|NCT00701090|590162777|FG000|Overall Study|Withdrawal by Subject|11|||
163396682|NCT00701090|590162778|FG001|Overall Study|Withdrawal by Subject|16|||
163396683|NCT00701090|590162777|FG000|Overall Study|Other|7|||
163396684|NCT00701090|590162778|FG001|Overall Study|Other|12|||
163396685|NCT01299376|590162781|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
163396686|NCT01299376|590162782|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
163396687|NCT01299376|590162781|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
163396688|NCT01299376|590162782|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
163396689|NCT01299376|590162781|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
163396690|NCT01299376|590162782|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
163396691|NCT01299376|590162781|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
163396692|NCT01299376|590162782|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
163396693|NCT01299376|590162781|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
163396694|NCT01299376|590162782|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
163396695|NCT01299376|590162781|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
163396696|NCT01299376|590162782|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
163396697|NCT01299376|590162781|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
163396698|NCT01299376|590162782|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
163396699|NCT01299376|590162781|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
163396700|NCT01299376|590162782|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
163396701|NCT01299376|590162781|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
163396702|NCT01299376|590162782|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
163396703|NCT01299376|590162781|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
163396704|NCT01299376|590162782|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
163396705|NCT01299376|590162781|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
163396706|NCT01299376|590162782|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
163396707|NCT00736034|590162783|FG000|Overall Study|Adverse Event|2|||
163396708|NCT00773136|590162784|FG000|Overall Study|Physician Decision|2|||
163396709|NCT02463071|590162785|FG000|Overall Study|Adverse Event|3|||
163396710|NCT02463071|590162786|FG001|Overall Study|Adverse Event|5|||
163396711|NCT02463071|590162787|FG002|Overall Study|Adverse Event|1|||
163396712|NCT02463071|590162785|FG000|Overall Study|Death|1|||
163396713|NCT02463071|590162786|FG001|Overall Study|Death|0|||
163396714|NCT02463071|590162787|FG002|Overall Study|Death|0|||
163396715|NCT02463071|590162785|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
163396716|NCT02463071|590162786|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
163396717|NCT02463071|590162787|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
163396718|NCT02463071|590162785|FG000|Overall Study|Reason not specified|7|||
163396719|NCT02463071|590162786|FG001|Overall Study|Reason not specified|9|||
163396720|NCT02463071|590162787|FG002|Overall Study|Reason not specified|4|||
163396721|NCT02463071|590162785|FG000|Overall Study|Protocol Violation|0|||
163050670|NCT01435759|588893658|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
163305381|NCT03517969|589826209|FG001|Overall Study|Clinical progression|2|||
163305382|NCT03517969|589826208|FG000|Overall Study|Adverse Event|5|||
163305383|NCT03517969|589826209|FG001|Overall Study|Adverse Event|4|||
163305384|NCT03517969|589826208|FG000|Overall Study|Intercurrent illness|1|||
163050671|NCT01435759|588893659|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
163050672|NCT01435759|588893654|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
162963353|NCT02611323|588564799|FG001|Overall Study|Progressive Disease|0|||
163305385|NCT03517969|589826209|FG001|Overall Study|Intercurrent illness|2|||
163305386|NCT03517969|589826208|FG000|Overall Study|Death|1|||
163305387|NCT03517969|589826209|FG001|Overall Study|Death|1|||
163305388|NCT03517969|589826208|FG000|Overall Study|Withdrawal by Subject|1|||
163305389|NCT03517969|589826209|FG001|Overall Study|Withdrawal by Subject|2|||
163305390|NCT03517969|589826208|FG000|Overall Study|Physician Decision|1|||
163305391|NCT03517969|589826209|FG001|Overall Study|Physician Decision|1|||
163305392|NCT03517969|589826208|FG000|Overall Study|No clinical benefit|1|||
163305393|NCT03517969|589826209|FG001|Overall Study|No clinical benefit|0|||
163305394|NCT03517969|589826208|FG000|Overall Study|Delayed treatment for dental treatment|1|||
163305395|NCT03517969|589826209|FG001|Overall Study|Delayed treatment for dental treatment|0|||
163305396|NCT03517969|589826208|FG000|Overall Study|Difficult to maintain appointment|0|||
163305397|NCT03517969|589826209|FG001|Overall Study|Difficult to maintain appointment|1|||
163305398|NCT03517969|589826208|FG000|Overall Study|Protocol Violation|0|||
163305399|NCT03517969|589826209|FG001|Overall Study|Protocol Violation|1|||
163305400|NCT03271489|589826210|FG000|Double-Blind (DB) Period|Adverse Event|4|||
163305401|NCT03271489|589826211|FG001|Double-Blind (DB) Period|Adverse Event|1|||
163305402|NCT03271489|589826210|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
163305403|NCT03271489|589826211|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
163305404|NCT03271489|589826210|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
163305405|NCT03271489|589826211|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
163305406|NCT03271489|589826210|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
163305407|NCT03271489|589826211|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
163305408|NCT03271489|589826210|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
163305409|NCT03271489|589826211|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
163305410|NCT03271489|589826210|FG000|Double-Blind (DB) Period|Other|6|||
163305411|NCT03271489|589826211|FG001|Double-Blind (DB) Period|Other|1|||
163305412|NCT03271489|589826210|FG000|Double-Blind (DB) Period|Missing|1|||
163305413|NCT03271489|589826211|FG001|Double-Blind (DB) Period|Missing|0|||
163305414|NCT03271489|589826210|FG000|Open-Label (OL) Period|Adverse Event|2|||
163305415|NCT03271489|589826211|FG001|Open-Label (OL) Period|Adverse Event|0|||
163305416|NCT03271489|589826210|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
163305417|NCT03271489|589826211|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
163305418|NCT03271489|589826210|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
163305419|NCT03271489|589826211|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
163305420|NCT03271489|589826210|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
163305421|NCT03271489|589826211|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
163305422|NCT03271489|589826210|FG000|Open-Label (OL) Period|No Specified|2|||
163305423|NCT03271489|589826211|FG001|Open-Label (OL) Period|No Specified|2|||
163305424|NCT03271489|589826210|FG000|Open-Label (OL) Period|Missing|2|||
163305425|NCT03271489|589826211|FG001|Open-Label (OL) Period|Missing|0|||
163305426|NCT03271489|589826210|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
163305427|NCT03271489|589826211|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
163305428|NCT03271489|589826210|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
163305429|NCT03271489|589826211|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
163305430|NCT03271489|589826210|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
163305431|NCT03271489|589826211|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
163305432|NCT03271489|589826210|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
163305433|NCT03271489|589826211|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
163305434|NCT03271489|589826210|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
163305435|NCT03271489|589826211|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
163305436|NCT03271489|589826210|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
163305437|NCT03271489|589826211|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
163305438|NCT03271489|589826210|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
163305439|NCT03271489|589826211|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
163305440|NCT03271489|589826210|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
163305441|NCT03271489|589826211|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
162963354|NCT02611323|588564800|FG002|Overall Study|Progressive Disease|0|||
162963355|NCT02611323|588564801|FG003|Overall Study|Progressive Disease|0|||
162963356|NCT02611323|588564802|FG004|Overall Study|Progressive Disease|0|||
162963357|NCT02611323|588564803|FG005|Overall Study|Progressive Disease|0|||
162963358|NCT02611323|588564804|FG006|Overall Study|Progressive Disease|0|||
162963359|NCT02611323|588564805|FG007|Overall Study|Progressive Disease|0|||
163305442|NCT02860130|589826212|FG000|Overall Study|Adverse Event|2|||
163305443|NCT02860130|589826213|FG001|Overall Study|Adverse Event|3|||
162963360|NCT02611323|588564806|FG008|Overall Study|Progressive Disease|0|||
162963361|NCT02611323|588564807|FG009|Overall Study|Progressive Disease|0|||
162963362|NCT02611323|588564808|FG010|Overall Study|Progressive Disease|1|||
162963363|NCT02611323|588564798|FG000|Overall Study|Withdrawal by Subject|1|||
162963364|NCT02611323|588564799|FG001|Overall Study|Withdrawal by Subject|0|||
162963365|NCT02611323|588564800|FG002|Overall Study|Withdrawal by Subject|0|||
162963366|NCT02611323|588564801|FG003|Overall Study|Withdrawal by Subject|0|||
162963367|NCT02611323|588564802|FG004|Overall Study|Withdrawal by Subject|0|||
162963368|NCT02611323|588564803|FG005|Overall Study|Withdrawal by Subject|0|||
162963369|NCT02611323|588564804|FG006|Overall Study|Withdrawal by Subject|0|||
162963370|NCT02611323|588564805|FG007|Overall Study|Withdrawal by Subject|1|||
163396722|NCT02463071|590162786|FG001|Overall Study|Protocol Violation|2|||
163396723|NCT02463071|590162787|FG002|Overall Study|Protocol Violation|0|||
163396724|NCT02463071|590162785|FG000|Overall Study|Lost to Follow-up|0|||
162963371|NCT02611323|588564806|FG008|Overall Study|Withdrawal by Subject|0|||
162963372|NCT02611323|588564807|FG009|Overall Study|Withdrawal by Subject|1|||
162963373|NCT02611323|588564808|FG010|Overall Study|Withdrawal by Subject|0|||
163396725|NCT02463071|590162786|FG001|Overall Study|Lost to Follow-up|0|||
162963374|NCT00243347|588564809|FG000|Overall Study|Lack of Efficacy|4|||
163199321|NCT00224042|589445315|FG000|Overall Study|Adverse Event|2|||
162963375|NCT00243347|588564809|FG000|Overall Study|Adverse Event|2|||
162963376|NCT00243347|588564809|FG000|Overall Study|Death|1|||
163199322|NCT00224042|589445316|FG001|Overall Study|Adverse Event|1|||
163199323|NCT00224042|589445315|FG000|Overall Study|Protocol Violation|0|||
163199324|NCT00224042|589445316|FG001|Overall Study|Protocol Violation|1|||
163199325|NCT00224042|589445315|FG000|Overall Study|Physician Decision|0|||
163199326|NCT00224042|589445316|FG001|Overall Study|Physician Decision|1|||
163199327|NCT00224042|589445315|FG000|Overall Study|Did not meet lab incusion criteria|2|||
163199328|NCT00224042|589445316|FG001|Overall Study|Did not meet lab incusion criteria|3|||
163199329|NCT00224042|589445315|FG000|Overall Study|Other|2|||
163305444|NCT02860130|589826212|FG000|Overall Study|Protocol Violation|1|||
163305445|NCT02860130|589826213|FG001|Overall Study|Protocol Violation|1|||
163305446|NCT02860130|589826212|FG000|Overall Study|Withdrawal by Subject|0|||
163305447|NCT02860130|589826213|FG001|Overall Study|Withdrawal by Subject|2|||
163305448|NCT02860130|589826212|FG000|Overall Study|Physician Decision|2|||
163305449|NCT02860130|589826213|FG001|Overall Study|Physician Decision|2|||
163305450|NCT02860130|589826212|FG000|Overall Study|Other|2|||
163305451|NCT02860130|589826213|FG001|Overall Study|Other|1|||
163305452|NCT00522951|589826216|FG000|Period 1|body motion|0|||
162963377|NCT00243347|588564809|FG000|Overall Study|Withdrawal by Subject|5|||
163305453|NCT00522951|589826217|FG001|Period 1|body motion|1|||
163305454|NCT00522951|589826216|FG000|Washout Period|Adverse Event|0|||
162963378|NCT00243347|588564809|FG000|Overall Study|Condition worsened|7|||
162963379|NCT02011945|588564815|FG000|Overall Study|Participant requested to Discontinue|0|||
162963380|NCT02011945|588564816|FG001|Overall Study|Participant requested to Discontinue|1|||
162963381|NCT02011945|588564817|FG002|Overall Study|Participant requested to Discontinue|1|||
162963382|NCT02011945|588564815|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
162963383|NCT02011945|588564816|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
162963384|NCT02011945|588564817|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
162963385|NCT02011945|588564815|FG000|Overall Study|Study Drug Toxicity|0|||
162963386|NCT02011945|588564816|FG001|Overall Study|Study Drug Toxicity|0|||
162963387|NCT02011945|588564817|FG002|Overall Study|Study Drug Toxicity|1|||
162963388|NCT02011945|588564815|FG000|Overall Study|Treatment Failure|0|||
162963389|NCT02011945|588564816|FG001|Overall Study|Treatment Failure|7|||
162963390|NCT02011945|588564817|FG002|Overall Study|Treatment Failure|6|||
162963391|NCT02011945|588564815|FG000|Overall Study|No Longer Meets Study Criteria|1|||
162963392|NCT02011945|588564816|FG001|Overall Study|No Longer Meets Study Criteria|0|||
162963393|NCT02011945|588564817|FG002|Overall Study|No Longer Meets Study Criteria|0|||
162963394|NCT02011945|588564815|FG000|Overall Study|Proceeded to stem cell transplant|0|||
162963395|NCT02011945|588564816|FG001|Overall Study|Proceeded to stem cell transplant|0|||
163305455|NCT00522951|589826217|FG001|Washout Period|Adverse Event|1|||
163305456|NCT00522951|589826216|FG000|Washout Period|Death|0|||
163305457|NCT00522951|589826217|FG001|Washout Period|Death|1|||
163396726|NCT02463071|590162787|FG002|Overall Study|Lost to Follow-up|1|||
162963396|NCT02011945|588564817|FG002|Overall Study|Proceeded to stem cell transplant|1|||
162963397|NCT02011945|588564815|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
162963398|NCT02011945|588564816|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
162963399|NCT02011945|588564817|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
162963400|NCT03531827|588564818|FG000|Overall Study|Adverse Event|2|||
162963401|NCT03531827|588564819|FG001|Overall Study|Adverse Event|0|||
162963402|NCT03531827|588564818|FG000|Overall Study|Progressive disease|1|||
162963403|NCT03531827|588564819|FG001|Overall Study|Progressive disease|0|||
162963404|NCT00258856|588566468|FG000|Overall Study|Lost to Follow-up|1|||
162963405|NCT00258856|588566469|FG001|Overall Study|Lost to Follow-up|0|||
162963406|NCT00258856|588566470|FG002|Overall Study|Lost to Follow-up|2|||
162963407|NCT00258856|588566471|FG003|Overall Study|Lost to Follow-up|0|||
162963408|NCT00258856|588566468|FG000|Overall Study|Non-compliance|2|||
162963409|NCT00258856|588566469|FG001|Overall Study|Non-compliance|0|||
162963410|NCT00258856|588566470|FG002|Overall Study|Non-compliance|0|||
162963411|NCT00258856|588566471|FG003|Overall Study|Non-compliance|1|||
162963412|NCT02488109|588566477|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
162963413|NCT02488109|588566478|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
163305458|NCT00522951|589826216|FG000|Period 2|Withdrawal by Subject|1|||
163305459|NCT00522951|589826217|FG001|Period 2|Withdrawal by Subject|0|||
163305460|NCT00522951|589826216|FG000|Period 2|residual contrast medium|1|||
163305461|NCT00522951|589826217|FG001|Period 2|residual contrast medium|1|||
163305462|NCT05450458|589826220|FG000|Overall Study|Lost to Follow-up|4|||
163305463|NCT02671435|589826221|FG000|Overall Study|Death|1|||
163305464|NCT02671435|589826222|FG001|Overall Study|Death|3|||
163305465|NCT02671435|589826223|FG002|Overall Study|Death|0|||
163305466|NCT02671435|589826224|FG003|Overall Study|Death|16|||
163305467|NCT02671435|589826225|FG004|Overall Study|Death|14|||
163305468|NCT02671435|589826226|FG005|Overall Study|Death|29|||
163305469|NCT02671435|589826227|FG006|Overall Study|Death|34|||
163305470|NCT02671435|589826228|FG007|Overall Study|Death|28|||
163305471|NCT02671435|589826229|FG008|Overall Study|Death|19|||
163305472|NCT02671435|589826230|FG009|Overall Study|Death|10|||
163305473|NCT02671435|589826231|FG010|Overall Study|Death|8|||
163305474|NCT02671435|589826232|FG011|Overall Study|Death|29|||
163305475|NCT02671435|589826233|FG012|Overall Study|Death|29|||
163305476|NCT02671435|589826234|FG013|Overall Study|Death|29|||
163305477|NCT02671435|589826235|FG014|Overall Study|Death|27|||
163305478|NCT02671435|589826221|FG000|Overall Study|Lost to Follow-up|0|||
163305479|NCT02671435|589826222|FG001|Overall Study|Lost to Follow-up|0|||
163305480|NCT02671435|589826223|FG002|Overall Study|Lost to Follow-up|1|||
163305481|NCT02671435|589826224|FG003|Overall Study|Lost to Follow-up|0|||
163305482|NCT02671435|589826225|FG004|Overall Study|Lost to Follow-up|1|||
163305483|NCT02671435|589826226|FG005|Overall Study|Lost to Follow-up|1|||
163305484|NCT02671435|589826227|FG006|Overall Study|Lost to Follow-up|2|||
163305485|NCT02671435|589826228|FG007|Overall Study|Lost to Follow-up|2|||
162963414|NCT02488109|588566477|FG000|12-month Follow-Up|Lost to Follow-up|4|||
163305486|NCT02671435|589826229|FG008|Overall Study|Lost to Follow-up|0|||
163305487|NCT02671435|589826230|FG009|Overall Study|Lost to Follow-up|2|||
163305488|NCT02671435|589826231|FG010|Overall Study|Lost to Follow-up|0|||
162963415|NCT02488109|588566478|FG001|12-month Follow-Up|Lost to Follow-up|7|||
163305489|NCT02671435|589826232|FG011|Overall Study|Lost to Follow-up|3|||
163305490|NCT02671435|589826233|FG012|Overall Study|Lost to Follow-up|3|||
163305491|NCT02671435|589826234|FG013|Overall Study|Lost to Follow-up|2|||
163305492|NCT02671435|589826235|FG014|Overall Study|Lost to Follow-up|0|||
163305493|NCT02671435|589826221|FG000|Overall Study|Withdrawal by Subject|2|||
163305494|NCT02671435|589826222|FG001|Overall Study|Withdrawal by Subject|0|||
163305495|NCT02671435|589826223|FG002|Overall Study|Withdrawal by Subject|2|||
163050673|NCT01435759|588893655|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
163050674|NCT01435759|588893656|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
163050675|NCT01435759|588893657|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
163050676|NCT01435759|588893658|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
163050677|NCT01435759|588893659|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
163050678|NCT01435759|588893654|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
163050679|NCT01435759|588893655|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
163050680|NCT01435759|588893656|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
163050681|NCT01435759|588893657|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
163050682|NCT01435759|588893658|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
163050683|NCT01435759|588893659|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
163050684|NCT01435759|588893654|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
163050685|NCT01435759|588893655|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050686|NCT01435759|588893656|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050687|NCT01435759|588893657|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050688|NCT01435759|588893658|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050689|NCT01435759|588893659|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050690|NCT01435759|588893654|FG000|Antidepressant Lead-in Phase|Other|119|||
163199330|NCT00224042|589445316|FG001|Overall Study|Other|0|||
163199331|NCT00840450|589445317|FG000|Overall Study|Adverse Event|1|||
163199332|NCT00840450|589445317|FG000|Overall Study|Lack of Efficacy|2|||
163305496|NCT02671435|589826224|FG003|Overall Study|Withdrawal by Subject|2|||
163305497|NCT02671435|589826225|FG004|Overall Study|Withdrawal by Subject|2|||
163305498|NCT02671435|589826226|FG005|Overall Study|Withdrawal by Subject|7|||
163305499|NCT02671435|589826227|FG006|Overall Study|Withdrawal by Subject|2|||
163305500|NCT02671435|589826228|FG007|Overall Study|Withdrawal by Subject|7|||
163305501|NCT02671435|589826229|FG008|Overall Study|Withdrawal by Subject|1|||
163305502|NCT02671435|589826230|FG009|Overall Study|Withdrawal by Subject|1|||
163305503|NCT02671435|589826231|FG010|Overall Study|Withdrawal by Subject|2|||
163305504|NCT02671435|589826232|FG011|Overall Study|Withdrawal by Subject|4|||
163305505|NCT02671435|589826233|FG012|Overall Study|Withdrawal by Subject|4|||
163305506|NCT02671435|589826234|FG013|Overall Study|Withdrawal by Subject|4|||
163305507|NCT02671435|589826235|FG014|Overall Study|Withdrawal by Subject|2|||
163305508|NCT02671435|589826221|FG000|Overall Study|Un-specified|0|||
163305509|NCT02671435|589826222|FG001|Overall Study|Un-specified|0|||
163305510|NCT02671435|589826223|FG002|Overall Study|Un-specified|0|||
163305511|NCT02671435|589826224|FG003|Overall Study|Un-specified|0|||
163305512|NCT02671435|589826225|FG004|Overall Study|Un-specified|1|||
163305513|NCT02671435|589826226|FG005|Overall Study|Un-specified|3|||
163305514|NCT02671435|589826227|FG006|Overall Study|Un-specified|2|||
163305515|NCT02671435|589826228|FG007|Overall Study|Un-specified|3|||
163305516|NCT02671435|589826229|FG008|Overall Study|Un-specified|0|||
163305517|NCT02671435|589826230|FG009|Overall Study|Un-specified|5|||
163305518|NCT02671435|589826231|FG010|Overall Study|Un-specified|8|||
163305519|NCT02671435|589826232|FG011|Overall Study|Un-specified|4|||
163305520|NCT02671435|589826233|FG012|Overall Study|Un-specified|5|||
163305521|NCT02671435|589826234|FG013|Overall Study|Un-specified|9|||
163305522|NCT02671435|589826235|FG014|Overall Study|Un-specified|8|||
163305523|NCT04128319|589826238|FG000|Overall Study|Death|3|||
163305524|NCT00976937|589826239|FG000|Overall Study|Adverse Event|4|||
163305525|NCT00976937|589826240|FG001|Overall Study|Adverse Event|5|||
163305526|NCT00976937|589826239|FG000|Overall Study|Lost to Follow-up|2|||
163305527|NCT00976937|589826240|FG001|Overall Study|Lost to Follow-up|1|||
163305528|NCT00976937|589826239|FG000|Overall Study|Withdrawal by Subject|5|||
163305529|NCT00976937|589826240|FG001|Overall Study|Withdrawal by Subject|3|||
163305530|NCT00976937|589826239|FG000|Overall Study|Poor compliance to protocol|3|||
163305531|NCT00976937|589826240|FG001|Overall Study|Poor compliance to protocol|0|||
163305532|NCT00976937|589826239|FG000|Overall Study|Personal and Familial Reason|2|||
163305533|NCT00976937|589826240|FG001|Overall Study|Personal and Familial Reason|2|||
163305534|NCT01044303|589826243|FG000|Overall Study|Lost to Follow-up|2|||
163305535|NCT01227265|589826244|FG000|Overall Study|Did Not Receive Treatment|1|||
163305536|NCT01227265|589826245|FG001|Overall Study|Did Not Receive Treatment|2|||
163305537|NCT01227265|589826246|FG002|Overall Study|Did Not Receive Treatment|0|||
163305538|NCT01227265|589826244|FG000|Overall Study|Administrative|1|||
163305539|NCT01227265|589826245|FG001|Overall Study|Administrative|0|||
163305540|NCT01227265|589826246|FG002|Overall Study|Administrative|2|||
163305541|NCT01227265|589826244|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
163305542|NCT01227265|589826245|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
163305543|NCT01227265|589826246|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
163305544|NCT01227265|589826244|FG000|Overall Study|Protocol Violation|2|||
163305545|NCT01227265|589826245|FG001|Overall Study|Protocol Violation|1|||
163305546|NCT01227265|589826246|FG002|Overall Study|Protocol Violation|0|||
163305547|NCT01227265|589826244|FG000|Overall Study|Withdrawal by Subject|7|||
163305548|NCT01227265|589826245|FG001|Overall Study|Withdrawal by Subject|7|||
163305549|NCT01227265|589826246|FG002|Overall Study|Withdrawal by Subject|3|||
163305550|NCT01227265|589826244|FG000|Overall Study|Lost to Follow-up|2|||
163305551|NCT01227265|589826245|FG001|Overall Study|Lost to Follow-up|0|||
163305552|NCT01227265|589826246|FG002|Overall Study|Lost to Follow-up|3|||
163305553|NCT01227265|589826244|FG000|Overall Study|Adverse Event|6|||
163305554|NCT01227265|589826245|FG001|Overall Study|Adverse Event|10|||
163305555|NCT01227265|589826246|FG002|Overall Study|Adverse Event|5|||
163305556|NCT02910713|589826247|FG000|Overall Study|Protocol Violation|2|||
163305557|NCT02910713|589826247|FG000|Overall Study|Subject Choice|4|||
163305558|NCT02910713|589826247|FG000|Overall Study|Received One Application|10|||
163305559|NCT02910713|589826247|FG000|Overall Study|Received Neither Application|18|||
163305560|NCT02910713|589826247|FG000|Overall Study|Enrollment cap|7|||
163305561|NCT02910713|589826247|FG000|Overall Study|Investigator Discretion|1|||
163305562|NCT04442126|589826259|FG000|Overall Study|Withdrawal by Subject|0|||
163305563|NCT04442126|589826260|FG001|Overall Study|Withdrawal by Subject|0|||
163305564|NCT04442126|589826261|FG002|Overall Study|Withdrawal by Subject|0|||
163305565|NCT04442126|589826262|FG003|Overall Study|Withdrawal by Subject|2|||
163305566|NCT04442126|589826263|FG004|Overall Study|Withdrawal by Subject|1|||
163305567|NCT04442126|589826264|FG005|Overall Study|Withdrawal by Subject|0|||
162963416|NCT03969641|588566481|FG000|Overall Study|Lost to Follow-up|5|||
162963417|NCT03969641|588566482|FG001|Overall Study|Lost to Follow-up|3|||
162963418|NCT03969641|588566481|FG000|Overall Study|Withdrawal by Subject|1|||
162963419|NCT03969641|588566482|FG001|Overall Study|Withdrawal by Subject|2|||
162963420|NCT03969641|588566481|FG000|Overall Study|Found to be ineligible|1|||
162963421|NCT03969641|588566482|FG001|Overall Study|Found to be ineligible|1|||
162963422|NCT03969641|588566481|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
162963423|NCT03969641|588566482|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
162963424|NCT03969641|588566481|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
162963425|NCT03969641|588566482|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
162963426|NCT03969641|588566481|FG000|Overall Study|Elective termination|0|||
162963427|NCT03969641|588566482|FG001|Overall Study|Elective termination|1|||
162963428|NCT00754052|588566493|FG000|Overall Study|Study terminated by Sponsor|5|||
162963429|NCT00754052|588566494|FG001|Overall Study|Study terminated by Sponsor|3|||
162963430|NCT00557245|588566497|FG000|Overall Study|Lost to Follow-up|7|||
162963431|NCT00557245|588566498|FG001|Overall Study|Lost to Follow-up|8|||
162963432|NCT00557245|588566499|FG002|Overall Study|Lost to Follow-up|10|||
162963433|NCT00557245|588566497|FG000|Overall Study|Ineligible|5|||
163199333|NCT03095066|589445318|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
163396727|NCT00175877|590162788|FG000|Overall Study|Adverse Event|136|||
162963434|NCT00557245|588566498|FG001|Overall Study|Ineligible|4|||
162963435|NCT00557245|588566499|FG002|Overall Study|Ineligible|2|||
162963436|NCT02658019|588566500|FG000|Overall Study|Adverse Event|1|||
162963437|NCT00516295|588566504|FG000|Overall Study|Lack of Efficacy|2|||
162963438|NCT00516295|588566505|FG001|Overall Study|Lack of Efficacy|0|||
162963439|NCT00516295|588566506|FG002|Overall Study|Lack of Efficacy|0|||
162963440|NCT00516295|588566504|FG000|Overall Study|Ineligible|1|||
162963441|NCT00516295|588566505|FG001|Overall Study|Ineligible|0|||
162963442|NCT00516295|588566506|FG002|Overall Study|Ineligible|0|||
162963443|NCT00660660|588566509|FG000|Overall Study|Adverse Event|1|||
162963444|NCT00660660|588566510|FG001|Overall Study|Adverse Event|0|||
162963445|NCT00660660|588566509|FG000|Overall Study|Lost to Follow-up|0|||
162963446|NCT00660660|588566510|FG001|Overall Study|Lost to Follow-up|6|||
162963447|NCT00660660|588566509|FG000|Overall Study|Lack of Efficacy|0|||
162963448|NCT00660660|588566510|FG001|Overall Study|Lack of Efficacy|2|||
162963449|NCT00660660|588566509|FG000|Overall Study|Withdrawal by Subject|3|||
162963450|NCT00660660|588566510|FG001|Overall Study|Withdrawal by Subject|0|||
163396728|NCT00175877|590162788|FG000|Overall Study|Withdrawal by Subject|141|||
163396729|NCT00175877|590162788|FG000|Overall Study|Lost to Follow-up|9|||
163199334|NCT03095066|589445319|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
163199335|NCT03095066|589445320|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
163396730|NCT00175877|590162788|FG000|Overall Study|Lack of Efficacy|26|||
163396731|NCT00175877|590162788|FG000|Overall Study|Protocol Violation|15|||
163396732|NCT00175877|590162788|FG000|Overall Study|Other Reason|20|||
163396733|NCT00175877|590162788|FG000|Overall Study|AE & Other|1|||
163396734|NCT00175877|590162788|FG000|Overall Study|Withdrawal by subject & Other|1|||
163396735|NCT00617604|590162789|FG000|Overall Study|Death|2|||
163396736|NCT00617604|590162790|FG001|Overall Study|Death|1|||
163396737|NCT00617604|590162789|FG000|Overall Study|Lost to Follow-up|1|||
163396738|NCT00617604|590162790|FG001|Overall Study|Lost to Follow-up|0|||
163396739|NCT00617604|590162789|FG000|Overall Study|Miscellaneous Reasons|8|||
163396740|NCT00617604|590162790|FG001|Overall Study|Miscellaneous Reasons|10|||
163396741|NCT00617604|590162789|FG000|Overall Study|Withdrawal by Subject|4|||
163396742|NCT00617604|590162790|FG001|Overall Study|Withdrawal by Subject|6|||
163396743|NCT00617604|590162789|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
163396744|NCT00617604|590162790|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
163396745|NCT04029961|590162791|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
163396746|NCT04029961|590162792|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
163396747|NCT04029961|590162791|FG000|Overall Study|Change in Treatment Course|0|||
163396748|NCT04029961|590162792|FG001|Overall Study|Change in Treatment Course|1|||
163396749|NCT00688155|590162795|FG000|Overall Study|Withdrawal by Subject|2|||
163396750|NCT00688155|590162796|FG001|Overall Study|Withdrawal by Subject|2|||
163396751|NCT00688155|590162797|FG002|Overall Study|Withdrawal by Subject|1|||
163396752|NCT00688155|590162798|FG003|Overall Study|Withdrawal by Subject|1|||
163396753|NCT00445224|590162801|FG000|Specific Exercises|Withdrawal by Subject|3|||
163396754|NCT00445224|590162802|FG001|Specific Exercises|Withdrawal by Subject|3|||
163396755|NCT00445224|590162801|FG000|Specific Exercises|Withdrawal by Subject|1|||
163050691|NCT01435759|588893655|FG001|Antidepressant Lead-in Phase|Other|0|||
163050692|NCT01435759|588893656|FG002|Antidepressant Lead-in Phase|Other|0|||
163396756|NCT00445224|590162802|FG001|Specific Exercises|Withdrawal by Subject|0|||
163396757|NCT03184077|590162803|FG000|Overall Study|Lost to Follow-up|21|||
163396758|NCT03184077|590162804|FG001|Overall Study|Lost to Follow-up|21|||
163050693|NCT01435759|588893657|FG003|Antidepressant Lead-in Phase|Other|0|||
163050694|NCT01435759|588893658|FG004|Antidepressant Lead-in Phase|Other|0|||
163050695|NCT01435759|588893659|FG005|Antidepressant Lead-in Phase|Other|0|||
163050696|NCT01435759|588893654|FG000|Double-blind Phase|Adverse Event|7|||
163050697|NCT01435759|588893655|FG001|Double-blind Phase|Adverse Event|0|||
163050698|NCT01435759|588893656|FG002|Double-blind Phase|Adverse Event|1|||
163050699|NCT01435759|588893657|FG003|Double-blind Phase|Adverse Event|1|||
163050700|NCT01435759|588893658|FG004|Double-blind Phase|Adverse Event|1|||
163199336|NCT03095066|589445321|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
163199337|NCT03095066|589445322|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
163199338|NCT03095066|589445323|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
163396759|NCT04136184|590162805|FG000|Overall Study|Lost to Follow-up|0|||
163396760|NCT04136184|590162806|FG001|Overall Study|Lost to Follow-up|3|||
163396761|NCT04136184|590162805|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
163396762|NCT04136184|590162806|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
163396763|NCT03318978|590162807|FG000|Overall Study|Withdrawal by Subject|1|||
163396764|NCT02322125|590164274|FG000|Overall Study|Withdrawal by Subject|2|||
163396765|NCT04096274|590164277|FG000|Phase I|Lost to Follow-up|5|||
163050701|NCT01435759|588893659|FG005|Double-blind Phase|Adverse Event|3|||
163396766|NCT04096274|590164278|FG001|Phase I|Lost to Follow-up|5|||
163305568|NCT04442126|589826265|FG006|Overall Study|Withdrawal by Subject|1|||
163305569|NCT04442126|589826266|FG007|Overall Study|Withdrawal by Subject|1|||
163305570|NCT04442126|589826267|FG008|Overall Study|Withdrawal by Subject|3|||
163305571|NCT04442126|589826259|FG000|Overall Study|Death|1|||
163305572|NCT04442126|589826260|FG001|Overall Study|Death|0|||
163305573|NCT04442126|589826261|FG002|Overall Study|Death|0|||
163305574|NCT04442126|589826262|FG003|Overall Study|Death|1|||
163305575|NCT04442126|589826263|FG004|Overall Study|Death|2|||
163305576|NCT04442126|589826264|FG005|Overall Study|Death|2|||
163305577|NCT04442126|589826265|FG006|Overall Study|Death|4|||
163305578|NCT04442126|589826266|FG007|Overall Study|Death|1|||
163305579|NCT04442126|589826267|FG008|Overall Study|Death|5|||
163305580|NCT04442126|589826259|FG000|Overall Study|Study Terminated by Sponsor|0|||
163305581|NCT04442126|589826260|FG001|Overall Study|Study Terminated by Sponsor|0|||
163305582|NCT04442126|589826261|FG002|Overall Study|Study Terminated by Sponsor|0|||
163305583|NCT04442126|589826262|FG003|Overall Study|Study Terminated by Sponsor|0|||
163305584|NCT04442126|589826263|FG004|Overall Study|Study Terminated by Sponsor|0|||
163305585|NCT04442126|589826264|FG005|Overall Study|Study Terminated by Sponsor|1|||
163305586|NCT04442126|589826265|FG006|Overall Study|Study Terminated by Sponsor|4|||
163305587|NCT04442126|589826266|FG007|Overall Study|Study Terminated by Sponsor|2|||
163305588|NCT04442126|589826267|FG008|Overall Study|Study Terminated by Sponsor|10|||
163305589|NCT04442126|589826259|FG000|Overall Study|Lost to Follow-up|0|||
163305590|NCT04442126|589826260|FG001|Overall Study|Lost to Follow-up|0|||
163305591|NCT04442126|589826261|FG002|Overall Study|Lost to Follow-up|0|||
163305592|NCT04442126|589826262|FG003|Overall Study|Lost to Follow-up|0|||
163305593|NCT04442126|589826263|FG004|Overall Study|Lost to Follow-up|0|||
163305594|NCT04442126|589826264|FG005|Overall Study|Lost to Follow-up|0|||
163305595|NCT04442126|589826265|FG006|Overall Study|Lost to Follow-up|0|||
163305596|NCT04442126|589826266|FG007|Overall Study|Lost to Follow-up|1|||
163305597|NCT04442126|589826267|FG008|Overall Study|Lost to Follow-up|2|||
163305598|NCT04442126|589826259|FG000|Overall Study|Progressive Disease|0|||
163305599|NCT04442126|589826260|FG001|Overall Study|Progressive Disease|1|||
163305600|NCT04442126|589826261|FG002|Overall Study|Progressive Disease|3|||
163305601|NCT04442126|589826262|FG003|Overall Study|Progressive Disease|0|||
163305602|NCT04442126|589826263|FG004|Overall Study|Progressive Disease|3|||
163305603|NCT04442126|589826264|FG005|Overall Study|Progressive Disease|0|||
163305604|NCT04442126|589826265|FG006|Overall Study|Progressive Disease|0|||
163305605|NCT04442126|589826266|FG007|Overall Study|Progressive Disease|0|||
163305606|NCT04442126|589826267|FG008|Overall Study|Progressive Disease|0|||
163305607|NCT04442126|589826259|FG000|Overall Study|Other|0|||
163305608|NCT04442126|589826260|FG001|Overall Study|Other|0|||
163305609|NCT04442126|589826261|FG002|Overall Study|Other|0|||
163305610|NCT04442126|589826262|FG003|Overall Study|Other|0|||
163305611|NCT04442126|589826263|FG004|Overall Study|Other|0|||
163305612|NCT04442126|589826264|FG005|Overall Study|Other|0|||
163305613|NCT04442126|589826265|FG006|Overall Study|Other|0|||
163305614|NCT04442126|589826266|FG007|Overall Study|Other|0|||
163305615|NCT04442126|589826267|FG008|Overall Study|Other|1|||
163305616|NCT06450405|589826268|FG000|Overall Study|Study funding terminated.|0|||
163305617|NCT06450405|589826269|FG001|Overall Study|Study funding terminated.|2|||
163305618|NCT03767517|589826270|FG000|Overall Study|Lost to Follow-up|16|||
163305619|NCT03767517|589826271|FG001|Overall Study|Lost to Follow-up|10|||
163305620|NCT03767517|589826270|FG000|Overall Study|Death|2|||
163305621|NCT03767517|589826271|FG001|Overall Study|Death|3|||
163305622|NCT04994509|589826272|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
163305623|NCT04994509|589826273|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
163305624|NCT04994509|589826274|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
163305625|NCT04994509|589826272|FG000|Overall Study|Withdrew Consent|73|||
163305626|NCT04994509|589826273|FG001|Overall Study|Withdrew Consent|72|||
163305627|NCT04994509|589826274|FG002|Overall Study|Withdrew Consent|46|||
163305628|NCT04994509|589826272|FG000|Overall Study|Lost to Follow-up|39|||
163305629|NCT04994509|589826273|FG001|Overall Study|Lost to Follow-up|36|||
163305630|NCT04994509|589826274|FG002|Overall Study|Lost to Follow-up|26|||
163305631|NCT04994509|589826272|FG000|Overall Study|HIV-1 Infection|4|||
163305632|NCT04994509|589826273|FG001|Overall Study|HIV-1 Infection|20|||
163305633|NCT04994509|589826274|FG002|Overall Study|HIV-1 Infection|12|||
163305634|NCT04994509|589826272|FG000|Overall Study|Investigator's Discretion|9|||
163396767|NCT04096274|590164277|FG000|Phase II|Lost to Follow-up|11|||
163305635|NCT04994509|589826273|FG001|Overall Study|Investigator's Discretion|8|||
163305636|NCT04994509|589826274|FG002|Overall Study|Investigator's Discretion|11|||
163305637|NCT04994509|589826272|FG000|Overall Study|Randomized but Never Treated|10|||
163305638|NCT04994509|589826273|FG001|Overall Study|Randomized but Never Treated|10|||
163305639|NCT04994509|589826274|FG002|Overall Study|Randomized but Never Treated|3|||
163305640|NCT04994509|589826272|FG000|Overall Study|Pregnancy|5|||
163305641|NCT04994509|589826273|FG001|Overall Study|Pregnancy|5|||
163305642|NCT04994509|589826274|FG002|Overall Study|Pregnancy|0|||
163305643|NCT04994509|589826272|FG000|Overall Study|Death|0|||
163305644|NCT04994509|589826273|FG001|Overall Study|Death|5|||
163305645|NCT04994509|589826274|FG002|Overall Study|Death|0|||
163396768|NCT04096274|590164278|FG001|Phase II|Lost to Follow-up|11|||
163396769|NCT01462435|590164280|FG000|Overall Study|Lack of Efficacy|1|||
163396770|NCT01462435|590164281|FG001|Overall Study|Lack of Efficacy|0|||
163396771|NCT01462435|590164282|FG002|Overall Study|Lack of Efficacy|0|||
163396772|NCT01462435|590164283|FG003|Overall Study|Lack of Efficacy|3|||
163396773|NCT01462435|590164280|FG000|Overall Study|Physician Decision|0|||
163396774|NCT01462435|590164281|FG001|Overall Study|Physician Decision|0|||
163396775|NCT01462435|590164282|FG002|Overall Study|Physician Decision|1|||
163396776|NCT01462435|590164283|FG003|Overall Study|Physician Decision|0|||
163396777|NCT01462435|590164280|FG000|Overall Study|Withdrawal by Subject|0|||
163396778|NCT01462435|590164281|FG001|Overall Study|Withdrawal by Subject|0|||
163396779|NCT01462435|590164282|FG002|Overall Study|Withdrawal by Subject|0|||
163396780|NCT01462435|590164283|FG003|Overall Study|Withdrawal by Subject|1|||
163396781|NCT01462435|590164280|FG000|Overall Study|Lost to Follow-up|0|||
163396782|NCT01462435|590164281|FG001|Overall Study|Lost to Follow-up|0|||
163396783|NCT01462435|590164282|FG002|Overall Study|Lost to Follow-up|0|||
163396784|NCT01462435|590164283|FG003|Overall Study|Lost to Follow-up|1|||
163396785|NCT05092919|590164284|FG000|Overall Study|Lost to Follow-up|7|||
163396786|NCT05092919|590164284|FG000|Overall Study|Withdrawal by Subject|2|||
163396787|NCT02248259|590164286|FG000|Treatment Period 1|Adverse Event|0|||
163396788|NCT02248259|590164287|FG001|Treatment Period 1|Adverse Event|0|||
163396789|NCT02248259|590164288|FG002|Treatment Period 1|Adverse Event|1|||
163396790|NCT02248259|590164289|FG003|Treatment Period 1|Adverse Event|0|||
163396791|NCT03281668|590164296|FG000|Overall Study|Physician Decision|1|||
163199339|NCT03095066|589445324|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
163199340|NCT03095066|589445325|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
163199341|NCT03095066|589445318|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
163199342|NCT03095066|589445319|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
163199343|NCT03095066|589445320|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
163199344|NCT03095066|589445321|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
163199345|NCT03095066|589445322|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
163199346|NCT03095066|589445323|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
163199347|NCT03095066|589445324|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
163199348|NCT03095066|589445325|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
163199349|NCT03095066|589445318|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
163199350|NCT03095066|589445319|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
163199351|NCT03095066|589445320|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
163199352|NCT03095066|589445321|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
163199353|NCT03095066|589445322|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
163199354|NCT03095066|589445323|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
163199355|NCT03095066|589445324|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
163199356|NCT03095066|589445325|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
163199357|NCT03095066|589445318|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
163199358|NCT03095066|589445319|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
163199359|NCT03095066|589445320|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
163199360|NCT03095066|589445321|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
163199361|NCT03095066|589445322|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
163199362|NCT03095066|589445323|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
163199363|NCT03095066|589445324|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
163199364|NCT03095066|589445325|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
163199365|NCT03095066|589445318|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
163199366|NCT03095066|589445319|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
163199367|NCT03095066|589445320|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
163199368|NCT03095066|589445321|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
163199369|NCT03095066|589445322|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
163199370|NCT03095066|589445323|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
163199371|NCT03095066|589445324|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
163199372|NCT03095066|589445325|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
163199373|NCT03095066|589445318|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
163199374|NCT03095066|589445319|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
163199375|NCT03095066|589445320|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
163199376|NCT03095066|589445321|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
163199377|NCT03095066|589445322|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
163199378|NCT03095066|589445323|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
163199379|NCT03095066|589445324|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
163199380|NCT03095066|589445325|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
163396792|NCT03281668|590164296|FG000|Overall Study|scheduling conflict, family circumstance|2|||
163396793|NCT03281668|590164296|FG000|Overall Study|Withdrawal by Subject|4|||
163396794|NCT03281668|590164296|FG000|Overall Study|Lost to Follow-up|1|||
163396795|NCT01543152|590164297|FG000|Overall Study|Withdrawal by Subject|0|||
163396796|NCT01543152|590164298|FG001|Overall Study|Withdrawal by Subject|2|||
163396797|NCT01543152|590164299|FG002|Overall Study|Withdrawal by Subject|0|||
163396798|NCT01543152|590164300|FG003|Overall Study|Withdrawal by Subject|0|||
163396799|NCT01543152|590164301|FG004|Overall Study|Withdrawal by Subject|0|||
163396800|NCT01838616|590164304|FG000|Titration Period|Adverse Event|18|||
163396801|NCT01838616|590164305|FG001|Titration Period|Adverse Event|48|||
163396802|NCT01838616|590164304|FG000|Titration Period|Lack of Efficacy|5|||
163305646|NCT04994509|589826272|FG000|Overall Study|Adverse Event|2|||
163305647|NCT04994509|589826273|FG001|Overall Study|Adverse Event|1|||
163305648|NCT04994509|589826274|FG002|Overall Study|Adverse Event|0|||
163305649|NCT04994509|589826272|FG000|Overall Study|Non-compliance With Study Drug|1|||
163305650|NCT04994509|589826273|FG001|Overall Study|Non-compliance With Study Drug|1|||
163305651|NCT04994509|589826274|FG002|Overall Study|Non-compliance With Study Drug|1|||
163305652|NCT04994509|589826272|FG000|Overall Study|Withdrew Assent|3|||
163305653|NCT04994509|589826273|FG001|Overall Study|Withdrew Assent|0|||
163305654|NCT04994509|589826274|FG002|Overall Study|Withdrew Assent|0|||
163305655|NCT04994509|589826272|FG000|Overall Study|Protocol Violation|1|||
163305656|NCT04994509|589826273|FG001|Overall Study|Protocol Violation|0|||
163305657|NCT04994509|589826274|FG002|Overall Study|Protocol Violation|0|||
163305658|NCT03152786|589827571|FG000|Overall Study|Withdrawal by Subject|2|||
163305659|NCT03152786|589827572|FG001|Overall Study|Withdrawal by Subject|1|||
163305660|NCT00979576|589827573|FG000|Combination Treatment Phase|Progressive disease|3|||
163305661|NCT00979576|589827574|FG001|Combination Treatment Phase|Progressive disease|1|||
163305662|NCT00979576|589827575|FG002|Combination Treatment Phase|Progressive disease|5|||
163305663|NCT00979576|589827573|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
163305664|NCT00979576|589827574|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
163305665|NCT00979576|589827575|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
163305666|NCT00979576|589827573|FG000|Combination Treatment Phase|Adverse Event|0|||
163305667|NCT00979576|589827574|FG001|Combination Treatment Phase|Adverse Event|2|||
163305668|NCT00979576|589827575|FG002|Combination Treatment Phase|Adverse Event|2|||
163305669|NCT00979576|589827573|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
163305670|NCT00979576|589827574|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
163305671|NCT00979576|589827575|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
162963451|NCT00660660|588566509|FG000|Overall Study|Incorrect enrollment and other|0|||
162963452|NCT00660660|588566510|FG001|Overall Study|Incorrect enrollment and other|1|||
162963453|NCT00660660|588566509|FG000|Overall Study|New medication after randomization|1|||
162963454|NCT00660660|588566510|FG001|Overall Study|New medication after randomization|0|||
162963455|NCT02651987|588566511|FG000|Overall Study|Adverse Event|2|||
162963456|NCT02651987|588566512|FG001|Overall Study|Adverse Event|2|||
162963457|NCT02651987|588566511|FG000|Overall Study|Consent Withdrawn|2|||
162963458|NCT02651987|588566512|FG001|Overall Study|Consent Withdrawn|0|||
162963459|NCT02651987|588566511|FG000|Overall Study|Local PD|0|||
162963460|NCT02651987|588566512|FG001|Overall Study|Local PD|2|||
162963461|NCT02651987|588566511|FG000|Overall Study|Investigator Decision|1|||
162963462|NCT02651987|588566512|FG001|Overall Study|Investigator Decision|1|||
162963463|NCT01630616|588566513|FG000|Overall Study|Adverse Event|0|||
162963464|NCT01630616|588566514|FG001|Overall Study|Adverse Event|0|||
162963465|NCT01630616|588566515|FG002|Overall Study|Adverse Event|0|||
162963466|NCT01630616|588566516|FG003|Overall Study|Adverse Event|1|||
162963467|NCT01630616|588566517|FG004|Overall Study|Adverse Event|0|||
162963468|NCT01630616|588566518|FG005|Overall Study|Adverse Event|0|||
162963469|NCT01630616|588566513|FG000|Overall Study|Withdrawal by Subject|0|||
162963470|NCT01630616|588566514|FG001|Overall Study|Withdrawal by Subject|0|||
162963471|NCT01630616|588566515|FG002|Overall Study|Withdrawal by Subject|0|||
162963472|NCT01630616|588566516|FG003|Overall Study|Withdrawal by Subject|2|||
162963473|NCT01630616|588566517|FG004|Overall Study|Withdrawal by Subject|0|||
163050702|NCT01435759|588893654|FG000|Double-blind Phase|Protocol Violation|2|||
163199381|NCT03095066|589445318|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
163199382|NCT03095066|589445319|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
163199383|NCT03095066|589445320|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
163199384|NCT03095066|589445321|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
163199385|NCT03095066|589445322|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
163199386|NCT03095066|589445323|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
163199387|NCT03095066|589445324|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
163199388|NCT03095066|589445325|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
163199389|NCT03095066|589445318|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
163199390|NCT03095066|589445319|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
163199391|NCT03095066|589445320|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
163199392|NCT03095066|589445321|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
163199393|NCT03095066|589445322|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
162963474|NCT01630616|588566518|FG005|Overall Study|Withdrawal by Subject|0|||
162963475|NCT02725515|588566519|FG000|Overall Study|Refused infusion (no study treatment)|1|||
162963476|NCT02725515|588566520|FG001|Overall Study|Refused infusion (no study treatment)|0|||
162963477|NCT02725515|588566519|FG000|Overall Study|Loss of Improvement per Protocol|14|||
162963478|NCT02725515|588566520|FG001|Overall Study|Loss of Improvement per Protocol|25|||
162963479|NCT02725515|588566519|FG000|Overall Study|Withdrawal by Subject|2|||
162963480|NCT02725515|588566520|FG001|Overall Study|Withdrawal by Subject|1|||
162963481|NCT02725515|588566519|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162963482|NCT02725515|588566520|FG001|Overall Study|Non-Compliance With Study Drug|3|||
163305672|NCT02163447|589827576|FG000|Overall Study|Withdrawal by Subject|2|||
163199394|NCT03095066|589445323|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
163199395|NCT03095066|589445324|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
163199396|NCT03095066|589445325|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
163199397|NCT03095066|589445318|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
163199398|NCT03095066|589445319|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
163199399|NCT03095066|589445320|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
163199400|NCT03095066|589445321|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
163199401|NCT03095066|589445322|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
163199402|NCT03095066|589445323|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
163199403|NCT03095066|589445324|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
163199404|NCT03095066|589445325|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
163199405|NCT03095066|589445318|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
163199406|NCT03095066|589445319|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
163199407|NCT03095066|589445320|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
163199408|NCT03095066|589445321|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
163199409|NCT03095066|589445322|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
163199410|NCT03095066|589445323|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
163199411|NCT03095066|589445324|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
163199412|NCT03095066|589445325|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
163199413|NCT03095066|589445318|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
163199414|NCT03095066|589445319|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
163199415|NCT03095066|589445320|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
163199416|NCT03095066|589445321|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
163199417|NCT03095066|589445322|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
163199418|NCT03095066|589445323|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
163199419|NCT03095066|589445324|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
163199420|NCT03095066|589445325|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
163199421|NCT03095066|589445318|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
163199422|NCT03095066|589445319|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
163199423|NCT03095066|589445320|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
163199424|NCT03095066|589445321|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
163199425|NCT03095066|589445322|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
163199426|NCT03095066|589445323|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
163199427|NCT03095066|589445324|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
163199428|NCT03095066|589445325|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
163305673|NCT02163447|589827577|FG001|Overall Study|Withdrawal by Subject|0|||
163305674|NCT02163447|589827578|FG002|Overall Study|Withdrawal by Subject|1|||
163199429|NCT03095066|589445318|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
163199430|NCT03095066|589445319|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
163199431|NCT03095066|589445320|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
163199432|NCT03095066|589445321|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
163199433|NCT03095066|589445322|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
163305675|NCT02163447|589827576|FG000|Overall Study|Lost to Follow-up|1|||
163305676|NCT02163447|589827577|FG001|Overall Study|Lost to Follow-up|3|||
163305677|NCT02163447|589827578|FG002|Overall Study|Lost to Follow-up|0|||
163305678|NCT02163447|589827576|FG000|Overall Study|Moved out of study area|2|||
163305679|NCT02163447|589827577|FG001|Overall Study|Moved out of study area|3|||
163305680|NCT02163447|589827578|FG002|Overall Study|Moved out of study area|2|||
163199434|NCT03095066|589445323|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
163305681|NCT02163447|589827576|FG000|Overall Study|Became HIV infected at time of delivery|1|||
163396803|NCT01838616|590164305|FG001|Titration Period|Lack of Efficacy|12|||
162963483|NCT02725515|588566519|FG000|Overall Study|Lost to Follow-up|1|||
163305682|NCT02163447|589827577|FG001|Overall Study|Became HIV infected at time of delivery|0|||
163305683|NCT02163447|589827578|FG002|Overall Study|Became HIV infected at time of delivery|0|||
163305684|NCT02597946|589827580|FG000|Overall Study|Withdrawal by Subject|1|||
163305685|NCT02597946|589827580|FG000|Overall Study|Progressive disease|16|||
163305686|NCT02597946|589827580|FG000|Overall Study|Other than above|1|||
163305687|NCT04823611|589827591|FG000|Overall Study|Adverse Event|2|||
163305688|NCT04823611|589827592|FG001|Overall Study|Adverse Event|0|||
163305689|NCT04823611|589827593|FG002|Overall Study|Adverse Event|1|||
163305690|NCT04823611|589827594|FG003|Overall Study|Adverse Event|0|||
163305691|NCT04823611|589827595|FG004|Overall Study|Adverse Event|0|||
163305692|NCT04823611|589827596|FG005|Overall Study|Adverse Event|0|||
163305693|NCT04823611|589827597|FG006|Overall Study|Adverse Event|0|||
163305694|NCT05038566|589827598|FG000|Overall Study|Technical Difficulties with the Device|0|||
163305695|NCT05038566|589827599|FG001|Overall Study|Technical Difficulties with the Device|1|||
163305696|NCT04850807|589827608|FG000|Overall Study|Death|50|||
163305697|NCT04850807|589827609|FG001|Overall Study|Death|55|||
163305698|NCT04850807|589827608|FG000|Overall Study|Discharged|17|||
163305699|NCT04850807|589827609|FG001|Overall Study|Discharged|13|||
163305700|NCT04850807|589827608|FG000|Overall Study|Incomplete baseline data|3|||
163305701|NCT04850807|589827609|FG001|Overall Study|Incomplete baseline data|2|||
163305702|NCT03739996|589827610|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
163305703|NCT03739996|589827610|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
163305704|NCT03739996|589827610|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
163305705|NCT03739996|589827610|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
163305706|NCT03739996|589827610|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
163305707|NCT03739996|589827610|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
163305708|NCT03739996|589827610|FG000|Step 3 (SOC ART)|Death|1|||
163305709|NCT03739996|589827610|FG000|Step 3 (SOC ART)|Participant moved|1|||
163305710|NCT04737772|589827614|FG000|Phase 2 Study|Lost to Follow-up|15|||
163305711|NCT04737772|589827615|FG001|Phase 2 Study|Lost to Follow-up|15|||
163305712|NCT04737772|589827614|FG000|Phase 2 Study|Withdrawal by Subject|0|||
163305713|NCT04737772|589827615|FG001|Phase 2 Study|Withdrawal by Subject|1|||
163305714|NCT04737772|589827614|FG000|Phase 2 Study|Did not take any coaching calls|4|||
163305715|NCT04737772|589827615|FG001|Phase 2 Study|Did not take any coaching calls|0|||
163305716|NCT04737772|589827614|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
163305717|NCT04737772|589827615|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
163305718|NCT04737772|589827614|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
163305719|NCT04737772|589827615|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
163305720|NCT02549339|589827616|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
163305721|NCT02549339|589827617|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
163305722|NCT02549339|589827616|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
163305723|NCT02549339|589827617|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
163305724|NCT02549339|589827616|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
163305725|NCT02549339|589827617|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
162963484|NCT02725515|588566520|FG001|Overall Study|Lost to Follow-up|1|||
162963485|NCT02725515|588566519|FG000|Overall Study|Adverse Event|7|||
162963486|NCT02725515|588566520|FG001|Overall Study|Adverse Event|2|||
162963487|NCT02725515|588566519|FG000|Overall Study|No Documented Disease Improvement|0|||
162963488|NCT02725515|588566520|FG001|Overall Study|No Documented Disease Improvement|1|||
163305726|NCT02549339|589827616|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
163305727|NCT02549339|589827617|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
163305728|NCT02549339|589827616|FG000|12-month Follow-up|Lack of Efficacy|0|||
163305729|NCT02549339|589827617|FG001|12-month Follow-up|Lack of Efficacy|2|||
163305730|NCT02549339|589827616|FG000|12-month Follow-up|Withdrawal by Subject|8|||
163305731|NCT02549339|589827617|FG001|12-month Follow-up|Withdrawal by Subject|3|||
163305732|NCT02549339|589827616|FG000|12-month Follow-up|Lost to Follow-up|1|||
163305733|NCT02549339|589827617|FG001|12-month Follow-up|Lost to Follow-up|3|||
163305734|NCT02549339|589827616|FG000|12-month Follow-up|Other|0|||
163305735|NCT02549339|589827617|FG001|12-month Follow-up|Other|3|||
162963489|NCT02725515|588566519|FG000|Overall Study|Completed Study Under Original Protocol|0|||
162963490|NCT02725515|588566520|FG001|Overall Study|Completed Study Under Original Protocol|1|||
162963491|NCT02725515|588566519|FG000|Overall Study|Lack of Response|0|||
162963492|NCT02725515|588566520|FG001|Overall Study|Lack of Response|1|||
162963493|NCT00640393|588566526|FG000|Part 1|Lost to Follow-up|2|||
163305736|NCT02728076|589827618|FG000|Overall Study|Physician Decision|4|||
163305737|NCT05054374|589827619|FG000|Overall Study|Withdrawal by Subject|1|||
163199435|NCT03095066|589445324|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
163199436|NCT03095066|589445325|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
163199437|NCT03095066|589445318|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
163199438|NCT03095066|589445319|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
163199439|NCT03095066|589445320|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
163199440|NCT03095066|589445321|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
163199441|NCT03095066|589445322|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
163199442|NCT03095066|589445323|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
163199443|NCT03095066|589445324|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
163199444|NCT03095066|589445325|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
163199445|NCT03095066|589445318|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
163199446|NCT03095066|589445319|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
163199447|NCT03095066|589445320|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
163396804|NCT01838616|590164304|FG000|Titration Period|Withdrawal by Subject|5|||
163199448|NCT03095066|589445321|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
163199449|NCT03095066|589445322|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
163199450|NCT03095066|589445323|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
163199451|NCT03095066|589445324|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
163199452|NCT03095066|589445325|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
163199453|NCT03095066|589445318|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
163199454|NCT03095066|589445319|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
163199455|NCT03095066|589445320|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
163199456|NCT03095066|589445321|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
163199457|NCT03095066|589445322|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
163199458|NCT03095066|589445323|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
163199459|NCT03095066|589445324|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
163199460|NCT03095066|589445325|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
163199461|NCT03095066|589445318|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
163199462|NCT03095066|589445319|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
163199463|NCT03095066|589445320|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
163199464|NCT03095066|589445321|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
163199465|NCT03095066|589445322|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
162963494|NCT00640393|588566527|FG001|Part 1|Lost to Follow-up|0|||
162963495|NCT00640393|588566528|FG002|Part 1|Lost to Follow-up|0|||
163050703|NCT01435759|588893655|FG001|Double-blind Phase|Protocol Violation|0|||
163050704|NCT01435759|588893656|FG002|Double-blind Phase|Protocol Violation|1|||
163050705|NCT01435759|588893657|FG003|Double-blind Phase|Protocol Violation|2|||
163305738|NCT05054374|589827620|FG001|Overall Study|Withdrawal by Subject|0|||
163396805|NCT01838616|590164305|FG001|Titration Period|Withdrawal by Subject|5|||
163396806|NCT01838616|590164304|FG000|Titration Period|Technical problems|1|||
163396807|NCT01838616|590164305|FG001|Titration Period|Technical problems|0|||
163396808|NCT01838616|590164304|FG000|Titration Period|Other|1|||
163396809|NCT01838616|590164305|FG001|Titration Period|Other|0|||
163396810|NCT01838616|590164304|FG000|Titration Period|Protocol Violation|0|||
163396811|NCT01838616|590164305|FG001|Titration Period|Protocol Violation|1|||
163396812|NCT01838616|590164304|FG000|Continuation Period|Lack of Efficacy|3|||
163396813|NCT01838616|590164305|FG001|Continuation Period|Lack of Efficacy|5|||
163396814|NCT01838616|590164304|FG000|Continuation Period|Adverse Event|8|||
163396815|NCT01838616|590164305|FG001|Continuation Period|Adverse Event|4|||
163396816|NCT01838616|590164304|FG000|Continuation Period|Protocol Violation|2|||
163396817|NCT01838616|590164305|FG001|Continuation Period|Protocol Violation|0|||
163396818|NCT01838616|590164304|FG000|Continuation Period|Lost to Follow-up|1|||
163396819|NCT01838616|590164305|FG001|Continuation Period|Lost to Follow-up|0|||
163396820|NCT01838616|590164304|FG000|Continuation Period|Withdrawal by Subject|0|||
163396821|NCT01838616|590164305|FG001|Continuation Period|Withdrawal by Subject|4|||
163396822|NCT01838616|590164304|FG000|Continuation Period|Technical problems|0|||
163396823|NCT01838616|590164305|FG001|Continuation Period|Technical problems|1|||
163396824|NCT01838616|590164304|FG000|Pick-up Arm|Lack of Efficacy|4|||
163396825|NCT01838616|590164305|FG001|Pick-up Arm|Lack of Efficacy|0|||
163396826|NCT01838616|590164304|FG000|Pick-up Arm|Adverse Event|9|||
163396827|NCT01838616|590164305|FG001|Pick-up Arm|Adverse Event|0|||
163396828|NCT01838616|590164304|FG000|Pick-up Arm|Withdrawal by Subject|1|||
163396829|NCT01838616|590164305|FG001|Pick-up Arm|Withdrawal by Subject|0|||
163396830|NCT01838616|590164304|FG000|Pick-up Arm|Technical problems|1|||
163396831|NCT01838616|590164305|FG001|Pick-up Arm|Technical problems|0|||
163396832|NCT00762892|590164307|FG000|Overall Study|Lost to Follow-up|2|||
163396833|NCT00762892|590164308|FG001|Overall Study|Lost to Follow-up|5|||
163396834|NCT00762892|590164307|FG000|Overall Study|Withdrawal by Subject|0|||
163396835|NCT00762892|590164308|FG001|Overall Study|Withdrawal by Subject|1|||
162963496|NCT00640393|588566526|FG000|Part 1|Withdrawal by Subject|3|||
162963497|NCT00640393|588566527|FG001|Part 1|Withdrawal by Subject|0|||
162963498|NCT00640393|588566528|FG002|Part 1|Withdrawal by Subject|0|||
163199466|NCT03095066|589445323|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
162963499|NCT00640393|588566526|FG000|Randomization|Withdrawn per protocol|17|||
162963500|NCT00640393|588566527|FG001|Randomization|Withdrawn per protocol|0|||
162963501|NCT00640393|588566528|FG002|Randomization|Withdrawn per protocol|0|||
162963502|NCT00640393|588566526|FG000|Randomization|Never randomized by site|2|||
162963503|NCT00640393|588566527|FG001|Randomization|Never randomized by site|0|||
162963504|NCT00640393|588566528|FG002|Randomization|Never randomized by site|0|||
162963505|NCT00640393|588566526|FG000|Part 2|Lost to Follow-up|0|||
163199467|NCT03095066|589445324|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
163199468|NCT03095066|589445325|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
163199469|NCT03095066|589445318|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
163199470|NCT03095066|589445319|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
163199471|NCT03095066|589445320|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
163199472|NCT03095066|589445321|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
163199473|NCT03095066|589445322|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
163199474|NCT03095066|589445323|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
163199475|NCT03095066|589445324|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
163199476|NCT03095066|589445325|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
163199477|NCT03095066|589445318|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
163199478|NCT03095066|589445319|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
163199479|NCT03095066|589445320|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
163199480|NCT03095066|589445321|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
163199481|NCT03095066|589445322|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
163199482|NCT03095066|589445323|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
163199483|NCT03095066|589445324|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
163199484|NCT03095066|589445325|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
163199485|NCT03095066|589445318|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
163199486|NCT03095066|589445319|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
163199487|NCT03095066|589445320|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
163199488|NCT03095066|589445321|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
163396836|NCT00762892|590164307|FG000|Overall Study|Death|1|||
163396837|NCT00762892|590164308|FG001|Overall Study|Death|0|||
163396838|NCT00762892|590164307|FG000|Overall Study|Pregnancy|1|||
163396839|NCT00762892|590164308|FG001|Overall Study|Pregnancy|0|||
163396840|NCT00762892|590164307|FG000|Overall Study|Incarceration|1|||
163396841|NCT00762892|590164308|FG001|Overall Study|Incarceration|0|||
162963506|NCT00640393|588566527|FG001|Part 2|Lost to Follow-up|2|||
162963507|NCT00640393|588566528|FG002|Part 2|Lost to Follow-up|2|||
162963508|NCT00640393|588566526|FG000|Part 2|Withdrawal by Subject|0|||
162963509|NCT00640393|588566527|FG001|Part 2|Withdrawal by Subject|6|||
162963510|NCT00640393|588566528|FG002|Part 2|Withdrawal by Subject|1|||
162963511|NCT00640393|588566526|FG000|Part 2|Non-adherence|0|||
162963512|NCT00640393|588566527|FG001|Part 2|Non-adherence|1|||
163199489|NCT03095066|589445322|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
163199490|NCT03095066|589445323|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
163305739|NCT05054374|589827621|FG002|Overall Study|Withdrawal by Subject|0|||
163305740|NCT05054374|589827622|FG003|Overall Study|Withdrawal by Subject|0|||
163305741|NCT05054374|589827619|FG000|Overall Study|Progressive Disease|5|||
163305742|NCT05054374|589827620|FG001|Overall Study|Progressive Disease|0|||
163305743|NCT05054374|589827621|FG002|Overall Study|Progressive Disease|0|||
163305744|NCT05054374|589827622|FG003|Overall Study|Progressive Disease|0|||
163305745|NCT05415410|589827623|FG000|Overall Study|Death|3|||
163305746|NCT05415410|589827624|FG001|Overall Study|Death|6|||
163305747|NCT05415410|589827625|FG002|Overall Study|Death|1|||
163305748|NCT05415410|589827623|FG000|Overall Study|Trial Terminated by Sponsor|1|||
163305749|NCT05415410|589827624|FG001|Overall Study|Trial Terminated by Sponsor|5|||
163305750|NCT05415410|589827625|FG002|Overall Study|Trial Terminated by Sponsor|0|||
163305751|NCT05415410|589827623|FG000|Overall Study|Adverse Event|2|||
163305752|NCT05415410|589827624|FG001|Overall Study|Adverse Event|1|||
163305753|NCT05415410|589827625|FG002|Overall Study|Adverse Event|0|||
163305754|NCT05415410|589827623|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
163305755|NCT05415410|589827624|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
163305756|NCT05415410|589827625|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
163305757|NCT05415410|589827623|FG000|Overall Study|Withdrawal by Subject|1|||
163305758|NCT05415410|589827624|FG001|Overall Study|Withdrawal by Subject|0|||
163305759|NCT05415410|589827625|FG002|Overall Study|Withdrawal by Subject|0|||
163305760|NCT05415410|589827623|FG000|Overall Study|Pregnancy|5|||
163305761|NCT05415410|589827624|FG001|Overall Study|Pregnancy|2|||
163305762|NCT05415410|589827625|FG002|Overall Study|Pregnancy|0|||
163305763|NCT02365766|589827626|FG000|Overall Study|Withdrawal by Subject|0|||
163305764|NCT02365766|589827627|FG001|Overall Study|Withdrawal by Subject|0|||
163305765|NCT02365766|589827628|FG002|Overall Study|Withdrawal by Subject|1|||
162963513|NCT00640393|588566528|FG002|Part 2|Non-adherence|0|||
162963514|NCT00640393|588566526|FG000|Part 2|Adverse Event|0|||
162963515|NCT00640393|588566527|FG001|Part 2|Adverse Event|1|||
163305766|NCT02365766|589827626|FG000|Overall Study|Eligibility Criteria Not Met|0|||
163305767|NCT02365766|589827627|FG001|Overall Study|Eligibility Criteria Not Met|0|||
163305768|NCT02365766|589827628|FG002|Overall Study|Eligibility Criteria Not Met|1|||
162963516|NCT00640393|588566528|FG002|Part 2|Adverse Event|0|||
163305769|NCT04791709|589827633|FG000|Overall Study|Withdrawal by Subject|3|||
163305770|NCT02724956|589827634|FG000|Overall Study|Physician Decision|1|||
163305771|NCT02724956|589827635|FG001|Overall Study|Physician Decision|0|||
163305772|NCT02724956|589827634|FG000|Overall Study|Lack of Efficacy|0|||
163305773|NCT02724956|589827635|FG001|Overall Study|Lack of Efficacy|1|||
163305774|NCT02724956|589827634|FG000|Overall Study|Withdrawal by Subject|0|||
163305775|NCT02724956|589827635|FG001|Overall Study|Withdrawal by Subject|1|||
163305776|NCT01532388|589827636|FG000|3-month Follow-up|Lost to Follow-up|68|||
163305777|NCT01532388|589827637|FG001|3-month Follow-up|Lost to Follow-up|68|||
163305778|NCT01532388|589827636|FG000|6-month Follow-up|Lost to Follow-up|74|||
163305779|NCT01532388|589827637|FG001|6-month Follow-up|Lost to Follow-up|66|||
163305780|NCT01532388|589827636|FG000|12-month Follow-up|Lost to Follow-up|69|||
163305781|NCT01532388|589827637|FG001|12-month Follow-up|Lost to Follow-up|67|||
163305782|NCT03385629|589827638|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
163305783|NCT03385629|589827639|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
163396842|NCT02234479|590164309|FG000|Overall Study|Withdrawal by Subject|1|||
163396843|NCT02234479|590164310|FG001|Overall Study|Withdrawal by Subject|3|||
162963517|NCT01701063|588566529|FG000|Overall Study|Lost to Follow-up|0|||
162963518|NCT01701063|588566530|FG001|Overall Study|Lost to Follow-up|1|||
162963519|NCT01701063|588566531|FG002|Overall Study|Lost to Follow-up|0|||
162963520|NCT01701063|588566529|FG000|Overall Study|Withdrawal by Subject|0|||
162963521|NCT01701063|588566530|FG001|Overall Study|Withdrawal by Subject|0|||
162963522|NCT01701063|588566531|FG002|Overall Study|Withdrawal by Subject|1|||
162963523|NCT01701063|588566529|FG000|Overall Study|Other|0|||
162963524|NCT01701063|588566530|FG001|Overall Study|Other|0|||
162963525|NCT01701063|588566531|FG002|Overall Study|Other|1|||
162963526|NCT03428750|588566532|FG000|Overall Study|Withdrawal by Subject|11|||
162963527|NCT03428750|588566533|FG001|Overall Study|Withdrawal by Subject|10|||
162963528|NCT03428750|588566532|FG000|Overall Study|Lost to Follow-up|3|||
162963529|NCT03428750|588566533|FG001|Overall Study|Lost to Follow-up|9|||
162963530|NCT03428750|588566532|FG000|Overall Study|Adverse Event|9|||
162963531|NCT03428750|588566533|FG001|Overall Study|Adverse Event|1|||
162963532|NCT03428750|588566532|FG000|Overall Study|Protocol Violation|1|||
162963533|NCT03428750|588566533|FG001|Overall Study|Protocol Violation|0|||
162963534|NCT03428750|588566532|FG000|Overall Study|Administrative|0|||
163050706|NCT01435759|588893658|FG004|Double-blind Phase|Protocol Violation|0|||
163396844|NCT03374995|590164311|FG000|Overall Study|Withdrawal by Subject|0|||
162963535|NCT03428750|588566533|FG001|Overall Study|Administrative|1|||
162963536|NCT01919112|588566534|FG000|Secondary Analysis-day 30|Death|1|||
162963537|NCT01919112|588566535|FG001|Secondary Analysis-day 30|Death|1|||
162963538|NCT01919112|588566536|FG002|Secondary Analysis-day 30|Death|1|||
162963539|NCT01919112|588566534|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
162963540|NCT01919112|588566535|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
162963541|NCT01919112|588566536|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
162963542|NCT00835666|588566539|FG000|Washout|Protocol Violation|1|||
162963543|NCT00835666|588566540|FG001|Washout|Protocol Violation|0|||
162963544|NCT00835666|588566539|FG000|Washout|Withdrawal by Subject|1|||
162963545|NCT00835666|588566540|FG001|Washout|Withdrawal by Subject|0|||
162963546|NCT00635648|588566541|FG000|Overall Study|Adverse Event|12|||
162963547|NCT00635648|588566541|FG000|Overall Study|Withdrawal by Subject|9|||
163305784|NCT03385629|589827638|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
163305785|NCT03385629|589827639|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
162963548|NCT00635648|588566541|FG000|Overall Study|Physician Decision|4|||
162963549|NCT00635648|588566541|FG000|Overall Study|Rapid progression of baseline disease|4|||
162963550|NCT00635648|588566541|FG000|Overall Study|Use of other antifungal agent needed|1|||
162963551|NCT00635648|588566541|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
162963552|NCT00635648|588566541|FG000|Overall Study|Noncompliance with protocol|1|||
162963553|NCT00635648|588566541|FG000|Overall Study|Other reason|2|||
162963554|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
162963555|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
163199491|NCT03095066|589445324|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
163199492|NCT03095066|589445325|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
163199493|NCT05988619|589445327|FG000|Overall Study|Lost to Follow-up|1|||
162963556|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
162963557|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
162963558|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
162963559|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
162963560|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
163199494|NCT05988619|589445328|FG001|Overall Study|Lost to Follow-up|4|||
163396845|NCT03374995|590164312|FG001|Overall Study|Withdrawal by Subject|1|||
163396846|NCT01383096|590164315|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
162963561|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
162963562|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
162963563|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
162963564|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
162963565|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
162963566|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
162963567|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
162963568|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
162963569|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
162963570|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
162963571|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
162963572|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
162963573|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
163199495|NCT05988619|589445327|FG000|Overall Study|Withdrawal by Subject|2|||
163199496|NCT05988619|589445328|FG001|Overall Study|Withdrawal by Subject|9|||
163199497|NCT00726232|589445331|FG000|Initial Phase (Dose-finding)|Death|0|||
163199498|NCT00726232|589445332|FG001|Initial Phase (Dose-finding)|Death|0|||
163199499|NCT00726232|589445333|FG002|Initial Phase (Dose-finding)|Death|0|||
163199500|NCT00726232|589445334|FG003|Initial Phase (Dose-finding)|Death|0|||
163199501|NCT00726232|589445335|FG004|Initial Phase (Dose-finding)|Death|1|||
163199502|NCT00726232|589445336|FG005|Initial Phase (Dose-finding)|Death|0|||
163199503|NCT00726232|589445337|FG006|Initial Phase (Dose-finding)|Death|0|||
163199504|NCT00726232|589445338|FG007|Initial Phase (Dose-finding)|Death|0|||
163199505|NCT00726232|589445331|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
163199506|NCT00726232|589445332|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
163050707|NCT01435759|588893659|FG005|Double-blind Phase|Protocol Violation|1|||
163050708|NCT01435759|588893654|FG000|Double-blind Phase|Withdrawal by Subject|17|||
163050709|NCT01435759|588893655|FG001|Double-blind Phase|Withdrawal by Subject|4|||
163050710|NCT01435759|588893656|FG002|Double-blind Phase|Withdrawal by Subject|3|||
163050711|NCT01435759|588893657|FG003|Double-blind Phase|Withdrawal by Subject|4|||
163050712|NCT01435759|588893658|FG004|Double-blind Phase|Withdrawal by Subject|2|||
163050713|NCT01435759|588893659|FG005|Double-blind Phase|Withdrawal by Subject|2|||
163050714|NCT01435759|588893654|FG000|Double-blind Phase|Lost to Follow-up|31|||
163401996|NCT01840579|590182958|FG005|Overall Study|Follow-up ended by Sponsor|0|||
163050715|NCT01435759|588893655|FG001|Double-blind Phase|Lost to Follow-up|1|||
163050716|NCT01435759|588893656|FG002|Double-blind Phase|Lost to Follow-up|2|||
163050717|NCT01435759|588893657|FG003|Double-blind Phase|Lost to Follow-up|0|||
163050718|NCT01435759|588893658|FG004|Double-blind Phase|Lost to Follow-up|3|||
163050719|NCT01435759|588893659|FG005|Double-blind Phase|Lost to Follow-up|3|||
163050720|NCT01435759|588893654|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
163050721|NCT01435759|588893655|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
163401997|NCT01840579|590182959|FG006|Overall Study|Follow-up ended by Sponsor|2|||
162963574|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
162963575|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
162963576|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
163199507|NCT00726232|589445333|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
163199508|NCT00726232|589445334|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
163199509|NCT00726232|589445335|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
163199510|NCT00726232|589445336|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
163199511|NCT00726232|589445337|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
163199512|NCT00726232|589445338|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
163199513|NCT00726232|589445331|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
163199514|NCT00726232|589445332|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
163199515|NCT00726232|589445333|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
162963577|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
162963578|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
162963579|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
162963580|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
162963581|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
162963582|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
163305786|NCT03385629|589827638|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
163305787|NCT03385629|589827639|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
163305788|NCT04600752|589827645|FG000|Overall Study|Physician Decision|0|||
163305789|NCT04600752|589827646|FG001|Overall Study|Physician Decision|0|||
163305790|NCT04600752|589827647|FG002|Overall Study|Physician Decision|1|||
163305791|NCT04600752|589827645|FG000|Overall Study|Adverse Event|0|||
163305792|NCT04600752|589827646|FG001|Overall Study|Adverse Event|1|||
163305793|NCT04600752|589827647|FG002|Overall Study|Adverse Event|0|||
163305794|NCT04600752|589827645|FG000|Overall Study|Withdrawal by Subject|2|||
163305795|NCT04600752|589827646|FG001|Overall Study|Withdrawal by Subject|1|||
163305796|NCT04600752|589827647|FG002|Overall Study|Withdrawal by Subject|0|||
163305797|NCT04600752|589827645|FG000|Overall Study|Lack of Efficacy|1|||
163305798|NCT04600752|589827646|FG001|Overall Study|Lack of Efficacy|0|||
163305799|NCT04600752|589827647|FG002|Overall Study|Lack of Efficacy|0|||
163305800|NCT04431726|589827648|FG000|Overall Study|Ongoing in the Study|55|||
163305801|NCT01095796|589827649|FG000|Overall Study|Randomized but Not Treated|5|||
163305802|NCT01095796|589827650|FG001|Overall Study|Randomized but Not Treated|2|||
163305803|NCT01095796|589827649|FG000|Overall Study|Adverse Event|9|||
163305804|NCT01095796|589827650|FG001|Overall Study|Adverse Event|19|||
163305805|NCT01095796|589827649|FG000|Overall Study|Death|3|||
163305806|NCT01095796|589827650|FG001|Overall Study|Death|2|||
163305807|NCT01095796|589827649|FG000|Overall Study|Pregnancy|2|||
163305808|NCT01095796|589827650|FG001|Overall Study|Pregnancy|0|||
163305809|NCT01095796|589827649|FG000|Overall Study|Lack of Efficacy|5|||
163305810|NCT01095796|589827650|FG001|Overall Study|Lack of Efficacy|3|||
163305811|NCT01095796|589827649|FG000|Overall Study|Investigator's Discretion|7|||
163305812|NCT01095796|589827650|FG001|Overall Study|Investigator's Discretion|2|||
163401998|NCT01840579|590182960|FG007|Overall Study|Follow-up ended by Sponsor|0|||
163305813|NCT01095796|589827649|FG000|Overall Study|Withdrew Consent|16|||
163305814|NCT01095796|589827650|FG001|Overall Study|Withdrew Consent|22|||
163305815|NCT01095796|589827649|FG000|Overall Study|Lost to Follow-up|27|||
163305816|NCT01095796|589827650|FG001|Overall Study|Lost to Follow-up|29|||
163305817|NCT01095796|589827649|FG000|Overall Study|Participant Noncompliance|5|||
163305818|NCT01095796|589827650|FG001|Overall Study|Participant Noncompliance|10|||
163050722|NCT01435759|588893656|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050723|NCT01435759|588893657|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050724|NCT01435759|588893658|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
163050725|NCT01435759|588893659|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050726|NCT01435759|588893654|FG000|Double-blind Phase|Other|8|||
163050727|NCT01435759|588893655|FG001|Double-blind Phase|Other|2|||
163050728|NCT01435759|588893656|FG002|Double-blind Phase|Other|0|||
163050729|NCT01435759|588893657|FG003|Double-blind Phase|Other|2|||
163050730|NCT01435759|588893658|FG004|Double-blind Phase|Other|0|||
163050731|NCT01435759|588893659|FG005|Double-blind Phase|Other|0|||
163050732|NCT00427908|588893660|FG000|Primary Phase|Lost to Follow-up|4|||
163050733|NCT00427908|588893661|FG001|Primary Phase|Lost to Follow-up|0|||
163050734|NCT00427908|588893662|FG002|Primary Phase|Lost to Follow-up|2|||
163050735|NCT00427908|588893663|FG003|Primary Phase|Lost to Follow-up|0|||
163050736|NCT00427908|588893660|FG000|Primary Phase|Withdrawal by Subject|1|||
163050737|NCT00427908|588893661|FG001|Primary Phase|Withdrawal by Subject|2|||
163050738|NCT00427908|588893662|FG002|Primary Phase|Withdrawal by Subject|1|||
163050739|NCT00427908|588893663|FG003|Primary Phase|Withdrawal by Subject|0|||
163050740|NCT00427908|588893660|FG000|Primary Phase|Adverse Event|0|||
163050741|NCT00427908|588893661|FG001|Primary Phase|Adverse Event|1|||
163050742|NCT00427908|588893662|FG002|Primary Phase|Adverse Event|0|||
163305819|NCT01095796|589827649|FG000|Overall Study|Protocol Violation|1|||
163305820|NCT01095796|589827650|FG001|Overall Study|Protocol Violation|0|||
163305821|NCT01095796|589827649|FG000|Overall Study|Participant Transferred to Another Study|215|||
163050743|NCT00427908|588893663|FG003|Primary Phase|Adverse Event|0|||
163050744|NCT01710020|588893664|FG000|Period 1|Protocol Violation|1|||
163050745|NCT01764841|588893665|FG000|Overall Study|Logistical Difficulties|0|||
163050746|NCT01764841|588893666|FG001|Overall Study|Logistical Difficulties|1|||
163050747|NCT01764841|588893667|FG002|Overall Study|Logistical Difficulties|0|||
163050748|NCT01764841|588893668|FG003|Overall Study|Logistical Difficulties|0|||
163050749|NCT01764841|588893665|FG000|Overall Study|Death|3|||
163050750|NCT01764841|588893666|FG001|Overall Study|Death|0|||
163050751|NCT01764841|588893667|FG002|Overall Study|Death|1|||
163050752|NCT01764841|588893668|FG003|Overall Study|Death|4|||
163050753|NCT01764841|588893665|FG000|Overall Study|No Follow Up|1|||
163050754|NCT01764841|588893666|FG001|Overall Study|No Follow Up|0|||
163050755|NCT01764841|588893667|FG002|Overall Study|No Follow Up|1|||
163050756|NCT01764841|588893668|FG003|Overall Study|No Follow Up|0|||
163050757|NCT01764841|588893665|FG000|Overall Study|Protocol Violation|0|||
163050758|NCT01764841|588893666|FG001|Overall Study|Protocol Violation|1|||
163050759|NCT01764841|588893667|FG002|Overall Study|Protocol Violation|0|||
163050760|NCT01764841|588893668|FG003|Overall Study|Protocol Violation|0|||
163050761|NCT01764841|588893665|FG000|Overall Study|Withdrawal by Subject|16|||
163050762|NCT01764841|588893666|FG001|Overall Study|Withdrawal by Subject|24|||
163050763|NCT01764841|588893667|FG002|Overall Study|Withdrawal by Subject|11|||
163050764|NCT01764841|588893668|FG003|Overall Study|Withdrawal by Subject|15|||
163050765|NCT01764841|588893665|FG000|Overall Study|Lost to Follow-up|3|||
163050766|NCT01764841|588893666|FG001|Overall Study|Lost to Follow-up|0|||
163050767|NCT01764841|588893667|FG002|Overall Study|Lost to Follow-up|1|||
163050768|NCT01764841|588893668|FG003|Overall Study|Lost to Follow-up|0|||
163305822|NCT01095796|589827650|FG001|Overall Study|Participant Transferred to Another Study|200|||
163305823|NCT00604669|589827651|FG000|Overall Study|lack of information in chart|7|||
163305824|NCT05480943|589827666|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
163305825|NCT05480943|589827666|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
163305826|NCT05480943|589827666|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
163305827|NCT05480943|589827666|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
163305828|NCT04999592|589827667|FG000|Overall Study|Withdrawal by Subject|1|||
163305829|NCT04999592|589827668|FG001|Overall Study|Withdrawal by Subject|0|||
163305830|NCT03069313|589827669|FG000|Overall Study|Adverse Event|5|||
163305831|NCT03912831|589827670|FG000|Overall Study|Death|1|||
163305832|NCT03912831|589827671|FG001|Overall Study|Death|1|||
163305833|NCT03912831|589827672|FG002|Overall Study|Death|1|||
163305834|NCT03912831|589827673|FG003|Overall Study|Death|1|||
163396847|NCT01383096|590164316|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
163396848|NCT01383096|590164317|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
163050769|NCT02115607|588893669|FG000|Overall Study|Withdrawal by Subject|1|||
163050770|NCT04863872|588893672|FG000|Overall Study|Withdrawal by Subject|4|||
163050771|NCT04863872|588893673|FG001|Overall Study|Withdrawal by Subject|15|||
163396849|NCT01383096|590164315|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
163050772|NCT04863872|588893672|FG000|Overall Study|Death|5|||
163050773|NCT04863872|588893673|FG001|Overall Study|Death|2|||
163050774|NCT04863872|588893672|FG000|Overall Study|Lost to Follow-up|2|||
163050775|NCT04863872|588893673|FG001|Overall Study|Lost to Follow-up|1|||
163305835|NCT03912831|589827674|FG004|Overall Study|Death|1|||
163305836|NCT03912831|589827675|FG005|Overall Study|Death|1|||
163050776|NCT00549549|588893674|FG000|Overall Study|Adverse Event|5|||
163050777|NCT00549549|588893675|FG001|Overall Study|Adverse Event|3|||
163050778|NCT00549549|588893676|FG002|Overall Study|Adverse Event|1|||
163050779|NCT00549549|588893677|FG003|Overall Study|Adverse Event|9|||
163050780|NCT00549549|588893674|FG000|Overall Study|Lack of Efficacy|9|||
163050781|NCT00549549|588893675|FG001|Overall Study|Lack of Efficacy|6|||
163050782|NCT00549549|588893676|FG002|Overall Study|Lack of Efficacy|4|||
163050783|NCT00549549|588893677|FG003|Overall Study|Lack of Efficacy|2|||
163050784|NCT00549549|588893674|FG000|Overall Study|Lost to Follow-up|1|||
163050785|NCT00549549|588893675|FG001|Overall Study|Lost to Follow-up|0|||
163396850|NCT01383096|590164316|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
163396851|NCT01383096|590164317|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
163396852|NCT01383096|590164315|FG000|Third Intervention (8 Days)|Elevated AST|0|||
163396853|NCT01383096|590164316|FG001|Third Intervention (8 Days)|Elevated AST|1|||
163396854|NCT01383096|590164317|FG002|Third Intervention (8 Days)|Elevated AST|0|||
163396855|NCT01383096|590164315|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
163396856|NCT01383096|590164316|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
163396857|NCT01383096|590164317|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
163396858|NCT01383096|590164315|FG000|Third Intervention (8 Days)|Adverse Event|1|||
163396859|NCT01383096|590164316|FG001|Third Intervention (8 Days)|Adverse Event|0|||
163396860|NCT01383096|590164317|FG002|Third Intervention (8 Days)|Adverse Event|0|||
163396861|NCT01383096|590164315|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
163396862|NCT01383096|590164316|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
163396863|NCT01383096|590164317|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
163396864|NCT01383096|590164315|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
163396865|NCT01383096|590164316|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
163396866|NCT01383096|590164317|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
163396867|NCT01383096|590164315|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
163396868|NCT01383096|590164316|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
163050786|NCT00549549|588893676|FG002|Overall Study|Lost to Follow-up|1|||
163050787|NCT00549549|588893677|FG003|Overall Study|Lost to Follow-up|2|||
163050788|NCT00549549|588893674|FG000|Overall Study|Withdrawal by Subject|0|||
163050789|NCT00549549|588893675|FG001|Overall Study|Withdrawal by Subject|4|||
163050790|NCT00549549|588893676|FG002|Overall Study|Withdrawal by Subject|1|||
163050791|NCT00549549|588893677|FG003|Overall Study|Withdrawal by Subject|0|||
163050792|NCT00549549|588893674|FG000|Overall Study|Other|9|||
163050793|NCT00549549|588893675|FG001|Overall Study|Other|9|||
163050794|NCT00549549|588893676|FG002|Overall Study|Other|9|||
163050795|NCT00549549|588893677|FG003|Overall Study|Other|11|||
163050796|NCT00549549|588893674|FG000|Overall Study|Randomized but not treated|0|||
163050797|NCT00549549|588893675|FG001|Overall Study|Randomized but not treated|0|||
163050798|NCT00549549|588893676|FG002|Overall Study|Randomized but not treated|1|||
163050799|NCT00549549|588893677|FG003|Overall Study|Randomized but not treated|1|||
163050800|NCT02155699|588893678|FG000|Overall Study|Withdrawal by Subject|0|||
163050801|NCT02155699|588893679|FG001|Overall Study|Withdrawal by Subject|3|||
163305837|NCT03912831|589827670|FG000|Overall Study|Reason not Specified|0|||
163305838|NCT03912831|589827671|FG001|Overall Study|Reason not Specified|0|||
163305839|NCT03912831|589827672|FG002|Overall Study|Reason not Specified|0|||
163305840|NCT03912831|589827673|FG003|Overall Study|Reason not Specified|0|||
163305841|NCT03912831|589827674|FG004|Overall Study|Reason not Specified|1|||
163305842|NCT03912831|589827675|FG005|Overall Study|Reason not Specified|0|||
163305843|NCT03912831|589827670|FG000|Overall Study|Withdrawal by Participant|0|||
163305844|NCT03912831|589827671|FG001|Overall Study|Withdrawal by Participant|0|||
163305845|NCT03912831|589827672|FG002|Overall Study|Withdrawal by Participant|0|||
163305846|NCT03912831|589827673|FG003|Overall Study|Withdrawal by Participant|0|||
163305847|NCT03912831|589827674|FG004|Overall Study|Withdrawal by Participant|1|||
163305848|NCT03912831|589827675|FG005|Overall Study|Withdrawal by Participant|0|||
163305849|NCT04623775|589827677|FG000|Randomization|No Longer Meets Study Criteria|2|||
163305850|NCT04623775|589827678|FG001|Randomization|No Longer Meets Study Criteria|1|||
163305851|NCT04623775|589827679|FG002|Randomization|No Longer Meets Study Criteria|0|||
163305852|NCT04623775|589827680|FG003|Randomization|No Longer Meets Study Criteria|0|||
163305853|NCT04623775|589827677|FG000|Randomization|Withdrew Consent|0|||
163305854|NCT04623775|589827678|FG001|Randomization|Withdrew Consent|0|||
163305855|NCT04623775|589827679|FG002|Randomization|Withdrew Consent|0|||
163305856|NCT04623775|589827680|FG003|Randomization|Withdrew Consent|1|||
163305857|NCT04623775|589827677|FG000|Randomization|Other Reasons|0|||
163305858|NCT04623775|589827678|FG001|Randomization|Other Reasons|0|||
163305859|NCT04623775|589827679|FG002|Randomization|Other Reasons|0|||
163305860|NCT04623775|589827680|FG003|Randomization|Other Reasons|1|||
163305861|NCT04623775|589827677|FG000|Treatment Period|participant withdrew consent|4|||
163305862|NCT04623775|589827678|FG001|Treatment Period|participant withdrew consent|0|||
163305863|NCT04623775|589827679|FG002|Treatment Period|participant withdrew consent|1|||
163305864|NCT04623775|589827680|FG003|Treatment Period|participant withdrew consent|2|||
163305865|NCT04623775|589827677|FG000|Treatment Period|Death|3|||
163305866|NCT04623775|589827678|FG001|Treatment Period|Death|1|||
163050802|NCT02155699|588893680|FG002|Overall Study|Withdrawal by Subject|6|||
163050803|NCT02155699|588893681|FG003|Overall Study|Withdrawal by Subject|1|||
163396869|NCT01383096|590164317|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
163396870|NCT01383096|590164315|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
163396871|NCT01383096|590164316|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
163396872|NCT01383096|590164317|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
163396873|NCT01383096|590164315|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
163396874|NCT01383096|590164316|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
163396875|NCT01383096|590164317|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
163396876|NCT01383096|590164315|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
163396877|NCT01383096|590164316|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
163396878|NCT01383096|590164317|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
163396879|NCT01211535|590164318|FG000|Overall Study|Adverse Event|0|||
163396880|NCT01211535|590164319|FG001|Overall Study|Adverse Event|1|||
163396881|NCT00914927|590164325|FG000|Overall Study|Adverse Event|0|||
163396882|NCT00914927|590164326|FG001|Overall Study|Adverse Event|0|||
163396883|NCT00914927|590164327|FG002|Overall Study|Adverse Event|0|||
163396884|NCT00914927|590164328|FG003|Overall Study|Adverse Event|0|||
163396885|NCT00914927|590164329|FG004|Overall Study|Adverse Event|1|||
163396886|NCT00914927|590164330|FG005|Overall Study|Adverse Event|0|||
163396887|NCT00914927|590164331|FG006|Overall Study|Adverse Event|0|||
163396888|NCT00914927|590164325|FG000|Overall Study|Withdrawal by Subject|0|||
163396889|NCT00914927|590164326|FG001|Overall Study|Withdrawal by Subject|1|||
163396890|NCT00914927|590164327|FG002|Overall Study|Withdrawal by Subject|0|||
163396891|NCT00914927|590164328|FG003|Overall Study|Withdrawal by Subject|1|||
163396892|NCT00914927|590164329|FG004|Overall Study|Withdrawal by Subject|0|||
163396893|NCT00914927|590164330|FG005|Overall Study|Withdrawal by Subject|0|||
163396894|NCT00914927|590164331|FG006|Overall Study|Withdrawal by Subject|0|||
163396895|NCT00914927|590164325|FG000|Overall Study|Lost to Follow-up|0|||
163396896|NCT00914927|590164326|FG001|Overall Study|Lost to Follow-up|0|||
163396897|NCT00914927|590164327|FG002|Overall Study|Lost to Follow-up|0|||
163396898|NCT00914927|590164328|FG003|Overall Study|Lost to Follow-up|1|||
163396899|NCT00914927|590164329|FG004|Overall Study|Lost to Follow-up|0|||
163396900|NCT00914927|590164330|FG005|Overall Study|Lost to Follow-up|0|||
163396901|NCT00914927|590164331|FG006|Overall Study|Lost to Follow-up|0|||
163396902|NCT00914927|590164325|FG000|Overall Study|Administrative/Other|2|||
163396903|NCT00914927|590164326|FG001|Overall Study|Administrative/Other|1|||
163396904|NCT00914927|590164327|FG002|Overall Study|Administrative/Other|0|||
163396905|NCT00914927|590164328|FG003|Overall Study|Administrative/Other|0|||
163396906|NCT00914927|590164329|FG004|Overall Study|Administrative/Other|1|||
162963583|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
162963584|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
162963585|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
162963586|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
162963587|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
162963588|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
162963589|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
162963590|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
162963591|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
162963592|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
162963593|NCT04194801|588566542|FG000|Part Ib/II End of Study|Death|2|||
162963594|NCT04194801|588566543|FG001|Part Ib/II End of Study|Death|3|||
162963595|NCT04194801|588566544|FG002|Part Ib/II End of Study|Death|3|||
162963596|NCT04194801|588566542|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
162963597|NCT04194801|588566543|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
162963598|NCT04194801|588566544|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
162963599|NCT04194801|588566542|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
162963600|NCT04194801|588566543|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
163199516|NCT00726232|589445334|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
163199517|NCT00726232|589445335|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
163199518|NCT00726232|589445336|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
162963601|NCT04194801|588566544|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
162963602|NCT04194801|588566542|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
162963603|NCT04194801|588566543|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
162963604|NCT04194801|588566544|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
163199519|NCT00726232|589445337|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
162963605|NCT04194801|588566542|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
163305867|NCT04623775|589827679|FG002|Treatment Period|Death|4|||
163305868|NCT04623775|589827680|FG003|Treatment Period|Death|2|||
162963606|NCT04194801|588566543|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
163305869|NCT04623775|589827677|FG000|Treatment Period|Lost to Follow-up|0|||
162963607|NCT04194801|588566544|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
162963608|NCT00294047|588566545|FG000|Month 48|Adverse Event|28|||
162963609|NCT00294047|588566546|FG001|Month 48|Adverse Event|13|||
162963610|NCT00294047|588566545|FG000|Month 48|Protocol Violation|4|||
162963611|NCT00294047|588566546|FG001|Month 48|Protocol Violation|4|||
162963612|NCT00294047|588566545|FG000|Month 48|Withdrawal by Subject|111|||
162963613|NCT00294047|588566546|FG001|Month 48|Withdrawal by Subject|115|||
162963614|NCT00294047|588566545|FG000|Month 48|Lost to Follow-up|272|||
162963615|NCT00294047|588566546|FG001|Month 48|Lost to Follow-up|287|||
162963616|NCT00294047|588566545|FG000|Month 48|Other|10|||
162963617|NCT00294047|588566546|FG001|Month 48|Other|14|||
162963618|NCT00294047|588566545|FG000|Month 84|Adverse Event|4|||
162963619|NCT00294047|588566546|FG001|Month 84|Adverse Event|2|||
162963620|NCT00294047|588566545|FG000|Month 84|Protocol Violation|1|||
162963621|NCT00294047|588566546|FG001|Month 84|Protocol Violation|1|||
162963622|NCT00294047|588566545|FG000|Month 84|Withdrawal by Subject|33|||
162963623|NCT00294047|588566546|FG001|Month 84|Withdrawal by Subject|31|||
163199520|NCT00726232|589445338|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
163199521|NCT00726232|589445331|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
163199522|NCT00726232|589445332|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
163199523|NCT00726232|589445333|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
163199524|NCT00726232|589445334|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
163305870|NCT04623775|589827678|FG001|Treatment Period|Lost to Follow-up|2|||
163305871|NCT04623775|589827679|FG002|Treatment Period|Lost to Follow-up|0|||
163305872|NCT04623775|589827680|FG003|Treatment Period|Lost to Follow-up|0|||
163305873|NCT04623775|589827677|FG000|Treatment Period|poor/non compliance|0|||
163305874|NCT04623775|589827678|FG001|Treatment Period|poor/non compliance|0|||
163305875|NCT04623775|589827679|FG002|Treatment Period|poor/non compliance|1|||
162963624|NCT00294047|588566545|FG000|Month 84|Lost to Follow-up|187|||
162963625|NCT00294047|588566546|FG001|Month 84|Lost to Follow-up|190|||
162963626|NCT00294047|588566545|FG000|Month 84|Absent Cervix|2|||
162963627|NCT00294047|588566546|FG001|Month 84|Absent Cervix|0|||
162963628|NCT00294047|588566545|FG000|Month 84|Work related reasons|4|||
162963629|NCT00294047|588566546|FG001|Month 84|Work related reasons|2|||
162963630|NCT00294047|588566545|FG000|Month 84|Center closed, subject did not transfer|1|||
162963631|NCT00294047|588566546|FG001|Month 84|Center closed, subject did not transfer|0|||
162963632|NCT00294047|588566545|FG000|Month 84|Family problems|2|||
163199525|NCT00726232|589445335|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
163199526|NCT00726232|589445336|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
162963633|NCT00294047|588566546|FG001|Month 84|Family problems|2|||
162963634|NCT00294047|588566545|FG000|Month 84|Lack of time|3|||
162963635|NCT00294047|588566546|FG001|Month 84|Lack of time|1|||
162963636|NCT00294047|588566545|FG000|Month 84|Personal reason|2|||
162963637|NCT00294047|588566546|FG001|Month 84|Personal reason|4|||
162963638|NCT00294047|588566545|FG000|Month 84|Subject does not want male physician|1|||
162963639|NCT00294047|588566546|FG001|Month 84|Subject does not want male physician|0|||
162963640|NCT00294047|588566545|FG000|Month 84|Transport reimbursement delayed|0|||
162963641|NCT00294047|588566546|FG001|Month 84|Transport reimbursement delayed|1|||
162963642|NCT00294047|588566545|FG000|Month 84|Unable to reach study site|1|||
162963643|NCT00294047|588566546|FG001|Month 84|Unable to reach study site|0|||
162963644|NCT00294047|588566545|FG000|Month 84|Under investigation locally|1|||
162963645|NCT00294047|588566546|FG001|Month 84|Under investigation locally|0|||
163199527|NCT00726232|589445337|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
163199528|NCT00726232|589445338|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
163199529|NCT00726232|589445331|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
163199530|NCT00726232|589445332|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
163199531|NCT00726232|589445333|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
163199532|NCT00726232|589445334|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
163199533|NCT00726232|589445335|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
163199534|NCT00726232|589445336|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
163199535|NCT00726232|589445337|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
163199536|NCT00726232|589445338|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
163199537|NCT00726232|589445331|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
163199538|NCT00726232|589445332|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
163199539|NCT00726232|589445333|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
163199540|NCT00726232|589445334|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
163199541|NCT00726232|589445335|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
163199542|NCT00726232|589445336|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
163199543|NCT00726232|589445337|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
163199544|NCT00726232|589445338|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
163199545|NCT00726232|589445331|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
163199546|NCT00726232|589445332|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
163199547|NCT00726232|589445333|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
163199548|NCT00726232|589445334|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
163199549|NCT00726232|589445335|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
163199550|NCT00726232|589445336|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
163199551|NCT00726232|589445337|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
163199552|NCT00726232|589445338|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
163199553|NCT00726232|589445331|FG000|Expansion Phase|Death|0|||
163199554|NCT00726232|589445332|FG001|Expansion Phase|Death|0|||
163199555|NCT00726232|589445333|FG002|Expansion Phase|Death|0|||
163199556|NCT00726232|589445334|FG003|Expansion Phase|Death|0|||
163199557|NCT00726232|589445335|FG004|Expansion Phase|Death|0|||
163199558|NCT00726232|589445336|FG005|Expansion Phase|Death|0|||
163199559|NCT00726232|589445337|FG006|Expansion Phase|Death|0|||
163305876|NCT04623775|589827680|FG003|Treatment Period|poor/non compliance|0|||
163305877|NCT04623775|589827677|FG000|Treatment Period|participant no longer meets study criteria|0|||
163305878|NCT04623775|589827678|FG001|Treatment Period|participant no longer meets study criteria|1|||
163305879|NCT04623775|589827679|FG002|Treatment Period|participant no longer meets study criteria|0|||
163199560|NCT00726232|589445338|FG007|Expansion Phase|Death|1|||
163050804|NCT02155699|588893678|FG000|Overall Study|Lost to Follow-up|0|||
163050805|NCT02155699|588893679|FG001|Overall Study|Lost to Follow-up|0|||
163050806|NCT02155699|588893680|FG002|Overall Study|Lost to Follow-up|0|||
163050807|NCT02155699|588893681|FG003|Overall Study|Lost to Follow-up|3|||
163199561|NCT00726232|589445331|FG000|Expansion Phase|Adverse Event|0|||
163199562|NCT00726232|589445332|FG001|Expansion Phase|Adverse Event|0|||
163199563|NCT00726232|589445333|FG002|Expansion Phase|Adverse Event|0|||
163199564|NCT00726232|589445334|FG003|Expansion Phase|Adverse Event|0|||
163199565|NCT00726232|589445335|FG004|Expansion Phase|Adverse Event|0|||
163199566|NCT00726232|589445336|FG005|Expansion Phase|Adverse Event|0|||
163199567|NCT00726232|589445337|FG006|Expansion Phase|Adverse Event|6|||
163199568|NCT00726232|589445338|FG007|Expansion Phase|Adverse Event|11|||
163199569|NCT00726232|589445331|FG000|Expansion Phase|Withdrawal by Subject|0|||
163199570|NCT00726232|589445332|FG001|Expansion Phase|Withdrawal by Subject|0|||
163199571|NCT00726232|589445333|FG002|Expansion Phase|Withdrawal by Subject|0|||
163199572|NCT00726232|589445334|FG003|Expansion Phase|Withdrawal by Subject|0|||
163199573|NCT00726232|589445335|FG004|Expansion Phase|Withdrawal by Subject|0|||
163199574|NCT00726232|589445336|FG005|Expansion Phase|Withdrawal by Subject|0|||
163199575|NCT00726232|589445337|FG006|Expansion Phase|Withdrawal by Subject|2|||
163199576|NCT00726232|589445338|FG007|Expansion Phase|Withdrawal by Subject|3|||
163199577|NCT00726232|589445331|FG000|Expansion Phase|Disease progression|0|||
163199578|NCT00726232|589445332|FG001|Expansion Phase|Disease progression|0|||
163199579|NCT00726232|589445333|FG002|Expansion Phase|Disease progression|0|||
163199580|NCT00726232|589445334|FG003|Expansion Phase|Disease progression|0|||
163199581|NCT00726232|589445335|FG004|Expansion Phase|Disease progression|0|||
163199582|NCT00726232|589445336|FG005|Expansion Phase|Disease progression|0|||
163199583|NCT00726232|589445337|FG006|Expansion Phase|Disease progression|4|||
163199584|NCT00726232|589445338|FG007|Expansion Phase|Disease progression|0|||
163199585|NCT00726232|589445331|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
163199586|NCT00726232|589445332|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
163199587|NCT00726232|589445333|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
163199588|NCT00726232|589445334|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
163199589|NCT00726232|589445335|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
163199590|NCT00726232|589445336|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
163199591|NCT00726232|589445337|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
163199592|NCT00726232|589445338|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
163199593|NCT00726232|589445331|FG000|Expansion Phase|Per Investigator: lack of response|0|||
163199594|NCT00726232|589445332|FG001|Expansion Phase|Per Investigator: lack of response|0|||
163199595|NCT00726232|589445333|FG002|Expansion Phase|Per Investigator: lack of response|0|||
163199596|NCT00726232|589445334|FG003|Expansion Phase|Per Investigator: lack of response|0|||
163199597|NCT00726232|589445335|FG004|Expansion Phase|Per Investigator: lack of response|0|||
163199598|NCT00726232|589445336|FG005|Expansion Phase|Per Investigator: lack of response|0|||
163199599|NCT00726232|589445337|FG006|Expansion Phase|Per Investigator: lack of response|1|||
163199600|NCT00726232|589445338|FG007|Expansion Phase|Per Investigator: lack of response|7|||
163199601|NCT00726232|589445331|FG000|Expansion Phase|Unspecified reason|0|||
163199602|NCT00726232|589445332|FG001|Expansion Phase|Unspecified reason|0|||
163199603|NCT00726232|589445333|FG002|Expansion Phase|Unspecified reason|0|||
163199604|NCT00726232|589445334|FG003|Expansion Phase|Unspecified reason|0|||
163199605|NCT00726232|589445335|FG004|Expansion Phase|Unspecified reason|0|||
163199606|NCT00726232|589445336|FG005|Expansion Phase|Unspecified reason|0|||
163199607|NCT00726232|589445337|FG006|Expansion Phase|Unspecified reason|1|||
163199608|NCT00726232|589445338|FG007|Expansion Phase|Unspecified reason|0|||
163199609|NCT01471171|589445339|FG000|Treatment Period 1|Adverse Event|4|||
163199610|NCT01471171|589445340|FG001|Treatment Period 1|Adverse Event|1|||
163199611|NCT01471171|589445339|FG000|Treatment Period 2|Adverse Event|1|||
163199612|NCT01471171|589445340|FG001|Treatment Period 2|Adverse Event|0|||
163199613|NCT02864498|589445341|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
163199614|NCT02864498|589445342|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
163199615|NCT02864498|589445343|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
163199616|NCT02864498|589445341|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
163199617|NCT02864498|589445342|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
163199618|NCT02864498|589445343|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
163199619|NCT02864498|589445341|FG000|Overall Study|Investigator Discretion|0|||
163199620|NCT02864498|589445342|FG001|Overall Study|Investigator Discretion|2|||
163199621|NCT02864498|589445343|FG002|Overall Study|Investigator Discretion|1|||
163199622|NCT02864498|589445341|FG000|Overall Study|Lost to Follow-up|8|||
163199623|NCT02864498|589445342|FG001|Overall Study|Lost to Follow-up|6|||
163199624|NCT02864498|589445343|FG002|Overall Study|Lost to Follow-up|3|||
163199625|NCT02864498|589445341|FG000|Overall Study|Lack of Efficacy|5|||
163199626|NCT02864498|589445342|FG001|Overall Study|Lack of Efficacy|3|||
163199627|NCT02864498|589445343|FG002|Overall Study|Lack of Efficacy|3|||
163199628|NCT02864498|589445341|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
163199629|NCT02864498|589445342|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
163305880|NCT04623775|589827680|FG003|Treatment Period|participant no longer meets study criteria|0|||
163305881|NCT04623775|589827677|FG000|Treatment Period|administrative reasons by sponsor|3|||
163305882|NCT04623775|589827678|FG001|Treatment Period|administrative reasons by sponsor|2|||
163305883|NCT04623775|589827679|FG002|Treatment Period|administrative reasons by sponsor|0|||
163305884|NCT04623775|589827680|FG003|Treatment Period|administrative reasons by sponsor|0|||
163305885|NCT04623775|589827677|FG000|Treatment Period|other reasons|2|||
163305886|NCT04623775|589827678|FG001|Treatment Period|other reasons|0|||
163305887|NCT04623775|589827679|FG002|Treatment Period|other reasons|1|||
163305888|NCT04623775|589827680|FG003|Treatment Period|other reasons|1|||
163305889|NCT04623775|589827677|FG000|Treatment Period|disease progression|40|||
163305890|NCT04623775|589827678|FG001|Treatment Period|disease progression|35|||
163305891|NCT04623775|589827679|FG002|Treatment Period|disease progression|63|||
163305892|NCT04623775|589827680|FG003|Treatment Period|disease progression|63|||
163305893|NCT04623775|589827677|FG000|Treatment Period|study drug toxicity|12|||
163305894|NCT04623775|589827678|FG001|Treatment Period|study drug toxicity|15|||
163305895|NCT04623775|589827679|FG002|Treatment Period|study drug toxicity|13|||
163305896|NCT04623775|589827680|FG003|Treatment Period|study drug toxicity|12|||
163305897|NCT04623775|589827677|FG000|Treatment Period|AE unrelated to study drug|4|||
163305898|NCT04623775|589827678|FG001|Treatment Period|AE unrelated to study drug|9|||
163305899|NCT04623775|589827679|FG002|Treatment Period|AE unrelated to study drug|12|||
163305900|NCT04623775|589827680|FG003|Treatment Period|AE unrelated to study drug|9|||
163305901|NCT04623775|589827677|FG000|Treatment Period|participant request to discontinue treatment|0|||
163305902|NCT04623775|589827678|FG001|Treatment Period|participant request to discontinue treatment|2|||
163305903|NCT04623775|589827679|FG002|Treatment Period|participant request to discontinue treatment|2|||
163305904|NCT04623775|589827680|FG003|Treatment Period|participant request to discontinue treatment|0|||
163305905|NCT06024174|589827682|FG000|Overall Study|Other Reasons|1|||
163305906|NCT06024174|589827682|FG000|Overall Study|Study terminated by Sponsor|4|||
163305907|NCT02525692|589828923|FG000|Overall Study|Withdrawal by Subject|1|||
163305908|NCT02525692|589828924|FG001|Overall Study|Withdrawal by Subject|1|||
163305909|NCT02525692|589828925|FG002|Overall Study|Withdrawal by Subject|0|||
163305910|NCT02525692|589828926|FG003|Overall Study|Withdrawal by Subject|5|||
163305911|NCT02525692|589828927|FG004|Overall Study|Withdrawal by Subject|0|||
163305912|NCT02525692|589828928|FG005|Overall Study|Withdrawal by Subject|1|||
163305913|NCT02525692|589828923|FG000|Overall Study|Death|16|||
163305914|NCT02525692|589828924|FG001|Overall Study|Death|18|||
163305915|NCT02525692|589828925|FG002|Overall Study|Death|7|||
163305916|NCT02525692|589828926|FG003|Overall Study|Death|20|||
163305917|NCT02525692|589828927|FG004|Overall Study|Death|3|||
163305918|NCT02525692|589828928|FG005|Overall Study|Death|6|||
163305919|NCT02525692|589828923|FG000|Overall Study|Lost to Follow-up|0|||
163305920|NCT02525692|589828924|FG001|Overall Study|Lost to Follow-up|0|||
163305921|NCT02525692|589828925|FG002|Overall Study|Lost to Follow-up|1|||
163305922|NCT02525692|589828926|FG003|Overall Study|Lost to Follow-up|5|||
163305923|NCT02525692|589828927|FG004|Overall Study|Lost to Follow-up|0|||
163305924|NCT02525692|589828928|FG005|Overall Study|Lost to Follow-up|0|||
163305925|NCT02396199|589828929|FG000|Overall Study|Lost to Follow-up|1|||
163305926|NCT02396199|589828929|FG000|Overall Study|Death|4|||
163305927|NCT04112316|589828932|FG000|First Period (8 Weeks)|Protocol Violation|1|||
163305928|NCT04112316|589828933|FG001|First Period (8 Weeks)|Protocol Violation|0|||
163305929|NCT04112316|589828932|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
163305930|NCT04112316|589828933|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
163305931|NCT04247542|589828945|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
163305932|NCT04247542|589828946|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
163305933|NCT04247542|589828947|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
163305934|NCT04247542|589828945|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
163305935|NCT04247542|589828946|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
163305936|NCT04247542|589828947|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
163305937|NCT03438188|589828948|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
163305938|NCT03438188|589828949|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
163305939|NCT03438188|589828950|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
163305940|NCT03438188|589828948|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
163305941|NCT03438188|589828949|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
163305942|NCT03438188|589828950|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
163305943|NCT03438188|589828948|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
163305944|NCT03438188|589828949|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
163305945|NCT03438188|589828950|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
163305946|NCT03438188|589828948|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
163305947|NCT03438188|589828949|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
163305948|NCT03438188|589828950|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
163305949|NCT03438188|589828948|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
163305950|NCT03438188|589828949|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
163305951|NCT03438188|589828950|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
163305952|NCT06066541|589828951|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
163305953|NCT06066541|589828952|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
163305954|NCT06066541|589828953|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
163305955|NCT06066541|589828954|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
163305956|NCT06066541|589828955|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
163305957|NCT06066541|589828956|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
163305958|NCT06066541|589828957|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
163305959|NCT06066541|589828951|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
163305960|NCT06066541|589828952|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
163305961|NCT06066541|589828953|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
163305962|NCT06066541|589828954|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
163305963|NCT06066541|589828955|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
163305964|NCT06066541|589828956|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
163305965|NCT06066541|589828957|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
163305966|NCT04533022|589828958|FG000|Overall Study|Withdrawal by Subject|15|||
163305967|NCT04533022|589828958|FG000|Overall Study|Adverse Event|6|||
163305968|NCT04533022|589828958|FG000|Overall Study|Death|1|||
163305969|NCT04533022|589828958|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
163305970|NCT04533022|589828958|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
163305971|NCT03897686|589828959|FG000|Overall Study|Protocol Violation|1|||
163305972|NCT03897686|589828960|FG001|Overall Study|Protocol Violation|1|||
163305973|NCT03897686|589828959|FG000|Overall Study|Withdrawal by Subject|1|||
163305974|NCT03897686|589828960|FG001|Overall Study|Withdrawal by Subject|1|||
163305975|NCT05415436|589828961|FG000|Overall Study|Surgeon cancelled procedure|1|||
163305976|NCT05415436|589828962|FG001|Overall Study|Surgeon cancelled procedure|0|||
163305977|NCT05415436|589828961|FG000|Overall Study|Death|1|||
163305978|NCT05415436|589828962|FG001|Overall Study|Death|0|||
163305979|NCT05386355|589828973|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
163305980|NCT05386355|589828974|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
163199630|NCT02864498|589445343|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
163199631|NCT02864498|589445341|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
163199632|NCT02864498|589445342|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
163199633|NCT02864498|589445343|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
163199634|NCT02864498|589445341|FG000|Overall Study|Subject moved out of the country.|0|||
163199635|NCT02864498|589445342|FG001|Overall Study|Subject moved out of the country.|0|||
163199636|NCT02864498|589445343|FG002|Overall Study|Subject moved out of the country.|1|||
163199637|NCT00730132|589445346|FG000|Overall Study|Protocol Violation|154|||
163199638|NCT00730132|589445346|FG000|Overall Study|Death|1|||
163199639|NCT00370032|589445347|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
163199640|NCT00370032|589445348|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
163199641|NCT00370032|589445347|FG000|Washout Period|Withdrawal by Subject|0|||
163305981|NCT05386355|589828975|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
163305982|NCT05386355|589828976|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
163305983|NCT03157167|589828979|FG000|Overall Study|Withdrawal by Subject|1|||
163199642|NCT00370032|589445348|FG001|Washout Period|Withdrawal by Subject|1|||
163050808|NCT02155699|588893678|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
162963646|NCT00294047|588566545|FG000|Month 84|Visit missed|0|||
162963647|NCT00294047|588566546|FG001|Month 84|Visit missed|1|||
162963648|NCT00294047|588566545|FG000|Month 84|No consent for Month 84 Follow-up|731|||
162963649|NCT00294047|588566546|FG001|Month 84|No consent for Month 84 Follow-up|754|||
162963650|NCT00506831|588566547|FG000|Overall Study|Death|1|||
162963651|NCT00506831|588566547|FG000|Overall Study|Withdrawal by Subject|1|||
162963652|NCT00608322|588566553|FG000|Overall Study|Death|2|||
162963653|NCT00608322|588566554|FG001|Overall Study|Death|1|||
162963654|NCT04002648|588566555|FG000|Overall Study|Lost to Follow-up|2|||
162963655|NCT04002648|588566556|FG001|Overall Study|Lost to Follow-up|0|||
162963656|NCT02280863|588566567|FG000|Integrated Platform|Met stopping criteria|0|||
162963657|NCT02280863|588566568|FG001|Integrated Platform|Met stopping criteria|1|||
162963658|NCT03158727|588566571|FG000|Overall Study|Withdrawal by Subject|2|||
162963659|NCT03158727|588566572|FG001|Overall Study|Withdrawal by Subject|6|||
162963660|NCT03158727|588566571|FG000|Overall Study|Death|11|||
162963661|NCT03158727|588566572|FG001|Overall Study|Death|12|||
162963662|NCT03158727|588566571|FG000|Overall Study|Lost to Follow-up|1|||
162963663|NCT03158727|588566572|FG001|Overall Study|Lost to Follow-up|0|||
162963664|NCT03158727|588566571|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
162963665|NCT03158727|588566572|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
162963666|NCT03158727|588566571|FG000|Overall Study|Visit 11 not done by mistake|0|||
162963667|NCT03158727|588566572|FG001|Overall Study|Visit 11 not done by mistake|1|||
162963668|NCT03158727|588566571|FG000|Overall Study|Enrolled, not treated|1|||
162963669|NCT03158727|588566572|FG001|Overall Study|Enrolled, not treated|0|||
162963670|NCT00985439|588566573|FG000|Overall Study|Adverse Event|0|||
162963671|NCT00985439|588566574|FG001|Overall Study|Adverse Event|0|||
162963672|NCT00985439|588566575|FG002|Overall Study|Adverse Event|1|||
162963673|NCT00985439|588566576|FG003|Overall Study|Adverse Event|0|||
162963674|NCT01174186|588566577|FG000|Overall Study|Lost to Follow-up|0|||
163199643|NCT00370032|589445347|FG000|Washout Period|Lost to Follow-up|0|||
162963675|NCT01174186|588566578|FG001|Overall Study|Lost to Follow-up|1|||
162963676|NCT01174186|588566577|FG000|Overall Study|Withdrawal by Subject|0|||
162963677|NCT01174186|588566578|FG001|Overall Study|Withdrawal by Subject|2|||
162963678|NCT00918684|588566579|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
162963679|NCT00918684|588566579|FG000|Treatment Phase|Lack of Efficacy|6|||
162963680|NCT00918684|588566579|FG000|Treatment Phase|Lost to Follow-up|2|||
163199644|NCT00370032|589445348|FG001|Washout Period|Lost to Follow-up|1|||
163199645|NCT00370032|589445347|FG000|Washout Period|Adverse Event|1|||
163199646|NCT00370032|589445348|FG001|Washout Period|Adverse Event|0|||
163199647|NCT00370032|589445347|FG000|Follow-up Period|Withdrawal by Subject|1|||
163199648|NCT00370032|589445348|FG001|Follow-up Period|Withdrawal by Subject|0|||
163199649|NCT00801632|589445349|FG000|Overall Study|Re-transplant|1|||
163199650|NCT01203098|589445356|FG000|Overall Study|Adverse Event|3|||
163199651|NCT01203098|589445357|FG001|Overall Study|Adverse Event|1|||
163199652|NCT01203098|589445358|FG002|Overall Study|Adverse Event|7|||
163199653|NCT01203098|589445356|FG000|Overall Study|Lost to Follow-up|0|||
163199654|NCT01203098|589445357|FG001|Overall Study|Lost to Follow-up|0|||
163199655|NCT01203098|589445358|FG002|Overall Study|Lost to Follow-up|1|||
163199656|NCT01203098|589445356|FG000|Overall Study|Physician Decision|2|||
163199657|NCT01203098|589445357|FG001|Overall Study|Physician Decision|2|||
163199658|NCT01203098|589445358|FG002|Overall Study|Physician Decision|0|||
163199659|NCT01203098|589445356|FG000|Overall Study|Withdrawal by Subject|1|||
163199660|NCT01203098|589445357|FG001|Overall Study|Withdrawal by Subject|1|||
163305984|NCT03157167|589828980|FG001|Overall Study|Withdrawal by Subject|0|||
163305985|NCT03157167|589828981|FG002|Overall Study|Withdrawal by Subject|0|||
163305986|NCT03263026|589828984|FG000|Overall Study|Withdrawal by Subject|1|||
163305987|NCT03263026|589828985|FG001|Overall Study|Withdrawal by Subject|0|||
163305988|NCT03263026|589828984|FG000|Overall Study|Death|1|||
163305989|NCT03263026|589828985|FG001|Overall Study|Death|0|||
163305990|NCT03263026|589828984|FG000|Overall Study|Other/ Various|41|||
163305991|NCT03263026|589828985|FG001|Overall Study|Other/ Various|29|||
163305992|NCT03775109|589828986|FG000|Overall Study|Adverse Event|1|||
163305993|NCT03775109|589828987|FG001|Overall Study|Adverse Event|0|||
163305994|NCT03775109|589828986|FG000|Overall Study|COVID-19 outbreak|2|||
163305995|NCT03775109|589828987|FG001|Overall Study|COVID-19 outbreak|0|||
163305996|NCT03775109|589828986|FG000|Overall Study|Lost to Follow-up|0|||
163305997|NCT03775109|589828987|FG001|Overall Study|Lost to Follow-up|2|||
163305998|NCT03775109|589828986|FG000|Overall Study|Withdrawal by Subject|1|||
163305999|NCT03775109|589828987|FG001|Overall Study|Withdrawal by Subject|1|||
163306000|NCT03775109|589828986|FG000|Overall Study|Death|0|||
163306001|NCT03775109|589828987|FG001|Overall Study|Death|1|||
163306002|NCT03775109|589828986|FG000|Overall Study|Lack of Efficacy|1|||
163306003|NCT03775109|589828987|FG001|Overall Study|Lack of Efficacy|0|||
163306004|NCT05691452|589828988|FG000|Overall Study|Withdrawal by Subject|1|||
163306005|NCT05691452|589828989|FG001|Overall Study|Withdrawal by Subject|1|||
163306006|NCT05691452|589828990|FG002|Overall Study|Withdrawal by Subject|0|||
163306007|NCT05691452|589828988|FG000|Overall Study|Physician Decision|1|||
163306008|NCT05691452|589828989|FG001|Overall Study|Physician Decision|0|||
163306009|NCT05691452|589828990|FG002|Overall Study|Physician Decision|0|||
163306010|NCT05691452|589828988|FG000|Overall Study|Lost to Follow-up|0|||
163306011|NCT05691452|589828989|FG001|Overall Study|Lost to Follow-up|0|||
163306012|NCT05691452|589828990|FG002|Overall Study|Lost to Follow-up|1|||
163306013|NCT05691452|589828988|FG000|Overall Study|Adverse Event|0|||
163306014|NCT05691452|589828989|FG001|Overall Study|Adverse Event|0|||
163306015|NCT05691452|589828990|FG002|Overall Study|Adverse Event|1|||
163050809|NCT02155699|588893679|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
163050810|NCT02155699|588893680|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
163050811|NCT02155699|588893681|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
163306016|NCT01938547|589828993|FG000|Overall Study|Physician Decision|1|||
163306017|NCT05320432|589828998|FG000|Overall Study|Withdrawal by Subject|0|||
163306018|NCT05320432|589828999|FG001|Overall Study|Withdrawal by Subject|2|||
163306019|NCT01894061|589829003|FG000|Overall Study|Screen failure|1|||
163306020|NCT01894061|589829003|FG000|Overall Study|Withdrawal by Subject|1|||
163306021|NCT04638998|589829007|FG000|Overall Study|Withdrawal by Subject|1|||
163306022|NCT04638998|589829008|FG001|Overall Study|Withdrawal by Subject|3|||
163306023|NCT03713086|589829009|FG000|Overall Study|Withdrawal by Subject|0|||
163306024|NCT03713086|589829010|FG001|Overall Study|Withdrawal by Subject|2|||
163306025|NCT03713086|589829011|FG002|Overall Study|Withdrawal by Subject|1|||
163306026|NCT03713086|589829012|FG003|Overall Study|Withdrawal by Subject|0|||
163306027|NCT03713086|589829009|FG000|Overall Study|Lost to Follow-up|0|||
163306028|NCT03713086|589829010|FG001|Overall Study|Lost to Follow-up|1|||
163306029|NCT03713086|589829011|FG002|Overall Study|Lost to Follow-up|0|||
163306030|NCT03713086|589829012|FG003|Overall Study|Lost to Follow-up|1|||
163306031|NCT05374837|589829014|FG000|Overall Study|Lost to Follow-up|17|||
163306032|NCT05374837|589829015|FG001|Overall Study|Lost to Follow-up|18|||
163306033|NCT05406921|589829018|FG000|Overall Study|Withdrawal by Subject|25|||
163306034|NCT05406921|589829019|FG001|Overall Study|Withdrawal by Subject|0|||
163306035|NCT05406921|589829020|FG002|Overall Study|Withdrawal by Subject|25|||
163306036|NCT05406921|589829018|FG000|Overall Study|Protocol Violation|0|||
163306037|NCT05406921|589829019|FG001|Overall Study|Protocol Violation|12|||
163306038|NCT05406921|589829020|FG002|Overall Study|Protocol Violation|0|||
163306039|NCT04831281|589829023|FG000|Overall Study|Adverse Event|1|||
163306040|NCT04831281|589829024|FG001|Overall Study|Adverse Event|0|||
163306041|NCT04831281|589829025|FG002|Overall Study|Adverse Event|3|||
163306042|NCT04831281|589829023|FG000|Overall Study|Withdrawal by Subject|0|||
163306043|NCT04831281|589829024|FG001|Overall Study|Withdrawal by Subject|1|||
163306044|NCT04831281|589829025|FG002|Overall Study|Withdrawal by Subject|2|||
163396907|NCT00914927|590164330|FG005|Overall Study|Administrative/Other|0|||
163306045|NCT04831281|589829023|FG000|Overall Study|Undetermined|1|||
163306046|NCT04831281|589829024|FG001|Overall Study|Undetermined|1|||
163306047|NCT04831281|589829025|FG002|Overall Study|Undetermined|0|||
163306048|NCT02249949|589829026|FG000|Overall Study|Cancelled prior to treatment|2|||
163306049|NCT02097420|589829029|FG000|Overall Study|Death|6|||
163306050|NCT02097420|589829029|FG000|Overall Study|Valve explanted|13|||
163306051|NCT02097420|589829029|FG000|Overall Study|Other Reason|1|||
163306052|NCT05691309|589829046|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
163306053|NCT05691309|589829046|FG000|Overall Study|vancomycin levels not evaluable|2|||
163306054|NCT01707030|589829047|FG000|Overall Study|Death|1|||
163306055|NCT01707030|589829048|FG001|Overall Study|Death|1|||
163306056|NCT01707030|589829047|FG000|Overall Study|Withdrawal by Subject|2|||
163396908|NCT00914927|590164331|FG006|Overall Study|Administrative/Other|0|||
163306057|NCT01707030|589829048|FG001|Overall Study|Withdrawal by Subject|3|||
163306058|NCT01707030|589829047|FG000|Overall Study|Lost to Follow-up|8|||
163306059|NCT01707030|589829048|FG001|Overall Study|Lost to Follow-up|13|||
163306060|NCT04263311|589829050|FG000|Overall Study|Lost to Follow-up|1|||
163306061|NCT04263311|589829051|FG001|Overall Study|Lost to Follow-up|2|||
163306062|NCT04263311|589829052|FG002|Overall Study|Lost to Follow-up|0|||
163306063|NCT04263311|589829050|FG000|Overall Study|Health Issues|1|||
163306064|NCT04263311|589829051|FG001|Overall Study|Health Issues|0|||
163306065|NCT04263311|589829052|FG002|Overall Study|Health Issues|0|||
163306066|NCT04263311|589829050|FG000|Overall Study|Left the country|1|||
163306067|NCT04263311|589829051|FG001|Overall Study|Left the country|0|||
163306068|NCT04263311|589829052|FG002|Overall Study|Left the country|0|||
163306069|NCT04263311|589829050|FG000|Overall Study|Unable to maintain time commitment|1|||
163306070|NCT04263311|589829051|FG001|Overall Study|Unable to maintain time commitment|0|||
163306071|NCT04263311|589829052|FG002|Overall Study|Unable to maintain time commitment|0|||
163306072|NCT04263311|589829050|FG000|Overall Study|No longer interested|1|||
163306073|NCT04263311|589829051|FG001|Overall Study|No longer interested|0|||
163306074|NCT04263311|589829052|FG002|Overall Study|No longer interested|0|||
163306075|NCT04263311|589829050|FG000|Overall Study|Ineligible post consent|0|||
163306076|NCT04263311|589829051|FG001|Overall Study|Ineligible post consent|0|||
163306077|NCT04263311|589829052|FG002|Overall Study|Ineligible post consent|5|||
163306078|NCT03580369|589829053|FG000|Overall Study|No treatment due to mis-randomization|1|||
163306079|NCT03580369|589829054|FG001|Overall Study|No treatment due to mis-randomization|0|||
163306080|NCT03580369|589829055|FG002|Overall Study|No treatment due to mis-randomization|0|||
163306081|NCT03580369|589829056|FG003|Overall Study|No treatment due to mis-randomization|0|||
163306082|NCT03580369|589829057|FG004|Overall Study|No treatment due to mis-randomization|3|||
163306083|NCT03580369|589829058|FG005|Overall Study|No treatment due to mis-randomization|0|||
163306084|NCT03580369|589829059|FG006|Overall Study|No treatment due to mis-randomization|0|||
163306085|NCT03580369|589829060|FG007|Overall Study|No treatment due to mis-randomization|0|||
163306086|NCT03580369|589829053|FG000|Overall Study|Reason unknown|0|||
163306087|NCT03580369|589829054|FG001|Overall Study|Reason unknown|0|||
163306088|NCT03580369|589829055|FG002|Overall Study|Reason unknown|1|||
163306089|NCT03580369|589829056|FG003|Overall Study|Reason unknown|0|||
163306090|NCT03580369|589829057|FG004|Overall Study|Reason unknown|0|||
163306091|NCT03580369|589829058|FG005|Overall Study|Reason unknown|0|||
163306092|NCT03580369|589829059|FG006|Overall Study|Reason unknown|0|||
163306093|NCT03580369|589829060|FG007|Overall Study|Reason unknown|0|||
163050812|NCT05547386|588893682|FG000|Overall Study|Withdrawal by Subject|7|||
163050813|NCT02573259|588893691|FG000|Overall Study|Death|1|||
163050814|NCT02573259|588893692|FG001|Overall Study|Death|6|||
163050815|NCT02573259|588893693|FG002|Overall Study|Death|5|||
163050816|NCT02573259|588893694|FG003|Overall Study|Death|6|||
163050817|NCT02573259|588893695|FG004|Overall Study|Death|9|||
163050818|NCT02573259|588893696|FG005|Overall Study|Death|32|||
163050819|NCT02573259|588893697|FG006|Overall Study|Death|21|||
163050820|NCT02573259|588893691|FG000|Overall Study|Lost to Follow-up|0|||
163050821|NCT02573259|588893692|FG001|Overall Study|Lost to Follow-up|0|||
163050822|NCT02573259|588893693|FG002|Overall Study|Lost to Follow-up|0|||
163396909|NCT04784897|590164332|FG000|Overall Study|Death|4|||
163396910|NCT04784897|590164333|FG001|Overall Study|Death|2|||
163396911|NCT04784897|590164334|FG002|Overall Study|Death|1|||
163396912|NCT04784897|590164332|FG000|Overall Study|Withdrawal by Subject|0|||
163050823|NCT02573259|588893694|FG003|Overall Study|Lost to Follow-up|0|||
163050824|NCT02573259|588893695|FG004|Overall Study|Lost to Follow-up|0|||
163050825|NCT02573259|588893696|FG005|Overall Study|Lost to Follow-up|2|||
163050826|NCT02573259|588893697|FG006|Overall Study|Lost to Follow-up|1|||
163050827|NCT02573259|588893691|FG000|Overall Study|Participant refused further follow-up|0|||
163199661|NCT01203098|589445358|FG002|Overall Study|Withdrawal by Subject|3|||
163199662|NCT03851705|589445366|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
163199663|NCT03851705|589445367|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
163199664|NCT03851705|589445368|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
163199665|NCT03851705|589445369|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
163199666|NCT03851705|589445366|FG000|Part 1: Double-Blind Period|Other reason|1|||
163199667|NCT03851705|589445367|FG001|Part 1: Double-Blind Period|Other reason|0|||
163199668|NCT03851705|589445368|FG002|Part 1: Double-Blind Period|Other reason|0|||
163199669|NCT03851705|589445369|FG003|Part 1: Double-Blind Period|Other reason|0|||
163199670|NCT03851705|589445366|FG000|Part 2: Open-Label Period|Other reason|0|||
163199671|NCT03851705|589445367|FG001|Part 2: Open-Label Period|Other reason|0|||
163199672|NCT03851705|589445368|FG002|Part 2: Open-Label Period|Other reason|0|||
163199673|NCT03851705|589445369|FG003|Part 2: Open-Label Period|Other reason|1|||
163199674|NCT03851705|589445366|FG000|Part 2: Open-Label Period|Death|0|||
163199675|NCT03851705|589445367|FG001|Part 2: Open-Label Period|Death|0|||
163199676|NCT03851705|589445368|FG002|Part 2: Open-Label Period|Death|3|||
163199677|NCT03851705|589445369|FG003|Part 2: Open-Label Period|Death|0|||
163199678|NCT03851705|589445366|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
163199679|NCT03851705|589445367|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
163199680|NCT03851705|589445368|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
163199681|NCT03851705|589445369|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
163199682|NCT03095612|589445370|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
163199683|NCT03095612|589445371|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
163199684|NCT03095612|589445372|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
163199685|NCT03095612|589445373|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
163199686|NCT03095612|589445374|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
163199687|NCT03095612|589445375|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
163199688|NCT03095612|589445376|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
163199689|NCT00621582|589445377|FG000|Overall Study|Adverse Event|7|||
163199690|NCT00621582|589445377|FG000|Overall Study|Protocol Violation|57|||
163199691|NCT00621582|589445377|FG000|Overall Study|Lost to Follow-up|24|||
163199692|NCT00621582|589445377|FG000|Overall Study|issues not identified by investigators|18|||
163199693|NCT01042678|589445378|FG000|Overall Study|Physician Decision|1|||
163199694|NCT01042678|589445379|FG001|Overall Study|Physician Decision|0|||
163199695|NCT01042678|589445380|FG002|Overall Study|Physician Decision|0|||
163199696|NCT01042678|589445381|FG003|Overall Study|Physician Decision|0|||
163199697|NCT01042678|589445382|FG004|Overall Study|Physician Decision|0|||
163199698|NCT01042678|589445383|FG005|Overall Study|Physician Decision|0|||
163199699|NCT03617185|589445384|FG000|Baseline|Lost to Follow-up|0|||
163199700|NCT03617185|589445385|FG001|Baseline|Lost to Follow-up|2|||
163199701|NCT03617185|589445386|FG002|Baseline|Lost to Follow-up|1|||
163199702|NCT03617185|589445387|FG003|Baseline|Lost to Follow-up|1|||
163199703|NCT03617185|589445384|FG000|Baseline|Withdrawal by Subject|0|||
163199704|NCT03617185|589445385|FG001|Baseline|Withdrawal by Subject|1|||
163199705|NCT03617185|589445386|FG002|Baseline|Withdrawal by Subject|0|||
163199706|NCT03617185|589445387|FG003|Baseline|Withdrawal by Subject|1|||
163199707|NCT03617185|589445384|FG000|Baseline|Driving Distance/Travel|0|||
163199708|NCT03617185|589445385|FG001|Baseline|Driving Distance/Travel|0|||
163199709|NCT03617185|589445386|FG002|Baseline|Driving Distance/Travel|2|||
163199710|NCT03617185|589445387|FG003|Baseline|Driving Distance/Travel|0|||
163050828|NCT02573259|588893692|FG001|Overall Study|Participant refused further follow-up|2|||
163050829|NCT02573259|588893693|FG002|Overall Study|Participant refused further follow-up|1|||
163050830|NCT02573259|588893694|FG003|Overall Study|Participant refused further follow-up|0|||
163199711|NCT03617185|589445384|FG000|Baseline|Family Obligations|0|||
163396913|NCT04784897|590164333|FG001|Overall Study|Withdrawal by Subject|0|||
163306094|NCT03580369|589829053|FG000|Overall Study|Technical problems|0|||
163306095|NCT03580369|589829054|FG001|Overall Study|Technical problems|0|||
163306096|NCT03580369|589829055|FG002|Overall Study|Technical problems|0|||
163306097|NCT03580369|589829056|FG003|Overall Study|Technical problems|0|||
163306098|NCT03580369|589829057|FG004|Overall Study|Technical problems|1|||
163306099|NCT03580369|589829058|FG005|Overall Study|Technical problems|0|||
163306100|NCT03580369|589829059|FG006|Overall Study|Technical problems|2|||
163306101|NCT03580369|589829060|FG007|Overall Study|Technical problems|0|||
163306102|NCT03580369|589829053|FG000|Overall Study|Pregnancy|2|||
163306103|NCT03580369|589829054|FG001|Overall Study|Pregnancy|0|||
163306104|NCT03580369|589829055|FG002|Overall Study|Pregnancy|3|||
163306105|NCT03580369|589829056|FG003|Overall Study|Pregnancy|0|||
163306106|NCT03580369|589829057|FG004|Overall Study|Pregnancy|2|||
163306107|NCT03580369|589829058|FG005|Overall Study|Pregnancy|0|||
163306108|NCT03580369|589829059|FG006|Overall Study|Pregnancy|0|||
163306109|NCT03580369|589829060|FG007|Overall Study|Pregnancy|0|||
163306110|NCT03580369|589829053|FG000|Overall Study|Lost to Follow-up|2|||
163306111|NCT03580369|589829054|FG001|Overall Study|Lost to Follow-up|0|||
163306112|NCT03580369|589829055|FG002|Overall Study|Lost to Follow-up|2|||
163306113|NCT03580369|589829056|FG003|Overall Study|Lost to Follow-up|0|||
163306114|NCT03580369|589829057|FG004|Overall Study|Lost to Follow-up|3|||
163306115|NCT03580369|589829058|FG005|Overall Study|Lost to Follow-up|0|||
163306116|NCT03580369|589829059|FG006|Overall Study|Lost to Follow-up|1|||
163306117|NCT03580369|589829060|FG007|Overall Study|Lost to Follow-up|0|||
163306118|NCT03580369|589829053|FG000|Overall Study|Physician Decision|4|||
163306119|NCT03580369|589829054|FG001|Overall Study|Physician Decision|0|||
163306120|NCT03580369|589829055|FG002|Overall Study|Physician Decision|4|||
163306121|NCT03580369|589829056|FG003|Overall Study|Physician Decision|1|||
163306122|NCT03580369|589829057|FG004|Overall Study|Physician Decision|1|||
163306123|NCT03580369|589829058|FG005|Overall Study|Physician Decision|0|||
163306124|NCT03580369|589829059|FG006|Overall Study|Physician Decision|0|||
163306125|NCT03580369|589829060|FG007|Overall Study|Physician Decision|0|||
163306126|NCT03580369|589829053|FG000|Overall Study|Lack of Efficacy|3|||
163306127|NCT03580369|589829054|FG001|Overall Study|Lack of Efficacy|0|||
163306128|NCT03580369|589829055|FG002|Overall Study|Lack of Efficacy|7|||
163306129|NCT03580369|589829056|FG003|Overall Study|Lack of Efficacy|0|||
163306130|NCT03580369|589829057|FG004|Overall Study|Lack of Efficacy|2|||
163306131|NCT03580369|589829058|FG005|Overall Study|Lack of Efficacy|0|||
163306132|NCT03580369|589829059|FG006|Overall Study|Lack of Efficacy|3|||
163306133|NCT03580369|589829060|FG007|Overall Study|Lack of Efficacy|0|||
163306134|NCT03580369|589829053|FG000|Overall Study|Protocol Violation|6|||
163306135|NCT03580369|589829054|FG001|Overall Study|Protocol Violation|0|||
163306136|NCT03580369|589829055|FG002|Overall Study|Protocol Violation|6|||
163306137|NCT03580369|589829056|FG003|Overall Study|Protocol Violation|1|||
163306138|NCT03580369|589829057|FG004|Overall Study|Protocol Violation|8|||
163306139|NCT03580369|589829058|FG005|Overall Study|Protocol Violation|2|||
163306140|NCT03580369|589829059|FG006|Overall Study|Protocol Violation|1|||
163306141|NCT03580369|589829060|FG007|Overall Study|Protocol Violation|0|||
163306142|NCT03580369|589829053|FG000|Overall Study|Adverse Event|7|||
163306143|NCT03580369|589829054|FG001|Overall Study|Adverse Event|0|||
163306144|NCT03580369|589829055|FG002|Overall Study|Adverse Event|14|||
163306145|NCT03580369|589829056|FG003|Overall Study|Adverse Event|1|||
163306146|NCT03580369|589829057|FG004|Overall Study|Adverse Event|6|||
163306147|NCT03580369|589829058|FG005|Overall Study|Adverse Event|0|||
163306148|NCT03580369|589829059|FG006|Overall Study|Adverse Event|1|||
163306149|NCT03580369|589829060|FG007|Overall Study|Adverse Event|0|||
163050831|NCT02573259|588893695|FG004|Overall Study|Participant refused further follow-up|3|||
163306150|NCT03580369|589829053|FG000|Overall Study|Withdrawal by Subject|19|||
163306151|NCT03580369|589829054|FG001|Overall Study|Withdrawal by Subject|0|||
163306152|NCT03580369|589829055|FG002|Overall Study|Withdrawal by Subject|17|||
163306153|NCT03580369|589829056|FG003|Overall Study|Withdrawal by Subject|0|||
163306154|NCT03580369|589829057|FG004|Overall Study|Withdrawal by Subject|16|||
163306155|NCT03580369|589829058|FG005|Overall Study|Withdrawal by Subject|1|||
163306156|NCT03580369|589829059|FG006|Overall Study|Withdrawal by Subject|7|||
163306157|NCT03580369|589829060|FG007|Overall Study|Withdrawal by Subject|0|||
163306158|NCT03819686|589830489|FG000|Overall Study|Lost to Follow-up|2|||
163306159|NCT03819686|589830490|FG001|Overall Study|Lost to Follow-up|3|||
163306160|NCT06143670|589830491|FG000|Overall Study|Lost to Follow-up|0|||
163306161|NCT06143670|589830492|FG001|Overall Study|Lost to Follow-up|1|||
163306162|NCT06143670|589830491|FG000|Overall Study|Withdrawal by Subject|3|||
163306163|NCT06143670|589830492|FG001|Overall Study|Withdrawal by Subject|0|||
163306164|NCT03625882|589830495|FG000|Overall Study|Protocol Violation|3|||
163306165|NCT05058391|589830496|FG000|Overall Study|Adverse Event|1|||
163306166|NCT03833245|589830501|FG000|Overall Study|Death|0|||
163306167|NCT03833245|589830502|FG001|Overall Study|Death|1|||
163306168|NCT03347383|589830503|FG000|Overall Study|Death|39|||
163306169|NCT03347383|589830503|FG000|Overall Study|Withdrawal by Subject|3|||
163306170|NCT03347383|589830503|FG000|Overall Study|Lost to Follow-up|9|||
163306171|NCT04842643|589830505|FG000|Overall Study|Physician Decision|1|||
163306172|NCT04842643|589830505|FG000|Overall Study|Other|1|||
163306173|NCT03484702|589830506|FG000|Treatment Period|Death|3|||
163306174|NCT03484702|589830507|FG001|Treatment Period|Death|1|||
163306175|NCT03484702|589830508|FG002|Treatment Period|Death|0|||
163306176|NCT03484702|589830509|FG003|Treatment Period|Death|0|||
163306177|NCT03484702|589830510|FG004|Treatment Period|Death|0|||
163306178|NCT03484702|589830511|FG005|Treatment Period|Death|0|||
163306179|NCT03484702|589830506|FG000|Treatment Period|Adverse Event|1|||
163306180|NCT03484702|589830507|FG001|Treatment Period|Adverse Event|0|||
163306181|NCT03484702|589830508|FG002|Treatment Period|Adverse Event|0|||
163306182|NCT03484702|589830509|FG003|Treatment Period|Adverse Event|0|||
163306183|NCT03484702|589830510|FG004|Treatment Period|Adverse Event|0|||
163306184|NCT03484702|589830511|FG005|Treatment Period|Adverse Event|0|||
163306185|NCT03484702|589830506|FG000|Treatment Period|Participant Withdrew from Study|0|||
163306186|NCT03484702|589830507|FG001|Treatment Period|Participant Withdrew from Study|1|||
163306187|NCT03484702|589830508|FG002|Treatment Period|Participant Withdrew from Study|0|||
163306188|NCT03484702|589830509|FG003|Treatment Period|Participant Withdrew from Study|0|||
163306189|NCT03484702|589830510|FG004|Treatment Period|Participant Withdrew from Study|0|||
163306190|NCT03484702|589830511|FG005|Treatment Period|Participant Withdrew from Study|0|||
163306191|NCT03484702|589830506|FG000|Treatment Period|Physician Decision|0|||
163306192|NCT03484702|589830507|FG001|Treatment Period|Physician Decision|1|||
163306193|NCT03484702|589830508|FG002|Treatment Period|Physician Decision|0|||
163306194|NCT03484702|589830509|FG003|Treatment Period|Physician Decision|0|||
163306195|NCT03484702|589830510|FG004|Treatment Period|Physician Decision|0|||
163306196|NCT03484702|589830511|FG005|Treatment Period|Physician Decision|1|||
163306197|NCT02840474|589830512|FG000|Overall Study|Lost to Follow-up|1|||
163306198|NCT02840474|589830513|FG001|Overall Study|Lost to Follow-up|0|||
163306199|NCT05059262|589830517|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
163306200|NCT05059262|589830518|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
163306201|NCT05059262|589830517|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
163306202|NCT05059262|589830518|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
163306203|NCT05059262|589830517|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
163306204|NCT05059262|589830518|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
163306205|NCT05059262|589830517|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
163306206|NCT05059262|589830518|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
163306207|NCT05059262|589830517|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
163306208|NCT05059262|589830518|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
163306209|NCT05059262|589830517|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
163306210|NCT05059262|589830518|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
163306211|NCT05059262|589830517|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
163306212|NCT05059262|589830518|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
163306213|NCT05059262|589830517|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
163306214|NCT05059262|589830518|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
163306215|NCT05059262|589830517|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
163306216|NCT05059262|589830518|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
163306217|NCT02312960|589830519|FG000|Overall Study|Death|24|||
163306218|NCT02312960|589830520|FG001|Overall Study|Death|32|||
163306219|NCT02312960|589830521|FG002|Overall Study|Death|25|||
163306220|NCT02312960|589830522|FG003|Overall Study|Death|11|||
163306221|NCT02312960|589830523|FG004|Overall Study|Death|5|||
163306222|NCT02312960|589830524|FG005|Overall Study|Death|5|||
162963681|NCT00918684|588566579|FG000|Treatment Phase|Physician Decision|8|||
162963682|NCT00918684|588566579|FG000|Treatment Phase|Protocol Violation|1|||
162963683|NCT00918684|588566579|FG000|Treatment Phase|Withdrawal by Subject|8|||
162963684|NCT00402103|588566580|FG000|Overall Study|Adverse Event|60|||
162963685|NCT00402103|588566581|FG001|Overall Study|Adverse Event|7|||
162963686|NCT00402103|588566580|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162963687|NCT00402103|588566581|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163306223|NCT02312960|589830525|FG006|Overall Study|Death|8|||
163306224|NCT02312960|589830526|FG007|Overall Study|Death|5|||
163306225|NCT02312960|589830527|FG008|Overall Study|Death|7|||
163306226|NCT02312960|589830528|FG009|Overall Study|Death|3|||
163306227|NCT02312960|589830529|FG010|Overall Study|Death|3|||
163050832|NCT02573259|588893696|FG005|Overall Study|Participant refused further follow-up|20|||
163050833|NCT02573259|588893697|FG006|Overall Study|Participant refused further follow-up|7|||
163306228|NCT02312960|589830530|FG011|Overall Study|Death|1|||
163306229|NCT02312960|589830531|FG012|Overall Study|Death|25|||
163306230|NCT02312960|589830532|FG013|Overall Study|Death|19|||
163306231|NCT02312960|589830519|FG000|Overall Study|Missing|0|||
163306232|NCT02312960|589830520|FG001|Overall Study|Missing|0|||
163306233|NCT02312960|589830521|FG002|Overall Study|Missing|2|||
162963688|NCT00402103|588566580|FG000|Overall Study|Condition no longer requires study drug|2|||
163306234|NCT02312960|589830522|FG003|Overall Study|Missing|0|||
163306235|NCT02312960|589830523|FG004|Overall Study|Missing|0|||
163306236|NCT02312960|589830524|FG005|Overall Study|Missing|0|||
163306237|NCT02312960|589830525|FG006|Overall Study|Missing|0|||
163306238|NCT02312960|589830526|FG007|Overall Study|Missing|0|||
163306239|NCT02312960|589830527|FG008|Overall Study|Missing|0|||
163306240|NCT02312960|589830528|FG009|Overall Study|Missing|0|||
163306241|NCT02312960|589830529|FG010|Overall Study|Missing|0|||
163306242|NCT02312960|589830530|FG011|Overall Study|Missing|0|||
163306243|NCT02312960|589830531|FG012|Overall Study|Missing|0|||
163306244|NCT02312960|589830532|FG013|Overall Study|Missing|0|||
163306245|NCT02312960|589830519|FG000|Overall Study|Lost to Follow-up|0|||
163306246|NCT02312960|589830520|FG001|Overall Study|Lost to Follow-up|0|||
163306247|NCT02312960|589830521|FG002|Overall Study|Lost to Follow-up|1|||
163306248|NCT02312960|589830522|FG003|Overall Study|Lost to Follow-up|0|||
163306249|NCT02312960|589830523|FG004|Overall Study|Lost to Follow-up|0|||
163306250|NCT02312960|589830524|FG005|Overall Study|Lost to Follow-up|0|||
163306251|NCT02312960|589830525|FG006|Overall Study|Lost to Follow-up|1|||
163306252|NCT02312960|589830526|FG007|Overall Study|Lost to Follow-up|1|||
163306253|NCT02312960|589830527|FG008|Overall Study|Lost to Follow-up|0|||
163306254|NCT02312960|589830528|FG009|Overall Study|Lost to Follow-up|1|||
163306255|NCT02312960|589830529|FG010|Overall Study|Lost to Follow-up|0|||
163306256|NCT02312960|589830530|FG011|Overall Study|Lost to Follow-up|0|||
163306257|NCT02312960|589830531|FG012|Overall Study|Lost to Follow-up|1|||
163306258|NCT02312960|589830532|FG013|Overall Study|Lost to Follow-up|0|||
163306259|NCT02312960|589830519|FG000|Overall Study|Withdrawal by Subject|1|||
163306260|NCT02312960|589830520|FG001|Overall Study|Withdrawal by Subject|2|||
163306261|NCT02312960|589830521|FG002|Overall Study|Withdrawal by Subject|0|||
163306262|NCT02312960|589830522|FG003|Overall Study|Withdrawal by Subject|0|||
163306263|NCT02312960|589830523|FG004|Overall Study|Withdrawal by Subject|1|||
163306264|NCT02312960|589830524|FG005|Overall Study|Withdrawal by Subject|0|||
163306265|NCT02312960|589830525|FG006|Overall Study|Withdrawal by Subject|1|||
163306266|NCT02312960|589830526|FG007|Overall Study|Withdrawal by Subject|2|||
163306267|NCT02312960|589830527|FG008|Overall Study|Withdrawal by Subject|2|||
163306268|NCT02312960|589830528|FG009|Overall Study|Withdrawal by Subject|3|||
163306269|NCT02312960|589830529|FG010|Overall Study|Withdrawal by Subject|0|||
163306270|NCT02312960|589830530|FG011|Overall Study|Withdrawal by Subject|0|||
163306271|NCT02312960|589830531|FG012|Overall Study|Withdrawal by Subject|2|||
163306272|NCT02312960|589830532|FG013|Overall Study|Withdrawal by Subject|0|||
163306273|NCT03131648|589830533|FG000|Initial Treatment Period|Not dosed|2|||
163306274|NCT03131648|589830534|FG001|Initial Treatment Period|Not dosed|2|||
163306275|NCT03131648|589830535|FG002|Initial Treatment Period|Not dosed|0|||
163306276|NCT03131648|589830536|FG003|Initial Treatment Period|Not dosed|0|||
163306277|NCT03131648|589830537|FG004|Initial Treatment Period|Not dosed|0|||
163306278|NCT03131648|589830538|FG005|Initial Treatment Period|Not dosed|0|||
163306279|NCT03131648|589830539|FG006|Initial Treatment Period|Not dosed|0|||
163306280|NCT03131648|589830540|FG007|Initial Treatment Period|Not dosed|0|||
163306281|NCT03131648|589830533|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
163306282|NCT03131648|589830534|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
163306283|NCT03131648|589830535|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163306284|NCT03131648|589830536|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163306285|NCT03131648|589830537|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163306286|NCT03131648|589830538|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163306287|NCT03131648|589830539|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163306288|NCT03131648|589830540|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163396914|NCT04784897|590164334|FG002|Overall Study|Withdrawal by Subject|1|||
163396915|NCT01490814|590164337|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
162963689|NCT00402103|588566581|FG001|Overall Study|Condition no longer requires study drug|0|||
162963690|NCT00402103|588566580|FG000|Overall Study|Protocol Deviation|8|||
162963691|NCT00402103|588566581|FG001|Overall Study|Protocol Deviation|0|||
162963692|NCT00402103|588566580|FG000|Overall Study|Patient withdrew consent|12|||
162963693|NCT00402103|588566581|FG001|Overall Study|Patient withdrew consent|1|||
162963694|NCT00402103|588566580|FG000|Overall Study|Lost to Follow-up|6|||
162963695|NCT00402103|588566581|FG001|Overall Study|Lost to Follow-up|3|||
162963696|NCT00402103|588566580|FG000|Overall Study|Administrative problems|2|||
163050834|NCT02573259|588893691|FG000|Overall Study|Other|0|||
163050835|NCT02573259|588893692|FG001|Overall Study|Other|0|||
163306289|NCT03131648|589830533|FG000|Open-label Treatment|Discontinued IMP|0|||
163306290|NCT03131648|589830534|FG001|Open-label Treatment|Discontinued IMP|0|||
163306291|NCT03131648|589830535|FG002|Open-label Treatment|Discontinued IMP|0|||
163306292|NCT03131648|589830536|FG003|Open-label Treatment|Discontinued IMP|0|||
163306293|NCT03131648|589830537|FG004|Open-label Treatment|Discontinued IMP|0|||
163306294|NCT03131648|589830538|FG005|Open-label Treatment|Discontinued IMP|0|||
163306295|NCT03131648|589830539|FG006|Open-label Treatment|Discontinued IMP|112|||
163306296|NCT03131648|589830540|FG007|Open-label Treatment|Discontinued IMP|0|||
163306297|NCT03131648|589830533|FG000|Open-label Treatment|Completed Week 50|0|||
163306298|NCT03131648|589830534|FG001|Open-label Treatment|Completed Week 50|0|||
163306299|NCT03131648|589830535|FG002|Open-label Treatment|Completed Week 50|0|||
163306300|NCT03131648|589830536|FG003|Open-label Treatment|Completed Week 50|0|||
163306301|NCT03131648|589830537|FG004|Open-label Treatment|Completed Week 50|0|||
163306302|NCT03131648|589830538|FG005|Open-label Treatment|Completed Week 50|0|||
163306303|NCT03131648|589830539|FG006|Open-label Treatment|Completed Week 50|6|||
163306304|NCT03131648|589830540|FG007|Open-label Treatment|Completed Week 50|0|||
163306305|NCT03131648|589830533|FG000|Maintenance Treatment Period|Not dosed|0|||
163306306|NCT03131648|589830534|FG001|Maintenance Treatment Period|Not dosed|0|||
163306307|NCT03131648|589830535|FG002|Maintenance Treatment Period|Not dosed|3|||
163306308|NCT03131648|589830536|FG003|Maintenance Treatment Period|Not dosed|2|||
163306309|NCT03131648|589830537|FG004|Maintenance Treatment Period|Not dosed|1|||
162963697|NCT00402103|588566581|FG001|Overall Study|Administrative problems|0|||
162963698|NCT00484679|588566582|FG000|Overall Study|Withdrawal by Subject|3|||
162963699|NCT00418145|588566585|FG000|Overall Study|study terminated|6|||
162963700|NCT00472212|588566586|FG000|Overall Study|Lost to Follow-up|6|||
162963701|NCT00472212|588566587|FG001|Overall Study|Lost to Follow-up|4|||
162963702|NCT00425308|588566588|FG000|Overall Study|Adverse Event|2|||
162963703|NCT00425308|588566589|FG001|Overall Study|Adverse Event|1|||
163306310|NCT03131648|589830538|FG005|Maintenance Treatment Period|Not dosed|0|||
163306311|NCT03131648|589830539|FG006|Maintenance Treatment Period|Not dosed|0|||
163306312|NCT03131648|589830540|FG007|Maintenance Treatment Period|Not dosed|0|||
163306313|NCT03131648|589830533|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
163306314|NCT03131648|589830534|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
163306315|NCT03131648|589830535|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
163306316|NCT03131648|589830536|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
163306317|NCT03131648|589830537|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
163306318|NCT03131648|589830538|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
163306319|NCT03131648|589830539|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
163306320|NCT03131648|589830540|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
163306321|NCT03131648|589830533|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
163306322|NCT03131648|589830534|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
163199712|NCT03617185|589445385|FG001|Baseline|Family Obligations|0|||
163199713|NCT03617185|589445386|FG002|Baseline|Family Obligations|0|||
163199714|NCT03617185|589445387|FG003|Baseline|Family Obligations|1|||
163199715|NCT03617185|589445384|FG000|3 Months|Lost to Follow-up|4|||
163306323|NCT03131648|589830535|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
163306324|NCT03131648|589830536|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
163306325|NCT03131648|589830537|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
163306326|NCT03131648|589830538|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
163306327|NCT03131648|589830539|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
163306328|NCT03131648|589830540|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
162963704|NCT00425308|588566588|FG000|Overall Study|Withdrawal by Subject|1|||
162963705|NCT00425308|588566589|FG001|Overall Study|Withdrawal by Subject|0|||
162963706|NCT00425308|588566588|FG000|Overall Study|Death|1|||
163199716|NCT03617185|589445385|FG001|3 Months|Lost to Follow-up|1|||
163199717|NCT03617185|589445386|FG002|3 Months|Lost to Follow-up|0|||
163199718|NCT03617185|589445387|FG003|3 Months|Lost to Follow-up|2|||
163199719|NCT03617185|589445384|FG000|3 Months|Withdrawal by Subject|1|||
163199720|NCT03617185|589445385|FG001|3 Months|Withdrawal by Subject|3|||
163199721|NCT03617185|589445386|FG002|3 Months|Withdrawal by Subject|0|||
163199722|NCT03617185|589445387|FG003|3 Months|Withdrawal by Subject|0|||
163199723|NCT03617185|589445384|FG000|3 Months|Driving Distance/Travel|1|||
163199724|NCT03617185|589445385|FG001|3 Months|Driving Distance/Travel|0|||
163199725|NCT03617185|589445386|FG002|3 Months|Driving Distance/Travel|0|||
163199726|NCT03617185|589445387|FG003|3 Months|Driving Distance/Travel|0|||
163199727|NCT03617185|589445384|FG000|3 Months|Family Obligations|0|||
163199728|NCT03617185|589445385|FG001|3 Months|Family Obligations|0|||
163199729|NCT03617185|589445386|FG002|3 Months|Family Obligations|0|||
163199730|NCT03617185|589445387|FG003|3 Months|Family Obligations|1|||
163199731|NCT03617185|589445384|FG000|12 Months|Lost to Follow-up|3|||
163199732|NCT03617185|589445385|FG001|12 Months|Lost to Follow-up|1|||
163199733|NCT03617185|589445386|FG002|12 Months|Lost to Follow-up|3|||
163306329|NCT03131648|589830533|FG000|Maintenance Treatment Period|Completed Week 50|0|||
162963707|NCT00425308|588566589|FG001|Overall Study|Death|0|||
162963708|NCT01252953|588566591|FG000|Overall Study|Withdrawal by Subject|16|||
162963709|NCT01252953|588566592|FG001|Overall Study|Withdrawal by Subject|17|||
162963710|NCT01252953|588566591|FG000|Overall Study|Lost to Follow-up|22|||
162963711|NCT01252953|588566592|FG001|Overall Study|Lost to Follow-up|21|||
162963712|NCT00101439|588566599|FG000|Period 2|Withdrawal by Subject|0|||
163199734|NCT03617185|589445387|FG003|12 Months|Lost to Follow-up|0|||
163199735|NCT03617185|589445384|FG000|12 Months|Withdrawal by Subject|0|||
163306330|NCT03131648|589830534|FG001|Maintenance Treatment Period|Completed Week 50|0|||
163306331|NCT03131648|589830535|FG002|Maintenance Treatment Period|Completed Week 50|0|||
163199736|NCT03617185|589445385|FG001|12 Months|Withdrawal by Subject|0|||
163199737|NCT03617185|589445386|FG002|12 Months|Withdrawal by Subject|0|||
163306332|NCT03131648|589830536|FG003|Maintenance Treatment Period|Completed Week 50|0|||
163306333|NCT03131648|589830537|FG004|Maintenance Treatment Period|Completed Week 50|1|||
163306334|NCT03131648|589830538|FG005|Maintenance Treatment Period|Completed Week 50|0|||
163306335|NCT03131648|589830539|FG006|Maintenance Treatment Period|Completed Week 50|0|||
163306336|NCT03131648|589830540|FG007|Maintenance Treatment Period|Completed Week 50|0|||
163306337|NCT03131648|589830533|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
163306338|NCT03131648|589830534|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
163306339|NCT03131648|589830535|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
163306340|NCT03131648|589830536|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
163306341|NCT03131648|589830537|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
163306342|NCT03131648|589830538|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
163306343|NCT03131648|589830539|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
162963713|NCT00101439|588566600|FG001|Period 2|Withdrawal by Subject|2|||
162963714|NCT00863330|588566606|FG000|Overall Study|study terminated early due to administra|6|||
162963715|NCT02272803|588566607|FG000|Overall Study|Disease progression|16|||
162963716|NCT02272803|588566608|FG001|Overall Study|Disease progression|8|||
162963717|NCT02272803|588566607|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
162963718|NCT02272803|588566608|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
162963719|NCT02272803|588566607|FG000|Overall Study|Study drug toxicity|4|||
162963720|NCT02272803|588566608|FG001|Overall Study|Study drug toxicity|9|||
162963721|NCT02272803|588566607|FG000|Overall Study|Participant request to discontinue study treatment|3|||
162963722|NCT02272803|588566608|FG001|Overall Study|Participant request to discontinue study treatment|7|||
162963723|NCT02272803|588566607|FG000|Overall Study|Maximum clinical benefit|4|||
162963724|NCT02272803|588566608|FG001|Overall Study|Maximum clinical benefit|2|||
162963725|NCT02272803|588566607|FG000|Overall Study|Poor/non-compliance|2|||
162963726|NCT02272803|588566608|FG001|Overall Study|Poor/non-compliance|2|||
162963727|NCT02272803|588566607|FG000|Overall Study|Withdrawal by Subject|2|||
162963728|NCT02272803|588566608|FG001|Overall Study|Withdrawal by Subject|1|||
162963729|NCT02272803|588566607|FG000|Overall Study|Death|0|||
162963730|NCT02272803|588566608|FG001|Overall Study|Death|1|||
162963731|NCT02272803|588566607|FG000|Overall Study|Other reasons|1|||
162963732|NCT02272803|588566608|FG001|Overall Study|Other reasons|3|||
162963733|NCT02272803|588566607|FG000|Overall Study|Administrative reason by sponsor|5|||
162963734|NCT02272803|588566608|FG001|Overall Study|Administrative reason by sponsor|4|||
162963735|NCT03067987|588566610|FG000|Overall Study|Lost to Follow-up|7|||
162963736|NCT03067987|588566611|FG001|Overall Study|Lost to Follow-up|10|||
162963737|NCT03067987|588566610|FG000|Overall Study|Protocol Violation|1|||
162963738|NCT03067987|588566611|FG001|Overall Study|Protocol Violation|2|||
162963739|NCT03067987|588566610|FG000|Overall Study|Withdrawal by Subject|2|||
162963740|NCT03067987|588566611|FG001|Overall Study|Withdrawal by Subject|1|||
162963741|NCT03733145|588566612|FG000|Overall Study|screenfail|3|||
162963742|NCT03733145|588566613|FG001|Overall Study|screenfail|3|||
162963743|NCT03733145|588566614|FG002|Overall Study|screenfail|2|||
162963744|NCT00829764|588566615|FG000|First Intervention|Adverse Event|1|||
162963745|NCT00829764|588566616|FG001|First Intervention|Adverse Event|0|||
162963746|NCT00829764|588566615|FG000|First Intervention|Withdrawal by Subject|1|||
162963747|NCT00829764|588566616|FG001|First Intervention|Withdrawal by Subject|1|||
162963748|NCT00183196|588567878|FG000|Overall Study|Withdrawal by Subject|18|||
162963749|NCT00183196|588567879|FG001|Overall Study|Withdrawal by Subject|11|||
162963750|NCT00183196|588567880|FG002|Overall Study|Withdrawal by Subject|13|||
162963751|NCT00183196|588567878|FG000|Overall Study|Adverse Event|1|||
162963752|NCT00183196|588567879|FG001|Overall Study|Adverse Event|2|||
162963753|NCT00183196|588567880|FG002|Overall Study|Adverse Event|2|||
162963754|NCT00183196|588567878|FG000|Overall Study|Legal event|1|||
162963755|NCT00183196|588567879|FG001|Overall Study|Legal event|1|||
162963756|NCT00183196|588567880|FG002|Overall Study|Legal event|1|||
162963757|NCT00183196|588567878|FG000|Overall Study|Required more intensive care|0|||
162963758|NCT00183196|588567879|FG001|Overall Study|Required more intensive care|1|||
162963759|NCT00183196|588567880|FG002|Overall Study|Required more intensive care|2|||
162963760|NCT00385736|588567881|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
162963761|NCT00385736|588567882|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
162963762|NCT00385736|588567883|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
162963763|NCT00385736|588567881|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
162963764|NCT00385736|588567882|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
162963765|NCT00385736|588567883|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
162963766|NCT00385736|588567881|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
162963767|NCT00385736|588567882|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
162963768|NCT00385736|588567883|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
162963769|NCT00385736|588567881|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
162963770|NCT00385736|588567882|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
162963771|NCT00385736|588567883|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
162963772|NCT00385736|588567881|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
162963773|NCT00385736|588567882|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
163306344|NCT03131648|589830540|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
163306345|NCT02724878|589830541|FG000|Overall Study|Still on Active Therapy|15|||
163306346|NCT02724878|589830541|FG000|Overall Study|Disease Progression|31|||
163306347|NCT02724878|589830541|FG000|Overall Study|Toxicity|5|||
163306348|NCT02724878|589830541|FG000|Overall Study|Death|1|||
163306349|NCT02724878|589830541|FG000|Overall Study|Withdrawal by Subject|4|||
163306350|NCT02724878|589830541|FG000|Overall Study|Lost to Follow-up|2|||
163306351|NCT02724878|589830541|FG000|Overall Study|Protocol Violation|1|||
163306352|NCT02724878|589830541|FG000|Overall Study|Ineligible for Study Drug|5|||
163306353|NCT02724878|589830541|FG000|Overall Study|not started|1|||
163306354|NCT04820855|589830542|FG000|Overall Study|Lost to Follow-up|6|||
163306355|NCT04820855|589830543|FG001|Overall Study|Lost to Follow-up|9|||
163306356|NCT04838262|589830544|FG000|Overall Study|Withdrawal by Subject|9|||
163306357|NCT04838262|589830545|FG001|Overall Study|Withdrawal by Subject|4|||
163306358|NCT02927769|589830546|FG000|Induction Phase|Study drug toxicity|1|||
163306359|NCT02927769|589830547|FG001|Induction Phase|Study drug toxicity|1|||
163306360|NCT02927769|589830546|FG000|Induction Phase|Disease progression|0|||
163306361|NCT02927769|589830547|FG001|Induction Phase|Disease progression|1|||
163306362|NCT02927769|589830546|FG000|Intensification Phase|Study drug toxicity|1|||
163306363|NCT02927769|589830547|FG001|Intensification Phase|Study drug toxicity|0|||
163306364|NCT05524233|589830552|FG000|Overall Study|Lost to Follow-up|2|||
163306365|NCT05524233|589830552|FG000|Overall Study|Adverse Event|2|||
163306366|NCT05524233|589830552|FG000|Overall Study|Withdrawal by Subject|1|||
163306367|NCT02307565|589830554|FG000|Overall Study|Adverse Event|3|||
163306368|NCT02307565|589830555|FG001|Overall Study|Adverse Event|2|||
163306369|NCT02307565|589830554|FG000|Overall Study|Withdrawal by Subject|2|||
163306370|NCT02307565|589830555|FG001|Overall Study|Withdrawal by Subject|2|||
163306371|NCT00650104|589830556|FG000|Overall Study|Adverse Event|17|||
163306372|NCT00650104|589830556|FG000|Overall Study|Death|2|||
163306373|NCT00650104|589830556|FG000|Overall Study|Withdrawal by Subject|11|||
163306374|NCT00650104|589830556|FG000|Overall Study|Physician Decision|7|||
163306375|NCT00650104|589830556|FG000|Overall Study|Lost to Follow-up|1|||
163306376|NCT00650104|589830556|FG000|Overall Study|Non-compliance|2|||
163306377|NCT00650104|589830556|FG000|Overall Study|Sponsor Terminated Dosing|1|||
163306378|NCT00792636|589830557|FG000|Overall Study|Protocol Violation|17|||
163306379|NCT00792636|589830558|FG001|Overall Study|Protocol Violation|23|||
163306380|NCT00792636|589830559|FG002|Overall Study|Protocol Violation|20|||
163306381|NCT00792636|589830557|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
163306382|NCT00792636|589830558|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
163306383|NCT00792636|589830559|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
163306384|NCT00792636|589830557|FG000|Overall Study|Lost to Follow-up|13|||
163306385|NCT00792636|589830558|FG001|Overall Study|Lost to Follow-up|19|||
163306386|NCT00792636|589830559|FG002|Overall Study|Lost to Follow-up|14|||
163306387|NCT00792636|589830557|FG000|Overall Study|Withdrew Consent|10|||
163306388|NCT00792636|589830558|FG001|Overall Study|Withdrew Consent|13|||
163306389|NCT00792636|589830559|FG002|Overall Study|Withdrew Consent|9|||
163306390|NCT00792636|589830557|FG000|Overall Study|Lack of Efficacy|3|||
163306391|NCT00792636|589830558|FG001|Overall Study|Lack of Efficacy|4|||
163306392|NCT00792636|589830559|FG002|Overall Study|Lack of Efficacy|13|||
163306393|NCT00792636|589830557|FG000|Overall Study|Adverse Event|4|||
163306394|NCT00792636|589830558|FG001|Overall Study|Adverse Event|2|||
163306395|NCT00792636|589830559|FG002|Overall Study|Adverse Event|3|||
163306396|NCT00792636|589830557|FG000|Overall Study|Investigator Discretion|2|||
163306397|NCT00792636|589830558|FG001|Overall Study|Investigator Discretion|0|||
163306398|NCT00792636|589830559|FG002|Overall Study|Investigator Discretion|2|||
163306399|NCT05633407|589830564|FG000|Overall Study|Physician Decision|2|||
163306400|NCT05633407|589830565|FG001|Overall Study|Physician Decision|0|||
163306401|NCT05633407|589830564|FG000|Overall Study|Adverse Event|1|||
163306402|NCT05633407|589830565|FG001|Overall Study|Adverse Event|0|||
163306403|NCT05633407|589830564|FG000|Overall Study|Withdrawal by Subject|1|||
163306404|NCT05633407|589830565|FG001|Overall Study|Withdrawal by Subject|0|||
163306405|NCT05633407|589830564|FG000|Overall Study|Other|1|||
163306406|NCT05633407|589830565|FG001|Overall Study|Other|1|||
163306407|NCT04838613|589830567|FG000|Overall Study|Withdrawal by Subject|3|||
163306408|NCT04838613|589830568|FG001|Overall Study|Withdrawal by Subject|6|||
163306409|NCT04838613|589830567|FG000|Overall Study|Protocol Deviation|3|||
163306410|NCT04838613|589830568|FG001|Overall Study|Protocol Deviation|2|||
163306411|NCT04838613|589830567|FG000|Overall Study|Technical Problems|0|||
163306412|NCT04838613|589830568|FG001|Overall Study|Technical Problems|5|||
163306413|NCT04838613|589830567|FG000|Overall Study|Physician Decision|2|||
163306414|NCT04838613|589830568|FG001|Overall Study|Physician Decision|0|||
163306415|NCT04757610|589830569|FG000|Overall Study|Adverse Event|13|||
163306416|NCT04757610|589830570|FG001|Overall Study|Adverse Event|10|||
163306417|NCT04757610|589830571|FG002|Overall Study|Adverse Event|5|||
163306418|NCT04757610|589830569|FG000|Overall Study|Death|5|||
163306419|NCT04757610|589830570|FG001|Overall Study|Death|13|||
163306420|NCT04757610|589830571|FG002|Overall Study|Death|8|||
163306421|NCT04757610|589830569|FG000|Overall Study|Lack of Efficacy|1|||
163050836|NCT02573259|588893693|FG002|Overall Study|Other|0|||
163306422|NCT04757610|589830570|FG001|Overall Study|Lack of Efficacy|2|||
163306423|NCT04757610|589830571|FG002|Overall Study|Lack of Efficacy|3|||
163306424|NCT04757610|589830569|FG000|Overall Study|Lost to Follow-up|7|||
163306425|NCT04757610|589830570|FG001|Overall Study|Lost to Follow-up|2|||
163306426|NCT04757610|589830571|FG002|Overall Study|Lost to Follow-up|7|||
163306427|NCT04757610|589830569|FG000|Overall Study|Physician Decision|4|||
163306428|NCT04757610|589830570|FG001|Overall Study|Physician Decision|1|||
163306429|NCT04757610|589830571|FG002|Overall Study|Physician Decision|2|||
163306430|NCT04757610|589830569|FG000|Overall Study|Withdrawal by Subject|26|||
163306431|NCT04757610|589830570|FG001|Overall Study|Withdrawal by Subject|25|||
163199738|NCT03617185|589445387|FG003|12 Months|Withdrawal by Subject|1|||
163306432|NCT04757610|589830571|FG002|Overall Study|Withdrawal by Subject|25|||
163306433|NCT04757610|589830569|FG000|Overall Study|Study Terminated by Sponsor|105|||
163306434|NCT04757610|589830570|FG001|Overall Study|Study Terminated by Sponsor|105|||
163306435|NCT04757610|589830571|FG002|Overall Study|Study Terminated by Sponsor|110|||
163306436|NCT04757610|589830569|FG000|Overall Study|Randomized in Error|1|||
163199739|NCT03617185|589445384|FG000|12 Months|Driving Distance/Travel|0|||
163199740|NCT03617185|589445385|FG001|12 Months|Driving Distance/Travel|0|||
163199741|NCT03617185|589445386|FG002|12 Months|Driving Distance/Travel|1|||
163199742|NCT03617185|589445387|FG003|12 Months|Driving Distance/Travel|0|||
163199743|NCT01387932|589445389|FG000|Randomized and Treated|Physician Decision|3|||
163199744|NCT01387932|589445390|FG001|Randomized and Treated|Physician Decision|2|||
163199745|NCT01387932|589445389|FG000|Randomized and Treated|Withdrawal by Subject|4|||
163199746|NCT01387932|589445390|FG001|Randomized and Treated|Withdrawal by Subject|2|||
163199747|NCT01387932|589445389|FG000|Survival Follow-up|Liver Transplant|24|||
163199748|NCT01387932|589445390|FG001|Survival Follow-up|Liver Transplant|28|||
163199749|NCT01387932|589445389|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
163199750|NCT01387932|589445390|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
163199751|NCT01387932|589445389|FG000|Survival Follow-up|Withdrawal by Subject|2|||
163199752|NCT01387932|589445390|FG001|Survival Follow-up|Withdrawal by Subject|4|||
163199753|NCT01387932|589445389|FG000|Survival Follow-up|Lost to Follow-up|6|||
163199754|NCT01387932|589445390|FG001|Survival Follow-up|Lost to Follow-up|5|||
163199755|NCT01964430|589445391|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
163199756|NCT01964430|589445392|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
163199757|NCT01964430|589445391|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
163199758|NCT01964430|589445392|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
163199759|NCT01964430|589445391|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
163199760|NCT01964430|589445392|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
163199761|NCT01964430|589445391|FG000|Treatment Period|Adverse Event|71|||
163199762|NCT01964430|589445392|FG001|Treatment Period|Adverse Event|37|||
163199763|NCT01964430|589445391|FG000|Treatment Period|Withdrawal by Subject|36|||
163199764|NCT01964430|589445392|FG001|Treatment Period|Withdrawal by Subject|27|||
163199765|NCT01964430|589445391|FG000|Treatment Period|Death|1|||
163199766|NCT01964430|589445392|FG001|Treatment Period|Death|3|||
163199767|NCT01964430|589445391|FG000|Treatment Period|Protocol Deviation|0|||
163306437|NCT04757610|589830570|FG001|Overall Study|Randomized in Error|0|||
163306438|NCT04757610|589830571|FG002|Overall Study|Randomized in Error|0|||
163306439|NCT00593489|589830576|FG000|Allocation|did not attend workshop; allocation not|2|||
163306440|NCT00593489|589830577|FG001|Allocation|did not attend workshop; allocation not|1|||
163306441|NCT00951379|589830578|FG000|Overall Study|Adverse Event|4|||
163306442|NCT00951379|589830579|FG001|Overall Study|Adverse Event|1|||
163306443|NCT00951379|589830578|FG000|Overall Study|Withdrawal by Subject|1|||
163306444|NCT00951379|589830579|FG001|Overall Study|Withdrawal by Subject|0|||
163306445|NCT00951379|589830578|FG000|Overall Study|Noncompliance|1|||
163306446|NCT00951379|589830579|FG001|Overall Study|Noncompliance|0|||
163306447|NCT00951379|589830578|FG000|Overall Study|Disease Progression|0|||
163306448|NCT00951379|589830579|FG001|Overall Study|Disease Progression|1|||
163306449|NCT03432858|589830580|FG000|Overall Study|Protocol Violation|2|||
163306450|NCT03432858|589830581|FG001|Overall Study|Protocol Violation|1|||
163306451|NCT03432858|589830582|FG002|Overall Study|Protocol Violation|9|||
163306452|NCT03432858|589830580|FG000|Overall Study|Withdrawal by Subject|0|||
163306453|NCT03432858|589830581|FG001|Overall Study|Withdrawal by Subject|1|||
163306454|NCT03432858|589830582|FG002|Overall Study|Withdrawal by Subject|1|||
163306455|NCT03432858|589830580|FG000|Overall Study|Procedure canceled/rescheduled|0|||
163306456|NCT03432858|589830581|FG001|Overall Study|Procedure canceled/rescheduled|9|||
163199768|NCT01964430|589445392|FG001|Treatment Period|Protocol Deviation|1|||
163199769|NCT01964430|589445391|FG000|Treatment Period|Physician Decision|5|||
163199770|NCT01964430|589445392|FG001|Treatment Period|Physician Decision|4|||
163199771|NCT01964430|589445391|FG000|Treatment Period|Disease Relapse|28|||
163306457|NCT03432858|589830582|FG002|Overall Study|Procedure canceled/rescheduled|6|||
163306458|NCT03432858|589830580|FG000|Overall Study|Required postop mobilization with splinting|0|||
163306459|NCT03432858|589830581|FG001|Overall Study|Required postop mobilization with splinting|0|||
163306460|NCT03432858|589830582|FG002|Overall Study|Required postop mobilization with splinting|1|||
163306461|NCT01011946|589830583|FG000|Overall Study|Transferred to another hospital|2|||
163306462|NCT01011946|589830583|FG000|Overall Study|No pathological lab value|1|||
163306463|NCT03527160|589830588|FG000|Overall Study|No urine collected|13|||
163306464|NCT03527160|589830588|FG000|Overall Study|No clinical serum creatinine collected|6|||
163306465|NCT03527160|589830588|FG000|Overall Study|Did not meet inclusion|2|||
163306466|NCT01721291|589830590|FG000|Overall Study|Withdrawal by Subject|1|||
163306467|NCT01721291|589830591|FG001|Overall Study|Withdrawal by Subject|0|||
163306468|NCT01721291|589830590|FG000|Overall Study|did not like the treatment|1|||
163306469|NCT01721291|589830591|FG001|Overall Study|did not like the treatment|0|||
163306470|NCT05239039|589830594|FG000|Overall Study|Withdrawal by Subject|0|||
163306471|NCT05239039|589830595|FG001|Overall Study|Withdrawal by Subject|1|||
163306472|NCT03690206|589830596|FG000|Overall Study|Withdrawal by Subject|2|||
163306473|NCT03690206|589830597|FG001|Overall Study|Withdrawal by Subject|0|||
163306474|NCT03690206|589830598|FG002|Overall Study|Withdrawal by Subject|0|||
163306475|NCT03690206|589830596|FG000|Overall Study|ICF withdrawal|2|||
163396916|NCT01490814|590164338|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
163396917|NCT01490814|590164337|FG000|Overall Study|Physician Decision|1|||
163396918|NCT01490814|590164338|FG001|Overall Study|Physician Decision|0|||
163396919|NCT01490814|590164337|FG000|Overall Study|Withdrawal by Subject|0|||
163199772|NCT01964430|589445392|FG001|Treatment Period|Disease Relapse|38|||
163199773|NCT01964430|589445391|FG000|Treatment Period|Other reasons|1|||
163199774|NCT01964430|589445392|FG001|Treatment Period|Other reasons|3|||
163199775|NCT02591290|589445393|FG000|Overall Study|Withdrawal by Subject|2|||
163199776|NCT02571075|589445394|FG000|Overall Study|Lost to Follow-up|20|||
163199777|NCT02571075|589445395|FG001|Overall Study|Lost to Follow-up|24|||
163199778|NCT02197520|589445400|FG000|Period 1|Withdrawal by Subject|1|||
163199779|NCT02197520|589445401|FG001|Period 1|Withdrawal by Subject|0|||
163199780|NCT02197520|589445400|FG000|Period 2|Adverse Event|0|||
163199781|NCT02197520|589445401|FG001|Period 2|Adverse Event|2|||
163199782|NCT02197520|589445400|FG000|Period 2|Withdrawal by Subject|1|||
163199783|NCT02197520|589445401|FG001|Period 2|Withdrawal by Subject|0|||
163199784|NCT00913497|589445402|FG000|Overall Study|Adverse Event|1|||
163199785|NCT00913497|589445402|FG000|Overall Study|Withdrawal by Subject|2|||
163199786|NCT03208244|589445403|FG000|Overall Study|Death|1|||
163199787|NCT04431453|589445408|FG000|Overall Study|Withdrew Consent|0|||
163199788|NCT04431453|589445409|FG001|Overall Study|Withdrew Consent|1|||
163199789|NCT04431453|589445410|FG002|Overall Study|Withdrew Consent|0|||
163199790|NCT04431453|589445411|FG003|Overall Study|Withdrew Consent|2|||
163199791|NCT04431453|589445412|FG004|Overall Study|Withdrew Consent|0|||
163199792|NCT04431453|589445413|FG005|Overall Study|Withdrew Consent|0|||
163199793|NCT04431453|589445414|FG006|Overall Study|Withdrew Consent|0|||
163199794|NCT04431453|589445415|FG007|Overall Study|Withdrew Consent|0|||
163199795|NCT04431453|589445408|FG000|Overall Study|Death|1|||
163199796|NCT04431453|589445409|FG001|Overall Study|Death|0|||
163199797|NCT04431453|589445410|FG002|Overall Study|Death|0|||
163199798|NCT04431453|589445411|FG003|Overall Study|Death|0|||
163199799|NCT04431453|589445412|FG004|Overall Study|Death|0|||
163199800|NCT04431453|589445413|FG005|Overall Study|Death|0|||
163199801|NCT04431453|589445414|FG006|Overall Study|Death|0|||
163199802|NCT04431453|589445415|FG007|Overall Study|Death|1|||
163199803|NCT04431453|589445408|FG000|Overall Study|Lost to Follow-up|0|||
163199804|NCT04431453|589445409|FG001|Overall Study|Lost to Follow-up|0|||
163199805|NCT04431453|589445410|FG002|Overall Study|Lost to Follow-up|1|||
163199806|NCT04431453|589445411|FG003|Overall Study|Lost to Follow-up|1|||
163199807|NCT04431453|589445412|FG004|Overall Study|Lost to Follow-up|0|||
163199808|NCT04431453|589445413|FG005|Overall Study|Lost to Follow-up|0|||
163199809|NCT04431453|589445414|FG006|Overall Study|Lost to Follow-up|0|||
163199810|NCT04431453|589445415|FG007|Overall Study|Lost to Follow-up|0|||
163199811|NCT04431453|589445408|FG000|Overall Study|Enrolled but Never Treated|0|||
163199812|NCT04431453|589445409|FG001|Overall Study|Enrolled but Never Treated|0|||
163199813|NCT04431453|589445410|FG002|Overall Study|Enrolled but Never Treated|0|||
163199814|NCT04431453|589445411|FG003|Overall Study|Enrolled but Never Treated|0|||
163199815|NCT04431453|589445412|FG004|Overall Study|Enrolled but Never Treated|1|||
163199816|NCT04431453|589445413|FG005|Overall Study|Enrolled but Never Treated|0|||
163199817|NCT04431453|589445414|FG006|Overall Study|Enrolled but Never Treated|0|||
163199818|NCT04431453|589445415|FG007|Overall Study|Enrolled but Never Treated|0|||
163199819|NCT03385564|589445416|FG000|Overall Study|Adverse Event|0|||
163199820|NCT03385564|589445417|FG001|Overall Study|Adverse Event|0|||
163199821|NCT03385564|589445418|FG002|Overall Study|Adverse Event|3|||
163199822|NCT03385564|589445419|FG003|Overall Study|Adverse Event|3|||
163199823|NCT03385564|589445416|FG000|Overall Study|Other than listed|0|||
163199824|NCT03385564|589445417|FG001|Overall Study|Other than listed|0|||
163199825|NCT03385564|589445418|FG002|Overall Study|Other than listed|0|||
163199826|NCT03385564|589445419|FG003|Overall Study|Other than listed|5|||
163199827|NCT03385564|589445416|FG000|Overall Study|Withdrawal by Subject|0|||
163199828|NCT03385564|589445417|FG001|Overall Study|Withdrawal by Subject|1|||
163199829|NCT03385564|589445418|FG002|Overall Study|Withdrawal by Subject|1|||
163199830|NCT03385564|589445419|FG003|Overall Study|Withdrawal by Subject|0|||
163199831|NCT03385564|589445416|FG000|Overall Study|Lack of Efficacy|0|||
163199832|NCT03385564|589445417|FG001|Overall Study|Lack of Efficacy|0|||
163199833|NCT03385564|589445418|FG002|Overall Study|Lack of Efficacy|0|||
163306476|NCT03690206|589830597|FG001|Overall Study|ICF withdrawal|0|||
163306477|NCT03690206|589830598|FG002|Overall Study|ICF withdrawal|0|||
163306478|NCT03978637|589830600|FG000|Overall Study|Death|0|||
163306479|NCT03978637|589830601|FG001|Overall Study|Death|2|||
163306480|NCT03978637|589830602|FG002|Overall Study|Death|2|||
163306481|NCT03978637|589830603|FG003|Overall Study|Death|0|||
163306482|NCT03978637|589830600|FG000|Overall Study|Withdrawal by Subject|0|||
163306483|NCT03978637|589830601|FG001|Overall Study|Withdrawal by Subject|0|||
163306484|NCT03978637|589830602|FG002|Overall Study|Withdrawal by Subject|1|||
163306485|NCT03978637|589830603|FG003|Overall Study|Withdrawal by Subject|0|||
163306486|NCT03978637|589830600|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
163306487|NCT03978637|589830601|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
163306488|NCT03978637|589830602|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
163306489|NCT03978637|589830603|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
163306490|NCT01959698|589830604|FG000|Overall Study|Adverse Event|0|||
163306491|NCT01959698|589830605|FG001|Overall Study|Adverse Event|0|||
163306492|NCT01959698|589830606|FG002|Overall Study|Adverse Event|0|||
163306493|NCT01959698|589830607|FG003|Overall Study|Adverse Event|0|||
163306494|NCT01959698|589830608|FG004|Overall Study|Adverse Event|0|||
163306495|NCT01959698|589830609|FG005|Overall Study|Adverse Event|0|||
163306496|NCT01959698|589830610|FG006|Overall Study|Adverse Event|1|||
163306497|NCT01959698|589830604|FG000|Overall Study|Physician Decision|1|||
163306498|NCT01959698|589830605|FG001|Overall Study|Physician Decision|0|||
163306499|NCT01959698|589830606|FG002|Overall Study|Physician Decision|1|||
163306500|NCT01959698|589830607|FG003|Overall Study|Physician Decision|2|||
163306501|NCT01959698|589830608|FG004|Overall Study|Physician Decision|0|||
163306502|NCT01959698|589830609|FG005|Overall Study|Physician Decision|3|||
163306503|NCT01959698|589830610|FG006|Overall Study|Physician Decision|3|||
163306504|NCT00739648|589831823|FG000|Overall Study|Adverse Event|3|||
163306505|NCT00739648|589831824|FG001|Overall Study|Adverse Event|15|||
163306506|NCT00739648|589831823|FG000|Overall Study|Withdrawal by Subject|13|||
163306507|NCT00739648|589831824|FG001|Overall Study|Withdrawal by Subject|25|||
163306508|NCT00739648|589831823|FG000|Overall Study|Lost to Follow-up|4|||
163306509|NCT00739648|589831824|FG001|Overall Study|Lost to Follow-up|7|||
163306510|NCT00739648|589831823|FG000|Overall Study|Death|2|||
163306511|NCT00739648|589831824|FG001|Overall Study|Death|0|||
163306512|NCT00739648|589831823|FG000|Overall Study|Do not know|4|||
163306513|NCT00739648|589831824|FG001|Overall Study|Do not know|6|||
163306514|NCT05110495|589831825|FG000|Overall Study|Lost to Follow-up|1|||
163306515|NCT05110495|589831825|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
163306516|NCT04173663|589831826|FG000|Overall Study|Withdrawal by Subject|1|||
163306517|NCT04173663|589831827|FG001|Overall Study|Withdrawal by Subject|6|||
163306518|NCT04173663|589831826|FG000|Overall Study|Lost to Follow-up|17|||
163306519|NCT04173663|589831827|FG001|Overall Study|Lost to Follow-up|24|||
163306520|NCT04716634|589831832|FG000|Overall Study|Death|24|||
163306521|NCT04716634|589831833|FG001|Overall Study|Death|24|||
163306522|NCT04716634|589831834|FG002|Overall Study|Death|8|||
163306523|NCT04716634|589831832|FG000|Overall Study|Closed by Sponsor|4|||
163306524|NCT04716634|589831833|FG001|Overall Study|Closed by Sponsor|4|||
163306525|NCT04716634|589831834|FG002|Overall Study|Closed by Sponsor|5|||
163306526|NCT04716634|589831832|FG000|Overall Study|Lost to Follow-up|1|||
163306527|NCT04716634|589831833|FG001|Overall Study|Lost to Follow-up|0|||
163306528|NCT04716634|589831834|FG002|Overall Study|Lost to Follow-up|1|||
163306529|NCT04716634|589831832|FG000|Overall Study|Withdrawal by Subject|0|||
163306530|NCT04716634|589831833|FG001|Overall Study|Withdrawal by Subject|0|||
163306531|NCT04716634|589831834|FG002|Overall Study|Withdrawal by Subject|1|||
163306532|NCT04833777|589831835|FG000|Overall Study|Lost to Follow-up|1|||
163306533|NCT04833777|589831836|FG001|Overall Study|Lost to Follow-up|0|||
163306534|NCT03089398|589831844|FG000|Overall Study|Death|4|||
163306535|NCT03089398|589831845|FG001|Overall Study|Death|9|||
163306536|NCT03089398|589831844|FG000|Overall Study|Lost to Follow-up|21|||
163306537|NCT03089398|589831845|FG001|Overall Study|Lost to Follow-up|30|||
163306538|NCT03089398|589831844|FG000|Overall Study|Withdrawal by Subject|2|||
163306539|NCT03089398|589831845|FG001|Overall Study|Withdrawal by Subject|2|||
163306540|NCT05418296|589831850|FG000|Overall Study|Withdrawal by Subject|4|||
163306541|NCT05418296|589831851|FG001|Overall Study|Withdrawal by Subject|1|||
163306542|NCT04703322|589831852|FG000|Overall Study|Ongoing|8|||
163306543|NCT04703322|589831852|FG000|Overall Study|Withdrawal by Subject|1|||
163306544|NCT04419168|589831853|FG000|Overall Study|Protocol Violation|1|||
163306545|NCT04419168|589831854|FG001|Overall Study|Protocol Violation|1|||
163306546|NCT04419168|589831853|FG000|Overall Study|Lost to Follow-up|7|||
163306547|NCT04419168|589831854|FG001|Overall Study|Lost to Follow-up|7|||
163306548|NCT04419168|589831853|FG000|Overall Study|Missed 6-month Visit|48|||
163306549|NCT04419168|589831854|FG001|Overall Study|Missed 6-month Visit|45|||
163306550|NCT05009251|589831858|FG000|Overall Study|Protocol Violation|100|||
163306551|NCT05009251|589831859|FG001|Overall Study|Protocol Violation|105|||
163306552|NCT05009251|589831860|FG002|Overall Study|Protocol Violation|119|||
163306553|NCT05009251|589831861|FG003|Overall Study|Protocol Violation|120|||
163306554|NCT05009251|589831862|FG004|Overall Study|Protocol Violation|119|||
163306555|NCT05009251|589831858|FG000|Overall Study|Death|25|||
163306556|NCT05009251|589831859|FG001|Overall Study|Death|22|||
163306557|NCT05009251|589831860|FG002|Overall Study|Death|24|||
163306558|NCT05009251|589831861|FG003|Overall Study|Death|19|||
163306559|NCT05009251|589831862|FG004|Overall Study|Death|15|||
163306560|NCT00676715|589831867|FG000|Treatment Period (TP)|Adverse Event|0|||
163306561|NCT00676715|589831868|FG001|Treatment Period (TP)|Adverse Event|3|||
163306562|NCT00676715|589831869|FG002|Treatment Period (TP)|Adverse Event|2|||
163306563|NCT00676715|589831870|FG003|Treatment Period (TP)|Adverse Event|2|||
163306564|NCT00676715|589831867|FG000|Treatment Period (TP)|Death|0|||
163306565|NCT00676715|589831868|FG001|Treatment Period (TP)|Death|0|||
163306566|NCT00676715|589831869|FG002|Treatment Period (TP)|Death|1|||
163306567|NCT00676715|589831870|FG003|Treatment Period (TP)|Death|0|||
163306568|NCT00676715|589831867|FG000|Treatment Period (TP)|Failure to return|1|||
163306569|NCT00676715|589831868|FG001|Treatment Period (TP)|Failure to return|0|||
163306570|NCT00676715|589831869|FG002|Treatment Period (TP)|Failure to return|0|||
163306571|NCT00676715|589831870|FG003|Treatment Period (TP)|Failure to return|0|||
163306572|NCT00676715|589831867|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
163306573|NCT00676715|589831868|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
163306574|NCT00676715|589831869|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
163306575|NCT00676715|589831870|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
163306576|NCT00676715|589831867|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
163306577|NCT00676715|589831868|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
163306578|NCT00676715|589831869|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
163306579|NCT00676715|589831870|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
163306580|NCT00676715|589831867|FG000|Treatment Period (TP)|Withdrew consent|3|||
163306581|NCT00676715|589831868|FG001|Treatment Period (TP)|Withdrew consent|3|||
163306582|NCT00676715|589831869|FG002|Treatment Period (TP)|Withdrew consent|3|||
163306583|NCT00676715|589831870|FG003|Treatment Period (TP)|Withdrew consent|3|||
163306584|NCT00676715|589831867|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
163306585|NCT00676715|589831868|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
163306586|NCT00676715|589831869|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
163306587|NCT00676715|589831870|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
163306588|NCT00676715|589831867|FG000|Treatment Period (TP)|Administrative|0|||
163306589|NCT00676715|589831868|FG001|Treatment Period (TP)|Administrative|0|||
163199834|NCT03385564|589445419|FG003|Overall Study|Lack of Efficacy|1|||
163199835|NCT03385564|589445416|FG000|Overall Study|Death|0|||
163199836|NCT03385564|589445417|FG001|Overall Study|Death|0|||
163199837|NCT03385564|589445418|FG002|Overall Study|Death|1|||
163199838|NCT03385564|589445419|FG003|Overall Study|Death|0|||
163199839|NCT01702961|589445426|FG000|Overall Study|Additional treatment|3|||
163199840|NCT01702961|589445426|FG000|Overall Study|Progressive disease|5|||
163199841|NCT01702961|589445426|FG000|Overall Study|Relapse|20|||
163199842|NCT01702961|589445426|FG000|Overall Study|Death|6|||
163306590|NCT00676715|589831869|FG002|Treatment Period (TP)|Administrative|0|||
163306591|NCT00676715|589831870|FG003|Treatment Period (TP)|Administrative|1|||
163306592|NCT00676715|589831867|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
163306593|NCT00676715|589831868|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
163306594|NCT00676715|589831869|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
163306595|NCT00676715|589831870|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
163306596|NCT00676715|589831867|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
163306597|NCT00676715|589831868|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
163306598|NCT00676715|589831869|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
163306599|NCT00676715|589831870|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
163306600|NCT00676715|589831867|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
163306601|NCT00676715|589831868|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
163199843|NCT01702961|589445426|FG000|Overall Study|Lost to Follow-up|2|||
163306602|NCT00676715|589831869|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
163306603|NCT00676715|589831870|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
163306604|NCT00676715|589831867|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
163306605|NCT00676715|589831868|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
163306606|NCT00676715|589831869|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
163306607|NCT00676715|589831870|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
163306608|NCT00676715|589831867|FG000|Treatment-free Period (TFP)|Death|1|||
163306609|NCT00676715|589831868|FG001|Treatment-free Period (TFP)|Death|1|||
163306610|NCT00676715|589831869|FG002|Treatment-free Period (TFP)|Death|1|||
163306611|NCT00676715|589831870|FG003|Treatment-free Period (TFP)|Death|0|||
163306612|NCT00676715|589831867|FG000|Open Label Extension (OLE)|Reason not provided|3|||
163306613|NCT00676715|589831868|FG001|Open Label Extension (OLE)|Reason not provided|4|||
163306614|NCT00676715|589831869|FG002|Open Label Extension (OLE)|Reason not provided|1|||
163306615|NCT00676715|589831870|FG003|Open Label Extension (OLE)|Reason not provided|4|||
163306616|NCT00676715|589831867|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
163306617|NCT00676715|589831868|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
163199844|NCT01702961|589445426|FG000|Overall Study|Ongoing|11|||
163306618|NCT00676715|589831869|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
163306619|NCT00676715|589831870|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
163306620|NCT00676715|589831867|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
163306621|NCT00676715|589831868|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
163306622|NCT00676715|589831869|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
163306623|NCT00676715|589831870|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
163306624|NCT00676715|589831867|FG000|Open Label Extension (OLE)|Adverse Event|0|||
163306625|NCT00676715|589831868|FG001|Open Label Extension (OLE)|Adverse Event|3|||
163306626|NCT00676715|589831869|FG002|Open Label Extension (OLE)|Adverse Event|1|||
163306627|NCT00676715|589831870|FG003|Open Label Extension (OLE)|Adverse Event|0|||
163306628|NCT00676715|589831867|FG000|Open Label Extension (OLE)|Death|2|||
163306629|NCT00676715|589831868|FG001|Open Label Extension (OLE)|Death|0|||
163306630|NCT00676715|589831869|FG002|Open Label Extension (OLE)|Death|2|||
163306631|NCT00676715|589831870|FG003|Open Label Extension (OLE)|Death|2|||
163306632|NCT05249439|589831871|FG000|Overall Study|Withdrawal by Subject|2|||
163306633|NCT05249439|589831872|FG001|Overall Study|Withdrawal by Subject|5|||
163306634|NCT05249439|589831871|FG000|Overall Study|Physician Decision|3|||
163306635|NCT05249439|589831872|FG001|Overall Study|Physician Decision|1|||
163306636|NCT00616967|589831873|FG000|Overall Study|Withdrawal by Subject|0|||
163396920|NCT01490814|590164338|FG001|Overall Study|Withdrawal by Subject|5|||
163396921|NCT01537198|590164339|FG000|Overall Study|RSV infection|2|||
163396922|NCT01537198|590164339|FG000|Overall Study|Adverse Event|4|||
163396923|NCT01537198|590164339|FG000|Overall Study|No Further Visits to the Clinic|37|||
163396924|NCT01537198|590164339|FG000|Overall Study|Other|111|||
163396925|NCT00496730|590164341|FG000|Overall Study|Lost to Follow-up|4|||
163396926|NCT00496730|590164342|FG001|Overall Study|Lost to Follow-up|3|||
163396927|NCT00496730|590164341|FG000|Overall Study|Withdrawal by Subject|2|||
163396928|NCT00496730|590164342|FG001|Overall Study|Withdrawal by Subject|2|||
163396929|NCT03962738|590164352|FG000|Overall Study|Protocol Deviation|3|||
163396930|NCT03962738|590164353|FG001|Overall Study|Protocol Deviation|0|||
163396931|NCT03962738|590164354|FG002|Overall Study|Protocol Deviation|1|||
163396932|NCT03962738|590164355|FG003|Overall Study|Protocol Deviation|1|||
163396933|NCT03962738|590164352|FG000|Overall Study|Withdrawal by Subject|4|||
163396934|NCT03962738|590164353|FG001|Overall Study|Withdrawal by Subject|0|||
163396935|NCT03962738|590164354|FG002|Overall Study|Withdrawal by Subject|0|||
163396936|NCT03962738|590164355|FG003|Overall Study|Withdrawal by Subject|0|||
163396937|NCT03962738|590164352|FG000|Overall Study|Lost to Follow-up|0|||
163396938|NCT03962738|590164353|FG001|Overall Study|Lost to Follow-up|0|||
163396939|NCT03962738|590164354|FG002|Overall Study|Lost to Follow-up|1|||
163396940|NCT03962738|590164355|FG003|Overall Study|Lost to Follow-up|0|||
163396941|NCT02170779|590164356|FG000|Overall Study|Withdrawal by Subject|1|||
163396942|NCT02170779|590164357|FG001|Overall Study|Withdrawal by Subject|0|||
163396943|NCT02170779|590164356|FG000|Overall Study|Lost to Follow-up|0|||
163396944|NCT02170779|590164357|FG001|Overall Study|Lost to Follow-up|1|||
163396945|NCT01010633|590164360|FG000|Overall Study|Adverse Event|1|||
163396946|NCT01010633|590164361|FG001|Overall Study|Adverse Event|1|||
163396947|NCT01010633|590164360|FG000|Overall Study|Protocol Violation|1|||
163396948|NCT01010633|590164361|FG001|Overall Study|Protocol Violation|2|||
163396949|NCT01010633|590164360|FG000|Overall Study|Withdrawal by Subject|2|||
163396950|NCT01010633|590164361|FG001|Overall Study|Withdrawal by Subject|1|||
163396951|NCT01010633|590164360|FG000|Overall Study|Investigator decision|0|||
163396952|NCT01010633|590164361|FG001|Overall Study|Investigator decision|1|||
163396953|NCT02941926|590164362|FG000|Core Phase|Progressive disease|1109|||
163396954|NCT02941926|590164362|FG000|Core Phase|Adverse Event|504|||
163396955|NCT02941926|590164362|FG000|Core Phase|Subject/guardian decision|127|||
163396956|NCT02941926|590164362|FG000|Core Phase|Physician Decision|112|||
163396957|NCT02941926|590164362|FG000|Core Phase|Death|46|||
163396958|NCT02941926|590164362|FG000|Core Phase|Protocol deviation|34|||
163396959|NCT02941926|590164362|FG000|Core Phase|Lost to Follow-up|8|||
163396960|NCT02941926|590164362|FG000|Core Phase|Technical problems|5|||
163396961|NCT02941926|590164362|FG000|Extension Phase|Physician Decision|155|||
163396962|NCT02941926|590164362|FG000|Extension Phase|Progressive disease|115|||
163396963|NCT02941926|590164362|FG000|Extension Phase|Adverse Event|13|||
163396964|NCT02941926|590164362|FG000|Extension Phase|Subject/Guardian decision|12|||
163396965|NCT02941926|590164362|FG000|Extension Phase|Death|6|||
163396966|NCT00097773|590164363|FG000|Overall Study|Lost to Follow-up|2|||
163396967|NCT00097773|590164364|FG001|Overall Study|Lost to Follow-up|2|||
163396968|NCT00097773|590164365|FG002|Overall Study|Lost to Follow-up|0|||
163050837|NCT02573259|588893694|FG003|Overall Study|Other|0|||
163306637|NCT00616967|589831874|FG001|Overall Study|Withdrawal by Subject|0|||
163306638|NCT00616967|589831875|FG002|Overall Study|Withdrawal by Subject|1|||
163306639|NCT04245501|589831879|FG000|Overall Study|Adverse Event|2|||
163306640|NCT04245501|589831880|FG001|Overall Study|Adverse Event|0|||
163396969|NCT00097773|590164366|FG003|Overall Study|Lost to Follow-up|1|||
163396970|NCT00097773|590164363|FG000|Overall Study|Physician Decision|2|||
163396971|NCT00097773|590164364|FG001|Overall Study|Physician Decision|2|||
163396972|NCT00097773|590164365|FG002|Overall Study|Physician Decision|3|||
163396973|NCT00097773|590164366|FG003|Overall Study|Physician Decision|1|||
163306641|NCT04245501|589831879|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
163306642|NCT04245501|589831880|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
163306643|NCT05337748|589831882|FG000|Overall Study|Withdrawal by Subject|1|||
163306644|NCT05337748|589831883|FG001|Overall Study|Withdrawal by Subject|0|||
163306645|NCT05337748|589831882|FG000|Overall Study|Death|1|||
163306646|NCT05337748|589831883|FG001|Overall Study|Death|0|||
163306647|NCT02506959|589831887|FG000|Overall Study|Physician Decision|2|||
163306648|NCT02506959|589831888|FG001|Overall Study|Physician Decision|1|||
163306649|NCT04541706|589831890|FG000|Overall Study|Withdrawal by Subject|3|||
163306650|NCT04541706|589831890|FG000|Overall Study|Progressive disease|33|||
163306651|NCT04541706|589831890|FG000|Overall Study|Physician Decision|1|||
163306652|NCT04541706|589831890|FG000|Overall Study|Lost to Follow-up|2|||
163306653|NCT04541706|589831890|FG000|Overall Study|Death|5|||
163306654|NCT04541706|589831890|FG000|Overall Study|Adverse Event|1|||
163306655|NCT03436745|589831892|FG000|Overall Study|Ineligible|0|||
163306656|NCT03436745|589831893|FG001|Overall Study|Ineligible|0|||
163306657|NCT03436745|589831894|FG002|Overall Study|Ineligible|1|||
163306658|NCT01772472|589831902|FG000|Overall Study|Death|126|||
163306659|NCT01772472|589831903|FG001|Overall Study|Death|94|||
163306660|NCT01772472|589831902|FG000|Overall Study|Lost to Follow-up|51|||
163306661|NCT01772472|589831903|FG001|Overall Study|Lost to Follow-up|50|||
163306662|NCT01772472|589831902|FG000|Overall Study|Other|9|||
163306663|NCT01772472|589831903|FG001|Overall Study|Other|7|||
163306664|NCT01772472|589831902|FG000|Overall Study|Physician Decision|1|||
163306665|NCT01772472|589831903|FG001|Overall Study|Physician Decision|7|||
163306666|NCT01772472|589831902|FG000|Overall Study|Withdrawal by Subject|115|||
163306667|NCT01772472|589831903|FG001|Overall Study|Withdrawal by Subject|90|||
163306668|NCT01772472|589831902|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
163306669|NCT01772472|589831903|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
163306670|NCT02697136|589831904|FG000|Overall Study|Adverse Event|3|||
163306671|NCT02697136|589831905|FG001|Overall Study|Adverse Event|0|||
163306672|NCT04391894|589831906|FG000|Overall Study|Adverse Event|1|||
163306673|NCT04391894|589831907|FG001|Overall Study|Adverse Event|1|||
163306674|NCT04391894|589831908|FG002|Overall Study|Adverse Event|1|||
163306675|NCT04391894|589831909|FG003|Overall Study|Adverse Event|1|||
163306676|NCT04391894|589831910|FG004|Overall Study|Adverse Event|1|||
163306677|NCT04391894|589831906|FG000|Overall Study|Lost to Follow-up|1|||
163306678|NCT04391894|589831907|FG001|Overall Study|Lost to Follow-up|0|||
163306679|NCT04391894|589831908|FG002|Overall Study|Lost to Follow-up|0|||
163306680|NCT04391894|589831909|FG003|Overall Study|Lost to Follow-up|0|||
163306681|NCT04391894|589831910|FG004|Overall Study|Lost to Follow-up|0|||
163306682|NCT04391894|589831906|FG000|Overall Study|Protocol Violation|0|||
163306683|NCT04391894|589831907|FG001|Overall Study|Protocol Violation|0|||
163306684|NCT04391894|589831908|FG002|Overall Study|Protocol Violation|0|||
163306685|NCT04391894|589831909|FG003|Overall Study|Protocol Violation|1|||
163306686|NCT04391894|589831910|FG004|Overall Study|Protocol Violation|0|||
163306687|NCT04391894|589831906|FG000|Overall Study|Withdrawal by Subject|2|||
163306688|NCT04391894|589831907|FG001|Overall Study|Withdrawal by Subject|0|||
163306689|NCT04391894|589831908|FG002|Overall Study|Withdrawal by Subject|3|||
163306690|NCT04391894|589831909|FG003|Overall Study|Withdrawal by Subject|0|||
163306691|NCT04391894|589831910|FG004|Overall Study|Withdrawal by Subject|1|||
163306692|NCT04391894|589831906|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
163306693|NCT04391894|589831907|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
163306694|NCT04391894|589831908|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
163306695|NCT04391894|589831909|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
163306696|NCT04391894|589831910|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
163306697|NCT02323321|589831914|FG000|Overall Study|Re-Transplant|1|||
163306698|NCT02323321|589831914|FG000|Overall Study|Death|12|||
163306699|NCT00446225|589831915|FG000|Overall Study|Protocol Violation|1|||
163306700|NCT00446225|589831916|FG001|Overall Study|Protocol Violation|0|||
163306701|NCT02500758|589831919|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
163306702|NCT02500758|589831920|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
163306703|NCT02500758|589831919|FG000|Washout (1 Week)|Lost to Follow-up|2|||
163306704|NCT02500758|589831920|FG001|Washout (1 Week)|Lost to Follow-up|2|||
163306705|NCT02500758|589831919|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
163306706|NCT02500758|589831920|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
163306707|NCT02500758|589831919|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
163396974|NCT00097773|590164363|FG000|Overall Study|Withdrawal by Subject|3|||
163306708|NCT02500758|589831920|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
163306709|NCT02500758|589831919|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
163396975|NCT00097773|590164364|FG001|Overall Study|Withdrawal by Subject|3|||
163306710|NCT02500758|589831920|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
163306711|NCT00220740|589831921|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
163306712|NCT00220740|589831922|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
163306713|NCT00220740|589831921|FG000|Efficacy Period|Adverse Event|1|||
163306714|NCT00220740|589831922|FG001|Efficacy Period|Adverse Event|1|||
163306715|NCT00220740|589831921|FG000|Efficacy Period|Withdrawal by Subject|1|||
163306716|NCT00220740|589831922|FG001|Efficacy Period|Withdrawal by Subject|0|||
163306717|NCT00220740|589831921|FG000|Efficacy Period|Protocol Violation|1|||
163306718|NCT00220740|589831922|FG001|Efficacy Period|Protocol Violation|0|||
163306719|NCT00220740|589831921|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
163306720|NCT00220740|589831922|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
163306721|NCT01057433|589831923|FG000|Overall Study|Adverse Event|1|||
163306722|NCT04854096|589831925|FG000|Overall Study|Adverse Event|1|||
163306723|NCT04854096|589831926|FG001|Overall Study|Adverse Event|0|||
163306724|NCT04854096|589831925|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
163306725|NCT04854096|589831926|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
163306726|NCT04854096|589831925|FG000|Overall Study|Withdrawal by Subject|1|||
163306727|NCT04854096|589831926|FG001|Overall Study|Withdrawal by Subject|0|||
163306728|NCT04854096|589831925|FG000|Overall Study|Other reasons|1|||
163306729|NCT04854096|589831926|FG001|Overall Study|Other reasons|0|||
163050838|NCT02573259|588893695|FG004|Overall Study|Other|1|||
163050839|NCT02573259|588893696|FG005|Overall Study|Other|4|||
163050840|NCT02573259|588893697|FG006|Overall Study|Other|5|||
163050841|NCT00751140|588893698|FG000|Overall Study|benign angioma excluded from analysis|1|||
163050842|NCT00808067|588893699|FG000|Overall Study|Major/minor bleed|30|||
163050843|NCT00808067|588893700|FG001|Overall Study|Major/minor bleed|44|||
163050844|NCT00808067|588893699|FG000|Overall Study|Outcome event - other|33|||
163050845|NCT00808067|588893700|FG001|Overall Study|Outcome event - other|25|||
163050846|NCT00808067|588893699|FG000|Overall Study|Adverse Event|111|||
163050847|NCT00808067|588893700|FG001|Overall Study|Adverse Event|121|||
163050848|NCT00808067|588893699|FG000|Overall Study|Hospitalization (not including surgery)|18|||
163050849|NCT00808067|588893700|FG001|Overall Study|Hospitalization (not including surgery)|17|||
163050850|NCT00808067|588893699|FG000|Overall Study|Hospitalization due to surgery|37|||
163050851|NCT00808067|588893700|FG001|Overall Study|Hospitalization due to surgery|40|||
163050852|NCT00808067|588893699|FG000|Overall Study|Reduced creatinine clearance|53|||
163050853|NCT00808067|588893700|FG001|Overall Study|Reduced creatinine clearance|55|||
163050854|NCT00808067|588893699|FG000|Overall Study|Elevated LFT results|7|||
163050855|NCT00808067|588893700|FG001|Overall Study|Elevated LFT results|3|||
163050856|NCT00808067|588893699|FG000|Overall Study|Patient refused to take study medication|65|||
163050857|NCT00808067|588893700|FG001|Overall Study|Patient refused to take study medication|76|||
163050858|NCT00808067|588893699|FG000|Overall Study|Missing|1|||
163050859|NCT00808067|588893700|FG001|Overall Study|Missing|0|||
163050860|NCT00808067|588893699|FG000|Overall Study|Death|1|||
163050861|NCT00808067|588893700|FG001|Overall Study|Death|1|||
163306730|NCT03930342|589831929|FG000|Overall Study|Lost to Follow-up|70|||
163306731|NCT03930342|589831930|FG001|Overall Study|Lost to Follow-up|77|||
163306732|NCT02742519|589831933|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
163306733|NCT02742519|589831934|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
163306734|NCT02742519|589831935|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
163306735|NCT02742519|589831933|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
163306736|NCT02742519|589831934|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
163306737|NCT02742519|589831935|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
163306738|NCT02742519|589831933|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
163306739|NCT02742519|589831934|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
163306740|NCT02742519|589831935|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
163306741|NCT01872078|589831937|FG000|Overall Study|Adverse Event|0|||
163050862|NCT00808067|588893699|FG000|Overall Study|Procedure|6|||
163306742|NCT01872078|589831938|FG001|Overall Study|Adverse Event|0|||
163306743|NCT01872078|589831939|FG002|Overall Study|Adverse Event|1|||
163050863|NCT00808067|588893700|FG001|Overall Study|Procedure|7|||
163050864|NCT00808067|588893699|FG000|Overall Study|Withdrawal by Subject|21|||
163050865|NCT00808067|588893700|FG001|Overall Study|Withdrawal by Subject|25|||
163050866|NCT00808067|588893699|FG000|Overall Study|Site closed|4|||
163050867|NCT00808067|588893700|FG001|Overall Study|Site closed|3|||
163199845|NCT03724032|589445429|FG000|Overall Study|Physician Decision|1|||
163199846|NCT03724032|589445430|FG001|Overall Study|Physician Decision|0|||
163199847|NCT03724032|589445431|FG002|Overall Study|Physician Decision|0|||
163199848|NCT03724032|589445429|FG000|Overall Study|Protocol Violation|2|||
163199849|NCT03724032|589445430|FG001|Overall Study|Protocol Violation|2|||
163199850|NCT03724032|589445431|FG002|Overall Study|Protocol Violation|1|||
163199851|NCT00751933|589445432|FG000|Overall Study|Withdrawal by Subject|0|||
163199852|NCT00751933|589445433|FG001|Overall Study|Withdrawal by Subject|1|||
163199853|NCT00751933|589445434|FG002|Overall Study|Withdrawal by Subject|0|||
163199854|NCT00751933|589445435|FG003|Overall Study|Withdrawal by Subject|0|||
163306744|NCT01872078|589831940|FG003|Overall Study|Adverse Event|0|||
163306745|NCT01872078|589831937|FG000|Overall Study|Dose administration non-compliance|0|||
163306746|NCT01872078|589831938|FG001|Overall Study|Dose administration non-compliance|0|||
163306747|NCT01872078|589831939|FG002|Overall Study|Dose administration non-compliance|0|||
163306748|NCT01872078|589831940|FG003|Overall Study|Dose administration non-compliance|1|||
163306749|NCT01872078|589831937|FG000|Overall Study|Protocol Violation|0|||
163306750|NCT01872078|589831938|FG001|Overall Study|Protocol Violation|0|||
163306751|NCT01872078|589831939|FG002|Overall Study|Protocol Violation|1|||
163306752|NCT01872078|589831940|FG003|Overall Study|Protocol Violation|0|||
163306753|NCT01872078|589831937|FG000|Overall Study|Withdrawal by Subject|0|||
163306754|NCT01872078|589831938|FG001|Overall Study|Withdrawal by Subject|0|||
163306755|NCT01872078|589831939|FG002|Overall Study|Withdrawal by Subject|1|||
163306756|NCT01872078|589831940|FG003|Overall Study|Withdrawal by Subject|0|||
163306757|NCT01872078|589831937|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
163306758|NCT01872078|589831938|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
163306759|NCT01872078|589831939|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
163306760|NCT01872078|589831940|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
163306761|NCT01091168|589831941|FG000|Overall Study|Progressive disease|250|||
163306762|NCT01091168|589831942|FG001|Overall Study|Progressive disease|234|||
163306763|NCT01091168|589831941|FG000|Overall Study|Adverse Event|21|||
163306764|NCT01091168|589831942|FG001|Overall Study|Adverse Event|24|||
163306765|NCT01091168|589831941|FG000|Overall Study|Lost to Follow-up|0|||
163306766|NCT01091168|589831942|FG001|Overall Study|Lost to Follow-up|1|||
163306767|NCT01091168|589831941|FG000|Overall Study|Physician, patient's decision, other|27|||
163306768|NCT01091168|589831942|FG001|Overall Study|Physician, patient's decision, other|37|||
163306769|NCT05792423|589831943|FG000|Overall Study|Withdrawal by Subject|2|||
163306770|NCT04052516|589833766|FG000|Overall Study|Withdrawal by Subject|4|||
163306771|NCT04052516|589833767|FG001|Overall Study|Withdrawal by Subject|5|||
163306772|NCT04052516|589833768|FG002|Overall Study|Withdrawal by Subject|6|||
163306773|NCT04052516|589833766|FG000|Overall Study|Adverse Event|3|||
163306774|NCT04052516|589833767|FG001|Overall Study|Adverse Event|2|||
163306775|NCT04052516|589833768|FG002|Overall Study|Adverse Event|8|||
163306776|NCT04052516|589833766|FG000|Overall Study|Lost to Follow-up|2|||
163306777|NCT04052516|589833767|FG001|Overall Study|Lost to Follow-up|5|||
163306778|NCT04052516|589833768|FG002|Overall Study|Lost to Follow-up|3|||
163306779|NCT04052516|589833766|FG000|Overall Study|Protocol Violation|1|||
163306780|NCT04052516|589833767|FG001|Overall Study|Protocol Violation|1|||
163306781|NCT04052516|589833768|FG002|Overall Study|Protocol Violation|0|||
163306782|NCT04052516|589833766|FG000|Overall Study|Death|1|||
163306783|NCT04052516|589833767|FG001|Overall Study|Death|0|||
163306784|NCT04052516|589833768|FG002|Overall Study|Death|0|||
163306785|NCT04052516|589833766|FG000|Overall Study|Physician Decision|0|||
163306786|NCT04052516|589833767|FG001|Overall Study|Physician Decision|1|||
163306787|NCT04052516|589833768|FG002|Overall Study|Physician Decision|0|||
163306788|NCT04052516|589833766|FG000|Overall Study|Pregnancy|1|||
163306789|NCT04052516|589833767|FG001|Overall Study|Pregnancy|0|||
163306790|NCT04052516|589833768|FG002|Overall Study|Pregnancy|0|||
163306791|NCT04052516|589833766|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
163199855|NCT00751933|589445432|FG000|Overall Study|Physician Decision|0|||
163199856|NCT00751933|589445433|FG001|Overall Study|Physician Decision|0|||
163199857|NCT00751933|589445434|FG002|Overall Study|Physician Decision|1|||
163199858|NCT00751933|589445435|FG003|Overall Study|Physician Decision|1|||
163199859|NCT00361569|589445437|FG000|Overall Study|Protocol Violation|3|||
163199860|NCT00361569|589445438|FG001|Overall Study|Protocol Violation|2|||
163199861|NCT00361569|589445439|FG002|Overall Study|Protocol Violation|4|||
163199862|NCT00361569|589445440|FG003|Overall Study|Protocol Violation|2|||
163199863|NCT00361569|589445437|FG000|Overall Study|Withdrawal by Subject|2|||
163199864|NCT00361569|589445438|FG001|Overall Study|Withdrawal by Subject|1|||
163199865|NCT00361569|589445439|FG002|Overall Study|Withdrawal by Subject|9|||
163199866|NCT00361569|589445440|FG003|Overall Study|Withdrawal by Subject|14|||
163199867|NCT00361569|589445437|FG000|Overall Study|Adverse Event|3|||
163199868|NCT00361569|589445438|FG001|Overall Study|Adverse Event|5|||
163199869|NCT00361569|589445439|FG002|Overall Study|Adverse Event|2|||
163199870|NCT00361569|589445440|FG003|Overall Study|Adverse Event|2|||
163199871|NCT00361569|589445437|FG000|Overall Study|Lost to Follow-up|2|||
163199872|NCT00361569|589445438|FG001|Overall Study|Lost to Follow-up|3|||
163199873|NCT00361569|589445439|FG002|Overall Study|Lost to Follow-up|3|||
163199874|NCT00361569|589445440|FG003|Overall Study|Lost to Follow-up|2|||
163199875|NCT00361569|589445437|FG000|Overall Study|Not specified by investigator|2|||
163199876|NCT00361569|589445438|FG001|Overall Study|Not specified by investigator|0|||
163199877|NCT00361569|589445439|FG002|Overall Study|Not specified by investigator|0|||
163199878|NCT00361569|589445440|FG003|Overall Study|Not specified by investigator|1|||
163199879|NCT02605824|589445441|FG000|Overall Study|Physician Decision|1|||
163199880|NCT02605824|589445442|FG001|Overall Study|Physician Decision|0|||
163199881|NCT04875195|589445443|FG000|Overall Study|Death|9|||
163199882|NCT04875195|589445444|FG001|Overall Study|Death|3|||
163199883|NCT04875195|589445443|FG000|Overall Study|Withdrawal by Subject|2|||
163199884|NCT04875195|589445444|FG001|Overall Study|Withdrawal by Subject|1|||
163199885|NCT04875195|589445443|FG000|Overall Study|Ongoing in study|49|||
163199886|NCT04875195|589445444|FG001|Overall Study|Ongoing in study|2|||
163199887|NCT02339584|589445445|FG000|Overall Study|Adverse Event|11|||
163199888|NCT02339584|589445446|FG001|Overall Study|Adverse Event|7|||
163199889|NCT02339584|589445445|FG000|Overall Study|Lack of Efficacy|0|||
163199890|NCT02339584|589445446|FG001|Overall Study|Lack of Efficacy|1|||
163199891|NCT02339584|589445445|FG000|Overall Study|Physician Decision|1|||
163199892|NCT02339584|589445446|FG001|Overall Study|Physician Decision|2|||
163199893|NCT02339584|589445445|FG000|Overall Study|Protocol Violation|1|||
163199894|NCT02339584|589445446|FG001|Overall Study|Protocol Violation|1|||
163199895|NCT02339584|589445445|FG000|Overall Study|Withdrawal by Subject|2|||
163199896|NCT02339584|589445446|FG001|Overall Study|Withdrawal by Subject|4|||
163199897|NCT00826943|589445447|FG000|Overall Study|Withdrawal by Subject|0|||
163199898|NCT00826943|589445448|FG001|Overall Study|Withdrawal by Subject|0|||
163199899|NCT00826943|589445449|FG002|Overall Study|Withdrawal by Subject|0|||
163199900|NCT00826943|589445450|FG003|Overall Study|Withdrawal by Subject|0|||
163199901|NCT00826943|589445451|FG004|Overall Study|Withdrawal by Subject|1|||
163199902|NCT00826943|589445452|FG005|Overall Study|Withdrawal by Subject|0|||
163199903|NCT03715530|589445453|FG000|Overall Study|Lost to Follow-up|3|||
163199904|NCT03715530|589445454|FG001|Overall Study|Lost to Follow-up|1|||
163199905|NCT03715530|589445455|FG002|Overall Study|Lost to Follow-up|2|||
163199906|NCT01594762|589445456|FG000|Overall Study|Withdrawal by Subject|1|||
163199907|NCT01594762|589445457|FG001|Overall Study|Withdrawal by Subject|0|||
163199908|NCT01594762|589445456|FG000|Overall Study|Lost to Follow-up|10|||
163199909|NCT01594762|589445457|FG001|Overall Study|Lost to Follow-up|10|||
163199910|NCT03338998|589445461|FG000|Treatment Period|Withdrawal by Subject|1|||
163199911|NCT03338998|589445462|FG001|Treatment Period|Withdrawal by Subject|1|||
163199912|NCT03338998|589445461|FG000|Treatment Period|Adverse Event|0|||
163199913|NCT03338998|589445462|FG001|Treatment Period|Adverse Event|2|||
163199914|NCT03338998|589445461|FG000|Treatment Period|Protocol deviation|1|||
163199915|NCT03338998|589445462|FG001|Treatment Period|Protocol deviation|0|||
163199916|NCT03338998|589445461|FG000|Treatment Period|Physician Decision|2|||
163199917|NCT03338998|589445462|FG001|Treatment Period|Physician Decision|0|||
163199918|NCT03338998|589445461|FG000|Treatment Period|Subject failed swallow test|4|||
163199919|NCT03338998|589445462|FG001|Treatment Period|Subject failed swallow test|0|||
163199920|NCT03338998|589445461|FG000|Safety Follow-Up Period|Adverse Event|0|||
163199921|NCT03338998|589445462|FG001|Safety Follow-Up Period|Adverse Event|1|||
163199922|NCT03338998|589445461|FG000|Safety Follow-Up Period|Protocol deviation|1|||
163199923|NCT03338998|589445462|FG001|Safety Follow-Up Period|Protocol deviation|0|||
163050868|NCT00808067|588893699|FG000|Overall Study|Physician Decision|47|||
163199924|NCT03338998|589445461|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
163199925|NCT03338998|589445462|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
163199926|NCT04706091|589445465|FG000|Treatment 2|Withdrawal by Subject|1|||
163199927|NCT04706091|589445466|FG001|Treatment 2|Withdrawal by Subject|0|||
163199928|NCT03329573|589445467|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
163050869|NCT00808067|588893700|FG001|Overall Study|Physician Decision|38|||
163050870|NCT00808067|588893699|FG000|Overall Study|Protocol Violation|3|||
163050871|NCT00808067|588893700|FG001|Overall Study|Protocol Violation|11|||
163050872|NCT00808067|588893699|FG000|Overall Study|Patient elected|7|||
163050873|NCT00808067|588893700|FG001|Overall Study|Patient elected|9|||
163050874|NCT00808067|588893699|FG000|Overall Study|Site closed for cause|19|||
163050875|NCT00808067|588893700|FG001|Overall Study|Site closed for cause|19|||
163050876|NCT00808067|588893699|FG000|Overall Study|Other reason not defined above|5|||
163050877|NCT00808067|588893700|FG001|Overall Study|Other reason not defined above|5|||
163050878|NCT00808067|588893699|FG000|Overall Study|Excluded from analysis|13|||
163050879|NCT00808067|588893700|FG001|Overall Study|Excluded from analysis|19|||
163050880|NCT01107925|588893703|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
163050881|NCT01107925|588893704|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
163050882|NCT01107925|588893705|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
163050883|NCT01107925|588893706|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
163050884|NCT01107925|588893707|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
163050885|NCT01107925|588893708|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
163050886|NCT01107925|588893703|FG000|Period 2|Withdrawal by Subject|0|||
163050887|NCT01107925|588893704|FG001|Period 2|Withdrawal by Subject|1|||
163050888|NCT01107925|588893705|FG002|Period 2|Withdrawal by Subject|0|||
163050889|NCT01107925|588893706|FG003|Period 2|Withdrawal by Subject|0|||
163050890|NCT01107925|588893707|FG004|Period 2|Withdrawal by Subject|0|||
163050891|NCT01107925|588893708|FG005|Period 2|Withdrawal by Subject|1|||
163050892|NCT01817075|588893710|FG000|Overall Study|Adverse Event|7|||
163050893|NCT01817075|588893711|FG001|Overall Study|Adverse Event|5|||
163050894|NCT01817075|588893710|FG000|Overall Study|Physician Decision|9|||
163050895|NCT01817075|588893711|FG001|Overall Study|Physician Decision|12|||
163050896|NCT01817075|588893710|FG000|Overall Study|Withdrawal by Subject|31|||
163050897|NCT01817075|588893711|FG001|Overall Study|Withdrawal by Subject|15|||
163050898|NCT01817075|588893710|FG000|Overall Study|Received Sorafenib after enrollment|0|||
163050899|NCT01817075|588893711|FG001|Overall Study|Received Sorafenib after enrollment|1|||
163050900|NCT01817075|588893710|FG000|Overall Study|Ineligible|0|||
163050901|NCT01817075|588893711|FG001|Overall Study|Ineligible|2|||
163050902|NCT04157517|588893712|FG000|Overall Study|Death|1|||
163050903|NCT04157517|588893713|FG001|Overall Study|Death|2|||
163050904|NCT04157517|588893714|FG002|Overall Study|Death|2|||
163050905|NCT04157517|588893715|FG003|Overall Study|Death|3|||
163050906|NCT04157517|588893716|FG004|Overall Study|Death|3|||
163050907|NCT04157517|588893717|FG005|Overall Study|Death|4|||
163050908|NCT04157517|588893718|FG006|Overall Study|Death|1|||
163050909|NCT04157517|588893719|FG007|Overall Study|Death|2|||
163050910|NCT04157517|588893720|FG008|Overall Study|Death|4|||
163050911|NCT04157517|588893721|FG009|Overall Study|Death|0|||
163050912|NCT04157517|588893712|FG000|Overall Study|Withdrawal by Subject|1|||
163050913|NCT04157517|588893713|FG001|Overall Study|Withdrawal by Subject|1|||
163050914|NCT04157517|588893714|FG002|Overall Study|Withdrawal by Subject|1|||
163050915|NCT04157517|588893715|FG003|Overall Study|Withdrawal by Subject|0|||
163050916|NCT04157517|588893716|FG004|Overall Study|Withdrawal by Subject|0|||
163050917|NCT04157517|588893717|FG005|Overall Study|Withdrawal by Subject|1|||
163050918|NCT04157517|588893718|FG006|Overall Study|Withdrawal by Subject|0|||
163050919|NCT04157517|588893719|FG007|Overall Study|Withdrawal by Subject|0|||
163050920|NCT04157517|588893720|FG008|Overall Study|Withdrawal by Subject|1|||
163050921|NCT04157517|588893721|FG009|Overall Study|Withdrawal by Subject|0|||
163050922|NCT04157517|588893712|FG000|Overall Study|Other|1|||
163050923|NCT04157517|588893713|FG001|Overall Study|Other|0|||
163050924|NCT04157517|588893714|FG002|Overall Study|Other|0|||
163050925|NCT04157517|588893715|FG003|Overall Study|Other|0|||
163199929|NCT03329573|589445468|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
163050926|NCT04157517|588893716|FG004|Overall Study|Other|0|||
163050927|NCT04157517|588893717|FG005|Overall Study|Other|1|||
163050928|NCT04157517|588893718|FG006|Overall Study|Other|2|||
163050929|NCT04157517|588893719|FG007|Overall Study|Other|7|||
163050930|NCT04157517|588893720|FG008|Overall Study|Other|7|||
163050931|NCT04157517|588893721|FG009|Overall Study|Other|0|||
163199930|NCT03329573|589445469|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
163050932|NCT01395810|588893728|FG000|Overall Study|Adverse Event|0|||
163050933|NCT01395810|588893729|FG001|Overall Study|Adverse Event|1|||
163050934|NCT01395810|588893730|FG002|Overall Study|Adverse Event|0|||
163050935|NCT01395810|588893731|FG003|Overall Study|Adverse Event|0|||
163050936|NCT01395810|588893728|FG000|Overall Study|Lack of Efficacy|0|||
163050937|NCT01395810|588893729|FG001|Overall Study|Lack of Efficacy|1|||
163050938|NCT01395810|588893730|FG002|Overall Study|Lack of Efficacy|0|||
163050939|NCT01395810|588893731|FG003|Overall Study|Lack of Efficacy|0|||
163050940|NCT01395810|588893728|FG000|Overall Study|Withdrawal criteria|0|||
163050941|NCT01395810|588893729|FG001|Overall Study|Withdrawal criteria|2|||
163050942|NCT01395810|588893730|FG002|Overall Study|Withdrawal criteria|0|||
163050943|NCT01395810|588893731|FG003|Overall Study|Withdrawal criteria|0|||
163050944|NCT01395810|588893728|FG000|Overall Study|Unclassified|2|||
163050945|NCT01395810|588893729|FG001|Overall Study|Unclassified|0|||
163050946|NCT01395810|588893730|FG002|Overall Study|Unclassified|0|||
163050947|NCT01395810|588893731|FG003|Overall Study|Unclassified|0|||
163050948|NCT00830219|588895326|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
163050949|NCT00830219|588895327|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
163050950|NCT01130272|588895328|FG000|Overall Study|Adverse Event|2|||
163050951|NCT01130272|588895329|FG001|Overall Study|Adverse Event|5|||
163050952|NCT01130272|588895330|FG002|Overall Study|Adverse Event|6|||
163050953|NCT01130272|588895331|FG003|Overall Study|Adverse Event|22|||
163050954|NCT01130272|588895332|FG004|Overall Study|Adverse Event|7|||
163199931|NCT03329573|589445470|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
163199932|NCT03329573|589445467|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
163199933|NCT03329573|589445468|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
163199934|NCT03329573|589445469|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163199935|NCT03329573|589445470|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163199936|NCT03329573|589445467|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
163199937|NCT03329573|589445468|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
163199938|NCT03329573|589445469|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
163199939|NCT03329573|589445470|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
163199940|NCT03329573|589445467|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
163199941|NCT03329573|589445468|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
163199942|NCT03329573|589445469|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
163199943|NCT03329573|589445470|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
163199944|NCT05695209|589445480|FG000|3-months|Withdrawal by Subject|2|||
163199945|NCT05695209|589445481|FG001|3-months|Withdrawal by Subject|0|||
163199946|NCT05695209|589445480|FG000|3-months|Unable to contact for 3-month data collection|0|||
163199947|NCT05695209|589445481|FG001|3-months|Unable to contact for 3-month data collection|1|||
163199948|NCT05695209|589445480|FG000|6-months|Lost to Follow-up|1|||
163199949|NCT05695209|589445481|FG001|6-months|Lost to Follow-up|1|||
163199950|NCT03069378|589445482|FG000|Overall Study|Withdrawal by Subject|1|||
163199951|NCT01397708|589445483|FG000|Overall Study|Withdrawal by Subject|0|||
163199952|NCT01397708|589445484|FG001|Overall Study|Withdrawal by Subject|0|||
163199953|NCT01397708|589445485|FG002|Overall Study|Withdrawal by Subject|1|||
163199954|NCT01397708|589445486|FG003|Overall Study|Withdrawal by Subject|0|||
163199955|NCT01397708|589445487|FG004|Overall Study|Withdrawal by Subject|0|||
163199956|NCT01397708|589445488|FG005|Overall Study|Withdrawal by Subject|0|||
163199957|NCT01397708|589445489|FG006|Overall Study|Withdrawal by Subject|0|||
163199958|NCT01397708|589445490|FG007|Overall Study|Withdrawal by Subject|1|||
163199959|NCT01397708|589445483|FG000|Overall Study|Death|0|||
163199960|NCT01397708|589445484|FG001|Overall Study|Death|0|||
163199961|NCT01397708|589445485|FG002|Overall Study|Death|1|||
163199962|NCT01397708|589445486|FG003|Overall Study|Death|1|||
163199963|NCT01397708|589445487|FG004|Overall Study|Death|0|||
163199964|NCT01397708|589445488|FG005|Overall Study|Death|0|||
163199965|NCT01397708|589445489|FG006|Overall Study|Death|0|||
163199966|NCT01397708|589445490|FG007|Overall Study|Death|0|||
163199967|NCT01397708|589445483|FG000|Overall Study|Lost to Follow-up|0|||
163199968|NCT01397708|589445484|FG001|Overall Study|Lost to Follow-up|0|||
163199969|NCT01397708|589445485|FG002|Overall Study|Lost to Follow-up|0|||
163199970|NCT01397708|589445486|FG003|Overall Study|Lost to Follow-up|0|||
163199971|NCT01397708|589445487|FG004|Overall Study|Lost to Follow-up|1|||
163199972|NCT01397708|589445488|FG005|Overall Study|Lost to Follow-up|0|||
163199973|NCT01397708|589445489|FG006|Overall Study|Lost to Follow-up|0|||
163050955|NCT01130272|588895328|FG000|Overall Study|IVRS-confirmed constipation|0|||
163050956|NCT01130272|588895329|FG001|Overall Study|IVRS-confirmed constipation|1|||
163050957|NCT01130272|588895330|FG002|Overall Study|IVRS-confirmed constipation|1|||
163050958|NCT01130272|588895331|FG003|Overall Study|IVRS-confirmed constipation|2|||
163199974|NCT01397708|589445490|FG007|Overall Study|Lost to Follow-up|0|||
163199975|NCT01397708|589445483|FG000|Overall Study|Other|0|||
163050959|NCT01130272|588895332|FG004|Overall Study|IVRS-confirmed constipation|0|||
163050960|NCT01130272|588895328|FG000|Overall Study|Rescue medications due to diarrhea|3|||
163199976|NCT01397708|589445484|FG001|Overall Study|Other|0|||
163199977|NCT01397708|589445485|FG002|Overall Study|Other|0|||
163199978|NCT01397708|589445486|FG003|Overall Study|Other|0|||
163199979|NCT01397708|589445487|FG004|Overall Study|Other|0|||
163199980|NCT01397708|589445488|FG005|Overall Study|Other|0|||
163199981|NCT01397708|589445489|FG006|Overall Study|Other|1|||
163199982|NCT01397708|589445490|FG007|Overall Study|Other|0|||
163199983|NCT04997304|589445491|FG000|Overall Study|Lost to Follow-up|11|||
163199984|NCT04997304|589445491|FG000|Overall Study|Death|1|||
163199985|NCT04997304|589445491|FG000|Overall Study|Withdrawal by Subject|14|||
163199986|NCT01606800|589447097|FG000|Overall Study|Adverse Event|3|||
163199987|NCT01606800|589447098|FG001|Overall Study|Adverse Event|1|||
163199988|NCT01606800|589447097|FG000|Overall Study|Participant withdrew consent|0|||
163199989|NCT01606800|589447098|FG001|Overall Study|Participant withdrew consent|1|||
163199990|NCT01606800|589447097|FG000|Overall Study|Missing completion status|2|||
163199991|NCT01606800|589447098|FG001|Overall Study|Missing completion status|0|||
163199992|NCT00612690|589447104|FG000|Overall Study|Lost to Follow-up|72|||
163199993|NCT00612690|589447105|FG001|Overall Study|Lost to Follow-up|98|||
163199994|NCT00612690|589447104|FG000|Overall Study|Withdrawal by Subject|32|||
163199995|NCT00612690|589447105|FG001|Overall Study|Withdrawal by Subject|20|||
163199996|NCT00612690|589447104|FG000|Overall Study|Withdrawal by Site|11|||
163199997|NCT00612690|589447105|FG001|Overall Study|Withdrawal by Site|0|||
163199998|NCT02370160|589447108|FG000|Overall Study|Death|3|||
163199999|NCT02370160|589447109|FG001|Overall Study|Death|4|||
163200000|NCT02370160|589447110|FG002|Overall Study|Death|1|||
163200001|NCT04487730|589447111|FG000|Overall Study|Withdrawal by Subject|3|||
163200002|NCT04487730|589447112|FG001|Overall Study|Withdrawal by Subject|1|||
163200003|NCT04487730|589447111|FG000|Overall Study|Lost to Follow-up|0|||
163200004|NCT04487730|589447112|FG001|Overall Study|Lost to Follow-up|1|||
163200005|NCT04487730|589447111|FG000|Overall Study|Physician Decision|0|||
163200006|NCT04487730|589447112|FG001|Overall Study|Physician Decision|1|||
163200007|NCT00907777|589447113|FG000|Overall Study|Withdrawal by Subject|0|||
163200008|NCT00907777|589447114|FG001|Overall Study|Withdrawal by Subject|1|||
163200009|NCT03291808|589447115|FG000|Overall Study|Lost to Follow-up|6|||
163200010|NCT03291808|589447115|FG000|Overall Study|Research burden|4|||
163200011|NCT00638378|589447116|FG000|Overall Study|Death|2|||
163200012|NCT00638378|589447116|FG000|Overall Study|Adverse Event|1|||
163200013|NCT00638378|589447116|FG000|Overall Study|Disease progression|15|||
163200014|NCT00638378|589447116|FG000|Overall Study|Physician Decision|4|||
163200015|NCT03364023|589447119|FG000|Overall Study|Lost to Follow-up|3|||
163200016|NCT03364023|589447119|FG000|Overall Study|Death|14|||
163200017|NCT02891850|589447120|FG000|Overall Study|Adverse Event|3|||
163200018|NCT02891850|589447121|FG001|Overall Study|Adverse Event|0|||
163200019|NCT02891850|589447120|FG000|Overall Study|Death|0|||
163200020|NCT02891850|589447121|FG001|Overall Study|Death|4|||
163200021|NCT02891850|589447120|FG000|Overall Study|Physician Decision|1|||
163200022|NCT02891850|589447121|FG001|Overall Study|Physician Decision|0|||
163200023|NCT02891850|589447120|FG000|Overall Study|Pregnancy|1|||
163200024|NCT02891850|589447121|FG001|Overall Study|Pregnancy|0|||
163200025|NCT02891850|589447120|FG000|Overall Study|Withdrawal by Subject|2|||
163200026|NCT02891850|589447121|FG001|Overall Study|Withdrawal by Subject|3|||
163200027|NCT03797014|589447124|FG000|Overall Study|Withdrawal by Subject|1|||
163200028|NCT03797014|589447124|FG000|Overall Study|Lost to Follow-up|1|||
163200029|NCT03797014|589447124|FG000|Overall Study|Protocol Violation|1|||
163200030|NCT01970397|589447125|FG000|Overall Study|Adverse Event|0|||
163200031|NCT01970397|589447126|FG001|Overall Study|Adverse Event|1|||
163200032|NCT01970397|589447125|FG000|Overall Study|Lost to Follow-up|0|||
163200033|NCT01970397|589447126|FG001|Overall Study|Lost to Follow-up|1|||
163200034|NCT01970397|589447125|FG000|Overall Study|Personal Reasons|1|||
163200035|NCT01970397|589447126|FG001|Overall Study|Personal Reasons|2|||
163200036|NCT01970397|589447125|FG000|Overall Study|Protocol Violation|1|||
163200037|NCT01970397|589447126|FG001|Overall Study|Protocol Violation|1|||
163200038|NCT00105469|589447131|FG000|Overall Study|Adverse Event|9|||
163200039|NCT00105469|589447132|FG001|Overall Study|Adverse Event|8|||
163200040|NCT00105469|589447131|FG000|Overall Study|Protocol Violation|4|||
163200041|NCT00105469|589447132|FG001|Overall Study|Protocol Violation|0|||
163200042|NCT00105469|589447131|FG000|Overall Study|Withdrawal by Subject|2|||
163200043|NCT00105469|589447132|FG001|Overall Study|Withdrawal by Subject|3|||
163200044|NCT00105469|589447131|FG000|Overall Study|Lost to Follow-up|1|||
163200045|NCT00105469|589447132|FG001|Overall Study|Lost to Follow-up|0|||
163200046|NCT00105469|589447131|FG000|Overall Study|Lack of Efficacy|2|||
163200047|NCT00105469|589447132|FG001|Overall Study|Lack of Efficacy|0|||
163306792|NCT04052516|589833767|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
163200048|NCT00105469|589447131|FG000|Overall Study|Other Reason|4|||
163200049|NCT00105469|589447132|FG001|Overall Study|Other Reason|0|||
163200050|NCT02820753|589447137|FG000|2 Month|Withdrawal by Subject|3|||
163200051|NCT02820753|589447138|FG001|2 Month|Withdrawal by Subject|3|||
163200052|NCT02820753|589447137|FG000|2 Month|Lost to Follow-up|24|||
163200053|NCT02820753|589447138|FG001|2 Month|Lost to Follow-up|26|||
163200054|NCT02820753|589447137|FG000|2 Month|Stopped per NIH Hold|51|||
163200055|NCT02820753|589447138|FG001|2 Month|Stopped per NIH Hold|13|||
163200056|NCT02820753|589447137|FG000|6 Month|Withdrawal by Subject|2|||
163200057|NCT02820753|589447138|FG001|6 Month|Withdrawal by Subject|2|||
163306793|NCT04052516|589833768|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
163306794|NCT04052516|589833766|FG000|Overall Study|Reason not recorded|0|||
163306795|NCT04052516|589833767|FG001|Overall Study|Reason not recorded|1|||
163306796|NCT04052516|589833768|FG002|Overall Study|Reason not recorded|0|||
163306797|NCT03747484|589833769|FG000|Overall Study|Lack of Efficacy|0|||
163306798|NCT03747484|589833770|FG001|Overall Study|Lack of Efficacy|1|||
163306799|NCT03747484|589833771|FG002|Overall Study|Lack of Efficacy|1|||
163306800|NCT03747484|589833772|FG003|Overall Study|Lack of Efficacy|2|||
163050961|NCT01130272|588895329|FG001|Overall Study|Rescue medications due to diarrhea|5|||
163050962|NCT01130272|588895330|FG002|Overall Study|Rescue medications due to diarrhea|8|||
163050963|NCT01130272|588895331|FG003|Overall Study|Rescue medications due to diarrhea|8|||
163050964|NCT01130272|588895332|FG004|Overall Study|Rescue medications due to diarrhea|6|||
163050965|NCT01130272|588895328|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
163050966|NCT01130272|588895329|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
163050967|NCT01130272|588895330|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
163050968|NCT01130272|588895331|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
163050969|NCT01130272|588895332|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
163050970|NCT01130272|588895328|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
163050971|NCT01130272|588895329|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
163050972|NCT01130272|588895330|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
163050973|NCT01130272|588895331|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
163050974|NCT01130272|588895332|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
163200058|NCT02820753|589447137|FG000|6 Month|Lost to Follow-up|20|||
163200059|NCT02820753|589447138|FG001|6 Month|Lost to Follow-up|27|||
163200060|NCT02820753|589447137|FG000|6 Month|Stopped per NIH Hold|81|||
163200061|NCT02820753|589447138|FG001|6 Month|Stopped per NIH Hold|81|||
163200062|NCT02820753|589447137|FG000|6 Month|Death|0|||
163200063|NCT02820753|589447138|FG001|6 Month|Death|1|||
163200064|NCT01652703|589447139|FG000|Overall Study|Withdrawal by Subject|0|||
163200065|NCT01652703|589447140|FG001|Overall Study|Withdrawal by Subject|1|||
163200066|NCT01652703|589447141|FG002|Overall Study|Withdrawal by Subject|3|||
163200067|NCT01652703|589447142|FG003|Overall Study|Withdrawal by Subject|1|||
163200068|NCT01652703|589447143|FG004|Overall Study|Withdrawal by Subject|0|||
163200069|NCT01652703|589447144|FG005|Overall Study|Withdrawal by Subject|1|||
163200070|NCT01652703|589447139|FG000|Overall Study|Other|0|||
163200071|NCT01652703|589447140|FG001|Overall Study|Other|0|||
163200072|NCT01652703|589447141|FG002|Overall Study|Other|0|||
163200073|NCT01652703|589447142|FG003|Overall Study|Other|1|||
163200074|NCT01652703|589447143|FG004|Overall Study|Other|1|||
163200075|NCT01652703|589447144|FG005|Overall Study|Other|1|||
163200076|NCT03555591|589447145|FG000|Overall Study|Protocol Violation|77|||
163200077|NCT02380677|589447153|FG000|Overall Study|Adverse Event|0|||
163200078|NCT02380677|589447154|FG001|Overall Study|Adverse Event|0|||
163200079|NCT02380677|589447155|FG002|Overall Study|Adverse Event|0|||
163200080|NCT02380677|589447156|FG003|Overall Study|Adverse Event|1|||
163200081|NCT02380677|589447157|FG004|Overall Study|Adverse Event|1|||
163200082|NCT02380677|589447158|FG005|Overall Study|Adverse Event|4|||
163200083|NCT02380677|589447159|FG006|Overall Study|Adverse Event|2|||
163200084|NCT02380677|589447160|FG007|Overall Study|Adverse Event|2|||
163200085|NCT02380677|589447161|FG008|Overall Study|Adverse Event|2|||
163200086|NCT02380677|589447162|FG009|Overall Study|Adverse Event|1|||
163200087|NCT02380677|589447163|FG010|Overall Study|Adverse Event|2|||
163200088|NCT02380677|589447164|FG011|Overall Study|Adverse Event|1|||
163200089|NCT02380677|589447153|FG000|Overall Study|Physician Decision|1|||
163200090|NCT02380677|589447154|FG001|Overall Study|Physician Decision|0|||
163200091|NCT02380677|589447155|FG002|Overall Study|Physician Decision|1|||
163200092|NCT02380677|589447156|FG003|Overall Study|Physician Decision|1|||
163200093|NCT02380677|589447157|FG004|Overall Study|Physician Decision|0|||
163200094|NCT02380677|589447158|FG005|Overall Study|Physician Decision|0|||
163200095|NCT02380677|589447159|FG006|Overall Study|Physician Decision|0|||
163200096|NCT02380677|589447160|FG007|Overall Study|Physician Decision|0|||
163200097|NCT02380677|589447161|FG008|Overall Study|Physician Decision|0|||
163200098|NCT02380677|589447162|FG009|Overall Study|Physician Decision|0|||
163200099|NCT02380677|589447163|FG010|Overall Study|Physician Decision|0|||
163200100|NCT02380677|589447164|FG011|Overall Study|Physician Decision|0|||
163200101|NCT02380677|589447153|FG000|Overall Study|Lack of Efficacy|0|||
163200102|NCT02380677|589447154|FG001|Overall Study|Lack of Efficacy|1|||
163200103|NCT02380677|589447155|FG002|Overall Study|Lack of Efficacy|2|||
163200104|NCT02380677|589447156|FG003|Overall Study|Lack of Efficacy|0|||
163200105|NCT02380677|589447157|FG004|Overall Study|Lack of Efficacy|4|||
163306801|NCT03747484|589833773|FG004|Overall Study|Lack of Efficacy|2|||
163200106|NCT02380677|589447158|FG005|Overall Study|Lack of Efficacy|1|||
163200107|NCT02380677|589447159|FG006|Overall Study|Lack of Efficacy|1|||
163200108|NCT02380677|589447160|FG007|Overall Study|Lack of Efficacy|2|||
163200109|NCT02380677|589447161|FG008|Overall Study|Lack of Efficacy|2|||
163200110|NCT02380677|589447162|FG009|Overall Study|Lack of Efficacy|0|||
163200111|NCT02380677|589447163|FG010|Overall Study|Lack of Efficacy|2|||
163200112|NCT02380677|589447164|FG011|Overall Study|Lack of Efficacy|1|||
163200113|NCT02380677|589447153|FG000|Overall Study|Withdrawal by Subject|0|||
163200114|NCT02380677|589447154|FG001|Overall Study|Withdrawal by Subject|0|||
163200115|NCT02380677|589447155|FG002|Overall Study|Withdrawal by Subject|0|||
163200116|NCT02380677|589447156|FG003|Overall Study|Withdrawal by Subject|0|||
163200117|NCT02380677|589447157|FG004|Overall Study|Withdrawal by Subject|0|||
163200118|NCT02380677|589447158|FG005|Overall Study|Withdrawal by Subject|0|||
163200119|NCT02380677|589447159|FG006|Overall Study|Withdrawal by Subject|0|||
163200120|NCT02380677|589447160|FG007|Overall Study|Withdrawal by Subject|0|||
163200121|NCT02380677|589447161|FG008|Overall Study|Withdrawal by Subject|0|||
163200122|NCT02380677|589447162|FG009|Overall Study|Withdrawal by Subject|1|||
163200123|NCT02380677|589447163|FG010|Overall Study|Withdrawal by Subject|0|||
163200124|NCT02380677|589447164|FG011|Overall Study|Withdrawal by Subject|3|||
163200125|NCT02380677|589447153|FG000|Overall Study|Other|0|||
163200126|NCT02380677|589447154|FG001|Overall Study|Other|0|||
163200127|NCT02380677|589447155|FG002|Overall Study|Other|0|||
163200128|NCT02380677|589447156|FG003|Overall Study|Other|1|||
163200129|NCT02380677|589447157|FG004|Overall Study|Other|1|||
163200130|NCT02380677|589447158|FG005|Overall Study|Other|1|||
163200131|NCT02380677|589447159|FG006|Overall Study|Other|0|||
163200132|NCT02380677|589447160|FG007|Overall Study|Other|0|||
163200133|NCT02380677|589447161|FG008|Overall Study|Other|0|||
163200134|NCT02380677|589447162|FG009|Overall Study|Other|0|||
163200135|NCT02380677|589447163|FG010|Overall Study|Other|0|||
163200136|NCT02380677|589447164|FG011|Overall Study|Other|0|||
163200137|NCT05035550|589447165|FG000|Overall Study|Withdrawal by Subject|3|||
163200138|NCT05035550|589447166|FG001|Overall Study|Withdrawal by Subject|0|||
163200139|NCT00160693|589447169|FG000|Overall Study|Adverse Event|97|||
163200140|NCT00160693|589447169|FG000|Overall Study|Lack of Efficacy|30|||
163200141|NCT00160693|589447169|FG000|Overall Study|Protocol Violation|24|||
163200142|NCT00160693|589447169|FG000|Overall Study|Lost to Follow-up|15|||
163200143|NCT00160693|589447169|FG000|Overall Study|Withdrawal by Subject|54|||
163200144|NCT00160693|589447169|FG000|Overall Study|Study terminated by sponsor|15|||
163200145|NCT00617123|589447170|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
163200146|NCT00617123|589447171|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
163200147|NCT00617123|589447170|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
163200148|NCT00617123|589447171|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
163200149|NCT00617123|589447170|FG000|Referral Screening Period|Adverse Event|0|||
163200150|NCT00617123|589447171|FG001|Referral Screening Period|Adverse Event|1|||
163200151|NCT00617123|589447170|FG000|Study Treatment Period|Withdrawal by Subject|8|||
163200152|NCT00617123|589447171|FG001|Study Treatment Period|Withdrawal by Subject|12|||
163200153|NCT00617123|589447170|FG000|Study Treatment Period|Adverse Event|7|||
163200154|NCT00617123|589447171|FG001|Study Treatment Period|Adverse Event|3|||
163200155|NCT00617123|589447170|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
163200156|NCT00617123|589447171|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
163200157|NCT00617123|589447170|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
163200158|NCT00617123|589447171|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
163200159|NCT03052725|589447172|FG000|Overall Study|Adverse Event|2|||
163200160|NCT03052725|589447173|FG001|Overall Study|Adverse Event|0|||
163200161|NCT03052725|589447172|FG000|Overall Study|Withdrawal by Subject|3|||
163200162|NCT03052725|589447173|FG001|Overall Study|Withdrawal by Subject|4|||
163200163|NCT03052725|589447172|FG000|Overall Study|Pregnancy|0|||
163200164|NCT03052725|589447173|FG001|Overall Study|Pregnancy|1|||
163200165|NCT03052725|589447172|FG000|Overall Study|Site closure|0|||
163200166|NCT03052725|589447173|FG001|Overall Study|Site closure|1|||
163200167|NCT03052725|589447172|FG000|Overall Study|Study terminated by sponsor|143|||
163200168|NCT03052725|589447173|FG001|Overall Study|Study terminated by sponsor|144|||
163200169|NCT00777608|589447175|FG000|Overall Study|Lost to Follow-up|1|||
163200170|NCT00777608|589447176|FG001|Overall Study|Lost to Follow-up|1|||
163200171|NCT00777608|589447175|FG000|Overall Study|Withdrawal by Subject|1|||
163200172|NCT00777608|589447176|FG001|Overall Study|Withdrawal by Subject|3|||
163200173|NCT00777608|589447175|FG000|Overall Study|Protocol Violation|1|||
163200174|NCT00777608|589447176|FG001|Overall Study|Protocol Violation|0|||
163200175|NCT00777608|589447175|FG000|Overall Study|Investigator Decision|1|||
163200176|NCT00777608|589447176|FG001|Overall Study|Investigator Decision|2|||
163200177|NCT04213079|589447177|FG000|Overall Study|Lost to Follow-up|0|||
163200178|NCT04213079|589447178|FG001|Overall Study|Lost to Follow-up|2|||
163200179|NCT00520936|589447179|FG000|Overall Study|Physician Decision|0|||
163200180|NCT00520936|589447180|FG001|Overall Study|Physician Decision|2|||
163200181|NCT00520936|589447181|FG002|Overall Study|Physician Decision|1|||
163200182|NCT00520936|589447182|FG003|Overall Study|Physician Decision|0|||
163200183|NCT00520936|589447183|FG004|Overall Study|Physician Decision|0|||
163200184|NCT00520936|589447184|FG005|Overall Study|Physician Decision|0|||
163200185|NCT00520936|589447185|FG006|Overall Study|Physician Decision|0|||
163200186|NCT00520936|589447186|FG007|Overall Study|Physician Decision|0|||
163200187|NCT00520936|589447179|FG000|Overall Study|Withdrawal by Subject|0|||
163200188|NCT00520936|589447180|FG001|Overall Study|Withdrawal by Subject|0|||
163306802|NCT05062265|589833779|FG000|Overall Study|Withdrawal by Subject|1|||
163306803|NCT05062265|589833780|FG001|Overall Study|Withdrawal by Subject|0|||
163306804|NCT03101904|589833784|FG000|Wash Out (10 Days)|Adverse Event|1|||
163306805|NCT03101904|589833785|FG001|Wash Out (10 Days)|Adverse Event|0|||
163306806|NCT03101904|589833784|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
163306807|NCT03101904|589833785|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
163306808|NCT04538417|589833786|FG000|Overall Study|Withdrawal by Subject|2|||
163306809|NCT01180634|589833788|FG000|Overall Study|Adverse Event|4|||
163306810|NCT01180634|589833789|FG001|Overall Study|Adverse Event|1|||
163050975|NCT01130272|588895328|FG000|Overall Study|Protocol Violation|0|||
163050976|NCT01130272|588895329|FG001|Overall Study|Protocol Violation|0|||
163050977|NCT01130272|588895330|FG002|Overall Study|Protocol Violation|3|||
163050978|NCT01130272|588895331|FG003|Overall Study|Protocol Violation|5|||
163050979|NCT01130272|588895332|FG004|Overall Study|Protocol Violation|5|||
163050980|NCT01130272|588895328|FG000|Overall Study|Lost to Follow-up|4|||
163050981|NCT01130272|588895329|FG001|Overall Study|Lost to Follow-up|3|||
163050982|NCT01130272|588895330|FG002|Overall Study|Lost to Follow-up|4|||
163306811|NCT01180634|589833788|FG000|Overall Study|Miscellaneous|2|||
163306812|NCT01180634|589833789|FG001|Overall Study|Miscellaneous|0|||
163306813|NCT01180634|589833788|FG000|Overall Study|Withdrawal by Subject|4|||
163306814|NCT01180634|589833789|FG001|Overall Study|Withdrawal by Subject|0|||
163306815|NCT02662062|589833790|FG000|Overall Study|Withdrawal by Subject|1|||
163306816|NCT02910583|589833792|FG000|Overall Study|Death|7|||
163306817|NCT02910583|589833793|FG001|Overall Study|Death|3|||
163306818|NCT02910583|589833792|FG000|Overall Study|Lost to Follow-up|1|||
163306819|NCT02910583|589833793|FG001|Overall Study|Lost to Follow-up|0|||
163306820|NCT02910583|589833792|FG000|Overall Study|Withdrawal by Subject|12|||
163306821|NCT02910583|589833793|FG001|Overall Study|Withdrawal by Subject|8|||
163306822|NCT02910583|589833792|FG000|Overall Study|Other, Not Specified|6|||
163306823|NCT02910583|589833793|FG001|Overall Study|Other, Not Specified|3|||
163306824|NCT01331005|589833794|FG000|Overall Study|Lost to Follow-up|2|||
163306825|NCT01331005|589833795|FG001|Overall Study|Lost to Follow-up|1|||
163306826|NCT01331005|589833794|FG000|Overall Study|Withdrawal by Subject|2|||
163306827|NCT01331005|589833795|FG001|Overall Study|Withdrawal by Subject|3|||
163306828|NCT03161379|589833806|FG000|Overall Study|Withdrawal by Subject|4|||
163306829|NCT03161379|589833806|FG000|Overall Study|disease progression during chemotherapy|5|||
163306830|NCT03161379|589833806|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
163306831|NCT03161379|589833806|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
163306832|NCT05021640|589833807|FG000|Overall Study|Lost to Follow-up|0|||
163306833|NCT05021640|589833808|FG001|Overall Study|Lost to Follow-up|0|||
163306834|NCT05021640|589833809|FG002|Overall Study|Lost to Follow-up|0|||
163306835|NCT05021640|589833810|FG003|Overall Study|Lost to Follow-up|0|||
163306836|NCT05021640|589833811|FG004|Overall Study|Lost to Follow-up|1|||
163306837|NCT03779204|589833813|FG000|Overall Study|Lost to Follow-up|2|||
163050983|NCT01130272|588895331|FG003|Overall Study|Lost to Follow-up|7|||
163050984|NCT01130272|588895332|FG004|Overall Study|Lost to Follow-up|6|||
163050985|NCT01130272|588895328|FG000|Overall Study|Withdrawal by Subject|4|||
163050986|NCT01130272|588895329|FG001|Overall Study|Withdrawal by Subject|11|||
163050987|NCT01130272|588895330|FG002|Overall Study|Withdrawal by Subject|10|||
163050988|NCT01130272|588895331|FG003|Overall Study|Withdrawal by Subject|9|||
163050989|NCT01130272|588895332|FG004|Overall Study|Withdrawal by Subject|8|||
163050990|NCT01130272|588895328|FG000|Overall Study|Physician Decision|1|||
163050991|NCT01130272|588895329|FG001|Overall Study|Physician Decision|1|||
163050992|NCT01130272|588895330|FG002|Overall Study|Physician Decision|0|||
163050993|NCT01130272|588895331|FG003|Overall Study|Physician Decision|1|||
163050994|NCT01130272|588895332|FG004|Overall Study|Physician Decision|2|||
163050995|NCT01130272|588895328|FG000|Overall Study|Sponsor decision|6|||
163050996|NCT01130272|588895329|FG001|Overall Study|Sponsor decision|15|||
163050997|NCT01130272|588895330|FG002|Overall Study|Sponsor decision|16|||
163050998|NCT01130272|588895331|FG003|Overall Study|Sponsor decision|13|||
163050999|NCT01130272|588895332|FG004|Overall Study|Sponsor decision|16|||
163051000|NCT01130272|588895328|FG000|Overall Study|Study arm discontinued|38|||
163051001|NCT01130272|588895329|FG001|Overall Study|Study arm discontinued|0|||
163051002|NCT01130272|588895330|FG002|Overall Study|Study arm discontinued|0|||
163051003|NCT01130272|588895331|FG003|Overall Study|Study arm discontinued|0|||
163051004|NCT01130272|588895332|FG004|Overall Study|Study arm discontinued|0|||
163306838|NCT03779204|589833814|FG001|Overall Study|Lost to Follow-up|0|||
163306839|NCT03315754|589833817|FG000|Overall Study|COVID-19 complications leading to death|1|||
163306840|NCT03315754|589833817|FG000|Overall Study|insurance coverage issue|1|||
163306841|NCT02954341|589833818|FG000|Overall Study|Attempted Implant unsuccessful|5|||
163306842|NCT02954341|589833818|FG000|Overall Study|Death|90|||
163051005|NCT00641056|588895333|FG000|Overall Study|Adverse Event|12|||
163051006|NCT00641056|588895334|FG001|Overall Study|Adverse Event|2|||
163051007|NCT00641056|588895333|FG000|Overall Study|Lost to Follow-up|2|||
163306843|NCT02954341|589833818|FG000|Overall Study|Withdrawal by Subject|4|||
163051008|NCT00641056|588895334|FG001|Overall Study|Lost to Follow-up|1|||
163051009|NCT00641056|588895333|FG000|Overall Study|Physician Decision|3|||
163051010|NCT00641056|588895334|FG001|Overall Study|Physician Decision|1|||
163051011|NCT00641056|588895333|FG000|Overall Study|Protocol Violation|2|||
163051012|NCT00641056|588895334|FG001|Overall Study|Protocol Violation|0|||
163051013|NCT00641056|588895333|FG000|Overall Study|Entry Criteria Not Met|3|||
163051014|NCT00641056|588895334|FG001|Overall Study|Entry Criteria Not Met|0|||
163051015|NCT00641056|588895333|FG000|Overall Study|Subject Decision|6|||
163051016|NCT00641056|588895334|FG001|Overall Study|Subject Decision|19|||
163051017|NCT00641056|588895333|FG000|Overall Study|Sponsor Decision|1|||
163051018|NCT00641056|588895334|FG001|Overall Study|Sponsor Decision|2|||
163051019|NCT00239720|588895336|FG000|Overall Study|Adverse Event|1|||
163051020|NCT00239720|588895337|FG001|Overall Study|Adverse Event|0|||
163051021|NCT00239720|588895336|FG000|Overall Study|Lost to Follow-up|0|||
163051022|NCT00239720|588895337|FG001|Overall Study|Lost to Follow-up|1|||
163051023|NCT01811732|588895338|FG000|Overall Study|Lost to Follow-up|24|||
163051024|NCT01811732|588895339|FG001|Overall Study|Lost to Follow-up|30|||
163051025|NCT01811732|588895338|FG000|Overall Study|Withdrawal by Subject|16|||
163051026|NCT01811732|588895339|FG001|Overall Study|Withdrawal by Subject|10|||
163051027|NCT01811732|588895338|FG000|Overall Study|Adverse Event|3|||
163051028|NCT01811732|588895339|FG001|Overall Study|Adverse Event|9|||
163051029|NCT01811732|588895338|FG000|Overall Study|Lack of Efficacy|3|||
163051030|NCT01811732|588895339|FG001|Overall Study|Lack of Efficacy|1|||
163051031|NCT01811732|588895338|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
163051032|NCT01811732|588895339|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
163051033|NCT01811732|588895338|FG000|Overall Study|Physician Decision|2|||
163051034|NCT01811732|588895339|FG001|Overall Study|Physician Decision|0|||
163051035|NCT01811732|588895338|FG000|Overall Study|Death|1|||
163051036|NCT01811732|588895339|FG001|Overall Study|Death|1|||
163051037|NCT01811732|588895338|FG000|Overall Study|Insufficient venous access|0|||
163051038|NCT01811732|588895339|FG001|Overall Study|Insufficient venous access|1|||
163051039|NCT01811732|588895338|FG000|Overall Study|Protocol Violation|0|||
163051040|NCT01811732|588895339|FG001|Overall Study|Protocol Violation|1|||
163051041|NCT01811732|588895338|FG000|Overall Study|Subject incarcerated|1|||
163051042|NCT01811732|588895339|FG001|Overall Study|Subject incarcerated|2|||
163051043|NCT01811732|588895338|FG000|Overall Study|Admitted to another facility|1|||
163051044|NCT01811732|588895339|FG001|Overall Study|Admitted to another facility|0|||
163051045|NCT01811732|588895338|FG000|Overall Study|Correct study drug not available on site|1|||
163051046|NCT01811732|588895339|FG001|Overall Study|Correct study drug not available on site|0|||
163051047|NCT01405560|588895340|FG000|Overall Study|Physician Decision|1|||
163051048|NCT00896493|588895343|FG000|Overall Study|Early disease relapse|3|||
163051049|NCT00536510|588895344|FG000|Overall Study|Adverse Event|27|||
163051050|NCT00536510|588895345|FG001|Overall Study|Adverse Event|4|||
163051051|NCT00536510|588895344|FG000|Overall Study|Lost to Follow-up|11|||
163051052|NCT00536510|588895345|FG001|Overall Study|Lost to Follow-up|8|||
163051053|NCT00536510|588895344|FG000|Overall Study|Protocol Violation|4|||
163051054|NCT00536510|588895345|FG001|Overall Study|Protocol Violation|5|||
163051055|NCT00536510|588895344|FG000|Overall Study|Withdrawal by Subject|16|||
163051056|NCT00536510|588895345|FG001|Overall Study|Withdrawal by Subject|9|||
163051057|NCT00536510|588895344|FG000|Overall Study|Flushing with Product|20|||
163051058|NCT00536510|588895345|FG001|Overall Study|Flushing with Product|0|||
163051059|NCT00536510|588895344|FG000|Overall Study|Laboratory Adverse Event|2|||
163051060|NCT00536510|588895345|FG001|Overall Study|Laboratory Adverse Event|1|||
163306844|NCT02954341|589833818|FG000|Overall Study|Physician Decision|13|||
163306845|NCT02954341|589833818|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
163306846|NCT02954341|589833818|FG000|Overall Study|Not implanted due to physician's decision|1|||
163306847|NCT02954341|589833818|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
163051061|NCT00536510|588895344|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
163306848|NCT05227209|589833819|FG000|Overall Study|Adverse Event|11|||
163306849|NCT05227209|589833819|FG000|Overall Study|Lost to Follow-up|1|||
163306850|NCT05227209|589833819|FG000|Overall Study|Withdrawal by Subject|7|||
163306851|NCT05227209|589833819|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
163306852|NCT05633953|589833820|FG000|Overall Study|Adverse Event|7|||
163306853|NCT05633953|589833820|FG000|Overall Study|Death|30|||
163306854|NCT05633953|589833820|FG000|Overall Study|Lost to Follow-up|1|||
163306855|NCT05633953|589833820|FG000|Overall Study|Osilodrostat discontinued|4|||
163306856|NCT05633953|589833820|FG000|Overall Study|Physician Decision|1|||
163306857|NCT05633953|589833820|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
163051062|NCT00536510|588895345|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
163051063|NCT02035553|588895346|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
163051064|NCT02035553|588895347|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
163051065|NCT02035553|588895346|FG000|Overall Study|Adverse Event|10|||
163051066|NCT02035553|588895347|FG001|Overall Study|Adverse Event|6|||
163051067|NCT02035553|588895346|FG000|Overall Study|Physician Decision|3|||
163051068|NCT02035553|588895347|FG001|Overall Study|Physician Decision|2|||
163051069|NCT02035553|588895346|FG000|Overall Study|Lack of Efficacy|1|||
163306858|NCT05633953|589833820|FG000|Overall Study|Progressive disease|2|||
163306859|NCT03526861|589833835|FG000|Initial Treatment Period|Not dosed|1|||
163306860|NCT03526861|589833836|FG001|Initial Treatment Period|Not dosed|1|||
163306861|NCT03526861|589833837|FG002|Initial Treatment Period|Not dosed|1|||
163306862|NCT03526861|589833838|FG003|Initial Treatment Period|Not dosed|0|||
163306863|NCT03526861|589833839|FG004|Initial Treatment Period|Not dosed|0|||
163306864|NCT03526861|589833840|FG005|Initial Treatment Period|Not dosed|0|||
163306865|NCT03526861|589833841|FG006|Initial Treatment Period|Not dosed|0|||
163306866|NCT03526861|589833842|FG007|Initial Treatment Period|Not dosed|0|||
163306867|NCT03526861|589833843|FG008|Initial Treatment Period|Not dosed|0|||
163306868|NCT03526861|589833835|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
163306869|NCT03526861|589833836|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
163306870|NCT03526861|589833837|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
163306871|NCT03526861|589833838|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306872|NCT03526861|589833839|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306873|NCT03526861|589833840|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306874|NCT03526861|589833841|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306875|NCT03526861|589833842|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306876|NCT03526861|589833843|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306877|NCT03526861|589833835|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
163306878|NCT03526861|589833836|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
163306879|NCT03526861|589833837|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
163306880|NCT03526861|589833838|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
163306881|NCT03526861|589833839|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
163306882|NCT03526861|589833840|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
163306883|NCT03526861|589833841|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
163306884|NCT03526861|589833842|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
163306885|NCT03526861|589833843|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
163306886|NCT03526861|589833835|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163306887|NCT03526861|589833836|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163306888|NCT03526861|589833837|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163306889|NCT03526861|589833838|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
163306890|NCT03526861|589833839|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
163306891|NCT03526861|589833840|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163306892|NCT03526861|589833841|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
163306893|NCT03526861|589833842|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163306894|NCT03526861|589833843|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163306895|NCT03526861|589833835|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
163306896|NCT03526861|589833836|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
163306897|NCT03526861|589833837|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
163306898|NCT03526861|589833838|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
163306899|NCT03526861|589833839|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
163051070|NCT02035553|588895347|FG001|Overall Study|Lack of Efficacy|1|||
163051071|NCT02035553|588895346|FG000|Overall Study|Withdrawal by Subject|4|||
163051072|NCT02035553|588895347|FG001|Overall Study|Withdrawal by Subject|7|||
163051073|NCT02035553|588895346|FG000|Overall Study|Non-compliance with Study Drug|0|||
163051074|NCT02035553|588895347|FG001|Overall Study|Non-compliance with Study Drug|1|||
163051075|NCT02035553|588895346|FG000|Overall Study|Lost to Follow-up|0|||
163051076|NCT02035553|588895347|FG001|Overall Study|Lost to Follow-up|1|||
163051077|NCT02035553|588895346|FG000|Overall Study|Other Reason|0|||
163051078|NCT02035553|588895347|FG001|Overall Study|Other Reason|4|||
163051079|NCT04539964|588895348|FG000|Overall Study|device malfunction|1|||
163051080|NCT04539964|588895349|FG001|Overall Study|device malfunction|0|||
163051081|NCT04539964|588895348|FG000|Overall Study|Withdrawal by Subject|1|||
163051082|NCT04539964|588895349|FG001|Overall Study|Withdrawal by Subject|2|||
163051083|NCT04539964|588895348|FG000|Overall Study|Adverse Event|0|||
163051084|NCT04539964|588895349|FG001|Overall Study|Adverse Event|2|||
163051085|NCT01674725|588895350|FG000|Overall Study|Adverse Event|1|||
163051086|NCT01674725|588895351|FG001|Overall Study|Adverse Event|0|||
163051087|NCT01674725|588895350|FG000|Overall Study|Did not receive study drug|1|||
163051088|NCT01674725|588895351|FG001|Overall Study|Did not receive study drug|0|||
163051089|NCT01674725|588895350|FG000|Overall Study|Withdrawal by Subject|1|||
163200189|NCT00520936|589447181|FG002|Overall Study|Withdrawal by Subject|0|||
163200190|NCT00520936|589447182|FG003|Overall Study|Withdrawal by Subject|0|||
163200191|NCT00520936|589447183|FG004|Overall Study|Withdrawal by Subject|0|||
163200192|NCT00520936|589447184|FG005|Overall Study|Withdrawal by Subject|0|||
163200193|NCT00520936|589447185|FG006|Overall Study|Withdrawal by Subject|0|||
163200194|NCT00520936|589447186|FG007|Overall Study|Withdrawal by Subject|1|||
163306900|NCT03526861|589833840|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
163306901|NCT03526861|589833841|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
163306902|NCT03526861|589833842|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
163306903|NCT03526861|589833843|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
163306904|NCT03526861|589833835|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306905|NCT03526861|589833836|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306906|NCT03526861|589833837|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306907|NCT03526861|589833838|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
163306908|NCT03526861|589833839|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306909|NCT03526861|589833840|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306910|NCT03526861|589833841|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306911|NCT03526861|589833842|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306912|NCT03526861|589833843|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306913|NCT03526861|589833835|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163306914|NCT03526861|589833836|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163306915|NCT03526861|589833837|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163306916|NCT03526861|589833838|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163306917|NCT03526861|589833839|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163306918|NCT03526861|589833840|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163306919|NCT03526861|589833841|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163306920|NCT03526861|589833842|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163306921|NCT03526861|589833843|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
163306922|NCT03526861|589833835|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163306923|NCT03526861|589833836|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163306924|NCT03526861|589833837|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163306925|NCT03526861|589833838|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163306926|NCT03526861|589833839|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163306927|NCT03526861|589833840|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163306928|NCT03526861|589833841|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163306929|NCT03526861|589833842|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163306930|NCT03526861|589833843|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
163306931|NCT03526861|589833835|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163396976|NCT00097773|590164365|FG002|Overall Study|Withdrawal by Subject|3|||
163396977|NCT00097773|590164366|FG003|Overall Study|Withdrawal by Subject|1|||
162963774|NCT00385736|588567883|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
162963775|NCT00385736|588567881|FG000|Efficacy Analysis Set - Induction|Other|0|||
163200195|NCT00520936|589447179|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
163200196|NCT00520936|589447180|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
162963776|NCT00385736|588567882|FG001|Efficacy Analysis Set - Induction|Other|0|||
162963777|NCT00385736|588567883|FG002|Efficacy Analysis Set - Induction|Other|1|||
162963778|NCT00385736|588567881|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
162963779|NCT00385736|588567882|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
162963780|NCT00385736|588567883|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
162963781|NCT00385736|588567881|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
162963782|NCT00385736|588567882|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
162963783|NCT00385736|588567883|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
163200197|NCT00520936|589447181|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
163200198|NCT00520936|589447182|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
162963784|NCT00385736|588567881|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
162963785|NCT00385736|588567882|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
162963786|NCT00385736|588567883|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
162963787|NCT00385736|588567881|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
163200199|NCT00520936|589447183|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
163200200|NCT00520936|589447184|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
163200201|NCT00520936|589447185|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
163200202|NCT00520936|589447186|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
163200203|NCT00520936|589447179|FG000|Overall Study|Death|0|||
163200204|NCT00520936|589447180|FG001|Overall Study|Death|0|||
163200205|NCT00520936|589447181|FG002|Overall Study|Death|0|||
163200206|NCT00520936|589447182|FG003|Overall Study|Death|0|||
163200207|NCT00520936|589447183|FG004|Overall Study|Death|0|||
163200208|NCT00520936|589447184|FG005|Overall Study|Death|0|||
163200209|NCT00520936|589447185|FG006|Overall Study|Death|1|||
163200210|NCT00520936|589447186|FG007|Overall Study|Death|0|||
163200211|NCT00520936|589447179|FG000|Overall Study|Protocol Violation|0|||
163200212|NCT00520936|589447180|FG001|Overall Study|Protocol Violation|1|||
163200213|NCT00520936|589447181|FG002|Overall Study|Protocol Violation|1|||
163200214|NCT00520936|589447182|FG003|Overall Study|Protocol Violation|0|||
163200215|NCT00520936|589447183|FG004|Overall Study|Protocol Violation|1|||
163200216|NCT00520936|589447184|FG005|Overall Study|Protocol Violation|0|||
163200217|NCT00520936|589447185|FG006|Overall Study|Protocol Violation|1|||
163200218|NCT00520936|589447186|FG007|Overall Study|Protocol Violation|0|||
163200219|NCT00587054|589447190|FG000|Overall Study|Patient not treated|9|||
163200220|NCT03858309|589447191|FG000|Overall Study|Withdrawal by Subject|2|||
163200221|NCT03858309|589447192|FG001|Overall Study|Withdrawal by Subject|3|||
163200222|NCT01812174|589447193|FG000|Overall Study|Death|1|||
163200223|NCT01812174|589447194|FG001|Overall Study|Death|0|||
163200224|NCT01812174|589447193|FG000|Overall Study|Protocol Violation|2|||
163200225|NCT01812174|589447194|FG001|Overall Study|Protocol Violation|0|||
163200226|NCT01051323|589447197|FG000|Overall Study|Discontinuation of treatment|103|||
163200227|NCT01051323|589447197|FG000|Overall Study|Transplantation|28|||
163200228|NCT01051323|589447197|FG000|Overall Study|Dialysis dependency|22|||
163200229|NCT01051323|589447197|FG000|Overall Study|Withdrawal by Subject|13|||
163200230|NCT01051323|589447197|FG000|Overall Study|Lost to Follow-up|31|||
163200231|NCT01051323|589447197|FG000|Overall Study|Death|129|||
163200232|NCT01051323|589447197|FG000|Overall Study|Hospitalization|28|||
163200233|NCT01051323|589447197|FG000|Overall Study|Other|148|||
163200234|NCT01051323|589447197|FG000|Overall Study|Missing|37|||
163200235|NCT05469178|589447198|FG000|Overall Study|Death|1|||
163200236|NCT05469178|589447199|FG001|Overall Study|Death|1|||
163200237|NCT05469178|589447200|FG002|Overall Study|Death|3|||
163200238|NCT05469178|589447201|FG003|Overall Study|Death|6|||
163200239|NCT05469178|589447198|FG000|Overall Study|Lack of Efficacy|2|||
163200240|NCT05469178|589447199|FG001|Overall Study|Lack of Efficacy|2|||
163200241|NCT05469178|589447200|FG002|Overall Study|Lack of Efficacy|1|||
163200242|NCT05469178|589447201|FG003|Overall Study|Lack of Efficacy|10|||
163200243|NCT00968513|589447202|FG000|Overall Study|Death|4|||
163200244|NCT00968513|589447203|FG001|Overall Study|Death|10|||
163200245|NCT00968513|589447204|FG002|Overall Study|Death|15|||
163200246|NCT05466682|589447207|FG000|Overall Study|Withdrawal by Subject|0|||
163200247|NCT05466682|589447208|FG001|Overall Study|Withdrawal by Subject|2|||
163200248|NCT05466682|589447207|FG000|Overall Study|Lost to Follow-up|2|||
163200249|NCT05466682|589447208|FG001|Overall Study|Lost to Follow-up|1|||
163200250|NCT02801396|589447209|FG000|Period 1|Withdrawal by Subject|0|||
163200251|NCT02801396|589447210|FG001|Period 1|Withdrawal by Subject|0|||
163200252|NCT02801396|589447211|FG002|Period 1|Withdrawal by Subject|0|||
163200253|NCT02801396|589447212|FG003|Period 1|Withdrawal by Subject|0|||
163200254|NCT02801396|589447213|FG004|Period 1|Withdrawal by Subject|1|||
163200255|NCT02801396|589447214|FG005|Period 1|Withdrawal by Subject|0|||
163200256|NCT03087643|589447221|FG000|Overall Study|Withdrawal by Subject|2|||
163200257|NCT03087643|589447222|FG001|Overall Study|Withdrawal by Subject|4|||
163200258|NCT03087643|589447221|FG000|Overall Study|Death|2|||
163200259|NCT03087643|589447222|FG001|Overall Study|Death|2|||
163200260|NCT02083783|589447223|FG000|Overall Study|Withdrawal by Subject|1|||
163200261|NCT02083783|589447224|FG001|Overall Study|Withdrawal by Subject|0|||
163200262|NCT04528732|589447225|FG000|Overall Study|Death|1|||
163200263|NCT04528732|589447226|FG001|Overall Study|Death|0|||
163200264|NCT04528732|589447227|FG002|Overall Study|Death|1|||
163200265|NCT04528732|589447225|FG000|Overall Study|Lost to Follow-up|0|||
163200266|NCT04528732|589447226|FG001|Overall Study|Lost to Follow-up|1|||
163200267|NCT04528732|589447227|FG002|Overall Study|Lost to Follow-up|2|||
163200268|NCT02405780|589447239|FG000|Period I|Adverse Event|8|||
163200269|NCT02405780|589447240|FG001|Period I|Adverse Event|0|||
163200270|NCT02405780|589447241|FG002|Period I|Adverse Event|3|||
163200271|NCT02405780|589447242|FG003|Period I|Adverse Event|7|||
163200272|NCT02405780|589447239|FG000|Period I|Medical reasons|1|||
163200273|NCT02405780|589447240|FG001|Period I|Medical reasons|1|||
163200274|NCT02405780|589447241|FG002|Period I|Medical reasons|0|||
163200275|NCT02405780|589447242|FG003|Period I|Medical reasons|1|||
163200276|NCT02405780|589447239|FG000|Period I|Screening Failure|1|||
163200277|NCT02405780|589447240|FG001|Period I|Screening Failure|0|||
163200278|NCT02405780|589447241|FG002|Period I|Screening Failure|1|||
163200279|NCT02405780|589447242|FG003|Period I|Screening Failure|0|||
163200280|NCT02405780|589447239|FG000|Period I|Withdrawal by Subject|9|||
163200281|NCT02405780|589447240|FG001|Period I|Withdrawal by Subject|1|||
163200282|NCT02405780|589447241|FG002|Period I|Withdrawal by Subject|3|||
163200283|NCT02405780|589447242|FG003|Period I|Withdrawal by Subject|4|||
163200284|NCT02405780|589447239|FG000|Period I|Non-compliance with study procedures|8|||
163200285|NCT02405780|589447240|FG001|Period I|Non-compliance with study procedures|6|||
163200286|NCT02405780|589447241|FG002|Period I|Non-compliance with study procedures|8|||
163200287|NCT02405780|589447242|FG003|Period I|Non-compliance with study procedures|11|||
163200288|NCT02405780|589447239|FG000|Period II|Adverse Event|3|||
163200289|NCT02405780|589447240|FG001|Period II|Adverse Event|5|||
163200290|NCT02405780|589447241|FG002|Period II|Adverse Event|4|||
163200291|NCT02405780|589447242|FG003|Period II|Adverse Event|11|||
163200292|NCT02405780|589447239|FG000|Period II|Medical reason|0|||
163200293|NCT02405780|589447240|FG001|Period II|Medical reason|1|||
163200294|NCT02405780|589447241|FG002|Period II|Medical reason|0|||
163200295|NCT02405780|589447242|FG003|Period II|Medical reason|0|||
163200296|NCT02405780|589447239|FG000|Period II|Pregnancy|0|||
163200297|NCT02405780|589447240|FG001|Period II|Pregnancy|0|||
163200298|NCT02405780|589447241|FG002|Period II|Pregnancy|1|||
163200299|NCT02405780|589447242|FG003|Period II|Pregnancy|0|||
163200300|NCT02405780|589447239|FG000|Period II|Withdrawal by Subject|7|||
163200301|NCT02405780|589447240|FG001|Period II|Withdrawal by Subject|4|||
163200302|NCT02405780|589447241|FG002|Period II|Withdrawal by Subject|0|||
163200303|NCT02405780|589447242|FG003|Period II|Withdrawal by Subject|3|||
163200304|NCT02405780|589447239|FG000|Period II|Non-compliance with study procedures|5|||
163200305|NCT02405780|589447240|FG001|Period II|Non-compliance with study procedures|2|||
163200306|NCT02405780|589447241|FG002|Period II|Non-compliance with study procedures|7|||
163200307|NCT02405780|589447242|FG003|Period II|Non-compliance with study procedures|4|||
163200308|NCT01654536|589447243|FG000|Overall Study|Lost to Follow-up|5|||
163200309|NCT01654536|589447244|FG001|Overall Study|Lost to Follow-up|5|||
163200310|NCT01654536|589447243|FG000|Overall Study|Physician Decision|12|||
163306932|NCT03526861|589833836|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163051090|NCT01674725|588895351|FG001|Overall Study|Withdrawal by Subject|0|||
163051091|NCT01674725|588895350|FG000|Overall Study|Lost to Follow-up|0|||
163051092|NCT01674725|588895351|FG001|Overall Study|Lost to Follow-up|1|||
163051093|NCT03102762|588895352|FG000|Overall Study|Lost to Follow-up|1|||
163051094|NCT03102762|588895353|FG001|Overall Study|Lost to Follow-up|0|||
163051095|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
163051096|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
163051097|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
163051098|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
163051099|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
163051100|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
163051101|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
163051102|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
163051103|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
163051104|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
163051105|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
163051106|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
163051107|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
163051108|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
163306933|NCT03526861|589833837|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306934|NCT03526861|589833838|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306935|NCT03526861|589833839|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306936|NCT03526861|589833840|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306937|NCT03526861|589833841|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163200311|NCT01654536|589447244|FG001|Overall Study|Physician Decision|8|||
163200312|NCT01654536|589447243|FG000|Overall Study|Withdrawal by Subject|27|||
163200313|NCT01654536|589447244|FG001|Overall Study|Withdrawal by Subject|25|||
163200314|NCT00668707|589447245|FG000|Overall Study|Cancer Recurrence|58|||
163200315|NCT00668707|589447246|FG001|Overall Study|Cancer Recurrence|58|||
163200316|NCT00668707|589447245|FG000|Overall Study|Withdrawal by Subject|117|||
163200317|NCT00668707|589447246|FG001|Overall Study|Withdrawal by Subject|100|||
163200318|NCT00668707|589447245|FG000|Overall Study|Lost to Follow-up|3|||
163200319|NCT00668707|589447246|FG001|Overall Study|Lost to Follow-up|6|||
163200320|NCT00668707|589447245|FG000|Overall Study|Protocol Violation|10|||
163200321|NCT00668707|589447246|FG001|Overall Study|Protocol Violation|12|||
163306938|NCT03526861|589833842|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163306939|NCT03526861|589833843|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
163306940|NCT05323084|589833847|FG000|Period 2 - Washout|Lost to Follow-up|0|||
163306941|NCT05323084|589833848|FG001|Period 2 - Washout|Lost to Follow-up|1|||
163306942|NCT01261312|589833849|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
163306943|NCT01261312|589833850|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
163306944|NCT01261312|589833851|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
163306945|NCT01261312|589833852|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163306946|NCT01261312|589833853|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163306947|NCT01261312|589833854|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163306948|NCT01261312|589833855|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163306949|NCT01261312|589833856|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163306950|NCT01261312|589833857|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163306951|NCT01261312|589833858|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163306952|NCT01261312|589833859|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163306953|NCT01261312|589833860|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163306954|NCT01261312|589833861|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163306955|NCT01261312|589833849|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
163306956|NCT01261312|589833850|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
163306957|NCT01261312|589833851|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163306958|NCT01261312|589833852|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163306959|NCT01261312|589833853|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163306960|NCT01261312|589833854|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163306961|NCT01261312|589833855|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163306962|NCT01261312|589833856|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163306963|NCT01261312|589833857|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163306964|NCT01261312|589833858|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163306965|NCT01261312|589833859|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163306966|NCT01261312|589833860|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163306967|NCT01261312|589833861|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163306968|NCT01261312|589833849|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
163306969|NCT01261312|589833850|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
163306970|NCT01261312|589833851|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163306971|NCT01261312|589833852|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163306972|NCT01261312|589833853|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163306973|NCT01261312|589833854|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163306974|NCT01261312|589833855|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163306975|NCT01261312|589833856|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163306976|NCT01261312|589833857|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163306977|NCT01261312|589833858|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163396978|NCT00097773|590164363|FG000|Overall Study|Adverse Event|0|||
163051109|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
163051110|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
163051111|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
163051112|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
163051113|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
163051114|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
163051115|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
163051116|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
163051117|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
163051118|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
163051119|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
163051120|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
163051121|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
163051122|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
163051123|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
163051124|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
163051125|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
163051126|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
163051127|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
163051128|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
163051129|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
163051130|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
163051131|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
163051132|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
163051133|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
163051134|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
163051135|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
163051136|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
163051137|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
163051138|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
163051139|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
163051140|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
163051141|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
163051142|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
163051143|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
163051144|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
163051145|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
163051146|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
163051147|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
163051148|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
163051149|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
163051150|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
163051151|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
163051152|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
163051153|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
163051154|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
163051155|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
163051156|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
163051157|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
163051158|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
163051159|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
163051160|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
163051161|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
163051162|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
163051163|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
163051164|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
163051165|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
163051166|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
163200322|NCT00668707|589447245|FG000|Overall Study|Death|11|||
163200323|NCT00668707|589447246|FG001|Overall Study|Death|4|||
163200324|NCT03846804|589447251|FG000|Overall Study|Refused blood draw|1|||
163200325|NCT03846804|589447251|FG000|Overall Study|Protocol Violation|1|||
163200326|NCT04698187|589447254|FG000|Overall Study|Withdrawal by Subject|7|||
163200327|NCT04698187|589447254|FG000|Overall Study|Death|21|||
163200328|NCT04698187|589447254|FG000|Overall Study|Sponsor Decision|15|||
163396979|NCT00097773|590164364|FG001|Overall Study|Adverse Event|1|||
162963788|NCT00385736|588567882|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
163200329|NCT04698187|589447254|FG000|Overall Study|In-transit Disease|1|||
163200330|NCT02993146|589447255|FG000|Overall Study|Withdrawal by Subject|0|||
163200331|NCT02993146|589447256|FG001|Overall Study|Withdrawal by Subject|0|||
163200332|NCT02993146|589447257|FG002|Overall Study|Withdrawal by Subject|1|||
163200333|NCT02993146|589447258|FG003|Overall Study|Withdrawal by Subject|1|||
163200334|NCT04362072|589447259|FG000|Treatment|Adverse Event|1|||
163200335|NCT04362072|589447259|FG000|Treatment|Death|9|||
163200336|NCT04362072|589447259|FG000|Treatment|Physician Decision|2|||
163200337|NCT04362072|589447259|FG000|Treatment|Progressive disease|27|||
163200338|NCT04362072|589447259|FG000|Treatment|Withdrawal by Subject|4|||
163200339|NCT04362072|589447259|FG000|Treatment|Global deterioration of health status|1|||
162963789|NCT00385736|588567883|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
162963790|NCT00385736|588567881|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
162963791|NCT00385736|588567882|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
162963792|NCT00385736|588567883|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
162963793|NCT00385736|588567881|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
162963794|NCT00385736|588567882|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
162963795|NCT00385736|588567883|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
162963796|NCT00385736|588567881|FG000|Safety Analysis Set|Adverse Event|23|||
162963797|NCT00385736|588567882|FG001|Safety Analysis Set|Adverse Event|15|||
162963798|NCT00385736|588567883|FG002|Safety Analysis Set|Adverse Event|23|||
162963799|NCT00385736|588567881|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
162963800|NCT00385736|588567882|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
162963801|NCT00385736|588567883|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
162963802|NCT00385736|588567881|FG000|Safety Analysis Set|Lost to Follow-up|0|||
162963803|NCT00385736|588567882|FG001|Safety Analysis Set|Lost to Follow-up|2|||
162963804|NCT00385736|588567883|FG002|Safety Analysis Set|Lost to Follow-up|2|||
162963805|NCT00385736|588567881|FG000|Safety Analysis Set|Lack of Efficacy|38|||
162963806|NCT00385736|588567882|FG001|Safety Analysis Set|Lack of Efficacy|16|||
162963807|NCT00385736|588567883|FG002|Safety Analysis Set|Lack of Efficacy|31|||
162963808|NCT00385736|588567881|FG000|Safety Analysis Set|Protocol Violation|2|||
162963809|NCT00385736|588567882|FG001|Safety Analysis Set|Protocol Violation|1|||
162963810|NCT00385736|588567883|FG002|Safety Analysis Set|Protocol Violation|6|||
162963811|NCT00385736|588567881|FG000|Safety Analysis Set|Other|1|||
162963812|NCT00385736|588567882|FG001|Safety Analysis Set|Other|4|||
162963813|NCT00385736|588567883|FG002|Safety Analysis Set|Other|4|||
162963814|NCT03602339|588567890|FG000|Overall Study|Withdrawal by Subject|9|||
162963815|NCT03602339|588567890|FG000|Overall Study|Physician Decision|2|||
162963816|NCT03602339|588567890|FG000|Overall Study|Other reason|4|||
162963817|NCT00829452|588567895|FG000|First Intervention|Withdrawal by Subject|0|||
162963818|NCT00829452|588567896|FG001|First Intervention|Withdrawal by Subject|1|||
162963819|NCT00829452|588567895|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
162963820|NCT00829452|588567896|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
162963821|NCT00829452|588567895|FG000|Second Intervention|Physician Decision|0|||
162963822|NCT00829452|588567896|FG001|Second Intervention|Physician Decision|1|||
162963823|NCT02615249|588567897|FG000|Overall Study|Withdrawal by Subject|1|||
162963824|NCT05098743|588567908|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
162963825|NCT05098743|588567909|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
162963826|NCT05098743|588567908|FG000|Overall Study|Lost to Follow-up|1|||
162963827|NCT05098743|588567909|FG001|Overall Study|Lost to Follow-up|2|||
162963828|NCT04060251|588567910|FG000|Overall Study|Study terminated due to low enrollment.|7|||
162963829|NCT04060251|588567911|FG001|Overall Study|Study terminated due to low enrollment.|5|||
162963830|NCT04060251|588567912|FG002|Overall Study|Study terminated due to low enrollment.|7|||
162963831|NCT04060251|588567910|FG000|Overall Study|Adverse Event|1|||
162963832|NCT04060251|588567911|FG001|Overall Study|Adverse Event|1|||
162963833|NCT04060251|588567912|FG002|Overall Study|Adverse Event|0|||
162963834|NCT00487435|588567913|FG000|Overall Study|Adverse Event|146|||
162963835|NCT00487435|588567913|FG000|Overall Study|Death|2|||
162963836|NCT00487435|588567913|FG000|Overall Study|Lack of Efficacy|33|||
162963837|NCT00487435|588567913|FG000|Overall Study|Lost to Follow-up|54|||
162963838|NCT00487435|588567913|FG000|Overall Study|Pregnancy|2|||
162963839|NCT00487435|588567913|FG000|Overall Study|Withdrawal by Subject|132|||
162963840|NCT00487435|588567913|FG000|Overall Study|Resolution Of Pain|1|||
162963841|NCT00487435|588567913|FG000|Overall Study|Study Medication Non-Compliant|32|||
162963842|NCT00487435|588567913|FG000|Overall Study|Other|83|||
162963843|NCT01087502|588567920|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
162963844|NCT01087502|588567921|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
162963845|NCT01087502|588567920|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
162963846|NCT01087502|588567921|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
162963847|NCT01087502|588567920|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
162963848|NCT01087502|588567921|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
162963849|NCT01087502|588567920|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
162963850|NCT01087502|588567921|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
163306978|NCT01261312|589833859|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163306979|NCT01261312|589833860|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163306980|NCT01261312|589833861|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163306981|NCT01261312|589833849|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
163306982|NCT01261312|589833850|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
163306983|NCT01261312|589833851|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163306984|NCT01261312|589833852|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163306985|NCT01261312|589833853|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163306986|NCT01261312|589833854|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163306987|NCT01261312|589833855|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163306988|NCT01261312|589833856|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163306989|NCT01261312|589833857|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163306990|NCT01261312|589833858|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163306991|NCT01261312|589833859|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163306992|NCT01261312|589833860|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163306993|NCT01261312|589833861|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163306994|NCT01261312|589833849|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
163306995|NCT01261312|589833850|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
163306996|NCT01261312|589833851|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
163306997|NCT01261312|589833852|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163306998|NCT01261312|589833853|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163306999|NCT01261312|589833854|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163307000|NCT01261312|589833855|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163307001|NCT01261312|589833856|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163307002|NCT01261312|589833857|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163307003|NCT01261312|589833858|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163307004|NCT01261312|589833859|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163307005|NCT01261312|589833860|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163307006|NCT01261312|589833861|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163307007|NCT01261312|589833849|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
163307008|NCT01261312|589833850|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
163307009|NCT01261312|589833851|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
163307010|NCT01261312|589833852|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163307011|NCT01261312|589833853|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163307012|NCT01261312|589833854|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163307013|NCT01261312|589833855|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163307014|NCT01261312|589833856|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163307015|NCT01261312|589833857|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163307016|NCT01261312|589833858|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163307017|NCT01261312|589833859|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163307018|NCT01261312|589833860|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163307019|NCT01261312|589833861|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163307020|NCT01261312|589833849|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
163307021|NCT01261312|589833850|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163307022|NCT01261312|589833851|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
163307023|NCT01261312|589833852|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163307024|NCT01261312|589833853|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163307025|NCT01261312|589833854|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163396980|NCT00097773|590164365|FG002|Overall Study|Adverse Event|0|||
163200340|NCT04362072|589447259|FG000|Treatment|Switched to commercial Lorlatinib|13|||
163200341|NCT04362072|589447259|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
163200342|NCT04362072|589447259|FG000|Treatment|Other|3|||
163200343|NCT04362072|589447259|FG000|Follow up|Death|2|||
163200344|NCT04362072|589447259|FG000|Follow up|Other|2|||
163200345|NCT04524689|589447260|FG000|Overall Study|Withdrawal by Subject|1|||
163200346|NCT04524689|589447261|FG001|Overall Study|Withdrawal by Subject|1|||
163200347|NCT04524689|589447262|FG002|Overall Study|Withdrawal by Subject|0|||
163200348|NCT04524689|589447263|FG003|Overall Study|Withdrawal by Subject|0|||
163200349|NCT04524689|589447264|FG004|Overall Study|Withdrawal by Subject|2|||
163200350|NCT04524689|589447265|FG005|Overall Study|Withdrawal by Subject|0|||
163200351|NCT04524689|589447260|FG000|Overall Study|Study terminated by Sponsor|6|||
163200352|NCT04524689|589447261|FG001|Overall Study|Study terminated by Sponsor|0|||
163200353|NCT04524689|589447262|FG002|Overall Study|Study terminated by Sponsor|1|||
163200354|NCT04524689|589447263|FG003|Overall Study|Study terminated by Sponsor|0|||
163200355|NCT04524689|589447264|FG004|Overall Study|Study terminated by Sponsor|4|||
163200356|NCT04524689|589447265|FG005|Overall Study|Study terminated by Sponsor|0|||
163200357|NCT04524689|589447260|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
163200358|NCT04524689|589447261|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
163200359|NCT04524689|589447262|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
163200360|NCT04524689|589447263|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
163200361|NCT04524689|589447264|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
163200362|NCT04524689|589447265|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
163200363|NCT01133522|589447266|FG000|Overall Study|Withdrawal by Subject|0|||
163200364|NCT01133522|589447267|FG001|Overall Study|Withdrawal by Subject|1|||
163200365|NCT01133522|589447268|FG002|Overall Study|Withdrawal by Subject|0|||
163200366|NCT01133522|589447269|FG003|Overall Study|Withdrawal by Subject|1|||
163200367|NCT01133522|589447270|FG004|Overall Study|Withdrawal by Subject|0|||
163200368|NCT01133522|589447271|FG005|Overall Study|Withdrawal by Subject|0|||
163200369|NCT01133522|589447272|FG006|Overall Study|Withdrawal by Subject|0|||
163200370|NCT01133522|589447273|FG007|Overall Study|Withdrawal by Subject|0|||
163200371|NCT01133522|589447274|FG008|Overall Study|Withdrawal by Subject|0|||
163200372|NCT01133522|589447275|FG009|Overall Study|Withdrawal by Subject|0|||
163200373|NCT01133522|589447266|FG000|Overall Study|Physician Decision|0|||
163200374|NCT01133522|589447267|FG001|Overall Study|Physician Decision|0|||
163200375|NCT01133522|589447268|FG002|Overall Study|Physician Decision|0|||
163200376|NCT01133522|589447269|FG003|Overall Study|Physician Decision|0|||
163200377|NCT01133522|589447270|FG004|Overall Study|Physician Decision|1|||
163200378|NCT01133522|589447271|FG005|Overall Study|Physician Decision|0|||
163200379|NCT01133522|589447272|FG006|Overall Study|Physician Decision|0|||
163200380|NCT01133522|589447273|FG007|Overall Study|Physician Decision|0|||
163200381|NCT01133522|589447274|FG008|Overall Study|Physician Decision|0|||
163200382|NCT01133522|589447275|FG009|Overall Study|Physician Decision|0|||
163200383|NCT01664533|589449157|FG000|Overall Study|Death|42|||
163200384|NCT01664533|589449157|FG000|Overall Study|Lost to Follow-up|3|||
163200385|NCT01664533|589449157|FG000|Overall Study|Study termination|9|||
163200386|NCT01664533|589449157|FG000|Overall Study|Protocol Violation|3|||
163200387|NCT00844831|589449159|FG000|Overall Study|Withdrawal by Subject|4|||
163200388|NCT00844831|589449159|FG000|Overall Study|Adverse Event|1|||
163200389|NCT00844831|589449159|FG000|Overall Study|Physician Decision|1|||
163200390|NCT05255068|589449160|FG000|Overall Study|Lost to Follow-up|0|||
163200391|NCT05255068|589449161|FG001|Overall Study|Lost to Follow-up|1|||
163200392|NCT03156543|589449163|FG000|Overall Study|Withdrawal by Subject|1|||
163200393|NCT03156543|589449164|FG001|Overall Study|Withdrawal by Subject|0|||
163200394|NCT02397278|589449165|FG000|Overall Study|Withdrawal by Subject|0|||
163200395|NCT02397278|589449166|FG001|Overall Study|Withdrawal by Subject|2|||
163200396|NCT02397278|589449165|FG000|Overall Study|Deemed ineligible following surgery|1|||
163200397|NCT02397278|589449166|FG001|Overall Study|Deemed ineligible following surgery|1|||
163200398|NCT02601469|589449168|FG000|Overall Study|Enrolled in Error|1|||
163200399|NCT02601469|589449169|FG001|Overall Study|Enrolled in Error|0|||
163200400|NCT00056316|589449170|FG000|Overall Study|Withdrawal by Subject|2|||
163200401|NCT00056316|589449171|FG001|Overall Study|Withdrawal by Subject|2|||
163200402|NCT00056316|589449170|FG000|Overall Study|Death/NH placement of pt|1|||
163200403|NCT00056316|589449171|FG001|Overall Study|Death/NH placement of pt|1|||
163200404|NCT01315678|589449176|FG000|Overall Study|Withdrawal by Subject|7|||
163200405|NCT01315678|589449177|FG001|Overall Study|Withdrawal by Subject|3|||
163200406|NCT01315678|589449176|FG000|Overall Study|Adverse Event|3|||
163200407|NCT01315678|589449177|FG001|Overall Study|Adverse Event|1|||
163200408|NCT01315678|589449176|FG000|Overall Study|Lost to Follow-up|1|||
163200409|NCT01315678|589449177|FG001|Overall Study|Lost to Follow-up|0|||
163200410|NCT01315678|589449176|FG000|Overall Study|similar reason to those listed above|3|||
163200411|NCT01315678|589449177|FG001|Overall Study|similar reason to those listed above|2|||
163200412|NCT00790023|589449181|FG000|Overall Study|Adverse Event|2|||
163200413|NCT00790023|589449182|FG001|Overall Study|Adverse Event|1|||
163200414|NCT00790023|589449183|FG002|Overall Study|Adverse Event|4|||
163200415|NCT00790023|589449181|FG000|Overall Study|Protocol Violation|2|||
163200416|NCT00790023|589449182|FG001|Overall Study|Protocol Violation|4|||
163200417|NCT00790023|589449183|FG002|Overall Study|Protocol Violation|2|||
163200418|NCT00790023|589449181|FG000|Overall Study|Withdrawal by Subject|2|||
163200419|NCT00790023|589449182|FG001|Overall Study|Withdrawal by Subject|0|||
163200420|NCT00790023|589449183|FG002|Overall Study|Withdrawal by Subject|6|||
163200421|NCT00790023|589449181|FG000|Overall Study|Lost to Follow-up|0|||
163200422|NCT00790023|589449182|FG001|Overall Study|Lost to Follow-up|0|||
163200423|NCT00790023|589449183|FG002|Overall Study|Lost to Follow-up|1|||
163307026|NCT01261312|589833855|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163307027|NCT01261312|589833856|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163307028|NCT01261312|589833857|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163307029|NCT01261312|589833858|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163307030|NCT01261312|589833859|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163307031|NCT01261312|589833860|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163307032|NCT01261312|589833861|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163307033|NCT01261312|589833849|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163307034|NCT01261312|589833850|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163307035|NCT01261312|589833851|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163307036|NCT01261312|589833852|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
163307037|NCT01261312|589833853|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
163307038|NCT01261312|589833854|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
163307039|NCT01261312|589833855|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163307040|NCT01261312|589833856|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163307041|NCT01261312|589833857|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163307042|NCT01261312|589833858|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163307043|NCT01261312|589833859|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163307044|NCT01261312|589833860|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163307045|NCT01261312|589833861|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163307046|NCT01261312|589833849|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163307047|NCT01261312|589833850|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163307048|NCT01261312|589833851|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163307049|NCT01261312|589833852|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163307050|NCT01261312|589833853|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
163307051|NCT01261312|589833854|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
163307052|NCT01261312|589833855|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163307053|NCT01261312|589833856|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163307054|NCT01261312|589833857|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163307055|NCT01261312|589833858|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163307056|NCT01261312|589833859|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163307057|NCT01261312|589833860|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163307058|NCT01261312|589833861|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163307059|NCT01261312|589833849|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163307060|NCT01261312|589833850|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163307061|NCT01261312|589833851|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163307062|NCT01261312|589833852|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163307063|NCT01261312|589833853|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
163307064|NCT01261312|589833854|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
163307065|NCT01261312|589833855|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163307066|NCT01261312|589833856|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163307067|NCT01261312|589833857|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163307068|NCT01261312|589833858|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163307069|NCT01261312|589833859|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163307070|NCT01261312|589833860|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163200424|NCT00790023|589449181|FG000|Overall Study|Other|5|||
163307071|NCT01261312|589833861|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163307072|NCT01261312|589833849|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
163307073|NCT01261312|589833850|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
163307074|NCT01261312|589833851|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
163307075|NCT01261312|589833852|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
163307076|NCT01261312|589833853|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
163307077|NCT01261312|589833854|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
163307078|NCT01261312|589833855|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
163307079|NCT01261312|589833856|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
163200425|NCT00790023|589449182|FG001|Overall Study|Other|5|||
163200426|NCT00790023|589449183|FG002|Overall Study|Other|8|||
163200427|NCT02468414|589449184|FG000|Overall Study|Early Study Termination by Sponsor|1|||
163200428|NCT02468414|589449185|FG001|Overall Study|Early Study Termination by Sponsor|0|||
163200429|NCT02468414|589449184|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
163200430|NCT02468414|589449185|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
163200431|NCT02468414|589449184|FG000|Overall Study|Screen Failure|1|||
163200432|NCT02468414|589449185|FG001|Overall Study|Screen Failure|0|||
163200433|NCT00573469|589449186|FG000|Overall Study|Adverse Event|1|||
163200434|NCT00573469|589449187|FG001|Overall Study|Adverse Event|1|||
163200435|NCT00573469|589449188|FG002|Overall Study|Adverse Event|1|||
163200436|NCT00573469|589449186|FG000|Overall Study|Withdrawal by Subject|0|||
163200437|NCT00573469|589449187|FG001|Overall Study|Withdrawal by Subject|2|||
163200438|NCT00573469|589449188|FG002|Overall Study|Withdrawal by Subject|0|||
163200439|NCT00573469|589449186|FG000|Overall Study|Other|5|||
163200440|NCT00573469|589449187|FG001|Overall Study|Other|1|||
163200441|NCT00573469|589449188|FG002|Overall Study|Other|3|||
163200442|NCT01338792|589449189|FG000|Overall Study|Adverse Event|2|||
163200443|NCT01338792|589449189|FG000|Overall Study|Death|1|||
163200444|NCT01338792|589449189|FG000|Overall Study|Withdrawal by Subject|1|||
163200445|NCT00004978|589449190|FG000|Overall Study|Death|107|||
163200446|NCT00004978|589449191|FG001|Overall Study|Death|116|||
163200447|NCT00004978|589449190|FG000|Overall Study|Lost to Follow-up|101|||
163200448|NCT00004978|589449191|FG001|Overall Study|Lost to Follow-up|108|||
163200449|NCT00004978|589449190|FG000|Overall Study|Withdrawal by Subject|17|||
163200450|NCT00004978|589449191|FG001|Overall Study|Withdrawal by Subject|26|||
163200451|NCT00004978|589449190|FG000|Overall Study|site closure - not in analysis cohort|19|||
163200452|NCT00004978|589449191|FG001|Overall Study|site closure - not in analysis cohort|20|||
163200453|NCT00062374|589449195|FG000|Overall Study|Not treated|12|||
163200454|NCT02155608|589449199|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
163200455|NCT02155608|589449200|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
163200456|NCT02155608|589449199|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
163200457|NCT02155608|589449200|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
163200458|NCT01532414|589449201|FG000|Overall Study|Lost to Follow-up|3|||
163200459|NCT01532414|589449202|FG001|Overall Study|Lost to Follow-up|0|||
163200460|NCT01532414|589449203|FG002|Overall Study|Lost to Follow-up|1|||
163200461|NCT01532414|589449201|FG000|Overall Study|Withdrawal by Subject|3|||
163200462|NCT01532414|589449202|FG001|Overall Study|Withdrawal by Subject|0|||
163200463|NCT01532414|589449203|FG002|Overall Study|Withdrawal by Subject|0|||
163200464|NCT01532414|589449201|FG000|Overall Study|No V6 semen sample|0|||
163200465|NCT01532414|589449202|FG001|Overall Study|No V6 semen sample|1|||
163200466|NCT01532414|589449203|FG002|Overall Study|No V6 semen sample|0|||
163200467|NCT01532414|589449201|FG000|Overall Study|Adverse Event|0|||
163200468|NCT01532414|589449202|FG001|Overall Study|Adverse Event|1|||
163200469|NCT01532414|589449203|FG002|Overall Study|Adverse Event|1|||
163200470|NCT01532414|589449201|FG000|Overall Study|Unable to complete 24 hour PK|0|||
163200471|NCT01532414|589449202|FG001|Overall Study|Unable to complete 24 hour PK|0|||
163200472|NCT01532414|589449203|FG002|Overall Study|Unable to complete 24 hour PK|1|||
163200473|NCT01532414|589449201|FG000|Overall Study|Withdrawn by sponsor|1|||
163200474|NCT01532414|589449202|FG001|Overall Study|Withdrawn by sponsor|0|||
163200475|NCT01532414|589449203|FG002|Overall Study|Withdrawn by sponsor|0|||
163200476|NCT02599129|589449208|FG000|Overall Study|Lack of Efficacy|2|||
163200477|NCT02599129|589449209|FG001|Overall Study|Lack of Efficacy|2|||
163200478|NCT02599129|589449208|FG000|Overall Study|Lost to Follow-up|1|||
163200479|NCT02599129|589449209|FG001|Overall Study|Lost to Follow-up|0|||
163200480|NCT02599129|589449208|FG000|Overall Study|Withdrawal by Subject|2|||
163200481|NCT02599129|589449209|FG001|Overall Study|Withdrawal by Subject|1|||
163200482|NCT00617773|589449210|FG000|Overall Study|Physician Decision|1|||
163200483|NCT00617773|589449210|FG000|Overall Study|Lack of compliance with the protocol|1|||
163200484|NCT00617773|589449210|FG000|Overall Study|Withdrawal by Subject|1|||
163200485|NCT00617773|589449210|FG000|Overall Study|Death|1|||
163200486|NCT00617773|589449210|FG000|Overall Study|Progressive disease|19|||
163200487|NCT00617773|589449210|FG000|Overall Study|Protocol Violation|1|||
163200488|NCT01029795|589449211|FG000|Overall Study|Entry Criteria Not Met|2|||
163200489|NCT01029795|589449212|FG001|Overall Study|Entry Criteria Not Met|1|||
163200490|NCT01029795|589449211|FG000|Overall Study|Physician Decision|2|||
163200491|NCT01029795|589449212|FG001|Overall Study|Physician Decision|1|||
163200492|NCT01029795|589449211|FG000|Overall Study|Sponsor Decision|11|||
163200493|NCT01029795|589449212|FG001|Overall Study|Sponsor Decision|17|||
163200494|NCT01029795|589449211|FG000|Overall Study|Withdrawal by Subject|1|||
163200495|NCT01029795|589449212|FG001|Overall Study|Withdrawal by Subject|3|||
163200496|NCT01061177|589449223|FG000|Overall Study|Adverse Event|117|||
163200497|NCT01061177|589449223|FG000|Overall Study|Withdrawal by Subject|27|||
163200498|NCT01061177|589449223|FG000|Overall Study|Disease progression|17|||
163200499|NCT01061177|589449223|FG000|Overall Study|Protocol Violation|11|||
163200500|NCT01061177|589449223|FG000|Overall Study|Lost to Follow-up|9|||
163200501|NCT01061177|589449223|FG000|Overall Study|New cancer therapy|9|||
163200502|NCT01061177|589449223|FG000|Overall Study|Abnormal laboratory values|6|||
163200503|NCT01061177|589449223|FG000|Overall Study|Abnormal test procedure results|4|||
163307080|NCT01261312|589833857|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
163307081|NCT01261312|589833858|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
163307082|NCT01261312|589833859|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
163307083|NCT01261312|589833860|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
163307084|NCT01261312|589833861|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
163307085|NCT01261312|589833849|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163307086|NCT01261312|589833850|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163307087|NCT01261312|589833851|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163307088|NCT01261312|589833852|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163307089|NCT01261312|589833853|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163307090|NCT01261312|589833854|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
163307091|NCT01261312|589833855|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163307092|NCT01261312|589833856|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163307093|NCT01261312|589833857|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163307094|NCT01261312|589833858|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163307095|NCT01261312|589833859|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163307096|NCT01261312|589833860|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163307097|NCT01261312|589833861|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163307098|NCT01261312|589833849|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163307099|NCT01261312|589833850|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163307100|NCT01261312|589833851|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163307101|NCT01261312|589833852|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
163307102|NCT01261312|589833853|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
163307103|NCT01261312|589833854|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
163307104|NCT01261312|589833855|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163307105|NCT01261312|589833856|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163307106|NCT01261312|589833857|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163307107|NCT01261312|589833858|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162963851|NCT01087502|588567920|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
162963852|NCT01087502|588567921|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
162963853|NCT01087502|588567920|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
162963854|NCT01087502|588567921|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
162963855|NCT01087502|588567920|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
163307108|NCT01261312|589833859|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163307109|NCT01261312|589833860|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163307110|NCT01261312|589833861|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163307111|NCT01261312|589833849|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163307112|NCT01261312|589833850|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163307113|NCT01261312|589833851|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163307114|NCT01261312|589833852|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
163307115|NCT01261312|589833853|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
162963856|NCT01087502|588567921|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
162963857|NCT01087502|588567920|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
162963858|NCT01087502|588567921|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
163307116|NCT01261312|589833854|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
163307117|NCT01261312|589833855|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163051167|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
163051168|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
163051169|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
163051170|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
163307118|NCT01261312|589833856|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163307119|NCT01261312|589833857|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163307120|NCT01261312|589833858|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163307121|NCT01261312|589833859|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163307122|NCT01261312|589833860|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163307123|NCT01261312|589833861|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163307124|NCT01261312|589833849|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163307125|NCT01261312|589833850|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163307126|NCT01261312|589833851|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163307127|NCT01261312|589833852|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163307128|NCT01261312|589833853|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163307129|NCT01261312|589833854|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163307130|NCT01261312|589833855|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
163307131|NCT01261312|589833856|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
163307132|NCT01261312|589833857|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
163307133|NCT01261312|589833858|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163307134|NCT01261312|589833859|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163307135|NCT01261312|589833860|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163307136|NCT01261312|589833861|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163307137|NCT01261312|589833849|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163307138|NCT01261312|589833850|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163307139|NCT01261312|589833851|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163307140|NCT01261312|589833852|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163307141|NCT01261312|589833853|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163307142|NCT01261312|589833854|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163307143|NCT01261312|589833855|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163307144|NCT01261312|589833856|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
163307145|NCT01261312|589833857|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
163307146|NCT01261312|589833858|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163307147|NCT01261312|589833859|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163307148|NCT01261312|589833860|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163307149|NCT01261312|589833861|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163307150|NCT01261312|589833849|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163307151|NCT01261312|589833850|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163307152|NCT01261312|589833851|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163307153|NCT01261312|589833852|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163307154|NCT01261312|589833853|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163307155|NCT01261312|589833854|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163307156|NCT01261312|589833855|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
163307157|NCT01261312|589833856|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
163307158|NCT01261312|589833857|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
163307159|NCT01261312|589833858|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163307160|NCT01261312|589833859|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163307161|NCT01261312|589833860|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163307162|NCT01261312|589833861|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163307163|NCT01261312|589833849|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
163307164|NCT01261312|589833850|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
163307165|NCT01261312|589833851|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
163307166|NCT01261312|589833852|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
163307167|NCT01261312|589833853|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
163396981|NCT00097773|590164366|FG003|Overall Study|Adverse Event|0|||
163396982|NCT00097773|590164363|FG000|Overall Study|Other|1|||
163051171|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
163051172|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
163307168|NCT01261312|589833854|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
163307169|NCT01261312|589833855|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
163307170|NCT01261312|589833856|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
163307171|NCT01261312|589833857|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
163307172|NCT01261312|589833858|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
163396983|NCT00097773|590164364|FG001|Overall Study|Other|0|||
163396984|NCT00097773|590164365|FG002|Overall Study|Other|2|||
163396985|NCT00097773|590164366|FG003|Overall Study|Other|0|||
163396986|NCT01494350|590164367|FG000|Overall Study|Worsening of lesion|1|||
163396987|NCT00474708|590164368|FG000|Overall Study|Lack of Efficacy|11|||
163396988|NCT00474708|590164369|FG001|Overall Study|Lack of Efficacy|5|||
163396989|NCT00474708|590164368|FG000|Overall Study|Suicide ideation/behavior|0|||
163396990|NCT00474708|590164369|FG001|Overall Study|Suicide ideation/behavior|1|||
163396991|NCT00474708|590164368|FG000|Overall Study|Withdrawal by Subject|7|||
163396992|NCT00474708|590164369|FG001|Overall Study|Withdrawal by Subject|0|||
163396993|NCT00474708|590164368|FG000|Overall Study|Lack of compliance|12|||
163396994|NCT00474708|590164369|FG001|Overall Study|Lack of compliance|4|||
163396995|NCT00474708|590164368|FG000|Overall Study|Lost to Follow-up|18|||
163396996|NCT00474708|590164369|FG001|Overall Study|Lost to Follow-up|9|||
163396997|NCT00474708|590164368|FG000|Overall Study|Physician Decision|9|||
163051173|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
163051174|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
163200504|NCT01061177|589449223|FG000|Overall Study|Administratie problems|4|||
163396998|NCT00474708|590164369|FG001|Overall Study|Physician Decision|6|||
163396999|NCT03700320|590164370|FG000|Overall Study|Adverse Event|5|||
163397000|NCT03700320|590164371|FG001|Overall Study|Adverse Event|31|||
163397001|NCT03700320|590164370|FG000|Overall Study|Lack of Efficacy|2|||
163397002|NCT03700320|590164371|FG001|Overall Study|Lack of Efficacy|5|||
162963859|NCT01087502|588567920|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
162963860|NCT01087502|588567921|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
162963861|NCT01087502|588567920|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
162963862|NCT01087502|588567921|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
162963863|NCT01087502|588567920|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
162963864|NCT01087502|588567921|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
162963865|NCT01087502|588567920|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
162963866|NCT01087502|588567921|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
162963867|NCT01151618|588567922|FG000|Overall Study|Adverse Event|2|||
163200505|NCT01061177|589449223|FG000|Overall Study|Death|4|||
163397003|NCT03700320|590164370|FG000|Overall Study|Withdrawal by Subject|29|||
163397004|NCT03700320|590164371|FG001|Overall Study|Withdrawal by Subject|75|||
163397005|NCT03700320|590164370|FG000|Overall Study|Lost to Follow-up|16|||
163397006|NCT03700320|590164371|FG001|Overall Study|Lost to Follow-up|23|||
163397007|NCT03700320|590164370|FG000|Overall Study|Pregnancy|2|||
163397008|NCT03700320|590164371|FG001|Overall Study|Pregnancy|4|||
163397009|NCT03700320|590164370|FG000|Overall Study|Protocol Deviation|7|||
163397010|NCT03700320|590164371|FG001|Overall Study|Protocol Deviation|31|||
163397011|NCT03700320|590164370|FG000|Overall Study|Non-compliance with Study Drug|1|||
163397012|NCT03700320|590164371|FG001|Overall Study|Non-compliance with Study Drug|3|||
163397013|NCT03700320|590164370|FG000|Overall Study|Reason not Specified|0|||
163397014|NCT03700320|590164371|FG001|Overall Study|Reason not Specified|1|||
163397015|NCT04305275|590164372|FG000|Overall Study|Adverse Event|4|||
163397016|NCT04305275|590164373|FG001|Overall Study|Adverse Event|0|||
163397017|NCT04305275|590164372|FG000|Overall Study|Lost to Follow-up|1|||
163397018|NCT04305275|590164373|FG001|Overall Study|Lost to Follow-up|1|||
163397019|NCT04305275|590164372|FG000|Overall Study|Withdrawal by Participant|8|||
163397020|NCT04305275|590164373|FG001|Overall Study|Withdrawal by Participant|1|||
163397021|NCT00199836|590164376|FG000|Overall Study|Progressive Disease|5|||
163397022|NCT00199836|590164376|FG000|Overall Study|Death|1|||
163397023|NCT03061175|590164377|FG000|Baseline|Participant was deemed ineligible|1|||
163397024|NCT03061175|590164378|FG001|Baseline|Participant was deemed ineligible|0|||
163397025|NCT03061175|590164377|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
163397026|NCT03061175|590164378|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
163397027|NCT03061175|590164377|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
163397028|NCT03061175|590164378|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
163397029|NCT03061175|590164377|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
163397030|NCT03061175|590164378|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
163397031|NCT00760669|590164379|FG000|Overall Study|Not assessed for overall improvement|18|||
163397032|NCT00760669|590164379|FG000|Overall Study|Participants missing efficacy assessment|6|||
163397033|NCT00760669|590164379|FG000|Overall Study|Participants with overlapping cases|1|||
162963868|NCT01151618|588567922|FG000|Overall Study|Withdrawal by Subject|7|||
162963869|NCT00868998|588567923|FG000|Overall Study|Screen Failure|1|||
163200506|NCT03616600|589449224|FG000|Overall Study|Withdrawal by Subject|1|||
162963870|NCT00868998|588567923|FG000|Overall Study|Withdrawal by Subject|1|||
162963871|NCT00868998|588567923|FG000|Overall Study|Progression of disease|2|||
162963872|NCT00868998|588567923|FG000|Overall Study|Death|1|||
163397034|NCT00760669|590164379|FG000|Overall Study|Took drug before entering in contract|5|||
163397035|NCT02456662|590164383|FG000|Overall Study|Lost to Follow-up|2|||
163397036|NCT02456662|590164384|FG001|Overall Study|Lost to Follow-up|1|||
163397037|NCT00504153|590164389|FG000|Overall Study|Withdrawal by Subject|1|||
163397038|NCT00504153|590164389|FG000|Overall Study|Adverse Event|4|||
162963873|NCT01483820|588567925|FG000|Overall Study|Lack of Efficacy|6|||
162963874|NCT01483820|588567925|FG000|Overall Study|Adverse Event|1|||
162963875|NCT01483820|588567925|FG000|Overall Study|Death|1|||
162963876|NCT00474188|588567929|FG000|Overall Study|Withdrawal by Subject|1|||
162963877|NCT00474188|588567929|FG000|Overall Study|Study discontinued by sponsor|5|||
162963878|NCT05412121|588567930|FG000|Overall Study|Withdrawal by Subject|4|||
162963879|NCT05412121|588567930|FG000|Overall Study|Physician Decision|1|||
162963880|NCT05412121|588567930|FG000|Overall Study|Lost to Follow-up|5|||
162963881|NCT03541252|588567931|FG000|Overall Study|Withdrawal by Subject|1|||
162963882|NCT01962298|588567938|FG000|Overall Study|Protocol Violation|1|||
162963883|NCT01962298|588567939|FG001|Overall Study|Protocol Violation|0|||
162963884|NCT01962298|588567940|FG002|Overall Study|Protocol Violation|1|||
162963885|NCT01962298|588567941|FG003|Overall Study|Protocol Violation|1|||
162963886|NCT01962298|588567942|FG004|Overall Study|Protocol Violation|0|||
162963887|NCT01962298|588567938|FG000|Overall Study|Data quality insufficient|2|||
162963888|NCT01962298|588567939|FG001|Overall Study|Data quality insufficient|0|||
162963889|NCT01962298|588567940|FG002|Overall Study|Data quality insufficient|3|||
162963890|NCT01962298|588567941|FG003|Overall Study|Data quality insufficient|1|||
162963891|NCT01962298|588567942|FG004|Overall Study|Data quality insufficient|4|||
162963892|NCT01962298|588567938|FG000|Overall Study|Insufficient data|0|||
162963893|NCT01962298|588567939|FG001|Overall Study|Insufficient data|2|||
163051175|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
163051176|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
163200507|NCT03616600|589449225|FG001|Overall Study|Withdrawal by Subject|0|||
163200508|NCT03984994|589449226|FG000|Overall Study|Withdrawal by Subject|2|||
162963894|NCT01962298|588567940|FG002|Overall Study|Insufficient data|1|||
162963895|NCT01962298|588567941|FG003|Overall Study|Insufficient data|0|||
162963896|NCT01962298|588567942|FG004|Overall Study|Insufficient data|1|||
163051177|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
162963897|NCT01962298|588567938|FG000|Overall Study|Incorrect data recorded|0|||
162963898|NCT01962298|588567939|FG001|Overall Study|Incorrect data recorded|1|||
162963899|NCT01962298|588567940|FG002|Overall Study|Incorrect data recorded|0|||
162963900|NCT01962298|588567941|FG003|Overall Study|Incorrect data recorded|0|||
162963901|NCT01962298|588567942|FG004|Overall Study|Incorrect data recorded|0|||
162963902|NCT01962298|588567938|FG000|Overall Study|Physician Decision|0|||
162963903|NCT01962298|588567939|FG001|Overall Study|Physician Decision|1|||
162963904|NCT01962298|588567940|FG002|Overall Study|Physician Decision|0|||
162963905|NCT01962298|588567941|FG003|Overall Study|Physician Decision|0|||
162963906|NCT01962298|588567942|FG004|Overall Study|Physician Decision|1|||
162963907|NCT01576705|588567943|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
162963908|NCT01576705|588567944|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
162963909|NCT01576705|588567945|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
162963910|NCT01576705|588567946|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
162963911|NCT01576705|588567943|FG000|Overall Study|invalid ICF|0|||
162963912|NCT01576705|588567944|FG001|Overall Study|invalid ICF|1|||
162963913|NCT01576705|588567945|FG002|Overall Study|invalid ICF|0|||
162963914|NCT01576705|588567946|FG003|Overall Study|invalid ICF|0|||
162963915|NCT03727139|588567947|FG000|Overall Study|Protocol Violation|60|||
162963916|NCT00566722|588567948|FG000|Overall Study|Adverse Event|0|||
162963917|NCT00566722|588567949|FG001|Overall Study|Adverse Event|1|||
162963918|NCT00566722|588567950|FG002|Overall Study|Adverse Event|0|||
162963919|NCT00566722|588567948|FG000|Overall Study|Withdrawal by Subject|0|||
162963920|NCT00566722|588567949|FG001|Overall Study|Withdrawal by Subject|0|||
162963921|NCT00566722|588567950|FG002|Overall Study|Withdrawal by Subject|1|||
162963922|NCT00566722|588567948|FG000|Overall Study|Lost to Follow-up|1|||
162963923|NCT00566722|588567949|FG001|Overall Study|Lost to Follow-up|1|||
162963924|NCT00566722|588567950|FG002|Overall Study|Lost to Follow-up|1|||
162963925|NCT00566722|588567948|FG000|Overall Study|Lack of Efficacy|1|||
162963926|NCT00566722|588567949|FG001|Overall Study|Lack of Efficacy|2|||
162963927|NCT00566722|588567950|FG002|Overall Study|Lack of Efficacy|4|||
162963928|NCT00566722|588567948|FG000|Overall Study|Did not meet exclusion criteria|0|||
162963929|NCT00566722|588567949|FG001|Overall Study|Did not meet exclusion criteria|0|||
162963930|NCT00566722|588567950|FG002|Overall Study|Did not meet exclusion criteria|2|||
162963931|NCT00566722|588567948|FG000|Overall Study|Serious adverse event|0|||
162963932|NCT00566722|588567949|FG001|Overall Study|Serious adverse event|1|||
162963933|NCT00566722|588567950|FG002|Overall Study|Serious adverse event|0|||
162963934|NCT00566722|588567948|FG000|Overall Study|Noncompliant with drug administration|0|||
162963935|NCT00566722|588567949|FG001|Overall Study|Noncompliant with drug administration|0|||
162963936|NCT00566722|588567950|FG002|Overall Study|Noncompliant with drug administration|1|||
162963937|NCT00858403|588567951|FG000|Overall Study|Withdrawal by Subject|1|||
163200509|NCT03984994|589449227|FG001|Overall Study|Withdrawal by Subject|1|||
163200510|NCT03010176|589449229|FG000|Overall Study|Death|21|||
163200511|NCT03010176|589449230|FG001|Overall Study|Death|35|||
163200512|NCT03010176|589449231|FG002|Overall Study|Death|19|||
163200513|NCT03010176|589449232|FG003|Overall Study|Death|19|||
163200514|NCT03010176|589449233|FG004|Overall Study|Death|14|||
163200515|NCT03010176|589449234|FG005|Overall Study|Death|0|||
163200516|NCT03010176|589449229|FG000|Overall Study|Lost to Follow-up|0|||
163200517|NCT03010176|589449230|FG001|Overall Study|Lost to Follow-up|0|||
163200518|NCT03010176|589449231|FG002|Overall Study|Lost to Follow-up|0|||
163200519|NCT03010176|589449232|FG003|Overall Study|Lost to Follow-up|0|||
163200520|NCT03010176|589449233|FG004|Overall Study|Lost to Follow-up|1|||
163200521|NCT03010176|589449234|FG005|Overall Study|Lost to Follow-up|0|||
163200522|NCT03010176|589449229|FG000|Overall Study|Physician Decision|0|||
163200523|NCT03010176|589449230|FG001|Overall Study|Physician Decision|4|||
163200524|NCT03010176|589449231|FG002|Overall Study|Physician Decision|0|||
163200525|NCT03010176|589449232|FG003|Overall Study|Physician Decision|1|||
163200526|NCT03010176|589449233|FG004|Overall Study|Physician Decision|0|||
163200527|NCT03010176|589449234|FG005|Overall Study|Physician Decision|0|||
163200528|NCT03010176|589449229|FG000|Overall Study|Sponsor Decision|0|||
163200529|NCT03010176|589449230|FG001|Overall Study|Sponsor Decision|4|||
163200530|NCT03010176|589449231|FG002|Overall Study|Sponsor Decision|4|||
163200531|NCT03010176|589449232|FG003|Overall Study|Sponsor Decision|1|||
163200532|NCT03010176|589449233|FG004|Overall Study|Sponsor Decision|6|||
163200533|NCT03010176|589449234|FG005|Overall Study|Sponsor Decision|0|||
163200534|NCT03010176|589449229|FG000|Overall Study|Withdrawal by Subject|11|||
163200535|NCT03010176|589449230|FG001|Overall Study|Withdrawal by Subject|9|||
163200536|NCT03010176|589449231|FG002|Overall Study|Withdrawal by Subject|3|||
163200537|NCT03010176|589449232|FG003|Overall Study|Withdrawal by Subject|0|||
163200538|NCT03010176|589449233|FG004|Overall Study|Withdrawal by Subject|4|||
163200539|NCT03010176|589449234|FG005|Overall Study|Withdrawal by Subject|0|||
163200540|NCT04220866|589449235|FG000|Overall Study|Death|4|||
163200541|NCT04220866|589449236|FG001|Overall Study|Death|5|||
163200542|NCT04220866|589449235|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
163200543|NCT04220866|589449236|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
163200544|NCT04220866|589449235|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
163200545|NCT04220866|589449236|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
162963938|NCT00858403|588567951|FG000|Overall Study|Death|3|||
163200546|NCT04220866|589449235|FG000|Overall Study|Withdrawal by Subject|0|||
163200547|NCT04220866|589449236|FG001|Overall Study|Withdrawal by Subject|1|||
163200548|NCT00709761|589449241|FG000|Overall Study|Withdrawal by Subject|8|||
163200549|NCT00709761|589449241|FG000|Overall Study|study closed/terminated|17|||
163200550|NCT00709761|589449241|FG000|Overall Study|Lost to Follow-up|2|||
163200551|NCT03478930|589449242|FG000|Overall Study|Adverse Event|0|||
163051178|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
163051179|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
163051180|NCT03074695|588895359|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
163051181|NCT03074695|588895360|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
163051182|NCT03074695|588895359|FG000|Overall Study|Research staff not available|1|||
163051183|NCT03074695|588895360|FG001|Overall Study|Research staff not available|2|||
163051184|NCT03074695|588895359|FG000|Overall Study|Did not receive neuraxial block|2|||
163051185|NCT03074695|588895360|FG001|Overall Study|Did not receive neuraxial block|2|||
163051186|NCT00902577|588895361|FG000|Overall Study|Withdrawal by Subject|6|||
163051187|NCT00902577|588895361|FG000|Overall Study|FMISO production failure|2|||
163051188|NCT01232790|588895362|FG000|Randomization|Withdrawal by Subject|2|||
163051189|NCT01232790|588895363|FG001|Randomization|Withdrawal by Subject|0|||
163051190|NCT01232790|588895362|FG000|Randomization|Protocol Violation|0|||
163051191|NCT01232790|588895363|FG001|Randomization|Protocol Violation|1|||
163051192|NCT01232790|588895362|FG000|Randomization|Physician Decision|0|||
163051193|NCT01232790|588895363|FG001|Randomization|Physician Decision|1|||
163051194|NCT01232790|588895362|FG000|Initial Assessment|Withdrawal by Subject|0|||
163200552|NCT03478930|589449243|FG001|Overall Study|Adverse Event|1|||
163200553|NCT03478930|589449242|FG000|Overall Study|Lack of Efficacy|3|||
163200554|NCT03478930|589449243|FG001|Overall Study|Lack of Efficacy|3|||
163200555|NCT03478930|589449242|FG000|Overall Study|Withdrawal by Subject|6|||
163200556|NCT03478930|589449243|FG001|Overall Study|Withdrawal by Subject|5|||
163200557|NCT00553644|589449246|FG000|Overall Study|Adverse Event|17|||
163200558|NCT00553644|589449246|FG000|Overall Study|Withdrawal by Subject|4|||
162963939|NCT00858403|588567951|FG000|Overall Study|Disease Progression|1|||
162963940|NCT02264977|588567952|FG000|Overall Study|Death|3|||
162963941|NCT02264977|588567952|FG000|Overall Study|Physician Decision|1|||
162963942|NCT02264977|588567952|FG000|Overall Study|Refuse to return|1|||
162963943|NCT03573544|588567953|FG000|Overall Study|Adverse Event|0|||
162963944|NCT03573544|588567954|FG001|Overall Study|Adverse Event|0|||
162963945|NCT03573544|588567955|FG002|Overall Study|Adverse Event|0|||
162963946|NCT03573544|588567956|FG003|Overall Study|Adverse Event|3|||
162963947|NCT03573544|588567957|FG004|Overall Study|Adverse Event|1|||
162963948|NCT03573544|588567958|FG005|Overall Study|Adverse Event|0|||
162963949|NCT03573544|588567959|FG006|Overall Study|Adverse Event|2|||
162963950|NCT03573544|588567960|FG007|Overall Study|Adverse Event|0|||
162963951|NCT03573544|588567953|FG000|Overall Study|Physician Decision|0|||
162963952|NCT03573544|588567954|FG001|Overall Study|Physician Decision|0|||
163200559|NCT00553644|589449246|FG000|Overall Study|Physician Decision|1|||
163200560|NCT00553644|589449246|FG000|Overall Study|Alternative therapy|6|||
163200561|NCT01336764|589449247|FG000|Overall Study|Withdrawal by Subject|5|||
163200562|NCT01336764|589449248|FG001|Overall Study|Withdrawal by Subject|5|||
163200563|NCT00555971|589449249|FG000|Overall Study|Adverse Event|1|||
163200564|NCT00555971|589449250|FG001|Overall Study|Adverse Event|1|||
163200565|NCT01626391|589449251|FG000|Overall Study|Physician Decision|1|||
163200566|NCT01626391|589449252|FG001|Overall Study|Physician Decision|0|||
163200567|NCT01626391|589449251|FG000|Overall Study|Withdrawal by Subject|1|||
163200568|NCT01626391|589449252|FG001|Overall Study|Withdrawal by Subject|0|||
163200569|NCT02573311|589449253|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
163200570|NCT02573311|589449254|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
163200571|NCT02573311|589449253|FG000|Disposition for Part 2|Physician Decision|25|||
163200572|NCT02573311|589449254|FG001|Disposition for Part 2|Physician Decision|7|||
163307173|NCT01261312|589833859|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
163307174|NCT01261312|589833860|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
163307175|NCT01261312|589833861|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
163307176|NCT01261312|589833849|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163307177|NCT01261312|589833850|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163307178|NCT01261312|589833851|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163307179|NCT01261312|589833852|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163307180|NCT01261312|589833853|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163307181|NCT01261312|589833854|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163307182|NCT01261312|589833855|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
163307183|NCT01261312|589833856|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
163307184|NCT01261312|589833857|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
163307185|NCT01261312|589833858|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163307186|NCT01261312|589833859|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162963953|NCT03573544|588567955|FG002|Overall Study|Physician Decision|0|||
162963954|NCT03573544|588567956|FG003|Overall Study|Physician Decision|0|||
162963955|NCT03573544|588567957|FG004|Overall Study|Physician Decision|0|||
162963956|NCT03573544|588567958|FG005|Overall Study|Physician Decision|0|||
162963957|NCT03573544|588567959|FG006|Overall Study|Physician Decision|1|||
162963958|NCT03573544|588567960|FG007|Overall Study|Physician Decision|0|||
163051195|NCT01232790|588895363|FG001|Initial Assessment|Withdrawal by Subject|1|||
162963959|NCT03573544|588567953|FG000|Overall Study|Withdrawal by Subject|2|||
162963960|NCT03573544|588567954|FG001|Overall Study|Withdrawal by Subject|0|||
162963961|NCT03573544|588567955|FG002|Overall Study|Withdrawal by Subject|0|||
163397039|NCT00504153|590164389|FG000|Overall Study|Death|1|||
163397040|NCT00805025|590164390|FG000|Overall Study|Screened but not enrolled/treated|42|||
163397041|NCT00805025|590164390|FG000|Overall Study|Adverse Event|4|||
163397042|NCT00805025|590164390|FG000|Overall Study|Withdrawal by Subject|2|||
163397043|NCT00805025|590164390|FG000|Overall Study|Physician Decision|1|||
163397044|NCT00932425|590164396|FG000|Overall Study|Lost to Follow-up|0|||
163397045|NCT00932425|590164397|FG001|Overall Study|Lost to Follow-up|1|||
163397046|NCT00932425|590164396|FG000|Overall Study|Withdrawal by Subject|0|||
163397047|NCT00932425|590164397|FG001|Overall Study|Withdrawal by Subject|1|||
163397048|NCT01252810|590164398|FG000|Overall Study|Withdrawal by Subject|4|||
163397049|NCT01252810|590164399|FG001|Overall Study|Withdrawal by Subject|1|||
163397050|NCT01252810|590164398|FG000|Overall Study|Lost to Follow-up|0|||
163397051|NCT01252810|590164399|FG001|Overall Study|Lost to Follow-up|1|||
163397052|NCT01252810|590164398|FG000|Overall Study|Physician Decision|2|||
163397053|NCT01252810|590164399|FG001|Overall Study|Physician Decision|1|||
163397054|NCT01252810|590164398|FG000|Overall Study|Various reasons|8|||
163397055|NCT01252810|590164399|FG001|Overall Study|Various reasons|0|||
163397056|NCT02811549|590164401|FG000|Overall Study|Lost to Follow-up|1|||
163397057|NCT02811549|590164401|FG000|Overall Study|Withdrawal by Subject|3|||
163397058|NCT02811549|590164401|FG000|Overall Study|Subject screen failed|4|||
163397059|NCT02811549|590164401|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
163397060|NCT05293743|590164402|FG000|Overall Study|Withdrawal by Subject|1|||
163397061|NCT05293743|590164403|FG001|Overall Study|Withdrawal by Subject|0|||
163397062|NCT01889238|590164408|FG000|Overall Study|Death|1|||
163397063|NCT01889238|590164408|FG000|Overall Study|Withdrawal by Subject|1|||
163397064|NCT01889238|590164408|FG000|Overall Study|Adverse Event|6|||
163397065|NCT01889238|590164408|FG000|Overall Study|Disease Progression|104|||
163397066|NCT01889238|590164408|FG000|Overall Study|Other|6|||
163397067|NCT01200238|590164414|FG000|Overall Study|Adverse Event|2|||
163397068|NCT01200238|590164415|FG001|Overall Study|Adverse Event|1|||
163397069|NCT01200238|590164414|FG000|Overall Study|Progressive Disease|5|||
163397070|NCT01200238|590164415|FG001|Overall Study|Progressive Disease|8|||
163397071|NCT01200238|590164414|FG000|Overall Study|Withdrawal by Subject|0|||
163397072|NCT01200238|590164415|FG001|Overall Study|Withdrawal by Subject|1|||
163397073|NCT02717754|590164416|FG000|Overall Study|Incorrect Infusion Duration|0|||
163397074|NCT02717754|590164417|FG001|Overall Study|Incorrect Infusion Duration|0|||
163397075|NCT02717754|590164418|FG002|Overall Study|Incorrect Infusion Duration|0|||
163397076|NCT02717754|590164419|FG003|Overall Study|Incorrect Infusion Duration|10|||
163397077|NCT02717754|590164420|FG004|Overall Study|Incorrect Infusion Duration|20|||
163397078|NCT02717754|590164421|FG005|Overall Study|Incorrect Infusion Duration|20|||
163397079|NCT00482703|590164422|FG000|Overall Study|Poor compliance|1|||
163397080|NCT00482703|590164423|FG001|Overall Study|Poor compliance|0|||
163397081|NCT00667823|590164425|FG000|Overall Study|Lost to Follow-up|5|||
163397082|NCT00667823|590164425|FG000|Overall Study|Adverse Event|7|||
163397083|NCT00667823|590164425|FG000|Overall Study|Death|182|||
162963962|NCT03573544|588567956|FG003|Overall Study|Withdrawal by Subject|1|||
162963963|NCT03573544|588567957|FG004|Overall Study|Withdrawal by Subject|1|||
162963964|NCT03573544|588567958|FG005|Overall Study|Withdrawal by Subject|1|||
162963965|NCT03573544|588567959|FG006|Overall Study|Withdrawal by Subject|0|||
162963966|NCT03573544|588567960|FG007|Overall Study|Withdrawal by Subject|1|||
163397084|NCT00667823|590164425|FG000|Overall Study|Withdrawal by Subject|12|||
163397085|NCT00667823|590164425|FG000|Overall Study|Other|8|||
163397086|NCT00667823|590164425|FG000|Overall Study|Missing (completion page missing)|2|||
162963967|NCT03573544|588567953|FG000|Overall Study|Disease progression|3|||
163397087|NCT04360551|590166136|FG000|Overall Study|Withdrawal by Subject|1|||
162963968|NCT03573544|588567954|FG001|Overall Study|Disease progression|3|||
162963969|NCT03573544|588567955|FG002|Overall Study|Disease progression|6|||
162963970|NCT03573544|588567956|FG003|Overall Study|Disease progression|4|||
163397088|NCT04360551|590166137|FG001|Overall Study|Withdrawal by Subject|0|||
163397089|NCT03496012|590166141|FG000|Overall Study|Withdrawal by Subject|2|||
163397090|NCT03496012|590166142|FG001|Overall Study|Withdrawal by Subject|0|||
163397091|NCT03496012|590166143|FG002|Overall Study|Withdrawal by Subject|2|||
163307187|NCT01261312|589833860|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163307188|NCT01261312|589833861|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163307189|NCT01261312|589833849|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163307190|NCT01261312|589833850|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163307191|NCT01261312|589833851|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163307192|NCT01261312|589833852|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163307193|NCT01261312|589833853|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163307194|NCT01261312|589833854|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163307195|NCT01261312|589833855|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
163307196|NCT01261312|589833856|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
163307197|NCT01261312|589833857|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
163307198|NCT01261312|589833858|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163307199|NCT01261312|589833859|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163307200|NCT01261312|589833860|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163307201|NCT01261312|589833861|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163307202|NCT01261312|589833849|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163307203|NCT01261312|589833850|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163307204|NCT01261312|589833851|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163307205|NCT01261312|589833852|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163307206|NCT01261312|589833853|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163307207|NCT01261312|589833854|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163307208|NCT01261312|589833855|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
163397092|NCT03496012|590166141|FG000|Overall Study|Adverse Event|0|||
163397093|NCT03496012|590166142|FG001|Overall Study|Adverse Event|0|||
162924466|NCT03539952|588423897|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
162963971|NCT03573544|588567957|FG004|Overall Study|Disease progression|5|||
163051196|NCT01232790|588895362|FG000|First Crossover|Withdrawal by Subject|1|||
163051197|NCT01232790|588895363|FG001|First Crossover|Withdrawal by Subject|0|||
163051198|NCT01232790|588895362|FG000|Second Crossover|Withdrawal by Subject|1|||
163051199|NCT01232790|588895363|FG001|Second Crossover|Withdrawal by Subject|2|||
163051200|NCT00083915|588895364|FG000|Overall Study|Death|6|||
163051201|NCT00083915|588895365|FG001|Overall Study|Death|3|||
163051202|NCT00083915|588895364|FG000|Overall Study|Physician Decision|11|||
163051203|NCT00083915|588895365|FG001|Overall Study|Physician Decision|6|||
163051204|NCT00083915|588895364|FG000|Overall Study|Withdrawal by Subject|8|||
163051205|NCT00083915|588895365|FG001|Overall Study|Withdrawal by Subject|3|||
163397094|NCT03496012|590166143|FG002|Overall Study|Adverse Event|1|||
163397095|NCT03496012|590166141|FG000|Overall Study|Reason Not Specified|2|||
163051206|NCT00083915|588895364|FG000|Overall Study|disease progression|18|||
163051207|NCT00083915|588895365|FG001|Overall Study|disease progression|23|||
163051208|NCT00083915|588895364|FG000|Overall Study|Failure to collect|3|||
163051209|NCT00083915|588895365|FG001|Overall Study|Failure to collect|0|||
163051210|NCT00083915|588895364|FG000|Overall Study|No response|3|||
163051211|NCT00083915|588895365|FG001|Overall Study|No response|1|||
163051212|NCT00083915|588895364|FG000|Overall Study|Insurance issues|1|||
163051213|NCT00083915|588895365|FG001|Overall Study|Insurance issues|1|||
163051214|NCT04456686|588895369|FG000|Overall Study|Adverse Event|2|||
163051215|NCT04456686|588895370|FG001|Overall Study|Adverse Event|1|||
163051216|NCT04456686|588895369|FG000|Overall Study|Lack of Efficacy|3|||
163051217|NCT04456686|588895370|FG001|Overall Study|Lack of Efficacy|1|||
163051218|NCT04456686|588895369|FG000|Overall Study|Withdrew consent|3|||
163051219|NCT04456686|588895370|FG001|Overall Study|Withdrew consent|1|||
163051220|NCT04456686|588895369|FG000|Overall Study|Physician Decision|2|||
163051221|NCT04456686|588895370|FG001|Overall Study|Physician Decision|2|||
163051222|NCT04456686|588895369|FG000|Overall Study|Withdrawal by Subject|5|||
163051223|NCT04456686|588895370|FG001|Overall Study|Withdrawal by Subject|1|||
163051224|NCT04456686|588895369|FG000|Overall Study|Protocol Violation|0|||
163051225|NCT04456686|588895370|FG001|Overall Study|Protocol Violation|1|||
163051226|NCT03722576|588895373|FG000|Overall Study|Withdrawal by Subject|3|||
163051227|NCT03722576|588895373|FG000|Overall Study|Adverse Event|2|||
163051228|NCT03722576|588895373|FG000|Overall Study|Physician Decision|1|||
163051229|NCT03722576|588895373|FG000|Overall Study|Lost to Follow-up|1|||
163051230|NCT02059239|588895377|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
163051231|NCT02059239|588895378|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
163051232|NCT02059239|588895377|FG000|Overall Study|Physician Decision|1|||
163051233|NCT02059239|588895378|FG001|Overall Study|Physician Decision|0|||
163051234|NCT01408706|588895380|FG000|Overall Study|Physician Decision|1|||
163051235|NCT01408706|588895381|FG001|Overall Study|Physician Decision|0|||
163051236|NCT02204917|588895382|FG000|Overall Study|Protocol Violation|1|||
163397096|NCT03496012|590166142|FG001|Overall Study|Reason Not Specified|0|||
163397097|NCT03496012|590166143|FG002|Overall Study|Reason Not Specified|1|||
163397098|NCT01524198|590166150|FG000|Overall Study|Protocol Violation|8|||
163397099|NCT01524198|590166151|FG001|Overall Study|Protocol Violation|6|||
163397100|NCT01524198|590166150|FG000|Overall Study|Withdrawal by Subject|15|||
163397101|NCT01524198|590166151|FG001|Overall Study|Withdrawal by Subject|10|||
163051237|NCT02048722|588895383|FG000|2 Cycles of Treatment|Adverse Event|2|||
163051238|NCT02048722|588895383|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
163051239|NCT02048722|588895383|FG000|2 Cycles of Treatment|Progressive Disease|2|||
163200573|NCT02573311|589449253|FG000|Disposition for Part 2|Adverse Event|36|||
163397102|NCT02232802|590166153|FG000|Period 1|Sponsor request|1|||
163051240|NCT02048722|588895383|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
163051241|NCT02048722|588895383|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
163051242|NCT02048722|588895383|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
163051243|NCT03575702|588895386|FG000|Overall Study|Withdrawal by Subject|1|||
163397103|NCT02232802|590166154|FG001|Period 1|Sponsor request|0|||
163307209|NCT01261312|589833856|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
163307210|NCT01261312|589833857|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
163307211|NCT01261312|589833858|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163307212|NCT01261312|589833859|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163307213|NCT01261312|589833860|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163307214|NCT01261312|589833861|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163307215|NCT01261312|589833849|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162963972|NCT03573544|588567958|FG005|Overall Study|Disease progression|7|||
162963973|NCT03573544|588567959|FG006|Overall Study|Disease progression|6|||
162963974|NCT03573544|588567960|FG007|Overall Study|Disease progression|7|||
162963975|NCT03105297|588567964|FG000|Baseline Phase (Day 1)|Other|21|||
162963976|NCT03105297|588567964|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
162963977|NCT03105297|588567964|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
162963978|NCT00714051|588567965|FG000|Overall Study|Withdrawal by Subject|1|||
162963979|NCT00714051|588567966|FG001|Overall Study|Withdrawal by Subject|0|||
162963980|NCT00714051|588567965|FG000|Overall Study|Death|0|||
162963981|NCT00714051|588567966|FG001|Overall Study|Death|1|||
162963982|NCT00227370|588567967|FG000|Overall Study|Withdrawal by Subject|1|||
162963983|NCT00227370|588567968|FG001|Overall Study|Withdrawal by Subject|2|||
163397104|NCT02232802|590166153|FG000|Period 1|Adverse Event|1|||
163397105|NCT02232802|590166154|FG001|Period 1|Adverse Event|1|||
163397106|NCT00885703|590166159|FG000|Overall Study|Death|9|||
162963984|NCT00227370|588567967|FG000|Overall Study|Death|3|||
162963985|NCT00227370|588567968|FG001|Overall Study|Death|4|||
162963986|NCT00227370|588567967|FG000|Overall Study|Adverse Event|6|||
162963987|NCT00227370|588567968|FG001|Overall Study|Adverse Event|11|||
162963988|NCT00227370|588567967|FG000|Overall Study|Physician Decision|9|||
162963989|NCT00227370|588567968|FG001|Overall Study|Physician Decision|6|||
162963990|NCT00227370|588567967|FG000|Overall Study|Other reasons|2|||
162963991|NCT00227370|588567968|FG001|Overall Study|Other reasons|1|||
162963992|NCT03846193|588567969|FG000|Overall Study|Physician Decision|0|||
162963993|NCT03846193|588567970|FG001|Overall Study|Physician Decision|0|||
162963994|NCT03846193|588567971|FG002|Overall Study|Physician Decision|1|||
162963995|NCT03846193|588567972|FG003|Overall Study|Physician Decision|0|||
162963996|NCT03846193|588567973|FG004|Overall Study|Physician Decision|0|||
162963997|NCT03846193|588567969|FG000|Overall Study|Lost to Follow-up|0|||
162963998|NCT03846193|588567970|FG001|Overall Study|Lost to Follow-up|0|||
163200574|NCT02573311|589449254|FG001|Disposition for Part 2|Adverse Event|5|||
163200575|NCT02573311|589449253|FG000|Disposition for Part 2|Lost to Follow-up|76|||
163200576|NCT02573311|589449254|FG001|Disposition for Part 2|Lost to Follow-up|7|||
163200577|NCT02573311|589449253|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
163200578|NCT02573311|589449254|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
163200579|NCT02573311|589449253|FG000|Disposition for Part 2|Investigator decision|0|||
163200580|NCT02573311|589449254|FG001|Disposition for Part 2|Investigator decision|1|||
163200581|NCT02573311|589449253|FG000|Disposition for Part 2|Other than specified above|13|||
163200582|NCT02573311|589449254|FG001|Disposition for Part 2|Other than specified above|3|||
163200583|NCT05683249|589449255|FG000|Overall Study|Adverse Event|3|||
163200584|NCT05683249|589449256|FG001|Overall Study|Adverse Event|1|||
163200585|NCT05683249|589449255|FG000|Overall Study|Lack of Efficacy|0|||
163200586|NCT05683249|589449256|FG001|Overall Study|Lack of Efficacy|2|||
163200587|NCT05683249|589449255|FG000|Overall Study|Lost to Follow-up|6|||
163200588|NCT05683249|589449256|FG001|Overall Study|Lost to Follow-up|5|||
163200589|NCT05683249|589449255|FG000|Overall Study|Non-compliance with Study Drug|2|||
163200590|NCT05683249|589449256|FG001|Overall Study|Non-compliance with Study Drug|0|||
163200591|NCT05683249|589449255|FG000|Overall Study|Protocol Violation|6|||
163200592|NCT05683249|589449256|FG001|Overall Study|Protocol Violation|3|||
163200593|NCT05683249|589449255|FG000|Overall Study|Withdrawal by Subject|9|||
163200594|NCT05683249|589449256|FG001|Overall Study|Withdrawal by Subject|8|||
163200595|NCT05683249|589449255|FG000|Overall Study|Other|0|||
163200596|NCT05683249|589449256|FG001|Overall Study|Other|2|||
163200597|NCT01328431|589449257|FG000|Baseline|Protocol Violation|0|||
163200598|NCT01328431|589449258|FG001|Baseline|Protocol Violation|2|||
163200599|NCT01328431|589449257|FG000|1 Month (1M)|Lost to Follow-up|55|||
163200600|NCT01328431|589449258|FG001|1 Month (1M)|Lost to Follow-up|58|||
163200601|NCT01328431|589449257|FG000|3 Month (3M)|Death|2|||
163200602|NCT01328431|589449258|FG001|3 Month (3M)|Death|2|||
163200603|NCT01328431|589449257|FG000|3 Month (3M)|Lost to Follow-up|75|||
163200604|NCT01328431|589449258|FG001|3 Month (3M)|Lost to Follow-up|70|||
163200605|NCT01328431|589449257|FG000|12 Month (12M)|Death|2|||
163200606|NCT01328431|589449258|FG001|12 Month (12M)|Death|6|||
163200607|NCT01328431|589449257|FG000|12 Month (12M)|Lost to Follow-up|82|||
163200608|NCT01328431|589449258|FG001|12 Month (12M)|Lost to Follow-up|91|||
163200609|NCT02256631|589449261|FG000|Overall Study|Lost to Follow-up|1|||
163200610|NCT02256631|589449262|FG001|Overall Study|Lost to Follow-up|1|||
162963999|NCT03846193|588567971|FG002|Overall Study|Lost to Follow-up|0|||
162964000|NCT03846193|588567972|FG003|Overall Study|Lost to Follow-up|0|||
162964001|NCT03846193|588567973|FG004|Overall Study|Lost to Follow-up|1|||
163200611|NCT02256631|589449263|FG002|Overall Study|Lost to Follow-up|0|||
163200612|NCT02256631|589449264|FG003|Overall Study|Lost to Follow-up|2|||
163200613|NCT02256631|589449265|FG004|Overall Study|Lost to Follow-up|0|||
163200614|NCT02256631|589449266|FG005|Overall Study|Lost to Follow-up|4|||
163200615|NCT02256631|589449267|FG006|Overall Study|Lost to Follow-up|1|||
163200616|NCT02256631|589449261|FG000|Overall Study|Withdrawal by Subject|0|||
163200617|NCT02256631|589449262|FG001|Overall Study|Withdrawal by Subject|0|||
163200618|NCT02256631|589449263|FG002|Overall Study|Withdrawal by Subject|0|||
163397107|NCT00885703|590166160|FG001|Overall Study|Death|7|||
162964002|NCT03846193|588567969|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
162964003|NCT03846193|588567970|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
162964004|NCT03846193|588567971|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
162964005|NCT03846193|588567972|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
162964006|NCT03846193|588567973|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
162964007|NCT01390948|588567974|FG000|Overall Study|End of Study|1|||
162964008|NCT01390948|588567975|FG001|Overall Study|End of Study|0|||
162964009|NCT01390948|588567976|FG002|Overall Study|End of Study|0|||
162964010|NCT01390948|588567974|FG000|Overall Study|Withdrew consent|2|||
162964011|NCT01390948|588567975|FG001|Overall Study|Withdrew consent|2|||
162964012|NCT01390948|588567976|FG002|Overall Study|Withdrew consent|0|||
162964013|NCT01390948|588567974|FG000|Overall Study|Progressive Disease|2|||
162964014|NCT01390948|588567975|FG001|Overall Study|Progressive Disease|5|||
162964015|NCT01390948|588567976|FG002|Overall Study|Progressive Disease|0|||
162964016|NCT01390948|588567974|FG000|Overall Study|Death during follow-up|10|||
162964017|NCT01390948|588567975|FG001|Overall Study|Death during follow-up|11|||
162964018|NCT01390948|588567976|FG002|Overall Study|Death during follow-up|1|||
162964019|NCT03961204|588567977|FG000|Overall Study|Withdrawal by Subject|2|||
162964020|NCT03961204|588567977|FG000|Overall Study|Lost to Follow-up|3|||
162964021|NCT03961204|588567977|FG000|Overall Study|Other|1|||
162964022|NCT03961204|588567977|FG000|Overall Study|Missing|1|||
162964023|NCT02218216|588567978|FG000|Overall Study|Study terminated before completed|6|||
162964024|NCT02218216|588567979|FG001|Overall Study|Study terminated before completed|0|||
162964025|NCT02218216|588567980|FG002|Overall Study|Study terminated before completed|0|||
162964026|NCT05740098|588567985|FG000|Overall Study|Lost to Follow-up|26|||
163307216|NCT01261312|589833850|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163307217|NCT01261312|589833851|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163307218|NCT01261312|589833852|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163307219|NCT01261312|589833853|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163307220|NCT01261312|589833854|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163307221|NCT01261312|589833855|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163307222|NCT01261312|589833856|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163307223|NCT01261312|589833857|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163307224|NCT01261312|589833858|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
163397108|NCT00885703|590166161|FG002|Overall Study|Death|8|||
163397109|NCT00885703|590166162|FG003|Overall Study|Death|7|||
163397110|NCT00885703|590166163|FG004|Overall Study|Death|7|||
163397111|NCT00885703|590166164|FG005|Overall Study|Death|8|||
163397112|NCT00885703|590166165|FG006|Overall Study|Death|4|||
163397113|NCT00885703|590166159|FG000|Overall Study|Lost to Follow-up|0|||
163397114|NCT00885703|590166160|FG001|Overall Study|Lost to Follow-up|0|||
163397115|NCT00885703|590166161|FG002|Overall Study|Lost to Follow-up|1|||
163397116|NCT00885703|590166162|FG003|Overall Study|Lost to Follow-up|0|||
163397117|NCT00885703|590166163|FG004|Overall Study|Lost to Follow-up|0|||
162964027|NCT05740098|588567986|FG001|Overall Study|Lost to Follow-up|17|||
162964028|NCT05740098|588567987|FG002|Overall Study|Lost to Follow-up|21|||
162964029|NCT02452463|588567988|FG000|Overall Study|Death|1|||
163397118|NCT00885703|590166164|FG005|Overall Study|Lost to Follow-up|1|||
162964030|NCT02452463|588567989|FG001|Overall Study|Death|0|||
162964031|NCT02452463|588567990|FG002|Overall Study|Death|0|||
162964032|NCT02452463|588567988|FG000|Overall Study|Study Suspended|1|||
162964033|NCT02452463|588567989|FG001|Overall Study|Study Suspended|0|||
163397119|NCT00885703|590166165|FG006|Overall Study|Lost to Follow-up|0|||
163397120|NCT00885703|590166159|FG000|Overall Study|Withdrawal by Subject|0|||
162964034|NCT02452463|588567990|FG002|Overall Study|Study Suspended|0|||
162964035|NCT02452463|588567988|FG000|Overall Study|Recommended by DSMB|0|||
162964036|NCT02452463|588567989|FG001|Overall Study|Recommended by DSMB|1|||
163200619|NCT02256631|589449264|FG003|Overall Study|Withdrawal by Subject|1|||
163200620|NCT02256631|589449265|FG004|Overall Study|Withdrawal by Subject|1|||
163200621|NCT02256631|589449266|FG005|Overall Study|Withdrawal by Subject|0|||
163200622|NCT02256631|589449267|FG006|Overall Study|Withdrawal by Subject|1|||
163200623|NCT02256631|589449261|FG000|Overall Study|Unable to get to clinic|0|||
163200624|NCT02256631|589449262|FG001|Overall Study|Unable to get to clinic|2|||
163200625|NCT02256631|589449263|FG002|Overall Study|Unable to get to clinic|0|||
163200626|NCT02256631|589449264|FG003|Overall Study|Unable to get to clinic|1|||
163200627|NCT02256631|589449265|FG004|Overall Study|Unable to get to clinic|0|||
163200628|NCT02256631|589449266|FG005|Overall Study|Unable to get to clinic|1|||
163200629|NCT02256631|589449267|FG006|Overall Study|Unable to get to clinic|2|||
163200630|NCT01427972|589449268|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
163200631|NCT01427972|589449269|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
163200632|NCT01427972|589449270|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
163200633|NCT01427972|589449271|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
163200634|NCT01427972|589449272|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
163200635|NCT01427972|589449273|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
163200636|NCT01427972|589449274|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
163200637|NCT01427972|589449275|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
163200638|NCT01427972|589449276|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
163200639|NCT01427972|589449277|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
163200640|NCT01427972|589449278|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
163200641|NCT01427972|589449279|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
163200642|NCT01427972|589449268|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
163200643|NCT01427972|589449269|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
163200644|NCT01427972|589449270|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
163200645|NCT01427972|589449271|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
163200646|NCT01427972|589449272|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
163200647|NCT01427972|589449273|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
163200648|NCT01427972|589449274|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
163200649|NCT01427972|589449275|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
163200650|NCT01427972|589449276|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
163200651|NCT01427972|589449277|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
163200652|NCT01427972|589449278|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
163200653|NCT01427972|589449279|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
163200654|NCT01427972|589449268|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
163307225|NCT01261312|589833859|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
163307226|NCT01261312|589833860|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
163307227|NCT01261312|589833861|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
163307228|NCT01261312|589833849|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163307229|NCT01261312|589833850|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163307230|NCT01261312|589833851|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163307231|NCT01261312|589833852|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163307232|NCT01261312|589833853|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163307233|NCT01261312|589833854|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163307234|NCT01261312|589833855|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163307235|NCT01261312|589833856|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163307236|NCT01261312|589833857|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163307237|NCT01261312|589833858|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
163307238|NCT01261312|589833859|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163307239|NCT01261312|589833860|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
163307240|NCT01261312|589833861|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
163307241|NCT01261312|589833849|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163307242|NCT01261312|589833850|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163307243|NCT01261312|589833851|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163307244|NCT01261312|589833852|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163307245|NCT01261312|589833853|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163307246|NCT01261312|589833854|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163307247|NCT01261312|589833855|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163307248|NCT01261312|589833856|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163307249|NCT01261312|589833857|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163307250|NCT01261312|589833858|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
163307251|NCT01261312|589833859|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
163200655|NCT01427972|589449269|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
163200656|NCT01427972|589449270|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
163200657|NCT01427972|589449271|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
163200658|NCT01427972|589449272|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
163200659|NCT01427972|589449273|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
163200660|NCT01427972|589449274|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
163200661|NCT01427972|589449275|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
163200662|NCT01427972|589449276|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
163200663|NCT01427972|589449277|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
163200664|NCT01427972|589449278|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
163200665|NCT01427972|589449279|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
163200666|NCT02094677|589449280|FG000|Overall Study|Screening|3|||
163200667|NCT02094677|589449281|FG001|Overall Study|Screening|1|||
163200668|NCT04967443|589449285|FG000|Open Label Treatment|Death|1|||
163200669|NCT04967443|589449286|FG001|Open Label Treatment|Death|0|||
163200670|NCT04967443|589449287|FG002|Open Label Treatment|Death|0|||
163200671|NCT04967443|589449288|FG003|Open Label Treatment|Death|0|||
163200672|NCT04967443|589449289|FG004|Open Label Treatment|Death|0|||
163200673|NCT04967443|589449290|FG005|Open Label Treatment|Death|0|||
163200674|NCT04967443|589449291|FG006|Open Label Treatment|Death|0|||
163200675|NCT04967443|589449292|FG007|Open Label Treatment|Death|0|||
163200676|NCT04967443|589449285|FG000|Open Label Treatment|Lost to Follow-up|0|||
163200677|NCT04967443|589449286|FG001|Open Label Treatment|Lost to Follow-up|0|||
163200678|NCT04967443|589449287|FG002|Open Label Treatment|Lost to Follow-up|1|||
163200679|NCT04967443|589449288|FG003|Open Label Treatment|Lost to Follow-up|0|||
163200680|NCT04967443|589449289|FG004|Open Label Treatment|Lost to Follow-up|0|||
163200681|NCT04967443|589449290|FG005|Open Label Treatment|Lost to Follow-up|0|||
163200682|NCT04967443|589449291|FG006|Open Label Treatment|Lost to Follow-up|0|||
163200683|NCT04967443|589449292|FG007|Open Label Treatment|Lost to Follow-up|0|||
163200684|NCT04967443|589449285|FG000|Open Label Treatment|Withdrawal by Subject|0|||
163200685|NCT04967443|589449286|FG001|Open Label Treatment|Withdrawal by Subject|1|||
163200686|NCT04967443|589449287|FG002|Open Label Treatment|Withdrawal by Subject|0|||
163200687|NCT04967443|589449288|FG003|Open Label Treatment|Withdrawal by Subject|1|||
163200688|NCT04967443|589449289|FG004|Open Label Treatment|Withdrawal by Subject|0|||
163200689|NCT04967443|589449290|FG005|Open Label Treatment|Withdrawal by Subject|1|||
163200690|NCT04967443|589449291|FG006|Open Label Treatment|Withdrawal by Subject|2|||
163200691|NCT04967443|589449292|FG007|Open Label Treatment|Withdrawal by Subject|3|||
163200692|NCT04967443|589449285|FG000|Follow-Up|Death|1|||
163397121|NCT00885703|590166160|FG001|Overall Study|Withdrawal by Subject|0|||
163397122|NCT00885703|590166161|FG002|Overall Study|Withdrawal by Subject|0|||
163200693|NCT04967443|589449286|FG001|Follow-Up|Death|0|||
163200694|NCT04967443|589449287|FG002|Follow-Up|Death|0|||
163200695|NCT04967443|589449288|FG003|Follow-Up|Death|0|||
163200696|NCT04967443|589449289|FG004|Follow-Up|Death|0|||
163200697|NCT04967443|589449290|FG005|Follow-Up|Death|0|||
163200698|NCT04967443|589449291|FG006|Follow-Up|Death|0|||
163200699|NCT04967443|589449292|FG007|Follow-Up|Death|0|||
163200700|NCT04967443|589449285|FG000|Follow-Up|Lost to Follow-up|0|||
163200701|NCT04967443|589449286|FG001|Follow-Up|Lost to Follow-up|0|||
163200702|NCT04967443|589449287|FG002|Follow-Up|Lost to Follow-up|1|||
163200703|NCT04967443|589449288|FG003|Follow-Up|Lost to Follow-up|1|||
162964037|NCT02452463|588567990|FG002|Overall Study|Recommended by DSMB|0|||
162964038|NCT02452463|588567988|FG000|Overall Study|Withdrawal by Subject|0|||
162964039|NCT02452463|588567989|FG001|Overall Study|Withdrawal by Subject|1|||
162964040|NCT02452463|588567990|FG002|Overall Study|Withdrawal by Subject|0|||
163200704|NCT04967443|589449289|FG004|Follow-Up|Lost to Follow-up|0|||
163200705|NCT04967443|589449290|FG005|Follow-Up|Lost to Follow-up|0|||
163200706|NCT04967443|589449291|FG006|Follow-Up|Lost to Follow-up|0|||
162964041|NCT01073631|588567991|FG000|Overall Study|Death|82|||
163200707|NCT04967443|589449292|FG007|Follow-Up|Lost to Follow-up|0|||
163200708|NCT04967443|589449285|FG000|Follow-Up|Withdrawal by Subject|0|||
163200709|NCT04967443|589449286|FG001|Follow-Up|Withdrawal by Subject|1|||
163200710|NCT04967443|589449287|FG002|Follow-Up|Withdrawal by Subject|0|||
163200711|NCT04967443|589449288|FG003|Follow-Up|Withdrawal by Subject|1|||
163200712|NCT04967443|589449289|FG004|Follow-Up|Withdrawal by Subject|0|||
163200713|NCT04967443|589449290|FG005|Follow-Up|Withdrawal by Subject|1|||
163307252|NCT01261312|589833860|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
163307253|NCT01261312|589833861|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
163307254|NCT01261312|589833849|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163307255|NCT01261312|589833850|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163307256|NCT01261312|589833851|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163307257|NCT01261312|589833852|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163307258|NCT01261312|589833853|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163307259|NCT01261312|589833854|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163307260|NCT01261312|589833855|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163307261|NCT01261312|589833856|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163307262|NCT01261312|589833857|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163307263|NCT01261312|589833858|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
163307264|NCT01261312|589833859|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
163307265|NCT01261312|589833860|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
163307266|NCT01261312|589833861|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
163307267|NCT01261312|589833849|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163307268|NCT01261312|589833850|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163307269|NCT01261312|589833851|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163307270|NCT01261312|589833852|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163307271|NCT01261312|589833853|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163307272|NCT01261312|589833854|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163307273|NCT01261312|589833855|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163307274|NCT01261312|589833856|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163307275|NCT01261312|589833857|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163200714|NCT04967443|589449291|FG006|Follow-Up|Withdrawal by Subject|2|||
163307276|NCT01261312|589833858|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
163307277|NCT01261312|589833859|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
163307278|NCT01261312|589833860|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
163397123|NCT00885703|590166162|FG003|Overall Study|Withdrawal by Subject|1|||
162964042|NCT01073631|588567991|FG000|Overall Study|Adverse Event|24|||
163200715|NCT04967443|589449292|FG007|Follow-Up|Withdrawal by Subject|3|||
163200716|NCT04502693|589449293|FG000|Overall Study|Adverse Event|7|||
163200717|NCT04502693|589449294|FG001|Overall Study|Adverse Event|6|||
163200718|NCT04502693|589449295|FG002|Overall Study|Adverse Event|11|||
163200719|NCT04502693|589449296|FG003|Overall Study|Adverse Event|1|||
163051244|NCT03575702|588895387|FG001|Overall Study|Withdrawal by Subject|1|||
163051245|NCT03575702|588895386|FG000|Overall Study|Lost to Follow-up|1|||
163051246|NCT03575702|588895387|FG001|Overall Study|Lost to Follow-up|2|||
163051247|NCT03575702|588895386|FG000|Overall Study|Protocol Violation|0|||
163200720|NCT04502693|589449293|FG000|Overall Study|Lost to Follow-up|32|||
163200721|NCT04502693|589449294|FG001|Overall Study|Lost to Follow-up|36|||
163051248|NCT03575702|588895387|FG001|Overall Study|Protocol Violation|1|||
163200722|NCT04502693|589449295|FG002|Overall Study|Lost to Follow-up|69|||
163200723|NCT04502693|589449296|FG003|Overall Study|Lost to Follow-up|4|||
163200724|NCT04502693|589449293|FG000|Overall Study|Protocol Violation|8|||
163200725|NCT04502693|589449294|FG001|Overall Study|Protocol Violation|8|||
163200726|NCT04502693|589449295|FG002|Overall Study|Protocol Violation|16|||
163200727|NCT04502693|589449296|FG003|Overall Study|Protocol Violation|1|||
163200728|NCT04502693|589449293|FG000|Overall Study|Withdrawal by Subject|46|||
163200729|NCT04502693|589449294|FG001|Overall Study|Withdrawal by Subject|38|||
163200730|NCT04502693|589449295|FG002|Overall Study|Withdrawal by Subject|54|||
163200731|NCT04502693|589449296|FG003|Overall Study|Withdrawal by Subject|7|||
163200732|NCT04502693|589449293|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
163200733|NCT04502693|589449294|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
163200734|NCT04502693|589449295|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
163200735|NCT04502693|589449296|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163200736|NCT04502693|589449293|FG000|Overall Study|Other|1|||
163200737|NCT04502693|589449294|FG001|Overall Study|Other|0|||
163200738|NCT04502693|589449295|FG002|Overall Study|Other|1|||
163200739|NCT04502693|589449296|FG003|Overall Study|Other|1|||
163200740|NCT02784431|589449297|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
163200741|NCT02784431|589449297|FG000|Overall Study|Early Study Termination|19|||
163200742|NCT00279305|589449298|FG000|Overall Study|Pregnancy|1|||
163200743|NCT00279305|589449299|FG001|Overall Study|Pregnancy|0|||
163200744|NCT00279305|589449298|FG000|Overall Study|Withdrawal by Subject|2|||
163200745|NCT00279305|589449299|FG001|Overall Study|Withdrawal by Subject|0|||
163200746|NCT00279305|589449298|FG000|Overall Study|Dificulting establishing IV|1|||
163200747|NCT00279305|589449299|FG001|Overall Study|Dificulting establishing IV|0|||
163200748|NCT00279305|589449298|FG000|Overall Study|FDA Safety Alert|4|||
163200749|NCT00279305|589449299|FG001|Overall Study|FDA Safety Alert|1|||
163200750|NCT04404361|589449300|FG000|Overall Study|Death|12|||
163200751|NCT04404361|589449301|FG001|Overall Study|Death|12|||
163200752|NCT04404361|589449300|FG000|Overall Study|Withdrawal by Subject|13|||
163200753|NCT04404361|589449301|FG001|Overall Study|Withdrawal by Subject|5|||
163200754|NCT04404361|589449300|FG000|Overall Study|Lost to Follow-up|6|||
163200755|NCT04404361|589449301|FG001|Overall Study|Lost to Follow-up|3|||
163210552|NCT03045887|589485285|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
162964043|NCT01073631|588567991|FG000|Overall Study|Other|63|||
162964044|NCT01131260|588567996|FG000|Overall Study|Randomization error|5|||
162964045|NCT01131260|588567997|FG001|Overall Study|Randomization error|1|||
162964046|NCT01131260|588567996|FG000|Overall Study|Declined to continue participation|8|||
162964047|NCT01131260|588567997|FG001|Overall Study|Declined to continue participation|13|||
162964048|NCT01131260|588567996|FG000|Overall Study|Physician Decision|22|||
162964049|NCT01131260|588567997|FG001|Overall Study|Physician Decision|24|||
163307279|NCT01261312|589833861|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
162964050|NCT01131260|588567996|FG000|Overall Study|Technical problems|7|||
162964051|NCT01131260|588567997|FG001|Overall Study|Technical problems|6|||
162964052|NCT01131260|588567996|FG000|Overall Study|Staff error|2|||
162964053|NCT01131260|588567997|FG001|Overall Study|Staff error|1|||
162964054|NCT01131260|588567996|FG000|Overall Study|Ineligible|0|||
162964055|NCT01131260|588567997|FG001|Overall Study|Ineligible|2|||
162964056|NCT01494532|588568002|FG000|Overall Study|Adverse Event|4|||
162964057|NCT01494532|588568003|FG001|Overall Study|Adverse Event|1|||
162964058|NCT01494532|588568004|FG002|Overall Study|Adverse Event|8|||
162964059|NCT01494532|588568005|FG003|Overall Study|Adverse Event|6|||
162964060|NCT01494532|588568006|FG004|Overall Study|Adverse Event|5|||
162964061|NCT01494532|588568007|FG005|Overall Study|Adverse Event|0|||
162964062|NCT01494532|588568002|FG000|Overall Study|Lack of Efficacy|0|||
162964063|NCT01494532|588568003|FG001|Overall Study|Lack of Efficacy|0|||
162964064|NCT01494532|588568004|FG002|Overall Study|Lack of Efficacy|0|||
163307280|NCT01261312|589833849|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163307281|NCT01261312|589833850|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163307282|NCT01261312|589833851|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163307283|NCT01261312|589833852|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163307284|NCT01261312|589833853|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163307285|NCT01261312|589833854|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163307286|NCT01261312|589833855|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163307287|NCT01261312|589833856|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163307288|NCT01261312|589833857|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163307289|NCT01261312|589833858|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
163307290|NCT01261312|589833859|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
163307291|NCT01261312|589833860|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
163307292|NCT01261312|589833861|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
163307293|NCT01261312|589833849|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163307294|NCT01261312|589833850|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163307295|NCT01261312|589833851|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163307296|NCT01261312|589833852|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163307297|NCT01261312|589833853|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163307298|NCT01261312|589833854|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163307299|NCT01261312|589833855|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163307300|NCT01261312|589833856|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163307301|NCT01261312|589833857|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163307302|NCT01261312|589833858|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
163307303|NCT01261312|589833859|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
163307304|NCT01261312|589833860|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
163307305|NCT01261312|589833861|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
163307306|NCT04294225|589833862|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
163307307|NCT04294225|589833862|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
163307308|NCT04294225|589833862|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
163307309|NCT04294225|589833862|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
163307310|NCT04294225|589833862|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
163307311|NCT04812535|589833870|FG000|Overall Study|Withdrawal by Subject|0|||
163307312|NCT04812535|589833871|FG001|Overall Study|Withdrawal by Subject|0|||
163307313|NCT04812535|589833872|FG002|Overall Study|Withdrawal by Subject|0|||
163307314|NCT04812535|589833873|FG003|Overall Study|Withdrawal by Subject|1|||
163307315|NCT04812535|589833870|FG000|Overall Study|Death|7|||
163307316|NCT04812535|589833871|FG001|Overall Study|Death|2|||
163307317|NCT04812535|589833872|FG002|Overall Study|Death|4|||
163307318|NCT04812535|589833873|FG003|Overall Study|Death|1|||
163307319|NCT04812535|589833870|FG000|Overall Study|Due to premature study termination by sponsor|2|||
163307320|NCT04812535|589833871|FG001|Overall Study|Due to premature study termination by sponsor|0|||
163307321|NCT04812535|589833872|FG002|Overall Study|Due to premature study termination by sponsor|1|||
163307322|NCT04812535|589833873|FG003|Overall Study|Due to premature study termination by sponsor|3|||
163307323|NCT03336333|589833874|FG000|Overall Study|Remained on study at time of data cut-off|202|||
163307324|NCT03336333|589833875|FG001|Overall Study|Remained on study at time of data cut-off|219|||
162964065|NCT01494532|588568005|FG003|Overall Study|Lack of Efficacy|0|||
162964066|NCT01494532|588568006|FG004|Overall Study|Lack of Efficacy|2|||
162964067|NCT01494532|588568007|FG005|Overall Study|Lack of Efficacy|0|||
162964068|NCT01494532|588568002|FG000|Overall Study|Protocol deviation|2|||
162964069|NCT01494532|588568003|FG001|Overall Study|Protocol deviation|1|||
162964070|NCT01494532|588568004|FG002|Overall Study|Protocol deviation|3|||
162964071|NCT01494532|588568005|FG003|Overall Study|Protocol deviation|2|||
162964072|NCT01494532|588568006|FG004|Overall Study|Protocol deviation|3|||
162964073|NCT01494532|588568007|FG005|Overall Study|Protocol deviation|0|||
162964074|NCT01494532|588568002|FG000|Overall Study|Protocol-defined stopping criteria|0|||
162964075|NCT01494532|588568003|FG001|Overall Study|Protocol-defined stopping criteria|0|||
162964076|NCT01494532|588568004|FG002|Overall Study|Protocol-defined stopping criteria|1|||
162964077|NCT01494532|588568005|FG003|Overall Study|Protocol-defined stopping criteria|0|||
162964078|NCT01494532|588568006|FG004|Overall Study|Protocol-defined stopping criteria|0|||
162964079|NCT01494532|588568007|FG005|Overall Study|Protocol-defined stopping criteria|0|||
162964080|NCT01494532|588568002|FG000|Overall Study|Lost to Follow-up|1|||
162964081|NCT01494532|588568003|FG001|Overall Study|Lost to Follow-up|0|||
162964082|NCT01494532|588568004|FG002|Overall Study|Lost to Follow-up|0|||
162964083|NCT01494532|588568005|FG003|Overall Study|Lost to Follow-up|2|||
162964084|NCT01494532|588568006|FG004|Overall Study|Lost to Follow-up|0|||
162964085|NCT01494532|588568007|FG005|Overall Study|Lost to Follow-up|0|||
162964086|NCT01494532|588568002|FG000|Overall Study|Physician Decision|0|||
162964087|NCT01494532|588568003|FG001|Overall Study|Physician Decision|1|||
163051249|NCT03575702|588895386|FG000|Overall Study|Patient non compliance|4|||
163051250|NCT03575702|588895387|FG001|Overall Study|Patient non compliance|0|||
162964088|NCT01494532|588568004|FG002|Overall Study|Physician Decision|1|||
162964089|NCT01494532|588568005|FG003|Overall Study|Physician Decision|2|||
162964090|NCT01494532|588568006|FG004|Overall Study|Physician Decision|0|||
162964091|NCT01494532|588568007|FG005|Overall Study|Physician Decision|0|||
162964092|NCT01494532|588568002|FG000|Overall Study|Withdrawal by Subject|3|||
162964093|NCT01494532|588568003|FG001|Overall Study|Withdrawal by Subject|1|||
163307325|NCT03336333|589833876|FG002|Overall Study|Remained on study at time of data cut-off|102|||
163307326|NCT03336333|589833874|FG000|Overall Study|Death|14|||
163307327|NCT03336333|589833875|FG001|Overall Study|Death|16|||
163307328|NCT03336333|589833876|FG002|Overall Study|Death|8|||
163307329|NCT03336333|589833874|FG000|Overall Study|Withdrawal by Subject|16|||
163307330|NCT03336333|589833875|FG001|Overall Study|Withdrawal by Subject|5|||
163307331|NCT03336333|589833876|FG002|Overall Study|Withdrawal by Subject|1|||
163307332|NCT03336333|589833874|FG000|Overall Study|Physician Decision|5|||
163307333|NCT03336333|589833875|FG001|Overall Study|Physician Decision|1|||
163307334|NCT03336333|589833876|FG002|Overall Study|Physician Decision|0|||
163307335|NCT03336333|589833874|FG000|Overall Study|Lost to Follow-up|1|||
163307336|NCT03336333|589833875|FG001|Overall Study|Lost to Follow-up|0|||
163307337|NCT03336333|589833876|FG002|Overall Study|Lost to Follow-up|0|||
163307338|NCT04401800|589833879|FG000|Overall Study|Death|17|||
163307339|NCT04401800|589833879|FG000|Overall Study|Lost to Follow-up|5|||
163307340|NCT04401800|589833879|FG000|Overall Study|Withdrawal by Subject|4|||
163307341|NCT04927065|589833880|FG000|First Booster|Adverse Event|1|||
163307342|NCT04927065|589833881|FG001|First Booster|Adverse Event|0|||
163307343|NCT04927065|589833882|FG002|First Booster|Adverse Event|0|||
163307344|NCT04927065|589833883|FG003|First Booster|Adverse Event|0|||
163307345|NCT04927065|589833884|FG004|First Booster|Adverse Event|0|||
163307346|NCT04927065|589833885|FG005|First Booster|Adverse Event|0|||
163307347|NCT04927065|589833886|FG006|First Booster|Adverse Event|0|||
163307348|NCT04927065|589833887|FG007|First Booster|Adverse Event|1|||
163307349|NCT04927065|589833888|FG008|First Booster|Adverse Event|0|||
163307350|NCT04927065|589833889|FG009|First Booster|Adverse Event|0|||
163307351|NCT04927065|589833890|FG010|First Booster|Adverse Event|0|||
163307352|NCT04927065|589833891|FG011|First Booster|Adverse Event|0|||
163307353|NCT04927065|589833892|FG012|First Booster|Adverse Event|0|||
163307354|NCT04927065|589833893|FG013|First Booster|Adverse Event|0|||
163307355|NCT04927065|589833894|FG014|First Booster|Adverse Event|0|||
163307356|NCT04927065|589833895|FG015|First Booster|Adverse Event|0|||
163307357|NCT04927065|589833880|FG000|First Booster|Death|1|||
163307358|NCT04927065|589833881|FG001|First Booster|Death|0|||
163307359|NCT04927065|589833882|FG002|First Booster|Death|0|||
163307360|NCT04927065|589833883|FG003|First Booster|Death|1|||
163307361|NCT04927065|589833884|FG004|First Booster|Death|0|||
163307362|NCT04927065|589833885|FG005|First Booster|Death|1|||
163307363|NCT04927065|589833886|FG006|First Booster|Death|0|||
163307364|NCT04927065|589833887|FG007|First Booster|Death|0|||
163307365|NCT04927065|589833888|FG008|First Booster|Death|0|||
163307366|NCT04927065|589833889|FG009|First Booster|Death|0|||
163307367|NCT04927065|589833890|FG010|First Booster|Death|0|||
163307368|NCT04927065|589833891|FG011|First Booster|Death|0|||
163307369|NCT04927065|589833892|FG012|First Booster|Death|0|||
163307370|NCT04927065|589833893|FG013|First Booster|Death|0|||
163307371|NCT04927065|589833894|FG014|First Booster|Death|0|||
163307372|NCT04927065|589833895|FG015|First Booster|Death|0|||
163307373|NCT04927065|589833880|FG000|First Booster|Lost to Follow-up|8|||
163307374|NCT04927065|589833881|FG001|First Booster|Lost to Follow-up|20|||
163307375|NCT04927065|589833882|FG002|First Booster|Lost to Follow-up|0|||
163307376|NCT04927065|589833883|FG003|First Booster|Lost to Follow-up|11|||
163307377|NCT04927065|589833884|FG004|First Booster|Lost to Follow-up|43|||
163307378|NCT04927065|589833885|FG005|First Booster|Lost to Follow-up|30|||
163307379|NCT04927065|589833886|FG006|First Booster|Lost to Follow-up|28|||
163307380|NCT04927065|589833887|FG007|First Booster|Lost to Follow-up|23|||
163307381|NCT04927065|589833888|FG008|First Booster|Lost to Follow-up|4|||
163307382|NCT04927065|589833889|FG009|First Booster|Lost to Follow-up|15|||
163307383|NCT04927065|589833890|FG010|First Booster|Lost to Follow-up|0|||
163307384|NCT04927065|589833891|FG011|First Booster|Lost to Follow-up|0|||
163307385|NCT04927065|589833892|FG012|First Booster|Lost to Follow-up|0|||
163307386|NCT04927065|589833893|FG013|First Booster|Lost to Follow-up|0|||
163307387|NCT04927065|589833894|FG014|First Booster|Lost to Follow-up|0|||
163307388|NCT04927065|589833895|FG015|First Booster|Lost to Follow-up|0|||
163307389|NCT04927065|589833880|FG000|First Booster|Physician Decision|1|||
163307390|NCT04927065|589833881|FG001|First Booster|Physician Decision|0|||
163307391|NCT04927065|589833882|FG002|First Booster|Physician Decision|0|||
163307392|NCT04927065|589833883|FG003|First Booster|Physician Decision|3|||
163307393|NCT04927065|589833884|FG004|First Booster|Physician Decision|1|||
163307394|NCT04927065|589833885|FG005|First Booster|Physician Decision|1|||
163307395|NCT04927065|589833886|FG006|First Booster|Physician Decision|0|||
163307396|NCT04927065|589833887|FG007|First Booster|Physician Decision|3|||
163307397|NCT04927065|589833888|FG008|First Booster|Physician Decision|0|||
163307398|NCT04927065|589833889|FG009|First Booster|Physician Decision|0|||
163307399|NCT04927065|589833890|FG010|First Booster|Physician Decision|0|||
163307400|NCT04927065|589833891|FG011|First Booster|Physician Decision|0|||
163307401|NCT04927065|589833892|FG012|First Booster|Physician Decision|0|||
163307402|NCT04927065|589833893|FG013|First Booster|Physician Decision|0|||
163307403|NCT04927065|589833894|FG014|First Booster|Physician Decision|0|||
163307404|NCT04927065|589833895|FG015|First Booster|Physician Decision|0|||
163307405|NCT04927065|589833880|FG000|First Booster|Protocol Violation|4|||
163307406|NCT04927065|589833881|FG001|First Booster|Protocol Violation|4|||
163307407|NCT04927065|589833882|FG002|First Booster|Protocol Violation|0|||
163307408|NCT04927065|589833883|FG003|First Booster|Protocol Violation|3|||
163307409|NCT04927065|589833884|FG004|First Booster|Protocol Violation|0|||
163307410|NCT04927065|589833885|FG005|First Booster|Protocol Violation|0|||
163307411|NCT04927065|589833886|FG006|First Booster|Protocol Violation|0|||
163307412|NCT04927065|589833887|FG007|First Booster|Protocol Violation|2|||
163307413|NCT04927065|589833888|FG008|First Booster|Protocol Violation|0|||
163307414|NCT04927065|589833889|FG009|First Booster|Protocol Violation|0|||
163307415|NCT04927065|589833890|FG010|First Booster|Protocol Violation|0|||
163307416|NCT04927065|589833891|FG011|First Booster|Protocol Violation|0|||
163307417|NCT04927065|589833892|FG012|First Booster|Protocol Violation|0|||
163307418|NCT04927065|589833893|FG013|First Booster|Protocol Violation|0|||
163307419|NCT04927065|589833894|FG014|First Booster|Protocol Violation|0|||
163307420|NCT04927065|589833895|FG015|First Booster|Protocol Violation|0|||
163307421|NCT04927065|589833880|FG000|First Booster|Withdrawal by Subject|8|||
163307422|NCT04927065|589833881|FG001|First Booster|Withdrawal by Subject|23|||
163307423|NCT04927065|589833882|FG002|First Booster|Withdrawal by Subject|0|||
163397124|NCT00885703|590166163|FG004|Overall Study|Withdrawal by Subject|3|||
162964094|NCT01494532|588568004|FG002|Overall Study|Withdrawal by Subject|4|||
163307424|NCT04927065|589833883|FG003|First Booster|Withdrawal by Subject|19|||
163307425|NCT04927065|589833884|FG004|First Booster|Withdrawal by Subject|20|||
163307426|NCT04927065|589833885|FG005|First Booster|Withdrawal by Subject|15|||
163307427|NCT04927065|589833886|FG006|First Booster|Withdrawal by Subject|6|||
163307428|NCT04927065|589833887|FG007|First Booster|Withdrawal by Subject|24|||
163307429|NCT04927065|589833888|FG008|First Booster|Withdrawal by Subject|0|||
163307430|NCT04927065|589833889|FG009|First Booster|Withdrawal by Subject|4|||
163307431|NCT04927065|589833890|FG010|First Booster|Withdrawal by Subject|0|||
163307432|NCT04927065|589833891|FG011|First Booster|Withdrawal by Subject|0|||
163307433|NCT04927065|589833892|FG012|First Booster|Withdrawal by Subject|0|||
163307434|NCT04927065|589833893|FG013|First Booster|Withdrawal by Subject|0|||
163307435|NCT04927065|589833894|FG014|First Booster|Withdrawal by Subject|0|||
163307436|NCT04927065|589833895|FG015|First Booster|Withdrawal by Subject|0|||
163307437|NCT04927065|589833880|FG000|First Booster|Other Than Specified|1|||
163307438|NCT04927065|589833881|FG001|First Booster|Other Than Specified|1|||
163307439|NCT04927065|589833882|FG002|First Booster|Other Than Specified|0|||
163307440|NCT04927065|589833883|FG003|First Booster|Other Than Specified|1|||
163307441|NCT04927065|589833884|FG004|First Booster|Other Than Specified|2|||
163307442|NCT04927065|589833885|FG005|First Booster|Other Than Specified|3|||
163307443|NCT04927065|589833886|FG006|First Booster|Other Than Specified|2|||
163307444|NCT04927065|589833887|FG007|First Booster|Other Than Specified|6|||
163307445|NCT04927065|589833888|FG008|First Booster|Other Than Specified|0|||
163307446|NCT04927065|589833889|FG009|First Booster|Other Than Specified|4|||
163307447|NCT04927065|589833890|FG010|First Booster|Other Than Specified|0|||
163307448|NCT04927065|589833891|FG011|First Booster|Other Than Specified|0|||
163307449|NCT04927065|589833892|FG012|First Booster|Other Than Specified|0|||
163307450|NCT04927065|589833893|FG013|First Booster|Other Than Specified|0|||
163307451|NCT04927065|589833894|FG014|First Booster|Other Than Specified|0|||
163307452|NCT04927065|589833895|FG015|First Booster|Other Than Specified|0|||
163307453|NCT04927065|589833880|FG000|Second Booster|Death|0|||
163307454|NCT04927065|589833881|FG001|Second Booster|Death|0|||
163307455|NCT04927065|589833882|FG002|Second Booster|Death|0|||
163307456|NCT04927065|589833883|FG003|Second Booster|Death|0|||
163307457|NCT04927065|589833884|FG004|Second Booster|Death|0|||
163307458|NCT04927065|589833885|FG005|Second Booster|Death|0|||
163307459|NCT04927065|589833886|FG006|Second Booster|Death|0|||
163307460|NCT04927065|589833887|FG007|Second Booster|Death|0|||
163307461|NCT04927065|589833888|FG008|Second Booster|Death|0|||
163307462|NCT04927065|589833889|FG009|Second Booster|Death|0|||
163307463|NCT04927065|589833890|FG010|Second Booster|Death|2|||
163307464|NCT04927065|589833891|FG011|Second Booster|Death|0|||
163307465|NCT04927065|589833892|FG012|Second Booster|Death|2|||
163307466|NCT04927065|589833893|FG013|Second Booster|Death|2|||
163307467|NCT04927065|589833894|FG014|Second Booster|Death|0|||
163307468|NCT04927065|589833895|FG015|Second Booster|Death|0|||
163307469|NCT04927065|589833880|FG000|Second Booster|Lost to Follow-up|0|||
163307470|NCT04927065|589833881|FG001|Second Booster|Lost to Follow-up|0|||
163307471|NCT04927065|589833882|FG002|Second Booster|Lost to Follow-up|3|||
163307472|NCT04927065|589833883|FG003|Second Booster|Lost to Follow-up|0|||
163307473|NCT04927065|589833884|FG004|Second Booster|Lost to Follow-up|0|||
163307474|NCT04927065|589833885|FG005|Second Booster|Lost to Follow-up|0|||
163307475|NCT04927065|589833886|FG006|Second Booster|Lost to Follow-up|0|||
163307476|NCT04927065|589833887|FG007|Second Booster|Lost to Follow-up|0|||
163307477|NCT04927065|589833888|FG008|Second Booster|Lost to Follow-up|0|||
163307478|NCT04927065|589833889|FG009|Second Booster|Lost to Follow-up|0|||
163307479|NCT04927065|589833890|FG010|Second Booster|Lost to Follow-up|14|||
163307480|NCT04927065|589833891|FG011|Second Booster|Lost to Follow-up|10|||
163307481|NCT04927065|589833892|FG012|Second Booster|Lost to Follow-up|13|||
163307482|NCT04927065|589833893|FG013|Second Booster|Lost to Follow-up|16|||
163307483|NCT04927065|589833894|FG014|Second Booster|Lost to Follow-up|0|||
163307484|NCT04927065|589833895|FG015|Second Booster|Lost to Follow-up|0|||
163307485|NCT04927065|589833880|FG000|Second Booster|Physician Decision|0|||
163307486|NCT04927065|589833881|FG001|Second Booster|Physician Decision|0|||
163307487|NCT04927065|589833882|FG002|Second Booster|Physician Decision|0|||
163307488|NCT04927065|589833883|FG003|Second Booster|Physician Decision|0|||
163307489|NCT04927065|589833884|FG004|Second Booster|Physician Decision|0|||
163307490|NCT04927065|589833885|FG005|Second Booster|Physician Decision|0|||
163307491|NCT04927065|589833886|FG006|Second Booster|Physician Decision|0|||
163307492|NCT04927065|589833887|FG007|Second Booster|Physician Decision|0|||
163307493|NCT04927065|589833888|FG008|Second Booster|Physician Decision|0|||
163307494|NCT04927065|589833889|FG009|Second Booster|Physician Decision|0|||
163307495|NCT04927065|589833890|FG010|Second Booster|Physician Decision|0|||
163307496|NCT04927065|589833891|FG011|Second Booster|Physician Decision|3|||
163307497|NCT04927065|589833892|FG012|Second Booster|Physician Decision|0|||
163307498|NCT04927065|589833893|FG013|Second Booster|Physician Decision|1|||
163307499|NCT04927065|589833894|FG014|Second Booster|Physician Decision|0|||
163307500|NCT04927065|589833895|FG015|Second Booster|Physician Decision|0|||
163307501|NCT04927065|589833880|FG000|Second Booster|Withdrawal by Subject|0|||
163307502|NCT04927065|589833881|FG001|Second Booster|Withdrawal by Subject|0|||
163307503|NCT04927065|589833882|FG002|Second Booster|Withdrawal by Subject|4|||
163307504|NCT04927065|589833883|FG003|Second Booster|Withdrawal by Subject|0|||
163307505|NCT04927065|589833884|FG004|Second Booster|Withdrawal by Subject|0|||
163307506|NCT04927065|589833885|FG005|Second Booster|Withdrawal by Subject|0|||
163307507|NCT04927065|589833886|FG006|Second Booster|Withdrawal by Subject|0|||
163307508|NCT04927065|589833887|FG007|Second Booster|Withdrawal by Subject|0|||
163307509|NCT04927065|589833888|FG008|Second Booster|Withdrawal by Subject|0|||
163307510|NCT04927065|589833889|FG009|Second Booster|Withdrawal by Subject|0|||
163307511|NCT04927065|589833890|FG010|Second Booster|Withdrawal by Subject|3|||
163307512|NCT04927065|589833891|FG011|Second Booster|Withdrawal by Subject|16|||
163307513|NCT04927065|589833892|FG012|Second Booster|Withdrawal by Subject|13|||
163307514|NCT04927065|589833893|FG013|Second Booster|Withdrawal by Subject|9|||
162964095|NCT01494532|588568005|FG003|Overall Study|Withdrawal by Subject|3|||
162964096|NCT01494532|588568006|FG004|Overall Study|Withdrawal by Subject|2|||
162964097|NCT01494532|588568007|FG005|Overall Study|Withdrawal by Subject|0|||
162964098|NCT00679081|588568008|FG000|Overall Study|Lost to Follow-up|1|||
162964099|NCT01404988|588568013|FG000|Overall Study|Death|2|||
163307515|NCT04927065|589833894|FG014|Second Booster|Withdrawal by Subject|0|||
162964100|NCT01404988|588568014|FG001|Overall Study|Death|0|||
162964101|NCT01404988|588568015|FG002|Overall Study|Death|2|||
163307516|NCT04927065|589833895|FG015|Second Booster|Withdrawal by Subject|0|||
163307517|NCT04927065|589833880|FG000|Second Booster|Other Than Specified|0|||
163307518|NCT04927065|589833881|FG001|Second Booster|Other Than Specified|0|||
163307519|NCT04927065|589833882|FG002|Second Booster|Other Than Specified|0|||
163307520|NCT04927065|589833883|FG003|Second Booster|Other Than Specified|0|||
163307521|NCT04927065|589833884|FG004|Second Booster|Other Than Specified|0|||
163307522|NCT04927065|589833885|FG005|Second Booster|Other Than Specified|0|||
163307523|NCT04927065|589833886|FG006|Second Booster|Other Than Specified|0|||
163307524|NCT04927065|589833887|FG007|Second Booster|Other Than Specified|0|||
162964102|NCT01404988|588568013|FG000|Overall Study|Adverse Event|1|||
163307525|NCT04927065|589833888|FG008|Second Booster|Other Than Specified|0|||
163307526|NCT04927065|589833889|FG009|Second Booster|Other Than Specified|0|||
163307527|NCT04927065|589833890|FG010|Second Booster|Other Than Specified|1|||
163307528|NCT04927065|589833891|FG011|Second Booster|Other Than Specified|1|||
163307529|NCT04927065|589833892|FG012|Second Booster|Other Than Specified|4|||
163307530|NCT04927065|589833893|FG013|Second Booster|Other Than Specified|0|||
163307531|NCT04927065|589833894|FG014|Second Booster|Other Than Specified|0|||
163307532|NCT04927065|589833895|FG015|Second Booster|Other Than Specified|0|||
163307533|NCT04927065|589833880|FG000|Third Booster|Lost to Follow-up|0|||
163307534|NCT04927065|589833881|FG001|Third Booster|Lost to Follow-up|0|||
163307535|NCT04927065|589833882|FG002|Third Booster|Lost to Follow-up|0|||
163307536|NCT04927065|589833883|FG003|Third Booster|Lost to Follow-up|0|||
163307537|NCT04927065|589833884|FG004|Third Booster|Lost to Follow-up|0|||
163307538|NCT04927065|589833885|FG005|Third Booster|Lost to Follow-up|0|||
163307539|NCT04927065|589833886|FG006|Third Booster|Lost to Follow-up|0|||
163307540|NCT04927065|589833887|FG007|Third Booster|Lost to Follow-up|0|||
163307541|NCT04927065|589833888|FG008|Third Booster|Lost to Follow-up|0|||
163307542|NCT04927065|589833889|FG009|Third Booster|Lost to Follow-up|0|||
163307543|NCT04927065|589833890|FG010|Third Booster|Lost to Follow-up|0|||
163307544|NCT04927065|589833891|FG011|Third Booster|Lost to Follow-up|0|||
162964103|NCT01404988|588568014|FG001|Overall Study|Adverse Event|0|||
162964104|NCT01404988|588568015|FG002|Overall Study|Adverse Event|0|||
162964105|NCT01404988|588568013|FG000|Overall Study|Withdrawal by Subject|2|||
162964106|NCT01404988|588568014|FG001|Overall Study|Withdrawal by Subject|2|||
162964107|NCT01404988|588568015|FG002|Overall Study|Withdrawal by Subject|0|||
162964108|NCT01404988|588568013|FG000|Overall Study|Lost to Follow-up|1|||
162964109|NCT01404988|588568014|FG001|Overall Study|Lost to Follow-up|2|||
162964110|NCT01404988|588568015|FG002|Overall Study|Lost to Follow-up|1|||
162964111|NCT04594252|588568016|FG000|Overall Study|Adverse Event|0|||
162964112|NCT04594252|588568017|FG001|Overall Study|Adverse Event|2|||
162964113|NCT01691430|588569673|FG000|Overall Study|Death|17|||
162964114|NCT01691430|588569674|FG001|Overall Study|Death|16|||
162964115|NCT01691430|588569673|FG000|Overall Study|Withdrawal by Subject|5|||
162964116|NCT01691430|588569674|FG001|Overall Study|Withdrawal by Subject|1|||
162964117|NCT01691430|588569673|FG000|Overall Study|Lost to Follow-up|0|||
162964118|NCT01691430|588569674|FG001|Overall Study|Lost to Follow-up|3|||
162964119|NCT01109849|588569675|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
162964120|NCT01109849|588569676|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
162964121|NCT01109849|588569677|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
162964122|NCT01109849|588569678|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
162964123|NCT01109849|588569679|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
162964124|NCT01109849|588569675|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
162964125|NCT01109849|588569676|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
162964126|NCT01109849|588569677|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
162964127|NCT01109849|588569678|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
162964128|NCT01109849|588569679|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
162964129|NCT01109849|588569675|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
162964130|NCT01109849|588569676|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
162964131|NCT01109849|588569677|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
162964132|NCT01109849|588569678|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
162964133|NCT01109849|588569679|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
163397125|NCT00885703|590166164|FG005|Overall Study|Withdrawal by Subject|1|||
163397126|NCT00885703|590166165|FG006|Overall Study|Withdrawal by Subject|1|||
163397127|NCT00885703|590166159|FG000|Overall Study|Ineligible (no CM)|1|||
163397128|NCT00885703|590166160|FG001|Overall Study|Ineligible (no CM)|3|||
163397129|NCT00885703|590166161|FG002|Overall Study|Ineligible (no CM)|2|||
162964134|NCT01109849|588569675|FG000|Initial Randomization: ADHD Treatment|move away|2|||
162964135|NCT01109849|588569676|FG001|Initial Randomization: ADHD Treatment|move away|7|||
162964136|NCT01109849|588569677|FG002|Initial Randomization: ADHD Treatment|move away|0|||
163051251|NCT00490035|588895388|FG000|Overall Study|AE, non-serious non-fatal|3|||
163307545|NCT04927065|589833892|FG012|Third Booster|Lost to Follow-up|0|||
163307546|NCT04927065|589833893|FG013|Third Booster|Lost to Follow-up|0|||
163307547|NCT04927065|589833894|FG014|Third Booster|Lost to Follow-up|0|||
163307548|NCT04927065|589833895|FG015|Third Booster|Lost to Follow-up|1|||
163307549|NCT04927065|589833880|FG000|Third Booster|Withdrawal by Subject|0|||
163307550|NCT04927065|589833881|FG001|Third Booster|Withdrawal by Subject|0|||
163397130|NCT00885703|590166162|FG003|Overall Study|Ineligible (no CM)|1|||
163397131|NCT00885703|590166163|FG004|Overall Study|Ineligible (no CM)|2|||
163397132|NCT00885703|590166164|FG005|Overall Study|Ineligible (no CM)|3|||
163397133|NCT00885703|590166165|FG006|Overall Study|Ineligible (no CM)|1|||
163397134|NCT00346073|590166166|FG000|Overall Study|Serious Adverse Event|2|||
163397135|NCT00346073|590166167|FG001|Overall Study|Serious Adverse Event|0|||
163397136|NCT00346073|590166166|FG000|Overall Study|Lost to Follow-up|39|||
163397137|NCT00346073|590166167|FG001|Overall Study|Lost to Follow-up|24|||
163397138|NCT02053168|590166169|FG000|Overall Study|Withdrawal by Subject|1|||
163397139|NCT02053168|590166169|FG000|Overall Study|Physician Decision|1|||
163397140|NCT02053168|590166169|FG000|Overall Study|Lost to Follow-up|1|||
163397141|NCT02687542|590166170|FG000|Overall Study|Medication error without associated AEs|0|||
163397142|NCT02687542|590166171|FG001|Overall Study|Medication error without associated AEs|0|||
163397143|NCT02687542|590166172|FG002|Overall Study|Medication error without associated AEs|0|||
163397144|NCT02687542|590166173|FG003|Overall Study|Medication error without associated AEs|0|||
163397145|NCT02687542|590166174|FG004|Overall Study|Medication error without associated AEs|1|||
163397146|NCT02687542|590166170|FG000|Overall Study|Lost to Follow-up|0|||
163397147|NCT02687542|590166171|FG001|Overall Study|Lost to Follow-up|0|||
163397148|NCT02687542|590166172|FG002|Overall Study|Lost to Follow-up|0|||
163397149|NCT02687542|590166173|FG003|Overall Study|Lost to Follow-up|0|||
163397150|NCT02687542|590166174|FG004|Overall Study|Lost to Follow-up|1|||
163397151|NCT02687542|590166170|FG000|Overall Study|Protocol Violation|0|||
163397152|NCT02687542|590166171|FG001|Overall Study|Protocol Violation|1|||
163397153|NCT02687542|590166172|FG002|Overall Study|Protocol Violation|0|||
163397154|NCT02687542|590166173|FG003|Overall Study|Protocol Violation|0|||
163397155|NCT02687542|590166174|FG004|Overall Study|Protocol Violation|0|||
163397156|NCT02687542|590166170|FG000|Overall Study|Other|5|||
163397157|NCT02687542|590166171|FG001|Overall Study|Other|9|||
163397158|NCT02687542|590166172|FG002|Overall Study|Other|10|||
163397159|NCT02687542|590166173|FG003|Overall Study|Other|6|||
163397160|NCT02687542|590166174|FG004|Overall Study|Other|5|||
163397161|NCT02687542|590166170|FG000|Overall Study|Adverse Event|3|||
163397162|NCT02687542|590166171|FG001|Overall Study|Adverse Event|1|||
163397163|NCT02687542|590166172|FG002|Overall Study|Adverse Event|3|||
163397164|NCT02687542|590166173|FG003|Overall Study|Adverse Event|2|||
163397165|NCT02687542|590166174|FG004|Overall Study|Adverse Event|9|||
163397166|NCT02687542|590166170|FG000|Overall Study|Withdrawal by Subject|0|||
163397167|NCT02687542|590166171|FG001|Overall Study|Withdrawal by Subject|1|||
163397168|NCT02687542|590166172|FG002|Overall Study|Withdrawal by Subject|1|||
163397169|NCT02687542|590166173|FG003|Overall Study|Withdrawal by Subject|2|||
163397170|NCT02687542|590166174|FG004|Overall Study|Withdrawal by Subject|4|||
163397171|NCT00096785|590166176|FG000|Overall Study|Lost to Follow-up|1|||
163397172|NCT00096785|590166177|FG001|Overall Study|Lost to Follow-up|0|||
163397173|NCT00096785|590166176|FG000|Overall Study|Withdrawal by Subject|0|||
163397174|NCT00096785|590166177|FG001|Overall Study|Withdrawal by Subject|1|||
163397175|NCT00096785|590166176|FG000|Overall Study|Relocated|1|||
163397176|NCT00096785|590166177|FG001|Overall Study|Relocated|0|||
163397177|NCT00176605|590166179|FG000|Overall Study|Withdrawal by Subject|2|||
163397178|NCT01227187|590166180|FG000|Overall Study|Physician Decision|0|||
163397179|NCT01227187|590166181|FG001|Overall Study|Physician Decision|0|||
163397180|NCT01227187|590166182|FG002|Overall Study|Physician Decision|0|||
163397181|NCT01227187|590166183|FG003|Overall Study|Physician Decision|1|||
163397182|NCT01566773|590166185|FG000|Overall Study|Protocol specified criteria|4|||
163397183|NCT01566773|590166185|FG000|Overall Study|Protocol Violation|4|||
163397184|NCT01566773|590166185|FG000|Overall Study|Withdrawal by Subject|9|||
163397185|NCT01566773|590166185|FG000|Overall Study|Administrative reason|1|||
162964137|NCT01109849|588569678|FG003|Initial Randomization: ADHD Treatment|move away|0|||
163397186|NCT01566773|590166185|FG000|Overall Study|Adverse Event|10|||
163397187|NCT01566773|590166185|FG000|Overall Study|Physician Decision|2|||
163397188|NCT00833053|590166186|FG000|Overall Study|Adverse Event|4|||
163397189|NCT00833053|590166187|FG001|Overall Study|Adverse Event|0|||
162964138|NCT01109849|588569679|FG004|Initial Randomization: ADHD Treatment|move away|0|||
162964139|NCT01109849|588569675|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
162964140|NCT01109849|588569676|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
162964141|NCT01109849|588569677|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
162964142|NCT01109849|588569678|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
162964143|NCT01109849|588569679|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
163397190|NCT00833053|590166186|FG000|Overall Study|Treatment Failure|3|||
163397191|NCT00833053|590166187|FG001|Overall Study|Treatment Failure|1|||
163307551|NCT04927065|589833882|FG002|Third Booster|Withdrawal by Subject|0|||
163307552|NCT04927065|589833883|FG003|Third Booster|Withdrawal by Subject|0|||
163307553|NCT04927065|589833884|FG004|Third Booster|Withdrawal by Subject|0|||
163307554|NCT04927065|589833885|FG005|Third Booster|Withdrawal by Subject|0|||
163307555|NCT04927065|589833886|FG006|Third Booster|Withdrawal by Subject|0|||
163307556|NCT04927065|589833887|FG007|Third Booster|Withdrawal by Subject|0|||
163307557|NCT04927065|589833888|FG008|Third Booster|Withdrawal by Subject|0|||
163307558|NCT04927065|589833889|FG009|Third Booster|Withdrawal by Subject|0|||
163307559|NCT04927065|589833890|FG010|Third Booster|Withdrawal by Subject|0|||
163307560|NCT04927065|589833891|FG011|Third Booster|Withdrawal by Subject|0|||
163307561|NCT04927065|589833892|FG012|Third Booster|Withdrawal by Subject|0|||
163307562|NCT04927065|589833893|FG013|Third Booster|Withdrawal by Subject|0|||
163307563|NCT04927065|589833894|FG014|Third Booster|Withdrawal by Subject|0|||
163307564|NCT04927065|589833895|FG015|Third Booster|Withdrawal by Subject|1|||
163307565|NCT03846505|589833901|FG000|Treatment Phase|Withdrawal by Subject|9|||
163307566|NCT03846505|589833902|FG001|Treatment Phase|Withdrawal by Subject|11|||
163307567|NCT03846505|589833901|FG000|Treatment Phase|Lost to Follow-up|6|||
163307568|NCT03846505|589833902|FG001|Treatment Phase|Lost to Follow-up|2|||
163307569|NCT03846505|589833901|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
163307570|NCT03846505|589833902|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
163307571|NCT03846505|589833901|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
163307572|NCT03846505|589833902|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
163307573|NCT04021602|589833909|FG000|Overall Study|Lost to Follow-up|3|||
163307574|NCT04021602|589833910|FG001|Overall Study|Lost to Follow-up|3|||
163307575|NCT04021602|589833911|FG002|Overall Study|Lost to Follow-up|1|||
163051252|NCT00490035|588895389|FG001|Overall Study|AE, non-serious non-fatal|4|||
163051253|NCT00490035|588895390|FG002|Overall Study|AE, non-serious non-fatal|4|||
163051254|NCT00490035|588895391|FG003|Overall Study|AE, non-serious non-fatal|5|||
163200756|NCT04404361|589449300|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
163200757|NCT04404361|589449301|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
163200758|NCT01063868|589449306|FG000|Overall Study|Adverse Event|9|||
163200759|NCT01063868|589449307|FG001|Overall Study|Adverse Event|7|||
163200760|NCT01063868|589449306|FG000|Overall Study|Withdrawal by Subject|3|||
163200761|NCT01063868|589449307|FG001|Overall Study|Withdrawal by Subject|1|||
163200762|NCT01063868|589449306|FG000|Overall Study|Study Terminated By Sponsor|23|||
163200763|NCT01063868|589449307|FG001|Overall Study|Study Terminated By Sponsor|4|||
163200764|NCT01949506|589449308|FG000|Overall Study|Physician Decision|1|||
163200765|NCT01446289|589449309|FG000|Overall Study|Withdrawal by Subject|1|||
163200766|NCT01446289|589449310|FG001|Overall Study|Withdrawal by Subject|0|||
163200767|NCT01446289|589449311|FG002|Overall Study|Withdrawal by Subject|1|||
163200768|NCT01446289|589449312|FG003|Overall Study|Withdrawal by Subject|0|||
163200769|NCT03307967|589449313|FG000|Overall Study|Lost to Follow-up|4|||
163200770|NCT02915016|589449314|FG000|Overall Study|Lost to Follow-up|4|||
163200771|NCT02915016|589449315|FG001|Overall Study|Lost to Follow-up|2|||
163200772|NCT02915016|589449316|FG002|Overall Study|Lost to Follow-up|5|||
163200773|NCT02915016|589449317|FG003|Overall Study|Lost to Follow-up|3|||
163200774|NCT02915016|589449318|FG004|Overall Study|Lost to Follow-up|5|||
163200775|NCT02915016|589449319|FG005|Overall Study|Lost to Follow-up|2|||
163200776|NCT02915016|589449320|FG006|Overall Study|Lost to Follow-up|8|||
163200777|NCT02915016|589449321|FG007|Overall Study|Lost to Follow-up|2|||
163200778|NCT02915016|589449314|FG000|Overall Study|Physician Decision|0|||
163200779|NCT02915016|589449315|FG001|Overall Study|Physician Decision|0|||
163200780|NCT02915016|589449316|FG002|Overall Study|Physician Decision|1|||
163200781|NCT02915016|589449317|FG003|Overall Study|Physician Decision|0|||
163200782|NCT02915016|589449318|FG004|Overall Study|Physician Decision|0|||
163200783|NCT02915016|589449319|FG005|Overall Study|Physician Decision|1|||
163200784|NCT02915016|589449320|FG006|Overall Study|Physician Decision|2|||
163200785|NCT02915016|589449321|FG007|Overall Study|Physician Decision|0|||
163200786|NCT02915016|589449314|FG000|Overall Study|Withdrawal by Subject|2|||
163200787|NCT02915016|589449315|FG001|Overall Study|Withdrawal by Subject|0|||
163200788|NCT02915016|589449316|FG002|Overall Study|Withdrawal by Subject|1|||
163200789|NCT02915016|589449317|FG003|Overall Study|Withdrawal by Subject|0|||
163200790|NCT02915016|589449318|FG004|Overall Study|Withdrawal by Subject|1|||
163200791|NCT02915016|589449319|FG005|Overall Study|Withdrawal by Subject|3|||
163200792|NCT02915016|589449320|FG006|Overall Study|Withdrawal by Subject|1|||
163200793|NCT02915016|589449321|FG007|Overall Study|Withdrawal by Subject|1|||
163200794|NCT02915016|589449314|FG000|Overall Study|Elected not to continue|0|||
163200795|NCT02915016|589449315|FG001|Overall Study|Elected not to continue|0|||
163200796|NCT02915016|589449316|FG002|Overall Study|Elected not to continue|0|||
163200797|NCT02915016|589449317|FG003|Overall Study|Elected not to continue|1|||
163200798|NCT02915016|589449318|FG004|Overall Study|Elected not to continue|0|||
163200799|NCT02915016|589449319|FG005|Overall Study|Elected not to continue|0|||
163200800|NCT02915016|589449320|FG006|Overall Study|Elected not to continue|1|||
163307576|NCT04021602|589833909|FG000|Overall Study|Adverse Event|1|||
163307577|NCT04021602|589833910|FG001|Overall Study|Adverse Event|0|||
163307578|NCT04021602|589833911|FG002|Overall Study|Adverse Event|1|||
163051255|NCT00490035|588895388|FG000|Overall Study|Lost to Follow-up|2|||
163051256|NCT00490035|588895389|FG001|Overall Study|Lost to Follow-up|0|||
163200801|NCT02915016|589449321|FG007|Overall Study|Elected not to continue|0|||
163200802|NCT02915016|589449314|FG000|Overall Study|HIV infection|1|||
163200803|NCT02915016|589449315|FG001|Overall Study|HIV infection|1|||
163200804|NCT02915016|589449316|FG002|Overall Study|HIV infection|1|||
163200805|NCT02915016|589449317|FG003|Overall Study|HIV infection|0|||
163200806|NCT02915016|589449318|FG004|Overall Study|HIV infection|1|||
163200807|NCT02915016|589449319|FG005|Overall Study|HIV infection|0|||
163200808|NCT02915016|589449320|FG006|Overall Study|HIV infection|0|||
163200809|NCT02915016|589449321|FG007|Overall Study|HIV infection|0|||
163200810|NCT02915016|589449314|FG000|Overall Study|Participant unable to adhere|0|||
163200811|NCT02915016|589449315|FG001|Overall Study|Participant unable to adhere|0|||
163200812|NCT02915016|589449316|FG002|Overall Study|Participant unable to adhere|0|||
163200813|NCT02915016|589449317|FG003|Overall Study|Participant unable to adhere|0|||
163200814|NCT02915016|589449318|FG004|Overall Study|Participant unable to adhere|0|||
163200815|NCT02915016|589449319|FG005|Overall Study|Participant unable to adhere|0|||
163200816|NCT02915016|589449320|FG006|Overall Study|Participant unable to adhere|0|||
163200817|NCT02915016|589449321|FG007|Overall Study|Participant unable to adhere|1|||
163200818|NCT02578316|589449322|FG000|Extension Phase|Progression of disease|6|||
163200819|NCT02166905|589449323|FG000|Overall Study|Withdrawal by Subject|1|||
163200820|NCT02166905|589449324|FG001|Overall Study|Withdrawal by Subject|0|||
163200821|NCT02166905|589449325|FG002|Overall Study|Withdrawal by Subject|0|||
163200822|NCT02166905|589449326|FG003|Overall Study|Withdrawal by Subject|0|||
163200823|NCT02617628|589449327|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
163200824|NCT02617628|589449328|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
163200825|NCT03278873|589449333|FG000|Overall Study|Withdrawal by Subject|0|||
163200826|NCT03278873|589449334|FG001|Overall Study|Withdrawal by Subject|1|||
163200827|NCT03278873|589449335|FG002|Overall Study|Withdrawal by Subject|0|||
163200828|NCT03278873|589449336|FG003|Overall Study|Withdrawal by Subject|0|||
163200829|NCT03278873|589449333|FG000|Overall Study|Sponsor's decision|0|||
163200830|NCT03278873|589449334|FG001|Overall Study|Sponsor's decision|1|||
163200831|NCT03278873|589449335|FG002|Overall Study|Sponsor's decision|0|||
163200832|NCT03278873|589449336|FG003|Overall Study|Sponsor's decision|0|||
163200833|NCT03278873|589449333|FG000|Overall Study|Early Termination|2|||
163200834|NCT03278873|589449334|FG001|Overall Study|Early Termination|6|||
163200835|NCT03278873|589449335|FG002|Overall Study|Early Termination|0|||
163200836|NCT03278873|589449336|FG003|Overall Study|Early Termination|4|||
163200837|NCT03278873|589449333|FG000|Overall Study|Lost to Follow-up|0|||
163200838|NCT03278873|589449334|FG001|Overall Study|Lost to Follow-up|0|||
163200839|NCT03278873|589449335|FG002|Overall Study|Lost to Follow-up|2|||
163200840|NCT03278873|589449336|FG003|Overall Study|Lost to Follow-up|0|||
163200841|NCT03278873|589449333|FG000|Overall Study|The patient decided to withdraw via email|1|||
163200842|NCT03278873|589449334|FG001|Overall Study|The patient decided to withdraw via email|0|||
163200843|NCT03278873|589449335|FG002|Overall Study|The patient decided to withdraw via email|0|||
163200844|NCT03278873|589449336|FG003|Overall Study|The patient decided to withdraw via email|0|||
163200845|NCT03278873|589449333|FG000|Overall Study|The patient was unresponsive to contact|0|||
163200846|NCT03278873|589449334|FG001|Overall Study|The patient was unresponsive to contact|0|||
163200847|NCT03278873|589449335|FG002|Overall Study|The patient was unresponsive to contact|0|||
163200848|NCT03278873|589449336|FG003|Overall Study|The patient was unresponsive to contact|4|||
163051257|NCT00490035|588895390|FG002|Overall Study|Lost to Follow-up|1|||
163200849|NCT03278873|589449333|FG000|Overall Study|The patient wished to participate no longer|0|||
163200850|NCT03278873|589449334|FG001|Overall Study|The patient wished to participate no longer|1|||
163200851|NCT03278873|589449335|FG002|Overall Study|The patient wished to participate no longer|0|||
163200852|NCT03278873|589449336|FG003|Overall Study|The patient wished to participate no longer|0|||
163200853|NCT03278873|589449333|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
163200854|NCT03278873|589449334|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
163051258|NCT00490035|588895391|FG003|Overall Study|Lost to Follow-up|0|||
163307579|NCT02689284|589833912|FG000|Overall Study|Adverse Event|1|||
163307580|NCT02689284|589833913|FG001|Overall Study|Adverse Event|8|||
163307581|NCT02689284|589833912|FG000|Overall Study|Death|0|||
163307582|NCT02689284|589833913|FG001|Overall Study|Death|1|||
163307583|NCT02689284|589833912|FG000|Overall Study|Physician Decision|1|||
163307584|NCT02689284|589833913|FG001|Overall Study|Physician Decision|2|||
163307585|NCT02689284|589833912|FG000|Overall Study|Withdrawal by Subject|0|||
163051259|NCT00490035|588895388|FG000|Overall Study|Withdrawal by Subject|2|||
163051260|NCT00490035|588895389|FG001|Overall Study|Withdrawal by Subject|1|||
163051261|NCT00490035|588895390|FG002|Overall Study|Withdrawal by Subject|1|||
163051262|NCT00490035|588895391|FG003|Overall Study|Withdrawal by Subject|0|||
163051263|NCT00490035|588895388|FG000|Overall Study|Other reason|0|||
163051264|NCT00490035|588895389|FG001|Overall Study|Other reason|1|||
163051265|NCT00490035|588895390|FG002|Overall Study|Other reason|3|||
163051266|NCT00490035|588895391|FG003|Overall Study|Other reason|1|||
163051267|NCT00490035|588895388|FG000|Overall Study|AE, serious fatal|1|||
163051268|NCT00490035|588895389|FG001|Overall Study|AE, serious fatal|0|||
163051269|NCT00490035|588895390|FG002|Overall Study|AE, serious fatal|0|||
163051270|NCT00490035|588895391|FG003|Overall Study|AE, serious fatal|0|||
163051271|NCT00490035|588895388|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
163051272|NCT00490035|588895389|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
163051273|NCT00490035|588895390|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
163051274|NCT00490035|588895391|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
163307586|NCT02689284|589833913|FG001|Overall Study|Withdrawal by Subject|1|||
163307587|NCT02689284|589833912|FG000|Overall Study|progression of cancer|1|||
163307588|NCT02689284|589833913|FG001|Overall Study|progression of cancer|72|||
163307589|NCT02689284|589833912|FG000|Overall Study|decreased heart function|0|||
163307590|NCT02689284|589833913|FG001|Overall Study|decreased heart function|1|||
163307591|NCT02689284|589833912|FG000|Overall Study|concern for anemia|0|||
163307592|NCT02689284|589833913|FG001|Overall Study|concern for anemia|1|||
163307593|NCT02689284|589833912|FG000|Overall Study|no measurable cancer for evaluation|0|||
163307594|NCT02689284|589833913|FG001|Overall Study|no measurable cancer for evaluation|1|||
163307595|NCT05592418|589833914|FG000|Overall Study|Adverse Event|1|||
163307596|NCT05592418|589833915|FG001|Overall Study|Adverse Event|0|||
163307597|NCT05592418|589833914|FG000|Overall Study|Lost to Follow-up|1|||
163307598|NCT05592418|589833915|FG001|Overall Study|Lost to Follow-up|3|||
163307599|NCT05592418|589833914|FG000|Overall Study|Withdrawal by Subject|2|||
163307600|NCT05592418|589833915|FG001|Overall Study|Withdrawal by Subject|7|||
163307601|NCT04450342|589833918|FG000|Overall Study|Adverse Event|1|||
163307602|NCT04450342|589833919|FG001|Overall Study|Adverse Event|1|||
163307603|NCT04450342|589833920|FG002|Overall Study|Adverse Event|0|||
163307604|NCT04450342|589833918|FG000|Overall Study|Device not used|1|||
163307605|NCT04450342|589833919|FG001|Overall Study|Device not used|0|||
163307606|NCT04450342|589833920|FG002|Overall Study|Device not used|0|||
163307607|NCT04450342|589833918|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
163307608|NCT04450342|589833919|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
163307609|NCT04450342|589833920|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
163307610|NCT04450342|589833918|FG000|Overall Study|Physician Decision|1|||
163307611|NCT04450342|589833919|FG001|Overall Study|Physician Decision|0|||
163307612|NCT04450342|589833920|FG002|Overall Study|Physician Decision|1|||
163307613|NCT04450342|589833918|FG000|Overall Study|Protocol Deviation|0|||
163307614|NCT04450342|589833919|FG001|Overall Study|Protocol Deviation|1|||
163307615|NCT04450342|589833920|FG002|Overall Study|Protocol Deviation|0|||
163307616|NCT04450342|589833918|FG000|Overall Study|Reoperation|1|||
163307617|NCT04450342|589833919|FG001|Overall Study|Reoperation|1|||
163307618|NCT04450342|589833920|FG002|Overall Study|Reoperation|0|||
163307619|NCT04450342|589833918|FG000|Overall Study|Screen Failures|0|||
163307620|NCT04450342|589833919|FG001|Overall Study|Screen Failures|0|||
163051275|NCT00490035|588895388|FG000|Overall Study|AE of unknown type|0|||
163307621|NCT04450342|589833920|FG002|Overall Study|Screen Failures|2|||
163307622|NCT04450342|589833918|FG000|Overall Study|Site Terminated by Sponsor|1|||
163307623|NCT04450342|589833919|FG001|Overall Study|Site Terminated by Sponsor|1|||
163307624|NCT04450342|589833920|FG002|Overall Study|Site Terminated by Sponsor|1|||
163307625|NCT04450342|589833918|FG000|Overall Study|Study Terminated by Sponsor|31|||
163307626|NCT04450342|589833919|FG001|Overall Study|Study Terminated by Sponsor|29|||
163307627|NCT04450342|589833920|FG002|Overall Study|Study Terminated by Sponsor|6|||
163307628|NCT04450342|589833918|FG000|Overall Study|Withdrawal by Subject|0|||
163307629|NCT04450342|589833919|FG001|Overall Study|Withdrawal by Subject|1|||
163307630|NCT04450342|589833920|FG002|Overall Study|Withdrawal by Subject|2|||
163307631|NCT05481320|589833921|FG000|Overall Study|Withdrawal by Subject|1|||
163051276|NCT00490035|588895389|FG001|Overall Study|AE of unknown type|0|||
163051277|NCT00490035|588895390|FG002|Overall Study|AE of unknown type|2|||
163307632|NCT05481320|589833922|FG001|Overall Study|Withdrawal by Subject|1|||
163307633|NCT05481320|589833921|FG000|Overall Study|Care recipent passed away|0|||
163307634|NCT05481320|589833922|FG001|Overall Study|Care recipent passed away|1|||
163307635|NCT05481320|589833921|FG000|Overall Study|Out-of-window assessment|0|||
163307636|NCT05481320|589833922|FG001|Overall Study|Out-of-window assessment|1|||
163307637|NCT05481320|589833921|FG000|Overall Study|No longer a primary caregiver|3|||
163307638|NCT05481320|589833922|FG001|Overall Study|No longer a primary caregiver|0|||
163307639|NCT05481320|589833921|FG000|Overall Study|Unable to contact|1|||
163307640|NCT05481320|589833922|FG001|Overall Study|Unable to contact|0|||
163307641|NCT02923180|589833923|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
163307642|NCT02923180|589833923|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
163307643|NCT05198310|589833924|FG000|Overall Study|Lost to Follow-up|0|||
163307644|NCT05198310|589833925|FG001|Overall Study|Lost to Follow-up|1|||
163307645|NCT05198310|589833926|FG002|Overall Study|Lost to Follow-up|0|||
163307646|NCT05198310|589833927|FG003|Overall Study|Lost to Follow-up|0|||
163307647|NCT05198310|589833928|FG004|Overall Study|Lost to Follow-up|0|||
163307648|NCT05198310|589833929|FG005|Overall Study|Lost to Follow-up|0|||
163307649|NCT05198310|589833930|FG006|Overall Study|Lost to Follow-up|0|||
163307650|NCT05198310|589833931|FG007|Overall Study|Lost to Follow-up|0|||
163307651|NCT05198310|589833924|FG000|Overall Study|Withdrawal by Subject|0|||
163307652|NCT05198310|589833925|FG001|Overall Study|Withdrawal by Subject|0|||
163307653|NCT05198310|589833926|FG002|Overall Study|Withdrawal by Subject|0|||
163307654|NCT05198310|589833927|FG003|Overall Study|Withdrawal by Subject|2|||
163307655|NCT05198310|589833928|FG004|Overall Study|Withdrawal by Subject|0|||
163307656|NCT05198310|589833929|FG005|Overall Study|Withdrawal by Subject|2|||
163307657|NCT05198310|589833930|FG006|Overall Study|Withdrawal by Subject|1|||
163307658|NCT05198310|589833931|FG007|Overall Study|Withdrawal by Subject|3|||
163307659|NCT04116736|589833932|FG000|Overall Study|Withdrew consent during study|3|||
163307660|NCT04116736|589833933|FG001|Overall Study|Withdrew consent during study|1|||
163307661|NCT04116736|589833932|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
163307662|NCT04116736|589833933|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
163307663|NCT04116736|589833932|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
163307664|NCT04116736|589833933|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
163307665|NCT04116736|589833932|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
163307666|NCT04116736|589833933|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
163307667|NCT04116736|589833932|FG000|Overall Study|Subject was enrolled in error|2|||
163307668|NCT04116736|589833933|FG001|Overall Study|Subject was enrolled in error|0|||
163307669|NCT04116736|589833932|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
162964144|NCT01109849|588569675|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
162964145|NCT01109849|588569676|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
162964146|NCT01109849|588569677|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
162964147|NCT01109849|588569678|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
162964148|NCT01109849|588569679|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
162964149|NCT02485158|588569683|FG000|Overall Study|Withdrawal by Subject|3|||
162964150|NCT02485158|588569683|FG000|Overall Study|expected drug side effect|1|||
162964151|NCT01098851|588569684|FG000|Overall Study|Equipment failure|1|||
162964152|NCT01098851|588569685|FG001|Overall Study|Equipment failure|0|||
162964153|NCT03087786|588569686|FG000|Overall Study|Withdrawal by Subject|2|||
162964154|NCT03087786|588569687|FG001|Overall Study|Withdrawal by Subject|0|||
162964155|NCT04661202|588569688|FG000|Overall Study|Withdrawal by Subject|1|||
162964156|NCT04661202|588569689|FG001|Overall Study|Withdrawal by Subject|1|||
162964157|NCT04661202|588569688|FG000|Overall Study|Lack of Efficacy|2|||
162964158|NCT04661202|588569689|FG001|Overall Study|Lack of Efficacy|0|||
162964159|NCT02313558|588569690|FG000|Overall Study|Withdrawal by Subject|2|||
162964160|NCT02313558|588569691|FG001|Overall Study|Withdrawal by Subject|0|||
162964161|NCT02313558|588569690|FG000|Overall Study|Lost to Follow-up|4|||
162964162|NCT02313558|588569691|FG001|Overall Study|Lost to Follow-up|4|||
162964163|NCT04158687|588569694|FG000|Overall Study|Adverse Event|2|||
162964164|NCT04158687|588569695|FG001|Overall Study|Adverse Event|3|||
162964165|NCT04158687|588569696|FG002|Overall Study|Adverse Event|0|||
162964166|NCT04158687|588569697|FG003|Overall Study|Adverse Event|3|||
162964167|NCT04158687|588569694|FG000|Overall Study|Lost to Follow-up|5|||
162964168|NCT04158687|588569695|FG001|Overall Study|Lost to Follow-up|12|||
163307670|NCT04116736|589833933|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
163307671|NCT04116736|589833932|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
163307672|NCT04116736|589833933|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
162964169|NCT04158687|588569696|FG002|Overall Study|Lost to Follow-up|4|||
163307673|NCT04116736|589833932|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
163307674|NCT04116736|589833933|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
163307675|NCT03941860|589833939|FG000|Overall Study|Withdrawal by Subject|0|||
162964170|NCT04158687|588569697|FG003|Overall Study|Lost to Follow-up|5|||
162964171|NCT04158687|588569694|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
162964172|NCT04158687|588569695|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
162964173|NCT04158687|588569696|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
162964174|NCT04158687|588569697|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
163307676|NCT03941860|589833940|FG001|Overall Study|Withdrawal by Subject|1|||
163307677|NCT04093752|589833941|FG000|Overall Study|Adverse Event|7|||
163307678|NCT04093752|589833942|FG001|Overall Study|Adverse Event|19|||
163307679|NCT04093752|589833943|FG002|Overall Study|Adverse Event|18|||
163307680|NCT04093752|589833944|FG003|Overall Study|Adverse Event|4|||
163307681|NCT04093752|589833941|FG000|Overall Study|Withdrawal by Subject|6|||
163307682|NCT04093752|589833942|FG001|Overall Study|Withdrawal by Subject|6|||
163307683|NCT04093752|589833943|FG002|Overall Study|Withdrawal by Subject|8|||
163307684|NCT04093752|589833944|FG003|Overall Study|Withdrawal by Subject|20|||
163307685|NCT04093752|589833941|FG000|Overall Study|Lost to Follow-up|2|||
163307686|NCT04093752|589833942|FG001|Overall Study|Lost to Follow-up|1|||
163307687|NCT04093752|589833943|FG002|Overall Study|Lost to Follow-up|1|||
163307688|NCT04093752|589833944|FG003|Overall Study|Lost to Follow-up|1|||
163307689|NCT04093752|589833941|FG000|Overall Study|Death|0|||
163307690|NCT04093752|589833942|FG001|Overall Study|Death|0|||
163307691|NCT04093752|589833943|FG002|Overall Study|Death|1|||
163307692|NCT04093752|589833944|FG003|Overall Study|Death|2|||
163307693|NCT04093752|589833941|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
163307694|NCT04093752|589833942|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
163307695|NCT04093752|589833943|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
163307696|NCT04093752|589833944|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
163307697|NCT04093752|589833941|FG000|Overall Study|Covid 19|0|||
163307698|NCT04093752|589833942|FG001|Overall Study|Covid 19|0|||
163307699|NCT04093752|589833943|FG002|Overall Study|Covid 19|0|||
163307700|NCT04093752|589833944|FG003|Overall Study|Covid 19|1|||
163307701|NCT04093752|589833941|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
163307702|NCT04093752|589833942|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
163307703|NCT04093752|589833943|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
163307704|NCT04093752|589833944|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
163307705|NCT04093752|589833941|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
163307706|NCT04093752|589833942|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
163307707|NCT04093752|589833943|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
163307708|NCT04093752|589833944|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
163307709|NCT04093752|589833941|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
163307710|NCT04093752|589833942|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
163307711|NCT04093752|589833943|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
163307712|NCT04093752|589833944|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
163307713|NCT00753090|589835979|FG000|Overall Study|Withdrawal by Subject|10|||
163307714|NCT00753090|589835980|FG001|Overall Study|Withdrawal by Subject|10|||
163307715|NCT00753090|589835979|FG000|Overall Study|Death|17|||
163307716|NCT00753090|589835980|FG001|Overall Study|Death|6|||
163307717|NCT00753090|589835979|FG000|Overall Study|Study Prosthesis Removed|12|||
163200855|NCT03278873|589449335|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
163200856|NCT03278873|589449336|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
163200857|NCT05243641|589449337|FG000|Overall Study|Adverse Event|3|||
163200858|NCT05243641|589449338|FG001|Overall Study|Adverse Event|0|||
163200859|NCT05243641|589449339|FG002|Overall Study|Adverse Event|0|||
163200860|NCT05243641|589449340|FG003|Overall Study|Adverse Event|1|||
163200861|NCT05243641|589449341|FG004|Overall Study|Adverse Event|0|||
163200862|NCT05243641|589449342|FG005|Overall Study|Adverse Event|0|||
163200863|NCT05243641|589449337|FG000|Overall Study|Disease progression|4|||
163200864|NCT05243641|589449338|FG001|Overall Study|Disease progression|0|||
163200865|NCT05243641|589449339|FG002|Overall Study|Disease progression|0|||
163200866|NCT05243641|589449340|FG003|Overall Study|Disease progression|2|||
163200867|NCT05243641|589449341|FG004|Overall Study|Disease progression|0|||
163200868|NCT05243641|589449342|FG005|Overall Study|Disease progression|0|||
163200869|NCT05372419|589449354|FG000|Overall Study|Protocol Deviation|1|||
163200870|NCT05372419|589449354|FG000|Overall Study|Withdrawal by Subject|5|||
163200871|NCT05372419|589449354|FG000|Overall Study|Lost to Follow-up|7|||
163200872|NCT02801331|589449355|FG000|Overall Study|Transferred to another hospital|8|||
163200873|NCT02801331|589449356|FG001|Overall Study|Transferred to another hospital|7|||
163200874|NCT02801331|589449355|FG000|Overall Study|Withdrawal by Subject|0|||
163200875|NCT02801331|589449356|FG001|Overall Study|Withdrawal by Subject|4|||
163200876|NCT02801331|589449355|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
163200877|NCT02801331|589449356|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
163200878|NCT02443987|589449357|FG000|Overall Study|Bladder injury|1|||
163200879|NCT02443987|589449358|FG001|Overall Study|Bladder injury|1|||
163200880|NCT02443987|589449357|FG000|Overall Study|Other|0|||
163200881|NCT02443987|589449358|FG001|Overall Study|Other|1|||
163200882|NCT02513394|589449360|FG000|Overall Study|Withdrawal by Subject|11|||
163200883|NCT02513394|589449361|FG001|Overall Study|Withdrawal by Subject|23|||
163200884|NCT02513394|589449360|FG000|Overall Study|Ineligible|1|||
163200885|NCT02513394|589449361|FG001|Overall Study|Ineligible|0|||
163200886|NCT02161731|589451059|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
163200887|NCT02161731|589451060|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
163200888|NCT02161731|589451059|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
163200889|NCT02161731|589451060|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
163200890|NCT03633695|589451061|FG000|Overall Study|Lost to Follow-up|4|||
163200891|NCT03633695|589451062|FG001|Overall Study|Lost to Follow-up|5|||
163200892|NCT03633695|589451061|FG000|Overall Study|Discontinued|8|||
163200893|NCT03633695|589451062|FG001|Overall Study|Discontinued|4|||
163200894|NCT00684593|589451063|FG000|Overall Study|Adverse Event|0|||
163200895|NCT00684593|589451064|FG001|Overall Study|Adverse Event|2|||
163200896|NCT03217175|589451068|FG000|Overall Study|Physician Decision|4|||
163200897|NCT03217175|589451069|FG001|Overall Study|Physician Decision|1|||
163200898|NCT00429273|589451070|FG000|Overall Study|Lost to Follow-up|1|||
163200899|NCT00429273|589451071|FG001|Overall Study|Lost to Follow-up|2|||
163200900|NCT00429273|589451072|FG002|Overall Study|Lost to Follow-up|2|||
163200901|NCT00429273|589451070|FG000|Overall Study|Physician Decision|6|||
163200902|NCT00429273|589451071|FG001|Overall Study|Physician Decision|5|||
163200903|NCT00429273|589451072|FG002|Overall Study|Physician Decision|5|||
163307718|NCT00753090|589835980|FG001|Overall Study|Study Prosthesis Removed|3|||
162964175|NCT04158687|588569694|FG000|Overall Study|Non-Compliance with Study Medication|2|||
162964176|NCT04158687|588569695|FG001|Overall Study|Non-Compliance with Study Medication|2|||
162964177|NCT04158687|588569696|FG002|Overall Study|Non-Compliance with Study Medication|3|||
162964178|NCT04158687|588569697|FG003|Overall Study|Non-Compliance with Study Medication|0|||
163200904|NCT00429273|589451070|FG000|Overall Study|Adverse Event|1|||
163200905|NCT00429273|589451071|FG001|Overall Study|Adverse Event|1|||
163200906|NCT00429273|589451072|FG002|Overall Study|Adverse Event|2|||
163200907|NCT01218204|589451077|FG000|Part B Washout|Adverse Event|0|||
163200908|NCT01218204|589451078|FG001|Part B Washout|Adverse Event|1|||
163200909|NCT01218204|589451079|FG002|Part B Washout|Adverse Event|0|||
163200910|NCT01218204|589451080|FG003|Part B Washout|Adverse Event|0|||
163200911|NCT01218204|589451077|FG000|Part B Washout|Lost to Follow-up|0|||
163200912|NCT01218204|589451078|FG001|Part B Washout|Lost to Follow-up|2|||
163200913|NCT01218204|589451079|FG002|Part B Washout|Lost to Follow-up|0|||
163307719|NCT00753090|589835979|FG000|Overall Study|Lost to Follow-up|2|||
163307720|NCT00753090|589835980|FG001|Overall Study|Lost to Follow-up|2|||
163307721|NCT00753090|589835979|FG000|Overall Study|Other|127|||
163307722|NCT00753090|589835980|FG001|Overall Study|Other|75|||
163307723|NCT04521478|589835983|FG000|Overall Study|Protocol Violation|2|||
163307724|NCT04521478|589835984|FG001|Overall Study|Protocol Violation|0|||
163307725|NCT04521478|589835985|FG002|Overall Study|Protocol Violation|1|||
163307726|NCT04521478|589835986|FG003|Overall Study|Protocol Violation|0|||
163307727|NCT04521478|589835987|FG004|Overall Study|Protocol Violation|0|||
163307728|NCT04521478|589835988|FG005|Overall Study|Protocol Violation|0|||
163307729|NCT04521478|589835983|FG000|Overall Study|Technical Problems|0|||
163307730|NCT04521478|589835984|FG001|Overall Study|Technical Problems|0|||
163307731|NCT04521478|589835985|FG002|Overall Study|Technical Problems|0|||
163307732|NCT04521478|589835986|FG003|Overall Study|Technical Problems|1|||
163307733|NCT04521478|589835987|FG004|Overall Study|Technical Problems|0|||
163307734|NCT04521478|589835988|FG005|Overall Study|Technical Problems|0|||
163307735|NCT04521478|589835983|FG000|Overall Study|Burden of Study Procedures|1|||
163307736|NCT04521478|589835984|FG001|Overall Study|Burden of Study Procedures|0|||
163307737|NCT04521478|589835985|FG002|Overall Study|Burden of Study Procedures|0|||
163307738|NCT04521478|589835986|FG003|Overall Study|Burden of Study Procedures|1|||
163307739|NCT04521478|589835987|FG004|Overall Study|Burden of Study Procedures|0|||
163307740|NCT04521478|589835988|FG005|Overall Study|Burden of Study Procedures|1|||
163307741|NCT04521478|589835983|FG000|Overall Study|Lack of Efficacy|0|||
163307742|NCT04521478|589835984|FG001|Overall Study|Lack of Efficacy|0|||
163307743|NCT04521478|589835985|FG002|Overall Study|Lack of Efficacy|0|||
163307744|NCT04521478|589835986|FG003|Overall Study|Lack of Efficacy|0|||
163307745|NCT04521478|589835987|FG004|Overall Study|Lack of Efficacy|1|||
163307746|NCT04521478|589835988|FG005|Overall Study|Lack of Efficacy|1|||
163307747|NCT04521478|589835983|FG000|Overall Study|Adverse Event|7|||
163307748|NCT04521478|589835984|FG001|Overall Study|Adverse Event|0|||
163307749|NCT04521478|589835985|FG002|Overall Study|Adverse Event|2|||
163307750|NCT04521478|589835986|FG003|Overall Study|Adverse Event|1|||
163307751|NCT04521478|589835987|FG004|Overall Study|Adverse Event|2|||
163307752|NCT04521478|589835988|FG005|Overall Study|Adverse Event|7|||
163307753|NCT04521478|589835983|FG000|Overall Study|No Reason Available|0|||
163307754|NCT04521478|589835984|FG001|Overall Study|No Reason Available|2|||
163307755|NCT04521478|589835985|FG002|Overall Study|No Reason Available|0|||
163307756|NCT04521478|589835986|FG003|Overall Study|No Reason Available|0|||
163307757|NCT04521478|589835987|FG004|Overall Study|No Reason Available|1|||
163307758|NCT04521478|589835988|FG005|Overall Study|No Reason Available|0|||
163307759|NCT04521478|589835983|FG000|Overall Study|Other than listed|3|||
163307760|NCT04521478|589835984|FG001|Overall Study|Other than listed|3|||
163307761|NCT04521478|589835985|FG002|Overall Study|Other than listed|3|||
163307762|NCT04521478|589835986|FG003|Overall Study|Other than listed|2|||
163307763|NCT04521478|589835987|FG004|Overall Study|Other than listed|3|||
163307764|NCT04521478|589835988|FG005|Overall Study|Other than listed|3|||
163307765|NCT04521478|589835983|FG000|Overall Study|Not treated|0|||
163307766|NCT04521478|589835984|FG001|Overall Study|Not treated|0|||
163307767|NCT04521478|589835985|FG002|Overall Study|Not treated|0|||
163307768|NCT04521478|589835986|FG003|Overall Study|Not treated|0|||
163307769|NCT04521478|589835987|FG004|Overall Study|Not treated|0|||
163307770|NCT04521478|589835988|FG005|Overall Study|Not treated|1|||
163307771|NCT06311084|589835992|FG000|Overall Study|Lost to Follow-up|14|||
163307772|NCT04725240|589835993|FG000|Overall Study|Adverse Event|2|||
163307773|NCT03393975|589836000|FG000|Urgent Treatment Period|Physician Decision|0|||
163397192|NCT00833053|590166186|FG000|Overall Study|Withdrawal by Subject|0|||
162964179|NCT04158687|588569694|FG000|Overall Study|Investigator Decision|0|||
162964180|NCT04158687|588569695|FG001|Overall Study|Investigator Decision|0|||
163307774|NCT03393975|589836001|FG001|Urgent Treatment Period|Physician Decision|0|||
163307775|NCT03393975|589836002|FG002|Urgent Treatment Period|Physician Decision|0|||
163307776|NCT03393975|589836003|FG003|Urgent Treatment Period|Physician Decision|1|||
163307777|NCT03393975|589836000|FG000|Prophylaxis Period 1|Reason not Specified|0|||
163307778|NCT03393975|589836001|FG001|Prophylaxis Period 1|Reason not Specified|1|||
163307779|NCT03393975|589836002|FG002|Prophylaxis Period 1|Reason not Specified|0|||
163307780|NCT03393975|589836003|FG003|Prophylaxis Period 1|Reason not Specified|0|||
163397193|NCT00833053|590166187|FG001|Overall Study|Withdrawal by Subject|1|||
163397194|NCT00833053|590166186|FG000|Overall Study|Protocol Violation|2|||
163397195|NCT00833053|590166187|FG001|Overall Study|Protocol Violation|1|||
163397196|NCT02187471|590166188|FG000|Overall Study|Protocol Violation|4|||
162964181|NCT04158687|588569696|FG002|Overall Study|Investigator Decision|2|||
162964182|NCT04158687|588569697|FG003|Overall Study|Investigator Decision|0|||
162964183|NCT04158687|588569694|FG000|Overall Study|Protocol Violation|0|||
163200914|NCT01218204|589451080|FG003|Part B Washout|Lost to Follow-up|0|||
163200915|NCT01218204|589451077|FG000|Part B Washout|Physician Decision|0|||
163200916|NCT01218204|589451078|FG001|Part B Washout|Physician Decision|14|||
163200917|NCT01218204|589451079|FG002|Part B Washout|Physician Decision|0|||
163200918|NCT01218204|589451080|FG003|Part B Washout|Physician Decision|0|||
163200919|NCT01218204|589451077|FG000|Part B Washout|Withdrawal by Subject|0|||
163200920|NCT01218204|589451078|FG001|Part B Washout|Withdrawal by Subject|14|||
163200921|NCT01218204|589451079|FG002|Part B Washout|Withdrawal by Subject|0|||
163200922|NCT01218204|589451080|FG003|Part B Washout|Withdrawal by Subject|0|||
163200923|NCT01218204|589451077|FG000|Part B Washout|Reached defined stopping criteria|0|||
163200924|NCT01218204|589451078|FG001|Part B Washout|Reached defined stopping criteria|2|||
163200925|NCT01218204|589451079|FG002|Part B Washout|Reached defined stopping criteria|0|||
163200926|NCT01218204|589451080|FG003|Part B Washout|Reached defined stopping criteria|0|||
163200927|NCT01218204|589451077|FG000|Part B Washout|Did not meet continuation criteria|0|||
163200928|NCT01218204|589451078|FG001|Part B Washout|Did not meet continuation criteria|112|||
163200929|NCT01218204|589451079|FG002|Part B Washout|Did not meet continuation criteria|0|||
163200930|NCT01218204|589451080|FG003|Part B Washout|Did not meet continuation criteria|0|||
163200931|NCT01218204|589451077|FG000|Part B Run-in|Adverse Event|0|||
163200932|NCT01218204|589451078|FG001|Part B Run-in|Adverse Event|0|||
163200933|NCT01218204|589451079|FG002|Part B Run-in|Adverse Event|1|||
163200934|NCT01218204|589451080|FG003|Part B Run-in|Adverse Event|0|||
163200935|NCT01218204|589451077|FG000|Part B Run-in|Protocol Violation|0|||
163200936|NCT01218204|589451078|FG001|Part B Run-in|Protocol Violation|0|||
163200937|NCT01218204|589451079|FG002|Part B Run-in|Protocol Violation|2|||
163200938|NCT01218204|589451080|FG003|Part B Run-in|Protocol Violation|0|||
163200939|NCT01218204|589451077|FG000|Part B Run-in|Withdrawal by Subject|0|||
163200940|NCT01218204|589451078|FG001|Part B Run-in|Withdrawal by Subject|0|||
163200941|NCT01218204|589451079|FG002|Part B Run-in|Withdrawal by Subject|3|||
163200942|NCT01218204|589451080|FG003|Part B Run-in|Withdrawal by Subject|0|||
163200943|NCT01218204|589451077|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
163200944|NCT01218204|589451078|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
163200945|NCT01218204|589451079|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
163200946|NCT01218204|589451080|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
163200947|NCT01218204|589451077|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
163200948|NCT01218204|589451078|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
163200949|NCT01218204|589451079|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
163200950|NCT01218204|589451080|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
163200951|NCT00407797|589451088|FG000|Overall Study|Lost to Follow-up|2|||
163200952|NCT00407797|589451088|FG000|Overall Study|Adverse Event|6|||
163200953|NCT00407797|589451088|FG000|Overall Study|Other|7|||
163200954|NCT00407797|589451088|FG000|Overall Study|Withdrawal by Subject|3|||
163200955|NCT01402492|589451092|FG000|Overall Study|Withdrawal by Subject|17|||
163200956|NCT01402492|589451093|FG001|Overall Study|Withdrawal by Subject|11|||
163200957|NCT01402492|589451094|FG002|Overall Study|Withdrawal by Subject|11|||
163200958|NCT01402492|589451092|FG000|Overall Study|Adverse Event|2|||
163200959|NCT01402492|589451093|FG001|Overall Study|Adverse Event|3|||
163200960|NCT01402492|589451094|FG002|Overall Study|Adverse Event|4|||
163200961|NCT01402492|589451092|FG000|Overall Study|Physician Decision|0|||
163200962|NCT01402492|589451093|FG001|Overall Study|Physician Decision|3|||
163200963|NCT01402492|589451094|FG002|Overall Study|Physician Decision|0|||
163200964|NCT01402492|589451092|FG000|Overall Study|Incarcerated (N=3)|2|||
163200965|NCT01402492|589451093|FG001|Overall Study|Incarcerated (N=3)|0|||
163200966|NCT01402492|589451094|FG002|Overall Study|Incarcerated (N=3)|1|||
163200967|NCT02002091|589451106|FG000|Screening|Lost to Follow-up|10|||
163200968|NCT02002091|589451107|FG001|Screening|Lost to Follow-up|12|||
163200969|NCT02002091|589451106|FG000|Screening|Death|3|||
163200970|NCT02002091|589451107|FG001|Screening|Death|2|||
163200971|NCT01233258|589451110|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
163200972|NCT01233258|589451111|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
163307781|NCT03393975|589836000|FG000|Prophylaxis Period 2|Reason not Specified|0|||
163307782|NCT03393975|589836001|FG001|Prophylaxis Period 2|Reason not Specified|1|||
163307783|NCT03393975|589836002|FG002|Prophylaxis Period 2|Reason not Specified|0|||
163307784|NCT03393975|589836003|FG003|Prophylaxis Period 2|Reason not Specified|0|||
163307785|NCT03016169|589836010|FG000|Overall Study|Lost to Follow-up|4|||
163307786|NCT03016169|589836010|FG000|Overall Study|Death|54|||
163307787|NCT03016169|589836010|FG000|Overall Study|Device Explant|11|||
163307788|NCT03016169|589836010|FG000|Overall Study|Withdrawal by Subject|19|||
163307789|NCT03016169|589836010|FG000|Overall Study|Other Reasons|1|||
163307790|NCT04060355|589836011|FG000|Overall Study|Lost to Follow-up|41|||
163307791|NCT01140880|589836012|FG000|Overall Study|Death|0|||
163307792|NCT01140880|589836013|FG001|Overall Study|Death|1|||
163307793|NCT01140880|589836012|FG000|Overall Study|Withdrawal by Subject|6|||
163307794|NCT01140880|589836013|FG001|Overall Study|Withdrawal by Subject|3|||
163307795|NCT01140880|589836012|FG000|Overall Study|Lost to Follow-up|8|||
163307796|NCT01140880|589836013|FG001|Overall Study|Lost to Follow-up|10|||
163307797|NCT01140880|589836012|FG000|Overall Study|Protocol Violation|0|||
163307798|NCT01140880|589836013|FG001|Overall Study|Protocol Violation|30|||
163307799|NCT04421378|589836018|FG000|Overall Study|Adverse Event|2|||
163307800|NCT04421378|589836019|FG001|Overall Study|Adverse Event|7|||
163307801|NCT04421378|589836020|FG002|Overall Study|Adverse Event|0|||
163307802|NCT04421378|589836021|FG003|Overall Study|Adverse Event|1|||
162964184|NCT04158687|588569695|FG001|Overall Study|Protocol Violation|2|||
162964185|NCT04158687|588569696|FG002|Overall Study|Protocol Violation|1|||
163307803|NCT04421378|589836022|FG004|Overall Study|Adverse Event|0|||
163307804|NCT04421378|589836018|FG000|Overall Study|Physician Decision|1|||
163051278|NCT00490035|588895391|FG003|Overall Study|AE of unknown type|0|||
163051279|NCT02127658|588895392|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
163051280|NCT02127658|588895393|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
163051281|NCT02127658|588895392|FG000|Overall Study|Withdrawal by Subject|0|||
163051282|NCT02127658|588895393|FG001|Overall Study|Withdrawal by Subject|2|||
163051283|NCT02127658|588895392|FG000|Overall Study|Physician Decision|0|||
163051284|NCT02127658|588895393|FG001|Overall Study|Physician Decision|1|||
163051285|NCT05559905|588895394|FG000|Overall Study|Withdrawal by Subject|1|||
163051286|NCT05559905|588895395|FG001|Overall Study|Withdrawal by Subject|0|||
163051287|NCT05559905|588895396|FG002|Overall Study|Withdrawal by Subject|0|||
163051288|NCT05559905|588895394|FG000|Overall Study|Not Reported|1|||
163051289|NCT05559905|588895395|FG001|Overall Study|Not Reported|0|||
163051290|NCT05559905|588895396|FG002|Overall Study|Not Reported|0|||
163051291|NCT05276973|588895397|FG000|Overall Study|Treated and DLT unevaluable|1|||
163051292|NCT05276973|588895398|FG001|Overall Study|Treated and DLT unevaluable|1|||
163051293|NCT05276973|588895399|FG002|Overall Study|Treated and DLT unevaluable|0|||
163051294|NCT03180736|588895400|FG000|Overall Study|Adverse Event|3|||
163051295|NCT03180736|588895401|FG001|Overall Study|Adverse Event|4|||
163051296|NCT03180736|588895400|FG000|Overall Study|Death|10|||
163051297|NCT03180736|588895401|FG001|Overall Study|Death|7|||
163307805|NCT04421378|589836019|FG001|Overall Study|Physician Decision|2|||
163307806|NCT04421378|589836020|FG002|Overall Study|Physician Decision|0|||
163307807|NCT04421378|589836021|FG003|Overall Study|Physician Decision|0|||
163307808|NCT04421378|589836022|FG004|Overall Study|Physician Decision|0|||
163307809|NCT04421378|589836018|FG000|Overall Study|Progressive Disease|16|||
163307810|NCT04421378|589836019|FG001|Overall Study|Progressive Disease|4|||
163307811|NCT04421378|589836020|FG002|Overall Study|Progressive Disease|18|||
163307812|NCT04421378|589836021|FG003|Overall Study|Progressive Disease|11|||
163307813|NCT04421378|589836022|FG004|Overall Study|Progressive Disease|3|||
163307814|NCT04421378|589836018|FG000|Overall Study|Study Terminated by Sponsor|0|||
163307815|NCT04421378|589836019|FG001|Overall Study|Study Terminated by Sponsor|1|||
163307816|NCT04421378|589836020|FG002|Overall Study|Study Terminated by Sponsor|1|||
163307817|NCT04421378|589836021|FG003|Overall Study|Study Terminated by Sponsor|0|||
163307818|NCT04421378|589836022|FG004|Overall Study|Study Terminated by Sponsor|0|||
163307819|NCT04421378|589836018|FG000|Overall Study|Withdrawal by Subject|3|||
163307820|NCT04421378|589836019|FG001|Overall Study|Withdrawal by Subject|1|||
163307821|NCT04421378|589836020|FG002|Overall Study|Withdrawal by Subject|0|||
163307822|NCT04421378|589836021|FG003|Overall Study|Withdrawal by Subject|2|||
163307823|NCT04421378|589836022|FG004|Overall Study|Withdrawal by Subject|0|||
163307824|NCT04421378|589836018|FG000|Overall Study|Other|1|||
163307825|NCT04421378|589836019|FG001|Overall Study|Other|0|||
163307826|NCT04421378|589836020|FG002|Overall Study|Other|0|||
163307827|NCT04421378|589836021|FG003|Overall Study|Other|0|||
163307828|NCT04421378|589836022|FG004|Overall Study|Other|0|||
163307829|NCT04258709|589836023|FG000|Overall Study|Lost to Follow-up|10|||
163307830|NCT04258709|589836024|FG001|Overall Study|Lost to Follow-up|4|||
163307831|NCT04258709|589836023|FG000|Overall Study|Withdrawal by Subject|1|||
163307832|NCT04258709|589836024|FG001|Overall Study|Withdrawal by Subject|0|||
163307833|NCT04258709|589836023|FG000|Overall Study|Fetal demise|0|||
163307834|NCT04258709|589836024|FG001|Overall Study|Fetal demise|1|||
163307835|NCT04258709|589836023|FG000|Overall Study|Protocol Violation|1|||
163307836|NCT04258709|589836024|FG001|Overall Study|Protocol Violation|1|||
163307837|NCT02592330|589836025|FG000|Overall Study|Withdrawal by Subject|1|||
163307838|NCT02592330|589836026|FG001|Overall Study|Withdrawal by Subject|0|||
163307839|NCT02592330|589836025|FG000|Overall Study|Failed Biopsy|1|||
163307840|NCT02592330|589836026|FG001|Overall Study|Failed Biopsy|0|||
163307841|NCT03090152|589836027|FG000|Overall Study|Withdrawal by Subject|0|||
163307842|NCT03090152|589836028|FG001|Overall Study|Withdrawal by Subject|2|||
163307843|NCT03090152|589836029|FG002|Overall Study|Withdrawal by Subject|1|||
163307844|NCT03090152|589836027|FG000|Overall Study|Surgery Canceled|1|||
163307845|NCT03090152|589836028|FG001|Overall Study|Surgery Canceled|0|||
163307846|NCT03090152|589836029|FG002|Overall Study|Surgery Canceled|0|||
163307847|NCT03090152|589836027|FG000|Overall Study|Epidural catheter could not be placed|0|||
163307848|NCT03090152|589836028|FG001|Overall Study|Epidural catheter could not be placed|2|||
163307849|NCT03090152|589836029|FG002|Overall Study|Epidural catheter could not be placed|0|||
163307850|NCT03958955|589836030|FG000|Overall Study|Adverse Event|1|||
163307851|NCT04673929|589836031|FG000|Overall Study|Death|73|||
163307852|NCT04673929|589836031|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
163307853|NCT02807636|589836035|FG000|Overall Study|Lost to Follow-up|10|||
163307854|NCT02807636|589836036|FG001|Overall Study|Lost to Follow-up|13|||
163307855|NCT02807636|589836037|FG002|Overall Study|Lost to Follow-up|6|||
163307856|NCT02807636|589836035|FG000|Overall Study|Protocol Deviation|1|||
163307857|NCT02807636|589836036|FG001|Overall Study|Protocol Deviation|0|||
163307858|NCT02807636|589836037|FG002|Overall Study|Protocol Deviation|0|||
163051298|NCT03180736|588895400|FG000|Overall Study|Withdrawal by Subject|5|||
163051299|NCT03180736|588895401|FG001|Overall Study|Withdrawal by Subject|12|||
163307859|NCT02807636|589836035|FG000|Overall Study|Symptomatic Deterioration|0|||
163307860|NCT02807636|589836036|FG001|Overall Study|Symptomatic Deterioration|1|||
163307861|NCT02807636|589836037|FG002|Overall Study|Symptomatic Deterioration|0|||
163307862|NCT02807636|589836035|FG000|Overall Study|Withdrawal by Subject|39|||
163307863|NCT02807636|589836036|FG001|Overall Study|Withdrawal by Subject|28|||
163307864|NCT02807636|589836037|FG002|Overall Study|Withdrawal by Subject|24|||
163307865|NCT02807636|589836035|FG000|Overall Study|Death|303|||
163307866|NCT02807636|589836036|FG001|Overall Study|Death|332|||
163307867|NCT02807636|589836037|FG002|Overall Study|Death|272|||
163307868|NCT02807636|589836035|FG000|Overall Study|Study Terminated By Sponsor|47|||
163307869|NCT02807636|589836036|FG001|Overall Study|Study Terminated By Sponsor|76|||
163307870|NCT02807636|589836037|FG002|Overall Study|Study Terminated By Sponsor|60|||
163307871|NCT02807636|589836035|FG000|Overall Study|Physician Decision|0|||
163307872|NCT02807636|589836036|FG001|Overall Study|Physician Decision|1|||
163307873|NCT02807636|589836037|FG002|Overall Study|Physician Decision|0|||
163307874|NCT05082909|589836038|FG000|Overall Study|Protocol Violation|0|||
163307875|NCT05082909|589836039|FG001|Overall Study|Protocol Violation|0|||
163307876|NCT05082909|589836040|FG002|Overall Study|Protocol Violation|1|||
163307877|NCT05082909|589836041|FG003|Overall Study|Protocol Violation|0|||
163307878|NCT05082909|589836042|FG004|Overall Study|Protocol Violation|0|||
163307879|NCT05082909|589836043|FG005|Overall Study|Protocol Violation|0|||
163307880|NCT04088630|589836044|FG000|Overall Study|Lost to Follow-up|3|||
163307881|NCT04088630|589836045|FG001|Overall Study|Lost to Follow-up|2|||
163307882|NCT04088630|589836046|FG002|Overall Study|Lost to Follow-up|6|||
163307883|NCT04088630|589836044|FG000|Overall Study|Death|3|||
163307884|NCT04088630|589836045|FG001|Overall Study|Death|1|||
163307885|NCT04088630|589836046|FG002|Overall Study|Death|1|||
163307886|NCT04088630|589836044|FG000|Overall Study|Physician Decision|0|||
163307887|NCT04088630|589836045|FG001|Overall Study|Physician Decision|1|||
163307888|NCT04088630|589836046|FG002|Overall Study|Physician Decision|1|||
163307889|NCT03175029|589836049|FG000|Overall Study|Withdrawal by Subject|2|||
163307890|NCT03175029|589836050|FG001|Overall Study|Withdrawal by Subject|1|||
163307891|NCT03175029|589836049|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
163307892|NCT03175029|589836050|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
163307893|NCT05324124|589836054|FG000|Period 1|Withdrawal by Subject|1|||
163307894|NCT05324124|589836055|FG001|Period 1|Withdrawal by Subject|0|||
163307895|NCT05324124|589836054|FG000|Period 1|Physician Decision|0|||
163307896|NCT05324124|589836055|FG001|Period 1|Physician Decision|1|||
163307897|NCT04089371|589836058|FG000|Overall Study|Withdrawal by Subject|0|||
163307898|NCT04089371|589836059|FG001|Overall Study|Withdrawal by Subject|1|||
163307899|NCT04089371|589836058|FG000|Overall Study|Study terminated early|0|||
163307900|NCT04089371|589836059|FG001|Overall Study|Study terminated early|9|||
163307901|NCT03453619|589836060|FG000|Core Study (Part A)|Physician Decision|0|||
163307902|NCT03453619|589836061|FG001|Core Study (Part A)|Physician Decision|0|||
163307903|NCT03453619|589836062|FG002|Core Study (Part A)|Physician Decision|2|||
163307904|NCT03453619|589836063|FG003|Core Study (Part A)|Physician Decision|0|||
163307905|NCT03453619|589836060|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
163307906|NCT03453619|589836061|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
163307907|NCT03453619|589836062|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
163307908|NCT03453619|589836063|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
163307909|NCT03453619|589836060|FG000|Core Study (Part A)|Other|0|||
163307910|NCT03453619|589836061|FG001|Core Study (Part A)|Other|1|||
163307911|NCT03453619|589836062|FG002|Core Study (Part A)|Other|0|||
163307912|NCT03453619|589836063|FG003|Core Study (Part A)|Other|0|||
163307913|NCT03453619|589836060|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
163307914|NCT03453619|589836061|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
163307915|NCT03453619|589836062|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
163307916|NCT03453619|589836063|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
163307917|NCT03453619|589836060|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
163307918|NCT03453619|589836061|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
163307919|NCT03453619|589836062|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
162964186|NCT04158687|588569697|FG003|Overall Study|Protocol Violation|0|||
163307920|NCT03453619|589836063|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
163307921|NCT03453619|589836060|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
163307922|NCT03453619|589836061|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
163307923|NCT03453619|589836062|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
163307924|NCT03453619|589836063|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
163307925|NCT03453619|589836060|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
163307926|NCT03453619|589836061|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
163307927|NCT03453619|589836062|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
163307928|NCT03453619|589836063|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
163307929|NCT04382898|589836064|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
162964187|NCT04158687|588569694|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
162964188|NCT04158687|588569695|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
163307930|NCT04382898|589836065|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
163307931|NCT04382898|589836066|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
163200973|NCT01233258|589451112|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
163200974|NCT01233258|589451113|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
163200975|NCT01233258|589451114|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
163200976|NCT01233258|589451115|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
163307932|NCT04382898|589836067|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
163307933|NCT04382898|589836068|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
163200977|NCT01233258|589451110|FG000|First Intervention (6 Months)|Protocol Violation|0|||
163200978|NCT01233258|589451111|FG001|First Intervention (6 Months)|Protocol Violation|0|||
163200979|NCT01233258|589451112|FG002|First Intervention (6 Months)|Protocol Violation|1|||
163200980|NCT01233258|589451113|FG003|First Intervention (6 Months)|Protocol Violation|0|||
163200981|NCT01233258|589451114|FG004|First Intervention (6 Months)|Protocol Violation|0|||
163200982|NCT01233258|589451115|FG005|First Intervention (6 Months)|Protocol Violation|0|||
163200983|NCT01233258|589451110|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
163200984|NCT01233258|589451111|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
163200985|NCT01233258|589451112|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
163200986|NCT01233258|589451113|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
163200987|NCT01233258|589451114|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
163200988|NCT01233258|589451115|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
163200989|NCT00530946|589451119|FG000|Overall Study|Adverse Event|1|||
163200990|NCT00530946|589451120|FG001|Overall Study|Adverse Event|2|||
163200991|NCT00530946|589451121|FG002|Overall Study|Adverse Event|1|||
163200992|NCT00530946|589451122|FG003|Overall Study|Adverse Event|1|||
163200993|NCT00530946|589451119|FG000|Overall Study|Protocol Violation|0|||
163307934|NCT04382898|589836064|FG000|Part 1: Dose Titration|Death|6|||
163200994|NCT00530946|589451120|FG001|Overall Study|Protocol Violation|0|||
163200995|NCT00530946|589451121|FG002|Overall Study|Protocol Violation|0|||
163200996|NCT00530946|589451122|FG003|Overall Study|Protocol Violation|1|||
163307935|NCT04382898|589836065|FG001|Part 1: Dose Titration|Death|0|||
163307936|NCT04382898|589836066|FG002|Part 1: Dose Titration|Death|0|||
163307937|NCT04382898|589836067|FG003|Part 1: Dose Titration|Death|0|||
163307938|NCT04382898|589836068|FG004|Part 1: Dose Titration|Death|0|||
163307939|NCT04382898|589836064|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163307940|NCT04382898|589836065|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163307941|NCT04382898|589836066|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
163307942|NCT04382898|589836067|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163307943|NCT04382898|589836068|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163307944|NCT04382898|589836064|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
163307945|NCT04382898|589836065|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
163307946|NCT04382898|589836066|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
163307947|NCT04382898|589836067|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
163307948|NCT04382898|589836068|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
163307949|NCT04382898|589836064|FG000|Part 2: Dose Expansion|Death|0|||
163307950|NCT04382898|589836065|FG001|Part 2: Dose Expansion|Death|17|||
163307951|NCT04382898|589836066|FG002|Part 2: Dose Expansion|Death|13|||
163307952|NCT04382898|589836067|FG003|Part 2: Dose Expansion|Death|1|||
163307953|NCT04382898|589836068|FG004|Part 2: Dose Expansion|Death|0|||
163307954|NCT04382898|589836064|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
163307955|NCT04382898|589836065|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
163307956|NCT04382898|589836066|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
163307957|NCT04382898|589836067|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
163307958|NCT04382898|589836068|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
163307959|NCT04382898|589836064|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
163307960|NCT04382898|589836065|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
163307961|NCT04382898|589836066|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
163307962|NCT04382898|589836067|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
163307963|NCT04382898|589836068|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
163307964|NCT04382898|589836064|FG000|Part 2: Dose Expansion|Other|0|||
163307965|NCT04382898|589836065|FG001|Part 2: Dose Expansion|Other|0|||
163307966|NCT04382898|589836066|FG002|Part 2: Dose Expansion|Other|1|||
163307967|NCT04382898|589836067|FG003|Part 2: Dose Expansion|Other|0|||
163307968|NCT04382898|589836068|FG004|Part 2: Dose Expansion|Other|0|||
163307969|NCT05229120|589836069|FG000|Overall Study|Withdrawal by Subject|8|||
163307970|NCT03932682|589836072|FG000|Overall Study|Death|1|||
163307971|NCT03932682|589836073|FG001|Overall Study|Death|2|||
163307972|NCT03932682|589836072|FG000|Overall Study|Withdrawal by Subject|37|||
163307973|NCT03932682|589836073|FG001|Overall Study|Withdrawal by Subject|45|||
163307974|NCT03932682|589836072|FG000|Overall Study|Lost to Follow-up|19|||
163397197|NCT02187471|590166189|FG001|Overall Study|Protocol Violation|5|||
163307975|NCT03932682|589836073|FG001|Overall Study|Lost to Follow-up|25|||
163307976|NCT03932682|589836072|FG000|Overall Study|Protocol Violation|0|||
163397198|NCT02187471|590166190|FG002|Overall Study|Protocol Violation|4|||
163307977|NCT03932682|589836073|FG001|Overall Study|Protocol Violation|2|||
163307978|NCT03932682|589836072|FG000|Overall Study|Other|9|||
163307979|NCT03932682|589836073|FG001|Overall Study|Other|23|||
163307980|NCT04321031|589836074|FG000|Overall Study|Adverse Event|0|||
163307981|NCT04321031|589836075|FG001|Overall Study|Adverse Event|2|||
163307982|NCT04321031|589836076|FG002|Overall Study|Adverse Event|2|||
163307983|NCT04321031|589836077|FG003|Overall Study|Adverse Event|2|||
163397199|NCT02187471|590166191|FG003|Overall Study|Protocol Violation|4|||
163307984|NCT04321031|589836078|FG004|Overall Study|Adverse Event|2|||
163307985|NCT04321031|589836079|FG005|Overall Study|Adverse Event|2|||
163200997|NCT00530946|589451119|FG000|Overall Study|Noncompliance|1|||
163200998|NCT00530946|589451120|FG001|Overall Study|Noncompliance|0|||
163200999|NCT00530946|589451121|FG002|Overall Study|Noncompliance|0|||
163201000|NCT00530946|589451122|FG003|Overall Study|Noncompliance|0|||
163201001|NCT03322631|589451127|FG000|Overall Study|Withdrawal by Subject|0|||
163201002|NCT03322631|589451128|FG001|Overall Study|Withdrawal by Subject|1|||
163201003|NCT03322631|589451129|FG002|Overall Study|Withdrawal by Subject|0|||
163201004|NCT03322631|589451130|FG003|Overall Study|Withdrawal by Subject|0|||
163201005|NCT03322631|589451127|FG000|Overall Study|Adverse Event|0|||
163201006|NCT03322631|589451128|FG001|Overall Study|Adverse Event|0|||
163201007|NCT03322631|589451129|FG002|Overall Study|Adverse Event|1|||
163201008|NCT03322631|589451130|FG003|Overall Study|Adverse Event|0|||
163201009|NCT01300650|589451132|FG000|Overall Study|Adverse Event|1|||
163201010|NCT00602797|589451133|FG000|Overall Study|Adverse Event|1|||
163201011|NCT03943147|589451134|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
163201012|NCT03943147|589451135|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
163201013|NCT03943147|589451134|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
163201014|NCT03943147|589451135|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
163201015|NCT03943147|589451134|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
163201016|NCT03943147|589451135|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
163201017|NCT03943147|589451134|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
163201018|NCT03943147|589451135|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
163201019|NCT03943147|589451134|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
163201020|NCT03943147|589451135|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
163201021|NCT03943147|589451134|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
163201022|NCT03943147|589451135|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
163201023|NCT01318993|589451136|FG000|Overall Study|Adverse Event|53|||
163201024|NCT01318993|589451136|FG000|Overall Study|Lack of Efficacy|121|||
163201025|NCT01318993|589451136|FG000|Overall Study|Protocol Violation|3|||
163201026|NCT01318993|589451136|FG000|Overall Study|Protocol based stopping criteria|6|||
163201027|NCT01318993|589451136|FG000|Overall Study|Study closed or terminated|174|||
163201028|NCT01318993|589451136|FG000|Overall Study|Lost to Follow-up|4|||
163201029|NCT01318993|589451136|FG000|Overall Study|Physician Decision|13|||
163201030|NCT01318993|589451136|FG000|Overall Study|Withdrawal by Subject|24|||
163201031|NCT03736447|589451140|FG000|Overall Study|Adverse Event|5|||
163201032|NCT03736447|589451141|FG001|Overall Study|Adverse Event|1|||
163201033|NCT03736447|589451140|FG000|Overall Study|Withdrawal by Subject|5|||
163201034|NCT03736447|589451141|FG001|Overall Study|Withdrawal by Subject|1|||
163201035|NCT03736447|589451140|FG000|Overall Study|Lost to Follow-up|1|||
163201036|NCT03736447|589451141|FG001|Overall Study|Lost to Follow-up|0|||
163201037|NCT03736447|589451140|FG000|Overall Study|Physician Decision|1|||
163307986|NCT04321031|589836080|FG006|Overall Study|Adverse Event|0|||
163307987|NCT04321031|589836074|FG000|Overall Study|Lost to Follow-up|0|||
163201038|NCT03736447|589451141|FG001|Overall Study|Physician Decision|0|||
163201039|NCT03736447|589451140|FG000|Overall Study|Continued commitment to study treatment|3|||
163201040|NCT03736447|589451141|FG001|Overall Study|Continued commitment to study treatment|0|||
163201041|NCT03736447|589451140|FG000|Overall Study|Taste aversion to study product|0|||
163201042|NCT03736447|589451141|FG001|Overall Study|Taste aversion to study product|1|||
163201043|NCT02619175|589451142|FG000|Overall Study|Withdrawal by Subject|1|||
163201044|NCT02619175|589451143|FG001|Overall Study|Withdrawal by Subject|0|||
163201045|NCT02619175|589451142|FG000|Overall Study|foot pain|1|||
163201046|NCT02619175|589451143|FG001|Overall Study|foot pain|0|||
163201047|NCT02795832|589451147|FG000|Overall Study|Adverse Event|0|||
163307988|NCT04321031|589836075|FG001|Overall Study|Lost to Follow-up|0|||
163307989|NCT04321031|589836076|FG002|Overall Study|Lost to Follow-up|0|||
163307990|NCT04321031|589836077|FG003|Overall Study|Lost to Follow-up|1|||
163307991|NCT04321031|589836078|FG004|Overall Study|Lost to Follow-up|0|||
163307992|NCT04321031|589836079|FG005|Overall Study|Lost to Follow-up|2|||
163307993|NCT04321031|589836080|FG006|Overall Study|Lost to Follow-up|1|||
163307994|NCT04321031|589836074|FG000|Overall Study|Withdrawal by Subject|2|||
163307995|NCT04321031|589836075|FG001|Overall Study|Withdrawal by Subject|2|||
163307996|NCT04321031|589836076|FG002|Overall Study|Withdrawal by Subject|1|||
163307997|NCT04321031|589836077|FG003|Overall Study|Withdrawal by Subject|3|||
163307998|NCT04321031|589836078|FG004|Overall Study|Withdrawal by Subject|1|||
163307999|NCT04321031|589836079|FG005|Overall Study|Withdrawal by Subject|0|||
163308000|NCT04321031|589836080|FG006|Overall Study|Withdrawal by Subject|1|||
163308001|NCT04321031|589836074|FG000|Overall Study|Non-compliance with study drug|0|||
163308002|NCT04321031|589836075|FG001|Overall Study|Non-compliance with study drug|0|||
163308003|NCT04321031|589836076|FG002|Overall Study|Non-compliance with study drug|0|||
163308004|NCT04321031|589836077|FG003|Overall Study|Non-compliance with study drug|0|||
163308005|NCT04321031|589836078|FG004|Overall Study|Non-compliance with study drug|0|||
163308006|NCT04321031|589836079|FG005|Overall Study|Non-compliance with study drug|1|||
163308007|NCT04321031|589836080|FG006|Overall Study|Non-compliance with study drug|0|||
163308008|NCT04321031|589836074|FG000|Overall Study|Other|0|||
163308009|NCT04321031|589836075|FG001|Overall Study|Other|0|||
163308010|NCT04321031|589836076|FG002|Overall Study|Other|0|||
163308011|NCT04321031|589836077|FG003|Overall Study|Other|1|||
163308012|NCT04321031|589836078|FG004|Overall Study|Other|0|||
163308013|NCT04321031|589836079|FG005|Overall Study|Other|0|||
163308014|NCT04321031|589836080|FG006|Overall Study|Other|0|||
163308015|NCT04237298|589836081|FG000|Overall Study|Lost to Follow-up|4|||
163308016|NCT04237298|589836082|FG001|Overall Study|Lost to Follow-up|5|||
163308017|NCT04556656|589836086|FG000|Overall Study|Withdrawal by Subject|14|||
163308018|NCT04556656|589836087|FG001|Overall Study|Withdrawal by Subject|12|||
163308019|NCT04556656|589836086|FG000|Overall Study|Physician Decision|1|||
163308020|NCT04556656|589836087|FG001|Overall Study|Physician Decision|0|||
163308021|NCT04556656|589836086|FG000|Overall Study|Adverse Event|4|||
163308022|NCT04556656|589836087|FG001|Overall Study|Adverse Event|7|||
163308023|NCT04556656|589836086|FG000|Overall Study|Death|4|||
163308024|NCT04556656|589836087|FG001|Overall Study|Death|0|||
163308025|NCT04556656|589836086|FG000|Overall Study|Lost to Follow-up|3|||
163308026|NCT04556656|589836087|FG001|Overall Study|Lost to Follow-up|2|||
163308027|NCT04556656|589836086|FG000|Overall Study|Not further specified|2|||
163308028|NCT04556656|589836087|FG001|Overall Study|Not further specified|1|||
163308029|NCT05536440|589836088|FG000|Overall Study|Adverse Event|0|||
163308030|NCT05536440|589836089|FG001|Overall Study|Adverse Event|0|||
162964189|NCT04158687|588569696|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
162964190|NCT04158687|588569697|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
162964191|NCT04158687|588569694|FG000|Overall Study|Reason not Specified|3|||
163308031|NCT05536440|589836090|FG002|Overall Study|Adverse Event|0|||
163308032|NCT05536440|589836091|FG003|Overall Study|Adverse Event|0|||
163308033|NCT05536440|589836092|FG004|Overall Study|Adverse Event|0|||
163308034|NCT05536440|589836093|FG005|Overall Study|Adverse Event|0|||
163308035|NCT05536440|589836094|FG006|Overall Study|Adverse Event|0|||
163308036|NCT05536440|589836095|FG007|Overall Study|Adverse Event|0|||
163308037|NCT05536440|589836096|FG008|Overall Study|Adverse Event|1|||
163308038|NCT01566695|589836099|FG000|Overall Study|Lack of Efficacy|1|||
163308039|NCT01566695|589836100|FG001|Overall Study|Lack of Efficacy|0|||
163308040|NCT01566695|589836099|FG000|Overall Study|Adverse Event|3|||
163308041|NCT01566695|589836100|FG001|Overall Study|Adverse Event|0|||
163308042|NCT01566695|589836099|FG000|Overall Study|Death|79|||
163308043|NCT01566695|589836100|FG001|Overall Study|Death|86|||
163308044|NCT01566695|589836099|FG000|Overall Study|Withdrawal by Subject|13|||
163308045|NCT01566695|589836100|FG001|Overall Study|Withdrawal by Subject|12|||
163308046|NCT01566695|589836099|FG000|Overall Study|Lost to Follow-up|0|||
163308047|NCT01566695|589836100|FG001|Overall Study|Lost to Follow-up|3|||
163308048|NCT01566695|589836099|FG000|Overall Study|Other reasons|11|||
163308049|NCT01566695|589836100|FG001|Overall Study|Other reasons|8|||
163308050|NCT01416831|589836102|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
163397200|NCT02187471|590166188|FG000|Overall Study|Missing|0|||
162964192|NCT04158687|588569695|FG001|Overall Study|Reason not Specified|2|||
162964193|NCT04158687|588569696|FG002|Overall Study|Reason not Specified|4|||
163308051|NCT01416831|589836103|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
163308052|NCT05470400|589836104|FG000|Overall Study|Lost to Follow-up|0|||
163308053|NCT05470400|589836105|FG001|Overall Study|Lost to Follow-up|0|||
163308054|NCT05470400|589836106|FG002|Overall Study|Lost to Follow-up|0|||
163308055|NCT05470400|589836107|FG003|Overall Study|Lost to Follow-up|0|||
163308056|NCT05470400|589836108|FG004|Overall Study|Lost to Follow-up|0|||
163308057|NCT05470400|589836109|FG005|Overall Study|Lost to Follow-up|0|||
163308058|NCT05470400|589836110|FG006|Overall Study|Lost to Follow-up|0|||
163308059|NCT05470400|589836111|FG007|Overall Study|Lost to Follow-up|1|||
163308060|NCT05470400|589836104|FG000|Overall Study|Withdrawal by Subject|1|||
163308061|NCT05470400|589836105|FG001|Overall Study|Withdrawal by Subject|0|||
163308062|NCT05470400|589836106|FG002|Overall Study|Withdrawal by Subject|0|||
163308063|NCT05470400|589836107|FG003|Overall Study|Withdrawal by Subject|0|||
163397201|NCT02187471|590166189|FG001|Overall Study|Missing|0|||
163397202|NCT02187471|590166190|FG002|Overall Study|Missing|0|||
163397203|NCT02187471|590166191|FG003|Overall Study|Missing|1|||
163397204|NCT02187471|590166188|FG000|Overall Study|Lack of Efficacy|18|||
163397205|NCT02187471|590166189|FG001|Overall Study|Lack of Efficacy|9|||
163397206|NCT02187471|590166190|FG002|Overall Study|Lack of Efficacy|13|||
163397207|NCT02187471|590166191|FG003|Overall Study|Lack of Efficacy|11|||
163397208|NCT02187471|590166188|FG000|Overall Study|Adverse Event|24|||
163397209|NCT02187471|590166189|FG001|Overall Study|Adverse Event|34|||
163397210|NCT02187471|590166190|FG002|Overall Study|Adverse Event|44|||
163397211|NCT02187471|590166191|FG003|Overall Study|Adverse Event|36|||
163397212|NCT02187471|590166188|FG000|Overall Study|Withdrawal by Subject|23|||
163397213|NCT02187471|590166189|FG001|Overall Study|Withdrawal by Subject|29|||
163397214|NCT02187471|590166190|FG002|Overall Study|Withdrawal by Subject|22|||
163397215|NCT02187471|590166191|FG003|Overall Study|Withdrawal by Subject|24|||
163397216|NCT02187471|590166188|FG000|Overall Study|Other|7|||
163397217|NCT02187471|590166189|FG001|Overall Study|Other|5|||
163397218|NCT02187471|590166190|FG002|Overall Study|Other|3|||
163397219|NCT02187471|590166191|FG003|Overall Study|Other|4|||
163397220|NCT00957528|590166194|FG000|Overall Study|Protocol Violation|0|||
163397221|NCT00957528|590166195|FG001|Overall Study|Protocol Violation|1|||
163397222|NCT00957528|590166196|FG002|Overall Study|Protocol Violation|0|||
163397223|NCT00957528|590166194|FG000|Overall Study|Withdrawal by Subject|0|||
163397224|NCT00957528|590166195|FG001|Overall Study|Withdrawal by Subject|0|||
163397225|NCT00957528|590166196|FG002|Overall Study|Withdrawal by Subject|1|||
163397226|NCT01735279|590166199|FG000|Overall Study|Lost to Follow-up|11|||
163397227|NCT01735279|590166200|FG001|Overall Study|Lost to Follow-up|8|||
163397228|NCT00806195|590166201|FG000|Overall Study|Death|6|||
163397229|NCT00806195|590166202|FG001|Overall Study|Death|0|||
163397230|NCT00806195|590166203|FG002|Overall Study|Death|1|||
163397231|NCT00806195|590166204|FG003|Overall Study|Death|0|||
163397232|NCT00806195|590166201|FG000|Overall Study|Adverse Event|25|||
163397233|NCT00806195|590166202|FG001|Overall Study|Adverse Event|5|||
163397234|NCT00806195|590166203|FG002|Overall Study|Adverse Event|11|||
163397235|NCT00806195|590166204|FG003|Overall Study|Adverse Event|2|||
163397236|NCT00806195|590166201|FG000|Overall Study|Withdrawal by Subject|119|||
163397237|NCT00806195|590166202|FG001|Overall Study|Withdrawal by Subject|31|||
163397238|NCT00806195|590166203|FG002|Overall Study|Withdrawal by Subject|76|||
163397239|NCT00806195|590166204|FG003|Overall Study|Withdrawal by Subject|35|||
163397240|NCT00806195|590166201|FG000|Overall Study|Lost to Follow-up|217|||
163397241|NCT00806195|590166202|FG001|Overall Study|Lost to Follow-up|66|||
163397242|NCT00806195|590166203|FG002|Overall Study|Lost to Follow-up|90|||
163397243|NCT00806195|590166204|FG003|Overall Study|Lost to Follow-up|34|||
163397244|NCT00806195|590166201|FG000|Overall Study|Inappropriate Enrollment|0|||
163397245|NCT00806195|590166202|FG001|Overall Study|Inappropriate Enrollment|1|||
163397246|NCT00806195|590166203|FG002|Overall Study|Inappropriate Enrollment|0|||
163397247|NCT00806195|590166204|FG003|Overall Study|Inappropriate Enrollment|0|||
163308064|NCT05470400|589836108|FG004|Overall Study|Withdrawal by Subject|0|||
163308065|NCT05470400|589836109|FG005|Overall Study|Withdrawal by Subject|1|||
163308066|NCT05470400|589836110|FG006|Overall Study|Withdrawal by Subject|0|||
163308067|NCT05470400|589836111|FG007|Overall Study|Withdrawal by Subject|2|||
163308068|NCT05956002|589836112|FG000|Treatment Period 3|Adverse Event|0|||
163308069|NCT05956002|589836113|FG001|Treatment Period 3|Adverse Event|0|||
163308070|NCT05956002|589836114|FG002|Treatment Period 3|Adverse Event|1|||
163308071|NCT05956002|589836115|FG003|Treatment Period 3|Adverse Event|0|||
163308072|NCT04784559|589836116|FG000|Overall Study|Withdrawal by Subject|3|||
163308073|NCT04784559|589836117|FG001|Overall Study|Withdrawal by Subject|2|||
163308074|NCT04784559|589836118|FG002|Overall Study|Withdrawal by Subject|1|||
163397248|NCT00806195|590166201|FG000|Overall Study|Administrative Reason|113|||
163397249|NCT00806195|590166202|FG001|Overall Study|Administrative Reason|35|||
163397250|NCT00806195|590166203|FG002|Overall Study|Administrative Reason|66|||
163397251|NCT00806195|590166204|FG003|Overall Study|Administrative Reason|26|||
163397252|NCT00806195|590166201|FG000|Overall Study|Protocol Violation|34|||
163397253|NCT00806195|590166202|FG001|Overall Study|Protocol Violation|24|||
163397254|NCT00806195|590166203|FG002|Overall Study|Protocol Violation|26|||
163308075|NCT04784559|589836116|FG000|Overall Study|Death|2|||
163397255|NCT00806195|590166204|FG003|Overall Study|Protocol Violation|9|||
163397256|NCT00326209|590166213|FG000|Overall Study|Adverse Event|28|||
163397257|NCT00326209|590166213|FG000|Overall Study|Withdrawal by Subject|22|||
163397258|NCT00326209|590166213|FG000|Overall Study|Lack of Efficacy|31|||
163397259|NCT00326209|590166213|FG000|Overall Study|Lost to Follow-up|18|||
163397260|NCT00326209|590166213|FG000|Overall Study|Participant non-compliant|6|||
162964194|NCT04158687|588569697|FG003|Overall Study|Reason not Specified|4|||
163308076|NCT04784559|589836117|FG001|Overall Study|Death|1|||
163308077|NCT04784559|589836118|FG002|Overall Study|Death|2|||
163397261|NCT00326209|590166213|FG000|Overall Study|Sponsor closed study|173|||
163397262|NCT00326209|590166213|FG000|Overall Study|Prohibited medication use|1|||
163308078|NCT04784559|589836116|FG000|Overall Study|Lost to Follow-up|0|||
163308079|NCT04784559|589836117|FG001|Overall Study|Lost to Follow-up|0|||
163308080|NCT04784559|589836118|FG002|Overall Study|Lost to Follow-up|2|||
163308081|NCT04784559|589836116|FG000|Overall Study|Participant worsened, PI decision|1|||
163308082|NCT04784559|589836117|FG001|Overall Study|Participant worsened, PI decision|0|||
163308083|NCT04784559|589836118|FG002|Overall Study|Participant worsened, PI decision|0|||
163308084|NCT04784559|589836116|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
163308085|NCT04784559|589836117|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
163308086|NCT04784559|589836118|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
163308087|NCT04784559|589836116|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
163308088|NCT04784559|589836117|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
163308089|NCT04784559|589836118|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
163308090|NCT04784559|589836116|FG000|Overall Study|Did not meet all inclusion criteria|0|||
163308091|NCT04784559|589836117|FG001|Overall Study|Did not meet all inclusion criteria|1|||
163308092|NCT04784559|589836118|FG002|Overall Study|Did not meet all inclusion criteria|0|||
163308093|NCT04784559|589836116|FG000|Overall Study|The participant was transferred to IRCU|0|||
163308094|NCT04784559|589836117|FG001|Overall Study|The participant was transferred to IRCU|1|||
163308095|NCT04784559|589836118|FG002|Overall Study|The participant was transferred to IRCU|0|||
163308096|NCT04784559|589836116|FG000|Overall Study|SAE|0|||
163308097|NCT04784559|589836117|FG001|Overall Study|SAE|1|||
163308098|NCT04784559|589836118|FG002|Overall Study|SAE|0|||
163308099|NCT04784559|589836116|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
163308100|NCT04784559|589836117|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
163308101|NCT04784559|589836118|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
163308102|NCT00931710|589836119|FG000|Overall Study|Adverse Event|16|||
163308103|NCT00931710|589836120|FG001|Overall Study|Adverse Event|10|||
163308104|NCT00931710|589836119|FG000|Overall Study|Abnormal test procedure results|2|||
163308105|NCT00931710|589836120|FG001|Overall Study|Abnormal test procedure results|0|||
163308106|NCT00931710|589836119|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
163308107|NCT00931710|589836120|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
163308108|NCT00931710|589836119|FG000|Overall Study|Patient withdrew consent|4|||
163308109|NCT00931710|589836120|FG001|Overall Study|Patient withdrew consent|9|||
163308110|NCT00931710|589836119|FG000|Overall Study|Lost to Follow-up|6|||
163308111|NCT00931710|589836120|FG001|Overall Study|Lost to Follow-up|5|||
163308112|NCT00931710|589836119|FG000|Overall Study|Protocol deviation|1|||
163308113|NCT00931710|589836120|FG001|Overall Study|Protocol deviation|2|||
163308114|NCT03665597|589836121|FG000|Period 1|Adverse Event|1|||
163308115|NCT03665597|589836122|FG001|Period 1|Adverse Event|0|||
163308116|NCT03665597|589836123|FG002|Period 1|Adverse Event|0|||
163308117|NCT03665597|589836124|FG003|Period 1|Adverse Event|1|||
163308118|NCT03665597|589836125|FG004|Period 1|Adverse Event|0|||
163308119|NCT03665597|589836126|FG005|Period 1|Adverse Event|0|||
163308120|NCT03665597|589836127|FG006|Period 1|Adverse Event|0|||
163308121|NCT03665597|589836121|FG000|Period 1|Screen Failure|0|||
163308122|NCT03665597|589836122|FG001|Period 1|Screen Failure|0|||
163308123|NCT03665597|589836123|FG002|Period 1|Screen Failure|0|||
163308124|NCT03665597|589836124|FG003|Period 1|Screen Failure|1|||
163308125|NCT03665597|589836125|FG004|Period 1|Screen Failure|0|||
162964195|NCT02906917|588569703|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
162964196|NCT02906917|588569704|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
162964197|NCT02906917|588569703|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
162964198|NCT02906917|588569704|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
162964199|NCT02906917|588569703|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
162964200|NCT02906917|588569704|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
162964201|NCT02906917|588569703|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
162964202|NCT02906917|588569704|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
162964203|NCT02906917|588569703|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
162964204|NCT02906917|588569704|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
162964205|NCT02906917|588569703|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
162964206|NCT02906917|588569704|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
162964207|NCT02906917|588569703|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
162964208|NCT02906917|588569704|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
162964209|NCT02906917|588569703|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
162964210|NCT02906917|588569704|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
163308126|NCT03665597|589836126|FG005|Period 1|Screen Failure|0|||
163308127|NCT03665597|589836127|FG006|Period 1|Screen Failure|0|||
163308128|NCT03665597|589836121|FG000|Period 1|Death|0|||
163308129|NCT03665597|589836122|FG001|Period 1|Death|0|||
163308130|NCT03665597|589836123|FG002|Period 1|Death|0|||
163308131|NCT03665597|589836124|FG003|Period 1|Death|0|||
162964211|NCT00687739|588569705|FG000|Overall Study|Lost to Follow-up|2|||
163308132|NCT03665597|589836125|FG004|Period 1|Death|0|||
163308133|NCT03665597|589836126|FG005|Period 1|Death|0|||
162964212|NCT00687739|588569706|FG001|Overall Study|Lost to Follow-up|2|||
163308134|NCT03665597|589836127|FG006|Period 1|Death|45|||
163308135|NCT03665597|589836121|FG000|Period 1|Withdrawal by Subject|0|||
163308136|NCT03665597|589836122|FG001|Period 1|Withdrawal by Subject|0|||
163308137|NCT03665597|589836123|FG002|Period 1|Withdrawal by Subject|0|||
163308138|NCT03665597|589836124|FG003|Period 1|Withdrawal by Subject|0|||
163308139|NCT03665597|589836125|FG004|Period 1|Withdrawal by Subject|0|||
163308140|NCT03665597|589836126|FG005|Period 1|Withdrawal by Subject|0|||
163308141|NCT03665597|589836127|FG006|Period 1|Withdrawal by Subject|5|||
163308142|NCT03665597|589836121|FG000|Period 2|Adverse Event|0|||
163308143|NCT03665597|589836122|FG001|Period 2|Adverse Event|0|||
163308144|NCT03665597|589836123|FG002|Period 2|Adverse Event|0|||
163308145|NCT03665597|589836124|FG003|Period 2|Adverse Event|0|||
163308146|NCT03665597|589836125|FG004|Period 2|Adverse Event|0|||
163308147|NCT03665597|589836126|FG005|Period 2|Adverse Event|1|||
163308148|NCT03665597|589836127|FG006|Period 2|Adverse Event|0|||
163308149|NCT03665597|589836121|FG000|Period 3|Adverse Event|0|||
163308150|NCT03665597|589836122|FG001|Period 3|Adverse Event|1|||
163308151|NCT03665597|589836123|FG002|Period 3|Adverse Event|0|||
163308152|NCT03665597|589836124|FG003|Period 3|Adverse Event|0|||
163308153|NCT03665597|589836125|FG004|Period 3|Adverse Event|0|||
163308154|NCT03665597|589836126|FG005|Period 3|Adverse Event|0|||
163308155|NCT03665597|589836127|FG006|Period 3|Adverse Event|0|||
163308156|NCT03665597|589836121|FG000|Period 3|Death|0|||
163308157|NCT03665597|589836122|FG001|Period 3|Death|0|||
163308158|NCT03665597|589836123|FG002|Period 3|Death|0|||
163308159|NCT03665597|589836124|FG003|Period 3|Death|0|||
163308160|NCT03665597|589836125|FG004|Period 3|Death|1|||
163308161|NCT03665597|589836126|FG005|Period 3|Death|0|||
163308162|NCT03665597|589836127|FG006|Period 3|Death|0|||
163308163|NCT03665597|589836121|FG000|Period 4|Adverse Event|2|||
163308164|NCT03665597|589836122|FG001|Period 4|Adverse Event|2|||
163308165|NCT03665597|589836123|FG002|Period 4|Adverse Event|2|||
163308166|NCT03665597|589836124|FG003|Period 4|Adverse Event|2|||
163308167|NCT03665597|589836125|FG004|Period 4|Adverse Event|1|||
163308168|NCT03665597|589836126|FG005|Period 4|Adverse Event|0|||
163308169|NCT03665597|589836127|FG006|Period 4|Adverse Event|0|||
163308170|NCT03665597|589836121|FG000|Period 4|Death|0|||
163308171|NCT03665597|589836122|FG001|Period 4|Death|0|||
163308172|NCT03665597|589836123|FG002|Period 4|Death|2|||
163308173|NCT03665597|589836124|FG003|Period 4|Death|0|||
163308174|NCT03665597|589836125|FG004|Period 4|Death|0|||
163308175|NCT03665597|589836126|FG005|Period 4|Death|0|||
162964213|NCT00687739|588569707|FG002|Overall Study|Lost to Follow-up|1|||
162964214|NCT00687739|588569708|FG003|Overall Study|Lost to Follow-up|2|||
162964215|NCT00687739|588569705|FG000|Overall Study|Adverse Event|0|||
162964216|NCT00687739|588569706|FG001|Overall Study|Adverse Event|1|||
162964217|NCT00687739|588569707|FG002|Overall Study|Adverse Event|1|||
162964218|NCT00687739|588569708|FG003|Overall Study|Adverse Event|0|||
162964219|NCT02043132|588569713|FG000|Overall Study|Lost to Follow-up|1|||
162964220|NCT02043132|588569714|FG001|Overall Study|Lost to Follow-up|1|||
162964221|NCT02043132|588569713|FG000|Overall Study|screen failures|4|||
162964222|NCT02043132|588569714|FG001|Overall Study|screen failures|8|||
162964223|NCT02554877|588569715|FG000|Overall Study|Adverse Event|2|||
162964224|NCT02554877|588569716|FG001|Overall Study|Adverse Event|0|||
162964225|NCT02554877|588569717|FG002|Overall Study|Adverse Event|0|||
162964226|NCT02554877|588569718|FG003|Overall Study|Adverse Event|1|||
162964227|NCT02554877|588569715|FG000|Overall Study|Lost to Follow-up|1|||
162964228|NCT02554877|588569716|FG001|Overall Study|Lost to Follow-up|1|||
162964229|NCT02554877|588569717|FG002|Overall Study|Lost to Follow-up|1|||
162964230|NCT02554877|588569718|FG003|Overall Study|Lost to Follow-up|2|||
162964231|NCT02554877|588569715|FG000|Overall Study|Did not meet entrance criteria|0|||
162964232|NCT02554877|588569716|FG001|Overall Study|Did not meet entrance criteria|0|||
162964233|NCT02554877|588569717|FG002|Overall Study|Did not meet entrance criteria|1|||
162964234|NCT02554877|588569718|FG003|Overall Study|Did not meet entrance criteria|0|||
162964235|NCT02554877|588569715|FG000|Overall Study|No longer met eligibility criteria|1|||
162964236|NCT02554877|588569716|FG001|Overall Study|No longer met eligibility criteria|0|||
162964237|NCT02554877|588569717|FG002|Overall Study|No longer met eligibility criteria|1|||
162964238|NCT02554877|588569718|FG003|Overall Study|No longer met eligibility criteria|1|||
162964239|NCT02554877|588569715|FG000|Overall Study|Protocol Violation|3|||
162964240|NCT02554877|588569716|FG001|Overall Study|Protocol Violation|1|||
162964241|NCT02554877|588569717|FG002|Overall Study|Protocol Violation|1|||
162964242|NCT02554877|588569718|FG003|Overall Study|Protocol Violation|0|||
163397263|NCT00326209|590166213|FG000|Overall Study|Violation of entry criteria|1|||
162964243|NCT02554877|588569715|FG000|Overall Study|Other|1|||
162964244|NCT02554877|588569716|FG001|Overall Study|Other|3|||
162964245|NCT02554877|588569717|FG002|Overall Study|Other|0|||
162964246|NCT02554877|588569718|FG003|Overall Study|Other|3|||
163308176|NCT03665597|589836127|FG006|Period 4|Death|0|||
163308177|NCT03665597|589836121|FG000|Period 4|Physician Decision|1|||
163308178|NCT03665597|589836122|FG001|Period 4|Physician Decision|2|||
163308179|NCT03665597|589836123|FG002|Period 4|Physician Decision|0|||
163308180|NCT03665597|589836124|FG003|Period 4|Physician Decision|0|||
163308181|NCT03665597|589836125|FG004|Period 4|Physician Decision|0|||
163308182|NCT03665597|589836126|FG005|Period 4|Physician Decision|0|||
163051300|NCT03180736|588895400|FG000|Overall Study|Lost to Follow-up|1|||
163051301|NCT03180736|588895401|FG001|Overall Study|Lost to Follow-up|0|||
163051302|NCT03180736|588895400|FG000|Overall Study|Lack of Efficacy|66|||
163051303|NCT03180736|588895401|FG001|Overall Study|Lack of Efficacy|87|||
163051304|NCT03180736|588895400|FG000|Overall Study|Physician Decision|4|||
163051305|NCT03180736|588895401|FG001|Overall Study|Physician Decision|7|||
163051306|NCT03180736|588895400|FG000|Overall Study|randomized but not treated|2|||
163051307|NCT03180736|588895401|FG001|Overall Study|randomized but not treated|3|||
163051308|NCT03258593|588895402|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
163051309|NCT03258593|588895403|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
163051310|NCT03258593|588895404|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
163051311|NCT03258593|588895405|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
163051312|NCT03258593|588895402|FG000|Run-In Maintenance Phase|Disease progression|3|||
163201048|NCT02795832|589451148|FG001|Overall Study|Adverse Event|0|||
163201049|NCT02795832|589451149|FG002|Overall Study|Adverse Event|0|||
163201050|NCT02795832|589451150|FG003|Overall Study|Adverse Event|0|||
163201051|NCT02795832|589451151|FG004|Overall Study|Adverse Event|0|||
163201052|NCT02795832|589451152|FG005|Overall Study|Adverse Event|3|||
163201053|NCT02695329|589451155|FG000|Overall Study|Adverse Event|1|||
163201054|NCT02695329|589451156|FG001|Overall Study|Adverse Event|0|||
163201055|NCT02695329|589451155|FG000|Overall Study|Poor X-ray quality for measurement|4|||
163201056|NCT02695329|589451156|FG001|Overall Study|Poor X-ray quality for measurement|5|||
163201057|NCT01382212|589451157|FG000|Overall Study|Kidney transplant|1|||
163201058|NCT01382212|589451157|FG000|Overall Study|Withdrew consent|1|||
163201059|NCT01273597|589451158|FG000|Overall Study|Adverse Event|5|||
163201060|NCT01273597|589451158|FG000|Overall Study|Underwent Kidney Transplantation|2|||
163201061|NCT01273597|589451158|FG000|Overall Study|Reason Not Reported|1|||
163201062|NCT00393029|589451159|FG000|Overall Study|Not treated|0|||
163201063|NCT00393029|589451160|FG001|Overall Study|Not treated|1|||
163201064|NCT03547583|589451162|FG000|Overall Study|Adverse Event|16|||
163201065|NCT03547583|589451163|FG001|Overall Study|Adverse Event|11|||
163201066|NCT03547583|589451164|FG002|Overall Study|Adverse Event|10|||
163201067|NCT03547583|589451162|FG000|Overall Study|Death|11|||
163201068|NCT03547583|589451163|FG001|Overall Study|Death|7|||
163201069|NCT03547583|589451164|FG002|Overall Study|Death|4|||
163201070|NCT03547583|589451162|FG000|Overall Study|Lost to Follow-up|1|||
163201071|NCT03547583|589451163|FG001|Overall Study|Lost to Follow-up|0|||
163201072|NCT03547583|589451164|FG002|Overall Study|Lost to Follow-up|0|||
163201073|NCT03547583|589451162|FG000|Overall Study|Non-compliance with study drug|0|||
163201074|NCT03547583|589451163|FG001|Overall Study|Non-compliance with study drug|0|||
163201075|NCT03547583|589451164|FG002|Overall Study|Non-compliance with study drug|1|||
163201076|NCT03547583|589451162|FG000|Overall Study|Physician Decision|1|||
163201077|NCT03547583|589451163|FG001|Overall Study|Physician Decision|0|||
163201078|NCT03547583|589451164|FG002|Overall Study|Physician Decision|3|||
163201079|NCT03547583|589451162|FG000|Overall Study|Protocol Violation|2|||
163201080|NCT03547583|589451163|FG001|Overall Study|Protocol Violation|1|||
163201081|NCT03547583|589451164|FG002|Overall Study|Protocol Violation|1|||
163201082|NCT03547583|589451162|FG000|Overall Study|Withdrawal by Subject|12|||
163201083|NCT03547583|589451163|FG001|Overall Study|Withdrawal by Subject|19|||
163201084|NCT03547583|589451164|FG002|Overall Study|Withdrawal by Subject|10|||
163201085|NCT03547583|589451162|FG000|Overall Study|Other|2|||
163201086|NCT03547583|589451163|FG001|Overall Study|Other|2|||
163201087|NCT03547583|589451164|FG002|Overall Study|Other|3|||
163201088|NCT01846416|589451165|FG000|Treatment Phase|Death|2|||
163201089|NCT01846416|589451166|FG001|Treatment Phase|Death|9|||
163201090|NCT01846416|589451167|FG002|Treatment Phase|Death|1|||
163201091|NCT01846416|589451165|FG000|Treatment Phase|Withdrawal by Subject|2|||
163201092|NCT01846416|589451166|FG001|Treatment Phase|Withdrawal by Subject|4|||
163201093|NCT01846416|589451167|FG002|Treatment Phase|Withdrawal by Subject|2|||
163201094|NCT01846416|589451165|FG000|Treatment Phase|Other|1|||
163201095|NCT01846416|589451166|FG001|Treatment Phase|Other|5|||
163201096|NCT01846416|589451167|FG002|Treatment Phase|Other|1|||
163201097|NCT01846416|589451165|FG000|Treatment Phase|Physician Decision|1|||
163201098|NCT01846416|589451166|FG001|Treatment Phase|Physician Decision|2|||
163201099|NCT01846416|589451167|FG002|Treatment Phase|Physician Decision|0|||
163201100|NCT01846416|589451165|FG000|Treatment Phase|Adverse Event|3|||
163201101|NCT01846416|589451166|FG001|Treatment Phase|Adverse Event|4|||
163201102|NCT01846416|589451167|FG002|Treatment Phase|Adverse Event|0|||
163201103|NCT01846416|589451165|FG000|Treatment Phase|Non-compliance|0|||
163201104|NCT01846416|589451166|FG001|Treatment Phase|Non-compliance|2|||
163201105|NCT01846416|589451167|FG002|Treatment Phase|Non-compliance|0|||
163201106|NCT01846416|589451165|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
163201107|NCT01846416|589451166|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
163201108|NCT01846416|589451167|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
163201109|NCT01846416|589451165|FG000|Treatment Phase|Progressive Disease|21|||
163201110|NCT01846416|589451166|FG001|Treatment Phase|Progressive Disease|63|||
163201111|NCT01846416|589451167|FG002|Treatment Phase|Progressive Disease|9|||
163308183|NCT03665597|589836127|FG006|Period 4|Physician Decision|0|||
163308184|NCT05516147|589836128|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
163308185|NCT02874534|589836129|FG000|Overall Study|Withdrawal by Subject|5|||
163308186|NCT02874534|589836130|FG001|Overall Study|Withdrawal by Subject|8|||
163308187|NCT02874534|589836129|FG000|Overall Study|Lost to Follow-up|2|||
163308188|NCT02874534|589836130|FG001|Overall Study|Lost to Follow-up|2|||
163308189|NCT02874534|589836129|FG000|Overall Study|Ongoing in study|1|||
163308190|NCT02874534|589836130|FG001|Overall Study|Ongoing in study|1|||
163308191|NCT03361748|589836134|FG000|Overall Study|Death|77|||
163308192|NCT03361748|589836134|FG000|Overall Study|Lost to Follow-up|4|||
163308193|NCT03361748|589836134|FG000|Overall Study|Withdrawal by Subject|20|||
163308194|NCT01084707|589836138|FG000|Overall Study|Withdrawal by Subject|6|||
163308195|NCT00901901|589836139|FG000|Treatment Period|Adverse Event|120|||
163308196|NCT00901901|589836140|FG001|Treatment Period|Adverse Event|128|||
163308197|NCT00901901|589836139|FG000|Treatment Period|Withdrawal by Subject|26|||
163308198|NCT00901901|589836140|FG001|Treatment Period|Withdrawal by Subject|24|||
163308199|NCT00901901|589836139|FG000|Treatment Period|Physician Decision|2|||
163308200|NCT00901901|589836140|FG001|Treatment Period|Physician Decision|2|||
163308201|NCT00901901|589836139|FG000|Treatment Period|Lost to Follow-up|3|||
163308202|NCT00901901|589836140|FG001|Treatment Period|Lost to Follow-up|5|||
163308203|NCT00901901|589836139|FG000|Treatment Period|Noncompliance with study medication|4|||
163308204|NCT00901901|589836140|FG001|Treatment Period|Noncompliance with study medication|1|||
163308205|NCT00901901|589836139|FG000|Treatment Period|Missing|1|||
163308206|NCT00901901|589836140|FG001|Treatment Period|Missing|0|||
163308207|NCT00901901|589836139|FG000|Treatment Period|Never treated|0|||
163308208|NCT00901901|589836140|FG001|Treatment Period|Never treated|3|||
163308209|NCT00901901|589836139|FG000|Treatment Period|Protocol driven decision point|0|||
163308210|NCT00901901|589836140|FG001|Treatment Period|Protocol driven decision point|2|||
163308211|NCT00901901|589836139|FG000|Treatment Period|Study terminated by sponsor|2|||
163308212|NCT00901901|589836140|FG001|Treatment Period|Study terminated by sponsor|0|||
163308213|NCT00901901|589836139|FG000|Treatment Period|Protocol Violation|5|||
163308214|NCT00901901|589836140|FG001|Treatment Period|Protocol Violation|9|||
163308215|NCT00901901|589836139|FG000|Treatment Period|Switch to commercial drug|1|||
163308216|NCT00901901|589836140|FG001|Treatment Period|Switch to commercial drug|1|||
163308217|NCT00901901|589836139|FG000|Treatment Period|Transfer to treatment continuation study|5|||
163308218|NCT00901901|589836140|FG001|Treatment Period|Transfer to treatment continuation study|2|||
163308219|NCT00901901|589836139|FG000|Follow-up Period|Death|181|||
163308220|NCT00901901|589836140|FG001|Follow-up Period|Death|208|||
163308221|NCT00901901|589836139|FG000|Follow-up Period|Protocol driven decision point|47|||
163308222|NCT00901901|589836140|FG001|Follow-up Period|Protocol driven decision point|36|||
163308223|NCT00901901|589836139|FG000|Follow-up Period|Withdrawal by Subject|6|||
163308224|NCT00901901|589836140|FG001|Follow-up Period|Withdrawal by Subject|9|||
163308225|NCT00901901|589836139|FG000|Follow-up Period|Lost to Follow-up|12|||
163308226|NCT00901901|589836140|FG001|Follow-up Period|Lost to Follow-up|8|||
163308227|NCT00901901|589836139|FG000|Follow-up Period|Missing|94|||
163308228|NCT00901901|589836140|FG001|Follow-up Period|Missing|80|||
163308229|NCT04774237|589836144|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
163308230|NCT04774237|589836145|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
163308231|NCT04774237|589836146|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
163308232|NCT04774237|589836147|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
163308233|NCT04774237|589836148|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
163308234|NCT04774237|589836149|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
163308235|NCT02630823|589837662|FG000|Overall Study|Withdrawal by Subject|1|||
163308236|NCT02630823|589837662|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
163308237|NCT05382936|589837674|FG000|Overall Study|Progressive Disease|3|||
163308238|NCT05382936|589837675|FG001|Overall Study|Progressive Disease|5|||
163308239|NCT05382936|589837676|FG002|Overall Study|Progressive Disease|2|||
163308240|NCT05382936|589837677|FG003|Overall Study|Progressive Disease|5|||
163308241|NCT05382936|589837674|FG000|Overall Study|Adverse Event|0|||
163308242|NCT05382936|589837675|FG001|Overall Study|Adverse Event|1|||
163308243|NCT05382936|589837676|FG002|Overall Study|Adverse Event|1|||
163308244|NCT05382936|589837677|FG003|Overall Study|Adverse Event|0|||
163308245|NCT05382936|589837674|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
163308246|NCT05382936|589837675|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
163308247|NCT05382936|589837676|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
163308248|NCT05382936|589837677|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
163308249|NCT05382936|589837674|FG000|Overall Study|Withdrawal by Subject|0|||
163308250|NCT05382936|589837675|FG001|Overall Study|Withdrawal by Subject|0|||
163308251|NCT05382936|589837676|FG002|Overall Study|Withdrawal by Subject|1|||
163308252|NCT05382936|589837677|FG003|Overall Study|Withdrawal by Subject|1|||
163308253|NCT02682316|589837680|FG000|Overall Study|Benign Final Pathology|27|||
163308254|NCT02682316|589837681|FG001|Overall Study|Benign Final Pathology|26|||
163308255|NCT02682316|589837680|FG000|Overall Study|Reoperation before 30 days|7|||
163308256|NCT02682316|589837681|FG001|Overall Study|Reoperation before 30 days|6|||
163308257|NCT02682316|589837680|FG000|Overall Study|Ineligible|1|||
163308258|NCT02682316|589837681|FG001|Overall Study|Ineligible|0|||
163308259|NCT02682316|589837680|FG000|Overall Study|Death|1|||
163308260|NCT02682316|589837681|FG001|Overall Study|Death|0|||
163308261|NCT02682316|589837680|FG000|Overall Study|Lost to Follow-up|7|||
163308262|NCT02682316|589837681|FG001|Overall Study|Lost to Follow-up|3|||
163308263|NCT04630262|589837686|FG000|Overall Study|Intraoperative Screen Failure|5|||
163308264|NCT04630262|589837686|FG000|Overall Study|Study terminated prematurely|71|||
163308265|NCT04630262|589837686|FG000|Overall Study|Withdrawal by Subject|2|||
163308266|NCT04630262|589837686|FG000|Overall Study|Physician Decision|2|||
163308267|NCT01195831|589837687|FG000|Overall Study|Lost to Follow-up|2|||
163308268|NCT01195831|589837688|FG001|Overall Study|Lost to Follow-up|4|||
163308269|NCT01195831|589837687|FG000|Overall Study|Withdrawal by Subject|2|||
163308270|NCT01195831|589837688|FG001|Overall Study|Withdrawal by Subject|2|||
163308271|NCT01195831|589837687|FG000|Overall Study|Adverse Event|4|||
163308272|NCT01195831|589837688|FG001|Overall Study|Adverse Event|2|||
163308273|NCT01195831|589837687|FG000|Overall Study|Protocol Violation|0|||
163308274|NCT01195831|589837688|FG001|Overall Study|Protocol Violation|2|||
163308275|NCT03692676|589837690|FG000|Overall Study|exclude patients with prior use|4424|||
163308276|NCT03692676|589837691|FG001|Overall Study|exclude patients with prior use|24726|||
163308277|NCT03692676|589837692|FG002|Overall Study|exclude patients with prior use|0|||
163308278|NCT03692676|589837693|FG003|Overall Study|exclude patients with prior use|0|||
163308279|NCT03692676|589837690|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
163308280|NCT03692676|589837691|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
163308281|NCT03692676|589837692|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
163308282|NCT03692676|589837693|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
163308283|NCT03692676|589837690|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
163308284|NCT03692676|589837691|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
163308285|NCT03692676|589837692|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
163308286|NCT03692676|589837693|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
163308287|NCT03692676|589837690|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
163308288|NCT03692676|589837691|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
163308289|NCT03692676|589837692|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
163308290|NCT03692676|589837693|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
163308291|NCT03692676|589837690|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
163308292|NCT03692676|589837691|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
163308293|NCT03692676|589837692|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
163308294|NCT03692676|589837693|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
163308295|NCT03692676|589837690|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
163308296|NCT03692676|589837691|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
163308297|NCT03692676|589837692|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
163308298|NCT03692676|589837693|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
163308299|NCT03692676|589837690|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
163308300|NCT03692676|589837691|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
163308301|NCT03692676|589837692|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
163308302|NCT03692676|589837693|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
163308303|NCT03692676|589837690|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
163308304|NCT03692676|589837691|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
163308305|NCT03692676|589837692|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
163308306|NCT03692676|589837693|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
163308307|NCT03692676|589837690|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
163308308|NCT03692676|589837691|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
163308309|NCT03692676|589837692|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
163308310|NCT03692676|589837693|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
163308311|NCT03692676|589837690|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
163308312|NCT03692676|589837691|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
163308313|NCT03692676|589837692|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
163397264|NCT00326209|590166213|FG000|Overall Study|Withdrawn in error|1|||
163308314|NCT03692676|589837693|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
163308315|NCT03692676|589837690|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
163308316|NCT03692676|589837691|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
163308317|NCT03692676|589837692|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
163308318|NCT03692676|589837693|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
163308319|NCT03692676|589837690|FG000|Overall Study|Other|0|||
163308320|NCT03692676|589837691|FG001|Overall Study|Other|805|||
163308321|NCT03692676|589837692|FG002|Overall Study|Other|758|||
163308322|NCT03692676|589837693|FG003|Overall Study|Other|277|||
163308323|NCT03692676|589837690|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
163308324|NCT03692676|589837691|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
163308325|NCT03692676|589837692|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
163308326|NCT03692676|589837693|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
163308327|NCT03692611|589837694|FG000|Overall Study|Found to be ineligible postrandomization|3|||
163308328|NCT03692611|589837695|FG001|Overall Study|Found to be ineligible postrandomization|0|||
163308329|NCT03988634|589837696|FG000|Double-Blind|Adverse Event|4|||
163308330|NCT03988634|589837697|FG001|Double-Blind|Adverse Event|0|||
163308331|NCT03988634|589837698|FG002|Double-Blind|Adverse Event|0|||
163308332|NCT03988634|589837696|FG000|Double-Blind|Death|18|||
163308333|NCT03988634|589837697|FG001|Double-Blind|Death|26|||
163308334|NCT03988634|589837698|FG002|Double-Blind|Death|0|||
163308335|NCT03988634|589837696|FG000|Double-Blind|Lost to Follow-up|6|||
163308336|NCT03988634|589837697|FG001|Double-Blind|Lost to Follow-up|7|||
163308337|NCT03988634|589837698|FG002|Double-Blind|Lost to Follow-up|0|||
163308338|NCT03988634|589837696|FG000|Double-Blind|Physician Decision|9|||
163308339|NCT03988634|589837697|FG001|Double-Blind|Physician Decision|5|||
163308340|NCT03988634|589837698|FG002|Double-Blind|Physician Decision|0|||
163308341|NCT03988634|589837696|FG000|Double-Blind|Subject decision|24|||
163308342|NCT03988634|589837697|FG001|Double-Blind|Subject decision|13|||
163308343|NCT03988634|589837698|FG002|Double-Blind|Subject decision|0|||
163308344|NCT03988634|589837696|FG000|Open-Label|Adverse Event|0|||
163308345|NCT03988634|589837697|FG001|Open-Label|Adverse Event|0|||
163308346|NCT03988634|589837698|FG002|Open-Label|Adverse Event|7|||
163308347|NCT03988634|589837696|FG000|Open-Label|Physician Decision|0|||
163308348|NCT03988634|589837697|FG001|Open-Label|Physician Decision|0|||
163308349|NCT03988634|589837698|FG002|Open-Label|Physician Decision|1|||
163308350|NCT03988634|589837696|FG000|Open-Label|Technical problems|0|||
163308351|NCT03988634|589837697|FG001|Open-Label|Technical problems|0|||
163308352|NCT03988634|589837698|FG002|Open-Label|Technical problems|1|||
163308353|NCT04083235|589837710|FG000|Overall Study|Death|252|||
163308354|NCT04083235|589837711|FG001|Overall Study|Death|277|||
163308355|NCT04083235|589837710|FG000|Overall Study|Withdrawal by Subject|13|||
163308356|NCT04083235|589837711|FG001|Overall Study|Withdrawal by Subject|17|||
163308357|NCT04083235|589837710|FG000|Overall Study|Lost to Follow-up|1|||
163308358|NCT04083235|589837711|FG001|Overall Study|Lost to Follow-up|1|||
163308359|NCT04083235|589837710|FG000|Overall Study|Does not meet entry criteria|1|||
163308360|NCT04083235|589837711|FG001|Overall Study|Does not meet entry criteria|0|||
163308361|NCT04083235|589837710|FG000|Overall Study|Did not receive treatment|13|||
163308362|NCT04083235|589837711|FG001|Overall Study|Did not receive treatment|8|||
163308363|NCT04083235|589837710|FG000|Overall Study|Ongoing at the time of DCO|44|||
163308364|NCT04083235|589837711|FG001|Overall Study|Ongoing at the time of DCO|7|||
163308365|NCT03047928|589837712|FG000|Overall Study|Adverse Event|0|||
163308366|NCT03047928|589837713|FG001|Overall Study|Adverse Event|2|||
163308367|NCT03047928|589837714|FG002|Overall Study|Adverse Event|0|||
163308368|NCT03047928|589837712|FG000|Overall Study|Protocol Violation|0|||
163308369|NCT03047928|589837713|FG001|Overall Study|Protocol Violation|1|||
163308370|NCT03047928|589837714|FG002|Overall Study|Protocol Violation|0|||
163308371|NCT03047928|589837712|FG000|Overall Study|included in another protocol|0|||
163308372|NCT03047928|589837713|FG001|Overall Study|included in another protocol|1|||
163308373|NCT03047928|589837714|FG002|Overall Study|included in another protocol|0|||
163308374|NCT02729311|589837715|FG000|Overall Study|Withdrawal by Subject|8|||
163308375|NCT02729311|589837716|FG001|Overall Study|Withdrawal by Subject|2|||
163308376|NCT05034952|589837717|FG000|Overall Study|Adverse Event|1|||
163308377|NCT05034952|589837718|FG001|Overall Study|Adverse Event|0|||
163308378|NCT05034952|589837719|FG002|Overall Study|Adverse Event|0|||
163308379|NCT05034952|589837720|FG003|Overall Study|Adverse Event|0|||
163308380|NCT05034952|589837717|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
163308381|NCT05034952|589837718|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
163308382|NCT05034952|589837719|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
163308383|NCT05034952|589837720|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
163308384|NCT05034952|589837717|FG000|Overall Study|Lost to Follow-up|1|||
163308385|NCT05034952|589837718|FG001|Overall Study|Lost to Follow-up|4|||
163308386|NCT05034952|589837719|FG002|Overall Study|Lost to Follow-up|3|||
163308387|NCT05034952|589837720|FG003|Overall Study|Lost to Follow-up|3|||
163308388|NCT05034952|589837717|FG000|Overall Study|Other|0|||
163308389|NCT05034952|589837718|FG001|Overall Study|Other|0|||
163308390|NCT05034952|589837719|FG002|Overall Study|Other|0|||
163308391|NCT05034952|589837720|FG003|Overall Study|Other|1|||
163308392|NCT02287610|589837721|FG000|Overall Study|Lost to Follow-up|3|||
163308393|NCT02287610|589837721|FG000|Overall Study|Withdrawal by Subject|8|||
163308394|NCT02287610|589837721|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
163308395|NCT04950660|589837722|FG000|Overall Study|Protocol Violation|4|||
163308396|NCT04950660|589837723|FG001|Overall Study|Protocol Violation|2|||
163308397|NCT04950660|589837722|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
163308398|NCT04950660|589837723|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
163308399|NCT04950660|589837722|FG000|Overall Study|Withdrawal by Subject|0|||
163308400|NCT04950660|589837723|FG001|Overall Study|Withdrawal by Subject|1|||
163308401|NCT04950660|589837722|FG000|Overall Study|Hypotension|1|||
163308402|NCT04950660|589837723|FG001|Overall Study|Hypotension|0|||
163308403|NCT04783935|589837726|FG000|Overall Study|Withdrawal by Subject|6|||
163308404|NCT04783935|589837726|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
163308405|NCT04783935|589837726|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
163308406|NCT04783935|589837726|FG000|Overall Study|Lost to Follow-up|3|||
163308407|NCT04783935|589837726|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
163308408|NCT05273749|589837729|FG000|Overall Study|Adverse Event|14|||
163308409|NCT05273749|589837730|FG001|Overall Study|Adverse Event|8|||
163308410|NCT05273749|589837729|FG000|Overall Study|Lack of Efficacy|2|||
163308411|NCT05273749|589837730|FG001|Overall Study|Lack of Efficacy|8|||
163308412|NCT05273749|589837729|FG000|Overall Study|Physician Decision|0|||
163308413|NCT05273749|589837730|FG001|Overall Study|Physician Decision|2|||
163308414|NCT05273749|589837729|FG000|Overall Study|Withdrawal by Subject|14|||
163308415|NCT05273749|589837730|FG001|Overall Study|Withdrawal by Subject|16|||
163308416|NCT05273749|589837729|FG000|Overall Study|Lost to Follow-up|10|||
163308417|NCT05273749|589837730|FG001|Overall Study|Lost to Follow-up|10|||
163308418|NCT05273749|589837729|FG000|Overall Study|Pregnancy|1|||
163308419|NCT05273749|589837730|FG001|Overall Study|Pregnancy|0|||
163308420|NCT05273749|589837729|FG000|Overall Study|Non-Compliance|3|||
163308421|NCT05273749|589837730|FG001|Overall Study|Non-Compliance|2|||
163308422|NCT05273749|589837729|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
163308423|NCT05273749|589837730|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
163201112|NCT01846416|589451165|FG000|Survival Follow-up|Death|21|||
163201113|NCT01846416|589451166|FG001|Survival Follow-up|Death|62|||
163308424|NCT05687916|589837735|FG000|Overall Study|Adverse Event|1|||
163308425|NCT05687916|589837736|FG001|Overall Study|Adverse Event|2|||
163308426|NCT05687916|589837737|FG002|Overall Study|Adverse Event|0|||
163308427|NCT05687916|589837735|FG000|Overall Study|Withdrawal by Subject|1|||
163308428|NCT05687916|589837736|FG001|Overall Study|Withdrawal by Subject|0|||
163308429|NCT05687916|589837737|FG002|Overall Study|Withdrawal by Subject|1|||
163308430|NCT05687916|589837735|FG000|Overall Study|Protocol Violation|0|||
163308431|NCT05687916|589837736|FG001|Overall Study|Protocol Violation|2|||
163308432|NCT05687916|589837737|FG002|Overall Study|Protocol Violation|1|||
163308433|NCT05687916|589837735|FG000|Overall Study|Reason not Specified|1|||
163308434|NCT05687916|589837736|FG001|Overall Study|Reason not Specified|0|||
163308435|NCT05687916|589837737|FG002|Overall Study|Reason not Specified|0|||
163308436|NCT03338790|589837738|FG000|Overall Study|Disease Progression|65|||
163308437|NCT03338790|589837739|FG001|Overall Study|Disease Progression|43|||
163308438|NCT03338790|589837740|FG002|Overall Study|Disease Progression|50|||
163201114|NCT01846416|589451167|FG002|Survival Follow-up|Death|9|||
163201115|NCT01846416|589451165|FG000|Survival Follow-up|Lost to Follow-up|0|||
163201116|NCT01846416|589451166|FG001|Survival Follow-up|Lost to Follow-up|2|||
163201117|NCT01846416|589451167|FG002|Survival Follow-up|Lost to Follow-up|2|||
163201118|NCT01846416|589451165|FG000|Survival Follow-up|Withdrawal by Subject|2|||
163201119|NCT01846416|589451166|FG001|Survival Follow-up|Withdrawal by Subject|7|||
163201120|NCT01846416|589451167|FG002|Survival Follow-up|Withdrawal by Subject|0|||
163201121|NCT01846416|589451165|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
163201122|NCT01846416|589451166|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
163201123|NCT01846416|589451167|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
163201124|NCT01846416|589451165|FG000|Survival Follow-up|Other|3|||
163201125|NCT01846416|589451166|FG001|Survival Follow-up|Other|1|||
163201126|NCT01846416|589451167|FG002|Survival Follow-up|Other|1|||
163201127|NCT00382252|589451168|FG000|Overall Study|Death|4|||
163201128|NCT00382252|589451168|FG000|Overall Study|Protocol Violation|8|||
163201129|NCT00382252|589451168|FG000|Overall Study|Not treated by RFA|1|||
163201130|NCT00833794|589451169|FG000|Open-label Phase|Adverse Event|225|||
163201131|NCT00833794|589451170|FG001|Open-label Phase|Adverse Event|0|||
163201132|NCT00833794|589451169|FG000|Open-label Phase|Lack of Efficacy|28|||
163201133|NCT00833794|589451170|FG001|Open-label Phase|Lack of Efficacy|0|||
163201134|NCT00833794|589451169|FG000|Open-label Phase|Withdrawal by Subject|48|||
163201135|NCT00833794|589451170|FG001|Open-label Phase|Withdrawal by Subject|0|||
163201136|NCT00833794|589451169|FG000|Open-label Phase|Physician Decision|20|||
163201137|NCT00833794|589451170|FG001|Open-label Phase|Physician Decision|0|||
163201138|NCT00833794|589451169|FG000|Open-label Phase|Administrative reason|1|||
163201139|NCT00833794|589451170|FG001|Open-label Phase|Administrative reason|0|||
163201140|NCT00833794|589451169|FG000|Open-label Phase|Protocol Violation|47|||
163201141|NCT00833794|589451170|FG001|Open-label Phase|Protocol Violation|0|||
163201142|NCT00833794|589451169|FG000|Open-label Phase|Did not complete wash-out period|12|||
163201143|NCT00833794|589451170|FG001|Open-label Phase|Did not complete wash-out period|0|||
163201144|NCT00833794|589451169|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
163201145|NCT00833794|589451170|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
163201146|NCT00833794|589451169|FG000|Double-blind Phase|Adverse Event|44|||
163201147|NCT00833794|589451170|FG001|Double-blind Phase|Adverse Event|11|||
163201148|NCT00833794|589451169|FG000|Double-blind Phase|Lack of Efficacy|34|||
163308439|NCT03338790|589837741|FG003|Overall Study|Disease Progression|37|||
163308440|NCT03338790|589837738|FG000|Overall Study|Study Drug Toxicity|9|||
163308441|NCT03338790|589837739|FG001|Overall Study|Study Drug Toxicity|8|||
163308442|NCT03338790|589837740|FG002|Overall Study|Study Drug Toxicity|15|||
163308443|NCT03338790|589837741|FG003|Overall Study|Study Drug Toxicity|0|||
163308444|NCT03338790|589837738|FG000|Overall Study|Death|1|||
163308445|NCT03338790|589837739|FG001|Overall Study|Death|1|||
163308446|NCT03338790|589837740|FG002|Overall Study|Death|1|||
163308447|NCT03338790|589837741|FG003|Overall Study|Death|0|||
163308448|NCT03338790|589837738|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
163308449|NCT03338790|589837739|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
163308450|NCT03338790|589837740|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
163308451|NCT03338790|589837741|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
163201149|NCT00833794|589451170|FG001|Double-blind Phase|Lack of Efficacy|22|||
163201150|NCT00833794|589451169|FG000|Double-blind Phase|Withdrawal by Subject|23|||
163201151|NCT00833794|589451170|FG001|Double-blind Phase|Withdrawal by Subject|6|||
163201152|NCT00833794|589451169|FG000|Double-blind Phase|Physician Decision|4|||
163201153|NCT00833794|589451170|FG001|Double-blind Phase|Physician Decision|7|||
163201154|NCT00833794|589451169|FG000|Double-blind Phase|Administrative reason|1|||
163051313|NCT03258593|588895403|FG001|Run-In Maintenance Phase|Disease progression|0|||
163051314|NCT03258593|588895404|FG002|Run-In Maintenance Phase|Disease progression|0|||
163051315|NCT03258593|588895405|FG003|Run-In Maintenance Phase|Disease progression|0|||
163051316|NCT03258593|588895402|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
163051317|NCT03258593|588895403|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
163051318|NCT03258593|588895404|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
163051319|NCT03258593|588895405|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
163051320|NCT03258593|588895402|FG000|Expansion Maintenance Phase|Physician Decision|0|||
163051321|NCT03258593|588895403|FG001|Expansion Maintenance Phase|Physician Decision|1|||
163051322|NCT03258593|588895404|FG002|Expansion Maintenance Phase|Physician Decision|0|||
163051323|NCT03258593|588895405|FG003|Expansion Maintenance Phase|Physician Decision|0|||
163051324|NCT05457257|588895412|FG000|Overall Study|Withdrawal by Subject|0|||
163308452|NCT03338790|589837738|FG000|Overall Study|Participant request to discontinue study treatment|3|||
163308453|NCT03338790|589837739|FG001|Overall Study|Participant request to discontinue study treatment|3|||
163308454|NCT03338790|589837740|FG002|Overall Study|Participant request to discontinue study treatment|2|||
163308455|NCT03338790|589837741|FG003|Overall Study|Participant request to discontinue study treatment|1|||
163308456|NCT03338790|589837738|FG000|Overall Study|Poor/non-compliance|0|||
163308457|NCT03338790|589837739|FG001|Overall Study|Poor/non-compliance|1|||
163308458|NCT03338790|589837740|FG002|Overall Study|Poor/non-compliance|0|||
163308459|NCT03338790|589837741|FG003|Overall Study|Poor/non-compliance|0|||
163308460|NCT03338790|589837738|FG000|Overall Study|Participant withdrew consent|1|||
163308461|NCT03338790|589837739|FG001|Overall Study|Participant withdrew consent|0|||
163308462|NCT03338790|589837740|FG002|Overall Study|Participant withdrew consent|1|||
163308463|NCT03338790|589837741|FG003|Overall Study|Participant withdrew consent|1|||
163308464|NCT03338790|589837738|FG000|Overall Study|Other reasons|0|||
163308465|NCT03338790|589837739|FG001|Overall Study|Other reasons|5|||
163308466|NCT03338790|589837740|FG002|Overall Study|Other reasons|0|||
163308467|NCT03338790|589837741|FG003|Overall Study|Other reasons|2|||
163308468|NCT03338790|589837738|FG000|Overall Study|Not reported|0|||
163308469|NCT03338790|589837739|FG001|Overall Study|Not reported|0|||
163308470|NCT03338790|589837740|FG002|Overall Study|Not reported|1|||
163308471|NCT03338790|589837741|FG003|Overall Study|Not reported|0|||
163308472|NCT03338790|589837738|FG000|Overall Study|Completed treatment period|1|||
163308473|NCT03338790|589837739|FG001|Overall Study|Completed treatment period|2|||
163308474|NCT03338790|589837740|FG002|Overall Study|Completed treatment period|0|||
163308475|NCT03338790|589837741|FG003|Overall Study|Completed treatment period|0|||
163308476|NCT04588298|589837745|FG000|Overall Study|Adverse Event|0|||
163308477|NCT04588298|589837746|FG001|Overall Study|Adverse Event|0|||
163308478|NCT04588298|589837747|FG002|Overall Study|Adverse Event|1|||
163308479|NCT04588298|589837748|FG003|Overall Study|Adverse Event|0|||
163308480|NCT04588298|589837749|FG004|Overall Study|Adverse Event|2|||
163308481|NCT04588298|589837745|FG000|Overall Study|Withdrawal by Subject|1|||
163308482|NCT04588298|589837746|FG001|Overall Study|Withdrawal by Subject|0|||
163308483|NCT04588298|589837747|FG002|Overall Study|Withdrawal by Subject|0|||
163308484|NCT04588298|589837748|FG003|Overall Study|Withdrawal by Subject|1|||
163308485|NCT04588298|589837749|FG004|Overall Study|Withdrawal by Subject|0|||
163308486|NCT02281955|589837750|FG000|Overall Study|Death|1|||
163051325|NCT05457257|588895413|FG001|Overall Study|Withdrawal by Subject|2|||
163051326|NCT05457257|588895412|FG000|Overall Study|Death|10|||
163051327|NCT05457257|588895413|FG001|Overall Study|Death|3|||
163051328|NCT05457257|588895412|FG000|Overall Study|Ongoing|19|||
163051329|NCT05457257|588895413|FG001|Overall Study|Ongoing|9|||
163051330|NCT02131064|588895418|FG000|Overall Study|Death|5|||
163051331|NCT02131064|588895419|FG001|Overall Study|Death|6|||
163051332|NCT02131064|588895418|FG000|Overall Study|Lost to Follow-up|4|||
163051333|NCT02131064|588895419|FG001|Overall Study|Lost to Follow-up|8|||
163051334|NCT02131064|588895418|FG000|Overall Study|Withdrawal by Subject|14|||
163051335|NCT02131064|588895419|FG001|Overall Study|Withdrawal by Subject|18|||
163051336|NCT02131064|588895418|FG000|Overall Study|Other|2|||
163051337|NCT02131064|588895419|FG001|Overall Study|Other|2|||
163051338|NCT00593918|588895422|FG000|Overall Study|Withdrawal by Subject|5|||
163051339|NCT00593918|588895423|FG001|Overall Study|Withdrawal by Subject|24|||
163051340|NCT00871234|588895430|FG000|Overall Study|Adverse Event|2|||
163051341|NCT00871234|588895430|FG000|Overall Study|Lost to Follow-up|3|||
163308487|NCT03892616|589837751|FG000|Washout Period 2|Met discontinuation criterion|0|||
163308488|NCT03892616|589837752|FG001|Washout Period 2|Met discontinuation criterion|0|||
163308489|NCT03892616|589837753|FG002|Washout Period 2|Met discontinuation criterion|0|||
163308490|NCT03892616|589837754|FG003|Washout Period 2|Met discontinuation criterion|0|||
163308491|NCT03892616|589837755|FG004|Washout Period 2|Met discontinuation criterion|0|||
163308492|NCT03892616|589837756|FG005|Washout Period 2|Met discontinuation criterion|0|||
163308493|NCT03892616|589837757|FG006|Washout Period 2|Met discontinuation criterion|0|||
163051342|NCT04344301|588895432|FG000|Overall Study|Withdrawal by Subject|1|||
163051343|NCT04344301|588895433|FG001|Overall Study|Withdrawal by Subject|0|||
163051344|NCT04344301|588895432|FG000|Overall Study|Death|0|||
163051345|NCT04344301|588895433|FG001|Overall Study|Death|1|||
163051346|NCT00072410|588895434|FG000|Overall Study|Progressive disease|0|||
163201155|NCT00833794|589451170|FG001|Double-blind Phase|Administrative reason|3|||
163201156|NCT00039130|589451173|FG000|Overall Study|Adverse Event|11|||
163201157|NCT00039130|589451173|FG000|Overall Study|Death|9|||
163201158|NCT00039130|589451173|FG000|Overall Study|Withdrawal by Subject|3|||
163201159|NCT00039130|589451173|FG000|Overall Study|Progression|2|||
163201160|NCT00039130|589451173|FG000|Overall Study|Subsequent treatment|2|||
163201161|NCT00039130|589451173|FG000|Overall Study|Physician Decision|3|||
163201162|NCT01269463|589451174|FG000|First Intervention|Withdrawal by Subject|1|||
163201163|NCT01269463|589451175|FG001|First Intervention|Withdrawal by Subject|0|||
163201164|NCT01269463|589451174|FG000|First Intervention|Adverse Event|1|||
163201165|NCT01269463|589451175|FG001|First Intervention|Adverse Event|0|||
163201166|NCT01269463|589451174|FG000|First Intervention|Lack of Efficacy|0|||
163201167|NCT01269463|589451175|FG001|First Intervention|Lack of Efficacy|1|||
163201168|NCT01269463|589451174|FG000|First Intervention|Physician Decision|0|||
163201169|NCT01269463|589451175|FG001|First Intervention|Physician Decision|1|||
163201170|NCT02612727|589451179|FG000|Overall Study|Parent request|4|||
163201171|NCT02612727|589451180|FG001|Overall Study|Parent request|1|||
163201172|NCT02612727|589451179|FG000|Overall Study|Needed treatment incompatible with PT|1|||
163201173|NCT02612727|589451180|FG001|Overall Study|Needed treatment incompatible with PT|1|||
163201174|NCT02612727|589451179|FG000|Overall Study|Direct hyperbilirubinemia|0|||
163201175|NCT02612727|589451180|FG001|Overall Study|Direct hyperbilirubinemia|2|||
163201176|NCT04518306|589451183|FG000|Double-Blind Period|Run in failure|0|||
163201177|NCT04518306|589451184|FG001|Double-Blind Period|Run in failure|0|||
163201178|NCT04518306|589451185|FG002|Double-Blind Period|Run in failure|1|||
163201179|NCT04518306|589451183|FG000|Double-Blind Period|Adverse Event|0|||
163201180|NCT04518306|589451184|FG001|Double-Blind Period|Adverse Event|2|||
163201181|NCT04518306|589451185|FG002|Double-Blind Period|Adverse Event|2|||
163201182|NCT04518306|589451183|FG000|Double-Blind Period|Lost to Follow-up|1|||
163201183|NCT04518306|589451184|FG001|Double-Blind Period|Lost to Follow-up|2|||
163201184|NCT04518306|589451185|FG002|Double-Blind Period|Lost to Follow-up|2|||
163201185|NCT04518306|589451183|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
163201186|NCT04518306|589451184|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
163201187|NCT04518306|589451185|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
163201188|NCT04518306|589451183|FG000|Double-Blind Period|Other|0|||
163201189|NCT04518306|589451184|FG001|Double-Blind Period|Other|2|||
163201190|NCT04518306|589451185|FG002|Double-Blind Period|Other|0|||
163201191|NCT04518306|589451183|FG000|Double-Blind Period|Missing|0|||
163201192|NCT04518306|589451184|FG001|Double-Blind Period|Missing|1|||
163201193|NCT04518306|589451185|FG002|Double-Blind Period|Missing|0|||
163201194|NCT03268954|589451186|FG000|Overall Study|Withdrawal by Subject|27|||
163201195|NCT03268954|589451187|FG001|Overall Study|Withdrawal by Subject|17|||
163201196|NCT03268954|589451186|FG000|Overall Study|Lost to Follow-up|2|||
163201197|NCT03268954|589451187|FG001|Overall Study|Lost to Follow-up|3|||
163201198|NCT03268954|589451186|FG000|Overall Study|Reason Not Specified|3|||
163201199|NCT03268954|589451187|FG001|Overall Study|Reason Not Specified|8|||
163201200|NCT05358444|589451188|FG000|Overall Study|Withdrawal by Subject|0|||
163201201|NCT05358444|589451189|FG001|Overall Study|Withdrawal by Subject|1|||
163201202|NCT05358444|589451188|FG000|Overall Study|Lost to Follow-up|0|||
163201203|NCT05358444|589451189|FG001|Overall Study|Lost to Follow-up|3|||
163201204|NCT03820986|589451193|FG000|Overall Study|Death|201|||
163201205|NCT03820986|589451194|FG001|Overall Study|Death|175|||
163201206|NCT03820986|589451193|FG000|Overall Study|Lost to Follow-up|1|||
163201207|NCT03820986|589451194|FG001|Overall Study|Lost to Follow-up|1|||
163201208|NCT03820986|589451193|FG000|Overall Study|Physician Decision|1|||
163201209|NCT03820986|589451194|FG001|Overall Study|Physician Decision|0|||
163201210|NCT03820986|589451193|FG000|Overall Study|Sponsor Decision|122|||
163201211|NCT03820986|589451194|FG001|Overall Study|Sponsor Decision|160|||
163201212|NCT03820986|589451193|FG000|Overall Study|Withdrawal by Subject|9|||
163201213|NCT03820986|589451194|FG001|Overall Study|Withdrawal by Subject|4|||
163201214|NCT01638546|589451205|FG000|Overall Study|Adverse Event|1|||
163201215|NCT01638546|589451206|FG001|Overall Study|Adverse Event|3|||
163201216|NCT05766423|589451207|FG000|Overall Study|Withdrawal by Subject|1|||
163201217|NCT05766423|589451208|FG001|Overall Study|Withdrawal by Subject|0|||
163201218|NCT05766423|589451207|FG000|Overall Study|Consented, not scheduled|3|||
163201219|NCT05766423|589451208|FG001|Overall Study|Consented, not scheduled|5|||
163201220|NCT00540514|589452936|FG000|Overall Study|Still on treatment|3|||
163201221|NCT00540514|589452937|FG001|Overall Study|Still on treatment|0|||
163201222|NCT00540514|589452936|FG000|Overall Study|Unacceptable Toxicity|61|||
163201223|NCT00540514|589452937|FG001|Overall Study|Unacceptable Toxicity|62|||
163308494|NCT03892616|589837758|FG007|Washout Period 2|Met discontinuation criterion|0|||
163201224|NCT00540514|589452936|FG000|Overall Study|Adverse Event|20|||
163201225|NCT00540514|589452937|FG001|Overall Study|Adverse Event|24|||
163201226|NCT00540514|589452936|FG000|Overall Study|Physician Decision|86|||
163308495|NCT03892616|589837759|FG008|Washout Period 2|Met discontinuation criterion|1|||
163201227|NCT00540514|589452937|FG001|Overall Study|Physician Decision|99|||
163201228|NCT00540514|589452936|FG000|Overall Study|Protocol Deviation|3|||
163201229|NCT00540514|589452937|FG001|Overall Study|Protocol Deviation|4|||
163201230|NCT00540514|589452936|FG000|Overall Study|Lost to Follow-up|1|||
163308496|NCT03892616|589837760|FG009|Washout Period 2|Met discontinuation criterion|0|||
163201231|NCT00540514|589452937|FG001|Overall Study|Lost to Follow-up|1|||
163308497|NCT03892616|589837761|FG010|Washout Period 2|Met discontinuation criterion|0|||
163308498|NCT03892616|589837762|FG011|Washout Period 2|Met discontinuation criterion|0|||
163308499|NCT04177823|589837763|FG000|Overall Study|Physician Decision|1|||
163308500|NCT04177823|589837763|FG000|Overall Study|Withdrawal by Subject|1|||
163308501|NCT03683719|589837764|FG000|Overall Study|Lack of Efficacy|1|||
163308502|NCT03683719|589837765|FG001|Overall Study|Lack of Efficacy|3|||
163308503|NCT03683719|589837766|FG002|Overall Study|Lack of Efficacy|4|||
163308504|NCT03683719|589837767|FG003|Overall Study|Lack of Efficacy|0|||
163308505|NCT03683719|589837768|FG004|Overall Study|Lack of Efficacy|4|||
163308506|NCT03683719|589837764|FG000|Overall Study|Adverse Event|6|||
163308507|NCT03683719|589837765|FG001|Overall Study|Adverse Event|6|||
163308508|NCT03683719|589837766|FG002|Overall Study|Adverse Event|0|||
163308509|NCT03683719|589837767|FG003|Overall Study|Adverse Event|1|||
163308510|NCT03683719|589837768|FG004|Overall Study|Adverse Event|3|||
163308511|NCT03683719|589837764|FG000|Overall Study|Withdrawal by Subject|4|||
163308512|NCT03683719|589837765|FG001|Overall Study|Withdrawal by Subject|4|||
163308513|NCT03683719|589837766|FG002|Overall Study|Withdrawal by Subject|3|||
163308514|NCT03683719|589837767|FG003|Overall Study|Withdrawal by Subject|5|||
163308515|NCT03683719|589837768|FG004|Overall Study|Withdrawal by Subject|5|||
163308516|NCT03683719|589837764|FG000|Overall Study|Lost to Follow-up|1|||
163308517|NCT03683719|589837765|FG001|Overall Study|Lost to Follow-up|0|||
163308518|NCT03683719|589837766|FG002|Overall Study|Lost to Follow-up|0|||
163308519|NCT03683719|589837767|FG003|Overall Study|Lost to Follow-up|1|||
163308520|NCT03683719|589837768|FG004|Overall Study|Lost to Follow-up|1|||
163308521|NCT03683719|589837764|FG000|Overall Study|Other personal reasons|0|||
163308522|NCT03683719|589837765|FG001|Overall Study|Other personal reasons|0|||
163308523|NCT03683719|589837766|FG002|Overall Study|Other personal reasons|1|||
163308524|NCT03683719|589837767|FG003|Overall Study|Other personal reasons|0|||
163308525|NCT03683719|589837768|FG004|Overall Study|Other personal reasons|1|||
163308526|NCT00601900|589837770|FG000|Overall Study|Withdrawal by Subject|0|||
163308527|NCT00601900|589837771|FG001|Overall Study|Withdrawal by Subject|3|||
163308528|NCT03924986|589837772|FG000|Overall Study|Death|57|||
163308529|NCT03924986|589837773|FG001|Overall Study|Death|66|||
163308530|NCT03924986|589837772|FG000|Overall Study|Study Concluded by Sponsor|51|||
163308531|NCT03924986|589837773|FG001|Overall Study|Study Concluded by Sponsor|41|||
163308532|NCT03924986|589837772|FG000|Overall Study|Withdrawal by Subject|15|||
163308533|NCT03924986|589837773|FG001|Overall Study|Withdrawal by Subject|20|||
163308534|NCT03924986|589837772|FG000|Overall Study|Lost to Follow-up|7|||
163308535|NCT03924986|589837773|FG001|Overall Study|Lost to Follow-up|5|||
163308536|NCT03924986|589837772|FG000|Overall Study|Miscellaneous|1|||
163308537|NCT03924986|589837773|FG001|Overall Study|Miscellaneous|0|||
163308538|NCT03699709|589837779|FG000|Overall Study|Death|1|||
163308539|NCT03699709|589837780|FG001|Overall Study|Death|2|||
163308540|NCT03699709|589837779|FG000|Overall Study|Lost to Follow-up|10|||
163308541|NCT03699709|589837780|FG001|Overall Study|Lost to Follow-up|3|||
163308542|NCT03699709|589837779|FG000|Overall Study|Withdrawal by Subject|5|||
163308543|NCT03699709|589837780|FG001|Overall Study|Withdrawal by Subject|0|||
163308544|NCT03699709|589837779|FG000|Overall Study|incarcerated|1|||
163308545|NCT03699709|589837780|FG001|Overall Study|incarcerated|0|||
163308546|NCT03699709|589837779|FG000|Overall Study|scheduled, but no show|0|||
163201232|NCT00540514|589452936|FG000|Overall Study|Withdrawal by Subject|65|||
163201233|NCT00540514|589452937|FG001|Overall Study|Withdrawal by Subject|67|||
163201234|NCT00540514|589452936|FG000|Overall Study|Excluded prior to treatment|7|||
163201235|NCT00540514|589452937|FG001|Overall Study|Excluded prior to treatment|7|||
163201236|NCT00540514|589452936|FG000|Overall Study|Paclitaxel not available|0|||
163201237|NCT00540514|589452937|FG001|Overall Study|Paclitaxel not available|2|||
163201238|NCT01892293|589452944|FG000|Overall Study|Apheresed but not treated|4|||
163308547|NCT03699709|589837780|FG001|Overall Study|scheduled, but no show|1|||
163308548|NCT02907099|589837781|FG000|Overall Study|Adverse Event|1|||
163308549|NCT02907099|589837781|FG000|Overall Study|Withdrawal by Subject|2|||
163308550|NCT02907099|589837781|FG000|Overall Study|Screen Fail|2|||
163308551|NCT05569252|589837782|FG000|Overall Study|Adverse event (central vision loss)|1|||
163308552|NCT05569252|589837783|FG001|Overall Study|Adverse event (central vision loss)|0|||
163308553|NCT05569252|589837784|FG002|Overall Study|Adverse event (central vision loss)|0|||
163308554|NCT05569252|589837785|FG003|Overall Study|Adverse event (central vision loss)|0|||
163308555|NCT02949362|589837786|FG000|Retrospective Period|Inform consent not signed by participant|4|||
163308556|NCT02949362|589837787|FG001|Retrospective Period|Inform consent not signed by participant|1|||
163308557|NCT02949362|589837788|FG002|Retrospective Period|Inform consent not signed by participant|0|||
163308558|NCT02949362|589837789|FG003|Retrospective Period|Inform consent not signed by participant|0|||
163308559|NCT02949362|589837786|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
162964247|NCT02554877|588569715|FG000|Overall Study|Insufficient clinical response|4|||
163201239|NCT03602482|589452949|FG000|Overall Study|Withdrawal by Subject|6|||
163201240|NCT03602482|589452950|FG001|Overall Study|Withdrawal by Subject|7|||
163201241|NCT03602482|589452951|FG002|Overall Study|Withdrawal by Subject|0|||
163201242|NCT03602482|589452952|FG003|Overall Study|Withdrawal by Subject|0|||
163201243|NCT00618072|589452972|FG000|Overall Study|Lost to Follow-up|2|||
163201244|NCT00618072|589452973|FG001|Overall Study|Lost to Follow-up|0|||
163201245|NCT00618072|589452974|FG002|Overall Study|Lost to Follow-up|3|||
163201246|NCT00618072|589452972|FG000|Overall Study|Physician Decision|0|||
163201247|NCT00618072|589452973|FG001|Overall Study|Physician Decision|1|||
163201248|NCT00618072|589452974|FG002|Overall Study|Physician Decision|1|||
163201249|NCT00684307|589452975|FG000|Overall Study|Adverse Event|11|||
163201250|NCT00684307|589452976|FG001|Overall Study|Adverse Event|6|||
163201251|NCT00684307|589452977|FG002|Overall Study|Adverse Event|15|||
163201252|NCT00684307|589452978|FG003|Overall Study|Adverse Event|16|||
163201253|NCT00684307|589452979|FG004|Overall Study|Adverse Event|8|||
163201254|NCT00684307|589452975|FG000|Overall Study|Development of increasing Liver Function|0|||
163201255|NCT00684307|589452976|FG001|Overall Study|Development of increasing Liver Function|2|||
163201256|NCT00684307|589452977|FG002|Overall Study|Development of increasing Liver Function|0|||
163201257|NCT00684307|589452978|FG003|Overall Study|Development of increasing Liver Function|1|||
163201258|NCT00684307|589452979|FG004|Overall Study|Development of increasing Liver Function|0|||
163201259|NCT00684307|589452975|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
163201260|NCT00684307|589452976|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
163201261|NCT00684307|589452977|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
163201262|NCT00684307|589452978|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
163201263|NCT00684307|589452979|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
163201264|NCT00684307|589452975|FG000|Overall Study|Incorrect enrolment or randomization|4|||
163201265|NCT00684307|589452976|FG001|Overall Study|Incorrect enrolment or randomization|0|||
163201266|NCT00684307|589452977|FG002|Overall Study|Incorrect enrolment or randomization|0|||
163201267|NCT00684307|589452978|FG003|Overall Study|Incorrect enrolment or randomization|0|||
163201268|NCT00684307|589452979|FG004|Overall Study|Incorrect enrolment or randomization|0|||
163201269|NCT00684307|589452975|FG000|Overall Study|Interupted IP for more than 7 days|0|||
163201270|NCT00684307|589452976|FG001|Overall Study|Interupted IP for more than 7 days|4|||
163201271|NCT00684307|589452977|FG002|Overall Study|Interupted IP for more than 7 days|1|||
163201272|NCT00684307|589452978|FG003|Overall Study|Interupted IP for more than 7 days|3|||
163201273|NCT00684307|589452979|FG004|Overall Study|Interupted IP for more than 7 days|3|||
163201274|NCT00684307|589452975|FG000|Overall Study|Severe non compliance to protocol|1|||
163201275|NCT00684307|589452976|FG001|Overall Study|Severe non compliance to protocol|0|||
163201276|NCT00684307|589452977|FG002|Overall Study|Severe non compliance to protocol|0|||
163201277|NCT00684307|589452978|FG003|Overall Study|Severe non compliance to protocol|1|||
163201278|NCT00684307|589452979|FG004|Overall Study|Severe non compliance to protocol|2|||
163201279|NCT00684307|589452975|FG000|Overall Study|Participant not willing to continue|7|||
163201280|NCT00684307|589452976|FG001|Overall Study|Participant not willing to continue|10|||
163201281|NCT00684307|589452977|FG002|Overall Study|Participant not willing to continue|11|||
163201282|NCT00684307|589452978|FG003|Overall Study|Participant not willing to continue|5|||
163201283|NCT00684307|589452979|FG004|Overall Study|Participant not willing to continue|8|||
163201284|NCT00684307|589452975|FG000|Overall Study|Criteria from the CSR|0|||
163201285|NCT00684307|589452976|FG001|Overall Study|Criteria from the CSR|0|||
163201286|NCT00684307|589452977|FG002|Overall Study|Criteria from the CSR|1|||
163201287|NCT00684307|589452978|FG003|Overall Study|Criteria from the CSR|3|||
163201288|NCT00684307|589452979|FG004|Overall Study|Criteria from the CSR|3|||
163201289|NCT02170298|589452982|FG000|Overall Study|Withdrawal by Subject|0|||
163201290|NCT02170298|589452983|FG001|Overall Study|Withdrawal by Subject|1|||
163201291|NCT02170298|589452982|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
163201292|NCT02170298|589452983|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
163201293|NCT05048784|589452986|FG000|Period 1|Adverse Event|3|||
163201294|NCT05048784|589452987|FG001|Period 1|Adverse Event|1|||
163201295|NCT05048784|589452988|FG002|Period 1|Adverse Event|0|||
163201296|NCT05048784|589452989|FG003|Period 1|Adverse Event|0|||
163201297|NCT05048784|589452986|FG000|Period 2|Lost to Follow-up|0|||
163201298|NCT05048784|589452987|FG001|Period 2|Lost to Follow-up|1|||
163201299|NCT05048784|589452988|FG002|Period 2|Lost to Follow-up|0|||
163201300|NCT05048784|589452989|FG003|Period 2|Lost to Follow-up|0|||
163201301|NCT02853604|589452994|FG000|Overall Study|Withdrawal by Subject|12|||
163201302|NCT02853604|589452995|FG001|Overall Study|Withdrawal by Subject|35|||
163201303|NCT02853604|589452994|FG000|Overall Study|Lost to Follow-up|4|||
163201304|NCT02853604|589452995|FG001|Overall Study|Lost to Follow-up|8|||
163201305|NCT02853604|589452994|FG000|Overall Study|Death|1|||
163201306|NCT02853604|589452995|FG001|Overall Study|Death|5|||
163201307|NCT02853604|589452994|FG000|Overall Study|Miscellaneous|11|||
163201308|NCT02853604|589452995|FG001|Overall Study|Miscellaneous|2|||
163201309|NCT02853604|589452994|FG000|Overall Study|Progressive Disease|0|||
163201310|NCT02853604|589452995|FG001|Overall Study|Progressive Disease|2|||
163201311|NCT00727025|589452996|FG000|Overall Study|Physician Decision|23|||
163201312|NCT02269241|589452997|FG000|Overall Study|Lost to Follow-up|269|||
163201313|NCT02269241|589452997|FG000|Overall Study|Withdrawal by Subject|155|||
163201314|NCT02269241|589452997|FG000|Overall Study|Protocol Violation|1|||
163201315|NCT02269241|589452997|FG000|Overall Study|Physician Decision|7|||
163308560|NCT02949362|589837787|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
163201316|NCT02269241|589452997|FG000|Overall Study|Pregnancy|15|||
163308561|NCT02949362|589837788|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
163308562|NCT02949362|589837789|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
163308563|NCT02949362|589837786|FG000|Prospective Period|Other|0|||
163308564|NCT02949362|589837787|FG001|Prospective Period|Other|0|||
163308565|NCT02949362|589837788|FG002|Prospective Period|Other|0|||
163308566|NCT02949362|589837789|FG003|Prospective Period|Other|4|||
163308567|NCT05268302|589837790|FG000|Overall Study|Death|0|||
163308568|NCT05268302|589837791|FG001|Overall Study|Death|1|||
163308569|NCT02811679|589837792|FG000|Overall Study|Adverse Event|1|||
163308570|NCT02811679|589837792|FG000|Overall Study|Lack of Efficacy|6|||
163308571|NCT02811679|589837792|FG000|Overall Study|Early study closure due to slow accrual|3|||
163308572|NCT05319860|589837796|FG000|Overall Study|Death|1|||
163308573|NCT05319860|589837797|FG001|Overall Study|Death|1|||
163308574|NCT05319860|589837796|FG000|Overall Study|Lost to Follow-up|3|||
163308575|NCT05319860|589837797|FG001|Overall Study|Lost to Follow-up|1|||
163201317|NCT02269241|589452997|FG000|Overall Study|Wish for pregnancy|5|||
163201318|NCT02269241|589452997|FG000|Overall Study|Development of an exclusion criteria|16|||
163201319|NCT02269241|589452997|FG000|Overall Study|Adverse Event|113|||
163201320|NCT02269241|589452997|FG000|Overall Study|At the specific request of the sponsor|20|||
163201321|NCT02269241|589452997|FG000|Overall Study|Several reasons not classified|53|||
163201322|NCT02269241|589452997|FG000|Overall Study|Screening failures|546|||
163201323|NCT03020160|589452998|FG000|Overall Study|Withdrawal by Subject|1|||
163201324|NCT03020160|589452999|FG001|Overall Study|Withdrawal by Subject|0|||
163201325|NCT02270957|589453000|FG000|Overall Study|Lack of Efficacy|2|||
163201326|NCT02270957|589453001|FG001|Overall Study|Lack of Efficacy|4|||
163201327|NCT02270957|589453000|FG000|Overall Study|Adverse Event|2|||
163201328|NCT02270957|589453001|FG001|Overall Study|Adverse Event|0|||
163201329|NCT01539538|589453009|FG000|Overall Study|Adverse Event|13|||
163201330|NCT01539538|589453010|FG001|Overall Study|Adverse Event|18|||
163201331|NCT01539538|589453009|FG000|Overall Study|Lack of Efficacy|13|||
163201332|NCT01539538|589453010|FG001|Overall Study|Lack of Efficacy|16|||
163201333|NCT01539538|589453009|FG000|Overall Study|Withdrawal by Subject|2|||
163201334|NCT01539538|589453010|FG001|Overall Study|Withdrawal by Subject|3|||
163201335|NCT01539538|589453009|FG000|Overall Study|PCA no longer required or PCA problem|3|||
163201336|NCT01539538|589453010|FG001|Overall Study|PCA no longer required or PCA problem|7|||
163201337|NCT03897465|589453011|FG000|Overall Study|Lost to Follow-up|2|||
163201338|NCT03897465|589453012|FG001|Overall Study|Lost to Follow-up|1|||
163201339|NCT03897465|589453011|FG000|Overall Study|Adverse Event|2|||
163201340|NCT03897465|589453012|FG001|Overall Study|Adverse Event|0|||
163201341|NCT03897465|589453011|FG000|Overall Study|complete healing by V2|1|||
163201342|NCT03897465|589453012|FG001|Overall Study|complete healing by V2|0|||
163201343|NCT03897465|589453011|FG000|Overall Study|occurence of exclusion criterion|1|||
163201344|NCT03897465|589453012|FG001|Overall Study|occurence of exclusion criterion|1|||
163201345|NCT03897465|589453011|FG000|Overall Study|Other|1|||
163201346|NCT03897465|589453012|FG001|Overall Study|Other|0|||
163201347|NCT00847379|589453013|FG000|Overall Study|Study terminated by Sponsor|59|||
163201348|NCT00847379|589453014|FG001|Overall Study|Study terminated by Sponsor|57|||
163201349|NCT00847379|589453015|FG002|Overall Study|Study terminated by Sponsor|57|||
163201350|NCT00521014|589453016|FG000|Overall Study|Inevaluable, not treated|1|||
163201351|NCT04390191|589453017|FG000|Overall Study|Withdrawal by Subject|1|||
163201352|NCT04390191|589453018|FG001|Overall Study|Withdrawal by Subject|0|||
163201353|NCT03978832|589453021|FG000|Overall Study|Adverse Event|1|||
163201354|NCT03978832|589453021|FG000|Overall Study|Lost to Follow-up|1|||
163201355|NCT03978832|589453021|FG000|Overall Study|Withdrawal by Subject|6|||
163201356|NCT03978832|589453021|FG000|Overall Study|Physician Decision|2|||
163201357|NCT03978832|589453021|FG000|Overall Study|did not pass screening criteria|44|||
163308576|NCT05319860|589837796|FG000|Overall Study|Withdrawal by Subject|1|||
163308577|NCT05319860|589837797|FG001|Overall Study|Withdrawal by Subject|7|||
163308578|NCT04314895|589837798|FG000|Overall Study|Lost to Follow-up|1|||
163308579|NCT04314895|589837798|FG000|Overall Study|Death|10|||
163308580|NCT04314895|589837798|FG000|Overall Study|Physician Decision|2|||
163201358|NCT00003499|589453022|FG000|Overall Study|Not evaluable|8|||
163201359|NCT02042183|589453027|FG000|Overall Study|Physician Decision|7|||
163201360|NCT02042183|589453028|FG001|Overall Study|Physician Decision|2|||
163201361|NCT02042183|589453027|FG000|Overall Study|Lack of Efficacy|4|||
163308581|NCT05113966|589839857|FG000|Overall Study|Death|21|||
163308582|NCT05113966|589839857|FG000|Overall Study|Study Terminated by Sponsor|9|||
163308583|NCT02187003|589839860|FG000|Overall Study|Adverse Event|2|||
163308584|NCT02187003|589839861|FG001|Overall Study|Adverse Event|0|||
163308585|NCT02187003|589839860|FG000|Overall Study|Lost to Follow-up|14|||
163201362|NCT02042183|589453028|FG001|Overall Study|Lack of Efficacy|3|||
163201363|NCT02042183|589453027|FG000|Overall Study|Non-compliance with Study Drug|2|||
163201364|NCT02042183|589453028|FG001|Overall Study|Non-compliance with Study Drug|3|||
163201365|NCT02042183|589453027|FG000|Overall Study|Adverse Event|17|||
163308586|NCT02187003|589839861|FG001|Overall Study|Lost to Follow-up|10|||
163308587|NCT02187003|589839860|FG000|Overall Study|Withdrawal by Subject|3|||
163308588|NCT02187003|589839861|FG001|Overall Study|Withdrawal by Subject|7|||
163308589|NCT02187003|589839860|FG000|Overall Study|Protocol Violation|2|||
163308590|NCT02187003|589839861|FG001|Overall Study|Protocol Violation|4|||
163308591|NCT02187003|589839860|FG000|Overall Study|Other|5|||
163308592|NCT02187003|589839861|FG001|Overall Study|Other|5|||
163308593|NCT02187003|589839860|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163308594|NCT02187003|589839861|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
163308595|NCT03648840|589839863|FG000|First IV Infusion Session|Adverse Event|0|||
163308596|NCT03648840|589839864|FG001|First IV Infusion Session|Adverse Event|2|||
163308597|NCT03648840|589839863|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
163308598|NCT03648840|589839864|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
163308599|NCT03648840|589839863|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
163308600|NCT03648840|589839864|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
163308601|NCT03648840|589839863|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
163308602|NCT03648840|589839864|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
163308603|NCT05063994|589839865|FG000|Cortef Run-In|Withdrawal of Consent|1|||
163308604|NCT05063994|589839866|FG001|Cortef Run-In|Withdrawal of Consent|0|||
163308605|NCT05063994|589839867|FG002|Cortef Run-In|Withdrawal of Consent|0|||
163308606|NCT05063994|589839865|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
163308607|NCT05063994|589839866|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
163308608|NCT05063994|589839867|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
163308609|NCT05063994|589839865|FG000|Treatment|Physician Decision|0|||
163308610|NCT05063994|589839866|FG001|Treatment|Physician Decision|0|||
163308611|NCT05063994|589839867|FG002|Treatment|Physician Decision|1|||
163308612|NCT05063994|589839865|FG000|Treatment|Withdrawal by Subject|0|||
163308613|NCT05063994|589839866|FG001|Treatment|Withdrawal by Subject|0|||
163308614|NCT05063994|589839867|FG002|Treatment|Withdrawal by Subject|1|||
163308615|NCT05063994|589839865|FG000|Treatment|Withdrawal of Consent|0|||
163308616|NCT05063994|589839866|FG001|Treatment|Withdrawal of Consent|0|||
163308617|NCT05063994|589839867|FG002|Treatment|Withdrawal of Consent|1|||
163308618|NCT04490915|589839869|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
163308619|NCT04490915|589839870|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
163308620|NCT04490915|589839869|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
163308621|NCT04490915|589839870|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
163308622|NCT04490915|589839869|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
163308623|NCT04490915|589839870|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
163308624|NCT04490915|589839869|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
163308625|NCT04490915|589839870|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
163308626|NCT04490915|589839869|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
163308627|NCT04490915|589839870|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
163308628|NCT04490915|589839869|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
163308629|NCT04490915|589839870|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
163308630|NCT04490915|589839869|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
163308631|NCT04490915|589839870|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
163308632|NCT00667251|589839872|FG000|Overall Study|Disease progression|232|||
163308633|NCT00667251|589839873|FG001|Overall Study|Disease progression|203|||
163308634|NCT00667251|589839872|FG000|Overall Study|Toxicity|44|||
163308635|NCT00667251|589839873|FG001|Overall Study|Toxicity|23|||
163308636|NCT00667251|589839872|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
163308637|NCT00667251|589839873|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
163308638|NCT00667251|589839872|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
163308639|NCT00667251|589839873|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
163308640|NCT00667251|589839872|FG000|Overall Study|Symptomatic progression|8|||
163308641|NCT00667251|589839873|FG001|Overall Study|Symptomatic progression|4|||
163308642|NCT00667251|589839872|FG000|Overall Study|Death|6|||
163308643|NCT00667251|589839873|FG001|Overall Study|Death|11|||
163308644|NCT00667251|589839872|FG000|Overall Study|Intercurrent illness|5|||
163308645|NCT00667251|589839873|FG001|Overall Study|Intercurrent illness|6|||
163308646|NCT00667251|589839872|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
163308647|NCT00667251|589839873|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
163308648|NCT00667251|589839872|FG000|Overall Study|Randomized not Treated|4|||
163308649|NCT00667251|589839873|FG001|Overall Study|Randomized not Treated|1|||
163308650|NCT03376321|589839874|FG000|Overall Study|Other|5|||
163308651|NCT03376321|589839875|FG001|Overall Study|Other|1|||
163308652|NCT03376321|589839874|FG000|Overall Study|Withdrawal by Subject|8|||
163308653|NCT03376321|589839875|FG001|Overall Study|Withdrawal by Subject|14|||
163308654|NCT03376321|589839874|FG000|Overall Study|Lost to Follow-up|1|||
163308655|NCT03376321|589839875|FG001|Overall Study|Lost to Follow-up|7|||
163308656|NCT03376321|589839874|FG000|Overall Study|Death|4|||
163308657|NCT03376321|589839875|FG001|Overall Study|Death|0|||
163308658|NCT03376321|589839874|FG000|Overall Study|Randomized, not treated|5|||
163308659|NCT03376321|589839875|FG001|Overall Study|Randomized, not treated|3|||
163308660|NCT02995434|589839876|FG000|Overall Study|Adverse Event|1|||
163308661|NCT02995434|589839877|FG001|Overall Study|Adverse Event|0|||
163308662|NCT02995434|589839876|FG000|Overall Study|Withdrawal by Subject|6|||
163308663|NCT02995434|589839877|FG001|Overall Study|Withdrawal by Subject|3|||
163308664|NCT04150718|589839883|FG000|Overall Study|Withdrawal by Subject|2|||
163308665|NCT04150718|589839884|FG001|Overall Study|Withdrawal by Subject|7|||
163308666|NCT04150718|589839885|FG002|Overall Study|Withdrawal by Subject|1|||
163308667|NCT04150718|589839883|FG000|Overall Study|Lost to Follow-up|1|||
163308668|NCT04150718|589839884|FG001|Overall Study|Lost to Follow-up|2|||
163308669|NCT04150718|589839885|FG002|Overall Study|Lost to Follow-up|0|||
163308670|NCT04150718|589839883|FG000|Overall Study|Ineligible|1|||
163308671|NCT04150718|589839884|FG001|Overall Study|Ineligible|0|||
163308672|NCT04150718|589839885|FG002|Overall Study|Ineligible|10|||
163308673|NCT02437318|589839886|FG000|Overall Study|Progressive disease|207|||
163308674|NCT02437318|589839887|FG001|Overall Study|Progressive disease|240|||
163308675|NCT02437318|589839886|FG000|Overall Study|Subject/guardian decision|24|||
163308676|NCT02437318|589839887|FG001|Overall Study|Subject/guardian decision|11|||
163308677|NCT02437318|589839886|FG000|Overall Study|Physician Decision|29|||
163308678|NCT02437318|589839887|FG001|Overall Study|Physician Decision|22|||
163308679|NCT02437318|589839886|FG000|Overall Study|Adverse Event|14|||
163308680|NCT02437318|589839887|FG001|Overall Study|Adverse Event|4|||
163308681|NCT02437318|589839886|FG000|Overall Study|Death|4|||
163308682|NCT02437318|589839887|FG001|Overall Study|Death|4|||
163308683|NCT02437318|589839886|FG000|Overall Study|Protocol deviation|5|||
163308684|NCT02437318|589839887|FG001|Overall Study|Protocol deviation|7|||
163308685|NCT02437318|589839886|FG000|Overall Study|Sponsor decision|1|||
163308686|NCT02437318|589839887|FG001|Overall Study|Sponsor decision|0|||
163308687|NCT06074523|589839889|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
163308688|NCT06074523|589839889|FG000|Overall Study|Withdrawal by Subject|1|||
163308689|NCT02900924|589839893|FG000|Overall Study|Death|52|||
163308690|NCT02900924|589839893|FG000|Overall Study|Lost to Follow-up|4|||
163308691|NCT02900924|589839893|FG000|Overall Study|Withdrawal by Subject|20|||
163308692|NCT02900924|589839893|FG000|Overall Study|Missed Visit|33|||
163308693|NCT04382404|589839896|FG000|Overall Study|Adverse Event|1|||
163308694|NCT04382404|589839896|FG000|Overall Study|Lost to Follow-up|2|||
163308695|NCT03406871|589839901|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
163308696|NCT03406871|589839902|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
163308697|NCT03406871|589839903|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
163308698|NCT03406871|589839901|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
163308699|NCT03406871|589839902|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
163308700|NCT03406871|589839903|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
163308701|NCT03406871|589839901|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
163308702|NCT03406871|589839902|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
163308703|NCT03406871|589839903|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
163308704|NCT03406871|589839901|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
163308705|NCT03406871|589839902|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
163051347|NCT00072410|588895435|FG001|Overall Study|Progressive disease|3|||
163308706|NCT03406871|589839903|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
163308707|NCT03406871|589839901|FG000|Expansion Cohort(Final Analysis)|Death|0|||
163308708|NCT03406871|589839902|FG001|Expansion Cohort(Final Analysis)|Death|1|||
163308709|NCT03406871|589839903|FG002|Expansion Cohort(Final Analysis)|Death|0|||
163308710|NCT03406871|589839901|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
163308711|NCT03406871|589839902|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
163308712|NCT03406871|589839903|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
163308713|NCT05784662|589839908|FG000|Overall Study|Lost to Follow-up|21|||
163308714|NCT05784662|589839909|FG001|Overall Study|Lost to Follow-up|17|||
163308715|NCT04739956|589839910|FG000|Overall Study|Withdrawal by Subject|1|||
163308716|NCT04739956|589839911|FG001|Overall Study|Withdrawal by Subject|1|||
163051348|NCT03160716|588895436|FG000|Overall Study|Lost to Follow-up|1|||
163308717|NCT03519581|589839914|FG000|Overall Study|Lost to Follow-up|3|||
163308718|NCT03519581|589839915|FG001|Overall Study|Lost to Follow-up|2|||
163308719|NCT03519581|589839914|FG000|Overall Study|Adverse Event|5|||
163308720|NCT03519581|589839915|FG001|Overall Study|Adverse Event|2|||
163308721|NCT03519581|589839914|FG000|Overall Study|Withdrawal by Subject|2|||
163308722|NCT03519581|589839915|FG001|Overall Study|Withdrawal by Subject|0|||
163397265|NCT00326209|590166213|FG000|Overall Study|Pregnancy|1|||
163051349|NCT01628848|588895437|FG000|Overall Study|Adverse Event|9|||
163308723|NCT03519581|589839914|FG000|Overall Study|Change to insurance|2|||
163308724|NCT03519581|589839915|FG001|Overall Study|Change to insurance|1|||
163308725|NCT03519581|589839914|FG000|Overall Study|Other|2|||
163397266|NCT02138617|590166214|FG000|Overall Study|Death|1|||
163397267|NCT02138617|590166215|FG001|Overall Study|Death|2|||
163397268|NCT02138617|590166216|FG002|Overall Study|Death|2|||
163397269|NCT02138617|590166214|FG000|Overall Study|Adverse Event|8|||
163397270|NCT02138617|590166215|FG001|Overall Study|Adverse Event|5|||
163397271|NCT02138617|590166216|FG002|Overall Study|Adverse Event|2|||
163397272|NCT02138617|590166214|FG000|Overall Study|Disease Progression|20|||
163397273|NCT02138617|590166215|FG001|Overall Study|Disease Progression|13|||
163397274|NCT02138617|590166216|FG002|Overall Study|Disease Progression|4|||
163397275|NCT02138617|590166214|FG000|Overall Study|Withdrawal by Subject|7|||
163397276|NCT02138617|590166215|FG001|Overall Study|Withdrawal by Subject|10|||
163397277|NCT02138617|590166216|FG002|Overall Study|Withdrawal by Subject|2|||
163397278|NCT02138617|590166214|FG000|Overall Study|other complicating disease|0|||
163397279|NCT02138617|590166215|FG001|Overall Study|other complicating disease|2|||
163397280|NCT02138617|590166216|FG002|Overall Study|other complicating disease|0|||
163397281|NCT02138617|590166214|FG000|Overall Study|Protocol Violation|1|||
163397282|NCT02138617|590166215|FG001|Overall Study|Protocol Violation|0|||
163397283|NCT02138617|590166216|FG002|Overall Study|Protocol Violation|0|||
163397284|NCT02138617|590166214|FG000|Overall Study|Physician Decision|7|||
163397285|NCT02138617|590166215|FG001|Overall Study|Physician Decision|6|||
163201366|NCT02042183|589453028|FG001|Overall Study|Adverse Event|6|||
163201367|NCT02042183|589453027|FG000|Overall Study|Other|3|||
163201368|NCT02042183|589453028|FG001|Overall Study|Other|3|||
163397286|NCT02138617|590166216|FG002|Overall Study|Physician Decision|0|||
163397287|NCT02138617|590166214|FG000|Overall Study|financial reason|0|||
163397288|NCT02138617|590166215|FG001|Overall Study|financial reason|1|||
163397289|NCT02138617|590166216|FG002|Overall Study|financial reason|0|||
163397290|NCT02138617|590166214|FG000|Overall Study|other therapy|3|||
163397291|NCT02138617|590166215|FG001|Overall Study|other therapy|4|||
163397292|NCT02138617|590166216|FG002|Overall Study|other therapy|0|||
163397293|NCT01671111|590166218|FG000|Overall Study|Adverse Event|2|||
163397294|NCT01671111|590166218|FG000|Overall Study|Lack of Efficacy|1|||
163397295|NCT01671111|590166218|FG000|Overall Study|Withdrawal by Subject|2|||
163397296|NCT01671111|590166218|FG000|Overall Study|Physician Decision|1|||
163397297|NCT01671111|590166218|FG000|Overall Study|Other|24|||
163397298|NCT00113074|590166228|FG000|Overall Study|Lost to Follow-up|10|||
163397299|NCT00113074|590166229|FG001|Overall Study|Lost to Follow-up|10|||
163201369|NCT02042183|589453027|FG000|Overall Study|Withdrawal by Subject|21|||
163201370|NCT02042183|589453028|FG001|Overall Study|Withdrawal by Subject|16|||
163201371|NCT02042183|589453027|FG000|Overall Study|Site Terminated by Sponsor|2|||
163201372|NCT02042183|589453028|FG001|Overall Study|Site Terminated by Sponsor|1|||
163201373|NCT02042183|589453027|FG000|Overall Study|Lost to Follow-up|9|||
163201374|NCT02042183|589453028|FG001|Overall Study|Lost to Follow-up|2|||
163201375|NCT01256008|589453029|FG000|Overall Study|Lost to Follow-up|6|||
163201376|NCT01256008|589453030|FG001|Overall Study|Lost to Follow-up|4|||
163201377|NCT01256008|589453031|FG002|Overall Study|Lost to Follow-up|11|||
163201378|NCT01256008|589453029|FG000|Overall Study|Withdrawal by Subject|2|||
163201379|NCT01256008|589453030|FG001|Overall Study|Withdrawal by Subject|3|||
163201380|NCT01256008|589453031|FG002|Overall Study|Withdrawal by Subject|10|||
163201381|NCT00378378|589453034|FG000|Overall Study|Withdrawal by Subject|0|||
163201382|NCT00378378|589453035|FG001|Overall Study|Withdrawal by Subject|1|||
163201383|NCT00378378|589453036|FG002|Overall Study|Withdrawal by Subject|0|||
163201384|NCT00378378|589453034|FG000|Overall Study|Treatment Failure|0|||
163201385|NCT00378378|589453035|FG001|Overall Study|Treatment Failure|0|||
163201386|NCT00378378|589453036|FG002|Overall Study|Treatment Failure|1|||
163201387|NCT00378378|589453034|FG000|Overall Study|Non-compliance with protocol|0|||
163201388|NCT00378378|589453035|FG001|Overall Study|Non-compliance with protocol|0|||
163201389|NCT00378378|589453036|FG002|Overall Study|Non-compliance with protocol|1|||
163201390|NCT01854710|589453037|FG000|Overall Study|Withdrawal by Subject|2|||
163201391|NCT01854710|589453038|FG001|Overall Study|Withdrawal by Subject|1|||
163201392|NCT01854710|589453039|FG002|Overall Study|Withdrawal by Subject|0|||
163201393|NCT01854710|589453040|FG003|Overall Study|Withdrawal by Subject|0|||
163201394|NCT01854710|589453041|FG004|Overall Study|Withdrawal by Subject|0|||
163201395|NCT01854710|589453042|FG005|Overall Study|Withdrawal by Subject|0|||
163201396|NCT01854710|589453037|FG000|Overall Study|CRI procedural error|2|||
163201397|NCT01854710|589453038|FG001|Overall Study|CRI procedural error|2|||
163201398|NCT01854710|589453039|FG002|Overall Study|CRI procedural error|2|||
163201399|NCT01854710|589453040|FG003|Overall Study|CRI procedural error|2|||
163201400|NCT01854710|589453041|FG004|Overall Study|CRI procedural error|2|||
163201401|NCT01854710|589453042|FG005|Overall Study|CRI procedural error|2|||
163201402|NCT03132220|589453047|FG000|Overall Study|Lost to Follow-up|17|||
163201403|NCT03132220|589453048|FG001|Overall Study|Lost to Follow-up|8|||
163201404|NCT03132220|589453047|FG000|Overall Study|Withdrawal by Subject|1|||
163397300|NCT00113074|590166230|FG002|Overall Study|Lost to Follow-up|14|||
163397301|NCT03680911|590166231|FG000|At Home Treatment|Study Termination|3|||
163397302|NCT03680911|590166232|FG001|At Home Treatment|Study Termination|0|||
163397303|NCT03680911|590166231|FG000|At Home Treatment|Lost to Follow-up|0|||
163201405|NCT03132220|589453048|FG001|Overall Study|Withdrawal by Subject|4|||
163201406|NCT00601458|589453052|FG000|Overall Study|Dosing Error|1|||
163201407|NCT00601458|589453053|FG001|Overall Study|Dosing Error|0|||
163201408|NCT00601458|589453054|FG002|Overall Study|Dosing Error|0|||
163201409|NCT00601458|589453052|FG000|Overall Study|Incomplete Data|0|||
163201410|NCT00601458|589453053|FG001|Overall Study|Incomplete Data|2|||
163201411|NCT00601458|589453054|FG002|Overall Study|Incomplete Data|0|||
163201412|NCT00601458|589453052|FG000|Overall Study|Protocol Violation|3|||
163201413|NCT00601458|589453053|FG001|Overall Study|Protocol Violation|2|||
163201414|NCT00601458|589453054|FG002|Overall Study|Protocol Violation|1|||
163201415|NCT00601458|589453052|FG000|Overall Study|Early Termination|0|||
163201416|NCT00601458|589453053|FG001|Overall Study|Early Termination|1|||
163201417|NCT00601458|589453054|FG002|Overall Study|Early Termination|1|||
163201418|NCT00518986|589453055|FG000|Overall Study|Adverse Event|12|||
163201419|NCT00518986|589453056|FG001|Overall Study|Adverse Event|7|||
163201420|NCT00518986|589453055|FG000|Overall Study|Lack of Efficacy|0|||
163201421|NCT00518986|589453056|FG001|Overall Study|Lack of Efficacy|2|||
163201422|NCT00518986|589453055|FG000|Overall Study|Lost to Follow-up|3|||
163201423|NCT00518986|589453056|FG001|Overall Study|Lost to Follow-up|2|||
163201424|NCT00518986|589453055|FG000|Overall Study|Physician Decision|0|||
163201425|NCT00518986|589453056|FG001|Overall Study|Physician Decision|3|||
163201426|NCT00518986|589453055|FG000|Overall Study|Protocol Violation|5|||
163201427|NCT00518986|589453056|FG001|Overall Study|Protocol Violation|7|||
163201428|NCT00518986|589453055|FG000|Overall Study|Withdrawal by Subject|4|||
163201429|NCT00518986|589453056|FG001|Overall Study|Withdrawal by Subject|4|||
163201430|NCT00518986|589453055|FG000|Overall Study|Non-Specific|2|||
163201431|NCT00518986|589453056|FG001|Overall Study|Non-Specific|1|||
163201432|NCT04862585|589453060|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
163201433|NCT04862585|589453061|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
163201434|NCT04862585|589453060|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
163201435|NCT04862585|589453061|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
163201436|NCT04862585|589453060|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
163201437|NCT04862585|589453061|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
163201438|NCT04862585|589453060|FG000|Overall Study|one withdrew without providing a reason|0|||
163201439|NCT04862585|589453061|FG001|Overall Study|one withdrew without providing a reason|1|||
163201440|NCT05288062|589453062|FG000|Overall Study|Ineligible|0|||
163201441|NCT05288062|589453063|FG001|Overall Study|Ineligible|0|||
163201442|NCT05288062|589453064|FG002|Overall Study|Ineligible|1|||
163201443|NCT05288062|589453065|FG003|Overall Study|Ineligible|0|||
163201444|NCT05288062|589453062|FG000|Overall Study|Withdrawal by Subject|0|||
163201445|NCT05288062|589453063|FG001|Overall Study|Withdrawal by Subject|0|||
163201446|NCT05288062|589453064|FG002|Overall Study|Withdrawal by Subject|1|||
163201447|NCT05288062|589453065|FG003|Overall Study|Withdrawal by Subject|0|||
163201448|NCT02099708|589453067|FG000|Overall Study|Data Not Available|30|||
163201449|NCT02099708|589453067|FG000|Overall Study|Lost to Follow-up|141|||
163201450|NCT02099708|589453067|FG000|Overall Study|Other|29|||
163201451|NCT05229406|589453068|FG000|Overall Study|Withdrawal by Subject|1|||
163201452|NCT05229406|589453069|FG001|Overall Study|Withdrawal by Subject|2|||
163201453|NCT01930123|589453070|FG000|Overall Study|Adverse Event|1|||
163201454|NCT01930123|589453071|FG001|Overall Study|Adverse Event|0|||
163201455|NCT01930123|589453070|FG000|Overall Study|Physician Decision|21|||
163201456|NCT01930123|589453071|FG001|Overall Study|Physician Decision|8|||
163201457|NCT01930123|589453070|FG000|Overall Study|Withdrawal by Subject|1|||
163201458|NCT01930123|589453071|FG001|Overall Study|Withdrawal by Subject|0|||
163201459|NCT00729651|589453074|FG000|Overall Study|Withdrawal by Subject|5|||
163201460|NCT00729651|589453075|FG001|Overall Study|Withdrawal by Subject|6|||
163201461|NCT00729651|589453074|FG000|Overall Study|Lost to Follow-up|5|||
163201462|NCT00729651|589453075|FG001|Overall Study|Lost to Follow-up|4|||
163201463|NCT00729651|589453074|FG000|Overall Study|Protocol Violation|0|||
163201464|NCT00729651|589453075|FG001|Overall Study|Protocol Violation|1|||
163308726|NCT03519581|589839915|FG001|Overall Study|Other|4|||
163308727|NCT03110315|589839917|FG000|Overall Study|Withdrawal by Subject|1|||
163201465|NCT00729651|589453074|FG000|Overall Study|Adverse Event|7|||
163201466|NCT00729651|589453075|FG001|Overall Study|Adverse Event|3|||
163201467|NCT00729651|589453074|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
163201468|NCT00729651|589453075|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
163201469|NCT00729651|589453074|FG000|Overall Study|Subject's private reason|2|||
163201470|NCT00729651|589453075|FG001|Overall Study|Subject's private reason|0|||
163308728|NCT03110315|589839918|FG001|Overall Study|Withdrawal by Subject|0|||
163051350|NCT01628848|588895438|FG001|Overall Study|Adverse Event|7|||
163201471|NCT03310021|589453076|FG000|Overall Study|Withdrawal by Subject|0|||
163201472|NCT03310021|589453077|FG001|Overall Study|Withdrawal by Subject|0|||
163201473|NCT03310021|589453078|FG002|Overall Study|Withdrawal by Subject|0|||
163201474|NCT03310021|589453079|FG003|Overall Study|Withdrawal by Subject|0|||
163308729|NCT05371652|589839922|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
163308730|NCT05371652|589839922|FG000|Overall Study|Withdrawal by Subject|12|||
163308731|NCT05371652|589839922|FG000|Overall Study|Adverse Event|1|||
163308732|NCT05371652|589839922|FG000|Overall Study|Other|11|||
163308733|NCT05256706|589839923|FG000|Overall Study|Lost to Follow-up|9|||
163308734|NCT05256706|589839924|FG001|Overall Study|Lost to Follow-up|3|||
163308735|NCT05256706|589839923|FG000|Overall Study|Withdrawal by Subject|7|||
163308736|NCT05256706|589839924|FG001|Overall Study|Withdrawal by Subject|11|||
163308737|NCT05256706|589839923|FG000|Overall Study|Screen Failures|3|||
163308738|NCT05256706|589839924|FG001|Overall Study|Screen Failures|0|||
163308739|NCT04410042|589839926|FG000|Overall Study|Not Eligible|1|||
163308740|NCT04410042|589839927|FG001|Overall Study|Not Eligible|1|||
163308741|NCT01494662|589839930|FG000|Overall Study|Withdrawal by Subject|0|||
163308742|NCT01494662|589839931|FG001|Overall Study|Withdrawal by Subject|0|||
163308743|NCT01494662|589839932|FG002|Overall Study|Withdrawal by Subject|1|||
163308744|NCT01494662|589839933|FG003|Overall Study|Withdrawal by Subject|0|||
163308745|NCT01494662|589839934|FG004|Overall Study|Withdrawal by Subject|0|||
163308746|NCT01494662|589839935|FG005|Overall Study|Withdrawal by Subject|0|||
163308747|NCT01494662|589839936|FG006|Overall Study|Withdrawal by Subject|0|||
163308748|NCT01494662|589839930|FG000|Overall Study|Physician Decision|0|||
163308749|NCT01494662|589839931|FG001|Overall Study|Physician Decision|0|||
163308750|NCT01494662|589839932|FG002|Overall Study|Physician Decision|1|||
163308751|NCT01494662|589839933|FG003|Overall Study|Physician Decision|0|||
163308752|NCT01494662|589839934|FG004|Overall Study|Physician Decision|0|||
163308753|NCT01494662|589839935|FG005|Overall Study|Physician Decision|0|||
163308754|NCT01494662|589839936|FG006|Overall Study|Physician Decision|0|||
163308755|NCT04322643|589839937|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
163308756|NCT05486078|589839940|FG000|Overall Study|4 drop out and one withdrawn|5|||
163397304|NCT03680911|590166232|FG001|At Home Treatment|Lost to Follow-up|1|||
163397305|NCT03680911|590166231|FG000|At Home Treatment|Withdrawal by Subject|0|||
163397306|NCT03680911|590166232|FG001|At Home Treatment|Withdrawal by Subject|2|||
163397307|NCT03680911|590166231|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
163397308|NCT03680911|590166232|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
163397309|NCT04556136|590166236|FG000|Overall Study|Lost to Follow-up|6|||
163397310|NCT04556136|590166237|FG001|Overall Study|Lost to Follow-up|6|||
163397311|NCT04556136|590166236|FG000|Overall Study|Physician Decision|2|||
163397312|NCT04556136|590166237|FG001|Overall Study|Physician Decision|1|||
162964248|NCT02554877|588569716|FG001|Overall Study|Insufficient clinical response|0|||
162964249|NCT02554877|588569717|FG002|Overall Study|Insufficient clinical response|0|||
162964250|NCT02554877|588569718|FG003|Overall Study|Insufficient clinical response|0|||
162964251|NCT02554877|588569715|FG000|Overall Study|No longer willing to participate|0|||
162964252|NCT02554877|588569716|FG001|Overall Study|No longer willing to participate|2|||
163397313|NCT04556136|590166236|FG000|Overall Study|Withdrawal by Subject|2|||
163397314|NCT04556136|590166237|FG001|Overall Study|Withdrawal by Subject|1|||
163397315|NCT00935272|590166240|FG000|Overall Study|Lost to Follow-up|10|||
163397316|NCT00935272|590166241|FG001|Overall Study|Lost to Follow-up|3|||
163397317|NCT00935272|590166240|FG000|Overall Study|Withdrawal by Subject|8|||
163397318|NCT00935272|590166241|FG001|Overall Study|Withdrawal by Subject|2|||
163397319|NCT00935272|590166240|FG000|Overall Study|Physician Decision|1|||
163397320|NCT00935272|590166241|FG001|Overall Study|Physician Decision|0|||
163397321|NCT00935272|590166240|FG000|Overall Study|Protocol Violation|0|||
163397322|NCT00935272|590166241|FG001|Overall Study|Protocol Violation|1|||
162964253|NCT02554877|588569717|FG002|Overall Study|No longer willing to participate|2|||
162964254|NCT02554877|588569718|FG003|Overall Study|No longer willing to participate|0|||
162964255|NCT03827395|588569719|FG000|Overall Study|Lost to Follow-up|1|||
162964256|NCT03827395|588569720|FG001|Overall Study|Lost to Follow-up|0|||
162964257|NCT03827395|588569719|FG000|Overall Study|Protocol Violation|1|||
162964258|NCT03827395|588569720|FG001|Overall Study|Protocol Violation|0|||
163201475|NCT03310021|589453080|FG004|Overall Study|Withdrawal by Subject|0|||
163201476|NCT03310021|589453081|FG005|Overall Study|Withdrawal by Subject|0|||
163201477|NCT03310021|589453082|FG006|Overall Study|Withdrawal by Subject|1|||
163201478|NCT03310021|589453083|FG007|Overall Study|Withdrawal by Subject|0|||
163201479|NCT03310021|589453084|FG008|Overall Study|Withdrawal by Subject|0|||
163201480|NCT03310021|589453085|FG009|Overall Study|Withdrawal by Subject|0|||
163201481|NCT03310021|589453086|FG010|Overall Study|Withdrawal by Subject|0|||
163201482|NCT03310021|589453087|FG011|Overall Study|Withdrawal by Subject|0|||
162964259|NCT03827395|588569719|FG000|Overall Study|Became ineligible after enrollment|1|||
163201483|NCT03310021|589453088|FG012|Overall Study|Withdrawal by Subject|0|||
163201484|NCT03310021|589453089|FG013|Overall Study|Withdrawal by Subject|0|||
163308757|NCT03302494|589839941|FG000|Overall Study|Other|7|||
163308758|NCT03302494|589839942|FG001|Overall Study|Other|4|||
163308759|NCT03302494|589839943|FG002|Overall Study|Other|6|||
163308760|NCT03302494|589839941|FG000|Overall Study|Withdrawal by Subject|10|||
163308761|NCT03302494|589839942|FG001|Overall Study|Withdrawal by Subject|2|||
163308762|NCT03302494|589839943|FG002|Overall Study|Withdrawal by Subject|9|||
163397323|NCT03492554|590166242|FG000|Overall Study|Protocol Violation|0|||
163397324|NCT03492554|590166243|FG001|Overall Study|Protocol Violation|14|||
163308763|NCT03302494|589839941|FG000|Overall Study|Study Terminated by Sponsor|32|||
163308764|NCT03302494|589839942|FG001|Overall Study|Study Terminated by Sponsor|29|||
163308765|NCT03302494|589839943|FG002|Overall Study|Study Terminated by Sponsor|30|||
163308766|NCT03302494|589839941|FG000|Overall Study|Physician Decision|1|||
163308767|NCT03302494|589839942|FG001|Overall Study|Physician Decision|0|||
163308768|NCT03302494|589839943|FG002|Overall Study|Physician Decision|1|||
163308769|NCT03302494|589839941|FG000|Overall Study|Lost to Follow-up|1|||
163397325|NCT01478360|590166244|FG000|Overall Study|Lost to Follow-up|1|||
163308770|NCT03302494|589839942|FG001|Overall Study|Lost to Follow-up|3|||
163397326|NCT01478360|590166245|FG001|Overall Study|Lost to Follow-up|0|||
163397327|NCT01478360|590166244|FG000|Overall Study|Adverse Event|0|||
163397328|NCT01478360|590166245|FG001|Overall Study|Adverse Event|1|||
163397329|NCT01478360|590166244|FG000|Overall Study|Administrative problems|1|||
163397330|NCT01478360|590166245|FG001|Overall Study|Administrative problems|2|||
163397331|NCT04340557|590166249|FG000|Overall Study|Transferred to ICU and/or death|1|||
163397332|NCT04340557|590166250|FG001|Overall Study|Transferred to ICU and/or death|2|||
163397333|NCT01221727|590166251|FG000|Overall Study|Physician Decision|2|||
163397334|NCT01221727|590166252|FG001|Overall Study|Physician Decision|0|||
163397335|NCT01221727|590166251|FG000|Overall Study|Withdrawal by Subject|1|||
163397336|NCT01221727|590166252|FG001|Overall Study|Withdrawal by Subject|1|||
163397337|NCT02566577|590166253|FG000|Overall Study|Withdrawal by Subject|1|||
163397338|NCT02566577|590166254|FG001|Overall Study|Withdrawal by Subject|1|||
163397339|NCT02566577|590166253|FG000|Overall Study|Equipment failure|1|||
163397340|NCT02566577|590166254|FG001|Overall Study|Equipment failure|1|||
163397341|NCT02566577|590166253|FG000|Overall Study|Physical limitation|1|||
163397342|NCT02566577|590166254|FG001|Overall Study|Physical limitation|0|||
163308771|NCT03302494|589839943|FG002|Overall Study|Lost to Follow-up|3|||
163308772|NCT03302494|589839941|FG000|Overall Study|Death|13|||
163308773|NCT03302494|589839942|FG001|Overall Study|Death|11|||
163308774|NCT03302494|589839943|FG002|Overall Study|Death|4|||
163308775|NCT03302494|589839941|FG000|Overall Study|Adverse Event|1|||
163308776|NCT03302494|589839942|FG001|Overall Study|Adverse Event|2|||
163308777|NCT03302494|589839943|FG002|Overall Study|Adverse Event|0|||
163308778|NCT03302494|589839941|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
163308779|NCT03302494|589839942|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
163308780|NCT03302494|589839943|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
163397343|NCT00529451|590166255|FG000|Overall Study|Subject withdrew consent|16|||
163397344|NCT00529451|590166256|FG001|Overall Study|Subject withdrew consent|21|||
163397345|NCT00529451|590166257|FG002|Overall Study|Subject withdrew consent|13|||
163397346|NCT00529451|590166258|FG003|Overall Study|Subject withdrew consent|12|||
163397347|NCT00529451|590166255|FG000|Overall Study|Adverse Event|9|||
163397348|NCT00529451|590166256|FG001|Overall Study|Adverse Event|16|||
163397349|NCT00529451|590166257|FG002|Overall Study|Adverse Event|14|||
163397350|NCT00529451|590166258|FG003|Overall Study|Adverse Event|8|||
163397351|NCT00529451|590166255|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
163397352|NCT00529451|590166256|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
163397353|NCT00529451|590166257|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
163397354|NCT00529451|590166258|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
163397355|NCT00529451|590166255|FG000|Overall Study|Lost to Follow-up|4|||
163397356|NCT00529451|590166256|FG001|Overall Study|Lost to Follow-up|7|||
163397357|NCT00529451|590166257|FG002|Overall Study|Lost to Follow-up|4|||
163397358|NCT00529451|590166258|FG003|Overall Study|Lost to Follow-up|4|||
163201485|NCT03310021|589453090|FG014|Overall Study|Withdrawal by Subject|0|||
163201486|NCT03310021|589453091|FG015|Overall Study|Withdrawal by Subject|0|||
163201487|NCT03310021|589453092|FG016|Overall Study|Withdrawal by Subject|0|||
163201488|NCT03310021|589453093|FG017|Overall Study|Withdrawal by Subject|0|||
163201489|NCT03310021|589453094|FG018|Overall Study|Withdrawal by Subject|0|||
163201490|NCT03310021|589453095|FG019|Overall Study|Withdrawal by Subject|0|||
163201491|NCT03310021|589453076|FG000|Overall Study|Lost to Follow-up|0|||
162964260|NCT03827395|588569720|FG001|Overall Study|Became ineligible after enrollment|2|||
163201492|NCT03310021|589453077|FG001|Overall Study|Lost to Follow-up|0|||
163201493|NCT03310021|589453078|FG002|Overall Study|Lost to Follow-up|0|||
163308781|NCT05134233|589839944|FG000|Overall Study|Pregnancy|1|||
163308782|NCT05134233|589839944|FG000|Overall Study|MEP value too low|2|||
163201494|NCT03310021|589453079|FG003|Overall Study|Lost to Follow-up|0|||
163201495|NCT03310021|589453080|FG004|Overall Study|Lost to Follow-up|0|||
163201496|NCT03310021|589453081|FG005|Overall Study|Lost to Follow-up|0|||
163201497|NCT03310021|589453082|FG006|Overall Study|Lost to Follow-up|0|||
163201498|NCT03310021|589453083|FG007|Overall Study|Lost to Follow-up|0|||
163201499|NCT03310021|589453084|FG008|Overall Study|Lost to Follow-up|0|||
163201500|NCT03310021|589453085|FG009|Overall Study|Lost to Follow-up|0|||
163201501|NCT03310021|589453086|FG010|Overall Study|Lost to Follow-up|1|||
163201502|NCT03310021|589453087|FG011|Overall Study|Lost to Follow-up|0|||
163308783|NCT05134233|589839944|FG000|Overall Study|Lost to Follow-up|1|||
163308784|NCT03978871|589839945|FG000|Overall Study|Lost to Follow-up|11|||
163308785|NCT03978871|589839946|FG001|Overall Study|Lost to Follow-up|12|||
163308786|NCT05710107|589839947|FG000|Overall Study|Withdrawal by Subject|1|||
163308787|NCT05710107|589839948|FG001|Overall Study|Withdrawal by Subject|1|||
163308788|NCT05710107|589839947|FG000|Overall Study|Lost to Follow-up|8|||
163308789|NCT05710107|589839948|FG001|Overall Study|Lost to Follow-up|9|||
163308790|NCT05710107|589839947|FG000|Overall Study|Unable to place assigned block|2|||
163308791|NCT05710107|589839948|FG001|Overall Study|Unable to place assigned block|0|||
163308792|NCT05710107|589839947|FG000|Overall Study|Withdrawn by study team|0|||
163308793|NCT05710107|589839948|FG001|Overall Study|Withdrawn by study team|1|||
163308794|NCT04166773|589839949|FG000|Overall Study|Adverse Event|2|||
163308795|NCT04166773|589839950|FG001|Overall Study|Adverse Event|0|||
163308796|NCT04166773|589839951|FG002|Overall Study|Adverse Event|2|||
163308797|NCT04166773|589839952|FG003|Overall Study|Adverse Event|1|||
163308798|NCT04166773|589839949|FG000|Overall Study|Lost to Follow-up|4|||
163308799|NCT04166773|589839950|FG001|Overall Study|Lost to Follow-up|2|||
163308800|NCT04166773|589839951|FG002|Overall Study|Lost to Follow-up|1|||
163308801|NCT04166773|589839952|FG003|Overall Study|Lost to Follow-up|3|||
163201503|NCT03310021|589453088|FG012|Overall Study|Lost to Follow-up|0|||
163201504|NCT03310021|589453089|FG013|Overall Study|Lost to Follow-up|0|||
163201505|NCT03310021|589453090|FG014|Overall Study|Lost to Follow-up|0|||
163201506|NCT03310021|589453091|FG015|Overall Study|Lost to Follow-up|0|||
163201507|NCT03310021|589453092|FG016|Overall Study|Lost to Follow-up|0|||
163201508|NCT03310021|589453093|FG017|Overall Study|Lost to Follow-up|0|||
163201509|NCT03310021|589453094|FG018|Overall Study|Lost to Follow-up|0|||
163201510|NCT03310021|589453095|FG019|Overall Study|Lost to Follow-up|0|||
163201511|NCT01874054|589453096|FG000|Overall Study|Withdrawal by Subject|3|||
163201512|NCT01874054|589453096|FG000|Overall Study|Study Termination by Sponsor|42|||
163201513|NCT01874054|589453096|FG000|Overall Study|Lost to Follow-up|5|||
163201514|NCT01874054|589453096|FG000|Overall Study|Death|5|||
163201515|NCT00702923|589453097|FG000|Overall Study|Adverse Event|1|||
163201516|NCT03953820|589453098|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
163308802|NCT04166773|589839949|FG000|Overall Study|Physician Decision|0|||
163308803|NCT04166773|589839950|FG001|Overall Study|Physician Decision|0|||
163308804|NCT04166773|589839951|FG002|Overall Study|Physician Decision|0|||
163308805|NCT04166773|589839952|FG003|Overall Study|Physician Decision|1|||
163308806|NCT04166773|589839949|FG000|Overall Study|Withdrawal by Subject|1|||
163308807|NCT04166773|589839950|FG001|Overall Study|Withdrawal by Subject|1|||
163308808|NCT04166773|589839951|FG002|Overall Study|Withdrawal by Subject|2|||
163308809|NCT04166773|589839952|FG003|Overall Study|Withdrawal by Subject|5|||
163308810|NCT04072822|589839953|FG000|Treatment|Adverse Event|9|||
163308811|NCT04072822|589839954|FG001|Treatment|Adverse Event|5|||
163308812|NCT04072822|589839953|FG000|Treatment|Met Stopping Criteria|13|||
163308813|NCT04072822|589839954|FG001|Treatment|Met Stopping Criteria|24|||
163308814|NCT04072822|589839953|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
163308815|NCT04072822|589839954|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
163308816|NCT04072822|589839953|FG000|Treatment|Withdrawal by Subject|0|||
163308817|NCT04072822|589839954|FG001|Treatment|Withdrawal by Subject|2|||
163308818|NCT04072822|589839953|FG000|Treatment|Death|0|||
163308819|NCT04072822|589839954|FG001|Treatment|Death|2|||
163308820|NCT04072822|589839953|FG000|Treatment|Lost to Follow-up|11|||
163201517|NCT03953820|589453099|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
163201518|NCT03953820|589453100|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
163201519|NCT03953820|589453098|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
163201520|NCT03953820|589453099|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
163201521|NCT03953820|589453100|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
163201522|NCT01534962|589453101|FG000|Overall Study|Randomized but did not start treatment|2|||
163308821|NCT04072822|589839954|FG001|Treatment|Lost to Follow-up|3|||
163308822|NCT04072822|589839953|FG000|Treatment|Physician Decision|1|||
163308823|NCT04072822|589839954|FG001|Treatment|Physician Decision|0|||
163308824|NCT04072822|589839953|FG000|Treatment|Other|7|||
163308825|NCT04072822|589839954|FG001|Treatment|Other|9|||
163308826|NCT04072822|589839953|FG000|Follow-up|Withdrawal by Subject|1|||
163308827|NCT04072822|589839954|FG001|Follow-up|Withdrawal by Subject|0|||
163308828|NCT04072822|589839953|FG000|Follow-up|Lost to Follow-up|5|||
163308829|NCT04072822|589839954|FG001|Follow-up|Lost to Follow-up|4|||
163308830|NCT03269136|589839955|FG000|Part 1: Dose Escalation|Other|0|||
163201523|NCT01534962|589453102|FG001|Overall Study|Randomized but did not start treatment|0|||
163201524|NCT01534962|589453103|FG002|Overall Study|Randomized but did not start treatment|0|||
163201525|NCT01534962|589453104|FG003|Overall Study|Randomized but did not start treatment|1|||
163201526|NCT01534962|589453101|FG000|Overall Study|Discontinued at AF recurrence|35|||
163201527|NCT01534962|589453102|FG001|Overall Study|Discontinued at AF recurrence|26|||
163201528|NCT01534962|589453103|FG002|Overall Study|Discontinued at AF recurrence|24|||
163201529|NCT01534962|589453104|FG003|Overall Study|Discontinued at AF recurrence|31|||
163201530|NCT00880009|589453105|FG000|Overall Study|Study terminated by sponsor|14|||
163397359|NCT00529451|590166255|FG000|Overall Study|Protocol deviation|1|||
163201531|NCT00880009|589453105|FG000|Overall Study|Withdrawal by Subject|1|||
163201532|NCT00880009|589453105|FG000|Overall Study|Protocol Violation|1|||
163201533|NCT01128842|589453108|FG000|Overall Study|Adverse Event|1|||
163201534|NCT01128842|589453108|FG000|Overall Study|Disease Progression|6|||
163201535|NCT02378961|589453109|FG000|Overall Study|Lack of Efficacy|4|||
163201536|NCT02378961|589453110|FG001|Overall Study|Lack of Efficacy|2|||
163201537|NCT02378961|589453111|FG002|Overall Study|Lack of Efficacy|0|||
163201538|NCT02378961|589453112|FG003|Overall Study|Lack of Efficacy|1|||
163201539|NCT02378961|589453109|FG000|Overall Study|Death|0|||
163201540|NCT02378961|589453110|FG001|Overall Study|Death|0|||
163201541|NCT02378961|589453111|FG002|Overall Study|Death|1|||
163201542|NCT02378961|589453112|FG003|Overall Study|Death|0|||
163201543|NCT00390468|589453113|FG000|Overall Study|Protocol Violation|2|||
163201544|NCT00390468|589453113|FG000|Overall Study|Lack of Efficacy|1|||
163201545|NCT01049308|589453114|FG000|Pill Counts|Withdrawal by Subject|83|||
163201546|NCT01348165|589453116|FG000|Overall Study|Adverse Event|0|||
163201547|NCT01348165|589453117|FG001|Overall Study|Adverse Event|0|||
163201548|NCT01348165|589453118|FG002|Overall Study|Adverse Event|0|||
163201549|NCT01348165|589453119|FG003|Overall Study|Adverse Event|0|||
163201550|NCT01348165|589453120|FG004|Overall Study|Adverse Event|0|||
163201551|NCT01348165|589453121|FG005|Overall Study|Adverse Event|0|||
163201552|NCT01348165|589453122|FG006|Overall Study|Adverse Event|1|||
163201553|NCT01411774|589455447|FG000|Overall Study|Withdrawal by Subject|0|||
163201554|NCT01411774|589455448|FG001|Overall Study|Withdrawal by Subject|3|||
163201555|NCT03808545|589455449|FG000|Overall Study|Withdrawal by Subject|1|||
163201556|NCT03808545|589455450|FG001|Overall Study|Withdrawal by Subject|1|||
163201557|NCT03292588|589455451|FG000|Overall Study|Death|1|||
163201558|NCT03292588|589455452|FG001|Overall Study|Death|0|||
163201559|NCT03292588|589455451|FG000|Overall Study|Lost to Follow-up|12|||
163201560|NCT03292588|589455452|FG001|Overall Study|Lost to Follow-up|16|||
163201561|NCT03292588|589455451|FG000|Overall Study|Physician Decision|0|||
163201562|NCT03292588|589455452|FG001|Overall Study|Physician Decision|1|||
163201563|NCT03292588|589455451|FG000|Overall Study|Withdrawal by Subject|4|||
163201564|NCT03292588|589455452|FG001|Overall Study|Withdrawal by Subject|4|||
163201565|NCT03292588|589455451|FG000|Overall Study|Move out of town|1|||
163201566|NCT03292588|589455452|FG001|Overall Study|Move out of town|0|||
163201567|NCT03292588|589455451|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
163201568|NCT03292588|589455452|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
163201569|NCT05526716|589455458|FG000|Overall Study|Death|1|||
163201570|NCT05526716|589455459|FG001|Overall Study|Death|2|||
163201571|NCT05526716|589455458|FG000|Overall Study|Lost to Follow-up|17|||
163201572|NCT05526716|589455459|FG001|Overall Study|Lost to Follow-up|15|||
163201573|NCT05526716|589455458|FG000|Overall Study|Physician Decision|0|||
163201574|NCT05526716|589455459|FG001|Overall Study|Physician Decision|1|||
163201575|NCT05526716|589455458|FG000|Overall Study|Randomized by mistake without study treatment|0|||
163201576|NCT05526716|589455459|FG001|Overall Study|Randomized by mistake without study treatment|1|||
163201577|NCT05526716|589455458|FG000|Overall Study|Withdrawal by Subject|12|||
163201578|NCT05526716|589455459|FG001|Overall Study|Withdrawal by Subject|12|||
163201579|NCT05526716|589455458|FG000|Overall Study|Not reported|0|||
163201580|NCT05526716|589455459|FG001|Overall Study|Not reported|2|||
163201581|NCT04932096|589455462|FG000|Overall Study|Withdrawal by Subject|1|||
163201582|NCT04932096|589455463|FG001|Overall Study|Withdrawal by Subject|1|||
163201583|NCT04932096|589455462|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
163201584|NCT04932096|589455463|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
163201585|NCT01438957|589455464|FG000|Overall Study|Physician Decision|1|||
163201586|NCT01438957|589455465|FG001|Overall Study|Physician Decision|1|||
163201587|NCT01438957|589455466|FG002|Overall Study|Physician Decision|0|||
163201588|NCT01438957|589455467|FG003|Overall Study|Physician Decision|1|||
163201589|NCT01438957|589455468|FG004|Overall Study|Physician Decision|0|||
163201590|NCT03902574|589455470|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
163201591|NCT03902574|589455471|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
163201592|NCT03902574|589455472|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
163201593|NCT00133952|589455474|FG000|Overall Study|Adverse Event|1|||
163201594|NCT00133952|589455475|FG001|Overall Study|Adverse Event|2|||
163201595|NCT00133952|589455474|FG000|Overall Study|Death|3|||
163308831|NCT03269136|589839956|FG001|Part 1: Dose Escalation|Other|0|||
163308832|NCT03269136|589839957|FG002|Part 1: Dose Escalation|Other|0|||
163308833|NCT03269136|589839958|FG003|Part 1: Dose Escalation|Other|0|||
163308834|NCT03269136|589839959|FG004|Part 1: Dose Escalation|Other|0|||
163308835|NCT03269136|589839960|FG005|Part 1: Dose Escalation|Other|0|||
163308836|NCT03269136|589839961|FG006|Part 1: Dose Escalation|Other|0|||
163201596|NCT00133952|589455475|FG001|Overall Study|Death|2|||
163201597|NCT00133952|589455474|FG000|Overall Study|Lost to Follow-up|9|||
163201598|NCT00133952|589455475|FG001|Overall Study|Lost to Follow-up|14|||
163201599|NCT00133952|589455474|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
163201600|NCT00133952|589455475|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
163201601|NCT00133952|589455474|FG000|Overall Study|Protocol Violation|1|||
163201602|NCT00133952|589455475|FG001|Overall Study|Protocol Violation|1|||
163201603|NCT00133952|589455474|FG000|Overall Study|Withdrawal by Subject|20|||
163201604|NCT00133952|589455475|FG001|Overall Study|Withdrawal by Subject|4|||
163201605|NCT00133952|589455474|FG000|Overall Study|Physician Decision|4|||
163201606|NCT00133952|589455475|FG001|Overall Study|Physician Decision|3|||
163201607|NCT00133952|589455474|FG000|Overall Study|Sponsor Decision|0|||
163201608|NCT00133952|589455475|FG001|Overall Study|Sponsor Decision|1|||
163201609|NCT02101060|589455481|FG000|Overall Study|Adverse Event|1|||
163201610|NCT02101060|589455482|FG001|Overall Study|Adverse Event|0|||
163201611|NCT02101060|589455481|FG000|Overall Study|Withdrawal by Subject|1|||
163201612|NCT02101060|589455482|FG001|Overall Study|Withdrawal by Subject|1|||
163201613|NCT02101060|589455481|FG000|Overall Study|Lost to Follow-up|3|||
163201614|NCT02101060|589455482|FG001|Overall Study|Lost to Follow-up|3|||
163201615|NCT01484197|589455485|FG000|Treatment Period 1|Adverse Event|1|||
163201616|NCT01484197|589455486|FG001|Treatment Period 1|Adverse Event|0|||
163201617|NCT01484197|589455487|FG002|Treatment Period 1|Adverse Event|0|||
163201618|NCT01484197|589455488|FG003|Treatment Period 1|Adverse Event|0|||
163201619|NCT01484197|589455485|FG000|Treatment Period 2|Subject withdrew consent|0|||
163201620|NCT01484197|589455486|FG001|Treatment Period 2|Subject withdrew consent|0|||
163201621|NCT01484197|589455487|FG002|Treatment Period 2|Subject withdrew consent|0|||
163201622|NCT01484197|589455488|FG003|Treatment Period 2|Subject withdrew consent|1|||
163201623|NCT02244606|589455489|FG000|Overall Study|Adverse Event|0|||
163201624|NCT02244606|589455490|FG001|Overall Study|Adverse Event|1|||
163201625|NCT02244606|589455491|FG002|Overall Study|Adverse Event|1|||
163201626|NCT02244606|589455492|FG003|Overall Study|Adverse Event|0|||
163201627|NCT02244606|589455489|FG000|Overall Study|Lost to Follow-up|2|||
163201628|NCT02244606|589455490|FG001|Overall Study|Lost to Follow-up|2|||
163201629|NCT02244606|589455491|FG002|Overall Study|Lost to Follow-up|1|||
163201630|NCT02244606|589455492|FG003|Overall Study|Lost to Follow-up|0|||
163201631|NCT02244606|589455489|FG000|Overall Study|Protocol Violation|0|||
163201632|NCT02244606|589455490|FG001|Overall Study|Protocol Violation|0|||
163201633|NCT02244606|589455491|FG002|Overall Study|Protocol Violation|0|||
163201634|NCT02244606|589455492|FG003|Overall Study|Protocol Violation|1|||
163201635|NCT02244606|589455489|FG000|Overall Study|Withdrawal by Subject|1|||
163201636|NCT02244606|589455490|FG001|Overall Study|Withdrawal by Subject|1|||
162964261|NCT01537887|588569721|FG000|Period 1|Physician Decision|0|||
163201637|NCT02244606|589455491|FG002|Overall Study|Withdrawal by Subject|0|||
163201638|NCT02244606|589455492|FG003|Overall Study|Withdrawal by Subject|0|||
163201639|NCT02244606|589455489|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
163201640|NCT02244606|589455490|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
163201641|NCT02244606|589455491|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
163201642|NCT02244606|589455492|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
163201643|NCT02321800|589455498|FG000|Overall Study|Withdrawal by Subject|3|||
163201644|NCT02321800|589455499|FG001|Overall Study|Withdrawal by Subject|3|||
163201645|NCT02321800|589455498|FG000|Overall Study|Death|1|||
163201646|NCT02321800|589455499|FG001|Overall Study|Death|0|||
163201647|NCT02321800|589455498|FG000|Overall Study|Protocol Violation|1|||
163201648|NCT02321800|589455499|FG001|Overall Study|Protocol Violation|0|||
163201649|NCT02321800|589455498|FG000|Overall Study|Lost to Follow-up|10|||
163201650|NCT02321800|589455499|FG001|Overall Study|Lost to Follow-up|4|||
163201651|NCT02321800|589455498|FG000|Overall Study|Adverse Event|2|||
163308837|NCT03269136|589839962|FG007|Part 1: Dose Escalation|Other|0|||
163201652|NCT02321800|589455499|FG001|Overall Study|Adverse Event|3|||
163201653|NCT02321800|589455498|FG000|Overall Study|Other, Miscellaneous|3|||
163201654|NCT02321800|589455499|FG001|Overall Study|Other, Miscellaneous|1|||
163201655|NCT00982878|589455503|FG000|Overall Study|Physician Decision|1|||
163201656|NCT00642460|589455507|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
163201657|NCT00642460|589455508|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
163201658|NCT00642460|589455509|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
163201659|NCT00642460|589455510|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
163201660|NCT00642460|589455511|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
163308838|NCT03269136|589839963|FG008|Part 1: Dose Escalation|Other|0|||
162964262|NCT01537887|588569722|FG001|Period 1|Physician Decision|0|||
163201661|NCT00642460|589455512|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
163201662|NCT00642460|589455507|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
163201663|NCT00642460|589455508|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
163201664|NCT00642460|589455509|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
163201665|NCT00642460|589455510|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
163201666|NCT00642460|589455511|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
163201667|NCT00642460|589455512|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
163201668|NCT00642460|589455507|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
163201669|NCT00642460|589455508|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
163201670|NCT00642460|589455509|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
163201671|NCT00642460|589455510|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
163201672|NCT00642460|589455511|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
163201673|NCT00642460|589455512|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
163201674|NCT00642460|589455507|FG000|Part II: Open-Label Up to Week 92|Death|0|||
163201675|NCT00642460|589455508|FG001|Part II: Open-Label Up to Week 92|Death|1|||
163201676|NCT00642460|589455509|FG002|Part II: Open-Label Up to Week 92|Death|0|||
163201677|NCT00642460|589455510|FG003|Part II: Open-Label Up to Week 92|Death|2|||
163201678|NCT00642460|589455511|FG004|Part II: Open-Label Up to Week 92|Death|0|||
163201679|NCT00642460|589455512|FG005|Part II: Open-Label Up to Week 92|Death|0|||
163201680|NCT00642460|589455507|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
163201681|NCT00642460|589455508|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
163201682|NCT00642460|589455509|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
163201683|NCT00642460|589455510|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
163201684|NCT00642460|589455511|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
163201685|NCT00642460|589455512|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
163201686|NCT00642460|589455507|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
163201687|NCT00642460|589455508|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
163201688|NCT00642460|589455509|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
163201689|NCT00642460|589455510|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
163201690|NCT00642460|589455511|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
163201691|NCT00642460|589455512|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
163201692|NCT00642460|589455507|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
163201693|NCT00642460|589455508|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
163201694|NCT00642460|589455509|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
162964263|NCT01537887|588569723|FG002|Period 1|Physician Decision|0|||
162964264|NCT01537887|588569724|FG003|Period 1|Physician Decision|0|||
162964265|NCT01537887|588569725|FG004|Period 1|Physician Decision|1|||
162964266|NCT01537887|588569726|FG005|Period 1|Physician Decision|1|||
162964267|NCT01537887|588569721|FG000|Period 1|Did not receive treatment|0|||
162964268|NCT01537887|588569722|FG001|Period 1|Did not receive treatment|0|||
162964269|NCT01537887|588569723|FG002|Period 1|Did not receive treatment|1|||
162964270|NCT01537887|588569724|FG003|Period 1|Did not receive treatment|0|||
163201695|NCT00642460|589455510|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
163201696|NCT00642460|589455511|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
163201697|NCT00642460|589455512|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
163201698|NCT00642460|589455507|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
163201699|NCT00642460|589455508|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
163201700|NCT00642460|589455509|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
163201701|NCT00642460|589455510|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
163201702|NCT00642460|589455511|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
163201703|NCT00642460|589455512|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
163201704|NCT00642460|589455507|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
163201705|NCT00642460|589455508|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
163201706|NCT00642460|589455509|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
163201707|NCT00642460|589455510|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
163201708|NCT00642460|589455511|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
163201709|NCT00642460|589455512|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
163201710|NCT00642460|589455507|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
163201711|NCT00642460|589455508|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
163201712|NCT00642460|589455509|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
163201713|NCT00642460|589455510|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
162964271|NCT01537887|588569725|FG004|Period 1|Did not receive treatment|0|||
163201714|NCT00642460|589455511|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
163201715|NCT00642460|589455512|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
162964272|NCT01537887|588569726|FG005|Period 1|Did not receive treatment|0|||
162964273|NCT01537887|588569721|FG000|Period 2|Withdrawal by Subject|0|||
162964274|NCT01537887|588569722|FG001|Period 2|Withdrawal by Subject|1|||
163308839|NCT03269136|589839964|FG009|Part 1: Dose Escalation|Other|0|||
163308840|NCT03269136|589839965|FG010|Part 1: Dose Escalation|Other|1|||
163308841|NCT03269136|589839966|FG011|Part 1: Dose Escalation|Other|1|||
163201716|NCT00642460|589455507|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
163201717|NCT00642460|589455508|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
163201718|NCT00642460|589455509|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
163201719|NCT00642460|589455510|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
163308842|NCT03269136|589839967|FG012|Part 1: Dose Escalation|Other|1|||
163308843|NCT03269136|589839968|FG013|Part 1: Dose Escalation|Other|0|||
163308844|NCT03269136|589839969|FG014|Part 1: Dose Escalation|Other|3|||
163308845|NCT03269136|589839970|FG015|Part 1: Dose Escalation|Other|1|||
163308846|NCT03269136|589839971|FG016|Part 1: Dose Escalation|Other|1|||
163308847|NCT03269136|589839972|FG017|Part 1: Dose Escalation|Other|0|||
163308848|NCT03269136|589839955|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
163308849|NCT03269136|589839956|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
163308850|NCT03269136|589839957|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
163308851|NCT03269136|589839958|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
163308852|NCT03269136|589839959|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
163308853|NCT03269136|589839960|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
163308854|NCT03269136|589839961|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
163308855|NCT03269136|589839962|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
163308856|NCT03269136|589839963|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
163308857|NCT03269136|589839964|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
163308858|NCT03269136|589839965|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
163308859|NCT03269136|589839966|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
163308860|NCT03269136|589839967|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
163308861|NCT03269136|589839968|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
163308862|NCT03269136|589839969|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
163308863|NCT03269136|589839970|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
163308864|NCT03269136|589839971|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
163308865|NCT03269136|589839972|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
163308866|NCT03269136|589839955|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308867|NCT03269136|589839956|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308868|NCT03269136|589839957|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308869|NCT03269136|589839958|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308870|NCT03269136|589839959|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308871|NCT03269136|589839960|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308872|NCT03269136|589839961|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308873|NCT03269136|589839962|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
163308874|NCT03269136|589839963|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308875|NCT03269136|589839964|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308876|NCT03269136|589839965|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308877|NCT03269136|589839966|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308878|NCT03269136|589839967|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308879|NCT03269136|589839968|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308880|NCT03269136|589839969|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308881|NCT03269136|589839970|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308882|NCT03269136|589839971|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163397360|NCT00529451|590166256|FG001|Overall Study|Protocol deviation|1|||
163201720|NCT00642460|589455511|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
163201721|NCT00642460|589455512|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
163201722|NCT00642460|589455507|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
163201723|NCT00642460|589455508|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
163201724|NCT00642460|589455509|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
163201725|NCT00642460|589455510|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
163201726|NCT00642460|589455511|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
163201727|NCT00642460|589455512|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
163201728|NCT00642460|589455507|FG000|Part III: Open-Label Up to Week 260|Other|0|||
163201729|NCT00642460|589455508|FG001|Part III: Open-Label Up to Week 260|Other|0|||
163201730|NCT00642460|589455509|FG002|Part III: Open-Label Up to Week 260|Other|0|||
163201731|NCT00642460|589455510|FG003|Part III: Open-Label Up to Week 260|Other|0|||
163201732|NCT00642460|589455511|FG004|Part III: Open-Label Up to Week 260|Other|2|||
163201733|NCT00642460|589455512|FG005|Part III: Open-Label Up to Week 260|Other|2|||
163201734|NCT00642460|589455507|FG000|Part III: Open-Label Up to Week 260|Death|0|||
163201735|NCT00642460|589455508|FG001|Part III: Open-Label Up to Week 260|Death|0|||
163201736|NCT00642460|589455509|FG002|Part III: Open-Label Up to Week 260|Death|0|||
163308883|NCT03269136|589839972|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163308884|NCT03269136|589839955|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
163308885|NCT03269136|589839956|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
162964275|NCT01537887|588569723|FG002|Period 2|Withdrawal by Subject|0|||
162964276|NCT01537887|588569724|FG003|Period 2|Withdrawal by Subject|0|||
162964277|NCT01537887|588569725|FG004|Period 2|Withdrawal by Subject|0|||
162964278|NCT01537887|588569726|FG005|Period 2|Withdrawal by Subject|0|||
163201737|NCT00642460|589455510|FG003|Part III: Open-Label Up to Week 260|Death|0|||
163201738|NCT00642460|589455511|FG004|Part III: Open-Label Up to Week 260|Death|0|||
163201739|NCT00642460|589455512|FG005|Part III: Open-Label Up to Week 260|Death|3|||
163201740|NCT00642460|589455507|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
163201741|NCT00642460|589455508|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
163201742|NCT00642460|589455509|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
163201743|NCT00642460|589455510|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
163201744|NCT00642460|589455511|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
163201745|NCT00642460|589455512|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
163201746|NCT00642460|589455507|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
163201747|NCT00642460|589455508|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
163201748|NCT00642460|589455509|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
163201749|NCT00642460|589455510|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
163201750|NCT00642460|589455511|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
163201751|NCT00642460|589455512|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
163201752|NCT04605484|589455515|FG000|Overall Study|Lost to Follow-up|0|||
163201753|NCT04605484|589455516|FG001|Overall Study|Lost to Follow-up|1|||
163201754|NCT04605484|589455517|FG002|Overall Study|Lost to Follow-up|1|||
163201755|NCT04605484|589455515|FG000|Overall Study|Other|0|||
163201756|NCT04605484|589455516|FG001|Overall Study|Other|1|||
163201757|NCT04605484|589455517|FG002|Overall Study|Other|0|||
163201758|NCT04171531|589455520|FG000|Overall Study|Lost to Follow-up|4|||
163201759|NCT04171531|589455521|FG001|Overall Study|Lost to Follow-up|5|||
163201760|NCT04171531|589455520|FG000|Overall Study|Consent only through 6 months|1|||
163201761|NCT04171531|589455521|FG001|Overall Study|Consent only through 6 months|1|||
163201762|NCT04171531|589455520|FG000|Overall Study|Insurance did not cover procedure|0|||
163201763|NCT04171531|589455521|FG001|Overall Study|Insurance did not cover procedure|1|||
163201764|NCT04171531|589455520|FG000|Overall Study|Physician Decision|0|||
163201765|NCT04171531|589455521|FG001|Overall Study|Physician Decision|3|||
163201766|NCT04171531|589455520|FG000|Overall Study|Withdrawal by Subject|1|||
163201767|NCT04171531|589455521|FG001|Overall Study|Withdrawal by Subject|5|||
163201768|NCT05537883|589455524|FG000|Overall Study|revisional surgery|4|||
163201769|NCT05537883|589455525|FG001|Overall Study|revisional surgery|2|||
163201770|NCT05537883|589455524|FG000|Overall Study|surgeries were cancelled|0|||
163201771|NCT05537883|589455525|FG001|Overall Study|surgeries were cancelled|2|||
163201772|NCT05537883|589455524|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
163201773|NCT05537883|589455525|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
163201774|NCT03366337|589455526|FG000|Overall Study|Lost to Follow-up|1|||
163201775|NCT03366337|589455527|FG001|Overall Study|Lost to Follow-up|0|||
163201776|NCT03366337|589455528|FG002|Overall Study|Lost to Follow-up|1|||
163201777|NCT03366337|589455529|FG003|Overall Study|Lost to Follow-up|0|||
163201778|NCT03366337|589455526|FG000|Overall Study|Withdrawal by Subject|2|||
163201779|NCT03366337|589455527|FG001|Overall Study|Withdrawal by Subject|0|||
163201780|NCT03366337|589455528|FG002|Overall Study|Withdrawal by Subject|1|||
163201781|NCT03366337|589455529|FG003|Overall Study|Withdrawal by Subject|1|||
163201782|NCT02296320|589455531|FG000|Overall Study|Withdrawal by Subject|4|||
163201783|NCT02296320|589455532|FG001|Overall Study|Withdrawal by Subject|0|||
163201784|NCT02296320|589455533|FG002|Overall Study|Withdrawal by Subject|2|||
163201785|NCT02296320|589455531|FG000|Overall Study|Death|24|||
163201786|NCT02296320|589455532|FG001|Overall Study|Death|3|||
163201787|NCT02296320|589455533|FG002|Overall Study|Death|27|||
163201788|NCT02296320|589455531|FG000|Overall Study|Lost to Follow-up|5|||
163201789|NCT02296320|589455532|FG001|Overall Study|Lost to Follow-up|2|||
163201790|NCT02296320|589455533|FG002|Overall Study|Lost to Follow-up|7|||
163201791|NCT02296320|589455531|FG000|Overall Study|Not treated|2|||
163201792|NCT02296320|589455532|FG001|Overall Study|Not treated|0|||
163201793|NCT02296320|589455533|FG002|Overall Study|Not treated|0|||
163201794|NCT02296320|589455531|FG000|Overall Study|Not - specified|0|||
163201795|NCT02296320|589455532|FG001|Overall Study|Not - specified|0|||
163201796|NCT02296320|589455533|FG002|Overall Study|Not - specified|1|||
163201797|NCT01697566|589455542|FG000|Overall Study|Withdrawal by Subject|0|||
163201798|NCT01697566|589455543|FG001|Overall Study|Withdrawal by Subject|0|||
163201799|NCT01697566|589455544|FG002|Overall Study|Withdrawal by Subject|1|||
163201800|NCT01697566|589455545|FG003|Overall Study|Withdrawal by Subject|1|||
163201801|NCT01697566|589455542|FG000|Overall Study|Final biopsy not obtained|0|||
163201802|NCT01697566|589455543|FG001|Overall Study|Final biopsy not obtained|0|||
163201803|NCT01697566|589455544|FG002|Overall Study|Final biopsy not obtained|1|||
163201804|NCT01697566|589455545|FG003|Overall Study|Final biopsy not obtained|0|||
163201805|NCT01447433|589455546|FG000|Overall Study|Lost to Follow-up|0|||
163201806|NCT01447433|589455547|FG001|Overall Study|Lost to Follow-up|2|||
163201807|NCT01447433|589455546|FG000|Overall Study|Withdrawal by Subject|3|||
163201808|NCT01447433|589455547|FG001|Overall Study|Withdrawal by Subject|3|||
163308886|NCT03269136|589839957|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
163308887|NCT03269136|589839958|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
163308888|NCT03269136|589839959|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
163308889|NCT03269136|589839960|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
163308890|NCT03269136|589839961|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
163308891|NCT03269136|589839962|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
163201809|NCT01447433|589455546|FG000|Overall Study|Protocol Violation|1|||
163201810|NCT01447433|589455547|FG001|Overall Study|Protocol Violation|1|||
163201811|NCT01578187|589455548|FG000|Usability Phase|Withdrawal by Subject|1|||
163201812|NCT02516163|589455553|FG000|Overall Study|Withdrawal by Subject|1|||
163201813|NCT02516163|589455553|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
163201814|NCT02516163|589455553|FG000|Overall Study|Unfit/delay in surgery|3|||
163201815|NCT02516163|589455553|FG000|Overall Study|Use of incorrect measurement technique|5|||
163201816|NCT02516163|589455553|FG000|Overall Study|Data not recorded|2|||
163201817|NCT02516163|589455553|FG000|Overall Study|MRI contraindication exclusion|6|||
163201818|NCT01217814|589455554|FG000|Overall Study|Adverse Event|1|||
163201819|NCT01217814|589455555|FG001|Overall Study|Adverse Event|1|||
163201820|NCT01217814|589455556|FG002|Overall Study|Adverse Event|0|||
163201821|NCT01217814|589455554|FG000|Overall Study|Lack of Efficacy|0|||
163201822|NCT01217814|589455555|FG001|Overall Study|Lack of Efficacy|0|||
163201823|NCT01217814|589455556|FG002|Overall Study|Lack of Efficacy|1|||
163308892|NCT03269136|589839963|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
163308893|NCT03269136|589839964|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
163308894|NCT03269136|589839965|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
163201824|NCT01658072|589455559|FG000|Overall Study|Protocol Violation|4|||
163201825|NCT01658072|589455560|FG001|Overall Study|Protocol Violation|2|||
163201826|NCT00040664|589455561|FG000|Overall Study|Adverse Event|12|||
163201827|NCT00040664|589455562|FG001|Overall Study|Adverse Event|3|||
163201828|NCT00040664|589455563|FG002|Overall Study|Adverse Event|2|||
163201829|NCT00040664|589455564|FG003|Overall Study|Adverse Event|7|||
163201830|NCT00040664|589455561|FG000|Overall Study|Lack of Efficacy|9|||
163201831|NCT00040664|589455562|FG001|Overall Study|Lack of Efficacy|2|||
163201832|NCT00040664|589455563|FG002|Overall Study|Lack of Efficacy|3|||
163201833|NCT00040664|589455564|FG003|Overall Study|Lack of Efficacy|4|||
163201834|NCT00040664|589455561|FG000|Overall Study|Insufficient CD4 response|1|||
163201835|NCT00040664|589455562|FG001|Overall Study|Insufficient CD4 response|0|||
163201836|NCT00040664|589455563|FG002|Overall Study|Insufficient CD4 response|1|||
163201837|NCT00040664|589455564|FG003|Overall Study|Insufficient CD4 response|0|||
163201838|NCT00040664|589455561|FG000|Overall Study|Lost to Follow-up|4|||
163201839|NCT00040664|589455562|FG001|Overall Study|Lost to Follow-up|2|||
163201840|NCT00040664|589455563|FG002|Overall Study|Lost to Follow-up|0|||
163201841|NCT00040664|589455564|FG003|Overall Study|Lost to Follow-up|2|||
163201842|NCT00040664|589455561|FG000|Overall Study|Protocol Violation|2|||
163201843|NCT00040664|589455562|FG001|Overall Study|Protocol Violation|1|||
163201844|NCT00040664|589455563|FG002|Overall Study|Protocol Violation|0|||
163201845|NCT00040664|589455564|FG003|Overall Study|Protocol Violation|1|||
163201846|NCT00040664|589455561|FG000|Overall Study|Withdrawal by Subject|7|||
163201847|NCT00040664|589455562|FG001|Overall Study|Withdrawal by Subject|0|||
163201848|NCT00040664|589455563|FG002|Overall Study|Withdrawal by Subject|3|||
163201849|NCT00040664|589455564|FG003|Overall Study|Withdrawal by Subject|4|||
163201850|NCT00040664|589455561|FG000|Overall Study|Pregnancy|3|||
163201851|NCT00040664|589455562|FG001|Overall Study|Pregnancy|0|||
163201852|NCT00040664|589455563|FG002|Overall Study|Pregnancy|0|||
163201853|NCT00040664|589455564|FG003|Overall Study|Pregnancy|3|||
163201854|NCT00040664|589455561|FG000|Overall Study|Medication adherence/compliance problems|8|||
163201855|NCT00040664|589455562|FG001|Overall Study|Medication adherence/compliance problems|2|||
163201856|NCT00040664|589455563|FG002|Overall Study|Medication adherence/compliance problems|1|||
163201857|NCT00040664|589455564|FG003|Overall Study|Medication adherence/compliance problems|5|||
163201858|NCT00040664|589455561|FG000|Overall Study|Poor taste|2|||
163201859|NCT00040664|589455562|FG001|Overall Study|Poor taste|0|||
163308895|NCT03269136|589839966|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
163308896|NCT03269136|589839967|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
163308897|NCT03269136|589839968|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
163201860|NCT00040664|589455563|FG002|Overall Study|Poor taste|2|||
163201861|NCT00040664|589455564|FG003|Overall Study|Poor taste|0|||
163201862|NCT00040664|589455561|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
163201863|NCT00040664|589455562|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
163201864|NCT00040664|589455563|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
163201865|NCT00040664|589455564|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
163201866|NCT00040664|589455561|FG000|Overall Study|Change of formulation|2|||
163201867|NCT00040664|589455562|FG001|Overall Study|Change of formulation|2|||
163201868|NCT00040664|589455563|FG002|Overall Study|Change of formulation|0|||
163201869|NCT00040664|589455564|FG003|Overall Study|Change of formulation|0|||
163201870|NCT00040664|589455561|FG000|Overall Study|Non-viability of oral suspension|1|||
163308898|NCT03269136|589839969|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
163308899|NCT03269136|589839970|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
163308900|NCT03269136|589839971|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
163308901|NCT03269136|589839972|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
163308902|NCT03269136|589839955|FG000|Part 1: Dose Escalation|Death|0|||
163308903|NCT03269136|589839956|FG001|Part 1: Dose Escalation|Death|0|||
163308904|NCT03269136|589839957|FG002|Part 1: Dose Escalation|Death|0|||
163308905|NCT03269136|589839958|FG003|Part 1: Dose Escalation|Death|0|||
163308906|NCT03269136|589839959|FG004|Part 1: Dose Escalation|Death|0|||
163308907|NCT03269136|589839960|FG005|Part 1: Dose Escalation|Death|0|||
163308908|NCT03269136|589839961|FG006|Part 1: Dose Escalation|Death|0|||
163308909|NCT03269136|589839962|FG007|Part 1: Dose Escalation|Death|0|||
163308910|NCT03269136|589839963|FG008|Part 1: Dose Escalation|Death|0|||
163308911|NCT03269136|589839964|FG009|Part 1: Dose Escalation|Death|1|||
163308912|NCT03269136|589839965|FG010|Part 1: Dose Escalation|Death|0|||
163308913|NCT03269136|589839966|FG011|Part 1: Dose Escalation|Death|1|||
163308914|NCT03269136|589839967|FG012|Part 1: Dose Escalation|Death|0|||
163308915|NCT03269136|589839968|FG013|Part 1: Dose Escalation|Death|1|||
163308916|NCT03269136|589839969|FG014|Part 1: Dose Escalation|Death|0|||
163308917|NCT03269136|589839970|FG015|Part 1: Dose Escalation|Death|0|||
163308918|NCT03269136|589839971|FG016|Part 1: Dose Escalation|Death|2|||
163308919|NCT03269136|589839972|FG017|Part 1: Dose Escalation|Death|0|||
163308920|NCT03269136|589839955|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
163308921|NCT03269136|589839956|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
163308922|NCT03269136|589839957|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
163308923|NCT03269136|589839958|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
163308924|NCT03269136|589839959|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
163308925|NCT03269136|589839960|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
163308926|NCT03269136|589839961|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
163308927|NCT03269136|589839962|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
163308928|NCT03269136|589839963|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
163308929|NCT03269136|589839964|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
163308930|NCT03269136|589839965|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
163308931|NCT03269136|589839966|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
163308932|NCT03269136|589839967|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
163308933|NCT03269136|589839968|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
163308934|NCT03269136|589839969|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
163308935|NCT03269136|589839970|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
163308936|NCT03269136|589839971|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
163308937|NCT03269136|589839972|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
163308938|NCT03269136|589839955|FG000|Part 1: Dose Escalation|Adverse Event|0|||
163308939|NCT03269136|589839956|FG001|Part 1: Dose Escalation|Adverse Event|0|||
163308940|NCT03269136|589839957|FG002|Part 1: Dose Escalation|Adverse Event|0|||
163308941|NCT03269136|589839958|FG003|Part 1: Dose Escalation|Adverse Event|0|||
163308942|NCT03269136|589839959|FG004|Part 1: Dose Escalation|Adverse Event|0|||
163308943|NCT03269136|589839960|FG005|Part 1: Dose Escalation|Adverse Event|0|||
163308944|NCT03269136|589839961|FG006|Part 1: Dose Escalation|Adverse Event|2|||
163308945|NCT03269136|589839962|FG007|Part 1: Dose Escalation|Adverse Event|0|||
163308946|NCT03269136|589839963|FG008|Part 1: Dose Escalation|Adverse Event|0|||
163308947|NCT03269136|589839964|FG009|Part 1: Dose Escalation|Adverse Event|0|||
163308948|NCT03269136|589839965|FG010|Part 1: Dose Escalation|Adverse Event|1|||
163308949|NCT03269136|589839966|FG011|Part 1: Dose Escalation|Adverse Event|2|||
163308950|NCT03269136|589839967|FG012|Part 1: Dose Escalation|Adverse Event|0|||
163308951|NCT03269136|589839968|FG013|Part 1: Dose Escalation|Adverse Event|1|||
163308952|NCT03269136|589839969|FG014|Part 1: Dose Escalation|Adverse Event|0|||
163308953|NCT03269136|589839970|FG015|Part 1: Dose Escalation|Adverse Event|0|||
163308954|NCT03269136|589839971|FG016|Part 1: Dose Escalation|Adverse Event|1|||
163308955|NCT03269136|589839972|FG017|Part 1: Dose Escalation|Adverse Event|0|||
163308956|NCT03269136|589839955|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
163308957|NCT03269136|589839956|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
163308958|NCT03269136|589839957|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
163308959|NCT03269136|589839958|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
163308960|NCT03269136|589839959|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
163308961|NCT03269136|589839960|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
163308962|NCT03269136|589839961|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
163308963|NCT03269136|589839962|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
163308964|NCT03269136|589839963|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
163308965|NCT03269136|589839964|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
163308966|NCT03269136|589839965|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
163308967|NCT03269136|589839966|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
163308968|NCT03269136|589839967|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
163308969|NCT03269136|589839968|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
163308970|NCT03269136|589839969|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
163308971|NCT03269136|589839970|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
163308972|NCT03269136|589839971|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
163308973|NCT03269136|589839972|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
163308974|NCT03269136|589839955|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163308975|NCT03269136|589839956|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163308976|NCT03269136|589839957|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163308977|NCT03269136|589839958|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163308978|NCT03269136|589839959|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163308979|NCT03269136|589839960|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163308980|NCT03269136|589839961|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163308981|NCT03269136|589839962|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163308982|NCT03269136|589839963|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163308983|NCT03269136|589839964|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162964279|NCT01537887|588569721|FG000|Period 3|Adverse Event|0|||
162964280|NCT01537887|588569722|FG001|Period 3|Adverse Event|0|||
162964281|NCT01537887|588569723|FG002|Period 3|Adverse Event|1|||
162964282|NCT01537887|588569724|FG003|Period 3|Adverse Event|0|||
162964283|NCT01537887|588569725|FG004|Period 3|Adverse Event|0|||
162964284|NCT01537887|588569726|FG005|Period 3|Adverse Event|0|||
162964285|NCT01537887|588569721|FG000|Period 3|Withdrawal by Subject|0|||
162964286|NCT01537887|588569722|FG001|Period 3|Withdrawal by Subject|1|||
162964287|NCT01537887|588569723|FG002|Period 3|Withdrawal by Subject|0|||
162964288|NCT01537887|588569724|FG003|Period 3|Withdrawal by Subject|0|||
162964289|NCT01537887|588569725|FG004|Period 3|Withdrawal by Subject|0|||
162964290|NCT01537887|588569726|FG005|Period 3|Withdrawal by Subject|0|||
162964291|NCT01370083|588569727|FG000|Overall Study|Lost to Follow-up|2|||
162964292|NCT01370083|588569728|FG001|Overall Study|Lost to Follow-up|0|||
162964293|NCT01370083|588569727|FG000|Overall Study|Adverse Event|0|||
162964294|NCT01370083|588569728|FG001|Overall Study|Adverse Event|1|||
162964295|NCT02450539|588569731|FG000|Overall Study|Withdrawal by Subject|12|||
162964296|NCT02450539|588569732|FG001|Overall Study|Withdrawal by Subject|6|||
162964297|NCT02450539|588569731|FG000|Overall Study|Lost to Follow-up|4|||
162964298|NCT02450539|588569732|FG001|Overall Study|Lost to Follow-up|1|||
162964299|NCT00585286|588569733|FG000|Overall Study|Lost to Follow-up|1|||
162964300|NCT03358147|588569735|FG000|Overall Study|Withdrawal by Subject|13|||
162964301|NCT03358147|588569736|FG001|Overall Study|Withdrawal by Subject|19|||
162964302|NCT03358147|588569737|FG002|Overall Study|Withdrawal by Subject|16|||
162964303|NCT03358147|588569738|FG003|Overall Study|Withdrawal by Subject|10|||
162964304|NCT03358147|588569739|FG004|Overall Study|Withdrawal by Subject|5|||
162964305|NCT03358147|588569735|FG000|Overall Study|Adverse Event|3|||
162964306|NCT03358147|588569736|FG001|Overall Study|Adverse Event|9|||
162964307|NCT03358147|588569737|FG002|Overall Study|Adverse Event|7|||
162964308|NCT03358147|588569738|FG003|Overall Study|Adverse Event|5|||
162964309|NCT03358147|588569739|FG004|Overall Study|Adverse Event|2|||
162964310|NCT03358147|588569735|FG000|Overall Study|Lost to Follow-up|4|||
162964311|NCT03358147|588569736|FG001|Overall Study|Lost to Follow-up|3|||
162964312|NCT03358147|588569737|FG002|Overall Study|Lost to Follow-up|7|||
162964313|NCT03358147|588569738|FG003|Overall Study|Lost to Follow-up|6|||
162964314|NCT03358147|588569739|FG004|Overall Study|Lost to Follow-up|4|||
162964315|NCT03358147|588569735|FG000|Overall Study|Major Protocol Deviation|11|||
163308984|NCT03269136|589839965|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163308985|NCT03269136|589839966|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162964316|NCT03358147|588569736|FG001|Overall Study|Major Protocol Deviation|3|||
162964317|NCT03358147|588569737|FG002|Overall Study|Major Protocol Deviation|2|||
162964318|NCT03358147|588569738|FG003|Overall Study|Major Protocol Deviation|3|||
162964319|NCT03358147|588569739|FG004|Overall Study|Major Protocol Deviation|1|||
162964320|NCT03358147|588569735|FG000|Overall Study|Protocol specified criteria|2|||
162964321|NCT03358147|588569736|FG001|Overall Study|Protocol specified criteria|3|||
162964322|NCT03358147|588569737|FG002|Overall Study|Protocol specified criteria|0|||
162964323|NCT03358147|588569738|FG003|Overall Study|Protocol specified criteria|3|||
163308986|NCT03269136|589839967|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
163308987|NCT03269136|589839968|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
163397361|NCT00529451|590166257|FG002|Overall Study|Protocol deviation|4|||
162964324|NCT03358147|588569739|FG004|Overall Study|Protocol specified criteria|1|||
163397362|NCT00529451|590166258|FG003|Overall Study|Protocol deviation|1|||
163308988|NCT03269136|589839969|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
163308989|NCT03269136|589839970|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163308990|NCT03269136|589839971|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
163308991|NCT03269136|589839972|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163308992|NCT03269136|589839955|FG000|Part 2A: Dose Expansion|Other|0|||
163308993|NCT03269136|589839956|FG001|Part 2A: Dose Expansion|Other|0|||
163308994|NCT03269136|589839957|FG002|Part 2A: Dose Expansion|Other|0|||
163308995|NCT03269136|589839958|FG003|Part 2A: Dose Expansion|Other|0|||
163308996|NCT03269136|589839959|FG004|Part 2A: Dose Expansion|Other|0|||
163308997|NCT03269136|589839960|FG005|Part 2A: Dose Expansion|Other|0|||
163308998|NCT03269136|589839961|FG006|Part 2A: Dose Expansion|Other|0|||
163308999|NCT03269136|589839962|FG007|Part 2A: Dose Expansion|Other|0|||
163309000|NCT03269136|589839963|FG008|Part 2A: Dose Expansion|Other|0|||
163309001|NCT03269136|589839964|FG009|Part 2A: Dose Expansion|Other|0|||
163309002|NCT03269136|589839965|FG010|Part 2A: Dose Expansion|Other|0|||
163309003|NCT03269136|589839966|FG011|Part 2A: Dose Expansion|Other|0|||
163309004|NCT03269136|589839967|FG012|Part 2A: Dose Expansion|Other|0|||
163309005|NCT03269136|589839968|FG013|Part 2A: Dose Expansion|Other|0|||
163309006|NCT03269136|589839969|FG014|Part 2A: Dose Expansion|Other|0|||
163309007|NCT03269136|589839970|FG015|Part 2A: Dose Expansion|Other|0|||
163309008|NCT03269136|589839971|FG016|Part 2A: Dose Expansion|Other|0|||
163309009|NCT03269136|589839972|FG017|Part 2A: Dose Expansion|Other|1|||
163309010|NCT03269136|589839955|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163309011|NCT03269136|589839956|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163309012|NCT03269136|589839957|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163309013|NCT03269136|589839958|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163309014|NCT03269136|589839959|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163309015|NCT03269136|589839960|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163309016|NCT03269136|589839961|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163309017|NCT03269136|589839962|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163309018|NCT03269136|589839963|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163309019|NCT03269136|589839964|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163201871|NCT00040664|589455562|FG001|Overall Study|Non-viability of oral suspension|0|||
163201872|NCT00040664|589455563|FG002|Overall Study|Non-viability of oral suspension|1|||
163201873|NCT00040664|589455564|FG003|Overall Study|Non-viability of oral suspension|0|||
163201874|NCT01709162|589455565|FG000|Overall Study|Disease progression|3|||
163201875|NCT01709162|589455566|FG001|Overall Study|Disease progression|3|||
163201876|NCT01709162|589455565|FG000|Overall Study|Study drug toxicity|2|||
163201877|NCT01709162|589455566|FG001|Overall Study|Study drug toxicity|0|||
163201878|NCT01709162|589455565|FG000|Overall Study|Administrative reason by sponsor|0|||
163201879|NCT01709162|589455566|FG001|Overall Study|Administrative reason by sponsor|1|||
163201880|NCT01709162|589455565|FG000|Overall Study|Other|1|||
163201881|NCT01709162|589455566|FG001|Overall Study|Other|0|||
163309020|NCT03269136|589839965|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163309021|NCT03269136|589839966|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163309022|NCT03269136|589839967|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163309023|NCT03269136|589839968|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163309024|NCT03269136|589839969|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163309025|NCT03269136|589839970|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163309026|NCT03269136|589839971|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163201882|NCT01709162|589455565|FG000|Overall Study|Withdrawal by Subject|0|||
163201883|NCT01709162|589455566|FG001|Overall Study|Withdrawal by Subject|1|||
163201884|NCT04545385|589455572|FG000|Overall Study|Withdrawal by Subject|2|||
163201885|NCT04545385|589455573|FG001|Overall Study|Withdrawal by Subject|0|||
163201886|NCT04545385|589455572|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
163201887|NCT04545385|589455573|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
163201888|NCT04545385|589455572|FG000|Overall Study|Study termination|10|||
163309027|NCT03269136|589839972|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
162964325|NCT03358147|588569735|FG000|Overall Study|Physician Decision|1|||
162964326|NCT03358147|588569736|FG001|Overall Study|Physician Decision|0|||
163201889|NCT04545385|589455573|FG001|Overall Study|Study termination|10|||
163201890|NCT04545385|589455572|FG000|Overall Study|Sponsor decision|2|||
163201891|NCT04545385|589455573|FG001|Overall Study|Sponsor decision|2|||
163201892|NCT04545385|589455572|FG000|Overall Study|Other than specified|1|||
163201893|NCT04545385|589455573|FG001|Overall Study|Other than specified|0|||
162964327|NCT03358147|588569737|FG002|Overall Study|Physician Decision|1|||
162964328|NCT03358147|588569738|FG003|Overall Study|Physician Decision|6|||
163201894|NCT01637272|589455582|FG000|Overall Study|Adverse Event|6|||
163309028|NCT03269136|589839955|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
163309029|NCT03269136|589839956|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
163309030|NCT03269136|589839957|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
163309031|NCT03269136|589839958|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
163309032|NCT03269136|589839959|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
163309033|NCT03269136|589839960|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
163309034|NCT03269136|589839961|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
163309035|NCT03269136|589839962|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
163309036|NCT03269136|589839963|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
163309037|NCT03269136|589839964|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
163309038|NCT03269136|589839965|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
163309039|NCT03269136|589839966|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
163309040|NCT03269136|589839967|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
163309041|NCT03269136|589839968|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
163309042|NCT03269136|589839969|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
163309043|NCT03269136|589839970|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
163309044|NCT03269136|589839971|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
163309045|NCT03269136|589839972|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
163309046|NCT03269136|589839955|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
163309047|NCT03269136|589839956|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
163309048|NCT03269136|589839957|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
163309049|NCT03269136|589839958|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
163309050|NCT03269136|589839959|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
163309051|NCT03269136|589839960|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
163309052|NCT03269136|589839961|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
163309053|NCT03269136|589839962|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
163309054|NCT03269136|589839963|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
163309055|NCT03269136|589839964|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
163309056|NCT03269136|589839965|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
163309057|NCT03269136|589839966|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
163309058|NCT03269136|589839967|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
163309059|NCT03269136|589839968|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
163309060|NCT03269136|589839969|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
163309061|NCT03269136|589839970|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
163309062|NCT03269136|589839971|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
163309063|NCT03269136|589839972|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
163309064|NCT03269136|589839955|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
163309065|NCT03269136|589839956|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
163309066|NCT03269136|589839957|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
163309067|NCT03269136|589839958|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
163309068|NCT03269136|589839959|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
163309069|NCT03269136|589839960|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
163309070|NCT03269136|589839961|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
163309071|NCT03269136|589839962|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
163309072|NCT03269136|589839963|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
163309073|NCT03269136|589839964|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
163309074|NCT03269136|589839965|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
163309075|NCT03269136|589839966|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
163309076|NCT03269136|589839967|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
163309077|NCT03269136|589839968|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
163309078|NCT03269136|589839969|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
163309079|NCT03269136|589839970|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
163309080|NCT03269136|589839971|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
163309081|NCT03269136|589839972|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
163309082|NCT02515773|589839975|FG000|Overall Study|Withdrawal by Subject|12|||
163309083|NCT02515773|589839976|FG001|Overall Study|Withdrawal by Subject|2|||
163309084|NCT02515773|589839975|FG000|Overall Study|Lost to Follow-up|119|||
163309085|NCT02515773|589839976|FG001|Overall Study|Lost to Follow-up|126|||
163309086|NCT02515773|589839975|FG000|Overall Study|Discharged from Clinic Services|53|||
163309087|NCT02515773|589839976|FG001|Overall Study|Discharged from Clinic Services|84|||
163309088|NCT02515773|589839975|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
163309089|NCT02515773|589839976|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
163309090|NCT02515773|589839975|FG000|Overall Study|Follow-up at non-study site|8|||
163309091|NCT02515773|589839976|FG001|Overall Study|Follow-up at non-study site|16|||
163309092|NCT02515773|589839975|FG000|Overall Study|Moved from area|9|||
163309093|NCT02515773|589839976|FG001|Overall Study|Moved from area|14|||
163309094|NCT04072380|589839978|FG000|Overall Study|Adverse Event|4|||
163309095|NCT04072380|589839979|FG001|Overall Study|Adverse Event|6|||
162964329|NCT03358147|588569739|FG004|Overall Study|Physician Decision|1|||
162964330|NCT03358147|588569735|FG000|Overall Study|Administrative reasons|0|||
163309096|NCT04072380|589839980|FG002|Overall Study|Adverse Event|0|||
163309097|NCT04072380|589839978|FG000|Overall Study|Withdrawal by Subject|3|||
163309098|NCT04072380|589839979|FG001|Overall Study|Withdrawal by Subject|1|||
163309099|NCT04072380|589839980|FG002|Overall Study|Withdrawal by Subject|1|||
163309100|NCT04072380|589839978|FG000|Overall Study|Physician Decision|2|||
163309101|NCT04072380|589839979|FG001|Overall Study|Physician Decision|0|||
163309102|NCT04072380|589839980|FG002|Overall Study|Physician Decision|0|||
163309103|NCT04072380|589839978|FG000|Overall Study|Protocol Violation|0|||
163051351|NCT01628848|588895437|FG000|Overall Study|Lack of Efficacy|0|||
163309104|NCT04072380|589839979|FG001|Overall Study|Protocol Violation|2|||
163309105|NCT04072380|589839980|FG002|Overall Study|Protocol Violation|3|||
163309106|NCT04072380|589839978|FG000|Overall Study|Intercurrent Illness and Others|3|||
163309107|NCT04072380|589839979|FG001|Overall Study|Intercurrent Illness and Others|5|||
163309108|NCT04072380|589839980|FG002|Overall Study|Intercurrent Illness and Others|6|||
163309109|NCT03468218|589839983|FG000|Overall Study|Adverse Event|5|||
163309110|NCT03468218|589839983|FG000|Overall Study|Progressive Disease|16|||
163309111|NCT03468218|589839983|FG000|Overall Study|Death|1|||
163309112|NCT03468218|589839983|FG000|Overall Study|Alternate therapy|1|||
163309113|NCT03468218|589839983|FG000|Overall Study|Withdrawal by Subject|2|||
163309114|NCT03033576|589839984|FG000|Overall Study|Ineligible|1|||
163309115|NCT03033576|589839985|FG001|Overall Study|Ineligible|1|||
163309116|NCT03033576|589839984|FG000|Overall Study|Adverse Event|4|||
163309117|NCT03033576|589839985|FG001|Overall Study|Adverse Event|20|||
163309118|NCT03033576|589839984|FG000|Overall Study|Progression/relapse|9|||
163309119|NCT03033576|589839985|FG001|Overall Study|Progression/relapse|36|||
163309120|NCT03033576|589839984|FG000|Overall Study|Death|1|||
163309121|NCT03033576|589839985|FG001|Overall Study|Death|1|||
163309122|NCT03033576|589839984|FG000|Overall Study|Patient refusal|1|||
163309123|NCT03033576|589839985|FG001|Overall Study|Patient refusal|6|||
163309124|NCT03033576|589839984|FG000|Overall Study|Other, unspecified reasons|0|||
163309125|NCT03033576|589839985|FG001|Overall Study|Other, unspecified reasons|4|||
163309126|NCT03033576|589839984|FG000|Overall Study|Currently on protocol therapy|0|||
163309127|NCT03033576|589839985|FG001|Overall Study|Currently on protocol therapy|2|||
163309128|NCT03719443|589839986|FG000|Overall Study|Lost to Follow-up|0|||
163309129|NCT03719443|589839987|FG001|Overall Study|Lost to Follow-up|0|||
163309130|NCT03719443|589839988|FG002|Overall Study|Lost to Follow-up|1|||
163309131|NCT03719443|589839989|FG003|Overall Study|Lost to Follow-up|0|||
163309132|NCT03719443|589839990|FG004|Overall Study|Lost to Follow-up|1|||
163309133|NCT03719443|589839991|FG005|Overall Study|Lost to Follow-up|0|||
163309134|NCT03719443|589839992|FG006|Overall Study|Lost to Follow-up|1|||
163309135|NCT03719443|589839986|FG000|Overall Study|Withdrawal by Subject|0|||
163309136|NCT03719443|589839987|FG001|Overall Study|Withdrawal by Subject|0|||
163309137|NCT03719443|589839988|FG002|Overall Study|Withdrawal by Subject|1|||
163309138|NCT03719443|589839989|FG003|Overall Study|Withdrawal by Subject|0|||
163309139|NCT03719443|589839990|FG004|Overall Study|Withdrawal by Subject|0|||
163309140|NCT03719443|589839991|FG005|Overall Study|Withdrawal by Subject|0|||
163309141|NCT03719443|589839992|FG006|Overall Study|Withdrawal by Subject|0|||
163309142|NCT01214616|589839999|FG000|Overall Study|Progressive disease|2|||
163309143|NCT01214616|589840000|FG001|Overall Study|Progressive disease|2|||
163309144|NCT01214616|589840001|FG002|Overall Study|Progressive disease|2|||
163309145|NCT01214616|589840002|FG003|Overall Study|Progressive disease|4|||
163309146|NCT01214616|589839999|FG000|Overall Study|Dose limiting toxicity|0|||
162964331|NCT03358147|588569736|FG001|Overall Study|Administrative reasons|1|||
162964332|NCT03358147|588569737|FG002|Overall Study|Administrative reasons|0|||
163309147|NCT01214616|589840000|FG001|Overall Study|Dose limiting toxicity|2|||
163309148|NCT01214616|589840001|FG002|Overall Study|Dose limiting toxicity|0|||
163309149|NCT01214616|589840002|FG003|Overall Study|Dose limiting toxicity|0|||
163309150|NCT01214616|589839999|FG000|Overall Study|Other adverse events|0|||
163309151|NCT01214616|589840000|FG001|Overall Study|Other adverse events|1|||
163309152|NCT01214616|589840001|FG002|Overall Study|Other adverse events|1|||
163309153|NCT01214616|589840002|FG003|Overall Study|Other adverse events|1|||
163309154|NCT01214616|589839999|FG000|Overall Study|Withdrawal by Subject|1|||
163309155|NCT01214616|589840000|FG001|Overall Study|Withdrawal by Subject|0|||
163309156|NCT01214616|589840001|FG002|Overall Study|Withdrawal by Subject|0|||
163309157|NCT01214616|589840002|FG003|Overall Study|Withdrawal by Subject|1|||
163309158|NCT03447470|589840003|FG000|Overall Study|Death|0|||
163309159|NCT03447470|589840004|FG001|Overall Study|Death|1|||
163309160|NCT03447470|589840005|FG002|Overall Study|Death|3|||
163309161|NCT03447470|589840006|FG003|Overall Study|Death|0|||
163309162|NCT03447470|589840007|FG004|Overall Study|Death|1|||
163309163|NCT03447470|589840008|FG005|Overall Study|Death|0|||
163309164|NCT03447470|589840009|FG006|Overall Study|Death|3|||
163309165|NCT03447470|589840010|FG007|Overall Study|Death|3|||
163309166|NCT03447470|589840011|FG008|Overall Study|Death|1|||
163309167|NCT03447470|589840003|FG000|Overall Study|Withdrawal by Subject|1|||
163309168|NCT03447470|589840004|FG001|Overall Study|Withdrawal by Subject|0|||
163309169|NCT03447470|589840005|FG002|Overall Study|Withdrawal by Subject|0|||
163309170|NCT03447470|589840006|FG003|Overall Study|Withdrawal by Subject|0|||
163309171|NCT03447470|589840007|FG004|Overall Study|Withdrawal by Subject|1|||
162964333|NCT03358147|588569738|FG003|Overall Study|Administrative reasons|3|||
163309172|NCT03447470|589840008|FG005|Overall Study|Withdrawal by Subject|0|||
163309173|NCT03447470|589840009|FG006|Overall Study|Withdrawal by Subject|1|||
163309174|NCT03447470|589840010|FG007|Overall Study|Withdrawal by Subject|1|||
163201895|NCT01637272|589455582|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163201896|NCT01637272|589455582|FG000|Overall Study|Withdrawal by Subject|3|||
163201897|NCT01637272|589455582|FG000|Overall Study|Lost to Follow-up|2|||
163201898|NCT01637272|589455582|FG000|Overall Study|completed core, did not enter ext. phase|4|||
163201899|NCT01637272|589455582|FG000|Overall Study|Administrative problems|1|||
163201900|NCT01637272|589455582|FG000|Overall Study|Protocol Violation|2|||
163201901|NCT01844518|589455583|FG000|Overall Study|Adverse Event|7|||
163201902|NCT01844518|589455584|FG001|Overall Study|Adverse Event|1|||
163201903|NCT01844518|589455583|FG000|Overall Study|Lack of Efficacy|17|||
163201904|NCT01844518|589455584|FG001|Overall Study|Lack of Efficacy|5|||
163201905|NCT01844518|589455583|FG000|Overall Study|Participant's request to discontinue|4|||
163201906|NCT01844518|589455584|FG001|Overall Study|Participant's request to discontinue|1|||
163201907|NCT01844518|589455583|FG000|Overall Study|Poor/Non-compliance|1|||
163201908|NCT01844518|589455584|FG001|Overall Study|Poor/Non-compliance|0|||
163201909|NCT01844518|589455583|FG000|Overall Study|No Longer Met Study Criteria|2|||
163201910|NCT01844518|589455584|FG001|Overall Study|No Longer Met Study Criteria|0|||
163201911|NCT01844518|589455583|FG000|Overall Study|Withdrawal by Subject|9|||
163201912|NCT01844518|589455584|FG001|Overall Study|Withdrawal by Subject|0|||
163201913|NCT01844518|589455583|FG000|Overall Study|Pregnancy|1|||
163201914|NCT01844518|589455584|FG001|Overall Study|Pregnancy|0|||
163201915|NCT05399641|589455585|FG000|Overall Study|Adverse Event|0|||
163201916|NCT05399641|589455586|FG001|Overall Study|Adverse Event|1|||
163201917|NCT05399641|589455587|FG002|Overall Study|Adverse Event|1|||
163201918|NCT05399641|589455585|FG000|Overall Study|Lost to Follow-up|1|||
163201919|NCT05399641|589455586|FG001|Overall Study|Lost to Follow-up|2|||
163201920|NCT05399641|589455587|FG002|Overall Study|Lost to Follow-up|2|||
163201921|NCT05399641|589455585|FG000|Overall Study|Physician Decision|1|||
163201922|NCT05399641|589455586|FG001|Overall Study|Physician Decision|3|||
163201923|NCT05399641|589455587|FG002|Overall Study|Physician Decision|3|||
163201924|NCT05399641|589455585|FG000|Overall Study|Withdrawal by Subject|4|||
163201925|NCT05399641|589455586|FG001|Overall Study|Withdrawal by Subject|11|||
163201926|NCT05399641|589455587|FG002|Overall Study|Withdrawal by Subject|7|||
163201927|NCT05399641|589455585|FG000|Overall Study|Reason not defined|3|||
163201928|NCT05399641|589455586|FG001|Overall Study|Reason not defined|5|||
163201929|NCT05399641|589455587|FG002|Overall Study|Reason not defined|6|||
163201930|NCT03334539|589455592|FG000|Overall Study|Adverse Event|3|||
163201931|NCT03334539|589455593|FG001|Overall Study|Adverse Event|5|||
163201932|NCT03334539|589455594|FG002|Overall Study|Adverse Event|0|||
163201933|NCT03334539|589455592|FG000|Overall Study|Withdrawal by Subject|0|||
163201934|NCT03334539|589455593|FG001|Overall Study|Withdrawal by Subject|1|||
163201935|NCT03334539|589455594|FG002|Overall Study|Withdrawal by Subject|1|||
163201936|NCT03334539|589455592|FG000|Overall Study|Administrative Reasons|1|||
163201937|NCT03334539|589455593|FG001|Overall Study|Administrative Reasons|0|||
163201938|NCT03334539|589455594|FG002|Overall Study|Administrative Reasons|0|||
163201939|NCT03334539|589455592|FG000|Overall Study|Hypertension Not Controlled|0|||
163201940|NCT03334539|589455593|FG001|Overall Study|Hypertension Not Controlled|1|||
163201941|NCT03334539|589455594|FG002|Overall Study|Hypertension Not Controlled|0|||
163201942|NCT03706456|589455598|FG000|Overall Study|Adverse Event|1|||
163201943|NCT03706456|589455598|FG000|Overall Study|Lack of Efficacy|2|||
163201944|NCT04523220|589455599|FG000|Main Treatment Period|Physician Decision|1|||
163201945|NCT04523220|589455600|FG001|Main Treatment Period|Physician Decision|1|||
163201946|NCT04523220|589455601|FG002|Main Treatment Period|Physician Decision|0|||
163201947|NCT04523220|589455599|FG000|Main Treatment Period|Other|5|||
163201948|NCT04523220|589455600|FG001|Main Treatment Period|Other|2|||
163201949|NCT04523220|589455601|FG002|Main Treatment Period|Other|4|||
163201950|NCT04523220|589455599|FG000|Main Treatment Period|Subject Decision|5|||
163201951|NCT04523220|589455600|FG001|Main Treatment Period|Subject Decision|7|||
163201952|NCT04523220|589455601|FG002|Main Treatment Period|Subject Decision|3|||
163201953|NCT04523220|589455599|FG000|Main Treatment Period|Death|5|||
163201954|NCT04523220|589455600|FG001|Main Treatment Period|Death|11|||
163201955|NCT04523220|589455601|FG002|Main Treatment Period|Death|4|||
163201956|NCT04523220|589455599|FG000|Main Treatment Period|Adverse Event|11|||
163201957|NCT04523220|589455600|FG001|Main Treatment Period|Adverse Event|9|||
163201958|NCT04523220|589455601|FG002|Main Treatment Period|Adverse Event|9|||
163201959|NCT04523220|589455599|FG000|Main Treatment Period|Withdrawal by Subject|3|||
163201960|NCT04523220|589455600|FG001|Main Treatment Period|Withdrawal by Subject|3|||
163201961|NCT04523220|589455601|FG002|Main Treatment Period|Withdrawal by Subject|4|||
163201962|NCT04523220|589455599|FG000|Main Treatment Period|Study drug never adminstered|10|||
163201963|NCT04523220|589455600|FG001|Main Treatment Period|Study drug never adminstered|3|||
163201964|NCT04523220|589455601|FG002|Main Treatment Period|Study drug never adminstered|5|||
163201965|NCT04523220|589455599|FG000|Extension Treatment Period|Physician Decision|1|||
163201966|NCT04523220|589455600|FG001|Extension Treatment Period|Physician Decision|0|||
163201967|NCT04523220|589455601|FG002|Extension Treatment Period|Physician Decision|3|||
163201968|NCT04523220|589455599|FG000|Extension Treatment Period|Other|2|||
163201969|NCT04523220|589455600|FG001|Extension Treatment Period|Other|6|||
163201970|NCT04523220|589455601|FG002|Extension Treatment Period|Other|6|||
163201971|NCT04523220|589455599|FG000|Extension Treatment Period|Subject Decision|5|||
163201972|NCT04523220|589455600|FG001|Extension Treatment Period|Subject Decision|2|||
163201973|NCT04523220|589455601|FG002|Extension Treatment Period|Subject Decision|4|||
163201974|NCT04523220|589455599|FG000|Extension Treatment Period|Death|6|||
163201975|NCT04523220|589455600|FG001|Extension Treatment Period|Death|4|||
163201976|NCT04523220|589455601|FG002|Extension Treatment Period|Death|7|||
163201977|NCT04523220|589455599|FG000|Extension Treatment Period|Adverse Event|6|||
163201978|NCT04523220|589455600|FG001|Extension Treatment Period|Adverse Event|7|||
163201979|NCT04523220|589455601|FG002|Extension Treatment Period|Adverse Event|9|||
163201980|NCT04523220|589455599|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
163201981|NCT04523220|589455600|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
163201982|NCT04523220|589455601|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
163201983|NCT04523220|589455599|FG000|Extension Treatment Period|Study drug never administered|0|||
163309175|NCT03447470|589840011|FG008|Overall Study|Withdrawal by Subject|3|||
163201984|NCT04523220|589455600|FG001|Extension Treatment Period|Study drug never administered|1|||
163201985|NCT04523220|589455601|FG002|Extension Treatment Period|Study drug never administered|0|||
163201986|NCT00256750|589455603|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
163201987|NCT00256750|589455604|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
163201988|NCT00256750|589455605|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
163201989|NCT00256750|589455603|FG000|Transplanted Pre-Treatment|Other|2|||
163309176|NCT03447470|589840003|FG000|Overall Study|Treatment discontinued|3|||
163309177|NCT03447470|589840004|FG001|Overall Study|Treatment discontinued|2|||
163309178|NCT03447470|589840005|FG002|Overall Study|Treatment discontinued|4|||
163201990|NCT00256750|589455604|FG001|Transplanted Pre-Treatment|Other|0|||
163201991|NCT00256750|589455605|FG002|Transplanted Pre-Treatment|Other|0|||
163201992|NCT00256750|589455603|FG000|Transplanted Pre-Treatment|Death|1|||
163201993|NCT00256750|589455604|FG001|Transplanted Pre-Treatment|Death|0|||
163201994|NCT00256750|589455605|FG002|Transplanted Pre-Treatment|Death|0|||
163201995|NCT00256750|589455603|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
163201996|NCT00256750|589455604|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
163201997|NCT00256750|589455605|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
163201998|NCT00256750|589455603|FG000|Post-Transplant Treated (12 Months)|Death|3|||
163201999|NCT00256750|589455604|FG001|Post-Transplant Treated (12 Months)|Death|2|||
163202000|NCT00256750|589455605|FG002|Post-Transplant Treated (12 Months)|Death|4|||
163202001|NCT00256750|589455603|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
163309179|NCT03447470|589840006|FG003|Overall Study|Treatment discontinued|6|||
163309180|NCT03447470|589840007|FG004|Overall Study|Treatment discontinued|2|||
163309181|NCT03447470|589840008|FG005|Overall Study|Treatment discontinued|1|||
163309182|NCT03447470|589840009|FG006|Overall Study|Treatment discontinued|2|||
163309183|NCT03447470|589840010|FG007|Overall Study|Treatment discontinued|4|||
163202002|NCT00256750|589455604|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
163202003|NCT00256750|589455605|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
163202004|NCT00256750|589455603|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
163202005|NCT00256750|589455604|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
163202006|NCT00256750|589455605|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
163202007|NCT00256750|589455603|FG000|Post-Transplant Treated (12 Months)|Other|5|||
163202008|NCT00256750|589455604|FG001|Post-Transplant Treated (12 Months)|Other|4|||
163202009|NCT00256750|589455605|FG002|Post-Transplant Treated (12 Months)|Other|2|||
163202010|NCT00256750|589455603|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
163202011|NCT00256750|589455604|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
163202012|NCT00256750|589455605|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
163202013|NCT00256750|589455603|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
163202014|NCT00256750|589455604|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
163202015|NCT00256750|589455605|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
163202016|NCT00256750|589455603|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
163202017|NCT00256750|589455604|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
163202018|NCT00256750|589455605|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
163202019|NCT00256750|589455603|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
163202020|NCT00256750|589455604|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
163202021|NCT00256750|589455605|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
163202022|NCT00256750|589455603|FG000|Post-Transplant Treated (24 Months)|Death|3|||
163202023|NCT00256750|589455604|FG001|Post-Transplant Treated (24 Months)|Death|0|||
163202024|NCT00256750|589455605|FG002|Post-Transplant Treated (24 Months)|Death|0|||
163202025|NCT00256750|589455603|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
163202026|NCT00256750|589455604|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
163202027|NCT00256750|589455605|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
163202028|NCT00256750|589455603|FG000|Post-Transplant Treated (24 Months)|Other|2|||
163202029|NCT00256750|589455604|FG001|Post-Transplant Treated (24 Months)|Other|0|||
163309184|NCT03447470|589840011|FG008|Overall Study|Treatment discontinued|3|||
163309185|NCT01361711|589840015|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
163309186|NCT01361711|589840015|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
163309187|NCT01361711|589840015|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
163309188|NCT01361711|589840015|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
163309189|NCT01361711|589840015|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
163309190|NCT01361711|589840015|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
163309191|NCT01361711|589840015|FG000|Completed Week 18 of Treatment|Other|9|||
163309192|NCT01361711|589840015|FG000|10 Year Follow-up|Still in follow-up|22|||
163309193|NCT01361711|589840015|FG000|10 Year Follow-up|Death|7|||
163309194|NCT01361711|589840015|FG000|10 Year Follow-up|Developed new cancer|1|||
163309195|NCT01361711|589840015|FG000|10 Year Follow-up|Lost to Follow-up|2|||
163309196|NCT01361711|589840015|FG000|10 Year Follow-up|New treatment started|6|||
163202030|NCT00256750|589455605|FG002|Post-Transplant Treated (24 Months)|Other|1|||
163051352|NCT01628848|588895438|FG001|Overall Study|Lack of Efficacy|4|||
163309197|NCT01361711|589840015|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
163309198|NCT01361711|589840015|FG000|10 Year Follow-up|Progressive Disease|1|||
163309199|NCT02596126|589840016|FG000|Overall Study|Lost to Follow-up|12|||
163202031|NCT00256750|589455603|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
163202032|NCT00256750|589455604|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
163202033|NCT00256750|589455605|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
163202034|NCT00256750|589455603|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
163309200|NCT02596126|589840017|FG001|Overall Study|Lost to Follow-up|21|||
163309201|NCT02596126|589840016|FG000|Overall Study|Protocol Violation|7|||
163309202|NCT02596126|589840017|FG001|Overall Study|Protocol Violation|9|||
163309203|NCT02471638|589840023|FG000|Overall Study|Early Term Withdrawal|10|||
163309204|NCT04024813|589841697|FG000|Overall Study|Study terminated by Sponsor|1|||
163309205|NCT04034251|589841698|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
163309206|NCT04034251|589841699|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
163309207|NCT04034251|589841700|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
163309208|NCT00920621|589841703|FG000|Overall Study|Lost to Follow-up|16|||
163309209|NCT00920621|589841704|FG001|Overall Study|Lost to Follow-up|17|||
163309210|NCT00920621|589841705|FG002|Overall Study|Lost to Follow-up|19|||
163309211|NCT00920621|589841706|FG003|Overall Study|Lost to Follow-up|21|||
163309212|NCT00920621|589841703|FG000|Overall Study|Fetal/neonatal deaths|16|||
163309213|NCT00920621|589841704|FG001|Overall Study|Fetal/neonatal deaths|14|||
163309214|NCT00920621|589841705|FG002|Overall Study|Fetal/neonatal deaths|16|||
163309215|NCT00920621|589841706|FG003|Overall Study|Fetal/neonatal deaths|14|||
163309216|NCT00920621|589841703|FG000|Overall Study|Blood sample not collected|22|||
163309217|NCT00920621|589841704|FG001|Overall Study|Blood sample not collected|14|||
163309218|NCT00920621|589841705|FG002|Overall Study|Blood sample not collected|0|||
163309219|NCT00920621|589841706|FG003|Overall Study|Blood sample not collected|0|||
163309220|NCT01426425|589841707|FG000|Overall Study|Exited prior to EP study|22|||
163309221|NCT01426425|589841707|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
163309222|NCT01426425|589841707|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
163309223|NCT03281291|589841713|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
163309224|NCT03281291|589841714|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
163309225|NCT03281291|589841715|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
163309226|NCT03281291|589841716|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
163309227|NCT03281291|589841717|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
163309228|NCT03281291|589841713|FG000|Overall Study|Protocol Deviation|2|||
163309229|NCT03281291|589841714|FG001|Overall Study|Protocol Deviation|0|||
163309230|NCT03281291|589841715|FG002|Overall Study|Protocol Deviation|1|||
163309231|NCT03281291|589841716|FG003|Overall Study|Protocol Deviation|2|||
163309232|NCT03281291|589841717|FG004|Overall Study|Protocol Deviation|1|||
163309233|NCT03281291|589841713|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
163309234|NCT03281291|589841714|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
163309235|NCT03281291|589841715|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
163309236|NCT03281291|589841716|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
163309237|NCT03281291|589841717|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
163309238|NCT03281291|589841713|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
163309239|NCT03281291|589841714|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
163309240|NCT03281291|589841715|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
163309241|NCT03281291|589841716|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
163309242|NCT03281291|589841717|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
163309243|NCT03281291|589841713|FG000|Overall Study|Lost to Follow-up|10|||
163309244|NCT03281291|589841714|FG001|Overall Study|Lost to Follow-up|10|||
163309245|NCT03281291|589841715|FG002|Overall Study|Lost to Follow-up|4|||
163309246|NCT03281291|589841716|FG003|Overall Study|Lost to Follow-up|6|||
163309247|NCT03281291|589841717|FG004|Overall Study|Lost to Follow-up|10|||
163309248|NCT03281291|589841713|FG000|Overall Study|Other|0|||
163309249|NCT03281291|589841714|FG001|Overall Study|Other|2|||
163309250|NCT03281291|589841715|FG002|Overall Study|Other|0|||
163309251|NCT03281291|589841716|FG003|Overall Study|Other|2|||
163309252|NCT03281291|589841717|FG004|Overall Study|Other|1|||
163309253|NCT00512070|589841718|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
163309254|NCT00512070|589841719|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
163309255|NCT00512070|589841720|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
163309256|NCT00512070|589841718|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
163309257|NCT00512070|589841719|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
163309258|NCT00512070|589841720|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
163309259|NCT04956861|589841721|FG000|Overall Study|Withdrawal by Subject|4|||
163309260|NCT04956861|589841722|FG001|Overall Study|Withdrawal by Subject|4|||
163309261|NCT04956861|589841723|FG002|Overall Study|Withdrawal by Subject|2|||
163309262|NCT04956861|589841721|FG000|Overall Study|Physician Decision|4|||
163309263|NCT04956861|589841722|FG001|Overall Study|Physician Decision|5|||
163309264|NCT04956861|589841723|FG002|Overall Study|Physician Decision|1|||
163309265|NCT00961571|589841724|FG000|Overall Study|Physician Decision|39|||
163309266|NCT05862870|589841729|FG000|Overall Study|Lost to Follow-up|3|||
163309267|NCT02543281|589841732|FG000|Overall Study|Lost to Follow-up|0|||
163309268|NCT02543281|589841733|FG001|Overall Study|Lost to Follow-up|0|||
163309269|NCT02543281|589841734|FG002|Overall Study|Lost to Follow-up|1|||
163309270|NCT03143153|589841735|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
163309271|NCT03143153|589841736|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
162964334|NCT03358147|588569739|FG004|Overall Study|Administrative reasons|0|||
162964335|NCT03358147|588569735|FG000|Overall Study|Lack of Efficacy|0|||
162964336|NCT03358147|588569736|FG001|Overall Study|Lack of Efficacy|1|||
162964337|NCT03358147|588569737|FG002|Overall Study|Lack of Efficacy|1|||
162964338|NCT03358147|588569738|FG003|Overall Study|Lack of Efficacy|0|||
162964339|NCT03358147|588569739|FG004|Overall Study|Lack of Efficacy|0|||
162964340|NCT02072096|588569742|FG000|Overall Study|Lack of Efficacy|18|||
162964341|NCT02072096|588569743|FG001|Overall Study|Lack of Efficacy|29|||
162964342|NCT02072096|588569742|FG000|Overall Study|Protocol Violation|7|||
162964343|NCT02072096|588569743|FG001|Overall Study|Protocol Violation|7|||
162964344|NCT02072096|588569742|FG000|Overall Study|Withdrawal by Subject|5|||
162964345|NCT02072096|588569743|FG001|Overall Study|Withdrawal by Subject|7|||
162964346|NCT02072096|588569742|FG000|Overall Study|Adverse Event|5|||
162964347|NCT02072096|588569743|FG001|Overall Study|Adverse Event|2|||
162964348|NCT02072096|588569742|FG000|Overall Study|No Reason Provided|4|||
162964349|NCT02072096|588569743|FG001|Overall Study|No Reason Provided|2|||
162964350|NCT02072096|588569742|FG000|Overall Study|Death|2|||
162964351|NCT02072096|588569743|FG001|Overall Study|Death|0|||
162964352|NCT02072096|588569742|FG000|Overall Study|Physician Decision|0|||
162964353|NCT02072096|588569743|FG001|Overall Study|Physician Decision|1|||
162964354|NCT02072096|588569742|FG000|Overall Study|Study Terminated by Sponsor|43|||
162964355|NCT02072096|588569743|FG001|Overall Study|Study Terminated by Sponsor|30|||
162964356|NCT02072096|588569742|FG000|Overall Study|Lost to Follow-up|1|||
162964357|NCT02072096|588569743|FG001|Overall Study|Lost to Follow-up|0|||
162964358|NCT03236311|588569744|FG000|Overall Study|Study terminated by sponsor|0|||
162964359|NCT03236311|588569745|FG001|Overall Study|Study terminated by sponsor|2|||
162964360|NCT03236311|588569744|FG000|Overall Study|Adverse Event|0|||
162964361|NCT03236311|588569745|FG001|Overall Study|Adverse Event|1|||
162964362|NCT00669162|588569746|FG000|Overall Study|Withdrawal by Subject|1|||
162964363|NCT02704091|588569747|FG000|Overall Study|Adverse Event|4|||
162964364|NCT02704091|588569748|FG001|Overall Study|Adverse Event|3|||
162964365|NCT02704091|588569747|FG000|Overall Study|Protocol Violation|5|||
162964366|NCT02704091|588569748|FG001|Overall Study|Protocol Violation|3|||
162964367|NCT02704091|588569747|FG000|Overall Study|Consent withdrawn|4|||
162964368|NCT02704091|588569748|FG001|Overall Study|Consent withdrawn|4|||
162964369|NCT02704091|588569747|FG000|Overall Study|Lost to Follow-up|13|||
162964370|NCT02704091|588569748|FG001|Overall Study|Lost to Follow-up|5|||
162964371|NCT02704091|588569747|FG000|Overall Study|Other|2|||
162964372|NCT02704091|588569748|FG001|Overall Study|Other|8|||
162964373|NCT02412852|588569749|FG000|Overall Study|Withdrawal by Subject|0|||
162964374|NCT02412852|588569750|FG001|Overall Study|Withdrawal by Subject|1|||
162964375|NCT02412852|588569751|FG002|Overall Study|Withdrawal by Subject|0|||
162964376|NCT02412852|588569752|FG003|Overall Study|Withdrawal by Subject|0|||
162964377|NCT02412852|588569749|FG000|Overall Study|Physician Decision|0|||
162964378|NCT02412852|588569750|FG001|Overall Study|Physician Decision|0|||
162964379|NCT02412852|588569751|FG002|Overall Study|Physician Decision|0|||
162964380|NCT02412852|588569752|FG003|Overall Study|Physician Decision|1|||
162964381|NCT01051349|588569753|FG000|Overall Study|Adverse Event|88|||
163202035|NCT00256750|589455604|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
163202036|NCT00256750|589455605|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
163202037|NCT00256750|589455603|FG000|Post-Transplant Treated (36 Months)|Death|0|||
163202038|NCT00256750|589455604|FG001|Post-Transplant Treated (36 Months)|Death|2|||
163202039|NCT00256750|589455605|FG002|Post-Transplant Treated (36 Months)|Death|1|||
163202040|NCT00256750|589455603|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
163202041|NCT00256750|589455604|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
163202042|NCT00256750|589455605|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
163202043|NCT00256750|589455603|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
163202044|NCT00256750|589455604|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
163202045|NCT00256750|589455605|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
163202046|NCT00256750|589455603|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
163202047|NCT00256750|589455604|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
163202048|NCT00256750|589455605|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
163202049|NCT00256750|589455603|FG000|Post-Transplant Treated (36 Months)|Other|0|||
163397363|NCT00529451|590166255|FG000|Overall Study|Administrative problems|1|||
162964382|NCT01051349|588569753|FG000|Overall Study|Consent Withdrawn|54|||
162964383|NCT01051349|588569753|FG000|Overall Study|Investigator Decision|6|||
162964384|NCT01051349|588569753|FG000|Overall Study|Lost to Follow-up|6|||
162964385|NCT01051349|588569753|FG000|Overall Study|Subject non-compliance|7|||
162964386|NCT01051349|588569753|FG000|Overall Study|Reason not Specified|12|||
162964387|NCT02336074|588569761|FG000|Overall Study|Adverse Event|0|||
162964388|NCT02336074|588569762|FG001|Overall Study|Adverse Event|2|||
162964389|NCT05604014|588569763|FG000|Overall Study|Lost to Follow-up|13|||
162964390|NCT01266902|588569764|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
162964391|NCT01266902|588569765|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
162964392|NCT01266902|588569766|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
162964393|NCT01266902|588569764|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
162964394|NCT01266902|588569765|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
163309272|NCT03143153|589841737|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
163309273|NCT03143153|589841735|FG000|Pre-Treatment|Participant withdrew consent|0|||
163309274|NCT03143153|589841736|FG001|Pre-Treatment|Participant withdrew consent|1|||
163309275|NCT03143153|589841737|FG002|Pre-Treatment|Participant withdrew consent|12|||
163309276|NCT03143153|589841735|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
163309277|NCT03143153|589841736|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
163309278|NCT03143153|589841737|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
163309279|NCT03143153|589841735|FG000|Pre-Treatment|Other Reasons|1|||
163309280|NCT03143153|589841736|FG001|Pre-Treatment|Other Reasons|2|||
163309281|NCT03143153|589841737|FG002|Pre-Treatment|Other Reasons|1|||
163309282|NCT03143153|589841735|FG000|Pre-Treatment|Disease Progression|1|||
163309283|NCT03143153|589841736|FG001|Pre-Treatment|Disease Progression|1|||
163309284|NCT03143153|589841737|FG002|Pre-Treatment|Disease Progression|2|||
163309285|NCT03143153|589841735|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
163309286|NCT03143153|589841736|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
163309287|NCT03143153|589841737|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
163309288|NCT03143153|589841735|FG000|Treatment|Disease progression|174|||
163309289|NCT03143153|589841736|FG001|Treatment|Disease progression|184|||
163309290|NCT03143153|589841737|FG002|Treatment|Disease progression|193|||
163202050|NCT00256750|589455604|FG001|Post-Transplant Treated (36 Months)|Other|1|||
163202051|NCT00256750|589455605|FG002|Post-Transplant Treated (36 Months)|Other|1|||
163202052|NCT00256750|589455603|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
163202053|NCT00256750|589455604|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
163309291|NCT03143153|589841735|FG000|Treatment|Study drug toxicity|59|||
163309292|NCT03143153|589841736|FG001|Treatment|Study drug toxicity|33|||
163309293|NCT03143153|589841737|FG002|Treatment|Study drug toxicity|40|||
163309294|NCT03143153|589841735|FG000|Treatment|Death|5|||
163309295|NCT03143153|589841736|FG001|Treatment|Death|3|||
163309296|NCT03143153|589841737|FG002|Treatment|Death|4|||
163309297|NCT03143153|589841735|FG000|Treatment|Adverse event unrelated to study drug|19|||
163309298|NCT03143153|589841736|FG001|Treatment|Adverse event unrelated to study drug|28|||
163309299|NCT03143153|589841737|FG002|Treatment|Adverse event unrelated to study drug|12|||
163309300|NCT03143153|589841735|FG000|Treatment|Participant request to discontinue study treatment|13|||
163309301|NCT03143153|589841736|FG001|Treatment|Participant request to discontinue study treatment|15|||
163309302|NCT03143153|589841737|FG002|Treatment|Participant request to discontinue study treatment|20|||
163309303|NCT03143153|589841735|FG000|Treatment|Participant withdrew consent|3|||
163309304|NCT03143153|589841736|FG001|Treatment|Participant withdrew consent|4|||
163309305|NCT03143153|589841737|FG002|Treatment|Participant withdrew consent|12|||
163309306|NCT03143153|589841735|FG000|Treatment|Pregnancy|1|||
163309307|NCT03143153|589841736|FG001|Treatment|Pregnancy|0|||
163309308|NCT03143153|589841737|FG002|Treatment|Pregnancy|0|||
163309309|NCT03143153|589841735|FG000|Treatment|Maximum clinical benefit|1|||
163309310|NCT03143153|589841736|FG001|Treatment|Maximum clinical benefit|3|||
163309311|NCT03143153|589841737|FG002|Treatment|Maximum clinical benefit|4|||
163309312|NCT03143153|589841735|FG000|Treatment|Completed treatment as per Protocol|13|||
163309313|NCT03143153|589841736|FG001|Treatment|Completed treatment as per Protocol|8|||
163309314|NCT03143153|589841737|FG002|Treatment|Completed treatment as per Protocol|0|||
163309315|NCT03143153|589841735|FG000|Treatment|Other reasons|12|||
163309316|NCT03143153|589841736|FG001|Treatment|Other reasons|7|||
163309317|NCT03143153|589841737|FG002|Treatment|Other reasons|15|||
163309318|NCT03143153|589841735|FG000|Treatment|Not reported|1|||
163309319|NCT03143153|589841736|FG001|Treatment|Not reported|0|||
163309320|NCT03143153|589841737|FG002|Treatment|Not reported|0|||
163309321|NCT02736409|589841743|FG000|Overall Study|Withdrawal by Subject|4|||
163309322|NCT02736409|589841744|FG001|Overall Study|Withdrawal by Subject|2|||
163309323|NCT02736409|589841745|FG002|Overall Study|Withdrawal by Subject|17|||
163309324|NCT02736409|589841746|FG003|Overall Study|Withdrawal by Subject|3|||
163309325|NCT02736409|589841743|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163309326|NCT02736409|589841744|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163309327|NCT02736409|589841745|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163309328|NCT02736409|589841746|FG003|Overall Study|Non-Compliance with Study Drug|1|||
163309329|NCT02736409|589841743|FG000|Overall Study|Adverse Event|0|||
163309330|NCT02736409|589841744|FG001|Overall Study|Adverse Event|1|||
163309331|NCT02736409|589841745|FG002|Overall Study|Adverse Event|5|||
162964395|NCT01266902|588569766|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
162964396|NCT01266902|588569764|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
163202054|NCT00256750|589455605|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
163202055|NCT00256750|589455603|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
163202056|NCT00256750|589455604|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
163202057|NCT00256750|589455605|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
163309332|NCT02736409|589841746|FG003|Overall Study|Adverse Event|4|||
163309333|NCT02736409|589841743|FG000|Overall Study|Other|0|||
163309334|NCT02736409|589841744|FG001|Overall Study|Other|0|||
163051353|NCT01628848|588895437|FG000|Overall Study|Withdrawal by Subject|0|||
163051354|NCT01628848|588895438|FG001|Overall Study|Withdrawal by Subject|2|||
163051355|NCT01628848|588895437|FG000|Overall Study|Physician Decision|3|||
163051356|NCT01628848|588895438|FG001|Overall Study|Physician Decision|1|||
163051357|NCT01939314|588895440|FG000|Overall Study|Withdrawal by Subject|3|||
163051358|NCT01939314|588895441|FG001|Overall Study|Withdrawal by Subject|1|||
163051359|NCT01939314|588895440|FG000|Overall Study|Protocol Violation|1|||
163051360|NCT01939314|588895441|FG001|Overall Study|Protocol Violation|0|||
163051361|NCT01939314|588895440|FG000|Overall Study|Pregnancy|0|||
163051362|NCT01939314|588895441|FG001|Overall Study|Pregnancy|1|||
163051363|NCT01939314|588895440|FG000|Overall Study|Lost to Follow-up|5|||
163051364|NCT01939314|588895441|FG001|Overall Study|Lost to Follow-up|6|||
163051365|NCT00735007|588895442|FG000|Overall Study|Adverse Event|4|||
163051366|NCT00735007|588895442|FG000|Overall Study|Protocol Violation|1|||
163051367|NCT03311945|588895443|FG000|Overall Study|Adverse Event|2|||
163051368|NCT03311945|588895443|FG000|Overall Study|Lack of Efficacy|1|||
163051369|NCT03839394|588895444|FG000|Overall Study|Lost to Follow-up|6|||
163309335|NCT02736409|589841745|FG002|Overall Study|Other|1|||
163309336|NCT02736409|589841746|FG003|Overall Study|Other|1|||
163309337|NCT02736409|589841743|FG000|Overall Study|Pregnancy|0|||
163309338|NCT02736409|589841744|FG001|Overall Study|Pregnancy|0|||
163309339|NCT02736409|589841745|FG002|Overall Study|Pregnancy|1|||
163309340|NCT02736409|589841746|FG003|Overall Study|Pregnancy|0|||
163051370|NCT03839394|588895445|FG001|Overall Study|Lost to Follow-up|8|||
163051371|NCT03839394|588895444|FG000|Overall Study|Withdrawal by Subject|0|||
163051372|NCT03839394|588895445|FG001|Overall Study|Withdrawal by Subject|2|||
163051373|NCT01945944|588895454|FG000|Overall Study|Adverse Event|0|||
163051374|NCT01945944|588895455|FG001|Overall Study|Adverse Event|2|||
163051375|NCT01945944|588895454|FG000|Overall Study|Physician Decision|1|||
163051376|NCT01945944|588895455|FG001|Overall Study|Physician Decision|0|||
163051377|NCT01945944|588895454|FG000|Overall Study|Withdrawal by Subject|0|||
163051378|NCT01945944|588895455|FG001|Overall Study|Withdrawal by Subject|1|||
163051379|NCT04376515|588895458|FG000|Overall Study|Found to have been vaccinated before study start|6|||
163309341|NCT02736409|589841743|FG000|Overall Study|Lost to Follow-up|0|||
163309342|NCT02736409|589841744|FG001|Overall Study|Lost to Follow-up|0|||
163309343|NCT02736409|589841745|FG002|Overall Study|Lost to Follow-up|2|||
163309344|NCT02736409|589841746|FG003|Overall Study|Lost to Follow-up|1|||
163309345|NCT02736409|589841743|FG000|Overall Study|Physician Decision|0|||
163309346|NCT02736409|589841744|FG001|Overall Study|Physician Decision|0|||
163309347|NCT02736409|589841745|FG002|Overall Study|Physician Decision|0|||
163309348|NCT02736409|589841746|FG003|Overall Study|Physician Decision|2|||
163051380|NCT04376515|588895459|FG001|Overall Study|Found to have been vaccinated before study start|6|||
163051381|NCT04579380|588897109|FG000|Overall Study|Death|9|||
163309349|NCT01415154|589841747|FG000|Overall Study|Lack of Efficacy|4|||
163309350|NCT01415154|589841748|FG001|Overall Study|Lack of Efficacy|5|||
163309351|NCT01415154|589841747|FG000|Overall Study|Withdrawal by Subject|7|||
163309352|NCT01415154|589841748|FG001|Overall Study|Withdrawal by Subject|8|||
163309353|NCT01415154|589841747|FG000|Overall Study|Lost to Follow-up|1|||
163309354|NCT01415154|589841748|FG001|Overall Study|Lost to Follow-up|4|||
163309355|NCT01415154|589841747|FG000|Overall Study|Protocol Violation|0|||
163309356|NCT01415154|589841748|FG001|Overall Study|Protocol Violation|1|||
163309357|NCT01415154|589841747|FG000|Overall Study|Satisfactory Response|0|||
163309358|NCT01415154|589841748|FG001|Overall Study|Satisfactory Response|1|||
163309359|NCT01415154|589841747|FG000|Overall Study|Adverse Event|1|||
163309360|NCT01415154|589841748|FG001|Overall Study|Adverse Event|1|||
163309361|NCT00170573|589841751|FG000|Overall Study|Violation of inclusion criteria|13|||
163309362|NCT03763708|589841777|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
163309363|NCT03763708|589841778|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163309364|NCT03763708|589841779|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163309365|NCT03763708|589841780|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163309366|NCT03763708|589841781|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163309367|NCT03763708|589841782|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163309368|NCT03763708|589841783|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163051382|NCT04579380|588897110|FG001|Overall Study|Death|22|||
163051383|NCT04579380|588897111|FG002|Overall Study|Death|22|||
163051384|NCT04579380|588897112|FG003|Overall Study|Death|17|||
163051385|NCT04579380|588897113|FG004|Overall Study|Death|6|||
163309369|NCT03763708|589841784|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163309370|NCT03763708|589841785|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163309371|NCT03763708|589841777|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
163309372|NCT03763708|589841778|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
163309373|NCT03763708|589841779|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
163309374|NCT03763708|589841780|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
163309375|NCT03763708|589841781|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
163309376|NCT03763708|589841782|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
163309377|NCT03763708|589841783|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
163309378|NCT03763708|589841784|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
163309379|NCT03763708|589841785|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
163309380|NCT03763708|589841777|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163309381|NCT03763708|589841778|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163309382|NCT03763708|589841779|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163309383|NCT03763708|589841780|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
163309384|NCT03763708|589841781|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163309385|NCT03763708|589841782|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163309386|NCT03763708|589841783|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163309387|NCT03763708|589841784|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163309388|NCT03763708|589841785|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163309389|NCT03763708|589841777|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
163309390|NCT03763708|589841778|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
163309391|NCT03763708|589841779|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
163309392|NCT03763708|589841780|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
163309393|NCT03763708|589841781|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
163309394|NCT03763708|589841782|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
163309395|NCT03763708|589841783|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
163309396|NCT03763708|589841784|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
163309397|NCT03763708|589841785|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
163309398|NCT03763708|589841777|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
163309399|NCT03763708|589841778|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
163309400|NCT03763708|589841779|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
163309401|NCT03763708|589841780|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
163309402|NCT03763708|589841781|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
163309403|NCT03763708|589841782|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
163309404|NCT03763708|589841783|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
163309405|NCT03763708|589841784|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
163309406|NCT03763708|589841785|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
163309407|NCT03763708|589841777|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
163309408|NCT03763708|589841778|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
163309409|NCT03763708|589841779|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
163309410|NCT03763708|589841780|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
163309411|NCT03763708|589841781|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
163309412|NCT03763708|589841782|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
163309413|NCT03763708|589841783|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
163309414|NCT03763708|589841784|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
163309415|NCT03763708|589841785|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
163309416|NCT03763708|589841777|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
163309417|NCT03763708|589841778|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
163309418|NCT03763708|589841779|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
163309419|NCT03763708|589841780|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
163309420|NCT03763708|589841781|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
163309421|NCT03763708|589841782|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
163309422|NCT03763708|589841783|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
163309423|NCT03763708|589841784|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
163309424|NCT03763708|589841785|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
163309425|NCT03763708|589841777|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
163309426|NCT03763708|589841778|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
163309427|NCT03763708|589841779|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
163309428|NCT03763708|589841780|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
163309429|NCT03763708|589841781|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
163309430|NCT03763708|589841782|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
163309431|NCT03763708|589841783|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
163309432|NCT03763708|589841784|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
163309433|NCT03763708|589841785|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
163309434|NCT03763708|589841777|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
163309435|NCT03763708|589841778|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
163309436|NCT03763708|589841779|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
163309437|NCT03763708|589841780|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
163309438|NCT03763708|589841781|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
163309439|NCT03763708|589841782|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
162964397|NCT01266902|588569765|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
162964398|NCT01266902|588569766|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
162964399|NCT01266902|588569764|FG000|Period 1 (Main Study)|Adverse Event|3|||
162964400|NCT01266902|588569765|FG001|Period 1 (Main Study)|Adverse Event|11|||
162964401|NCT01266902|588569766|FG002|Period 1 (Main Study)|Adverse Event|0|||
162964402|NCT01266902|588569764|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
162964403|NCT01266902|588569765|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
162964404|NCT01266902|588569766|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
162964405|NCT01266902|588569764|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
162964406|NCT01266902|588569765|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
162964407|NCT01266902|588569766|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
162964408|NCT01266902|588569764|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
162964409|NCT01266902|588569765|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
162964410|NCT01266902|588569766|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
162964411|NCT01266902|588569764|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
162964412|NCT01266902|588569765|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
162964413|NCT01266902|588569766|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
162964414|NCT01266902|588569764|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
162964415|NCT01266902|588569765|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
162964416|NCT01266902|588569766|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
162964417|NCT01266902|588569764|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
162964418|NCT01266902|588569765|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
162964419|NCT01266902|588569766|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
162964420|NCT02121184|588569767|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
162964421|NCT02121184|588569768|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
162964422|NCT02121184|588569767|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
162964423|NCT02121184|588569768|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
162964424|NCT02121184|588569767|FG000|Overall Study|Emergency cesarean section required|0|||
162964425|NCT02121184|588569768|FG001|Overall Study|Emergency cesarean section required|2|||
162964426|NCT02121184|588569767|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
162964427|NCT02121184|588569768|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
162964428|NCT00840203|588569769|FG000|First Intervention|Protocol Violation|1|||
162964429|NCT00840203|588569770|FG001|First Intervention|Protocol Violation|1|||
162964430|NCT00840203|588569769|FG000|Washout|Protocol Violation|1|||
162964431|NCT00840203|588569770|FG001|Washout|Protocol Violation|0|||
162964432|NCT04567329|588569773|FG000|Overall Study|Withdrawal by Subject|5|||
162964433|NCT04567329|588569774|FG001|Overall Study|Withdrawal by Subject|6|||
162964434|NCT04567329|588569773|FG000|Overall Study|Protocol Violation|2|||
162964435|NCT04567329|588569774|FG001|Overall Study|Protocol Violation|3|||
162964436|NCT04567329|588569773|FG000|Overall Study|Discontinued|2|||
162964437|NCT04567329|588569774|FG001|Overall Study|Discontinued|2|||
162964438|NCT04567329|588569773|FG000|Overall Study|Lost to Follow-up|0|||
162964439|NCT04567329|588569774|FG001|Overall Study|Lost to Follow-up|1|||
162964440|NCT04567329|588569773|FG000|Overall Study|Lack of Efficacy|0|||
162964441|NCT04567329|588569774|FG001|Overall Study|Lack of Efficacy|1|||
162964442|NCT01438060|588569776|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
162964443|NCT01438060|588569777|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
162964444|NCT01438060|588569776|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
162964445|NCT01438060|588569777|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
162964446|NCT01438060|588569776|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
163202058|NCT00256750|589455603|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
163202059|NCT00256750|589455604|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
163202060|NCT00256750|589455605|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
163202061|NCT00256750|589455603|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
163202062|NCT00256750|589455604|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
163202063|NCT00256750|589455605|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
163202064|NCT00256750|589455603|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
163202065|NCT00256750|589455604|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
163202066|NCT00256750|589455605|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
163202067|NCT00256750|589455603|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
163202068|NCT00256750|589455604|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
163202069|NCT00256750|589455605|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
163202070|NCT00256750|589455603|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
163202071|NCT00256750|589455604|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
162964447|NCT01438060|588569777|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
162964448|NCT01438060|588569776|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
162964449|NCT01438060|588569777|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
162964450|NCT01438060|588569776|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
163202072|NCT00256750|589455605|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
163202073|NCT00256750|589455603|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
163202074|NCT00256750|589455604|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
163202075|NCT00256750|589455605|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
163202076|NCT00256750|589455603|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
163202077|NCT00256750|589455604|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
163202078|NCT00256750|589455605|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
163202079|NCT02439138|589455610|FG000|Overall Study|Adverse Event|1|||
163202080|NCT02439138|589455610|FG000|Overall Study|PI decision to terminate the study|2|||
163202081|NCT04659161|589455611|FG000|Overall Study|Adverse Event|10|||
163202082|NCT04659161|589455612|FG001|Overall Study|Adverse Event|6|||
163202083|NCT04659161|589455611|FG000|Overall Study|Withdrawal by Subject|13|||
163202084|NCT04659161|589455612|FG001|Overall Study|Withdrawal by Subject|12|||
163202085|NCT04659161|589455611|FG000|Overall Study|Other|9|||
163202086|NCT04659161|589455612|FG001|Overall Study|Other|8|||
163202087|NCT01929343|589455613|FG000|Overall Study|Physician Decision|0|||
163202088|NCT01929343|589455614|FG001|Overall Study|Physician Decision|2|||
163202089|NCT01929343|589455615|FG002|Overall Study|Physician Decision|0|||
163202090|NCT01929343|589455613|FG000|Overall Study|Withdrawal by Subject|1|||
163202091|NCT01929343|589455614|FG001|Overall Study|Withdrawal by Subject|0|||
163202092|NCT01929343|589455615|FG002|Overall Study|Withdrawal by Subject|0|||
163202093|NCT02197130|589455618|FG000|Overall Study|Adverse Event|13|||
163202094|NCT02197130|589455619|FG001|Overall Study|Adverse Event|4|||
163202095|NCT02197130|589455620|FG002|Overall Study|Adverse Event|23|||
163202096|NCT02197130|589455618|FG000|Overall Study|Death|0|||
163202097|NCT02197130|589455619|FG001|Overall Study|Death|1|||
163202098|NCT02197130|589455620|FG002|Overall Study|Death|0|||
163202099|NCT02197130|589455618|FG000|Overall Study|Lost to Follow-up|2|||
163202100|NCT02197130|589455619|FG001|Overall Study|Lost to Follow-up|0|||
163202101|NCT02197130|589455620|FG002|Overall Study|Lost to Follow-up|1|||
163202102|NCT02197130|589455618|FG000|Overall Study|Does not meet entrance criteria|0|||
163202103|NCT02197130|589455619|FG001|Overall Study|Does not meet entrance criteria|0|||
163202104|NCT02197130|589455620|FG002|Overall Study|Does not meet entrance criteria|1|||
163202105|NCT02197130|589455618|FG000|Overall Study|Withdrawal by Subject|0|||
163202106|NCT02197130|589455619|FG001|Overall Study|Withdrawal by Subject|3|||
163202107|NCT02197130|589455620|FG002|Overall Study|Withdrawal by Subject|4|||
163202108|NCT02197130|589455618|FG000|Overall Study|Other|1|||
163202109|NCT02197130|589455619|FG001|Overall Study|Other|0|||
163202110|NCT02197130|589455620|FG002|Overall Study|Other|3|||
163202111|NCT02615145|589455621|FG000|Overall Study|Did Not Start Treatment|0|||
163202112|NCT02615145|589455622|FG001|Overall Study|Did Not Start Treatment|0|||
163202113|NCT02615145|589455623|FG002|Overall Study|Did Not Start Treatment|1|||
163202114|NCT02615145|589455624|FG003|Overall Study|Did Not Start Treatment|1|||
163202115|NCT02615145|589455621|FG000|Overall Study|Failure to Return|20|||
163202116|NCT02615145|589455622|FG001|Overall Study|Failure to Return|10|||
163202117|NCT02615145|589455623|FG002|Overall Study|Failure to Return|7|||
163202118|NCT02615145|589455624|FG003|Overall Study|Failure to Return|0|||
163202119|NCT02615145|589455621|FG000|Overall Study|Death|2|||
163202120|NCT02615145|589455622|FG001|Overall Study|Death|3|||
163202121|NCT02615145|589455623|FG002|Overall Study|Death|0|||
163202122|NCT02615145|589455624|FG003|Overall Study|Death|0|||
163202123|NCT02615145|589455621|FG000|Overall Study|Other, Not Specified|5|||
163202124|NCT02615145|589455622|FG001|Overall Study|Other, Not Specified|2|||
163202125|NCT02615145|589455623|FG002|Overall Study|Other, Not Specified|0|||
163202126|NCT02615145|589455624|FG003|Overall Study|Other, Not Specified|0|||
163202127|NCT00006237|589455627|FG000|Overall Study|Adverse Event|39|||
163202128|NCT00006237|589455628|FG001|Overall Study|Adverse Event|29|||
163202129|NCT00006237|589455627|FG000|Overall Study|Death|1|||
163202130|NCT00006237|589455628|FG001|Overall Study|Death|0|||
163202131|NCT00006237|589455627|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
163202132|NCT00006237|589455628|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
163202133|NCT00006237|589455627|FG000|Overall Study|Progression/relapse|54|||
163202134|NCT00006237|589455628|FG001|Overall Study|Progression/relapse|2|||
163202135|NCT00006237|589455627|FG000|Overall Study|Not eligible|9|||
163202136|NCT00006237|589455628|FG001|Overall Study|Not eligible|20|||
163202137|NCT00006237|589455627|FG000|Overall Study|Withdrawal by Subject|0|||
163202138|NCT00006237|589455628|FG001|Overall Study|Withdrawal by Subject|1|||
163202139|NCT00006237|589455627|FG000|Overall Study|Not protocol specified|14|||
163202140|NCT00006237|589455628|FG001|Overall Study|Not protocol specified|5|||
163202141|NCT03648983|589455636|FG000|Overall Study|Study was terminated due to PI departure|95|||
163202142|NCT01943292|589457020|FG000|Overall Study|Withdrawal by Subject|1|||
163202143|NCT01943292|589457021|FG001|Overall Study|Withdrawal by Subject|0|||
163202144|NCT01943292|589457022|FG002|Overall Study|Withdrawal by Subject|0|||
163202145|NCT00911820|589457023|FG000|Overall Study|RECIST progression|12|||
163202146|NCT00911820|589457024|FG001|Overall Study|RECIST progression|8|||
163202147|NCT00911820|589457023|FG000|Overall Study|Adverse Event|8|||
163202148|NCT00911820|589457024|FG001|Overall Study|Adverse Event|8|||
163309440|NCT03763708|589841783|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
163309441|NCT03763708|589841784|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
163309442|NCT03763708|589841785|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
163309443|NCT03332017|589841788|FG000|Overall Study|Lost to Follow-up|1|||
163309444|NCT03332017|589841789|FG001|Overall Study|Lost to Follow-up|2|||
163309445|NCT03332017|589841788|FG000|Overall Study|Death|17|||
163202149|NCT00911820|589457023|FG000|Overall Study|Clinical Progression|7|||
163202150|NCT00911820|589457024|FG001|Overall Study|Clinical Progression|5|||
163202151|NCT00911820|589457023|FG000|Overall Study|Physician Decision|5|||
163202152|NCT00911820|589457024|FG001|Overall Study|Physician Decision|9|||
163202153|NCT00911820|589457023|FG000|Overall Study|Decline in Performance Status|4|||
163202154|NCT00911820|589457024|FG001|Overall Study|Decline in Performance Status|2|||
163202155|NCT00911820|589457023|FG000|Overall Study|Withdrawal by Subject|3|||
163202156|NCT00911820|589457024|FG001|Overall Study|Withdrawal by Subject|4|||
163202157|NCT00911820|589457023|FG000|Overall Study|Death|1|||
163202158|NCT00911820|589457024|FG001|Overall Study|Death|2|||
163202159|NCT00911820|589457023|FG000|Overall Study|Pursue surgery|1|||
163202160|NCT00911820|589457024|FG001|Overall Study|Pursue surgery|1|||
163202161|NCT00911820|589457023|FG000|Overall Study|Pursue Radiation|1|||
163202162|NCT00911820|589457024|FG001|Overall Study|Pursue Radiation|0|||
163202163|NCT00911820|589457023|FG000|Overall Study|Still on Therapy|2|||
163202164|NCT00911820|589457024|FG001|Overall Study|Still on Therapy|2|||
163202165|NCT00911820|589457023|FG000|Overall Study|Pathology Not Confirmed|1|||
163202166|NCT00911820|589457024|FG001|Overall Study|Pathology Not Confirmed|0|||
163202167|NCT00911820|589457023|FG000|Overall Study|Withdraw before Receive Treatment|0|||
163202168|NCT00911820|589457024|FG001|Overall Study|Withdraw before Receive Treatment|2|||
163202169|NCT00996216|589457025|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
163202170|NCT00996216|589457025|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
163202171|NCT00996216|589457025|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
163202172|NCT00187486|589457032|FG000|Overall Study|Protocol Violation|1|||
163202173|NCT03489720|589457033|FG000|Overall Study|Withdrawal by Subject|2|||
163202174|NCT03489720|589457034|FG001|Overall Study|Withdrawal by Subject|0|||
163202175|NCT02511184|589457035|FG000|Overall Study|Death|1|||
163309446|NCT03332017|589841789|FG001|Overall Study|Death|16|||
163309447|NCT03332017|589841788|FG000|Overall Study|Withdrawal by Subject|6|||
163309448|NCT03332017|589841789|FG001|Overall Study|Withdrawal by Subject|14|||
163309449|NCT03332017|589841788|FG000|Overall Study|Other|1|||
163202176|NCT02511184|589457036|FG001|Overall Study|Death|0|||
163202177|NCT02511184|589457035|FG000|Overall Study|Lost to Follow-up|0|||
163202178|NCT02511184|589457036|FG001|Overall Study|Lost to Follow-up|1|||
163202179|NCT02511184|589457035|FG000|Overall Study|Study terminated by sponsor|1|||
163202180|NCT02511184|589457036|FG001|Overall Study|Study terminated by sponsor|5|||
163202181|NCT02511184|589457035|FG000|Overall Study|Withdrawal by Subject|0|||
163202182|NCT02511184|589457036|FG001|Overall Study|Withdrawal by Subject|1|||
163202183|NCT01806545|589457037|FG000|Overall Study|Adverse Event|2|||
163202184|NCT01806545|589457038|FG001|Overall Study|Adverse Event|3|||
163202185|NCT01806545|589457037|FG000|Overall Study|Lost to Follow-up|1|||
163202186|NCT01806545|589457038|FG001|Overall Study|Lost to Follow-up|0|||
163309450|NCT03332017|589841789|FG001|Overall Study|Other|3|||
163202187|NCT01806545|589457037|FG000|Overall Study|Withdrawal by Subject|3|||
163202188|NCT01806545|589457038|FG001|Overall Study|Withdrawal by Subject|2|||
163202189|NCT00884312|589457039|FG000|Overall Study|Non-fatal Progressive Disease|0|||
163202190|NCT00884312|589457040|FG001|Overall Study|Non-fatal Progressive Disease|8|||
163202191|NCT00884312|589457039|FG000|Overall Study|Fatal Progressive Disease|0|||
163202192|NCT00884312|589457040|FG001|Overall Study|Fatal Progressive Disease|1|||
163202193|NCT00884312|589457039|FG000|Overall Study|Non-fatal Adverse Event|1|||
163309451|NCT03332017|589841788|FG000|Overall Study|Remained in Study (Ongoing)|47|||
163309452|NCT03332017|589841789|FG001|Overall Study|Remained in Study (Ongoing)|110|||
163309453|NCT01580488|589841793|FG000|Overall Study|Withdrawal by Subject|1|||
163309454|NCT02243709|589841798|FG000|Phase 1|Lost to Follow-up|0|||
163309455|NCT02243709|589841799|FG001|Phase 1|Lost to Follow-up|1|||
163202194|NCT00884312|589457040|FG001|Overall Study|Non-fatal Adverse Event|0|||
163202195|NCT00884312|589457039|FG000|Overall Study|Fatal Adverse Event|1|||
163202196|NCT00884312|589457040|FG001|Overall Study|Fatal Adverse Event|4|||
163202197|NCT00884312|589457039|FG000|Overall Study|Withdrawal by Subject|0|||
163202198|NCT00884312|589457040|FG001|Overall Study|Withdrawal by Subject|6|||
163202199|NCT00884312|589457039|FG000|Overall Study|Physician Decision|0|||
163202200|NCT00884312|589457040|FG001|Overall Study|Physician Decision|1|||
163309456|NCT02243709|589841798|FG000|Phase 1|Withdrawal by Subject|1|||
163309457|NCT02243709|589841799|FG001|Phase 1|Withdrawal by Subject|0|||
163309458|NCT02243709|589841798|FG000|Phase 1|Protocol Violation|0|||
163309459|NCT02243709|589841799|FG001|Phase 1|Protocol Violation|1|||
163309460|NCT02243709|589841798|FG000|Phase 1|Adverse Event|0|||
163202201|NCT00884312|589457039|FG000|Overall Study|Other|0|||
163202202|NCT00884312|589457040|FG001|Overall Study|Other|4|||
163202203|NCT00884312|589457039|FG000|Overall Study|Did Not Receive Study Drug|0|||
163202204|NCT00884312|589457040|FG001|Overall Study|Did Not Receive Study Drug|1|||
163202205|NCT03521934|589457050|FG000|Overall Study|Death|65|||
163309461|NCT02243709|589841799|FG001|Phase 1|Adverse Event|1|||
163309462|NCT05178316|589841801|FG000|Overall Study|Adverse Event|5|||
163309463|NCT05178316|589841802|FG001|Overall Study|Adverse Event|4|||
163309464|NCT05178316|589841803|FG002|Overall Study|Adverse Event|9|||
163309465|NCT05178316|589841801|FG000|Overall Study|Enrolled in Error|1|||
163309466|NCT05178316|589841802|FG001|Overall Study|Enrolled in Error|2|||
163309467|NCT05178316|589841803|FG002|Overall Study|Enrolled in Error|1|||
163309468|NCT05178316|589841801|FG000|Overall Study|Lost to Follow-up|3|||
163309469|NCT05178316|589841802|FG001|Overall Study|Lost to Follow-up|15|||
163309470|NCT05178316|589841803|FG002|Overall Study|Lost to Follow-up|11|||
163309471|NCT05178316|589841801|FG000|Overall Study|Noncompliance|1|||
163309472|NCT05178316|589841802|FG001|Overall Study|Noncompliance|3|||
163309473|NCT05178316|589841803|FG002|Overall Study|Noncompliance|1|||
163309474|NCT05178316|589841801|FG000|Overall Study|Other|0|||
163309475|NCT05178316|589841802|FG001|Overall Study|Other|1|||
163309476|NCT05178316|589841803|FG002|Overall Study|Other|0|||
163309477|NCT05178316|589841801|FG000|Overall Study|Physician Decision|0|||
163309478|NCT05178316|589841802|FG001|Overall Study|Physician Decision|3|||
163309479|NCT05178316|589841803|FG002|Overall Study|Physician Decision|2|||
163309480|NCT05178316|589841801|FG000|Overall Study|Protocol deviation|1|||
163309481|NCT05178316|589841802|FG001|Overall Study|Protocol deviation|0|||
163309482|NCT05178316|589841803|FG002|Overall Study|Protocol deviation|1|||
163309483|NCT05178316|589841801|FG000|Overall Study|Sponsor decision|1|||
163309484|NCT05178316|589841802|FG001|Overall Study|Sponsor decision|0|||
163309485|NCT05178316|589841803|FG002|Overall Study|Sponsor decision|1|||
163309486|NCT05178316|589841801|FG000|Overall Study|Withdrawal by Subject|5|||
163309487|NCT05178316|589841802|FG001|Overall Study|Withdrawal by Subject|11|||
163309488|NCT05178316|589841803|FG002|Overall Study|Withdrawal by Subject|5|||
163309489|NCT04347161|589841804|FG000|Overall Study|Death|0|||
163309490|NCT04347161|589841805|FG001|Overall Study|Death|2|||
163309491|NCT04347161|589841804|FG000|Overall Study|Withdrawal by Subject|1|||
163309492|NCT04347161|589841805|FG001|Overall Study|Withdrawal by Subject|0|||
163309493|NCT04347161|589841804|FG000|Overall Study|Lost to Follow-up|0|||
163309494|NCT04347161|589841805|FG001|Overall Study|Lost to Follow-up|1|||
163309495|NCT04347161|589841804|FG000|Overall Study|No longer on study medication|1|||
163309496|NCT04347161|589841805|FG001|Overall Study|No longer on study medication|1|||
163309497|NCT04610892|589841806|FG000|Overall Study|Adverse Event|1|||
163309498|NCT04610892|589841807|FG001|Overall Study|Adverse Event|0|||
163309499|NCT04610892|589841808|FG002|Overall Study|Adverse Event|0|||
163309500|NCT04610892|589841809|FG003|Overall Study|Adverse Event|1|||
163309501|NCT04610892|589841810|FG004|Overall Study|Adverse Event|3|||
163309502|NCT04610892|589841806|FG000|Overall Study|Death|0|||
163309503|NCT04610892|589841807|FG001|Overall Study|Death|1|||
163309504|NCT04610892|589841808|FG002|Overall Study|Death|0|||
163309505|NCT04610892|589841809|FG003|Overall Study|Death|1|||
163309506|NCT04610892|589841810|FG004|Overall Study|Death|0|||
163309507|NCT04610892|589841806|FG000|Overall Study|Withdrawal by Subject|3|||
163309508|NCT04610892|589841807|FG001|Overall Study|Withdrawal by Subject|2|||
163309509|NCT04610892|589841808|FG002|Overall Study|Withdrawal by Subject|0|||
163309510|NCT04610892|589841809|FG003|Overall Study|Withdrawal by Subject|6|||
163309511|NCT04610892|589841810|FG004|Overall Study|Withdrawal by Subject|6|||
163309512|NCT04610892|589841806|FG000|Overall Study|Subjects who did not receive treatment|1|||
163309513|NCT04610892|589841807|FG001|Overall Study|Subjects who did not receive treatment|0|||
163309514|NCT04610892|589841808|FG002|Overall Study|Subjects who did not receive treatment|0|||
163309515|NCT04610892|589841809|FG003|Overall Study|Subjects who did not receive treatment|0|||
163309516|NCT04610892|589841810|FG004|Overall Study|Subjects who did not receive treatment|2|||
163309517|NCT01413100|589841811|FG000|Overall Study|Withdrawal by Subject|1|||
163309518|NCT05369403|589841812|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
163309519|NCT05369403|589841813|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
163309520|NCT05369403|589841814|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
163309521|NCT05369403|589841812|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
163309522|NCT05369403|589841813|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
163309523|NCT05369403|589841814|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
163309524|NCT05369403|589841812|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
163309525|NCT05369403|589841813|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
163309526|NCT05369403|589841814|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
163309527|NCT05369403|589841812|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
163309528|NCT05369403|589841813|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
163309529|NCT05369403|589841814|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
163309530|NCT05369403|589841812|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
163309531|NCT05369403|589841813|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
163309532|NCT05369403|589841814|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
163309533|NCT05369403|589841812|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
163309534|NCT05369403|589841813|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
163309535|NCT05369403|589841814|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
163309536|NCT05369403|589841812|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
163309537|NCT05369403|589841813|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
163309538|NCT05369403|589841814|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
163309539|NCT05369403|589841812|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
163309540|NCT05369403|589841813|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
163309541|NCT05369403|589841814|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
163309542|NCT05369403|589841812|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
163309543|NCT05369403|589841813|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
163309544|NCT05369403|589841814|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
163309545|NCT05369403|589841812|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
163309546|NCT05369403|589841813|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
163309547|NCT05369403|589841814|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
163309548|NCT05369403|589841812|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
163309549|NCT05369403|589841813|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
163309550|NCT05369403|589841814|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
163309551|NCT03792256|589841815|FG000|Overall Study|Death|0|||
163309552|NCT03792256|589841816|FG001|Overall Study|Death|1|||
163309553|NCT03792256|589841815|FG000|Overall Study|Lack of Efficacy|0|||
163309554|NCT03792256|589841816|FG001|Overall Study|Lack of Efficacy|1|||
163309555|NCT03792256|589841815|FG000|Overall Study|Withdrawal by Subject|0|||
163309556|NCT03792256|589841816|FG001|Overall Study|Withdrawal by Subject|1|||
163309557|NCT01748448|589841819|FG000|Treatment Period|Consent withdrawn by subject|1|||
163309558|NCT01748448|589841820|FG001|Treatment Period|Consent withdrawn by subject|0|||
163309559|NCT01748448|589841819|FG000|Treatment Period|Adverse Event|1|||
163309560|NCT01748448|589841820|FG001|Treatment Period|Adverse Event|0|||
163309561|NCT01748448|589841819|FG000|Treatment Period|Personal|0|||
163309562|NCT01748448|589841820|FG001|Treatment Period|Personal|1|||
163309563|NCT04562649|589841824|FG000|Overall Study|Withdrawal by Subject|11|||
163309564|NCT04562649|589841825|FG001|Overall Study|Withdrawal by Subject|8|||
163309565|NCT04562649|589841824|FG000|Overall Study|Lost to Follow-up|26|||
163309566|NCT04562649|589841825|FG001|Overall Study|Lost to Follow-up|20|||
163309567|NCT05368103|589841826|FG000|Overall Study|Withdrawal by Subject|4|||
163309568|NCT05368103|589841826|FG000|Overall Study|Lost to Follow-up|1|||
163309569|NCT05368103|589841826|FG000|Overall Study|Lack of Efficacy|3|||
163309570|NCT02913872|589841841|FG000|Overall Study|Withdrawal by Subject|1|||
163309571|NCT03920111|589841842|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
163309572|NCT03920111|589841843|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
163309573|NCT03920111|589841844|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
163309574|NCT05177848|589841845|FG000|Overall Study|Lost to Follow-up|1|||
163309575|NCT05177848|589841846|FG001|Overall Study|Lost to Follow-up|4|||
163309576|NCT05177848|589841845|FG000|Overall Study|Discontinued|2|||
163309577|NCT05177848|589841846|FG001|Overall Study|Discontinued|1|||
163309578|NCT06414213|589841847|FG000|Overall Study|Lost to Follow-up|1|||
163309579|NCT06414213|589841848|FG001|Overall Study|Lost to Follow-up|1|||
163309580|NCT06414213|589841849|FG002|Overall Study|Lost to Follow-up|3|||
163309581|NCT03720795|589841850|FG000|Phase 1|Lost to Follow-up|4|||
163309582|NCT03720795|589841850|FG000|Phase 1|Withdrawal by Subject|6|||
163051386|NCT04579380|588897114|FG005|Overall Study|Death|21|||
163051387|NCT04579380|588897115|FG006|Overall Study|Death|10|||
163051388|NCT04579380|588897116|FG007|Overall Study|Death|11|||
163051389|NCT04579380|588897117|FG008|Overall Study|Death|25|||
163051390|NCT04579380|588897109|FG000|Overall Study|Withdrawal by Subject|0|||
163202206|NCT03521934|589457051|FG001|Overall Study|Death|73|||
163202207|NCT03521934|589457050|FG000|Overall Study|Withdrawal by Subject|18|||
163202208|NCT03521934|589457051|FG001|Overall Study|Withdrawal by Subject|23|||
163202209|NCT03521934|589457050|FG000|Overall Study|Site Terminated by Sponsor|39|||
163202210|NCT03521934|589457051|FG001|Overall Study|Site Terminated by Sponsor|35|||
163202211|NCT03521934|589457050|FG000|Overall Study|Study Terminated by Sponsor|483|||
163202212|NCT03521934|589457051|FG001|Overall Study|Study Terminated by Sponsor|477|||
163202213|NCT03521934|589457050|FG000|Overall Study|Reason not Specified|3|||
163202214|NCT03521934|589457051|FG001|Overall Study|Reason not Specified|6|||
163309583|NCT03720795|589841850|FG000|Phase 1|Protocol Violation|1|||
163309584|NCT03720795|589841850|FG000|Phase 1|Other|1|||
163309585|NCT03720795|589841850|FG000|Phase 2|Lost to Follow-up|5|||
163309586|NCT03720795|589841850|FG000|Phase 2|Withdrawal by Subject|10|||
163309587|NCT03720795|589841850|FG000|Phase 2|Protocol Violation|2|||
163309588|NCT03720795|589841850|FG000|3 Month Follow Up|Lost to Follow-up|2|||
163051391|NCT04579380|588897110|FG001|Overall Study|Withdrawal by Subject|3|||
163051392|NCT04579380|588897111|FG002|Overall Study|Withdrawal by Subject|4|||
163202215|NCT00284050|589457052|FG000|Overall Study|Adverse Event|1|||
163202216|NCT00284050|589457053|FG001|Overall Study|Adverse Event|1|||
163202217|NCT00284050|589457054|FG002|Overall Study|Adverse Event|1|||
163202218|NCT00284050|589457052|FG000|Overall Study|Lack of Efficacy|0|||
163202219|NCT00284050|589457053|FG001|Overall Study|Lack of Efficacy|1|||
163202220|NCT00284050|589457054|FG002|Overall Study|Lack of Efficacy|3|||
163202221|NCT00284050|589457052|FG000|Overall Study|Protocol Violation|0|||
163202222|NCT00284050|589457053|FG001|Overall Study|Protocol Violation|1|||
163202223|NCT00284050|589457054|FG002|Overall Study|Protocol Violation|2|||
163202224|NCT00284050|589457052|FG000|Overall Study|Withdrawal by Subject|2|||
163202225|NCT00284050|589457053|FG001|Overall Study|Withdrawal by Subject|2|||
163202226|NCT00284050|589457054|FG002|Overall Study|Withdrawal by Subject|2|||
163202227|NCT00284050|589457052|FG000|Overall Study|Lost to Follow-up|1|||
163202228|NCT00284050|589457053|FG001|Overall Study|Lost to Follow-up|0|||
163202229|NCT00284050|589457054|FG002|Overall Study|Lost to Follow-up|1|||
163202230|NCT00284050|589457052|FG000|Overall Study|Death|1|||
163202231|NCT00284050|589457053|FG001|Overall Study|Death|0|||
163202232|NCT00284050|589457054|FG002|Overall Study|Death|0|||
163202233|NCT00545168|589457063|FG000|Overall Study|Lost to Follow-up|5|||
163202234|NCT00545168|589457064|FG001|Overall Study|Lost to Follow-up|5|||
163202235|NCT00545168|589457065|FG002|Overall Study|Lost to Follow-up|5|||
163202236|NCT00545168|589457063|FG000|Overall Study|Withdrawal by Subject|9|||
163202237|NCT00545168|589457064|FG001|Overall Study|Withdrawal by Subject|0|||
163202238|NCT00545168|589457065|FG002|Overall Study|Withdrawal by Subject|13|||
163202239|NCT00545168|589457063|FG000|Overall Study|Protocol Violation|1|||
163202240|NCT00545168|589457064|FG001|Overall Study|Protocol Violation|0|||
163202241|NCT00545168|589457065|FG002|Overall Study|Protocol Violation|1|||
163202242|NCT00545168|589457063|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
163202243|NCT00545168|589457064|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
163202244|NCT00545168|589457065|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
163202245|NCT01833520|589457070|FG000|Overall Study|Lack of Efficacy|3|||
163202246|NCT01833520|589457071|FG001|Overall Study|Lack of Efficacy|3|||
163202247|NCT01833520|589457072|FG002|Overall Study|Lack of Efficacy|8|||
163202248|NCT01833520|589457073|FG003|Overall Study|Lack of Efficacy|3|||
163202249|NCT00489541|589457081|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
163202250|NCT00489541|589457082|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
163202251|NCT00489541|589457081|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
163202252|NCT00489541|589457082|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
163202253|NCT00489541|589457081|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
163202254|NCT00489541|589457082|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
163202255|NCT00489541|589457081|FG000|12-Month Clinical Follow-up|Death|3|||
163202256|NCT00489541|589457082|FG001|12-Month Clinical Follow-up|Death|2|||
163202257|NCT00489541|589457081|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
163202258|NCT00489541|589457082|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
163202259|NCT00489541|589457081|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
163202260|NCT00489541|589457082|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
163202261|NCT04182763|589457085|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
163202262|NCT04182763|589457086|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
163202263|NCT04182763|589457087|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
163202264|NCT04182763|589457088|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
163202265|NCT04182763|589457089|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
163202266|NCT04182763|589457085|FG000|Double-Blind Period, initial 6 months|Death|0|||
163202267|NCT04182763|589457086|FG001|Double-Blind Period, initial 6 months|Death|1|||
163202268|NCT04182763|589457087|FG002|Double-Blind Period, initial 6 months|Death|0|||
163202269|NCT04182763|589457088|FG003|Double-Blind Period, initial 6 months|Death|0|||
163202270|NCT04182763|589457089|FG004|Double-Blind Period, initial 6 months|Death|0|||
163202271|NCT04182763|589457085|FG000|Open-Label Period, subsequent 18 months|Death|3|||
163202272|NCT04182763|589457086|FG001|Open-Label Period, subsequent 18 months|Death|2|||
163202273|NCT04182763|589457087|FG002|Open-Label Period, subsequent 18 months|Death|2|||
163202274|NCT04182763|589457088|FG003|Open-Label Period, subsequent 18 months|Death|0|||
163202275|NCT04182763|589457089|FG004|Open-Label Period, subsequent 18 months|Death|1|||
163202276|NCT04182763|589457085|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
163202277|NCT04182763|589457086|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
163202278|NCT04182763|589457087|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
163202279|NCT04182763|589457088|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
163202280|NCT04182763|589457089|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
163202281|NCT04182763|589457085|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
163202282|NCT04182763|589457086|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
163202283|NCT04182763|589457087|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
163202284|NCT04182763|589457088|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
163309589|NCT01573442|589841853|FG000|Overall Study|Cancels|9|||
163309590|NCT01573442|589841854|FG001|Overall Study|Cancels|10|||
163309591|NCT04763265|589841857|FG000|Overall Study|Adverse Event|1|||
163309592|NCT04763265|589841858|FG001|Overall Study|Adverse Event|0|||
163309593|NCT04763265|589841857|FG000|Overall Study|Lost to Follow-up|2|||
163309594|NCT04763265|589841858|FG001|Overall Study|Lost to Follow-up|4|||
163309595|NCT04763265|589841857|FG000|Overall Study|Withdrawal by Subject|0|||
163309596|NCT04763265|589841858|FG001|Overall Study|Withdrawal by Subject|1|||
163309597|NCT05308004|589841868|FG000|Overall Study|Not seen by Palliative Care NP|0|||
163309598|NCT05308004|589841869|FG001|Overall Study|Not seen by Palliative Care NP|1|||
163309599|NCT04552223|589841876|FG000|Overall Study|Withdrawal by Subject|1|||
163309600|NCT04856163|589841877|FG000|Overall Study|Lost to Follow-up|97|||
163309601|NCT04856163|589841878|FG001|Overall Study|Lost to Follow-up|100|||
163309602|NCT05816551|589844374|FG000|Overall Study|Withdrawal by Subject|0|||
163309603|NCT05816551|589844375|FG001|Overall Study|Withdrawal by Subject|1|||
163309604|NCT05816551|589844374|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
163309605|NCT05816551|589844375|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
163309606|NCT04353661|589844376|FG000|Overall Study|Protocol Violation|0|||
163309607|NCT04353661|589844377|FG001|Overall Study|Protocol Violation|0|||
163309608|NCT04353661|589844378|FG002|Overall Study|Protocol Violation|1|||
163309609|NCT04353661|589844376|FG000|Overall Study|Study termination by the Sponsor|1|||
163309610|NCT04353661|589844377|FG001|Overall Study|Study termination by the Sponsor|1|||
163309611|NCT04353661|589844378|FG002|Overall Study|Study termination by the Sponsor|1|||
163309612|NCT02530671|589844386|FG000|Overall Study|Lost to Follow-up|2|||
163309613|NCT02530671|589844387|FG001|Overall Study|Lost to Follow-up|0|||
163309614|NCT02530671|589844386|FG000|Overall Study|Withdrawal by Subject|1|||
163309615|NCT02530671|589844387|FG001|Overall Study|Withdrawal by Subject|0|||
163309616|NCT05247489|589844388|FG000|Overall Study|Lost to Follow-up|5|||
163309617|NCT05247489|589844389|FG001|Overall Study|Lost to Follow-up|1|||
163309618|NCT05247489|589844388|FG000|Overall Study|Withdrawal by Subject|6|||
163309619|NCT05247489|589844389|FG001|Overall Study|Withdrawal by Subject|7|||
163309620|NCT05247489|589844388|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
163309621|NCT05247489|589844389|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
163309622|NCT05247489|589844388|FG000|Overall Study|Left Country|1|||
163309623|NCT05247489|589844389|FG001|Overall Study|Left Country|0|||
163309624|NCT05247489|589844388|FG000|Overall Study|Noncompliance with Investigational Product|1|||
163309625|NCT05247489|589844389|FG001|Overall Study|Noncompliance with Investigational Product|0|||
163309626|NCT05247489|589844388|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
163309627|NCT05247489|589844389|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
163309628|NCT03126019|589844390|FG000|Overall Study|Death|5|||
163309629|NCT03126019|589844391|FG001|Overall Study|Death|27|||
163309630|NCT03126019|589844390|FG000|Overall Study|Lost to Follow-up|2|||
163309631|NCT03126019|589844391|FG001|Overall Study|Lost to Follow-up|4|||
163309632|NCT03126019|589844390|FG000|Overall Study|Withdrawal by Subject|1|||
163309633|NCT03126019|589844391|FG001|Overall Study|Withdrawal by Subject|9|||
163309634|NCT03126019|589844390|FG000|Overall Study|Physician Decision|1|||
163309635|NCT03126019|589844391|FG001|Overall Study|Physician Decision|0|||
163309636|NCT03126019|589844390|FG000|Overall Study|Transitioned to Rollover Study|0|||
163309637|NCT03126019|589844391|FG001|Overall Study|Transitioned to Rollover Study|11|||
163309638|NCT03126019|589844390|FG000|Overall Study|Did Not Return to Site for Care|0|||
163309639|NCT03126019|589844391|FG001|Overall Study|Did Not Return to Site for Care|1|||
163309640|NCT03126019|589844390|FG000|Overall Study|Site Closed|0|||
163309641|NCT03126019|589844391|FG001|Overall Study|Site Closed|1|||
163309642|NCT05563246|589844414|FG000|Overall Study|Withdrawal by Subject|1|||
163309643|NCT05563246|589844415|FG001|Overall Study|Withdrawal by Subject|2|||
163309644|NCT05563246|589844416|FG002|Overall Study|Withdrawal by Subject|0|||
163309645|NCT05563246|589844417|FG003|Overall Study|Withdrawal by Subject|0|||
163309646|NCT05563246|589844414|FG000|Overall Study|Protocol Deviation|0|||
163309647|NCT05563246|589844415|FG001|Overall Study|Protocol Deviation|1|||
163309648|NCT05563246|589844416|FG002|Overall Study|Protocol Deviation|0|||
163309649|NCT05563246|589844417|FG003|Overall Study|Protocol Deviation|0|||
163309650|NCT05563246|589844414|FG000|Overall Study|Physician Decision|0|||
163309651|NCT05563246|589844415|FG001|Overall Study|Physician Decision|1|||
163309652|NCT05563246|589844416|FG002|Overall Study|Physician Decision|0|||
163309653|NCT05563246|589844417|FG003|Overall Study|Physician Decision|0|||
163309654|NCT05563246|589844414|FG000|Overall Study|Adverse Event|0|||
163309655|NCT05563246|589844415|FG001|Overall Study|Adverse Event|0|||
163309656|NCT05563246|589844416|FG002|Overall Study|Adverse Event|2|||
163309657|NCT05563246|589844417|FG003|Overall Study|Adverse Event|0|||
163309658|NCT05563246|589844414|FG000|Overall Study|Lost to Follow-up|0|||
163309659|NCT05563246|589844415|FG001|Overall Study|Lost to Follow-up|0|||
163309660|NCT05563246|589844416|FG002|Overall Study|Lost to Follow-up|1|||
163309661|NCT05563246|589844417|FG003|Overall Study|Lost to Follow-up|0|||
163309662|NCT05215314|589844418|FG000|Overall Study|Lost to Follow-up|2|||
163309663|NCT05215314|589844419|FG001|Overall Study|Lost to Follow-up|2|||
163309664|NCT05215314|589844418|FG000|Overall Study|Withdrawal by Subject|2|||
163309665|NCT05215314|589844419|FG001|Overall Study|Withdrawal by Subject|0|||
163309666|NCT05215314|589844418|FG000|Overall Study|Physician Decision|1|||
163309667|NCT05215314|589844419|FG001|Overall Study|Physician Decision|0|||
163309668|NCT04179500|589844420|FG000|Treatment|Withdrawal by Subject|1|||
163309669|NCT04179500|589844420|FG000|Treatment|Adverse Event|2|||
163309670|NCT04179500|589844420|FG000|Treatment|pyrazinamide resistance|1|||
163309671|NCT03138512|589844421|FG000|Randomization|Participants withdrew consent|0|||
163202285|NCT04182763|589457089|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
163202286|NCT00003479|589457091|FG000|Overall Study|Not evaluable|3|||
163202287|NCT02551731|589457093|FG000|Overall Study|Withdrawal by Subject|2|||
163309672|NCT03138512|589844422|FG001|Randomization|Participants withdrew consent|1|||
163309673|NCT03138512|589844423|FG002|Randomization|Participants withdrew consent|1|||
163309674|NCT03138512|589844424|FG003|Randomization|Participants withdrew consent|0|||
163309675|NCT03138512|589844425|FG004|Randomization|Participants withdrew consent|0|||
163309676|NCT03138512|589844421|FG000|Randomization|Participant no longer meets study criteria|0|||
163309677|NCT03138512|589844422|FG001|Randomization|Participant no longer meets study criteria|3|||
163309678|NCT03138512|589844423|FG002|Randomization|Participant no longer meets study criteria|1|||
163309679|NCT03138512|589844424|FG003|Randomization|Participant no longer meets study criteria|1|||
163309680|NCT03138512|589844425|FG004|Randomization|Participant no longer meets study criteria|3|||
163309681|NCT03138512|589844421|FG000|Randomization|Other reasons|1|||
163309682|NCT03138512|589844422|FG001|Randomization|Other reasons|0|||
163309683|NCT03138512|589844423|FG002|Randomization|Other reasons|0|||
163309684|NCT03138512|589844424|FG003|Randomization|Other reasons|0|||
163309685|NCT03138512|589844425|FG004|Randomization|Other reasons|0|||
163309686|NCT03138512|589844421|FG000|Treatment Part A|Disease recurrence|10|||
163309687|NCT03138512|589844422|FG001|Treatment Part A|Disease recurrence|20|||
163309688|NCT03138512|589844423|FG002|Treatment Part A|Disease recurrence|0|||
163309689|NCT03138512|589844424|FG003|Treatment Part A|Disease recurrence|0|||
163309690|NCT03138512|589844425|FG004|Treatment Part A|Disease recurrence|0|||
163309691|NCT03138512|589844421|FG000|Treatment Part A|Study Drug Toxicity|132|||
163309692|NCT03138512|589844422|FG001|Treatment Part A|Study Drug Toxicity|5|||
163309693|NCT03138512|589844423|FG002|Treatment Part A|Study Drug Toxicity|0|||
163309694|NCT03138512|589844424|FG003|Treatment Part A|Study Drug Toxicity|0|||
163309695|NCT03138512|589844425|FG004|Treatment Part A|Study Drug Toxicity|0|||
163309696|NCT03138512|589844421|FG000|Treatment Part A|Death|1|||
163309697|NCT03138512|589844422|FG001|Treatment Part A|Death|0|||
163309698|NCT03138512|589844423|FG002|Treatment Part A|Death|0|||
163309699|NCT03138512|589844424|FG003|Treatment Part A|Death|0|||
163309700|NCT03138512|589844425|FG004|Treatment Part A|Death|0|||
163309701|NCT03138512|589844421|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
163309702|NCT03138512|589844422|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
163309703|NCT03138512|589844423|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
163309704|NCT03138512|589844424|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
163309705|NCT03138512|589844425|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
163309706|NCT03138512|589844421|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
162964451|NCT01438060|588569777|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
163202288|NCT01727297|589457106|FG000|Overall Study|Death|13|||
163202289|NCT01727297|589457107|FG001|Overall Study|Death|0|||
163202290|NCT01727297|589457106|FG000|Overall Study|Protocol Violation|1|||
163202291|NCT01727297|589457107|FG001|Overall Study|Protocol Violation|10|||
163202292|NCT01727297|589457106|FG000|Overall Study|Adverse Event|3|||
163202293|NCT01727297|589457107|FG001|Overall Study|Adverse Event|1|||
163202294|NCT01727297|589457106|FG000|Overall Study|Lost to Follow-up|11|||
163309707|NCT03138512|589844422|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
163309708|NCT03138512|589844423|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
163309709|NCT03138512|589844424|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
163309710|NCT03138512|589844425|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
163202295|NCT01727297|589457107|FG001|Overall Study|Lost to Follow-up|0|||
163202296|NCT01727297|589457106|FG000|Overall Study|Withdrawal by Subject|26|||
163202297|NCT01727297|589457107|FG001|Overall Study|Withdrawal by Subject|27|||
163202298|NCT01727297|589457106|FG000|Overall Study|Physician Decision|19|||
163202299|NCT01727297|589457107|FG001|Overall Study|Physician Decision|5|||
163202300|NCT01727297|589457106|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
163202301|NCT01727297|589457107|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
163202302|NCT01192516|589457108|FG000|Overall Study|Lost to Follow-up|7|||
163202303|NCT01192516|589457109|FG001|Overall Study|Lost to Follow-up|10|||
163202304|NCT01192516|589457110|FG002|Overall Study|Lost to Follow-up|7|||
163202305|NCT01192516|589457108|FG000|Overall Study|Withdrawal by Subject|4|||
163202306|NCT01192516|589457109|FG001|Overall Study|Withdrawal by Subject|4|||
163202307|NCT01192516|589457110|FG002|Overall Study|Withdrawal by Subject|1|||
163202308|NCT01192516|589457108|FG000|Overall Study|started new treatment|5|||
163202309|NCT01192516|589457109|FG001|Overall Study|started new treatment|1|||
163202310|NCT01192516|589457110|FG002|Overall Study|started new treatment|0|||
163202311|NCT01192516|589457108|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
163202312|NCT01192516|589457109|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
163202313|NCT01192516|589457110|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
163202314|NCT05228132|589457115|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
163202315|NCT05228132|589457115|FG000|Overall Study|Adverse Event|3|||
163202316|NCT05228132|589457115|FG000|Overall Study|Lost to Follow-up|1|||
163202317|NCT05228132|589457115|FG000|Overall Study|Arteriovenous-fistula mature|1|||
163202318|NCT02627144|589457116|FG000|Overall Study|Serious adverse event|32|||
163202319|NCT02627144|589457116|FG000|Overall Study|Cancer progression|171|||
163202320|NCT02627144|589457116|FG000|Overall Study|Death from cancer|20|||
163202321|NCT02627144|589457116|FG000|Overall Study|Death from other cause|8|||
163202322|NCT02627144|589457116|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
163202323|NCT02627144|589457116|FG000|Overall Study|Administrative reasons|65|||
163202324|NCT02627144|589457116|FG000|Overall Study|Lost to Follow-up|8|||
163202325|NCT02627144|589457116|FG000|Overall Study|Enrolled, not treated|6|||
163202326|NCT02627144|589457116|FG000|Overall Study|Other|17|||
163202327|NCT01217801|589457123|FG000|Period 1|Protocol Violation|1|||
163202328|NCT01217801|589457124|FG001|Period 1|Protocol Violation|1|||
163202329|NCT01217801|589457123|FG000|Period 1|Withdrawal by Subject|0|||
163202330|NCT01217801|589457124|FG001|Period 1|Withdrawal by Subject|1|||
163202331|NCT00291577|589457126|FG000|Overall Study|Adverse Event|1|||
163202332|NCT00291577|589457126|FG000|Overall Study|Other|4|||
163202333|NCT00291577|589457126|FG000|Overall Study|Withdrawal by Subject|2|||
163202334|NCT00291577|589457126|FG000|Overall Study|Lack of Efficacy|14|||
163202335|NCT04584645|589457127|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
163202336|NCT04584645|589457128|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
163202337|NCT03845985|589457135|FG000|Overall Study|Lost to Follow-up|2|||
163202338|NCT03845985|589457136|FG001|Overall Study|Lost to Follow-up|1|||
163202339|NCT03845985|589457135|FG000|Overall Study|Physician Decision|1|||
163202340|NCT03845985|589457136|FG001|Overall Study|Physician Decision|0|||
163202341|NCT03845985|589457135|FG000|Overall Study|Withdrawal by Subject|4|||
163202342|NCT03845985|589457136|FG001|Overall Study|Withdrawal by Subject|1|||
163202343|NCT02756013|589457137|FG000|Overall Study|Adverse Event|1|||
163202344|NCT02756013|589457137|FG000|Overall Study|Hypersensitivity|1|||
163202345|NCT03926169|589457138|FG000|Period A|Adverse Event|2|||
163202346|NCT03926169|589457139|FG001|Period A|Adverse Event|2|||
163202347|NCT03926169|589457140|FG002|Period A|Adverse Event|1|||
163202348|NCT03926169|589457138|FG000|Period A|Withdrawal by Subject|2|||
163202349|NCT03926169|589457139|FG001|Period A|Withdrawal by Subject|2|||
163202350|NCT03926169|589457140|FG002|Period A|Withdrawal by Subject|2|||
163202351|NCT03926169|589457138|FG000|Period A|Lost to Follow-up|3|||
163202352|NCT03926169|589457139|FG001|Period A|Lost to Follow-up|1|||
163202353|NCT03926169|589457140|FG002|Period A|Lost to Follow-up|0|||
163202354|NCT03926169|589457138|FG000|Period A|Lack of Efficacy|0|||
163202355|NCT03926169|589457139|FG001|Period A|Lack of Efficacy|2|||
163202356|NCT03926169|589457140|FG002|Period A|Lack of Efficacy|2|||
163202357|NCT03926169|589457138|FG000|Period A|COVID-19 Infection|0|||
163202358|NCT03926169|589457139|FG001|Period A|COVID-19 Infection|1|||
163202359|NCT03926169|589457140|FG002|Period A|COVID-19 Infection|0|||
163202360|NCT03926169|589457138|FG000|Period A|COVID-19 Logistical Restrictions|0|||
163202361|NCT03926169|589457139|FG001|Period A|COVID-19 Logistical Restrictions|2|||
163202362|NCT03926169|589457140|FG002|Period A|COVID-19 Logistical Restrictions|1|||
163202363|NCT03926169|589457138|FG000|Period A|Other, Not Specified|1|||
163202364|NCT03926169|589457139|FG001|Period A|Other, Not Specified|0|||
163202365|NCT03926169|589457140|FG002|Period A|Other, Not Specified|0|||
163202366|NCT03926169|589457138|FG000|Period B|Adverse Event|3|||
163202367|NCT03926169|589457139|FG001|Period B|Adverse Event|1|||
163202368|NCT03926169|589457140|FG002|Period B|Adverse Event|1|||
163202369|NCT03926169|589457138|FG000|Period B|Withdrawal by Subject|1|||
163202370|NCT03926169|589457139|FG001|Period B|Withdrawal by Subject|3|||
163202371|NCT03926169|589457140|FG002|Period B|Withdrawal by Subject|0|||
163202372|NCT03926169|589457138|FG000|Period B|Lack of Efficacy|3|||
163309711|NCT03138512|589844421|FG000|Treatment Part A|Participant withdrew consent|2|||
163309712|NCT03138512|589844422|FG001|Treatment Part A|Participant withdrew consent|4|||
163309713|NCT03138512|589844423|FG002|Treatment Part A|Participant withdrew consent|0|||
163309714|NCT03138512|589844424|FG003|Treatment Part A|Participant withdrew consent|0|||
163309715|NCT03138512|589844425|FG004|Treatment Part A|Participant withdrew consent|0|||
163309716|NCT03138512|589844421|FG000|Treatment Part A|Lost to Follow-up|0|||
163309717|NCT03138512|589844422|FG001|Treatment Part A|Lost to Follow-up|1|||
163309718|NCT03138512|589844423|FG002|Treatment Part A|Lost to Follow-up|0|||
163309719|NCT03138512|589844424|FG003|Treatment Part A|Lost to Follow-up|0|||
163309720|NCT03138512|589844425|FG004|Treatment Part A|Lost to Follow-up|0|||
163309721|NCT03138512|589844421|FG000|Treatment Part A|Poor/non-compliance|1|||
163309722|NCT03138512|589844422|FG001|Treatment Part A|Poor/non-compliance|0|||
163309723|NCT03138512|589844423|FG002|Treatment Part A|Poor/non-compliance|0|||
163309724|NCT03138512|589844424|FG003|Treatment Part A|Poor/non-compliance|0|||
163309725|NCT03138512|589844425|FG004|Treatment Part A|Poor/non-compliance|0|||
163309726|NCT03138512|589844421|FG000|Treatment Part A|Pregnancy|0|||
163309727|NCT03138512|589844422|FG001|Treatment Part A|Pregnancy|1|||
162964452|NCT01438060|588569776|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
163202373|NCT03926169|589457139|FG001|Period B|Lack of Efficacy|1|||
163202374|NCT03926169|589457140|FG002|Period B|Lack of Efficacy|1|||
163202375|NCT03926169|589457138|FG000|Period B|Lost to Follow-up|1|||
163202376|NCT03926169|589457139|FG001|Period B|Lost to Follow-up|1|||
163202377|NCT03926169|589457140|FG002|Period B|Lost to Follow-up|4|||
163202378|NCT03926169|589457138|FG000|Period B|Other, Not Specified|62|||
163202379|NCT03926169|589457139|FG001|Period B|Other, Not Specified|57|||
163202380|NCT03926169|589457140|FG002|Period B|Other, Not Specified|65|||
163202381|NCT00968201|589457141|FG000|Base Study - (Period II)|Adverse Event|8|||
163202382|NCT00968201|589457142|FG001|Base Study - (Period II)|Adverse Event|0|||
163202383|NCT00968201|589457143|FG002|Base Study - (Period II)|Adverse Event|16|||
163202384|NCT00968201|589457141|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
163202385|NCT00968201|589457142|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
163202386|NCT00968201|589457143|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
163202387|NCT00968201|589457141|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
163202388|NCT00968201|589457142|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
163202389|NCT00968201|589457143|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
163202390|NCT00968201|589457141|FG000|Base Study - (Period II)|Protocol Violation|12|||
163202391|NCT00968201|589457142|FG001|Base Study - (Period II)|Protocol Violation|0|||
163202392|NCT00968201|589457143|FG002|Base Study - (Period II)|Protocol Violation|12|||
163202393|NCT00968201|589457141|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
163202394|NCT00968201|589457142|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
163202395|NCT00968201|589457143|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
163202396|NCT00968201|589457141|FG000|Base Study - (Period II)|Site Error|0|||
163202397|NCT00968201|589457142|FG001|Base Study - (Period II)|Site Error|0|||
163202398|NCT00968201|589457143|FG002|Base Study - (Period II)|Site Error|1|||
163202399|NCT00968201|589457141|FG000|Extension Study - (Period III)|Adverse Event|0|||
163202400|NCT00968201|589457142|FG001|Extension Study - (Period III)|Adverse Event|5|||
163202401|NCT00968201|589457143|FG002|Extension Study - (Period III)|Adverse Event|22|||
163202402|NCT00968201|589457141|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
163202403|NCT00968201|589457142|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
163202404|NCT00968201|589457143|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
163202405|NCT00968201|589457141|FG000|Extension Study - (Period III)|Protocol Violation|0|||
163202406|NCT00968201|589457142|FG001|Extension Study - (Period III)|Protocol Violation|17|||
163202407|NCT00968201|589457143|FG002|Extension Study - (Period III)|Protocol Violation|14|||
163202408|NCT00968201|589457141|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
163202409|NCT00968201|589457142|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
163202410|NCT00968201|589457143|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
163202411|NCT00968201|589457141|FG000|Extension Study - (Period III)|Patient Relocated|0|||
163202412|NCT00968201|589457142|FG001|Extension Study - (Period III)|Patient Relocated|1|||
163309728|NCT03138512|589844423|FG002|Treatment Part A|Pregnancy|0|||
163309729|NCT03138512|589844424|FG003|Treatment Part A|Pregnancy|0|||
163202413|NCT00968201|589457143|FG002|Extension Study - (Period III)|Patient Relocated|1|||
163202414|NCT00968201|589457141|FG000|Extension Study - (Period III)|Noncompliance|0|||
163309730|NCT03138512|589844425|FG004|Treatment Part A|Pregnancy|0|||
163309731|NCT03138512|589844421|FG000|Treatment Part A|Other reasons|11|||
163309732|NCT03138512|589844422|FG001|Treatment Part A|Other reasons|8|||
163309733|NCT03138512|589844423|FG002|Treatment Part A|Other reasons|0|||
163309734|NCT03138512|589844424|FG003|Treatment Part A|Other reasons|0|||
163309735|NCT03138512|589844425|FG004|Treatment Part A|Other reasons|0|||
163309736|NCT03138512|589844421|FG000|Treatment Part B|Disease recurrence|0|||
163309737|NCT03138512|589844422|FG001|Treatment Part B|Disease recurrence|0|||
163309738|NCT03138512|589844423|FG002|Treatment Part B|Disease recurrence|6|||
163309739|NCT03138512|589844424|FG003|Treatment Part B|Disease recurrence|12|||
163309740|NCT03138512|589844425|FG004|Treatment Part B|Disease recurrence|10|||
163309741|NCT03138512|589844421|FG000|Treatment Part B|Study drug toxicity|0|||
163309742|NCT03138512|589844422|FG001|Treatment Part B|Study drug toxicity|0|||
163309743|NCT03138512|589844423|FG002|Treatment Part B|Study drug toxicity|63|||
163309744|NCT03138512|589844424|FG003|Treatment Part B|Study drug toxicity|3|||
163309745|NCT03138512|589844425|FG004|Treatment Part B|Study drug toxicity|45|||
163309746|NCT03138512|589844421|FG000|Treatment Part B|Death|0|||
163309747|NCT03138512|589844422|FG001|Treatment Part B|Death|0|||
163309748|NCT03138512|589844423|FG002|Treatment Part B|Death|1|||
163309749|NCT03138512|589844424|FG003|Treatment Part B|Death|0|||
163309750|NCT03138512|589844425|FG004|Treatment Part B|Death|0|||
163309751|NCT03138512|589844421|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
163309752|NCT03138512|589844422|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
163309753|NCT03138512|589844423|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
163309754|NCT03138512|589844424|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
163309755|NCT03138512|589844425|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
163309756|NCT03138512|589844421|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
163309757|NCT03138512|589844422|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
163309758|NCT03138512|589844423|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
163309759|NCT03138512|589844424|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
163309760|NCT03138512|589844425|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
163309761|NCT03138512|589844421|FG000|Treatment Part B|Participant withdrew consent|0|||
163309762|NCT03138512|589844422|FG001|Treatment Part B|Participant withdrew consent|0|||
163309763|NCT03138512|589844423|FG002|Treatment Part B|Participant withdrew consent|1|||
163309764|NCT03138512|589844424|FG003|Treatment Part B|Participant withdrew consent|1|||
163309765|NCT03138512|589844425|FG004|Treatment Part B|Participant withdrew consent|2|||
163309766|NCT03138512|589844421|FG000|Treatment Part B|Lost to Follow-up|0|||
163309767|NCT03138512|589844422|FG001|Treatment Part B|Lost to Follow-up|0|||
163309768|NCT03138512|589844423|FG002|Treatment Part B|Lost to Follow-up|0|||
163309769|NCT03138512|589844424|FG003|Treatment Part B|Lost to Follow-up|1|||
163309770|NCT03138512|589844425|FG004|Treatment Part B|Lost to Follow-up|0|||
163051393|NCT04579380|588897112|FG003|Overall Study|Withdrawal by Subject|0|||
163051394|NCT04579380|588897113|FG004|Overall Study|Withdrawal by Subject|1|||
163202415|NCT00968201|589457142|FG001|Extension Study - (Period III)|Noncompliance|0|||
163202416|NCT00968201|589457143|FG002|Extension Study - (Period III)|Noncompliance|3|||
163202417|NCT00968201|589457141|FG000|Extension Study - (Period III)|Other|0|||
163202418|NCT00968201|589457142|FG001|Extension Study - (Period III)|Other|0|||
163202419|NCT00968201|589457143|FG002|Extension Study - (Period III)|Other|2|||
163202420|NCT00968201|589457141|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
163202421|NCT00968201|589457142|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
163202422|NCT00968201|589457143|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
163202423|NCT04974697|589457144|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
163202424|NCT04974697|589457144|FG000|Overall Study|Lens discomfort|1|||
163202425|NCT03302234|589457146|FG000|Overall Study|Death|191|||
163202426|NCT03302234|589457147|FG001|Overall Study|Death|192|||
163202427|NCT03302234|589457146|FG000|Overall Study|Withdrawal by Subject|2|||
163309771|NCT03138512|589844421|FG000|Treatment Part B|Poor/non-compliance|0|||
163309772|NCT03138512|589844422|FG001|Treatment Part B|Poor/non-compliance|0|||
163309773|NCT03138512|589844423|FG002|Treatment Part B|Poor/non-compliance|1|||
163202428|NCT03302234|589457147|FG001|Overall Study|Withdrawal by Subject|2|||
163202429|NCT03302234|589457146|FG000|Overall Study|Sponsor Decision|90|||
163309774|NCT03138512|589844424|FG003|Treatment Part B|Poor/non-compliance|1|||
163309775|NCT03138512|589844425|FG004|Treatment Part B|Poor/non-compliance|1|||
163309776|NCT03138512|589844421|FG000|Treatment Part B|Other reasons|0|||
163309777|NCT03138512|589844422|FG001|Treatment Part B|Other reasons|0|||
163309778|NCT03138512|589844423|FG002|Treatment Part B|Other reasons|3|||
163309779|NCT03138512|589844424|FG003|Treatment Part B|Other reasons|1|||
163309780|NCT03138512|589844425|FG004|Treatment Part B|Other reasons|5|||
163309781|NCT04005716|589844439|FG000|Overall Study|Death|175|||
163309782|NCT04005716|589844440|FG001|Overall Study|Death|196|||
163309783|NCT04005716|589844439|FG000|Overall Study|Withdrawal by Subject|1|||
163309784|NCT04005716|589844440|FG001|Overall Study|Withdrawal by Subject|6|||
163309785|NCT04005716|589844439|FG000|Overall Study|Lost to Follow-up|2|||
163309786|NCT04005716|589844440|FG001|Overall Study|Lost to Follow-up|2|||
163309787|NCT02783300|589844441|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309788|NCT02783300|589844442|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309789|NCT02783300|589844443|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309790|NCT02783300|589844444|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309791|NCT02783300|589844445|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309792|NCT02783300|589844446|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309793|NCT02783300|589844447|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
163309794|NCT02783300|589844448|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309795|NCT02783300|589844449|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309796|NCT02783300|589844450|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309797|NCT02783300|589844451|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309798|NCT02783300|589844452|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309799|NCT02783300|589844453|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309800|NCT02783300|589844454|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309801|NCT02783300|589844455|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309802|NCT02783300|589844456|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309803|NCT02783300|589844457|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309804|NCT02783300|589844458|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309805|NCT02783300|589844459|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309806|NCT02783300|589844460|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309807|NCT02783300|589844461|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309808|NCT02783300|589844462|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309809|NCT02783300|589844463|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309810|NCT02783300|589844464|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309811|NCT02783300|589844465|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309812|NCT02783300|589844466|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309813|NCT02783300|589844467|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163309814|NCT02783300|589844441|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309815|NCT02783300|589844442|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309816|NCT02783300|589844443|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309817|NCT02783300|589844444|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
163309818|NCT02783300|589844445|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309819|NCT02783300|589844446|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309820|NCT02783300|589844447|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309821|NCT02783300|589844448|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309822|NCT02783300|589844449|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309823|NCT02783300|589844450|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309824|NCT02783300|589844451|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309825|NCT02783300|589844452|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309826|NCT02783300|589844453|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309827|NCT02783300|589844454|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309828|NCT02783300|589844455|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309829|NCT02783300|589844456|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309830|NCT02783300|589844457|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309831|NCT02783300|589844458|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309832|NCT02783300|589844459|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309833|NCT02783300|589844460|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309834|NCT02783300|589844461|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309835|NCT02783300|589844462|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309836|NCT02783300|589844463|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309837|NCT02783300|589844464|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309838|NCT02783300|589844465|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309839|NCT02783300|589844466|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309840|NCT02783300|589844467|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163309841|NCT02783300|589844441|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
163309842|NCT02783300|589844442|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
163309843|NCT02783300|589844443|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
163309844|NCT02783300|589844444|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
163309845|NCT02783300|589844445|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
163309846|NCT02783300|589844446|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
163309847|NCT02783300|589844447|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
163309848|NCT02783300|589844448|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
163309849|NCT02783300|589844449|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
163309850|NCT02783300|589844450|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
163309851|NCT02783300|589844451|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
163309852|NCT02783300|589844452|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
163309853|NCT02783300|589844453|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
163309854|NCT02783300|589844454|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
163309855|NCT02783300|589844455|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
163309856|NCT02783300|589844456|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
163309857|NCT02783300|589844457|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
163309858|NCT02783300|589844458|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
163309859|NCT02783300|589844459|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
163309860|NCT02783300|589844460|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
163309861|NCT02783300|589844461|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
163309862|NCT02783300|589844462|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
163309863|NCT02783300|589844463|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
163309864|NCT02783300|589844464|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
163309865|NCT02783300|589844465|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
163309866|NCT02783300|589844466|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
163309867|NCT02783300|589844467|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
163309868|NCT02783300|589844441|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309869|NCT02783300|589844442|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309870|NCT02783300|589844443|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309871|NCT02783300|589844444|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309872|NCT02783300|589844445|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309873|NCT02783300|589844446|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309874|NCT02783300|589844447|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
163309875|NCT02783300|589844448|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309876|NCT02783300|589844449|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309877|NCT02783300|589844450|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309878|NCT02783300|589844451|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309879|NCT02783300|589844452|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309880|NCT02783300|589844453|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
163309881|NCT02783300|589844454|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309882|NCT02783300|589844455|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309883|NCT02783300|589844456|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309884|NCT02783300|589844457|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309885|NCT02783300|589844458|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309886|NCT02783300|589844459|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309887|NCT02783300|589844460|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309888|NCT02783300|589844461|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309889|NCT02783300|589844462|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309890|NCT02783300|589844463|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309891|NCT02783300|589844464|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309892|NCT02783300|589844465|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309893|NCT02783300|589844466|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309894|NCT02783300|589844467|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163309895|NCT02783300|589844441|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309896|NCT02783300|589844442|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162964453|NCT01438060|588569777|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
162964454|NCT01438060|588569776|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
162964455|NCT01438060|588569777|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
162964456|NCT01438060|588569776|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
162964457|NCT01438060|588569777|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
163202430|NCT03302234|589457147|FG001|Overall Study|Sponsor Decision|89|||
163202431|NCT03302234|589457146|FG000|Overall Study|Laryngeal carcinoma|0|||
163202432|NCT03302234|589457147|FG001|Overall Study|Laryngeal carcinoma|1|||
163202433|NCT03302234|589457146|FG000|Overall Study|Not Reported|1|||
163202434|NCT03302234|589457147|FG001|Overall Study|Not Reported|0|||
163202435|NCT04112784|589457148|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
163202436|NCT04112784|589457148|FG000|Overall Study|Screen Failures|4|||
163202437|NCT00221403|589457149|FG000|Overall Study|Protocol Violation|1|||
163202438|NCT00221403|589457150|FG001|Overall Study|Protocol Violation|0|||
163202439|NCT00221403|589457151|FG002|Overall Study|Protocol Violation|0|||
163202440|NCT00221403|589457149|FG000|Overall Study|Physician Decision|1|||
163202441|NCT00221403|589457150|FG001|Overall Study|Physician Decision|0|||
163202442|NCT00221403|589457151|FG002|Overall Study|Physician Decision|0|||
163202443|NCT00221403|589457149|FG000|Overall Study|Withdrawal by Subject|0|||
163202444|NCT00221403|589457150|FG001|Overall Study|Withdrawal by Subject|3|||
163202445|NCT00221403|589457151|FG002|Overall Study|Withdrawal by Subject|0|||
163202446|NCT00221403|589457149|FG000|Overall Study|Lack of Efficacy|0|||
163202447|NCT00221403|589457150|FG001|Overall Study|Lack of Efficacy|1|||
163202448|NCT00221403|589457151|FG002|Overall Study|Lack of Efficacy|0|||
163202449|NCT00221403|589457149|FG000|Overall Study|Adverse Event|0|||
163202450|NCT00221403|589457150|FG001|Overall Study|Adverse Event|1|||
163202451|NCT00221403|589457151|FG002|Overall Study|Adverse Event|0|||
163202452|NCT02216591|589457154|FG000|Overall Study|Lost to Follow-up|0|||
163202453|NCT02216591|589457155|FG001|Overall Study|Lost to Follow-up|1|||
163202454|NCT01950741|589457157|FG000|Overall Study|Lost to Follow-up|1|||
163202455|NCT01950741|589457157|FG000|Overall Study|Death|1|||
163202456|NCT01950741|589457157|FG000|Overall Study|Withdrawal by Subject|1|||
163202457|NCT00558558|589457160|FG000|Overall Study|Unable to swallow|1|||
163202458|NCT00558558|589457160|FG000|Overall Study|Withdrawal by Subject|1|||
163202459|NCT00558558|589457160|FG000|Overall Study|Lack of Efficacy|4|||
163202460|NCT02549937|589457162|FG000|Overall Study|Death|0|||
163202461|NCT02549937|589457163|FG001|Overall Study|Death|1|||
163202462|NCT02549937|589457164|FG002|Overall Study|Death|0|||
163202463|NCT02549937|589457165|FG003|Overall Study|Death|1|||
163202464|NCT02549937|589457166|FG004|Overall Study|Death|0|||
163202465|NCT02549937|589457167|FG005|Overall Study|Death|8|||
163202466|NCT02549937|589457168|FG006|Overall Study|Death|0|||
163202467|NCT02549937|589457169|FG007|Overall Study|Death|0|||
163202468|NCT02549937|589457170|FG008|Overall Study|Death|19|||
163202469|NCT02549937|589457162|FG000|Overall Study|No follow up required|3|||
163202470|NCT02549937|589457163|FG001|Overall Study|No follow up required|6|||
163202471|NCT02549937|589457164|FG002|Overall Study|No follow up required|3|||
163202472|NCT02549937|589457165|FG003|Overall Study|No follow up required|8|||
163202473|NCT02549937|589457166|FG004|Overall Study|No follow up required|12|||
163202474|NCT02549937|589457167|FG005|Overall Study|No follow up required|21|||
163202475|NCT02549937|589457168|FG006|Overall Study|No follow up required|9|||
163202476|NCT02549937|589457169|FG007|Overall Study|No follow up required|11|||
163202477|NCT02549937|589457170|FG008|Overall Study|No follow up required|0|||
163202478|NCT02549937|589457162|FG000|Overall Study|Other|0|||
163202479|NCT02549937|589457163|FG001|Overall Study|Other|0|||
163202480|NCT02549937|589457164|FG002|Overall Study|Other|0|||
163202481|NCT02549937|589457165|FG003|Overall Study|Other|0|||
163202482|NCT02549937|589457166|FG004|Overall Study|Other|1|||
163202483|NCT02549937|589457167|FG005|Overall Study|Other|0|||
163202484|NCT02549937|589457168|FG006|Overall Study|Other|3|||
163202485|NCT02549937|589457169|FG007|Overall Study|Other|2|||
163202486|NCT02549937|589457170|FG008|Overall Study|Other|3|||
163202487|NCT02549937|589457162|FG000|Overall Study|Lost to Follow-up|0|||
163202488|NCT02549937|589457163|FG001|Overall Study|Lost to Follow-up|0|||
163202489|NCT02549937|589457164|FG002|Overall Study|Lost to Follow-up|0|||
163202490|NCT02549937|589457165|FG003|Overall Study|Lost to Follow-up|0|||
163202491|NCT02549937|589457166|FG004|Overall Study|Lost to Follow-up|0|||
163202492|NCT02549937|589457167|FG005|Overall Study|Lost to Follow-up|0|||
163202493|NCT02549937|589457168|FG006|Overall Study|Lost to Follow-up|0|||
163202494|NCT02549937|589457169|FG007|Overall Study|Lost to Follow-up|0|||
163202495|NCT02549937|589457170|FG008|Overall Study|Lost to Follow-up|3|||
163202496|NCT02549937|589457162|FG000|Overall Study|Withdrawal by Subject|0|||
163202497|NCT02549937|589457163|FG001|Overall Study|Withdrawal by Subject|0|||
163202498|NCT02549937|589457164|FG002|Overall Study|Withdrawal by Subject|0|||
163202499|NCT02549937|589457165|FG003|Overall Study|Withdrawal by Subject|0|||
163202500|NCT02549937|589457166|FG004|Overall Study|Withdrawal by Subject|0|||
163202501|NCT02549937|589457167|FG005|Overall Study|Withdrawal by Subject|1|||
163309897|NCT02783300|589844443|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309898|NCT02783300|589844444|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309899|NCT02783300|589844445|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
163309900|NCT02783300|589844446|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309901|NCT02783300|589844447|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
163309902|NCT02783300|589844448|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309903|NCT02783300|589844449|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309904|NCT02783300|589844450|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
163309905|NCT02783300|589844451|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163051395|NCT04579380|588897114|FG005|Overall Study|Withdrawal by Subject|2|||
163051396|NCT04579380|588897115|FG006|Overall Study|Withdrawal by Subject|0|||
163051397|NCT04579380|588897116|FG007|Overall Study|Withdrawal by Subject|1|||
163051398|NCT04579380|588897117|FG008|Overall Study|Withdrawal by Subject|2|||
163051399|NCT04579380|588897109|FG000|Overall Study|Ongoing|2|||
163051400|NCT04579380|588897110|FG001|Overall Study|Ongoing|6|||
163051401|NCT04579380|588897111|FG002|Overall Study|Ongoing|4|||
163051402|NCT04579380|588897112|FG003|Overall Study|Ongoing|8|||
163051403|NCT04579380|588897113|FG004|Overall Study|Ongoing|5|||
163051404|NCT04579380|588897114|FG005|Overall Study|Ongoing|8|||
163051405|NCT04579380|588897115|FG006|Overall Study|Ongoing|3|||
163051406|NCT04579380|588897116|FG007|Overall Study|Ongoing|19|||
163051407|NCT04579380|588897117|FG008|Overall Study|Ongoing|6|||
163051408|NCT04113694|588897118|FG000|Overall Study|Adverse Event|2|||
163051409|NCT04113694|588897118|FG000|Overall Study|Lost to Follow-up|2|||
163051410|NCT04113694|588897118|FG000|Overall Study|Withdrawal by Subject|6|||
163051411|NCT04113694|588897118|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
163051412|NCT05630196|588897121|FG000|Overall Study|Adverse Event|2|||
163051413|NCT05630196|588897122|FG001|Overall Study|Adverse Event|1|||
163051414|NCT05630196|588897121|FG000|Overall Study|Lost to Follow-up|1|||
163051415|NCT05630196|588897122|FG001|Overall Study|Lost to Follow-up|1|||
163051416|NCT05630196|588897121|FG000|Overall Study|Protocol Violation|2|||
163051417|NCT05630196|588897122|FG001|Overall Study|Protocol Violation|3|||
163051418|NCT05630196|588897121|FG000|Overall Study|Physician Decision|1|||
163051419|NCT05630196|588897122|FG001|Overall Study|Physician Decision|0|||
163051420|NCT05630196|588897121|FG000|Overall Study|Withdrawal by Subject|3|||
163051421|NCT05630196|588897122|FG001|Overall Study|Withdrawal by Subject|4|||
163051422|NCT03973996|588897124|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163051423|NCT03973996|588897125|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163051424|NCT03973996|588897126|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163051425|NCT03973996|588897127|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
163051426|NCT04070989|588897128|FG000|Overall Study|Death|1|||
163051427|NCT04070989|588897129|FG001|Overall Study|Death|0|||
163051428|NCT04070989|588897130|FG002|Overall Study|Death|0|||
163051429|NCT04070989|588897128|FG000|Overall Study|Study Terminated by Sponsor|7|||
163051430|NCT04070989|588897129|FG001|Overall Study|Study Terminated by Sponsor|8|||
163051431|NCT04070989|588897130|FG002|Overall Study|Study Terminated by Sponsor|23|||
163051432|NCT04070989|588897128|FG000|Overall Study|Withdrawal by Subject|0|||
163051433|NCT04070989|588897129|FG001|Overall Study|Withdrawal by Subject|1|||
163051434|NCT04070989|588897130|FG002|Overall Study|Withdrawal by Subject|0|||
163309906|NCT02783300|589844452|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309907|NCT02783300|589844453|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
163309908|NCT02783300|589844454|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163051435|NCT04070989|588897128|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
163051436|NCT04070989|588897129|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
163051437|NCT04070989|588897130|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
163309909|NCT02783300|589844455|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309910|NCT02783300|589844456|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309911|NCT02783300|589844457|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309912|NCT02783300|589844458|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309913|NCT02783300|589844459|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309914|NCT02783300|589844460|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309915|NCT02783300|589844461|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309916|NCT02783300|589844462|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309917|NCT02783300|589844463|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309918|NCT02783300|589844464|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309919|NCT02783300|589844465|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309920|NCT02783300|589844466|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309921|NCT02783300|589844467|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163309922|NCT02783300|589844441|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309923|NCT02783300|589844442|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309924|NCT02783300|589844443|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309925|NCT02783300|589844444|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163051438|NCT04070989|588897128|FG000|Overall Study|Other|1|||
163051439|NCT04070989|588897129|FG001|Overall Study|Other|1|||
163051440|NCT04070989|588897130|FG002|Overall Study|Other|0|||
163051441|NCT06088784|588897131|FG000|Overall Study|Adverse Event|0|||
163051442|NCT06088784|588897132|FG001|Overall Study|Adverse Event|0|||
163051443|NCT06088784|588897133|FG002|Overall Study|Adverse Event|0|||
163051444|NCT06088784|588897134|FG003|Overall Study|Adverse Event|0|||
163051445|NCT06088784|588897135|FG004|Overall Study|Adverse Event|0|||
163051446|NCT06088784|588897136|FG005|Overall Study|Adverse Event|0|||
163051447|NCT06088784|588897137|FG006|Overall Study|Adverse Event|3|||
163051448|NCT06088784|588897138|FG007|Overall Study|Adverse Event|0|||
163051449|NCT06088784|588897139|FG008|Overall Study|Adverse Event|0|||
163051450|NCT06088784|588897140|FG009|Overall Study|Adverse Event|0|||
163051451|NCT06088784|588897141|FG010|Overall Study|Adverse Event|0|||
163051452|NCT06088784|588897142|FG011|Overall Study|Adverse Event|0|||
163051453|NCT06088784|588897131|FG000|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163051454|NCT06088784|588897132|FG001|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163309926|NCT02783300|589844445|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309927|NCT02783300|589844446|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309928|NCT02783300|589844447|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309929|NCT02783300|589844448|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309930|NCT02783300|589844449|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309931|NCT02783300|589844450|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163051455|NCT06088784|588897133|FG002|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163051456|NCT06088784|588897134|FG003|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163309932|NCT02783300|589844451|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309933|NCT02783300|589844452|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309934|NCT02783300|589844453|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309935|NCT02783300|589844454|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309936|NCT02783300|589844455|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309937|NCT02783300|589844456|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
163309938|NCT02783300|589844457|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309939|NCT02783300|589844458|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
163309940|NCT02783300|589844459|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
163309941|NCT02783300|589844460|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
163309942|NCT02783300|589844461|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309943|NCT02783300|589844462|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309944|NCT02783300|589844463|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163051457|NCT06088784|588897135|FG004|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163051458|NCT06088784|588897136|FG005|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163309945|NCT02783300|589844464|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163202502|NCT02549937|589457168|FG006|Overall Study|Withdrawal by Subject|4|||
163202503|NCT02549937|589457169|FG007|Overall Study|Withdrawal by Subject|3|||
163202504|NCT02549937|589457170|FG008|Overall Study|Withdrawal by Subject|2|||
163202505|NCT02549937|589457162|FG000|Overall Study|Sponsor Decision|0|||
163202506|NCT02549937|589457163|FG001|Overall Study|Sponsor Decision|0|||
163202507|NCT02549937|589457164|FG002|Overall Study|Sponsor Decision|0|||
163202508|NCT02549937|589457165|FG003|Overall Study|Sponsor Decision|0|||
163202509|NCT02549937|589457166|FG004|Overall Study|Sponsor Decision|0|||
163202510|NCT02549937|589457167|FG005|Overall Study|Sponsor Decision|0|||
163202511|NCT02549937|589457168|FG006|Overall Study|Sponsor Decision|0|||
163202512|NCT02549937|589457169|FG007|Overall Study|Sponsor Decision|0|||
163202513|NCT02549937|589457170|FG008|Overall Study|Sponsor Decision|6|||
163202514|NCT02144012|589457173|FG000|Overall Study|Adverse Event|1|||
163202515|NCT02144012|589457174|FG001|Overall Study|Adverse Event|0|||
163202516|NCT02144012|589457173|FG000|Overall Study|Death|1|||
163202517|NCT02144012|589457174|FG001|Overall Study|Death|0|||
163202518|NCT02144012|589457173|FG000|Overall Study|Withdrawal by Subject|11|||
163202519|NCT02144012|589457174|FG001|Overall Study|Withdrawal by Subject|3|||
163202520|NCT02144012|589457173|FG000|Overall Study|Study Terminated by Sponsor|18|||
163202521|NCT02144012|589457174|FG001|Overall Study|Study Terminated by Sponsor|12|||
163202522|NCT02144012|589457173|FG000|Overall Study|Other|3|||
163202523|NCT02144012|589457174|FG001|Overall Study|Other|0|||
163202524|NCT00317356|589457175|FG000|Overall Study|Adverse Event|0|||
163202525|NCT00317356|589457176|FG001|Overall Study|Adverse Event|0|||
163202526|NCT00317356|589457177|FG002|Overall Study|Adverse Event|1|||
163202527|NCT00317356|589457178|FG003|Overall Study|Adverse Event|0|||
163202528|NCT00317356|589457175|FG000|Overall Study|Lack of Efficacy|1|||
163202529|NCT00317356|589457176|FG001|Overall Study|Lack of Efficacy|1|||
163202530|NCT00317356|589457177|FG002|Overall Study|Lack of Efficacy|0|||
163202531|NCT00317356|589457178|FG003|Overall Study|Lack of Efficacy|3|||
163202532|NCT00317356|589457175|FG000|Overall Study|Physician Decision|0|||
163202533|NCT00317356|589457176|FG001|Overall Study|Physician Decision|1|||
163202534|NCT00317356|589457177|FG002|Overall Study|Physician Decision|0|||
163202535|NCT00317356|589457178|FG003|Overall Study|Physician Decision|0|||
163202536|NCT04342897|589457179|FG000|Overall Study|Death|7|||
163202537|NCT04342897|589457180|FG001|Overall Study|Death|4|||
163202538|NCT04342897|589457179|FG000|Overall Study|Lost to Follow-up|6|||
163202539|NCT04342897|589457180|FG001|Overall Study|Lost to Follow-up|6|||
163202540|NCT04342897|589457179|FG000|Overall Study|Withdrawal by Subject|1|||
163202541|NCT04342897|589457180|FG001|Overall Study|Withdrawal by Subject|2|||
163202542|NCT02674529|589459564|FG000|Overall Study|Lost to Follow-up|1|||
163202543|NCT02674529|589459565|FG001|Overall Study|Lost to Follow-up|2|||
163202544|NCT02674529|589459564|FG000|Overall Study|Withdrawal by Subject|2|||
163202545|NCT02674529|589459565|FG001|Overall Study|Withdrawal by Subject|1|||
163202546|NCT02674529|589459564|FG000|Overall Study|Physician Decision|0|||
163202547|NCT02674529|589459565|FG001|Overall Study|Physician Decision|1|||
163202548|NCT02674529|589459564|FG000|Overall Study|Protocol Violation|0|||
163202549|NCT02674529|589459565|FG001|Overall Study|Protocol Violation|1|||
163202550|NCT02141282|589459567|FG000|Overall Study|Adverse event, not related to progression|8|||
163202551|NCT02141282|589459568|FG001|Overall Study|Adverse event, not related to progression|1|||
163202552|NCT02141282|589459569|FG002|Overall Study|Adverse event, not related to progression|3|||
163202553|NCT02141282|589459570|FG003|Overall Study|Adverse event, not related to progression|1|||
163309946|NCT02783300|589844465|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
163309947|NCT02783300|589844466|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309948|NCT02783300|589844467|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163309949|NCT02783300|589844441|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309950|NCT02783300|589844442|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309951|NCT02783300|589844443|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309952|NCT02783300|589844444|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309953|NCT02783300|589844445|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309954|NCT02783300|589844446|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309955|NCT02783300|589844447|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309956|NCT02783300|589844448|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309957|NCT02783300|589844449|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309958|NCT02783300|589844450|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309959|NCT02783300|589844451|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309960|NCT02783300|589844452|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309961|NCT02783300|589844453|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309962|NCT02783300|589844454|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309963|NCT02783300|589844455|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309964|NCT02783300|589844456|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309965|NCT02783300|589844457|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
163309966|NCT02783300|589844458|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309967|NCT02783300|589844459|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
163309968|NCT02783300|589844460|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
163309969|NCT02783300|589844461|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309970|NCT02783300|589844462|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309971|NCT02783300|589844463|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309972|NCT02783300|589844464|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309973|NCT02783300|589844465|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309974|NCT02783300|589844466|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309975|NCT02783300|589844467|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163309976|NCT02783300|589844441|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309977|NCT02783300|589844442|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309978|NCT02783300|589844443|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309979|NCT02783300|589844444|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309980|NCT02783300|589844445|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309981|NCT02783300|589844446|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309982|NCT02783300|589844447|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309983|NCT02783300|589844448|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309984|NCT02783300|589844449|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309985|NCT02783300|589844450|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309986|NCT02783300|589844451|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309987|NCT02783300|589844452|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309988|NCT02783300|589844453|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309989|NCT02783300|589844454|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309990|NCT02783300|589844455|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309991|NCT02783300|589844456|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309992|NCT02783300|589844457|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
163309993|NCT02783300|589844458|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309994|NCT02783300|589844459|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
163309995|NCT02783300|589844460|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
163309996|NCT02783300|589844461|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
163309997|NCT02783300|589844462|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309998|NCT02783300|589844463|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163309999|NCT02783300|589844464|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163310000|NCT02783300|589844465|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163310001|NCT02783300|589844466|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163310002|NCT02783300|589844467|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163310003|NCT02783300|589844441|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162964458|NCT01438060|588569776|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
162964459|NCT01438060|588569777|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
163310004|NCT02783300|589844442|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163202554|NCT02141282|589459567|FG000|Overall Study|Adverse event, related to progression|1|||
162964460|NCT01438060|588569776|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
162964461|NCT01438060|588569777|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
162964462|NCT01438060|588569776|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
162964463|NCT01438060|588569777|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
162964464|NCT01438060|588569776|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
162964465|NCT01438060|588569777|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
163202555|NCT02141282|589459568|FG001|Overall Study|Adverse event, related to progression|0|||
163202556|NCT02141282|589459569|FG002|Overall Study|Adverse event, related to progression|2|||
163202557|NCT02141282|589459570|FG003|Overall Study|Adverse event, related to progression|0|||
163202558|NCT02141282|589459567|FG000|Overall Study|COVID-19 infection|1|||
163202559|NCT02141282|589459568|FG001|Overall Study|COVID-19 infection|0|||
163202560|NCT02141282|589459569|FG002|Overall Study|COVID-19 infection|0|||
163202561|NCT02141282|589459570|FG003|Overall Study|COVID-19 infection|0|||
163202562|NCT02141282|589459567|FG000|Overall Study|Lost to Follow-up|0|||
163202563|NCT02141282|589459568|FG001|Overall Study|Lost to Follow-up|0|||
163202564|NCT02141282|589459569|FG002|Overall Study|Lost to Follow-up|4|||
163202565|NCT02141282|589459570|FG003|Overall Study|Lost to Follow-up|2|||
163202566|NCT02141282|589459567|FG000|Overall Study|Other, not specified|14|||
163202567|NCT02141282|589459568|FG001|Overall Study|Other, not specified|11|||
163202568|NCT02141282|589459569|FG002|Overall Study|Other, not specified|23|||
163202569|NCT02141282|589459570|FG003|Overall Study|Other, not specified|9|||
163202570|NCT02141282|589459567|FG000|Overall Study|Progressive disease, Richter's|4|||
163202571|NCT02141282|589459568|FG001|Overall Study|Progressive disease, Richter's|1|||
163202572|NCT02141282|589459569|FG002|Overall Study|Progressive disease, Richter's|1|||
163202573|NCT02141282|589459570|FG003|Overall Study|Progressive disease, Richter's|1|||
163202574|NCT02141282|589459567|FG000|Overall Study|Progressive disease per protocol|12|||
163202575|NCT02141282|589459568|FG001|Overall Study|Progressive disease per protocol|7|||
163202576|NCT02141282|589459569|FG002|Overall Study|Progressive disease per protocol|9|||
163202577|NCT02141282|589459570|FG003|Overall Study|Progressive disease per protocol|2|||
163202578|NCT02141282|589459567|FG000|Overall Study|Stem cell transplant|1|||
163202579|NCT02141282|589459568|FG001|Overall Study|Stem cell transplant|0|||
163202580|NCT02141282|589459569|FG002|Overall Study|Stem cell transplant|1|||
163202581|NCT02141282|589459570|FG003|Overall Study|Stem cell transplant|0|||
163202582|NCT02141282|589459567|FG000|Overall Study|Study terminated by Sponsor|0|||
163202583|NCT02141282|589459568|FG001|Overall Study|Study terminated by Sponsor|1|||
163202584|NCT02141282|589459569|FG002|Overall Study|Study terminated by Sponsor|0|||
163202585|NCT02141282|589459570|FG003|Overall Study|Study terminated by Sponsor|0|||
163202586|NCT02141282|589459567|FG000|Overall Study|Subject non-compliance|0|||
163202587|NCT02141282|589459568|FG001|Overall Study|Subject non-compliance|0|||
163202588|NCT02141282|589459569|FG002|Overall Study|Subject non-compliance|1|||
163202589|NCT02141282|589459570|FG003|Overall Study|Subject non-compliance|0|||
163202590|NCT02141282|589459567|FG000|Overall Study|Withdrew consent|2|||
163202591|NCT02141282|589459568|FG001|Overall Study|Withdrew consent|0|||
163202592|NCT02141282|589459569|FG002|Overall Study|Withdrew consent|4|||
163202593|NCT02141282|589459570|FG003|Overall Study|Withdrew consent|0|||
163202594|NCT00963547|589459573|FG000|Overall Study|Adverse Event|0|||
163202595|NCT00963547|589459574|FG001|Overall Study|Adverse Event|1|||
163202596|NCT00963547|589459575|FG002|Overall Study|Adverse Event|0|||
163202597|NCT00963547|589459576|FG003|Overall Study|Adverse Event|1|||
163202598|NCT00963547|589459577|FG004|Overall Study|Adverse Event|0|||
163202599|NCT00963547|589459578|FG005|Overall Study|Adverse Event|0|||
163202600|NCT00963547|589459579|FG006|Overall Study|Adverse Event|0|||
163202601|NCT00963547|589459573|FG000|Overall Study|Physician Decision|1|||
163202602|NCT00963547|589459574|FG001|Overall Study|Physician Decision|1|||
163202603|NCT00963547|589459575|FG002|Overall Study|Physician Decision|0|||
163202604|NCT00963547|589459576|FG003|Overall Study|Physician Decision|0|||
163202605|NCT00963547|589459577|FG004|Overall Study|Physician Decision|0|||
163202606|NCT00963547|589459578|FG005|Overall Study|Physician Decision|0|||
163202607|NCT00963547|589459579|FG006|Overall Study|Physician Decision|0|||
163202608|NCT00963547|589459573|FG000|Overall Study|Progressive Disease|3|||
163202609|NCT00963547|589459574|FG001|Overall Study|Progressive Disease|8|||
163202610|NCT00963547|589459575|FG002|Overall Study|Progressive Disease|9|||
163202611|NCT00963547|589459576|FG003|Overall Study|Progressive Disease|5|||
163202612|NCT00963547|589459577|FG004|Overall Study|Progressive Disease|0|||
163202613|NCT00963547|589459578|FG005|Overall Study|Progressive Disease|0|||
163202614|NCT00963547|589459579|FG006|Overall Study|Progressive Disease|0|||
163202615|NCT00963547|589459573|FG000|Overall Study|Withdrawal by Subject|0|||
163202616|NCT00963547|589459574|FG001|Overall Study|Withdrawal by Subject|0|||
163202617|NCT00963547|589459575|FG002|Overall Study|Withdrawal by Subject|3|||
163202618|NCT00963547|589459576|FG003|Overall Study|Withdrawal by Subject|0|||
163202619|NCT00963547|589459577|FG004|Overall Study|Withdrawal by Subject|0|||
163202620|NCT00963547|589459578|FG005|Overall Study|Withdrawal by Subject|0|||
163202621|NCT00963547|589459579|FG006|Overall Study|Withdrawal by Subject|0|||
163202622|NCT00963547|589459573|FG000|Overall Study|Reason Unknown|0|||
163202623|NCT00963547|589459574|FG001|Overall Study|Reason Unknown|1|||
163310005|NCT02783300|589844443|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310006|NCT02783300|589844444|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310007|NCT02783300|589844445|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310008|NCT02783300|589844446|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310009|NCT02783300|589844447|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310010|NCT02783300|589844448|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310011|NCT02783300|589844449|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310012|NCT02783300|589844450|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310013|NCT02783300|589844451|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310014|NCT02783300|589844452|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310015|NCT02783300|589844453|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310016|NCT02783300|589844454|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310017|NCT02783300|589844455|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310018|NCT02783300|589844456|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
163310019|NCT02783300|589844457|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310020|NCT02783300|589844458|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310021|NCT02783300|589844459|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310022|NCT02783300|589844460|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310023|NCT02783300|589844461|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310024|NCT02783300|589844462|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310025|NCT02783300|589844463|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
163310026|NCT02783300|589844464|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310027|NCT02783300|589844465|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310028|NCT02783300|589844466|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310029|NCT02783300|589844467|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163310030|NCT02783300|589844441|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310031|NCT02783300|589844442|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310032|NCT02783300|589844443|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310033|NCT02783300|589844444|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310034|NCT02783300|589844445|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310035|NCT02783300|589844446|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310036|NCT02783300|589844447|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310037|NCT02783300|589844448|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310038|NCT02783300|589844449|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310039|NCT02783300|589844450|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310040|NCT02783300|589844451|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310041|NCT02783300|589844452|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310042|NCT02783300|589844453|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310043|NCT02783300|589844454|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
163310044|NCT02783300|589844455|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
163310045|NCT02783300|589844456|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
163310046|NCT02783300|589844457|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
163310047|NCT02783300|589844458|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310048|NCT02783300|589844459|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
163310049|NCT02783300|589844460|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
163310050|NCT02783300|589844461|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310051|NCT02783300|589844462|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310052|NCT02783300|589844463|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310053|NCT02783300|589844464|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310054|NCT02783300|589844465|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310055|NCT02783300|589844466|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310056|NCT02783300|589844467|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163310057|NCT02783300|589844441|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163310058|NCT02783300|589844442|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163310059|NCT02783300|589844443|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163310060|NCT02783300|589844444|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163051459|NCT06088784|588897137|FG006|Overall Study|Exclusion criterion: QTcF >450 msec|1|||
163051460|NCT06088784|588897138|FG007|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163310061|NCT02783300|589844445|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163310062|NCT02783300|589844446|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163051461|NCT06088784|588897139|FG008|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163310063|NCT02783300|589844447|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163310064|NCT02783300|589844448|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163310065|NCT02783300|589844449|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163310066|NCT02783300|589844450|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163310067|NCT02783300|589844451|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163310068|NCT02783300|589844452|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163310069|NCT02783300|589844453|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163310070|NCT02783300|589844454|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
163310071|NCT02783300|589844455|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
163310072|NCT02783300|589844456|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
163310073|NCT02783300|589844457|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
163202624|NCT00963547|589459575|FG002|Overall Study|Reason Unknown|0|||
163202625|NCT00963547|589459576|FG003|Overall Study|Reason Unknown|0|||
163202626|NCT00963547|589459577|FG004|Overall Study|Reason Unknown|0|||
163310074|NCT02783300|589844458|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
163310075|NCT02783300|589844459|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
163310076|NCT02783300|589844460|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
163310077|NCT02783300|589844461|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
163310078|NCT02783300|589844462|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
163310079|NCT02783300|589844463|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
163310080|NCT02783300|589844464|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
163310081|NCT02783300|589844465|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
163310082|NCT02783300|589844466|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
163310083|NCT02783300|589844467|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163310084|NCT02783300|589844441|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310085|NCT02783300|589844442|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310086|NCT02783300|589844443|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310087|NCT02783300|589844444|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310088|NCT02783300|589844445|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310089|NCT02783300|589844446|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163051462|NCT06088784|588897140|FG009|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163051463|NCT06088784|588897141|FG010|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163051464|NCT06088784|588897142|FG011|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163051465|NCT05556616|588897145|FG000|Overall Study|Withdrawal by Subject|1|||
163051466|NCT05556616|588897146|FG001|Overall Study|Withdrawal by Subject|0|||
163051467|NCT05556616|588897147|FG002|Overall Study|Withdrawal by Subject|0|||
163051468|NCT05556616|588897148|FG003|Overall Study|Withdrawal by Subject|0|||
163051469|NCT05556616|588897149|FG004|Overall Study|Withdrawal by Subject|0|||
163051470|NCT05556616|588897150|FG005|Overall Study|Withdrawal by Subject|0|||
163051471|NCT05556616|588897151|FG006|Overall Study|Withdrawal by Subject|0|||
163051472|NCT05556616|588897145|FG000|Overall Study|Death|0|||
163051473|NCT05556616|588897146|FG001|Overall Study|Death|0|||
163051474|NCT05556616|588897147|FG002|Overall Study|Death|2|||
163051475|NCT05556616|588897148|FG003|Overall Study|Death|1|||
163051476|NCT05556616|588897149|FG004|Overall Study|Death|0|||
163051477|NCT05556616|588897150|FG005|Overall Study|Death|0|||
163051478|NCT05556616|588897151|FG006|Overall Study|Death|0|||
163051479|NCT05556616|588897145|FG000|Overall Study|Study Terminated by Sponsor|0|||
163051480|NCT05556616|588897146|FG001|Overall Study|Study Terminated by Sponsor|3|||
163310090|NCT02783300|589844447|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310091|NCT02783300|589844448|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310092|NCT02783300|589844449|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163202627|NCT00963547|589459578|FG005|Overall Study|Reason Unknown|0|||
163202628|NCT00963547|589459579|FG006|Overall Study|Reason Unknown|0|||
163310093|NCT02783300|589844450|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310094|NCT02783300|589844451|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310095|NCT02783300|589844452|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310096|NCT02783300|589844453|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310097|NCT02783300|589844454|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310098|NCT02783300|589844455|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310099|NCT02783300|589844456|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163202629|NCT00331682|589459580|FG000|Overall Study|Adverse Event|1|||
163310100|NCT02783300|589844457|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163202630|NCT03761277|589459581|FG000|Enrollment to Implant|Screen Failure|17|||
163202631|NCT03761277|589459581|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
163202632|NCT03761277|589459581|FG000|Enrollment to Implant|Physician Decision|2|||
163051481|NCT05556616|588897147|FG002|Overall Study|Study Terminated by Sponsor|0|||
163202633|NCT03761277|589459581|FG000|Enrollment to Implant|Site Closure|3|||
163202634|NCT03761277|589459581|FG000|Enrollment to Implant|Sponsor Request|2|||
163202635|NCT03761277|589459581|FG000|Post-Implant to 6 Months|Adverse Event|2|||
163202636|NCT03761277|589459581|FG000|Post-Implant to 6 Months|Death|1|||
163202637|NCT03761277|589459581|FG000|Post-Implant to 6 Months|Site Closure|2|||
163202638|NCT03761277|589459581|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
163202639|NCT03761277|589459581|FG000|6 Months to 12 Months|Physician Decision|2|||
163202640|NCT03761277|589459581|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
163202641|NCT00759031|589459582|FG000|First Intervention (1 Day)|Physician Decision|1|||
163202642|NCT00759031|589459583|FG001|First Intervention (1 Day)|Physician Decision|0|||
163202643|NCT00759031|589459582|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
163202644|NCT00759031|589459583|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
163202645|NCT00759031|589459582|FG000|First Intervention (1 Day)|Screening failure|1|||
163202646|NCT00759031|589459583|FG001|First Intervention (1 Day)|Screening failure|0|||
163202647|NCT00543140|589459584|FG000|Overall Study|Lost to Follow-up|33|||
163202648|NCT00543140|589459584|FG000|Overall Study|Withdrawal by Subject|13|||
163202649|NCT00543140|589459584|FG000|Overall Study|Protocol Violation|10|||
163202650|NCT00543140|589459584|FG000|Overall Study|Insufficient weight loss|10|||
163202651|NCT00543140|589459584|FG000|Overall Study|SAE leading to explant of SAGB|3|||
163202652|NCT00543140|589459584|FG000|Overall Study|Death|1|||
163202653|NCT00543140|589459584|FG000|Overall Study|Subject moved|1|||
163202654|NCT00543140|589459584|FG000|Overall Study|Conversion to different procedure|1|||
163202655|NCT04532164|589459585|FG000|Overall Study|Adverse Event|1|||
163202656|NCT04532164|589459585|FG000|Overall Study|Protocol Violation|5|||
163202657|NCT04532164|589459585|FG000|Overall Study|Lost to Follow-up|1|||
163202658|NCT04532164|589459585|FG000|Overall Study|Found to be Ineligible|3|||
163202659|NCT04532164|589459585|FG000|Overall Study|Withdrawal by Subject|14|||
163202660|NCT02483520|589459586|FG000|Overall Study|Lost to Follow-up|3|||
163202661|NCT02483520|589459587|FG001|Overall Study|Lost to Follow-up|4|||
163202662|NCT02483520|589459586|FG000|Overall Study|Withdrawal by Subject|4|||
163202663|NCT02483520|589459587|FG001|Overall Study|Withdrawal by Subject|14|||
163202664|NCT02483520|589459586|FG000|Overall Study|Hospitalized|2|||
163202665|NCT02483520|589459587|FG001|Overall Study|Hospitalized|3|||
163202666|NCT02483520|589459586|FG000|Overall Study|Moved to LTC|2|||
163202667|NCT02483520|589459587|FG001|Overall Study|Moved to LTC|3|||
163202668|NCT01104493|589459590|FG000|Overall Study|Lost to Follow-up|0|||
163202669|NCT01104493|589459591|FG001|Overall Study|Lost to Follow-up|2|||
163202670|NCT00743340|589459595|FG000|Overall Study|Study medication non-compliance|1|||
163202671|NCT00743340|589459595|FG000|Overall Study|Lost to Follow-up|1|||
163202672|NCT00743340|589459595|FG000|Overall Study|Withdrawal from the Study|5|||
163202673|NCT00743340|589459595|FG000|Overall Study|Protocol Violation|1|||
163202674|NCT00743340|589459595|FG000|Overall Study|Virologic failure|8|||
163202675|NCT00743340|589459595|FG000|Overall Study|Pregnancy|1|||
163202676|NCT00743340|589459595|FG000|Overall Study|Rolled over to other Gilead Study|23|||
163202677|NCT00743340|589459595|FG000|Overall Study|Participant Relocated|1|||
163202678|NCT00127660|589459596|FG000|Overall Study|Protocol Violation|3|||
163202679|NCT00127660|589459597|FG001|Overall Study|Protocol Violation|3|||
163202680|NCT00127660|589459598|FG002|Overall Study|Protocol Violation|5|||
163202681|NCT00127660|589459599|FG003|Overall Study|Protocol Violation|0|||
163202682|NCT01987505|589459600|FG000|Overall Study|Other|9|||
163202683|NCT01987505|589459600|FG000|Overall Study|Withdrawal by Subject|2|||
163202684|NCT01987505|589459600|FG000|Overall Study|Other Reason|2|||
163202685|NCT01987505|589459600|FG000|Overall Study|Lost to Follow-up|15|||
163202686|NCT01987505|589459600|FG000|Overall Study|Investigator Decision|2|||
163202687|NCT01987505|589459600|FG000|Overall Study|Death|4|||
163202688|NCT01425281|589459601|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
163202689|NCT01425281|589459602|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
163202690|NCT01425281|589459601|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
163202691|NCT01425281|589459602|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
163202692|NCT01425281|589459601|FG000|At 180-day Clinical Follow-up|Death|0|||
163202693|NCT01425281|589459602|FG001|At 180-day Clinical Follow-up|Death|1|||
163202694|NCT01425281|589459601|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
163202695|NCT01425281|589459602|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
163202696|NCT01425281|589459601|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
163202697|NCT01425281|589459602|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
163202698|NCT01425281|589459601|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
163202699|NCT01425281|589459602|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
163202700|NCT01425281|589459601|FG000|At 2-year Clinical Follow-up|Death|2|||
163202701|NCT01425281|589459602|FG001|At 2-year Clinical Follow-up|Death|0|||
162964466|NCT01438060|588569776|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
162964467|NCT01438060|588569777|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
162964468|NCT01438060|588569776|FG000|On Study Beyond Week 140|Adverse Event|0|||
162964469|NCT01438060|588569777|FG001|On Study Beyond Week 140|Adverse Event|2|||
162964470|NCT01438060|588569776|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
162964471|NCT01438060|588569777|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
162964472|NCT01438060|588569776|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
162964473|NCT01438060|588569777|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
162964474|NCT01438060|588569776|FG000|On Study Beyond Week 140|Death|0|||
162964475|NCT01438060|588569777|FG001|On Study Beyond Week 140|Death|1|||
162964476|NCT01438060|588569776|FG000|On Study Beyond Week 140|Other Reason|0|||
162964477|NCT01438060|588569777|FG001|On Study Beyond Week 140|Other Reason|3|||
162964478|NCT01964950|588569778|FG000|Overall Study|Protocol Violation|25|||
162964479|NCT01190865|588569787|FG000|Overall Study|Withdrawal by Subject|1|||
162964480|NCT01190865|588569787|FG000|Overall Study|Non-compliance|2|||
162964481|NCT00875524|588569788|FG000|Overall Study|Serious adverse event|0|||
162964482|NCT00875524|588569789|FG001|Overall Study|Serious adverse event|1|||
163310101|NCT02783300|589844458|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310102|NCT02783300|589844459|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310103|NCT02783300|589844460|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310104|NCT02783300|589844461|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310105|NCT02783300|589844462|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310106|NCT02783300|589844463|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310107|NCT02783300|589844464|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310108|NCT02783300|589844465|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310109|NCT02783300|589844466|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163310110|NCT02783300|589844467|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
163310111|NCT02783300|589844441|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310112|NCT02783300|589844442|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310113|NCT02783300|589844443|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310114|NCT02783300|589844444|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
162964483|NCT00875524|588569788|FG000|Overall Study|Protocol Violation|4|||
162964484|NCT00875524|588569789|FG001|Overall Study|Protocol Violation|0|||
162964485|NCT00875524|588569788|FG000|Overall Study|Lost to Follow-up|1|||
162964486|NCT00875524|588569789|FG001|Overall Study|Lost to Follow-up|0|||
162964487|NCT00875524|588569788|FG000|Overall Study|Withdrawal by Subject|3|||
162964488|NCT00875524|588569789|FG001|Overall Study|Withdrawal by Subject|5|||
162964489|NCT00574847|588569799|FG000|Overall Study|Adverse Event|2|||
162964490|NCT00574847|588569800|FG001|Overall Study|Adverse Event|0|||
163202702|NCT01425281|589459601|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
163202703|NCT01425281|589459602|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
163202704|NCT01425281|589459601|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
163202705|NCT01425281|589459602|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
163202706|NCT01425281|589459601|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
163202707|NCT01425281|589459602|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
163202708|NCT01425281|589459601|FG000|At 3-year Clinical Follow-up|Death|2|||
163202709|NCT01425281|589459602|FG001|At 3-year Clinical Follow-up|Death|3|||
163202710|NCT01425281|589459601|FG000|At 4-year Clinical Follow-up|Death|7|||
163202711|NCT01425281|589459602|FG001|At 4-year Clinical Follow-up|Death|3|||
163202712|NCT01425281|589459601|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
163202713|NCT01425281|589459602|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
163202714|NCT01425281|589459601|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
163202715|NCT01425281|589459602|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
163202716|NCT01425281|589459601|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
163202717|NCT01425281|589459602|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
163202718|NCT01425281|589459601|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
163202719|NCT01425281|589459602|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
163202720|NCT01425281|589459601|FG000|At 5-year Clinical Follow-up|Death|2|||
163202721|NCT01425281|589459602|FG001|At 5-year Clinical Follow-up|Death|0|||
163202722|NCT01425281|589459601|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
163202723|NCT01425281|589459602|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
163202724|NCT01425281|589459601|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
163202725|NCT01425281|589459602|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
163202726|NCT01425281|589459601|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
163202727|NCT01425281|589459602|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
163202728|NCT01749514|589459603|FG000|Overall Study|Lost to Follow-up|0|||
163202729|NCT01749514|589459604|FG001|Overall Study|Lost to Follow-up|0|||
163202730|NCT01749514|589459605|FG002|Overall Study|Lost to Follow-up|0|||
163202731|NCT01749514|589459606|FG003|Overall Study|Lost to Follow-up|0|||
163202732|NCT01749514|589459607|FG004|Overall Study|Lost to Follow-up|0|||
163202733|NCT01749514|589459608|FG005|Overall Study|Lost to Follow-up|0|||
163202734|NCT01749514|589459609|FG006|Overall Study|Lost to Follow-up|0|||
163202735|NCT01749514|589459610|FG007|Overall Study|Lost to Follow-up|1|||
163202736|NCT01749514|589459603|FG000|Overall Study|Withdrawal by Subject|0|||
163202737|NCT01749514|589459604|FG001|Overall Study|Withdrawal by Subject|0|||
163202738|NCT01749514|589459605|FG002|Overall Study|Withdrawal by Subject|0|||
163202739|NCT01749514|589459606|FG003|Overall Study|Withdrawal by Subject|0|||
163202740|NCT01749514|589459607|FG004|Overall Study|Withdrawal by Subject|0|||
163202741|NCT01749514|589459608|FG005|Overall Study|Withdrawal by Subject|1|||
163202742|NCT01749514|589459609|FG006|Overall Study|Withdrawal by Subject|0|||
163202743|NCT01749514|589459610|FG007|Overall Study|Withdrawal by Subject|1|||
163202744|NCT01749514|589459603|FG000|Overall Study|Not Reported|0|||
163202745|NCT01749514|589459604|FG001|Overall Study|Not Reported|0|||
163202746|NCT01749514|589459605|FG002|Overall Study|Not Reported|0|||
163202747|NCT01749514|589459606|FG003|Overall Study|Not Reported|0|||
163202748|NCT01749514|589459607|FG004|Overall Study|Not Reported|0|||
163202749|NCT01749514|589459608|FG005|Overall Study|Not Reported|0|||
163202750|NCT01749514|589459609|FG006|Overall Study|Not Reported|0|||
163202751|NCT01749514|589459610|FG007|Overall Study|Not Reported|5|||
163202752|NCT02509156|589459611|FG000|Randomized Phase|Death|1|||
163202753|NCT02509156|589459612|FG001|Randomized Phase|Death|0|||
163202754|NCT02509156|589459611|FG000|Randomized Phase|Withdrawal by Subject|1|||
163202755|NCT02509156|589459612|FG001|Randomized Phase|Withdrawal by Subject|1|||
163202756|NCT05131646|589459613|FG000|Overall Study|Withdrawal by Subject|1|||
163202757|NCT05131646|589459614|FG001|Overall Study|Withdrawal by Subject|0|||
163202758|NCT05131646|589459615|FG002|Overall Study|Withdrawal by Subject|0|||
163202759|NCT02128113|589459616|FG000|Overall Study|Withdrawal by Subject|3|||
163202760|NCT02128113|589459617|FG001|Overall Study|Withdrawal by Subject|1|||
163202761|NCT02128113|589459618|FG002|Overall Study|Withdrawal by Subject|0|||
163202762|NCT02128113|589459616|FG000|Overall Study|Protocol Violation|0|||
163202763|NCT02128113|589459617|FG001|Overall Study|Protocol Violation|1|||
163202764|NCT02128113|589459618|FG002|Overall Study|Protocol Violation|0|||
163202765|NCT02128113|589459616|FG000|Overall Study|Surgery cancelled|0|||
163202766|NCT02128113|589459617|FG001|Overall Study|Surgery cancelled|1|||
163202767|NCT02128113|589459618|FG002|Overall Study|Surgery cancelled|0|||
163202768|NCT02128113|589459616|FG000|Overall Study|Adverse Event|0|||
163202769|NCT02128113|589459617|FG001|Overall Study|Adverse Event|0|||
163202770|NCT02128113|589459618|FG002|Overall Study|Adverse Event|1|||
163202771|NCT01750242|589459619|FG000|Overall Study|Unreadable Images|3|||
163202772|NCT03765918|589459620|FG000|Overall Study|Death|109|||
163202773|NCT03765918|589459621|FG001|Overall Study|Death|127|||
163202774|NCT03765918|589459620|FG000|Overall Study|Lost to Follow-up|2|||
163202775|NCT03765918|589459621|FG001|Overall Study|Lost to Follow-up|3|||
163202776|NCT03765918|589459620|FG000|Overall Study|Withdrawal by Subject|12|||
163202777|NCT03765918|589459621|FG001|Overall Study|Withdrawal by Subject|16|||
163202778|NCT03765918|589459620|FG000|Overall Study|Participants Ongoing|240|||
163202779|NCT03765918|589459621|FG001|Overall Study|Participants Ongoing|205|||
163202780|NCT04202965|589459622|FG000|Overall Study|Adverse Event|3|||
163202781|NCT04202965|589459622|FG000|Overall Study|Did not meet inclusion criteria|1|||
163202782|NCT02969369|589459623|FG000|Study|Adverse Event|1|||
163202783|NCT02969369|589459624|FG001|Study|Adverse Event|6|||
163202784|NCT02969369|589459623|FG000|Study|Lack of Efficacy|0|||
163202785|NCT02969369|589459624|FG001|Study|Lack of Efficacy|1|||
163202786|NCT02969369|589459623|FG000|Study|Lost to Follow-up|0|||
163202787|NCT02969369|589459624|FG001|Study|Lost to Follow-up|1|||
163202788|NCT02969369|589459623|FG000|Study|Withdrawal by Subject|3|||
163202789|NCT02969369|589459624|FG001|Study|Withdrawal by Subject|5|||
163202790|NCT02969369|589459623|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
163202791|NCT02969369|589459624|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
163202792|NCT02969369|589459623|FG000|Double-blind Period|Adverse Event|1|||
163202793|NCT02969369|589459624|FG001|Double-blind Period|Adverse Event|5|||
163202794|NCT02969369|589459623|FG000|Double-blind Period|Lost to Follow-up|0|||
163202795|NCT02969369|589459624|FG001|Double-blind Period|Lost to Follow-up|1|||
163202796|NCT02969369|589459623|FG000|Double-blind Period|Withdrawal by Subject|2|||
163202797|NCT02969369|589459624|FG001|Double-blind Period|Withdrawal by Subject|3|||
163202798|NCT02969369|589459623|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
163202799|NCT02969369|589459624|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
163202800|NCT02969369|589459623|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
163202801|NCT02969369|589459624|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
163202802|NCT02969369|589459623|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
163202803|NCT02969369|589459624|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
163202804|NCT02969369|589459623|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
163202805|NCT02969369|589459624|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
163202806|NCT01980992|589459627|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
163202807|NCT01980992|589459628|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
163310115|NCT02783300|589844445|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310116|NCT02783300|589844446|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310117|NCT02783300|589844447|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310118|NCT02783300|589844448|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310119|NCT02783300|589844449|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310120|NCT02783300|589844450|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310121|NCT02783300|589844451|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310122|NCT02783300|589844452|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310123|NCT02783300|589844453|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310124|NCT02783300|589844454|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310125|NCT02783300|589844455|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310126|NCT02783300|589844456|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310127|NCT02783300|589844457|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310128|NCT02783300|589844458|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310129|NCT02783300|589844459|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310130|NCT02783300|589844460|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310131|NCT02783300|589844461|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310132|NCT02783300|589844462|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310133|NCT02783300|589844463|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310134|NCT02783300|589844464|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310135|NCT02783300|589844465|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310136|NCT02783300|589844466|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
163310137|NCT02783300|589844467|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
163310138|NCT00378105|589844468|FG000|Overall Study|Adverse Event|3|||
163310139|NCT00378105|589844469|FG001|Overall Study|Adverse Event|1|||
163310140|NCT00378105|589844468|FG000|Overall Study|Withdrawal by Subject|3|||
163310141|NCT00378105|589844469|FG001|Overall Study|Withdrawal by Subject|3|||
163310142|NCT00378105|589844468|FG000|Overall Study|Death|1|||
163310143|NCT00378105|589844469|FG001|Overall Study|Death|0|||
163310144|NCT00378105|589844468|FG000|Overall Study|Going to transplant|7|||
163310145|NCT00378105|589844469|FG001|Overall Study|Going to transplant|8|||
163310146|NCT00378105|589844468|FG000|Overall Study|Progressive disease|3|||
163310147|NCT00378105|589844469|FG001|Overall Study|Progressive disease|3|||
163310148|NCT00378105|589844468|FG000|Overall Study|remain on study|3|||
163310149|NCT00378105|589844469|FG001|Overall Study|remain on study|11|||
163310150|NCT00378105|589844468|FG000|Overall Study|Physician Decision|0|||
163310151|NCT00378105|589844469|FG001|Overall Study|Physician Decision|2|||
163310152|NCT00378105|589844468|FG000|Overall Study|Going non-protocol therapy|0|||
163310153|NCT00378105|589844469|FG001|Overall Study|Going non-protocol therapy|1|||
163310154|NCT00378105|589844468|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
163310155|NCT00378105|589844469|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
163310156|NCT04241068|589844473|FG000|Core Treatment Period|Adverse Event|91|||
163310157|NCT04241068|589844473|FG000|Core Treatment Period|Change of Treatment|4|||
163310158|NCT04241068|589844473|FG000|Core Treatment Period|Consent Withdrawn|143|||
163310159|NCT04241068|589844473|FG000|Core Treatment Period|Death|26|||
163310160|NCT04241068|589844473|FG000|Core Treatment Period|Disease Progression|67|||
163310161|NCT04241068|589844473|FG000|Core Treatment Period|Investigator Decision|40|||
163310162|NCT04241068|589844473|FG000|Core Treatment Period|Loss of Capacity|9|||
163310163|NCT04241068|589844473|FG000|Core Treatment Period|Lost to Follow-up|11|||
163310164|NCT04241068|589844473|FG000|Core Treatment Period|Relocation|4|||
163310165|NCT04241068|589844473|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
163310166|NCT04241068|589844473|FG000|Core Treatment Period|Study Visit Burden|40|||
163310167|NCT04241068|589844473|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
163310168|NCT04241068|589844473|FG000|Core Treatment Period|Missing|2|||
163310169|NCT04241068|589844473|FG000|Core Treatment Period|Reason Not Specified|41|||
163310170|NCT04241068|589844473|FG000|LTE Period|Adverse Event|19|||
163310171|NCT04241068|589844473|FG000|LTE Period|Change of Treatment|1|||
163310172|NCT04241068|589844473|FG000|LTE Period|Consent Withdrawn|71|||
163310173|NCT04241068|589844473|FG000|LTE Period|Death|8|||
163310174|NCT04241068|589844473|FG000|LTE Period|Disease Progression|11|||
163310175|NCT04241068|589844473|FG000|LTE Period|Investigator Decision|12|||
163310176|NCT04241068|589844473|FG000|LTE Period|Loss of Capacity|2|||
163310177|NCT04241068|589844473|FG000|LTE Period|Lost to Follow-up|7|||
163310178|NCT04241068|589844473|FG000|LTE Period|Relocation|6|||
163310179|NCT04241068|589844473|FG000|LTE Period|Site Terminated by Sponsor|26|||
163310180|NCT04241068|589844473|FG000|LTE Period|Study Terminated by Sponsor|276|||
163310181|NCT04241068|589844473|FG000|LTE Period|Study Visit Burden|10|||
163310182|NCT04241068|589844473|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
163310183|NCT04241068|589844473|FG000|LTE Period|Reason Not Specified|65|||
163310184|NCT03443323|589844477|FG000|Overall Study|Lost to Follow-up|2|||
163310185|NCT03443323|589844478|FG001|Overall Study|Lost to Follow-up|2|||
163310186|NCT03443323|589844477|FG000|Overall Study|PI withdrawal|1|||
163310187|NCT03443323|589844478|FG001|Overall Study|PI withdrawal|0|||
163310188|NCT04492007|589844484|FG000|Overall Study|Lost to Follow-up|1|||
163202808|NCT01980992|589459627|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
163202809|NCT01980992|589459628|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
163202810|NCT01980992|589459627|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
163202811|NCT01980992|589459628|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
162964491|NCT00574847|588569799|FG000|Overall Study|Death|1|||
162964492|NCT00574847|588569800|FG001|Overall Study|Death|0|||
162964493|NCT00574847|588569799|FG000|Overall Study|Withdrawal by Subject|2|||
162964494|NCT00574847|588569800|FG001|Overall Study|Withdrawal by Subject|2|||
162964495|NCT00574847|588569799|FG000|Overall Study|Physician Decision|1|||
162964496|NCT00574847|588569800|FG001|Overall Study|Physician Decision|0|||
162964497|NCT00574847|588569799|FG000|Overall Study|Did not receive medication (declined)|2|||
163310189|NCT04492007|589844485|FG001|Overall Study|Lost to Follow-up|1|||
163310190|NCT04492007|589844486|FG002|Overall Study|Lost to Follow-up|2|||
163310191|NCT04492007|589844487|FG003|Overall Study|Lost to Follow-up|2|||
163310192|NCT04492007|589844484|FG000|Overall Study|Protocol Violation|1|||
163310193|NCT04492007|589844485|FG001|Overall Study|Protocol Violation|1|||
163310194|NCT04492007|589844486|FG002|Overall Study|Protocol Violation|1|||
163310195|NCT04492007|589844487|FG003|Overall Study|Protocol Violation|1|||
163310196|NCT04492007|589844484|FG000|Overall Study|Withdrawal by Subject|0|||
162964498|NCT00574847|588569800|FG001|Overall Study|Did not receive medication (declined)|5|||
162964499|NCT00957021|588569801|FG000|Overall Study|Death|5|||
162964500|NCT00957021|588569801|FG000|Overall Study|Lost to Follow-up|8|||
163202812|NCT01980992|589459627|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
163202813|NCT01980992|589459628|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
163202814|NCT01980992|589459627|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
163202815|NCT01980992|589459628|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
163202816|NCT01980992|589459627|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
163202817|NCT01980992|589459628|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
163202818|NCT00299975|589459629|FG000|Overall Study|Adverse Event|1|||
163202819|NCT00299975|589459630|FG001|Overall Study|Adverse Event|0|||
163202820|NCT00299975|589459631|FG002|Overall Study|Adverse Event|2|||
163202821|NCT00299975|589459629|FG000|Overall Study|Pregnancy|0|||
163202822|NCT00299975|589459630|FG001|Overall Study|Pregnancy|0|||
163202823|NCT00299975|589459631|FG002|Overall Study|Pregnancy|1|||
163202824|NCT00299975|589459629|FG000|Overall Study|Lack of Efficacy|1|||
163202825|NCT00299975|589459630|FG001|Overall Study|Lack of Efficacy|0|||
163202826|NCT00299975|589459631|FG002|Overall Study|Lack of Efficacy|1|||
163202827|NCT00299975|589459629|FG000|Overall Study|Lost to Follow-up|1|||
163202828|NCT00299975|589459630|FG001|Overall Study|Lost to Follow-up|0|||
163202829|NCT00299975|589459631|FG002|Overall Study|Lost to Follow-up|0|||
163202830|NCT00299975|589459629|FG000|Overall Study|Withdrawal by Subject|0|||
163202831|NCT00299975|589459630|FG001|Overall Study|Withdrawal by Subject|1|||
163202832|NCT00299975|589459631|FG002|Overall Study|Withdrawal by Subject|3|||
163202833|NCT00299975|589459629|FG000|Overall Study|Physician Decision|0|||
163202834|NCT00299975|589459630|FG001|Overall Study|Physician Decision|0|||
163202835|NCT00299975|589459631|FG002|Overall Study|Physician Decision|1|||
163202836|NCT01169493|589459635|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
163202837|NCT01169493|589459636|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
163202838|NCT01169493|589459637|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
163310197|NCT04492007|589844485|FG001|Overall Study|Withdrawal by Subject|0|||
163310198|NCT04492007|589844486|FG002|Overall Study|Withdrawal by Subject|1|||
162964501|NCT00957021|588569801|FG000|Overall Study|Withdrawal by Subject|34|||
162964502|NCT00957021|588569801|FG000|Overall Study|No 2 yr ROM data|35|||
162964503|NCT00957021|588569801|FG000|Overall Study|Revised study component by 2 yr visit|8|||
162964504|NCT00957021|588569801|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
162964505|NCT00957021|588569801|FG000|Overall Study|Surgery Cancelled|9|||
162964506|NCT00957021|588569801|FG000|Overall Study|Termination due to language issue|2|||
162964507|NCT00819169|588569805|FG000|Overall Study|Withdrawal by Subject|2|||
162964508|NCT00819169|588569806|FG001|Overall Study|Withdrawal by Subject|0|||
162964509|NCT00819169|588569807|FG002|Overall Study|Withdrawal by Subject|0|||
162964510|NCT00819169|588569808|FG003|Overall Study|Withdrawal by Subject|1|||
162964511|NCT00819169|588569809|FG004|Overall Study|Withdrawal by Subject|1|||
162964512|NCT00819169|588569810|FG005|Overall Study|Withdrawal by Subject|1|||
162964513|NCT00819169|588569811|FG006|Overall Study|Withdrawal by Subject|5|||
163310199|NCT04492007|589844487|FG003|Overall Study|Withdrawal by Subject|1|||
163202839|NCT01169493|589459638|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
163202840|NCT01169493|589459639|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
163202841|NCT01169493|589459640|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
163202842|NCT01169493|589459635|FG000|Period 3 (6 Months)|Adverse Event|0|||
163202843|NCT01169493|589459636|FG001|Period 3 (6 Months)|Adverse Event|1|||
162964514|NCT00819169|588569812|FG007|Overall Study|Withdrawal by Subject|1|||
162964515|NCT00819169|588569813|FG008|Overall Study|Withdrawal by Subject|4|||
162964516|NCT00819169|588569805|FG000|Overall Study|Lost to Follow-up|0|||
162964517|NCT00819169|588569806|FG001|Overall Study|Lost to Follow-up|2|||
162964518|NCT00819169|588569807|FG002|Overall Study|Lost to Follow-up|0|||
162964519|NCT00819169|588569808|FG003|Overall Study|Lost to Follow-up|1|||
162964520|NCT00819169|588569809|FG004|Overall Study|Lost to Follow-up|0|||
162964521|NCT00819169|588569810|FG005|Overall Study|Lost to Follow-up|6|||
162964522|NCT00819169|588569811|FG006|Overall Study|Lost to Follow-up|2|||
162964523|NCT00819169|588569812|FG007|Overall Study|Lost to Follow-up|2|||
162964524|NCT00819169|588569813|FG008|Overall Study|Lost to Follow-up|1|||
162964525|NCT00819169|588569805|FG000|Overall Study|Death|1|||
162964526|NCT00819169|588569806|FG001|Overall Study|Death|1|||
162964527|NCT00819169|588569807|FG002|Overall Study|Death|3|||
162964528|NCT00819169|588569808|FG003|Overall Study|Death|8|||
162964529|NCT00819169|588569809|FG004|Overall Study|Death|5|||
162964530|NCT00819169|588569810|FG005|Overall Study|Death|7|||
162964531|NCT00819169|588569811|FG006|Overall Study|Death|9|||
162964532|NCT00819169|588569812|FG007|Overall Study|Death|4|||
162964533|NCT00819169|588569813|FG008|Overall Study|Death|7|||
162964534|NCT00819169|588569805|FG000|Overall Study|Ineligibility determined|0|||
162964535|NCT00819169|588569806|FG001|Overall Study|Ineligibility determined|0|||
162964536|NCT00819169|588569807|FG002|Overall Study|Ineligibility determined|0|||
162964537|NCT00819169|588569808|FG003|Overall Study|Ineligibility determined|2|||
162964538|NCT00819169|588569809|FG004|Overall Study|Ineligibility determined|0|||
162964539|NCT00819169|588569810|FG005|Overall Study|Ineligibility determined|0|||
162964540|NCT00819169|588569811|FG006|Overall Study|Ineligibility determined|0|||
162964541|NCT00819169|588569812|FG007|Overall Study|Ineligibility determined|0|||
163202844|NCT01169493|589459637|FG002|Period 3 (6 Months)|Adverse Event|0|||
163202845|NCT01169493|589459638|FG003|Period 3 (6 Months)|Adverse Event|0|||
163202846|NCT01169493|589459639|FG004|Period 3 (6 Months)|Adverse Event|0|||
163202847|NCT01169493|589459640|FG005|Period 3 (6 Months)|Adverse Event|0|||
163202848|NCT01169493|589459635|FG000|Period 3 (6 Months)|Physician Decision|0|||
163202849|NCT01169493|589459636|FG001|Period 3 (6 Months)|Physician Decision|1|||
163202850|NCT01169493|589459637|FG002|Period 3 (6 Months)|Physician Decision|1|||
163202851|NCT01169493|589459638|FG003|Period 3 (6 Months)|Physician Decision|0|||
163202852|NCT01169493|589459639|FG004|Period 3 (6 Months)|Physician Decision|0|||
163202853|NCT01169493|589459640|FG005|Period 3 (6 Months)|Physician Decision|0|||
163202854|NCT00496470|589459647|FG000|Overall Study|Adverse Event|8|||
163202855|NCT00496470|589459648|FG001|Overall Study|Adverse Event|10|||
163202856|NCT00496470|589459647|FG000|Overall Study|Withdrawal by Subject|5|||
163202857|NCT00496470|589459648|FG001|Overall Study|Withdrawal by Subject|12|||
163202858|NCT00496470|589459647|FG000|Overall Study|Incorrectly enrolled|13|||
163202859|NCT00496470|589459648|FG001|Overall Study|Incorrectly enrolled|5|||
163202860|NCT00496470|589459647|FG000|Overall Study|Other reason|0|||
163202861|NCT00496470|589459648|FG001|Overall Study|Other reason|2|||
163202862|NCT01370356|589459649|FG000|Overall Study|Death|1|||
163202863|NCT01370356|589459650|FG001|Overall Study|Death|0|||
163202864|NCT01370356|589459649|FG000|Overall Study|Lack of Efficacy|6|||
163051482|NCT05556616|588897148|FG003|Overall Study|Study Terminated by Sponsor|0|||
163051483|NCT05556616|588897149|FG004|Overall Study|Study Terminated by Sponsor|0|||
163051484|NCT05556616|588897150|FG005|Overall Study|Study Terminated by Sponsor|0|||
163051485|NCT05556616|588897151|FG006|Overall Study|Study Terminated by Sponsor|0|||
163051486|NCT03256578|588897152|FG000|Overall Study|Excluded Post Randomization|66|||
163051487|NCT03256578|588897153|FG001|Overall Study|Excluded Post Randomization|56|||
163051488|NCT05428436|588897154|FG000|Period 1 - 2 washout|Adverse Event|1|||
163051489|NCT05428436|588897155|FG001|Period 1 - 2 washout|Adverse Event|0|||
163051490|NCT05428436|588897156|FG002|Period 1 - 2 washout|Adverse Event|0|||
162964542|NCT00819169|588569813|FG008|Overall Study|Ineligibility determined|1|||
162964543|NCT00819169|588569805|FG000|Overall Study|Adverse Event|0|||
162964544|NCT00819169|588569806|FG001|Overall Study|Adverse Event|0|||
162964545|NCT00819169|588569807|FG002|Overall Study|Adverse Event|0|||
162964546|NCT00819169|588569808|FG003|Overall Study|Adverse Event|0|||
162964547|NCT00819169|588569809|FG004|Overall Study|Adverse Event|1|||
162964548|NCT00819169|588569810|FG005|Overall Study|Adverse Event|0|||
162964549|NCT00819169|588569811|FG006|Overall Study|Adverse Event|0|||
162964550|NCT00819169|588569812|FG007|Overall Study|Adverse Event|0|||
162964551|NCT00819169|588569813|FG008|Overall Study|Adverse Event|0|||
163051491|NCT03964207|588897157|FG000|First Treatment|Withdrawal by Subject|1|||
163051492|NCT03964207|588897158|FG001|First Treatment|Withdrawal by Subject|2|||
163051493|NCT03964207|588897157|FG000|First Treatment|Protocol Violation|1|||
163051494|NCT03964207|588897158|FG001|First Treatment|Protocol Violation|0|||
163051495|NCT03964207|588897157|FG000|First Treatment|Lost to Follow-up|1|||
163051496|NCT03964207|588897158|FG001|First Treatment|Lost to Follow-up|0|||
163051497|NCT03964207|588897157|FG000|Second Treatment|Lost to Follow-up|0|||
163051498|NCT03964207|588897158|FG001|Second Treatment|Lost to Follow-up|1|||
163051499|NCT03964207|588897157|FG000|Second Treatment|Adverse Event|1|||
163051500|NCT03964207|588897158|FG001|Second Treatment|Adverse Event|2|||
163051501|NCT00001566|588897163|FG000|Overall Study|patients' choice to discontinue protocol|3|||
163310200|NCT04229992|589844490|FG000|Overall Study|Withdrawal by Subject|0|||
163310201|NCT04229992|589844491|FG001|Overall Study|Withdrawal by Subject|2|||
163310202|NCT04229992|589844492|FG002|Overall Study|Withdrawal by Subject|1|||
163310203|NCT04229992|589844493|FG003|Overall Study|Withdrawal by Subject|1|||
163310204|NCT04229992|589844490|FG000|Overall Study|Adverse Event|1|||
163310205|NCT04229992|589844491|FG001|Overall Study|Adverse Event|1|||
163310206|NCT04229992|589844492|FG002|Overall Study|Adverse Event|3|||
162964552|NCT00819169|588569805|FG000|Overall Study|Administrative Decision|0|||
163051502|NCT00001566|588897163|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
163051503|NCT00001566|588897163|FG000|Overall Study|Death|13|||
163051504|NCT00001566|588897163|FG000|Overall Study|Lost to Follow-up|1|||
162964553|NCT00819169|588569806|FG001|Overall Study|Administrative Decision|0|||
162964554|NCT00819169|588569807|FG002|Overall Study|Administrative Decision|0|||
162964555|NCT00819169|588569808|FG003|Overall Study|Administrative Decision|0|||
163310207|NCT04229992|589844493|FG003|Overall Study|Adverse Event|1|||
163051505|NCT00001566|588897163|FG000|Overall Study|unable to complete initial apheresis|1|||
163051506|NCT01290718|588897164|FG000|Overall Study|Early termination of the study|4|||
163051507|NCT00433836|588897166|FG000|Overall Study|Adverse Event|7|||
163051508|NCT00433836|588897167|FG001|Overall Study|Adverse Event|0|||
163051509|NCT00433836|588897166|FG000|Overall Study|Lost to Follow-up|3|||
163051510|NCT00433836|588897167|FG001|Overall Study|Lost to Follow-up|0|||
163051511|NCT00433836|588897166|FG000|Overall Study|Withdrawal by Subject|2|||
163051512|NCT00433836|588897167|FG001|Overall Study|Withdrawal by Subject|1|||
163051513|NCT00433836|588897166|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163202865|NCT01370356|589459650|FG001|Overall Study|Lack of Efficacy|28|||
163202866|NCT01370356|589459649|FG000|Overall Study|Lost to Follow-up|76|||
163051514|NCT00433836|588897167|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163051515|NCT00433836|588897166|FG000|Overall Study|Protocol Violation|0|||
163310208|NCT04229992|589844490|FG000|Overall Study|Lost to Follow-up|0|||
163051516|NCT00433836|588897167|FG001|Overall Study|Protocol Violation|2|||
163202867|NCT01370356|589459650|FG001|Overall Study|Lost to Follow-up|81|||
163202868|NCT01370356|589459649|FG000|Overall Study|Withdrawal by Subject|54|||
163202869|NCT01370356|589459650|FG001|Overall Study|Withdrawal by Subject|59|||
163202870|NCT01370356|589459649|FG000|Overall Study|Reason not specified|39|||
163202871|NCT01370356|589459650|FG001|Overall Study|Reason not specified|43|||
163202872|NCT01370356|589459649|FG000|Overall Study|Protocol Violation|3|||
163202873|NCT01370356|589459650|FG001|Overall Study|Protocol Violation|3|||
163310209|NCT04229992|589844491|FG001|Overall Study|Lost to Follow-up|0|||
163310210|NCT04229992|589844492|FG002|Overall Study|Lost to Follow-up|0|||
163310211|NCT04229992|589844493|FG003|Overall Study|Lost to Follow-up|1|||
163310212|NCT03770273|589844494|FG000|Overall Study|Adverse Event|2|||
163310213|NCT03770273|589844495|FG001|Overall Study|Adverse Event|0|||
163310214|NCT03770273|589844494|FG000|Overall Study|Lost to Follow-up|1|||
163310215|NCT03770273|589844495|FG001|Overall Study|Lost to Follow-up|1|||
162964556|NCT00819169|588569809|FG004|Overall Study|Administrative Decision|1|||
162964557|NCT00819169|588569810|FG005|Overall Study|Administrative Decision|2|||
162964558|NCT00819169|588569811|FG006|Overall Study|Administrative Decision|0|||
162964559|NCT00819169|588569812|FG007|Overall Study|Administrative Decision|2|||
162964560|NCT00819169|588569813|FG008|Overall Study|Administrative Decision|0|||
163310216|NCT00418886|589844496|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
162964561|NCT02637141|588569817|FG000|Overall Study|Adverse Event|1|||
162964562|NCT02637141|588569818|FG001|Overall Study|Adverse Event|1|||
163310217|NCT00418886|589844497|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
163310218|NCT00418886|589844496|FG000|Randomized Period|Death|122|||
163310219|NCT00418886|589844497|FG001|Randomized Period|Death|147|||
163310220|NCT00418886|589844496|FG000|Randomized Period|Withdrawal by Subject|9|||
163310221|NCT00418886|589844497|FG001|Randomized Period|Withdrawal by Subject|10|||
163310222|NCT00418886|589844496|FG000|Randomized Period|Lost to Follow-up|4|||
163310223|NCT00418886|589844497|FG001|Randomized Period|Lost to Follow-up|6|||
162964563|NCT02637141|588569819|FG002|Overall Study|Adverse Event|0|||
162964564|NCT02637141|588569817|FG000|Overall Study|Withdrawal by Subject|1|||
162964565|NCT02637141|588569818|FG001|Overall Study|Withdrawal by Subject|1|||
162964566|NCT02637141|588569819|FG002|Overall Study|Withdrawal by Subject|1|||
162964567|NCT01155531|588569823|FG000|Overall Study|Adverse Event|0|||
162964568|NCT01155531|588569824|FG001|Overall Study|Adverse Event|0|||
162964569|NCT01155531|588569825|FG002|Overall Study|Adverse Event|1|||
162964570|NCT01155531|588569826|FG003|Overall Study|Adverse Event|0|||
162964571|NCT01155531|588569823|FG000|Overall Study|Lost to Follow-up|0|||
162964572|NCT01155531|588569824|FG001|Overall Study|Lost to Follow-up|0|||
162964573|NCT01155531|588569825|FG002|Overall Study|Lost to Follow-up|0|||
162964574|NCT01155531|588569826|FG003|Overall Study|Lost to Follow-up|1|||
163202874|NCT01370356|589459649|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
163202875|NCT01370356|589459650|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
163202876|NCT01370356|589459649|FG000|Overall Study|AE Not Related to Study Drug|1|||
163202877|NCT01370356|589459650|FG001|Overall Study|AE Not Related to Study Drug|4|||
163202878|NCT00799422|589459657|FG000|First Week of Wear|Lost to Follow-up|0|||
163202879|NCT00799422|589459658|FG001|First Week of Wear|Lost to Follow-up|0|||
163202880|NCT00799422|589459659|FG002|First Week of Wear|Lost to Follow-up|1|||
163202881|NCT00799422|589459660|FG003|First Week of Wear|Lost to Follow-up|0|||
163202882|NCT00799422|589459661|FG004|First Week of Wear|Lost to Follow-up|0|||
163202883|NCT00799422|589459662|FG005|First Week of Wear|Lost to Follow-up|0|||
163202884|NCT00799422|589459657|FG000|First Week of Wear|Adverse Event|0|||
163202885|NCT00799422|589459658|FG001|First Week of Wear|Adverse Event|0|||
163202886|NCT00799422|589459659|FG002|First Week of Wear|Adverse Event|0|||
163202887|NCT00799422|589459660|FG003|First Week of Wear|Adverse Event|1|||
163202888|NCT00799422|589459661|FG004|First Week of Wear|Adverse Event|0|||
163202889|NCT00799422|589459662|FG005|First Week of Wear|Adverse Event|0|||
163202890|NCT01496612|589459663|FG000|1st Intervention|Adverse Event|1|||
163202891|NCT01496612|589459664|FG001|1st Intervention|Adverse Event|0|||
163202892|NCT01496612|589459663|FG000|1st Intervention|Withdrawal by Subject|1|||
163202893|NCT01496612|589459664|FG001|1st Intervention|Withdrawal by Subject|0|||
163202894|NCT03129100|589459666|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
163202895|NCT03129100|589459667|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
163202896|NCT03129100|589459668|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
163202897|NCT03129100|589459669|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
163310224|NCT00418886|589844496|FG000|Randomized Period|withdrawn due to other reason|1|||
163310225|NCT00418886|589844497|FG001|Randomized Period|withdrawn due to other reason|0|||
163310226|NCT00418886|589844496|FG000|Randomized Period|randomised but no treatment received|0|||
163310227|NCT00418886|589844497|FG001|Randomized Period|randomised but no treatment received|1|||
163310228|NCT04169373|589844498|FG000|Week 1 to Week 14|Adverse Event|1|||
163310229|NCT04169373|589844499|FG001|Week 1 to Week 14|Adverse Event|0|||
163310230|NCT04169373|589844500|FG002|Week 1 to Week 14|Adverse Event|1|||
163310231|NCT04169373|589844501|FG003|Week 1 to Week 14|Adverse Event|2|||
163310232|NCT04169373|589844498|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
163310233|NCT04169373|589844499|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
162964575|NCT01155531|588569823|FG000|Overall Study|Withdrawal by Subject|1|||
163310234|NCT04169373|589844500|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
163310235|NCT04169373|589844501|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
163310236|NCT04169373|589844498|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
163310237|NCT04169373|589844499|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
163310238|NCT04169373|589844500|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
163310239|NCT04169373|589844501|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
163310240|NCT04169373|589844498|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
163310241|NCT04169373|589844499|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
163310242|NCT04169373|589844500|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
163310243|NCT04169373|589844501|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
163310244|NCT04169373|589844498|FG000|Week 1 to Week 14|Other|1|||
163310245|NCT04169373|589844499|FG001|Week 1 to Week 14|Other|3|||
163310246|NCT04169373|589844500|FG002|Week 1 to Week 14|Other|3|||
163310247|NCT04169373|589844501|FG003|Week 1 to Week 14|Other|5|||
163310248|NCT04169373|589844498|FG000|Week 14 to Week 52|Adverse Event|1|||
163310249|NCT04169373|589844499|FG001|Week 14 to Week 52|Adverse Event|0|||
163310250|NCT04169373|589844500|FG002|Week 14 to Week 52|Adverse Event|0|||
163310251|NCT04169373|589844501|FG003|Week 14 to Week 52|Adverse Event|1|||
163310252|NCT04169373|589844498|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
163310253|NCT04169373|589844499|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
163310254|NCT04169373|589844500|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
163310255|NCT04169373|589844501|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
163310256|NCT04169373|589844498|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
163310257|NCT04169373|589844499|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
163310258|NCT04169373|589844500|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
163310259|NCT04169373|589844501|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
163310260|NCT04169373|589844498|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
163310261|NCT04169373|589844499|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
162964576|NCT01155531|588569824|FG001|Overall Study|Withdrawal by Subject|0|||
162964577|NCT01155531|588569825|FG002|Overall Study|Withdrawal by Subject|1|||
162964578|NCT01155531|588569826|FG003|Overall Study|Withdrawal by Subject|0|||
163310262|NCT04169373|589844500|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
163310263|NCT04169373|589844501|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
163310264|NCT04169373|589844498|FG000|Week 14 to Week 52|Other|4|||
163310265|NCT04169373|589844499|FG001|Week 14 to Week 52|Other|5|||
163310266|NCT04169373|589844500|FG002|Week 14 to Week 52|Other|4|||
163310267|NCT04169373|589844501|FG003|Week 14 to Week 52|Other|5|||
162964579|NCT02705716|588569827|FG000|Overall Study|Adverse Event|0|||
163310268|NCT04169373|589844498|FG000|Week 14 to Week 52|Ongoing|0|||
163310269|NCT04169373|589844499|FG001|Week 14 to Week 52|Ongoing|1|||
163310270|NCT04169373|589844500|FG002|Week 14 to Week 52|Ongoing|0|||
163310271|NCT04169373|589844501|FG003|Week 14 to Week 52|Ongoing|0|||
163310272|NCT03907397|589844504|FG000|Overall Study|Lost to Follow-up|0|||
163310273|NCT03907397|589844505|FG001|Overall Study|Lost to Follow-up|1|||
163310274|NCT03907397|589844504|FG000|Overall Study|Physician Decision|2|||
163310275|NCT03907397|589844505|FG001|Overall Study|Physician Decision|1|||
163310276|NCT03907397|589844504|FG000|Overall Study|Withdrawal by Subject|5|||
163310277|NCT03907397|589844505|FG001|Overall Study|Withdrawal by Subject|4|||
163310278|NCT03907397|589844504|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
163310279|NCT03907397|589844505|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
163310280|NCT04760678|589844506|FG000|Overall Study|Death|13|||
163310281|NCT04760678|589844506|FG000|Overall Study|Lost to Follow-up|48|||
163310282|NCT04760678|589844506|FG000|Overall Study|Withdrawal by Subject|1|||
163310283|NCT03675282|589844513|FG000|Overall Study|Lost to Follow-up|4|||
163310284|NCT03675282|589844514|FG001|Overall Study|Lost to Follow-up|8|||
163310285|NCT03675282|589844515|FG002|Overall Study|Lost to Follow-up|1|||
163310286|NCT03675282|589844516|FG003|Overall Study|Lost to Follow-up|0|||
163310287|NCT03675282|589844517|FG004|Overall Study|Lost to Follow-up|2|||
163310288|NCT03675282|589844518|FG005|Overall Study|Lost to Follow-up|7|||
163310289|NCT03675282|589844513|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
163310290|NCT03675282|589844514|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
163310291|NCT03675282|589844515|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
163310292|NCT03675282|589844516|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
163310293|NCT03675282|589844517|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
163310294|NCT03675282|589844518|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
163310295|NCT03675282|589844513|FG000|Overall Study|Physician Decision|1|||
163310296|NCT03675282|589844514|FG001|Overall Study|Physician Decision|0|||
163310297|NCT03675282|589844515|FG002|Overall Study|Physician Decision|0|||
163310298|NCT03675282|589844516|FG003|Overall Study|Physician Decision|0|||
163310299|NCT03675282|589844517|FG004|Overall Study|Physician Decision|0|||
163310300|NCT03675282|589844518|FG005|Overall Study|Physician Decision|0|||
163310301|NCT03232138|589844522|FG000|Overall Study|Physician Decision|1|||
163310302|NCT03232138|589844523|FG001|Overall Study|Physician Decision|0|||
163310303|NCT03232138|589844522|FG000|Overall Study|Adverse Event|2|||
163310304|NCT03232138|589844523|FG001|Overall Study|Adverse Event|0|||
163310305|NCT03232138|589844522|FG000|Overall Study|Withdrawal by Subject|1|||
163310306|NCT03232138|589844523|FG001|Overall Study|Withdrawal by Subject|2|||
163310307|NCT03853746|589844525|FG000|Overall Study|Withdrawal by Subject|1|||
163310308|NCT04952909|589844530|FG000|Overall Study|Death|3|||
163310309|NCT00881621|589844531|FG000|Overall Study|Physician Decision|34|||
163310310|NCT04359108|589844532|FG000|Overall Study|Withdrawal by Subject|1|||
163310311|NCT04359108|589844533|FG001|Overall Study|Withdrawal by Subject|0|||
163310312|NCT04359108|589844532|FG000|Overall Study|Unable or too feeble to walk independently|0|||
163310313|NCT04359108|589844533|FG001|Overall Study|Unable or too feeble to walk independently|2|||
163310314|NCT04359108|589844532|FG000|Overall Study|Argus II system stopped functioning|0|||
163310315|NCT04359108|589844533|FG001|Overall Study|Argus II system stopped functioning|1|||
163310316|NCT04359108|589844532|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
163310317|NCT04359108|589844533|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
163310318|NCT06393088|589844534|FG000|Overall Study|Withdrawal by Subject|0|||
163310319|NCT06393088|589844535|FG001|Overall Study|Withdrawal by Subject|2|||
163310320|NCT04176965|589844536|FG000|Overall Study|Death|1|||
163310321|NCT04176965|589844537|FG001|Overall Study|Death|2|||
163310322|NCT04176965|589844536|FG000|Overall Study|Lost to Follow-up|10|||
163310323|NCT04176965|589844537|FG001|Overall Study|Lost to Follow-up|2|||
163310324|NCT04176965|589844536|FG000|Overall Study|Withdrawal by Subject|6|||
163310325|NCT04176965|589844537|FG001|Overall Study|Withdrawal by Subject|1|||
163310326|NCT03903146|589844538|FG000|Overall Study|Lost to Follow-up|6|||
163310327|NCT03903146|589844539|FG001|Overall Study|Lost to Follow-up|4|||
163310328|NCT03903146|589844538|FG000|Overall Study|Withdrawal by Subject|0|||
163310329|NCT03903146|589844539|FG001|Overall Study|Withdrawal by Subject|1|||
163310330|NCT05434078|589844540|FG000|Overall Study|Lost to Follow-up|2|||
163310331|NCT05434078|589844541|FG001|Overall Study|Lost to Follow-up|1|||
163310332|NCT05434078|589844540|FG000|Overall Study|Withdrawal by Subject|1|||
163310333|NCT05434078|589844541|FG001|Overall Study|Withdrawal by Subject|0|||
163310334|NCT03652688|589844542|FG000|Baseline|Withdrawal by Subject|0|||
163310335|NCT03652688|589844543|FG001|Baseline|Withdrawal by Subject|3|||
163310336|NCT03652688|589844542|FG000|Follow-up|Lost to Follow-up|56|||
163310337|NCT03652688|589844543|FG001|Follow-up|Lost to Follow-up|54|||
163310338|NCT05179837|589844544|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
163310339|NCT05179837|589844544|FG000|Overall Study|Device malfunctioned|1|||
163310340|NCT05179837|589844544|FG000|Overall Study|Image quality too low|2|||
163310341|NCT00554788|589844545|FG000|Overall Study|Adverse Event|0|||
163310342|NCT00554788|589844546|FG001|Overall Study|Adverse Event|1|||
163310343|NCT00554788|589844547|FG002|Overall Study|Adverse Event|2|||
163310344|NCT00554788|589844545|FG000|Overall Study|Lost to Follow-up|4|||
163310345|NCT00554788|589844546|FG001|Overall Study|Lost to Follow-up|3|||
163310346|NCT00554788|589844547|FG002|Overall Study|Lost to Follow-up|3|||
163310347|NCT00554788|589844545|FG000|Overall Study|Physician Decision|1|||
163310348|NCT00554788|589844546|FG001|Overall Study|Physician Decision|1|||
163310349|NCT00554788|589844547|FG002|Overall Study|Physician Decision|3|||
163310350|NCT00554788|589844545|FG000|Overall Study|Withdrawal by Subject|0|||
163310351|NCT00554788|589844546|FG001|Overall Study|Withdrawal by Subject|0|||
163310352|NCT00554788|589844547|FG002|Overall Study|Withdrawal by Subject|1|||
163310353|NCT00554788|589844545|FG000|Overall Study|Refusal of further protocol therapy|0|||
163310354|NCT00554788|589844546|FG001|Overall Study|Refusal of further protocol therapy|1|||
163310355|NCT00554788|589844547|FG002|Overall Study|Refusal of further protocol therapy|1|||
163310356|NCT00554788|589844545|FG000|Overall Study|Progressive disease|0|||
163310357|NCT00554788|589844546|FG001|Overall Study|Progressive disease|0|||
163310358|NCT00554788|589844547|FG002|Overall Study|Progressive disease|3|||
163310359|NCT00554788|589844545|FG000|Overall Study|Ineligible|2|||
163310360|NCT00554788|589844546|FG001|Overall Study|Ineligible|0|||
163310361|NCT00554788|589844547|FG002|Overall Study|Ineligible|1|||
163310362|NCT03197662|589844553|FG000|Overall Study|Withdrawn by family|0|||
163310363|NCT03197662|589844554|FG001|Overall Study|Withdrawn by family|2|||
163310364|NCT03721952|589844555|FG000|Overall Study|Lost to Follow-up|0|||
163310365|NCT03721952|589844556|FG001|Overall Study|Lost to Follow-up|0|||
163310366|NCT03721952|589844557|FG002|Overall Study|Lost to Follow-up|2|||
163310367|NCT03721952|589844558|FG003|Overall Study|Lost to Follow-up|0|||
163310368|NCT03721952|589844559|FG004|Overall Study|Lost to Follow-up|0|||
163310369|NCT03721952|589844555|FG000|Overall Study|Protocol Violation|0|||
163310370|NCT03721952|589844556|FG001|Overall Study|Protocol Violation|1|||
163310371|NCT03721952|589844557|FG002|Overall Study|Protocol Violation|0|||
163310372|NCT03721952|589844558|FG003|Overall Study|Protocol Violation|0|||
163310373|NCT03721952|589844559|FG004|Overall Study|Protocol Violation|0|||
163310374|NCT03721952|589844555|FG000|Overall Study|Withdrawal by Subject|1|||
163310375|NCT03721952|589844556|FG001|Overall Study|Withdrawal by Subject|0|||
162964580|NCT02705716|588569828|FG001|Overall Study|Adverse Event|1|||
162964581|NCT02705716|588569827|FG000|Overall Study|Protocol Violation|3|||
162964582|NCT02705716|588569828|FG001|Overall Study|Protocol Violation|0|||
162964583|NCT02705716|588569827|FG000|Overall Study|Withdrawal of Consent|1|||
162964584|NCT02705716|588569828|FG001|Overall Study|Withdrawal of Consent|1|||
162964585|NCT00562718|588569829|FG000|Overall Study|Death|1|||
162964586|NCT00562718|588569829|FG000|Overall Study|Withdrawal by Subject|3|||
163202898|NCT03129100|589459670|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
163202899|NCT03129100|589459671|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
163202900|NCT03129100|589459672|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
163202901|NCT03129100|589459673|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
163202902|NCT03129100|589459674|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
163202903|NCT03129100|589459675|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
163202904|NCT03129100|589459676|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
163202905|NCT03129100|589459677|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
163202906|NCT03129100|589459678|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
163202907|NCT03129100|589459679|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
163202908|NCT03129100|589459680|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
163202909|NCT03129100|589459681|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
163202910|NCT03129100|589459682|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
163202911|NCT03129100|589459683|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
163202912|NCT03129100|589459684|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
163202913|NCT03129100|589459685|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
163202914|NCT03129100|589459686|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
163202915|NCT03129100|589459687|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
163202916|NCT03129100|589459688|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
163202917|NCT03129100|589459689|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
163202918|NCT03129100|589459690|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
163202919|NCT03129100|589459691|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
163202920|NCT03129100|589459666|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
163202921|NCT03129100|589459667|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202922|NCT03129100|589459668|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202923|NCT03129100|589459669|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202924|NCT03129100|589459670|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202925|NCT03129100|589459671|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202926|NCT03129100|589459672|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202927|NCT03129100|589459673|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162964587|NCT00562718|588569829|FG000|Overall Study|Adverse Event|4|||
162964588|NCT00562718|588569829|FG000|Overall Study|Lack of Efficacy|2|||
163202928|NCT03129100|589459674|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202929|NCT03129100|589459675|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202930|NCT03129100|589459676|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202931|NCT03129100|589459677|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202932|NCT03129100|589459678|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202933|NCT03129100|589459679|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202934|NCT03129100|589459680|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202935|NCT03129100|589459681|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202936|NCT03129100|589459682|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202937|NCT03129100|589459683|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202938|NCT03129100|589459684|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202939|NCT03129100|589459685|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202940|NCT03129100|589459686|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163397364|NCT00529451|590166256|FG001|Overall Study|Administrative problems|1|||
162964589|NCT00562718|588569829|FG000|Overall Study|not stated|1|||
162964590|NCT04025021|588569830|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
162964591|NCT04025021|588569831|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
162964592|NCT01663896|588569832|FG000|Overall Study|Various reasons|43|||
162964593|NCT00842309|588569833|FG000|Overall Study|Withdrawal by Subject|3|||
162964594|NCT00842309|588569834|FG001|Overall Study|Withdrawal by Subject|1|||
162964595|NCT02670551|588569835|FG000|Overall Study|Adverse Event|4|||
162964596|NCT02670551|588569836|FG001|Overall Study|Adverse Event|7|||
162964597|NCT02670551|588569837|FG002|Overall Study|Adverse Event|9|||
162964598|NCT02670551|588569835|FG000|Overall Study|Lack of Efficacy|2|||
162964599|NCT02670551|588569836|FG001|Overall Study|Lack of Efficacy|0|||
162964600|NCT02670551|588569837|FG002|Overall Study|Lack of Efficacy|3|||
162964601|NCT02670551|588569835|FG000|Overall Study|Withdrawal of Consent|6|||
162964602|NCT02670551|588569836|FG001|Overall Study|Withdrawal of Consent|3|||
162964603|NCT02670551|588569837|FG002|Overall Study|Withdrawal of Consent|8|||
162964604|NCT02670551|588569835|FG000|Overall Study|Lost to Follow-up|5|||
162964605|NCT02670551|588569836|FG001|Overall Study|Lost to Follow-up|7|||
162964606|NCT02670551|588569837|FG002|Overall Study|Lost to Follow-up|6|||
162964607|NCT02670551|588569835|FG000|Overall Study|Protocol Violation|1|||
162964608|NCT02670551|588569836|FG001|Overall Study|Protocol Violation|0|||
163202941|NCT03129100|589459687|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163310376|NCT03721952|589844557|FG002|Overall Study|Withdrawal by Subject|40|||
163310377|NCT03721952|589844558|FG003|Overall Study|Withdrawal by Subject|28|||
163310378|NCT03721952|589844559|FG004|Overall Study|Withdrawal by Subject|0|||
163310379|NCT03364647|589844560|FG000|Overall Study|Withdrawal by Subject|3|||
162964609|NCT02670551|588569837|FG002|Overall Study|Protocol Violation|0|||
162964610|NCT02670551|588569835|FG000|Overall Study|Noncompliance with study drug|3|||
162964611|NCT02670551|588569836|FG001|Overall Study|Noncompliance with study drug|3|||
162964612|NCT02670551|588569837|FG002|Overall Study|Noncompliance with study drug|2|||
162964613|NCT02670551|588569835|FG000|Overall Study|Other Miscellaneous Reasons|2|||
162964614|NCT02670551|588569836|FG001|Overall Study|Other Miscellaneous Reasons|3|||
162964615|NCT02670551|588569837|FG002|Overall Study|Other Miscellaneous Reasons|3|||
162964616|NCT02670551|588569835|FG000|Overall Study|Did Not Receive Treatment|5|||
162964617|NCT02670551|588569836|FG001|Overall Study|Did Not Receive Treatment|3|||
162964618|NCT02670551|588569837|FG002|Overall Study|Did Not Receive Treatment|0|||
162964619|NCT04476277|588569838|FG000|Overall Study|Withdrawal by Subject|0|||
162964620|NCT04476277|588569839|FG001|Overall Study|Withdrawal by Subject|0|||
162964621|NCT04476277|588569840|FG002|Overall Study|Withdrawal by Subject|1|||
162964622|NCT04476277|588569841|FG003|Overall Study|Withdrawal by Subject|0|||
162964623|NCT00849797|588569842|FG000|First Intervention|bad veins|1|||
162964624|NCT00849797|588569843|FG001|First Intervention|bad veins|0|||
162964625|NCT00849797|588569842|FG000|First Intervention|Adverse Event|0|||
162964626|NCT00849797|588569843|FG001|First Intervention|Adverse Event|1|||
162964627|NCT00849797|588569842|FG000|Washout: One Week|Withdrawal by Subject|0|||
162964628|NCT00849797|588569843|FG001|Washout: One Week|Withdrawal by Subject|2|||
162964629|NCT01139762|588569847|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
162964630|NCT01139762|588569848|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
162964631|NCT01139762|588569849|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
162964632|NCT01139762|588569847|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
162964633|NCT01139762|588569848|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
162964634|NCT01139762|588569849|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
162964635|NCT01139762|588569847|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
162964636|NCT01139762|588569848|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
162964637|NCT01139762|588569849|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
162964638|NCT01139762|588569847|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
162964639|NCT01139762|588569848|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
162964640|NCT01139762|588569849|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
162964641|NCT01139762|588569847|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
162964642|NCT01139762|588569848|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
162964643|NCT01139762|588569849|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
162964644|NCT01139762|588569847|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
162964645|NCT01139762|588569848|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
162964646|NCT01139762|588569849|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
163310380|NCT03364647|589844561|FG001|Overall Study|Withdrawal by Subject|1|||
163310381|NCT03476460|589844562|FG000|Overall Study|Withdrawal by Subject|3|||
163310382|NCT03476460|589844563|FG001|Overall Study|Withdrawal by Subject|2|||
163310383|NCT03476460|589844562|FG000|Overall Study|Non-compliance with treatment|3|||
163310384|NCT03476460|589844563|FG001|Overall Study|Non-compliance with treatment|0|||
162964647|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
162964648|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
162964649|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
163310385|NCT03476460|589844562|FG000|Overall Study|Missing laboratory tests|5|||
163310386|NCT03476460|589844563|FG001|Overall Study|Missing laboratory tests|5|||
163310387|NCT03476460|589844562|FG000|Overall Study|Adverse Event|0|||
163310388|NCT03476460|589844563|FG001|Overall Study|Adverse Event|1|||
163202942|NCT03129100|589459688|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202943|NCT03129100|589459689|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202944|NCT03129100|589459690|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202945|NCT03129100|589459691|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
163202946|NCT03129100|589459666|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
163202947|NCT03129100|589459667|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
163202948|NCT03129100|589459668|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202949|NCT03129100|589459669|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163310389|NCT04624633|589844567|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
162964650|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Death|0|||
163310390|NCT04624633|589844568|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
162964651|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Death|1|||
162964652|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Death|1|||
163202950|NCT03129100|589459670|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202951|NCT03129100|589459671|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202952|NCT03129100|589459672|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202953|NCT03129100|589459673|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202954|NCT03129100|589459674|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202955|NCT03129100|589459675|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202956|NCT03129100|589459676|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202957|NCT03129100|589459677|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202958|NCT03129100|589459678|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202959|NCT03129100|589459679|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202960|NCT03129100|589459680|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202961|NCT03129100|589459681|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163310391|NCT04624633|589844567|FG000|Overall Study|Death|1|||
163310392|NCT04624633|589844568|FG001|Overall Study|Death|0|||
163310393|NCT01902173|589844572|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
163310394|NCT01902173|589844573|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
163310395|NCT01902173|589844574|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
163310396|NCT01902173|589844575|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
163310397|NCT01902173|589844576|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
163310398|NCT01902173|589844577|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
163310399|NCT01902173|589844572|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
163310400|NCT01902173|589844573|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
163310401|NCT01902173|589844574|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
163310402|NCT01902173|589844575|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
163310403|NCT01902173|589844576|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
163310404|NCT01902173|589844577|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
163310405|NCT01902173|589844572|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
163310406|NCT01902173|589844573|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
163310407|NCT01902173|589844574|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
163310408|NCT01902173|589844575|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
163310409|NCT01902173|589844576|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
163310410|NCT01902173|589844577|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
163310411|NCT01902173|589844572|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
163310412|NCT01902173|589844573|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
163310413|NCT01902173|589844574|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
163310414|NCT01902173|589844575|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
163310415|NCT01902173|589844576|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
163310416|NCT01902173|589844577|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
163310417|NCT01902173|589844572|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
163310418|NCT01902173|589844573|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
163310419|NCT01902173|589844574|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
163310420|NCT01902173|589844575|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
163310421|NCT01902173|589844576|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
163310422|NCT01902173|589844577|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
163310423|NCT01902173|589844572|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
163310424|NCT01902173|589844573|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
163310425|NCT01902173|589844574|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
163310426|NCT01902173|589844575|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
163310427|NCT01902173|589844576|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
163310428|NCT01902173|589844577|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
163310429|NCT01902173|589844572|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
163310430|NCT01902173|589844573|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
163310431|NCT01902173|589844574|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
163310432|NCT01902173|589844575|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
163310433|NCT01902173|589844576|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
163310434|NCT01902173|589844577|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
163310435|NCT01902173|589844572|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
163310436|NCT01902173|589844573|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
163310437|NCT01902173|589844574|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
163310438|NCT01902173|589844575|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
163310439|NCT01902173|589844576|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
163310440|NCT01902173|589844577|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
163310441|NCT01902173|589844572|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
163310442|NCT01902173|589844573|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
163310443|NCT01902173|589844574|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
163310444|NCT01902173|589844575|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
163310445|NCT01902173|589844576|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
163310446|NCT01902173|589844577|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
163310447|NCT01902173|589844572|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
163310448|NCT01902173|589844573|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
163310449|NCT01902173|589844574|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
163310450|NCT01902173|589844575|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
163310451|NCT01902173|589844576|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
163310452|NCT01902173|589844577|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
163310453|NCT01902173|589844572|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
163310454|NCT01902173|589844573|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
163202962|NCT03129100|589459682|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202963|NCT03129100|589459683|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202964|NCT03129100|589459684|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202965|NCT03129100|589459685|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202966|NCT03129100|589459686|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202967|NCT03129100|589459687|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202968|NCT03129100|589459688|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202969|NCT03129100|589459689|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202970|NCT03129100|589459690|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202971|NCT03129100|589459691|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
163202972|NCT03129100|589459666|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
163202973|NCT03129100|589459667|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
163202974|NCT03129100|589459668|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202975|NCT03129100|589459669|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202976|NCT03129100|589459670|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202977|NCT03129100|589459671|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202978|NCT03129100|589459672|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202979|NCT03129100|589459673|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202980|NCT03129100|589459674|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202981|NCT03129100|589459675|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202982|NCT03129100|589459676|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202983|NCT03129100|589459677|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202984|NCT03129100|589459678|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202985|NCT03129100|589459679|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202986|NCT03129100|589459680|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202987|NCT03129100|589459681|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202988|NCT03129100|589459682|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202989|NCT03129100|589459683|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202990|NCT03129100|589459684|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202991|NCT03129100|589459685|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202992|NCT03129100|589459686|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202993|NCT03129100|589459687|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202994|NCT03129100|589459688|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202995|NCT03129100|589459689|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202996|NCT03129100|589459690|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202997|NCT03129100|589459691|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
163202998|NCT03129100|589459666|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
163202999|NCT03129100|589459667|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
163203000|NCT03129100|589459668|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203001|NCT03129100|589459669|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203002|NCT03129100|589459670|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203003|NCT03129100|589459671|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203004|NCT03129100|589459672|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203005|NCT03129100|589459673|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203006|NCT03129100|589459674|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203007|NCT03129100|589459675|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203008|NCT03129100|589459676|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203009|NCT03129100|589459677|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203010|NCT03129100|589459678|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203011|NCT03129100|589459679|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203012|NCT03129100|589459680|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203013|NCT03129100|589459681|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203014|NCT03129100|589459682|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203015|NCT03129100|589459683|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203016|NCT03129100|589459684|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203017|NCT03129100|589459685|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203018|NCT03129100|589459686|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203019|NCT03129100|589459687|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203020|NCT03129100|589459688|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203021|NCT03129100|589459689|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203022|NCT03129100|589459690|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203023|NCT03129100|589459691|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
163203024|NCT03129100|589459666|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203025|NCT03129100|589459667|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203026|NCT03129100|589459668|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
163203027|NCT03129100|589459669|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
163203028|NCT03129100|589459670|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203029|NCT03129100|589459671|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
163203030|NCT03129100|589459672|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203031|NCT03129100|589459673|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203032|NCT03129100|589459674|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203033|NCT03129100|589459675|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203034|NCT03129100|589459676|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203035|NCT03129100|589459677|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203036|NCT03129100|589459678|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203037|NCT03129100|589459679|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203038|NCT03129100|589459680|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203039|NCT03129100|589459681|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203040|NCT03129100|589459682|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203041|NCT03129100|589459683|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203042|NCT03129100|589459684|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203043|NCT03129100|589459685|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203044|NCT03129100|589459686|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203045|NCT03129100|589459687|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203046|NCT03129100|589459688|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203047|NCT03129100|589459689|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203048|NCT03129100|589459690|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203049|NCT03129100|589459691|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
163203050|NCT03129100|589459666|FG000|Period2 Extension Period (Group A and B)|Death|0|||
163203051|NCT03129100|589459667|FG001|Period2 Extension Period (Group A and B)|Death|0|||
163203052|NCT03129100|589459668|FG002|Period2 Extension Period (Group A and B)|Death|1|||
163203053|NCT03129100|589459669|FG003|Period2 Extension Period (Group A and B)|Death|0|||
163203054|NCT03129100|589459670|FG004|Period2 Extension Period (Group A and B)|Death|0|||
163203055|NCT03129100|589459671|FG005|Period2 Extension Period (Group A and B)|Death|0|||
163203056|NCT03129100|589459672|FG006|Period2 Extension Period (Group A and B)|Death|0|||
163203057|NCT03129100|589459673|FG007|Period2 Extension Period (Group A and B)|Death|0|||
163203058|NCT03129100|589459674|FG008|Period2 Extension Period (Group A and B)|Death|0|||
163203059|NCT03129100|589459675|FG009|Period2 Extension Period (Group A and B)|Death|0|||
163203060|NCT03129100|589459676|FG010|Period2 Extension Period (Group A and B)|Death|0|||
163203061|NCT03129100|589459677|FG011|Period2 Extension Period (Group A and B)|Death|0|||
163203062|NCT03129100|589459678|FG012|Period2 Extension Period (Group A and B)|Death|0|||
163203063|NCT03129100|589459679|FG013|Period2 Extension Period (Group A and B)|Death|0|||
163203064|NCT03129100|589459680|FG014|Period2 Extension Period (Group A and B)|Death|0|||
163203065|NCT03129100|589459681|FG015|Period2 Extension Period (Group A and B)|Death|0|||
163203066|NCT03129100|589459682|FG016|Period2 Extension Period (Group A and B)|Death|0|||
163203067|NCT03129100|589459683|FG017|Period2 Extension Period (Group A and B)|Death|0|||
163051517|NCT00433836|588897166|FG000|Overall Study|Condition no longer requires study drug|0|||
163310455|NCT01902173|589844574|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
163310456|NCT01902173|589844575|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
163310457|NCT01902173|589844576|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
163310458|NCT01902173|589844577|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
163310459|NCT01902173|589844572|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
163310460|NCT01902173|589844573|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
163310461|NCT01902173|589844574|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
163310462|NCT01902173|589844575|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
163310463|NCT01902173|589844576|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
163310464|NCT01902173|589844577|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
163310465|NCT01902173|589844572|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
163310466|NCT01902173|589844573|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
163310467|NCT01902173|589844574|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
163310468|NCT01902173|589844575|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
163310469|NCT01902173|589844576|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
163310470|NCT01902173|589844577|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
163310471|NCT01902173|589844572|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
163310472|NCT01902173|589844573|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
163310473|NCT01902173|589844574|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
163310474|NCT01902173|589844575|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
163310475|NCT01902173|589844576|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
163310476|NCT01902173|589844577|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
163310477|NCT03640312|589844582|FG000|Overall Study|Lost to Follow-up|3|||
163310478|NCT03640312|589844583|FG001|Overall Study|Lost to Follow-up|6|||
163310479|NCT03536754|589844584|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
163310480|NCT03536754|589844585|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
163310481|NCT03536754|589844586|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
163310482|NCT03536754|589844587|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
163310483|NCT03536754|589844588|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
163310484|NCT03536754|589844584|FG000|Open Label Extension|Other|0|||
163310485|NCT03536754|589844585|FG001|Open Label Extension|Other|0|||
163310486|NCT03536754|589844586|FG002|Open Label Extension|Other|0|||
163310487|NCT03536754|589844587|FG003|Open Label Extension|Other|0|||
163310488|NCT03536754|589844588|FG004|Open Label Extension|Other|1|||
163310489|NCT03382652|589844591|FG000|Overall Study|Lost to Follow-up|6|||
163310490|NCT03382652|589844591|FG000|Overall Study|Death|4|||
163310491|NCT03382652|589844591|FG000|Overall Study|Revision|5|||
163310492|NCT03382652|589844591|FG000|Overall Study|Patient withdrew|3|||
163310493|NCT03382652|589844591|FG000|Overall Study|Other reasons|21|||
163310494|NCT05008835|589844595|FG000|Overall Study|Adverse Event|5|||
163310495|NCT05008835|589844596|FG001|Overall Study|Adverse Event|2|||
163310496|NCT05008835|589844597|FG002|Overall Study|Adverse Event|1|||
163310497|NCT05008835|589844595|FG000|Overall Study|Lack of Efficacy|0|||
163310498|NCT05008835|589844596|FG001|Overall Study|Lack of Efficacy|0|||
163310499|NCT05008835|589844597|FG002|Overall Study|Lack of Efficacy|1|||
163310500|NCT05008835|589844595|FG000|Overall Study|Study terminated by sponsor|0|||
163310501|NCT05008835|589844596|FG001|Overall Study|Study terminated by sponsor|0|||
163310502|NCT05008835|589844597|FG002|Overall Study|Study terminated by sponsor|1|||
163310503|NCT05008835|589844595|FG000|Overall Study|Not further specified|3|||
163310504|NCT05008835|589844596|FG001|Overall Study|Not further specified|2|||
163310505|NCT05008835|589844597|FG002|Overall Study|Not further specified|1|||
163310506|NCT04876118|589844598|FG000|Overall Study|Pregnancy|1|||
163310507|NCT04876118|589844598|FG000|Overall Study|Withdrawal by Subject|14|||
163310508|NCT04593472|589846509|FG000|Overall Study|Death|31|||
163310509|NCT04593472|589846510|FG001|Overall Study|Death|27|||
163310510|NCT04593472|589846509|FG000|Overall Study|Withdrawal by Subject|12|||
163310511|NCT04593472|589846510|FG001|Overall Study|Withdrawal by Subject|12|||
163310512|NCT04593472|589846509|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
163310513|NCT04593472|589846510|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
163310514|NCT04593472|589846509|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
163310515|NCT04593472|589846510|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
163310516|NCT04593472|589846509|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
163310517|NCT04593472|589846510|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
163310518|NCT04593472|589846509|FG000|Overall Study|Lost to Follow-up|0|||
163310519|NCT04593472|589846510|FG001|Overall Study|Lost to Follow-up|2|||
163310520|NCT04593472|589846509|FG000|Overall Study|Still collecting 24-month assessment|17|||
162964653|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
162964654|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
162964655|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
162964656|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
162964657|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
162964658|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
162964659|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
162964660|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
162964661|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
162964662|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
162964663|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
162964664|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
162964665|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
162964666|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
162964667|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
162964668|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
162964669|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
162964670|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
162964671|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
162964672|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
162964673|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
162964674|NCT01675596|588569850|FG000|Overall Study|Death|6|||
162964675|NCT01675596|588569850|FG000|Overall Study|Exit with other reason|1|||
162964676|NCT01675596|588569850|FG000|Overall Study|Missed Visit|1|||
162964677|NCT01018862|588569855|FG000|Overall Study|Adverse Event|2|||
162964678|NCT01018862|588569856|FG001|Overall Study|Adverse Event|0|||
162964679|NCT01018862|588569857|FG002|Overall Study|Adverse Event|6|||
162964680|NCT01018862|588569855|FG000|Overall Study|Lack of Efficacy|1|||
162964681|NCT01018862|588569856|FG001|Overall Study|Lack of Efficacy|0|||
162964682|NCT01018862|588569857|FG002|Overall Study|Lack of Efficacy|2|||
162964683|NCT01018862|588569855|FG000|Overall Study|Lost to Follow-up|3|||
162964684|NCT01018862|588569856|FG001|Overall Study|Lost to Follow-up|1|||
163310521|NCT04593472|589846510|FG001|Overall Study|Still collecting 24-month assessment|10|||
163310522|NCT02671903|589846518|FG000|Period 0 (Run-In)|Death|0|||
163310523|NCT02671903|589846519|FG001|Period 0 (Run-In)|Death|0|||
163310524|NCT02671903|589846520|FG002|Period 0 (Run-In)|Death|3|||
163310525|NCT02671903|589846518|FG000|Period 0 (Run-In)|Physician Decision|0|||
163310526|NCT02671903|589846519|FG001|Period 0 (Run-In)|Physician Decision|0|||
162964685|NCT01018862|588569857|FG002|Overall Study|Lost to Follow-up|0|||
162964686|NCT01018862|588569855|FG000|Overall Study|Protocol Violation|1|||
162964687|NCT01018862|588569856|FG001|Overall Study|Protocol Violation|3|||
162964688|NCT01018862|588569857|FG002|Overall Study|Protocol Violation|3|||
162964689|NCT01018862|588569855|FG000|Overall Study|Withdrawal by Subject|1|||
162964690|NCT01018862|588569856|FG001|Overall Study|Withdrawal by Subject|2|||
162964691|NCT01018862|588569857|FG002|Overall Study|Withdrawal by Subject|1|||
162964692|NCT01018862|588569855|FG000|Overall Study|administrative problems|5|||
162964693|NCT01018862|588569856|FG001|Overall Study|administrative problems|4|||
162964694|NCT01018862|588569857|FG002|Overall Study|administrative problems|4|||
162964695|NCT01968031|588569861|FG000|Overall Study|Adverse Event|13|||
162964696|NCT01968031|588569862|FG001|Overall Study|Adverse Event|10|||
162964697|NCT01968031|588569863|FG002|Overall Study|Adverse Event|22|||
162964698|NCT01968031|588569861|FG000|Overall Study|Withdrawal by Subject|3|||
162964699|NCT01968031|588569862|FG001|Overall Study|Withdrawal by Subject|7|||
162964700|NCT01968031|588569863|FG002|Overall Study|Withdrawal by Subject|3|||
162964701|NCT01968031|588569861|FG000|Overall Study|Did not meet entry criteria|1|||
162964702|NCT01968031|588569862|FG001|Overall Study|Did not meet entry criteria|1|||
162964703|NCT01968031|588569863|FG002|Overall Study|Did not meet entry criteria|1|||
162964704|NCT01968031|588569861|FG000|Overall Study|Noncompliance|0|||
163310527|NCT02671903|589846520|FG002|Period 0 (Run-In)|Physician Decision|4|||
163310528|NCT02671903|589846518|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
163310529|NCT02671903|589846519|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
163310530|NCT02671903|589846520|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
162964705|NCT01968031|588569862|FG001|Overall Study|Noncompliance|0|||
162964706|NCT01968031|588569863|FG002|Overall Study|Noncompliance|2|||
163310531|NCT02671903|589846518|FG000|Period 0 (Run-In)|Protocol Violation|0|||
163310532|NCT02671903|589846519|FG001|Period 0 (Run-In)|Protocol Violation|0|||
163310533|NCT02671903|589846520|FG002|Period 0 (Run-In)|Protocol Violation|1|||
162964707|NCT01968031|588569861|FG000|Overall Study|Failed inclusion criteria|0|||
162964708|NCT01968031|588569862|FG001|Overall Study|Failed inclusion criteria|2|||
162964709|NCT01968031|588569863|FG002|Overall Study|Failed inclusion criteria|0|||
162964710|NCT01968031|588569861|FG000|Overall Study|Death|0|||
162964711|NCT01968031|588569862|FG001|Overall Study|Death|0|||
162964712|NCT01968031|588569863|FG002|Overall Study|Death|1|||
163203068|NCT03129100|589459684|FG018|Period2 Extension Period (Group A and B)|Death|0|||
163203069|NCT03129100|589459685|FG019|Period2 Extension Period (Group A and B)|Death|0|||
163203070|NCT03129100|589459686|FG020|Period2 Extension Period (Group A and B)|Death|0|||
163203071|NCT03129100|589459687|FG021|Period2 Extension Period (Group A and B)|Death|0|||
163203072|NCT03129100|589459688|FG022|Period2 Extension Period (Group A and B)|Death|0|||
163203073|NCT03129100|589459689|FG023|Period2 Extension Period (Group A and B)|Death|0|||
163203074|NCT03129100|589459690|FG024|Period2 Extension Period (Group A and B)|Death|0|||
163203075|NCT03129100|589459691|FG025|Period2 Extension Period (Group A and B)|Death|0|||
163203076|NCT03129100|589459666|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203077|NCT03129100|589459667|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203078|NCT03129100|589459668|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
163203079|NCT03129100|589459669|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
163203080|NCT03129100|589459670|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
163203081|NCT03129100|589459671|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
163397365|NCT00529451|590166257|FG002|Overall Study|Administrative problems|0|||
163397366|NCT00529451|590166258|FG003|Overall Study|Administrative problems|2|||
163397367|NCT01009034|590166259|FG000|Overall Study|Lost to Follow-up|2|||
163397368|NCT01009034|590166259|FG000|Overall Study|Withdrawal by Subject|2|||
163397369|NCT02303704|590166267|FG000|Overall Study|Protocol Violation|5|||
163397370|NCT02303704|590166268|FG001|Overall Study|Protocol Violation|9|||
163397371|NCT01034540|590166269|FG000|Overall Study|Adverse Event|0|||
163397372|NCT01034540|590166270|FG001|Overall Study|Adverse Event|1|||
163397373|NCT01721876|590166273|FG000|Overall Study|Not treated|1|||
163203082|NCT03129100|589459672|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
163203083|NCT03129100|589459673|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203084|NCT03129100|589459674|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203085|NCT03129100|589459675|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203086|NCT03129100|589459676|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163397374|NCT01721876|590166274|FG001|Overall Study|Not treated|4|||
163397375|NCT01721876|590166273|FG000|Overall Study|Disease progression / relapse|123|||
163397376|NCT01721876|590166274|FG001|Overall Study|Disease progression / relapse|156|||
163397377|NCT01721876|590166273|FG000|Overall Study|Death|6|||
163397378|NCT01721876|590166274|FG001|Overall Study|Death|13|||
163397379|NCT01721876|590166273|FG000|Overall Study|Adverse Event|41|||
163397380|NCT01721876|590166274|FG001|Overall Study|Adverse Event|165|||
163397381|NCT01721876|590166273|FG000|Overall Study|Protocol Violation|2|||
163203087|NCT03129100|589459677|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203088|NCT03129100|589459678|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203089|NCT03129100|589459679|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203090|NCT03129100|589459680|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203091|NCT03129100|589459681|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203092|NCT03129100|589459682|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203093|NCT03129100|589459683|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163397382|NCT01721876|590166274|FG001|Overall Study|Protocol Violation|1|||
163397383|NCT01721876|590166273|FG000|Overall Study|Withdrawal by Subject|15|||
163397384|NCT01721876|590166274|FG001|Overall Study|Withdrawal by Subject|38|||
163397385|NCT01721876|590166273|FG000|Overall Study|Reason not listed|34|||
163397386|NCT01721876|590166274|FG001|Overall Study|Reason not listed|63|||
163397387|NCT01721876|590166273|FG000|Overall Study|Sponsor terminated trial|0|||
163397388|NCT01721876|590166274|FG001|Overall Study|Sponsor terminated trial|4|||
163397389|NCT03805750|590166275|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
163397390|NCT03805750|590166276|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
163397391|NCT00493220|590166277|FG000|Third Intervention|Withdrawal by Subject|1|||
163397392|NCT00493220|590166278|FG001|Third Intervention|Withdrawal by Subject|0|||
163397393|NCT00493220|590166279|FG002|Third Intervention|Withdrawal by Subject|0|||
163397394|NCT00493220|590166280|FG003|Third Intervention|Withdrawal by Subject|0|||
163397395|NCT00493220|590166281|FG004|Third Intervention|Withdrawal by Subject|0|||
163397396|NCT00493220|590166282|FG005|Third Intervention|Withdrawal by Subject|0|||
163397397|NCT00310804|590166283|FG000|Overall Study|Lost to Follow-up|2|||
163397398|NCT00310804|590166284|FG001|Overall Study|Lost to Follow-up|0|||
163397399|NCT00310804|590166283|FG000|Overall Study|Withdrawal by Subject|3|||
163397400|NCT00310804|590166284|FG001|Overall Study|Withdrawal by Subject|0|||
163203094|NCT03129100|589459684|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203095|NCT03129100|589459685|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203096|NCT03129100|589459686|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203097|NCT03129100|589459687|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203098|NCT03129100|589459688|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162964713|NCT01968031|588569861|FG000|Overall Study|Prohibited concomitant medication|1|||
163203099|NCT03129100|589459689|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203100|NCT03129100|589459690|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203101|NCT03129100|589459691|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
163203102|NCT03129100|589459666|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203103|NCT03129100|589459667|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203104|NCT03129100|589459668|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
163203105|NCT03129100|589459669|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203106|NCT03129100|589459670|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203107|NCT03129100|589459671|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203108|NCT03129100|589459672|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203109|NCT03129100|589459673|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203110|NCT03129100|589459674|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203111|NCT03129100|589459675|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203112|NCT03129100|589459676|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203113|NCT03129100|589459677|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203114|NCT03129100|589459678|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203115|NCT03129100|589459679|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203116|NCT03129100|589459680|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203117|NCT03129100|589459681|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203118|NCT03129100|589459682|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203119|NCT03129100|589459683|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203120|NCT03129100|589459684|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203121|NCT03129100|589459685|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203122|NCT03129100|589459686|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203123|NCT03129100|589459687|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203124|NCT03129100|589459688|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203125|NCT03129100|589459689|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203126|NCT03129100|589459690|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203127|NCT03129100|589459691|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163203128|NCT03129100|589459666|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203129|NCT03129100|589459667|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203130|NCT03129100|589459668|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
163203131|NCT03129100|589459669|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203132|NCT03129100|589459670|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203133|NCT03129100|589459671|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203134|NCT03129100|589459672|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203135|NCT03129100|589459673|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203136|NCT03129100|589459674|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203137|NCT03129100|589459675|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163051518|NCT00433836|588897167|FG001|Overall Study|Condition no longer requires study drug|1|||
163051519|NCT00433836|588897166|FG000|Overall Study|Abnormal laboratory values|0|||
163051520|NCT00433836|588897167|FG001|Overall Study|Abnormal laboratory values|1|||
163051521|NCT00748241|588897168|FG000|Overall Study|Implant failure|1|||
163051522|NCT00748241|588897168|FG000|Overall Study|Lost to Follow-up|5|||
163310534|NCT02671903|589846518|FG000|Period 0 (Run-In)|Adverse Event|0|||
163310535|NCT02671903|589846519|FG001|Period 0 (Run-In)|Adverse Event|0|||
163310536|NCT02671903|589846520|FG002|Period 0 (Run-In)|Adverse Event|1|||
163310537|NCT02671903|589846518|FG000|Period 0 (Run-In)|Implantation Failure|0|||
163310538|NCT02671903|589846519|FG001|Period 0 (Run-In)|Implantation Failure|0|||
163310539|NCT02671903|589846520|FG002|Period 0 (Run-In)|Implantation Failure|2|||
163310540|NCT02671903|589846518|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
163310541|NCT02671903|589846519|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
163310542|NCT02671903|589846520|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
163310543|NCT04806594|589846521|FG000|Overall Study|Withdrawal by Subject|2|||
163310544|NCT04806594|589846521|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
163310545|NCT04390048|589846522|FG000|Overall Study|Withdrawal by Subject|1|||
163310546|NCT04390048|589846523|FG001|Overall Study|Withdrawal by Subject|3|||
163310547|NCT03673111|589846524|FG000|Overall Study|Protocol Violation|0|||
163310548|NCT03673111|589846525|FG001|Overall Study|Protocol Violation|0|||
163310549|NCT03673111|589846526|FG002|Overall Study|Protocol Violation|0|||
163310550|NCT03673111|589846527|FG003|Overall Study|Protocol Violation|0|||
163310551|NCT03673111|589846528|FG004|Overall Study|Protocol Violation|0|||
163310552|NCT03673111|589846529|FG005|Overall Study|Protocol Violation|0|||
163310553|NCT03673111|589846530|FG006|Overall Study|Protocol Violation|0|||
163310554|NCT03673111|589846531|FG007|Overall Study|Protocol Violation|0|||
163310555|NCT03673111|589846532|FG008|Overall Study|Protocol Violation|0|||
163310556|NCT03673111|589846533|FG009|Overall Study|Protocol Violation|0|||
163310557|NCT03673111|589846534|FG010|Overall Study|Protocol Violation|1|||
163310558|NCT03673111|589846535|FG011|Overall Study|Protocol Violation|0|||
163310559|NCT03673111|589846536|FG012|Overall Study|Protocol Violation|0|||
163310560|NCT03673111|589846537|FG013|Overall Study|Protocol Violation|0|||
163310561|NCT03673111|589846524|FG000|Overall Study|Adverse Event|1|||
163310562|NCT03673111|589846525|FG001|Overall Study|Adverse Event|0|||
163310563|NCT03673111|589846526|FG002|Overall Study|Adverse Event|0|||
163310564|NCT03673111|589846527|FG003|Overall Study|Adverse Event|0|||
163310565|NCT03673111|589846528|FG004|Overall Study|Adverse Event|0|||
163310566|NCT03673111|589846529|FG005|Overall Study|Adverse Event|0|||
163310567|NCT03673111|589846530|FG006|Overall Study|Adverse Event|0|||
163310568|NCT03673111|589846531|FG007|Overall Study|Adverse Event|0|||
163310569|NCT03673111|589846532|FG008|Overall Study|Adverse Event|0|||
163310570|NCT03673111|589846533|FG009|Overall Study|Adverse Event|0|||
163051523|NCT00748241|588897168|FG000|Overall Study|Death|2|||
163051524|NCT01240382|588897169|FG000|Overall Study|Adverse Event|2|||
163051525|NCT01240382|588897170|FG001|Overall Study|Adverse Event|1|||
163051526|NCT01240382|588897169|FG000|Overall Study|Lack of Efficacy|0|||
163051527|NCT01240382|588897170|FG001|Overall Study|Lack of Efficacy|2|||
163051528|NCT01240382|588897169|FG000|Overall Study|Fear of adverse events|0|||
163051529|NCT01240382|588897170|FG001|Overall Study|Fear of adverse events|1|||
163051530|NCT02643693|588897171|FG000|Overall Study|Physician Decision|0|||
163051531|NCT02643693|588897172|FG001|Overall Study|Physician Decision|1|||
163310571|NCT03673111|589846534|FG010|Overall Study|Adverse Event|0|||
163310572|NCT03673111|589846535|FG011|Overall Study|Adverse Event|0|||
163051532|NCT02643693|588897173|FG002|Overall Study|Physician Decision|0|||
163051533|NCT02643693|588897174|FG003|Overall Study|Physician Decision|0|||
163310573|NCT03673111|589846536|FG012|Overall Study|Adverse Event|0|||
163310574|NCT03673111|589846537|FG013|Overall Study|Adverse Event|0|||
163310575|NCT03792555|589846543|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
163310576|NCT03792555|589846544|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
163310577|NCT03792555|589846545|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
163310578|NCT03792555|589846543|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
163310579|NCT03792555|589846544|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
163318908|NCT05485779|589878807|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
163051534|NCT02643693|588897175|FG004|Overall Study|Physician Decision|0|||
163051535|NCT02643693|588897176|FG005|Overall Study|Physician Decision|0|||
163051536|NCT02643693|588897171|FG000|Overall Study|Withdrawal by Subject|0|||
163051537|NCT02643693|588897172|FG001|Overall Study|Withdrawal by Subject|1|||
163051538|NCT02643693|588897173|FG002|Overall Study|Withdrawal by Subject|0|||
163051539|NCT02643693|588897174|FG003|Overall Study|Withdrawal by Subject|0|||
163051540|NCT02643693|588897175|FG004|Overall Study|Withdrawal by Subject|0|||
163051541|NCT02643693|588897176|FG005|Overall Study|Withdrawal by Subject|0|||
163051542|NCT02643693|588897171|FG000|Overall Study|Protocol Adherence Issues|2|||
163051543|NCT02643693|588897172|FG001|Overall Study|Protocol Adherence Issues|0|||
163051544|NCT02643693|588897173|FG002|Overall Study|Protocol Adherence Issues|1|||
163051545|NCT02643693|588897174|FG003|Overall Study|Protocol Adherence Issues|0|||
163051546|NCT02643693|588897175|FG004|Overall Study|Protocol Adherence Issues|0|||
163051547|NCT02643693|588897176|FG005|Overall Study|Protocol Adherence Issues|1|||
163051548|NCT01222104|588897177|FG000|Overall Study|Lost to Follow-up|37|||
163051549|NCT01222104|588897177|FG000|Overall Study|Death|10|||
163051550|NCT00888654|588897178|FG000|Overall Study|Problems swallowing oral meds.|1|||
163051551|NCT00888654|588897178|FG000|Overall Study|Not enough oral meds before surgery|3|||
163051552|NCT00888654|588897178|FG000|Overall Study|Surgery aborted|2|||
163051553|NCT00888654|588897178|FG000|Overall Study|Withdrawal by Subject|1|||
163051554|NCT00888654|588897178|FG000|Overall Study|Inelig. due to contraindication of med|1|||
163051555|NCT00888654|588897178|FG000|Overall Study|Change in surg date|1|||
163051556|NCT00888654|588897178|FG000|Overall Study|Stopped meds due to headaches|1|||
163051557|NCT03669549|588897183|FG000|Overall Study|Adverse Event|4|||
163051558|NCT03669549|588897183|FG000|Overall Study|Withdrawal by Subject|1|||
163051559|NCT03669549|588897183|FG000|Overall Study|Study terminated by the Sponsor|1|||
163051560|NCT00698815|588897185|FG000|Overall Study|Death|1|||
163051561|NCT00698815|588897186|FG001|Overall Study|Death|2|||
163051562|NCT00698815|588897187|FG002|Overall Study|Death|4|||
163051563|NCT00698815|588897185|FG000|Overall Study|Withdrawal by Subject|6|||
163051564|NCT00698815|588897186|FG001|Overall Study|Withdrawal by Subject|3|||
163051565|NCT00698815|588897187|FG002|Overall Study|Withdrawal by Subject|2|||
163051566|NCT00698815|588897185|FG000|Overall Study|MD discretion|2|||
163051567|NCT00698815|588897186|FG001|Overall Study|MD discretion|7|||
163051568|NCT00698815|588897187|FG002|Overall Study|MD discretion|2|||
163051569|NCT00698815|588897185|FG000|Overall Study|Did not receive protocol treatment|1|||
163051570|NCT00698815|588897186|FG001|Overall Study|Did not receive protocol treatment|2|||
163051571|NCT00698815|588897187|FG002|Overall Study|Did not receive protocol treatment|2|||
163051572|NCT00706004|588897188|FG000|Overall Study|Did not meet eligibility criteria|2|||
163051573|NCT02674516|588897189|FG000|Overall Study|Lost to Follow-up|3|||
163051574|NCT02674516|588897190|FG001|Overall Study|Lost to Follow-up|0|||
163051575|NCT02674516|588897189|FG000|Overall Study|Protocol Violation|0|||
163051576|NCT02674516|588897190|FG001|Overall Study|Protocol Violation|4|||
163051577|NCT02674516|588897189|FG000|Overall Study|Knowledge of study hypothesis|1|||
163051578|NCT02674516|588897190|FG001|Overall Study|Knowledge of study hypothesis|0|||
163051579|NCT01064479|588897191|FG000|Overall Study|Death|10|||
163051580|NCT01064479|588897192|FG001|Overall Study|Death|11|||
163051581|NCT01064479|588897191|FG000|Overall Study|Withdrawal by Subject|2|||
163051582|NCT01064479|588897192|FG001|Overall Study|Withdrawal by Subject|2|||
163051583|NCT01064479|588897191|FG000|Overall Study|Disease progression|1|||
163051584|NCT01064479|588897192|FG001|Overall Study|Disease progression|1|||
163051585|NCT01064479|588897191|FG000|Overall Study|Toxicity|1|||
163051586|NCT01064479|588897192|FG001|Overall Study|Toxicity|1|||
163051587|NCT01064479|588897191|FG000|Overall Study|Other|1|||
163310580|NCT03792555|589846545|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
163310581|NCT03792555|589846543|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
163310582|NCT03792555|589846544|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
163310583|NCT03792555|589846545|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
163310584|NCT04485039|589846549|FG000|TPOXX Only|Adverse Event|2|||
163051588|NCT01064479|588897192|FG001|Overall Study|Other|2|||
163051589|NCT00705757|588897199|FG000|Overall Study|Lack of Efficacy|5|||
163310585|NCT04485039|589846549|FG000|TPOXX Only|Physician Decision|1|||
163051590|NCT00705757|588897200|FG001|Overall Study|Lack of Efficacy|1|||
163051591|NCT00705757|588897201|FG002|Overall Study|Lack of Efficacy|3|||
163051592|NCT00705757|588897199|FG000|Overall Study|Lost to Follow-up|7|||
163051593|NCT00705757|588897200|FG001|Overall Study|Lost to Follow-up|6|||
163051594|NCT00705757|588897201|FG002|Overall Study|Lost to Follow-up|6|||
163051595|NCT00705757|588897199|FG000|Overall Study|Withdrawal by Subject|1|||
163051596|NCT00705757|588897200|FG001|Overall Study|Withdrawal by Subject|1|||
163051597|NCT00705757|588897201|FG002|Overall Study|Withdrawal by Subject|2|||
163051598|NCT05696392|588897206|FG000|Overall Study|Lost to Follow-up|3|||
163051599|NCT05696392|588897206|FG000|Overall Study|Protocol Violation|1|||
163051600|NCT05696392|588897206|FG000|Overall Study|Withdrawal by Subject|1|||
163051601|NCT03389620|588897216|FG000|Overall Study|Lost to Follow-up|5|||
163051602|NCT03389620|588897217|FG001|Overall Study|Lost to Follow-up|1|||
163051603|NCT04782180|588897224|FG000|Overall Study|Withdrawal by Subject|2|||
163051604|NCT04782180|588897224|FG000|Overall Study|Lost to Follow-up|2|||
163051605|NCT05852353|588897225|FG000|Overall Study|Family (dyad with LUTS) who consented but withdrew|2|||
163051606|NCT05852353|588897225|FG000|Overall Study|Family (dyad did not have LUTS) who consented but withdrew|1|||
163051607|NCT05852353|588897225|FG000|Overall Study|Family (dyad) who consented but did not complete intervention|24|||
163051608|NCT05852353|588897225|FG000|Overall Study|Family (dyad) who completed intervention but was lost to follow-up|7|||
163051609|NCT01005745|588897226|FG000|Overall Study|No TIL growth|1|||
163051610|NCT01005745|588897226|FG000|Overall Study|Disease progressed during TIL growth|3|||
163051611|NCT01005745|588897226|FG000|Overall Study|Death prior to treatment|1|||
163051612|NCT01005745|588897226|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
163051613|NCT06077773|588897227|FG000|Overall Study|Withdrawal by Subject|1|||
163051614|NCT06077773|588897228|FG001|Overall Study|Withdrawal by Subject|0|||
163051615|NCT06077773|588897229|FG002|Overall Study|Withdrawal by Subject|1|||
163051616|NCT06077773|588897227|FG000|Overall Study|Lost to Follow-up|0|||
163051617|NCT06077773|588897228|FG001|Overall Study|Lost to Follow-up|1|||
163051618|NCT06077773|588897229|FG002|Overall Study|Lost to Follow-up|0|||
163051619|NCT06077773|588897227|FG000|Overall Study|Adverse Event|0|||
163051620|NCT06077773|588897228|FG001|Overall Study|Adverse Event|0|||
163051621|NCT06077773|588897229|FG002|Overall Study|Adverse Event|2|||
163051622|NCT03834506|588897230|FG000|Overall Study|Death|336|||
163051623|NCT03834506|588897231|FG001|Overall Study|Death|326|||
163051624|NCT03834506|588897230|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163051625|NCT03834506|588897231|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163051626|NCT03834506|588897230|FG000|Overall Study|Withdrawal by Subject|10|||
163051627|NCT03834506|588897231|FG001|Overall Study|Withdrawal by Subject|8|||
163051628|NCT03834506|588897230|FG000|Overall Study|Sponsor decision|165|||
163051629|NCT03834506|588897231|FG001|Overall Study|Sponsor decision|178|||
163051630|NCT03834506|588897230|FG000|Overall Study|Physician Decision|3|||
163051631|NCT03834506|588897231|FG001|Overall Study|Physician Decision|1|||
163051632|NCT03834506|588897230|FG000|Overall Study|Lost to Follow-up|0|||
163051633|NCT03834506|588897231|FG001|Overall Study|Lost to Follow-up|1|||
163051634|NCT04577794|588897232|FG000|Overall Study|Adverse Event|1|||
163051635|NCT04577794|588897233|FG001|Overall Study|Adverse Event|1|||
163051636|NCT00689338|588897234|FG000|Overall Study|Death|65|||
163051637|NCT00689338|588897234|FG000|Overall Study|Adverse Event|13|||
163051638|NCT00689338|588897234|FG000|Overall Study|Insufficient Clinical Response|1|||
163051639|NCT00689338|588897234|FG000|Overall Study|Lack of Efficacy|6|||
163051640|NCT00689338|588897234|FG000|Overall Study|Other|8|||
163051641|NCT00689338|588897234|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
163051642|NCT00689338|588897234|FG000|Overall Study|Lost to Follow-up|5|||
163051643|NCT00689338|588897234|FG000|Overall Study|Withdrawal by Subject|3|||
163051644|NCT00689338|588897234|FG000|Overall Study|Protocol Violation|15|||
163051645|NCT02104895|588897237|FG000|Overall Study|Withdrawal by Subject|0|||
163051646|NCT02104895|588897238|FG001|Overall Study|Withdrawal by Subject|14|||
163051647|NCT00969228|588897239|FG000|Overall Study|Adverse Event|1|||
163051648|NCT00969228|588897240|FG001|Overall Study|Adverse Event|0|||
163051649|NCT00969228|588897239|FG000|Overall Study|Withdrawal by Subject|4|||
163051650|NCT00969228|588897240|FG001|Overall Study|Withdrawal by Subject|0|||
163051651|NCT00969228|588897239|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
163051652|NCT00969228|588897240|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
163051653|NCT01883895|588897244|FG000|Overall Study|Lost to Follow-up|2|||
163051654|NCT02895295|588897245|FG000|Overall Study|Survey Non-response|71|||
163051655|NCT02895295|588897246|FG001|Overall Study|Survey Non-response|94|||
163051656|NCT02895295|588897247|FG002|Overall Study|Survey Non-response|92|||
163051657|NCT02532283|588897248|FG000|Overall Study|Adverse Event|0|||
163051658|NCT02532283|588897249|FG001|Overall Study|Adverse Event|1|||
163051659|NCT02532283|588897248|FG000|Overall Study|Death|1|||
163051660|NCT02532283|588897249|FG001|Overall Study|Death|0|||
163051661|NCT02532283|588897248|FG000|Overall Study|Lost to Follow-up|0|||
163051662|NCT02532283|588897249|FG001|Overall Study|Lost to Follow-up|1|||
163051663|NCT02532283|588897248|FG000|Overall Study|Withdrawal by Subject|8|||
163051664|NCT02532283|588897249|FG001|Overall Study|Withdrawal by Subject|3|||
163051665|NCT03811821|588897250|FG000|Overall Study|Adverse Event|1|||
163051666|NCT03811821|588897251|FG001|Overall Study|Adverse Event|1|||
163051667|NCT03811821|588897250|FG000|Overall Study|Withdrawal by Subject|5|||
163051668|NCT03811821|588897251|FG001|Overall Study|Withdrawal by Subject|4|||
163203138|NCT03129100|589459676|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163051669|NCT03811821|588897250|FG000|Overall Study|Lost to Follow-up|2|||
163051670|NCT03811821|588897251|FG001|Overall Study|Lost to Follow-up|2|||
163051671|NCT03811821|588897250|FG000|Overall Study|Contraindication for treatment|0|||
163051672|NCT03811821|588897251|FG001|Overall Study|Contraindication for treatment|1|||
163051673|NCT03811821|588897250|FG000|Overall Study|Tolerability|0|||
163051674|NCT03811821|588897251|FG001|Overall Study|Tolerability|3|||
163051675|NCT03811821|588897250|FG000|Overall Study|Comorbidities|0|||
163051676|NCT03811821|588897251|FG001|Overall Study|Comorbidities|2|||
163310586|NCT04485039|589846549|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
163310587|NCT04485039|589846549|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
163310588|NCT03535272|589846553|FG000|Overall Study|Lost to Follow-up|71|||
163310589|NCT03535272|589846554|FG001|Overall Study|Lost to Follow-up|73|||
163310590|NCT01744782|589846555|FG000|Overall Study|Death|1|||
163310591|NCT02120456|589846557|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
163310592|NCT02120456|589846558|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
163051677|NCT03433898|588897252|FG000|Overall Study|Progressive disease|6|||
163051678|NCT03433898|588897253|FG001|Overall Study|Progressive disease|3|||
163051679|NCT03433898|588897254|FG002|Overall Study|Progressive disease|3|||
163051680|NCT03433898|588897255|FG003|Overall Study|Progressive disease|2|||
163051681|NCT03433898|588897256|FG004|Overall Study|Progressive disease|30|||
163051682|NCT03433898|588897257|FG005|Overall Study|Progressive disease|29|||
163051683|NCT03433898|588897258|FG006|Overall Study|Progressive disease|17|||
163051684|NCT03433898|588897259|FG007|Overall Study|Progressive disease|30|||
163051685|NCT03433898|588897252|FG000|Overall Study|Not treated|1|||
163051686|NCT03433898|588897253|FG001|Overall Study|Not treated|0|||
163051687|NCT03433898|588897254|FG002|Overall Study|Not treated|0|||
163051688|NCT03433898|588897255|FG003|Overall Study|Not treated|0|||
163051689|NCT03433898|588897256|FG004|Overall Study|Not treated|1|||
163051690|NCT03433898|588897257|FG005|Overall Study|Not treated|0|||
163051691|NCT03433898|588897258|FG006|Overall Study|Not treated|0|||
163051692|NCT03433898|588897259|FG007|Overall Study|Not treated|0|||
163051693|NCT03433898|588897252|FG000|Overall Study|Death|0|||
163051694|NCT03433898|588897253|FG001|Overall Study|Death|0|||
163051695|NCT03433898|588897254|FG002|Overall Study|Death|0|||
163051696|NCT03433898|588897255|FG003|Overall Study|Death|0|||
163051697|NCT03433898|588897256|FG004|Overall Study|Death|0|||
163051698|NCT03433898|588897257|FG005|Overall Study|Death|0|||
163051699|NCT03433898|588897258|FG006|Overall Study|Death|1|||
163051700|NCT03433898|588897259|FG007|Overall Study|Death|1|||
163051701|NCT03433898|588897252|FG000|Overall Study|Withdrawal by Subject|0|||
163051702|NCT03433898|588897253|FG001|Overall Study|Withdrawal by Subject|0|||
163051703|NCT03433898|588897254|FG002|Overall Study|Withdrawal by Subject|0|||
163051704|NCT03433898|588897255|FG003|Overall Study|Withdrawal by Subject|0|||
163051705|NCT03433898|588897256|FG004|Overall Study|Withdrawal by Subject|2|||
163051706|NCT03433898|588897257|FG005|Overall Study|Withdrawal by Subject|0|||
163051707|NCT03433898|588897258|FG006|Overall Study|Withdrawal by Subject|0|||
163051708|NCT03433898|588897259|FG007|Overall Study|Withdrawal by Subject|0|||
163051709|NCT03433898|588897252|FG000|Overall Study|Adverse Event|0|||
163051710|NCT03433898|588897253|FG001|Overall Study|Adverse Event|0|||
163051711|NCT03433898|588897254|FG002|Overall Study|Adverse Event|0|||
163051712|NCT03433898|588897255|FG003|Overall Study|Adverse Event|0|||
163051713|NCT03433898|588897256|FG004|Overall Study|Adverse Event|0|||
163051714|NCT03433898|588897257|FG005|Overall Study|Adverse Event|5|||
163051715|NCT03433898|588897258|FG006|Overall Study|Adverse Event|2|||
163051716|NCT03433898|588897259|FG007|Overall Study|Adverse Event|2|||
163051717|NCT03433898|588897252|FG000|Overall Study|Fatal adverse event: Acute kidney injury|0|||
163051718|NCT03433898|588897253|FG001|Overall Study|Fatal adverse event: Acute kidney injury|0|||
163051719|NCT03433898|588897254|FG002|Overall Study|Fatal adverse event: Acute kidney injury|0|||
163051720|NCT03433898|588897255|FG003|Overall Study|Fatal adverse event: Acute kidney injury|0|||
163051721|NCT03433898|588897256|FG004|Overall Study|Fatal adverse event: Acute kidney injury|1|||
163051722|NCT03433898|588897257|FG005|Overall Study|Fatal adverse event: Acute kidney injury|0|||
163051723|NCT03433898|588897258|FG006|Overall Study|Fatal adverse event: Acute kidney injury|0|||
163051724|NCT03433898|588897259|FG007|Overall Study|Fatal adverse event: Acute kidney injury|0|||
163051725|NCT05069259|588897263|FG000|Overall Study|Withdrawal by Subject|1|||
163051726|NCT05069259|588897263|FG000|Overall Study|Sponsor decision|1|||
163051727|NCT01496976|588898691|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
163051728|NCT00922636|588898692|FG000|Overall Study|Adverse Event|3|||
163051729|NCT00922636|588898693|FG001|Overall Study|Adverse Event|3|||
163051730|NCT00922636|588898694|FG002|Overall Study|Adverse Event|2|||
163051731|NCT00922636|588898695|FG003|Overall Study|Adverse Event|3|||
163310593|NCT02120456|589846559|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
163310594|NCT02120456|589846560|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
163051732|NCT00922636|588898696|FG004|Overall Study|Adverse Event|2|||
163051733|NCT00922636|588898692|FG000|Overall Study|Lack of Efficacy|1|||
163051734|NCT00922636|588898693|FG001|Overall Study|Lack of Efficacy|7|||
163051735|NCT00922636|588898694|FG002|Overall Study|Lack of Efficacy|3|||
163051736|NCT00922636|588898695|FG003|Overall Study|Lack of Efficacy|2|||
163051737|NCT00922636|588898696|FG004|Overall Study|Lack of Efficacy|4|||
163051738|NCT00922636|588898692|FG000|Overall Study|Sponsor Decision|0|||
163051739|NCT00922636|588898693|FG001|Overall Study|Sponsor Decision|0|||
163051740|NCT00922636|588898694|FG002|Overall Study|Sponsor Decision|2|||
163051741|NCT00922636|588898695|FG003|Overall Study|Sponsor Decision|0|||
163051742|NCT00922636|588898696|FG004|Overall Study|Sponsor Decision|0|||
163051743|NCT00922636|588898692|FG000|Overall Study|Withdrawal by Subject|0|||
163051744|NCT00922636|588898693|FG001|Overall Study|Withdrawal by Subject|0|||
163051745|NCT00922636|588898694|FG002|Overall Study|Withdrawal by Subject|5|||
163051746|NCT00922636|588898695|FG003|Overall Study|Withdrawal by Subject|2|||
163051747|NCT00922636|588898696|FG004|Overall Study|Withdrawal by Subject|4|||
163051748|NCT00922636|588898692|FG000|Overall Study|Protocol Violation|0|||
163051749|NCT00922636|588898693|FG001|Overall Study|Protocol Violation|0|||
163051750|NCT00922636|588898694|FG002|Overall Study|Protocol Violation|2|||
163051751|NCT00922636|588898695|FG003|Overall Study|Protocol Violation|2|||
163051752|NCT00922636|588898696|FG004|Overall Study|Protocol Violation|0|||
163051753|NCT00922636|588898692|FG000|Overall Study|Entry Criteria Not Met|0|||
163051754|NCT00922636|588898693|FG001|Overall Study|Entry Criteria Not Met|0|||
163051755|NCT00922636|588898694|FG002|Overall Study|Entry Criteria Not Met|1|||
163051756|NCT00922636|588898695|FG003|Overall Study|Entry Criteria Not Met|1|||
163051757|NCT00922636|588898696|FG004|Overall Study|Entry Criteria Not Met|0|||
163051758|NCT00922636|588898692|FG000|Overall Study|Parent/Caregiver Decision|2|||
163051759|NCT00922636|588898693|FG001|Overall Study|Parent/Caregiver Decision|4|||
163051760|NCT00922636|588898694|FG002|Overall Study|Parent/Caregiver Decision|3|||
163051761|NCT00922636|588898695|FG003|Overall Study|Parent/Caregiver Decision|5|||
163051762|NCT00922636|588898696|FG004|Overall Study|Parent/Caregiver Decision|2|||
163051763|NCT00922636|588898692|FG000|Overall Study|Lost to Follow-up|1|||
163051764|NCT00922636|588898693|FG001|Overall Study|Lost to Follow-up|2|||
163051765|NCT00922636|588898694|FG002|Overall Study|Lost to Follow-up|2|||
163051766|NCT00922636|588898695|FG003|Overall Study|Lost to Follow-up|2|||
163051767|NCT00922636|588898696|FG004|Overall Study|Lost to Follow-up|4|||
163051768|NCT00870727|588898697|FG000|Overall Study|Lost to Follow-up|0|||
163051769|NCT00870727|588898698|FG001|Overall Study|Lost to Follow-up|1|||
163051770|NCT00870727|588898697|FG000|Overall Study|Lack of Efficacy|1|||
163051771|NCT00870727|588898698|FG001|Overall Study|Lack of Efficacy|3|||
163051772|NCT00870727|588898697|FG000|Overall Study|Adverse Event|0|||
163051773|NCT00870727|588898698|FG001|Overall Study|Adverse Event|1|||
163051774|NCT01117870|588898706|FG000|Overall Study|Inability to place needle|1|||
163051775|NCT01117870|588898707|FG001|Overall Study|Inability to place needle|0|||
163051776|NCT01309386|588898708|FG000|Overall Study|Other|2|||
163051777|NCT01309386|588898709|FG001|Overall Study|Other|0|||
163051778|NCT01309386|588898708|FG000|Overall Study|Withdrawal by Subject|2|||
163051779|NCT01309386|588898709|FG001|Overall Study|Withdrawal by Subject|0|||
163051780|NCT01309386|588898708|FG000|Overall Study|Progressive disease|9|||
163051781|NCT01309386|588898709|FG001|Overall Study|Progressive disease|11|||
163051782|NCT01309386|588898708|FG000|Overall Study|Physician Decision|1|||
163051783|NCT01309386|588898709|FG001|Overall Study|Physician Decision|1|||
163051784|NCT01309386|588898708|FG000|Overall Study|Lack of Efficacy|3|||
163051785|NCT01309386|588898709|FG001|Overall Study|Lack of Efficacy|1|||
163051786|NCT01309386|588898708|FG000|Overall Study|Adverse Event|5|||
163051787|NCT01309386|588898709|FG001|Overall Study|Adverse Event|8|||
163051788|NCT01774981|588898714|FG000|Overall Study|Adverse Event|0|||
163051789|NCT01774981|588898715|FG001|Overall Study|Adverse Event|0|||
163051790|NCT01774981|588898716|FG002|Overall Study|Adverse Event|0|||
163051791|NCT01774981|588898717|FG003|Overall Study|Adverse Event|0|||
163051792|NCT01774981|588898718|FG004|Overall Study|Adverse Event|0|||
163051793|NCT01774981|588898719|FG005|Overall Study|Adverse Event|1|||
163051794|NCT01774981|588898720|FG006|Overall Study|Adverse Event|0|||
163051795|NCT01774981|588898721|FG007|Overall Study|Adverse Event|0|||
163051796|NCT01774981|588898714|FG000|Overall Study|Withdrawal by Subject|0|||
163051797|NCT01774981|588898715|FG001|Overall Study|Withdrawal by Subject|0|||
163051798|NCT01774981|588898716|FG002|Overall Study|Withdrawal by Subject|0|||
163051799|NCT01774981|588898717|FG003|Overall Study|Withdrawal by Subject|0|||
163051800|NCT01774981|588898718|FG004|Overall Study|Withdrawal by Subject|0|||
163051801|NCT01774981|588898719|FG005|Overall Study|Withdrawal by Subject|0|||
163310595|NCT02120456|589846561|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
163310596|NCT02120456|589846562|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
163051802|NCT01774981|588898720|FG006|Overall Study|Withdrawal by Subject|0|||
163051803|NCT01774981|588898721|FG007|Overall Study|Withdrawal by Subject|1|||
163051804|NCT01774981|588898714|FG000|Overall Study|Death|0|||
163051805|NCT01774981|588898715|FG001|Overall Study|Death|0|||
163051806|NCT01774981|588898716|FG002|Overall Study|Death|0|||
163051807|NCT01774981|588898717|FG003|Overall Study|Death|0|||
163051808|NCT01774981|588898718|FG004|Overall Study|Death|1|||
163051809|NCT01774981|588898719|FG005|Overall Study|Death|0|||
163051810|NCT01774981|588898720|FG006|Overall Study|Death|0|||
163051811|NCT01774981|588898721|FG007|Overall Study|Death|0|||
163051812|NCT02915835|588898724|FG000|Overall Study|Physician Decision|1|||
163051813|NCT02915835|588898725|FG001|Overall Study|Physician Decision|0|||
163051814|NCT02915835|588898724|FG000|Overall Study|Withdrawal by Subject|0|||
163051815|NCT02915835|588898725|FG001|Overall Study|Withdrawal by Subject|1|||
163051816|NCT02456727|588898726|FG000|Overall Study|Lost to Follow-up|63|||
163051817|NCT02456727|588898727|FG001|Overall Study|Lost to Follow-up|65|||
163051818|NCT02456727|588898726|FG000|Overall Study|Death|2|||
163203139|NCT03129100|589459677|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203140|NCT03129100|589459678|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203141|NCT03129100|589459679|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203142|NCT03129100|589459680|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203143|NCT03129100|589459681|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203144|NCT03129100|589459682|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203145|NCT03129100|589459683|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163051819|NCT02456727|588898727|FG001|Overall Study|Death|1|||
163310597|NCT02120456|589846563|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
163310598|NCT02120456|589846564|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
163310599|NCT02120456|589846565|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
163310600|NCT02120456|589846557|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
163310601|NCT02120456|589846558|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
163310602|NCT02120456|589846559|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
163310603|NCT02120456|589846560|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
163310604|NCT02120456|589846561|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
163310605|NCT02120456|589846562|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
163310606|NCT02120456|589846563|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
163310607|NCT02120456|589846564|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
163310608|NCT02120456|589846565|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
163310609|NCT02120456|589846557|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163310610|NCT02120456|589846558|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163310611|NCT02120456|589846559|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163310612|NCT02120456|589846560|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163310613|NCT02120456|589846561|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163310614|NCT02120456|589846562|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163310615|NCT02120456|589846563|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163310616|NCT02120456|589846564|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163310617|NCT02120456|589846565|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
163310618|NCT05192200|589846566|FG000|Treatment Period|Other|1|||
163310619|NCT05192200|589846566|FG000|Treatment Period|Lack of Efficacy|1|||
163310620|NCT05192200|589846566|FG000|Treatment Period|Withdrawal by Subject|1|||
163203146|NCT03129100|589459684|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203147|NCT03129100|589459685|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203148|NCT03129100|589459686|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203149|NCT03129100|589459687|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163051820|NCT02456727|588898726|FG000|Overall Study|Withdrawal by Subject|1|||
163051821|NCT02456727|588898727|FG001|Overall Study|Withdrawal by Subject|10|||
163051822|NCT02456727|588898726|FG000|Overall Study|Never Initiated Treatment|43|||
163051823|NCT02456727|588898727|FG001|Overall Study|Never Initiated Treatment|30|||
163051824|NCT01319565|588898728|FG000|Overall Study|Not treated: Rapid disease progression prior to start|0|||
163051825|NCT01319565|588898729|FG001|Overall Study|Not treated: Rapid disease progression prior to start|2|||
163051826|NCT01319565|588898730|FG002|Overall Study|Not treated: Rapid disease progression prior to start|0|||
163051827|NCT00113607|588898731|FG000|Overall Study|Adverse Event|40|||
163051828|NCT00113607|588898732|FG001|Overall Study|Adverse Event|71|||
163051829|NCT00113607|588898731|FG000|Overall Study|Death|8|||
163051830|NCT00113607|588898732|FG001|Overall Study|Death|8|||
163051831|NCT00113607|588898731|FG000|Overall Study|Withdrawal by Subject|50|||
163051832|NCT00113607|588898732|FG001|Overall Study|Withdrawal by Subject|58|||
163051833|NCT00113607|588898731|FG000|Overall Study|Lost to Follow-up|0|||
163051834|NCT00113607|588898732|FG001|Overall Study|Lost to Follow-up|2|||
163051835|NCT00113607|588898731|FG000|Overall Study|Disease Progression|180|||
163051836|NCT00113607|588898732|FG001|Overall Study|Disease Progression|142|||
163051837|NCT00113607|588898731|FG000|Overall Study|Complete Response (Confirmed)|14|||
163051838|NCT00113607|588898732|FG001|Overall Study|Complete Response (Confirmed)|24|||
163051839|NCT00113607|588898731|FG000|Overall Study|Other|43|||
163051840|NCT00113607|588898732|FG001|Overall Study|Other|32|||
163051841|NCT00909844|588898733|FG000|Overall Study|Adverse Event|1|||
163051842|NCT00909844|588898733|FG000|Overall Study|Withdrawal by Subject|1|||
163051843|NCT00909844|588898733|FG000|Overall Study|Lost to Follow-up|2|||
163051844|NCT02974868|588898734|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
163051845|NCT02974868|588898735|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
163051846|NCT02974868|588898736|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
163397401|NCT02844816|590166285|FG000|Overall Study|No protocol treatment received|5|||
162964714|NCT01968031|588569862|FG001|Overall Study|Prohibited concomitant medication|0|||
162964715|NCT01968031|588569863|FG002|Overall Study|Prohibited concomitant medication|0|||
162964716|NCT00840879|588569864|FG000|Second Intervention|Withdrawal by Subject|1|||
162964717|NCT00840879|588569865|FG001|Second Intervention|Withdrawal by Subject|0|||
162964718|NCT00477594|588569866|FG000|Year 1 and Year 2|Adverse Event|4|||
162964719|NCT00477594|588569867|FG001|Year 1 and Year 2|Adverse Event|2|||
162964720|NCT00477594|588569866|FG000|Year 1 and Year 2|Physician Decision|2|||
163310621|NCT05192200|589846566|FG000|Follow-up|Withdrawal by Subject|1|||
163310622|NCT03623321|589846567|FG000|Overall Study|Adverse Event|32|||
163310623|NCT03623321|589846567|FG000|Overall Study|Death|9|||
163310624|NCT03623321|589846567|FG000|Overall Study|Lack of Efficacy|9|||
163310625|NCT03623321|589846567|FG000|Overall Study|Lost to Follow-up|6|||
163310626|NCT03623321|589846567|FG000|Overall Study|Noncompliance with study drug|6|||
163310627|NCT03623321|589846567|FG000|Overall Study|Use of prohibited medication|3|||
163310628|NCT03623321|589846567|FG000|Overall Study|Physician Decision|5|||
163310629|NCT03623321|589846567|FG000|Overall Study|Protocol Violation|1|||
163397402|NCT02844816|590166286|FG001|Overall Study|No protocol treatment received|1|||
163397403|NCT02844816|590166285|FG000|Overall Study|Ineligible|22|||
163397404|NCT02844816|590166286|FG001|Overall Study|Ineligible|15|||
163397405|NCT02844816|590166285|FG000|Overall Study|Participant refusal|5|||
163397406|NCT02844816|590166286|FG001|Overall Study|Participant refusal|5|||
163397407|NCT02844816|590166285|FG000|Overall Study|Adverse Event|5|||
163397408|NCT02844816|590166286|FG001|Overall Study|Adverse Event|4|||
162964721|NCT00477594|588569867|FG001|Year 1 and Year 2|Physician Decision|1|||
163397409|NCT02844816|590166285|FG000|Overall Study|Death|0|||
162964722|NCT00477594|588569866|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
163397410|NCT02844816|590166286|FG001|Overall Study|Death|1|||
163051847|NCT02974868|588898737|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
163051848|NCT02974868|588898734|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
163310630|NCT03623321|589846567|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
163310631|NCT03623321|589846567|FG000|Overall Study|Not further specified|43|||
163310632|NCT01999075|589846568|FG000|Overall Study|Lost to Follow-up|0|||
163310633|NCT01999075|589846569|FG001|Overall Study|Lost to Follow-up|2|||
163310634|NCT01999075|589846568|FG000|Overall Study|Withdrawal by Subject|2|||
163310635|NCT01999075|589846569|FG001|Overall Study|Withdrawal by Subject|7|||
163310636|NCT01999075|589846568|FG000|Overall Study|Enrolled in drug trial|3|||
163051849|NCT02974868|588898735|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
163051850|NCT02974868|588898736|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
163310637|NCT01999075|589846569|FG001|Overall Study|Enrolled in drug trial|1|||
163310638|NCT01999075|589846568|FG000|Overall Study|Became ineligible|0|||
163310639|NCT01999075|589846569|FG001|Overall Study|Became ineligible|2|||
163310640|NCT05948670|589846577|FG000|Overall Study|Protocol Violation|6|||
163310641|NCT05948670|589846578|FG001|Overall Study|Protocol Violation|8|||
162964723|NCT00477594|588569867|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
162964724|NCT00477594|588569866|FG000|Year 1 and Year 2|Other|1|||
162964725|NCT00477594|588569867|FG001|Year 1 and Year 2|Other|0|||
162964726|NCT00477594|588569866|FG000|Year 3|Adverse Event|1|||
162964727|NCT00477594|588569867|FG001|Year 3|Adverse Event|0|||
162964728|NCT00477594|588569866|FG000|Year 3|Withdrawal by Subject|1|||
163310642|NCT05948670|589846577|FG000|Overall Study|Withdrawal by Subject|0|||
163310643|NCT05948670|589846578|FG001|Overall Study|Withdrawal by Subject|1|||
162964729|NCT00477594|588569867|FG001|Year 3|Withdrawal by Subject|0|||
162964730|NCT00477594|588569866|FG000|Follow-up Period|Withdrawal by Subject|2|||
162964731|NCT00477594|588569867|FG001|Follow-up Period|Withdrawal by Subject|1|||
162964732|NCT00477594|588569866|FG000|Follow-up Period|Other|1|||
163051851|NCT02974868|588898737|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
163051852|NCT02974868|588898734|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
162964733|NCT00477594|588569867|FG001|Follow-up Period|Other|0|||
162964734|NCT01894230|588571930|FG000|Overall Study|Lost to Follow-up|2|||
163203150|NCT03129100|589459688|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203151|NCT03129100|589459689|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203152|NCT03129100|589459690|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163203153|NCT03129100|589459691|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
163397411|NCT02844816|590166285|FG000|Overall Study|Disease progression/recurrence|50|||
163397412|NCT02844816|590166286|FG001|Overall Study|Disease progression/recurrence|24|||
163397413|NCT02844816|590166285|FG000|Overall Study|Physician Decision|1|||
162964735|NCT01894230|588571931|FG001|Overall Study|Lost to Follow-up|2|||
162964736|NCT01894230|588571930|FG000|Overall Study|Withdrawal by Subject|4|||
162964737|NCT01894230|588571931|FG001|Overall Study|Withdrawal by Subject|4|||
162964738|NCT01894230|588571930|FG000|Overall Study|Non-adherent|0|||
162964739|NCT01894230|588571931|FG001|Overall Study|Non-adherent|1|||
162964740|NCT01894230|588571930|FG000|Overall Study|Death|1|||
162964741|NCT01894230|588571931|FG001|Overall Study|Death|0|||
162964742|NCT02219009|588571932|FG000|Overall Study|Withdrawal by Subject|5|||
162964743|NCT02219009|588571933|FG001|Overall Study|Withdrawal by Subject|1|||
162964744|NCT02219009|588571932|FG000|Overall Study|Adverse Event|2|||
162964745|NCT02219009|588571933|FG001|Overall Study|Adverse Event|4|||
162964746|NCT02219009|588571932|FG000|Overall Study|Lost to Follow-up|2|||
162964747|NCT02219009|588571933|FG001|Overall Study|Lost to Follow-up|2|||
162964748|NCT02219009|588571932|FG000|Overall Study|Protocol deviation|1|||
162964749|NCT02219009|588571933|FG001|Overall Study|Protocol deviation|0|||
162964750|NCT02219009|588571932|FG000|Overall Study|Physician Decision|0|||
162964751|NCT02219009|588571933|FG001|Overall Study|Physician Decision|1|||
162964752|NCT02259348|588571934|FG000|Overall Study|Donors|6|||
162964753|NCT02259348|588571934|FG000|Overall Study|Death|4|||
162964754|NCT01622660|588571935|FG000|Overall Study|Adverse Event|1|||
162964755|NCT00642993|588571936|FG000|Overall Study|Adverse Event|85|||
162964756|NCT00642993|588571937|FG001|Overall Study|Adverse Event|4|||
162964757|NCT00642993|588571936|FG000|Overall Study|Lost to Follow-up|8|||
162964758|NCT00642993|588571937|FG001|Overall Study|Lost to Follow-up|4|||
162964759|NCT00642993|588571936|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
162964760|NCT00642993|588571937|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
162964761|NCT00642993|588571936|FG000|Overall Study|Protocol Violation|1|||
162964762|NCT00642993|588571937|FG001|Overall Study|Protocol Violation|4|||
163310644|NCT03056040|589846580|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
162964763|NCT00642993|588571936|FG000|Overall Study|Did not meet protocol eligibility|0|||
163310645|NCT03056040|589846581|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
162964764|NCT00642993|588571937|FG001|Overall Study|Did not meet protocol eligibility|1|||
162964765|NCT00642993|588571936|FG000|Overall Study|Administrative|1|||
162964766|NCT00642993|588571937|FG001|Overall Study|Administrative|0|||
162964767|NCT02664415|588571938|FG000|Overall Study|Adverse Event|1|||
162964768|NCT02664415|588571939|FG001|Overall Study|Adverse Event|0|||
162964769|NCT02034513|588571940|FG000|Overall Study|Adverse Event|11|||
162964770|NCT02034513|588571941|FG001|Overall Study|Adverse Event|10|||
162964771|NCT02034513|588571940|FG000|Overall Study|Lack of Efficacy|0|||
162964772|NCT02034513|588571941|FG001|Overall Study|Lack of Efficacy|1|||
162964773|NCT02034513|588571940|FG000|Overall Study|Lost to Follow-up|6|||
162964774|NCT02034513|588571941|FG001|Overall Study|Lost to Follow-up|7|||
162964775|NCT02034513|588571940|FG000|Overall Study|Pregnancy|0|||
162964776|NCT02034513|588571941|FG001|Overall Study|Pregnancy|3|||
162964777|NCT02034513|588571940|FG000|Overall Study|Protocol Violation|7|||
162964778|NCT02034513|588571941|FG001|Overall Study|Protocol Violation|10|||
162964779|NCT02034513|588571940|FG000|Overall Study|Withdrawal by Subject|25|||
162964780|NCT02034513|588571941|FG001|Overall Study|Withdrawal by Subject|25|||
162964781|NCT02034513|588571940|FG000|Overall Study|Unclassified|0|||
162964782|NCT02034513|588571941|FG001|Overall Study|Unclassified|1|||
163051853|NCT02974868|588898735|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
163310646|NCT03056040|589846580|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
163310647|NCT03056040|589846581|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
163310648|NCT03056040|589846580|FG000|Primary Evaluation Period|Pregnancy|0|||
163310649|NCT03056040|589846581|FG001|Primary Evaluation Period|Pregnancy|1|||
163310650|NCT03056040|589846580|FG000|Primary Evaluation Period|Randomized, not treated|1|||
163310651|NCT03056040|589846581|FG001|Primary Evaluation Period|Randomized, not treated|1|||
163310652|NCT03056040|589846580|FG000|Extension Period|Physician Decision|3|||
163310653|NCT03056040|589846581|FG001|Extension Period|Physician Decision|3|||
163310654|NCT03056040|589846580|FG000|Extension Period|Lost to Follow-up|0|||
163310655|NCT03056040|589846581|FG001|Extension Period|Lost to Follow-up|1|||
163310656|NCT03056040|589846580|FG000|Extension Period|Death|0|||
163310657|NCT03056040|589846581|FG001|Extension Period|Death|3|||
163310658|NCT03056040|589846580|FG000|Extension Period|Withdrawal by Subject|1|||
162964783|NCT00960154|588571942|FG000|Overall Study|Study termination|25|||
162964784|NCT00960154|588571943|FG001|Overall Study|Study termination|25|||
162964785|NCT00757705|588571944|FG000|Overall Study|Adverse Event|19|||
162964786|NCT00757705|588571944|FG000|Overall Study|Lost to Follow-up|16|||
163310659|NCT03056040|589846581|FG001|Extension Period|Withdrawal by Subject|0|||
163310660|NCT04142788|589846582|FG000|Overall Study|Trial terminated prematurely|2|||
163310661|NCT04142788|589846583|FG001|Overall Study|Trial terminated prematurely|2|||
163310662|NCT02035787|589846587|FG000|Overall Study- 12 Months|Adverse Event|3|||
163310663|NCT02035787|589846588|FG001|Overall Study- 12 Months|Adverse Event|0|||
163310664|NCT02035787|589846587|FG000|Overall Study- 12 Months|Complete response|4|||
163310665|NCT02035787|589846588|FG001|Overall Study- 12 Months|Complete response|1|||
163310666|NCT02035787|589846587|FG000|Overall Study- 12 Months|Protocol Violation|1|||
163310667|NCT02035787|589846588|FG001|Overall Study- 12 Months|Protocol Violation|1|||
163310668|NCT00999804|589846591|FG000|Overall Study|Lack of Efficacy|9|||
163310669|NCT00999804|589846592|FG001|Overall Study|Lack of Efficacy|2|||
163310670|NCT00999804|589846591|FG000|Overall Study|Adverse Event|4|||
163310671|NCT00999804|589846592|FG001|Overall Study|Adverse Event|3|||
163310672|NCT00999804|589846591|FG000|Overall Study|Withdrawal by Subject|4|||
163310673|NCT00999804|589846592|FG001|Overall Study|Withdrawal by Subject|0|||
163310674|NCT00999804|589846591|FG000|Overall Study|Death|1|||
163310675|NCT00999804|589846592|FG001|Overall Study|Death|0|||
163310676|NCT00999804|589846591|FG000|Overall Study|Ineligible|3|||
163310677|NCT00999804|589846592|FG001|Overall Study|Ineligible|0|||
163310678|NCT05028634|589846594|FG000|Overall Study|Withdrawal by Subject|0|||
163310679|NCT05028634|589846595|FG001|Overall Study|Withdrawal by Subject|1|||
163310680|NCT01997840|589846596|FG000|Overall Study|Lost to Follow-up|0|||
163310681|NCT01997840|589846597|FG001|Overall Study|Lost to Follow-up|0|||
163310682|NCT01997840|589846598|FG002|Overall Study|Lost to Follow-up|1|||
163310683|NCT01997840|589846599|FG003|Overall Study|Lost to Follow-up|0|||
163310684|NCT01997840|589846596|FG000|Overall Study|Withdrawal by participant|0|||
163310685|NCT01997840|589846597|FG001|Overall Study|Withdrawal by participant|0|||
163310686|NCT01997840|589846598|FG002|Overall Study|Withdrawal by participant|8|||
163397414|NCT02844816|590166286|FG001|Overall Study|Physician Decision|1|||
163051854|NCT02974868|588898736|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
163203154|NCT03129100|589459666|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162964787|NCT00757705|588571944|FG000|Overall Study|Withdrawal by Subject|25|||
162964788|NCT00757705|588571944|FG000|Overall Study|Insufficient Response|26|||
163310687|NCT01997840|589846599|FG003|Overall Study|Withdrawal by participant|1|||
162964789|NCT00757705|588571944|FG000|Overall Study|Ineligible to continue|8|||
162964790|NCT00757705|588571944|FG000|Overall Study|Non-compliant|9|||
162964791|NCT00757705|588571944|FG000|Overall Study|Other|18|||
163203155|NCT03129100|589459667|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203156|NCT03129100|589459668|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
163203157|NCT03129100|589459669|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163310688|NCT01997840|589846596|FG000|Overall Study|Physician Decision|0|||
163310689|NCT01997840|589846597|FG001|Overall Study|Physician Decision|0|||
163310690|NCT01997840|589846598|FG002|Overall Study|Physician Decision|3|||
163310691|NCT01997840|589846599|FG003|Overall Study|Physician Decision|0|||
163310692|NCT01997840|589846596|FG000|Overall Study|Progressive disease|3|||
163310693|NCT01997840|589846597|FG001|Overall Study|Progressive disease|4|||
163310694|NCT01997840|589846598|FG002|Overall Study|Progressive disease|57|||
163310695|NCT01997840|589846599|FG003|Overall Study|Progressive disease|8|||
163310696|NCT01997840|589846596|FG000|Overall Study|Other reasons|0|||
163310697|NCT01997840|589846597|FG001|Overall Study|Other reasons|0|||
163310698|NCT01997840|589846598|FG002|Overall Study|Other reasons|1|||
163310699|NCT01997840|589846599|FG003|Overall Study|Other reasons|0|||
163310700|NCT01997840|589846596|FG000|Overall Study|Adverse Event|0|||
163310701|NCT01997840|589846597|FG001|Overall Study|Adverse Event|0|||
163310702|NCT01997840|589846598|FG002|Overall Study|Adverse Event|15|||
163310703|NCT01997840|589846599|FG003|Overall Study|Adverse Event|2|||
163310704|NCT03850678|589846600|FG000|Overall Study|Withdrawal by Subject|3|||
163310705|NCT03850678|589846601|FG001|Overall Study|Withdrawal by Subject|0|||
163310706|NCT03850678|589846600|FG000|Overall Study|Experimenter Error|1|||
163310707|NCT03850678|589846601|FG001|Overall Study|Experimenter Error|1|||
163310708|NCT03850678|589846600|FG000|Overall Study|Did Not Condition To Experiment|7|||
163310709|NCT03850678|589846601|FG001|Overall Study|Did Not Condition To Experiment|2|||
163310710|NCT05311384|589846612|FG000|Overall Study|Uncontrolled health conditions|2|||
163310711|NCT05311384|589846612|FG000|Overall Study|Withdrawal by Subject|1|||
163310712|NCT02724631|589846619|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
163310713|NCT05076708|589846620|FG000|Overall Study|Withdrawal by Subject|4|||
163310714|NCT05076708|589846620|FG000|Overall Study|Lost to study during switch phase|8|||
163310715|NCT02908477|589846621|FG000|Overall Study|Withdrawal by Subject|8|||
163310716|NCT02908477|589846622|FG001|Overall Study|Withdrawal by Subject|28|||
163310717|NCT05590403|589846625|FG000|Overall Study|Lost to Follow-up|13|||
163310718|NCT05590403|589846626|FG001|Overall Study|Lost to Follow-up|1|||
163310719|NCT05590403|589846627|FG002|Overall Study|Lost to Follow-up|7|||
163310720|NCT05590403|589846628|FG003|Overall Study|Lost to Follow-up|3|||
163310721|NCT05590403|589846629|FG004|Overall Study|Lost to Follow-up|4|||
163310722|NCT05590403|589846625|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
163203158|NCT03129100|589459670|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203159|NCT03129100|589459671|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203160|NCT03129100|589459672|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203161|NCT03129100|589459673|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203162|NCT03129100|589459674|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203163|NCT03129100|589459675|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203164|NCT03129100|589459676|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203165|NCT03129100|589459677|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203166|NCT03129100|589459678|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203167|NCT03129100|589459679|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203168|NCT03129100|589459680|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203169|NCT03129100|589459681|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203170|NCT03129100|589459682|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203171|NCT03129100|589459683|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203172|NCT03129100|589459684|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203173|NCT03129100|589459685|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203174|NCT03129100|589459686|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203175|NCT03129100|589459687|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203176|NCT03129100|589459688|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203177|NCT03129100|589459689|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203178|NCT03129100|589459690|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163203179|NCT03129100|589459691|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
163310723|NCT05590403|589846626|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
163310724|NCT05590403|589846627|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
163310725|NCT05590403|589846628|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
163310726|NCT05590403|589846629|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
163310727|NCT05590403|589846625|FG000|Overall Study|Other|2|||
163310728|NCT05590403|589846626|FG001|Overall Study|Other|0|||
163310729|NCT05590403|589846627|FG002|Overall Study|Other|2|||
163310730|NCT05590403|589846628|FG003|Overall Study|Other|2|||
163310731|NCT05590403|589846629|FG004|Overall Study|Other|0|||
163310732|NCT05590403|589846625|FG000|Overall Study|Migrated / moved from the study area|1|||
163310733|NCT05590403|589846626|FG001|Overall Study|Migrated / moved from the study area|1|||
163310734|NCT05590403|589846627|FG002|Overall Study|Migrated / moved from the study area|0|||
163310735|NCT05590403|589846628|FG003|Overall Study|Migrated / moved from the study area|3|||
163310736|NCT05590403|589846629|FG004|Overall Study|Migrated / moved from the study area|1|||
163310737|NCT05590403|589846625|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
163397415|NCT04376827|590166287|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
163397416|NCT04376827|590166288|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
163397417|NCT04376827|590166287|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
163397418|NCT04376827|590166288|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
163310738|NCT05590403|589846626|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
163310739|NCT05590403|589846627|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
163310740|NCT05590403|589846628|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
163310741|NCT05590403|589846629|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
163310742|NCT04717492|589846632|FG000|Overall Study|Withdrawal by Subject|2|||
163310743|NCT04717492|589846633|FG001|Overall Study|Withdrawal by Subject|13|||
163310744|NCT04717492|589846632|FG000|Overall Study|Lost to Follow-up|2|||
163310745|NCT04717492|589846633|FG001|Overall Study|Lost to Follow-up|9|||
163310746|NCT03766009|589846634|FG000|Usual Care|Death|0|||
163310747|NCT03766009|589846635|FG001|Usual Care|Death|0|||
163310748|NCT03766009|589846636|FG002|Usual Care|Death|0|||
163310749|NCT03766009|589846637|FG003|Usual Care|Death|1|||
163310750|NCT03766009|589846638|FG004|Usual Care|Death|0|||
163310751|NCT03766009|589846639|FG005|Usual Care|Death|0|||
163310752|NCT03766009|589846634|FG000|Usual Care|Lost to Follow-up|0|||
163310753|NCT03766009|589846635|FG001|Usual Care|Lost to Follow-up|0|||
163310754|NCT03766009|589846636|FG002|Usual Care|Lost to Follow-up|0|||
163310755|NCT03766009|589846637|FG003|Usual Care|Lost to Follow-up|1|||
163310756|NCT03766009|589846638|FG004|Usual Care|Lost to Follow-up|0|||
163310757|NCT03766009|589846639|FG005|Usual Care|Lost to Follow-up|0|||
163310758|NCT03766009|589846634|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
163310759|NCT03766009|589846635|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
163310760|NCT03766009|589846636|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
163310761|NCT03766009|589846637|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
163203180|NCT03129100|589459666|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203181|NCT03129100|589459667|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203182|NCT03129100|589459668|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203183|NCT03129100|589459669|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203184|NCT03129100|589459670|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
163203185|NCT03129100|589459671|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
163203186|NCT03129100|589459672|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
163203187|NCT03129100|589459673|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203188|NCT03129100|589459674|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203189|NCT03129100|589459675|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203190|NCT03129100|589459676|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203191|NCT03129100|589459677|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203192|NCT03129100|589459678|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203193|NCT03129100|589459679|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203194|NCT03129100|589459680|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203195|NCT03129100|589459681|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203196|NCT03129100|589459682|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203197|NCT03129100|589459683|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203198|NCT03129100|589459684|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203199|NCT03129100|589459685|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203200|NCT03129100|589459686|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203201|NCT03129100|589459687|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203202|NCT03129100|589459688|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203203|NCT03129100|589459689|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203204|NCT03129100|589459690|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163203205|NCT03129100|589459691|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
163310762|NCT03766009|589846638|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
163310763|NCT03766009|589846639|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
163203206|NCT03129100|589459666|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203207|NCT03129100|589459667|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203208|NCT03129100|589459668|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203209|NCT03129100|589459669|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203210|NCT03129100|589459670|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203211|NCT03129100|589459671|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203212|NCT03129100|589459672|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203213|NCT03129100|589459673|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203214|NCT03129100|589459674|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203215|NCT03129100|589459675|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
163203216|NCT03129100|589459676|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203217|NCT03129100|589459677|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203218|NCT03129100|589459678|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203219|NCT03129100|589459679|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203220|NCT03129100|589459680|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203221|NCT03129100|589459681|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203222|NCT03129100|589459682|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203223|NCT03129100|589459683|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203224|NCT03129100|589459684|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203225|NCT03129100|589459685|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203226|NCT03129100|589459686|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203227|NCT03129100|589459687|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203228|NCT03129100|589459688|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203229|NCT03129100|589459689|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203230|NCT03129100|589459690|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203231|NCT03129100|589459691|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
163203232|NCT03129100|589459666|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203233|NCT03129100|589459667|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203234|NCT03129100|589459668|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203235|NCT03129100|589459669|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203236|NCT03129100|589459670|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203237|NCT03129100|589459671|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203238|NCT03129100|589459672|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203239|NCT03129100|589459673|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203240|NCT03129100|589459674|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203241|NCT03129100|589459675|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203242|NCT03129100|589459676|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203243|NCT03129100|589459677|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
163203244|NCT03129100|589459678|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203245|NCT03129100|589459679|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203246|NCT03129100|589459680|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203247|NCT03129100|589459681|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203248|NCT03129100|589459682|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203249|NCT03129100|589459683|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203250|NCT03129100|589459684|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203251|NCT03129100|589459685|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203252|NCT03129100|589459686|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203253|NCT03129100|589459687|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163397419|NCT04376827|590166287|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
162964792|NCT04408924|588571948|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
162964793|NCT04408924|588571948|FG000|Overall Study|Lost to Follow-up|3|||
162964794|NCT04408924|588571948|FG000|Overall Study|Withdrawal by Subject|5|||
162964795|NCT04408924|588571948|FG000|Overall Study|Sponsor Decision|2|||
162964796|NCT00486434|588571949|FG000|Overall Study|Withdrawal by Subject|34|||
162964797|NCT00486434|588571950|FG001|Overall Study|Withdrawal by Subject|39|||
162964798|NCT00486434|588571949|FG000|Overall Study|Adverse Event|118|||
162964799|NCT00486434|588571950|FG001|Overall Study|Adverse Event|44|||
162964800|NCT00486434|588571949|FG000|Overall Study|Protocol Violation|22|||
162964801|NCT00486434|588571950|FG001|Overall Study|Protocol Violation|21|||
162964802|NCT00486434|588571949|FG000|Overall Study|Lack of Efficacy|12|||
162964803|NCT00486434|588571950|FG001|Overall Study|Lack of Efficacy|19|||
163310764|NCT03766009|589846634|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
163310765|NCT03766009|589846635|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
163310766|NCT03766009|589846636|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
163310767|NCT03766009|589846637|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
163310768|NCT03766009|589846638|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
163310769|NCT03766009|589846639|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
162964804|NCT00486434|588571949|FG000|Overall Study|Lost to Follow-up|2|||
162964805|NCT00486434|588571950|FG001|Overall Study|Lost to Follow-up|3|||
162964806|NCT00486434|588571949|FG000|Overall Study|Death|1|||
162964807|NCT00486434|588571950|FG001|Overall Study|Death|2|||
163310770|NCT03766009|589846634|FG000|Usual Care|No treatment or declined surgery|0|||
163310771|NCT03766009|589846635|FG001|Usual Care|No treatment or declined surgery|0|||
163310772|NCT03766009|589846636|FG002|Usual Care|No treatment or declined surgery|0|||
163310773|NCT03766009|589846637|FG003|Usual Care|No treatment or declined surgery|2|||
163310774|NCT03766009|589846638|FG004|Usual Care|No treatment or declined surgery|0|||
163310775|NCT03766009|589846639|FG005|Usual Care|No treatment or declined surgery|0|||
163310776|NCT03766009|589846634|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
163310777|NCT03766009|589846635|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
163310778|NCT03766009|589846636|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
163310779|NCT03766009|589846637|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
163310780|NCT03766009|589846638|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
163310781|NCT03766009|589846639|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
163310782|NCT03766009|589846634|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
163310783|NCT03766009|589846635|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
163310784|NCT03766009|589846636|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
163310785|NCT03766009|589846637|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
163310786|NCT03766009|589846638|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
163310787|NCT03766009|589846639|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
163310788|NCT03766009|589846634|FG000|Usual Care|Ineligible|0|||
163310789|NCT03766009|589846635|FG001|Usual Care|Ineligible|1|||
163310790|NCT03766009|589846636|FG002|Usual Care|Ineligible|0|||
163310791|NCT03766009|589846637|FG003|Usual Care|Ineligible|0|||
163310792|NCT03766009|589846638|FG004|Usual Care|Ineligible|0|||
163310793|NCT03766009|589846639|FG005|Usual Care|Ineligible|0|||
163310794|NCT03766009|589846634|FG000|Usual Care|Other: Staff turnover|0|||
163310795|NCT03766009|589846635|FG001|Usual Care|Other: Staff turnover|0|||
163310796|NCT03766009|589846636|FG002|Usual Care|Other: Staff turnover|0|||
163310797|NCT03766009|589846637|FG003|Usual Care|Other: Staff turnover|0|||
163310798|NCT03766009|589846638|FG004|Usual Care|Other: Staff turnover|0|||
163310799|NCT03766009|589846639|FG005|Usual Care|Other: Staff turnover|2|||
163310800|NCT05071807|589846644|FG000|Overall Study|Withdrawal by Subject|4|||
163310801|NCT05071807|589846645|FG001|Overall Study|Withdrawal by Subject|0|||
163310802|NCT05071807|589846644|FG000|Overall Study|Unrelated medical issues|3|||
163310803|NCT05071807|589846645|FG001|Overall Study|Unrelated medical issues|0|||
163310804|NCT05071807|589846644|FG000|Overall Study|Relocated|0|||
163310805|NCT05071807|589846645|FG001|Overall Study|Relocated|1|||
163310806|NCT04526704|589846650|FG000|Overall Study|Adverse Event|1|||
163310807|NCT04526704|589846651|FG001|Overall Study|Adverse Event|0|||
163310808|NCT04526704|589846650|FG000|Overall Study|Physician Decision|1|||
163310809|NCT04526704|589846651|FG001|Overall Study|Physician Decision|0|||
163310810|NCT04526704|589846650|FG000|Overall Study|Withdrawal by Subject|2|||
163310811|NCT04526704|589846651|FG001|Overall Study|Withdrawal by Subject|0|||
163310812|NCT04924660|589846652|FG000|United States|Death|29|||
163310813|NCT04924660|589846653|FG001|United States|Death|32|||
163310814|NCT04924660|589846654|FG002|United States|Death|34|||
163310815|NCT04924660|589846655|FG003|United States|Death|25|||
163310816|NCT04924660|589846656|FG004|United States|Death|26|||
163310817|NCT04924660|589846657|FG005|United States|Death|23|||
163310818|NCT04924660|589846652|FG000|United States|Lost to Follow-up|15|||
163310819|NCT04924660|589846653|FG001|United States|Lost to Follow-up|10|||
163310820|NCT04924660|589846654|FG002|United States|Lost to Follow-up|13|||
163310821|NCT04924660|589846655|FG003|United States|Lost to Follow-up|5|||
163310822|NCT04924660|589846656|FG004|United States|Lost to Follow-up|19|||
163310823|NCT04924660|589846657|FG005|United States|Lost to Follow-up|20|||
163310824|NCT04924660|589846652|FG000|United States|Withdrawal by Subject|8|||
163310825|NCT04924660|589846653|FG001|United States|Withdrawal by Subject|3|||
163310826|NCT04924660|589846654|FG002|United States|Withdrawal by Subject|3|||
163310827|NCT04924660|589846655|FG003|United States|Withdrawal by Subject|3|||
163310828|NCT04924660|589846656|FG004|United States|Withdrawal by Subject|8|||
163310829|NCT04924660|589846657|FG005|United States|Withdrawal by Subject|4|||
163310830|NCT04924660|589846652|FG000|Spain|Death|0|||
163310831|NCT04924660|589846653|FG001|Spain|Death|0|||
163310832|NCT04924660|589846654|FG002|Spain|Death|0|||
163310833|NCT04924660|589846655|FG003|Spain|Death|0|||
163310834|NCT04924660|589846656|FG004|Spain|Death|0|||
163310835|NCT04924660|589846657|FG005|Spain|Death|2|||
163310836|NCT04924660|589846652|FG000|Spain|Lost to Follow-up|0|||
163310837|NCT04924660|589846653|FG001|Spain|Lost to Follow-up|0|||
163310838|NCT04924660|589846654|FG002|Spain|Lost to Follow-up|0|||
163310839|NCT04924660|589846655|FG003|Spain|Lost to Follow-up|0|||
163310840|NCT04924660|589846656|FG004|Spain|Lost to Follow-up|1|||
163310841|NCT04924660|589846657|FG005|Spain|Lost to Follow-up|0|||
163310842|NCT04924660|589846652|FG000|Brazil|Death|0|||
163310843|NCT04924660|589846653|FG001|Brazil|Death|0|||
163310844|NCT04924660|589846654|FG002|Brazil|Death|0|||
163310845|NCT04924660|589846655|FG003|Brazil|Death|0|||
163310846|NCT04924660|589846656|FG004|Brazil|Death|1|||
163310847|NCT04924660|589846657|FG005|Brazil|Death|0|||
163310848|NCT04924660|589846652|FG000|Italy|Lost to Follow-up|0|||
163310849|NCT04924660|589846653|FG001|Italy|Lost to Follow-up|0|||
163310850|NCT04924660|589846654|FG002|Italy|Lost to Follow-up|0|||
163310851|NCT04924660|589846655|FG003|Italy|Lost to Follow-up|0|||
163310852|NCT04924660|589846656|FG004|Italy|Lost to Follow-up|0|||
163310853|NCT04924660|589846657|FG005|Italy|Lost to Follow-up|1|||
163310854|NCT04924660|589846652|FG000|South Africa|Death|0|||
163310855|NCT04924660|589846653|FG001|South Africa|Death|0|||
163310856|NCT04924660|589846654|FG002|South Africa|Death|0|||
163310857|NCT04924660|589846655|FG003|South Africa|Death|0|||
163310858|NCT04924660|589846656|FG004|South Africa|Death|0|||
163310859|NCT04924660|589846657|FG005|South Africa|Death|1|||
163310860|NCT04924660|589846652|FG000|South Africa|Lost to Follow-up|0|||
163310861|NCT04924660|589846653|FG001|South Africa|Lost to Follow-up|0|||
163310862|NCT04924660|589846654|FG002|South Africa|Lost to Follow-up|0|||
163310863|NCT04924660|589846655|FG003|South Africa|Lost to Follow-up|0|||
163310864|NCT04924660|589846656|FG004|South Africa|Lost to Follow-up|0|||
163310865|NCT04924660|589846657|FG005|South Africa|Lost to Follow-up|1|||
163310866|NCT02105766|589846658|FG000|Overall Study|Physician Decision|1|||
163310867|NCT02105766|589846659|FG001|Overall Study|Physician Decision|1|||
163310868|NCT02105766|589846660|FG002|Overall Study|Physician Decision|0|||
163310869|NCT02105766|589846658|FG000|Overall Study|Lost to Follow-up|2|||
163310870|NCT02105766|589846659|FG001|Overall Study|Lost to Follow-up|0|||
163310871|NCT02105766|589846660|FG002|Overall Study|Lost to Follow-up|0|||
163310872|NCT02105766|589846658|FG000|Overall Study|Death|1|||
163310873|NCT02105766|589846659|FG001|Overall Study|Death|1|||
163310874|NCT02105766|589846660|FG002|Overall Study|Death|0|||
163310875|NCT03557697|589846661|FG000|Overall Study|Withdrawal by Subject|2|||
163310876|NCT03557697|589846662|FG001|Overall Study|Withdrawal by Subject|4|||
163310877|NCT05409183|589846665|FG000|Complete Study|Adverse Event|1|||
163310878|NCT05409183|589846666|FG001|Complete Study|Adverse Event|2|||
163310879|NCT05409183|589846665|FG000|Complete Study|Withdrawal by Subject|3|||
163310880|NCT05409183|589846666|FG001|Complete Study|Withdrawal by Subject|0|||
163310881|NCT02274662|589846667|FG000|Overall Study|Death|1|||
163310882|NCT02274662|589846667|FG000|Overall Study|Lost to Follow-up|3|||
163310883|NCT02936752|589846668|FG000|Overall Study|Death|2|||
163310884|NCT02936752|589846669|FG001|Overall Study|Death|1|||
163310885|NCT02936752|589846668|FG000|Overall Study|Physician Decision|4|||
163310886|NCT02936752|589846669|FG001|Overall Study|Physician Decision|0|||
163310887|NCT02936752|589846668|FG000|Overall Study|Withdrawal by Subject|0|||
163310888|NCT02936752|589846669|FG001|Overall Study|Withdrawal by Subject|2|||
163310889|NCT04495894|589846675|FG000|Overall Study|Withdrawal by Subject|2|||
163310890|NCT04495894|589846676|FG001|Overall Study|Withdrawal by Subject|0|||
163310891|NCT04495894|589846677|FG002|Overall Study|Withdrawal by Subject|2|||
163310892|NCT04495894|589846678|FG003|Overall Study|Withdrawal by Subject|3|||
163310893|NCT04495894|589846675|FG000|Overall Study|Early termination|0|||
163310894|NCT04495894|589846676|FG001|Overall Study|Early termination|0|||
163310895|NCT04495894|589846677|FG002|Overall Study|Early termination|3|||
163310896|NCT04495894|589846678|FG003|Overall Study|Early termination|0|||
163310897|NCT01000961|589846679|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
163310898|NCT01000961|589846680|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
163310899|NCT01000961|589846679|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
163310900|NCT01000961|589846680|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
163310901|NCT05184192|589846683|FG000|Overall Study|Lost to Follow-up|4|||
163310902|NCT05184192|589846684|FG001|Overall Study|Lost to Follow-up|7|||
163310903|NCT05184192|589846683|FG000|Overall Study|Adverse Event|1|||
163310904|NCT05184192|589846684|FG001|Overall Study|Adverse Event|4|||
163310905|NCT05184192|589846683|FG000|Overall Study|PI withdrawal|1|||
163310906|NCT05184192|589846684|FG001|Overall Study|PI withdrawal|2|||
163310907|NCT05184192|589846683|FG000|Overall Study|Withdrew due to adverse effect|1|||
163310908|NCT05184192|589846684|FG001|Overall Study|Withdrew due to adverse effect|0|||
163310909|NCT05184192|589846683|FG000|Overall Study|Medication schedule|1|||
163310910|NCT05184192|589846684|FG001|Overall Study|Medication schedule|0|||
163310911|NCT05184192|589846683|FG000|Overall Study|Concern for adverse effects|0|||
163310912|NCT05184192|589846684|FG001|Overall Study|Concern for adverse effects|4|||
163310913|NCT04810650|589846688|FG000|Overall Study|Disenrolled in error|0|||
163310914|NCT04810650|589846689|FG001|Overall Study|Disenrolled in error|0|||
163310915|NCT04810650|589846690|FG002|Overall Study|Disenrolled in error|0|||
163310916|NCT04810650|589846691|FG003|Overall Study|Disenrolled in error|0|||
163310917|NCT04810650|589846692|FG004|Overall Study|Disenrolled in error|0|||
163310918|NCT04810650|589846693|FG005|Overall Study|Disenrolled in error|0|||
163310919|NCT04810650|589846694|FG006|Overall Study|Disenrolled in error|0|||
163310920|NCT04810650|589846695|FG007|Overall Study|Disenrolled in error|0|||
163310921|NCT04810650|589846696|FG008|Overall Study|Disenrolled in error|1|||
163310922|NCT04810650|589846697|FG009|Overall Study|Disenrolled in error|0|||
163310923|NCT04810650|589846698|FG010|Overall Study|Disenrolled in error|0|||
163310924|NCT04810650|589846699|FG011|Overall Study|Disenrolled in error|0|||
163310925|NCT04810650|589846700|FG012|Overall Study|Disenrolled in error|0|||
163310926|NCT04810650|589846701|FG013|Overall Study|Disenrolled in error|0|||
163310927|NCT04810650|589846688|FG000|Overall Study|Death|0|||
163310928|NCT04810650|589846689|FG001|Overall Study|Death|0|||
163310929|NCT04810650|589846690|FG002|Overall Study|Death|0|||
163310930|NCT04810650|589846691|FG003|Overall Study|Death|0|||
163310931|NCT04810650|589846692|FG004|Overall Study|Death|0|||
163310932|NCT04810650|589846693|FG005|Overall Study|Death|0|||
163310933|NCT04810650|589846694|FG006|Overall Study|Death|2|||
163310934|NCT04810650|589846695|FG007|Overall Study|Death|2|||
163310935|NCT04810650|589846696|FG008|Overall Study|Death|0|||
163310936|NCT04810650|589846697|FG009|Overall Study|Death|1|||
163310937|NCT04810650|589846698|FG010|Overall Study|Death|0|||
163310938|NCT04810650|589846699|FG011|Overall Study|Death|0|||
163310939|NCT04810650|589846700|FG012|Overall Study|Death|2|||
163310940|NCT04810650|589846701|FG013|Overall Study|Death|1|||
163310941|NCT04810650|589846688|FG000|Overall Study|Moved/transferred care|0|||
163310942|NCT04810650|589846689|FG001|Overall Study|Moved/transferred care|0|||
163310943|NCT04810650|589846690|FG002|Overall Study|Moved/transferred care|0|||
163310944|NCT04810650|589846691|FG003|Overall Study|Moved/transferred care|0|||
163310945|NCT04810650|589846692|FG004|Overall Study|Moved/transferred care|0|||
163310946|NCT04810650|589846693|FG005|Overall Study|Moved/transferred care|0|||
163310947|NCT04810650|589846694|FG006|Overall Study|Moved/transferred care|0|||
163310948|NCT04810650|589846695|FG007|Overall Study|Moved/transferred care|1|||
163310949|NCT04810650|589846696|FG008|Overall Study|Moved/transferred care|12|||
163310950|NCT04810650|589846697|FG009|Overall Study|Moved/transferred care|10|||
163310951|NCT04810650|589846698|FG010|Overall Study|Moved/transferred care|0|||
163310952|NCT04810650|589846699|FG011|Overall Study|Moved/transferred care|0|||
163310953|NCT04810650|589846700|FG012|Overall Study|Moved/transferred care|0|||
163310954|NCT04810650|589846701|FG013|Overall Study|Moved/transferred care|0|||
163310955|NCT04810650|589846688|FG000|Overall Study|Lost to Follow-up|15|||
163310956|NCT04810650|589846689|FG001|Overall Study|Lost to Follow-up|12|||
163310957|NCT04810650|589846690|FG002|Overall Study|Lost to Follow-up|7|||
163310958|NCT04810650|589846691|FG003|Overall Study|Lost to Follow-up|9|||
163310959|NCT04810650|589846692|FG004|Overall Study|Lost to Follow-up|10|||
163310960|NCT04810650|589846693|FG005|Overall Study|Lost to Follow-up|6|||
163310961|NCT04810650|589846694|FG006|Overall Study|Lost to Follow-up|0|||
163310962|NCT04810650|589846695|FG007|Overall Study|Lost to Follow-up|0|||
163310963|NCT04810650|589846696|FG008|Overall Study|Lost to Follow-up|0|||
163310964|NCT04810650|589846697|FG009|Overall Study|Lost to Follow-up|0|||
163310965|NCT04810650|589846698|FG010|Overall Study|Lost to Follow-up|1|||
163310966|NCT04810650|589846699|FG011|Overall Study|Lost to Follow-up|0|||
163310967|NCT04810650|589846700|FG012|Overall Study|Lost to Follow-up|3|||
163310968|NCT04810650|589846701|FG013|Overall Study|Lost to Follow-up|9|||
163310969|NCT04810650|589846688|FG000|Overall Study|Participant declined|0|||
163310970|NCT04810650|589846689|FG001|Overall Study|Participant declined|0|||
163310971|NCT04810650|589846690|FG002|Overall Study|Participant declined|0|||
163310972|NCT04810650|589846691|FG003|Overall Study|Participant declined|0|||
163310973|NCT04810650|589846692|FG004|Overall Study|Participant declined|0|||
163310974|NCT04810650|589846693|FG005|Overall Study|Participant declined|0|||
163310975|NCT04810650|589846694|FG006|Overall Study|Participant declined|0|||
163310976|NCT04810650|589846695|FG007|Overall Study|Participant declined|0|||
163310977|NCT04810650|589846696|FG008|Overall Study|Participant declined|0|||
163310978|NCT04810650|589846697|FG009|Overall Study|Participant declined|0|||
163310979|NCT04810650|589846698|FG010|Overall Study|Participant declined|2|||
163310980|NCT04810650|589846699|FG011|Overall Study|Participant declined|0|||
163310981|NCT04810650|589846700|FG012|Overall Study|Participant declined|0|||
163310982|NCT04810650|589846701|FG013|Overall Study|Participant declined|0|||
163310983|NCT05089734|589846702|FG000|Overall Study|Still on study|122|||
163310984|NCT05089734|589846703|FG001|Overall Study|Still on study|101|||
163310985|NCT05089734|589846702|FG000|Overall Study|Death|161|||
163310986|NCT05089734|589846703|FG001|Overall Study|Death|179|||
163310987|NCT05089734|589846702|FG000|Overall Study|Withdrew consent|11|||
163310988|NCT05089734|589846703|FG001|Overall Study|Withdrew consent|24|||
163310989|NCT05089734|589846702|FG000|Overall Study|Lost to Follow-up|5|||
163310990|NCT05089734|589846703|FG001|Overall Study|Lost to Follow-up|0|||
163310991|NCT06283173|589848265|FG000|Overall Study|Did not show for first visit|10|||
163310992|NCT06283173|589848265|FG000|Overall Study|Lost to Follow-up|12|||
163310993|NCT06283173|589848265|FG000|Overall Study|Physician Decision|7|||
163310994|NCT03457142|589848268|FG000|Overall Study|Death|1|||
163310995|NCT04060654|589848269|FG000|Overall Study|Withdrawal by Subject|1|||
163310996|NCT04060654|589848269|FG000|Overall Study|Lost to Follow-up|5|||
163310997|NCT03707951|589848270|FG000|Overall Study|Lost to Follow-up|8|||
163310998|NCT03707951|589848271|FG001|Overall Study|Lost to Follow-up|17|||
163310999|NCT03707951|589848270|FG000|Overall Study|Withdrawal by Subject|6|||
163311000|NCT03707951|589848271|FG001|Overall Study|Withdrawal by Subject|6|||
163311001|NCT04887129|589848272|FG000|Overall Study|Lost to Follow-up|0|||
163311002|NCT04887129|589848273|FG001|Overall Study|Lost to Follow-up|24|||
163311003|NCT04887129|589848272|FG000|Overall Study|Withdrawal by Subject|9|||
163311004|NCT04887129|589848273|FG001|Overall Study|Withdrawal by Subject|57|||
163311005|NCT04887129|589848272|FG000|Overall Study|Other|2|||
163311006|NCT04887129|589848273|FG001|Overall Study|Other|9|||
163311007|NCT04533347|589848275|FG000|Overall Study|Adverse Event|1|||
163311008|NCT04533347|589848276|FG001|Overall Study|Adverse Event|2|||
163311009|NCT04533347|589848275|FG000|Overall Study|Lost to Follow-up|2|||
163311010|NCT04533347|589848276|FG001|Overall Study|Lost to Follow-up|0|||
163311011|NCT04533347|589848275|FG000|Overall Study|Withdrawal by Subject|1|||
163311012|NCT04533347|589848276|FG001|Overall Study|Withdrawal by Subject|0|||
163311013|NCT05520190|589848277|FG000|Overall Study|Lost to Follow-up|7|||
163311014|NCT05520190|589848277|FG000|Overall Study|Withdrawal by Subject|2|||
163311015|NCT04896476|589848283|FG000|Overall Study|Withdrawal by Subject|1|||
163311016|NCT04896476|589848283|FG000|Overall Study|Lost to Follow-up|2|||
163311017|NCT03476187|589848284|FG000|Overall Study|Protocol Violation|7|||
163311018|NCT03476187|589848284|FG000|Overall Study|Physician Decision|5|||
163311019|NCT04977947|589848285|FG000|Overall Study|Lost to Follow-up|1|||
163311020|NCT04977947|589848286|FG001|Overall Study|Lost to Follow-up|1|||
163311021|NCT02921230|589848287|FG000|Overall Study|Withdrawal by Subject|20|||
163311022|NCT02921230|589848288|FG001|Overall Study|Withdrawal by Subject|8|||
163311023|NCT02921230|589848287|FG000|Overall Study|Death|12|||
163311024|NCT02921230|589848288|FG001|Overall Study|Death|3|||
163311025|NCT02921230|589848287|FG000|Overall Study|Protocol Violation|17|||
163311026|NCT02921230|589848288|FG001|Overall Study|Protocol Violation|6|||
163311027|NCT02921230|589848287|FG000|Overall Study|Early completion|5|||
163311028|NCT02921230|589848288|FG001|Overall Study|Early completion|1|||
163311029|NCT02921230|589848287|FG000|Overall Study|Pending data entry|1|||
163311030|NCT02921230|589848288|FG001|Overall Study|Pending data entry|0|||
163311031|NCT03445988|589848289|FG000|Overall Study|Lost to Follow-up|14|||
163311032|NCT03445988|589848290|FG001|Overall Study|Lost to Follow-up|26|||
163311033|NCT03445988|589848291|FG002|Overall Study|Lost to Follow-up|27|||
163311034|NCT03445988|589848292|FG003|Overall Study|Lost to Follow-up|66|||
163311035|NCT03445988|589848289|FG000|Overall Study|Withdrawal by Subject|7|||
163311036|NCT03445988|589848290|FG001|Overall Study|Withdrawal by Subject|4|||
163311037|NCT03445988|589848291|FG002|Overall Study|Withdrawal by Subject|3|||
163311038|NCT03445988|589848292|FG003|Overall Study|Withdrawal by Subject|5|||
163311039|NCT03445988|589848289|FG000|Overall Study|Death (unrelated to study)|5|||
163311040|NCT03445988|589848290|FG001|Overall Study|Death (unrelated to study)|1|||
163311041|NCT03445988|589848291|FG002|Overall Study|Death (unrelated to study)|2|||
163311042|NCT03445988|589848292|FG003|Overall Study|Death (unrelated to study)|4|||
163311043|NCT05875142|589848293|FG000|Overall Study|Lost to Follow-up|0|||
163311044|NCT05875142|589848294|FG001|Overall Study|Lost to Follow-up|1|||
163311045|NCT05875142|589848295|FG002|Overall Study|Lost to Follow-up|1|||
163311046|NCT04274764|589848296|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
163311047|NCT04274764|589848297|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
163311048|NCT05268393|589848302|FG000|Overall Study|Withdrawal by Subject|2|||
163311049|NCT05268393|589848303|FG001|Overall Study|Withdrawal by Subject|1|||
163311050|NCT03396926|589848304|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
163311051|NCT03396926|589848305|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
163311052|NCT01396278|589848307|FG000|Overall Study|Adverse Event|0|||
163311053|NCT01396278|589848308|FG001|Overall Study|Adverse Event|0|||
163311054|NCT01396278|589848309|FG002|Overall Study|Adverse Event|0|||
163311055|NCT01396278|589848310|FG003|Overall Study|Adverse Event|2|||
163311056|NCT01396278|589848311|FG004|Overall Study|Adverse Event|0|||
163311057|NCT01396278|589848307|FG000|Overall Study|Withdraw due to trial termination|2|||
163311058|NCT01396278|589848308|FG001|Overall Study|Withdraw due to trial termination|1|||
163311059|NCT01396278|589848309|FG002|Overall Study|Withdraw due to trial termination|1|||
163311060|NCT01396278|589848310|FG003|Overall Study|Withdraw due to trial termination|0|||
163311061|NCT01396278|589848311|FG004|Overall Study|Withdraw due to trial termination|2|||
163311062|NCT00450658|589848312|FG000|Overall Study|Adverse Event|24|||
163311063|NCT00450658|589848313|FG001|Overall Study|Adverse Event|15|||
163311064|NCT00450658|589848312|FG000|Overall Study|Withdrawal by Subject|43|||
163311065|NCT00450658|589848313|FG001|Overall Study|Withdrawal by Subject|26|||
163311066|NCT00450658|589848312|FG000|Overall Study|Lost to Follow-up|22|||
163311067|NCT00450658|589848313|FG001|Overall Study|Lost to Follow-up|5|||
163311068|NCT00450658|589848312|FG000|Overall Study|UGI ulcer|33|||
163311069|NCT00450658|589848313|FG001|Overall Study|UGI ulcer|34|||
163311070|NCT00450658|589848312|FG000|Overall Study|misc|21|||
163311071|NCT00450658|589848313|FG001|Overall Study|misc|10|||
163311072|NCT04727554|589848315|FG000|Overall Study|Lost to Follow-up|0|||
163311073|NCT04727554|589848316|FG001|Overall Study|Lost to Follow-up|1|||
163311074|NCT04727554|589848315|FG000|Overall Study|Death|2|||
163311075|NCT04727554|589848316|FG001|Overall Study|Death|6|||
163311076|NCT04727554|589848315|FG000|Overall Study|Withdrawal by Subject|1|||
163311077|NCT04727554|589848316|FG001|Overall Study|Withdrawal by Subject|0|||
163311078|NCT05763823|589848317|FG000|Overall Study|Death|6|||
163311079|NCT05763823|589848317|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163311080|NCT05763823|589848317|FG000|Overall Study|Withdrawal by Subject|6|||
163311081|NCT03891667|589848322|FG000|Overall Study|Physician Decision|1|||
163311082|NCT03891667|589848323|FG001|Overall Study|Physician Decision|1|||
163311083|NCT03891667|589848322|FG000|Overall Study|COVID related pause|1|||
163311084|NCT03891667|589848323|FG001|Overall Study|COVID related pause|0|||
163311085|NCT03891667|589848322|FG000|Overall Study|Withdrawal by Subject|0|||
163311086|NCT03891667|589848323|FG001|Overall Study|Withdrawal by Subject|1|||
163311087|NCT03891667|589848322|FG000|Overall Study|Adverse Event|0|||
163311088|NCT03891667|589848323|FG001|Overall Study|Adverse Event|1|||
163311089|NCT05659537|589848324|FG000|Overall Study|Adverse Event|5|||
163311090|NCT05659537|589848324|FG000|Overall Study|Lost to Follow-up|4|||
163311091|NCT05659537|589848324|FG000|Overall Study|Withdrawal by Subject|13|||
163311092|NCT05659537|589848324|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
163311093|NCT05659537|589848324|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
163311094|NCT05659537|589848324|FG000|Overall Study|Participant was suffering from anaemia|1|||
163311095|NCT04971395|589848325|FG000|Overall Study|Withdrawal by Subject|0|||
163311096|NCT04971395|589848326|FG001|Overall Study|Withdrawal by Subject|1|||
163311097|NCT04971395|589848327|FG002|Overall Study|Withdrawal by Subject|0|||
163311098|NCT04456517|589848328|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
163311099|NCT04456517|589848329|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
163311100|NCT02100813|589848332|FG000|Overall Study|Adverse Event|0|||
163311101|NCT02100813|589848333|FG001|Overall Study|Adverse Event|0|||
163311102|NCT02100813|589848334|FG002|Overall Study|Adverse Event|0|||
163311103|NCT02100813|589848335|FG003|Overall Study|Adverse Event|0|||
163311104|NCT02100813|589848336|FG004|Overall Study|Adverse Event|0|||
163311105|NCT02100813|589848337|FG005|Overall Study|Adverse Event|0|||
163311106|NCT02100813|589848338|FG006|Overall Study|Adverse Event|0|||
163311107|NCT02100813|589848339|FG007|Overall Study|Adverse Event|1|||
163311108|NCT03575897|589848341|FG000|Overall Study|Lost to Follow-up|12|||
163311109|NCT03575897|589848342|FG001|Overall Study|Lost to Follow-up|13|||
163311110|NCT03150810|589848345|FG000|Overall Study|Death|4|||
163311111|NCT03150810|589848346|FG001|Overall Study|Death|8|||
163311112|NCT03150810|589848347|FG002|Overall Study|Death|7|||
163311113|NCT03150810|589848348|FG003|Overall Study|Death|2|||
163311114|NCT03150810|589848349|FG004|Overall Study|Death|2|||
163311115|NCT03150810|589848350|FG005|Overall Study|Death|10|||
163311116|NCT03150810|589848351|FG006|Overall Study|Death|8|||
163311117|NCT03150810|589848352|FG007|Overall Study|Death|6|||
163311118|NCT03150810|589848353|FG008|Overall Study|Death|18|||
163311119|NCT03150810|589848354|FG009|Overall Study|Death|3|||
163311120|NCT03150810|589848355|FG010|Overall Study|Death|19|||
163311121|NCT03150810|589848356|FG011|Overall Study|Death|1|||
163311122|NCT03150810|589848357|FG012|Overall Study|Death|19|||
163311123|NCT03150810|589848345|FG000|Overall Study|Withdrawal by Subject|0|||
163311124|NCT03150810|589848346|FG001|Overall Study|Withdrawal by Subject|1|||
163311125|NCT03150810|589848347|FG002|Overall Study|Withdrawal by Subject|1|||
163311126|NCT03150810|589848348|FG003|Overall Study|Withdrawal by Subject|1|||
163311127|NCT03150810|589848349|FG004|Overall Study|Withdrawal by Subject|0|||
163311128|NCT03150810|589848350|FG005|Overall Study|Withdrawal by Subject|0|||
163311129|NCT03150810|589848351|FG006|Overall Study|Withdrawal by Subject|2|||
163311130|NCT03150810|589848352|FG007|Overall Study|Withdrawal by Subject|0|||
163311131|NCT03150810|589848353|FG008|Overall Study|Withdrawal by Subject|2|||
163311132|NCT03150810|589848354|FG009|Overall Study|Withdrawal by Subject|0|||
163311133|NCT03150810|589848355|FG010|Overall Study|Withdrawal by Subject|1|||
163311134|NCT03150810|589848356|FG011|Overall Study|Withdrawal by Subject|0|||
163311135|NCT03150810|589848357|FG012|Overall Study|Withdrawal by Subject|1|||
163311136|NCT03150810|589848345|FG000|Overall Study|Sponsor Decision|0|||
163311137|NCT03150810|589848346|FG001|Overall Study|Sponsor Decision|2|||
163311138|NCT03150810|589848347|FG002|Overall Study|Sponsor Decision|0|||
163311139|NCT03150810|589848348|FG003|Overall Study|Sponsor Decision|0|||
163311140|NCT03150810|589848349|FG004|Overall Study|Sponsor Decision|1|||
163311141|NCT03150810|589848350|FG005|Overall Study|Sponsor Decision|1|||
163311142|NCT03150810|589848351|FG006|Overall Study|Sponsor Decision|0|||
163311143|NCT03150810|589848352|FG007|Overall Study|Sponsor Decision|0|||
163311144|NCT03150810|589848353|FG008|Overall Study|Sponsor Decision|1|||
163311145|NCT03150810|589848354|FG009|Overall Study|Sponsor Decision|0|||
163311146|NCT03150810|589848355|FG010|Overall Study|Sponsor Decision|0|||
163311147|NCT03150810|589848356|FG011|Overall Study|Sponsor Decision|0|||
163311148|NCT03150810|589848357|FG012|Overall Study|Sponsor Decision|5|||
163311149|NCT03150810|589848345|FG000|Overall Study|Lost to Follow-up|0|||
163311150|NCT03150810|589848346|FG001|Overall Study|Lost to Follow-up|1|||
163311151|NCT03150810|589848347|FG002|Overall Study|Lost to Follow-up|1|||
163311152|NCT03150810|589848348|FG003|Overall Study|Lost to Follow-up|0|||
163311153|NCT03150810|589848349|FG004|Overall Study|Lost to Follow-up|0|||
163311154|NCT03150810|589848350|FG005|Overall Study|Lost to Follow-up|0|||
163311155|NCT03150810|589848351|FG006|Overall Study|Lost to Follow-up|1|||
163311156|NCT03150810|589848352|FG007|Overall Study|Lost to Follow-up|0|||
163311157|NCT03150810|589848353|FG008|Overall Study|Lost to Follow-up|0|||
163311158|NCT03150810|589848354|FG009|Overall Study|Lost to Follow-up|0|||
163311159|NCT03150810|589848355|FG010|Overall Study|Lost to Follow-up|1|||
163311160|NCT03150810|589848356|FG011|Overall Study|Lost to Follow-up|0|||
163311161|NCT03150810|589848357|FG012|Overall Study|Lost to Follow-up|0|||
163311162|NCT03150810|589848345|FG000|Overall Study|Physician Decision|0|||
163311163|NCT03150810|589848346|FG001|Overall Study|Physician Decision|0|||
163311164|NCT03150810|589848347|FG002|Overall Study|Physician Decision|0|||
162964808|NCT00486434|588571949|FG000|Overall Study|Personal reasons|5|||
162964809|NCT00486434|588571950|FG001|Overall Study|Personal reasons|6|||
162964810|NCT02218541|588571951|FG000|Overall Study|Lost to Follow-up|2|||
162964811|NCT02218541|588571952|FG001|Overall Study|Lost to Follow-up|1|||
162964812|NCT02218541|588571951|FG000|Overall Study|Implant Failure|4|||
162964813|NCT02218541|588571952|FG001|Overall Study|Implant Failure|1|||
162964814|NCT00856349|588571953|FG000|Overall Study|Death|418|||
162964815|NCT00856349|588571953|FG000|Overall Study|Withdrawal by Subject|116|||
162964816|NCT00856349|588571953|FG000|Overall Study|Lost to Follow-up|91|||
162964817|NCT00856349|588571953|FG000|Overall Study|Protocol Violation|38|||
162964818|NCT00856349|588571953|FG000|Overall Study|Physician Decision|13|||
163203254|NCT03129100|589459688|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203255|NCT03129100|589459689|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203256|NCT03129100|589459690|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203257|NCT03129100|589459691|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
163203258|NCT03129100|589459666|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203259|NCT03129100|589459667|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203260|NCT03129100|589459668|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203261|NCT03129100|589459669|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203262|NCT03129100|589459670|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203263|NCT03129100|589459671|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203264|NCT03129100|589459672|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203265|NCT03129100|589459673|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203266|NCT03129100|589459674|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203267|NCT03129100|589459675|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203268|NCT03129100|589459676|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203269|NCT03129100|589459677|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
163203270|NCT03129100|589459678|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
163311165|NCT03150810|589848348|FG003|Overall Study|Physician Decision|0|||
163311166|NCT03150810|589848349|FG004|Overall Study|Physician Decision|0|||
163311167|NCT03150810|589848350|FG005|Overall Study|Physician Decision|1|||
163311168|NCT03150810|589848351|FG006|Overall Study|Physician Decision|1|||
163311169|NCT03150810|589848352|FG007|Overall Study|Physician Decision|0|||
163311170|NCT03150810|589848353|FG008|Overall Study|Physician Decision|0|||
163311171|NCT03150810|589848354|FG009|Overall Study|Physician Decision|0|||
162964819|NCT00856349|588571953|FG000|Overall Study|Subject relocation|104|||
162964820|NCT00856349|588571953|FG000|Overall Study|Device explant|33|||
162964821|NCT00856349|588571953|FG000|Overall Study|Site closure|78|||
163051855|NCT02974868|588898737|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
163051856|NCT02974868|588898734|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
163051857|NCT02974868|588898735|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
163051858|NCT02974868|588898736|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
163051859|NCT02974868|588898737|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
163051860|NCT00749398|588898738|FG000|Overall Study|Lack of Efficacy|7|||
163051861|NCT00749398|588898738|FG000|Overall Study|Adverse Event|4|||
163051862|NCT00749398|588898738|FG000|Overall Study|Serious adverse event|11|||
163051863|NCT00749398|588898738|FG000|Overall Study|Withdrawal by Subject|17|||
163051864|NCT00749398|588898738|FG000|Overall Study|Lost to Follow-up|11|||
163051865|NCT00749398|588898738|FG000|Overall Study|Reason not specified|2|||
163051866|NCT00749398|588898738|FG000|Overall Study|Unknown reason|1|||
163051867|NCT01663402|588898739|FG000|Overall Study|Randomized but not treated|19|||
163051868|NCT01663402|588898740|FG001|Overall Study|Randomized but not treated|11|||
163051869|NCT01663402|588898739|FG000|Overall Study|Adverse Event|347|||
163051870|NCT01663402|588898740|FG001|Overall Study|Adverse Event|362|||
163051871|NCT01663402|588898739|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
163051872|NCT01663402|588898740|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
163051873|NCT01663402|588898739|FG000|Overall Study|Poor compliance to protocol|529|||
163311172|NCT03150810|589848355|FG010|Overall Study|Physician Decision|0|||
163311173|NCT03150810|589848356|FG011|Overall Study|Physician Decision|0|||
163311174|NCT03150810|589848357|FG012|Overall Study|Physician Decision|0|||
163311175|NCT03150810|589848345|FG000|Overall Study|Site withdrawal from study|0|||
163311176|NCT03150810|589848346|FG001|Overall Study|Site withdrawal from study|1|||
163311177|NCT03150810|589848347|FG002|Overall Study|Site withdrawal from study|0|||
163311178|NCT03150810|589848348|FG003|Overall Study|Site withdrawal from study|0|||
163311179|NCT03150810|589848349|FG004|Overall Study|Site withdrawal from study|0|||
163311180|NCT03150810|589848350|FG005|Overall Study|Site withdrawal from study|0|||
163311181|NCT03150810|589848351|FG006|Overall Study|Site withdrawal from study|0|||
163311182|NCT03150810|589848352|FG007|Overall Study|Site withdrawal from study|0|||
163311183|NCT03150810|589848353|FG008|Overall Study|Site withdrawal from study|0|||
163311184|NCT03150810|589848354|FG009|Overall Study|Site withdrawal from study|1|||
163311185|NCT03150810|589848355|FG010|Overall Study|Site withdrawal from study|1|||
163311186|NCT03150810|589848356|FG011|Overall Study|Site withdrawal from study|0|||
163311187|NCT03150810|589848357|FG012|Overall Study|Site withdrawal from study|0|||
163311188|NCT03150810|589848345|FG000|Overall Study|Hospice|0|||
163311189|NCT03150810|589848346|FG001|Overall Study|Hospice|0|||
163311190|NCT03150810|589848347|FG002|Overall Study|Hospice|0|||
163311191|NCT03150810|589848348|FG003|Overall Study|Hospice|0|||
163311192|NCT03150810|589848349|FG004|Overall Study|Hospice|0|||
163311193|NCT03150810|589848350|FG005|Overall Study|Hospice|1|||
163311194|NCT03150810|589848351|FG006|Overall Study|Hospice|0|||
163311195|NCT03150810|589848352|FG007|Overall Study|Hospice|0|||
163311196|NCT03150810|589848353|FG008|Overall Study|Hospice|0|||
163311197|NCT03150810|589848354|FG009|Overall Study|Hospice|0|||
163311198|NCT03150810|589848355|FG010|Overall Study|Hospice|0|||
163311199|NCT03150810|589848356|FG011|Overall Study|Hospice|0|||
163311200|NCT03150810|589848357|FG012|Overall Study|Hospice|0|||
163311201|NCT03150810|589848345|FG000|Overall Study|Participant relocated abroad.|0|||
163311202|NCT03150810|589848346|FG001|Overall Study|Participant relocated abroad.|0|||
163311203|NCT03150810|589848347|FG002|Overall Study|Participant relocated abroad.|0|||
163311204|NCT03150810|589848348|FG003|Overall Study|Participant relocated abroad.|0|||
163311205|NCT03150810|589848349|FG004|Overall Study|Participant relocated abroad.|0|||
163311206|NCT03150810|589848350|FG005|Overall Study|Participant relocated abroad.|1|||
163203271|NCT03129100|589459679|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
163203272|NCT03129100|589459680|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
163203273|NCT03129100|589459681|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203274|NCT03129100|589459682|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203275|NCT03129100|589459683|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203276|NCT03129100|589459684|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203277|NCT03129100|589459685|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203278|NCT03129100|589459686|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203279|NCT03129100|589459687|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203280|NCT03129100|589459688|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203281|NCT03129100|589459689|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203282|NCT03129100|589459690|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203283|NCT03129100|589459691|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
163203284|NCT03129100|589459666|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203285|NCT03129100|589459667|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203286|NCT03129100|589459668|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203287|NCT03129100|589459669|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203288|NCT03129100|589459670|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203289|NCT03129100|589459671|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203290|NCT03129100|589459672|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203291|NCT03129100|589459673|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203292|NCT03129100|589459674|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203293|NCT03129100|589459675|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203294|NCT03129100|589459676|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203295|NCT03129100|589459677|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
163203296|NCT03129100|589459678|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203297|NCT03129100|589459679|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
163203298|NCT03129100|589459680|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
163203299|NCT03129100|589459681|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203300|NCT03129100|589459682|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203301|NCT03129100|589459683|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203302|NCT03129100|589459684|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203303|NCT03129100|589459685|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203304|NCT03129100|589459686|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203305|NCT03129100|589459687|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203306|NCT03129100|589459688|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203307|NCT03129100|589459689|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203308|NCT03129100|589459690|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163203309|NCT03129100|589459691|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
163311207|NCT03150810|589848351|FG006|Overall Study|Participant relocated abroad.|0|||
163311208|NCT03150810|589848352|FG007|Overall Study|Participant relocated abroad.|0|||
163311209|NCT03150810|589848353|FG008|Overall Study|Participant relocated abroad.|0|||
163311210|NCT03150810|589848354|FG009|Overall Study|Participant relocated abroad.|0|||
163203310|NCT03129100|589459666|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203311|NCT03129100|589459667|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203312|NCT03129100|589459668|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203313|NCT03129100|589459669|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203314|NCT03129100|589459670|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203315|NCT03129100|589459671|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203316|NCT03129100|589459672|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203317|NCT03129100|589459673|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203318|NCT03129100|589459674|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203319|NCT03129100|589459675|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203320|NCT03129100|589459676|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203321|NCT03129100|589459677|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203322|NCT03129100|589459678|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203323|NCT03129100|589459679|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203324|NCT03129100|589459680|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203325|NCT03129100|589459681|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
163203326|NCT03129100|589459682|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203327|NCT03129100|589459683|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203328|NCT03129100|589459684|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203329|NCT03129100|589459685|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203330|NCT03129100|589459686|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203331|NCT03129100|589459687|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203332|NCT03129100|589459688|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203333|NCT03129100|589459689|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203334|NCT03129100|589459690|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203335|NCT03129100|589459691|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
163203336|NCT03129100|589459666|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203337|NCT03129100|589459667|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203338|NCT03129100|589459668|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203339|NCT03129100|589459669|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203340|NCT03129100|589459670|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203341|NCT03129100|589459671|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203342|NCT03129100|589459672|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203343|NCT03129100|589459673|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203344|NCT03129100|589459674|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203345|NCT03129100|589459675|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203346|NCT03129100|589459676|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203347|NCT03129100|589459677|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203348|NCT03129100|589459678|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
163203349|NCT03129100|589459679|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203350|NCT03129100|589459680|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
163203351|NCT03129100|589459681|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
163203352|NCT03129100|589459682|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203353|NCT03129100|589459683|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203354|NCT03129100|589459684|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203355|NCT03129100|589459685|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203356|NCT03129100|589459686|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203357|NCT03129100|589459687|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203358|NCT03129100|589459688|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163397420|NCT04376827|590166288|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
163397421|NCT04376827|590166287|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
163397422|NCT04376827|590166288|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
163051874|NCT01663402|588898740|FG001|Overall Study|Poor compliance to protocol|454|||
163203359|NCT03129100|589459689|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203360|NCT03129100|589459690|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203361|NCT03129100|589459691|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
163203362|NCT03129100|589459666|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203363|NCT03129100|589459667|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203364|NCT03129100|589459668|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203365|NCT03129100|589459669|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203366|NCT03129100|589459670|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203367|NCT03129100|589459671|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203368|NCT03129100|589459672|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203369|NCT03129100|589459673|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203370|NCT03129100|589459674|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203371|NCT03129100|589459675|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203372|NCT03129100|589459676|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203373|NCT03129100|589459677|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203374|NCT03129100|589459678|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203375|NCT03129100|589459679|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203376|NCT03129100|589459680|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203377|NCT03129100|589459681|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203378|NCT03129100|589459682|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203379|NCT03129100|589459683|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
163203380|NCT03129100|589459684|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203381|NCT03129100|589459685|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
163203382|NCT03129100|589459686|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203383|NCT03129100|589459687|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203384|NCT03129100|589459688|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203385|NCT03129100|589459689|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203386|NCT03129100|589459690|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203387|NCT03129100|589459691|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
163203388|NCT03129100|589459666|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203389|NCT03129100|589459667|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203390|NCT03129100|589459668|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203391|NCT03129100|589459669|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203392|NCT03129100|589459670|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203393|NCT03129100|589459671|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203394|NCT03129100|589459672|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203395|NCT03129100|589459673|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203396|NCT03129100|589459674|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203397|NCT03129100|589459675|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203398|NCT03129100|589459676|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203399|NCT03129100|589459677|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203400|NCT03129100|589459678|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203401|NCT03129100|589459679|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203402|NCT03129100|589459680|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203403|NCT03129100|589459681|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203404|NCT03129100|589459682|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203405|NCT03129100|589459683|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203406|NCT03129100|589459684|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203407|NCT03129100|589459685|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203408|NCT03129100|589459686|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
163203409|NCT03129100|589459687|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203410|NCT03129100|589459688|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203411|NCT03129100|589459689|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203412|NCT03129100|589459690|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203413|NCT03129100|589459691|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
163203414|NCT03129100|589459666|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
163203415|NCT03129100|589459667|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
163203416|NCT03129100|589459668|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
163203417|NCT03129100|589459669|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
163203418|NCT03129100|589459670|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
163203419|NCT03129100|589459671|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
163203420|NCT03129100|589459672|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
163203421|NCT03129100|589459673|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
163203422|NCT03129100|589459674|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
163203423|NCT03129100|589459675|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
163203424|NCT03129100|589459676|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
163203425|NCT03129100|589459677|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
163203426|NCT03129100|589459678|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
163203427|NCT03129100|589459679|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
163203428|NCT03129100|589459680|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
163203429|NCT03129100|589459681|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
163203430|NCT03129100|589459682|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
163203431|NCT03129100|589459683|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
163203432|NCT03129100|589459684|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
163203433|NCT03129100|589459685|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
163203434|NCT03129100|589459686|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
163203435|NCT03129100|589459687|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
163203436|NCT03129100|589459688|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
163203437|NCT03129100|589459689|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
163203438|NCT03129100|589459690|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
163203439|NCT03129100|589459691|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
163203440|NCT03129100|589459666|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203441|NCT03129100|589459667|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203442|NCT03129100|589459668|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203443|NCT03129100|589459669|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203444|NCT03129100|589459670|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203445|NCT03129100|589459671|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203446|NCT03129100|589459672|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203447|NCT03129100|589459673|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203448|NCT03129100|589459674|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203449|NCT03129100|589459675|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203450|NCT03129100|589459676|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203451|NCT03129100|589459677|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203452|NCT03129100|589459678|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203453|NCT03129100|589459679|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203454|NCT03129100|589459680|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203455|NCT03129100|589459681|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203456|NCT03129100|589459682|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203457|NCT03129100|589459683|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203458|NCT03129100|589459684|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203459|NCT03129100|589459685|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163051875|NCT01663402|588898739|FG000|Overall Study|Physician Decision|77|||
162964822|NCT00856349|588571953|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
162964823|NCT02998541|588571957|FG000|Overall Study|Adverse Event|4|||
162964824|NCT02998541|588571958|FG001|Overall Study|Adverse Event|5|||
162964825|NCT02998541|588571959|FG002|Overall Study|Adverse Event|1|||
163203460|NCT03129100|589459686|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
163203461|NCT03129100|589459687|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203462|NCT03129100|589459688|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203463|NCT03129100|589459689|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203464|NCT03129100|589459690|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203465|NCT03129100|589459691|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
163203466|NCT03129100|589459666|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
163203467|NCT03129100|589459667|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
163203468|NCT03129100|589459668|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
163203469|NCT03129100|589459669|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
163203470|NCT03129100|589459670|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
163203471|NCT03129100|589459671|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
163203472|NCT03129100|589459672|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
163203473|NCT03129100|589459673|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
163203474|NCT03129100|589459674|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
163203475|NCT03129100|589459675|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
163203476|NCT03129100|589459676|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
163203477|NCT03129100|589459677|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
163203478|NCT03129100|589459678|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
163203479|NCT03129100|589459679|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
163203480|NCT03129100|589459680|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
162964826|NCT02998541|588571957|FG000|Overall Study|Protocol Violation|1|||
162964827|NCT02998541|588571958|FG001|Overall Study|Protocol Violation|0|||
162964828|NCT02998541|588571959|FG002|Overall Study|Protocol Violation|0|||
162964829|NCT02998541|588571957|FG000|Overall Study|Withdrawal by Subject|3|||
162964830|NCT02998541|588571958|FG001|Overall Study|Withdrawal by Subject|1|||
162964831|NCT02998541|588571959|FG002|Overall Study|Withdrawal by Subject|0|||
162964832|NCT02998541|588571957|FG000|Overall Study|Lost to Follow-up|0|||
162964833|NCT02998541|588571958|FG001|Overall Study|Lost to Follow-up|3|||
162964834|NCT02998541|588571959|FG002|Overall Study|Lost to Follow-up|1|||
162964835|NCT02998541|588571957|FG000|Overall Study|Physician Decision|0|||
162964836|NCT02998541|588571958|FG001|Overall Study|Physician Decision|0|||
162964837|NCT02998541|588571959|FG002|Overall Study|Physician Decision|3|||
162964838|NCT02998541|588571957|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163051876|NCT01663402|588898740|FG001|Overall Study|Physician Decision|62|||
163203481|NCT03129100|589459681|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
163203482|NCT03129100|589459682|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
163203483|NCT03129100|589459683|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
162964839|NCT02998541|588571958|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162964840|NCT02998541|588571959|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
162964841|NCT03540160|588571960|FG000|Overall Study|Protocol Violation|1|||
162964842|NCT03540160|588571960|FG000|Overall Study|Physician Decision|8|||
162964843|NCT03540160|588571960|FG000|Overall Study|Lack of Efficacy|60|||
162964844|NCT03540160|588571960|FG000|Overall Study|Pregnancy|1|||
163311211|NCT03150810|589848355|FG010|Overall Study|Participant relocated abroad.|0|||
163311212|NCT03150810|589848356|FG011|Overall Study|Participant relocated abroad.|0|||
163311213|NCT03150810|589848357|FG012|Overall Study|Participant relocated abroad.|0|||
163311214|NCT03150810|589848345|FG000|Overall Study|Transferred care to oncologist|0|||
163311215|NCT03150810|589848346|FG001|Overall Study|Transferred care to oncologist|0|||
163311216|NCT03150810|589848347|FG002|Overall Study|Transferred care to oncologist|0|||
163311217|NCT03150810|589848348|FG003|Overall Study|Transferred care to oncologist|0|||
163311218|NCT03150810|589848349|FG004|Overall Study|Transferred care to oncologist|0|||
163311219|NCT03150810|589848350|FG005|Overall Study|Transferred care to oncologist|0|||
163311220|NCT03150810|589848351|FG006|Overall Study|Transferred care to oncologist|2|||
163311221|NCT03150810|589848352|FG007|Overall Study|Transferred care to oncologist|0|||
163311222|NCT03150810|589848353|FG008|Overall Study|Transferred care to oncologist|0|||
163311223|NCT03150810|589848354|FG009|Overall Study|Transferred care to oncologist|0|||
163397423|NCT04376827|590166287|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
163311224|NCT03150810|589848355|FG010|Overall Study|Transferred care to oncologist|0|||
163311225|NCT03150810|589848356|FG011|Overall Study|Transferred care to oncologist|0|||
163311226|NCT03150810|589848357|FG012|Overall Study|Transferred care to oncologist|0|||
163311227|NCT02737436|589848361|FG000|Washout Period|Lost to Follow-up|5|||
162964845|NCT03540160|588571960|FG000|Overall Study|Adverse Event|20|||
162964846|NCT03540160|588571960|FG000|Overall Study|Withdrawal by Subject|68|||
162964847|NCT03540160|588571960|FG000|Overall Study|COVID-19|2|||
162964848|NCT03540160|588571960|FG000|Overall Study|Study Closure|10|||
162964849|NCT03540160|588571960|FG000|Overall Study|Lost to Follow-up|18|||
162964850|NCT03540160|588571960|FG000|Overall Study|Sponsor decision|191|||
162964851|NCT01944722|588571961|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
162964852|NCT01944722|588571961|FG000|Overall Study|Specimen Shipping Issues|34|||
162964853|NCT01944722|588571961|FG000|Overall Study|Improper Storage/Transport|5|||
162964854|NCT01944722|588571961|FG000|Overall Study|Insufficient Volume for Test|1|||
162964855|NCT01944722|588571961|FG000|Overall Study|Missing Specimens|3|||
162964856|NCT01944722|588571961|FG000|Overall Study|Specimens Mislabeled|2|||
162964857|NCT01944722|588571961|FG000|Overall Study|Withdrawal by Subject|8|||
162964858|NCT01944722|588571961|FG000|Overall Study|NILM Subjects <30 years old|8106|||
162964859|NCT01944722|588571961|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
162964860|NCT01944722|588571961|FG000|Overall Study|>ASCUS Cytology|1122|||
162964861|NCT01923740|588571962|FG000|Overall Study|Lost to Follow-up|4|||
162964862|NCT01923740|588571963|FG001|Overall Study|Lost to Follow-up|9|||
162964863|NCT01923740|588571962|FG000|Overall Study|Withdrawal by Subject|2|||
162964864|NCT01923740|588571963|FG001|Overall Study|Withdrawal by Subject|0|||
162964865|NCT03345420|588571965|FG000|Overall Study|Withdrawal by Subject|1|||
162964866|NCT02933060|588571997|FG000|Overall Study|Withdrawal by Subject|0|||
162964867|NCT02933060|588571998|FG001|Overall Study|Withdrawal by Subject|1|||
162964868|NCT01945580|588571999|FG000|Overall Study|Withdrawal by Subject|13|||
162964869|NCT01945580|588572000|FG001|Overall Study|Withdrawal by Subject|35|||
162964870|NCT01945580|588571999|FG000|Overall Study|Physician Decision|3|||
162964871|NCT01945580|588572000|FG001|Overall Study|Physician Decision|2|||
162964872|NCT01945580|588571999|FG000|Overall Study|Lost to Follow-up|26|||
162964873|NCT01945580|588572000|FG001|Overall Study|Lost to Follow-up|39|||
162964874|NCT01945580|588571999|FG000|Overall Study|Death|7|||
162964875|NCT01945580|588572000|FG001|Overall Study|Death|2|||
162964876|NCT01945580|588571999|FG000|Overall Study|Patient moved out of state|0|||
162964877|NCT01945580|588572000|FG001|Overall Study|Patient moved out of state|1|||
162964878|NCT01945580|588571999|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
162964879|NCT01945580|588572000|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
162964880|NCT01945580|588571999|FG000|Overall Study|Family illness - unable to return|0|||
162964881|NCT01945580|588572000|FG001|Overall Study|Family illness - unable to return|1|||
162964882|NCT01945580|588571999|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
162964883|NCT01945580|588572000|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
162964884|NCT01945580|588571999|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
162964885|NCT01945580|588572000|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
162964886|NCT01945580|588571999|FG000|Overall Study|Noncompliance with 36 month visit|1|||
162964887|NCT01945580|588572000|FG001|Overall Study|Noncompliance with 36 month visit|0|||
162964888|NCT01945580|588571999|FG000|Overall Study|The patient moved.|1|||
162964889|NCT01945580|588572000|FG001|Overall Study|The patient moved.|0|||
162964890|NCT01945580|588571999|FG000|Overall Study|No data available|0|||
162964891|NCT01945580|588572000|FG001|Overall Study|No data available|2|||
162964892|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
162964893|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
162964894|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
162964895|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
162964896|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
162964897|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
163203484|NCT03129100|589459684|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
163203485|NCT03129100|589459685|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
163203486|NCT03129100|589459686|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
163203487|NCT03129100|589459687|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
163203488|NCT03129100|589459688|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
162964898|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
162964899|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
162964900|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
162964901|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
162964902|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
162964903|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
162964904|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
162964905|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
162964906|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
162964907|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
162964908|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
162964909|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
163311228|NCT02737436|589848362|FG001|Washout Period|Lost to Follow-up|11|||
163311229|NCT02737436|589848361|FG000|Data Analysis|Scanning data problems|5|||
163311230|NCT02737436|589848362|FG001|Data Analysis|Scanning data problems|8|||
163311231|NCT03936322|589848363|FG000|Overall Study|Lost to Follow-up|1|||
163311232|NCT03936322|589848363|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
163311233|NCT01160211|589848364|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
163311234|NCT01160211|589848365|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
163311235|NCT01160211|589848366|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
163311236|NCT01160211|589848364|FG000|Overall Study|Lost to Follow-up|4|||
163311237|NCT01160211|589848365|FG001|Overall Study|Lost to Follow-up|8|||
163311238|NCT01160211|589848366|FG002|Overall Study|Lost to Follow-up|4|||
163311239|NCT01160211|589848364|FG000|Overall Study|Physician Decision|1|||
163311240|NCT01160211|589848365|FG001|Overall Study|Physician Decision|0|||
163311241|NCT01160211|589848366|FG002|Overall Study|Physician Decision|0|||
163311242|NCT01160211|589848364|FG000|Overall Study|Withdrawal by Subject|4|||
163311243|NCT01160211|589848365|FG001|Overall Study|Withdrawal by Subject|2|||
163311244|NCT01160211|589848366|FG002|Overall Study|Withdrawal by Subject|2|||
163311245|NCT01160211|589848364|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
163311246|NCT01160211|589848365|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
163311247|NCT01160211|589848366|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
163311248|NCT05551637|589848367|FG000|Overall Study|Lack of Efficacy|0|||
163311249|NCT05551637|589848368|FG001|Overall Study|Lack of Efficacy|6|||
163311250|NCT05551637|589848367|FG000|Overall Study|Lost to Follow-up|1|||
163311251|NCT05551637|589848368|FG001|Overall Study|Lost to Follow-up|1|||
163311252|NCT02734290|589848371|FG000|Overall Study|Adverse Event|1|||
163311253|NCT02734290|589848372|FG001|Overall Study|Adverse Event|0|||
163311254|NCT02734290|589848371|FG000|Overall Study|Death|1|||
163311255|NCT02734290|589848372|FG001|Overall Study|Death|0|||
163311256|NCT03829410|589848374|FG000|Overall Study|Adverse Event|1|||
163311257|NCT03829410|589848375|FG001|Overall Study|Adverse Event|0|||
163311258|NCT03829410|589848376|FG002|Overall Study|Adverse Event|1|||
163311259|NCT03829410|589848377|FG003|Overall Study|Adverse Event|4|||
163311260|NCT03829410|589848374|FG000|Overall Study|Physician Decision|0|||
163311261|NCT03829410|589848375|FG001|Overall Study|Physician Decision|0|||
163311262|NCT03829410|589848376|FG002|Overall Study|Physician Decision|0|||
163311263|NCT03829410|589848377|FG003|Overall Study|Physician Decision|2|||
163311264|NCT03829410|589848374|FG000|Overall Study|Disease Progressing|3|||
163311265|NCT03829410|589848375|FG001|Overall Study|Disease Progressing|4|||
163311266|NCT03829410|589848376|FG002|Overall Study|Disease Progressing|2|||
163311267|NCT03829410|589848377|FG003|Overall Study|Disease Progressing|31|||
163311268|NCT03829410|589848374|FG000|Overall Study|Miscellaneous|2|||
163311269|NCT03829410|589848375|FG001|Overall Study|Miscellaneous|4|||
163311270|NCT03829410|589848376|FG002|Overall Study|Miscellaneous|3|||
163397424|NCT04376827|590166288|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
163311271|NCT03829410|589848377|FG003|Overall Study|Miscellaneous|10|||
163311272|NCT03158129|589848378|FG000|Overall Study|Adverse Event|0|||
163311273|NCT03158129|589848379|FG001|Overall Study|Adverse Event|1|||
163311274|NCT03158129|589848380|FG002|Overall Study|Adverse Event|0|||
163311275|NCT03158129|589848381|FG003|Overall Study|Adverse Event|0|||
163397425|NCT01490450|590167710|FG000|Period 1|Lack of Efficacy|2|||
163203489|NCT03129100|589459689|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
163203490|NCT03129100|589459690|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
163203491|NCT03129100|589459691|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
163203492|NCT03129100|589459666|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203493|NCT03129100|589459667|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203494|NCT03129100|589459668|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203495|NCT03129100|589459669|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203496|NCT03129100|589459670|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203497|NCT03129100|589459671|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203498|NCT03129100|589459672|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203499|NCT03129100|589459673|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203500|NCT03129100|589459674|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203501|NCT03129100|589459675|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203502|NCT03129100|589459676|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203503|NCT03129100|589459677|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203504|NCT03129100|589459678|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203505|NCT03129100|589459679|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203506|NCT03129100|589459680|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203507|NCT03129100|589459681|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203508|NCT03129100|589459682|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203509|NCT03129100|589459683|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203510|NCT03129100|589459684|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203511|NCT03129100|589459685|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203512|NCT03129100|589459686|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203513|NCT03129100|589459687|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203514|NCT03129100|589459688|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203515|NCT03129100|589459689|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
163203516|NCT03129100|589459690|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
163203517|NCT03129100|589459691|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
163203518|NCT03129100|589459666|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203519|NCT03129100|589459667|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203520|NCT03129100|589459668|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203521|NCT03129100|589459669|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203522|NCT03129100|589459670|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203523|NCT03129100|589459671|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163311276|NCT03158129|589848378|FG000|Overall Study|Death|0|||
163311277|NCT03158129|589848379|FG001|Overall Study|Death|0|||
163311278|NCT03158129|589848380|FG002|Overall Study|Death|0|||
163311279|NCT03158129|589848381|FG003|Overall Study|Death|1|||
163311280|NCT03158129|589848378|FG000|Overall Study|High surgical risk|1|||
163311281|NCT03158129|589848379|FG001|Overall Study|High surgical risk|1|||
163311282|NCT03158129|589848380|FG002|Overall Study|High surgical risk|0|||
163311283|NCT03158129|589848381|FG003|Overall Study|High surgical risk|0|||
163311284|NCT03158129|589848378|FG000|Overall Study|Progression|1|||
163311285|NCT03158129|589848379|FG001|Overall Study|Progression|1|||
163311286|NCT03158129|589848380|FG002|Overall Study|Progression|0|||
163311287|NCT03158129|589848381|FG003|Overall Study|Progression|0|||
163311288|NCT03158129|589848378|FG000|Overall Study|Lack of resectability|0|||
163311289|NCT03158129|589848379|FG001|Overall Study|Lack of resectability|1|||
163311290|NCT03158129|589848380|FG002|Overall Study|Lack of resectability|0|||
163311291|NCT03158129|589848381|FG003|Overall Study|Lack of resectability|0|||
163311292|NCT03158129|589848378|FG000|Overall Study|Declined surgery|0|||
163311293|NCT03158129|589848379|FG001|Overall Study|Declined surgery|1|||
163311294|NCT03158129|589848380|FG002|Overall Study|Declined surgery|0|||
163311295|NCT03158129|589848381|FG003|Overall Study|Declined surgery|0|||
163311296|NCT03158129|589848378|FG000|Overall Study|No longer surgical candidate|0|||
163311297|NCT03158129|589848379|FG001|Overall Study|No longer surgical candidate|0|||
163311298|NCT03158129|589848380|FG002|Overall Study|No longer surgical candidate|0|||
163311299|NCT03158129|589848381|FG003|Overall Study|No longer surgical candidate|1|||
163311300|NCT05051124|589848382|FG000|Overall Study|Lost to Follow-up|2|||
163311301|NCT05051124|589848382|FG000|Overall Study|Withdrawal by Subject|1|||
163311302|NCT05051124|589848382|FG000|Overall Study|Residential relocation|2|||
163311303|NCT05051124|589848382|FG000|Overall Study|Death|1|||
163311304|NCT04782973|589848383|FG000|Overall Study|Withdrawal by Subject|5|||
163311305|NCT04782973|589848383|FG000|Overall Study|Protocol Violation|6|||
163311306|NCT04782973|589848383|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
163311307|NCT04676022|589848384|FG000|Overall Study|Screen Failure/|1|||
163311308|NCT04676022|589848385|FG001|Overall Study|Screen Failure/|1|||
163311309|NCT04676022|589848386|FG002|Overall Study|Screen Failure/|85|||
163311310|NCT04676022|589848384|FG000|Overall Study|Lost to Follow-up|1|||
163311311|NCT04676022|589848385|FG001|Overall Study|Lost to Follow-up|1|||
163311312|NCT04676022|589848386|FG002|Overall Study|Lost to Follow-up|0|||
163311313|NCT04676022|589848384|FG000|Overall Study|Adverse Event|2|||
163311314|NCT04676022|589848385|FG001|Overall Study|Adverse Event|0|||
163311315|NCT04676022|589848386|FG002|Overall Study|Adverse Event|1|||
163311316|NCT04676022|589848384|FG000|Overall Study|Physician Decision|2|||
163311317|NCT04676022|589848385|FG001|Overall Study|Physician Decision|0|||
163311318|NCT04676022|589848386|FG002|Overall Study|Physician Decision|1|||
163311319|NCT04676022|589848384|FG000|Overall Study|Withdrawal by Subject|3|||
163311320|NCT04676022|589848385|FG001|Overall Study|Withdrawal by Subject|1|||
163311321|NCT04676022|589848386|FG002|Overall Study|Withdrawal by Subject|6|||
163311322|NCT04676022|589848384|FG000|Overall Study|Will not move forward with permanent implant|6|||
163311323|NCT04676022|589848385|FG001|Overall Study|Will not move forward with permanent implant|0|||
163311324|NCT04676022|589848386|FG002|Overall Study|Will not move forward with permanent implant|0|||
163311325|NCT04676022|589848384|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
163311326|NCT04676022|589848385|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
163311327|NCT04676022|589848386|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
163311328|NCT05894577|589848398|FG000|Overall Study|No receipt of study drug|14|||
162964910|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
162964911|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
163311329|NCT05894577|589848399|FG001|Overall Study|No receipt of study drug|13|||
163311330|NCT05894577|589848398|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
163311331|NCT05894577|589848399|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
163311332|NCT05894577|589848398|FG000|Overall Study|Screen Fail|2|||
162979002|NCT03545191|588623546|FG000|Overall Study|Withdrawal by Subject|13|||
163311333|NCT05894577|589848399|FG001|Overall Study|Screen Fail|0|||
163311334|NCT05894577|589848398|FG000|Overall Study|Study drug recall|86|||
163311335|NCT05894577|589848399|FG001|Overall Study|Study drug recall|63|||
163311336|NCT04064164|589848409|FG000|Overall Study|Withdrawal by Subject|8|||
163311337|NCT04064164|589848410|FG001|Overall Study|Withdrawal by Subject|8|||
163311338|NCT05746455|589848416|FG000|Overall Study|Discharged from Clinical Service|1|||
163311339|NCT05746455|589848416|FG000|Overall Study|Lost to Follow-up|1|||
163311340|NCT02023866|589848417|FG000|Overall Study|Non-compliance|2|||
163311341|NCT02023866|589848417|FG000|Overall Study|Adverse Event|3|||
163311342|NCT02023866|589848417|FG000|Overall Study|Withdrawal by Subject|1|||
163311343|NCT03307343|589848418|FG000|Overall Study|Withdrawal by Subject|1|||
163311344|NCT03307343|589848419|FG001|Overall Study|Withdrawal by Subject|2|||
163311345|NCT03307343|589848418|FG000|Overall Study|Pregnancy|0|||
163311346|NCT03307343|589848419|FG001|Overall Study|Pregnancy|2|||
163311347|NCT03307343|589848418|FG000|Overall Study|Physician Decision|1|||
163311348|NCT03307343|589848419|FG001|Overall Study|Physician Decision|0|||
163311349|NCT03307343|589848418|FG000|Overall Study|Lost to Follow-up|0|||
163311350|NCT03307343|589848419|FG001|Overall Study|Lost to Follow-up|2|||
163311351|NCT05609760|589848435|FG000|Overall Study|Lost to Follow-up|0|||
163311352|NCT05609760|589848436|FG001|Overall Study|Lost to Follow-up|1|||
163311353|NCT05609760|589848435|FG000|Overall Study|Withdrawal by Subject|1|||
163311354|NCT05609760|589848436|FG001|Overall Study|Withdrawal by Subject|0|||
163311355|NCT05179395|589848437|FG000|Overall Study|Lack of Efficacy|1|||
163311356|NCT04318548|589850283|FG000|Overall Study|Adverse Event|0|||
163311357|NCT04318548|589850284|FG001|Overall Study|Adverse Event|0|||
163311358|NCT04318548|589850285|FG002|Overall Study|Adverse Event|1|||
163311359|NCT04318548|589850283|FG000|Overall Study|Lost to Follow-up|6|||
163311360|NCT04318548|589850284|FG001|Overall Study|Lost to Follow-up|13|||
163311361|NCT04318548|589850285|FG002|Overall Study|Lost to Follow-up|9|||
163311362|NCT04318548|589850283|FG000|Overall Study|Protocol Violation|1|||
163311363|NCT04318548|589850284|FG001|Overall Study|Protocol Violation|0|||
163311364|NCT04318548|589850285|FG002|Overall Study|Protocol Violation|2|||
163311365|NCT04318548|589850283|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
163311366|NCT04318548|589850284|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
162964912|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
162964913|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
162964914|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
162964915|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
163311367|NCT04318548|589850285|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
163311368|NCT04318548|589850283|FG000|Overall Study|Migrated / moved from the study area|0|||
163311369|NCT04318548|589850284|FG001|Overall Study|Migrated / moved from the study area|0|||
163311370|NCT04318548|589850285|FG002|Overall Study|Migrated / moved from the study area|1|||
163311371|NCT04318548|589850283|FG000|Overall Study|Other|1|||
163311372|NCT04318548|589850284|FG001|Overall Study|Other|2|||
163311373|NCT04318548|589850285|FG002|Overall Study|Other|3|||
163311374|NCT03366649|589850288|FG000|Overall Study|Failed preoperative screening|4|||
162964916|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
162964917|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
162964918|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
162964919|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
163203524|NCT03129100|589459672|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203525|NCT03129100|589459673|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203526|NCT03129100|589459674|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203527|NCT03129100|589459675|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203528|NCT03129100|589459676|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203529|NCT03129100|589459677|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203530|NCT03129100|589459678|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203531|NCT03129100|589459679|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203532|NCT03129100|589459680|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203533|NCT03129100|589459681|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203534|NCT03129100|589459682|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203535|NCT03129100|589459683|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203536|NCT03129100|589459684|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203537|NCT03129100|589459685|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203538|NCT03129100|589459686|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203539|NCT03129100|589459687|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203540|NCT03129100|589459688|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
163203541|NCT03129100|589459689|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
163203542|NCT03129100|589459690|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
163203543|NCT03129100|589459691|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
163203544|NCT03129100|589459666|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203545|NCT03129100|589459667|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203546|NCT03129100|589459668|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203547|NCT03129100|589459669|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203548|NCT03129100|589459670|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203549|NCT03129100|589459671|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203550|NCT03129100|589459672|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203551|NCT03129100|589459673|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203552|NCT03129100|589459674|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203553|NCT03129100|589459675|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203554|NCT03129100|589459676|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203555|NCT03129100|589459677|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203556|NCT03129100|589459678|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203557|NCT03129100|589459679|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203558|NCT03129100|589459680|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203559|NCT03129100|589459681|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203560|NCT03129100|589459682|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203561|NCT03129100|589459683|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203562|NCT03129100|589459684|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203563|NCT03129100|589459685|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203564|NCT03129100|589459686|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203565|NCT03129100|589459687|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203566|NCT03129100|589459688|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203567|NCT03129100|589459689|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203568|NCT03129100|589459690|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
163203569|NCT03129100|589459691|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163203570|NCT03129100|589459666|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203571|NCT03129100|589459667|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203572|NCT03129100|589459668|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203573|NCT03129100|589459669|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203574|NCT03129100|589459670|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203575|NCT03129100|589459671|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203576|NCT03129100|589459672|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203577|NCT03129100|589459673|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203578|NCT03129100|589459674|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203579|NCT03129100|589459675|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203580|NCT03129100|589459676|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203581|NCT03129100|589459677|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203582|NCT03129100|589459678|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203583|NCT03129100|589459679|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203584|NCT03129100|589459680|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203585|NCT03129100|589459681|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203586|NCT03129100|589459682|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203587|NCT03129100|589459683|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203588|NCT03129100|589459684|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203589|NCT03129100|589459685|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203590|NCT03129100|589459686|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203591|NCT03129100|589459687|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203592|NCT03129100|589459688|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203593|NCT03129100|589459689|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203594|NCT03129100|589459690|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163203595|NCT03129100|589459691|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
163203596|NCT03129100|589459666|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
163203597|NCT03129100|589459667|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
163203598|NCT03129100|589459668|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
163203599|NCT03129100|589459669|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
163203600|NCT03129100|589459670|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
163203601|NCT03129100|589459671|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
163203602|NCT03129100|589459672|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
163203603|NCT03129100|589459673|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
163203604|NCT03129100|589459674|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
162964920|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
162964921|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
162964922|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
162964923|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
162964924|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
162964925|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
162964926|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
163203605|NCT03129100|589459675|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
162964927|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
162964928|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
163203606|NCT03129100|589459676|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
163203607|NCT03129100|589459677|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
163203608|NCT03129100|589459678|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
163203609|NCT03129100|589459679|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
163203610|NCT03129100|589459680|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
163203611|NCT03129100|589459681|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
163203612|NCT03129100|589459682|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
163203613|NCT03129100|589459683|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
163203614|NCT03129100|589459684|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
163203615|NCT03129100|589459685|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
163203616|NCT03129100|589459686|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
163203617|NCT03129100|589459687|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
163203618|NCT03129100|589459688|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
163203619|NCT03129100|589459689|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
163203620|NCT03129100|589459690|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
163203621|NCT03129100|589459691|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
163203622|NCT03708328|589459694|FG000|Overall Study|Death|3|||
163203623|NCT03708328|589459695|FG001|Overall Study|Death|3|||
163203624|NCT03708328|589459696|FG002|Overall Study|Death|4|||
163203625|NCT03708328|589459697|FG003|Overall Study|Death|2|||
163203626|NCT03708328|589459698|FG004|Overall Study|Death|2|||
163203627|NCT03708328|589459699|FG005|Overall Study|Death|13|||
163203628|NCT03708328|589459700|FG006|Overall Study|Death|26|||
163203629|NCT03708328|589459701|FG007|Overall Study|Death|18|||
163203630|NCT03708328|589459702|FG008|Overall Study|Death|13|||
163203631|NCT03708328|589459703|FG009|Overall Study|Death|8|||
163203632|NCT03708328|589459694|FG000|Overall Study|Lost to Follow-up|0|||
163203633|NCT03708328|589459695|FG001|Overall Study|Lost to Follow-up|1|||
163203634|NCT03708328|589459696|FG002|Overall Study|Lost to Follow-up|0|||
163203635|NCT03708328|589459697|FG003|Overall Study|Lost to Follow-up|1|||
163203636|NCT03708328|589459698|FG004|Overall Study|Lost to Follow-up|0|||
163203637|NCT03708328|589459699|FG005|Overall Study|Lost to Follow-up|3|||
163203638|NCT03708328|589459700|FG006|Overall Study|Lost to Follow-up|3|||
163203639|NCT03708328|589459701|FG007|Overall Study|Lost to Follow-up|0|||
163203640|NCT03708328|589459702|FG008|Overall Study|Lost to Follow-up|0|||
163203641|NCT03708328|589459703|FG009|Overall Study|Lost to Follow-up|1|||
163203642|NCT03708328|589459694|FG000|Overall Study|Physician Decision|0|||
163203643|NCT03708328|589459695|FG001|Overall Study|Physician Decision|0|||
163203644|NCT03708328|589459696|FG002|Overall Study|Physician Decision|0|||
163203645|NCT03708328|589459697|FG003|Overall Study|Physician Decision|0|||
163203646|NCT03708328|589459698|FG004|Overall Study|Physician Decision|0|||
163203647|NCT03708328|589459699|FG005|Overall Study|Physician Decision|1|||
163203648|NCT03708328|589459700|FG006|Overall Study|Physician Decision|0|||
163203649|NCT03708328|589459701|FG007|Overall Study|Physician Decision|0|||
163203650|NCT03708328|589459702|FG008|Overall Study|Physician Decision|0|||
163203651|NCT03708328|589459703|FG009|Overall Study|Physician Decision|0|||
163203652|NCT03708328|589459694|FG000|Overall Study|Withdrawal by Subject|0|||
163203653|NCT03708328|589459695|FG001|Overall Study|Withdrawal by Subject|0|||
163203654|NCT03708328|589459696|FG002|Overall Study|Withdrawal by Subject|0|||
163203655|NCT03708328|589459697|FG003|Overall Study|Withdrawal by Subject|0|||
163203656|NCT03708328|589459698|FG004|Overall Study|Withdrawal by Subject|1|||
163203657|NCT03708328|589459699|FG005|Overall Study|Withdrawal by Subject|0|||
163203658|NCT03708328|589459700|FG006|Overall Study|Withdrawal by Subject|2|||
163203659|NCT03708328|589459701|FG007|Overall Study|Withdrawal by Subject|4|||
163203660|NCT03708328|589459702|FG008|Overall Study|Withdrawal by Subject|1|||
163397426|NCT01490450|590167711|FG001|Period 1|Lack of Efficacy|0|||
163397427|NCT01490450|590167712|FG002|Period 1|Lack of Efficacy|3|||
162964929|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
162964930|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
162964931|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
162964932|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
162964933|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
163397428|NCT01490450|590167713|FG003|Period 1|Lack of Efficacy|0|||
163203661|NCT03708328|589459703|FG009|Overall Study|Withdrawal by Subject|5|||
163203662|NCT03708328|589459694|FG000|Overall Study|Study Closed Locally|0|||
163203663|NCT03708328|589459695|FG001|Overall Study|Study Closed Locally|0|||
163203664|NCT03708328|589459696|FG002|Overall Study|Study Closed Locally|0|||
163203665|NCT03708328|589459697|FG003|Overall Study|Study Closed Locally|0|||
163203666|NCT03708328|589459698|FG004|Overall Study|Study Closed Locally|0|||
163203667|NCT03708328|589459699|FG005|Overall Study|Study Closed Locally|0|||
163203668|NCT03708328|589459700|FG006|Overall Study|Study Closed Locally|0|||
163203669|NCT03708328|589459701|FG007|Overall Study|Study Closed Locally|1|||
163203670|NCT03708328|589459702|FG008|Overall Study|Study Closed Locally|0|||
163397429|NCT01490450|590167710|FG000|Period 1|Adverse Event|0|||
163203671|NCT03708328|589459703|FG009|Overall Study|Study Closed Locally|0|||
163203672|NCT03708328|589459694|FG000|Overall Study|Study Ended By Sponsor|0|||
163397430|NCT01490450|590167711|FG001|Period 1|Adverse Event|0|||
163051877|NCT01663402|588898739|FG000|Overall Study|Site terminated by sponsor|1|||
163051878|NCT01663402|588898740|FG001|Overall Study|Site terminated by sponsor|3|||
163051879|NCT01663402|588898739|FG000|Overall Study|Participant moved|139|||
163051880|NCT01663402|588898740|FG001|Overall Study|Participant moved|104|||
163051881|NCT01663402|588898739|FG000|Overall Study|Withdrawal by Subject|118|||
163051882|NCT01663402|588898740|FG001|Overall Study|Withdrawal by Subject|91|||
163051883|NCT01663402|588898739|FG000|Overall Study|Related to study drug administration|96|||
163051884|NCT01663402|588898740|FG001|Overall Study|Related to study drug administration|105|||
163051885|NCT01663402|588898739|FG000|Overall Study|Lost to Follow-up|17|||
163051886|NCT01663402|588898740|FG001|Overall Study|Lost to Follow-up|15|||
163051887|NCT01663402|588898739|FG000|Overall Study|Other than specified above|172|||
163051888|NCT01663402|588898740|FG001|Overall Study|Other than specified above|147|||
163051889|NCT05953363|588898743|FG000|Overall Study|Screen Failure|2|||
163051890|NCT05953363|588898743|FG000|Overall Study|Withdrawal by Subject|3|||
163051891|NCT05953363|588898743|FG000|Overall Study|Surgery cancelled|2|||
163051892|NCT05953363|588898743|FG000|Overall Study|Adverse Event|1|||
163051893|NCT01701674|588898744|FG000|Overall Study|Unable to safely complete treatment|1|||
163051894|NCT04464707|588898749|FG000|Overall Study|Adverse Event|1|||
163051895|NCT04464707|588898750|FG001|Overall Study|Adverse Event|0|||
163051896|NCT04464707|588898751|FG002|Overall Study|Adverse Event|0|||
163397431|NCT01490450|590167712|FG002|Period 1|Adverse Event|0|||
163051897|NCT04464707|588898749|FG000|Overall Study|Withdrawal by Subject|0|||
163051898|NCT04464707|588898750|FG001|Overall Study|Withdrawal by Subject|0|||
163397432|NCT01490450|590167713|FG003|Period 1|Adverse Event|5|||
162964934|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
162964935|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
162964936|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
163203673|NCT03708328|589459695|FG001|Overall Study|Study Ended By Sponsor|0|||
163203674|NCT03708328|589459696|FG002|Overall Study|Study Ended By Sponsor|0|||
163203675|NCT03708328|589459697|FG003|Overall Study|Study Ended By Sponsor|0|||
163203676|NCT03708328|589459698|FG004|Overall Study|Study Ended By Sponsor|0|||
163203677|NCT03708328|589459699|FG005|Overall Study|Study Ended By Sponsor|1|||
163203678|NCT03708328|589459700|FG006|Overall Study|Study Ended By Sponsor|0|||
163203679|NCT03708328|589459701|FG007|Overall Study|Study Ended By Sponsor|1|||
163203680|NCT03708328|589459702|FG008|Overall Study|Study Ended By Sponsor|0|||
163203681|NCT03708328|589459703|FG009|Overall Study|Study Ended By Sponsor|0|||
163203682|NCT03708328|589459694|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
163203683|NCT03708328|589459695|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
163203684|NCT03708328|589459696|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
163203685|NCT03708328|589459697|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
163203686|NCT03708328|589459698|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
163203687|NCT03708328|589459699|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
163203688|NCT03708328|589459700|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
163203689|NCT03708328|589459701|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
163203690|NCT03708328|589459702|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
163203691|NCT03708328|589459703|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
163203692|NCT00571948|589459704|FG000|Overall Study|Lost to Follow-up|2|||
163203693|NCT00571948|589459705|FG001|Overall Study|Lost to Follow-up|0|||
163203694|NCT00571948|589459704|FG000|Overall Study|Withdrawal by Subject|1|||
163203695|NCT00571948|589459705|FG001|Overall Study|Withdrawal by Subject|2|||
163203696|NCT00571948|589459704|FG000|Overall Study|Protocol Violation|3|||
163203697|NCT00571948|589459705|FG001|Overall Study|Protocol Violation|3|||
163203698|NCT00571948|589459704|FG000|Overall Study|infant refused study meal|3|||
163203699|NCT00571948|589459705|FG001|Overall Study|infant refused study meal|4|||
163203700|NCT00571948|589459704|FG000|Overall Study|Parent were afraid of blood colection|2|||
163203701|NCT00571948|589459705|FG001|Overall Study|Parent were afraid of blood colection|5|||
163203702|NCT01845831|589459707|FG000|Inpatient Phase|Withdrawal by Subject|1|||
163203703|NCT01845831|589459708|FG001|Inpatient Phase|Withdrawal by Subject|1|||
163311375|NCT03366649|589850289|FG001|Overall Study|Failed preoperative screening|0|||
163311376|NCT03366649|589850290|FG002|Overall Study|Failed preoperative screening|0|||
163311377|NCT03366649|589850288|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
163311378|NCT03366649|589850289|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
163311379|NCT03366649|589850290|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
163311380|NCT01785719|589850291|FG000|4-week Baseline Evaluation|Physician Decision|1|||
163311381|NCT01785719|589850292|FG001|4-week Baseline Evaluation|Physician Decision|0|||
163311382|NCT01785719|589850291|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
163311383|NCT01785719|589850292|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
163311384|NCT01785719|589850291|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
163311385|NCT01785719|589850292|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
163311386|NCT01785719|589850291|FG000|4-week Baseline Evaluation|Pregnancy|0|||
163311387|NCT01785719|589850292|FG001|4-week Baseline Evaluation|Pregnancy|2|||
163311388|NCT01785719|589850291|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
163311389|NCT01785719|589850292|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
163311390|NCT01785719|589850291|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
163311391|NCT01785719|589850292|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
163311392|NCT01785719|589850291|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
163311393|NCT01785719|589850292|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
163311394|NCT01785719|589850291|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
163311395|NCT01785719|589850292|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
163311396|NCT01785719|589850291|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
163311397|NCT01785719|589850292|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
163311398|NCT01785719|589850291|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
163311399|NCT01785719|589850292|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
163311400|NCT01785719|589850291|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
162964937|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
162964938|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
162964939|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
162964940|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
162964941|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
162964942|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
162964943|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
162964944|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
163311401|NCT01785719|589850292|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
163311402|NCT01785719|589850291|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
163203704|NCT01845831|589459709|FG002|Inpatient Phase|Withdrawal by Subject|0|||
163203705|NCT01845831|589459710|FG003|Inpatient Phase|Withdrawal by Subject|0|||
163203706|NCT01845831|589459711|FG004|Inpatient Phase|Withdrawal by Subject|0|||
163203707|NCT02010775|589459712|FG000|Overall Study|Adverse Event|0|||
163203708|NCT02010775|589459713|FG001|Overall Study|Adverse Event|0|||
163203709|NCT02010775|589459714|FG002|Overall Study|Adverse Event|0|||
163203710|NCT02010775|589459715|FG003|Overall Study|Adverse Event|0|||
163203711|NCT02010775|589459716|FG004|Overall Study|Adverse Event|1|||
163203712|NCT02010775|589459712|FG000|Overall Study|Pregnancy|0|||
163203713|NCT02010775|589459713|FG001|Overall Study|Pregnancy|0|||
163203714|NCT02010775|589459714|FG002|Overall Study|Pregnancy|2|||
163203715|NCT02010775|589459715|FG003|Overall Study|Pregnancy|0|||
163203716|NCT02010775|589459716|FG004|Overall Study|Pregnancy|0|||
163203717|NCT02010775|589459712|FG000|Overall Study|Lost to Follow-up|2|||
163203718|NCT02010775|589459713|FG001|Overall Study|Lost to Follow-up|0|||
163203719|NCT02010775|589459714|FG002|Overall Study|Lost to Follow-up|0|||
163203720|NCT02010775|589459715|FG003|Overall Study|Lost to Follow-up|1|||
163203721|NCT02010775|589459716|FG004|Overall Study|Lost to Follow-up|1|||
163203722|NCT02010775|589459712|FG000|Overall Study|Personal Reasons|3|||
163203723|NCT02010775|589459713|FG001|Overall Study|Personal Reasons|3|||
163203724|NCT02010775|589459714|FG002|Overall Study|Personal Reasons|1|||
163203725|NCT02010775|589459715|FG003|Overall Study|Personal Reasons|2|||
163203726|NCT02010775|589459716|FG004|Overall Study|Personal Reasons|4|||
163203727|NCT02030041|589459717|FG000|Overall Study|Withdrawal by Subject|2|||
163203728|NCT02030041|589459718|FG001|Overall Study|Withdrawal by Subject|2|||
163203729|NCT02030041|589459719|FG002|Overall Study|Withdrawal by Subject|1|||
163203730|NCT02006719|589459721|FG000|Overall Study|Withdrawal by Subject|10|||
163203731|NCT02006719|589459722|FG001|Overall Study|Withdrawal by Subject|2|||
163203732|NCT02006719|589459721|FG000|Overall Study|Lost to Follow-up|5|||
163203733|NCT02006719|589459722|FG001|Overall Study|Lost to Follow-up|1|||
163203734|NCT02006719|589459721|FG000|Overall Study|Protocol Violation|2|||
163203735|NCT02006719|589459722|FG001|Overall Study|Protocol Violation|0|||
163203736|NCT02006719|589459721|FG000|Overall Study|Adverse Event|1|||
163203737|NCT02006719|589459722|FG001|Overall Study|Adverse Event|1|||
163203738|NCT02006719|589459721|FG000|Overall Study|Other/Unknown|0|||
163203739|NCT02006719|589459722|FG001|Overall Study|Other/Unknown|1|||
163203740|NCT00496054|589459726|FG000|Overall Study|Adverse Event|1|||
163203741|NCT00496054|589459726|FG000|Overall Study|Lost to Follow-up|7|||
163203742|NCT01737697|589459727|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
163203743|NCT01737697|589459728|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
163203744|NCT01737697|589459729|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
163203745|NCT01737697|589459730|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
163203746|NCT01737697|589459731|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
163203747|NCT01737697|589459732|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
163203748|NCT01737697|589459733|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
163203749|NCT01737697|589459734|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
163203750|NCT01737697|589459735|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
163203751|NCT01737697|589459736|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
163203752|NCT01737697|589459737|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
163203753|NCT01737697|589459738|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
163203754|NCT01737697|589459739|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
163203755|NCT01737697|589459740|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
163203756|NCT01737697|589459741|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
163203757|NCT01737697|589459727|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
163203758|NCT01737697|589459728|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
163203759|NCT01737697|589459729|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
163203760|NCT01737697|589459730|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
163203761|NCT01737697|589459731|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
163203762|NCT01737697|589459732|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
163203763|NCT01737697|589459733|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
163203764|NCT01737697|589459734|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
163203765|NCT01737697|589459735|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
163203766|NCT01737697|589459736|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
163203767|NCT01737697|589459737|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
163203768|NCT01737697|589459738|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
163203769|NCT01737697|589459739|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
163203770|NCT01737697|589459740|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
163203771|NCT01737697|589459741|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
163203772|NCT01737697|589459727|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
163203773|NCT01737697|589459728|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
163203774|NCT01737697|589459729|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
163203775|NCT01737697|589459730|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
163203776|NCT01737697|589459731|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
163311403|NCT01785719|589850292|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
163311404|NCT01785719|589850291|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
163311405|NCT01785719|589850292|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
163311406|NCT01785719|589850291|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
163311407|NCT01785719|589850292|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
163311408|NCT01785719|589850291|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
163311409|NCT01785719|589850292|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
163311410|NCT04029688|589850300|FG000|Overall Study|Death|8|||
163311411|NCT04029688|589850301|FG001|Overall Study|Death|3|||
163311412|NCT04029688|589850302|FG002|Overall Study|Death|6|||
163311413|NCT04029688|589850303|FG003|Overall Study|Death|2|||
163397433|NCT01490450|590167710|FG000|Period 1|Request to discontinue treatment|1|||
163397434|NCT01490450|590167711|FG001|Period 1|Request to discontinue treatment|0|||
163203777|NCT01737697|589459732|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
163203778|NCT01737697|589459733|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
163203779|NCT01737697|589459734|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
163203780|NCT01737697|589459735|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
163203781|NCT01737697|589459736|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
163203782|NCT01737697|589459737|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
163203783|NCT01737697|589459738|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
163203784|NCT01737697|589459739|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
163203785|NCT01737697|589459740|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
163203786|NCT01737697|589459741|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
163203787|NCT01737697|589459727|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
163203788|NCT01737697|589459728|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
163203789|NCT01737697|589459729|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
163203790|NCT01737697|589459730|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
163203791|NCT01737697|589459731|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
163203792|NCT01737697|589459732|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
163203793|NCT01737697|589459733|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
163203794|NCT01737697|589459734|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
163203795|NCT01737697|589459735|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
163203796|NCT01737697|589459736|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
163203797|NCT01737697|589459737|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
163203798|NCT01737697|589459738|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
163203799|NCT01737697|589459739|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
163203800|NCT01737697|589459740|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
163203801|NCT01737697|589459741|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
163203802|NCT01737697|589459727|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
163203803|NCT01737697|589459728|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
163203804|NCT01737697|589459729|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
163203805|NCT01737697|589459730|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
163203806|NCT01737697|589459731|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
163203807|NCT01737697|589459732|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
163203808|NCT01737697|589459733|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
163203809|NCT01737697|589459734|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
163203810|NCT01737697|589459735|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
163203811|NCT01737697|589459736|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
163203812|NCT01737697|589459737|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
163203813|NCT01737697|589459738|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
163203814|NCT01737697|589459739|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
163203815|NCT01737697|589459740|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
163203816|NCT01737697|589459741|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
163203817|NCT01737697|589459727|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
163203818|NCT01737697|589459728|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
163203819|NCT01737697|589459729|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
163203820|NCT01737697|589459730|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
163203821|NCT01737697|589459731|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
163203822|NCT01737697|589459732|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
163203823|NCT01737697|589459733|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
163203824|NCT01737697|589459734|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
163203825|NCT01737697|589459735|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
163203826|NCT01737697|589459736|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
163203827|NCT01737697|589459737|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
163203828|NCT01737697|589459738|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
163203829|NCT01737697|589459739|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
163203830|NCT01737697|589459740|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
163203831|NCT01737697|589459741|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
163203832|NCT01737697|589459727|FG000|Subacute Phase|Adverse Event|0|||
163203833|NCT01737697|589459728|FG001|Subacute Phase|Adverse Event|0|||
163311414|NCT04029688|589850304|FG004|Overall Study|Death|5|||
163397435|NCT01490450|590167712|FG002|Period 1|Request to discontinue treatment|0|||
163203834|NCT01737697|589459729|FG002|Subacute Phase|Adverse Event|0|||
163203835|NCT01737697|589459730|FG003|Subacute Phase|Adverse Event|0|||
163203836|NCT01737697|589459731|FG004|Subacute Phase|Adverse Event|0|||
163203837|NCT01737697|589459732|FG005|Subacute Phase|Adverse Event|1|||
163203838|NCT01737697|589459733|FG006|Subacute Phase|Adverse Event|1|||
163203839|NCT01737697|589459734|FG007|Subacute Phase|Adverse Event|1|||
163203840|NCT01737697|589459735|FG008|Subacute Phase|Adverse Event|1|||
163203841|NCT01737697|589459736|FG009|Subacute Phase|Adverse Event|1|||
163203842|NCT01737697|589459737|FG010|Subacute Phase|Adverse Event|4|||
163203843|NCT01737697|589459738|FG011|Subacute Phase|Adverse Event|1|||
163203844|NCT01737697|589459739|FG012|Subacute Phase|Adverse Event|1|||
163203845|NCT01737697|589459740|FG013|Subacute Phase|Adverse Event|0|||
163203846|NCT01737697|589459741|FG014|Subacute Phase|Adverse Event|0|||
163203847|NCT01737697|589459727|FG000|Subacute Phase|Withdrawal by Subject|0|||
163203848|NCT01737697|589459728|FG001|Subacute Phase|Withdrawal by Subject|0|||
163203849|NCT01737697|589459729|FG002|Subacute Phase|Withdrawal by Subject|0|||
163203850|NCT01737697|589459730|FG003|Subacute Phase|Withdrawal by Subject|0|||
163203851|NCT01737697|589459731|FG004|Subacute Phase|Withdrawal by Subject|0|||
163203852|NCT01737697|589459732|FG005|Subacute Phase|Withdrawal by Subject|1|||
163203853|NCT01737697|589459733|FG006|Subacute Phase|Withdrawal by Subject|0|||
163203854|NCT01737697|589459734|FG007|Subacute Phase|Withdrawal by Subject|2|||
163203855|NCT01737697|589459735|FG008|Subacute Phase|Withdrawal by Subject|0|||
163203856|NCT01737697|589459736|FG009|Subacute Phase|Withdrawal by Subject|1|||
163203857|NCT01737697|589459737|FG010|Subacute Phase|Withdrawal by Subject|0|||
163203858|NCT01737697|589459738|FG011|Subacute Phase|Withdrawal by Subject|1|||
163203859|NCT01737697|589459739|FG012|Subacute Phase|Withdrawal by Subject|1|||
163203860|NCT01737697|589459740|FG013|Subacute Phase|Withdrawal by Subject|1|||
163203861|NCT01737697|589459741|FG014|Subacute Phase|Withdrawal by Subject|0|||
163203862|NCT01737697|589459727|FG000|Subacute Phase|Lost to Follow-up|0|||
163203863|NCT01737697|589459728|FG001|Subacute Phase|Lost to Follow-up|0|||
163203864|NCT01737697|589459729|FG002|Subacute Phase|Lost to Follow-up|0|||
163203865|NCT01737697|589459730|FG003|Subacute Phase|Lost to Follow-up|0|||
163203866|NCT01737697|589459731|FG004|Subacute Phase|Lost to Follow-up|0|||
163203867|NCT01737697|589459732|FG005|Subacute Phase|Lost to Follow-up|0|||
163203868|NCT01737697|589459733|FG006|Subacute Phase|Lost to Follow-up|0|||
163203869|NCT01737697|589459734|FG007|Subacute Phase|Lost to Follow-up|0|||
163203870|NCT01737697|589459735|FG008|Subacute Phase|Lost to Follow-up|0|||
163203871|NCT01737697|589459736|FG009|Subacute Phase|Lost to Follow-up|0|||
163203872|NCT01737697|589459737|FG010|Subacute Phase|Lost to Follow-up|0|||
163203873|NCT01737697|589459738|FG011|Subacute Phase|Lost to Follow-up|0|||
163203874|NCT01737697|589459739|FG012|Subacute Phase|Lost to Follow-up|0|||
163203875|NCT01737697|589459740|FG013|Subacute Phase|Lost to Follow-up|0|||
163203876|NCT01737697|589459741|FG014|Subacute Phase|Lost to Follow-up|1|||
163203877|NCT01737697|589459727|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
163203878|NCT01737697|589459728|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
163203879|NCT01737697|589459729|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
163203880|NCT01737697|589459730|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
163203881|NCT01737697|589459731|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
163203882|NCT01737697|589459732|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
163203883|NCT01737697|589459733|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
163203884|NCT01737697|589459734|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
163203885|NCT01737697|589459735|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
163203886|NCT01737697|589459736|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
163203887|NCT01737697|589459737|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
163203888|NCT01737697|589459738|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
163203889|NCT01737697|589459739|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
163203890|NCT01737697|589459740|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
163203891|NCT01737697|589459741|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
163203892|NCT01737697|589459727|FG000|Subacute Phase|Protocol Violation|0|||
163203893|NCT01737697|589459728|FG001|Subacute Phase|Protocol Violation|0|||
163203894|NCT01737697|589459729|FG002|Subacute Phase|Protocol Violation|0|||
163203895|NCT01737697|589459730|FG003|Subacute Phase|Protocol Violation|0|||
163203896|NCT01737697|589459731|FG004|Subacute Phase|Protocol Violation|0|||
163203897|NCT01737697|589459732|FG005|Subacute Phase|Protocol Violation|1|||
163203898|NCT01737697|589459733|FG006|Subacute Phase|Protocol Violation|0|||
163311415|NCT04029688|589850305|FG005|Overall Study|Death|0|||
163311416|NCT04029688|589850306|FG006|Overall Study|Death|2|||
163311417|NCT04029688|589850307|FG007|Overall Study|Death|3|||
163311418|NCT04029688|589850300|FG000|Overall Study|Study Terminated by Sponsor|0|||
163311419|NCT04029688|589850301|FG001|Overall Study|Study Terminated by Sponsor|0|||
163311420|NCT04029688|589850302|FG002|Overall Study|Study Terminated by Sponsor|0|||
163311421|NCT04029688|589850303|FG003|Overall Study|Study Terminated by Sponsor|0|||
163311422|NCT04029688|589850304|FG004|Overall Study|Study Terminated by Sponsor|1|||
163311423|NCT04029688|589850305|FG005|Overall Study|Study Terminated by Sponsor|3|||
163311424|NCT04029688|589850306|FG006|Overall Study|Study Terminated by Sponsor|1|||
163311425|NCT04029688|589850307|FG007|Overall Study|Study Terminated by Sponsor|3|||
163311426|NCT04029688|589850300|FG000|Overall Study|Withdrawal by Subject|0|||
163311427|NCT04029688|589850301|FG001|Overall Study|Withdrawal by Subject|0|||
163311428|NCT04029688|589850302|FG002|Overall Study|Withdrawal by Subject|0|||
163311429|NCT04029688|589850303|FG003|Overall Study|Withdrawal by Subject|1|||
163311430|NCT04029688|589850304|FG004|Overall Study|Withdrawal by Subject|0|||
163311431|NCT04029688|589850305|FG005|Overall Study|Withdrawal by Subject|0|||
163311432|NCT04029688|589850306|FG006|Overall Study|Withdrawal by Subject|0|||
163311433|NCT04029688|589850307|FG007|Overall Study|Withdrawal by Subject|0|||
163311434|NCT03436290|589850308|FG000|Overall Study|Post-randomization Exclusion|1|||
163311435|NCT03436290|589850309|FG001|Overall Study|Post-randomization Exclusion|0|||
163311436|NCT03436290|589850308|FG000|Overall Study|Death|6|||
163311437|NCT03436290|589850309|FG001|Overall Study|Death|0|||
163311438|NCT03436290|589850308|FG000|Overall Study|Withdrawal by Subject|4|||
163311439|NCT03436290|589850309|FG001|Overall Study|Withdrawal by Subject|0|||
163311440|NCT03436290|589850308|FG000|Overall Study|Protocol Violation|30|||
163311441|NCT03436290|589850309|FG001|Overall Study|Protocol Violation|0|||
163311442|NCT02924272|589850320|FG000|Overall Study|Site Terminated by Sponsor|4|||
163311443|NCT02924272|589850321|FG001|Overall Study|Site Terminated by Sponsor|1|||
163311444|NCT02924272|589850320|FG000|Overall Study|Withdrawal by Subject|2|||
163311445|NCT02924272|589850321|FG001|Overall Study|Withdrawal by Subject|0|||
163311446|NCT02924272|589850320|FG000|Overall Study|Adverse Event|3|||
163311447|NCT02924272|589850321|FG001|Overall Study|Adverse Event|0|||
163311448|NCT02924272|589850320|FG000|Overall Study|Progressive Disease|11|||
163311449|NCT02924272|589850321|FG001|Overall Study|Progressive Disease|8|||
163311450|NCT02924272|589850320|FG000|Overall Study|Clinical Deterioration|1|||
163311451|NCT02924272|589850321|FG001|Overall Study|Clinical Deterioration|0|||
163311452|NCT02924272|589850320|FG000|Overall Study|Death|1|||
163311453|NCT02924272|589850321|FG001|Overall Study|Death|0|||
163311454|NCT02924272|589850320|FG000|Overall Study|Reason Not Specified|1|||
163311455|NCT02924272|589850321|FG001|Overall Study|Reason Not Specified|0|||
163311456|NCT00506519|589850328|FG000|Overall Study|Death|4|||
163311457|NCT00506519|589850329|FG001|Overall Study|Death|6|||
163311458|NCT00506519|589850330|FG002|Overall Study|Death|0|||
163311459|NCT00506519|589850328|FG000|Overall Study|Adverse Event|1|||
163311460|NCT00506519|589850329|FG001|Overall Study|Adverse Event|0|||
163311461|NCT00506519|589850330|FG002|Overall Study|Adverse Event|0|||
163311462|NCT01186367|589850331|FG000|Overall Study|Lost to Follow-up|7|||
163311463|NCT01186367|589850332|FG001|Overall Study|Lost to Follow-up|4|||
163311464|NCT01186367|589850333|FG002|Overall Study|Lost to Follow-up|7|||
163311465|NCT01186367|589850331|FG000|Overall Study|Did not receive study treatment|0|||
163311466|NCT01186367|589850332|FG001|Overall Study|Did not receive study treatment|1|||
163311467|NCT01186367|589850333|FG002|Overall Study|Did not receive study treatment|0|||
163311468|NCT02975882|589850334|FG000|Overall Study|Adverse Event|1|||
163311469|NCT02975882|589850335|FG001|Overall Study|Adverse Event|2|||
163311470|NCT02975882|589850336|FG002|Overall Study|Adverse Event|1|||
163311471|NCT02975882|589850337|FG003|Overall Study|Adverse Event|1|||
163311472|NCT02975882|589850334|FG000|Overall Study|Death|0|||
163051899|NCT04464707|588898751|FG002|Overall Study|Withdrawal by Subject|2|||
163051900|NCT04464707|588898749|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163051901|NCT04464707|588898750|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163051902|NCT04464707|588898751|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163051903|NCT04464707|588898749|FG000|Overall Study|Protocol Deviation|1|||
163311473|NCT02975882|589850335|FG001|Overall Study|Death|1|||
163311474|NCT02975882|589850336|FG002|Overall Study|Death|0|||
163311475|NCT02975882|589850337|FG003|Overall Study|Death|0|||
163311476|NCT02975882|589850334|FG000|Overall Study|Lack of Efficacy|3|||
163311477|NCT02975882|589850335|FG001|Overall Study|Lack of Efficacy|7|||
163051904|NCT04464707|588898750|FG001|Overall Study|Protocol Deviation|0|||
163311478|NCT02975882|589850336|FG002|Overall Study|Lack of Efficacy|4|||
163311479|NCT02975882|589850337|FG003|Overall Study|Lack of Efficacy|3|||
163311480|NCT02975882|589850334|FG000|Overall Study|Physician Decision|0|||
163311481|NCT02975882|589850335|FG001|Overall Study|Physician Decision|2|||
163311482|NCT02975882|589850336|FG002|Overall Study|Physician Decision|4|||
163311483|NCT02975882|589850337|FG003|Overall Study|Physician Decision|2|||
163311484|NCT02975882|589850334|FG000|Overall Study|Ineligible|0|||
163311485|NCT02975882|589850335|FG001|Overall Study|Ineligible|1|||
163311486|NCT02975882|589850336|FG002|Overall Study|Ineligible|0|||
163311487|NCT02975882|589850337|FG003|Overall Study|Ineligible|0|||
163203899|NCT01737697|589459734|FG007|Subacute Phase|Protocol Violation|0|||
163203900|NCT01737697|589459735|FG008|Subacute Phase|Protocol Violation|0|||
163203901|NCT01737697|589459736|FG009|Subacute Phase|Protocol Violation|0|||
163311488|NCT05116787|589850338|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
163311489|NCT05116787|589850339|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
163311490|NCT05116787|589850338|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
163203902|NCT01737697|589459737|FG010|Subacute Phase|Protocol Violation|1|||
163203903|NCT01737697|589459738|FG011|Subacute Phase|Protocol Violation|0|||
163203904|NCT01737697|589459739|FG012|Subacute Phase|Protocol Violation|0|||
163203905|NCT01737697|589459740|FG013|Subacute Phase|Protocol Violation|0|||
163203906|NCT01737697|589459741|FG014|Subacute Phase|Protocol Violation|0|||
163203907|NCT01737697|589459727|FG000|Subacute Phase|Physician Decision|0|||
163203908|NCT01737697|589459728|FG001|Subacute Phase|Physician Decision|0|||
163203909|NCT01737697|589459729|FG002|Subacute Phase|Physician Decision|0|||
163203910|NCT01737697|589459730|FG003|Subacute Phase|Physician Decision|0|||
163203911|NCT01737697|589459731|FG004|Subacute Phase|Physician Decision|0|||
163203912|NCT01737697|589459732|FG005|Subacute Phase|Physician Decision|0|||
163203913|NCT01737697|589459733|FG006|Subacute Phase|Physician Decision|0|||
163203914|NCT01737697|589459734|FG007|Subacute Phase|Physician Decision|0|||
163203915|NCT01737697|589459735|FG008|Subacute Phase|Physician Decision|1|||
163203916|NCT01737697|589459736|FG009|Subacute Phase|Physician Decision|0|||
163203917|NCT01737697|589459737|FG010|Subacute Phase|Physician Decision|0|||
163203918|NCT01737697|589459738|FG011|Subacute Phase|Physician Decision|0|||
163203919|NCT01737697|589459739|FG012|Subacute Phase|Physician Decision|0|||
163203920|NCT01737697|589459740|FG013|Subacute Phase|Physician Decision|0|||
163203921|NCT01737697|589459741|FG014|Subacute Phase|Physician Decision|0|||
163203922|NCT01737697|589459727|FG000|Subacute Phase|Death|0|||
163203923|NCT01737697|589459728|FG001|Subacute Phase|Death|0|||
163203924|NCT01737697|589459729|FG002|Subacute Phase|Death|0|||
163203925|NCT01737697|589459730|FG003|Subacute Phase|Death|0|||
163203926|NCT01737697|589459731|FG004|Subacute Phase|Death|0|||
163203927|NCT01737697|589459732|FG005|Subacute Phase|Death|0|||
163203928|NCT01737697|589459733|FG006|Subacute Phase|Death|0|||
163203929|NCT01737697|589459734|FG007|Subacute Phase|Death|0|||
162964945|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
163203930|NCT01737697|589459735|FG008|Subacute Phase|Death|0|||
163203931|NCT01737697|589459736|FG009|Subacute Phase|Death|0|||
163203932|NCT01737697|589459737|FG010|Subacute Phase|Death|1|||
163203933|NCT01737697|589459738|FG011|Subacute Phase|Death|0|||
163203934|NCT01737697|589459739|FG012|Subacute Phase|Death|0|||
163203935|NCT01737697|589459740|FG013|Subacute Phase|Death|0|||
163203936|NCT01737697|589459741|FG014|Subacute Phase|Death|0|||
163311491|NCT05116787|589850339|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
163311492|NCT05116787|589850338|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
163311493|NCT05116787|589850339|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
163311494|NCT05116787|589850338|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
163311495|NCT05116787|589850339|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
163311496|NCT02919683|589850341|FG000|Post-Surgery Follow-Up|Death|2|||
163311497|NCT02919683|589850342|FG001|Post-Surgery Follow-Up|Death|2|||
163311498|NCT02919683|589850341|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
163311499|NCT02919683|589850342|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
163311500|NCT03867500|589850347|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
163311501|NCT06205407|589850348|FG000|Period 2|Withdrawal by Subject|0|||
163311502|NCT06205407|589850349|FG001|Period 2|Withdrawal by Subject|1|||
163311503|NCT06205407|589850348|FG000|Period 2|Adverse Event|2|||
163311504|NCT06205407|589850349|FG001|Period 2|Adverse Event|1|||
163311505|NCT06491433|589850350|FG000|Overall Study|Protocol Violation|51|||
163311506|NCT06491433|589850350|FG000|Overall Study|consent withdrawal|2|||
163311507|NCT06491433|589850350|FG000|Overall Study|screen failure|1|||
163311508|NCT04749615|589850352|FG000|Overall Study|Lost to Follow-up|6|||
163311509|NCT04749615|589850353|FG001|Overall Study|Lost to Follow-up|10|||
163311510|NCT03611491|589850354|FG000|Overall Study|Lost to Follow-up|1|||
163311511|NCT04806451|589850362|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
163311512|NCT04806451|589850363|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
163311513|NCT04806451|589850362|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
163311514|NCT04806451|589850363|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
163203937|NCT01866930|589459744|FG000|Treatment Period|Other|1|||
163203938|NCT01866930|589459745|FG001|Treatment Period|Other|0|||
163203939|NCT01866930|589459744|FG000|Treatment Period|Death|0|||
163311515|NCT04806451|589850362|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
163311516|NCT04806451|589850363|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
163311517|NCT05292365|589850364|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
163203940|NCT01866930|589459745|FG001|Treatment Period|Death|2|||
163203941|NCT01866930|589459744|FG000|Treatment Period|Poor/non compliance|0|||
163203942|NCT01866930|589459745|FG001|Treatment Period|Poor/non compliance|2|||
163203943|NCT01866930|589459744|FG000|Treatment Period|No longer meets study criteria|0|||
163311518|NCT05292365|589850365|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
163311519|NCT05292365|589850366|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
163311520|NCT05292365|589850367|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
163311521|NCT05282173|589850368|FG000|Overall Study|Missed|3|||
163311522|NCT05282173|589850369|FG001|Overall Study|Missed|2|||
163311523|NCT05282173|589850370|FG002|Overall Study|Missed|4|||
163311524|NCT03134196|589850378|FG000|Overall Study|Death|2|||
163311525|NCT03134196|589850379|FG001|Overall Study|Death|1|||
163311526|NCT03134196|589850378|FG000|Overall Study|Lost to Follow-up|13|||
163311527|NCT03134196|589850379|FG001|Overall Study|Lost to Follow-up|15|||
163311528|NCT03134196|589850378|FG000|Overall Study|Physician Decision|0|||
163311529|NCT03134196|589850379|FG001|Overall Study|Physician Decision|1|||
163311530|NCT03134196|589850378|FG000|Overall Study|Withdrawal by Subject|19|||
163311531|NCT03134196|589850379|FG001|Overall Study|Withdrawal by Subject|12|||
163311532|NCT03134196|589850378|FG000|Overall Study|Site Unable to Contact Participant|2|||
163311533|NCT03134196|589850379|FG001|Overall Study|Site Unable to Contact Participant|0|||
163311534|NCT03134196|589850378|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
163203944|NCT01866930|589459745|FG001|Treatment Period|No longer meets study criteria|1|||
163311535|NCT03134196|589850379|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
163311536|NCT03134196|589850378|FG000|Overall Study|Scheduling Conflict|1|||
163311537|NCT03134196|589850379|FG001|Overall Study|Scheduling Conflict|0|||
163311538|NCT04683744|589850387|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
163311539|NCT04683744|589850388|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
163203945|NCT01866930|589459744|FG000|Treatment Period|Withdrawal by Subject|2|||
163311540|NCT04683744|589850389|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
163311541|NCT01798498|589850390|FG000|Overall Study|Lost to Follow-up|1|||
162964946|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
162964947|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
162979003|NCT03545191|588623547|FG001|Overall Study|Withdrawal by Subject|10|||
163203946|NCT01866930|589459745|FG001|Treatment Period|Withdrawal by Subject|8|||
163203947|NCT01866930|589459744|FG000|Treatment Period|Lack of Efficacy|1|||
163203948|NCT01866930|589459745|FG001|Treatment Period|Lack of Efficacy|9|||
163203949|NCT01866930|589459744|FG000|Treatment Period|Adverse Event|4|||
163203950|NCT01866930|589459745|FG001|Treatment Period|Adverse Event|12|||
163203951|NCT01866930|589459744|FG000|Treatment Period|Lost to Follow-up|1|||
163203952|NCT01866930|589459745|FG001|Treatment Period|Lost to Follow-up|1|||
163203953|NCT01866930|589459744|FG000|Follow-up Period|Lost to Follow-up|1|||
163203954|NCT01866930|589459745|FG001|Follow-up Period|Lost to Follow-up|1|||
163203955|NCT01866930|589459744|FG000|Follow-up Period|Other|1|||
163203956|NCT01866930|589459745|FG001|Follow-up Period|Other|5|||
163203957|NCT01866930|589459744|FG000|Follow-up Period|No longer required per protocol|1|||
163203958|NCT01866930|589459745|FG001|Follow-up Period|No longer required per protocol|0|||
163203959|NCT01866930|589459744|FG000|Follow-up Period|Withdrawal by Subject|3|||
163203960|NCT01866930|589459745|FG001|Follow-up Period|Withdrawal by Subject|3|||
163203961|NCT00471328|589459750|FG000|Core Phase|Adverse Event|18|||
163203962|NCT00471328|589459751|FG001|Core Phase|Adverse Event|6|||
163203963|NCT00471328|589459750|FG000|Core Phase|Death|8|||
163203964|NCT00471328|589459751|FG001|Core Phase|Death|4|||
163203965|NCT00471328|589459750|FG000|Core Phase|Withdrawal by Subject|2|||
163203966|NCT00471328|589459751|FG001|Core Phase|Withdrawal by Subject|2|||
163203967|NCT00471328|589459750|FG000|Core Phase|Abnormal laboratory value|1|||
163203968|NCT00471328|589459751|FG001|Core Phase|Abnormal laboratory value|0|||
163203969|NCT00471328|589459750|FG000|Core Phase|Disease Progression|78|||
163203970|NCT00471328|589459751|FG001|Core Phase|Disease Progression|53|||
163203971|NCT00471328|589459750|FG000|Core Phase|Administrative Problem|0|||
163203972|NCT00471328|589459751|FG001|Core Phase|Administrative Problem|1|||
163203973|NCT00471328|589459750|FG000|Core Phase|Protocol Deviation|0|||
163203974|NCT00471328|589459751|FG001|Core Phase|Protocol Deviation|1|||
163203975|NCT00471328|589459750|FG000|Extension Phase|Adverse Event|3|||
163311542|NCT04592549|589850395|FG000|Overall Study|Withdrawal by Subject|0|||
163311543|NCT04592549|589850396|FG001|Overall Study|Withdrawal by Subject|1|||
163311544|NCT04592549|589850397|FG002|Overall Study|Withdrawal by Subject|0|||
163311545|NCT04592549|589850398|FG003|Overall Study|Withdrawal by Subject|1|||
163311546|NCT04592549|589850399|FG004|Overall Study|Withdrawal by Subject|1|||
163311547|NCT04592549|589850400|FG005|Overall Study|Withdrawal by Subject|0|||
163311548|NCT04592549|589850395|FG000|Overall Study|Lost to Follow-up|2|||
163311549|NCT04592549|589850396|FG001|Overall Study|Lost to Follow-up|0|||
163311550|NCT04592549|589850397|FG002|Overall Study|Lost to Follow-up|0|||
163311551|NCT04592549|589850398|FG003|Overall Study|Lost to Follow-up|1|||
163311552|NCT04592549|589850399|FG004|Overall Study|Lost to Follow-up|1|||
163311553|NCT04592549|589850400|FG005|Overall Study|Lost to Follow-up|1|||
163311554|NCT04295798|589850404|FG000|Overall Study|Lost to Follow-up|1|||
163311555|NCT04650269|589850405|FG000|Overall Study|Death|3|||
163311556|NCT04650269|589850405|FG000|Overall Study|Lost to Follow-up|6|||
163311557|NCT04091750|589850406|FG000|Overall Study|Adverse Event|4|||
163311558|NCT04091750|589850406|FG000|Overall Study|Withdrawal by Subject|1|||
163311559|NCT02919306|589850407|FG000|Overall Study|Withdrawal by Subject|1|||
163311560|NCT02919306|589850408|FG001|Overall Study|Withdrawal by Subject|0|||
163311561|NCT02919306|589850407|FG000|Overall Study|Protocol Violation|1|||
163311562|NCT02919306|589850408|FG001|Overall Study|Protocol Violation|0|||
163311563|NCT04293055|589850409|FG000|Overall Study|Lost to Follow-up|1|||
163311564|NCT04293055|589850410|FG001|Overall Study|Lost to Follow-up|1|||
163311565|NCT04293055|589850409|FG000|Overall Study|Did not trigger randomization|6|||
163311566|NCT04293055|589850410|FG001|Overall Study|Did not trigger randomization|5|||
163311567|NCT04625283|589850412|FG000|Overall Study|post randomization exclusion|28|||
163311568|NCT04625283|589850413|FG001|Overall Study|post randomization exclusion|20|||
163311569|NCT01824394|589850414|FG000|Overall Study|Early Termination|1|||
163311570|NCT01824394|589850415|FG001|Overall Study|Early Termination|1|||
163311571|NCT01824394|589850416|FG002|Overall Study|Early Termination|3|||
163311572|NCT01824394|589850414|FG000|Overall Study|Withdrawn due to Study Termination|91|||
163311573|NCT01824394|589850415|FG001|Overall Study|Withdrawn due to Study Termination|83|||
163311574|NCT01824394|589850416|FG002|Overall Study|Withdrawn due to Study Termination|41|||
163311575|NCT01824394|589850414|FG000|Overall Study|Lost to Follow-up|0|||
163311576|NCT01824394|589850415|FG001|Overall Study|Lost to Follow-up|9|||
163311577|NCT01824394|589850416|FG002|Overall Study|Lost to Follow-up|3|||
163311578|NCT01824394|589850414|FG000|Overall Study|Death|3|||
163311579|NCT01824394|589850415|FG001|Overall Study|Death|2|||
163311580|NCT01824394|589850416|FG002|Overall Study|Death|4|||
163311581|NCT01824394|589850414|FG000|Overall Study|Discontinued Subjects|1|||
163311582|NCT01824394|589850415|FG001|Overall Study|Discontinued Subjects|1|||
163311583|NCT01824394|589850416|FG002|Overall Study|Discontinued Subjects|2|||
163311584|NCT01824394|589850414|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
163311585|NCT01824394|589850415|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
163311586|NCT01824394|589850416|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
163311587|NCT02619838|589850417|FG000|Overall Study|Lost to Follow-up|9|||
163311588|NCT02619838|589850417|FG000|Overall Study|Withdrawal by Subject|15|||
163311589|NCT01715285|589850418|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
163311590|NCT01715285|589850419|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
163311591|NCT01715285|589850420|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
163311592|NCT01715285|589850418|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
163311593|NCT01715285|589850419|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
163311594|NCT01715285|589850420|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
163311595|NCT01715285|589850418|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
163311596|NCT01715285|589850419|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
163311597|NCT01715285|589850420|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
163311598|NCT01715285|589850418|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
163311599|NCT01715285|589850419|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
163311600|NCT01715285|589850420|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
163311601|NCT01715285|589850418|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
163311602|NCT01715285|589850419|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
163311603|NCT01715285|589850420|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
163311604|NCT01715285|589850418|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
163311605|NCT01715285|589850419|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
163203976|NCT00471328|589459751|FG001|Extension Phase|Adverse Event|12|||
163203977|NCT00471328|589459750|FG000|Extension Phase|Withdrawal by Subject|0|||
163203978|NCT00471328|589459751|FG001|Extension Phase|Withdrawal by Subject|2|||
163203979|NCT00471328|589459750|FG000|Extension Phase|Death|1|||
163203980|NCT00471328|589459751|FG001|Extension Phase|Death|7|||
163203981|NCT00471328|589459750|FG000|Extension Phase|Protocol Deviation|3|||
163203982|NCT00471328|589459751|FG001|Extension Phase|Protocol Deviation|1|||
163203983|NCT00471328|589459750|FG000|Extension Phase|Treatment duration as per protocol|0|||
163203984|NCT00471328|589459751|FG001|Extension Phase|Treatment duration as per protocol|1|||
163203985|NCT00471328|589459750|FG000|Extension Phase|Disease Progression|32|||
163203986|NCT00471328|589459751|FG001|Extension Phase|Disease Progression|44|||
163203987|NCT00471328|589459750|FG000|Extension Phase|New cancer Therapy|1|||
163203988|NCT00471328|589459751|FG001|Extension Phase|New cancer Therapy|0|||
163203989|NCT00471328|589459750|FG000|Extension Phase|Administrative Problem|1|||
163203990|NCT00471328|589459751|FG001|Extension Phase|Administrative Problem|0|||
163203991|NCT02854631|589459752|FG000|Overall Study|Adverse Event|1|||
163203992|NCT02854631|589459753|FG001|Overall Study|Adverse Event|2|||
163203993|NCT02854631|589459752|FG000|Overall Study|Withdrew Consent|3|||
163203994|NCT02854631|589459753|FG001|Overall Study|Withdrew Consent|2|||
163203995|NCT02854631|589459752|FG000|Overall Study|Investigator's Discretion|2|||
163203996|NCT02854631|589459753|FG001|Overall Study|Investigator's Discretion|0|||
163203997|NCT02854631|589459752|FG000|Overall Study|Death|12|||
163203998|NCT02854631|589459753|FG001|Overall Study|Death|8|||
163203999|NCT02854631|589459752|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
163204000|NCT02854631|589459753|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
163204001|NCT02854631|589459752|FG000|Overall Study|Protocol Violation|0|||
163204002|NCT02854631|589459753|FG001|Overall Study|Protocol Violation|1|||
163204003|NCT02854631|589459752|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
163204004|NCT02854631|589459753|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
163204005|NCT02854631|589459752|FG000|Overall Study|Lost to Follow-up|4|||
163204006|NCT02854631|589459753|FG001|Overall Study|Lost to Follow-up|2|||
163204007|NCT03930797|589459754|FG000|Overall Study|Lost to Follow-up|3|||
163204008|NCT03930797|589459755|FG001|Overall Study|Lost to Follow-up|10|||
163204009|NCT01962896|589459756|FG000|Overall Study|Lack of Efficacy|4|||
163204010|NCT00621153|589459758|FG000|Overall Study|Safety Reason|8|||
163204011|NCT00621153|589459759|FG001|Overall Study|Safety Reason|7|||
163204012|NCT00621153|589459758|FG000|Overall Study|Adverse Event|3|||
163204013|NCT00621153|589459759|FG001|Overall Study|Adverse Event|2|||
163204014|NCT00621153|589459758|FG000|Overall Study|Lost to Follow-up|5|||
163204015|NCT00621153|589459759|FG001|Overall Study|Lost to Follow-up|1|||
163204016|NCT00621153|589459758|FG000|Overall Study|Withdrawal by Subject|4|||
163204017|NCT00621153|589459759|FG001|Overall Study|Withdrawal by Subject|5|||
163204018|NCT00753415|589459760|FG000|Part A|Disease progression|1|||
163204019|NCT00753415|589459761|FG001|Part A|Disease progression|0|||
163204020|NCT00753415|589459762|FG002|Part A|Disease progression|1|||
163204021|NCT00753415|589459763|FG003|Part A|Disease progression|2|||
163204022|NCT00753415|589459764|FG004|Part A|Disease progression|0|||
163204023|NCT00753415|589459765|FG005|Part A|Disease progression|0|||
163204024|NCT00753415|589459766|FG006|Part A|Disease progression|0|||
163204025|NCT00753415|589459767|FG007|Part A|Disease progression|0|||
163204026|NCT00753415|589459768|FG008|Part A|Disease progression|0|||
163204027|NCT00753415|589459769|FG009|Part A|Disease progression|0|||
163204028|NCT00753415|589459760|FG000|Part A|Withdrawal by Subject|0|||
163204029|NCT00753415|589459761|FG001|Part A|Withdrawal by Subject|0|||
163204030|NCT00753415|589459762|FG002|Part A|Withdrawal by Subject|1|||
163204031|NCT00753415|589459763|FG003|Part A|Withdrawal by Subject|0|||
163204032|NCT00753415|589459764|FG004|Part A|Withdrawal by Subject|0|||
163204033|NCT00753415|589459765|FG005|Part A|Withdrawal by Subject|0|||
163204034|NCT00753415|589459766|FG006|Part A|Withdrawal by Subject|0|||
163204035|NCT00753415|589459767|FG007|Part A|Withdrawal by Subject|0|||
163204036|NCT00753415|589459768|FG008|Part A|Withdrawal by Subject|0|||
163204037|NCT00753415|589459769|FG009|Part A|Withdrawal by Subject|0|||
163204038|NCT00753415|589459760|FG000|Part B|Lost to Follow-up|0|||
163204039|NCT00753415|589459761|FG001|Part B|Lost to Follow-up|0|||
163204040|NCT00753415|589459762|FG002|Part B|Lost to Follow-up|0|||
163204041|NCT00753415|589459763|FG003|Part B|Lost to Follow-up|0|||
163204042|NCT00753415|589459764|FG004|Part B|Lost to Follow-up|0|||
163204043|NCT00753415|589459765|FG005|Part B|Lost to Follow-up|0|||
162964948|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
163311606|NCT01715285|589850420|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
163311607|NCT01715285|589850418|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
163311608|NCT01715285|589850419|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
163311609|NCT01715285|589850420|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
163311610|NCT01715285|589850418|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
163311611|NCT01715285|589850419|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
163311612|NCT01715285|589850420|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
163311613|NCT01715285|589850418|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
163311614|NCT01715285|589850419|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
163204044|NCT00753415|589459766|FG006|Part B|Lost to Follow-up|0|||
163204045|NCT00753415|589459767|FG007|Part B|Lost to Follow-up|1|||
163204046|NCT00753415|589459768|FG008|Part B|Lost to Follow-up|1|||
163204047|NCT00753415|589459769|FG009|Part B|Lost to Follow-up|0|||
163204048|NCT00753415|589459760|FG000|Part B|Disease progression|0|||
163204049|NCT00753415|589459761|FG001|Part B|Disease progression|0|||
163204050|NCT00753415|589459762|FG002|Part B|Disease progression|0|||
163204051|NCT00753415|589459763|FG003|Part B|Disease progression|0|||
163204052|NCT00753415|589459764|FG004|Part B|Disease progression|0|||
163204053|NCT00753415|589459765|FG005|Part B|Disease progression|0|||
163204054|NCT00753415|589459766|FG006|Part B|Disease progression|0|||
163204055|NCT00753415|589459767|FG007|Part B|Disease progression|0|||
163311615|NCT01715285|589850420|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
163311616|NCT01715285|589850418|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
163311617|NCT01715285|589850419|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
163311618|NCT01715285|589850420|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
163311619|NCT01715285|589850418|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
163311620|NCT01715285|589850419|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
163311621|NCT01715285|589850420|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
163311622|NCT01715285|589850418|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
163311623|NCT01715285|589850419|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
163311624|NCT01715285|589850420|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
163311625|NCT01715285|589850418|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
163311626|NCT01715285|589850419|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
163311627|NCT01715285|589850420|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
163311628|NCT01715285|589850418|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
163311629|NCT01715285|589850419|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
163311630|NCT01715285|589850420|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
163311631|NCT05020249|589850421|FG000|Overall Study|Protocol Violation|1|||
163311632|NCT05020249|589850422|FG001|Overall Study|Protocol Violation|0|||
163311633|NCT05364671|589850423|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
163311634|NCT05364671|589850424|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
163311635|NCT05364671|589850423|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
163311636|NCT05364671|589850424|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
163311637|NCT05364671|589850423|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
163311638|NCT05364671|589850424|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
163311639|NCT05364671|589850423|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
163311640|NCT05364671|589850424|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
163311641|NCT05364671|589850423|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
163311642|NCT05364671|589850424|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
163311643|NCT04015167|589850425|FG000|Overall Study|Lost to Follow-up|40|||
163311644|NCT04015167|589850425|FG000|Overall Study|Adverse Event|5|||
163311645|NCT04015167|589850425|FG000|Overall Study|Withdrawal by Subject|2|||
163311646|NCT04015167|589850425|FG000|Overall Study|Subject went to jail|1|||
163311647|NCT05794243|589850426|FG000|Overall Study|Withdrawal by Subject|1|||
163311648|NCT05794243|589850427|FG001|Overall Study|Withdrawal by Subject|0|||
163311649|NCT05794243|589850428|FG002|Overall Study|Withdrawal by Subject|1|||
163311650|NCT05794243|589850426|FG000|Overall Study|Physician Decision|0|||
163311651|NCT05794243|589850427|FG001|Overall Study|Physician Decision|3|||
163311652|NCT05794243|589850428|FG002|Overall Study|Physician Decision|1|||
163311653|NCT05093829|589850435|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
163311654|NCT05093829|589850436|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
163311655|NCT05093829|589850437|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
163311656|NCT05093829|589850438|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
163311657|NCT05093829|589850439|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
163311658|NCT02727699|589852426|FG000|Overall Study|Adverse Event|2|||
163311659|NCT02727699|589852427|FG001|Overall Study|Adverse Event|0|||
163311660|NCT02727699|589852426|FG000|Overall Study|Withdrawal by Subject|5|||
163311661|NCT02727699|589852427|FG001|Overall Study|Withdrawal by Subject|3|||
163311662|NCT02727699|589852426|FG000|Overall Study|Protocol Violation|0|||
163311663|NCT02727699|589852427|FG001|Overall Study|Protocol Violation|1|||
163311664|NCT02727699|589852426|FG000|Overall Study|Physician Decision|0|||
163311665|NCT02727699|589852427|FG001|Overall Study|Physician Decision|1|||
163311666|NCT02727699|589852426|FG000|Overall Study|Lost to Follow-up|1|||
163311667|NCT02727699|589852427|FG001|Overall Study|Lost to Follow-up|0|||
163204056|NCT00753415|589459768|FG008|Part B|Disease progression|2|||
163204057|NCT00753415|589459769|FG009|Part B|Disease progression|1|||
163204058|NCT03727347|589459774|FG000|Overall Study|Withdrawal by Subject|2|||
163204059|NCT03727347|589459774|FG000|Overall Study|Lost to Follow-up|1|||
163204060|NCT04292743|589459775|FG000|Overall Study|Physician Decision|1|||
163204061|NCT04292743|589459776|FG001|Overall Study|Physician Decision|3|||
163204062|NCT04292743|589459777|FG002|Overall Study|Physician Decision|0|||
163204063|NCT04292743|589459778|FG003|Overall Study|Physician Decision|0|||
163204064|NCT04292743|589459775|FG000|Overall Study|Withdrawal by Subject|0|||
163204065|NCT04292743|589459776|FG001|Overall Study|Withdrawal by Subject|5|||
163204066|NCT04292743|589459777|FG002|Overall Study|Withdrawal by Subject|0|||
163204067|NCT04292743|589459778|FG003|Overall Study|Withdrawal by Subject|0|||
163204068|NCT04292743|589459775|FG000|Overall Study|Death|0|||
163204069|NCT04292743|589459776|FG001|Overall Study|Death|1|||
163204070|NCT04292743|589459777|FG002|Overall Study|Death|0|||
163204071|NCT04292743|589459778|FG003|Overall Study|Death|0|||
163204072|NCT04292743|589459775|FG000|Overall Study|Progression of Disease|2|||
163204073|NCT04292743|589459776|FG001|Overall Study|Progression of Disease|5|||
163204074|NCT04292743|589459777|FG002|Overall Study|Progression of Disease|0|||
163204075|NCT04292743|589459778|FG003|Overall Study|Progression of Disease|0|||
163204076|NCT04292743|589459775|FG000|Overall Study|No Treatment per protocol|0|||
163204077|NCT04292743|589459776|FG001|Overall Study|No Treatment per protocol|2|||
163204078|NCT04292743|589459777|FG002|Overall Study|No Treatment per protocol|0|||
163204079|NCT04292743|589459778|FG003|Overall Study|No Treatment per protocol|0|||
163204080|NCT05330702|589459779|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
163204081|NCT05330702|589459780|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
163204082|NCT05330702|589459781|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
163204083|NCT02881554|589459782|FG000|Overall Study|Withdrawal by Subject|2|||
163204084|NCT02881554|589459783|FG001|Overall Study|Withdrawal by Subject|0|||
163204085|NCT01852110|589461736|FG000|Overall Study|Adverse Event|12|||
163204086|NCT01852110|589461737|FG001|Overall Study|Adverse Event|5|||
163204087|NCT01852110|589461738|FG002|Overall Study|Adverse Event|0|||
163204088|NCT01852110|589461739|FG003|Overall Study|Adverse Event|0|||
163204089|NCT01852110|589461740|FG004|Overall Study|Adverse Event|0|||
163204090|NCT01852110|589461741|FG005|Overall Study|Adverse Event|0|||
163204091|NCT01852110|589461736|FG000|Overall Study|Lost to Follow-up|1|||
163204092|NCT01852110|589461737|FG001|Overall Study|Lost to Follow-up|3|||
163204093|NCT01852110|589461738|FG002|Overall Study|Lost to Follow-up|0|||
163204094|NCT01852110|589461739|FG003|Overall Study|Lost to Follow-up|0|||
163204095|NCT01852110|589461740|FG004|Overall Study|Lost to Follow-up|0|||
163204096|NCT01852110|589461741|FG005|Overall Study|Lost to Follow-up|0|||
163204097|NCT01852110|589461736|FG000|Overall Study|Non-compliance with Study Drug|2|||
163204098|NCT01852110|589461737|FG001|Overall Study|Non-compliance with Study Drug|1|||
163204099|NCT01852110|589461738|FG002|Overall Study|Non-compliance with Study Drug|0|||
163204100|NCT01852110|589461739|FG003|Overall Study|Non-compliance with Study Drug|0|||
163204101|NCT01852110|589461740|FG004|Overall Study|Non-compliance with Study Drug|0|||
163204102|NCT01852110|589461741|FG005|Overall Study|Non-compliance with Study Drug|0|||
163204103|NCT01852110|589461736|FG000|Overall Study|Physician Decision|1|||
163204104|NCT01852110|589461737|FG001|Overall Study|Physician Decision|0|||
163204105|NCT01852110|589461738|FG002|Overall Study|Physician Decision|0|||
163204106|NCT01852110|589461739|FG003|Overall Study|Physician Decision|0|||
163204107|NCT01852110|589461740|FG004|Overall Study|Physician Decision|0|||
163204108|NCT01852110|589461741|FG005|Overall Study|Physician Decision|0|||
163204109|NCT01852110|589461736|FG000|Overall Study|Protocol Violation|0|||
163204110|NCT01852110|589461737|FG001|Overall Study|Protocol Violation|1|||
163204111|NCT01852110|589461738|FG002|Overall Study|Protocol Violation|0|||
163204112|NCT01852110|589461739|FG003|Overall Study|Protocol Violation|0|||
163204113|NCT01852110|589461740|FG004|Overall Study|Protocol Violation|0|||
163204114|NCT01852110|589461741|FG005|Overall Study|Protocol Violation|0|||
163204115|NCT01852110|589461736|FG000|Overall Study|Study Terminated by Sponsor|30|||
163204116|NCT01852110|589461737|FG001|Overall Study|Study Terminated by Sponsor|32|||
163204117|NCT01852110|589461738|FG002|Overall Study|Study Terminated by Sponsor|0|||
163204118|NCT01852110|589461739|FG003|Overall Study|Study Terminated by Sponsor|0|||
163204119|NCT01852110|589461740|FG004|Overall Study|Study Terminated by Sponsor|0|||
163204120|NCT01852110|589461741|FG005|Overall Study|Study Terminated by Sponsor|0|||
163204121|NCT01852110|589461736|FG000|Overall Study|Withdrawal by Subject|4|||
163204122|NCT01852110|589461737|FG001|Overall Study|Withdrawal by Subject|4|||
163204123|NCT01852110|589461738|FG002|Overall Study|Withdrawal by Subject|0|||
163204124|NCT01852110|589461739|FG003|Overall Study|Withdrawal by Subject|0|||
163204125|NCT01852110|589461740|FG004|Overall Study|Withdrawal by Subject|0|||
163204126|NCT01852110|589461741|FG005|Overall Study|Withdrawal by Subject|0|||
163204127|NCT00903695|589461747|FG000|Overall Study|medical exclusion after 1st testing|1|||
163204128|NCT00903695|589461748|FG001|Overall Study|medical exclusion after 1st testing|0|||
163204129|NCT00903695|589461747|FG000|Overall Study|lung cancer|1|||
163204130|NCT00903695|589461748|FG001|Overall Study|lung cancer|0|||
163204131|NCT01549860|589461749|FG000|Overall Study|Withdrawal by Subject|1|||
163204132|NCT01549860|589461750|FG001|Overall Study|Withdrawal by Subject|0|||
163311668|NCT02727699|589852426|FG000|Overall Study|Sponsor Decision|1|||
163311669|NCT02727699|589852427|FG001|Overall Study|Sponsor Decision|0|||
163311670|NCT02677298|589852433|FG000|Double Blind Phase|Adverse Event|2|||
163311671|NCT02677298|589852434|FG001|Double Blind Phase|Adverse Event|1|||
163311672|NCT02677298|589852435|FG002|Double Blind Phase|Adverse Event|0|||
163311673|NCT02677298|589852433|FG000|Double Blind Phase|Physician Decision|5|||
163311674|NCT02677298|589852434|FG001|Double Blind Phase|Physician Decision|0|||
163311675|NCT02677298|589852435|FG002|Double Blind Phase|Physician Decision|0|||
163311676|NCT02677298|589852433|FG000|Double Blind Phase|Lost to Follow-up|11|||
163311677|NCT02677298|589852434|FG001|Double Blind Phase|Lost to Follow-up|7|||
163311678|NCT02677298|589852435|FG002|Double Blind Phase|Lost to Follow-up|0|||
163311679|NCT02677298|589852433|FG000|Double Blind Phase|Withdrawal by Subject|11|||
163311680|NCT02677298|589852434|FG001|Double Blind Phase|Withdrawal by Subject|8|||
163311681|NCT02677298|589852435|FG002|Double Blind Phase|Withdrawal by Subject|0|||
163311682|NCT02677298|589852433|FG000|Double Blind Phase|No study drug available at site|0|||
163311683|NCT02677298|589852434|FG001|Double Blind Phase|No study drug available at site|1|||
163311684|NCT02677298|589852435|FG002|Double Blind Phase|No study drug available at site|0|||
163311685|NCT02677298|589852433|FG000|Open Label Phase|Adverse Event|0|||
163311686|NCT02677298|589852434|FG001|Open Label Phase|Adverse Event|0|||
163311687|NCT02677298|589852435|FG002|Open Label Phase|Adverse Event|4|||
163311688|NCT02677298|589852433|FG000|Open Label Phase|Physician Decision|0|||
163311689|NCT02677298|589852434|FG001|Open Label Phase|Physician Decision|0|||
163311690|NCT02677298|589852435|FG002|Open Label Phase|Physician Decision|1|||
163311691|NCT02677298|589852433|FG000|Open Label Phase|Lost to Follow-up|0|||
163311692|NCT02677298|589852434|FG001|Open Label Phase|Lost to Follow-up|0|||
163311693|NCT02677298|589852435|FG002|Open Label Phase|Lost to Follow-up|17|||
163311694|NCT02677298|589852433|FG000|Open Label Phase|Withdrawal by Subject|0|||
163311695|NCT02677298|589852434|FG001|Open Label Phase|Withdrawal by Subject|0|||
163311696|NCT02677298|589852435|FG002|Open Label Phase|Withdrawal by Subject|38|||
163311697|NCT03611621|589852449|FG000|Overall Study|Graft loss|3|||
163311698|NCT03611621|589852449|FG000|Overall Study|Death|3|||
163311699|NCT03611621|589852449|FG000|Overall Study|Lost to Follow-up|1|||
163311700|NCT03812679|589852458|FG000|Overall Study|Adverse Event|2|||
163311701|NCT03812679|589852458|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
163311702|NCT03812679|589852458|FG000|Overall Study|Renal transplant|1|||
163311703|NCT03812679|589852458|FG000|Overall Study|Withdrawal by Subject|1|||
163311704|NCT03812679|589852458|FG000|Overall Study|Termination of study|2|||
163311705|NCT03812679|589852458|FG000|Overall Study|Water device replacement|1|||
163311706|NCT05653427|589852459|FG000|Overall Study|Study Terminated by Sponsor|13|||
163311707|NCT03524118|589852461|FG000|Overall Study|Lost to Follow-up|0|||
163311708|NCT03524118|589852462|FG001|Overall Study|Lost to Follow-up|0|||
163311709|NCT03524118|589852463|FG002|Overall Study|Lost to Follow-up|0|||
163311710|NCT03524118|589852464|FG003|Overall Study|Lost to Follow-up|0|||
163311711|NCT03524118|589852465|FG004|Overall Study|Lost to Follow-up|1|||
163311712|NCT03524118|589852466|FG005|Overall Study|Lost to Follow-up|0|||
163311713|NCT03524118|589852461|FG000|Overall Study|Other|0|||
163311714|NCT03524118|589852462|FG001|Overall Study|Other|1|||
163311715|NCT03524118|589852463|FG002|Overall Study|Other|0|||
163311716|NCT03524118|589852464|FG003|Overall Study|Other|0|||
163311717|NCT03524118|589852465|FG004|Overall Study|Other|1|||
163311718|NCT03524118|589852466|FG005|Overall Study|Other|1|||
163311719|NCT03524118|589852461|FG000|Overall Study|Physician Decision|0|||
163311720|NCT03524118|589852462|FG001|Overall Study|Physician Decision|0|||
163311721|NCT03524118|589852463|FG002|Overall Study|Physician Decision|0|||
163311722|NCT03524118|589852464|FG003|Overall Study|Physician Decision|0|||
163311723|NCT03524118|589852465|FG004|Overall Study|Physician Decision|1|||
163311724|NCT03524118|589852466|FG005|Overall Study|Physician Decision|0|||
163311725|NCT03524118|589852461|FG000|Overall Study|Protocol Violation|0|||
163311726|NCT03524118|589852462|FG001|Overall Study|Protocol Violation|0|||
163311727|NCT03524118|589852463|FG002|Overall Study|Protocol Violation|1|||
163204133|NCT01549860|589461749|FG000|Overall Study|Physician Decision|1|||
163204134|NCT01549860|589461750|FG001|Overall Study|Physician Decision|1|||
163204135|NCT01366521|589461752|FG000|Overall Study|Adverse Event|1|||
163204136|NCT01366521|589461753|FG001|Overall Study|Adverse Event|0|||
163204137|NCT01366521|589461754|FG002|Overall Study|Adverse Event|0|||
163204138|NCT01366521|589461755|FG003|Overall Study|Adverse Event|0|||
163204139|NCT01366521|589461752|FG000|Overall Study|Protocol Violation|0|||
163204140|NCT01366521|589461753|FG001|Overall Study|Protocol Violation|0|||
163204141|NCT01366521|589461754|FG002|Overall Study|Protocol Violation|1|||
163204142|NCT01366521|589461755|FG003|Overall Study|Protocol Violation|0|||
163204143|NCT01366521|589461752|FG000|Overall Study|Physician Decision|0|||
163204144|NCT01366521|589461753|FG001|Overall Study|Physician Decision|0|||
163204145|NCT01366521|589461754|FG002|Overall Study|Physician Decision|1|||
163204146|NCT01366521|589461755|FG003|Overall Study|Physician Decision|0|||
163204147|NCT01366521|589461752|FG000|Overall Study|Withdrawal by Subject|0|||
163204148|NCT01366521|589461753|FG001|Overall Study|Withdrawal by Subject|1|||
163204149|NCT01366521|589461754|FG002|Overall Study|Withdrawal by Subject|0|||
163204150|NCT01366521|589461755|FG003|Overall Study|Withdrawal by Subject|0|||
163204151|NCT02430311|589461756|FG000|Part A|Adverse Event|0|||
163204152|NCT02430311|589461757|FG001|Part A|Adverse Event|1|||
163204153|NCT02430311|589461756|FG000|Part A|Withdrawal by Subject|1|||
163204154|NCT02430311|589461757|FG001|Part A|Withdrawal by Subject|0|||
163204155|NCT02430311|589461756|FG000|Part B|Meet study-specific withdrawal criteria|6|||
163204156|NCT02430311|589461757|FG001|Part B|Meet study-specific withdrawal criteria|6|||
163204157|NCT02430311|589461756|FG000|Part B|Withdrawal by Subject|2|||
163204158|NCT02430311|589461757|FG001|Part B|Withdrawal by Subject|2|||
163204159|NCT02430311|589461756|FG000|Part B|Adverse Event|1|||
163204160|NCT02430311|589461757|FG001|Part B|Adverse Event|0|||
163204161|NCT02430311|589461756|FG000|Part B|Death|1|||
163204162|NCT02430311|589461757|FG001|Part B|Death|0|||
163204163|NCT00578812|589461758|FG000|Overall Study|Not treated|6|||
163204164|NCT00578812|589461759|FG001|Overall Study|Not treated|7|||
163204165|NCT01599234|589461764|FG000|Overall Study|Adverse Event|9|||
163204166|NCT01599234|589461765|FG001|Overall Study|Adverse Event|5|||
163204167|NCT01599234|589461764|FG000|Overall Study|Withdrawal by Subject|2|||
163204168|NCT01599234|589461765|FG001|Overall Study|Withdrawal by Subject|1|||
163204169|NCT01599234|589461764|FG000|Overall Study|Lost to Follow-up|1|||
163204170|NCT01599234|589461765|FG001|Overall Study|Lost to Follow-up|2|||
163204171|NCT01599234|589461764|FG000|Overall Study|Lack of Efficacy|2|||
163204172|NCT01599234|589461765|FG001|Overall Study|Lack of Efficacy|4|||
163204173|NCT01599234|589461764|FG000|Overall Study|Unable to operate spray|1|||
163204174|NCT01599234|589461765|FG001|Overall Study|Unable to operate spray|0|||
163204175|NCT01599234|589461764|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
163204176|NCT01599234|589461765|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
163204177|NCT01599234|589461764|FG000|Overall Study|Death|1|||
163204178|NCT01599234|589461765|FG001|Overall Study|Death|0|||
163204179|NCT01599234|589461764|FG000|Overall Study|Patient would not stop driving|1|||
163204180|NCT01599234|589461765|FG001|Overall Study|Patient would not stop driving|0|||
163204181|NCT01599234|589461764|FG000|Overall Study|Contra-indication discovered|0|||
163204182|NCT01599234|589461765|FG001|Overall Study|Contra-indication discovered|1|||
163204183|NCT01599234|589461764|FG000|Overall Study|Pregnancy|0|||
163204184|NCT01599234|589461765|FG001|Overall Study|Pregnancy|1|||
163204185|NCT01513473|589461781|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
163204186|NCT01513473|589461782|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
163204187|NCT01513473|589461781|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
163204188|NCT01513473|589461782|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
163204189|NCT01513473|589461781|FG000|Main Trial (26 Weeks)|Unclassified|0|||
163204190|NCT01513473|589461782|FG001|Main Trial (26 Weeks)|Unclassified|2|||
163204191|NCT01513473|589461781|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
163204192|NCT01513473|589461782|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
163204193|NCT01513473|589461781|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
163204194|NCT01513473|589461782|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
163204195|NCT04016285|589461783|FG000|Overall Study|Did not progress to surgery|2|||
163204196|NCT04016285|589461784|FG001|Overall Study|Did not progress to surgery|5|||
163204197|NCT04016285|589461783|FG000|Overall Study|Failed to collect outcome data|5|||
163204198|NCT04016285|589461784|FG001|Overall Study|Failed to collect outcome data|3|||
163204199|NCT03462082|589461785|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
162964949|NCT00858780|588572010|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
162964950|NCT00858780|588572011|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
162964951|NCT00858780|588572012|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
162964952|NCT00858780|588572013|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
162964953|NCT00858780|588572014|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
162964954|NCT00858780|588572010|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
162964955|NCT00858780|588572011|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
162964956|NCT00858780|588572012|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
162964957|NCT00858780|588572013|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
162964958|NCT00858780|588572014|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
162964959|NCT00858780|588572010|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
162964960|NCT00858780|588572011|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
163204200|NCT03462082|589461786|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
163204201|NCT03462082|589461787|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
163204202|NCT03462082|589461788|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
163204203|NCT03462082|589461789|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
163204204|NCT03462082|589461790|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
163204205|NCT03462082|589461791|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
163204206|NCT03462082|589461792|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
163204207|NCT00166114|589461795|FG000|Overall Study|Protocol Violation|2|||
163204208|NCT00166114|589461796|FG001|Overall Study|Protocol Violation|1|||
163204209|NCT00166114|589461795|FG000|Overall Study|Withdrawal by Subject|10|||
163204210|NCT00166114|589461796|FG001|Overall Study|Withdrawal by Subject|4|||
163204211|NCT00166114|589461795|FG000|Overall Study|Adverse Event|2|||
163204212|NCT00166114|589461796|FG001|Overall Study|Adverse Event|1|||
163204213|NCT02708121|589461801|FG000|Overall Study|Withdrawn by Study Team|1|||
163204214|NCT02708121|589461802|FG001|Overall Study|Withdrawn by Study Team|1|||
163204215|NCT02708121|589461801|FG000|Overall Study|Withdrawal by Subject|0|||
163204216|NCT02708121|589461802|FG001|Overall Study|Withdrawal by Subject|4|||
163204217|NCT03266107|589461805|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
163204218|NCT03266107|589461805|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
163204219|NCT03266107|589461805|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
163204220|NCT03266107|589461805|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
163204221|NCT02548650|589461808|FG000|Triple Therapy|Adverse Event|1|||
163204222|NCT02548650|589461809|FG001|Triple Therapy|Adverse Event|0|||
163204223|NCT02548650|589461808|FG000|Triple Therapy|Withdrawal by Subject|0|||
163204224|NCT02548650|589461809|FG001|Triple Therapy|Withdrawal by Subject|4|||
163204225|NCT02548650|589461808|FG000|Double Therapy|Adverse Event|1|||
163204226|NCT02548650|589461809|FG001|Double Therapy|Adverse Event|1|||
163204227|NCT02548650|589461808|FG000|Double Therapy|Withdrawal by Subject|0|||
163204228|NCT02548650|589461809|FG001|Double Therapy|Withdrawal by Subject|1|||
163204229|NCT01191801|589461810|FG000|Overall Study|Death|36|||
163204230|NCT01191801|589461811|FG001|Overall Study|Death|12|||
163204231|NCT01191801|589461810|FG000|Overall Study|Lack of Efficacy|176|||
163204232|NCT01191801|589461811|FG001|Overall Study|Lack of Efficacy|258|||
163204233|NCT01191801|589461810|FG000|Overall Study|Adverse Event|9|||
162964961|NCT00858780|588572012|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
162964962|NCT00858780|588572013|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
162964963|NCT00858780|588572014|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
162964964|NCT00858780|588572010|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
162964965|NCT00858780|588572011|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
162964966|NCT00858780|588572012|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
162964967|NCT00858780|588572013|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
162964968|NCT00858780|588572014|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
162964969|NCT00858780|588572010|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
162964970|NCT00858780|588572011|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
162964971|NCT00858780|588572012|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
162964972|NCT00858780|588572013|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
162964973|NCT00858780|588572014|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
162964974|NCT00858780|588572010|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
162964975|NCT00858780|588572011|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
162964976|NCT00858780|588572012|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
162964977|NCT00858780|588572013|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
162964978|NCT00858780|588572014|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
162964979|NCT01024855|588572017|FG000|Overall Study|Inclusion/exclusion criteria|1|||
162964980|NCT03306277|588572021|FG000|Overall Study|Death|1|||
162964981|NCT03306277|588572021|FG000|Overall Study|Adverse Event|1|||
162964982|NCT03306277|588572021|FG000|Overall Study|Withdrawal by Subject|1|||
162964983|NCT01926119|588572025|FG000|Overall Study|Withdrawal by Subject|1|||
162964984|NCT00645853|588572026|FG000|Overall Study|Adverse Event|18|||
162964985|NCT00645853|588572027|FG001|Overall Study|Adverse Event|7|||
162964986|NCT00645853|588572026|FG000|Overall Study|AZ study closure in Hungary|60|||
162964987|NCT00645853|588572027|FG001|Overall Study|AZ study closure in Hungary|40|||
162964988|NCT00645853|588572026|FG000|Overall Study|Withdrawal by Subject|5|||
162964989|NCT00645853|588572027|FG001|Overall Study|Withdrawal by Subject|2|||
162964990|NCT00645853|588572026|FG000|Overall Study|Protocol Violation|0|||
162964991|NCT00645853|588572027|FG001|Overall Study|Protocol Violation|2|||
162964992|NCT00645853|588572026|FG000|Overall Study|Discontinuation criteria|2|||
162964993|NCT00645853|588572027|FG001|Overall Study|Discontinuation criteria|2|||
162964994|NCT00645853|588572026|FG000|Overall Study|recall of ICF, planned operation, death|7|||
162964995|NCT00645853|588572027|FG001|Overall Study|recall of ICF, planned operation, death|4|||
162964996|NCT00406393|588572028|FG000|Overall Study|Did not undergo transplantation|2|||
162964997|NCT00406393|588572029|FG001|Overall Study|Did not undergo transplantation|1|||
162964998|NCT03885934|588572030|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
162964999|NCT03885934|588572031|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
162965000|NCT03885934|588572032|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
162965001|NCT03885934|588572033|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
162965002|NCT03885934|588572034|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
162965003|NCT03885934|588572035|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
162965004|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
162965005|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
162965006|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
162965007|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
162965008|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
162965009|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
162965010|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
163311728|NCT03524118|589852464|FG003|Overall Study|Protocol Violation|0|||
163311729|NCT03524118|589852465|FG004|Overall Study|Protocol Violation|1|||
163311730|NCT03524118|589852466|FG005|Overall Study|Protocol Violation|0|||
163311731|NCT03524118|589852461|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163311732|NCT03524118|589852462|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163311733|NCT03524118|589852463|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163311734|NCT03524118|589852464|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
163311735|NCT03524118|589852465|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
163311736|NCT03524118|589852466|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
163311737|NCT01437709|589852469|FG000|Overall Study|Adverse Event|0|||
162965011|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
162965012|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
162965013|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
162965014|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
162965015|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
162965016|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
162965017|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
162965018|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
162965019|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
162965020|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
162965021|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
162965022|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
162965023|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
162965024|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
162965025|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
162965026|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
162965027|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
162965028|NCT02227238|588572036|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
162965029|NCT02227238|588572037|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
162965030|NCT02227238|588572038|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
162965031|NCT02227238|588572036|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
162965032|NCT02227238|588572037|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
162965033|NCT02227238|588572038|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
162965034|NCT02227238|588572036|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
162965035|NCT02227238|588572037|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
162965036|NCT02227238|588572038|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
162965037|NCT02227238|588572036|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
162965038|NCT02227238|588572037|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
162965039|NCT02227238|588572038|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
162965040|NCT02227238|588572036|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
162965041|NCT02227238|588572037|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
162965042|NCT02227238|588572038|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
162965043|NCT02227238|588572036|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
162965044|NCT02227238|588572037|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
162965045|NCT02227238|588572038|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
162965046|NCT00380588|588572039|FG000|Overall Study|Unequivocal Disease Progression|25|||
162965047|NCT00380588|588572040|FG001|Overall Study|Unequivocal Disease Progression|34|||
162965048|NCT00380588|588572039|FG000|Overall Study|Next Cycle Not Started|4|||
162965049|NCT00380588|588572040|FG001|Overall Study|Next Cycle Not Started|0|||
162965050|NCT00380588|588572039|FG000|Overall Study|Adverse Event|7|||
162965051|NCT00380588|588572040|FG001|Overall Study|Adverse Event|3|||
162965052|NCT00380588|588572039|FG000|Overall Study|Withdrawal by Subject|1|||
162965053|NCT00380588|588572040|FG001|Overall Study|Withdrawal by Subject|3|||
162965054|NCT00380588|588572039|FG000|Overall Study|Physician Decision|2|||
162965055|NCT00380588|588572040|FG001|Overall Study|Physician Decision|0|||
162965056|NCT02096705|588572041|FG000|Treatment|Adverse Event|6|||
162965057|NCT02096705|588572042|FG001|Treatment|Adverse Event|3|||
162965058|NCT02096705|588572041|FG000|Treatment|Subject request to discontinue treatment|1|||
162965059|NCT02096705|588572042|FG001|Treatment|Subject request to discontinue treatment|1|||
163397436|NCT01490450|590167713|FG003|Period 1|Request to discontinue treatment|0|||
163397437|NCT01490450|590167710|FG000|Period 1|Withdrawal by Subject|0|||
163311738|NCT01437709|589852470|FG001|Overall Study|Adverse Event|1|||
163311739|NCT01437709|589852471|FG002|Overall Study|Adverse Event|0|||
163311740|NCT01437709|589852469|FG000|Overall Study|Pt trasnferred care|0|||
163311741|NCT01437709|589852470|FG001|Overall Study|Pt trasnferred care|1|||
163311742|NCT01437709|589852471|FG002|Overall Study|Pt trasnferred care|0|||
163311743|NCT02761057|589852485|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
163311744|NCT02761057|589852486|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
163311745|NCT02761057|589852487|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
163311746|NCT02761057|589852488|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
163311747|NCT02761057|589852485|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
163311748|NCT02761057|589852486|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
163311749|NCT02761057|589852487|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
163311750|NCT02761057|589852488|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
163311751|NCT02761057|589852485|FG000|Overall Study|Currently On Study Treatment|0|||
163311752|NCT02761057|589852486|FG001|Overall Study|Currently On Study Treatment|3|||
163311753|NCT02761057|589852487|FG002|Overall Study|Currently On Study Treatment|0|||
163311754|NCT02761057|589852488|FG003|Overall Study|Currently On Study Treatment|0|||
163311755|NCT02761057|589852485|FG000|Overall Study|Adverse Event|11|||
163311756|NCT02761057|589852486|FG001|Overall Study|Adverse Event|9|||
163311757|NCT02761057|589852487|FG002|Overall Study|Adverse Event|5|||
163311758|NCT02761057|589852488|FG003|Overall Study|Adverse Event|3|||
163397438|NCT01490450|590167711|FG001|Period 1|Withdrawal by Subject|0|||
163204234|NCT01191801|589461811|FG001|Overall Study|Adverse Event|8|||
163204235|NCT01191801|589461810|FG000|Overall Study|Protocol Violation|2|||
162965060|NCT02096705|588572041|FG000|Treatment|Withdrawal by Subject|1|||
162965061|NCT02096705|588572042|FG001|Treatment|Withdrawal by Subject|0|||
163204236|NCT01191801|589461811|FG001|Overall Study|Protocol Violation|4|||
163204237|NCT01191801|589461810|FG000|Overall Study|Physician Decision|47|||
163204238|NCT01191801|589461811|FG001|Overall Study|Physician Decision|24|||
163204239|NCT01191801|589461810|FG000|Overall Study|Withdrawal by Subject|1|||
163204240|NCT01191801|589461811|FG001|Overall Study|Withdrawal by Subject|4|||
163204241|NCT01191801|589461810|FG000|Overall Study|Not Provided|45|||
163204242|NCT01191801|589461811|FG001|Overall Study|Not Provided|27|||
163204243|NCT02651922|589461815|FG000|Overall Study|due to exclusion criteria|2|||
163204244|NCT01366209|589461816|FG000|Overall Study|Adverse Event|6|||
163204245|NCT01366209|589461817|FG001|Overall Study|Adverse Event|7|||
163204246|NCT01366209|589461816|FG000|Overall Study|Withdrawal by Subject|4|||
163204247|NCT01366209|589461817|FG001|Overall Study|Withdrawal by Subject|4|||
163204248|NCT01366209|589461816|FG000|Overall Study|Death|12|||
163204249|NCT01366209|589461817|FG001|Overall Study|Death|19|||
163204250|NCT01366209|589461816|FG000|Overall Study|Lung transplantation|6|||
163204251|NCT01366209|589461817|FG001|Overall Study|Lung transplantation|1|||
163204252|NCT01366209|589461816|FG000|Overall Study|Lost to Follow-up|2|||
163204253|NCT01366209|589461817|FG001|Overall Study|Lost to Follow-up|1|||
163204254|NCT01366209|589461816|FG000|Overall Study|Physician Decision|1|||
163204255|NCT01366209|589461817|FG001|Overall Study|Physician Decision|0|||
163204256|NCT01366209|589461816|FG000|Overall Study|Sponsors decision|0|||
163204257|NCT01366209|589461817|FG001|Overall Study|Sponsors decision|1|||
163204258|NCT01366209|589461816|FG000|Overall Study|Withdrew consent|4|||
163204259|NCT01366209|589461817|FG001|Overall Study|Withdrew consent|3|||
163204260|NCT03018704|589461818|FG000|Overall Study|Lost to Follow-up|1|||
163204261|NCT03018704|589461819|FG001|Overall Study|Lost to Follow-up|1|||
163204262|NCT00320411|589461820|FG000|Overall Study|No investigational product admin.|4|||
163204263|NCT04448171|589461823|FG000|Overall Study|Procedure Cancelled|1|||
163204264|NCT04448171|589461824|FG001|Overall Study|Procedure Cancelled|0|||
163204265|NCT04448171|589461823|FG000|Overall Study|Protocol Violation|1|||
163204266|NCT04448171|589461824|FG001|Overall Study|Protocol Violation|0|||
163204267|NCT02088047|589461825|FG000|Overall Study|Withdrawal by Subject|1|||
163204268|NCT02088047|589461826|FG001|Overall Study|Withdrawal by Subject|0|||
163204269|NCT00211809|589461829|FG000|Overall Study|Lack of Efficacy|1|||
163204270|NCT00211809|589461829|FG000|Overall Study|Lost to Follow-up|2|||
163204271|NCT00211809|589461829|FG000|Overall Study|Pregnancy|1|||
163204272|NCT00211809|589461829|FG000|Overall Study|side effects|2|||
163204273|NCT01417234|589461830|FG000|Overall Study|Subject non-compliant|3|||
163204274|NCT00023764|589461831|FG000|Overall Study|Other|1|||
163204275|NCT00023764|589461831|FG000|Overall Study|Adverse Event|4|||
163204276|NCT00023764|589461831|FG000|Overall Study|Withdrawal by Subject|1|||
163204277|NCT00023764|589461831|FG000|Overall Study|Progression of disease|6|||
163311759|NCT02761057|589852485|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
163311760|NCT02761057|589852486|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
163311761|NCT02761057|589852487|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
163311762|NCT02761057|589852488|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
163311763|NCT02761057|589852485|FG000|Overall Study|Progression/Relapse|29|||
163311764|NCT02761057|589852486|FG001|Overall Study|Progression/Relapse|27|||
163311765|NCT02761057|589852487|FG002|Overall Study|Progression/Relapse|20|||
163311766|NCT02761057|589852488|FG003|Overall Study|Progression/Relapse|23|||
163311767|NCT02761057|589852485|FG000|Overall Study|Death|2|||
163311768|NCT02761057|589852486|FG001|Overall Study|Death|2|||
163311769|NCT02761057|589852487|FG002|Overall Study|Death|1|||
163311770|NCT02761057|589852488|FG003|Overall Study|Death|1|||
163311771|NCT02761057|589852485|FG000|Overall Study|Other - Not Protocol Specified|2|||
163311772|NCT02761057|589852486|FG001|Overall Study|Other - Not Protocol Specified|1|||
163311773|NCT02761057|589852487|FG002|Overall Study|Other - Not Protocol Specified|2|||
163311774|NCT02761057|589852488|FG003|Overall Study|Other - Not Protocol Specified|0|||
163311775|NCT04971681|589852489|FG000|Followup|Lost to Follow-up|1|||
163311776|NCT04971681|589852490|FG001|Followup|Lost to Follow-up|0|||
163311777|NCT00686335|589852491|FG000|Run-in Period|Adverse Event|1|||
163311778|NCT00686335|589852491|FG000|Run-in Period|asthma exacerbation|1|||
163311779|NCT00686335|589852491|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
163311780|NCT04376502|589852494|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
163397439|NCT01490450|590167712|FG002|Period 1|Withdrawal by Subject|0|||
163311781|NCT04111536|589852495|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
163311782|NCT04111536|589852496|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
163311783|NCT04111536|589852495|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
163311784|NCT04111536|589852496|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
163311785|NCT04111536|589852495|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
163311786|NCT04111536|589852496|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
163311787|NCT04111536|589852495|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
163311788|NCT04111536|589852496|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
163311789|NCT06037369|589852498|FG000|Overall Study|Lost to Follow-up|0|||
163311790|NCT06037369|589852499|FG001|Overall Study|Lost to Follow-up|1|||
163311791|NCT04209465|589852500|FG000|Overall Study|Adverse Event|0|||
163311792|NCT04209465|589852501|FG001|Overall Study|Adverse Event|0|||
163311793|NCT04209465|589852502|FG002|Overall Study|Adverse Event|0|||
163311794|NCT04209465|589852503|FG003|Overall Study|Adverse Event|0|||
163311795|NCT04209465|589852504|FG004|Overall Study|Adverse Event|0|||
163311796|NCT04209465|589852505|FG005|Overall Study|Adverse Event|1|||
163311797|NCT04209465|589852506|FG006|Overall Study|Adverse Event|0|||
163311798|NCT04209465|589852507|FG007|Overall Study|Adverse Event|0|||
163311799|NCT04209465|589852508|FG008|Overall Study|Adverse Event|1|||
163311800|NCT04209465|589852509|FG009|Overall Study|Adverse Event|0|||
163311801|NCT04209465|589852510|FG010|Overall Study|Adverse Event|2|||
163311802|NCT04209465|589852511|FG011|Overall Study|Adverse Event|1|||
163311803|NCT04209465|589852512|FG012|Overall Study|Adverse Event|1|||
163311804|NCT04209465|589852500|FG000|Overall Study|Death|1|||
163311805|NCT04209465|589852501|FG001|Overall Study|Death|0|||
163311806|NCT04209465|589852502|FG002|Overall Study|Death|0|||
163311807|NCT04209465|589852503|FG003|Overall Study|Death|0|||
163311808|NCT04209465|589852504|FG004|Overall Study|Death|2|||
163311809|NCT04209465|589852505|FG005|Overall Study|Death|7|||
163311810|NCT04209465|589852506|FG006|Overall Study|Death|2|||
163311811|NCT04209465|589852507|FG007|Overall Study|Death|2|||
163311812|NCT04209465|589852508|FG008|Overall Study|Death|1|||
163311813|NCT04209465|589852509|FG009|Overall Study|Death|1|||
163311814|NCT04209465|589852510|FG010|Overall Study|Death|1|||
163311815|NCT04209465|589852511|FG011|Overall Study|Death|0|||
163311816|NCT04209465|589852512|FG012|Overall Study|Death|10|||
163311817|NCT04209465|589852500|FG000|Overall Study|Physician Decision|0|||
163311818|NCT04209465|589852501|FG001|Overall Study|Physician Decision|1|||
163311819|NCT04209465|589852502|FG002|Overall Study|Physician Decision|0|||
163204278|NCT00023764|589461831|FG000|Overall Study|patient received other treatment|1|||
163204279|NCT00023764|589461831|FG000|Overall Study|delay in obtaining staging images|1|||
163204280|NCT01537393|589461832|FG000|Overall Study|Exclude prior to study|32|||
163204281|NCT01537393|589461833|FG001|Overall Study|Exclude prior to study|44|||
163204282|NCT01537393|589461832|FG000|Overall Study|Death|20|||
163204283|NCT01537393|589461833|FG001|Overall Study|Death|32|||
163204284|NCT01537393|589461832|FG000|Overall Study|Withdrawal by Subject|18|||
163204285|NCT01537393|589461833|FG001|Overall Study|Withdrawal by Subject|17|||
163204286|NCT01537393|589461832|FG000|Overall Study|Lost to Follow-up|53|||
163204287|NCT01537393|589461833|FG001|Overall Study|Lost to Follow-up|48|||
163204288|NCT01537393|589461832|FG000|Overall Study|Failure - Regrafted|28|||
163204289|NCT01537393|589461833|FG001|Overall Study|Failure - Regrafted|43|||
163204290|NCT01537393|589461832|FG000|Overall Study|Failure - Not regrafted|2|||
163204291|NCT01537393|589461833|FG001|Overall Study|Failure - Not regrafted|6|||
163204292|NCT01537393|589461832|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
163204293|NCT01537393|589461833|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
163204294|NCT00459953|589461835|FG000|Overall Study|not analyzed-household member in study|1|||
163204295|NCT00459953|589461836|FG001|Overall Study|not analyzed-household member in study|1|||
163204296|NCT00036270|589461837|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
163204297|NCT00036270|589461838|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
163204298|NCT00036270|589461837|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
163204299|NCT00036270|589461838|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
163204300|NCT00036270|589461837|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
163204301|NCT00036270|589461838|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
163204302|NCT00036270|589461837|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
163204303|NCT00036270|589461838|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
163204304|NCT00036270|589461837|FG000|Study Treatment to 5 Year Report|Other|277|||
163204305|NCT00036270|589461838|FG001|Study Treatment to 5 Year Report|Other|288|||
163204306|NCT00036270|589461837|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
163204307|NCT00036270|589461838|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
163204308|NCT00036270|589461837|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
163204309|NCT00036270|589461838|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
163204310|NCT00036270|589461837|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
163204311|NCT00036270|589461838|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
163311820|NCT04209465|589852503|FG003|Overall Study|Physician Decision|0|||
163311821|NCT04209465|589852504|FG004|Overall Study|Physician Decision|0|||
162965062|NCT02096705|588572041|FG000|Treatment|Other|1|||
163311822|NCT04209465|589852505|FG005|Overall Study|Physician Decision|0|||
163311823|NCT04209465|589852506|FG006|Overall Study|Physician Decision|0|||
163311824|NCT04209465|589852507|FG007|Overall Study|Physician Decision|0|||
163311825|NCT04209465|589852508|FG008|Overall Study|Physician Decision|0|||
163311826|NCT04209465|589852509|FG009|Overall Study|Physician Decision|0|||
163311827|NCT04209465|589852510|FG010|Overall Study|Physician Decision|0|||
163311828|NCT04209465|589852511|FG011|Overall Study|Physician Decision|0|||
163311829|NCT04209465|589852512|FG012|Overall Study|Physician Decision|0|||
163311830|NCT04209465|589852500|FG000|Overall Study|Progressive Disease|0|||
163311831|NCT04209465|589852501|FG001|Overall Study|Progressive Disease|0|||
163311832|NCT04209465|589852502|FG002|Overall Study|Progressive Disease|1|||
163311833|NCT04209465|589852503|FG003|Overall Study|Progressive Disease|2|||
163311834|NCT04209465|589852504|FG004|Overall Study|Progressive Disease|8|||
163311835|NCT04209465|589852505|FG005|Overall Study|Progressive Disease|5|||
163311836|NCT04209465|589852506|FG006|Overall Study|Progressive Disease|3|||
163311837|NCT04209465|589852507|FG007|Overall Study|Progressive Disease|4|||
163311838|NCT04209465|589852508|FG008|Overall Study|Progressive Disease|1|||
163311839|NCT04209465|589852509|FG009|Overall Study|Progressive Disease|3|||
163311840|NCT04209465|589852510|FG010|Overall Study|Progressive Disease|2|||
163311841|NCT04209465|589852511|FG011|Overall Study|Progressive Disease|1|||
163311842|NCT04209465|589852512|FG012|Overall Study|Progressive Disease|0|||
163311843|NCT04209465|589852500|FG000|Overall Study|Withdrawal by Subject|0|||
163311844|NCT04209465|589852501|FG001|Overall Study|Withdrawal by Subject|0|||
163311845|NCT04209465|589852502|FG002|Overall Study|Withdrawal by Subject|0|||
163311846|NCT04209465|589852503|FG003|Overall Study|Withdrawal by Subject|0|||
163311847|NCT04209465|589852504|FG004|Overall Study|Withdrawal by Subject|0|||
163311848|NCT04209465|589852505|FG005|Overall Study|Withdrawal by Subject|1|||
163311849|NCT04209465|589852506|FG006|Overall Study|Withdrawal by Subject|2|||
163311850|NCT04209465|589852507|FG007|Overall Study|Withdrawal by Subject|0|||
163311851|NCT04209465|589852508|FG008|Overall Study|Withdrawal by Subject|1|||
163311852|NCT04209465|589852509|FG009|Overall Study|Withdrawal by Subject|0|||
163311853|NCT04209465|589852510|FG010|Overall Study|Withdrawal by Subject|0|||
163311854|NCT04209465|589852511|FG011|Overall Study|Withdrawal by Subject|2|||
163311855|NCT04209465|589852512|FG012|Overall Study|Withdrawal by Subject|2|||
163311856|NCT04209465|589852500|FG000|Overall Study|Lost to Follow-up|0|||
163311857|NCT04209465|589852501|FG001|Overall Study|Lost to Follow-up|0|||
163311858|NCT04209465|589852502|FG002|Overall Study|Lost to Follow-up|0|||
163311859|NCT04209465|589852503|FG003|Overall Study|Lost to Follow-up|0|||
163311860|NCT04209465|589852504|FG004|Overall Study|Lost to Follow-up|0|||
163311861|NCT04209465|589852505|FG005|Overall Study|Lost to Follow-up|1|||
163311862|NCT04209465|589852506|FG006|Overall Study|Lost to Follow-up|0|||
163311863|NCT04209465|589852507|FG007|Overall Study|Lost to Follow-up|0|||
163311864|NCT04209465|589852508|FG008|Overall Study|Lost to Follow-up|1|||
163311865|NCT04209465|589852509|FG009|Overall Study|Lost to Follow-up|0|||
163311866|NCT04209465|589852510|FG010|Overall Study|Lost to Follow-up|0|||
163311867|NCT04209465|589852511|FG011|Overall Study|Lost to Follow-up|1|||
163311868|NCT04209465|589852512|FG012|Overall Study|Lost to Follow-up|0|||
163311869|NCT04209465|589852500|FG000|Overall Study|Started new therapy|0|||
163311870|NCT04209465|589852501|FG001|Overall Study|Started new therapy|0|||
163311871|NCT04209465|589852502|FG002|Overall Study|Started new therapy|0|||
163311872|NCT04209465|589852503|FG003|Overall Study|Started new therapy|0|||
163311873|NCT04209465|589852504|FG004|Overall Study|Started new therapy|0|||
163311874|NCT04209465|589852505|FG005|Overall Study|Started new therapy|1|||
163311875|NCT04209465|589852506|FG006|Overall Study|Started new therapy|0|||
163311876|NCT04209465|589852507|FG007|Overall Study|Started new therapy|0|||
163311877|NCT04209465|589852508|FG008|Overall Study|Started new therapy|0|||
163311878|NCT04209465|589852509|FG009|Overall Study|Started new therapy|0|||
163311879|NCT04209465|589852510|FG010|Overall Study|Started new therapy|0|||
163311880|NCT04209465|589852511|FG011|Overall Study|Started new therapy|0|||
163311881|NCT04209465|589852512|FG012|Overall Study|Started new therapy|0|||
163311882|NCT04209465|589852500|FG000|Overall Study|Study terminated early by sponsor|0|||
163311883|NCT04209465|589852501|FG001|Overall Study|Study terminated early by sponsor|0|||
163311884|NCT04209465|589852502|FG002|Overall Study|Study terminated early by sponsor|0|||
163311885|NCT04209465|589852503|FG003|Overall Study|Study terminated early by sponsor|0|||
163311886|NCT04209465|589852504|FG004|Overall Study|Study terminated early by sponsor|0|||
163311887|NCT04209465|589852505|FG005|Overall Study|Study terminated early by sponsor|0|||
163311888|NCT04209465|589852506|FG006|Overall Study|Study terminated early by sponsor|3|||
163311889|NCT04209465|589852507|FG007|Overall Study|Study terminated early by sponsor|0|||
163311890|NCT04209465|589852508|FG008|Overall Study|Study terminated early by sponsor|0|||
163311891|NCT04209465|589852509|FG009|Overall Study|Study terminated early by sponsor|0|||
163311892|NCT04209465|589852510|FG010|Overall Study|Study terminated early by sponsor|0|||
163311893|NCT04209465|589852511|FG011|Overall Study|Study terminated early by sponsor|0|||
163311894|NCT04209465|589852512|FG012|Overall Study|Study terminated early by sponsor|3|||
163311895|NCT04209465|589852500|FG000|Overall Study|Other|0|||
163311896|NCT04209465|589852501|FG001|Overall Study|Other|0|||
163311897|NCT04209465|589852502|FG002|Overall Study|Other|0|||
163311898|NCT04209465|589852503|FG003|Overall Study|Other|0|||
163311899|NCT04209465|589852504|FG004|Overall Study|Other|0|||
163311900|NCT04209465|589852505|FG005|Overall Study|Other|0|||
163311901|NCT04209465|589852506|FG006|Overall Study|Other|0|||
163311902|NCT04209465|589852507|FG007|Overall Study|Other|0|||
163311903|NCT04209465|589852508|FG008|Overall Study|Other|1|||
163311904|NCT04209465|589852509|FG009|Overall Study|Other|0|||
163311905|NCT04209465|589852510|FG010|Overall Study|Other|0|||
163311906|NCT04209465|589852511|FG011|Overall Study|Other|0|||
163311907|NCT04209465|589852512|FG012|Overall Study|Other|0|||
163311908|NCT05603143|589852513|FG000|Overall Study|Withdrew consent|6|||
163311909|NCT05603143|589852514|FG001|Overall Study|Withdrew consent|2|||
163311910|NCT05603143|589852513|FG000|Overall Study|Randomized but never treated|0|||
163311911|NCT05603143|589852514|FG001|Overall Study|Randomized but never treated|3|||
163311912|NCT05603143|589852513|FG000|Overall Study|Adverse Event|2|||
163311913|NCT05603143|589852514|FG001|Overall Study|Adverse Event|0|||
163311914|NCT05603143|589852513|FG000|Overall Study|Death|0|||
163311915|NCT05603143|589852514|FG001|Overall Study|Death|1|||
163311916|NCT05603143|589852513|FG000|Overall Study|Investigator's discretion|1|||
163311917|NCT05603143|589852514|FG001|Overall Study|Investigator's discretion|0|||
163311918|NCT05603143|589852513|FG000|Overall Study|Lost to Follow-up|0|||
163311919|NCT05603143|589852514|FG001|Overall Study|Lost to Follow-up|1|||
163311920|NCT05603143|589852513|FG000|Overall Study|Protocol Violation|0|||
163311921|NCT05603143|589852514|FG001|Overall Study|Protocol Violation|1|||
163311922|NCT05647304|589852515|FG000|Overall Study|Withdrawal by Subject|1|||
163311923|NCT05647304|589852516|FG001|Overall Study|Withdrawal by Subject|0|||
163311924|NCT04171999|589852517|FG000|Overall Study|deemed ineligible after randomization|2|||
163311925|NCT04171999|589852518|FG001|Overall Study|deemed ineligible after randomization|1|||
163311926|NCT04505904|589852523|FG000|Overall Study|Withdrawal by Subject|1|||
163311927|NCT04505904|589852524|FG001|Overall Study|Withdrawal by Subject|2|||
163311928|NCT04505904|589852525|FG002|Overall Study|Withdrawal by Subject|0|||
163311929|NCT04505904|589852526|FG003|Overall Study|Withdrawal by Subject|0|||
163311930|NCT04505904|589852523|FG000|Overall Study|Physician Decision|1|||
163311931|NCT04505904|589852524|FG001|Overall Study|Physician Decision|0|||
163311932|NCT04505904|589852525|FG002|Overall Study|Physician Decision|0|||
163311933|NCT04505904|589852526|FG003|Overall Study|Physician Decision|0|||
163311934|NCT04505904|589852523|FG000|Overall Study|Adverse Event|0|||
163311935|NCT04505904|589852524|FG001|Overall Study|Adverse Event|1|||
163311936|NCT04505904|589852525|FG002|Overall Study|Adverse Event|0|||
163311937|NCT04505904|589852526|FG003|Overall Study|Adverse Event|0|||
163311938|NCT04277442|589852529|FG000|Overall Study|Death|1|||
163311939|NCT03092518|589852530|FG000|Overall Study|Ineligible|2|||
163311940|NCT01824537|589852533|FG000|Overall Study|Lost to Follow-up|78|||
163311941|NCT01824537|589852534|FG001|Overall Study|Lost to Follow-up|87|||
163311942|NCT02547987|589852535|FG000|Overall Study|Withdrawal by Subject|1|||
163311943|NCT02547987|589852535|FG000|Overall Study|Adverse Event|2|||
163311944|NCT04282148|589852536|FG000|Overall Study|Death|7|||
163311945|NCT04282148|589852536|FG000|Overall Study|Withdrawal by Subject|1|||
163311946|NCT04282148|589852536|FG000|Overall Study|Physician Decision|1|||
163311947|NCT04096040|589852545|FG000|Overall Study|Protocol Violation|12|||
163311948|NCT04096040|589852545|FG000|Overall Study|Non-compliant site|4|||
163311949|NCT04044768|589852546|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
163311950|NCT04044768|589852547|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
163311951|NCT03808818|589852551|FG000|Overall Study|Death|6|||
163311952|NCT03808818|589852552|FG001|Overall Study|Death|6|||
163311953|NCT03808818|589852551|FG000|Overall Study|Withdrawal by Subject|7|||
163311954|NCT03808818|589852552|FG001|Overall Study|Withdrawal by Subject|18|||
163311955|NCT03808818|589852551|FG000|Overall Study|Lost to Follow-up|31|||
163311956|NCT03808818|589852552|FG001|Overall Study|Lost to Follow-up|33|||
163311957|NCT03858634|589852553|FG000|Overall Study|Withdrawal by Subject|1|||
163311958|NCT03858634|589852554|FG001|Overall Study|Withdrawal by Subject|0|||
163311959|NCT03858634|589852553|FG000|Overall Study|Adverse Event|1|||
163311960|NCT03858634|589852554|FG001|Overall Study|Adverse Event|0|||
163311961|NCT03858634|589852553|FG000|Overall Study|Lost to Follow-up|0|||
163311962|NCT03858634|589852554|FG001|Overall Study|Lost to Follow-up|1|||
163311963|NCT03858634|589852553|FG000|Overall Study|Other, Not Specified|1|||
163311964|NCT03858634|589852554|FG001|Overall Study|Other, Not Specified|1|||
163311965|NCT06181760|589852555|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
163311966|NCT06181760|589852556|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
163311967|NCT06181760|589852557|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
163311968|NCT06181760|589852558|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
163311969|NCT04537715|589852561|FG000|Overall Study|Death|3|||
163311970|NCT04537715|589852562|FG001|Overall Study|Death|1|||
163311971|NCT04537715|589852561|FG000|Overall Study|Withdrawal by Subject|3|||
163311972|NCT04537715|589852562|FG001|Overall Study|Withdrawal by Subject|1|||
163311973|NCT04537715|589852561|FG000|Overall Study|Other|4|||
163311974|NCT04537715|589852562|FG001|Overall Study|Other|3|||
163311975|NCT04537715|589852561|FG000|Overall Study|Progressive disease|1|||
163311976|NCT04537715|589852562|FG001|Overall Study|Progressive disease|0|||
163311977|NCT04938492|589852563|FG000|Overall Study|Lost to Follow-up|17|||
163311978|NCT04938492|589852564|FG001|Overall Study|Lost to Follow-up|18|||
163311979|NCT03865498|589852565|FG000|Overall Study|Lack of Efficacy|12|||
163311980|NCT03865498|589852566|FG001|Overall Study|Lack of Efficacy|11|||
163311981|NCT03865498|589852565|FG000|Overall Study|Lost to Follow-up|125|||
163311982|NCT03865498|589852566|FG001|Overall Study|Lost to Follow-up|133|||
163311983|NCT03865498|589852565|FG000|Overall Study|Withdrawal by Subject|2|||
163051905|NCT04464707|588898751|FG002|Overall Study|Protocol Deviation|0|||
163051906|NCT04464707|588898749|FG000|Overall Study|Lost to Follow-up|2|||
163051907|NCT04464707|588898750|FG001|Overall Study|Lost to Follow-up|0|||
163051908|NCT04464707|588898751|FG002|Overall Study|Lost to Follow-up|1|||
163051909|NCT04613518|588898752|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
163051910|NCT04613518|588898753|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
163311984|NCT03865498|589852566|FG001|Overall Study|Withdrawal by Subject|4|||
163311985|NCT05084508|589852567|FG000|Overall Study|Lost to Follow-up|6|||
163311986|NCT05084508|589852568|FG001|Overall Study|Lost to Follow-up|3|||
163311987|NCT05084508|589852569|FG002|Overall Study|Lost to Follow-up|7|||
163311988|NCT05084508|589852570|FG003|Overall Study|Lost to Follow-up|3|||
163311989|NCT05084508|589852567|FG000|Overall Study|Withdrawal by Subject|0|||
163311990|NCT05084508|589852568|FG001|Overall Study|Withdrawal by Subject|2|||
163397440|NCT01490450|590167713|FG003|Period 1|Withdrawal by Subject|3|||
163311991|NCT05084508|589852569|FG002|Overall Study|Withdrawal by Subject|3|||
163051911|NCT04613518|588898754|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
163051912|NCT04613518|588898752|FG000|Double-Blind Treatment Period|Adverse Event|2|||
163311992|NCT05084508|589852570|FG003|Overall Study|Withdrawal by Subject|1|||
163311993|NCT05084508|589852567|FG000|Overall Study|Other|0|||
163311994|NCT05084508|589852568|FG001|Overall Study|Other|0|||
163311995|NCT05084508|589852569|FG002|Overall Study|Other|0|||
163311996|NCT05084508|589852570|FG003|Overall Study|Other|1|||
163311997|NCT04137289|589852571|FG000|Overall Study|Death|0|||
163311998|NCT04137289|589852572|FG001|Overall Study|Death|0|||
163311999|NCT04137289|589852573|FG002|Overall Study|Death|0|||
163312000|NCT04137289|589852574|FG003|Overall Study|Death|0|||
163312001|NCT04137289|589852575|FG004|Overall Study|Death|0|||
163312002|NCT04137289|589852576|FG005|Overall Study|Death|0|||
163312003|NCT04137289|589852577|FG006|Overall Study|Death|1|||
163312004|NCT04137289|589852578|FG007|Overall Study|Death|0|||
163312005|NCT04137289|589852579|FG008|Overall Study|Death|0|||
163312006|NCT04137289|589852571|FG000|Overall Study|Clinical disease progression|0|||
163312007|NCT04137289|589852572|FG001|Overall Study|Clinical disease progression|0|||
163312008|NCT04137289|589852573|FG002|Overall Study|Clinical disease progression|0|||
163312009|NCT04137289|589852574|FG003|Overall Study|Clinical disease progression|4|||
163312010|NCT04137289|589852575|FG004|Overall Study|Clinical disease progression|4|||
163312011|NCT04137289|589852576|FG005|Overall Study|Clinical disease progression|2|||
163312012|NCT04137289|589852577|FG006|Overall Study|Clinical disease progression|5|||
163312013|NCT04137289|589852578|FG007|Overall Study|Clinical disease progression|1|||
163312014|NCT04137289|589852579|FG008|Overall Study|Clinical disease progression|0|||
163312015|NCT04137289|589852571|FG000|Overall Study|Lost to Follow-up|0|||
163312016|NCT04137289|589852572|FG001|Overall Study|Lost to Follow-up|0|||
163312017|NCT04137289|589852573|FG002|Overall Study|Lost to Follow-up|0|||
163312018|NCT04137289|589852574|FG003|Overall Study|Lost to Follow-up|1|||
163312019|NCT04137289|589852575|FG004|Overall Study|Lost to Follow-up|0|||
163312020|NCT04137289|589852576|FG005|Overall Study|Lost to Follow-up|0|||
163312021|NCT04137289|589852577|FG006|Overall Study|Lost to Follow-up|0|||
163312022|NCT04137289|589852578|FG007|Overall Study|Lost to Follow-up|0|||
163312023|NCT04137289|589852579|FG008|Overall Study|Lost to Follow-up|0|||
163312024|NCT04137289|589852571|FG000|Overall Study|Adverse Event|0|||
163312025|NCT04137289|589852572|FG001|Overall Study|Adverse Event|0|||
163312026|NCT04137289|589852573|FG002|Overall Study|Adverse Event|1|||
163312027|NCT04137289|589852574|FG003|Overall Study|Adverse Event|0|||
163312028|NCT04137289|589852575|FG004|Overall Study|Adverse Event|0|||
163312029|NCT04137289|589852576|FG005|Overall Study|Adverse Event|1|||
163312030|NCT04137289|589852577|FG006|Overall Study|Adverse Event|0|||
163312031|NCT04137289|589852578|FG007|Overall Study|Adverse Event|0|||
163312032|NCT04137289|589852579|FG008|Overall Study|Adverse Event|0|||
163312033|NCT04137289|589852571|FG000|Overall Study|Lack of clinical benefit|0|||
163312034|NCT04137289|589852572|FG001|Overall Study|Lack of clinical benefit|0|||
163312035|NCT04137289|589852573|FG002|Overall Study|Lack of clinical benefit|0|||
163312036|NCT04137289|589852574|FG003|Overall Study|Lack of clinical benefit|0|||
163312037|NCT04137289|589852575|FG004|Overall Study|Lack of clinical benefit|0|||
163312038|NCT04137289|589852576|FG005|Overall Study|Lack of clinical benefit|0|||
163312039|NCT04137289|589852577|FG006|Overall Study|Lack of clinical benefit|0|||
163312040|NCT04137289|589852578|FG007|Overall Study|Lack of clinical benefit|0|||
163312041|NCT04137289|589852579|FG008|Overall Study|Lack of clinical benefit|1|||
163312042|NCT04137289|589852571|FG000|Overall Study|Objective disease progression|1|||
163312043|NCT04137289|589852572|FG001|Overall Study|Objective disease progression|1|||
163312044|NCT04137289|589852573|FG002|Overall Study|Objective disease progression|6|||
163312045|NCT04137289|589852574|FG003|Overall Study|Objective disease progression|18|||
163312046|NCT04137289|589852575|FG004|Overall Study|Objective disease progression|12|||
163312047|NCT04137289|589852576|FG005|Overall Study|Objective disease progression|20|||
163312048|NCT04137289|589852577|FG006|Overall Study|Objective disease progression|18|||
163312049|NCT04137289|589852578|FG007|Overall Study|Objective disease progression|7|||
163312050|NCT04137289|589852579|FG008|Overall Study|Objective disease progression|6|||
163312051|NCT03931174|589852584|FG000|Providers|Staff left organization|26|||
163312052|NCT03931174|589852585|FG001|Providers|Staff left organization|25|||
163312053|NCT03931174|589852584|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
163312054|NCT03931174|589852585|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
163312055|NCT03931174|589852584|FG000|Providers|Lost to Follow-up|4|||
163312056|NCT03931174|589852585|FG001|Providers|Lost to Follow-up|4|||
162965063|NCT02096705|588572042|FG001|Treatment|Other|1|||
163312057|NCT03931174|589852584|FG000|Patients|Post-consent screening failure|1|||
163312058|NCT03931174|589852585|FG001|Patients|Post-consent screening failure|1|||
163312059|NCT03931174|589852584|FG000|Patients|Death|1|||
163312060|NCT03931174|589852585|FG001|Patients|Death|1|||
163312061|NCT03931174|589852584|FG000|Patients|Lost to Follow-up|60|||
163312062|NCT03931174|589852585|FG001|Patients|Lost to Follow-up|89|||
163312063|NCT05386030|589852586|FG000|Overall Study|Death|1|||
163312064|NCT05386030|589852587|FG001|Overall Study|Death|0|||
163312065|NCT05386030|589852586|FG000|Overall Study|Physician Decision|2|||
163312066|NCT05386030|589852587|FG001|Overall Study|Physician Decision|1|||
162965064|NCT02096705|588572041|FG000|Follow-up|Withdrawal by Subject|1|||
163397441|NCT01490450|590167710|FG000|Period 1|No longer met study criteria|0|||
163397442|NCT01490450|590167711|FG001|Period 1|No longer met study criteria|1|||
163397443|NCT01490450|590167712|FG002|Period 1|No longer met study criteria|1|||
163312067|NCT05386030|589852586|FG000|Overall Study|Lost to Follow-up|19|||
163312068|NCT05386030|589852587|FG001|Overall Study|Lost to Follow-up|7|||
163312069|NCT05386030|589852586|FG000|Overall Study|Withdrawal by Subject|20|||
163312070|NCT05386030|589852587|FG001|Overall Study|Withdrawal by Subject|10|||
163312071|NCT05386030|589852586|FG000|Overall Study|Eligibility criteria violation|1|||
163312072|NCT05386030|589852587|FG001|Overall Study|Eligibility criteria violation|1|||
163312073|NCT05386030|589852586|FG000|Overall Study|Personal Reasons|1|||
163312074|NCT05386030|589852587|FG001|Overall Study|Personal Reasons|0|||
163312075|NCT05228457|589852588|FG000|Overall Study|Withdrawal by Subject|1|||
163312076|NCT05228457|589852589|FG001|Overall Study|Withdrawal by Subject|1|||
163312077|NCT03213691|589852594|FG000|Overall Study|Adverse Event|2|||
163312078|NCT03213691|589852594|FG000|Overall Study|Death|3|||
163312079|NCT03213691|589852594|FG000|Overall Study|Physician Decision|1|||
163312080|NCT03213691|589852594|FG000|Overall Study|Progressive Disease|14|||
163312081|NCT03213691|589852594|FG000|Overall Study|Ineligible|1|||
163312082|NCT03161028|589852595|FG000|Overall Study|Withdrawal by Subject|6|||
163312083|NCT03161028|589852596|FG001|Overall Study|Withdrawal by Subject|4|||
163312084|NCT03161028|589852595|FG000|Overall Study|Adverse Event|5|||
163312085|NCT03161028|589852596|FG001|Overall Study|Adverse Event|1|||
163312086|NCT03161028|589852595|FG000|Overall Study|Study drug side effects|2|||
163312087|NCT03161028|589852596|FG001|Overall Study|Study drug side effects|2|||
163312088|NCT03161028|589852595|FG000|Overall Study|Administrative PD/UP|4|||
163312089|NCT03161028|589852596|FG001|Overall Study|Administrative PD/UP|2|||
163312090|NCT03161028|589852595|FG000|Overall Study|Lost to Follow-up|2|||
163312091|NCT03161028|589852596|FG001|Overall Study|Lost to Follow-up|0|||
163312092|NCT03161028|589852595|FG000|Overall Study|Unable to comply with procedures|1|||
163312093|NCT03161028|589852596|FG001|Overall Study|Unable to comply with procedures|1|||
163312094|NCT03492216|589852599|FG000|Overall Study|Death|1|||
163312095|NCT03492216|589852600|FG001|Overall Study|Death|0|||
163312096|NCT03492216|589852601|FG002|Overall Study|Death|4|||
163312097|NCT03492216|589852602|FG003|Overall Study|Death|0|||
163312098|NCT03492216|589852599|FG000|Overall Study|Withdrawal by Subject|5|||
163312099|NCT03492216|589852600|FG001|Overall Study|Withdrawal by Subject|3|||
163312100|NCT03492216|589852601|FG002|Overall Study|Withdrawal by Subject|1|||
163312101|NCT03492216|589852602|FG003|Overall Study|Withdrawal by Subject|1|||
163312102|NCT03492216|589852599|FG000|Overall Study|Lost to Follow-up|9|||
163312103|NCT03492216|589852600|FG001|Overall Study|Lost to Follow-up|2|||
163312104|NCT03492216|589852601|FG002|Overall Study|Lost to Follow-up|7|||
163312105|NCT03492216|589852602|FG003|Overall Study|Lost to Follow-up|8|||
163312106|NCT03492216|589852599|FG000|Overall Study|Moved|5|||
163312107|NCT03492216|589852600|FG001|Overall Study|Moved|3|||
163312108|NCT03492216|589852601|FG002|Overall Study|Moved|3|||
163312109|NCT03492216|589852602|FG003|Overall Study|Moved|5|||
163312110|NCT03492216|589852599|FG000|Overall Study|Too ill|0|||
163312111|NCT03492216|589852600|FG001|Overall Study|Too ill|1|||
163312112|NCT03492216|589852601|FG002|Overall Study|Too ill|0|||
163397444|NCT01490450|590167713|FG003|Period 1|No longer met study criteria|0|||
163397445|NCT01490450|590167710|FG000|Period 2|Lack of Efficacy|0|||
163397446|NCT01490450|590167711|FG001|Period 2|Lack of Efficacy|0|||
163397447|NCT01490450|590167712|FG002|Period 2|Lack of Efficacy|0|||
163397448|NCT01490450|590167713|FG003|Period 2|Lack of Efficacy|1|||
163397449|NCT01490450|590167710|FG000|Period 2|Adverse Event|1|||
163397450|NCT01490450|590167711|FG001|Period 2|Adverse Event|1|||
163397451|NCT01490450|590167712|FG002|Period 2|Adverse Event|0|||
163397452|NCT01490450|590167713|FG003|Period 2|Adverse Event|1|||
163397453|NCT01490450|590167710|FG000|Period 2|Withdrawal by Subject|1|||
163397454|NCT01490450|590167711|FG001|Period 2|Withdrawal by Subject|0|||
163312113|NCT03492216|589852602|FG003|Overall Study|Too ill|0|||
163312114|NCT03492216|589852599|FG000|Overall Study|Incarcerated|0|||
163312115|NCT03492216|589852600|FG001|Overall Study|Incarcerated|0|||
163312116|NCT03492216|589852601|FG002|Overall Study|Incarcerated|2|||
163312117|NCT03492216|589852602|FG003|Overall Study|Incarcerated|0|||
163312118|NCT00736723|589852603|FG000|Overall Study|Withdrawal by Subject|4|||
163312119|NCT00736723|589852604|FG001|Overall Study|Withdrawal by Subject|3|||
163312120|NCT01799265|589852607|FG000|Overall Study|Lost to Follow-up|1|||
163312121|NCT01799265|589852608|FG001|Overall Study|Lost to Follow-up|0|||
163312122|NCT01799265|589852607|FG000|Overall Study|Protocol Violation|2|||
163312123|NCT01799265|589852608|FG001|Overall Study|Protocol Violation|1|||
163312124|NCT01799265|589852607|FG000|Overall Study|inadequate sleep study|0|||
163312125|NCT01799265|589852608|FG001|Overall Study|inadequate sleep study|2|||
163312126|NCT05704543|589852612|FG000|Overall Study|Withdrawal by Subject|1|||
163312127|NCT05704543|589852613|FG001|Overall Study|Withdrawal by Subject|1|||
163312128|NCT05704543|589852614|FG002|Overall Study|Withdrawal by Subject|0|||
163312129|NCT05704543|589852615|FG003|Overall Study|Withdrawal by Subject|2|||
163312130|NCT05704543|589852612|FG000|Overall Study|Lost to Follow-up|1|||
163312131|NCT05704543|589852613|FG001|Overall Study|Lost to Follow-up|2|||
163397455|NCT01490450|590167712|FG002|Period 2|Withdrawal by Subject|0|||
163312132|NCT05704543|589852614|FG002|Overall Study|Lost to Follow-up|0|||
163312133|NCT05704543|589852615|FG003|Overall Study|Lost to Follow-up|0|||
163312134|NCT04830800|589852619|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
163312135|NCT04830800|589852620|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
163312136|NCT04830800|589852621|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
163312137|NCT04830800|589852622|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
163312138|NCT04830800|589852623|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
163312139|NCT03396588|589852626|FG000|Overall Study|Physician Decision|2|||
163312140|NCT03396588|589852627|FG001|Overall Study|Physician Decision|3|||
163312141|NCT00812461|589852628|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
163312142|NCT00812461|589852629|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
163312143|NCT00812461|589852628|FG000|All Treated Patients|Adverse Event|8|||
163312144|NCT00812461|589852629|FG001|All Treated Patients|Adverse Event|15|||
162965065|NCT02096705|588572042|FG001|Follow-up|Withdrawal by Subject|0|||
163312145|NCT00812461|589852628|FG000|All Treated Patients|Lack of Efficacy|13|||
163312146|NCT00812461|589852629|FG001|All Treated Patients|Lack of Efficacy|7|||
163312147|NCT00812461|589852628|FG000|All Treated Patients|Non-compliance|6|||
163312148|NCT00812461|589852629|FG001|All Treated Patients|Non-compliance|9|||
163312149|NCT00812461|589852628|FG000|All Treated Patients|Protocol Violation|36|||
163312150|NCT00812461|589852629|FG001|All Treated Patients|Protocol Violation|27|||
163312151|NCT00812461|589852628|FG000|All Treated Patients|Withdrawal by Subject|45|||
163312152|NCT00812461|589852629|FG001|All Treated Patients|Withdrawal by Subject|54|||
163312153|NCT00812461|589852628|FG000|All Treated Patients|Lost to Follow-up|11|||
163312154|NCT00812461|589852629|FG001|All Treated Patients|Lost to Follow-up|14|||
163312155|NCT00812461|589852628|FG000|All Treated Patients|Other Reason|13|||
163312156|NCT00812461|589852629|FG001|All Treated Patients|Other Reason|21|||
163312157|NCT05351554|589852631|FG000|Overall Study|Study terminated by sponsor|1|||
163312158|NCT05030233|589852632|FG000|Overall Study|withdrawn for transfer|1|||
163312159|NCT05030233|589852633|FG001|Overall Study|withdrawn for transfer|0|||
163312160|NCT05251909|589854507|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
163312161|NCT05251909|589854508|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
163312162|NCT02140554|589854517|FG000|Overall Study|Withdrawal of consent|1|||
163312163|NCT02140554|589854518|FG001|Overall Study|Withdrawal of consent|0|||
163312164|NCT02140554|589854519|FG002|Overall Study|Withdrawal of consent|4|||
163312165|NCT02140554|589854517|FG000|Overall Study|Physician Decision|1|||
163312166|NCT02140554|589854518|FG001|Overall Study|Physician Decision|0|||
163312167|NCT02140554|589854519|FG002|Overall Study|Physician Decision|2|||
163312168|NCT02140554|589854517|FG000|Overall Study|Death|0|||
163312169|NCT02140554|589854518|FG001|Overall Study|Death|0|||
163312170|NCT02140554|589854519|FG002|Overall Study|Death|1|||
163312171|NCT02140554|589854517|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
163312172|NCT02140554|589854518|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
163312173|NCT02140554|589854519|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
163312174|NCT03953508|589854521|FG000|Baseline|Lost to Follow-up|3|||
163312175|NCT03953508|589854522|FG001|Baseline|Lost to Follow-up|2|||
163312176|NCT03953508|589854521|FG000|6-month Follow-up|Lost to Follow-up|62|||
163312177|NCT03953508|589854522|FG001|6-month Follow-up|Lost to Follow-up|70|||
163312178|NCT03771417|589854523|FG000|Overall Study|Withdrawal by Subject|1|||
163312179|NCT03771417|589854524|FG001|Overall Study|Withdrawal by Subject|0|||
163312180|NCT03771417|589854525|FG002|Overall Study|Withdrawal by Subject|0|||
163312181|NCT03771417|589854523|FG000|Overall Study|Covid-19 Shutdown|0|||
163312182|NCT03771417|589854524|FG001|Overall Study|Covid-19 Shutdown|1|||
163312183|NCT03771417|589854525|FG002|Overall Study|Covid-19 Shutdown|0|||
163312184|NCT03016754|589854526|FG000|Overall Study|Death|5|||
163312185|NCT03016754|589854527|FG001|Overall Study|Death|4|||
163312186|NCT03016754|589854528|FG002|Overall Study|Death|5|||
163312187|NCT03016754|589854529|FG003|Overall Study|Death|1|||
163312188|NCT03016754|589854526|FG000|Overall Study|Lost to Follow-up|23|||
163312189|NCT03016754|589854527|FG001|Overall Study|Lost to Follow-up|17|||
163312190|NCT03016754|589854528|FG002|Overall Study|Lost to Follow-up|4|||
163312191|NCT03016754|589854529|FG003|Overall Study|Lost to Follow-up|2|||
163397456|NCT01490450|590167713|FG003|Period 2|Withdrawal by Subject|0|||
162965066|NCT02096705|588572041|FG000|Follow-up|Adverse Event|2|||
163312192|NCT03016754|589854526|FG000|Overall Study|Withdrawal by Subject|6|||
163312193|NCT03016754|589854527|FG001|Overall Study|Withdrawal by Subject|6|||
163312194|NCT03016754|589854528|FG002|Overall Study|Withdrawal by Subject|2|||
163312195|NCT03016754|589854529|FG003|Overall Study|Withdrawal by Subject|2|||
163312196|NCT03016754|589854526|FG000|Overall Study|Other/Unknown|2|||
163312197|NCT03016754|589854527|FG001|Overall Study|Other/Unknown|4|||
163312198|NCT03016754|589854528|FG002|Overall Study|Other/Unknown|2|||
163312199|NCT03016754|589854529|FG003|Overall Study|Other/Unknown|1|||
163312200|NCT03016754|589854526|FG000|Overall Study|Protocol Violation|0|||
163312201|NCT03016754|589854527|FG001|Overall Study|Protocol Violation|0|||
163312202|NCT03016754|589854528|FG002|Overall Study|Protocol Violation|0|||
163312203|NCT03016754|589854529|FG003|Overall Study|Protocol Violation|4|||
163312204|NCT04185298|589854530|FG000|Overall Study|Lost to Follow-up|1|||
163312205|NCT04185298|589854531|FG001|Overall Study|Lost to Follow-up|3|||
163312206|NCT04185298|589854530|FG000|Overall Study|Withdrawal by Subject|0|||
163312207|NCT04185298|589854531|FG001|Overall Study|Withdrawal by Subject|3|||
163312208|NCT01606215|589854532|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
163312209|NCT01606215|589854533|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
163312210|NCT04316871|589854534|FG000|Overall Study|Protocol Violation|2|||
163312211|NCT04316871|589854535|FG001|Overall Study|Protocol Violation|2|||
163312212|NCT04316871|589854536|FG002|Overall Study|Protocol Violation|2|||
163312213|NCT04316871|589854537|FG003|Overall Study|Protocol Violation|2|||
163312214|NCT01842542|589854538|FG000|Overall Study|Withdrawal by Subject|2|||
163312215|NCT01842542|589854538|FG000|Overall Study|Lack of Efficacy|1|||
163312216|NCT01842542|589854538|FG000|Overall Study|Protocol Non-compliance|2|||
163312217|NCT01842542|589854538|FG000|Overall Study|Lost to Follow-up|1|||
163312218|NCT02262728|589854539|FG000|Follow-up Phase (3 Years)|Death|0|||
163312219|NCT02262728|589854540|FG001|Follow-up Phase (3 Years)|Death|1|||
163312220|NCT02262728|589854539|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
163312221|NCT02262728|589854540|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
163312222|NCT02262728|589854539|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
163312223|NCT02262728|589854540|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
163312224|NCT03474679|589854552|FG000|Overall Study|Death|7|||
163312225|NCT03474679|589854552|FG000|Overall Study|Withdrawal by Subject|1|||
163312226|NCT03452579|589854553|FG000|Overall Study|Death|0|||
163312227|NCT03452579|589854554|FG001|Overall Study|Death|1|||
163312228|NCT03452579|589854553|FG000|Overall Study|Withdrawal by Subject|2|||
163312229|NCT03452579|589854554|FG001|Overall Study|Withdrawal by Subject|0|||
163312230|NCT03452579|589854553|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
163312231|NCT03452579|589854554|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
163312232|NCT03452579|589854553|FG000|Overall Study|Physician Decision|1|||
163312233|NCT03452579|589854554|FG001|Overall Study|Physician Decision|1|||
162965067|NCT02096705|588572042|FG001|Follow-up|Adverse Event|2|||
162965068|NCT02096705|588572041|FG000|Follow-up|Subjects not reporting status|1|||
163312234|NCT03452579|589854553|FG000|Overall Study|Adverse Event|1|||
163312235|NCT03452579|589854554|FG001|Overall Study|Adverse Event|4|||
163312236|NCT04858321|589854561|FG000|Overall Study|Withdrawal by Subject|3|||
163312237|NCT01539083|589854562|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
163312238|NCT01539083|589854563|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
163312239|NCT01539083|589854564|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
163312240|NCT01539083|589854562|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
163312241|NCT01539083|589854563|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
163312242|NCT01539083|589854564|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
163312243|NCT01539083|589854562|FG000|Before Randomization (VCD Induction)|Death|6|||
163312244|NCT01539083|589854563|FG001|Before Randomization (VCD Induction)|Death|0|||
163312245|NCT01539083|589854564|FG002|Before Randomization (VCD Induction)|Death|0|||
163312246|NCT01539083|589854562|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
163312247|NCT01539083|589854563|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
163312248|NCT01539083|589854564|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
163312249|NCT01539083|589854562|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
163312250|NCT01539083|589854563|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
163312251|NCT01539083|589854564|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
163312252|NCT01539083|589854562|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
163312253|NCT01539083|589854563|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
163312254|NCT01539083|589854564|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
163312255|NCT01539083|589854562|FG000|Before Randomization (VCD Induction)|Other|5|||
163312256|NCT01539083|589854563|FG001|Before Randomization (VCD Induction)|Other|0|||
163312257|NCT01539083|589854564|FG002|Before Randomization (VCD Induction)|Other|0|||
163312258|NCT01539083|589854562|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
163312259|NCT01539083|589854563|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
163312260|NCT01539083|589854564|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
163312261|NCT01539083|589854562|FG000|After Randomization (TP and VTP)|Other|0|||
163312262|NCT01539083|589854563|FG001|After Randomization (TP and VTP)|Other|1|||
163312263|NCT01539083|589854564|FG002|After Randomization (TP and VTP)|Other|1|||
163312264|NCT01539083|589854562|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
163312265|NCT01539083|589854563|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
163312266|NCT01539083|589854564|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
163312267|NCT01539083|589854562|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
163312268|NCT01539083|589854563|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
163312269|NCT01539083|589854564|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
163312270|NCT01539083|589854562|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
163312271|NCT01539083|589854563|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
163312272|NCT01539083|589854564|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
163312273|NCT01539083|589854562|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
163312274|NCT01539083|589854563|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
163312275|NCT01539083|589854564|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
163312276|NCT01539083|589854562|FG000|After Randomization (TP and VTP)|Death|0|||
163312277|NCT01539083|589854563|FG001|After Randomization (TP and VTP)|Death|6|||
163312278|NCT01539083|589854564|FG002|After Randomization (TP and VTP)|Death|11|||
163312279|NCT02573493|589854568|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
163312280|NCT02573493|589854569|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
163312281|NCT02573493|589854570|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
163312282|NCT02573493|589854571|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
163312283|NCT04149704|589854575|FG000|Three Month Follow-up|Death|2|||
163312284|NCT04149704|589854576|FG001|Three Month Follow-up|Death|0|||
163312285|NCT04149704|589854577|FG002|Three Month Follow-up|Death|0|||
163312286|NCT04149704|589854578|FG003|Three Month Follow-up|Death|0|||
163312287|NCT04149704|589854575|FG000|Three Month Follow-up|Lost to Follow-up|1|||
163312288|NCT04149704|589854576|FG001|Three Month Follow-up|Lost to Follow-up|4|||
163312289|NCT04149704|589854577|FG002|Three Month Follow-up|Lost to Follow-up|5|||
163312290|NCT04149704|589854578|FG003|Three Month Follow-up|Lost to Follow-up|5|||
163312291|NCT04149704|589854575|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
163312292|NCT04149704|589854576|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
163312293|NCT04149704|589854577|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
163312294|NCT04149704|589854578|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
163312295|NCT04149704|589854575|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
163312296|NCT04149704|589854576|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
163312297|NCT04149704|589854577|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
163312298|NCT04149704|589854578|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
163312299|NCT04632992|589854588|FG000|Overall Study|Adverse Event|0|||
163312300|NCT04632992|589854589|FG001|Overall Study|Adverse Event|0|||
163312301|NCT04632992|589854590|FG002|Overall Study|Adverse Event|0|||
163312302|NCT04632992|589854591|FG003|Overall Study|Adverse Event|0|||
163312303|NCT04632992|589854592|FG004|Overall Study|Adverse Event|0|||
163312304|NCT04632992|589854593|FG005|Overall Study|Adverse Event|0|||
163397457|NCT01490450|590167710|FG000|Period 2|Lost to Follow-up|0|||
163312305|NCT04632992|589854594|FG006|Overall Study|Adverse Event|0|||
163312306|NCT04632992|589854595|FG007|Overall Study|Adverse Event|0|||
163312307|NCT04632992|589854596|FG008|Overall Study|Adverse Event|0|||
163312308|NCT04632992|589854597|FG009|Overall Study|Adverse Event|0|||
163312309|NCT04632992|589854598|FG010|Overall Study|Adverse Event|0|||
163312310|NCT04632992|589854599|FG011|Overall Study|Adverse Event|0|||
163312311|NCT04632992|589854600|FG012|Overall Study|Adverse Event|1|||
163312312|NCT04632992|589854601|FG013|Overall Study|Adverse Event|0|||
163312313|NCT04632992|589854588|FG000|Overall Study|Death|17|||
163312314|NCT04632992|589854589|FG001|Overall Study|Death|1|||
163312315|NCT04632992|589854590|FG002|Overall Study|Death|14|||
163312316|NCT04632992|589854591|FG003|Overall Study|Death|14|||
163312317|NCT04632992|589854592|FG004|Overall Study|Death|13|||
163312318|NCT04632992|589854593|FG005|Overall Study|Death|6|||
163312319|NCT04632992|589854594|FG006|Overall Study|Death|7|||
163312320|NCT04632992|589854595|FG007|Overall Study|Death|12|||
163312321|NCT04632992|589854596|FG008|Overall Study|Death|15|||
163312322|NCT04632992|589854597|FG009|Overall Study|Death|20|||
163312323|NCT04632992|589854598|FG010|Overall Study|Death|8|||
163312324|NCT04632992|589854599|FG011|Overall Study|Death|2|||
163312325|NCT04632992|589854600|FG012|Overall Study|Death|10|||
163312326|NCT04632992|589854601|FG013|Overall Study|Death|1|||
163312327|NCT04632992|589854588|FG000|Overall Study|Lost to Follow-up|1|||
163312328|NCT04632992|589854589|FG001|Overall Study|Lost to Follow-up|0|||
163312329|NCT04632992|589854590|FG002|Overall Study|Lost to Follow-up|1|||
163312330|NCT04632992|589854591|FG003|Overall Study|Lost to Follow-up|0|||
163312331|NCT04632992|589854592|FG004|Overall Study|Lost to Follow-up|2|||
163312332|NCT04632992|589854593|FG005|Overall Study|Lost to Follow-up|0|||
163312333|NCT04632992|589854594|FG006|Overall Study|Lost to Follow-up|1|||
163312334|NCT04632992|589854595|FG007|Overall Study|Lost to Follow-up|1|||
163312335|NCT04632992|589854596|FG008|Overall Study|Lost to Follow-up|1|||
163312336|NCT04632992|589854597|FG009|Overall Study|Lost to Follow-up|1|||
163312337|NCT04632992|589854598|FG010|Overall Study|Lost to Follow-up|2|||
163312338|NCT04632992|589854599|FG011|Overall Study|Lost to Follow-up|0|||
163312339|NCT04632992|589854600|FG012|Overall Study|Lost to Follow-up|0|||
163312340|NCT04632992|589854601|FG013|Overall Study|Lost to Follow-up|0|||
163312341|NCT04632992|589854588|FG000|Overall Study|Reason not Specified|2|||
163312342|NCT04632992|589854589|FG001|Overall Study|Reason not Specified|0|||
163312343|NCT04632992|589854590|FG002|Overall Study|Reason not Specified|1|||
163312344|NCT04632992|589854591|FG003|Overall Study|Reason not Specified|1|||
163312345|NCT04632992|589854592|FG004|Overall Study|Reason not Specified|0|||
163312346|NCT04632992|589854593|FG005|Overall Study|Reason not Specified|0|||
163312347|NCT04632992|589854594|FG006|Overall Study|Reason not Specified|0|||
163312348|NCT04632992|589854595|FG007|Overall Study|Reason not Specified|0|||
163312349|NCT04632992|589854596|FG008|Overall Study|Reason not Specified|0|||
163312350|NCT04632992|589854597|FG009|Overall Study|Reason not Specified|0|||
163312351|NCT04632992|589854598|FG010|Overall Study|Reason not Specified|1|||
163312352|NCT04632992|589854599|FG011|Overall Study|Reason not Specified|0|||
163312353|NCT04632992|589854600|FG012|Overall Study|Reason not Specified|0|||
163312354|NCT04632992|589854601|FG013|Overall Study|Reason not Specified|0|||
163312355|NCT04632992|589854588|FG000|Overall Study|Physician Decision|0|||
163312356|NCT04632992|589854589|FG001|Overall Study|Physician Decision|0|||
163312357|NCT04632992|589854590|FG002|Overall Study|Physician Decision|0|||
163312358|NCT04632992|589854591|FG003|Overall Study|Physician Decision|2|||
163312359|NCT04632992|589854592|FG004|Overall Study|Physician Decision|1|||
163312360|NCT04632992|589854593|FG005|Overall Study|Physician Decision|0|||
163312361|NCT04632992|589854594|FG006|Overall Study|Physician Decision|0|||
163312362|NCT04632992|589854595|FG007|Overall Study|Physician Decision|0|||
163312363|NCT04632992|589854596|FG008|Overall Study|Physician Decision|0|||
163312364|NCT04632992|589854597|FG009|Overall Study|Physician Decision|0|||
163312365|NCT04632992|589854598|FG010|Overall Study|Physician Decision|0|||
163312366|NCT04632992|589854599|FG011|Overall Study|Physician Decision|0|||
163312367|NCT04632992|589854600|FG012|Overall Study|Physician Decision|3|||
163312368|NCT04632992|589854601|FG013|Overall Study|Physician Decision|0|||
163312369|NCT04632992|589854588|FG000|Overall Study|Progressive Disease|0|||
163312370|NCT04632992|589854589|FG001|Overall Study|Progressive Disease|0|||
163312371|NCT04632992|589854590|FG002|Overall Study|Progressive Disease|0|||
163312372|NCT04632992|589854591|FG003|Overall Study|Progressive Disease|0|||
163312373|NCT04632992|589854592|FG004|Overall Study|Progressive Disease|1|||
163312374|NCT04632992|589854593|FG005|Overall Study|Progressive Disease|0|||
163312375|NCT04632992|589854594|FG006|Overall Study|Progressive Disease|0|||
163312376|NCT04632992|589854595|FG007|Overall Study|Progressive Disease|0|||
163312377|NCT04632992|589854596|FG008|Overall Study|Progressive Disease|0|||
163312378|NCT04632992|589854597|FG009|Overall Study|Progressive Disease|1|||
163312379|NCT04632992|589854598|FG010|Overall Study|Progressive Disease|1|||
163312380|NCT04632992|589854599|FG011|Overall Study|Progressive Disease|0|||
163312381|NCT04632992|589854600|FG012|Overall Study|Progressive Disease|2|||
163312382|NCT04632992|589854601|FG013|Overall Study|Progressive Disease|0|||
163312383|NCT04632992|589854588|FG000|Overall Study|Withdrawal by Subject|4|||
163312384|NCT04632992|589854589|FG001|Overall Study|Withdrawal by Subject|1|||
163312385|NCT04632992|589854590|FG002|Overall Study|Withdrawal by Subject|5|||
163051913|NCT04613518|588898753|FG001|Double-Blind Treatment Period|Adverse Event|0|||
163051914|NCT04613518|588898754|FG002|Double-Blind Treatment Period|Adverse Event|1|||
163051915|NCT04613518|588898752|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
163051916|NCT04613518|588898753|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
163051917|NCT04613518|588898754|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
163204312|NCT00036270|589461837|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
163204313|NCT00036270|589461838|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
163204314|NCT00036270|589461837|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
163204315|NCT00036270|589461838|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
163204316|NCT00036270|589461837|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
163204317|NCT00036270|589461838|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
163204318|NCT01218243|589461840|FG000|Overall Study|Lack of Efficacy|1|||
163204319|NCT01218243|589461841|FG001|Overall Study|Lack of Efficacy|1|||
163204320|NCT01218243|589461840|FG000|Overall Study|Lost to Follow-up|3|||
163204321|NCT01218243|589461841|FG001|Overall Study|Lost to Follow-up|3|||
163204322|NCT01218243|589461840|FG000|Overall Study|Protocol Violation|5|||
163204323|NCT01218243|589461841|FG001|Overall Study|Protocol Violation|10|||
163204324|NCT01197560|589461842|FG000|Overall Study|Adverse Event|6|||
163204325|NCT01197560|589461843|FG001|Overall Study|Adverse Event|8|||
163204326|NCT01197560|589461842|FG000|Overall Study|Death|3|||
163204327|NCT01197560|589461843|FG001|Overall Study|Death|5|||
163204328|NCT01197560|589461842|FG000|Overall Study|Withdrawal by Subject|1|||
163204329|NCT01197560|589461843|FG001|Overall Study|Withdrawal by Subject|1|||
163204330|NCT01197560|589461842|FG000|Overall Study|Disease progression|40|||
163204331|NCT01197560|589461843|FG001|Overall Study|Disease progression|35|||
163204332|NCT01197560|589461842|FG000|Overall Study|Miscellaneous|4|||
163204333|NCT01197560|589461843|FG001|Overall Study|Miscellaneous|3|||
163204334|NCT01197560|589461842|FG000|Overall Study|Missing|0|||
163204335|NCT01197560|589461843|FG001|Overall Study|Missing|1|||
163204336|NCT00211510|589461846|FG000|Overall Study|Physician Decision|3|||
163204337|NCT00211510|589461847|FG001|Overall Study|Physician Decision|1|||
163204338|NCT00211510|589461846|FG000|Overall Study|Withdrawal by Subject|3|||
163204339|NCT00211510|589461847|FG001|Overall Study|Withdrawal by Subject|1|||
163204340|NCT01487200|589461848|FG000|Overall Study|Withdrawal by Subject|0|||
163204341|NCT01487200|589461849|FG001|Overall Study|Withdrawal by Subject|1|||
163204342|NCT01487200|589461850|FG002|Overall Study|Withdrawal by Subject|0|||
163204343|NCT01487200|589461851|FG003|Overall Study|Withdrawal by Subject|0|||
163204344|NCT02207244|589461854|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
163204345|NCT02207244|589461855|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
163312386|NCT04632992|589854591|FG003|Overall Study|Withdrawal by Subject|4|||
163312387|NCT04632992|589854592|FG004|Overall Study|Withdrawal by Subject|3|||
163204346|NCT02207244|589461856|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
163312388|NCT04632992|589854593|FG005|Overall Study|Withdrawal by Subject|3|||
163312389|NCT04632992|589854594|FG006|Overall Study|Withdrawal by Subject|0|||
163312390|NCT04632992|589854595|FG007|Overall Study|Withdrawal by Subject|5|||
163312391|NCT04632992|589854596|FG008|Overall Study|Withdrawal by Subject|0|||
163312392|NCT04632992|589854597|FG009|Overall Study|Withdrawal by Subject|2|||
162965069|NCT02096705|588572042|FG001|Follow-up|Subjects not reporting status|2|||
163312393|NCT04632992|589854598|FG010|Overall Study|Withdrawal by Subject|8|||
163312394|NCT04632992|589854599|FG011|Overall Study|Withdrawal by Subject|0|||
163312395|NCT04632992|589854600|FG012|Overall Study|Withdrawal by Subject|1|||
163312396|NCT04632992|589854601|FG013|Overall Study|Withdrawal by Subject|1|||
163312397|NCT02677805|589854602|FG000|Double Blind Phase|Lost to Follow-up|8|||
163312398|NCT02677805|589854603|FG001|Double Blind Phase|Lost to Follow-up|3|||
163312399|NCT02677805|589854604|FG002|Double Blind Phase|Lost to Follow-up|0|||
163312400|NCT02677805|589854602|FG000|Double Blind Phase|Withdrawal by Subject|5|||
162965070|NCT02905435|588572043|FG000|Overall Study|Death|2|||
162965071|NCT02905435|588572043|FG000|Overall Study|Physician Decision|1|||
162965072|NCT02905435|588572043|FG000|Overall Study|Lost to Follow-up|4|||
163312401|NCT02677805|589854603|FG001|Double Blind Phase|Withdrawal by Subject|2|||
163312402|NCT02677805|589854604|FG002|Double Blind Phase|Withdrawal by Subject|0|||
163312403|NCT02677805|589854602|FG000|Open Label Phase|Lost to Follow-up|0|||
163312404|NCT02677805|589854603|FG001|Open Label Phase|Lost to Follow-up|0|||
163051918|NCT04613518|588898752|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
163051919|NCT04613518|588898753|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
163051920|NCT04613518|588898754|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
163051921|NCT04613518|588898752|FG000|Double-Blind Treatment Period|Other Reasons|2|||
163051922|NCT04613518|588898753|FG001|Double-Blind Treatment Period|Other Reasons|0|||
163051923|NCT04613518|588898754|FG002|Double-Blind Treatment Period|Other Reasons|0|||
163051924|NCT04613518|588898752|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
163051925|NCT04613518|588898753|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
163051926|NCT04613518|588898754|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
163051927|NCT04613518|588898752|FG000|Open-Label Treatment Period|Adverse Event|1|||
163051928|NCT04613518|588898753|FG001|Open-Label Treatment Period|Adverse Event|0|||
163051929|NCT04613518|588898754|FG002|Open-Label Treatment Period|Adverse Event|3|||
163204347|NCT02207244|589461857|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
163204348|NCT02207244|589461858|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
163204349|NCT02207244|589461859|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
163204350|NCT02207244|589461860|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
163204351|NCT02207244|589461861|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
163204352|NCT02207244|589461862|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
163204353|NCT02207244|589461863|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
163204354|NCT02207244|589461864|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
163204355|NCT02207244|589461854|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
163204356|NCT02207244|589461855|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
163204357|NCT02207244|589461856|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
163204358|NCT02207244|589461857|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
163204359|NCT02207244|589461858|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
163204360|NCT02207244|589461859|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
163204361|NCT02207244|589461860|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
163204362|NCT02207244|589461861|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
163204363|NCT02207244|589461862|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
163204364|NCT02207244|589461863|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
163204365|NCT02207244|589461864|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
163204366|NCT02207244|589461854|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
163204367|NCT02207244|589461855|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
163204368|NCT02207244|589461856|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
163204369|NCT02207244|589461857|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
163204370|NCT02207244|589461858|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
163204371|NCT02207244|589461859|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
163204372|NCT02207244|589461860|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
163204373|NCT02207244|589461861|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
163204374|NCT02207244|589461862|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
163204375|NCT02207244|589461863|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
163204376|NCT02207244|589461864|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
163204377|NCT02207244|589461854|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
163204378|NCT02207244|589461855|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
163204379|NCT02207244|589461856|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
163204380|NCT02207244|589461857|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
163204381|NCT02207244|589461858|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
163204382|NCT02207244|589461859|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
163204383|NCT02207244|589461860|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
163204384|NCT02207244|589461861|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
163204385|NCT02207244|589461862|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
163204386|NCT02207244|589461863|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
163204387|NCT02207244|589461864|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
163397458|NCT01490450|590167711|FG001|Period 2|Lost to Follow-up|0|||
163312405|NCT02677805|589854604|FG002|Open Label Phase|Lost to Follow-up|10|||
163312406|NCT02677805|589854602|FG000|Open Label Phase|Withdrawal by Subject|0|||
163312407|NCT02677805|589854603|FG001|Open Label Phase|Withdrawal by Subject|0|||
163312408|NCT02677805|589854604|FG002|Open Label Phase|Withdrawal by Subject|6|||
163312409|NCT04350463|589854609|FG000|Overall Study|Other reason|0|||
163312410|NCT04350463|589854610|FG001|Overall Study|Other reason|0|||
163312411|NCT04350463|589854611|FG002|Overall Study|Other reason|0|||
163312412|NCT04350463|589854612|FG003|Overall Study|Other reason|1|||
163312413|NCT04350463|589854609|FG000|Overall Study|Lost to Follow-up|0|||
163312414|NCT04350463|589854610|FG001|Overall Study|Lost to Follow-up|0|||
163312415|NCT04350463|589854611|FG002|Overall Study|Lost to Follow-up|0|||
163312416|NCT04350463|589854612|FG003|Overall Study|Lost to Follow-up|2|||
163312417|NCT04350463|589854609|FG000|Overall Study|Withdrawal by Subject|4|||
163312418|NCT04350463|589854610|FG001|Overall Study|Withdrawal by Subject|0|||
163312419|NCT04350463|589854611|FG002|Overall Study|Withdrawal by Subject|1|||
163312420|NCT04350463|589854612|FG003|Overall Study|Withdrawal by Subject|4|||
163312421|NCT04350463|589854609|FG000|Overall Study|Adverse Event|0|||
163312422|NCT04350463|589854610|FG001|Overall Study|Adverse Event|0|||
163312423|NCT04350463|589854611|FG002|Overall Study|Adverse Event|0|||
163312424|NCT04350463|589854612|FG003|Overall Study|Adverse Event|2|||
163312425|NCT04350463|589854609|FG000|Overall Study|Death|27|||
163312426|NCT04350463|589854610|FG001|Overall Study|Death|2|||
163312427|NCT04350463|589854611|FG002|Overall Study|Death|13|||
163312428|NCT04350463|589854612|FG003|Overall Study|Death|26|||
163312429|NCT04652700|589854613|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
163312430|NCT04652700|589854614|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
163312431|NCT04652700|589854613|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
163312432|NCT04652700|589854614|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
163312433|NCT04652700|589854613|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
163312434|NCT04652700|589854614|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
163312435|NCT04652700|589854613|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
163312436|NCT04652700|589854614|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
163312437|NCT04652700|589854613|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
163312438|NCT04652700|589854614|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
163312439|NCT04652700|589854613|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
163312440|NCT04652700|589854614|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
163312441|NCT04652700|589854613|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
163312442|NCT04652700|589854614|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
163312443|NCT04652700|589854613|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
163312444|NCT04652700|589854614|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
163312445|NCT04652700|589854613|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
163312446|NCT04652700|589854614|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
163312447|NCT04187833|589854615|FG000|Overall Study|Withdrawal by Subject|1|||
163312448|NCT03097549|589854618|FG000|Overall Study|Withdrawal by Subject|1|||
163312449|NCT03097549|589854619|FG001|Overall Study|Withdrawal by Subject|0|||
163312450|NCT03097549|589854618|FG000|Overall Study|Lost to Follow-up|1|||
163312451|NCT03097549|589854619|FG001|Overall Study|Lost to Follow-up|0|||
163312452|NCT02146378|589854620|FG000|Overall Study|No information of administration|2|||
163312453|NCT06215521|589854621|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
163312454|NCT06215521|589854622|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
163312455|NCT06215521|589854623|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
163312456|NCT06215521|589854624|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
163312457|NCT06215521|589854625|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
163312458|NCT06215521|589854626|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
163312459|NCT05089019|589854627|FG000|Period 1|Withdrawal by Subject|0|||
163312460|NCT05089019|589854628|FG001|Period 1|Withdrawal by Subject|1|||
163312461|NCT05089019|589854627|FG000|Washout Period|Adverse Event|3|||
163312462|NCT05089019|589854628|FG001|Washout Period|Adverse Event|4|||
163312463|NCT05089019|589854627|FG000|Washout Period|Lost to Follow-up|1|||
163312464|NCT05089019|589854628|FG001|Washout Period|Lost to Follow-up|0|||
163312465|NCT05089019|589854627|FG000|Washout Period|Physician Decision|2|||
163312466|NCT05089019|589854628|FG001|Washout Period|Physician Decision|0|||
163312467|NCT05089019|589854627|FG000|Washout Period|Withdrawal by Subject|6|||
163312468|NCT05089019|589854628|FG001|Washout Period|Withdrawal by Subject|3|||
163312469|NCT05089019|589854627|FG000|Period 2|Adverse Event|4|||
163312470|NCT05089019|589854628|FG001|Period 2|Adverse Event|2|||
163312471|NCT05089019|589854627|FG000|Period 2|Lost to Follow-up|1|||
163312472|NCT05089019|589854628|FG001|Period 2|Lost to Follow-up|0|||
163312473|NCT05089019|589854627|FG000|Period 2|Withdrawal by Subject|0|||
163312474|NCT05089019|589854628|FG001|Period 2|Withdrawal by Subject|1|||
163312475|NCT04925986|589854629|FG000|Overall Study|Death|0|||
163312476|NCT04925986|589854630|FG001|Overall Study|Death|0|||
163312477|NCT04925986|589854631|FG002|Overall Study|Death|2|||
163312478|NCT04925986|589854632|FG003|Overall Study|Death|0|||
163312479|NCT04925986|589854629|FG000|Overall Study|Lack of Efficacy|1|||
163312480|NCT04925986|589854630|FG001|Overall Study|Lack of Efficacy|2|||
163312481|NCT04925986|589854631|FG002|Overall Study|Lack of Efficacy|0|||
163312482|NCT04925986|589854632|FG003|Overall Study|Lack of Efficacy|1|||
163312483|NCT04925986|589854629|FG000|Overall Study|Withdrawal by Subject|0|||
163312484|NCT04925986|589854630|FG001|Overall Study|Withdrawal by Subject|0|||
163058601|NCT00042289|588924241|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
163312485|NCT04925986|589854631|FG002|Overall Study|Withdrawal by Subject|1|||
163312486|NCT04925986|589854632|FG003|Overall Study|Withdrawal by Subject|2|||
163312487|NCT05415722|589854633|FG000|Overall Study|Lost to Follow-up|0|||
163312488|NCT05415722|589854634|FG001|Overall Study|Lost to Follow-up|2|||
163312489|NCT05415722|589854635|FG002|Overall Study|Lost to Follow-up|0|||
163312490|NCT05415722|589854636|FG003|Overall Study|Lost to Follow-up|1|||
163312491|NCT05415722|589854637|FG004|Overall Study|Lost to Follow-up|0|||
163312492|NCT05415722|589854638|FG005|Overall Study|Lost to Follow-up|0|||
163312493|NCT05415722|589854639|FG006|Overall Study|Lost to Follow-up|1|||
163312494|NCT05415722|589854633|FG000|Overall Study|Physician Decision|0|||
163312495|NCT05415722|589854634|FG001|Overall Study|Physician Decision|0|||
163312496|NCT05415722|589854635|FG002|Overall Study|Physician Decision|0|||
162965073|NCT02377349|588572047|FG000|Overall Study|Serious Adverse Event|1|||
162965074|NCT02377349|588572048|FG001|Overall Study|Serious Adverse Event|0|||
162965075|NCT02377349|588572047|FG000|Overall Study|Protocol Violation|3|||
163312497|NCT05415722|589854636|FG003|Overall Study|Physician Decision|1|||
163312498|NCT05415722|589854637|FG004|Overall Study|Physician Decision|0|||
163204388|NCT02207244|589461854|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
163204389|NCT02207244|589461855|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
163204390|NCT02207244|589461856|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
163204391|NCT02207244|589461857|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
163204392|NCT02207244|589461858|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
163204393|NCT02207244|589461859|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
163204394|NCT02207244|589461860|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
163204395|NCT02207244|589461861|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
163204396|NCT02207244|589461862|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
163204397|NCT02207244|589461863|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
163204398|NCT02207244|589461864|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
163204399|NCT02207244|589461854|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
163204400|NCT02207244|589461855|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
163204401|NCT02207244|589461856|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
163204402|NCT02207244|589461857|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
163312499|NCT05415722|589854638|FG005|Overall Study|Physician Decision|0|||
163312500|NCT05415722|589854639|FG006|Overall Study|Physician Decision|1|||
163312501|NCT05415722|589854633|FG000|Overall Study|Protocol Violation|0|||
163312502|NCT05415722|589854634|FG001|Overall Study|Protocol Violation|0|||
163312503|NCT05415722|589854635|FG002|Overall Study|Protocol Violation|0|||
163312504|NCT05415722|589854636|FG003|Overall Study|Protocol Violation|1|||
163312505|NCT05415722|589854637|FG004|Overall Study|Protocol Violation|0|||
163312506|NCT05415722|589854638|FG005|Overall Study|Protocol Violation|0|||
163312507|NCT05415722|589854639|FG006|Overall Study|Protocol Violation|0|||
163312508|NCT05415722|589854633|FG000|Overall Study|Sponsor Discretion|0|||
163312509|NCT05415722|589854634|FG001|Overall Study|Sponsor Discretion|0|||
163312510|NCT05415722|589854635|FG002|Overall Study|Sponsor Discretion|0|||
163312511|NCT05415722|589854636|FG003|Overall Study|Sponsor Discretion|0|||
163312512|NCT05415722|589854637|FG004|Overall Study|Sponsor Discretion|1|||
163312513|NCT05415722|589854638|FG005|Overall Study|Sponsor Discretion|1|||
163312514|NCT05415722|589854639|FG006|Overall Study|Sponsor Discretion|0|||
163312515|NCT05415722|589854633|FG000|Overall Study|Withdrawal by Subject|0|||
162924467|NCT03539952|588423898|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
162924468|NCT03539952|588423897|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
162924469|NCT03539952|588423898|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
162924470|NCT03539952|588423897|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
162924471|NCT03539952|588423898|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
162924472|NCT02184988|588423899|FG000|Overall Study|Pregnancy|2|||
162924473|NCT02184988|588423899|FG000|Overall Study|Adverse Event|2|||
162924474|NCT02184988|588423899|FG000|Overall Study|moving away/travelling/unable to complet|6|||
162924475|NCT02184988|588423899|FG000|Overall Study|work scheduling issues|4|||
162924476|NCT02184988|588423899|FG000|Overall Study|various other reasons|9|||
162924477|NCT02184988|588423899|FG000|Overall Study|Lost to Follow-up|32|||
162924478|NCT01371006|588426025|FG000|Overall Study|Adverse Event|1|||
162924479|NCT01371006|588426026|FG001|Overall Study|Adverse Event|0|||
162924480|NCT03256526|588426027|FG000|Overall Study|Adverse Event|1|||
162924481|NCT03256526|588426028|FG001|Overall Study|Adverse Event|0|||
162924482|NCT03256526|588426029|FG002|Overall Study|Adverse Event|1|||
162924483|NCT03256526|588426027|FG000|Overall Study|Lost to Follow-up|1|||
162924484|NCT03256526|588426028|FG001|Overall Study|Lost to Follow-up|0|||
162924485|NCT03256526|588426029|FG002|Overall Study|Lost to Follow-up|2|||
162924486|NCT00891527|588426030|FG000|Overall Study|Withdrawal by Subject|2|||
162924487|NCT01186744|588426031|FG000|Overall Study|Lack of Efficacy|156|||
162924488|NCT01186744|588426032|FG001|Overall Study|Lack of Efficacy|99|||
162924489|NCT01186744|588426033|FG002|Overall Study|Lack of Efficacy|0|||
162924490|NCT01186744|588426034|FG003|Overall Study|Lack of Efficacy|2|||
162924491|NCT01186744|588426035|FG004|Overall Study|Lack of Efficacy|2|||
162924492|NCT01186744|588426036|FG005|Overall Study|Lack of Efficacy|5|||
162924493|NCT01186744|588426031|FG000|Overall Study|Protocol Violation|1|||
162924494|NCT01186744|588426032|FG001|Overall Study|Protocol Violation|2|||
162924495|NCT01186744|588426033|FG002|Overall Study|Protocol Violation|0|||
162924496|NCT01186744|588426034|FG003|Overall Study|Protocol Violation|1|||
162924497|NCT01186744|588426035|FG004|Overall Study|Protocol Violation|1|||
162924498|NCT01186744|588426036|FG005|Overall Study|Protocol Violation|2|||
163312516|NCT05415722|589854634|FG001|Overall Study|Withdrawal by Subject|1|||
163312517|NCT05415722|589854635|FG002|Overall Study|Withdrawal by Subject|0|||
163312518|NCT05415722|589854636|FG003|Overall Study|Withdrawal by Subject|1|||
163312519|NCT05415722|589854637|FG004|Overall Study|Withdrawal by Subject|1|||
163312520|NCT05415722|589854638|FG005|Overall Study|Withdrawal by Subject|0|||
163312521|NCT05415722|589854639|FG006|Overall Study|Withdrawal by Subject|1|||
163312522|NCT03524612|589854640|FG000|Overall Study|Lack of Efficacy|10|||
163204403|NCT02207244|589461858|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
163204404|NCT02207244|589461859|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
163204405|NCT02207244|589461860|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
163204406|NCT02207244|589461861|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
163204407|NCT02207244|589461862|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
163204408|NCT02207244|589461863|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
163204409|NCT02207244|589461864|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
163204410|NCT02207244|589461854|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
163204411|NCT02207244|589461855|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
163204412|NCT02207244|589461856|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
163204413|NCT02207244|589461857|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
163204414|NCT02207244|589461858|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
163051930|NCT04613518|588898752|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
163051931|NCT04613518|588898753|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
163051932|NCT04613518|588898754|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
163051933|NCT04613518|588898752|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
163051934|NCT04613518|588898753|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
163051935|NCT04613518|588898754|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
163051936|NCT04613518|588898752|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
163204415|NCT02207244|589461859|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
163204416|NCT02207244|589461860|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
163204417|NCT02207244|589461861|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
163204418|NCT02207244|589461862|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
163204419|NCT02207244|589461863|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
163204420|NCT02207244|589461864|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
163204421|NCT02207244|589461854|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
163204422|NCT02207244|589461855|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
163204423|NCT02207244|589461856|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
163204424|NCT02207244|589461857|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
163204425|NCT02207244|589461858|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
163204426|NCT02207244|589461859|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
162965076|NCT02377349|588572048|FG001|Overall Study|Protocol Violation|2|||
162965077|NCT02377349|588572047|FG000|Overall Study|Withdrawal by Subject|5|||
162965078|NCT02377349|588572048|FG001|Overall Study|Withdrawal by Subject|3|||
162965079|NCT02377349|588572047|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
162965080|NCT02377349|588572048|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
162965081|NCT02377349|588572047|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
162965082|NCT02377349|588572048|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
162965083|NCT02377349|588572047|FG000|Overall Study|Other|0|||
162965084|NCT02377349|588572048|FG001|Overall Study|Other|1|||
162965085|NCT01507662|588572057|FG000|Overall Study|Death|26|||
162965086|NCT01507662|588572058|FG001|Overall Study|Death|18|||
162965087|NCT01507662|588572057|FG000|Overall Study|Withdrawal by Subject|290|||
162965088|NCT01507662|588572058|FG001|Overall Study|Withdrawal by Subject|287|||
162965089|NCT01507662|588572057|FG000|Overall Study|Lost to Follow-up|498|||
162965090|NCT01507662|588572058|FG001|Overall Study|Lost to Follow-up|523|||
162965091|NCT01507662|588572057|FG000|Overall Study|Proxy interview done|2|||
162965092|NCT01507662|588572058|FG001|Overall Study|Proxy interview done|3|||
162965093|NCT01395017|588572063|FG000|Overall Study|Lost to Follow-up|1|||
162965094|NCT01395017|588572064|FG001|Overall Study|Lost to Follow-up|0|||
162965095|NCT01395017|588572063|FG000|Overall Study|Adverse Event|26|||
162965096|NCT01395017|588572064|FG001|Overall Study|Adverse Event|12|||
162965097|NCT01395017|588572063|FG000|Overall Study|Physician Decision|11|||
162965098|NCT01395017|588572064|FG001|Overall Study|Physician Decision|15|||
162965099|NCT01395017|588572063|FG000|Overall Study|Withdrawal by Subject|14|||
162965100|NCT01395017|588572064|FG001|Overall Study|Withdrawal by Subject|8|||
162965101|NCT01395017|588572063|FG000|Overall Study|Protocol deviation|1|||
162965102|NCT01395017|588572064|FG001|Overall Study|Protocol deviation|2|||
162965103|NCT01395017|588572063|FG000|Overall Study|Death|4|||
162965104|NCT01395017|588572064|FG001|Overall Study|Death|3|||
162965105|NCT01395017|588572063|FG000|Overall Study|Disease progression|42|||
162965106|NCT01395017|588572064|FG001|Overall Study|Disease progression|58|||
163204427|NCT02207244|589461860|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162965107|NCT01395017|588572063|FG000|Overall Study|Sponsor discontinued study|1|||
162965108|NCT01395017|588572064|FG001|Overall Study|Sponsor discontinued study|4|||
162965109|NCT00999687|588572068|FG000|First Intervention|Withdrawal by Subject|1|||
162965110|NCT00999687|588572068|FG000|Second Intervention|Withdrawal by Subject|2|||
162965111|NCT00999687|588572068|FG000|Second Intervention|Lack of Efficacy|1|||
163204428|NCT02207244|589461861|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
163204429|NCT02207244|589461862|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
163204430|NCT02207244|589461863|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
163204431|NCT02207244|589461864|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
163051937|NCT04613518|588898753|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
163051938|NCT04613518|588898754|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
163051939|NCT04613518|588898752|FG000|Open-Label Treatment Period|Other reasons|1|||
163051940|NCT04613518|588898753|FG001|Open-Label Treatment Period|Other reasons|0|||
163051941|NCT04613518|588898754|FG002|Open-Label Treatment Period|Other reasons|0|||
163051942|NCT04831138|588898755|FG000|Overall Study|Lost to Follow-up|2|||
163051943|NCT04831138|588898756|FG001|Overall Study|Lost to Follow-up|0|||
163051944|NCT04202497|588898759|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
163051945|NCT04202497|588898760|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
163051946|NCT04202497|588898761|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
163051947|NCT04202497|588898762|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
163051948|NCT05590377|588898763|FG000|Overall Study|Death|1|||
163051949|NCT05590377|588898764|FG001|Overall Study|Death|1|||
163051950|NCT05590377|588898765|FG002|Overall Study|Death|2|||
163051951|NCT05590377|588898766|FG003|Overall Study|Death|0|||
163051952|NCT05590377|588898767|FG004|Overall Study|Death|0|||
163051953|NCT05590377|588898763|FG000|Overall Study|Study Terminated by Sponsor|1|||
163051954|NCT05590377|588898764|FG001|Overall Study|Study Terminated by Sponsor|5|||
163051955|NCT05590377|588898765|FG002|Overall Study|Study Terminated by Sponsor|4|||
163051956|NCT05590377|588898766|FG003|Overall Study|Study Terminated by Sponsor|0|||
163051957|NCT05590377|588898767|FG004|Overall Study|Study Terminated by Sponsor|0|||
163051958|NCT05590377|588898763|FG000|Overall Study|Withdrawal by Subject|1|||
163051959|NCT05590377|588898764|FG001|Overall Study|Withdrawal by Subject|0|||
163051960|NCT05590377|588898765|FG002|Overall Study|Withdrawal by Subject|0|||
163051961|NCT05590377|588898766|FG003|Overall Study|Withdrawal by Subject|0|||
163051962|NCT05590377|588898767|FG004|Overall Study|Withdrawal by Subject|0|||
163051963|NCT02499146|588898768|FG000|Overall Study|Global deterioration of health status|1|||
163051964|NCT02499146|588898768|FG000|Overall Study|Objective progression or relapse|20|||
163397459|NCT01490450|590167712|FG002|Period 2|Lost to Follow-up|0|||
163051965|NCT02499146|588898768|FG000|Overall Study|Other|2|||
163051966|NCT02499146|588898768|FG000|Overall Study|Participant refused continued treatment for reason other than adverse event|3|||
163051967|NCT04325828|588898769|FG000|Overall Study|Ongoing|26|||
163051968|NCT05115630|588898770|FG000|Overall Study|Due to COVID19|1|||
163051969|NCT05115630|588898770|FG000|Overall Study|Due to Bacteremia|1|||
163051970|NCT05115630|588898770|FG000|Overall Study|Due to viral infection|1|||
163204432|NCT02207244|589461854|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
163204433|NCT02207244|589461855|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
163204434|NCT02207244|589461856|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
163204435|NCT02207244|589461857|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
163204436|NCT02207244|589461858|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
163204437|NCT02207244|589461859|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
163204438|NCT02207244|589461860|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
163204439|NCT02207244|589461861|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
163204440|NCT02207244|589461862|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
163204441|NCT02207244|589461863|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
163204442|NCT02207244|589461864|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
163204443|NCT02207244|589461854|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
163204444|NCT02207244|589461855|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
163204445|NCT02207244|589461856|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
163204446|NCT02207244|589461857|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
163204447|NCT02207244|589461858|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
163397460|NCT01490450|590167713|FG003|Period 2|Lost to Follow-up|2|||
163051971|NCT02287038|588898773|FG000|Overall Study|Stopped attending appointments|3|||
163051972|NCT02287038|588898774|FG001|Overall Study|Stopped attending appointments|2|||
162965112|NCT03614728|588572071|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
162965113|NCT03614728|588572072|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
162965114|NCT03614728|588572073|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
162965115|NCT03614728|588572074|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
162965116|NCT03614728|588572071|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
162965117|NCT03614728|588572072|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
162965118|NCT03614728|588572073|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
162965119|NCT03614728|588572074|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
162965120|NCT01401062|588572082|FG000|Overall Study|Death|9|||
162965121|NCT01401062|588572083|FG001|Overall Study|Death|7|||
162965122|NCT01401062|588572082|FG000|Overall Study|Physician Decision|1|||
162965123|NCT01401062|588572083|FG001|Overall Study|Physician Decision|0|||
162965124|NCT01401062|588572082|FG000|Overall Study|Withdrawal by Subject|1|||
162965125|NCT01401062|588572083|FG001|Overall Study|Withdrawal by Subject|1|||
162965126|NCT04203823|588572086|FG000|Overall Study|Withdrawal by Subject|2|||
162965127|NCT04203823|588572087|FG001|Overall Study|Withdrawal by Subject|2|||
163397461|NCT00404820|590167714|FG000|Overall Study|Adverse Event|4|||
162965128|NCT04203823|588572086|FG000|Overall Study|Adverse Event|1|||
162965129|NCT04203823|588572087|FG001|Overall Study|Adverse Event|1|||
162965130|NCT04203823|588572086|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162965131|NCT04203823|588572087|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
162965132|NCT03684928|588572088|FG000|First Intervention|Lost to Follow-up|0|||
162965133|NCT03684928|588572089|FG001|First Intervention|Lost to Follow-up|1|||
162965134|NCT03684928|588572088|FG000|First Intervention|Withdrawal by Subject|0|||
163051973|NCT02287038|588898773|FG000|Overall Study|Anxiety after starting medication|0|||
163051974|NCT02287038|588898774|FG001|Overall Study|Anxiety after starting medication|1|||
163051975|NCT02287038|588898773|FG000|Overall Study|Nausea after starting medication|1|||
163051976|NCT02287038|588898774|FG001|Overall Study|Nausea after starting medication|0|||
163051977|NCT02287038|588898773|FG000|Overall Study|Abnormal ECG after starting medication|1|||
163051978|NCT02287038|588898774|FG001|Overall Study|Abnormal ECG after starting medication|0|||
163051979|NCT02667301|588898782|FG000|Overall Study|Adverse Event|1|||
163051980|NCT02667301|588898782|FG000|Overall Study|Lack of Efficacy|1|||
163051981|NCT00846586|588898784|FG000|Overall Study|Adverse Event|20|||
163051982|NCT00846586|588898785|FG001|Overall Study|Adverse Event|10|||
163051983|NCT00846586|588898784|FG000|Overall Study|Subject withdrew consent|8|||
163051984|NCT00846586|588898785|FG001|Overall Study|Subject withdrew consent|10|||
163051985|NCT00846586|588898784|FG000|Overall Study|Administrative problems|5|||
163051986|NCT00846586|588898785|FG001|Overall Study|Administrative problems|4|||
163051987|NCT00846586|588898784|FG000|Overall Study|Death|2|||
163051988|NCT00846586|588898785|FG001|Overall Study|Death|0|||
163051989|NCT00846586|588898784|FG000|Overall Study|Protocol deviation|2|||
163051990|NCT00846586|588898785|FG001|Overall Study|Protocol deviation|6|||
163204448|NCT02207244|589461859|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
163204449|NCT02207244|589461860|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
163204450|NCT02207244|589461861|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
163204451|NCT02207244|589461862|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
163204452|NCT02207244|589461863|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
163204453|NCT02207244|589461864|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
163204454|NCT02207244|589461854|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
163204455|NCT02207244|589461855|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
163204456|NCT02207244|589461856|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
163204457|NCT02207244|589461857|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
163204458|NCT02207244|589461858|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
163204459|NCT02207244|589461859|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
163204460|NCT02207244|589461860|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
163204461|NCT02207244|589461861|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
163204462|NCT02207244|589461862|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
163204463|NCT02207244|589461863|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
163204464|NCT02207244|589461864|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
163204465|NCT02207244|589461854|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
163204466|NCT02207244|589461855|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
163204467|NCT02207244|589461856|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
163204468|NCT02207244|589461857|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
163204469|NCT02207244|589461858|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
163204470|NCT02207244|589461859|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
163204471|NCT02207244|589461860|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
163204472|NCT02207244|589461861|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
163204473|NCT02207244|589461862|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
163204474|NCT02207244|589461863|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
163204475|NCT02207244|589461864|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
163204476|NCT02207244|589461854|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
163204477|NCT02207244|589461855|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
163204478|NCT02207244|589461856|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
163204479|NCT02207244|589461857|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
163204480|NCT02207244|589461858|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
163204481|NCT02207244|589461859|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
163204482|NCT02207244|589461860|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
163204483|NCT02207244|589461861|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
163204484|NCT02207244|589461862|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
163204485|NCT02207244|589461863|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
163051991|NCT00846586|588898784|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163051992|NCT00846586|588898785|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163051993|NCT00846586|588898784|FG000|Overall Study|Lost to Follow-up|1|||
163051994|NCT00846586|588898785|FG001|Overall Study|Lost to Follow-up|4|||
163204486|NCT02207244|589461864|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
163204487|NCT02207244|589461854|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
163204488|NCT02207244|589461855|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
163204489|NCT02207244|589461856|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
163204490|NCT02207244|589461857|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
163204491|NCT02207244|589461858|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
163204492|NCT02207244|589461859|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
163204493|NCT02207244|589461860|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
163204494|NCT02207244|589461861|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
163204495|NCT02207244|589461862|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
163204496|NCT02207244|589461863|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
163204497|NCT02207244|589461864|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
163204498|NCT02207244|589461854|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
163204499|NCT02207244|589461855|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
163204500|NCT02207244|589461856|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
163204501|NCT02207244|589461857|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
163204502|NCT02207244|589461858|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
163204503|NCT02207244|589461859|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
163204504|NCT02207244|589461860|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
163204505|NCT02207244|589461861|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
163204506|NCT02207244|589461862|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
163204507|NCT02207244|589461863|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
163204508|NCT02207244|589461864|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
163204509|NCT02207244|589461854|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
163204510|NCT02207244|589461855|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
163204511|NCT02207244|589461856|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
163204512|NCT02207244|589461857|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
163204513|NCT02207244|589461858|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
163204514|NCT02207244|589461859|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
163204515|NCT02207244|589461860|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
163204516|NCT02207244|589461861|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
163204517|NCT02207244|589461862|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
163204518|NCT02207244|589461863|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
163204519|NCT02207244|589461864|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
163204520|NCT02207244|589461854|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
163204521|NCT02207244|589461855|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
163204522|NCT02207244|589461856|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
163204523|NCT02207244|589461857|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
163204524|NCT02207244|589461858|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
163204525|NCT02207244|589461859|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
163204526|NCT02207244|589461860|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
163204527|NCT02207244|589461861|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
163204528|NCT02207244|589461862|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
163204529|NCT02207244|589461863|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
163204530|NCT02207244|589461864|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
163204531|NCT02207244|589461854|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
163204532|NCT02207244|589461855|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
163204533|NCT02207244|589461856|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
163204534|NCT02207244|589461857|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
163204535|NCT02207244|589461858|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
163204536|NCT02207244|589461859|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
163204537|NCT02207244|589461860|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
163204538|NCT02207244|589461861|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
163204539|NCT02207244|589461862|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
163204540|NCT02207244|589461863|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
163204541|NCT02207244|589461864|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
163204542|NCT02207244|589461854|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
163204543|NCT02207244|589461855|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
163204544|NCT02207244|589461856|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
163204545|NCT02207244|589461857|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
163204546|NCT02207244|589461858|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
163204547|NCT02207244|589461859|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
163204548|NCT02207244|589461860|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
163204549|NCT02207244|589461861|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
163204550|NCT02207244|589461862|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
163204551|NCT02207244|589461863|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
163204552|NCT02207244|589461864|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
163204553|NCT02207244|589461854|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
163204554|NCT02207244|589461855|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
163204555|NCT02207244|589461856|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
163204556|NCT02207244|589461857|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
163204557|NCT02207244|589461858|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
163204558|NCT02207244|589461859|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
163204559|NCT02207244|589461860|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
163204560|NCT02207244|589461861|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
163204561|NCT02207244|589461862|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
163204562|NCT02207244|589461863|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
163204563|NCT02207244|589461864|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
163204564|NCT02207244|589461854|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
163204565|NCT02207244|589461855|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
163204566|NCT02207244|589461856|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
163204567|NCT02207244|589461857|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
163204568|NCT02207244|589461858|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
163204569|NCT02207244|589461859|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
163204570|NCT02207244|589461860|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
163204571|NCT02207244|589461861|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
163312523|NCT03524612|589854640|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
163312524|NCT03524612|589854640|FG000|Overall Study|Adverse Event|10|||
163312525|NCT03524612|589854640|FG000|Overall Study|Withdrawal by Subject|7|||
163312526|NCT03524612|589854640|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
163312527|NCT03524612|589854640|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
163312528|NCT03524612|589854640|FG000|Overall Study|New therapy for study indication|6|||
163312529|NCT03524612|589854640|FG000|Overall Study|Death|3|||
163312530|NCT03524612|589854640|FG000|Overall Study|Lost to Follow-up|2|||
163312531|NCT03524612|589854640|FG000|Overall Study|Protocol Violation|1|||
163312532|NCT05457647|589854642|FG000|Overall Study|Lost to Follow-up|3|||
163312533|NCT04623671|589854643|FG000|Overall Study|Adverse Event|0|||
163312534|NCT04623671|589854644|FG001|Overall Study|Adverse Event|1|||
163312535|NCT04623671|589854643|FG000|Overall Study|Lost to Follow-up|2|||
163312536|NCT04623671|589854644|FG001|Overall Study|Lost to Follow-up|1|||
163312537|NCT04623671|589854643|FG000|Overall Study|Death|5|||
163312538|NCT04623671|589854644|FG001|Overall Study|Death|5|||
163312539|NCT03448107|589854645|FG000|Overall Study|Lost to Follow-up|229|||
163312540|NCT03448107|589854646|FG001|Overall Study|Lost to Follow-up|258|||
163312541|NCT04025554|589854647|FG000|Overall Study|Adverse Event|3|||
163312542|NCT03115476|589854648|FG000|LP0084-1369|Death|1|||
163312543|NCT03115476|589854649|FG001|LP0084-1369|Death|0|||
163312544|NCT03115476|589854650|FG002|LP0084-1369|Death|2|||
163312545|NCT03115476|589854648|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
163312546|NCT03115476|589854649|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
163312547|NCT03115476|589854650|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
163312548|NCT01802788|589854651|FG000|Overall Study|Withdrawal by Subject|102|||
163312549|NCT01802788|589854652|FG001|Overall Study|Withdrawal by Subject|5|||
163312550|NCT01802788|589854651|FG000|Overall Study|Death|382|||
163312551|NCT01802788|589854652|FG001|Overall Study|Death|18|||
163397462|NCT00404820|590167715|FG001|Overall Study|Adverse Event|16|||
163397463|NCT00404820|590167714|FG000|Overall Study|Withdrawal by Subject|5|||
163312552|NCT01802788|589854651|FG000|Overall Study|Lost to Follow-up|31|||
163312553|NCT01802788|589854652|FG001|Overall Study|Lost to Follow-up|2|||
163312554|NCT01802788|589854651|FG000|Overall Study|Physician Decision|3|||
163312555|NCT01802788|589854652|FG001|Overall Study|Physician Decision|0|||
163312556|NCT01802788|589854651|FG000|Overall Study|Patient Non-Compliance|1|||
163312557|NCT01802788|589854652|FG001|Overall Study|Patient Non-Compliance|0|||
163312558|NCT01802788|589854651|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
163312559|NCT01802788|589854652|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
163312560|NCT01802788|589854651|FG000|Overall Study|Other Reasons|19|||
163312561|NCT01802788|589854652|FG001|Overall Study|Other Reasons|0|||
163204572|NCT02207244|589461862|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
163204573|NCT02207244|589461863|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
163204574|NCT02207244|589461864|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
163204575|NCT02207244|589461854|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
163204576|NCT02207244|589461855|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
163204577|NCT02207244|589461856|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
163204578|NCT02207244|589461857|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
163204579|NCT02207244|589461858|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
163204580|NCT02207244|589461859|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
163204581|NCT02207244|589461860|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
163204582|NCT02207244|589461861|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
163204583|NCT02207244|589461862|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
163204584|NCT02207244|589461863|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
163204585|NCT02207244|589461864|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
163204586|NCT02207244|589461854|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
163204587|NCT02207244|589461855|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
163204588|NCT02207244|589461856|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
163204589|NCT02207244|589461857|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
163204590|NCT02207244|589461858|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
163204591|NCT02207244|589461859|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
163204592|NCT02207244|589461860|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
163204593|NCT02207244|589461861|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
163204594|NCT02207244|589461862|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
163204595|NCT02207244|589461863|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
163204596|NCT02207244|589461864|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
163204597|NCT02207244|589461854|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
163204598|NCT02207244|589461855|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
163204599|NCT02207244|589461856|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
163204600|NCT02207244|589461857|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
163204601|NCT02207244|589461858|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
163204602|NCT02207244|589461859|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
163204603|NCT02207244|589461860|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
163312562|NCT04700163|589854655|FG000|Overall Study|Lost to Follow-up|0|||
163312563|NCT04700163|589854656|FG001|Overall Study|Lost to Follow-up|0|||
163312564|NCT04700163|589854657|FG002|Overall Study|Lost to Follow-up|0|||
163051995|NCT00846586|588898784|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163312565|NCT04700163|589854658|FG003|Overall Study|Lost to Follow-up|0|||
163312566|NCT04700163|589854659|FG004|Overall Study|Lost to Follow-up|0|||
163312567|NCT04700163|589854660|FG005|Overall Study|Lost to Follow-up|1|||
163312568|NCT03270501|589854661|FG000|Overall Study|Screen failure|6|||
163312569|NCT03270501|589854661|FG000|Overall Study|Lost to Follow-up|2|||
163312570|NCT03270501|589854661|FG000|Overall Study|Adverse Event|1|||
163312571|NCT01648023|589854662|FG000|Overall Study|Screen Fail Post Randomization|1|||
163312572|NCT01648023|589854663|FG001|Overall Study|Screen Fail Post Randomization|2|||
163312573|NCT00764751|589854668|FG000|Overall Study|Adverse Event|1|||
163312574|NCT00764751|589854669|FG001|Overall Study|Adverse Event|1|||
163312575|NCT00764751|589854668|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
163312576|NCT00764751|589854669|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
163312577|NCT05296525|589854673|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
162965135|NCT03684928|588572089|FG001|First Intervention|Withdrawal by Subject|2|||
163312578|NCT05296525|589854674|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
163312579|NCT05296525|589854675|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
163397464|NCT00404820|590167715|FG001|Overall Study|Withdrawal by Subject|3|||
162965136|NCT03684928|588572088|FG000|Second Intervention|Soft Tissue Injury|1|||
163312580|NCT05296525|589854676|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
163397465|NCT00404820|590167714|FG000|Overall Study|Lost to Follow-up|7|||
163051996|NCT00846586|588898785|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163051997|NCT01619878|588898786|FG000|6 Week Follow-up Phase|Adverse Event|1|||
163051998|NCT01619878|588898786|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
163051999|NCT01619878|588898786|FG000|Follow-up at 12 Months of Age|Death|2|||
163052000|NCT04414787|588898787|FG000|Overall Study|Patient Death|18|||
163052001|NCT04414787|588898788|FG001|Overall Study|Patient Death|18|||
163052002|NCT04414787|588898789|FG002|Overall Study|Patient Death|15|||
163052003|NCT04414787|588898790|FG003|Overall Study|Patient Death|15|||
163052004|NCT04414787|588898787|FG000|Overall Study|Patient Hospitalization|1|||
163052005|NCT04414787|588898788|FG001|Overall Study|Patient Hospitalization|1|||
163052006|NCT04414787|588898789|FG002|Overall Study|Patient Hospitalization|2|||
163052007|NCT04414787|588898790|FG003|Overall Study|Patient Hospitalization|2|||
163052008|NCT04414787|588898787|FG000|Overall Study|Lost to Follow-up|7|||
163052009|NCT04414787|588898788|FG001|Overall Study|Lost to Follow-up|7|||
163052010|NCT04414787|588898789|FG002|Overall Study|Lost to Follow-up|5|||
163052011|NCT04414787|588898790|FG003|Overall Study|Lost to Follow-up|5|||
163052012|NCT04414787|588898787|FG000|Overall Study|Residence in post-acute care facility|3|||
163052013|NCT04414787|588898788|FG001|Overall Study|Residence in post-acute care facility|3|||
163052014|NCT04414787|588898789|FG002|Overall Study|Residence in post-acute care facility|5|||
163052015|NCT04414787|588898790|FG003|Overall Study|Residence in post-acute care facility|5|||
163052016|NCT05093933|588898791|FG000|Overall Study|Death|372|||
163052017|NCT05093933|588898792|FG001|Overall Study|Death|434|||
163052018|NCT05093933|588898791|FG000|Overall Study|Lost to Follow-up|13|||
163052019|NCT05093933|588898792|FG001|Overall Study|Lost to Follow-up|16|||
163052020|NCT05093933|588898791|FG000|Overall Study|Physician Decision|0|||
163052021|NCT05093933|588898792|FG001|Overall Study|Physician Decision|2|||
163052022|NCT05093933|588898791|FG000|Overall Study|Sponsor Decision|1|||
163052023|NCT05093933|588898792|FG001|Overall Study|Sponsor Decision|3|||
163052024|NCT05093933|588898791|FG000|Overall Study|Withdrawal by Guardian|1|||
163052025|NCT05093933|588898792|FG001|Overall Study|Withdrawal by Guardian|1|||
163397466|NCT00404820|590167715|FG001|Overall Study|Lost to Follow-up|3|||
163052026|NCT05093933|588898791|FG000|Overall Study|Withdrawal by Subject|18|||
163052027|NCT05093933|588898792|FG001|Overall Study|Withdrawal by Subject|25|||
163052028|NCT05027815|588898795|FG000|Overall Study|Death|2|||
163052029|NCT05027815|588898796|FG001|Overall Study|Death|1|||
163052030|NCT04802161|588898798|FG000|Overall Study|Alternate Therapy prior to Day 21|1|||
163052031|NCT04802161|588898799|FG001|Overall Study|Alternate Therapy prior to Day 21|0|||
163052032|NCT04802161|588898800|FG002|Overall Study|Alternate Therapy prior to Day 21|1|||
163052033|NCT04802161|588898801|FG003|Overall Study|Alternate Therapy prior to Day 21|1|||
163052034|NCT04802161|588898798|FG000|Overall Study|Clinical Instability|0|||
163052035|NCT04802161|588898799|FG001|Overall Study|Clinical Instability|0|||
163052036|NCT04802161|588898800|FG002|Overall Study|Clinical Instability|1|||
163204604|NCT02207244|589461861|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
163204605|NCT02207244|589461862|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
163204606|NCT02207244|589461863|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
163204607|NCT02207244|589461864|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
163204608|NCT02207244|589461854|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162965137|NCT03684928|588572089|FG001|Second Intervention|Soft Tissue Injury|0|||
162965138|NCT03193021|588572090|FG000|Overall Study|Lost to Follow-up|1|||
163204609|NCT02207244|589461855|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
163204610|NCT02207244|589461856|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
163204611|NCT02207244|589461857|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
163204612|NCT02207244|589461858|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
163204613|NCT02207244|589461859|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
163204614|NCT02207244|589461860|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
163204615|NCT02207244|589461861|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162965139|NCT03193021|588572091|FG001|Overall Study|Lost to Follow-up|1|||
163052037|NCT04802161|588898801|FG003|Overall Study|Clinical Instability|0|||
163052038|NCT04802161|588898798|FG000|Overall Study|Adverse Event|0|||
163052039|NCT04802161|588898799|FG001|Overall Study|Adverse Event|0|||
163052040|NCT04802161|588898800|FG002|Overall Study|Adverse Event|1|||
163397467|NCT00404820|590167714|FG000|Overall Study|Administrative problems|2|||
163204616|NCT02207244|589461862|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
163204617|NCT02207244|589461863|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
163204618|NCT02207244|589461864|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
163204619|NCT02207244|589461854|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
163204620|NCT02207244|589461855|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
163204621|NCT02207244|589461856|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
163204622|NCT02207244|589461857|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
163204623|NCT02207244|589461858|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
163052041|NCT04802161|588898801|FG003|Overall Study|Adverse Event|0|||
162965140|NCT02286466|588572092|FG000|Overall Study|Death|1|||
162965141|NCT02286466|588572093|FG001|Overall Study|Death|3|||
162965142|NCT02286466|588572092|FG000|Overall Study|Withdrawal by Subject|5|||
162965143|NCT02286466|588572093|FG001|Overall Study|Withdrawal by Subject|2|||
162965144|NCT02286466|588572092|FG000|Overall Study|Lost to Follow-up|1|||
162965145|NCT02286466|588572093|FG001|Overall Study|Lost to Follow-up|4|||
162965146|NCT02286466|588572092|FG000|Overall Study|Declined Clinician Assessment|0|||
162965147|NCT02286466|588572093|FG001|Overall Study|Declined Clinician Assessment|1|||
162965148|NCT00835081|588572094|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
162965149|NCT00835081|588572095|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
162965150|NCT00874276|588572096|FG000|Overall Study|Withdrawal by Subject|1|||
162965151|NCT00874276|588572097|FG001|Overall Study|Withdrawal by Subject|1|||
162965152|NCT04573309|588573214|FG000|Overall Study|Protocol Violation|1|||
162965153|NCT04573309|588573215|FG001|Overall Study|Protocol Violation|0|||
162965154|NCT02300987|588573216|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
162965155|NCT02300987|588573217|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
162965156|NCT02300987|588573216|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
162965157|NCT02300987|588573217|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
162965158|NCT02300987|588573216|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
162965159|NCT02300987|588573217|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
162965160|NCT02300987|588573216|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
162965161|NCT02300987|588573217|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
162965162|NCT02300987|588573216|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
162965163|NCT02300987|588573217|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
162965164|NCT04211766|588573218|FG000|Overall Study|Withdrawal by Subject|5|||
162965165|NCT04211766|588573219|FG001|Overall Study|Withdrawal by Subject|1|||
162965166|NCT05330975|588573220|FG000|Primary|Lost to Follow-up|12|||
162965167|NCT05330975|588573221|FG001|Primary|Lost to Follow-up|21|||
162965168|NCT05330975|588573222|FG002|Primary|Lost to Follow-up|38|||
162965169|NCT05330975|588573223|FG003|Primary|Lost to Follow-up|30|||
162965170|NCT05330975|588573224|FG004|Primary|Lost to Follow-up|25|||
162965171|NCT05330975|588573225|FG005|Primary|Lost to Follow-up|28|||
162965172|NCT05330975|588573226|FG006|Primary|Lost to Follow-up|0|||
162965173|NCT05330975|588573220|FG000|Primary|Withdrawal by Subject|4|||
162965174|NCT05330975|588573221|FG001|Primary|Withdrawal by Subject|11|||
162965175|NCT05330975|588573222|FG002|Primary|Withdrawal by Subject|8|||
162965176|NCT05330975|588573223|FG003|Primary|Withdrawal by Subject|23|||
162965177|NCT05330975|588573224|FG004|Primary|Withdrawal by Subject|20|||
162965178|NCT05330975|588573225|FG005|Primary|Withdrawal by Subject|19|||
162965179|NCT05330975|588573226|FG006|Primary|Withdrawal by Subject|0|||
162965180|NCT05330975|588573220|FG000|Primary|Protocol Violation|0|||
162965181|NCT05330975|588573221|FG001|Primary|Protocol Violation|2|||
162965182|NCT05330975|588573222|FG002|Primary|Protocol Violation|0|||
162965183|NCT05330975|588573223|FG003|Primary|Protocol Violation|4|||
162965184|NCT05330975|588573224|FG004|Primary|Protocol Violation|0|||
162965185|NCT05330975|588573225|FG005|Primary|Protocol Violation|3|||
162965186|NCT05330975|588573226|FG006|Primary|Protocol Violation|0|||
162965187|NCT05330975|588573220|FG000|Primary|Death|0|||
162965188|NCT05330975|588573221|FG001|Primary|Death|3|||
162965189|NCT05330975|588573222|FG002|Primary|Death|1|||
162965190|NCT05330975|588573223|FG003|Primary|Death|1|||
162965191|NCT05330975|588573224|FG004|Primary|Death|0|||
162965192|NCT05330975|588573225|FG005|Primary|Death|0|||
162965193|NCT05330975|588573226|FG006|Primary|Death|0|||
162965194|NCT05330975|588573220|FG000|Primary|Other Than Specified|0|||
162965195|NCT05330975|588573221|FG001|Primary|Other Than Specified|1|||
163204624|NCT02207244|589461859|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
163312581|NCT02465268|589854680|FG000|Overall Study|Withdrawal by Subject|4|||
163204625|NCT02207244|589461860|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
163204626|NCT02207244|589461861|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
163204627|NCT02207244|589461862|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
163204628|NCT02207244|589461863|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
163204629|NCT02207244|589461864|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
163204630|NCT02207244|589461854|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
163204631|NCT02207244|589461855|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
162924499|NCT01186744|588426031|FG000|Overall Study|Lost to Follow-up|15|||
163312582|NCT02465268|589854681|FG001|Overall Study|Withdrawal by Subject|3|||
163312583|NCT02465268|589854682|FG002|Overall Study|Withdrawal by Subject|1|||
163312584|NCT02465268|589854680|FG000|Overall Study|Not evaluable per protocol criteria|3|||
163312585|NCT02465268|589854681|FG001|Overall Study|Not evaluable per protocol criteria|2|||
163312586|NCT02465268|589854682|FG002|Overall Study|Not evaluable per protocol criteria|1|||
163312587|NCT02465268|589854680|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
163312588|NCT02465268|589854681|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
163312589|NCT02465268|589854682|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
163312590|NCT02465268|589854680|FG000|Overall Study|Study drug did not pass QA/QC|1|||
163312591|NCT02465268|589854681|FG001|Overall Study|Study drug did not pass QA/QC|0|||
163312592|NCT02465268|589854682|FG002|Overall Study|Study drug did not pass QA/QC|0|||
163312593|NCT02465268|589854680|FG000|Overall Study|Adverse Event|0|||
163312594|NCT02465268|589854681|FG001|Overall Study|Adverse Event|1|||
163312595|NCT02465268|589854682|FG002|Overall Study|Adverse Event|0|||
163312596|NCT02465268|589854680|FG000|Overall Study|Physician Decision|0|||
163312597|NCT02465268|589854681|FG001|Overall Study|Physician Decision|1|||
163312598|NCT02465268|589854682|FG002|Overall Study|Physician Decision|0|||
163312599|NCT02547363|589854685|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
163312600|NCT02547363|589854686|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
163397468|NCT00404820|590167715|FG001|Overall Study|Administrative problems|0|||
163397469|NCT00404820|590167714|FG000|Overall Study|Death|1|||
163312601|NCT02547363|589854685|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
163312602|NCT02547363|589854686|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
163312603|NCT02547363|589854685|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
163312604|NCT02547363|589854686|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
163312605|NCT02547363|589854685|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
163312606|NCT02547363|589854686|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
163312607|NCT02547363|589854685|FG000|12-month Follow-up|Withdrawal by Subject|4|||
163312608|NCT02547363|589854686|FG001|12-month Follow-up|Withdrawal by Subject|3|||
163312609|NCT02547363|589854685|FG000|12-month Follow-up|Lost to Follow-up|4|||
163312610|NCT02547363|589854686|FG001|12-month Follow-up|Lost to Follow-up|1|||
163312611|NCT02547363|589854685|FG000|12-month Follow-up|Lack of Efficacy|1|||
163312612|NCT02547363|589854686|FG001|12-month Follow-up|Lack of Efficacy|1|||
163312613|NCT02547363|589854685|FG000|12-month Follow-up|Other|1|||
163312614|NCT02547363|589854686|FG001|12-month Follow-up|Other|0|||
163312615|NCT03322267|589854688|FG000|Overall Study|Lack of Efficacy|11|||
163312616|NCT03322267|589854688|FG000|Overall Study|Adverse Event|1|||
163312617|NCT03322267|589854688|FG000|Overall Study|Withdrawal by Subject|2|||
163312618|NCT03084536|589854691|FG000|Overall Study|Determined to be ineligible|0|||
163312619|NCT03084536|589854692|FG001|Overall Study|Determined to be ineligible|0|||
163312620|NCT03084536|589854693|FG002|Overall Study|Determined to be ineligible|16|||
163312621|NCT03084536|589854691|FG000|Overall Study|Withdrawal by Subject|0|||
163312622|NCT03084536|589854692|FG001|Overall Study|Withdrawal by Subject|0|||
163312623|NCT03084536|589854693|FG002|Overall Study|Withdrawal by Subject|4|||
163312624|NCT03084536|589854691|FG000|Overall Study|Physician Decision|0|||
163312625|NCT03084536|589854692|FG001|Overall Study|Physician Decision|0|||
163312626|NCT03084536|589854693|FG002|Overall Study|Physician Decision|3|||
163312627|NCT03084536|589854691|FG000|Overall Study|Death|0|||
163312628|NCT03084536|589854692|FG001|Overall Study|Death|0|||
163312629|NCT03084536|589854693|FG002|Overall Study|Death|1|||
163312630|NCT03084536|589854691|FG000|Overall Study|Lost to Follow-up|0|||
163312631|NCT03084536|589854692|FG001|Overall Study|Lost to Follow-up|0|||
163312632|NCT03084536|589854693|FG002|Overall Study|Lost to Follow-up|1|||
163312633|NCT03084536|589854691|FG000|Overall Study|Protocol Violation|0|||
163312634|NCT03084536|589854692|FG001|Overall Study|Protocol Violation|0|||
163312635|NCT03084536|589854693|FG002|Overall Study|Protocol Violation|1|||
163312636|NCT03084536|589854691|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
163312637|NCT03084536|589854692|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
163312638|NCT03084536|589854693|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
163312639|NCT05302596|589854703|FG000|Overall Study|Withdrawal by Subject|1|||
163312640|NCT05302596|589854704|FG001|Overall Study|Withdrawal by Subject|1|||
163312641|NCT03287817|589856409|FG000|Overall Study|Progressive disease|4|||
163312642|NCT03287817|589856410|FG001|Overall Study|Progressive disease|2|||
163312643|NCT03287817|589856411|FG002|Overall Study|Progressive disease|3|||
163312644|NCT03287817|589856412|FG003|Overall Study|Progressive disease|10|||
163312645|NCT03287817|589856413|FG004|Overall Study|Progressive disease|8|||
163312646|NCT03287817|589856409|FG000|Overall Study|Death|0|||
163312647|NCT03287817|589856410|FG001|Overall Study|Death|0|||
163312648|NCT03287817|589856411|FG002|Overall Study|Death|2|||
163312649|NCT03287817|589856412|FG003|Overall Study|Death|3|||
163312650|NCT03287817|589856413|FG004|Overall Study|Death|4|||
163312651|NCT03287817|589856409|FG000|Overall Study|Physician Decision|0|||
163312652|NCT03287817|589856410|FG001|Overall Study|Physician Decision|0|||
163312653|NCT03287817|589856411|FG002|Overall Study|Physician Decision|0|||
163312654|NCT03287817|589856412|FG003|Overall Study|Physician Decision|1|||
163312655|NCT03287817|589856413|FG004|Overall Study|Physician Decision|0|||
163312656|NCT03287817|589856409|FG000|Overall Study|Withdrawal by Subject|0|||
163312657|NCT03287817|589856410|FG001|Overall Study|Withdrawal by Subject|0|||
163312658|NCT03287817|589856411|FG002|Overall Study|Withdrawal by Subject|0|||
163312659|NCT03287817|589856412|FG003|Overall Study|Withdrawal by Subject|0|||
163312660|NCT03287817|589856413|FG004|Overall Study|Withdrawal by Subject|4|||
162965196|NCT05330975|588573222|FG002|Primary|Other Than Specified|2|||
162965197|NCT05330975|588573223|FG003|Primary|Other Than Specified|1|||
162965198|NCT05330975|588573224|FG004|Primary|Other Than Specified|2|||
162965199|NCT05330975|588573225|FG005|Primary|Other Than Specified|2|||
163312661|NCT04130438|589856418|FG000|Overall Study|Lost to Follow-up|0|||
163312662|NCT04130438|589856419|FG001|Overall Study|Lost to Follow-up|0|||
163312663|NCT04130438|589856420|FG002|Overall Study|Lost to Follow-up|1|||
163312664|NCT03338933|589856422|FG000|Screening Visit|Lost to Follow-up|1|||
163312665|NCT03338933|589856423|FG001|Screening Visit|Lost to Follow-up|3|||
163312666|NCT03338933|589856424|FG002|Screening Visit|Lost to Follow-up|1|||
162965200|NCT05330975|588573226|FG006|Primary|Other Than Specified|0|||
163312667|NCT03338933|589856425|FG003|Screening Visit|Lost to Follow-up|4|||
163312668|NCT03338933|589856422|FG000|Screening Visit|Screen fail after consent|2|||
163312669|NCT03338933|589856423|FG001|Screening Visit|Screen fail after consent|7|||
163312670|NCT03338933|589856424|FG002|Screening Visit|Screen fail after consent|1|||
163312671|NCT03338933|589856425|FG003|Screening Visit|Screen fail after consent|4|||
163397470|NCT00404820|590167715|FG001|Overall Study|Death|0|||
162965201|NCT05330975|588573220|FG000|Primary|Adverse Event|0|||
163312672|NCT03338933|589856422|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
163312673|NCT03338933|589856423|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
163312674|NCT03338933|589856424|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
163312675|NCT03338933|589856425|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
163312676|NCT03338933|589856422|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
163312677|NCT03338933|589856423|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
163312678|NCT03338933|589856424|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
163312679|NCT03338933|589856425|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
163312680|NCT03338933|589856422|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
163312681|NCT03338933|589856423|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
163312682|NCT03338933|589856424|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
163312683|NCT03338933|589856425|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
163312684|NCT01084876|589856426|FG000|Main Study Treatment Period|Adverse Event|12|||
163312685|NCT01084876|589856427|FG001|Main Study Treatment Period|Adverse Event|7|||
163312686|NCT01084876|589856426|FG000|Main Study Treatment Period|Disease Progression|41|||
163312687|NCT01084876|589856427|FG001|Main Study Treatment Period|Disease Progression|24|||
163312688|NCT01084876|589856426|FG000|Main Study Treatment Period|Physician Decision|2|||
163312689|NCT01084876|589856427|FG001|Main Study Treatment Period|Physician Decision|0|||
163312690|NCT01084876|589856426|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
163312691|NCT01084876|589856427|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
163312692|NCT01084876|589856426|FG000|Main Study Treatment Period|Other Reason|0|||
163312693|NCT01084876|589856427|FG001|Main Study Treatment Period|Other Reason|1|||
163312694|NCT01084876|589856426|FG000|Main Study Treatment Period|Other|0|||
163312695|NCT01084876|589856427|FG001|Main Study Treatment Period|Other|1|||
163312696|NCT01084876|589856426|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
163312697|NCT01084876|589856427|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
163312698|NCT01084876|589856426|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
163312699|NCT01084876|589856427|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
163312700|NCT01084876|589856426|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
163312701|NCT01084876|589856427|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
163312702|NCT01084876|589856426|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
163312703|NCT01084876|589856427|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
163312704|NCT01084876|589856426|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
163312705|NCT01084876|589856427|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
163312706|NCT01084876|589856426|FG000|Treatment Period Beyond Cycle 8|Other|6|||
163312707|NCT01084876|589856427|FG001|Treatment Period Beyond Cycle 8|Other|9|||
163312708|NCT04515576|589856428|FG000|Overall Study|Withdrawal by Subject|0|||
163312709|NCT04515576|589856429|FG001|Overall Study|Withdrawal by Subject|0|||
163312710|NCT04515576|589856430|FG002|Overall Study|Withdrawal by Subject|0|||
163312711|NCT04515576|589856431|FG003|Overall Study|Withdrawal by Subject|0|||
163312712|NCT04515576|589856432|FG004|Overall Study|Withdrawal by Subject|0|||
163312713|NCT04515576|589856433|FG005|Overall Study|Withdrawal by Subject|1|||
163312714|NCT04256941|589856435|FG000|Overall Study|Withdrawal by Subject|0|||
163312715|NCT04256941|589856436|FG001|Overall Study|Withdrawal by Subject|1|||
163312716|NCT04256941|589856435|FG000|Overall Study|Death|1|||
163312717|NCT04256941|589856436|FG001|Overall Study|Death|0|||
163312718|NCT04256941|589856435|FG000|Overall Study|Disease Progession|0|||
163312719|NCT04256941|589856436|FG001|Overall Study|Disease Progession|2|||
163312720|NCT03869866|589856443|FG000|Overall Study|Protocol Violation|1|||
163312721|NCT03869866|589856443|FG000|Overall Study|Withdrawal by Subject|3|||
163312722|NCT06181227|589856444|FG000|Overall Study|Study terminated by sponsor|7|||
163312723|NCT06181227|589856445|FG001|Overall Study|Study terminated by sponsor|9|||
163312724|NCT05543915|589856446|FG000|Overall Study|Lost to Follow-up|0|||
163312725|NCT05543915|589856447|FG001|Overall Study|Lost to Follow-up|1|||
163312726|NCT02577835|589856448|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
163312727|NCT04342494|589856449|FG000|Overall Study|Questionnaire partially completed|1|||
163312728|NCT04342494|589856450|FG001|Overall Study|Questionnaire partially completed|0|||
163312729|NCT04342494|589856451|FG002|Overall Study|Questionnaire partially completed|2|||
163312730|NCT04342494|589856452|FG003|Overall Study|Questionnaire partially completed|0|||
163312731|NCT04342494|589856453|FG004|Overall Study|Questionnaire partially completed|1|||
163052042|NCT04802161|588898798|FG000|Overall Study|Death|0|||
163052043|NCT04802161|588898799|FG001|Overall Study|Death|0|||
163052044|NCT04802161|588898800|FG002|Overall Study|Death|1|||
163052045|NCT04802161|588898801|FG003|Overall Study|Death|0|||
163052046|NCT02997163|588900884|FG000|Overall Study|Adverse Event|1|||
163052047|NCT02997163|588900885|FG001|Overall Study|Adverse Event|0|||
163052048|NCT02997163|588900886|FG002|Overall Study|Adverse Event|0|||
163052049|NCT02997163|588900887|FG003|Overall Study|Adverse Event|1|||
163052050|NCT00557466|588900890|FG000|Overall Study|Adverse Event|3|||
163052051|NCT00557466|588900891|FG001|Overall Study|Adverse Event|1|||
163052052|NCT00557466|588900892|FG002|Overall Study|Adverse Event|4|||
163052053|NCT00557466|588900893|FG003|Overall Study|Adverse Event|1|||
163052054|NCT00557466|588900894|FG004|Overall Study|Adverse Event|2|||
163052055|NCT00557466|588900895|FG005|Overall Study|Adverse Event|4|||
163052056|NCT00557466|588900890|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163052057|NCT00557466|588900891|FG001|Overall Study|Abnormal laboratory value(s)|2|||
163052058|NCT00557466|588900892|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163052059|NCT00557466|588900893|FG003|Overall Study|Abnormal laboratory value(s)|0|||
163052060|NCT00557466|588900894|FG004|Overall Study|Abnormal laboratory value(s)|0|||
163052061|NCT00557466|588900895|FG005|Overall Study|Abnormal laboratory value(s)|0|||
163052062|NCT00557466|588900890|FG000|Overall Study|Protocol deviation|0|||
163052063|NCT00557466|588900891|FG001|Overall Study|Protocol deviation|1|||
163052064|NCT00557466|588900892|FG002|Overall Study|Protocol deviation|0|||
163052065|NCT00557466|588900893|FG003|Overall Study|Protocol deviation|2|||
163052066|NCT00557466|588900894|FG004|Overall Study|Protocol deviation|0|||
163052067|NCT00557466|588900895|FG005|Overall Study|Protocol deviation|0|||
163052068|NCT00557466|588900890|FG000|Overall Study|Subject withdrew consent|0|||
163052069|NCT00557466|588900891|FG001|Overall Study|Subject withdrew consent|0|||
163052070|NCT00557466|588900892|FG002|Overall Study|Subject withdrew consent|0|||
163052071|NCT00557466|588900893|FG003|Overall Study|Subject withdrew consent|0|||
163312732|NCT04342494|589856449|FG000|Overall Study|Lost to Follow-up|49|||
163312733|NCT04342494|589856450|FG001|Overall Study|Lost to Follow-up|38|||
163312734|NCT04342494|589856451|FG002|Overall Study|Lost to Follow-up|34|||
163312735|NCT04342494|589856452|FG003|Overall Study|Lost to Follow-up|34|||
163312736|NCT04342494|589856453|FG004|Overall Study|Lost to Follow-up|35|||
163312737|NCT05119023|589856455|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
163397471|NCT00404820|590167714|FG000|Overall Study|Other|0|||
163312738|NCT05119023|589856455|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
163312739|NCT05119023|589856455|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
163312740|NCT03194217|589856456|FG000|Overall Study|Adverse Event|0|||
163312741|NCT03194217|589856457|FG001|Overall Study|Adverse Event|2|||
163312742|NCT03194217|589856458|FG002|Overall Study|Adverse Event|3|||
163312743|NCT03194217|589856459|FG003|Overall Study|Adverse Event|3|||
163312744|NCT03194217|589856456|FG000|Overall Study|Failure to meet randomisation criteria|0|||
163312745|NCT03194217|589856457|FG001|Overall Study|Failure to meet randomisation criteria|0|||
163312746|NCT03194217|589856458|FG002|Overall Study|Failure to meet randomisation criteria|0|||
163312747|NCT03194217|589856459|FG003|Overall Study|Failure to meet randomisation criteria|1|||
163312748|NCT03194217|589856456|FG000|Overall Study|Other|0|||
163312749|NCT03194217|589856457|FG001|Overall Study|Other|1|||
163312750|NCT03194217|589856458|FG002|Overall Study|Other|1|||
163312751|NCT03194217|589856459|FG003|Overall Study|Other|0|||
163312752|NCT02962895|589856460|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
163312753|NCT02962895|589856461|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
163312754|NCT02962895|589856462|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
163312755|NCT02962895|589856463|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
163312756|NCT02962895|589856464|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
163312757|NCT02962895|589856465|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
163312758|NCT02962895|589856466|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
163312759|NCT02962895|589856460|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
163312760|NCT02962895|589856461|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
163312761|NCT02962895|589856462|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
163312762|NCT02962895|589856463|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
163312763|NCT02962895|589856464|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
163312764|NCT02962895|589856465|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
163312765|NCT02962895|589856466|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
163312766|NCT02962895|589856460|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
163312767|NCT02962895|589856461|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
163312768|NCT02962895|589856462|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
163312769|NCT02962895|589856463|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
163312770|NCT02962895|589856464|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
163312771|NCT02962895|589856465|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
163312772|NCT02962895|589856466|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
163312773|NCT02962895|589856460|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
163312774|NCT02962895|589856461|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
163312775|NCT02962895|589856462|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
163312776|NCT02962895|589856463|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
163312777|NCT02962895|589856464|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
162965202|NCT05330975|588573221|FG001|Primary|Adverse Event|0|||
162965203|NCT05330975|588573222|FG002|Primary|Adverse Event|0|||
162965204|NCT05330975|588573223|FG003|Primary|Adverse Event|1|||
162965205|NCT05330975|588573224|FG004|Primary|Adverse Event|0|||
162965206|NCT05330975|588573225|FG005|Primary|Adverse Event|0|||
162965207|NCT05330975|588573226|FG006|Primary|Adverse Event|0|||
162965208|NCT05330975|588573220|FG000|Primary|Physician Decision|0|||
162965209|NCT05330975|588573221|FG001|Primary|Physician Decision|0|||
162965210|NCT05330975|588573222|FG002|Primary|Physician Decision|0|||
162965211|NCT05330975|588573223|FG003|Primary|Physician Decision|0|||
162965212|NCT05330975|588573224|FG004|Primary|Physician Decision|1|||
162965213|NCT05330975|588573225|FG005|Primary|Physician Decision|0|||
162965214|NCT05330975|588573226|FG006|Primary|Physician Decision|0|||
162965215|NCT05330975|588573220|FG000|Revaccination|Adverse Event|0|||
162965216|NCT05330975|588573221|FG001|Revaccination|Adverse Event|0|||
162965217|NCT05330975|588573222|FG002|Revaccination|Adverse Event|0|||
162965218|NCT05330975|588573223|FG003|Revaccination|Adverse Event|0|||
162965219|NCT05330975|588573224|FG004|Revaccination|Adverse Event|0|||
162965220|NCT05330975|588573225|FG005|Revaccination|Adverse Event|0|||
162965221|NCT05330975|588573226|FG006|Revaccination|Adverse Event|3|||
162965222|NCT05330975|588573220|FG000|Revaccination|Lost to Follow-up|0|||
162965223|NCT05330975|588573221|FG001|Revaccination|Lost to Follow-up|0|||
162965224|NCT05330975|588573222|FG002|Revaccination|Lost to Follow-up|0|||
162965225|NCT05330975|588573223|FG003|Revaccination|Lost to Follow-up|0|||
162965226|NCT05330975|588573224|FG004|Revaccination|Lost to Follow-up|0|||
162965227|NCT05330975|588573225|FG005|Revaccination|Lost to Follow-up|0|||
162965228|NCT05330975|588573226|FG006|Revaccination|Lost to Follow-up|10|||
162965229|NCT05330975|588573220|FG000|Revaccination|Withdrawal by Subject|0|||
162965230|NCT05330975|588573221|FG001|Revaccination|Withdrawal by Subject|0|||
162965231|NCT05330975|588573222|FG002|Revaccination|Withdrawal by Subject|0|||
162965232|NCT05330975|588573223|FG003|Revaccination|Withdrawal by Subject|0|||
163052072|NCT00557466|588900894|FG004|Overall Study|Subject withdrew consent|1|||
163052073|NCT00557466|588900895|FG005|Overall Study|Subject withdrew consent|2|||
162965233|NCT05330975|588573224|FG004|Revaccination|Withdrawal by Subject|0|||
162965234|NCT05330975|588573225|FG005|Revaccination|Withdrawal by Subject|0|||
162965235|NCT05330975|588573226|FG006|Revaccination|Withdrawal by Subject|2|||
163052074|NCT00557466|588900890|FG000|Overall Study|Administrative problems|0|||
163052075|NCT00557466|588900891|FG001|Overall Study|Administrative problems|1|||
163052076|NCT00557466|588900892|FG002|Overall Study|Administrative problems|1|||
163052077|NCT00557466|588900893|FG003|Overall Study|Administrative problems|0|||
162965236|NCT05330975|588573220|FG000|Revaccination|Death|0|||
163052078|NCT00557466|588900894|FG004|Overall Study|Administrative problems|0|||
163052079|NCT00557466|588900895|FG005|Overall Study|Administrative problems|0|||
163052080|NCT00557466|588900890|FG000|Overall Study|Abnormal test procedure results|0|||
163052081|NCT00557466|588900891|FG001|Overall Study|Abnormal test procedure results|0|||
163052082|NCT00557466|588900892|FG002|Overall Study|Abnormal test procedure results|1|||
163052083|NCT00557466|588900893|FG003|Overall Study|Abnormal test procedure results|0|||
163052084|NCT00557466|588900894|FG004|Overall Study|Abnormal test procedure results|0|||
163052085|NCT00557466|588900895|FG005|Overall Study|Abnormal test procedure results|0|||
163052086|NCT00557466|588900890|FG000|Overall Study|Lost to Follow-up|0|||
163052087|NCT00557466|588900891|FG001|Overall Study|Lost to Follow-up|0|||
163052088|NCT00557466|588900892|FG002|Overall Study|Lost to Follow-up|0|||
163052089|NCT00557466|588900893|FG003|Overall Study|Lost to Follow-up|1|||
163052090|NCT00557466|588900894|FG004|Overall Study|Lost to Follow-up|0|||
163052091|NCT00557466|588900895|FG005|Overall Study|Lost to Follow-up|0|||
163052092|NCT01712516|588900896|FG000|Overall Study|Technical problems|0|||
163052093|NCT01712516|588900897|FG001|Overall Study|Technical problems|0|||
163052094|NCT01712516|588900898|FG002|Overall Study|Technical problems|0|||
163052095|NCT01712516|588900899|FG003|Overall Study|Technical problems|2|||
163052096|NCT01712516|588900896|FG000|Overall Study|Lost to Follow-up|0|||
163052097|NCT01712516|588900897|FG001|Overall Study|Lost to Follow-up|0|||
163052098|NCT01712516|588900898|FG002|Overall Study|Lost to Follow-up|2|||
163052099|NCT01712516|588900899|FG003|Overall Study|Lost to Follow-up|1|||
163052100|NCT01712516|588900896|FG000|Overall Study|Death|0|||
163052101|NCT01712516|588900897|FG001|Overall Study|Death|1|||
163312778|NCT02962895|589856465|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
163312779|NCT02962895|589856466|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
163312780|NCT02962895|589856460|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
163312781|NCT02962895|589856461|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
163312782|NCT02962895|589856462|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
163312783|NCT02962895|589856463|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
163318909|NCT05485779|589878808|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
163312784|NCT02962895|589856464|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
163312785|NCT02962895|589856465|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
163312786|NCT02962895|589856466|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
163312787|NCT02962895|589856460|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
163312788|NCT02962895|589856461|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
163312789|NCT02962895|589856462|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
163312790|NCT02962895|589856463|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
163312791|NCT02962895|589856464|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
163312792|NCT02962895|589856465|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
163312793|NCT02962895|589856466|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
163397472|NCT00404820|590167715|FG001|Overall Study|Other|2|||
163312794|NCT02962895|589856460|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
162965237|NCT05330975|588573221|FG001|Revaccination|Death|0|||
162965238|NCT05330975|588573222|FG002|Revaccination|Death|0|||
162965239|NCT05330975|588573223|FG003|Revaccination|Death|0|||
162965240|NCT05330975|588573224|FG004|Revaccination|Death|0|||
162965241|NCT05330975|588573225|FG005|Revaccination|Death|0|||
162965242|NCT05330975|588573226|FG006|Revaccination|Death|3|||
162965243|NCT05267106|588573230|FG000|Overall Study|Death|50|||
162965244|NCT05267106|588573231|FG001|Overall Study|Death|2|||
162965245|NCT05267106|588573230|FG000|Overall Study|Study terminated by Sponsor|24|||
162965246|NCT05267106|588573231|FG001|Overall Study|Study terminated by Sponsor|6|||
162965247|NCT05267106|588573230|FG000|Overall Study|Withdrawal by Subject|0|||
162965248|NCT05267106|588573231|FG001|Overall Study|Withdrawal by Subject|1|||
162965249|NCT04165824|588573232|FG000|Overall Study|Adverse Event|23|||
162965250|NCT04165824|588573232|FG000|Overall Study|Physician Decision|1|||
162965251|NCT04165824|588573232|FG000|Overall Study|Withdrawal by Subject|17|||
162965252|NCT04165824|588573232|FG000|Overall Study|Other|5|||
162965253|NCT00834444|588573238|FG000|First Intervention|Adverse Event|1|||
162965254|NCT00834444|588573239|FG001|First Intervention|Adverse Event|0|||
162965255|NCT00834444|588573238|FG000|First Intervention|Intolerance to Venopuncture|0|||
162965256|NCT00834444|588573239|FG001|First Intervention|Intolerance to Venopuncture|1|||
162965257|NCT00834444|588573238|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
162965258|NCT00834444|588573239|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
162965259|NCT00834444|588573238|FG000|Second Intervention|Adverse Event|1|||
162965260|NCT00834444|588573239|FG001|Second Intervention|Adverse Event|0|||
162965261|NCT02890992|588573240|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
162965262|NCT02890992|588573241|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
162965263|NCT02890992|588573242|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
162965264|NCT02890992|588573243|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
162965265|NCT02890992|588573244|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
162965266|NCT02890992|588573245|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
162965267|NCT02890992|588573246|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
162965268|NCT02890992|588573247|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
162965269|NCT02890992|588573240|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
162965270|NCT02890992|588573241|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
162965271|NCT02890992|588573242|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
162965272|NCT02890992|588573243|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
162965273|NCT02890992|588573244|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
162965274|NCT02890992|588573245|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
162965275|NCT02890992|588573246|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
162965276|NCT02890992|588573247|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
163312795|NCT02962895|589856461|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
163312796|NCT02962895|589856462|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
163397473|NCT00636675|590167722|FG000|Overall Study|Lost to Follow-up|121|||
162965277|NCT02890992|588573240|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
162965278|NCT02890992|588573241|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
162965279|NCT02890992|588573242|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
163052102|NCT01712516|588900898|FG002|Overall Study|Death|0|||
162965280|NCT02890992|588573243|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
162965281|NCT02890992|588573244|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
162965282|NCT02890992|588573245|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
162965283|NCT02890992|588573246|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
162965284|NCT02890992|588573247|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
162965285|NCT01496118|588573248|FG000|Overall Study|Disease progression|3|||
162965286|NCT01496118|588573249|FG001|Overall Study|Disease progression|2|||
162965287|NCT01496118|588573250|FG002|Overall Study|Disease progression|3|||
163204632|NCT02207244|589461856|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
163204633|NCT02207244|589461857|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
163204634|NCT02207244|589461858|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
163204635|NCT02207244|589461859|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
163204636|NCT02207244|589461860|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
163204637|NCT02207244|589461861|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
163204638|NCT02207244|589461862|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
163204639|NCT02207244|589461863|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
163204640|NCT02207244|589461864|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
163204641|NCT02207244|589461854|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
163312797|NCT02962895|589856463|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
163312798|NCT02962895|589856464|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
163312799|NCT02962895|589856465|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
162924500|NCT01186744|588426032|FG001|Overall Study|Lost to Follow-up|16|||
162924501|NCT01186744|588426033|FG002|Overall Study|Lost to Follow-up|2|||
162924502|NCT01186744|588426034|FG003|Overall Study|Lost to Follow-up|1|||
162924503|NCT01186744|588426035|FG004|Overall Study|Lost to Follow-up|1|||
162924504|NCT01186744|588426036|FG005|Overall Study|Lost to Follow-up|4|||
162924505|NCT01186744|588426031|FG000|Overall Study|Screen failure|1|||
162924506|NCT01186744|588426032|FG001|Overall Study|Screen failure|1|||
162924507|NCT01186744|588426033|FG002|Overall Study|Screen failure|0|||
162924508|NCT01186744|588426034|FG003|Overall Study|Screen failure|1|||
162924509|NCT01186744|588426035|FG004|Overall Study|Screen failure|0|||
162924510|NCT01186744|588426036|FG005|Overall Study|Screen failure|0|||
162924511|NCT01186744|588426031|FG000|Overall Study|Withdrawal by Subject|14|||
162924512|NCT01186744|588426032|FG001|Overall Study|Withdrawal by Subject|10|||
162924513|NCT01186744|588426033|FG002|Overall Study|Withdrawal by Subject|2|||
162924514|NCT01186744|588426034|FG003|Overall Study|Withdrawal by Subject|5|||
162924515|NCT01186744|588426035|FG004|Overall Study|Withdrawal by Subject|0|||
162924516|NCT01186744|588426036|FG005|Overall Study|Withdrawal by Subject|6|||
162924517|NCT01186744|588426031|FG000|Overall Study|Study terminated by Sponsor|1|||
162924518|NCT01186744|588426032|FG001|Overall Study|Study terminated by Sponsor|0|||
162924519|NCT01186744|588426033|FG002|Overall Study|Study terminated by Sponsor|0|||
162924520|NCT01186744|588426034|FG003|Overall Study|Study terminated by Sponsor|0|||
162924521|NCT01186744|588426035|FG004|Overall Study|Study terminated by Sponsor|0|||
162924522|NCT01186744|588426036|FG005|Overall Study|Study terminated by Sponsor|0|||
162924523|NCT01186744|588426031|FG000|Overall Study|Other|9|||
162924524|NCT01186744|588426032|FG001|Overall Study|Other|10|||
162924525|NCT01186744|588426033|FG002|Overall Study|Other|1|||
162924526|NCT01186744|588426034|FG003|Overall Study|Other|2|||
162924527|NCT01186744|588426035|FG004|Overall Study|Other|1|||
162924528|NCT01186744|588426036|FG005|Overall Study|Other|5|||
162924529|NCT01186744|588426031|FG000|Overall Study|Adverse Event|10|||
162924530|NCT01186744|588426032|FG001|Overall Study|Adverse Event|14|||
162924531|NCT01186744|588426033|FG002|Overall Study|Adverse Event|1|||
162924532|NCT01186744|588426034|FG003|Overall Study|Adverse Event|0|||
162924533|NCT01186744|588426035|FG004|Overall Study|Adverse Event|1|||
162924534|NCT01186744|588426036|FG005|Overall Study|Adverse Event|4|||
162924535|NCT01186744|588426031|FG000|Overall Study|Death|1|||
162924536|NCT01186744|588426032|FG001|Overall Study|Death|0|||
162924537|NCT01186744|588426033|FG002|Overall Study|Death|0|||
162924538|NCT01186744|588426034|FG003|Overall Study|Death|0|||
162924539|NCT01186744|588426035|FG004|Overall Study|Death|0|||
162924540|NCT01186744|588426036|FG005|Overall Study|Death|0|||
162924541|NCT03515837|588426040|FG000|Overall Study|Death|219|||
162924542|NCT03515837|588426041|FG001|Overall Study|Death|227|||
162924543|NCT03515837|588426040|FG000|Overall Study|Lost to Follow-up|0|||
162924544|NCT03515837|588426041|FG001|Overall Study|Lost to Follow-up|1|||
162924545|NCT03515837|588426040|FG000|Overall Study|Withdrawal by Subject|0|||
162924546|NCT03515837|588426041|FG001|Overall Study|Withdrawal by Subject|4|||
162924547|NCT03515837|588426040|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
162924548|NCT03515837|588426041|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
162924549|NCT02325401|588426042|FG000|Overall Study|Withdrawal by Subject|0|||
162924550|NCT02325401|588426043|FG001|Overall Study|Withdrawal by Subject|1|||
162924551|NCT02325401|588426044|FG002|Overall Study|Withdrawal by Subject|1|||
162924552|NCT01856686|588426045|FG000|Overall Study|Lost to Follow-up|5|||
162924553|NCT01856686|588426046|FG001|Overall Study|Lost to Follow-up|11|||
162924554|NCT02406742|588426049|FG000|Overall Study|Progression of Disease|5|||
163312800|NCT02962895|589856466|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
163312801|NCT02962895|589856460|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
163312802|NCT02962895|589856461|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
163312803|NCT02962895|589856462|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
163312804|NCT02962895|589856463|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
163312805|NCT02962895|589856464|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
163312806|NCT02962895|589856465|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
163312807|NCT02962895|589856466|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
163312808|NCT02962895|589856460|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
163312809|NCT02962895|589856461|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
163312810|NCT02962895|589856462|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
163312811|NCT02962895|589856463|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
163312812|NCT02962895|589856464|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
163312813|NCT02962895|589856465|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
163312814|NCT02962895|589856466|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
163312815|NCT02962895|589856460|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
163312816|NCT02962895|589856461|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
163312817|NCT02962895|589856462|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
163312818|NCT02962895|589856463|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
163312819|NCT02962895|589856464|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
163312820|NCT02962895|589856465|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
163312821|NCT02962895|589856466|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
163312822|NCT02962895|589856460|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
162965288|NCT01496118|588573251|FG003|Overall Study|Disease progression|1|||
162965289|NCT01496118|588573252|FG004|Overall Study|Disease progression|2|||
162965290|NCT01496118|588573253|FG005|Overall Study|Disease progression|2|||
163052103|NCT01712516|588900899|FG003|Overall Study|Death|0|||
163052104|NCT01712516|588900896|FG000|Overall Study|Protocol deviation|1|||
163052105|NCT01712516|588900897|FG001|Overall Study|Protocol deviation|0|||
163052106|NCT01712516|588900898|FG002|Overall Study|Protocol deviation|1|||
163052107|NCT01712516|588900899|FG003|Overall Study|Protocol deviation|0|||
163052108|NCT01712516|588900896|FG000|Overall Study|Physician Decision|2|||
163052109|NCT01712516|588900897|FG001|Overall Study|Physician Decision|0|||
163052110|NCT01712516|588900898|FG002|Overall Study|Physician Decision|0|||
163052111|NCT01712516|588900899|FG003|Overall Study|Physician Decision|1|||
163052112|NCT01712516|588900896|FG000|Overall Study|Withdrawal by Subject|3|||
163052113|NCT01712516|588900897|FG001|Overall Study|Withdrawal by Subject|9|||
163052114|NCT01712516|588900898|FG002|Overall Study|Withdrawal by Subject|3|||
163052115|NCT01712516|588900899|FG003|Overall Study|Withdrawal by Subject|9|||
163052116|NCT01251952|588900900|FG000|Overall Study|Adverse Event|1|||
163052117|NCT00496769|588900901|FG000|Double Blind|>=1 reason assigned per patient|558|||
163052118|NCT00496769|588900902|FG001|Double Blind|>=1 reason assigned per patient|649|||
163312823|NCT02962895|589856461|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
163312824|NCT02962895|589856462|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
163312825|NCT02962895|589856463|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
163312826|NCT02962895|589856464|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
163312827|NCT02962895|589856465|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
163312828|NCT02962895|589856466|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
162965291|NCT01496118|588573254|FG006|Overall Study|Disease progression|14|||
162965292|NCT01496118|588573255|FG007|Overall Study|Disease progression|10|||
162965293|NCT01496118|588573248|FG000|Overall Study|Physician Decision|0|||
162965294|NCT01496118|588573249|FG001|Overall Study|Physician Decision|0|||
162965295|NCT01496118|588573250|FG002|Overall Study|Physician Decision|0|||
162965296|NCT01496118|588573251|FG003|Overall Study|Physician Decision|0|||
162965297|NCT01496118|588573252|FG004|Overall Study|Physician Decision|1|||
163312829|NCT02962895|589856460|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
163312830|NCT02962895|589856461|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
163052119|NCT00496769|588900903|FG002|Double Blind|>=1 reason assigned per patient|0|||
162965298|NCT01496118|588573253|FG005|Overall Study|Physician Decision|0|||
162965299|NCT01496118|588573254|FG006|Overall Study|Physician Decision|3|||
162965300|NCT01496118|588573255|FG007|Overall Study|Physician Decision|6|||
163204642|NCT02207244|589461855|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
163204643|NCT02207244|589461856|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
163204644|NCT02207244|589461857|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
163204645|NCT02207244|589461858|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
163204646|NCT02207244|589461859|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
163204647|NCT02207244|589461860|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
163204648|NCT02207244|589461861|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
163204649|NCT02207244|589461862|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
163204650|NCT02207244|589461863|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
163204651|NCT02207244|589461864|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
163204652|NCT02207244|589461854|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
163204653|NCT02207244|589461855|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
163204654|NCT02207244|589461856|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
163204655|NCT02207244|589461857|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
163204656|NCT02207244|589461858|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
163204657|NCT02207244|589461859|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
163204658|NCT02207244|589461860|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
163204659|NCT02207244|589461861|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
163204660|NCT02207244|589461862|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
163204661|NCT02207244|589461863|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
163204662|NCT02207244|589461864|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
163204663|NCT02521870|589461870|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
163204664|NCT02521870|589461871|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
163204665|NCT02521870|589461872|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
163204666|NCT02521870|589461873|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
163204667|NCT02521870|589461874|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
163204668|NCT02521870|589461875|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
163204669|NCT02521870|589461876|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
163204670|NCT02521870|589461877|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
163204671|NCT02521870|589461878|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
163204672|NCT02521870|589461879|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
163204673|NCT02521870|589461880|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
163204674|NCT02521870|589461881|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
163204675|NCT02521870|589461870|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
163204676|NCT02521870|589461871|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
163204677|NCT02521870|589461872|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
163204678|NCT02521870|589461873|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
163204679|NCT02521870|589461874|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
163204680|NCT02521870|589461875|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
163204681|NCT02521870|589461876|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
163204682|NCT02521870|589461877|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
163204683|NCT02521870|589461878|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
163204684|NCT02521870|589461879|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
163204685|NCT02521870|589461880|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
163204686|NCT02521870|589461881|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
163204687|NCT02521870|589461870|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
163204688|NCT02521870|589461871|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
163204689|NCT02521870|589461872|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
163312831|NCT02962895|589856462|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
163397474|NCT00636675|590167723|FG001|Overall Study|Lost to Follow-up|31|||
162965301|NCT01496118|588573248|FG000|Overall Study|Adverse Event|1|||
162965302|NCT01496118|588573249|FG001|Overall Study|Adverse Event|1|||
162965303|NCT01496118|588573250|FG002|Overall Study|Adverse Event|0|||
162965304|NCT01496118|588573251|FG003|Overall Study|Adverse Event|0|||
162965305|NCT01496118|588573252|FG004|Overall Study|Adverse Event|0|||
162965306|NCT01496118|588573253|FG005|Overall Study|Adverse Event|0|||
162965307|NCT01496118|588573254|FG006|Overall Study|Adverse Event|6|||
162965308|NCT01496118|588573255|FG007|Overall Study|Adverse Event|10|||
162965309|NCT01496118|588573248|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
162965310|NCT01496118|588573249|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
162965311|NCT01496118|588573250|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
163204690|NCT02521870|589461873|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
163204691|NCT02521870|589461874|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
163204692|NCT02521870|589461875|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
163204693|NCT02521870|589461876|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
163204694|NCT02521870|589461877|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
163204695|NCT02521870|589461878|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
163204696|NCT02521870|589461879|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
163204697|NCT02521870|589461880|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
163204698|NCT02521870|589461881|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
163052120|NCT00496769|588900901|FG000|Open Label|>=1 reason assigned per patient|0|||
163052121|NCT00496769|588900902|FG001|Open Label|>=1 reason assigned per patient|0|||
163052122|NCT00496769|588900903|FG002|Open Label|>=1 reason assigned per patient|1011|||
163052123|NCT02308046|588900904|FG000|Overall Study|Negative yeast culture at Baseline|32|||
163052124|NCT02308046|588900905|FG001|Overall Study|Negative yeast culture at Baseline|33|||
163052125|NCT02308046|588900904|FG000|Overall Study|Positive for STD at Baseline|1|||
163052126|NCT02308046|588900905|FG001|Overall Study|Positive for STD at Baseline|2|||
163052127|NCT02308046|588900904|FG000|Overall Study|Lost to Follow-up|1|||
163052128|NCT02308046|588900905|FG001|Overall Study|Lost to Follow-up|3|||
163052129|NCT02224625|588900911|FG000|Irritation|Adverse Event|6|||
163052130|NCT02224625|588900911|FG000|Sensitization|Adverse Event|55|||
163052131|NCT01181167|588900912|FG000|Overall Study|Adverse Event|11|||
163052132|NCT01181167|588900913|FG001|Overall Study|Adverse Event|21|||
163052133|NCT01181167|588900912|FG000|Overall Study|Lost to Follow-up|1|||
163052134|NCT01181167|588900913|FG001|Overall Study|Lost to Follow-up|0|||
163052135|NCT01181167|588900912|FG000|Overall Study|Physician Decision|2|||
163052136|NCT01181167|588900913|FG001|Overall Study|Physician Decision|3|||
163052137|NCT01181167|588900912|FG000|Overall Study|Protocol Violation|3|||
163052138|NCT01181167|588900913|FG001|Overall Study|Protocol Violation|0|||
163052139|NCT01181167|588900912|FG000|Overall Study|Withdrawal by Subject|6|||
163052140|NCT01181167|588900913|FG001|Overall Study|Withdrawal by Subject|8|||
163052141|NCT01573000|588900914|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
163052142|NCT01573000|588900915|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
163052143|NCT01573000|588900914|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
163052144|NCT01573000|588900915|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
163052145|NCT01573000|588900914|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
163052146|NCT01573000|588900915|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
163052147|NCT01573000|588900914|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
163052148|NCT01573000|588900915|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
163052149|NCT01573000|588900914|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
163052150|NCT01573000|588900915|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
163204699|NCT02521870|589461870|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
163204700|NCT02521870|589461871|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
163204701|NCT02521870|589461872|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
163312832|NCT02962895|589856463|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
163312833|NCT02962895|589856464|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
163312834|NCT02962895|589856465|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
163312835|NCT02962895|589856466|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
163312836|NCT02962895|589856460|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
163312837|NCT02962895|589856461|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
163312838|NCT02962895|589856462|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
163312839|NCT02962895|589856463|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
163312840|NCT02962895|589856464|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
163312841|NCT02962895|589856465|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
163312842|NCT02962895|589856466|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
163312843|NCT02962895|589856460|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
163312844|NCT02962895|589856461|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
163312845|NCT02962895|589856462|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
163312846|NCT02962895|589856463|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
163312847|NCT02962895|589856464|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
163397475|NCT00636675|590167722|FG000|Overall Study|Withdrawal by Subject|19|||
163397476|NCT00636675|590167723|FG001|Overall Study|Withdrawal by Subject|10|||
162965312|NCT01496118|588573251|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
162965313|NCT01496118|588573252|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
162965314|NCT01496118|588573253|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
163052151|NCT01573000|588900914|FG000|Crossover Phase|Lack of Efficacy|0|||
163397477|NCT03785925|590167724|FG000|Overall Study|Withdrawal by Subject|15|||
163312848|NCT02962895|589856465|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
163312849|NCT02962895|589856466|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
163312850|NCT04509674|589856469|FG000|Overall Study|Not treated|33|||
163312851|NCT04509674|589856470|FG001|Overall Study|Not treated|26|||
163312852|NCT04509674|589856469|FG000|Overall Study|Protocol Violation|9|||
163312853|NCT04509674|589856470|FG001|Overall Study|Protocol Violation|10|||
163312854|NCT04509674|589856469|FG000|Overall Study|Lost to Follow-up|31|||
163312855|NCT04509674|589856470|FG001|Overall Study|Lost to Follow-up|39|||
163312856|NCT04509674|589856469|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
163312857|NCT04509674|589856470|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
163312858|NCT04509674|589856469|FG000|Overall Study|Adverse event, serious fatal event|11|||
163312859|NCT04509674|589856470|FG001|Overall Study|Adverse event, serious fatal event|4|||
163312860|NCT04509674|589856469|FG000|Overall Study|Adverse event, non-fatal event|107|||
163312861|NCT04509674|589856470|FG001|Overall Study|Adverse event, non-fatal event|118|||
163312862|NCT04509674|589856469|FG000|Overall Study|Other reason than listed|106|||
163312863|NCT04509674|589856470|FG001|Overall Study|Other reason than listed|95|||
163312864|NCT04719390|589856481|FG000|Overall Study|Withdrawal by Subject|1|||
163312865|NCT06190691|589856482|FG000|Overall Study|Adverse Event|2|||
163312866|NCT06190691|589856483|FG001|Overall Study|Adverse Event|0|||
163312867|NCT06190691|589856484|FG002|Overall Study|Adverse Event|0|||
163312868|NCT06190691|589856485|FG003|Overall Study|Adverse Event|0|||
163312869|NCT04633122|589856487|FG000|Overall Study|Remained on treatment|19|||
163312870|NCT04633122|589856488|FG001|Overall Study|Remained on treatment|14|||
163312871|NCT04633122|589856487|FG000|Overall Study|Survival follow-up stopped|22|||
163312872|NCT04633122|589856488|FG001|Overall Study|Survival follow-up stopped|25|||
163312873|NCT03241745|589856489|FG000|Overall Study|Adverse Event|7|||
163312874|NCT03241745|589856489|FG000|Overall Study|Death|1|||
163312875|NCT03241745|589856489|FG000|Overall Study|Withdrawal by Subject|5|||
163312876|NCT03241745|589856489|FG000|Overall Study|Treatment delay >28 days|2|||
163312877|NCT03241745|589856489|FG000|Overall Study|Lack of Efficacy|14|||
163312878|NCT04019873|589856490|FG000|Overall Study|Discontinued from the treatment|1|||
163312879|NCT04019873|589856491|FG001|Overall Study|Discontinued from the treatment|39|||
163312880|NCT04019873|589856492|FG002|Overall Study|Discontinued from the treatment|2|||
163312881|NCT03896789|589856500|FG000|Baseline|Lost to Follow-up|1|||
163312882|NCT03896789|589856501|FG001|Baseline|Lost to Follow-up|2|||
163312883|NCT03896789|589856500|FG000|Baseline|Death|3|||
163312884|NCT03896789|589856501|FG001|Baseline|Death|6|||
163312885|NCT03896789|589856500|FG000|Post-Randomization|Lost to Follow-up|12|||
163312886|NCT03896789|589856501|FG001|Post-Randomization|Lost to Follow-up|11|||
163397478|NCT03785925|590167724|FG000|Overall Study|Lost to Follow-up|1|||
162965315|NCT01496118|588573254|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
162965316|NCT01496118|588573255|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
162965317|NCT01496118|588573248|FG000|Overall Study|Death|0|||
163312887|NCT03896789|589856500|FG000|Post-Randomization|Death|12|||
163312888|NCT03896789|589856501|FG001|Post-Randomization|Death|13|||
163312889|NCT05087992|589856507|FG000|Overall Study|Adverse Event|0|||
163312890|NCT05087992|589856508|FG001|Overall Study|Adverse Event|1|||
163312891|NCT05087992|589856509|FG002|Overall Study|Adverse Event|0|||
163312892|NCT05087992|589856507|FG000|Overall Study|Withdrawal by Subject|2|||
163312893|NCT05087992|589856508|FG001|Overall Study|Withdrawal by Subject|0|||
163312894|NCT05087992|589856509|FG002|Overall Study|Withdrawal by Subject|0|||
163312895|NCT05087992|589856507|FG000|Overall Study|clinical disease progression|3|||
163312896|NCT05087992|589856508|FG001|Overall Study|clinical disease progression|1|||
163397479|NCT02318667|590167725|FG000|Overall Study|Adverse Event|1|||
163397480|NCT02318667|590167725|FG000|Overall Study|Lack of Efficacy|6|||
162965318|NCT01496118|588573249|FG001|Overall Study|Death|0|||
162965319|NCT01496118|588573250|FG002|Overall Study|Death|0|||
162965320|NCT01496118|588573251|FG003|Overall Study|Death|0|||
162965321|NCT01496118|588573252|FG004|Overall Study|Death|0|||
162965322|NCT01496118|588573253|FG005|Overall Study|Death|0|||
162965323|NCT01496118|588573254|FG006|Overall Study|Death|1|||
162965324|NCT01496118|588573255|FG007|Overall Study|Death|1|||
162965325|NCT01496118|588573248|FG000|Overall Study|Withdrawal by Subject|0|||
162965326|NCT01496118|588573249|FG001|Overall Study|Withdrawal by Subject|0|||
162965327|NCT01496118|588573250|FG002|Overall Study|Withdrawal by Subject|0|||
162965328|NCT01496118|588573251|FG003|Overall Study|Withdrawal by Subject|2|||
162965329|NCT01496118|588573252|FG004|Overall Study|Withdrawal by Subject|0|||
162965330|NCT01496118|588573253|FG005|Overall Study|Withdrawal by Subject|1|||
162965331|NCT01496118|588573254|FG006|Overall Study|Withdrawal by Subject|6|||
162965332|NCT01496118|588573255|FG007|Overall Study|Withdrawal by Subject|3|||
162965333|NCT00841659|588573256|FG000|Washout: 2 Weeks|Protocol Violation|1|||
162965334|NCT00841659|588573257|FG001|Washout: 2 Weeks|Protocol Violation|0|||
162965335|NCT03499873|588573261|FG000|Overall Study|Withdrawal by Subject|4|||
162965336|NCT03499873|588573262|FG001|Overall Study|Withdrawal by Subject|6|||
162965337|NCT03499873|588573263|FG002|Overall Study|Withdrawal by Subject|1|||
162965338|NCT03499873|588573261|FG000|Overall Study|Subjects condition worsened|0|||
162965339|NCT03499873|588573262|FG001|Overall Study|Subjects condition worsened|3|||
162965340|NCT03499873|588573263|FG002|Overall Study|Subjects condition worsened|11|||
162965341|NCT03499873|588573261|FG000|Overall Study|Adverse Event|8|||
162965342|NCT03499873|588573262|FG001|Overall Study|Adverse Event|3|||
162965343|NCT03499873|588573263|FG002|Overall Study|Adverse Event|6|||
162965344|NCT03499873|588573261|FG000|Overall Study|Physician Decision|1|||
162965345|NCT03499873|588573262|FG001|Overall Study|Physician Decision|0|||
162965346|NCT03499873|588573263|FG002|Overall Study|Physician Decision|0|||
163052152|NCT01573000|588900915|FG001|Crossover Phase|Lack of Efficacy|13|||
163204702|NCT02521870|589461873|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
163204703|NCT02521870|589461874|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
163204704|NCT02521870|589461875|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
163204705|NCT02521870|589461876|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
163204706|NCT02521870|589461877|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
163204707|NCT02521870|589461878|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
163204708|NCT02521870|589461879|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
163204709|NCT02521870|589461880|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
163204710|NCT02521870|589461881|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
163204711|NCT02521870|589461870|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
163204712|NCT02521870|589461871|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
163204713|NCT02521870|589461872|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
163204714|NCT02521870|589461873|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
163204715|NCT02521870|589461874|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
163204716|NCT02521870|589461875|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
163204717|NCT02521870|589461876|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
163204718|NCT02521870|589461877|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
163204719|NCT02521870|589461878|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
163204720|NCT02521870|589461879|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
163397481|NCT02318667|590167725|FG000|Overall Study|Protocol Violation|2|||
163312897|NCT05087992|589856509|FG002|Overall Study|clinical disease progression|0|||
163312898|NCT05087992|589856507|FG000|Overall Study|objective disease progression|4|||
163312899|NCT05087992|589856508|FG001|Overall Study|objective disease progression|1|||
163312900|NCT05087992|589856509|FG002|Overall Study|objective disease progression|0|||
163312901|NCT04473222|589856510|FG000|Overall Study|Lost to Follow-up|13|||
163312902|NCT04473222|589856511|FG001|Overall Study|Lost to Follow-up|13|||
163312903|NCT04473222|589856510|FG000|Overall Study|Withdrawal by Subject|0|||
163312904|NCT04473222|589856511|FG001|Overall Study|Withdrawal by Subject|1|||
163312905|NCT04473222|589856510|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
163312906|NCT04473222|589856511|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
163312907|NCT01098812|589856520|FG000|Overall Study|Death|2|||
163312908|NCT01098812|589856521|FG001|Overall Study|Death|0|||
163312909|NCT01098812|589856522|FG002|Overall Study|Death|1|||
163312910|NCT01098812|589856520|FG000|Overall Study|Lost to Follow-up|0|||
163312911|NCT01098812|589856521|FG001|Overall Study|Lost to Follow-up|1|||
163312912|NCT01098812|589856522|FG002|Overall Study|Lost to Follow-up|0|||
163312913|NCT02319759|589856523|FG000|Week 0 - 16|Lack of Efficacy|1|||
163312914|NCT02319759|589856524|FG001|Week 0 - 16|Lack of Efficacy|0|||
163312915|NCT02319759|589856525|FG002|Week 0 - 16|Lack of Efficacy|0|||
163312916|NCT02319759|589856526|FG003|Week 0 - 16|Lack of Efficacy|0|||
163312917|NCT02319759|589856527|FG004|Week 0 - 16|Lack of Efficacy|0|||
163312918|NCT02319759|589856523|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
163312919|NCT02319759|589856524|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
163312920|NCT02319759|589856525|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
163312921|NCT02319759|589856526|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
163312922|NCT02319759|589856527|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
163312923|NCT02319759|589856523|FG000|Week 16 - 24|Lack of Efficacy|1|||
163312924|NCT02319759|589856524|FG001|Week 16 - 24|Lack of Efficacy|0|||
163052153|NCT01573000|588900914|FG000|Crossover Phase|Lost to Follow-up|0|||
163052154|NCT01573000|588900915|FG001|Crossover Phase|Lost to Follow-up|2|||
163204721|NCT02521870|589461880|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
163204722|NCT02521870|589461881|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
163204723|NCT02521870|589461870|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
163052155|NCT01573000|588900914|FG000|Crossover Phase|Death|0|||
163052156|NCT01573000|588900915|FG001|Crossover Phase|Death|3|||
163052157|NCT01573000|588900914|FG000|Long-Term Follow-Up|Death|3|||
163052158|NCT01573000|588900915|FG001|Long-Term Follow-Up|Death|0|||
163052159|NCT01573000|588900914|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
163052160|NCT01573000|588900915|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
163052161|NCT03342001|588900921|FG000|Overall Study|Adverse Event|1|||
163052162|NCT03342001|588900921|FG000|Overall Study|Lost to Follow-up|1|||
163052163|NCT01384877|588900922|FG000|Treatment 2|Lost to Follow-up|2|||
163052164|NCT01384877|588900923|FG001|Treatment 2|Lost to Follow-up|2|||
163052165|NCT01930539|588900932|FG000|Overall Study|Withdrawal by Subject|2|||
163052166|NCT01930539|588900933|FG001|Overall Study|Withdrawal by Subject|2|||
163052167|NCT01548404|588900934|FG000|Overall Study|Adverse Event|3|||
163052168|NCT01548404|588900935|FG001|Overall Study|Adverse Event|1|||
163052169|NCT01548404|588900934|FG000|Overall Study|Physician Decision|2|||
163052170|NCT01548404|588900935|FG001|Overall Study|Physician Decision|1|||
163052171|NCT01548404|588900934|FG000|Overall Study|Inadequate response to study treatment|23|||
163052172|NCT01548404|588900935|FG001|Overall Study|Inadequate response to study treatment|7|||
163052173|NCT01548404|588900934|FG000|Overall Study|Lost to Follow-up|2|||
163052174|NCT01548404|588900935|FG001|Overall Study|Lost to Follow-up|0|||
163052175|NCT01548404|588900934|FG000|Overall Study|Withdrawal by Subject|0|||
163052176|NCT01548404|588900935|FG001|Overall Study|Withdrawal by Subject|3|||
163052177|NCT01548404|588900934|FG000|Overall Study|Other than specified above|0|||
163052178|NCT01548404|588900935|FG001|Overall Study|Other than specified above|2|||
163052179|NCT04040439|588900936|FG000|Overall Study|Invalid registration|11|||
163052180|NCT04040439|588900936|FG000|Overall Study|No IC* on publication of study results|2|||
163052181|NCT00426270|588900937|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
163052182|NCT00426270|588900937|FG000|Overall Study|Adverse Event|5|||
163052183|NCT01450813|588900938|FG000|Overall Study|Physician Decision|1|||
163052184|NCT01450813|588900939|FG001|Overall Study|Physician Decision|1|||
163052185|NCT01450813|588900940|FG002|Overall Study|Physician Decision|0|||
163052186|NCT01450813|588900941|FG003|Overall Study|Physician Decision|3|||
163052187|NCT02062437|588900944|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
163052188|NCT02062437|588900944|FG000|Overall Study|Patient not available for the 2y visit|18|||
163052189|NCT02062437|588900944|FG000|Overall Study|Death|2|||
163204724|NCT02521870|589461871|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
163204725|NCT02521870|589461872|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
163204726|NCT02521870|589461873|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
163204727|NCT02521870|589461874|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
163204728|NCT02521870|589461875|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
163204729|NCT02521870|589461876|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
163204730|NCT02521870|589461877|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
163204731|NCT02521870|589461878|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
163204732|NCT02521870|589461879|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
163204733|NCT02521870|589461880|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
163204734|NCT02521870|589461881|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
163204735|NCT02521870|589461870|FG000|Phase 2: Dose Expansion|Death|0|||
163204736|NCT02521870|589461871|FG001|Phase 2: Dose Expansion|Death|0|||
163204737|NCT02521870|589461872|FG002|Phase 2: Dose Expansion|Death|0|||
163204738|NCT02521870|589461873|FG003|Phase 2: Dose Expansion|Death|0|||
163204739|NCT02521870|589461874|FG004|Phase 2: Dose Expansion|Death|1|||
163204740|NCT02521870|589461875|FG005|Phase 2: Dose Expansion|Death|1|||
163204741|NCT02521870|589461876|FG006|Phase 2: Dose Expansion|Death|3|||
163204742|NCT02521870|589461877|FG007|Phase 2: Dose Expansion|Death|1|||
163204743|NCT02521870|589461878|FG008|Phase 2: Dose Expansion|Death|1|||
163204744|NCT02521870|589461879|FG009|Phase 2: Dose Expansion|Death|5|||
163204745|NCT02521870|589461880|FG010|Phase 2: Dose Expansion|Death|2|||
163204746|NCT02521870|589461881|FG011|Phase 2: Dose Expansion|Death|2|||
163204747|NCT02521870|589461870|FG000|Phase 2: Dose Expansion|Other|0|||
163204748|NCT02521870|589461871|FG001|Phase 2: Dose Expansion|Other|0|||
163204749|NCT02521870|589461872|FG002|Phase 2: Dose Expansion|Other|0|||
163204750|NCT02521870|589461873|FG003|Phase 2: Dose Expansion|Other|0|||
163204751|NCT02521870|589461874|FG004|Phase 2: Dose Expansion|Other|10|||
163204752|NCT02521870|589461875|FG005|Phase 2: Dose Expansion|Other|3|||
163204753|NCT02521870|589461876|FG006|Phase 2: Dose Expansion|Other|2|||
163204754|NCT02521870|589461877|FG007|Phase 2: Dose Expansion|Other|0|||
163204755|NCT02521870|589461878|FG008|Phase 2: Dose Expansion|Other|10|||
163052190|NCT02062437|588900944|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
163312925|NCT02319759|589856525|FG002|Week 16 - 24|Lack of Efficacy|1|||
163312926|NCT02319759|589856526|FG003|Week 16 - 24|Lack of Efficacy|0|||
163312927|NCT02319759|589856527|FG004|Week 16 - 24|Lack of Efficacy|0|||
163312928|NCT02319759|589856523|FG000|Week 16 - 24|Lost to Follow-up|1|||
163312929|NCT02319759|589856524|FG001|Week 16 - 24|Lost to Follow-up|0|||
163312930|NCT02319759|589856525|FG002|Week 16 - 24|Lost to Follow-up|0|||
162965347|NCT03499873|588573261|FG000|Overall Study|Administrative reasons|0|||
162965348|NCT03499873|588573262|FG001|Overall Study|Administrative reasons|1|||
162965349|NCT03499873|588573263|FG002|Overall Study|Administrative reasons|0|||
162965350|NCT03499873|588573261|FG000|Overall Study|Concomitant therapy|5|||
162965351|NCT03499873|588573262|FG001|Overall Study|Concomitant therapy|4|||
162965352|NCT03499873|588573263|FG002|Overall Study|Concomitant therapy|7|||
162965353|NCT03499873|588573261|FG000|Overall Study|Miscellaneous|1|||
162965354|NCT03499873|588573262|FG001|Overall Study|Miscellaneous|2|||
162965355|NCT03499873|588573263|FG002|Overall Study|Miscellaneous|2|||
162965356|NCT03499873|588573261|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
163312931|NCT02319759|589856526|FG003|Week 16 - 24|Lost to Follow-up|0|||
163312932|NCT02319759|589856527|FG004|Week 16 - 24|Lost to Follow-up|0|||
162965357|NCT03499873|588573262|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
162965358|NCT03499873|588573263|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
162965359|NCT04608448|588573264|FG000|Overall Study|Withdrawal by Subject|1|||
163204756|NCT02521870|589461879|FG009|Phase 2: Dose Expansion|Other|5|||
163204757|NCT02521870|589461880|FG010|Phase 2: Dose Expansion|Other|1|||
162965360|NCT04608448|588573264|FG000|Overall Study|Adverse Event|1|||
162965361|NCT01297504|588573265|FG000|Overall Study|Invalid Consent|1|||
162965362|NCT01297504|588573265|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
162965363|NCT01297504|588573265|FG000|Overall Study|No Study Visits|4|||
162965364|NCT01297504|588573265|FG000|Overall Study|Death|3|||
162965365|NCT01297504|588573265|FG000|Overall Study|Lost to Follow-up|43|||
162965366|NCT01297504|588573265|FG000|Overall Study|Withdrawal by Subject|9|||
162965367|NCT01297504|588573265|FG000|Overall Study|Site Closure|3|||
162965368|NCT01297504|588573265|FG000|Overall Study|Protocol Violation|3|||
162965369|NCT00654186|588573266|FG000|Overall Study|Withdrawal by Subject|5|||
162965370|NCT00577655|588573267|FG000|Overall Study|Patient Request|0|||
162965371|NCT00577655|588573268|FG001|Overall Study|Patient Request|2|||
162965372|NCT00577655|588573267|FG000|Overall Study|Protocol Violation|0|||
162965373|NCT00577655|588573268|FG001|Overall Study|Protocol Violation|1|||
162965374|NCT00577655|588573267|FG000|Overall Study|Lost to Follow-up|1|||
162965375|NCT00577655|588573268|FG001|Overall Study|Lost to Follow-up|1|||
162965376|NCT01370863|588573269|FG000|Overall Study|Adverse Event|1|||
162965377|NCT01370863|588573270|FG001|Overall Study|Adverse Event|1|||
162965378|NCT01370863|588573269|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
162965379|NCT01370863|588573270|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
162965380|NCT01370863|588573269|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
162965381|NCT01370863|588573270|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
162965382|NCT00881751|588573271|FG000|Overall Study|Physician Decision|0|||
162965383|NCT00881751|588573272|FG001|Overall Study|Physician Decision|1|||
162965384|NCT00881751|588573271|FG000|Overall Study|Adverse Event|0|||
162965385|NCT00881751|588573272|FG001|Overall Study|Adverse Event|2|||
162965386|NCT00881751|588573271|FG000|Overall Study|Withdrawal by Subject|0|||
162965387|NCT00881751|588573272|FG001|Overall Study|Withdrawal by Subject|2|||
162965388|NCT05004649|588573275|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
162965389|NCT05004649|588573275|FG000|Overall Study|Lost to Follow-up|1|||
163204758|NCT02521870|589461881|FG011|Phase 2: Dose Expansion|Other|7|||
163204759|NCT02521870|589461870|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163204760|NCT02521870|589461871|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163204761|NCT02521870|589461872|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163204762|NCT02521870|589461873|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163204763|NCT02521870|589461874|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
163204764|NCT02521870|589461875|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163204765|NCT02521870|589461876|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163204766|NCT02521870|589461877|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163204767|NCT02521870|589461878|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163204768|NCT02521870|589461879|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163052191|NCT00752089|588900945|FG000|Overall Study|Adverse Event|1|||
163052192|NCT00752089|588900945|FG000|Overall Study|Protocol Deviation|2|||
163052193|NCT00752089|588900945|FG000|Overall Study|Could not attend visit 9|1|||
163052194|NCT00752089|588900945|FG000|Overall Study|Not capable of wearing partial denture|1|||
163052195|NCT00752089|588900945|FG000|Overall Study|Cannot continue the study|1|||
163052196|NCT01324102|588900946|FG000|Overall Study|illness|1|||
163052197|NCT01324102|588900947|FG001|Overall Study|illness|6|||
163052198|NCT00728494|588900950|FG000|Overall Study|Adverse Event|7|||
163052199|NCT00728494|588900951|FG001|Overall Study|Adverse Event|0|||
163052200|NCT00728494|588900950|FG000|Overall Study|Withdrawal by Subject|0|||
163052201|NCT00728494|588900951|FG001|Overall Study|Withdrawal by Subject|2|||
163052202|NCT00728494|588900950|FG000|Overall Study|Lack of Efficacy|2|||
163052203|NCT00728494|588900951|FG001|Overall Study|Lack of Efficacy|4|||
163052204|NCT00728494|588900950|FG000|Overall Study|No data available|0|||
163052205|NCT00728494|588900951|FG001|Overall Study|No data available|1|||
163052206|NCT00975416|588900952|FG000|Overall Study|early discharge from tx|3|||
163052207|NCT00975416|588900953|FG001|Overall Study|early discharge from tx|5|||
163052208|NCT03426345|588900954|FG000|Overall Study|Adverse Event|4|||
163052209|NCT03426345|588900955|FG001|Overall Study|Adverse Event|4|||
163052210|NCT03426345|588900954|FG000|Overall Study|Lack of Efficacy|1|||
163052211|NCT03426345|588900955|FG001|Overall Study|Lack of Efficacy|0|||
163052212|NCT03426345|588900954|FG000|Overall Study|Withdrawal by Subject|5|||
163052213|NCT03426345|588900955|FG001|Overall Study|Withdrawal by Subject|6|||
163052214|NCT03426345|588900954|FG000|Overall Study|Lost to Follow-up|3|||
163397482|NCT01101438|590167727|FG000|Overall Study|Withdrawal by Subject|8|||
163052215|NCT03426345|588900955|FG001|Overall Study|Lost to Follow-up|1|||
163052216|NCT03426345|588900954|FG000|Overall Study|Protocol Deviation|3|||
163052217|NCT03426345|588900955|FG001|Overall Study|Protocol Deviation|4|||
163052218|NCT03426345|588900954|FG000|Overall Study|Reason Not Specified|1|||
163052219|NCT03426345|588900955|FG001|Overall Study|Reason Not Specified|2|||
163052220|NCT03426345|588900954|FG000|Overall Study|Missing Completion Status|1|||
163052221|NCT03426345|588900955|FG001|Overall Study|Missing Completion Status|0|||
163052222|NCT00192114|588900962|FG000|Overall Study|Objective Tumor Progression|19|||
163312933|NCT02319759|589856523|FG000|Week 16 - 24|Withdrawal by Subject|0|||
163312934|NCT02319759|589856524|FG001|Week 16 - 24|Withdrawal by Subject|0|||
163312935|NCT02319759|589856525|FG002|Week 16 - 24|Withdrawal by Subject|2|||
163312936|NCT02319759|589856526|FG003|Week 16 - 24|Withdrawal by Subject|0|||
163312937|NCT02319759|589856527|FG004|Week 16 - 24|Withdrawal by Subject|0|||
163312938|NCT02319759|589856523|FG000|Week 24 - 56|Adverse Event|0|||
163312939|NCT02319759|589856524|FG001|Week 24 - 56|Adverse Event|0|||
163312940|NCT02319759|589856525|FG002|Week 24 - 56|Adverse Event|2|||
163312941|NCT02319759|589856526|FG003|Week 24 - 56|Adverse Event|0|||
163312942|NCT02319759|589856527|FG004|Week 24 - 56|Adverse Event|0|||
163312943|NCT02319759|589856523|FG000|Week 24 - 56|Lack of Efficacy|0|||
163312944|NCT02319759|589856524|FG001|Week 24 - 56|Lack of Efficacy|0|||
163312945|NCT02319759|589856525|FG002|Week 24 - 56|Lack of Efficacy|0|||
163204769|NCT02521870|589461880|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163204770|NCT02521870|589461881|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163204771|NCT02521870|589461870|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
163204772|NCT02521870|589461871|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
163204773|NCT02521870|589461872|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
163052223|NCT00192114|588900962|FG000|Overall Study|Adverse Event|2|||
163204774|NCT02521870|589461873|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
163204775|NCT02521870|589461874|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
163204776|NCT02521870|589461875|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
163204777|NCT02521870|589461876|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
163204778|NCT02521870|589461877|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
163204779|NCT02521870|589461878|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
163204780|NCT02521870|589461879|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
163204781|NCT02521870|589461880|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
163312946|NCT02319759|589856526|FG003|Week 24 - 56|Lack of Efficacy|2|||
163312947|NCT02319759|589856527|FG004|Week 24 - 56|Lack of Efficacy|1|||
163312948|NCT02319759|589856523|FG000|Week 24 - 56|Withdrawal by Subject|0|||
163312949|NCT02319759|589856524|FG001|Week 24 - 56|Withdrawal by Subject|1|||
163312950|NCT02319759|589856525|FG002|Week 24 - 56|Withdrawal by Subject|0|||
163312951|NCT02319759|589856526|FG003|Week 24 - 56|Withdrawal by Subject|0|||
163312952|NCT02319759|589856527|FG004|Week 24 - 56|Withdrawal by Subject|0|||
163312953|NCT02319759|589856523|FG000|Week 24 - 56|Lost to Follow-up|0|||
163312954|NCT02319759|589856524|FG001|Week 24 - 56|Lost to Follow-up|0|||
163312955|NCT02319759|589856525|FG002|Week 24 - 56|Lost to Follow-up|0|||
163312956|NCT02319759|589856526|FG003|Week 24 - 56|Lost to Follow-up|0|||
163312957|NCT02319759|589856527|FG004|Week 24 - 56|Lost to Follow-up|1|||
163312958|NCT05006872|589856528|FG000|Overall Study|Lost to Follow-up|37|||
163312959|NCT05006872|589856529|FG001|Overall Study|Lost to Follow-up|31|||
163312960|NCT04332926|589856530|FG000|Overall Study|Withdrawal by Subject|6|||
163312961|NCT04332926|589856530|FG000|Overall Study|Physician Decision|6|||
163312962|NCT05783102|589856531|FG000|Overall Study|Lost to Follow-up|1|||
163312963|NCT05783102|589856531|FG000|Overall Study|Withdrawal by Subject|2|||
163312964|NCT05362487|589856532|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
163312965|NCT04973254|589856533|FG000|Overall Study|Not adherent|0|||
163312966|NCT04973254|589856534|FG001|Overall Study|Not adherent|1|||
163312967|NCT04973254|589856535|FG002|Overall Study|Not adherent|0|||
163312968|NCT05170009|589856536|FG000|Overall Study|Physician Decision|0|||
163312969|NCT05170009|589856537|FG001|Overall Study|Physician Decision|1|||
163312970|NCT04629716|589856538|FG000|Overall Study|Lost to Follow-up|7|||
163312971|NCT04629716|589856539|FG001|Overall Study|Lost to Follow-up|3|||
163052224|NCT00192114|588900962|FG000|Overall Study|Clinical Progression|2|||
163052225|NCT00192114|588900962|FG000|Overall Study|Death|1|||
163052226|NCT00492297|588900963|FG000|Treatment|Death|2|||
163312972|NCT05257486|589856545|FG000|Overall Study|Protocol Violation|3|||
163312973|NCT04542317|589856546|FG000|Overall Study|Care recipients passed away|18|||
163312974|NCT04542317|589856547|FG001|Overall Study|Care recipients passed away|13|||
163312975|NCT04542317|589856546|FG000|Overall Study|No longer a primary caregiver|5|||
163312976|NCT04542317|589856547|FG001|Overall Study|No longer a primary caregiver|1|||
163312977|NCT04542317|589856546|FG000|Overall Study|Withdrawal by Subject|4|||
162965390|NCT05004649|588573275|FG000|Overall Study|Withdrawal by Subject|2|||
162965391|NCT05004649|588573275|FG000|Overall Study|COVID-19|1|||
162965392|NCT00301964|588573276|FG000|Overall Study|Second primary|2|||
162965393|NCT00301964|588573276|FG000|Overall Study|Wrong primary|1|||
162965394|NCT00301964|588573276|FG000|Overall Study|Inadequate pathology|1|||
162965395|NCT02385708|588573278|FG000|Overall Study|Withdrawal by Subject|0|||
162965396|NCT02385708|588573279|FG001|Overall Study|Withdrawal by Subject|2|||
162965397|NCT02385708|588573278|FG000|Overall Study|Withdrawn - surgery canceled|2|||
162965398|NCT02385708|588573279|FG001|Overall Study|Withdrawn - surgery canceled|5|||
162965399|NCT02385708|588573278|FG000|Overall Study|Investigator decision|5|||
162965400|NCT02385708|588573279|FG001|Overall Study|Investigator decision|7|||
162965401|NCT02385708|588573278|FG000|Overall Study|Protocol Violation|1|||
162965402|NCT02385708|588573279|FG001|Overall Study|Protocol Violation|1|||
162965403|NCT02436200|588573280|FG000|Overall Study|Significant outlier|1|||
162965404|NCT02761915|588573281|FG000|Overall Study|Death|3|||
162965405|NCT02761915|588573282|FG001|Overall Study|Death|1|||
162965406|NCT02761915|588573283|FG002|Overall Study|Death|1|||
162965407|NCT02761915|588573284|FG003|Overall Study|Death|1|||
162965408|NCT02761915|588573285|FG004|Overall Study|Death|0|||
162965409|NCT02761915|588573286|FG005|Overall Study|Death|1|||
162965410|NCT02761915|588573281|FG000|Overall Study|Withdrawal by Subject|1|||
162965411|NCT02761915|588573282|FG001|Overall Study|Withdrawal by Subject|0|||
162965412|NCT02761915|588573283|FG002|Overall Study|Withdrawal by Subject|0|||
162965413|NCT02761915|588573284|FG003|Overall Study|Withdrawal by Subject|0|||
162965414|NCT02761915|588573285|FG004|Overall Study|Withdrawal by Subject|1|||
162965415|NCT02761915|588573286|FG005|Overall Study|Withdrawal by Subject|2|||
162965416|NCT02761915|588573281|FG000|Overall Study|Disease Progression|0|||
162965417|NCT02761915|588573282|FG001|Overall Study|Disease Progression|0|||
162965418|NCT02761915|588573283|FG002|Overall Study|Disease Progression|0|||
162965419|NCT02761915|588573284|FG003|Overall Study|Disease Progression|2|||
162965420|NCT02761915|588573285|FG004|Overall Study|Disease Progression|2|||
162965421|NCT02761915|588573286|FG005|Overall Study|Disease Progression|2|||
162965422|NCT02654145|588573293|FG000|Overall Study|Lack of Efficacy|1|||
162965423|NCT02654145|588573293|FG000|Overall Study|Protocol Violation|1|||
163204782|NCT02521870|589461881|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
163204783|NCT00519831|589461882|FG000|Overall Study|Adverse Event|3|||
163204784|NCT04051008|589461883|FG000|Overall Study|Withdrawal by Subject|2|||
163204785|NCT04051008|589461884|FG001|Overall Study|Withdrawal by Subject|0|||
163204786|NCT04051008|589461885|FG002|Overall Study|Withdrawal by Subject|1|||
163204787|NCT02862171|589461886|FG000|Overall Study|Death|1|||
162965424|NCT02654145|588573293|FG000|Overall Study|Withdrawal by Subject|5|||
162965425|NCT00354835|588573294|FG000|Overall Study|Death|1|||
162965426|NCT00354835|588573295|FG001|Overall Study|Death|1|||
162965427|NCT00354835|588573294|FG000|Overall Study|Physician Decision|8|||
163052227|NCT00492297|588900963|FG000|Treatment|Study terminated by sponsor|3|||
163204788|NCT02862171|589461886|FG000|Overall Study|Lost to Follow-up|13|||
163204789|NCT02862171|589461886|FG000|Overall Study|Withdrawal by Subject|57|||
163204790|NCT02862171|589461886|FG000|Overall Study|Non-compliance|4|||
163204791|NCT02862171|589461886|FG000|Overall Study|HIV-1 seroconversion|18|||
163204792|NCT00662012|589461887|FG000|Overall Study|Lost to Follow-up|85|||
162965428|NCT00354835|588573295|FG001|Overall Study|Physician Decision|13|||
162965429|NCT00354835|588573294|FG000|Overall Study|Withdrawal by Subject|2|||
163204793|NCT00662012|589461887|FG000|Overall Study|Death|1|||
162965430|NCT00354835|588573295|FG001|Overall Study|Withdrawal by Subject|1|||
162965431|NCT00354835|588573294|FG000|Overall Study|Ineligible|17|||
162965432|NCT00354835|588573295|FG001|Overall Study|Ineligible|16|||
163052228|NCT00492297|588900963|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
163312978|NCT04542317|589856547|FG001|Overall Study|Withdrawal by Subject|2|||
163312979|NCT04542317|589856546|FG000|Overall Study|Caregivers passed away|0|||
163312980|NCT04542317|589856547|FG001|Overall Study|Caregivers passed away|2|||
163312981|NCT03848065|589856550|FG000|Overall Study|Death|0|||
163312982|NCT03848065|589856551|FG001|Overall Study|Death|1|||
163312983|NCT03848065|589856552|FG002|Overall Study|Death|0|||
163312984|NCT03848065|589856550|FG000|Overall Study|Lost to Follow-up|0|||
163312985|NCT03848065|589856551|FG001|Overall Study|Lost to Follow-up|0|||
163312986|NCT03848065|589856552|FG002|Overall Study|Lost to Follow-up|1|||
163312987|NCT03848065|589856550|FG000|Overall Study|Physician Decision|0|||
163312988|NCT03848065|589856551|FG001|Overall Study|Physician Decision|0|||
162924555|NCT02406742|588426050|FG001|Overall Study|Progression of Disease|1|||
162924556|NCT02406742|588426051|FG002|Overall Study|Progression of Disease|6|||
162924557|NCT02406742|588426049|FG000|Overall Study|Adverse Event|3|||
162924558|NCT02406742|588426050|FG001|Overall Study|Adverse Event|0|||
162924559|NCT02406742|588426051|FG002|Overall Study|Adverse Event|2|||
162924560|NCT02406742|588426049|FG000|Overall Study|Death|1|||
162924561|NCT02406742|588426050|FG001|Overall Study|Death|0|||
162924562|NCT02406742|588426051|FG002|Overall Study|Death|0|||
162924563|NCT02406742|588426049|FG000|Overall Study|Lack of Efficacy|0|||
162924564|NCT02406742|588426050|FG001|Overall Study|Lack of Efficacy|0|||
162924565|NCT02406742|588426051|FG002|Overall Study|Lack of Efficacy|1|||
162924566|NCT02406742|588426049|FG000|Overall Study|Withdrawal by Participant|1|||
162924567|NCT02406742|588426050|FG001|Overall Study|Withdrawal by Participant|2|||
162924568|NCT02406742|588426051|FG002|Overall Study|Withdrawal by Participant|0|||
162924569|NCT02406742|588426049|FG000|Overall Study|Physician Decision|1|||
162924570|NCT02406742|588426050|FG001|Overall Study|Physician Decision|2|||
162924571|NCT02406742|588426051|FG002|Overall Study|Physician Decision|1|||
163312989|NCT03848065|589856552|FG002|Overall Study|Physician Decision|1|||
163312990|NCT04564742|589856555|FG000|Overall Study|Lost to Follow-up|1|||
163312991|NCT04564742|589856556|FG001|Overall Study|Lost to Follow-up|0|||
163312992|NCT04564742|589856555|FG000|Overall Study|Consent Withdrawal|4|||
163312993|NCT04564742|589856556|FG001|Overall Study|Consent Withdrawal|4|||
163312994|NCT03313076|589856559|FG000|Overall Study|Withdrawal by Subject|2|||
163312995|NCT03313076|589856560|FG001|Overall Study|Withdrawal by Subject|0|||
163312996|NCT03313076|589856561|FG002|Overall Study|Withdrawal by Subject|0|||
163312997|NCT03313076|589856562|FG003|Overall Study|Withdrawal by Subject|0|||
163312998|NCT03313076|589856559|FG000|Overall Study|Lost to Follow-up|0|||
163312999|NCT03313076|589856560|FG001|Overall Study|Lost to Follow-up|2|||
163313000|NCT03313076|589856561|FG002|Overall Study|Lost to Follow-up|2|||
163313001|NCT03313076|589856562|FG003|Overall Study|Lost to Follow-up|2|||
163313002|NCT05869383|589856563|FG000|Overall Study|Withdrawal by Subject|2|||
163313003|NCT05869383|589856564|FG001|Overall Study|Withdrawal by Subject|0|||
163313004|NCT05270408|589856575|FG000|Started Treatment|Withdrawal by Subject|0|||
163313005|NCT05270408|589856576|FG001|Started Treatment|Withdrawal by Subject|0|||
163313006|NCT05270408|589856577|FG002|Started Treatment|Withdrawal by Subject|3|||
163313007|NCT05270408|589856575|FG000|Started Treatment|Adverse Event|0|||
163313008|NCT05270408|589856576|FG001|Started Treatment|Adverse Event|0|||
163313009|NCT05270408|589856577|FG002|Started Treatment|Adverse Event|1|||
163313010|NCT05270408|589856575|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
163313011|NCT05270408|589856576|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
163313012|NCT05270408|589856577|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
163313013|NCT04338061|589856578|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
163313014|NCT04338061|589856579|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
163313015|NCT04338061|589856578|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
163313016|NCT04338061|589856579|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
163313017|NCT04338061|589856578|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
163313018|NCT04338061|589856579|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
163313019|NCT04338061|589856578|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
163313020|NCT04338061|589856579|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
163313021|NCT04338061|589856578|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
163313022|NCT04338061|589856579|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
163313023|NCT04338061|589856578|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
163313024|NCT04338061|589856579|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
163313025|NCT04338061|589856578|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
163313026|NCT04338061|589856579|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
163313027|NCT04338061|589856578|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
163313028|NCT04338061|589856579|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
163313029|NCT04338061|589856578|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
163313030|NCT04338061|589856579|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
163313031|NCT04338061|589856578|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
163313032|NCT04338061|589856579|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
163313033|NCT04338061|589856578|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
163313034|NCT04338061|589856579|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
163313035|NCT04338061|589856578|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
163313036|NCT04338061|589856579|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
163313037|NCT03631784|589856580|FG000|Overall Study|Participants Ongoing|1|||
163313038|NCT03631784|589856581|FG001|Overall Study|Participants Ongoing|0|||
163313039|NCT03631784|589856580|FG000|Overall Study|Withdrawal by Subject|3|||
163313040|NCT03631784|589856581|FG001|Overall Study|Withdrawal by Subject|3|||
163313041|NCT03631784|589856580|FG000|Overall Study|Sponsor's Decision|36|||
163313042|NCT03631784|589856581|FG001|Overall Study|Sponsor's Decision|52|||
163313043|NCT03631784|589856580|FG000|Overall Study|Lost to Follow-up|1|||
163313044|NCT03631784|589856581|FG001|Overall Study|Lost to Follow-up|0|||
163313045|NCT03631784|589856580|FG000|Overall Study|Death|71|||
163313046|NCT03631784|589856581|FG001|Overall Study|Death|49|||
163313047|NCT04764448|589859330|FG000|Overall Study|Study terminated by sponsor|2|||
163313048|NCT04764448|589859331|FG001|Overall Study|Study terminated by sponsor|2|||
163313049|NCT04764448|589859332|FG002|Overall Study|Study terminated by sponsor|5|||
163313050|NCT04764448|589859330|FG000|Overall Study|Withdrawal by Subject|3|||
163313051|NCT04764448|589859331|FG001|Overall Study|Withdrawal by Subject|3|||
163313052|NCT04764448|589859332|FG002|Overall Study|Withdrawal by Subject|1|||
163313053|NCT04728347|589859333|FG000|Overall Study|Sponsor decision|0|||
163313054|NCT04728347|589859334|FG001|Overall Study|Sponsor decision|0|||
163313055|NCT04728347|589859335|FG002|Overall Study|Sponsor decision|1|||
163313056|NCT04728347|589859336|FG003|Overall Study|Sponsor decision|0|||
163313057|NCT05835336|589859338|FG000|Overall Study|Withdrawal by Subject|5|||
163313058|NCT05835336|589859338|FG000|Overall Study|Did not complete the personalization process|3|||
163313059|NCT02561247|589859339|FG000|Overall Study|Protocol Violation|1|||
163313060|NCT02561247|589859339|FG000|Overall Study|Withdrawal by Subject|1|||
163313061|NCT02561247|589859339|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
163313062|NCT04908722|589859340|FG000|Overall Study|Protocol deviation|1|||
163313063|NCT04908722|589859341|FG001|Overall Study|Protocol deviation|0|||
163313064|NCT04908722|589859342|FG002|Overall Study|Protocol deviation|0|||
163313065|NCT04908722|589859343|FG003|Overall Study|Protocol deviation|0|||
163313066|NCT04908722|589859344|FG004|Overall Study|Protocol deviation|0|||
163313067|NCT04908722|589859345|FG005|Overall Study|Protocol deviation|1|||
163313068|NCT04908722|589859340|FG000|Overall Study|Lost to Follow-up|33|||
163313069|NCT04908722|589859341|FG001|Overall Study|Lost to Follow-up|33|||
163313070|NCT04908722|589859342|FG002|Overall Study|Lost to Follow-up|36|||
163313071|NCT04908722|589859343|FG003|Overall Study|Lost to Follow-up|30|||
163313072|NCT04908722|589859344|FG004|Overall Study|Lost to Follow-up|32|||
163313073|NCT04908722|589859345|FG005|Overall Study|Lost to Follow-up|34|||
163313074|NCT04908722|589859340|FG000|Overall Study|Physician Decision|1|||
163313075|NCT04908722|589859341|FG001|Overall Study|Physician Decision|1|||
163313076|NCT04908722|589859342|FG002|Overall Study|Physician Decision|1|||
163313077|NCT04908722|589859343|FG003|Overall Study|Physician Decision|2|||
163313078|NCT04908722|589859344|FG004|Overall Study|Physician Decision|0|||
163313079|NCT04908722|589859345|FG005|Overall Study|Physician Decision|0|||
163313080|NCT04908722|589859340|FG000|Overall Study|Death|1|||
163313081|NCT04908722|589859341|FG001|Overall Study|Death|0|||
163313082|NCT04908722|589859342|FG002|Overall Study|Death|0|||
163313083|NCT04908722|589859343|FG003|Overall Study|Death|0|||
163313084|NCT04908722|589859344|FG004|Overall Study|Death|0|||
163313085|NCT04908722|589859345|FG005|Overall Study|Death|1|||
163313086|NCT04908722|589859340|FG000|Overall Study|Withdrawal by Subject|12|||
163313087|NCT04908722|589859341|FG001|Overall Study|Withdrawal by Subject|8|||
163313088|NCT04908722|589859342|FG002|Overall Study|Withdrawal by Subject|7|||
163313089|NCT04908722|589859343|FG003|Overall Study|Withdrawal by Subject|6|||
163313090|NCT04908722|589859344|FG004|Overall Study|Withdrawal by Subject|12|||
163313091|NCT04908722|589859345|FG005|Overall Study|Withdrawal by Subject|14|||
163313092|NCT04908722|589859340|FG000|Overall Study|Other|3|||
163313093|NCT04908722|589859341|FG001|Overall Study|Other|1|||
163313094|NCT04908722|589859342|FG002|Overall Study|Other|3|||
163313095|NCT04908722|589859343|FG003|Overall Study|Other|2|||
163313096|NCT04908722|589859344|FG004|Overall Study|Other|4|||
163313097|NCT04908722|589859345|FG005|Overall Study|Other|1|||
163313098|NCT04908722|589859340|FG000|Overall Study|Initiated prohibited medication|0|||
163313099|NCT04908722|589859341|FG001|Overall Study|Initiated prohibited medication|0|||
163313100|NCT04908722|589859342|FG002|Overall Study|Initiated prohibited medication|0|||
163313101|NCT04908722|589859343|FG003|Overall Study|Initiated prohibited medication|1|||
163313102|NCT04908722|589859344|FG004|Overall Study|Initiated prohibited medication|0|||
163313103|NCT04908722|589859345|FG005|Overall Study|Initiated prohibited medication|1|||
163313104|NCT04908722|589859340|FG000|Overall Study|Randomized but not vaccinated|3|||
163313105|NCT04908722|589859341|FG001|Overall Study|Randomized but not vaccinated|1|||
163313106|NCT04908722|589859342|FG002|Overall Study|Randomized but not vaccinated|2|||
163313107|NCT04908722|589859343|FG003|Overall Study|Randomized but not vaccinated|2|||
163313108|NCT04908722|589859344|FG004|Overall Study|Randomized but not vaccinated|3|||
163313109|NCT04908722|589859345|FG005|Overall Study|Randomized but not vaccinated|4|||
163313110|NCT01369355|589859350|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
163052229|NCT00492297|588900963|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
163052230|NCT00492297|588900963|FG000|Survival Only Follow-up|Death|46|||
163052231|NCT00492297|588900963|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
163052232|NCT00492297|588900963|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
163052233|NCT03885908|588900964|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
163052234|NCT03885908|588900965|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
163052235|NCT03885908|588900964|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
163052236|NCT03885908|588900965|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
163052237|NCT03885908|588900964|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
163313111|NCT01369355|589859351|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
163313112|NCT01369355|589859352|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
163313113|NCT01369355|589859353|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
163313114|NCT01369355|589859354|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
163313115|NCT01369355|589859355|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
163313116|NCT01369355|589859356|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
163313117|NCT01369355|589859357|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
163313118|NCT01369355|589859358|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
163052238|NCT03885908|588900965|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
163052239|NCT03885908|588900964|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
163052240|NCT03885908|588900965|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
163052241|NCT01900444|588900975|FG000|Overall Study|Protocol Violation|2|||
163052242|NCT01900444|588900975|FG000|Overall Study|Lost to Follow-up|1|||
163313119|NCT01369355|589859350|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
163313120|NCT01369355|589859351|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
163313121|NCT01369355|589859352|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
163313122|NCT01369355|589859353|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
163313123|NCT01369355|589859354|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
163313124|NCT01369355|589859355|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
163313125|NCT01369355|589859356|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
163313126|NCT01369355|589859357|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
163052243|NCT00072384|588900976|FG000|Overall Study|Physician Decision|1|||
163052244|NCT00072384|588900976|FG000|Overall Study|Ineligible|8|||
163313127|NCT01369355|589859358|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
163313128|NCT01369355|589859350|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
163313129|NCT01369355|589859351|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
163313130|NCT01369355|589859352|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
163313131|NCT01369355|589859353|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
163313132|NCT01369355|589859354|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
163313133|NCT01369355|589859355|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
163313134|NCT01369355|589859356|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
163313135|NCT01369355|589859357|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
163313136|NCT01369355|589859358|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
163313137|NCT01369355|589859350|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
163313138|NCT01369355|589859351|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
163313139|NCT01369355|589859352|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
163204794|NCT00662012|589461887|FG000|Overall Study|Withdrawal by Subject|1|||
163204795|NCT04212650|589461891|FG000|Overall Study|Withdrawal by Subject|1|||
162965433|NCT00354835|588573294|FG000|Overall Study|Disease progression or relapse|15|||
163204796|NCT04212650|589461892|FG001|Overall Study|Withdrawal by Subject|0|||
163204797|NCT00838578|589461893|FG000|Overall Study|Protocol Violation|2|||
163204798|NCT00598832|589461894|FG000|Overall Study|Lack of Efficacy|3|||
163204799|NCT00598832|589461895|FG001|Overall Study|Lack of Efficacy|7|||
163313140|NCT01369355|589859353|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
163313141|NCT01369355|589859354|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
163313142|NCT01369355|589859355|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
163313143|NCT01369355|589859356|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
163313144|NCT01369355|589859357|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
163313145|NCT01369355|589859358|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
163313146|NCT01369355|589859350|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
163313147|NCT01369355|589859351|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
163313148|NCT01369355|589859352|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
163313149|NCT01369355|589859353|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
163313150|NCT01369355|589859354|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
163313151|NCT01369355|589859355|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
163204800|NCT00598832|589461894|FG000|Overall Study|Adverse Event|6|||
163204801|NCT00598832|589461895|FG001|Overall Study|Adverse Event|2|||
163204802|NCT00598832|589461894|FG000|Overall Study|Withdrawal by Subject|25|||
163204803|NCT00598832|589461895|FG001|Overall Study|Withdrawal by Subject|36|||
163204804|NCT00598832|589461894|FG000|Overall Study|Protocol Violation|0|||
163204805|NCT00598832|589461895|FG001|Overall Study|Protocol Violation|2|||
163313152|NCT01369355|589859356|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
163204806|NCT00598832|589461894|FG000|Overall Study|Lost to Follow-up|24|||
162965434|NCT00354835|588573295|FG001|Overall Study|Disease progression or relapse|22|||
162965435|NCT00354835|588573294|FG000|Overall Study|Adverse Event|6|||
162965436|NCT00354835|588573295|FG001|Overall Study|Adverse Event|0|||
162965437|NCT00354835|588573294|FG000|Overall Study|Refusal of further therapy|3|||
162965438|NCT00354835|588573295|FG001|Overall Study|Refusal of further therapy|8|||
162965439|NCT01968551|588573296|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
162965440|NCT01968551|588573297|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
162965441|NCT01968551|588573298|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
162965442|NCT01968551|588573296|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
162965443|NCT01968551|588573297|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
162965444|NCT01968551|588573298|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
162965445|NCT01968551|588573296|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
162965446|NCT01968551|588573297|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
163052245|NCT06058390|588900978|FG000|Overall Study|Lost to Follow-up|0|||
163052246|NCT06058390|588900979|FG001|Overall Study|Lost to Follow-up|0|||
163052247|NCT06058390|588900980|FG002|Overall Study|Lost to Follow-up|2|||
163052248|NCT06058390|588900981|FG003|Overall Study|Lost to Follow-up|1|||
163052249|NCT06058390|588900978|FG000|Overall Study|Physician Decision|0|||
163052250|NCT06058390|588900979|FG001|Overall Study|Physician Decision|0|||
163052251|NCT06058390|588900980|FG002|Overall Study|Physician Decision|0|||
163052252|NCT06058390|588900981|FG003|Overall Study|Physician Decision|1|||
163052253|NCT06058390|588900978|FG000|Overall Study|Participants did not receive any study intervention|0|||
163052254|NCT06058390|588900979|FG001|Overall Study|Participants did not receive any study intervention|0|||
163052255|NCT06058390|588900980|FG002|Overall Study|Participants did not receive any study intervention|0|||
163052256|NCT06058390|588900981|FG003|Overall Study|Participants did not receive any study intervention|1|||
163052257|NCT03292016|588900982|FG000|Second Washout|Adverse Event|0|||
163052258|NCT03292016|588900983|FG001|Second Washout|Adverse Event|1|||
163052259|NCT03292016|588900984|FG002|Second Washout|Adverse Event|0|||
163052260|NCT03292016|588900985|FG003|Second Washout|Adverse Event|0|||
163052261|NCT03292016|588900986|FG004|Second Washout|Adverse Event|0|||
163052262|NCT03292016|588900987|FG005|Second Washout|Adverse Event|0|||
163052263|NCT01172873|588900988|FG000|Overall Study|Withdrawal by Subject|3|||
163052264|NCT01172873|588900989|FG001|Overall Study|Withdrawal by Subject|2|||
163052265|NCT05518539|588900990|FG000|Overall Study|Lost to Follow-up|6|||
163052266|NCT03589807|588900992|FG000|Overall Study|Lost to Follow-up|0|||
163052267|NCT03589807|588900993|FG001|Overall Study|Lost to Follow-up|2|||
163052268|NCT03589807|588900994|FG002|Overall Study|Lost to Follow-up|2|||
163052269|NCT03589807|588900995|FG003|Overall Study|Lost to Follow-up|3|||
163052270|NCT03589807|588900996|FG004|Overall Study|Lost to Follow-up|1|||
163052271|NCT03589807|588900997|FG005|Overall Study|Lost to Follow-up|1|||
163052272|NCT03589807|588900992|FG000|Overall Study|Withdrawal by Subject|0|||
163052273|NCT03589807|588900993|FG001|Overall Study|Withdrawal by Subject|5|||
163052274|NCT03589807|588900994|FG002|Overall Study|Withdrawal by Subject|0|||
163052275|NCT03589807|588900995|FG003|Overall Study|Withdrawal by Subject|0|||
163052276|NCT03589807|588900996|FG004|Overall Study|Withdrawal by Subject|0|||
163052277|NCT03589807|588900997|FG005|Overall Study|Withdrawal by Subject|0|||
163052278|NCT03589807|588900992|FG000|Overall Study|Protocol Violation|0|||
163052279|NCT03589807|588900993|FG001|Overall Study|Protocol Violation|0|||
163052280|NCT03589807|588900994|FG002|Overall Study|Protocol Violation|0|||
163052281|NCT03589807|588900995|FG003|Overall Study|Protocol Violation|1|||
163052282|NCT03589807|588900996|FG004|Overall Study|Protocol Violation|0|||
163052283|NCT03589807|588900997|FG005|Overall Study|Protocol Violation|0|||
163052284|NCT03589807|588900992|FG000|Overall Study|Enrolled but treatment not administered|0|||
163052285|NCT03589807|588900993|FG001|Overall Study|Enrolled but treatment not administered|0|||
163052286|NCT03589807|588900994|FG002|Overall Study|Enrolled but treatment not administered|0|||
163052287|NCT03589807|588900995|FG003|Overall Study|Enrolled but treatment not administered|0|||
163052288|NCT03589807|588900996|FG004|Overall Study|Enrolled but treatment not administered|1|||
163204807|NCT00598832|589461895|FG001|Overall Study|Lost to Follow-up|29|||
163204808|NCT00598832|589461894|FG000|Overall Study|Pregnancy|2|||
162965447|NCT01968551|588573298|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
162965448|NCT01968551|588573296|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
163052289|NCT03589807|588900997|FG005|Overall Study|Enrolled but treatment not administered|0|||
163052290|NCT01211145|588900998|FG000|Overall Study|Reason not specified|3|||
163052291|NCT01211145|588900999|FG001|Overall Study|Reason not specified|2|||
163052292|NCT01211145|588901000|FG002|Overall Study|Reason not specified|2|||
163052293|NCT01211145|588901001|FG003|Overall Study|Reason not specified|1|||
163052294|NCT01211145|588900998|FG000|Overall Study|Lost to Follow-up|3|||
163052295|NCT01211145|588900999|FG001|Overall Study|Lost to Follow-up|2|||
163052296|NCT01211145|588901000|FG002|Overall Study|Lost to Follow-up|1|||
163052297|NCT01211145|588901001|FG003|Overall Study|Lost to Follow-up|2|||
163052298|NCT01211145|588900998|FG000|Overall Study|Study-specific withdrawal criteria|1|||
163204809|NCT00598832|589461895|FG001|Overall Study|Pregnancy|2|||
163204810|NCT00598832|589461894|FG000|Overall Study|Physician Decision|1|||
162965449|NCT01968551|588573297|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
162965450|NCT01968551|588573298|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
162965451|NCT01968551|588573296|FG000|Extension Phase|Adverse Event|0|||
162965452|NCT01968551|588573297|FG001|Extension Phase|Adverse Event|0|||
162965453|NCT01968551|588573298|FG002|Extension Phase|Adverse Event|2|||
162965454|NCT01968551|588573296|FG000|Extension Phase|Death|0|||
162965455|NCT01968551|588573297|FG001|Extension Phase|Death|1|||
162965456|NCT01968551|588573298|FG002|Extension Phase|Death|0|||
162965457|NCT01968551|588573296|FG000|Extension Phase|Withdrew Consent|0|||
162965458|NCT01968551|588573297|FG001|Extension Phase|Withdrew Consent|0|||
162965459|NCT01968551|588573298|FG002|Extension Phase|Withdrew Consent|1|||
162965460|NCT01968551|588573296|FG000|Extension Phase|Lost to Follow-up|1|||
162965461|NCT01968551|588573297|FG001|Extension Phase|Lost to Follow-up|0|||
162965462|NCT01968551|588573298|FG002|Extension Phase|Lost to Follow-up|1|||
162965463|NCT06475729|588573299|FG000|Overall Study|Withdrawal by Subject|2|||
162965464|NCT06475729|588573300|FG001|Overall Study|Withdrawal by Subject|1|||
162965465|NCT06475729|588573299|FG000|Overall Study|Randomized but did not receive any dose|3|||
163313153|NCT01369355|589859357|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
163313154|NCT01369355|589859358|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
163313155|NCT01369355|589859350|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
163313156|NCT01369355|589859351|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
163313157|NCT01369355|589859352|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
163313158|NCT01369355|589859353|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
163313159|NCT01369355|589859354|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
163313160|NCT01369355|589859355|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
163313161|NCT01369355|589859356|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
163313162|NCT01369355|589859357|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
163313163|NCT01369355|589859358|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
163313164|NCT01369355|589859350|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
163313165|NCT01369355|589859351|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
163313166|NCT01369355|589859352|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
163313167|NCT01369355|589859353|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
163313168|NCT01369355|589859354|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
163313169|NCT01369355|589859355|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
163313170|NCT01369355|589859356|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
163313171|NCT01369355|589859357|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
163313172|NCT01369355|589859358|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
163313173|NCT01369355|589859350|FG000|Long-term Extension (Week 44-272)|Death|0|||
163313174|NCT01369355|589859351|FG001|Long-term Extension (Week 44-272)|Death|0|||
163313175|NCT01369355|589859352|FG002|Long-term Extension (Week 44-272)|Death|0|||
163313176|NCT01369355|589859353|FG003|Long-term Extension (Week 44-272)|Death|0|||
163313177|NCT01369355|589859354|FG004|Long-term Extension (Week 44-272)|Death|0|||
163313178|NCT01369355|589859355|FG005|Long-term Extension (Week 44-272)|Death|0|||
163313179|NCT01369355|589859356|FG006|Long-term Extension (Week 44-272)|Death|0|||
163313180|NCT01369355|589859357|FG007|Long-term Extension (Week 44-272)|Death|1|||
163313181|NCT01369355|589859358|FG008|Long-term Extension (Week 44-272)|Death|3|||
163313182|NCT01369355|589859350|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
163313183|NCT01369355|589859351|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
163313184|NCT01369355|589859352|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
163313185|NCT01369355|589859353|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
163313186|NCT01369355|589859354|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
163313187|NCT01369355|589859355|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
162965466|NCT06475729|588573300|FG001|Overall Study|Randomized but did not receive any dose|2|||
162965467|NCT06475729|588573299|FG000|Overall Study|Lost to Follow-up|1|||
162965468|NCT06475729|588573300|FG001|Overall Study|Lost to Follow-up|2|||
162965469|NCT06475729|588573299|FG000|Overall Study|Physician Decision|5|||
162965470|NCT06475729|588573300|FG001|Overall Study|Physician Decision|2|||
162965471|NCT06475729|588573299|FG000|Overall Study|Adverse Event|1|||
162965472|NCT06475729|588573300|FG001|Overall Study|Adverse Event|1|||
163052299|NCT01211145|588900999|FG001|Overall Study|Study-specific withdrawal criteria|0|||
163052300|NCT01211145|588901000|FG002|Overall Study|Study-specific withdrawal criteria|0|||
163052301|NCT01211145|588901001|FG003|Overall Study|Study-specific withdrawal criteria|0|||
163052302|NCT01211145|588900998|FG000|Overall Study|Severe noncompliance to protocol|1|||
163052303|NCT01211145|588900999|FG001|Overall Study|Severe noncompliance to protocol|0|||
163052304|NCT01211145|588901000|FG002|Overall Study|Severe noncompliance to protocol|0|||
163052305|NCT01211145|588901001|FG003|Overall Study|Severe noncompliance to protocol|0|||
163052306|NCT01211145|588900998|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
163052307|NCT01211145|588900999|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
163204811|NCT00598832|589461895|FG001|Overall Study|Physician Decision|4|||
163204812|NCT00598832|589461894|FG000|Overall Study|Non compliance|1|||
163204813|NCT00598832|589461895|FG001|Overall Study|Non compliance|0|||
163204814|NCT00357968|589461900|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
163204815|NCT00357968|589461901|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
163204816|NCT00357968|589461900|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
163204817|NCT00357968|589461901|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
163313188|NCT01369355|589859356|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
163313189|NCT01369355|589859357|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
163313190|NCT01369355|589859358|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
163204818|NCT03919799|589461902|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
163204819|NCT03919799|589461903|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
163052308|NCT01211145|588901000|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
162965473|NCT03922750|588573307|FG000|Overall Study|Unclassified|0|||
162965474|NCT03922750|588573308|FG001|Overall Study|Unclassified|0|||
162965475|NCT03922750|588573309|FG002|Overall Study|Unclassified|1|||
162965476|NCT03922750|588573307|FG000|Overall Study|Adverse Event|0|||
162965477|NCT03922750|588573308|FG001|Overall Study|Adverse Event|1|||
162965478|NCT03922750|588573309|FG002|Overall Study|Adverse Event|0|||
162965479|NCT03366428|588573310|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
162965480|NCT03366428|588573310|FG000|Overall Study|Adverse Event|12|||
162965481|NCT03366428|588573310|FG000|Overall Study|Clinical progression|2|||
162965482|NCT03366428|588573310|FG000|Overall Study|Withdrawal by Subject|4|||
162965483|NCT01046084|588573314|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
162965484|NCT01046084|588573315|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
162965485|NCT02166606|588573316|FG000|Overall Study|Adverse Event|3|||
162965486|NCT02166606|588573316|FG000|Overall Study|Death|31|||
162965487|NCT02166606|588573316|FG000|Overall Study|Protocol Violation|7|||
162965488|NCT02166606|588573316|FG000|Overall Study|Lost to Follow-up|30|||
162965489|NCT02166606|588573316|FG000|Overall Study|Withdrawal by Subject|1|||
162965490|NCT02166606|588573316|FG000|Overall Study|Physician Decision|1|||
162965491|NCT02166606|588573316|FG000|Overall Study|Device upgrade|1|||
162965492|NCT02166606|588573316|FG000|Overall Study|Enrolled after End of Enrollment|4|||
162965493|NCT01958476|588573317|FG000|Overall Study|Parent requested exclusion from analysis|1|||
162965494|NCT01958476|588573318|FG001|Overall Study|Parent requested exclusion from analysis|0|||
162965495|NCT01971645|588573319|FG000|Overall Study|Adverse Event|1|||
162965496|NCT01971645|588573320|FG001|Overall Study|Adverse Event|0|||
162965497|NCT01971645|588573321|FG002|Overall Study|Adverse Event|0|||
162965498|NCT01971645|588573319|FG000|Overall Study|Lost to Follow-up|1|||
162965499|NCT01971645|588573320|FG001|Overall Study|Lost to Follow-up|0|||
162965500|NCT01971645|588573321|FG002|Overall Study|Lost to Follow-up|1|||
162965501|NCT01971645|588573319|FG000|Overall Study|Protocol Violation|0|||
162965502|NCT01971645|588573320|FG001|Overall Study|Protocol Violation|0|||
162965503|NCT01971645|588573321|FG002|Overall Study|Protocol Violation|1|||
162965504|NCT02943096|588573324|FG000|Overall Study|Lack of Efficacy|0|||
162965505|NCT02943096|588573325|FG001|Overall Study|Lack of Efficacy|1|||
163313191|NCT01369355|589859350|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
163313192|NCT01369355|589859351|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
163313193|NCT01369355|589859352|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
163313194|NCT01369355|589859353|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
163313195|NCT01369355|589859354|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
163313196|NCT01369355|589859355|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
163313197|NCT01369355|589859356|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
163313198|NCT01369355|589859357|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
163313199|NCT01369355|589859358|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
163313200|NCT01369355|589859350|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
163313201|NCT01369355|589859351|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
163313202|NCT01369355|589859352|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
163313203|NCT01369355|589859353|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
163313204|NCT01369355|589859354|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
163313205|NCT01369355|589859355|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
163313206|NCT01369355|589859356|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
163313207|NCT01369355|589859357|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
163313208|NCT01369355|589859358|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
163313209|NCT01369355|589859350|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
163313210|NCT01369355|589859351|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
163313211|NCT01369355|589859352|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
163313212|NCT01369355|589859353|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
163313213|NCT01369355|589859354|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
163313214|NCT01369355|589859355|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
163313215|NCT01369355|589859356|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
163313216|NCT01369355|589859357|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
163313217|NCT01369355|589859358|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
163313218|NCT01369355|589859350|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
163313219|NCT01369355|589859351|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
163313220|NCT01369355|589859352|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
163313221|NCT01369355|589859353|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
163313222|NCT01369355|589859354|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
163313223|NCT01369355|589859355|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
163313224|NCT01369355|589859356|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
163313225|NCT01369355|589859357|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
163313226|NCT01369355|589859358|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
163313227|NCT01369355|589859350|FG000|Long-term Extension (Week 44-272)|Other|0|||
163204820|NCT03919799|589461904|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
163204821|NCT03919799|589461905|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
163204822|NCT03919799|589461906|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
163204823|NCT03919799|589461902|FG000|DB Period (28 Weeks)|Adverse Event|1|||
163204824|NCT03919799|589461903|FG001|DB Period (28 Weeks)|Adverse Event|1|||
163204825|NCT03919799|589461904|FG002|DB Period (28 Weeks)|Adverse Event|1|||
163204826|NCT03919799|589461905|FG003|DB Period (28 Weeks)|Adverse Event|0|||
163204827|NCT03919799|589461906|FG004|DB Period (28 Weeks)|Adverse Event|0|||
163204828|NCT03919799|589461902|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
163204829|NCT03919799|589461903|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
163204830|NCT03919799|589461904|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
163204831|NCT03919799|589461905|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
163204832|NCT03919799|589461906|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
163204833|NCT03919799|589461902|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
163313228|NCT01369355|589859351|FG001|Long-term Extension (Week 44-272)|Other|0|||
163204834|NCT03919799|589461903|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
163204835|NCT03919799|589461904|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
163204836|NCT03919799|589461905|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
163204837|NCT03919799|589461906|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
163204838|NCT03919799|589461902|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
163204839|NCT03919799|589461903|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
163204840|NCT03919799|589461904|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
163204841|NCT03919799|589461905|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
163204842|NCT03919799|589461906|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
163204843|NCT02142959|589461907|FG000|Overall Study|Adverse Event|1|||
163204844|NCT02142959|589461908|FG001|Overall Study|Adverse Event|0|||
163204845|NCT02142959|589461909|FG002|Overall Study|Adverse Event|0|||
163313229|NCT01369355|589859352|FG002|Long-term Extension (Week 44-272)|Other|0|||
163313230|NCT01369355|589859353|FG003|Long-term Extension (Week 44-272)|Other|0|||
163313231|NCT01369355|589859354|FG004|Long-term Extension (Week 44-272)|Other|0|||
163313232|NCT01369355|589859355|FG005|Long-term Extension (Week 44-272)|Other|0|||
163313233|NCT01369355|589859356|FG006|Long-term Extension (Week 44-272)|Other|110|||
163313234|NCT01369355|589859357|FG007|Long-term Extension (Week 44-272)|Other|9|||
162965506|NCT03868631|588573326|FG000|Baseline to Week 6|Adverse Event|0|||
162965507|NCT03868631|588573327|FG001|Baseline to Week 6|Adverse Event|3|||
162965508|NCT03868631|588573326|FG000|Baseline to Week 6|Protocol Violation|1|||
162965509|NCT03868631|588573327|FG001|Baseline to Week 6|Protocol Violation|1|||
162965510|NCT03868631|588573326|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
162965511|NCT03868631|588573327|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
162965512|NCT03868631|588573326|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
162965513|NCT03868631|588573327|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
162965514|NCT03868631|588573326|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
162965515|NCT03868631|588573327|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
162965516|NCT03868631|588573326|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
162965517|NCT03868631|588573327|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
162965518|NCT03867760|588573328|FG000|Overall Study|Lost to Follow-up|2|||
162965519|NCT03867760|588573329|FG001|Overall Study|Lost to Follow-up|3|||
162965520|NCT03867760|588573328|FG000|Overall Study|Withdrawal by Subject|1|||
162965521|NCT03867760|588573329|FG001|Overall Study|Withdrawal by Subject|2|||
162965522|NCT03867760|588573328|FG000|Overall Study|subject could not meet study logistics|3|||
162965523|NCT03867760|588573329|FG001|Overall Study|subject could not meet study logistics|3|||
162965524|NCT01717040|588573331|FG000|Overall Study|Lost to Follow-up|2|||
162965525|NCT01717040|588573332|FG001|Overall Study|Lost to Follow-up|3|||
162965526|NCT01717040|588573331|FG000|Overall Study|Lack of Efficacy|1|||
162965527|NCT01717040|588573332|FG001|Overall Study|Lack of Efficacy|1|||
162965528|NCT01717040|588573331|FG000|Overall Study|Adverse Event|1|||
162965529|NCT01717040|588573332|FG001|Overall Study|Adverse Event|0|||
162965530|NCT01717040|588573331|FG000|Overall Study|Required Medication Change|0|||
162965531|NCT01717040|588573332|FG001|Overall Study|Required Medication Change|1|||
162965532|NCT01717040|588573331|FG000|Overall Study|New Substance Use Disorder|1|||
162965533|NCT01717040|588573332|FG001|Overall Study|New Substance Use Disorder|0|||
162965534|NCT04236596|588573333|FG000|Overall Study|Withdrawal by Subject|1|||
162965535|NCT04236596|588573333|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
162965536|NCT04236596|588573333|FG000|Overall Study|Participants did not receive implant at all|4|||
162965537|NCT02588339|588573335|FG000|Overall Study|Withdrawal by Subject|1|||
162965538|NCT02588339|588573335|FG000|Overall Study|GVHD Progression prior to treatment|2|||
162965539|NCT02966340|588574552|FG000|Overall Study|Adverse Event|0|||
162965540|NCT02966340|588574553|FG001|Overall Study|Adverse Event|1|||
162965541|NCT02966340|588574552|FG000|Overall Study|Lost to Follow-up|0|||
162965542|NCT02966340|588574553|FG001|Overall Study|Lost to Follow-up|1|||
162965543|NCT02966340|588574552|FG000|Overall Study|Withdrawal by Subject|1|||
162965544|NCT02966340|588574553|FG001|Overall Study|Withdrawal by Subject|0|||
162965545|NCT02966340|588574552|FG000|Overall Study|data acquisition error|1|||
162965546|NCT02966340|588574553|FG001|Overall Study|data acquisition error|0|||
162965547|NCT02966340|588574552|FG000|Overall Study|startle non-responder|1|||
162965548|NCT02966340|588574553|FG001|Overall Study|startle non-responder|1|||
162965549|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
162965550|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
162965551|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
162965552|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
162965553|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
162965554|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
162965555|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
162965556|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
162965557|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
162965558|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
162965559|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
163204846|NCT02142959|589461907|FG000|Overall Study|Death|0|||
163204847|NCT02142959|589461908|FG001|Overall Study|Death|1|||
163204848|NCT02142959|589461909|FG002|Overall Study|Death|0|||
163204849|NCT02142959|589461907|FG000|Overall Study|Withdrawal by Subject|3|||
163204850|NCT02142959|589461908|FG001|Overall Study|Withdrawal by Subject|1|||
163204851|NCT02142959|589461909|FG002|Overall Study|Withdrawal by Subject|3|||
163204852|NCT02142959|589461907|FG000|Overall Study|Administrative Reasons|1|||
163204853|NCT02142959|589461908|FG001|Overall Study|Administrative Reasons|0|||
163204854|NCT02142959|589461909|FG002|Overall Study|Administrative Reasons|1|||
163204855|NCT02142959|589461907|FG000|Overall Study|Missing|0|||
163204856|NCT02142959|589461908|FG001|Overall Study|Missing|1|||
163204857|NCT02142959|589461909|FG002|Overall Study|Missing|0|||
163204858|NCT02142959|589461907|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
163204859|NCT02142959|589461908|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
163204860|NCT02142959|589461909|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
163204861|NCT02142959|589461907|FG000|Overall Study|Patient didn't complete end of study visit|0|||
163204862|NCT02142959|589461908|FG001|Overall Study|Patient didn't complete end of study visit|0|||
163204863|NCT02142959|589461909|FG002|Overall Study|Patient didn't complete end of study visit|1|||
163204864|NCT03547687|589461912|FG000|Overall Study|Withdrawal by Subject|1|||
163204865|NCT03547687|589461912|FG000|Overall Study|Death|1|||
163204866|NCT00646776|589461913|FG000|Overall Study|Adverse Event|1|||
163204867|NCT00646776|589461914|FG001|Overall Study|Adverse Event|9|||
163204868|NCT00646776|589461913|FG000|Overall Study|Investigator discretion|0|||
163204869|NCT00646776|589461914|FG001|Overall Study|Investigator discretion|4|||
163204870|NCT01753856|589461919|FG000|Overall Study|Adverse Event|1|||
163204871|NCT01753856|589461920|FG001|Overall Study|Adverse Event|0|||
163204872|NCT01753856|589461919|FG000|Overall Study|Withdrawal by Subject|0|||
163204873|NCT01753856|589461920|FG001|Overall Study|Withdrawal by Subject|2|||
163204874|NCT01753856|589461919|FG000|Overall Study|Sponsor Decision|2|||
163204875|NCT01753856|589461920|FG001|Overall Study|Sponsor Decision|0|||
163204876|NCT05980182|589461921|FG000|Overall Study|Lost to Follow-up|10|||
163204877|NCT04419714|589461929|FG000|Overall Study|Technical Fault|5|||
163204878|NCT04419714|589461929|FG000|Overall Study|Protocol Deviation|2|||
163204879|NCT04419714|589461929|FG000|Overall Study|Withdrawal by Subject|1|||
163204880|NCT04023526|589463461|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
163204881|NCT04023526|589463462|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
163204882|NCT04023526|589463461|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
163204883|NCT04023526|589463462|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
163204884|NCT01955733|589463463|FG000|Period 1|Lost to Follow-up|1|||
163204885|NCT01955733|589463464|FG001|Period 1|Lost to Follow-up|0|||
163204886|NCT01955733|589463465|FG002|Period 1|Lost to Follow-up|0|||
163204887|NCT01955733|589463463|FG000|Period 2|Adverse Event|1|||
163204888|NCT01955733|589463464|FG001|Period 2|Adverse Event|0|||
163204889|NCT01955733|589463465|FG002|Period 2|Adverse Event|0|||
163204890|NCT01955733|589463463|FG000|Period 2|Physician Decision|0|||
163204891|NCT01955733|589463464|FG001|Period 2|Physician Decision|0|||
163204892|NCT01955733|589463465|FG002|Period 2|Physician Decision|1|||
163204893|NCT01955733|589463463|FG000|Period 2|Withdrawal by Subject|1|||
163204894|NCT01955733|589463464|FG001|Period 2|Withdrawal by Subject|3|||
163204895|NCT01955733|589463465|FG002|Period 2|Withdrawal by Subject|2|||
163204896|NCT01955733|589463463|FG000|Period 2|Study terminated by sponsor|8|||
163204897|NCT01955733|589463464|FG001|Period 2|Study terminated by sponsor|14|||
163204898|NCT01955733|589463465|FG002|Period 2|Study terminated by sponsor|16|||
163204899|NCT01955733|589463463|FG000|Period 2|Lost to Follow-up|2|||
163204900|NCT01955733|589463464|FG001|Period 2|Lost to Follow-up|0|||
163204901|NCT01955733|589463465|FG002|Period 2|Lost to Follow-up|0|||
163204902|NCT01955733|589463463|FG000|Period 2|Other not defined above|0|||
163204903|NCT01955733|589463464|FG001|Period 2|Other not defined above|2|||
163204904|NCT01955733|589463465|FG002|Period 2|Other not defined above|2|||
163204905|NCT02324569|589463475|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
163204906|NCT02324569|589463476|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
163204907|NCT02324569|589463475|FG000|Overall Study|Voluntary Withdrawal|3|||
163204908|NCT02324569|589463476|FG001|Overall Study|Voluntary Withdrawal|6|||
163204909|NCT02324569|589463475|FG000|Overall Study|Lack of Efficacy|2|||
163204910|NCT02324569|589463476|FG001|Overall Study|Lack of Efficacy|3|||
163204911|NCT02324569|589463475|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
163204912|NCT02324569|589463476|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
163204913|NCT02324569|589463475|FG000|Overall Study|Inconvenient Schedule|2|||
163204914|NCT02324569|589463476|FG001|Overall Study|Inconvenient Schedule|0|||
163204915|NCT00793403|589463485|FG000|Overall Study|Other|73|||
163313235|NCT01369355|589859358|FG008|Long-term Extension (Week 44-272)|Other|17|||
163313236|NCT06424236|589859363|FG000|Overall Study|Adverse Event|0|||
163313237|NCT06424236|589859364|FG001|Overall Study|Adverse Event|1|||
163313238|NCT06424236|589859365|FG002|Overall Study|Adverse Event|0|||
163313239|NCT06424236|589859363|FG000|Overall Study|Withdrawal by Subject|3|||
163313240|NCT06424236|589859364|FG001|Overall Study|Withdrawal by Subject|1|||
163313241|NCT06424236|589859365|FG002|Overall Study|Withdrawal by Subject|2|||
163313242|NCT06424236|589859363|FG000|Overall Study|Physician Decision|0|||
163313243|NCT06424236|589859364|FG001|Overall Study|Physician Decision|1|||
163313244|NCT06424236|589859365|FG002|Overall Study|Physician Decision|0|||
163313245|NCT06424236|589859363|FG000|Overall Study|Study Terminated by Sponsor|11|||
163313246|NCT06424236|589859364|FG001|Overall Study|Study Terminated by Sponsor|20|||
163313247|NCT06424236|589859365|FG002|Overall Study|Study Terminated by Sponsor|16|||
163313248|NCT06424236|589859363|FG000|Overall Study|Lost to Follow-up|0|||
163313249|NCT06424236|589859364|FG001|Overall Study|Lost to Follow-up|1|||
163313250|NCT06424236|589859365|FG002|Overall Study|Lost to Follow-up|0|||
163313251|NCT06424236|589859363|FG000|Overall Study|Disease Progression|0|||
163313252|NCT06424236|589859364|FG001|Overall Study|Disease Progression|1|||
163313253|NCT06424236|589859365|FG002|Overall Study|Disease Progression|2|||
163313254|NCT06424236|589859363|FG000|Overall Study|Other|0|||
163313255|NCT06424236|589859364|FG001|Overall Study|Other|0|||
163313256|NCT06424236|589859365|FG002|Overall Study|Other|1|||
163313257|NCT03339713|589859367|FG000|Overall Study|Lost to Follow-up|2|||
163313258|NCT03339713|589859368|FG001|Overall Study|Lost to Follow-up|1|||
163313259|NCT03339713|589859367|FG000|Overall Study|Protocol Violation|1|||
163313260|NCT03339713|589859368|FG001|Overall Study|Protocol Violation|0|||
163313261|NCT03339713|589859367|FG000|Overall Study|Withdrawal by Subject|1|||
163313262|NCT03339713|589859368|FG001|Overall Study|Withdrawal by Subject|1|||
163313263|NCT01959425|589859371|FG000|Overall Study|Withdrawal by Subject|5|||
163313264|NCT01959425|589859372|FG001|Overall Study|Withdrawal by Subject|4|||
163313265|NCT01959425|589859371|FG000|Overall Study|Lost to Follow-up|1|||
163313266|NCT01959425|589859372|FG001|Overall Study|Lost to Follow-up|0|||
163313267|NCT01959425|589859371|FG000|Overall Study|Discontinued Subjects|6|||
163313268|NCT01959425|589859372|FG001|Overall Study|Discontinued Subjects|4|||
163313269|NCT01987895|589859374|FG000|Overall Study|Withdrawal by Subject|12|||
163313270|NCT01987895|589859375|FG001|Overall Study|Withdrawal by Subject|7|||
163313271|NCT01987895|589859374|FG000|Overall Study|Physician Decision|8|||
163313272|NCT01987895|589859375|FG001|Overall Study|Physician Decision|10|||
163313273|NCT01987895|589859374|FG000|Overall Study|Death|7|||
163313274|NCT01987895|589859375|FG001|Overall Study|Death|7|||
163313275|NCT01987895|589859374|FG000|Overall Study|Lost to Follow-up|3|||
163313276|NCT01987895|589859375|FG001|Overall Study|Lost to Follow-up|5|||
163313277|NCT01987895|589859374|FG000|Overall Study|randomized before giving IC|0|||
163052309|NCT01211145|588901001|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
163313278|NCT01987895|589859375|FG001|Overall Study|randomized before giving IC|1|||
163313279|NCT02979327|589859376|FG000|First Intervention|Protocol Violation|1|||
163313280|NCT02979327|589859377|FG001|First Intervention|Protocol Violation|0|||
163313281|NCT03628924|589859379|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
163313282|NCT03628924|589859380|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
163313283|NCT03628924|589859381|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
163313284|NCT03628924|589859382|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
163313285|NCT03628924|589859383|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
162965560|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
162965561|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
162965562|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
162965563|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
162965564|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
162965565|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
162965566|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
162965567|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
162965568|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
162965569|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
162965570|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
162965571|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
162965572|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
162965573|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
162965574|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
162965575|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
162965576|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
162965577|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
162965578|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
162965579|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
162965580|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
162965581|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
162965582|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
162965583|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
162965584|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
162965585|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
162965586|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
162965587|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
162965588|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
162965589|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
162965590|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
162965591|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
163204916|NCT02961751|589463494|FG000|Overall Study|Lost to Follow-up|11|||
163204917|NCT02961751|589463494|FG000|Overall Study|Physician Decision|2|||
163204918|NCT02961751|589463494|FG000|Overall Study|Not Eligible at Enrollment|1|||
163204919|NCT02961751|589463494|FG000|Overall Study|Protocol Violation|1|||
163204920|NCT00842712|589463495|FG000|Safety Run-in Part|Adverse Event|0|||
163204921|NCT00842712|589463496|FG001|Safety Run-in Part|Adverse Event|1|||
163204922|NCT00842712|589463497|FG002|Safety Run-in Part|Adverse Event|0|||
163204923|NCT00842712|589463498|FG003|Safety Run-in Part|Adverse Event|0|||
163204924|NCT00842712|589463499|FG004|Safety Run-in Part|Adverse Event|0|||
163204925|NCT00842712|589463500|FG005|Safety Run-in Part|Adverse Event|0|||
163204926|NCT00842712|589463501|FG006|Safety Run-in Part|Adverse Event|0|||
163204927|NCT00842712|589463495|FG000|Safety Run-in Part|Progressive disease|3|||
163204928|NCT00842712|589463496|FG001|Safety Run-in Part|Progressive disease|1|||
163204929|NCT00842712|589463497|FG002|Safety Run-in Part|Progressive disease|0|||
163204930|NCT00842712|589463498|FG003|Safety Run-in Part|Progressive disease|1|||
163204931|NCT00842712|589463499|FG004|Safety Run-in Part|Progressive disease|0|||
163204932|NCT00842712|589463500|FG005|Safety Run-in Part|Progressive disease|0|||
163204933|NCT00842712|589463501|FG006|Safety Run-in Part|Progressive disease|0|||
163204934|NCT00842712|589463495|FG000|Randomized Part|Randomized but not treated|0|||
163204935|NCT00842712|589463496|FG001|Randomized Part|Randomized but not treated|0|||
163204936|NCT00842712|589463497|FG002|Randomized Part|Randomized but not treated|0|||
163204937|NCT00842712|589463498|FG003|Randomized Part|Randomized but not treated|0|||
163204938|NCT00842712|589463499|FG004|Randomized Part|Randomized but not treated|0|||
163204939|NCT00842712|589463500|FG005|Randomized Part|Randomized but not treated|1|||
163204940|NCT00842712|589463501|FG006|Randomized Part|Randomized but not treated|4|||
163204941|NCT00842712|589463495|FG000|Randomized Part|Ongoing at cut-off date|0|||
163204942|NCT00842712|589463496|FG001|Randomized Part|Ongoing at cut-off date|0|||
163204943|NCT00842712|589463497|FG002|Randomized Part|Ongoing at cut-off date|0|||
163204944|NCT00842712|589463498|FG003|Randomized Part|Ongoing at cut-off date|0|||
163204945|NCT00842712|589463499|FG004|Randomized Part|Ongoing at cut-off date|0|||
163204946|NCT00842712|589463500|FG005|Randomized Part|Ongoing at cut-off date|0|||
163204947|NCT00842712|589463501|FG006|Randomized Part|Ongoing at cut-off date|2|||
163204948|NCT01384760|589463508|FG000|Overall Study|Lost to Follow-up|0|||
163204949|NCT01384760|589463509|FG001|Overall Study|Lost to Follow-up|6|||
163204950|NCT01384760|589463508|FG000|Overall Study|Protocol Violation|16|||
163204951|NCT01384760|589463509|FG001|Overall Study|Protocol Violation|0|||
163204952|NCT00309387|589463520|FG000|Overall Study|Death|72|||
163204953|NCT00309387|589463521|FG001|Overall Study|Death|73|||
163204954|NCT00309387|589463520|FG000|Overall Study|Lost to Follow-up|70|||
163204955|NCT00309387|589463521|FG001|Overall Study|Lost to Follow-up|86|||
163204956|NCT02899988|589463524|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
163204957|NCT02899988|589463525|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
163052310|NCT01211145|588900998|FG000|Overall Study|Patient decision|2|||
163052311|NCT01211145|588900999|FG001|Overall Study|Patient decision|1|||
163052312|NCT01211145|588901000|FG002|Overall Study|Patient decision|0|||
163052313|NCT01211145|588901001|FG003|Overall Study|Patient decision|2|||
163052314|NCT00249834|588901004|FG000|Overall Study|Ovarian stimulation failed|1|||
163052315|NCT00249834|588901005|FG001|Overall Study|Ovarian stimulation failed|0|||
163052316|NCT00249834|588901006|FG002|Overall Study|Ovarian stimulation failed|0|||
163052317|NCT00249834|588901007|FG003|Overall Study|Ovarian stimulation failed|0|||
163052318|NCT00249834|588901008|FG004|Overall Study|Ovarian stimulation failed|0|||
163052319|NCT00249834|588901009|FG005|Overall Study|Ovarian stimulation failed|0|||
163052320|NCT00249834|588901010|FG006|Overall Study|Ovarian stimulation failed|0|||
163204958|NCT02899988|589463526|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163204959|NCT02899988|589463527|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163204960|NCT02899988|589463528|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163204961|NCT02899988|589463529|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163204962|NCT02899988|589463530|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163204963|NCT02899988|589463531|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163204964|NCT02899988|589463532|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163052321|NCT00249834|588901011|FG007|Overall Study|Ovarian stimulation failed|0|||
163052322|NCT00249834|588901004|FG000|Overall Study|Failure of down-regulation|0|||
163052323|NCT00249834|588901005|FG001|Overall Study|Failure of down-regulation|0|||
163052324|NCT00249834|588901006|FG002|Overall Study|Failure of down-regulation|0|||
163052325|NCT00249834|588901007|FG003|Overall Study|Failure of down-regulation|0|||
163052326|NCT00249834|588901008|FG004|Overall Study|Failure of down-regulation|0|||
163052327|NCT00249834|588901009|FG005|Overall Study|Failure of down-regulation|0|||
163052328|NCT00249834|588901010|FG006|Overall Study|Failure of down-regulation|1|||
163052329|NCT00249834|588901011|FG007|Overall Study|Failure of down-regulation|0|||
163052330|NCT00249834|588901004|FG000|Overall Study|Protocol Violation|0|||
163052331|NCT00249834|588901005|FG001|Overall Study|Protocol Violation|19|||
163052332|NCT00249834|588901006|FG002|Overall Study|Protocol Violation|14|||
163052333|NCT00249834|588901007|FG003|Overall Study|Protocol Violation|8|||
163052334|NCT00249834|588901008|FG004|Overall Study|Protocol Violation|5|||
163052335|NCT00249834|588901009|FG005|Overall Study|Protocol Violation|2|||
163052336|NCT00249834|588901010|FG006|Overall Study|Protocol Violation|0|||
163052337|NCT00249834|588901011|FG007|Overall Study|Protocol Violation|0|||
163052338|NCT02688933|588901014|FG000|Overall Study|Adverse Event|3|||
163052339|NCT02688933|588901015|FG001|Overall Study|Adverse Event|1|||
163052340|NCT02688933|588901014|FG000|Overall Study|Lack of Efficacy|2|||
163052341|NCT02688933|588901015|FG001|Overall Study|Lack of Efficacy|2|||
163052342|NCT02688933|588901014|FG000|Overall Study|Poor compliance to protocol|7|||
163052343|NCT02688933|588901015|FG001|Overall Study|Poor compliance to protocol|4|||
163052344|NCT02688933|588901014|FG000|Overall Study|Hypoglycemia|2|||
163052345|NCT02688933|588901015|FG001|Overall Study|Hypoglycemia|0|||
163052346|NCT02688933|588901014|FG000|Overall Study|Other than Specified|14|||
163052347|NCT02688933|588901015|FG001|Overall Study|Other than Specified|25|||
163052348|NCT02688933|588901014|FG000|Overall Study|Lost to Follow-up|1|||
163052349|NCT02688933|588901015|FG001|Overall Study|Lost to Follow-up|5|||
163052350|NCT03509467|588901018|FG000|Overall Study|Withdrawal by Subject|5|||
163052351|NCT03509467|588901019|FG001|Overall Study|Withdrawal by Subject|1|||
163052352|NCT03509467|588901020|FG002|Overall Study|Withdrawal by Subject|6|||
163052353|NCT03509467|588901021|FG003|Overall Study|Withdrawal by Subject|7|||
163052354|NCT03509467|588901022|FG004|Overall Study|Withdrawal by Subject|10|||
163052355|NCT03509467|588901023|FG005|Overall Study|Withdrawal by Subject|10|||
163052356|NCT03509467|588901024|FG006|Overall Study|Withdrawal by Subject|10|||
163052357|NCT03509467|588901025|FG007|Overall Study|Withdrawal by Subject|10|||
163052358|NCT03509467|588901018|FG000|Overall Study|Death|0|||
163313286|NCT03628924|589859384|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
163313287|NCT03628924|589859385|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
163313288|NCT03628924|589859379|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163313289|NCT03628924|589859380|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163313290|NCT03628924|589859381|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
163313291|NCT03628924|589859382|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163313292|NCT03628924|589859383|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163313293|NCT03628924|589859384|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163313294|NCT03628924|589859385|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163313295|NCT03628924|589859379|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
163313296|NCT03628924|589859380|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
163313297|NCT03628924|589859381|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
163313298|NCT03628924|589859382|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
163313299|NCT03628924|589859383|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
163313300|NCT03628924|589859384|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
163313301|NCT03628924|589859385|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
163313302|NCT03628924|589859379|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163313303|NCT03628924|589859380|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
163313304|NCT03628924|589859381|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163313305|NCT03628924|589859382|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163313306|NCT03628924|589859383|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163313307|NCT03628924|589859384|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163052359|NCT03509467|588901019|FG001|Overall Study|Death|0|||
163052360|NCT03509467|588901020|FG002|Overall Study|Death|2|||
163052361|NCT03509467|588901021|FG003|Overall Study|Death|2|||
163052362|NCT03509467|588901022|FG004|Overall Study|Death|1|||
163204965|NCT02899988|589463533|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163204966|NCT02899988|589463534|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163204967|NCT02899988|589463524|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
163052363|NCT03509467|588901023|FG005|Overall Study|Death|0|||
163204968|NCT02899988|589463525|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
163204969|NCT02899988|589463526|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
163052364|NCT03509467|588901024|FG006|Overall Study|Death|1|||
163204970|NCT02899988|589463527|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
163204971|NCT02899988|589463528|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
163204972|NCT02899988|589463529|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
163204973|NCT02899988|589463530|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
163204974|NCT02899988|589463531|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
163204975|NCT02899988|589463532|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
163204976|NCT02899988|589463533|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
163204977|NCT02899988|589463534|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
163204978|NCT02899988|589463524|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
163204979|NCT02899988|589463525|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
163204980|NCT02899988|589463526|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
163204981|NCT02899988|589463527|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
163313308|NCT03628924|589859385|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163313309|NCT03628924|589859379|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
163313310|NCT03628924|589859380|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
163313311|NCT03628924|589859381|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
163313312|NCT03628924|589859382|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
163313313|NCT03628924|589859383|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
163204982|NCT02899988|589463528|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
163204983|NCT02899988|589463529|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
163204984|NCT02899988|589463530|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
163204985|NCT02899988|589463531|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
163204986|NCT02899988|589463532|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
163204987|NCT02899988|589463533|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
163204988|NCT02899988|589463534|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
163204989|NCT02899988|589463524|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
163204990|NCT02899988|589463525|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
163204991|NCT02899988|589463526|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
163204992|NCT02899988|589463527|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
163204993|NCT02899988|589463528|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
163204994|NCT02899988|589463529|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
163204995|NCT02899988|589463530|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
163204996|NCT02899988|589463531|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
163204997|NCT02899988|589463532|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
163204998|NCT02899988|589463533|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
163204999|NCT02899988|589463534|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
163205000|NCT02899988|589463524|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
163205001|NCT02899988|589463525|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
163205002|NCT02899988|589463526|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
163205003|NCT02899988|589463527|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
163205004|NCT02899988|589463528|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
163205005|NCT02899988|589463529|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
163205006|NCT02899988|589463530|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
163205007|NCT02899988|589463531|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
163205008|NCT02899988|589463532|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
163205009|NCT02899988|589463533|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
163205010|NCT02899988|589463534|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
163205011|NCT02899988|589463524|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
163205012|NCT02899988|589463525|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
163205013|NCT02899988|589463526|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
163205014|NCT02899988|589463527|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
163205015|NCT02899988|589463528|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
163205016|NCT02899988|589463529|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
163205017|NCT02899988|589463530|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
163205018|NCT02899988|589463531|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
163205019|NCT02899988|589463532|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
163205020|NCT02899988|589463533|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
163205021|NCT02899988|589463534|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
163205022|NCT02041286|589463535|FG000|Overall Study|Adverse Event|1|||
163205023|NCT03138889|589463543|FG000|Overall Study|Withdrawal by Subject|5|||
163205024|NCT03138889|589463544|FG001|Overall Study|Withdrawal by Subject|5|||
163205025|NCT03138889|589463545|FG002|Overall Study|Withdrawal by Subject|0|||
163205026|NCT03138889|589463546|FG003|Overall Study|Withdrawal by Subject|2|||
163205027|NCT03138889|589463547|FG004|Overall Study|Withdrawal by Subject|1|||
163205028|NCT03138889|589463548|FG005|Overall Study|Withdrawal by Subject|3|||
163205029|NCT03138889|589463549|FG006|Overall Study|Withdrawal by Subject|0|||
163205030|NCT03138889|589463550|FG007|Overall Study|Withdrawal by Subject|1|||
163205031|NCT00085631|589463551|FG000|Overall Study|Missing Data|4|||
163205032|NCT00085631|589463552|FG001|Overall Study|Missing Data|11|||
163205033|NCT00085631|589463553|FG002|Overall Study|Missing Data|7|||
163205034|NCT00411645|589463554|FG000|Overall Study|Consent Withdrawn|13|||
163205035|NCT00411645|589463555|FG001|Overall Study|Consent Withdrawn|22|||
163205036|NCT00411645|589463554|FG000|Overall Study|Death|56|||
163205037|NCT00411645|589463555|FG001|Overall Study|Death|135|||
163205038|NCT00411645|589463554|FG000|Overall Study|Investigator/Sponsor Decision|10|||
163205039|NCT00411645|589463555|FG001|Overall Study|Investigator/Sponsor Decision|7|||
163205040|NCT00411645|589463554|FG000|Overall Study|Lost to Follow-up|2|||
163205041|NCT00411645|589463555|FG001|Overall Study|Lost to Follow-up|0|||
163205042|NCT01349790|589463556|FG000|Overall Study|Investigator Judgement|3|||
163205043|NCT01349790|589463556|FG000|Overall Study|Death|2|||
163205044|NCT01349790|589463556|FG000|Overall Study|Withdrawal by Patient|2|||
163205045|NCT01349790|589463556|FG000|Overall Study|Adverse Event|1|||
163205046|NCT01349790|589463556|FG000|Overall Study|Lost to Follow-up|1|||
163205047|NCT02289690|589463557|FG000|Overall Study|Adverse Event Related to Progression|0|||
163205048|NCT02289690|589463558|FG001|Overall Study|Adverse Event Related to Progression|1|||
163205049|NCT02289690|589463559|FG002|Overall Study|Adverse Event Related to Progression|1|||
163205050|NCT02289690|589463560|FG003|Overall Study|Adverse Event Related to Progression|0|||
163205051|NCT02289690|589463561|FG004|Overall Study|Adverse Event Related to Progression|1|||
163205052|NCT02289690|589463562|FG005|Overall Study|Adverse Event Related to Progression|0|||
163205053|NCT02289690|589463563|FG006|Overall Study|Adverse Event Related to Progression|1|||
163205054|NCT02289690|589463564|FG007|Overall Study|Adverse Event Related to Progression|0|||
163205055|NCT02289690|589463565|FG008|Overall Study|Adverse Event Related to Progression|0|||
163205056|NCT02289690|589463566|FG009|Overall Study|Adverse Event Related to Progression|0|||
163205057|NCT02289690|589463557|FG000|Overall Study|Withdrawal by Subject|1|||
163205058|NCT02289690|589463558|FG001|Overall Study|Withdrawal by Subject|0|||
162965592|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
162965593|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
162965594|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
162965595|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
162965596|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
162965597|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
162965598|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
162965599|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
162965600|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
162965601|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
162965602|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
162965603|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
162965604|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
162965605|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
162965606|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
162965607|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
162965608|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
162965609|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
162965610|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
162965611|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
162965612|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
162965613|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
162965614|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
162965615|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Death|0|||
162965616|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Death|0|||
162965617|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Death|0|||
162965618|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Death|0|||
162965619|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Death|1|||
162965620|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Death|4|||
162965621|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
162965622|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
162965623|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
162965624|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
162965625|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
162965626|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
162965627|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
162965628|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
162965629|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
162965630|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
162965631|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
162965632|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
162965633|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
162965634|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
162965635|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
162965636|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
162965637|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
162965638|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
163052365|NCT03509467|588901025|FG007|Overall Study|Death|0|||
163205059|NCT02289690|589463559|FG002|Overall Study|Withdrawal by Subject|0|||
163205060|NCT02289690|589463560|FG003|Overall Study|Withdrawal by Subject|0|||
163205061|NCT02289690|589463561|FG004|Overall Study|Withdrawal by Subject|1|||
162965639|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
162965640|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
162965641|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
162965642|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
162965643|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
162965644|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
162965645|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
162965646|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
162965647|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
162965648|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
162965649|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
162965650|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
162965651|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
162965652|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
162965653|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
162965654|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
162965655|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
162965656|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
162965657|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Other|0|||
162965658|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Other|0|||
162965659|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Other|0|||
162965660|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Other|0|||
162965661|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Other|3|||
162965662|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Other|3|||
162965663|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
162965664|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
162965665|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
162965666|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
162965667|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
162965668|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
162965669|NCT02308241|588574565|FG000|Overall Study|Withdrawal by Subject|3|||
162965670|NCT03609944|588574566|FG000|Overall Study|Lost to Follow-up|1|||
162965671|NCT03609944|588574567|FG001|Overall Study|Lost to Follow-up|5|||
162965672|NCT03609944|588574566|FG000|Overall Study|Withdrawal by Subject|1|||
162965673|NCT03609944|588574567|FG001|Overall Study|Withdrawal by Subject|1|||
162965674|NCT00659815|588574568|FG000|Overall Study|Study related symptoms and complaints|2|||
163205062|NCT02289690|589463562|FG005|Overall Study|Withdrawal by Subject|1|||
162965675|NCT00659815|588574569|FG001|Overall Study|Study related symptoms and complaints|1|||
162965676|NCT00659815|588574568|FG000|Overall Study|Inability to maintain wearing schedule|1|||
163205063|NCT02289690|589463563|FG006|Overall Study|Withdrawal by Subject|0|||
163205064|NCT02289690|589463564|FG007|Overall Study|Withdrawal by Subject|0|||
163205065|NCT02289690|589463565|FG008|Overall Study|Withdrawal by Subject|4|||
163205066|NCT02289690|589463566|FG009|Overall Study|Withdrawal by Subject|2|||
163205067|NCT02289690|589463557|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
163205068|NCT02289690|589463558|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
163205069|NCT02289690|589463559|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
163313314|NCT03628924|589859384|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
163313315|NCT03628924|589859385|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
163313316|NCT03628924|589859379|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
163313317|NCT03628924|589859380|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
163313318|NCT03628924|589859381|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
163313319|NCT03628924|589859382|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
163313320|NCT03628924|589859383|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
163313321|NCT03628924|589859384|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
163313322|NCT03628924|589859385|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
163313323|NCT03628924|589859379|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
163313324|NCT03628924|589859380|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
163313325|NCT03628924|589859381|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
163313326|NCT03628924|589859382|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
163313327|NCT03628924|589859383|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
163313328|NCT03628924|589859384|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
163313329|NCT03628924|589859385|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
163313330|NCT03628924|589859379|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
163313331|NCT03628924|589859380|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
163313332|NCT03628924|589859381|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
163313333|NCT03628924|589859382|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
163313334|NCT03628924|589859383|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
163313335|NCT03628924|589859384|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
163313336|NCT03628924|589859385|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
163313337|NCT03628924|589859379|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
163313338|NCT03628924|589859380|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
163205070|NCT02289690|589463560|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
163205071|NCT02289690|589463561|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
163205072|NCT02289690|589463562|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
162965677|NCT00659815|588574569|FG001|Overall Study|Inability to maintain wearing schedule|2|||
162965678|NCT00659815|588574568|FG000|Overall Study|Withdrawal by Subject|1|||
162965679|NCT00659815|588574569|FG001|Overall Study|Withdrawal by Subject|1|||
162965680|NCT02578641|588574570|FG000|Overall Study|Adverse Event|5|||
162965681|NCT02578641|588574571|FG001|Overall Study|Adverse Event|15|||
162965682|NCT02578641|588574570|FG000|Overall Study|Death|16|||
162965683|NCT02578641|588574571|FG001|Overall Study|Death|8|||
162965684|NCT02578641|588574570|FG000|Overall Study|Lost to Follow-up|0|||
163205073|NCT02289690|589463563|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
163205074|NCT02289690|589463564|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
163205075|NCT02289690|589463565|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
163205076|NCT02289690|589463566|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
163205077|NCT02289690|589463557|FG000|Overall Study|Lost to Follow-up|0|||
163205078|NCT02289690|589463558|FG001|Overall Study|Lost to Follow-up|0|||
163205079|NCT02289690|589463559|FG002|Overall Study|Lost to Follow-up|0|||
163205080|NCT02289690|589463560|FG003|Overall Study|Lost to Follow-up|0|||
163205081|NCT02289690|589463561|FG004|Overall Study|Lost to Follow-up|0|||
163205082|NCT02289690|589463562|FG005|Overall Study|Lost to Follow-up|0|||
163205083|NCT02289690|589463563|FG006|Overall Study|Lost to Follow-up|0|||
163205084|NCT02289690|589463564|FG007|Overall Study|Lost to Follow-up|1|||
163205085|NCT02289690|589463565|FG008|Overall Study|Lost to Follow-up|0|||
163205086|NCT02289690|589463566|FG009|Overall Study|Lost to Follow-up|2|||
163205087|NCT02289690|589463557|FG000|Overall Study|Death|0|||
163205088|NCT02289690|589463558|FG001|Overall Study|Death|0|||
163205089|NCT02289690|589463559|FG002|Overall Study|Death|0|||
163205090|NCT02289690|589463560|FG003|Overall Study|Death|0|||
163205091|NCT02289690|589463561|FG004|Overall Study|Death|0|||
163205092|NCT02289690|589463562|FG005|Overall Study|Death|0|||
163205093|NCT02289690|589463563|FG006|Overall Study|Death|0|||
163313339|NCT03628924|589859381|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
163313340|NCT03628924|589859382|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
163313341|NCT03628924|589859383|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
163313342|NCT03628924|589859384|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
163313343|NCT03628924|589859385|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
163313344|NCT03628924|589859379|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
163313345|NCT03628924|589859380|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
163313346|NCT03628924|589859381|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
163313347|NCT03628924|589859382|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
163313348|NCT03628924|589859383|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
163313349|NCT03628924|589859384|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
163313350|NCT03628924|589859385|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
163313351|NCT05499377|589859392|FG000|Overall Study|Withdrawal by Subject|2|||
163313352|NCT05499377|589859393|FG001|Overall Study|Withdrawal by Subject|0|||
163313353|NCT05499377|589859392|FG000|Overall Study|Physician Decision|1|||
163313354|NCT05499377|589859393|FG001|Overall Study|Physician Decision|0|||
163313355|NCT03544281|589859396|FG000|Main Study Phase|Death|3|||
163313356|NCT03544281|589859397|FG001|Main Study Phase|Death|2|||
163313357|NCT03544281|589859398|FG002|Main Study Phase|Death|6|||
163313358|NCT03544281|589859399|FG003|Main Study Phase|Death|8|||
163313359|NCT03544281|589859400|FG004|Main Study Phase|Death|4|||
163313360|NCT03544281|589859401|FG005|Main Study Phase|Death|2|||
163313361|NCT03544281|589859402|FG006|Main Study Phase|Death|4|||
163313362|NCT03544281|589859403|FG007|Main Study Phase|Death|5|||
163313363|NCT03544281|589859404|FG008|Main Study Phase|Death|5|||
163313364|NCT03544281|589859405|FG009|Main Study Phase|Death|8|||
163313365|NCT03544281|589859406|FG010|Main Study Phase|Death|6|||
163313366|NCT03544281|589859407|FG011|Main Study Phase|Death|4|||
163205094|NCT02289690|589463564|FG007|Overall Study|Death|49|||
163205095|NCT02289690|589463565|FG008|Overall Study|Death|45|||
163205096|NCT02289690|589463566|FG009|Overall Study|Death|41|||
163205097|NCT02289690|589463557|FG000|Overall Study|Sponsor Discontinued Study|0|||
163313367|NCT03544281|589859408|FG012|Main Study Phase|Death|0|||
163313368|NCT03544281|589859409|FG013|Main Study Phase|Death|0|||
163205098|NCT02289690|589463558|FG001|Overall Study|Sponsor Discontinued Study|0|||
163205099|NCT02289690|589463559|FG002|Overall Study|Sponsor Discontinued Study|0|||
163205100|NCT02289690|589463560|FG003|Overall Study|Sponsor Discontinued Study|0|||
163205101|NCT02289690|589463561|FG004|Overall Study|Sponsor Discontinued Study|0|||
163205102|NCT02289690|589463562|FG005|Overall Study|Sponsor Discontinued Study|0|||
163205103|NCT02289690|589463563|FG006|Overall Study|Sponsor Discontinued Study|0|||
163205104|NCT02289690|589463564|FG007|Overall Study|Sponsor Discontinued Study|9|||
163205105|NCT02289690|589463565|FG008|Overall Study|Sponsor Discontinued Study|7|||
163205106|NCT02289690|589463566|FG009|Overall Study|Sponsor Discontinued Study|15|||
163205107|NCT02289690|589463557|FG000|Overall Study|Other|0|||
163205108|NCT02289690|589463558|FG001|Overall Study|Other|0|||
163205109|NCT02289690|589463559|FG002|Overall Study|Other|0|||
163205110|NCT02289690|589463560|FG003|Overall Study|Other|1|||
163205111|NCT02289690|589463561|FG004|Overall Study|Other|1|||
163205112|NCT02289690|589463562|FG005|Overall Study|Other|0|||
163205113|NCT02289690|589463563|FG006|Overall Study|Other|1|||
163205114|NCT02289690|589463564|FG007|Overall Study|Other|2|||
163205115|NCT02289690|589463565|FG008|Overall Study|Other|3|||
163205116|NCT02289690|589463566|FG009|Overall Study|Other|1|||
163205117|NCT04166435|589463569|FG000|Overall Study|2 patients ineligible for response|2|||
163205118|NCT00299104|589463571|FG000|Treatment Period|Adverse Event|14|||
163205119|NCT00299104|589463572|FG001|Treatment Period|Adverse Event|9|||
163205120|NCT00299104|589463573|FG002|Treatment Period|Adverse Event|7|||
163205121|NCT00299104|589463571|FG000|Treatment Period|Death|1|||
163205122|NCT00299104|589463572|FG001|Treatment Period|Death|1|||
163205123|NCT00299104|589463573|FG002|Treatment Period|Death|1|||
163313369|NCT03544281|589859410|FG014|Main Study Phase|Death|0|||
163313370|NCT03544281|589859411|FG015|Main Study Phase|Death|0|||
163313371|NCT03544281|589859412|FG016|Main Study Phase|Death|0|||
163313372|NCT03544281|589859413|FG017|Main Study Phase|Death|0|||
163313373|NCT03544281|589859414|FG018|Main Study Phase|Death|0|||
163205124|NCT00299104|589463571|FG000|Treatment Period|Insufficient therapeutic response|34|||
163205125|NCT00299104|589463572|FG001|Treatment Period|Insufficient therapeutic response|13|||
163205126|NCT00299104|589463573|FG002|Treatment Period|Insufficient therapeutic response|8|||
163205127|NCT00299104|589463571|FG000|Treatment Period|Failure to return|9|||
163205128|NCT00299104|589463572|FG001|Treatment Period|Failure to return|8|||
163205129|NCT00299104|589463573|FG002|Treatment Period|Failure to return|8|||
163313374|NCT03544281|589859415|FG019|Main Study Phase|Death|0|||
163313375|NCT03544281|589859416|FG020|Main Study Phase|Death|0|||
163313376|NCT03544281|589859417|FG021|Main Study Phase|Death|0|||
163313377|NCT03544281|589859396|FG000|Main Study Phase|Lost to Follow-up|0|||
163313378|NCT03544281|589859397|FG001|Main Study Phase|Lost to Follow-up|0|||
163313379|NCT03544281|589859398|FG002|Main Study Phase|Lost to Follow-up|0|||
163313380|NCT03544281|589859399|FG003|Main Study Phase|Lost to Follow-up|0|||
163052366|NCT03509467|588901018|FG000|Overall Study|Proxy Withdrawal|0|||
163052367|NCT03509467|588901019|FG001|Overall Study|Proxy Withdrawal|0|||
163052368|NCT03509467|588901020|FG002|Overall Study|Proxy Withdrawal|0|||
163052369|NCT03509467|588901021|FG003|Overall Study|Proxy Withdrawal|0|||
163052370|NCT03509467|588901022|FG004|Overall Study|Proxy Withdrawal|0|||
163052371|NCT03509467|588901023|FG005|Overall Study|Proxy Withdrawal|0|||
163052372|NCT03509467|588901024|FG006|Overall Study|Proxy Withdrawal|0|||
163052373|NCT03509467|588901025|FG007|Overall Study|Proxy Withdrawal|1|||
163052374|NCT04275973|588901028|FG000|Overall Study|Withdrawal by Subject|2|||
163052375|NCT04275973|588901029|FG001|Overall Study|Withdrawal by Subject|1|||
163052376|NCT06110754|588901030|FG000|Overall Study|Withdrawal by Subject|0|||
163052377|NCT06110754|588901031|FG001|Overall Study|Withdrawal by Subject|0|||
163052378|NCT06110754|588901032|FG002|Overall Study|Withdrawal by Subject|1|||
163052379|NCT06110754|588901033|FG003|Overall Study|Withdrawal by Subject|0|||
163052380|NCT05502302|588901038|FG000|Overall Study|Lost to Follow-up|6|||
163052381|NCT05502302|588901038|FG000|Overall Study|Death|2|||
163052382|NCT04037358|588901045|FG000|Overall Study|Patient withdrew before intervention|1|||
163052383|NCT04037358|588901046|FG001|Overall Study|Patient withdrew before intervention|0|||
163052384|NCT01949142|588901047|FG000|Overall Study|Withdrawal of consent|1|||
163052385|NCT01949142|588901048|FG001|Overall Study|Withdrawal of consent|0|||
163052386|NCT01949142|588901047|FG000|Overall Study|Lost to Follow-up|1|||
163052387|NCT01949142|588901048|FG001|Overall Study|Lost to Follow-up|1|||
163052388|NCT01949142|588901047|FG000|Overall Study|Parent changed their mind|1|||
163052389|NCT01949142|588901048|FG001|Overall Study|Parent changed their mind|0|||
163052390|NCT00447902|588901054|FG000|Overall Study|Adverse Event|0|||
163052391|NCT00447902|588901055|FG001|Overall Study|Adverse Event|3|||
163052392|NCT00447902|588901054|FG000|Overall Study|Protocol Violation|1|||
163052393|NCT00447902|588901055|FG001|Overall Study|Protocol Violation|0|||
163052394|NCT00447902|588901054|FG000|Overall Study|Withdrawal by Subject|0|||
163052395|NCT00447902|588901055|FG001|Overall Study|Withdrawal by Subject|1|||
163052396|NCT00447902|588901054|FG000|Overall Study|included patients who discontinued|1|||
163052397|NCT00447902|588901055|FG001|Overall Study|included patients who discontinued|1|||
163052398|NCT00447902|588901054|FG000|Overall Study|Lack of Efficacy|2|||
163052399|NCT00447902|588901055|FG001|Overall Study|Lack of Efficacy|1|||
163052400|NCT02873689|588903016|FG000|Overall Study|Lack of Efficacy|1|||
163052401|NCT02873689|588903017|FG001|Overall Study|Lack of Efficacy|0|||
163052402|NCT02873689|588903016|FG000|Overall Study|Withdrawal by Subject|2|||
163052403|NCT02873689|588903017|FG001|Overall Study|Withdrawal by Subject|2|||
163052404|NCT02873689|588903016|FG000|Overall Study|Protocol Violation|1|||
163205130|NCT00299104|589463571|FG000|Treatment Period|Violation of selection criteria|1|||
163205131|NCT00299104|589463572|FG001|Treatment Period|Violation of selection criteria|2|||
163205132|NCT00299104|589463573|FG002|Treatment Period|Violation of selection criteria|0|||
163205133|NCT00299104|589463571|FG000|Treatment Period|Protocol Violation|1|||
163205134|NCT00299104|589463572|FG001|Treatment Period|Protocol Violation|1|||
163205135|NCT00299104|589463573|FG002|Treatment Period|Protocol Violation|0|||
163205136|NCT00299104|589463571|FG000|Treatment Period|Refused treatment|9|||
163205137|NCT00299104|589463572|FG001|Treatment Period|Refused treatment|2|||
163205138|NCT00299104|589463573|FG002|Treatment Period|Refused treatment|2|||
163205139|NCT00299104|589463571|FG000|Treatment Period|Withdrew consent|14|||
163205140|NCT00299104|589463572|FG001|Treatment Period|Withdrew consent|19|||
163205141|NCT00299104|589463573|FG002|Treatment Period|Withdrew consent|9|||
163205142|NCT00299104|589463571|FG000|Treatment Period|Administrative reasons|106|||
163205143|NCT00299104|589463572|FG001|Treatment Period|Administrative reasons|120|||
163205144|NCT00299104|589463573|FG002|Treatment Period|Administrative reasons|137|||
163205145|NCT00299104|589463571|FG000|Safety Follow-Up (SFU) Period|Death|3|||
163205146|NCT00299104|589463572|FG001|Safety Follow-Up (SFU) Period|Death|2|||
163205147|NCT00299104|589463573|FG002|Safety Follow-Up (SFU) Period|Death|1|||
163205148|NCT00299104|589463571|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
163205149|NCT00299104|589463572|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
163205150|NCT00299104|589463573|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
163205151|NCT00299104|589463571|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
163205152|NCT00299104|589463572|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
163205153|NCT00299104|589463573|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
163205154|NCT00299104|589463571|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
163205155|NCT00299104|589463572|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
163205156|NCT00299104|589463573|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
163205157|NCT00299104|589463571|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
163205158|NCT00299104|589463572|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
163205159|NCT00299104|589463573|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
163205160|NCT00299104|589463571|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
163205161|NCT00299104|589463572|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
163205162|NCT00299104|589463573|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
163052405|NCT02873689|588903017|FG001|Overall Study|Protocol Violation|0|||
163052406|NCT02873689|588903016|FG000|Overall Study|Adverse Event|2|||
163052407|NCT02873689|588903017|FG001|Overall Study|Adverse Event|2|||
163052408|NCT02873689|588903016|FG000|Overall Study|Randomized but not Treated|1|||
163205163|NCT00299104|589463571|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
163205164|NCT00299104|589463572|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
163205165|NCT00299104|589463573|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
163205166|NCT00299104|589463571|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
163205167|NCT00299104|589463572|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
163205168|NCT00299104|589463573|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
163205169|NCT00814164|589463576|FG000|Overall Study|Progression|7|||
163205170|NCT00814164|589463576|FG000|Overall Study|not stated|7|||
163205171|NCT00814164|589463576|FG000|Overall Study|Death|5|||
163205172|NCT03167411|589463577|FG000|Overall Study|Adverse Event|0|||
163205173|NCT03167411|589463578|FG001|Overall Study|Adverse Event|1|||
163205174|NCT01053221|589463579|FG000|Overall Study|The study was closed prematurely|5|||
163205175|NCT01053221|589463580|FG001|Overall Study|The study was closed prematurely|9|||
163205176|NCT00420927|589463581|FG000|Period 1|Adverse Event|19|||
163205177|NCT00420927|589463582|FG001|Period 1|Adverse Event|15|||
163205178|NCT00420927|589463583|FG002|Period 1|Adverse Event|0|||
163205179|NCT00420927|589463584|FG003|Period 1|Adverse Event|0|||
163205180|NCT00420927|589463585|FG004|Period 1|Adverse Event|0|||
163205181|NCT00420927|589463586|FG005|Period 1|Adverse Event|0|||
163205182|NCT00420927|589463587|FG006|Period 1|Adverse Event|0|||
163205183|NCT00420927|589463581|FG000|Period 1|Withdrawal by Subject|7|||
163205184|NCT00420927|589463582|FG001|Period 1|Withdrawal by Subject|12|||
163205185|NCT00420927|589463583|FG002|Period 1|Withdrawal by Subject|0|||
163205186|NCT00420927|589463584|FG003|Period 1|Withdrawal by Subject|0|||
163205187|NCT00420927|589463585|FG004|Period 1|Withdrawal by Subject|0|||
163205188|NCT00420927|589463586|FG005|Period 1|Withdrawal by Subject|0|||
163205189|NCT00420927|589463587|FG006|Period 1|Withdrawal by Subject|0|||
163205190|NCT00420927|589463581|FG000|Period 1|Lost to Follow-up|8|||
163205191|NCT00420927|589463582|FG001|Period 1|Lost to Follow-up|6|||
163205192|NCT00420927|589463583|FG002|Period 1|Lost to Follow-up|0|||
163205193|NCT00420927|589463584|FG003|Period 1|Lost to Follow-up|0|||
163052409|NCT02873689|588903017|FG001|Overall Study|Randomized but not Treated|1|||
163205194|NCT00420927|589463585|FG004|Period 1|Lost to Follow-up|0|||
163313381|NCT03544281|589859400|FG004|Main Study Phase|Lost to Follow-up|0|||
163313382|NCT03544281|589859401|FG005|Main Study Phase|Lost to Follow-up|0|||
163313383|NCT03544281|589859402|FG006|Main Study Phase|Lost to Follow-up|0|||
163313384|NCT03544281|589859403|FG007|Main Study Phase|Lost to Follow-up|0|||
163313385|NCT03544281|589859404|FG008|Main Study Phase|Lost to Follow-up|0|||
163313386|NCT03544281|589859405|FG009|Main Study Phase|Lost to Follow-up|0|||
163313387|NCT03544281|589859406|FG010|Main Study Phase|Lost to Follow-up|1|||
163313388|NCT03544281|589859407|FG011|Main Study Phase|Lost to Follow-up|0|||
163313389|NCT03544281|589859408|FG012|Main Study Phase|Lost to Follow-up|0|||
163313390|NCT03544281|589859409|FG013|Main Study Phase|Lost to Follow-up|0|||
163313391|NCT03544281|589859410|FG014|Main Study Phase|Lost to Follow-up|0|||
163313392|NCT03544281|589859411|FG015|Main Study Phase|Lost to Follow-up|0|||
163313393|NCT03544281|589859412|FG016|Main Study Phase|Lost to Follow-up|0|||
163313394|NCT03544281|589859413|FG017|Main Study Phase|Lost to Follow-up|0|||
163313395|NCT03544281|589859414|FG018|Main Study Phase|Lost to Follow-up|0|||
163313396|NCT03544281|589859415|FG019|Main Study Phase|Lost to Follow-up|0|||
163313397|NCT03544281|589859416|FG020|Main Study Phase|Lost to Follow-up|0|||
163313398|NCT03544281|589859417|FG021|Main Study Phase|Lost to Follow-up|0|||
163313399|NCT03544281|589859396|FG000|Main Study Phase|Physician Decision|0|||
163313400|NCT03544281|589859397|FG001|Main Study Phase|Physician Decision|0|||
163313401|NCT03544281|589859398|FG002|Main Study Phase|Physician Decision|0|||
163313402|NCT03544281|589859399|FG003|Main Study Phase|Physician Decision|0|||
163313403|NCT03544281|589859400|FG004|Main Study Phase|Physician Decision|0|||
163313404|NCT03544281|589859401|FG005|Main Study Phase|Physician Decision|0|||
163313405|NCT03544281|589859402|FG006|Main Study Phase|Physician Decision|0|||
163313406|NCT03544281|589859403|FG007|Main Study Phase|Physician Decision|1|||
163313407|NCT03544281|589859404|FG008|Main Study Phase|Physician Decision|0|||
163313408|NCT03544281|589859405|FG009|Main Study Phase|Physician Decision|0|||
163313409|NCT03544281|589859406|FG010|Main Study Phase|Physician Decision|0|||
162965685|NCT02578641|588574571|FG001|Overall Study|Lost to Follow-up|1|||
163313410|NCT03544281|589859407|FG011|Main Study Phase|Physician Decision|0|||
163313411|NCT03544281|589859408|FG012|Main Study Phase|Physician Decision|0|||
162965686|NCT02578641|588574570|FG000|Overall Study|Withdrawal by Subject|14|||
162965687|NCT02578641|588574571|FG001|Overall Study|Withdrawal by Subject|7|||
162965688|NCT02578641|588574570|FG000|Overall Study|Progressive Disease|69|||
163313412|NCT03544281|589859409|FG013|Main Study Phase|Physician Decision|0|||
163313413|NCT03544281|589859410|FG014|Main Study Phase|Physician Decision|0|||
163313414|NCT03544281|589859411|FG015|Main Study Phase|Physician Decision|0|||
163313415|NCT03544281|589859412|FG016|Main Study Phase|Physician Decision|0|||
163313416|NCT03544281|589859413|FG017|Main Study Phase|Physician Decision|0|||
163313417|NCT03544281|589859414|FG018|Main Study Phase|Physician Decision|0|||
163313418|NCT03544281|589859415|FG019|Main Study Phase|Physician Decision|0|||
163313419|NCT03544281|589859416|FG020|Main Study Phase|Physician Decision|0|||
163313420|NCT03544281|589859417|FG021|Main Study Phase|Physician Decision|0|||
163313421|NCT03544281|589859396|FG000|Main Study Phase|Withdrawal by Subject|2|||
163313422|NCT03544281|589859397|FG001|Main Study Phase|Withdrawal by Subject|0|||
163313423|NCT03544281|589859398|FG002|Main Study Phase|Withdrawal by Subject|1|||
163313424|NCT03544281|589859399|FG003|Main Study Phase|Withdrawal by Subject|2|||
163313425|NCT03544281|589859400|FG004|Main Study Phase|Withdrawal by Subject|0|||
163313426|NCT03544281|589859401|FG005|Main Study Phase|Withdrawal by Subject|0|||
163313427|NCT03544281|589859402|FG006|Main Study Phase|Withdrawal by Subject|0|||
163313428|NCT03544281|589859403|FG007|Main Study Phase|Withdrawal by Subject|0|||
163313429|NCT03544281|589859404|FG008|Main Study Phase|Withdrawal by Subject|2|||
163313430|NCT03544281|589859405|FG009|Main Study Phase|Withdrawal by Subject|3|||
163313431|NCT03544281|589859406|FG010|Main Study Phase|Withdrawal by Subject|0|||
163313432|NCT03544281|589859407|FG011|Main Study Phase|Withdrawal by Subject|4|||
163313433|NCT03544281|589859408|FG012|Main Study Phase|Withdrawal by Subject|0|||
163313434|NCT03544281|589859409|FG013|Main Study Phase|Withdrawal by Subject|0|||
163313435|NCT03544281|589859410|FG014|Main Study Phase|Withdrawal by Subject|0|||
163313436|NCT03544281|589859411|FG015|Main Study Phase|Withdrawal by Subject|0|||
163313437|NCT03544281|589859412|FG016|Main Study Phase|Withdrawal by Subject|0|||
163313438|NCT03544281|589859413|FG017|Main Study Phase|Withdrawal by Subject|0|||
163313439|NCT03544281|589859414|FG018|Main Study Phase|Withdrawal by Subject|0|||
163313440|NCT03544281|589859415|FG019|Main Study Phase|Withdrawal by Subject|0|||
163313441|NCT03544281|589859416|FG020|Main Study Phase|Withdrawal by Subject|0|||
163313442|NCT03544281|589859417|FG021|Main Study Phase|Withdrawal by Subject|0|||
163313443|NCT03544281|589859396|FG000|Main Study Phase|Ongoing|3|||
163313444|NCT03544281|589859397|FG001|Main Study Phase|Ongoing|1|||
163313445|NCT03544281|589859398|FG002|Main Study Phase|Ongoing|2|||
163313446|NCT03544281|589859399|FG003|Main Study Phase|Ongoing|4|||
163313447|NCT03544281|589859400|FG004|Main Study Phase|Ongoing|2|||
163313448|NCT03544281|589859401|FG005|Main Study Phase|Ongoing|4|||
163313449|NCT03544281|589859402|FG006|Main Study Phase|Ongoing|4|||
163313450|NCT03544281|589859403|FG007|Main Study Phase|Ongoing|0|||
163313451|NCT03544281|589859404|FG008|Main Study Phase|Ongoing|2|||
163313452|NCT03544281|589859405|FG009|Main Study Phase|Ongoing|2|||
163313453|NCT03544281|589859406|FG010|Main Study Phase|Ongoing|1|||
163313454|NCT03544281|589859407|FG011|Main Study Phase|Ongoing|0|||
163313455|NCT03544281|589859408|FG012|Main Study Phase|Ongoing|0|||
163313456|NCT03544281|589859409|FG013|Main Study Phase|Ongoing|0|||
163313457|NCT03544281|589859410|FG014|Main Study Phase|Ongoing|0|||
163313458|NCT03544281|589859411|FG015|Main Study Phase|Ongoing|0|||
163313459|NCT03544281|589859412|FG016|Main Study Phase|Ongoing|0|||
163313460|NCT03544281|589859413|FG017|Main Study Phase|Ongoing|0|||
163313461|NCT03544281|589859414|FG018|Main Study Phase|Ongoing|0|||
163313462|NCT03544281|589859415|FG019|Main Study Phase|Ongoing|0|||
163313463|NCT03544281|589859416|FG020|Main Study Phase|Ongoing|0|||
163313464|NCT03544281|589859417|FG021|Main Study Phase|Ongoing|0|||
163313465|NCT03544281|589859396|FG000|Main Study Phase|Investigator Site Closed|0|||
163313466|NCT03544281|589859397|FG001|Main Study Phase|Investigator Site Closed|0|||
163313467|NCT03544281|589859398|FG002|Main Study Phase|Investigator Site Closed|0|||
163313468|NCT03544281|589859399|FG003|Main Study Phase|Investigator Site Closed|0|||
163313469|NCT03544281|589859400|FG004|Main Study Phase|Investigator Site Closed|0|||
163313470|NCT03544281|589859401|FG005|Main Study Phase|Investigator Site Closed|0|||
163313471|NCT03544281|589859402|FG006|Main Study Phase|Investigator Site Closed|0|||
163313472|NCT03544281|589859403|FG007|Main Study Phase|Investigator Site Closed|0|||
163313473|NCT03544281|589859404|FG008|Main Study Phase|Investigator Site Closed|0|||
163313474|NCT03544281|589859405|FG009|Main Study Phase|Investigator Site Closed|1|||
163313475|NCT03544281|589859406|FG010|Main Study Phase|Investigator Site Closed|0|||
163313476|NCT03544281|589859407|FG011|Main Study Phase|Investigator Site Closed|0|||
163313477|NCT03544281|589859408|FG012|Main Study Phase|Investigator Site Closed|0|||
163313478|NCT03544281|589859409|FG013|Main Study Phase|Investigator Site Closed|0|||
163313479|NCT03544281|589859410|FG014|Main Study Phase|Investigator Site Closed|0|||
163313480|NCT03544281|589859411|FG015|Main Study Phase|Investigator Site Closed|0|||
163313481|NCT03544281|589859412|FG016|Main Study Phase|Investigator Site Closed|0|||
163313482|NCT03544281|589859413|FG017|Main Study Phase|Investigator Site Closed|0|||
163313483|NCT03544281|589859414|FG018|Main Study Phase|Investigator Site Closed|0|||
163313484|NCT03544281|589859415|FG019|Main Study Phase|Investigator Site Closed|0|||
163313485|NCT03544281|589859416|FG020|Main Study Phase|Investigator Site Closed|0|||
163313486|NCT03544281|589859417|FG021|Main Study Phase|Investigator Site Closed|0|||
163313487|NCT03544281|589859396|FG000|Main Study Phase|Did not receive study treatment|0|||
163313488|NCT03544281|589859397|FG001|Main Study Phase|Did not receive study treatment|0|||
163313489|NCT03544281|589859398|FG002|Main Study Phase|Did not receive study treatment|0|||
163313490|NCT03544281|589859399|FG003|Main Study Phase|Did not receive study treatment|0|||
163313491|NCT03544281|589859400|FG004|Main Study Phase|Did not receive study treatment|0|||
163313492|NCT03544281|589859401|FG005|Main Study Phase|Did not receive study treatment|0|||
163313493|NCT03544281|589859402|FG006|Main Study Phase|Did not receive study treatment|1|||
163313494|NCT03544281|589859403|FG007|Main Study Phase|Did not receive study treatment|0|||
163313495|NCT03544281|589859404|FG008|Main Study Phase|Did not receive study treatment|0|||
163313496|NCT03544281|589859405|FG009|Main Study Phase|Did not receive study treatment|0|||
163313497|NCT03544281|589859406|FG010|Main Study Phase|Did not receive study treatment|0|||
163313498|NCT03544281|589859407|FG011|Main Study Phase|Did not receive study treatment|0|||
163313499|NCT03544281|589859408|FG012|Main Study Phase|Did not receive study treatment|0|||
163313500|NCT03544281|589859409|FG013|Main Study Phase|Did not receive study treatment|0|||
163313501|NCT03544281|589859410|FG014|Main Study Phase|Did not receive study treatment|0|||
163313502|NCT03544281|589859411|FG015|Main Study Phase|Did not receive study treatment|0|||
163313503|NCT03544281|589859412|FG016|Main Study Phase|Did not receive study treatment|0|||
163313504|NCT03544281|589859413|FG017|Main Study Phase|Did not receive study treatment|0|||
163313505|NCT03544281|589859414|FG018|Main Study Phase|Did not receive study treatment|0|||
163313506|NCT03544281|589859415|FG019|Main Study Phase|Did not receive study treatment|0|||
163313507|NCT03544281|589859416|FG020|Main Study Phase|Did not receive study treatment|0|||
163313508|NCT03544281|589859417|FG021|Main Study Phase|Did not receive study treatment|0|||
163313509|NCT03544281|589859396|FG000|PACT Phase|Adverse Event|0|||
163313510|NCT03544281|589859397|FG001|PACT Phase|Adverse Event|0|||
163313511|NCT03544281|589859398|FG002|PACT Phase|Adverse Event|0|||
163313512|NCT03544281|589859399|FG003|PACT Phase|Adverse Event|0|||
163313513|NCT03544281|589859400|FG004|PACT Phase|Adverse Event|0|||
163313514|NCT03544281|589859401|FG005|PACT Phase|Adverse Event|0|||
163313515|NCT03544281|589859402|FG006|PACT Phase|Adverse Event|0|||
163313516|NCT03544281|589859403|FG007|PACT Phase|Adverse Event|0|||
163313517|NCT03544281|589859404|FG008|PACT Phase|Adverse Event|0|||
163313518|NCT03544281|589859405|FG009|PACT Phase|Adverse Event|0|||
163313519|NCT03544281|589859406|FG010|PACT Phase|Adverse Event|0|||
163313520|NCT03544281|589859407|FG011|PACT Phase|Adverse Event|0|||
163313521|NCT03544281|589859408|FG012|PACT Phase|Adverse Event|1|||
163313522|NCT03544281|589859409|FG013|PACT Phase|Adverse Event|0|||
163313523|NCT03544281|589859410|FG014|PACT Phase|Adverse Event|0|||
163313524|NCT03544281|589859411|FG015|PACT Phase|Adverse Event|0|||
163313525|NCT03544281|589859412|FG016|PACT Phase|Adverse Event|0|||
163313526|NCT03544281|589859413|FG017|PACT Phase|Adverse Event|1|||
163052410|NCT00434252|588903018|FG000|Overall Study|Lack of Efficacy|50|||
163052411|NCT00434252|588903019|FG001|Overall Study|Lack of Efficacy|100|||
163052412|NCT00434252|588903018|FG000|Overall Study|Adverse Event|6|||
163052413|NCT00434252|588903019|FG001|Overall Study|Adverse Event|13|||
163052414|NCT00434252|588903018|FG000|Overall Study|Death|1|||
163052415|NCT00434252|588903019|FG001|Overall Study|Death|2|||
163052416|NCT00434252|588903018|FG000|Overall Study|Lost to Follow-up|0|||
163052417|NCT00434252|588903019|FG001|Overall Study|Lost to Follow-up|1|||
163052418|NCT00434252|588903018|FG000|Overall Study|Physician Decision|4|||
163052419|NCT00434252|588903019|FG001|Overall Study|Physician Decision|8|||
163052420|NCT00434252|588903018|FG000|Overall Study|Withdrawal by Subject|3|||
163052421|NCT00434252|588903019|FG001|Overall Study|Withdrawal by Subject|7|||
163052422|NCT00352118|588903022|FG000|Overall Study|Physician Decision|4|||
163052423|NCT02337764|588903023|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
163052424|NCT02337764|588903023|FG000|Overall Study|Voluntary Withdrawal|12|||
163313527|NCT03544281|589859414|FG018|PACT Phase|Adverse Event|1|||
163052425|NCT02337764|588903023|FG000|Overall Study|Lack of Efficacy|2|||
163052426|NCT02990000|588903024|FG000|Overall Study|Failed to provide data beyond baseline|36|||
163052427|NCT02990000|588903025|FG001|Overall Study|Failed to provide data beyond baseline|34|||
163052428|NCT02810418|588903037|FG000|Arm A Dose Escalation|Adverse Event|2|||
163052429|NCT02810418|588903038|FG001|Arm A Dose Escalation|Adverse Event|1|||
163052430|NCT02810418|588903039|FG002|Arm A Dose Escalation|Adverse Event|0|||
163052431|NCT02810418|588903040|FG003|Arm A Dose Escalation|Adverse Event|0|||
163052432|NCT02810418|588903041|FG004|Arm A Dose Escalation|Adverse Event|0|||
163052433|NCT02810418|588903042|FG005|Arm A Dose Escalation|Adverse Event|0|||
163052434|NCT02810418|588903043|FG006|Arm A Dose Escalation|Adverse Event|0|||
163052435|NCT02810418|588903037|FG000|Dose Expansion|Adverse Event|0|||
163052436|NCT02810418|588903038|FG001|Dose Expansion|Adverse Event|1|||
163052437|NCT02810418|588903039|FG002|Dose Expansion|Adverse Event|1|||
163313528|NCT03544281|589859415|FG019|PACT Phase|Adverse Event|0|||
163313529|NCT03544281|589859416|FG020|PACT Phase|Adverse Event|0|||
163313530|NCT03544281|589859417|FG021|PACT Phase|Adverse Event|0|||
163313531|NCT02547233|589859418|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
163052438|NCT02810418|588903040|FG003|Dose Expansion|Adverse Event|0|||
163052439|NCT02810418|588903041|FG004|Dose Expansion|Adverse Event|0|||
163052440|NCT02810418|588903042|FG005|Dose Expansion|Adverse Event|0|||
163052441|NCT02810418|588903043|FG006|Dose Expansion|Adverse Event|0|||
163052442|NCT02810418|588903037|FG000|Dose Expansion|Physician Decision|0|||
163052443|NCT02810418|588903038|FG001|Dose Expansion|Physician Decision|0|||
163052444|NCT02810418|588903039|FG002|Dose Expansion|Physician Decision|2|||
163052445|NCT02810418|588903040|FG003|Dose Expansion|Physician Decision|0|||
163052446|NCT02810418|588903041|FG004|Dose Expansion|Physician Decision|0|||
163052447|NCT02810418|588903042|FG005|Dose Expansion|Physician Decision|0|||
163052448|NCT02810418|588903043|FG006|Dose Expansion|Physician Decision|0|||
163052449|NCT02810418|588903037|FG000|Arm B Dose Escalation|Adverse Event|0|||
163052450|NCT02810418|588903038|FG001|Arm B Dose Escalation|Adverse Event|0|||
163052451|NCT02810418|588903039|FG002|Arm B Dose Escalation|Adverse Event|0|||
163052452|NCT02810418|588903040|FG003|Arm B Dose Escalation|Adverse Event|0|||
163052453|NCT02810418|588903041|FG004|Arm B Dose Escalation|Adverse Event|1|||
163052454|NCT02810418|588903042|FG005|Arm B Dose Escalation|Adverse Event|2|||
163052455|NCT02810418|588903043|FG006|Arm B Dose Escalation|Adverse Event|0|||
163052456|NCT03103503|588903044|FG000|Overall Study|Death|64|||
163052457|NCT03103503|588903044|FG000|Overall Study|Physician Decision|57|||
163052458|NCT03103503|588903044|FG000|Overall Study|Withdrawal by Subject|10|||
163052459|NCT03103503|588903044|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
163313532|NCT02547233|589859419|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
163313533|NCT02547233|589859418|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
163313534|NCT02547233|589859419|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
163313535|NCT02547233|589859418|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
163313536|NCT02547233|589859419|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
163313537|NCT02547233|589859418|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
163313538|NCT02547233|589859419|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
163313539|NCT02547233|589859418|FG000|12-month Follow-up|Withdrawal by Subject|10|||
163313540|NCT02547233|589859419|FG001|12-month Follow-up|Withdrawal by Subject|10|||
163313541|NCT02547233|589859418|FG000|12-month Follow-up|Lost to Follow-up|3|||
163052460|NCT03103503|588903044|FG000|Overall Study|Lost to Follow-up|3|||
163052461|NCT03103503|588903044|FG000|Overall Study|Study Closure|757|||
163052462|NCT01433159|588903049|FG000|Overall Study|Adverse Event|1|||
163052463|NCT01433159|588903050|FG001|Overall Study|Adverse Event|0|||
163052464|NCT01433159|588903049|FG000|Overall Study|Physician Decision|1|||
163052465|NCT01433159|588903050|FG001|Overall Study|Physician Decision|0|||
163052466|NCT01433159|588903049|FG000|Overall Study|Protocol Violation|0|||
163052467|NCT01433159|588903050|FG001|Overall Study|Protocol Violation|1|||
163052468|NCT01100853|588903051|FG000|Overall Study|Lost to Follow-up|11|||
163052469|NCT01100853|588903052|FG001|Overall Study|Lost to Follow-up|6|||
163052470|NCT01100853|588903051|FG000|Overall Study|Received <4 study injections|10|||
163052471|NCT01100853|588903052|FG001|Overall Study|Received <4 study injections|13|||
163052472|NCT01100853|588903051|FG000|Overall Study|Withdrawal by Subject|6|||
163052473|NCT01100853|588903052|FG001|Overall Study|Withdrawal by Subject|4|||
163052474|NCT04161391|588903055|FG000|Overall Study|Adverse Event|0|||
163052475|NCT04161391|588903056|FG001|Overall Study|Adverse Event|1|||
163052476|NCT04161391|588903057|FG002|Overall Study|Adverse Event|0|||
163052477|NCT04161391|588903058|FG003|Overall Study|Adverse Event|1|||
163052478|NCT04161391|588903059|FG004|Overall Study|Adverse Event|0|||
163052479|NCT04161391|588903060|FG005|Overall Study|Adverse Event|0|||
163052480|NCT04161391|588903061|FG006|Overall Study|Adverse Event|0|||
163052481|NCT04161391|588903062|FG007|Overall Study|Adverse Event|3|||
163052482|NCT04161391|588903063|FG008|Overall Study|Adverse Event|0|||
163052483|NCT04161391|588903055|FG000|Overall Study|Death|0|||
162965689|NCT02578641|588574571|FG001|Overall Study|Progressive Disease|21|||
162965690|NCT02578641|588574570|FG000|Overall Study|No Study Drug|2|||
162965691|NCT02578641|588574571|FG001|Overall Study|No Study Drug|0|||
162965692|NCT02578641|588574570|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
162965693|NCT02578641|588574571|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
162965694|NCT02578641|588574570|FG000|Overall Study|Non-compliance with Study Schedule|1|||
162965695|NCT02578641|588574571|FG001|Overall Study|Non-compliance with Study Schedule|0|||
162965696|NCT02578641|588574570|FG000|Overall Study|Other|1|||
162965697|NCT02578641|588574571|FG001|Overall Study|Other|10|||
162965698|NCT02578641|588574570|FG000|Overall Study|Not treated|1|||
162965699|NCT02578641|588574571|FG001|Overall Study|Not treated|4|||
162965700|NCT02655224|588574574|FG000|Overall Study|Adverse Event|1|||
162965701|NCT02655224|588574575|FG001|Overall Study|Adverse Event|1|||
162965702|NCT03036930|588574576|FG000|Overall Study|Lost to Follow-up|7|||
162965703|NCT03036930|588574576|FG000|Overall Study|Withdrawal by Subject|3|||
162965704|NCT03036930|588574576|FG000|Overall Study|Not eligible to receive transplant within 12 months|15|||
162965705|NCT04227899|588574583|FG000|Overall Study|Withdrawal by Subject|6|||
162965706|NCT04227899|588574584|FG001|Overall Study|Withdrawal by Subject|3|||
162965707|NCT04227899|588574583|FG000|Overall Study|Death|12|||
162965708|NCT04227899|588574584|FG001|Overall Study|Death|6|||
162965709|NCT04227899|588574583|FG000|Overall Study|Lost to Follow-up|2|||
162965710|NCT04227899|588574584|FG001|Overall Study|Lost to Follow-up|1|||
162965711|NCT05151471|588574585|FG000|Overall Study|Adverse Event|21|||
162965712|NCT05151471|588574586|FG001|Overall Study|Adverse Event|16|||
162965713|NCT05151471|588574585|FG000|Overall Study|Death|1|||
162965714|NCT05151471|588574586|FG001|Overall Study|Death|0|||
162965715|NCT05151471|588574585|FG000|Overall Study|Lost to Follow-up|0|||
162965716|NCT05151471|588574586|FG001|Overall Study|Lost to Follow-up|1|||
162965717|NCT05151471|588574585|FG000|Overall Study|Withdrawal by Subject|7|||
162965718|NCT05151471|588574586|FG001|Overall Study|Withdrawal by Subject|9|||
162965719|NCT05151471|588574585|FG000|Overall Study|Study terminated by sponsor|49|||
162965720|NCT05151471|588574586|FG001|Overall Study|Study terminated by sponsor|47|||
162965721|NCT05151471|588574585|FG000|Overall Study|Other|2|||
162965722|NCT05151471|588574586|FG001|Overall Study|Other|1|||
163052484|NCT04161391|588903056|FG001|Overall Study|Death|0|||
163052485|NCT04161391|588903057|FG002|Overall Study|Death|0|||
163052486|NCT04161391|588903058|FG003|Overall Study|Death|0|||
162965723|NCT03292458|588574594|FG000|Period 1|Adverse Event|2|||
162965724|NCT03292458|588574595|FG001|Period 1|Adverse Event|0|||
162965725|NCT01513239|588574596|FG000|Period 1: Main Phase|Adverse Event|1|||
163052487|NCT04161391|588903059|FG004|Overall Study|Death|0|||
163052488|NCT04161391|588903060|FG005|Overall Study|Death|0|||
162965726|NCT01513239|588574597|FG001|Period 1: Main Phase|Adverse Event|1|||
162965727|NCT01513239|588574598|FG002|Period 1: Main Phase|Adverse Event|2|||
163052489|NCT04161391|588903061|FG006|Overall Study|Death|0|||
162965728|NCT01513239|588574599|FG003|Period 1: Main Phase|Adverse Event|0|||
162965729|NCT01513239|588574600|FG004|Period 1: Main Phase|Adverse Event|0|||
162965730|NCT01513239|588574601|FG005|Period 1: Main Phase|Adverse Event|0|||
163052490|NCT04161391|588903062|FG007|Overall Study|Death|1|||
163052491|NCT04161391|588903063|FG008|Overall Study|Death|0|||
162965731|NCT01513239|588574596|FG000|Period 1: Main Phase|Death|29|||
162965732|NCT01513239|588574597|FG001|Period 1: Main Phase|Death|22|||
162965733|NCT01513239|588574598|FG002|Period 1: Main Phase|Death|32|||
162965734|NCT01513239|588574599|FG003|Period 1: Main Phase|Death|0|||
162965735|NCT01513239|588574600|FG004|Period 1: Main Phase|Death|0|||
162965736|NCT01513239|588574601|FG005|Period 1: Main Phase|Death|0|||
162965737|NCT01513239|588574596|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
162965738|NCT01513239|588574597|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
162965739|NCT01513239|588574598|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
162965740|NCT01513239|588574599|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
162965741|NCT01513239|588574600|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
162965742|NCT01513239|588574601|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
162965743|NCT01513239|588574596|FG000|Period 1: Main Phase|Physician Decision|4|||
162965744|NCT01513239|588574597|FG001|Period 1: Main Phase|Physician Decision|4|||
162965745|NCT01513239|588574598|FG002|Period 1: Main Phase|Physician Decision|4|||
162965746|NCT01513239|588574599|FG003|Period 1: Main Phase|Physician Decision|0|||
162965747|NCT01513239|588574600|FG004|Period 1: Main Phase|Physician Decision|0|||
162965748|NCT01513239|588574601|FG005|Period 1: Main Phase|Physician Decision|0|||
162965749|NCT01513239|588574596|FG000|Period 1: Main Phase|Protocol Violation|2|||
162965750|NCT01513239|588574597|FG001|Period 1: Main Phase|Protocol Violation|2|||
162965751|NCT01513239|588574598|FG002|Period 1: Main Phase|Protocol Violation|2|||
162965752|NCT01513239|588574599|FG003|Period 1: Main Phase|Protocol Violation|0|||
162965753|NCT01513239|588574600|FG004|Period 1: Main Phase|Protocol Violation|0|||
162965754|NCT01513239|588574601|FG005|Period 1: Main Phase|Protocol Violation|0|||
162965755|NCT01513239|588574596|FG000|Period 1: Main Phase|Technical Problems|1|||
162965756|NCT01513239|588574597|FG001|Period 1: Main Phase|Technical Problems|2|||
162965757|NCT01513239|588574598|FG002|Period 1: Main Phase|Technical Problems|0|||
162965758|NCT01513239|588574599|FG003|Period 1: Main Phase|Technical Problems|0|||
162965759|NCT01513239|588574600|FG004|Period 1: Main Phase|Technical Problems|0|||
162965760|NCT01513239|588574601|FG005|Period 1: Main Phase|Technical Problems|0|||
162965761|NCT01513239|588574596|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
162965762|NCT01513239|588574597|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
162965763|NCT01513239|588574598|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
162965764|NCT01513239|588574599|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
162965765|NCT01513239|588574600|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
162965766|NCT01513239|588574601|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
162965767|NCT01513239|588574596|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
162965768|NCT01513239|588574597|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
162965769|NCT01513239|588574598|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
162965770|NCT01513239|588574599|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
162965771|NCT01513239|588574600|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
162965772|NCT01513239|588574601|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
162965773|NCT01513239|588574596|FG000|Period 2: 9 Month Extension Phase|Death|0|||
163052492|NCT04161391|588903055|FG000|Overall Study|Physician Decision|0|||
162965774|NCT01513239|588574597|FG001|Period 2: 9 Month Extension Phase|Death|0|||
162965775|NCT01513239|588574598|FG002|Period 2: 9 Month Extension Phase|Death|0|||
162965776|NCT01513239|588574599|FG003|Period 2: 9 Month Extension Phase|Death|2|||
162965777|NCT01513239|588574600|FG004|Period 2: 9 Month Extension Phase|Death|5|||
163052493|NCT04161391|588903056|FG001|Overall Study|Physician Decision|0|||
163205195|NCT00420927|589463586|FG005|Period 1|Lost to Follow-up|0|||
163205196|NCT00420927|589463587|FG006|Period 1|Lost to Follow-up|0|||
163205197|NCT00420927|589463581|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
163205198|NCT00420927|589463582|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
163205199|NCT00420927|589463583|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
163205200|NCT00420927|589463584|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
163205201|NCT00420927|589463585|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
163205202|NCT00420927|589463586|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
163205203|NCT00420927|589463587|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
163313542|NCT02547233|589859419|FG001|12-month Follow-up|Lost to Follow-up|3|||
163052494|NCT04161391|588903057|FG002|Overall Study|Physician Decision|1|||
163205204|NCT00420927|589463581|FG000|Period 1|Death|2|||
163205205|NCT00420927|589463582|FG001|Period 1|Death|0|||
163397483|NCT01101438|590167728|FG001|Overall Study|Withdrawal by Subject|9|||
163397484|NCT02289742|590167737|FG000|First Wear Period|Adverse event prior to treatment|0|||
163397485|NCT02289742|590167738|FG001|First Wear Period|Adverse event prior to treatment|1|||
163052495|NCT04161391|588903058|FG003|Overall Study|Physician Decision|2|||
163052496|NCT04161391|588903059|FG004|Overall Study|Physician Decision|0|||
163052497|NCT04161391|588903060|FG005|Overall Study|Physician Decision|0|||
163052498|NCT04161391|588903061|FG006|Overall Study|Physician Decision|2|||
163205206|NCT00420927|589463583|FG002|Period 1|Death|0|||
163205207|NCT00420927|589463584|FG003|Period 1|Death|0|||
163205208|NCT00420927|589463585|FG004|Period 1|Death|0|||
163205209|NCT00420927|589463586|FG005|Period 1|Death|0|||
163205210|NCT00420927|589463587|FG006|Period 1|Death|0|||
163205211|NCT00420927|589463581|FG000|Period 1|Subject moved/relocated|0|||
163205212|NCT00420927|589463582|FG001|Period 1|Subject moved/relocated|2|||
163205213|NCT00420927|589463583|FG002|Period 1|Subject moved/relocated|0|||
163205214|NCT00420927|589463584|FG003|Period 1|Subject moved/relocated|0|||
163205215|NCT00420927|589463585|FG004|Period 1|Subject moved/relocated|0|||
163205216|NCT00420927|589463586|FG005|Period 1|Subject moved/relocated|0|||
163205217|NCT00420927|589463587|FG006|Period 1|Subject moved/relocated|0|||
163205218|NCT00420927|589463581|FG000|Period 1|Noncompliant with study drug|1|||
163205219|NCT00420927|589463582|FG001|Period 1|Noncompliant with study drug|1|||
163205220|NCT00420927|589463583|FG002|Period 1|Noncompliant with study drug|0|||
163205221|NCT00420927|589463584|FG003|Period 1|Noncompliant with study drug|0|||
163205222|NCT00420927|589463585|FG004|Period 1|Noncompliant with study drug|0|||
163205223|NCT00420927|589463586|FG005|Period 1|Noncompliant with study drug|0|||
163052499|NCT04161391|588903062|FG007|Overall Study|Physician Decision|0|||
163052500|NCT04161391|588903063|FG008|Overall Study|Physician Decision|0|||
163205224|NCT00420927|589463587|FG006|Period 1|Noncompliant with study drug|0|||
163205225|NCT00420927|589463581|FG000|Period 1|Randomization error|1|||
163205226|NCT00420927|589463582|FG001|Period 1|Randomization error|0|||
163205227|NCT00420927|589463583|FG002|Period 1|Randomization error|0|||
163205228|NCT00420927|589463584|FG003|Period 1|Randomization error|0|||
163205229|NCT00420927|589463585|FG004|Period 1|Randomization error|0|||
163205230|NCT00420927|589463586|FG005|Period 1|Randomization error|0|||
163205231|NCT00420927|589463587|FG006|Period 1|Randomization error|0|||
163205232|NCT00420927|589463581|FG000|Period 1|Suspected tuberculosis/positive test|1|||
163205233|NCT00420927|589463582|FG001|Period 1|Suspected tuberculosis/positive test|1|||
163205234|NCT00420927|589463583|FG002|Period 1|Suspected tuberculosis/positive test|0|||
163205235|NCT00420927|589463584|FG003|Period 1|Suspected tuberculosis/positive test|0|||
163205236|NCT00420927|589463585|FG004|Period 1|Suspected tuberculosis/positive test|0|||
163205237|NCT00420927|589463586|FG005|Period 1|Suspected tuberculosis/positive test|0|||
163205238|NCT00420927|589463587|FG006|Period 1|Suspected tuberculosis/positive test|0|||
163205239|NCT00420927|589463581|FG000|Period 1|Study site closure|0|||
163205240|NCT00420927|589463582|FG001|Period 1|Study site closure|1|||
163205241|NCT00420927|589463583|FG002|Period 1|Study site closure|0|||
163205242|NCT00420927|589463584|FG003|Period 1|Study site closure|0|||
163205243|NCT00420927|589463585|FG004|Period 1|Study site closure|0|||
163205244|NCT00420927|589463586|FG005|Period 1|Study site closure|0|||
163205245|NCT00420927|589463587|FG006|Period 1|Study site closure|0|||
163205246|NCT00420927|589463581|FG000|Period 1|Subject received new diagnosis|0|||
163205247|NCT00420927|589463582|FG001|Period 1|Subject received new diagnosis|2|||
163205248|NCT00420927|589463583|FG002|Period 1|Subject received new diagnosis|0|||
163205249|NCT00420927|589463584|FG003|Period 1|Subject received new diagnosis|0|||
163205250|NCT00420927|589463585|FG004|Period 1|Subject received new diagnosis|0|||
163205251|NCT00420927|589463586|FG005|Period 1|Subject received new diagnosis|0|||
163205252|NCT00420927|589463587|FG006|Period 1|Subject received new diagnosis|0|||
163205253|NCT00420927|589463581|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
163205254|NCT00420927|589463582|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
163205255|NCT00420927|589463583|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
163205256|NCT00420927|589463584|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
163205257|NCT00420927|589463585|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
163205258|NCT00420927|589463586|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
163205259|NCT00420927|589463587|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
163205260|NCT00420927|589463581|FG000|Period 1|Failed to meet entry criteria|8|||
163205261|NCT00420927|589463582|FG001|Period 1|Failed to meet entry criteria|7|||
163205262|NCT00420927|589463583|FG002|Period 1|Failed to meet entry criteria|0|||
163205263|NCT00420927|589463584|FG003|Period 1|Failed to meet entry criteria|0|||
163205264|NCT00420927|589463585|FG004|Period 1|Failed to meet entry criteria|0|||
163205265|NCT00420927|589463586|FG005|Period 1|Failed to meet entry criteria|0|||
163205266|NCT00420927|589463587|FG006|Period 1|Failed to meet entry criteria|0|||
163205267|NCT00420927|589463581|FG000|Period 1|Took prohibited medication|1|||
163205268|NCT00420927|589463582|FG001|Period 1|Took prohibited medication|3|||
163205269|NCT00420927|589463583|FG002|Period 1|Took prohibited medication|0|||
163205270|NCT00420927|589463584|FG003|Period 1|Took prohibited medication|0|||
163205271|NCT00420927|589463585|FG004|Period 1|Took prohibited medication|0|||
163205272|NCT00420927|589463586|FG005|Period 1|Took prohibited medication|0|||
163205273|NCT00420927|589463587|FG006|Period 1|Took prohibited medication|0|||
163205274|NCT00420927|589463581|FG000|Period 2|Adverse Event|0|||
163205275|NCT00420927|589463582|FG001|Period 2|Adverse Event|0|||
163052501|NCT04161391|588903055|FG000|Overall Study|Progressive Disease|4|||
163052502|NCT04161391|588903056|FG001|Overall Study|Progressive Disease|3|||
163205276|NCT00420927|589463583|FG002|Period 2|Adverse Event|7|||
163205277|NCT00420927|589463584|FG003|Period 2|Adverse Event|3|||
163205278|NCT00420927|589463585|FG004|Period 2|Adverse Event|17|||
163205279|NCT00420927|589463586|FG005|Period 2|Adverse Event|6|||
163205280|NCT00420927|589463587|FG006|Period 2|Adverse Event|20|||
163205281|NCT00420927|589463581|FG000|Period 2|Withdrawal by Subject|0|||
163205282|NCT00420927|589463582|FG001|Period 2|Withdrawal by Subject|0|||
163205283|NCT00420927|589463583|FG002|Period 2|Withdrawal by Subject|1|||
163205284|NCT00420927|589463584|FG003|Period 2|Withdrawal by Subject|3|||
163205285|NCT00420927|589463585|FG004|Period 2|Withdrawal by Subject|11|||
163205286|NCT00420927|589463586|FG005|Period 2|Withdrawal by Subject|2|||
163205287|NCT00420927|589463587|FG006|Period 2|Withdrawal by Subject|12|||
163205288|NCT00420927|589463581|FG000|Period 2|Lost to Follow-up|0|||
163205289|NCT00420927|589463582|FG001|Period 2|Lost to Follow-up|0|||
163205290|NCT00420927|589463583|FG002|Period 2|Lost to Follow-up|2|||
163205291|NCT00420927|589463584|FG003|Period 2|Lost to Follow-up|2|||
163205292|NCT00420927|589463585|FG004|Period 2|Lost to Follow-up|6|||
163205293|NCT00420927|589463586|FG005|Period 2|Lost to Follow-up|3|||
163205294|NCT00420927|589463587|FG006|Period 2|Lost to Follow-up|9|||
163205295|NCT00420927|589463581|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
163205296|NCT00420927|589463582|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
163205297|NCT00420927|589463583|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
163205298|NCT00420927|589463584|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
163205299|NCT00420927|589463585|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
163205300|NCT00420927|589463586|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
163205301|NCT00420927|589463587|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
163205302|NCT00420927|589463581|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
163205303|NCT00420927|589463582|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
163205304|NCT00420927|589463583|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
163205305|NCT00420927|589463584|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
163205306|NCT00420927|589463585|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
163205307|NCT00420927|589463586|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
163205308|NCT00420927|589463587|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
163205309|NCT00420927|589463581|FG000|Period 2|Subject unable to find transportation|0|||
163205310|NCT00420927|589463582|FG001|Period 2|Subject unable to find transportation|0|||
163205311|NCT00420927|589463583|FG002|Period 2|Subject unable to find transportation|0|||
163205312|NCT00420927|589463584|FG003|Period 2|Subject unable to find transportation|0|||
163205313|NCT00420927|589463585|FG004|Period 2|Subject unable to find transportation|0|||
163205314|NCT00420927|589463586|FG005|Period 2|Subject unable to find transportation|0|||
163205315|NCT00420927|589463587|FG006|Period 2|Subject unable to find transportation|1|||
163205316|NCT00420927|589463581|FG000|Period 2|Physician Decision|0|||
163205317|NCT00420927|589463582|FG001|Period 2|Physician Decision|0|||
163205318|NCT00420927|589463583|FG002|Period 2|Physician Decision|0|||
163205319|NCT00420927|589463584|FG003|Period 2|Physician Decision|0|||
163205320|NCT00420927|589463585|FG004|Period 2|Physician Decision|1|||
163205321|NCT00420927|589463586|FG005|Period 2|Physician Decision|1|||
163205322|NCT00420927|589463587|FG006|Period 2|Physician Decision|0|||
163205323|NCT00420927|589463581|FG000|Period 2|Sponsor decision|0|||
163205324|NCT00420927|589463582|FG001|Period 2|Sponsor decision|0|||
163205325|NCT00420927|589463583|FG002|Period 2|Sponsor decision|1|||
162965778|NCT01513239|588574601|FG005|Period 2: 9 Month Extension Phase|Death|2|||
163205326|NCT00420927|589463584|FG003|Period 2|Sponsor decision|0|||
162965779|NCT01513239|588574596|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
162965780|NCT01513239|588574597|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
162965781|NCT01513239|588574598|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
162965782|NCT01513239|588574599|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
162965783|NCT01513239|588574600|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
162965784|NCT01513239|588574601|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
162965785|NCT01513239|588574596|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
162965786|NCT01513239|588574597|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
162965787|NCT01513239|588574598|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
162965788|NCT01513239|588574599|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
162965789|NCT01513239|588574600|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
162965790|NCT01513239|588574601|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
162965791|NCT01513239|588574596|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
162965792|NCT01513239|588574597|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
163205327|NCT00420927|589463585|FG004|Period 2|Sponsor decision|0|||
163205328|NCT00420927|589463586|FG005|Period 2|Sponsor decision|0|||
163205329|NCT00420927|589463587|FG006|Period 2|Sponsor decision|1|||
163205330|NCT00420927|589463581|FG000|Period 2|Randomization error|0|||
163205331|NCT00420927|589463582|FG001|Period 2|Randomization error|0|||
163205332|NCT00420927|589463583|FG002|Period 2|Randomization error|0|||
163205333|NCT00420927|589463584|FG003|Period 2|Randomization error|0|||
163205334|NCT00420927|589463585|FG004|Period 2|Randomization error|1|||
163205335|NCT00420927|589463586|FG005|Period 2|Randomization error|1|||
163205336|NCT00420927|589463587|FG006|Period 2|Randomization error|0|||
163205337|NCT00420927|589463581|FG000|Period 2|Noncompliant with study drug|0|||
163205338|NCT00420927|589463582|FG001|Period 2|Noncompliant with study drug|0|||
163205339|NCT00420927|589463583|FG002|Period 2|Noncompliant with study drug|0|||
163205340|NCT00420927|589463584|FG003|Period 2|Noncompliant with study drug|1|||
163205341|NCT00420927|589463585|FG004|Period 2|Noncompliant with study drug|0|||
163205342|NCT00420927|589463586|FG005|Period 2|Noncompliant with study drug|0|||
163205343|NCT00420927|589463587|FG006|Period 2|Noncompliant with study drug|2|||
163052503|NCT04161391|588903057|FG002|Overall Study|Progressive Disease|3|||
163205344|NCT00420927|589463581|FG000|Period 2|Methotrexate intolerance|0|||
163205345|NCT00420927|589463582|FG001|Period 2|Methotrexate intolerance|0|||
163205346|NCT00420927|589463583|FG002|Period 2|Methotrexate intolerance|0|||
163205347|NCT00420927|589463584|FG003|Period 2|Methotrexate intolerance|0|||
163205348|NCT00420927|589463585|FG004|Period 2|Methotrexate intolerance|0|||
163205349|NCT00420927|589463586|FG005|Period 2|Methotrexate intolerance|0|||
163205350|NCT00420927|589463587|FG006|Period 2|Methotrexate intolerance|1|||
163205351|NCT00420927|589463581|FG000|Period 2|Took prohibited medication|0|||
163205352|NCT00420927|589463582|FG001|Period 2|Took prohibited medication|0|||
163205353|NCT00420927|589463583|FG002|Period 2|Took prohibited medication|0|||
163205354|NCT00420927|589463584|FG003|Period 2|Took prohibited medication|0|||
163205355|NCT00420927|589463585|FG004|Period 2|Took prohibited medication|1|||
163205356|NCT00420927|589463586|FG005|Period 2|Took prohibited medication|0|||
163205357|NCT00420927|589463587|FG006|Period 2|Took prohibited medication|0|||
163205358|NCT01025752|589463588|FG000|Overall Study|Lost to Follow-up|7|||
163205359|NCT01025752|589463589|FG001|Overall Study|Lost to Follow-up|10|||
163205360|NCT01025752|589463588|FG000|Overall Study|Physician Decision|1|||
163205361|NCT01025752|589463589|FG001|Overall Study|Physician Decision|3|||
163205362|NCT00855920|589463590|FG000|Overall Study|Protocol Violation|0|||
163205363|NCT00855920|589463591|FG001|Overall Study|Protocol Violation|0|||
163205364|NCT00855920|589463592|FG002|Overall Study|Protocol Violation|2|||
163205365|NCT00855920|589463590|FG000|Overall Study|Adverse Event|2|||
163205366|NCT00855920|589463591|FG001|Overall Study|Adverse Event|1|||
163205367|NCT00855920|589463592|FG002|Overall Study|Adverse Event|1|||
163205368|NCT00855920|589463590|FG000|Overall Study|Lack of Efficacy|2|||
163205369|NCT00855920|589463591|FG001|Overall Study|Lack of Efficacy|2|||
163205370|NCT00855920|589463592|FG002|Overall Study|Lack of Efficacy|2|||
163205371|NCT00855920|589463590|FG000|Overall Study|Withdrawal by Subject|2|||
163205372|NCT00855920|589463591|FG001|Overall Study|Withdrawal by Subject|3|||
163205373|NCT00855920|589463592|FG002|Overall Study|Withdrawal by Subject|2|||
163205374|NCT00855920|589463590|FG000|Overall Study|Lost to Follow-up|1|||
163205375|NCT00855920|589463591|FG001|Overall Study|Lost to Follow-up|0|||
163205376|NCT00855920|589463592|FG002|Overall Study|Lost to Follow-up|2|||
163205377|NCT00855920|589463590|FG000|Overall Study|Death|0|||
163205378|NCT00855920|589463591|FG001|Overall Study|Death|1|||
163205379|NCT00855920|589463592|FG002|Overall Study|Death|0|||
163205380|NCT00855920|589463590|FG000|Overall Study|Decision by the sponsor|0|||
163205381|NCT00855920|589463591|FG001|Overall Study|Decision by the sponsor|1|||
163205382|NCT00855920|589463592|FG002|Overall Study|Decision by the sponsor|1|||
163205383|NCT00855920|589463590|FG000|Overall Study|Other than specified above|1|||
163205384|NCT00855920|589463591|FG001|Overall Study|Other than specified above|1|||
163205385|NCT00855920|589463592|FG002|Overall Study|Other than specified above|1|||
163205386|NCT01032837|589463595|FG000|Overall Study|Adverse event/internal illness|0|||
163205387|NCT01032837|589463596|FG001|Overall Study|Adverse event/internal illness|1|||
163205388|NCT01032837|589463597|FG002|Overall Study|Adverse event/internal illness|0|||
163205389|NCT01032837|589463598|FG003|Overall Study|Adverse event/internal illness|1|||
163205390|NCT01032837|589463595|FG000|Overall Study|Withdrew consent|0|||
163205391|NCT01032837|589463596|FG001|Overall Study|Withdrew consent|2|||
163205392|NCT01032837|589463597|FG002|Overall Study|Withdrew consent|0|||
163205393|NCT01032837|589463598|FG003|Overall Study|Withdrew consent|1|||
163205394|NCT01032837|589463595|FG000|Overall Study|Failed to return|0|||
163205395|NCT01032837|589463596|FG001|Overall Study|Failed to return|0|||
163205396|NCT01032837|589463597|FG002|Overall Study|Failed to return|1|||
163052504|NCT04161391|588903058|FG003|Overall Study|Progressive Disease|5|||
163052505|NCT04161391|588903059|FG004|Overall Study|Progressive Disease|3|||
163052506|NCT04161391|588903060|FG005|Overall Study|Progressive Disease|3|||
163052507|NCT04161391|588903061|FG006|Overall Study|Progressive Disease|5|||
163052508|NCT04161391|588903062|FG007|Overall Study|Progressive Disease|2|||
163052509|NCT04161391|588903063|FG008|Overall Study|Progressive Disease|2|||
163313543|NCT02547233|589859418|FG000|12-month Follow-up|Lack of Efficacy|1|||
163313544|NCT02547233|589859419|FG001|12-month Follow-up|Lack of Efficacy|2|||
163313545|NCT02547233|589859418|FG000|12-month Follow-up|Protocol Violation|0|||
163313546|NCT02547233|589859419|FG001|12-month Follow-up|Protocol Violation|1|||
163313547|NCT02547233|589859418|FG000|12-month Follow-up|Other|0|||
163313548|NCT02547233|589859419|FG001|12-month Follow-up|Other|1|||
163313549|NCT06019559|589859421|FG000|Overall Study|Withdrawal by Subject|7|||
163313550|NCT06019559|589859422|FG001|Overall Study|Withdrawal by Subject|6|||
163313551|NCT06019559|589859423|FG002|Overall Study|Withdrawal by Subject|5|||
163313552|NCT06019559|589859421|FG000|Overall Study|Lost to Follow-up|2|||
163052510|NCT01739335|588903070|FG000|Overall Study|Lost to Follow-up|7|||
163052511|NCT01739335|588903071|FG001|Overall Study|Lost to Follow-up|4|||
163052512|NCT01739335|588903070|FG000|Overall Study|Ineligible patient randomized|0|||
163052513|NCT01739335|588903071|FG001|Overall Study|Ineligible patient randomized|1|||
163052514|NCT01863771|588903073|FG000|Induction Phase|Adverse Event|9|||
163052515|NCT01863771|588903074|FG001|Induction Phase|Adverse Event|0|||
163052516|NCT01863771|588903075|FG002|Induction Phase|Adverse Event|0|||
163052517|NCT01863771|588903076|FG003|Induction Phase|Adverse Event|0|||
163052518|NCT01863771|588903073|FG000|Induction Phase|Lack of Efficacy|10|||
163052519|NCT01863771|588903074|FG001|Induction Phase|Lack of Efficacy|0|||
163052520|NCT01863771|588903075|FG002|Induction Phase|Lack of Efficacy|0|||
163052521|NCT01863771|588903076|FG003|Induction Phase|Lack of Efficacy|0|||
163052522|NCT01863771|588903073|FG000|Induction Phase|Withdrawal by Subject|2|||
163052523|NCT01863771|588903074|FG001|Induction Phase|Withdrawal by Subject|0|||
163052524|NCT01863771|588903075|FG002|Induction Phase|Withdrawal by Subject|0|||
163052525|NCT01863771|588903076|FG003|Induction Phase|Withdrawal by Subject|0|||
163052526|NCT01863771|588903073|FG000|Maintenance Phase|Adverse Event|0|||
163313553|NCT06019559|589859422|FG001|Overall Study|Lost to Follow-up|0|||
163313554|NCT06019559|589859423|FG002|Overall Study|Lost to Follow-up|3|||
163052527|NCT01863771|588903074|FG001|Maintenance Phase|Adverse Event|0|||
163052528|NCT01863771|588903075|FG002|Maintenance Phase|Adverse Event|1|||
163052529|NCT01863771|588903076|FG003|Maintenance Phase|Adverse Event|1|||
163052530|NCT01863771|588903073|FG000|Maintenance Phase|Lack of Efficacy|0|||
163052531|NCT01863771|588903074|FG001|Maintenance Phase|Lack of Efficacy|3|||
163052532|NCT01863771|588903075|FG002|Maintenance Phase|Lack of Efficacy|7|||
163052533|NCT01863771|588903076|FG003|Maintenance Phase|Lack of Efficacy|38|||
163052534|NCT01863771|588903073|FG000|Maintenance Phase|Physician Decision|0|||
163052535|NCT01863771|588903074|FG001|Maintenance Phase|Physician Decision|0|||
163052536|NCT01863771|588903075|FG002|Maintenance Phase|Physician Decision|2|||
163052537|NCT01863771|588903076|FG003|Maintenance Phase|Physician Decision|1|||
163052538|NCT01863771|588903073|FG000|Maintenance Phase|Pregnancy|0|||
163052539|NCT01863771|588903074|FG001|Maintenance Phase|Pregnancy|1|||
163052540|NCT01863771|588903075|FG002|Maintenance Phase|Pregnancy|0|||
163052541|NCT01863771|588903076|FG003|Maintenance Phase|Pregnancy|0|||
163052542|NCT01863771|588903073|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163052543|NCT01863771|588903074|FG001|Maintenance Phase|Withdrawal by Subject|1|||
163052544|NCT01863771|588903075|FG002|Maintenance Phase|Withdrawal by Subject|2|||
163052545|NCT01863771|588903076|FG003|Maintenance Phase|Withdrawal by Subject|3|||
163052546|NCT00883181|588903077|FG000|Overall Study|Hematological Adverse Event|26|||
163052547|NCT00883181|588903077|FG000|Overall Study|Non-hematological Adverse Event|55|||
163052548|NCT00883181|588903077|FG000|Overall Study|Disease Progression|94|||
163052549|NCT00883181|588903077|FG000|Overall Study|Administrative Reason|24|||
163052550|NCT00883181|588903077|FG000|Overall Study|Withdrawal by Subject|4|||
163052551|NCT00883181|588903077|FG000|Overall Study|Death|31|||
163052552|NCT00883181|588903077|FG000|Overall Study|Other|38|||
163052553|NCT00883181|588903077|FG000|Overall Study|Protocol Deviation|3|||
163052554|NCT00883181|588903077|FG000|Overall Study|Noncompliance|3|||
163052555|NCT00386334|588903080|FG000|Double Blind Period|Adverse Event|9|||
163052556|NCT00386334|588903081|FG001|Double Blind Period|Adverse Event|14|||
163052557|NCT00386334|588903080|FG000|Double Blind Period|Protocol Violation|1|||
163052558|NCT00386334|588903081|FG001|Double Blind Period|Protocol Violation|1|||
163052559|NCT00386334|588903080|FG000|Double Blind Period|Withdrawal by Subject|9|||
163052560|NCT00386334|588903081|FG001|Double Blind Period|Withdrawal by Subject|13|||
163052561|NCT00386334|588903080|FG000|Double Blind Period|Lack of Efficacy|20|||
163052562|NCT00386334|588903081|FG001|Double Blind Period|Lack of Efficacy|11|||
163052563|NCT00386334|588903080|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
163052564|NCT00386334|588903081|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
163052565|NCT00386334|588903080|FG000|Double Blind Period|Other|3|||
163397486|NCT02289742|590167739|FG002|First Wear Period|Adverse event prior to treatment|0|||
163052566|NCT00386334|588903081|FG001|Double Blind Period|Other|3|||
163052567|NCT00386334|588903080|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
163052568|NCT00386334|588903081|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
163052569|NCT03238417|588903082|FG000|Overall|non-response|955|||
163052570|NCT03238417|588903083|FG001|Overall|non-response|1920|||
163052571|NCT03238417|588903082|FG000|Overall|partial completion|48|||
163052572|NCT03238417|588903083|FG001|Overall|partial completion|68|||
163052573|NCT03238417|588903082|FG000|Baseline|Partial completion|17|||
163052574|NCT03238417|588903083|FG001|Baseline|Partial completion|48|||
163052575|NCT03238417|588903082|FG000|Baseline|non-response|372|||
163052576|NCT03238417|588903083|FG001|Baseline|non-response|669|||
163052577|NCT03238417|588903082|FG000|12-month|non-response|296|||
163052578|NCT03238417|588903083|FG001|12-month|non-response|669|||
163052579|NCT03238417|588903082|FG000|12-month|partial completion|23|||
163052580|NCT03238417|588903083|FG001|12-month|partial completion|37|||
163052581|NCT03238417|588903082|FG000|24-month|non-response|287|||
163052582|NCT03238417|588903083|FG001|24-month|non-response|594|||
163052583|NCT03238417|588903082|FG000|24-month|partial completion|8|||
163052584|NCT03238417|588903083|FG001|24-month|partial completion|31|||
163052585|NCT02089347|588903084|FG000|Overall Study|Protocol Violation|1|||
163052586|NCT02089347|588903085|FG001|Overall Study|Protocol Violation|0|||
163052587|NCT02914834|588903086|FG000|Overall Study|Study halted due to COVID|1|||
163052588|NCT02914834|588903087|FG001|Overall Study|Study halted due to COVID|1|||
163052589|NCT02914834|588903086|FG000|Overall Study|1 subject withdrew|0|||
163052590|NCT02914834|588903087|FG001|Overall Study|1 subject withdrew|1|||
163052591|NCT01249131|588903090|FG000|Washout Period of 10 Days|Adverse Event|0|||
163205397|NCT01032837|589463598|FG003|Overall Study|Failed to return|0|||
163205398|NCT01032837|589463595|FG000|Overall Study|Refused treatment|0|||
163205399|NCT01032837|589463596|FG001|Overall Study|Refused treatment|0|||
163205400|NCT01032837|589463597|FG002|Overall Study|Refused treatment|0|||
163205401|NCT01032837|589463598|FG003|Overall Study|Refused treatment|1|||
163205402|NCT00843024|589463599|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
163205403|NCT00843024|589463600|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
163205404|NCT00843024|589463601|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
163205405|NCT00843024|589463602|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
163205406|NCT00843024|589463603|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
163205407|NCT00843024|589463604|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
163205408|NCT00843024|589463599|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
163205409|NCT00843024|589463600|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
163205410|NCT00843024|589463601|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
163205411|NCT00843024|589463602|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
163205412|NCT00843024|589463603|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
163205413|NCT00843024|589463604|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
163205414|NCT00843024|589463599|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
163205415|NCT00843024|589463600|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
163205416|NCT00843024|589463601|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
163205417|NCT00843024|589463602|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
163205418|NCT00843024|589463603|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
163205419|NCT00843024|589463604|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
163205420|NCT00843024|589463599|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
163205421|NCT00843024|589463600|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
163205422|NCT00843024|589463601|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
163205423|NCT00843024|589463602|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
163205424|NCT00843024|589463603|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
163205425|NCT00843024|589463604|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
163205426|NCT00843024|589463599|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
163205427|NCT00843024|589463600|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
163205428|NCT00843024|589463601|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
163205429|NCT00843024|589463602|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
163205430|NCT00843024|589463603|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
163205431|NCT00843024|589463604|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
163313555|NCT03603600|589859425|FG000|Overall Study|Withdrawal by Subject|5|||
163313556|NCT03603600|589859426|FG001|Overall Study|Withdrawal by Subject|7|||
163313557|NCT03603600|589859425|FG000|Overall Study|Lost to Follow-up|2|||
163313558|NCT03603600|589859426|FG001|Overall Study|Lost to Follow-up|3|||
163313559|NCT03603600|589859425|FG000|Overall Study|Death|3|||
163313560|NCT03603600|589859426|FG001|Overall Study|Death|1|||
163313561|NCT03603600|589859425|FG000|Overall Study|Physician Decision|2|||
163313562|NCT03603600|589859426|FG001|Overall Study|Physician Decision|1|||
163205432|NCT00843024|589463599|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
163205433|NCT00843024|589463600|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
163205434|NCT00843024|589463601|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
163205435|NCT00843024|589463602|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
163205436|NCT00843024|589463603|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
162965793|NCT01513239|588574598|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
162965794|NCT01513239|588574599|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
162965795|NCT01513239|588574600|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
162965796|NCT01513239|588574601|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
162965797|NCT00396162|588574602|FG000|Overall Study|Withdrawal by Subject|2|||
163205437|NCT00843024|589463604|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
163205438|NCT00843024|589463599|FG000|Single-blind Placebo Run-In Phase|Other|0|||
163205439|NCT00843024|589463600|FG001|Single-blind Placebo Run-In Phase|Other|1|||
163205440|NCT00843024|589463601|FG002|Single-blind Placebo Run-In Phase|Other|0|||
163205441|NCT00843024|589463602|FG003|Single-blind Placebo Run-In Phase|Other|0|||
163205442|NCT00843024|589463603|FG004|Single-blind Placebo Run-In Phase|Other|0|||
163205443|NCT00843024|589463604|FG005|Single-blind Placebo Run-In Phase|Other|0|||
163205444|NCT00843024|589463599|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
163205445|NCT00843024|589463600|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
163205446|NCT00843024|589463601|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
163205447|NCT00843024|589463602|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
163205448|NCT00843024|589463603|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
163205449|NCT00843024|589463604|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
163205450|NCT00843024|589463599|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
163205451|NCT00843024|589463600|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
163205452|NCT00843024|589463601|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
163205453|NCT00843024|589463602|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
163205454|NCT00843024|589463603|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
163205455|NCT00843024|589463604|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
163205456|NCT00843024|589463599|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
163205457|NCT00843024|589463600|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
163205458|NCT00843024|589463601|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
163205459|NCT00843024|589463602|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
163205460|NCT00843024|589463603|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
163205461|NCT00843024|589463604|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
163205462|NCT00843024|589463599|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
163205463|NCT00843024|589463600|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
163205464|NCT00843024|589463601|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
163205465|NCT00843024|589463602|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
163205466|NCT00843024|589463603|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
163205467|NCT00843024|589463604|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
163205468|NCT00843024|589463599|FG000|Double-blind Treatment Phase|Physician Decision|0|||
163205469|NCT00843024|589463600|FG001|Double-blind Treatment Phase|Physician Decision|0|||
163205470|NCT00843024|589463601|FG002|Double-blind Treatment Phase|Physician Decision|0|||
163205471|NCT00843024|589463602|FG003|Double-blind Treatment Phase|Physician Decision|3|||
163205472|NCT00843024|589463603|FG004|Double-blind Treatment Phase|Physician Decision|1|||
163205473|NCT00843024|589463604|FG005|Double-blind Treatment Phase|Physician Decision|1|||
163205474|NCT00843024|589463599|FG000|Double-blind Treatment Phase|Adverse Event|0|||
163205475|NCT00843024|589463600|FG001|Double-blind Treatment Phase|Adverse Event|0|||
163205476|NCT00843024|589463601|FG002|Double-blind Treatment Phase|Adverse Event|0|||
163205477|NCT00843024|589463602|FG003|Double-blind Treatment Phase|Adverse Event|0|||
163205478|NCT00843024|589463603|FG004|Double-blind Treatment Phase|Adverse Event|1|||
163205479|NCT00843024|589463604|FG005|Double-blind Treatment Phase|Adverse Event|1|||
163205480|NCT00843024|589463599|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
163205481|NCT00843024|589463600|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
163205482|NCT00843024|589463601|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
163205483|NCT00843024|589463602|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
163205484|NCT00843024|589463603|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
163205485|NCT00843024|589463604|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
163205486|NCT05201703|589463605|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
163205487|NCT05201703|589463606|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
163205488|NCT05201703|589463605|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
163205489|NCT05201703|589463606|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
163205490|NCT00844896|589463607|FG000|Overall Study|Lost to Follow-up|12|||
163205491|NCT00844896|589463608|FG001|Overall Study|Lost to Follow-up|16|||
163205492|NCT00844896|589463607|FG000|Overall Study|Parents did not have time to complete|0|||
163313563|NCT03603600|589859425|FG000|Overall Study|Other reason|1|||
162965798|NCT00396162|588574603|FG001|Overall Study|Withdrawal by Subject|3|||
162965799|NCT02694536|588574604|FG000|Overall Study|Progressive Disease|40|||
162965800|NCT02694536|588574604|FG000|Overall Study|Lost to Follow-up|1|||
162965801|NCT02694536|588574604|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
162965802|NCT02694536|588574604|FG000|Overall Study|Withdrawal by Subject|8|||
162965803|NCT02694536|588574604|FG000|Overall Study|Death|8|||
162965804|NCT02694536|588574604|FG000|Overall Study|Other|22|||
162965805|NCT01741545|588574605|FG000|Treatment Period|Lack of Efficacy|0|||
162965806|NCT01741545|588574606|FG001|Treatment Period|Lack of Efficacy|1|||
162965807|NCT01741545|588574605|FG000|Treatment Period|Adverse event, non-fatal|1|||
162965808|NCT01741545|588574606|FG001|Treatment Period|Adverse event, non-fatal|3|||
163397487|NCT02289742|590167740|FG003|First Wear Period|Adverse event prior to treatment|0|||
162965809|NCT01741545|588574605|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
162965810|NCT01741545|588574606|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
162965811|NCT01741545|588574605|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
162965812|NCT01741545|588574606|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
162965813|NCT01911429|588574607|FG000|Overall Study|Adverse Event|5|||
162965814|NCT01911429|588574608|FG001|Overall Study|Adverse Event|3|||
162965815|NCT01911429|588574609|FG002|Overall Study|Adverse Event|9|||
162965816|NCT01911429|588574607|FG000|Overall Study|Lack of Efficacy|1|||
162965817|NCT01911429|588574608|FG001|Overall Study|Lack of Efficacy|2|||
162965818|NCT01911429|588574609|FG002|Overall Study|Lack of Efficacy|4|||
162965819|NCT01911429|588574607|FG000|Overall Study|Lost to Follow-up|0|||
162965820|NCT01911429|588574608|FG001|Overall Study|Lost to Follow-up|0|||
162965821|NCT01911429|588574609|FG002|Overall Study|Lost to Follow-up|1|||
162965822|NCT01911429|588574607|FG000|Overall Study|Protocol Violation|0|||
162965823|NCT01911429|588574608|FG001|Overall Study|Protocol Violation|0|||
162965824|NCT01911429|588574609|FG002|Overall Study|Protocol Violation|1|||
162965825|NCT01911429|588574607|FG000|Overall Study|Withdrawal by Subject|5|||
162965826|NCT01911429|588574608|FG001|Overall Study|Withdrawal by Subject|5|||
162965827|NCT01911429|588574609|FG002|Overall Study|Withdrawal by Subject|4|||
162965828|NCT01911429|588574607|FG000|Overall Study|Accidental randomization|0|||
162965829|NCT01911429|588574608|FG001|Overall Study|Accidental randomization|0|||
162965830|NCT01911429|588574609|FG002|Overall Study|Accidental randomization|1|||
162965831|NCT01911429|588574607|FG000|Overall Study|subject left study|1|||
162965832|NCT01911429|588574608|FG001|Overall Study|subject left study|0|||
162965833|NCT01911429|588574609|FG002|Overall Study|subject left study|0|||
162965834|NCT01664039|588574613|FG000|Overall Study|Adverse Event|3|||
162965835|NCT01664039|588574614|FG001|Overall Study|Adverse Event|4|||
162965836|NCT01664039|588574613|FG000|Overall Study|Lost to Follow-up|1|||
162965837|NCT01664039|588574614|FG001|Overall Study|Lost to Follow-up|1|||
162965838|NCT01664039|588574613|FG000|Overall Study|Withdrawal by Subject|1|||
162965839|NCT01664039|588574614|FG001|Overall Study|Withdrawal by Subject|3|||
162965840|NCT01664039|588574613|FG000|Overall Study|Noncompliance|1|||
162965841|NCT01664039|588574614|FG001|Overall Study|Noncompliance|1|||
162965842|NCT01853176|588574615|FG000|Overall Study|Study terminated|4|||
162965843|NCT01853176|588574616|FG001|Overall Study|Study terminated|0|||
162965844|NCT02276885|588574617|FG000|Overall Study|Withdrawal by Subject|2|||
162965845|NCT02276885|588574618|FG001|Overall Study|Withdrawal by Subject|0|||
162965846|NCT02276885|588574617|FG000|Overall Study|Lost to Follow-up|5|||
162965847|NCT02276885|588574618|FG001|Overall Study|Lost to Follow-up|2|||
162965848|NCT04569032|588574619|FG000|Overall Study|Death|10|||
162965849|NCT04569032|588574620|FG001|Overall Study|Death|13|||
162965850|NCT04569032|588574619|FG000|Overall Study|Withdrawal by Subject|2|||
162965851|NCT04569032|588574620|FG001|Overall Study|Withdrawal by Subject|0|||
162965852|NCT04569032|588574619|FG000|Overall Study|Lost to Follow-up|0|||
162965853|NCT04569032|588574620|FG001|Overall Study|Lost to Follow-up|1|||
162965854|NCT04569032|588574619|FG000|Overall Study|In long term follow up|22|||
162965855|NCT04569032|588574620|FG001|Overall Study|In long term follow up|34|||
162965856|NCT03837626|588574626|FG000|Overall Study|Adverse Event|3|||
162965857|NCT03837626|588574627|FG001|Overall Study|Adverse Event|3|||
162965858|NCT03837626|588574626|FG000|Overall Study|Withdrawal by Subject|2|||
162965859|NCT03837626|588574627|FG001|Overall Study|Withdrawal by Subject|4|||
162965860|NCT03837626|588574626|FG000|Overall Study|Physician Decision|2|||
162965861|NCT03837626|588574627|FG001|Overall Study|Physician Decision|3|||
162965862|NCT03837626|588574626|FG000|Overall Study|Lost to Follow-up|3|||
162965863|NCT03837626|588574627|FG001|Overall Study|Lost to Follow-up|1|||
163205493|NCT00844896|589463608|FG001|Overall Study|Parents did not have time to complete|1|||
163205494|NCT00458211|589463609|FG000|Overall Study|Lack of Efficacy|12|||
162965864|NCT03599362|588574628|FG000|Overall Study|Screen Failure|3|||
162965865|NCT03707587|588574629|FG000|Overall Study|Death|0|||
162965866|NCT03707587|588574630|FG001|Overall Study|Death|1|||
162965867|NCT00958724|588574640|FG000|Overall Study|Disease Progression|6|||
162965868|NCT04442503|588574641|FG000|Overall Study|Adverse Event|1|||
162965869|NCT04442503|588574642|FG001|Overall Study|Adverse Event|1|||
162965870|NCT04442503|588574641|FG000|Overall Study|Lost to Follow-up|8|||
162965871|NCT04442503|588574642|FG001|Overall Study|Lost to Follow-up|6|||
163205495|NCT00458211|589463609|FG000|Overall Study|Withdrawal by Subject|2|||
162965872|NCT04442503|588574641|FG000|Overall Study|Physician Decision|0|||
163052592|NCT01249131|588903091|FG001|Washout Period of 10 Days|Adverse Event|0|||
163052593|NCT01249131|588903092|FG002|Washout Period of 10 Days|Adverse Event|0|||
163052594|NCT01249131|588903093|FG003|Washout Period of 10 Days|Adverse Event|0|||
163052595|NCT01249131|588903094|FG004|Washout Period of 10 Days|Adverse Event|1|||
163052596|NCT01249131|588903095|FG005|Washout Period of 10 Days|Adverse Event|0|||
163052597|NCT01225549|588903096|FG000|Period 4 - Washout|Disallowed medication|0|||
163052598|NCT01225549|588903097|FG001|Period 4 - Washout|Disallowed medication|1|||
163052599|NCT01225549|588903098|FG002|Period 4 - Washout|Disallowed medication|0|||
163052600|NCT01225549|588903099|FG003|Period 4 - Washout|Disallowed medication|0|||
163052601|NCT01225549|588903100|FG004|Period 4 - Washout|Disallowed medication|0|||
163052602|NCT01225549|588903101|FG005|Period 4 - Washout|Disallowed medication|0|||
163052603|NCT01225549|588903102|FG006|Period 4 - Washout|Disallowed medication|0|||
163052604|NCT01225549|588903103|FG007|Period 4 - Washout|Disallowed medication|0|||
163052605|NCT01225549|588903104|FG008|Period 4 - Washout|Disallowed medication|0|||
163052606|NCT01225549|588903105|FG009|Period 4 - Washout|Disallowed medication|0|||
163052607|NCT01225549|588903096|FG000|Period 6 - Washout|Disallowed medication|0|||
163052608|NCT01225549|588903097|FG001|Period 6 - Washout|Disallowed medication|0|||
163052609|NCT01225549|588903098|FG002|Period 6 - Washout|Disallowed medication|0|||
163052610|NCT01225549|588903099|FG003|Period 6 - Washout|Disallowed medication|1|||
163052611|NCT01225549|588903100|FG004|Period 6 - Washout|Disallowed medication|0|||
163052612|NCT01225549|588903101|FG005|Period 6 - Washout|Disallowed medication|0|||
163052613|NCT01225549|588903102|FG006|Period 6 - Washout|Disallowed medication|0|||
163052614|NCT01225549|588903103|FG007|Period 6 - Washout|Disallowed medication|0|||
163052615|NCT01225549|588903104|FG008|Period 6 - Washout|Disallowed medication|0|||
163052616|NCT01225549|588903105|FG009|Period 6 - Washout|Disallowed medication|0|||
163052617|NCT00473083|588903108|FG000|Overall Study|Adverse Event|1|||
163052618|NCT00473083|588903109|FG001|Overall Study|Adverse Event|0|||
163052619|NCT00473083|588903110|FG002|Overall Study|Adverse Event|0|||
163052620|NCT01184872|588903111|FG000|Overall Study|Adverse Event|3|||
163052621|NCT01184872|588903112|FG001|Overall Study|Adverse Event|4|||
163052622|NCT01184872|588903111|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
163052623|NCT01184872|588903112|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163052624|NCT01184872|588903111|FG000|Overall Study|Withdrawal by Subject|2|||
163052625|NCT01184872|588903112|FG001|Overall Study|Withdrawal by Subject|0|||
163313564|NCT03603600|589859426|FG001|Overall Study|Other reason|0|||
163313565|NCT02310646|589859431|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
163313566|NCT02310646|589859432|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
163313567|NCT02310646|589859431|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
163052626|NCT01184872|588903111|FG000|Overall Study|Lost to Follow-up|0|||
163052627|NCT01184872|588903112|FG001|Overall Study|Lost to Follow-up|1|||
163052628|NCT01184872|588903111|FG000|Overall Study|Administrative problems|1|||
163052629|NCT01184872|588903112|FG001|Overall Study|Administrative problems|1|||
163052630|NCT01184872|588903111|FG000|Overall Study|Protocol deviation|1|||
163052631|NCT01184872|588903112|FG001|Overall Study|Protocol deviation|0|||
163052632|NCT02446691|588903113|FG000|Overall Study|Withdrawal by Subject|2|||
163052633|NCT02446691|588903113|FG000|Overall Study|Lost to Follow-up|8|||
163052634|NCT02446691|588903113|FG000|Overall Study|Protocol Violation|1|||
163052635|NCT03903172|588903116|FG000|Overall Study|screen fail|4|||
163313568|NCT02310646|589859432|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
163313569|NCT00613106|589859439|FG000|Overall Study|Adverse Event|3|||
162965873|NCT04442503|588574642|FG001|Overall Study|Physician Decision|2|||
162965874|NCT04442503|588574641|FG000|Overall Study|Withdrawal by Subject|3|||
162965875|NCT04442503|588574642|FG001|Overall Study|Withdrawal by Subject|4|||
162965876|NCT04442503|588574641|FG000|Overall Study|Reason not Specified|0|||
162965877|NCT04442503|588574642|FG001|Overall Study|Reason not Specified|1|||
162965878|NCT04442503|588574641|FG000|Overall Study|Randomized but not Treated|3|||
162965879|NCT04442503|588574642|FG001|Overall Study|Randomized but not Treated|1|||
162965880|NCT05034874|588574649|FG000|Overall Study|Withdrawal by Subject|6|||
163313570|NCT00613106|589859440|FG001|Overall Study|Adverse Event|1|||
163052636|NCT03903172|588903117|FG001|Overall Study|screen fail|1|||
163052637|NCT01545388|588903118|FG000|Overall Study|Adverse Event|2|||
163052638|NCT01545388|588903119|FG001|Overall Study|Adverse Event|4|||
162965881|NCT05034874|588574650|FG001|Overall Study|Withdrawal by Subject|6|||
162965882|NCT05034874|588574649|FG000|Overall Study|Lost to Follow-up|18|||
162965883|NCT05034874|588574650|FG001|Overall Study|Lost to Follow-up|8|||
162965884|NCT05034874|588574649|FG000|Overall Study|Physician Decision|0|||
162965885|NCT05034874|588574650|FG001|Overall Study|Physician Decision|1|||
162965886|NCT05034874|588574649|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
162965887|NCT05034874|588574650|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
162965888|NCT01867658|588574651|FG000|Overall Study|Withdrawal by Subject|6|||
162965889|NCT01867658|588574651|FG000|Overall Study|Death|2|||
162965890|NCT01867658|588574651|FG000|Overall Study|Subject could not be contacted|1|||
162965891|NCT05278858|588574652|FG000|Overall Study|Withdrawal by Subject|1|||
162965892|NCT00474058|588574653|FG000|Overall Study|Adverse Event|11|||
162965893|NCT00474058|588574654|FG001|Overall Study|Adverse Event|6|||
162965894|NCT00474058|588574653|FG000|Overall Study|Lack of Efficacy|0|||
162965895|NCT00474058|588574654|FG001|Overall Study|Lack of Efficacy|4|||
162965896|NCT00474058|588574653|FG000|Overall Study|Withdrawal by Subject|11|||
162965897|NCT00474058|588574654|FG001|Overall Study|Withdrawal by Subject|7|||
162965898|NCT00474058|588574653|FG000|Overall Study|Other|2|||
162965899|NCT00474058|588574654|FG001|Overall Study|Other|0|||
162965900|NCT03101358|588574655|FG000|Overall Study|Non-compliance with study schedule|1|||
162965901|NCT03101358|588574656|FG001|Overall Study|Non-compliance with study schedule|0|||
162965902|NCT03101358|588574657|FG002|Overall Study|Non-compliance with study schedule|0|||
162965903|NCT03101358|588574658|FG003|Overall Study|Non-compliance with study schedule|1|||
162965904|NCT03101358|588574655|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
162965905|NCT03101358|588574656|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
162965906|NCT03101358|588574657|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
162965907|NCT03101358|588574658|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
162965908|NCT03101358|588574655|FG000|Overall Study|Physician Decision|1|||
162965909|NCT03101358|588574656|FG001|Overall Study|Physician Decision|0|||
162965910|NCT03101358|588574657|FG002|Overall Study|Physician Decision|0|||
162965911|NCT03101358|588574658|FG003|Overall Study|Physician Decision|3|||
162965912|NCT03101358|588574655|FG000|Overall Study|Adverse Event|0|||
162965913|NCT03101358|588574656|FG001|Overall Study|Adverse Event|0|||
162965914|NCT03101358|588574657|FG002|Overall Study|Adverse Event|1|||
162965915|NCT03101358|588574658|FG003|Overall Study|Adverse Event|0|||
162965916|NCT03101358|588574655|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
162965917|NCT03101358|588574656|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
162965918|NCT03101358|588574657|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
162965919|NCT03101358|588574658|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
162965920|NCT03101358|588574655|FG000|Overall Study|Lost to Follow-up|1|||
162965921|NCT03101358|588574656|FG001|Overall Study|Lost to Follow-up|0|||
162965922|NCT03101358|588574657|FG002|Overall Study|Lost to Follow-up|0|||
162965923|NCT03101358|588574658|FG003|Overall Study|Lost to Follow-up|1|||
162965924|NCT02640235|588574659|FG000|Overall Study|Withdrawal by Subject|7|||
162965925|NCT02640235|588574660|FG001|Overall Study|Withdrawal by Subject|6|||
162965926|NCT02640235|588574659|FG000|Overall Study|Lost to Follow-up|4|||
162965927|NCT02640235|588574660|FG001|Overall Study|Lost to Follow-up|3|||
162965928|NCT02640235|588574659|FG000|Overall Study|Death|2|||
162965929|NCT02640235|588574660|FG001|Overall Study|Death|3|||
162965930|NCT02640235|588574659|FG000|Overall Study|Other|1|||
162965931|NCT02640235|588574660|FG001|Overall Study|Other|2|||
162965932|NCT02426918|588574661|FG000|Overall Study|Adverse Event|2|||
162965933|NCT02426918|588574662|FG001|Overall Study|Adverse Event|2|||
162965934|NCT02426918|588574663|FG002|Overall Study|Adverse Event|0|||
162965935|NCT02426918|588574661|FG000|Overall Study|Physician Decision|1|||
162965936|NCT02426918|588574662|FG001|Overall Study|Physician Decision|1|||
162965937|NCT02426918|588574663|FG002|Overall Study|Physician Decision|1|||
162965938|NCT02426918|588574661|FG000|Overall Study|Withdrawal by Subject|5|||
162965939|NCT02426918|588574662|FG001|Overall Study|Withdrawal by Subject|5|||
162965940|NCT02426918|588574663|FG002|Overall Study|Withdrawal by Subject|4|||
162965941|NCT02426918|588574661|FG000|Overall Study|Other|9|||
162965942|NCT02426918|588574662|FG001|Overall Study|Other|11|||
162965943|NCT02426918|588574663|FG002|Overall Study|Other|9|||
162965944|NCT02420353|588574666|FG000|Overall Study|Withdrawal by Subject|0|||
162965945|NCT02420353|588574667|FG001|Overall Study|Withdrawal by Subject|1|||
162965946|NCT00503867|588574668|FG000|Overall Study|Lost to Follow-up|1|||
162965947|NCT00503867|588574668|FG000|Overall Study|Adverse Event|1|||
163052639|NCT01545388|588903120|FG002|Overall Study|Adverse Event|1|||
162965948|NCT01149057|588574669|FG000|Overall Study|Lack of Efficacy|16|||
162965949|NCT01149057|588574669|FG000|Overall Study|Adverse Event|13|||
162965950|NCT01149057|588574669|FG000|Overall Study|Withdrawal by Subject|9|||
162965951|NCT01149057|588574669|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
162965952|NCT01149057|588574669|FG000|Overall Study|B Cell Depletion|4|||
162965953|NCT01149057|588574669|FG000|Overall Study|Participant Non-Compliance|2|||
162965954|NCT01149057|588574669|FG000|Overall Study|Lost to Follow-up|1|||
163052640|NCT01545388|588903118|FG000|Overall Study|Lack of Efficacy|3|||
163052641|NCT01545388|588903119|FG001|Overall Study|Lack of Efficacy|2|||
163052642|NCT01545388|588903120|FG002|Overall Study|Lack of Efficacy|5|||
163052643|NCT01545388|588903118|FG000|Overall Study|Participant moved or relocated|1|||
163052644|NCT01545388|588903119|FG001|Overall Study|Participant moved or relocated|0|||
163052645|NCT01545388|588903120|FG002|Overall Study|Participant moved or relocated|0|||
163052646|NCT01545388|588903118|FG000|Overall Study|Withdrawal by Subject|1|||
163052647|NCT01545388|588903119|FG001|Overall Study|Withdrawal by Subject|4|||
163052648|NCT01545388|588903120|FG002|Overall Study|Withdrawal by Subject|2|||
163052649|NCT01545388|588903118|FG000|Overall Study|Other|1|||
163052650|NCT01545388|588903119|FG001|Overall Study|Other|1|||
163052651|NCT01545388|588903120|FG002|Overall Study|Other|0|||
163052652|NCT01825200|588903123|FG000|Overall Study|Lost to Follow-up|5|||
163052653|NCT01825200|588903124|FG001|Overall Study|Lost to Follow-up|6|||
163052654|NCT01825200|588903123|FG000|Overall Study|Withdrawal by Subject|0|||
163052655|NCT01825200|588903124|FG001|Overall Study|Withdrawal by Subject|1|||
163052656|NCT01474486|588903125|FG000|Overall Study|Death|2|||
163052657|NCT01474486|588903125|FG000|Overall Study|Withdrawal by Subject|4|||
163052658|NCT01474486|588903125|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
163052659|NCT01255163|588903126|FG000|Overall Study|Withdrawal by Subject|1|||
163052660|NCT01255163|588903127|FG001|Overall Study|Withdrawal by Subject|0|||
163052661|NCT01255163|588903126|FG000|Overall Study|Lost to Follow-up|2|||
163052662|NCT01255163|588903127|FG001|Overall Study|Lost to Follow-up|0|||
163052663|NCT01255163|588903126|FG000|Overall Study|Adverse Event|0|||
163052664|NCT01255163|588903127|FG001|Overall Study|Adverse Event|2|||
163052665|NCT01255163|588903126|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
163052666|NCT01255163|588903127|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
163052667|NCT04219189|588903128|FG000|Overall Study|Withdrawal by Subject|1|||
163052668|NCT04219189|588903129|FG001|Overall Study|Withdrawal by Subject|2|||
163052669|NCT04219189|588903128|FG000|Overall Study|Protocol Violation|0|||
163052670|NCT04219189|588903129|FG001|Overall Study|Protocol Violation|1|||
163052671|NCT04219189|588903128|FG000|Overall Study|Lost to Follow-up|0|||
163052672|NCT04219189|588903129|FG001|Overall Study|Lost to Follow-up|1|||
163052673|NCT04219189|588903128|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
163052674|NCT04219189|588903129|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
163052675|NCT02495389|588903130|FG000|Overall Study|Withdrawal by Subject|40|||
163052676|NCT01924533|588903131|FG000|Overall Study|Death|181|||
163052677|NCT01924533|588903132|FG001|Overall Study|Death|200|||
163052678|NCT01924533|588903131|FG000|Overall Study|Lost to Follow-up|0|||
163052679|NCT01924533|588903132|FG001|Overall Study|Lost to Follow-up|1|||
163052680|NCT01924533|588903131|FG000|Overall Study|Withdrawal by Subject|7|||
163052681|NCT01924533|588903132|FG001|Overall Study|Withdrawal by Subject|3|||
163052682|NCT01924533|588903131|FG000|Overall Study|Other Eligibility criteria|1|||
163052683|NCT01924533|588903132|FG001|Overall Study|Other Eligibility criteria|1|||
163052684|NCT05817669|588903133|FG000|Overall Study|Prohibited medication used|1|||
163052685|NCT05817669|588903134|FG001|Overall Study|Prohibited medication used|2|||
163205496|NCT00458211|589463609|FG000|Overall Study|Protocol Violation|2|||
163205497|NCT02132130|589463610|FG000|Overall Study|Lost to Follow-up|0|||
163205498|NCT02132130|589463611|FG001|Overall Study|Lost to Follow-up|2|||
163205499|NCT02132130|589463612|FG002|Overall Study|Lost to Follow-up|0|||
163205500|NCT02132130|589463613|FG003|Overall Study|Lost to Follow-up|0|||
163052686|NCT05817669|588903133|FG000|Overall Study|Adverse Event|1|||
163052687|NCT05817669|588903134|FG001|Overall Study|Adverse Event|0|||
163052688|NCT05817669|588903133|FG000|Overall Study|Withdrawal by Subject|1|||
163205501|NCT02132130|589463610|FG000|Overall Study|Withdrawal by Subject|0|||
163205502|NCT02132130|589463611|FG001|Overall Study|Withdrawal by Subject|0|||
163205503|NCT02132130|589463612|FG002|Overall Study|Withdrawal by Subject|0|||
163397488|NCT02289742|590167737|FG000|First Wear Period|Adverse Event|0|||
163397489|NCT02289742|590167738|FG001|First Wear Period|Adverse Event|0|||
163397490|NCT02289742|590167739|FG002|First Wear Period|Adverse Event|1|||
163205504|NCT02132130|589463613|FG003|Overall Study|Withdrawal by Subject|1|||
163205505|NCT00679302|589463614|FG000|Overall Study|Lost to Follow-up|8|||
163205506|NCT00679302|589463615|FG001|Overall Study|Lost to Follow-up|4|||
163205507|NCT04656691|589463616|FG000|Overall Study|Adverse Event|1|||
163205508|NCT00439244|589463619|FG000|Overall Study|Adverse Event|5|||
163205509|NCT00439244|589463620|FG001|Overall Study|Adverse Event|2|||
163205510|NCT00439244|589463621|FG002|Overall Study|Adverse Event|3|||
163205511|NCT00439244|589463619|FG000|Overall Study|Withdrawal by Subject|3|||
163205512|NCT00439244|589463620|FG001|Overall Study|Withdrawal by Subject|1|||
163205513|NCT00439244|589463621|FG002|Overall Study|Withdrawal by Subject|2|||
163205514|NCT00439244|589463619|FG000|Overall Study|Lost to Follow-up|2|||
163205515|NCT00439244|589463620|FG001|Overall Study|Lost to Follow-up|1|||
163205516|NCT00439244|589463621|FG002|Overall Study|Lost to Follow-up|2|||
163205517|NCT00439244|589463619|FG000|Overall Study|Death|0|||
163205518|NCT00439244|589463620|FG001|Overall Study|Death|1|||
163205519|NCT00439244|589463621|FG002|Overall Study|Death|0|||
163205520|NCT00439244|589463619|FG000|Overall Study|Protocol Violation|0|||
163205521|NCT00439244|589463620|FG001|Overall Study|Protocol Violation|1|||
163205522|NCT00439244|589463621|FG002|Overall Study|Protocol Violation|0|||
163205523|NCT00439244|589463619|FG000|Overall Study|Administrative problems|1|||
163205524|NCT00439244|589463620|FG001|Overall Study|Administrative problems|0|||
163205525|NCT00439244|589463621|FG002|Overall Study|Administrative problems|0|||
163205526|NCT00887978|589463622|FG000|Overall Study|Adverse Event|18|||
163205527|NCT00887978|589463623|FG001|Overall Study|Adverse Event|5|||
163205528|NCT00887978|589463622|FG000|Overall Study|Clinical Worsening|4|||
163205529|NCT00887978|589463623|FG001|Overall Study|Clinical Worsening|4|||
163205530|NCT00887978|589463622|FG000|Overall Study|Death|2|||
163205531|NCT00887978|589463623|FG001|Overall Study|Death|3|||
163205532|NCT00887978|589463622|FG000|Overall Study|Withdrawal by Subject|1|||
163205533|NCT00887978|589463623|FG001|Overall Study|Withdrawal by Subject|2|||
163205534|NCT00887978|589463622|FG000|Overall Study|Lost to Follow-up|0|||
163205535|NCT00887978|589463623|FG001|Overall Study|Lost to Follow-up|1|||
163205536|NCT04600921|589463624|FG000|Overall Study|Withdrawal by Subject|3|||
163205537|NCT04600921|589463625|FG001|Overall Study|Withdrawal by Subject|5|||
163205538|NCT04600921|589463624|FG000|Overall Study|Death|0|||
163205539|NCT04600921|589463625|FG001|Overall Study|Death|1|||
163205540|NCT05425745|589463629|FG000|Overall Study|Withdrawal of Consent|3|||
163205541|NCT05425745|589463630|FG001|Overall Study|Withdrawal of Consent|3|||
163205542|NCT05425745|589463629|FG000|Overall Study|Death|2|||
163205543|NCT05425745|589463630|FG001|Overall Study|Death|3|||
163205544|NCT05425745|589463629|FG000|Overall Study|Lost to Follow-up|1|||
163205545|NCT05425745|589463630|FG001|Overall Study|Lost to Follow-up|2|||
163205546|NCT05425745|589463629|FG000|Overall Study|Adverse Event|0|||
163205547|NCT05425745|589463630|FG001|Overall Study|Adverse Event|1|||
163205548|NCT05425745|589463629|FG000|Overall Study|Did not return for end of study visit|0|||
163205549|NCT05425745|589463630|FG001|Overall Study|Did not return for end of study visit|1|||
163205550|NCT05425745|589463629|FG000|Overall Study|End of study visit completed by phone|1|||
163205551|NCT05425745|589463630|FG001|Overall Study|End of study visit completed by phone|0|||
163205552|NCT05425745|589463629|FG000|Overall Study|Subject decision|1|||
163205553|NCT05425745|589463630|FG001|Overall Study|Subject decision|0|||
163205554|NCT02700815|589464989|FG000|Overall Study|Adverse Event|0|||
163313571|NCT00613106|589859439|FG000|Overall Study|Withdrawal by Subject|6|||
163313572|NCT00613106|589859440|FG001|Overall Study|Withdrawal by Subject|3|||
162965955|NCT01149057|588574669|FG000|Overall Study|High Parathyroid Hormone Value|1|||
162965956|NCT01149057|588574669|FG000|Overall Study|Other|6|||
162965957|NCT05616728|588574670|FG000|Overall Study|Lost to Follow-up|0|||
162965958|NCT05616728|588574671|FG001|Overall Study|Lost to Follow-up|0|||
162965959|NCT05616728|588574672|FG002|Overall Study|Lost to Follow-up|1|||
162965960|NCT05616728|588574670|FG000|Overall Study|Withdrawal by Subject|1|||
162965961|NCT05616728|588574671|FG001|Overall Study|Withdrawal by Subject|1|||
162965962|NCT05616728|588574672|FG002|Overall Study|Withdrawal by Subject|0|||
162965963|NCT05616728|588574670|FG000|Overall Study|Physician Decision|1|||
162965964|NCT05616728|588574671|FG001|Overall Study|Physician Decision|1|||
162965965|NCT05616728|588574672|FG002|Overall Study|Physician Decision|1|||
162965966|NCT05616728|588574670|FG000|Overall Study|Other|0|||
162965967|NCT05616728|588574671|FG001|Overall Study|Other|2|||
162965968|NCT05616728|588574672|FG002|Overall Study|Other|0|||
162965969|NCT05468320|588574682|FG000|Overall Study|Other|1|||
162965970|NCT05468320|588574682|FG000|Overall Study|Adverse Event|1|||
162965971|NCT03921554|588574683|FG000|Overall Study|Adverse Event|2|||
162965972|NCT03921554|588574683|FG000|Overall Study|Withdrawal by Subject|1|||
162965973|NCT03921554|588574683|FG000|Overall Study|Death|3|||
162965974|NCT04440592|588574684|FG000|Overall Study|Adverse Event|8|||
162965975|NCT04440592|588574685|FG001|Overall Study|Adverse Event|0|||
162965976|NCT04440592|588574684|FG000|Overall Study|Lost to Follow-up|1|||
162965977|NCT04440592|588574685|FG001|Overall Study|Lost to Follow-up|0|||
162965978|NCT04440592|588574684|FG000|Overall Study|Withdrawal by Subject|1|||
162965979|NCT04440592|588574685|FG001|Overall Study|Withdrawal by Subject|1|||
163205555|NCT02700815|589464990|FG001|Overall Study|Adverse Event|6|||
162965980|NCT04440592|588574684|FG000|Overall Study|Other therapy needed|0|||
162965981|NCT04440592|588574685|FG001|Overall Study|Other therapy needed|1|||
162965982|NCT02957331|588574688|FG000|Overall Study|Protocol Violation|1|||
162965983|NCT02957331|588574689|FG001|Overall Study|Protocol Violation|0|||
162965984|NCT05568615|588576366|FG000|Overall Study|Death|1|||
162965985|NCT05568615|588576366|FG000|Overall Study|Physician Decision|1|||
162965986|NCT00565851|588576367|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
162965987|NCT00565851|588576368|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
162965988|NCT00565851|588576369|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
162965989|NCT00565851|588576370|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
162965990|NCT00565851|588576371|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
162965991|NCT00565851|588576372|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
162965992|NCT00565851|588576373|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
162965993|NCT00565851|588576374|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
162965994|NCT00565851|588576367|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
162965995|NCT00565851|588576368|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
162965996|NCT00565851|588576369|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
162965997|NCT00565851|588576370|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
162965998|NCT00565851|588576371|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
162965999|NCT00565851|588576372|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
162966000|NCT00565851|588576373|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
162966001|NCT00565851|588576374|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
162966002|NCT03291067|588576375|FG000|Overall Study|Adverse Event|0|||
162966003|NCT03291067|588576376|FG001|Overall Study|Adverse Event|2|||
162966004|NCT03291067|588576377|FG002|Overall Study|Adverse Event|17|||
162966005|NCT03291067|588576378|FG003|Overall Study|Adverse Event|3|||
162966006|NCT03291067|588576375|FG000|Overall Study|Lost to Follow-up|2|||
162966007|NCT03291067|588576376|FG001|Overall Study|Lost to Follow-up|1|||
162966008|NCT03291067|588576377|FG002|Overall Study|Lost to Follow-up|0|||
162966009|NCT03291067|588576378|FG003|Overall Study|Lost to Follow-up|1|||
162966010|NCT03291067|588576375|FG000|Overall Study|Physician Decision|0|||
162966011|NCT03291067|588576376|FG001|Overall Study|Physician Decision|0|||
162966012|NCT03291067|588576377|FG002|Overall Study|Physician Decision|1|||
162966013|NCT03291067|588576378|FG003|Overall Study|Physician Decision|0|||
162966014|NCT03291067|588576375|FG000|Overall Study|Protocol Violation|5|||
162966015|NCT03291067|588576376|FG001|Overall Study|Protocol Violation|3|||
163397491|NCT02289742|590167740|FG003|First Wear Period|Adverse Event|0|||
162966016|NCT03291067|588576377|FG002|Overall Study|Protocol Violation|4|||
162966017|NCT03291067|588576378|FG003|Overall Study|Protocol Violation|2|||
162966018|NCT03291067|588576375|FG000|Overall Study|Withdrawal by Subject|3|||
162966019|NCT03291067|588576376|FG001|Overall Study|Withdrawal by Subject|4|||
162966020|NCT03291067|588576377|FG002|Overall Study|Withdrawal by Subject|7|||
163205556|NCT02700815|589464991|FG002|Overall Study|Adverse Event|2|||
163205557|NCT02700815|589464992|FG003|Overall Study|Adverse Event|3|||
163205558|NCT02700815|589464989|FG000|Overall Study|Lack of Efficacy|0|||
163205559|NCT02700815|589464990|FG001|Overall Study|Lack of Efficacy|0|||
163205560|NCT02700815|589464991|FG002|Overall Study|Lack of Efficacy|1|||
163205561|NCT02700815|589464992|FG003|Overall Study|Lack of Efficacy|2|||
163205562|NCT02700815|589464989|FG000|Overall Study|Lost to Follow-up|1|||
163205563|NCT02700815|589464990|FG001|Overall Study|Lost to Follow-up|0|||
163205564|NCT02700815|589464991|FG002|Overall Study|Lost to Follow-up|0|||
163205565|NCT02700815|589464992|FG003|Overall Study|Lost to Follow-up|1|||
163205566|NCT02700815|589464989|FG000|Overall Study|Refusal to continue medication|0|||
163205567|NCT02700815|589464990|FG001|Overall Study|Refusal to continue medication|1|||
163397492|NCT02289742|590167737|FG000|First Wear Period|Other prior to treatment|0|||
163205568|NCT02700815|589464991|FG002|Overall Study|Refusal to continue medication|0|||
163205569|NCT02700815|589464992|FG003|Overall Study|Refusal to continue medication|1|||
163205570|NCT02700815|589464989|FG000|Overall Study|Withdrawal by Subject|0|||
163205571|NCT02700815|589464990|FG001|Overall Study|Withdrawal by Subject|0|||
163205572|NCT02700815|589464991|FG002|Overall Study|Withdrawal by Subject|1|||
163205573|NCT02700815|589464992|FG003|Overall Study|Withdrawal by Subject|0|||
163205574|NCT02239978|589464996|FG000|Overall Study|Withdrawal by Subject|2|||
163205575|NCT02239978|589464997|FG001|Overall Study|Withdrawal by Subject|0|||
163205576|NCT03909295|589465001|FG000|Overall Study|Adverse Event|2|||
163205577|NCT03909295|589465001|FG000|Overall Study|Study terminated by sponsor|50|||
163205578|NCT03312933|589465005|FG000|Overall Study|Protocol Violation|15|||
163205579|NCT03312933|589465005|FG000|Overall Study|Lost to Follow-up|36|||
163205580|NCT03312933|589465005|FG000|Overall Study|Withdrawal by Subject|3|||
163205581|NCT00848081|589465006|FG000|Overall Study|Adverse Event|6|||
163205582|NCT00848081|589465007|FG001|Overall Study|Adverse Event|7|||
163205583|NCT00848081|589465006|FG000|Overall Study|Protocol Violation|8|||
163205584|NCT00848081|589465007|FG001|Overall Study|Protocol Violation|5|||
163205585|NCT00848081|589465006|FG000|Overall Study|Lost to Follow-up|1|||
163205586|NCT00848081|589465007|FG001|Overall Study|Lost to Follow-up|0|||
163205587|NCT00848081|589465006|FG000|Overall Study|Physician Decision|0|||
163205588|NCT00848081|589465007|FG001|Overall Study|Physician Decision|3|||
163205589|NCT00848081|589465006|FG000|Overall Study|Withdrawal by Subject|5|||
163205590|NCT00848081|589465007|FG001|Overall Study|Withdrawal by Subject|3|||
163205591|NCT01752907|589465009|FG000|Overall Study|Withdrawal by Subject|4|||
163205592|NCT01752907|589465010|FG001|Overall Study|Withdrawal by Subject|10|||
163205593|NCT01752907|589465009|FG000|Overall Study|Lost to Follow-up|2|||
163205594|NCT01752907|589465010|FG001|Overall Study|Lost to Follow-up|1|||
163205595|NCT01752907|589465009|FG000|Overall Study|Decision by Sponsor|6|||
163205596|NCT01752907|589465010|FG001|Overall Study|Decision by Sponsor|9|||
163052689|NCT05817669|588903134|FG001|Overall Study|Withdrawal by Subject|2|||
163052690|NCT04233879|588903135|FG000|Overall Study|Death|2|||
163052691|NCT04233879|588903136|FG001|Overall Study|Death|0|||
163052692|NCT04233879|588903135|FG000|Overall Study|Lost to Follow-up|3|||
163052693|NCT04233879|588903136|FG001|Overall Study|Lost to Follow-up|8|||
163052694|NCT04233879|588903135|FG000|Overall Study|Physician Decision|4|||
163052695|NCT04233879|588903136|FG001|Overall Study|Physician Decision|4|||
162966021|NCT03291067|588576378|FG003|Overall Study|Withdrawal by Subject|5|||
162966022|NCT03291067|588576375|FG000|Overall Study|Other|0|||
162966023|NCT03291067|588576376|FG001|Overall Study|Other|4|||
163052696|NCT04233879|588903135|FG000|Overall Study|Withdrawal by Subject|7|||
163052697|NCT04233879|588903136|FG001|Overall Study|Withdrawal by Subject|10|||
163052698|NCT04233879|588903135|FG000|Overall Study|Other|281|||
163052699|NCT04233879|588903136|FG001|Overall Study|Other|279|||
163052700|NCT03585270|588903139|FG000|Overall Study|Withdrawal by Subject|2|||
163052701|NCT03585270|588903140|FG001|Overall Study|Withdrawal by Subject|6|||
163052702|NCT03585270|588903139|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
163052703|NCT03585270|588903140|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
163052704|NCT03585270|588903139|FG000|Overall Study|Adverse Event|5|||
163052705|NCT03585270|588903140|FG001|Overall Study|Adverse Event|2|||
163052706|NCT03585270|588903139|FG000|Overall Study|Lost to Follow-up|1|||
163052707|NCT03585270|588903140|FG001|Overall Study|Lost to Follow-up|4|||
163052708|NCT03585270|588903139|FG000|Overall Study|Death|5|||
163052709|NCT03585270|588903140|FG001|Overall Study|Death|3|||
163052710|NCT03585270|588903139|FG000|Overall Study|Other reasons|2|||
163052711|NCT03585270|588903140|FG001|Overall Study|Other reasons|2|||
163052712|NCT01802385|588903142|FG000|Overall Study|Death|106|||
163052713|NCT01802385|588903143|FG001|Overall Study|Death|120|||
163052714|NCT00323063|588903145|FG000|Overall Study|Adverse Event|1|||
163052715|NCT00323063|588903146|FG001|Overall Study|Adverse Event|0|||
163052716|NCT00323063|588903145|FG000|Overall Study|brain mets discovered prior to treatment|1|||
163052717|NCT00323063|588903146|FG001|Overall Study|brain mets discovered prior to treatment|0|||
163052718|NCT03904693|588903147|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
163052719|NCT03904693|588903148|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
163052720|NCT03904693|588903149|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
163052721|NCT03904693|588903150|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
162966024|NCT03291067|588576377|FG002|Overall Study|Other|4|||
162966025|NCT03291067|588576378|FG003|Overall Study|Other|6|||
162966026|NCT01520987|588576386|FG000|Overall Study|Withdrawal by Subject|1|||
162966027|NCT01520987|588576387|FG001|Overall Study|Withdrawal by Subject|0|||
162966028|NCT01520987|588576388|FG002|Overall Study|Withdrawal by Subject|0|||
162966029|NCT01520987|588576389|FG003|Overall Study|Withdrawal by Subject|0|||
162966030|NCT01520987|588576390|FG004|Overall Study|Withdrawal by Subject|0|||
162966031|NCT01520987|588576391|FG005|Overall Study|Withdrawal by Subject|1|||
162966032|NCT01520987|588576392|FG006|Overall Study|Withdrawal by Subject|0|||
162966033|NCT01520987|588576393|FG007|Overall Study|Withdrawal by Subject|0|||
163052722|NCT03904693|588903151|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
163052723|NCT03904693|588903152|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
163052724|NCT03904693|588903147|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
163052725|NCT03904693|588903148|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
163052726|NCT03904693|588903149|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
163052727|NCT03904693|588903150|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
162966034|NCT02005562|588576394|FG000|Overall Study|Death|2|||
162966035|NCT02005562|588576395|FG001|Overall Study|Death|2|||
162966036|NCT02005562|588576394|FG000|Overall Study|Graft loss|7|||
162966037|NCT02005562|588576395|FG001|Overall Study|Graft loss|6|||
162966038|NCT02005562|588576394|FG000|Overall Study|Withdrawal by Subject|2|||
163052728|NCT03904693|588903151|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
162966039|NCT02005562|588576395|FG001|Overall Study|Withdrawal by Subject|2|||
163052729|NCT03904693|588903152|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
163052730|NCT03904693|588903147|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
163052731|NCT03904693|588903148|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
163052732|NCT03904693|588903149|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
162966040|NCT02005562|588576394|FG000|Overall Study|No transplant|1|||
162966041|NCT02005562|588576395|FG001|Overall Study|No transplant|4|||
162966042|NCT02005562|588576394|FG000|Overall Study|Physician Decision|0|||
163052733|NCT03904693|588903150|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
163052734|NCT03904693|588903151|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
163052735|NCT03904693|588903152|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
163052736|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
163052737|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
163052738|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
163052739|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
163052740|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
163052741|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
163052742|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
163052743|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
163052744|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
163052745|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
163052746|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
163052747|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
163052748|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
163052749|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
163052750|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
163052751|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
163052752|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
163052753|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
163397493|NCT02289742|590167738|FG001|First Wear Period|Other prior to treatment|0|||
163052754|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
163397494|NCT02289742|590167739|FG002|First Wear Period|Other prior to treatment|0|||
163052755|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
163313573|NCT00613106|589859439|FG000|Overall Study|Lost to Follow-up|7|||
163313574|NCT00613106|589859440|FG001|Overall Study|Lost to Follow-up|2|||
163313575|NCT00613106|589859439|FG000|Overall Study|misc|4|||
163313576|NCT00613106|589859440|FG001|Overall Study|misc|3|||
163313577|NCT03496168|589859441|FG000|Overall Study|Other Reasons|1|||
163313578|NCT03496168|589859441|FG000|Overall Study|Adverse Event|1|||
163313579|NCT05543629|589859444|FG000|Overall Study|Death|1|||
163313580|NCT05543629|589859445|FG001|Overall Study|Death|0|||
163313581|NCT05543629|589859446|FG002|Overall Study|Death|1|||
163313582|NCT05543629|589859447|FG003|Overall Study|Death|0|||
163313583|NCT05543629|589859448|FG004|Overall Study|Death|0|||
163313584|NCT05543629|589859449|FG005|Overall Study|Death|1|||
163313585|NCT05543629|589859450|FG006|Overall Study|Death|2|||
163313586|NCT05543629|589859451|FG007|Overall Study|Death|2|||
163313587|NCT05543629|589859444|FG000|Overall Study|Other Reasons|0|||
163052756|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
163052757|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
163052758|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
163052759|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
163052760|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
163052761|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
163052762|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
163052763|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
163052764|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
163052765|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
163052766|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
163052767|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
163052768|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
163052769|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
163052770|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
163052771|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
163052772|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
163052773|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
163052774|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
163052775|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
163052776|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
163052777|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
163052778|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
163052779|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
163052780|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
163052781|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
163052782|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
163052783|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
163052784|NCT05002972|588903154|FG000|Overall Study|Withdrawal by Subject|2|||
163052785|NCT01664091|588903155|FG000|Overall Study|Death|1|||
163313588|NCT05543629|589859445|FG001|Overall Study|Other Reasons|0|||
163313589|NCT05543629|589859446|FG002|Overall Study|Other Reasons|0|||
163313590|NCT05543629|589859447|FG003|Overall Study|Other Reasons|0|||
163313591|NCT05543629|589859448|FG004|Overall Study|Other Reasons|1|||
163313592|NCT05543629|589859449|FG005|Overall Study|Other Reasons|0|||
163313593|NCT05543629|589859450|FG006|Overall Study|Other Reasons|0|||
163052786|NCT01664091|588903155|FG000|Overall Study|Disease Progression|2|||
163313594|NCT05543629|589859451|FG007|Overall Study|Other Reasons|0|||
163313595|NCT05543629|589859444|FG000|Overall Study|Physician Decision|0|||
163313596|NCT05543629|589859445|FG001|Overall Study|Physician Decision|0|||
163313597|NCT05543629|589859446|FG002|Overall Study|Physician Decision|3|||
163313598|NCT05543629|589859447|FG003|Overall Study|Physician Decision|0|||
163313599|NCT05543629|589859448|FG004|Overall Study|Physician Decision|0|||
163313600|NCT05543629|589859449|FG005|Overall Study|Physician Decision|0|||
163313601|NCT05543629|589859450|FG006|Overall Study|Physician Decision|1|||
163313602|NCT05543629|589859451|FG007|Overall Study|Physician Decision|0|||
163313603|NCT05543629|589859444|FG000|Overall Study|Study terminated by Sponsor|1|||
163313604|NCT05543629|589859445|FG001|Overall Study|Study terminated by Sponsor|0|||
162966043|NCT02005562|588576395|FG001|Overall Study|Physician Decision|1|||
162966044|NCT04768296|588576396|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
162966045|NCT04768296|588576397|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
162966046|NCT00255346|588576404|FG000|Overall Study|Adverse Event|1|||
162966047|NCT00255346|588576405|FG001|Overall Study|Adverse Event|0|||
163205597|NCT03098550|589465011|FG000|Overall Study|Disease Progression|30|||
163205598|NCT03098550|589465012|FG001|Overall Study|Disease Progression|19|||
163205599|NCT03098550|589465013|FG002|Overall Study|Disease Progression|41|||
163205600|NCT03098550|589465011|FG000|Overall Study|Study Drug Toxicity|2|||
162966048|NCT00255346|588576406|FG002|Overall Study|Adverse Event|0|||
162966049|NCT00255346|588576407|FG003|Overall Study|Adverse Event|0|||
162966050|NCT00255346|588576408|FG004|Overall Study|Adverse Event|0|||
162966051|NCT04402489|588576414|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
162966052|NCT04402489|588576415|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
162966053|NCT04402489|588576416|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
162966054|NCT04402489|588576417|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
163205601|NCT03098550|589465012|FG001|Overall Study|Study Drug Toxicity|1|||
163205602|NCT03098550|589465013|FG002|Overall Study|Study Drug Toxicity|0|||
162966055|NCT04402489|588576418|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
162966056|NCT04402489|588576414|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
163205603|NCT03098550|589465011|FG000|Overall Study|Death|1|||
162966057|NCT04402489|588576415|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
162966058|NCT04402489|588576416|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
163205604|NCT03098550|589465012|FG001|Overall Study|Death|0|||
163205605|NCT03098550|589465013|FG002|Overall Study|Death|0|||
163205606|NCT03098550|589465011|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
163205607|NCT03098550|589465012|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
163205608|NCT03098550|589465013|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
163205609|NCT03098550|589465011|FG000|Overall Study|Administrative reason by sponsor|0|||
163205610|NCT03098550|589465012|FG001|Overall Study|Administrative reason by sponsor|0|||
163205611|NCT03098550|589465013|FG002|Overall Study|Administrative reason by sponsor|1|||
163205612|NCT03098550|589465011|FG000|Overall Study|Other reasons|2|||
163205613|NCT03098550|589465012|FG001|Overall Study|Other reasons|0|||
163205614|NCT03098550|589465013|FG002|Overall Study|Other reasons|0|||
163205615|NCT00630396|589465017|FG000|Overall Study|Death|4|||
163205616|NCT00630396|589465017|FG000|Overall Study|Lost to Follow-up|3|||
163205617|NCT02990910|589465021|FG000|Overall Study|Lack of Efficacy|6|||
163205618|NCT02990910|589465022|FG001|Overall Study|Lack of Efficacy|10|||
163205619|NCT02064868|589465024|FG000|Overall Study|Lost to Follow-up|14|||
162966059|NCT04402489|588576417|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
162966060|NCT04402489|588576418|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
162966061|NCT04402489|588576414|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
162966062|NCT04402489|588576415|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
162966063|NCT04402489|588576416|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
162966064|NCT04402489|588576417|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
162966065|NCT04402489|588576418|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
162966066|NCT04402489|588576414|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
162966067|NCT04402489|588576415|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
162966068|NCT04402489|588576416|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
162966069|NCT04402489|588576417|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
162966070|NCT04402489|588576418|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
162966071|NCT04402489|588576414|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
162966072|NCT04402489|588576415|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
162966073|NCT04402489|588576416|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
162966074|NCT04402489|588576417|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
162966075|NCT04402489|588576418|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
162966076|NCT04402489|588576414|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
162966077|NCT04402489|588576415|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
162966078|NCT04402489|588576416|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
162966079|NCT04402489|588576417|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
162966080|NCT04402489|588576418|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
162966081|NCT03192891|588576419|FG000|Overall Study|Lost to Follow-up|55|||
163205620|NCT02064868|589465025|FG001|Overall Study|Lost to Follow-up|8|||
162966082|NCT05223868|588576420|FG000|Overall Study|Lost to Follow-up|1|||
163052787|NCT01664091|588903155|FG000|Overall Study|Lost to Follow-up|2|||
163052788|NCT01664091|588903155|FG000|Overall Study|Withdrawal by Subject|1|||
163052789|NCT02053493|588903158|FG000|Overall Study|Withdrawal by Subject|1|||
163052790|NCT02053493|588903159|FG001|Overall Study|Withdrawal by Subject|1|||
163052791|NCT01076543|588903162|FG000|Overall Study|Withdrawal by Subject|2|||
163052792|NCT01076543|588903163|FG001|Overall Study|Withdrawal by Subject|0|||
162966083|NCT05223868|588576421|FG001|Overall Study|Lost to Follow-up|3|||
162966084|NCT05223868|588576422|FG002|Overall Study|Lost to Follow-up|0|||
162966085|NCT05223868|588576423|FG003|Overall Study|Lost to Follow-up|0|||
162966086|NCT05223868|588576424|FG004|Overall Study|Lost to Follow-up|0|||
162966087|NCT05223868|588576425|FG005|Overall Study|Lost to Follow-up|1|||
162966088|NCT05223868|588576420|FG000|Overall Study|Withdrawal by Subject|6|||
162966089|NCT05223868|588576421|FG001|Overall Study|Withdrawal by Subject|2|||
162966090|NCT05223868|588576422|FG002|Overall Study|Withdrawal by Subject|3|||
162966091|NCT05223868|588576423|FG003|Overall Study|Withdrawal by Subject|1|||
162966092|NCT05223868|588576424|FG004|Overall Study|Withdrawal by Subject|1|||
162966093|NCT05223868|588576425|FG005|Overall Study|Withdrawal by Subject|2|||
162966094|NCT05223868|588576420|FG000|Overall Study|Other|0|||
162966095|NCT05223868|588576421|FG001|Overall Study|Other|2|||
162966096|NCT05223868|588576422|FG002|Overall Study|Other|0|||
162966097|NCT05223868|588576423|FG003|Overall Study|Other|0|||
162966098|NCT05223868|588576424|FG004|Overall Study|Other|1|||
162966099|NCT05223868|588576425|FG005|Overall Study|Other|1|||
162966100|NCT05029687|588576426|FG000|Overall Study|Withdrawal by Subject|4|||
162966101|NCT05029687|588576427|FG001|Overall Study|Withdrawal by Subject|0|||
162966102|NCT05029687|588576428|FG002|Overall Study|Withdrawal by Subject|2|||
162966103|NCT05029687|588576426|FG000|Overall Study|Lost to Follow-up|4|||
162966104|NCT05029687|588576427|FG001|Overall Study|Lost to Follow-up|0|||
162966105|NCT05029687|588576428|FG002|Overall Study|Lost to Follow-up|2|||
162966106|NCT05740371|588576431|FG000|Overall Study|Death|1|||
162966107|NCT00874822|588576435|FG000|Overall Study|excluded by criteria|8|||
163205621|NCT02064868|589465024|FG000|Overall Study|Physician Decision|1|||
163397495|NCT02289742|590167740|FG003|First Wear Period|Other prior to treatment|1|||
162966108|NCT02854800|588576436|FG000|Overall Study|Protocol Violation|16|||
162966109|NCT02854800|588576437|FG001|Overall Study|Protocol Violation|11|||
162966110|NCT02854800|588576438|FG002|Overall Study|Protocol Violation|3|||
162966111|NCT02854800|588576436|FG000|Overall Study|Withdrawal by Subject|4|||
162966112|NCT02854800|588576437|FG001|Overall Study|Withdrawal by Subject|2|||
162966113|NCT02854800|588576438|FG002|Overall Study|Withdrawal by Subject|3|||
162966114|NCT01634139|588576440|FG000|Overall Study|Non compliant with protocol|1|||
162966115|NCT01634139|588576441|FG001|Overall Study|Non compliant with protocol|0|||
163052793|NCT01076543|588903164|FG002|Overall Study|Withdrawal by Subject|0|||
163397496|NCT02289742|590167737|FG000|Third Wear Period|Adverse Event|0|||
163205622|NCT02064868|589465025|FG001|Overall Study|Physician Decision|0|||
163205623|NCT02064868|589465024|FG000|Overall Study|Withdrawal by Subject|14|||
163205624|NCT02064868|589465025|FG001|Overall Study|Withdrawal by Subject|3|||
163205625|NCT02064868|589465024|FG000|Overall Study|Technical Problems or Missing|5|||
163205626|NCT02064868|589465025|FG001|Overall Study|Technical Problems or Missing|2|||
163205627|NCT00482612|589465026|FG000|In-treatment Period|No study medication administered|0|||
163205628|NCT00482612|589465027|FG001|In-treatment Period|No study medication administered|0|||
163205629|NCT00482612|589465028|FG002|In-treatment Period|No study medication administered|1|||
163205630|NCT00482612|589465029|FG003|In-treatment Period|No study medication administered|0|||
163205631|NCT00482612|589465026|FG000|Follow-up Period|Other|4|||
163205632|NCT00482612|589465027|FG001|Follow-up Period|Other|2|||
163205633|NCT00482612|589465028|FG002|Follow-up Period|Other|1|||
163205634|NCT00482612|589465029|FG003|Follow-up Period|Other|2|||
163205635|NCT00482612|589465026|FG000|Follow-up Period|Lack of compliance|0|||
163205636|NCT00482612|589465027|FG001|Follow-up Period|Lack of compliance|0|||
163205637|NCT00482612|589465028|FG002|Follow-up Period|Lack of compliance|1|||
163397497|NCT02289742|590167738|FG001|Third Wear Period|Adverse Event|1|||
163397498|NCT02289742|590167739|FG002|Third Wear Period|Adverse Event|0|||
163205638|NCT00482612|589465029|FG003|Follow-up Period|Lack of compliance|0|||
163205639|NCT00482612|589465026|FG000|Follow-up Period|Lost to Follow-up|0|||
163205640|NCT00482612|589465027|FG001|Follow-up Period|Lost to Follow-up|4|||
163205641|NCT00482612|589465028|FG002|Follow-up Period|Lost to Follow-up|2|||
162966116|NCT01634139|588576442|FG002|Overall Study|Non compliant with protocol|0|||
163205642|NCT00482612|589465029|FG003|Follow-up Period|Lost to Follow-up|1|||
163205643|NCT00482612|589465026|FG000|Follow-up Period|Adverse Event|4|||
163205644|NCT00482612|589465027|FG001|Follow-up Period|Adverse Event|7|||
163205645|NCT00482612|589465028|FG002|Follow-up Period|Adverse Event|9|||
163205646|NCT00482612|589465029|FG003|Follow-up Period|Adverse Event|0|||
163205647|NCT00482612|589465026|FG000|Follow-up Period|Lack of Efficacy|2|||
162966117|NCT01634139|588576440|FG000|Overall Study|Consent withdrawn not due to AE|4|||
163205648|NCT00482612|589465027|FG001|Follow-up Period|Lack of Efficacy|0|||
163205649|NCT00482612|589465028|FG002|Follow-up Period|Lack of Efficacy|1|||
163205650|NCT00482612|589465029|FG003|Follow-up Period|Lack of Efficacy|0|||
163205651|NCT00482612|589465026|FG000|Follow-up Period|Withdrawal by Subject|3|||
163205652|NCT00482612|589465027|FG001|Follow-up Period|Withdrawal by Subject|5|||
163205653|NCT00482612|589465028|FG002|Follow-up Period|Withdrawal by Subject|7|||
163205654|NCT00482612|589465029|FG003|Follow-up Period|Withdrawal by Subject|2|||
163205655|NCT00482612|589465026|FG000|Follow-up Period|Reasons not related to trial|1|||
163205656|NCT00482612|589465027|FG001|Follow-up Period|Reasons not related to trial|0|||
163052794|NCT01076543|588903165|FG003|Overall Study|Withdrawal by Subject|0|||
163052795|NCT01076543|588903166|FG004|Overall Study|Withdrawal by Subject|0|||
163052796|NCT01076543|588903167|FG005|Overall Study|Withdrawal by Subject|0|||
163052797|NCT00338741|588903168|FG000|Overall Study|Lost to Follow-up|2|||
163052798|NCT00338741|588903169|FG001|Overall Study|Lost to Follow-up|0|||
163052799|NCT01534273|588903170|FG000|Period 1|Physician Decision|0|||
163052800|NCT01534273|588903171|FG001|Period 1|Physician Decision|0|||
163052801|NCT01534273|588903172|FG002|Period 1|Physician Decision|0|||
163052802|NCT01534273|588903173|FG003|Period 1|Physician Decision|1|||
163052803|NCT01534273|588903174|FG004|Period 1|Physician Decision|0|||
163052804|NCT01534273|588903175|FG005|Period 1|Physician Decision|0|||
163052805|NCT01534273|588903176|FG006|Period 1|Physician Decision|0|||
163052806|NCT01619865|588903177|FG000|Overall Study|Adverse Event|1|||
163052807|NCT01619865|588903177|FG000|Overall Study|Death|2|||
163052808|NCT01619865|588903177|FG000|Overall Study|subject not able to comply|1|||
163052809|NCT03586050|588903178|FG000|Overall Study|Death|3|||
163052810|NCT03586050|588903178|FG000|Overall Study|Withdrawal by Subject|2|||
163052811|NCT01494818|588903179|FG000|Overall Study|Relocation|1|||
163052812|NCT01494818|588903180|FG001|Overall Study|Relocation|2|||
163052813|NCT01494818|588903179|FG000|Overall Study|Lost to Follow-up|1|||
163052814|NCT01494818|588903180|FG001|Overall Study|Lost to Follow-up|0|||
163052815|NCT00791999|588903181|FG000|Overall Study|Protocol planed withdrawal|14|||
163397499|NCT02289742|590167740|FG003|Third Wear Period|Adverse Event|0|||
163052816|NCT00791999|588903182|FG001|Overall Study|Protocol planed withdrawal|11|||
163205657|NCT00482612|589465028|FG002|Follow-up Period|Reasons not related to trial|1|||
163052817|NCT00791999|588903183|FG002|Overall Study|Protocol planed withdrawal|11|||
163052818|NCT00791999|588903184|FG003|Overall Study|Protocol planed withdrawal|45|||
163052819|NCT00791999|588903181|FG000|Overall Study|Withdrawal by Subject|0|||
163205658|NCT00482612|589465029|FG003|Follow-up Period|Reasons not related to trial|3|||
163205659|NCT00660023|589465030|FG000|Overall Study|Adverse Event|2|||
163205660|NCT00660023|589465030|FG000|Overall Study|Death|8|||
163205661|NCT00660023|589465030|FG000|Overall Study|Blood Transfusion|5|||
163205662|NCT00660023|589465030|FG000|Overall Study|Renal Transplantation|3|||
163205663|NCT00660023|589465030|FG000|Overall Study|Withdrawal by Subject|1|||
163205664|NCT00660023|589465030|FG000|Overall Study|Missed Pregnancy Test|1|||
163205665|NCT00660023|589465030|FG000|Overall Study|Other Screening Failure|9|||
163205666|NCT04180488|589465032|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
163205667|NCT04180488|589465033|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
163205668|NCT04180488|589465034|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
163205669|NCT04180488|589465035|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
163205670|NCT04180488|589465036|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
163205671|NCT04180488|589465037|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
163205672|NCT04180488|589465032|FG000|Overall Study|Withdrawal by Subject|8|||
163205673|NCT04180488|589465033|FG001|Overall Study|Withdrawal by Subject|4|||
163205674|NCT04180488|589465034|FG002|Overall Study|Withdrawal by Subject|5|||
163205675|NCT04180488|589465035|FG003|Overall Study|Withdrawal by Subject|2|||
163205676|NCT04180488|589465036|FG004|Overall Study|Withdrawal by Subject|8|||
163205677|NCT04180488|589465037|FG005|Overall Study|Withdrawal by Subject|6|||
163205678|NCT04180488|589465032|FG000|Overall Study|Adverse Event|3|||
163205679|NCT04180488|589465033|FG001|Overall Study|Adverse Event|2|||
163205680|NCT04180488|589465034|FG002|Overall Study|Adverse Event|0|||
163205681|NCT04180488|589465035|FG003|Overall Study|Adverse Event|0|||
163205682|NCT04180488|589465036|FG004|Overall Study|Adverse Event|0|||
163205683|NCT04180488|589465037|FG005|Overall Study|Adverse Event|0|||
163205684|NCT04180488|589465032|FG000|Overall Study|Poor compliance to protocol|0|||
163205685|NCT04180488|589465033|FG001|Overall Study|Poor compliance to protocol|0|||
163205686|NCT04180488|589465034|FG002|Overall Study|Poor compliance to protocol|1|||
163205687|NCT04180488|589465035|FG003|Overall Study|Poor compliance to protocol|0|||
163205688|NCT04180488|589465036|FG004|Overall Study|Poor compliance to protocol|0|||
163205689|NCT04180488|589465037|FG005|Overall Study|Poor compliance to protocol|0|||
163205690|NCT03506815|589465038|FG000|Overall Study|Adverse Event|8|||
163205691|NCT03506815|589465039|FG001|Overall Study|Adverse Event|0|||
163205692|NCT03506815|589465038|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
163205693|NCT03506815|589465039|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
163205694|NCT03506815|589465038|FG000|Overall Study|Protocol Violation|1|||
163205695|NCT03506815|589465039|FG001|Overall Study|Protocol Violation|0|||
163205696|NCT03506815|589465038|FG000|Overall Study|Elective Surgery|1|||
163205697|NCT03506815|589465039|FG001|Overall Study|Elective Surgery|0|||
163205698|NCT00381095|589465043|FG000|Overall Study|Death|3|||
162966118|NCT01634139|588576441|FG001|Overall Study|Consent withdrawn not due to AE|3|||
162966119|NCT01634139|588576442|FG002|Overall Study|Consent withdrawn not due to AE|2|||
162966120|NCT01634139|588576440|FG000|Overall Study|Other|4|||
162966121|NCT01634139|588576441|FG001|Overall Study|Other|0|||
162966122|NCT01634139|588576442|FG002|Overall Study|Other|3|||
162966123|NCT01634139|588576440|FG000|Overall Study|Lost to Follow-up|0|||
162966124|NCT01634139|588576441|FG001|Overall Study|Lost to Follow-up|2|||
162966125|NCT01634139|588576442|FG002|Overall Study|Lost to Follow-up|0|||
162966126|NCT01634139|588576440|FG000|Overall Study|Not treated|1|||
162966127|NCT01634139|588576441|FG001|Overall Study|Not treated|1|||
162966128|NCT01634139|588576442|FG002|Overall Study|Not treated|0|||
162966129|NCT02627963|588576448|FG000|Overall Study|Randomized but not treated|2|||
162966130|NCT02627963|588576449|FG001|Overall Study|Randomized but not treated|6|||
162966131|NCT01168856|588576450|FG000|Overall Study|Lost to Follow-up|4|||
162966132|NCT01168856|588576451|FG001|Overall Study|Lost to Follow-up|34|||
162966133|NCT01168856|588576450|FG000|Overall Study|Withdrawal by Subject|6|||
162966134|NCT01168856|588576451|FG001|Overall Study|Withdrawal by Subject|8|||
162966135|NCT01168856|588576450|FG000|Overall Study|Physician Decision|2|||
162966136|NCT01168856|588576451|FG001|Overall Study|Physician Decision|1|||
162966137|NCT01168856|588576450|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
162966138|NCT01168856|588576451|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
162966139|NCT01168856|588576450|FG000|Overall Study|Participant received anti-HCV treatment|1|||
162966140|NCT01168856|588576451|FG001|Overall Study|Participant received anti-HCV treatment|0|||
162966141|NCT01168856|588576450|FG000|Overall Study|Death|0|||
162966142|NCT01168856|588576451|FG001|Overall Study|Death|2|||
162966143|NCT01168856|588576450|FG000|Overall Study|Other|1|||
162966144|NCT01168856|588576451|FG001|Overall Study|Other|291|||
162966145|NCT01168856|588576450|FG000|Overall Study|Protocol Violation|4|||
162966146|NCT01168856|588576451|FG001|Overall Study|Protocol Violation|6|||
162966147|NCT05562011|588576452|FG000|Overall Study|Withdrawal by Subject|3|||
162966148|NCT05562011|588576452|FG000|Overall Study|Lost to Follow-up|1|||
162966149|NCT05562011|588576452|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
162966150|NCT05562011|588576452|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
162966151|NCT05562011|588576452|FG000|Overall Study|Device malfunction|13|||
162966152|NCT00387153|588576453|FG000|Overall Study|Adverse Event|1|||
162966153|NCT00387153|588576453|FG000|Overall Study|Disease Progression|3|||
162966154|NCT00387153|588576453|FG000|Overall Study|Lack of Response|4|||
162966155|NCT03073798|588576454|FG000|Overall Study|Adverse Event|1|||
162966156|NCT03073798|588576454|FG000|Overall Study|Withdrawal by Subject|1|||
162966157|NCT04411680|588576459|FG000|Treatment Period|Adverse Event|3|||
162966158|NCT04411680|588576460|FG001|Treatment Period|Adverse Event|0|||
162966159|NCT04411680|588576459|FG000|Treatment Period|Discharged from hospital|18|||
162966160|NCT04411680|588576460|FG001|Treatment Period|Discharged from hospital|7|||
162966161|NCT04411680|588576459|FG000|Treatment Period|Missed 1 or more doses|8|||
162966162|NCT04411680|588576460|FG001|Treatment Period|Missed 1 or more doses|0|||
162966163|NCT04411680|588576459|FG000|Treatment Period|Transferred to another hospital|0|||
162966164|NCT04411680|588576460|FG001|Treatment Period|Transferred to another hospital|1|||
162966165|NCT04411680|588576459|FG000|Follow up Period|Withdrawal by Subject|2|||
162966166|NCT04411680|588576460|FG001|Follow up Period|Withdrawal by Subject|0|||
162966167|NCT04411680|588576459|FG000|Follow up Period|Lost to Follow-up|5|||
162966168|NCT04411680|588576460|FG001|Follow up Period|Lost to Follow-up|6|||
162966169|NCT04411680|588576459|FG000|Follow up Period|Death|11|||
162966170|NCT04411680|588576460|FG001|Follow up Period|Death|8|||
162966171|NCT00840658|588576461|FG000|Overall Study|Death|2|||
162966172|NCT00840658|588576462|FG001|Overall Study|Death|2|||
162966173|NCT00840658|588576463|FG002|Overall Study|Death|3|||
162966174|NCT00840658|588576464|FG003|Overall Study|Death|3|||
162966175|NCT00840658|588576461|FG000|Overall Study|Lost to Follow-up|3|||
162966176|NCT00840658|588576462|FG001|Overall Study|Lost to Follow-up|1|||
162966177|NCT00840658|588576463|FG002|Overall Study|Lost to Follow-up|2|||
162966178|NCT00840658|588576464|FG003|Overall Study|Lost to Follow-up|1|||
162966179|NCT02372006|588576469|FG000|Overall Study|Progressive disease|8|||
162966180|NCT02372006|588576470|FG001|Overall Study|Progressive disease|7|||
162966181|NCT02372006|588576471|FG002|Overall Study|Progressive disease|34|||
162966182|NCT02372006|588576469|FG000|Overall Study|Dose limiting toxicity|0|||
162966183|NCT02372006|588576470|FG001|Overall Study|Dose limiting toxicity|1|||
162966184|NCT02372006|588576471|FG002|Overall Study|Dose limiting toxicity|0|||
162966185|NCT02372006|588576469|FG000|Overall Study|Adverse Event|0|||
162966186|NCT02372006|588576470|FG001|Overall Study|Adverse Event|0|||
162966187|NCT02372006|588576471|FG002|Overall Study|Adverse Event|3|||
162966188|NCT02372006|588576469|FG000|Overall Study|Withdrawal by Subject|0|||
162966189|NCT02372006|588576470|FG001|Overall Study|Withdrawal by Subject|1|||
162966190|NCT02372006|588576471|FG002|Overall Study|Withdrawal by Subject|1|||
162966191|NCT02372006|588576469|FG000|Overall Study|Other reason for not completing|0|||
162966192|NCT02372006|588576470|FG001|Overall Study|Other reason for not completing|0|||
162966193|NCT02372006|588576471|FG002|Overall Study|Other reason for not completing|1|||
162966194|NCT03504085|588576472|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
162966195|NCT03504085|588576473|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
163205699|NCT00381095|589465044|FG001|Overall Study|Death|4|||
163205700|NCT00381095|589465043|FG000|Overall Study|Lack of Efficacy|2|||
163205701|NCT00381095|589465044|FG001|Overall Study|Lack of Efficacy|4|||
163205702|NCT00381095|589465043|FG000|Overall Study|Other|2|||
163205703|NCT00381095|589465044|FG001|Overall Study|Other|2|||
163205704|NCT00381095|589465043|FG000|Overall Study|Protocol Violation|1|||
163205705|NCT00381095|589465044|FG001|Overall Study|Protocol Violation|1|||
163205706|NCT00381095|589465043|FG000|Overall Study|Withdrawal by Subject|3|||
163205707|NCT00381095|589465044|FG001|Overall Study|Withdrawal by Subject|3|||
163205708|NCT00381095|589465043|FG000|Overall Study|Adverse Event|2|||
163205709|NCT00381095|589465044|FG001|Overall Study|Adverse Event|7|||
163205710|NCT03562481|589465045|FG000|First Intervention|Lost to Follow-up|1|||
163205711|NCT03562481|589465046|FG001|First Intervention|Lost to Follow-up|0|||
163205712|NCT00856284|589465048|FG000|Overall Study|Hyperglycemic rescue|231|||
163205713|NCT00856284|589465049|FG001|Overall Study|Hyperglycemic rescue|201|||
163205714|NCT00856284|589465050|FG002|Overall Study|Hyperglycemic rescue|235|||
163205715|NCT00856284|589465048|FG000|Overall Study|Adverse Event|60|||
163205716|NCT00856284|589465049|FG001|Overall Study|Adverse Event|74|||
163205717|NCT00856284|589465050|FG002|Overall Study|Adverse Event|82|||
163205718|NCT00856284|589465048|FG000|Overall Study|Major protocol deviation|24|||
163205719|NCT00856284|589465049|FG001|Overall Study|Major protocol deviation|16|||
163205720|NCT00856284|589465050|FG002|Overall Study|Major protocol deviation|15|||
163205721|NCT00856284|589465048|FG000|Overall Study|Lost to Follow-up|20|||
163205722|NCT00856284|589465049|FG001|Overall Study|Lost to Follow-up|22|||
163205723|NCT00856284|589465050|FG002|Overall Study|Lost to Follow-up|28|||
163205724|NCT00856284|589465048|FG000|Overall Study|Voluntary withdrawal|48|||
163205725|NCT00856284|589465049|FG001|Overall Study|Voluntary withdrawal|52|||
163205726|NCT00856284|589465050|FG002|Overall Study|Voluntary withdrawal|62|||
163205727|NCT00856284|589465048|FG000|Overall Study|Pregnancy|1|||
163205728|NCT00856284|589465049|FG001|Overall Study|Pregnancy|2|||
163205729|NCT00856284|589465050|FG002|Overall Study|Pregnancy|0|||
163205730|NCT00856284|589465048|FG000|Overall Study|Investigator discretion|9|||
163205731|NCT00856284|589465049|FG001|Overall Study|Investigator discretion|8|||
163205732|NCT00856284|589465050|FG002|Overall Study|Investigator discretion|10|||
163205733|NCT00856284|589465048|FG000|Overall Study|Other|15|||
163205734|NCT00856284|589465049|FG001|Overall Study|Other|17|||
163205735|NCT00856284|589465050|FG002|Overall Study|Other|14|||
163205736|NCT00856284|589465048|FG000|Overall Study|Randomized in error|0|||
163205737|NCT00856284|589465049|FG001|Overall Study|Randomized in error|0|||
163205738|NCT00856284|589465050|FG002|Overall Study|Randomized in error|1|||
163205739|NCT04271605|589465051|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
163205740|NCT02485301|589465052|FG000|Overall Study|Serious Adverse Events|2|||
163205741|NCT02485301|589465053|FG001|Overall Study|Serious Adverse Events|1|||
163205742|NCT02485301|589465052|FG000|Overall Study|Protocol Violation|0|||
163205743|NCT02485301|589465053|FG001|Overall Study|Protocol Violation|1|||
163205744|NCT02485301|589465052|FG000|Overall Study|Withdrawal by Subject|6|||
163205745|NCT02485301|589465053|FG001|Overall Study|Withdrawal by Subject|7|||
163205746|NCT02485301|589465052|FG000|Overall Study|Migrated/moved from study area|10|||
163205747|NCT02485301|589465053|FG001|Overall Study|Migrated/moved from study area|19|||
163205748|NCT02485301|589465052|FG000|Overall Study|Lost to Follow-up|17|||
163205749|NCT02485301|589465053|FG001|Overall Study|Lost to Follow-up|17|||
163205750|NCT02485301|589465052|FG000|Overall Study|Other|3|||
163205751|NCT02485301|589465053|FG001|Overall Study|Other|4|||
163205752|NCT01059825|589465057|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
163205753|NCT01059825|589465058|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
163205754|NCT01059825|589465059|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
163205755|NCT01059825|589465060|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
163205756|NCT01059825|589465061|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
163205757|NCT01059825|589465062|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
163205758|NCT01059825|589465063|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
163205759|NCT01059825|589465057|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
163205760|NCT01059825|589465058|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
163205761|NCT01059825|589465059|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
163205762|NCT01059825|589465060|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
163205763|NCT01059825|589465061|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
163205764|NCT01059825|589465062|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
163205765|NCT01059825|589465063|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
163205766|NCT01059825|589465057|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
163205767|NCT01059825|589465058|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
163205768|NCT01059825|589465059|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
163205769|NCT01059825|589465060|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
163205770|NCT01059825|589465061|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
163205771|NCT01059825|589465062|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
163205772|NCT01059825|589465063|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
163205773|NCT01059825|589465057|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
163205774|NCT01059825|589465058|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
163205775|NCT01059825|589465059|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
163205776|NCT01059825|589465060|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
163205777|NCT01059825|589465061|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
163205778|NCT01059825|589465062|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
163205779|NCT01059825|589465063|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
163205780|NCT01059825|589465057|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
163205781|NCT01059825|589465058|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
163205782|NCT01059825|589465059|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
163205783|NCT01059825|589465060|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
163205784|NCT01059825|589465061|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
163205785|NCT01059825|589465062|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
163205786|NCT01059825|589465063|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
163205787|NCT01059825|589465057|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
163205788|NCT01059825|589465058|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
163205789|NCT01059825|589465059|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
163205790|NCT01059825|589465060|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
163205791|NCT01059825|589465061|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
163205792|NCT01059825|589465062|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
163205793|NCT01059825|589465063|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
163205794|NCT01059825|589465057|FG000|Treatment Period|Lost to Follow-up|2|||
163205795|NCT01059825|589465058|FG001|Treatment Period|Lost to Follow-up|1|||
162966196|NCT03504085|588576472|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
162966197|NCT03504085|588576473|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
162966198|NCT04133311|588576475|FG000|Period 1 Double Masked Treatment Period|Death|1|||
162966199|NCT04133311|588576476|FG001|Period 1 Double Masked Treatment Period|Death|0|||
162966200|NCT04133311|588576477|FG002|Period 1 Double Masked Treatment Period|Death|0|||
162966201|NCT04133311|588576478|FG003|Period 1 Double Masked Treatment Period|Death|0|||
162966202|NCT04133311|588576475|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
163052820|NCT00791999|588903182|FG001|Overall Study|Withdrawal by Subject|1|||
163052821|NCT00791999|588903183|FG002|Overall Study|Withdrawal by Subject|0|||
163205796|NCT01059825|589465059|FG002|Treatment Period|Lost to Follow-up|0|||
163205797|NCT01059825|589465060|FG003|Treatment Period|Lost to Follow-up|1|||
163205798|NCT01059825|589465061|FG004|Treatment Period|Lost to Follow-up|2|||
163205799|NCT01059825|589465062|FG005|Treatment Period|Lost to Follow-up|0|||
163205800|NCT01059825|589465063|FG006|Treatment Period|Lost to Follow-up|0|||
163205801|NCT01059825|589465057|FG000|Treatment Period|Withdrawal by Subject|3|||
163205802|NCT01059825|589465058|FG001|Treatment Period|Withdrawal by Subject|0|||
163205803|NCT01059825|589465059|FG002|Treatment Period|Withdrawal by Subject|1|||
163205804|NCT01059825|589465060|FG003|Treatment Period|Withdrawal by Subject|5|||
163205805|NCT01059825|589465061|FG004|Treatment Period|Withdrawal by Subject|4|||
163205806|NCT01059825|589465062|FG005|Treatment Period|Withdrawal by Subject|1|||
163205807|NCT01059825|589465063|FG006|Treatment Period|Withdrawal by Subject|0|||
163205808|NCT01059825|589465057|FG000|Treatment Period|Other reason not specified|1|||
163205809|NCT01059825|589465058|FG001|Treatment Period|Other reason not specified|2|||
163205810|NCT01059825|589465059|FG002|Treatment Period|Other reason not specified|1|||
163313605|NCT05543629|589859446|FG002|Overall Study|Study terminated by Sponsor|0|||
163313606|NCT05543629|589859447|FG003|Overall Study|Study terminated by Sponsor|1|||
163313607|NCT05543629|589859448|FG004|Overall Study|Study terminated by Sponsor|0|||
163313608|NCT05543629|589859449|FG005|Overall Study|Study terminated by Sponsor|4|||
163313609|NCT05543629|589859450|FG006|Overall Study|Study terminated by Sponsor|1|||
163313610|NCT05543629|589859451|FG007|Overall Study|Study terminated by Sponsor|0|||
163313611|NCT05543629|589859444|FG000|Overall Study|Withdrawal by Subject|1|||
163313612|NCT05543629|589859445|FG001|Overall Study|Withdrawal by Subject|1|||
163313613|NCT05543629|589859446|FG002|Overall Study|Withdrawal by Subject|0|||
163313614|NCT05543629|589859447|FG003|Overall Study|Withdrawal by Subject|2|||
163313615|NCT05543629|589859448|FG004|Overall Study|Withdrawal by Subject|1|||
163052822|NCT00791999|588903184|FG003|Overall Study|Withdrawal by Subject|2|||
163052823|NCT00791999|588903181|FG000|Overall Study|Protocol Violation|3|||
163052824|NCT00791999|588903182|FG001|Overall Study|Protocol Violation|0|||
163052825|NCT00791999|588903183|FG002|Overall Study|Protocol Violation|1|||
163052826|NCT00791999|588903184|FG003|Overall Study|Protocol Violation|0|||
163052827|NCT00791999|588903181|FG000|Overall Study|Adverse Event|3|||
163052828|NCT00791999|588903182|FG001|Overall Study|Adverse Event|3|||
163052829|NCT00791999|588903183|FG002|Overall Study|Adverse Event|7|||
163052830|NCT00791999|588903184|FG003|Overall Study|Adverse Event|3|||
163052831|NCT00791999|588903181|FG000|Overall Study|Lack of Efficacy|0|||
163052832|NCT00791999|588903182|FG001|Overall Study|Lack of Efficacy|1|||
163052833|NCT00791999|588903183|FG002|Overall Study|Lack of Efficacy|0|||
163052834|NCT00791999|588903184|FG003|Overall Study|Lack of Efficacy|2|||
163052835|NCT00791999|588903181|FG000|Overall Study|Reason other than those above|1|||
163052836|NCT00791999|588903182|FG001|Overall Study|Reason other than those above|0|||
163052837|NCT00791999|588903183|FG002|Overall Study|Reason other than those above|1|||
163205811|NCT01059825|589465060|FG003|Treatment Period|Other reason not specified|2|||
163205812|NCT01059825|589465061|FG004|Treatment Period|Other reason not specified|0|||
163052838|NCT00791999|588903184|FG003|Overall Study|Reason other than those above|0|||
163052839|NCT02998151|588903187|FG000|Overall Study|Withdrawal by Subject|3|||
163052840|NCT02998151|588903187|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
163052841|NCT02998151|588903187|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
163052842|NCT00350545|588904727|FG000|Overall Study|Withdrawal by Subject|2|||
163052843|NCT01655901|588904731|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
163052844|NCT01655901|588904732|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
163052845|NCT01655901|588904733|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
163313616|NCT05543629|589859449|FG005|Overall Study|Withdrawal by Subject|1|||
163052846|NCT01655901|588904734|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
163052847|NCT01655901|588904735|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
163052848|NCT01655901|588904736|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
163052849|NCT02579629|588904740|FG000|Overall Study|Withdrawal by Subject|0|||
163052850|NCT02579629|588904741|FG001|Overall Study|Withdrawal by Subject|1|||
163052851|NCT02579629|588904742|FG002|Overall Study|Withdrawal by Subject|0|||
163052852|NCT02579629|588904740|FG000|Overall Study|Screen Failure|2|||
163052853|NCT02579629|588904741|FG001|Overall Study|Screen Failure|0|||
163052854|NCT02579629|588904742|FG002|Overall Study|Screen Failure|2|||
163052855|NCT01190891|588904743|FG000|Overall Study|Protocol Violation|1|||
163052856|NCT01190891|588904744|FG001|Overall Study|Protocol Violation|0|||
163052857|NCT01190891|588904743|FG000|Overall Study|Withdrawal by Subject|5|||
163052858|NCT01190891|588904744|FG001|Overall Study|Withdrawal by Subject|0|||
163052859|NCT00737048|588904745|FG000|Overall Study|Physician Decision|0|||
163052860|NCT00737048|588904746|FG001|Overall Study|Physician Decision|0|||
163052861|NCT00737048|588904747|FG002|Overall Study|Physician Decision|1|||
163052862|NCT00737048|588904745|FG000|Overall Study|Adverse Event|0|||
163052863|NCT00737048|588904746|FG001|Overall Study|Adverse Event|1|||
163052864|NCT00737048|588904747|FG002|Overall Study|Adverse Event|0|||
163052865|NCT00737048|588904745|FG000|Overall Study|Worsening of the symptoms|3|||
163052866|NCT00737048|588904746|FG001|Overall Study|Worsening of the symptoms|5|||
163052867|NCT00737048|588904747|FG002|Overall Study|Worsening of the symptoms|3|||
163052868|NCT00301834|588904748|FG000|Overall Study|Death|1|||
163052869|NCT02737358|588904749|FG000|Overall Study|Withdrawal by Subject|7|||
163052870|NCT02737358|588904750|FG001|Overall Study|Withdrawal by Subject|12|||
163052871|NCT02737358|588904749|FG000|Overall Study|Lost to Follow-up|2|||
163052872|NCT02737358|588904750|FG001|Overall Study|Lost to Follow-up|3|||
163052873|NCT00744939|588904751|FG000|Overall Study|Withdrawal by Subject|9|||
163052874|NCT00744939|588904751|FG000|Overall Study|Protocol Violation|13|||
163052875|NCT00744939|588904751|FG000|Overall Study|Death|24|||
163052876|NCT00744939|588904751|FG000|Overall Study|distance|4|||
163052877|NCT00744939|588904751|FG000|Overall Study|Lost to Follow-up|12|||
163052878|NCT00744939|588904751|FG000|Overall Study|Medical history exclusionary|1|||
163052879|NCT00744939|588904751|FG000|Overall Study|Did not receive Magnevist|7|||
163052880|NCT00744939|588904751|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
163052881|NCT00744939|588904751|FG000|Overall Study|coma|1|||
163052882|NCT00744939|588904751|FG000|Overall Study|incorrect race|1|||
163052883|NCT00183430|588904752|FG000|Overall Study|Adverse Event|1|||
163052884|NCT00183430|588904753|FG001|Overall Study|Adverse Event|0|||
163052885|NCT00183430|588904752|FG000|Overall Study|Lost to Follow-up|3|||
163052886|NCT00183430|588904753|FG001|Overall Study|Lost to Follow-up|0|||
163052887|NCT00183430|588904752|FG000|Overall Study|did not meet inclusion criteria|1|||
163052888|NCT00183430|588904753|FG001|Overall Study|did not meet inclusion criteria|0|||
163052889|NCT00183430|588904752|FG000|Overall Study|Withdrawal by Subject|1|||
163052890|NCT00183430|588904753|FG001|Overall Study|Withdrawal by Subject|0|||
163052891|NCT03636256|588904758|FG000|Overall Study|Lost to Follow-up|3|||
163052892|NCT03636256|588904759|FG001|Overall Study|Lost to Follow-up|0|||
163052893|NCT03636256|588904760|FG002|Overall Study|Lost to Follow-up|2|||
163397500|NCT02289742|590167737|FG000|Third Wear Period|Reason not given|0|||
163052894|NCT03636256|588904761|FG003|Overall Study|Lost to Follow-up|1|||
163052895|NCT03636256|588904762|FG004|Overall Study|Lost to Follow-up|0|||
163205813|NCT01059825|589465062|FG005|Treatment Period|Other reason not specified|0|||
163205814|NCT01059825|589465063|FG006|Treatment Period|Other reason not specified|0|||
163205815|NCT01059825|589465057|FG000|Treatment Period|Protocol Violation|0|||
163205816|NCT01059825|589465058|FG001|Treatment Period|Protocol Violation|0|||
163205817|NCT01059825|589465059|FG002|Treatment Period|Protocol Violation|1|||
163205818|NCT01059825|589465060|FG003|Treatment Period|Protocol Violation|1|||
163205819|NCT01059825|589465061|FG004|Treatment Period|Protocol Violation|1|||
163205820|NCT01059825|589465062|FG005|Treatment Period|Protocol Violation|1|||
163205821|NCT01059825|589465063|FG006|Treatment Period|Protocol Violation|0|||
163205822|NCT01059825|589465057|FG000|Treatment Period|Adverse event related to study drug|1|||
163205823|NCT01059825|589465058|FG001|Treatment Period|Adverse event related to study drug|0|||
163205824|NCT01059825|589465059|FG002|Treatment Period|Adverse event related to study drug|1|||
163205825|NCT01059825|589465060|FG003|Treatment Period|Adverse event related to study drug|1|||
163205826|NCT01059825|589465061|FG004|Treatment Period|Adverse event related to study drug|0|||
163205827|NCT01059825|589465062|FG005|Treatment Period|Adverse event related to study drug|0|||
163205828|NCT01059825|589465063|FG006|Treatment Period|Adverse event related to study drug|0|||
163205829|NCT01059825|589465057|FG000|Treatment Period|Insufficient clinical response|3|||
163205830|NCT01059825|589465058|FG001|Treatment Period|Insufficient clinical response|0|||
163205831|NCT01059825|589465059|FG002|Treatment Period|Insufficient clinical response|0|||
163205832|NCT01059825|589465060|FG003|Treatment Period|Insufficient clinical response|0|||
163205833|NCT01059825|589465061|FG004|Treatment Period|Insufficient clinical response|0|||
163205834|NCT01059825|589465062|FG005|Treatment Period|Insufficient clinical response|0|||
163205835|NCT01059825|589465063|FG006|Treatment Period|Insufficient clinical response|0|||
163397501|NCT02289742|590167738|FG001|Third Wear Period|Reason not given|0|||
162966203|NCT04133311|588576476|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
162966204|NCT04133311|588576477|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
162966205|NCT04133311|588576478|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
162966206|NCT04133311|588576475|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
162966207|NCT04133311|588576476|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
162966208|NCT04133311|588576477|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
162966209|NCT04133311|588576478|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
162966210|NCT04133311|588576475|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
162966211|NCT04133311|588576476|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
162966212|NCT04133311|588576477|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
162966213|NCT04133311|588576478|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
162966214|NCT04133311|588576475|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
162966215|NCT04133311|588576476|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
162966216|NCT04133311|588576477|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
162966217|NCT04133311|588576478|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
162966218|NCT04133311|588576475|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
162966219|NCT04133311|588576476|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
162966220|NCT04133311|588576477|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
162966221|NCT04133311|588576478|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
162966222|NCT04133311|588576475|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
162966223|NCT04133311|588576476|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
162966224|NCT04133311|588576477|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
162966225|NCT04133311|588576478|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
162966226|NCT04133311|588576475|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
162966227|NCT04133311|588576476|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
162966228|NCT04133311|588576477|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
162966229|NCT04133311|588576478|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
162966230|NCT00728754|588576481|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
162966231|NCT00728754|588576482|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
162966232|NCT00728754|588576481|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
162966233|NCT00728754|588576482|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
162966234|NCT00728754|588576481|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
162966235|NCT00728754|588576482|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
162966236|NCT01859598|588576483|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
162966237|NCT00672984|588576484|FG000|First Intervention|Adverse Event|5|||
162966238|NCT00672984|588576485|FG001|First Intervention|Adverse Event|0|||
162966239|NCT00672984|588576486|FG002|First Intervention|Adverse Event|0|||
162966240|NCT00672984|588576484|FG000|First Intervention|Withdrawal by Subject|1|||
163052896|NCT03636256|588904763|FG005|Overall Study|Lost to Follow-up|4|||
163313617|NCT05543629|589859450|FG006|Overall Study|Withdrawal by Subject|1|||
163313618|NCT05543629|589859451|FG007|Overall Study|Withdrawal by Subject|1|||
162966241|NCT00672984|588576485|FG001|First Intervention|Withdrawal by Subject|2|||
162966242|NCT00672984|588576486|FG002|First Intervention|Withdrawal by Subject|2|||
162966243|NCT00672984|588576484|FG000|First Intervention|Sponsor decision|3|||
162966244|NCT00672984|588576485|FG001|First Intervention|Sponsor decision|0|||
162966245|NCT00672984|588576486|FG002|First Intervention|Sponsor decision|0|||
162966246|NCT00672984|588576484|FG000|Second Intervention|Non-compliance with facility policies|0|||
162966247|NCT00672984|588576485|FG001|Second Intervention|Non-compliance with facility policies|2|||
162966248|NCT00672984|588576486|FG002|Second Intervention|Non-compliance with facility policies|0|||
162966249|NCT00672984|588576484|FG000|Second Intervention|Withdrawal by Subject|0|||
162966250|NCT00672984|588576485|FG001|Second Intervention|Withdrawal by Subject|3|||
162966251|NCT00672984|588576486|FG002|Second Intervention|Withdrawal by Subject|0|||
162966252|NCT00672984|588576484|FG000|Second Intervention|Protocol Violation|0|||
162966253|NCT00672984|588576485|FG001|Second Intervention|Protocol Violation|1|||
162966254|NCT00672984|588576486|FG002|Second Intervention|Protocol Violation|1|||
162966255|NCT00672984|588576484|FG000|Third Intervention|Adverse Event|1|||
162966256|NCT00672984|588576485|FG001|Third Intervention|Adverse Event|0|||
162966257|NCT00672984|588576486|FG002|Third Intervention|Adverse Event|1|||
162966258|NCT00009945|588576487|FG000|Overall Study|no follow up data|7|||
162966259|NCT00009945|588576488|FG001|Overall Study|no follow up data|5|||
162966260|NCT00573313|588576493|FG000|Overall Study|Protocol Violation|5|||
162966261|NCT00573313|588576494|FG001|Overall Study|Protocol Violation|0|||
162966262|NCT00573313|588576495|FG002|Overall Study|Protocol Violation|6|||
162966263|NCT00573313|588576496|FG003|Overall Study|Protocol Violation|0|||
162966264|NCT00295490|588576499|FG000|Overall Study|Protocol Violation|0|||
162966265|NCT00295490|588576500|FG001|Overall Study|Protocol Violation|0|||
162966266|NCT00295490|588576501|FG002|Overall Study|Protocol Violation|3|||
162966267|NCT00295490|588576502|FG003|Overall Study|Protocol Violation|3|||
162966268|NCT00295490|588576499|FG000|Overall Study|Withdrawal by Subject|0|||
162966269|NCT00295490|588576500|FG001|Overall Study|Withdrawal by Subject|2|||
162966270|NCT00295490|588576501|FG002|Overall Study|Withdrawal by Subject|0|||
162966271|NCT00295490|588576502|FG003|Overall Study|Withdrawal by Subject|1|||
162966272|NCT00295490|588576499|FG000|Overall Study|Lost to Follow-up|0|||
163052897|NCT03636256|588904764|FG006|Overall Study|Lost to Follow-up|2|||
163313619|NCT05543629|589859444|FG000|Overall Study|Not Reported|2|||
162966273|NCT00295490|588576500|FG001|Overall Study|Lost to Follow-up|0|||
163052898|NCT03636256|588904765|FG007|Overall Study|Lost to Follow-up|0|||
163205836|NCT01059825|589465057|FG000|Treatment Period|Adverse event not related to study drug|0|||
163205837|NCT01059825|589465058|FG001|Treatment Period|Adverse event not related to study drug|1|||
163205838|NCT01059825|589465059|FG002|Treatment Period|Adverse event not related to study drug|2|||
163205839|NCT01059825|589465060|FG003|Treatment Period|Adverse event not related to study drug|1|||
163205840|NCT01059825|589465061|FG004|Treatment Period|Adverse event not related to study drug|1|||
163205841|NCT01059825|589465062|FG005|Treatment Period|Adverse event not related to study drug|1|||
163205842|NCT01059825|589465063|FG006|Treatment Period|Adverse event not related to study drug|0|||
163205843|NCT03342690|589465066|FG000|Overall Study|Missing Information|9|||
163205844|NCT03342690|589465066|FG000|Overall Study|Protocol Violation|16|||
163205845|NCT00105482|589465077|FG000|Overall Study|Adverse Event|1|||
163205846|NCT00105482|589465078|FG001|Overall Study|Adverse Event|1|||
163205847|NCT00105482|589465077|FG000|Overall Study|Lost to Follow-up|26|||
163205848|NCT00105482|589465078|FG001|Overall Study|Lost to Follow-up|17|||
163205849|NCT00105482|589465077|FG000|Overall Study|Withdrawal by Subject|0|||
163205850|NCT00105482|589465078|FG001|Overall Study|Withdrawal by Subject|1|||
163205851|NCT00105482|589465077|FG000|Overall Study|Lost Interest|29|||
163205852|NCT00105482|589465078|FG001|Overall Study|Lost Interest|32|||
163205853|NCT00105482|589465077|FG000|Overall Study|Scheduling Conflict|2|||
163205854|NCT00105482|589465078|FG001|Overall Study|Scheduling Conflict|3|||
163205855|NCT00105482|589465077|FG000|Overall Study|Withdrawn by PI|1|||
163205856|NCT00105482|589465078|FG001|Overall Study|Withdrawn by PI|1|||
163205857|NCT02495168|589465084|FG000|Overall Study|Other than Specified|18|||
163205858|NCT02495168|589465085|FG001|Overall Study|Other than Specified|22|||
163205859|NCT02495168|589465086|FG002|Overall Study|Other than Specified|5|||
163205860|NCT02495168|589465084|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
163205861|NCT02495168|589465085|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
163205862|NCT02495168|589465086|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
163205863|NCT02495168|589465084|FG000|Overall Study|Physician Decision|1|||
163205864|NCT02495168|589465085|FG001|Overall Study|Physician Decision|1|||
163205865|NCT02495168|589465086|FG002|Overall Study|Physician Decision|0|||
163205866|NCT02495168|589465084|FG000|Overall Study|Lost to Follow-up|10|||
163205867|NCT02495168|589465085|FG001|Overall Study|Lost to Follow-up|6|||
163205868|NCT02495168|589465086|FG002|Overall Study|Lost to Follow-up|1|||
163205869|NCT02495168|589465084|FG000|Overall Study|Withdrawal by Subject|1|||
163205870|NCT02495168|589465085|FG001|Overall Study|Withdrawal by Subject|4|||
163205871|NCT02495168|589465086|FG002|Overall Study|Withdrawal by Subject|2|||
163205872|NCT02495168|589465084|FG000|Overall Study|Protocol Violation|0|||
163205873|NCT02495168|589465085|FG001|Overall Study|Protocol Violation|10|||
163205874|NCT02495168|589465086|FG002|Overall Study|Protocol Violation|1|||
163205875|NCT02495168|589465084|FG000|Overall Study|Adverse Event|4|||
163205876|NCT02495168|589465085|FG001|Overall Study|Adverse Event|8|||
163205877|NCT02495168|589465086|FG002|Overall Study|Adverse Event|3|||
163205878|NCT02495168|589465084|FG000|Overall Study|Lack of Efficacy|0|||
163205879|NCT02495168|589465085|FG001|Overall Study|Lack of Efficacy|0|||
163205880|NCT02495168|589465086|FG002|Overall Study|Lack of Efficacy|3|||
163205881|NCT00644995|589465087|FG000|Overall Study|Lost to Follow-up|1|||
163205882|NCT00644995|589465088|FG001|Overall Study|Lost to Follow-up|4|||
163205883|NCT00644995|589465087|FG000|Overall Study|Refused|1|||
163205884|NCT00644995|589465088|FG001|Overall Study|Refused|0|||
163205885|NCT03247530|589465089|FG000|Overall Study|Withdrawal by caregiver|19|||
163205886|NCT03247530|589465090|FG001|Overall Study|Withdrawal by caregiver|8|||
163205887|NCT03247530|589465091|FG002|Overall Study|Withdrawal by caregiver|10|||
163205888|NCT03247530|589465089|FG000|Overall Study|Lost to Follow-up|3|||
163205889|NCT03247530|589465090|FG001|Overall Study|Lost to Follow-up|9|||
162966274|NCT00295490|588576501|FG002|Overall Study|Lost to Follow-up|1|||
162966275|NCT00295490|588576502|FG003|Overall Study|Lost to Follow-up|0|||
162966276|NCT00295490|588576499|FG000|Overall Study|Adverse Event|1|||
162966277|NCT00295490|588576500|FG001|Overall Study|Adverse Event|0|||
162966278|NCT00295490|588576501|FG002|Overall Study|Adverse Event|0|||
162966279|NCT00295490|588576502|FG003|Overall Study|Adverse Event|0|||
162966280|NCT00295490|588576499|FG000|Overall Study|Other|0|||
163205890|NCT03247530|589465091|FG002|Overall Study|Lost to Follow-up|6|||
163205891|NCT03247530|589465089|FG000|Overall Study|Adverse Event|2|||
163205892|NCT03247530|589465090|FG001|Overall Study|Adverse Event|5|||
163205893|NCT03247530|589465091|FG002|Overall Study|Adverse Event|2|||
163205894|NCT03247530|589465089|FG000|Overall Study|Failure to follow procedure|1|||
163205895|NCT03247530|589465090|FG001|Overall Study|Failure to follow procedure|1|||
163205896|NCT03247530|589465091|FG002|Overall Study|Failure to follow procedure|1|||
163205897|NCT03247530|589465089|FG000|Overall Study|Withdrawal by Subject|1|||
163205898|NCT03247530|589465090|FG001|Overall Study|Withdrawal by Subject|1|||
163205899|NCT03247530|589465091|FG002|Overall Study|Withdrawal by Subject|0|||
163205900|NCT03247530|589465089|FG000|Overall Study|Study medication misuse|0|||
163205901|NCT03247530|589465090|FG001|Overall Study|Study medication misuse|1|||
163205902|NCT03247530|589465091|FG002|Overall Study|Study medication misuse|0|||
163205903|NCT03247530|589465089|FG000|Overall Study|Other, multiple categories|1|||
163205904|NCT03247530|589465090|FG001|Overall Study|Other, multiple categories|3|||
163205905|NCT03247530|589465091|FG002|Overall Study|Other, multiple categories|1|||
163205906|NCT03042533|589465092|FG000|Overall Study|MD left program|1|||
163205907|NCT03042533|589465093|FG001|Overall Study|MD left program|4|||
163205908|NCT03042533|589465094|FG002|Overall Study|MD left program|1|||
163205909|NCT01587001|589465095|FG000|Overall Study|Lost to Follow-up|2|||
163205910|NCT01587001|589465096|FG001|Overall Study|Lost to Follow-up|0|||
163205911|NCT01587001|589465095|FG000|Overall Study|Insufficient samples to complete testing|4|||
163205912|NCT01587001|589465096|FG001|Overall Study|Insufficient samples to complete testing|1|||
163313620|NCT05543629|589859445|FG001|Overall Study|Not Reported|2|||
163205913|NCT04786990|589465097|FG000|Overall Study|Withdrawal by Subject|1|||
163205914|NCT04786990|589465097|FG000|Overall Study|Adverse Event|1|||
163205915|NCT04786990|589465097|FG000|Overall Study|Lost to Follow-up|1|||
163205916|NCT04786990|589465097|FG000|Overall Study|Noncompliance|1|||
163205917|NCT04786990|589465097|FG000|Overall Study|Unable to complete site visits|1|||
163205918|NCT04786990|589465097|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
163205919|NCT02233647|589465098|FG000|Overall Study|Adverse Event|1|||
163205920|NCT02846779|589465102|FG000|Overall Study|Lost Enrollment|83|||
163205921|NCT02846779|589465103|FG001|Overall Study|Lost Enrollment|82|||
163205922|NCT02846779|589465104|FG002|Overall Study|Lost Enrollment|86|||
163205923|NCT02846779|589465102|FG000|Overall Study|Less than 31 days of follow-up|56|||
163205924|NCT02846779|589465103|FG001|Overall Study|Less than 31 days of follow-up|45|||
163205925|NCT02846779|589465104|FG002|Overall Study|Less than 31 days of follow-up|52|||
163205926|NCT05353985|589465109|FG000|Overall Study|Adverse Event|5|||
163205927|NCT05353985|589465110|FG001|Overall Study|Adverse Event|7|||
163205928|NCT05353985|589465109|FG000|Overall Study|Lost to Follow-up|1|||
163205929|NCT05353985|589465110|FG001|Overall Study|Lost to Follow-up|1|||
163205930|NCT05353985|589465109|FG000|Overall Study|Protocol Violation|1|||
163313621|NCT05543629|589859446|FG002|Overall Study|Not Reported|0|||
163313622|NCT05543629|589859447|FG003|Overall Study|Not Reported|0|||
163313623|NCT05543629|589859448|FG004|Overall Study|Not Reported|1|||
163313624|NCT05543629|589859449|FG005|Overall Study|Not Reported|1|||
163313625|NCT05543629|589859450|FG006|Overall Study|Not Reported|3|||
163313626|NCT05543629|589859451|FG007|Overall Study|Not Reported|0|||
163313627|NCT04568603|589859452|FG000|Overall Study|Physician Decision|1|||
163313628|NCT04137367|589859456|FG000|Overall Study|Lost to Follow-up|8|||
163052899|NCT03636256|588904766|FG008|Overall Study|Lost to Follow-up|4|||
163205931|NCT05353985|589465110|FG001|Overall Study|Protocol Violation|0|||
163205932|NCT05353985|589465109|FG000|Overall Study|Withdrawal by Subject|13|||
163205933|NCT05353985|589465110|FG001|Overall Study|Withdrawal by Subject|17|||
163205934|NCT05353985|589465109|FG000|Overall Study|Reason Not Specified|1|||
163205935|NCT05353985|589465110|FG001|Overall Study|Reason Not Specified|0|||
163313629|NCT04137367|589859457|FG001|Overall Study|Lost to Follow-up|6|||
163313630|NCT04137367|589859458|FG002|Overall Study|Lost to Follow-up|4|||
163052900|NCT03636256|588904758|FG000|Overall Study|Withdrawal by Subject|0|||
163052901|NCT03636256|588904759|FG001|Overall Study|Withdrawal by Subject|0|||
163052902|NCT03636256|588904760|FG002|Overall Study|Withdrawal by Subject|0|||
163052903|NCT03636256|588904761|FG003|Overall Study|Withdrawal by Subject|0|||
163052904|NCT03636256|588904762|FG004|Overall Study|Withdrawal by Subject|0|||
163052905|NCT03636256|588904763|FG005|Overall Study|Withdrawal by Subject|0|||
163052906|NCT03636256|588904764|FG006|Overall Study|Withdrawal by Subject|0|||
163052907|NCT03636256|588904765|FG007|Overall Study|Withdrawal by Subject|0|||
163313631|NCT05144009|589859459|FG000|Overall Study|Lost to Follow-up|0|||
163313632|NCT05144009|589859460|FG001|Overall Study|Lost to Follow-up|1|||
163313633|NCT05144009|589859459|FG000|Overall Study|Study Termination by the Sponsor|11|||
163313634|NCT05144009|589859460|FG001|Overall Study|Study Termination by the Sponsor|11|||
163313635|NCT05144009|589859459|FG000|Overall Study|Disease Progression|1|||
163313636|NCT05144009|589859460|FG001|Overall Study|Disease Progression|0|||
163313637|NCT05144009|589859459|FG000|Overall Study|Participant Decision|0|||
163313638|NCT05144009|589859460|FG001|Overall Study|Participant Decision|2|||
163313639|NCT05144009|589859459|FG000|Overall Study|Death|5|||
163313640|NCT05144009|589859460|FG001|Overall Study|Death|10|||
163313641|NCT02815566|589859465|FG000|Overall Study|Adverse Event|1|||
163313642|NCT02815566|589859466|FG001|Overall Study|Adverse Event|1|||
163313643|NCT02815566|589859465|FG000|Overall Study|Withdrawal by Subject|1|||
163313644|NCT02815566|589859466|FG001|Overall Study|Withdrawal by Subject|0|||
163313645|NCT02815566|589859465|FG000|Overall Study|Lost to Follow-up|0|||
163313646|NCT02815566|589859466|FG001|Overall Study|Lost to Follow-up|1|||
163313647|NCT04492722|589859468|FG000|Overall Study|Adverse Event|7|||
163313648|NCT04492722|589859469|FG001|Overall Study|Adverse Event|2|||
163313649|NCT04492722|589859470|FG002|Overall Study|Adverse Event|3|||
163313650|NCT04492722|589859471|FG003|Overall Study|Adverse Event|0|||
163313651|NCT04492722|589859468|FG000|Overall Study|Death|0|||
163313652|NCT04492722|589859469|FG001|Overall Study|Death|0|||
163313653|NCT04492722|589859470|FG002|Overall Study|Death|0|||
163313654|NCT04492722|589859471|FG003|Overall Study|Death|1|||
163313655|NCT04492722|589859468|FG000|Overall Study|Lost to Follow-up|0|||
163313656|NCT04492722|589859469|FG001|Overall Study|Lost to Follow-up|1|||
163052908|NCT03636256|588904766|FG008|Overall Study|Withdrawal by Subject|1|||
163052909|NCT01218308|588904767|FG000|Overall Study|Adverse Event|1|||
163052910|NCT01218308|588904768|FG001|Overall Study|Adverse Event|2|||
163052911|NCT01218308|588904767|FG000|Overall Study|Protocol Violation|0|||
163052912|NCT01218308|588904768|FG001|Overall Study|Protocol Violation|2|||
163052913|NCT01218308|588904767|FG000|Overall Study|Withdrawal by Subject|61|||
163052914|NCT01218308|588904768|FG001|Overall Study|Withdrawal by Subject|64|||
163052915|NCT01218308|588904767|FG000|Overall Study|Lost to Follow-up|27|||
163052916|NCT01218308|588904768|FG001|Overall Study|Lost to Follow-up|31|||
163052917|NCT01218308|588904767|FG000|Overall Study|Other|14|||
163052918|NCT01218308|588904768|FG001|Overall Study|Other|21|||
163052919|NCT00960193|588904773|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
163052920|NCT01245101|588904781|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
163052921|NCT01245101|588904782|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
163052922|NCT01245101|588904781|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
163052923|NCT01245101|588904782|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
163313657|NCT04492722|589859470|FG002|Overall Study|Lost to Follow-up|0|||
163313658|NCT04492722|589859471|FG003|Overall Study|Lost to Follow-up|1|||
163313659|NCT04492722|589859468|FG000|Overall Study|Physician Decision|0|||
163313660|NCT04492722|589859469|FG001|Overall Study|Physician Decision|3|||
163313661|NCT04492722|589859470|FG002|Overall Study|Physician Decision|1|||
163313662|NCT04492722|589859471|FG003|Overall Study|Physician Decision|1|||
163313663|NCT04492722|589859468|FG000|Overall Study|Withdrawal by Subject|6|||
163313664|NCT04492722|589859469|FG001|Overall Study|Withdrawal by Subject|6|||
163313665|NCT04492722|589859470|FG002|Overall Study|Withdrawal by Subject|0|||
163313666|NCT04492722|589859471|FG003|Overall Study|Withdrawal by Subject|3|||
163052924|NCT01245101|588904781|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
163313667|NCT04492722|589859468|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
163313668|NCT04492722|589859469|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
163313669|NCT04492722|589859470|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
163052925|NCT01245101|588904782|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
163052926|NCT02666222|588904786|FG000|Overall Study|Death|2|||
163313670|NCT04492722|589859471|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
163313671|NCT04492722|589859468|FG000|Overall Study|Due to Covid-19 pandemic|7|||
163313672|NCT04492722|589859469|FG001|Overall Study|Due to Covid-19 pandemic|3|||
163313673|NCT04492722|589859470|FG002|Overall Study|Due to Covid-19 pandemic|7|||
163052927|NCT03504917|588904790|FG000|Blinded Treatment Period|Protocol Violation|1|||
163313674|NCT04492722|589859471|FG003|Overall Study|Due to Covid-19 pandemic|6|||
163313675|NCT04492722|589859468|FG000|Overall Study|Failure to meet randomisation criteria|2|||
163052928|NCT03504917|588904791|FG001|Blinded Treatment Period|Protocol Violation|0|||
163313676|NCT04492722|589859469|FG001|Overall Study|Failure to meet randomisation criteria|3|||
163313677|NCT04492722|589859470|FG002|Overall Study|Failure to meet randomisation criteria|4|||
163313678|NCT04492722|589859471|FG003|Overall Study|Failure to meet randomisation criteria|2|||
163313679|NCT04492722|589859468|FG000|Overall Study|Early termination from the study|54|||
163313680|NCT04492722|589859469|FG001|Overall Study|Early termination from the study|51|||
163313681|NCT04492722|589859470|FG002|Overall Study|Early termination from the study|50|||
163313682|NCT04492722|589859471|FG003|Overall Study|Early termination from the study|50|||
163313683|NCT04492722|589859468|FG000|Overall Study|Missing|3|||
163313684|NCT04492722|589859469|FG001|Overall Study|Missing|0|||
163313685|NCT04492722|589859470|FG002|Overall Study|Missing|0|||
163313686|NCT04492722|589859471|FG003|Overall Study|Missing|5|||
163313687|NCT04492722|589859468|FG000|Overall Study|Participants who did not receive treatment|0|||
163313688|NCT04492722|589859469|FG001|Overall Study|Participants who did not receive treatment|1|||
163313689|NCT04492722|589859470|FG002|Overall Study|Participants who did not receive treatment|4|||
163313690|NCT04492722|589859471|FG003|Overall Study|Participants who did not receive treatment|0|||
163313691|NCT04074759|589859472|FG000|Overall Study|Withdrawal by Subject|0|||
163313692|NCT04074759|589859473|FG001|Overall Study|Withdrawal by Subject|0|||
163313693|NCT04074759|589859474|FG002|Overall Study|Withdrawal by Subject|0|||
163052929|NCT03504917|588904790|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
163052930|NCT03504917|588904791|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
163052931|NCT03504917|588904790|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
163052932|NCT03504917|588904791|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
163052933|NCT03504917|588904790|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
163052934|NCT03504917|588904791|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
163052935|NCT03504917|588904790|FG000|Blinded Treatment Period|Adverse Event|4|||
163052936|NCT03504917|588904791|FG001|Blinded Treatment Period|Adverse Event|4|||
163052937|NCT03504917|588904790|FG000|Blinded Treatment Period|Physician Decision|1|||
163052938|NCT03504917|588904791|FG001|Blinded Treatment Period|Physician Decision|0|||
163052939|NCT03504917|588904790|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
163052940|NCT03504917|588904791|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
163052941|NCT03504917|588904790|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
163052942|NCT03504917|588904791|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
163052943|NCT03504917|588904790|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
163052944|NCT03504917|588904791|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
163052945|NCT03504917|588904790|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
163052946|NCT03504917|588904791|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
163052947|NCT03504917|588904790|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
163052948|NCT03504917|588904791|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
163052949|NCT03504917|588904790|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
163052950|NCT03504917|588904791|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
162966281|NCT00295490|588576500|FG001|Overall Study|Other|2|||
162966282|NCT00295490|588576501|FG002|Overall Study|Other|0|||
163205936|NCT05353985|589465109|FG000|Overall Study|Randomized in Error & Not Treated|0|||
162966283|NCT00295490|588576502|FG003|Overall Study|Other|1|||
162966284|NCT03255980|588576503|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
162966285|NCT03255980|588576504|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
162966286|NCT03255980|588576505|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
162966287|NCT03255980|588576506|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
162966288|NCT03255980|588576503|FG000|Overall Study|Adverse Event|1|||
162966289|NCT03255980|588576504|FG001|Overall Study|Adverse Event|1|||
162966290|NCT03255980|588576505|FG002|Overall Study|Adverse Event|0|||
162966291|NCT03255980|588576506|FG003|Overall Study|Adverse Event|1|||
162966292|NCT03255980|588576503|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
162966293|NCT03255980|588576504|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
162966294|NCT03255980|588576505|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
162966295|NCT03255980|588576506|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
162966296|NCT03255980|588576503|FG000|Overall Study|Lost to Follow-up|1|||
162966297|NCT03255980|588576504|FG001|Overall Study|Lost to Follow-up|1|||
162966298|NCT03255980|588576505|FG002|Overall Study|Lost to Follow-up|0|||
162966299|NCT03255980|588576506|FG003|Overall Study|Lost to Follow-up|3|||
162966300|NCT03255980|588576503|FG000|Overall Study|Withdrawal by Subject|0|||
162966301|NCT03255980|588576504|FG001|Overall Study|Withdrawal by Subject|1|||
162966302|NCT03255980|588576505|FG002|Overall Study|Withdrawal by Subject|0|||
162966303|NCT03255980|588576506|FG003|Overall Study|Withdrawal by Subject|3|||
162966304|NCT01597791|588576507|FG000|Overall Study|Physician Decision|2|||
162966305|NCT01597791|588576508|FG001|Overall Study|Physician Decision|1|||
162966306|NCT01597791|588576507|FG000|Overall Study|Cesarean Section|6|||
162966307|NCT01597791|588576508|FG001|Overall Study|Cesarean Section|7|||
162966308|NCT01597791|588576507|FG000|Overall Study|Subject withdrawal|0|||
162966309|NCT01597791|588576508|FG001|Overall Study|Subject withdrawal|1|||
162966310|NCT01597791|588576507|FG000|Overall Study|Protocol Violation|0|||
162966311|NCT01597791|588576508|FG001|Overall Study|Protocol Violation|1|||
162966312|NCT02611362|588576509|FG000|Overall Study|Withdrawal by Subject|7|||
162966313|NCT02611362|588576510|FG001|Overall Study|Withdrawal by Subject|2|||
162966314|NCT02611362|588576509|FG000|Overall Study|Lost to Follow-up|2|||
162966315|NCT02611362|588576510|FG001|Overall Study|Lost to Follow-up|4|||
162966316|NCT00354159|588576511|FG000|Randomized Study Period|Withdrawal by Subject|5|||
162966317|NCT00354159|588576512|FG001|Randomized Study Period|Withdrawal by Subject|3|||
162966318|NCT00354159|588576511|FG000|Randomized Study Period|Physician Decision|6|||
162966319|NCT00354159|588576512|FG001|Randomized Study Period|Physician Decision|10|||
162966320|NCT00354159|588576511|FG000|Randomized Study Period|Lost to Follow-up|4|||
162966321|NCT00354159|588576512|FG001|Randomized Study Period|Lost to Follow-up|0|||
162966322|NCT00354159|588576511|FG000|Randomized Study Period|Death|7|||
162966323|NCT00354159|588576512|FG001|Randomized Study Period|Death|9|||
162966324|NCT00354159|588576511|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
162966325|NCT00354159|588576512|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
162966326|NCT00354159|588576511|FG000|Long-term Follow-up|Physician Decision|127|||
162966327|NCT00354159|588576512|FG001|Long-term Follow-up|Physician Decision|122|||
162966328|NCT00354159|588576511|FG000|Long-term Follow-up|Lost to Follow-up|1|||
162966329|NCT00354159|588576512|FG001|Long-term Follow-up|Lost to Follow-up|0|||
162966330|NCT00354159|588576511|FG000|Long-term Follow-up|Death|14|||
163205937|NCT05353985|589465110|FG001|Overall Study|Randomized in Error & Not Treated|1|||
163205938|NCT00524368|589466754|FG000|Overall Study|Adverse Event|10|||
163205939|NCT00524368|589466755|FG001|Overall Study|Adverse Event|12|||
163205940|NCT00524368|589466754|FG000|Overall Study|Lost to Follow-up|9|||
163205941|NCT00524368|589466755|FG001|Overall Study|Lost to Follow-up|13|||
163205942|NCT00524368|589466754|FG000|Overall Study|Withdrawal by Subject|4|||
163205943|NCT00524368|589466755|FG001|Overall Study|Withdrawal by Subject|5|||
162966331|NCT00354159|588576512|FG001|Long-term Follow-up|Death|11|||
162966332|NCT00354159|588576511|FG000|Long-term Follow-up|Study Closed|29|||
163205944|NCT00524368|589466754|FG000|Overall Study|Non-compliant|8|||
162966333|NCT00354159|588576512|FG001|Long-term Follow-up|Study Closed|34|||
162966334|NCT02229084|588576514|FG000|Overall Study|Adverse Event|1|||
162966335|NCT02229084|588576515|FG001|Overall Study|Adverse Event|0|||
162966336|NCT02229084|588576516|FG002|Overall Study|Adverse Event|0|||
162966337|NCT02229084|588576517|FG003|Overall Study|Adverse Event|0|||
162966338|NCT02229084|588576518|FG004|Overall Study|Adverse Event|0|||
162966339|NCT02229084|588576519|FG005|Overall Study|Adverse Event|0|||
162966340|NCT02229084|588576520|FG006|Overall Study|Adverse Event|0|||
162966341|NCT02229084|588576514|FG000|Overall Study|Lost to Follow-up|0|||
162966342|NCT02229084|588576515|FG001|Overall Study|Lost to Follow-up|0|||
162966343|NCT02229084|588576516|FG002|Overall Study|Lost to Follow-up|1|||
163052951|NCT03504917|588904790|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
163313694|NCT04074759|589859475|FG003|Overall Study|Withdrawal by Subject|0|||
163313695|NCT04074759|589859476|FG004|Overall Study|Withdrawal by Subject|0|||
163313696|NCT04074759|589859477|FG005|Overall Study|Withdrawal by Subject|2|||
163313697|NCT04074759|589859478|FG006|Overall Study|Withdrawal by Subject|0|||
163313698|NCT04074759|589859479|FG007|Overall Study|Withdrawal by Subject|2|||
163313699|NCT04074759|589859480|FG008|Overall Study|Withdrawal by Subject|1|||
163313700|NCT04074759|589859481|FG009|Overall Study|Withdrawal by Subject|2|||
163313701|NCT04074759|589859482|FG010|Overall Study|Withdrawal by Subject|9|||
163313702|NCT04074759|589859483|FG011|Overall Study|Withdrawal by Subject|2|||
163313703|NCT04074759|589859484|FG012|Overall Study|Withdrawal by Subject|1|||
163313704|NCT04074759|589859485|FG013|Overall Study|Withdrawal by Subject|3|||
163313705|NCT04074759|589859486|FG014|Overall Study|Withdrawal by Subject|2|||
163313706|NCT04074759|589859487|FG015|Overall Study|Withdrawal by Subject|0|||
163313707|NCT04074759|589859488|FG016|Overall Study|Withdrawal by Subject|0|||
163313708|NCT04074759|589859489|FG017|Overall Study|Withdrawal by Subject|3|||
163313709|NCT04074759|589859490|FG018|Overall Study|Withdrawal by Subject|1|||
163313710|NCT04074759|589859472|FG000|Overall Study|Death|1|||
163313711|NCT04074759|589859473|FG001|Overall Study|Death|0|||
163313712|NCT04074759|589859474|FG002|Overall Study|Death|1|||
163313713|NCT04074759|589859475|FG003|Overall Study|Death|1|||
163313714|NCT04074759|589859476|FG004|Overall Study|Death|2|||
163313715|NCT04074759|589859477|FG005|Overall Study|Death|0|||
163313716|NCT04074759|589859478|FG006|Overall Study|Death|1|||
163313717|NCT04074759|589859479|FG007|Overall Study|Death|0|||
163313718|NCT04074759|589859480|FG008|Overall Study|Death|3|||
163313719|NCT04074759|589859481|FG009|Overall Study|Death|2|||
163313720|NCT04074759|589859482|FG010|Overall Study|Death|4|||
163397502|NCT02289742|590167739|FG002|Third Wear Period|Reason not given|0|||
163397503|NCT02289742|590167740|FG003|Third Wear Period|Reason not given|1|||
163397504|NCT00709111|590167741|FG000|Overall Study|Withdrawal by Subject|1|||
163052952|NCT03504917|588904791|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
163052953|NCT03504917|588904790|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
163052954|NCT03504917|588904791|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
163052955|NCT03504917|588904790|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
163052956|NCT03504917|588904791|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
163052957|NCT03504917|588904790|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
163052958|NCT03504917|588904791|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
163052959|NCT03863353|588904792|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
163052960|NCT03863353|588904793|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
163052961|NCT04079790|588904797|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
163052962|NCT04079790|588904798|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
163052963|NCT04079790|588904799|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
163052964|NCT04079790|588904800|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
163052965|NCT04079790|588904797|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
163052966|NCT04079790|588904798|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
163052967|NCT04079790|588904799|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
163052968|NCT04079790|588904800|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
163052969|NCT04079790|588904797|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
163052970|NCT04079790|588904798|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
163052971|NCT04079790|588904799|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
163052972|NCT04079790|588904800|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
163052973|NCT03810183|588904802|FG000|Overall Study|Study terminated by Sponsor|2|||
163052974|NCT03810183|588904803|FG001|Overall Study|Study terminated by Sponsor|1|||
163052975|NCT04275336|588904806|FG000|Overall Study|First venipuncture failed|4|||
163052976|NCT04275336|588904807|FG001|Overall Study|First venipuncture failed|6|||
163052977|NCT04275336|588904808|FG002|Overall Study|First venipuncture failed|5|||
163052978|NCT04275336|588904806|FG000|Overall Study|Unscheduled venipuncture|9|||
163052979|NCT04275336|588904807|FG001|Overall Study|Unscheduled venipuncture|13|||
163052980|NCT04275336|588904808|FG002|Overall Study|Unscheduled venipuncture|7|||
163052981|NCT04275336|588904806|FG000|Overall Study|Failed specimen of saliva|4|||
163052982|NCT04275336|588904807|FG001|Overall Study|Failed specimen of saliva|3|||
163052983|NCT04275336|588904808|FG002|Overall Study|Failed specimen of saliva|4|||
163052984|NCT03055936|588904809|FG000|Overall Study|Adverse Event|0|||
163052985|NCT03055936|588904810|FG001|Overall Study|Adverse Event|1|||
163052986|NCT03055936|588904811|FG002|Overall Study|Adverse Event|1|||
163052987|NCT03055936|588904812|FG003|Overall Study|Adverse Event|1|||
163052988|NCT03055936|588904809|FG000|Overall Study|Personal reason|2|||
163052989|NCT03055936|588904810|FG001|Overall Study|Personal reason|0|||
163052990|NCT03055936|588904811|FG002|Overall Study|Personal reason|1|||
163052991|NCT03055936|588904812|FG003|Overall Study|Personal reason|0|||
163313721|NCT04074759|589859483|FG011|Overall Study|Death|1|||
163313722|NCT04074759|589859484|FG012|Overall Study|Death|0|||
163313723|NCT04074759|589859485|FG013|Overall Study|Death|2|||
162966344|NCT02229084|588576517|FG003|Overall Study|Lost to Follow-up|1|||
162966345|NCT02229084|588576518|FG004|Overall Study|Lost to Follow-up|0|||
162966346|NCT02229084|588576519|FG005|Overall Study|Lost to Follow-up|0|||
162966347|NCT02229084|588576520|FG006|Overall Study|Lost to Follow-up|1|||
162966348|NCT02229084|588576514|FG000|Overall Study|Physician Decision|0|||
162966349|NCT02229084|588576515|FG001|Overall Study|Physician Decision|0|||
162966350|NCT02229084|588576516|FG002|Overall Study|Physician Decision|0|||
162966351|NCT02229084|588576517|FG003|Overall Study|Physician Decision|1|||
162966352|NCT02229084|588576518|FG004|Overall Study|Physician Decision|3|||
162966353|NCT02229084|588576519|FG005|Overall Study|Physician Decision|0|||
162966354|NCT02229084|588576520|FG006|Overall Study|Physician Decision|1|||
162966355|NCT02229084|588576514|FG000|Overall Study|Withdrawal by Subject|0|||
162966356|NCT02229084|588576515|FG001|Overall Study|Withdrawal by Subject|0|||
162966357|NCT02229084|588576516|FG002|Overall Study|Withdrawal by Subject|1|||
162966358|NCT02229084|588576517|FG003|Overall Study|Withdrawal by Subject|0|||
162966359|NCT02229084|588576518|FG004|Overall Study|Withdrawal by Subject|1|||
162966360|NCT02229084|588576519|FG005|Overall Study|Withdrawal by Subject|1|||
162966361|NCT02229084|588576520|FG006|Overall Study|Withdrawal by Subject|1|||
162966362|NCT02229084|588576514|FG000|Overall Study|Death|0|||
162966363|NCT02229084|588576515|FG001|Overall Study|Death|0|||
162966364|NCT02229084|588576516|FG002|Overall Study|Death|0|||
162966365|NCT02229084|588576517|FG003|Overall Study|Death|0|||
162966366|NCT02229084|588576518|FG004|Overall Study|Death|0|||
162966367|NCT02229084|588576519|FG005|Overall Study|Death|0|||
162966368|NCT02229084|588576520|FG006|Overall Study|Death|1|||
162966369|NCT01728116|588576523|FG000|Overall Study|Sponsor Terminated Study|106|||
162966370|NCT01728116|588576524|FG001|Overall Study|Sponsor Terminated Study|35|||
162966371|NCT01728116|588576523|FG000|Overall Study|Withdrawal by Subject|16|||
162966372|NCT01728116|588576524|FG001|Overall Study|Withdrawal by Subject|9|||
162966373|NCT01728116|588576523|FG000|Overall Study|Adverse Event|13|||
162966374|NCT01728116|588576524|FG001|Overall Study|Adverse Event|0|||
162966375|NCT01728116|588576523|FG000|Overall Study|Procedure/device failure|7|||
162966376|NCT01728116|588576524|FG001|Overall Study|Procedure/device failure|0|||
162966377|NCT01728116|588576523|FG000|Overall Study|Lost to Follow-up|9|||
162966378|NCT01728116|588576524|FG001|Overall Study|Lost to Follow-up|2|||
162966379|NCT01728116|588576523|FG000|Overall Study|Physician Decision|2|||
162966380|NCT01728116|588576524|FG001|Overall Study|Physician Decision|0|||
163205945|NCT00524368|589466755|FG001|Overall Study|Non-compliant|9|||
162966381|NCT01728116|588576523|FG000|Overall Study|Subject Non-Compliance|2|||
162966382|NCT01728116|588576524|FG001|Overall Study|Subject Non-Compliance|0|||
162966383|NCT01728116|588576523|FG000|Overall Study|Inter-current finding at procedure|1|||
162966384|NCT01728116|588576524|FG001|Overall Study|Inter-current finding at procedure|0|||
162966385|NCT01728116|588576523|FG000|Overall Study|Incorrectly enrolled in Study|0|||
162966386|NCT01728116|588576524|FG001|Overall Study|Incorrectly enrolled in Study|1|||
162966387|NCT01728116|588576523|FG000|Overall Study|various not noted previously|5|||
162966388|NCT01728116|588576524|FG001|Overall Study|various not noted previously|0|||
162966389|NCT01868243|588576527|FG000|Overall Study|Death|0|||
163052992|NCT01909804|588904819|FG000|Overall Study|Randomized but Never Treated|0|||
163052993|NCT01909804|588904820|FG001|Overall Study|Randomized but Never Treated|0|||
163052994|NCT01909804|588904821|FG002|Overall Study|Randomized but Never Treated|0|||
163052995|NCT01909804|588904822|FG003|Overall Study|Randomized but Never Treated|0|||
163052996|NCT01909804|588904823|FG004|Overall Study|Randomized but Never Treated|0|||
163052997|NCT01909804|588904824|FG005|Overall Study|Randomized but Never Treated|0|||
163052998|NCT01909804|588904825|FG006|Overall Study|Randomized but Never Treated|1|||
163052999|NCT01909804|588904826|FG007|Overall Study|Randomized but Never Treated|0|||
163053000|NCT01909804|588904827|FG008|Overall Study|Randomized but Never Treated|0|||
163053001|NCT01909804|588904828|FG009|Overall Study|Randomized but Never Treated|0|||
163053002|NCT01909804|588904829|FG010|Overall Study|Randomized but Never Treated|0|||
163053003|NCT01909804|588904830|FG011|Overall Study|Randomized but Never Treated|1|||
163053004|NCT01909804|588904819|FG000|Overall Study|Death|0|||
163053005|NCT01909804|588904820|FG001|Overall Study|Death|0|||
163053006|NCT01909804|588904821|FG002|Overall Study|Death|0|||
163053007|NCT01909804|588904822|FG003|Overall Study|Death|0|||
163053008|NCT01909804|588904823|FG004|Overall Study|Death|0|||
163053009|NCT01909804|588904824|FG005|Overall Study|Death|0|||
163053010|NCT01909804|588904825|FG006|Overall Study|Death|0|||
163053011|NCT01909804|588904826|FG007|Overall Study|Death|0|||
163053012|NCT01909804|588904827|FG008|Overall Study|Death|0|||
163053013|NCT01909804|588904828|FG009|Overall Study|Death|0|||
163053014|NCT01909804|588904829|FG010|Overall Study|Death|1|||
163053015|NCT01909804|588904830|FG011|Overall Study|Death|0|||
163053016|NCT01909804|588904819|FG000|Overall Study|Lack of Efficacy|4|||
163053017|NCT01909804|588904820|FG001|Overall Study|Lack of Efficacy|1|||
163053018|NCT01909804|588904821|FG002|Overall Study|Lack of Efficacy|0|||
163053019|NCT01909804|588904822|FG003|Overall Study|Lack of Efficacy|0|||
163053020|NCT01909804|588904823|FG004|Overall Study|Lack of Efficacy|7|||
163053021|NCT01909804|588904824|FG005|Overall Study|Lack of Efficacy|3|||
163053022|NCT01909804|588904825|FG006|Overall Study|Lack of Efficacy|1|||
163053023|NCT01909804|588904826|FG007|Overall Study|Lack of Efficacy|1|||
163053024|NCT01909804|588904827|FG008|Overall Study|Lack of Efficacy|0|||
163053025|NCT01909804|588904828|FG009|Overall Study|Lack of Efficacy|1|||
163053026|NCT01909804|588904829|FG010|Overall Study|Lack of Efficacy|0|||
163053027|NCT01909804|588904830|FG011|Overall Study|Lack of Efficacy|1|||
163053028|NCT01909804|588904819|FG000|Overall Study|Withdrew Consent|0|||
163053029|NCT01909804|588904820|FG001|Overall Study|Withdrew Consent|0|||
163053030|NCT01909804|588904821|FG002|Overall Study|Withdrew Consent|0|||
163053031|NCT01909804|588904822|FG003|Overall Study|Withdrew Consent|0|||
163313724|NCT04074759|589859486|FG014|Overall Study|Death|1|||
163313725|NCT04074759|589859487|FG015|Overall Study|Death|0|||
163313726|NCT04074759|589859488|FG016|Overall Study|Death|1|||
163053032|NCT01909804|588904823|FG004|Overall Study|Withdrew Consent|1|||
163053033|NCT01909804|588904824|FG005|Overall Study|Withdrew Consent|1|||
163313727|NCT04074759|589859489|FG017|Overall Study|Death|0|||
163053034|NCT01909804|588904825|FG006|Overall Study|Withdrew Consent|0|||
163053035|NCT01909804|588904826|FG007|Overall Study|Withdrew Consent|0|||
163053036|NCT01909804|588904827|FG008|Overall Study|Withdrew Consent|0|||
163053037|NCT01909804|588904828|FG009|Overall Study|Withdrew Consent|0|||
163053038|NCT01909804|588904829|FG010|Overall Study|Withdrew Consent|0|||
162966390|NCT01868243|588576528|FG001|Overall Study|Death|1|||
162966391|NCT01745094|588576529|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
162966392|NCT01745094|588576530|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
163205946|NCT00524368|589466754|FG000|Overall Study|Reached a Virologic Endpoint|3|||
163205947|NCT00524368|589466755|FG001|Overall Study|Reached a Virologic Endpoint|2|||
163205948|NCT00524368|589466754|FG000|Overall Study|Sponsor's Decision|2|||
163205949|NCT00524368|589466755|FG001|Overall Study|Sponsor's Decision|0|||
163053039|NCT01909804|588904830|FG011|Overall Study|Withdrew Consent|0|||
163053040|NCT01909804|588904819|FG000|Overall Study|Protocol Violation|0|||
163053041|NCT01909804|588904820|FG001|Overall Study|Protocol Violation|0|||
163053042|NCT01909804|588904821|FG002|Overall Study|Protocol Violation|0|||
163313728|NCT04074759|589859490|FG018|Overall Study|Death|1|||
163313729|NCT04074759|589859472|FG000|Overall Study|Lost to Follow-up|0|||
163313730|NCT04074759|589859473|FG001|Overall Study|Lost to Follow-up|0|||
163313731|NCT04074759|589859474|FG002|Overall Study|Lost to Follow-up|0|||
163313732|NCT04074759|589859475|FG003|Overall Study|Lost to Follow-up|0|||
163313733|NCT04074759|589859476|FG004|Overall Study|Lost to Follow-up|0|||
163313734|NCT04074759|589859477|FG005|Overall Study|Lost to Follow-up|0|||
163313735|NCT04074759|589859478|FG006|Overall Study|Lost to Follow-up|0|||
163313736|NCT04074759|589859479|FG007|Overall Study|Lost to Follow-up|0|||
163313737|NCT04074759|589859480|FG008|Overall Study|Lost to Follow-up|0|||
163313738|NCT04074759|589859481|FG009|Overall Study|Lost to Follow-up|0|||
163053043|NCT01909804|588904822|FG003|Overall Study|Protocol Violation|0|||
163053044|NCT01909804|588904823|FG004|Overall Study|Protocol Violation|0|||
163053045|NCT01909804|588904824|FG005|Overall Study|Protocol Violation|0|||
163053046|NCT01909804|588904825|FG006|Overall Study|Protocol Violation|0|||
163053047|NCT01909804|588904826|FG007|Overall Study|Protocol Violation|0|||
163053048|NCT01909804|588904827|FG008|Overall Study|Protocol Violation|0|||
163053049|NCT01909804|588904828|FG009|Overall Study|Protocol Violation|0|||
163053050|NCT01909804|588904829|FG010|Overall Study|Protocol Violation|0|||
163053051|NCT01909804|588904830|FG011|Overall Study|Protocol Violation|1|||
163053052|NCT05401565|588904832|FG000|Overall Study|Lost to Follow-up|1|||
163053053|NCT05401565|588904833|FG001|Overall Study|Lost to Follow-up|0|||
163053054|NCT05401565|588904832|FG000|Overall Study|Adverse Event|2|||
163053055|NCT05401565|588904833|FG001|Overall Study|Adverse Event|0|||
163053056|NCT00617357|588904834|FG000|Overall Study|Lost to Follow-up|7|||
163053057|NCT00617357|588904834|FG000|Overall Study|Death|5|||
163053058|NCT00617357|588904834|FG000|Overall Study|insurance concerns|2|||
163053059|NCT00617357|588904834|FG000|Overall Study|Withdrawal by Subject|1|||
163053060|NCT00617357|588904834|FG000|Overall Study|Physician Decision|1|||
163053061|NCT02153918|588904839|FG000|Overall Study|Refused further treatment|1|||
163053062|NCT03327324|588904840|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053063|NCT03327324|588904841|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
163053064|NCT03327324|588904842|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053065|NCT03327324|588904843|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
163053066|NCT03327324|588904844|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053067|NCT03327324|588904845|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
163053068|NCT03327324|588904840|FG000|Baseline (Month 0-Month 3)|Refused|0|||
163053069|NCT03327324|588904841|FG001|Baseline (Month 0-Month 3)|Refused|0|||
163053070|NCT03327324|588904842|FG002|Baseline (Month 0-Month 3)|Refused|0|||
163053071|NCT03327324|588904843|FG003|Baseline (Month 0-Month 3)|Refused|0|||
163053072|NCT03327324|588904844|FG004|Baseline (Month 0-Month 3)|Refused|1|||
163053073|NCT03327324|588904845|FG005|Baseline (Month 0-Month 3)|Refused|0|||
163053074|NCT03327324|588904840|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
163053075|NCT03327324|588904841|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
163053076|NCT03327324|588904842|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
163053077|NCT03327324|588904843|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
163053078|NCT03327324|588904844|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
163053079|NCT03327324|588904845|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
163053080|NCT03327324|588904840|FG000|Baseline (Month 0-Month 3)|Death|0|||
163053081|NCT03327324|588904841|FG001|Baseline (Month 0-Month 3)|Death|0|||
163053082|NCT03327324|588904842|FG002|Baseline (Month 0-Month 3)|Death|0|||
163053083|NCT03327324|588904843|FG003|Baseline (Month 0-Month 3)|Death|0|||
163053084|NCT03327324|588904844|FG004|Baseline (Month 0-Month 3)|Death|1|||
163053085|NCT03327324|588904845|FG005|Baseline (Month 0-Month 3)|Death|0|||
163058602|NCT00042289|588924242|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
163313739|NCT04074759|589859482|FG010|Overall Study|Lost to Follow-up|1|||
163313740|NCT04074759|589859483|FG011|Overall Study|Lost to Follow-up|0|||
163313741|NCT04074759|589859484|FG012|Overall Study|Lost to Follow-up|0|||
163053086|NCT03327324|588904840|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053087|NCT03327324|588904841|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053088|NCT03327324|588904842|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053089|NCT03327324|588904843|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053090|NCT03327324|588904844|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053091|NCT03327324|588904845|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
163053092|NCT03327324|588904840|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053093|NCT03327324|588904841|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053094|NCT03327324|588904842|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
163313742|NCT04074759|589859485|FG013|Overall Study|Lost to Follow-up|0|||
163313743|NCT04074759|589859486|FG014|Overall Study|Lost to Follow-up|0|||
163313744|NCT04074759|589859487|FG015|Overall Study|Lost to Follow-up|0|||
163313745|NCT04074759|589859488|FG016|Overall Study|Lost to Follow-up|1|||
163053095|NCT03327324|588904843|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053096|NCT03327324|588904844|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053097|NCT03327324|588904845|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053098|NCT03327324|588904840|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
163053099|NCT03327324|588904841|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
163053100|NCT03327324|588904842|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
163053101|NCT03327324|588904843|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
163053102|NCT03327324|588904844|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
163053103|NCT03327324|588904845|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
163053104|NCT03327324|588904840|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
163053105|NCT03327324|588904841|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
163053106|NCT03327324|588904842|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
163053107|NCT03327324|588904843|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
163053108|NCT03327324|588904844|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
163053109|NCT03327324|588904845|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
163053110|NCT03327324|588904840|FG000|Intervention (Month 3-Month 6)|Death|1|||
163053111|NCT03327324|588904841|FG001|Intervention (Month 3-Month 6)|Death|0|||
163053112|NCT03327324|588904842|FG002|Intervention (Month 3-Month 6)|Death|1|||
163053113|NCT03327324|588904843|FG003|Intervention (Month 3-Month 6)|Death|1|||
163053114|NCT03327324|588904844|FG004|Intervention (Month 3-Month 6)|Death|1|||
163053115|NCT03327324|588904845|FG005|Intervention (Month 3-Month 6)|Death|0|||
163053116|NCT03327324|588904840|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163313746|NCT04074759|589859489|FG017|Overall Study|Lost to Follow-up|0|||
163313747|NCT04074759|589859490|FG018|Overall Study|Lost to Follow-up|1|||
163313748|NCT04074759|589859472|FG000|Overall Study|Other|0|||
163313749|NCT04074759|589859473|FG001|Overall Study|Other|1|||
163313750|NCT04074759|589859474|FG002|Overall Study|Other|1|||
163313751|NCT04074759|589859475|FG003|Overall Study|Other|0|||
163313752|NCT04074759|589859476|FG004|Overall Study|Other|2|||
163313753|NCT04074759|589859477|FG005|Overall Study|Other|1|||
163313754|NCT04074759|589859478|FG006|Overall Study|Other|2|||
163313755|NCT04074759|589859479|FG007|Overall Study|Other|1|||
163313756|NCT04074759|589859480|FG008|Overall Study|Other|1|||
163397505|NCT00709111|590167741|FG000|Overall Study|Unable to attend clinic visits|1|||
163053117|NCT03327324|588904841|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053118|NCT03327324|588904842|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053119|NCT03327324|588904843|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163313757|NCT04074759|589859481|FG009|Overall Study|Other|4|||
163053120|NCT03327324|588904844|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053121|NCT03327324|588904845|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
163053122|NCT03327324|588904840|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
163053123|NCT03327324|588904841|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053124|NCT03327324|588904842|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053125|NCT03327324|588904843|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053126|NCT03327324|588904844|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053127|NCT03327324|588904845|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053128|NCT03327324|588904840|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
163053129|NCT03327324|588904841|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
163053130|NCT03327324|588904842|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
163053131|NCT03327324|588904843|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
163053132|NCT03327324|588904844|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
163053133|NCT03327324|588904845|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
163053134|NCT03327324|588904840|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
163053135|NCT03327324|588904841|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
163053136|NCT03327324|588904842|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
163053137|NCT03327324|588904843|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
163053138|NCT03327324|588904844|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
163053139|NCT03327324|588904845|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
163053140|NCT03327324|588904840|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053141|NCT03327324|588904841|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053142|NCT03327324|588904842|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053143|NCT03327324|588904843|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
163053144|NCT03327324|588904844|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
163053145|NCT03327324|588904845|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053146|NCT03327324|588904840|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
163053147|NCT03327324|588904841|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
163053148|NCT03327324|588904842|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
163053149|NCT03327324|588904843|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
163053150|NCT03327324|588904844|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
163053151|NCT03327324|588904845|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
163053152|NCT03327324|588904840|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
163053153|NCT03327324|588904841|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
163053154|NCT03327324|588904842|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
163053155|NCT03327324|588904843|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
163053156|NCT03327324|588904844|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
163053157|NCT03327324|588904845|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
163053158|NCT01791985|588904846|FG000|Overall Study|Adverse Event|7|||
163053159|NCT01791985|588904846|FG000|Overall Study|Withdrawal by Subject|1|||
163053160|NCT01103323|588904847|FG000|Without/Before Drug Switch|Adverse Event|50|||
163053161|NCT01103323|588904848|FG001|Without/Before Drug Switch|Adverse Event|7|||
163053162|NCT01103323|588904847|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
163053163|NCT01103323|588904848|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
163053164|NCT01103323|588904847|FG000|Without/Before Drug Switch|Protocol Violation|2|||
163053165|NCT01103323|588904848|FG001|Without/Before Drug Switch|Protocol Violation|0|||
163053166|NCT01103323|588904847|FG000|Without/Before Drug Switch|Physician Decision|2|||
163053167|NCT01103323|588904848|FG001|Without/Before Drug Switch|Physician Decision|0|||
163053168|NCT01103323|588904847|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
163053169|NCT01103323|588904848|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
163053170|NCT01103323|588904847|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
163053171|NCT01103323|588904848|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
163053172|NCT01103323|588904847|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
163053173|NCT01103323|588904848|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
163053174|NCT01946204|588904854|FG000|Overall Study|Death|38|||
163053175|NCT01946204|588904855|FG001|Overall Study|Death|59|||
163053176|NCT01946204|588904854|FG000|Overall Study|Withdrawal by Subject|37|||
163053177|NCT01946204|588904855|FG001|Overall Study|Withdrawal by Subject|50|||
163053178|NCT01946204|588904854|FG000|Overall Study|Lost to Follow-up|3|||
163053179|NCT01946204|588904855|FG001|Overall Study|Lost to Follow-up|7|||
163053180|NCT01946204|588904854|FG000|Overall Study|Ongoing|316|||
163053181|NCT01946204|588904855|FG001|Overall Study|Ongoing|687|||
163053182|NCT01946204|588904854|FG000|Overall Study|Other|7|||
163053183|NCT01946204|588904855|FG001|Overall Study|Other|3|||
163053184|NCT03797898|588904856|FG000|Overall Study|Lost to Follow-up|60|||
163053185|NCT03797898|588904857|FG001|Overall Study|Lost to Follow-up|69|||
163053186|NCT03797898|588904856|FG000|Overall Study|Withdrawal by Subject|9|||
163053187|NCT03797898|588904857|FG001|Overall Study|Withdrawal by Subject|7|||
163053188|NCT03797898|588904856|FG000|Overall Study|Became ineligible|5|||
163053189|NCT03797898|588904857|FG001|Overall Study|Became ineligible|2|||
163053190|NCT00485069|588904858|FG000|Overall Study|Adverse Event|10|||
163053191|NCT00485069|588904859|FG001|Overall Study|Adverse Event|4|||
163053192|NCT00485069|588904858|FG000|Overall Study|Lack of Efficacy|2|||
163053193|NCT00485069|588904859|FG001|Overall Study|Lack of Efficacy|1|||
163053194|NCT00485069|588904858|FG000|Overall Study|Protocol Violation|0|||
163053195|NCT00485069|588904859|FG001|Overall Study|Protocol Violation|1|||
163053196|NCT00485069|588904858|FG000|Overall Study|Withdrawal by Subject|6|||
163053197|NCT00485069|588904859|FG001|Overall Study|Withdrawal by Subject|6|||
163053198|NCT03217591|588904860|FG000|Overall Study|Adverse Event|1|||
163053199|NCT03217591|588904861|FG001|Overall Study|Adverse Event|2|||
163053200|NCT03217591|588904862|FG002|Overall Study|Adverse Event|6|||
163053201|NCT03217591|588904860|FG000|Overall Study|Withdrawal by Subject|0|||
163053202|NCT03217591|588904861|FG001|Overall Study|Withdrawal by Subject|1|||
163053203|NCT03217591|588904862|FG002|Overall Study|Withdrawal by Subject|3|||
163053204|NCT03217591|588904860|FG000|Overall Study|Lost to Follow-up|1|||
163053205|NCT03217591|588904861|FG001|Overall Study|Lost to Follow-up|0|||
163053206|NCT03217591|588904862|FG002|Overall Study|Lost to Follow-up|0|||
163053207|NCT03217591|588904860|FG000|Overall Study|Protocol Violation|1|||
163053208|NCT03217591|588904861|FG001|Overall Study|Protocol Violation|0|||
163053209|NCT03217591|588904862|FG002|Overall Study|Protocol Violation|1|||
163053210|NCT00086190|588904863|FG000|Overall Study|Adverse Event|6|||
163053211|NCT00086190|588904864|FG001|Overall Study|Adverse Event|2|||
163053212|NCT00086190|588904865|FG002|Overall Study|Adverse Event|2|||
163053213|NCT00086190|588904863|FG000|Overall Study|Withdrawal by Subject|0|||
163053214|NCT00086190|588904864|FG001|Overall Study|Withdrawal by Subject|2|||
163053215|NCT00086190|588904865|FG002|Overall Study|Withdrawal by Subject|2|||
163053216|NCT00086190|588904863|FG000|Overall Study|Protocol Violation|1|||
163053217|NCT00086190|588904864|FG001|Overall Study|Protocol Violation|0|||
163053218|NCT00086190|588904865|FG002|Overall Study|Protocol Violation|0|||
163053219|NCT00086190|588904863|FG000|Overall Study|Moved|1|||
163053220|NCT00086190|588904864|FG001|Overall Study|Moved|0|||
163053221|NCT00086190|588904865|FG002|Overall Study|Moved|0|||
163053222|NCT00086190|588904863|FG000|Overall Study|Worsening depression|0|||
163053223|NCT00086190|588904864|FG001|Overall Study|Worsening depression|0|||
163053224|NCT00086190|588904865|FG002|Overall Study|Worsening depression|2|||
163053225|NCT03528551|588904871|FG000|Overall Study|Lost to Follow-up|0|||
163053226|NCT03528551|588904872|FG001|Overall Study|Lost to Follow-up|1|||
163053227|NCT03528551|588904873|FG002|Overall Study|Lost to Follow-up|0|||
163053228|NCT03528551|588904871|FG000|Overall Study|Transferred to other arm/group|2|||
163053229|NCT03528551|588904872|FG001|Overall Study|Transferred to other arm/group|3|||
163053230|NCT03528551|588904873|FG002|Overall Study|Transferred to other arm/group|0|||
163053231|NCT03528551|588904871|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163053232|NCT03528551|588904872|FG001|Overall Study|Withdrawal by parent/guardian|5|||
163053233|NCT03528551|588904873|FG002|Overall Study|Withdrawal by parent/guardian|0|||
163053234|NCT03528551|588904871|FG000|Overall Study|Protocol Violation|0|||
163053235|NCT03528551|588904872|FG001|Overall Study|Protocol Violation|3|||
163053236|NCT03528551|588904873|FG002|Overall Study|Protocol Violation|0|||
163053237|NCT03528551|588904871|FG000|Overall Study|Withdrawal by Subject|0|||
163053238|NCT03528551|588904872|FG001|Overall Study|Withdrawal by Subject|7|||
163053239|NCT03528551|588904873|FG002|Overall Study|Withdrawal by Subject|0|||
163053240|NCT01789047|588904874|FG000|Overall Study|Adverse Event|3|||
163053241|NCT01789047|588904875|FG001|Overall Study|Adverse Event|2|||
163053242|NCT01789047|588904874|FG000|Overall Study|Withdrawal by Subject|1|||
163053243|NCT01789047|588904875|FG001|Overall Study|Withdrawal by Subject|2|||
163053244|NCT02700048|588904876|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
163053245|NCT02700048|588904877|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
163053246|NCT01204671|588904878|FG000|Overall Study|Adverse Event|4|||
163053247|NCT01204671|588904879|FG001|Overall Study|Adverse Event|3|||
163053248|NCT01204671|588904880|FG002|Overall Study|Adverse Event|3|||
163053249|NCT01204671|588904881|FG003|Overall Study|Adverse Event|3|||
163053250|NCT01204671|588904882|FG004|Overall Study|Adverse Event|1|||
163053251|NCT01204671|588904878|FG000|Overall Study|Withdrawal by Subject|2|||
163053252|NCT01204671|588904879|FG001|Overall Study|Withdrawal by Subject|3|||
163053253|NCT01204671|588904880|FG002|Overall Study|Withdrawal by Subject|4|||
163053254|NCT01204671|588904881|FG003|Overall Study|Withdrawal by Subject|5|||
163053255|NCT01204671|588904882|FG004|Overall Study|Withdrawal by Subject|3|||
163053256|NCT01204671|588904878|FG000|Overall Study|Lost to Follow-up|7|||
163053257|NCT01204671|588904879|FG001|Overall Study|Lost to Follow-up|8|||
163053258|NCT01204671|588904880|FG002|Overall Study|Lost to Follow-up|6|||
163205950|NCT00524368|589466754|FG000|Overall Study|Ineligible to Continue the study|2|||
163205951|NCT00524368|589466755|FG001|Overall Study|Ineligible to Continue the study|5|||
163205952|NCT00524368|589466754|FG000|Overall Study|Other|3|||
163205953|NCT00524368|589466755|FG001|Overall Study|Other|2|||
163205954|NCT04221009|589466758|FG000|Overall Study|Withdrawal by Subject|4|||
163205955|NCT00793598|589466759|FG000|Overall Study|Patient Request|0|||
163205956|NCT00793598|589466760|FG001|Overall Study|Patient Request|1|||
163205957|NCT00793598|589466761|FG002|Overall Study|Patient Request|0|||
163205958|NCT00793598|589466762|FG003|Overall Study|Patient Request|0|||
163205959|NCT00793598|589466763|FG004|Overall Study|Patient Request|0|||
163205960|NCT00793598|589466764|FG005|Overall Study|Patient Request|0|||
163205961|NCT00793598|589466765|FG006|Overall Study|Patient Request|0|||
163205962|NCT00793598|589466766|FG007|Overall Study|Patient Request|0|||
162966393|NCT01745094|588576531|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
162966394|NCT01745094|588576532|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
162966395|NCT01745094|588576529|FG000|Overall Study|Adverse Event|0|||
162966396|NCT01745094|588576530|FG001|Overall Study|Adverse Event|0|||
162966397|NCT01745094|588576531|FG002|Overall Study|Adverse Event|3|||
162966398|NCT01745094|588576532|FG003|Overall Study|Adverse Event|0|||
162966399|NCT01745094|588576529|FG000|Overall Study|Withdrawal by Subject|2|||
162966400|NCT01745094|588576530|FG001|Overall Study|Withdrawal by Subject|0|||
162966401|NCT01745094|588576531|FG002|Overall Study|Withdrawal by Subject|1|||
162966402|NCT01745094|588576532|FG003|Overall Study|Withdrawal by Subject|2|||
162966403|NCT01745094|588576529|FG000|Overall Study|Protocol Violation|1|||
162966404|NCT01745094|588576530|FG001|Overall Study|Protocol Violation|0|||
162966405|NCT01745094|588576531|FG002|Overall Study|Protocol Violation|3|||
162966406|NCT01745094|588576532|FG003|Overall Study|Protocol Violation|1|||
162966407|NCT01745094|588576529|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
162966408|NCT01745094|588576530|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
162966409|NCT01745094|588576531|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
162966410|NCT01745094|588576532|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
162966411|NCT01745094|588576529|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
162966412|NCT01745094|588576530|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
162966413|NCT01745094|588576531|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
162966414|NCT01745094|588576532|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
162966415|NCT01745094|588576529|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
162966416|NCT01745094|588576530|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
162966417|NCT01745094|588576531|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
162966418|NCT01745094|588576532|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
162966419|NCT01451541|588576534|FG000|Overall Study|Adverse Event|4|||
162966420|NCT01451541|588576535|FG001|Overall Study|Adverse Event|3|||
162966421|NCT01451541|588576536|FG002|Overall Study|Adverse Event|6|||
162966422|NCT01451541|588576534|FG000|Overall Study|Lack of Efficacy|2|||
162966423|NCT01451541|588576535|FG001|Overall Study|Lack of Efficacy|0|||
162966424|NCT01451541|588576536|FG002|Overall Study|Lack of Efficacy|0|||
162966425|NCT01451541|588576534|FG000|Overall Study|Lost to Follow-up|4|||
162966426|NCT01451541|588576535|FG001|Overall Study|Lost to Follow-up|4|||
162966427|NCT01451541|588576536|FG002|Overall Study|Lost to Follow-up|7|||
162966428|NCT01451541|588576534|FG000|Overall Study|Withdrawal by Subject|15|||
162966429|NCT01451541|588576535|FG001|Overall Study|Withdrawal by Subject|8|||
162966430|NCT01451541|588576536|FG002|Overall Study|Withdrawal by Subject|6|||
162966431|NCT01451541|588576534|FG000|Overall Study|randomization error, noncompliance|11|||
162966432|NCT01451541|588576535|FG001|Overall Study|randomization error, noncompliance|10|||
162966433|NCT01451541|588576536|FG002|Overall Study|randomization error, noncompliance|8|||
162966434|NCT05665387|588576539|FG000|Overall Study|Withdrawal by Subject|1|||
162966435|NCT05665387|588576540|FG001|Overall Study|Withdrawal by Subject|0|||
162966436|NCT05665387|588576541|FG002|Overall Study|Withdrawal by Subject|1|||
162966437|NCT01824498|588576542|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
162966438|NCT01824498|588576543|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
162966439|NCT01824498|588576544|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
162966440|NCT01824498|588576545|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
162966441|NCT01824498|588576546|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
162966442|NCT01824498|588576547|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
162966443|NCT00006436|588576548|FG000|Overall Study|Refused further treatment|2|||
162966444|NCT00006436|588576548|FG000|Overall Study|Declined to participate (before treatment started)|1|||
162966445|NCT00939523|588576549|FG000|Overall Study|Lack of Efficacy|1|||
162966446|NCT00939523|588576549|FG000|Overall Study|Physician Decision|2|||
162966447|NCT00757172|588576550|FG000|Overall Study|Withdrawal by Subject|4|||
162966448|NCT00757172|588576550|FG000|Overall Study|Physician Decision|3|||
162966449|NCT00757172|588576550|FG000|Overall Study|Progression|4|||
162966450|NCT00660387|588577931|FG000|Overall Study|Adverse Event|1|||
162966451|NCT00660387|588577932|FG001|Overall Study|Adverse Event|2|||
162966452|NCT00660387|588577931|FG000|Overall Study|Lack of Efficacy|0|||
162966453|NCT00660387|588577932|FG001|Overall Study|Lack of Efficacy|1|||
162966454|NCT00660387|588577931|FG000|Overall Study|Protocol Violation|1|||
162966455|NCT00660387|588577932|FG001|Overall Study|Protocol Violation|0|||
162966456|NCT03086135|588577933|FG000|Overall Study|Adverse Event|1|||
162966457|NCT03086135|588577933|FG000|Overall Study|Lost to Follow-up|2|||
162966458|NCT01023061|588577934|FG000|Overall Study|Withdrawal prior to treatment|2|||
162966459|NCT02710214|588577936|FG000|Overall Study|Lost to Follow-up|1|||
162966460|NCT02710214|588577937|FG001|Overall Study|Lost to Follow-up|0|||
162966461|NCT02710214|588577936|FG000|Overall Study|Lack of Efficacy|0|||
162966462|NCT02710214|588577937|FG001|Overall Study|Lack of Efficacy|1|||
162966463|NCT02710214|588577936|FG000|Overall Study|Death|0|||
162966464|NCT02710214|588577937|FG001|Overall Study|Death|1|||
162966465|NCT02832167|588577938|FG000|Treatment Period 1|Disease progression|90|||
162966466|NCT02832167|588577938|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
162966467|NCT02832167|588577938|FG000|Treatment Period 1|Death|2|||
162966468|NCT02832167|588577938|FG000|Treatment Period 1|Study Drug Toxicity|6|||
163053259|NCT01204671|588904881|FG003|Overall Study|Lost to Follow-up|4|||
163053260|NCT01204671|588904882|FG004|Overall Study|Lost to Follow-up|0|||
163053261|NCT01204671|588904878|FG000|Overall Study|Unknown Completion Status|1|||
163053262|NCT01204671|588904879|FG001|Overall Study|Unknown Completion Status|1|||
163053263|NCT01204671|588904880|FG002|Overall Study|Unknown Completion Status|0|||
163053264|NCT01204671|588904881|FG003|Overall Study|Unknown Completion Status|0|||
163053265|NCT01204671|588904882|FG004|Overall Study|Unknown Completion Status|0|||
163053266|NCT01204671|588904878|FG000|Overall Study|Physician Decision|0|||
163053267|NCT01204671|588904879|FG001|Overall Study|Physician Decision|0|||
163053268|NCT01204671|588904880|FG002|Overall Study|Physician Decision|0|||
163053269|NCT01204671|588904881|FG003|Overall Study|Physician Decision|1|||
163053270|NCT01204671|588904882|FG004|Overall Study|Physician Decision|0|||
163053271|NCT02340000|588904883|FG000|Time Period 1|Withdrawal by Subject|6|||
163053272|NCT02340000|588904884|FG001|Time Period 1|Withdrawal by Subject|8|||
163053273|NCT02340000|588904883|FG000|Time Period 1|Lost to Follow-up|6|||
163053274|NCT02340000|588904884|FG001|Time Period 1|Lost to Follow-up|7|||
163053275|NCT02340000|588904883|FG000|Time Period 2|Withdrawal by Subject|9|||
163053276|NCT02340000|588904884|FG001|Time Period 2|Withdrawal by Subject|7|||
163053277|NCT02340000|588904883|FG000|Time Period 2|Lost to Follow-up|10|||
163053278|NCT02340000|588904884|FG001|Time Period 2|Lost to Follow-up|8|||
163053279|NCT02668640|588904885|FG000|Overall Study|Lost to Follow-up|13|||
163053280|NCT02668640|588904885|FG000|Overall Study|Other, not specified|1|||
163053281|NCT00919633|588904895|FG000|Overall Study|Adverse Event|1|||
163053282|NCT00919633|588904896|FG001|Overall Study|Adverse Event|9|||
163053283|NCT00919633|588904897|FG002|Overall Study|Adverse Event|12|||
163053284|NCT00919633|588904898|FG003|Overall Study|Adverse Event|10|||
163053285|NCT00919633|588904895|FG000|Overall Study|Death|0|||
163053286|NCT00919633|588904896|FG001|Overall Study|Death|0|||
163053287|NCT00919633|588904897|FG002|Overall Study|Death|2|||
163053288|NCT00919633|588904898|FG003|Overall Study|Death|0|||
163053289|NCT00919633|588904895|FG000|Overall Study|Lack of Efficacy|17|||
163053290|NCT00919633|588904896|FG001|Overall Study|Lack of Efficacy|3|||
162966469|NCT02832167|588577938|FG000|Treatment Period 1|Participant request to discontinue|9|||
162966470|NCT02832167|588577938|FG000|Treatment Period 1|No longer meet study criteria|1|||
162966471|NCT02832167|588577938|FG000|Treatment Period 1|Participant withdrew consent|3|||
162966472|NCT02832167|588577938|FG000|Treatment Period 1|Other reasons|6|||
162966473|NCT02832167|588577938|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
162966474|NCT02832167|588577938|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
162966475|NCT02832167|588577938|FG000|Transition From Period 1 to Period 2|Death|2|||
162966476|NCT02832167|588577938|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
163053291|NCT00919633|588904897|FG002|Overall Study|Lack of Efficacy|2|||
163053292|NCT00919633|588904898|FG003|Overall Study|Lack of Efficacy|3|||
163053293|NCT00919633|588904895|FG000|Overall Study|Withdrawal by Subject|1|||
163053294|NCT00919633|588904896|FG001|Overall Study|Withdrawal by Subject|2|||
163053295|NCT00919633|588904897|FG002|Overall Study|Withdrawal by Subject|4|||
163053296|NCT00919633|588904898|FG003|Overall Study|Withdrawal by Subject|3|||
163053297|NCT00919633|588904895|FG000|Overall Study|Lost to Follow-up|3|||
163053298|NCT00919633|588904896|FG001|Overall Study|Lost to Follow-up|1|||
163053299|NCT00919633|588904897|FG002|Overall Study|Lost to Follow-up|0|||
163053300|NCT00919633|588904898|FG003|Overall Study|Lost to Follow-up|2|||
163053301|NCT00919633|588904895|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
163053302|NCT00919633|588904896|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
163053303|NCT00919633|588904897|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
163053304|NCT00919633|588904898|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
163053305|NCT00919633|588904895|FG000|Overall Study|Protocol Violation|0|||
163053306|NCT00919633|588904896|FG001|Overall Study|Protocol Violation|0|||
163053307|NCT00919633|588904897|FG002|Overall Study|Protocol Violation|0|||
163053308|NCT00919633|588904898|FG003|Overall Study|Protocol Violation|1|||
163053309|NCT00919633|588904895|FG000|Overall Study|Physician Decision|0|||
163053310|NCT00919633|588904896|FG001|Overall Study|Physician Decision|0|||
163053311|NCT00919633|588904897|FG002|Overall Study|Physician Decision|0|||
163053312|NCT00919633|588904898|FG003|Overall Study|Physician Decision|1|||
163053313|NCT00919633|588904895|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
163053314|NCT00919633|588904896|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
163053315|NCT00919633|588904897|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
163053316|NCT00919633|588904898|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
163053317|NCT00919633|588904895|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
163053318|NCT00919633|588904896|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
163053319|NCT00919633|588904897|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
163053320|NCT00919633|588904898|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
163053321|NCT01526785|588904899|FG000|Overall Study|Study Terminated by Sponsor|8|||
163053322|NCT01526785|588904899|FG000|Overall Study|Death|2|||
163053323|NCT01526785|588904899|FG000|Overall Study|Physician Decision|1|||
163053324|NCT01526785|588904899|FG000|Overall Study|Withdrawal by Subject|2|||
163053325|NCT01121263|588904902|FG000|Overall Study|Death|3|||
163053326|NCT01121263|588904903|FG001|Overall Study|Death|2|||
163053327|NCT01121263|588904902|FG000|Overall Study|Lost to Follow-up|22|||
163053328|NCT01121263|588904903|FG001|Overall Study|Lost to Follow-up|12|||
163053329|NCT01121263|588904902|FG000|Overall Study|Withdrawal by Subject|0|||
163053330|NCT01121263|588904903|FG001|Overall Study|Withdrawal by Subject|1|||
163053331|NCT02337491|588906392|FG000|Overall Study|Death|1|||
163053332|NCT02337491|588906393|FG001|Overall Study|Death|1|||
163053333|NCT02337491|588906392|FG000|Overall Study|Adverse Event|0|||
163053334|NCT02337491|588906393|FG001|Overall Study|Adverse Event|1|||
163053335|NCT02337491|588906392|FG000|Overall Study|Withdrawal by Subject|3|||
163053336|NCT02337491|588906393|FG001|Overall Study|Withdrawal by Subject|0|||
163053337|NCT02337491|588906392|FG000|Overall Study|Progressive Disease|44|||
163053338|NCT02337491|588906393|FG001|Overall Study|Progressive Disease|28|||
163053339|NCT02337491|588906392|FG000|Overall Study|On Treatment|2|||
163053340|NCT02337491|588906393|FG001|Overall Study|On Treatment|0|||
163053341|NCT00723229|588906394|FG000|First Intervention|Lost to Follow-up|7|||
163053342|NCT00723229|588906395|FG001|First Intervention|Lost to Follow-up|3|||
163053343|NCT01432951|588906396|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
163053344|NCT02900352|588906397|FG000|Overall Study|Lost to Follow-up|28|||
163053345|NCT02900352|588906398|FG001|Overall Study|Lost to Follow-up|17|||
163053346|NCT00785356|588906400|FG000|Overall Study|Study prematurely terminated|8|||
163053347|NCT03712280|588906406|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
163053348|NCT03712280|588906407|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
163053349|NCT03712280|588906408|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
163053350|NCT03712280|588906409|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
163053351|NCT03712280|588906406|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
163053352|NCT03712280|588906407|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
163053353|NCT03712280|588906408|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
163053354|NCT03712280|588906409|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
163053355|NCT03712280|588906406|FG000|Overall Study|Adverse Event|0|||
163053356|NCT03712280|588906407|FG001|Overall Study|Adverse Event|0|||
163053357|NCT03712280|588906408|FG002|Overall Study|Adverse Event|1|||
163053358|NCT03712280|588906409|FG003|Overall Study|Adverse Event|0|||
163053359|NCT00106002|588906410|FG000|Overall Study|Did not take any study drug|1|||
163205963|NCT00793598|589466759|FG000|Overall Study|Protocol Violation|0|||
163053360|NCT00106002|588906410|FG000|Overall Study|Ineligible after Registration|1|||
162966477|NCT02832167|588577938|FG000|Treatment Period 2|Disease progression|69|||
162966478|NCT02832167|588577938|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
162966479|NCT02832167|588577938|FG000|Treatment Period 2|Maximum clinical benefit|1|||
162966480|NCT02832167|588577938|FG000|Treatment Period 2|Study Drug Toxicity|5|||
162966481|NCT02832167|588577938|FG000|Treatment Period 2|Participant request to discontinue|2|||
162966482|NCT02832167|588577938|FG000|Treatment Period 2|Participant withdrew consent|3|||
162966483|NCT02832167|588577938|FG000|Treatment Period 2|Other reasons|3|||
163053361|NCT01122173|588906415|FG000|Overall Study|Lost to Follow-up|3|||
163053362|NCT01122173|588906415|FG000|Overall Study|Withdrawal by Subject|3|||
163053363|NCT01122173|588906415|FG000|Overall Study|Left study for other reasons|3|||
163053364|NCT04076917|588906417|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
163053365|NCT04076917|588906417|FG000|Overall Study|Study closure|13|||
162966484|NCT01754376|588577939|FG000|Overall Study|Adverse Event|1|||
162966485|NCT01754376|588577939|FG000|Overall Study|Lack of Efficacy|2|||
162966486|NCT04590781|588577940|FG000|Overall Study|Death|0|||
162966487|NCT04590781|588577941|FG001|Overall Study|Death|2|||
163053366|NCT04076917|588906417|FG000|Overall Study|Physician Decision|3|||
163053367|NCT04076917|588906417|FG000|Overall Study|Death|1|||
163053368|NCT04076917|588906417|FG000|Overall Study|Lost to Follow-up|1|||
163053369|NCT04076917|588906417|FG000|Overall Study|Withdrawal by Subject|1|||
163053370|NCT04076917|588906417|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
163053371|NCT04210986|588906418|FG000|Overall Study|Lost to Follow-up|5|||
162966488|NCT04590781|588577940|FG000|Overall Study|Withdrawal by Subject|2|||
162966489|NCT04590781|588577941|FG001|Overall Study|Withdrawal by Subject|0|||
162966490|NCT00820599|588577943|FG000|Overall Study|Death|129|||
162966491|NCT00820599|588577943|FG000|Overall Study|Withdrawal by Subject|2|||
162966492|NCT03686215|588577944|FG000|Overall Study|Adverse Event|0|||
163053372|NCT04210986|588906419|FG001|Overall Study|Lost to Follow-up|2|||
163205964|NCT00793598|589466760|FG001|Overall Study|Protocol Violation|0|||
163053373|NCT04210986|588906418|FG000|Overall Study|Withdrawal by Subject|3|||
163053374|NCT04210986|588906419|FG001|Overall Study|Withdrawal by Subject|1|||
163053375|NCT04210986|588906418|FG000|Overall Study|Protocol Violation|1|||
163053376|NCT04210986|588906419|FG001|Overall Study|Protocol Violation|1|||
163053377|NCT04210986|588906418|FG000|Overall Study|Physician Decision|0|||
163053378|NCT04210986|588906419|FG001|Overall Study|Physician Decision|1|||
163053379|NCT01774591|588906420|FG000|Overall Study|Physician Decision|1|||
163053380|NCT01774591|588906421|FG001|Overall Study|Physician Decision|1|||
163053381|NCT01774591|588906420|FG000|Overall Study|Withdrawal by Subject|0|||
163053382|NCT01774591|588906421|FG001|Overall Study|Withdrawal by Subject|1|||
163053383|NCT01774591|588906420|FG000|Overall Study|Adverse Event|0|||
163053384|NCT01774591|588906421|FG001|Overall Study|Adverse Event|2|||
163053385|NCT05222880|588906422|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
163053386|NCT05222880|588906422|FG000|Overall Study|Withdrew Consent during Study|1|||
163053387|NCT05222880|588906422|FG000|Overall Study|COVID-19 Related|1|||
163053388|NCT01077323|588906425|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
163053389|NCT01077323|588906426|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
163053390|NCT01077323|588906427|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
163053391|NCT01077323|588906425|FG000|Overall Study|Dispensing of drug in baseline period|0|||
163053392|NCT01077323|588906426|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
163053393|NCT01077323|588906427|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
163053394|NCT01077323|588906425|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
163053395|NCT01077323|588906426|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
163053396|NCT01077323|588906427|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
163053397|NCT02984982|588906428|FG000|Overall Study|Adverse Event|2|||
163053398|NCT02984982|588906429|FG001|Overall Study|Adverse Event|5|||
163053399|NCT02984982|588906428|FG000|Overall Study|Poor Compliance to Protocol|4|||
163053400|NCT02984982|588906429|FG001|Overall Study|Poor Compliance to Protocol|4|||
163053401|NCT02984982|588906428|FG000|Overall Study|Withdrawal by Subject|2|||
163053402|NCT02984982|588906429|FG001|Overall Study|Withdrawal by Subject|0|||
163053403|NCT02984982|588906428|FG000|Overall Study|Randomized but not treated|0|||
163053404|NCT02984982|588906429|FG001|Overall Study|Randomized but not treated|1|||
163053405|NCT02144701|588906430|FG000|Overall Study|development of relapse, GVHD or death|9|||
163053406|NCT02144701|588906431|FG001|Overall Study|development of relapse, GVHD or death|3|||
163053407|NCT03902613|588906442|FG000|Overall Study|Physician Decision|1|||
163053408|NCT04622969|588906447|FG000|Overall Study|Withdrawal by Subject|2|||
163053409|NCT04622969|588906448|FG001|Overall Study|Withdrawal by Subject|3|||
163053410|NCT04249427|588906451|FG000|Overall Study|Adverse Event|3|||
163053411|NCT04249427|588906452|FG001|Overall Study|Adverse Event|1|||
163053412|NCT04249427|588906451|FG000|Overall Study|Lack of Efficacy|0|||
163053413|NCT04249427|588906452|FG001|Overall Study|Lack of Efficacy|1|||
163053414|NCT04249427|588906451|FG000|Overall Study|Withdrawal by Subject|1|||
163053415|NCT04249427|588906452|FG001|Overall Study|Withdrawal by Subject|2|||
163053416|NCT01676012|588906457|FG000|Overall Study|Adverse Event|2|||
163053417|NCT01676012|588906457|FG000|Overall Study|incomplete set of videos|1|||
163053418|NCT02849080|588906458|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
163053419|NCT02849080|588906459|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
163205965|NCT00793598|589466761|FG002|Overall Study|Protocol Violation|0|||
163205966|NCT00793598|589466762|FG003|Overall Study|Protocol Violation|0|||
162966493|NCT03686215|588577945|FG001|Overall Study|Adverse Event|0|||
162966494|NCT03686215|588577946|FG002|Overall Study|Adverse Event|7|||
162966495|NCT03686215|588577944|FG000|Overall Study|Physician Decision|0|||
162966496|NCT03686215|588577945|FG001|Overall Study|Physician Decision|0|||
162966497|NCT03686215|588577946|FG002|Overall Study|Physician Decision|1|||
162966498|NCT03686215|588577944|FG000|Overall Study|Protocol Violation|0|||
162966499|NCT03686215|588577945|FG001|Overall Study|Protocol Violation|0|||
162966500|NCT03686215|588577946|FG002|Overall Study|Protocol Violation|4|||
162966501|NCT03686215|588577944|FG000|Overall Study|Device issue|1|||
162966502|NCT03686215|588577945|FG001|Overall Study|Device issue|0|||
162966503|NCT03686215|588577946|FG002|Overall Study|Device issue|2|||
162966504|NCT00202839|588577947|FG000|Overall Study|Adverse Event|1|||
162966505|NCT00202839|588577948|FG001|Overall Study|Adverse Event|5|||
162966506|NCT00202839|588577947|FG000|Overall Study|Physician Decision|12|||
162966507|NCT00202839|588577948|FG001|Overall Study|Physician Decision|0|||
162966508|NCT00202839|588577947|FG000|Overall Study|Withdrawal by Subject|6|||
162966509|NCT00202839|588577948|FG001|Overall Study|Withdrawal by Subject|2|||
163053420|NCT02849080|588906460|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
163053421|NCT02849080|588906461|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
163053422|NCT02849080|588906458|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
163053423|NCT02849080|588906459|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
163053424|NCT02849080|588906460|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
163053425|NCT02849080|588906461|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
163053426|NCT02849080|588906458|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
163053427|NCT02849080|588906459|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
163053428|NCT02849080|588906460|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
163053429|NCT02849080|588906461|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
163053430|NCT02849080|588906458|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
163053431|NCT02849080|588906459|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
163053432|NCT02849080|588906460|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
163053433|NCT02849080|588906461|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
163053434|NCT02849080|588906458|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
163053435|NCT02849080|588906459|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
163053436|NCT02849080|588906460|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
163053437|NCT02849080|588906461|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
163053438|NCT02849080|588906458|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
163053439|NCT02849080|588906459|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
163053440|NCT02849080|588906460|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
163053441|NCT02849080|588906461|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
163053442|NCT01819727|588906466|FG000|Overall Study|Adverse Event|8|||
163053443|NCT01819727|588906467|FG001|Overall Study|Adverse Event|9|||
163053444|NCT01819727|588906466|FG000|Overall Study|Death|1|||
163053445|NCT01819727|588906467|FG001|Overall Study|Death|0|||
163053446|NCT01819727|588906466|FG000|Overall Study|Lost to Follow-up|1|||
163053447|NCT01819727|588906467|FG001|Overall Study|Lost to Follow-up|1|||
163053448|NCT01819727|588906466|FG000|Overall Study|Physician Decision|3|||
163053449|NCT01819727|588906467|FG001|Overall Study|Physician Decision|2|||
163053450|NCT01819727|588906466|FG000|Overall Study|Pregnancy|1|||
163053451|NCT01819727|588906467|FG001|Overall Study|Pregnancy|0|||
163053452|NCT01819727|588906466|FG000|Overall Study|Protocol Violation|0|||
163053453|NCT01819727|588906467|FG001|Overall Study|Protocol Violation|2|||
163053454|NCT01819727|588906466|FG000|Overall Study|Study Terminated by Sponsor|0|||
163053455|NCT01819727|588906467|FG001|Overall Study|Study Terminated by Sponsor|1|||
163053456|NCT01819727|588906466|FG000|Overall Study|Withdrawal by Subject|6|||
163053457|NCT01819727|588906467|FG001|Overall Study|Withdrawal by Subject|11|||
163053458|NCT01819727|588906466|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
163053459|NCT01819727|588906467|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
163053460|NCT01819727|588906466|FG000|Overall Study|Quit due to lack of health benifits|0|||
163053461|NCT01819727|588906467|FG001|Overall Study|Quit due to lack of health benifits|1|||
163053462|NCT02155985|588906474|FG000|Overall Study|Withdrawal by Subject|0|||
163053463|NCT02155985|588906475|FG001|Overall Study|Withdrawal by Subject|0|||
163053464|NCT02155985|588906476|FG002|Overall Study|Withdrawal by Subject|1|||
163053465|NCT02155985|588906474|FG000|Overall Study|Lost to Follow-up|1|||
163053466|NCT02155985|588906475|FG001|Overall Study|Lost to Follow-up|0|||
163053467|NCT02155985|588906476|FG002|Overall Study|Lost to Follow-up|0|||
163053468|NCT00402727|588906477|FG000|Overall Study|Adverse Event|10|||
163053469|NCT00402727|588906478|FG001|Overall Study|Adverse Event|6|||
163053470|NCT00402727|588906477|FG000|Overall Study|Death|1|||
163053471|NCT00402727|588906478|FG001|Overall Study|Death|0|||
163053472|NCT00402727|588906477|FG000|Overall Study|Lack of Efficacy|1|||
163053473|NCT00402727|588906478|FG001|Overall Study|Lack of Efficacy|3|||
163053474|NCT00402727|588906477|FG000|Overall Study|Lost to Follow-up|24|||
163053475|NCT00402727|588906478|FG001|Overall Study|Lost to Follow-up|11|||
163053476|NCT00402727|588906477|FG000|Overall Study|Physician Decision|1|||
163053477|NCT00402727|588906478|FG001|Overall Study|Physician Decision|1|||
163053478|NCT00402727|588906477|FG000|Overall Study|Protocol Violation|0|||
163053479|NCT00402727|588906478|FG001|Overall Study|Protocol Violation|4|||
163053480|NCT00402727|588906477|FG000|Overall Study|Withdrawal by Subject|3|||
163053481|NCT00402727|588906478|FG001|Overall Study|Withdrawal by Subject|7|||
163053482|NCT00402727|588906477|FG000|Overall Study|supply problems|2|||
163053483|NCT00402727|588906478|FG001|Overall Study|supply problems|1|||
163053484|NCT00402727|588906477|FG000|Overall Study|non-compliance|0|||
163053485|NCT00402727|588906478|FG001|Overall Study|non-compliance|1|||
163053486|NCT00732069|588906479|FG000|Washout After First Study Drug|Adverse Event|1|||
163053487|NCT00732069|588906480|FG001|Washout After First Study Drug|Adverse Event|0|||
163053488|NCT00732069|588906481|FG002|Washout After First Study Drug|Adverse Event|0|||
163053489|NCT00732069|588906482|FG003|Washout After First Study Drug|Adverse Event|0|||
163053490|NCT00732069|588906483|FG004|Washout After First Study Drug|Adverse Event|0|||
163053491|NCT00732069|588906484|FG005|Washout After First Study Drug|Adverse Event|0|||
163053492|NCT04460326|588906485|FG000|Completed at Least 4 Meals|Early discharge|5|||
163053493|NCT04460326|588906486|FG001|Completed at Least 4 Meals|Early discharge|5|||
163053494|NCT04460326|588906485|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
163053495|NCT04460326|588906486|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
163053496|NCT04460326|588906485|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
163053497|NCT04460326|588906486|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
163053498|NCT04460326|588906485|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
163053499|NCT04460326|588906486|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
163053500|NCT04460326|588906485|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
163053501|NCT04460326|588906486|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
163053502|NCT04460326|588906485|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
163053503|NCT04460326|588906486|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
163053504|NCT00577317|588906487|FG000|Overall Study|Study Terminated|0|||
163053505|NCT00577317|588906488|FG001|Overall Study|Study Terminated|2|||
163053506|NCT03372798|588906489|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
163053507|NCT03372798|588906490|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
163053508|NCT03372798|588906489|FG000|Overall Study|Failure of imaging probe|0|||
163053509|NCT03372798|588906490|FG001|Overall Study|Failure of imaging probe|1|||
163053510|NCT04794751|588906492|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
163053511|NCT04794751|588906493|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
163053512|NCT04794751|588906492|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
163053513|NCT04794751|588906493|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
163053514|NCT04794751|588906492|FG000|Period 1|Protocol Violation|0|||
163053515|NCT04794751|588906493|FG001|Period 1|Protocol Violation|2|||
163053516|NCT04794751|588906492|FG000|Period 1|Withdrawal by Subject|0|||
163053517|NCT04794751|588906493|FG001|Period 1|Withdrawal by Subject|1|||
163053518|NCT04794751|588906492|FG000|Period 2|Withdrawal by Subject|0|||
163053519|NCT04794751|588906493|FG001|Period 2|Withdrawal by Subject|1|||
163053520|NCT04794751|588906492|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
163053521|NCT04794751|588906493|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
163053522|NCT04794751|588906492|FG000|Period 2|Protocol Violation|1|||
163053523|NCT04794751|588906493|FG001|Period 2|Protocol Violation|0|||
163053524|NCT01405898|588906496|FG000|Overall Study|Withdrawal by Subject|2|||
163053525|NCT01405898|588906497|FG001|Overall Study|Withdrawal by Subject|2|||
163053526|NCT02283658|588906498|FG000|Overall Study|Withdrawal by Subject|1|||
163053527|NCT01687218|588906499|FG000|Overall Study|Withdrawal by Subject|2|||
163053528|NCT01687218|588906500|FG001|Overall Study|Withdrawal by Subject|3|||
163053529|NCT01687218|588906501|FG002|Overall Study|Withdrawal by Subject|0|||
163053530|NCT01687218|588906502|FG003|Overall Study|Withdrawal by Subject|1|||
163053531|NCT01687218|588906503|FG004|Overall Study|Withdrawal by Subject|1|||
163053532|NCT01687218|588906504|FG005|Overall Study|Withdrawal by Subject|0|||
163053533|NCT01687218|588906499|FG000|Overall Study|Relocated, no follow-up planned|1|||
163053534|NCT01687218|588906500|FG001|Overall Study|Relocated, no follow-up planned|0|||
163053535|NCT01687218|588906501|FG002|Overall Study|Relocated, no follow-up planned|1|||
163053536|NCT01687218|588906502|FG003|Overall Study|Relocated, no follow-up planned|1|||
163053537|NCT01687218|588906503|FG004|Overall Study|Relocated, no follow-up planned|0|||
163053538|NCT01687218|588906504|FG005|Overall Study|Relocated, no follow-up planned|0|||
163053539|NCT03608826|588906506|FG000|Overall Study|Death|3|||
163205967|NCT00793598|589466763|FG004|Overall Study|Protocol Violation|0|||
163205968|NCT00793598|589466764|FG005|Overall Study|Protocol Violation|0|||
163205969|NCT00793598|589466765|FG006|Overall Study|Protocol Violation|0|||
163205970|NCT00793598|589466766|FG007|Overall Study|Protocol Violation|1|||
163205971|NCT00793598|589466759|FG000|Overall Study|Subject not dosed|0|||
163205972|NCT00793598|589466760|FG001|Overall Study|Subject not dosed|0|||
163205973|NCT00793598|589466761|FG002|Overall Study|Subject not dosed|0|||
163205974|NCT00793598|589466762|FG003|Overall Study|Subject not dosed|0|||
163205975|NCT00793598|589466763|FG004|Overall Study|Subject not dosed|0|||
163205976|NCT00793598|589466764|FG005|Overall Study|Subject not dosed|1|||
163313758|NCT04074759|589859482|FG010|Overall Study|Other|4|||
163313759|NCT04074759|589859483|FG011|Overall Study|Other|2|||
163313760|NCT04074759|589859484|FG012|Overall Study|Other|0|||
163313761|NCT04074759|589859485|FG013|Overall Study|Other|0|||
163313762|NCT04074759|589859486|FG014|Overall Study|Other|0|||
163313763|NCT04074759|589859487|FG015|Overall Study|Other|1|||
163313764|NCT04074759|589859488|FG016|Overall Study|Other|0|||
163313765|NCT04074759|589859489|FG017|Overall Study|Other|0|||
163313766|NCT04074759|589859490|FG018|Overall Study|Other|0|||
163313767|NCT04074759|589859472|FG000|Overall Study|Missing end of study status|0|||
163313768|NCT04074759|589859473|FG001|Overall Study|Missing end of study status|0|||
163313769|NCT04074759|589859474|FG002|Overall Study|Missing end of study status|0|||
163313770|NCT04074759|589859475|FG003|Overall Study|Missing end of study status|0|||
163313771|NCT04074759|589859476|FG004|Overall Study|Missing end of study status|0|||
163313772|NCT04074759|589859477|FG005|Overall Study|Missing end of study status|0|||
163313773|NCT04074759|589859478|FG006|Overall Study|Missing end of study status|0|||
163313774|NCT04074759|589859479|FG007|Overall Study|Missing end of study status|0|||
163313775|NCT04074759|589859480|FG008|Overall Study|Missing end of study status|0|||
162966510|NCT00202839|588577947|FG000|Overall Study|Protocol Violation|2|||
162966511|NCT00202839|588577948|FG001|Overall Study|Protocol Violation|1|||
162966512|NCT00202839|588577947|FG000|Overall Study|Lost to Follow-up|3|||
162966513|NCT00202839|588577948|FG001|Overall Study|Lost to Follow-up|2|||
162966514|NCT01662024|588577951|FG000|Overall Study|Pregnancy|2|||
162966515|NCT01662024|588577951|FG000|Overall Study|Withdrawal by Subject|3|||
162966516|NCT01490190|588577955|FG000|Overall Study|Withdrawal by Subject|9|||
162966517|NCT01490190|588577955|FG000|Overall Study|Adverse Event|17|||
162966518|NCT01490190|588577955|FG000|Overall Study|Protocol Violation|5|||
162966519|NCT01490190|588577955|FG000|Overall Study|Lost to Follow-up|13|||
162966520|NCT01490190|588577955|FG000|Overall Study|Relocation|1|||
162966521|NCT01490190|588577955|FG000|Overall Study|Inconvenience|1|||
162966522|NCT01490190|588577955|FG000|Overall Study|Ring expulsion|2|||
162966523|NCT00063258|588577958|FG000|Overall Study|Physician Decision|2|||
162966524|NCT00063258|588577959|FG001|Overall Study|Physician Decision|0|||
162966525|NCT00063258|588577958|FG000|Overall Study|Lack of Efficacy|2|||
162966526|NCT00063258|588577959|FG001|Overall Study|Lack of Efficacy|0|||
162966527|NCT03988608|588577960|FG000|Overall Study|Adverse Event|1|||
162966528|NCT03988608|588577960|FG000|Overall Study|Lost to Follow-up|1|||
162966529|NCT03988608|588577960|FG000|Overall Study|Withdrawal by Subject|3|||
163313776|NCT04074759|589859481|FG009|Overall Study|Missing end of study status|0|||
162966530|NCT03988608|588577960|FG000|Overall Study|Death|1|||
162966531|NCT01456962|588577970|FG000|Overall Study|Lost to Follow-up|2|||
162966532|NCT01456962|588577971|FG001|Overall Study|Lost to Follow-up|1|||
162966533|NCT02483416|588577972|FG000|Overall Study|Other reason|0|||
163053540|NCT03608826|588906506|FG000|Overall Study|Heart Transplant|3|||
163053541|NCT03608826|588906506|FG000|Overall Study|Physician Decision|4|||
163053542|NCT00875810|588906521|FG000|Overall Study|Withdrawal by Subject|1|||
163053543|NCT00875810|588906521|FG000|Overall Study|Physician Decision|3|||
163053544|NCT00875810|588906521|FG000|Overall Study|Lost to Follow-up|39|||
163053545|NCT00875810|588906521|FG000|Overall Study|Patient enroled but not implanted|2|||
163053546|NCT00875810|588906521|FG000|Overall Study|Device explanted|1|||
163053547|NCT03644017|588906525|FG000|Overall Study|Access Abandonment|5|||
163053548|NCT03644017|588906525|FG000|Overall Study|Kidney Transplant|2|||
163053549|NCT02175225|588906526|FG000|Overall Study|Withdrawal by Subject|1|||
163053550|NCT02175225|588906527|FG001|Overall Study|Withdrawal by Subject|2|||
163053551|NCT02175225|588906526|FG000|Overall Study|Lost to Follow-up|6|||
163053552|NCT02175225|588906527|FG001|Overall Study|Lost to Follow-up|7|||
163053553|NCT02175225|588906526|FG000|Overall Study|Study drug not administered|1|||
163053554|NCT02175225|588906527|FG001|Overall Study|Study drug not administered|2|||
163053555|NCT03106077|588906528|FG000|Overall Study|Screen Failure|94|||
163053556|NCT03106077|588906529|FG001|Overall Study|Screen Failure|0|||
163053557|NCT02008526|588906530|FG000|Overall Study|Death|0|||
163053558|NCT02008526|588906531|FG001|Overall Study|Death|2|||
163053559|NCT02008526|588906532|FG002|Overall Study|Death|1|||
163053560|NCT02008526|588906530|FG000|Overall Study|Withdrawal by Subject|3|||
163053561|NCT02008526|588906531|FG001|Overall Study|Withdrawal by Subject|3|||
163053562|NCT02008526|588906532|FG002|Overall Study|Withdrawal by Subject|2|||
163053563|NCT02008526|588906530|FG000|Overall Study|Lost to Follow-up|5|||
163053564|NCT02008526|588906531|FG001|Overall Study|Lost to Follow-up|9|||
163053565|NCT02008526|588906532|FG002|Overall Study|Lost to Follow-up|6|||
163053566|NCT01305564|588906535|FG000|Overall Study|Death|21|||
163053567|NCT01305564|588906535|FG000|Overall Study|Lost to Follow-up|12|||
163053568|NCT01305564|588906535|FG000|Overall Study|Withdrawal by Subject|1|||
163053569|NCT01305564|588906535|FG000|Overall Study|Physician Decision|3|||
163053570|NCT01190813|588906536|FG000|Overall Study|Lost to Follow-up|1|||
163053571|NCT01190813|588906537|FG001|Overall Study|Lost to Follow-up|2|||
163053572|NCT01190813|588906536|FG000|Overall Study|Withdrawal by Subject|2|||
163053573|NCT01190813|588906537|FG001|Overall Study|Withdrawal by Subject|1|||
163053574|NCT01190813|588906536|FG000|Overall Study|Refused study treatment after randomized|1|||
163053575|NCT01190813|588906537|FG001|Overall Study|Refused study treatment after randomized|0|||
163053576|NCT01190813|588906536|FG000|Overall Study|Adverse Event|0|||
163053577|NCT01190813|588906537|FG001|Overall Study|Adverse Event|1|||
163053578|NCT03810456|588906538|FG000|Treatment|Urgent Family Matters|3|||
163053579|NCT03810456|588906539|FG001|Treatment|Urgent Family Matters|0|||
163053580|NCT03810456|588906540|FG002|Treatment|Urgent Family Matters|0|||
163053581|NCT03810456|588906538|FG000|Treatment|Scheduling Conflicts|0|||
163313777|NCT04074759|589859482|FG010|Overall Study|Missing end of study status|2|||
163313778|NCT04074759|589859483|FG011|Overall Study|Missing end of study status|0|||
163313779|NCT04074759|589859484|FG012|Overall Study|Missing end of study status|0|||
163313780|NCT04074759|589859485|FG013|Overall Study|Missing end of study status|0|||
163313781|NCT04074759|589859486|FG014|Overall Study|Missing end of study status|0|||
163313782|NCT04074759|589859487|FG015|Overall Study|Missing end of study status|0|||
163313783|NCT04074759|589859488|FG016|Overall Study|Missing end of study status|1|||
163313784|NCT04074759|589859489|FG017|Overall Study|Missing end of study status|0|||
163313785|NCT04074759|589859490|FG018|Overall Study|Missing end of study status|0|||
163313786|NCT05329220|589859494|FG000|Active Trial Period|Adverse Event|0|||
163053582|NCT03810456|588906539|FG001|Treatment|Scheduling Conflicts|11|||
163313787|NCT05329220|589859495|FG001|Active Trial Period|Adverse Event|0|||
163313788|NCT05329220|589859496|FG002|Active Trial Period|Adverse Event|0|||
163313789|NCT05329220|589859497|FG003|Active Trial Period|Adverse Event|0|||
163313790|NCT05329220|589859498|FG004|Active Trial Period|Adverse Event|1|||
163313791|NCT05329220|589859499|FG005|Active Trial Period|Adverse Event|0|||
163313792|NCT05329220|589859494|FG000|Active Trial Period|Lost to Follow-up|0|||
163313793|NCT05329220|589859495|FG001|Active Trial Period|Lost to Follow-up|0|||
162966534|NCT02483416|588577973|FG001|Overall Study|Other reason|1|||
162966535|NCT02483416|588577972|FG000|Overall Study|Treatment stop|3|||
162966536|NCT02483416|588577973|FG001|Overall Study|Treatment stop|0|||
162966537|NCT03387462|588577975|FG000|Overall Study|Lost to Follow-up|1|||
162966538|NCT01460628|588577976|FG000|Overall Study|Adverse Event|3|||
162966539|NCT01460628|588577976|FG000|Overall Study|Withdrawal by Subject|2|||
162966540|NCT00210639|588577978|FG000|Overall Study|Lost to Follow-up|37|||
163053583|NCT03810456|588906540|FG002|Treatment|Scheduling Conflicts|0|||
163053584|NCT03810456|588906538|FG000|Treatment|No Longer Interested|0|||
163053585|NCT03810456|588906539|FG001|Treatment|No Longer Interested|12|||
163053586|NCT03810456|588906540|FG002|Treatment|No Longer Interested|0|||
163053587|NCT03810456|588906538|FG000|Treatment|Transportation Issues|0|||
163053588|NCT03810456|588906539|FG001|Treatment|Transportation Issues|1|||
163053589|NCT03810456|588906540|FG002|Treatment|Transportation Issues|0|||
163053590|NCT03810456|588906538|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
163053591|NCT03810456|588906539|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
163053592|NCT03810456|588906540|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
163053593|NCT03810456|588906538|FG000|1 Month Follow-Up|Relocated to Different State|1|||
163053594|NCT03810456|588906539|FG001|1 Month Follow-Up|Relocated to Different State|0|||
163053595|NCT03810456|588906540|FG002|1 Month Follow-Up|Relocated to Different State|1|||
163053596|NCT03810456|588906538|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
163053597|NCT03810456|588906539|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
163053598|NCT03810456|588906540|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
163053599|NCT03810456|588906538|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
163053600|NCT03810456|588906539|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
163053601|NCT03810456|588906540|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
163053602|NCT03810456|588906538|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
163313794|NCT05329220|589859496|FG002|Active Trial Period|Lost to Follow-up|0|||
162966541|NCT00210639|588577979|FG001|Overall Study|Lost to Follow-up|29|||
162966542|NCT00210639|588577978|FG000|Overall Study|Withdrawal by Subject|8|||
162966543|NCT00210639|588577979|FG001|Overall Study|Withdrawal by Subject|1|||
162966544|NCT00210639|588577978|FG000|Overall Study|Other|18|||
162966545|NCT00210639|588577979|FG001|Overall Study|Other|12|||
162966546|NCT01559116|588578003|FG000|Overall Study|Adverse Event|10|||
162966547|NCT01559116|588578003|FG000|Overall Study|Lack of Efficacy|1|||
162966548|NCT01559116|588578003|FG000|Overall Study|Lost to Follow-up|1|||
163053603|NCT03810456|588906539|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
163053604|NCT03810456|588906540|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
163053605|NCT03810456|588906538|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
163053606|NCT03810456|588906539|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
163053607|NCT03810456|588906540|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
163313795|NCT05329220|589859497|FG003|Active Trial Period|Lost to Follow-up|0|||
162966549|NCT01559116|588578003|FG000|Overall Study|Protocol Violation|1|||
162966550|NCT01559116|588578003|FG000|Overall Study|Withdrawal by Subject|4|||
162966551|NCT01559116|588578003|FG000|Overall Study|other than stated above|9|||
162966552|NCT04610580|588578005|FG000|Two-way Crossover Period|Adverse Event|1|||
162966553|NCT04610580|588578006|FG001|Two-way Crossover Period|Adverse Event|0|||
162966554|NCT04610580|588578007|FG002|Two-way Crossover Period|Adverse Event|0|||
162966555|NCT04610580|588578008|FG003|Two-way Crossover Period|Adverse Event|0|||
162966556|NCT04610580|588578009|FG004|Two-way Crossover Period|Adverse Event|0|||
162966557|NCT04610580|588578010|FG005|Two-way Crossover Period|Adverse Event|0|||
162966558|NCT04610580|588578005|FG000|Two-way Crossover Period|Physician Decision|1|||
162966559|NCT04610580|588578006|FG001|Two-way Crossover Period|Physician Decision|0|||
162966560|NCT04610580|588578007|FG002|Two-way Crossover Period|Physician Decision|0|||
162966561|NCT04610580|588578008|FG003|Two-way Crossover Period|Physician Decision|0|||
162966562|NCT04610580|588578009|FG004|Two-way Crossover Period|Physician Decision|0|||
162966563|NCT04610580|588578010|FG005|Two-way Crossover Period|Physician Decision|0|||
162966564|NCT04610580|588578005|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
162966565|NCT04610580|588578006|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
162966566|NCT04610580|588578007|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
162966567|NCT04610580|588578008|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
162966568|NCT04610580|588578009|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
162966569|NCT04610580|588578010|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
162966570|NCT04610580|588578005|FG000|Two-way Crossover Period|Other than specified|0|||
162966571|NCT04610580|588578006|FG001|Two-way Crossover Period|Other than specified|1|||
162966572|NCT04610580|588578007|FG002|Two-way Crossover Period|Other than specified|0|||
162966573|NCT04610580|588578008|FG003|Two-way Crossover Period|Other than specified|0|||
162966574|NCT04610580|588578009|FG004|Two-way Crossover Period|Other than specified|0|||
162966575|NCT04610580|588578010|FG005|Two-way Crossover Period|Other than specified|0|||
162966576|NCT04610580|588578005|FG000|Washout Before Extension Period|Other than specified|0|||
162966577|NCT04610580|588578006|FG001|Washout Before Extension Period|Other than specified|1|||
162966578|NCT04610580|588578007|FG002|Washout Before Extension Period|Other than specified|0|||
162966579|NCT04610580|588578008|FG003|Washout Before Extension Period|Other than specified|0|||
162966580|NCT04610580|588578009|FG004|Washout Before Extension Period|Other than specified|0|||
162966581|NCT04610580|588578010|FG005|Washout Before Extension Period|Other than specified|0|||
162966582|NCT04610580|588578005|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
162966583|NCT04610580|588578006|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
162966584|NCT04610580|588578007|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
162966585|NCT04610580|588578008|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
162966586|NCT04610580|588578009|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
162966587|NCT04610580|588578010|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
162966588|NCT04610580|588578005|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
162966589|NCT04610580|588578006|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
162966590|NCT04610580|588578007|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
162966591|NCT04610580|588578008|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
162966592|NCT04610580|588578009|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
162966593|NCT04610580|588578010|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
162966594|NCT01528735|588578015|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
162966595|NCT01528735|588578016|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
162966596|NCT01528735|588578015|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
162966597|NCT01528735|588578016|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
162966598|NCT01942135|588578019|FG000|Overall Study|Adverse Event|21|||
162966599|NCT01942135|588578020|FG001|Overall Study|Adverse Event|7|||
162966600|NCT01942135|588578019|FG000|Overall Study|Global Deterioration of Health Status|9|||
162966601|NCT01942135|588578020|FG001|Overall Study|Global Deterioration of Health Status|6|||
162966602|NCT01942135|588578019|FG000|Overall Study|Randomized Not Treated|2|||
162966603|NCT01942135|588578020|FG001|Overall Study|Randomized Not Treated|2|||
162966604|NCT01942135|588578019|FG000|Overall Study|Death|2|||
163053608|NCT03810456|588906538|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
163053609|NCT03810456|588906539|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
162966605|NCT01942135|588578020|FG001|Overall Study|Death|1|||
163053610|NCT03810456|588906540|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
162966606|NCT01942135|588578019|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
162966607|NCT01942135|588578020|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
162966608|NCT01942135|588578019|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
163205977|NCT00793598|589466765|FG006|Overall Study|Subject not dosed|0|||
163313796|NCT05329220|589859498|FG004|Active Trial Period|Lost to Follow-up|32|||
163313797|NCT05329220|589859499|FG005|Active Trial Period|Lost to Follow-up|28|||
163313798|NCT05329220|589859494|FG000|Active Trial Period|Physician Decision|0|||
163313799|NCT05329220|589859495|FG001|Active Trial Period|Physician Decision|0|||
163313800|NCT05329220|589859496|FG002|Active Trial Period|Physician Decision|0|||
163313801|NCT05329220|589859497|FG003|Active Trial Period|Physician Decision|0|||
163313802|NCT05329220|589859498|FG004|Active Trial Period|Physician Decision|2|||
163313803|NCT05329220|589859499|FG005|Active Trial Period|Physician Decision|0|||
163313804|NCT05329220|589859494|FG000|Active Trial Period|Protocol Violation|0|||
163313805|NCT05329220|589859495|FG001|Active Trial Period|Protocol Violation|0|||
163313806|NCT05329220|589859496|FG002|Active Trial Period|Protocol Violation|0|||
163313807|NCT05329220|589859497|FG003|Active Trial Period|Protocol Violation|0|||
163313808|NCT05329220|589859498|FG004|Active Trial Period|Protocol Violation|1|||
163313809|NCT05329220|589859499|FG005|Active Trial Period|Protocol Violation|3|||
163313810|NCT05329220|589859494|FG000|Active Trial Period|Withdrawal by Subject|0|||
163313811|NCT05329220|589859495|FG001|Active Trial Period|Withdrawal by Subject|0|||
163313812|NCT05329220|589859496|FG002|Active Trial Period|Withdrawal by Subject|0|||
163313813|NCT05329220|589859497|FG003|Active Trial Period|Withdrawal by Subject|1|||
163313814|NCT05329220|589859498|FG004|Active Trial Period|Withdrawal by Subject|12|||
163313815|NCT05329220|589859499|FG005|Active Trial Period|Withdrawal by Subject|13|||
163313816|NCT05329220|589859494|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
163053611|NCT03408899|588908369|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
163053612|NCT04745351|588908373|FG000|Overall Study|Death|51|||
163053613|NCT04745351|588908374|FG001|Overall Study|Death|25|||
163053614|NCT04745351|588908373|FG000|Overall Study|Lost to Follow-up|9|||
163053615|NCT04745351|588908374|FG001|Overall Study|Lost to Follow-up|3|||
163053616|NCT04745351|588908373|FG000|Overall Study|Randomized but Never Treated|3|||
163053617|NCT04745351|588908374|FG001|Overall Study|Randomized but Never Treated|3|||
163053618|NCT04745351|588908373|FG000|Overall Study|Adverse Event|4|||
163053619|NCT04745351|588908374|FG001|Overall Study|Adverse Event|0|||
163053620|NCT04745351|588908373|FG000|Overall Study|Withdrew Consent|1|||
163053621|NCT04745351|588908374|FG001|Overall Study|Withdrew Consent|2|||
163053622|NCT04745351|588908373|FG000|Overall Study|Investigator's Discretion|2|||
163053623|NCT04745351|588908374|FG001|Overall Study|Investigator's Discretion|0|||
163053624|NCT04745351|588908373|FG000|Overall Study|Protocol Violation|1|||
163053625|NCT04745351|588908374|FG001|Overall Study|Protocol Violation|0|||
163053626|NCT02014272|588908375|FG000|Intervention Period 1|Withdrawal by Subject|1|||
163053627|NCT02014272|588908376|FG001|Intervention Period 1|Withdrawal by Subject|0|||
163053628|NCT02014272|588908375|FG000|Intervention Period 1|Adverse Event|0|||
163053629|NCT02014272|588908376|FG001|Intervention Period 1|Adverse Event|1|||
163053630|NCT03499795|588908377|FG000|Overall Study|Adverse Event|1|||
163053631|NCT03499795|588908377|FG000|Overall Study|Lost to Follow-up|1|||
163053632|NCT02265510|588908378|FG000|Overall Study|Withdrawal by Subject|1|||
163053633|NCT02265510|588908379|FG001|Overall Study|Withdrawal by Subject|1|||
163053634|NCT02265510|588908380|FG002|Overall Study|Withdrawal by Subject|2|||
163313817|NCT05329220|589859495|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
163313818|NCT05329220|589859496|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
163313819|NCT05329220|589859497|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
163313820|NCT05329220|589859498|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
163313821|NCT05329220|589859499|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
163313822|NCT05329220|589859494|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
163313823|NCT05329220|589859495|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
163397506|NCT02865018|590167742|FG000|Overall Study|Withdrawal by Subject|1|||
163397507|NCT00294060|590167745|FG000|Overall Study|Death|225|||
163053635|NCT02265510|588908381|FG003|Overall Study|Withdrawal by Subject|1|||
163053636|NCT02265510|588908382|FG004|Overall Study|Withdrawal by Subject|0|||
163053637|NCT02265510|588908383|FG005|Overall Study|Withdrawal by Subject|2|||
163053638|NCT02265510|588908384|FG006|Overall Study|Withdrawal by Subject|0|||
163053639|NCT02265510|588908385|FG007|Overall Study|Withdrawal by Subject|2|||
163053640|NCT02265510|588908386|FG008|Overall Study|Withdrawal by Subject|0|||
163053641|NCT02265510|588908387|FG009|Overall Study|Withdrawal by Subject|0|||
163053642|NCT02265510|588908388|FG010|Overall Study|Withdrawal by Subject|0|||
163053643|NCT02265510|588908389|FG011|Overall Study|Withdrawal by Subject|0|||
163053644|NCT02265510|588908390|FG012|Overall Study|Withdrawal by Subject|1|||
163053645|NCT02265510|588908391|FG013|Overall Study|Withdrawal by Subject|0|||
163053646|NCT02265510|588908378|FG000|Overall Study|Disease Progression|0|||
163053647|NCT02265510|588908379|FG001|Overall Study|Disease Progression|1|||
163053648|NCT02265510|588908380|FG002|Overall Study|Disease Progression|2|||
163053649|NCT02265510|588908381|FG003|Overall Study|Disease Progression|1|||
163053650|NCT02265510|588908382|FG004|Overall Study|Disease Progression|1|||
163053651|NCT02265510|588908383|FG005|Overall Study|Disease Progression|0|||
163053652|NCT02265510|588908384|FG006|Overall Study|Disease Progression|0|||
163053653|NCT02265510|588908385|FG007|Overall Study|Disease Progression|0|||
163053654|NCT02265510|588908386|FG008|Overall Study|Disease Progression|0|||
163053655|NCT02265510|588908387|FG009|Overall Study|Disease Progression|0|||
163053656|NCT02265510|588908388|FG010|Overall Study|Disease Progression|0|||
163053657|NCT02265510|588908389|FG011|Overall Study|Disease Progression|0|||
163053658|NCT02265510|588908390|FG012|Overall Study|Disease Progression|0|||
163053659|NCT02265510|588908391|FG013|Overall Study|Disease Progression|0|||
163053660|NCT02265510|588908378|FG000|Overall Study|Death|2|||
163313824|NCT05329220|589859496|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
163313825|NCT05329220|589859497|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
163313826|NCT05329220|589859498|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
163313827|NCT05329220|589859499|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
163313828|NCT05329220|589859494|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
163313829|NCT05329220|589859495|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
163313830|NCT05329220|589859496|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
163313831|NCT05329220|589859497|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
163313832|NCT05329220|589859498|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
163313833|NCT05329220|589859499|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
163313834|NCT05329220|589859494|FG000|Follow-up Period|Adverse Event|0|||
163313835|NCT05329220|589859495|FG001|Follow-up Period|Adverse Event|0|||
163053661|NCT02265510|588908379|FG001|Overall Study|Death|0|||
163053662|NCT02265510|588908380|FG002|Overall Study|Death|2|||
163053663|NCT02265510|588908381|FG003|Overall Study|Death|2|||
163053664|NCT02265510|588908382|FG004|Overall Study|Death|1|||
163053665|NCT02265510|588908383|FG005|Overall Study|Death|3|||
163053666|NCT02265510|588908384|FG006|Overall Study|Death|2|||
163053667|NCT02265510|588908385|FG007|Overall Study|Death|1|||
163053668|NCT02265510|588908386|FG008|Overall Study|Death|3|||
163053669|NCT02265510|588908387|FG009|Overall Study|Death|3|||
163053670|NCT02265510|588908388|FG010|Overall Study|Death|4|||
163053671|NCT02265510|588908389|FG011|Overall Study|Death|12|||
162966609|NCT01942135|588578020|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
162966610|NCT01942135|588578019|FG000|Overall Study|Withdrawal by Subject|4|||
162966611|NCT01942135|588578020|FG001|Overall Study|Withdrawal by Subject|3|||
162966612|NCT01942135|588578019|FG000|Overall Study|Protocol Violation|1|||
162966613|NCT01942135|588578020|FG001|Overall Study|Protocol Violation|0|||
162966614|NCT01942135|588578019|FG000|Overall Study|Other|19|||
162966615|NCT01942135|588578020|FG001|Overall Study|Other|4|||
162966616|NCT01499043|588578021|FG000|Overall Study|Progressive disease (radiographic)|2|||
162966617|NCT01499043|588578021|FG000|Overall Study|Progressive disease (clinical)|1|||
162966618|NCT01499043|588578021|FG000|Overall Study|Withdrawal by Subject|2|||
162966619|NCT01499043|588578021|FG000|Overall Study|Adverse Event|1|||
162966620|NCT01596127|588578024|FG000|Overall Study|Patient Ineligible|1|||
162966621|NCT01566435|588578025|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
162966622|NCT00438633|588578026|FG000|Overall Study|Withdrawal by Subject|1|||
162966623|NCT00438633|588578027|FG001|Overall Study|Withdrawal by Subject|0|||
162966624|NCT00438633|588578026|FG000|Overall Study|Lost to Follow-up|15|||
162966625|NCT00438633|588578027|FG001|Overall Study|Lost to Follow-up|17|||
162966626|NCT04569084|588578028|FG000|Overall Study|Adverse Event|10|||
162966627|NCT04569084|588578029|FG001|Overall Study|Adverse Event|14|||
162966628|NCT04569084|588578028|FG000|Overall Study|Death|2|||
162966629|NCT04569084|588578029|FG001|Overall Study|Death|3|||
162966630|NCT04569084|588578028|FG000|Overall Study|Lost to Follow-up|1|||
162966631|NCT04569084|588578029|FG001|Overall Study|Lost to Follow-up|1|||
162966632|NCT04569084|588578028|FG000|Overall Study|Physician Decision|3|||
162966633|NCT04569084|588578029|FG001|Overall Study|Physician Decision|3|||
162966634|NCT04569084|588578028|FG000|Overall Study|Protocol Violation|2|||
162966635|NCT04569084|588578029|FG001|Overall Study|Protocol Violation|1|||
163313836|NCT05329220|589859496|FG002|Follow-up Period|Adverse Event|0|||
162966636|NCT04569084|588578028|FG000|Overall Study|Withdrawal by Subject|20|||
162966637|NCT04569084|588578029|FG001|Overall Study|Withdrawal by Subject|21|||
162966638|NCT04569084|588578028|FG000|Overall Study|Study terminated by sponsor|26|||
162966639|NCT04569084|588578029|FG001|Overall Study|Study terminated by sponsor|23|||
162966640|NCT04569084|588578028|FG000|Overall Study|Other|3|||
162966641|NCT04569084|588578029|FG001|Overall Study|Other|5|||
162966642|NCT03196284|588578030|FG000|Main Part|Withdrawal by Subject|0|||
162966643|NCT03196284|588578031|FG001|Main Part|Withdrawal by Subject|1|||
162966644|NCT03196284|588578032|FG002|Main Part|Withdrawal by Subject|0|||
162966645|NCT03196284|588578030|FG000|Extension Part|Lack of Efficacy|0|||
162966646|NCT03196284|588578031|FG001|Extension Part|Lack of Efficacy|0|||
162966647|NCT03196284|588578032|FG002|Extension Part|Lack of Efficacy|1|||
162966648|NCT03196284|588578030|FG000|Extension Part|Withdrawal by Subject|0|||
162966649|NCT03196284|588578031|FG001|Extension Part|Withdrawal by Subject|0|||
162966650|NCT03196284|588578032|FG002|Extension Part|Withdrawal by Subject|1|||
162966651|NCT03196284|588578030|FG000|Extension Part|Physician Decision|0|||
162966652|NCT03196284|588578031|FG001|Extension Part|Physician Decision|0|||
162966653|NCT03196284|588578032|FG002|Extension Part|Physician Decision|1|||
162966654|NCT00685334|588578038|FG000|Overall Study|Withdrawal by Subject|5|||
162966655|NCT00685334|588578039|FG001|Overall Study|Withdrawal by Subject|6|||
162966656|NCT00685334|588578038|FG000|Overall Study|Lost to Follow-up|4|||
163053672|NCT02265510|588908390|FG012|Overall Study|Death|7|||
163053673|NCT02265510|588908391|FG013|Overall Study|Death|6|||
163053674|NCT02265510|588908378|FG000|Overall Study|Lost to Follow-up|0|||
163053675|NCT02265510|588908379|FG001|Overall Study|Lost to Follow-up|0|||
163053676|NCT02265510|588908380|FG002|Overall Study|Lost to Follow-up|0|||
163053677|NCT02265510|588908381|FG003|Overall Study|Lost to Follow-up|0|||
163053678|NCT02265510|588908382|FG004|Overall Study|Lost to Follow-up|1|||
163053679|NCT02265510|588908383|FG005|Overall Study|Lost to Follow-up|0|||
163053680|NCT02265510|588908384|FG006|Overall Study|Lost to Follow-up|0|||
163053681|NCT02265510|588908385|FG007|Overall Study|Lost to Follow-up|0|||
162966657|NCT00685334|588578039|FG001|Overall Study|Lost to Follow-up|0|||
162966658|NCT00685334|588578038|FG000|Overall Study|Chose to enter hospital|1|||
162966659|NCT00685334|588578039|FG001|Overall Study|Chose to enter hospital|1|||
162966660|NCT04577404|588578040|FG000|Overall Study|Adverse Event|31|||
162966661|NCT04577404|588578040|FG000|Overall Study|Death|1|||
162966662|NCT04577404|588578040|FG000|Overall Study|Lack of Efficacy|3|||
162966663|NCT04577404|588578040|FG000|Overall Study|Physician Decision|7|||
162966664|NCT04577404|588578040|FG000|Overall Study|Withdrawal by Subject|21|||
162966665|NCT04577404|588578040|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
162966666|NCT04729101|588579493|FG000|Overall Study|Adverse Event|1|||
162966667|NCT04729101|588579494|FG001|Overall Study|Adverse Event|0|||
162966668|NCT04729101|588579493|FG000|Overall Study|Physician Decision|1|||
162966669|NCT04729101|588579494|FG001|Overall Study|Physician Decision|0|||
162966670|NCT04729101|588579493|FG000|Overall Study|Withdrawal by Subject|1|||
162966671|NCT04729101|588579494|FG001|Overall Study|Withdrawal by Subject|0|||
162966672|NCT00762411|588579495|FG000|Initial Treatment|Death|7|||
163053682|NCT02265510|588908386|FG008|Overall Study|Lost to Follow-up|0|||
162966673|NCT00762411|588579496|FG001|Initial Treatment|Death|6|||
162966674|NCT00762411|588579495|FG000|Initial Treatment|Adverse Event|132|||
162966675|NCT00762411|588579496|FG001|Initial Treatment|Adverse Event|40|||
162966676|NCT00762411|588579495|FG000|Initial Treatment|Protocol Violation|4|||
162966677|NCT00762411|588579496|FG001|Initial Treatment|Protocol Violation|1|||
162966678|NCT00762411|588579495|FG000|Initial Treatment|Withdrawal by Subject|65|||
162966679|NCT00762411|588579496|FG001|Initial Treatment|Withdrawal by Subject|52|||
162966680|NCT00762411|588579495|FG000|Initial Treatment|Physician Decision|1|||
162966681|NCT00762411|588579496|FG001|Initial Treatment|Physician Decision|0|||
162966682|NCT00762411|588579495|FG000|Initial Treatment|Sponsor Decision|293|||
162966683|NCT00762411|588579496|FG001|Initial Treatment|Sponsor Decision|401|||
162966684|NCT00762411|588579495|FG000|Initial Treatment|Lost to Follow-up|5|||
162966685|NCT00762411|588579496|FG001|Initial Treatment|Lost to Follow-up|0|||
162966686|NCT00762411|588579495|FG000|Initial Treatment|Caregiver Decision|21|||
162966687|NCT00762411|588579496|FG001|Initial Treatment|Caregiver Decision|16|||
162966688|NCT00762411|588579495|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
162966689|NCT00762411|588579496|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
162966690|NCT00762411|588579495|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
162966691|NCT00762411|588579496|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
162966692|NCT00762411|588579495|FG000|Delayed Start|Adverse Event|0|||
162966693|NCT00762411|588579496|FG001|Delayed Start|Adverse Event|4|||
162966694|NCT00762411|588579495|FG000|Delayed Start|Protocol Violation|0|||
162966695|NCT00762411|588579496|FG001|Delayed Start|Protocol Violation|1|||
162966696|NCT00762411|588579495|FG000|Delayed Start|Sponsor Decision|16|||
162966697|NCT00762411|588579496|FG001|Delayed Start|Sponsor Decision|20|||
162966698|NCT00762411|588579495|FG000|Delayed Start|Caregiver Decision|1|||
162966699|NCT00762411|588579496|FG001|Delayed Start|Caregiver Decision|1|||
162966700|NCT00762411|588579495|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
162966701|NCT00762411|588579496|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
162966702|NCT00762411|588579495|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
162966703|NCT00762411|588579496|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
162966704|NCT00762411|588579495|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
162966705|NCT00762411|588579496|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
162966706|NCT00762411|588579495|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
162966707|NCT00762411|588579496|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
162966708|NCT00762411|588579495|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
162966709|NCT00762411|588579496|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
162966710|NCT00762411|588579495|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
162966711|NCT00762411|588579496|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
162966712|NCT04556734|588579500|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
162966713|NCT04556734|588579501|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
162966714|NCT04556734|588579502|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
162966715|NCT04556734|588579503|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162966716|NCT04556734|588579504|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162966717|NCT04556734|588579505|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162966718|NCT04556734|588579506|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162966719|NCT04556734|588579507|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162966720|NCT04556734|588579500|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
162966721|NCT04556734|588579501|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162966722|NCT04556734|588579502|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162966723|NCT04556734|588579503|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162966724|NCT04556734|588579504|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162966725|NCT04556734|588579505|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162966726|NCT04556734|588579506|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162966727|NCT04556734|588579507|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162966728|NCT04556734|588579500|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162966729|NCT04556734|588579501|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162966730|NCT04556734|588579502|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162966731|NCT04556734|588579503|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162966732|NCT04556734|588579504|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162966733|NCT04556734|588579505|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162966734|NCT04556734|588579506|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163053683|NCT02265510|588908387|FG009|Overall Study|Lost to Follow-up|2|||
163053684|NCT02265510|588908388|FG010|Overall Study|Lost to Follow-up|0|||
163053685|NCT02265510|588908389|FG011|Overall Study|Lost to Follow-up|0|||
163053686|NCT02265510|588908390|FG012|Overall Study|Lost to Follow-up|0|||
163053687|NCT02265510|588908391|FG013|Overall Study|Lost to Follow-up|2|||
162966735|NCT04556734|588579507|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162966736|NCT04556734|588579500|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
162966737|NCT04556734|588579501|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162966738|NCT04556734|588579502|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162966739|NCT04556734|588579503|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162966740|NCT04556734|588579504|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162966741|NCT04556734|588579505|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162966742|NCT04556734|588579506|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
163053688|NCT02265510|588908378|FG000|Overall Study|Other|0|||
163205978|NCT00793598|589466766|FG007|Overall Study|Subject not dosed|0|||
163205979|NCT02762266|589466767|FG000|Overall Study|Physician Decision|2|||
163205980|NCT02762266|589466768|FG001|Overall Study|Physician Decision|0|||
163205981|NCT02373202|589466774|FG000|Overall Study|Adverse Event|2|||
163205982|NCT02373202|589466775|FG001|Overall Study|Adverse Event|5|||
163205983|NCT02373202|589466776|FG002|Overall Study|Adverse Event|2|||
163205984|NCT02373202|589466777|FG003|Overall Study|Adverse Event|1|||
163205985|NCT02373202|589466774|FG000|Overall Study|Lack of Efficacy|0|||
163205986|NCT02373202|589466775|FG001|Overall Study|Lack of Efficacy|0|||
163205987|NCT02373202|589466776|FG002|Overall Study|Lack of Efficacy|1|||
163205988|NCT02373202|589466777|FG003|Overall Study|Lack of Efficacy|0|||
163205989|NCT02373202|589466774|FG000|Overall Study|Other|0|||
163205990|NCT02373202|589466775|FG001|Overall Study|Other|1|||
163205991|NCT02373202|589466776|FG002|Overall Study|Other|0|||
163205992|NCT02373202|589466777|FG003|Overall Study|Other|0|||
163205993|NCT00410046|589466778|FG000|Overall Study|Adverse Event|3|||
163205994|NCT00410046|589466778|FG000|Overall Study|Withdrawal by Subject|1|||
163205995|NCT00410046|589466778|FG000|Overall Study|Lost to Follow-up|1|||
163205996|NCT03010254|589466779|FG000|Overall Study|Adverse Event|0|||
163205997|NCT03010254|589466780|FG001|Overall Study|Adverse Event|1|||
163205998|NCT03010254|589466779|FG000|Overall Study|Lost to Follow-up|4|||
163205999|NCT03010254|589466780|FG001|Overall Study|Lost to Follow-up|0|||
163206000|NCT03010254|589466779|FG000|Overall Study|Withdrawal by Subject|1|||
163206001|NCT03010254|589466780|FG001|Overall Study|Withdrawal by Subject|1|||
163206002|NCT03010254|589466779|FG000|Overall Study|Other|2|||
163206003|NCT03010254|589466780|FG001|Overall Study|Other|3|||
163206004|NCT01404325|589466787|FG000|Overall Study|Lost to Follow-up|1|||
163206005|NCT01404325|589466788|FG001|Overall Study|Lost to Follow-up|0|||
163206006|NCT01404325|589466787|FG000|Overall Study|Death|2|||
163206007|NCT01404325|589466788|FG001|Overall Study|Death|0|||
163206008|NCT01404325|589466787|FG000|Overall Study|Graft loss/Retransplantation|1|||
163206009|NCT01404325|589466788|FG001|Overall Study|Graft loss/Retransplantation|0|||
163206010|NCT01404325|589466787|FG000|Overall Study|non-specified reason|0|||
163206011|NCT01404325|589466788|FG001|Overall Study|non-specified reason|2|||
163206012|NCT02310568|589466791|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
163206013|NCT02310568|589466792|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
163206014|NCT02310568|589466793|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
163206015|NCT02310568|589466794|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
163206016|NCT02310568|589466795|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
163206017|NCT02310568|589466791|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
163313837|NCT05329220|589859497|FG003|Follow-up Period|Adverse Event|0|||
163206018|NCT02310568|589466792|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
162966743|NCT04556734|588579507|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162966744|NCT04556734|588579500|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
162966745|NCT04556734|588579501|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
162966746|NCT04556734|588579502|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
162966747|NCT04556734|588579503|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
162966748|NCT04556734|588579504|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
162966749|NCT04556734|588579505|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
162966750|NCT04556734|588579506|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
162966751|NCT04556734|588579507|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
162966752|NCT04556734|588579500|FG000|OLE Period (28 Weeks)|Not reported|0|||
162966753|NCT04556734|588579501|FG001|OLE Period (28 Weeks)|Not reported|0|||
162966754|NCT04556734|588579502|FG002|OLE Period (28 Weeks)|Not reported|0|||
162966755|NCT04556734|588579503|FG003|OLE Period (28 Weeks)|Not reported|0|||
162966756|NCT04556734|588579504|FG004|OLE Period (28 Weeks)|Not reported|0|||
162966757|NCT04556734|588579505|FG005|OLE Period (28 Weeks)|Not reported|1|||
162966758|NCT04556734|588579506|FG006|OLE Period (28 Weeks)|Not reported|0|||
162966759|NCT04556734|588579507|FG007|OLE Period (28 Weeks)|Not reported|0|||
162966760|NCT04556734|588579500|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162966761|NCT04556734|588579501|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162966762|NCT04556734|588579502|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162966763|NCT04556734|588579503|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162966764|NCT04556734|588579504|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162966765|NCT04556734|588579505|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162966766|NCT04556734|588579506|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
163206019|NCT02310568|589466793|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
163206020|NCT02310568|589466794|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
163313838|NCT05329220|589859498|FG004|Follow-up Period|Adverse Event|2|||
162966767|NCT04556734|588579507|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
162966768|NCT04556734|588579500|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
162966769|NCT04556734|588579501|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
162966770|NCT04556734|588579502|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
162966771|NCT04556734|588579503|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
162966772|NCT04556734|588579504|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
162966773|NCT04556734|588579505|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
162966774|NCT04556734|588579506|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
162966775|NCT04556734|588579507|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
162966776|NCT04556734|588579500|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
162966777|NCT04556734|588579501|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
162966778|NCT04556734|588579502|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
162966779|NCT04556734|588579503|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
162966780|NCT04556734|588579504|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
162966781|NCT04556734|588579505|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
162966782|NCT04556734|588579506|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
162966783|NCT04556734|588579507|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
162966784|NCT01813435|588579510|FG000|Overall Study|did not finish experimental regimen|1902|||
162966785|NCT01813435|588579511|FG001|Overall Study|did not finish experimental regimen|770|||
162966786|NCT01813435|588579510|FG000|Overall Study|Lost to Follow-up|268|||
162966787|NCT01813435|588579511|FG001|Overall Study|Lost to Follow-up|237|||
162966788|NCT01765751|588579518|FG000|Overall Study|Lost to Follow-up|0|||
162966789|NCT01765751|588579519|FG001|Overall Study|Lost to Follow-up|2|||
162966790|NCT01765751|588579520|FG002|Overall Study|Lost to Follow-up|1|||
162966791|NCT01120899|588579521|FG000|Overall Study|Withdrawal by Subject|3|||
162966792|NCT00452348|588579522|FG000|Overall Study|Adverse Event|6|||
162966793|NCT00452348|588579523|FG001|Overall Study|Adverse Event|9|||
162966794|NCT00452348|588579522|FG000|Overall Study|Lack of Efficacy|10|||
162966795|NCT00452348|588579523|FG001|Overall Study|Lack of Efficacy|9|||
162966796|NCT00452348|588579522|FG000|Overall Study|Lost to Follow-up|14|||
162966797|NCT00452348|588579523|FG001|Overall Study|Lost to Follow-up|8|||
162966798|NCT00452348|588579522|FG000|Overall Study|Protocol Violation|22|||
162966799|NCT00452348|588579523|FG001|Overall Study|Protocol Violation|28|||
162966800|NCT00452348|588579522|FG000|Overall Study|Withdrawal by Subject|18|||
162966801|NCT00452348|588579523|FG001|Overall Study|Withdrawal by Subject|21|||
163053689|NCT02265510|588908379|FG001|Overall Study|Other|1|||
163053690|NCT02265510|588908380|FG002|Overall Study|Other|0|||
163053691|NCT02265510|588908381|FG003|Overall Study|Other|0|||
162966802|NCT00452348|588579522|FG000|Overall Study|Other|9|||
162966803|NCT00452348|588579523|FG001|Overall Study|Other|9|||
162966804|NCT00544167|588579527|FG000|Overall Study|Adverse Event|21|||
162966805|NCT00544167|588579527|FG000|Overall Study|Physician Decision|8|||
162966806|NCT00874549|588579528|FG000|Overall Study|Adverse Event|0|||
162966807|NCT00874549|588579529|FG001|Overall Study|Adverse Event|0|||
162966808|NCT00874549|588579530|FG002|Overall Study|Adverse Event|1|||
163053692|NCT02265510|588908382|FG004|Overall Study|Other|0|||
162966809|NCT00874549|588579531|FG003|Overall Study|Adverse Event|0|||
162966810|NCT00874549|588579528|FG000|Overall Study|Protocol Violation|1|||
162966811|NCT00874549|588579529|FG001|Overall Study|Protocol Violation|0|||
162966812|NCT00874549|588579530|FG002|Overall Study|Protocol Violation|2|||
162966813|NCT00874549|588579531|FG003|Overall Study|Protocol Violation|1|||
162966814|NCT00874549|588579528|FG000|Overall Study|Lost to Follow-up|0|||
162966815|NCT00874549|588579529|FG001|Overall Study|Lost to Follow-up|0|||
162966816|NCT00874549|588579530|FG002|Overall Study|Lost to Follow-up|1|||
163053693|NCT02265510|588908383|FG005|Overall Study|Other|0|||
163053694|NCT02265510|588908384|FG006|Overall Study|Other|0|||
163053695|NCT02265510|588908385|FG007|Overall Study|Other|0|||
162966817|NCT00874549|588579531|FG003|Overall Study|Lost to Follow-up|0|||
162966818|NCT00874549|588579528|FG000|Overall Study|Withdrawal by Subject|0|||
162966819|NCT00874549|588579529|FG001|Overall Study|Withdrawal by Subject|1|||
163053696|NCT02265510|588908386|FG008|Overall Study|Other|0|||
163053697|NCT02265510|588908387|FG009|Overall Study|Other|0|||
163053698|NCT02265510|588908388|FG010|Overall Study|Other|0|||
163053699|NCT02265510|588908389|FG011|Overall Study|Other|0|||
163053700|NCT02265510|588908390|FG012|Overall Study|Other|0|||
163053701|NCT02265510|588908391|FG013|Overall Study|Other|0|||
163397508|NCT00294060|590167745|FG000|Overall Study|Other|59|||
163397509|NCT00294060|590167745|FG000|Overall Study|Lost to Follow-up|55|||
163397510|NCT00294060|590167745|FG000|Overall Study|Withdrawal by Subject|11|||
163397511|NCT00294060|590167745|FG000|Overall Study|Physician Decision|797|||
163397512|NCT00294060|590167745|FG000|Overall Study|Medical condition|3|||
163397513|NCT00294060|590167745|FG000|Overall Study|Device explanted/not replaced|23|||
163397514|NCT00139776|590167746|FG000|Period I|Did not enter Period II|575|||
163397515|NCT00139776|590167747|FG001|Period I|Did not enter Period II|0|||
162966820|NCT00874549|588579530|FG002|Overall Study|Withdrawal by Subject|0|||
162966821|NCT00874549|588579531|FG003|Overall Study|Withdrawal by Subject|1|||
162966822|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
162966823|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
162966824|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
162966825|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
162966826|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
162966827|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
162966828|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
163206021|NCT02310568|589466795|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
163206022|NCT02310568|589466791|FG000|Stage 1 ( 4 Weeks)|Other|1|||
163206023|NCT02310568|589466792|FG001|Stage 1 ( 4 Weeks)|Other|1|||
163206024|NCT02310568|589466793|FG002|Stage 1 ( 4 Weeks)|Other|0|||
163053702|NCT02265510|588908378|FG000|Overall Study|Study Terminated by Sponsor|0|||
163053703|NCT02265510|588908379|FG001|Overall Study|Study Terminated by Sponsor|0|||
163053704|NCT02265510|588908380|FG002|Overall Study|Study Terminated by Sponsor|0|||
163053705|NCT02265510|588908381|FG003|Overall Study|Study Terminated by Sponsor|0|||
163053706|NCT02265510|588908382|FG004|Overall Study|Study Terminated by Sponsor|0|||
163053707|NCT02265510|588908383|FG005|Overall Study|Study Terminated by Sponsor|1|||
163053708|NCT02265510|588908384|FG006|Overall Study|Study Terminated by Sponsor|1|||
163053709|NCT02265510|588908385|FG007|Overall Study|Study Terminated by Sponsor|1|||
163053710|NCT02265510|588908386|FG008|Overall Study|Study Terminated by Sponsor|1|||
163053711|NCT02265510|588908387|FG009|Overall Study|Study Terminated by Sponsor|2|||
163053712|NCT02265510|588908388|FG010|Overall Study|Study Terminated by Sponsor|1|||
163053713|NCT02265510|588908389|FG011|Overall Study|Study Terminated by Sponsor|4|||
163053714|NCT02265510|588908390|FG012|Overall Study|Study Terminated by Sponsor|1|||
163053715|NCT02265510|588908391|FG013|Overall Study|Study Terminated by Sponsor|2|||
163053716|NCT02530385|588908392|FG000|Overall Study|Withdrawal by Subject|0|||
163053717|NCT02530385|588908393|FG001|Overall Study|Withdrawal by Subject|1|||
162966829|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
162966830|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
162966831|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
162966832|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
163206025|NCT02310568|589466794|FG003|Stage 1 ( 4 Weeks)|Other|0|||
163206026|NCT02310568|589466795|FG004|Stage 1 ( 4 Weeks)|Other|0|||
163397516|NCT00139776|590167748|FG002|Period I|Did not enter Period II|0|||
163397517|NCT00139776|590167749|FG003|Period I|Did not enter Period II|0|||
163053718|NCT00116142|588908394|FG000|Overall Study|Adverse Event|8|||
163053719|NCT00116142|588908395|FG001|Overall Study|Adverse Event|7|||
163053720|NCT00116142|588908394|FG000|Overall Study|Protocol Violation|2|||
163206027|NCT02310568|589466791|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
163206028|NCT02310568|589466792|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
163206029|NCT02310568|589466793|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
162966833|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
162966834|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
162966835|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
162966836|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
162966837|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
162966838|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
162966839|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
162966840|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
162966841|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
162966842|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
162966843|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
162966844|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
162966845|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
162966846|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
162966847|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
162966848|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
162966849|NCT01710358|588579534|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
163053721|NCT00116142|588908395|FG001|Overall Study|Protocol Violation|1|||
163053722|NCT00116142|588908394|FG000|Overall Study|Withdrawal by Subject|5|||
163053723|NCT00116142|588908395|FG001|Overall Study|Withdrawal by Subject|5|||
163053724|NCT00116142|588908394|FG000|Overall Study|Physician Decision|3|||
163053725|NCT00116142|588908395|FG001|Overall Study|Physician Decision|1|||
163053726|NCT00116142|588908394|FG000|Overall Study|Delayed Radiation Therapy|1|||
163053727|NCT00116142|588908395|FG001|Overall Study|Delayed Radiation Therapy|0|||
163053728|NCT00116142|588908394|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
163053729|NCT00116142|588908395|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
163053730|NCT00116142|588908394|FG000|Overall Study|Patient stopped due to depression|0|||
163053731|NCT00116142|588908395|FG001|Overall Study|Patient stopped due to depression|1|||
163053732|NCT00116142|588908394|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
163053733|NCT00116142|588908395|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
163053734|NCT00116142|588908394|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
163053735|NCT00116142|588908395|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
163053736|NCT00116142|588908394|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
163053737|NCT00116142|588908395|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
163053738|NCT03093181|588908396|FG000|Overall Study|Withdrawal by Subject|2|||
163053739|NCT03093181|588908397|FG001|Overall Study|Withdrawal by Subject|1|||
163053740|NCT03093181|588908398|FG002|Overall Study|Withdrawal by Subject|2|||
163053741|NCT03093181|588908396|FG000|Overall Study|Other (Not specified)|1|||
163053742|NCT03093181|588908397|FG001|Overall Study|Other (Not specified)|0|||
163053743|NCT03093181|588908398|FG002|Overall Study|Other (Not specified)|0|||
163053744|NCT03093181|588908396|FG000|Overall Study|Adverse Event|0|||
162966850|NCT01710358|588579535|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
162966851|NCT01710358|588579536|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
162966852|NCT01710358|588579534|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
162966853|NCT01710358|588579535|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
162966854|NCT01710358|588579536|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
163053745|NCT03093181|588908397|FG001|Overall Study|Adverse Event|1|||
162966855|NCT01710358|588579534|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
162966856|NCT01710358|588579535|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
163206030|NCT02310568|589466794|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
163206031|NCT02310568|589466795|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
163206032|NCT02310568|589466791|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
163206033|NCT02310568|589466792|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
163206034|NCT02310568|589466793|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
163206035|NCT02310568|589466794|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
163206036|NCT02310568|589466795|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
163206037|NCT02310568|589466791|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
163206038|NCT02310568|589466792|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
163206039|NCT02310568|589466793|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
163206040|NCT02310568|589466794|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
163397518|NCT00139776|590167746|FG000|Period II|Not Randomized into Period III|0|||
163397519|NCT00139776|590167747|FG001|Period II|Not Randomized into Period III|322|||
163313839|NCT05329220|589859499|FG005|Follow-up Period|Adverse Event|1|||
163313840|NCT05329220|589859494|FG000|Follow-up Period|Death|0|||
163313841|NCT05329220|589859495|FG001|Follow-up Period|Death|0|||
163313842|NCT05329220|589859496|FG002|Follow-up Period|Death|1|||
163313843|NCT05329220|589859497|FG003|Follow-up Period|Death|1|||
163313844|NCT05329220|589859498|FG004|Follow-up Period|Death|0|||
163313845|NCT05329220|589859499|FG005|Follow-up Period|Death|1|||
163313846|NCT05329220|589859494|FG000|Follow-up Period|Lost to Follow-up|0|||
163313847|NCT05329220|589859495|FG001|Follow-up Period|Lost to Follow-up|1|||
163313848|NCT05329220|589859496|FG002|Follow-up Period|Lost to Follow-up|2|||
163313849|NCT05329220|589859497|FG003|Follow-up Period|Lost to Follow-up|2|||
163313850|NCT05329220|589859498|FG004|Follow-up Period|Lost to Follow-up|113|||
163313851|NCT05329220|589859499|FG005|Follow-up Period|Lost to Follow-up|89|||
163313852|NCT05329220|589859494|FG000|Follow-up Period|Physician Decision|0|||
163313853|NCT05329220|589859495|FG001|Follow-up Period|Physician Decision|0|||
162966857|NCT01710358|588579536|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
162966858|NCT01710358|588579534|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
162966859|NCT01710358|588579535|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
162966860|NCT01710358|588579536|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
162966861|NCT01710358|588579534|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
162966862|NCT01710358|588579535|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
162966863|NCT01710358|588579536|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
162966864|NCT01710358|588579534|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
162966865|NCT01710358|588579535|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
162966866|NCT01710358|588579536|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
162966867|NCT01710358|588579534|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
162966868|NCT01710358|588579535|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
162966869|NCT01710358|588579536|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
162966870|NCT01710358|588579534|FG000|Rescue Period|Adverse Event|0|||
162966871|NCT01710358|588579535|FG001|Rescue Period|Adverse Event|15|||
162966872|NCT01710358|588579536|FG002|Rescue Period|Adverse Event|0|||
162966873|NCT01710358|588579534|FG000|Rescue Period|Death|0|||
162966874|NCT01710358|588579535|FG001|Rescue Period|Death|1|||
162966875|NCT01710358|588579536|FG002|Rescue Period|Death|0|||
162966876|NCT01710358|588579534|FG000|Rescue Period|Lack of Efficacy|0|||
163053746|NCT03093181|588908398|FG002|Overall Study|Adverse Event|0|||
163053747|NCT03093181|588908396|FG000|Overall Study|Other (Protocol violation)|0|||
163053748|NCT03093181|588908397|FG001|Overall Study|Other (Protocol violation)|0|||
163053749|NCT03093181|588908398|FG002|Overall Study|Other (Protocol violation)|1|||
163053750|NCT02378662|588908399|FG000|Overall Study|Early Discontinuation|2|||
163053751|NCT02378662|588908400|FG001|Overall Study|Early Discontinuation|0|||
163053752|NCT01159574|588908401|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
163053753|NCT01159574|588908401|FG000|Treatment Phase|Adverse Event|3|||
162966877|NCT01710358|588579535|FG001|Rescue Period|Lack of Efficacy|7|||
162966878|NCT01710358|588579536|FG002|Rescue Period|Lack of Efficacy|0|||
162966879|NCT01710358|588579534|FG000|Rescue Period|Withdrawal by Subject|0|||
162966880|NCT01710358|588579535|FG001|Rescue Period|Withdrawal by Subject|8|||
162966881|NCT01710358|588579536|FG002|Rescue Period|Withdrawal by Subject|0|||
162966882|NCT00880334|588579537|FG000|Randomized Phase|Physician Decision|1|||
162966883|NCT00880334|588579538|FG001|Randomized Phase|Physician Decision|0|||
162966884|NCT00880334|588579537|FG000|Randomized Phase|Withdrawal by Subject|2|||
162966885|NCT00880334|588579538|FG001|Randomized Phase|Withdrawal by Subject|1|||
162966886|NCT00880334|588579537|FG000|Randomized Phase|Inadequate Labs|1|||
162966887|NCT00880334|588579538|FG001|Randomized Phase|Inadequate Labs|1|||
162966888|NCT00880334|588579537|FG000|Randomized Phase|Brain Metastasis|0|||
162966889|NCT00880334|588579538|FG001|Randomized Phase|Brain Metastasis|1|||
162966890|NCT00880334|588579537|FG000|Randomized Phase|Crossover Participants|0|||
162966891|NCT00880334|588579538|FG001|Randomized Phase|Crossover Participants|37|||
162966892|NCT00084864|588579543|FG000|Overall Study|Adverse Event|1|||
162966893|NCT00084864|588579544|FG001|Overall Study|Adverse Event|0|||
162966894|NCT00084864|588579545|FG002|Overall Study|Adverse Event|0|||
162966895|NCT00084864|588579546|FG003|Overall Study|Adverse Event|0|||
162966896|NCT02460835|588579551|FG000|Overall Study|Disease progression prior to treatment|3|||
162966897|NCT02460835|588579551|FG000|Overall Study|Unable to complete planning scans|2|||
162966898|NCT02460835|588579551|FG000|Overall Study|Decrease in performance status|1|||
162966899|NCT02460835|588579551|FG000|Overall Study|Withdrawal by Subject|3|||
162966900|NCT02460835|588579551|FG000|Overall Study|Underwent fractionated RT|10|||
162966901|NCT02460835|588579551|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
162966902|NCT00969124|588579566|FG000|Overall Study|Protocol Violation|2|||
162966903|NCT00969124|588579566|FG000|Overall Study|Inadequate bowel preparation|15|||
162966904|NCT00969124|588579566|FG000|Overall Study|Inability to reach cecum|9|||
162966905|NCT00969124|588579566|FG000|Overall Study|Previously unrecognized disease|3|||
162966906|NCT00969124|588579566|FG000|Overall Study|Technical error|1|||
162966907|NCT02786953|588579571|FG000|Overall Study|Withdrawal by Subject|3|||
162966908|NCT02786953|588579572|FG001|Overall Study|Withdrawal by Subject|0|||
162966909|NCT02786953|588579571|FG000|Overall Study|Physician Decision|0|||
162966910|NCT02786953|588579572|FG001|Overall Study|Physician Decision|1|||
162966911|NCT01186458|588579578|FG000|Overall Study|Adverse Event|1|||
162966912|NCT04281472|588579579|FG000|Stage A|Lack of Efficacy|8|||
162966913|NCT04281472|588579580|FG001|Stage A|Lack of Efficacy|0|||
162966914|NCT04281472|588579581|FG002|Stage A|Lack of Efficacy|0|||
162966915|NCT04281472|588579579|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
163053754|NCT01159574|588908401|FG000|Treatment Phase|Death|6|||
163053755|NCT01159574|588908401|FG000|Treatment Phase|Physician Decision|2|||
163053756|NCT01159574|588908401|FG000|Treatment Phase|Withdrawal by Subject|7|||
163053757|NCT01159574|588908401|FG000|Treatment Phase|still on treatment|2|||
163053758|NCT01159574|588908401|FG000|Follow Up Phase|Lost to Follow-up|2|||
163053759|NCT01159574|588908401|FG000|Follow Up Phase|still being followed for overall surviva|18|||
163053760|NCT00324155|588908402|FG000|Enrolled and Randomized|No longer met study criteria|3|||
163053761|NCT00324155|588908403|FG001|Enrolled and Randomized|No longer met study criteria|0|||
162966916|NCT04281472|588579580|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
162966917|NCT04281472|588579581|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
163053762|NCT00324155|588908402|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
163053763|NCT00324155|588908403|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
163053764|NCT00324155|588908402|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
163053765|NCT00324155|588908403|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
163206041|NCT02310568|589466795|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
163206042|NCT02310568|589466791|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
163206043|NCT02310568|589466792|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
163206044|NCT02310568|589466793|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
162966918|NCT04281472|588579579|FG000|Stage A|Adverse Event|20|||
163206045|NCT02310568|589466794|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
163206046|NCT02310568|589466795|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
163206047|NCT02310568|589466791|FG000|Stage 2 (4 Weeks)|Other|0|||
163206048|NCT02310568|589466792|FG001|Stage 2 (4 Weeks)|Other|1|||
163206049|NCT02310568|589466793|FG002|Stage 2 (4 Weeks)|Other|1|||
163206050|NCT02310568|589466794|FG003|Stage 2 (4 Weeks)|Other|0|||
163206051|NCT02310568|589466795|FG004|Stage 2 (4 Weeks)|Other|0|||
163206052|NCT02310568|589466791|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
163206053|NCT02310568|589466792|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
163206054|NCT02310568|589466793|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
163206055|NCT02310568|589466794|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
163206056|NCT02310568|589466795|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
163206057|NCT02310568|589466791|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
163206058|NCT02310568|589466792|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
163397520|NCT00139776|590167748|FG002|Period II|Not Randomized into Period III|0|||
163397521|NCT00139776|590167749|FG003|Period II|Not Randomized into Period III|0|||
163397522|NCT00139776|590167746|FG000|Period III|Adverse Event|0|||
163397523|NCT00139776|590167747|FG001|Period III|Adverse Event|0|||
162966919|NCT04281472|588579580|FG001|Stage A|Adverse Event|0|||
162966920|NCT04281472|588579581|FG002|Stage A|Adverse Event|0|||
162966921|NCT04281472|588579579|FG000|Stage A|Death|1|||
162966922|NCT04281472|588579580|FG001|Stage A|Death|0|||
162966923|NCT04281472|588579581|FG002|Stage A|Death|0|||
162966924|NCT04281472|588579579|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
162966925|NCT04281472|588579580|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
162966926|NCT04281472|588579581|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
162966927|NCT04281472|588579579|FG000|Stage A|Lost to Follow-up|2|||
162966928|NCT04281472|588579580|FG001|Stage A|Lost to Follow-up|0|||
162966929|NCT04281472|588579581|FG002|Stage A|Lost to Follow-up|0|||
162966930|NCT04281472|588579579|FG000|Stage A|Non-compliance with study drug|1|||
163053766|NCT00324155|588908402|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
163053767|NCT00324155|588908403|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
163053768|NCT00324155|588908402|FG000|Received Treatment in Induction Phase|Death|8|||
163053769|NCT00324155|588908403|FG001|Received Treatment in Induction Phase|Death|15|||
163053770|NCT00324155|588908402|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
163053771|NCT00324155|588908403|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
163053772|NCT00324155|588908402|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
163053773|NCT00324155|588908403|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
163053774|NCT00324155|588908402|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
163053775|NCT00324155|588908403|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
163053776|NCT00324155|588908402|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
163053777|NCT00324155|588908403|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
163053778|NCT00324155|588908402|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
163397524|NCT00139776|590167748|FG002|Period III|Adverse Event|22|||
163053779|NCT00324155|588908403|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
163397525|NCT00139776|590167749|FG003|Period III|Adverse Event|23|||
163397526|NCT00139776|590167746|FG000|Period III|Other|0|||
162966931|NCT04281472|588579580|FG001|Stage A|Non-compliance with study drug|0|||
162966932|NCT04281472|588579581|FG002|Stage A|Non-compliance with study drug|0|||
162966933|NCT04281472|588579579|FG000|Stage A|Physician Decision|1|||
162966934|NCT04281472|588579580|FG001|Stage A|Physician Decision|0|||
162966935|NCT04281472|588579581|FG002|Stage A|Physician Decision|0|||
162966936|NCT04281472|588579579|FG000|Stage A|Prohibited medications|2|||
162966937|NCT04281472|588579580|FG001|Stage A|Prohibited medications|0|||
163053780|NCT00324155|588908402|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
162966938|NCT04281472|588579581|FG002|Stage A|Prohibited medications|0|||
162966939|NCT04281472|588579579|FG000|Stage A|Withdrawal by Subject|11|||
162966940|NCT04281472|588579580|FG001|Stage A|Withdrawal by Subject|0|||
162966941|NCT04281472|588579581|FG002|Stage A|Withdrawal by Subject|0|||
162966942|NCT04281472|588579579|FG000|Stage A|Other|5|||
162966943|NCT04281472|588579580|FG001|Stage A|Other|0|||
162966944|NCT04281472|588579581|FG002|Stage A|Other|0|||
162966945|NCT04281472|588579579|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
162966946|NCT04281472|588579580|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
162966947|NCT04281472|588579581|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
162966948|NCT04281472|588579579|FG000|Stage B|Adverse Event|0|||
162966949|NCT04281472|588579580|FG001|Stage B|Adverse Event|3|||
162966950|NCT04281472|588579581|FG002|Stage B|Adverse Event|0|||
162966951|NCT04281472|588579579|FG000|Stage B|Death|0|||
162966952|NCT04281472|588579580|FG001|Stage B|Death|0|||
162966953|NCT04281472|588579581|FG002|Stage B|Death|1|||
162966954|NCT04281472|588579579|FG000|Stage B|Lack of Efficacy|0|||
162966955|NCT04281472|588579580|FG001|Stage B|Lack of Efficacy|0|||
162966956|NCT04281472|588579581|FG002|Stage B|Lack of Efficacy|1|||
162966957|NCT04281472|588579579|FG000|Stage B|Lost to Follow-up|0|||
162966958|NCT04281472|588579580|FG001|Stage B|Lost to Follow-up|0|||
162966959|NCT04281472|588579581|FG002|Stage B|Lost to Follow-up|2|||
162966960|NCT04281472|588579579|FG000|Stage B|Prohibited medications|0|||
162966961|NCT04281472|588579580|FG001|Stage B|Prohibited medications|2|||
163397527|NCT00139776|590167747|FG001|Period III|Other|0|||
162966962|NCT04281472|588579581|FG002|Stage B|Prohibited medications|1|||
162966963|NCT04281472|588579579|FG000|Stage B|Protocol Violation|0|||
162966964|NCT04281472|588579580|FG001|Stage B|Protocol Violation|1|||
163053781|NCT00324155|588908403|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
163053782|NCT00324155|588908402|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
163053783|NCT00324155|588908403|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
163053784|NCT00324155|588908402|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
163053785|NCT00324155|588908403|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
163053786|NCT00324155|588908402|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
163053787|NCT00324155|588908403|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
162966965|NCT04281472|588579581|FG002|Stage B|Protocol Violation|1|||
162966966|NCT04281472|588579579|FG000|Stage B|Sponsor decision|0|||
162966967|NCT04281472|588579580|FG001|Stage B|Sponsor decision|0|||
162966968|NCT04281472|588579581|FG002|Stage B|Sponsor decision|1|||
162966969|NCT04281472|588579579|FG000|Stage B|Withdrawal by Subject|0|||
162966970|NCT04281472|588579580|FG001|Stage B|Withdrawal by Subject|3|||
162966971|NCT04281472|588579581|FG002|Stage B|Withdrawal by Subject|3|||
162966972|NCT04281472|588579579|FG000|Stage B|Other|0|||
162966973|NCT04281472|588579580|FG001|Stage B|Other|3|||
162966974|NCT04281472|588579581|FG002|Stage B|Other|0|||
162966975|NCT04697173|588579590|FG000|Overall Study|Withdrawal by Subject|34|||
162966976|NCT04697173|588579591|FG001|Overall Study|Withdrawal by Subject|38|||
162966977|NCT03277248|588579596|FG000|Overall Study|Adverse Event|3|||
162966978|NCT03277248|588579597|FG001|Overall Study|Adverse Event|1|||
162966979|NCT03277248|588579596|FG000|Overall Study|Subject Withdrawal of Consent|6|||
162966980|NCT03277248|588579597|FG001|Overall Study|Subject Withdrawal of Consent|23|||
162966981|NCT03277248|588579596|FG000|Overall Study|Investigator/Sponsor Decision|2|||
162966982|NCT03277248|588579597|FG001|Overall Study|Investigator/Sponsor Decision|2|||
162966983|NCT03277248|588579596|FG000|Overall Study|Pregnancy|4|||
162966984|NCT03277248|588579597|FG001|Overall Study|Pregnancy|1|||
162966985|NCT03277248|588579596|FG000|Overall Study|Lost to Follow-up|0|||
162966986|NCT03277248|588579597|FG001|Overall Study|Lost to Follow-up|2|||
162966987|NCT03277248|588579596|FG000|Overall Study|Lack of Efficacy|0|||
162966988|NCT03277248|588579597|FG001|Overall Study|Lack of Efficacy|2|||
162966989|NCT03277248|588579596|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
162966990|NCT03277248|588579597|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
162966991|NCT01993940|588579598|FG000|Overall Study|Adverse Event|16|||
162966992|NCT01993940|588579599|FG001|Overall Study|Adverse Event|11|||
162966993|NCT01993940|588579598|FG000|Overall Study|Withdrawal by Subject|15|||
162966994|NCT01993940|588579599|FG001|Overall Study|Withdrawal by Subject|19|||
162966995|NCT01993940|588579598|FG000|Overall Study|Lost to Follow-up|2|||
162966996|NCT01993940|588579599|FG001|Overall Study|Lost to Follow-up|5|||
162966997|NCT01993940|588579598|FG000|Overall Study|Protocol Violation|5|||
162966998|NCT01993940|588579599|FG001|Overall Study|Protocol Violation|8|||
162966999|NCT01993940|588579598|FG000|Overall Study|Death|1|||
162967000|NCT01993940|588579599|FG001|Overall Study|Death|0|||
162967001|NCT01993940|588579598|FG000|Overall Study|Other - Miscellaneous|1|||
162967002|NCT01993940|588579599|FG001|Overall Study|Other - Miscellaneous|1|||
162967003|NCT01949532|588579600|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
162967004|NCT01949532|588579601|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
162967005|NCT00379353|588579602|FG000|Overall Study|Hospitalization|3|||
162967006|NCT00379353|588579603|FG001|Overall Study|Hospitalization|3|||
162967007|NCT00379353|588579602|FG000|Overall Study|Withdrawal by Subject|5|||
162967008|NCT00379353|588579603|FG001|Overall Study|Withdrawal by Subject|2|||
162967009|NCT00379353|588579602|FG000|Overall Study|Death|1|||
162967010|NCT00379353|588579603|FG001|Overall Study|Death|0|||
162967011|NCT00379353|588579602|FG000|Overall Study|Cardiac Tamponade|1|||
162967012|NCT00379353|588579603|FG001|Overall Study|Cardiac Tamponade|0|||
162967013|NCT00379353|588579602|FG000|Overall Study|Non-compliance|1|||
162967014|NCT00379353|588579603|FG001|Overall Study|Non-compliance|0|||
162967015|NCT00379353|588579602|FG000|Overall Study|Conflicting drug treatment|0|||
162967016|NCT00379353|588579603|FG001|Overall Study|Conflicting drug treatment|1|||
162967017|NCT01211262|588579608|FG000|Overall Study|Progressive Disease|18|||
162967018|NCT01211262|588579609|FG001|Overall Study|Progressive Disease|9|||
162967019|NCT01211262|588579608|FG000|Overall Study|Adverse Event|4|||
162967020|NCT01211262|588579609|FG001|Overall Study|Adverse Event|0|||
162967021|NCT01211262|588579608|FG000|Overall Study|Withdrawal of Consent|1|||
162967022|NCT01211262|588579609|FG001|Overall Study|Withdrawal of Consent|0|||
162967023|NCT01211262|588579608|FG000|Overall Study|Other|0|||
162967024|NCT01211262|588579609|FG001|Overall Study|Other|1|||
162967025|NCT01277510|588579612|FG000|Double-blind Phase|Non-compliance|0|||
162967026|NCT01277510|588579613|FG001|Double-blind Phase|Non-compliance|1|||
162967027|NCT01277510|588579612|FG000|Double-blind Phase|Adverse Event|1|||
162967028|NCT01277510|588579613|FG001|Double-blind Phase|Adverse Event|0|||
162967029|NCT01277510|588579612|FG000|Double-blind Phase|Withdrawal by Subject|2|||
162967030|NCT01277510|588579613|FG001|Double-blind Phase|Withdrawal by Subject|0|||
162967031|NCT01277510|588579612|FG000|Double-blind Phase|Administrative decision|7|||
162967032|NCT01277510|588579613|FG001|Double-blind Phase|Administrative decision|9|||
163053788|NCT00324155|588908402|FG000|Follow-up Phase|On-going participants still on drug|11|||
163313854|NCT05329220|589859496|FG002|Follow-up Period|Physician Decision|0|||
162967033|NCT01277510|588579612|FG000|Double-blind Phase|Death|0|||
163313855|NCT05329220|589859497|FG003|Follow-up Period|Physician Decision|0|||
162967034|NCT01277510|588579613|FG001|Double-blind Phase|Death|1|||
162967035|NCT01277510|588579612|FG000|Double-blind Phase|Protocol-specified criteria|2|||
162967036|NCT01277510|588579613|FG001|Double-blind Phase|Protocol-specified criteria|6|||
162967037|NCT01277510|588579612|FG000|Double-blind Phase|Other|1|||
162967038|NCT01277510|588579613|FG001|Double-blind Phase|Other|1|||
163313856|NCT05329220|589859498|FG004|Follow-up Period|Physician Decision|2|||
163313857|NCT05329220|589859499|FG005|Follow-up Period|Physician Decision|2|||
163313858|NCT05329220|589859494|FG000|Follow-up Period|Protocol Violation|0|||
163313859|NCT05329220|589859495|FG001|Follow-up Period|Protocol Violation|0|||
163313860|NCT05329220|589859496|FG002|Follow-up Period|Protocol Violation|0|||
163313861|NCT05329220|589859497|FG003|Follow-up Period|Protocol Violation|0|||
163313862|NCT05329220|589859498|FG004|Follow-up Period|Protocol Violation|0|||
163313863|NCT05329220|589859499|FG005|Follow-up Period|Protocol Violation|1|||
163313864|NCT05329220|589859494|FG000|Follow-up Period|Withdrawal by Subject|0|||
162967039|NCT01277510|588579612|FG000|Open-label Phase|Administrative decision|4|||
162967040|NCT01277510|588579613|FG001|Open-label Phase|Administrative decision|3|||
162967041|NCT01277510|588579612|FG000|Open-label Phase|Protocol-specified criteria|1|||
163053789|NCT00324155|588908403|FG001|Follow-up Phase|On-going participants still on drug|6|||
163053790|NCT00390689|588908404|FG000|Overall Study|Adverse Event|2|||
163053791|NCT00390689|588908405|FG001|Overall Study|Adverse Event|5|||
163053792|NCT00390689|588908406|FG002|Overall Study|Adverse Event|2|||
163053793|NCT00390689|588908404|FG000|Overall Study|Lack of Efficacy|0|||
163053794|NCT00390689|588908405|FG001|Overall Study|Lack of Efficacy|0|||
163053795|NCT00390689|588908406|FG002|Overall Study|Lack of Efficacy|1|||
163053796|NCT00390689|588908404|FG000|Overall Study|Protocol Violation|1|||
163053797|NCT00390689|588908405|FG001|Overall Study|Protocol Violation|0|||
163053798|NCT00390689|588908406|FG002|Overall Study|Protocol Violation|0|||
163053799|NCT00390689|588908404|FG000|Overall Study|Investigator's judgement|2|||
163053800|NCT00390689|588908405|FG001|Overall Study|Investigator's judgement|0|||
163053801|NCT00390689|588908406|FG002|Overall Study|Investigator's judgement|0|||
163053802|NCT01253161|588908407|FG000|Overall Study|Adverse Event|1|||
163053803|NCT03101020|588908409|FG000|Overall Study|Lack of time to participate|1|||
163053804|NCT03101020|588908410|FG001|Overall Study|Lack of time to participate|0|||
163053805|NCT03101020|588908409|FG000|Overall Study|Ran over by a car|0|||
163053806|NCT03101020|588908410|FG001|Overall Study|Ran over by a car|1|||
163053807|NCT03101020|588908409|FG000|Overall Study|Withdrawal by Subject|0|||
163053808|NCT03101020|588908410|FG001|Overall Study|Withdrawal by Subject|2|||
163053809|NCT05412134|588908411|FG000|Overall Study|Lost to Follow-up|2|||
163397528|NCT00139776|590167748|FG002|Period III|Other|23|||
163053810|NCT05412134|588908412|FG001|Overall Study|Lost to Follow-up|0|||
163053811|NCT03167242|588908414|FG000|Overall Study|Patient/Guardian Decision|0|||
163397529|NCT00139776|590167749|FG003|Period III|Other|34|||
162967042|NCT01277510|588579613|FG001|Open-label Phase|Protocol-specified criteria|0|||
163206059|NCT02310568|589466793|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
163206060|NCT02310568|589466794|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
163206061|NCT02310568|589466795|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
163206062|NCT02310568|589466791|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
163206063|NCT02310568|589466792|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
163206064|NCT02310568|589466793|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
163053812|NCT03167242|588908415|FG001|Overall Study|Patient/Guardian Decision|1|||
163053813|NCT03167242|588908416|FG002|Overall Study|Patient/Guardian Decision|2|||
163053814|NCT03167242|588908417|FG003|Overall Study|Patient/Guardian Decision|1|||
163053815|NCT03167242|588908418|FG004|Overall Study|Patient/Guardian Decision|1|||
163053816|NCT03167242|588908419|FG005|Overall Study|Patient/Guardian Decision|1|||
163053817|NCT03167242|588908420|FG006|Overall Study|Patient/Guardian Decision|0|||
163053818|NCT03167242|588908421|FG007|Overall Study|Patient/Guardian Decision|0|||
163053819|NCT03167242|588908422|FG008|Overall Study|Patient/Guardian Decision|0|||
163053820|NCT03167242|588908423|FG009|Overall Study|Patient/Guardian Decision|0|||
163053821|NCT03167242|588908424|FG010|Overall Study|Patient/Guardian Decision|1|||
163053822|NCT03167242|588908425|FG011|Overall Study|Patient/Guardian Decision|0|||
163053823|NCT03167242|588908414|FG000|Overall Study|Lost to Follow-up|0|||
163053824|NCT03167242|588908415|FG001|Overall Study|Lost to Follow-up|0|||
163053825|NCT03167242|588908416|FG002|Overall Study|Lost to Follow-up|1|||
163053826|NCT03167242|588908417|FG003|Overall Study|Lost to Follow-up|0|||
163053827|NCT03167242|588908418|FG004|Overall Study|Lost to Follow-up|0|||
163053828|NCT03167242|588908419|FG005|Overall Study|Lost to Follow-up|1|||
163053829|NCT03167242|588908420|FG006|Overall Study|Lost to Follow-up|2|||
163053830|NCT03167242|588908421|FG007|Overall Study|Lost to Follow-up|1|||
163053831|NCT03167242|588908422|FG008|Overall Study|Lost to Follow-up|0|||
163053832|NCT03167242|588908423|FG009|Overall Study|Lost to Follow-up|0|||
163053833|NCT03167242|588908424|FG010|Overall Study|Lost to Follow-up|1|||
163053834|NCT03167242|588908425|FG011|Overall Study|Lost to Follow-up|1|||
163053835|NCT03167242|588908414|FG000|Overall Study|Reason not provided|0|||
163053836|NCT03167242|588908415|FG001|Overall Study|Reason not provided|0|||
163053837|NCT03167242|588908416|FG002|Overall Study|Reason not provided|0|||
163053838|NCT03167242|588908417|FG003|Overall Study|Reason not provided|0|||
163053839|NCT03167242|588908418|FG004|Overall Study|Reason not provided|0|||
163053840|NCT03167242|588908419|FG005|Overall Study|Reason not provided|0|||
163053841|NCT03167242|588908420|FG006|Overall Study|Reason not provided|0|||
163053842|NCT03167242|588908421|FG007|Overall Study|Reason not provided|0|||
163053843|NCT03167242|588908422|FG008|Overall Study|Reason not provided|1|||
163053844|NCT03167242|588908423|FG009|Overall Study|Reason not provided|0|||
163053845|NCT03167242|588908424|FG010|Overall Study|Reason not provided|0|||
163053846|NCT03167242|588908425|FG011|Overall Study|Reason not provided|0|||
163053847|NCT03444584|588908426|FG000|Overall Study|Withdrawal by Subject|0|||
163053848|NCT03444584|588908427|FG001|Overall Study|Withdrawal by Subject|1|||
163053849|NCT03444584|588908426|FG000|Overall Study|Other|0|||
163053850|NCT03444584|588908427|FG001|Overall Study|Other|1|||
163053851|NCT03786380|588908428|FG000|Overall Study|Adverse Event|1|||
163053852|NCT03786380|588908429|FG001|Overall Study|Adverse Event|0|||
163053853|NCT03786380|588908430|FG002|Overall Study|Adverse Event|0|||
163053854|NCT03786380|588908431|FG003|Overall Study|Adverse Event|3|||
163053855|NCT03786380|588908432|FG004|Overall Study|Adverse Event|1|||
163053856|NCT03786380|588908428|FG000|Overall Study|Lack of Efficacy|0|||
163053857|NCT03786380|588908429|FG001|Overall Study|Lack of Efficacy|0|||
163053858|NCT03786380|588908430|FG002|Overall Study|Lack of Efficacy|0|||
163053859|NCT03786380|588908431|FG003|Overall Study|Lack of Efficacy|0|||
163053860|NCT03786380|588908432|FG004|Overall Study|Lack of Efficacy|1|||
163053861|NCT03786380|588908428|FG000|Overall Study|Withdrawal by Subject|1|||
163053862|NCT03786380|588908429|FG001|Overall Study|Withdrawal by Subject|2|||
163053863|NCT03786380|588908430|FG002|Overall Study|Withdrawal by Subject|2|||
163053864|NCT03786380|588908431|FG003|Overall Study|Withdrawal by Subject|1|||
163053865|NCT03786380|588908432|FG004|Overall Study|Withdrawal by Subject|2|||
163053866|NCT03786380|588908428|FG000|Overall Study|Lost to Follow-up|3|||
163053867|NCT03786380|588908429|FG001|Overall Study|Lost to Follow-up|0|||
163053868|NCT03786380|588908430|FG002|Overall Study|Lost to Follow-up|1|||
163053869|NCT03786380|588908431|FG003|Overall Study|Lost to Follow-up|2|||
163053870|NCT03786380|588908432|FG004|Overall Study|Lost to Follow-up|0|||
163053871|NCT03786380|588908428|FG000|Overall Study|Physician Decision|0|||
163053872|NCT03786380|588908429|FG001|Overall Study|Physician Decision|0|||
163053873|NCT03786380|588908430|FG002|Overall Study|Physician Decision|1|||
163053874|NCT03786380|588908431|FG003|Overall Study|Physician Decision|0|||
163053875|NCT03786380|588908432|FG004|Overall Study|Physician Decision|0|||
163397530|NCT00139776|590167746|FG000|Period III|Lack of Efficacy|0|||
162967043|NCT01277510|588579612|FG000|Open-label Phase|Never received investigational product|2|||
162967044|NCT01277510|588579613|FG001|Open-label Phase|Never received investigational product|0|||
162967045|NCT00533507|588579614|FG000|Overall Study|Withdrawal by Subject|1|||
162967046|NCT02119936|588579623|FG000|Overall Study|Lost to Follow-up|10|||
162967047|NCT00570128|588579624|FG000|Overall Study|Adverse Event|1|||
162967048|NCT00570128|588579625|FG001|Overall Study|Adverse Event|0|||
162967049|NCT00570128|588579624|FG000|Overall Study|Lost to Follow-up|1|||
162967050|NCT00570128|588579625|FG001|Overall Study|Lost to Follow-up|0|||
162967051|NCT00570128|588579624|FG000|Overall Study|Withdrawal by Subject|2|||
162967052|NCT00570128|588579625|FG001|Overall Study|Withdrawal by Subject|0|||
162967053|NCT03555695|588579630|FG000|Overall Study|Withdrawal by Subject|1|||
162967054|NCT03555695|588579630|FG000|Overall Study|Lost to Follow-up|1|||
162967055|NCT03555695|588579630|FG000|Overall Study|appendicitis (unrelated)|1|||
162967056|NCT03555695|588579630|FG000|Overall Study|pre-existing sciatica|1|||
162967057|NCT01426854|588579631|FG000|Overall Study|Adverse Event|1|||
162967058|NCT01426854|588579632|FG001|Overall Study|Adverse Event|5|||
162967059|NCT01426854|588579631|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
162967060|NCT01426854|588579632|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
162967061|NCT01426854|588579631|FG000|Overall Study|Lost to Follow-up|3|||
162967062|NCT01426854|588579632|FG001|Overall Study|Lost to Follow-up|0|||
162967063|NCT01426854|588579631|FG000|Overall Study|Noncompliance|0|||
162967064|NCT01426854|588579632|FG001|Overall Study|Noncompliance|1|||
162967065|NCT01426854|588579631|FG000|Overall Study|Treatment Failure|0|||
162967066|NCT01426854|588579632|FG001|Overall Study|Treatment Failure|16|||
162967067|NCT01426854|588579631|FG000|Overall Study|Protocol Deviation|0|||
162967068|NCT01426854|588579632|FG001|Overall Study|Protocol Deviation|1|||
162967069|NCT01426854|588579631|FG000|Overall Study|Other|3|||
162967070|NCT01426854|588579632|FG001|Overall Study|Other|2|||
162967071|NCT03820947|588579634|FG000|Overall Study|Physician Decision|0|||
162967072|NCT03820947|588579635|FG001|Overall Study|Physician Decision|1|||
162967073|NCT03820947|588579636|FG002|Overall Study|Physician Decision|1|||
162967074|NCT03820947|588579637|FG003|Overall Study|Physician Decision|0|||
162967075|NCT03820947|588579638|FG004|Overall Study|Physician Decision|3|||
162967076|NCT03820947|588579634|FG000|Overall Study|Withdrawal by Subject|6|||
162967077|NCT03820947|588579635|FG001|Overall Study|Withdrawal by Subject|10|||
162967078|NCT03820947|588579636|FG002|Overall Study|Withdrawal by Subject|3|||
162967079|NCT03820947|588579637|FG003|Overall Study|Withdrawal by Subject|8|||
162967080|NCT03820947|588579638|FG004|Overall Study|Withdrawal by Subject|5|||
162967081|NCT03820947|588579634|FG000|Overall Study|Procedure Not Attempted|0|||
162967082|NCT03820947|588579635|FG001|Overall Study|Procedure Not Attempted|2|||
162967083|NCT03820947|588579636|FG002|Overall Study|Procedure Not Attempted|1|||
162967084|NCT03820947|588579637|FG003|Overall Study|Procedure Not Attempted|0|||
162967085|NCT03820947|588579638|FG004|Overall Study|Procedure Not Attempted|0|||
162967086|NCT03820947|588579634|FG000|Overall Study|Other Exit|1|||
162967087|NCT03820947|588579635|FG001|Overall Study|Other Exit|3|||
162967088|NCT03820947|588579636|FG002|Overall Study|Other Exit|3|||
162967089|NCT03820947|588579637|FG003|Overall Study|Other Exit|3|||
162967090|NCT03820947|588579638|FG004|Overall Study|Other Exit|0|||
162967091|NCT03820947|588579634|FG000|Overall Study|Follow-up Not Done|10|||
162967092|NCT03820947|588579635|FG001|Overall Study|Follow-up Not Done|13|||
162967093|NCT03820947|588579636|FG002|Overall Study|Follow-up Not Done|2|||
162967094|NCT03820947|588579637|FG003|Overall Study|Follow-up Not Done|3|||
162967095|NCT03820947|588579638|FG004|Overall Study|Follow-up Not Done|12|||
162967096|NCT03820947|588579634|FG000|Overall Study|Death|0|||
162967097|NCT03820947|588579635|FG001|Overall Study|Death|0|||
162967098|NCT03820947|588579636|FG002|Overall Study|Death|0|||
162967099|NCT03820947|588579637|FG003|Overall Study|Death|0|||
162967100|NCT03820947|588579638|FG004|Overall Study|Death|9|||
162967101|NCT03820947|588579634|FG000|Overall Study|Lost to Follow-up|4|||
162967102|NCT03820947|588579635|FG001|Overall Study|Lost to Follow-up|6|||
162967103|NCT03820947|588579636|FG002|Overall Study|Lost to Follow-up|0|||
162967104|NCT03820947|588579637|FG003|Overall Study|Lost to Follow-up|0|||
162967105|NCT03820947|588579638|FG004|Overall Study|Lost to Follow-up|9|||
162967106|NCT02940522|588581223|FG000|Overall Study|Lost to Follow-up|1|||
162967107|NCT02940522|588581224|FG001|Overall Study|Lost to Follow-up|2|||
162967108|NCT02940522|588581223|FG000|Overall Study|Withdrawal by Subject|1|||
162967109|NCT02940522|588581224|FG001|Overall Study|Withdrawal by Subject|0|||
162967110|NCT00274625|588581225|FG000|Overall Study|Lost to Follow-up|46|||
162967111|NCT00274625|588581226|FG001|Overall Study|Lost to Follow-up|54|||
162967112|NCT00274625|588581225|FG000|Overall Study|Excluded from analysis|14|||
162967113|NCT00274625|588581226|FG001|Overall Study|Excluded from analysis|8|||
162967114|NCT05135273|588581229|FG000|Overall Study|Recruited into the army|0|||
162967115|NCT05135273|588581230|FG001|Overall Study|Recruited into the army|0|||
162967116|NCT05135273|588581231|FG002|Overall Study|Recruited into the army|0|||
162967117|NCT05135273|588581232|FG003|Overall Study|Recruited into the army|0|||
162967118|NCT05135273|588581233|FG004|Overall Study|Recruited into the army|1|||
162967119|NCT05135273|588581234|FG005|Overall Study|Recruited into the army|0|||
162967120|NCT05135273|588581235|FG006|Overall Study|Recruited into the army|0|||
162967121|NCT05135273|588581236|FG007|Overall Study|Recruited into the army|0|||
162967122|NCT05135273|588581229|FG000|Overall Study|Moved away from study site|0|||
162967123|NCT05135273|588581230|FG001|Overall Study|Moved away from study site|0|||
162967124|NCT05135273|588581231|FG002|Overall Study|Moved away from study site|0|||
162967125|NCT05135273|588581232|FG003|Overall Study|Moved away from study site|0|||
162967126|NCT05135273|588581233|FG004|Overall Study|Moved away from study site|0|||
162967127|NCT05135273|588581234|FG005|Overall Study|Moved away from study site|1|||
162967128|NCT05135273|588581235|FG006|Overall Study|Moved away from study site|1|||
162967129|NCT05135273|588581236|FG007|Overall Study|Moved away from study site|0|||
162967130|NCT05135273|588581229|FG000|Overall Study|Travel|0|||
162967131|NCT05135273|588581230|FG001|Overall Study|Travel|0|||
162967132|NCT05135273|588581231|FG002|Overall Study|Travel|0|||
162967133|NCT05135273|588581232|FG003|Overall Study|Travel|0|||
162967134|NCT05135273|588581233|FG004|Overall Study|Travel|0|||
162967135|NCT05135273|588581234|FG005|Overall Study|Travel|0|||
162967136|NCT05135273|588581235|FG006|Overall Study|Travel|0|||
162967137|NCT05135273|588581236|FG007|Overall Study|Travel|1|||
162967138|NCT04264819|588581242|FG000|Overall Study|Physician Decision|19|||
162967139|NCT04264819|588581242|FG000|Overall Study|Adverse Event|12|||
162967140|NCT04264819|588581242|FG000|Overall Study|Withdrawal by Subject|11|||
162967141|NCT04264819|588581242|FG000|Overall Study|Lost to Follow-up|2|||
162967142|NCT04264819|588581242|FG000|Overall Study|Death|2|||
162967143|NCT01680016|588581244|FG000|Overall Study|Adverse Event|0|||
162967144|NCT01680016|588581245|FG001|Overall Study|Adverse Event|0|||
162967145|NCT01680016|588581246|FG002|Overall Study|Adverse Event|1|||
162967146|NCT01680016|588581247|FG003|Overall Study|Adverse Event|4|||
162967147|NCT01680016|588581244|FG000|Overall Study|The Subject went out of The Trial|1|||
162967148|NCT01680016|588581245|FG001|Overall Study|The Subject went out of The Trial|0|||
162967149|NCT01680016|588581246|FG002|Overall Study|The Subject went out of The Trial|3|||
162967150|NCT01680016|588581247|FG003|Overall Study|The Subject went out of The Trial|0|||
162967151|NCT01680016|588581244|FG000|Overall Study|Protocol Violation|0|||
162967152|NCT01680016|588581245|FG001|Overall Study|Protocol Violation|1|||
162967153|NCT01680016|588581246|FG002|Overall Study|Protocol Violation|0|||
162967154|NCT01680016|588581247|FG003|Overall Study|Protocol Violation|0|||
163397531|NCT00139776|590167747|FG001|Period III|Lack of Efficacy|0|||
162967155|NCT01680016|588581244|FG000|Overall Study|Withdrawal by Subject|5|||
162967156|NCT01680016|588581245|FG001|Overall Study|Withdrawal by Subject|7|||
162967157|NCT01680016|588581246|FG002|Overall Study|Withdrawal by Subject|1|||
162967158|NCT01680016|588581247|FG003|Overall Study|Withdrawal by Subject|1|||
162967159|NCT01958060|588581251|FG000|Overall Study|Not treated|2|||
162967160|NCT01958060|588581252|FG001|Overall Study|Not treated|0|||
162967161|NCT01958060|588581253|FG002|Overall Study|Not treated|0|||
162967162|NCT01958060|588581254|FG003|Overall Study|Not treated|0|||
162967163|NCT01958060|588581255|FG004|Overall Study|Not treated|1|||
162967164|NCT01958060|588581256|FG005|Overall Study|Not treated|0|||
163206065|NCT02310568|589466794|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
163206066|NCT02310568|589466795|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
163206067|NCT02989194|589466800|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
163206068|NCT02989194|589466801|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
163206069|NCT02989194|589466802|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
163206070|NCT02989194|589466800|FG000|Overall Study|Lost to Follow-up|0|||
163206071|NCT02989194|589466801|FG001|Overall Study|Lost to Follow-up|1|||
163206072|NCT02989194|589466802|FG002|Overall Study|Lost to Follow-up|0|||
163206073|NCT02989194|589466800|FG000|Overall Study|Withdrawal by Subject|0|||
163206074|NCT02989194|589466801|FG001|Overall Study|Withdrawal by Subject|1|||
162967165|NCT02846883|588581262|FG000|Overall Study|Death|0|||
163053876|NCT03786380|588908428|FG000|Overall Study|Study Terminated by the Sponsor|30|||
163053877|NCT03786380|588908429|FG001|Overall Study|Study Terminated by the Sponsor|20|||
163053878|NCT03786380|588908430|FG002|Overall Study|Study Terminated by the Sponsor|50|||
163053879|NCT03786380|588908431|FG003|Overall Study|Study Terminated by the Sponsor|57|||
163053880|NCT03786380|588908432|FG004|Overall Study|Study Terminated by the Sponsor|23|||
163053881|NCT03786380|588908428|FG000|Overall Study|Reason Not Specified|0|||
163053882|NCT03786380|588908429|FG001|Overall Study|Reason Not Specified|0|||
163053883|NCT03786380|588908430|FG002|Overall Study|Reason Not Specified|0|||
163206075|NCT02989194|589466802|FG002|Overall Study|Withdrawal by Subject|0|||
163053884|NCT03786380|588908431|FG003|Overall Study|Reason Not Specified|0|||
163053885|NCT03786380|588908432|FG004|Overall Study|Reason Not Specified|1|||
163206076|NCT04160091|589466805|FG000|Overall Study|Terminated by Sponsor|7|||
163206077|NCT04160091|589466806|FG001|Overall Study|Terminated by Sponsor|3|||
163397532|NCT00139776|590167748|FG002|Period III|Lack of Efficacy|10|||
163397533|NCT00139776|590167749|FG003|Period III|Lack of Efficacy|24|||
163397534|NCT00139776|590167746|FG000|Period III|Lost to Follow-up|0|||
162967166|NCT02846883|588581263|FG001|Overall Study|Death|1|||
162967167|NCT02846883|588581264|FG002|Overall Study|Death|1|||
163206078|NCT04160091|589466807|FG002|Overall Study|Terminated by Sponsor|5|||
163206079|NCT04160091|589466808|FG003|Overall Study|Terminated by Sponsor|2|||
162967168|NCT02846883|588581262|FG000|Overall Study|Lost to Follow-up|0|||
163053886|NCT00467519|588908435|FG000|Overall Study|Protocol Violation|8|||
163053887|NCT00467519|588908436|FG001|Overall Study|Protocol Violation|4|||
163206080|NCT04160091|589466805|FG000|Overall Study|Noncompliance|0|||
163206081|NCT04160091|589466806|FG001|Overall Study|Noncompliance|0|||
163206082|NCT04160091|589466807|FG002|Overall Study|Noncompliance|0|||
162967169|NCT02846883|588581263|FG001|Overall Study|Lost to Follow-up|0|||
162967170|NCT02846883|588581264|FG002|Overall Study|Lost to Follow-up|1|||
162967171|NCT02846883|588581262|FG000|Overall Study|Withdrawal by Subject|1|||
162967172|NCT02846883|588581263|FG001|Overall Study|Withdrawal by Subject|0|||
162967173|NCT02846883|588581264|FG002|Overall Study|Withdrawal by Subject|0|||
162967174|NCT02846883|588581262|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
162967175|NCT02846883|588581263|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
162967176|NCT02846883|588581264|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
162967177|NCT02846883|588581262|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
162967178|NCT02846883|588581263|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
162967179|NCT02846883|588581264|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
162967180|NCT00927251|588581265|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
162967181|NCT00442351|588581269|FG000|Overall Study|Administrative|6|||
162967182|NCT00442351|588581270|FG001|Overall Study|Administrative|5|||
162967183|NCT00442351|588581269|FG000|Overall Study|Did not meet protocol eligibility|1|||
162967184|NCT00442351|588581270|FG001|Overall Study|Did not meet protocol eligibility|0|||
162967185|NCT00442351|588581269|FG000|Overall Study|Other|0|||
162967186|NCT00442351|588581270|FG001|Overall Study|Other|1|||
162967187|NCT00500318|588581271|FG000|Overall Study|Adverse Event|3|||
162967188|NCT00500318|588581272|FG001|Overall Study|Adverse Event|8|||
162967189|NCT00500318|588581271|FG000|Overall Study|Protocol Violation|1|||
162967190|NCT00500318|588581272|FG001|Overall Study|Protocol Violation|3|||
162967191|NCT00500318|588581271|FG000|Overall Study|Withdrawal by Subject|1|||
162967192|NCT00500318|588581272|FG001|Overall Study|Withdrawal by Subject|2|||
162967193|NCT00500318|588581271|FG000|Overall Study|Lack of Efficacy|0|||
162967194|NCT00500318|588581272|FG001|Overall Study|Lack of Efficacy|3|||
162967195|NCT00500318|588581271|FG000|Overall Study|Other Reason|0|||
162967196|NCT00500318|588581272|FG001|Overall Study|Other Reason|1|||
162967197|NCT01011335|588581275|FG000|Overall Study|Lost to Follow-up|0|||
162967198|NCT01011335|588581276|FG001|Overall Study|Lost to Follow-up|0|||
162967199|NCT01011335|588581277|FG002|Overall Study|Lost to Follow-up|1|||
162967200|NCT01011335|588581278|FG003|Overall Study|Lost to Follow-up|1|||
162967201|NCT01011335|588581279|FG004|Overall Study|Lost to Follow-up|1|||
162967202|NCT01011335|588581280|FG005|Overall Study|Lost to Follow-up|1|||
162967203|NCT01011335|588581281|FG006|Overall Study|Lost to Follow-up|2|||
162967204|NCT01011335|588581282|FG007|Overall Study|Lost to Follow-up|2|||
162967205|NCT01011335|588581283|FG008|Overall Study|Lost to Follow-up|1|||
162967206|NCT01011335|588581284|FG009|Overall Study|Lost to Follow-up|0|||
162967207|NCT01011335|588581285|FG010|Overall Study|Lost to Follow-up|0|||
162967208|NCT01011335|588581286|FG011|Overall Study|Lost to Follow-up|1|||
162967209|NCT01011335|588581287|FG012|Overall Study|Lost to Follow-up|2|||
162967210|NCT01011335|588581275|FG000|Overall Study|Protocol Violation|0|||
162967211|NCT01011335|588581276|FG001|Overall Study|Protocol Violation|1|||
162967212|NCT01011335|588581277|FG002|Overall Study|Protocol Violation|0|||
163206083|NCT04160091|589466808|FG003|Overall Study|Noncompliance|1|||
163206084|NCT04160091|589466805|FG000|Overall Study|Withdrawal by Subject|0|||
163206085|NCT04160091|589466806|FG001|Overall Study|Withdrawal by Subject|0|||
163206086|NCT04160091|589466807|FG002|Overall Study|Withdrawal by Subject|0|||
163206087|NCT04160091|589466808|FG003|Overall Study|Withdrawal by Subject|1|||
163206088|NCT00609492|589466811|FG000|Overall Study|Withdrawal by Subject|0|||
163206089|NCT00609492|589466812|FG001|Overall Study|Withdrawal by Subject|2|||
163206090|NCT00609492|589466813|FG002|Overall Study|Withdrawal by Subject|3|||
163206091|NCT00609492|589466811|FG000|Overall Study|Lost to Follow-up|1|||
163206092|NCT00609492|589466812|FG001|Overall Study|Lost to Follow-up|1|||
163206093|NCT00609492|589466813|FG002|Overall Study|Lost to Follow-up|4|||
163206094|NCT01224431|589466814|FG000|Overall Study|not randomized|0|||
163206095|NCT01224431|589466815|FG001|Overall Study|not randomized|4|||
163206096|NCT01224431|589466814|FG000|Overall Study|no video record|0|||
163206097|NCT01224431|589466815|FG001|Overall Study|no video record|1|||
163206098|NCT02057406|589466816|FG000|Overall Study|Physician Decision|0|||
163206099|NCT02057406|589466817|FG001|Overall Study|Physician Decision|0|||
163206100|NCT02057406|589466818|FG002|Overall Study|Physician Decision|2|||
163206101|NCT02057406|589466816|FG000|Overall Study|Withdrawal by Subject|0|||
163206102|NCT02057406|589466817|FG001|Overall Study|Withdrawal by Subject|2|||
163206103|NCT02057406|589466818|FG002|Overall Study|Withdrawal by Subject|0|||
163206104|NCT02057406|589466816|FG000|Overall Study|Lost to Follow-up|0|||
163206105|NCT02057406|589466817|FG001|Overall Study|Lost to Follow-up|0|||
163206106|NCT02057406|589466818|FG002|Overall Study|Lost to Follow-up|1|||
163206107|NCT02057406|589466816|FG000|Overall Study|Death|1|||
163206108|NCT02057406|589466817|FG001|Overall Study|Death|0|||
163206109|NCT02057406|589466818|FG002|Overall Study|Death|0|||
162967213|NCT01011335|588581278|FG003|Overall Study|Protocol Violation|0|||
162967214|NCT01011335|588581279|FG004|Overall Study|Protocol Violation|0|||
162967215|NCT01011335|588581280|FG005|Overall Study|Protocol Violation|0|||
163206110|NCT02057406|589466816|FG000|Overall Study|Protocol Violation|0|||
163206111|NCT02057406|589466817|FG001|Overall Study|Protocol Violation|1|||
163206112|NCT02057406|589466818|FG002|Overall Study|Protocol Violation|0|||
163206113|NCT02057406|589466816|FG000|Overall Study|Patient transportation issues|0|||
163206114|NCT02057406|589466817|FG001|Overall Study|Patient transportation issues|0|||
163206115|NCT02057406|589466818|FG002|Overall Study|Patient transportation issues|1|||
163206116|NCT04492618|589466819|FG000|Overall Study|Withdrawal by Subject|1|||
163206117|NCT01401283|589466820|FG000|Overall Study|surgery cancelled|5|||
163206118|NCT01401283|589466821|FG001|Overall Study|surgery cancelled|8|||
163206119|NCT01401283|589466820|FG000|Overall Study|preoperative arrhythmia|5|||
163206120|NCT01401283|589466821|FG001|Overall Study|preoperative arrhythmia|0|||
163206121|NCT01401283|589466820|FG000|Overall Study|no central venous access|0|||
163206122|NCT01401283|589466821|FG001|Overall Study|no central venous access|1|||
163206123|NCT01401283|589466820|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
163206124|NCT01401283|589466821|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
163206125|NCT02433483|589466822|FG000|Overall Study|Unacceptable toxicity|1|||
163206126|NCT02433483|589466822|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
163206127|NCT01327885|589466831|FG000|Overall Study|Disease progression-according to RECIST|173|||
163206128|NCT01327885|589466832|FG001|Overall Study|Disease progression-according to RECIST|165|||
163206129|NCT01327885|589466831|FG000|Overall Study|Clinical progression|24|||
163206130|NCT01327885|589466832|FG001|Overall Study|Clinical progression|27|||
163206131|NCT01327885|589466831|FG000|Overall Study|Adverse Event|14|||
163206132|NCT01327885|589466832|FG001|Overall Study|Adverse Event|10|||
163206133|NCT01327885|589466831|FG000|Overall Study|Subject choice|5|||
163206134|NCT01327885|589466832|FG001|Overall Study|Subject choice|10|||
163206135|NCT01327885|589466831|FG000|Overall Study|Other|8|||
163053888|NCT00467519|588908435|FG000|Overall Study|Lost to Follow-up|2|||
163053889|NCT00467519|588908436|FG001|Overall Study|Lost to Follow-up|9|||
163053890|NCT00467519|588908435|FG000|Overall Study|Withdrawal by Subject|4|||
163053891|NCT00467519|588908436|FG001|Overall Study|Withdrawal by Subject|10|||
163206136|NCT01327885|589466832|FG001|Overall Study|Other|6|||
163206137|NCT01327885|589466831|FG000|Overall Study|Withdrawal of consent from study|3|||
163053892|NCT00372424|588908437|FG000|Overall Study|Adverse Event|2|||
163053893|NCT00372424|588908437|FG000|Overall Study|Withdrawal by Subject|1|||
163053894|NCT00372424|588908437|FG000|Overall Study|Death|1|||
163053895|NCT00372424|588908437|FG000|Overall Study|Objective Progression or Relapse|14|||
163206138|NCT01327885|589466832|FG001|Overall Study|Withdrawal of consent from study|4|||
163053896|NCT00372424|588908437|FG000|Overall Study|Other|7|||
163206139|NCT01327885|589466831|FG000|Overall Study|Not treated|1|||
163053897|NCT00372424|588908437|FG000|Overall Study|Enrolled, Not Treated|1|||
163206140|NCT01327885|589466832|FG001|Overall Study|Not treated|1|||
163053898|NCT02314728|588908448|FG000|Overall Study|Protocol Violation|1|||
163053899|NCT02314728|588908449|FG001|Overall Study|Protocol Violation|0|||
163053900|NCT02314728|588908448|FG000|Overall Study|Lost to Follow-up|0|||
163053901|NCT02314728|588908449|FG001|Overall Study|Lost to Follow-up|1|||
163053902|NCT03118934|588908451|FG000|Overall Study|Adverse Event|0|||
163053903|NCT03118934|588908452|FG001|Overall Study|Adverse Event|0|||
163053904|NCT03118934|588908453|FG002|Overall Study|Adverse Event|0|||
163053905|NCT03118934|588908454|FG003|Overall Study|Adverse Event|0|||
163053906|NCT03118934|588908455|FG004|Overall Study|Adverse Event|0|||
163053907|NCT03118934|588908456|FG005|Overall Study|Adverse Event|1|||
163053908|NCT03118934|588908451|FG000|Overall Study|Physician Decision|0|||
163053909|NCT03118934|588908452|FG001|Overall Study|Physician Decision|0|||
163053910|NCT03118934|588908453|FG002|Overall Study|Physician Decision|0|||
163053911|NCT03118934|588908454|FG003|Overall Study|Physician Decision|0|||
163053912|NCT03118934|588908455|FG004|Overall Study|Physician Decision|0|||
163053913|NCT03118934|588908456|FG005|Overall Study|Physician Decision|1|||
163053914|NCT03118934|588908451|FG000|Overall Study|Discontinued prior to exposure|0|||
163053915|NCT03118934|588908452|FG001|Overall Study|Discontinued prior to exposure|1|||
163053916|NCT03118934|588908453|FG002|Overall Study|Discontinued prior to exposure|1|||
163053917|NCT03118934|588908454|FG003|Overall Study|Discontinued prior to exposure|1|||
163053918|NCT03118934|588908455|FG004|Overall Study|Discontinued prior to exposure|2|||
163053919|NCT03118934|588908456|FG005|Overall Study|Discontinued prior to exposure|0|||
163053920|NCT00069264|588908459|FG000|Overall Study|Adverse Event|3|||
163053921|NCT00069264|588908459|FG000|Overall Study|Progressive Disease|23|||
163053922|NCT00069264|588908459|FG000|Overall Study|Withdrawal by Subject|3|||
163397535|NCT00139776|590167747|FG001|Period III|Lost to Follow-up|0|||
163397536|NCT00139776|590167748|FG002|Period III|Lost to Follow-up|5|||
163206141|NCT01327885|589466831|FG000|Overall Study|Administrative decision|0|||
163206142|NCT01327885|589466832|FG001|Overall Study|Administrative decision|1|||
163206143|NCT03824912|589466838|FG000|Overall Study|Lost to Follow-up|18|||
163053923|NCT00069264|588908459|FG000|Overall Study|Discon Therapy|3|||
163053924|NCT04467515|588908460|FG000|Overall Study|Lost to Follow-up|1|||
163053925|NCT04467515|588908461|FG001|Overall Study|Lost to Follow-up|0|||
163053926|NCT04467515|588908462|FG002|Overall Study|Lost to Follow-up|0|||
163206144|NCT03824912|589466839|FG001|Overall Study|Lost to Follow-up|15|||
163206145|NCT03824912|589466840|FG002|Overall Study|Lost to Follow-up|8|||
163206146|NCT03824912|589466838|FG000|Overall Study|Negative Baseline Culture Result|118|||
163206147|NCT03824912|589466839|FG001|Overall Study|Negative Baseline Culture Result|112|||
163206148|NCT03824912|589466840|FG002|Overall Study|Negative Baseline Culture Result|57|||
163206149|NCT03824912|589466838|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163206150|NCT03824912|589466839|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163206151|NCT03824912|589466840|FG002|Overall Study|Non-Compliance with Study Drug|1|||
163206152|NCT03824912|589466838|FG000|Overall Study|Protocol Violation|1|||
163206153|NCT03824912|589466839|FG001|Overall Study|Protocol Violation|4|||
163206154|NCT03824912|589466840|FG002|Overall Study|Protocol Violation|1|||
163206155|NCT03824912|589466838|FG000|Overall Study|Withdrawal by Subject|3|||
163206156|NCT03824912|589466839|FG001|Overall Study|Withdrawal by Subject|2|||
163206157|NCT03824912|589466840|FG002|Overall Study|Withdrawal by Subject|1|||
163206158|NCT03824912|589466838|FG000|Overall Study|Participation in another study|0|||
163206159|NCT03824912|589466839|FG001|Overall Study|Participation in another study|1|||
163206160|NCT03824912|589466840|FG002|Overall Study|Participation in another study|0|||
163206161|NCT00549302|589466845|FG000|Double-Blind|Death|2|||
163206162|NCT00549302|589466846|FG001|Double-Blind|Death|9|||
163206163|NCT00549302|589466847|FG002|Double-Blind|Death|0|||
163206164|NCT00549302|589466845|FG000|Double-Blind|Adverse Event|3|||
163053927|NCT04467515|588908460|FG000|Overall Study|Withdrawal by Subject|1|||
163053928|NCT04467515|588908461|FG001|Overall Study|Withdrawal by Subject|0|||
163053929|NCT04467515|588908462|FG002|Overall Study|Withdrawal by Subject|1|||
163053930|NCT04467515|588908460|FG000|Overall Study|Progressive Disease|0|||
163053931|NCT04467515|588908461|FG001|Overall Study|Progressive Disease|1|||
163053932|NCT04467515|588908462|FG002|Overall Study|Progressive Disease|3|||
163053933|NCT04467515|588908460|FG000|Overall Study|Death|0|||
163053934|NCT04467515|588908461|FG001|Overall Study|Death|1|||
163053935|NCT04467515|588908462|FG002|Overall Study|Death|0|||
163053936|NCT03886272|588908463|FG000|Period 1|Withdrawal by Subject|0|||
163053937|NCT03886272|588908464|FG001|Period 1|Withdrawal by Subject|0|||
163053938|NCT03886272|588908465|FG002|Period 1|Withdrawal by Subject|0|||
163053939|NCT03886272|588908466|FG003|Period 1|Withdrawal by Subject|0|||
163053940|NCT03886272|588908467|FG004|Period 1|Withdrawal by Subject|0|||
163053941|NCT03886272|588908468|FG005|Period 1|Withdrawal by Subject|1|||
163053942|NCT03886272|588908469|FG006|Period 1|Withdrawal by Subject|0|||
163053943|NCT03014206|588908470|FG000|Overall Study|Registration Violation|12|||
163053944|NCT01091246|588908471|FG000|Overall Study|Lost to Follow-up|23|||
163053945|NCT01091246|588908472|FG001|Overall Study|Lost to Follow-up|11|||
163053946|NCT01091246|588908473|FG002|Overall Study|Lost to Follow-up|7|||
163053947|NCT01091246|588908471|FG000|Overall Study|Adverse Event|1|||
163053948|NCT01091246|588908472|FG001|Overall Study|Adverse Event|0|||
163053949|NCT01091246|588908473|FG002|Overall Study|Adverse Event|1|||
163053950|NCT01091246|588908471|FG000|Overall Study|Withdrawal by Subject|9|||
163053951|NCT01091246|588908472|FG001|Overall Study|Withdrawal by Subject|5|||
163053952|NCT01091246|588908473|FG002|Overall Study|Withdrawal by Subject|4|||
163206165|NCT00549302|589466846|FG001|Double-Blind|Adverse Event|16|||
163206166|NCT00549302|589466847|FG002|Double-Blind|Adverse Event|0|||
163206167|NCT00549302|589466845|FG000|Double-Blind|Withdrawal by Subject|3|||
163397537|NCT00139776|590167749|FG003|Period III|Lost to Follow-up|4|||
163053953|NCT01091246|588908471|FG000|Overall Study|Subject not dosed|2|||
163053954|NCT01091246|588908472|FG001|Overall Study|Subject not dosed|0|||
163053955|NCT01091246|588908473|FG002|Overall Study|Subject not dosed|1|||
163053956|NCT01673178|588908474|FG000|Overall Study|Lost to Follow-up|0|||
163206168|NCT00549302|589466846|FG001|Double-Blind|Withdrawal by Subject|8|||
163053957|NCT01673178|588908475|FG001|Overall Study|Lost to Follow-up|1|||
163053958|NCT01673178|588908476|FG002|Overall Study|Lost to Follow-up|0|||
163053959|NCT01673178|588908477|FG003|Overall Study|Lost to Follow-up|0|||
163053960|NCT01673178|588908478|FG004|Overall Study|Lost to Follow-up|0|||
163053961|NCT01673178|588908474|FG000|Overall Study|Withdrawal by Subject|0|||
163053962|NCT01673178|588908475|FG001|Overall Study|Withdrawal by Subject|0|||
163053963|NCT01673178|588908476|FG002|Overall Study|Withdrawal by Subject|1|||
163053964|NCT01673178|588908477|FG003|Overall Study|Withdrawal by Subject|4|||
163206169|NCT00549302|589466847|FG002|Double-Blind|Withdrawal by Subject|0|||
162967216|NCT01011335|588581281|FG006|Overall Study|Protocol Violation|0|||
162967217|NCT01011335|588581282|FG007|Overall Study|Protocol Violation|0|||
162967218|NCT01011335|588581283|FG008|Overall Study|Protocol Violation|0|||
162967219|NCT01011335|588581284|FG009|Overall Study|Protocol Violation|0|||
162967220|NCT01011335|588581285|FG010|Overall Study|Protocol Violation|0|||
162967221|NCT01011335|588581286|FG011|Overall Study|Protocol Violation|0|||
162967222|NCT01011335|588581287|FG012|Overall Study|Protocol Violation|0|||
162967223|NCT01011335|588581275|FG000|Overall Study|Moved/deployed or no booster|1|||
162967224|NCT01011335|588581276|FG001|Overall Study|Moved/deployed or no booster|0|||
162967225|NCT01011335|588581277|FG002|Overall Study|Moved/deployed or no booster|0|||
162967226|NCT01011335|588581278|FG003|Overall Study|Moved/deployed or no booster|1|||
162967227|NCT01011335|588581279|FG004|Overall Study|Moved/deployed or no booster|0|||
162967228|NCT01011335|588581280|FG005|Overall Study|Moved/deployed or no booster|0|||
162967229|NCT01011335|588581281|FG006|Overall Study|Moved/deployed or no booster|1|||
162967230|NCT01011335|588581282|FG007|Overall Study|Moved/deployed or no booster|0|||
162967231|NCT01011335|588581283|FG008|Overall Study|Moved/deployed or no booster|1|||
162967232|NCT01011335|588581284|FG009|Overall Study|Moved/deployed or no booster|0|||
163206170|NCT00549302|589466845|FG000|Double-Blind|Investigator Decision|1|||
162967233|NCT01011335|588581285|FG010|Overall Study|Moved/deployed or no booster|2|||
162967234|NCT01011335|588581286|FG011|Overall Study|Moved/deployed or no booster|0|||
162967235|NCT01011335|588581287|FG012|Overall Study|Moved/deployed or no booster|0|||
163053965|NCT01673178|588908478|FG004|Overall Study|Withdrawal by Subject|2|||
163053966|NCT01673178|588908474|FG000|Overall Study|Protocol Violation|1|||
163206171|NCT00549302|589466846|FG001|Double-Blind|Investigator Decision|5|||
163206172|NCT00549302|589466847|FG002|Double-Blind|Investigator Decision|0|||
163206173|NCT00549302|589466845|FG000|Double-Blind|Sponsor Decision|0|||
163206174|NCT00549302|589466846|FG001|Double-Blind|Sponsor Decision|1|||
163206175|NCT00549302|589466847|FG002|Double-Blind|Sponsor Decision|0|||
163206176|NCT00549302|589466845|FG000|Double-Blind|Lost to Follow-up|1|||
163206177|NCT00549302|589466846|FG001|Double-Blind|Lost to Follow-up|2|||
163206178|NCT00549302|589466847|FG002|Double-Blind|Lost to Follow-up|0|||
163206179|NCT00549302|589466845|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
163206180|NCT00549302|589466846|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
163206181|NCT00549302|589466847|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
163053967|NCT01673178|588908475|FG001|Overall Study|Protocol Violation|1|||
163053968|NCT01673178|588908476|FG002|Overall Study|Protocol Violation|0|||
163053969|NCT01673178|588908477|FG003|Overall Study|Protocol Violation|1|||
163053970|NCT01673178|588908478|FG004|Overall Study|Protocol Violation|0|||
163053971|NCT01673178|588908474|FG000|Overall Study|Adverse Event|1|||
163053972|NCT01673178|588908475|FG001|Overall Study|Adverse Event|0|||
163053973|NCT01673178|588908476|FG002|Overall Study|Adverse Event|0|||
163053974|NCT01673178|588908477|FG003|Overall Study|Adverse Event|2|||
163053975|NCT01673178|588908478|FG004|Overall Study|Adverse Event|0|||
163053976|NCT01673178|588908474|FG000|Overall Study|Other|1|||
163053977|NCT01673178|588908475|FG001|Overall Study|Other|0|||
163053978|NCT01673178|588908476|FG002|Overall Study|Other|2|||
163206182|NCT00549302|589466845|FG000|Double-Blind|New condition or starts new therapy|0|||
163206183|NCT00549302|589466846|FG001|Double-Blind|New condition or starts new therapy|2|||
163206184|NCT00549302|589466847|FG002|Double-Blind|New condition or starts new therapy|0|||
163206185|NCT00549302|589466845|FG000|Open-Label|Adverse Event|0|||
163206186|NCT00549302|589466846|FG001|Open-Label|Adverse Event|0|||
163206187|NCT00549302|589466847|FG002|Open-Label|Adverse Event|11|||
163206188|NCT00549302|589466845|FG000|Open-Label|Death|0|||
163206189|NCT00549302|589466846|FG001|Open-Label|Death|0|||
163206190|NCT00549302|589466847|FG002|Open-Label|Death|40|||
163206191|NCT00549302|589466845|FG000|Open-Label|Investigator Decision|0|||
163206192|NCT00549302|589466846|FG001|Open-Label|Investigator Decision|0|||
163206193|NCT00549302|589466847|FG002|Open-Label|Investigator Decision|5|||
163206194|NCT00549302|589466845|FG000|Open-Label|Lost to Follow-up|0|||
163206195|NCT00549302|589466846|FG001|Open-Label|Lost to Follow-up|0|||
163206196|NCT00549302|589466847|FG002|Open-Label|Lost to Follow-up|2|||
163206197|NCT00549302|589466845|FG000|Open-Label|Other|0|||
163206198|NCT00549302|589466846|FG001|Open-Label|Other|0|||
163206199|NCT00549302|589466847|FG002|Open-Label|Other|3|||
163206200|NCT00549302|589466845|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
163206201|NCT00549302|589466846|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
163206202|NCT00549302|589466847|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
163206203|NCT00549302|589466845|FG000|Open-Label|Withdrawal by Subject|0|||
163206204|NCT00549302|589466846|FG001|Open-Label|Withdrawal by Subject|0|||
163206205|NCT00549302|589466847|FG002|Open-Label|Withdrawal by Subject|6|||
163206206|NCT01414114|589466848|FG000|Overall Study|Adverse Event|2|||
163206207|NCT01414114|589466848|FG000|Overall Study|Withdrawal by Subject|1|||
163206208|NCT01414114|589466848|FG000|Overall Study|Other|2|||
163206209|NCT00865124|589466849|FG000|Overall Study|Physician Decision|2|||
163206210|NCT00865124|589466850|FG001|Overall Study|Physician Decision|1|||
163206211|NCT00865124|589466851|FG002|Overall Study|Physician Decision|0|||
163206212|NCT00865124|589466849|FG000|Overall Study|Withdrawn consent|2|||
163206213|NCT00865124|589466850|FG001|Overall Study|Withdrawn consent|0|||
163206214|NCT00865124|589466851|FG002|Overall Study|Withdrawn consent|0|||
163206215|NCT02743520|589466852|FG000|Overall Study|Withdrawal by Subject|1|||
163206216|NCT01111149|589466859|FG000|Overall Study|Protocol Violation|1|||
163206217|NCT01111149|589466860|FG001|Overall Study|Protocol Violation|1|||
163206218|NCT01111149|589466861|FG002|Overall Study|Protocol Violation|2|||
163206219|NCT01111149|589466859|FG000|Overall Study|Withdrawal by Subject|1|||
163206220|NCT01111149|589466860|FG001|Overall Study|Withdrawal by Subject|0|||
163206221|NCT01111149|589466861|FG002|Overall Study|Withdrawal by Subject|2|||
163206222|NCT00006903|589466864|FG000|Overall Study|Still receiving treatment|0|||
163206223|NCT00006903|589466865|FG001|Overall Study|Still receiving treatment|0|||
163206224|NCT00006903|589466866|FG002|Overall Study|Still receiving treatment|1|||
163206225|NCT00006903|589466864|FG000|Overall Study|Refused further treatment|0|||
163206226|NCT00006903|589466865|FG001|Overall Study|Refused further treatment|2|||
163206227|NCT00006903|589466866|FG002|Overall Study|Refused further treatment|1|||
163053979|NCT01673178|588908477|FG003|Overall Study|Other|1|||
163206228|NCT00006903|589466864|FG000|Overall Study|Adverse Event|0|||
163206229|NCT00006903|589466865|FG001|Overall Study|Adverse Event|0|||
163206230|NCT00006903|589466866|FG002|Overall Study|Adverse Event|1|||
163206231|NCT00006903|589466864|FG000|Overall Study|Death|0|||
163206232|NCT00006903|589466865|FG001|Overall Study|Death|1|||
163206233|NCT00006903|589466866|FG002|Overall Study|Death|0|||
163206234|NCT00006903|589466864|FG000|Overall Study|Patient never treated|0|||
163206235|NCT00006903|589466865|FG001|Overall Study|Patient never treated|0|||
163206236|NCT00006903|589466866|FG002|Overall Study|Patient never treated|1|||
163206237|NCT00006903|589466864|FG000|Overall Study|Ineligible|10|||
163206238|NCT00006903|589466865|FG001|Overall Study|Ineligible|1|||
163206239|NCT00006903|589466866|FG002|Overall Study|Ineligible|2|||
163206240|NCT02794883|589466867|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
163206241|NCT02794883|589466868|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
163206242|NCT02794883|589466869|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
163206243|NCT02794883|589466867|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
163206244|NCT02794883|589466868|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
163206245|NCT02794883|589466869|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
163206246|NCT02794883|589466867|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
163206247|NCT02794883|589466868|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
163206248|NCT02794883|589466869|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
163206249|NCT02794883|589466867|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
163206250|NCT02794883|589466868|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
163206251|NCT02794883|589466869|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
163206252|NCT02794883|589466867|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
163206253|NCT02794883|589466868|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
163397538|NCT00139776|590167746|FG000|Period III|Withdrawal by Subject|0|||
163053980|NCT01673178|588908478|FG004|Overall Study|Other|0|||
163053981|NCT03177148|588908479|FG000|Overall Study|Lost to Follow-up|50|||
163053982|NCT03177148|588908480|FG001|Overall Study|Lost to Follow-up|1|||
163053983|NCT03177148|588908479|FG000|Overall Study|Death|1|||
163053984|NCT03177148|588908480|FG001|Overall Study|Death|0|||
163053985|NCT02848664|588908484|FG000|Overall Study|Withdrawal by Subject|2|||
163053986|NCT02848664|588908484|FG000|Overall Study|Adverse Event|1|||
163053987|NCT02848664|588908484|FG000|Overall Study|no assistance for device training|1|||
163053988|NCT03139552|588908491|FG000|Overall Study|unable to attend tasting due to schedule|3|||
163053989|NCT00780975|588908498|FG000|Overall Study|Progressive disease|3|||
163053990|NCT00780975|588908498|FG000|Overall Study|Toxicity|5|||
163053991|NCT00887484|588908499|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
163053992|NCT00887484|588908499|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
163053993|NCT00887484|588908499|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
163053994|NCT01061606|588908500|FG000|Overall Study|Adverse Event|1|||
163053995|NCT01061606|588908500|FG000|Overall Study|Death|1|||
163053996|NCT01061606|588908500|FG000|Overall Study|Disease Progression|4|||
163053997|NCT01061606|588908500|FG000|Overall Study|alternative therapy|2|||
163053998|NCT03044314|588908501|FG000|Overall Study|Physician Decision|2|||
163053999|NCT03044314|588908501|FG000|Overall Study|Withdrawal by Subject|1|||
163054000|NCT03044314|588908501|FG000|Overall Study|Connector tubing not available|1|||
163054001|NCT03122171|588908502|FG000|Overall Study|Withdrawal by Subject|1|||
163054002|NCT01316224|588908503|FG000|Overall Study|Protocol Violation|3|||
163054003|NCT01316224|588908503|FG000|Overall Study|Adverse Event|3|||
163054004|NCT01316224|588908503|FG000|Overall Study|Lack of Efficacy|1|||
163054005|NCT01316224|588908503|FG000|Overall Study|Withdrawal by Subject|1|||
163054006|NCT01316224|588908503|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
163054007|NCT01316224|588908503|FG000|Overall Study|Other|1|||
163054008|NCT00264147|588908504|FG000|Treatment I Period|Adverse Event|3|||
163054009|NCT00264147|588908505|FG001|Treatment I Period|Adverse Event|6|||
163313865|NCT05329220|589859495|FG001|Follow-up Period|Withdrawal by Subject|0|||
163313866|NCT05329220|589859496|FG002|Follow-up Period|Withdrawal by Subject|1|||
163313867|NCT05329220|589859497|FG003|Follow-up Period|Withdrawal by Subject|1|||
163313868|NCT05329220|589859498|FG004|Follow-up Period|Withdrawal by Subject|34|||
163313869|NCT05329220|589859499|FG005|Follow-up Period|Withdrawal by Subject|35|||
163313870|NCT05329220|589859494|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
163313871|NCT05329220|589859495|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
163313872|NCT05329220|589859496|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
163206254|NCT02794883|589466869|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
163206255|NCT02794883|589466867|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
163206256|NCT02794883|589466868|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
162967236|NCT01011335|588581275|FG000|Overall Study|Adverse Event|0|||
163206257|NCT02794883|589466869|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
163206258|NCT02794883|589466867|FG000|Follow-up Period (up to 2 Years)|Death|12|||
163206259|NCT02794883|589466868|FG001|Follow-up Period (up to 2 Years)|Death|10|||
163206260|NCT02794883|589466869|FG002|Follow-up Period (up to 2 Years)|Death|10|||
163206261|NCT01906008|589466871|FG000|Overall Study|Lost to Follow-up|2|||
163206262|NCT01906008|589466872|FG001|Overall Study|Lost to Follow-up|0|||
163206263|NCT01906008|589466871|FG000|Overall Study|Oxaliplatin toxicity|2|||
163206264|NCT01906008|589466872|FG001|Overall Study|Oxaliplatin toxicity|0|||
163206265|NCT01906008|589466871|FG000|Overall Study|Protocol Violation|0|||
163206266|NCT01906008|589466872|FG001|Overall Study|Protocol Violation|1|||
163206267|NCT01906008|589466871|FG000|Overall Study|Withdrawal by Subject|1|||
162967237|NCT01011335|588581276|FG001|Overall Study|Adverse Event|0|||
162967238|NCT01011335|588581277|FG002|Overall Study|Adverse Event|0|||
162967239|NCT01011335|588581278|FG003|Overall Study|Adverse Event|0|||
162967240|NCT01011335|588581279|FG004|Overall Study|Adverse Event|0|||
162967241|NCT01011335|588581280|FG005|Overall Study|Adverse Event|0|||
162967242|NCT01011335|588581281|FG006|Overall Study|Adverse Event|0|||
162967243|NCT01011335|588581282|FG007|Overall Study|Adverse Event|0|||
162967244|NCT01011335|588581283|FG008|Overall Study|Adverse Event|0|||
162967245|NCT01011335|588581284|FG009|Overall Study|Adverse Event|0|||
162967246|NCT01011335|588581285|FG010|Overall Study|Adverse Event|4|||
162967247|NCT01011335|588581286|FG011|Overall Study|Adverse Event|0|||
163313873|NCT05329220|589859497|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
163313874|NCT05329220|589859498|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
163206268|NCT01906008|589466872|FG001|Overall Study|Withdrawal by Subject|5|||
162967248|NCT01011335|588581287|FG012|Overall Study|Adverse Event|1|||
163313875|NCT05329220|589859499|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
162967249|NCT02435433|588581288|FG000|Overall Study|Withdrawal by Subject|2|||
163206269|NCT01906008|589466871|FG000|Overall Study|Did not start study med|3|||
163206270|NCT01906008|589466872|FG001|Overall Study|Did not start study med|4|||
163054010|NCT00264147|588908506|FG002|Treatment I Period|Adverse Event|3|||
163054011|NCT00264147|588908507|FG003|Treatment I Period|Adverse Event|5|||
162967250|NCT02435433|588581289|FG001|Overall Study|Withdrawal by Subject|3|||
163054012|NCT00264147|588908508|FG004|Treatment I Period|Adverse Event|7|||
163206271|NCT01906008|589466871|FG000|Overall Study|Oxaliplatin stops|10|||
163206272|NCT01906008|589466872|FG001|Overall Study|Oxaliplatin stops|8|||
163206273|NCT01906008|589466871|FG000|Overall Study|Hospice|1|||
163206274|NCT01906008|589466872|FG001|Overall Study|Hospice|0|||
163206275|NCT01906008|589466871|FG000|Overall Study|Physician Decision|3|||
163206276|NCT01906008|589466872|FG001|Overall Study|Physician Decision|3|||
163206277|NCT01906008|589466871|FG000|Overall Study|Lack of compliance of study med|5|||
163206278|NCT01906008|589466872|FG001|Overall Study|Lack of compliance of study med|3|||
163206279|NCT01906008|589466871|FG000|Overall Study|Adverse Event|0|||
163206280|NCT01906008|589466872|FG001|Overall Study|Adverse Event|3|||
163206281|NCT01574326|589466873|FG000|Overall Study|Randomized but not treated|0|||
163206282|NCT01574326|589466874|FG001|Overall Study|Randomized but not treated|1|||
163206283|NCT01574326|589466873|FG000|Overall Study|Withdrawal by Participant|2|||
163206284|NCT01574326|589466874|FG001|Overall Study|Withdrawal by Participant|4|||
163206285|NCT01574326|589466873|FG000|Overall Study|Physician Decision|5|||
162967251|NCT02435433|588581290|FG002|Overall Study|Withdrawal by Subject|1|||
162967252|NCT02435433|588581291|FG003|Overall Study|Withdrawal by Subject|0|||
162967253|NCT02435433|588581292|FG004|Overall Study|Withdrawal by Subject|0|||
162967254|NCT02435433|588581288|FG000|Overall Study|Lost to Follow-up|2|||
162967255|NCT02435433|588581289|FG001|Overall Study|Lost to Follow-up|2|||
163206286|NCT01574326|589466874|FG001|Overall Study|Physician Decision|3|||
163206287|NCT01574326|589466873|FG000|Overall Study|Adverse Event|1|||
163206288|NCT01574326|589466874|FG001|Overall Study|Adverse Event|3|||
163206289|NCT01574326|589466873|FG000|Overall Study|Other: Mainly kidney transplant|8|||
163206290|NCT01574326|589466874|FG001|Overall Study|Other: Mainly kidney transplant|8|||
163397539|NCT00139776|590167747|FG001|Period III|Withdrawal by Subject|0|||
163397540|NCT00139776|590167748|FG002|Period III|Withdrawal by Subject|16|||
163397541|NCT00139776|590167749|FG003|Period III|Withdrawal by Subject|21|||
163397542|NCT00187096|590167750|FG000|Overall Study|unacceptable toxicity|0|||
163397543|NCT00187096|590167751|FG001|Overall Study|unacceptable toxicity|0|||
163397544|NCT00187096|590167752|FG002|Overall Study|unacceptable toxicity|1|||
163397545|NCT01519934|590167758|FG000|Overall Study|Lost to Follow-up|3|||
163397546|NCT00922480|590167759|FG000|Main Study|Protocol Violation|3|||
163397547|NCT00922480|590167760|FG001|Main Study|Protocol Violation|6|||
163397548|NCT00922480|590167759|FG000|Main Study|Adverse Event|6|||
163397549|NCT00922480|590167760|FG001|Main Study|Adverse Event|7|||
163397550|NCT00922480|590167759|FG000|Main Study|Lack of Efficacy|3|||
163397551|NCT00922480|590167760|FG001|Main Study|Lack of Efficacy|0|||
163397552|NCT00922480|590167759|FG000|Main Study|Withdrawal by Subject|20|||
163397553|NCT00922480|590167760|FG001|Main Study|Withdrawal by Subject|15|||
163397554|NCT00922480|590167759|FG000|Main Study|Lost to Follow-up|5|||
163397555|NCT00922480|590167760|FG001|Main Study|Lost to Follow-up|0|||
163397556|NCT00922480|590167759|FG000|Main Study|Physician Decision|0|||
163397557|NCT00922480|590167760|FG001|Main Study|Physician Decision|1|||
163397558|NCT00922480|590167759|FG000|Extension Study|Protocol Violation|3|||
163397559|NCT00922480|590167760|FG001|Extension Study|Protocol Violation|0|||
162967256|NCT02435433|588581290|FG002|Overall Study|Lost to Follow-up|4|||
162967257|NCT02435433|588581291|FG003|Overall Study|Lost to Follow-up|1|||
162967258|NCT02435433|588581292|FG004|Overall Study|Lost to Follow-up|0|||
162967259|NCT01243151|588581293|FG000|Overall Study|Adverse Event|0|||
162967260|NCT01243151|588581294|FG001|Overall Study|Adverse Event|1|||
162967261|NCT01243151|588581295|FG002|Overall Study|Adverse Event|0|||
162967262|NCT01243151|588581296|FG003|Overall Study|Adverse Event|0|||
162967263|NCT01243151|588581297|FG004|Overall Study|Adverse Event|0|||
162967264|NCT01243151|588581293|FG000|Overall Study|Protocol Violation|0|||
162967265|NCT01243151|588581294|FG001|Overall Study|Protocol Violation|0|||
162967266|NCT01243151|588581295|FG002|Overall Study|Protocol Violation|1|||
162967267|NCT01243151|588581296|FG003|Overall Study|Protocol Violation|0|||
162967268|NCT01243151|588581297|FG004|Overall Study|Protocol Violation|0|||
162967269|NCT01243151|588581293|FG000|Overall Study|Other|0|||
162967270|NCT01243151|588581294|FG001|Overall Study|Other|0|||
162967271|NCT01243151|588581295|FG002|Overall Study|Other|0|||
162967272|NCT01243151|588581296|FG003|Overall Study|Other|1|||
162967273|NCT01243151|588581297|FG004|Overall Study|Other|0|||
162967274|NCT01243151|588581293|FG000|Overall Study|Randomized but not treated|0|||
162967275|NCT01243151|588581294|FG001|Overall Study|Randomized but not treated|0|||
163206291|NCT00137046|589466875|FG000|Overall Study|Death|2|||
162967276|NCT01243151|588581295|FG002|Overall Study|Randomized but not treated|0|||
162967277|NCT01243151|588581296|FG003|Overall Study|Randomized but not treated|1|||
162967278|NCT01243151|588581297|FG004|Overall Study|Randomized but not treated|0|||
163206292|NCT00137046|589466876|FG001|Overall Study|Death|1|||
162967279|NCT03119662|588581298|FG000|Overall Study|Withdrawal by Subject|0|||
162967280|NCT03119662|588581299|FG001|Overall Study|Withdrawal by Subject|1|||
163397560|NCT00922480|590167759|FG000|Extension Study|Adverse Event|1|||
163397561|NCT00922480|590167760|FG001|Extension Study|Adverse Event|1|||
162967281|NCT02817828|588581300|FG000|Overall Study|Lost to Follow-up|41|||
162967282|NCT02817828|588581300|FG000|Overall Study|Adverse event not related to bleeding|104|||
162967283|NCT02817828|588581300|FG000|Overall Study|Adverse event related to bleeding|53|||
163397562|NCT00922480|590167759|FG000|Extension Study|Withdrawal by Subject|1|||
163313876|NCT05329220|589859494|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
163313877|NCT05329220|589859495|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
163054013|NCT00264147|588908509|FG005|Treatment I Period|Adverse Event|0|||
163054014|NCT00264147|588908504|FG000|Treatment I Period|Laboratory Adverse Event|0|||
163054015|NCT00264147|588908505|FG001|Treatment I Period|Laboratory Adverse Event|0|||
163054016|NCT00264147|588908506|FG002|Treatment I Period|Laboratory Adverse Event|0|||
163054017|NCT00264147|588908507|FG003|Treatment I Period|Laboratory Adverse Event|1|||
163054018|NCT00264147|588908508|FG004|Treatment I Period|Laboratory Adverse Event|0|||
163054019|NCT00264147|588908509|FG005|Treatment I Period|Laboratory Adverse Event|0|||
163054020|NCT00264147|588908504|FG000|Treatment I Period|Lack of Efficacy|6|||
163054021|NCT00264147|588908505|FG001|Treatment I Period|Lack of Efficacy|2|||
163054022|NCT00264147|588908506|FG002|Treatment I Period|Lack of Efficacy|8|||
163054023|NCT00264147|588908507|FG003|Treatment I Period|Lack of Efficacy|0|||
163054024|NCT00264147|588908508|FG004|Treatment I Period|Lack of Efficacy|1|||
163054025|NCT00264147|588908509|FG005|Treatment I Period|Lack of Efficacy|0|||
163054026|NCT00264147|588908504|FG000|Treatment I Period|Lost to Follow-up|1|||
163054027|NCT00264147|588908505|FG001|Treatment I Period|Lost to Follow-up|0|||
163313878|NCT05329220|589859496|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
163313879|NCT05329220|589859497|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
163313880|NCT05329220|589859498|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
163313881|NCT05329220|589859499|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
163313882|NCT05329220|589859494|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
163313883|NCT05329220|589859495|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
163313884|NCT05329220|589859496|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
163313885|NCT05329220|589859497|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
163313886|NCT05329220|589859498|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
163054028|NCT00264147|588908506|FG002|Treatment I Period|Lost to Follow-up|0|||
163054029|NCT00264147|588908507|FG003|Treatment I Period|Lost to Follow-up|1|||
163054030|NCT00264147|588908508|FG004|Treatment I Period|Lost to Follow-up|1|||
163054031|NCT00264147|588908509|FG005|Treatment I Period|Lost to Follow-up|0|||
163054032|NCT00264147|588908504|FG000|Treatment I Period|Protocol Violation|2|||
163054033|NCT00264147|588908505|FG001|Treatment I Period|Protocol Violation|2|||
163054034|NCT00264147|588908506|FG002|Treatment I Period|Protocol Violation|0|||
163054035|NCT00264147|588908507|FG003|Treatment I Period|Protocol Violation|0|||
163054036|NCT00264147|588908508|FG004|Treatment I Period|Protocol Violation|0|||
163054037|NCT00264147|588908509|FG005|Treatment I Period|Protocol Violation|0|||
163054038|NCT00264147|588908504|FG000|Treatment I Period|Withdrawal by Subject|2|||
163054039|NCT00264147|588908505|FG001|Treatment I Period|Withdrawal by Subject|0|||
163054040|NCT00264147|588908506|FG002|Treatment I Period|Withdrawal by Subject|0|||
163054041|NCT00264147|588908507|FG003|Treatment I Period|Withdrawal by Subject|2|||
163054042|NCT00264147|588908508|FG004|Treatment I Period|Withdrawal by Subject|2|||
163054043|NCT00264147|588908509|FG005|Treatment I Period|Withdrawal by Subject|0|||
163054044|NCT00264147|588908504|FG000|Treatment I Period|Patient out of town for an extended time|0|||
163054045|NCT00264147|588908505|FG001|Treatment I Period|Patient out of town for an extended time|1|||
163054046|NCT00264147|588908506|FG002|Treatment I Period|Patient out of town for an extended time|0|||
163054047|NCT00264147|588908507|FG003|Treatment I Period|Patient out of town for an extended time|0|||
163054048|NCT00264147|588908508|FG004|Treatment I Period|Patient out of town for an extended time|0|||
163054049|NCT00264147|588908509|FG005|Treatment I Period|Patient out of town for an extended time|0|||
163054050|NCT00264147|588908504|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
163054051|NCT00264147|588908505|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
163054052|NCT00264147|588908506|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
163054053|NCT00264147|588908507|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
163054054|NCT00264147|588908508|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
163054055|NCT00264147|588908509|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
163054056|NCT00264147|588908504|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
163054057|NCT00264147|588908505|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
163054058|NCT00264147|588908506|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
163054059|NCT00264147|588908507|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
163054060|NCT00264147|588908508|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
163054061|NCT00264147|588908509|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
163397563|NCT00922480|590167760|FG001|Extension Study|Withdrawal by Subject|1|||
163397564|NCT00922480|590167759|FG000|Extension Study|Others|0|||
163397565|NCT00922480|590167760|FG001|Extension Study|Others|1|||
163397566|NCT02161575|590167763|FG000|Overall Study|Protocol Violation|8|||
163397567|NCT02161575|590167763|FG000|Overall Study|Lack of Efficacy|1|||
163397568|NCT02161575|590167763|FG000|Overall Study|Adverse Event|2|||
163397569|NCT01970488|590167764|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
163206293|NCT00137046|589466875|FG000|Overall Study|Adverse Event|16|||
163206294|NCT00137046|589466876|FG001|Overall Study|Adverse Event|5|||
163397570|NCT01970488|590167765|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
163397571|NCT01970488|590167766|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
163397572|NCT01970488|590167767|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
163397573|NCT01970488|590167768|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
163397574|NCT01970488|590167764|FG000|Part 1: Through Week 16|Protocol Violation|1|||
163397575|NCT01970488|590167765|FG001|Part 1: Through Week 16|Protocol Violation|2|||
163397576|NCT01970488|590167766|FG002|Part 1: Through Week 16|Protocol Violation|0|||
163397577|NCT01970488|590167767|FG003|Part 1: Through Week 16|Protocol Violation|0|||
163397578|NCT01970488|590167768|FG004|Part 1: Through Week 16|Protocol Violation|0|||
163397579|NCT01970488|590167764|FG000|Part 1: Through Week 16|Adverse Event|6|||
163397580|NCT01970488|590167765|FG001|Part 1: Through Week 16|Adverse Event|5|||
163397581|NCT01970488|590167766|FG002|Part 1: Through Week 16|Adverse Event|0|||
163397582|NCT01970488|590167767|FG003|Part 1: Through Week 16|Adverse Event|0|||
163397583|NCT01970488|590167768|FG004|Part 1: Through Week 16|Adverse Event|0|||
163397584|NCT01970488|590167764|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
163397585|NCT01970488|590167765|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
163397586|NCT01970488|590167766|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
163397587|NCT01970488|590167767|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
163397588|NCT01970488|590167768|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
163397589|NCT01970488|590167764|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
163397590|NCT01970488|590167765|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
163397591|NCT01970488|590167766|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
163397592|NCT01970488|590167767|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
163397593|NCT01970488|590167768|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
163397594|NCT01970488|590167764|FG000|Part 2: Post Week 16|Physician Decision|0|||
163397595|NCT01970488|590167765|FG001|Part 2: Post Week 16|Physician Decision|0|||
163397596|NCT01970488|590167766|FG002|Part 2: Post Week 16|Physician Decision|0|||
163397597|NCT01970488|590167767|FG003|Part 2: Post Week 16|Physician Decision|0|||
163397598|NCT01970488|590167768|FG004|Part 2: Post Week 16|Physician Decision|1|||
163397599|NCT01970488|590167764|FG000|Part 2: Post Week 16|Non-compliance|0|||
163397600|NCT01970488|590167765|FG001|Part 2: Post Week 16|Non-compliance|0|||
163397601|NCT01970488|590167766|FG002|Part 2: Post Week 16|Non-compliance|1|||
163397602|NCT01970488|590167767|FG003|Part 2: Post Week 16|Non-compliance|0|||
163397603|NCT01970488|590167768|FG004|Part 2: Post Week 16|Non-compliance|0|||
163397604|NCT01970488|590167764|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
163397605|NCT01970488|590167765|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
163397606|NCT01970488|590167766|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
163397607|NCT01970488|590167767|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
163397608|NCT01970488|590167768|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
163397609|NCT01970488|590167764|FG000|Part 2: Post Week 16|Adverse Event|0|||
163397610|NCT01970488|590167765|FG001|Part 2: Post Week 16|Adverse Event|0|||
163206295|NCT00137046|589466875|FG000|Overall Study|Laboratory Abnormality|2|||
163206296|NCT00137046|589466876|FG001|Overall Study|Laboratory Abnormality|0|||
162967284|NCT02817828|588581300|FG000|Overall Study|Protocol Violation|11|||
162967285|NCT02817828|588581300|FG000|Overall Study|Pregnancy|7|||
163206297|NCT00137046|589466875|FG000|Overall Study|Lack of Efficacy|13|||
163206298|NCT00137046|589466876|FG001|Overall Study|Lack of Efficacy|1|||
163206299|NCT00137046|589466875|FG000|Overall Study|Lost to Follow-up|8|||
163206300|NCT00137046|589466876|FG001|Overall Study|Lost to Follow-up|24|||
163206301|NCT00137046|589466875|FG000|Overall Study|Other|23|||
163206302|NCT00137046|589466876|FG001|Overall Study|Other|19|||
163206303|NCT00137046|589466875|FG000|Overall Study|Withdrawal by Subject|33|||
163206304|NCT00137046|589466876|FG001|Overall Study|Withdrawal by Subject|42|||
163206305|NCT00137046|589466875|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
162967286|NCT02817828|588581300|FG000|Overall Study|Pregnancy wish|15|||
163206306|NCT00137046|589466876|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
163206307|NCT00137046|589466875|FG000|Overall Study|Withdrew prior to study treatment|1|||
163206308|NCT00137046|589466876|FG001|Overall Study|Withdrew prior to study treatment|1|||
163206309|NCT02268084|589466883|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
163206310|NCT02268084|589466884|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
163206311|NCT02268084|589466883|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
163206312|NCT02268084|589466884|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
163206313|NCT05227027|589466885|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
163206314|NCT05227027|589466886|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
163206315|NCT03552198|589466887|FG000|Overall Study|Lost to Follow-up|42|||
163206316|NCT03552198|589466888|FG001|Overall Study|Lost to Follow-up|48|||
163206317|NCT03552198|589466889|FG002|Overall Study|Lost to Follow-up|15|||
163206318|NCT03552198|589466890|FG003|Overall Study|Lost to Follow-up|19|||
163206319|NCT03552198|589466887|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
163206320|NCT03552198|589466888|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
163206321|NCT03552198|589466889|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
163206322|NCT03552198|589466890|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
163206323|NCT03552198|589466887|FG000|Overall Study|Did not receive air alerts|1|||
163206324|NCT03552198|589466888|FG001|Overall Study|Did not receive air alerts|0|||
163206325|NCT03552198|589466889|FG002|Overall Study|Did not receive air alerts|0|||
163206326|NCT03552198|589466890|FG003|Overall Study|Did not receive air alerts|1|||
163206327|NCT06149247|589466891|FG000|Overall Study|Adverse Event|0|||
163206328|NCT06149247|589466892|FG001|Overall Study|Adverse Event|1|||
163206329|NCT00371137|589466899|FG000|Overall Study|Adverse Event|20|||
163206330|NCT00371137|589466900|FG001|Overall Study|Adverse Event|35|||
163206331|NCT00371137|589466901|FG002|Overall Study|Adverse Event|42|||
163206332|NCT00371137|589466899|FG000|Overall Study|Withdrawal by Subject|11|||
163206333|NCT00371137|589466900|FG001|Overall Study|Withdrawal by Subject|10|||
163206334|NCT00371137|589466901|FG002|Overall Study|Withdrawal by Subject|15|||
163206335|NCT00371137|589466899|FG000|Overall Study|Lost to Follow-up|6|||
163206336|NCT00371137|589466900|FG001|Overall Study|Lost to Follow-up|3|||
163206337|NCT00371137|589466901|FG002|Overall Study|Lost to Follow-up|5|||
163206338|NCT00371137|589466899|FG000|Overall Study|Lack of Efficacy|30|||
163206339|NCT00371137|589466900|FG001|Overall Study|Lack of Efficacy|12|||
163206340|NCT00371137|589466901|FG002|Overall Study|Lack of Efficacy|13|||
163206341|NCT00371137|589466899|FG000|Overall Study|Sponsor Decision|2|||
163206342|NCT00371137|589466900|FG001|Overall Study|Sponsor Decision|1|||
163206343|NCT00371137|589466901|FG002|Overall Study|Sponsor Decision|2|||
163206344|NCT00371137|589466899|FG000|Overall Study|Physician Decision|1|||
163206345|NCT00371137|589466900|FG001|Overall Study|Physician Decision|1|||
163206346|NCT00371137|589466901|FG002|Overall Study|Physician Decision|1|||
163206347|NCT00371137|589466899|FG000|Overall Study|Protocol Violation|2|||
163206348|NCT00371137|589466900|FG001|Overall Study|Protocol Violation|1|||
163206349|NCT00371137|589466901|FG002|Overall Study|Protocol Violation|1|||
163206350|NCT01756898|589466902|FG000|Overall Study|Adverse Event|7|||
163206351|NCT01756898|589466903|FG001|Overall Study|Adverse Event|1|||
163206352|NCT01756898|589466904|FG002|Overall Study|Adverse Event|0|||
163206353|NCT01756898|589466905|FG003|Overall Study|Adverse Event|0|||
163206354|NCT01756898|589466902|FG000|Overall Study|Lack of Efficacy|4|||
163206355|NCT01756898|589466903|FG001|Overall Study|Lack of Efficacy|7|||
163206356|NCT01756898|589466904|FG002|Overall Study|Lack of Efficacy|6|||
163206357|NCT01756898|589466905|FG003|Overall Study|Lack of Efficacy|6|||
163206358|NCT01756898|589466902|FG000|Overall Study|Lost to Follow-up|2|||
163206359|NCT01756898|589466903|FG001|Overall Study|Lost to Follow-up|4|||
163206360|NCT01756898|589466904|FG002|Overall Study|Lost to Follow-up|2|||
163206361|NCT01756898|589466905|FG003|Overall Study|Lost to Follow-up|3|||
163206362|NCT01756898|589466902|FG000|Overall Study|Protocol Violation|1|||
163206363|NCT01756898|589466903|FG001|Overall Study|Protocol Violation|2|||
163206364|NCT01756898|589466904|FG002|Overall Study|Protocol Violation|2|||
163206365|NCT01756898|589466905|FG003|Overall Study|Protocol Violation|1|||
163206366|NCT01756898|589466902|FG000|Overall Study|Withdrew Consent|5|||
163206367|NCT01756898|589466903|FG001|Overall Study|Withdrew Consent|3|||
163206368|NCT01756898|589466904|FG002|Overall Study|Withdrew Consent|5|||
163206369|NCT01756898|589466905|FG003|Overall Study|Withdrew Consent|6|||
163206370|NCT01756898|589466902|FG000|Overall Study|Other|0|||
163206371|NCT01756898|589466903|FG001|Overall Study|Other|2|||
163206372|NCT01756898|589466904|FG002|Overall Study|Other|2|||
163206373|NCT01756898|589466905|FG003|Overall Study|Other|0|||
163206374|NCT01500694|589466906|FG000|Overall Study|Adverse Event|4|||
163206375|NCT01500694|589466907|FG001|Overall Study|Adverse Event|3|||
163206376|NCT01500694|589466906|FG000|Overall Study|Protocol Violation|0|||
163206377|NCT01500694|589466907|FG001|Overall Study|Protocol Violation|1|||
163206378|NCT01500694|589466906|FG000|Overall Study|Withdrawal by Subject|23|||
163206379|NCT01500694|589466907|FG001|Overall Study|Withdrawal by Subject|14|||
163206380|NCT01500694|589466906|FG000|Overall Study|Lost to Follow-up|2|||
163206381|NCT01500694|589466907|FG001|Overall Study|Lost to Follow-up|3|||
163206382|NCT01500694|589466906|FG000|Overall Study|Lack of Efficacy|14|||
163206383|NCT01500694|589466907|FG001|Overall Study|Lack of Efficacy|5|||
163206384|NCT01500694|589466906|FG000|Overall Study|Other|9|||
163206385|NCT01500694|589466907|FG001|Overall Study|Other|3|||
163206386|NCT02837783|589466908|FG000|Overall Study|Adverse Event|1|||
163206387|NCT02837783|589466909|FG001|Overall Study|Adverse Event|0|||
163206388|NCT02837783|589466908|FG000|Overall Study|Other, Not Specified|1|||
163206389|NCT02837783|589466909|FG001|Overall Study|Other, Not Specified|2|||
163206390|NCT01438424|589468721|FG000|Overall Study|Continuing treatment|29|||
163206391|NCT01438424|589468721|FG000|Overall Study|Minimal virologic response|95|||
163206392|NCT01438424|589468721|FG000|Overall Study|Not identified|55|||
163206393|NCT01438424|589468721|FG000|Overall Study|Withdrawal by Subject|104|||
163206394|NCT01438424|589468721|FG000|Overall Study|Progression of chronic hepatitis B|22|||
163206395|NCT01438424|589468721|FG000|Overall Study|Death|22|||
163206396|NCT01438424|589468721|FG000|Overall Study|Adverse Event|17|||
163206397|NCT01438424|589468721|FG000|Overall Study|Lost to Follow-up|17|||
163206398|NCT01438424|589468721|FG000|Overall Study|Abnormal laboratory test result|14|||
163206399|NCT01438424|589468721|FG000|Overall Study|Need for drug prohibited by protocol|14|||
163206400|NCT01438424|589468721|FG000|Overall Study|Pregnancy|7|||
163206401|NCT01438424|589468721|FG000|Overall Study|No longer met inclusion criteria|1|||
163206402|NCT01438424|589468721|FG000|Overall Study|Participant noncompliance|20|||
163206403|NCT02927080|589468722|FG000|Overall Study|Withdrawal by Subject|0|||
163206404|NCT02927080|589468723|FG001|Overall Study|Withdrawal by Subject|0|||
163206405|NCT02927080|589468724|FG002|Overall Study|Withdrawal by Subject|0|||
163206406|NCT02927080|589468725|FG003|Overall Study|Withdrawal by Subject|0|||
163206407|NCT02927080|589468726|FG004|Overall Study|Withdrawal by Subject|1|||
163206408|NCT02927080|589468727|FG005|Overall Study|Withdrawal by Subject|0|||
163206409|NCT02927080|589468728|FG006|Overall Study|Withdrawal by Subject|1|||
163206410|NCT02927080|589468729|FG007|Overall Study|Withdrawal by Subject|1|||
163206411|NCT02927080|589468730|FG008|Overall Study|Withdrawal by Subject|0|||
163206412|NCT02927080|589468731|FG009|Overall Study|Withdrawal by Subject|2|||
163206413|NCT02927080|589468722|FG000|Overall Study|Willingness to comply with protocol|0|||
163206414|NCT02927080|589468723|FG001|Overall Study|Willingness to comply with protocol|0|||
163206415|NCT02927080|589468724|FG002|Overall Study|Willingness to comply with protocol|0|||
163206416|NCT02927080|589468725|FG003|Overall Study|Willingness to comply with protocol|0|||
163206417|NCT02927080|589468726|FG004|Overall Study|Willingness to comply with protocol|0|||
163206418|NCT02927080|589468727|FG005|Overall Study|Willingness to comply with protocol|0|||
163206419|NCT02927080|589468728|FG006|Overall Study|Willingness to comply with protocol|0|||
163206420|NCT02927080|589468729|FG007|Overall Study|Willingness to comply with protocol|0|||
163206421|NCT02927080|589468730|FG008|Overall Study|Willingness to comply with protocol|0|||
163206422|NCT02927080|589468731|FG009|Overall Study|Willingness to comply with protocol|1|||
163206423|NCT02927080|589468722|FG000|Overall Study|Study terminated by Sponsor|0|||
163206424|NCT02927080|589468723|FG001|Overall Study|Study terminated by Sponsor|0|||
163206425|NCT02927080|589468724|FG002|Overall Study|Study terminated by Sponsor|0|||
163206426|NCT02927080|589468725|FG003|Overall Study|Study terminated by Sponsor|0|||
163206427|NCT02927080|589468726|FG004|Overall Study|Study terminated by Sponsor|0|||
163206428|NCT02927080|589468727|FG005|Overall Study|Study terminated by Sponsor|0|||
163206429|NCT02927080|589468728|FG006|Overall Study|Study terminated by Sponsor|6|||
163206430|NCT02927080|589468729|FG007|Overall Study|Study terminated by Sponsor|7|||
163206431|NCT02927080|589468730|FG008|Overall Study|Study terminated by Sponsor|2|||
163206432|NCT02927080|589468731|FG009|Overall Study|Study terminated by Sponsor|3|||
163206433|NCT02927080|589468722|FG000|Overall Study|Adverse Event|0|||
163206434|NCT02927080|589468723|FG001|Overall Study|Adverse Event|1|||
163206435|NCT02927080|589468724|FG002|Overall Study|Adverse Event|0|||
163206436|NCT02927080|589468725|FG003|Overall Study|Adverse Event|0|||
163206437|NCT02927080|589468726|FG004|Overall Study|Adverse Event|0|||
163206438|NCT02927080|589468727|FG005|Overall Study|Adverse Event|0|||
163206439|NCT02927080|589468728|FG006|Overall Study|Adverse Event|0|||
163206440|NCT02927080|589468729|FG007|Overall Study|Adverse Event|1|||
163206441|NCT02927080|589468730|FG008|Overall Study|Adverse Event|0|||
163206442|NCT02927080|589468731|FG009|Overall Study|Adverse Event|1|||
163206443|NCT02927080|589468722|FG000|Overall Study|Other|0|||
163206444|NCT02927080|589468723|FG001|Overall Study|Other|0|||
163206445|NCT02927080|589468724|FG002|Overall Study|Other|0|||
163206446|NCT02927080|589468725|FG003|Overall Study|Other|0|||
163206447|NCT02927080|589468726|FG004|Overall Study|Other|0|||
163206448|NCT02927080|589468727|FG005|Overall Study|Other|0|||
163206449|NCT02927080|589468728|FG006|Overall Study|Other|1|||
163206450|NCT02927080|589468729|FG007|Overall Study|Other|0|||
163206451|NCT02927080|589468730|FG008|Overall Study|Other|1|||
163206452|NCT02927080|589468731|FG009|Overall Study|Other|0|||
163206453|NCT01411228|589468733|FG000|Overall Study|Lost to Follow-up|0|||
163206454|NCT01411228|589468734|FG001|Overall Study|Lost to Follow-up|0|||
163206455|NCT01411228|589468735|FG002|Overall Study|Lost to Follow-up|1|||
163206456|NCT01411228|589468733|FG000|Overall Study|Withdrawal by Subject|1|||
163206457|NCT01411228|589468734|FG001|Overall Study|Withdrawal by Subject|0|||
163206458|NCT01411228|589468735|FG002|Overall Study|Withdrawal by Subject|0|||
163206459|NCT00664742|589468736|FG000|Overall Study|Withdrawn due to adverse events|3|||
163054062|NCT00264147|588908504|FG000|Treatment II Period|Adverse Event|0|||
163054063|NCT00264147|588908505|FG001|Treatment II Period|Adverse Event|0|||
163054064|NCT00264147|588908506|FG002|Treatment II Period|Adverse Event|0|||
163206460|NCT00664742|589468736|FG000|Overall Study|Withdrawal by Subject|31|||
163206461|NCT00664742|589468736|FG000|Overall Study|Lost to Follow-up|92|||
163206462|NCT02670083|589468737|FG000|Overall Study|Adverse Event|16|||
163206463|NCT02670083|589468738|FG001|Overall Study|Adverse Event|13|||
163206464|NCT02670083|589468737|FG000|Overall Study|Death|4|||
163206465|NCT02670083|589468738|FG001|Overall Study|Death|6|||
163206466|NCT02670083|589468737|FG000|Overall Study|Lost to Follow-up|2|||
163206467|NCT02670083|589468738|FG001|Overall Study|Lost to Follow-up|2|||
163206468|NCT02670083|589468737|FG000|Overall Study|Multiple Reasons|9|||
163206469|NCT02670083|589468738|FG001|Overall Study|Multiple Reasons|9|||
163206470|NCT02670083|589468737|FG000|Overall Study|Physician Decision|0|||
163206471|NCT02670083|589468738|FG001|Overall Study|Physician Decision|2|||
163206472|NCT02670083|589468737|FG000|Overall Study|Study Terminated By Sponsor|257|||
163206473|NCT02670083|589468738|FG001|Overall Study|Study Terminated By Sponsor|254|||
163206474|NCT02670083|589468737|FG000|Overall Study|Symptomatic Deterioration|0|||
163206475|NCT02670083|589468738|FG001|Overall Study|Symptomatic Deterioration|2|||
163206476|NCT02670083|589468737|FG000|Overall Study|Withdrawal by Subject|32|||
163206477|NCT02670083|589468738|FG001|Overall Study|Withdrawal by Subject|31|||
163206478|NCT02670083|589468737|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163206479|NCT02670083|589468738|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163206480|NCT02825992|589468739|FG000|Overall Study|Withdrawal by Subject|4|||
163397611|NCT01970488|590167766|FG002|Part 2: Post Week 16|Adverse Event|5|||
163397612|NCT01970488|590167767|FG003|Part 2: Post Week 16|Adverse Event|1|||
163397613|NCT01970488|590167768|FG004|Part 2: Post Week 16|Adverse Event|1|||
163397614|NCT01970488|590167764|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
163206481|NCT02825992|589468739|FG000|Overall Study|Lost to Follow-up|2|||
163206482|NCT02825992|589468739|FG000|Overall Study|Procedure terminated|2|||
163397615|NCT01970488|590167765|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
163397616|NCT01970488|590167766|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
163397617|NCT01970488|590167767|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
163397618|NCT01970488|590167768|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
163397619|NCT01970488|590167764|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
163397620|NCT01970488|590167765|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
163397621|NCT01970488|590167766|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
163397622|NCT01970488|590167767|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
163397623|NCT01970488|590167768|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
163397624|NCT05525689|590167769|FG000|Overall Study|Lost to Follow-up|1|||
163397625|NCT05525689|590167770|FG001|Overall Study|Lost to Follow-up|0|||
163397626|NCT01231659|590167771|FG000|Overall Study|Adverse Event|9|||
163397627|NCT01231659|590167771|FG000|Overall Study|Disease Progression|48|||
163397628|NCT01231659|590167771|FG000|Overall Study|Death|2|||
163397629|NCT01231659|590167771|FG000|Overall Study|Patient refused to complete study visit|1|||
163397630|NCT01231659|590167771|FG000|Overall Study|Other protocol defined criteria|12|||
163397631|NCT01075412|590167772|FG000|Overall Study|Withdrawal by Subject|0|||
163397632|NCT01075412|590167773|FG001|Overall Study|Withdrawal by Subject|1|||
163397633|NCT00509067|590167774|FG000|Overall Study|Lost to Follow-up|1|||
163397634|NCT00509067|590167775|FG001|Overall Study|Lost to Follow-up|1|||
163397635|NCT00509067|590167774|FG000|Overall Study|Adverse Event|3|||
163397636|NCT00509067|590167775|FG001|Overall Study|Adverse Event|1|||
163397637|NCT00509067|590167774|FG000|Overall Study|Protocol Violation|0|||
163397638|NCT00509067|590167775|FG001|Overall Study|Protocol Violation|3|||
163054065|NCT00264147|588908507|FG003|Treatment II Period|Adverse Event|0|||
163054066|NCT00264147|588908508|FG004|Treatment II Period|Adverse Event|9|||
163054067|NCT00264147|588908509|FG005|Treatment II Period|Adverse Event|9|||
163054068|NCT00264147|588908504|FG000|Treatment II Period|Laboratory Adverse Event|0|||
163054069|NCT00264147|588908505|FG001|Treatment II Period|Laboratory Adverse Event|0|||
163054070|NCT00264147|588908506|FG002|Treatment II Period|Laboratory Adverse Event|0|||
163054071|NCT00264147|588908507|FG003|Treatment II Period|Laboratory Adverse Event|0|||
163054072|NCT00264147|588908508|FG004|Treatment II Period|Laboratory Adverse Event|0|||
163054073|NCT00264147|588908509|FG005|Treatment II Period|Laboratory Adverse Event|1|||
163397639|NCT03716050|590167776|FG000|Overall Study|Lost to Follow-up|0|||
163397640|NCT03716050|590167777|FG001|Overall Study|Lost to Follow-up|0|||
163397641|NCT03716050|590167778|FG002|Overall Study|Lost to Follow-up|1|||
163397642|NCT03716050|590167779|FG003|Overall Study|Lost to Follow-up|0|||
163397643|NCT03716050|590167780|FG004|Overall Study|Lost to Follow-up|0|||
163397644|NCT03716050|590167781|FG005|Overall Study|Lost to Follow-up|0|||
163397645|NCT03716050|590167782|FG006|Overall Study|Lost to Follow-up|0|||
163054074|NCT00264147|588908504|FG000|Treatment II Period|Lack of Efficacy|0|||
163054075|NCT00264147|588908505|FG001|Treatment II Period|Lack of Efficacy|0|||
163054076|NCT00264147|588908506|FG002|Treatment II Period|Lack of Efficacy|0|||
163054077|NCT00264147|588908507|FG003|Treatment II Period|Lack of Efficacy|0|||
163206483|NCT05620563|589468740|FG000|Overall Study|Adverse Event|3|||
163206484|NCT05620563|589468741|FG001|Overall Study|Adverse Event|1|||
163397646|NCT03716050|590167783|FG007|Overall Study|Lost to Follow-up|0|||
163206485|NCT05620563|589468740|FG000|Overall Study|Lost to Follow-up|0|||
163206486|NCT05620563|589468741|FG001|Overall Study|Lost to Follow-up|2|||
163206487|NCT05620563|589468740|FG000|Overall Study|Protocol Deviation|1|||
163206488|NCT05620563|589468741|FG001|Overall Study|Protocol Deviation|2|||
163206489|NCT05620563|589468740|FG000|Overall Study|Withdrawal by Subject|3|||
163206490|NCT05620563|589468741|FG001|Overall Study|Withdrawal by Subject|3|||
163206491|NCT05620563|589468740|FG000|Overall Study|Physician Decision|0|||
163206492|NCT05620563|589468741|FG001|Overall Study|Physician Decision|1|||
163206493|NCT00779467|589468742|FG000|Overall Study|Lack of Efficacy|11|||
163206494|NCT00779467|589468743|FG001|Overall Study|Lack of Efficacy|2|||
163206495|NCT00779467|589468744|FG002|Overall Study|Lack of Efficacy|6|||
163206496|NCT00779467|589468745|FG003|Overall Study|Lack of Efficacy|11|||
163206497|NCT00779467|589468742|FG000|Overall Study|failed inclusion criteria|3|||
163206498|NCT00779467|589468743|FG001|Overall Study|failed inclusion criteria|3|||
163206499|NCT00779467|589468744|FG002|Overall Study|failed inclusion criteria|1|||
163206500|NCT00779467|589468745|FG003|Overall Study|failed inclusion criteria|2|||
163206501|NCT00779467|589468742|FG000|Overall Study|missing data|1|||
163206502|NCT00779467|589468743|FG001|Overall Study|missing data|0|||
163206503|NCT00779467|589468744|FG002|Overall Study|missing data|1|||
163206504|NCT00779467|589468745|FG003|Overall Study|missing data|4|||
163206505|NCT00779467|589468742|FG000|Overall Study|technical issue|0|||
163206506|NCT00779467|589468743|FG001|Overall Study|technical issue|0|||
163397647|NCT03716050|590167776|FG000|Overall Study|Physician Decision|0|||
163397648|NCT03716050|590167777|FG001|Overall Study|Physician Decision|0|||
163397649|NCT03716050|590167778|FG002|Overall Study|Physician Decision|0|||
163397650|NCT03716050|590167779|FG003|Overall Study|Physician Decision|1|||
163397651|NCT03716050|590167780|FG004|Overall Study|Physician Decision|0|||
163397652|NCT03716050|590167781|FG005|Overall Study|Physician Decision|0|||
163397653|NCT03716050|590167782|FG006|Overall Study|Physician Decision|0|||
163397654|NCT03716050|590167783|FG007|Overall Study|Physician Decision|0|||
163397655|NCT03716050|590167776|FG000|Overall Study|Protocol Violation|0|||
163397656|NCT03716050|590167777|FG001|Overall Study|Protocol Violation|0|||
163397657|NCT03716050|590167778|FG002|Overall Study|Protocol Violation|0|||
163397658|NCT03716050|590167779|FG003|Overall Study|Protocol Violation|1|||
163054078|NCT00264147|588908508|FG004|Treatment II Period|Lack of Efficacy|20|||
163397659|NCT03716050|590167780|FG004|Overall Study|Protocol Violation|0|||
163397660|NCT03716050|590167781|FG005|Overall Study|Protocol Violation|0|||
163397661|NCT03716050|590167782|FG006|Overall Study|Protocol Violation|0|||
163397662|NCT03716050|590167783|FG007|Overall Study|Protocol Violation|2|||
163206507|NCT00779467|589468744|FG002|Overall Study|technical issue|2|||
163206508|NCT00779467|589468745|FG003|Overall Study|technical issue|1|||
163206509|NCT00779467|589468742|FG000|Overall Study|unavailable research staff|0|||
163206510|NCT00779467|589468743|FG001|Overall Study|unavailable research staff|0|||
163206511|NCT00779467|589468744|FG002|Overall Study|unavailable research staff|0|||
163206512|NCT00779467|589468745|FG003|Overall Study|unavailable research staff|1|||
163206513|NCT00460408|589468752|FG000|Overall Study|Adverse Event|1|||
163206514|NCT00460408|589468753|FG001|Overall Study|Adverse Event|0|||
163054079|NCT00264147|588908509|FG005|Treatment II Period|Lack of Efficacy|19|||
163054080|NCT00264147|588908504|FG000|Treatment II Period|Lost to Follow-up|0|||
163054081|NCT00264147|588908505|FG001|Treatment II Period|Lost to Follow-up|0|||
163054082|NCT00264147|588908506|FG002|Treatment II Period|Lost to Follow-up|0|||
163054083|NCT00264147|588908507|FG003|Treatment II Period|Lost to Follow-up|0|||
163054084|NCT00264147|588908508|FG004|Treatment II Period|Lost to Follow-up|1|||
163054085|NCT00264147|588908509|FG005|Treatment II Period|Lost to Follow-up|1|||
163054086|NCT00264147|588908504|FG000|Treatment II Period|Withdrawal by Subject|0|||
163054087|NCT00264147|588908505|FG001|Treatment II Period|Withdrawal by Subject|0|||
163054088|NCT00264147|588908506|FG002|Treatment II Period|Withdrawal by Subject|0|||
163206515|NCT00460408|589468754|FG002|Overall Study|Adverse Event|0|||
163206516|NCT00460408|589468755|FG003|Overall Study|Adverse Event|0|||
163054089|NCT00264147|588908507|FG003|Treatment II Period|Withdrawal by Subject|0|||
163397663|NCT02243865|590167786|FG000|Overall Study|Protocol Violation|1|||
163397664|NCT02243865|590167787|FG001|Overall Study|Protocol Violation|3|||
163397665|NCT02243865|590167786|FG000|Overall Study|Lost to Follow-up|1|||
163397666|NCT02243865|590167787|FG001|Overall Study|Lost to Follow-up|1|||
163397667|NCT02243865|590167786|FG000|Overall Study|Withdrawal by Subject|1|||
163397668|NCT02243865|590167787|FG001|Overall Study|Withdrawal by Subject|0|||
163397669|NCT02243865|590167786|FG000|Overall Study|Adverse Event|1|||
163397670|NCT02243865|590167787|FG001|Overall Study|Adverse Event|1|||
163397671|NCT03654976|590167788|FG000|Overall Study|Withdrawal by Subject|12|||
163054090|NCT00264147|588908508|FG004|Treatment II Period|Withdrawal by Subject|3|||
163206517|NCT00460408|589468752|FG000|Overall Study|Death|7|||
163206518|NCT00460408|589468753|FG001|Overall Study|Death|0|||
163206519|NCT00460408|589468754|FG002|Overall Study|Death|0|||
163206520|NCT00460408|589468755|FG003|Overall Study|Death|0|||
163206521|NCT00460408|589468752|FG000|Overall Study|Lost to Follow-up|11|||
163206522|NCT00460408|589468753|FG001|Overall Study|Lost to Follow-up|0|||
163397672|NCT03654976|590167789|FG001|Overall Study|Withdrawal by Subject|11|||
163397673|NCT03654976|590167788|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
163397674|NCT03654976|590167789|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
163397675|NCT03654976|590167788|FG000|Overall Study|Adverse Event|5|||
163397676|NCT03654976|590167789|FG001|Overall Study|Adverse Event|0|||
163397677|NCT03654976|590167788|FG000|Overall Study|Lost to Follow-up|2|||
163397678|NCT03654976|590167789|FG001|Overall Study|Lost to Follow-up|0|||
163397679|NCT03654976|590167788|FG000|Overall Study|Lack of Efficacy|0|||
163397680|NCT03654976|590167789|FG001|Overall Study|Lack of Efficacy|1|||
163397681|NCT00117598|590167790|FG000|Prior to Treatment Cross Over|Death|40|||
163397682|NCT00117598|590167791|FG001|Prior to Treatment Cross Over|Death|41|||
163397683|NCT00117598|590167792|FG002|Prior to Treatment Cross Over|Death|37|||
163397684|NCT00117598|590167793|FG003|Prior to Treatment Cross Over|Death|0|||
163397685|NCT00117598|590167794|FG004|Prior to Treatment Cross Over|Death|0|||
163397686|NCT00117598|590167790|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
163397687|NCT00117598|590167791|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
163397688|NCT00117598|590167792|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
163397689|NCT00117598|590167793|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
163397690|NCT00117598|590167794|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
163397691|NCT00117598|590167790|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
163397692|NCT00117598|590167791|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
163397693|NCT00117598|590167792|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
163397694|NCT00117598|590167793|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
163397695|NCT00117598|590167794|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
163397696|NCT00117598|590167790|FG000|Prior to Treatment Cross Over|Other|15|||
163397697|NCT00117598|590167791|FG001|Prior to Treatment Cross Over|Other|9|||
163397698|NCT00117598|590167792|FG002|Prior to Treatment Cross Over|Other|9|||
163397699|NCT00117598|590167793|FG003|Prior to Treatment Cross Over|Other|0|||
163206523|NCT00460408|589468754|FG002|Overall Study|Lost to Follow-up|1|||
163206524|NCT00460408|589468755|FG003|Overall Study|Lost to Follow-up|0|||
163206525|NCT00460408|589468752|FG000|Overall Study|Withdrawal by Subject|31|||
163206526|NCT00460408|589468753|FG001|Overall Study|Withdrawal by Subject|0|||
163206527|NCT00460408|589468754|FG002|Overall Study|Withdrawal by Subject|0|||
163206528|NCT00460408|589468755|FG003|Overall Study|Withdrawal by Subject|0|||
163206529|NCT00460408|589468752|FG000|Overall Study|Insufficient clinical response|5|||
163206530|NCT00460408|589468753|FG001|Overall Study|Insufficient clinical response|1|||
163206531|NCT00460408|589468754|FG002|Overall Study|Insufficient clinical response|5|||
163206532|NCT00460408|589468755|FG003|Overall Study|Insufficient clinical response|0|||
163206533|NCT00460408|589468752|FG000|Overall Study|Other|12|||
163206534|NCT00460408|589468753|FG001|Overall Study|Other|2|||
163397700|NCT00117598|590167794|FG004|Prior to Treatment Cross Over|Other|0|||
163397701|NCT00117598|590167790|FG000|After Treament Cross Over|Death|0|||
163397702|NCT00117598|590167791|FG001|After Treament Cross Over|Death|0|||
163206535|NCT00460408|589468754|FG002|Overall Study|Other|0|||
163206536|NCT00460408|589468755|FG003|Overall Study|Other|0|||
163206537|NCT02573350|589468756|FG000|Overall Study|Lost to Follow-up|2|||
163206538|NCT02573350|589468757|FG001|Overall Study|Lost to Follow-up|1|||
162967287|NCT02817828|588581300|FG000|Overall Study|Withdrawal by Subject|78|||
162967288|NCT02817828|588581300|FG000|Overall Study|Other|26|||
162967289|NCT00522041|588581302|FG000|Overall Study|Adverse Event|9|||
162967290|NCT00522041|588581303|FG001|Overall Study|Adverse Event|3|||
162967291|NCT00522041|588581302|FG000|Overall Study|Protocol Violation|2|||
162967292|NCT00522041|588581303|FG001|Overall Study|Protocol Violation|0|||
162967293|NCT00522041|588581302|FG000|Overall Study|Lost to Follow-up|1|||
162967294|NCT00522041|588581303|FG001|Overall Study|Lost to Follow-up|4|||
162967295|NCT00522041|588581302|FG000|Overall Study|Voluntary withdrawal|5|||
162967296|NCT00522041|588581303|FG001|Overall Study|Voluntary withdrawal|4|||
162967297|NCT00522041|588581302|FG000|Overall Study|Did not receive treatment|0|||
162967298|NCT00522041|588581303|FG001|Overall Study|Did not receive treatment|1|||
162967299|NCT01579006|588581304|FG000|Overall Study|Lack of Efficacy|10|||
162967300|NCT01579006|588581304|FG000|Overall Study|Adverse Event|13|||
162967301|NCT01579006|588581304|FG000|Overall Study|Withdrawal by Subject|5|||
162967302|NCT01579006|588581304|FG000|Overall Study|Non-compliance|3|||
162967303|NCT01579006|588581304|FG000|Overall Study|Due to participant's health fund|1|||
162967304|NCT01579006|588581304|FG000|Overall Study|Scheduled surgery|1|||
162967305|NCT00799708|588581308|FG000|Overall Study|non-compliance|1|||
162967306|NCT00799708|588581309|FG001|Overall Study|non-compliance|0|||
162967307|NCT00799708|588581310|FG002|Overall Study|non-compliance|0|||
162967308|NCT03343639|588581311|FG000|Overall Study|Withdrawal by Subject|10|||
162967309|NCT03343639|588581312|FG001|Overall Study|Withdrawal by Subject|6|||
162967310|NCT03343639|588581311|FG000|Overall Study|Lost to Follow-up|4|||
162967311|NCT03343639|588581312|FG001|Overall Study|Lost to Follow-up|5|||
162967312|NCT03343639|588581311|FG000|Overall Study|Protocol Violation|0|||
162967313|NCT03343639|588581312|FG001|Overall Study|Protocol Violation|1|||
163206539|NCT02573350|589468756|FG000|Overall Study|Adverse Event|3|||
162967314|NCT00735696|588581315|FG000|Overall Study|Withdrawal by Subject|1|||
162967315|NCT00735696|588581315|FG000|Overall Study|Enrolled but never Treated|1|||
162967316|NCT01192776|588581316|FG000|Overall Study|Death|8|||
162967317|NCT01192776|588581317|FG001|Overall Study|Death|15|||
162967318|NCT01192776|588581318|FG002|Overall Study|Death|18|||
163054091|NCT00264147|588908509|FG005|Treatment II Period|Withdrawal by Subject|2|||
163054092|NCT00264147|588908504|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
163054093|NCT00264147|588908505|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
163054094|NCT00264147|588908506|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
163054095|NCT00264147|588908507|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
163054096|NCT00264147|588908508|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
163054097|NCT00264147|588908509|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
163054098|NCT03234465|588908510|FG000|Overall Study|Adverse Event|4|||
163054099|NCT03234465|588908511|FG001|Overall Study|Adverse Event|2|||
163054100|NCT03234465|588908510|FG000|Overall Study|Death|0|||
163054101|NCT03234465|588908511|FG001|Overall Study|Death|1|||
163054102|NCT03234465|588908510|FG000|Overall Study|Lost to Follow-up|1|||
163054103|NCT03234465|588908511|FG001|Overall Study|Lost to Follow-up|1|||
163054104|NCT03234465|588908510|FG000|Overall Study|Withdrawal by Subject|12|||
163054105|NCT03234465|588908511|FG001|Overall Study|Withdrawal by Subject|27|||
163054106|NCT03234465|588908510|FG000|Overall Study|Symptomatic deterioration|0|||
163054107|NCT03234465|588908511|FG001|Overall Study|Symptomatic deterioration|1|||
163054108|NCT03234465|588908510|FG000|Overall Study|Non-compliance|2|||
163054109|NCT03234465|588908511|FG001|Overall Study|Non-compliance|0|||
163054110|NCT03234465|588908510|FG000|Overall Study|Other|14|||
163054111|NCT03234465|588908511|FG001|Overall Study|Other|8|||
163054112|NCT01274533|588908516|FG000|Overall Study|Withdrawal by Subject|1|||
163054113|NCT01274533|588908516|FG000|Overall Study|Non-compliance|1|||
163054114|NCT01274533|588908516|FG000|Overall Study|Disease progression|2|||
163054115|NCT02563899|588908517|FG000|Overall Study|Protocol Violation|1|||
163313887|NCT05329220|589859499|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
163313888|NCT05329220|589859494|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
163313889|NCT05329220|589859495|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
163313890|NCT05329220|589859496|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
163313891|NCT05329220|589859497|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
163313892|NCT05329220|589859498|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
163313893|NCT05329220|589859499|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
163313894|NCT05329220|589859494|FG000|Follow-up Period|EARLY TERMINATION|0|||
163313895|NCT05329220|589859495|FG001|Follow-up Period|EARLY TERMINATION|0|||
163313896|NCT05329220|589859496|FG002|Follow-up Period|EARLY TERMINATION|0|||
163313897|NCT05329220|589859497|FG003|Follow-up Period|EARLY TERMINATION|0|||
163313898|NCT05329220|589859498|FG004|Follow-up Period|EARLY TERMINATION|0|||
163313899|NCT05329220|589859499|FG005|Follow-up Period|EARLY TERMINATION|1|||
163313900|NCT05329220|589859494|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
163313901|NCT05329220|589859495|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
163313902|NCT05329220|589859496|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
163313903|NCT05329220|589859497|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
163313904|NCT05329220|589859498|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
163313905|NCT05329220|589859499|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
163313906|NCT05329220|589859494|FG000|Follow-up Period|DROPPED|0|||
163313907|NCT05329220|589859495|FG001|Follow-up Period|DROPPED|0|||
163313908|NCT05329220|589859496|FG002|Follow-up Period|DROPPED|0|||
163054116|NCT02563899|588908518|FG001|Overall Study|Protocol Violation|0|||
163054117|NCT02563899|588908519|FG002|Overall Study|Protocol Violation|0|||
163054118|NCT02563899|588908520|FG003|Overall Study|Protocol Violation|0|||
163054119|NCT02563899|588908517|FG000|Overall Study|Withdrawal by Subject|0|||
163054120|NCT02563899|588908518|FG001|Overall Study|Withdrawal by Subject|0|||
163054121|NCT02563899|588908519|FG002|Overall Study|Withdrawal by Subject|1|||
163054122|NCT02563899|588908520|FG003|Overall Study|Withdrawal by Subject|0|||
163054123|NCT00369343|588908533|FG000|Double-blind Phase|Adverse Event|19|||
163054124|NCT00369343|588908534|FG001|Double-blind Phase|Adverse Event|4|||
163054125|NCT00369343|588908533|FG000|Double-blind Phase|Failed to return|2|||
163054126|NCT00369343|588908534|FG001|Double-blind Phase|Failed to return|0|||
163054127|NCT00369343|588908533|FG000|Double-blind Phase|Lost to Follow-up|9|||
163054128|NCT00369343|588908534|FG001|Double-blind Phase|Lost to Follow-up|2|||
163054129|NCT00369343|588908533|FG000|Double-blind Phase|Protocol Violation|2|||
163054130|NCT00369343|588908534|FG001|Double-blind Phase|Protocol Violation|0|||
163054131|NCT00369343|588908533|FG000|Double-blind Phase|Withdrawal by Subject|8|||
163054132|NCT00369343|588908534|FG001|Double-blind Phase|Withdrawal by Subject|6|||
163313909|NCT05329220|589859497|FG003|Follow-up Period|DROPPED|0|||
163313910|NCT05329220|589859498|FG004|Follow-up Period|DROPPED|0|||
163313911|NCT05329220|589859499|FG005|Follow-up Period|DROPPED|1|||
163313912|NCT05329220|589859494|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
163313913|NCT05329220|589859495|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
163313914|NCT05329220|589859496|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
163054133|NCT00369343|588908533|FG000|Double-blind Phase|Lack of Efficacy|0|||
163397703|NCT00117598|590167792|FG002|After Treament Cross Over|Death|0|||
163397704|NCT00117598|590167793|FG003|After Treament Cross Over|Death|1|||
163397705|NCT00117598|590167794|FG004|After Treament Cross Over|Death|2|||
163397706|NCT00117598|590167790|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
163397707|NCT00117598|590167791|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
163397708|NCT00117598|590167792|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
163397709|NCT00117598|590167793|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
163397710|NCT00117598|590167794|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
163397711|NCT00117598|590167790|FG000|After Treament Cross Over|Other|0|||
163397712|NCT00117598|590167791|FG001|After Treament Cross Over|Other|0|||
163397713|NCT00117598|590167792|FG002|After Treament Cross Over|Other|0|||
163397714|NCT00117598|590167793|FG003|After Treament Cross Over|Other|1|||
163206540|NCT02573350|589468757|FG001|Overall Study|Adverse Event|4|||
163206541|NCT02573350|589468756|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
163206542|NCT02573350|589468757|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
163206543|NCT02573350|589468756|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
163206544|NCT02573350|589468757|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
163206545|NCT02573350|589468756|FG000|Overall Study|Subject withdrew consent to participate|6|||
163206546|NCT02573350|589468757|FG001|Overall Study|Subject withdrew consent to participate|1|||
163206547|NCT02573350|589468756|FG000|Overall Study|Protocol Deviation|1|||
163206548|NCT02573350|589468757|FG001|Overall Study|Protocol Deviation|1|||
163206549|NCT01442493|589468759|FG000|Overall Study|withdrawn from study|3|||
163206550|NCT01442493|589468760|FG001|Overall Study|withdrawn from study|2|||
163206551|NCT02547649|589468763|FG000|Overall Study|Lost to Follow-up|3|||
163206552|NCT02547649|589468764|FG001|Overall Study|Lost to Follow-up|1|||
163206553|NCT02547649|589468765|FG002|Overall Study|Lost to Follow-up|1|||
163206554|NCT02547649|589468763|FG000|Overall Study|Not vaccinated|0|||
163206555|NCT02547649|589468764|FG001|Overall Study|Not vaccinated|0|||
163206556|NCT02547649|589468765|FG002|Overall Study|Not vaccinated|1|||
163206557|NCT02547649|589468763|FG000|Overall Study|Withdrawal by Subject|0|||
163206558|NCT02547649|589468764|FG001|Overall Study|Withdrawal by Subject|4|||
163206559|NCT02547649|589468765|FG002|Overall Study|Withdrawal by Subject|2|||
163206560|NCT04326231|589468766|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
163206561|NCT03303079|589468767|FG000|Overall Study|Adverse Event|0|||
163206562|NCT03303079|589468768|FG001|Overall Study|Adverse Event|1|||
163206563|NCT03303079|589468769|FG002|Overall Study|Adverse Event|3|||
163206564|NCT03303079|589468767|FG000|Overall Study|Protocol Violation|5|||
163206565|NCT03303079|589468768|FG001|Overall Study|Protocol Violation|4|||
163313915|NCT05329220|589859497|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
163313916|NCT05329220|589859498|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
163313917|NCT05329220|589859499|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
163313918|NCT04313972|589859506|FG000|Overall Study|Withdrawal by Subject|0|||
163397715|NCT00117598|590167794|FG004|After Treament Cross Over|Other|2|||
163397716|NCT01235793|590167795|FG000|Overall Study|Death|6|||
163397717|NCT00545064|590167796|FG000|Overall Study|Lost to Follow-up|3|||
163397718|NCT00545064|590167796|FG000|Overall Study|Withdrawal by Subject|2|||
163397719|NCT00545064|590167796|FG000|Overall Study|did not complete course of treatment|1|||
163397720|NCT00545064|590167796|FG000|Overall Study|cancel all appointments, no rebooking|1|||
163397721|NCT00545064|590167796|FG000|Overall Study|inclement weather|1|||
163397722|NCT05093322|590167797|FG000|Overall Study|Death|6|||
163397723|NCT05093322|590167798|FG001|Overall Study|Death|2|||
163397724|NCT05093322|590167797|FG000|Overall Study|Other|4|||
163397725|NCT05093322|590167798|FG001|Overall Study|Other|1|||
163397726|NCT00898443|590167799|FG000|Overall Study|Withdrawal by Subject|1|||
163206566|NCT03303079|589468769|FG002|Overall Study|Protocol Violation|7|||
163206567|NCT03303079|589468767|FG000|Overall Study|Withdrawal by Subject|2|||
163206568|NCT03303079|589468768|FG001|Overall Study|Withdrawal by Subject|4|||
163206569|NCT03303079|589468769|FG002|Overall Study|Withdrawal by Subject|2|||
163206570|NCT03303079|589468767|FG000|Overall Study|Other than specified|0|||
163206571|NCT03303079|589468768|FG001|Overall Study|Other than specified|2|||
163206572|NCT03303079|589468769|FG002|Overall Study|Other than specified|0|||
163206573|NCT03454997|589468770|FG000|Overall Study|Staff Coach - Left Oranization|1|||
163206574|NCT03454997|589468771|FG001|Overall Study|Staff Coach - Left Oranization|1|||
163206575|NCT03454997|589468770|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
163313919|NCT04313972|589859507|FG001|Overall Study|Withdrawal by Subject|1|||
163313920|NCT05201079|589859521|FG000|Overall Study|Adverse Event|7|||
163313921|NCT05201079|589859522|FG001|Overall Study|Adverse Event|11|||
163397727|NCT00898443|590167800|FG001|Overall Study|Withdrawal by Subject|0|||
163397728|NCT00074581|590167804|FG000|Overall Study|Death|15|||
163206576|NCT03454997|589468771|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
163206577|NCT03454997|589468770|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
163206578|NCT03454997|589468771|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
163206579|NCT03454997|589468770|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
163397729|NCT00074581|590167805|FG001|Overall Study|Death|16|||
163397730|NCT00074581|590167804|FG000|Overall Study|Withdrawal by Subject|50|||
163206580|NCT03454997|589468771|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
163206581|NCT03454997|589468770|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
163206582|NCT03454997|589468771|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
163206583|NCT03454997|589468770|FG000|Overall Study|Client with SMI - Left organization|0|||
163206584|NCT03454997|589468771|FG001|Overall Study|Client with SMI - Left organization|1|||
163206585|NCT03454997|589468770|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
163206586|NCT03454997|589468771|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
163206587|NCT01909674|589468780|FG000|Overall Study|Withdrawal by Subject|5|||
163397731|NCT00074581|590167805|FG001|Overall Study|Withdrawal by Subject|49|||
163397732|NCT00074581|590167804|FG000|Overall Study|Unable to adhere to visit schedule|13|||
163397733|NCT00074581|590167805|FG001|Overall Study|Unable to adhere to visit schedule|14|||
163206588|NCT01909674|589468781|FG001|Overall Study|Withdrawal by Subject|2|||
163206589|NCT01678911|589468784|FG000|Second Intervention|Lost to Follow-up|2|||
163206590|NCT01678911|589468785|FG001|Second Intervention|Lost to Follow-up|0|||
163206591|NCT01830972|589468786|FG000|Part II|Withdrawal by Subject|2|||
163397734|NCT00074581|590167804|FG000|Overall Study|Relocated|14|||
163397735|NCT00074581|590167805|FG001|Overall Study|Relocated|9|||
163397736|NCT00074581|590167804|FG000|Overall Study|Were withdrawn by investigator|5|||
163397737|NCT00074581|590167805|FG001|Overall Study|Were withdrawn by investigator|2|||
163397738|NCT00074581|590167804|FG000|Overall Study|Lost to Follow-up|16|||
163397739|NCT00074581|590167805|FG001|Overall Study|Lost to Follow-up|11|||
163397740|NCT00074581|590167804|FG000|Overall Study|Ended relationship w. index participant|117|||
163397741|NCT00074581|590167805|FG001|Overall Study|Ended relationship w. index participant|106|||
163397742|NCT00074581|590167804|FG000|Overall Study|Other|14|||
163397743|NCT00074581|590167805|FG001|Overall Study|Other|19|||
163397744|NCT01770912|590167806|FG000|Overall Study|Lost to Follow-up|2|||
163397745|NCT01770912|590167807|FG001|Overall Study|Lost to Follow-up|0|||
163397746|NCT03250832|590167809|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
163397747|NCT03250832|590167810|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
163397748|NCT03250832|590167811|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
163397749|NCT03250832|590167812|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
163397750|NCT03250832|590167813|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
163397751|NCT03250832|590167814|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
163397752|NCT03250832|590167815|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
163397753|NCT03250832|590167816|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
163397754|NCT03250832|590167817|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
163397755|NCT03250832|590167818|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
163397756|NCT03250832|590167819|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
163397757|NCT03250832|590167820|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
163397758|NCT03250832|590167809|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
163397759|NCT03250832|590167810|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
163397760|NCT03250832|590167811|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
163397761|NCT03250832|590167812|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
163397762|NCT03250832|590167813|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
163397763|NCT03250832|590167814|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
163397764|NCT03250832|590167815|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
163397765|NCT03250832|590167816|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
163397766|NCT03250832|590167817|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
163397767|NCT03250832|590167818|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
163397768|NCT03250832|590167819|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
163397769|NCT03250832|590167820|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
163397770|NCT03250832|590167809|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163397771|NCT03250832|590167810|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163397772|NCT03250832|590167811|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
163397773|NCT03250832|590167812|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163397774|NCT03250832|590167813|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163397775|NCT03250832|590167814|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163397776|NCT03250832|590167815|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163397777|NCT03250832|590167816|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163397778|NCT03250832|590167817|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163206592|NCT01830972|589468787|FG001|Part II|Withdrawal by Subject|2|||
163206593|NCT01830972|589468786|FG000|Part III|Withdrawal by Subject|1|||
163206594|NCT01830972|589468787|FG001|Part III|Withdrawal by Subject|0|||
163206595|NCT01830972|589468786|FG000|Part III|Noncompliance|1|||
163206596|NCT01830972|589468787|FG001|Part III|Noncompliance|0|||
163206597|NCT01830972|589468786|FG000|Part IV|Withdrawal by Subject|2|||
163206598|NCT01830972|589468787|FG001|Part IV|Withdrawal by Subject|1|||
163206599|NCT01830972|589468786|FG000|Part IV|Non-Compliance|1|||
163206600|NCT01830972|589468787|FG001|Part IV|Non-Compliance|0|||
163206601|NCT02117648|589468788|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
163206602|NCT02117648|589468788|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
163313922|NCT05201079|589859521|FG000|Overall Study|Death|1|||
163313923|NCT05201079|589859522|FG001|Overall Study|Death|1|||
163313924|NCT05201079|589859521|FG000|Overall Study|Lack of Efficacy|0|||
163313925|NCT05201079|589859522|FG001|Overall Study|Lack of Efficacy|2|||
163313926|NCT05201079|589859521|FG000|Overall Study|Lost to Follow-up|0|||
163313927|NCT05201079|589859522|FG001|Overall Study|Lost to Follow-up|1|||
163313928|NCT05201079|589859521|FG000|Overall Study|Physician Decision|1|||
163313929|NCT05201079|589859522|FG001|Overall Study|Physician Decision|1|||
163313930|NCT05201079|589859521|FG000|Overall Study|Protocol Violation|1|||
163313931|NCT05201079|589859522|FG001|Overall Study|Protocol Violation|0|||
163313932|NCT05201079|589859521|FG000|Overall Study|Withdrawal by Subject|1|||
163313933|NCT05201079|589859522|FG001|Overall Study|Withdrawal by Subject|0|||
163313934|NCT05201079|589859521|FG000|Overall Study|Forbidden medication|9|||
163313935|NCT05201079|589859522|FG001|Overall Study|Forbidden medication|5|||
163313936|NCT05201079|589859521|FG000|Overall Study|Transfer to another hospital|0|||
163313937|NCT05201079|589859522|FG001|Overall Study|Transfer to another hospital|1|||
163313938|NCT05201079|589859521|FG000|Overall Study|Clinical condition|1|||
163313939|NCT05201079|589859522|FG001|Overall Study|Clinical condition|0|||
163313940|NCT05201079|589859521|FG000|Overall Study|SAE and sepsis|1|||
163054134|NCT00369343|588908534|FG001|Double-blind Phase|Lack of Efficacy|4|||
163054135|NCT00369343|588908533|FG000|Double-blind Phase|Protocol deviation|4|||
163054136|NCT00369343|588908534|FG001|Double-blind Phase|Protocol deviation|0|||
163054137|NCT00369343|588908533|FG000|Open-label Phase|Adverse Event|19|||
163054138|NCT00369343|588908534|FG001|Open-label Phase|Adverse Event|7|||
163054139|NCT00369343|588908533|FG000|Open-label Phase|Failed to return|4|||
163054140|NCT00369343|588908534|FG001|Open-label Phase|Failed to return|0|||
163054141|NCT00369343|588908533|FG000|Open-label Phase|Physician Decision|2|||
163054142|NCT00369343|588908534|FG001|Open-label Phase|Physician Decision|0|||
163054143|NCT00369343|588908533|FG000|Open-label Phase|Lost to Follow-up|5|||
163054144|NCT00369343|588908534|FG001|Open-label Phase|Lost to Follow-up|3|||
163054145|NCT00369343|588908533|FG000|Open-label Phase|inadvertently reported study completers|3|||
163054146|NCT00369343|588908534|FG001|Open-label Phase|inadvertently reported study completers|2|||
163054147|NCT00369343|588908533|FG000|Open-label Phase|Protocol Violation|1|||
163054148|NCT00369343|588908534|FG001|Open-label Phase|Protocol Violation|3|||
163054149|NCT00369343|588908533|FG000|Open-label Phase|Withdrawal by Subject|15|||
163054150|NCT00369343|588908534|FG001|Open-label Phase|Withdrawal by Subject|6|||
163054151|NCT00369343|588908533|FG000|Open-label Phase|Lack of Efficacy|4|||
163054152|NCT00369343|588908534|FG001|Open-label Phase|Lack of Efficacy|3|||
163054153|NCT00369343|588908533|FG000|Open-label Phase|Lack of continuance tolerability|3|||
163054154|NCT00369343|588908534|FG001|Open-label Phase|Lack of continuance tolerability|4|||
163054155|NCT00369343|588908533|FG000|Open-label Phase|did not take study drug|1|||
163054156|NCT00369343|588908534|FG001|Open-label Phase|did not take study drug|2|||
163054157|NCT02322749|588908535|FG000|Period 2|Adverse Event|0|||
163054158|NCT02322749|588908536|FG001|Period 2|Adverse Event|0|||
163054159|NCT02322749|588908537|FG002|Period 2|Adverse Event|0|||
163054160|NCT02322749|588908538|FG003|Period 2|Adverse Event|1|||
163054161|NCT02322749|588908539|FG004|Period 2|Adverse Event|0|||
163054162|NCT02322749|588908540|FG005|Period 2|Adverse Event|0|||
163054163|NCT02322749|588908535|FG000|Period 2|Withdrawal by Subject|0|||
163054164|NCT02322749|588908536|FG001|Period 2|Withdrawal by Subject|0|||
163054165|NCT02322749|588908537|FG002|Period 2|Withdrawal by Subject|0|||
163054166|NCT02322749|588908538|FG003|Period 2|Withdrawal by Subject|1|||
163054167|NCT02322749|588908539|FG004|Period 2|Withdrawal by Subject|0|||
163054168|NCT02322749|588908540|FG005|Period 2|Withdrawal by Subject|0|||
163054169|NCT02322749|588908535|FG000|Period 3|Withdrawal by Subject|0|||
163054170|NCT02322749|588908536|FG001|Period 3|Withdrawal by Subject|0|||
163054171|NCT02322749|588908537|FG002|Period 3|Withdrawal by Subject|1|||
163054172|NCT02322749|588908538|FG003|Period 3|Withdrawal by Subject|0|||
163054173|NCT02322749|588908539|FG004|Period 3|Withdrawal by Subject|0|||
163313941|NCT05201079|589859522|FG001|Overall Study|SAE and sepsis|0|||
163313942|NCT05281562|589859525|FG000|Overall Study|Ineligible patient|1|||
163313943|NCT05281562|589859526|FG001|Overall Study|Ineligible patient|0|||
163313944|NCT04524442|589859534|FG000|Overall Study|Subject Decision|1|||
163313945|NCT04719832|589859535|FG000|Overall Study|Adverse Event|2|||
163313946|NCT04719832|589859536|FG001|Overall Study|Adverse Event|0|||
163313947|NCT04719832|589859535|FG000|Overall Study|Lack of Efficacy|2|||
163313948|NCT04719832|589859536|FG001|Overall Study|Lack of Efficacy|4|||
163206603|NCT02117648|589468788|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
163397779|NCT03250832|590167818|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163397780|NCT03250832|590167819|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163397781|NCT03250832|590167820|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163397782|NCT03250832|590167809|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
163206604|NCT02117648|589468788|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
163206605|NCT02117648|589468788|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
163206606|NCT02117648|589468788|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
163206607|NCT02117648|589468788|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
163206608|NCT02117648|589468788|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
163206609|NCT02117648|589468788|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
163206610|NCT02117648|589468788|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
163206611|NCT02117648|589468788|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
163206612|NCT05025241|589468790|FG000|Screening|Failed Screening|5|||
163206613|NCT05025241|589468790|FG000|Treatment and Follow Up|Adverse Event|3|||
163206614|NCT02670837|589468791|FG000|Overall Study|Death|2|||
163206615|NCT02670837|589468792|FG001|Overall Study|Death|0|||
163206616|NCT02670837|589468793|FG002|Overall Study|Death|0|||
163206617|NCT02220205|589468794|FG000|Overall Study|Withdrawal by Subject|1|||
163206618|NCT02220205|589468795|FG001|Overall Study|Withdrawal by Subject|0|||
163206619|NCT02266225|589468796|FG000|Overall Study|Lost to Follow-up|2|||
163206620|NCT02266225|589468796|FG000|Overall Study|Death|1|||
163206621|NCT02266225|589468796|FG000|Overall Study|Withdrawal by Subject|13|||
163206622|NCT00660309|589468799|FG000|Overall Study|Adverse Event|2|||
163397783|NCT03250832|590167810|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
163397784|NCT03250832|590167811|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
163206623|NCT00660309|589468800|FG001|Overall Study|Adverse Event|0|||
163206624|NCT00660309|589468799|FG000|Overall Study|Withdrawal by Subject|0|||
163206625|NCT00660309|589468800|FG001|Overall Study|Withdrawal by Subject|3|||
163206626|NCT02532972|589468804|FG000|Overall Study|Withdrawal by Subject|1|||
163206627|NCT00110149|589468805|FG000|Overall Study|Physician Decision|3|||
163206628|NCT01018186|589468806|FG000|2-week Run-in Period|Protocol Violation|1|||
163206629|NCT01018186|589468807|FG001|2-week Run-in Period|Protocol Violation|0|||
163206630|NCT01018186|589468808|FG002|2-week Run-in Period|Protocol Violation|0|||
163206631|NCT01018186|589468809|FG003|2-week Run-in Period|Protocol Violation|0|||
163206632|NCT01018186|589468806|FG000|2-week Run-in Period|Lost to Follow-up|2|||
163206633|NCT01018186|589468807|FG001|2-week Run-in Period|Lost to Follow-up|0|||
163206634|NCT01018186|589468808|FG002|2-week Run-in Period|Lost to Follow-up|0|||
163206635|NCT01018186|589468809|FG003|2-week Run-in Period|Lost to Follow-up|0|||
163206636|NCT01018186|589468806|FG000|2-week Run-in Period|Physician Decision|3|||
163206637|NCT01018186|589468807|FG001|2-week Run-in Period|Physician Decision|0|||
163206638|NCT01018186|589468808|FG002|2-week Run-in Period|Physician Decision|0|||
163206639|NCT01018186|589468809|FG003|2-week Run-in Period|Physician Decision|0|||
163206640|NCT01018186|589468806|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
163206641|NCT01018186|589468807|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
163397785|NCT03250832|590167812|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
163397786|NCT03250832|590167813|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
163397787|NCT03250832|590167814|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
163397788|NCT03250832|590167815|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
163397789|NCT03250832|590167816|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
163397790|NCT03250832|590167817|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
163397791|NCT03250832|590167818|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
163206642|NCT01018186|589468808|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
163206643|NCT01018186|589468809|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
163206644|NCT01018186|589468806|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
163206645|NCT01018186|589468807|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
163206646|NCT01018186|589468808|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
163206647|NCT01018186|589468809|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
163206648|NCT01018186|589468806|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
163206649|NCT01018186|589468807|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
163206650|NCT01018186|589468808|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
163206651|NCT01018186|589468809|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
163206652|NCT01018186|589468806|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
163206653|NCT01018186|589468807|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
163397792|NCT03250832|590167819|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
163397793|NCT03250832|590167820|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
163397794|NCT03250832|590167809|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163054174|NCT02322749|588908540|FG005|Period 3|Withdrawal by Subject|0|||
163206654|NCT01018186|589468808|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
163206655|NCT01018186|589468809|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
163206656|NCT01018186|589468806|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
163397795|NCT03250832|590167810|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163397796|NCT03250832|590167811|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163397797|NCT03250832|590167812|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163397798|NCT03250832|590167813|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163397799|NCT03250832|590167814|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163397800|NCT03250832|590167815|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163397801|NCT03250832|590167816|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
163397802|NCT03250832|590167817|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163397803|NCT03250832|590167818|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163397804|NCT03250832|590167819|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163397805|NCT03250832|590167820|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163397806|NCT03250832|590167809|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163397807|NCT03250832|590167810|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163397808|NCT03250832|590167811|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163397809|NCT03250832|590167812|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163397810|NCT03250832|590167813|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163397811|NCT03250832|590167814|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163397812|NCT03250832|590167815|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163397813|NCT03250832|590167816|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
163397814|NCT03250832|590167817|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163397815|NCT03250832|590167818|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163397816|NCT03250832|590167819|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163397817|NCT03250832|590167820|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163397818|NCT03250832|590167809|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163397819|NCT03250832|590167810|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163397820|NCT03250832|590167811|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163397821|NCT03250832|590167812|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163397822|NCT03250832|590167813|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163397823|NCT03250832|590167814|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163397824|NCT03250832|590167815|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163397825|NCT03250832|590167816|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
163397826|NCT03250832|590167817|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163397827|NCT03250832|590167818|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163397828|NCT03250832|590167819|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163397829|NCT03250832|590167820|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163206657|NCT01018186|589468807|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
163397830|NCT03250832|590167809|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
163206658|NCT01018186|589468808|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
163206659|NCT01018186|589468809|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
163206660|NCT01018186|589468806|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
163206661|NCT01018186|589468807|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
163206662|NCT01018186|589468808|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
163206663|NCT01018186|589468809|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
163206664|NCT01018186|589468806|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
163206665|NCT01018186|589468807|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
163206666|NCT01018186|589468808|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
163206667|NCT01018186|589468809|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
163206668|NCT01018186|589468806|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
163206669|NCT01018186|589468807|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
163206670|NCT01018186|589468808|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
163206671|NCT01018186|589468809|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
163206672|NCT01018186|589468806|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
163206673|NCT01018186|589468807|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
163206674|NCT01018186|589468808|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
163206675|NCT01018186|589468809|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
163206676|NCT02603419|589468810|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
163206677|NCT02603419|589468811|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
163054175|NCT02033759|588908543|FG000|Overall Study|Withdrawal by Subject|2|||
163054176|NCT02033759|588908544|FG001|Overall Study|Withdrawal by Subject|1|||
163054177|NCT02033759|588908543|FG000|Overall Study|Protocol Violation|1|||
163054178|NCT02033759|588908544|FG001|Overall Study|Protocol Violation|1|||
163054179|NCT04265261|588908553|FG000|Overall Study|Adverse Event|2|||
163054180|NCT04265261|588908554|FG001|Overall Study|Adverse Event|0|||
163054181|NCT04265261|588908555|FG002|Overall Study|Adverse Event|0|||
163054182|NCT04265261|588908553|FG000|Overall Study|Death|1|||
163054183|NCT04265261|588908554|FG001|Overall Study|Death|0|||
163054184|NCT04265261|588908555|FG002|Overall Study|Death|0|||
163054185|NCT04265261|588908553|FG000|Overall Study|Lost to Follow-up|4|||
163054186|NCT04265261|588908554|FG001|Overall Study|Lost to Follow-up|1|||
163054187|NCT04265261|588908555|FG002|Overall Study|Lost to Follow-up|3|||
163054188|NCT04265261|588908553|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163054189|NCT04265261|588908554|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163054190|NCT04265261|588908555|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163054191|NCT04265261|588908553|FG000|Overall Study|Physician Decision|0|||
163054192|NCT04265261|588908554|FG001|Overall Study|Physician Decision|0|||
163054193|NCT04265261|588908555|FG002|Overall Study|Physician Decision|1|||
163054194|NCT04265261|588908553|FG000|Overall Study|Protocol Deviation|0|||
163054195|NCT04265261|588908554|FG001|Overall Study|Protocol Deviation|2|||
163054196|NCT04265261|588908555|FG002|Overall Study|Protocol Deviation|0|||
162967319|NCT01192776|588581319|FG003|Overall Study|Death|15|||
162967320|NCT01192776|588581316|FG000|Overall Study|Lost to Follow-up|3|||
162967321|NCT01192776|588581317|FG001|Overall Study|Lost to Follow-up|6|||
162967322|NCT01192776|588581318|FG002|Overall Study|Lost to Follow-up|3|||
162967323|NCT01192776|588581319|FG003|Overall Study|Lost to Follow-up|5|||
162967324|NCT02587143|588581320|FG000|Overall Study|Adverse Event|1|||
162967325|NCT02587143|588581321|FG001|Overall Study|Adverse Event|0|||
162967326|NCT00611884|588581322|FG000|Overall Study|Adverse Event|1|||
162967327|NCT00611884|588581323|FG001|Overall Study|Adverse Event|0|||
162967328|NCT00611884|588581324|FG002|Overall Study|Adverse Event|0|||
162967329|NCT00611884|588581325|FG003|Overall Study|Adverse Event|1|||
162967330|NCT00611884|588581322|FG000|Overall Study|Non-Compliance|1|||
162967331|NCT00611884|588581323|FG001|Overall Study|Non-Compliance|4|||
162967332|NCT00611884|588581324|FG002|Overall Study|Non-Compliance|2|||
162967333|NCT00611884|588581325|FG003|Overall Study|Non-Compliance|2|||
162967334|NCT00611884|588581322|FG000|Overall Study|Lack of Efficacy|0|||
162967335|NCT00611884|588581323|FG001|Overall Study|Lack of Efficacy|1|||
162967336|NCT00611884|588581324|FG002|Overall Study|Lack of Efficacy|0|||
162967337|NCT00611884|588581325|FG003|Overall Study|Lack of Efficacy|0|||
162967338|NCT00611884|588581322|FG000|Overall Study|Unclassified|7|||
162967339|NCT00611884|588581323|FG001|Overall Study|Unclassified|4|||
162967340|NCT00611884|588581324|FG002|Overall Study|Unclassified|2|||
162967341|NCT00611884|588581325|FG003|Overall Study|Unclassified|3|||
162967342|NCT00981799|588581326|FG000|Overall Study|Adverse Event|1|||
162967343|NCT00981799|588581327|FG001|Overall Study|Adverse Event|1|||
162967344|NCT00981799|588581328|FG002|Overall Study|Adverse Event|0|||
162967345|NCT00981799|588581329|FG003|Overall Study|Adverse Event|0|||
163054197|NCT04265261|588908553|FG000|Overall Study|Withdrawal by Subject|2|||
163054198|NCT04265261|588908554|FG001|Overall Study|Withdrawal by Subject|1|||
163054199|NCT04265261|588908555|FG002|Overall Study|Withdrawal by Subject|4|||
163054200|NCT00499122|588910183|FG000|Overall Study|Withdrawal by Subject|2|||
163054201|NCT02466399|588910187|FG000|Overall Study|Adverse Event|1|||
163054202|NCT02466399|588910188|FG001|Overall Study|Adverse Event|0|||
163054203|NCT02466399|588910187|FG000|Overall Study|Early exit due to family emergency|1|||
163054204|NCT02466399|588910188|FG001|Overall Study|Early exit due to family emergency|0|||
163054205|NCT02669849|588910189|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
163054206|NCT02669849|588910190|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
163054207|NCT02669849|588910191|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
163313949|NCT04719832|589859535|FG000|Overall Study|Lost to Follow-up|0|||
163313950|NCT04719832|589859536|FG001|Overall Study|Lost to Follow-up|2|||
163313951|NCT04719832|589859535|FG000|Overall Study|Physician Decision|0|||
162967346|NCT01055834|588581336|FG000|Treatment Period I|Adverse Event|1|||
163313952|NCT04719832|589859536|FG001|Overall Study|Physician Decision|1|||
163313953|NCT04719832|589859535|FG000|Overall Study|Pregnancy|1|||
163313954|NCT04719832|589859536|FG001|Overall Study|Pregnancy|1|||
163313955|NCT04719832|589859535|FG000|Overall Study|Withdrawal by Subject|5|||
162967347|NCT01055834|588581337|FG001|Treatment Period I|Adverse Event|0|||
162967348|NCT01943435|588581338|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
162967349|NCT01943435|588581339|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
162967350|NCT01943435|588581340|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
162967351|NCT01943435|588581338|FG000|Intervention Period|Withdrawal by Subject|3|||
162967352|NCT01943435|588581339|FG001|Intervention Period|Withdrawal by Subject|3|||
163054208|NCT02669849|588910189|FG000|Overall Study|Lost to Follow-up|1|||
163054209|NCT02669849|588910190|FG001|Overall Study|Lost to Follow-up|0|||
163313956|NCT04719832|589859536|FG001|Overall Study|Withdrawal by Subject|5|||
163313957|NCT04719832|589859535|FG000|Overall Study|Randomized, not treated|0|||
163397831|NCT03250832|590167810|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
163397832|NCT03250832|590167811|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
163397833|NCT03250832|590167812|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
163397834|NCT03250832|590167813|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
163397835|NCT03250832|590167814|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
163397836|NCT03250832|590167815|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
163397837|NCT03250832|590167816|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
163397838|NCT03250832|590167817|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
163397839|NCT03250832|590167818|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
163313958|NCT04719832|589859536|FG001|Overall Study|Randomized, not treated|2|||
163313959|NCT04719832|589859535|FG000|Overall Study|GCP violations|4|||
163313960|NCT04719832|589859536|FG001|Overall Study|GCP violations|7|||
163313961|NCT05526430|589859539|FG000|Overall Study|Withdrawal by Subject|0|||
163313962|NCT05526430|589859540|FG001|Overall Study|Withdrawal by Subject|2|||
163397840|NCT03250832|590167819|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
163397841|NCT03250832|590167820|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
163397842|NCT03250832|590167809|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
163397843|NCT03250832|590167810|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
163397844|NCT03250832|590167811|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
163397845|NCT03250832|590167812|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
163397846|NCT03250832|590167813|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
163206678|NCT02603419|589468812|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
163206679|NCT02603419|589468813|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
163206680|NCT02603419|589468814|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
163206681|NCT02603419|589468815|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
163206682|NCT02603419|589468810|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
163206683|NCT02603419|589468811|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
163313963|NCT05526430|589859541|FG002|Overall Study|Withdrawal by Subject|0|||
163313964|NCT05526430|589859542|FG003|Overall Study|Withdrawal by Subject|0|||
163313965|NCT03085810|589859543|FG000|Main Study|Withdrawal by Subject|77|||
163313966|NCT03085810|589859544|FG001|Main Study|Withdrawal by Subject|0|||
163313967|NCT03085810|589859545|FG002|Main Study|Withdrawal by Subject|0|||
163313968|NCT03085810|589859543|FG000|Main Study|Terminated By Sponsor|14|||
163397847|NCT03250832|590167814|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
163397848|NCT03250832|590167815|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
163397849|NCT03250832|590167816|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
163397850|NCT03250832|590167817|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
163206684|NCT02603419|589468812|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
163206685|NCT02603419|589468813|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
163206686|NCT02603419|589468814|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
163206687|NCT02603419|589468815|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
163206688|NCT02603419|589468810|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
163206689|NCT02603419|589468811|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
163206690|NCT02603419|589468812|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
163206691|NCT02603419|589468813|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
163206692|NCT02603419|589468814|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
163206693|NCT02603419|589468815|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
163206694|NCT02603419|589468810|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
163313969|NCT03085810|589859544|FG001|Main Study|Terminated By Sponsor|0|||
163313970|NCT03085810|589859545|FG002|Main Study|Terminated By Sponsor|0|||
163313971|NCT03085810|589859543|FG000|Main Study|Protocol Violation|15|||
163313972|NCT03085810|589859544|FG001|Main Study|Protocol Violation|0|||
163313973|NCT03085810|589859545|FG002|Main Study|Protocol Violation|0|||
163313974|NCT03085810|589859543|FG000|Main Study|Physician Decision|13|||
163313975|NCT03085810|589859544|FG001|Main Study|Physician Decision|0|||
163313976|NCT03085810|589859545|FG002|Main Study|Physician Decision|0|||
163313977|NCT03085810|589859543|FG000|Main Study|Lost to Follow-up|17|||
163397851|NCT03250832|590167818|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
163397852|NCT03250832|590167819|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
163397853|NCT03250832|590167820|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
163397854|NCT03250832|590167809|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163313978|NCT03085810|589859544|FG001|Main Study|Lost to Follow-up|0|||
163313979|NCT03085810|589859545|FG002|Main Study|Lost to Follow-up|0|||
163313980|NCT03085810|589859543|FG000|Main Study|Adverse Event|25|||
163313981|NCT03085810|589859544|FG001|Main Study|Adverse Event|0|||
163313982|NCT03085810|589859545|FG002|Main Study|Adverse Event|0|||
163313983|NCT03085810|589859543|FG000|Main Study|Pregnancy|7|||
163313984|NCT03085810|589859544|FG001|Main Study|Pregnancy|0|||
163313985|NCT03085810|589859545|FG002|Main Study|Pregnancy|0|||
163313986|NCT03085810|589859543|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
163313987|NCT03085810|589859544|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
163313988|NCT03085810|589859545|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
163313989|NCT03085810|589859543|FG000|Main Study|Lack of Efficacy|10|||
163397855|NCT03250832|590167810|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163397856|NCT03250832|590167811|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163397857|NCT03250832|590167812|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163397858|NCT03250832|590167813|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163397859|NCT03250832|590167814|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163397860|NCT03250832|590167815|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163397861|NCT03250832|590167816|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163397862|NCT03250832|590167817|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
163397863|NCT03250832|590167818|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
163313990|NCT03085810|589859544|FG001|Main Study|Lack of Efficacy|0|||
163313991|NCT03085810|589859545|FG002|Main Study|Lack of Efficacy|0|||
163313992|NCT03085810|589859543|FG000|Main Study|Death|12|||
163313993|NCT03085810|589859544|FG001|Main Study|Death|0|||
163397864|NCT03250832|590167819|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163397865|NCT03250832|590167820|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163397866|NCT03250832|590167809|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163397867|NCT03250832|590167810|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163397868|NCT03250832|590167811|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163397869|NCT03250832|590167812|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163397870|NCT03250832|590167813|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163397871|NCT03250832|590167814|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163397872|NCT03250832|590167815|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163397873|NCT03250832|590167816|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163397874|NCT03250832|590167817|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
163397875|NCT03250832|590167818|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
163313994|NCT03085810|589859545|FG002|Main Study|Death|0|||
163313995|NCT03085810|589859543|FG000|Main Study|Disease progression|1|||
163313996|NCT03085810|589859544|FG001|Main Study|Disease progression|0|||
163313997|NCT03085810|589859545|FG002|Main Study|Disease progression|0|||
163313998|NCT03085810|589859543|FG000|Main Study|Site Closure|3|||
163313999|NCT03085810|589859544|FG001|Main Study|Site Closure|0|||
163314000|NCT03085810|589859545|FG002|Main Study|Site Closure|0|||
163314001|NCT03085810|589859543|FG000|Main Study|Planned pregnancy|17|||
163397876|NCT03250832|590167819|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163397877|NCT03250832|590167820|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163397878|NCT03250832|590167809|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163397879|NCT03250832|590167810|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163397880|NCT03250832|590167811|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163397881|NCT03250832|590167812|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163397882|NCT03250832|590167813|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163397883|NCT03250832|590167814|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163397884|NCT03250832|590167815|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163397885|NCT03250832|590167816|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163397886|NCT03250832|590167817|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163397887|NCT03250832|590167818|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163397888|NCT03250832|590167819|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163397889|NCT03250832|590167820|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
163397890|NCT01708291|590167821|FG000|Overall Study|fighting|2|||
163397891|NCT01708291|590167822|FG001|Overall Study|fighting|1|||
163397892|NCT04411628|590167824|FG000|Overall Study|Withdrawal by Subject|1|||
163397893|NCT04411628|590167825|FG001|Overall Study|Withdrawal by Subject|1|||
163397894|NCT04411628|590167826|FG002|Overall Study|Withdrawal by Subject|2|||
163397895|NCT04411628|590167827|FG003|Overall Study|Withdrawal by Subject|0|||
163397896|NCT04411628|590167824|FG000|Overall Study|Lost to Follow-up|0|||
163397897|NCT04411628|590167825|FG001|Overall Study|Lost to Follow-up|1|||
163397898|NCT04411628|590167826|FG002|Overall Study|Lost to Follow-up|0|||
163397899|NCT04411628|590167827|FG003|Overall Study|Lost to Follow-up|0|||
163397900|NCT01843972|590167828|FG000|Overall Study|Withdrawal by Subject|0|||
163397901|NCT01843972|590167829|FG001|Overall Study|Withdrawal by Subject|0|||
163397902|NCT01843972|590167830|FG002|Overall Study|Withdrawal by Subject|0|||
163397903|NCT01843972|590167831|FG003|Overall Study|Withdrawal by Subject|0|||
163397904|NCT01843972|590167832|FG004|Overall Study|Withdrawal by Subject|1|||
163397905|NCT01843972|590167833|FG005|Overall Study|Withdrawal by Subject|0|||
163206695|NCT02603419|589468811|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
163206696|NCT02603419|589468812|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
163206697|NCT02603419|589468813|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
163206698|NCT02603419|589468814|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
163206699|NCT02603419|589468815|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
163206700|NCT02603419|589468810|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
163206701|NCT02603419|589468811|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
163206702|NCT02603419|589468812|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
163206703|NCT02603419|589468813|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
163206704|NCT02603419|589468814|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
163206705|NCT02603419|589468815|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
163206706|NCT02603419|589468810|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
163206707|NCT02603419|589468811|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
163206708|NCT02603419|589468812|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
163206709|NCT02603419|589468813|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
163206710|NCT02603419|589468814|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
163206711|NCT02603419|589468815|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
163206712|NCT02603419|589468810|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
163206713|NCT02603419|589468811|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
163206714|NCT02603419|589468812|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
163206715|NCT02603419|589468813|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
163206716|NCT02603419|589468814|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
163206717|NCT02603419|589468815|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
163206718|NCT02603419|589468810|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
163206719|NCT02603419|589468811|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
163206720|NCT02603419|589468812|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
163206721|NCT02603419|589468813|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
163206722|NCT02603419|589468814|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
163206723|NCT02603419|589468815|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
163206724|NCT02603419|589468810|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
163206725|NCT02603419|589468811|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
163206726|NCT02603419|589468812|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
163206727|NCT02603419|589468813|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
163206728|NCT02603419|589468814|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
163206729|NCT02603419|589468815|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
163206730|NCT02603419|589468810|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
163206731|NCT02603419|589468811|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
163206732|NCT02603419|589468812|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
163206733|NCT02603419|589468813|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
163206734|NCT02603419|589468814|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
163206735|NCT02603419|589468815|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
163206736|NCT02925494|589468816|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
163206737|NCT02925494|589468817|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
163206738|NCT02925494|589468818|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
163206739|NCT02925494|589468819|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
163206740|NCT02925494|589468816|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
163206741|NCT02925494|589468817|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
163206742|NCT02925494|589468818|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
163206743|NCT02925494|589468819|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
163206744|NCT02925494|589468816|FG000|Post-Treatment Follow-Up Period|Other|1|||
163206745|NCT02925494|589468817|FG001|Post-Treatment Follow-Up Period|Other|4|||
163206746|NCT02925494|589468818|FG002|Post-Treatment Follow-Up Period|Other|3|||
163206747|NCT02925494|589468819|FG003|Post-Treatment Follow-Up Period|Other|6|||
163206748|NCT02925494|589468816|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
163206749|NCT02925494|589468817|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
163206750|NCT02925494|589468818|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
163206751|NCT02925494|589468819|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
163206752|NCT02925494|589468816|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
163397906|NCT01843972|590167834|FG006|Overall Study|Withdrawal by Subject|0|||
163397907|NCT01843972|590167835|FG007|Overall Study|Withdrawal by Subject|0|||
163397908|NCT01843972|590167836|FG008|Overall Study|Withdrawal by Subject|0|||
163397909|NCT01843972|590167837|FG009|Overall Study|Withdrawal by Subject|0|||
163397910|NCT01817751|590167843|FG000|Overall Study|Physician Decision|1|||
163397911|NCT00545402|590167844|FG000|Overall Study|Discontinuation of treatment|17|||
163397912|NCT00545402|590167845|FG001|Overall Study|Discontinuation of treatment|9|||
163206753|NCT02925494|589468817|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
163206754|NCT02925494|589468818|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
163206755|NCT02925494|589468819|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
163206756|NCT02925494|589468816|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
163206757|NCT02925494|589468817|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
163206758|NCT02925494|589468818|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
163206759|NCT02925494|589468819|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
163206760|NCT02925494|589468816|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
163206761|NCT02925494|589468817|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
163314002|NCT03085810|589859544|FG001|Main Study|Planned pregnancy|0|||
163314003|NCT03085810|589859545|FG002|Main Study|Planned pregnancy|0|||
163314004|NCT03085810|589859543|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
163314005|NCT03085810|589859544|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
163314006|NCT03085810|589859545|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
163314007|NCT03085810|589859543|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
163314008|NCT03085810|589859544|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
163314009|NCT03085810|589859545|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
163314010|NCT03085810|589859543|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
163314011|NCT03085810|589859544|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
163314012|NCT03085810|589859545|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
163314013|NCT03085810|589859543|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
163314014|NCT03085810|589859544|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
163314015|NCT03085810|589859545|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
163314016|NCT02601313|589859546|FG000|Overall Study|Death|2|||
163314017|NCT02601313|589859547|FG001|Overall Study|Death|41|||
163314018|NCT02601313|589859548|FG002|Overall Study|Death|6|||
163314019|NCT02601313|589859546|FG000|Overall Study|Enrolled but never treated|0|||
163314020|NCT02601313|589859547|FG001|Overall Study|Enrolled but never treated|6|||
163314021|NCT02601313|589859548|FG002|Overall Study|Enrolled but never treated|3|||
163314022|NCT02601313|589859546|FG000|Overall Study|Enrolled, did not initiate AC|4|||
163314023|NCT02601313|589859547|FG001|Overall Study|Enrolled, did not initiate AC|0|||
163314024|NCT02601313|589859548|FG002|Overall Study|Enrolled, did not initiate AC|0|||
163314025|NCT02601313|589859546|FG000|Overall Study|Full consent withdrawal|0|||
163314026|NCT02601313|589859547|FG001|Overall Study|Full consent withdrawal|3|||
163314027|NCT02601313|589859548|FG002|Overall Study|Full consent withdrawal|2|||
163314028|NCT02601313|589859546|FG000|Overall Study|Lost to Follow-up|0|||
163314029|NCT02601313|589859547|FG001|Overall Study|Lost to Follow-up|1|||
163314030|NCT02601313|589859548|FG002|Overall Study|Lost to Follow-up|1|||
163314031|NCT05239455|589859549|FG000|Overall Study|Adverse Event|1|||
163314032|NCT05239455|589859549|FG000|Overall Study|Sponsor Decision|5|||
163314033|NCT05239455|589859549|FG000|Overall Study|Incomplete Blood Collection|1|||
163314034|NCT03701763|589859551|FG000|Placebo-controlled Phase|Adverse Event|1|||
163314035|NCT03701763|589859552|FG001|Placebo-controlled Phase|Adverse Event|5|||
163314036|NCT03701763|589859553|FG002|Placebo-controlled Phase|Adverse Event|0|||
163314037|NCT03701763|589859554|FG003|Placebo-controlled Phase|Adverse Event|0|||
163314038|NCT03701763|589859551|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
163314039|NCT03701763|589859552|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
163314040|NCT03701763|589859553|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
163314041|NCT03701763|589859554|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
163314042|NCT03701763|589859551|FG000|Placebo-controlled Phase|Miscellaneous|2|||
163314043|NCT03701763|589859552|FG001|Placebo-controlled Phase|Miscellaneous|0|||
163314044|NCT03701763|589859553|FG002|Placebo-controlled Phase|Miscellaneous|0|||
163314045|NCT03701763|589859554|FG003|Placebo-controlled Phase|Miscellaneous|0|||
163314046|NCT03701763|589859551|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
163314047|NCT03701763|589859552|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
163314048|NCT03701763|589859553|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
163314049|NCT03701763|589859554|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
163314050|NCT03701763|589859551|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
163314051|NCT03701763|589859552|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
163314052|NCT03701763|589859553|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
163314053|NCT03701763|589859554|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
163314054|NCT03701763|589859551|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
163314055|NCT03701763|589859552|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
163314056|NCT03701763|589859553|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
163314057|NCT03701763|589859554|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
163314058|NCT03701763|589859551|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
163314059|NCT03701763|589859552|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
163314060|NCT03701763|589859553|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
163314061|NCT03701763|589859554|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
163314062|NCT03701763|589859551|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
163314063|NCT03701763|589859552|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
163314064|NCT03701763|589859553|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
163314065|NCT03701763|589859554|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
163314066|NCT03701763|589859551|FG000|Apremilast Extension Phase|Adverse Event|0|||
163314067|NCT03701763|589859552|FG001|Apremilast Extension Phase|Adverse Event|0|||
163314068|NCT03701763|589859553|FG002|Apremilast Extension Phase|Adverse Event|3|||
163314069|NCT03701763|589859554|FG003|Apremilast Extension Phase|Adverse Event|1|||
163314070|NCT03701763|589859551|FG000|Apremilast Extension Phase|Miscellaneous|0|||
163314071|NCT03701763|589859552|FG001|Apremilast Extension Phase|Miscellaneous|0|||
163314072|NCT03701763|589859553|FG002|Apremilast Extension Phase|Miscellaneous|2|||
163314073|NCT03701763|589859554|FG003|Apremilast Extension Phase|Miscellaneous|1|||
163314074|NCT03701763|589859551|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
163314075|NCT03701763|589859552|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
163314076|NCT03701763|589859553|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
163314077|NCT03701763|589859554|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
163314078|NCT03701763|589859551|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
163314079|NCT03701763|589859552|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
163314080|NCT03701763|589859553|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
163314081|NCT03701763|589859554|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
163314082|NCT03701763|589859551|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
163314083|NCT03701763|589859552|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
163314084|NCT03701763|589859553|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
163206762|NCT02925494|589468818|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
163206763|NCT02925494|589468819|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
163206764|NCT01666782|589468825|FG000|Overall Study|Received 2 doses of vaccine|0|||
163206765|NCT01666782|589468826|FG001|Overall Study|Received 2 doses of vaccine|1|||
163206766|NCT01666782|589468825|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
163206767|NCT01666782|589468826|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
163206768|NCT02007109|589468829|FG000|Overall Study|Diary not returned or excluded|102|||
163206769|NCT02007109|589468829|FG000|Overall Study|Excluded - Age<7yo|9|||
163314085|NCT03701763|589859554|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
163314086|NCT03701763|589859551|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
163206770|NCT03572062|589468830|FG000|Overall Study|Adverse Event|0|||
163206771|NCT03572062|589468831|FG001|Overall Study|Adverse Event|0|||
163314087|NCT03701763|589859552|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
163314088|NCT03701763|589859553|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
163314089|NCT03701763|589859554|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
163314090|NCT03701763|589859551|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
163314091|NCT03701763|589859552|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
163314092|NCT03701763|589859553|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
163314093|NCT03701763|589859554|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
163314094|NCT03701763|589859551|FG000|14-Week Observational Follow-up Phase|Other|0|||
163314095|NCT03701763|589859552|FG001|14-Week Observational Follow-up Phase|Other|0|||
163314096|NCT03701763|589859553|FG002|14-Week Observational Follow-up Phase|Other|1|||
163314097|NCT03701763|589859554|FG003|14-Week Observational Follow-up Phase|Other|0|||
163314098|NCT03701763|589859551|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
163314099|NCT03701763|589859552|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
163314100|NCT03701763|589859553|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
163314101|NCT03701763|589859554|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
163206772|NCT03572062|589468832|FG002|Overall Study|Adverse Event|0|||
163206773|NCT03572062|589468833|FG003|Overall Study|Adverse Event|0|||
163206774|NCT03572062|589468834|FG004|Overall Study|Adverse Event|0|||
163206775|NCT03572062|589468835|FG005|Overall Study|Adverse Event|0|||
163206776|NCT03572062|589468836|FG006|Overall Study|Adverse Event|0|||
163206777|NCT03572062|589468837|FG007|Overall Study|Adverse Event|0|||
163206778|NCT03572062|589468838|FG008|Overall Study|Adverse Event|1|||
163206779|NCT03572062|589468839|FG009|Overall Study|Adverse Event|3|||
163206780|NCT03572062|589468830|FG000|Overall Study|Death|0|||
163206781|NCT03572062|589468831|FG001|Overall Study|Death|0|||
163206782|NCT03572062|589468832|FG002|Overall Study|Death|0|||
163206783|NCT03572062|589468833|FG003|Overall Study|Death|0|||
163206784|NCT03572062|589468834|FG004|Overall Study|Death|0|||
163206785|NCT03572062|589468835|FG005|Overall Study|Death|1|||
163206786|NCT03572062|589468836|FG006|Overall Study|Death|0|||
163206787|NCT03572062|589468837|FG007|Overall Study|Death|0|||
163206788|NCT03572062|589468838|FG008|Overall Study|Death|0|||
163206789|NCT03572062|589468839|FG009|Overall Study|Death|0|||
163206790|NCT03572062|589468830|FG000|Overall Study|Lost to Follow-up|0|||
163206791|NCT03572062|589468831|FG001|Overall Study|Lost to Follow-up|0|||
163206792|NCT03572062|589468832|FG002|Overall Study|Lost to Follow-up|0|||
163206793|NCT03572062|589468833|FG003|Overall Study|Lost to Follow-up|0|||
163206794|NCT03572062|589468834|FG004|Overall Study|Lost to Follow-up|0|||
163206795|NCT03572062|589468835|FG005|Overall Study|Lost to Follow-up|1|||
163206796|NCT03572062|589468836|FG006|Overall Study|Lost to Follow-up|1|||
163206797|NCT03572062|589468837|FG007|Overall Study|Lost to Follow-up|0|||
163206798|NCT03572062|589468838|FG008|Overall Study|Lost to Follow-up|0|||
163206799|NCT03572062|589468839|FG009|Overall Study|Lost to Follow-up|0|||
163206800|NCT03572062|589468830|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
163206801|NCT03572062|589468831|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
163206802|NCT03572062|589468832|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
163314102|NCT03701763|589859551|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
163314103|NCT03701763|589859552|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
163314104|NCT03701763|589859553|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
163314105|NCT03701763|589859554|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
163314106|NCT05192109|589859557|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
163314107|NCT05192109|589859558|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
163314108|NCT05192109|589859559|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163314109|NCT05192109|589859560|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163314110|NCT05192109|589859557|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
163314111|NCT05192109|589859558|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
163206803|NCT03572062|589468833|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
163206804|NCT03572062|589468834|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
163206805|NCT03572062|589468835|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
163206806|NCT03572062|589468836|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
163314112|NCT05192109|589859559|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163314113|NCT05192109|589859560|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163314114|NCT04489771|589861779|FG000|Overall Study|Death|27|||
163314115|NCT04489771|589861780|FG001|Overall Study|Death|25|||
163314116|NCT04489771|589861779|FG000|Overall Study|Withdrawal by Subject|1|||
163206807|NCT03572062|589468837|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
163206808|NCT03572062|589468838|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
163206809|NCT03572062|589468839|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
163206810|NCT03572062|589468830|FG000|Overall Study|Study Terminated By Sponsor|0|||
163206811|NCT03572062|589468831|FG001|Overall Study|Study Terminated By Sponsor|0|||
163206812|NCT03572062|589468832|FG002|Overall Study|Study Terminated By Sponsor|0|||
163206813|NCT03572062|589468833|FG003|Overall Study|Study Terminated By Sponsor|0|||
163206814|NCT03572062|589468834|FG004|Overall Study|Study Terminated By Sponsor|0|||
163206815|NCT03572062|589468835|FG005|Overall Study|Study Terminated By Sponsor|0|||
163206816|NCT03572062|589468836|FG006|Overall Study|Study Terminated By Sponsor|0|||
163206817|NCT03572062|589468837|FG007|Overall Study|Study Terminated By Sponsor|0|||
163206818|NCT03572062|589468838|FG008|Overall Study|Study Terminated By Sponsor|29|||
163206819|NCT03572062|589468839|FG009|Overall Study|Study Terminated By Sponsor|27|||
163206820|NCT03572062|589468830|FG000|Overall Study|Physician Decision|0|||
163206821|NCT03572062|589468831|FG001|Overall Study|Physician Decision|0|||
163206822|NCT03572062|589468832|FG002|Overall Study|Physician Decision|0|||
163206823|NCT03572062|589468833|FG003|Overall Study|Physician Decision|0|||
163206824|NCT03572062|589468834|FG004|Overall Study|Physician Decision|0|||
163206825|NCT03572062|589468835|FG005|Overall Study|Physician Decision|0|||
163206826|NCT03572062|589468836|FG006|Overall Study|Physician Decision|0|||
163206827|NCT03572062|589468837|FG007|Overall Study|Physician Decision|0|||
163206828|NCT03572062|589468838|FG008|Overall Study|Physician Decision|1|||
163206829|NCT03572062|589468839|FG009|Overall Study|Physician Decision|0|||
163206830|NCT03572062|589468830|FG000|Overall Study|Withdrawal by Subject|0|||
163206831|NCT03572062|589468831|FG001|Overall Study|Withdrawal by Subject|0|||
163206832|NCT03572062|589468832|FG002|Overall Study|Withdrawal by Subject|0|||
163206833|NCT03572062|589468833|FG003|Overall Study|Withdrawal by Subject|0|||
163206834|NCT03572062|589468834|FG004|Overall Study|Withdrawal by Subject|0|||
163206835|NCT03572062|589468835|FG005|Overall Study|Withdrawal by Subject|0|||
163206836|NCT03572062|589468836|FG006|Overall Study|Withdrawal by Subject|0|||
163206837|NCT03572062|589468837|FG007|Overall Study|Withdrawal by Subject|0|||
163206838|NCT03572062|589468838|FG008|Overall Study|Withdrawal by Subject|0|||
163206839|NCT03572062|589468839|FG009|Overall Study|Withdrawal by Subject|1|||
163206840|NCT03572062|589468830|FG000|Overall Study|Randomized But Not Treated|0|||
163206841|NCT03572062|589468831|FG001|Overall Study|Randomized But Not Treated|0|||
163206842|NCT03572062|589468832|FG002|Overall Study|Randomized But Not Treated|0|||
163206843|NCT03572062|589468833|FG003|Overall Study|Randomized But Not Treated|0|||
163206844|NCT03572062|589468834|FG004|Overall Study|Randomized But Not Treated|1|||
163206845|NCT03572062|589468835|FG005|Overall Study|Randomized But Not Treated|2|||
163206846|NCT03572062|589468836|FG006|Overall Study|Randomized But Not Treated|0|||
163206847|NCT03572062|589468837|FG007|Overall Study|Randomized But Not Treated|1|||
163206848|NCT03572062|589468838|FG008|Overall Study|Randomized But Not Treated|0|||
163206849|NCT03572062|589468839|FG009|Overall Study|Randomized But Not Treated|0|||
163206850|NCT01858389|589468840|FG000|Overall Study|Death|1|||
163206851|NCT01858389|589468841|FG001|Overall Study|Death|3|||
163206852|NCT01858389|589468840|FG000|Overall Study|Study terminated by sponsor|0|||
163206853|NCT01858389|589468841|FG001|Overall Study|Study terminated by sponsor|2|||
163206854|NCT01858389|589468840|FG000|Overall Study|Withdrawal by Subject|0|||
163206855|NCT01858389|589468841|FG001|Overall Study|Withdrawal by Subject|1|||
163206856|NCT01858389|589468840|FG000|Overall Study|Progressive disease|10|||
163206857|NCT01858389|589468841|FG001|Overall Study|Progressive disease|11|||
163206858|NCT01858389|589468840|FG000|Overall Study|Other|2|||
163206859|NCT01858389|589468841|FG001|Overall Study|Other|4|||
163206860|NCT01858389|589468840|FG000|Overall Study|Adverse Event|3|||
163206861|NCT01858389|589468841|FG001|Overall Study|Adverse Event|1|||
163206862|NCT01858389|589468840|FG000|Overall Study|Did not receive treatment|0|||
163206863|NCT01858389|589468841|FG001|Overall Study|Did not receive treatment|3|||
163314117|NCT04489771|589861780|FG001|Overall Study|Withdrawal by Subject|0|||
163314118|NCT04489771|589861779|FG000|Overall Study|Participants Ongoing in Study|50|||
163314119|NCT04489771|589861780|FG001|Overall Study|Participants Ongoing in Study|51|||
163314120|NCT06516705|589861788|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
163314121|NCT06516705|589861789|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
163206864|NCT01691781|589468842|FG000|Overall Study|Withdrawal by Subject|4|||
163206865|NCT01691781|589468843|FG001|Overall Study|Withdrawal by Subject|3|||
163206866|NCT01691781|589468842|FG000|Overall Study|Physician Decision|1|||
163206867|NCT01691781|589468843|FG001|Overall Study|Physician Decision|1|||
163206868|NCT01691781|589468842|FG000|Overall Study|Protocol Violation|2|||
163206869|NCT01691781|589468843|FG001|Overall Study|Protocol Violation|2|||
163206870|NCT01691781|589468842|FG000|Overall Study|Adverse Event|0|||
163206871|NCT01691781|589468843|FG001|Overall Study|Adverse Event|1|||
163206872|NCT03978520|589468844|FG000|Overall Study|Adverse Event|2|||
163206873|NCT03978520|589468845|FG001|Overall Study|Adverse Event|5|||
163206874|NCT03978520|589468846|FG002|Overall Study|Adverse Event|3|||
163206875|NCT03978520|589468847|FG003|Overall Study|Adverse Event|5|||
163206876|NCT03978520|589468848|FG004|Overall Study|Adverse Event|6|||
163206877|NCT03978520|589468844|FG000|Overall Study|Withdrawal by Subject|10|||
163314122|NCT06516705|589861788|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
163314123|NCT06516705|589861789|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
163206878|NCT03978520|589468845|FG001|Overall Study|Withdrawal by Subject|4|||
163206879|NCT03978520|589468846|FG002|Overall Study|Withdrawal by Subject|5|||
163206880|NCT03978520|589468847|FG003|Overall Study|Withdrawal by Subject|6|||
163206881|NCT03978520|589468848|FG004|Overall Study|Withdrawal by Subject|5|||
163206882|NCT03978520|589468844|FG000|Overall Study|Lost to Follow-up|2|||
163206883|NCT03978520|589468845|FG001|Overall Study|Lost to Follow-up|2|||
163206884|NCT03978520|589468846|FG002|Overall Study|Lost to Follow-up|2|||
163206885|NCT03978520|589468847|FG003|Overall Study|Lost to Follow-up|0|||
163206886|NCT03978520|589468848|FG004|Overall Study|Lost to Follow-up|1|||
163206887|NCT03978520|589468844|FG000|Overall Study|COVID-19 infection|0|||
163206888|NCT03978520|589468845|FG001|Overall Study|COVID-19 infection|1|||
163206889|NCT03978520|589468846|FG002|Overall Study|COVID-19 infection|0|||
163206890|NCT03978520|589468847|FG003|Overall Study|COVID-19 infection|0|||
163206891|NCT03978520|589468848|FG004|Overall Study|COVID-19 infection|0|||
163206892|NCT03978520|589468844|FG000|Overall Study|Other, not specified|9|||
163206893|NCT03978520|589468845|FG001|Overall Study|Other, not specified|4|||
163206894|NCT03978520|589468846|FG002|Overall Study|Other, not specified|1|||
163206895|NCT03978520|589468847|FG003|Overall Study|Other, not specified|1|||
163206896|NCT03978520|589468848|FG004|Overall Study|Other, not specified|2|||
163206897|NCT03978520|589468844|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
163206898|NCT03978520|589468845|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
163206899|NCT03978520|589468846|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
163206900|NCT03978520|589468847|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
163206901|NCT03978520|589468848|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
163206902|NCT02760069|589468849|FG000|Overall Study|Withdrawal by Subject|0|||
163206903|NCT02760069|589468850|FG001|Overall Study|Withdrawal by Subject|1|||
163206904|NCT02760069|589468851|FG002|Overall Study|Withdrawal by Subject|1|||
163206905|NCT00600483|589468854|FG000|Overall Study|Lost to Follow-up|26|||
163206906|NCT00600483|589468855|FG001|Overall Study|Lost to Follow-up|47|||
163206907|NCT00600483|589468854|FG000|Overall Study|Randomized but not treated|10|||
163206908|NCT00600483|589468855|FG001|Overall Study|Randomized but not treated|0|||
163206909|NCT03031678|589468861|FG000|Overall Study|Study closed prior to completion|1|||
163206910|NCT03694821|589468862|FG000|Overall Study|Study terminated|4|||
163206911|NCT03694821|589468863|FG001|Overall Study|Study terminated|8|||
163054210|NCT02669849|588910191|FG002|Overall Study|Lost to Follow-up|3|||
163054211|NCT02669849|588910189|FG000|Overall Study|Death|1|||
163054212|NCT02669849|588910190|FG001|Overall Study|Death|1|||
163054213|NCT02669849|588910191|FG002|Overall Study|Death|2|||
163054214|NCT02669849|588910189|FG000|Overall Study|Study terminated by sponsor|16|||
163054215|NCT02669849|588910190|FG001|Overall Study|Study terminated by sponsor|1|||
163054216|NCT02669849|588910191|FG002|Overall Study|Study terminated by sponsor|14|||
163054217|NCT02669849|588910189|FG000|Overall Study|Other|0|||
163054218|NCT02669849|588910190|FG001|Overall Study|Other|0|||
163054219|NCT02669849|588910191|FG002|Overall Study|Other|2|||
163054220|NCT00606008|588910192|FG000|Overall Study|Adverse Event|1|||
163054221|NCT00606008|588910192|FG000|Overall Study|Withdrawal by Subject|4|||
163054222|NCT03736967|588910193|FG000|Overall Study|Withdrawal by Subject|26|||
163054223|NCT03736967|588910194|FG001|Overall Study|Withdrawal by Subject|25|||
163054224|NCT03736967|588910195|FG002|Overall Study|Withdrawal by Subject|23|||
163314124|NCT06516705|589861788|FG000|T3 ( 3 Month After Education)|covid-19|1|||
163314125|NCT06516705|589861789|FG001|T3 ( 3 Month After Education)|covid-19|2|||
163314126|NCT06516705|589861788|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
163314127|NCT06516705|589861789|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
163206912|NCT03694821|589468864|FG002|Overall Study|Study terminated|4|||
163206913|NCT05109442|589468869|FG000|Overall Study|Withdrawal by Subject|0|||
163206914|NCT05109442|589468870|FG001|Overall Study|Withdrawal by Subject|0|||
163054225|NCT03736967|588910196|FG003|Overall Study|Withdrawal by Subject|26|||
163054226|NCT03736967|588910193|FG000|Overall Study|Lost to Follow-up|3|||
163054227|NCT03736967|588910194|FG001|Overall Study|Lost to Follow-up|2|||
163314128|NCT06516705|589861788|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
163314129|NCT06516705|589861789|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
163054228|NCT03736967|588910195|FG002|Overall Study|Lost to Follow-up|1|||
163054229|NCT03736967|588910196|FG003|Overall Study|Lost to Follow-up|1|||
163206915|NCT05109442|589468871|FG002|Overall Study|Withdrawal by Subject|1|||
163314130|NCT06516705|589861788|FG000|T4 ( 6 Month After Education)|covid-19|3|||
163206916|NCT05109442|589468872|FG003|Overall Study|Withdrawal by Subject|0|||
163206917|NCT05109442|589468873|FG004|Overall Study|Withdrawal by Subject|0|||
163206918|NCT05109442|589468874|FG005|Overall Study|Withdrawal by Subject|0|||
163206919|NCT05109442|589468869|FG000|Overall Study|Adverse Event|0|||
163206920|NCT05109442|589468870|FG001|Overall Study|Adverse Event|1|||
163206921|NCT05109442|589468871|FG002|Overall Study|Adverse Event|5|||
163206922|NCT05109442|589468872|FG003|Overall Study|Adverse Event|0|||
163206923|NCT05109442|589468873|FG004|Overall Study|Adverse Event|0|||
163206924|NCT05109442|589468874|FG005|Overall Study|Adverse Event|2|||
163206925|NCT05109442|589468869|FG000|Overall Study|Death|0|||
163206926|NCT05109442|589468870|FG001|Overall Study|Death|0|||
163206927|NCT05109442|589468871|FG002|Overall Study|Death|4|||
163206928|NCT05109442|589468872|FG003|Overall Study|Death|0|||
163206929|NCT05109442|589468873|FG004|Overall Study|Death|0|||
163206930|NCT05109442|589468874|FG005|Overall Study|Death|1|||
163206931|NCT05109442|589468869|FG000|Overall Study|Physician Decision|1|||
163206932|NCT05109442|589468870|FG001|Overall Study|Physician Decision|0|||
163206933|NCT05109442|589468871|FG002|Overall Study|Physician Decision|1|||
163206934|NCT05109442|589468872|FG003|Overall Study|Physician Decision|0|||
163206935|NCT05109442|589468873|FG004|Overall Study|Physician Decision|0|||
163206936|NCT05109442|589468874|FG005|Overall Study|Physician Decision|2|||
163206937|NCT05109442|589468869|FG000|Overall Study|Other than listed|0|||
163206938|NCT05109442|589468870|FG001|Overall Study|Other than listed|0|||
163206939|NCT05109442|589468871|FG002|Overall Study|Other than listed|9|||
163206940|NCT05109442|589468872|FG003|Overall Study|Other than listed|2|||
163206941|NCT05109442|589468873|FG004|Overall Study|Other than listed|0|||
163206942|NCT05109442|589468874|FG005|Overall Study|Other than listed|8|||
163206943|NCT05109442|589468869|FG000|Overall Study|Lack of Efficacy|3|||
163206944|NCT05109442|589468870|FG001|Overall Study|Lack of Efficacy|5|||
163206945|NCT05109442|589468871|FG002|Overall Study|Lack of Efficacy|29|||
163206946|NCT05109442|589468872|FG003|Overall Study|Lack of Efficacy|10|||
163206947|NCT05109442|589468873|FG004|Overall Study|Lack of Efficacy|11|||
163206948|NCT05109442|589468874|FG005|Overall Study|Lack of Efficacy|17|||
163206949|NCT03278613|589468880|FG000|Overall Study|Lost to Follow-up|3|||
163206950|NCT03278613|589468881|FG001|Overall Study|Lost to Follow-up|1|||
163206951|NCT01405456|589468882|FG000|Overall Study|Lost to Follow-up|2|||
163206952|NCT01405456|589468883|FG001|Overall Study|Lost to Follow-up|1|||
163206953|NCT01405456|589468882|FG000|Overall Study|Physician Decision|1|||
163206954|NCT01405456|589468883|FG001|Overall Study|Physician Decision|0|||
163206955|NCT05475236|589468885|FG000|Overall Study|Withdrawal by Subject|0|||
163206956|NCT05475236|589468886|FG001|Overall Study|Withdrawal by Subject|1|||
163397913|NCT00545402|590167844|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
163206957|NCT02154490|589470960|FG000|Overall Study|No tissue submitted|23|||
163206958|NCT02154490|589470960|FG000|Overall Study|No biomarker results|167|||
163206959|NCT02154490|589470960|FG000|Overall Study|Not assigned to a sub-study|270|||
163206960|NCT02154490|589470960|FG000|Overall Study|Did not register to a sub-study|749|||
163206961|NCT02692716|589470962|FG000|Overall Study|Lost to Follow-up|2|||
163206962|NCT02692716|589470963|FG001|Overall Study|Lost to Follow-up|5|||
163206963|NCT02692716|589470962|FG000|Overall Study|Withdrawal by Subject|3|||
163206964|NCT02692716|589470963|FG001|Overall Study|Withdrawal by Subject|1|||
163206965|NCT02904512|589470973|FG000|Overall Study|Withdrawal by Subject|1|||
163206966|NCT02904512|589470974|FG001|Overall Study|Withdrawal by Subject|0|||
163206967|NCT02904512|589470973|FG000|Overall Study|Transferred to ICU|1|||
163206968|NCT02904512|589470974|FG001|Overall Study|Transferred to ICU|0|||
163206969|NCT02904512|589470973|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
163397914|NCT00545402|590167845|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
163397915|NCT00545402|590167844|FG000|Overall Study|Death|5|||
163397916|NCT00545402|590167845|FG001|Overall Study|Death|7|||
163397917|NCT00545402|590167844|FG000|Overall Study|Graft loss|2|||
163397918|NCT00545402|590167845|FG001|Overall Study|Graft loss|4|||
163397919|NCT00545402|590167844|FG000|Overall Study|Withdrawal by Subject|0|||
163397920|NCT00545402|590167845|FG001|Overall Study|Withdrawal by Subject|1|||
163397921|NCT00545402|590167844|FG000|Overall Study|Protocol Violation|1|||
163397922|NCT00545402|590167845|FG001|Overall Study|Protocol Violation|0|||
163397923|NCT00545402|590167844|FG000|Overall Study|Reason not specified|1|||
163397924|NCT00545402|590167845|FG001|Overall Study|Reason not specified|1|||
163397925|NCT00382018|590167846|FG000|Overall Study|Progression|0|||
163397926|NCT00382018|590167847|FG001|Overall Study|Progression|136|||
163397927|NCT00382018|590167848|FG002|Overall Study|Progression|51|||
163397928|NCT00382018|590167849|FG003|Overall Study|Progression|43|||
163397929|NCT00382018|590167846|FG000|Overall Study|Death|0|||
163397930|NCT00382018|590167847|FG001|Overall Study|Death|9|||
163397931|NCT00382018|590167848|FG002|Overall Study|Death|7|||
163397932|NCT00382018|590167849|FG003|Overall Study|Death|11|||
163206970|NCT02904512|589470974|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
163206971|NCT01963403|589470981|FG000|Overall Study|Lost to Follow-up|2|||
163206972|NCT01963403|589470982|FG001|Overall Study|Lost to Follow-up|3|||
163206973|NCT01963403|589470981|FG000|Overall Study|Implant removal|0|||
163206974|NCT01963403|589470982|FG001|Overall Study|Implant removal|1|||
163206975|NCT02564042|589470983|FG000|Overall Study|Adverse Event|4|||
163206976|NCT02564042|589470984|FG001|Overall Study|Adverse Event|4|||
163206977|NCT02564042|589470985|FG002|Overall Study|Adverse Event|3|||
163397933|NCT00382018|590167846|FG000|Overall Study|Withdrawal by Subject|0|||
163397934|NCT00382018|590167847|FG001|Overall Study|Withdrawal by Subject|4|||
163397935|NCT00382018|590167848|FG002|Overall Study|Withdrawal by Subject|3|||
163397936|NCT00382018|590167849|FG003|Overall Study|Withdrawal by Subject|4|||
163397937|NCT00382018|590167846|FG000|Overall Study|Other, not protocol specified|0|||
163397938|NCT00382018|590167847|FG001|Overall Study|Other, not protocol specified|16|||
163206978|NCT02564042|589470986|FG003|Overall Study|Adverse Event|0|||
163206979|NCT02564042|589470987|FG004|Overall Study|Adverse Event|0|||
163206980|NCT02564042|589470988|FG005|Overall Study|Adverse Event|1|||
163206981|NCT02564042|589470983|FG000|Overall Study|Lost to Follow-up|1|||
163206982|NCT02564042|589470984|FG001|Overall Study|Lost to Follow-up|1|||
163206983|NCT02564042|589470985|FG002|Overall Study|Lost to Follow-up|1|||
163206984|NCT02564042|589470986|FG003|Overall Study|Lost to Follow-up|0|||
163206985|NCT02564042|589470987|FG004|Overall Study|Lost to Follow-up|1|||
163206986|NCT02564042|589470988|FG005|Overall Study|Lost to Follow-up|1|||
163206987|NCT02564042|589470983|FG000|Overall Study|Physician Decision|1|||
163206988|NCT02564042|589470984|FG001|Overall Study|Physician Decision|0|||
163206989|NCT02564042|589470985|FG002|Overall Study|Physician Decision|0|||
163206990|NCT02564042|589470986|FG003|Overall Study|Physician Decision|1|||
163206991|NCT02564042|589470987|FG004|Overall Study|Physician Decision|0|||
163206992|NCT02564042|589470988|FG005|Overall Study|Physician Decision|0|||
163206993|NCT02564042|589470983|FG000|Overall Study|Withdrawal by Subject|5|||
163206994|NCT02564042|589470984|FG001|Overall Study|Withdrawal by Subject|3|||
163397939|NCT00382018|590167848|FG002|Overall Study|Other, not protocol specified|3|||
163397940|NCT00382018|590167849|FG003|Overall Study|Other, not protocol specified|1|||
163397941|NCT01984164|590167850|FG000|Overall Study|Withdrawal by Subject|4|||
163397942|NCT01984164|590167851|FG001|Overall Study|Withdrawal by Subject|3|||
163397943|NCT01984164|590167850|FG000|Overall Study|Adverse Event|5|||
163397944|NCT01984164|590167851|FG001|Overall Study|Adverse Event|19|||
163397945|NCT01984164|590167850|FG000|Overall Study|Lost to Follow-up|1|||
163397946|NCT01984164|590167851|FG001|Overall Study|Lost to Follow-up|3|||
163397947|NCT00427349|590167854|FG000|Overall Study|Lack of Efficacy|23|||
163397948|NCT00427349|590167854|FG000|Overall Study|Adverse Event|14|||
163397949|NCT00427349|590167854|FG000|Overall Study|Death|1|||
163397950|NCT00427349|590167854|FG000|Overall Study|Withdrawal by Subject|3|||
163397951|NCT00427349|590167854|FG000|Overall Study|Alternative therapy|1|||
163397952|NCT00427349|590167854|FG000|Overall Study|Other|2|||
163397953|NCT00427349|590167854|FG000|Overall Study|Ineligible|1|||
163397954|NCT00427349|590167854|FG000|Overall Study|Never started therapy|1|||
163397955|NCT01428661|590167862|FG000|Double-Masked Phase|Protocol Violation|9|||
163397956|NCT01428661|590167863|FG001|Double-Masked Phase|Protocol Violation|4|||
163206995|NCT02564042|589470985|FG002|Overall Study|Withdrawal by Subject|2|||
163206996|NCT02564042|589470986|FG003|Overall Study|Withdrawal by Subject|2|||
163206997|NCT02564042|589470987|FG004|Overall Study|Withdrawal by Subject|10|||
163206998|NCT02564042|589470988|FG005|Overall Study|Withdrawal by Subject|12|||
163206999|NCT01356966|589470989|FG000|Overall Study|Withdrawal by Subject|1|||
163207000|NCT01356966|589470990|FG001|Overall Study|Withdrawal by Subject|2|||
163207001|NCT01356966|589470989|FG000|Overall Study|Physician Decision|1|||
163207002|NCT01356966|589470990|FG001|Overall Study|Physician Decision|0|||
163207003|NCT02692703|589470993|FG000|Overall Study|Lost to Follow-up|1|||
163207004|NCT02692703|589470993|FG000|Overall Study|Other|1|||
163207005|NCT01979016|589470998|FG000|Overall Study|Withdrawal by Subject|2|||
163397957|NCT01428661|590167864|FG002|Double-Masked Phase|Protocol Violation|0|||
163397958|NCT01428661|590167862|FG000|Double-Masked Phase|Adverse Event|13|||
163397959|NCT01428661|590167863|FG001|Double-Masked Phase|Adverse Event|4|||
163397960|NCT01428661|590167864|FG002|Double-Masked Phase|Adverse Event|0|||
163397961|NCT01428661|590167862|FG000|Double-Masked Phase|Lost to Follow-up|14|||
163397962|NCT01428661|590167863|FG001|Double-Masked Phase|Lost to Follow-up|14|||
163397963|NCT01428661|590167864|FG002|Double-Masked Phase|Lost to Follow-up|0|||
163397964|NCT01428661|590167862|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
163397965|NCT01428661|590167863|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
163397966|NCT01428661|590167864|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
163207006|NCT01979016|589470999|FG001|Overall Study|Withdrawal by Subject|0|||
163207007|NCT01979016|589470998|FG000|Overall Study|Adverse Event|0|||
163207008|NCT01979016|589470999|FG001|Overall Study|Adverse Event|1|||
163207009|NCT00938639|589471000|FG000|Overall Study|Moved away from study area|0|||
163207010|NCT00938639|589471001|FG001|Overall Study|Moved away from study area|1|||
163207011|NCT00938639|589471000|FG000|Overall Study|Lost to Follow-up|1|||
163207012|NCT00938639|589471001|FG001|Overall Study|Lost to Follow-up|2|||
163207013|NCT00938639|589471000|FG000|Overall Study|Family issues|1|||
163207014|NCT00938639|589471001|FG001|Overall Study|Family issues|1|||
163207015|NCT00938639|589471000|FG000|Overall Study|Participant noncompliance|1|||
163207016|NCT00938639|589471001|FG001|Overall Study|Participant noncompliance|0|||
163207017|NCT02706691|589471004|FG000|Overall Study|Adverse Event|1|||
163397967|NCT01428661|590167862|FG000|Double-Masked Phase|Lack of Efficacy|2|||
163397968|NCT01428661|590167863|FG001|Double-Masked Phase|Lack of Efficacy|1|||
163397969|NCT01428661|590167864|FG002|Double-Masked Phase|Lack of Efficacy|0|||
163397970|NCT01428661|590167862|FG000|Double-Masked Phase|*Various|1|||
163397971|NCT01428661|590167863|FG001|Double-Masked Phase|*Various|6|||
163397972|NCT01428661|590167864|FG002|Double-Masked Phase|*Various|0|||
163397973|NCT01428661|590167862|FG000|Open Label Extension|Protocol Violation|0|||
163207018|NCT00171730|589471010|FG000|Overall Study|Adverse Event|3|||
163207019|NCT00171730|589471010|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
163207020|NCT00171730|589471010|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
163207021|NCT00171730|589471010|FG000|Overall Study|Withdrawal by Subject|3|||
163207022|NCT01985867|589471011|FG000|Overall Study|Lost to Follow-up|3|||
163207023|NCT01985867|589471012|FG001|Overall Study|Lost to Follow-up|4|||
163207024|NCT01985867|589471011|FG000|Overall Study|Adverse Event|3|||
163207025|NCT01985867|589471012|FG001|Overall Study|Adverse Event|2|||
163207026|NCT01985867|589471011|FG000|Overall Study|Lack of Efficacy|1|||
163207027|NCT01985867|589471012|FG001|Overall Study|Lack of Efficacy|0|||
163207028|NCT01829191|589471013|FG000|Overall Study|Relocation|0|||
163207029|NCT01829191|589471014|FG001|Overall Study|Relocation|1|||
163207030|NCT01829191|589471013|FG000|Overall Study|Lens discomfort|0|||
163207031|NCT01829191|589471014|FG001|Overall Study|Lens discomfort|3|||
163207032|NCT01829191|589471013|FG000|Overall Study|Lens handling difficulty|1|||
163397974|NCT01428661|590167863|FG001|Open Label Extension|Protocol Violation|0|||
163397975|NCT01428661|590167864|FG002|Open Label Extension|Protocol Violation|9|||
163397976|NCT01428661|590167862|FG000|Open Label Extension|Adverse Event|0|||
163397977|NCT01428661|590167863|FG001|Open Label Extension|Adverse Event|0|||
163397978|NCT01428661|590167864|FG002|Open Label Extension|Adverse Event|15|||
163397979|NCT01428661|590167862|FG000|Open Label Extension|Lost to Follow-up|0|||
163397980|NCT01428661|590167863|FG001|Open Label Extension|Lost to Follow-up|0|||
163397981|NCT01428661|590167864|FG002|Open Label Extension|Lost to Follow-up|38|||
163397982|NCT01428661|590167862|FG000|Open Label Extension|Withdrawal by Subject|0|||
163397983|NCT01428661|590167863|FG001|Open Label Extension|Withdrawal by Subject|0|||
163397984|NCT01428661|590167864|FG002|Open Label Extension|Withdrawal by Subject|49|||
163397985|NCT01428661|590167862|FG000|Open Label Extension|Lack of Efficacy|0|||
163397986|NCT01428661|590167863|FG001|Open Label Extension|Lack of Efficacy|0|||
163397987|NCT01428661|590167864|FG002|Open Label Extension|Lack of Efficacy|24|||
163397988|NCT01428661|590167862|FG000|Open Label Extension|**Various|0|||
163397989|NCT01428661|590167863|FG001|Open Label Extension|**Various|0|||
163397990|NCT01428661|590167864|FG002|Open Label Extension|**Various|185|||
163397991|NCT06156215|590167865|FG000|Overall Study|Withdrawal by Subject|2|||
163397992|NCT06156215|590167866|FG001|Overall Study|Withdrawal by Subject|4|||
163397993|NCT06156215|590167867|FG002|Overall Study|Withdrawal by Subject|4|||
163397994|NCT06156215|590167868|FG003|Overall Study|Withdrawal by Subject|0|||
163397995|NCT06156215|590167869|FG004|Overall Study|Withdrawal by Subject|2|||
163397996|NCT06156215|590167870|FG005|Overall Study|Withdrawal by Subject|2|||
163397997|NCT06156215|590167865|FG000|Overall Study|Left ED without completing study|9|||
163397998|NCT06156215|590167866|FG001|Overall Study|Left ED without completing study|3|||
163397999|NCT06156215|590167867|FG002|Overall Study|Left ED without completing study|9|||
163398000|NCT06156215|590167868|FG003|Overall Study|Left ED without completing study|0|||
163207033|NCT01829191|589471014|FG001|Overall Study|Lens handling difficulty|4|||
163207034|NCT01829191|589471013|FG000|Overall Study|Protocol Violation|4|||
163207035|NCT01829191|589471014|FG001|Overall Study|Protocol Violation|1|||
163207036|NCT01829191|589471013|FG000|Overall Study|Withdrawal by Subject|2|||
163207037|NCT01829191|589471014|FG001|Overall Study|Withdrawal by Subject|3|||
163207038|NCT01829191|589471013|FG000|Overall Study|Lost to Follow-up|0|||
163207039|NCT01829191|589471014|FG001|Overall Study|Lost to Follow-up|1|||
163207040|NCT01829191|589471013|FG000|Overall Study|Subject was fit for ortho - k|0|||
163207041|NCT01829191|589471014|FG001|Overall Study|Subject was fit for ortho - k|1|||
163207042|NCT01276353|589471017|FG000|Double-blind|Adverse Event|2|||
163207043|NCT01276353|589471018|FG001|Double-blind|Adverse Event|0|||
163207044|NCT01276353|589471017|FG000|Double-blind|Withdrawal by Subject|1|||
163207045|NCT01276353|589471018|FG001|Double-blind|Withdrawal by Subject|0|||
163207046|NCT01276353|589471017|FG000|Extension|Adverse Event|2|||
163207047|NCT01276353|589471018|FG001|Extension|Adverse Event|5|||
163207048|NCT01276353|589471017|FG000|Extension|Withdrawal by Subject|1|||
163207049|NCT01276353|589471018|FG001|Extension|Withdrawal by Subject|2|||
163207050|NCT01276353|589471017|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
163398001|NCT06156215|590167869|FG004|Overall Study|Left ED without completing study|8|||
163398002|NCT06156215|590167870|FG005|Overall Study|Left ED without completing study|16|||
163207051|NCT01276353|589471018|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
163207052|NCT01276353|589471017|FG000|Extension|Physician Decision|1|||
163207053|NCT01276353|589471018|FG001|Extension|Physician Decision|0|||
163207054|NCT01276353|589471017|FG000|Extension|Prohibited concomitant medications|0|||
163207055|NCT01276353|589471018|FG001|Extension|Prohibited concomitant medications|1|||
163207056|NCT00553514|589471022|FG000|Overall Study|Protocol deviation|0|||
163207057|NCT00553514|589471023|FG001|Overall Study|Protocol deviation|0|||
163207058|NCT00553514|589471024|FG002|Overall Study|Protocol deviation|0|||
163207059|NCT00553514|589471025|FG003|Overall Study|Protocol deviation|1|||
163207060|NCT00553514|589471026|FG004|Overall Study|Protocol deviation|0|||
163207061|NCT00553514|589471022|FG000|Overall Study|Lack of ovarian response|4|||
163207062|NCT00553514|589471023|FG001|Overall Study|Lack of ovarian response|5|||
163207063|NCT00553514|589471024|FG002|Overall Study|Lack of ovarian response|5|||
163207064|NCT00553514|589471025|FG003|Overall Study|Lack of ovarian response|5|||
163207065|NCT00553514|589471026|FG004|Overall Study|Lack of ovarian response|6|||
163207066|NCT00553514|589471022|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
163207067|NCT00553514|589471023|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
163207068|NCT00553514|589471024|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
163207069|NCT00553514|589471025|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
163207070|NCT00553514|589471026|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
163207071|NCT00553514|589471022|FG000|Overall Study|Risk of multiple pregnancy|0|||
163207072|NCT00553514|589471023|FG001|Overall Study|Risk of multiple pregnancy|2|||
163207073|NCT00553514|589471024|FG002|Overall Study|Risk of multiple pregnancy|0|||
163207074|NCT00553514|589471025|FG003|Overall Study|Risk of multiple pregnancy|1|||
163207075|NCT00553514|589471026|FG004|Overall Study|Risk of multiple pregnancy|0|||
163207076|NCT00553514|589471022|FG000|Overall Study|Other|1|||
163207077|NCT00553514|589471023|FG001|Overall Study|Other|1|||
163207078|NCT00553514|589471024|FG002|Overall Study|Other|0|||
163207079|NCT00553514|589471025|FG003|Overall Study|Other|0|||
163207080|NCT00553514|589471026|FG004|Overall Study|Other|1|||
163207081|NCT01465997|589471027|FG000|Overall Study|Adverse Event|12|||
163207082|NCT01465997|589471028|FG001|Overall Study|Adverse Event|22|||
163207083|NCT01465997|589471027|FG000|Overall Study|Lack of Efficacy|13|||
163207084|NCT01465997|589471028|FG001|Overall Study|Lack of Efficacy|1|||
163207085|NCT01465997|589471027|FG000|Overall Study|Protocol Violation|1|||
163207086|NCT01465997|589471028|FG001|Overall Study|Protocol Violation|4|||
163207087|NCT01465997|589471027|FG000|Overall Study|Lost to Follow-up|6|||
163207088|NCT01465997|589471028|FG001|Overall Study|Lost to Follow-up|9|||
163207089|NCT01465997|589471027|FG000|Overall Study|Withdrawal by Subject|32|||
163207090|NCT01465997|589471028|FG001|Overall Study|Withdrawal by Subject|35|||
163207091|NCT01465997|589471027|FG000|Overall Study|investigator's decision|1|||
163207092|NCT01465997|589471028|FG001|Overall Study|investigator's decision|1|||
163207093|NCT01465997|589471027|FG000|Overall Study|Death|0|||
163207094|NCT01465997|589471028|FG001|Overall Study|Death|1|||
163207095|NCT01465997|589471027|FG000|Overall Study|sponsor's decision|1|||
163207096|NCT01465997|589471028|FG001|Overall Study|sponsor's decision|1|||
163207097|NCT01465997|589471027|FG000|Overall Study|subject withdrew consent|1|||
163207098|NCT01465997|589471028|FG001|Overall Study|subject withdrew consent|0|||
163398003|NCT06156215|590167865|FG000|Overall Study|Physician Decision|1|||
163398004|NCT06156215|590167866|FG001|Overall Study|Physician Decision|0|||
163398005|NCT06156215|590167867|FG002|Overall Study|Physician Decision|0|||
163398006|NCT06156215|590167868|FG003|Overall Study|Physician Decision|0|||
163398007|NCT06156215|590167869|FG004|Overall Study|Physician Decision|0|||
163398008|NCT06156215|590167870|FG005|Overall Study|Physician Decision|0|||
163054230|NCT03736967|588910193|FG000|Overall Study|Physician Decision|1|||
163054231|NCT03736967|588910194|FG001|Overall Study|Physician Decision|0|||
163398009|NCT06156215|590167865|FG000|Overall Study|Became or found ineligible|2|||
163398010|NCT06156215|590167866|FG001|Overall Study|Became or found ineligible|0|||
163398011|NCT06156215|590167867|FG002|Overall Study|Became or found ineligible|2|||
163398012|NCT06156215|590167868|FG003|Overall Study|Became or found ineligible|0|||
163398013|NCT06156215|590167869|FG004|Overall Study|Became or found ineligible|1|||
163054232|NCT03736967|588910195|FG002|Overall Study|Physician Decision|0|||
163054233|NCT03736967|588910196|FG003|Overall Study|Physician Decision|1|||
163398014|NCT06156215|590167870|FG005|Overall Study|Became or found ineligible|2|||
163398015|NCT00736255|590169326|FG000|Overall Study|Adverse Event|1|||
163398016|NCT00736255|590169327|FG001|Overall Study|Adverse Event|0|||
163398017|NCT00736255|590169326|FG000|Overall Study|Physician Decision|1|||
163398018|NCT00736255|590169327|FG001|Overall Study|Physician Decision|0|||
163054234|NCT03736967|588910193|FG000|Overall Study|Adverse Event|0|||
163054235|NCT03736967|588910194|FG001|Overall Study|Adverse Event|1|||
163398019|NCT00736255|590169326|FG000|Overall Study|Non-compliance|1|||
163054236|NCT03736967|588910195|FG002|Overall Study|Adverse Event|0|||
163398020|NCT00736255|590169327|FG001|Overall Study|Non-compliance|1|||
163054237|NCT03736967|588910196|FG003|Overall Study|Adverse Event|1|||
163207099|NCT01465997|589471027|FG000|Overall Study|local lab unblinded site|1|||
163207100|NCT01465997|589471028|FG001|Overall Study|local lab unblinded site|0|||
163207101|NCT01465997|589471027|FG000|Overall Study|withdrew before follow-up|0|||
163207102|NCT01465997|589471028|FG001|Overall Study|withdrew before follow-up|13|||
163398021|NCT00457015|590169333|FG000|Overall Study|Left study site against medical advice|0|||
163398022|NCT00457015|590169334|FG001|Overall Study|Left study site against medical advice|1|||
163398023|NCT03670953|590169335|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
163398024|NCT03670953|590169336|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
163398025|NCT03670953|590169337|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
163398026|NCT03670953|590169338|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
163398027|NCT03670953|590169335|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
163398028|NCT03670953|590169336|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
163398029|NCT03670953|590169337|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
163398030|NCT03670953|590169338|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
163398031|NCT03670953|590169335|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
163398032|NCT03670953|590169336|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
163398033|NCT03670953|590169337|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
163398034|NCT03670953|590169338|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
163398035|NCT03670953|590169335|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
163398036|NCT03670953|590169336|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
163207103|NCT01465997|589471027|FG000|Overall Study|decision by site staff|0|||
163207104|NCT01465997|589471028|FG001|Overall Study|decision by site staff|1|||
163207105|NCT01465997|589471027|FG000|Overall Study|subject left participation SP0993|0|||
163207106|NCT01465997|589471028|FG001|Overall Study|subject left participation SP0993|1|||
163207107|NCT02205814|589471029|FG000|Overall Study|Lost to Follow-up|0|||
163207108|NCT02205814|589471030|FG001|Overall Study|Lost to Follow-up|0|||
163207109|NCT02205814|589471031|FG002|Overall Study|Lost to Follow-up|0|||
163207110|NCT02205814|589471032|FG003|Overall Study|Lost to Follow-up|1|||
163207111|NCT02205814|589471029|FG000|Overall Study|Lack of Efficacy|1|||
163207112|NCT02205814|589471030|FG001|Overall Study|Lack of Efficacy|0|||
163207113|NCT02205814|589471031|FG002|Overall Study|Lack of Efficacy|1|||
163207114|NCT02205814|589471032|FG003|Overall Study|Lack of Efficacy|1|||
163207115|NCT02205814|589471029|FG000|Overall Study|Physician Decision|0|||
163207116|NCT02205814|589471030|FG001|Overall Study|Physician Decision|0|||
163207117|NCT02205814|589471031|FG002|Overall Study|Physician Decision|1|||
163207118|NCT02205814|589471032|FG003|Overall Study|Physician Decision|0|||
163207119|NCT02205814|589471029|FG000|Overall Study|Protocol Violation|1|||
163207120|NCT02205814|589471030|FG001|Overall Study|Protocol Violation|0|||
163207121|NCT02205814|589471031|FG002|Overall Study|Protocol Violation|0|||
163207122|NCT02205814|589471032|FG003|Overall Study|Protocol Violation|1|||
163207123|NCT02205814|589471029|FG000|Overall Study|Withdrawal by Subject|0|||
163398037|NCT03670953|590169337|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
163398038|NCT03670953|590169338|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
163398039|NCT03670953|590169335|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
163398040|NCT03670953|590169336|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
163398041|NCT03670953|590169337|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
163398042|NCT03670953|590169338|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
163398043|NCT03670953|590169335|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
163398044|NCT03670953|590169336|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
163398045|NCT03670953|590169337|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
163398046|NCT03670953|590169338|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
163398047|NCT03670953|590169335|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
163398048|NCT03670953|590169336|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
163398049|NCT03670953|590169337|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
163398050|NCT03670953|590169338|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
163398051|NCT03670953|590169335|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
163398052|NCT03670953|590169336|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
163398053|NCT03670953|590169337|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
163398054|NCT03670953|590169338|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
163398055|NCT03670953|590169335|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
163398056|NCT03670953|590169336|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
163398057|NCT03670953|590169337|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
163398058|NCT03670953|590169338|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
163398059|NCT03670953|590169335|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
163398060|NCT03670953|590169336|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
163398061|NCT03670953|590169337|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
163207124|NCT02205814|589471030|FG001|Overall Study|Withdrawal by Subject|1|||
163207125|NCT02205814|589471031|FG002|Overall Study|Withdrawal by Subject|2|||
163398062|NCT03670953|590169338|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
163398063|NCT03670953|590169335|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
163207126|NCT02205814|589471032|FG003|Overall Study|Withdrawal by Subject|1|||
163207127|NCT02205814|589471029|FG000|Overall Study|not compliant with study procedures|0|||
163207128|NCT02205814|589471030|FG001|Overall Study|not compliant with study procedures|0|||
163207129|NCT02205814|589471031|FG002|Overall Study|not compliant with study procedures|1|||
163207130|NCT02205814|589471032|FG003|Overall Study|not compliant with study procedures|0|||
163207131|NCT01426373|589471033|FG000|Overall Study|Adverse Event|6|||
163314131|NCT06516705|589861789|FG001|T4 ( 6 Month After Education)|covid-19|2|||
163314132|NCT06516705|589861788|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
163314133|NCT06516705|589861789|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
163314134|NCT05579899|589861790|FG000|Overall Study|Lost to Follow-up|3|||
163314135|NCT05579899|589861791|FG001|Overall Study|Lost to Follow-up|1|||
163314136|NCT05579899|589861790|FG000|Overall Study|Adverse Event|0|||
163314137|NCT05579899|589861791|FG001|Overall Study|Adverse Event|3|||
163314138|NCT05579899|589861790|FG000|Overall Study|Pregnancy|0|||
163314139|NCT05579899|589861791|FG001|Overall Study|Pregnancy|1|||
163314140|NCT05579899|589861790|FG000|Overall Study|Withdrawal by Subject|0|||
163314141|NCT05579899|589861791|FG001|Overall Study|Withdrawal by Subject|3|||
163314142|NCT04059484|589861793|FG000|Overall Study|Adverse Event|2|||
163314143|NCT04059484|589861794|FG001|Overall Study|Adverse Event|5|||
163314144|NCT04059484|589861793|FG000|Overall Study|Withdrawal by Subject|5|||
163314145|NCT04059484|589861794|FG001|Overall Study|Withdrawal by Subject|3|||
163314146|NCT04059484|589861793|FG000|Overall Study|Progressive disease|112|||
163314147|NCT04059484|589861794|FG001|Overall Study|Progressive disease|112|||
163314148|NCT04059484|589861793|FG000|Overall Study|Other|8|||
163314149|NCT04059484|589861794|FG001|Overall Study|Other|3|||
163314150|NCT04059484|589861793|FG000|Overall Study|Ongoing|20|||
163314151|NCT04059484|589861794|FG001|Overall Study|Ongoing|20|||
163314152|NCT04292223|589861795|FG000|Overall Study|Adverse Event|1|||
163314153|NCT04292223|589861795|FG000|Overall Study|Lost to Follow-up|1|||
163314154|NCT04292223|589861795|FG000|Overall Study|Noncompliance with study drug|2|||
163314155|NCT04292223|589861795|FG000|Overall Study|Patient moved out of the state|1|||
163314156|NCT00753545|589861796|FG000|Overall Study|Death|98|||
163314157|NCT00753545|589861797|FG001|Overall Study|Death|112|||
163314158|NCT00753545|589861796|FG000|Overall Study|Lost to Follow-up|2|||
163314159|NCT00753545|589861797|FG001|Overall Study|Lost to Follow-up|3|||
163314160|NCT00753545|589861796|FG000|Overall Study|Protocol Violation|1|||
163314161|NCT00753545|589861797|FG001|Overall Study|Protocol Violation|0|||
163314162|NCT00753545|589861796|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
163314163|NCT00753545|589861797|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
163314164|NCT05453773|589861798|FG000|Overall Study|Withdrawal by Subject|3|||
163314165|NCT05453773|589861798|FG000|Overall Study|Lost to Follow-up|3|||
163314166|NCT05453773|589861798|FG000|Overall Study|Difficult Blood Draw|3|||
163314167|NCT02485938|589861801|FG000|Overall Study|Withdrawal of consent|2|||
163314168|NCT02485938|589861802|FG001|Overall Study|Withdrawal of consent|0|||
163314169|NCT03839940|589861803|FG000|Overall Study|Withdrawal by Subject|3|||
163314170|NCT03839940|589861804|FG001|Overall Study|Withdrawal by Subject|0|||
163314171|NCT03839940|589861803|FG000|Overall Study|Protocol Violation|0|||
163314172|NCT03839940|589861804|FG001|Overall Study|Protocol Violation|1|||
163314173|NCT03839940|589861803|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
163314174|NCT03839940|589861804|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
163314175|NCT00470704|589861805|FG000|Overall Study|Withdrawal by Subject|4|||
163314176|NCT00470704|589861806|FG001|Overall Study|Withdrawal by Subject|3|||
163314177|NCT00470704|589861805|FG000|Overall Study|Relapse/Progression|37|||
163314178|NCT00470704|589861806|FG001|Overall Study|Relapse/Progression|42|||
163314179|NCT00470704|589861805|FG000|Overall Study|toxicity|0|||
163314180|NCT00470704|589861806|FG001|Overall Study|toxicity|1|||
163314181|NCT04963270|589861808|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
163314182|NCT04963270|589861809|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
163314183|NCT04963270|589861810|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
163314184|NCT04963270|589861811|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
163314185|NCT04963270|589861808|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
163314186|NCT04963270|589861809|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
163314187|NCT04963270|589861810|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
163314188|NCT04963270|589861811|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
163314189|NCT04963270|589861808|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
163314190|NCT04963270|589861809|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
163314191|NCT04963270|589861810|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
163314192|NCT04963270|589861811|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
163314193|NCT04963270|589861808|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
163314194|NCT04963270|589861809|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
163314195|NCT04963270|589861810|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
163314196|NCT04963270|589861811|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
163314197|NCT04963270|589861808|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
163314198|NCT04963270|589861809|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
163314199|NCT04963270|589861810|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
163314200|NCT04963270|589861811|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
163314201|NCT04963270|589861808|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
163314202|NCT04963270|589861809|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
163314203|NCT04963270|589861810|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
163314204|NCT04963270|589861811|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
163398064|NCT03670953|590169336|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
163398065|NCT03670953|590169337|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
163398066|NCT03670953|590169338|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
163398067|NCT03670953|590169335|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
163398068|NCT03670953|590169336|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
163398069|NCT03670953|590169337|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
163398070|NCT03670953|590169338|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
163398071|NCT03670953|590169335|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
163398072|NCT03670953|590169336|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
163398073|NCT03670953|590169337|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
163398074|NCT03670953|590169338|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
163398075|NCT03670953|590169335|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
163398076|NCT03670953|590169336|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
163398077|NCT03670953|590169337|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
163398078|NCT03670953|590169338|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
163398079|NCT03670953|590169335|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
163398080|NCT03670953|590169336|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
163398081|NCT03670953|590169337|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
163398082|NCT03670953|590169338|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
163398083|NCT03670953|590169335|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
163398084|NCT03670953|590169336|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
163398085|NCT03670953|590169337|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
163398086|NCT03670953|590169338|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
163398087|NCT03670953|590169335|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
163398088|NCT03670953|590169336|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
163398089|NCT03670953|590169337|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
163398090|NCT03670953|590169338|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
163398091|NCT03670953|590169335|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
163398092|NCT03670953|590169336|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
163398093|NCT03670953|590169337|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
163398094|NCT03670953|590169338|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
163398095|NCT04179734|590169339|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
163398096|NCT04179734|590169340|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
163398097|NCT04179734|590169339|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
163398098|NCT04179734|590169340|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
163398099|NCT00937937|590169341|FG000|Overall Study|Adverse Event|6|||
163398100|NCT00937937|590169341|FG000|Overall Study|Withdrawal by Subject|2|||
163398101|NCT00937937|590169341|FG000|Overall Study|Progression/relapse|61|||
163398102|NCT00937937|590169341|FG000|Overall Study|Death|1|||
163398103|NCT00937937|590169341|FG000|Overall Study|Other|2|||
163398104|NCT00054704|590169342|FG000|Overall Study|Lack of Efficacy|2|||
163398105|NCT00054704|590169343|FG001|Overall Study|Lack of Efficacy|3|||
163398106|NCT00054704|590169342|FG000|Overall Study|Adverse Event|3|||
163398107|NCT00054704|590169343|FG001|Overall Study|Adverse Event|1|||
163398108|NCT00054704|590169342|FG000|Overall Study|Lost to Follow-up|0|||
163398109|NCT00054704|590169343|FG001|Overall Study|Lost to Follow-up|1|||
163398110|NCT00362414|590169344|FG000|Overall Study|Death|2|||
163398111|NCT00362414|590169344|FG000|Overall Study|Adverse Event|1|||
163398112|NCT00915772|590169353|FG000|Overall Study|Adverse Event|12|||
163398113|NCT00915772|590169354|FG001|Overall Study|Adverse Event|13|||
163398114|NCT00915772|590169355|FG002|Overall Study|Adverse Event|11|||
163398115|NCT00915772|590169353|FG000|Overall Study|Protocol Violation|4|||
163398116|NCT00915772|590169354|FG001|Overall Study|Protocol Violation|1|||
163398117|NCT00915772|590169355|FG002|Overall Study|Protocol Violation|2|||
163398118|NCT00915772|590169353|FG000|Overall Study|Lost to Follow-up|1|||
162967353|NCT01943435|588581340|FG002|Intervention Period|Withdrawal by Subject|4|||
162967354|NCT01943435|588581338|FG000|2 Month Follow up|Lost to Follow-up|2|||
163398119|NCT00915772|590169354|FG001|Overall Study|Lost to Follow-up|2|||
163398120|NCT00915772|590169355|FG002|Overall Study|Lost to Follow-up|2|||
163398121|NCT00915772|590169353|FG000|Overall Study|Lack of Efficacy|9|||
163398122|NCT00915772|590169354|FG001|Overall Study|Lack of Efficacy|15|||
163398123|NCT00915772|590169355|FG002|Overall Study|Lack of Efficacy|3|||
163398124|NCT00915772|590169353|FG000|Overall Study|Refused to continue trial medication|6|||
163398125|NCT00915772|590169354|FG001|Overall Study|Refused to continue trial medication|8|||
163398126|NCT00915772|590169355|FG002|Overall Study|Refused to continue trial medication|4|||
163398127|NCT00915772|590169353|FG000|Overall Study|Any other reason|4|||
163398128|NCT00915772|590169354|FG001|Overall Study|Any other reason|7|||
163398129|NCT00915772|590169355|FG002|Overall Study|Any other reason|7|||
163398130|NCT01911442|590169362|FG000|Overall Study|Adverse Event|2|||
163398131|NCT01911442|590169363|FG001|Overall Study|Adverse Event|2|||
162967355|NCT01943435|588581339|FG001|2 Month Follow up|Lost to Follow-up|3|||
163054238|NCT03736967|588910193|FG000|Overall Study|Death|0|||
163054239|NCT03736967|588910194|FG001|Overall Study|Death|0|||
163054240|NCT03736967|588910195|FG002|Overall Study|Death|0|||
163054241|NCT03736967|588910196|FG003|Overall Study|Death|1|||
163054242|NCT03736967|588910193|FG000|Overall Study|Randomized but never treated|1|||
163054243|NCT03736967|588910194|FG001|Overall Study|Randomized but never treated|0|||
163054244|NCT03736967|588910195|FG002|Overall Study|Randomized but never treated|0|||
163054245|NCT03736967|588910196|FG003|Overall Study|Randomized but never treated|0|||
163054246|NCT02369653|588910197|FG000|Overall Study|Lost to Follow-up|0|||
163054247|NCT02369653|588910198|FG001|Overall Study|Lost to Follow-up|1|||
163054248|NCT02369653|588910197|FG000|Overall Study|Administrative reason by sponsor|0|||
163054249|NCT02369653|588910198|FG001|Overall Study|Administrative reason by sponsor|1|||
163054250|NCT02369653|588910197|FG000|Overall Study|Death|1|||
163054251|NCT02369653|588910198|FG001|Overall Study|Death|2|||
163314205|NCT04963270|589861808|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
163314206|NCT04963270|589861809|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
163314207|NCT04963270|589861810|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
163314208|NCT04963270|589861811|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
163314209|NCT04963270|589861808|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
163314210|NCT04963270|589861809|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
163314211|NCT04963270|589861810|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
163314212|NCT04963270|589861811|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
163314213|NCT04963270|589861808|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
163314214|NCT04963270|589861809|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
163314215|NCT04963270|589861810|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
163314216|NCT04963270|589861811|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
163314217|NCT04963270|589861808|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
163314218|NCT04963270|589861809|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
163314219|NCT04963270|589861810|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
163314220|NCT04963270|589861811|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
163314221|NCT04963270|589861808|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
163314222|NCT04963270|589861809|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
163314223|NCT04963270|589861810|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
163314224|NCT04963270|589861811|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
163314225|NCT04963270|589861808|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
163314226|NCT04963270|589861809|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
163314227|NCT04963270|589861810|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
163314228|NCT04963270|589861811|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
163314229|NCT04963270|589861808|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
163314230|NCT04963270|589861809|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
163314231|NCT04963270|589861810|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
163314232|NCT04963270|589861811|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
163314233|NCT04963270|589861808|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
163314234|NCT04963270|589861809|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
163314235|NCT04963270|589861810|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
163314236|NCT04963270|589861811|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
163314237|NCT04802967|589861812|FG000|Part B|Withdrawal by Subject|0|||
163314238|NCT04802967|589861813|FG001|Part B|Withdrawal by Subject|0|||
163314239|NCT04802967|589861814|FG002|Part B|Withdrawal by Subject|0|||
163314240|NCT04802967|589861815|FG003|Part B|Withdrawal by Subject|0|||
163314241|NCT04802967|589861816|FG004|Part B|Withdrawal by Subject|0|||
163314242|NCT04802967|589861817|FG005|Part B|Withdrawal by Subject|1|||
163314243|NCT04802967|589861818|FG006|Part B|Withdrawal by Subject|0|||
163314244|NCT04802967|589861819|FG007|Part B|Withdrawal by Subject|0|||
163314245|NCT04802967|589861820|FG008|Part B|Withdrawal by Subject|0|||
163314246|NCT04802967|589861821|FG009|Part B|Withdrawal by Subject|0|||
163314247|NCT03560609|589861826|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
163314248|NCT03560609|589861827|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
163314249|NCT05540665|589861830|FG000|Overall Study|Study terminated by sponsor|6|||
163314250|NCT05540665|589861831|FG001|Overall Study|Study terminated by sponsor|6|||
163314251|NCT05540665|589861832|FG002|Overall Study|Study terminated by sponsor|7|||
163314252|NCT03462030|589861833|FG000|Overall Study|Withdrawal by Subject|1|||
163314253|NCT03462030|589861834|FG001|Overall Study|Withdrawal by Subject|1|||
163314254|NCT03381196|589861835|FG000|Overall Study|Withdrawal by Subject|7|||
163314255|NCT03381196|589861836|FG001|Overall Study|Withdrawal by Subject|7|||
163314256|NCT03381196|589861835|FG000|Overall Study|Other|0|||
163314257|NCT03381196|589861836|FG001|Overall Study|Other|1|||
163314258|NCT03381196|589861835|FG000|Overall Study|Lost to Follow-up|5|||
163314259|NCT03381196|589861836|FG001|Overall Study|Lost to Follow-up|4|||
163314260|NCT03381196|589861835|FG000|Overall Study|Death|0|||
163398132|NCT01911442|590169364|FG002|Overall Study|Adverse Event|4|||
163398133|NCT01911442|590169362|FG000|Overall Study|Lack of Efficacy|1|||
163398134|NCT01911442|590169363|FG001|Overall Study|Lack of Efficacy|1|||
163398135|NCT01911442|590169364|FG002|Overall Study|Lack of Efficacy|1|||
163398136|NCT01911442|590169362|FG000|Overall Study|Lost to Follow-up|2|||
163398137|NCT01911442|590169363|FG001|Overall Study|Lost to Follow-up|0|||
163398138|NCT01911442|590169364|FG002|Overall Study|Lost to Follow-up|1|||
163398139|NCT01911442|590169362|FG000|Overall Study|Withdrawal by Subject|1|||
163398140|NCT01911442|590169363|FG001|Overall Study|Withdrawal by Subject|0|||
163398141|NCT01911442|590169364|FG002|Overall Study|Withdrawal by Subject|6|||
163398142|NCT01911442|590169362|FG000|Overall Study|Mother's Work Schedule|0|||
163398143|NCT01911442|590169363|FG001|Overall Study|Mother's Work Schedule|1|||
163398144|NCT01911442|590169364|FG002|Overall Study|Mother's Work Schedule|0|||
163398145|NCT00971178|590169376|FG000|Overall Study|Lost to Follow-up|2|||
163398146|NCT00971178|590169377|FG001|Overall Study|Lost to Follow-up|2|||
163398147|NCT00971178|590169378|FG002|Overall Study|Lost to Follow-up|2|||
163398148|NCT00714285|590169379|FG000|Overall Study|Lost to Follow-up|0|||
163398149|NCT00714285|590169380|FG001|Overall Study|Lost to Follow-up|2|||
163398150|NCT00714285|590169381|FG002|Overall Study|Lost to Follow-up|0|||
163398151|NCT00714285|590169382|FG003|Overall Study|Lost to Follow-up|1|||
163398152|NCT00714285|590169379|FG000|Overall Study|Migrated/moved from study area|0|||
163398153|NCT00714285|590169380|FG001|Overall Study|Migrated/moved from study area|1|||
163398154|NCT00714285|590169381|FG002|Overall Study|Migrated/moved from study area|0|||
163398155|NCT00714285|590169382|FG003|Overall Study|Migrated/moved from study area|0|||
163398156|NCT01816061|590169384|FG000|Overall Study|Lost to Follow-up|13|||
163398157|NCT01816061|590169385|FG001|Overall Study|Lost to Follow-up|24|||
163398158|NCT00702325|590169398|FG000|Overall Study|Adverse Event|1|||
163398159|NCT00702325|590169399|FG001|Overall Study|Adverse Event|0|||
163398160|NCT00702325|590169398|FG000|Overall Study|Withdrawal by Subject|7|||
163398161|NCT00702325|590169399|FG001|Overall Study|Withdrawal by Subject|7|||
163398162|NCT00702325|590169398|FG000|Overall Study|Lost to Follow-up|3|||
163398163|NCT00702325|590169399|FG001|Overall Study|Lost to Follow-up|4|||
163398164|NCT00702325|590169398|FG000|Overall Study|Incorrect enrollment|5|||
163398165|NCT00702325|590169399|FG001|Overall Study|Incorrect enrollment|7|||
163398166|NCT00702325|590169398|FG000|Overall Study|Developed study discontinuation criteria|18|||
163398167|NCT00702325|590169399|FG001|Overall Study|Developed study discontinuation criteria|28|||
163398168|NCT00702325|590169398|FG000|Overall Study|Severe noncompliance to protocol|3|||
163398169|NCT00702325|590169399|FG001|Overall Study|Severe noncompliance to protocol|3|||
163398170|NCT00702325|590169398|FG000|Overall Study|Termination due to lab results|1|||
163398171|NCT00702325|590169399|FG001|Overall Study|Termination due to lab results|0|||
163398172|NCT00702325|590169398|FG000|Overall Study|Didn't follow study medication dosage|0|||
163398173|NCT00702325|590169399|FG001|Overall Study|Didn't follow study medication dosage|2|||
163398174|NCT00702325|590169398|FG000|Overall Study|Withdrew consent|0|||
163398175|NCT00702325|590169399|FG001|Overall Study|Withdrew consent|1|||
163398176|NCT00702325|590169398|FG000|Overall Study|Incorrectly Discontinued|0|||
163398177|NCT00702325|590169399|FG001|Overall Study|Incorrectly Discontinued|1|||
163398178|NCT01022502|590169402|FG000|Overall Study|Adverse Event|1|||
163398179|NCT01022502|590169402|FG000|Overall Study|employment related reasons|1|||
163398180|NCT01022502|590169402|FG000|Overall Study|Withdrawal by Subject|1|||
163398181|NCT01289821|590169406|FG000|Treatment Period|Withdrawal by Subject|1|||
163398182|NCT01289821|590169406|FG000|Treatment Period|Physician Decision|3|||
163398183|NCT01289821|590169406|FG000|Treatment Period|Adverse Event|4|||
163398184|NCT01289821|590169406|FG000|Treatment Period|Radiological Progression|43|||
163398185|NCT01289821|590169406|FG000|Treatment Period|Clinical Progression|2|||
163398186|NCT01289821|590169406|FG000|Treatment Period|Therapeutic procedure required|1|||
163398187|NCT01289821|590169406|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
163398188|NCT01289821|590169406|FG000|Safety Follow-up Period|Protocol Violation|3|||
163398189|NCT01289821|590169406|FG000|Safety Follow-up Period|Unspecified reason|1|||
163398190|NCT01289821|590169406|FG000|Survival Follow-up Period|Protocol Violation|1|||
163398191|NCT01289821|590169406|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
163398192|NCT01289821|590169406|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
163398193|NCT03086057|590169407|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
163398194|NCT03086057|590169408|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
163398195|NCT03086057|590169409|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
163398196|NCT03086057|590169410|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
163398197|NCT03086057|590169407|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
163398198|NCT03086057|590169408|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
163398199|NCT03086057|590169409|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
163398200|NCT03086057|590169410|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
163398201|NCT03086057|590169407|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
163398202|NCT03086057|590169408|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
163398203|NCT03086057|590169409|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
163398204|NCT03086057|590169410|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
163398205|NCT03086057|590169407|FG000|Stage 1: PrEP Uptake|Death|1|||
163398206|NCT03086057|590169408|FG001|Stage 1: PrEP Uptake|Death|0|||
163207132|NCT01426373|589471033|FG000|Overall Study|Lost to Follow-up|14|||
163207133|NCT01426373|589471033|FG000|Overall Study|Participant Convenience|10|||
163207134|NCT01426373|589471033|FG000|Overall Study|Miscellaneous Reasons|4|||
163207135|NCT00726661|589471036|FG000|Overall Study|Lost to Follow-up|36|||
163207136|NCT00726661|589471037|FG001|Overall Study|Lost to Follow-up|11|||
163314261|NCT03381196|589861836|FG001|Overall Study|Death|1|||
163207137|NCT00726661|589471036|FG000|Overall Study|Withdrawal by Subject|17|||
163207138|NCT00726661|589471037|FG001|Overall Study|Withdrawal by Subject|13|||
163207139|NCT00726661|589471036|FG000|Overall Study|Trial terminated by sponsor|214|||
163207140|NCT00726661|589471037|FG001|Overall Study|Trial terminated by sponsor|187|||
163207141|NCT00726661|589471036|FG000|Overall Study|Death|475|||
163207142|NCT00726661|589471037|FG001|Overall Study|Death|159|||
163207143|NCT00726661|589471036|FG000|Overall Study|Physician Decision|25|||
163207144|NCT00726661|589471037|FG001|Overall Study|Physician Decision|13|||
163207145|NCT00726661|589471036|FG000|Overall Study|Other|47|||
163207146|NCT00726661|589471037|FG001|Overall Study|Other|35|||
163207147|NCT02557646|589471040|FG000|Overall Study|Adverse Event|40|||
163207148|NCT02557646|589471040|FG000|Overall Study|Death|1|||
163207149|NCT02557646|589471040|FG000|Overall Study|Lack of Efficacy|186|||
163207150|NCT02557646|589471040|FG000|Overall Study|Withdrawal by Subject|18|||
163207151|NCT02557646|589471040|FG000|Overall Study|Lost to Follow-up|17|||
163207152|NCT02557646|589471040|FG000|Overall Study|Other|14|||
163207153|NCT00005937|589471046|FG000|Overall Study|Lack of Efficacy|5|||
163207154|NCT00160251|589471047|FG000|Prior to Amendment 2|Adverse Event|2|||
163207155|NCT00160251|589471048|FG001|Prior to Amendment 2|Adverse Event|1|||
163207156|NCT00160251|589471049|FG002|Prior to Amendment 2|Adverse Event|3|||
163207157|NCT00160251|589471050|FG003|Prior to Amendment 2|Adverse Event|1|||
163207158|NCT00160251|589471051|FG004|Prior to Amendment 2|Adverse Event|1|||
163207159|NCT00160251|589471052|FG005|Prior to Amendment 2|Adverse Event|1|||
163314262|NCT03381196|589861835|FG000|Overall Study|Adverse Event|1|||
163314263|NCT03381196|589861836|FG001|Overall Study|Adverse Event|0|||
163314264|NCT03381196|589861835|FG000|Overall Study|Randomized, not treated|3|||
163314265|NCT03381196|589861836|FG001|Overall Study|Randomized, not treated|6|||
163314266|NCT00227344|589861837|FG000|Overall Study|study terminated early|12|||
163314267|NCT00227344|589861838|FG001|Overall Study|study terminated early|5|||
163314268|NCT03371381|589861839|FG000|Overall Study|Death|5|||
163314269|NCT03371381|589861839|FG000|Overall Study|Study terminated by sponsor|3|||
163314270|NCT03371381|589861839|FG000|Overall Study|Other|4|||
163314271|NCT01073566|589861845|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
163314272|NCT01073566|589861846|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
163314273|NCT05780437|589861847|FG000|Overall Study|Withdrawal by Subject|22|||
163314274|NCT05780437|589861848|FG001|Overall Study|Withdrawal by Subject|16|||
163314275|NCT03461276|589861851|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
163314276|NCT03461276|589861852|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
163314277|NCT03461276|589861851|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
163314278|NCT03461276|589861852|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
163314279|NCT03461276|589861851|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
163314280|NCT03461276|589861852|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
163314281|NCT03461276|589861851|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
163314282|NCT03461276|589861852|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
163314283|NCT03461276|589861851|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
163314284|NCT03461276|589861852|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
163207160|NCT00160251|589471053|FG006|Prior to Amendment 2|Adverse Event|1|||
163207161|NCT00160251|589471054|FG007|Prior to Amendment 2|Adverse Event|0|||
163207162|NCT00160251|589471047|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
163207163|NCT00160251|589471048|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
163207164|NCT00160251|589471049|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
163207165|NCT00160251|589471050|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
163207166|NCT00160251|589471051|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
163207167|NCT00160251|589471052|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
163207168|NCT00160251|589471053|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
163207169|NCT00160251|589471054|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
163207170|NCT00160251|589471047|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
163207171|NCT00160251|589471048|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
163207172|NCT00160251|589471049|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
163207173|NCT00160251|589471050|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
163207174|NCT00160251|589471051|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
163207175|NCT00160251|589471052|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
163207176|NCT00160251|589471053|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
163207177|NCT00160251|589471054|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
163207178|NCT00160251|589471047|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
163207179|NCT00160251|589471048|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
163207180|NCT00160251|589471049|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
163207181|NCT00160251|589471050|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
163207182|NCT00160251|589471051|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
163207183|NCT00160251|589471052|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
163207184|NCT00160251|589471053|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
163207185|NCT00160251|589471054|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
163207186|NCT00160251|589471047|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
163207187|NCT00160251|589471048|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
163207188|NCT00160251|589471049|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
163207189|NCT00160251|589471050|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
163207190|NCT00160251|589471051|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
163207191|NCT00160251|589471052|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
163207192|NCT00160251|589471053|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
163207193|NCT00160251|589471054|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
163207194|NCT00160251|589471047|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
163207195|NCT00160251|589471048|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
163207196|NCT00160251|589471049|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
163207197|NCT00160251|589471050|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
163207198|NCT00160251|589471051|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
163207199|NCT00160251|589471052|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
163207200|NCT00160251|589471053|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
163207201|NCT00160251|589471054|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
163207202|NCT00160251|589471047|FG000|Post-amendment 2|Adverse Event|0|||
163314285|NCT03461276|589861851|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
163314286|NCT03461276|589861852|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
163314287|NCT03461276|589861851|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
163314288|NCT03461276|589861852|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
163314289|NCT03461276|589861851|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
163314290|NCT03461276|589861852|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
163314291|NCT03461276|589861851|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
163314292|NCT03461276|589861852|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
163314293|NCT03461276|589861851|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
163314294|NCT03461276|589861852|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
163314295|NCT02043678|589861857|FG000|Overall Study|Never treated|11|||
163314296|NCT02043678|589861858|FG001|Overall Study|Never treated|9|||
163314297|NCT02043678|589861857|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
163398207|NCT03086057|590169409|FG002|Stage 1: PrEP Uptake|Death|0|||
163398208|NCT03086057|590169410|FG003|Stage 1: PrEP Uptake|Death|0|||
163398209|NCT03086057|590169407|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
163398210|NCT03086057|590169408|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
163398211|NCT03086057|590169409|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
163398212|NCT03086057|590169410|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
163398213|NCT03086057|590169407|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
163398214|NCT03086057|590169408|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
163398215|NCT03086057|590169409|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
163398216|NCT03086057|590169410|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
163398217|NCT03086057|590169407|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
163398218|NCT03086057|590169408|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
163398219|NCT03086057|590169409|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
163398220|NCT03086057|590169410|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
163398221|NCT01092143|590169415|FG000|Overall Study|Adverse Event|10|||
163398222|NCT01092143|590169416|FG001|Overall Study|Adverse Event|5|||
163398223|NCT01092143|590169417|FG002|Overall Study|Adverse Event|1|||
163398224|NCT01092143|590169418|FG003|Overall Study|Adverse Event|4|||
163398225|NCT01092143|590169419|FG004|Overall Study|Adverse Event|3|||
163398226|NCT01092143|590169415|FG000|Overall Study|Lost to Follow-up|1|||
163398227|NCT01092143|590169416|FG001|Overall Study|Lost to Follow-up|0|||
163398228|NCT01092143|590169417|FG002|Overall Study|Lost to Follow-up|1|||
163398229|NCT01092143|590169418|FG003|Overall Study|Lost to Follow-up|0|||
163398230|NCT01092143|590169419|FG004|Overall Study|Lost to Follow-up|0|||
163398231|NCT01092143|590169415|FG000|Overall Study|Consent withdrawn|2|||
163398232|NCT01092143|590169416|FG001|Overall Study|Consent withdrawn|1|||
163398233|NCT01092143|590169417|FG002|Overall Study|Consent withdrawn|0|||
163398234|NCT01092143|590169418|FG003|Overall Study|Consent withdrawn|1|||
163398235|NCT01092143|590169419|FG004|Overall Study|Consent withdrawn|3|||
163398236|NCT01092143|590169415|FG000|Overall Study|Not treated|0|||
163398237|NCT01092143|590169416|FG001|Overall Study|Not treated|0|||
163398238|NCT01092143|590169417|FG002|Overall Study|Not treated|1|||
163398239|NCT01092143|590169418|FG003|Overall Study|Not treated|0|||
163398240|NCT01092143|590169419|FG004|Overall Study|Not treated|0|||
163398241|NCT01092143|590169415|FG000|Overall Study|did not reversibility criteria|0|||
163398242|NCT01092143|590169416|FG001|Overall Study|did not reversibility criteria|0|||
163398243|NCT01092143|590169417|FG002|Overall Study|did not reversibility criteria|1|||
163398244|NCT01092143|590169418|FG003|Overall Study|did not reversibility criteria|0|||
163398245|NCT01092143|590169419|FG004|Overall Study|did not reversibility criteria|0|||
163398246|NCT01092143|590169415|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
163398247|NCT01092143|590169416|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
163398248|NCT01092143|590169417|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
163398249|NCT01092143|590169418|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
163398250|NCT01092143|590169419|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
163398251|NCT01092143|590169415|FG000|Overall Study|Ineligible patient|1|||
163398252|NCT01092143|590169416|FG001|Overall Study|Ineligible patient|0|||
163398253|NCT01092143|590169417|FG002|Overall Study|Ineligible patient|0|||
163398254|NCT01092143|590169418|FG003|Overall Study|Ineligible patient|0|||
163398255|NCT01092143|590169419|FG004|Overall Study|Ineligible patient|0|||
163207203|NCT00160251|589471048|FG001|Post-amendment 2|Adverse Event|0|||
163207204|NCT00160251|589471049|FG002|Post-amendment 2|Adverse Event|0|||
163398256|NCT01092143|590169415|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
163398257|NCT01092143|590169416|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
163398258|NCT01092143|590169417|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
163398259|NCT01092143|590169418|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
163398260|NCT01092143|590169419|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
163398261|NCT01092143|590169415|FG000|Overall Study|Patient travel|0|||
163398262|NCT01092143|590169416|FG001|Overall Study|Patient travel|0|||
163398263|NCT01092143|590169417|FG002|Overall Study|Patient travel|0|||
163398264|NCT01092143|590169418|FG003|Overall Study|Patient travel|0|||
163398265|NCT01092143|590169419|FG004|Overall Study|Patient travel|1|||
163398266|NCT01092143|590169415|FG000|Overall Study|Non compliance with study medication|0|||
163398267|NCT01092143|590169416|FG001|Overall Study|Non compliance with study medication|0|||
163398268|NCT01092143|590169417|FG002|Overall Study|Non compliance with study medication|0|||
163207205|NCT00160251|589471050|FG003|Post-amendment 2|Adverse Event|0|||
163398269|NCT01092143|590169418|FG003|Overall Study|Non compliance with study medication|0|||
163207206|NCT00160251|589471051|FG004|Post-amendment 2|Adverse Event|0|||
163207207|NCT00160251|589471052|FG005|Post-amendment 2|Adverse Event|0|||
163207208|NCT00160251|589471053|FG006|Post-amendment 2|Adverse Event|0|||
163207209|NCT00160251|589471054|FG007|Post-amendment 2|Adverse Event|20|||
163207210|NCT00160251|589471047|FG000|Post-amendment 2|Lack of Efficacy|0|||
163207211|NCT00160251|589471048|FG001|Post-amendment 2|Lack of Efficacy|0|||
163207212|NCT00160251|589471049|FG002|Post-amendment 2|Lack of Efficacy|0|||
163207213|NCT00160251|589471050|FG003|Post-amendment 2|Lack of Efficacy|0|||
163207214|NCT00160251|589471051|FG004|Post-amendment 2|Lack of Efficacy|0|||
163207215|NCT00160251|589471052|FG005|Post-amendment 2|Lack of Efficacy|0|||
163207216|NCT00160251|589471053|FG006|Post-amendment 2|Lack of Efficacy|0|||
163207217|NCT00160251|589471054|FG007|Post-amendment 2|Lack of Efficacy|24|||
163207218|NCT00160251|589471047|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
163207219|NCT00160251|589471048|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
163207220|NCT00160251|589471049|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
163207221|NCT00160251|589471050|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
163207222|NCT00160251|589471051|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
163207223|NCT00160251|589471052|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
163207224|NCT00160251|589471053|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
163207225|NCT00160251|589471054|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
163207226|NCT01288469|589471055|FG000|Overall Study|Adverse Event|4|||
163207227|NCT01288469|589471056|FG001|Overall Study|Adverse Event|1|||
163207228|NCT01288469|589471057|FG002|Overall Study|Adverse Event|1|||
163207229|NCT01288469|589471055|FG000|Overall Study|Poor compliance to protocol|0|||
163398270|NCT01092143|590169419|FG004|Overall Study|Non compliance with study medication|1|||
163398271|NCT01092143|590169415|FG000|Overall Study|Randomized by mistake|0|||
163398272|NCT01092143|590169416|FG001|Overall Study|Randomized by mistake|0|||
163207230|NCT01288469|589471056|FG001|Overall Study|Poor compliance to protocol|1|||
163207231|NCT01288469|589471057|FG002|Overall Study|Poor compliance to protocol|0|||
163207232|NCT01288469|589471055|FG000|Overall Study|Participant Moved|1|||
163207233|NCT01288469|589471056|FG001|Overall Study|Participant Moved|0|||
163398273|NCT01092143|590169417|FG002|Overall Study|Randomized by mistake|0|||
163398274|NCT01092143|590169418|FG003|Overall Study|Randomized by mistake|1|||
163398275|NCT01092143|590169419|FG004|Overall Study|Randomized by mistake|0|||
163398276|NCT01092143|590169415|FG000|Overall Study|Pregnancy|0|||
163398277|NCT01092143|590169416|FG001|Overall Study|Pregnancy|0|||
163398278|NCT01092143|590169417|FG002|Overall Study|Pregnancy|0|||
163398279|NCT01092143|590169418|FG003|Overall Study|Pregnancy|1|||
163398280|NCT01092143|590169419|FG004|Overall Study|Pregnancy|0|||
163398281|NCT03098836|590169423|FG000|Overall Study|Adverse Event|1|||
163398282|NCT03098836|590169424|FG001|Overall Study|Adverse Event|3|||
163398283|NCT03098836|590169423|FG000|Overall Study|Lack of Efficacy|30|||
163398284|NCT03098836|590169424|FG001|Overall Study|Lack of Efficacy|15|||
163398285|NCT03098836|590169423|FG000|Overall Study|Physician Decision|2|||
163398286|NCT03098836|590169424|FG001|Overall Study|Physician Decision|1|||
163398287|NCT03098836|590169423|FG000|Overall Study|Withdrawal by Subject|3|||
163398288|NCT03098836|590169424|FG001|Overall Study|Withdrawal by Subject|2|||
163398289|NCT03986866|590169425|FG000|Overall Study|Withdrawal by Subject|0|||
163398290|NCT03986866|590169426|FG001|Overall Study|Withdrawal by Subject|3|||
163398291|NCT03986866|590169425|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
163398292|NCT03986866|590169426|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
163398293|NCT01660451|590169429|FG000|Overall Study|Protocol Violation|0|||
163398294|NCT01660451|590169430|FG001|Overall Study|Protocol Violation|1|||
163398295|NCT01660451|590169431|FG002|Overall Study|Protocol Violation|1|||
163398296|NCT01660451|590169429|FG000|Overall Study|AE not associated with clinical disease progression|13|||
163398297|NCT01660451|590169430|FG001|Overall Study|AE not associated with clinical disease progression|10|||
163054252|NCT02369653|588910197|FG000|Overall Study|Participant withdrew consent|13|||
163207234|NCT01288469|589471057|FG002|Overall Study|Participant Moved|0|||
163207235|NCT01288469|589471055|FG000|Overall Study|Consent withdrawn by subject|1|||
163207236|NCT01288469|589471056|FG001|Overall Study|Consent withdrawn by subject|1|||
163207237|NCT01288469|589471057|FG002|Overall Study|Consent withdrawn by subject|1|||
163398298|NCT01660451|590169431|FG002|Overall Study|AE not associated with clinical disease progression|40|||
163398299|NCT01660451|590169429|FG000|Overall Study|AE associated with clinical disease progression|1|||
163398300|NCT01660451|590169430|FG001|Overall Study|AE associated with clinical disease progression|3|||
163398301|NCT01660451|590169431|FG002|Overall Study|AE associated with clinical disease progression|11|||
163398302|NCT01660451|590169429|FG000|Overall Study|Sponsor Decision|0|||
163054253|NCT02369653|588910198|FG001|Overall Study|Participant withdrew consent|3|||
163398303|NCT01660451|590169430|FG001|Overall Study|Sponsor Decision|0|||
163398304|NCT01660451|590169431|FG002|Overall Study|Sponsor Decision|1|||
163398305|NCT01660451|590169429|FG000|Overall Study|Protocol Deviation|0|||
163207238|NCT01288469|589471055|FG000|Overall Study|Exclusion criteria finally met|1|||
163207239|NCT01288469|589471056|FG001|Overall Study|Exclusion criteria finally met|0|||
163207240|NCT01288469|589471057|FG002|Overall Study|Exclusion criteria finally met|0|||
163398306|NCT01660451|590169430|FG001|Overall Study|Protocol Deviation|0|||
163207241|NCT01574612|589471058|FG000|Overall Study|Adverse Event|3|||
163207242|NCT01574612|589471058|FG000|Overall Study|non compliant with drug|2|||
163207243|NCT01574612|589471058|FG000|Overall Study|Withdrawal by Subject|1|||
163207244|NCT01574612|589471058|FG000|Overall Study|Lost to Follow-up|2|||
163207245|NCT00582166|589471059|FG000|Overall Study|Death|1|||
163207246|NCT00582166|589471059|FG000|Overall Study|Ineligible pathology|1|||
163207247|NCT01606436|589471062|FG000|Overall Study|Withdrawal by Subject|0|||
163207248|NCT01606436|589471063|FG001|Overall Study|Withdrawal by Subject|0|||
163207249|NCT01606436|589471064|FG002|Overall Study|Withdrawal by Subject|1|||
163207250|NCT01606436|589471065|FG003|Overall Study|Withdrawal by Subject|1|||
163207251|NCT01606436|589471066|FG004|Overall Study|Withdrawal by Subject|1|||
163207252|NCT01606436|589471067|FG005|Overall Study|Withdrawal by Subject|0|||
163207253|NCT01606436|589471062|FG000|Overall Study|Adverse Event|0|||
163207254|NCT01606436|589471063|FG001|Overall Study|Adverse Event|0|||
163207255|NCT01606436|589471064|FG002|Overall Study|Adverse Event|1|||
163314298|NCT02043678|589861858|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
163314299|NCT02043678|589861857|FG000|Overall Study|AE without clinical PD|54|||
163314300|NCT02043678|589861858|FG001|Overall Study|AE without clinical PD|36|||
163314301|NCT02043678|589861857|FG000|Overall Study|Lost to Follow-up|1|||
163314302|NCT02043678|589861858|FG001|Overall Study|Lost to Follow-up|1|||
163314303|NCT02043678|589861857|FG000|Overall Study|Other|10|||
163314304|NCT02043678|589861858|FG001|Overall Study|Other|14|||
163314305|NCT02043678|589861857|FG000|Overall Study|Clinical PD|114|||
163314306|NCT02043678|589861858|FG001|Overall Study|Clinical PD|148|||
163314307|NCT02043678|589861857|FG000|Overall Study|Radiological PD|100|||
163314308|NCT02043678|589861858|FG001|Overall Study|Radiological PD|90|||
163314309|NCT02043678|589861857|FG000|Overall Study|Protocol-driven decision point|59|||
163314310|NCT02043678|589861858|FG001|Overall Study|Protocol-driven decision point|58|||
163314311|NCT02043678|589861857|FG000|Overall Study|Withdrawal by Subject|16|||
163314312|NCT02043678|589861858|FG001|Overall Study|Withdrawal by Subject|20|||
163314313|NCT02043678|589861857|FG000|Overall Study|Protocol Violation|1|||
163314314|NCT02043678|589861858|FG001|Overall Study|Protocol Violation|0|||
163314315|NCT02043678|589861857|FG000|Overall Study|Deterioration of general conditions|1|||
163314316|NCT02043678|589861858|FG001|Overall Study|Deterioration of general conditions|1|||
163314317|NCT02043678|589861857|FG000|Overall Study|Logistical difficulties|2|||
163314318|NCT02043678|589861858|FG001|Overall Study|Logistical difficulties|0|||
163314319|NCT02043678|589861857|FG000|Overall Study|Non-compliance with study drug|3|||
163314320|NCT02043678|589861858|FG001|Overall Study|Non-compliance with study drug|1|||
163314321|NCT02043678|589861857|FG000|Overall Study|Physician Decision|4|||
163314322|NCT02043678|589861858|FG001|Overall Study|Physician Decision|3|||
163314323|NCT02043678|589861857|FG000|Overall Study|Subject decision|0|||
163314324|NCT02043678|589861858|FG001|Overall Study|Subject decision|1|||
163314325|NCT02043678|589861857|FG000|Overall Study|Switching to other therapy|3|||
163314326|NCT02043678|589861858|FG001|Overall Study|Switching to other therapy|2|||
163314327|NCT02043678|589861857|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
163314328|NCT02043678|589861858|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
163314329|NCT02043678|589861857|FG000|Overall Study|Missing|1|||
163314330|NCT02043678|589861858|FG001|Overall Study|Missing|0|||
163314331|NCT02043678|589861857|FG000|Overall Study|Adverse Event|0|||
163314332|NCT02043678|589861858|FG001|Overall Study|Adverse Event|1|||
163314333|NCT04307355|589861866|FG000|Overall Study|Non-Compliance|3|||
163314334|NCT04307355|589861867|FG001|Overall Study|Non-Compliance|3|||
163314335|NCT04307355|589861868|FG002|Overall Study|Non-Compliance|0|||
163314336|NCT04065841|589861869|FG000|Overall Study|Adverse Event|4|||
163314337|NCT04065841|589861870|FG001|Overall Study|Adverse Event|2|||
163314338|NCT04065841|589861871|FG002|Overall Study|Adverse Event|10|||
163314339|NCT04065841|589861872|FG003|Overall Study|Adverse Event|1|||
163314340|NCT04065841|589861869|FG000|Overall Study|Lost to Follow-up|1|||
163314341|NCT04065841|589861870|FG001|Overall Study|Lost to Follow-up|2|||
163314342|NCT04065841|589861871|FG002|Overall Study|Lost to Follow-up|2|||
163314343|NCT04065841|589861872|FG003|Overall Study|Lost to Follow-up|2|||
163314344|NCT04065841|589861869|FG000|Overall Study|Physician Decision|1|||
163314345|NCT04065841|589861870|FG001|Overall Study|Physician Decision|0|||
163314346|NCT04065841|589861871|FG002|Overall Study|Physician Decision|0|||
163314347|NCT04065841|589861872|FG003|Overall Study|Physician Decision|0|||
163314348|NCT04065841|589861869|FG000|Overall Study|Protocol Violation|0|||
163314349|NCT04065841|589861870|FG001|Overall Study|Protocol Violation|1|||
163314350|NCT04065841|589861871|FG002|Overall Study|Protocol Violation|0|||
163314351|NCT04065841|589861872|FG003|Overall Study|Protocol Violation|0|||
163314352|NCT04065841|589861869|FG000|Overall Study|Study terminated by Sponsor|22|||
163314353|NCT04065841|589861870|FG001|Overall Study|Study terminated by Sponsor|16|||
163314354|NCT04065841|589861871|FG002|Overall Study|Study terminated by Sponsor|28|||
163314355|NCT04065841|589861872|FG003|Overall Study|Study terminated by Sponsor|17|||
163314356|NCT04065841|589861869|FG000|Overall Study|Withdrawal by Subject|1|||
163314357|NCT04065841|589861870|FG001|Overall Study|Withdrawal by Subject|1|||
163314358|NCT04065841|589861871|FG002|Overall Study|Withdrawal by Subject|2|||
163314359|NCT04065841|589861872|FG003|Overall Study|Withdrawal by Subject|0|||
163314360|NCT01420237|589861876|FG000|Overall Study|Death|13|||
163398307|NCT01660451|590169431|FG002|Overall Study|Protocol Deviation|1|||
163398308|NCT01660451|590169429|FG000|Overall Study|Physician Decision|1|||
163398309|NCT01660451|590169430|FG001|Overall Study|Physician Decision|2|||
163398310|NCT01660451|590169431|FG002|Overall Study|Physician Decision|5|||
163398311|NCT01660451|590169429|FG000|Overall Study|Withdrawal by Subject|1|||
163398312|NCT01660451|590169430|FG001|Overall Study|Withdrawal by Subject|1|||
163398313|NCT01660451|590169431|FG002|Overall Study|Withdrawal by Subject|20|||
163398314|NCT01660451|590169429|FG000|Overall Study|Trial closure.|0|||
163398315|NCT01660451|590169430|FG001|Overall Study|Trial closure.|0|||
163398316|NCT01660451|590169431|FG002|Overall Study|Trial closure.|1|||
163398317|NCT01660451|590169429|FG000|Overall Study|Switching to other therapy|0|||
163398318|NCT01660451|590169430|FG001|Overall Study|Switching to other therapy|1|||
163398319|NCT01660451|590169431|FG002|Overall Study|Switching to other therapy|1|||
163398320|NCT01660451|590169429|FG000|Overall Study|Progressive disease - clinical progression|4|||
163398321|NCT01660451|590169430|FG001|Overall Study|Progressive disease - clinical progression|10|||
163398322|NCT01660451|590169431|FG002|Overall Study|Progressive disease - clinical progression|9|||
163398323|NCT01660451|590169429|FG000|Overall Study|Progressive disease - radiological progression|12|||
163398324|NCT01660451|590169430|FG001|Overall Study|Progressive disease - radiological progression|23|||
163398325|NCT01660451|590169431|FG002|Overall Study|Progressive disease - radiological progression|50|||
163398326|NCT01660451|590169429|FG000|Overall Study|Death|1|||
163398327|NCT01660451|590169430|FG001|Overall Study|Death|0|||
163398328|NCT01660451|590169431|FG002|Overall Study|Death|1|||
163398329|NCT01660451|590169429|FG000|Overall Study|Other|0|||
163398330|NCT01660451|590169430|FG001|Overall Study|Other|0|||
163398331|NCT01660451|590169431|FG002|Overall Study|Other|1|||
163398332|NCT04688775|590169432|FG000|Placebo-controlled Period|Randomized, not treated|1|||
163398333|NCT04688775|590169433|FG001|Placebo-controlled Period|Randomized, not treated|1|||
163398334|NCT04688775|590169434|FG002|Placebo-controlled Period|Randomized, not treated|0|||
163398335|NCT04688775|590169435|FG003|Placebo-controlled Period|Randomized, not treated|0|||
163398336|NCT04688775|590169432|FG000|Placebo-controlled Period|Adverse Event|2|||
163398337|NCT04688775|590169433|FG001|Placebo-controlled Period|Adverse Event|0|||
163398338|NCT04688775|590169434|FG002|Placebo-controlled Period|Adverse Event|0|||
163398339|NCT04688775|590169435|FG003|Placebo-controlled Period|Adverse Event|0|||
163398340|NCT04688775|590169432|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
163398341|NCT04688775|590169433|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
163398342|NCT04688775|590169434|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
163398343|NCT04688775|590169435|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
163398344|NCT04688775|590169432|FG000|Placebo-controlled Period|Protocol Violation|0|||
163398345|NCT04688775|590169433|FG001|Placebo-controlled Period|Protocol Violation|1|||
163398346|NCT04688775|590169434|FG002|Placebo-controlled Period|Protocol Violation|0|||
163398347|NCT04688775|590169435|FG003|Placebo-controlled Period|Protocol Violation|0|||
163398348|NCT04688775|590169432|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
163398349|NCT04688775|590169433|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
163398350|NCT04688775|590169434|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
163398351|NCT04688775|590169435|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
163398352|NCT04688775|590169432|FG000|Placebo-controlled Period|Other reasons|0|||
163398353|NCT04688775|590169433|FG001|Placebo-controlled Period|Other reasons|1|||
163398354|NCT04688775|590169434|FG002|Placebo-controlled Period|Other reasons|0|||
163398355|NCT04688775|590169435|FG003|Placebo-controlled Period|Other reasons|0|||
163398356|NCT04688775|590169432|FG000|Delayed Start Period|Adverse Event|0|||
163398357|NCT04688775|590169433|FG001|Delayed Start Period|Adverse Event|0|||
163398358|NCT04688775|590169434|FG002|Delayed Start Period|Adverse Event|1|||
163398359|NCT04688775|590169435|FG003|Delayed Start Period|Adverse Event|0|||
163398360|NCT04688775|590169432|FG000|Delayed Start Period|Lack of Efficacy|0|||
163398361|NCT04688775|590169433|FG001|Delayed Start Period|Lack of Efficacy|0|||
163398362|NCT04688775|590169434|FG002|Delayed Start Period|Lack of Efficacy|0|||
163398363|NCT04688775|590169435|FG003|Delayed Start Period|Lack of Efficacy|3|||
163398364|NCT04688775|590169432|FG000|Delayed Start Period|Withdrawal by Subject|0|||
163398365|NCT04688775|590169433|FG001|Delayed Start Period|Withdrawal by Subject|0|||
163398366|NCT04688775|590169434|FG002|Delayed Start Period|Withdrawal by Subject|2|||
163398367|NCT04688775|590169435|FG003|Delayed Start Period|Withdrawal by Subject|4|||
163398368|NCT04688775|590169432|FG000|Delayed Start Period|Lost to Follow-up|0|||
163398369|NCT04688775|590169433|FG001|Delayed Start Period|Lost to Follow-up|0|||
163398370|NCT04688775|590169434|FG002|Delayed Start Period|Lost to Follow-up|2|||
163398371|NCT04688775|590169435|FG003|Delayed Start Period|Lost to Follow-up|1|||
163398372|NCT04688775|590169432|FG000|Delayed Start Period|other reasons|0|||
163398373|NCT04688775|590169433|FG001|Delayed Start Period|other reasons|0|||
163398374|NCT04688775|590169434|FG002|Delayed Start Period|other reasons|1|||
163398375|NCT04688775|590169435|FG003|Delayed Start Period|other reasons|0|||
163398376|NCT01536951|590169439|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163398377|NCT01536951|590169440|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163398378|NCT01536951|590169441|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
163398379|NCT01536951|590169442|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163398380|NCT01536951|590169443|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163398381|NCT01536951|590169444|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163398382|NCT01536951|590169445|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163398383|NCT01536951|590169446|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163398384|NCT01536951|590169447|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163398385|NCT01536951|590169439|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
163398386|NCT01536951|590169440|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
163398387|NCT01536951|590169441|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
163398388|NCT01536951|590169442|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
163398389|NCT01536951|590169443|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
163398390|NCT01536951|590169444|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
163398391|NCT01536951|590169445|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
163398392|NCT01536951|590169446|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
163398393|NCT01536951|590169447|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
163398394|NCT00555477|590169450|FG000|Overall Study|Adverse Event|0|||
163398395|NCT00555477|590169451|FG001|Overall Study|Adverse Event|9|||
163398396|NCT00555477|590169450|FG000|Overall Study|Withdrawal by Subject|1|||
163398397|NCT00555477|590169451|FG001|Overall Study|Withdrawal by Subject|2|||
163398398|NCT00555477|590169450|FG000|Overall Study|Physician Decision|1|||
163398399|NCT00555477|590169451|FG001|Overall Study|Physician Decision|2|||
163398400|NCT01977820|590169452|FG000|Overall Study|Sponsor terminated the study|1|||
163398401|NCT01977820|590169453|FG001|Overall Study|Sponsor terminated the study|1|||
163398402|NCT00698997|590169454|FG000|Overall Study|Lost to Follow-up|3|||
163398403|NCT00698997|590169455|FG001|Overall Study|Lost to Follow-up|0|||
163398404|NCT00698997|590169454|FG000|Overall Study|Withdrawal by Subject|7|||
163398405|NCT00698997|590169455|FG001|Overall Study|Withdrawal by Subject|27|||
163398406|NCT00475722|590169456|FG000|Overall Study|Withdrawal by Subject|12|||
163398407|NCT00475722|590169457|FG001|Overall Study|Withdrawal by Subject|12|||
163398408|NCT00475722|590169456|FG000|Overall Study|Protocol Violation|3|||
163398409|NCT00475722|590169457|FG001|Overall Study|Protocol Violation|0|||
163398410|NCT05082376|590169460|FG000|Overall Study|Lost to Follow-up|2|||
163398411|NCT02568475|590169461|FG000|Overall Study|Lost to Follow-up|40|||
163398412|NCT02568475|590169462|FG001|Overall Study|Lost to Follow-up|39|||
163398413|NCT02568475|590169461|FG000|Overall Study|Withdrawal by Subject|2|||
163398414|NCT02568475|590169462|FG001|Overall Study|Withdrawal by Subject|0|||
163398415|NCT02568475|590169461|FG000|Overall Study|Discharged home|4|||
163398416|NCT02568475|590169462|FG001|Overall Study|Discharged home|4|||
163398417|NCT02568475|590169461|FG000|Overall Study|Short-term: Discharge location unknown|4|||
163398418|NCT02568475|590169462|FG001|Overall Study|Short-term: Discharge location unknown|0|||
163398419|NCT02568475|590169461|FG000|Overall Study|Transferred to another facility|1|||
163398420|NCT02568475|590169462|FG001|Overall Study|Transferred to another facility|0|||
163398421|NCT02625233|590169463|FG000|Overall Study|Adverse Event|2|||
163398422|NCT02625233|590169464|FG001|Overall Study|Adverse Event|0|||
163398423|NCT00916279|590169467|FG000|Overall Study|Death|2|||
163398424|NCT00916279|590169467|FG000|Overall Study|Lost to Follow-up|2|||
163398425|NCT00290186|590169468|FG000|Overall Study|Adverse Event|1|||
163207256|NCT01606436|589471065|FG003|Overall Study|Adverse Event|0|||
163207257|NCT01606436|589471066|FG004|Overall Study|Adverse Event|0|||
163207258|NCT01606436|589471067|FG005|Overall Study|Adverse Event|0|||
163207259|NCT01606436|589471062|FG000|Overall Study|Sponsor Decision|0|||
163207260|NCT01606436|589471063|FG001|Overall Study|Sponsor Decision|0|||
163207261|NCT01606436|589471064|FG002|Overall Study|Sponsor Decision|0|||
163207262|NCT01606436|589471065|FG003|Overall Study|Sponsor Decision|1|||
163207263|NCT01606436|589471066|FG004|Overall Study|Sponsor Decision|0|||
163207264|NCT01606436|589471067|FG005|Overall Study|Sponsor Decision|0|||
163207265|NCT02859454|589471068|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
163207266|NCT02452398|589471073|FG000|Overall Study|Adverse Event|1|||
163207267|NCT02452398|589471073|FG000|Overall Study|Lost to Follow-up|28|||
163207268|NCT02452398|589471073|FG000|Overall Study|Physician Decision|2|||
163314361|NCT01420237|589861876|FG000|Overall Study|Withdrawal by Subject|41|||
163314362|NCT01420237|589861876|FG000|Overall Study|Lost to Follow-up|32|||
163314363|NCT01420237|589861876|FG000|Overall Study|Adverse Event|10|||
163314364|NCT01420237|589861876|FG000|Overall Study|Investigative Site Termination|43|||
163314365|NCT01420237|589861876|FG000|Overall Study|Censored because study device not implanted|21|||
163314366|NCT01420237|589861876|FG000|Overall Study|Censored because surgery not performed|2|||
163314367|NCT01420237|589861876|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
163314368|NCT01420237|589861876|FG000|Overall Study|Sponsor terminated study early|127|||
163314369|NCT05269667|589861877|FG000|Overall Study|Study Terminated by Sponsor|4|||
163314370|NCT03768505|589861878|FG000|Overall Study|sponsor decision|76|||
163314371|NCT03768505|589861878|FG000|Overall Study|Death|35|||
163314372|NCT03768505|589861878|FG000|Overall Study|Other -Various|30|||
163314373|NCT03768505|589861878|FG000|Overall Study|Withdrawal by Subject|22|||
163314374|NCT03768505|589861878|FG000|Overall Study|Lost to Follow-up|6|||
163314375|NCT02861300|589861882|FG000|Overall Study|Death|0|||
163314376|NCT02861300|589861883|FG001|Overall Study|Death|0|||
163314377|NCT02861300|589861884|FG002|Overall Study|Death|0|||
163314378|NCT02861300|589861885|FG003|Overall Study|Death|0|||
163314379|NCT02861300|589861886|FG004|Overall Study|Death|0|||
163314380|NCT02861300|589861887|FG005|Overall Study|Death|0|||
163314381|NCT02861300|589861888|FG006|Overall Study|Death|24|||
163314382|NCT02861300|589861882|FG000|Overall Study|Delay in treatment|0|||
163314383|NCT02861300|589861883|FG001|Overall Study|Delay in treatment|0|||
163314384|NCT02861300|589861884|FG002|Overall Study|Delay in treatment|0|||
163314385|NCT02861300|589861885|FG003|Overall Study|Delay in treatment|0|||
163314386|NCT02861300|589861886|FG004|Overall Study|Delay in treatment|0|||
163314387|NCT02861300|589861887|FG005|Overall Study|Delay in treatment|1|||
163314388|NCT02861300|589861888|FG006|Overall Study|Delay in treatment|0|||
163314389|NCT02861300|589861882|FG000|Overall Study|Disease Progression|0|||
163314390|NCT02861300|589861883|FG001|Overall Study|Disease Progression|1|||
163314391|NCT02861300|589861884|FG002|Overall Study|Disease Progression|0|||
163314392|NCT02861300|589861885|FG003|Overall Study|Disease Progression|0|||
163314393|NCT02861300|589861886|FG004|Overall Study|Disease Progression|0|||
163314394|NCT02861300|589861887|FG005|Overall Study|Disease Progression|0|||
163314395|NCT02861300|589861888|FG006|Overall Study|Disease Progression|2|||
163314396|NCT02861300|589861882|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
163314397|NCT02861300|589861883|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
163314398|NCT02861300|589861884|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
163314399|NCT02861300|589861885|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
163314400|NCT02861300|589861886|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
163314401|NCT02861300|589861887|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
163314402|NCT02861300|589861888|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
163314403|NCT02861300|589861882|FG000|Overall Study|Clinical Complications|0|||
163314404|NCT02861300|589861883|FG001|Overall Study|Clinical Complications|0|||
163314405|NCT02861300|589861884|FG002|Overall Study|Clinical Complications|0|||
163314406|NCT02861300|589861885|FG003|Overall Study|Clinical Complications|0|||
163314407|NCT02861300|589861886|FG004|Overall Study|Clinical Complications|0|||
163314408|NCT02861300|589861887|FG005|Overall Study|Clinical Complications|0|||
163314409|NCT02861300|589861888|FG006|Overall Study|Clinical Complications|1|||
163314410|NCT03133546|589861894|FG000|Overall Study|Death|46|||
163314411|NCT03133546|589861895|FG001|Overall Study|Death|43|||
163314412|NCT03133546|589861894|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
163314413|NCT03133546|589861895|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
163207269|NCT02452398|589471073|FG000|Overall Study|Withdrawal by Subject|6|||
163207270|NCT02452398|589471073|FG000|Overall Study|Moved away|4|||
163207271|NCT00748033|589471074|FG000|Overall Study|Adverse Event|0|||
163314414|NCT02993159|589861896|FG000|Overall Study|Withdrawal by Subject|1|||
163314415|NCT02993159|589861897|FG001|Overall Study|Withdrawal by Subject|3|||
163314416|NCT02993159|589861896|FG000|Overall Study|Protocol Violation|1|||
163314417|NCT02993159|589861897|FG001|Overall Study|Protocol Violation|0|||
163314418|NCT02993159|589861896|FG000|Overall Study|Opted out of surgery|2|||
163314419|NCT02993159|589861897|FG001|Overall Study|Opted out of surgery|0|||
163314420|NCT02993159|589861896|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
163398426|NCT00290186|590169469|FG001|Overall Study|Adverse Event|1|||
163207272|NCT00748033|589471075|FG001|Overall Study|Adverse Event|1|||
163398427|NCT00290186|590169468|FG000|Overall Study|Lost to Follow-up|3|||
163398428|NCT00290186|590169469|FG001|Overall Study|Lost to Follow-up|2|||
163398429|NCT00290186|590169468|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
163398430|NCT00290186|590169469|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
163398431|NCT00290186|590169468|FG000|Overall Study|Withdrawal by Subject|0|||
163398432|NCT00290186|590169469|FG001|Overall Study|Withdrawal by Subject|1|||
163398433|NCT02592018|590169470|FG000|Overall Study|Adverse Event|1|||
163398434|NCT02592018|590169470|FG000|Overall Study|Lost to Follow-up|1|||
163398435|NCT00798135|590169473|FG000|Overall Study|Disease progression, relapse|11|||
163398436|NCT00798135|590169473|FG000|Overall Study|Disease progression, refractory|1|||
163398437|NCT00798135|590169473|FG000|Overall Study|Physician Decision|1|||
163398438|NCT02228720|590169474|FG000|Open Label - Day 30|Lost to Follow-up|1|||
163398439|NCT01401842|590169475|FG000|Overall Study|Withdrawal by Subject|3|||
163398440|NCT01401842|590169476|FG001|Overall Study|Withdrawal by Subject|2|||
163398441|NCT01401842|590169475|FG000|Overall Study|academic reason|4|||
163398442|NCT01401842|590169476|FG001|Overall Study|academic reason|1|||
163398443|NCT01401842|590169475|FG000|Overall Study|changed companies|20|||
163398444|NCT01401842|590169476|FG001|Overall Study|changed companies|34|||
163398445|NCT01401842|590169475|FG000|Overall Study|discharged from US Army|3|||
163398446|NCT01401842|590169476|FG001|Overall Study|discharged from US Army|4|||
163398447|NCT01401842|590169475|FG000|Overall Study|invalid follow-up strength data|1|||
163398448|NCT01401842|590169476|FG001|Overall Study|invalid follow-up strength data|4|||
163314421|NCT02993159|589861897|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
163314422|NCT02993159|589861896|FG000|Overall Study|Physician Decision|0|||
163314423|NCT02993159|589861897|FG001|Overall Study|Physician Decision|1|||
163314424|NCT05034328|589861898|FG000|Overall Study|Protocol Violation|1|||
163314425|NCT05034328|589861899|FG001|Overall Study|Protocol Violation|0|||
163314426|NCT05034328|589861898|FG000|Overall Study|Lost to Follow-up|0|||
163314427|NCT05034328|589861899|FG001|Overall Study|Lost to Follow-up|10|||
163314428|NCT04992520|589861900|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
163314429|NCT04992520|589861901|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
163314430|NCT04992520|589861902|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
163314431|NCT04992520|589861903|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
163314432|NCT04992520|589861904|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
163314433|NCT04992520|589861905|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
163314434|NCT04992520|589861900|FG000|Part A: First Challenge|Non-compliance|0|||
163314435|NCT04992520|589861901|FG001|Part A: First Challenge|Non-compliance|0|||
163314436|NCT04992520|589861902|FG002|Part A: First Challenge|Non-compliance|0|||
163314437|NCT04992520|589861903|FG003|Part A: First Challenge|Non-compliance|1|||
163314438|NCT04992520|589861904|FG004|Part A: First Challenge|Non-compliance|0|||
163314439|NCT04992520|589861905|FG005|Part A: First Challenge|Non-compliance|0|||
163398449|NCT01401842|590169475|FG000|Overall Study|on profile|9|||
163398450|NCT01401842|590169476|FG001|Overall Study|on profile|5|||
162967356|NCT01943435|588581340|FG002|2 Month Follow up|Lost to Follow-up|0|||
162967357|NCT01943435|588581338|FG000|6 Month Follow up|Lost to Follow-up|12|||
162967358|NCT01943435|588581339|FG001|6 Month Follow up|Lost to Follow-up|7|||
162967359|NCT01943435|588581340|FG002|6 Month Follow up|Lost to Follow-up|15|||
162967360|NCT04535986|588581343|FG000|Overall Study|Death|4|||
162967361|NCT04535986|588581344|FG001|Overall Study|Death|5|||
162967362|NCT04535986|588581343|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
162967363|NCT04535986|588581344|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
162967364|NCT04535986|588581343|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
162967365|NCT04535986|588581344|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
162967366|NCT04535986|588581343|FG000|Overall Study|Adverse Event|10|||
162967367|NCT04535986|588581344|FG001|Overall Study|Adverse Event|1|||
162967368|NCT04535986|588581343|FG000|Overall Study|Lack of Efficacy|3|||
162967369|NCT04535986|588581344|FG001|Overall Study|Lack of Efficacy|2|||
162967370|NCT04535986|588581343|FG000|Overall Study|Investigator discretion|3|||
162967371|NCT04535986|588581344|FG001|Overall Study|Investigator discretion|0|||
162967372|NCT04535986|588581343|FG000|Overall Study|Withdrawal by Subject|32|||
162967373|NCT04535986|588581344|FG001|Overall Study|Withdrawal by Subject|14|||
162967374|NCT04535986|588581343|FG000|Overall Study|Lost to Follow-up|5|||
162967375|NCT04535986|588581344|FG001|Overall Study|Lost to Follow-up|3|||
162967376|NCT04535986|588581343|FG000|Overall Study|Other|7|||
162967377|NCT04535986|588581344|FG001|Overall Study|Other|3|||
163054254|NCT01587885|588910199|FG000|Treatment Period 1|Failure to Return|0|||
163054255|NCT01587885|588910200|FG001|Treatment Period 1|Failure to Return|1|||
163398451|NCT01401842|590169475|FG000|Overall Study|other/unknown|28|||
162967378|NCT01632306|588581345|FG000|Overall Study|Protocol Violation|1|||
162967379|NCT01632306|588581346|FG001|Overall Study|Protocol Violation|0|||
162967380|NCT01632306|588581347|FG002|Overall Study|Protocol Violation|0|||
162967381|NCT00467597|588581348|FG000|Overall Study|Withdrawal by Subject|2|||
162967382|NCT00467597|588581349|FG001|Overall Study|Withdrawal by Subject|0|||
162967383|NCT03141151|588581354|FG000|Overall Study|Lost to Follow-up|3|||
162967384|NCT03141151|588581355|FG001|Overall Study|Lost to Follow-up|2|||
163398452|NCT01401842|590169476|FG001|Overall Study|other/unknown|17|||
163314440|NCT04992520|589861900|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
163314441|NCT04992520|589861901|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
163314442|NCT04992520|589861902|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
163314443|NCT04992520|589861903|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
163314444|NCT04992520|589861904|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
163314445|NCT04992520|589861905|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
163314446|NCT04992520|589861900|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
163314447|NCT04992520|589861901|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
163398453|NCT00282295|590169477|FG000|Overall Study|Adverse Event|0|||
163398454|NCT00282295|590169478|FG001|Overall Study|Adverse Event|1|||
162967385|NCT03141151|588581354|FG000|Overall Study|Withdrawal by Subject|3|||
162967386|NCT03141151|588581355|FG001|Overall Study|Withdrawal by Subject|2|||
162967387|NCT04561115|588581362|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
162967388|NCT04561115|588581363|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
162967389|NCT04561115|588581362|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
162967390|NCT04561115|588581363|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
162979004|NCT03545191|588623548|FG002|Overall Study|Withdrawal by Subject|12|||
163207273|NCT03334448|589471076|FG000|Washout|Personal Reason|0|||
163207274|NCT03334448|589471077|FG001|Washout|Personal Reason|1|||
163207275|NCT03334448|589471078|FG002|Washout|Personal Reason|0|||
163207276|NCT03334448|589471079|FG003|Washout|Personal Reason|0|||
163207277|NCT03334448|589471076|FG000|Washout|Protocol Violation|0|||
163207278|NCT03334448|589471077|FG001|Washout|Protocol Violation|0|||
163207279|NCT03334448|589471078|FG002|Washout|Protocol Violation|0|||
163207280|NCT03334448|589471079|FG003|Washout|Protocol Violation|1|||
163207281|NCT02326025|589471080|FG000|Overall Study|Adverse Event|3|||
163207282|NCT02326025|589471081|FG001|Overall Study|Adverse Event|0|||
163207283|NCT02326025|589471080|FG000|Overall Study|Physician Decision|1|||
163207284|NCT02326025|589471081|FG001|Overall Study|Physician Decision|2|||
163207285|NCT02326025|589471080|FG000|Overall Study|Physician and Participant Decision|1|||
163207286|NCT02326025|589471081|FG001|Overall Study|Physician and Participant Decision|0|||
163207287|NCT02326025|589471080|FG000|Overall Study|Withdrawal by Subject|0|||
163207288|NCT02326025|589471081|FG001|Overall Study|Withdrawal by Subject|2|||
163207289|NCT02326025|589471080|FG000|Overall Study|Protocol Violation|0|||
163207290|NCT02326025|589471081|FG001|Overall Study|Protocol Violation|1|||
163207291|NCT01365910|589471082|FG000|Overall Study|Withdrawal by Subject|7|||
163207292|NCT01365910|589471082|FG000|Overall Study|disease progression|18|||
163207293|NCT01365910|589471082|FG000|Overall Study|Adverse Event|3|||
163207294|NCT01365910|589471082|FG000|Overall Study|other complicating disease|1|||
163207295|NCT01365910|589471082|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
163207296|NCT02013791|589471083|FG000|Period 1|Lost to Follow-up|0|||
163207297|NCT02013791|589471084|FG001|Period 1|Lost to Follow-up|0|||
163207298|NCT02013791|589471085|FG002|Period 1|Lost to Follow-up|0|||
163207299|NCT02013791|589471086|FG003|Period 1|Lost to Follow-up|1|||
163207300|NCT02013791|589471087|FG004|Period 1|Lost to Follow-up|0|||
163207301|NCT02013791|589471088|FG005|Period 1|Lost to Follow-up|0|||
163207302|NCT02013791|589471089|FG006|Period 1|Lost to Follow-up|1|||
163207303|NCT02013791|589471090|FG007|Period 1|Lost to Follow-up|1|||
163207304|NCT02013791|589471091|FG008|Period 1|Lost to Follow-up|0|||
163207305|NCT02013791|589471083|FG000|Period 1|Other Miscellaneous Reasons|0|||
163207306|NCT02013791|589471084|FG001|Period 1|Other Miscellaneous Reasons|2|||
163207307|NCT02013791|589471085|FG002|Period 1|Other Miscellaneous Reasons|0|||
163207308|NCT02013791|589471086|FG003|Period 1|Other Miscellaneous Reasons|0|||
163207309|NCT02013791|589471087|FG004|Period 1|Other Miscellaneous Reasons|0|||
163207310|NCT02013791|589471088|FG005|Period 1|Other Miscellaneous Reasons|0|||
163207311|NCT02013791|589471089|FG006|Period 1|Other Miscellaneous Reasons|0|||
163207312|NCT02013791|589471090|FG007|Period 1|Other Miscellaneous Reasons|0|||
163207313|NCT02013791|589471091|FG008|Period 1|Other Miscellaneous Reasons|0|||
163207314|NCT03798483|589471092|FG000|Overall Study|Lost to Follow-up|2|||
163207315|NCT02643082|589471093|FG000|Period 1|Adverse Event|1|||
163207316|NCT02643082|589471094|FG001|Period 1|Adverse Event|0|||
163207317|NCT02289417|589471095|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
163207318|NCT02289417|589471096|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
163207319|NCT02289417|589471097|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
163207320|NCT02289417|589471098|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
163207321|NCT02289417|589471099|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
163207322|NCT02289417|589471100|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
163207323|NCT02289417|589471101|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
163207324|NCT02289417|589471102|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
163207325|NCT02289417|589471103|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
163207326|NCT02289417|589471095|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
163207327|NCT02289417|589471096|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
163207328|NCT02289417|589471097|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
163398455|NCT00282295|590169479|FG002|Overall Study|Adverse Event|0|||
163398456|NCT00282295|590169477|FG000|Overall Study|Serious Adverse Events|0|||
163398457|NCT00282295|590169478|FG001|Overall Study|Serious Adverse Events|0|||
163398458|NCT00282295|590169479|FG002|Overall Study|Serious Adverse Events|1|||
163398459|NCT00282295|590169477|FG000|Overall Study|Protocol Violation|0|||
163398460|NCT00282295|590169478|FG001|Overall Study|Protocol Violation|2|||
163398461|NCT00282295|590169479|FG002|Overall Study|Protocol Violation|1|||
163398462|NCT00282295|590169477|FG000|Overall Study|Withdrawal by Subject|2|||
163398463|NCT00282295|590169478|FG001|Overall Study|Withdrawal by Subject|6|||
163398464|NCT00282295|590169479|FG002|Overall Study|Withdrawal by Subject|4|||
163398465|NCT00282295|590169477|FG000|Overall Study|Lost to Follow-up|1|||
163398466|NCT00282295|590169478|FG001|Overall Study|Lost to Follow-up|7|||
163398467|NCT00282295|590169479|FG002|Overall Study|Lost to Follow-up|2|||
163398468|NCT00282295|590169477|FG000|Overall Study|Other|0|||
163398469|NCT00282295|590169478|FG001|Overall Study|Other|1|||
163398470|NCT00282295|590169479|FG002|Overall Study|Other|0|||
163398471|NCT03337542|590169480|FG000|Overall Study|Withdrew Consent|17|||
163398472|NCT03337542|590169480|FG000|Overall Study|Allergic Adverse Event|1|||
163398473|NCT03337542|590169480|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
163398474|NCT03337542|590169480|FG000|Overall Study|Lost to Follow-up|1|||
163398475|NCT03337542|590169480|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
163398476|NCT03828292|590169485|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
163398477|NCT03828292|590169486|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
163398478|NCT03828292|590169487|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
163398479|NCT03828292|590169488|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
163398480|NCT03828292|590169489|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
163398481|NCT03828292|590169490|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
163398482|NCT03828292|590169485|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
163398483|NCT03828292|590169486|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
163398484|NCT03828292|590169487|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
163398485|NCT03828292|590169488|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
163398486|NCT03828292|590169489|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
163398487|NCT03828292|590169490|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
163398488|NCT03828292|590169485|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
163398489|NCT03828292|590169486|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
163398490|NCT03828292|590169487|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
163398491|NCT03828292|590169488|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
163398492|NCT03828292|590169489|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
163398493|NCT03828292|590169490|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
163398494|NCT03828292|590169485|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
163398495|NCT03828292|590169486|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
163398496|NCT03828292|590169487|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
163398497|NCT03828292|590169488|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
163398498|NCT03828292|590169489|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
163398499|NCT03828292|590169490|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
163398500|NCT03828292|590169485|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
163398501|NCT03828292|590169486|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
163398502|NCT03828292|590169487|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
163398503|NCT03828292|590169488|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
163398504|NCT03828292|590169489|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
163398505|NCT03828292|590169490|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
163398506|NCT04198623|590170785|FG000|Overall Study|1 patient was taken off due to covid-19 pandemic shut down|1|||
163398507|NCT00574145|590170792|FG000|Overall Study|Withdrawal by Subject|2|||
163398508|NCT00574145|590170793|FG001|Overall Study|Withdrawal by Subject|1|||
163398509|NCT03227471|590170794|FG000|Overall Study|Withdrawal by Subject|0|||
163398510|NCT03227471|590170795|FG001|Overall Study|Withdrawal by Subject|0|||
163398511|NCT03227471|590170796|FG002|Overall Study|Withdrawal by Subject|0|||
163398512|NCT03227471|590170797|FG003|Overall Study|Withdrawal by Subject|0|||
163398513|NCT03227471|590170798|FG004|Overall Study|Withdrawal by Subject|1|||
163398514|NCT03227471|590170799|FG005|Overall Study|Withdrawal by Subject|0|||
163398515|NCT03227471|590170800|FG006|Overall Study|Withdrawal by Subject|0|||
163398516|NCT03227471|590170801|FG007|Overall Study|Withdrawal by Subject|0|||
163398517|NCT03227471|590170802|FG008|Overall Study|Withdrawal by Subject|0|||
163398518|NCT03227471|590170803|FG009|Overall Study|Withdrawal by Subject|0|||
163398519|NCT03227471|590170804|FG010|Overall Study|Withdrawal by Subject|0|||
163398520|NCT03227471|590170805|FG011|Overall Study|Withdrawal by Subject|0|||
163398521|NCT03227471|590170806|FG012|Overall Study|Withdrawal by Subject|1|||
163054256|NCT01587885|588910199|FG000|Treatment Period 1|Protocol Violation|0|||
163398522|NCT03227471|590170807|FG013|Overall Study|Withdrawal by Subject|0|||
163398523|NCT03227471|590170808|FG014|Overall Study|Withdrawal by Subject|0|||
163398524|NCT03227471|590170794|FG000|Overall Study|Randomized, Never Dosed|0|||
163398525|NCT03227471|590170795|FG001|Overall Study|Randomized, Never Dosed|0|||
163398526|NCT03227471|590170796|FG002|Overall Study|Randomized, Never Dosed|0|||
163398527|NCT03227471|590170797|FG003|Overall Study|Randomized, Never Dosed|0|||
163398528|NCT03227471|590170798|FG004|Overall Study|Randomized, Never Dosed|0|||
163398529|NCT03227471|590170799|FG005|Overall Study|Randomized, Never Dosed|0|||
163398530|NCT03227471|590170800|FG006|Overall Study|Randomized, Never Dosed|0|||
163398531|NCT03227471|590170801|FG007|Overall Study|Randomized, Never Dosed|0|||
163398532|NCT03227471|590170802|FG008|Overall Study|Randomized, Never Dosed|0|||
163398533|NCT03227471|590170803|FG009|Overall Study|Randomized, Never Dosed|0|||
163398534|NCT03227471|590170804|FG010|Overall Study|Randomized, Never Dosed|0|||
163398535|NCT03227471|590170805|FG011|Overall Study|Randomized, Never Dosed|0|||
163398536|NCT03227471|590170806|FG012|Overall Study|Randomized, Never Dosed|0|||
163398537|NCT03227471|590170807|FG013|Overall Study|Randomized, Never Dosed|0|||
163398538|NCT03227471|590170808|FG014|Overall Study|Randomized, Never Dosed|1|||
163398539|NCT00980200|590170812|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
163398540|NCT00980200|590170813|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
163398541|NCT00980200|590170814|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
163398542|NCT00980200|590170815|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
163398543|NCT00980200|590170816|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
163398544|NCT00980200|590170812|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
163398545|NCT00980200|590170813|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
163398546|NCT00980200|590170814|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
163398547|NCT00980200|590170815|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
163398548|NCT00980200|590170816|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
163398549|NCT01617460|590170817|FG000|Overall Study|Adverse Event|10|||
163398550|NCT01617460|590170817|FG000|Overall Study|Physician Decision|16|||
163398551|NCT01617460|590170817|FG000|Overall Study|Protocol Violation|5|||
163398552|NCT01617460|590170817|FG000|Overall Study|Withdrawal by Subject|9|||
163398553|NCT03197493|590170819|FG000|Overall Study|Withdrawal by Subject|5|||
163398554|NCT01469182|590170820|FG000|Overall Study|Adverse Event|21|||
163398555|NCT01469182|590170821|FG001|Overall Study|Adverse Event|3|||
163398556|NCT01469182|590170820|FG000|Overall Study|Lost to Follow-up|3|||
163398557|NCT01469182|590170821|FG001|Overall Study|Lost to Follow-up|0|||
163398558|NCT01469182|590170820|FG000|Overall Study|Withdrawal by Subject|4|||
163398559|NCT01469182|590170821|FG001|Overall Study|Withdrawal by Subject|1|||
163398560|NCT01469182|590170820|FG000|Overall Study|Protocol Violation|4|||
163398561|NCT01469182|590170821|FG001|Overall Study|Protocol Violation|2|||
163398562|NCT01469182|590170820|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
163398563|NCT01469182|590170821|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
163398564|NCT02236520|590170823|FG000|Overall Study|Physician Decision|0|||
163398565|NCT02236520|590170824|FG001|Overall Study|Physician Decision|5|||
163398566|NCT02236520|590170825|FG002|Overall Study|Physician Decision|0|||
163398567|NCT02236520|590170826|FG003|Overall Study|Physician Decision|0|||
163398568|NCT02236520|590170823|FG000|Overall Study|Withdrawal by Subject|1|||
163398569|NCT02236520|590170824|FG001|Overall Study|Withdrawal by Subject|0|||
163398570|NCT02236520|590170825|FG002|Overall Study|Withdrawal by Subject|0|||
163398571|NCT02236520|590170826|FG003|Overall Study|Withdrawal by Subject|1|||
163398572|NCT02236520|590170823|FG000|Overall Study|Pregnancy|1|||
163398573|NCT02236520|590170824|FG001|Overall Study|Pregnancy|0|||
163398574|NCT02236520|590170825|FG002|Overall Study|Pregnancy|0|||
163398575|NCT02236520|590170826|FG003|Overall Study|Pregnancy|0|||
163398576|NCT01785160|590170827|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
163398577|NCT01785160|590170827|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
163398578|NCT01365039|590170829|FG000|Overall Study|Study related symptoms and complaints|1|||
163398579|NCT01365039|590170830|FG001|Overall Study|Study related symptoms and complaints|0|||
163398580|NCT00549939|590170833|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
163398581|NCT00549939|590170834|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
163398582|NCT00549939|590170835|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
163398583|NCT00549939|590170833|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
163398584|NCT00549939|590170834|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
163398585|NCT00549939|590170835|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
163398586|NCT00549939|590170833|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
163398587|NCT00549939|590170834|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
163398588|NCT00549939|590170835|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
163398589|NCT00549939|590170833|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
163398590|NCT00549939|590170834|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
163398591|NCT00549939|590170835|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
163398592|NCT00549939|590170833|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
163398593|NCT00549939|590170834|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
163398594|NCT00549939|590170835|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
163398595|NCT00549939|590170833|FG000|40-week Open Label Treatment Period|Other|0|||
163398596|NCT00549939|590170834|FG001|40-week Open Label Treatment Period|Other|1|||
163398597|NCT00549939|590170835|FG002|40-week Open Label Treatment Period|Other|4|||
163398598|NCT03677596|590170836|FG000|Overall Study|Adverse Event|0|||
163398599|NCT03677596|590170837|FG001|Overall Study|Adverse Event|1|||
163398600|NCT03677596|590170836|FG000|Overall Study|Death|10|||
163398601|NCT03677596|590170837|FG001|Overall Study|Death|6|||
163398602|NCT03677596|590170836|FG000|Overall Study|Lost to Follow-up|0|||
163398603|NCT03677596|590170837|FG001|Overall Study|Lost to Follow-up|1|||
163398604|NCT03677596|590170836|FG000|Overall Study|Progressive Disease|8|||
163398605|NCT03677596|590170837|FG001|Overall Study|Progressive Disease|8|||
163398606|NCT03677596|590170836|FG000|Overall Study|Withdrawal by Subject|3|||
163398607|NCT03677596|590170837|FG001|Overall Study|Withdrawal by Subject|0|||
163398608|NCT03677596|590170836|FG000|Overall Study|Disease Relapse|2|||
163398609|NCT03677596|590170837|FG001|Overall Study|Disease Relapse|2|||
163398610|NCT03677596|590170836|FG000|Overall Study|Other|0|||
163398611|NCT03677596|590170837|FG001|Overall Study|Other|1|||
163398612|NCT01360554|590170838|FG000|Overall Study|Death|359|||
163398613|NCT01360554|590170839|FG001|Overall Study|Death|371|||
163398614|NCT01360554|590170838|FG000|Overall Study|Lost to Follow-up|4|||
163398615|NCT01360554|590170839|FG001|Overall Study|Lost to Follow-up|4|||
163398616|NCT01360554|590170838|FG000|Overall Study|Withdrawal by Subject|23|||
163398617|NCT01360554|590170839|FG001|Overall Study|Withdrawal by Subject|24|||
163398618|NCT01360554|590170838|FG000|Overall Study|Study terminated by sponsor|49|||
163398619|NCT01360554|590170839|FG001|Overall Study|Study terminated by sponsor|37|||
163398620|NCT01360554|590170838|FG000|Overall Study|Other, not specified|1|||
163398621|NCT01360554|590170839|FG001|Overall Study|Other, not specified|0|||
163398622|NCT01360554|590170838|FG000|Overall Study|Randomized but not treated.|3|||
163398623|NCT01360554|590170839|FG001|Overall Study|Randomized but not treated.|3|||
163398624|NCT03668600|590170846|FG000|Overall Study|Study Terminated by the Sponsor|157|||
163398625|NCT03668600|590170846|FG000|Overall Study|Protocol Violation|1|||
163398626|NCT03668600|590170846|FG000|Overall Study|Pregnancy|1|||
163398627|NCT03668600|590170846|FG000|Overall Study|Lost to Follow-up|7|||
163398628|NCT03668600|590170846|FG000|Overall Study|Withdrawal by Subject|56|||
163398629|NCT03668600|590170846|FG000|Overall Study|Lack of Efficacy|7|||
163398630|NCT03668600|590170846|FG000|Overall Study|Adverse Event|1|||
163398631|NCT00424749|590170848|FG000|Overall Study|Withdrawal by Subject|1|||
163398632|NCT01263483|590170849|FG000|Overall Study|Adverse Event|4|||
163398633|NCT01263483|590170850|FG001|Overall Study|Adverse Event|0|||
163398634|NCT01263483|590170851|FG002|Overall Study|Adverse Event|3|||
163398635|NCT01263483|590170849|FG000|Overall Study|Withdrawal by Subject|1|||
163398636|NCT01263483|590170850|FG001|Overall Study|Withdrawal by Subject|0|||
163398637|NCT01263483|590170851|FG002|Overall Study|Withdrawal by Subject|0|||
163398638|NCT01263483|590170849|FG000|Overall Study|Lack of Efficacy|2|||
163398639|NCT01263483|590170850|FG001|Overall Study|Lack of Efficacy|0|||
163398640|NCT01263483|590170851|FG002|Overall Study|Lack of Efficacy|0|||
163398641|NCT01263483|590170849|FG000|Overall Study|Protocol Violation|0|||
163398642|NCT01263483|590170850|FG001|Overall Study|Protocol Violation|1|||
163398643|NCT01263483|590170851|FG002|Overall Study|Protocol Violation|1|||
163398644|NCT01263483|590170849|FG000|Overall Study|Participant Unavailability|0|||
163398645|NCT01263483|590170850|FG001|Overall Study|Participant Unavailability|1|||
163398646|NCT01263483|590170851|FG002|Overall Study|Participant Unavailability|1|||
163398647|NCT01131676|590170856|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
163398648|NCT01131676|590170857|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
163398649|NCT01131676|590170858|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
163398650|NCT01131676|590170856|FG000|Discontinuation From Treatment|Not treated|4|||
163398651|NCT01131676|590170857|FG001|Discontinuation From Treatment|Not treated|2|||
163398652|NCT01131676|590170858|FG002|Discontinuation From Treatment|Not treated|2|||
163398653|NCT01131676|590170856|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
163398654|NCT01131676|590170857|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
163398655|NCT01131676|590170858|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
163398656|NCT01131676|590170856|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
163398657|NCT01131676|590170857|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
163398658|NCT01131676|590170858|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
163398659|NCT01131676|590170856|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
163398660|NCT01131676|590170857|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
163398661|NCT01131676|590170858|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
163398662|NCT01131676|590170856|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
163398663|NCT01131676|590170857|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
163398664|NCT01131676|590170858|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
162967391|NCT04561115|588581362|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
162979005|NCT03545191|588623546|FG000|Overall Study|Lost to Follow-up|1|||
163398665|NCT01131676|590170856|FG000|Discontinuation From Treatment|Other than those specified|162|||
163398666|NCT01131676|590170857|FG001|Discontinuation From Treatment|Other than those specified|142|||
163398667|NCT01131676|590170858|FG002|Discontinuation From Treatment|Other than those specified|125|||
163398668|NCT01131676|590170856|FG000|Discontinuation From Treatment|Adverse Event|303|||
163398669|NCT01131676|590170857|FG001|Discontinuation From Treatment|Adverse Event|267|||
163398670|NCT01131676|590170858|FG002|Discontinuation From Treatment|Adverse Event|273|||
163398671|NCT01131676|590170856|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
163398672|NCT01131676|590170857|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
163398673|NCT01131676|590170858|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
163398674|NCT01131676|590170856|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
163398675|NCT01131676|590170857|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
163398676|NCT01131676|590170858|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
163398677|NCT01131676|590170856|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
163398678|NCT01131676|590170857|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
163398679|NCT01131676|590170858|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
163398680|NCT01131676|590170856|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
163398681|NCT01131676|590170857|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
163398682|NCT01131676|590170858|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
163398683|NCT01131676|590170856|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
163398684|NCT01131676|590170857|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
163398685|NCT01131676|590170858|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
163398686|NCT01131676|590170856|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
163398687|NCT01131676|590170857|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
163398688|NCT01131676|590170858|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
163398689|NCT04109222|590170859|FG000|Overall Study|Adverse Event|1|||
163398690|NCT04109222|590170860|FG001|Overall Study|Adverse Event|0|||
163398691|NCT04109222|590170861|FG002|Overall Study|Adverse Event|0|||
163398692|NCT02577406|590170862|FG000|Randomized Period|Death|1|||
163398693|NCT02577406|590170863|FG001|Randomized Period|Death|0|||
163398694|NCT02577406|590170862|FG000|Randomized Period|Other reasons|0|||
163398695|NCT02577406|590170863|FG001|Randomized Period|Other reasons|20|||
163398696|NCT02577406|590170862|FG000|Treatment Period|Death|38|||
163398697|NCT02577406|590170863|FG001|Treatment Period|Death|23|||
163398698|NCT02577406|590170862|FG000|Treatment Period|Adverse Event|17|||
163398699|NCT02577406|590170863|FG001|Treatment Period|Adverse Event|12|||
163398700|NCT02577406|590170862|FG000|Treatment Period|Progressive Disease|53|||
163398701|NCT02577406|590170863|FG001|Treatment Period|Progressive Disease|37|||
163398702|NCT02577406|590170862|FG000|Treatment Period|Withdrawal by Subject|10|||
163398703|NCT02577406|590170863|FG001|Treatment Period|Withdrawal by Subject|24|||
163398704|NCT02577406|590170862|FG000|Treatment Period|Lost to Follow-up|0|||
163398705|NCT02577406|590170863|FG001|Treatment Period|Lost to Follow-up|1|||
163398706|NCT02577406|590170862|FG000|Treatment Period|Transition to commercially available treatment|1|||
163398707|NCT02577406|590170863|FG001|Treatment Period|Transition to commercially available treatment|1|||
163398708|NCT02577406|590170862|FG000|Treatment Period|Physician Decision|1|||
163398709|NCT02577406|590170863|FG001|Treatment Period|Physician Decision|0|||
163398710|NCT02577406|590170862|FG000|Treatment Period|Disease Relapse|28|||
163398711|NCT02577406|590170863|FG001|Treatment Period|Disease Relapse|1|||
163398712|NCT02577406|590170862|FG000|Treatment Period|Protocol Violation|0|||
163398713|NCT02577406|590170863|FG001|Treatment Period|Protocol Violation|1|||
163398714|NCT02577406|590170862|FG000|Treatment Period|Other Reasons|3|||
163398715|NCT02577406|590170863|FG001|Treatment Period|Other Reasons|39|||
163398716|NCT02577406|590170862|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
163398717|NCT02577406|590170863|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
163398718|NCT01961349|590170866|FG000|Overall Study|Withdrawal by Subject|1|||
163398719|NCT01961349|590170867|FG001|Overall Study|Withdrawal by Subject|4|||
163398720|NCT01961349|590170868|FG002|Overall Study|Withdrawal by Subject|0|||
163398721|NCT01961349|590170866|FG000|Overall Study|Adverse Event|0|||
163398722|NCT01961349|590170867|FG001|Overall Study|Adverse Event|0|||
163398723|NCT01961349|590170868|FG002|Overall Study|Adverse Event|1|||
163398724|NCT01961349|590170866|FG000|Overall Study|registration error, personal reason etc|2|||
163398725|NCT01961349|590170867|FG001|Overall Study|registration error, personal reason etc|2|||
163398726|NCT01961349|590170868|FG002|Overall Study|registration error, personal reason etc|1|||
163398727|NCT02343159|590170874|FG000|Overall Study|Early Study Termination|16|||
163398728|NCT02343159|590170875|FG001|Overall Study|Early Study Termination|19|||
163398729|NCT02343159|590170876|FG002|Overall Study|Early Study Termination|23|||
163398730|NCT02343159|590170874|FG000|Overall Study|Physician Decision|2|||
163398731|NCT02343159|590170875|FG001|Overall Study|Physician Decision|0|||
163398732|NCT02343159|590170876|FG002|Overall Study|Physician Decision|1|||
163398733|NCT02343159|590170874|FG000|Overall Study|Withdrawal by Subject|3|||
163398734|NCT02343159|590170875|FG001|Overall Study|Withdrawal by Subject|0|||
163398735|NCT02343159|590170876|FG002|Overall Study|Withdrawal by Subject|2|||
163398736|NCT02343159|590170874|FG000|Overall Study|Lost to Follow-up|0|||
163398737|NCT02343159|590170875|FG001|Overall Study|Lost to Follow-up|2|||
163398738|NCT02343159|590170876|FG002|Overall Study|Lost to Follow-up|2|||
163398739|NCT02343159|590170874|FG000|Overall Study|Adverse Event|4|||
163398740|NCT02343159|590170875|FG001|Overall Study|Adverse Event|4|||
163398741|NCT02343159|590170876|FG002|Overall Study|Adverse Event|2|||
163398742|NCT02343159|590170874|FG000|Overall Study|Sponsor Decision|0|||
163398743|NCT02343159|590170875|FG001|Overall Study|Sponsor Decision|1|||
163398744|NCT02343159|590170876|FG002|Overall Study|Sponsor Decision|0|||
163398745|NCT02343159|590170874|FG000|Overall Study|Enrollment Error|1|||
163398746|NCT02343159|590170875|FG001|Overall Study|Enrollment Error|0|||
163398747|NCT02343159|590170876|FG002|Overall Study|Enrollment Error|0|||
163398748|NCT02114268|590170879|FG000|Overall Study|Lost to Follow-up|4|||
163398749|NCT02114268|590170880|FG001|Overall Study|Lost to Follow-up|1|||
163398750|NCT02114268|590170881|FG002|Overall Study|Lost to Follow-up|1|||
163398751|NCT02114268|590170882|FG003|Overall Study|Lost to Follow-up|0|||
163398752|NCT02114268|590170883|FG004|Overall Study|Lost to Follow-up|0|||
163398753|NCT02114268|590170884|FG005|Overall Study|Lost to Follow-up|2|||
163398754|NCT02114268|590170879|FG000|Overall Study|Withdrawal by Subject|1|||
163398755|NCT02114268|590170880|FG001|Overall Study|Withdrawal by Subject|0|||
163398756|NCT02114268|590170881|FG002|Overall Study|Withdrawal by Subject|0|||
163398757|NCT02114268|590170882|FG003|Overall Study|Withdrawal by Subject|0|||
163398758|NCT02114268|590170883|FG004|Overall Study|Withdrawal by Subject|0|||
163398759|NCT02114268|590170884|FG005|Overall Study|Withdrawal by Subject|1|||
163398760|NCT02114268|590170879|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
163398761|NCT02114268|590170880|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
163398762|NCT02114268|590170881|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
163398763|NCT02114268|590170882|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
163398764|NCT02114268|590170883|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
163398765|NCT02114268|590170884|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
163398766|NCT02790138|590170891|FG000|Overall Study|Adverse Event|5|||
163398767|NCT02790138|590170892|FG001|Overall Study|Adverse Event|2|||
163398768|NCT02790138|590170891|FG000|Overall Study|Significant Protocol Deviation|0|||
163398769|NCT02790138|590170892|FG001|Overall Study|Significant Protocol Deviation|1|||
163398770|NCT02790138|590170891|FG000|Overall Study|Lost to Follow-up|1|||
163398771|NCT02790138|590170892|FG001|Overall Study|Lost to Follow-up|0|||
163398772|NCT02790138|590170891|FG000|Overall Study|Voluntary Withdrawal|8|||
163398773|NCT02790138|590170892|FG001|Overall Study|Voluntary Withdrawal|9|||
163398774|NCT02790138|590170891|FG000|Overall Study|Lack of Efficacy|6|||
163398775|NCT02790138|590170892|FG001|Overall Study|Lack of Efficacy|7|||
163398776|NCT02790138|590170891|FG000|Overall Study|Reason not Specified|1|||
163398777|NCT02790138|590170892|FG001|Overall Study|Reason not Specified|0|||
163398778|NCT03199040|590170893|FG000|Overall Study|Lack of Efficacy|2|||
163398779|NCT03199040|590170894|FG001|Overall Study|Lack of Efficacy|0|||
163398780|NCT03199040|590170893|FG000|Overall Study|Withdrawal by Subject|2|||
163314448|NCT04992520|589861902|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
163314449|NCT04992520|589861903|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
163314450|NCT04992520|589861904|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
163314451|NCT04992520|589861905|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
163314452|NCT02231164|589861906|FG000|Overall Study|Adverse Event|1|||
163314453|NCT02231164|589861907|FG001|Overall Study|Adverse Event|1|||
163314454|NCT02231164|589861906|FG000|Overall Study|Lack of Efficacy|4|||
163314455|NCT02231164|589861907|FG001|Overall Study|Lack of Efficacy|3|||
163314456|NCT02231164|589861906|FG000|Overall Study|Withdrawal by Subject|1|||
163314457|NCT02231164|589861907|FG001|Overall Study|Withdrawal by Subject|2|||
163314458|NCT01175356|589861908|FG000|Overall Study|Death|1|||
163314459|NCT01175356|589861908|FG000|Overall Study|Lack of Efficacy|12|||
163314460|NCT01175356|589861908|FG000|Overall Study|Lost to Follow-up|1|||
163314461|NCT01175356|589861908|FG000|Overall Study|Physician Decision|23|||
163314462|NCT01175356|589861908|FG000|Overall Study|Ineligible|1|||
163314463|NCT01175356|589861908|FG000|Overall Study|Treatment Slot Not Available|18|||
163314464|NCT01175356|589861908|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
163314465|NCT01175356|589861908|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
163314466|NCT01175356|589861908|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
163314467|NCT01175356|589861908|FG000|Overall Study|Inadequate stem cell for transplant|1|||
163314468|NCT01175356|589861908|FG000|Overall Study|Initiation other tx prior to completion|9|||
163314469|NCT05808257|589861913|FG000|Overall Study|Lost to Follow-up|8|||
163314470|NCT05808257|589861914|FG001|Overall Study|Lost to Follow-up|8|||
163314471|NCT04568486|589861915|FG000|Overall Study|Withdrawal by Subject|26|||
163314472|NCT04568486|589861915|FG000|Overall Study|Lost to Follow-up|7|||
163314473|NCT04042233|589861916|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
163314474|NCT04042233|589861917|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
163314475|NCT04042233|589861916|FG000|Overall Study|Protocol Violation|0|||
163314476|NCT04042233|589861917|FG001|Overall Study|Protocol Violation|2|||
163314477|NCT04907851|589861920|FG000|Overall Study|Consent withdrawn|1|||
163314478|NCT04907851|589861921|FG001|Overall Study|Consent withdrawn|2|||
163314479|NCT04907851|589861922|FG002|Overall Study|Consent withdrawn|0|||
163314480|NCT04907851|589861920|FG000|Overall Study|Death|5|||
163314481|NCT04907851|589861921|FG001|Overall Study|Death|15|||
163314482|NCT04907851|589861922|FG002|Overall Study|Death|10|||
163314483|NCT00324805|589861930|FG000|Overall Study|Adverse Event|62|||
163314484|NCT00324805|589861931|FG001|Overall Study|Adverse Event|203|||
163314485|NCT00324805|589861930|FG000|Overall Study|Progression|7|||
163314486|NCT00324805|589861931|FG001|Overall Study|Progression|35|||
163314487|NCT00324805|589861930|FG000|Overall Study|Withdrawal by Subject|51|||
163314488|NCT00324805|589861931|FG001|Overall Study|Withdrawal by Subject|174|||
163314489|NCT00324805|589861930|FG000|Overall Study|Death|6|||
163314490|NCT00324805|589861931|FG001|Overall Study|Death|9|||
163314491|NCT00324805|589861930|FG000|Overall Study|Alternative therapy|4|||
163314492|NCT00324805|589861931|FG001|Overall Study|Alternative therapy|8|||
163314493|NCT00324805|589861930|FG000|Overall Study|Other complicating disease|1|||
163314494|NCT00324805|589861931|FG001|Overall Study|Other complicating disease|9|||
163314495|NCT00324805|589861930|FG000|Overall Study|Other reasons|7|||
163314496|NCT00324805|589861931|FG001|Overall Study|Other reasons|26|||
163314497|NCT00324805|589861930|FG000|Overall Study|Other|0|||
163314498|NCT00324805|589861931|FG001|Overall Study|Other|2|||
163314499|NCT00324805|589861930|FG000|Overall Study|Did not start therapy|12|||
163314500|NCT00324805|589861931|FG001|Overall Study|Did not start therapy|17|||
163314501|NCT05792085|589861933|FG000|Overall Study|Death|0|||
163314502|NCT05792085|589861934|FG001|Overall Study|Death|0|||
163314503|NCT05792085|589861935|FG002|Overall Study|Death|0|||
163314504|NCT05792085|589861936|FG003|Overall Study|Death|0|||
163314505|NCT05792085|589861937|FG004|Overall Study|Death|1|||
163314506|NCT03819153|589861939|FG000|Overall Study|Withdrawal by Subject|20|||
163314507|NCT03819153|589861940|FG001|Overall Study|Withdrawal by Subject|28|||
163314508|NCT03819153|589861939|FG000|Overall Study|Lost to Follow-up|23|||
163314509|NCT03819153|589861940|FG001|Overall Study|Lost to Follow-up|30|||
163314510|NCT04898673|589861943|FG000|Overall Study|Screenfail|1|||
163314511|NCT04898673|589861944|FG001|Overall Study|Screenfail|0|||
163314512|NCT04797897|589861945|FG000|Overall Study|Study Termination by Sponsor|1|||
163314513|NCT04797897|589861946|FG001|Overall Study|Study Termination by Sponsor|1|||
163314514|NCT03058289|589861951|FG000|Overall Study|Radiographic Deterioration|0|||
163314515|NCT03058289|589861952|FG001|Overall Study|Radiographic Deterioration|3|||
163314516|NCT03058289|589861953|FG002|Overall Study|Radiographic Deterioration|1|||
163314517|NCT03058289|589861954|FG003|Overall Study|Radiographic Deterioration|2|||
163314518|NCT03058289|589861955|FG004|Overall Study|Radiographic Deterioration|6|||
163314519|NCT03058289|589861956|FG005|Overall Study|Radiographic Deterioration|3|||
163314520|NCT03058289|589861957|FG006|Overall Study|Radiographic Deterioration|0|||
163314521|NCT03058289|589861958|FG007|Overall Study|Radiographic Deterioration|4|||
163314522|NCT03058289|589861959|FG008|Overall Study|Radiographic Deterioration|2|||
163207329|NCT02289417|589471098|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
163207330|NCT02289417|589471099|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
163207331|NCT02289417|589471100|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
163207332|NCT02289417|589471101|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
163207333|NCT02289417|589471102|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
163207334|NCT02289417|589471103|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
163207335|NCT02289417|589471095|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
163207336|NCT02289417|589471096|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
163207337|NCT02289417|589471097|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
163207338|NCT02289417|589471098|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
163207339|NCT02289417|589471099|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
163207340|NCT02289417|589471100|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
163207341|NCT02289417|589471101|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
163207342|NCT02289417|589471102|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
163207343|NCT02289417|589471103|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
163207344|NCT02289417|589471095|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
163207345|NCT02289417|589471096|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
163207346|NCT02289417|589471097|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
163207347|NCT02289417|589471098|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
163207348|NCT02289417|589471099|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
163207349|NCT02289417|589471100|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
163314523|NCT03058289|589861951|FG000|Overall Study|Adverse Event|2|||
163314524|NCT03058289|589861952|FG001|Overall Study|Adverse Event|0|||
163314525|NCT03058289|589861953|FG002|Overall Study|Adverse Event|1|||
163314526|NCT03058289|589861954|FG003|Overall Study|Adverse Event|3|||
163314527|NCT03058289|589861955|FG004|Overall Study|Adverse Event|1|||
163314528|NCT03058289|589861956|FG005|Overall Study|Adverse Event|0|||
163314529|NCT03058289|589861957|FG006|Overall Study|Adverse Event|1|||
163314530|NCT03058289|589861958|FG007|Overall Study|Adverse Event|3|||
163314531|NCT03058289|589861959|FG008|Overall Study|Adverse Event|0|||
163314532|NCT03058289|589861951|FG000|Overall Study|Withdrawal by Subject|0|||
163314533|NCT03058289|589861952|FG001|Overall Study|Withdrawal by Subject|0|||
163314534|NCT03058289|589861953|FG002|Overall Study|Withdrawal by Subject|0|||
163314535|NCT03058289|589861954|FG003|Overall Study|Withdrawal by Subject|2|||
163314536|NCT03058289|589861955|FG004|Overall Study|Withdrawal by Subject|0|||
163314537|NCT03058289|589861956|FG005|Overall Study|Withdrawal by Subject|2|||
163314538|NCT03058289|589861957|FG006|Overall Study|Withdrawal by Subject|0|||
163314539|NCT03058289|589861958|FG007|Overall Study|Withdrawal by Subject|4|||
163314540|NCT03058289|589861959|FG008|Overall Study|Withdrawal by Subject|1|||
163314541|NCT03058289|589861951|FG000|Overall Study|Physician Decision|1|||
163314542|NCT03058289|589861952|FG001|Overall Study|Physician Decision|0|||
163314543|NCT03058289|589861953|FG002|Overall Study|Physician Decision|0|||
163314544|NCT03058289|589861954|FG003|Overall Study|Physician Decision|2|||
163314545|NCT03058289|589861955|FG004|Overall Study|Physician Decision|1|||
163314546|NCT03058289|589861956|FG005|Overall Study|Physician Decision|0|||
163314547|NCT03058289|589861957|FG006|Overall Study|Physician Decision|2|||
163314548|NCT03058289|589861958|FG007|Overall Study|Physician Decision|3|||
163314549|NCT03058289|589861959|FG008|Overall Study|Physician Decision|0|||
163314550|NCT03058289|589861951|FG000|Overall Study|Clinical Deterioration|2|||
163314551|NCT03058289|589861952|FG001|Overall Study|Clinical Deterioration|0|||
163314552|NCT03058289|589861953|FG002|Overall Study|Clinical Deterioration|0|||
163314553|NCT03058289|589861954|FG003|Overall Study|Clinical Deterioration|2|||
163314554|NCT03058289|589861955|FG004|Overall Study|Clinical Deterioration|1|||
163314555|NCT03058289|589861956|FG005|Overall Study|Clinical Deterioration|1|||
163314556|NCT03058289|589861957|FG006|Overall Study|Clinical Deterioration|0|||
163314557|NCT03058289|589861958|FG007|Overall Study|Clinical Deterioration|3|||
163314558|NCT03058289|589861959|FG008|Overall Study|Clinical Deterioration|2|||
163314559|NCT03058289|589861951|FG000|Overall Study|Lost to Follow-up|0|||
163314560|NCT03058289|589861952|FG001|Overall Study|Lost to Follow-up|0|||
163314561|NCT03058289|589861953|FG002|Overall Study|Lost to Follow-up|0|||
163314562|NCT03058289|589861954|FG003|Overall Study|Lost to Follow-up|0|||
163314563|NCT03058289|589861955|FG004|Overall Study|Lost to Follow-up|1|||
163314564|NCT03058289|589861956|FG005|Overall Study|Lost to Follow-up|0|||
163314565|NCT03058289|589861957|FG006|Overall Study|Lost to Follow-up|0|||
163314566|NCT03058289|589861958|FG007|Overall Study|Lost to Follow-up|0|||
163314567|NCT03058289|589861959|FG008|Overall Study|Lost to Follow-up|0|||
163314568|NCT03058289|589861951|FG000|Overall Study|Refused Further Treatment|0|||
163314569|NCT03058289|589861952|FG001|Overall Study|Refused Further Treatment|0|||
163314570|NCT03058289|589861953|FG002|Overall Study|Refused Further Treatment|1|||
163314571|NCT03058289|589861954|FG003|Overall Study|Refused Further Treatment|0|||
163314572|NCT03058289|589861955|FG004|Overall Study|Refused Further Treatment|1|||
163314573|NCT03058289|589861956|FG005|Overall Study|Refused Further Treatment|0|||
163314574|NCT03058289|589861957|FG006|Overall Study|Refused Further Treatment|0|||
163314575|NCT03058289|589861958|FG007|Overall Study|Refused Further Treatment|0|||
163314576|NCT03058289|589861959|FG008|Overall Study|Refused Further Treatment|0|||
163314577|NCT03058289|589861951|FG000|Overall Study|Rapid Progression of Disease|0|||
163314578|NCT03058289|589861952|FG001|Overall Study|Rapid Progression of Disease|0|||
163314579|NCT03058289|589861953|FG002|Overall Study|Rapid Progression of Disease|0|||
163314580|NCT03058289|589861954|FG003|Overall Study|Rapid Progression of Disease|1|||
163314581|NCT03058289|589861955|FG004|Overall Study|Rapid Progression of Disease|0|||
163398781|NCT03199040|590170894|FG001|Overall Study|Withdrawal by Subject|0|||
163314582|NCT03058289|589861956|FG005|Overall Study|Rapid Progression of Disease|0|||
163314583|NCT03058289|589861957|FG006|Overall Study|Rapid Progression of Disease|0|||
163314584|NCT03058289|589861958|FG007|Overall Study|Rapid Progression of Disease|0|||
163314585|NCT03058289|589861959|FG008|Overall Study|Rapid Progression of Disease|0|||
163314586|NCT04049643|589861965|FG000|Overall Study|Lack of Efficacy|1|||
163207350|NCT02289417|589471101|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
163207351|NCT02289417|589471102|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
163207352|NCT02289417|589471103|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
163207353|NCT02289417|589471095|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
163207354|NCT02289417|589471096|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
163207355|NCT02289417|589471097|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
163207356|NCT02289417|589471098|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
163207357|NCT02289417|589471099|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
163207358|NCT02289417|589471100|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
163207359|NCT02289417|589471101|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
163207360|NCT02289417|589471102|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
163207361|NCT02289417|589471103|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
163207362|NCT02289417|589471095|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
163207363|NCT02289417|589471096|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
163207364|NCT02289417|589471097|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
163207365|NCT02289417|589471098|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
163207366|NCT02289417|589471099|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
163207367|NCT02289417|589471100|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
163207368|NCT02289417|589471101|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
163207369|NCT02289417|589471102|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
163207370|NCT02289417|589471103|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
163207371|NCT02289417|589471095|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
163207372|NCT02289417|589471096|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
163207373|NCT02289417|589471097|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
163207374|NCT02289417|589471098|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
163207375|NCT02289417|589471099|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
163207376|NCT02289417|589471100|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
163314587|NCT04049643|589861966|FG001|Overall Study|Lack of Efficacy|1|||
163314588|NCT04049643|589861967|FG002|Overall Study|Lack of Efficacy|0|||
163314589|NCT04049643|589861965|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
163314590|NCT04049643|589861966|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
163314591|NCT04049643|589861967|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
163314592|NCT05623228|589861968|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
163314593|NCT05623228|589861969|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
163314594|NCT05623228|589861970|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
163314595|NCT05623228|589861971|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
163314596|NCT05623228|589861972|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
163314597|NCT05623228|589861973|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
163314598|NCT05623228|589861974|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
163314599|NCT05623228|589861975|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
163314600|NCT05623228|589861968|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
163314601|NCT05623228|589861969|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
163314602|NCT05623228|589861970|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
163314603|NCT05623228|589861971|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
163314604|NCT05623228|589861972|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
163314605|NCT05623228|589861973|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
163314606|NCT05623228|589861974|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
163314607|NCT05623228|589861975|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
163207377|NCT02289417|589471101|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
163207378|NCT02289417|589471102|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
163314608|NCT04437615|589861980|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
163314609|NCT04828005|589861981|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
163314610|NCT04828005|589861982|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
163054257|NCT01587885|588910200|FG001|Treatment Period 1|Protocol Violation|2|||
163054258|NCT01458587|588910201|FG000|Overall Study|Withdrawal by Subject|1|||
163054259|NCT01458587|588910202|FG001|Overall Study|Withdrawal by Subject|0|||
163054260|NCT01603602|588910203|FG000|Overall Study|Adverse Event|1|||
163054261|NCT01603602|588910204|FG001|Overall Study|Adverse Event|0|||
163054262|NCT01603602|588910205|FG002|Overall Study|Adverse Event|0|||
163054263|NCT01603602|588910203|FG000|Overall Study|Personal Reasons|1|||
163054264|NCT01603602|588910204|FG001|Overall Study|Personal Reasons|0|||
163054265|NCT01603602|588910205|FG002|Overall Study|Personal Reasons|1|||
163314611|NCT04828005|589861983|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
163054266|NCT04748718|588910209|FG000|Overall Study|Lost to Follow-up|50|||
163054267|NCT00316004|588910210|FG000|Overall Study|Subject was not given study fluid.|14|||
163054268|NCT00316004|588910211|FG001|Overall Study|Subject was not given study fluid.|14|||
163314612|NCT04828005|589861984|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
163314613|NCT04828005|589861981|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
163314614|NCT04828005|589861982|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
163314615|NCT04828005|589861983|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
163314616|NCT04828005|589861984|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
163314617|NCT04828005|589861981|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
163314618|NCT04828005|589861982|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
163314619|NCT04828005|589861983|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
163314620|NCT04828005|589861984|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
163314621|NCT04828005|589861981|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
163314622|NCT04828005|589861982|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
163314623|NCT04828005|589861983|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
163314624|NCT04828005|589861984|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
163314625|NCT04828005|589861981|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
163314626|NCT04828005|589861982|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
162979006|NCT03545191|588623547|FG001|Overall Study|Lost to Follow-up|2|||
162967392|NCT04561115|588581363|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
162967393|NCT00743145|588581364|FG000|Overall Study|Withdrawal by Subject|1|||
162967394|NCT00743145|588581364|FG000|Overall Study|Adverse Event|2|||
162967395|NCT00743145|588581364|FG000|Overall Study|Pregnancy|1|||
162967396|NCT02179190|588581365|FG000|Enrollment|Exit Prior to Device Attempt|11|||
162967397|NCT02179190|588581365|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
162967398|NCT02179190|588581365|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
162967399|NCT02179190|588581365|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
162967400|NCT02179190|588581365|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
162967401|NCT02179190|588581365|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
162967402|NCT01670097|588581366|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
162967403|NCT01670097|588581367|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
162967404|NCT01670097|588581366|FG000|Overall Study|Study burden|1|||
163054269|NCT00316004|588910212|FG002|Overall Study|Subject was not given study fluid.|21|||
163054270|NCT01118299|588910214|FG000|Overall Study|Death|7|||
163054271|NCT01118299|588910215|FG001|Overall Study|Death|5|||
163054272|NCT01118299|588910214|FG000|Overall Study|Withdrawal by Subject|8|||
163054273|NCT01118299|588910215|FG001|Overall Study|Withdrawal by Subject|8|||
163054274|NCT01118299|588910214|FG000|Overall Study|Lost to Follow-up|2|||
163054275|NCT01118299|588910215|FG001|Overall Study|Lost to Follow-up|1|||
163054276|NCT01118299|588910214|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
163054277|NCT01118299|588910215|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
163054278|NCT01935089|588910216|FG000|Overall Study|Adverse Event|2|||
163054279|NCT01935089|588910216|FG000|Overall Study|Withdrawal by Subject|1|||
163054280|NCT02932943|588910217|FG000|Overall Study|Lost to Follow-up|0|||
163054281|NCT02932943|588910218|FG001|Overall Study|Lost to Follow-up|2|||
163054282|NCT02932943|588910217|FG000|Overall Study|Adverse Event|2|||
163054283|NCT02932943|588910218|FG001|Overall Study|Adverse Event|2|||
163054284|NCT02932943|588910217|FG000|Overall Study|Withdrawal by Subject|3|||
163054285|NCT02932943|588910218|FG001|Overall Study|Withdrawal by Subject|3|||
163054286|NCT02665117|588910221|FG000|Overall Study|Physician Decision|1|||
163054287|NCT02665117|588910222|FG001|Overall Study|Physician Decision|0|||
163054288|NCT00977197|588910223|FG000|Overall Study|Withdrawal by Subject|3|||
163054289|NCT00977197|588910224|FG001|Overall Study|Withdrawal by Subject|4|||
163314627|NCT04828005|589861983|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
163314628|NCT04828005|589861984|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
163314629|NCT04828005|589861981|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
163314630|NCT04828005|589861982|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
163314631|NCT04828005|589861983|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
162967405|NCT01670097|588581367|FG001|Overall Study|Study burden|0|||
162967406|NCT01670097|588581366|FG000|Overall Study|COPD exacerbation|0|||
162967407|NCT01670097|588581367|FG001|Overall Study|COPD exacerbation|1|||
163054290|NCT00977197|588910223|FG000|Overall Study|Adverse Event|3|||
162967408|NCT01670097|588581366|FG000|Overall Study|Neutropenia|0|||
162967409|NCT01670097|588581367|FG001|Overall Study|Neutropenia|1|||
163054291|NCT00977197|588910224|FG001|Overall Study|Adverse Event|1|||
163054292|NCT00977197|588910223|FG000|Overall Study|Lack of Efficacy|1|||
163054293|NCT00977197|588910224|FG001|Overall Study|Lack of Efficacy|0|||
163054294|NCT00977197|588910223|FG000|Overall Study|Lost to Follow-up|1|||
163314632|NCT04828005|589861984|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
163054295|NCT00977197|588910224|FG001|Overall Study|Lost to Follow-up|3|||
163314633|NCT04828005|589861981|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
163314634|NCT04828005|589861982|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
163314635|NCT04828005|589861983|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
162967410|NCT01670097|588581366|FG000|Overall Study|Clinical deterioration|0|||
163054296|NCT00977197|588910223|FG000|Overall Study|Nonadherence|1|||
163314636|NCT04828005|589861984|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
163314637|NCT04828005|589861981|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
163314638|NCT04828005|589861982|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
163314639|NCT04828005|589861983|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
163314640|NCT04828005|589861984|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
163314641|NCT04828005|589861981|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
163314642|NCT04828005|589861982|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
163314643|NCT04828005|589861983|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
163314644|NCT04828005|589861984|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
163314645|NCT02675751|589863194|FG000|Overall Study|Lost to Follow-up|16|||
163314646|NCT02359890|589863195|FG000|Overall Study|Not meeting eligibility|4|||
163314647|NCT02359890|589863195|FG000|Overall Study|Never treated with study catheter|6|||
163314648|NCT02268253|589863199|FG000|Stage 1|Withdrawal by Subject|1|||
163314649|NCT02268253|589863200|FG001|Stage 1|Withdrawal by Subject|0|||
163314650|NCT02268253|589863201|FG002|Stage 1|Withdrawal by Subject|0|||
163314651|NCT02268253|589863202|FG003|Stage 1|Withdrawal by Subject|0|||
163314652|NCT02268253|589863203|FG004|Stage 1|Withdrawal by Subject|0|||
163314653|NCT02268253|589863204|FG005|Stage 1|Withdrawal by Subject|0|||
163314654|NCT02268253|589863205|FG006|Stage 1|Withdrawal by Subject|0|||
163314655|NCT02268253|589863199|FG000|Stage 1|Death|0|||
163314656|NCT02268253|589863200|FG001|Stage 1|Death|2|||
163314657|NCT02268253|589863201|FG002|Stage 1|Death|2|||
163314658|NCT02268253|589863202|FG003|Stage 1|Death|2|||
163314659|NCT02268253|589863203|FG004|Stage 1|Death|1|||
163314660|NCT02268253|589863204|FG005|Stage 1|Death|1|||
163314661|NCT02268253|589863205|FG006|Stage 1|Death|0|||
163314662|NCT02268253|589863199|FG000|Stage 2|Disease Recurrence/ Progression|0|||
163314663|NCT02268253|589863200|FG001|Stage 2|Disease Recurrence/ Progression|0|||
163314664|NCT02268253|589863201|FG002|Stage 2|Disease Recurrence/ Progression|1|||
163314665|NCT02268253|589863202|FG003|Stage 2|Disease Recurrence/ Progression|0|||
163314666|NCT02268253|589863203|FG004|Stage 2|Disease Recurrence/ Progression|0|||
163314667|NCT02268253|589863204|FG005|Stage 2|Disease Recurrence/ Progression|0|||
163314668|NCT02268253|589863205|FG006|Stage 2|Disease Recurrence/ Progression|0|||
163314669|NCT02268253|589863199|FG000|Stage 2|Withdrawal by Subject|0|||
163314670|NCT02268253|589863200|FG001|Stage 2|Withdrawal by Subject|0|||
163314671|NCT02268253|589863201|FG002|Stage 2|Withdrawal by Subject|2|||
163314672|NCT02268253|589863202|FG003|Stage 2|Withdrawal by Subject|0|||
163314673|NCT02268253|589863203|FG004|Stage 2|Withdrawal by Subject|0|||
163314674|NCT02268253|589863204|FG005|Stage 2|Withdrawal by Subject|2|||
163314675|NCT02268253|589863205|FG006|Stage 2|Withdrawal by Subject|0|||
163314676|NCT02268253|589863199|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
163314677|NCT02268253|589863200|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
163314678|NCT02268253|589863201|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
163314679|NCT02268253|589863202|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
163314680|NCT02268253|589863203|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
163314681|NCT02268253|589863204|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
163314682|NCT02268253|589863205|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
163314683|NCT02268253|589863199|FG000|Stage 2|Death|0|||
163314684|NCT02268253|589863200|FG001|Stage 2|Death|0|||
163314685|NCT02268253|589863201|FG002|Stage 2|Death|19|||
163314686|NCT02268253|589863202|FG003|Stage 2|Death|0|||
163314687|NCT02268253|589863203|FG004|Stage 2|Death|0|||
163314688|NCT02268253|589863204|FG005|Stage 2|Death|20|||
163314689|NCT02268253|589863205|FG006|Stage 2|Death|1|||
163314690|NCT02268253|589863199|FG000|Stage 2|Lost to Follow-up|0|||
163314691|NCT02268253|589863200|FG001|Stage 2|Lost to Follow-up|0|||
163314692|NCT02268253|589863201|FG002|Stage 2|Lost to Follow-up|0|||
163314693|NCT02268253|589863202|FG003|Stage 2|Lost to Follow-up|0|||
163314694|NCT02268253|589863203|FG004|Stage 2|Lost to Follow-up|0|||
163314695|NCT02268253|589863204|FG005|Stage 2|Lost to Follow-up|4|||
163314696|NCT02268253|589863205|FG006|Stage 2|Lost to Follow-up|0|||
163314697|NCT02268253|589863199|FG000|Stage 2|Transferred to Hospice|0|||
163314698|NCT02268253|589863200|FG001|Stage 2|Transferred to Hospice|0|||
163314699|NCT02268253|589863201|FG002|Stage 2|Transferred to Hospice|0|||
163314700|NCT02268253|589863202|FG003|Stage 2|Transferred to Hospice|0|||
163314701|NCT02268253|589863203|FG004|Stage 2|Transferred to Hospice|0|||
163314702|NCT02268253|589863204|FG005|Stage 2|Transferred to Hospice|2|||
163314703|NCT02268253|589863205|FG006|Stage 2|Transferred to Hospice|0|||
163314704|NCT02268253|589863199|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
163314705|NCT02268253|589863200|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
163314706|NCT02268253|589863201|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
163314707|NCT02268253|589863202|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
163314708|NCT02268253|589863203|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
163314709|NCT02268253|589863204|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
163314710|NCT02268253|589863205|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
163314711|NCT02268253|589863199|FG000|Stage 3A|Withdrawal by Subject|0|||
163314712|NCT02268253|589863200|FG001|Stage 3A|Withdrawal by Subject|0|||
163314713|NCT02268253|589863201|FG002|Stage 3A|Withdrawal by Subject|2|||
163314714|NCT02268253|589863202|FG003|Stage 3A|Withdrawal by Subject|0|||
163314715|NCT02268253|589863203|FG004|Stage 3A|Withdrawal by Subject|0|||
163314716|NCT02268253|589863204|FG005|Stage 3A|Withdrawal by Subject|0|||
163314717|NCT02268253|589863205|FG006|Stage 3A|Withdrawal by Subject|0|||
163314718|NCT02268253|589863199|FG000|Stage 3A|Physician Decision|0|||
163314719|NCT02268253|589863200|FG001|Stage 3A|Physician Decision|0|||
163314720|NCT02268253|589863201|FG002|Stage 3A|Physician Decision|2|||
163314721|NCT02268253|589863202|FG003|Stage 3A|Physician Decision|0|||
163314722|NCT02268253|589863203|FG004|Stage 3A|Physician Decision|0|||
163314723|NCT02268253|589863204|FG005|Stage 3A|Physician Decision|0|||
163314724|NCT02268253|589863205|FG006|Stage 3A|Physician Decision|0|||
163314725|NCT02268253|589863199|FG000|Stage 3A|Study Terminated by Sponsor|0|||
163314726|NCT02268253|589863200|FG001|Stage 3A|Study Terminated by Sponsor|0|||
163314727|NCT02268253|589863201|FG002|Stage 3A|Study Terminated by Sponsor|2|||
163314728|NCT02268253|589863202|FG003|Stage 3A|Study Terminated by Sponsor|0|||
163314729|NCT02268253|589863203|FG004|Stage 3A|Study Terminated by Sponsor|0|||
163314730|NCT02268253|589863204|FG005|Stage 3A|Study Terminated by Sponsor|0|||
163314731|NCT02268253|589863205|FG006|Stage 3A|Study Terminated by Sponsor|0|||
163314732|NCT02268253|589863199|FG000|Stage 3A|Lost to Follow-up|0|||
163314733|NCT02268253|589863200|FG001|Stage 3A|Lost to Follow-up|0|||
163314734|NCT02268253|589863201|FG002|Stage 3A|Lost to Follow-up|1|||
163314735|NCT02268253|589863202|FG003|Stage 3A|Lost to Follow-up|0|||
163314736|NCT02268253|589863203|FG004|Stage 3A|Lost to Follow-up|0|||
163314737|NCT02268253|589863204|FG005|Stage 3A|Lost to Follow-up|0|||
163314738|NCT02268253|589863205|FG006|Stage 3A|Lost to Follow-up|0|||
163314739|NCT02268253|589863199|FG000|Stage 3A|Death|0|||
163314740|NCT02268253|589863200|FG001|Stage 3A|Death|0|||
163314741|NCT02268253|589863201|FG002|Stage 3A|Death|5|||
163314742|NCT02268253|589863202|FG003|Stage 3A|Death|0|||
163314743|NCT02268253|589863203|FG004|Stage 3A|Death|0|||
163314744|NCT02268253|589863204|FG005|Stage 3A|Death|0|||
163314745|NCT02268253|589863205|FG006|Stage 3A|Death|0|||
163314746|NCT05714761|589863206|FG000|Overall Study|Lost to Follow-up|3|||
163314747|NCT05714761|589863206|FG000|Overall Study|Withdrawal by Subject|3|||
163314748|NCT05714761|589863206|FG000|Overall Study|unblinding of sensor data|1|||
163314749|NCT05714761|589863206|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
163314750|NCT05714761|589863206|FG000|Overall Study|did not return second CGM sensor|4|||
163314751|NCT05672069|589863207|FG000|Overall Study|Implant removal|1|||
163314752|NCT05672069|589863207|FG000|Overall Study|Lost to Follow-up|2|||
163314753|NCT05213390|589863208|FG000|Overall Study|Withdrawal by Subject|2|||
163314754|NCT05213390|589863208|FG000|Overall Study|Lost to Follow-up|12|||
163314755|NCT05213390|589863208|FG000|Overall Study|Protocol Violation|9|||
163314756|NCT03031470|589863214|FG000|Overall Study|Adverse Event|3|||
163314757|NCT03031470|589863215|FG001|Overall Study|Adverse Event|0|||
163314758|NCT03031470|589863214|FG000|Overall Study|Death|3|||
163314759|NCT03031470|589863215|FG001|Overall Study|Death|1|||
163314760|NCT03031470|589863214|FG000|Overall Study|Lost to Follow-up|1|||
163314761|NCT03031470|589863215|FG001|Overall Study|Lost to Follow-up|1|||
163314762|NCT03031470|589863214|FG000|Overall Study|Withdrawal by Subject|1|||
163314763|NCT03031470|589863215|FG001|Overall Study|Withdrawal by Subject|0|||
163314764|NCT03031470|589863214|FG000|Overall Study|Protocol entry criteria not met|0|||
163314765|NCT03031470|589863215|FG001|Overall Study|Protocol entry criteria not met|1|||
163314766|NCT03031470|589863214|FG000|Overall Study|Cancel the operation|0|||
163314767|NCT03031470|589863215|FG001|Overall Study|Cancel the operation|1|||
163314768|NCT01593917|589863216|FG000|Overall Study|Death|67|||
163314769|NCT01593917|589863216|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
163207379|NCT02289417|589471103|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
163207380|NCT02289417|589471095|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
163207381|NCT02289417|589471096|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
163207382|NCT02289417|589471097|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
163207383|NCT02289417|589471098|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
163207384|NCT02289417|589471099|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
163207385|NCT02289417|589471100|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
163207386|NCT02289417|589471101|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
163207387|NCT02289417|589471102|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
163207388|NCT02289417|589471103|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
163207389|NCT02289417|589471095|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
163207390|NCT02289417|589471096|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
163207391|NCT02289417|589471097|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
163207392|NCT02289417|589471098|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
163207393|NCT02289417|589471099|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
163207394|NCT02289417|589471100|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
163207395|NCT02289417|589471101|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
163207396|NCT02289417|589471102|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
163207397|NCT02289417|589471103|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
163314770|NCT01593917|589863216|FG000|Overall Study|Withdrawal by Subject|23|||
163314771|NCT01593917|589863216|FG000|Overall Study|Lost to Follow-up|12|||
163314772|NCT01593917|589863216|FG000|Overall Study|Protocol Violation|5|||
163314773|NCT01593917|589863216|FG000|Overall Study|Physician Decision|3|||
163314774|NCT02683447|589863220|FG000|Overall Study|Lost to Follow-up|2|||
163314775|NCT04663737|589863221|FG000|Overall Study|Withdrawal by Subject|2|||
163398782|NCT03199040|590170893|FG000|Overall Study|Adverse Event|0|||
163398783|NCT03199040|590170894|FG001|Overall Study|Adverse Event|1|||
163398784|NCT03199040|590170893|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
163398785|NCT03199040|590170894|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
163398786|NCT01786603|590170895|FG000|Overall Study|Death|5|||
163398787|NCT01786603|590170896|FG001|Overall Study|Death|1|||
163398788|NCT01786603|590170895|FG000|Overall Study|Adverse Event|6|||
163398789|NCT01786603|590170896|FG001|Overall Study|Adverse Event|2|||
163398790|NCT01786603|590170895|FG000|Overall Study|Physician decision to withdraw|6|||
163398791|NCT01786603|590170896|FG001|Overall Study|Physician decision to withdraw|7|||
163398792|NCT01786603|590170895|FG000|Overall Study|Lost to Follow-up|1|||
163398793|NCT01786603|590170896|FG001|Overall Study|Lost to Follow-up|2|||
163398794|NCT01226459|590170897|FG000|Overall Study|Adverse Event|2|||
163398795|NCT01226459|590170898|FG001|Overall Study|Adverse Event|8|||
163398796|NCT01226459|590170897|FG000|Overall Study|Protocol Violation|4|||
163398797|NCT01226459|590170898|FG001|Overall Study|Protocol Violation|3|||
163398798|NCT01226459|590170897|FG000|Overall Study|Withdrawal by Subject|10|||
163207398|NCT02289417|589471095|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
163207399|NCT02289417|589471096|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
163207400|NCT02289417|589471097|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
163207401|NCT02289417|589471098|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
163314776|NCT04663737|589863222|FG001|Overall Study|Withdrawal by Subject|0|||
163314777|NCT04016662|589863223|FG000|Run-In Phase|Death|1|||
163314778|NCT04016662|589863223|FG000|Run-In Phase|Withdrawal by Subject|11|||
163314779|NCT04016662|589863223|FG000|Run-In Phase|Not meeting screening eligibility|9|||
163314780|NCT04016662|589863223|FG000|Run-In Phase|Physician Decision|3|||
163314781|NCT04016662|589863223|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
163314782|NCT04016662|589863223|FG000|PLGS (12 Weeks)|Death|1|||
163314783|NCT04016662|589863223|FG000|SAP (12 Weeks)|Death|1|||
163314784|NCT03021096|589863224|FG000|Overall Study|Lost to Follow-up|4|||
163314785|NCT03021096|589863224|FG000|Overall Study|Protocol Violation|2|||
163314786|NCT03216057|589863225|FG000|Overall Study|Lost to Follow-up|2|||
163314787|NCT03216057|589863226|FG001|Overall Study|Lost to Follow-up|2|||
163314788|NCT05126433|589863227|FG000|Overall Study|Withdrawal by Subject|3|||
163314789|NCT05126433|589863228|FG001|Overall Study|Withdrawal by Subject|0|||
163314790|NCT05126433|589863229|FG002|Overall Study|Withdrawal by Subject|4|||
163314791|NCT05126433|589863227|FG000|Overall Study|Death|9|||
163314792|NCT05126433|589863228|FG001|Overall Study|Death|3|||
163314793|NCT05126433|589863229|FG002|Overall Study|Death|5|||
163314794|NCT05126433|589863227|FG000|Overall Study|Study Terminated by sponsor|0|||
163398799|NCT01226459|590170898|FG001|Overall Study|Withdrawal by Subject|13|||
163398800|NCT01226459|590170897|FG000|Overall Study|Lost to Follow-up|4|||
163398801|NCT01226459|590170898|FG001|Overall Study|Lost to Follow-up|8|||
163207402|NCT02289417|589471099|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
163207403|NCT02289417|589471100|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
163207404|NCT02289417|589471101|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
163207405|NCT02289417|589471102|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
163207406|NCT02289417|589471103|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
163207407|NCT02289417|589471095|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
163207408|NCT02289417|589471096|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
163207409|NCT02289417|589471097|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
163207410|NCT02289417|589471098|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
163207411|NCT02289417|589471099|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
163207412|NCT02289417|589471100|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
163207413|NCT02289417|589471101|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
163207414|NCT02289417|589471102|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
163207415|NCT02289417|589471103|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
163207416|NCT02289417|589471095|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
163207417|NCT02289417|589471096|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
163207418|NCT02289417|589471097|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
163207419|NCT02289417|589471098|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
163207420|NCT02289417|589471099|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
163207421|NCT02289417|589471100|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
163207422|NCT02289417|589471101|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
163207423|NCT02289417|589471102|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
163207424|NCT02289417|589471103|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
163207425|NCT02289417|589471095|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
163207426|NCT02289417|589471096|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
163207427|NCT02289417|589471097|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
163207428|NCT02289417|589471098|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
163207429|NCT02289417|589471099|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
163207430|NCT02289417|589471100|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
163314795|NCT05126433|589863228|FG001|Overall Study|Study Terminated by sponsor|1|||
163314796|NCT05126433|589863229|FG002|Overall Study|Study Terminated by sponsor|2|||
163398802|NCT01226459|590170897|FG000|Overall Study|Pregnancy|1|||
163398803|NCT01226459|590170898|FG001|Overall Study|Pregnancy|0|||
163398804|NCT01854645|590170902|FG000|Overall Study|Protocol-Specified Criteria|13|||
163398805|NCT01854645|590170903|FG001|Overall Study|Protocol-Specified Criteria|10|||
163398806|NCT01854645|590170904|FG002|Overall Study|Protocol-Specified Criteria|8|||
163398807|NCT01854645|590170905|FG003|Overall Study|Protocol-Specified Criteria|5|||
163398808|NCT01854645|590170906|FG004|Overall Study|Protocol-Specified Criteria|7|||
163398809|NCT01854645|590170902|FG000|Overall Study|Administrative Reasons / Missing|0|||
163398810|NCT01854645|590170903|FG001|Overall Study|Administrative Reasons / Missing|0|||
163398811|NCT01854645|590170904|FG002|Overall Study|Administrative Reasons / Missing|0|||
163398812|NCT01854645|590170905|FG003|Overall Study|Administrative Reasons / Missing|1|||
163398813|NCT01854645|590170906|FG004|Overall Study|Administrative Reasons / Missing|1|||
163398814|NCT01854645|590170902|FG000|Overall Study|Protocol Violation|3|||
163398815|NCT01854645|590170903|FG001|Overall Study|Protocol Violation|0|||
163314797|NCT05126433|589863227|FG000|Overall Study|Progressive Disease|1|||
163314798|NCT05126433|589863228|FG001|Overall Study|Progressive Disease|4|||
163314799|NCT05126433|589863229|FG002|Overall Study|Progressive Disease|3|||
163314800|NCT05126433|589863227|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
163314801|NCT05126433|589863228|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
163314802|NCT05126433|589863229|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
163314803|NCT03907878|589863230|FG000|Treatment Period|Withdrawal by Subject|5|||
163314804|NCT03907878|589863230|FG000|Treatment Period|Adverse Event|4|||
163314805|NCT03907878|589863230|FG000|Treatment Period|Lack of Efficacy|1|||
163314806|NCT03907878|589863230|FG000|Treatment Period|Protocol Violation|1|||
163314807|NCT03907878|589863230|FG000|Follow-up Period|Adverse Event|3|||
163314808|NCT03907878|589863230|FG000|Follow-up Period|Withdrawal by Subject|3|||
163398816|NCT01854645|590170904|FG002|Overall Study|Protocol Violation|5|||
163398817|NCT01854645|590170905|FG003|Overall Study|Protocol Violation|4|||
163398818|NCT01854645|590170906|FG004|Overall Study|Protocol Violation|1|||
163398819|NCT01854645|590170902|FG000|Overall Study|Lost to Follow-up|10|||
163398820|NCT01854645|590170903|FG001|Overall Study|Lost to Follow-up|7|||
163398821|NCT01854645|590170904|FG002|Overall Study|Lost to Follow-up|8|||
163398822|NCT01854645|590170905|FG003|Overall Study|Lost to Follow-up|5|||
163398823|NCT01854645|590170906|FG004|Overall Study|Lost to Follow-up|0|||
163398824|NCT01854645|590170902|FG000|Overall Study|Physician Decision|1|||
163398825|NCT01854645|590170903|FG001|Overall Study|Physician Decision|5|||
163398826|NCT01854645|590170904|FG002|Overall Study|Physician Decision|3|||
163398827|NCT01854645|590170905|FG003|Overall Study|Physician Decision|3|||
163398828|NCT01854645|590170906|FG004|Overall Study|Physician Decision|7|||
163398829|NCT01854645|590170902|FG000|Overall Study|Withdrawal by Subject|31|||
163398830|NCT01854645|590170903|FG001|Overall Study|Withdrawal by Subject|41|||
163398831|NCT01854645|590170904|FG002|Overall Study|Withdrawal by Subject|30|||
163398832|NCT01854645|590170905|FG003|Overall Study|Withdrawal by Subject|21|||
163398833|NCT01854645|590170906|FG004|Overall Study|Withdrawal by Subject|24|||
163398834|NCT01854645|590170902|FG000|Overall Study|Lack of Efficacy|7|||
163398835|NCT01854645|590170903|FG001|Overall Study|Lack of Efficacy|12|||
163398836|NCT01854645|590170904|FG002|Overall Study|Lack of Efficacy|9|||
163398837|NCT01854645|590170905|FG003|Overall Study|Lack of Efficacy|3|||
163398838|NCT01854645|590170906|FG004|Overall Study|Lack of Efficacy|9|||
163398839|NCT01854645|590170902|FG000|Overall Study|Adverse Event|33|||
163398840|NCT01854645|590170903|FG001|Overall Study|Adverse Event|31|||
163398841|NCT01854645|590170904|FG002|Overall Study|Adverse Event|19|||
163398842|NCT01854645|590170905|FG003|Overall Study|Adverse Event|20|||
163398843|NCT01854645|590170906|FG004|Overall Study|Adverse Event|11|||
163398844|NCT04702737|590170907|FG000|Overall Study|Decision by Sponsor|1|||
163398845|NCT04702737|590170907|FG000|Overall Study|Withdrawal of Consent from Study|3|||
163398846|NCT04702737|590170907|FG000|Overall Study|Lost to Follow-up|1|||
163398847|NCT04702737|590170907|FG000|Overall Study|Death|35|||
163398848|NCT02064920|590170910|FG000|Overall Study|Adverse Event|0|||
163398849|NCT02064920|590170911|FG001|Overall Study|Adverse Event|4|||
163398850|NCT02064920|590170910|FG000|Overall Study|Physician Decision|0|||
163398851|NCT02064920|590170911|FG001|Overall Study|Physician Decision|1|||
163398852|NCT02064920|590170910|FG000|Overall Study|Technical Problems|0|||
163398853|NCT02064920|590170911|FG001|Overall Study|Technical Problems|1|||
163398854|NCT02064920|590170910|FG000|Overall Study|Withdrawal by Subject|1|||
163398855|NCT02064920|590170911|FG001|Overall Study|Withdrawal by Subject|3|||
163314809|NCT03904147|589863235|FG000|Overall Study|Death|15|||
163314810|NCT03904147|589863236|FG001|Overall Study|Death|13|||
163398856|NCT02109562|590170912|FG000|Overall Study|Insufficient clinical response|2|||
163398857|NCT02109562|590170913|FG001|Overall Study|Insufficient clinical response|0|||
163398858|NCT02109562|590170914|FG002|Overall Study|Insufficient clinical response|4|||
163398859|NCT02109562|590170912|FG000|Overall Study|Adverse Event|0|||
163314811|NCT03904147|589863237|FG002|Overall Study|Death|15|||
163314812|NCT03904147|589863235|FG000|Overall Study|Withdrawal by Subject|7|||
163398860|NCT02109562|590170913|FG001|Overall Study|Adverse Event|2|||
163398861|NCT02109562|590170914|FG002|Overall Study|Adverse Event|3|||
163398862|NCT02109562|590170912|FG000|Overall Study|Lost to Follow-up|1|||
163398863|NCT02109562|590170913|FG001|Overall Study|Lost to Follow-up|0|||
163207431|NCT02289417|589471101|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
163207432|NCT02289417|589471102|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
163314813|NCT03904147|589863236|FG001|Overall Study|Withdrawal by Subject|12|||
163314814|NCT03904147|589863237|FG002|Overall Study|Withdrawal by Subject|1|||
163314815|NCT03904147|589863235|FG000|Overall Study|1Y visit completed after 365 days|1|||
163207433|NCT02289417|589471103|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
163207434|NCT02289417|589471095|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
163207435|NCT02289417|589471096|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
163207436|NCT02289417|589471097|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
163207437|NCT02289417|589471098|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
163207438|NCT02289417|589471099|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
163207439|NCT02289417|589471100|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
163207440|NCT02289417|589471101|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
163207441|NCT02289417|589471102|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
163207442|NCT02289417|589471103|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
163207443|NCT02725710|589471104|FG000|Overall Study|Lost to Follow-up|1|||
163207444|NCT02725710|589471105|FG001|Overall Study|Lost to Follow-up|0|||
163207445|NCT02505867|589471106|FG000|Overall Study|Lack of Efficacy|6|||
163207446|NCT02505867|589471107|FG001|Overall Study|Lack of Efficacy|6|||
163207447|NCT01782222|589471108|FG000|Overall Study|Adverse Event|4|||
163207448|NCT01782222|589471109|FG001|Overall Study|Adverse Event|5|||
163207449|NCT01782222|589471110|FG002|Overall Study|Adverse Event|3|||
163207450|NCT01782222|589471108|FG000|Overall Study|Lack of Efficacy|2|||
163207451|NCT01782222|589471109|FG001|Overall Study|Lack of Efficacy|1|||
163207452|NCT01782222|589471110|FG002|Overall Study|Lack of Efficacy|0|||
163207453|NCT01782222|589471108|FG000|Overall Study|Protocol Violation|1|||
163207454|NCT01782222|589471109|FG001|Overall Study|Protocol Violation|0|||
163207455|NCT01782222|589471110|FG002|Overall Study|Protocol Violation|0|||
163207456|NCT01782222|589471108|FG000|Overall Study|Withdrawal by Subject|1|||
163207457|NCT01782222|589471109|FG001|Overall Study|Withdrawal by Subject|4|||
163207458|NCT01782222|589471110|FG002|Overall Study|Withdrawal by Subject|1|||
163207459|NCT01782222|589471108|FG000|Overall Study|Moved to other state|0|||
163207460|NCT01782222|589471109|FG001|Overall Study|Moved to other state|1|||
163207461|NCT01782222|589471110|FG002|Overall Study|Moved to other state|0|||
163207462|NCT03200860|589471111|FG000|Overall Study|Withdrawal by Subject|1|||
163207463|NCT03200860|589471112|FG001|Overall Study|Withdrawal by Subject|0|||
163207464|NCT01605877|589471113|FG000|Overall Study|Withdrawal by Subject|1|||
163207465|NCT01918085|589471118|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
163207466|NCT01918085|589471119|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
163207467|NCT02634320|589471123|FG000|Overall Study|Adverse Event|2|||
163207468|NCT02634320|589471123|FG000|Overall Study|Lost to Follow-up|3|||
163207469|NCT02634320|589471123|FG000|Overall Study|Moved out of area|2|||
163207470|NCT02634320|589471123|FG000|Overall Study|Out of window for study visits|1|||
163207471|NCT02634320|589471123|FG000|Overall Study|Protocol Violation|1|||
163207472|NCT02634320|589471123|FG000|Overall Study|Withdrawal by Subject|5|||
163207473|NCT02634320|589471123|FG000|Overall Study|Lack of Efficacy|2|||
163207474|NCT00687323|589471124|FG000|Overall Study|Death|25|||
163207475|NCT00687323|589471124|FG000|Overall Study|Withdrawal by Subject|1|||
163207476|NCT00687323|589471124|FG000|Overall Study|Excluded from efficacy evaluations|6|||
163207477|NCT00687323|589471124|FG000|Overall Study|Screen failure|148|||
163207478|NCT03655691|589471132|FG000|Overall Study|Adverse Event|0|||
163207479|NCT03655691|589471133|FG001|Overall Study|Adverse Event|0|||
163207480|NCT03655691|589471134|FG002|Overall Study|Adverse Event|1|||
163207481|NCT03655691|589471132|FG000|Overall Study|Lost to Follow-up|1|||
163207482|NCT03655691|589471133|FG001|Overall Study|Lost to Follow-up|1|||
163207483|NCT03655691|589471134|FG002|Overall Study|Lost to Follow-up|2|||
163207484|NCT03655691|589471132|FG000|Overall Study|Protocol Violation|0|||
163207485|NCT03655691|589471133|FG001|Overall Study|Protocol Violation|1|||
163207486|NCT03655691|589471134|FG002|Overall Study|Protocol Violation|0|||
163207487|NCT03655691|589471132|FG000|Overall Study|Withdrawal by Subject|1|||
163314816|NCT03904147|589863236|FG001|Overall Study|1Y visit completed after 365 days|1|||
163207488|NCT03655691|589471133|FG001|Overall Study|Withdrawal by Subject|1|||
163207489|NCT03655691|589471134|FG002|Overall Study|Withdrawal by Subject|0|||
163398864|NCT02109562|590170914|FG002|Overall Study|Lost to Follow-up|1|||
163398865|NCT02109562|590170912|FG000|Overall Study|Protocol Violation|0|||
163398866|NCT02109562|590170913|FG001|Overall Study|Protocol Violation|3|||
163207490|NCT04557371|589471135|FG000|Overall Study|Covid-19-related|0|||
163207491|NCT04557371|589471136|FG001|Overall Study|Covid-19-related|1|||
163207492|NCT04557371|589471137|FG002|Overall Study|Covid-19-related|0|||
163207493|NCT04557371|589471135|FG000|Overall Study|Withdrawal by Subject|0|||
163207494|NCT04557371|589471136|FG001|Overall Study|Withdrawal by Subject|1|||
163207495|NCT04557371|589471137|FG002|Overall Study|Withdrawal by Subject|0|||
163207496|NCT04557371|589471135|FG000|Overall Study|Adverse Event|1|||
163207497|NCT04557371|589471136|FG001|Overall Study|Adverse Event|0|||
163207498|NCT04557371|589471137|FG002|Overall Study|Adverse Event|0|||
163207499|NCT01428453|589471140|FG000|Overall Study|Adverse Event|2|||
163207500|NCT01428453|589471141|FG001|Overall Study|Adverse Event|7|||
163207501|NCT01428453|589471140|FG000|Overall Study|Protocol Violation|1|||
163207502|NCT01428453|589471141|FG001|Overall Study|Protocol Violation|0|||
163207503|NCT01428453|589471140|FG000|Overall Study|Lost to Follow-up|0|||
163207504|NCT01428453|589471141|FG001|Overall Study|Lost to Follow-up|1|||
163207505|NCT01428453|589471140|FG000|Overall Study|Withdrawal by Subject|3|||
163207506|NCT01428453|589471141|FG001|Overall Study|Withdrawal by Subject|1|||
163207507|NCT01996709|589471142|FG000|Overall Study|Withdrawal by Subject|1|||
162979007|NCT03545191|588623548|FG002|Overall Study|Lost to Follow-up|3|||
163314817|NCT03904147|589863237|FG002|Overall Study|1Y visit completed after 365 days|0|||
163314818|NCT05399459|589863241|FG000|Overall Study|Randomized but not treated|29|||
163314819|NCT05399459|589863242|FG001|Overall Study|Randomized but not treated|30|||
163314820|NCT05399459|589863243|FG002|Overall Study|Randomized but not treated|38|||
163314821|NCT05399459|589863241|FG000|Overall Study|Lost to Follow-up|1|||
163314822|NCT05399459|589863242|FG001|Overall Study|Lost to Follow-up|0|||
163314823|NCT05399459|589863243|FG002|Overall Study|Lost to Follow-up|0|||
163314824|NCT03625167|589863244|FG000|Overall Study|Protocol Violation|5|||
163314825|NCT05583578|589863245|FG000|Overall Study|Withdrawal by Subject|2|||
163314826|NCT05583578|589863246|FG001|Overall Study|Withdrawal by Subject|0|||
163314827|NCT05877976|589863247|FG000|Overall Study|Lost to Follow-up|31|||
163314828|NCT00248287|589863248|FG000|Overall Study|Adverse Event|11|||
163314829|NCT00248287|589863249|FG001|Overall Study|Adverse Event|10|||
163314830|NCT00248287|589863248|FG000|Overall Study|Death|1|||
163314831|NCT00248287|589863249|FG001|Overall Study|Death|0|||
163314832|NCT00248287|589863248|FG000|Overall Study|Lost to Follow-up|0|||
163314833|NCT00248287|589863249|FG001|Overall Study|Lost to Follow-up|1|||
163314834|NCT00248287|589863248|FG000|Overall Study|Investigator Request|4|||
163314835|NCT00248287|589863249|FG001|Overall Study|Investigator Request|3|||
163314836|NCT00248287|589863248|FG000|Overall Study|Patient Request|5|||
163314837|NCT00248287|589863249|FG001|Overall Study|Patient Request|3|||
163314838|NCT00248287|589863248|FG000|Overall Study|Other|3|||
163314839|NCT00248287|589863249|FG001|Overall Study|Other|2|||
163314840|NCT04103580|589863252|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
163314841|NCT04103580|589863253|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
163314842|NCT04103580|589863252|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
163314843|NCT04103580|589863253|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
163314844|NCT04103580|589863252|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
163314845|NCT04103580|589863253|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
163314846|NCT04103580|589863252|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
163314847|NCT04103580|589863253|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
163314848|NCT04103580|589863252|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
163314849|NCT04103580|589863253|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
163314850|NCT04103580|589863252|FG000|Phase 1 Active Caregiving|Other|3|||
163314851|NCT04103580|589863253|FG001|Phase 1 Active Caregiving|Other|3|||
163314852|NCT04103580|589863252|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
163314853|NCT04103580|589863253|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
163314854|NCT04103580|589863252|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
163314855|NCT04103580|589863253|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
163314856|NCT04103580|589863252|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
163314857|NCT04103580|589863253|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
163314858|NCT04103580|589863252|FG000|Phase 2 Bereavement|Other|8|||
163314859|NCT04103580|589863253|FG001|Phase 2 Bereavement|Other|6|||
163314860|NCT04145440|589863254|FG000|Overall Study|Physician Decision|3|||
163314861|NCT04145440|589863255|FG001|Overall Study|Physician Decision|0|||
163314862|NCT04145440|589863254|FG000|Overall Study|Use of prohibited therapy|2|||
163314863|NCT04145440|589863255|FG001|Overall Study|Use of prohibited therapy|3|||
163314864|NCT04248725|589863269|FG000|Post-Treatment|Lost to Follow-up|6|||
163314865|NCT04248725|589863270|FG001|Post-Treatment|Lost to Follow-up|5|||
163314866|NCT04248725|589863269|FG000|6-Month Follow Up|Lost to Follow-up|9|||
163314867|NCT04248725|589863270|FG001|6-Month Follow Up|Lost to Follow-up|8|||
163314868|NCT01210807|589863277|FG000|Overall Study|Lost to Follow-up|1|||
163314869|NCT01210807|589863278|FG001|Overall Study|Lost to Follow-up|2|||
163314870|NCT01210807|589863277|FG000|Overall Study|Not implanted bilaterally|2|||
163314871|NCT01210807|589863278|FG001|Overall Study|Not implanted bilaterally|1|||
163314872|NCT05977530|589863279|FG000|Overall Study|Withdrawal by Subject|1|||
163314873|NCT05977530|589863279|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
163314874|NCT05496231|589863280|FG000|Overall Study|Adverse Event|1|||
163314875|NCT05496231|589863281|FG001|Overall Study|Adverse Event|1|||
163314876|NCT05496231|589863282|FG002|Overall Study|Adverse Event|0|||
162967411|NCT01670097|588581367|FG001|Overall Study|Clinical deterioration|1|||
162967412|NCT01670097|588581366|FG000|Overall Study|Disease progression|0|||
162967413|NCT01670097|588581367|FG001|Overall Study|Disease progression|1|||
162967414|NCT02311894|588581368|FG000|Overall Study|Discontinued in error|1|||
162967415|NCT02311894|588581368|FG000|Overall Study|Lost to Follow-up|1|||
162967416|NCT02311894|588581368|FG000|Overall Study|Adverse Event|1|||
163314877|NCT05496231|589863283|FG003|Overall Study|Adverse Event|4|||
163314878|NCT05496231|589863280|FG000|Overall Study|Withdrawal by Subject|5|||
162967417|NCT02311894|588581368|FG000|Overall Study|Withdrawal by Subject|1|||
163314879|NCT05496231|589863281|FG001|Overall Study|Withdrawal by Subject|5|||
163314880|NCT05496231|589863282|FG002|Overall Study|Withdrawal by Subject|4|||
163314881|NCT05496231|589863283|FG003|Overall Study|Withdrawal by Subject|11|||
163314882|NCT05496231|589863280|FG000|Overall Study|Migrated/moved from the study area|3|||
163314883|NCT05496231|589863281|FG001|Overall Study|Migrated/moved from the study area|5|||
163314884|NCT05496231|589863282|FG002|Overall Study|Migrated/moved from the study area|3|||
163314885|NCT05496231|589863283|FG003|Overall Study|Migrated/moved from the study area|3|||
163314886|NCT05496231|589863280|FG000|Overall Study|Lost to Follow-up|13|||
163314887|NCT05496231|589863281|FG001|Overall Study|Lost to Follow-up|6|||
163314888|NCT05496231|589863282|FG002|Overall Study|Lost to Follow-up|11|||
163314889|NCT05496231|589863283|FG003|Overall Study|Lost to Follow-up|6|||
163314890|NCT05496231|589863280|FG000|Overall Study|Other|9|||
163314891|NCT05496231|589863281|FG001|Overall Study|Other|7|||
163314892|NCT05496231|589863282|FG002|Overall Study|Other|7|||
163314893|NCT05496231|589863283|FG003|Overall Study|Other|8|||
163314894|NCT05940194|589863300|FG000|Overall Study|Adverse Event|0|||
163314895|NCT05940194|589863301|FG001|Overall Study|Adverse Event|1|||
163314896|NCT05940194|589863302|FG002|Overall Study|Adverse Event|0|||
163314897|NCT05940194|589863300|FG000|Overall Study|Migrated/Moved from the study area|2|||
163314898|NCT05940194|589863301|FG001|Overall Study|Migrated/Moved from the study area|2|||
163314899|NCT05940194|589863302|FG002|Overall Study|Migrated/Moved from the study area|4|||
163314900|NCT04568434|589863309|FG000|Overall Study|Voluntary Withdrawal|0|||
163314901|NCT04568434|589863310|FG001|Overall Study|Voluntary Withdrawal|1|||
163314902|NCT04568434|589863311|FG002|Overall Study|Voluntary Withdrawal|1|||
163314903|NCT04568434|589863309|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
163314904|NCT04568434|589863310|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
163314905|NCT04568434|589863311|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
163314906|NCT04568434|589863309|FG000|Overall Study|Investigator Judgement|1|||
163314907|NCT04568434|589863310|FG001|Overall Study|Investigator Judgement|0|||
163314908|NCT04568434|589863311|FG002|Overall Study|Investigator Judgement|0|||
163314909|NCT04081103|589863318|FG000|Overall Study|Adverse Event|1|||
163314910|NCT04081103|589863319|FG001|Overall Study|Adverse Event|1|||
163314911|NCT04081103|589863320|FG002|Overall Study|Adverse Event|1|||
163314912|NCT04081103|589863318|FG000|Overall Study|Physician Decision|0|||
163314913|NCT04081103|589863319|FG001|Overall Study|Physician Decision|0|||
163314914|NCT04081103|589863320|FG002|Overall Study|Physician Decision|1|||
163314915|NCT03365882|589863321|FG000|Randomization|Still Receiving Protocol Treatment|2|||
163314916|NCT03365882|589863322|FG001|Randomization|Still Receiving Protocol Treatment|0|||
163314917|NCT03365882|589863321|FG000|Randomization|Adverse Event|1|||
163314918|NCT03365882|589863322|FG001|Randomization|Adverse Event|2|||
163314919|NCT03365882|589863321|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
163314920|NCT03365882|589863322|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
163314921|NCT03365882|589863321|FG000|Randomization|Progression/Relapse|21|||
163314922|NCT03365882|589863322|FG001|Randomization|Progression/Relapse|3|||
163314923|NCT03365882|589863321|FG000|Randomization|Death|1|||
163314924|NCT03365882|589863322|FG001|Randomization|Death|0|||
163314925|NCT03365882|589863321|FG000|Randomization|Other - Not Protocol Specified|1|||
163314926|NCT03365882|589863322|FG001|Randomization|Other - Not Protocol Specified|1|||
163398867|NCT02109562|590170914|FG002|Overall Study|Protocol Violation|1|||
163398868|NCT02109562|590170912|FG000|Overall Study|Withdrawal by Subject|20|||
163398869|NCT02109562|590170913|FG001|Overall Study|Withdrawal by Subject|25|||
163398870|NCT02109562|590170914|FG002|Overall Study|Withdrawal by Subject|21|||
163398871|NCT02109562|590170912|FG000|Overall Study|Physician Decision|3|||
163398872|NCT02109562|590170913|FG001|Overall Study|Physician Decision|4|||
163398873|NCT02109562|590170914|FG002|Overall Study|Physician Decision|5|||
163398874|NCT00262522|590170926|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
163398875|NCT00262522|590170927|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
163398876|NCT00262522|590170928|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
163398877|NCT00262522|590170929|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
163398878|NCT00262522|590170926|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
163398879|NCT00262522|590170927|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
163054297|NCT00977197|588910224|FG001|Overall Study|Nonadherence|1|||
163054298|NCT05379920|588910225|FG000|Overall Study|Lost to Follow-up|0|||
163398880|NCT00262522|590170928|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
163398881|NCT00262522|590170929|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
163054299|NCT05379920|588910226|FG001|Overall Study|Lost to Follow-up|5|||
163398882|NCT00262522|590170926|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
163314927|NCT03365882|589863321|FG000|Randomization|Major Protocol Deviation|0|||
163314928|NCT03365882|589863322|FG001|Randomization|Major Protocol Deviation|1|||
163314929|NCT03365882|589863321|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
163314930|NCT03365882|589863322|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
163314931|NCT03365882|589863321|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
163314932|NCT03365882|589863322|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
163314933|NCT03365882|589863321|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
163314934|NCT03365882|589863322|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
163314935|NCT03365882|589863321|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
163314936|NCT03365882|589863322|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
163314937|NCT03023410|589866029|FG000|Overall Study|study termination|0|||
163314938|NCT03023410|589866030|FG001|Overall Study|study termination|1|||
163314939|NCT04799899|589866031|FG000|Overall Study|Lost to Follow-up|2|||
163314940|NCT04799899|589866032|FG001|Overall Study|Lost to Follow-up|4|||
163314941|NCT05459688|589866033|FG000|Overall Study|Lost to Follow-up|6|||
163314942|NCT05459688|589866033|FG000|Overall Study|Physician Decision|1|||
163314943|NCT05459688|589866033|FG000|Overall Study|Withdrawal by Subject|19|||
163314944|NCT05459688|589866033|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
163314945|NCT03379675|589866036|FG000|Overall Study|Lost to Follow-up|0|||
163314946|NCT03379675|589866037|FG001|Overall Study|Lost to Follow-up|1|||
163314947|NCT03379675|589866038|FG002|Overall Study|Lost to Follow-up|0|||
163314948|NCT03379675|589866036|FG000|Overall Study|Adverse Event|2|||
163314949|NCT03379675|589866037|FG001|Overall Study|Adverse Event|0|||
163314950|NCT03379675|589866038|FG002|Overall Study|Adverse Event|0|||
163314951|NCT03379675|589866036|FG000|Overall Study|Withdrawal by Subject|2|||
163314952|NCT03379675|589866037|FG001|Overall Study|Withdrawal by Subject|1|||
163314953|NCT03379675|589866038|FG002|Overall Study|Withdrawal by Subject|2|||
163314954|NCT02817776|589866039|FG000|Overall Study|Excluded|33|||
163314955|NCT02817776|589866039|FG000|Overall Study|Lost to Follow-up|20|||
163314956|NCT02817776|589866039|FG000|Overall Study|Withdrawal by Subject|33|||
163314957|NCT02817776|589866039|FG000|Overall Study|Death|2|||
163314958|NCT06504862|589866042|FG000|Transition period|Adverse Event|1|||
163314959|NCT06504862|589866043|FG001|Transition period|Adverse Event|0|||
163314960|NCT05949788|589866044|FG000|Overall Study|severe birth deformity|2|||
163314961|NCT05949788|589866045|FG001|Overall Study|severe birth deformity|7|||
163314962|NCT05949788|589866044|FG000|Overall Study|twin-twin transfusion syndrome|2|||
163314963|NCT05949788|589866045|FG001|Overall Study|twin-twin transfusion syndrome|7|||
163314964|NCT05949788|589866044|FG000|Overall Study|neonatal hemolytic disease|3|||
163314965|NCT05949788|589866045|FG001|Overall Study|neonatal hemolytic disease|8|||
163314966|NCT05949788|589866044|FG000|Overall Study|death within 14 days after birth|2|||
163314967|NCT05949788|589866045|FG001|Overall Study|death within 14 days after birth|6|||
163314968|NCT05949788|589866044|FG000|Overall Study|transfer to another hospital|2|||
163314969|NCT05949788|589866045|FG001|Overall Study|transfer to another hospital|6|||
163314970|NCT01574274|589866046|FG000|Overall Study|Ineligible|0|||
163314971|NCT01574274|589866047|FG001|Overall Study|Ineligible|1|||
163314972|NCT01574274|589866046|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
163314973|NCT01574274|589866047|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
163314974|NCT01574274|589866046|FG000|Overall Study|Ph+ B-ALL|3|||
163314975|NCT01574274|589866047|FG001|Overall Study|Ph+ B-ALL|4|||
163314976|NCT01574274|589866046|FG000|Overall Study|Induction Death|2|||
163314977|NCT01574274|589866047|FG001|Overall Study|Induction Death|0|||
163314978|NCT01574274|589866046|FG000|Overall Study|Induction Failure|4|||
163314979|NCT01574274|589866047|FG001|Overall Study|Induction Failure|1|||
163314980|NCT01574274|589866046|FG000|Overall Study|Adverse Event|16|||
163314981|NCT01574274|589866047|FG001|Overall Study|Adverse Event|13|||
163314982|NCT01574274|589866046|FG000|Overall Study|Remission Death|1|||
163314983|NCT01574274|589866047|FG001|Overall Study|Remission Death|0|||
163314984|NCT01574274|589866046|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
163314985|NCT01574274|589866047|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
163314986|NCT01574274|589866046|FG000|Overall Study|Other, unknown|3|||
163314987|NCT01574274|589866047|FG001|Overall Study|Other, unknown|2|||
163314988|NCT02191618|589866057|FG000|Overall Study|Withdrawal by Subject|3|||
163314989|NCT02191618|589866057|FG000|Overall Study|Missed Visit|4|||
163314990|NCT01943409|589866061|FG000|Overall Study|resumed oral/entral|24|||
163314991|NCT01943409|589866062|FG001|Overall Study|resumed oral/entral|20|||
163314992|NCT01943409|589866061|FG000|Overall Study|Protocol Violation|14|||
163314993|NCT01943409|589866062|FG001|Overall Study|Protocol Violation|24|||
163314994|NCT01943409|589866061|FG000|Overall Study|Death|3|||
163314995|NCT01943409|589866062|FG001|Overall Study|Death|1|||
163314996|NCT01943409|589866061|FG000|Overall Study|Withdrawal by Subject|4|||
163314997|NCT01943409|589866062|FG001|Overall Study|Withdrawal by Subject|3|||
163314998|NCT02489903|589866063|FG000|Screening|Screen Failure|24|||
163314999|NCT02489903|589866064|FG001|Screening|Screen Failure|0|||
163398883|NCT00262522|590170927|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
163398884|NCT00262522|590170928|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
163398885|NCT00262522|590170929|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
163398886|NCT00262522|590170926|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
163398887|NCT00262522|590170927|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
163398888|NCT00262522|590170928|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
163398889|NCT00262522|590170929|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
163398890|NCT00262522|590170926|FG000|Study Start Through 8 Weeks|Death|1|||
163398891|NCT00262522|590170927|FG001|Study Start Through 8 Weeks|Death|0|||
163398892|NCT00262522|590170928|FG002|Study Start Through 8 Weeks|Death|0|||
163398893|NCT00262522|590170929|FG003|Study Start Through 8 Weeks|Death|0|||
163398894|NCT00262522|590170926|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
163398895|NCT00262522|590170927|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
163398896|NCT00262522|590170928|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
163398897|NCT00262522|590170929|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
163398898|NCT00262522|590170926|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
163398899|NCT00262522|590170927|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
163398900|NCT00262522|590170928|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
163398901|NCT00262522|590170929|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
163398902|NCT00262522|590170926|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
163398903|NCT00262522|590170927|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
163315000|NCT02489903|589866065|FG002|Screening|Screen Failure|0|||
163315001|NCT02489903|589866066|FG003|Screening|Screen Failure|8|||
163315002|NCT02489903|589866063|FG000|Randomized and Received Treatment|Protocol Violation|0|||
163315003|NCT02489903|589866064|FG001|Randomized and Received Treatment|Protocol Violation|1|||
163315004|NCT02489903|589866065|FG002|Randomized and Received Treatment|Protocol Violation|0|||
163315005|NCT02489903|589866066|FG003|Randomized and Received Treatment|Protocol Violation|0|||
163315006|NCT02489903|589866063|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
163315007|NCT02489903|589866064|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
163315008|NCT02489903|589866065|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
163315009|NCT02489903|589866066|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
163315010|NCT02489903|589866063|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
163315011|NCT02489903|589866064|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
163315012|NCT02489903|589866065|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
163315013|NCT02489903|589866066|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
163315014|NCT02489903|589866063|FG000|Randomized and Received Treatment|Death|10|||
163315015|NCT02489903|589866064|FG001|Randomized and Received Treatment|Death|1|||
163315016|NCT02489903|589866065|FG002|Randomized and Received Treatment|Death|0|||
163315017|NCT02489903|589866066|FG003|Randomized and Received Treatment|Death|0|||
163315018|NCT04413708|589866067|FG000|Overall Study|Lost to Follow-up|1|||
163315019|NCT04413708|589866068|FG001|Overall Study|Lost to Follow-up|2|||
163315020|NCT04599062|589866069|FG000|Overall Study|Physician Decision|1|||
163315021|NCT04599062|589866070|FG001|Overall Study|Physician Decision|0|||
163315022|NCT06103188|589866075|FG000|Overall Study|Lost to Follow-up|1|||
163315023|NCT06103188|589866076|FG001|Overall Study|Lost to Follow-up|6|||
163315024|NCT06103188|589866077|FG002|Overall Study|Lost to Follow-up|4|||
163315025|NCT02969707|589866080|FG000|Overall Study|Withdrawal by Subject|6|||
163315026|NCT02969707|589866081|FG001|Overall Study|Withdrawal by Subject|5|||
163315027|NCT02969707|589866080|FG000|Overall Study|Severe anxiety|0|||
163315028|NCT02969707|589866081|FG001|Overall Study|Severe anxiety|1|||
163315029|NCT02969707|589866080|FG000|Overall Study|Positive toxicology screen|0|||
163315030|NCT02969707|589866081|FG001|Overall Study|Positive toxicology screen|2|||
163315031|NCT02969707|589866080|FG000|Overall Study|Claustrophobia|2|||
163315032|NCT02969707|589866081|FG001|Overall Study|Claustrophobia|2|||
163315033|NCT02969707|589866080|FG000|Overall Study|Non-compliance|1|||
163315034|NCT02969707|589866081|FG001|Overall Study|Non-compliance|2|||
163315035|NCT03020199|589866086|FG000|Treatment Period|Adverse Event|0|||
163315036|NCT03020199|589866087|FG001|Treatment Period|Adverse Event|2|||
163315037|NCT03020199|589866086|FG000|Treatment Period|Lack of Efficacy|1|||
163315038|NCT03020199|589866087|FG001|Treatment Period|Lack of Efficacy|6|||
163315039|NCT03020199|589866086|FG000|Treatment Period|Lost to Follow-up|1|||
163315040|NCT03020199|589866087|FG001|Treatment Period|Lost to Follow-up|6|||
163315041|NCT03020199|589866086|FG000|Treatment Period|Physician Decision|0|||
163398904|NCT00262522|590170928|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
163398905|NCT00262522|590170929|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
163398906|NCT00262522|590170926|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
163398907|NCT00262522|590170927|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
163315042|NCT03020199|589866087|FG001|Treatment Period|Physician Decision|1|||
163398908|NCT00262522|590170928|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
163398909|NCT00262522|590170929|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
163315043|NCT03020199|589866086|FG000|Treatment Period|Subject/guardian decision|8|||
163315044|NCT03020199|589866087|FG001|Treatment Period|Subject/guardian decision|15|||
163315045|NCT03020199|589866086|FG000|Treatment Period|Subjects not treated|3|||
163315046|NCT03020199|589866087|FG001|Treatment Period|Subjects not treated|4|||
163315047|NCT03020199|589866086|FG000|Follow-up Period|Disease relapse|32|||
163315048|NCT03020199|589866087|FG001|Follow-up Period|Disease relapse|7|||
163315049|NCT03020199|589866086|FG000|Follow-up Period|Lack of Efficacy|1|||
163315050|NCT03020199|589866087|FG001|Follow-up Period|Lack of Efficacy|2|||
163315051|NCT03020199|589866086|FG000|Follow-up Period|Lost to Follow-up|4|||
163315052|NCT03020199|589866087|FG001|Follow-up Period|Lost to Follow-up|6|||
163315053|NCT03020199|589866086|FG000|Follow-up Period|Physician Decision|2|||
163315054|NCT03020199|589866087|FG001|Follow-up Period|Physician Decision|2|||
163315055|NCT03020199|589866086|FG000|Follow-up Period|Protocol Violation|1|||
163315056|NCT03020199|589866087|FG001|Follow-up Period|Protocol Violation|2|||
163315057|NCT03020199|589866086|FG000|Follow-up Period|Study terminated by Sponsor|6|||
163315058|NCT03020199|589866087|FG001|Follow-up Period|Study terminated by Sponsor|3|||
163315059|NCT03020199|589866086|FG000|Follow-up Period|Subject/guardian decision|14|||
163315060|NCT03020199|589866087|FG001|Follow-up Period|Subject/guardian decision|9|||
163315061|NCT04314713|589866088|FG000|Overall Study|Lost to Follow-up|0|||
163315062|NCT04314713|589866089|FG001|Overall Study|Lost to Follow-up|0|||
163315063|NCT04314713|589866090|FG002|Overall Study|Lost to Follow-up|0|||
163315064|NCT04314713|589866091|FG003|Overall Study|Lost to Follow-up|1|||
163315065|NCT04314713|589866092|FG004|Overall Study|Lost to Follow-up|0|||
163315066|NCT04314713|589866093|FG005|Overall Study|Lost to Follow-up|0|||
163315067|NCT02714257|589866096|FG000|Overall Study|Withdrawal by Subject|6|||
163315068|NCT02714257|589866097|FG001|Overall Study|Withdrawal by Subject|11|||
163315069|NCT02714257|589866096|FG000|Overall Study|Death|3|||
163315070|NCT02714257|589866097|FG001|Overall Study|Death|4|||
163315071|NCT02714257|589866096|FG000|Overall Study|Lost to Follow-up|1|||
163315072|NCT02714257|589866097|FG001|Overall Study|Lost to Follow-up|6|||
163315073|NCT04436276|589866104|FG000|Overall Study|Adverse Event|0|||
163315074|NCT04436276|589866105|FG001|Overall Study|Adverse Event|0|||
163315075|NCT04436276|589866106|FG002|Overall Study|Adverse Event|0|||
163315076|NCT04436276|589866107|FG003|Overall Study|Adverse Event|0|||
163315077|NCT04436276|589866108|FG004|Overall Study|Adverse Event|0|||
163315078|NCT04436276|589866109|FG005|Overall Study|Adverse Event|0|||
163315079|NCT04436276|589866110|FG006|Overall Study|Adverse Event|0|||
163315080|NCT04436276|589866111|FG007|Overall Study|Adverse Event|0|||
163315081|NCT04436276|589866112|FG008|Overall Study|Adverse Event|0|||
163315082|NCT04436276|589866113|FG009|Overall Study|Adverse Event|0|||
163315083|NCT04436276|589866114|FG010|Overall Study|Adverse Event|0|||
163315084|NCT04436276|589866115|FG011|Overall Study|Adverse Event|0|||
163315085|NCT04436276|589866116|FG012|Overall Study|Adverse Event|0|||
163315086|NCT04436276|589866117|FG013|Overall Study|Adverse Event|0|||
163315087|NCT04436276|589866118|FG014|Overall Study|Adverse Event|0|||
163315088|NCT04436276|589866119|FG015|Overall Study|Adverse Event|0|||
163315089|NCT04436276|589866120|FG016|Overall Study|Adverse Event|1|||
163315090|NCT04436276|589866121|FG017|Overall Study|Adverse Event|0|||
163315091|NCT04436276|589866122|FG018|Overall Study|Adverse Event|0|||
163315092|NCT04436276|589866123|FG019|Overall Study|Adverse Event|0|||
163315093|NCT04436276|589866124|FG020|Overall Study|Adverse Event|0|||
163315094|NCT04436276|589866125|FG021|Overall Study|Adverse Event|0|||
163315095|NCT04436276|589866126|FG022|Overall Study|Adverse Event|0|||
163315096|NCT04436276|589866104|FG000|Overall Study|Death|0|||
163315097|NCT04436276|589866105|FG001|Overall Study|Death|0|||
163315098|NCT04436276|589866106|FG002|Overall Study|Death|0|||
163315099|NCT04436276|589866107|FG003|Overall Study|Death|0|||
163315100|NCT04436276|589866108|FG004|Overall Study|Death|0|||
163315101|NCT04436276|589866109|FG005|Overall Study|Death|0|||
163315102|NCT04436276|589866110|FG006|Overall Study|Death|0|||
163315103|NCT04436276|589866111|FG007|Overall Study|Death|0|||
163315104|NCT04436276|589866112|FG008|Overall Study|Death|0|||
163315105|NCT04436276|589866113|FG009|Overall Study|Death|0|||
163315106|NCT04436276|589866114|FG010|Overall Study|Death|0|||
163315107|NCT04436276|589866115|FG011|Overall Study|Death|0|||
163315108|NCT04436276|589866116|FG012|Overall Study|Death|1|||
163315109|NCT04436276|589866117|FG013|Overall Study|Death|0|||
163315110|NCT04436276|589866118|FG014|Overall Study|Death|1|||
163315111|NCT04436276|589866119|FG015|Overall Study|Death|0|||
163315112|NCT04436276|589866120|FG016|Overall Study|Death|0|||
163315113|NCT04436276|589866121|FG017|Overall Study|Death|0|||
163315114|NCT04436276|589866122|FG018|Overall Study|Death|0|||
163315115|NCT04436276|589866123|FG019|Overall Study|Death|2|||
163315116|NCT04436276|589866124|FG020|Overall Study|Death|0|||
163315117|NCT04436276|589866125|FG021|Overall Study|Death|1|||
163315118|NCT04436276|589866126|FG022|Overall Study|Death|0|||
163315119|NCT04436276|589866104|FG000|Overall Study|Lost to Follow-up|0|||
163315120|NCT04436276|589866105|FG001|Overall Study|Lost to Follow-up|2|||
163315121|NCT04436276|589866106|FG002|Overall Study|Lost to Follow-up|2|||
163315122|NCT04436276|589866107|FG003|Overall Study|Lost to Follow-up|1|||
163315123|NCT04436276|589866108|FG004|Overall Study|Lost to Follow-up|4|||
163315124|NCT04436276|589866109|FG005|Overall Study|Lost to Follow-up|1|||
163315125|NCT04436276|589866110|FG006|Overall Study|Lost to Follow-up|0|||
163315126|NCT04436276|589866111|FG007|Overall Study|Lost to Follow-up|0|||
163315127|NCT04436276|589866112|FG008|Overall Study|Lost to Follow-up|1|||
163315128|NCT04436276|589866113|FG009|Overall Study|Lost to Follow-up|0|||
163315129|NCT04436276|589866114|FG010|Overall Study|Lost to Follow-up|5|||
163315130|NCT04436276|589866115|FG011|Overall Study|Lost to Follow-up|5|||
163315131|NCT04436276|589866116|FG012|Overall Study|Lost to Follow-up|4|||
163315132|NCT04436276|589866117|FG013|Overall Study|Lost to Follow-up|1|||
163315133|NCT04436276|589866118|FG014|Overall Study|Lost to Follow-up|7|||
163315134|NCT04436276|589866119|FG015|Overall Study|Lost to Follow-up|7|||
163315135|NCT04436276|589866120|FG016|Overall Study|Lost to Follow-up|1|||
163315136|NCT04436276|589866121|FG017|Overall Study|Lost to Follow-up|0|||
163315137|NCT04436276|589866122|FG018|Overall Study|Lost to Follow-up|1|||
163315138|NCT04436276|589866123|FG019|Overall Study|Lost to Follow-up|1|||
163315139|NCT04436276|589866124|FG020|Overall Study|Lost to Follow-up|2|||
163315140|NCT04436276|589866125|FG021|Overall Study|Lost to Follow-up|1|||
163315141|NCT04436276|589866126|FG022|Overall Study|Lost to Follow-up|1|||
163315142|NCT04436276|589866104|FG000|Overall Study|Physician Decision|1|||
163315143|NCT04436276|589866105|FG001|Overall Study|Physician Decision|0|||
163315144|NCT04436276|589866106|FG002|Overall Study|Physician Decision|2|||
163315145|NCT04436276|589866107|FG003|Overall Study|Physician Decision|1|||
163315146|NCT04436276|589866108|FG004|Overall Study|Physician Decision|0|||
163315147|NCT04436276|589866109|FG005|Overall Study|Physician Decision|0|||
163315148|NCT04436276|589866110|FG006|Overall Study|Physician Decision|0|||
163315149|NCT04436276|589866111|FG007|Overall Study|Physician Decision|0|||
163315150|NCT04436276|589866112|FG008|Overall Study|Physician Decision|0|||
163315151|NCT04436276|589866113|FG009|Overall Study|Physician Decision|0|||
163315152|NCT04436276|589866114|FG010|Overall Study|Physician Decision|0|||
163315153|NCT04436276|589866115|FG011|Overall Study|Physician Decision|1|||
163315154|NCT04436276|589866116|FG012|Overall Study|Physician Decision|2|||
163315155|NCT04436276|589866117|FG013|Overall Study|Physician Decision|0|||
163315156|NCT04436276|589866118|FG014|Overall Study|Physician Decision|0|||
163315157|NCT04436276|589866119|FG015|Overall Study|Physician Decision|0|||
163315158|NCT04436276|589866120|FG016|Overall Study|Physician Decision|0|||
163315159|NCT04436276|589866121|FG017|Overall Study|Physician Decision|0|||
163315160|NCT04436276|589866122|FG018|Overall Study|Physician Decision|0|||
163315161|NCT04436276|589866123|FG019|Overall Study|Physician Decision|0|||
163315162|NCT04436276|589866124|FG020|Overall Study|Physician Decision|1|||
163315163|NCT04436276|589866125|FG021|Overall Study|Physician Decision|2|||
163315164|NCT04436276|589866126|FG022|Overall Study|Physician Decision|0|||
163315165|NCT04436276|589866104|FG000|Overall Study|Protocol Violation|0|||
163315166|NCT04436276|589866105|FG001|Overall Study|Protocol Violation|0|||
163315167|NCT04436276|589866106|FG002|Overall Study|Protocol Violation|0|||
163315168|NCT04436276|589866107|FG003|Overall Study|Protocol Violation|0|||
163315169|NCT04436276|589866108|FG004|Overall Study|Protocol Violation|0|||
163315170|NCT04436276|589866109|FG005|Overall Study|Protocol Violation|0|||
163315171|NCT04436276|589866110|FG006|Overall Study|Protocol Violation|0|||
163315172|NCT04436276|589866111|FG007|Overall Study|Protocol Violation|0|||
163315173|NCT04436276|589866112|FG008|Overall Study|Protocol Violation|0|||
163315174|NCT04436276|589866113|FG009|Overall Study|Protocol Violation|0|||
163315175|NCT04436276|589866114|FG010|Overall Study|Protocol Violation|0|||
163315176|NCT04436276|589866115|FG011|Overall Study|Protocol Violation|0|||
163315177|NCT04436276|589866116|FG012|Overall Study|Protocol Violation|0|||
163315178|NCT04436276|589866117|FG013|Overall Study|Protocol Violation|1|||
163315179|NCT04436276|589866118|FG014|Overall Study|Protocol Violation|0|||
163315180|NCT04436276|589866119|FG015|Overall Study|Protocol Violation|1|||
163315181|NCT04436276|589866120|FG016|Overall Study|Protocol Violation|0|||
163315182|NCT04436276|589866121|FG017|Overall Study|Protocol Violation|0|||
163315183|NCT04436276|589866122|FG018|Overall Study|Protocol Violation|0|||
163315184|NCT04436276|589866123|FG019|Overall Study|Protocol Violation|0|||
163315185|NCT04436276|589866124|FG020|Overall Study|Protocol Violation|0|||
163315186|NCT04436276|589866125|FG021|Overall Study|Protocol Violation|0|||
163315187|NCT04436276|589866126|FG022|Overall Study|Protocol Violation|0|||
163315188|NCT04436276|589866104|FG000|Overall Study|Withdrawal by Subject|25|||
163315189|NCT04436276|589866105|FG001|Overall Study|Withdrawal by Subject|22|||
163315190|NCT04436276|589866106|FG002|Overall Study|Withdrawal by Subject|24|||
163315191|NCT04436276|589866107|FG003|Overall Study|Withdrawal by Subject|23|||
163315192|NCT04436276|589866108|FG004|Overall Study|Withdrawal by Subject|14|||
163315193|NCT04436276|589866109|FG005|Overall Study|Withdrawal by Subject|0|||
163315194|NCT04436276|589866110|FG006|Overall Study|Withdrawal by Subject|0|||
163315195|NCT04436276|589866111|FG007|Overall Study|Withdrawal by Subject|1|||
163315196|NCT04436276|589866112|FG008|Overall Study|Withdrawal by Subject|0|||
163315197|NCT04436276|589866113|FG009|Overall Study|Withdrawal by Subject|1|||
163315198|NCT04436276|589866114|FG010|Overall Study|Withdrawal by Subject|17|||
163315199|NCT04436276|589866115|FG011|Overall Study|Withdrawal by Subject|7|||
163315200|NCT04436276|589866116|FG012|Overall Study|Withdrawal by Subject|10|||
163315201|NCT04436276|589866117|FG013|Overall Study|Withdrawal by Subject|6|||
163315202|NCT04436276|589866118|FG014|Overall Study|Withdrawal by Subject|20|||
163315203|NCT04436276|589866119|FG015|Overall Study|Withdrawal by Subject|6|||
163315204|NCT04436276|589866120|FG016|Overall Study|Withdrawal by Subject|11|||
163315205|NCT04436276|589866121|FG017|Overall Study|Withdrawal by Subject|4|||
163315206|NCT04436276|589866122|FG018|Overall Study|Withdrawal by Subject|14|||
163315207|NCT04436276|589866123|FG019|Overall Study|Withdrawal by Subject|24|||
163315208|NCT04436276|589866124|FG020|Overall Study|Withdrawal by Subject|24|||
163315209|NCT04436276|589866125|FG021|Overall Study|Withdrawal by Subject|16|||
163315210|NCT04436276|589866126|FG022|Overall Study|Withdrawal by Subject|14|||
163315211|NCT04436276|589866104|FG000|Overall Study|Other|3|||
163315212|NCT04436276|589866105|FG001|Overall Study|Other|2|||
163315213|NCT04436276|589866106|FG002|Overall Study|Other|5|||
163315214|NCT04436276|589866107|FG003|Overall Study|Other|9|||
163315215|NCT04436276|589866108|FG004|Overall Study|Other|23|||
163315216|NCT04436276|589866109|FG005|Overall Study|Other|1|||
163315217|NCT04436276|589866110|FG006|Overall Study|Other|0|||
163315218|NCT04436276|589866111|FG007|Overall Study|Other|0|||
163315219|NCT04436276|589866112|FG008|Overall Study|Other|0|||
163315220|NCT04436276|589866113|FG009|Overall Study|Other|0|||
163315221|NCT04436276|589866114|FG010|Overall Study|Other|3|||
163315222|NCT04436276|589866115|FG011|Overall Study|Other|1|||
163398910|NCT00262522|590170926|FG000|Study Start Through 48 Weeks|Death|2|||
163398911|NCT00262522|590170927|FG001|Study Start Through 48 Weeks|Death|0|||
163398912|NCT00262522|590170928|FG002|Study Start Through 48 Weeks|Death|1|||
163398913|NCT00262522|590170929|FG003|Study Start Through 48 Weeks|Death|0|||
163398914|NCT00262522|590170926|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
163398915|NCT00262522|590170927|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
163398916|NCT00262522|590170928|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
163398917|NCT00262522|590170929|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
163398918|NCT00262522|590170926|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
163207508|NCT01996709|589471143|FG001|Overall Study|Withdrawal by Subject|0|||
163207509|NCT01996709|589471142|FG000|Overall Study|Lost to Follow-up|3|||
163207510|NCT01996709|589471143|FG001|Overall Study|Lost to Follow-up|0|||
163207511|NCT01996709|589471142|FG000|Overall Study|Subject Non-Compliant|1|||
163207512|NCT01996709|589471143|FG001|Overall Study|Subject Non-Compliant|0|||
163207513|NCT01996709|589471142|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
163207514|NCT01996709|589471143|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
163207515|NCT03918447|589471148|FG000|Overall Study|Death|1|||
163207516|NCT03918447|589471149|FG001|Overall Study|Death|0|||
163207517|NCT03918447|589471148|FG000|Overall Study|Lost to Follow-up|13|||
163207518|NCT03918447|589471149|FG001|Overall Study|Lost to Follow-up|6|||
163207519|NCT03918447|589471148|FG000|Overall Study|Withdrawal by Subject|19|||
163207520|NCT03918447|589471149|FG001|Overall Study|Withdrawal by Subject|17|||
163207521|NCT03918447|589471148|FG000|Overall Study|Study Terminated by Sponsor|195|||
163207522|NCT03918447|589471149|FG001|Overall Study|Study Terminated by Sponsor|197|||
163207523|NCT03918447|589471148|FG000|Overall Study|Reason not Specified|0|||
163207524|NCT03918447|589471149|FG001|Overall Study|Reason not Specified|1|||
163207525|NCT00477971|589471150|FG000|Overall Study|Disease progression|6|||
163207526|NCT00477971|589471151|FG001|Overall Study|Disease progression|0|||
163207527|NCT00477971|589471150|FG000|Overall Study|Withdrawal by Subject|3|||
163207528|NCT00477971|589471151|FG001|Overall Study|Withdrawal by Subject|1|||
163207529|NCT00477971|589471150|FG000|Overall Study|Adverse Event|3|||
163207530|NCT00477971|589471151|FG001|Overall Study|Adverse Event|0|||
163207531|NCT00477971|589471150|FG000|Overall Study|Death|2|||
163207532|NCT00477971|589471151|FG001|Overall Study|Death|4|||
163207533|NCT00477971|589471150|FG000|Overall Study|Alternative treatment|3|||
163207534|NCT00477971|589471151|FG001|Overall Study|Alternative treatment|1|||
163207535|NCT01774968|589471152|FG000|Overall Study|Adverse Event|4|||
163207536|NCT01774968|589471153|FG001|Overall Study|Adverse Event|4|||
163207537|NCT01774968|589471152|FG000|Overall Study|Death|0|||
163207538|NCT01774968|589471153|FG001|Overall Study|Death|1|||
163207539|NCT01774968|589471152|FG000|Overall Study|Lost to Follow-up|1|||
163207540|NCT01774968|589471153|FG001|Overall Study|Lost to Follow-up|3|||
163207541|NCT01774968|589471152|FG000|Overall Study|Physician Decision|5|||
163207542|NCT01774968|589471153|FG001|Overall Study|Physician Decision|1|||
163207543|NCT01774968|589471152|FG000|Overall Study|Protocol Violation|14|||
163207544|NCT01774968|589471153|FG001|Overall Study|Protocol Violation|13|||
163207545|NCT01774968|589471152|FG000|Overall Study|Sponsor Decision|0|||
163207546|NCT01774968|589471153|FG001|Overall Study|Sponsor Decision|2|||
163207547|NCT01774968|589471152|FG000|Overall Study|Withdrawal by Subject|6|||
163207548|NCT01774968|589471153|FG001|Overall Study|Withdrawal by Subject|11|||
163207549|NCT05355805|589471154|FG000|Overall Study|Lost to Follow-up|6|||
162967418|NCT00884390|588581369|FG000|Overall Study|Adverse Event|0|||
162967419|NCT00884390|588581370|FG001|Overall Study|Adverse Event|1|||
162967420|NCT00884390|588581369|FG000|Overall Study|Lost to Follow-up|0|||
163207550|NCT05355805|589471155|FG001|Overall Study|Lost to Follow-up|11|||
163207551|NCT05355805|589471156|FG002|Overall Study|Lost to Follow-up|10|||
163207552|NCT05355805|589471157|FG003|Overall Study|Lost to Follow-up|6|||
163207553|NCT05355805|589471154|FG000|Overall Study|Decision by Sponsor|0|||
163207554|NCT05355805|589471155|FG001|Overall Study|Decision by Sponsor|0|||
163207555|NCT05355805|589471156|FG002|Overall Study|Decision by Sponsor|1|||
163207556|NCT05355805|589471157|FG003|Overall Study|Decision by Sponsor|0|||
163207557|NCT05355805|589471154|FG000|Overall Study|Withdrawal by Subject|7|||
163207558|NCT05355805|589471155|FG001|Overall Study|Withdrawal by Subject|14|||
163207559|NCT05355805|589471156|FG002|Overall Study|Withdrawal by Subject|15|||
163207560|NCT05355805|589471157|FG003|Overall Study|Withdrawal by Subject|13|||
163207561|NCT01986855|589472551|FG000|Overall Study|Adverse Event|1|||
163207562|NCT01986855|589472552|FG001|Overall Study|Adverse Event|0|||
163207563|NCT01986855|589472553|FG002|Overall Study|Adverse Event|0|||
163207564|NCT01986855|589472551|FG000|Overall Study|Death|3|||
163207565|NCT01986855|589472552|FG001|Overall Study|Death|4|||
163207566|NCT01986855|589472553|FG002|Overall Study|Death|4|||
163207567|NCT01986855|589472551|FG000|Overall Study|Lost to Follow-up|2|||
163207568|NCT01986855|589472552|FG001|Overall Study|Lost to Follow-up|1|||
163207569|NCT01986855|589472553|FG002|Overall Study|Lost to Follow-up|0|||
163207570|NCT01986855|589472551|FG000|Overall Study|Screen Failure|0|||
163207571|NCT01986855|589472552|FG001|Overall Study|Screen Failure|1|||
163207572|NCT01986855|589472553|FG002|Overall Study|Screen Failure|0|||
163207573|NCT01986855|589472551|FG000|Overall Study|Participant Moved|0|||
163207574|NCT01986855|589472552|FG001|Overall Study|Participant Moved|0|||
163207575|NCT01986855|589472553|FG002|Overall Study|Participant Moved|2|||
163207576|NCT01986855|589472551|FG000|Overall Study|Withdrawal by Subject|7|||
163207577|NCT01986855|589472552|FG001|Overall Study|Withdrawal by Subject|8|||
163207578|NCT01986855|589472553|FG002|Overall Study|Withdrawal by Subject|5|||
163315223|NCT04436276|589866116|FG012|Overall Study|Other|1|||
163207579|NCT04317066|589472554|FG000|Overall Study|Sponsor decision|5|||
163207580|NCT04317066|589472554|FG000|Overall Study|Death|2|||
163207581|NCT02014597|589472558|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
163054300|NCT05379920|588910227|FG002|Overall Study|Lost to Follow-up|0|||
163054301|NCT05379920|588910228|FG003|Overall Study|Lost to Follow-up|0|||
163054302|NCT03530293|588910231|FG000|Pre-randomization|Adverse Event|12|||
163054303|NCT03530293|588910232|FG001|Pre-randomization|Adverse Event|0|||
163054304|NCT03530293|588910233|FG002|Pre-randomization|Adverse Event|0|||
163054305|NCT03530293|588910231|FG000|Pre-randomization|Protocol Violation|2|||
163054306|NCT03530293|588910232|FG001|Pre-randomization|Protocol Violation|0|||
163054307|NCT03530293|588910233|FG002|Pre-randomization|Protocol Violation|0|||
163054308|NCT03530293|588910231|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
163054309|NCT03530293|588910232|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
163054310|NCT03530293|588910233|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
163054311|NCT03530293|588910231|FG000|Pre-randomization|Withdrawal by Subject|5|||
163315224|NCT04436276|589866117|FG013|Overall Study|Other|2|||
163315225|NCT04436276|589866118|FG014|Overall Study|Other|3|||
163315226|NCT04436276|589866119|FG015|Overall Study|Other|0|||
163315227|NCT04436276|589866120|FG016|Overall Study|Other|0|||
163315228|NCT04436276|589866121|FG017|Overall Study|Other|6|||
163315229|NCT04436276|589866122|FG018|Overall Study|Other|1|||
163315230|NCT04436276|589866123|FG019|Overall Study|Other|0|||
163315231|NCT04436276|589866124|FG020|Overall Study|Other|2|||
163315232|NCT04436276|589866125|FG021|Overall Study|Other|2|||
163315233|NCT04436276|589866126|FG022|Overall Study|Other|60|||
163315234|NCT03656510|589866129|FG000|Overall Study|Lost to Follow-up|1|||
163315235|NCT03656510|589866130|FG001|Overall Study|Lost to Follow-up|0|||
163315236|NCT03656510|589866131|FG002|Overall Study|Lost to Follow-up|0|||
163315237|NCT03656510|589866132|FG003|Overall Study|Lost to Follow-up|0|||
163315238|NCT03656510|589866133|FG004|Overall Study|Lost to Follow-up|0|||
163315239|NCT03656510|589866134|FG005|Overall Study|Lost to Follow-up|0|||
163315240|NCT03656510|589866129|FG000|Overall Study|Withdrawal by Subject|1|||
163315241|NCT03656510|589866130|FG001|Overall Study|Withdrawal by Subject|1|||
163315242|NCT03656510|589866131|FG002|Overall Study|Withdrawal by Subject|0|||
163315243|NCT03656510|589866132|FG003|Overall Study|Withdrawal by Subject|1|||
163315244|NCT03656510|589866133|FG004|Overall Study|Withdrawal by Subject|0|||
163315245|NCT03656510|589866134|FG005|Overall Study|Withdrawal by Subject|0|||
163315246|NCT03852472|589866141|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
163315247|NCT03852472|589866142|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
163315248|NCT03852472|589866143|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
163315249|NCT03852472|589866144|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
163315250|NCT03852472|589866145|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
163315251|NCT03852472|589866141|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
163315252|NCT03852472|589866142|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
163315253|NCT03852472|589866143|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
163315254|NCT03852472|589866144|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
163315255|NCT03852472|589866145|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
163315256|NCT03852472|589866141|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
163315257|NCT03852472|589866142|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
163054312|NCT03530293|588910232|FG001|Pre-randomization|Withdrawal by Subject|0|||
163054313|NCT03530293|588910233|FG002|Pre-randomization|Withdrawal by Subject|0|||
163207582|NCT02014597|589472559|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
163207583|NCT02279173|589472561|FG000|Overall Study|Protocol-specified Criteria|67|||
163207584|NCT02279173|589472561|FG000|Overall Study|Withdrawal by Subject|20|||
163207585|NCT02279173|589472561|FG000|Overall Study|Decision by Sponsor|4|||
163207586|NCT02279173|589472561|FG000|Overall Study|Lost to Follow-up|3|||
163207587|NCT00754624|589472563|FG000|Overall Study|Adverse Event|16|||
163207588|NCT00754624|589472563|FG000|Overall Study|Death|1|||
163207589|NCT00754624|589472563|FG000|Overall Study|Physician Decision|8|||
163207590|NCT00754624|589472563|FG000|Overall Study|Protocol Violation|1|||
163207591|NCT00754624|589472563|FG000|Overall Study|Withdrawal by Subject|28|||
163207592|NCT00754624|589472563|FG000|Overall Study|Various|12|||
163207593|NCT00754624|589472563|FG000|Overall Study|Lost to Follow-up|3|||
163207594|NCT03585504|589472568|FG000|Overall Study|Lost to Follow-up|26|||
163207595|NCT03585504|589472569|FG001|Overall Study|Lost to Follow-up|29|||
163207596|NCT02743806|589472570|FG000|Overall Study|Adverse Event|9|||
163207597|NCT02743806|589472570|FG000|Overall Study|Lost to Follow-up|8|||
163207598|NCT02743806|589472570|FG000|Overall Study|Voluntary Withdrawal|54|||
163207599|NCT02743806|589472570|FG000|Overall Study|Study Termination|65|||
163207600|NCT02743806|589472570|FG000|Overall Study|Pregnancy|6|||
163315258|NCT03852472|589866143|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
163315259|NCT03852472|589866144|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
163315260|NCT03852472|589866145|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
163315261|NCT03852472|589866141|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
163315262|NCT03852472|589866142|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
163315263|NCT03852472|589866143|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
163315264|NCT03852472|589866144|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
163315265|NCT03852472|589866145|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
163315266|NCT03852472|589866141|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
163315267|NCT03852472|589866142|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
163315268|NCT03852472|589866143|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
163315269|NCT03852472|589866144|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
163315270|NCT03852472|589866145|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
163315271|NCT03852472|589866141|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
163315272|NCT03852472|589866142|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
163315273|NCT03852472|589866143|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
163315274|NCT03852472|589866144|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
163315275|NCT03852472|589866145|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
163315276|NCT03852472|589866141|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
163315277|NCT03852472|589866142|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
163315278|NCT03852472|589866143|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
163315279|NCT03852472|589866144|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
163315280|NCT03852472|589866145|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
163315281|NCT03852472|589866141|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
163315282|NCT03852472|589866142|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
163315283|NCT03852472|589866143|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
163315284|NCT03852472|589866144|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
163315285|NCT03852472|589866145|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
162967421|NCT00884390|588581370|FG001|Overall Study|Lost to Follow-up|1|||
163315286|NCT03852472|589866141|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
163315287|NCT03852472|589866142|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
163315288|NCT03852472|589866143|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
163315289|NCT03852472|589866144|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
163315290|NCT03852472|589866145|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
163315291|NCT03852472|589866141|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
163315292|NCT03852472|589866142|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
163315293|NCT03852472|589866143|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
163315294|NCT03852472|589866144|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
163315295|NCT03852472|589866145|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
163315296|NCT03852472|589866141|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
163315297|NCT03852472|589866142|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
163315298|NCT03852472|589866143|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
163398919|NCT00262522|590170927|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
163398920|NCT00262522|590170928|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
163398921|NCT00262522|590170929|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
163398922|NCT00262522|590170926|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
163398923|NCT00262522|590170927|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
163398924|NCT00262522|590170928|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
163398925|NCT00262522|590170929|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
163398926|NCT00262522|590170926|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
163398927|NCT00262522|590170927|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
163398928|NCT00262522|590170928|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
163398929|NCT00262522|590170929|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
163398930|NCT00262522|590170926|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
163207601|NCT02743806|589472570|FG000|Overall Study|No Longer Clinically Benefiting|27|||
163207602|NCT02743806|589472570|FG000|Overall Study|Reason Not Specified|12|||
163207603|NCT00849381|589472572|FG000|Overall Study|Adverse Event|1|||
163398931|NCT00262522|590170927|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
163207604|NCT00849381|589472572|FG000|Overall Study|Lost to Follow-up|129|||
163207605|NCT00849381|589472572|FG000|Overall Study|Protocol Violation|5|||
163207606|NCT00849381|589472572|FG000|Overall Study|Withdrawal by Subject|6|||
163207607|NCT00849381|589472572|FG000|Overall Study|Other|4|||
163207608|NCT04429061|589472576|FG000|Overall Study|Lost to Follow-up|62|||
163207609|NCT04429061|589472577|FG001|Overall Study|Lost to Follow-up|87|||
163207610|NCT04429061|589472576|FG000|Overall Study|Withdrawal by Subject|3|||
163207611|NCT04429061|589472577|FG001|Overall Study|Withdrawal by Subject|4|||
163207612|NCT02085785|589472578|FG000|Overall Study|Withdrawal by Subject|2|||
163207613|NCT02085785|589472579|FG001|Overall Study|Withdrawal by Subject|1|||
163207614|NCT02085785|589472578|FG000|Overall Study|Lost to Follow-up|0|||
163207615|NCT02085785|589472579|FG001|Overall Study|Lost to Follow-up|1|||
163207616|NCT03590041|589472580|FG000|Overall Study|Protocol Violation|4|||
163207617|NCT03590041|589472581|FG001|Overall Study|Protocol Violation|3|||
163207618|NCT03590041|589472580|FG000|Overall Study|No session data recorded|14|||
163207619|NCT03590041|589472581|FG001|Overall Study|No session data recorded|2|||
163207620|NCT04118166|589472582|FG000|Overall Study|Adverse Event|1|||
163207621|NCT03519932|589472583|FG000|First Intervention|Adverse Event|1|||
163207622|NCT03519932|589472584|FG001|First Intervention|Adverse Event|3|||
163207623|NCT02254486|589472585|FG000|Overall Study|Adverse Event|1|||
163207624|NCT02254486|589472586|FG001|Overall Study|Adverse Event|1|||
163207625|NCT02254486|589472585|FG000|Overall Study|Lack of Efficacy|1|||
163207626|NCT02254486|589472586|FG001|Overall Study|Lack of Efficacy|0|||
163207627|NCT02254486|589472585|FG000|Overall Study|Lost to Follow-up|2|||
163207628|NCT02254486|589472586|FG001|Overall Study|Lost to Follow-up|4|||
163207629|NCT02254486|589472585|FG000|Overall Study|Protocol Violation|1|||
163207630|NCT02254486|589472586|FG001|Overall Study|Protocol Violation|2|||
163207631|NCT02254486|589472585|FG000|Overall Study|Withdrawal by Subject|17|||
163207632|NCT02254486|589472586|FG001|Overall Study|Withdrawal by Subject|15|||
163207633|NCT02254486|589472585|FG000|Overall Study|GFR<60mL/min|16|||
163207634|NCT02254486|589472586|FG001|Overall Study|GFR<60mL/min|21|||
163207635|NCT02254486|589472585|FG000|Overall Study|Various|12|||
163207636|NCT02254486|589472586|FG001|Overall Study|Various|12|||
163207637|NCT01350414|589472587|FG000|Overall Study|Lost to Follow-up|13|||
163207638|NCT01350414|589472587|FG000|Overall Study|Withdrawal by Subject|4|||
163207639|NCT01350414|589472587|FG000|Overall Study|Physician Decision|2|||
163207640|NCT00267046|589472593|FG000|Overall Study|Disease progression|4|||
163207641|NCT00267046|589472594|FG001|Overall Study|Disease progression|2|||
163207642|NCT00267046|589472593|FG000|Overall Study|Chemotoxicity|2|||
163207643|NCT00267046|589472594|FG001|Overall Study|Chemotoxicity|0|||
163207644|NCT00267046|589472593|FG000|Overall Study|Open-label palifermin|2|||
163207645|NCT00267046|589472594|FG001|Overall Study|Open-label palifermin|7|||
163207646|NCT00267046|589472593|FG000|Overall Study|Surgery|3|||
163207647|NCT00267046|589472594|FG001|Overall Study|Surgery|1|||
163207648|NCT00267046|589472593|FG000|Overall Study|Withdrawal by Subject|1|||
163207649|NCT00267046|589472594|FG001|Overall Study|Withdrawal by Subject|0|||
163207650|NCT00267046|589472593|FG000|Overall Study|Radiation|0|||
163207651|NCT00267046|589472594|FG001|Overall Study|Radiation|1|||
163207652|NCT00103142|589472595|FG000|Overall Study|Adverse Event|1|||
163207653|NCT00103142|589472596|FG001|Overall Study|Adverse Event|0|||
163207654|NCT00103142|589472595|FG000|Overall Study|Progression of disease|2|||
163207655|NCT00103142|589472596|FG001|Overall Study|Progression of disease|1|||
163207656|NCT02772081|589472597|FG000|Overall Study|Physician Decision|1|||
163207657|NCT02772081|589472598|FG001|Overall Study|Physician Decision|1|||
163207658|NCT02772081|589472597|FG000|Overall Study|Death|1|||
163207659|NCT02772081|589472598|FG001|Overall Study|Death|1|||
163207660|NCT00759954|589472604|FG000|Overall Study|Personal reason|1|||
163207661|NCT00759954|589472605|FG001|Overall Study|Personal reason|0|||
163207662|NCT00759954|589472604|FG000|Overall Study|Adverse Event|1|||
163207663|NCT00759954|589472605|FG001|Overall Study|Adverse Event|2|||
163207664|NCT00022633|589472609|FG000|Overall Study|Adverse Event|11|||
163207665|NCT00022633|589472610|FG001|Overall Study|Adverse Event|1|||
163207666|NCT00022633|589472609|FG000|Overall Study|Refusal unrelated to adverse event|1|||
163207667|NCT00022633|589472610|FG001|Overall Study|Refusal unrelated to adverse event|0|||
163207668|NCT00022633|589472609|FG000|Overall Study|Progression/relapse|9|||
163207669|NCT00022633|589472610|FG001|Overall Study|Progression/relapse|2|||
163207670|NCT00022633|589472609|FG000|Overall Study|Death|4|||
163207671|NCT00022633|589472610|FG001|Overall Study|Death|0|||
163315299|NCT03852472|589866144|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
163315300|NCT03852472|589866145|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
163315301|NCT03852472|589866141|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
163315302|NCT03852472|589866142|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
163315303|NCT03852472|589866143|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
163315304|NCT03852472|589866144|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
163315305|NCT03852472|589866145|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
163315306|NCT03852472|589866141|FG000|Period 2 - Week 44|Adverse Event|0|||
163315307|NCT03852472|589866142|FG001|Period 2 - Week 44|Adverse Event|3|||
163315308|NCT03852472|589866143|FG002|Period 2 - Week 44|Adverse Event|1|||
163315309|NCT03852472|589866144|FG003|Period 2 - Week 44|Adverse Event|2|||
163315310|NCT03852472|589866145|FG004|Period 2 - Week 44|Adverse Event|2|||
163315311|NCT03852472|589866141|FG000|Period 2 - Week 44|COVID-19 Related|0|||
163315312|NCT03852472|589866142|FG001|Period 2 - Week 44|COVID-19 Related|0|||
163315313|NCT03852472|589866143|FG002|Period 2 - Week 44|COVID-19 Related|0|||
163315314|NCT03852472|589866144|FG003|Period 2 - Week 44|COVID-19 Related|1|||
163315315|NCT03852472|589866145|FG004|Period 2 - Week 44|COVID-19 Related|0|||
163315316|NCT03852472|589866141|FG000|Period 2 - Week 44|Reason not stated|0|||
163315317|NCT03852472|589866142|FG001|Period 2 - Week 44|Reason not stated|0|||
163315318|NCT03852472|589866143|FG002|Period 2 - Week 44|Reason not stated|0|||
163315319|NCT03852472|589866144|FG003|Period 2 - Week 44|Reason not stated|0|||
163315320|NCT03852472|589866145|FG004|Period 2 - Week 44|Reason not stated|1|||
163315321|NCT06457802|589866146|FG000|Overall Study|Early termination of study prior to participant completion|2|||
163315322|NCT06457802|589866147|FG001|Overall Study|Early termination of study prior to participant completion|2|||
163315323|NCT03974178|589866151|FG000|Overall Study|Death|0|||
163315324|NCT03974178|589866152|FG001|Overall Study|Death|1|||
163207672|NCT00022633|589472609|FG000|Overall Study|Other - not protocol specified|3|||
163207673|NCT00022633|589472610|FG001|Overall Study|Other - not protocol specified|2|||
163207674|NCT00022633|589472609|FG000|Overall Study|Ineligible|4|||
163207675|NCT00022633|589472610|FG001|Overall Study|Ineligible|0|||
163207676|NCT01741701|589472613|FG000|Overall Study|Adverse Event|5|||
163315325|NCT04880863|589866153|FG000|Overall Study|Adverse Event|1|||
163315326|NCT04880863|589866153|FG000|Overall Study|Patient decision|2|||
163315327|NCT04880863|589866153|FG000|Overall Study|Confirmed Disease Progression|15|||
163207677|NCT01741701|589472614|FG001|Overall Study|Adverse Event|1|||
163207678|NCT01741701|589472613|FG000|Overall Study|Withdrawal by Subject|0|||
163207679|NCT01741701|589472614|FG001|Overall Study|Withdrawal by Subject|1|||
163207680|NCT00372112|589472622|FG000|Overall Study|Adverse Event|0|||
163207681|NCT00372112|589472623|FG001|Overall Study|Adverse Event|1|||
163315328|NCT04880863|589866153|FG000|Overall Study|Death|3|||
163398932|NCT00262522|590170928|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
163398933|NCT00262522|590170929|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
163398934|NCT00262522|590170926|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
163398935|NCT00262522|590170927|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
163398936|NCT00262522|590170928|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
163398937|NCT00262522|590170929|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
163398938|NCT00262522|590170926|FG000|Study Start Through 96 Weeks|Death|2|||
163398939|NCT00262522|590170927|FG001|Study Start Through 96 Weeks|Death|0|||
163398940|NCT00262522|590170928|FG002|Study Start Through 96 Weeks|Death|2|||
163398941|NCT00262522|590170929|FG003|Study Start Through 96 Weeks|Death|0|||
163398942|NCT00262522|590170926|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
163398943|NCT00262522|590170927|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
163207682|NCT00372112|589472624|FG002|Overall Study|Adverse Event|1|||
163315329|NCT04880863|589866153|FG000|Overall Study|Physician Decision|4|||
163315330|NCT04880863|589866153|FG000|Overall Study|Unconfirmed Disease Progression|4|||
163315331|NCT04880863|589866153|FG000|Overall Study|Withdrawal by Subject|2|||
163315332|NCT04880863|589866153|FG000|Overall Study|Study discontinuation by the sponsor|4|||
163315333|NCT04880863|589866153|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
163315334|NCT04880863|589866153|FG000|Overall Study|Not received study drug NAP|2|||
163315335|NCT03899259|589866154|FG000|Overall Study|Adverse Event|5|||
163315336|NCT03899259|589866155|FG001|Overall Study|Adverse Event|4|||
163315337|NCT03899259|589866156|FG002|Overall Study|Adverse Event|6|||
163315338|NCT03899259|589866154|FG000|Overall Study|Lack of Efficacy|5|||
163315339|NCT03899259|589866155|FG001|Overall Study|Lack of Efficacy|0|||
163315340|NCT03899259|589866156|FG002|Overall Study|Lack of Efficacy|2|||
163315341|NCT03899259|589866154|FG000|Overall Study|Pregnancy|3|||
163315342|NCT03899259|589866155|FG001|Overall Study|Pregnancy|0|||
163315343|NCT03899259|589866156|FG002|Overall Study|Pregnancy|1|||
163315344|NCT03899259|589866154|FG000|Overall Study|Physician Decision|0|||
163315345|NCT03899259|589866155|FG001|Overall Study|Physician Decision|1|||
163315346|NCT03899259|589866156|FG002|Overall Study|Physician Decision|0|||
163315347|NCT03899259|589866154|FG000|Overall Study|Protocol Deviation|1|||
163315348|NCT03899259|589866155|FG001|Overall Study|Protocol Deviation|1|||
163315349|NCT03899259|589866156|FG002|Overall Study|Protocol Deviation|1|||
163315350|NCT03899259|589866154|FG000|Overall Study|Withdrawal by Subject|8|||
163315351|NCT03899259|589866155|FG001|Overall Study|Withdrawal by Subject|10|||
163315352|NCT03899259|589866156|FG002|Overall Study|Withdrawal by Subject|12|||
163315353|NCT03899259|589866154|FG000|Overall Study|Lost to Follow-up|5|||
163315354|NCT03899259|589866155|FG001|Overall Study|Lost to Follow-up|6|||
163315355|NCT03899259|589866156|FG002|Overall Study|Lost to Follow-up|2|||
163315356|NCT03899259|589866154|FG000|Overall Study|Lack of Adherence|1|||
163315357|NCT03899259|589866155|FG001|Overall Study|Lack of Adherence|0|||
163315358|NCT03899259|589866156|FG002|Overall Study|Lack of Adherence|0|||
163315359|NCT03899259|589866154|FG000|Overall Study|Screen Failure|1|||
163315360|NCT03899259|589866155|FG001|Overall Study|Screen Failure|0|||
163315361|NCT03899259|589866156|FG002|Overall Study|Screen Failure|0|||
163315362|NCT03899259|589866154|FG000|Overall Study|Ongoing Study Participation|127|||
163315363|NCT03899259|589866155|FG001|Overall Study|Ongoing Study Participation|134|||
163315364|NCT03899259|589866156|FG002|Overall Study|Ongoing Study Participation|210|||
163315365|NCT01152450|589866157|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
163398944|NCT00262522|590170928|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
163398945|NCT00262522|590170929|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
163398946|NCT00262522|590170926|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
163398947|NCT00262522|590170927|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
163207683|NCT00372112|589472625|FG003|Overall Study|Adverse Event|1|||
163207684|NCT00372112|589472622|FG000|Overall Study|Withdrawal by Subject|0|||
163207685|NCT00372112|589472623|FG001|Overall Study|Withdrawal by Subject|0|||
163207686|NCT00372112|589472624|FG002|Overall Study|Withdrawal by Subject|2|||
163207687|NCT00372112|589472625|FG003|Overall Study|Withdrawal by Subject|1|||
163207688|NCT00372112|589472622|FG000|Overall Study|Exacerbation|0|||
163207689|NCT00372112|589472623|FG001|Overall Study|Exacerbation|0|||
163207690|NCT00372112|589472624|FG002|Overall Study|Exacerbation|0|||
163207691|NCT00372112|589472625|FG003|Overall Study|Exacerbation|1|||
163315366|NCT01152450|589866158|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
163315367|NCT01152450|589866159|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
163315368|NCT01152450|589866160|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
163315369|NCT01152450|589866161|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
163398948|NCT00262522|590170928|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
163398949|NCT00262522|590170929|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
163398950|NCT04722042|590170930|FG000|Overall Study|Withdrawal by Subject|2|||
163398951|NCT04722042|590170931|FG001|Overall Study|Withdrawal by Subject|1|||
163398952|NCT04722042|590170932|FG002|Overall Study|Withdrawal by Subject|0|||
163398953|NCT01877915|590170940|FG000|Overall Study|Lost to Follow-up|10|||
163398954|NCT01877915|590170941|FG001|Overall Study|Lost to Follow-up|9|||
163398955|NCT01877915|590170940|FG000|Overall Study|Withdrawal by Subject|42|||
163398956|NCT01877915|590170941|FG001|Overall Study|Withdrawal by Subject|55|||
163398957|NCT01877915|590170940|FG000|Overall Study|Other|2|||
163398958|NCT01877915|590170941|FG001|Overall Study|Other|4|||
163398959|NCT05314517|590170946|FG000|Double-blind Period|Adverse Event|4|||
163398960|NCT05314517|590170947|FG001|Double-blind Period|Adverse Event|0|||
163398961|NCT05314517|590170948|FG002|Double-blind Period|Adverse Event|0|||
163398962|NCT05314517|590170949|FG003|Double-blind Period|Adverse Event|0|||
163398963|NCT05314517|590170946|FG000|Double-blind Period|Noncompliance|0|||
163398964|NCT05314517|590170947|FG001|Double-blind Period|Noncompliance|1|||
163398965|NCT05314517|590170948|FG002|Double-blind Period|Noncompliance|0|||
163398966|NCT05314517|590170949|FG003|Double-blind Period|Noncompliance|0|||
163398967|NCT05314517|590170946|FG000|Double-blind Period|Randomized, not treated|1|||
163398968|NCT05314517|590170947|FG001|Double-blind Period|Randomized, not treated|0|||
163398969|NCT05314517|590170948|FG002|Double-blind Period|Randomized, not treated|0|||
163398970|NCT05314517|590170949|FG003|Double-blind Period|Randomized, not treated|0|||
163398971|NCT05314517|590170946|FG000|Open-label Extension|Adverse Event|0|||
163398972|NCT05314517|590170947|FG001|Open-label Extension|Adverse Event|0|||
163398973|NCT05314517|590170948|FG002|Open-label Extension|Adverse Event|1|||
163398974|NCT05314517|590170949|FG003|Open-label Extension|Adverse Event|2|||
163398975|NCT05314517|590170946|FG000|Open-label Extension|Investigator decision|0|||
163398976|NCT05314517|590170947|FG001|Open-label Extension|Investigator decision|0|||
162967422|NCT00884390|588581369|FG000|Overall Study|Physician Decision|2|||
163398977|NCT05314517|590170948|FG002|Open-label Extension|Investigator decision|1|||
163398978|NCT05314517|590170949|FG003|Open-label Extension|Investigator decision|0|||
163398979|NCT05314517|590170946|FG000|Open-label Extension|Lost to Follow-up|0|||
163398980|NCT05314517|590170947|FG001|Open-label Extension|Lost to Follow-up|0|||
163398981|NCT05314517|590170948|FG002|Open-label Extension|Lost to Follow-up|0|||
163398982|NCT05314517|590170949|FG003|Open-label Extension|Lost to Follow-up|1|||
163315370|NCT01152450|589866162|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
163315371|NCT01152450|589866157|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
163315372|NCT01152450|589866158|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
163315373|NCT01152450|589866159|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
163315374|NCT01152450|589866160|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
163398983|NCT05314517|590170946|FG000|Open-label Extension|Withdrawal by Subject|0|||
163398984|NCT05314517|590170947|FG001|Open-label Extension|Withdrawal by Subject|0|||
163398985|NCT05314517|590170948|FG002|Open-label Extension|Withdrawal by Subject|1|||
163398986|NCT05314517|590170949|FG003|Open-label Extension|Withdrawal by Subject|2|||
163398987|NCT05314517|590170946|FG000|Open-label Extension|Use of prohibited medication|0|||
163398988|NCT05314517|590170947|FG001|Open-label Extension|Use of prohibited medication|0|||
163398989|NCT05314517|590170948|FG002|Open-label Extension|Use of prohibited medication|1|||
163398990|NCT05314517|590170949|FG003|Open-label Extension|Use of prohibited medication|0|||
163398991|NCT05314517|590170946|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
163398992|NCT05314517|590170947|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
163315375|NCT01152450|589866161|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
163315376|NCT01152450|589866162|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
163315377|NCT01152450|589866157|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
163315378|NCT01152450|589866158|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
163315379|NCT01152450|589866159|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
163315380|NCT01152450|589866160|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
163315381|NCT01152450|589866161|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
163315382|NCT01152450|589866162|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
163315383|NCT05670587|589866163|FG000|Overall Study|Withdrawal by Subject|3|||
163315384|NCT01544114|589866169|FG000|Overall Study|Withdrawal by Subject|0|||
163315385|NCT01544114|589866170|FG001|Overall Study|Withdrawal by Subject|0|||
163315386|NCT01544114|589866171|FG002|Overall Study|Withdrawal by Subject|3|||
163315387|NCT01544114|589866169|FG000|Overall Study|Lost to Follow-up|0|||
163315388|NCT01544114|589866170|FG001|Overall Study|Lost to Follow-up|2|||
163315389|NCT01544114|589866171|FG002|Overall Study|Lost to Follow-up|0|||
163315390|NCT01544114|589866169|FG000|Overall Study|Adverse Event|1|||
163315391|NCT01544114|589866170|FG001|Overall Study|Adverse Event|1|||
163315392|NCT01544114|589866171|FG002|Overall Study|Adverse Event|2|||
163315393|NCT01544114|589866169|FG000|Overall Study|Protocol Violation|0|||
163315394|NCT01544114|589866170|FG001|Overall Study|Protocol Violation|1|||
163315395|NCT01544114|589866171|FG002|Overall Study|Protocol Violation|0|||
163315396|NCT04508309|589866174|FG000|Overall Study|Death|0|||
163315397|NCT04508309|589866175|FG001|Overall Study|Death|0|||
163315398|NCT04508309|589866176|FG002|Overall Study|Death|0|||
163315399|NCT04508309|589866177|FG003|Overall Study|Death|0|||
163315400|NCT04508309|589866178|FG004|Overall Study|Death|1|||
163315401|NCT04508309|589866174|FG000|Overall Study|Lost to Follow-up|0|||
163315402|NCT04508309|589866175|FG001|Overall Study|Lost to Follow-up|0|||
163315403|NCT04508309|589866176|FG002|Overall Study|Lost to Follow-up|1|||
163315404|NCT04508309|589866177|FG003|Overall Study|Lost to Follow-up|1|||
163315405|NCT04508309|589866178|FG004|Overall Study|Lost to Follow-up|0|||
163315406|NCT04508309|589866174|FG000|Overall Study|Withdrawal by Subject|0|||
163315407|NCT04508309|589866175|FG001|Overall Study|Withdrawal by Subject|0|||
163315408|NCT04508309|589866176|FG002|Overall Study|Withdrawal by Subject|0|||
163315409|NCT04508309|589866177|FG003|Overall Study|Withdrawal by Subject|0|||
163315410|NCT04508309|589866178|FG004|Overall Study|Withdrawal by Subject|1|||
163315411|NCT02305888|589866183|FG000|Overall Study|Lost to Follow-up|0|||
163315412|NCT02305888|589866184|FG001|Overall Study|Lost to Follow-up|0|||
163315413|NCT02305888|589866185|FG002|Overall Study|Lost to Follow-up|1|||
163315414|NCT02305888|589866183|FG000|Overall Study|Adverse Event|0|||
163315415|NCT02305888|589866184|FG001|Overall Study|Adverse Event|1|||
163315416|NCT02305888|589866185|FG002|Overall Study|Adverse Event|0|||
163315417|NCT05139810|589866186|FG000|Overall Study|Voluntary Withdrawal|2|||
163315418|NCT05139810|589866187|FG001|Overall Study|Voluntary Withdrawal|1|||
163315419|NCT05139810|589866188|FG002|Overall Study|Voluntary Withdrawal|0|||
163315420|NCT05139810|589866186|FG000|Overall Study|Pregnancy|1|||
163315421|NCT05139810|589866187|FG001|Overall Study|Pregnancy|0|||
163315422|NCT05139810|589866188|FG002|Overall Study|Pregnancy|0|||
163315423|NCT05139810|589866186|FG000|Overall Study|Roll Over to CS7|19|||
163315424|NCT05139810|589866187|FG001|Overall Study|Roll Over to CS7|44|||
163315425|NCT05139810|589866188|FG002|Overall Study|Roll Over to CS7|20|||
163315426|NCT03800654|589866189|FG000|Overall Study|Time constraints|3|||
163315427|NCT03800654|589866190|FG001|Overall Study|Time constraints|3|||
163315428|NCT03800654|589866191|FG002|Overall Study|Time constraints|3|||
163315429|NCT03800654|589866189|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
163315430|NCT03800654|589866190|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
163315431|NCT03800654|589866191|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
163315432|NCT03800654|589866189|FG000|Overall Study|Lost to Follow-up|2|||
163315433|NCT03800654|589866190|FG001|Overall Study|Lost to Follow-up|1|||
163315434|NCT03800654|589866191|FG002|Overall Study|Lost to Follow-up|6|||
163315435|NCT03800654|589866189|FG000|Overall Study|Medical Health Issue|0|||
163315436|NCT03800654|589866190|FG001|Overall Study|Medical Health Issue|0|||
163315437|NCT03800654|589866191|FG002|Overall Study|Medical Health Issue|1|||
163315438|NCT03800654|589866189|FG000|Overall Study|Personal Issues|0|||
163315439|NCT03800654|589866190|FG001|Overall Study|Personal Issues|2|||
162967423|NCT00884390|588581370|FG001|Overall Study|Physician Decision|1|||
162967424|NCT00884390|588581369|FG000|Overall Study|Protocol Violation|4|||
162967425|NCT00884390|588581370|FG001|Overall Study|Protocol Violation|1|||
162967426|NCT00884390|588581369|FG000|Overall Study|Withdrawal by Subject|4|||
162967427|NCT00884390|588581370|FG001|Overall Study|Withdrawal by Subject|1|||
162967428|NCT00884390|588581369|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
162967429|NCT00884390|588581370|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
162967430|NCT00884390|588581369|FG000|Overall Study|Other|11|||
162967431|NCT00884390|588581370|FG001|Overall Study|Other|1|||
162967432|NCT01691612|588581371|FG000|Overall Study|deemed ineligible after 1st visit|6|||
162967433|NCT01691612|588581371|FG000|Overall Study|Adverse Event|1|||
162967434|NCT04049097|588581375|FG000|Overall Study|Adverse Event|18|||
162967435|NCT04049097|588581375|FG000|Overall Study|Death|2|||
162967436|NCT04049097|588581375|FG000|Overall Study|Lost to Follow-up|1|||
162967437|NCT04049097|588581375|FG000|Overall Study|Physician Decision|2|||
162967438|NCT04049097|588581375|FG000|Overall Study|Withdrawal by Subject|9|||
162967439|NCT04049097|588581375|FG000|Overall Study|Protocol Violation|2|||
162967440|NCT04049097|588581375|FG000|Overall Study|Other|1|||
162967441|NCT04049097|588581375|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
162967442|NCT01874535|588581379|FG000|Overall Study|Lost to Follow-up|10|||
162967443|NCT01874535|588581380|FG001|Overall Study|Lost to Follow-up|9|||
162967444|NCT01874535|588581379|FG000|Overall Study|incomplete symptom resolution|45|||
162967445|NCT01874535|588581380|FG001|Overall Study|incomplete symptom resolution|35|||
162967446|NCT02616380|588581382|FG000|Overall Study|Lost to Follow-up|1|||
162967447|NCT02616380|588581382|FG000|Overall Study|Other|2|||
162967448|NCT05065619|588581383|FG000|Up to Day 42|Lost to Follow-up|1|||
162967449|NCT05065619|588581384|FG001|Up to Day 42|Lost to Follow-up|0|||
162967450|NCT05065619|588581383|FG000|Up to Day 42|Withdrawal by Subject|1|||
163207692|NCT00372112|589472622|FG000|Overall Study|PR >240 at Visit 3|0|||
163207693|NCT00372112|589472623|FG001|Overall Study|PR >240 at Visit 3|0|||
163207694|NCT00372112|589472624|FG002|Overall Study|PR >240 at Visit 3|0|||
163207695|NCT00372112|589472625|FG003|Overall Study|PR >240 at Visit 3|1|||
163207696|NCT00372112|589472622|FG000|Overall Study|Hepatitis B|1|||
163207697|NCT00372112|589472623|FG001|Overall Study|Hepatitis B|0|||
163207698|NCT00372112|589472624|FG002|Overall Study|Hepatitis B|0|||
163207699|NCT00372112|589472625|FG003|Overall Study|Hepatitis B|0|||
163207700|NCT00372112|589472622|FG000|Overall Study|Other-protocol violation|0|||
163207701|NCT00372112|589472623|FG001|Overall Study|Other-protocol violation|0|||
163207702|NCT00372112|589472624|FG002|Overall Study|Other-protocol violation|1|||
163207703|NCT00372112|589472625|FG003|Overall Study|Other-protocol violation|0|||
163207704|NCT04649060|589472626|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
163207705|NCT04649060|589472627|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
163207706|NCT04649060|589472626|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
163207707|NCT04649060|589472627|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
163207708|NCT04649060|589472626|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
163207709|NCT04649060|589472627|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
163207710|NCT04649060|589472626|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
163207711|NCT04649060|589472627|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
163207712|NCT04649060|589472626|FG000|Arm A/Arm B Treatment|Patient Request|1|||
163315440|NCT03800654|589866191|FG002|Overall Study|Personal Issues|0|||
163315441|NCT03800654|589866189|FG000|Overall Study|Protocol Violation|0|||
163315442|NCT03800654|589866190|FG001|Overall Study|Protocol Violation|1|||
163207713|NCT04649060|589472627|FG001|Arm A/Arm B Treatment|Patient Request|0|||
163207714|NCT04649060|589472626|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
163207715|NCT04649060|589472627|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
163207716|NCT04649060|589472626|FG000|Arm A/Arm B Treatment|Other|1|||
163207717|NCT04649060|589472627|FG001|Arm A/Arm B Treatment|Other|0|||
163207718|NCT04649060|589472626|FG000|Crossover (Arm B)|Adverse Event|0|||
163315443|NCT03800654|589866191|FG002|Overall Study|Protocol Violation|0|||
163315444|NCT03459729|589866192|FG000|Overall Study|Physician Decision|2|||
163315445|NCT06182033|589866193|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
163315446|NCT06182033|589866194|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
163315447|NCT06182033|589866193|FG000|Overall Study|Target child relocation|1|||
163315448|NCT06182033|589866194|FG001|Overall Study|Target child relocation|1|||
163315449|NCT06182033|589866193|FG000|Overall Study|Withdrawal by Subject|1|||
163315450|NCT06182033|589866194|FG001|Overall Study|Withdrawal by Subject|0|||
163315451|NCT02626533|589866196|FG000|Overall Study|Protocol Violation|14|||
163315452|NCT02626533|589866196|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
163315453|NCT02626533|589866196|FG000|Overall Study|Withdrawal by Subject|1|||
163315454|NCT02151981|589866197|FG000|Overall Study|Death|184|||
163315455|NCT02151981|589866198|FG001|Overall Study|Death|88|||
163315456|NCT02151981|589866197|FG000|Overall Study|Lost to Follow-up|7|||
163315457|NCT02151981|589866198|FG001|Overall Study|Lost to Follow-up|1|||
163315458|NCT02151981|589866197|FG000|Overall Study|Withdrawal by Subject|27|||
163315459|NCT02151981|589866198|FG001|Overall Study|Withdrawal by Subject|21|||
163315460|NCT02151981|589866197|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163315461|NCT02151981|589866198|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163315462|NCT02151981|589866197|FG000|Overall Study|Other reasons|1|||
163315463|NCT02151981|589866198|FG001|Overall Study|Other reasons|2|||
163315464|NCT05645757|589866218|FG000|Overall Study|Enrolled but treatment not administered|0|||
163315465|NCT05645757|589866219|FG001|Overall Study|Enrolled but treatment not administered|0|||
163315466|NCT05645757|589866220|FG002|Overall Study|Enrolled but treatment not administered|0|||
163315467|NCT05645757|589866221|FG003|Overall Study|Enrolled but treatment not administered|0|||
163315468|NCT05645757|589866222|FG004|Overall Study|Enrolled but treatment not administered|1|||
163315469|NCT05645757|589866223|FG005|Overall Study|Enrolled but treatment not administered|1|||
163315470|NCT05645757|589866224|FG006|Overall Study|Enrolled but treatment not administered|0|||
163315471|NCT05645757|589866225|FG007|Overall Study|Enrolled but treatment not administered|0|||
163315472|NCT03463044|589866226|FG000|Overall Study|Lost to Follow-up|0|||
163315473|NCT03463044|589866227|FG001|Overall Study|Lost to Follow-up|0|||
163315474|NCT03463044|589866228|FG002|Overall Study|Lost to Follow-up|0|||
163315475|NCT03463044|589866229|FG003|Overall Study|Lost to Follow-up|0|||
163315476|NCT03463044|589866230|FG004|Overall Study|Lost to Follow-up|0|||
163315477|NCT03463044|589866231|FG005|Overall Study|Lost to Follow-up|0|||
163315478|NCT03463044|589866232|FG006|Overall Study|Lost to Follow-up|0|||
163315479|NCT03463044|589866233|FG007|Overall Study|Lost to Follow-up|1|||
163315480|NCT03463044|589866234|FG008|Overall Study|Lost to Follow-up|0|||
163315481|NCT05576155|589866235|FG000|Overall Study|Withdrawal by Subject|1|||
163315482|NCT05576155|589866236|FG001|Overall Study|Withdrawal by Subject|1|||
163315483|NCT04515849|589866237|FG000|Overall Study|Adverse Event|0|||
163315484|NCT04515849|589866238|FG001|Overall Study|Adverse Event|0|||
163315485|NCT04515849|589866239|FG002|Overall Study|Adverse Event|0|||
163315486|NCT04515849|589866240|FG003|Overall Study|Adverse Event|1|||
163315487|NCT04515849|589866241|FG004|Overall Study|Adverse Event|2|||
163315488|NCT04515849|589866237|FG000|Overall Study|Death|2|||
163315489|NCT04515849|589866238|FG001|Overall Study|Death|0|||
163315490|NCT04515849|589866239|FG002|Overall Study|Death|0|||
163315491|NCT04515849|589866240|FG003|Overall Study|Death|0|||
163315492|NCT04515849|589866241|FG004|Overall Study|Death|0|||
163315493|NCT04515849|589866237|FG000|Overall Study|Other:family emergency|0|||
163315494|NCT04515849|589866238|FG001|Overall Study|Other:family emergency|0|||
163315495|NCT04515849|589866239|FG002|Overall Study|Other:family emergency|0|||
163315496|NCT04515849|589866240|FG003|Overall Study|Other:family emergency|1|||
163315497|NCT04515849|589866241|FG004|Overall Study|Other:family emergency|0|||
163315498|NCT04515849|589866237|FG000|Overall Study|Other:randomised by error|0|||
163315499|NCT04515849|589866238|FG001|Overall Study|Other:randomised by error|1|||
163315500|NCT04515849|589866239|FG002|Overall Study|Other:randomised by error|0|||
163315501|NCT04515849|589866240|FG003|Overall Study|Other:randomised by error|0|||
163315502|NCT04515849|589866241|FG004|Overall Study|Other:randomised by error|0|||
163315503|NCT04515849|589866237|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
163398993|NCT05314517|590170948|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
163315504|NCT04515849|589866238|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
163315505|NCT04515849|589866239|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
163315506|NCT04515849|589866240|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
163315507|NCT04515849|589866241|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
163315508|NCT04515849|589866237|FG000|Overall Study|Physician Decision|0|||
163315509|NCT04515849|589866238|FG001|Overall Study|Physician Decision|1|||
163315510|NCT04515849|589866239|FG002|Overall Study|Physician Decision|0|||
163315511|NCT04515849|589866240|FG003|Overall Study|Physician Decision|0|||
163315512|NCT04515849|589866241|FG004|Overall Study|Physician Decision|0|||
163315513|NCT04515849|589866237|FG000|Overall Study|Withdrawal by Subject|1|||
163315514|NCT04515849|589866238|FG001|Overall Study|Withdrawal by Subject|2|||
163315515|NCT04515849|589866239|FG002|Overall Study|Withdrawal by Subject|1|||
163315516|NCT04515849|589866240|FG003|Overall Study|Withdrawal by Subject|0|||
163315517|NCT04515849|589866241|FG004|Overall Study|Withdrawal by Subject|0|||
163315518|NCT05693935|589867841|FG000|Double-blind Period (8 Weeks)|Adverse Event|5|||
163315519|NCT05693935|589867842|FG001|Double-blind Period (8 Weeks)|Adverse Event|4|||
163315520|NCT05693935|589867843|FG002|Double-blind Period (8 Weeks)|Adverse Event|2|||
163315521|NCT05693935|589867844|FG003|Double-blind Period (8 Weeks)|Adverse Event|3|||
163315522|NCT05693935|589867845|FG004|Double-blind Period (8 Weeks)|Adverse Event|0|||
163315523|NCT05693935|589867846|FG005|Double-blind Period (8 Weeks)|Adverse Event|0|||
163315524|NCT05693935|589867847|FG006|Double-blind Period (8 Weeks)|Adverse Event|0|||
163315525|NCT05693935|589867841|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|26|||
163315526|NCT05693935|589867842|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|35|||
163315527|NCT05693935|589867843|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|31|||
163315528|NCT05693935|589867844|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|33|||
163315529|NCT05693935|589867845|FG004|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
163315530|NCT05693935|589867846|FG005|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
163398994|NCT05314517|590170949|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
163398995|NCT02710136|590170952|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
163398996|NCT02710136|590170953|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
163398997|NCT02269787|590170954|FG000|Overall Study|Lost to Follow-up|20|||
163398998|NCT02269787|590170955|FG001|Overall Study|Lost to Follow-up|6|||
163398999|NCT02269787|590170954|FG000|Overall Study|Death|2|||
163399000|NCT02269787|590170955|FG001|Overall Study|Death|3|||
163399001|NCT02269787|590170954|FG000|Overall Study|Incapacitated|0|||
163399002|NCT02269787|590170955|FG001|Overall Study|Incapacitated|1|||
163399003|NCT05050318|590172547|FG000|Overall Study|Protocol Deviation|1|||
163399004|NCT05050318|590172548|FG001|Overall Study|Protocol Deviation|0|||
163399005|NCT05050318|590172549|FG002|Overall Study|Protocol Deviation|0|||
163399006|NCT04183790|590172550|FG000|Overall Study|Participants did not rollover to Part B|12|||
163399007|NCT04183790|590172551|FG001|Overall Study|Participants did not rollover to Part B|0|||
163399008|NCT04183790|590172550|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
163399009|NCT04183790|590172551|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
163399010|NCT04183790|590172550|FG000|Overall Study|Commercial drug is available for participant|6|||
163399011|NCT04183790|590172551|FG001|Overall Study|Commercial drug is available for participant|0|||
163399012|NCT04183790|590172550|FG000|Overall Study|Adverse Event|1|||
163399013|NCT04183790|590172551|FG001|Overall Study|Adverse Event|0|||
163399014|NCT04183790|590172550|FG000|Overall Study|Not enrolled in 107 study|0|||
163399015|NCT04183790|590172551|FG001|Overall Study|Not enrolled in 107 study|2|||
163399016|NCT01251653|590172552|FG000|Overall Study|Progressive Disease|1|||
163399017|NCT01251653|590172553|FG001|Overall Study|Progressive Disease|7|||
163399018|NCT01251653|590172554|FG002|Overall Study|Progressive Disease|16|||
163399019|NCT01251653|590172555|FG003|Overall Study|Progressive Disease|4|||
163399020|NCT01251653|590172556|FG004|Overall Study|Progressive Disease|0|||
163399021|NCT01251653|590172557|FG005|Overall Study|Progressive Disease|17|||
163399022|NCT01251653|590172558|FG006|Overall Study|Progressive Disease|14|||
163399023|NCT01251653|590172559|FG007|Overall Study|Progressive Disease|7|||
163399024|NCT01251653|590172560|FG008|Overall Study|Progressive Disease|5|||
163399025|NCT01251653|590172552|FG000|Overall Study|Dose-limiting toxicity|0|||
163399026|NCT01251653|590172553|FG001|Overall Study|Dose-limiting toxicity|1|||
163399027|NCT01251653|590172554|FG002|Overall Study|Dose-limiting toxicity|1|||
163399028|NCT01251653|590172555|FG003|Overall Study|Dose-limiting toxicity|1|||
163399029|NCT01251653|590172556|FG004|Overall Study|Dose-limiting toxicity|0|||
163399030|NCT01251653|590172557|FG005|Overall Study|Dose-limiting toxicity|0|||
163399031|NCT01251653|590172558|FG006|Overall Study|Dose-limiting toxicity|2|||
162967451|NCT05065619|588581384|FG001|Up to Day 42|Withdrawal by Subject|0|||
162967452|NCT05065619|588581383|FG000|After Day 43|Lost to Follow-up|1|||
162967453|NCT05065619|588581384|FG001|After Day 43|Lost to Follow-up|0|||
162967454|NCT05065619|588581383|FG000|After Day 43|Physician Decision|3|||
163399032|NCT01251653|590172559|FG007|Overall Study|Dose-limiting toxicity|0|||
162967455|NCT05065619|588581384|FG001|After Day 43|Physician Decision|0|||
162967456|NCT05065619|588581383|FG000|After Day 43|Withdrawal by Subject|1|||
162967457|NCT05065619|588581384|FG001|After Day 43|Withdrawal by Subject|2|||
162967458|NCT05065619|588581383|FG000|After Day 43|Public vaccination|6|||
162967459|NCT05065619|588581384|FG001|After Day 43|Public vaccination|8|||
162967460|NCT05065619|588581383|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
162967461|NCT05065619|588581384|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
162967462|NCT05065619|588581383|FG000|After Day 43|Study Terminated by Sponsor|88|||
162967463|NCT05065619|588581384|FG001|After Day 43|Study Terminated by Sponsor|16|||
163399033|NCT01251653|590172560|FG008|Overall Study|Dose-limiting toxicity|0|||
163399034|NCT01251653|590172552|FG000|Overall Study|Adverse Event|1|||
163399035|NCT01251653|590172553|FG001|Overall Study|Adverse Event|0|||
163399036|NCT01251653|590172554|FG002|Overall Study|Adverse Event|2|||
163399037|NCT01251653|590172555|FG003|Overall Study|Adverse Event|1|||
163315531|NCT05693935|589867847|FG006|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
163315532|NCT05693935|589867841|FG000|Double-blind Period (8 Weeks)|Lost to Follow-up|5|||
163315533|NCT05693935|589867842|FG001|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
163315534|NCT05693935|589867843|FG002|Double-blind Period (8 Weeks)|Lost to Follow-up|6|||
163315535|NCT05693935|589867844|FG003|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
163315536|NCT05693935|589867845|FG004|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
163315537|NCT05693935|589867846|FG005|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
163315538|NCT05693935|589867847|FG006|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
163315539|NCT05693935|589867841|FG000|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
163315540|NCT05693935|589867842|FG001|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
163315541|NCT05693935|589867843|FG002|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
163315542|NCT05693935|589867844|FG003|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
163315543|NCT05693935|589867845|FG004|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
163315544|NCT05693935|589867846|FG005|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
163315545|NCT05693935|589867847|FG006|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
163315546|NCT05693935|589867841|FG000|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
163315547|NCT05693935|589867842|FG001|Double-blind Period (8 Weeks)|Randomized But Not Treated|5|||
163315548|NCT05693935|589867843|FG002|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
163315549|NCT05693935|589867844|FG003|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
163315550|NCT05693935|589867845|FG004|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
163315551|NCT05693935|589867846|FG005|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
163315552|NCT05693935|589867847|FG006|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
163315553|NCT05693935|589867841|FG000|Double-blind Period (8 Weeks)|Other Than Specified|11|||
163315554|NCT05693935|589867842|FG001|Double-blind Period (8 Weeks)|Other Than Specified|5|||
163315555|NCT05693935|589867843|FG002|Double-blind Period (8 Weeks)|Other Than Specified|8|||
162967464|NCT01929681|588581385|FG000|Overall Study|Withdrawal by Subject|1|||
162967465|NCT01929681|588581386|FG001|Overall Study|Withdrawal by Subject|0|||
163315556|NCT05693935|589867844|FG003|Double-blind Period (8 Weeks)|Other Than Specified|7|||
163315557|NCT05693935|589867845|FG004|Double-blind Period (8 Weeks)|Other Than Specified|0|||
163399038|NCT01251653|590172556|FG004|Overall Study|Adverse Event|1|||
163054314|NCT03530293|588910231|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
163054315|NCT03530293|588910232|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
163054316|NCT03530293|588910233|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
163207719|NCT04649060|589472627|FG001|Crossover (Arm B)|Adverse Event|1|||
163207720|NCT04649060|589472626|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
163207721|NCT04649060|589472627|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
163207722|NCT03033394|589472628|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
163207723|NCT03033394|589472628|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
163207724|NCT03033394|589472628|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
163054317|NCT03530293|588910231|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
163207725|NCT03033394|589472628|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
163207726|NCT03033394|589472628|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
163207727|NCT02927431|589472629|FG000|Overall Study|Withdrawal by Subject|0|||
163207728|NCT02927431|589472630|FG001|Overall Study|Withdrawal by Subject|0|||
163207729|NCT02927431|589472631|FG002|Overall Study|Withdrawal by Subject|1|||
163207730|NCT02246660|589472632|FG000|Overall Study|Withdrawal by Subject|0|||
163207731|NCT02246660|589472633|FG001|Overall Study|Withdrawal by Subject|1|||
163207732|NCT02246660|589472634|FG002|Overall Study|Withdrawal by Subject|0|||
163207733|NCT02246660|589472632|FG000|Overall Study|Death|0|||
163207734|NCT02246660|589472633|FG001|Overall Study|Death|0|||
163207735|NCT02246660|589472634|FG002|Overall Study|Death|1|||
163207736|NCT04952402|589472635|FG000|Overall Study|Lost to Follow-up|1|||
163207737|NCT04952402|589472636|FG001|Overall Study|Lost to Follow-up|3|||
163207738|NCT04952402|589472635|FG000|Overall Study|Lack Of Venous Access|0|||
163207739|NCT04952402|589472636|FG001|Overall Study|Lack Of Venous Access|1|||
163207740|NCT00143403|589472637|FG000|Overall Study|Adverse Event|3|||
163315558|NCT05693935|589867846|FG005|Double-blind Period (8 Weeks)|Other Than Specified|0|||
163315559|NCT05693935|589867847|FG006|Double-blind Period (8 Weeks)|Other Than Specified|0|||
163315560|NCT05693935|589867841|FG000|Open-label Period (48 Weeks)|Adverse Event|0|||
163315561|NCT05693935|589867842|FG001|Open-label Period (48 Weeks)|Adverse Event|5|||
163315562|NCT05693935|589867843|FG002|Open-label Period (48 Weeks)|Adverse Event|6|||
163315563|NCT05693935|589867844|FG003|Open-label Period (48 Weeks)|Adverse Event|14|||
163315564|NCT05693935|589867845|FG004|Open-label Period (48 Weeks)|Adverse Event|4|||
163399039|NCT01251653|590172557|FG005|Overall Study|Adverse Event|0|||
163399040|NCT01251653|590172558|FG006|Overall Study|Adverse Event|2|||
163399041|NCT01251653|590172559|FG007|Overall Study|Adverse Event|2|||
163399042|NCT01251653|590172560|FG008|Overall Study|Adverse Event|1|||
163399043|NCT01251653|590172552|FG000|Overall Study|Withdrawal by Subject|1|||
163399044|NCT01251653|590172553|FG001|Overall Study|Withdrawal by Subject|0|||
163399045|NCT01251653|590172554|FG002|Overall Study|Withdrawal by Subject|1|||
163399046|NCT01251653|590172555|FG003|Overall Study|Withdrawal by Subject|0|||
163399047|NCT01251653|590172556|FG004|Overall Study|Withdrawal by Subject|1|||
163315565|NCT05693935|589867846|FG005|Open-label Period (48 Weeks)|Adverse Event|1|||
163315566|NCT05693935|589867847|FG006|Open-label Period (48 Weeks)|Adverse Event|3|||
163315567|NCT05693935|589867841|FG000|Open-label Period (48 Weeks)|Withdrawal by Subject|0|||
163315568|NCT05693935|589867842|FG001|Open-label Period (48 Weeks)|Withdrawal by Subject|32|||
163315569|NCT05693935|589867843|FG002|Open-label Period (48 Weeks)|Withdrawal by Subject|29|||
163315570|NCT05693935|589867844|FG003|Open-label Period (48 Weeks)|Withdrawal by Subject|39|||
163315571|NCT05693935|589867845|FG004|Open-label Period (48 Weeks)|Withdrawal by Subject|14|||
163399048|NCT01251653|590172557|FG005|Overall Study|Withdrawal by Subject|1|||
162967466|NCT01929681|588581385|FG000|Overall Study|Physician Decision|1|||
162967467|NCT01929681|588581386|FG001|Overall Study|Physician Decision|1|||
162967468|NCT05315713|588581387|FG000|Overall Study|Death|5|||
162967469|NCT05315713|588581387|FG000|Overall Study|Progressive disease|1|||
162967470|NCT05315713|588581387|FG000|Overall Study|Withdrawal by Subject|1|||
162967471|NCT05315713|588581387|FG000|Overall Study|Study terminated by sponsor|1|||
162967472|NCT00421304|588581388|FG000|Overall Study|Lost to Follow-up|5|||
162967473|NCT00421304|588581389|FG001|Overall Study|Lost to Follow-up|2|||
162967474|NCT00421304|588581390|FG002|Overall Study|Lost to Follow-up|5|||
162967475|NCT00421304|588581388|FG000|Overall Study|Withdrawal by Subject|2|||
162967476|NCT00421304|588581389|FG001|Overall Study|Withdrawal by Subject|2|||
162967477|NCT00421304|588581390|FG002|Overall Study|Withdrawal by Subject|2|||
162967478|NCT00421304|588581388|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
162967479|NCT00421304|588581389|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
162967480|NCT00421304|588581390|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
162967481|NCT00421304|588581388|FG000|Overall Study|Did not attend Day 360 visit|0|||
162967482|NCT00421304|588581389|FG001|Overall Study|Did not attend Day 360 visit|0|||
163399049|NCT01251653|590172558|FG006|Overall Study|Withdrawal by Subject|0|||
163399050|NCT01251653|590172559|FG007|Overall Study|Withdrawal by Subject|1|||
162967483|NCT00421304|588581390|FG002|Overall Study|Did not attend Day 360 visit|1|||
162967484|NCT00903877|588581391|FG000|Overall Study|Did not meet study criteria|33|||
162967485|NCT00903877|588581391|FG000|Overall Study|Withdrawal by Subject|3|||
162967486|NCT00903877|588581391|FG000|Overall Study|Adverse Event|2|||
162967487|NCT00903877|588581391|FG000|Overall Study|Lost to Follow-up|1|||
162967488|NCT00903877|588581391|FG000|Overall Study|Participation put on hold|4|||
162967489|NCT00919711|588581392|FG000|Overall Study|Withdrawal by Subject|15|||
162967490|NCT00919711|588581393|FG001|Overall Study|Withdrawal by Subject|7|||
162967491|NCT00919711|588581392|FG000|Overall Study|Adverse Event|13|||
162967492|NCT00919711|588581393|FG001|Overall Study|Adverse Event|3|||
162967493|NCT00919711|588581392|FG000|Overall Study|Other|1|||
162967494|NCT00919711|588581393|FG001|Overall Study|Other|2|||
162967495|NCT00919711|588581392|FG000|Overall Study|Administrative Decision|0|||
162967496|NCT00919711|588581393|FG001|Overall Study|Administrative Decision|1|||
162967497|NCT00919711|588581392|FG000|Overall Study|Lost to Follow-up|2|||
162967498|NCT00919711|588581393|FG001|Overall Study|Lost to Follow-up|0|||
162967499|NCT00919711|588581392|FG000|Overall Study|Death|1|||
162967500|NCT00919711|588581393|FG001|Overall Study|Death|0|||
162967501|NCT00919711|588581392|FG000|Overall Study|Noncompliance|1|||
162967502|NCT00919711|588581393|FG001|Overall Study|Noncompliance|0|||
163315572|NCT05693935|589867846|FG005|Open-label Period (48 Weeks)|Withdrawal by Subject|15|||
163315573|NCT05693935|589867847|FG006|Open-label Period (48 Weeks)|Withdrawal by Subject|8|||
163315574|NCT05693935|589867841|FG000|Open-label Period (48 Weeks)|Protocol Violation|0|||
163315575|NCT05693935|589867842|FG001|Open-label Period (48 Weeks)|Protocol Violation|1|||
163315576|NCT05693935|589867843|FG002|Open-label Period (48 Weeks)|Protocol Violation|1|||
163315577|NCT05693935|589867844|FG003|Open-label Period (48 Weeks)|Protocol Violation|1|||
163315578|NCT05693935|589867845|FG004|Open-label Period (48 Weeks)|Protocol Violation|0|||
163315579|NCT05693935|589867846|FG005|Open-label Period (48 Weeks)|Protocol Violation|0|||
163315580|NCT05693935|589867847|FG006|Open-label Period (48 Weeks)|Protocol Violation|0|||
163315581|NCT05693935|589867841|FG000|Open-label Period (48 Weeks)|Lost to Follow-up|0|||
163315582|NCT05693935|589867842|FG001|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
163315583|NCT05693935|589867843|FG002|Open-label Period (48 Weeks)|Lost to Follow-up|19|||
163315584|NCT05693935|589867844|FG003|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
163315585|NCT05693935|589867845|FG004|Open-label Period (48 Weeks)|Lost to Follow-up|3|||
163315586|NCT05693935|589867846|FG005|Open-label Period (48 Weeks)|Lost to Follow-up|5|||
163315587|NCT05693935|589867847|FG006|Open-label Period (48 Weeks)|Lost to Follow-up|4|||
163315588|NCT05693935|589867841|FG000|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
163315589|NCT05693935|589867842|FG001|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
163315590|NCT05693935|589867843|FG002|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
163315591|NCT05693935|589867844|FG003|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
163315592|NCT05693935|589867845|FG004|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
163315593|NCT05693935|589867846|FG005|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
163315594|NCT05693935|589867847|FG006|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
163315595|NCT05693935|589867841|FG000|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
163315596|NCT05693935|589867842|FG001|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
163315597|NCT05693935|589867843|FG002|Open-label Period (48 Weeks)|Randomized But Not Treated|1|||
163315598|NCT05693935|589867844|FG003|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
163315599|NCT05693935|589867845|FG004|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
163315600|NCT05693935|589867846|FG005|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
163315601|NCT05693935|589867847|FG006|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
163315602|NCT05693935|589867841|FG000|Open-label Period (48 Weeks)|Other Than Specified|0|||
163315603|NCT05693935|589867842|FG001|Open-label Period (48 Weeks)|Other Than Specified|12|||
163315604|NCT05693935|589867843|FG002|Open-label Period (48 Weeks)|Other Than Specified|9|||
163315605|NCT05693935|589867844|FG003|Open-label Period (48 Weeks)|Other Than Specified|10|||
163315606|NCT05693935|589867845|FG004|Open-label Period (48 Weeks)|Other Than Specified|4|||
163315607|NCT05693935|589867846|FG005|Open-label Period (48 Weeks)|Other Than Specified|3|||
163315608|NCT05693935|589867847|FG006|Open-label Period (48 Weeks)|Other Than Specified|4|||
163399051|NCT01251653|590172560|FG008|Overall Study|Withdrawal by Subject|0|||
163315609|NCT04987320|589867857|FG000|Overall Study|Withdrawal by Subject|0|||
163315610|NCT04987320|589867858|FG001|Overall Study|Withdrawal by Subject|1|||
163315611|NCT00085735|589867859|FG000|Overall Study|Adverse Event|1|||
163315612|NCT00085735|589867860|FG001|Overall Study|Adverse Event|0|||
163315613|NCT00085735|589867861|FG002|Overall Study|Adverse Event|0|||
163315614|NCT00085735|589867862|FG003|Overall Study|Adverse Event|0|||
163315615|NCT00085735|589867863|FG004|Overall Study|Adverse Event|0|||
162967503|NCT03694197|588581394|FG000|Overall Study|Adverse Event|9|||
162967504|NCT03694197|588581394|FG000|Overall Study|Protocol became inconvenient to participate|1|||
162967505|NCT03694197|588581394|FG000|Overall Study|Physician Decision|4|||
162967506|NCT03694197|588581394|FG000|Overall Study|Study terminated by sponsor|1350|||
162967507|NCT03694197|588581394|FG000|Overall Study|Participant moved|5|||
162967508|NCT03694197|588581394|FG000|Overall Study|Participant withdrew consent|10|||
163315616|NCT00085735|589867864|FG005|Overall Study|Adverse Event|0|||
163315617|NCT00085735|589867859|FG000|Overall Study|Lack of Efficacy|2|||
163315618|NCT00085735|589867860|FG001|Overall Study|Lack of Efficacy|4|||
163315619|NCT00085735|589867861|FG002|Overall Study|Lack of Efficacy|6|||
163315620|NCT00085735|589867862|FG003|Overall Study|Lack of Efficacy|3|||
163315621|NCT00085735|589867863|FG004|Overall Study|Lack of Efficacy|4|||
163315622|NCT00085735|589867864|FG005|Overall Study|Lack of Efficacy|3|||
163315623|NCT00085735|589867859|FG000|Overall Study|Lost to Follow-up|0|||
163315624|NCT00085735|589867860|FG001|Overall Study|Lost to Follow-up|1|||
163315625|NCT00085735|589867861|FG002|Overall Study|Lost to Follow-up|0|||
163315626|NCT00085735|589867862|FG003|Overall Study|Lost to Follow-up|0|||
163315627|NCT00085735|589867863|FG004|Overall Study|Lost to Follow-up|1|||
163315628|NCT00085735|589867864|FG005|Overall Study|Lost to Follow-up|0|||
163315629|NCT00085735|589867859|FG000|Overall Study|Physician Decision|2|||
163315630|NCT00085735|589867860|FG001|Overall Study|Physician Decision|3|||
163315631|NCT00085735|589867861|FG002|Overall Study|Physician Decision|2|||
163315632|NCT00085735|589867862|FG003|Overall Study|Physician Decision|3|||
163054318|NCT03530293|588910232|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
163054319|NCT03530293|588910233|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
163054320|NCT03530293|588910231|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
163054321|NCT03530293|588910232|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
163054322|NCT03530293|588910233|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
163054323|NCT03530293|588910231|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
163054324|NCT03530293|588910232|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
163054325|NCT03530293|588910233|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
163054326|NCT03530293|588910231|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
163054327|NCT03530293|588910232|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
163054328|NCT03530293|588910233|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
163054329|NCT03482024|588910235|FG000|Overall Study|Physician Decision|1|||
163054330|NCT03482024|588910236|FG001|Overall Study|Physician Decision|0|||
163054331|NCT03482024|588910237|FG002|Overall Study|Physician Decision|0|||
163054332|NCT03482024|588910238|FG003|Overall Study|Physician Decision|0|||
163054333|NCT03482024|588910239|FG004|Overall Study|Physician Decision|0|||
163054334|NCT00630916|588910240|FG000|Overall Study|Death|110|||
163315633|NCT00085735|589867863|FG004|Overall Study|Physician Decision|11|||
163315634|NCT00085735|589867864|FG005|Overall Study|Physician Decision|8|||
163315635|NCT00085735|589867859|FG000|Overall Study|Protocol Violation|1|||
163315636|NCT00085735|589867860|FG001|Overall Study|Protocol Violation|0|||
163315637|NCT00085735|589867861|FG002|Overall Study|Protocol Violation|0|||
163315638|NCT00085735|589867862|FG003|Overall Study|Protocol Violation|0|||
163315639|NCT00085735|589867863|FG004|Overall Study|Protocol Violation|0|||
163315640|NCT00085735|589867864|FG005|Overall Study|Protocol Violation|0|||
163315641|NCT00085735|589867859|FG000|Overall Study|Withdrawal by Subject|1|||
163315642|NCT00085735|589867860|FG001|Overall Study|Withdrawal by Subject|0|||
163315643|NCT00085735|589867861|FG002|Overall Study|Withdrawal by Subject|4|||
163315644|NCT00085735|589867862|FG003|Overall Study|Withdrawal by Subject|5|||
163315645|NCT00085735|589867863|FG004|Overall Study|Withdrawal by Subject|7|||
163315646|NCT00085735|589867864|FG005|Overall Study|Withdrawal by Subject|8|||
163315647|NCT00085735|589867859|FG000|Overall Study|Patient ineligible|1|||
163315648|NCT00085735|589867860|FG001|Overall Study|Patient ineligible|0|||
163315649|NCT00085735|589867861|FG002|Overall Study|Patient ineligible|3|||
163315650|NCT00085735|589867862|FG003|Overall Study|Patient ineligible|7|||
163315651|NCT00085735|589867863|FG004|Overall Study|Patient ineligible|17|||
163315652|NCT00085735|589867864|FG005|Overall Study|Patient ineligible|8|||
163315653|NCT00085735|589867859|FG000|Overall Study|Excess residual disease|2|||
163315654|NCT00085735|589867860|FG001|Overall Study|Excess residual disease|2|||
163315655|NCT00085735|589867861|FG002|Overall Study|Excess residual disease|1|||
163315656|NCT00085735|589867862|FG003|Overall Study|Excess residual disease|1|||
163315657|NCT00085735|589867863|FG004|Overall Study|Excess residual disease|1|||
163315658|NCT00085735|589867864|FG005|Overall Study|Excess residual disease|4|||
163315659|NCT00085735|589867859|FG000|Overall Study|Reason not documented|1|||
163315660|NCT00085735|589867860|FG001|Overall Study|Reason not documented|0|||
163315661|NCT00085735|589867861|FG002|Overall Study|Reason not documented|1|||
163315662|NCT00085735|589867862|FG003|Overall Study|Reason not documented|0|||
163315663|NCT00085735|589867863|FG004|Overall Study|Reason not documented|1|||
163054335|NCT00630916|588910240|FG000|Overall Study|Explant|8|||
163054336|NCT00630916|588910240|FG000|Overall Study|Lost to Follow-up|5|||
163054337|NCT00630916|588910240|FG000|Overall Study|Withdrawal by Subject|30|||
163054338|NCT00630916|588910240|FG000|Overall Study|Protocol Violation|7|||
163315664|NCT00085735|589867864|FG005|Overall Study|Reason not documented|0|||
163315665|NCT00085735|589867859|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
163315666|NCT00085735|589867860|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
163315667|NCT00085735|589867861|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
163315668|NCT00085735|589867862|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
163315669|NCT00085735|589867863|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
163315670|NCT00085735|589867864|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
163315671|NCT01824875|589867865|FG000|Overall Study|Disease progression|22|||
163315672|NCT01824875|589867866|FG001|Overall Study|Disease progression|15|||
163315673|NCT01824875|589867865|FG000|Overall Study|Withdrawal by Subject|5|||
163315674|NCT01824875|589867866|FG001|Overall Study|Withdrawal by Subject|4|||
163315675|NCT01824875|589867865|FG000|Overall Study|Adverse Event|4|||
163315676|NCT01824875|589867866|FG001|Overall Study|Adverse Event|10|||
163315677|NCT01824875|589867865|FG000|Overall Study|Alternative therapy|3|||
163315678|NCT01824875|589867866|FG001|Overall Study|Alternative therapy|0|||
163054339|NCT00630916|588910240|FG000|Overall Study|Physician Decision|47|||
163207741|NCT00143403|589472638|FG001|Overall Study|Adverse Event|8|||
163315679|NCT01824875|589867865|FG000|Overall Study|Complicating disease|1|||
163315680|NCT01824875|589867866|FG001|Overall Study|Complicating disease|0|||
163315681|NCT01824875|589867865|FG000|Overall Study|Physician Decision|0|||
163315682|NCT01824875|589867866|FG001|Overall Study|Physician Decision|1|||
163315683|NCT01824875|589867865|FG000|Overall Study|Non-compliance|1|||
163315684|NCT01824875|589867866|FG001|Overall Study|Non-compliance|1|||
163315685|NCT01824875|589867865|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
163315686|NCT01824875|589867866|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
163315687|NCT01824875|589867865|FG000|Overall Study|Administrative issues|0|||
163315688|NCT01824875|589867866|FG001|Overall Study|Administrative issues|2|||
163315689|NCT01824875|589867865|FG000|Overall Study|Ineligible or never started treatment|9|||
163315690|NCT01824875|589867866|FG001|Overall Study|Ineligible or never started treatment|5|||
163315691|NCT01824875|589867865|FG000|Overall Study|Other|0|||
163315692|NCT01824875|589867866|FG001|Overall Study|Other|2|||
163315693|NCT04195698|589867867|FG000|Overall Study|Adverse Event|4|||
163315694|NCT04195698|589867868|FG001|Overall Study|Adverse Event|11|||
163315695|NCT04195698|589867867|FG000|Overall Study|Withdrawal by Subject|9|||
163315696|NCT04195698|589867868|FG001|Overall Study|Withdrawal by Subject|10|||
163315697|NCT04195698|589867867|FG000|Overall Study|Lost to Follow-up|5|||
163315698|NCT04195698|589867868|FG001|Overall Study|Lost to Follow-up|4|||
163315699|NCT04195698|589867867|FG000|Overall Study|Lack of Efficacy|2|||
163315700|NCT04195698|589867868|FG001|Overall Study|Lack of Efficacy|10|||
163315701|NCT04195698|589867867|FG000|Overall Study|Other|5|||
163315702|NCT04195698|589867868|FG001|Overall Study|Other|4|||
163315703|NCT00433329|589867869|FG000|Overall Study|Adverse Event|9|||
163315704|NCT00433329|589867869|FG000|Overall Study|Death|4|||
163315705|NCT00433329|589867869|FG000|Overall Study|Withdrew consent|3|||
163315706|NCT00433329|589867869|FG000|Overall Study|Discontinued sildenafil|2|||
163207742|NCT00143403|589472637|FG000|Overall Study|Death|1|||
163207743|NCT00143403|589472638|FG001|Overall Study|Death|0|||
163207744|NCT00143403|589472637|FG000|Overall Study|Withdrawal by Subject|3|||
163207745|NCT00143403|589472638|FG001|Overall Study|Withdrawal by Subject|12|||
163207746|NCT00143403|589472637|FG000|Overall Study|Relapse|15|||
163207747|NCT00143403|589472638|FG001|Overall Study|Relapse|7|||
163207748|NCT00143403|589472637|FG000|Overall Study|Protocol Violation|2|||
163207749|NCT00143403|589472638|FG001|Overall Study|Protocol Violation|2|||
163207750|NCT00143403|589472637|FG000|Overall Study|specified by site|4|||
163207751|NCT00143403|589472638|FG001|Overall Study|specified by site|9|||
163207752|NCT00143403|589472637|FG000|Overall Study|Randomized Not Treated|7|||
163207753|NCT00143403|589472638|FG001|Overall Study|Randomized Not Treated|8|||
163207754|NCT00587639|589472639|FG000|Overall Study|Withdrawal by Subject|1|||
163207755|NCT01442675|589472640|FG000|Overall Study|Protocol Violation|6|||
163207756|NCT01442675|589472640|FG000|Overall Study|Lost to Follow-up|2|||
163207757|NCT01442675|589472640|FG000|Overall Study|Withdrawal by Subject|4|||
163207758|NCT03944954|589472645|FG000|Overall Study|Withdrawal by Subject|22|||
163207759|NCT03944954|589472646|FG001|Overall Study|Withdrawal by Subject|4|||
163207760|NCT03944954|589472645|FG000|Overall Study|Lost to Follow-up|18|||
163207761|NCT03944954|589472646|FG001|Overall Study|Lost to Follow-up|0|||
163207762|NCT03944954|589472645|FG000|Overall Study|Failed Medical Screening|7|||
162967509|NCT03694197|588581394|FG000|Overall Study|Related to IMP administration|1|||
162967510|NCT03694197|588581394|FG000|Overall Study|Not disclosed|5|||
162967511|NCT01188226|588582914|FG000|Overall Study|Withdrawal by Subject|4|||
162967512|NCT04980456|588582915|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
162967513|NCT04980456|588582916|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
162967514|NCT04980456|588582915|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
162967515|NCT04980456|588582916|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
162967516|NCT04980456|588582915|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
162967517|NCT04980456|588582916|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
162967518|NCT04980456|588582915|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
162967519|NCT04980456|588582916|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
162967520|NCT01350934|588582945|FG000|Base Study|Adverse Event|6|||
162967521|NCT01350934|588582946|FG001|Base Study|Adverse Event|0|||
162967522|NCT01350934|588582945|FG000|Base Study|Lost to Follow-up|1|||
162967523|NCT01350934|588582946|FG001|Base Study|Lost to Follow-up|0|||
162967524|NCT01350934|588582945|FG000|Base Study|Protocol Violation|1|||
162967525|NCT01350934|588582946|FG001|Base Study|Protocol Violation|1|||
162967526|NCT01350934|588582945|FG000|Base Study|Withdrawal by Subject|1|||
163207763|NCT03944954|589472646|FG001|Overall Study|Failed Medical Screening|0|||
163207764|NCT03235154|589472650|FG000|Overall Study|Withdrawal by Subject|1|||
163207765|NCT03235154|589472650|FG000|Overall Study|Adverse Event|1|||
163207766|NCT03235154|589472650|FG000|Overall Study|Lost to Follow-up|2|||
163207767|NCT00536198|589472651|FG000|Overall Study|Lost to Follow-up|15|||
163207768|NCT00536198|589472652|FG001|Overall Study|Lost to Follow-up|14|||
163207769|NCT00536198|589472651|FG000|Overall Study|Withdrawal by Subject|16|||
163207770|NCT00536198|589472652|FG001|Overall Study|Withdrawal by Subject|12|||
163207771|NCT00536198|589472651|FG000|Overall Study|Adverse Event|2|||
163207772|NCT00536198|589472652|FG001|Overall Study|Adverse Event|2|||
163207773|NCT00536198|589472651|FG000|Overall Study|Rescue|3|||
163207774|NCT00536198|589472652|FG001|Overall Study|Rescue|9|||
163207775|NCT00536198|589472651|FG000|Overall Study|Pregnancy|1|||
163207776|NCT00536198|589472652|FG001|Overall Study|Pregnancy|1|||
163207777|NCT00536198|589472651|FG000|Overall Study|Protocol Violation|0|||
163207778|NCT00536198|589472652|FG001|Overall Study|Protocol Violation|1|||
163207779|NCT00881712|589472653|FG000|Overall Study|Death|1|||
163207780|NCT00881712|589472654|FG001|Overall Study|Death|0|||
163207781|NCT00881712|589472655|FG002|Overall Study|Death|0|||
163207782|NCT00881712|589472653|FG000|Overall Study|Withdrawal by Subject|1|||
163207783|NCT00881712|589472654|FG001|Overall Study|Withdrawal by Subject|0|||
163207784|NCT00881712|589472655|FG002|Overall Study|Withdrawal by Subject|0|||
163207785|NCT00276744|589472656|FG000|PART A|Reason unknown|98|||
163207786|NCT00965718|589472675|FG000|Overall Study|Withdrawal by Subject|4|||
163207787|NCT03667924|589472676|FG000|Baseline Completed|Lost to Follow-up|0|||
163207788|NCT03667924|589472677|FG001|Baseline Completed|Lost to Follow-up|2|||
163207789|NCT03667924|589472678|FG002|Baseline Completed|Lost to Follow-up|0|||
163207790|NCT03667924|589472676|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
163207791|NCT03667924|589472677|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
163207792|NCT03667924|589472678|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
163207793|NCT03667924|589472676|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
163207794|NCT03667924|589472677|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
163207795|NCT03667924|589472678|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
163207796|NCT03667924|589472676|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
163207797|NCT03667924|589472677|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
163207798|NCT03667924|589472678|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
163207799|NCT03667924|589472676|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
163207800|NCT03667924|589472677|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
163207801|NCT03667924|589472678|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
163207802|NCT03667924|589472676|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
163207803|NCT03667924|589472677|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
163207804|NCT03667924|589472678|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
163207805|NCT03667924|589472676|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
163207806|NCT03667924|589472677|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
163207807|NCT03667924|589472678|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
163207808|NCT00126568|589472679|FG000|Overall Study|Death|2|||
163207809|NCT01244425|589472680|FG000|Overall Study|Withdrawal by Subject|2|||
163207810|NCT01244425|589472681|FG001|Overall Study|Withdrawal by Subject|2|||
163207811|NCT01244425|589472680|FG000|Overall Study|Adverse Event|1|||
163207812|NCT01244425|589472681|FG001|Overall Study|Adverse Event|1|||
163207813|NCT02547454|589472682|FG000|Overall Study|Due to hemodialysis|53|||
163207814|NCT02547454|589472682|FG000|Overall Study|Due to transplantation|1|||
163207815|NCT02547454|589472682|FG000|Overall Study|Due to no further need to treat|4|||
163207816|NCT02547454|589472682|FG000|Overall Study|Death|38|||
163207817|NCT02547454|589472682|FG000|Overall Study|Lost to Follow-up|26|||
163207818|NCT02547454|589472682|FG000|Overall Study|Other|39|||
163207819|NCT02547454|589472682|FG000|Overall Study|No data|11|||
163207820|NCT04232124|589474184|FG000|Overall Study|Lost to Follow-up|3|||
163207821|NCT00407563|589474189|FG000|Overall Study|Patient continues on treatment|1|||
163207822|NCT00464087|589474190|FG000|Overall Study|No PCI per inclusion criteria|0|||
163207823|NCT00464087|589474191|FG001|Overall Study|No PCI per inclusion criteria|0|||
163207824|NCT00464087|589474192|FG002|Overall Study|No PCI per inclusion criteria|29|||
163207825|NCT01164956|589474193|FG000|Overall Study|Side Effects|1|||
163207826|NCT01164956|589474194|FG001|Overall Study|Side Effects|0|||
163207827|NCT01164956|589474195|FG002|Overall Study|Side Effects|1|||
163207828|NCT00720434|589474196|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
163207829|NCT00720434|589474197|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
163207830|NCT00720434|589474198|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
163207831|NCT00720434|589474199|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
163207832|NCT00720434|589474196|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
163207833|NCT00720434|589474197|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
163207834|NCT00720434|589474198|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
163207835|NCT00720434|589474199|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
163207836|NCT00720434|589474196|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
163207837|NCT00720434|589474197|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
163207838|NCT00720434|589474198|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
163207839|NCT00720434|589474199|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
163207840|NCT00720434|589474196|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
163207841|NCT00720434|589474197|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
163207842|NCT00720434|589474198|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
163207843|NCT00720434|589474199|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
163207844|NCT00720434|589474196|FG000|Open-Label Period (Week 5-72)|Other|4|||
163207845|NCT00720434|589474197|FG001|Open-Label Period (Week 5-72)|Other|3|||
163207846|NCT00720434|589474198|FG002|Open-Label Period (Week 5-72)|Other|3|||
163207847|NCT00720434|589474199|FG003|Open-Label Period (Week 5-72)|Other|2|||
163207848|NCT00418314|589474200|FG000|Overall Study|Withdrawal by Subject|1|||
163207849|NCT00418314|589474201|FG001|Overall Study|Withdrawal by Subject|2|||
163207850|NCT00967798|589474202|FG000|Overall Study|Withdrawal by Subject|5|||
163207851|NCT00967798|589474203|FG001|Overall Study|Withdrawal by Subject|2|||
163207852|NCT00967798|589474202|FG000|Overall Study|Lost to Follow-up|4|||
163207853|NCT00967798|589474203|FG001|Overall Study|Lost to Follow-up|1|||
163207854|NCT02425046|589474204|FG000|Overall Study|Lost to Follow-up|52|||
163207855|NCT02425046|589474205|FG001|Overall Study|Lost to Follow-up|50|||
163207856|NCT02425046|589474206|FG002|Overall Study|Lost to Follow-up|56|||
163207857|NCT02425046|589474204|FG000|Overall Study|Withdrawal by Subject|16|||
163207858|NCT02425046|589474205|FG001|Overall Study|Withdrawal by Subject|12|||
163207859|NCT02425046|589474206|FG002|Overall Study|Withdrawal by Subject|0|||
163207860|NCT01409564|589474207|FG000|Overall Study|low medication compliance|4|||
163207861|NCT01409564|589474208|FG001|Overall Study|low medication compliance|3|||
163207862|NCT01409564|589474207|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
162967527|NCT01350934|588582946|FG001|Base Study|Withdrawal by Subject|2|||
162967528|NCT01350934|588582945|FG000|Base Study|Non-Compliance With Study Drug|2|||
162967529|NCT01350934|588582946|FG001|Base Study|Non-Compliance With Study Drug|0|||
163315707|NCT00433329|589867869|FG000|Overall Study|Moved out of state|1|||
163315708|NCT00433329|589867869|FG000|Overall Study|Lost to Follow-up|1|||
163315709|NCT00433329|589867869|FG000|Overall Study|Physician Decision|1|||
163315710|NCT01129102|589867870|FG000|Overall Study|No study drug treatment|2|||
163315711|NCT01129102|589867871|FG001|Overall Study|No study drug treatment|3|||
163315712|NCT01129102|589867872|FG002|Overall Study|No study drug treatment|1|||
163315713|NCT01129102|589867870|FG000|Overall Study|Withdrawal by Subject|2|||
163315714|NCT01129102|589867871|FG001|Overall Study|Withdrawal by Subject|0|||
163315715|NCT01129102|589867872|FG002|Overall Study|Withdrawal by Subject|3|||
163315716|NCT01129102|589867870|FG000|Overall Study|Protocol Violation|0|||
163315717|NCT01129102|589867871|FG001|Overall Study|Protocol Violation|1|||
163315718|NCT01129102|589867872|FG002|Overall Study|Protocol Violation|1|||
163315719|NCT01129102|589867870|FG000|Overall Study|Pregnancy|0|||
163315720|NCT01129102|589867871|FG001|Overall Study|Pregnancy|0|||
163315721|NCT01129102|589867872|FG002|Overall Study|Pregnancy|1|||
163315722|NCT01129102|589867870|FG000|Overall Study|Adverse Event|2|||
163315723|NCT01129102|589867871|FG001|Overall Study|Adverse Event|2|||
163315724|NCT01129102|589867872|FG002|Overall Study|Adverse Event|1|||
163315725|NCT01129102|589867870|FG000|Overall Study|Lost to Follow-up|2|||
163315726|NCT01129102|589867871|FG001|Overall Study|Lost to Follow-up|0|||
163315727|NCT01129102|589867872|FG002|Overall Study|Lost to Follow-up|0|||
163315728|NCT05256017|589867875|FG000|Treatment Period|Withdrawal by Subject|1|||
163315729|NCT05256017|589867876|FG001|Treatment Period|Withdrawal by Subject|1|||
163315730|NCT05256017|589867875|FG000|Follow-up|Lost to Follow-up|7|||
163315731|NCT05256017|589867876|FG001|Follow-up|Lost to Follow-up|1|||
163315732|NCT05256017|589867875|FG000|Follow-up|Withdrawal by Subject|1|||
163315733|NCT05256017|589867876|FG001|Follow-up|Withdrawal by Subject|0|||
163315734|NCT05256017|589867875|FG000|Follow-up|Death|0|||
163315735|NCT05256017|589867876|FG001|Follow-up|Death|1|||
163315736|NCT05082025|589867877|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
163315737|NCT03854227|589867879|FG000|Overall Study|Adverse Event|0|||
163315738|NCT03854227|589867880|FG001|Overall Study|Adverse Event|0|||
163315739|NCT03854227|589867881|FG002|Overall Study|Adverse Event|0|||
163315740|NCT03854227|589867882|FG003|Overall Study|Adverse Event|1|||
163315741|NCT03854227|589867883|FG004|Overall Study|Adverse Event|0|||
163315742|NCT03854227|589867884|FG005|Overall Study|Adverse Event|0|||
163315743|NCT03854227|589867885|FG006|Overall Study|Adverse Event|1|||
163315744|NCT03854227|589867886|FG007|Overall Study|Adverse Event|0|||
163315745|NCT03854227|589867887|FG008|Overall Study|Adverse Event|0|||
163315746|NCT03854227|589867888|FG009|Overall Study|Adverse Event|3|||
163315747|NCT03854227|589867889|FG010|Overall Study|Adverse Event|0|||
163315748|NCT03854227|589867890|FG011|Overall Study|Adverse Event|1|||
163315749|NCT03854227|589867879|FG000|Overall Study|Death|0|||
163315750|NCT03854227|589867880|FG001|Overall Study|Death|0|||
163315751|NCT03854227|589867881|FG002|Overall Study|Death|0|||
163315752|NCT03854227|589867882|FG003|Overall Study|Death|0|||
163315753|NCT03854227|589867883|FG004|Overall Study|Death|0|||
163315754|NCT03854227|589867884|FG005|Overall Study|Death|1|||
163315755|NCT03854227|589867885|FG006|Overall Study|Death|0|||
163315756|NCT03854227|589867886|FG007|Overall Study|Death|0|||
163315757|NCT03854227|589867887|FG008|Overall Study|Death|0|||
163315758|NCT03854227|589867888|FG009|Overall Study|Death|1|||
163315759|NCT03854227|589867889|FG010|Overall Study|Death|0|||
163315760|NCT03854227|589867890|FG011|Overall Study|Death|1|||
163315761|NCT03854227|589867879|FG000|Overall Study|Physician Decision|0|||
163315762|NCT03854227|589867880|FG001|Overall Study|Physician Decision|0|||
163315763|NCT03854227|589867881|FG002|Overall Study|Physician Decision|0|||
163315764|NCT03854227|589867882|FG003|Overall Study|Physician Decision|0|||
163315765|NCT03854227|589867883|FG004|Overall Study|Physician Decision|0|||
163315766|NCT03854227|589867884|FG005|Overall Study|Physician Decision|1|||
163315767|NCT03854227|589867885|FG006|Overall Study|Physician Decision|0|||
163315768|NCT03854227|589867886|FG007|Overall Study|Physician Decision|0|||
163315769|NCT03854227|589867887|FG008|Overall Study|Physician Decision|1|||
163315770|NCT03854227|589867888|FG009|Overall Study|Physician Decision|1|||
163315771|NCT03854227|589867889|FG010|Overall Study|Physician Decision|0|||
163315772|NCT03854227|589867890|FG011|Overall Study|Physician Decision|1|||
163399052|NCT01251653|590172552|FG000|Overall Study|Other reason not mentioned above|0|||
163315773|NCT03854227|589867879|FG000|Overall Study|Progressive disease|1|||
163315774|NCT03854227|589867880|FG001|Overall Study|Progressive disease|1|||
163315775|NCT03854227|589867881|FG002|Overall Study|Progressive disease|1|||
163315776|NCT03854227|589867882|FG003|Overall Study|Progressive disease|2|||
163315777|NCT03854227|589867883|FG004|Overall Study|Progressive disease|3|||
163315778|NCT03854227|589867884|FG005|Overall Study|Progressive disease|1|||
163315779|NCT03854227|589867885|FG006|Overall Study|Progressive disease|2|||
163315780|NCT03854227|589867886|FG007|Overall Study|Progressive disease|5|||
163315781|NCT03854227|589867887|FG008|Overall Study|Progressive disease|2|||
163315782|NCT03854227|589867888|FG009|Overall Study|Progressive disease|5|||
163315783|NCT03854227|589867889|FG010|Overall Study|Progressive disease|1|||
163315784|NCT03854227|589867890|FG011|Overall Study|Progressive disease|6|||
163315785|NCT03854227|589867879|FG000|Overall Study|Study terminated by sponsor|0|||
163315786|NCT03854227|589867880|FG001|Overall Study|Study terminated by sponsor|0|||
163315787|NCT03854227|589867881|FG002|Overall Study|Study terminated by sponsor|0|||
163315788|NCT03854227|589867882|FG003|Overall Study|Study terminated by sponsor|0|||
163315789|NCT03854227|589867883|FG004|Overall Study|Study terminated by sponsor|0|||
163315790|NCT03854227|589867884|FG005|Overall Study|Study terminated by sponsor|0|||
163315791|NCT03854227|589867885|FG006|Overall Study|Study terminated by sponsor|0|||
163315792|NCT03854227|589867886|FG007|Overall Study|Study terminated by sponsor|0|||
163315793|NCT03854227|589867887|FG008|Overall Study|Study terminated by sponsor|0|||
163315794|NCT03854227|589867888|FG009|Overall Study|Study terminated by sponsor|1|||
163315795|NCT03854227|589867889|FG010|Overall Study|Study terminated by sponsor|0|||
163315796|NCT03854227|589867890|FG011|Overall Study|Study terminated by sponsor|0|||
163315797|NCT03854227|589867879|FG000|Overall Study|Withdrawal by Subject|0|||
163315798|NCT03854227|589867880|FG001|Overall Study|Withdrawal by Subject|0|||
163315799|NCT03854227|589867881|FG002|Overall Study|Withdrawal by Subject|1|||
163315800|NCT03854227|589867882|FG003|Overall Study|Withdrawal by Subject|0|||
163315801|NCT03854227|589867883|FG004|Overall Study|Withdrawal by Subject|0|||
163315802|NCT03854227|589867884|FG005|Overall Study|Withdrawal by Subject|0|||
163315803|NCT03854227|589867885|FG006|Overall Study|Withdrawal by Subject|0|||
163315804|NCT03854227|589867886|FG007|Overall Study|Withdrawal by Subject|0|||
163315805|NCT03854227|589867887|FG008|Overall Study|Withdrawal by Subject|0|||
163315806|NCT03854227|589867888|FG009|Overall Study|Withdrawal by Subject|1|||
163315807|NCT03854227|589867889|FG010|Overall Study|Withdrawal by Subject|1|||
163315808|NCT03854227|589867890|FG011|Overall Study|Withdrawal by Subject|0|||
163315809|NCT03854227|589867879|FG000|Overall Study|Disease relapse|0|||
163315810|NCT03854227|589867880|FG001|Overall Study|Disease relapse|0|||
163315811|NCT03854227|589867881|FG002|Overall Study|Disease relapse|0|||
163315812|NCT03854227|589867882|FG003|Overall Study|Disease relapse|0|||
163315813|NCT03854227|589867883|FG004|Overall Study|Disease relapse|0|||
163315814|NCT03854227|589867884|FG005|Overall Study|Disease relapse|0|||
163315815|NCT03854227|589867885|FG006|Overall Study|Disease relapse|0|||
163315816|NCT03854227|589867886|FG007|Overall Study|Disease relapse|0|||
163399053|NCT01251653|590172553|FG001|Overall Study|Other reason not mentioned above|0|||
163399054|NCT01251653|590172554|FG002|Overall Study|Other reason not mentioned above|0|||
163399055|NCT01251653|590172555|FG003|Overall Study|Other reason not mentioned above|0|||
163399056|NCT01251653|590172556|FG004|Overall Study|Other reason not mentioned above|0|||
163399057|NCT01251653|590172557|FG005|Overall Study|Other reason not mentioned above|0|||
163315817|NCT03854227|589867887|FG008|Overall Study|Disease relapse|1|||
162967530|NCT01350934|588582945|FG000|Extension Study|Adverse Event|2|||
162967531|NCT01350934|588582946|FG001|Extension Study|Adverse Event|1|||
162967532|NCT01350934|588582945|FG000|Extension Study|Lost to Follow-up|2|||
162967533|NCT01350934|588582946|FG001|Extension Study|Lost to Follow-up|0|||
162967534|NCT01350934|588582945|FG000|Extension Study|Protocol Violation|1|||
162967535|NCT01350934|588582946|FG001|Extension Study|Protocol Violation|1|||
162967536|NCT01350934|588582945|FG000|Extension Study|Lack of Efficacy|0|||
162967537|NCT01350934|588582946|FG001|Extension Study|Lack of Efficacy|1|||
163315818|NCT03854227|589867888|FG009|Overall Study|Disease relapse|0|||
163315819|NCT03854227|589867889|FG010|Overall Study|Disease relapse|0|||
163315820|NCT03854227|589867890|FG011|Overall Study|Disease relapse|0|||
163315821|NCT03854227|589867879|FG000|Overall Study|Global deterioration of health status|0|||
162967538|NCT01350934|588582945|FG000|Extension Study|Withdrawal by Subject|0|||
163315822|NCT03854227|589867880|FG001|Overall Study|Global deterioration of health status|0|||
163207863|NCT01409564|589474208|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
163207864|NCT02782780|589474209|FG000|Overall Study|dropped out after randomization.|7|||
163207865|NCT02782780|589474210|FG001|Overall Study|dropped out after randomization.|5|||
163207866|NCT02782780|589474209|FG000|Overall Study|Protocol Violation|0|||
163207867|NCT02782780|589474210|FG001|Overall Study|Protocol Violation|2|||
163207868|NCT01413191|589474211|FG000|Overall Study|Lost to Follow-up|5|||
163207869|NCT01413191|589474211|FG000|Overall Study|Disease Progression|5|||
163207870|NCT01413191|589474211|FG000|Overall Study|Death|1|||
163207871|NCT03654651|589474212|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
163207872|NCT03654651|589474213|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
163207873|NCT05040386|589474214|FG000|Overall Study|Withdrawal by Subject|1|||
163207874|NCT05040386|589474215|FG001|Overall Study|Withdrawal by Subject|0|||
163207875|NCT05040386|589474216|FG002|Overall Study|Withdrawal by Subject|1|||
163207876|NCT05040386|589474217|FG003|Overall Study|Withdrawal by Subject|0|||
163207877|NCT05040386|589474214|FG000|Overall Study|Lost to Follow-up|0|||
163207878|NCT05040386|589474215|FG001|Overall Study|Lost to Follow-up|0|||
163207879|NCT05040386|589474216|FG002|Overall Study|Lost to Follow-up|1|||
163207880|NCT05040386|589474217|FG003|Overall Study|Lost to Follow-up|0|||
163207881|NCT03045328|589474218|FG000|Overall Study|Withdrawal by Subject|2|||
163207882|NCT00589914|589474223|FG000|Overall Study|Adverse Event|19|||
163207883|NCT00589914|589474224|FG001|Overall Study|Adverse Event|10|||
163207884|NCT00589914|589474223|FG000|Overall Study|Death|2|||
163207885|NCT00589914|589474224|FG001|Overall Study|Death|0|||
163207886|NCT00589914|589474223|FG000|Overall Study|Lack of Efficacy|40|||
163207887|NCT00589914|589474224|FG001|Overall Study|Lack of Efficacy|43|||
163207888|NCT00589914|589474223|FG000|Overall Study|Lost to Follow-up|11|||
163207889|NCT00589914|589474224|FG001|Overall Study|Lost to Follow-up|18|||
163207890|NCT00589914|589474223|FG000|Overall Study|Pregnancy|1|||
163207891|NCT00589914|589474224|FG001|Overall Study|Pregnancy|0|||
163207892|NCT00589914|589474223|FG000|Overall Study|Withdrawal by Subject|55|||
163207893|NCT00589914|589474224|FG001|Overall Study|Withdrawal by Subject|49|||
163207894|NCT00589914|589474223|FG000|Overall Study|Other|22|||
163207895|NCT00589914|589474224|FG001|Overall Study|Other|17|||
163207896|NCT02618434|589474229|FG000|Overall Study|Withdrawal by Subject|0|||
163207897|NCT02618434|589474230|FG001|Overall Study|Withdrawal by Subject|2|||
163207898|NCT02618434|589474231|FG002|Overall Study|Withdrawal by Subject|3|||
163207899|NCT02618434|589474229|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
163207900|NCT02618434|589474230|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
163207901|NCT02618434|589474231|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
163207902|NCT02618434|589474229|FG000|Overall Study|Lost to Follow-up|3|||
163207903|NCT02618434|589474230|FG001|Overall Study|Lost to Follow-up|1|||
163207904|NCT02618434|589474231|FG002|Overall Study|Lost to Follow-up|3|||
163207905|NCT02618434|589474229|FG000|Overall Study|Adverse Event|1|||
163207906|NCT02618434|589474230|FG001|Overall Study|Adverse Event|0|||
163207907|NCT02618434|589474231|FG002|Overall Study|Adverse Event|12|||
163207908|NCT02618434|589474229|FG000|Overall Study|Physician Decision|0|||
163207909|NCT02618434|589474230|FG001|Overall Study|Physician Decision|1|||
163207910|NCT02618434|589474231|FG002|Overall Study|Physician Decision|0|||
163207911|NCT02618434|589474229|FG000|Overall Study|Protocol Violation|0|||
163207912|NCT02618434|589474230|FG001|Overall Study|Protocol Violation|0|||
163207913|NCT02618434|589474231|FG002|Overall Study|Protocol Violation|1|||
163315823|NCT03854227|589867881|FG002|Overall Study|Global deterioration of health status|0|||
163315824|NCT03854227|589867882|FG003|Overall Study|Global deterioration of health status|0|||
163315825|NCT03854227|589867883|FG004|Overall Study|Global deterioration of health status|0|||
163315826|NCT03854227|589867884|FG005|Overall Study|Global deterioration of health status|1|||
163315827|NCT03854227|589867885|FG006|Overall Study|Global deterioration of health status|0|||
163315828|NCT03854227|589867886|FG007|Overall Study|Global deterioration of health status|1|||
163315829|NCT03854227|589867887|FG008|Overall Study|Global deterioration of health status|0|||
163315830|NCT03854227|589867888|FG009|Overall Study|Global deterioration of health status|0|||
163315831|NCT03854227|589867889|FG010|Overall Study|Global deterioration of health status|0|||
163315832|NCT03854227|589867890|FG011|Overall Study|Global deterioration of health status|0|||
163315833|NCT03854227|589867879|FG000|Overall Study|Refused further treatment|0|||
163315834|NCT03854227|589867880|FG001|Overall Study|Refused further treatment|0|||
163315835|NCT03854227|589867881|FG002|Overall Study|Refused further treatment|0|||
163315836|NCT03854227|589867882|FG003|Overall Study|Refused further treatment|0|||
163315837|NCT03854227|589867883|FG004|Overall Study|Refused further treatment|0|||
163315838|NCT03854227|589867884|FG005|Overall Study|Refused further treatment|0|||
163315839|NCT03854227|589867885|FG006|Overall Study|Refused further treatment|0|||
163315840|NCT03854227|589867886|FG007|Overall Study|Refused further treatment|0|||
163315841|NCT03854227|589867887|FG008|Overall Study|Refused further treatment|0|||
163315842|NCT03854227|589867888|FG009|Overall Study|Refused further treatment|1|||
163315843|NCT03854227|589867889|FG010|Overall Study|Refused further treatment|0|||
163315844|NCT03854227|589867890|FG011|Overall Study|Refused further treatment|1|||
163315845|NCT03854227|589867879|FG000|Overall Study|Other|0|||
163315846|NCT03854227|589867880|FG001|Overall Study|Other|0|||
163315847|NCT03854227|589867881|FG002|Overall Study|Other|0|||
163315848|NCT03854227|589867882|FG003|Overall Study|Other|0|||
163315849|NCT03854227|589867883|FG004|Overall Study|Other|0|||
163315850|NCT03854227|589867884|FG005|Overall Study|Other|0|||
163315851|NCT03854227|589867885|FG006|Overall Study|Other|0|||
163315852|NCT03854227|589867886|FG007|Overall Study|Other|0|||
163315853|NCT03854227|589867887|FG008|Overall Study|Other|1|||
163315854|NCT03854227|589867888|FG009|Overall Study|Other|1|||
163315855|NCT03854227|589867889|FG010|Overall Study|Other|0|||
163315856|NCT03854227|589867890|FG011|Overall Study|Other|0|||
163315857|NCT04948697|589867891|FG000|Overall Study|Progressive disease|27|||
163399058|NCT01251653|590172558|FG006|Overall Study|Other reason not mentioned above|0|||
163399059|NCT01251653|590172559|FG007|Overall Study|Other reason not mentioned above|2|||
163399060|NCT01251653|590172560|FG008|Overall Study|Other reason not mentioned above|0|||
163315858|NCT04948697|589867892|FG001|Overall Study|Progressive disease|18|||
163315859|NCT04948697|589867891|FG000|Overall Study|Adverse Event|14|||
163315860|NCT04948697|589867892|FG001|Overall Study|Adverse Event|4|||
163315861|NCT04948697|589867891|FG000|Overall Study|Participant moved to long term extension study|7|||
163315862|NCT04948697|589867892|FG001|Overall Study|Participant moved to long term extension study|4|||
163315863|NCT04948697|589867891|FG000|Overall Study|Withdrawal by Subject|10|||
163207914|NCT02618434|589474229|FG000|Overall Study|Other, Multiple categories|1|||
163207915|NCT02618434|589474230|FG001|Overall Study|Other, Multiple categories|1|||
163207916|NCT02618434|589474231|FG002|Overall Study|Other, Multiple categories|1|||
163207917|NCT02289898|589474237|FG000|Overall Study|Death|5|||
163207918|NCT02289898|589474238|FG001|Overall Study|Death|4|||
163207919|NCT02289898|589474239|FG002|Overall Study|Death|3|||
163207920|NCT02289898|589474237|FG000|Overall Study|Physician Decision|2|||
163207921|NCT02289898|589474238|FG001|Overall Study|Physician Decision|5|||
163315864|NCT04948697|589867892|FG001|Overall Study|Withdrawal by Subject|0|||
163315865|NCT04948697|589867891|FG000|Overall Study|Closed by Sponsor|3|||
163315866|NCT04948697|589867892|FG001|Overall Study|Closed by Sponsor|2|||
163315867|NCT04948697|589867891|FG000|Overall Study|Physician Decision|0|||
163315868|NCT04948697|589867892|FG001|Overall Study|Physician Decision|2|||
163315869|NCT04948697|589867891|FG000|Overall Study|Lost to Follow-up|0|||
163315870|NCT04948697|589867892|FG001|Overall Study|Lost to Follow-up|1|||
163315871|NCT04948697|589867891|FG000|Overall Study|Other-Miscellaneous|1|||
163315872|NCT04948697|589867892|FG001|Overall Study|Other-Miscellaneous|0|||
163207922|NCT02289898|589474239|FG002|Overall Study|Physician Decision|2|||
163207923|NCT02289898|589474237|FG000|Overall Study|Withdrawal by Subject|0|||
163207924|NCT02289898|589474238|FG001|Overall Study|Withdrawal by Subject|4|||
163207925|NCT02289898|589474239|FG002|Overall Study|Withdrawal by Subject|1|||
163207926|NCT02289898|589474237|FG000|Overall Study|Adverse Event|3|||
163207927|NCT02289898|589474238|FG001|Overall Study|Adverse Event|5|||
163207928|NCT02289898|589474239|FG002|Overall Study|Adverse Event|5|||
163207929|NCT02289898|589474237|FG000|Overall Study|Disease progression|34|||
163207930|NCT02289898|589474238|FG001|Overall Study|Disease progression|28|||
163207931|NCT02289898|589474239|FG002|Overall Study|Disease progression|34|||
163207932|NCT02289898|589474237|FG000|Overall Study|Use of another anticancer therapy|0|||
163207933|NCT02289898|589474238|FG001|Overall Study|Use of another anticancer therapy|0|||
163207934|NCT02289898|589474239|FG002|Overall Study|Use of another anticancer therapy|1|||
163207935|NCT02289898|589474237|FG000|Overall Study|Other|8|||
163207936|NCT02289898|589474238|FG001|Overall Study|Other|7|||
163399061|NCT00847145|590172561|FG000|Overall Study|AE or Death|0|||
163399062|NCT00847145|590172562|FG001|Overall Study|AE or Death|1|||
163399063|NCT00847145|590172563|FG002|Overall Study|AE or Death|1|||
163399064|NCT00847145|590172564|FG003|Overall Study|AE or Death|0|||
163399065|NCT00847145|590172565|FG004|Overall Study|AE or Death|0|||
163399066|NCT00847145|590172566|FG005|Overall Study|AE or Death|0|||
163399067|NCT00847145|590172567|FG006|Overall Study|AE or Death|0|||
163399068|NCT00847145|590172568|FG007|Overall Study|AE or Death|0|||
163207937|NCT02289898|589474239|FG002|Overall Study|Other|10|||
163207938|NCT04626297|589474240|FG000|Overall Study|Adverse Event|5|||
163399069|NCT00847145|590172561|FG000|Overall Study|Withdrawal by Subject|3|||
163399070|NCT00847145|590172562|FG001|Overall Study|Withdrawal by Subject|4|||
163399071|NCT00847145|590172563|FG002|Overall Study|Withdrawal by Subject|6|||
163207939|NCT04626297|589474241|FG001|Overall Study|Adverse Event|3|||
163207940|NCT04626297|589474240|FG000|Overall Study|Lost to Follow-up|7|||
163207941|NCT04626297|589474241|FG001|Overall Study|Lost to Follow-up|3|||
163054340|NCT00630916|588910240|FG000|Overall Study|Lack of Efficacy|3|||
163054341|NCT02295644|588910241|FG000|Overall Study|Did not meet inclusion criterion|0|||
163054342|NCT02295644|588910242|FG001|Overall Study|Did not meet inclusion criterion|0|||
163054343|NCT02295644|588910243|FG002|Overall Study|Did not meet inclusion criterion|1|||
163054344|NCT02295644|588910244|FG003|Overall Study|Did not meet inclusion criterion|2|||
163315873|NCT04948697|589867891|FG000|Overall Study|Randomized but not treated|0|||
163315874|NCT04948697|589867892|FG001|Overall Study|Randomized but not treated|1|||
163315875|NCT04870515|589867893|FG000|Overall Study|Lost to Follow-up|0|||
163054345|NCT02147626|588910245|FG000|Overall Study|Lost to Follow-up|4|||
163315876|NCT04870515|589867894|FG001|Overall Study|Lost to Follow-up|2|||
163315877|NCT04870515|589867893|FG000|Overall Study|Withdrawal by Subject|0|||
162967539|NCT01350934|588582946|FG001|Extension Study|Withdrawal by Subject|1|||
163315878|NCT04870515|589867894|FG001|Overall Study|Withdrawal by Subject|1|||
163315879|NCT04870515|589867893|FG000|Overall Study|Withdrawal due to complications with standard of care treatment|2|||
163315880|NCT04870515|589867894|FG001|Overall Study|Withdrawal due to complications with standard of care treatment|0|||
163315881|NCT04032704|589867895|FG000|Part A|Withdrawal by Subject|0|||
163315882|NCT04032704|589867896|FG001|Part A|Withdrawal by Subject|0|||
163315883|NCT04032704|589867897|FG002|Part A|Withdrawal by Subject|3|||
163315884|NCT04032704|589867898|FG003|Part A|Withdrawal by Subject|0|||
162967540|NCT02415387|588582947|FG000|Overall Study|Withdrawal by Subject|6|||
162967541|NCT02415387|588582948|FG001|Overall Study|Withdrawal by Subject|1|||
162967542|NCT02415387|588582947|FG000|Overall Study|blood draw problem|0|||
162967543|NCT02415387|588582948|FG001|Overall Study|blood draw problem|1|||
162967544|NCT02415387|588582947|FG000|Overall Study|Protocol Violation|1|||
162967545|NCT02415387|588582948|FG001|Overall Study|Protocol Violation|0|||
162967546|NCT02733627|588582950|FG000|Overall Study|Adverse Event|0|||
162967547|NCT02733627|588582951|FG001|Overall Study|Adverse Event|1|||
162967548|NCT02733627|588582952|FG002|Overall Study|Adverse Event|1|||
162967549|NCT02733627|588582953|FG003|Overall Study|Adverse Event|0|||
162967550|NCT02733627|588582950|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
162967551|NCT02733627|588582951|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
162967552|NCT02733627|588582952|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
162967553|NCT02733627|588582953|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
162967554|NCT02246764|588582954|FG000|Overall Study|Adverse Event|15|||
162967555|NCT02246764|588582955|FG001|Overall Study|Adverse Event|29|||
162967556|NCT02246764|588582956|FG002|Overall Study|Adverse Event|1|||
162967557|NCT02246764|588582954|FG000|Overall Study|Withdrawal by Subject|0|||
162967558|NCT02246764|588582955|FG001|Overall Study|Withdrawal by Subject|0|||
162967559|NCT02246764|588582956|FG002|Overall Study|Withdrawal by Subject|1|||
162967560|NCT02246764|588582954|FG000|Overall Study|Disallowed Concomitant Medication|1|||
162967561|NCT02246764|588582955|FG001|Overall Study|Disallowed Concomitant Medication|0|||
162967562|NCT02246764|588582956|FG002|Overall Study|Disallowed Concomitant Medication|0|||
162967563|NCT02246764|588582954|FG000|Overall Study|Physician Decision|0|||
162967564|NCT02246764|588582955|FG001|Overall Study|Physician Decision|2|||
162967565|NCT02246764|588582956|FG002|Overall Study|Physician Decision|1|||
162967566|NCT02246764|588582954|FG000|Overall Study|Protocol Violation|2|||
162967567|NCT02246764|588582955|FG001|Overall Study|Protocol Violation|1|||
162967568|NCT02246764|588582956|FG002|Overall Study|Protocol Violation|1|||
162967569|NCT05393271|588582957|FG000|Overall Study|Physician Decision|0|||
162967570|NCT05393271|588582958|FG001|Overall Study|Physician Decision|0|||
162967571|NCT05393271|588582959|FG002|Overall Study|Physician Decision|0|||
162967572|NCT05393271|588582960|FG003|Overall Study|Physician Decision|0|||
162967573|NCT05393271|588582961|FG004|Overall Study|Physician Decision|0|||
162967574|NCT05393271|588582962|FG005|Overall Study|Physician Decision|0|||
162967575|NCT05393271|588582963|FG006|Overall Study|Physician Decision|1|||
162967576|NCT05393271|588582964|FG007|Overall Study|Physician Decision|0|||
162967577|NCT05393271|588582965|FG008|Overall Study|Physician Decision|0|||
162967578|NCT05393271|588582966|FG009|Overall Study|Physician Decision|0|||
162967579|NCT05393271|588582967|FG010|Overall Study|Physician Decision|0|||
162967580|NCT02048813|588582968|FG000|Overall Study|Still on treatment|279|||
162967581|NCT02048813|588582969|FG001|Overall Study|Still on treatment|0|||
163315885|NCT04032704|589867899|FG004|Part A|Withdrawal by Subject|1|||
163054346|NCT02147626|588910246|FG001|Overall Study|Lost to Follow-up|4|||
163054347|NCT02147626|588910245|FG000|Overall Study|Pregnancy|1|||
163054348|NCT02147626|588910246|FG001|Overall Study|Pregnancy|2|||
163054349|NCT02147626|588910245|FG000|Overall Study|Withdrawal by Subject|0|||
163315886|NCT04032704|589867900|FG005|Part A|Withdrawal by Subject|7|||
163315887|NCT04032704|589867901|FG006|Part A|Withdrawal by Subject|0|||
163315888|NCT04032704|589867902|FG007|Part A|Withdrawal by Subject|0|||
163315889|NCT04032704|589867903|FG008|Part A|Withdrawal by Subject|0|||
163315890|NCT04032704|589867904|FG009|Part A|Withdrawal by Subject|0|||
163315891|NCT04032704|589867905|FG010|Part A|Withdrawal by Subject|0|||
163315892|NCT04032704|589867906|FG011|Part A|Withdrawal by Subject|0|||
163315893|NCT04032704|589867907|FG012|Part A|Withdrawal by Subject|0|||
163315894|NCT04032704|589867908|FG013|Part A|Withdrawal by Subject|0|||
163315895|NCT04032704|589867909|FG014|Part A|Withdrawal by Subject|0|||
163315896|NCT04032704|589867910|FG015|Part A|Withdrawal by Subject|0|||
163315897|NCT04032704|589867911|FG016|Part A|Withdrawal by Subject|0|||
163315898|NCT04032704|589867912|FG017|Part A|Withdrawal by Subject|0|||
163315899|NCT04032704|589867895|FG000|Part A|Lost to Follow-up|1|||
163315900|NCT04032704|589867896|FG001|Part A|Lost to Follow-up|0|||
163315901|NCT04032704|589867897|FG002|Part A|Lost to Follow-up|0|||
163315902|NCT04032704|589867898|FG003|Part A|Lost to Follow-up|0|||
163315903|NCT04032704|589867899|FG004|Part A|Lost to Follow-up|0|||
163315904|NCT04032704|589867900|FG005|Part A|Lost to Follow-up|0|||
163315905|NCT04032704|589867901|FG006|Part A|Lost to Follow-up|0|||
163315906|NCT04032704|589867902|FG007|Part A|Lost to Follow-up|0|||
163315907|NCT04032704|589867903|FG008|Part A|Lost to Follow-up|0|||
163315908|NCT04032704|589867904|FG009|Part A|Lost to Follow-up|0|||
163315909|NCT04032704|589867905|FG010|Part A|Lost to Follow-up|0|||
163315910|NCT04032704|589867906|FG011|Part A|Lost to Follow-up|0|||
163315911|NCT04032704|589867907|FG012|Part A|Lost to Follow-up|0|||
163315912|NCT04032704|589867908|FG013|Part A|Lost to Follow-up|0|||
163315913|NCT04032704|589867909|FG014|Part A|Lost to Follow-up|0|||
163315914|NCT04032704|589867910|FG015|Part A|Lost to Follow-up|0|||
163315915|NCT04032704|589867911|FG016|Part A|Lost to Follow-up|0|||
163315916|NCT04032704|589867912|FG017|Part A|Lost to Follow-up|0|||
163315917|NCT04032704|589867895|FG000|Part A|Death|9|||
163315918|NCT04032704|589867896|FG001|Part A|Death|2|||
163315919|NCT04032704|589867897|FG002|Part A|Death|10|||
163315920|NCT04032704|589867898|FG003|Part A|Death|7|||
163315921|NCT04032704|589867899|FG004|Part A|Death|4|||
163315922|NCT04032704|589867900|FG005|Part A|Death|5|||
163315923|NCT04032704|589867901|FG006|Part A|Death|0|||
163315924|NCT04032704|589867902|FG007|Part A|Death|0|||
163315925|NCT04032704|589867903|FG008|Part A|Death|0|||
163315926|NCT04032704|589867904|FG009|Part A|Death|0|||
163399072|NCT00847145|590172564|FG003|Overall Study|Withdrawal by Subject|1|||
163054350|NCT02147626|588910246|FG001|Overall Study|Withdrawal by Subject|1|||
163054351|NCT00423046|588910248|FG000|Overall Study|Other|340|||
163315927|NCT04032704|589867905|FG010|Part A|Death|0|||
163399073|NCT00847145|590172565|FG004|Overall Study|Withdrawal by Subject|0|||
163054352|NCT00423046|588910249|FG001|Overall Study|Other|345|||
163315928|NCT04032704|589867906|FG011|Part A|Death|0|||
163315929|NCT04032704|589867907|FG012|Part A|Death|0|||
163315930|NCT04032704|589867908|FG013|Part A|Death|0|||
163315931|NCT04032704|589867909|FG014|Part A|Death|0|||
163315932|NCT04032704|589867910|FG015|Part A|Death|0|||
163315933|NCT04032704|589867911|FG016|Part A|Death|0|||
163315934|NCT04032704|589867912|FG017|Part A|Death|0|||
163315935|NCT04032704|589867895|FG000|Part B|Other|0|||
163315936|NCT04032704|589867896|FG001|Part B|Other|0|||
163207942|NCT04626297|589474240|FG000|Overall Study|Protocol Violation|5|||
163207943|NCT04626297|589474241|FG001|Overall Study|Protocol Violation|1|||
163207944|NCT04626297|589474240|FG000|Overall Study|Withdrawal by Subject|20|||
163207945|NCT04626297|589474241|FG001|Overall Study|Withdrawal by Subject|6|||
163207946|NCT04626297|589474240|FG000|Overall Study|Sponsor decision|2|||
163207947|NCT04626297|589474241|FG001|Overall Study|Sponsor decision|1|||
163207948|NCT00885105|589474242|FG000|Overall Study|Withdrawal by Subject|0|||
163207949|NCT00885105|589474243|FG001|Overall Study|Withdrawal by Subject|8|||
163207950|NCT00885105|589474242|FG000|Overall Study|Adverse Event|1|||
163207951|NCT00885105|589474243|FG001|Overall Study|Adverse Event|0|||
163207952|NCT00885105|589474242|FG000|Overall Study|Protocol Violation|0|||
163207953|NCT00885105|589474243|FG001|Overall Study|Protocol Violation|2|||
163207954|NCT02066233|589474246|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
163207955|NCT02066233|589474247|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
163207956|NCT02598076|589474248|FG000|Overall Study|Lost to Follow-up|2|||
163207957|NCT02598076|589474249|FG001|Overall Study|Lost to Follow-up|3|||
163207958|NCT02005445|589474250|FG000|Overall Study|Dual study enrollment|0|||
163207959|NCT02005445|589474251|FG001|Overall Study|Dual study enrollment|1|||
163207960|NCT00010374|589474252|FG000|Overall Study|False positive phrenic nerve test|1|||
163207961|NCT00533845|589474259|FG000|Overall Study|Physician Decision|1|||
163207962|NCT00533845|589474260|FG001|Overall Study|Physician Decision|0|||
163207963|NCT00667368|589474269|FG000|Overall Study|Lost to Follow-up|176|||
163207964|NCT00667368|589474270|FG001|Overall Study|Lost to Follow-up|155|||
163207965|NCT00667368|589474269|FG000|Overall Study|Discontinued early|24|||
163207966|NCT00667368|589474270|FG001|Overall Study|Discontinued early|17|||
163315937|NCT04032704|589867897|FG002|Part B|Other|0|||
163315938|NCT04032704|589867898|FG003|Part B|Other|0|||
163315939|NCT04032704|589867899|FG004|Part B|Other|0|||
163315940|NCT04032704|589867900|FG005|Part B|Other|0|||
163315941|NCT04032704|589867901|FG006|Part B|Other|0|||
163315942|NCT04032704|589867902|FG007|Part B|Other|1|||
163315943|NCT04032704|589867903|FG008|Part B|Other|2|||
163315944|NCT04032704|589867904|FG009|Part B|Other|1|||
163315945|NCT04032704|589867905|FG010|Part B|Other|1|||
163399074|NCT00847145|590172566|FG005|Overall Study|Withdrawal by Subject|0|||
163207967|NCT02407704|589474271|FG000|Overall Study|Lost to Follow-up|0|||
163207968|NCT02407704|589474272|FG001|Overall Study|Lost to Follow-up|0|||
163399075|NCT00847145|590172567|FG006|Overall Study|Withdrawal by Subject|1|||
163207969|NCT02407704|589474273|FG002|Overall Study|Lost to Follow-up|0|||
163207970|NCT02407704|589474274|FG003|Overall Study|Lost to Follow-up|2|||
163207971|NCT02407704|589474271|FG000|Overall Study|Protocol Violation|0|||
163207972|NCT02407704|589474272|FG001|Overall Study|Protocol Violation|0|||
163315946|NCT04032704|589867906|FG011|Part B|Other|1|||
163315947|NCT04032704|589867907|FG012|Part B|Other|5|||
163315948|NCT04032704|589867908|FG013|Part B|Other|13|||
163315949|NCT04032704|589867909|FG014|Part B|Other|0|||
163054353|NCT01038687|588910250|FG000|Overall Study|Adverse Event|0|||
163054354|NCT01038687|588910251|FG001|Overall Study|Adverse Event|2|||
163054355|NCT01038687|588910252|FG002|Overall Study|Adverse Event|1|||
163054356|NCT02783911|588910253|FG000|Overall Study|Lost to Follow-up|3|||
163054357|NCT02783911|588910254|FG001|Overall Study|Lost to Follow-up|32|||
163054358|NCT02616783|588910255|FG000|Overall Study|Randomized but Not Treated|1|||
163054359|NCT02616783|588910256|FG001|Overall Study|Randomized but Not Treated|0|||
163054360|NCT02616783|588910255|FG000|Overall Study|Adverse Event|1|||
163054361|NCT02616783|588910256|FG001|Overall Study|Adverse Event|0|||
163054362|NCT02616783|588910255|FG000|Overall Study|Death|1|||
163207973|NCT02407704|589474273|FG002|Overall Study|Protocol Violation|0|||
163207974|NCT02407704|589474274|FG003|Overall Study|Protocol Violation|1|||
163207975|NCT02407704|589474271|FG000|Overall Study|Withdrawal by Subject|0|||
163207976|NCT02407704|589474272|FG001|Overall Study|Withdrawal by Subject|0|||
163207977|NCT02407704|589474273|FG002|Overall Study|Withdrawal by Subject|1|||
163207978|NCT02407704|589474274|FG003|Overall Study|Withdrawal by Subject|0|||
163207979|NCT01683383|589474275|FG000|Overall Study|Infant was not transported|1|||
163207980|NCT01683383|589474276|FG001|Overall Study|Infant was not transported|0|||
163207981|NCT02496611|589474277|FG000|Overall Study|Lost to Follow-up|2|||
163207982|NCT02496611|589474278|FG001|Overall Study|Lost to Follow-up|1|||
163207983|NCT02496611|589474277|FG000|Overall Study|Withdrawal by Subject|5|||
163207984|NCT02496611|589474278|FG001|Overall Study|Withdrawal by Subject|2|||
163207985|NCT02850965|589474279|FG000|Overall Study|Other than listed|3|||
163207986|NCT02850965|589474280|FG001|Overall Study|Other than listed|4|||
163207987|NCT02850965|589474279|FG000|Overall Study|Protocol Violation|0|||
163207988|NCT02850965|589474280|FG001|Overall Study|Protocol Violation|2|||
163207989|NCT02850965|589474279|FG000|Overall Study|Lost to Follow-up|5|||
163207990|NCT02850965|589474280|FG001|Overall Study|Lost to Follow-up|3|||
163207991|NCT02850965|589474279|FG000|Overall Study|Lack of Efficacy|4|||
163207992|NCT02850965|589474280|FG001|Overall Study|Lack of Efficacy|8|||
163207993|NCT02850965|589474279|FG000|Overall Study|Adverse Event|3|||
163315950|NCT04032704|589867910|FG015|Part B|Other|0|||
163315951|NCT04032704|589867911|FG016|Part B|Other|0|||
163315952|NCT04032704|589867912|FG017|Part B|Other|0|||
163315953|NCT04032704|589867895|FG000|Part B|Study termination by Sponsor|0|||
163315954|NCT04032704|589867896|FG001|Part B|Study termination by Sponsor|0|||
163315955|NCT04032704|589867897|FG002|Part B|Study termination by Sponsor|0|||
163315956|NCT04032704|589867898|FG003|Part B|Study termination by Sponsor|0|||
163315957|NCT04032704|589867899|FG004|Part B|Study termination by Sponsor|0|||
163315958|NCT04032704|589867900|FG005|Part B|Study termination by Sponsor|0|||
163315959|NCT04032704|589867901|FG006|Part B|Study termination by Sponsor|0|||
163315960|NCT04032704|589867902|FG007|Part B|Study termination by Sponsor|0|||
163315961|NCT04032704|589867903|FG008|Part B|Study termination by Sponsor|1|||
163315962|NCT04032704|589867904|FG009|Part B|Study termination by Sponsor|0|||
163315963|NCT04032704|589867905|FG010|Part B|Study termination by Sponsor|0|||
163315964|NCT04032704|589867906|FG011|Part B|Study termination by Sponsor|0|||
163315965|NCT04032704|589867907|FG012|Part B|Study termination by Sponsor|0|||
163315966|NCT04032704|589867908|FG013|Part B|Study termination by Sponsor|0|||
163315967|NCT04032704|589867909|FG014|Part B|Study termination by Sponsor|0|||
163315968|NCT04032704|589867910|FG015|Part B|Study termination by Sponsor|0|||
163315969|NCT04032704|589867911|FG016|Part B|Study termination by Sponsor|0|||
163315970|NCT04032704|589867912|FG017|Part B|Study termination by Sponsor|0|||
162967582|NCT02048813|588582968|FG000|Overall Study|Adverse Event|40|||
162967583|NCT02048813|588582969|FG001|Overall Study|Adverse Event|38|||
162967584|NCT02048813|588582968|FG000|Overall Study|Disease progression|13|||
162967585|NCT02048813|588582969|FG001|Overall Study|Disease progression|3|||
162967586|NCT02048813|588582968|FG000|Overall Study|Withdrawal by Subject|7|||
162967587|NCT02048813|588582969|FG001|Overall Study|Withdrawal by Subject|8|||
162967588|NCT02048813|588582968|FG000|Overall Study|Death|2|||
162967589|NCT02048813|588582969|FG001|Overall Study|Death|1|||
162967590|NCT02048813|588582968|FG000|Overall Study|Complication|2|||
162967591|NCT02048813|588582969|FG001|Overall Study|Complication|2|||
162967592|NCT02048813|588582968|FG000|Overall Study|Non-protocol therapy|0|||
163207994|NCT02850965|589474280|FG001|Overall Study|Adverse Event|2|||
163207995|NCT02850965|589474279|FG000|Overall Study|Withdrawal by Subject|3|||
163207996|NCT02850965|589474280|FG001|Overall Study|Withdrawal by Subject|4|||
163207997|NCT02850965|589474279|FG000|Overall Study|Physician Decision|0|||
163207998|NCT02850965|589474280|FG001|Overall Study|Physician Decision|1|||
163207999|NCT02850965|589474279|FG000|Overall Study|Randomized but not treated|0|||
163208000|NCT02850965|589474280|FG001|Overall Study|Randomized but not treated|1|||
163315971|NCT04032704|589867895|FG000|Part B|Withdrawal by Subject|0|||
163315972|NCT04032704|589867896|FG001|Part B|Withdrawal by Subject|0|||
163315973|NCT04032704|589867897|FG002|Part B|Withdrawal by Subject|0|||
163315974|NCT04032704|589867898|FG003|Part B|Withdrawal by Subject|0|||
163315975|NCT04032704|589867899|FG004|Part B|Withdrawal by Subject|0|||
163315976|NCT04032704|589867900|FG005|Part B|Withdrawal by Subject|0|||
163315977|NCT04032704|589867901|FG006|Part B|Withdrawal by Subject|3|||
163315978|NCT04032704|589867902|FG007|Part B|Withdrawal by Subject|2|||
163315979|NCT04032704|589867903|FG008|Part B|Withdrawal by Subject|2|||
163315980|NCT04032704|589867904|FG009|Part B|Withdrawal by Subject|1|||
163315981|NCT04032704|589867905|FG010|Part B|Withdrawal by Subject|4|||
163315982|NCT04032704|589867906|FG011|Part B|Withdrawal by Subject|6|||
163315983|NCT04032704|589867907|FG012|Part B|Withdrawal by Subject|2|||
163315984|NCT04032704|589867908|FG013|Part B|Withdrawal by Subject|1|||
163315985|NCT04032704|589867909|FG014|Part B|Withdrawal by Subject|0|||
163208001|NCT00230607|589474289|FG000|Overall Study|Other|3|||
163208002|NCT03672747|589474290|FG000|Overall Study|Lost to Follow-up|1|||
163315986|NCT04032704|589867910|FG015|Part B|Withdrawal by Subject|1|||
163315987|NCT04032704|589867911|FG016|Part B|Withdrawal by Subject|0|||
163315988|NCT04032704|589867912|FG017|Part B|Withdrawal by Subject|0|||
163315989|NCT04032704|589867895|FG000|Part B|Lost to Follow-up|0|||
163399076|NCT00847145|590172568|FG007|Overall Study|Withdrawal by Subject|1|||
163315990|NCT04032704|589867896|FG001|Part B|Lost to Follow-up|0|||
163315991|NCT04032704|589867897|FG002|Part B|Lost to Follow-up|0|||
163399077|NCT00847145|590172561|FG000|Overall Study|Lost to Follow-up|3|||
163315992|NCT04032704|589867898|FG003|Part B|Lost to Follow-up|0|||
163399078|NCT00847145|590172562|FG001|Overall Study|Lost to Follow-up|1|||
163399079|NCT00847145|590172563|FG002|Overall Study|Lost to Follow-up|1|||
163399080|NCT00847145|590172564|FG003|Overall Study|Lost to Follow-up|0|||
163399081|NCT00847145|590172565|FG004|Overall Study|Lost to Follow-up|4|||
163399082|NCT00847145|590172566|FG005|Overall Study|Lost to Follow-up|4|||
163399083|NCT00847145|590172567|FG006|Overall Study|Lost to Follow-up|8|||
163399084|NCT00847145|590172568|FG007|Overall Study|Lost to Follow-up|2|||
163399085|NCT00847145|590172561|FG000|Overall Study|Inappropriate enrollment|0|||
163399086|NCT00847145|590172562|FG001|Overall Study|Inappropriate enrollment|0|||
163399087|NCT00847145|590172563|FG002|Overall Study|Inappropriate enrollment|0|||
163399088|NCT00847145|590172564|FG003|Overall Study|Inappropriate enrollment|0|||
163399089|NCT00847145|590172565|FG004|Overall Study|Inappropriate enrollment|1|||
163399090|NCT00847145|590172566|FG005|Overall Study|Inappropriate enrollment|0|||
163399091|NCT00847145|590172567|FG006|Overall Study|Inappropriate enrollment|0|||
163399092|NCT00847145|590172568|FG007|Overall Study|Inappropriate enrollment|0|||
163399093|NCT00847145|590172561|FG000|Overall Study|Protocol Violation|0|||
163399094|NCT00847145|590172562|FG001|Overall Study|Protocol Violation|0|||
163399095|NCT00847145|590172563|FG002|Overall Study|Protocol Violation|3|||
163399096|NCT00847145|590172564|FG003|Overall Study|Protocol Violation|0|||
163399097|NCT00847145|590172565|FG004|Overall Study|Protocol Violation|1|||
163399098|NCT00847145|590172566|FG005|Overall Study|Protocol Violation|0|||
163399099|NCT00847145|590172567|FG006|Overall Study|Protocol Violation|0|||
163399100|NCT00847145|590172568|FG007|Overall Study|Protocol Violation|1|||
163399101|NCT02833974|590172569|FG000|Overall Study|Lost to Follow-up|1|||
163399102|NCT02833974|590172570|FG001|Overall Study|Lost to Follow-up|0|||
163399103|NCT02833974|590172569|FG000|Overall Study|Adverse Event|0|||
163399104|NCT02833974|590172570|FG001|Overall Study|Adverse Event|3|||
163399105|NCT04419610|590172571|FG000|Overall Study|Withdrawal by Subject|3|||
163399106|NCT04419610|590172572|FG001|Overall Study|Withdrawal by Subject|1|||
163399107|NCT04419610|590172571|FG000|Overall Study|Adverse Event|1|||
163399108|NCT04419610|590172572|FG001|Overall Study|Adverse Event|0|||
163399109|NCT04419610|590172571|FG000|Overall Study|discharged early|1|||
163399110|NCT04419610|590172572|FG001|Overall Study|discharged early|1|||
163399111|NCT01439282|590172573|FG000|Overall Study|Adverse Event|5|||
163399112|NCT01439282|590172574|FG001|Overall Study|Adverse Event|0|||
163399113|NCT01439282|590172573|FG000|Overall Study|Withdrawal by Subject|2|||
163399114|NCT01439282|590172574|FG001|Overall Study|Withdrawal by Subject|0|||
163399115|NCT01439282|590172573|FG000|Overall Study|Other|1|||
163315993|NCT04032704|589867899|FG004|Part B|Lost to Follow-up|0|||
163315994|NCT04032704|589867900|FG005|Part B|Lost to Follow-up|0|||
163315995|NCT04032704|589867901|FG006|Part B|Lost to Follow-up|0|||
163315996|NCT04032704|589867902|FG007|Part B|Lost to Follow-up|0|||
163315997|NCT04032704|589867903|FG008|Part B|Lost to Follow-up|0|||
163399116|NCT01439282|590172574|FG001|Overall Study|Other|1|||
163399117|NCT00916357|590172576|FG000|Period 1|Withdrawal by Subject|1|||
163399118|NCT00916357|590172577|FG001|Period 1|Withdrawal by Subject|0|||
163399119|NCT00916357|590172578|FG002|Period 1|Withdrawal by Subject|0|||
163399120|NCT00916357|590172579|FG003|Period 1|Withdrawal by Subject|0|||
163399121|NCT00916357|590172580|FG004|Period 1|Withdrawal by Subject|0|||
163315998|NCT04032704|589867904|FG009|Part B|Lost to Follow-up|0|||
163315999|NCT04032704|589867905|FG010|Part B|Lost to Follow-up|0|||
163316000|NCT04032704|589867906|FG011|Part B|Lost to Follow-up|1|||
163316001|NCT04032704|589867907|FG012|Part B|Lost to Follow-up|0|||
163399122|NCT00916357|590172581|FG005|Period 1|Withdrawal by Subject|0|||
163399123|NCT00916357|590172576|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
163399124|NCT00916357|590172577|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
163399125|NCT00916357|590172578|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
163399126|NCT00916357|590172579|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
163399127|NCT00916357|590172580|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
163399128|NCT00916357|590172581|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
163399129|NCT01033734|590172582|FG000|Overall Study|Withdrawal by Subject|1|||
163399130|NCT03807349|590172584|FG000|Overall Study|Early Study Termination|9|||
163399131|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
163399132|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
163399133|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
163399134|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
163399135|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
163399136|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
163399137|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
163399138|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
163399139|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
163399140|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
163399141|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
163399142|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
163399143|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
163399144|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
163399145|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
163399146|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
163399147|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
163399148|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
163399149|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
163399150|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
163399151|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
163399152|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
163399153|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
163399154|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
163399155|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
163399156|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
163399157|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
163399158|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
163399159|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
163399160|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
163399161|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
163399162|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
163399163|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
163399164|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
163399165|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
163399166|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
163399167|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
163399168|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
163399169|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
163399170|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
163399171|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
163399172|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
163399173|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
163399174|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
163399175|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
163399176|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
163399177|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
163399178|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
163399179|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
163399180|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
163399181|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
163399182|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
163399183|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
163399184|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
163399185|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
163399186|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
163399187|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
163399188|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
163399189|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
163399190|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
163399191|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
163399192|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
163399193|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
163399194|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
163208003|NCT03672747|589474291|FG001|Overall Study|Lost to Follow-up|1|||
162967593|NCT02048813|588582969|FG001|Overall Study|Non-protocol therapy|1|||
162967594|NCT02048813|588582968|FG000|Overall Study|Second primary cancer|2|||
163316002|NCT04032704|589867908|FG013|Part B|Lost to Follow-up|0|||
163316003|NCT04032704|589867909|FG014|Part B|Lost to Follow-up|0|||
163316004|NCT04032704|589867910|FG015|Part B|Lost to Follow-up|0|||
163316005|NCT04032704|589867911|FG016|Part B|Lost to Follow-up|0|||
163316006|NCT04032704|589867912|FG017|Part B|Lost to Follow-up|0|||
163316007|NCT04032704|589867895|FG000|Part B|Death|0|||
163316008|NCT04032704|589867896|FG001|Part B|Death|0|||
163316009|NCT04032704|589867897|FG002|Part B|Death|0|||
163316010|NCT04032704|589867898|FG003|Part B|Death|0|||
163316011|NCT04032704|589867899|FG004|Part B|Death|0|||
163316012|NCT04032704|589867900|FG005|Part B|Death|0|||
163316013|NCT04032704|589867901|FG006|Part B|Death|13|||
163316014|NCT04032704|589867902|FG007|Part B|Death|13|||
163316015|NCT04032704|589867903|FG008|Part B|Death|14|||
163316016|NCT04032704|589867904|FG009|Part B|Death|12|||
163316017|NCT04032704|589867905|FG010|Part B|Death|12|||
163316018|NCT04032704|589867906|FG011|Part B|Death|13|||
163316019|NCT04032704|589867907|FG012|Part B|Death|7|||
163316020|NCT04032704|589867908|FG013|Part B|Death|17|||
163316021|NCT04032704|589867909|FG014|Part B|Death|2|||
163316022|NCT04032704|589867910|FG015|Part B|Death|1|||
163316023|NCT04032704|589867911|FG016|Part B|Death|2|||
163316024|NCT04032704|589867912|FG017|Part B|Death|2|||
163316025|NCT04068181|589867923|FG000|Overall Study|Death|17|||
162967595|NCT02048813|588582969|FG001|Overall Study|Second primary cancer|0|||
162967596|NCT02048813|588582968|FG000|Overall Study|Insurance|2|||
162967597|NCT02048813|588582969|FG001|Overall Study|Insurance|0|||
162967598|NCT02048813|588582968|FG000|Overall Study|Wound infection/healing|2|||
162967599|NCT02048813|588582969|FG001|Overall Study|Wound infection/healing|0|||
162967600|NCT02048813|588582968|FG000|Overall Study|Missed appointment|3|||
162967601|NCT02048813|588582969|FG001|Overall Study|Missed appointment|0|||
162967602|NCT02048813|588582968|FG000|Overall Study|Never started treatment|2|||
162967603|NCT02048813|588582969|FG001|Overall Study|Never started treatment|17|||
162967604|NCT01708954|588582970|FG000|Step 1|Disease progression|26|||
162967605|NCT01708954|588582971|FG001|Step 1|Disease progression|17|||
163316026|NCT04068181|589867924|FG001|Overall Study|Death|12|||
163316027|NCT04068181|589867925|FG002|Overall Study|Death|4|||
163316028|NCT04068181|589867926|FG003|Overall Study|Death|7|||
163316029|NCT04068181|589867923|FG000|Overall Study|Lost to Follow-up|1|||
163316030|NCT04068181|589867924|FG001|Overall Study|Lost to Follow-up|0|||
163316031|NCT04068181|589867925|FG002|Overall Study|Lost to Follow-up|0|||
163316032|NCT04068181|589867926|FG003|Overall Study|Lost to Follow-up|0|||
163316033|NCT04068181|589867923|FG000|Overall Study|Withdrawal of consent from study|3|||
163316034|NCT04068181|589867924|FG001|Overall Study|Withdrawal of consent from study|0|||
163316035|NCT04068181|589867925|FG002|Overall Study|Withdrawal of consent from study|0|||
163316036|NCT04068181|589867926|FG003|Overall Study|Withdrawal of consent from study|0|||
163316037|NCT03785964|589867929|FG000|Overall Study|Adverse Event|14|||
163316038|NCT03785964|589867930|FG001|Overall Study|Adverse Event|1|||
163316039|NCT03785964|589867929|FG000|Overall Study|Unqualified Clinical Progression|1|||
163316040|NCT03785964|589867930|FG001|Overall Study|Unqualified Clinical Progression|1|||
163316041|NCT03785964|589867929|FG000|Overall Study|Participant non-compliance|1|||
163316042|NCT03785964|589867930|FG001|Overall Study|Participant non-compliance|1|||
163316043|NCT03785964|589867929|FG000|Overall Study|Not treated|1|||
163316044|NCT03785964|589867930|FG001|Overall Study|Not treated|0|||
163316045|NCT03785964|589867929|FG000|Overall Study|Other reason|5|||
163316046|NCT03785964|589867930|FG001|Overall Study|Other reason|11|||
163316047|NCT03785964|589867929|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
163316048|NCT03785964|589867930|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
163316049|NCT02723591|589867931|FG000|Overall Study|Adverse Event|48|||
163316050|NCT02723591|589867932|FG001|Overall Study|Adverse Event|40|||
163316051|NCT02723591|589867931|FG000|Overall Study|Death|2|||
163316052|NCT02723591|589867932|FG001|Overall Study|Death|2|||
163316053|NCT02723591|589867931|FG000|Overall Study|Lack of Efficacy|4|||
163316054|NCT02723591|589867932|FG001|Overall Study|Lack of Efficacy|3|||
163316055|NCT02723591|589867931|FG000|Overall Study|Lost to Follow-up|1|||
163316056|NCT02723591|589867932|FG001|Overall Study|Lost to Follow-up|7|||
163316057|NCT02723591|589867931|FG000|Overall Study|Protocol Violation|20|||
163316058|NCT02723591|589867932|FG001|Overall Study|Protocol Violation|23|||
163316059|NCT02723591|589867931|FG000|Overall Study|Withdrawal by Subject|4|||
163316060|NCT02723591|589867932|FG001|Overall Study|Withdrawal by Subject|8|||
163316061|NCT02723591|589867931|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
163316062|NCT02723591|589867932|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
163316063|NCT02723591|589867931|FG000|Overall Study|Miscellaneous|5|||
163316064|NCT02723591|589867932|FG001|Overall Study|Miscellaneous|6|||
163316065|NCT05070728|589867933|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
163316066|NCT05070728|589867934|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
163316067|NCT03905798|589867935|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
163316068|NCT05374798|589867936|FG000|Overall Study|Lost to Follow-up|2|||
163316069|NCT05374798|589867936|FG000|Overall Study|Withdrawal by Subject|2|||
163316070|NCT05374798|589867936|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
163316071|NCT03334630|589867937|FG000|Overall Study|Withdrawal by Subject|7|||
163316072|NCT03334630|589867938|FG001|Overall Study|Withdrawal by Subject|7|||
163316073|NCT03334630|589867937|FG000|Overall Study|Lost to Follow-up|3|||
163316074|NCT03334630|589867938|FG001|Overall Study|Lost to Follow-up|1|||
163316075|NCT03334630|589867937|FG000|Overall Study|Adverse Event|0|||
163316076|NCT03334630|589867938|FG001|Overall Study|Adverse Event|1|||
163316077|NCT03334630|589867937|FG000|Overall Study|Physician Decision|1|||
163316078|NCT03334630|589867938|FG001|Overall Study|Physician Decision|1|||
163316079|NCT03334630|589867937|FG000|Overall Study|Enrollment closed|2|||
163316080|NCT03334630|589867938|FG001|Overall Study|Enrollment closed|1|||
163316081|NCT03334630|589867937|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
163316082|NCT03334630|589867938|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
163316083|NCT03334630|589867937|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
163316084|NCT03334630|589867938|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
163316085|NCT04498390|589867943|FG000|Overall Study|Adverse Event|0|||
163316086|NCT04498390|589867944|FG001|Overall Study|Adverse Event|0|||
163316087|NCT04498390|589867945|FG002|Overall Study|Adverse Event|1|||
163316088|NCT04498390|589867946|FG003|Overall Study|Adverse Event|0|||
163316089|NCT04498390|589867947|FG004|Overall Study|Adverse Event|0|||
163316090|NCT04498390|589867943|FG000|Overall Study|Withdrawal by Subject|0|||
163316091|NCT04498390|589867944|FG001|Overall Study|Withdrawal by Subject|0|||
163316092|NCT04498390|589867945|FG002|Overall Study|Withdrawal by Subject|0|||
163316093|NCT04498390|589867946|FG003|Overall Study|Withdrawal by Subject|1|||
163316094|NCT04498390|589867947|FG004|Overall Study|Withdrawal by Subject|0|||
163316095|NCT04068311|589867950|FG000|Overall Study|Death|3|||
163316096|NCT04068311|589867951|FG001|Overall Study|Death|3|||
163316097|NCT04068311|589867950|FG000|Overall Study|Lost to Follow-up|24|||
163208004|NCT03672747|589474292|FG002|Overall Study|Lost to Follow-up|2|||
163208005|NCT03672747|589474293|FG003|Overall Study|Lost to Follow-up|2|||
163208006|NCT03672747|589474294|FG004|Overall Study|Lost to Follow-up|2|||
163208007|NCT03672747|589474295|FG005|Overall Study|Lost to Follow-up|1|||
163208008|NCT03228537|589474298|FG000|Neoadjuvant|Adverse Event|2|||
163208009|NCT03228537|589474298|FG000|Neoadjuvant|Progression/Relapse|4|||
163208010|NCT03228537|589474298|FG000|Neoadjuvant|Death|1|||
163208011|NCT03228537|589474298|FG000|Surgery|Death|1|||
163316098|NCT04068311|589867951|FG001|Overall Study|Lost to Follow-up|68|||
163316099|NCT04068311|589867950|FG000|Overall Study|Withdrawal by Subject|5|||
163316100|NCT04068311|589867951|FG001|Overall Study|Withdrawal by Subject|0|||
163316101|NCT02068885|589867952|FG000|Overall Study|Withdrew|3|||
163316102|NCT02068885|589867953|FG001|Overall Study|Withdrew|5|||
163316103|NCT02068885|589867954|FG002|Overall Study|Withdrew|8|||
163316104|NCT04721977|589867959|FG000|Overall Study|Death|15|||
163316105|NCT04721977|589867959|FG000|Overall Study|Ongoing|51|||
163316106|NCT02670525|589867960|FG000|Overall Study|Death|94|||
163316107|NCT02670525|589867961|FG001|Overall Study|Death|14|||
163316108|NCT02670525|589867960|FG000|Overall Study|Lost to Follow-up|4|||
163316109|NCT02670525|589867961|FG001|Overall Study|Lost to Follow-up|1|||
163316110|NCT02670525|589867960|FG000|Overall Study|Subject withdrew consent|1|||
163316111|NCT02670525|589867961|FG001|Overall Study|Subject withdrew consent|0|||
163316112|NCT02670525|589867960|FG000|Overall Study|Unknown, data entry delayed|123|||
163316113|NCT02670525|589867961|FG001|Overall Study|Unknown, data entry delayed|78|||
163316114|NCT04304820|589869501|FG000|Overall Study|Death|1|||
163316115|NCT04304820|589869501|FG000|Overall Study|Lost to Follow-up|1|||
163316116|NCT04304820|589869501|FG000|Overall Study|Pursuing Stem Cell Transplant|4|||
163316117|NCT04304820|589869501|FG000|Overall Study|Pursuing Additional Immunosuppressive therapy|4|||
163316118|NCT04304820|589869501|FG000|Overall Study|Evolution to Myeloid Malignancy|1|||
163316119|NCT03873818|589869502|FG000|Overall Study|Death|9|||
163316120|NCT03873818|589869503|FG001|Overall Study|Death|3|||
163316121|NCT03873818|589869502|FG000|Overall Study|Lost to Follow-up|1|||
163316122|NCT03873818|589869503|FG001|Overall Study|Lost to Follow-up|0|||
163316123|NCT03474107|589869504|FG000|Overall Study|Adverse Event|42|||
163316124|NCT03474107|589869505|FG001|Overall Study|Adverse Event|46|||
163316125|NCT03474107|589869504|FG000|Overall Study|Death|2|||
163316126|NCT03474107|589869505|FG001|Overall Study|Death|2|||
163316127|NCT03474107|589869504|FG000|Overall Study|Lost to Follow-up|0|||
163316128|NCT03474107|589869505|FG001|Overall Study|Lost to Follow-up|1|||
163316129|NCT03474107|589869504|FG000|Overall Study|Progressive Disease|177|||
163316130|NCT03474107|589869505|FG001|Overall Study|Progressive Disease|180|||
163316131|NCT03474107|589869504|FG000|Overall Study|Protocol Violation|1|||
163316132|NCT03474107|589869505|FG001|Overall Study|Protocol Violation|1|||
163316133|NCT03474107|589869504|FG000|Overall Study|Withdrawal by Subject|15|||
163316134|NCT03474107|589869505|FG001|Overall Study|Withdrawal by Subject|27|||
163316135|NCT03474107|589869504|FG000|Overall Study|Physician Decision|7|||
163316136|NCT03474107|589869505|FG001|Overall Study|Physician Decision|22|||
163316137|NCT03474107|589869504|FG000|Overall Study|Miscellaneous|1|||
163316138|NCT03474107|589869505|FG001|Overall Study|Miscellaneous|6|||
163316139|NCT05171855|589869506|FG000|Overall Study|Death|1|||
163316140|NCT05171855|589869507|FG001|Overall Study|Death|0|||
163399195|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
163399196|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
163399197|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
163399198|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
163399199|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
163208012|NCT03228537|589474298|FG000|Surgery|Other - Not Protocol Specified|2|||
163399200|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
163399201|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
163399202|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
163399203|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
163399204|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
163399205|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
163399206|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
163399207|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
163399208|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
163399209|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
163399210|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
163399211|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
163399212|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
163399213|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
163399214|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
163399215|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
163399216|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
163399217|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
163399218|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
163399219|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
162967606|NCT01708954|588582972|FG002|Step 1|Disease progression|14|||
162967607|NCT01708954|588582970|FG000|Step 1|Adverse Event|3|||
162967608|NCT01708954|588582971|FG001|Step 1|Adverse Event|11|||
162967609|NCT01708954|588582972|FG002|Step 1|Adverse Event|13|||
162967610|NCT01708954|588582970|FG000|Step 1|Death|3|||
162967611|NCT01708954|588582971|FG001|Step 1|Death|2|||
162967612|NCT01708954|588582972|FG002|Step 1|Death|3|||
163401999|NCT01840579|590182961|FG008|Overall Study|Follow-up ended by Sponsor|0|||
162967613|NCT01708954|588582970|FG000|Step 1|Withdrawal by Subject|2|||
162967614|NCT01708954|588582971|FG001|Step 1|Withdrawal by Subject|5|||
162967615|NCT01708954|588582972|FG002|Step 1|Withdrawal by Subject|3|||
162967616|NCT01708954|588582970|FG000|Step 1|Other complicating disease|0|||
163208013|NCT03228537|589474298|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
163208014|NCT03228537|589474298|FG000|Maintenance|Progression/Relapse|10|||
163208015|NCT00580606|589474302|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
163316141|NCT05171855|589869508|FG002|Overall Study|Death|0|||
163208016|NCT00580606|589474303|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
163208017|NCT00580606|589474302|FG000|Open Label (OL)|Withdrawal by Subject|4|||
163208018|NCT00580606|589474303|FG001|Open Label (OL)|Withdrawal by Subject|6|||
163208019|NCT00580606|589474302|FG000|Open Label (OL)|Dosing Symptoms|0|||
163208020|NCT00580606|589474303|FG001|Open Label (OL)|Dosing Symptoms|1|||
163208021|NCT00580606|589474302|FG000|Open Label (OL)|Lost to Follow-up|0|||
163208022|NCT00580606|589474303|FG001|Open Label (OL)|Lost to Follow-up|1|||
163316142|NCT05171855|589869506|FG000|Overall Study|Withdrawal by Subject|2|||
163316143|NCT05171855|589869507|FG001|Overall Study|Withdrawal by Subject|0|||
163316144|NCT05171855|589869508|FG002|Overall Study|Withdrawal by Subject|5|||
163316145|NCT05171855|589869506|FG000|Overall Study|Physician Decision|1|||
163054363|NCT02616783|588910256|FG001|Overall Study|Death|0|||
163316146|NCT05171855|589869507|FG001|Overall Study|Physician Decision|0|||
163316147|NCT05171855|589869508|FG002|Overall Study|Physician Decision|0|||
163316148|NCT05171855|589869506|FG000|Overall Study|Adverse Event|2|||
163316149|NCT05171855|589869507|FG001|Overall Study|Adverse Event|4|||
163054364|NCT02616783|588910255|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163054365|NCT02616783|588910256|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163054366|NCT02616783|588910255|FG000|Overall Study|Protocol Violation|1|||
163054367|NCT02616783|588910256|FG001|Overall Study|Protocol Violation|1|||
163054368|NCT02616783|588910255|FG000|Overall Study|Withdrew Consent|1|||
163054369|NCT02616783|588910256|FG001|Overall Study|Withdrew Consent|1|||
163054370|NCT05214118|588910257|FG000|Overall Study|Lost to Follow-up|0|||
163316150|NCT05171855|589869508|FG002|Overall Study|Adverse Event|2|||
163316151|NCT05171855|589869506|FG000|Overall Study|Other|0|||
163316152|NCT05171855|589869507|FG001|Overall Study|Other|0|||
163316153|NCT05171855|589869508|FG002|Overall Study|Other|1|||
163316154|NCT05041257|589869509|FG000|Overall Study|Death|37|||
163054371|NCT05214118|588910258|FG001|Overall Study|Lost to Follow-up|2|||
163208023|NCT00580606|589474302|FG000|Open Label (OL)|Pregnancy|0|||
163208024|NCT00580606|589474303|FG001|Open Label (OL)|Pregnancy|1|||
163316155|NCT05041257|589869509|FG000|Overall Study|Lost to Follow-up|3|||
163316156|NCT05041257|589869509|FG000|Overall Study|Sponsor decision|39|||
163316157|NCT03067480|589869510|FG000|Overall Study|Lost to Follow-up|2|||
163316158|NCT03067480|589869511|FG001|Overall Study|Lost to Follow-up|4|||
163316159|NCT03067480|589869510|FG000|Overall Study|started insulin|1|||
163399220|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
162967617|NCT01708954|588582971|FG001|Step 1|Other complicating disease|2|||
162967618|NCT01708954|588582972|FG002|Step 1|Other complicating disease|0|||
162967619|NCT01708954|588582970|FG000|Step 1|Crossed over to Step 2|2|||
162967620|NCT01708954|588582971|FG001|Step 1|Crossed over to Step 2|0|||
162967621|NCT01708954|588582972|FG002|Step 1|Crossed over to Step 2|0|||
162967622|NCT01708954|588582970|FG000|Step 1|Symptomatic deterioration|1|||
162967623|NCT01708954|588582971|FG001|Step 1|Symptomatic deterioration|0|||
162967624|NCT01708954|588582972|FG002|Step 1|Symptomatic deterioration|1|||
162967625|NCT01708954|588582970|FG000|Step 1|Off-treatment reason not submitted|1|||
162967626|NCT01708954|588582971|FG001|Step 1|Off-treatment reason not submitted|1|||
162967627|NCT01708954|588582972|FG002|Step 1|Off-treatment reason not submitted|1|||
162967628|NCT01708954|588582970|FG000|Step 1|Ineligible or never received treatment|4|||
162967629|NCT01708954|588582971|FG001|Step 1|Ineligible or never received treatment|2|||
162967630|NCT01708954|588582972|FG002|Step 1|Ineligible or never received treatment|8|||
162967631|NCT01708954|588582970|FG000|Step 2|Disease progression|9|||
162967632|NCT01708954|588582971|FG001|Step 2|Disease progression|4|||
162967633|NCT01708954|588582972|FG002|Step 2|Disease progression|0|||
162967634|NCT01708954|588582970|FG000|Step 2|Adverse Event|3|||
162967635|NCT01708954|588582971|FG001|Step 2|Adverse Event|2|||
162967636|NCT01708954|588582972|FG002|Step 2|Adverse Event|0|||
162967637|NCT01708954|588582970|FG000|Step 2|Withdrawal by Subject|1|||
162967638|NCT01708954|588582971|FG001|Step 2|Withdrawal by Subject|1|||
162967639|NCT01708954|588582972|FG002|Step 2|Withdrawal by Subject|0|||
162967640|NCT03314857|588582976|FG000|Overall Study|Death|4|||
162967641|NCT03314857|588582976|FG000|Overall Study|Physician Decision|1|||
162967642|NCT01119625|588582977|FG000|Overall Study|Lost to Follow-up|1|||
162967643|NCT01119625|588582978|FG001|Overall Study|Lost to Follow-up|2|||
162967644|NCT01119625|588582977|FG000|Overall Study|Withdrawal by Subject|2|||
162967645|NCT01119625|588582978|FG001|Overall Study|Withdrawal by Subject|1|||
162967646|NCT01119625|588582977|FG000|Overall Study|Other|0|||
162967647|NCT01119625|588582978|FG001|Overall Study|Other|1|||
162967648|NCT01721772|588582983|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
162967649|NCT01721772|588582984|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
162967650|NCT01721772|588582983|FG000|Pre-Treatment|Poor/non-compliance|0|||
162967651|NCT01721772|588582984|FG001|Pre-Treatment|Poor/non-compliance|1|||
162967652|NCT01721772|588582983|FG000|Pre-Treatment|Participant withdrew consent|0|||
162967653|NCT01721772|588582984|FG001|Pre-Treatment|Participant withdrew consent|1|||
162967654|NCT01721772|588582983|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
162967655|NCT01721772|588582984|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
162967656|NCT01721772|588582983|FG000|Treatment|Disease progression|119|||
162967657|NCT01721772|588582984|FG001|Treatment|Disease progression|168|||
162967658|NCT01721772|588582983|FG000|Treatment|Study drug toxicity|19|||
162967659|NCT01721772|588582984|FG001|Treatment|Study drug toxicity|10|||
162967660|NCT01721772|588582983|FG000|Treatment|Adverse event unrelated to study drug|7|||
162967661|NCT01721772|588582984|FG001|Treatment|Adverse event unrelated to study drug|7|||
163208025|NCT00580606|589474302|FG000|Open Label (OL)|Non-compliance|2|||
163208026|NCT00580606|589474303|FG001|Open Label (OL)|Non-compliance|0|||
163208027|NCT00580606|589474302|FG000|Open Label (OL)|Physician Decision|1|||
163208028|NCT00580606|589474303|FG001|Open Label (OL)|Physician Decision|1|||
163208029|NCT00580606|589474302|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
163208030|NCT00580606|589474303|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
163208031|NCT03358290|589474305|FG000|Overall Study|Study discontinued by Sponsor|0|||
163208032|NCT03358290|589474306|FG001|Overall Study|Study discontinued by Sponsor|1|||
163208033|NCT03358290|589474307|FG002|Overall Study|Study discontinued by Sponsor|1|||
163208034|NCT03358290|589474308|FG003|Overall Study|Study discontinued by Sponsor|0|||
163208035|NCT03358290|589474309|FG004|Overall Study|Study discontinued by Sponsor|0|||
163208036|NCT03358290|589474305|FG000|Overall Study|Adverse Event|0|||
163208037|NCT03358290|589474306|FG001|Overall Study|Adverse Event|0|||
163208038|NCT03358290|589474307|FG002|Overall Study|Adverse Event|1|||
163208039|NCT03358290|589474308|FG003|Overall Study|Adverse Event|2|||
163316160|NCT03067480|589869511|FG001|Overall Study|started insulin|1|||
163316161|NCT05782816|589869514|FG000|Overall Study|Withdrawal by Subject|1|||
163316162|NCT05782816|589869515|FG001|Overall Study|Withdrawal by Subject|0|||
163316163|NCT04221490|589869516|FG000|At 30 Days Follow-up|Death|7|||
163316164|NCT04221490|589869516|FG000|At 30 Days Follow-up|Physician Decision|1|||
163316165|NCT04221490|589869516|FG000|At 30 Days Follow-up|Missed Visit|4|||
163316166|NCT04221490|589869516|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
163316167|NCT04221490|589869516|FG000|At 6 Months Follow-up|Death|9|||
163316168|NCT04221490|589869516|FG000|At 6 Months Follow-up|Missed Visit|8|||
163208040|NCT03358290|589474309|FG004|Overall Study|Adverse Event|0|||
163208041|NCT03358290|589474305|FG000|Overall Study|Withdrawal by Subject|0|||
163208042|NCT03358290|589474306|FG001|Overall Study|Withdrawal by Subject|0|||
163208043|NCT03358290|589474307|FG002|Overall Study|Withdrawal by Subject|0|||
163208044|NCT03358290|589474308|FG003|Overall Study|Withdrawal by Subject|0|||
163208045|NCT03358290|589474309|FG004|Overall Study|Withdrawal by Subject|1|||
163208046|NCT01482884|589474310|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
163208047|NCT01482884|589474311|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
163208048|NCT01482884|589474310|FG000|Overall Study|Protocol Violation|1|||
163208049|NCT01482884|589474311|FG001|Overall Study|Protocol Violation|0|||
163208050|NCT01482884|589474310|FG000|Overall Study|Lost to Follow-up|2|||
163208051|NCT01482884|589474311|FG001|Overall Study|Lost to Follow-up|2|||
163208052|NCT01482884|589474310|FG000|Overall Study|Lack of Efficacy|0|||
163208053|NCT01482884|589474311|FG001|Overall Study|Lack of Efficacy|1|||
163208054|NCT01482884|589474310|FG000|Overall Study|Adverse Event|2|||
163208055|NCT01482884|589474311|FG001|Overall Study|Adverse Event|1|||
163208056|NCT01482884|589474310|FG000|Overall Study|Withdrawal by Subject|8|||
163208057|NCT01482884|589474311|FG001|Overall Study|Withdrawal by Subject|13|||
163208058|NCT04102020|589474312|FG000|Overall Study|Adverse Event|1|||
163208059|NCT04102020|589474313|FG001|Overall Study|Adverse Event|0|||
163208060|NCT04102020|589474314|FG002|Overall Study|Adverse Event|0|||
163208061|NCT04102020|589474315|FG003|Overall Study|Adverse Event|1|||
163208062|NCT04102020|589474316|FG004|Overall Study|Adverse Event|0|||
163208063|NCT04102020|589474312|FG000|Overall Study|Withdrawal by Subject|0|||
163208064|NCT04102020|589474313|FG001|Overall Study|Withdrawal by Subject|1|||
163208065|NCT04102020|589474314|FG002|Overall Study|Withdrawal by Subject|1|||
163208066|NCT04102020|589474315|FG003|Overall Study|Withdrawal by Subject|1|||
163208067|NCT04102020|589474316|FG004|Overall Study|Withdrawal by Subject|1|||
163208068|NCT04102020|589474312|FG000|Overall Study|Death|1|||
163208069|NCT04102020|589474313|FG001|Overall Study|Death|4|||
163208070|NCT04102020|589474314|FG002|Overall Study|Death|1|||
163208071|NCT04102020|589474315|FG003|Overall Study|Death|1|||
163208072|NCT04102020|589474316|FG004|Overall Study|Death|0|||
163208073|NCT04102020|589474312|FG000|Overall Study|Physician Decision|1|||
163208074|NCT04102020|589474313|FG001|Overall Study|Physician Decision|2|||
163208075|NCT04102020|589474314|FG002|Overall Study|Physician Decision|2|||
163208076|NCT04102020|589474315|FG003|Overall Study|Physician Decision|0|||
163208077|NCT04102020|589474316|FG004|Overall Study|Physician Decision|1|||
163208078|NCT04102020|589474312|FG000|Overall Study|COVID-19 Infection|1|||
163208079|NCT04102020|589474313|FG001|Overall Study|COVID-19 Infection|0|||
163399221|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
163399222|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
163399223|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
163399224|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
163399225|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
163399226|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
163399227|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
163399228|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
163399229|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
163399230|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
163399231|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
163399232|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
163054372|NCT05214118|588910257|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
163054373|NCT05214118|588910258|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
163399233|NCT00111800|590172585|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
163054374|NCT05214118|588910257|FG000|Overall Study|moved|1|||
163399234|NCT00111800|590172586|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
163399235|NCT00111800|590172587|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
163054375|NCT05214118|588910258|FG001|Overall Study|moved|0|||
163054376|NCT03080935|588910259|FG000|Overall Study|Death|34|||
163054377|NCT03080935|588910260|FG001|Overall Study|Death|50|||
163054378|NCT03080935|588910259|FG000|Overall Study|Lost to Follow-up|5|||
163054379|NCT03080935|588910260|FG001|Overall Study|Lost to Follow-up|4|||
163054380|NCT03080935|588910259|FG000|Overall Study|Withdrawal by Subject|11|||
163054381|NCT03080935|588910260|FG001|Overall Study|Withdrawal by Subject|15|||
163054382|NCT01614470|588910261|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
163054383|NCT01614470|588910262|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
163054384|NCT01614470|588910263|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
163054385|NCT01614470|588910261|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
163054386|NCT01614470|588910262|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
163054387|NCT01614470|588910263|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
163054388|NCT02895347|588910266|FG000|Overall Study|Withdrawal by Subject|3|||
163054389|NCT02895347|588910267|FG001|Overall Study|Withdrawal by Subject|1|||
163054390|NCT00449163|588910271|FG000|Overall Study|Physician Decision|3|||
163054391|NCT00606307|588910274|FG000|Overall Study|Adverse Event|2|||
163054392|NCT00606307|588910274|FG000|Overall Study|Withdrawal by Subject|2|||
163054393|NCT00606307|588910274|FG000|Overall Study|Disease progression|6|||
163054394|NCT00606307|588910274|FG000|Overall Study|QTc prolongation|1|||
163054395|NCT03368807|588910275|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
163054396|NCT03368807|588910275|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
163054397|NCT03368807|588910275|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
163054398|NCT03368807|588910275|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
163054399|NCT03669588|588910289|FG000|Overall Study|Adverse Event|1|||
163054400|NCT03669588|588910290|FG001|Overall Study|Adverse Event|0|||
163054401|NCT03669588|588910289|FG000|Overall Study|Physician Decision|0|||
163054402|NCT03669588|588910290|FG001|Overall Study|Physician Decision|1|||
163054403|NCT03669588|588910289|FG000|Overall Study|Protocol Violation|1|||
163054404|NCT03669588|588910290|FG001|Overall Study|Protocol Violation|0|||
163054405|NCT03669588|588910289|FG000|Overall Study|Sponsor Decision|1|||
163054406|NCT03669588|588910290|FG001|Overall Study|Sponsor Decision|1|||
163054407|NCT03669588|588910289|FG000|Overall Study|Withdrawal by Subject|1|||
163054408|NCT03669588|588910290|FG001|Overall Study|Withdrawal by Subject|4|||
163054409|NCT03669588|588910289|FG000|Overall Study|Rescue Therapy Needed|0|||
163054410|NCT03669588|588910290|FG001|Overall Study|Rescue Therapy Needed|1|||
163054411|NCT02949947|588910293|FG000|Overall Study|Non Compliance|0|||
163054412|NCT02949947|588910294|FG001|Overall Study|Non Compliance|1|||
163054413|NCT02949947|588910293|FG000|Overall Study|Insurance change|1|||
163399236|NCT00111800|590172588|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
163399237|NCT00111800|590172589|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
163399238|NCT00111800|590172590|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
163399239|NCT00111800|590172585|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
163399240|NCT00111800|590172586|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
163399241|NCT00111800|590172587|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
163399242|NCT00111800|590172588|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
163399243|NCT00111800|590172589|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
163399244|NCT00111800|590172590|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
163399245|NCT00111800|590172585|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
163399246|NCT00111800|590172586|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
163399247|NCT00111800|590172587|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
163399248|NCT00111800|590172588|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
163399249|NCT00111800|590172589|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
163399250|NCT00111800|590172590|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
163399251|NCT00111800|590172585|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
163208080|NCT04102020|589474314|FG002|Overall Study|COVID-19 Infection|0|||
163208081|NCT04102020|589474315|FG003|Overall Study|COVID-19 Infection|0|||
163208082|NCT04102020|589474316|FG004|Overall Study|COVID-19 Infection|0|||
163208083|NCT04102020|589474312|FG000|Overall Study|Not disclosed|5|||
163208084|NCT04102020|589474313|FG001|Overall Study|Not disclosed|3|||
163208085|NCT04102020|589474314|FG002|Overall Study|Not disclosed|8|||
163208086|NCT04102020|589474315|FG003|Overall Study|Not disclosed|0|||
163208087|NCT04102020|589474316|FG004|Overall Study|Not disclosed|1|||
163316169|NCT04221490|589869516|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
163316170|NCT04221490|589869516|FG000|At 1 Year Follow-up|Death|7|||
163316171|NCT04221490|589869516|FG000|At 1 Year Follow-up|Withdrawal by Subject|2|||
163316172|NCT04221490|589869516|FG000|At 1 Year Follow-up|Missed Visit|9|||
163316173|NCT04221490|589869516|FG000|At 1 Year Follow-up|Exited for Other Reasons|1|||
163316174|NCT02998268|589869523|FG000|Overall Study|Adverse Event|0|||
163316175|NCT02998268|589869524|FG001|Overall Study|Adverse Event|2|||
163316176|NCT02998268|589869523|FG000|Overall Study|Withdrawal by Subject|0|||
163316177|NCT02998268|589869524|FG001|Overall Study|Withdrawal by Subject|1|||
163316178|NCT04225273|589869525|FG000|Overall Study|Lost to Follow-up|3|||
163316179|NCT04192266|589869526|FG000|Overall Study|Withdrawal by Subject|3|||
163316180|NCT04192266|589869527|FG001|Overall Study|Withdrawal by Subject|2|||
163316181|NCT01501955|589869528|FG000|Overall Study|Withdrawal by Subject|1|||
163316182|NCT01501955|589869529|FG001|Overall Study|Withdrawal by Subject|0|||
163316183|NCT01501955|589869528|FG000|Overall Study|Adverse Event|1|||
163316184|NCT01501955|589869529|FG001|Overall Study|Adverse Event|3|||
163316185|NCT04298983|589869530|FG000|Overall Study|Adverse Event|4|||
163316186|NCT04298983|589869530|FG000|Overall Study|Lack of Efficacy|3|||
163316187|NCT02927236|589869531|FG000|Characterization Phase|Physician Decision|0|||
163316188|NCT02927236|589869532|FG001|Characterization Phase|Physician Decision|3|||
163316189|NCT02927236|589869533|FG002|Characterization Phase|Physician Decision|0|||
163316190|NCT02927236|589869534|FG003|Characterization Phase|Physician Decision|2|||
163316191|NCT02927236|589869531|FG000|Characterization Phase|Lost to Follow-up|0|||
163316192|NCT02927236|589869532|FG001|Characterization Phase|Lost to Follow-up|0|||
163316193|NCT02927236|589869533|FG002|Characterization Phase|Lost to Follow-up|0|||
163316194|NCT02927236|589869534|FG003|Characterization Phase|Lost to Follow-up|3|||
163316195|NCT02927236|589869531|FG000|Characterization Phase|Withdrawal by Subject|1|||
163316196|NCT02927236|589869532|FG001|Characterization Phase|Withdrawal by Subject|0|||
163316197|NCT02927236|589869533|FG002|Characterization Phase|Withdrawal by Subject|0|||
163316198|NCT02927236|589869534|FG003|Characterization Phase|Withdrawal by Subject|1|||
163316199|NCT02927236|589869531|FG000|Treatment Phase|Adverse Event|1|||
163316200|NCT02927236|589869532|FG001|Treatment Phase|Adverse Event|0|||
163316201|NCT02927236|589869533|FG002|Treatment Phase|Adverse Event|1|||
163316202|NCT02927236|589869534|FG003|Treatment Phase|Adverse Event|1|||
163316203|NCT02927236|589869531|FG000|Treatment Phase|Protocol Violation|3|||
163316204|NCT02927236|589869532|FG001|Treatment Phase|Protocol Violation|0|||
163316205|NCT02927236|589869533|FG002|Treatment Phase|Protocol Violation|0|||
163316206|NCT02927236|589869534|FG003|Treatment Phase|Protocol Violation|1|||
163316207|NCT02927236|589869531|FG000|Treatment Phase|Lost to Follow-up|1|||
163316208|NCT02927236|589869532|FG001|Treatment Phase|Lost to Follow-up|0|||
163316209|NCT02927236|589869533|FG002|Treatment Phase|Lost to Follow-up|0|||
163316210|NCT02927236|589869534|FG003|Treatment Phase|Lost to Follow-up|0|||
163316211|NCT02927236|589869531|FG000|Follow-up Phase|Lost to Follow-up|1|||
163316212|NCT02927236|589869532|FG001|Follow-up Phase|Lost to Follow-up|0|||
163316213|NCT02927236|589869533|FG002|Follow-up Phase|Lost to Follow-up|1|||
163316214|NCT02927236|589869534|FG003|Follow-up Phase|Lost to Follow-up|0|||
163316215|NCT05477186|589869535|FG000|Overall Study|Vaccine not administered|0|||
163316216|NCT05477186|589869536|FG001|Overall Study|Vaccine not administered|2|||
163399252|NCT00111800|590172586|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
163208088|NCT04102020|589474312|FG000|Overall Study|MIssing|1|||
163208089|NCT04102020|589474313|FG001|Overall Study|MIssing|0|||
163208090|NCT04102020|589474314|FG002|Overall Study|MIssing|1|||
163208091|NCT04102020|589474315|FG003|Overall Study|MIssing|1|||
163208092|NCT04102020|589474316|FG004|Overall Study|MIssing|1|||
163208093|NCT04102020|589474312|FG000|Overall Study|Continuing in ongoing study|13|||
163208094|NCT04102020|589474313|FG001|Overall Study|Continuing in ongoing study|13|||
163316217|NCT05477186|589869537|FG002|Overall Study|Vaccine not administered|1|||
163316218|NCT05477186|589869538|FG003|Overall Study|Vaccine not administered|0|||
163316219|NCT05477186|589869539|FG004|Overall Study|Vaccine not administered|1|||
163316220|NCT05477186|589869540|FG005|Overall Study|Vaccine not administered|0|||
163316221|NCT05477186|589869541|FG006|Overall Study|Vaccine not administered|0|||
163316222|NCT05477186|589869535|FG000|Overall Study|Withdrawal by Subject|1|||
163316223|NCT05477186|589869536|FG001|Overall Study|Withdrawal by Subject|0|||
163316224|NCT05477186|589869537|FG002|Overall Study|Withdrawal by Subject|0|||
163316225|NCT05477186|589869538|FG003|Overall Study|Withdrawal by Subject|0|||
163316226|NCT05477186|589869539|FG004|Overall Study|Withdrawal by Subject|0|||
163316227|NCT05477186|589869540|FG005|Overall Study|Withdrawal by Subject|1|||
163316228|NCT05477186|589869541|FG006|Overall Study|Withdrawal by Subject|0|||
163316229|NCT05477186|589869535|FG000|Overall Study|Lost to Follow-up|1|||
163316230|NCT05477186|589869536|FG001|Overall Study|Lost to Follow-up|0|||
163316231|NCT05477186|589869537|FG002|Overall Study|Lost to Follow-up|2|||
163316232|NCT05477186|589869538|FG003|Overall Study|Lost to Follow-up|1|||
163316233|NCT05477186|589869539|FG004|Overall Study|Lost to Follow-up|1|||
163316234|NCT05477186|589869540|FG005|Overall Study|Lost to Follow-up|0|||
163316235|NCT05477186|589869541|FG006|Overall Study|Lost to Follow-up|2|||
163316236|NCT01919554|589869543|FG000|Overall Study|Withdrawal by Subject|0|||
163316237|NCT01919554|589869544|FG001|Overall Study|Withdrawal by Subject|0|||
163316238|NCT01919554|589869545|FG002|Overall Study|Withdrawal by Subject|1|||
163316239|NCT01919554|589869546|FG003|Overall Study|Withdrawal by Subject|1|||
162967662|NCT01721772|588582983|FG000|Treatment|Maximum clinical benefit|16|||
162967663|NCT01721772|588582984|FG001|Treatment|Maximum clinical benefit|4|||
162967664|NCT01721772|588582983|FG000|Treatment|Other|19|||
162967665|NCT01721772|588582984|FG001|Treatment|Other|2|||
163208095|NCT04102020|589474314|FG002|Overall Study|Continuing in ongoing study|7|||
163208096|NCT04102020|589474315|FG003|Overall Study|Continuing in ongoing study|26|||
163208097|NCT04102020|589474316|FG004|Overall Study|Continuing in ongoing study|12|||
163208098|NCT04853225|589474317|FG000|Overall Study|Withdrawal by Subject|81|||
163208099|NCT04853225|589474318|FG001|Overall Study|Withdrawal by Subject|4|||
163208100|NCT04853225|589474319|FG002|Overall Study|Withdrawal by Subject|1|||
163208101|NCT04853225|589474317|FG000|Overall Study|Physician Decision|12|||
163208102|NCT04853225|589474318|FG001|Overall Study|Physician Decision|4|||
163208103|NCT04853225|589474319|FG002|Overall Study|Physician Decision|1|||
163208104|NCT04853225|589474317|FG000|Overall Study|Lost to Follow-up|50|||
163316240|NCT01733316|589869548|FG000|RP103 Phase|Non-compliance|1|||
163316241|NCT01733316|589869548|FG000|Long Term Extension Phase|Adverse Event|1|||
163316242|NCT01733316|589869548|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
162967666|NCT01721772|588582983|FG000|Treatment|Participant withdrew consent|2|||
163208105|NCT04853225|589474318|FG001|Overall Study|Lost to Follow-up|0|||
163208106|NCT04853225|589474319|FG002|Overall Study|Lost to Follow-up|0|||
163208107|NCT04853225|589474317|FG000|Overall Study|Other|102|||
163208108|NCT04853225|589474318|FG001|Overall Study|Other|11|||
163208109|NCT04853225|589474319|FG002|Overall Study|Other|5|||
163208110|NCT04853225|589474317|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
163208111|NCT04853225|589474318|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
163208112|NCT04853225|589474319|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
163208113|NCT04853225|589474317|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
163208114|NCT04853225|589474318|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
163208115|NCT04853225|589474319|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
163208116|NCT03789318|589474320|FG000|Overall Study|Adverse Event|0|||
163208117|NCT03789318|589474321|FG001|Overall Study|Adverse Event|0|||
163208118|NCT03789318|589474322|FG002|Overall Study|Adverse Event|1|||
163208119|NCT03789318|589474323|FG003|Overall Study|Adverse Event|1|||
163208120|NCT03789318|589474324|FG004|Overall Study|Adverse Event|0|||
163208121|NCT03789318|589474320|FG000|Overall Study|Lost to Follow-up|0|||
163208122|NCT03789318|589474321|FG001|Overall Study|Lost to Follow-up|0|||
163208123|NCT03789318|589474322|FG002|Overall Study|Lost to Follow-up|1|||
163208124|NCT03789318|589474323|FG003|Overall Study|Lost to Follow-up|0|||
163208125|NCT03789318|589474324|FG004|Overall Study|Lost to Follow-up|0|||
163208126|NCT03789318|589474320|FG000|Overall Study|Withdrawal by Subject|0|||
163208127|NCT03789318|589474321|FG001|Overall Study|Withdrawal by Subject|0|||
163208128|NCT03789318|589474322|FG002|Overall Study|Withdrawal by Subject|1|||
163208129|NCT03789318|589474323|FG003|Overall Study|Withdrawal by Subject|0|||
163208130|NCT03789318|589474324|FG004|Overall Study|Withdrawal by Subject|0|||
163208131|NCT00733408|589476089|FG000|Overall Study|Adverse Event|4|||
163208132|NCT01134783|589476090|FG000|Overall Study|Pregnancy|16|||
163208133|NCT01134783|589476091|FG001|Overall Study|Pregnancy|8|||
163208134|NCT01134783|589476090|FG000|Overall Study|Withdrawal by Subject|15|||
163208135|NCT01134783|589476091|FG001|Overall Study|Withdrawal by Subject|9|||
163208136|NCT01134783|589476090|FG000|Overall Study|Lost to Follow-up|5|||
163208137|NCT01134783|589476091|FG001|Overall Study|Lost to Follow-up|20|||
163208138|NCT00531232|589476094|FG000|Overall Study|Investigator decision|0|||
163208139|NCT00531232|589476095|FG001|Overall Study|Investigator decision|0|||
163208140|NCT00531232|589476096|FG002|Overall Study|Investigator decision|4|||
163208141|NCT00531232|589476094|FG000|Overall Study|Participants refused further treatment|0|||
163208142|NCT00531232|589476095|FG001|Overall Study|Participants refused further treatment|1|||
163208143|NCT00531232|589476096|FG002|Overall Study|Participants refused further treatment|2|||
163208144|NCT00531232|589476094|FG000|Overall Study|Adverse events (AEs)|1|||
163208145|NCT00531232|589476095|FG001|Overall Study|Adverse events (AEs)|2|||
163208146|NCT00531232|589476096|FG002|Overall Study|Adverse events (AEs)|2|||
163208147|NCT00531232|589476094|FG000|Overall Study|Treatment failure|1|||
163208148|NCT00531232|589476095|FG001|Overall Study|Treatment failure|3|||
163208149|NCT00531232|589476096|FG002|Overall Study|Treatment failure|7|||
163208150|NCT00531232|589476094|FG000|Overall Study|Disease recurrence|0|||
163208151|NCT00531232|589476095|FG001|Overall Study|Disease recurrence|0|||
163208152|NCT00531232|589476096|FG002|Overall Study|Disease recurrence|1|||
163208153|NCT00531232|589476094|FG000|Overall Study|Deceased|2|||
163208154|NCT00531232|589476095|FG001|Overall Study|Deceased|2|||
163208155|NCT00531232|589476096|FG002|Overall Study|Deceased|2|||
163208156|NCT00531232|589476094|FG000|Overall Study|Withdrawal by Subject|0|||
163208157|NCT00531232|589476095|FG001|Overall Study|Withdrawal by Subject|1|||
163208158|NCT00531232|589476096|FG002|Overall Study|Withdrawal by Subject|2|||
163208159|NCT00531232|589476094|FG000|Overall Study|Other|0|||
163208160|NCT00531232|589476095|FG001|Overall Study|Other|0|||
163208161|NCT00531232|589476096|FG002|Overall Study|Other|5|||
163208162|NCT00463346|589476097|FG000|Overall Study|Withdrawal by Subject|3|||
163208163|NCT00463346|589476098|FG001|Overall Study|Withdrawal by Subject|3|||
163208164|NCT03641651|589476099|FG000|Overall Study|organizational issues at one study site|1|||
163316243|NCT01733316|589869548|FG000|Long Term Extension Phase|Sponsor Decision|2|||
163316244|NCT02838420|589869553|FG000|Overall Study|Ongoing in Study|113|||
163316245|NCT02838420|589869554|FG001|Overall Study|Ongoing in Study|45|||
163316246|NCT02838420|589869553|FG000|Overall Study|Lost to Follow-up|1|||
163316247|NCT02838420|589869554|FG001|Overall Study|Lost to Follow-up|0|||
163316248|NCT02838420|589869553|FG000|Overall Study|Withdrawal by Subject|3|||
163316249|NCT02838420|589869554|FG001|Overall Study|Withdrawal by Subject|4|||
163316250|NCT02838420|589869553|FG000|Overall Study|Death|8|||
163316251|NCT02838420|589869554|FG001|Overall Study|Death|13|||
163208165|NCT01991067|589476101|FG000|Overall Study|Lost to Follow-up|6|||
163208166|NCT01991067|589476102|FG001|Overall Study|Lost to Follow-up|5|||
163316252|NCT03024437|589869555|FG000|Overall Study|Adverse Event|0|||
163316253|NCT03024437|589869556|FG001|Overall Study|Adverse Event|1|||
162967667|NCT01721772|588582984|FG001|Treatment|Participant withdrew consent|5|||
162967668|NCT01721772|588582983|FG000|Treatment|Participant request to discontinue study treatment|21|||
162967669|NCT01721772|588582984|FG001|Treatment|Participant request to discontinue study treatment|8|||
162967670|NCT01721772|588582983|FG000|Treatment|Death|1|||
162967671|NCT01721772|588582984|FG001|Treatment|Death|0|||
162967672|NCT01721772|588582983|FG000|Treatment|Not reported|1|||
162967673|NCT01721772|588582984|FG001|Treatment|Not reported|0|||
162967674|NCT01721772|588582983|FG000|Treatment|Poor/non-compliance|1|||
162967675|NCT01721772|588582984|FG001|Treatment|Poor/non-compliance|0|||
162967676|NCT01721772|588582983|FG000|Treatment|Lost to Follow-up|0|||
162967677|NCT01721772|588582984|FG001|Treatment|Lost to Follow-up|1|||
162967678|NCT02754492|588582985|FG000|Overall Study|Protocol Violation|2|||
162967679|NCT02754492|588582986|FG001|Overall Study|Protocol Violation|2|||
162967680|NCT02754492|588582987|FG002|Overall Study|Protocol Violation|0|||
162967681|NCT02754492|588582988|FG003|Overall Study|Protocol Violation|1|||
162967682|NCT02754492|588582985|FG000|Overall Study|Withdrawal by Subject|2|||
162967683|NCT02754492|588582986|FG001|Overall Study|Withdrawal by Subject|0|||
162967684|NCT02754492|588582987|FG002|Overall Study|Withdrawal by Subject|0|||
162967685|NCT02754492|588582988|FG003|Overall Study|Withdrawal by Subject|0|||
162967686|NCT02754492|588582985|FG000|Overall Study|Equipment malfuntion|0|||
162967687|NCT02754492|588582986|FG001|Overall Study|Equipment malfuntion|0|||
162967688|NCT02754492|588582987|FG002|Overall Study|Equipment malfuntion|2|||
162967689|NCT02754492|588582988|FG003|Overall Study|Equipment malfuntion|5|||
162967690|NCT02754492|588582985|FG000|Overall Study|Adverse Event|0|||
162967691|NCT02754492|588582986|FG001|Overall Study|Adverse Event|0|||
162967692|NCT02754492|588582987|FG002|Overall Study|Adverse Event|0|||
162967693|NCT02754492|588582988|FG003|Overall Study|Adverse Event|13|||
162967694|NCT02754492|588582985|FG000|Overall Study|Venous access issues not resulting in AE|0|||
162967695|NCT02754492|588582986|FG001|Overall Study|Venous access issues not resulting in AE|0|||
162967696|NCT02754492|588582987|FG002|Overall Study|Venous access issues not resulting in AE|0|||
163208167|NCT00224055|589476104|FG000|Overall Study|Adverse Event|9|||
162967697|NCT02754492|588582988|FG003|Overall Study|Venous access issues not resulting in AE|4|||
162967698|NCT01408888|588582989|FG000|First Intervention|Adverse Event|0|||
162967699|NCT01408888|588582990|FG001|First Intervention|Adverse Event|1|||
162967700|NCT01408888|588582989|FG000|First Intervention|Withdrawal by Subject|0|||
162967701|NCT01408888|588582990|FG001|First Intervention|Withdrawal by Subject|2|||
163054414|NCT02949947|588910294|FG001|Overall Study|Insurance change|0|||
162967702|NCT01408888|588582989|FG000|Second Intervention|Withdrawal by Subject|1|||
162967703|NCT01408888|588582990|FG001|Second Intervention|Withdrawal by Subject|0|||
162967704|NCT01408888|588582989|FG000|Second Intervention|Adverse Event|1|||
162967705|NCT01408888|588582990|FG001|Second Intervention|Adverse Event|0|||
162967706|NCT04542694|588582991|FG000|Overall Study|The need for prohibited therapy|2|||
162967707|NCT04542694|588582992|FG001|Overall Study|The need for prohibited therapy|0|||
162967708|NCT04542694|588582991|FG000|Overall Study|Adverse Event|1|||
162967709|NCT04542694|588582992|FG001|Overall Study|Adverse Event|0|||
162967710|NCT04542694|588582991|FG000|Overall Study|Protocol Violation|1|||
162967711|NCT04542694|588582992|FG001|Overall Study|Protocol Violation|0|||
162967712|NCT04633642|588582995|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
162967713|NCT04633642|588582996|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
162967714|NCT05387408|588582997|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
162967715|NCT01717313|588583001|FG000|Phase A (Weeks 0 to 24)|Death|0|||
162967716|NCT01717313|588583002|FG001|Phase A (Weeks 0 to 24)|Death|1|||
162967717|NCT01717313|588583001|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
162967718|NCT01717313|588583002|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
162967719|NCT01717313|588583001|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
162967720|NCT01717313|588583002|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
162967721|NCT01717313|588583001|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
162967722|NCT01717313|588583002|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
162967723|NCT01717313|588583001|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
162967724|NCT01717313|588583002|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
162967725|NCT01717313|588583001|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
162967726|NCT01717313|588583002|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
162967727|NCT01717313|588583001|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
162967728|NCT01717313|588583002|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
162967729|NCT01717313|588583001|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
162967730|NCT01717313|588583002|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
162967731|NCT01717313|588583001|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
162967732|NCT01717313|588583002|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
162967733|NCT01617096|588583007|FG000|Overall Study|Withdrawal by Subject|96|||
162967734|NCT01617096|588583008|FG001|Overall Study|Withdrawal by Subject|81|||
162967735|NCT01617096|588583007|FG000|Overall Study|Lost to Follow-up|37|||
162967736|NCT01617096|588583008|FG001|Overall Study|Lost to Follow-up|32|||
162967737|NCT01617096|588583007|FG000|Overall Study|Physician Decision|10|||
163208168|NCT00224055|589476105|FG001|Overall Study|Adverse Event|3|||
163208169|NCT00224055|589476104|FG000|Overall Study|Lost to Follow-up|1|||
163208170|NCT00224055|589476105|FG001|Overall Study|Lost to Follow-up|2|||
162967738|NCT01617096|588583008|FG001|Overall Study|Physician Decision|18|||
162967739|NCT01617096|588583007|FG000|Overall Study|Death|4|||
162967740|NCT01617096|588583008|FG001|Overall Study|Death|3|||
163399253|NCT00111800|590172587|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
163399254|NCT00111800|590172588|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
163399255|NCT00111800|590172589|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
163399256|NCT00111800|590172590|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
163399257|NCT00111800|590172585|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
163399258|NCT00111800|590172586|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
163399259|NCT00111800|590172587|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
163399260|NCT00111800|590172588|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
163399261|NCT00111800|590172589|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
163399262|NCT00111800|590172590|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
163399263|NCT00111800|590172585|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
163399264|NCT00111800|590172586|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
163399265|NCT00111800|590172587|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
163399266|NCT00111800|590172588|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
163399267|NCT00111800|590172589|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
163399268|NCT00111800|590172590|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
163399269|NCT00111800|590172585|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
163399270|NCT00111800|590172586|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
163399271|NCT00111800|590172587|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
163399272|NCT00111800|590172588|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
163399273|NCT00111800|590172589|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
162967741|NCT01617096|588583007|FG000|Overall Study|Other|1|||
162967742|NCT01617096|588583008|FG001|Overall Study|Other|3|||
162967743|NCT01532908|588583011|FG000|Overall Study|Not Transplanted|1|||
162967744|NCT01532908|588583012|FG001|Overall Study|Not Transplanted|0|||
162967745|NCT01196390|588583013|FG000|Overall Study|Protocol Violation|4|||
162967746|NCT01196390|588583014|FG001|Overall Study|Protocol Violation|5|||
162967747|NCT00252564|588583015|FG000|Overall Study|Adverse Event|17|||
162967748|NCT00252564|588583016|FG001|Overall Study|Adverse Event|13|||
162967749|NCT00252564|588583015|FG000|Overall Study|Unrelated Complication|2|||
163208171|NCT00224055|589476104|FG000|Overall Study|Protocol Violation|1|||
163399274|NCT00111800|590172590|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
163399275|NCT00111800|590172585|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
163399276|NCT00111800|590172586|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
162967750|NCT00252564|588583016|FG001|Overall Study|Unrelated Complication|1|||
162967751|NCT00252564|588583015|FG000|Overall Study|Disease Progression|14|||
162967752|NCT00252564|588583016|FG001|Overall Study|Disease Progression|20|||
162967753|NCT00252564|588583015|FG000|Overall Study|Death|0|||
162967754|NCT00252564|588583016|FG001|Overall Study|Death|3|||
162967755|NCT00252564|588583015|FG000|Overall Study|Physician Decision|1|||
162967756|NCT00252564|588583016|FG001|Overall Study|Physician Decision|0|||
162967757|NCT00252564|588583015|FG000|Overall Study|Lost to Follow-up|1|||
162967758|NCT00252564|588583016|FG001|Overall Study|Lost to Follow-up|0|||
162967759|NCT00252564|588583015|FG000|Overall Study|Patient Request|4|||
162967760|NCT00252564|588583016|FG001|Overall Study|Patient Request|5|||
162967761|NCT00252564|588583015|FG000|Overall Study|Withdrawal by Subject|0|||
162967762|NCT00252564|588583016|FG001|Overall Study|Withdrawal by Subject|2|||
162967763|NCT03480022|588583017|FG000|Overall Study|Pregnancy|2|||
162967764|NCT03480022|588583018|FG001|Overall Study|Pregnancy|0|||
162967765|NCT03480022|588583017|FG000|Overall Study|Adverse Event|6|||
162967766|NCT03480022|588583018|FG001|Overall Study|Adverse Event|0|||
162967767|NCT03480022|588583017|FG000|Overall Study|Lack of Efficacy|0|||
162967768|NCT03480022|588583018|FG001|Overall Study|Lack of Efficacy|2|||
162967769|NCT03480022|588583017|FG000|Overall Study|Physician Decision|0|||
162967770|NCT03480022|588583018|FG001|Overall Study|Physician Decision|1|||
162967771|NCT03480022|588583017|FG000|Overall Study|Withdrawal by Subject|2|||
162967772|NCT03480022|588583018|FG001|Overall Study|Withdrawal by Subject|0|||
162967773|NCT03480022|588583017|FG000|Overall Study|Medication concerns|1|||
163316254|NCT03024437|589869557|FG002|Overall Study|Adverse Event|3|||
163316255|NCT03024437|589869558|FG003|Overall Study|Adverse Event|5|||
162967774|NCT03480022|588583018|FG001|Overall Study|Medication concerns|0|||
162967775|NCT03480022|588583017|FG000|Overall Study|Family member COVID exposure|0|||
162967776|NCT03480022|588583018|FG001|Overall Study|Family member COVID exposure|1|||
162967777|NCT00881569|588583019|FG000|Overall Study|Disease progression|1|||
162967778|NCT00881569|588583020|FG001|Overall Study|Disease progression|1|||
162967779|NCT02623218|588583025|FG000|Overall Study|Lost to Follow-up|0|||
162967780|NCT02623218|588583026|FG001|Overall Study|Lost to Follow-up|1|||
162967781|NCT02623218|588583027|FG002|Overall Study|Lost to Follow-up|0|||
162967782|NCT02623218|588583028|FG003|Overall Study|Lost to Follow-up|0|||
163208172|NCT00224055|589476105|FG001|Overall Study|Protocol Violation|1|||
163208173|NCT00224055|589476104|FG000|Overall Study|Inclusion Violation|3|||
163208174|NCT00224055|589476105|FG001|Overall Study|Inclusion Violation|6|||
163208175|NCT00224055|589476104|FG000|Overall Study|Withdrawal by Subject|0|||
163208176|NCT00224055|589476105|FG001|Overall Study|Withdrawal by Subject|2|||
163208177|NCT00224055|589476104|FG000|Overall Study|Other|1|||
163208178|NCT00224055|589476105|FG001|Overall Study|Other|0|||
163208179|NCT00127712|589476106|FG000|Overall Study|Adverse Event|3|||
163208180|NCT00127712|589476107|FG001|Overall Study|Adverse Event|0|||
163208181|NCT00127712|589476106|FG000|Overall Study|Lack of GI access to continue|2|||
163208182|NCT00127712|589476107|FG001|Overall Study|Lack of GI access to continue|0|||
163208183|NCT03055260|589476108|FG000|Overall Study|Withdrawal by Subject|1|||
163208184|NCT03055260|589476109|FG001|Overall Study|Withdrawal by Subject|0|||
163208185|NCT00592839|589476110|FG000|Overall Study|Withdrawal by Subject|1|||
163208186|NCT00592839|589476111|FG001|Overall Study|Withdrawal by Subject|1|||
163208187|NCT00592839|589476112|FG002|Overall Study|Withdrawal by Subject|3|||
163208188|NCT00592839|589476110|FG000|Overall Study|Protocol Violation|1|||
163208189|NCT00592839|589476111|FG001|Overall Study|Protocol Violation|1|||
163208190|NCT00592839|589476112|FG002|Overall Study|Protocol Violation|2|||
163208191|NCT00592839|589476110|FG000|Overall Study|Adverse Event|0|||
163208192|NCT00592839|589476111|FG001|Overall Study|Adverse Event|1|||
163208193|NCT00592839|589476112|FG002|Overall Study|Adverse Event|0|||
163208194|NCT00592839|589476110|FG000|Overall Study|Lost to Follow-up|0|||
163208195|NCT00592839|589476111|FG001|Overall Study|Lost to Follow-up|1|||
163208196|NCT00592839|589476112|FG002|Overall Study|Lost to Follow-up|1|||
163208197|NCT00799487|589476114|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
163208198|NCT00799487|589476115|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
163208199|NCT00799487|589476116|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
163208200|NCT00799487|589476114|FG000|Dose Adjustment Period|Adverse Event|2|||
163208201|NCT00799487|589476115|FG001|Dose Adjustment Period|Adverse Event|0|||
163208202|NCT00799487|589476116|FG002|Dose Adjustment Period|Adverse Event|0|||
163208203|NCT00799487|589476114|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
163208204|NCT00799487|589476115|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
163208205|NCT00799487|589476116|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
163208206|NCT00799487|589476114|FG000|Dose Adjustment Period|Investigator Discretion|2|||
163208207|NCT00799487|589476115|FG001|Dose Adjustment Period|Investigator Discretion|0|||
163208208|NCT00799487|589476116|FG002|Dose Adjustment Period|Investigator Discretion|0|||
163208209|NCT00799487|589476114|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
163208210|NCT00799487|589476115|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
163208211|NCT00799487|589476116|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
163208212|NCT00799487|589476114|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
163208213|NCT00799487|589476115|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
163208214|NCT00799487|589476116|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
163208215|NCT00799487|589476114|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
163316256|NCT03024437|589869559|FG004|Overall Study|Adverse Event|0|||
163316257|NCT03024437|589869555|FG000|Overall Study|Physician Decision|1|||
163316258|NCT03024437|589869556|FG001|Overall Study|Physician Decision|0|||
162967783|NCT02623218|588583029|FG004|Overall Study|Lost to Follow-up|0|||
162967784|NCT00537095|588583033|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
162967785|NCT00537095|588583034|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
162967786|NCT00537095|588583033|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
162967787|NCT00537095|588583034|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
162967788|NCT00537095|588583033|FG000|Randomized Treatment Period (433 Days)|Death|3|||
162967789|NCT00537095|588583034|FG001|Randomized Treatment Period (433 Days)|Death|1|||
162967790|NCT00537095|588583033|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
162967791|NCT00537095|588583034|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
162967792|NCT00537095|588583033|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
162967793|NCT00537095|588583034|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
162967794|NCT00537095|588583033|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
162967795|NCT00537095|588583034|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
162967796|NCT00537095|588583033|FG000|Open-label Period (590 Days)|Adverse Event|2|||
162967797|NCT00537095|588583034|FG001|Open-label Period (590 Days)|Adverse Event|11|||
162967798|NCT00537095|588583033|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
162967799|NCT00537095|588583034|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
162967800|NCT00537095|588583033|FG000|Open-label Period (590 Days)|Death|2|||
162967801|NCT00537095|588583034|FG001|Open-label Period (590 Days)|Death|2|||
162967802|NCT00537095|588583033|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
162967803|NCT00537095|588583034|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
162967804|NCT00537095|588583033|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
162967805|NCT00537095|588583034|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
162967806|NCT01970592|588583035|FG000|Overall Study|Withdrawal by Subject|4|||
162967807|NCT01970592|588583035|FG000|Overall Study|Physician Decision|1|||
162967808|NCT01970592|588583035|FG000|Overall Study|Adverse Event|1|||
163208216|NCT00799487|589476115|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
163316259|NCT03024437|589869557|FG002|Overall Study|Physician Decision|0|||
163399277|NCT00111800|590172587|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
163399278|NCT00111800|590172588|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
163399279|NCT00111800|590172589|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
163399280|NCT00111800|590172590|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
163399281|NCT00111800|590172585|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
163399282|NCT00111800|590172586|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
163399283|NCT00111800|590172587|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
163399284|NCT00111800|590172588|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
163399285|NCT00111800|590172589|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
163399286|NCT00111800|590172590|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
163399287|NCT00094770|590172591|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
163399288|NCT00094770|590172592|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
163399289|NCT00094770|590172591|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
163399290|NCT00094770|590172592|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
163399291|NCT00094770|590172591|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
163399292|NCT00094770|590172592|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
163399293|NCT00094770|590172591|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
163399294|NCT00094770|590172592|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
163399295|NCT00094770|590172591|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
163399296|NCT00094770|590172592|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
163399297|NCT00094770|590172591|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
163399298|NCT00094770|590172592|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
163399299|NCT00094770|590172591|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
163399300|NCT00094770|590172592|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
163399301|NCT00094770|590172591|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
163399302|NCT00094770|590172592|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
163399303|NCT00094770|590172591|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
163399304|NCT00094770|590172592|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
163399305|NCT00094770|590172591|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
163399306|NCT00094770|590172592|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
163399307|NCT00094770|590172591|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
163399308|NCT00094770|590172592|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
163399309|NCT00094770|590172591|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
163399310|NCT00094770|590172592|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
163399311|NCT00094770|590172591|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
163399312|NCT00094770|590172592|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
163399313|NCT00094770|590172591|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
163399314|NCT00094770|590172592|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
163399315|NCT00094770|590172591|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
163399316|NCT00094770|590172592|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
163399317|NCT00094770|590172591|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
163399318|NCT00094770|590172592|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
163399319|NCT00094770|590172591|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
163399320|NCT00094770|590172592|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
163399321|NCT00094770|590172591|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
163399322|NCT00094770|590172592|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
163399323|NCT02752035|590172593|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
163399324|NCT02752035|590172594|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
162967809|NCT03980522|588583038|FG000|Treatment Period|Adverse Event|1|||
162967810|NCT03980522|588583039|FG001|Treatment Period|Adverse Event|0|||
162967811|NCT03980522|588583040|FG002|Treatment Period|Adverse Event|0|||
162967812|NCT03980522|588583041|FG003|Treatment Period|Adverse Event|0|||
162967813|NCT03980522|588583042|FG004|Treatment Period|Adverse Event|0|||
162967814|NCT01320722|588583043|FG000|Overall Study|Did not Receive Intervention|3|||
162967815|NCT01320722|588583044|FG001|Overall Study|Did not Receive Intervention|2|||
162967816|NCT01320722|588583045|FG002|Overall Study|Did not Receive Intervention|1|||
162967817|NCT01320722|588583046|FG003|Overall Study|Did not Receive Intervention|1|||
162967818|NCT01320722|588583047|FG004|Overall Study|Did not Receive Intervention|2|||
162967819|NCT01320722|588583043|FG000|Overall Study|Lost to Follow-up|0|||
162967820|NCT01320722|588583044|FG001|Overall Study|Lost to Follow-up|1|||
162967821|NCT01320722|588583045|FG002|Overall Study|Lost to Follow-up|0|||
162967822|NCT01320722|588583046|FG003|Overall Study|Lost to Follow-up|1|||
162967823|NCT01320722|588583047|FG004|Overall Study|Lost to Follow-up|3|||
162967824|NCT01320722|588583043|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
162967825|NCT01320722|588583044|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
162967826|NCT01320722|588583045|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
162967827|NCT01320722|588583046|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
162967828|NCT01320722|588583047|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
162967829|NCT01320722|588583043|FG000|Overall Study|Participant Developed a Rash|0|||
162967830|NCT01320722|588583044|FG001|Overall Study|Participant Developed a Rash|0|||
162967831|NCT01320722|588583045|FG002|Overall Study|Participant Developed a Rash|2|||
162967832|NCT01320722|588583046|FG003|Overall Study|Participant Developed a Rash|1|||
162967833|NCT01320722|588583047|FG004|Overall Study|Participant Developed a Rash|1|||
162967834|NCT01320722|588583043|FG000|Overall Study|Non-compliant with Medication|0|||
162967835|NCT01320722|588583044|FG001|Overall Study|Non-compliant with Medication|0|||
162967836|NCT01320722|588583045|FG002|Overall Study|Non-compliant with Medication|1|||
162967837|NCT01320722|588583046|FG003|Overall Study|Non-compliant with Medication|0|||
162967838|NCT01320722|588583047|FG004|Overall Study|Non-compliant with Medication|0|||
162967839|NCT01320722|588583043|FG000|Overall Study|Adverse Event|0|||
162967840|NCT01320722|588583044|FG001|Overall Study|Adverse Event|0|||
162967841|NCT01320722|588583045|FG002|Overall Study|Adverse Event|3|||
162967842|NCT01320722|588583046|FG003|Overall Study|Adverse Event|6|||
162967843|NCT01320722|588583047|FG004|Overall Study|Adverse Event|0|||
162967844|NCT01320722|588583043|FG000|Overall Study|Not Compliant with Study Procedures|0|||
162967845|NCT01320722|588583044|FG001|Overall Study|Not Compliant with Study Procedures|0|||
162967846|NCT01320722|588583045|FG002|Overall Study|Not Compliant with Study Procedures|0|||
162967847|NCT01320722|588583046|FG003|Overall Study|Not Compliant with Study Procedures|4|||
162967848|NCT01320722|588583047|FG004|Overall Study|Not Compliant with Study Procedures|0|||
163208217|NCT00799487|589476116|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
163208218|NCT00799487|589476114|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
163208219|NCT00799487|589476115|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
163399325|NCT02752035|590172595|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
162967849|NCT01320722|588583043|FG000|Overall Study|Pregnancy|0|||
162967850|NCT01320722|588583044|FG001|Overall Study|Pregnancy|0|||
162967851|NCT01320722|588583045|FG002|Overall Study|Pregnancy|0|||
162967852|NCT01320722|588583046|FG003|Overall Study|Pregnancy|1|||
162967853|NCT01320722|588583047|FG004|Overall Study|Pregnancy|0|||
163208220|NCT00799487|589476116|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
163208221|NCT00799487|589476114|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
163208222|NCT00799487|589476115|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
163399326|NCT02752035|590172596|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
163054415|NCT00794664|588910295|FG000|Treatment Period|Withdrawal by Subject|0|||
163208223|NCT00799487|589476116|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
163208224|NCT00799487|589476114|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
163208225|NCT00799487|589476115|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
163208226|NCT00799487|589476116|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
163208227|NCT00799487|589476114|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
163208228|NCT00799487|589476115|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
163208229|NCT00799487|589476116|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
163208230|NCT00799487|589476114|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
163208231|NCT00799487|589476115|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
163208232|NCT00799487|589476116|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
163208233|NCT01463878|589476117|FG000|Overall Study|no longer met criteria for tube feed|2|||
163208234|NCT01463878|589476118|FG001|Overall Study|no longer met criteria for tube feed|2|||
163208235|NCT02051608|589476121|FG000|Part 1: Double Blind Treatment|Death|3|||
163208236|NCT02051608|589476122|FG001|Part 1: Double Blind Treatment|Death|3|||
163208237|NCT02051608|589476123|FG002|Part 1: Double Blind Treatment|Death|0|||
163208238|NCT02051608|589476124|FG003|Part 1: Double Blind Treatment|Death|0|||
163316260|NCT03024437|589869558|FG003|Overall Study|Physician Decision|1|||
163316261|NCT03024437|589869559|FG004|Overall Study|Physician Decision|0|||
162967854|NCT01320722|588583043|FG000|Overall Study|Started an Exclusionary Medication|0|||
162967855|NCT01320722|588583044|FG001|Overall Study|Started an Exclusionary Medication|0|||
162967856|NCT01320722|588583045|FG002|Overall Study|Started an Exclusionary Medication|0|||
162967857|NCT01320722|588583046|FG003|Overall Study|Started an Exclusionary Medication|0|||
162967858|NCT01320722|588583047|FG004|Overall Study|Started an Exclusionary Medication|1|||
162967859|NCT01320722|588583043|FG000|Overall Study|Withdrew due to Health Condition|0|||
162967860|NCT01320722|588583044|FG001|Overall Study|Withdrew due to Health Condition|0|||
162967861|NCT01320722|588583045|FG002|Overall Study|Withdrew due to Health Condition|0|||
162967862|NCT01320722|588583046|FG003|Overall Study|Withdrew due to Health Condition|0|||
162967863|NCT01320722|588583047|FG004|Overall Study|Withdrew due to Health Condition|1|||
162967864|NCT01091363|588583048|FG000|Overall Study|Withdrawal by Subject|11|||
162967865|NCT01091363|588583049|FG001|Overall Study|Withdrawal by Subject|15|||
162967866|NCT01091363|588583048|FG000|Overall Study|Lost to Follow-up|2|||
162967867|NCT01091363|588583049|FG001|Overall Study|Lost to Follow-up|2|||
162967868|NCT00160524|588583050|FG000|Overall Study|Adverse Event|119|||
162967869|NCT00160524|588583050|FG000|Overall Study|Adverse Event and Other|94|||
162967870|NCT00160524|588583050|FG000|Overall Study|Protocol Violation|16|||
162967871|NCT00160524|588583050|FG000|Overall Study|Protocol Violation and Other|2|||
162967872|NCT00160524|588583050|FG000|Overall Study|Withdrawal by Subject|141|||
162967873|NCT00160524|588583050|FG000|Overall Study|Withdrawal by Subject and Other|17|||
162967874|NCT00160524|588583050|FG000|Overall Study|Physician Decision|27|||
162967875|NCT00160524|588583050|FG000|Overall Study|Physician Decision and Other|6|||
162967876|NCT00160524|588583050|FG000|Overall Study|Lost to Follow-up|13|||
162967877|NCT00160524|588583050|FG000|Overall Study|Lost to Follow-up and Other|1|||
162967878|NCT00160524|588583050|FG000|Overall Study|Lack of Efficacy|21|||
162967879|NCT00160524|588583050|FG000|Overall Study|Lack of Efficacy and Other|1|||
162967880|NCT00160524|588583050|FG000|Overall Study|Other|20|||
162967881|NCT00021541|588583051|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
162967882|NCT00021541|588583052|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
162967883|NCT00021541|588583051|FG000|Period 1-First Treatment|Adverse Event|2|||
162967884|NCT00021541|588583052|FG001|Period 1-First Treatment|Adverse Event|1|||
162967885|NCT00021541|588583051|FG000|Period 1-First Treatment|non-adherence|3|||
162967886|NCT00021541|588583052|FG001|Period 1-First Treatment|non-adherence|0|||
162967887|NCT00021541|588583051|FG000|Period 1-First Treatment|Death|1|||
162967888|NCT00021541|588583052|FG001|Period 1-First Treatment|Death|0|||
162967889|NCT00021541|588583051|FG000|Period 1-First Treatment|Pts that did not progress|2|||
162967890|NCT00021541|588583052|FG001|Period 1-First Treatment|Pts that did not progress|2|||
162967891|NCT00021541|588583051|FG000|Period 1-First Treatment|Ineligible|0|||
162967892|NCT00021541|588583052|FG001|Period 1-First Treatment|Ineligible|2|||
162967893|NCT00021541|588583051|FG000|Period 2-crossover|refused phase B|2|||
162967894|NCT00021541|588583052|FG001|Period 2-crossover|refused phase B|2|||
162967895|NCT00021541|588583051|FG000|Period 2-crossover|Withdrawal by Subject|3|||
162967896|NCT00021541|588583052|FG001|Period 2-crossover|Withdrawal by Subject|4|||
162967897|NCT00021541|588583051|FG000|Period 2-crossover|Adverse Event|2|||
162967898|NCT00021541|588583052|FG001|Period 2-crossover|Adverse Event|2|||
162967899|NCT00021541|588583051|FG000|Period 2-crossover|non-adherence|1|||
162967900|NCT00021541|588583052|FG001|Period 2-crossover|non-adherence|0|||
162967901|NCT00021541|588583051|FG000|Period 2-crossover|Pts that did not progress|2|||
162967902|NCT00021541|588583052|FG001|Period 2-crossover|Pts that did not progress|3|||
162967903|NCT04892147|588583053|FG000|Overall Study|Withdrawal by Subject|2|||
162967904|NCT04892147|588583054|FG001|Overall Study|Withdrawal by Subject|0|||
162967905|NCT01215721|588583056|FG000|Overall Study|Adverse Event|2|||
162967906|NCT00045162|588583057|FG000|Overall Study|Ineligible|12|||
162967907|NCT00045162|588583058|FG001|Overall Study|Ineligible|8|||
163208239|NCT02051608|589476121|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
162967908|NCT00045162|588583057|FG000|Overall Study|Not treated|7|||
163054416|NCT00794664|588910296|FG001|Treatment Period|Withdrawal by Subject|2|||
163054417|NCT00794664|588910295|FG000|Treatment Period|Protocol non-compliance|0|||
163054418|NCT00794664|588910296|FG001|Treatment Period|Protocol non-compliance|1|||
163054419|NCT00794664|588910295|FG000|Treatment Period|Other|0|||
163054420|NCT00794664|588910296|FG001|Treatment Period|Other|1|||
163054421|NCT00794664|588910295|FG000|Treatment Period|Adverse Event|1|||
162967909|NCT00045162|588583058|FG001|Overall Study|Not treated|2|||
162967910|NCT00045162|588583057|FG000|Overall Study|Adverse Event|55|||
162967911|NCT00045162|588583058|FG001|Overall Study|Adverse Event|50|||
162967912|NCT00045162|588583057|FG000|Overall Study|Lack of Efficacy|32|||
162967913|NCT00045162|588583058|FG001|Overall Study|Lack of Efficacy|29|||
162967914|NCT00045162|588583057|FG000|Overall Study|Death|10|||
162967915|NCT00045162|588583058|FG001|Overall Study|Death|10|||
162967916|NCT00045162|588583057|FG000|Overall Study|Withdrawal by Subject|5|||
162967917|NCT00045162|588583058|FG001|Overall Study|Withdrawal by Subject|3|||
163054422|NCT00794664|588910296|FG001|Treatment Period|Adverse Event|8|||
163054423|NCT00794664|588910295|FG000|Follow-up Period|Other|1|||
163054424|NCT00794664|588910296|FG001|Follow-up Period|Other|2|||
162967918|NCT00045162|588583057|FG000|Overall Study|Other|21|||
162967919|NCT00045162|588583058|FG001|Overall Study|Other|16|||
162967920|NCT01044433|588583059|FG000|Overall Study|Lost to Follow-up|3|||
162967921|NCT01044433|588583059|FG000|Overall Study|Withdrawal by Subject|3|||
162967922|NCT05263505|588583060|FG000|Overall Study|Adverse Event|0|||
162967923|NCT05263505|588583061|FG001|Overall Study|Adverse Event|1|||
162967924|NCT00826241|588583062|FG000|Overall Study|Withdrawal from Follow-up|1|||
162967925|NCT00826241|588583062|FG000|Overall Study|Withdrew consent|2|||
162967926|NCT00826241|588583062|FG000|Overall Study|Death|4|||
162967927|NCT00826241|588583062|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
162967928|NCT00826241|588583062|FG000|Overall Study|Non-compliance|1|||
162967929|NCT00826241|588583062|FG000|Overall Study|Progression of disease|1|||
162967930|NCT00826241|588583062|FG000|Overall Study|Patient refused follow-up|3|||
162967931|NCT00826241|588583062|FG000|Overall Study|Lost to Follow-up|9|||
162967932|NCT00826241|588583062|FG000|Overall Study|Could not obtain records|1|||
162967933|NCT00826241|588583062|FG000|Overall Study|Screen failure|2|||
162967934|NCT00826241|588583062|FG000|Overall Study|Pt unable to proceed to registration|1|||
162967935|NCT00826241|588583062|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
162967936|NCT01050764|588583063|FG000|Overall Study|Death, before HSCT|1|||
162967937|NCT01050764|588583063|FG000|Overall Study|Donor mobilization failure, death|1|||
162967938|NCT01050764|588583063|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
162967939|NCT00556673|588583069|FG000|Overall Study|Protocol deviation|3|||
162967940|NCT00556673|588583070|FG001|Overall Study|Protocol deviation|2|||
162967941|NCT01971554|588583071|FG000|Overall Study|Lost to Follow-up|1|||
162967942|NCT01971554|588583072|FG001|Overall Study|Lost to Follow-up|0|||
162967943|NCT01971554|588583073|FG002|Overall Study|Lost to Follow-up|0|||
162967944|NCT01971554|588583074|FG003|Overall Study|Lost to Follow-up|0|||
162967945|NCT04194151|588583076|FG000|Overall Study|Physician Decision|1|||
162967946|NCT04194151|588583077|FG001|Overall Study|Physician Decision|1|||
162967947|NCT04194151|588583078|FG002|Overall Study|Physician Decision|1|||
162967948|NCT04194151|588583079|FG003|Overall Study|Physician Decision|1|||
162967949|NCT04194151|588583080|FG004|Overall Study|Physician Decision|0|||
162967950|NCT04194151|588583081|FG005|Overall Study|Physician Decision|1|||
162967951|NCT04194151|588583076|FG000|Overall Study|Monitorization problem|0|||
162967952|NCT04194151|588583077|FG001|Overall Study|Monitorization problem|1|||
162967953|NCT04194151|588583078|FG002|Overall Study|Monitorization problem|0|||
162967954|NCT04194151|588583079|FG003|Overall Study|Monitorization problem|0|||
162967955|NCT04194151|588583080|FG004|Overall Study|Monitorization problem|0|||
162967956|NCT04194151|588583081|FG005|Overall Study|Monitorization problem|0|||
162967957|NCT00087529|588583083|FG000|Overall Study|Death|1|||
162967958|NCT00087529|588583084|FG001|Overall Study|Death|0|||
162967959|NCT00087529|588583083|FG000|Overall Study|Adverse Event|0|||
162967960|NCT00087529|588583084|FG001|Overall Study|Adverse Event|8|||
162967961|NCT00087529|588583083|FG000|Overall Study|Pregnancy|0|||
162967962|NCT00087529|588583084|FG001|Overall Study|Pregnancy|1|||
162967963|NCT00087529|588583083|FG000|Overall Study|Lost to Follow-up|2|||
162967964|NCT00087529|588583084|FG001|Overall Study|Lost to Follow-up|3|||
162967965|NCT00087529|588583083|FG000|Overall Study|Participant Decision|14|||
162967966|NCT00087529|588583084|FG001|Overall Study|Participant Decision|37|||
162967967|NCT00087529|588583083|FG000|Overall Study|Physician Decision|4|||
162967968|NCT00087529|588583084|FG001|Overall Study|Physician Decision|8|||
162967969|NCT00087529|588583083|FG000|Overall Study|Initiation of Excluded Therapy|0|||
162967970|NCT00087529|588583084|FG001|Overall Study|Initiation of Excluded Therapy|1|||
162967971|NCT00087529|588583083|FG000|Overall Study|Participant Noncompliance|0|||
162967972|NCT00087529|588583084|FG001|Overall Study|Participant Noncompliance|1|||
162967973|NCT00087529|588583083|FG000|Overall Study|Disease Progression|5|||
162967974|NCT00087529|588583084|FG001|Overall Study|Disease Progression|4|||
162967975|NCT00087529|588583083|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
162967976|NCT00087529|588583084|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
162967977|NCT02535923|588583085|FG000|Overall Study|Lost to Follow-up|5|||
162967978|NCT02535923|588583086|FG001|Overall Study|Lost to Follow-up|5|||
162967979|NCT02535923|588583085|FG000|Overall Study|Withdrawal by Subject|4|||
162967980|NCT02535923|588583086|FG001|Overall Study|Withdrawal by Subject|3|||
163316262|NCT03024437|589869555|FG000|Overall Study|Disease progression, relapse|1|||
163316263|NCT03024437|589869556|FG001|Overall Study|Disease progression, relapse|0|||
163316264|NCT03024437|589869557|FG002|Overall Study|Disease progression, relapse|0|||
163316265|NCT03024437|589869558|FG003|Overall Study|Disease progression, relapse|3|||
163316266|NCT03024437|589869559|FG004|Overall Study|Disease progression, relapse|0|||
163316267|NCT03024437|589869555|FG000|Overall Study|Disease progression, refractory disease|4|||
163316268|NCT03024437|589869556|FG001|Overall Study|Disease progression, refractory disease|4|||
163316269|NCT03024437|589869557|FG002|Overall Study|Disease progression, refractory disease|2|||
163316270|NCT03024437|589869558|FG003|Overall Study|Disease progression, refractory disease|2|||
163316271|NCT03024437|589869559|FG004|Overall Study|Disease progression, refractory disease|1|||
163316272|NCT03024437|589869555|FG000|Overall Study|Newly diagnosed cancer|0|||
163316273|NCT03024437|589869556|FG001|Overall Study|Newly diagnosed cancer|0|||
163316274|NCT03024437|589869557|FG002|Overall Study|Newly diagnosed cancer|0|||
163316275|NCT03024437|589869558|FG003|Overall Study|Newly diagnosed cancer|1|||
163316276|NCT03024437|589869559|FG004|Overall Study|Newly diagnosed cancer|0|||
163316277|NCT03024437|589869555|FG000|Overall Study|Moved out of state|0|||
163316278|NCT03024437|589869556|FG001|Overall Study|Moved out of state|1|||
163316279|NCT03024437|589869557|FG002|Overall Study|Moved out of state|0|||
163316280|NCT03024437|589869558|FG003|Overall Study|Moved out of state|0|||
163316281|NCT03024437|589869559|FG004|Overall Study|Moved out of state|0|||
163316282|NCT03024437|589869555|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
163316283|NCT03024437|589869556|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
163316284|NCT03024437|589869557|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
163316285|NCT03024437|589869558|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
163316286|NCT03024437|589869559|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
163316287|NCT03240016|589869562|FG000|Overall Study|Adverse Event|9|||
163316288|NCT03240016|589869562|FG000|Overall Study|Withdrawal by Subject|7|||
163316289|NCT03240016|589869562|FG000|Overall Study|Death|1|||
163316290|NCT03240016|589869562|FG000|Overall Study|Physician Decision|2|||
163316291|NCT05200403|589869563|FG000|Overall Study|Withdrawal by Subject|4|||
163316292|NCT05200403|589869564|FG001|Overall Study|Withdrawal by Subject|2|||
163316293|NCT05200403|589869565|FG002|Overall Study|Withdrawal by Subject|6|||
163316294|NCT05546411|589869566|FG000|Overall Study|Progressive Disease|1|||
163316295|NCT05546411|589869567|FG001|Overall Study|Progressive Disease|0|||
163316296|NCT05546411|589869566|FG000|Overall Study|Adverse Event|0|||
163316297|NCT05546411|589869567|FG001|Overall Study|Adverse Event|1|||
163316298|NCT05546411|589869566|FG000|Overall Study|Metastatic disease|1|||
163316299|NCT05546411|589869567|FG001|Overall Study|Metastatic disease|0|||
163316300|NCT02606422|589869568|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
163316301|NCT02606422|589869569|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
163316302|NCT02606422|589869568|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
163316303|NCT02606422|589869569|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
163316304|NCT02606422|589869568|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
163316305|NCT02606422|589869569|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
163316306|NCT02606422|589869568|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
163316307|NCT02606422|589869569|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
163316308|NCT04625465|589869570|FG000|Overall Study|Lost to Follow-up|2|||
163316309|NCT04625465|589869571|FG001|Overall Study|Lost to Follow-up|2|||
163316310|NCT04625465|589869572|FG002|Overall Study|Lost to Follow-up|1|||
163316311|NCT04625465|589869573|FG003|Overall Study|Lost to Follow-up|0|||
163316312|NCT04625465|589869574|FG004|Overall Study|Lost to Follow-up|0|||
163316313|NCT04625465|589869575|FG005|Overall Study|Lost to Follow-up|2|||
163316314|NCT04625465|589869576|FG006|Overall Study|Lost to Follow-up|0|||
163316315|NCT04625465|589869577|FG007|Overall Study|Lost to Follow-up|0|||
163316316|NCT04625465|589869570|FG000|Overall Study|Death|1|||
163316317|NCT04625465|589869571|FG001|Overall Study|Death|0|||
163316318|NCT04625465|589869572|FG002|Overall Study|Death|0|||
163316319|NCT04625465|589869573|FG003|Overall Study|Death|0|||
163316320|NCT04625465|589869574|FG004|Overall Study|Death|0|||
163316321|NCT04625465|589869575|FG005|Overall Study|Death|0|||
163316322|NCT04625465|589869576|FG006|Overall Study|Death|0|||
162967981|NCT04388787|588583087|FG000|Blinded Period|Patient could not follow instructions|1|||
162967982|NCT04388787|588583087|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
162967983|NCT02129062|588584739|FG000|Overall Study|Death|1|||
162967984|NCT02129062|588584739|FG000|Overall Study|Disease Progression|2|||
162967985|NCT04662710|588584740|FG000|Overall Study|Death|14|||
162967986|NCT04662710|588584741|FG001|Overall Study|Death|331|||
162967987|NCT04662710|588584742|FG002|Overall Study|Death|367|||
163316323|NCT04625465|589869577|FG007|Overall Study|Death|0|||
163316324|NCT04625465|589869570|FG000|Overall Study|Withdrawal by Subject|1|||
163316325|NCT04625465|589869571|FG001|Overall Study|Withdrawal by Subject|0|||
163399327|NCT02752035|590172593|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
163399328|NCT02752035|590172594|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
163399329|NCT02752035|590172595|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
162967988|NCT04662710|588584740|FG000|Overall Study|Ongoing|1|||
162967989|NCT04662710|588584741|FG001|Overall Study|Ongoing|109|||
163316326|NCT04625465|589869572|FG002|Overall Study|Withdrawal by Subject|4|||
163316327|NCT04625465|589869573|FG003|Overall Study|Withdrawal by Subject|4|||
163316328|NCT04625465|589869574|FG004|Overall Study|Withdrawal by Subject|4|||
163316329|NCT04625465|589869575|FG005|Overall Study|Withdrawal by Subject|0|||
163316330|NCT04625465|589869576|FG006|Overall Study|Withdrawal by Subject|0|||
163316331|NCT04625465|589869577|FG007|Overall Study|Withdrawal by Subject|0|||
163316332|NCT05566639|589869581|FG000|Overall Study|Adverse Event|1|||
163316333|NCT05566639|589869582|FG001|Overall Study|Adverse Event|1|||
163316334|NCT05566639|589869581|FG000|Overall Study|Serious Adverse Event|1|||
163316335|NCT05566639|589869582|FG001|Overall Study|Serious Adverse Event|3|||
163316336|NCT05566639|589869581|FG000|Overall Study|Death|44|||
163316337|NCT05566639|589869582|FG001|Overall Study|Death|45|||
163316338|NCT05566639|589869581|FG000|Overall Study|Lost to Follow-up|467|||
163316339|NCT05566639|589869582|FG001|Overall Study|Lost to Follow-up|461|||
163316340|NCT05566639|589869581|FG000|Overall Study|Physician Decision|45|||
163316341|NCT05566639|589869582|FG001|Overall Study|Physician Decision|44|||
163316342|NCT05566639|589869581|FG000|Overall Study|Protocol Deviation|4|||
163316343|NCT05566639|589869582|FG001|Overall Study|Protocol Deviation|4|||
163316344|NCT05566639|589869581|FG000|Overall Study|Withdrawal by Subject|277|||
163316345|NCT05566639|589869582|FG001|Overall Study|Withdrawal by Subject|271|||
163316346|NCT05566639|589869581|FG000|Overall Study|Other Than Specified|52|||
163316347|NCT05566639|589869582|FG001|Overall Study|Other Than Specified|64|||
163316348|NCT04054193|589869590|FG000|Cycle 1|Physician Decision|1|||
163316349|NCT04054193|589869590|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
163316350|NCT04054193|589869590|FG000|Cycle 1|Allocated but not treated|3|||
163316351|NCT04054193|589869590|FG000|Cycles 2-3|Physician Decision|2|||
163316352|NCT04054193|589869590|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
163316353|NCT04054193|589869590|FG000|Cycles 2-3|Various reasons|17|||
163316354|NCT05436262|589869593|FG000|Pre-Randomization|Withdrawal by Subject|1|||
163316355|NCT05436262|589869594|FG001|Pre-Randomization|Withdrawal by Subject|0|||
163316356|NCT05436262|589869595|FG002|Pre-Randomization|Withdrawal by Subject|0|||
163316357|NCT05436262|589869593|FG000|Randomization|Withdrawal by Subject|0|||
163316358|NCT05436262|589869594|FG001|Randomization|Withdrawal by Subject|1|||
163316359|NCT05436262|589869595|FG002|Randomization|Withdrawal by Subject|0|||
163316360|NCT05299073|589869596|FG000|Overall Study|Withdrawal by Subject|0|||
163316361|NCT05299073|589869597|FG001|Overall Study|Withdrawal by Subject|0|||
163316362|NCT05299073|589869598|FG002|Overall Study|Withdrawal by Subject|1|||
163316363|NCT05299073|589869596|FG000|Overall Study|Adverse Event|0|||
163316364|NCT05299073|589869597|FG001|Overall Study|Adverse Event|1|||
163316365|NCT05299073|589869598|FG002|Overall Study|Adverse Event|0|||
163316366|NCT05299073|589869596|FG000|Overall Study|Lost to Follow-up|0|||
163316367|NCT05299073|589869597|FG001|Overall Study|Lost to Follow-up|1|||
163316368|NCT05299073|589869598|FG002|Overall Study|Lost to Follow-up|0|||
163316369|NCT03952338|589869599|FG000|Overall Study|Lost to Follow-up|11|||
163316370|NCT03952338|589869600|FG001|Overall Study|Lost to Follow-up|17|||
163316371|NCT03952338|589869599|FG000|Overall Study|Withdrawal by Subject|1|||
163316372|NCT03952338|589869600|FG001|Overall Study|Withdrawal by Subject|1|||
163316373|NCT03952338|589869599|FG000|Overall Study|Protocol Violation|1|||
163316374|NCT03952338|589869600|FG001|Overall Study|Protocol Violation|0|||
163316375|NCT01456949|589869601|FG000|Enrollment|PI death- incomplete data|6|||
163316376|NCT01456949|589869601|FG000|Enrollment|Death|1|||
162967990|NCT04662710|588584742|FG002|Overall Study|Ongoing|56|||
162967991|NCT04662710|588584740|FG000|Overall Study|Withdrawal by Subject|0|||
162967992|NCT04662710|588584741|FG001|Overall Study|Withdrawal by Subject|3|||
162967993|NCT04662710|588584742|FG002|Overall Study|Withdrawal by Subject|14|||
162967994|NCT02722616|588584744|FG000|Overall Study|Sponsor closed study after one month|2|||
162967995|NCT02722616|588584745|FG001|Overall Study|Sponsor closed study after one month|0|||
162967996|NCT02722616|588584746|FG002|Overall Study|Sponsor closed study after one month|0|||
162967997|NCT00224484|588584747|FG000|Overall Study|Serious Adverse Event|1|||
162967998|NCT00224484|588584748|FG001|Overall Study|Serious Adverse Event|1|||
162967999|NCT00224484|588584749|FG002|Overall Study|Serious Adverse Event|0|||
162968000|NCT00224484|588584747|FG000|Overall Study|Non-Serious Adverse Event|5|||
162968001|NCT00224484|588584748|FG001|Overall Study|Non-Serious Adverse Event|7|||
162968002|NCT00224484|588584749|FG002|Overall Study|Non-Serious Adverse Event|3|||
162968003|NCT00224484|588584747|FG000|Overall Study|Protocol Violation|2|||
162968004|NCT00224484|588584748|FG001|Overall Study|Protocol Violation|2|||
162968005|NCT00224484|588584749|FG002|Overall Study|Protocol Violation|0|||
162968006|NCT00224484|588584747|FG000|Overall Study|Withdrawal by Subject|49|||
162968007|NCT00224484|588584748|FG001|Overall Study|Withdrawal by Subject|18|||
162968008|NCT00224484|588584749|FG002|Overall Study|Withdrawal by Subject|16|||
162968009|NCT00224484|588584747|FG000|Overall Study|Migrated/moved from study area|18|||
162968010|NCT00224484|588584748|FG001|Overall Study|Migrated/moved from study area|5|||
162968011|NCT00224484|588584749|FG002|Overall Study|Migrated/moved from study area|5|||
162968012|NCT00224484|588584747|FG000|Overall Study|Lost to Follow-up|66|||
162968013|NCT00224484|588584748|FG001|Overall Study|Lost to Follow-up|28|||
162968014|NCT00224484|588584749|FG002|Overall Study|Lost to Follow-up|36|||
162968015|NCT00224484|588584747|FG000|Overall Study|Reason not specified|5|||
162968016|NCT00224484|588584748|FG001|Overall Study|Reason not specified|4|||
162968017|NCT00224484|588584749|FG002|Overall Study|Reason not specified|2|||
162968018|NCT00108628|588584752|FG000|Overall Study|Withdrawal by Subject|17|||
162968019|NCT00108628|588584753|FG001|Overall Study|Withdrawal by Subject|9|||
162968020|NCT00108628|588584752|FG000|Overall Study|Lack of Efficacy|2|||
162968021|NCT00108628|588584753|FG001|Overall Study|Lack of Efficacy|1|||
162968022|NCT00108628|588584752|FG000|Overall Study|Death|1|||
162968023|NCT00108628|588584753|FG001|Overall Study|Death|0|||
162968024|NCT01453153|588584754|FG000|Overall Study|Physician Decision|0|||
162968025|NCT01453153|588584755|FG001|Overall Study|Physician Decision|0|||
162968026|NCT01453153|588584756|FG002|Overall Study|Physician Decision|1|||
162968027|NCT01453153|588584754|FG000|Overall Study|Progressive Disease|3|||
162968028|NCT01453153|588584755|FG001|Overall Study|Progressive Disease|2|||
162968029|NCT01453153|588584756|FG002|Overall Study|Progressive Disease|16|||
162968030|NCT01453153|588584754|FG000|Overall Study|Withdrawal by Subject|0|||
162968031|NCT01453153|588584755|FG001|Overall Study|Withdrawal by Subject|1|||
162968032|NCT01453153|588584756|FG002|Overall Study|Withdrawal by Subject|2|||
162968033|NCT01453153|588584754|FG000|Overall Study|Adverse Event|1|||
162968034|NCT01453153|588584755|FG001|Overall Study|Adverse Event|1|||
162968035|NCT01453153|588584756|FG002|Overall Study|Adverse Event|1|||
162968036|NCT03547635|588584759|FG000|Overall Study|Adverse Event|5|||
163316377|NCT01456949|589869601|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
162968037|NCT03547635|588584760|FG001|Overall Study|Adverse Event|2|||
162968038|NCT03547635|588584761|FG002|Overall Study|Adverse Event|3|||
162968039|NCT03547635|588584759|FG000|Overall Study|Lost to Follow-up|1|||
162968040|NCT03547635|588584760|FG001|Overall Study|Lost to Follow-up|3|||
162968041|NCT03547635|588584761|FG002|Overall Study|Lost to Follow-up|4|||
163316378|NCT01456949|589869601|FG000|Enrollment|Physician Decision|10|||
162968042|NCT03547635|588584759|FG000|Overall Study|Withdrawal by Subject|1|||
163316379|NCT01456949|589869601|FG000|Enrollment|Withdrawal by Subject|7|||
163316380|NCT01456949|589869601|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
163316381|NCT01456949|589869601|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
163316382|NCT01456949|589869601|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
163316383|NCT01456949|589869601|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
163316384|NCT01456949|589869601|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
163316385|NCT01456949|589869601|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
163316386|NCT01456949|589869601|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
163316387|NCT01456949|589869601|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
163316388|NCT05934942|589869606|FG000|Run-in Period|Not treated|1|||
163316389|NCT05934942|589869606|FG000|Run-in Period|Withdrawal by Subject|1|||
163316390|NCT03924635|589869607|FG000|Overall Study|Withdrawal by Subject|2|||
163316391|NCT03924635|589869608|FG001|Overall Study|Withdrawal by Subject|4|||
163316392|NCT05469464|589869609|FG000|Overall Study|Withdrawal by Subject|8|||
163316393|NCT05469464|589869610|FG001|Overall Study|Withdrawal by Subject|7|||
163316394|NCT05469464|589869611|FG002|Overall Study|Withdrawal by Subject|4|||
163316395|NCT05469464|589869612|FG003|Overall Study|Withdrawal by Subject|5|||
163316396|NCT05469464|589869609|FG000|Overall Study|Adverse Event|8|||
163316397|NCT05469464|589869610|FG001|Overall Study|Adverse Event|14|||
163316398|NCT05469464|589869611|FG002|Overall Study|Adverse Event|13|||
163316399|NCT05469464|589869612|FG003|Overall Study|Adverse Event|2|||
163316400|NCT05469464|589869609|FG000|Overall Study|Lost to Follow-up|2|||
163316401|NCT05469464|589869610|FG001|Overall Study|Lost to Follow-up|5|||
163316402|NCT05469464|589869611|FG002|Overall Study|Lost to Follow-up|3|||
163316403|NCT05469464|589869612|FG003|Overall Study|Lost to Follow-up|3|||
163316404|NCT05469464|589869609|FG000|Overall Study|Lack of Efficacy|4|||
163316405|NCT05469464|589869610|FG001|Overall Study|Lack of Efficacy|1|||
163316406|NCT05469464|589869611|FG002|Overall Study|Lack of Efficacy|2|||
163316407|NCT05469464|589869612|FG003|Overall Study|Lack of Efficacy|2|||
163316408|NCT05469464|589869609|FG000|Overall Study|Physician Decision|0|||
163316409|NCT05469464|589869610|FG001|Overall Study|Physician Decision|0|||
163316410|NCT05469464|589869611|FG002|Overall Study|Physician Decision|0|||
163316411|NCT05469464|589869612|FG003|Overall Study|Physician Decision|1|||
163316412|NCT04585815|589869615|FG000|Sub-study A- Treatment Phase|Adverse Event|1|||
163316413|NCT04585815|589869616|FG001|Sub-study A- Treatment Phase|Adverse Event|4|||
163316414|NCT04585815|589869617|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
163316415|NCT04585815|589869618|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
163316416|NCT04585815|589869619|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
163316417|NCT04585815|589869620|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
163316418|NCT04585815|589869621|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
163316419|NCT04585815|589869615|FG000|Sub-study A- Treatment Phase|Death|0|||
163316420|NCT04585815|589869616|FG001|Sub-study A- Treatment Phase|Death|2|||
163316421|NCT04585815|589869617|FG002|Sub-study A- Treatment Phase|Death|0|||
163316422|NCT04585815|589869618|FG003|Sub-study A- Treatment Phase|Death|0|||
163316423|NCT04585815|589869619|FG004|Sub-study A- Treatment Phase|Death|0|||
163316424|NCT04585815|589869620|FG005|Sub-study A- Treatment Phase|Death|0|||
163316425|NCT04585815|589869621|FG006|Sub-study A- Treatment Phase|Death|0|||
163316426|NCT04585815|589869615|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
163316427|NCT04585815|589869616|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
163316428|NCT04585815|589869617|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
163316429|NCT04585815|589869618|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
163316430|NCT04585815|589869619|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
163316431|NCT04585815|589869620|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
163316432|NCT04585815|589869621|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
163316433|NCT04585815|589869615|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
163316434|NCT04585815|589869616|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
163316435|NCT04585815|589869617|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
163316436|NCT04585815|589869618|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
163316437|NCT04585815|589869619|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
163316438|NCT04585815|589869620|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
163316439|NCT04585815|589869621|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
162968043|NCT03547635|588584760|FG001|Overall Study|Withdrawal by Subject|0|||
162968044|NCT03547635|588584761|FG002|Overall Study|Withdrawal by Subject|0|||
162968045|NCT03547635|588584759|FG000|Overall Study|Withdrawal By PI|0|||
162968046|NCT03547635|588584760|FG001|Overall Study|Withdrawal By PI|1|||
162968047|NCT03547635|588584761|FG002|Overall Study|Withdrawal By PI|0|||
162968048|NCT03547635|588584759|FG000|Overall Study|Withdrawal by Sponsor|0|||
162968049|NCT03547635|588584760|FG001|Overall Study|Withdrawal by Sponsor|0|||
162968050|NCT03547635|588584761|FG002|Overall Study|Withdrawal by Sponsor|1|||
163316440|NCT04585815|589869615|FG000|Sub-study A- Treatment Phase|Progressive disease|0|||
163316441|NCT04585815|589869616|FG001|Sub-study A- Treatment Phase|Progressive disease|1|||
163316442|NCT04585815|589869617|FG002|Sub-study A- Treatment Phase|Progressive disease|0|||
163316443|NCT04585815|589869618|FG003|Sub-study A- Treatment Phase|Progressive disease|0|||
163316444|NCT04585815|589869619|FG004|Sub-study A- Treatment Phase|Progressive disease|0|||
163316445|NCT04585815|589869620|FG005|Sub-study A- Treatment Phase|Progressive disease|0|||
163316446|NCT04585815|589869621|FG006|Sub-study A- Treatment Phase|Progressive disease|0|||
163316447|NCT04585815|589869615|FG000|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
163316448|NCT04585815|589869616|FG001|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
163316449|NCT04585815|589869617|FG002|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
163316450|NCT04585815|589869618|FG003|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
163316451|NCT04585815|589869619|FG004|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
163316452|NCT04585815|589869620|FG005|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
163316453|NCT04585815|589869621|FG006|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
163316454|NCT04585815|589869615|FG000|Sub-study A- Treatment Phase|Other|1|||
163316455|NCT04585815|589869616|FG001|Sub-study A- Treatment Phase|Other|0|||
163316456|NCT04585815|589869617|FG002|Sub-study A- Treatment Phase|Other|0|||
163316457|NCT04585815|589869618|FG003|Sub-study A- Treatment Phase|Other|0|||
163316458|NCT04585815|589869619|FG004|Sub-study A- Treatment Phase|Other|0|||
163316459|NCT04585815|589869620|FG005|Sub-study A- Treatment Phase|Other|0|||
163316460|NCT04585815|589869621|FG006|Sub-study A- Treatment Phase|Other|0|||
163316461|NCT04585815|589869615|FG000|Sub-study A- Follow-up Phase|Death|0|||
163316462|NCT04585815|589869616|FG001|Sub-study A- Follow-up Phase|Death|1|||
163316463|NCT04585815|589869617|FG002|Sub-study A- Follow-up Phase|Death|0|||
163316464|NCT04585815|589869618|FG003|Sub-study A- Follow-up Phase|Death|0|||
163316465|NCT04585815|589869619|FG004|Sub-study A- Follow-up Phase|Death|0|||
163316466|NCT04585815|589869620|FG005|Sub-study A- Follow-up Phase|Death|0|||
163316467|NCT04585815|589869621|FG006|Sub-study A- Follow-up Phase|Death|0|||
163316468|NCT04585815|589869615|FG000|Sub-study A- Follow-up Phase|Study terminated by sponsor|1|||
163316469|NCT04585815|589869616|FG001|Sub-study A- Follow-up Phase|Study terminated by sponsor|3|||
163316470|NCT04585815|589869617|FG002|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
163316471|NCT04585815|589869618|FG003|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
163316472|NCT04585815|589869619|FG004|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
163316473|NCT04585815|589869620|FG005|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
163316474|NCT04585815|589869621|FG006|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
163316475|NCT04585815|589869615|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
163316476|NCT04585815|589869616|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
163316477|NCT04585815|589869617|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
163316478|NCT04585815|589869618|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
163316479|NCT04585815|589869619|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
163316480|NCT04585815|589869620|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
163316481|NCT04585815|589869621|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
163316482|NCT04585815|589869615|FG000|Sub-study B- Treatment Phase|Death|0|||
163316483|NCT04585815|589869616|FG001|Sub-study B- Treatment Phase|Death|0|||
163316484|NCT04585815|589869617|FG002|Sub-study B- Treatment Phase|Death|0|||
163316485|NCT04585815|589869618|FG003|Sub-study B- Treatment Phase|Death|1|||
163316486|NCT04585815|589869619|FG004|Sub-study B- Treatment Phase|Death|0|||
163316487|NCT04585815|589869620|FG005|Sub-study B- Treatment Phase|Death|0|||
163316488|NCT04585815|589869621|FG006|Sub-study B- Treatment Phase|Death|0|||
163316489|NCT04585815|589869615|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
163316490|NCT04585815|589869616|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
163316491|NCT04585815|589869617|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
163316492|NCT04585815|589869618|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
163316493|NCT04585815|589869619|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
163316494|NCT04585815|589869620|FG005|Sub-study B- Treatment Phase|Progressive disease|1|||
163316495|NCT04585815|589869621|FG006|Sub-study B- Treatment Phase|Progressive disease|5|||
163316496|NCT04585815|589869615|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
163316497|NCT04585815|589869616|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
163316498|NCT04585815|589869617|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
163316499|NCT04585815|589869618|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
163316500|NCT04585815|589869619|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
163316501|NCT04585815|589869620|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
163316502|NCT04585815|589869621|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
163316503|NCT04585815|589869615|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
163316504|NCT04585815|589869616|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
163316505|NCT04585815|589869617|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
163316506|NCT04585815|589869618|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
163316507|NCT04585815|589869619|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
163316508|NCT04585815|589869620|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
163316509|NCT04585815|589869621|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
163316510|NCT04585815|589869615|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
163316511|NCT04585815|589869616|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
163316512|NCT04585815|589869617|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
163316513|NCT04585815|589869618|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
163316514|NCT04585815|589869619|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
163316515|NCT04585815|589869620|FG005|Sub-study B- Treatment Phase|Physician Decision|0|||
163316516|NCT04585815|589869621|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
163316517|NCT04585815|589869615|FG000|Sub-study B- Follow-up Phase|Death|0|||
163316518|NCT04585815|589869616|FG001|Sub-study B- Follow-up Phase|Death|0|||
163316519|NCT04585815|589869617|FG002|Sub-study B- Follow-up Phase|Death|1|||
163316520|NCT04585815|589869618|FG003|Sub-study B- Follow-up Phase|Death|3|||
163316521|NCT04585815|589869619|FG004|Sub-study B- Follow-up Phase|Death|1|||
163316522|NCT04585815|589869620|FG005|Sub-study B- Follow-up Phase|Death|0|||
163316523|NCT04585815|589869621|FG006|Sub-study B- Follow-up Phase|Death|3|||
163316524|NCT04585815|589869615|FG000|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
163316525|NCT04585815|589869616|FG001|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
163316526|NCT04585815|589869617|FG002|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
162968051|NCT03547635|588584759|FG000|Overall Study|Errant Randomization before Treatment|0|||
162968052|NCT03547635|588584760|FG001|Overall Study|Errant Randomization before Treatment|1|||
163316527|NCT04585815|589869618|FG003|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
163316528|NCT04585815|589869619|FG004|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
163316529|NCT04585815|589869620|FG005|Sub-study B- Follow-up Phase|Study terminated by sponsor|1|||
163399330|NCT02752035|590172596|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
162968053|NCT03547635|588584761|FG002|Overall Study|Errant Randomization before Treatment|0|||
162968054|NCT03547635|588584759|FG000|Overall Study|Withdrawal by Subject|1|||
163208240|NCT02051608|589476122|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
163208241|NCT02051608|589476123|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
163208242|NCT02051608|589476124|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
163208243|NCT02051608|589476121|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
163208244|NCT02051608|589476122|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
163208245|NCT02051608|589476123|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
163208246|NCT02051608|589476124|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
163208247|NCT02051608|589476121|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
163208248|NCT02051608|589476122|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
163208249|NCT02051608|589476123|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
163208250|NCT02051608|589476124|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
163208251|NCT02051608|589476121|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
163208252|NCT02051608|589476122|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
163208253|NCT02051608|589476123|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
163208254|NCT02051608|589476124|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
163208255|NCT02051608|589476121|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
163208256|NCT02051608|589476122|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
163208257|NCT02051608|589476123|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
163208258|NCT02051608|589476124|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
163208259|NCT02051608|589476121|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
163208260|NCT02051608|589476122|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
163208261|NCT02051608|589476123|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
163208262|NCT02051608|589476124|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
163208263|NCT02051608|589476121|FG000|Part 1: Double Blind Treatment|Other|6|||
163208264|NCT02051608|589476122|FG001|Part 1: Double Blind Treatment|Other|3|||
163208265|NCT02051608|589476123|FG002|Part 1: Double Blind Treatment|Other|0|||
163208266|NCT02051608|589476124|FG003|Part 1: Double Blind Treatment|Other|0|||
163208267|NCT02051608|589476121|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
163208268|NCT02051608|589476122|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
163208269|NCT02051608|589476123|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
163208270|NCT02051608|589476124|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
163208271|NCT02051608|589476121|FG000|Part 2: Open-label Extension|Adverse Event|0|||
163208272|NCT02051608|589476122|FG001|Part 2: Open-label Extension|Adverse Event|0|||
163208273|NCT02051608|589476123|FG002|Part 2: Open-label Extension|Adverse Event|6|||
163208274|NCT02051608|589476124|FG003|Part 2: Open-label Extension|Adverse Event|8|||
163208275|NCT02051608|589476121|FG000|Part 2: Open-label Extension|Death|0|||
163208276|NCT02051608|589476122|FG001|Part 2: Open-label Extension|Death|0|||
163208277|NCT02051608|589476123|FG002|Part 2: Open-label Extension|Death|7|||
163208278|NCT02051608|589476124|FG003|Part 2: Open-label Extension|Death|4|||
163208279|NCT02051608|589476121|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
163208280|NCT02051608|589476122|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
163208281|NCT02051608|589476123|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
163208282|NCT02051608|589476124|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
163208283|NCT02051608|589476121|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
163208284|NCT02051608|589476122|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
163208285|NCT02051608|589476123|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
163316530|NCT04585815|589869621|FG006|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
163316531|NCT01854775|589869622|FG000|Treatment Phase (48 Weeks)|Withdrew consent|1|||
163316532|NCT01854775|589869623|FG001|Treatment Phase (48 Weeks)|Withdrew consent|1|||
163316533|NCT01854775|589869624|FG002|Treatment Phase (48 Weeks)|Withdrew consent|0|||
163316534|NCT01854775|589869622|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
163316535|NCT01854775|589869623|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
163316536|NCT01854775|589869624|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
163316537|NCT01854775|589869622|FG000|Extension Phase|Pregnancy|1|||
163316538|NCT01854775|589869623|FG001|Extension Phase|Pregnancy|0|||
163316539|NCT01854775|589869624|FG002|Extension Phase|Pregnancy|0|||
163316540|NCT01854775|589869622|FG000|Extension Phase|Investigator's Discretion|1|||
163316541|NCT01854775|589869623|FG001|Extension Phase|Investigator's Discretion|0|||
163316542|NCT01854775|589869624|FG002|Extension Phase|Investigator's Discretion|0|||
163316543|NCT01854775|589869622|FG000|Extension Phase|Non-Compliance with study drug|1|||
163316544|NCT01854775|589869623|FG001|Extension Phase|Non-Compliance with study drug|0|||
163316545|NCT01854775|589869624|FG002|Extension Phase|Non-Compliance with study drug|0|||
163316546|NCT01854775|589869622|FG000|Extension Phase|Lost to Follow-up|1|||
163316547|NCT01854775|589869623|FG001|Extension Phase|Lost to Follow-up|0|||
163316548|NCT01854775|589869624|FG002|Extension Phase|Lost to Follow-up|0|||
163316549|NCT01854775|589869622|FG000|Extension Phase|Withdrew consent|0|||
163316550|NCT01854775|589869623|FG001|Extension Phase|Withdrew consent|1|||
163316551|NCT01854775|589869624|FG002|Extension Phase|Withdrew consent|0|||
163316552|NCT03100149|589869625|FG000|Overall Study|Adverse Event|0|||
163316553|NCT03100149|589869626|FG001|Overall Study|Adverse Event|1|||
163316554|NCT03100149|589869627|FG002|Overall Study|Adverse Event|0|||
163316555|NCT03100149|589869625|FG000|Overall Study|Participant Moved out of Country|0|||
163316556|NCT03100149|589869626|FG001|Overall Study|Participant Moved out of Country|0|||
163316557|NCT03100149|589869627|FG002|Overall Study|Participant Moved out of Country|1|||
163316558|NCT03100149|589869625|FG000|Overall Study|Withdrawal by Subject|0|||
163316559|NCT03100149|589869626|FG001|Overall Study|Withdrawal by Subject|3|||
163316560|NCT03100149|589869627|FG002|Overall Study|Withdrawal by Subject|1|||
163316561|NCT03697876|589869628|FG000|Overall Study|Lost to Follow-up|0|||
163316562|NCT03697876|589869629|FG001|Overall Study|Lost to Follow-up|1|||
163316563|NCT03697876|589869628|FG000|Overall Study|Adverse Event|1|||
163316564|NCT03697876|589869629|FG001|Overall Study|Adverse Event|0|||
163316565|NCT02442349|589871017|FG000|Overall Study|Death|95|||
163316566|NCT02442349|589871017|FG000|Overall Study|Withdrawal by Subject|27|||
163316567|NCT02442349|589871017|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
163316568|NCT02442349|589871017|FG000|Overall Study|Lost to Follow-up|1|||
163316569|NCT03748953|589871021|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
163316570|NCT03748953|589871022|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
163316571|NCT03748953|589871021|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
163316572|NCT03748953|589871022|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
163316573|NCT03748953|589871021|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
163316574|NCT03748953|589871022|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
163316575|NCT03748953|589871021|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
163316576|NCT03748953|589871022|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
163316577|NCT03748953|589871021|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
163316578|NCT03748953|589871022|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
163316579|NCT04676763|589871023|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
163316580|NCT04676763|589871024|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
163316581|NCT04676763|589871025|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
163316582|NCT04676763|589871023|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
163316583|NCT04676763|589871024|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
163316584|NCT04676763|589871025|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
163316585|NCT04676763|589871023|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
163316586|NCT04676763|589871024|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
163316587|NCT04676763|589871025|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
163316588|NCT02296125|589871026|FG000|Overall Study|Withdrawal by Subject|18|||
163316589|NCT02296125|589871027|FG001|Overall Study|Withdrawal by Subject|8|||
163316590|NCT02296125|589871028|FG002|Overall Study|Withdrawal by Subject|6|||
163316591|NCT02296125|589871029|FG003|Overall Study|Withdrawal by Subject|2|||
163316592|NCT02296125|589871026|FG000|Overall Study|Adverse Event|41|||
163316593|NCT02296125|589871027|FG001|Overall Study|Adverse Event|52|||
163316594|NCT02296125|589871028|FG002|Overall Study|Adverse Event|9|||
163316595|NCT02296125|589871029|FG003|Overall Study|Adverse Event|4|||
163316596|NCT02296125|589871026|FG000|Overall Study|Severe non-compliance to protocol|0|||
163316597|NCT02296125|589871027|FG001|Overall Study|Severe non-compliance to protocol|1|||
163316598|NCT02296125|589871028|FG002|Overall Study|Severe non-compliance to protocol|0|||
163316599|NCT02296125|589871029|FG003|Overall Study|Severe non-compliance to protocol|0|||
163316600|NCT02296125|589871026|FG000|Overall Study|Condition under investigation worsened|153|||
163316601|NCT02296125|589871027|FG001|Overall Study|Condition under investigation worsened|199|||
163316602|NCT02296125|589871028|FG002|Overall Study|Condition under investigation worsened|39|||
163316603|NCT02296125|589871029|FG003|Overall Study|Condition under investigation worsened|56|||
163316604|NCT02296125|589871026|FG000|Overall Study|Any reason not specifically recorded|6|||
163316605|NCT02296125|589871027|FG001|Overall Study|Any reason not specifically recorded|4|||
162968055|NCT03547635|588584760|FG001|Overall Study|Withdrawal by Subject|0|||
162968056|NCT03547635|588584761|FG002|Overall Study|Withdrawal by Subject|0|||
163316606|NCT02296125|589871028|FG002|Overall Study|Any reason not specifically recorded|2|||
163316607|NCT02296125|589871029|FG003|Overall Study|Any reason not specifically recorded|0|||
163316608|NCT04858451|589871030|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
163316609|NCT04858451|589871031|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163316610|NCT04858451|589871032|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163316611|NCT04858451|589871033|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163316612|NCT04858451|589871034|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163316613|NCT04858451|589871035|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163316614|NCT04858451|589871036|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163316615|NCT04858451|589871037|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163316616|NCT04858451|589871038|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163316617|NCT04858451|589871030|FG000|Part 2|Discontinued|0|||
163316618|NCT04858451|589871031|FG001|Part 2|Discontinued|0|||
163316619|NCT04858451|589871032|FG002|Part 2|Discontinued|0|||
163316620|NCT04858451|589871033|FG003|Part 2|Discontinued|0|||
163316621|NCT04858451|589871034|FG004|Part 2|Discontinued|0|||
163316622|NCT04858451|589871035|FG005|Part 2|Discontinued|0|||
163316623|NCT04858451|589871036|FG006|Part 2|Discontinued|0|||
163316624|NCT04858451|589871037|FG007|Part 2|Discontinued|0|||
163316625|NCT04858451|589871038|FG008|Part 2|Discontinued|63|||
162968057|NCT03243396|588584762|FG000|Overall Study|Lost to Follow-up|2|||
162968058|NCT03243396|588584763|FG001|Overall Study|Lost to Follow-up|3|||
162968059|NCT03243396|588584764|FG002|Overall Study|Lost to Follow-up|15|||
162968060|NCT03243396|588584765|FG003|Overall Study|Lost to Follow-up|8|||
162968061|NCT03243396|588584766|FG004|Overall Study|Lost to Follow-up|1|||
162968062|NCT03243396|588584767|FG005|Overall Study|Lost to Follow-up|4|||
163316626|NCT02966873|589871039|FG000|Overall Study|Lost to Follow-up|16|||
163316627|NCT02966873|589871040|FG001|Overall Study|Lost to Follow-up|15|||
163316628|NCT03235544|589871042|FG000|Overall Study|Death|11|||
163316629|NCT03235544|589871043|FG001|Overall Study|Death|31|||
163316630|NCT03235544|589871044|FG002|Overall Study|Death|19|||
162968063|NCT03243396|588584768|FG006|Overall Study|Lost to Follow-up|9|||
163316631|NCT03235544|589871045|FG003|Overall Study|Death|34|||
163316632|NCT03235544|589871042|FG000|Overall Study|Lost to Follow-up|0|||
163316633|NCT03235544|589871043|FG001|Overall Study|Lost to Follow-up|1|||
162968064|NCT03687242|588584769|FG000|Overall Study|Adverse Event|1|||
162968065|NCT01151280|588584770|FG000|Overall Study|Adverse Event|1|||
162968066|NCT01151280|588584770|FG000|Overall Study|Lack of Efficacy|3|||
163316634|NCT03235544|589871044|FG002|Overall Study|Lost to Follow-up|1|||
163316635|NCT03235544|589871045|FG003|Overall Study|Lost to Follow-up|1|||
163316636|NCT03235544|589871042|FG000|Overall Study|Withdrawal by Subject|0|||
163316637|NCT03235544|589871043|FG001|Overall Study|Withdrawal by Subject|3|||
163316638|NCT03235544|589871044|FG002|Overall Study|Withdrawal by Subject|1|||
163316639|NCT03235544|589871045|FG003|Overall Study|Withdrawal by Subject|5|||
163316640|NCT03235544|589871042|FG000|Overall Study|Disease Progression|0|||
163316641|NCT03235544|589871043|FG001|Overall Study|Disease Progression|1|||
163316642|NCT03235544|589871044|FG002|Overall Study|Disease Progression|0|||
163316643|NCT03235544|589871045|FG003|Overall Study|Disease Progression|2|||
163316644|NCT03235544|589871042|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
163316645|NCT03235544|589871043|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
163316646|NCT03235544|589871044|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
163316647|NCT03235544|589871045|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
163316648|NCT03235544|589871042|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
163316649|NCT03235544|589871043|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
163316650|NCT03235544|589871044|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
163316651|NCT03235544|589871045|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
163316652|NCT00950742|589871046|FG000|Overall Study|Other Adverse Event|1|||
163316653|NCT00950742|589871047|FG001|Overall Study|Other Adverse Event|0|||
163316654|NCT00950742|589871046|FG000|Overall Study|Withdrawal by Subject|3|||
162968067|NCT02473393|588584771|FG000|Overall Study|Adverse Event|0|||
162968068|NCT02473393|588584772|FG001|Overall Study|Adverse Event|0|||
162968069|NCT02473393|588584773|FG002|Overall Study|Adverse Event|1|||
162968070|NCT02473393|588584774|FG003|Overall Study|Adverse Event|0|||
162968071|NCT02473393|588584771|FG000|Overall Study|Withdrawal by Subject|0|||
162968072|NCT02473393|588584772|FG001|Overall Study|Withdrawal by Subject|0|||
162968073|NCT02473393|588584773|FG002|Overall Study|Withdrawal by Subject|1|||
162968074|NCT02473393|588584774|FG003|Overall Study|Withdrawal by Subject|1|||
162968075|NCT02274558|588584777|FG000|Overall Study|Adverse Event|2|||
162968076|NCT02274558|588584778|FG001|Overall Study|Adverse Event|4|||
162968077|NCT02274558|588584779|FG002|Overall Study|Adverse Event|2|||
162968078|NCT02274558|588584777|FG000|Overall Study|Non-compliance|2|||
162968079|NCT02274558|588584778|FG001|Overall Study|Non-compliance|1|||
162968080|NCT02274558|588584779|FG002|Overall Study|Non-compliance|0|||
162968081|NCT02274558|588584777|FG000|Overall Study|Withdrawal by Subject|1|||
162968082|NCT02274558|588584778|FG001|Overall Study|Withdrawal by Subject|5|||
162968083|NCT02274558|588584779|FG002|Overall Study|Withdrawal by Subject|4|||
163316655|NCT00950742|589871047|FG001|Overall Study|Withdrawal by Subject|0|||
163316656|NCT00950742|589871046|FG000|Overall Study|Progressive Disease|6|||
163316657|NCT00950742|589871047|FG001|Overall Study|Progressive Disease|2|||
162968084|NCT02274558|588584777|FG000|Overall Study|Death|0|||
162968085|NCT02274558|588584778|FG001|Overall Study|Death|0|||
162968086|NCT02274558|588584779|FG002|Overall Study|Death|1|||
162968087|NCT02274558|588584777|FG000|Overall Study|Lost to Follow-up|2|||
162968088|NCT02274558|588584778|FG001|Overall Study|Lost to Follow-up|1|||
162968089|NCT02274558|588584779|FG002|Overall Study|Lost to Follow-up|1|||
163316658|NCT00950742|589871046|FG000|Overall Study|Dose limiting toxicity|6|||
163316659|NCT00950742|589871047|FG001|Overall Study|Dose limiting toxicity|0|||
163316660|NCT04753697|589871049|FG000|Induction Phase|Withdrawal by Subject|12|||
163316661|NCT04753697|589871050|FG001|Induction Phase|Withdrawal by Subject|5|||
162968090|NCT02274558|588584777|FG000|Overall Study|Physician Decision|0|||
163316662|NCT04753697|589871051|FG002|Induction Phase|Withdrawal by Subject|6|||
163316663|NCT04753697|589871049|FG000|Induction Phase|Physician Decision|1|||
163316664|NCT04753697|589871050|FG001|Induction Phase|Physician Decision|0|||
163316665|NCT04753697|589871051|FG002|Induction Phase|Physician Decision|0|||
163316666|NCT04753697|589871049|FG000|Induction Phase|Lost to Follow-up|2|||
163316667|NCT04753697|589871050|FG001|Induction Phase|Lost to Follow-up|2|||
163316668|NCT04753697|589871051|FG002|Induction Phase|Lost to Follow-up|1|||
163316669|NCT04753697|589871049|FG000|Induction Phase|Lack of Efficacy|1|||
163316670|NCT04753697|589871050|FG001|Induction Phase|Lack of Efficacy|0|||
163316671|NCT04753697|589871051|FG002|Induction Phase|Lack of Efficacy|0|||
163316672|NCT04753697|589871049|FG000|Maintenance Phase|Physician Decision|0|||
163316673|NCT04753697|589871050|FG001|Maintenance Phase|Physician Decision|0|||
163316674|NCT04753697|589871051|FG002|Maintenance Phase|Physician Decision|1|||
163316675|NCT04753697|589871049|FG000|Maintenance Phase|Withdrawal by Subject|3|||
163316676|NCT04753697|589871050|FG001|Maintenance Phase|Withdrawal by Subject|4|||
163316677|NCT04753697|589871051|FG002|Maintenance Phase|Withdrawal by Subject|6|||
163316678|NCT04753697|589871049|FG000|Maintenance Phase|Lost to Follow-up|2|||
163316679|NCT04753697|589871050|FG001|Maintenance Phase|Lost to Follow-up|2|||
163316680|NCT04753697|589871051|FG002|Maintenance Phase|Lost to Follow-up|0|||
163316681|NCT04753697|589871049|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
163316682|NCT04753697|589871050|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
163316683|NCT04753697|589871051|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
163316684|NCT04753697|589871049|FG000|Maintenance Phase|Adverse Event|0|||
163316685|NCT04753697|589871050|FG001|Maintenance Phase|Adverse Event|1|||
163316686|NCT04753697|589871051|FG002|Maintenance Phase|Adverse Event|1|||
163316687|NCT04753697|589871049|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
163316688|NCT04753697|589871050|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
163316689|NCT04753697|589871051|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
163316690|NCT04200456|589871054|FG000|Overall Study|Physician Decision|0|||
163316691|NCT04200456|589871055|FG001|Overall Study|Physician Decision|1|||
163316692|NCT04200456|589871054|FG000|Overall Study|Withdrawal by Subject|2|||
163316693|NCT04200456|589871055|FG001|Overall Study|Withdrawal by Subject|2|||
163316694|NCT04200456|589871054|FG000|Overall Study|Lack of Efficacy|1|||
163316695|NCT04200456|589871055|FG001|Overall Study|Lack of Efficacy|1|||
163316696|NCT04200456|589871054|FG000|Overall Study|Adverse event, non-fatal|0|||
163316697|NCT04200456|589871055|FG001|Overall Study|Adverse event, non-fatal|1|||
163316698|NCT04200456|589871054|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
163316699|NCT04200456|589871055|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
163316700|NCT00592852|589871056|FG000|Overall Study|Non-compliance|1|||
163316701|NCT00592852|589871056|FG000|Overall Study|Adverse Event|3|||
163316702|NCT00592852|589871056|FG000|Overall Study|Found ineligible|1|||
163316703|NCT00592852|589871056|FG000|Overall Study|Withdrawal by Subject|1|||
163316704|NCT05002088|589871057|FG000|Overall Study|Withdrawal by Subject|9|||
163316705|NCT05002088|589871058|FG001|Overall Study|Withdrawal by Subject|0|||
163316706|NCT05002088|589871057|FG000|Overall Study|Lost to Follow-up|0|||
163316707|NCT05002088|589871058|FG001|Overall Study|Lost to Follow-up|1|||
163316708|NCT05002088|589871057|FG000|Overall Study|Death|16|||
163316709|NCT05002088|589871058|FG001|Overall Study|Death|2|||
163316710|NCT05002088|589871057|FG000|Overall Study|Protocol Violation|25|||
163316711|NCT05002088|589871058|FG001|Overall Study|Protocol Violation|7|||
163316712|NCT04770402|589871060|FG000|Overall Study|Lost to Follow-up|1|||
163316713|NCT04770402|589871061|FG001|Overall Study|Lost to Follow-up|2|||
163316714|NCT04770402|589871060|FG000|Overall Study|Non-compliance|1|||
163316715|NCT04770402|589871061|FG001|Overall Study|Non-compliance|0|||
163316716|NCT04770402|589871060|FG000|Overall Study|Withdrawal by Subject|0|||
163316717|NCT04770402|589871061|FG001|Overall Study|Withdrawal by Subject|1|||
163316718|NCT03599661|589871062|FG000|Overall Study|Lost to Follow-up|9|||
163316719|NCT04811040|589871063|FG000|Overall Study|Lost to Follow-up|2|||
163316720|NCT04811040|589871064|FG001|Overall Study|Lost to Follow-up|0|||
163316721|NCT04811040|589871065|FG002|Overall Study|Lost to Follow-up|0|||
163316722|NCT04811040|589871066|FG003|Overall Study|Lost to Follow-up|0|||
163316723|NCT04811040|589871063|FG000|Overall Study|Withdrew consent|1|||
163316724|NCT04811040|589871064|FG001|Overall Study|Withdrew consent|1|||
163316725|NCT04811040|589871065|FG002|Overall Study|Withdrew consent|0|||
163316726|NCT04811040|589871066|FG003|Overall Study|Withdrew consent|0|||
163316727|NCT05446168|589871069|FG000|Overall Study|Physician Decision|0|||
163316728|NCT05446168|589871070|FG001|Overall Study|Physician Decision|1|||
163316729|NCT01828099|589871074|FG000|Treatment Period|Adverse Event|24|||
163316730|NCT01828099|589871075|FG001|Treatment Period|Adverse Event|23|||
163316731|NCT01828099|589871074|FG000|Treatment Period|Death|10|||
163316732|NCT01828099|589871075|FG001|Treatment Period|Death|12|||
163316733|NCT01828099|589871074|FG000|Treatment Period|Lost to Follow-up|2|||
163316734|NCT01828099|589871075|FG001|Treatment Period|Lost to Follow-up|1|||
163316735|NCT01828099|589871074|FG000|Treatment Period|Non-compliance with study treatment|1|||
163316736|NCT01828099|589871075|FG001|Treatment Period|Non-compliance with study treatment|0|||
163316737|NCT01828099|589871074|FG000|Treatment Period|Physician Decision|17|||
163316738|NCT01828099|589871075|FG001|Treatment Period|Physician Decision|16|||
163316739|NCT01828099|589871074|FG000|Treatment Period|Progressive disease|99|||
163316740|NCT01828099|589871075|FG001|Treatment Period|Progressive disease|107|||
163399331|NCT02752035|590172593|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
163316741|NCT01828099|589871074|FG000|Treatment Period|Subject/guardian decision|22|||
163316742|NCT01828099|589871075|FG001|Treatment Period|Subject/guardian decision|26|||
162968091|NCT02274558|588584778|FG001|Overall Study|Physician Decision|2|||
162968092|NCT02274558|588584779|FG002|Overall Study|Physician Decision|1|||
162968093|NCT00397254|588584780|FG000|Overall Study|Lost to Follow-up|2|||
162968094|NCT00397254|588584781|FG001|Overall Study|Lost to Follow-up|2|||
162968095|NCT00152451|588584784|FG000|Overall Study|Adverse Event|4|||
162968096|NCT00323258|588584787|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
162968097|NCT00323258|588584788|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
162968098|NCT00323258|588584787|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
162968099|NCT00323258|588584788|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
162968100|NCT00323258|588584787|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
163399332|NCT02752035|590172594|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
163399333|NCT02752035|590172595|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
162968101|NCT00323258|588584788|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
162968102|NCT00323258|588584787|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
162968103|NCT00323258|588584788|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
162968104|NCT00323258|588584787|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
163208286|NCT02051608|589476124|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
163208287|NCT02051608|589476121|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
163208288|NCT02051608|589476122|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
162968105|NCT00323258|588584788|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
163208289|NCT02051608|589476123|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
162968106|NCT00323258|588584787|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
162968107|NCT00323258|588584788|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
162968108|NCT00323258|588584787|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
162968109|NCT00323258|588584788|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
162968110|NCT04473326|588584793|FG000|Overall Study|Death|0|||
162968111|NCT04473326|588584794|FG001|Overall Study|Death|1|||
162968112|NCT04473326|588584793|FG000|Overall Study|Withdrawal by Subject|1|||
162968113|NCT04473326|588584794|FG001|Overall Study|Withdrawal by Subject|2|||
162968114|NCT02046122|588584795|FG000|Overall Study|Physician Decision|8|||
162968115|NCT02046122|588584795|FG000|Overall Study|Withdrawal by Subject|1|||
162968116|NCT01097694|588584800|FG000|Overall Study|Adverse Event|5|||
162968117|NCT01097694|588584801|FG001|Overall Study|Adverse Event|0|||
163208290|NCT02051608|589476124|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
163208291|NCT02051608|589476121|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
163208292|NCT02051608|589476122|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
163208293|NCT02051608|589476123|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
163208294|NCT02051608|589476124|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
163208295|NCT02051608|589476121|FG000|Part 2: Open-label Extension|Physician Decision|0|||
162968118|NCT01097694|588584800|FG000|Overall Study|Lost to Follow-up|0|||
162968119|NCT01097694|588584801|FG001|Overall Study|Lost to Follow-up|3|||
162968120|NCT01097694|588584800|FG000|Overall Study|Withdrawal by Subject|3|||
162968121|NCT01097694|588584801|FG001|Overall Study|Withdrawal by Subject|1|||
162968122|NCT00668395|588584803|FG000|Overall Study|Withdrawal by Subject|4|||
162968123|NCT00668395|588584804|FG001|Overall Study|Withdrawal by Subject|4|||
162968124|NCT00668395|588584805|FG002|Overall Study|Withdrawal by Subject|1|||
162968125|NCT00668395|588584803|FG000|Overall Study|Adverse Event|1|||
162968126|NCT00668395|588584804|FG001|Overall Study|Adverse Event|1|||
162968127|NCT00668395|588584805|FG002|Overall Study|Adverse Event|0|||
162968128|NCT00668395|588584803|FG000|Overall Study|Physician Decision|1|||
162968129|NCT00668395|588584804|FG001|Overall Study|Physician Decision|1|||
162968130|NCT00668395|588584805|FG002|Overall Study|Physician Decision|0|||
162968131|NCT04164758|588584806|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
162968132|NCT04164758|588584807|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
162968133|NCT04164758|588584808|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
162968134|NCT04164758|588584806|FG000|Overall Study|Adverse Event|0|||
162968135|NCT04164758|588584807|FG001|Overall Study|Adverse Event|1|||
162968136|NCT04164758|588584808|FG002|Overall Study|Adverse Event|0|||
162968137|NCT00697827|588584809|FG000|Overall Study|enrolled but not treated|2|||
162968138|NCT00697827|588584810|FG001|Overall Study|enrolled but not treated|1|||
162968139|NCT03259165|588584811|FG000|Overall Study|COVID 19 pandemic|1|||
162968140|NCT03259165|588584812|FG001|Overall Study|COVID 19 pandemic|1|||
162968141|NCT03732833|588584813|FG000|Overall Study|Adverse Event|0|||
162968142|NCT03732833|588584814|FG001|Overall Study|Adverse Event|3|||
162968143|NCT03732833|588584815|FG002|Overall Study|Adverse Event|1|||
162968144|NCT03732833|588584813|FG000|Overall Study|Withdrawal by Subject|11|||
162968145|NCT03732833|588584814|FG001|Overall Study|Withdrawal by Subject|13|||
162968146|NCT03732833|588584815|FG002|Overall Study|Withdrawal by Subject|8|||
162968147|NCT03732833|588584813|FG000|Overall Study|Lost to Follow-up|3|||
162968148|NCT03732833|588584814|FG001|Overall Study|Lost to Follow-up|5|||
162968149|NCT03732833|588584815|FG002|Overall Study|Lost to Follow-up|4|||
162968150|NCT03732833|588584813|FG000|Overall Study|Pregnancy|0|||
162968151|NCT03732833|588584814|FG001|Overall Study|Pregnancy|2|||
162968152|NCT03732833|588584815|FG002|Overall Study|Pregnancy|0|||
162968153|NCT03732833|588584813|FG000|Overall Study|Physician Decision|2|||
162968154|NCT03732833|588584814|FG001|Overall Study|Physician Decision|3|||
162968155|NCT03732833|588584815|FG002|Overall Study|Physician Decision|1|||
162968156|NCT03732833|588584813|FG000|Overall Study|Covid-19 related and other reasons|2|||
162968157|NCT03732833|588584814|FG001|Overall Study|Covid-19 related and other reasons|7|||
162968158|NCT03732833|588584815|FG002|Overall Study|Covid-19 related and other reasons|3|||
162968159|NCT01567527|588584818|FG000|Conversion Phase.|Protocol deviation|3|||
162968160|NCT01567527|588584819|FG001|Conversion Phase.|Protocol deviation|0|||
162968161|NCT01567527|588584820|FG002|Conversion Phase.|Protocol deviation|0|||
162968162|NCT01567527|588584821|FG003|Conversion Phase.|Protocol deviation|0|||
162968163|NCT01567527|588584822|FG004|Conversion Phase.|Protocol deviation|0|||
162968164|NCT01567527|588584818|FG000|Conversion Phase.|Met withdrawal criteria|10|||
162968165|NCT01567527|588584819|FG001|Conversion Phase.|Met withdrawal criteria|0|||
162968166|NCT01567527|588584820|FG002|Conversion Phase.|Met withdrawal criteria|0|||
162968167|NCT01567527|588584821|FG003|Conversion Phase.|Met withdrawal criteria|0|||
162968168|NCT01567527|588584822|FG004|Conversion Phase.|Met withdrawal criteria|0|||
162968169|NCT01567527|588584818|FG000|Conversion Phase.|Withdrawal by Subject|32|||
162968170|NCT01567527|588584819|FG001|Conversion Phase.|Withdrawal by Subject|0|||
162968171|NCT01567527|588584820|FG002|Conversion Phase.|Withdrawal by Subject|0|||
162968172|NCT01567527|588584821|FG003|Conversion Phase.|Withdrawal by Subject|0|||
162968173|NCT01567527|588584822|FG004|Conversion Phase.|Withdrawal by Subject|0|||
162968174|NCT01567527|588584818|FG000|Conversion Phase.|Lost to Follow-up|16|||
162968175|NCT01567527|588584819|FG001|Conversion Phase.|Lost to Follow-up|0|||
162968176|NCT01567527|588584820|FG002|Conversion Phase.|Lost to Follow-up|0|||
162968177|NCT01567527|588584821|FG003|Conversion Phase.|Lost to Follow-up|0|||
162968178|NCT01567527|588584822|FG004|Conversion Phase.|Lost to Follow-up|0|||
162968179|NCT01567527|588584818|FG000|Conversion Phase.|Lack of Efficacy|2|||
162968180|NCT01567527|588584819|FG001|Conversion Phase.|Lack of Efficacy|0|||
162968181|NCT01567527|588584820|FG002|Conversion Phase.|Lack of Efficacy|0|||
162968182|NCT01567527|588584821|FG003|Conversion Phase.|Lack of Efficacy|0|||
162968183|NCT01567527|588584822|FG004|Conversion Phase.|Lack of Efficacy|0|||
162968184|NCT01567527|588584818|FG000|Conversion Phase.|Adverse Event|33|||
162968185|NCT01567527|588584819|FG001|Conversion Phase.|Adverse Event|0|||
162968186|NCT01567527|588584820|FG002|Conversion Phase.|Adverse Event|0|||
162968187|NCT01567527|588584821|FG003|Conversion Phase.|Adverse Event|0|||
163316743|NCT01828099|589871074|FG000|Treatment Period|Study terminated by Sponsor|13|||
163316744|NCT01828099|589871075|FG001|Treatment Period|Study terminated by Sponsor|1|||
163316745|NCT01828099|589871074|FG000|Treatment Period|Protocol deviation|1|||
162968188|NCT01567527|588584822|FG004|Conversion Phase.|Adverse Event|0|||
162968189|NCT01567527|588584818|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
162968190|NCT01567527|588584819|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
163054425|NCT00794664|588910295|FG000|Follow-up Period|Withdrawal by Subject|0|||
163316746|NCT01828099|589871075|FG001|Treatment Period|Protocol deviation|0|||
163316747|NCT01828099|589871074|FG000|Treatment Period|No longer requires treatment|0|||
163316748|NCT01828099|589871075|FG001|Treatment Period|No longer requires treatment|1|||
163316749|NCT01828099|589871074|FG000|Extension-treatment Phase|Adverse Event|0|||
163316750|NCT01828099|589871075|FG001|Extension-treatment Phase|Adverse Event|17|||
162968191|NCT01567527|588584820|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
163208296|NCT02051608|589476122|FG001|Part 2: Open-label Extension|Physician Decision|0|||
163208297|NCT02051608|589476123|FG002|Part 2: Open-label Extension|Physician Decision|8|||
163208298|NCT02051608|589476124|FG003|Part 2: Open-label Extension|Physician Decision|5|||
163208299|NCT02051608|589476121|FG000|Part 2: Open-label Extension|Other|0|||
163208300|NCT02051608|589476122|FG001|Part 2: Open-label Extension|Other|0|||
162968192|NCT01567527|588584821|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
162968193|NCT01567527|588584822|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
162968194|NCT01567527|588584818|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
162968195|NCT01567527|588584819|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
162968196|NCT01567527|588584820|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
162968197|NCT01567527|588584821|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
162968198|NCT01567527|588584822|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
162968199|NCT01567527|588584818|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
162968200|NCT01567527|588584819|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
163316751|NCT01828099|589871074|FG000|Extension-treatment Phase|Death|0|||
163316752|NCT01828099|589871075|FG001|Extension-treatment Phase|Death|11|||
163399334|NCT02752035|590172596|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
163399335|NCT02752035|590172593|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
163399336|NCT02752035|590172594|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
163399337|NCT02752035|590172595|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
163399338|NCT02752035|590172596|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
163399339|NCT02752035|590172593|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
163399340|NCT02752035|590172594|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
163399341|NCT02752035|590172595|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
163399342|NCT02752035|590172596|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
163399343|NCT02752035|590172593|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
163399344|NCT02752035|590172594|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
163399345|NCT02752035|590172595|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
163399346|NCT02752035|590172596|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
163399347|NCT02752035|590172593|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
163399348|NCT02752035|590172594|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
163399349|NCT02752035|590172595|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
163399350|NCT02752035|590172596|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
163399351|NCT02752035|590172593|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
163399352|NCT02752035|590172594|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
163399353|NCT02752035|590172595|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
163399354|NCT02752035|590172596|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
163399355|NCT02752035|590172593|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
163399356|NCT02752035|590172594|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
163399357|NCT02752035|590172595|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
163399358|NCT02752035|590172596|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
163399359|NCT02752035|590172593|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
163399360|NCT02752035|590172594|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
163399361|NCT02752035|590172595|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
163399362|NCT02752035|590172596|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
163399363|NCT02752035|590172593|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
163399364|NCT02752035|590172594|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
163399365|NCT02752035|590172595|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
163399366|NCT02752035|590172596|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
163399367|NCT02752035|590172593|FG000|Randomization: Approximately 3 Years|Death|0|||
163399368|NCT02752035|590172594|FG001|Randomization: Approximately 3 Years|Death|25|||
163399369|NCT02752035|590172595|FG002|Randomization: Approximately 3 Years|Death|13|||
163399370|NCT02752035|590172596|FG003|Randomization: Approximately 3 Years|Death|4|||
163399371|NCT02752035|590172593|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
163399372|NCT02752035|590172594|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
163399373|NCT02752035|590172595|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
163399374|NCT02752035|590172596|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
163399375|NCT02752035|590172593|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
163399376|NCT02752035|590172594|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
163399377|NCT02752035|590172595|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
163399378|NCT02752035|590172596|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
163399379|NCT02752035|590172593|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
163399380|NCT02752035|590172594|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
163399381|NCT02752035|590172595|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
163399382|NCT02752035|590172596|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
163399383|NCT02752035|590172593|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
163399384|NCT02752035|590172594|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
163399385|NCT02752035|590172595|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
163399386|NCT02752035|590172596|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
163399387|NCT02752035|590172593|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
163399388|NCT02752035|590172594|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
163399389|NCT02752035|590172595|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
162968201|NCT01567527|588584820|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
162968202|NCT01567527|588584821|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
163399390|NCT02752035|590172596|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
163399391|NCT01111851|590172600|FG000|Overall Study|All planned PET scans were not obtained.|2|||
163399392|NCT01111851|590172601|FG001|Overall Study|All planned PET scans were not obtained.|0|||
163399393|NCT05500274|590172602|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
163399394|NCT05500274|590172603|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
163399395|NCT05500274|590172602|FG000|Overall Study|Lost to Follow-up|76|||
163399396|NCT05500274|590172603|FG001|Overall Study|Lost to Follow-up|51|||
163399397|NCT01555151|590172604|FG000|Overall Study|Withdrawal by Subject|6|||
163399398|NCT01555151|590172605|FG001|Overall Study|Withdrawal by Subject|2|||
163399399|NCT01555151|590172606|FG002|Overall Study|Withdrawal by Subject|0|||
163399400|NCT01555151|590172607|FG003|Overall Study|Withdrawal by Subject|2|||
163399401|NCT01555151|590172604|FG000|Overall Study|Administrative|3|||
163399402|NCT01555151|590172605|FG001|Overall Study|Administrative|1|||
163399403|NCT01555151|590172606|FG002|Overall Study|Administrative|2|||
163399404|NCT01555151|590172607|FG003|Overall Study|Administrative|0|||
162968203|NCT01567527|588584822|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
162968204|NCT01567527|588584818|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
162968205|NCT01567527|588584819|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
162968206|NCT01567527|588584820|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
162968207|NCT01567527|588584821|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
162968208|NCT01567527|588584822|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
162968209|NCT01567527|588584818|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
162968210|NCT01567527|588584819|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
162968211|NCT01567527|588584820|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
162968212|NCT01567527|588584821|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
163399405|NCT01555151|590172604|FG000|Overall Study|Protocol Violation|3|||
163399406|NCT01555151|590172605|FG001|Overall Study|Protocol Violation|3|||
163399407|NCT01555151|590172606|FG002|Overall Study|Protocol Violation|3|||
163399408|NCT01555151|590172607|FG003|Overall Study|Protocol Violation|5|||
163399409|NCT01555151|590172604|FG000|Overall Study|Adverse Event|1|||
163399410|NCT01555151|590172605|FG001|Overall Study|Adverse Event|2|||
163399411|NCT01555151|590172606|FG002|Overall Study|Adverse Event|1|||
163399412|NCT01555151|590172607|FG003|Overall Study|Adverse Event|2|||
163399413|NCT01555151|590172604|FG000|Overall Study|Lost to Follow-up|0|||
163399414|NCT01555151|590172605|FG001|Overall Study|Lost to Follow-up|0|||
163399415|NCT01555151|590172606|FG002|Overall Study|Lost to Follow-up|0|||
163399416|NCT01555151|590172607|FG003|Overall Study|Lost to Follow-up|1|||
163399417|NCT00596947|590172608|FG000|Overall Study|study halted due to low enrollment|5|||
163399418|NCT00596947|590172609|FG001|Overall Study|study halted due to low enrollment|3|||
163399419|NCT00596947|590172608|FG000|Overall Study|Lost to Follow-up|1|||
163399420|NCT00596947|590172609|FG001|Overall Study|Lost to Follow-up|0|||
163399421|NCT03000179|590172610|FG000|Overall Study|Lost to Follow-up|2|||
163399422|NCT00073528|590172615|FG000|Overall Study|Death|488|||
163399423|NCT00073528|590172616|FG001|Overall Study|Death|473|||
163399424|NCT00073528|590172615|FG000|Overall Study|Lost to Follow-up|52|||
163399425|NCT00073528|590172616|FG001|Overall Study|Lost to Follow-up|45|||
163399426|NCT00073528|590172615|FG000|Overall Study|Withdrawal by Subject|50|||
163399427|NCT00073528|590172616|FG001|Overall Study|Withdrawal by Subject|45|||
163399428|NCT00073528|590172615|FG000|Overall Study|Study terminated by Sponsor|10|||
163399429|NCT00073528|590172616|FG001|Overall Study|Study terminated by Sponsor|29|||
163399430|NCT00073528|590172615|FG000|Overall Study|Other|18|||
163399431|NCT00073528|590172616|FG001|Overall Study|Other|19|||
163399432|NCT00073528|590172615|FG000|Overall Study|Other|9|||
163399433|NCT00073528|590172616|FG001|Overall Study|Other|12|||
163399434|NCT00073528|590172615|FG000|Overall Study|Protocol Violation|3|||
163399435|NCT00073528|590172616|FG001|Overall Study|Protocol Violation|5|||
163399436|NCT04037748|590172621|FG000|Treatment Period 1|Withdrawal by Subject|3|||
163399437|NCT04037748|590172622|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163399438|NCT04037748|590172621|FG000|Treatment Period 1|Adverse Event|1|||
163399439|NCT04037748|590172622|FG001|Treatment Period 1|Adverse Event|1|||
163399440|NCT04037748|590172621|FG000|Treatment Period 1|Protocol Violation|4|||
162968213|NCT01567527|588584822|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
162968214|NCT01567527|588584818|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
162968215|NCT01567527|588584819|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
162968216|NCT01567527|588584820|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
163399441|NCT04037748|590172622|FG001|Treatment Period 1|Protocol Violation|5|||
163399442|NCT04037748|590172621|FG000|Treatment Period 2|Adverse Event|0|||
163399443|NCT04037748|590172622|FG001|Treatment Period 2|Adverse Event|1|||
163399444|NCT04037748|590172621|FG000|Treatment Period 2|Protocol Violation|2|||
163399445|NCT04037748|590172622|FG001|Treatment Period 2|Protocol Violation|0|||
163399446|NCT01358760|590172627|FG000|Overall Study|Adverse Event|3|||
163399447|NCT01358760|590172628|FG001|Overall Study|Adverse Event|4|||
163399448|NCT01358760|590172629|FG002|Overall Study|Adverse Event|3|||
163399449|NCT01358760|590172627|FG000|Overall Study|Lost to Follow-up|1|||
163399450|NCT01358760|590172628|FG001|Overall Study|Lost to Follow-up|1|||
163399451|NCT01358760|590172629|FG002|Overall Study|Lost to Follow-up|3|||
163399452|NCT01358760|590172627|FG000|Overall Study|Withdrawal by Subject|5|||
162968217|NCT01567527|588584821|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
162968218|NCT01567527|588584822|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
162968219|NCT01567527|588584818|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
162968220|NCT01567527|588584819|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
162968221|NCT01567527|588584820|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
162968222|NCT01567527|588584821|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
162968223|NCT01567527|588584822|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
162968224|NCT01567527|588584818|FG000|IM Depot Stabilization.|Protocol deviation|0|||
162968225|NCT01567527|588584819|FG001|IM Depot Stabilization.|Protocol deviation|0|||
163399453|NCT01358760|590172628|FG001|Overall Study|Withdrawal by Subject|3|||
162968226|NCT01567527|588584820|FG002|IM Depot Stabilization.|Protocol deviation|5|||
162968227|NCT01567527|588584821|FG003|IM Depot Stabilization.|Protocol deviation|0|||
163399454|NCT01358760|590172629|FG002|Overall Study|Withdrawal by Subject|2|||
163399455|NCT01358760|590172627|FG000|Overall Study|Physician Decision|1|||
163399456|NCT01358760|590172628|FG001|Overall Study|Physician Decision|0|||
163399457|NCT01358760|590172629|FG002|Overall Study|Physician Decision|1|||
163399458|NCT01358760|590172627|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
163399459|NCT01358760|590172628|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
163399460|NCT01358760|590172629|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
163399461|NCT01506960|590172630|FG000|Overall Study|Did not meet angiographic criteria|47|||
163399462|NCT00397033|590172631|FG000|Overall Study|Adverse Event|7|||
163399463|NCT00397033|590172632|FG001|Overall Study|Adverse Event|10|||
163399464|NCT00397033|590172633|FG002|Overall Study|Adverse Event|4|||
163399465|NCT00397033|590172631|FG000|Overall Study|Lack of Efficacy|22|||
163399466|NCT00397033|590172632|FG001|Overall Study|Lack of Efficacy|12|||
163399467|NCT00397033|590172633|FG002|Overall Study|Lack of Efficacy|9|||
163399468|NCT00397033|590172631|FG000|Overall Study|Lost to Follow-up|3|||
163399469|NCT00397033|590172632|FG001|Overall Study|Lost to Follow-up|3|||
163399470|NCT00397033|590172633|FG002|Overall Study|Lost to Follow-up|3|||
163399471|NCT00397033|590172631|FG000|Overall Study|Withdrawal by Subject|12|||
163399472|NCT00397033|590172632|FG001|Overall Study|Withdrawal by Subject|7|||
163399473|NCT00397033|590172633|FG002|Overall Study|Withdrawal by Subject|5|||
163399474|NCT00397033|590172631|FG000|Overall Study|Other|0|||
163399475|NCT00397033|590172632|FG001|Overall Study|Other|5|||
162968228|NCT01567527|588584822|FG004|IM Depot Stabilization.|Protocol deviation|0|||
162968229|NCT01567527|588584818|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
162968230|NCT01567527|588584819|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
162968231|NCT01567527|588584820|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
162968232|NCT01567527|588584821|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
162968233|NCT01567527|588584822|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
162968234|NCT01567527|588584818|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
162968235|NCT01567527|588584819|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
162968236|NCT01567527|588584820|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
162968237|NCT01567527|588584821|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
162968238|NCT01567527|588584822|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
162968239|NCT01567527|588584818|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
162968240|NCT01567527|588584819|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
162968241|NCT01567527|588584820|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
163316753|NCT01828099|589871074|FG000|Extension-treatment Phase|Physician Decision|0|||
163316754|NCT01828099|589871075|FG001|Extension-treatment Phase|Physician Decision|5|||
163316755|NCT01828099|589871074|FG000|Extension-treatment Phase|Progressive disease|0|||
163316756|NCT01828099|589871075|FG001|Extension-treatment Phase|Progressive disease|54|||
163316757|NCT01828099|589871074|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
163316758|NCT01828099|589871075|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
163316759|NCT01828099|589871074|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
163316760|NCT01828099|589871075|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
163316761|NCT06473662|589871076|FG000|Overall Study|Withdrawal by Subject|1|||
163316762|NCT06473662|589871077|FG001|Overall Study|Withdrawal by Subject|6|||
163316763|NCT06473662|589871078|FG002|Overall Study|Withdrawal by Subject|5|||
163316764|NCT06473662|589871076|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
163316765|NCT06473662|589871077|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
163316766|NCT06473662|589871078|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
163316767|NCT06473662|589871076|FG000|Overall Study|Starting HbA1c below 7%|0|||
163399476|NCT00397033|590172633|FG002|Overall Study|Other|2|||
163399477|NCT03519867|590172634|FG000|Overall Study|Adverse Event|1|||
163399478|NCT03519867|590172635|FG001|Overall Study|Adverse Event|1|||
163399479|NCT03519867|590172636|FG002|Overall Study|Adverse Event|0|||
163316768|NCT06473662|589871077|FG001|Overall Study|Starting HbA1c below 7%|1|||
163316769|NCT06473662|589871078|FG002|Overall Study|Starting HbA1c below 7%|1|||
163316770|NCT06473662|589871076|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
163399480|NCT03519867|590172637|FG003|Overall Study|Adverse Event|0|||
163208301|NCT02051608|589476123|FG002|Part 2: Open-label Extension|Other|9|||
163208302|NCT02051608|589476124|FG003|Part 2: Open-label Extension|Other|9|||
162968242|NCT01567527|588584821|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
162968243|NCT01567527|588584822|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
162968244|NCT01567527|588584818|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
162968245|NCT01567527|588584819|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
162968246|NCT01567527|588584820|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
162968247|NCT01567527|588584821|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
162968248|NCT01567527|588584822|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
162968249|NCT01567527|588584818|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
162968250|NCT01567527|588584819|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
162968251|NCT01567527|588584820|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
162968252|NCT01567527|588584821|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
162968253|NCT01567527|588584822|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
162968254|NCT01567527|588584818|FG000|IM Depot Stabilization.|Adverse Event|0|||
162968255|NCT01567527|588584819|FG001|IM Depot Stabilization.|Adverse Event|0|||
162968256|NCT01567527|588584820|FG002|IM Depot Stabilization.|Adverse Event|37|||
162968257|NCT01567527|588584821|FG003|IM Depot Stabilization.|Adverse Event|0|||
162968258|NCT01567527|588584822|FG004|IM Depot Stabilization.|Adverse Event|0|||
162968259|NCT01567527|588584818|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
162968260|NCT01567527|588584819|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
163054426|NCT00794664|588910296|FG001|Follow-up Period|Withdrawal by Subject|2|||
162968261|NCT01567527|588584820|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
162968262|NCT01567527|588584821|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
162968263|NCT01567527|588584822|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
162968264|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
163054427|NCT00794664|588910295|FG000|Follow-up Period|Protocol non-compliance|0|||
163054428|NCT00794664|588910296|FG001|Follow-up Period|Protocol non-compliance|1|||
163316771|NCT06473662|589871077|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
163316772|NCT06473662|589871078|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
163316773|NCT06473662|589871076|FG000|Overall Study|Did not take medication|2|||
163316774|NCT06473662|589871077|FG001|Overall Study|Did not take medication|3|||
163316775|NCT06473662|589871078|FG002|Overall Study|Did not take medication|2|||
163316776|NCT04471246|589871083|FG000|Overall Study|Lost to Follow-up|2|||
163316777|NCT04471246|589871084|FG001|Overall Study|Lost to Follow-up|2|||
163316778|NCT04826471|589871085|FG000|Overall Study|Lost to Follow-up|2|||
163316779|NCT04826471|589871085|FG000|Overall Study|Protocol Violation|3|||
163316780|NCT04826471|589871085|FG000|Overall Study|Withdrawal by Subject|1|||
163316781|NCT05764525|589871086|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
163316782|NCT05764525|589871087|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
163316783|NCT05764525|589871086|FG000|Overall Study|Withdrawal by Subject|4|||
163316784|NCT05764525|589871087|FG001|Overall Study|Withdrawal by Subject|8|||
163316785|NCT05764525|589871086|FG000|Overall Study|Physician Decision|1|||
163316786|NCT05764525|589871087|FG001|Overall Study|Physician Decision|0|||
163316787|NCT04079218|589871088|FG000|Overall Study|Death|1|||
163316788|NCT04079218|589871089|FG001|Overall Study|Death|0|||
163316789|NCT04079218|589871088|FG000|Overall Study|Withdrawal by Subject|3|||
163316790|NCT04079218|589871089|FG001|Overall Study|Withdrawal by Subject|0|||
163316791|NCT04079218|589871088|FG000|Overall Study|Physician Decision|4|||
163316792|NCT04079218|589871089|FG001|Overall Study|Physician Decision|0|||
163316793|NCT04079218|589871088|FG000|Overall Study|Lost to Follow-up|0|||
163399481|NCT03519867|590172638|FG004|Overall Study|Adverse Event|0|||
163054429|NCT01973218|588910297|FG000|Overall Study|Adverse Event|1|||
163399482|NCT03519867|590172639|FG005|Overall Study|Adverse Event|0|||
163054430|NCT01973218|588910298|FG001|Overall Study|Adverse Event|0|||
163054431|NCT01973218|588910297|FG000|Overall Study|Withdrawal by Subject|1|||
162968265|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
162968266|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
162968267|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
162968268|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
162968269|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
162968270|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
162968271|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
162968272|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
162968273|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
162968274|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
163316794|NCT04079218|589871089|FG001|Overall Study|Lost to Follow-up|1|||
163316795|NCT03910478|589871097|FG000|Overall Study|Death|13|||
163316796|NCT03910478|589871098|FG001|Overall Study|Death|6|||
162968275|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
162968276|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
162968277|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
162968278|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
162968279|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
162968280|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
162968281|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
162968282|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
162968283|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
162968284|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
162968285|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
162968286|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
162968287|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
162968288|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
162968289|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
162968290|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
162968291|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
162968292|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
162968293|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
162968294|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
162968295|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
163316797|NCT03910478|589871097|FG000|Overall Study|Withdrawal by Subject|23|||
163316798|NCT03910478|589871098|FG001|Overall Study|Withdrawal by Subject|2|||
162968296|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
162968297|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
162968298|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
163316799|NCT03910478|589871097|FG000|Overall Study|Physician Decision|5|||
163208303|NCT00142584|589476125|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
163208304|NCT00142584|589476126|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
163208305|NCT00142584|589476125|FG000|Overall Study|Withdrawal by Subject|30|||
163208306|NCT00142584|589476126|FG001|Overall Study|Withdrawal by Subject|16|||
163208307|NCT00142584|589476125|FG000|Overall Study|Lost to Follow-up|22|||
163208308|NCT00142584|589476126|FG001|Overall Study|Lost to Follow-up|12|||
163208309|NCT00142584|589476125|FG000|Overall Study|Adverse Event|14|||
163208310|NCT00142584|589476126|FG001|Overall Study|Adverse Event|5|||
163208311|NCT00142584|589476125|FG000|Overall Study|Protocol Violation|4|||
163399483|NCT03519867|590172640|FG006|Overall Study|Adverse Event|0|||
163399484|NCT03519867|590172641|FG007|Overall Study|Adverse Event|0|||
162968299|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162968300|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162968301|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162968302|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
163208312|NCT00142584|589476126|FG001|Overall Study|Protocol Violation|7|||
163208313|NCT00142584|589476125|FG000|Overall Study|Treatment Failure|2|||
162968303|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
163208314|NCT00142584|589476126|FG001|Overall Study|Treatment Failure|0|||
163208315|NCT01083576|589476127|FG000|Overall Study|Treatment Failure|6|||
163208316|NCT01083576|589476128|FG001|Overall Study|Treatment Failure|1|||
163208317|NCT01986985|589476129|FG000|Overall Study|Withdrawal by Subject|4|||
162968304|NCT02004691|588584823|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
162968305|NCT02004691|588584824|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
162968306|NCT02004691|588584823|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
162968307|NCT02004691|588584824|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
162968308|NCT02004691|588584823|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
162968309|NCT02004691|588584824|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
162968310|NCT02004691|588584823|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
162968311|NCT02004691|588584824|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
162968312|NCT02004691|588584823|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
162968313|NCT02004691|588584824|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
162968314|NCT02004691|588584823|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
162968315|NCT02004691|588584824|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
162968316|NCT01726803|588584825|FG000|Overall Study|Lost to Follow-up|6|||
162968317|NCT01726803|588584826|FG001|Overall Study|Lost to Follow-up|1|||
162968318|NCT01726803|588584825|FG000|Overall Study|Withdrawal by Subject|1|||
162968319|NCT01726803|588584826|FG001|Overall Study|Withdrawal by Subject|0|||
162968320|NCT03407729|588584828|FG000|Overall Study|Lost to Follow-up|2|||
162968321|NCT03407729|588584829|FG001|Overall Study|Lost to Follow-up|0|||
162968322|NCT03407729|588584828|FG000|Overall Study|Unable to schedule|0|||
162968323|NCT03407729|588584829|FG001|Overall Study|Unable to schedule|3|||
162968324|NCT01849458|588584830|FG000|Overall Study|Lost to Follow-up|4|||
163208318|NCT01986985|589476129|FG000|Overall Study|Scan not completed due to malfunction|3|||
163208319|NCT00449540|589476130|FG000|Pretreatment Phase|No migraine experienced|66|||
163208320|NCT00449540|589476131|FG001|Pretreatment Phase|No migraine experienced|0|||
163208321|NCT00449540|589476132|FG002|Pretreatment Phase|No migraine experienced|0|||
163208322|NCT00449540|589476130|FG000|Treatment Phase|did not experience or treat migraine|0|||
163208323|NCT00449540|589476131|FG001|Treatment Phase|did not experience or treat migraine|20|||
163208324|NCT00449540|589476132|FG002|Treatment Phase|did not experience or treat migraine|17|||
162968325|NCT00024258|588584833|FG000|Overall Study|Withdrawal by Subject|1|||
163399485|NCT03519867|590172642|FG008|Overall Study|Adverse Event|0|||
163399486|NCT03519867|590172643|FG009|Overall Study|Adverse Event|0|||
163399487|NCT03519867|590172634|FG000|Overall Study|Protocol Violation|0|||
163399488|NCT03519867|590172635|FG001|Overall Study|Protocol Violation|0|||
163399489|NCT03519867|590172636|FG002|Overall Study|Protocol Violation|0|||
163399490|NCT03519867|590172637|FG003|Overall Study|Protocol Violation|0|||
163399491|NCT03519867|590172638|FG004|Overall Study|Protocol Violation|0|||
163399492|NCT03519867|590172639|FG005|Overall Study|Protocol Violation|1|||
163399493|NCT03519867|590172640|FG006|Overall Study|Protocol Violation|0|||
163399494|NCT03519867|590172641|FG007|Overall Study|Protocol Violation|0|||
163399495|NCT03519867|590172642|FG008|Overall Study|Protocol Violation|0|||
163399496|NCT03519867|590172643|FG009|Overall Study|Protocol Violation|0|||
163399497|NCT03519867|590172634|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163399498|NCT03519867|590172635|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163399499|NCT03519867|590172636|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163399500|NCT03519867|590172637|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163399501|NCT03519867|590172638|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163399502|NCT03519867|590172639|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163399503|NCT03519867|590172640|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
163399504|NCT03519867|590172641|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163399505|NCT03519867|590172642|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163399506|NCT03519867|590172643|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163399507|NCT03519867|590172634|FG000|Overall Study|Admin. of other reversal agent|1|||
163399508|NCT03519867|590172635|FG001|Overall Study|Admin. of other reversal agent|1|||
163399509|NCT03519867|590172636|FG002|Overall Study|Admin. of other reversal agent|0|||
163399510|NCT03519867|590172637|FG003|Overall Study|Admin. of other reversal agent|0|||
163399511|NCT03519867|590172638|FG004|Overall Study|Admin. of other reversal agent|0|||
163399512|NCT03519867|590172639|FG005|Overall Study|Admin. of other reversal agent|1|||
163399513|NCT03519867|590172640|FG006|Overall Study|Admin. of other reversal agent|0|||
163399514|NCT03519867|590172641|FG007|Overall Study|Admin. of other reversal agent|0|||
163399515|NCT03519867|590172642|FG008|Overall Study|Admin. of other reversal agent|0|||
163399516|NCT03519867|590172643|FG009|Overall Study|Admin. of other reversal agent|0|||
163399517|NCT03519867|590172634|FG000|Overall Study|Reason not provided|1|||
163399518|NCT03519867|590172635|FG001|Overall Study|Reason not provided|1|||
163399519|NCT03519867|590172636|FG002|Overall Study|Reason not provided|1|||
163399520|NCT03519867|590172637|FG003|Overall Study|Reason not provided|1|||
163399521|NCT03519867|590172638|FG004|Overall Study|Reason not provided|0|||
163399522|NCT03519867|590172639|FG005|Overall Study|Reason not provided|1|||
163399523|NCT03519867|590172640|FG006|Overall Study|Reason not provided|0|||
163399524|NCT03519867|590172641|FG007|Overall Study|Reason not provided|1|||
163399525|NCT03519867|590172642|FG008|Overall Study|Reason not provided|1|||
163399526|NCT03519867|590172643|FG009|Overall Study|Reason not provided|0|||
163399527|NCT01846624|590172644|FG000|Overall Study|Died during induction, no midostaurin|1|||
163399528|NCT03472924|590172647|FG000|Overall Study|Adverse Event|1|||
163399529|NCT03472924|590172648|FG001|Overall Study|Adverse Event|0|||
163399530|NCT02546765|590172650|FG000|Overall Study|Withdrawal by Subject|0|||
163399531|NCT02546765|590172651|FG001|Overall Study|Withdrawal by Subject|1|||
163399532|NCT02546765|590172652|FG002|Overall Study|Withdrawal by Subject|0|||
163399533|NCT02546765|590172653|FG003|Overall Study|Withdrawal by Subject|0|||
163399534|NCT04425720|590172656|FG000|Overall Study|Withdrawal by Subject|0|||
163399535|NCT04425720|590172657|FG001|Overall Study|Withdrawal by Subject|20|||
163399536|NCT04814823|590172658|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
163399537|NCT05318937|590172663|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163399538|NCT05318937|590172664|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163399539|NCT05318937|590172663|FG000|Overall Study|Lost to Follow-up|0|||
163399540|NCT05318937|590172664|FG001|Overall Study|Lost to Follow-up|1|||
163399541|NCT05318937|590172663|FG000|Overall Study|Withdrawal by Subject|0|||
163399542|NCT05318937|590172664|FG001|Overall Study|Withdrawal by Subject|2|||
163399543|NCT05318937|590172663|FG000|Overall Study|Protocol Violation|0|||
163399544|NCT05318937|590172664|FG001|Overall Study|Protocol Violation|1|||
163399545|NCT05678257|590172665|FG000|Overall Study|Withdrawal by Subject|2|||
163399546|NCT05678257|590172666|FG001|Overall Study|Withdrawal by Subject|0|||
163208325|NCT04577118|589476133|FG000|Overall Study|Withdrawal by Subject|4|||
162968326|NCT00024258|588584833|FG000|Overall Study|Disease Progression|8|||
162968327|NCT01863433|588584834|FG000|Overall Study|Protocol Violation|1|||
162968328|NCT03950674|588584835|FG000|Overall Study|Death|16|||
162968329|NCT03950674|588584836|FG001|Overall Study|Death|15|||
162968330|NCT03950674|588584835|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
162968331|NCT03950674|588584836|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
162968332|NCT00830167|588584839|FG000|Overall Study|Lack of Efficacy|26|||
162968333|NCT00830167|588584840|FG001|Overall Study|Lack of Efficacy|10|||
162968334|NCT00830167|588584839|FG000|Overall Study|Adverse Event|8|||
162968335|NCT00830167|588584840|FG001|Overall Study|Adverse Event|24|||
162968336|NCT00830167|588584839|FG000|Overall Study|Not meeting entrance criteria|2|||
162968337|NCT00830167|588584840|FG001|Overall Study|Not meeting entrance criteria|5|||
162968338|NCT00830167|588584839|FG000|Overall Study|Withdrawal by Subject|2|||
162968339|NCT00830167|588584840|FG001|Overall Study|Withdrawal by Subject|0|||
162968340|NCT00830167|588584839|FG000|Overall Study|Lost to Follow-up|0|||
162968341|NCT00830167|588584840|FG001|Overall Study|Lost to Follow-up|1|||
162968342|NCT00830167|588584839|FG000|Overall Study|Protocol Violation|0|||
162968343|NCT00830167|588584840|FG001|Overall Study|Protocol Violation|1|||
162968344|NCT00830167|588584839|FG000|Overall Study|Other|2|||
162968345|NCT00830167|588584840|FG001|Overall Study|Other|2|||
162968346|NCT03428945|588584841|FG000|Overall Study|Lost to Follow-up|5|||
162968347|NCT03428945|588584842|FG001|Overall Study|Lost to Follow-up|3|||
162968348|NCT03428945|588584841|FG000|Overall Study|Withdrawal by Subject|10|||
162968349|NCT03428945|588584842|FG001|Overall Study|Withdrawal by Subject|10|||
162968350|NCT00982228|588584843|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
162968351|NCT00982228|588584844|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
162968352|NCT00982228|588584843|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
162968353|NCT00982228|588584844|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
162968354|NCT00982228|588584843|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
162968355|NCT00982228|588584844|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
162968356|NCT00982228|588584843|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
162968357|NCT00982228|588584844|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
162968358|NCT00982228|588584843|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
162968359|NCT00982228|588584844|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
162968360|NCT00982228|588584843|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
162968361|NCT00982228|588584844|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
162968362|NCT00982228|588584843|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
163208326|NCT00356369|589476134|FG000|Active Phase|Withdrawal by Subject|2|||
163208327|NCT00356369|589476135|FG001|Active Phase|Withdrawal by Subject|1|||
162968363|NCT00982228|588584844|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
162968364|NCT00982228|588584843|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
162968365|NCT00982228|588584844|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
162968366|NCT00982228|588584843|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
162968367|NCT00982228|588584844|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
163208328|NCT00673465|589476136|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
163399547|NCT05678257|590172667|FG002|Overall Study|Withdrawal by Subject|5|||
162968368|NCT00982228|588584843|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
162968369|NCT00982228|588584844|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
162968370|NCT00360490|588584848|FG000|Overall Study|Adverse Event|4|||
162968371|NCT00360490|588584849|FG001|Overall Study|Adverse Event|2|||
162968372|NCT00360490|588584848|FG000|Overall Study|Lost to Follow-up|2|||
162968373|NCT00360490|588584849|FG001|Overall Study|Lost to Follow-up|1|||
162968374|NCT00360490|588584848|FG000|Overall Study|Physician Decision|2|||
162968375|NCT00360490|588584849|FG001|Overall Study|Physician Decision|1|||
162968376|NCT00360490|588584848|FG000|Overall Study|Protocol Violation|0|||
162968377|NCT00360490|588584849|FG001|Overall Study|Protocol Violation|4|||
162968378|NCT00360490|588584848|FG000|Overall Study|Withdrawal by Subject|1|||
162968379|NCT00360490|588584849|FG001|Overall Study|Withdrawal by Subject|3|||
162968380|NCT02289820|588584850|FG000|Overall Study|Withdrawal by Subject|2|||
162968381|NCT02289820|588584851|FG001|Overall Study|Withdrawal by Subject|1|||
162968382|NCT02289820|588584852|FG002|Overall Study|Withdrawal by Subject|2|||
162968383|NCT02289820|588584853|FG003|Overall Study|Withdrawal by Subject|1|||
162968384|NCT02289820|588584854|FG004|Overall Study|Withdrawal by Subject|0|||
162968385|NCT02289820|588584855|FG005|Overall Study|Withdrawal by Subject|0|||
162968386|NCT02289820|588584856|FG006|Overall Study|Withdrawal by Subject|1|||
162968387|NCT02289820|588584850|FG000|Overall Study|Death|0|||
162968388|NCT02289820|588584851|FG001|Overall Study|Death|0|||
163208329|NCT00673465|589476137|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
163208330|NCT00673465|589476138|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
163208331|NCT00673465|589476139|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
163208332|NCT00673465|589476140|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
163208333|NCT00673465|589476141|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
163208334|NCT00673465|589476142|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
163208335|NCT00673465|589476143|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
163208336|NCT00673465|589476144|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
163208337|NCT00673465|589476145|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
163208338|NCT00673465|589476146|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
163208339|NCT00673465|589476147|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
163208340|NCT00673465|589476136|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
163208341|NCT00673465|589476137|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
163208342|NCT00673465|589476138|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
163208343|NCT00673465|589476139|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
163208344|NCT00673465|589476140|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
163208345|NCT00673465|589476141|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
163208346|NCT00673465|589476142|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
162968389|NCT02289820|588584852|FG002|Overall Study|Death|1|||
162968390|NCT02289820|588584853|FG003|Overall Study|Death|0|||
162968391|NCT02289820|588584854|FG004|Overall Study|Death|0|||
162968392|NCT02289820|588584855|FG005|Overall Study|Death|0|||
162968393|NCT02289820|588584856|FG006|Overall Study|Death|0|||
162968394|NCT02289820|588584850|FG000|Overall Study|Lost to Follow-up|0|||
162968395|NCT02289820|588584851|FG001|Overall Study|Lost to Follow-up|0|||
162968396|NCT02289820|588584852|FG002|Overall Study|Lost to Follow-up|3|||
162968397|NCT02289820|588584853|FG003|Overall Study|Lost to Follow-up|1|||
162968398|NCT02289820|588584854|FG004|Overall Study|Lost to Follow-up|0|||
162968399|NCT02289820|588584855|FG005|Overall Study|Lost to Follow-up|1|||
162968400|NCT02289820|588584856|FG006|Overall Study|Lost to Follow-up|1|||
162968401|NCT02289820|588584850|FG000|Overall Study|withdrawal of consent|0|||
162968402|NCT02289820|588584851|FG001|Overall Study|withdrawal of consent|1|||
162968403|NCT02289820|588584852|FG002|Overall Study|withdrawal of consent|0|||
162968404|NCT02289820|588584853|FG003|Overall Study|withdrawal of consent|0|||
162968405|NCT02289820|588584854|FG004|Overall Study|withdrawal of consent|0|||
162968406|NCT02289820|588584855|FG005|Overall Study|withdrawal of consent|0|||
162968407|NCT02289820|588584856|FG006|Overall Study|withdrawal of consent|0|||
162968408|NCT02005276|588584857|FG000|Overall Study|No longer interested|5|||
162968409|NCT02005276|588584858|FG001|Overall Study|No longer interested|2|||
162968410|NCT02005276|588584859|FG002|Overall Study|No longer interested|3|||
162968411|NCT02005276|588584860|FG003|Overall Study|No longer interested|3|||
162968412|NCT01688882|588584867|FG000|Overall Study|Adverse Event|1|||
162968413|NCT01688882|588584868|FG001|Overall Study|Adverse Event|0|||
162968414|NCT01688882|588584867|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162968415|NCT01688882|588584868|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162968416|NCT01688882|588584867|FG000|Overall Study|Administrative problems|1|||
162968417|NCT01688882|588584868|FG001|Overall Study|Administrative problems|0|||
162968418|NCT00124618|588584869|FG000|Overall Study|Ineligible|1|||
162968419|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
163316800|NCT03910478|589871098|FG001|Overall Study|Physician Decision|0|||
163316801|NCT03910478|589871097|FG000|Overall Study|Protocol Violation|1|||
162968420|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
162968421|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
163316802|NCT03910478|589871098|FG001|Overall Study|Protocol Violation|0|||
162968422|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
163316803|NCT03910478|589871097|FG000|Overall Study|Failure to meet continuation criteria|2|||
163316804|NCT03910478|589871098|FG001|Overall Study|Failure to meet continuation criteria|0|||
163316805|NCT03910478|589871097|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
163054432|NCT01973218|588910298|FG001|Overall Study|Withdrawal by Subject|0|||
163054433|NCT00720499|588910299|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
163208347|NCT00673465|589476143|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
163208348|NCT00673465|589476144|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
163208349|NCT00673465|589476145|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
163208350|NCT00673465|589476146|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
163208351|NCT00673465|589476147|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
163208352|NCT01195415|589476166|FG000|Overall Study|No repeat biopsy due to progression|2|||
163208353|NCT01919723|589476167|FG000|Overall Study|Blood Samples Hemolyzed|2|||
163208354|NCT01919723|589476168|FG001|Overall Study|Blood Samples Hemolyzed|2|||
163208355|NCT04294472|589476169|FG000|Overall Study|Adverse Event|0|||
163208356|NCT04294472|589476170|FG001|Overall Study|Adverse Event|1|||
162968423|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
162968424|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
162968425|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
162968426|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
162968427|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
162968428|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
162968429|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
162968430|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
162968431|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
162968432|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
162968433|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
162968434|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
162968435|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
162968436|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
162968437|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
162968438|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
162968439|NCT00950300|588584870|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
162968440|NCT00950300|588584871|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
162968441|NCT00950300|588584870|FG000|TFFU Period|Death|4|||
162968442|NCT00950300|588584871|FG001|TFFU Period|Death|1|||
162968443|NCT00950300|588584870|FG000|TFFU Period|Refused Treatment|10|||
162968444|NCT00950300|588584871|FG001|TFFU Period|Refused Treatment|11|||
162968445|NCT00950300|588584870|FG000|TFFU Period|Failure to Return|16|||
162968446|NCT00950300|588584871|FG001|TFFU Period|Failure to Return|16|||
162968447|NCT00950300|588584870|FG000|TFFU Period|Recurrence of Disease|63|||
162968448|NCT00950300|588584871|FG001|TFFU Period|Recurrence of Disease|72|||
162968449|NCT00950300|588584870|FG000|TFFU Period|Other|4|||
162968450|NCT00950300|588584871|FG001|TFFU Period|Other|3|||
162968451|NCT00950300|588584870|FG000|SFU Period|Death|44|||
162968452|NCT00950300|588584871|FG001|SFU Period|Death|42|||
162968453|NCT00950300|588584870|FG000|SFU Period|Lost to Follow-up|30|||
162968454|NCT00950300|588584871|FG001|SFU Period|Lost to Follow-up|28|||
162968455|NCT00950300|588584870|FG000|SFU Period|Withdrawal by Subject|4|||
162968456|NCT00950300|588584871|FG001|SFU Period|Withdrawal by Subject|8|||
162968457|NCT01912807|588584872|FG000|Overall Study|Did not meet elegibility criteria|6|||
162968458|NCT01912807|588584873|FG001|Overall Study|Did not meet elegibility criteria|4|||
162968459|NCT01912807|588584872|FG000|Overall Study|Lost to Follow-up|36|||
162968460|NCT01912807|588584873|FG001|Overall Study|Lost to Follow-up|37|||
163208357|NCT04294472|589476171|FG002|Overall Study|Adverse Event|1|||
163208358|NCT04294472|589476169|FG000|Overall Study|Randomized but not treated|0|||
163208359|NCT04294472|589476170|FG001|Overall Study|Randomized but not treated|1|||
162968461|NCT04750239|588584874|FG000|Overall Study|Withdrawal by Subject|2|||
162968462|NCT04750239|588584874|FG000|Overall Study|Trial terminated by sponsor|1|||
162968463|NCT00834613|588584877|FG000|First Intervention|Protocol Violation|1|||
162968464|NCT00834613|588584878|FG001|First Intervention|Protocol Violation|0|||
163208360|NCT04294472|589476171|FG002|Overall Study|Randomized but not treated|1|||
163399548|NCT05678257|590172665|FG000|Overall Study|Physician Decision|1|||
163399549|NCT05678257|590172666|FG001|Overall Study|Physician Decision|0|||
163399550|NCT05678257|590172667|FG002|Overall Study|Physician Decision|1|||
163399551|NCT05678257|590172665|FG000|Overall Study|Adverse Event|1|||
163399552|NCT05678257|590172666|FG001|Overall Study|Adverse Event|3|||
163399553|NCT05678257|590172667|FG002|Overall Study|Adverse Event|1|||
163399554|NCT05678257|590172665|FG000|Overall Study|Progressive disease|11|||
163399555|NCT05678257|590172666|FG001|Overall Study|Progressive disease|18|||
163399556|NCT05678257|590172667|FG002|Overall Study|Progressive disease|7|||
163399557|NCT05678257|590172665|FG000|Overall Study|No longer clinically benefitting|2|||
163399558|NCT05678257|590172666|FG001|Overall Study|No longer clinically benefitting|1|||
163399559|NCT05678257|590172667|FG002|Overall Study|No longer clinically benefitting|0|||
163399560|NCT05678257|590172665|FG000|Overall Study|Sponsor decision|5|||
163399561|NCT05678257|590172666|FG001|Overall Study|Sponsor decision|9|||
162968465|NCT00663234|588584879|FG000|Overall Study|Not willing to adhere to requirements|1|||
162968466|NCT01253564|588584882|FG000|Overall Study|Disease Progression|22|||
162968467|NCT01253564|588584882|FG000|Overall Study|Withdrawal by Subject|1|||
162968468|NCT01253564|588584882|FG000|Overall Study|Serious Adverse Event|1|||
162968469|NCT04584983|588584883|FG000|Overall Study|Parental request for withdraw|2|||
162968470|NCT04584983|588584884|FG001|Overall Study|Parental request for withdraw|0|||
163208361|NCT00563381|589476172|FG000|Overall Study|Adverse Event|264|||
163208362|NCT00563381|589476173|FG001|Overall Study|Adverse Event|292|||
162968471|NCT00288704|588586237|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
163208363|NCT00563381|589476172|FG000|Overall Study|Protocol Violation|66|||
162968472|NCT00288704|588586238|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
162968473|NCT00288704|588586239|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
162968474|NCT00288704|588586237|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
162968475|NCT00288704|588586238|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
162968476|NCT00288704|588586239|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
162968477|NCT00288704|588586237|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
162968478|NCT00288704|588586238|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
162968479|NCT00288704|588586239|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
162968480|NCT00288704|588586237|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
162968481|NCT00288704|588586238|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
162968482|NCT00288704|588586239|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
162968483|NCT00288704|588586237|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
162968484|NCT00288704|588586238|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
162968485|NCT00288704|588586239|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
162968486|NCT00288704|588586237|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
162968487|NCT00288704|588586238|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
162968488|NCT00288704|588586239|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
162968489|NCT00288704|588586237|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
162968490|NCT00288704|588586238|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
162968491|NCT00288704|588586239|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
162968492|NCT00676650|588586240|FG000|Overall Study|Death|45|||
162968493|NCT00676650|588586241|FG001|Overall Study|Death|14|||
162968494|NCT00676650|588586240|FG000|Overall Study|Adverse Event|159|||
162968495|NCT00676650|588586241|FG001|Overall Study|Adverse Event|21|||
162968496|NCT00676650|588586240|FG000|Overall Study|Global deterioration of health status|66|||
162968497|NCT00676650|588586241|FG001|Overall Study|Global deterioration of health status|31|||
162968498|NCT00676650|588586240|FG000|Overall Study|Lost to Follow-up|0|||
162968499|NCT00676650|588586241|FG001|Overall Study|Lost to Follow-up|1|||
163208364|NCT00563381|589476173|FG001|Overall Study|Protocol Violation|74|||
163208365|NCT00563381|589476172|FG000|Overall Study|Lost to Follow-up|7|||
163208366|NCT00563381|589476173|FG001|Overall Study|Lost to Follow-up|15|||
163208367|NCT00563381|589476172|FG000|Overall Study|Withdrawal by Subject|192|||
163208368|NCT00563381|589476173|FG001|Overall Study|Withdrawal by Subject|209|||
163208369|NCT00563381|589476172|FG000|Overall Study|Lack of Efficacy|32|||
163208370|NCT00563381|589476173|FG001|Overall Study|Lack of Efficacy|24|||
163208371|NCT00563381|589476172|FG000|Overall Study|Individual different reasons|24|||
163208372|NCT00563381|589476173|FG001|Overall Study|Individual different reasons|34|||
163208373|NCT01957644|589476174|FG000|Overall Study|Adverse Event|4|||
163208374|NCT01957644|589476175|FG001|Overall Study|Adverse Event|2|||
163208375|NCT01957644|589476176|FG002|Overall Study|Adverse Event|0|||
163208376|NCT01957644|589476177|FG003|Overall Study|Adverse Event|0|||
163208377|NCT01957644|589476178|FG004|Overall Study|Adverse Event|1|||
163208378|NCT01957644|589476174|FG000|Overall Study|Progressive disease / relapse|0|||
163208379|NCT01957644|589476175|FG001|Overall Study|Progressive disease / relapse|1|||
163208380|NCT01957644|589476176|FG002|Overall Study|Progressive disease / relapse|0|||
163208381|NCT01957644|589476177|FG003|Overall Study|Progressive disease / relapse|1|||
163208382|NCT01957644|589476178|FG004|Overall Study|Progressive disease / relapse|0|||
163399562|NCT05678257|590172667|FG002|Overall Study|Sponsor decision|8|||
162968500|NCT00676650|588586240|FG000|Overall Study|Objective progression or relapse|189|||
162968501|NCT00676650|588586241|FG001|Overall Study|Objective progression or relapse|140|||
162968502|NCT00676650|588586240|FG000|Overall Study|Other|14|||
162968503|NCT00676650|588586241|FG001|Overall Study|Other|10|||
162968504|NCT00676650|588586240|FG000|Overall Study|Protocol Violation|3|||
162968505|NCT00676650|588586241|FG001|Overall Study|Protocol Violation|1|||
162968506|NCT00676650|588586240|FG000|Overall Study|Study terminated by sponsor|57|||
162968507|NCT00676650|588586241|FG001|Overall Study|Study terminated by sponsor|43|||
162968508|NCT00676650|588586240|FG000|Overall Study|Withdrawal by Subject|48|||
162968509|NCT00676650|588586241|FG001|Overall Study|Withdrawal by Subject|24|||
162968510|NCT00676650|588586240|FG000|Overall Study|Randomized but not treated|3|||
162968511|NCT00676650|588586241|FG001|Overall Study|Randomized but not treated|4|||
162968512|NCT02297841|588586245|FG000|Overall Study|Withdrawal by Subject|1|||
162968513|NCT02297841|588586245|FG000|Overall Study|Protocol Violation|7|||
162968514|NCT05061992|588586246|FG000|Overall Study|Excess bowel movements|1|||
162968515|NCT05061992|588586247|FG001|Overall Study|Excess bowel movements|0|||
162968516|NCT05061992|588586246|FG000|Overall Study|Complications of Medical Care|1|||
162968517|NCT05061992|588586247|FG001|Overall Study|Complications of Medical Care|0|||
162968518|NCT05061992|588586246|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
162968519|NCT05061992|588586247|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
162968520|NCT05061992|588586246|FG000|Overall Study|Withdrawal by Subject|0|||
162968521|NCT05061992|588586247|FG001|Overall Study|Withdrawal by Subject|1|||
163208383|NCT01957644|589476174|FG000|Overall Study|Other reason|1|||
162968522|NCT01257581|588586252|FG000|Overall Study|Early Termination|3|||
162968523|NCT01257581|588586253|FG001|Overall Study|Early Termination|1|||
163208384|NCT01957644|589476175|FG001|Overall Study|Other reason|2|||
162968524|NCT01257581|588586254|FG002|Overall Study|Early Termination|2|||
163208385|NCT01957644|589476176|FG002|Overall Study|Other reason|1|||
163399563|NCT05678257|590172665|FG000|Overall Study|Protocol Violation|0|||
163399564|NCT05678257|590172666|FG001|Overall Study|Protocol Violation|0|||
163399565|NCT05678257|590172667|FG002|Overall Study|Protocol Violation|1|||
163399566|NCT05678257|590172665|FG000|Overall Study|Patient non-compliance|0|||
163399567|NCT05678257|590172666|FG001|Overall Study|Patient non-compliance|0|||
163399568|NCT05678257|590172667|FG002|Overall Study|Patient non-compliance|3|||
163399569|NCT01045798|590172668|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
163399570|NCT01045798|590172669|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
163399571|NCT01045798|590172668|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
163399572|NCT01045798|590172669|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
163399573|NCT01045798|590172668|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
163399574|NCT01045798|590172669|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
163399575|NCT01045798|590172668|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
163399576|NCT01045798|590172669|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
163399577|NCT01449461|590172670|FG000|Overall Study|Adverse Event|0|||
163399578|NCT01449461|590172671|FG001|Overall Study|Adverse Event|3|||
163399579|NCT01449461|590172672|FG002|Overall Study|Adverse Event|2|||
163399580|NCT01449461|590172673|FG003|Overall Study|Adverse Event|3|||
163399581|NCT01449461|590172674|FG004|Overall Study|Adverse Event|4|||
163399582|NCT01449461|590172675|FG005|Overall Study|Adverse Event|4|||
163399583|NCT01449461|590172670|FG000|Overall Study|Death|0|||
163399584|NCT01449461|590172671|FG001|Overall Study|Death|2|||
162968525|NCT01257581|588586252|FG000|Overall Study|Death|2|||
163054434|NCT00720499|588910300|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
163054435|NCT00720499|588910299|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
163054436|NCT00720499|588910300|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
163054437|NCT00720499|588910299|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
163054438|NCT00720499|588910300|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
163054439|NCT02247466|588910301|FG000|Overall Study|Procedure changed to open surgery|0|||
163054440|NCT02247466|588910302|FG001|Overall Study|Procedure changed to open surgery|3|||
163054441|NCT00492726|588910303|FG000|Overall Study|Adverse Event|10|||
163054442|NCT00492726|588910304|FG001|Overall Study|Adverse Event|6|||
163054443|NCT00492726|588910303|FG000|Overall Study|Death|7|||
163054444|NCT00492726|588910304|FG001|Overall Study|Death|2|||
163054445|NCT00492726|588910303|FG000|Overall Study|Lack of Efficacy|0|||
163054446|NCT00492726|588910304|FG001|Overall Study|Lack of Efficacy|2|||
163054447|NCT00492726|588910303|FG000|Overall Study|Lost to Follow-up|27|||
163054448|NCT00492726|588910304|FG001|Overall Study|Lost to Follow-up|19|||
163054449|NCT00492726|588910303|FG000|Overall Study|Physician Decision|0|||
163054450|NCT00492726|588910304|FG001|Overall Study|Physician Decision|1|||
163054451|NCT00492726|588910303|FG000|Overall Study|Withdrawal by Subject|6|||
163054452|NCT00492726|588910304|FG001|Overall Study|Withdrawal by Subject|3|||
163054453|NCT00492726|588910303|FG000|Overall Study|Non compliant with study medication|0|||
163054454|NCT00492726|588910304|FG001|Overall Study|Non compliant with study medication|3|||
163054455|NCT01100502|588910305|FG000|Overall Study|Withdrawal by Subject|18|||
163054456|NCT01100502|588910306|FG001|Overall Study|Withdrawal by Subject|25|||
163054457|NCT01100502|588910305|FG000|Overall Study|Lost to Follow-up|13|||
163054458|NCT01100502|588910306|FG001|Overall Study|Lost to Follow-up|28|||
163054459|NCT01100502|588910305|FG000|Overall Study|Site request to end participation in study|0|||
163054460|NCT01100502|588910306|FG001|Overall Study|Site request to end participation in study|1|||
163054461|NCT01100502|588910305|FG000|Overall Study|Death|45|||
163054462|NCT01100502|588910306|FG001|Overall Study|Death|40|||
163054463|NCT04386902|588910307|FG000|Overall Study|Withdrawal by Subject|5|||
163054464|NCT04386902|588910307|FG000|Overall Study|Technical problems in the recording|5|||
163054465|NCT00073918|588910318|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
163054466|NCT00073918|588910318|FG000|Overall Study|Rapid disease progression|2|||
163054467|NCT00073918|588910318|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
163054468|NCT04356937|588910320|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
163054469|NCT04356937|588910321|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
163054470|NCT00807365|588910322|FG000|Overall Study|Study Terminated|5|||
163054471|NCT04821830|588910325|FG000|Overall Study|Withdrawal by Subject|1|||
163054472|NCT04821830|588910326|FG001|Overall Study|Withdrawal by Subject|0|||
163054473|NCT02557399|588910327|FG000|Overall Study|Adverse Event|6|||
163054474|NCT02557399|588910328|FG001|Overall Study|Adverse Event|5|||
163054475|NCT02557399|588910327|FG000|Overall Study|Protocol Violation|0|||
163054476|NCT02557399|588910328|FG001|Overall Study|Protocol Violation|1|||
163054477|NCT02557399|588910327|FG000|Overall Study|Protocol-defined stopping criteria|0|||
163054478|NCT02557399|588910328|FG001|Overall Study|Protocol-defined stopping criteria|1|||
162968526|NCT01257581|588586253|FG001|Overall Study|Death|2|||
162968527|NCT01257581|588586254|FG002|Overall Study|Death|4|||
162968528|NCT01157234|588586255|FG000|Overall Study|Withdrawal by Subject|1|||
162968529|NCT01157234|588586256|FG001|Overall Study|Withdrawal by Subject|0|||
162968530|NCT05996198|588586269|FG000|Overall Study|Withdrawal by Subject|1|||
162968531|NCT05996198|588586270|FG001|Overall Study|Withdrawal by Subject|0|||
162968532|NCT00059332|588586274|FG000|Overall Study|Withdrawal by Subject|2|||
162968533|NCT00059332|588586275|FG001|Overall Study|Withdrawal by Subject|1|||
162968534|NCT00059332|588586274|FG000|Overall Study|Lost to Follow-up|1|||
163054479|NCT02557399|588910327|FG000|Overall Study|Withdrawal by Subject|1|||
163054480|NCT02557399|588910328|FG001|Overall Study|Withdrawal by Subject|1|||
163054481|NCT00960804|588910329|FG000|Overall Study|Adverse Event|1|||
163054482|NCT00960804|588910330|FG001|Overall Study|Adverse Event|0|||
163054483|NCT00960804|588910331|FG002|Overall Study|Adverse Event|0|||
163054484|NCT00960804|588910329|FG000|Overall Study|Withdrawal by Subject|1|||
163054485|NCT00960804|588910330|FG001|Overall Study|Withdrawal by Subject|0|||
163054486|NCT00960804|588910331|FG002|Overall Study|Withdrawal by Subject|0|||
163054487|NCT00960804|588910329|FG000|Overall Study|Study terminated by the sponsor|5|||
163054488|NCT00960804|588910330|FG001|Overall Study|Study terminated by the sponsor|4|||
163054489|NCT00960804|588910331|FG002|Overall Study|Study terminated by the sponsor|10|||
163054490|NCT02007720|588910332|FG000|Overall Study|Withdrawal by Subject|9|||
163054491|NCT02007720|588910333|FG001|Overall Study|Withdrawal by Subject|11|||
163054492|NCT02007720|588910332|FG000|Overall Study|study terminated by sponsor|58|||
163054493|NCT02007720|588910333|FG001|Overall Study|study terminated by sponsor|54|||
163054494|NCT02007720|588910332|FG000|Overall Study|technical problem|4|||
163054495|NCT02007720|588910333|FG001|Overall Study|technical problem|2|||
163054496|NCT02007720|588910332|FG000|Overall Study|patient followd less than 165 days|11|||
163054497|NCT02007720|588910333|FG001|Overall Study|patient followd less than 165 days|5|||
163054498|NCT00490919|588910335|FG000|Open-label Run-in Period|Adverse Event|239|||
163054499|NCT00490919|588910336|FG001|Open-label Run-in Period|Adverse Event|0|||
163054500|NCT00490919|588910337|FG002|Open-label Run-in Period|Adverse Event|0|||
163054501|NCT00490919|588910335|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
163054502|NCT00490919|588910336|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
163054503|NCT00490919|588910337|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
163054504|NCT00490919|588910335|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
163054505|NCT00490919|588910336|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
163054506|NCT00490919|588910337|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
163054507|NCT00490919|588910335|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
163054508|NCT00490919|588910336|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
163054509|NCT00490919|588910337|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
163054510|NCT00490919|588910335|FG000|Open-label Run-in Period|Administrative|40|||
163054511|NCT00490919|588910336|FG001|Open-label Run-in Period|Administrative|0|||
163054512|NCT00490919|588910337|FG002|Open-label Run-in Period|Administrative|0|||
163054513|NCT00490919|588910335|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
163054514|NCT00490919|588910336|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
163054515|NCT00490919|588910337|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
163054516|NCT00490919|588910335|FG000|Double-blind Phase|Adverse Event|0|||
163054517|NCT00490919|588910336|FG001|Double-blind Phase|Adverse Event|40|||
163054518|NCT00490919|588910337|FG002|Double-blind Phase|Adverse Event|20|||
163054519|NCT00490919|588910335|FG000|Double-blind Phase|Withdrawal by Subject|0|||
163054520|NCT00490919|588910336|FG001|Double-blind Phase|Withdrawal by Subject|10|||
163054521|NCT00490919|588910337|FG002|Double-blind Phase|Withdrawal by Subject|11|||
163054522|NCT00490919|588910335|FG000|Double-blind Phase|Lost to Follow-up|0|||
163054523|NCT00490919|588910336|FG001|Double-blind Phase|Lost to Follow-up|8|||
163054524|NCT00490919|588910337|FG002|Double-blind Phase|Lost to Follow-up|11|||
163054525|NCT00490919|588910335|FG000|Double-blind Phase|Lack of Efficacy|0|||
163054526|NCT00490919|588910336|FG001|Double-blind Phase|Lack of Efficacy|22|||
163054527|NCT00490919|588910337|FG002|Double-blind Phase|Lack of Efficacy|36|||
163054528|NCT00490919|588910335|FG000|Double-blind Phase|Administrative|0|||
163054529|NCT00490919|588910336|FG001|Double-blind Phase|Administrative|6|||
163054530|NCT00490919|588910337|FG002|Double-blind Phase|Administrative|6|||
163054531|NCT02100124|588910340|FG000|Overall Study|Lost to Follow-up|5|||
163054532|NCT02100124|588910341|FG001|Overall Study|Lost to Follow-up|11|||
163054533|NCT02100124|588910342|FG002|Overall Study|Lost to Follow-up|3|||
163054534|NCT02100124|588910340|FG000|Overall Study|Withdrawal by Subject|1|||
163054535|NCT02100124|588910341|FG001|Overall Study|Withdrawal by Subject|0|||
163054536|NCT02100124|588910342|FG002|Overall Study|Withdrawal by Subject|0|||
163054537|NCT04350827|588910343|FG000|Overall Study|Lost to Follow-up|1|||
163054538|NCT04350827|588910344|FG001|Overall Study|Lost to Follow-up|2|||
163054539|NCT07116759|588910345|FG000|Overall Study|Incompatibility with the RHMC device|2|||
163054540|NCT02034006|588911684|FG000|Overall Study|Withdrawal by Subject|7|||
163054541|NCT02034006|588911684|FG000|Overall Study|Lost to Follow-up|5|||
163054542|NCT02034006|588911684|FG000|Overall Study|Death|1|||
163054543|NCT02034006|588911684|FG000|Overall Study|Pregnancy|1|||
162968535|NCT00059332|588586275|FG001|Overall Study|Lost to Follow-up|1|||
162968536|NCT00487695|588586278|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
162968537|NCT00487695|588586279|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
162968538|NCT00487695|588586278|FG000|First Procedure|active wheezing (did not have procedure)|1|||
162968539|NCT00487695|588586279|FG001|First Procedure|active wheezing (did not have procedure)|0|||
162968540|NCT00487695|588586278|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
162968541|NCT00487695|588586279|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
162968542|NCT00487695|588586278|FG000|Second Procedure|active wheezing|0|||
162968543|NCT00487695|588586279|FG001|Second Procedure|active wheezing|1|||
162968544|NCT00487695|588586278|FG000|Second Procedure|Withdrawal by Subject|1|||
162968545|NCT00487695|588586279|FG001|Second Procedure|Withdrawal by Subject|2|||
162968546|NCT01358877|588586280|FG000|Overall Study|Withdrawal by Subject|475|||
162968547|NCT01358877|588586281|FG001|Overall Study|Withdrawal by Subject|466|||
162968548|NCT01358877|588586280|FG000|Overall Study|Recurrence of disease|181|||
162968549|NCT01358877|588586281|FG001|Overall Study|Recurrence of disease|269|||
162968550|NCT01358877|588586280|FG000|Overall Study|Lost to Follow-up|181|||
162968551|NCT01358877|588586281|FG001|Overall Study|Lost to Follow-up|176|||
162968552|NCT01358877|588586280|FG000|Overall Study|Death|41|||
162968553|NCT01358877|588586281|FG001|Overall Study|Death|46|||
162968554|NCT01358877|588586280|FG000|Overall Study|Adverse Event|39|||
162968555|NCT01358877|588586281|FG001|Overall Study|Adverse Event|42|||
162968556|NCT01358877|588586280|FG000|Overall Study|Physician Decision|43|||
162968557|NCT01358877|588586281|FG001|Overall Study|Physician Decision|32|||
162968558|NCT01358877|588586280|FG000|Overall Study|Contralateral breast cancer|42|||
162968559|NCT01358877|588586281|FG001|Overall Study|Contralateral breast cancer|28|||
162968560|NCT01358877|588586280|FG000|Overall Study|Reason not specified|37|||
162968561|NCT01358877|588586281|FG001|Overall Study|Reason not specified|29|||
162968562|NCT01698554|588586287|FG000|Overall Study|Adverse Event|2|||
162968563|NCT01698554|588586288|FG001|Overall Study|Adverse Event|5|||
162968564|NCT01698554|588586289|FG002|Overall Study|Adverse Event|0|||
162968565|NCT01698554|588586290|FG003|Overall Study|Adverse Event|1|||
162968566|NCT01698554|588586287|FG000|Overall Study|Lost to Follow-up|1|||
162968567|NCT01698554|588586288|FG001|Overall Study|Lost to Follow-up|0|||
162968568|NCT01698554|588586289|FG002|Overall Study|Lost to Follow-up|0|||
162968569|NCT01698554|588586290|FG003|Overall Study|Lost to Follow-up|0|||
162968570|NCT01698554|588586287|FG000|Overall Study|Personal Reasons|0|||
162968571|NCT01698554|588586288|FG001|Overall Study|Personal Reasons|5|||
162968572|NCT01698554|588586289|FG002|Overall Study|Personal Reasons|1|||
162968573|NCT01698554|588586290|FG003|Overall Study|Personal Reasons|1|||
162968574|NCT01698554|588586287|FG000|Overall Study|Protocol Violation|2|||
162968575|NCT01698554|588586288|FG001|Overall Study|Protocol Violation|0|||
162968576|NCT01698554|588586289|FG002|Overall Study|Protocol Violation|1|||
162968577|NCT01698554|588586290|FG003|Overall Study|Protocol Violation|0|||
162968578|NCT01698554|588586287|FG000|Overall Study|Other Miscellaneous Reasons|1|||
162968579|NCT01698554|588586288|FG001|Overall Study|Other Miscellaneous Reasons|0|||
162968580|NCT01698554|588586289|FG002|Overall Study|Other Miscellaneous Reasons|0|||
162968581|NCT01698554|588586290|FG003|Overall Study|Other Miscellaneous Reasons|0|||
162968582|NCT00751023|588586293|FG000|Overall Study|Lost to Follow-up|11|||
162968583|NCT00751023|588586294|FG001|Overall Study|Lost to Follow-up|7|||
162968584|NCT01547728|588586298|FG000|Overall Study|Change in procedure and equipment|1|||
162968585|NCT01547728|588586298|FG000|Overall Study|Drug not ready for subject|1|||
162968586|NCT01547728|588586298|FG000|Overall Study|Screen failure|39|||
162968587|NCT00766493|588586299|FG000|30 Days Post-Procedure|Discontinued|7|||
162968588|NCT00766493|588586299|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
162968589|NCT00766493|588586299|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
162968590|NCT03448692|588586304|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
162968591|NCT03448692|588586305|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
162968592|NCT03448692|588586304|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
162968593|NCT03448692|588586305|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
163054544|NCT00750269|588911697|FG000|Overall Study|Protocol Violation|0|||
163054545|NCT00750269|588911698|FG001|Overall Study|Protocol Violation|1|||
163054546|NCT00750269|588911699|FG002|Overall Study|Protocol Violation|1|||
163054547|NCT00750269|588911700|FG003|Overall Study|Protocol Violation|2|||
163054548|NCT00750269|588911701|FG004|Overall Study|Protocol Violation|4|||
163054549|NCT00750269|588911697|FG000|Overall Study|Withdrawal by Subject|0|||
163054550|NCT00750269|588911698|FG001|Overall Study|Withdrawal by Subject|0|||
163054551|NCT00750269|588911699|FG002|Overall Study|Withdrawal by Subject|2|||
163054552|NCT00750269|588911700|FG003|Overall Study|Withdrawal by Subject|2|||
163054553|NCT00750269|588911701|FG004|Overall Study|Withdrawal by Subject|2|||
163054554|NCT00750269|588911697|FG000|Overall Study|Physician Decision|0|||
163054555|NCT00750269|588911698|FG001|Overall Study|Physician Decision|0|||
163054556|NCT00750269|588911699|FG002|Overall Study|Physician Decision|0|||
163054557|NCT00750269|588911700|FG003|Overall Study|Physician Decision|0|||
163054558|NCT00750269|588911701|FG004|Overall Study|Physician Decision|2|||
163054559|NCT00750269|588911697|FG000|Overall Study|Patient too large for positioning|0|||
163054560|NCT00750269|588911698|FG001|Overall Study|Patient too large for positioning|0|||
163054561|NCT00750269|588911699|FG002|Overall Study|Patient too large for positioning|1|||
163054562|NCT00750269|588911700|FG003|Overall Study|Patient too large for positioning|0|||
163054563|NCT00750269|588911701|FG004|Overall Study|Patient too large for positioning|0|||
163054564|NCT00750269|588911697|FG000|Overall Study|Site error|0|||
163054565|NCT00750269|588911698|FG001|Overall Study|Site error|0|||
163054566|NCT00750269|588911699|FG002|Overall Study|Site error|0|||
163054567|NCT00750269|588911700|FG003|Overall Study|Site error|1|||
163054568|NCT00750269|588911701|FG004|Overall Study|Site error|0|||
163054569|NCT00750269|588911697|FG000|Overall Study|SBRT plan could not be drawn|0|||
163054570|NCT00750269|588911698|FG001|Overall Study|SBRT plan could not be drawn|0|||
163054571|NCT00750269|588911699|FG002|Overall Study|SBRT plan could not be drawn|0|||
163054572|NCT00750269|588911700|FG003|Overall Study|SBRT plan could not be drawn|0|||
163054573|NCT00750269|588911701|FG004|Overall Study|SBRT plan could not be drawn|1|||
163054574|NCT00750269|588911697|FG000|Overall Study|Fiducials could not be placed|0|||
163054575|NCT00750269|588911698|FG001|Overall Study|Fiducials could not be placed|0|||
163054576|NCT00750269|588911699|FG002|Overall Study|Fiducials could not be placed|0|||
163054577|NCT00750269|588911700|FG003|Overall Study|Fiducials could not be placed|0|||
163054578|NCT00750269|588911701|FG004|Overall Study|Fiducials could not be placed|1|||
163054579|NCT01898078|588911702|FG000|Overall Study|Progressive Disease|1|||
163054580|NCT01898078|588911703|FG001|Overall Study|Progressive Disease|5|||
163054581|NCT01898078|588911702|FG000|Overall Study|Adverse Event|2|||
163054582|NCT01898078|588911703|FG001|Overall Study|Adverse Event|1|||
163054583|NCT01898078|588911702|FG000|Overall Study|Withdrawal by Subject|1|||
163054584|NCT01898078|588911703|FG001|Overall Study|Withdrawal by Subject|1|||
163054585|NCT01898078|588911702|FG000|Overall Study|Symptomatic Deterioration|2|||
163054586|NCT01898078|588911703|FG001|Overall Study|Symptomatic Deterioration|0|||
163054587|NCT01898078|588911702|FG000|Overall Study|Reason not Specified|0|||
163054588|NCT01898078|588911703|FG001|Overall Study|Reason not Specified|1|||
163054589|NCT00161213|588911710|FG000|Overall Study|Withdrawal by Subject|1|||
163054590|NCT00161213|588911710|FG000|Overall Study|Evaluable for toxicity but not response|1|||
163054591|NCT03630393|588911711|FG000|Overall Study|Death|1|||
163054592|NCT03630393|588911712|FG001|Overall Study|Death|0|||
163054593|NCT02351934|588911713|FG000|Allocation|POD weight<pre-op weight|3|||
163054594|NCT02351934|588911714|FG001|Allocation|POD weight<pre-op weight|0|||
163054595|NCT02351934|588911713|FG000|Allocation|Hypotension preventing administration|2|||
163054596|NCT02351934|588911714|FG001|Allocation|Hypotension preventing administration|0|||
163054597|NCT02351934|588911713|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
163054598|NCT02351934|588911714|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
163054599|NCT02351934|588911713|FG000|Follow-Up|POD weight<pre-op weight|3|||
163054600|NCT02351934|588911714|FG001|Follow-Up|POD weight<pre-op weight|0|||
163054601|NCT02351934|588911713|FG000|Follow-Up|Acute Kidney Injury|1|||
163054602|NCT02351934|588911714|FG001|Follow-Up|Acute Kidney Injury|0|||
163054603|NCT02351934|588911713|FG000|Follow-Up|Early dismissal|3|||
163054604|NCT02351934|588911714|FG001|Follow-Up|Early dismissal|0|||
163054605|NCT02351934|588911713|FG000|Follow-Up|Hypotension|3|||
163054606|NCT02351934|588911714|FG001|Follow-Up|Hypotension|0|||
163054607|NCT02351934|588911713|FG000|Follow-Up|No documentation|2|||
163054608|NCT02351934|588911714|FG001|Follow-Up|No documentation|0|||
163054609|NCT02351934|588911713|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
163054610|NCT02351934|588911714|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
163208386|NCT01957644|589476177|FG003|Overall Study|Other reason|1|||
163208387|NCT01957644|589476178|FG004|Overall Study|Other reason|0|||
163054611|NCT02351934|588911713|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
163054612|NCT02351934|588911714|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
163208388|NCT01957644|589476174|FG000|Overall Study|Withdrawal by Subject|1|||
163054613|NCT04635839|588911715|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
163054614|NCT04635839|588911716|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
163054615|NCT02870868|588911717|FG000|Overall Study|Withdrawal by Subject|2|||
163054616|NCT02870868|588911718|FG001|Overall Study|Withdrawal by Subject|1|||
163054617|NCT00288912|588911720|FG000|Overall Study|Developed exclusion criterion|4|||
162968594|NCT03448692|588586304|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
162968595|NCT03448692|588586305|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
162968596|NCT03448692|588586304|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
162968597|NCT03448692|588586305|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
162968598|NCT03448692|588586304|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
162968599|NCT03448692|588586305|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
163399585|NCT01449461|590172672|FG002|Overall Study|Death|0|||
162968600|NCT02786927|588586308|FG000|Overall Study|Adverse Event|1|||
162968601|NCT02786927|588586308|FG000|Overall Study|Protocol Violation|4|||
163399586|NCT01449461|590172673|FG003|Overall Study|Death|0|||
163399587|NCT01449461|590172674|FG004|Overall Study|Death|7|||
163399588|NCT01449461|590172675|FG005|Overall Study|Death|1|||
163054618|NCT00288912|588911721|FG001|Overall Study|Developed exclusion criterion|6|||
163054619|NCT00288912|588911722|FG002|Overall Study|Developed exclusion criterion|7|||
163054620|NCT00288912|588911720|FG000|Overall Study|Lost to Follow-up|9|||
163054621|NCT00288912|588911721|FG001|Overall Study|Lost to Follow-up|6|||
163054622|NCT00288912|588911722|FG002|Overall Study|Lost to Follow-up|9|||
163054623|NCT00288912|588911720|FG000|Overall Study|Withdrawal by Subject|4|||
163054624|NCT00288912|588911721|FG001|Overall Study|Withdrawal by Subject|5|||
163054625|NCT00288912|588911722|FG002|Overall Study|Withdrawal by Subject|12|||
163054626|NCT03312738|588911723|FG000|Overall Study|Progressive disease|58|||
163054627|NCT03312738|588911724|FG001|Overall Study|Progressive disease|67|||
163054628|NCT03312738|588911723|FG000|Overall Study|Patient/guardian decision|13|||
163054629|NCT03312738|588911724|FG001|Overall Study|Patient/guardian decision|5|||
163054630|NCT03312738|588911723|FG000|Overall Study|Adverse Event|5|||
163054631|NCT03312738|588911724|FG001|Overall Study|Adverse Event|3|||
163054632|NCT03312738|588911723|FG000|Overall Study|Protocol deviation|2|||
163054633|NCT03312738|588911724|FG001|Overall Study|Protocol deviation|0|||
163054634|NCT03312738|588911723|FG000|Overall Study|Technical problems|0|||
163054635|NCT03312738|588911724|FG001|Overall Study|Technical problems|1|||
163054636|NCT03312738|588911723|FG000|Overall Study|Physician Decision|2|||
163054637|NCT03312738|588911724|FG001|Overall Study|Physician Decision|3|||
162968602|NCT01801917|588586309|FG000|Period 1 - Randomized|Adverse Event|1|||
162968603|NCT01801917|588586310|FG001|Period 1 - Randomized|Adverse Event|0|||
162968604|NCT01801917|588586311|FG002|Period 1 - Randomized|Adverse Event|1|||
162968605|NCT01801917|588586312|FG003|Period 1 - Randomized|Adverse Event|0|||
162968606|NCT01924364|588586313|FG000|Overall Study|Physician Decision|3|||
162968607|NCT00265785|588586314|FG000|Overall Study|Adverse Event|4|||
162968608|NCT00265785|588586314|FG000|Overall Study|Withdrawal by Subject|3|||
162968609|NCT00265785|588586314|FG000|Overall Study|Progression/Relapse|15|||
162968610|NCT00265785|588586314|FG000|Overall Study|Not protocol specified|2|||
162968611|NCT00265785|588586314|FG000|Overall Study|Ineligible|1|||
162968612|NCT00265785|588586314|FG000|Overall Study|Did not receive protocol treatment|2|||
162968613|NCT03919695|588586315|FG000|3-month Follow-up|Death|1|||
162968614|NCT03919695|588586316|FG001|3-month Follow-up|Death|1|||
162968615|NCT03919695|588586315|FG000|3-month Follow-up|unable to contact|0|||
162968616|NCT03919695|588586316|FG001|3-month Follow-up|unable to contact|3|||
162968617|NCT03919695|588586315|FG000|3-month Follow-up|in prison|0|||
162968618|NCT03919695|588586316|FG001|3-month Follow-up|in prison|1|||
162968619|NCT03919695|588586315|FG000|6-month Follow-up|Death|0|||
162968620|NCT03919695|588586316|FG001|6-month Follow-up|Death|1|||
162968621|NCT03919695|588586315|FG000|6-month Follow-up|Lost to Follow-up|1|||
162968622|NCT03919695|588586316|FG001|6-month Follow-up|Lost to Follow-up|2|||
162968623|NCT03919695|588586315|FG000|6-month Follow-up|in prison|0|||
162968624|NCT03919695|588586316|FG001|6-month Follow-up|in prison|2|||
162968625|NCT03919695|588586315|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
162968626|NCT03919695|588586316|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
162968627|NCT03919695|588586315|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
162968628|NCT03919695|588586316|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
162968629|NCT02416934|588586318|FG000|Overall Study|given steroids|1|||
162968630|NCT02416934|588586319|FG001|Overall Study|given steroids|2|||
162968631|NCT02416934|588586318|FG000|Overall Study|Lost to Follow-up|0|||
162968632|NCT02416934|588586319|FG001|Overall Study|Lost to Follow-up|2|||
162968633|NCT02416934|588586318|FG000|Overall Study|Withdrawal by Subject|1|||
162968634|NCT02416934|588586319|FG001|Overall Study|Withdrawal by Subject|0|||
163054638|NCT00607893|588911730|FG000|Overall Study|Lost to Follow-up|4|||
163054639|NCT00607893|588911731|FG001|Overall Study|Lost to Follow-up|0|||
163399589|NCT01449461|590172670|FG000|Overall Study|Physician Decision|0|||
163399590|NCT01449461|590172671|FG001|Overall Study|Physician Decision|1|||
162968635|NCT02416934|588586318|FG000|Overall Study|recruited during continuing renewal proc|0|||
162968636|NCT02416934|588586319|FG001|Overall Study|recruited during continuing renewal proc|1|||
162968637|NCT02416934|588586318|FG000|Overall Study|Protocol Violation|0|||
162968638|NCT02416934|588586319|FG001|Overall Study|Protocol Violation|1|||
162968639|NCT02416934|588586318|FG000|Overall Study|surgery started late|0|||
162968640|NCT02416934|588586319|FG001|Overall Study|surgery started late|1|||
162968641|NCT02416934|588586318|FG000|Overall Study|re-operation|1|||
162968642|NCT02416934|588586319|FG001|Overall Study|re-operation|0|||
162968643|NCT00494013|588586320|FG000|Overall Study|Adverse Event|0|||
162968644|NCT00494013|588586321|FG001|Overall Study|Adverse Event|1|||
162968645|NCT00494013|588586320|FG000|Overall Study|Entry Criteria Not Met|1|||
162968646|NCT00494013|588586321|FG001|Overall Study|Entry Criteria Not Met|4|||
162968647|NCT00494013|588586320|FG000|Overall Study|Lost to Follow-up|5|||
162968648|NCT00494013|588586321|FG001|Overall Study|Lost to Follow-up|6|||
162968649|NCT00494013|588586320|FG000|Overall Study|Physician Decision|3|||
162968650|NCT00494013|588586321|FG001|Overall Study|Physician Decision|5|||
162968651|NCT00494013|588586320|FG000|Overall Study|Protocol Violation|8|||
162968652|NCT00494013|588586321|FG001|Overall Study|Protocol Violation|5|||
162968653|NCT00494013|588586320|FG000|Overall Study|Withdrawal by Subject|13|||
162968654|NCT00494013|588586321|FG001|Overall Study|Withdrawal by Subject|14|||
162968655|NCT00494013|588586320|FG000|Overall Study|Sponsor Decision|0|||
162968656|NCT00494013|588586321|FG001|Overall Study|Sponsor Decision|1|||
162968657|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Adverse Event|8|||
162968658|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Adverse Event|5|||
162968659|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Adverse Event|9|||
162968660|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Adverse Event|0|||
162968661|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Adverse Event|0|||
162968662|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Adverse Event|0|||
162968663|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
162968664|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
162968665|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
162968666|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
162968667|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
162968668|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
162968669|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
162968670|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
162968671|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
162968672|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
162968673|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
162968674|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
162968675|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Physician Decision|4|||
162968676|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Physician Decision|0|||
162968677|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Physician Decision|2|||
162968678|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Physician Decision|0|||
162968679|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Physician Decision|0|||
162968680|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Physician Decision|0|||
162968681|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Pregnancy|1|||
162968682|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Pregnancy|2|||
162968683|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Pregnancy|0|||
162968684|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Pregnancy|0|||
162968685|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Pregnancy|0|||
162968686|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Pregnancy|0|||
162968687|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
162968688|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
162968689|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
162968690|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
162968691|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
162968692|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
162968693|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
162968694|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
162968695|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
163208389|NCT01957644|589476175|FG001|Overall Study|Withdrawal by Subject|0|||
163399591|NCT01449461|590172672|FG002|Overall Study|Physician Decision|0|||
162968696|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
162968697|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
162968698|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
162968699|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
162968700|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
162968701|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
162968702|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
163054640|NCT00607893|588911730|FG000|Overall Study|withdrew due to loss of interest|0|||
163054641|NCT00607893|588911731|FG001|Overall Study|withdrew due to loss of interest|1|||
163054642|NCT00607893|588911730|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
163054643|NCT00607893|588911731|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
163054644|NCT00607893|588911730|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
163054645|NCT00607893|588911731|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
163054646|NCT00607893|588911730|FG000|Overall Study|Declined to be treated|1|||
163054647|NCT00607893|588911731|FG001|Overall Study|Declined to be treated|0|||
163054648|NCT00607893|588911730|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
162968703|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
162968704|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
162968705|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
162968706|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
162968707|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
162968708|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
162968709|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
162968710|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
162968711|NCT02614196|588586325|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
162968712|NCT02614196|588586326|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
162968713|NCT02614196|588586327|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
162968714|NCT02614196|588586328|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
162968715|NCT02614196|588586329|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
162968716|NCT02614196|588586330|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
162968717|NCT02614196|588586325|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
162968718|NCT02614196|588586326|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
162968719|NCT02614196|588586327|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
162968720|NCT02614196|588586328|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
162968721|NCT02614196|588586329|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
162968722|NCT02614196|588586330|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
162968723|NCT02614196|588586325|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
162968724|NCT02614196|588586326|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
162968725|NCT02614196|588586327|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
162968726|NCT02614196|588586328|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
162968727|NCT02614196|588586329|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
162968728|NCT02614196|588586330|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
162968729|NCT02614196|588586325|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
162968730|NCT02614196|588586326|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
162968731|NCT02614196|588586327|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
162968732|NCT02614196|588586328|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
162968733|NCT02614196|588586329|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
162968734|NCT02614196|588586330|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
162968735|NCT01539239|588586331|FG000|Overall Study|Death|5|||
162968736|NCT01539239|588586332|FG001|Overall Study|Death|5|||
162968737|NCT01539239|588586331|FG000|Overall Study|Lost to Follow-up|7|||
162968738|NCT01539239|588586332|FG001|Overall Study|Lost to Follow-up|12|||
162968739|NCT01562613|588586333|FG000|Overall Study|Lost to Follow-up|2|||
162968740|NCT01562613|588586333|FG000|Overall Study|Withdrawal by Subject|2|||
162968741|NCT00633022|588586336|FG000|Overall Study|Adverse Event|1|||
162968742|NCT00633022|588586337|FG001|Overall Study|Adverse Event|0|||
162968743|NCT00633022|588586338|FG002|Overall Study|Adverse Event|5|||
162968744|NCT00633022|588586336|FG000|Overall Study|Physician Decision|0|||
162968745|NCT00633022|588586337|FG001|Overall Study|Physician Decision|1|||
162968746|NCT00633022|588586338|FG002|Overall Study|Physician Decision|0|||
162968747|NCT03382041|588586340|FG000|Overall Study|Consent Form Lost|2|||
162968748|NCT03382041|588586341|FG001|Overall Study|Consent Form Lost|1|||
162968749|NCT03382041|588586340|FG000|Overall Study|Withdrawal by Subject|1|||
162968750|NCT03382041|588586341|FG001|Overall Study|Withdrawal by Subject|4|||
162968751|NCT03382041|588586340|FG000|Overall Study|Lost to Follow-up|1|||
162968752|NCT03382041|588586341|FG001|Overall Study|Lost to Follow-up|4|||
162968753|NCT01374451|588586344|FG000|Overall Study|Administrative problems|1|||
162968754|NCT01374451|588586345|FG001|Overall Study|Administrative problems|0|||
162968755|NCT01337596|588586346|FG000|Overall Study|Withdrawal by Subject|0|||
162968756|NCT01337596|588586347|FG001|Overall Study|Withdrawal by Subject|0|||
162968757|NCT01337596|588586348|FG002|Overall Study|Withdrawal by Subject|0|||
162968758|NCT01337596|588586349|FG003|Overall Study|Withdrawal by Subject|0|||
162968759|NCT01337596|588586350|FG004|Overall Study|Withdrawal by Subject|2|||
162968760|NCT01337596|588586351|FG005|Overall Study|Withdrawal by Subject|0|||
162968761|NCT01337596|588586352|FG006|Overall Study|Withdrawal by Subject|0|||
163054649|NCT00607893|588911731|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
163054650|NCT00547339|588911736|FG000|Overall Study|Physician Decision|0|||
163054651|NCT00547339|588911737|FG001|Overall Study|Physician Decision|0|||
163208390|NCT01957644|589476176|FG002|Overall Study|Withdrawal by Subject|0|||
163208391|NCT01957644|589476177|FG003|Overall Study|Withdrawal by Subject|0|||
163208392|NCT01957644|589476178|FG004|Overall Study|Withdrawal by Subject|0|||
163054652|NCT00547339|588911738|FG002|Overall Study|Physician Decision|1|||
163208393|NCT01957644|589476174|FG000|Overall Study|Protocol Violation|0|||
162968762|NCT01337596|588586353|FG007|Overall Study|Withdrawal by Subject|0|||
162968763|NCT01337596|588586354|FG008|Overall Study|Withdrawal by Subject|0|||
162968764|NCT04640194|588586355|FG000|Overall Study|Adverse Event|3|||
162968765|NCT04640194|588586356|FG001|Overall Study|Adverse Event|7|||
162968766|NCT04640194|588586357|FG002|Overall Study|Adverse Event|0|||
162968767|NCT04640194|588586358|FG003|Overall Study|Adverse Event|5|||
162968768|NCT04640194|588586359|FG004|Overall Study|Adverse Event|0|||
162968769|NCT04640194|588586360|FG005|Overall Study|Adverse Event|4|||
162968770|NCT04640194|588586361|FG006|Overall Study|Adverse Event|0|||
162968771|NCT04640194|588586355|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
162968772|NCT04640194|588586356|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
162968773|NCT04640194|588586357|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
162968774|NCT04640194|588586358|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
162968775|NCT04640194|588586359|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
162968776|NCT04640194|588586360|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
162968777|NCT04640194|588586361|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
162968778|NCT04640194|588586355|FG000|Overall Study|fibrinogen level too low|0|||
162968779|NCT04640194|588586356|FG001|Overall Study|fibrinogen level too low|0|||
162968780|NCT04640194|588586357|FG002|Overall Study|fibrinogen level too low|0|||
162968781|NCT04640194|588586358|FG003|Overall Study|fibrinogen level too low|1|||
162968782|NCT04640194|588586359|FG004|Overall Study|fibrinogen level too low|0|||
162968783|NCT04640194|588586360|FG005|Overall Study|fibrinogen level too low|0|||
162968784|NCT04640194|588586361|FG006|Overall Study|fibrinogen level too low|0|||
162968785|NCT04640194|588586355|FG000|Overall Study|mild bleeding|0|||
162968786|NCT04640194|588586356|FG001|Overall Study|mild bleeding|0|||
162968787|NCT04640194|588586357|FG002|Overall Study|mild bleeding|0|||
162968788|NCT04640194|588586358|FG003|Overall Study|mild bleeding|1|||
162968789|NCT04640194|588586359|FG004|Overall Study|mild bleeding|0|||
162968790|NCT04640194|588586360|FG005|Overall Study|mild bleeding|0|||
162968791|NCT04640194|588586361|FG006|Overall Study|mild bleeding|0|||
162968792|NCT04640194|588586355|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
162968793|NCT04640194|588586356|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
162968794|NCT04640194|588586357|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
162968795|NCT04640194|588586358|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
162968796|NCT04640194|588586359|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
162968797|NCT04640194|588586360|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
162968798|NCT04640194|588586361|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
162968799|NCT03201003|588586365|FG000|Overall Study|Adverse Event|14|||
162968800|NCT03201003|588586366|FG001|Overall Study|Adverse Event|1|||
162968801|NCT03201003|588586365|FG000|Overall Study|Other reasons|5|||
162968802|NCT03201003|588586366|FG001|Overall Study|Other reasons|1|||
162968803|NCT03201003|588586365|FG000|Overall Study|Withdrawal by Subject|4|||
162968804|NCT03201003|588586366|FG001|Overall Study|Withdrawal by Subject|1|||
162968805|NCT03201003|588586365|FG000|Overall Study|Lost to Follow-up|2|||
162968806|NCT03201003|588586366|FG001|Overall Study|Lost to Follow-up|0|||
162968807|NCT03201003|588586365|FG000|Overall Study|Protocol Violation|1|||
162968808|NCT03201003|588586366|FG001|Overall Study|Protocol Violation|0|||
162968809|NCT01709903|588586372|FG000|Overall Study|administrative problems|2|||
162968810|NCT01709903|588586373|FG001|Overall Study|administrative problems|6|||
162968811|NCT01709903|588586372|FG000|Overall Study|Abnormal test procedure results|1|||
162968812|NCT01709903|588586373|FG001|Overall Study|Abnormal test procedure results|0|||
162968813|NCT01709903|588586372|FG000|Overall Study|In ability to use device|1|||
162968814|NCT01709903|588586373|FG001|Overall Study|In ability to use device|1|||
162968815|NCT01709903|588586372|FG000|Overall Study|no longer needed study drug|0|||
163208394|NCT01957644|589476175|FG001|Overall Study|Protocol Violation|1|||
163208395|NCT01957644|589476176|FG002|Overall Study|Protocol Violation|0|||
163208396|NCT01957644|589476177|FG003|Overall Study|Protocol Violation|0|||
163208397|NCT01957644|589476178|FG004|Overall Study|Protocol Violation|0|||
163208398|NCT04044716|589476179|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
162968816|NCT01709903|588586373|FG001|Overall Study|no longer needed study drug|1|||
162968817|NCT01709903|588586372|FG000|Overall Study|Lost to Follow-up|0|||
162968818|NCT01709903|588586373|FG001|Overall Study|Lost to Follow-up|2|||
162968819|NCT01709903|588586372|FG000|Overall Study|Death|2|||
162968820|NCT01709903|588586373|FG001|Overall Study|Death|0|||
162968821|NCT01709903|588586372|FG000|Overall Study|Protocol Violation|3|||
163208399|NCT04044716|589476180|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
163208400|NCT04044716|589476181|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
163208401|NCT04044716|589476179|FG000|Overall Study|Lost to Follow-up|2|||
163208402|NCT04044716|589476180|FG001|Overall Study|Lost to Follow-up|3|||
163208403|NCT04044716|589476181|FG002|Overall Study|Lost to Follow-up|0|||
163208404|NCT01957553|589476182|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
163208405|NCT01957553|589476183|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
163208406|NCT01957553|589476182|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
163208407|NCT01957553|589476183|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
163054653|NCT00547339|588911739|FG003|Overall Study|Physician Decision|0|||
163054654|NCT02426684|588911740|FG000|Overall Study|Physician Decision|1|||
163054655|NCT03587636|588911741|FG000|Overall Study|Lost to Follow-up|2|||
163054656|NCT03587636|588911742|FG001|Overall Study|Lost to Follow-up|5|||
163208408|NCT01957553|589476182|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
163208409|NCT01957553|589476183|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
163208410|NCT01957553|589476182|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
163208411|NCT01957553|589476183|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
163399592|NCT01449461|590172673|FG003|Overall Study|Physician Decision|4|||
163054657|NCT01483118|588911752|FG000|Overall Study|Lost to Follow-up|12|||
163054658|NCT01483118|588911753|FG001|Overall Study|Lost to Follow-up|16|||
163054659|NCT01079780|588911755|FG000|Overall Study|Disease progression|43|||
163054660|NCT01079780|588911756|FG001|Overall Study|Disease progression|7|||
163054661|NCT01079780|588911757|FG002|Overall Study|Disease progression|31|||
163054662|NCT01079780|588911755|FG000|Overall Study|Adverse Event|13|||
163054663|NCT01079780|588911756|FG001|Overall Study|Adverse Event|5|||
163054664|NCT01079780|588911757|FG002|Overall Study|Adverse Event|7|||
163054665|NCT01079780|588911755|FG000|Overall Study|Death|2|||
163054666|NCT01079780|588911756|FG001|Overall Study|Death|0|||
163054667|NCT01079780|588911757|FG002|Overall Study|Death|2|||
163054668|NCT01079780|588911755|FG000|Overall Study|Withdrawal by Subject|6|||
163054669|NCT01079780|588911756|FG001|Overall Study|Withdrawal by Subject|4|||
163054670|NCT01079780|588911757|FG002|Overall Study|Withdrawal by Subject|4|||
163054671|NCT01079780|588911755|FG000|Overall Study|Alternative therapy|2|||
163054672|NCT01079780|588911756|FG001|Overall Study|Alternative therapy|0|||
163054673|NCT01079780|588911757|FG002|Overall Study|Alternative therapy|2|||
163054674|NCT01079780|588911755|FG000|Overall Study|Physician Decision|1|||
163054675|NCT01079780|588911756|FG001|Overall Study|Physician Decision|0|||
163054676|NCT01079780|588911757|FG002|Overall Study|Physician Decision|1|||
163054677|NCT01079780|588911755|FG000|Overall Study|Error made in lesion measurement|1|||
163054678|NCT01079780|588911756|FG001|Overall Study|Error made in lesion measurement|0|||
163054679|NCT01079780|588911757|FG002|Overall Study|Error made in lesion measurement|0|||
163054680|NCT01079780|588911755|FG000|Overall Study|Patient had surgery|1|||
163054681|NCT01079780|588911756|FG001|Overall Study|Patient had surgery|0|||
163054682|NCT01079780|588911757|FG002|Overall Study|Patient had surgery|0|||
163054683|NCT01079780|588911755|FG000|Overall Study|Treatment cycle delay|0|||
163054684|NCT01079780|588911756|FG001|Overall Study|Treatment cycle delay|0|||
163054685|NCT01079780|588911757|FG002|Overall Study|Treatment cycle delay|1|||
163054686|NCT01079780|588911755|FG000|Overall Study|Never started treatment|1|||
163054687|NCT01079780|588911756|FG001|Overall Study|Never started treatment|0|||
163054688|NCT01079780|588911757|FG002|Overall Study|Never started treatment|2|||
163054689|NCT01178294|588911758|FG000|Overall Study|Adverse Event|4|||
163054690|NCT01178294|588911758|FG000|Overall Study|Lost to Follow-up|2|||
163054691|NCT01178294|588911758|FG000|Overall Study|Lack of Efficacy|1|||
163054692|NCT01178294|588911758|FG000|Overall Study|Death|1|||
163054693|NCT01178294|588911758|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
163054694|NCT01178294|588911758|FG000|Overall Study|Subject status is terminal|1|||
163054695|NCT01178294|588911758|FG000|Overall Study|Completion status could not be verified|1|||
163399593|NCT01449461|590172674|FG004|Overall Study|Physician Decision|1|||
163399594|NCT01449461|590172675|FG005|Overall Study|Physician Decision|0|||
163054696|NCT02783066|588911759|FG000|Overall Study|Withdrawal by Subject|13|||
163054697|NCT00551369|588911760|FG000|Overall Study|Protocol Violation|5|||
163054698|NCT00551369|588911760|FG000|Overall Study|Withdrawal by Subject|1|||
163054699|NCT00551369|588911760|FG000|Overall Study|Not treated per protocol and re|1|||
163054700|NCT01663623|588911763|FG000|Overall Study|Adverse Event|3|||
163054701|NCT01663623|588911764|FG001|Overall Study|Adverse Event|7|||
163054702|NCT01663623|588911763|FG000|Overall Study|Lack of Efficacy|5|||
163054703|NCT01663623|588911764|FG001|Overall Study|Lack of Efficacy|6|||
163054704|NCT01663623|588911763|FG000|Overall Study|Protocol Violation|0|||
163054705|NCT01663623|588911764|FG001|Overall Study|Protocol Violation|1|||
163054706|NCT01663623|588911763|FG000|Overall Study|Other-Study closed/terminated|1|||
163054707|NCT01663623|588911764|FG001|Overall Study|Other-Study closed/terminated|1|||
163054708|NCT01663623|588911763|FG000|Overall Study|Physician Decision|1|||
163054709|NCT01663623|588911764|FG001|Overall Study|Physician Decision|4|||
163054710|NCT01663623|588911763|FG000|Overall Study|Withdrawal by Subject|2|||
163054711|NCT01663623|588911764|FG001|Overall Study|Withdrawal by Subject|1|||
163054712|NCT02251275|588911765|FG000|Overall Study|Adverse Event|23|||
163054713|NCT02251275|588911766|FG001|Overall Study|Adverse Event|60|||
163054714|NCT02251275|588911767|FG002|Overall Study|Adverse Event|28|||
163054715|NCT02251275|588911768|FG003|Overall Study|Adverse Event|0|||
163054716|NCT02251275|588911769|FG004|Overall Study|Adverse Event|0|||
163054717|NCT02251275|588911765|FG000|Overall Study|Lost to Follow-up|5|||
163054718|NCT02251275|588911766|FG001|Overall Study|Lost to Follow-up|6|||
163054719|NCT02251275|588911767|FG002|Overall Study|Lost to Follow-up|4|||
163054720|NCT02251275|588911768|FG003|Overall Study|Lost to Follow-up|0|||
163054721|NCT02251275|588911769|FG004|Overall Study|Lost to Follow-up|0|||
163054722|NCT02251275|588911765|FG000|Overall Study|Physician Decision|19|||
163054723|NCT02251275|588911766|FG001|Overall Study|Physician Decision|30|||
163054724|NCT02251275|588911767|FG002|Overall Study|Physician Decision|26|||
163054725|NCT02251275|588911768|FG003|Overall Study|Physician Decision|0|||
163054726|NCT02251275|588911769|FG004|Overall Study|Physician Decision|1|||
163054727|NCT02251275|588911765|FG000|Overall Study|Protocol Deviation|0|||
163054728|NCT02251275|588911766|FG001|Overall Study|Protocol Deviation|0|||
163054729|NCT02251275|588911767|FG002|Overall Study|Protocol Deviation|1|||
163054730|NCT02251275|588911768|FG003|Overall Study|Protocol Deviation|0|||
163054731|NCT02251275|588911769|FG004|Overall Study|Protocol Deviation|0|||
163054732|NCT02251275|588911765|FG000|Overall Study|Withdrawal by Subject|25|||
163054733|NCT02251275|588911766|FG001|Overall Study|Withdrawal by Subject|51|||
163054734|NCT02251275|588911767|FG002|Overall Study|Withdrawal by Subject|35|||
163054735|NCT02251275|588911768|FG003|Overall Study|Withdrawal by Subject|1|||
163054736|NCT02251275|588911769|FG004|Overall Study|Withdrawal by Subject|0|||
163054737|NCT01004614|588911773|FG000|Washout|Withdrawal by Subject|0|||
163054738|NCT01004614|588911774|FG001|Washout|Withdrawal by Subject|1|||
163054739|NCT01004614|588911775|FG002|Washout|Withdrawal by Subject|0|||
163054740|NCT01004614|588911776|FG003|Washout|Withdrawal by Subject|0|||
163054741|NCT02834975|588911777|FG000|Overall Study|Physician Decision|2|||
163054742|NCT02834975|588911777|FG000|Overall Study|Adverse Event|1|||
163054743|NCT02834975|588911777|FG000|Overall Study|Withdrawal by Subject|1|||
163054744|NCT02834975|588911777|FG000|Overall Study|Lack of Efficacy|1|||
163054745|NCT02175121|588911780|FG000|Overall Study|Lack of Efficacy|1|||
163054746|NCT02175121|588911781|FG001|Overall Study|Lack of Efficacy|0|||
163054747|NCT02175121|588911782|FG002|Overall Study|Lack of Efficacy|0|||
163054748|NCT02175121|588911783|FG003|Overall Study|Lack of Efficacy|0|||
163054749|NCT02175121|588911784|FG004|Overall Study|Lack of Efficacy|0|||
163054750|NCT02175121|588911780|FG000|Overall Study|Lost to Follow-up|0|||
163399595|NCT01449461|590172670|FG000|Overall Study|Documented Progressive Disease|4|||
163399596|NCT01449461|590172671|FG001|Overall Study|Documented Progressive Disease|7|||
163054751|NCT02175121|588911781|FG001|Overall Study|Lost to Follow-up|1|||
163054752|NCT02175121|588911782|FG002|Overall Study|Lost to Follow-up|0|||
163054753|NCT02175121|588911783|FG003|Overall Study|Lost to Follow-up|1|||
163054754|NCT02175121|588911784|FG004|Overall Study|Lost to Follow-up|0|||
163054755|NCT02175121|588911780|FG000|Overall Study|Personal emergency|0|||
163054756|NCT02175121|588911781|FG001|Overall Study|Personal emergency|0|||
163054757|NCT02175121|588911782|FG002|Overall Study|Personal emergency|0|||
163054758|NCT02175121|588911783|FG003|Overall Study|Personal emergency|0|||
163054759|NCT02175121|588911784|FG004|Overall Study|Personal emergency|1|||
163054760|NCT02175121|588911780|FG000|Overall Study|Schedule conflict|0|||
163054761|NCT02175121|588911781|FG001|Overall Study|Schedule conflict|0|||
163054762|NCT02175121|588911782|FG002|Overall Study|Schedule conflict|1|||
163054763|NCT02175121|588911783|FG003|Overall Study|Schedule conflict|0|||
163054764|NCT02175121|588911784|FG004|Overall Study|Schedule conflict|0|||
163054765|NCT02175121|588911780|FG000|Overall Study|Time issues|0|||
163054766|NCT02175121|588911781|FG001|Overall Study|Time issues|0|||
163208412|NCT01957553|589476182|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
163054767|NCT02175121|588911782|FG002|Overall Study|Time issues|1|||
163054768|NCT02175121|588911783|FG003|Overall Study|Time issues|0|||
163054769|NCT02175121|588911784|FG004|Overall Study|Time issues|0|||
163054770|NCT00931632|588911789|FG000|Overall Study|Withdrawal by Subject|2|||
163054771|NCT00931632|588911790|FG001|Overall Study|Withdrawal by Subject|3|||
163054772|NCT00931632|588911789|FG000|Overall Study|Adverse Event|19|||
163054773|NCT00931632|588911790|FG001|Overall Study|Adverse Event|15|||
163054774|NCT01419314|588911791|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
163054775|NCT01419314|588911792|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
163054776|NCT01419314|588911791|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
163054777|NCT01419314|588911792|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
163054778|NCT01419314|588911791|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
163054779|NCT01419314|588911792|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
163054780|NCT01118052|588911797|FG000|Overall Study|Never treated|2|||
163054781|NCT00843492|588911798|FG000|Overall Study|Adverse Event|0|||
163054782|NCT00843492|588911799|FG001|Overall Study|Adverse Event|3|||
163054783|NCT00843492|588911798|FG000|Overall Study|Lost to Follow-up|4|||
163054784|NCT00843492|588911799|FG001|Overall Study|Lost to Follow-up|4|||
163054785|NCT00843492|588911798|FG000|Overall Study|Withdrawal by Subject|0|||
163054786|NCT00843492|588911799|FG001|Overall Study|Withdrawal by Subject|4|||
163054787|NCT00843492|588911798|FG000|Overall Study|Immobilization Stopped|1|||
163054788|NCT00843492|588911799|FG001|Overall Study|Immobilization Stopped|0|||
163054789|NCT00843492|588911798|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
163054790|NCT00843492|588911799|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
163054791|NCT00843492|588911798|FG000|Overall Study|Orthopedic Surgery|0|||
163054792|NCT00843492|588911799|FG001|Overall Study|Orthopedic Surgery|2|||
163054793|NCT00843492|588911798|FG000|Overall Study|Visit Not Performed|1|||
163054794|NCT00843492|588911799|FG001|Overall Study|Visit Not Performed|0|||
163054795|NCT00843492|588911798|FG000|Overall Study|Deep-vein Thrombosis|1|||
163054796|NCT00843492|588911799|FG001|Overall Study|Deep-vein Thrombosis|0|||
163054797|NCT01677741|588911800|FG000|Overall Study|Death|0|||
163054798|NCT01677741|588911801|FG001|Overall Study|Death|0|||
163054799|NCT01677741|588911802|FG002|Overall Study|Death|0|||
163054800|NCT01677741|588911803|FG003|Overall Study|Death|1|||
163054801|NCT01677741|588911804|FG004|Overall Study|Death|0|||
163054802|NCT01677741|588911805|FG005|Overall Study|Death|1|||
163054803|NCT01677741|588911806|FG006|Overall Study|Death|0|||
163054804|NCT01677741|588911807|FG007|Overall Study|Death|0|||
163054805|NCT01677741|588911800|FG000|Overall Study|Withdrawal by Subject|2|||
163054806|NCT01677741|588911801|FG001|Overall Study|Withdrawal by Subject|7|||
163054807|NCT01677741|588911802|FG002|Overall Study|Withdrawal by Subject|5|||
163054808|NCT01677741|588911803|FG003|Overall Study|Withdrawal by Subject|4|||
163054809|NCT01677741|588911804|FG004|Overall Study|Withdrawal by Subject|11|||
163054810|NCT01677741|588911805|FG005|Overall Study|Withdrawal by Subject|20|||
163054811|NCT01677741|588911806|FG006|Overall Study|Withdrawal by Subject|4|||
163054812|NCT01677741|588911807|FG007|Overall Study|Withdrawal by Subject|2|||
163054813|NCT01677741|588911800|FG000|Overall Study|Enrolled in a rollover study|0|||
163054814|NCT01677741|588911801|FG001|Overall Study|Enrolled in a rollover study|3|||
163054815|NCT01677741|588911802|FG002|Overall Study|Enrolled in a rollover study|2|||
163054816|NCT01677741|588911803|FG003|Overall Study|Enrolled in a rollover study|1|||
163054817|NCT01677741|588911804|FG004|Overall Study|Enrolled in a rollover study|6|||
163054818|NCT01677741|588911805|FG005|Overall Study|Enrolled in a rollover study|6|||
163054819|NCT01677741|588911806|FG006|Overall Study|Enrolled in a rollover study|7|||
163054820|NCT01677741|588911807|FG007|Overall Study|Enrolled in a rollover study|0|||
163054821|NCT01677741|588911800|FG000|Overall Study|Progressive disease|1|||
163054822|NCT01677741|588911801|FG001|Overall Study|Progressive disease|0|||
163054823|NCT01677741|588911802|FG002|Overall Study|Progressive disease|1|||
163054824|NCT01677741|588911803|FG003|Overall Study|Progressive disease|0|||
163054825|NCT01677741|588911804|FG004|Overall Study|Progressive disease|0|||
163054826|NCT01677741|588911805|FG005|Overall Study|Progressive disease|1|||
163054827|NCT01677741|588911806|FG006|Overall Study|Progressive disease|0|||
163054828|NCT01677741|588911807|FG007|Overall Study|Progressive disease|0|||
163054829|NCT00721799|588911810|FG000|Overall Study|Withdrawal by Subject|7|||
163208413|NCT01957553|589476183|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
163208414|NCT01957553|589476182|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
163208415|NCT01957553|589476183|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
163054830|NCT00721799|588911810|FG000|Overall Study|withdraw by subject after scan 1|1|||
163054831|NCT01441973|588911811|FG000|Overall Study|Disease progression|8|||
163054832|NCT01441973|588911812|FG001|Overall Study|Disease progression|6|||
163054833|NCT01441973|588911811|FG000|Overall Study|Adverse event unrelated to study drug|3|||
163208416|NCT01957553|589476182|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
163208417|NCT01957553|589476183|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
163208418|NCT01957553|589476182|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
163054834|NCT01441973|588911812|FG001|Overall Study|Adverse event unrelated to study drug|2|||
163054835|NCT01441973|588911811|FG000|Overall Study|Participant request to discontinue|1|||
163054836|NCT01441973|588911812|FG001|Overall Study|Participant request to discontinue|1|||
163054837|NCT01441973|588911811|FG000|Overall Study|Poor compliance/noncompliance|0|||
163054838|NCT01441973|588911812|FG001|Overall Study|Poor compliance/noncompliance|1|||
163054839|NCT01441973|588911811|FG000|Overall Study|Administrative reason by sponsor|3|||
163054840|NCT01441973|588911812|FG001|Overall Study|Administrative reason by sponsor|5|||
162968822|NCT01709903|588586373|FG001|Overall Study|Protocol Violation|2|||
162968823|NCT01709903|588586372|FG000|Overall Study|Lack of Efficacy|3|||
163054841|NCT01441973|588911811|FG000|Overall Study|Participant withdrew consent|0|||
163054842|NCT01441973|588911812|FG001|Overall Study|Participant withdrew consent|1|||
163054843|NCT01926028|588913937|FG000|Overall Study|Lost to Follow-up|7|||
163054844|NCT01926028|588913938|FG001|Overall Study|Lost to Follow-up|6|||
163054845|NCT01926028|588913939|FG002|Overall Study|Lost to Follow-up|0|||
163054846|NCT01926028|588913937|FG000|Overall Study|Physician Decision|1|||
163054847|NCT01926028|588913938|FG001|Overall Study|Physician Decision|5|||
163054848|NCT01926028|588913939|FG002|Overall Study|Physician Decision|0|||
163054849|NCT01926028|588913937|FG000|Overall Study|Withdrawal by Subject|9|||
163054850|NCT01926028|588913938|FG001|Overall Study|Withdrawal by Subject|9|||
163054851|NCT01926028|588913939|FG002|Overall Study|Withdrawal by Subject|2|||
163054852|NCT01926028|588913937|FG000|Overall Study|Non compliance or other reasons|4|||
163054853|NCT01926028|588913938|FG001|Overall Study|Non compliance or other reasons|2|||
163054854|NCT01926028|588913939|FG002|Overall Study|Non compliance or other reasons|0|||
163054855|NCT04539275|588913940|FG000|Overall Study|Death|2|||
163054856|NCT04539275|588913941|FG001|Overall Study|Death|4|||
163054857|NCT04539275|588913940|FG000|Overall Study|Lost to Follow-up|1|||
163054858|NCT04539275|588913941|FG001|Overall Study|Lost to Follow-up|1|||
163054859|NCT04539275|588913940|FG000|Overall Study|Withdrawal by Subject|3|||
163054860|NCT04539275|588913941|FG001|Overall Study|Withdrawal by Subject|0|||
163054861|NCT01799941|588913942|FG000|Overall Study|Adverse Event|34|||
163054862|NCT01799941|588913942|FG000|Overall Study|Withdrawal by Subject|21|||
163054863|NCT01799941|588913942|FG000|Overall Study|Death|2|||
163054864|NCT01799941|588913942|FG000|Overall Study|Investigator Decision|4|||
163054865|NCT01799941|588913942|FG000|Overall Study|Lack of Efficacy|3|||
163054866|NCT01799941|588913942|FG000|Overall Study|Lost to Follow-up|17|||
163054867|NCT01799941|588913942|FG000|Overall Study|Other|15|||
163054868|NCT00900562|588913950|FG000|Overall Study|Progressive disease|9|||
163054869|NCT00900562|588913951|FG001|Overall Study|Progressive disease|5|||
163054870|NCT00900562|588913950|FG000|Overall Study|Toxicity|1|||
163054871|NCT00900562|588913951|FG001|Overall Study|Toxicity|0|||
163054872|NCT00900562|588913950|FG000|Overall Study|Death|1|||
163054873|NCT00900562|588913951|FG001|Overall Study|Death|1|||
163054874|NCT00900562|588913950|FG000|Overall Study|Withdrawal by Subject|0|||
163054875|NCT00900562|588913951|FG001|Overall Study|Withdrawal by Subject|1|||
163054876|NCT00900562|588913950|FG000|Overall Study|Unrelated adverse event|1|||
163054877|NCT00900562|588913951|FG001|Overall Study|Unrelated adverse event|0|||
163054878|NCT00095979|588913954|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
163054879|NCT02051296|588913960|FG000|Overall Study|Lost to Follow-up|1|||
163054880|NCT02051296|588913961|FG001|Overall Study|Lost to Follow-up|2|||
163054881|NCT02051296|588913960|FG000|Overall Study|withdraw prior to treatment|7|||
163399597|NCT01449461|590172672|FG002|Overall Study|Documented Progressive Disease|14|||
163054882|NCT02051296|588913961|FG001|Overall Study|withdraw prior to treatment|7|||
163054883|NCT01569022|588913963|FG000|First Intervention|Lost to Follow-up|2|||
163054884|NCT01569022|588913964|FG001|First Intervention|Lost to Follow-up|1|||
163054885|NCT01569022|588913963|FG000|Second Intervention|Lost to Follow-up|2|||
163054886|NCT01569022|588913964|FG001|Second Intervention|Lost to Follow-up|2|||
163054887|NCT00644059|588913969|FG000|Overall Study|Lost to Follow-up|37|||
163054888|NCT00644059|588913970|FG001|Overall Study|Lost to Follow-up|34|||
163054889|NCT00644059|588913971|FG002|Overall Study|Lost to Follow-up|16|||
163054890|NCT00644059|588913969|FG000|Overall Study|Withdrawal by Subject|52|||
163054891|NCT00644059|588913970|FG001|Overall Study|Withdrawal by Subject|60|||
163054892|NCT00644059|588913971|FG002|Overall Study|Withdrawal by Subject|30|||
163054893|NCT00644059|588913969|FG000|Overall Study|Adverse Event|8|||
163054894|NCT00644059|588913970|FG001|Overall Study|Adverse Event|5|||
163054895|NCT00644059|588913971|FG002|Overall Study|Adverse Event|1|||
163054896|NCT00644059|588913969|FG000|Overall Study|Inappropriate Enrollment|1|||
163054897|NCT00644059|588913970|FG001|Overall Study|Inappropriate Enrollment|3|||
163054898|NCT00644059|588913971|FG002|Overall Study|Inappropriate Enrollment|0|||
163054899|NCT00644059|588913969|FG000|Overall Study|Protocol Deviation/violation|20|||
163054900|NCT00644059|588913970|FG001|Overall Study|Protocol Deviation/violation|19|||
163054901|NCT00644059|588913971|FG002|Overall Study|Protocol Deviation/violation|15|||
163054902|NCT00644059|588913969|FG000|Overall Study|Unable to classify|6|||
163054903|NCT00644059|588913970|FG001|Overall Study|Unable to classify|2|||
163054904|NCT00644059|588913971|FG002|Overall Study|Unable to classify|3|||
163054905|NCT02133508|588913972|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
163054906|NCT02133508|588913972|FG000|Overall Study|Death|12|||
163054907|NCT02133508|588913972|FG000|Overall Study|Lost to Follow-up|2|||
163054908|NCT01302899|588913973|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
163054909|NCT01302899|588913974|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
163054910|NCT01302899|588913973|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
163054911|NCT01302899|588913974|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
163054912|NCT02497469|588913976|FG000|Overall Study|Randomized but not Treated|0|||
163054913|NCT02497469|588913977|FG001|Overall Study|Randomized but not Treated|2|||
163054914|NCT02497469|588913976|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
163054915|NCT02497469|588913977|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
163054916|NCT02497469|588913976|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
163054917|NCT02497469|588913977|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
163054918|NCT02497469|588913976|FG000|Overall Study|Significant Protocol Deviation|4|||
163054919|NCT02497469|588913977|FG001|Overall Study|Significant Protocol Deviation|5|||
163054920|NCT02497469|588913976|FG000|Overall Study|Lost to Follow-up|14|||
163054921|NCT02497469|588913977|FG001|Overall Study|Lost to Follow-up|4|||
163054922|NCT02497469|588913976|FG000|Overall Study|Voluntary Withdrawal|39|||
163054923|NCT02497469|588913977|FG001|Overall Study|Voluntary Withdrawal|41|||
163054924|NCT02497469|588913976|FG000|Overall Study|Pregnancy|1|||
163054925|NCT02497469|588913977|FG001|Overall Study|Pregnancy|1|||
163054926|NCT02497469|588913976|FG000|Overall Study|Lack of Efficacy|86|||
163054927|NCT02497469|588913977|FG001|Overall Study|Lack of Efficacy|40|||
163054928|NCT02497469|588913976|FG000|Overall Study|Reason not Specified|6|||
163054929|NCT02497469|588913977|FG001|Overall Study|Reason not Specified|6|||
163054930|NCT03558516|588913978|FG000|Overall Study|Protocol Violation|2|||
163054931|NCT03558516|588913979|FG001|Overall Study|Protocol Violation|2|||
163054932|NCT00472420|588913980|FG000|Induction Treatment Period|Physician Decision|9|||
163054933|NCT00472420|588913980|FG000|Induction Treatment Period|Adverse Event|3|||
163054934|NCT00472420|588913980|FG000|Induction Treatment Period|Non-compliance|1|||
163054935|NCT00472420|588913980|FG000|Induction Treatment Period|Death|3|||
163054936|NCT00472420|588913980|FG000|Follow-up Period|Death|5|||
163054937|NCT00472420|588913980|FG000|Follow-up Period|Physician Decision|9|||
163054938|NCT00472420|588913980|FG000|Follow-up Period|Lost to Follow-up|2|||
163054939|NCT00472420|588913980|FG000|Follow-up Period|Protocol Violation|1|||
163054940|NCT02065557|588913981|FG000|Induction Period|Withdrawal by Subject|2|||
163054941|NCT02065557|588913982|FG001|Induction Period|Withdrawal by Subject|1|||
163054942|NCT02065557|588913983|FG002|Induction Period|Withdrawal by Subject|0|||
163054943|NCT02065557|588913984|FG003|Induction Period|Withdrawal by Subject|0|||
163054944|NCT02065557|588913985|FG004|Induction Period|Withdrawal by Subject|0|||
163054945|NCT02065557|588913986|FG005|Induction Period|Withdrawal by Subject|0|||
163054946|NCT02065557|588913981|FG000|Induction Period|Lack of Efficacy|2|||
163054947|NCT02065557|588913982|FG001|Induction Period|Lack of Efficacy|1|||
163054948|NCT02065557|588913983|FG002|Induction Period|Lack of Efficacy|1|||
163054949|NCT02065557|588913984|FG003|Induction Period|Lack of Efficacy|0|||
163054950|NCT02065557|588913985|FG004|Induction Period|Lack of Efficacy|0|||
163054951|NCT02065557|588913986|FG005|Induction Period|Lack of Efficacy|0|||
163054952|NCT02065557|588913981|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
163054953|NCT02065557|588913982|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
163054954|NCT02065557|588913983|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
163054955|NCT02065557|588913984|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
163054956|NCT02065557|588913985|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
163054957|NCT02065557|588913986|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
163054958|NCT02065557|588913981|FG000|Induction Period|Non-Responder at Week 8|4|||
163054959|NCT02065557|588913982|FG001|Induction Period|Non-Responder at Week 8|4|||
162968824|NCT01709903|588586373|FG001|Overall Study|Lack of Efficacy|3|||
162968825|NCT01709903|588586372|FG000|Overall Study|Withdrawal by Subject|6|||
162968826|NCT01709903|588586373|FG001|Overall Study|Withdrawal by Subject|6|||
162968827|NCT01709903|588586372|FG000|Overall Study|Adverse Event|11|||
162968828|NCT01709903|588586373|FG001|Overall Study|Adverse Event|18|||
162968829|NCT01751087|588586378|FG000|Overall Study|Withdrawal by Subject|1|||
162968830|NCT01751087|588586379|FG001|Overall Study|Withdrawal by Subject|0|||
162968831|NCT01751087|588586380|FG002|Overall Study|Withdrawal by Subject|0|||
162968832|NCT01751087|588586378|FG000|Overall Study|Physician Decision|0|||
163054960|NCT02065557|588913983|FG002|Induction Period|Non-Responder at Week 8|0|||
162968833|NCT01751087|588586379|FG001|Overall Study|Physician Decision|0|||
163054961|NCT02065557|588913984|FG003|Induction Period|Non-Responder at Week 8|0|||
163054962|NCT02065557|588913985|FG004|Induction Period|Non-Responder at Week 8|0|||
163054963|NCT02065557|588913986|FG005|Induction Period|Non-Responder at Week 8|0|||
163054964|NCT02065557|588913981|FG000|Induction Period|Adverse Event|1|||
163054965|NCT02065557|588913982|FG001|Induction Period|Adverse Event|1|||
163054966|NCT02065557|588913983|FG002|Induction Period|Adverse Event|0|||
163054967|NCT02065557|588913984|FG003|Induction Period|Adverse Event|0|||
163054968|NCT02065557|588913985|FG004|Induction Period|Adverse Event|0|||
163054969|NCT02065557|588913986|FG005|Induction Period|Adverse Event|0|||
163054970|NCT02065557|588913981|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
163054971|NCT02065557|588913982|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
163054972|NCT02065557|588913983|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
163054973|NCT02065557|588913984|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
162968834|NCT01751087|588586380|FG002|Overall Study|Physician Decision|1|||
162968835|NCT05377489|588586381|FG000|Overall Study|Withdrawal by Subject|122|||
162968836|NCT05377489|588586381|FG000|Overall Study|Lost to Follow-up|21|||
162968837|NCT05377489|588586381|FG000|Overall Study|Lack of Efficacy|10|||
162968838|NCT05377489|588586381|FG000|Overall Study|Adverse Event|5|||
162968839|NCT05377489|588586381|FG000|Overall Study|Death|4|||
163054974|NCT02065557|588913985|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
163054975|NCT02065557|588913986|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
163054976|NCT02065557|588913981|FG000|Maintenance Period|Withdrawal by Subject|0|||
163054977|NCT02065557|588913982|FG001|Maintenance Period|Withdrawal by Subject|0|||
163054978|NCT02065557|588913983|FG002|Maintenance Period|Withdrawal by Subject|0|||
163054979|NCT02065557|588913984|FG003|Maintenance Period|Withdrawal by Subject|0|||
163054980|NCT02065557|588913985|FG004|Maintenance Period|Withdrawal by Subject|2|||
163054981|NCT02065557|588913986|FG005|Maintenance Period|Withdrawal by Subject|1|||
163054982|NCT02065557|588913981|FG000|Maintenance Period|Lack of Efficacy|0|||
163054983|NCT02065557|588913982|FG001|Maintenance Period|Lack of Efficacy|0|||
163054984|NCT02065557|588913983|FG002|Maintenance Period|Lack of Efficacy|0|||
163054985|NCT02065557|588913984|FG003|Maintenance Period|Lack of Efficacy|0|||
163054986|NCT02065557|588913985|FG004|Maintenance Period|Lack of Efficacy|5|||
163054987|NCT02065557|588913986|FG005|Maintenance Period|Lack of Efficacy|2|||
163054988|NCT02065557|588913981|FG000|Maintenance Period|Subject Non-Compliance|0|||
163054989|NCT02065557|588913982|FG001|Maintenance Period|Subject Non-Compliance|0|||
163054990|NCT02065557|588913983|FG002|Maintenance Period|Subject Non-Compliance|0|||
162968840|NCT05377489|588586381|FG000|Overall Study|Physician Decision|3|||
162968841|NCT05377489|588586381|FG000|Overall Study|Protocol Violation|1|||
162968842|NCT05377489|588586381|FG000|Overall Study|Other|9|||
162968843|NCT00724958|588586382|FG000|Overall Study|Adverse Event|28|||
162968844|NCT00724958|588586382|FG000|Overall Study|Loss of Response|40|||
163054991|NCT02065557|588913984|FG003|Maintenance Period|Subject Non-Compliance|0|||
163054992|NCT02065557|588913985|FG004|Maintenance Period|Subject Non-Compliance|0|||
163054993|NCT02065557|588913986|FG005|Maintenance Period|Subject Non-Compliance|1|||
163054994|NCT01462942|588913990|FG000|Overall Study|Adverse Event|7|||
163054995|NCT01462942|588913991|FG001|Overall Study|Adverse Event|12|||
163054996|NCT01462942|588913992|FG002|Overall Study|Adverse Event|10|||
163054997|NCT01462942|588913993|FG003|Overall Study|Adverse Event|11|||
163054998|NCT01462942|588913994|FG004|Overall Study|Adverse Event|11|||
162968845|NCT00724958|588586382|FG000|Overall Study|No Response|18|||
163054999|NCT01462942|588913990|FG000|Overall Study|Other, including COPD exacerbation|3|||
163055000|NCT01462942|588913991|FG001|Overall Study|Other, including COPD exacerbation|5|||
162968846|NCT00724958|588586382|FG000|Overall Study|Remission|7|||
162968847|NCT00724958|588586382|FG000|Overall Study|Other Reason|76|||
162968848|NCT00724958|588586382|FG000|Overall Study|No documentation for end of therapy|13|||
162968849|NCT00697619|588586383|FG000|Overall Study|Lack of Efficacy|2|||
162968850|NCT00697619|588586384|FG001|Overall Study|Lack of Efficacy|2|||
162968851|NCT00697619|588586383|FG000|Overall Study|Adverse Event|4|||
162968852|NCT00697619|588586384|FG001|Overall Study|Adverse Event|6|||
163208419|NCT01957553|589476183|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
162968853|NCT00559637|588587789|FG000|Overall Study|Adverse Event|22|||
162968854|NCT00559637|588587789|FG000|Overall Study|Withdrawal by Subject|4|||
162968855|NCT00559637|588587789|FG000|Overall Study|Protocol Violation|6|||
162968856|NCT00559637|588587789|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
162968857|NCT00559637|588587789|FG000|Overall Study|Failure to return|6|||
162968858|NCT00559637|588587789|FG000|Overall Study|Insufficient response|3|||
162968859|NCT00559637|588587789|FG000|Overall Study|Started requiring dialysis after month 7|2|||
162968860|NCT00559637|588587789|FG000|Overall Study|Suspected lung cancer|1|||
162968861|NCT00559637|588587789|FG000|Overall Study|Participation in another study|1|||
162968862|NCT00559637|588587789|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
162968863|NCT00559637|588587789|FG000|Overall Study|Change of center|1|||
162968864|NCT00559637|588587789|FG000|Overall Study|Change of home|1|||
162968865|NCT00559637|588587789|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
162968866|NCT01705717|588587790|FG000|Overall Study|Adverse Event|2|||
162968867|NCT01705717|588587791|FG001|Overall Study|Adverse Event|2|||
162968868|NCT01705717|588587790|FG000|Overall Study|Lack of Efficacy|0|||
162968869|NCT01705717|588587791|FG001|Overall Study|Lack of Efficacy|1|||
162968870|NCT01705717|588587790|FG000|Overall Study|Other|0|||
162968871|NCT01705717|588587791|FG001|Overall Study|Other|2|||
162968872|NCT02031237|588587792|FG000|Overall Study|Death|1|||
162968873|NCT02031237|588587793|FG001|Overall Study|Death|5|||
162968874|NCT02031237|588587794|FG002|Overall Study|Death|0|||
162968875|NCT02031237|588587792|FG000|Overall Study|Physician Decision|0|||
162968876|NCT02031237|588587793|FG001|Overall Study|Physician Decision|1|||
162968877|NCT02031237|588587794|FG002|Overall Study|Physician Decision|0|||
162968878|NCT02031237|588587792|FG000|Overall Study|Withdrawal by Subject|2|||
162968879|NCT02031237|588587793|FG001|Overall Study|Withdrawal by Subject|2|||
162968880|NCT02031237|588587794|FG002|Overall Study|Withdrawal by Subject|0|||
162968881|NCT02031237|588587792|FG000|Overall Study|Protocol Violation|2|||
162968882|NCT02031237|588587793|FG001|Overall Study|Protocol Violation|6|||
162968883|NCT02031237|588587794|FG002|Overall Study|Protocol Violation|0|||
162968884|NCT02031237|588587792|FG000|Overall Study|Alternate Treatment Given|0|||
162968885|NCT02031237|588587793|FG001|Overall Study|Alternate Treatment Given|0|||
162968886|NCT02031237|588587794|FG002|Overall Study|Alternate Treatment Given|3|||
162968887|NCT02293460|588587795|FG000|Overall Study|Protocol Violation|1|||
162968888|NCT02293460|588587795|FG000|Overall Study|Lack of Efficacy|2|||
162968889|NCT02293460|588587795|FG000|Overall Study|Adverse Event|2|||
162968890|NCT02293460|588587795|FG000|Overall Study|Withdrawal by Subject|1|||
162968891|NCT01074008|588587800|FG000|Overall Study|Adverse Event|0|||
162968892|NCT01074008|588587801|FG001|Overall Study|Adverse Event|1|||
162968893|NCT01074008|588587802|FG002|Overall Study|Adverse Event|0|||
162968894|NCT01074008|588587803|FG003|Overall Study|Adverse Event|0|||
162968895|NCT01074008|588587804|FG004|Overall Study|Adverse Event|0|||
162968896|NCT01074008|588587805|FG005|Overall Study|Adverse Event|0|||
163399598|NCT01449461|590172673|FG003|Overall Study|Documented Progressive Disease|15|||
163399599|NCT01449461|590172674|FG004|Overall Study|Documented Progressive Disease|24|||
162968897|NCT01074008|588587806|FG006|Overall Study|Adverse Event|0|||
162968898|NCT01074008|588587807|FG007|Overall Study|Adverse Event|0|||
162968899|NCT01074008|588587808|FG008|Overall Study|Adverse Event|0|||
162968900|NCT01074008|588587800|FG000|Overall Study|Withdrawal by Subject|1|||
162968901|NCT01074008|588587801|FG001|Overall Study|Withdrawal by Subject|1|||
162968902|NCT01074008|588587802|FG002|Overall Study|Withdrawal by Subject|1|||
162968903|NCT01074008|588587803|FG003|Overall Study|Withdrawal by Subject|0|||
162968904|NCT01074008|588587804|FG004|Overall Study|Withdrawal by Subject|1|||
162968905|NCT01074008|588587805|FG005|Overall Study|Withdrawal by Subject|0|||
162968906|NCT01074008|588587806|FG006|Overall Study|Withdrawal by Subject|0|||
162968907|NCT01074008|588587807|FG007|Overall Study|Withdrawal by Subject|0|||
162968908|NCT01074008|588587808|FG008|Overall Study|Withdrawal by Subject|0|||
162968909|NCT01074008|588587800|FG000|Overall Study|Lost to Follow-up|0|||
162968910|NCT01074008|588587801|FG001|Overall Study|Lost to Follow-up|1|||
162968911|NCT01074008|588587802|FG002|Overall Study|Lost to Follow-up|1|||
162968912|NCT01074008|588587803|FG003|Overall Study|Lost to Follow-up|1|||
162968913|NCT01074008|588587804|FG004|Overall Study|Lost to Follow-up|1|||
162968914|NCT01074008|588587805|FG005|Overall Study|Lost to Follow-up|0|||
162968915|NCT01074008|588587806|FG006|Overall Study|Lost to Follow-up|1|||
162968916|NCT01074008|588587807|FG007|Overall Study|Lost to Follow-up|0|||
162968917|NCT01074008|588587808|FG008|Overall Study|Lost to Follow-up|4|||
162968918|NCT02805309|588587811|FG000|Overall Study|Lost to Follow-up|2|||
162968919|NCT02805309|588587812|FG001|Overall Study|Lost to Follow-up|2|||
162968920|NCT02805309|588587813|FG002|Overall Study|Lost to Follow-up|2|||
162968921|NCT02805309|588587811|FG000|Overall Study|Post-Randomization Exclusion|0|||
162968922|NCT02805309|588587812|FG001|Overall Study|Post-Randomization Exclusion|2|||
162968923|NCT02805309|588587813|FG002|Overall Study|Post-Randomization Exclusion|1|||
162968924|NCT01636934|588587814|FG000|Overall Study|Withdrawal by Subject|3|||
162968925|NCT01636934|588587815|FG001|Overall Study|Withdrawal by Subject|2|||
162968926|NCT01636934|588587814|FG000|Overall Study|Chemo cancel|1|||
162968927|NCT01636934|588587815|FG001|Overall Study|Chemo cancel|0|||
162968928|NCT01636934|588587814|FG000|Overall Study|Too ill to continue|1|||
162968929|NCT01636934|588587815|FG001|Overall Study|Too ill to continue|0|||
162968930|NCT01636934|588587814|FG000|Overall Study|Never started study medication|1|||
162968931|NCT01636934|588587815|FG001|Overall Study|Never started study medication|1|||
162968932|NCT03035890|588587824|FG000|Overall Study|Death|1|||
162968933|NCT05480800|588587827|FG000|Overall Study|Withdrawal by Subject|0|||
162968934|NCT05480800|588587828|FG001|Overall Study|Withdrawal by Subject|0|||
162968935|NCT05480800|588587829|FG002|Overall Study|Withdrawal by Subject|2|||
162968936|NCT05480800|588587830|FG003|Overall Study|Withdrawal by Subject|1|||
162968937|NCT05480800|588587831|FG004|Overall Study|Withdrawal by Subject|0|||
162968938|NCT05480800|588587832|FG005|Overall Study|Withdrawal by Subject|0|||
162968939|NCT05480800|588587833|FG006|Overall Study|Withdrawal by Subject|1|||
162968940|NCT05480800|588587834|FG007|Overall Study|Withdrawal by Subject|0|||
162968941|NCT05480800|588587827|FG000|Overall Study|Other|0|||
162968942|NCT05480800|588587828|FG001|Overall Study|Other|0|||
162968943|NCT05480800|588587829|FG002|Overall Study|Other|0|||
162968944|NCT05480800|588587830|FG003|Overall Study|Other|0|||
162968945|NCT05480800|588587831|FG004|Overall Study|Other|0|||
162968946|NCT05480800|588587832|FG005|Overall Study|Other|0|||
162968947|NCT05480800|588587833|FG006|Overall Study|Other|1|||
162968948|NCT05480800|588587834|FG007|Overall Study|Other|0|||
162968949|NCT00377156|588587839|FG000|Overall Study|Death|23|||
162968950|NCT00377156|588587840|FG001|Overall Study|Death|19|||
162968951|NCT00377156|588587839|FG000|Overall Study|Withdrawal by Subject|16|||
162968952|NCT00377156|588587840|FG001|Overall Study|Withdrawal by Subject|24|||
162968953|NCT00377156|588587839|FG000|Overall Study|Had follow-up <90 d|3|||
162968954|NCT00377156|588587840|FG001|Overall Study|Had follow-up <90 d|6|||
162968955|NCT00377156|588587839|FG000|Overall Study|Cancellation|1|||
162968956|NCT00377156|588587840|FG001|Overall Study|Cancellation|0|||
162968957|NCT00377156|588587839|FG000|Overall Study|Refused testing|0|||
162968958|NCT00377156|588587840|FG001|Overall Study|Refused testing|1|||
162968959|NCT00377156|588587839|FG000|Overall Study|Ineligible|0|||
162968960|NCT00377156|588587840|FG001|Overall Study|Ineligible|1|||
162968961|NCT00377156|588587839|FG000|Overall Study|Disability or language problem|0|||
162968962|NCT00377156|588587840|FG001|Overall Study|Disability or language problem|1|||
163055001|NCT01462942|588913992|FG002|Overall Study|Other, including COPD exacerbation|2|||
163055002|NCT01462942|588913993|FG003|Overall Study|Other, including COPD exacerbation|8|||
163055003|NCT01462942|588913994|FG004|Overall Study|Other, including COPD exacerbation|5|||
163055004|NCT01462942|588913990|FG000|Overall Study|Withdrawal by Subject|14|||
163055005|NCT01462942|588913991|FG001|Overall Study|Withdrawal by Subject|10|||
163055006|NCT01462942|588913992|FG002|Overall Study|Withdrawal by Subject|14|||
163055007|NCT01462942|588913993|FG003|Overall Study|Withdrawal by Subject|16|||
163055008|NCT01462942|588913994|FG004|Overall Study|Withdrawal by Subject|19|||
163055009|NCT01462942|588913990|FG000|Overall Study|Lack of Efficacy|6|||
163055010|NCT01462942|588913991|FG001|Overall Study|Lack of Efficacy|0|||
163055011|NCT01462942|588913992|FG002|Overall Study|Lack of Efficacy|4|||
163055012|NCT01462942|588913993|FG003|Overall Study|Lack of Efficacy|5|||
163055013|NCT01462942|588913994|FG004|Overall Study|Lack of Efficacy|3|||
163055014|NCT01462942|588913990|FG000|Overall Study|Lost to Follow-up|0|||
163055015|NCT01462942|588913991|FG001|Overall Study|Lost to Follow-up|1|||
163055016|NCT01462942|588913992|FG002|Overall Study|Lost to Follow-up|1|||
163208420|NCT01957553|589476182|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
163208421|NCT01957553|589476183|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
163208422|NCT00996307|589476190|FG000|Overall Study|Adverse Event|0|||
163055017|NCT01462942|588913993|FG003|Overall Study|Lost to Follow-up|1|||
163055018|NCT01462942|588913994|FG004|Overall Study|Lost to Follow-up|1|||
163055019|NCT01462942|588913990|FG000|Overall Study|Protocol Violation|4|||
163055020|NCT01462942|588913991|FG001|Overall Study|Protocol Violation|6|||
163055021|NCT01462942|588913992|FG002|Overall Study|Protocol Violation|9|||
163055022|NCT01462942|588913993|FG003|Overall Study|Protocol Violation|9|||
163055023|NCT01462942|588913994|FG004|Overall Study|Protocol Violation|6|||
163208423|NCT00996307|589476191|FG001|Overall Study|Adverse Event|1|||
163208424|NCT00996307|589476192|FG002|Overall Study|Adverse Event|0|||
163208425|NCT00996307|589476193|FG003|Overall Study|Adverse Event|0|||
162968963|NCT00377156|588587839|FG000|Overall Study|Other|5|||
162968964|NCT00377156|588587840|FG001|Overall Study|Other|2|||
162968965|NCT01802216|588587843|FG000|4 Month Visit|Participant did not show to visit|3|||
162968966|NCT01802216|588587844|FG001|4 Month Visit|Participant did not show to visit|4|||
162968967|NCT01802216|588587843|FG000|8 Month Visit|Participant did not show to visit|3|||
163055024|NCT02737722|588913995|FG000|Overall Study|Physician Decision|0|||
163055025|NCT02737722|588913996|FG001|Overall Study|Physician Decision|0|||
162968968|NCT01802216|588587844|FG001|8 Month Visit|Participant did not show to visit|5|||
162968969|NCT01802216|588587843|FG000|12 Month Visit|Participant did not show to visit|3|||
162968970|NCT01802216|588587844|FG001|12 Month Visit|Participant did not show to visit|4|||
162968971|NCT02459418|588587845|FG000|Overall Study|Exclusion Criteria|4|||
162968972|NCT02459418|588587846|FG001|Overall Study|Exclusion Criteria|0|||
162968973|NCT02459418|588587845|FG000|Overall Study|Protocol Violation|0|||
162968974|NCT02459418|588587846|FG001|Overall Study|Protocol Violation|2|||
162968975|NCT02459418|588587845|FG000|Overall Study|Physician Decision|0|||
163055026|NCT02737722|588913997|FG002|Overall Study|Physician Decision|1|||
163055027|NCT02737722|588913998|FG003|Overall Study|Physician Decision|0|||
163055028|NCT01026493|588914001|FG000|Overall Study|Protocol Violation|0|||
163055029|NCT01026493|588914002|FG001|Overall Study|Protocol Violation|1|||
163055030|NCT01026493|588914003|FG002|Overall Study|Protocol Violation|0|||
163055031|NCT01026493|588914004|FG003|Overall Study|Protocol Violation|0|||
163055032|NCT01026493|588914005|FG004|Overall Study|Protocol Violation|2|||
163055033|NCT01026493|588914006|FG005|Overall Study|Protocol Violation|3|||
163055034|NCT01026493|588914007|FG006|Overall Study|Protocol Violation|4|||
163055035|NCT01026493|588914008|FG007|Overall Study|Protocol Violation|1|||
163055036|NCT02662569|588914009|FG000|Overall Study|Withdrawal by Subject|6|||
163055037|NCT02662569|588914010|FG001|Overall Study|Withdrawal by Subject|1|||
163055038|NCT02662569|588914011|FG002|Overall Study|Withdrawal by Subject|6|||
163055039|NCT02662569|588914012|FG003|Overall Study|Withdrawal by Subject|4|||
163055040|NCT02662569|588914009|FG000|Overall Study|Lost to Follow-up|1|||
163055041|NCT02662569|588914010|FG001|Overall Study|Lost to Follow-up|0|||
163055042|NCT02662569|588914011|FG002|Overall Study|Lost to Follow-up|0|||
163055043|NCT02662569|588914012|FG003|Overall Study|Lost to Follow-up|0|||
163055044|NCT03154086|588914013|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055045|NCT03154086|588914014|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055046|NCT03154086|588914015|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055047|NCT03154086|588914016|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
163055048|NCT03154086|588914017|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055049|NCT03154086|588914018|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055050|NCT03154086|588914019|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055051|NCT03154086|588914020|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163208426|NCT00996307|589476190|FG000|Overall Study|Withdrawal by Subject|3|||
163208427|NCT00996307|589476191|FG001|Overall Study|Withdrawal by Subject|2|||
163208428|NCT00996307|589476192|FG002|Overall Study|Withdrawal by Subject|5|||
163208429|NCT00996307|589476193|FG003|Overall Study|Withdrawal by Subject|5|||
163208430|NCT00996307|589476190|FG000|Overall Study|Lost to Follow-up|13|||
163208431|NCT00996307|589476191|FG001|Overall Study|Lost to Follow-up|13|||
163208432|NCT00996307|589476192|FG002|Overall Study|Lost to Follow-up|7|||
163208433|NCT00996307|589476193|FG003|Overall Study|Lost to Follow-up|15|||
163208434|NCT00996307|589476190|FG000|Overall Study|Administrative reason|0|||
163208435|NCT00996307|589476191|FG001|Overall Study|Administrative reason|1|||
163208436|NCT00996307|589476192|FG002|Overall Study|Administrative reason|0|||
163208437|NCT00996307|589476193|FG003|Overall Study|Administrative reason|0|||
163208438|NCT00996307|589476190|FG000|Overall Study|Unable to classify|4|||
163208439|NCT00996307|589476191|FG001|Overall Study|Unable to classify|0|||
163208440|NCT00996307|589476192|FG002|Overall Study|Unable to classify|2|||
163208441|NCT00996307|589476193|FG003|Overall Study|Unable to classify|1|||
163208442|NCT02788357|589476194|FG000|Overall Study|Lost to Follow-up|3|||
163208443|NCT02788357|589476195|FG001|Overall Study|Lost to Follow-up|0|||
163208444|NCT00640601|589476196|FG000|Overall Study|Adverse Event|43|||
163208445|NCT00640601|589476196|FG000|Overall Study|Withdrawal by Subject|20|||
163208446|NCT00640601|589476196|FG000|Overall Study|Protocol Violation|6|||
163208447|NCT00640601|589476196|FG000|Overall Study|Lack of Efficacy|16|||
163208448|NCT00640601|589476196|FG000|Overall Study|Lost to Follow-up|9|||
163208449|NCT00640601|589476196|FG000|Overall Study|Physician Decision|8|||
163208450|NCT00640601|589476196|FG000|Overall Study|treatment naive, combination therapy|10|||
163208451|NCT01835587|589476198|FG000|Overall Study|Disease Recurrence or Relapse|0|||
163208452|NCT01835587|589476199|FG001|Overall Study|Disease Recurrence or Relapse|3|||
163208453|NCT01835587|589476200|FG002|Overall Study|Disease Recurrence or Relapse|0|||
163208454|NCT01835587|589476201|FG003|Overall Study|Disease Recurrence or Relapse|3|||
163208455|NCT01835587|589476198|FG000|Overall Study|Withdrawal by Subject|2|||
163208456|NCT01835587|589476199|FG001|Overall Study|Withdrawal by Subject|0|||
163208457|NCT01835587|589476200|FG002|Overall Study|Withdrawal by Subject|0|||
163055052|NCT03154086|588914021|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055053|NCT03154086|588914022|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055054|NCT03154086|588914023|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163208458|NCT01835587|589476201|FG003|Overall Study|Withdrawal by Subject|3|||
163208459|NCT01835587|589476198|FG000|Overall Study|Adverse Event|0|||
163208460|NCT01835587|589476199|FG001|Overall Study|Adverse Event|0|||
163208461|NCT01835587|589476200|FG002|Overall Study|Adverse Event|2|||
163208462|NCT01835587|589476201|FG003|Overall Study|Adverse Event|2|||
163208463|NCT01835587|589476198|FG000|Overall Study|Death|0|||
163208464|NCT01835587|589476199|FG001|Overall Study|Death|0|||
163208465|NCT01835587|589476200|FG002|Overall Study|Death|0|||
163208466|NCT01835587|589476201|FG003|Overall Study|Death|1|||
163055055|NCT03154086|588914024|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055056|NCT03154086|588914025|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055057|NCT03154086|588914026|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163208467|NCT01835587|589476198|FG000|Overall Study|Miscellaneous|0|||
163208468|NCT01835587|589476199|FG001|Overall Study|Miscellaneous|1|||
163208469|NCT01835587|589476200|FG002|Overall Study|Miscellaneous|0|||
162968976|NCT02459418|588587846|FG001|Overall Study|Physician Decision|2|||
162968977|NCT02459418|588587845|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
162968978|NCT02459418|588587846|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
162968979|NCT02459418|588587845|FG000|Overall Study|Adverse Event|0|||
162968980|NCT02459418|588587846|FG001|Overall Study|Adverse Event|1|||
162968981|NCT02459418|588587845|FG000|Overall Study|Withdrawal by Subject|1|||
162968982|NCT02459418|588587846|FG001|Overall Study|Withdrawal by Subject|1|||
162968983|NCT02459418|588587845|FG000|Overall Study|Elevated Creatine Kinase|1|||
162968984|NCT02459418|588587846|FG001|Overall Study|Elevated Creatine Kinase|0|||
162968985|NCT02459418|588587845|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
162968986|NCT02459418|588587846|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
162968987|NCT00683592|588587849|FG000|Overall Study|Adverse Event|12|||
162968988|NCT00683592|588587850|FG001|Overall Study|Adverse Event|4|||
162968989|NCT00683592|588587849|FG000|Overall Study|Withdrawal by Subject|11|||
162968990|NCT00683592|588587850|FG001|Overall Study|Withdrawal by Subject|11|||
162968991|NCT00683592|588587849|FG000|Overall Study|Lost to Follow-up|17|||
162968992|NCT00683592|588587850|FG001|Overall Study|Lost to Follow-up|17|||
162968993|NCT00683592|588587849|FG000|Overall Study|Lack of Efficacy|3|||
162968994|NCT00683592|588587850|FG001|Overall Study|Lack of Efficacy|7|||
162968995|NCT00683592|588587849|FG000|Overall Study|Physician Decision|0|||
162968996|NCT00683592|588587850|FG001|Overall Study|Physician Decision|1|||
162968997|NCT00683592|588587849|FG000|Overall Study|Non-compliance|3|||
162968998|NCT00683592|588587850|FG001|Overall Study|Non-compliance|5|||
162968999|NCT00683592|588587849|FG000|Overall Study|Other|1|||
162969000|NCT00683592|588587850|FG001|Overall Study|Other|1|||
162969001|NCT03303417|588587859|FG000|Overall Study|Withdrawal by Subject|1|||
162969002|NCT03303417|588587860|FG001|Overall Study|Withdrawal by Subject|1|||
162969003|NCT02697617|588587861|FG000|Overall Study|Withdrawal by Subject|0|||
162969004|NCT02697617|588587862|FG001|Overall Study|Withdrawal by Subject|2|||
162969005|NCT02697617|588587861|FG000|Overall Study|Pregnancy|1|||
162969006|NCT02697617|588587862|FG001|Overall Study|Pregnancy|0|||
162969007|NCT00329160|588587865|FG000|Overall Study|Adverse Event|27|||
162969008|NCT00329160|588587865|FG000|Overall Study|Withdrawal by Subject|13|||
162969009|NCT00329160|588587865|FG000|Overall Study|Protocol Violation|2|||
162969010|NCT00329160|588587865|FG000|Overall Study|Did not Receive Study Drug|1|||
162969011|NCT00329160|588587865|FG000|Overall Study|Incomplete IVUS|45|||
162969012|NCT05212948|588587870|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
162969013|NCT05212948|588587871|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
162969014|NCT05212948|588587870|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
162969015|NCT05212948|588587871|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
162969016|NCT05212948|588587870|FG000|Initial Vaccination Period|Pregnancy|20|||
162969017|NCT05212948|588587871|FG001|Initial Vaccination Period|Pregnancy|14|||
162969018|NCT05212948|588587870|FG000|Initial Vaccination Period|Physician Decision|686|||
162969019|NCT05212948|588587871|FG001|Initial Vaccination Period|Physician Decision|401|||
162969020|NCT05212948|588587870|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
162969021|NCT05212948|588587871|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
162969022|NCT05212948|588587870|FG000|Initial Vaccination Period|Death|23|||
162969023|NCT05212948|588587871|FG001|Initial Vaccination Period|Death|18|||
162969024|NCT05212948|588587870|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
162969025|NCT05212948|588587871|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
162969026|NCT05212948|588587870|FG000|Initial Vaccination Period|Adverse Event|36|||
162969027|NCT05212948|588587871|FG001|Initial Vaccination Period|Adverse Event|23|||
162969028|NCT05212948|588587870|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
162969029|NCT05212948|588587871|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
162969030|NCT05212948|588587870|FG000|Crossover Vaccination Period|Pregnancy|6|||
162969031|NCT05212948|588587871|FG001|Crossover Vaccination Period|Pregnancy|1|||
162969032|NCT05212948|588587870|FG000|Crossover Vaccination Period|Physician Decision|49|||
162969033|NCT05212948|588587871|FG001|Crossover Vaccination Period|Physician Decision|24|||
162969034|NCT05212948|588587870|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
162969035|NCT05212948|588587871|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
162969036|NCT05212948|588587870|FG000|Crossover Vaccination Period|Death|10|||
162969037|NCT05212948|588587871|FG001|Crossover Vaccination Period|Death|5|||
162969038|NCT05212948|588587870|FG000|Crossover Vaccination Period|Adverse Event|9|||
162969039|NCT05212948|588587871|FG001|Crossover Vaccination Period|Adverse Event|4|||
162969040|NCT05347693|588587872|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
162969041|NCT05347693|588587873|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
162969042|NCT05347693|588587874|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
162969043|NCT05347693|588587872|FG000|Inpatient Period|Withdrawal of consent|10|||
162969044|NCT05347693|588587873|FG001|Inpatient Period|Withdrawal of consent|0|||
162969045|NCT05347693|588587874|FG002|Inpatient Period|Withdrawal of consent|0|||
162969046|NCT05347693|588587872|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
162969047|NCT05347693|588587873|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
162969048|NCT05347693|588587874|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
162969049|NCT05347693|588587872|FG000|Inpatient Period|Screening Failure|8|||
162969050|NCT05347693|588587873|FG001|Inpatient Period|Screening Failure|0|||
162969051|NCT05347693|588587874|FG002|Inpatient Period|Screening Failure|0|||
162969052|NCT05347693|588587872|FG000|Inpatient Period|Death|2|||
162969053|NCT05347693|588587873|FG001|Inpatient Period|Death|0|||
162969054|NCT05347693|588587874|FG002|Inpatient Period|Death|0|||
162969055|NCT05347693|588587872|FG000|Inpatient Period|Physician Decision|5|||
162969056|NCT05347693|588587873|FG001|Inpatient Period|Physician Decision|0|||
162969057|NCT05347693|588587874|FG002|Inpatient Period|Physician Decision|0|||
162969058|NCT05347693|588587872|FG000|Inpatient Period|Adverse Event|3|||
162969059|NCT05347693|588587873|FG001|Inpatient Period|Adverse Event|0|||
162969060|NCT05347693|588587874|FG002|Inpatient Period|Adverse Event|0|||
162969061|NCT05347693|588587872|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
162969062|NCT05347693|588587873|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
162969063|NCT05347693|588587874|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
162969064|NCT05347693|588587872|FG000|Outpatient Period|Adverse Event|0|||
162969065|NCT05347693|588587873|FG001|Outpatient Period|Adverse Event|9|||
162969066|NCT05347693|588587874|FG002|Outpatient Period|Adverse Event|0|||
162969067|NCT05347693|588587872|FG000|Outpatient Period|Death|0|||
162969068|NCT05347693|588587873|FG001|Outpatient Period|Death|6|||
162969069|NCT05347693|588587874|FG002|Outpatient Period|Death|2|||
162969070|NCT05347693|588587872|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
162969071|NCT05347693|588587873|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
162969072|NCT05347693|588587874|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
162969073|NCT05347693|588587872|FG000|Outpatient Period|Lost to Follow-up|0|||
162969074|NCT05347693|588587873|FG001|Outpatient Period|Lost to Follow-up|0|||
162969075|NCT05347693|588587874|FG002|Outpatient Period|Lost to Follow-up|1|||
162969076|NCT05347693|588587872|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
162969077|NCT05347693|588587873|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
162969078|NCT05347693|588587874|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
162969079|NCT05347693|588587872|FG000|Outpatient Period|Scheduled hemodialysis|0|||
162969080|NCT05347693|588587873|FG001|Outpatient Period|Scheduled hemodialysis|1|||
162969081|NCT05347693|588587874|FG002|Outpatient Period|Scheduled hemodialysis|0|||
162969082|NCT05347693|588587872|FG000|Outpatient Period|Severe HK|0|||
162969083|NCT05347693|588587873|FG001|Outpatient Period|Severe HK|0|||
162969084|NCT05347693|588587874|FG002|Outpatient Period|Severe HK|1|||
162969085|NCT05347693|588587872|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
162969086|NCT05347693|588587873|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
162969087|NCT05347693|588587874|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
162969088|NCT05347693|588587872|FG000|Outpatient Period|Start of dialysis|0|||
162969089|NCT05347693|588587873|FG001|Outpatient Period|Start of dialysis|0|||
162969090|NCT05347693|588587874|FG002|Outpatient Period|Start of dialysis|1|||
162969091|NCT05347693|588587872|FG000|Outpatient Period|The participant entered hemodialysis|0|||
162969092|NCT05347693|588587873|FG001|Outpatient Period|The participant entered hemodialysis|0|||
162969093|NCT05347693|588587874|FG002|Outpatient Period|The participant entered hemodialysis|1|||
162969094|NCT05347693|588587872|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
162969095|NCT05347693|588587873|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
163055058|NCT03154086|588914027|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055059|NCT03154086|588914013|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055060|NCT03154086|588914014|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
163055061|NCT03154086|588914015|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055062|NCT03154086|588914016|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055063|NCT03154086|588914017|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055064|NCT03154086|588914018|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055065|NCT03154086|588914019|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055066|NCT03154086|588914020|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055067|NCT03154086|588914021|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055068|NCT03154086|588914022|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055069|NCT03154086|588914023|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055070|NCT03154086|588914024|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055071|NCT03154086|588914025|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055072|NCT03154086|588914026|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055073|NCT03154086|588914027|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055074|NCT03154086|588914013|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055075|NCT03154086|588914014|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055076|NCT03154086|588914015|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
163055077|NCT03154086|588914016|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055078|NCT03154086|588914017|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055079|NCT03154086|588914018|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055080|NCT03154086|588914019|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055081|NCT03154086|588914020|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055082|NCT03154086|588914021|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055083|NCT03154086|588914022|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055084|NCT03154086|588914023|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055085|NCT03154086|588914024|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055086|NCT03154086|588914025|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055087|NCT03154086|588914026|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055088|NCT03154086|588914027|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055089|NCT03154086|588914013|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
163055090|NCT03154086|588914014|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055091|NCT03154086|588914015|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055092|NCT03154086|588914016|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055093|NCT03154086|588914017|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055094|NCT03154086|588914018|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055095|NCT03154086|588914019|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055096|NCT03154086|588914020|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055097|NCT03154086|588914021|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055098|NCT03154086|588914022|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055099|NCT03154086|588914023|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055100|NCT03154086|588914024|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055101|NCT03154086|588914025|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055102|NCT03154086|588914026|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055103|NCT03154086|588914027|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163399600|NCT01449461|590172675|FG005|Overall Study|Documented Progressive Disease|5|||
163399601|NCT01449461|590172670|FG000|Overall Study|Clinical Progressive Disease|2|||
163055104|NCT03154086|588914013|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055105|NCT03154086|588914014|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055106|NCT03154086|588914015|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055107|NCT03154086|588914016|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055108|NCT03154086|588914017|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055109|NCT03154086|588914018|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055110|NCT03154086|588914019|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055111|NCT03154086|588914020|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055112|NCT03154086|588914021|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
163055113|NCT03154086|588914022|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055114|NCT03154086|588914023|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055115|NCT03154086|588914024|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163208470|NCT01835587|589476201|FG003|Overall Study|Miscellaneous|0|||
163208471|NCT03310775|589476206|FG000|Overall Study|Lost to Follow-up|2|||
163208472|NCT03310775|589476207|FG001|Overall Study|Lost to Follow-up|3|||
163208473|NCT03310775|589476206|FG000|Overall Study|aggravation of depression|0|||
163399602|NCT01449461|590172671|FG001|Overall Study|Clinical Progressive Disease|2|||
163208474|NCT03310775|589476207|FG001|Overall Study|aggravation of depression|1|||
163208475|NCT01648205|589476208|FG000|Placebo|Pregnancy|1|||
163208476|NCT01648205|589476208|FG000|Placebo|Withdrawal by Subject|1|||
163208477|NCT01648205|589476208|FG000|Placebo|Protocol Violation|2|||
163208478|NCT01648205|589476208|FG000|Ranolazine|Death|1|||
163055116|NCT03154086|588914025|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055117|NCT03154086|588914026|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055118|NCT03154086|588914027|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055119|NCT03154086|588914013|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055120|NCT03154086|588914014|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055121|NCT03154086|588914015|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055122|NCT03154086|588914016|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055123|NCT03154086|588914017|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055124|NCT03154086|588914018|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055125|NCT03154086|588914019|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055126|NCT03154086|588914020|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
163055127|NCT03154086|588914021|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055128|NCT03154086|588914022|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055129|NCT03154086|588914023|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055130|NCT03154086|588914024|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055131|NCT03154086|588914025|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055132|NCT03154086|588914026|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055133|NCT03154086|588914027|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055134|NCT03154086|588914013|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
163055135|NCT03154086|588914014|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
163055136|NCT03154086|588914015|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
163055137|NCT03154086|588914016|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
163055138|NCT03154086|588914017|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
163055139|NCT03154086|588914018|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
163055140|NCT03154086|588914019|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
163055141|NCT03154086|588914020|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
163055142|NCT03154086|588914021|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
163055143|NCT03154086|588914022|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
163055144|NCT03154086|588914023|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
163055145|NCT03154086|588914024|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
163055146|NCT03154086|588914025|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
163055147|NCT03154086|588914026|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
163055148|NCT03154086|588914027|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
163055149|NCT01603277|588914030|FG000|Overall Study|Adverse Event|1|||
163055150|NCT01603277|588914031|FG001|Overall Study|Adverse Event|2|||
163055151|NCT01603277|588914030|FG000|Overall Study|Physician Decision|0|||
163055152|NCT01603277|588914031|FG001|Overall Study|Physician Decision|1|||
163055153|NCT01603277|588914030|FG000|Overall Study|Protocol Violation|6|||
163055154|NCT01603277|588914031|FG001|Overall Study|Protocol Violation|10|||
163055155|NCT01603277|588914030|FG000|Overall Study|Withdrawal by Subject|5|||
163055156|NCT01603277|588914031|FG001|Overall Study|Withdrawal by Subject|4|||
163055157|NCT01603277|588914030|FG000|Overall Study|Non-Compliance|2|||
163055158|NCT01603277|588914031|FG001|Overall Study|Non-Compliance|1|||
163055159|NCT01701245|588914037|FG000|Overall Study|Protocol Violation|1|||
163055160|NCT01701245|588914038|FG001|Overall Study|Protocol Violation|3|||
163055161|NCT01701245|588914037|FG000|Overall Study|Did not complete the open label period|11|||
163055162|NCT01701245|588914038|FG001|Overall Study|Did not complete the open label period|12|||
163055163|NCT02785939|588914057|FG000|Overall Study|Progression|25|||
163055164|NCT02785939|588914058|FG001|Overall Study|Progression|8|||
163055165|NCT02785939|588914057|FG000|Overall Study|Adverse Event|3|||
163055166|NCT02785939|588914058|FG001|Overall Study|Adverse Event|1|||
163055167|NCT02785939|588914057|FG000|Overall Study|Death|1|||
163055168|NCT02785939|588914058|FG001|Overall Study|Death|0|||
163055169|NCT02785939|588914057|FG000|Overall Study|Refusal|1|||
163055170|NCT02785939|588914058|FG001|Overall Study|Refusal|0|||
163055171|NCT02785939|588914057|FG000|Overall Study|Deteriorating health|1|||
163055172|NCT02785939|588914058|FG001|Overall Study|Deteriorating health|0|||
163055173|NCT02785939|588914057|FG000|Overall Study|Not protocol specified|0|||
163055174|NCT02785939|588914058|FG001|Overall Study|Not protocol specified|1|||
163055175|NCT04465422|588914059|FG000|Overall Study|Lost to Follow-up|0|||
163055176|NCT04465422|588914060|FG001|Overall Study|Lost to Follow-up|2|||
163055177|NCT01787552|588914063|FG000|Overall Study|Withdrawal by Subject|2|||
163055178|NCT01787552|588914064|FG001|Overall Study|Withdrawal by Subject|0|||
163055179|NCT01787552|588914065|FG002|Overall Study|Withdrawal by Subject|0|||
163055180|NCT01787552|588914066|FG003|Overall Study|Withdrawal by Subject|4|||
163055181|NCT01787552|588914063|FG000|Overall Study|Physician Decision|2|||
163055182|NCT01787552|588914064|FG001|Overall Study|Physician Decision|2|||
163055183|NCT01787552|588914065|FG002|Overall Study|Physician Decision|1|||
163055184|NCT01787552|588914066|FG003|Overall Study|Physician Decision|2|||
163316806|NCT03910478|589871098|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
163316807|NCT05293171|589871099|FG000|Washout 5 to 7 Days|Adverse Event|1|||
163316808|NCT05293171|589871100|FG001|Washout 5 to 7 Days|Adverse Event|1|||
163316809|NCT05293171|589871101|FG002|Washout 5 to 7 Days|Adverse Event|0|||
163316810|NCT05293171|589871102|FG003|Washout 5 to 7 Days|Adverse Event|0|||
163316811|NCT05293171|589871103|FG004|Washout 5 to 7 Days|Adverse Event|0|||
163316812|NCT05293171|589871104|FG005|Washout 5 to 7 Days|Adverse Event|0|||
163316813|NCT05293171|589871105|FG006|Washout 5 to 7 Days|Adverse Event|0|||
163316814|NCT05293171|589871106|FG007|Washout 5 to 7 Days|Adverse Event|0|||
163316815|NCT05293171|589871107|FG008|Washout 5 to 7 Days|Adverse Event|0|||
163208479|NCT01648205|589476208|FG000|Ranolazine|Withdrawal by Subject|1|||
163208480|NCT01648205|589476208|FG000|Ranolazine|Protocol Violation|3|||
163208481|NCT02260921|589476216|FG000|Overall Study|Adverse Event|1|||
163208482|NCT02260921|589476217|FG001|Overall Study|Adverse Event|0|||
163316816|NCT05293171|589871108|FG009|Washout 5 to 7 Days|Adverse Event|0|||
163316817|NCT05293171|589871109|FG010|Washout 5 to 7 Days|Adverse Event|0|||
163316818|NCT05293171|589871110|FG011|Washout 5 to 7 Days|Adverse Event|0|||
163316819|NCT05293171|589871099|FG000|Washout 5 to 7 Days|Adverse Event|0|||
163316820|NCT05293171|589871100|FG001|Washout 5 to 7 Days|Adverse Event|0|||
163316821|NCT05293171|589871101|FG002|Washout 5 to 7 Days|Adverse Event|0|||
163316822|NCT05293171|589871102|FG003|Washout 5 to 7 Days|Adverse Event|0|||
163316823|NCT05293171|589871103|FG004|Washout 5 to 7 Days|Adverse Event|0|||
163316824|NCT05293171|589871104|FG005|Washout 5 to 7 Days|Adverse Event|1|||
163316825|NCT05293171|589871105|FG006|Washout 5 to 7 Days|Adverse Event|0|||
162969096|NCT05347693|588587874|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
162969097|NCT05347693|588587872|FG000|Outpatient Period|Withdrawal by Subject|0|||
162969098|NCT05347693|588587873|FG001|Outpatient Period|Withdrawal by Subject|8|||
163055185|NCT01787552|588914063|FG000|Overall Study|Death|0|||
163316826|NCT05293171|589871106|FG007|Washout 5 to 7 Days|Adverse Event|0|||
163208483|NCT02260921|589476216|FG000|Overall Study|Lost to Follow-up|4|||
163208484|NCT02260921|589476217|FG001|Overall Study|Lost to Follow-up|3|||
163208485|NCT02260921|589476216|FG000|Overall Study|Withdraw Consent|4|||
163208486|NCT02260921|589476217|FG001|Overall Study|Withdraw Consent|1|||
163208487|NCT02260921|589476216|FG000|Overall Study|Death|1|||
163208488|NCT02260921|589476217|FG001|Overall Study|Death|0|||
163208489|NCT02260921|589476216|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
163208490|NCT02260921|589476217|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
163208491|NCT02999854|589476227|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
163208492|NCT02999854|589476228|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
163208493|NCT02999854|589476227|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
163208494|NCT02999854|589476228|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
163208495|NCT02999854|589476227|FG000|Active Study Phase (up to 18 Months)|Death|7|||
163208496|NCT02999854|589476228|FG001|Active Study Phase (up to 18 Months)|Death|5|||
163208497|NCT02999854|589476227|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
163208498|NCT02999854|589476228|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
163208499|NCT02999854|589476227|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
163208500|NCT02999854|589476228|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
163208501|NCT02999854|589476227|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
163208502|NCT02999854|589476228|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
163316827|NCT05293171|589871107|FG008|Washout 5 to 7 Days|Adverse Event|0|||
162969099|NCT05347693|588587874|FG002|Outpatient Period|Withdrawal by Subject|5|||
162969100|NCT03167606|588587875|FG000|Overall Study|Lost to Follow-up|73|||
162969101|NCT03167606|588587876|FG001|Overall Study|Lost to Follow-up|64|||
163316828|NCT05293171|589871108|FG009|Washout 5 to 7 Days|Adverse Event|0|||
163316829|NCT05293171|589871109|FG010|Washout 5 to 7 Days|Adverse Event|0|||
163316830|NCT05293171|589871110|FG011|Washout 5 to 7 Days|Adverse Event|0|||
163316831|NCT04066205|589871111|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
163316832|NCT04066205|589871112|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
162969102|NCT03167606|588587875|FG000|Overall Study|Withdrawal by Subject|6|||
162969103|NCT03167606|588587876|FG001|Overall Study|Withdrawal by Subject|5|||
162969104|NCT03167606|588587875|FG000|Overall Study|Withdrawal by Investigator|0|||
162969105|NCT03167606|588587876|FG001|Overall Study|Withdrawal by Investigator|2|||
162969106|NCT00413049|588587877|FG000|Overall Study|Adverse Event|10|||
162969107|NCT00413049|588587878|FG001|Overall Study|Adverse Event|8|||
162969108|NCT00413049|588587877|FG000|Overall Study|Withdrawal by Subject|7|||
162969109|NCT00413049|588587878|FG001|Overall Study|Withdrawal by Subject|5|||
162969110|NCT00413049|588587877|FG000|Overall Study|Lost to Follow-up|2|||
162969111|NCT00413049|588587878|FG001|Overall Study|Lost to Follow-up|3|||
162969112|NCT00413049|588587877|FG000|Overall Study|Protocol Violation|3|||
162969113|NCT00413049|588587878|FG001|Overall Study|Protocol Violation|1|||
162969114|NCT00413049|588587877|FG000|Overall Study|Subject no longer requires study drug|0|||
162969115|NCT00413049|588587878|FG001|Overall Study|Subject no longer requires study drug|1|||
162969116|NCT00413049|588587877|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162969117|NCT00413049|588587878|FG001|Overall Study|Abnormal laboratory value(s)|0|||
162969118|NCT00413049|588587877|FG000|Overall Study|Lack of Efficacy|1|||
162969119|NCT00413049|588587878|FG001|Overall Study|Lack of Efficacy|0|||
162969120|NCT01755975|588587885|FG000|Overall Study|Adverse Event|0|||
162969121|NCT01755975|588587886|FG001|Overall Study|Adverse Event|0|||
162969122|NCT01755975|588587887|FG002|Overall Study|Adverse Event|1|||
163316833|NCT04066205|589871111|FG000|T2 Immediate Post-Intervention|did not respond|5|||
163316834|NCT04066205|589871112|FG001|T2 Immediate Post-Intervention|did not respond|3|||
162969123|NCT01755975|588587888|FG003|Overall Study|Adverse Event|0|||
162969124|NCT01755975|588587889|FG004|Overall Study|Adverse Event|2|||
162969125|NCT03653026|588587890|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
162969126|NCT03653026|588587891|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
162969127|NCT03653026|588587892|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
162969128|NCT03653026|588587893|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
162969129|NCT03653026|588587890|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
162969130|NCT03653026|588587891|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
162969131|NCT03653026|588587892|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
162969132|NCT03653026|588587893|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
162969133|NCT03653026|588587890|FG000|Part 1: Placebo-controlled Period|Other|0|||
162969134|NCT03653026|588587891|FG001|Part 1: Placebo-controlled Period|Other|3|||
162969135|NCT03653026|588587892|FG002|Part 1: Placebo-controlled Period|Other|0|||
162969136|NCT03653026|588587893|FG003|Part 1: Placebo-controlled Period|Other|0|||
162969137|NCT03653026|588587890|FG000|Part 2: Open-label Extension|Adverse Event|0|||
162969138|NCT03653026|588587891|FG001|Part 2: Open-label Extension|Adverse Event|0|||
162969139|NCT03653026|588587892|FG002|Part 2: Open-label Extension|Adverse Event|1|||
162969140|NCT03653026|588587893|FG003|Part 2: Open-label Extension|Adverse Event|1|||
162969141|NCT03653026|588587890|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
162969142|NCT03653026|588587891|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
162969143|NCT03653026|588587892|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
162969144|NCT03653026|588587893|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
162969145|NCT03653026|588587890|FG000|Part 2: Open-label Extension|Other|0|||
162969146|NCT03653026|588587891|FG001|Part 2: Open-label Extension|Other|0|||
162969147|NCT03653026|588587892|FG002|Part 2: Open-label Extension|Other|1|||
162969148|NCT03653026|588587893|FG003|Part 2: Open-label Extension|Other|2|||
162969149|NCT02104817|588587896|FG000|Overall Study|Death|363|||
162969150|NCT02104817|588587897|FG001|Overall Study|Death|330|||
162969151|NCT02104817|588587896|FG000|Overall Study|Lost to Follow-up|3|||
162969152|NCT02104817|588587897|FG001|Overall Study|Lost to Follow-up|2|||
162969153|NCT02104817|588587896|FG000|Overall Study|Protocol Violation|0|||
162969154|NCT02104817|588587897|FG001|Overall Study|Protocol Violation|1|||
162969155|NCT02104817|588587896|FG000|Overall Study|Study terminated by sponsor|5854|||
162969156|NCT02104817|588587897|FG001|Overall Study|Study terminated by sponsor|5901|||
162969157|NCT02104817|588587896|FG000|Overall Study|Withdrawal by Subject|111|||
162969158|NCT02104817|588587897|FG001|Overall Study|Withdrawal by Subject|78|||
162969159|NCT02104817|588587896|FG000|Overall Study|Other reasons|128|||
162969160|NCT02104817|588587897|FG001|Overall Study|Other reasons|135|||
162969161|NCT00852917|588587898|FG000|Overall Study|Adverse Event|13|||
162969162|NCT00852917|588587899|FG001|Overall Study|Adverse Event|20|||
162969163|NCT00852917|588587900|FG002|Overall Study|Adverse Event|35|||
162969164|NCT00852917|588587901|FG003|Overall Study|Adverse Event|17|||
162969165|NCT00852917|588587898|FG000|Overall Study|Lack of Efficacy|21|||
162969166|NCT00852917|588587899|FG001|Overall Study|Lack of Efficacy|11|||
162969167|NCT00852917|588587900|FG002|Overall Study|Lack of Efficacy|11|||
162969168|NCT00852917|588587901|FG003|Overall Study|Lack of Efficacy|47|||
162969169|NCT00852917|588587898|FG000|Overall Study|Withdrawal by Subject|4|||
162969170|NCT00852917|588587899|FG001|Overall Study|Withdrawal by Subject|8|||
162969171|NCT00852917|588587900|FG002|Overall Study|Withdrawal by Subject|10|||
162969172|NCT00852917|588587901|FG003|Overall Study|Withdrawal by Subject|9|||
162969173|NCT00852917|588587898|FG000|Overall Study|Physician Decision|6|||
162969174|NCT00852917|588587899|FG001|Overall Study|Physician Decision|7|||
162969175|NCT00852917|588587900|FG002|Overall Study|Physician Decision|2|||
162969176|NCT00852917|588587901|FG003|Overall Study|Physician Decision|19|||
162969177|NCT00852917|588587898|FG000|Overall Study|Death|0|||
162969178|NCT00852917|588587899|FG001|Overall Study|Death|0|||
163055186|NCT01787552|588914064|FG001|Overall Study|Death|0|||
163055187|NCT01787552|588914065|FG002|Overall Study|Death|0|||
163055188|NCT01787552|588914066|FG003|Overall Study|Death|1|||
163055189|NCT01787552|588914063|FG000|Overall Study|Adverse Event|2|||
163055190|NCT01787552|588914064|FG001|Overall Study|Adverse Event|5|||
163055191|NCT01787552|588914065|FG002|Overall Study|Adverse Event|2|||
163055192|NCT01787552|588914066|FG003|Overall Study|Adverse Event|16|||
163055193|NCT01787552|588914063|FG000|Overall Study|Study terminated by Sponsor|0|||
163055194|NCT01787552|588914064|FG001|Overall Study|Study terminated by Sponsor|0|||
163055195|NCT01787552|588914065|FG002|Overall Study|Study terminated by Sponsor|1|||
163055196|NCT01787552|588914066|FG003|Overall Study|Study terminated by Sponsor|3|||
163055197|NCT01787552|588914063|FG000|Overall Study|Progressive Disease|2|||
163055198|NCT01787552|588914064|FG001|Overall Study|Progressive Disease|2|||
163055199|NCT01787552|588914065|FG002|Overall Study|Progressive Disease|1|||
163055200|NCT01787552|588914066|FG003|Overall Study|Progressive Disease|1|||
163055201|NCT01299584|588914077|FG000|Overall Study|Protocol Violation|9|||
163055202|NCT00572832|588914078|FG000|Overall Study|Lost to Follow-up|0|||
163055203|NCT00572832|588914079|FG001|Overall Study|Lost to Follow-up|11|||
163055204|NCT00572832|588914078|FG000|Overall Study|Pregnancy|0|||
163055205|NCT00572832|588914079|FG001|Overall Study|Pregnancy|1|||
163055206|NCT01604785|588914087|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
163055207|NCT01604785|588914088|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
163055208|NCT01776554|588914091|FG000|Overall Study|Adverse Event|1|||
163055209|NCT01776554|588914092|FG001|Overall Study|Adverse Event|0|||
163055210|NCT01776554|588914091|FG000|Overall Study|Withdrawal by Subject|3|||
163055211|NCT01776554|588914092|FG001|Overall Study|Withdrawal by Subject|8|||
163055212|NCT01776554|588914091|FG000|Overall Study|Lost to Follow-up|6|||
163055213|NCT01776554|588914092|FG001|Overall Study|Lost to Follow-up|9|||
163055214|NCT01776554|588914091|FG000|Overall Study|Administrative Reason|2|||
163055215|NCT01776554|588914092|FG001|Overall Study|Administrative Reason|5|||
163055216|NCT01776554|588914091|FG000|Overall Study|Protocol Violation|1|||
163055217|NCT01776554|588914092|FG001|Overall Study|Protocol Violation|0|||
163055218|NCT01776554|588914091|FG000|Overall Study|Unclassified|4|||
163055219|NCT01776554|588914092|FG001|Overall Study|Unclassified|1|||
163055220|NCT01041859|588914093|FG000|Open-Label Titration|Adverse Event|69|||
163055221|NCT01041859|588914094|FG001|Open-Label Titration|Adverse Event|0|||
163055222|NCT01041859|588914095|FG002|Open-Label Titration|Adverse Event|0|||
163055223|NCT01041859|588914093|FG000|Open-Label Titration|Lack of Efficacy|3|||
163055224|NCT01041859|588914094|FG001|Open-Label Titration|Lack of Efficacy|0|||
163055225|NCT01041859|588914095|FG002|Open-Label Titration|Lack of Efficacy|0|||
163055226|NCT01041859|588914093|FG000|Open-Label Titration|Lost to Follow-up|1|||
163055227|NCT01041859|588914094|FG001|Open-Label Titration|Lost to Follow-up|0|||
163055228|NCT01041859|588914095|FG002|Open-Label Titration|Lost to Follow-up|0|||
163055229|NCT01041859|588914093|FG000|Open-Label Titration|Physician Decision|1|||
163055230|NCT01041859|588914094|FG001|Open-Label Titration|Physician Decision|0|||
163055231|NCT01041859|588914095|FG002|Open-Label Titration|Physician Decision|0|||
163055232|NCT01041859|588914093|FG000|Open-Label Titration|Protocol Violation|1|||
163055233|NCT01041859|588914094|FG001|Open-Label Titration|Protocol Violation|0|||
163055234|NCT01041859|588914095|FG002|Open-Label Titration|Protocol Violation|0|||
163055235|NCT01041859|588914093|FG000|Open-Label Titration|Other|7|||
163055236|NCT01041859|588914094|FG001|Open-Label Titration|Other|0|||
163055237|NCT01041859|588914095|FG002|Open-Label Titration|Other|0|||
163055238|NCT01041859|588914093|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
163208503|NCT02999854|589476227|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
163208504|NCT02999854|589476228|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
163208505|NCT02999854|589476227|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
163208506|NCT02999854|589476228|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
163208507|NCT00203996|589476229|FG000|Overall Study|Lost to Follow-up|0|||
163208508|NCT00203996|589476230|FG001|Overall Study|Lost to Follow-up|0|||
163208509|NCT00203996|589476231|FG002|Overall Study|Lost to Follow-up|0|||
162969179|NCT00852917|588587900|FG002|Overall Study|Death|0|||
162969180|NCT00852917|588587901|FG003|Overall Study|Death|1|||
162969181|NCT01597479|588587905|FG000|Overall Study|Protocol Violation|1|||
162969182|NCT01597479|588587906|FG001|Overall Study|Protocol Violation|0|||
162969183|NCT01597479|588587905|FG000|Overall Study|Lost to Follow-up|1|||
162969184|NCT01597479|588587906|FG001|Overall Study|Lost to Follow-up|0|||
162969185|NCT02167594|588587907|FG000|Overall Study|Withdrawal by Subject|2|||
162969186|NCT02167594|588587908|FG001|Overall Study|Withdrawal by Subject|0|||
162969187|NCT02167594|588587909|FG002|Overall Study|Withdrawal by Subject|0|||
162969188|NCT02167594|588587907|FG000|Overall Study|Death|0|||
162969189|NCT02167594|588587908|FG001|Overall Study|Death|1|||
162969190|NCT02167594|588587909|FG002|Overall Study|Death|0|||
162969191|NCT02340780|588587910|FG000|Overall Study|Ineligible|1|||
162969192|NCT03433703|588587911|FG000|Overall Study|Study terminated by Sponsor|2|||
162969193|NCT01583530|588587914|FG000|Overall Study|Adverse Event|0|||
162969194|NCT01583530|588587915|FG001|Overall Study|Adverse Event|0|||
162969195|NCT01583530|588587916|FG002|Overall Study|Adverse Event|0|||
162969196|NCT01583530|588587917|FG003|Overall Study|Adverse Event|0|||
162969197|NCT01583530|588587918|FG004|Overall Study|Adverse Event|0|||
162969198|NCT01583530|588587919|FG005|Overall Study|Adverse Event|1|||
162969199|NCT01583530|588587914|FG000|Overall Study|Withdrawal by Subject|0|||
162969200|NCT01583530|588587915|FG001|Overall Study|Withdrawal by Subject|3|||
162969201|NCT01583530|588587916|FG002|Overall Study|Withdrawal by Subject|0|||
162969202|NCT01583530|588587917|FG003|Overall Study|Withdrawal by Subject|1|||
162969203|NCT01583530|588587918|FG004|Overall Study|Withdrawal by Subject|1|||
162969204|NCT01583530|588587919|FG005|Overall Study|Withdrawal by Subject|2|||
162969205|NCT01583530|588587914|FG000|Overall Study|Lost to Follow-up|0|||
162969206|NCT01583530|588587915|FG001|Overall Study|Lost to Follow-up|0|||
162969207|NCT01583530|588587916|FG002|Overall Study|Lost to Follow-up|0|||
162969208|NCT01583530|588587917|FG003|Overall Study|Lost to Follow-up|0|||
162969209|NCT01583530|588587918|FG004|Overall Study|Lost to Follow-up|3|||
162969210|NCT01583530|588587919|FG005|Overall Study|Lost to Follow-up|0|||
162969211|NCT01583530|588587914|FG000|Overall Study|Lack of compliance|0|||
162969212|NCT01583530|588587915|FG001|Overall Study|Lack of compliance|0|||
162969213|NCT01583530|588587916|FG002|Overall Study|Lack of compliance|0|||
162969214|NCT01583530|588587917|FG003|Overall Study|Lack of compliance|0|||
162969215|NCT01583530|588587918|FG004|Overall Study|Lack of compliance|1|||
162969216|NCT01583530|588587919|FG005|Overall Study|Lack of compliance|0|||
162969217|NCT02416180|588587920|FG000|Overall Study|Withdrawal by Subject|1|||
162969218|NCT00640926|588587921|FG000|Overall Study|Adverse Event|2|||
162969219|NCT00640926|588587922|FG001|Overall Study|Adverse Event|3|||
163399603|NCT01449461|590172672|FG002|Overall Study|Clinical Progressive Disease|0|||
162969220|NCT00640926|588587923|FG002|Overall Study|Adverse Event|2|||
162969221|NCT00640926|588587921|FG000|Overall Study|Lack of Efficacy|0|||
162969222|NCT00640926|588587922|FG001|Overall Study|Lack of Efficacy|2|||
162969223|NCT00640926|588587923|FG002|Overall Study|Lack of Efficacy|1|||
162969224|NCT00640926|588587921|FG000|Overall Study|Protocol Violation|2|||
162969225|NCT00640926|588587922|FG001|Overall Study|Protocol Violation|0|||
162969226|NCT00640926|588587923|FG002|Overall Study|Protocol Violation|2|||
162969227|NCT00640926|588587921|FG000|Overall Study|Lost to Follow-up|3|||
162969228|NCT00640926|588587922|FG001|Overall Study|Lost to Follow-up|1|||
162969229|NCT00640926|588587923|FG002|Overall Study|Lost to Follow-up|2|||
162969230|NCT00640926|588587921|FG000|Overall Study|Withdrawal by Subject|1|||
162969231|NCT00640926|588587922|FG001|Overall Study|Withdrawal by Subject|0|||
162969232|NCT00640926|588587923|FG002|Overall Study|Withdrawal by Subject|1|||
162969233|NCT02985398|588587924|FG000|Overall Study|Adverse Event|1|||
162969234|NCT02985398|588587924|FG000|Overall Study|Lost to Follow-up|4|||
162969235|NCT02985398|588587924|FG000|Overall Study|Withdrawal by Subject|8|||
162969236|NCT02985398|588587924|FG000|Overall Study|Study Burden|9|||
162969237|NCT02050321|588587925|FG000|Overall Study|Withdrawal by Subject|1|||
162969238|NCT02050321|588587925|FG000|Overall Study|Adverse Event|1|||
162969239|NCT04768114|588587926|FG000|Overall Study|Lost to Follow-up|5|||
162969240|NCT04768114|588587927|FG001|Overall Study|Lost to Follow-up|10|||
162969241|NCT04768114|588587926|FG000|Overall Study|Withdrawal by Subject|0|||
162969242|NCT04768114|588587927|FG001|Overall Study|Withdrawal by Subject|1|||
162969243|NCT00715676|588587933|FG000|Overall Study|Adverse Event|3|||
162969244|NCT00715676|588587934|FG001|Overall Study|Adverse Event|5|||
162969245|NCT00715676|588587935|FG002|Overall Study|Adverse Event|21|||
162969246|NCT00715676|588587933|FG000|Overall Study|Withdrawal by Subject|1|||
162969247|NCT00715676|588587934|FG001|Overall Study|Withdrawal by Subject|3|||
162969248|NCT00715676|588587935|FG002|Overall Study|Withdrawal by Subject|8|||
162969249|NCT00715676|588587933|FG000|Overall Study|Lost to Follow-up|1|||
162969250|NCT00715676|588587934|FG001|Overall Study|Lost to Follow-up|2|||
162969251|NCT00715676|588587935|FG002|Overall Study|Lost to Follow-up|1|||
162969252|NCT00715676|588587933|FG000|Overall Study|Terminated by Sponsor|1|||
162969253|NCT00715676|588587934|FG001|Overall Study|Terminated by Sponsor|0|||
162969254|NCT00715676|588587935|FG002|Overall Study|Terminated by Sponsor|0|||
162969255|NCT00715676|588587933|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
162969256|NCT00715676|588587934|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
162969257|NCT00715676|588587935|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
162969258|NCT00715676|588587933|FG000|Overall Study|Use of Exclusionary Medication|0|||
163316835|NCT02052882|589871113|FG000|Overall Study|Not treated|11|||
162969259|NCT00715676|588587934|FG001|Overall Study|Use of Exclusionary Medication|0|||
162969260|NCT00715676|588587935|FG002|Overall Study|Use of Exclusionary Medication|1|||
162969261|NCT00715676|588587933|FG000|Overall Study|Elevated Blood Glucose|0|||
162969262|NCT00715676|588587934|FG001|Overall Study|Elevated Blood Glucose|1|||
162969263|NCT00715676|588587935|FG002|Overall Study|Elevated Blood Glucose|0|||
162969264|NCT03828539|588587936|FG000|Overall Study|Adverse Event|3|||
163316836|NCT02052882|589871113|FG000|Overall Study|Protocol Violation|1|||
163316837|NCT02052882|589871113|FG000|Overall Study|Inadequate testing|1|||
162969265|NCT03828539|588587937|FG001|Overall Study|Adverse Event|12|||
163208510|NCT00203996|589476232|FG003|Overall Study|Lost to Follow-up|1|||
162969266|NCT03828539|588587936|FG000|Overall Study|Patient's/guardian's decision|3|||
162969267|NCT03828539|588587937|FG001|Overall Study|Patient's/guardian's decision|5|||
162969268|NCT03828539|588587936|FG000|Overall Study|Lost to Follow-up|4|||
162969269|NCT03828539|588587937|FG001|Overall Study|Lost to Follow-up|2|||
162969270|NCT03828539|588587936|FG000|Overall Study|Protocol Violation|3|||
162969271|NCT03828539|588587937|FG001|Overall Study|Protocol Violation|2|||
162969272|NCT03828539|588587936|FG000|Overall Study|Withdrawal of informed consent|2|||
162969273|NCT03828539|588587937|FG001|Overall Study|Withdrawal of informed consent|1|||
162969274|NCT03828539|588587936|FG000|Overall Study|New therapy for study indication|1|||
162969275|NCT03828539|588587937|FG001|Overall Study|New therapy for study indication|0|||
162969276|NCT05467540|588587943|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
162969277|NCT05467540|588587943|FG000|3-Month Follow-up|Lost to Follow-up|4|||
162969278|NCT05467540|588587943|FG000|3-Month Follow-up|Death|5|||
163399604|NCT01449461|590172673|FG003|Overall Study|Clinical Progressive Disease|3|||
162969279|NCT05467540|588587943|FG000|12-Month Follow-up|Lost to Follow-up|6|||
162969280|NCT05467540|588587943|FG000|12-Month Follow-up|Death|8|||
162969281|NCT05467540|588587943|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
162969282|NCT00653159|588589921|FG000|Overall Study|Adverse Event|4|||
162969283|NCT00653159|588589922|FG001|Overall Study|Adverse Event|1|||
163208511|NCT00203996|589476233|FG004|Overall Study|Lost to Follow-up|0|||
163208512|NCT00203996|589476234|FG005|Overall Study|Lost to Follow-up|0|||
162969284|NCT00653159|588589921|FG000|Overall Study|Lost to Follow-up|1|||
162969285|NCT00653159|588589922|FG001|Overall Study|Lost to Follow-up|2|||
162969286|NCT01872715|588589923|FG000|Overall Study|Adverse Event|1|||
162969287|NCT01872715|588589923|FG000|Overall Study|Protocol Violation|1|||
162969288|NCT01872715|588589923|FG000|Overall Study|Withdrawal by Subject|2|||
162969289|NCT01848210|588589924|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
162969290|NCT01848210|588589925|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
162969291|NCT01848210|588589924|FG000|Overall Study|Lost to Follow-up|24|||
162969292|NCT01848210|588589925|FG001|Overall Study|Lost to Follow-up|12|||
162969293|NCT01848210|588589924|FG000|Overall Study|Protocol Violation|3|||
162969294|NCT01848210|588589925|FG001|Overall Study|Protocol Violation|5|||
162969295|NCT01848210|588589924|FG000|Overall Study|Use of Forbidden Drugs|9|||
162969296|NCT01848210|588589925|FG001|Overall Study|Use of Forbidden Drugs|10|||
162969297|NCT01848210|588589924|FG000|Overall Study|Impedition Condition|5|||
162969298|NCT01848210|588589925|FG001|Overall Study|Impedition Condition|9|||
162969299|NCT01848210|588589924|FG000|Overall Study|Adverse Event|7|||
162969300|NCT01848210|588589925|FG001|Overall Study|Adverse Event|9|||
162969301|NCT01848210|588589924|FG000|Overall Study|Discontinuation Criterion|5|||
162969302|NCT01848210|588589925|FG001|Overall Study|Discontinuation Criterion|7|||
162969303|NCT01848210|588589924|FG000|Overall Study|Hypesensitivity|1|||
162969304|NCT01848210|588589925|FG001|Overall Study|Hypesensitivity|0|||
162969305|NCT01848210|588589924|FG000|Overall Study|Hepatic Function Alteration|4|||
162969306|NCT01848210|588589925|FG001|Overall Study|Hepatic Function Alteration|0|||
162969307|NCT01848210|588589924|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
162969308|NCT01848210|588589925|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
162969309|NCT01848210|588589924|FG000|Overall Study|Administrative|1|||
162969310|NCT01848210|588589925|FG001|Overall Study|Administrative|0|||
162969311|NCT00381849|588589926|FG000|Wash Out|Withdrawal by Subject|0|||
162969312|NCT00381849|588589927|FG001|Wash Out|Withdrawal by Subject|1|||
162969313|NCT01765270|588589931|FG000|Overall Study|Physician Decision|1|||
162969314|NCT01765270|588589932|FG001|Overall Study|Physician Decision|0|||
162969315|NCT01765270|588589931|FG000|Overall Study|Withdrawal by Subject|0|||
162969316|NCT01765270|588589932|FG001|Overall Study|Withdrawal by Subject|1|||
162969317|NCT00517192|588589933|FG000|Overall Study|Adverse Event|1|||
162969318|NCT00517192|588589934|FG001|Overall Study|Adverse Event|1|||
162969319|NCT00517192|588589933|FG000|Overall Study|Lost to Follow-up|1|||
162969320|NCT00517192|588589934|FG001|Overall Study|Lost to Follow-up|1|||
162969321|NCT00517192|588589933|FG000|Overall Study|Withdrawal by Subject|1|||
162969322|NCT00517192|588589934|FG001|Overall Study|Withdrawal by Subject|0|||
162969323|NCT00517192|588589933|FG000|Overall Study|Early termination of the trial|16|||
162969324|NCT00517192|588589934|FG001|Overall Study|Early termination of the trial|18|||
162969325|NCT04501094|588589936|FG000|Overall Study|Death (unrelated to research)|1|||
162969326|NCT04501094|588589937|FG001|Overall Study|Death (unrelated to research)|0|||
162969327|NCT05693805|588589940|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
162969328|NCT05693805|588589941|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
162969329|NCT02943993|588589942|FG000|Overall Study|Withdrawal by Subject|52|||
162969330|NCT02943993|588589942|FG000|Overall Study|Transfer to another institution|6|||
162969331|NCT02943993|588589942|FG000|Overall Study|Lost to Follow-up|135|||
162969332|NCT02943993|588589942|FG000|Overall Study|Death|98|||
162969333|NCT02943993|588589942|FG000|Overall Study|Other reason for premature termination|32|||
162969334|NCT02943993|588589942|FG000|Overall Study|Missing reason for termination|7|||
162969335|NCT02510261|588589943|FG000|Overall Study|Adverse Event|5|||
162969336|NCT02510261|588589944|FG001|Overall Study|Adverse Event|8|||
162969337|NCT02510261|588589945|FG002|Overall Study|Adverse Event|0|||
162969338|NCT02510261|588589943|FG000|Overall Study|Physician Decision|1|||
162969339|NCT02510261|588589944|FG001|Overall Study|Physician Decision|5|||
162969340|NCT02510261|588589945|FG002|Overall Study|Physician Decision|0|||
162969341|NCT02510261|588589943|FG000|Overall Study|Death|19|||
162969342|NCT02510261|588589944|FG001|Overall Study|Death|19|||
162969343|NCT02510261|588589945|FG002|Overall Study|Death|0|||
162969344|NCT02510261|588589943|FG000|Overall Study|Withdrawal by Subject|3|||
162969345|NCT02510261|588589944|FG001|Overall Study|Withdrawal by Subject|10|||
162969346|NCT02510261|588589945|FG002|Overall Study|Withdrawal by Subject|3|||
162969347|NCT02003222|588589947|FG000|Induction|Never started treatment|0|||
162969348|NCT02003222|588589948|FG001|Induction|Never started treatment|0|||
162969349|NCT02003222|588589949|FG002|Induction|Never started treatment|0|||
162969350|NCT02003222|588589950|FG003|Induction|Never started treatment|0|||
162969351|NCT02003222|588589951|FG004|Induction|Never started treatment|8|||
163208513|NCT00203996|589476235|FG006|Overall Study|Lost to Follow-up|0|||
163208514|NCT00203996|589476236|FG007|Overall Study|Lost to Follow-up|0|||
163208515|NCT00203996|589476237|FG008|Overall Study|Lost to Follow-up|0|||
163208516|NCT00203996|589476238|FG009|Overall Study|Lost to Follow-up|0|||
163208517|NCT00203996|589476229|FG000|Overall Study|Protocol Violation|0|||
163208518|NCT00203996|589476230|FG001|Overall Study|Protocol Violation|0|||
163208519|NCT00203996|589476231|FG002|Overall Study|Protocol Violation|0|||
163208520|NCT00203996|589476232|FG003|Overall Study|Protocol Violation|6|||
163208521|NCT00203996|589476233|FG004|Overall Study|Protocol Violation|1|||
163208522|NCT00203996|589476234|FG005|Overall Study|Protocol Violation|0|||
163208523|NCT00203996|589476235|FG006|Overall Study|Protocol Violation|0|||
163208524|NCT00203996|589476236|FG007|Overall Study|Protocol Violation|0|||
163208525|NCT00203996|589476237|FG008|Overall Study|Protocol Violation|0|||
163208526|NCT00203996|589476238|FG009|Overall Study|Protocol Violation|0|||
163208527|NCT00203996|589476229|FG000|Overall Study|Physician Decision|0|||
163208528|NCT00203996|589476230|FG001|Overall Study|Physician Decision|0|||
163208529|NCT00203996|589476231|FG002|Overall Study|Physician Decision|0|||
163208530|NCT00203996|589476232|FG003|Overall Study|Physician Decision|2|||
163208531|NCT00203996|589476233|FG004|Overall Study|Physician Decision|0|||
163208532|NCT00203996|589476234|FG005|Overall Study|Physician Decision|0|||
163208533|NCT00203996|589476235|FG006|Overall Study|Physician Decision|0|||
163208534|NCT00203996|589476236|FG007|Overall Study|Physician Decision|0|||
163208535|NCT00203996|589476237|FG008|Overall Study|Physician Decision|0|||
163055239|NCT01041859|588914094|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
163208536|NCT00203996|589476238|FG009|Overall Study|Physician Decision|1|||
163208537|NCT00203996|589476229|FG000|Overall Study|CPAP machine malfunction|0|||
162969352|NCT02003222|588589947|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
162969353|NCT02003222|588589948|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
162969354|NCT02003222|588589949|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
163208538|NCT00203996|589476230|FG001|Overall Study|CPAP machine malfunction|0|||
163208539|NCT00203996|589476231|FG002|Overall Study|CPAP machine malfunction|0|||
163208540|NCT00203996|589476232|FG003|Overall Study|CPAP machine malfunction|1|||
163208541|NCT00203996|589476233|FG004|Overall Study|CPAP machine malfunction|0|||
163208542|NCT00203996|589476234|FG005|Overall Study|CPAP machine malfunction|0|||
163316838|NCT03734679|589871119|FG000|Overall Study|Missed Visit|1|||
163316839|NCT05218096|589871125|FG000|Primary Evaluation|Withdrawal by Subject|0|||
163316840|NCT05218096|589871126|FG001|Primary Evaluation|Withdrawal by Subject|0|||
163316841|NCT05218096|589871127|FG002|Primary Evaluation|Withdrawal by Subject|2|||
163316842|NCT05218096|589871128|FG003|Primary Evaluation|Withdrawal by Subject|0|||
163316843|NCT05218096|589871129|FG004|Primary Evaluation|Withdrawal by Subject|0|||
163316844|NCT05218096|589871125|FG000|Primary Evaluation|Physician Decision|1|||
163316845|NCT05218096|589871126|FG001|Primary Evaluation|Physician Decision|0|||
163316846|NCT05218096|589871127|FG002|Primary Evaluation|Physician Decision|0|||
163316847|NCT05218096|589871128|FG003|Primary Evaluation|Physician Decision|0|||
163316848|NCT05218096|589871129|FG004|Primary Evaluation|Physician Decision|0|||
163316849|NCT05218096|589871125|FG000|Extended Treatment|Clinical Deterioration|1|||
163316850|NCT05218096|589871126|FG001|Extended Treatment|Clinical Deterioration|1|||
163316851|NCT05218096|589871127|FG002|Extended Treatment|Clinical Deterioration|0|||
163316852|NCT05218096|589871128|FG003|Extended Treatment|Clinical Deterioration|0|||
163316853|NCT05218096|589871129|FG004|Extended Treatment|Clinical Deterioration|0|||
163316854|NCT05218096|589871125|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
163316855|NCT05218096|589871126|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
163316856|NCT05218096|589871127|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
163316857|NCT05218096|589871128|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
163316858|NCT05218096|589871129|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
163316859|NCT05218096|589871125|FG000|Extended Treatment|Withdrawal by Subject|1|||
163316860|NCT05218096|589871126|FG001|Extended Treatment|Withdrawal by Subject|3|||
163316861|NCT05218096|589871127|FG002|Extended Treatment|Withdrawal by Subject|0|||
163316862|NCT05218096|589871128|FG003|Extended Treatment|Withdrawal by Subject|2|||
163316863|NCT05218096|589871129|FG004|Extended Treatment|Withdrawal by Subject|2|||
163316864|NCT05218096|589871125|FG000|Extended Treatment|Lack of Efficacy|3|||
163316865|NCT05218096|589871126|FG001|Extended Treatment|Lack of Efficacy|0|||
163316866|NCT05218096|589871127|FG002|Extended Treatment|Lack of Efficacy|0|||
163316867|NCT05218096|589871128|FG003|Extended Treatment|Lack of Efficacy|0|||
163316868|NCT05218096|589871129|FG004|Extended Treatment|Lack of Efficacy|0|||
163316869|NCT05218096|589871125|FG000|Extended Treatment|Physician Decision|0|||
163316870|NCT05218096|589871126|FG001|Extended Treatment|Physician Decision|1|||
163316871|NCT05218096|589871127|FG002|Extended Treatment|Physician Decision|0|||
162969355|NCT02003222|588589950|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
162969356|NCT02003222|588589951|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
162969357|NCT02003222|588589947|FG000|Induction|Adverse Event|0|||
162969358|NCT02003222|588589948|FG001|Induction|Adverse Event|0|||
162969359|NCT02003222|588589949|FG002|Induction|Adverse Event|0|||
162969360|NCT02003222|588589950|FG003|Induction|Adverse Event|0|||
162969361|NCT02003222|588589951|FG004|Induction|Adverse Event|13|||
162969362|NCT02003222|588589947|FG000|Induction|Alternative therapy|0|||
162969363|NCT02003222|588589948|FG001|Induction|Alternative therapy|0|||
162969364|NCT02003222|588589949|FG002|Induction|Alternative therapy|0|||
162969365|NCT02003222|588589950|FG003|Induction|Alternative therapy|0|||
162969366|NCT02003222|588589951|FG004|Induction|Alternative therapy|12|||
162969367|NCT02003222|588589947|FG000|Induction|Disease progression|0|||
162969368|NCT02003222|588589948|FG001|Induction|Disease progression|0|||
163208543|NCT00203996|589476235|FG006|Overall Study|CPAP machine malfunction|0|||
163208544|NCT00203996|589476236|FG007|Overall Study|CPAP machine malfunction|0|||
163208545|NCT00203996|589476237|FG008|Overall Study|CPAP machine malfunction|0|||
163208546|NCT00203996|589476238|FG009|Overall Study|CPAP machine malfunction|0|||
163208547|NCT00203996|589476229|FG000|Overall Study|Scheduling issue|0|||
163208548|NCT00203996|589476230|FG001|Overall Study|Scheduling issue|0|||
163208549|NCT00203996|589476231|FG002|Overall Study|Scheduling issue|0|||
163208550|NCT00203996|589476232|FG003|Overall Study|Scheduling issue|0|||
163208551|NCT00203996|589476233|FG004|Overall Study|Scheduling issue|0|||
163208552|NCT00203996|589476234|FG005|Overall Study|Scheduling issue|0|||
163208553|NCT00203996|589476235|FG006|Overall Study|Scheduling issue|0|||
162969369|NCT02003222|588589949|FG002|Induction|Disease progression|0|||
162969370|NCT02003222|588589950|FG003|Induction|Disease progression|0|||
163055240|NCT01041859|588914095|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
163055241|NCT01041859|588914093|FG000|Open-Label Titration|Withdrawal by Subject|11|||
163055242|NCT01041859|588914094|FG001|Open-Label Titration|Withdrawal by Subject|0|||
163316872|NCT05218096|589871128|FG003|Extended Treatment|Physician Decision|0|||
163316873|NCT05218096|589871129|FG004|Extended Treatment|Physician Decision|0|||
163316874|NCT05218096|589871125|FG000|Open-label Extension|Adverse Event|1|||
163055243|NCT01041859|588914095|FG002|Open-Label Titration|Withdrawal by Subject|0|||
163055244|NCT01041859|588914093|FG000|Double-Blind Maintenance|Adverse Event|0|||
163055245|NCT01041859|588914094|FG001|Double-Blind Maintenance|Adverse Event|23|||
163055246|NCT01041859|588914095|FG002|Double-Blind Maintenance|Adverse Event|13|||
163055247|NCT01041859|588914093|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
163055248|NCT01041859|588914094|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
163055249|NCT01041859|588914095|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
163055250|NCT01041859|588914093|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
163055251|NCT01041859|588914094|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
163055252|NCT01041859|588914095|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
163055253|NCT01041859|588914093|FG000|Double-Blind Maintenance|Physician Decision|0|||
163055254|NCT01041859|588914094|FG001|Double-Blind Maintenance|Physician Decision|2|||
163316875|NCT05218096|589871126|FG001|Open-label Extension|Adverse Event|0|||
163055255|NCT01041859|588914095|FG002|Double-Blind Maintenance|Physician Decision|1|||
163055256|NCT01041859|588914093|FG000|Double-Blind Maintenance|Protocol Violation|0|||
163316876|NCT05218096|589871127|FG002|Open-label Extension|Adverse Event|0|||
163055257|NCT01041859|588914094|FG001|Double-Blind Maintenance|Protocol Violation|1|||
163055258|NCT01041859|588914095|FG002|Double-Blind Maintenance|Protocol Violation|3|||
162969371|NCT02003222|588589951|FG004|Induction|Disease progression|22|||
162969372|NCT02003222|588589947|FG000|Induction|Death|0|||
163316877|NCT05218096|589871128|FG003|Open-label Extension|Adverse Event|0|||
163316878|NCT05218096|589871129|FG004|Open-label Extension|Adverse Event|1|||
163316879|NCT05218096|589871125|FG000|Open-label Extension|Pregnancy|0|||
163316880|NCT05218096|589871126|FG001|Open-label Extension|Pregnancy|0|||
163316881|NCT05218096|589871127|FG002|Open-label Extension|Pregnancy|0|||
163316882|NCT05218096|589871128|FG003|Open-label Extension|Pregnancy|0|||
163316883|NCT05218096|589871129|FG004|Open-label Extension|Pregnancy|1|||
163316884|NCT05218096|589871125|FG000|Open-label Extension|Lack of Efficacy|1|||
163316885|NCT05218096|589871126|FG001|Open-label Extension|Lack of Efficacy|2|||
163316886|NCT05218096|589871127|FG002|Open-label Extension|Lack of Efficacy|0|||
163316887|NCT05218096|589871128|FG003|Open-label Extension|Lack of Efficacy|0|||
163316888|NCT05218096|589871129|FG004|Open-label Extension|Lack of Efficacy|0|||
162969373|NCT02003222|588589948|FG001|Induction|Death|0|||
163208554|NCT00203996|589476236|FG007|Overall Study|Scheduling issue|2|||
163208555|NCT00203996|589476237|FG008|Overall Study|Scheduling issue|0|||
163208556|NCT00203996|589476238|FG009|Overall Study|Scheduling issue|0|||
163208557|NCT03064451|589476239|FG000|Overall Study|Lost to Follow-up|1|||
163208558|NCT03064451|589476239|FG000|Overall Study|Mapping Failure|4|||
163208559|NCT03064451|589476239|FG000|Overall Study|Exited prior to procedure|8|||
163208560|NCT03064451|589476239|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
163208561|NCT00897104|589476240|FG000|Overall Study|Lost to Follow-up|12|||
163208562|NCT00897104|589476241|FG001|Overall Study|Lost to Follow-up|17|||
163208563|NCT00897104|589476242|FG002|Overall Study|Lost to Follow-up|2|||
163208564|NCT00897104|589476240|FG000|Overall Study|Pregnancy|0|||
163208565|NCT00897104|589476241|FG001|Overall Study|Pregnancy|1|||
163208566|NCT00897104|589476242|FG002|Overall Study|Pregnancy|0|||
163208567|NCT00897104|589476240|FG000|Overall Study|Protocol Violation|0|||
163208568|NCT00897104|589476241|FG001|Overall Study|Protocol Violation|1|||
163208569|NCT00897104|589476242|FG002|Overall Study|Protocol Violation|0|||
163208570|NCT00897104|589476240|FG000|Overall Study|Withdrawal by Subject|23|||
162969374|NCT02003222|588589949|FG002|Induction|Death|0|||
162969375|NCT02003222|588589950|FG003|Induction|Death|0|||
162969376|NCT02003222|588589951|FG004|Induction|Death|3|||
162969377|NCT02003222|588589947|FG000|Induction|Withdrawal by Subject|0|||
162969378|NCT02003222|588589948|FG001|Induction|Withdrawal by Subject|0|||
162969379|NCT02003222|588589949|FG002|Induction|Withdrawal by Subject|0|||
162969380|NCT02003222|588589950|FG003|Induction|Withdrawal by Subject|0|||
162969381|NCT02003222|588589951|FG004|Induction|Withdrawal by Subject|8|||
162969382|NCT02003222|588589947|FG000|Induction|Other reasons|0|||
162969383|NCT02003222|588589948|FG001|Induction|Other reasons|0|||
162969384|NCT02003222|588589949|FG002|Induction|Other reasons|0|||
162969385|NCT02003222|588589950|FG003|Induction|Other reasons|0|||
162969386|NCT02003222|588589951|FG004|Induction|Other reasons|22|||
162969387|NCT02003222|588589947|FG000|Intensification|Never started treatment|0|||
162969388|NCT02003222|588589948|FG001|Intensification|Never started treatment|0|||
162969389|NCT02003222|588589949|FG002|Intensification|Never started treatment|0|||
162969390|NCT02003222|588589950|FG003|Intensification|Never started treatment|0|||
163399605|NCT01449461|590172674|FG004|Overall Study|Clinical Progressive Disease|4|||
162969391|NCT02003222|588589951|FG004|Intensification|Never started treatment|2|||
162969392|NCT02003222|588589947|FG000|Intensification|Adverse Event|0|||
162969393|NCT02003222|588589948|FG001|Intensification|Adverse Event|0|||
162969394|NCT02003222|588589949|FG002|Intensification|Adverse Event|0|||
162969395|NCT02003222|588589950|FG003|Intensification|Adverse Event|0|||
162969396|NCT02003222|588589951|FG004|Intensification|Adverse Event|6|||
162969397|NCT02003222|588589947|FG000|Intensification|Alternative therapy|0|||
162969398|NCT02003222|588589948|FG001|Intensification|Alternative therapy|0|||
162969399|NCT02003222|588589949|FG002|Intensification|Alternative therapy|0|||
162969400|NCT02003222|588589950|FG003|Intensification|Alternative therapy|0|||
162969401|NCT02003222|588589951|FG004|Intensification|Alternative therapy|8|||
162969402|NCT02003222|588589947|FG000|Intensification|Disease progression|0|||
162969403|NCT02003222|588589948|FG001|Intensification|Disease progression|0|||
162969404|NCT02003222|588589949|FG002|Intensification|Disease progression|0|||
162969405|NCT02003222|588589950|FG003|Intensification|Disease progression|0|||
162969406|NCT02003222|588589951|FG004|Intensification|Disease progression|18|||
162969407|NCT02003222|588589947|FG000|Intensification|Withdrawal by Subject|0|||
163055259|NCT01041859|588914093|FG000|Double-Blind Maintenance|Other|0|||
163208571|NCT00897104|589476241|FG001|Overall Study|Withdrawal by Subject|27|||
163208572|NCT00897104|589476242|FG002|Overall Study|Withdrawal by Subject|3|||
163208573|NCT00897104|589476240|FG000|Overall Study|Abnormal Prestudy Labs|2|||
163055260|NCT01041859|588914094|FG001|Double-Blind Maintenance|Other|6|||
163055261|NCT01041859|588914095|FG002|Double-Blind Maintenance|Other|2|||
163055262|NCT01041859|588914093|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
163055263|NCT01041859|588914094|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
163055264|NCT01041859|588914095|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
163208574|NCT00897104|589476241|FG001|Overall Study|Abnormal Prestudy Labs|0|||
162969408|NCT02003222|588589948|FG001|Intensification|Withdrawal by Subject|0|||
162969409|NCT02003222|588589949|FG002|Intensification|Withdrawal by Subject|0|||
162969410|NCT02003222|588589950|FG003|Intensification|Withdrawal by Subject|0|||
162969411|NCT02003222|588589951|FG004|Intensification|Withdrawal by Subject|5|||
162969412|NCT02003222|588589947|FG000|Intensification|Other reasons|0|||
163208575|NCT00897104|589476242|FG002|Overall Study|Abnormal Prestudy Labs|0|||
163208576|NCT00897104|589476240|FG000|Overall Study|Abnormal Baseline ECG|2|||
162969413|NCT02003222|588589948|FG001|Intensification|Other reasons|0|||
163208577|NCT00897104|589476241|FG001|Overall Study|Abnormal Baseline ECG|2|||
163208578|NCT00897104|589476242|FG002|Overall Study|Abnormal Baseline ECG|0|||
163208579|NCT00897104|589476240|FG000|Overall Study|Need for Concom. Med.|0|||
163208580|NCT00897104|589476241|FG001|Overall Study|Need for Concom. Med.|1|||
163208581|NCT00897104|589476242|FG002|Overall Study|Need for Concom. Med.|1|||
163208582|NCT00897104|589476240|FG000|Overall Study|Lack of Migraine Attack|20|||
163208583|NCT00897104|589476241|FG001|Overall Study|Lack of Migraine Attack|22|||
163208584|NCT00897104|589476242|FG002|Overall Study|Lack of Migraine Attack|1|||
163208585|NCT00897104|589476240|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
163208586|NCT00897104|589476241|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
163316889|NCT05218096|589871125|FG000|Open-label Extension|Lost to Follow-up|1|||
163316890|NCT05218096|589871126|FG001|Open-label Extension|Lost to Follow-up|0|||
163316891|NCT05218096|589871127|FG002|Open-label Extension|Lost to Follow-up|0|||
163316892|NCT05218096|589871128|FG003|Open-label Extension|Lost to Follow-up|0|||
163316893|NCT05218096|589871129|FG004|Open-label Extension|Lost to Follow-up|0|||
163316894|NCT05218096|589871125|FG000|Open-label Extension|Death|0|||
163316895|NCT05218096|589871126|FG001|Open-label Extension|Death|0|||
163316896|NCT05218096|589871127|FG002|Open-label Extension|Death|0|||
163316897|NCT05218096|589871128|FG003|Open-label Extension|Death|1|||
163316898|NCT05218096|589871129|FG004|Open-label Extension|Death|0|||
163316899|NCT05218096|589871125|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
163316900|NCT05218096|589871126|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
163316901|NCT05218096|589871127|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
163316902|NCT05218096|589871128|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
163316903|NCT05218096|589871129|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
163208587|NCT00897104|589476242|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
163208588|NCT00897104|589476240|FG000|Overall Study|Other|3|||
163399606|NCT01449461|590172675|FG005|Overall Study|Clinical Progressive Disease|2|||
163399607|NCT01449461|590172670|FG000|Overall Study|Protocol Violation|0|||
163399608|NCT01449461|590172671|FG001|Overall Study|Protocol Violation|0|||
163399609|NCT01449461|590172672|FG002|Overall Study|Protocol Violation|0|||
163399610|NCT01449461|590172673|FG003|Overall Study|Protocol Violation|1|||
163399611|NCT01449461|590172674|FG004|Overall Study|Protocol Violation|0|||
163399612|NCT01449461|590172675|FG005|Overall Study|Protocol Violation|0|||
163399613|NCT01449461|590172670|FG000|Overall Study|Site Terminated by Sponsor|0|||
163399614|NCT01449461|590172671|FG001|Overall Study|Site Terminated by Sponsor|1|||
163399615|NCT01449461|590172672|FG002|Overall Study|Site Terminated by Sponsor|2|||
163399616|NCT01449461|590172673|FG003|Overall Study|Site Terminated by Sponsor|3|||
163399617|NCT01449461|590172674|FG004|Overall Study|Site Terminated by Sponsor|4|||
163399618|NCT01449461|590172675|FG005|Overall Study|Site Terminated by Sponsor|1|||
163399619|NCT01449461|590172670|FG000|Overall Study|Withdrawal by Subject|0|||
163399620|NCT01449461|590172671|FG001|Overall Study|Withdrawal by Subject|1|||
163399621|NCT01449461|590172672|FG002|Overall Study|Withdrawal by Subject|0|||
163399622|NCT01449461|590172673|FG003|Overall Study|Withdrawal by Subject|0|||
163399623|NCT01449461|590172674|FG004|Overall Study|Withdrawal by Subject|2|||
163399624|NCT01449461|590172675|FG005|Overall Study|Withdrawal by Subject|1|||
163399625|NCT01449461|590172670|FG000|Overall Study|Reason not Specified|0|||
163399626|NCT01449461|590172671|FG001|Overall Study|Reason not Specified|1|||
163399627|NCT01449461|590172672|FG002|Overall Study|Reason not Specified|0|||
163399628|NCT01449461|590172673|FG003|Overall Study|Reason not Specified|3|||
163399629|NCT01449461|590172674|FG004|Overall Study|Reason not Specified|2|||
163399630|NCT01449461|590172675|FG005|Overall Study|Reason not Specified|1|||
163399631|NCT00430482|590172688|FG000|Completed Treatment|Insufficient Treatment|7|||
163399632|NCT00430482|590172689|FG001|Completed Treatment|Insufficient Treatment|11|||
163399633|NCT04259411|590174114|FG000|Overall Study|Death|1|||
163399634|NCT04259411|590174114|FG000|Overall Study|Missed visit|2|||
163399635|NCT00449670|590174117|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
163399636|NCT00449670|590174118|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
163399637|NCT00449670|590174117|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
163399638|NCT00449670|590174118|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
163399639|NCT00449670|590174117|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
163399640|NCT00449670|590174118|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
163399641|NCT00449670|590174117|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
163399642|NCT00449670|590174118|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
163399643|NCT00449670|590174117|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
163399644|NCT00449670|590174118|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
163399645|NCT00449670|590174117|FG000|Booster Phase (Study no.109873)|Other|0|||
163399646|NCT00449670|590174118|FG001|Booster Phase (Study no.109873)|Other|2|||
163399647|NCT02966509|590174124|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
163399648|NCT02966509|590174125|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
163399649|NCT02966509|590174124|FG000|Baseline Satisfaction Survey|Death|0|||
163399650|NCT02966509|590174125|FG001|Baseline Satisfaction Survey|Death|1|||
163399651|NCT02966509|590174124|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
163399652|NCT02966509|590174125|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
163399653|NCT02966509|590174124|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
163399654|NCT02966509|590174125|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
163399655|NCT02966509|590174124|FG000|6 Month Satisfaction Decision Survey|Death|22|||
163399656|NCT02966509|590174125|FG001|6 Month Satisfaction Decision Survey|Death|25|||
163399657|NCT02966509|590174124|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
163399658|NCT02966509|590174125|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
163399659|NCT02966509|590174124|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
163399660|NCT02966509|590174125|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
163399661|NCT02966509|590174124|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
163399662|NCT02966509|590174125|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
163399663|NCT02966509|590174124|FG000|6 Month Satisfaction Survey|Death|36|||
163399664|NCT02966509|590174125|FG001|6 Month Satisfaction Survey|Death|33|||
163399665|NCT02966509|590174124|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
163399666|NCT02966509|590174125|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
163399667|NCT02966509|590174124|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
163399668|NCT02966509|590174125|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
163399669|NCT02966509|590174124|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
163399670|NCT02966509|590174125|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
163399671|NCT02966509|590174124|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
163399672|NCT02966509|590174125|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
163399673|NCT02966509|590174124|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
163399674|NCT02966509|590174125|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
163399675|NCT02982954|590174126|FG000|Overall Study|Death|55|||
163399676|NCT02982954|590174127|FG001|Overall Study|Death|29|||
163399677|NCT02982954|590174128|FG002|Overall Study|Death|15|||
163399678|NCT02982954|590174129|FG003|Overall Study|Death|20|||
163399679|NCT02982954|590174126|FG000|Overall Study|Lost to Follow-up|2|||
163399680|NCT02982954|590174127|FG001|Overall Study|Lost to Follow-up|1|||
163399681|NCT02982954|590174128|FG002|Overall Study|Lost to Follow-up|0|||
163399682|NCT02982954|590174129|FG003|Overall Study|Lost to Follow-up|0|||
163399683|NCT02982954|590174126|FG000|Overall Study|Participant withdrew consent|7|||
163399684|NCT02982954|590174127|FG001|Overall Study|Participant withdrew consent|5|||
163399685|NCT02982954|590174128|FG002|Overall Study|Participant withdrew consent|1|||
163399686|NCT02982954|590174129|FG003|Overall Study|Participant withdrew consent|1|||
163399687|NCT02982954|590174126|FG000|Overall Study|Other reasons|42|||
163399688|NCT02982954|590174127|FG001|Overall Study|Other reasons|17|||
163399689|NCT02982954|590174128|FG002|Overall Study|Other reasons|12|||
163399690|NCT02982954|590174129|FG003|Overall Study|Other reasons|3|||
163399691|NCT02982954|590174126|FG000|Overall Study|Premature site closure|0|||
163399692|NCT02982954|590174127|FG001|Overall Study|Premature site closure|0|||
163399693|NCT02982954|590174128|FG002|Overall Study|Premature site closure|0|||
163399694|NCT02982954|590174129|FG003|Overall Study|Premature site closure|1|||
163399695|NCT02603120|590174130|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
163399696|NCT02603120|590174131|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
163399697|NCT02603120|590174130|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
163399698|NCT02603120|590174131|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
163399699|NCT02603120|590174130|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
163399700|NCT02603120|590174131|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
163399701|NCT02603120|590174130|FG000|Double-Blind Treatment Phase|Death|2|||
163399702|NCT02603120|590174131|FG001|Double-Blind Treatment Phase|Death|0|||
163399703|NCT02603120|590174130|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
163399704|NCT02603120|590174131|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
163399705|NCT02603120|590174130|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
163399706|NCT02603120|590174131|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
163399707|NCT02603120|590174130|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
163399708|NCT02603120|590174131|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
163399709|NCT02603120|590174130|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
163399710|NCT02603120|590174131|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
163399711|NCT02603120|590174130|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
163399712|NCT02603120|590174131|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
163399713|NCT02603120|590174130|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
163399714|NCT02603120|590174131|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
163399715|NCT02603120|590174130|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
163399716|NCT02603120|590174131|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
163399717|NCT02603120|590174130|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
163399718|NCT02603120|590174131|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
163399719|NCT02603120|590174130|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
163399720|NCT02603120|590174131|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
163399721|NCT02603120|590174130|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
163399722|NCT02603120|590174131|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
163399723|NCT03810781|590174134|FG000|Overall Study|COVID shut down|2|||
163399724|NCT00253643|590174137|FG000|Overall Study|Withdrawal by Subject|0|||
163399725|NCT00253643|590174138|FG001|Overall Study|Withdrawal by Subject|0|||
163399726|NCT00253643|590174139|FG002|Overall Study|Withdrawal by Subject|1|||
163399727|NCT00253643|590174140|FG003|Overall Study|Withdrawal by Subject|1|||
163399728|NCT00253643|590174137|FG000|Overall Study|Non-Compliance|0|||
163399729|NCT00253643|590174138|FG001|Overall Study|Non-Compliance|0|||
163399730|NCT00253643|590174139|FG002|Overall Study|Non-Compliance|0|||
163399731|NCT00253643|590174140|FG003|Overall Study|Non-Compliance|2|||
163399732|NCT05807464|590174143|FG000|Overall Study|Adverse Event|1|||
163399733|NCT04451161|590174144|FG000|Overall Study|Lost to Follow-up|28|||
163399734|NCT04451161|590174145|FG001|Overall Study|Lost to Follow-up|37|||
163399735|NCT04451161|590174146|FG002|Overall Study|Lost to Follow-up|22|||
163399736|NCT04451161|590174147|FG003|Overall Study|Lost to Follow-up|13|||
163399737|NCT04451161|590174148|FG004|Overall Study|Lost to Follow-up|11|||
163399738|NCT04451161|590174149|FG005|Overall Study|Lost to Follow-up|14|||
163399739|NCT04451161|590174144|FG000|Overall Study|Withdrawal by Subject|3|||
163399740|NCT04451161|590174145|FG001|Overall Study|Withdrawal by Subject|0|||
163399741|NCT04451161|590174146|FG002|Overall Study|Withdrawal by Subject|0|||
163399742|NCT04451161|590174147|FG003|Overall Study|Withdrawal by Subject|0|||
163399743|NCT04451161|590174148|FG004|Overall Study|Withdrawal by Subject|2|||
163399744|NCT04451161|590174149|FG005|Overall Study|Withdrawal by Subject|4|||
163399745|NCT03596866|590174150|FG000|Overall Study|Site terminated by Sponsor|64|||
163399746|NCT03596866|590174151|FG001|Overall Study|Site terminated by Sponsor|65|||
163399747|NCT03596866|590174150|FG000|Overall Study|Death|37|||
163399748|NCT03596866|590174151|FG001|Overall Study|Death|24|||
163399749|NCT03596866|590174150|FG000|Overall Study|Withdrawal by Subject|4|||
163399750|NCT03596866|590174151|FG001|Overall Study|Withdrawal by Subject|6|||
163399751|NCT03596866|590174150|FG000|Overall Study|Missing|0|||
162969414|NCT02003222|588589949|FG002|Intensification|Other reasons|0|||
162969415|NCT02003222|588589950|FG003|Intensification|Other reasons|0|||
162969416|NCT02003222|588589951|FG004|Intensification|Other reasons|8|||
162969417|NCT04941768|588589956|FG000|Overall Study|Lost to Follow-up|10|||
162969418|NCT04941768|588589956|FG000|Overall Study|Death|24|||
162969419|NCT04941768|588589956|FG000|Overall Study|Progressive Disease|4|||
162969420|NCT04941768|588589956|FG000|Overall Study|Withdrawal by Subject|4|||
163208589|NCT00897104|589476241|FG001|Overall Study|Other|0|||
163208590|NCT00897104|589476242|FG002|Overall Study|Other|0|||
163208591|NCT00897104|589476240|FG000|Overall Study|Protocol Violation|1|||
163208592|NCT00897104|589476241|FG001|Overall Study|Protocol Violation|0|||
163208593|NCT00897104|589476242|FG002|Overall Study|Protocol Violation|0|||
163208594|NCT00897104|589476240|FG000|Overall Study|Withdrawal by Subject|0|||
163208595|NCT00897104|589476241|FG001|Overall Study|Withdrawal by Subject|0|||
163208596|NCT00897104|589476242|FG002|Overall Study|Withdrawal by Subject|1|||
163208597|NCT00750204|589476243|FG000|Overall Study|study halted prematurely|1|||
163208598|NCT00750204|589476244|FG001|Overall Study|study halted prematurely|1|||
163208599|NCT00434330|589476247|FG000|Overall Study|Adverse Event|0|||
163208600|NCT00434330|589476248|FG001|Overall Study|Adverse Event|0|||
163208601|NCT00434330|589476249|FG002|Overall Study|Adverse Event|1|||
163208602|NCT00434330|589476250|FG003|Overall Study|Adverse Event|0|||
163208603|NCT00434330|589476251|FG004|Overall Study|Adverse Event|0|||
163208604|NCT00434330|589476252|FG005|Overall Study|Adverse Event|0|||
163208605|NCT00434330|589476247|FG000|Overall Study|Death|1|||
163208606|NCT00434330|589476248|FG001|Overall Study|Death|0|||
163208607|NCT00434330|589476249|FG002|Overall Study|Death|0|||
163208608|NCT00434330|589476250|FG003|Overall Study|Death|0|||
163208609|NCT00434330|589476251|FG004|Overall Study|Death|1|||
163208610|NCT00434330|589476252|FG005|Overall Study|Death|1|||
163208611|NCT00434330|589476247|FG000|Overall Study|Withdrawal by Subject|0|||
163208612|NCT00434330|589476248|FG001|Overall Study|Withdrawal by Subject|0|||
163208613|NCT00434330|589476249|FG002|Overall Study|Withdrawal by Subject|1|||
163208614|NCT00434330|589476250|FG003|Overall Study|Withdrawal by Subject|1|||
163208615|NCT00434330|589476251|FG004|Overall Study|Withdrawal by Subject|0|||
163208616|NCT00434330|589476252|FG005|Overall Study|Withdrawal by Subject|0|||
162969421|NCT04941768|588589956|FG000|Overall Study|Other|3|||
162969422|NCT04941768|588589956|FG000|Overall Study|Treatment ongoing|21|||
162969423|NCT04941768|588589956|FG000|Overall Study|Off treatment and in follow-up|21|||
163208617|NCT00434330|589476247|FG000|Overall Study|Renal transplant|0|||
163208618|NCT00434330|589476248|FG001|Overall Study|Renal transplant|0|||
163208619|NCT00434330|589476249|FG002|Overall Study|Renal transplant|0|||
163208620|NCT00434330|589476250|FG003|Overall Study|Renal transplant|1|||
163208621|NCT00434330|589476251|FG004|Overall Study|Renal transplant|0|||
163208622|NCT00434330|589476252|FG005|Overall Study|Renal transplant|0|||
163208623|NCT00434330|589476247|FG000|Overall Study|Subject Not Compliant With Study|0|||
163208624|NCT00434330|589476248|FG001|Overall Study|Subject Not Compliant With Study|0|||
163316904|NCT04032847|589871144|FG000|Overall Study|Study termination by sponsor|8|||
163208625|NCT00434330|589476249|FG002|Overall Study|Subject Not Compliant With Study|1|||
163208626|NCT00434330|589476250|FG003|Overall Study|Subject Not Compliant With Study|0|||
163208627|NCT00434330|589476251|FG004|Overall Study|Subject Not Compliant With Study|0|||
163208628|NCT00434330|589476252|FG005|Overall Study|Subject Not Compliant With Study|0|||
163208629|NCT00850564|589476253|FG000|Overall Study|Withdrawal by Subject|2|||
163208630|NCT03032705|589476254|FG000|Overall Study|Lost to Follow-up|16|||
163208631|NCT03032705|589476255|FG001|Overall Study|Lost to Follow-up|17|||
163208632|NCT03032705|589476254|FG000|Overall Study|did not quality|6|||
163208633|NCT03032705|589476255|FG001|Overall Study|did not quality|6|||
163208634|NCT02167893|589476258|FG000|Overall Study|Investigator transferred|85|||
163208635|NCT02167893|589476258|FG000|Overall Study|Investigator health reasons|10|||
163208636|NCT02167893|589476258|FG000|Overall Study|Case report forms not collected|68|||
163208637|NCT04818840|589476259|FG000|Overall Study|Lost to Follow-up|0|||
163208638|NCT04818840|589476260|FG001|Overall Study|Lost to Follow-up|5|||
163208639|NCT04818840|589476259|FG000|Overall Study|Physician Decision|1|||
163208640|NCT04818840|589476260|FG001|Overall Study|Physician Decision|0|||
163208641|NCT04818840|589476259|FG000|Overall Study|Site Terminated by Sponsor|0|||
163316905|NCT04032847|589871145|FG001|Overall Study|Study termination by sponsor|0|||
163316906|NCT04032847|589871146|FG002|Overall Study|Study termination by sponsor|4|||
163316907|NCT04032847|589871144|FG000|Overall Study|Death|12|||
163316908|NCT04032847|589871145|FG001|Overall Study|Death|0|||
163316909|NCT04032847|589871146|FG002|Overall Study|Death|0|||
163316910|NCT04032847|589871144|FG000|Overall Study|Progressive disease|2|||
163316911|NCT04032847|589871145|FG001|Overall Study|Progressive disease|0|||
163316912|NCT04032847|589871146|FG002|Overall Study|Progressive disease|1|||
163316913|NCT03056573|589871147|FG000|Overall Study|Death|2|||
163316914|NCT03056573|589871148|FG001|Overall Study|Death|4|||
163316915|NCT03056573|589871147|FG000|Overall Study|Withdrawal by Subject|2|||
163316916|NCT03056573|589871148|FG001|Overall Study|Withdrawal by Subject|0|||
163316917|NCT03056573|589871147|FG000|Overall Study|Lost to Follow-up|1|||
163316918|NCT03056573|589871148|FG001|Overall Study|Lost to Follow-up|1|||
162969424|NCT03302078|588589958|FG000|Washout Period|Adverse Event|0|||
162969425|NCT03302078|588589959|FG001|Washout Period|Adverse Event|1|||
162969426|NCT01886872|588589960|FG000|Overall Study|Ineligible|7|||
162969427|NCT01886872|588589961|FG001|Overall Study|Ineligible|4|||
162969428|NCT01886872|588589962|FG002|Overall Study|Ineligible|12|||
162969429|NCT05148299|588589963|FG000|Treatment Period|Adverse Event|1|||
162969430|NCT05148299|588589963|FG000|Treatment Period|Physician Decision|1|||
162969431|NCT05148299|588589963|FG000|Treatment Period|Death|1|||
162969432|NCT05148299|588589963|FG000|Follow-up Period|Death|3|||
162969433|NCT02161549|588589964|FG000|Overall Study|Physician Decision|6|||
162969434|NCT02161549|588589965|FG001|Overall Study|Physician Decision|2|||
162969435|NCT01957150|588589966|FG000|Overall Study|Adverse Event|23|||
162969436|NCT01957150|588589967|FG001|Overall Study|Adverse Event|20|||
162969437|NCT01957150|588589966|FG000|Overall Study|Withdrawal by Subject|13|||
162969438|NCT01957150|588589967|FG001|Overall Study|Withdrawal by Subject|17|||
162969439|NCT01957150|588589966|FG000|Overall Study|Physician Decision|3|||
162969440|NCT01957150|588589967|FG001|Overall Study|Physician Decision|6|||
162969441|NCT01957150|588589966|FG000|Overall Study|Lost to Follow-up|4|||
162969442|NCT01957150|588589967|FG001|Overall Study|Lost to Follow-up|4|||
162969443|NCT01957150|588589966|FG000|Overall Study|Protocol Violation|1|||
162969444|NCT01957150|588589967|FG001|Overall Study|Protocol Violation|0|||
162969445|NCT01957150|588589966|FG000|Overall Study|Lack of Efficacy|11|||
163208642|NCT04818840|589476260|FG001|Overall Study|Site Terminated by Sponsor|3|||
163208643|NCT04818840|589476259|FG000|Overall Study|Study Terminated by Sponsor|43|||
163208644|NCT04818840|589476260|FG001|Overall Study|Study Terminated by Sponsor|7|||
163316919|NCT05104463|589871149|FG000|Overall Study|Adverse Event|1|||
163316920|NCT05104463|589871150|FG001|Overall Study|Adverse Event|1|||
163316921|NCT05104463|589871149|FG000|Overall Study|Lost to Follow-up|1|||
162969446|NCT01957150|588589967|FG001|Overall Study|Lack of Efficacy|11|||
162969447|NCT01856192|588589968|FG000|Overall Study|Adverse Event|12|||
162969448|NCT01856192|588589969|FG001|Overall Study|Adverse Event|4|||
162969449|NCT01856192|588589968|FG000|Overall Study|Alternative therapy|0|||
163055265|NCT01041859|588914093|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
163316922|NCT05104463|589871150|FG001|Overall Study|Lost to Follow-up|1|||
163399752|NCT03596866|590174151|FG001|Overall Study|Missing|6|||
163208645|NCT04818840|589476259|FG000|Overall Study|Withdrawal by Subject|0|||
163208646|NCT04818840|589476260|FG001|Overall Study|Withdrawal by Subject|1|||
163208647|NCT04847557|589476265|FG000|Overall Study|Adverse Event|1|||
163208648|NCT04847557|589476266|FG001|Overall Study|Adverse Event|0|||
163208649|NCT04847557|589476265|FG000|Overall Study|Death|19|||
163399753|NCT03596866|590174150|FG000|Overall Study|Lost to Follow-up|2|||
163055266|NCT01041859|588914094|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
163055267|NCT01041859|588914095|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
163055268|NCT04798027|588914096|FG000|Overall Study|Protocol Violation|0|||
163208650|NCT04847557|589476266|FG001|Overall Study|Death|15|||
163208651|NCT04847557|589476265|FG000|Overall Study|Lost to Follow-up|3|||
163208652|NCT04847557|589476266|FG001|Overall Study|Lost to Follow-up|6|||
163208653|NCT04847557|589476265|FG000|Overall Study|Physician Decision|1|||
163208654|NCT04847557|589476266|FG001|Overall Study|Physician Decision|0|||
163208655|NCT04847557|589476265|FG000|Overall Study|Protocol Violation|0|||
163208656|NCT04847557|589476266|FG001|Overall Study|Protocol Violation|1|||
163208657|NCT04847557|589476265|FG000|Overall Study|Withdrawal by Subject|8|||
163208658|NCT04847557|589476266|FG001|Overall Study|Withdrawal by Subject|14|||
163208659|NCT01325584|589476267|FG000|Overall Study|Death|1|||
163208660|NCT00397982|589478608|FG000|Overall Study|Withdrawal by Subject|1|||
163208661|NCT00397982|589478608|FG000|Overall Study|Adverse Event|1|||
163208662|NCT00397982|589478608|FG000|Overall Study|noncompliance|1|||
163208663|NCT00397982|589478608|FG000|Overall Study|Unrelated health issues|1|||
163208664|NCT02329730|589478609|FG000|Overall Study|Protocol Violation|0|||
163208665|NCT02329730|589478610|FG001|Overall Study|Protocol Violation|0|||
163208666|NCT02329730|589478611|FG002|Overall Study|Protocol Violation|0|||
163208667|NCT02329730|589478612|FG003|Overall Study|Protocol Violation|0|||
163208668|NCT02329730|589478613|FG004|Overall Study|Protocol Violation|2|||
163208669|NCT02329730|589478614|FG005|Overall Study|Protocol Violation|2|||
163399754|NCT03596866|590174151|FG001|Overall Study|Lost to Follow-up|3|||
163399755|NCT03596866|590174150|FG000|Overall Study|Protocol Violation|1|||
163399756|NCT03596866|590174151|FG001|Overall Study|Protocol Violation|0|||
163399757|NCT03596866|590174150|FG000|Overall Study|Reason Not Specified|14|||
163399758|NCT03596866|590174151|FG001|Overall Study|Reason Not Specified|13|||
163399759|NCT04770532|590174152|FG000|Overall Study|Withdrawal by Subject|0|||
163399760|NCT04770532|590174153|FG001|Overall Study|Withdrawal by Subject|3|||
163399761|NCT04770532|590174152|FG000|Overall Study|Physician Decision|1|||
163399762|NCT04770532|590174153|FG001|Overall Study|Physician Decision|0|||
163399763|NCT04770532|590174152|FG000|Overall Study|Death|2|||
163399764|NCT04770532|590174153|FG001|Overall Study|Death|2|||
163399765|NCT01431274|590174158|FG000|Overall Study|Adverse Event|51|||
163399766|NCT01431274|590174159|FG001|Overall Study|Adverse Event|37|||
163399767|NCT01431274|590174160|FG002|Overall Study|Adverse Event|43|||
163399768|NCT01431274|590174161|FG003|Overall Study|Adverse Event|30|||
163399769|NCT01431274|590174162|FG004|Overall Study|Adverse Event|37|||
163399770|NCT01431274|590174158|FG000|Overall Study|Consent withdrawn not due to AE|29|||
163399771|NCT01431274|590174159|FG001|Overall Study|Consent withdrawn not due to AE|20|||
163399772|NCT01431274|590174160|FG002|Overall Study|Consent withdrawn not due to AE|17|||
163399773|NCT01431274|590174161|FG003|Overall Study|Consent withdrawn not due to AE|20|||
163399774|NCT01431274|590174162|FG004|Overall Study|Consent withdrawn not due to AE|11|||
163399775|NCT01431274|590174158|FG000|Overall Study|Non compliant with protocol|5|||
163399776|NCT01431274|590174159|FG001|Overall Study|Non compliant with protocol|8|||
163399777|NCT01431274|590174160|FG002|Overall Study|Non compliant with protocol|4|||
163399778|NCT01431274|590174161|FG003|Overall Study|Non compliant with protocol|4|||
163399779|NCT01431274|590174162|FG004|Overall Study|Non compliant with protocol|4|||
163399780|NCT01431274|590174158|FG000|Overall Study|Lost to Follow-up|6|||
163399781|NCT01431274|590174159|FG001|Overall Study|Lost to Follow-up|7|||
163399782|NCT01431274|590174160|FG002|Overall Study|Lost to Follow-up|1|||
163399783|NCT01431274|590174161|FG003|Overall Study|Lost to Follow-up|4|||
163399784|NCT01431274|590174162|FG004|Overall Study|Lost to Follow-up|0|||
163399785|NCT01431274|590174158|FG000|Overall Study|Other reason not stated above|6|||
163399786|NCT01431274|590174159|FG001|Overall Study|Other reason not stated above|5|||
163399787|NCT01431274|590174160|FG002|Overall Study|Other reason not stated above|7|||
163399788|NCT01431274|590174161|FG003|Overall Study|Other reason not stated above|2|||
163399789|NCT01431274|590174162|FG004|Overall Study|Other reason not stated above|4|||
163399790|NCT00243386|590174165|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
163399791|NCT00243386|590174166|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
163399792|NCT00243386|590174167|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
163399793|NCT00243386|590174165|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
163399794|NCT00243386|590174166|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
163399795|NCT00243386|590174167|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
163399796|NCT00243386|590174165|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
163399797|NCT00243386|590174166|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
163399798|NCT00243386|590174167|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
163399799|NCT00243386|590174165|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
163399800|NCT00243386|590174166|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
163399801|NCT00243386|590174167|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
163399802|NCT00243386|590174165|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
163399803|NCT00243386|590174166|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
163399804|NCT00243386|590174167|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
163399805|NCT00243386|590174165|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
163399806|NCT00243386|590174166|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
163399807|NCT00243386|590174167|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
163399808|NCT00243386|590174165|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
162969450|NCT01856192|588589969|FG001|Overall Study|Alternative therapy|3|||
163399809|NCT00243386|590174166|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
163399810|NCT00243386|590174167|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
163399811|NCT00243386|590174165|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
163055269|NCT04798027|588914097|FG001|Overall Study|Protocol Violation|0|||
163055270|NCT04798027|588914098|FG002|Overall Study|Protocol Violation|0|||
163055271|NCT04798027|588914099|FG003|Overall Study|Protocol Violation|0|||
163055272|NCT04798027|588914100|FG004|Overall Study|Protocol Violation|1|||
163055273|NCT04798027|588914101|FG005|Overall Study|Protocol Violation|0|||
163055274|NCT04798027|588914102|FG006|Overall Study|Protocol Violation|0|||
163055275|NCT04798027|588914103|FG007|Overall Study|Protocol Violation|1|||
163055276|NCT04798027|588914104|FG008|Overall Study|Protocol Violation|0|||
163055277|NCT04798027|588914096|FG000|Overall Study|Withdrawal by Subject|1|||
163055278|NCT04798027|588914097|FG001|Overall Study|Withdrawal by Subject|0|||
163055279|NCT04798027|588914098|FG002|Overall Study|Withdrawal by Subject|1|||
163055280|NCT04798027|588914099|FG003|Overall Study|Withdrawal by Subject|1|||
163055281|NCT04798027|588914100|FG004|Overall Study|Withdrawal by Subject|1|||
163055282|NCT04798027|588914101|FG005|Overall Study|Withdrawal by Subject|1|||
163055283|NCT04798027|588914102|FG006|Overall Study|Withdrawal by Subject|3|||
163055284|NCT04798027|588914103|FG007|Overall Study|Withdrawal by Subject|2|||
163055285|NCT04798027|588914104|FG008|Overall Study|Withdrawal by Subject|2|||
163055286|NCT04798027|588914096|FG000|Overall Study|Lost to Follow-up|1|||
163055287|NCT04798027|588914097|FG001|Overall Study|Lost to Follow-up|3|||
163055288|NCT04798027|588914098|FG002|Overall Study|Lost to Follow-up|0|||
163055289|NCT04798027|588914099|FG003|Overall Study|Lost to Follow-up|0|||
163055290|NCT04798027|588914100|FG004|Overall Study|Lost to Follow-up|0|||
163055291|NCT04798027|588914101|FG005|Overall Study|Lost to Follow-up|1|||
163055292|NCT04798027|588914102|FG006|Overall Study|Lost to Follow-up|0|||
163055293|NCT04798027|588914103|FG007|Overall Study|Lost to Follow-up|0|||
163055294|NCT04798027|588914104|FG008|Overall Study|Lost to Follow-up|1|||
163055295|NCT04798027|588914096|FG000|Overall Study|Withdrawal by Sponsor|8|||
163055296|NCT04798027|588914097|FG001|Overall Study|Withdrawal by Sponsor|22|||
163055297|NCT04798027|588914098|FG002|Overall Study|Withdrawal by Sponsor|9|||
163055298|NCT04798027|588914099|FG003|Overall Study|Withdrawal by Sponsor|26|||
163055299|NCT04798027|588914100|FG004|Overall Study|Withdrawal by Sponsor|24|||
163055300|NCT04798027|588914101|FG005|Overall Study|Withdrawal by Sponsor|11|||
163055301|NCT04798027|588914102|FG006|Overall Study|Withdrawal by Sponsor|25|||
163055302|NCT04798027|588914103|FG007|Overall Study|Withdrawal by Sponsor|26|||
163055303|NCT04798027|588914104|FG008|Overall Study|Withdrawal by Sponsor|11|||
163055304|NCT03087058|588914108|FG000|Overall Study|Withdrawal by Subject|2|||
163055305|NCT03087058|588914109|FG001|Overall Study|Withdrawal by Subject|0|||
163055306|NCT03087058|588914110|FG002|Overall Study|Withdrawal by Subject|0|||
163055307|NCT05158140|588914114|FG000|Overall Study|Death|0|||
163055308|NCT05158140|588914115|FG001|Overall Study|Death|0|||
163055309|NCT05158140|588914116|FG002|Overall Study|Death|0|||
163055310|NCT05158140|588914117|FG003|Overall Study|Death|1|||
163055311|NCT05158140|588914114|FG000|Overall Study|Lost to Follow-up|3|||
163055312|NCT05158140|588914115|FG001|Overall Study|Lost to Follow-up|6|||
163055313|NCT05158140|588914116|FG002|Overall Study|Lost to Follow-up|4|||
163055314|NCT05158140|588914117|FG003|Overall Study|Lost to Follow-up|3|||
163055315|NCT05158140|588914114|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163055316|NCT05158140|588914115|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163055317|NCT05158140|588914116|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
163055318|NCT05158140|588914117|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
163055319|NCT05158140|588914114|FG000|Overall Study|Withdrawal by Subject|3|||
163055320|NCT05158140|588914115|FG001|Overall Study|Withdrawal by Subject|7|||
163055321|NCT05158140|588914116|FG002|Overall Study|Withdrawal by Subject|3|||
163055322|NCT05158140|588914117|FG003|Overall Study|Withdrawal by Subject|7|||
163055323|NCT00617279|588914118|FG000|Overall Study|Study terminated by Sponsor|10|||
163055324|NCT00617279|588914119|FG001|Overall Study|Study terminated by Sponsor|15|||
163055325|NCT00617279|588914118|FG000|Overall Study|Graft abandonment|2|||
163055326|NCT00617279|588914119|FG001|Overall Study|Graft abandonment|0|||
163055327|NCT00617279|588914118|FG000|Overall Study|Lost to Follow-up|1|||
163055328|NCT00617279|588914119|FG001|Overall Study|Lost to Follow-up|0|||
163055329|NCT00617279|588914118|FG000|Overall Study|Death|1|||
163055330|NCT00617279|588914119|FG001|Overall Study|Death|2|||
163055331|NCT01814007|588914121|FG000|Overall Study|Withdrawal by Subject|1|||
163055332|NCT01274351|588914122|FG000|Overall Study|Lost to Follow-up|1|||
163055333|NCT01274351|588914122|FG000|Overall Study|patient not compliant with the protocol|1|||
163055334|NCT01274351|588914122|FG000|Overall Study|Pregnancy|1|||
163208670|NCT02329730|589478615|FG006|Overall Study|Protocol Violation|0|||
163055335|NCT01274351|588914122|FG000|Overall Study|Death|2|||
163055336|NCT01274351|588914122|FG000|Overall Study|Withdrawal by Subject|3|||
163055337|NCT01274351|588914122|FG000|Overall Study|Adverse Event|8|||
163055338|NCT01274351|588914122|FG000|Overall Study|progression of disease|3|||
163055339|NCT01274351|588914122|FG000|Overall Study|hospitalization|1|||
163208671|NCT02329730|589478616|FG007|Overall Study|Protocol Violation|0|||
163055340|NCT03861039|588915953|FG000|Overall Study|Adverse Event|2|||
163055341|NCT03861039|588915954|FG001|Overall Study|Adverse Event|5|||
163055342|NCT03861039|588915955|FG002|Overall Study|Adverse Event|11|||
163208672|NCT02329730|589478617|FG008|Overall Study|Protocol Violation|0|||
163208673|NCT02329730|589478618|FG009|Overall Study|Protocol Violation|0|||
163055343|NCT03861039|588915953|FG000|Overall Study|Withdrawal by Subject|1|||
163055344|NCT03861039|588915954|FG001|Overall Study|Withdrawal by Subject|3|||
163055345|NCT03861039|588915955|FG002|Overall Study|Withdrawal by Subject|4|||
163055346|NCT01113749|588915956|FG000|Overall Study|Lost to Follow-up|1|||
163055347|NCT01113749|588915957|FG001|Overall Study|Lost to Follow-up|2|||
163055348|NCT03427892|588915958|FG000|Overall Study|Lost to Follow-up|2|||
163055349|NCT02934178|588915959|FG000|Received Vaccination 2|Death|0|||
163055350|NCT02934178|588915960|FG001|Received Vaccination 2|Death|1|||
163055351|NCT02934178|588915959|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
163055352|NCT02934178|588915960|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
163055353|NCT03944616|588915965|FG000|Overall Study|Lost to Follow-up|0|||
163055354|NCT03944616|588915966|FG001|Overall Study|Lost to Follow-up|2|||
163055355|NCT01287936|588915967|FG000|Overall Study|Lost to Follow-up|0|||
163055356|NCT01287936|588915968|FG001|Overall Study|Lost to Follow-up|1|||
163055357|NCT01287936|588915969|FG002|Overall Study|Lost to Follow-up|1|||
163055358|NCT00427934|588915971|FG000|Overall Study|Adverse Event|1|||
163055359|NCT00427934|588915972|FG001|Overall Study|Adverse Event|0|||
163055360|NCT00427934|588915973|FG002|Overall Study|Adverse Event|5|||
163055361|NCT00427934|588915974|FG003|Overall Study|Adverse Event|4|||
163055362|NCT00427934|588915971|FG000|Overall Study|Lack of Efficacy|0|||
163055363|NCT00427934|588915972|FG001|Overall Study|Lack of Efficacy|0|||
163055364|NCT00427934|588915973|FG002|Overall Study|Lack of Efficacy|5|||
163055365|NCT00427934|588915974|FG003|Overall Study|Lack of Efficacy|2|||
163055366|NCT00427934|588915971|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
163055367|NCT00427934|588915972|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
163055368|NCT00427934|588915973|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
163055369|NCT00427934|588915974|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
163055370|NCT00427934|588915971|FG000|Overall Study|Other|0|||
163055371|NCT00427934|588915972|FG001|Overall Study|Other|0|||
163055372|NCT00427934|588915973|FG002|Overall Study|Other|11|||
163055373|NCT00427934|588915974|FG003|Overall Study|Other|5|||
163055374|NCT00427934|588915971|FG000|Overall Study|Withdrawal by Subject|0|||
163055375|NCT00427934|588915972|FG001|Overall Study|Withdrawal by Subject|0|||
163055376|NCT00427934|588915973|FG002|Overall Study|Withdrawal by Subject|1|||
163055377|NCT00427934|588915974|FG003|Overall Study|Withdrawal by Subject|3|||
163055378|NCT02791269|588915975|FG000|Overall Study|Lost to Follow-up|0|||
163055379|NCT02791269|588915976|FG001|Overall Study|Lost to Follow-up|1|||
163055380|NCT02683109|588915977|FG000|Overall Study|Adverse Event|1|||
163055381|NCT02683109|588915978|FG001|Overall Study|Adverse Event|0|||
163055382|NCT00368251|588915979|FG000|Overall Study|SAE, non-fatal|1|||
163055383|NCT00368251|588915980|FG001|Overall Study|SAE, non-fatal|0|||
163055384|NCT00368251|588915981|FG002|Overall Study|SAE, non-fatal|0|||
163055385|NCT00368251|588915979|FG000|Overall Study|AE, non-serious non-fatal|0|||
163055386|NCT00368251|588915980|FG001|Overall Study|AE, non-serious non-fatal|0|||
163055387|NCT00368251|588915981|FG002|Overall Study|AE, non-serious non-fatal|1|||
163055388|NCT03617588|588915982|FG000|Overall Study|Withdrawal by Subject|1|||
163055389|NCT03617588|588915983|FG001|Overall Study|Withdrawal by Subject|0|||
163055390|NCT00784875|588915990|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
163055391|NCT00784875|588915991|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
163055392|NCT00784875|588915992|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
163055393|NCT00784875|588915993|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
163055394|NCT00784875|588915990|FG000|Period A - Baseline|Adverse Event|0|||
163055395|NCT00784875|588915991|FG001|Period A - Baseline|Adverse Event|0|||
163055396|NCT00784875|588915992|FG002|Period A - Baseline|Adverse Event|0|||
163055397|NCT00784875|588915993|FG003|Period A - Baseline|Adverse Event|8|||
163055398|NCT00784875|588915990|FG000|Period A - Baseline|Protocol Violation|0|||
163055399|NCT00784875|588915991|FG001|Period A - Baseline|Protocol Violation|0|||
163208674|NCT02329730|589478619|FG010|Overall Study|Protocol Violation|0|||
163208675|NCT02329730|589478620|FG011|Overall Study|Protocol Violation|0|||
163208676|NCT02329730|589478609|FG000|Overall Study|Withdrawal by Subject|0|||
163208677|NCT02329730|589478610|FG001|Overall Study|Withdrawal by Subject|0|||
163208678|NCT02329730|589478611|FG002|Overall Study|Withdrawal by Subject|0|||
163208679|NCT02329730|589478612|FG003|Overall Study|Withdrawal by Subject|0|||
163208680|NCT02329730|589478613|FG004|Overall Study|Withdrawal by Subject|1|||
163208681|NCT02329730|589478614|FG005|Overall Study|Withdrawal by Subject|0|||
163208682|NCT02329730|589478615|FG006|Overall Study|Withdrawal by Subject|1|||
163055400|NCT00784875|588915992|FG002|Period A - Baseline|Protocol Violation|0|||
163055401|NCT00784875|588915993|FG003|Period A - Baseline|Protocol Violation|25|||
163055402|NCT00784875|588915990|FG000|Period A - Baseline|Withdrawal by Subject|0|||
163055403|NCT00784875|588915991|FG001|Period A - Baseline|Withdrawal by Subject|0|||
163055404|NCT00784875|588915992|FG002|Period A - Baseline|Withdrawal by Subject|0|||
163055405|NCT00784875|588915993|FG003|Period A - Baseline|Withdrawal by Subject|27|||
163055406|NCT00784875|588915990|FG000|Period A - Baseline|Physician Decision|0|||
163055407|NCT00784875|588915991|FG001|Period A - Baseline|Physician Decision|0|||
163055408|NCT00784875|588915992|FG002|Period A - Baseline|Physician Decision|0|||
163055409|NCT00784875|588915993|FG003|Period A - Baseline|Physician Decision|2|||
163055410|NCT00784875|588915990|FG000|Period A - Baseline|Sponsor Decision|0|||
163055411|NCT00784875|588915991|FG001|Period A - Baseline|Sponsor Decision|0|||
163055412|NCT00784875|588915992|FG002|Period A - Baseline|Sponsor Decision|0|||
163055413|NCT00784875|588915993|FG003|Period A - Baseline|Sponsor Decision|113|||
163055414|NCT00784875|588915990|FG000|Period A - Baseline|Lost to Follow-up|0|||
163055415|NCT00784875|588915991|FG001|Period A - Baseline|Lost to Follow-up|0|||
163055416|NCT00784875|588915992|FG002|Period A - Baseline|Lost to Follow-up|0|||
163055417|NCT00784875|588915993|FG003|Period A - Baseline|Lost to Follow-up|2|||
163055418|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
163055419|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
163055420|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
163055421|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
163055422|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
163055423|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
163055424|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
163055425|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
163055426|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
163055427|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
163055428|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
163055429|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
163055430|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
163055431|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
163055432|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
163055433|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
163055434|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
163055435|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
163055436|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
163055437|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
163055438|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
163055439|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
163055440|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
163055441|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
163055442|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
163055443|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
163055444|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
163055445|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
163055446|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
163055447|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
163055448|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
163055449|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
163055450|NCT00784875|588915990|FG000|Period C|Adverse Event|1|||
163055451|NCT00784875|588915991|FG001|Period C|Adverse Event|0|||
163055452|NCT00784875|588915992|FG002|Period C|Adverse Event|4|||
163055453|NCT00784875|588915993|FG003|Period C|Adverse Event|2|||
163055454|NCT00784875|588915990|FG000|Period C|Protocol Violation|0|||
163055455|NCT00784875|588915991|FG001|Period C|Protocol Violation|0|||
163055456|NCT00784875|588915992|FG002|Period C|Protocol Violation|1|||
163055457|NCT00784875|588915993|FG003|Period C|Protocol Violation|2|||
163055458|NCT00784875|588915990|FG000|Period C|Lack of Efficacy|0|||
163055459|NCT00784875|588915991|FG001|Period C|Lack of Efficacy|0|||
163055460|NCT00784875|588915992|FG002|Period C|Lack of Efficacy|1|||
163055461|NCT00784875|588915993|FG003|Period C|Lack of Efficacy|0|||
163055462|NCT00784875|588915990|FG000|Period C|Withdrawal by Subject|1|||
163055463|NCT00784875|588915991|FG001|Period C|Withdrawal by Subject|1|||
163055464|NCT00784875|588915992|FG002|Period C|Withdrawal by Subject|2|||
163055465|NCT00784875|588915993|FG003|Period C|Withdrawal by Subject|0|||
163055466|NCT00784875|588915990|FG000|Period C|Physician Decision|0|||
163055467|NCT00784875|588915991|FG001|Period C|Physician Decision|0|||
163055468|NCT00784875|588915992|FG002|Period C|Physician Decision|1|||
163055469|NCT00784875|588915993|FG003|Period C|Physician Decision|1|||
163055470|NCT00784875|588915990|FG000|Period C|Sponsor Decision|5|||
163055471|NCT00784875|588915991|FG001|Period C|Sponsor Decision|5|||
163055472|NCT00784875|588915992|FG002|Period C|Sponsor Decision|4|||
163055473|NCT00784875|588915993|FG003|Period C|Sponsor Decision|2|||
163055474|NCT00784875|588915990|FG000|Period D|Adverse Event|0|||
163399812|NCT00243386|590174166|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
163399813|NCT00243386|590174167|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
163399814|NCT00133991|590174168|FG000|Overall Study|Death|4|||
163399815|NCT04995055|590174172|FG000|Period 1|COVID-19 Related|1|||
163399816|NCT04995055|590174173|FG001|Period 1|COVID-19 Related|0|||
163399817|NCT04995055|590174172|FG000|Period 1|Withdrawal by Subject|0|||
163399818|NCT04995055|590174173|FG001|Period 1|Withdrawal by Subject|1|||
163399819|NCT04995055|590174172|FG000|Period 1|Subject discontinued due to timing|4|||
163399820|NCT04995055|590174173|FG001|Period 1|Subject discontinued due to timing|4|||
163399821|NCT03418129|590174174|FG000|Overall Study|Lost to Follow-up|11|||
163399822|NCT03418129|590174175|FG001|Overall Study|Lost to Follow-up|20|||
163399823|NCT03418129|590174176|FG002|Overall Study|Lost to Follow-up|15|||
163055475|NCT00784875|588915991|FG001|Period D|Adverse Event|2|||
163399824|NCT03418129|590174174|FG000|Overall Study|Withdrawal by Subject|3|||
163399825|NCT03418129|590174175|FG001|Overall Study|Withdrawal by Subject|6|||
163055476|NCT00784875|588915992|FG002|Period D|Adverse Event|2|||
163055477|NCT00784875|588915993|FG003|Period D|Adverse Event|0|||
163055478|NCT00784875|588915990|FG000|Period D|Protocol Violation|1|||
163055479|NCT00784875|588915991|FG001|Period D|Protocol Violation|0|||
163055480|NCT00784875|588915992|FG002|Period D|Protocol Violation|0|||
163055481|NCT00784875|588915993|FG003|Period D|Protocol Violation|0|||
163055482|NCT00784875|588915990|FG000|Period D|Withdrawal by Subject|2|||
163055483|NCT00784875|588915991|FG001|Period D|Withdrawal by Subject|0|||
163055484|NCT00784875|588915992|FG002|Period D|Withdrawal by Subject|2|||
163055485|NCT00784875|588915993|FG003|Period D|Withdrawal by Subject|0|||
163055486|NCT00784875|588915990|FG000|Period D|Physician Decision|0|||
163055487|NCT00784875|588915991|FG001|Period D|Physician Decision|1|||
163055488|NCT00784875|588915992|FG002|Period D|Physician Decision|0|||
163055489|NCT00784875|588915993|FG003|Period D|Physician Decision|0|||
163055490|NCT00784875|588915990|FG000|Period D|Sponsor Decision|1|||
163055491|NCT00784875|588915991|FG001|Period D|Sponsor Decision|1|||
163055492|NCT00784875|588915992|FG002|Period D|Sponsor Decision|1|||
163055493|NCT00784875|588915993|FG003|Period D|Sponsor Decision|0|||
163055494|NCT00784875|588915990|FG000|Period D|Lost to Follow-up|1|||
163055495|NCT00784875|588915991|FG001|Period D|Lost to Follow-up|0|||
163055496|NCT00784875|588915992|FG002|Period D|Lost to Follow-up|1|||
163055497|NCT00784875|588915993|FG003|Period D|Lost to Follow-up|1|||
163055498|NCT02300610|588915994|FG000|Overall Study|Withdrawal by Subject|1|||
163055499|NCT02300610|588915995|FG001|Overall Study|Withdrawal by Subject|0|||
163055500|NCT02300610|588915996|FG002|Overall Study|Withdrawal by Subject|1|||
163055501|NCT02515227|588915998|FG000|Overall Study|Adverse Event|0|||
163055502|NCT02515227|588915999|FG001|Overall Study|Adverse Event|2|||
163055503|NCT02515227|588915998|FG000|Overall Study|Progressive disease|2|||
163055504|NCT02515227|588915999|FG001|Overall Study|Progressive disease|9|||
163055505|NCT02111083|588916000|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
163055506|NCT02111083|588916001|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
163055507|NCT02152007|588916002|FG000|Overall Study|Withdrawal by Subject|1|||
163055508|NCT03451071|588916013|FG000|First Vaccine|Withdrawal by Subject|1|||
163055509|NCT03451071|588916013|FG000|Second Vaccine|Lost to Follow-up|19|||
163055510|NCT03451071|588916013|FG000|Third Vaccine|Lost to Follow-up|22|||
163055511|NCT03451071|588916013|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
163055512|NCT03363906|588916018|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
163055513|NCT03363906|588916019|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
163055514|NCT03363906|588916018|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
163055515|NCT03363906|588916019|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
163055516|NCT03363906|588916018|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
163055517|NCT03363906|588916019|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
163055518|NCT03363906|588916018|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
163055519|NCT03363906|588916019|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
163055520|NCT00676143|588916020|FG000|Overall Study|Adverse Event|34|||
163055521|NCT00676143|588916021|FG001|Overall Study|Adverse Event|60|||
163055522|NCT00676143|588916020|FG000|Overall Study|Death|4|||
163399826|NCT03418129|590174176|FG002|Overall Study|Withdrawal by Subject|4|||
163399827|NCT01378858|590174179|FG000|Overall Study|Withdrawal by Subject|4|||
163399828|NCT01378858|590174180|FG001|Overall Study|Withdrawal by Subject|4|||
163399829|NCT02664272|590174181|FG000|Overall Study|Fluoroscopic images not made available|2|||
163399830|NCT03073980|590174182|FG000|Overall Study|Lost to Follow-up|10|||
163399831|NCT03073980|590174183|FG001|Overall Study|Lost to Follow-up|2|||
163055523|NCT00676143|588916021|FG001|Overall Study|Death|4|||
163055524|NCT00676143|588916020|FG000|Overall Study|Lack of Efficacy|0|||
163055525|NCT00676143|588916021|FG001|Overall Study|Lack of Efficacy|6|||
163055526|NCT00676143|588916020|FG000|Overall Study|Lost to Follow-up|0|||
162969451|NCT01856192|588589968|FG000|Overall Study|Death|3|||
162969452|NCT01856192|588589969|FG001|Overall Study|Death|5|||
162969453|NCT01856192|588589968|FG000|Overall Study|Lack of Efficacy|0|||
162969454|NCT01856192|588589969|FG001|Overall Study|Lack of Efficacy|5|||
162969455|NCT01856192|588589968|FG000|Overall Study|Withdrawal by Subject|1|||
162969456|NCT01856192|588589969|FG001|Overall Study|Withdrawal by Subject|1|||
162969457|NCT01856192|588589968|FG000|Overall Study|Other diseases|1|||
162969458|NCT01856192|588589969|FG001|Overall Study|Other diseases|0|||
162969459|NCT01856192|588589968|FG000|Overall Study|Never started treatment|7|||
162969460|NCT01856192|588589969|FG001|Overall Study|Never started treatment|5|||
162969461|NCT01856192|588589968|FG000|Overall Study|Path ineligible|20|||
162969462|NCT01856192|588589969|FG001|Overall Study|Path ineligible|34|||
162969463|NCT01856192|588589968|FG000|Overall Study|Non-path ineligible|2|||
162969464|NCT01856192|588589969|FG001|Overall Study|Non-path ineligible|2|||
162969465|NCT01856192|588589968|FG000|Overall Study|Physician Decision|1|||
162969466|NCT01856192|588589969|FG001|Overall Study|Physician Decision|1|||
162969467|NCT01856192|588589968|FG000|Overall Study|Suspicion of progressive disease|1|||
162969468|NCT01856192|588589969|FG001|Overall Study|Suspicion of progressive disease|0|||
162969469|NCT01856192|588589968|FG000|Overall Study|Non-compliance|1|||
162969470|NCT01856192|588589969|FG001|Overall Study|Non-compliance|0|||
162969471|NCT00098475|588589970|FG000|Step 1|Progressive disease|33|||
162969472|NCT00098475|588589971|FG001|Step 1|Progressive disease|35|||
162969473|NCT00098475|588589972|FG002|Step 1|Progressive disease|2|||
162969474|NCT00098475|588589973|FG003|Step 1|Progressive disease|1|||
162969475|NCT00098475|588589970|FG000|Step 1|Adverse Event|56|||
162969476|NCT00098475|588589971|FG001|Step 1|Adverse Event|37|||
162969477|NCT00098475|588589972|FG002|Step 1|Adverse Event|0|||
162969478|NCT00098475|588589973|FG003|Step 1|Adverse Event|1|||
162969479|NCT00098475|588589970|FG000|Step 1|Death|8|||
162969480|NCT00098475|588589971|FG001|Step 1|Death|5|||
163055527|NCT00676143|588916021|FG001|Overall Study|Lost to Follow-up|13|||
163055528|NCT00676143|588916020|FG000|Overall Study|Physician Decision|5|||
163055529|NCT00676143|588916021|FG001|Overall Study|Physician Decision|8|||
163055530|NCT00676143|588916020|FG000|Overall Study|Protocol Violation|4|||
163055531|NCT00676143|588916021|FG001|Overall Study|Protocol Violation|8|||
163316923|NCT05104463|589871149|FG000|Overall Study|Physician Decision|1|||
163316924|NCT05104463|589871150|FG001|Overall Study|Physician Decision|0|||
163316925|NCT05104463|589871149|FG000|Overall Study|Protocol Violation|0|||
162969481|NCT00098475|588589972|FG002|Step 1|Death|0|||
163208683|NCT02329730|589478616|FG007|Overall Study|Withdrawal by Subject|1|||
163208684|NCT02329730|589478617|FG008|Overall Study|Withdrawal by Subject|1|||
163208685|NCT02329730|589478618|FG009|Overall Study|Withdrawal by Subject|1|||
163208686|NCT02329730|589478619|FG010|Overall Study|Withdrawal by Subject|0|||
163208687|NCT02329730|589478620|FG011|Overall Study|Withdrawal by Subject|0|||
163208688|NCT02345850|589478621|FG000|Overall Study|Not transplanted|10|||
163208689|NCT02345850|589478622|FG001|Overall Study|Not transplanted|5|||
163208690|NCT02345850|589478623|FG002|Overall Study|Not transplanted|4|||
163208691|NCT02345850|589478621|FG000|Overall Study|Lost to Follow-up|2|||
163208692|NCT02345850|589478622|FG001|Overall Study|Lost to Follow-up|3|||
163208693|NCT02345850|589478623|FG002|Overall Study|Lost to Follow-up|2|||
163208694|NCT02345850|589478621|FG000|Overall Study|Withdrawal by Subject|1|||
163208695|NCT02345850|589478622|FG001|Overall Study|Withdrawal by Subject|0|||
163208696|NCT02345850|589478623|FG002|Overall Study|Withdrawal by Subject|0|||
163208697|NCT02392247|589478624|FG000|Overall Study|Withdrawal by Subject|1|||
163208698|NCT02392247|589478624|FG000|Overall Study|Surgery cancelled; no data|1|||
163208699|NCT00951665|589478625|FG000|Phase 1b|Adverse Event|2|||
163208700|NCT00951665|589478626|FG001|Phase 1b|Adverse Event|1|||
163316926|NCT05104463|589871150|FG001|Overall Study|Protocol Violation|2|||
162969482|NCT00098475|588589973|FG003|Step 1|Death|1|||
162969483|NCT00098475|588589970|FG000|Step 1|Withdrawal by Subject|14|||
162969484|NCT00098475|588589971|FG001|Step 1|Withdrawal by Subject|11|||
162969485|NCT00098475|588589972|FG002|Step 1|Withdrawal by Subject|0|||
162969486|NCT00098475|588589973|FG003|Step 1|Withdrawal by Subject|0|||
162969487|NCT00098475|588589970|FG000|Step 1|Physician Decision|5|||
162969488|NCT00098475|588589971|FG001|Step 1|Physician Decision|2|||
163055532|NCT00676143|588916020|FG000|Overall Study|Withdrawal by Subject|24|||
163208701|NCT00951665|589478627|FG002|Phase 1b|Adverse Event|0|||
163208702|NCT00951665|589478628|FG003|Phase 1b|Adverse Event|1|||
163055533|NCT00676143|588916021|FG001|Overall Study|Withdrawal by Subject|42|||
163055534|NCT00676143|588916020|FG000|Overall Study|Discontinuation of study by sponsor|65|||
163055535|NCT00676143|588916021|FG001|Overall Study|Discontinuation of study by sponsor|88|||
163055536|NCT00676143|588916020|FG000|Overall Study|Failed to return|2|||
163055537|NCT00676143|588916021|FG001|Overall Study|Failed to return|1|||
163055538|NCT00676143|588916020|FG000|Overall Study|Loss of caregiver|5|||
163055539|NCT00676143|588916021|FG001|Overall Study|Loss of caregiver|3|||
163055540|NCT00676143|588916020|FG000|Overall Study|Other|11|||
163055541|NCT00676143|588916021|FG001|Overall Study|Other|20|||
163055542|NCT00676143|588916020|FG000|Overall Study|Participant participation unknown|1|||
163055543|NCT00676143|588916021|FG001|Overall Study|Participant participation unknown|4|||
163055544|NCT00676143|588916020|FG000|Overall Study|Vasogenic edema recurrence|1|||
163055545|NCT00676143|588916021|FG001|Overall Study|Vasogenic edema recurrence|3|||
163055546|NCT00929669|588916022|FG000|Overall Study|elevated glucose levels|1|||
163055547|NCT02714153|588916024|FG000|Overall Study|Death|1|||
163055548|NCT00686972|588916025|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
163055549|NCT01901185|588916026|FG000|Overall Study|Withdrawal by Subject|2|||
163055550|NCT00250588|588916029|FG000|Overall Study|Withdrawal by Subject|3|||
163055551|NCT00250588|588916030|FG001|Overall Study|Withdrawal by Subject|6|||
163055552|NCT00250588|588916031|FG002|Overall Study|Withdrawal by Subject|0|||
163055553|NCT00250588|588916029|FG000|Overall Study|Lost to Follow-up|6|||
163055554|NCT00250588|588916030|FG001|Overall Study|Lost to Follow-up|13|||
163055555|NCT00250588|588916031|FG002|Overall Study|Lost to Follow-up|13|||
163055556|NCT00706797|588916032|FG000|Overall Study|Lack of Efficacy|3|||
163055557|NCT00706797|588916033|FG001|Overall Study|Lack of Efficacy|0|||
163055558|NCT00706797|588916032|FG000|Overall Study|Adverse Event|0|||
163055559|NCT00706797|588916033|FG001|Overall Study|Adverse Event|3|||
163055560|NCT00706797|588916032|FG000|Overall Study|Withdrawal by Subject|8|||
163055561|NCT00706797|588916033|FG001|Overall Study|Withdrawal by Subject|1|||
163055562|NCT00706797|588916032|FG000|Overall Study|Death|1|||
163055563|NCT00706797|588916033|FG001|Overall Study|Death|0|||
163055564|NCT00706797|588916032|FG000|Overall Study|Discontinuation of study by sponsor|52|||
163055565|NCT00706797|588916033|FG001|Overall Study|Discontinuation of study by sponsor|63|||
163055566|NCT00706797|588916032|FG000|Overall Study|Protocol Violation|3|||
163055567|NCT00706797|588916033|FG001|Overall Study|Protocol Violation|2|||
163055568|NCT00706797|588916032|FG000|Overall Study|Lost to Follow-up|1|||
163055569|NCT00706797|588916033|FG001|Overall Study|Lost to Follow-up|2|||
163055570|NCT00706797|588916032|FG000|Overall Study|Other|1|||
163055571|NCT00706797|588916033|FG001|Overall Study|Other|0|||
163055572|NCT01670292|588916036|FG000|Overall Study|Lost to Follow-up|14|||
163055573|NCT03555149|588916040|FG000|Overall Study|Death|18|||
163055574|NCT03555149|588916041|FG001|Overall Study|Death|15|||
163055575|NCT03555149|588916042|FG002|Overall Study|Death|15|||
163055576|NCT03555149|588916043|FG003|Overall Study|Death|4|||
163055577|NCT03555149|588916044|FG004|Overall Study|Death|4|||
163055578|NCT03555149|588916045|FG005|Overall Study|Death|11|||
163055579|NCT03555149|588916046|FG006|Overall Study|Death|12|||
163055580|NCT03555149|588916047|FG007|Overall Study|Death|1|||
163055581|NCT03555149|588916040|FG000|Overall Study|Lost to Follow-up|1|||
163055582|NCT03555149|588916041|FG001|Overall Study|Lost to Follow-up|0|||
163208703|NCT00951665|589478629|FG004|Phase 1b|Adverse Event|0|||
163399832|NCT03073980|590174184|FG002|Overall Study|Lost to Follow-up|9|||
163055583|NCT03555149|588916042|FG002|Overall Study|Lost to Follow-up|0|||
163055584|NCT03555149|588916043|FG003|Overall Study|Lost to Follow-up|0|||
163055585|NCT03555149|588916044|FG004|Overall Study|Lost to Follow-up|0|||
163055586|NCT03555149|588916045|FG005|Overall Study|Lost to Follow-up|1|||
163055587|NCT03555149|588916046|FG006|Overall Study|Lost to Follow-up|0|||
163055588|NCT03555149|588916047|FG007|Overall Study|Lost to Follow-up|0|||
163208704|NCT00951665|589478630|FG005|Phase 1b|Adverse Event|0|||
163208705|NCT00951665|589478625|FG000|Phase 1b|Death|1|||
163208706|NCT00951665|589478626|FG001|Phase 1b|Death|0|||
163208707|NCT00951665|589478627|FG002|Phase 1b|Death|2|||
163208708|NCT00951665|589478628|FG003|Phase 1b|Death|0|||
163208709|NCT00951665|589478629|FG004|Phase 1b|Death|0|||
163208710|NCT00951665|589478630|FG005|Phase 1b|Death|0|||
163208711|NCT00951665|589478625|FG000|Phase 1b|Physician Decision|4|||
163208712|NCT00951665|589478626|FG001|Phase 1b|Physician Decision|0|||
163208713|NCT00951665|589478627|FG002|Phase 1b|Physician Decision|1|||
163208714|NCT00951665|589478628|FG003|Phase 1b|Physician Decision|0|||
163208715|NCT00951665|589478629|FG004|Phase 1b|Physician Decision|0|||
163208716|NCT00951665|589478630|FG005|Phase 1b|Physician Decision|0|||
163208717|NCT00951665|589478625|FG000|Phase 1b|Withdrawal by Subject|0|||
163208718|NCT00951665|589478626|FG001|Phase 1b|Withdrawal by Subject|1|||
163208719|NCT00951665|589478627|FG002|Phase 1b|Withdrawal by Subject|0|||
163208720|NCT00951665|589478628|FG003|Phase 1b|Withdrawal by Subject|0|||
163208721|NCT00951665|589478629|FG004|Phase 1b|Withdrawal by Subject|0|||
163055589|NCT03555149|588916040|FG000|Overall Study|Physician Decision|1|||
163055590|NCT03555149|588916041|FG001|Overall Study|Physician Decision|0|||
163055591|NCT03555149|588916042|FG002|Overall Study|Physician Decision|0|||
163055592|NCT03555149|588916043|FG003|Overall Study|Physician Decision|0|||
163208722|NCT00951665|589478630|FG005|Phase 1b|Withdrawal by Subject|0|||
163399833|NCT03073980|590174182|FG000|Overall Study|No post-procedure data|0|||
163399834|NCT03073980|590174183|FG001|Overall Study|No post-procedure data|0|||
163399835|NCT03073980|590174184|FG002|Overall Study|No post-procedure data|2|||
163399836|NCT04810689|590174185|FG000|Overall Study|Withdrawal by Subject|0|||
163399837|NCT04810689|590174186|FG001|Overall Study|Withdrawal by Subject|1|||
163399838|NCT01940471|590174187|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
163399839|NCT01940471|590174188|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
163399840|NCT01940471|590174189|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
163399841|NCT01940471|590174190|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
163399842|NCT01940471|590174187|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
163399843|NCT01940471|590174188|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
163399844|NCT01940471|590174189|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
163399845|NCT01940471|590174190|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
163399846|NCT01940471|590174187|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
162969489|NCT00098475|588589972|FG002|Step 1|Physician Decision|0|||
162969490|NCT00098475|588589973|FG003|Step 1|Physician Decision|0|||
162969491|NCT00098475|588589970|FG000|Step 1|Alternative therapy|31|||
163316927|NCT05104463|589871149|FG000|Overall Study|Withdrawal by Subject|1|||
163316928|NCT05104463|589871150|FG001|Overall Study|Withdrawal by Subject|1|||
163316929|NCT05321082|589871151|FG000|Overall Study|Other than listed|40|||
163316930|NCT05321082|589871152|FG001|Overall Study|Other than listed|26|||
163316931|NCT05321082|589871153|FG002|Overall Study|Other than listed|27|||
163316932|NCT05321082|589871151|FG000|Overall Study|Lost to Follow-up|0|||
163316933|NCT05321082|589871152|FG001|Overall Study|Lost to Follow-up|1|||
163316934|NCT05321082|589871153|FG002|Overall Study|Lost to Follow-up|0|||
163316935|NCT05321082|589871151|FG000|Overall Study|Withdrawal by Subject|30|||
163316936|NCT05321082|589871152|FG001|Overall Study|Withdrawal by Subject|34|||
163316937|NCT05321082|589871153|FG002|Overall Study|Withdrawal by Subject|42|||
163316938|NCT05321082|589871151|FG000|Overall Study|Protocol Violation|0|||
163316939|NCT05321082|589871152|FG001|Overall Study|Protocol Violation|0|||
163316940|NCT05321082|589871153|FG002|Overall Study|Protocol Violation|1|||
163316941|NCT05321082|589871151|FG000|Overall Study|Adverse Event|49|||
163316942|NCT05321082|589871152|FG001|Overall Study|Adverse Event|49|||
163316943|NCT05321082|589871153|FG002|Overall Study|Adverse Event|48|||
163316944|NCT05321082|589871151|FG000|Overall Study|Lack of Efficacy|2|||
163316945|NCT05321082|589871152|FG001|Overall Study|Lack of Efficacy|0|||
163316946|NCT05321082|589871153|FG002|Overall Study|Lack of Efficacy|1|||
163316947|NCT05321082|589871151|FG000|Overall Study|Not treated|1|||
163316948|NCT05321082|589871152|FG001|Overall Study|Not treated|0|||
163316949|NCT05321082|589871153|FG002|Overall Study|Not treated|1|||
163316950|NCT07147257|589871154|FG000|Overall Study|Pregnancy|1|||
163316951|NCT07147257|589871155|FG001|Overall Study|Pregnancy|0|||
163316952|NCT07147257|589871154|FG000|Overall Study|Physician Decision|0|||
163316953|NCT07147257|589871155|FG001|Overall Study|Physician Decision|1|||
163316954|NCT07147257|589871154|FG000|Overall Study|Withdrawal by Subject|0|||
163316955|NCT07147257|589871155|FG001|Overall Study|Withdrawal by Subject|1|||
163316956|NCT07147257|589871154|FG000|Overall Study|Drug administration failure|0|||
163316957|NCT07147257|589871155|FG001|Overall Study|Drug administration failure|1|||
163316958|NCT04171141|589873054|FG000|Overall Study|Adverse Event|0|||
163316959|NCT04171141|589873055|FG001|Overall Study|Adverse Event|0|||
163316960|NCT04171141|589873056|FG002|Overall Study|Adverse Event|2|||
163316961|NCT04171141|589873057|FG003|Overall Study|Adverse Event|0|||
163316962|NCT04171141|589873058|FG004|Overall Study|Adverse Event|0|||
163316963|NCT04171141|589873059|FG005|Overall Study|Adverse Event|0|||
163316964|NCT04171141|589873060|FG006|Overall Study|Adverse Event|0|||
163316965|NCT04171141|589873061|FG007|Overall Study|Adverse Event|0|||
163316966|NCT04171141|589873062|FG008|Overall Study|Adverse Event|0|||
163316967|NCT04171141|589873063|FG009|Overall Study|Adverse Event|0|||
163316968|NCT04171141|589873064|FG010|Overall Study|Adverse Event|0|||
163316969|NCT04171141|589873065|FG011|Overall Study|Adverse Event|0|||
163316970|NCT04171141|589873066|FG012|Overall Study|Adverse Event|0|||
163399847|NCT01940471|590174188|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
163399848|NCT01940471|590174189|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
163399849|NCT01940471|590174190|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
163399850|NCT01940471|590174187|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
162969492|NCT00098475|588589971|FG001|Step 1|Alternative therapy|43|||
163316971|NCT04171141|589873067|FG013|Overall Study|Adverse Event|2|||
163316972|NCT04171141|589873068|FG014|Overall Study|Adverse Event|0|||
163316973|NCT04171141|589873069|FG015|Overall Study|Adverse Event|0|||
163316974|NCT04171141|589873054|FG000|Overall Study|Physician Decision|0|||
163316975|NCT04171141|589873055|FG001|Overall Study|Physician Decision|0|||
163316976|NCT04171141|589873056|FG002|Overall Study|Physician Decision|0|||
162969493|NCT00098475|588589972|FG002|Step 1|Alternative therapy|1|||
163316977|NCT04171141|589873057|FG003|Overall Study|Physician Decision|0|||
163316978|NCT04171141|589873058|FG004|Overall Study|Physician Decision|1|||
163316979|NCT04171141|589873059|FG005|Overall Study|Physician Decision|0|||
163316980|NCT04171141|589873060|FG006|Overall Study|Physician Decision|0|||
163316981|NCT04171141|589873061|FG007|Overall Study|Physician Decision|0|||
163399851|NCT01940471|590174188|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
163399852|NCT01940471|590174189|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
163399853|NCT01940471|590174190|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
163399854|NCT01940471|590174187|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
163399855|NCT01940471|590174188|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
163399856|NCT01940471|590174189|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
163399857|NCT01940471|590174190|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
163399858|NCT01940471|590174187|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
163399859|NCT01940471|590174188|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
163399860|NCT01940471|590174189|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
163399861|NCT01940471|590174190|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
163399862|NCT01940471|590174187|FG000|Period 1: Double-blind Phase|Death|2|||
163399863|NCT01940471|590174188|FG001|Period 1: Double-blind Phase|Death|1|||
163399864|NCT01940471|590174189|FG002|Period 1: Double-blind Phase|Death|0|||
163399865|NCT01940471|590174190|FG003|Period 1: Double-blind Phase|Death|0|||
163399866|NCT01940471|590174187|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
163399867|NCT01940471|590174188|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
163399868|NCT01940471|590174189|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
163399869|NCT01940471|590174190|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
163399870|NCT01940471|590174187|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
163399871|NCT01940471|590174188|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
163399872|NCT01940471|590174189|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
163399873|NCT01940471|590174190|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
163399874|NCT01940471|590174187|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
163399875|NCT01940471|590174188|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
163399876|NCT01940471|590174189|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
163399877|NCT01940471|590174190|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
163399878|NCT01940471|590174187|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
163399879|NCT01940471|590174188|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
163399880|NCT01940471|590174189|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
163399881|NCT01940471|590174190|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
163399882|NCT01940471|590174187|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
163399883|NCT01940471|590174188|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
163399884|NCT01940471|590174189|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
163399885|NCT01940471|590174190|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
163399886|NCT01940471|590174187|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
163399887|NCT01940471|590174188|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
163399888|NCT01940471|590174189|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
163399889|NCT01940471|590174190|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
163399890|NCT01940471|590174187|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
163399891|NCT01940471|590174188|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
163399892|NCT01940471|590174189|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
163399893|NCT01940471|590174190|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
163399894|NCT01940471|590174187|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
163399895|NCT01940471|590174188|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
163399896|NCT01940471|590174189|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
163399897|NCT01940471|590174190|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
163399898|NCT01940471|590174187|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
163399899|NCT01940471|590174188|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
163399900|NCT01940471|590174189|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
163399901|NCT01940471|590174190|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
163399902|NCT01940471|590174187|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
163399903|NCT01940471|590174188|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
163399904|NCT01940471|590174189|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
163399905|NCT01940471|590174190|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
163399906|NCT01940471|590174187|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
163399907|NCT01940471|590174188|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
163399908|NCT01940471|590174189|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
163399909|NCT01940471|590174190|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
163399910|NCT01940471|590174187|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
163399911|NCT01940471|590174188|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
163399912|NCT01940471|590174189|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
163399913|NCT01940471|590174190|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
163399914|NCT01940471|590174187|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
163399915|NCT01940471|590174188|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
163399916|NCT01940471|590174189|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
163399917|NCT01940471|590174190|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
163399918|NCT01940471|590174187|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
163399919|NCT01940471|590174188|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
163399920|NCT01940471|590174189|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
163399921|NCT01940471|590174190|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
163399922|NCT04695392|590174191|FG000|Overall Study|Withdrawn by parent/guardian|0|||
163399923|NCT04695392|590174192|FG001|Overall Study|Withdrawn by parent/guardian|1|||
163399924|NCT04695392|590174191|FG000|Overall Study|Withdrawn by physician|0|||
163399925|NCT04695392|590174192|FG001|Overall Study|Withdrawn by physician|1|||
163399926|NCT00450723|590174195|FG000|Overall Study|Physician Decision|5|||
163399927|NCT01721057|590174198|FG000|Treatment Period|Withdrawal by Subject|11|||
163399928|NCT01721057|590174199|FG001|Treatment Period|Withdrawal by Subject|5|||
163399929|NCT01721057|590174200|FG002|Treatment Period|Withdrawal by Subject|8|||
163399930|NCT01721057|590174201|FG003|Treatment Period|Withdrawal by Subject|0|||
163399931|NCT01721057|590174202|FG004|Treatment Period|Withdrawal by Subject|0|||
163399932|NCT01721057|590174203|FG005|Treatment Period|Withdrawal by Subject|0|||
163399933|NCT01721057|590174204|FG006|Treatment Period|Withdrawal by Subject|0|||
163399934|NCT01721057|590174198|FG000|Treatment Period|Adverse Event|7|||
163399935|NCT01721057|590174199|FG001|Treatment Period|Adverse Event|10|||
163399936|NCT01721057|590174200|FG002|Treatment Period|Adverse Event|12|||
163399937|NCT01721057|590174201|FG003|Treatment Period|Adverse Event|0|||
163399938|NCT01721057|590174202|FG004|Treatment Period|Adverse Event|0|||
163399939|NCT01721057|590174203|FG005|Treatment Period|Adverse Event|0|||
163399940|NCT01721057|590174204|FG006|Treatment Period|Adverse Event|0|||
163399941|NCT01721057|590174198|FG000|Treatment Period|Lack of Efficacy|7|||
163399942|NCT01721057|590174199|FG001|Treatment Period|Lack of Efficacy|3|||
163399943|NCT01721057|590174200|FG002|Treatment Period|Lack of Efficacy|0|||
163399944|NCT01721057|590174201|FG003|Treatment Period|Lack of Efficacy|0|||
163399945|NCT01721057|590174202|FG004|Treatment Period|Lack of Efficacy|0|||
163399946|NCT01721057|590174203|FG005|Treatment Period|Lack of Efficacy|0|||
163399947|NCT01721057|590174204|FG006|Treatment Period|Lack of Efficacy|0|||
163399948|NCT01721057|590174198|FG000|Treatment Period|Lost to Follow-up|1|||
163399949|NCT01721057|590174199|FG001|Treatment Period|Lost to Follow-up|0|||
163399950|NCT01721057|590174200|FG002|Treatment Period|Lost to Follow-up|0|||
163399951|NCT01721057|590174201|FG003|Treatment Period|Lost to Follow-up|0|||
163399952|NCT01721057|590174202|FG004|Treatment Period|Lost to Follow-up|0|||
163399953|NCT01721057|590174203|FG005|Treatment Period|Lost to Follow-up|0|||
163399954|NCT01721057|590174204|FG006|Treatment Period|Lost to Follow-up|0|||
163399955|NCT01721057|590174198|FG000|Treatment Period|Physician Decision|0|||
163399956|NCT01721057|590174199|FG001|Treatment Period|Physician Decision|1|||
163399957|NCT01721057|590174200|FG002|Treatment Period|Physician Decision|3|||
163399958|NCT01721057|590174201|FG003|Treatment Period|Physician Decision|0|||
163399959|NCT01721057|590174202|FG004|Treatment Period|Physician Decision|0|||
163399960|NCT01721057|590174203|FG005|Treatment Period|Physician Decision|0|||
163399961|NCT01721057|590174204|FG006|Treatment Period|Physician Decision|0|||
163399962|NCT01721057|590174198|FG000|Treatment Period|Death|2|||
163399963|NCT01721057|590174199|FG001|Treatment Period|Death|0|||
163399964|NCT01721057|590174200|FG002|Treatment Period|Death|0|||
163399965|NCT01721057|590174201|FG003|Treatment Period|Death|0|||
163399966|NCT01721057|590174202|FG004|Treatment Period|Death|0|||
163399967|NCT01721057|590174203|FG005|Treatment Period|Death|0|||
163399968|NCT01721057|590174204|FG006|Treatment Period|Death|0|||
163399969|NCT01721057|590174198|FG000|Rescue Period|Adverse Event|0|||
163399970|NCT01721057|590174199|FG001|Rescue Period|Adverse Event|0|||
163208723|NCT00951665|589478625|FG000|Phase 1b|Disease Progression|13|||
163399971|NCT01721057|590174200|FG002|Rescue Period|Adverse Event|0|||
163399972|NCT01721057|590174201|FG003|Rescue Period|Adverse Event|1|||
163399973|NCT01721057|590174202|FG004|Rescue Period|Adverse Event|0|||
163399974|NCT01721057|590174203|FG005|Rescue Period|Adverse Event|0|||
163399975|NCT01721057|590174204|FG006|Rescue Period|Adverse Event|0|||
163399976|NCT01721057|590174198|FG000|Rescue Period|Lack of Efficacy|0|||
163399977|NCT01721057|590174199|FG001|Rescue Period|Lack of Efficacy|0|||
163399978|NCT01721057|590174200|FG002|Rescue Period|Lack of Efficacy|0|||
163399979|NCT01721057|590174201|FG003|Rescue Period|Lack of Efficacy|2|||
163399980|NCT01721057|590174202|FG004|Rescue Period|Lack of Efficacy|0|||
163399981|NCT01721057|590174203|FG005|Rescue Period|Lack of Efficacy|0|||
163399982|NCT01721057|590174204|FG006|Rescue Period|Lack of Efficacy|0|||
163399983|NCT01202279|590174205|FG000|Overall Study|Adverse Event|8|||
163399984|NCT01202279|590174206|FG001|Overall Study|Adverse Event|6|||
163399985|NCT01202279|590174205|FG000|Overall Study|Withdrawal by Subject|13|||
163399986|NCT01202279|590174206|FG001|Overall Study|Withdrawal by Subject|10|||
163399987|NCT01202279|590174205|FG000|Overall Study|Physician Decision|0|||
163399988|NCT01202279|590174206|FG001|Overall Study|Physician Decision|1|||
163399989|NCT01202279|590174205|FG000|Overall Study|Lost to Follow-up|10|||
163399990|NCT01202279|590174206|FG001|Overall Study|Lost to Follow-up|7|||
163399991|NCT01202279|590174205|FG000|Overall Study|Protocol Violation|1|||
163399992|NCT01202279|590174206|FG001|Overall Study|Protocol Violation|1|||
163399993|NCT01202279|590174205|FG000|Overall Study|study compliance|5|||
163399994|NCT01202279|590174206|FG001|Overall Study|study compliance|2|||
163399995|NCT03574753|590174207|FG000|Overall Study|Adverse Event|3|||
163399996|NCT03574753|590174207|FG000|Overall Study|Progression/relapse|19|||
163399997|NCT03574753|590174207|FG000|Overall Study|Death|1|||
163399998|NCT00807742|590174210|FG000|Overall Study|Death|9|||
163399999|NCT00807742|590174211|FG001|Overall Study|Death|2|||
163400000|NCT00807742|590174210|FG000|Overall Study|Withdrawal by Subject|2|||
163400001|NCT00807742|590174211|FG001|Overall Study|Withdrawal by Subject|1|||
163400002|NCT00807742|590174210|FG000|Overall Study|Lost to Follow-up|35|||
163400003|NCT00807742|590174211|FG001|Overall Study|Lost to Follow-up|51|||
163400004|NCT00609986|590174213|FG000|Overall Study|Did not receive transplant or treatment|8|||
163400005|NCT00609986|590174214|FG001|Overall Study|Did not receive transplant or treatment|3|||
163400006|NCT03159091|590174215|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
163400007|NCT03159091|590174216|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
163400008|NCT03159091|590174215|FG000|Overall Study|Patient has taken no dose of study drug|0|||
163400009|NCT03159091|590174216|FG001|Overall Study|Patient has taken no dose of study drug|1|||
163400010|NCT02044133|590174220|FG000|Overall Study|Lost to Follow-up|1|||
163400011|NCT02044133|590174221|FG001|Overall Study|Lost to Follow-up|1|||
163400012|NCT02044133|590174220|FG000|Overall Study|Death|1|||
163400013|NCT02044133|590174221|FG001|Overall Study|Death|0|||
163400014|NCT02044133|590174220|FG000|Overall Study|Release|3|||
163400015|NCT02044133|590174221|FG001|Overall Study|Release|4|||
163400016|NCT02044133|590174220|FG000|Overall Study|Transfer|1|||
163400017|NCT02044133|590174221|FG001|Overall Study|Transfer|0|||
163400018|NCT02044133|590174220|FG000|Overall Study|refusal of blood sampling|0|||
163400019|NCT02044133|590174221|FG001|Overall Study|refusal of blood sampling|1|||
163400020|NCT04085523|590174222|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
163400021|NCT04085523|590174223|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
163400022|NCT04085523|590174224|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
163400023|NCT04085523|590174225|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
163400024|NCT04085523|590174226|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
163400025|NCT04085523|590174227|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
163400026|NCT02046096|590174228|FG000|Overall Study|Death|28|||
163400027|NCT02046096|590174229|FG001|Overall Study|Death|45|||
163400028|NCT02046096|590174228|FG000|Overall Study|Lost to Follow-up|9|||
163400029|NCT02046096|590174229|FG001|Overall Study|Lost to Follow-up|20|||
163400030|NCT02046096|590174228|FG000|Overall Study|Withdrawal by Subject|5|||
163400031|NCT02046096|590174229|FG001|Overall Study|Withdrawal by Subject|17|||
163400032|NCT02046096|590174228|FG000|Overall Study|Other endpoint|2|||
163400033|NCT02046096|590174229|FG001|Overall Study|Other endpoint|19|||
163400034|NCT03520959|590174230|FG000|Overall Study|Study terminated by Sponsor|0|||
163400035|NCT03520959|590174231|FG001|Overall Study|Study terminated by Sponsor|1|||
163400036|NCT04969276|590174232|FG000|Overall Study|Protocol Deviation|0|||
163400037|NCT04969276|590174233|FG001|Overall Study|Protocol Deviation|1|||
162969494|NCT00098475|588589973|FG003|Step 1|Alternative therapy|0|||
162969495|NCT00098475|588589970|FG000|Step 1|Other disease|2|||
162969496|NCT00098475|588589971|FG001|Step 1|Other disease|1|||
162969497|NCT00098475|588589972|FG002|Step 1|Other disease|1|||
162969498|NCT00098475|588589973|FG003|Step 1|Other disease|0|||
162969499|NCT00098475|588589970|FG000|Step 1|Never started treatment|0|||
163400038|NCT04969276|590174234|FG002|Overall Study|Protocol Deviation|0|||
163400039|NCT04969276|590174232|FG000|Overall Study|Withdrawal by Subject|1|||
163400040|NCT04969276|590174233|FG001|Overall Study|Withdrawal by Subject|10|||
163400041|NCT04969276|590174234|FG002|Overall Study|Withdrawal by Subject|0|||
163400042|NCT04969276|590174232|FG000|Overall Study|Lost to Follow-up|0|||
163400043|NCT04969276|590174233|FG001|Overall Study|Lost to Follow-up|1|||
163400044|NCT04969276|590174234|FG002|Overall Study|Lost to Follow-up|0|||
163400045|NCT00418665|590174240|FG000|Treatment Period|Ineligibility determined|1|||
163400046|NCT00418665|590174241|FG001|Treatment Period|Ineligibility determined|1|||
163400047|NCT00418665|590174242|FG002|Treatment Period|Ineligibility determined|0|||
163400048|NCT00418665|590174240|FG000|Treatment Period|Adverse Event|2|||
163400049|NCT00418665|590174241|FG001|Treatment Period|Adverse Event|2|||
163400050|NCT00418665|590174242|FG002|Treatment Period|Adverse Event|0|||
162969500|NCT00098475|588589971|FG001|Step 1|Never started treatment|2|||
162969501|NCT00098475|588589972|FG002|Step 1|Never started treatment|0|||
162969502|NCT00098475|588589973|FG003|Step 1|Never started treatment|0|||
162969503|NCT00098475|588589970|FG000|Step 1|Still on treatment as of this analysis|14|||
162969504|NCT00098475|588589971|FG001|Step 1|Still on treatment as of this analysis|27|||
162969505|NCT00098475|588589972|FG002|Step 1|Still on treatment as of this analysis|0|||
162969506|NCT00098475|588589973|FG003|Step 1|Still on treatment as of this analysis|0|||
162969507|NCT00098475|588589970|FG000|Step 1|Knee surgery|1|||
162969508|NCT00098475|588589971|FG001|Step 1|Knee surgery|0|||
162969509|NCT00098475|588589972|FG002|Step 1|Knee surgery|0|||
162969510|NCT00098475|588589973|FG003|Step 1|Knee surgery|0|||
162969511|NCT00098475|588589970|FG000|Step 1|Complications|1|||
162969512|NCT00098475|588589971|FG001|Step 1|Complications|0|||
162969513|NCT00098475|588589972|FG002|Step 1|Complications|0|||
162969514|NCT00098475|588589973|FG003|Step 1|Complications|0|||
162969515|NCT00098475|588589970|FG000|Step 1|Cannot comply due to other tx|0|||
162969516|NCT00098475|588589971|FG001|Step 1|Cannot comply due to other tx|1|||
162969517|NCT00098475|588589972|FG002|Step 1|Cannot comply due to other tx|0|||
162969518|NCT00098475|588589973|FG003|Step 1|Cannot comply due to other tx|0|||
162969519|NCT00098475|588589970|FG000|Step 1|Both patient and physician's decision|2|||
162969520|NCT00098475|588589971|FG001|Step 1|Both patient and physician's decision|1|||
162969521|NCT00098475|588589972|FG002|Step 1|Both patient and physician's decision|0|||
162969522|NCT00098475|588589973|FG003|Step 1|Both patient and physician's decision|0|||
162969523|NCT00098475|588589970|FG000|Step 1|Incorrect disease assessment|2|||
162969524|NCT00098475|588589971|FG001|Step 1|Incorrect disease assessment|0|||
162969525|NCT00098475|588589972|FG002|Step 1|Incorrect disease assessment|0|||
162969526|NCT00098475|588589973|FG003|Step 1|Incorrect disease assessment|0|||
162969527|NCT00098475|588589970|FG000|Step 1|Off treatment for > specified timeframe|1|||
162969528|NCT00098475|588589971|FG001|Step 1|Off treatment for > specified timeframe|1|||
162969529|NCT00098475|588589972|FG002|Step 1|Off treatment for > specified timeframe|0|||
162969530|NCT00098475|588589973|FG003|Step 1|Off treatment for > specified timeframe|0|||
162969531|NCT00098475|588589970|FG000|Step 1|Declining performance status|0|||
162969532|NCT00098475|588589971|FG001|Step 1|Declining performance status|1|||
162969533|NCT00098475|588589972|FG002|Step 1|Declining performance status|0|||
162969534|NCT00098475|588589973|FG003|Step 1|Declining performance status|0|||
162969535|NCT00098475|588589970|FG000|Step 1|Insurance issue|0|||
162969536|NCT00098475|588589971|FG001|Step 1|Insurance issue|1|||
162969537|NCT00098475|588589972|FG002|Step 1|Insurance issue|0|||
162969538|NCT00098475|588589973|FG003|Step 1|Insurance issue|0|||
162969539|NCT00098475|588589970|FG000|Step 1|Rising paraprotein|0|||
162969540|NCT00098475|588589971|FG001|Step 1|Rising paraprotein|1|||
162969541|NCT00098475|588589972|FG002|Step 1|Rising paraprotein|0|||
162969542|NCT00098475|588589973|FG003|Step 1|Rising paraprotein|0|||
162969543|NCT00098475|588589970|FG000|Step 1|Referred to other physicians|0|||
162969544|NCT00098475|588589971|FG001|Step 1|Referred to other physicians|1|||
162969545|NCT00098475|588589972|FG002|Step 1|Referred to other physicians|0|||
162969546|NCT00098475|588589973|FG003|Step 1|Referred to other physicians|0|||
162969547|NCT00098475|588589970|FG000|Step 1|Criteria to continue treatment not met|0|||
162969548|NCT00098475|588589971|FG001|Step 1|Criteria to continue treatment not met|1|||
162969549|NCT00098475|588589972|FG002|Step 1|Criteria to continue treatment not met|0|||
162969550|NCT00098475|588589973|FG003|Step 1|Criteria to continue treatment not met|0|||
162969551|NCT00098475|588589970|FG000|Step 1|Misinterpretation of lab data|0|||
162969552|NCT00098475|588589971|FG001|Step 1|Misinterpretation of lab data|1|||
162969553|NCT00098475|588589972|FG002|Step 1|Misinterpretation of lab data|0|||
162969554|NCT00098475|588589973|FG003|Step 1|Misinterpretation of lab data|0|||
162969555|NCT00098475|588589970|FG000|Step 1|Patient fell with fracture|1|||
162969556|NCT00098475|588589971|FG001|Step 1|Patient fell with fracture|0|||
162969557|NCT00098475|588589972|FG002|Step 1|Patient fell with fracture|0|||
162969558|NCT00098475|588589973|FG003|Step 1|Patient fell with fracture|0|||
162969559|NCT00098475|588589970|FG000|Step 1|Not documented|0|||
162969560|NCT00098475|588589971|FG001|Step 1|Not documented|1|||
162969561|NCT00098475|588589972|FG002|Step 1|Not documented|0|||
162969562|NCT00098475|588589973|FG003|Step 1|Not documented|0|||
162969563|NCT00098475|588589970|FG000|Step 2|Disease progression|1|||
162969564|NCT00098475|588589971|FG001|Step 2|Disease progression|4|||
162969565|NCT00098475|588589972|FG002|Step 2|Disease progression|0|||
162969566|NCT00098475|588589973|FG003|Step 2|Disease progression|0|||
163055593|NCT03555149|588916044|FG004|Overall Study|Physician Decision|0|||
163055594|NCT03555149|588916045|FG005|Overall Study|Physician Decision|0|||
163055595|NCT03555149|588916046|FG006|Overall Study|Physician Decision|0|||
163055596|NCT03555149|588916047|FG007|Overall Study|Physician Decision|0|||
163055597|NCT03555149|588916040|FG000|Overall Study|Study Terminated By Sponsor|1|||
163055598|NCT03555149|588916041|FG001|Overall Study|Study Terminated By Sponsor|0|||
163055599|NCT03555149|588916042|FG002|Overall Study|Study Terminated By Sponsor|0|||
163055600|NCT03555149|588916043|FG003|Overall Study|Study Terminated By Sponsor|0|||
162969567|NCT00098475|588589970|FG000|Step 2|Adverse Event|2|||
162969568|NCT00098475|588589971|FG001|Step 2|Adverse Event|0|||
162969569|NCT00098475|588589972|FG002|Step 2|Adverse Event|0|||
162969570|NCT00098475|588589973|FG003|Step 2|Adverse Event|0|||
162969571|NCT00098475|588589970|FG000|Step 2|Withdrawal by Subject|0|||
163055601|NCT03555149|588916044|FG004|Overall Study|Study Terminated By Sponsor|0|||
162969572|NCT00098475|588589971|FG001|Step 2|Withdrawal by Subject|2|||
163055602|NCT03555149|588916045|FG005|Overall Study|Study Terminated By Sponsor|2|||
163055603|NCT03555149|588916046|FG006|Overall Study|Study Terminated By Sponsor|3|||
163055604|NCT03555149|588916047|FG007|Overall Study|Study Terminated By Sponsor|1|||
163055605|NCT03555149|588916040|FG000|Overall Study|Withdrawal by Subject|3|||
163055606|NCT03555149|588916041|FG001|Overall Study|Withdrawal by Subject|0|||
163055607|NCT03555149|588916042|FG002|Overall Study|Withdrawal by Subject|0|||
163055608|NCT03555149|588916043|FG003|Overall Study|Withdrawal by Subject|2|||
163055609|NCT03555149|588916044|FG004|Overall Study|Withdrawal by Subject|0|||
163055610|NCT03555149|588916045|FG005|Overall Study|Withdrawal by Subject|1|||
163055611|NCT03555149|588916046|FG006|Overall Study|Withdrawal by Subject|0|||
163055612|NCT03555149|588916047|FG007|Overall Study|Withdrawal by Subject|0|||
163055613|NCT01692119|588916053|FG000|Overall Study|Protocol Violation|3|||
163055614|NCT01692119|588916054|FG001|Overall Study|Protocol Violation|1|||
163055615|NCT01692119|588916053|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
163055616|NCT01692119|588916054|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
163055617|NCT04656652|588916055|FG000|Overall Study|Lost to Follow-up|2|||
163055618|NCT04656652|588916056|FG001|Overall Study|Lost to Follow-up|2|||
163055619|NCT04656652|588916055|FG000|Overall Study|Death|213|||
163055620|NCT04656652|588916056|FG001|Overall Study|Death|212|||
163055621|NCT04656652|588916055|FG000|Overall Study|Other|1|||
163055622|NCT04656652|588916056|FG001|Overall Study|Other|0|||
163055623|NCT04656652|588916055|FG000|Overall Study|Withdrawal by Subject|15|||
163055624|NCT04656652|588916056|FG001|Overall Study|Withdrawal by Subject|29|||
163055625|NCT02722967|588916057|FG000|Overall Study|Adverse Event|1|||
163055626|NCT02722967|588916058|FG001|Overall Study|Adverse Event|0|||
163055627|NCT02722967|588916059|FG002|Overall Study|Adverse Event|0|||
163055628|NCT02722967|588916057|FG000|Overall Study|Lost to Follow-up|0|||
163055629|NCT02722967|588916058|FG001|Overall Study|Lost to Follow-up|1|||
163055630|NCT02722967|588916059|FG002|Overall Study|Lost to Follow-up|0|||
163055631|NCT02722967|588916057|FG000|Overall Study|Non-compliance with patch wearing|2|||
163055632|NCT02722967|588916058|FG001|Overall Study|Non-compliance with patch wearing|1|||
163055633|NCT02722967|588916059|FG002|Overall Study|Non-compliance with patch wearing|1|||
163055634|NCT02722967|588916057|FG000|Overall Study|Withdrawal by Subject|1|||
163055635|NCT02722967|588916058|FG001|Overall Study|Withdrawal by Subject|0|||
163055636|NCT02722967|588916059|FG002|Overall Study|Withdrawal by Subject|1|||
163055637|NCT02722967|588916057|FG000|Overall Study|Physician Decision|1|||
163055638|NCT02722967|588916058|FG001|Overall Study|Physician Decision|0|||
163055639|NCT02722967|588916059|FG002|Overall Study|Physician Decision|0|||
163055640|NCT02722967|588916057|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
163055641|NCT02722967|588916058|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
163055642|NCT02722967|588916059|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
163055643|NCT04142242|588916060|FG000|Stage I|Non-compliance with the protocol|1|||
163055644|NCT04142242|588916061|FG001|Stage I|Non-compliance with the protocol|0|||
163055645|NCT04142242|588916062|FG002|Stage I|Non-compliance with the protocol|0|||
163055646|NCT04142242|588916063|FG003|Stage I|Non-compliance with the protocol|0|||
163055647|NCT04142242|588916064|FG004|Stage I|Non-compliance with the protocol|0|||
163055648|NCT04142242|588916065|FG005|Stage I|Non-compliance with the protocol|1|||
163055649|NCT04142242|588916060|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
163055650|NCT04142242|588916061|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
163055651|NCT04142242|588916062|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
163055652|NCT04142242|588916063|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
163055653|NCT04142242|588916064|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
163055654|NCT04142242|588916065|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
163055655|NCT04142242|588916060|FG000|Stage II|Non-compliance with the protocol|0|||
163055656|NCT04142242|588916061|FG001|Stage II|Non-compliance with the protocol|0|||
163055657|NCT04142242|588916062|FG002|Stage II|Non-compliance with the protocol|0|||
163055658|NCT04142242|588916063|FG003|Stage II|Non-compliance with the protocol|2|||
163055659|NCT04142242|588916064|FG004|Stage II|Non-compliance with the protocol|0|||
163055660|NCT04142242|588916065|FG005|Stage II|Non-compliance with the protocol|0|||
163055661|NCT04142242|588916060|FG000|Stage II|Lost to Follow-up|0|||
163055662|NCT04142242|588916061|FG001|Stage II|Lost to Follow-up|0|||
163055663|NCT04142242|588916062|FG002|Stage II|Lost to Follow-up|1|||
163055664|NCT04142242|588916063|FG003|Stage II|Lost to Follow-up|2|||
163055665|NCT04142242|588916064|FG004|Stage II|Lost to Follow-up|0|||
163055666|NCT04142242|588916065|FG005|Stage II|Lost to Follow-up|0|||
163055667|NCT04142242|588916060|FG000|Stage II|Withdrawal by Subject|0|||
163055668|NCT04142242|588916061|FG001|Stage II|Withdrawal by Subject|0|||
163055669|NCT04142242|588916062|FG002|Stage II|Withdrawal by Subject|5|||
163055670|NCT04142242|588916063|FG003|Stage II|Withdrawal by Subject|9|||
163055671|NCT04142242|588916064|FG004|Stage II|Withdrawal by Subject|0|||
163055672|NCT04142242|588916065|FG005|Stage II|Withdrawal by Subject|0|||
163055673|NCT00846053|588916068|FG000|Overall Study|Physician Decision|3|||
163055674|NCT00846053|588916069|FG001|Overall Study|Physician Decision|0|||
163055675|NCT02027025|588916078|FG000|Overall Study|Adverse Event|0|||
163055676|NCT02027025|588916079|FG001|Overall Study|Adverse Event|1|||
163400051|NCT00418665|590174240|FG000|Treatment Period|Withdrawal by Subject|0|||
163400052|NCT00418665|590174241|FG001|Treatment Period|Withdrawal by Subject|3|||
163400053|NCT00418665|590174242|FG002|Treatment Period|Withdrawal by Subject|1|||
163400054|NCT00418665|590174240|FG000|Treatment Period|Requirement for alternative therapy|1|||
163400055|NCT00418665|590174241|FG001|Treatment Period|Requirement for alternative therapy|0|||
163400056|NCT00418665|590174242|FG002|Treatment Period|Requirement for alternative therapy|0|||
163400057|NCT00418665|590174240|FG000|Treatment Period|Physician Decision|1|||
163400058|NCT00418665|590174241|FG001|Treatment Period|Physician Decision|0|||
163400059|NCT00418665|590174242|FG002|Treatment Period|Physician Decision|3|||
163400060|NCT00418665|590174240|FG000|Treatment Extension|Adverse Event|1|||
163400061|NCT00418665|590174241|FG001|Treatment Extension|Adverse Event|0|||
163400062|NCT00418665|590174242|FG002|Treatment Extension|Adverse Event|0|||
163400063|NCT00418665|590174240|FG000|Treatment Extension|Withdrawal by Subject|1|||
163400064|NCT00418665|590174241|FG001|Treatment Extension|Withdrawal by Subject|0|||
163400065|NCT00418665|590174242|FG002|Treatment Extension|Withdrawal by Subject|0|||
163400066|NCT00418665|590174240|FG000|Treatment Extension|Requirement for alternative therapy|2|||
163400067|NCT00418665|590174241|FG001|Treatment Extension|Requirement for alternative therapy|2|||
163400068|NCT00418665|590174242|FG002|Treatment Extension|Requirement for alternative therapy|0|||
163400069|NCT00418665|590174240|FG000|Treatment Extension|Physician Decision|2|||
163400070|NCT00418665|590174241|FG001|Treatment Extension|Physician Decision|2|||
163400071|NCT00418665|590174242|FG002|Treatment Extension|Physician Decision|1|||
163400072|NCT00418665|590174240|FG000|Treatment Extension|Death|0|||
163400073|NCT00418665|590174241|FG001|Treatment Extension|Death|0|||
163400074|NCT00418665|590174242|FG002|Treatment Extension|Death|1|||
163400075|NCT00853749|590174243|FG000|Overall Study|Lost to Follow-up|0|||
163400076|NCT00853749|590174244|FG001|Overall Study|Lost to Follow-up|1|||
163400077|NCT00687440|590174245|FG000|Overall Study|Adverse Event|3|||
163400078|NCT00687440|590174245|FG000|Overall Study|Lost to Follow-up|3|||
163400079|NCT00687440|590174245|FG000|Overall Study|Lack of Efficacy|2|||
163400080|NCT00687440|590174245|FG000|Overall Study|Death|2|||
163400081|NCT00687440|590174245|FG000|Overall Study|Other|1|||
163400082|NCT00687440|590174245|FG000|Overall Study|Missing|1|||
163400083|NCT00583024|590174250|FG000|Overall Study|Lost to Follow-up|4|||
163400084|NCT00766038|590175570|FG000|Overall Study|Lost to Follow-up|15|||
163400085|NCT00766038|590175571|FG001|Overall Study|Lost to Follow-up|14|||
163400086|NCT01502709|590175572|FG000|Overall Study|Lost to Follow-up|4|||
163400087|NCT01502709|590175573|FG001|Overall Study|Lost to Follow-up|0|||
163400088|NCT03703882|590175574|FG000|Overall Study|Adverse Event|1|||
163400089|NCT03703882|590175575|FG001|Overall Study|Adverse Event|0|||
163400090|NCT03703882|590175574|FG000|Overall Study|Lost to Follow-up|0|||
163400091|NCT03703882|590175575|FG001|Overall Study|Lost to Follow-up|2|||
163400092|NCT03703882|590175574|FG000|Overall Study|Non-compliance with study drug|0|||
163400093|NCT03703882|590175575|FG001|Overall Study|Non-compliance with study drug|1|||
163400094|NCT03703882|590175574|FG000|Overall Study|Physician Decision|0|||
163400095|NCT03703882|590175575|FG001|Overall Study|Physician Decision|1|||
163400096|NCT03703882|590175574|FG000|Overall Study|Progressive disease|1|||
163400097|NCT03703882|590175575|FG001|Overall Study|Progressive disease|0|||
163400098|NCT03703882|590175574|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163400099|NCT03703882|590175575|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163400100|NCT03703882|590175574|FG000|Overall Study|Starting another treatment|0|||
163400101|NCT03703882|590175575|FG001|Overall Study|Starting another treatment|1|||
163400102|NCT03703882|590175574|FG000|Overall Study|noncompliance with study procedures|0|||
163400103|NCT03703882|590175575|FG001|Overall Study|noncompliance with study procedures|1|||
163400104|NCT02263079|590175581|FG000|Overall Study|Physician Decision|1|||
163400105|NCT02263079|590175582|FG001|Overall Study|Physician Decision|0|||
163400106|NCT02263079|590175583|FG002|Overall Study|Physician Decision|0|||
163400107|NCT02263079|590175581|FG000|Overall Study|Withdrawal by Subject|2|||
163400108|NCT02263079|590175582|FG001|Overall Study|Withdrawal by Subject|8|||
163400109|NCT02263079|590175583|FG002|Overall Study|Withdrawal by Subject|0|||
163400110|NCT00402649|590175584|FG000|Overall Study|Lost to Follow-up|1|||
163400111|NCT00402649|590175584|FG000|Overall Study|Withdrawal by Subject|1|||
163400112|NCT01761292|590175590|FG000|Part 1|Adverse Event|1|||
163400113|NCT01761292|590175590|FG000|Part 1|not receiving treatment in Part 1|1|||
163400114|NCT01761292|590175590|FG000|Extension 1|Withdrawal by Subject|1|||
163400115|NCT00840086|590175591|FG000|Overall Study|Adverse Event|1|||
163400116|NCT00840086|590175591|FG000|Overall Study|Protocol Violation|2|||
163400117|NCT00840086|590175591|FG000|Overall Study|Lost to Follow-up|1|||
163400118|NCT03332498|590175592|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
163400119|NCT03332498|590175593|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
163400120|NCT03332498|590175594|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
163400121|NCT03577730|590175595|FG000|Overall Study|Physician Decision|3|||
163400122|NCT03577730|590175596|FG001|Overall Study|Physician Decision|1|||
163400123|NCT03577730|590175595|FG000|Overall Study|Did not receive allocated intervention|1|||
162969573|NCT00098475|588589972|FG002|Step 2|Withdrawal by Subject|0|||
162969574|NCT00098475|588589973|FG003|Step 2|Withdrawal by Subject|0|||
162969575|NCT00098475|588589970|FG000|Step 2|Physician Decision|0|||
162969576|NCT00098475|588589971|FG001|Step 2|Physician Decision|1|||
162969577|NCT00098475|588589972|FG002|Step 2|Physician Decision|0|||
162969578|NCT00098475|588589973|FG003|Step 2|Physician Decision|0|||
162969579|NCT00098475|588589970|FG000|Step 2|Alternative therapy|1|||
162969580|NCT00098475|588589971|FG001|Step 2|Alternative therapy|2|||
162969581|NCT00098475|588589972|FG002|Step 2|Alternative therapy|0|||
162969582|NCT00098475|588589973|FG003|Step 2|Alternative therapy|0|||
162969583|NCT00098475|588589970|FG000|Step 2|Never started treatment|1|||
162969584|NCT00098475|588589971|FG001|Step 2|Never started treatment|1|||
162969585|NCT00098475|588589972|FG002|Step 2|Never started treatment|0|||
162969586|NCT00098475|588589973|FG003|Step 2|Never started treatment|0|||
162969587|NCT03422068|588589974|FG000|Overall Study|Adverse Event|0|||
162969588|NCT03422068|588589975|FG001|Overall Study|Adverse Event|1|||
162969589|NCT03422068|588589974|FG000|Overall Study|Inconvenience to frequent study visits|0|||
162969590|NCT03422068|588589975|FG001|Overall Study|Inconvenience to frequent study visits|1|||
162969591|NCT01841073|588589977|FG000|Overall Study|Adverse Event|1|||
162969592|NCT01841073|588589978|FG001|Overall Study|Adverse Event|1|||
162969593|NCT01841073|588589977|FG000|Overall Study|Physician Decision|1|||
162969594|NCT01841073|588589978|FG001|Overall Study|Physician Decision|0|||
162969595|NCT01841073|588589977|FG000|Overall Study|Lost to Follow-up|0|||
162969596|NCT01841073|588589978|FG001|Overall Study|Lost to Follow-up|2|||
162969597|NCT02858037|588589979|FG000|Overall Study|Death|1|||
162969598|NCT02858037|588589979|FG000|Overall Study|Withdrawal by Subject|18|||
162969599|NCT02858037|588589979|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
162969600|NCT02858037|588589979|FG000|Overall Study|Lost to Follow-up|3|||
162969601|NCT02858037|588589979|FG000|Overall Study|Other|4|||
162969602|NCT00283842|588589988|FG000|Overall Study|Adverse Event|8|||
162969603|NCT00283842|588589989|FG001|Overall Study|Adverse Event|7|||
162969604|NCT00283842|588589990|FG002|Overall Study|Adverse Event|21|||
162969605|NCT00283842|588589991|FG003|Overall Study|Adverse Event|21|||
162969606|NCT00283842|588589992|FG004|Overall Study|Adverse Event|5|||
162969607|NCT00283842|588589988|FG000|Overall Study|Protocol Violation|1|||
162969608|NCT00283842|588589989|FG001|Overall Study|Protocol Violation|5|||
162969609|NCT00283842|588589990|FG002|Overall Study|Protocol Violation|4|||
162969610|NCT00283842|588589991|FG003|Overall Study|Protocol Violation|0|||
162969611|NCT00283842|588589992|FG004|Overall Study|Protocol Violation|0|||
162969612|NCT00283842|588589988|FG000|Overall Study|Protocol deviation|0|||
162969613|NCT00283842|588589989|FG001|Overall Study|Protocol deviation|0|||
162969614|NCT00283842|588589990|FG002|Overall Study|Protocol deviation|0|||
162969615|NCT00283842|588589991|FG003|Overall Study|Protocol deviation|0|||
162969616|NCT00283842|588589992|FG004|Overall Study|Protocol deviation|2|||
162969617|NCT00283842|588589988|FG000|Overall Study|Withdrawal by Subject|2|||
162969618|NCT00283842|588589989|FG001|Overall Study|Withdrawal by Subject|1|||
162969619|NCT00283842|588589990|FG002|Overall Study|Withdrawal by Subject|1|||
162969620|NCT00283842|588589991|FG003|Overall Study|Withdrawal by Subject|5|||
162969621|NCT00283842|588589992|FG004|Overall Study|Withdrawal by Subject|4|||
162969622|NCT00283842|588589988|FG000|Overall Study|Lack of Efficacy|1|||
162969623|NCT00283842|588589989|FG001|Overall Study|Lack of Efficacy|3|||
162969624|NCT00283842|588589990|FG002|Overall Study|Lack of Efficacy|1|||
162969625|NCT00283842|588589991|FG003|Overall Study|Lack of Efficacy|0|||
162969626|NCT00283842|588589992|FG004|Overall Study|Lack of Efficacy|3|||
162969627|NCT00283842|588589988|FG000|Overall Study|Lost to Follow-up|0|||
162969628|NCT00283842|588589989|FG001|Overall Study|Lost to Follow-up|2|||
162969629|NCT00283842|588589990|FG002|Overall Study|Lost to Follow-up|4|||
162969630|NCT00283842|588589991|FG003|Overall Study|Lost to Follow-up|1|||
162969631|NCT00283842|588589992|FG004|Overall Study|Lost to Follow-up|1|||
162969632|NCT00550147|588589993|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
162969633|NCT00550147|588589993|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
162969634|NCT00550147|588589993|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
162969635|NCT00550147|588589993|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
162969636|NCT00550147|588589993|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
162969637|NCT04320745|588589994|FG000|Overall Study|Adverse Event|26|||
162969638|NCT04320745|588589994|FG000|Overall Study|Withdrawal by Subject|4|||
162969639|NCT04320745|588589994|FG000|Overall Study|Lost to Follow-up|12|||
162969640|NCT04320745|588589994|FG000|Overall Study|Protocol Deviation|2|||
162969641|NCT04320745|588589994|FG000|Overall Study|Non-compliance With Study Drug|2|||
162969642|NCT04320745|588589994|FG000|Overall Study|Reason Not Specified|1|||
162969643|NCT02472639|588589995|FG000|Overall Study|Physician Decision|4|||
162969644|NCT02472639|588589996|FG001|Overall Study|Physician Decision|3|||
163055677|NCT02027025|588916080|FG002|Overall Study|Adverse Event|1|||
162969645|NCT00046839|588589997|FG000|Overall Study|Ineligible / No protocol treatment|0|||
162969646|NCT00046839|588589998|FG001|Overall Study|Ineligible / No protocol treatment|2|||
162969647|NCT00046839|588589997|FG000|Overall Study|Withdrawal of consent|1|||
162969648|NCT00046839|588589998|FG001|Overall Study|Withdrawal of consent|0|||
162969649|NCT01685008|588590003|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
163400124|NCT03577730|590175596|FG001|Overall Study|Did not receive allocated intervention|0|||
163400125|NCT05611671|590175600|FG000|Overall Study|Adverse Event|1|||
163400126|NCT05611671|590175601|FG001|Overall Study|Adverse Event|1|||
163400127|NCT05611671|590175602|FG002|Overall Study|Adverse Event|0|||
163400128|NCT05611671|590175603|FG003|Overall Study|Adverse Event|1|||
163400129|NCT05611671|590175600|FG000|Overall Study|Lack of Efficacy|1|||
163400130|NCT05611671|590175601|FG001|Overall Study|Lack of Efficacy|0|||
163400131|NCT05611671|590175602|FG002|Overall Study|Lack of Efficacy|1|||
163400132|NCT05611671|590175603|FG003|Overall Study|Lack of Efficacy|2|||
163400133|NCT05611671|590175600|FG000|Overall Study|Lost to Follow-up|0|||
163400134|NCT05611671|590175601|FG001|Overall Study|Lost to Follow-up|0|||
163400135|NCT05611671|590175602|FG002|Overall Study|Lost to Follow-up|0|||
163400136|NCT05611671|590175603|FG003|Overall Study|Lost to Follow-up|1|||
163400137|NCT05611671|590175600|FG000|Overall Study|Protocol Violation|0|||
163400138|NCT05611671|590175601|FG001|Overall Study|Protocol Violation|1|||
163400139|NCT05611671|590175602|FG002|Overall Study|Protocol Violation|0|||
163400140|NCT05611671|590175603|FG003|Overall Study|Protocol Violation|0|||
163400141|NCT05611671|590175600|FG000|Overall Study|Withdrawal by Subject|2|||
163400142|NCT05611671|590175601|FG001|Overall Study|Withdrawal by Subject|1|||
163400143|NCT05611671|590175602|FG002|Overall Study|Withdrawal by Subject|2|||
163400144|NCT05611671|590175603|FG003|Overall Study|Withdrawal by Subject|1|||
163400145|NCT01368536|590175604|FG000|Overall Study|Adverse Event|5|||
163400146|NCT01368536|590175605|FG001|Overall Study|Adverse Event|6|||
163400147|NCT01368536|590175606|FG002|Overall Study|Adverse Event|8|||
163400148|NCT01368536|590175604|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163400149|NCT01368536|590175605|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163400150|NCT01368536|590175606|FG002|Overall Study|Abnormal laboratory value(s)|2|||
163055678|NCT02027025|588916078|FG000|Overall Study|Protocol Violation|1|||
163055679|NCT02027025|588916079|FG001|Overall Study|Protocol Violation|0|||
163055680|NCT02027025|588916080|FG002|Overall Study|Protocol Violation|0|||
163055681|NCT02027025|588916078|FG000|Overall Study|Lost to Follow-up|0|||
163055682|NCT02027025|588916079|FG001|Overall Study|Lost to Follow-up|2|||
163055683|NCT02027025|588916080|FG002|Overall Study|Lost to Follow-up|0|||
163055684|NCT02027025|588916078|FG000|Overall Study|Withdrawal by Subject|0|||
163055685|NCT02027025|588916079|FG001|Overall Study|Withdrawal by Subject|1|||
163055686|NCT02027025|588916080|FG002|Overall Study|Withdrawal by Subject|0|||
163055687|NCT02027025|588916078|FG000|Overall Study|Sponsor's decision|0|||
163055688|NCT02027025|588916079|FG001|Overall Study|Sponsor's decision|1|||
163055689|NCT02027025|588916080|FG002|Overall Study|Sponsor's decision|0|||
163055690|NCT00828711|588916081|FG000|Overall Study|Lost to Follow-up|1|||
163055691|NCT00828711|588916082|FG001|Overall Study|Lost to Follow-up|0|||
163055692|NCT00828711|588916083|FG002|Overall Study|Lost to Follow-up|0|||
163055693|NCT01618968|588916084|FG000|Overall Study|Adverse Event|1|||
163055694|NCT01618968|588916085|FG001|Overall Study|Adverse Event|0|||
163055695|NCT01618968|588916086|FG002|Overall Study|Adverse Event|0|||
163055696|NCT01618968|588916087|FG003|Overall Study|Adverse Event|0|||
163055697|NCT01618968|588916084|FG000|Overall Study|Death|0|||
163055698|NCT01618968|588916085|FG001|Overall Study|Death|0|||
163055699|NCT01618968|588916086|FG002|Overall Study|Death|0|||
163055700|NCT01618968|588916087|FG003|Overall Study|Death|1|||
163055701|NCT03883386|588916088|FG000|First Assignment|Lost to Follow-up|1|||
163055702|NCT03883386|588916089|FG001|First Assignment|Lost to Follow-up|0|||
163055703|NCT03883386|588916088|FG000|First Assignment|Withdrawal by Subject|1|||
163055704|NCT03883386|588916089|FG001|First Assignment|Withdrawal by Subject|1|||
163055705|NCT01326871|588916090|FG000|Overall Study|Major surgery|0|||
163055706|NCT01326871|588916091|FG001|Overall Study|Major surgery|1|||
163055707|NCT01326871|588916092|FG002|Overall Study|Major surgery|0|||
163055708|NCT01326871|588916090|FG000|Overall Study|SAE and death|0|||
163055709|NCT01326871|588916091|FG001|Overall Study|SAE and death|2|||
163055710|NCT01326871|588916092|FG002|Overall Study|SAE and death|0|||
163208724|NCT00951665|589478626|FG001|Phase 1b|Disease Progression|2|||
163208725|NCT00951665|589478627|FG002|Phase 1b|Disease Progression|14|||
163208726|NCT00951665|589478628|FG003|Phase 1b|Disease Progression|0|||
163400151|NCT01368536|590175604|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163400152|NCT01368536|590175605|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163400153|NCT01368536|590175606|FG002|Overall Study|Abnormal test procedure result(s)|1|||
163208727|NCT00951665|589478629|FG004|Phase 1b|Disease Progression|0|||
163208728|NCT00951665|589478630|FG005|Phase 1b|Disease Progression|0|||
163400154|NCT01368536|590175604|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
163400155|NCT01368536|590175605|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163400156|NCT01368536|590175606|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
163400157|NCT01368536|590175604|FG000|Overall Study|No longer required study medication|0|||
163055711|NCT01326871|588916090|FG000|Overall Study|Physician decision and decreased performance status|0|||
163055712|NCT01326871|588916091|FG001|Overall Study|Physician decision and decreased performance status|1|||
163055713|NCT01326871|588916092|FG002|Overall Study|Physician decision and decreased performance status|0|||
163055714|NCT01326871|588916090|FG000|Overall Study|Disease progression|0|||
163055715|NCT01326871|588916091|FG001|Overall Study|Disease progression|11|||
163055716|NCT01326871|588916092|FG002|Overall Study|Disease progression|5|||
163400158|NCT01368536|590175605|FG001|Overall Study|No longer required study medication|0|||
163400159|NCT01368536|590175606|FG002|Overall Study|No longer required study medication|1|||
163400160|NCT01368536|590175604|FG000|Overall Study|Withdrawal by Subject|2|||
163400161|NCT01368536|590175605|FG001|Overall Study|Withdrawal by Subject|5|||
163400162|NCT01368536|590175606|FG002|Overall Study|Withdrawal by Subject|4|||
163400163|NCT01368536|590175604|FG000|Overall Study|Lost to Follow-up|3|||
163400164|NCT01368536|590175605|FG001|Overall Study|Lost to Follow-up|3|||
163400165|NCT01368536|590175606|FG002|Overall Study|Lost to Follow-up|5|||
163400166|NCT01368536|590175604|FG000|Overall Study|Administrative problems|34|||
163400167|NCT01368536|590175605|FG001|Overall Study|Administrative problems|39|||
163400168|NCT01368536|590175606|FG002|Overall Study|Administrative problems|35|||
163400169|NCT01368536|590175604|FG000|Overall Study|Protocol deviation|0|||
163400170|NCT01368536|590175605|FG001|Overall Study|Protocol deviation|3|||
163400171|NCT01368536|590175606|FG002|Overall Study|Protocol deviation|1|||
163400172|NCT00383084|590175613|FG000|Overall Study|Withdrawal by Subject|12|||
163400173|NCT00383084|590175614|FG001|Overall Study|Withdrawal by Subject|10|||
163400174|NCT02113436|590175615|FG000|Period 1: 8 Weeks|Adverse Event|1|||
163400175|NCT02113436|590175616|FG001|Period 1: 8 Weeks|Adverse Event|0|||
163400176|NCT02113436|590175617|FG002|Period 1: 8 Weeks|Adverse Event|0|||
163400177|NCT02113436|590175618|FG003|Period 1: 8 Weeks|Adverse Event|0|||
163400178|NCT02113436|590175615|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
163400179|NCT02113436|590175616|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
163400180|NCT02113436|590175617|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
163400181|NCT02113436|590175618|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
163400182|NCT02113436|590175615|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
163400183|NCT02113436|590175616|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
163400184|NCT02113436|590175617|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
163400185|NCT02113436|590175618|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
163400186|NCT02113436|590175615|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
163400187|NCT02113436|590175616|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
163400188|NCT02113436|590175617|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
163400189|NCT02113436|590175618|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
163400190|NCT02113436|590175615|FG000|Period 2: 16 Weeks|Adverse Event|0|||
163400191|NCT02113436|590175616|FG001|Period 2: 16 Weeks|Adverse Event|0|||
163400192|NCT02113436|590175617|FG002|Period 2: 16 Weeks|Adverse Event|4|||
163400193|NCT02113436|590175618|FG003|Period 2: 16 Weeks|Adverse Event|5|||
163400194|NCT02113436|590175615|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
163400195|NCT02113436|590175616|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
163400196|NCT02113436|590175617|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
163400197|NCT02113436|590175618|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
163400198|NCT02113436|590175615|FG000|Period 2: 16 Weeks|Physician Decision|0|||
163400199|NCT02113436|590175616|FG001|Period 2: 16 Weeks|Physician Decision|0|||
163400200|NCT02113436|590175617|FG002|Period 2: 16 Weeks|Physician Decision|2|||
163400201|NCT02113436|590175618|FG003|Period 2: 16 Weeks|Physician Decision|0|||
163400202|NCT02113436|590175615|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
163400203|NCT02113436|590175616|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
163400204|NCT02113436|590175617|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
163400205|NCT02113436|590175618|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
163400206|NCT01486927|590175619|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
163400207|NCT01486927|590175619|FG000|Overall Study|Physician Decision|1|||
163400208|NCT01486927|590175619|FG000|Overall Study|50 Exposure days not reached|2|||
163400209|NCT01486927|590175619|FG000|Overall Study|Withdrawal by Subject|8|||
163400210|NCT01486927|590175619|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
163400211|NCT03810911|590175620|FG000|Overall Study|Death|1|||
163400212|NCT03810911|590175621|FG001|Overall Study|Death|1|||
163400213|NCT03810911|590175620|FG000|Overall Study|Withdrawal by Subject|1|||
163400214|NCT03810911|590175621|FG001|Overall Study|Withdrawal by Subject|1|||
163400215|NCT05374525|590175622|FG000|Overall Study|Adverse Event|5|||
163400216|NCT05374525|590175623|FG001|Overall Study|Adverse Event|6|||
163400217|NCT05374525|590175622|FG000|Overall Study|Lost to Follow-up|3|||
163400218|NCT05374525|590175623|FG001|Overall Study|Lost to Follow-up|3|||
163400219|NCT05374525|590175622|FG000|Overall Study|Physician Decision|2|||
163400220|NCT05374525|590175623|FG001|Overall Study|Physician Decision|2|||
163400221|NCT05374525|590175622|FG000|Overall Study|Withdrawal by Subject|26|||
163400222|NCT05374525|590175623|FG001|Overall Study|Withdrawal by Subject|8|||
163400223|NCT01349101|590175629|FG000|Overall Study|Disease Progression|1|||
163400224|NCT01349101|590175630|FG001|Overall Study|Disease Progression|1|||
163400225|NCT01349101|590175629|FG000|Overall Study|Death|3|||
163400226|NCT01349101|590175630|FG001|Overall Study|Death|8|||
163400227|NCT00454857|590175631|FG000|Overall Study|Withdrawal by Subject|15|||
163400228|NCT00454857|590175631|FG000|Overall Study|Lost to Follow-up|16|||
163400229|NCT00454857|590175631|FG000|Overall Study|Noncompliance|6|||
163400230|NCT00454857|590175631|FG000|Overall Study|Death|5|||
163400231|NCT00454857|590175631|FG000|Overall Study|Other|11|||
163400232|NCT00454857|590175631|FG000|Overall Study|Reason unknown|1|||
163055717|NCT01326871|588916090|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
163055718|NCT01326871|588916091|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
163208729|NCT00951665|589478625|FG000|Phase 1b|Protocol Violation|2|||
163208730|NCT00951665|589478626|FG001|Phase 1b|Protocol Violation|0|||
163208731|NCT00951665|589478627|FG002|Phase 1b|Protocol Violation|0|||
163208732|NCT00951665|589478628|FG003|Phase 1b|Protocol Violation|0|||
163208733|NCT00951665|589478629|FG004|Phase 1b|Protocol Violation|0|||
163208734|NCT00951665|589478630|FG005|Phase 1b|Protocol Violation|0|||
163208735|NCT00951665|589478625|FG000|Phase 2a|Adverse Event|0|||
163208736|NCT00951665|589478626|FG001|Phase 2a|Adverse Event|0|||
163208737|NCT00951665|589478627|FG002|Phase 2a|Adverse Event|0|||
163208738|NCT00951665|589478628|FG003|Phase 2a|Adverse Event|0|||
163208739|NCT00951665|589478629|FG004|Phase 2a|Adverse Event|2|||
163208740|NCT00951665|589478630|FG005|Phase 2a|Adverse Event|0|||
163208741|NCT00951665|589478625|FG000|Phase 2a|Death|0|||
163208742|NCT00951665|589478626|FG001|Phase 2a|Death|0|||
163208743|NCT00951665|589478627|FG002|Phase 2a|Death|0|||
163208744|NCT00951665|589478628|FG003|Phase 2a|Death|0|||
163208745|NCT00951665|589478629|FG004|Phase 2a|Death|1|||
163208746|NCT00951665|589478630|FG005|Phase 2a|Death|1|||
163208747|NCT00951665|589478625|FG000|Phase 2a|Lost to Follow-up|0|||
163208748|NCT00951665|589478626|FG001|Phase 2a|Lost to Follow-up|0|||
163208749|NCT00951665|589478627|FG002|Phase 2a|Lost to Follow-up|0|||
163208750|NCT00951665|589478628|FG003|Phase 2a|Lost to Follow-up|0|||
163208751|NCT00951665|589478629|FG004|Phase 2a|Lost to Follow-up|1|||
163208752|NCT00951665|589478630|FG005|Phase 2a|Lost to Follow-up|0|||
163208753|NCT00951665|589478625|FG000|Phase 2a|Physician Decision|0|||
163208754|NCT00951665|589478626|FG001|Phase 2a|Physician Decision|0|||
163208755|NCT00951665|589478627|FG002|Phase 2a|Physician Decision|0|||
163208756|NCT00951665|589478628|FG003|Phase 2a|Physician Decision|0|||
163208757|NCT00951665|589478629|FG004|Phase 2a|Physician Decision|0|||
163208758|NCT00951665|589478630|FG005|Phase 2a|Physician Decision|1|||
163208759|NCT00951665|589478625|FG000|Phase 2a|Withdrawal by Subject|0|||
163208760|NCT00951665|589478626|FG001|Phase 2a|Withdrawal by Subject|0|||
163208761|NCT00951665|589478627|FG002|Phase 2a|Withdrawal by Subject|0|||
163208762|NCT00951665|589478628|FG003|Phase 2a|Withdrawal by Subject|0|||
163208763|NCT00951665|589478629|FG004|Phase 2a|Withdrawal by Subject|2|||
163208764|NCT00951665|589478630|FG005|Phase 2a|Withdrawal by Subject|0|||
163208765|NCT00951665|589478625|FG000|Phase 2a|Disease Progression|0|||
163208766|NCT00951665|589478626|FG001|Phase 2a|Disease Progression|0|||
163208767|NCT00951665|589478627|FG002|Phase 2a|Disease Progression|0|||
163208768|NCT00951665|589478628|FG003|Phase 2a|Disease Progression|0|||
163208769|NCT00951665|589478629|FG004|Phase 2a|Disease Progression|6|||
163208770|NCT00951665|589478630|FG005|Phase 2a|Disease Progression|5|||
163208771|NCT02450903|589478633|FG000|Overall Study|Adverse Event|3|||
163208772|NCT02450903|589478633|FG000|Overall Study|Progressive disease|15|||
163208773|NCT02450903|589478633|FG000|Overall Study|Switched to commercial drug|1|||
163208774|NCT02450903|589478633|FG000|Overall Study|Subject/guardian decision|1|||
163208775|NCT00254540|589478634|FG000|Overall Study|Adverse Event|6|||
163208776|NCT00254540|589478635|FG001|Overall Study|Adverse Event|7|||
163208777|NCT00254540|589478634|FG000|Overall Study|Lack of Efficacy|13|||
163208778|NCT00254540|589478635|FG001|Overall Study|Lack of Efficacy|13|||
163208779|NCT00254540|589478634|FG000|Overall Study|Death|0|||
163208780|NCT00254540|589478635|FG001|Overall Study|Death|1|||
163208781|NCT00254540|589478634|FG000|Overall Study|Laboratory Test Abnormality|0|||
163208782|NCT00254540|589478635|FG001|Overall Study|Laboratory Test Abnormality|1|||
163208783|NCT01313767|589478636|FG000|Overall Study|Adverse Event|1|||
163208784|NCT01313767|589478637|FG001|Overall Study|Adverse Event|0|||
163208785|NCT01313767|589478636|FG000|Overall Study|Lost to Follow-up|1|||
163208786|NCT01313767|589478637|FG001|Overall Study|Lost to Follow-up|0|||
163208787|NCT01313767|589478636|FG000|Overall Study|Withdrawal by Subject|2|||
163208788|NCT01313767|589478637|FG001|Overall Study|Withdrawal by Subject|1|||
163208789|NCT01313767|589478636|FG000|Overall Study|Protocol Violation|3|||
163208790|NCT01313767|589478637|FG001|Overall Study|Protocol Violation|1|||
163208791|NCT00249444|589478638|FG000|Overall Study|Lost to Follow-up|2|||
163208792|NCT00249444|589478639|FG001|Overall Study|Lost to Follow-up|2|||
163208793|NCT00249444|589478638|FG000|Overall Study|non-compliant|9|||
163208794|NCT00249444|589478639|FG001|Overall Study|non-compliant|11|||
163208795|NCT00249444|589478638|FG000|Overall Study|Adverse Event|1|||
163208796|NCT00249444|589478639|FG001|Overall Study|Adverse Event|1|||
163208797|NCT00249444|589478638|FG000|Overall Study|life event|0|||
163208798|NCT00249444|589478639|FG001|Overall Study|life event|1|||
163208799|NCT00232817|589478640|FG000|Overall Study|Protocol Violation|2|||
163208800|NCT00232817|589478641|FG001|Overall Study|Protocol Violation|1|||
163208801|NCT01084174|589478645|FG000|Overall Study|gastrointestinal symptoms|1|||
163208802|NCT01084174|589478646|FG001|Overall Study|gastrointestinal symptoms|1|||
163208803|NCT01084174|589478645|FG000|Overall Study|Eosinophilic esophagitis|0|||
163208804|NCT01084174|589478646|FG001|Overall Study|Eosinophilic esophagitis|1|||
163208805|NCT01084174|589478645|FG000|Overall Study|Anaphylaxis|0|||
163208806|NCT01084174|589478646|FG001|Overall Study|Anaphylaxis|1|||
163208807|NCT01084174|589478645|FG000|Overall Study|Participant noncompliance|0|||
163208808|NCT01084174|589478646|FG001|Overall Study|Participant noncompliance|1|||
163400233|NCT00829179|590175632|FG000|Overall Study|Withdrawal by Subject|1|||
163400234|NCT00271596|590175635|FG000|Overall Study|Protocol Violation|1|||
163400235|NCT00271596|590175636|FG001|Overall Study|Protocol Violation|0|||
163400236|NCT00271596|590175635|FG000|Overall Study|Withdrawal by Subject|0|||
163400237|NCT00271596|590175636|FG001|Overall Study|Withdrawal by Subject|1|||
163400238|NCT04707157|590175637|FG000|Overall Study|Adverse Event|12|||
163400239|NCT04707157|590175638|FG001|Overall Study|Adverse Event|3|||
163400240|NCT04707157|590175637|FG000|Overall Study|Lost to Follow-up|2|||
163400241|NCT04707157|590175638|FG001|Overall Study|Lost to Follow-up|0|||
163400242|NCT04707157|590175637|FG000|Overall Study|Sponsor's decision|1|||
163400243|NCT04707157|590175638|FG001|Overall Study|Sponsor's decision|0|||
163400244|NCT04707157|590175637|FG000|Overall Study|Physician Decision|8|||
163400245|NCT04707157|590175638|FG001|Overall Study|Physician Decision|5|||
163400246|NCT04707157|590175637|FG000|Overall Study|Protocol Deviation|1|||
163400247|NCT04707157|590175638|FG001|Overall Study|Protocol Deviation|0|||
163400248|NCT04707157|590175637|FG000|Overall Study|Withdrawal by Subject|1|||
163400249|NCT04707157|590175638|FG001|Overall Study|Withdrawal by Subject|1|||
163400250|NCT04232553|590175639|FG000|Overall Study|Adverse Event|3|||
163400251|NCT04232553|590175640|FG001|Overall Study|Adverse Event|2|||
163400252|NCT04232553|590175641|FG002|Overall Study|Adverse Event|1|||
163400253|NCT04232553|590175642|FG003|Overall Study|Adverse Event|2|||
163400254|NCT04232553|590175643|FG004|Overall Study|Adverse Event|1|||
163400255|NCT04232553|590175644|FG005|Overall Study|Adverse Event|1|||
163400256|NCT04232553|590175645|FG006|Overall Study|Adverse Event|0|||
163400257|NCT04232553|590175646|FG007|Overall Study|Adverse Event|0|||
163400258|NCT04232553|590175647|FG008|Overall Study|Adverse Event|0|||
163400259|NCT04232553|590175639|FG000|Overall Study|Death|0|||
163400260|NCT04232553|590175640|FG001|Overall Study|Death|1|||
163400261|NCT04232553|590175641|FG002|Overall Study|Death|0|||
163400262|NCT04232553|590175642|FG003|Overall Study|Death|1|||
163400263|NCT04232553|590175643|FG004|Overall Study|Death|0|||
163400264|NCT04232553|590175644|FG005|Overall Study|Death|0|||
163400265|NCT04232553|590175645|FG006|Overall Study|Death|0|||
163400266|NCT04232553|590175646|FG007|Overall Study|Death|0|||
163400267|NCT04232553|590175647|FG008|Overall Study|Death|0|||
163400268|NCT04232553|590175639|FG000|Overall Study|Lack of Efficacy|0|||
163400269|NCT04232553|590175640|FG001|Overall Study|Lack of Efficacy|2|||
163400270|NCT04232553|590175641|FG002|Overall Study|Lack of Efficacy|0|||
163400271|NCT04232553|590175642|FG003|Overall Study|Lack of Efficacy|0|||
163400272|NCT04232553|590175643|FG004|Overall Study|Lack of Efficacy|0|||
163400273|NCT04232553|590175644|FG005|Overall Study|Lack of Efficacy|0|||
163400274|NCT04232553|590175645|FG006|Overall Study|Lack of Efficacy|0|||
163400275|NCT04232553|590175646|FG007|Overall Study|Lack of Efficacy|0|||
163400276|NCT04232553|590175647|FG008|Overall Study|Lack of Efficacy|1|||
163400277|NCT04232553|590175639|FG000|Overall Study|Lost to Follow-up|0|||
163400278|NCT04232553|590175640|FG001|Overall Study|Lost to Follow-up|1|||
163400279|NCT04232553|590175641|FG002|Overall Study|Lost to Follow-up|0|||
163400280|NCT04232553|590175642|FG003|Overall Study|Lost to Follow-up|0|||
163400281|NCT04232553|590175643|FG004|Overall Study|Lost to Follow-up|1|||
163400282|NCT04232553|590175644|FG005|Overall Study|Lost to Follow-up|0|||
163400283|NCT04232553|590175645|FG006|Overall Study|Lost to Follow-up|0|||
163400284|NCT04232553|590175646|FG007|Overall Study|Lost to Follow-up|0|||
163400285|NCT04232553|590175647|FG008|Overall Study|Lost to Follow-up|1|||
163400286|NCT04232553|590175639|FG000|Overall Study|Other - As reported by the investigator|0|||
163400287|NCT04232553|590175640|FG001|Overall Study|Other - As reported by the investigator|1|||
163400288|NCT04232553|590175641|FG002|Overall Study|Other - As reported by the investigator|0|||
163400289|NCT04232553|590175642|FG003|Overall Study|Other - As reported by the investigator|0|||
163400290|NCT04232553|590175643|FG004|Overall Study|Other - As reported by the investigator|0|||
163400291|NCT04232553|590175644|FG005|Overall Study|Other - As reported by the investigator|0|||
163400292|NCT04232553|590175645|FG006|Overall Study|Other - As reported by the investigator|0|||
163400293|NCT04232553|590175646|FG007|Overall Study|Other - As reported by the investigator|0|||
163400294|NCT04232553|590175647|FG008|Overall Study|Other - As reported by the investigator|0|||
163400295|NCT04232553|590175639|FG000|Overall Study|Physician Decision|1|||
163400296|NCT04232553|590175640|FG001|Overall Study|Physician Decision|1|||
163400297|NCT04232553|590175641|FG002|Overall Study|Physician Decision|0|||
163400298|NCT04232553|590175642|FG003|Overall Study|Physician Decision|0|||
163400299|NCT04232553|590175643|FG004|Overall Study|Physician Decision|1|||
163400300|NCT04232553|590175644|FG005|Overall Study|Physician Decision|0|||
163400301|NCT04232553|590175645|FG006|Overall Study|Physician Decision|0|||
163400302|NCT04232553|590175646|FG007|Overall Study|Physician Decision|0|||
163400303|NCT04232553|590175647|FG008|Overall Study|Physician Decision|0|||
163400304|NCT04232553|590175639|FG000|Overall Study|Pregnancy|1|||
163400305|NCT04232553|590175640|FG001|Overall Study|Pregnancy|0|||
163400306|NCT04232553|590175641|FG002|Overall Study|Pregnancy|0|||
163316982|NCT04171141|589873062|FG008|Overall Study|Physician Decision|0|||
163316983|NCT04171141|589873063|FG009|Overall Study|Physician Decision|0|||
163316984|NCT04171141|589873064|FG010|Overall Study|Physician Decision|0|||
163316985|NCT04171141|589873065|FG011|Overall Study|Physician Decision|0|||
163316986|NCT04171141|589873066|FG012|Overall Study|Physician Decision|0|||
163316987|NCT04171141|589873067|FG013|Overall Study|Physician Decision|0|||
163316988|NCT04171141|589873068|FG014|Overall Study|Physician Decision|0|||
163316989|NCT04171141|589873069|FG015|Overall Study|Physician Decision|1|||
163316990|NCT04171141|589873054|FG000|Overall Study|Progressive disease|2|||
163316991|NCT04171141|589873055|FG001|Overall Study|Progressive disease|3|||
163316992|NCT04171141|589873056|FG002|Overall Study|Progressive disease|4|||
163316993|NCT04171141|589873057|FG003|Overall Study|Progressive disease|7|||
163316994|NCT04171141|589873058|FG004|Overall Study|Progressive disease|1|||
163316995|NCT04171141|589873059|FG005|Overall Study|Progressive disease|8|||
163316996|NCT04171141|589873060|FG006|Overall Study|Progressive disease|4|||
163316997|NCT04171141|589873061|FG007|Overall Study|Progressive disease|6|||
163316998|NCT04171141|589873062|FG008|Overall Study|Progressive disease|7|||
163316999|NCT04171141|589873063|FG009|Overall Study|Progressive disease|3|||
163317000|NCT04171141|589873064|FG010|Overall Study|Progressive disease|4|||
163317001|NCT04171141|589873065|FG011|Overall Study|Progressive disease|3|||
163317002|NCT04171141|589873066|FG012|Overall Study|Progressive disease|4|||
163317003|NCT04171141|589873067|FG013|Overall Study|Progressive disease|2|||
163317004|NCT04171141|589873068|FG014|Overall Study|Progressive disease|4|||
163317005|NCT04171141|589873069|FG015|Overall Study|Progressive disease|1|||
163317006|NCT04171141|589873054|FG000|Overall Study|Withdrawal by Subject|0|||
163317007|NCT04171141|589873055|FG001|Overall Study|Withdrawal by Subject|0|||
163317008|NCT04171141|589873056|FG002|Overall Study|Withdrawal by Subject|0|||
163317009|NCT04171141|589873057|FG003|Overall Study|Withdrawal by Subject|1|||
163317010|NCT04171141|589873058|FG004|Overall Study|Withdrawal by Subject|0|||
163317011|NCT04171141|589873059|FG005|Overall Study|Withdrawal by Subject|0|||
163317012|NCT04171141|589873060|FG006|Overall Study|Withdrawal by Subject|1|||
163317013|NCT04171141|589873061|FG007|Overall Study|Withdrawal by Subject|0|||
163317014|NCT04171141|589873062|FG008|Overall Study|Withdrawal by Subject|0|||
163317015|NCT04171141|589873063|FG009|Overall Study|Withdrawal by Subject|1|||
163317016|NCT04171141|589873064|FG010|Overall Study|Withdrawal by Subject|0|||
163317017|NCT04171141|589873065|FG011|Overall Study|Withdrawal by Subject|0|||
163317018|NCT04171141|589873066|FG012|Overall Study|Withdrawal by Subject|0|||
163317019|NCT04171141|589873067|FG013|Overall Study|Withdrawal by Subject|0|||
163317020|NCT04171141|589873068|FG014|Overall Study|Withdrawal by Subject|0|||
163317021|NCT04171141|589873069|FG015|Overall Study|Withdrawal by Subject|0|||
163317022|NCT04171141|589873054|FG000|Overall Study|Global deterioration of health status|0|||
163317023|NCT04171141|589873055|FG001|Overall Study|Global deterioration of health status|0|||
163317024|NCT04171141|589873056|FG002|Overall Study|Global deterioration of health status|0|||
163317025|NCT04171141|589873057|FG003|Overall Study|Global deterioration of health status|1|||
163317026|NCT04171141|589873058|FG004|Overall Study|Global deterioration of health status|0|||
163317027|NCT04171141|589873059|FG005|Overall Study|Global deterioration of health status|2|||
163317028|NCT04171141|589873060|FG006|Overall Study|Global deterioration of health status|1|||
163317029|NCT04171141|589873061|FG007|Overall Study|Global deterioration of health status|0|||
163317030|NCT04171141|589873062|FG008|Overall Study|Global deterioration of health status|1|||
163317031|NCT04171141|589873063|FG009|Overall Study|Global deterioration of health status|0|||
163317032|NCT04171141|589873064|FG010|Overall Study|Global deterioration of health status|0|||
163317033|NCT04171141|589873065|FG011|Overall Study|Global deterioration of health status|0|||
163317034|NCT04171141|589873066|FG012|Overall Study|Global deterioration of health status|0|||
163317035|NCT04171141|589873067|FG013|Overall Study|Global deterioration of health status|0|||
163317036|NCT04171141|589873068|FG014|Overall Study|Global deterioration of health status|1|||
163317037|NCT04171141|589873069|FG015|Overall Study|Global deterioration of health status|1|||
163317038|NCT04231149|589873070|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
163317039|NCT04231149|589873071|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
163317040|NCT04231149|589873072|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
163317041|NCT04231149|589873073|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
163317042|NCT04231149|589873074|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
163317043|NCT03252847|589873075|FG000|Overall Study|Withdrawal by Subject|0|||
163317044|NCT03252847|589873076|FG001|Overall Study|Withdrawal by Subject|0|||
163317045|NCT03252847|589873077|FG002|Overall Study|Withdrawal by Subject|1|||
163317046|NCT03252847|589873078|FG003|Overall Study|Withdrawal by Subject|0|||
163317047|NCT03252847|589873079|FG004|Overall Study|Withdrawal by Subject|0|||
163317048|NCT03252847|589873080|FG005|Overall Study|Withdrawal by Subject|0|||
163317049|NCT03252847|589873081|FG006|Overall Study|Withdrawal by Subject|0|||
163317050|NCT03252847|589873075|FG000|Overall Study|Other: Patient decision|0|||
163317051|NCT03252847|589873076|FG001|Overall Study|Other: Patient decision|0|||
163317052|NCT03252847|589873077|FG002|Overall Study|Other: Patient decision|0|||
163317053|NCT03252847|589873078|FG003|Overall Study|Other: Patient decision|0|||
163317054|NCT03252847|589873079|FG004|Overall Study|Other: Patient decision|1|||
163317055|NCT03252847|589873080|FG005|Overall Study|Other: Patient decision|0|||
163317056|NCT03252847|589873081|FG006|Overall Study|Other: Patient decision|0|||
163317057|NCT04979442|589873086|FG000|Overall Study|Death|43|||
163317058|NCT04979442|589873087|FG001|Overall Study|Death|30|||
163317059|NCT04979442|589873086|FG000|Overall Study|Withdrawal by Subject|8|||
163317060|NCT04979442|589873087|FG001|Overall Study|Withdrawal by Subject|13|||
163317061|NCT04979442|589873086|FG000|Overall Study|Physician Decision|1|||
163317062|NCT04979442|589873087|FG001|Overall Study|Physician Decision|1|||
163317063|NCT04979442|589873086|FG000|Overall Study|Lost to Follow-up|0|||
163317064|NCT04979442|589873087|FG001|Overall Study|Lost to Follow-up|2|||
163317065|NCT04979442|589873086|FG000|Overall Study|do not want to continue|0|||
163317066|NCT04979442|589873087|FG001|Overall Study|do not want to continue|1|||
163317067|NCT04005794|589873088|FG000|Overall Study|Lost to Follow-up|0|||
163317068|NCT04005794|589873089|FG001|Overall Study|Lost to Follow-up|4|||
163317069|NCT04005794|589873090|FG002|Overall Study|Lost to Follow-up|0|||
163317070|NCT02116530|589873094|FG000|Overall Study|Withdrawal by Subject|1|||
163317071|NCT02116530|589873095|FG001|Overall Study|Withdrawal by Subject|2|||
163317072|NCT02116530|589873094|FG000|Overall Study|Adverse Event|4|||
163317073|NCT02116530|589873095|FG001|Overall Study|Adverse Event|0|||
163317074|NCT02116530|589873094|FG000|Overall Study|Physician Decision|1|||
163317075|NCT02116530|589873095|FG001|Overall Study|Physician Decision|0|||
163317076|NCT02116530|589873094|FG000|Overall Study|Lost to Follow-up|1|||
163317077|NCT02116530|589873095|FG001|Overall Study|Lost to Follow-up|0|||
163317078|NCT02116530|589873094|FG000|Overall Study|Other Medical Problems|2|||
163317079|NCT02116530|589873095|FG001|Overall Study|Other Medical Problems|2|||
163317080|NCT05671653|589873096|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
163317081|NCT05671653|589873097|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
163317082|NCT05671653|589873098|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
163317083|NCT05671653|589873099|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
163317084|NCT05671653|589873100|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
163317085|NCT05671653|589873101|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
163317086|NCT05671653|589873102|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
163317087|NCT05671653|589873103|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
163317088|NCT05671653|589873104|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
163317089|NCT05671653|589873105|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
163317090|NCT05671653|589873106|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
163317091|NCT05671653|589873107|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
163317092|NCT05671653|589873108|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
163317093|NCT05671653|589873096|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163317094|NCT05671653|589873097|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163317095|NCT05671653|589873098|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163317096|NCT05671653|589873099|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163317097|NCT05671653|589873100|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163317098|NCT05671653|589873101|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
163317099|NCT05671653|589873102|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163317100|NCT05671653|589873103|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163317101|NCT05671653|589873104|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163317102|NCT05671653|589873105|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163317103|NCT05671653|589873106|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163317104|NCT05671653|589873107|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163317105|NCT05671653|589873108|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163317106|NCT05671653|589873096|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163317107|NCT05671653|589873097|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163317108|NCT05671653|589873098|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163317109|NCT05671653|589873099|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163317110|NCT05671653|589873100|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163317111|NCT05671653|589873101|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
163317112|NCT05671653|589873102|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163317113|NCT05671653|589873103|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163317114|NCT05671653|589873104|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163317115|NCT05671653|589873105|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163317116|NCT05671653|589873106|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163317117|NCT05671653|589873107|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163317118|NCT05671653|589873108|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163317119|NCT05671653|589873096|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163317120|NCT05671653|589873097|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163317121|NCT05671653|589873098|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163317122|NCT05671653|589873099|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163317123|NCT05671653|589873100|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163317124|NCT05671653|589873101|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163317125|NCT05671653|589873102|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163317126|NCT05671653|589873103|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163055719|NCT01326871|588916092|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
163055720|NCT01326871|588916090|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
163055721|NCT01326871|588916091|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
163055722|NCT01326871|588916092|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
163055723|NCT01326871|588916090|FG000|Overall Study|Withdrawal by Subject|0|||
163055724|NCT01326871|588916091|FG001|Overall Study|Withdrawal by Subject|1|||
163055725|NCT01326871|588916092|FG002|Overall Study|Withdrawal by Subject|0|||
163055726|NCT01326871|588916090|FG000|Overall Study|DLT|0|||
163055727|NCT01326871|588916091|FG001|Overall Study|DLT|2|||
163055728|NCT01326871|588916092|FG002|Overall Study|DLT|0|||
163055729|NCT01326871|588916090|FG000|Overall Study|SAE, disease progression and subject decision|0|||
163055730|NCT01326871|588916091|FG001|Overall Study|SAE, disease progression and subject decision|1|||
163055731|NCT01326871|588916092|FG002|Overall Study|SAE, disease progression and subject decision|0|||
163055732|NCT01326871|588916090|FG000|Overall Study|Death|0|||
163055733|NCT01326871|588916091|FG001|Overall Study|Death|1|||
163055734|NCT01326871|588916092|FG002|Overall Study|Death|0|||
163055735|NCT01326871|588916090|FG000|Overall Study|Other|0|||
163055736|NCT01326871|588916091|FG001|Overall Study|Other|3|||
163055737|NCT01326871|588916092|FG002|Overall Study|Other|0|||
163055738|NCT01326871|588916090|FG000|Overall Study|SAE and disease progression|0|||
163055739|NCT01326871|588916091|FG001|Overall Study|SAE and disease progression|0|||
163055740|NCT01326871|588916092|FG002|Overall Study|SAE and disease progression|1|||
163055741|NCT01326871|588916090|FG000|Overall Study|SAE and physician decision|0|||
163055742|NCT01326871|588916091|FG001|Overall Study|SAE and physician decision|0|||
163055743|NCT01326871|588916092|FG002|Overall Study|SAE and physician decision|1|||
163055744|NCT01326871|588916090|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
163055745|NCT01326871|588916091|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
163055746|NCT01326871|588916092|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
163055747|NCT01326871|588916090|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
163055748|NCT01326871|588916091|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
163055749|NCT01326871|588916092|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
163055750|NCT01326871|588916090|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
163055751|NCT01326871|588916091|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
163055752|NCT01326871|588916092|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
163055753|NCT01326871|588916090|FG000|Overall Study|Physician Decision|0|||
163055754|NCT01326871|588916091|FG001|Overall Study|Physician Decision|0|||
163055755|NCT01326871|588916092|FG002|Overall Study|Physician Decision|1|||
163055756|NCT01326871|588916090|FG000|Overall Study|SAE|0|||
163055757|NCT01326871|588916091|FG001|Overall Study|SAE|0|||
163055758|NCT01326871|588916092|FG002|Overall Study|SAE|1|||
163055759|NCT01326871|588916090|FG000|Overall Study|Disease progression and death|0|||
163055760|NCT01326871|588916091|FG001|Overall Study|Disease progression and death|0|||
163055761|NCT01326871|588916092|FG002|Overall Study|Disease progression and death|1|||
163208809|NCT04273217|589478647|FG000|Overall Study|Lost to Follow-up|0|||
163208810|NCT04273217|589478648|FG001|Overall Study|Lost to Follow-up|0|||
163208811|NCT04273217|589478649|FG002|Overall Study|Lost to Follow-up|0|||
163208812|NCT04273217|589478650|FG003|Overall Study|Lost to Follow-up|0|||
163208813|NCT04273217|589478651|FG004|Overall Study|Lost to Follow-up|0|||
163208814|NCT04273217|589478652|FG005|Overall Study|Lost to Follow-up|1|||
163208815|NCT04273217|589478647|FG000|Overall Study|Participant non-compliance|0|||
163208816|NCT04273217|589478648|FG001|Overall Study|Participant non-compliance|0|||
163208817|NCT04273217|589478649|FG002|Overall Study|Participant non-compliance|0|||
163208818|NCT04273217|589478650|FG003|Overall Study|Participant non-compliance|0|||
163208819|NCT04273217|589478651|FG004|Overall Study|Participant non-compliance|1|||
163208820|NCT04273217|589478652|FG005|Overall Study|Participant non-compliance|0|||
163208821|NCT04273217|589478647|FG000|Overall Study|Positive urine drug screen|1|||
163208822|NCT04273217|589478648|FG001|Overall Study|Positive urine drug screen|0|||
163208823|NCT04273217|589478649|FG002|Overall Study|Positive urine drug screen|1|||
163208824|NCT04273217|589478650|FG003|Overall Study|Positive urine drug screen|0|||
163208825|NCT04273217|589478651|FG004|Overall Study|Positive urine drug screen|0|||
163208826|NCT04273217|589478652|FG005|Overall Study|Positive urine drug screen|1|||
163208827|NCT04532099|589478653|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
163208828|NCT04532099|589478654|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
163208829|NCT04532099|589478655|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
163208830|NCT05492942|589478656|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
163208831|NCT05492942|589478657|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
163208832|NCT05492942|589478658|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
163055762|NCT01326871|588916090|FG000|Overall Study|Subject decision|0|||
163400307|NCT04232553|590175642|FG003|Overall Study|Pregnancy|0|||
163400308|NCT04232553|590175643|FG004|Overall Study|Pregnancy|0|||
163400309|NCT04232553|590175644|FG005|Overall Study|Pregnancy|0|||
163400310|NCT04232553|590175645|FG006|Overall Study|Pregnancy|0|||
163400311|NCT04232553|590175646|FG007|Overall Study|Pregnancy|0|||
163400312|NCT04232553|590175647|FG008|Overall Study|Pregnancy|0|||
163400313|NCT04232553|590175639|FG000|Overall Study|Withdrawal by Subject|7|||
163400314|NCT04232553|590175640|FG001|Overall Study|Withdrawal by Subject|5|||
163400315|NCT04232553|590175641|FG002|Overall Study|Withdrawal by Subject|0|||
163400316|NCT04232553|590175642|FG003|Overall Study|Withdrawal by Subject|0|||
163400317|NCT04232553|590175643|FG004|Overall Study|Withdrawal by Subject|2|||
163400318|NCT04232553|590175644|FG005|Overall Study|Withdrawal by Subject|2|||
163400319|NCT04232553|590175645|FG006|Overall Study|Withdrawal by Subject|0|||
163400320|NCT04232553|590175646|FG007|Overall Study|Withdrawal by Subject|2|||
163400321|NCT04232553|590175647|FG008|Overall Study|Withdrawal by Subject|0|||
163400322|NCT02969915|590175648|FG000|Overall Study|Death|104|||
163400323|NCT02969915|590175649|FG001|Overall Study|Death|125|||
163400324|NCT02969915|590175648|FG000|Overall Study|Lost to Follow-up|108|||
163400325|NCT02969915|590175649|FG001|Overall Study|Lost to Follow-up|112|||
163400326|NCT02969915|590175648|FG000|Overall Study|Censored due to COVID-19|481|||
163400327|NCT02969915|590175649|FG001|Overall Study|Censored due to COVID-19|471|||
163400328|NCT03625687|590175650|FG000|Overall Study|Death|1|||
163400329|NCT01069172|590175651|FG000|Overall Study|Withdrawal by Subject|1|||
163400330|NCT01069172|590175652|FG001|Overall Study|Withdrawal by Subject|0|||
163400331|NCT04206605|590175653|FG000|Overall Study|Adverse Event|0|||
163400332|NCT04206605|590175654|FG001|Overall Study|Adverse Event|1|||
163400333|NCT04206605|590175653|FG000|Overall Study|Withdrawal by Subject|1|||
163400334|NCT04206605|590175654|FG001|Overall Study|Withdrawal by Subject|0|||
163400335|NCT00003702|590175662|FG000|Overall Study|Ineligible cell types|2|||
163400336|NCT00003702|590175663|FG001|Overall Study|Ineligible cell types|2|||
163400337|NCT00003702|590175662|FG000|Overall Study|Did not meet criteria for persistence|8|||
163400338|NCT00003702|590175663|FG001|Overall Study|Did not meet criteria for persistence|5|||
163400339|NCT00003702|590175662|FG000|Overall Study|WHO score > 6|2|||
163400340|NCT00003702|590175663|FG001|Overall Study|WHO score > 6|1|||
163400341|NCT00003702|590175662|FG000|Overall Study|Inadequate documentation of disease|1|||
163400342|NCT00003702|590175663|FG001|Overall Study|Inadequate documentation of disease|3|||
163400343|NCT00843518|590175666|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
163400344|NCT00843518|590175667|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
163400345|NCT00843518|590175666|FG000|Period 2 (Double-blind Treatment)|Death|0|||
163400346|NCT00843518|590175667|FG001|Period 2 (Double-blind Treatment)|Death|1|||
163400347|NCT00843518|590175666|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
163400348|NCT00843518|590175667|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
163400349|NCT00843518|590175666|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
163400350|NCT00843518|590175667|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
163400351|NCT00843518|590175666|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
163400352|NCT00843518|590175667|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
163400353|NCT00843518|590175666|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
163400354|NCT00843518|590175667|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
163400355|NCT00843518|590175666|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
163400356|NCT00843518|590175667|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
163400357|NCT00827606|590175668|FG000|Overall Study|Protocol Violation|4|||
163400358|NCT00827606|590175669|FG001|Overall Study|Protocol Violation|3|||
163400359|NCT00827606|590175668|FG000|Overall Study|Lost to Follow-up|3|||
163400360|NCT00827606|590175669|FG001|Overall Study|Lost to Follow-up|1|||
163400361|NCT00827606|590175668|FG000|Overall Study|Withdrawal by Subject|7|||
163400362|NCT00827606|590175669|FG001|Overall Study|Withdrawal by Subject|6|||
163400363|NCT00827606|590175668|FG000|Overall Study|Pregnancy|0|||
163400364|NCT00827606|590175669|FG001|Overall Study|Pregnancy|1|||
163400365|NCT00827606|590175668|FG000|Overall Study|Other|5|||
163400366|NCT00827606|590175669|FG001|Overall Study|Other|13|||
163055763|NCT01326871|588916091|FG001|Overall Study|Subject decision|0|||
163400367|NCT00827606|590175668|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
163400368|NCT00827606|590175669|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
163400369|NCT00827606|590175668|FG000|Overall Study|Adverse Event|4|||
163400370|NCT00827606|590175669|FG001|Overall Study|Adverse Event|2|||
163400371|NCT02047253|590175672|FG000|Overall Study|Lost to Follow-up|8|||
163400372|NCT01987960|590175674|FG000|Period 1|Adverse Event|24|||
163400373|NCT01987960|590175675|FG001|Period 1|Adverse Event|0|||
163400374|NCT01987960|590175676|FG002|Period 1|Adverse Event|0|||
163400375|NCT01987960|590175677|FG003|Period 1|Adverse Event|0|||
163400376|NCT01987960|590175674|FG000|Period 1|Lack of Efficacy|4|||
163055764|NCT01326871|588916092|FG002|Overall Study|Subject decision|1|||
163400377|NCT01987960|590175675|FG001|Period 1|Lack of Efficacy|0|||
163400378|NCT01987960|590175676|FG002|Period 1|Lack of Efficacy|0|||
163400379|NCT01987960|590175677|FG003|Period 1|Lack of Efficacy|0|||
163400380|NCT01987960|590175674|FG000|Period 1|Non-compliance with IMP|6|||
163400381|NCT01987960|590175675|FG001|Period 1|Non-compliance with IMP|0|||
163400382|NCT01987960|590175676|FG002|Period 1|Non-compliance with IMP|0|||
163400383|NCT01987960|590175677|FG003|Period 1|Non-compliance with IMP|0|||
163400384|NCT01987960|590175674|FG000|Period 1|Protocol Violation|12|||
163400385|NCT01987960|590175675|FG001|Period 1|Protocol Violation|0|||
163400386|NCT01987960|590175676|FG002|Period 1|Protocol Violation|0|||
163400387|NCT01987960|590175677|FG003|Period 1|Protocol Violation|0|||
163400388|NCT01987960|590175674|FG000|Period 1|Withdrawal by Subject|21|||
163055765|NCT00251758|588916093|FG000|Overall Study|Adverse Event|7|||
163208833|NCT05492942|589478659|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
163208834|NCT02506153|589478660|FG000|Overall Study|Adverse Event|359|||
162969650|NCT01685008|588590004|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
162969651|NCT01685008|588590005|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
162969652|NCT01685008|588590006|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
162969653|NCT01685008|588590003|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
162969654|NCT01685008|588590004|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
162969655|NCT01685008|588590005|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
162969656|NCT01685008|588590006|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
162969657|NCT01685008|588590003|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
162969658|NCT01685008|588590004|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
162969659|NCT01685008|588590005|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
162969660|NCT01685008|588590006|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
162969661|NCT01685008|588590003|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
162969662|NCT01685008|588590004|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
162969663|NCT01685008|588590005|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
162969664|NCT01685008|588590006|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
162969665|NCT01685008|588590003|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
162969666|NCT01685008|588590004|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
162969667|NCT01685008|588590005|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
162969668|NCT01685008|588590006|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
162969669|NCT01963260|588590010|FG000|Overall Study|Withdrawal by Subject|2|||
162969670|NCT01963260|588590011|FG001|Overall Study|Withdrawal by Subject|0|||
162969671|NCT01963260|588590012|FG002|Overall Study|Withdrawal by Subject|0|||
162969672|NCT01963260|588590013|FG003|Overall Study|Withdrawal by Subject|1|||
162969673|NCT01963260|588590014|FG004|Overall Study|Withdrawal by Subject|2|||
162969674|NCT01963260|588590015|FG005|Overall Study|Withdrawal by Subject|0|||
162969675|NCT01963260|588590016|FG006|Overall Study|Withdrawal by Subject|0|||
162969676|NCT01963260|588590017|FG007|Overall Study|Withdrawal by Subject|0|||
162969677|NCT01963260|588590018|FG008|Overall Study|Withdrawal by Subject|0|||
162969678|NCT01963260|588590019|FG009|Overall Study|Withdrawal by Subject|0|||
162969679|NCT02340962|588590020|FG000|Overall Study|Lost to Follow-up|1|||
162969680|NCT02340962|588590021|FG001|Overall Study|Lost to Follow-up|0|||
162969681|NCT04994431|588590022|FG000|Overall Study|Adverse Event|1|||
162969682|NCT04994431|588590023|FG001|Overall Study|Adverse Event|0|||
162969683|NCT01341405|588590025|FG000|Overall Study|Adverse Event|0|||
162969684|NCT01341405|588590026|FG001|Overall Study|Adverse Event|1|||
162969685|NCT01341405|588590027|FG002|Overall Study|Adverse Event|1|||
162969686|NCT01341405|588590025|FG000|Overall Study|Withdrawal by Subject|3|||
162969687|NCT01341405|588590026|FG001|Overall Study|Withdrawal by Subject|2|||
162969688|NCT01341405|588590027|FG002|Overall Study|Withdrawal by Subject|1|||
162969689|NCT02760433|588590028|FG000|Overall Study|Lost to Follow-up|1|||
162969690|NCT02760433|588590029|FG001|Overall Study|Lost to Follow-up|0|||
162969691|NCT02760433|588590030|FG002|Overall Study|Lost to Follow-up|1|||
162969692|NCT02760433|588590031|FG003|Overall Study|Lost to Follow-up|0|||
162969693|NCT02760433|588590032|FG004|Overall Study|Lost to Follow-up|0|||
162969694|NCT02760433|588590028|FG000|Overall Study|Withdrawal by Subject|23|||
162969695|NCT02760433|588590029|FG001|Overall Study|Withdrawal by Subject|9|||
162969696|NCT02760433|588590030|FG002|Overall Study|Withdrawal by Subject|0|||
162969697|NCT02760433|588590031|FG003|Overall Study|Withdrawal by Subject|2|||
162969698|NCT02760433|588590032|FG004|Overall Study|Withdrawal by Subject|9|||
162969699|NCT02760433|588590028|FG000|Overall Study|Lack of Response At Week 14|0|||
162969700|NCT02760433|588590029|FG001|Overall Study|Lack of Response At Week 14|0|||
163400389|NCT01987960|590175675|FG001|Period 1|Withdrawal by Subject|0|||
163400390|NCT01987960|590175676|FG002|Period 1|Withdrawal by Subject|0|||
163400391|NCT01987960|590175677|FG003|Period 1|Withdrawal by Subject|0|||
162969701|NCT02760433|588590030|FG002|Overall Study|Lack of Response At Week 14|0|||
162969702|NCT02760433|588590031|FG003|Overall Study|Lack of Response At Week 14|0|||
163055766|NCT00251758|588916094|FG001|Overall Study|Adverse Event|9|||
163055767|NCT00251758|588916095|FG002|Overall Study|Adverse Event|11|||
163317127|NCT05671653|589873104|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
163317128|NCT05671653|589873105|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163317129|NCT05671653|589873106|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163317130|NCT05671653|589873107|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163317131|NCT05671653|589873108|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163317132|NCT05671653|589873096|FG000|Cohort 2 Period 2|Adverse Event|0|||
163317133|NCT05671653|589873097|FG001|Cohort 2 Period 2|Adverse Event|0|||
163317134|NCT05671653|589873098|FG002|Cohort 2 Period 2|Adverse Event|0|||
163317135|NCT05671653|589873099|FG003|Cohort 2 Period 2|Adverse Event|0|||
163317136|NCT05671653|589873100|FG004|Cohort 2 Period 2|Adverse Event|0|||
163317137|NCT05671653|589873101|FG005|Cohort 2 Period 2|Adverse Event|0|||
163317138|NCT05671653|589873102|FG006|Cohort 2 Period 2|Adverse Event|0|||
163317139|NCT05671653|589873103|FG007|Cohort 2 Period 2|Adverse Event|0|||
163317140|NCT05671653|589873104|FG008|Cohort 2 Period 2|Adverse Event|0|||
163317141|NCT05671653|589873105|FG009|Cohort 2 Period 2|Adverse Event|0|||
163317142|NCT05671653|589873106|FG010|Cohort 2 Period 2|Adverse Event|1|||
163317143|NCT05671653|589873107|FG011|Cohort 2 Period 2|Adverse Event|0|||
163317144|NCT05671653|589873108|FG012|Cohort 2 Period 2|Adverse Event|0|||
163317145|NCT05671653|589873096|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
163317146|NCT05671653|589873097|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
163317147|NCT05671653|589873098|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
163317148|NCT05671653|589873099|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
163317149|NCT05671653|589873100|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
163317150|NCT05671653|589873101|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
163317151|NCT05671653|589873102|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
163317152|NCT05671653|589873103|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
163317153|NCT05671653|589873104|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
163317154|NCT05671653|589873105|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
163317155|NCT05671653|589873106|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
163317156|NCT05671653|589873107|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
163317157|NCT05671653|589873108|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
163317158|NCT05671653|589873096|FG000|Cohort 2 Period 2|Pregnancy|0|||
163317159|NCT05671653|589873097|FG001|Cohort 2 Period 2|Pregnancy|0|||
163317160|NCT05671653|589873098|FG002|Cohort 2 Period 2|Pregnancy|0|||
163317161|NCT05671653|589873099|FG003|Cohort 2 Period 2|Pregnancy|0|||
163317162|NCT05671653|589873100|FG004|Cohort 2 Period 2|Pregnancy|0|||
163317163|NCT05671653|589873101|FG005|Cohort 2 Period 2|Pregnancy|0|||
163317164|NCT05671653|589873102|FG006|Cohort 2 Period 2|Pregnancy|0|||
163317165|NCT05671653|589873103|FG007|Cohort 2 Period 2|Pregnancy|0|||
163317166|NCT05671653|589873104|FG008|Cohort 2 Period 2|Pregnancy|0|||
163317167|NCT05671653|589873105|FG009|Cohort 2 Period 2|Pregnancy|0|||
163317168|NCT05671653|589873106|FG010|Cohort 2 Period 2|Pregnancy|1|||
163317169|NCT05671653|589873107|FG011|Cohort 2 Period 2|Pregnancy|0|||
163317170|NCT05671653|589873108|FG012|Cohort 2 Period 2|Pregnancy|0|||
163317171|NCT05671653|589873096|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
163317172|NCT05671653|589873097|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
163317173|NCT05671653|589873098|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
163317174|NCT05671653|589873099|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
163317175|NCT05671653|589873100|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
163317176|NCT05671653|589873101|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
163317177|NCT05671653|589873102|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
163317178|NCT05671653|589873103|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
163317179|NCT05671653|589873104|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
163317180|NCT05671653|589873105|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
163317181|NCT05671653|589873106|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
163317182|NCT05671653|589873107|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
163317183|NCT05671653|589873108|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
163317184|NCT05671653|589873096|FG000|Cohort 2 Period 2|Other|0|||
163317185|NCT05671653|589873097|FG001|Cohort 2 Period 2|Other|0|||
163317186|NCT05671653|589873098|FG002|Cohort 2 Period 2|Other|0|||
163317187|NCT05671653|589873099|FG003|Cohort 2 Period 2|Other|0|||
163317188|NCT05671653|589873100|FG004|Cohort 2 Period 2|Other|0|||
163317189|NCT05671653|589873101|FG005|Cohort 2 Period 2|Other|0|||
163317190|NCT05671653|589873102|FG006|Cohort 2 Period 2|Other|0|||
163317191|NCT05671653|589873103|FG007|Cohort 2 Period 2|Other|0|||
162969703|NCT02760433|588590032|FG004|Overall Study|Lack of Response At Week 14|1|||
162969704|NCT02760433|588590028|FG000|Overall Study|Subject refused to continue the study|1|||
162969705|NCT02760433|588590029|FG001|Overall Study|Subject refused to continue the study|0|||
162969706|NCT02760433|588590030|FG002|Overall Study|Subject refused to continue the study|0|||
162969707|NCT02760433|588590031|FG003|Overall Study|Subject refused to continue the study|0|||
162969708|NCT02760433|588590032|FG004|Overall Study|Subject refused to continue the study|0|||
162969709|NCT02760433|588590028|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
162969710|NCT02760433|588590029|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
162969711|NCT02760433|588590030|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
162969712|NCT02760433|588590031|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
162969713|NCT02760433|588590032|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
162969714|NCT02760433|588590028|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
162969715|NCT02760433|588590029|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
162969716|NCT02760433|588590030|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
162969717|NCT02760433|588590031|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
162969718|NCT02760433|588590032|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
162969719|NCT02151149|588590033|FG000|Treatment Period|Death|2|||
162969720|NCT02151149|588590034|FG001|Treatment Period|Death|3|||
162969721|NCT02151149|588590033|FG000|Treatment Period|Adverse Event|17|||
162969722|NCT02151149|588590034|FG001|Treatment Period|Adverse Event|14|||
162969723|NCT02151149|588590033|FG000|Treatment Period|Progressive Disease|25|||
162969724|NCT02151149|588590034|FG001|Treatment Period|Progressive Disease|24|||
162969725|NCT02151149|588590033|FG000|Treatment Period|Symptomatic Deterioration|2|||
162969726|NCT02151149|588590034|FG001|Treatment Period|Symptomatic Deterioration|10|||
162969727|NCT02151149|588590033|FG000|Treatment Period|Withdrawal by Subject|13|||
162969728|NCT02151149|588590034|FG001|Treatment Period|Withdrawal by Subject|11|||
162969729|NCT02151149|588590033|FG000|Treatment Period|Miscellaneous|8|||
162969730|NCT02151149|588590034|FG001|Treatment Period|Miscellaneous|7|||
162969731|NCT02151149|588590033|FG000|Treatment Period|Participants randomized but not treated|3|||
162969732|NCT02151149|588590034|FG001|Treatment Period|Participants randomized but not treated|2|||
162969733|NCT02151149|588590033|FG000|Follow-Up Period|Lost to Follow-up|2|||
162969734|NCT02151149|588590034|FG001|Follow-Up Period|Lost to Follow-up|3|||
162969735|NCT02151149|588590033|FG000|Follow-Up Period|Death|37|||
162969736|NCT02151149|588590034|FG001|Follow-Up Period|Death|34|||
162969737|NCT03419962|588590038|FG000|Overall Study|Change to other medication|1|||
162969738|NCT03419962|588590038|FG000|Overall Study|Refusal of continuing with trial drug|1|||
162969739|NCT03419962|588590038|FG000|Overall Study|Lost to Follow-up|3|||
162969740|NCT03419962|588590038|FG000|Overall Study|Difficulty in inhaling the doses|1|||
162969741|NCT03419962|588590038|FG000|Overall Study|Missing completion data|31|||
162969742|NCT03439085|588590039|FG000|Overall Study|Death|2|||
162969743|NCT03439085|588590039|FG000|Overall Study|Screen Failure|20|||
162969744|NCT02224053|588590040|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
163317192|NCT05671653|589873104|FG008|Cohort 2 Period 2|Other|0|||
162969745|NCT02224053|588590040|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
162969746|NCT02224053|588590040|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
163317193|NCT05671653|589873105|FG009|Cohort 2 Period 2|Other|0|||
162969747|NCT02224053|588590040|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
162969748|NCT02224053|588590040|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
162969749|NCT01898598|588590044|FG000|Overall Study|Adverse Event|1|||
163317194|NCT05671653|589873106|FG010|Cohort 2 Period 2|Other|1|||
163317195|NCT05671653|589873107|FG011|Cohort 2 Period 2|Other|0|||
162969750|NCT01898598|588590045|FG001|Overall Study|Adverse Event|0|||
162969751|NCT01898598|588590044|FG000|Overall Study|Withdrawal by Subject|3|||
162969752|NCT01898598|588590045|FG001|Overall Study|Withdrawal by Subject|0|||
162969753|NCT01898598|588590044|FG000|Overall Study|Lost to Follow-up|0|||
162969754|NCT01898598|588590045|FG001|Overall Study|Lost to Follow-up|1|||
162969755|NCT01898598|588590044|FG000|Overall Study|Other|0|||
162969756|NCT01898598|588590045|FG001|Overall Study|Other|1|||
162969757|NCT03833427|588590046|FG000|Overall Study|Death|4|||
162969758|NCT03833427|588590047|FG001|Overall Study|Death|2|||
162969759|NCT03833427|588590048|FG002|Overall Study|Death|9|||
162969760|NCT03833427|588590049|FG003|Overall Study|Death|11|||
162969761|NCT03833427|588590050|FG004|Overall Study|Death|0|||
162969762|NCT03833427|588590051|FG005|Overall Study|Death|0|||
162969763|NCT03833427|588590052|FG006|Overall Study|Death|0|||
162969764|NCT03833427|588590046|FG000|Overall Study|Withdrawal by Subject|0|||
162969765|NCT03833427|588590047|FG001|Overall Study|Withdrawal by Subject|1|||
162969766|NCT03833427|588590048|FG002|Overall Study|Withdrawal by Subject|1|||
162969767|NCT03833427|588590049|FG003|Overall Study|Withdrawal by Subject|0|||
162969768|NCT03833427|588590050|FG004|Overall Study|Withdrawal by Subject|0|||
163317196|NCT05671653|589873108|FG012|Cohort 2 Period 2|Other|0|||
162969769|NCT03833427|588590051|FG005|Overall Study|Withdrawal by Subject|0|||
163317197|NCT05671653|589873096|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163317198|NCT05671653|589873097|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162969770|NCT03833427|588590052|FG006|Overall Study|Withdrawal by Subject|0|||
162969771|NCT03833427|588590046|FG000|Overall Study|Sponsor Decision|0|||
162969772|NCT03833427|588590047|FG001|Overall Study|Sponsor Decision|0|||
162969773|NCT03833427|588590048|FG002|Overall Study|Sponsor Decision|1|||
162969774|NCT03833427|588590049|FG003|Overall Study|Sponsor Decision|3|||
162924572|NCT02406742|588426049|FG000|Overall Study|Transition to other treatment|2|||
163317199|NCT05671653|589873098|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163317200|NCT05671653|589873099|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163317201|NCT05671653|589873100|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163317202|NCT05671653|589873101|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163317203|NCT05671653|589873102|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163317204|NCT05671653|589873103|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163317205|NCT05671653|589873104|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163317206|NCT05671653|589873105|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163317207|NCT05671653|589873106|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163317208|NCT05671653|589873107|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
163317209|NCT05671653|589873108|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163317210|NCT04914676|589873109|FG000|Overall Study|Study termination|3|||
163317211|NCT04914676|589873110|FG001|Overall Study|Study termination|0|||
163317212|NCT02433379|589873111|FG000|Overall Study|Screen Failures|55|||
163317213|NCT02433379|589873111|FG000|Overall Study|Death|57|||
163317214|NCT02433379|589873111|FG000|Overall Study|Total Withdrawals|209|||
163317215|NCT02505984|589873114|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
163400392|NCT01987960|590175674|FG000|Period 1|Lost to Follow-up|40|||
163400393|NCT01987960|590175675|FG001|Period 1|Lost to Follow-up|0|||
163317216|NCT02505984|589873115|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
163317217|NCT02505984|589873114|FG000|Overall Study|Unreliable self-report data|1|||
163317218|NCT02505984|589873115|FG001|Overall Study|Unreliable self-report data|0|||
163317219|NCT02505984|589873114|FG000|Overall Study|Study blind opened during assessment|0|||
163317220|NCT02505984|589873115|FG001|Overall Study|Study blind opened during assessment|1|||
163317221|NCT02505984|589873114|FG000|Overall Study|Noncompliance with study protocol|0|||
163317222|NCT02505984|589873115|FG001|Overall Study|Noncompliance with study protocol|1|||
163400394|NCT01987960|590175676|FG002|Period 1|Lost to Follow-up|0|||
163400395|NCT01987960|590175677|FG003|Period 1|Lost to Follow-up|0|||
163400396|NCT01987960|590175674|FG000|Period 1|administrative or other reason|75|||
163400397|NCT01987960|590175675|FG001|Period 1|administrative or other reason|0|||
163400398|NCT01987960|590175676|FG002|Period 1|administrative or other reason|0|||
163400399|NCT01987960|590175677|FG003|Period 1|administrative or other reason|0|||
163400400|NCT01987960|590175674|FG000|Period 1|Withdrawal of consent before treatment|4|||
163400401|NCT01987960|590175675|FG001|Period 1|Withdrawal of consent before treatment|0|||
163400402|NCT01987960|590175676|FG002|Period 1|Withdrawal of consent before treatment|0|||
163400403|NCT01987960|590175677|FG003|Period 1|Withdrawal of consent before treatment|0|||
163400404|NCT01987960|590175674|FG000|Period 2|Adverse Event|0|||
163400405|NCT01987960|590175675|FG001|Period 2|Adverse Event|0|||
163400406|NCT01987960|590175676|FG002|Period 2|Adverse Event|1|||
163400407|NCT01987960|590175677|FG003|Period 2|Adverse Event|0|||
163400408|NCT01987960|590175674|FG000|Period 2|Withdrawal by Subject|0|||
163400409|NCT01987960|590175675|FG001|Period 2|Withdrawal by Subject|0|||
163400410|NCT01987960|590175676|FG002|Period 2|Withdrawal by Subject|1|||
163400411|NCT01987960|590175677|FG003|Period 2|Withdrawal by Subject|0|||
163400412|NCT01987960|590175674|FG000|Period 2|Administrative or other reason|0|||
163317223|NCT04299464|589873126|FG000|Overall Study|Adverse Event|1|||
163317224|NCT04299464|589873127|FG001|Overall Study|Adverse Event|0|||
163317225|NCT04299464|589873128|FG002|Overall Study|Adverse Event|2|||
163317226|NCT04299464|589873126|FG000|Overall Study|Non-compliance with Study Drug|1|||
163317227|NCT04299464|589873127|FG001|Overall Study|Non-compliance with Study Drug|0|||
163317228|NCT04299464|589873128|FG002|Overall Study|Non-compliance with Study Drug|0|||
163317229|NCT04299464|589873126|FG000|Overall Study|Reason not Specified|0|||
163400413|NCT01987960|590175675|FG001|Period 2|Administrative or other reason|5|||
163400414|NCT01987960|590175676|FG002|Period 2|Administrative or other reason|7|||
163400415|NCT01987960|590175677|FG003|Period 2|Administrative or other reason|0|||
163317230|NCT04299464|589873127|FG001|Overall Study|Reason not Specified|1|||
163317231|NCT04299464|589873128|FG002|Overall Study|Reason not Specified|3|||
163400416|NCT01987960|590175674|FG000|Period 3|Adverse Event|0|||
163400417|NCT01987960|590175675|FG001|Period 3|Adverse Event|0|||
163400418|NCT01987960|590175676|FG002|Period 3|Adverse Event|0|||
163400419|NCT01987960|590175677|FG003|Period 3|Adverse Event|7|||
163317232|NCT04299464|589873126|FG000|Overall Study|Physician Decision|0|||
163317233|NCT04299464|589873127|FG001|Overall Study|Physician Decision|1|||
163055768|NCT00251758|588916093|FG000|Overall Study|Lost to Follow-up|4|||
163055769|NCT00251758|588916094|FG001|Overall Study|Lost to Follow-up|2|||
163055770|NCT00251758|588916095|FG002|Overall Study|Lost to Follow-up|5|||
163055771|NCT00251758|588916093|FG000|Overall Study|Withdrawal by Subject|13|||
163055772|NCT00251758|588916094|FG001|Overall Study|Withdrawal by Subject|7|||
163055773|NCT00251758|588916095|FG002|Overall Study|Withdrawal by Subject|3|||
163055774|NCT00251758|588916093|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
163055775|NCT00251758|588916094|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
163055776|NCT00251758|588916095|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
163055777|NCT00251758|588916093|FG000|Overall Study|Lack of Efficacy|3|||
163055778|NCT00251758|588916094|FG001|Overall Study|Lack of Efficacy|0|||
163055779|NCT00251758|588916095|FG002|Overall Study|Lack of Efficacy|0|||
163055780|NCT00251758|588916093|FG000|Overall Study|Noncompliant|0|||
163055781|NCT00251758|588916094|FG001|Overall Study|Noncompliant|2|||
163055782|NCT00251758|588916095|FG002|Overall Study|Noncompliant|2|||
163055783|NCT00251758|588916093|FG000|Overall Study|Pregnancy|0|||
163055784|NCT00251758|588916094|FG001|Overall Study|Pregnancy|1|||
163055785|NCT00251758|588916095|FG002|Overall Study|Pregnancy|0|||
163055786|NCT00251758|588916093|FG000|Overall Study|Per Subject Request|0|||
163055787|NCT00251758|588916094|FG001|Overall Study|Per Subject Request|0|||
163055788|NCT00251758|588916095|FG002|Overall Study|Per Subject Request|1|||
163055789|NCT00251758|588916093|FG000|Overall Study|Per Investigator Request|1|||
163055790|NCT00251758|588916094|FG001|Overall Study|Per Investigator Request|0|||
163055791|NCT00251758|588916095|FG002|Overall Study|Per Investigator Request|0|||
163055792|NCT01387269|588916099|FG000|Overall Study|Death|38|||
163055793|NCT01387269|588916100|FG001|Overall Study|Death|20|||
163055794|NCT01387269|588916099|FG000|Overall Study|Other|8|||
163055795|NCT01387269|588916100|FG001|Overall Study|Other|7|||
163055796|NCT01387269|588916099|FG000|Overall Study|Unrelated AE|12|||
163055797|NCT01387269|588916100|FG001|Overall Study|Unrelated AE|3|||
163055798|NCT01387269|588916099|FG000|Overall Study|Withdrawal by patient|32|||
163055799|NCT01387269|588916100|FG001|Overall Study|Withdrawal by patient|10|||
163055800|NCT01387269|588916099|FG000|Overall Study|Study drug-related AE|1|||
163055801|NCT01387269|588916100|FG001|Overall Study|Study drug-related AE|0|||
163055802|NCT01387269|588916099|FG000|Overall Study|Lost to Follow-up|1|||
163055803|NCT01387269|588916100|FG001|Overall Study|Lost to Follow-up|0|||
163055804|NCT01200329|588916103|FG000|Overall Study|Lack of financial coverage|2|||
163055805|NCT01200329|588916103|FG000|Overall Study|Progressive disease|1|||
163055806|NCT02230891|588916106|FG000|Baseline|Did not meet inclusion|0|||
163055807|NCT02230891|588916107|FG001|Baseline|Did not meet inclusion|1|||
163055808|NCT02230891|588916108|FG002|Baseline|Did not meet inclusion|1|||
163055809|NCT02230891|588916106|FG000|2 Week|Withdrawal by Subject|2|||
163055810|NCT02230891|588916107|FG001|2 Week|Withdrawal by Subject|2|||
163055811|NCT02230891|588916108|FG002|2 Week|Withdrawal by Subject|0|||
163055812|NCT02230891|588916106|FG000|2 Week|Consent withdrawn|1|||
163055813|NCT02230891|588916107|FG001|2 Week|Consent withdrawn|0|||
163055814|NCT02230891|588916108|FG002|2 Week|Consent withdrawn|0|||
163055815|NCT02230891|588916106|FG000|6 Month|Withdrawal by Subject|1|||
163055816|NCT02230891|588916107|FG001|6 Month|Withdrawal by Subject|1|||
163055817|NCT02230891|588916108|FG002|6 Month|Withdrawal by Subject|1|||
163055818|NCT02230891|588916106|FG000|6 Month|Physician Decision|0|||
163055819|NCT02230891|588916107|FG001|6 Month|Physician Decision|2|||
163055820|NCT02230891|588916108|FG002|6 Month|Physician Decision|0|||
163055821|NCT02230891|588916106|FG000|12 Month|Death|1|||
163055822|NCT02230891|588916107|FG001|12 Month|Death|0|||
163055823|NCT02230891|588916108|FG002|12 Month|Death|0|||
163055824|NCT02230891|588916106|FG000|12 Month|Lost to Follow-up|0|||
163055825|NCT02230891|588916107|FG001|12 Month|Lost to Follow-up|1|||
163055826|NCT02230891|588916108|FG002|12 Month|Lost to Follow-up|0|||
163055827|NCT02230891|588916106|FG000|12 Month|Withdrawal by Subject|0|||
163055828|NCT02230891|588916107|FG001|12 Month|Withdrawal by Subject|2|||
163055829|NCT02230891|588916108|FG002|12 Month|Withdrawal by Subject|0|||
163055830|NCT02230891|588916106|FG000|18 Month End of Study|Death|0|||
163055831|NCT02230891|588916107|FG001|18 Month End of Study|Death|0|||
163055832|NCT02230891|588916108|FG002|18 Month End of Study|Death|1|||
163055833|NCT02230891|588916106|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
163317234|NCT04299464|589873128|FG002|Overall Study|Physician Decision|1|||
163317235|NCT04299464|589873126|FG000|Overall Study|Withdrawal by Subject|0|||
163055834|NCT02230891|588916107|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
163055835|NCT02230891|588916108|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
163055836|NCT03642990|588916111|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
163055837|NCT03642990|588916111|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
163055838|NCT04158219|588916120|FG000|Overall Study|Lost to Follow-up|1|||
163055839|NCT01324947|588916126|FG000|Overall Study|Adverse Event|7|||
163055840|NCT01324947|588916126|FG000|Overall Study|Death|10|||
163055841|NCT01324947|588916126|FG000|Overall Study|Other|3|||
163055842|NCT01324947|588916126|FG000|Overall Study|Progressive Disease|50|||
163055843|NCT01324947|588916126|FG000|Overall Study|Withdrawal by Subject|3|||
163400420|NCT01987960|590175674|FG000|Period 3|Non-compliance with IMP|0|||
163400421|NCT01987960|590175675|FG001|Period 3|Non-compliance with IMP|0|||
163400422|NCT01987960|590175676|FG002|Period 3|Non-compliance with IMP|0|||
163400423|NCT01987960|590175677|FG003|Period 3|Non-compliance with IMP|1|||
163400424|NCT01987960|590175674|FG000|Period 3|Protocol Violation|0|||
163400425|NCT01987960|590175675|FG001|Period 3|Protocol Violation|0|||
163400426|NCT01987960|590175676|FG002|Period 3|Protocol Violation|0|||
163400427|NCT01987960|590175677|FG003|Period 3|Protocol Violation|6|||
163400428|NCT01987960|590175674|FG000|Period 3|Withdrawal by Subject|0|||
163400429|NCT01987960|590175675|FG001|Period 3|Withdrawal by Subject|0|||
163400430|NCT01987960|590175676|FG002|Period 3|Withdrawal by Subject|0|||
163400431|NCT01987960|590175677|FG003|Period 3|Withdrawal by Subject|9|||
163400432|NCT01987960|590175674|FG000|Period 3|Lost to Follow-up|0|||
163400433|NCT01987960|590175675|FG001|Period 3|Lost to Follow-up|0|||
163055844|NCT01324947|588916126|FG000|Overall Study|1 discontinued before starting drug|1|||
163055845|NCT01296412|588916129|FG000|Overall Study|Adverse Event|8|||
163055846|NCT01296412|588916130|FG001|Overall Study|Adverse Event|29|||
163055847|NCT01296412|588916129|FG000|Overall Study|Lack of Efficacy|1|||
163055848|NCT01296412|588916130|FG001|Overall Study|Lack of Efficacy|0|||
163055849|NCT01296412|588916129|FG000|Overall Study|Lost to Follow-up|10|||
163055850|NCT01296412|588916130|FG001|Overall Study|Lost to Follow-up|7|||
163400434|NCT01987960|590175676|FG002|Period 3|Lost to Follow-up|0|||
162969775|NCT03833427|588590050|FG004|Overall Study|Sponsor Decision|0|||
162969776|NCT03833427|588590051|FG005|Overall Study|Sponsor Decision|0|||
162969777|NCT03833427|588590052|FG006|Overall Study|Sponsor Decision|0|||
162969778|NCT01499160|588590054|FG000|Overall Study|Adverse Event|1|||
162969779|NCT01499160|588590054|FG000|Overall Study|Withdrawal by Subject|1|||
162969780|NCT01438476|588590055|FG000|Overall Study|Protocol Violation|1|||
162969781|NCT01438476|588590056|FG001|Overall Study|Protocol Violation|0|||
162969782|NCT01438476|588590055|FG000|Overall Study|Withdrawal by Subject|1|||
162969783|NCT01438476|588590056|FG001|Overall Study|Withdrawal by Subject|0|||
162969784|NCT01438476|588590055|FG000|Overall Study|No Surgery- Disease|8|||
162969785|NCT01438476|588590056|FG001|Overall Study|No Surgery- Disease|10|||
162969786|NCT01438476|588590055|FG000|Overall Study|Communication barrier|0|||
162969787|NCT01438476|588590056|FG001|Overall Study|Communication barrier|1|||
162969788|NCT03294317|588590061|FG000|Overall Study|Physician Decision|1|||
162969789|NCT03294317|588590061|FG000|Overall Study|Withdrawal by Subject|6|||
162969790|NCT03294317|588590061|FG000|Overall Study|Lost to Follow-up|1|||
162969791|NCT03294317|588590061|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
162969792|NCT03294317|588590061|FG000|Overall Study|Failed HB lead implant|8|||
162969793|NCT03294317|588590061|FG000|Overall Study|Received CRT instead|1|||
162969794|NCT03294317|588590061|FG000|Overall Study|Exited after lead revision|2|||
162969795|NCT03847974|588590062|FG000|Overall Study|relocated out of region|3|||
162969796|NCT03847974|588590062|FG000|Overall Study|Withdrawal by Subject|2|||
163055851|NCT01296412|588916129|FG000|Overall Study|Non-compliance with study drug|1|||
163055852|NCT01296412|588916130|FG001|Overall Study|Non-compliance with study drug|2|||
162969797|NCT03847974|588590062|FG000|Overall Study|Adverse Event|1|||
162969798|NCT02911935|588590063|FG000|Overall Study|Lost to Follow-up|5|||
162969799|NCT02911935|588590064|FG001|Overall Study|Lost to Follow-up|7|||
162969800|NCT00603512|588590065|FG000|Overall Study|Adverse Event|0|||
163400435|NCT01987960|590175677|FG003|Period 3|Lost to Follow-up|5|||
163400436|NCT01987960|590175674|FG000|Period 3|Administrative or other reason|0|||
163400437|NCT01987960|590175675|FG001|Period 3|Administrative or other reason|0|||
162969801|NCT00603512|588590066|FG001|Overall Study|Adverse Event|2|||
162969802|NCT00603512|588590067|FG002|Overall Study|Adverse Event|4|||
163400438|NCT01987960|590175676|FG002|Period 3|Administrative or other reason|0|||
162969803|NCT00603512|588590068|FG003|Overall Study|Adverse Event|4|||
162969804|NCT00603512|588590069|FG004|Overall Study|Adverse Event|2|||
162969805|NCT00603512|588590065|FG000|Overall Study|Lack of Efficacy|0|||
162969806|NCT00603512|588590066|FG001|Overall Study|Lack of Efficacy|1|||
162969807|NCT00603512|588590067|FG002|Overall Study|Lack of Efficacy|0|||
162969808|NCT00603512|588590068|FG003|Overall Study|Lack of Efficacy|0|||
162969809|NCT00603512|588590069|FG004|Overall Study|Lack of Efficacy|1|||
162969810|NCT00603512|588590065|FG000|Overall Study|Other|2|||
162969811|NCT00603512|588590066|FG001|Overall Study|Other|1|||
162969812|NCT00603512|588590067|FG002|Overall Study|Other|0|||
162969813|NCT00603512|588590068|FG003|Overall Study|Other|1|||
162969814|NCT00603512|588590069|FG004|Overall Study|Other|1|||
162969815|NCT00603512|588590065|FG000|Overall Study|Withdrawal by Subject|0|||
162969816|NCT00603512|588590066|FG001|Overall Study|Withdrawal by Subject|0|||
162969817|NCT00603512|588590067|FG002|Overall Study|Withdrawal by Subject|0|||
162969818|NCT00603512|588590068|FG003|Overall Study|Withdrawal by Subject|0|||
162969819|NCT00603512|588590069|FG004|Overall Study|Withdrawal by Subject|1|||
162969820|NCT00603512|588590065|FG000|Overall Study|Randomized but not treated|0|||
162969821|NCT00603512|588590066|FG001|Overall Study|Randomized but not treated|1|||
162969822|NCT00603512|588590067|FG002|Overall Study|Randomized but not treated|1|||
162969823|NCT00603512|588590068|FG003|Overall Study|Randomized but not treated|2|||
162969824|NCT00603512|588590069|FG004|Overall Study|Randomized but not treated|0|||
162969825|NCT04979858|588590070|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
162969826|NCT04979858|588590071|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
162969827|NCT04253236|588590072|FG000|Overall Study|Adverse Event|1|||
162969828|NCT04253236|588590073|FG001|Overall Study|Adverse Event|0|||
162969829|NCT04253236|588590072|FG000|Overall Study|Safety Concerns|1|||
162969830|NCT04253236|588590073|FG001|Overall Study|Safety Concerns|0|||
162969831|NCT04253236|588590072|FG000|Overall Study|Study Terminated by Sponsor|1|||
162969832|NCT04253236|588590073|FG001|Overall Study|Study Terminated by Sponsor|0|||
162969833|NCT01896505|588590074|FG000|Overall Study|Adverse Event|1|||
162969834|NCT01896505|588590075|FG001|Overall Study|Adverse Event|0|||
162969835|NCT01896505|588590076|FG002|Overall Study|Adverse Event|2|||
162969836|NCT01896505|588590077|FG003|Overall Study|Adverse Event|1|||
162969837|NCT01896505|588590078|FG004|Overall Study|Adverse Event|1|||
162969838|NCT01896505|588590079|FG005|Overall Study|Adverse Event|0|||
162969839|NCT01896505|588590074|FG000|Overall Study|Physician Decision|1|||
162969840|NCT01896505|588590075|FG001|Overall Study|Physician Decision|3|||
162969841|NCT01896505|588590076|FG002|Overall Study|Physician Decision|2|||
162969842|NCT01896505|588590077|FG003|Overall Study|Physician Decision|0|||
162969843|NCT01896505|588590078|FG004|Overall Study|Physician Decision|0|||
162969844|NCT01896505|588590079|FG005|Overall Study|Physician Decision|1|||
162969845|NCT01896505|588590074|FG000|Overall Study|Withdrawal by Subject|1|||
162969846|NCT01896505|588590075|FG001|Overall Study|Withdrawal by Subject|0|||
162969847|NCT01896505|588590076|FG002|Overall Study|Withdrawal by Subject|3|||
162969848|NCT01896505|588590077|FG003|Overall Study|Withdrawal by Subject|1|||
162969849|NCT01896505|588590078|FG004|Overall Study|Withdrawal by Subject|0|||
162969850|NCT01896505|588590079|FG005|Overall Study|Withdrawal by Subject|0|||
162969851|NCT01896505|588590074|FG000|Overall Study|Disease Progression|7|||
162969852|NCT01896505|588590075|FG001|Overall Study|Disease Progression|5|||
162969853|NCT01896505|588590076|FG002|Overall Study|Disease Progression|8|||
162969854|NCT01896505|588590077|FG003|Overall Study|Disease Progression|4|||
162969855|NCT01896505|588590078|FG004|Overall Study|Disease Progression|4|||
162969856|NCT01896505|588590079|FG005|Overall Study|Disease Progression|4|||
162969857|NCT01896505|588590074|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
162969858|NCT01896505|588590075|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
162969859|NCT01896505|588590076|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
162969860|NCT01896505|588590077|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
162969861|NCT01896505|588590078|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
162969862|NCT01896505|588590079|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
162969863|NCT01896505|588590074|FG000|Overall Study|Intercurrent illness|0|||
162969864|NCT01896505|588590075|FG001|Overall Study|Intercurrent illness|1|||
162969865|NCT01896505|588590076|FG002|Overall Study|Intercurrent illness|0|||
162969866|NCT01896505|588590077|FG003|Overall Study|Intercurrent illness|0|||
163208835|NCT02506153|589478661|FG001|Overall Study|Adverse Event|114|||
162969867|NCT01896505|588590078|FG004|Overall Study|Intercurrent illness|0|||
162969868|NCT01896505|588590079|FG005|Overall Study|Intercurrent illness|0|||
162969869|NCT01896505|588590074|FG000|Overall Study|Death|0|||
162969870|NCT01896505|588590075|FG001|Overall Study|Death|0|||
162969871|NCT01896505|588590076|FG002|Overall Study|Death|1|||
162969872|NCT01896505|588590077|FG003|Overall Study|Death|1|||
162969873|NCT01896505|588590078|FG004|Overall Study|Death|0|||
162969874|NCT01896505|588590079|FG005|Overall Study|Death|1|||
162969875|NCT02063217|588590080|FG000|Overall Study|Withdrawal by Subject|1|||
162969876|NCT02063217|588590081|FG001|Overall Study|Withdrawal by Subject|0|||
162969877|NCT02063217|588590082|FG002|Overall Study|Withdrawal by Subject|0|||
162969878|NCT04291508|588590083|FG000|Overall Study|Withdrawal by Subject|1|||
162969879|NCT04291508|588590084|FG001|Overall Study|Withdrawal by Subject|0|||
162969880|NCT04291508|588590085|FG002|Overall Study|Withdrawal by Subject|1|||
162969881|NCT04291508|588590086|FG003|Overall Study|Withdrawal by Subject|0|||
162969882|NCT04291508|588590083|FG000|Overall Study|lost to follow up|4|||
162969883|NCT04291508|588590084|FG001|Overall Study|lost to follow up|0|||
162969884|NCT04291508|588590085|FG002|Overall Study|lost to follow up|1|||
162969885|NCT04291508|588590086|FG003|Overall Study|lost to follow up|0|||
162969886|NCT03566238|588590087|FG000|Overall Study|Adverse Event|0|||
162969887|NCT03566238|588590088|FG001|Overall Study|Adverse Event|0|||
162969888|NCT03566238|588590089|FG002|Overall Study|Adverse Event|1|||
162969889|NCT03566238|588590087|FG000|Overall Study|Lack of Efficacy|5|||
162969890|NCT03566238|588590088|FG001|Overall Study|Lack of Efficacy|4|||
162969891|NCT03566238|588590089|FG002|Overall Study|Lack of Efficacy|2|||
162969892|NCT03566238|588590087|FG000|Overall Study|Other|0|||
162969893|NCT03566238|588590088|FG001|Overall Study|Other|1|||
163208836|NCT02506153|589478660|FG000|Overall Study|Refused unrelated to adverse event|127|||
163208837|NCT02506153|589478661|FG001|Overall Study|Refused unrelated to adverse event|18|||
163208838|NCT02506153|589478660|FG000|Overall Study|Progression/relapse|91|||
163208839|NCT02506153|589478661|FG001|Overall Study|Progression/relapse|136|||
163208840|NCT02506153|589478660|FG000|Overall Study|Death|2|||
163208841|NCT02506153|589478661|FG001|Overall Study|Death|1|||
163208842|NCT02506153|589478660|FG000|Overall Study|Other - not protocol specified|23|||
163208843|NCT02506153|589478661|FG001|Overall Study|Other - not protocol specified|12|||
163208844|NCT03103919|589478662|FG000|Overall Study|Adverse Event|2|||
163208845|NCT03103919|589478663|FG001|Overall Study|Adverse Event|2|||
163208846|NCT01828281|589478664|FG000|Overall Study|Withdrawal by Subject|1|||
163208847|NCT01828281|589478665|FG001|Overall Study|Withdrawal by Subject|0|||
163208848|NCT01124422|589478666|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
163208849|NCT01124422|589478667|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
163208850|NCT01124422|589478668|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
163208851|NCT01124422|589478666|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
163208852|NCT01124422|589478667|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
163208853|NCT01124422|589478668|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
163208854|NCT01124422|589478666|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
163208855|NCT01124422|589478667|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
163208856|NCT01124422|589478668|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
163208857|NCT01124422|589478666|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
163208858|NCT01124422|589478667|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
163208859|NCT01124422|589478668|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
163208860|NCT01124422|589478666|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
163208861|NCT01124422|589478667|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
163208862|NCT01124422|589478668|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
163208863|NCT01124422|589478666|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
163208864|NCT01124422|589478667|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
163208865|NCT01124422|589478668|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
163208866|NCT01124422|589478666|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
163208867|NCT01124422|589478667|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
163208868|NCT01124422|589478668|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
163208869|NCT01124422|589478666|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
162969894|NCT03566238|588590089|FG002|Overall Study|Other|0|||
162969895|NCT00593827|588590096|FG000|Overall Study|On Active Treatment/Pending|0|||
162969896|NCT00593827|588590097|FG001|Overall Study|On Active Treatment/Pending|2|||
162969897|NCT00089973|588590098|FG000|Overall Study|Adverse Event|3|||
163208870|NCT01124422|589478667|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
163317236|NCT04299464|589873127|FG001|Overall Study|Withdrawal by Subject|2|||
162969898|NCT00089973|588590098|FG000|Overall Study|Withdrawal by Subject|1|||
162969899|NCT00089973|588590098|FG000|Overall Study|Disease progression|45|||
162969900|NCT00089973|588590098|FG000|Overall Study|Death|1|||
162969901|NCT01049581|588590101|FG000|Overall Study|Lost to Follow-up|2|||
162969902|NCT01049581|588590102|FG001|Overall Study|Lost to Follow-up|1|||
162969903|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
162969904|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
162969905|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
163208871|NCT01124422|589478668|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
163208872|NCT01124422|589478666|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
163317237|NCT04299464|589873128|FG002|Overall Study|Withdrawal by Subject|1|||
163208873|NCT01124422|589478667|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
163208874|NCT01124422|589478668|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
163317238|NCT05907174|589873134|FG000|3-Month Assessment|Withdrawal by Subject|0|||
162969906|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
162969907|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
162969908|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
162969909|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
163055853|NCT01296412|588916129|FG000|Overall Study|Other reason not specified|20|||
163317239|NCT05907174|589873135|FG001|3-Month Assessment|Withdrawal by Subject|0|||
163317240|NCT05907174|589873136|FG002|3-Month Assessment|Withdrawal by Subject|0|||
163317241|NCT05907174|589873137|FG003|3-Month Assessment|Withdrawal by Subject|1|||
163317242|NCT05907174|589873134|FG000|3-Month Assessment|Lost to Follow-up|1|||
163317243|NCT05907174|589873135|FG001|3-Month Assessment|Lost to Follow-up|1|||
163317244|NCT05907174|589873136|FG002|3-Month Assessment|Lost to Follow-up|1|||
163317245|NCT05907174|589873137|FG003|3-Month Assessment|Lost to Follow-up|1|||
163317246|NCT05907174|589873134|FG000|6-Month Assessment|Death|0|||
163317247|NCT05907174|589873135|FG001|6-Month Assessment|Death|0|||
163317248|NCT05907174|589873136|FG002|6-Month Assessment|Death|3|||
163317249|NCT05907174|589873137|FG003|6-Month Assessment|Death|0|||
163317250|NCT05907174|589873134|FG000|6-Month Assessment|Withdrawal by Subject|0|||
163317251|NCT05907174|589873135|FG001|6-Month Assessment|Withdrawal by Subject|0|||
163317252|NCT05907174|589873136|FG002|6-Month Assessment|Withdrawal by Subject|1|||
163317253|NCT05907174|589873137|FG003|6-Month Assessment|Withdrawal by Subject|1|||
163317254|NCT05907174|589873134|FG000|6-Month Assessment|Lost to Follow-up|0|||
163317255|NCT05907174|589873135|FG001|6-Month Assessment|Lost to Follow-up|1|||
163317256|NCT05907174|589873136|FG002|6-Month Assessment|Lost to Follow-up|1|||
163317257|NCT05907174|589873137|FG003|6-Month Assessment|Lost to Follow-up|1|||
163317258|NCT05093842|589873144|FG000|Overall Study|Pregnancy loss|1|||
163317259|NCT05093842|589873145|FG001|Overall Study|Pregnancy loss|1|||
163317260|NCT05093842|589873144|FG000|Overall Study|Lost to Follow-up|6|||
163317261|NCT05093842|589873145|FG001|Overall Study|Lost to Follow-up|0|||
163317262|NCT05093842|589873144|FG000|Overall Study|Physician Decision|0|||
163317263|NCT05093842|589873145|FG001|Overall Study|Physician Decision|1|||
163317264|NCT03209973|589873150|FG000|Overall Study|Withdrawal by Subject|7|||
163317265|NCT03209973|589873150|FG000|Overall Study|Lost to Follow-up|2|||
163317266|NCT03209973|589873150|FG000|Overall Study|Death|8|||
163317267|NCT03209973|589873150|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
163317268|NCT03209973|589873150|FG000|Overall Study|Sponsor Decision|18|||
163317269|NCT03209973|589873150|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
163317270|NCT03209973|589873150|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
163317271|NCT01275677|589873159|FG000|Overall Study|Not at risk for recurrence.|1|||
163317272|NCT01275677|589873160|FG001|Overall Study|Not at risk for recurrence.|1|||
163317273|NCT01275677|589873159|FG000|Overall Study|No follow-up|26|||
163317274|NCT01275677|589873160|FG001|Overall Study|No follow-up|37|||
163317275|NCT01275677|589873159|FG000|Overall Study|No clinical follow up.|1|||
163317276|NCT01275677|589873160|FG001|Overall Study|No clinical follow up.|4|||
163317277|NCT03478956|589873162|FG000|Randomized Treatment Period|Adverse Event|1|||
163317278|NCT03478956|589873163|FG001|Randomized Treatment Period|Adverse Event|0|||
163317279|NCT03478956|589873164|FG002|Randomized Treatment Period|Adverse Event|0|||
163317280|NCT03478956|589873165|FG003|Randomized Treatment Period|Adverse Event|0|||
163400439|NCT01987960|590175677|FG003|Period 3|Administrative or other reason|43|||
163317281|NCT03478956|589873162|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
163317282|NCT03478956|589873163|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
163317283|NCT03478956|589873164|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
163317284|NCT03478956|589873165|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
163317285|NCT03478956|589873162|FG000|Open Label Extension Period|Adverse Event|0|||
163317286|NCT03478956|589873163|FG001|Open Label Extension Period|Adverse Event|0|||
163317287|NCT03478956|589873164|FG002|Open Label Extension Period|Adverse Event|4|||
163317288|NCT03478956|589873165|FG003|Open Label Extension Period|Adverse Event|0|||
163317289|NCT03478956|589873162|FG000|Open Label Extension Period|Lack of Efficacy|0|||
163317290|NCT03478956|589873163|FG001|Open Label Extension Period|Lack of Efficacy|0|||
163317291|NCT03478956|589873164|FG002|Open Label Extension Period|Lack of Efficacy|8|||
163317292|NCT03478956|589873165|FG003|Open Label Extension Period|Lack of Efficacy|0|||
163317293|NCT03478956|589873162|FG000|Open Label Extension Period|Reason Not Provided|0|||
163317294|NCT03478956|589873163|FG001|Open Label Extension Period|Reason Not Provided|0|||
163317295|NCT03478956|589873164|FG002|Open Label Extension Period|Reason Not Provided|1|||
163317296|NCT03478956|589873165|FG003|Open Label Extension Period|Reason Not Provided|0|||
163317297|NCT03478956|589873162|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
163317298|NCT03478956|589873163|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
163317299|NCT03478956|589873164|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
163317300|NCT03478956|589873165|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
163317301|NCT03478956|589873162|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
163317302|NCT03478956|589873163|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
163317303|NCT03478956|589873164|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
163317304|NCT03478956|589873165|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
163317305|NCT03478956|589873162|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
163317306|NCT03478956|589873163|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
163317307|NCT03478956|589873164|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
163317308|NCT03478956|589873165|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
163317309|NCT04800211|589873166|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
163317310|NCT04800211|589873167|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
163317311|NCT04800211|589873168|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
163317312|NCT04800211|589873166|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
163317313|NCT04800211|589873167|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
163317314|NCT04800211|589873168|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
163317315|NCT04800211|589873166|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
163317316|NCT04800211|589873167|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
163317317|NCT04800211|589873168|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
163317318|NCT04800211|589873166|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
163317319|NCT04800211|589873167|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
163317320|NCT04800211|589873168|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
163317321|NCT04800211|589873166|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
163317322|NCT04800211|589873167|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
163317323|NCT04800211|589873168|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
163317324|NCT04800211|589873166|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
163055854|NCT01296412|588916130|FG001|Overall Study|Other reason not specified|15|||
163208875|NCT01124422|589478666|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
163208876|NCT01124422|589478667|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
163055855|NCT01296412|588916129|FG000|Overall Study|Physician Decision|1|||
163208877|NCT01124422|589478668|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
163208878|NCT03454893|589478671|FG000|Overall Study|Study Terminated by the Sponsor|5|||
163208879|NCT03454893|589478671|FG000|Overall Study|Did not pass screening|4|||
163208880|NCT04876274|589478672|FG000|Overall Study|Lost to Follow-up|9|||
163208881|NCT04876274|589478673|FG001|Overall Study|Lost to Follow-up|12|||
163208882|NCT03070782|589478676|FG000|Overall Study|Adverse Event|3|||
163208883|NCT03070782|589478677|FG001|Overall Study|Adverse Event|0|||
163208884|NCT03070782|589478678|FG002|Overall Study|Adverse Event|3|||
163208885|NCT03070782|589478679|FG003|Overall Study|Adverse Event|1|||
163208886|NCT03070782|589478680|FG004|Overall Study|Adverse Event|6|||
163208887|NCT03070782|589478681|FG005|Overall Study|Adverse Event|2|||
163208888|NCT03070782|589478676|FG000|Overall Study|Withdrawal by Subject|2|||
163208889|NCT03070782|589478677|FG001|Overall Study|Withdrawal by Subject|1|||
163208890|NCT03070782|589478678|FG002|Overall Study|Withdrawal by Subject|1|||
163208891|NCT03070782|589478679|FG003|Overall Study|Withdrawal by Subject|0|||
163208892|NCT03070782|589478680|FG004|Overall Study|Withdrawal by Subject|4|||
163208893|NCT03070782|589478681|FG005|Overall Study|Withdrawal by Subject|3|||
163208894|NCT03070782|589478676|FG000|Overall Study|Reason Not Specified|2|||
163208895|NCT03070782|589478677|FG001|Overall Study|Reason Not Specified|0|||
163208896|NCT03070782|589478678|FG002|Overall Study|Reason Not Specified|0|||
163208897|NCT03070782|589478679|FG003|Overall Study|Reason Not Specified|1|||
163208898|NCT03070782|589478680|FG004|Overall Study|Reason Not Specified|2|||
163208899|NCT03070782|589478681|FG005|Overall Study|Reason Not Specified|1|||
163208900|NCT03070782|589478676|FG000|Overall Study|Ineligibility|0|||
163208901|NCT03070782|589478677|FG001|Overall Study|Ineligibility|0|||
163208902|NCT03070782|589478678|FG002|Overall Study|Ineligibility|0|||
163208903|NCT03070782|589478679|FG003|Overall Study|Ineligibility|1|||
163208904|NCT03070782|589478680|FG004|Overall Study|Ineligibility|0|||
163208905|NCT03070782|589478681|FG005|Overall Study|Ineligibility|1|||
163208906|NCT03070782|589478676|FG000|Overall Study|Pregnancy|0|||
163208907|NCT03070782|589478677|FG001|Overall Study|Pregnancy|0|||
163208908|NCT03070782|589478678|FG002|Overall Study|Pregnancy|0|||
163208909|NCT03070782|589478679|FG003|Overall Study|Pregnancy|1|||
163208910|NCT03070782|589478680|FG004|Overall Study|Pregnancy|0|||
163208911|NCT03070782|589478681|FG005|Overall Study|Pregnancy|0|||
163208912|NCT03070782|589478676|FG000|Overall Study|Investigator Judgement|0|||
163208913|NCT03070782|589478677|FG001|Overall Study|Investigator Judgement|0|||
163208914|NCT03070782|589478678|FG002|Overall Study|Investigator Judgement|0|||
163208915|NCT03070782|589478679|FG003|Overall Study|Investigator Judgement|1|||
163208916|NCT03070782|589478680|FG004|Overall Study|Investigator Judgement|0|||
163208917|NCT03070782|589478681|FG005|Overall Study|Investigator Judgement|0|||
163208918|NCT03527966|589478684|FG000|Overall Study|Lost to Follow-up|3|||
163208919|NCT03527966|589478685|FG001|Overall Study|Lost to Follow-up|0|||
163208920|NCT01948050|589478686|FG000|Overall Study|Withdrawal by Subject|0|||
163208921|NCT01948050|589478687|FG001|Overall Study|Withdrawal by Subject|1|||
163208922|NCT02288559|589478688|FG000|Overall Study|Adverse Event|1|||
163208923|NCT02288559|589478689|FG001|Overall Study|Adverse Event|1|||
163208924|NCT02288559|589478690|FG002|Overall Study|Adverse Event|5|||
163208925|NCT02288559|589478691|FG003|Overall Study|Adverse Event|0|||
163208926|NCT02288559|589478688|FG000|Overall Study|Death|0|||
163208927|NCT02288559|589478689|FG001|Overall Study|Death|0|||
163208928|NCT02288559|589478690|FG002|Overall Study|Death|1|||
163208929|NCT02288559|589478691|FG003|Overall Study|Death|0|||
163208930|NCT02288559|589478688|FG000|Overall Study|Lost to Follow-up|0|||
163208931|NCT02288559|589478689|FG001|Overall Study|Lost to Follow-up|0|||
163208932|NCT02288559|589478690|FG002|Overall Study|Lost to Follow-up|0|||
163208933|NCT02288559|589478691|FG003|Overall Study|Lost to Follow-up|1|||
163208934|NCT02288559|589478688|FG000|Overall Study|Withdrawal by Subject|0|||
163208935|NCT02288559|589478689|FG001|Overall Study|Withdrawal by Subject|0|||
163208936|NCT02288559|589478690|FG002|Overall Study|Withdrawal by Subject|2|||
163208937|NCT02288559|589478691|FG003|Overall Study|Withdrawal by Subject|1|||
163208938|NCT02288559|589478688|FG000|Overall Study|Reason Not Specified|0|||
163208939|NCT02288559|589478689|FG001|Overall Study|Reason Not Specified|0|||
163208940|NCT02288559|589478690|FG002|Overall Study|Reason Not Specified|3|||
163208941|NCT02288559|589478691|FG003|Overall Study|Reason Not Specified|0|||
163208942|NCT02709785|589478694|FG000|Overall Study|Withdrawal by Subject|1|||
163208943|NCT02709785|589478695|FG001|Overall Study|Withdrawal by Subject|2|||
163208944|NCT02709785|589478696|FG002|Overall Study|Withdrawal by Subject|1|||
163208945|NCT01961323|589478699|FG000|Overall Study|Withdrawal by Subject|7|||
163208946|NCT01961323|589478699|FG000|Overall Study|Lost to Follow-up|8|||
163208947|NCT01961323|589478699|FG000|Overall Study|screen failure|34|||
163400440|NCT00789880|590175679|FG000|Overall Study|Adverse Event|0|||
163400441|NCT00789880|590175680|FG001|Overall Study|Adverse Event|0|||
163400442|NCT00789880|590175681|FG002|Overall Study|Adverse Event|0|||
163400443|NCT00789880|590175682|FG003|Overall Study|Adverse Event|0|||
163400444|NCT00789880|590175683|FG004|Overall Study|Adverse Event|1|||
163400445|NCT00789880|590175684|FG005|Overall Study|Adverse Event|0|||
163400446|NCT00789880|590175679|FG000|Overall Study|Protocol Violation|0|||
163400447|NCT00789880|590175680|FG001|Overall Study|Protocol Violation|1|||
163400448|NCT00789880|590175681|FG002|Overall Study|Protocol Violation|0|||
163400449|NCT00789880|590175682|FG003|Overall Study|Protocol Violation|1|||
163400450|NCT00789880|590175683|FG004|Overall Study|Protocol Violation|0|||
163400451|NCT00789880|590175684|FG005|Overall Study|Protocol Violation|0|||
163400452|NCT00789880|590175679|FG000|Overall Study|Withdrawal by Subject|1|||
163400453|NCT00789880|590175680|FG001|Overall Study|Withdrawal by Subject|0|||
163400454|NCT00789880|590175681|FG002|Overall Study|Withdrawal by Subject|0|||
163400455|NCT00789880|590175682|FG003|Overall Study|Withdrawal by Subject|0|||
163400456|NCT00789880|590175683|FG004|Overall Study|Withdrawal by Subject|2|||
163055856|NCT01296412|588916130|FG001|Overall Study|Physician Decision|3|||
163055857|NCT01296412|588916129|FG000|Overall Study|Pregnancy|0|||
163055858|NCT01296412|588916130|FG001|Overall Study|Pregnancy|1|||
163055859|NCT01296412|588916129|FG000|Overall Study|Withdrawal by Subject|10|||
163055860|NCT01296412|588916130|FG001|Overall Study|Withdrawal by Subject|13|||
163055861|NCT02160626|588916131|FG000|Overall Study|Adverse Event|1|||
163055862|NCT02160626|588916132|FG001|Overall Study|Adverse Event|0|||
163055863|NCT02160626|588916133|FG002|Overall Study|Adverse Event|0|||
163055864|NCT02160626|588916131|FG000|Overall Study|Schedule not conducive to study visits|0|||
163055865|NCT02160626|588916132|FG001|Overall Study|Schedule not conducive to study visits|0|||
163055866|NCT02160626|588916133|FG002|Overall Study|Schedule not conducive to study visits|1|||
163055867|NCT02160626|588916131|FG000|Overall Study|Withdrawal by Subject|0|||
163055868|NCT02160626|588916132|FG001|Overall Study|Withdrawal by Subject|1|||
163055869|NCT02160626|588916133|FG002|Overall Study|Withdrawal by Subject|0|||
163055870|NCT04239924|588916134|FG000|Overall Study|Lost to Follow-up|2|||
163055871|NCT04194814|588916135|FG000|Overall Study|Physician Decision|3|||
163400457|NCT00789880|590175684|FG005|Overall Study|Withdrawal by Subject|0|||
163400458|NCT01177683|590175685|FG000|Study Treatment|Disease Progressions during treatment|2|||
163400459|NCT01177683|590175686|FG001|Study Treatment|Disease Progressions during treatment|0|||
163400460|NCT01177683|590175687|FG002|Study Treatment|Disease Progressions during treatment|3|||
163400461|NCT01177683|590175685|FG000|Study Treatment|Adverse Event|0|||
163400462|NCT01177683|590175686|FG001|Study Treatment|Adverse Event|1|||
163400463|NCT01177683|590175687|FG002|Study Treatment|Adverse Event|12|||
163400464|NCT01177683|590175685|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
163400465|NCT01177683|590175686|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
163400466|NCT01177683|590175687|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
163055872|NCT04194814|588916136|FG001|Overall Study|Physician Decision|0|||
163055873|NCT04194814|588916135|FG000|Overall Study|Withdrawal by Subject|0|||
163055874|NCT04194814|588916136|FG001|Overall Study|Withdrawal by Subject|2|||
163055875|NCT03255187|588918265|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
163055876|NCT03255187|588918266|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
163055877|NCT03255187|588918265|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
163055878|NCT03255187|588918266|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
163055879|NCT00720278|588918267|FG000|Overall Study|Adverse Event|5|||
163055880|NCT00720278|588918268|FG001|Overall Study|Adverse Event|3|||
163055881|NCT00720278|588918269|FG002|Overall Study|Adverse Event|4|||
163055882|NCT00720278|588918267|FG000|Overall Study|Withdrawal by Subject|0|||
163055883|NCT00720278|588918268|FG001|Overall Study|Withdrawal by Subject|1|||
163055884|NCT00720278|588918269|FG002|Overall Study|Withdrawal by Subject|0|||
163055885|NCT00720278|588918267|FG000|Overall Study|Lost to Follow-up|0|||
163055886|NCT00720278|588918268|FG001|Overall Study|Lost to Follow-up|0|||
163055887|NCT00720278|588918269|FG002|Overall Study|Lost to Follow-up|1|||
163055888|NCT00720278|588918267|FG000|Overall Study|Non-compliance|1|||
163055889|NCT00720278|588918268|FG001|Overall Study|Non-compliance|0|||
163055890|NCT00720278|588918269|FG002|Overall Study|Non-compliance|0|||
163055891|NCT00720278|588918267|FG000|Overall Study|eligibility criteria violation|1|||
163055892|NCT00720278|588918268|FG001|Overall Study|eligibility criteria violation|0|||
163055893|NCT00720278|588918269|FG002|Overall Study|eligibility criteria violation|1|||
163055894|NCT01075048|588918270|FG000|Overall Study|Death|4|||
163055895|NCT01075048|588918271|FG001|Overall Study|Death|17|||
163055896|NCT01075048|588918272|FG002|Overall Study|Death|12|||
163055897|NCT01075048|588918270|FG000|Overall Study|Start of other or new therapy|4|||
163055898|NCT01075048|588918271|FG001|Overall Study|Start of other or new therapy|36|||
163055899|NCT01075048|588918272|FG002|Overall Study|Start of other or new therapy|46|||
163055900|NCT01075048|588918270|FG000|Overall Study|Withdrawal by Subject|1|||
163055901|NCT01075048|588918271|FG001|Overall Study|Withdrawal by Subject|6|||
163055902|NCT01075048|588918272|FG002|Overall Study|Withdrawal by Subject|3|||
163055903|NCT01075048|588918270|FG000|Overall Study|Lost to Follow-up|0|||
163055904|NCT01075048|588918271|FG001|Overall Study|Lost to Follow-up|1|||
163055905|NCT01075048|588918272|FG002|Overall Study|Lost to Follow-up|1|||
163055906|NCT00408499|588918274|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
163055907|NCT00408499|588918275|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
163055908|NCT00408499|588918276|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
163055909|NCT00408499|588918277|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
163055910|NCT00408499|588918278|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
163055911|NCT00408499|588918274|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
163055912|NCT00408499|588918275|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
163055913|NCT00408499|588918276|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
163055914|NCT00408499|588918277|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
163055915|NCT00408499|588918278|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
163055916|NCT00408499|588918274|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
163055917|NCT00408499|588918275|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
163055918|NCT00408499|588918276|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
163055919|NCT00408499|588918277|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
163055920|NCT00408499|588918278|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
163055921|NCT00408499|588918274|FG000|Phase II- MTD Expansion|Adverse Event|0|||
163055922|NCT00408499|588918275|FG001|Phase II- MTD Expansion|Adverse Event|0|||
163055923|NCT00408499|588918276|FG002|Phase II- MTD Expansion|Adverse Event|0|||
163055924|NCT00408499|588918277|FG003|Phase II- MTD Expansion|Adverse Event|0|||
163055925|NCT00408499|588918278|FG004|Phase II- MTD Expansion|Adverse Event|9|||
163055926|NCT00408499|588918274|FG000|Phase II- MTD Expansion|Death|0|||
163055927|NCT00408499|588918275|FG001|Phase II- MTD Expansion|Death|0|||
163055928|NCT00408499|588918276|FG002|Phase II- MTD Expansion|Death|0|||
163055929|NCT00408499|588918277|FG003|Phase II- MTD Expansion|Death|0|||
163055930|NCT00408499|588918278|FG004|Phase II- MTD Expansion|Death|2|||
163055931|NCT00408499|588918274|FG000|Phase II- MTD Expansion|Physician Decision|0|||
163055932|NCT00408499|588918275|FG001|Phase II- MTD Expansion|Physician Decision|0|||
163055933|NCT00408499|588918276|FG002|Phase II- MTD Expansion|Physician Decision|0|||
163055934|NCT00408499|588918277|FG003|Phase II- MTD Expansion|Physician Decision|0|||
163055935|NCT00408499|588918278|FG004|Phase II- MTD Expansion|Physician Decision|1|||
163055936|NCT00408499|588918274|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
163055937|NCT00408499|588918275|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
163208948|NCT00810407|589478700|FG000|Overall Study|Protocol Violation|3|||
163208949|NCT00810407|589478700|FG000|Overall Study|No Visit After First Day of Treatment|3|||
163208950|NCT02320149|589478704|FG000|Overall Study|Adverse Event|3|||
163208951|NCT02320149|589478705|FG001|Overall Study|Adverse Event|7|||
163208952|NCT02320149|589478704|FG000|Overall Study|Withdrawal of Consent|28|||
162969910|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
163055938|NCT00408499|588918276|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
163055939|NCT00408499|588918277|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
163055940|NCT00408499|588918278|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
163055941|NCT00408499|588918274|FG000|Phase II- MTD Expansion|treatment delay|0|||
163055942|NCT00408499|588918275|FG001|Phase II- MTD Expansion|treatment delay|0|||
163055943|NCT00408499|588918276|FG002|Phase II- MTD Expansion|treatment delay|0|||
163055944|NCT00408499|588918277|FG003|Phase II- MTD Expansion|treatment delay|0|||
163055945|NCT00408499|588918278|FG004|Phase II- MTD Expansion|treatment delay|3|||
163055946|NCT01586195|588918283|FG000|Overall Study|Death|11|||
163055947|NCT01586195|588918283|FG000|Overall Study|Withdrawal of Consent|5|||
163055948|NCT01586195|588918283|FG000|Overall Study|Started new anti-melanoma therapy|1|||
163055949|NCT01586195|588918283|FG000|Overall Study|Reason not specified|9|||
163055950|NCT00997334|588918285|FG000|Overall Study|still on therapy|12|||
163055951|NCT00997334|588918285|FG000|Overall Study|Adverse Event|3|||
163208953|NCT02320149|589478705|FG001|Overall Study|Withdrawal of Consent|32|||
163208954|NCT02320149|589478704|FG000|Overall Study|Lost to Follow-up|21|||
162969911|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
162969912|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
162969913|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
162969914|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
162969915|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
162969916|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
162969917|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
162969918|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
162969919|NCT04592419|588591898|FG000|Open-Label Extension Period|Adverse Event|1|||
162969920|NCT04592419|588591899|FG001|Open-Label Extension Period|Adverse Event|2|||
162969921|NCT04592419|588591898|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
162969922|NCT04592419|588591899|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
162969923|NCT04592419|588591898|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
162969924|NCT04592419|588591899|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
162969925|NCT04592419|588591898|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
162969926|NCT04592419|588591899|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
162969927|NCT04592419|588591898|FG000|Open-Label Extension Period|Sponsor Request|73|||
162969928|NCT04592419|588591899|FG001|Open-Label Extension Period|Sponsor Request|84|||
163055952|NCT00997334|588918285|FG000|Overall Study|Patient non-compliance|1|||
163208955|NCT02320149|589478705|FG001|Overall Study|Lost to Follow-up|34|||
162969929|NCT04241133|588591902|FG000|Overall Study|COVID19 Precautions|14|||
162969930|NCT04241133|588591903|FG001|Overall Study|COVID19 Precautions|34|||
163055953|NCT00997334|588918285|FG000|Overall Study|Withdrawal by Subject|3|||
163055954|NCT00997334|588918285|FG000|Overall Study|Death|2|||
163400467|NCT01177683|590175685|FG000|Study Treatment|Alternative therapy|0|||
163400468|NCT01177683|590175686|FG001|Study Treatment|Alternative therapy|0|||
162969931|NCT02152982|588591910|FG000|Overall Study|Withdrawal by Subject|17|||
162969932|NCT02152982|588591911|FG001|Overall Study|Withdrawal by Subject|16|||
162969933|NCT02152982|588591910|FG000|Overall Study|Did not start treatment|11|||
162969934|NCT02152982|588591911|FG001|Overall Study|Did not start treatment|5|||
163400469|NCT01177683|590175687|FG002|Study Treatment|Alternative therapy|4|||
163400470|NCT01177683|590175685|FG000|Study Treatment|Physician Decision|1|||
163400471|NCT01177683|590175686|FG001|Study Treatment|Physician Decision|0|||
163400472|NCT01177683|590175687|FG002|Study Treatment|Physician Decision|1|||
163400473|NCT01177683|590175685|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
163400474|NCT01177683|590175686|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
163400475|NCT01177683|590175687|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
163400476|NCT01177683|590175685|FG000|Study Treatment|Symptomatic Deterioration|0|||
163400477|NCT01177683|590175686|FG001|Study Treatment|Symptomatic Deterioration|0|||
163400478|NCT01177683|590175687|FG002|Study Treatment|Symptomatic Deterioration|1|||
163400479|NCT01177683|590175685|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
163400480|NCT01177683|590175686|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
163400481|NCT01177683|590175687|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
163400482|NCT01177683|590175685|FG000|Follow up|Patient lost to follow up|0|||
163400483|NCT01177683|590175686|FG001|Follow up|Patient lost to follow up|0|||
163400484|NCT01177683|590175687|FG002|Follow up|Patient lost to follow up|2|||
163400485|NCT01177683|590175685|FG000|Follow up|Death|2|||
163400486|NCT01177683|590175686|FG001|Follow up|Death|1|||
163400487|NCT01177683|590175687|FG002|Follow up|Death|7|||
163400488|NCT01177683|590175685|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
162969935|NCT02152982|588591910|FG000|Overall Study|Disease progression|41|||
162969936|NCT02152982|588591911|FG001|Overall Study|Disease progression|52|||
163055955|NCT00997334|588918285|FG000|Overall Study|Urgent Palliative Care|2|||
163400489|NCT01177683|590175686|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
163400490|NCT01177683|590175687|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
163400491|NCT06347731|590175688|FG000|Overall Study|Death|1|||
163400492|NCT06347731|590175688|FG000|Overall Study|Protocol Violation|1|||
162969937|NCT02152982|588591910|FG000|Overall Study|Adverse Event|7|||
162969938|NCT02152982|588591911|FG001|Overall Study|Adverse Event|12|||
163400493|NCT06347731|590175688|FG000|Overall Study|Withdrawal by Subject|2|||
163400494|NCT04066491|590175695|FG000|Overall Study|Randomized, not treated|0|||
163400495|NCT04066491|590175696|FG001|Overall Study|Randomized, not treated|0|||
163400496|NCT04066491|590175697|FG002|Overall Study|Randomized, not treated|2|||
163400497|NCT00943579|590175700|FG000|Overall Study|Adverse Event|4|||
163400498|NCT00943579|590175701|FG001|Overall Study|Adverse Event|3|||
163400499|NCT00943579|590175700|FG000|Overall Study|Lack of Efficacy|2|||
163400500|NCT00943579|590175701|FG001|Overall Study|Lack of Efficacy|2|||
163400501|NCT01538628|590175702|FG000|Overall Study|Withdrawal by Subject|1|||
163400502|NCT01538628|590175703|FG001|Overall Study|Withdrawal by Subject|1|||
163400503|NCT01538628|590175702|FG000|Overall Study|Lost to Follow-up|0|||
163400504|NCT01538628|590175703|FG001|Overall Study|Lost to Follow-up|1|||
163400505|NCT01357577|590175704|FG000|Overall Study|Lost to Follow-up|20|||
163400506|NCT01357577|590175705|FG001|Overall Study|Lost to Follow-up|16|||
163400507|NCT01357577|590175704|FG000|Overall Study|Withdrawal by Subject|16|||
163400508|NCT01357577|590175705|FG001|Overall Study|Withdrawal by Subject|8|||
163400509|NCT01357577|590175704|FG000|Overall Study|look at data in database?|1|||
163400510|NCT01357577|590175705|FG001|Overall Study|look at data in database?|2|||
163400511|NCT05493280|590175706|FG000|Part 2 intervention (7 months)|Withdrawal by Subject|1|||
163400512|NCT05493280|590175707|FG001|Part 2 intervention (7 months)|Withdrawal by Subject|0|||
163400513|NCT00307151|590176611|FG000|Overall Study|Death|4|||
163400514|NCT00307151|590176612|FG001|Overall Study|Death|3|||
163400515|NCT00307151|590176613|FG002|Overall Study|Death|10|||
163400516|NCT00307151|590176614|FG003|Overall Study|Death|3|||
163400517|NCT00307151|590176611|FG000|Overall Study|Severe debilitation, unable to continue|1|||
163400518|NCT00307151|590176612|FG001|Overall Study|Severe debilitation, unable to continue|0|||
163400519|NCT00307151|590176613|FG002|Overall Study|Severe debilitation, unable to continue|0|||
163400520|NCT00307151|590176614|FG003|Overall Study|Severe debilitation, unable to continue|0|||
163400521|NCT00307151|590176611|FG000|Overall Study|Subject unable to get to clinic|1|||
163400522|NCT00307151|590176612|FG001|Overall Study|Subject unable to get to clinic|0|||
163400523|NCT00307151|590176613|FG002|Overall Study|Subject unable to get to clinic|6|||
163400524|NCT00307151|590176614|FG003|Overall Study|Subject unable to get to clinic|2|||
163400525|NCT00307151|590176611|FG000|Overall Study|Withdrew consent|0|||
163400526|NCT00307151|590176612|FG001|Overall Study|Withdrew consent|1|||
163400527|NCT00307151|590176613|FG002|Overall Study|Withdrew consent|1|||
163400528|NCT00307151|590176614|FG003|Overall Study|Withdrew consent|3|||
163400529|NCT00307151|590176611|FG000|Overall Study|Not willing to adhere to study reqs|2|||
163400530|NCT00307151|590176612|FG001|Overall Study|Not willing to adhere to study reqs|0|||
163400531|NCT00307151|590176613|FG002|Overall Study|Not willing to adhere to study reqs|2|||
163400532|NCT00307151|590176614|FG003|Overall Study|Not willing to adhere to study reqs|2|||
163400533|NCT00307151|590176611|FG000|Overall Study|Clinic unable to contact subject|3|||
163400534|NCT00307151|590176612|FG001|Overall Study|Clinic unable to contact subject|3|||
163400535|NCT00307151|590176613|FG002|Overall Study|Clinic unable to contact subject|1|||
163400536|NCT00307151|590176614|FG003|Overall Study|Clinic unable to contact subject|1|||
163400537|NCT00516048|590176615|FG000|Overall Study|Death|0|||
163400538|NCT00516048|590176616|FG001|Overall Study|Death|0|||
163400539|NCT00516048|590176617|FG002|Overall Study|Death|1|||
163400540|NCT00516048|590176615|FG000|Overall Study|Subject Decision|0|||
163400541|NCT00516048|590176616|FG001|Overall Study|Subject Decision|2|||
163400542|NCT00516048|590176617|FG002|Overall Study|Subject Decision|0|||
163400543|NCT01321710|590176618|FG000|Overall Study|Lost to Follow-up|4|||
163400544|NCT01321710|590176619|FG001|Overall Study|Lost to Follow-up|5|||
163400545|NCT01321710|590176620|FG002|Overall Study|Lost to Follow-up|0|||
163400546|NCT01444742|590176621|FG000|Overall Study|Death|1|||
163400547|NCT03179891|590176622|FG000|First Intervention|Withdrawal by Subject|1|||
163400548|NCT03179891|590176623|FG001|First Intervention|Withdrawal by Subject|1|||
163400549|NCT03179891|590176622|FG000|First Intervention|Unspecified reason|1|||
163400550|NCT03179891|590176623|FG001|First Intervention|Unspecified reason|0|||
162969939|NCT02152982|588591910|FG000|Overall Study|Complicating disease|1|||
162969940|NCT02152982|588591911|FG001|Overall Study|Complicating disease|1|||
162969941|NCT02152982|588591910|FG000|Overall Study|Death|0|||
163400551|NCT03179891|590176622|FG000|First Intervention|Protocol Violation|0|||
163400552|NCT03179891|590176623|FG001|First Intervention|Protocol Violation|1|||
163400553|NCT02159729|590176624|FG000|Overall Study|Adverse Event|0|||
163400554|NCT02159729|590176625|FG001|Overall Study|Adverse Event|1|||
163400555|NCT02159729|590176624|FG000|Overall Study|Subject's Request|13|||
162969942|NCT02152982|588591911|FG001|Overall Study|Death|3|||
163400556|NCT02159729|590176625|FG001|Overall Study|Subject's Request|10|||
163400557|NCT02159729|590176624|FG000|Overall Study|Lost to Follow-up|24|||
163400558|NCT02159729|590176625|FG001|Overall Study|Lost to Follow-up|9|||
163400559|NCT02159729|590176624|FG000|Overall Study|Non compliance|2|||
163400560|NCT02159729|590176625|FG001|Overall Study|Non compliance|0|||
163208956|NCT02320149|589478704|FG000|Overall Study|Protocol Violation|2|||
163400561|NCT02159729|590176624|FG000|Overall Study|Other Unspecified|3|||
163400562|NCT02159729|590176625|FG001|Overall Study|Other Unspecified|1|||
163400563|NCT02636582|590176626|FG000|Overall Study|Surgical Pathology|1|||
162969943|NCT02152982|588591910|FG000|Overall Study|Physician Decision|3|||
162969944|NCT02152982|588591911|FG001|Overall Study|Physician Decision|0|||
162969945|NCT04968925|588591914|FG000|Phase I- Period 1|COVID-19 related|0|||
162969946|NCT04968925|588591915|FG001|Phase I- Period 1|COVID-19 related|1|||
162969947|NCT04968925|588591916|FG002|Phase I- Period 1|COVID-19 related|0|||
162969948|NCT04968925|588591917|FG003|Phase I- Period 1|COVID-19 related|0|||
162969949|NCT04968925|588591914|FG000|Phase I- Period 1|Subject enrolled in error|1|||
162969950|NCT04968925|588591915|FG001|Phase I- Period 1|Subject enrolled in error|1|||
162969951|NCT04968925|588591916|FG002|Phase I- Period 1|Subject enrolled in error|0|||
162969952|NCT04968925|588591917|FG003|Phase I- Period 1|Subject enrolled in error|0|||
162969953|NCT04968925|588591914|FG000|Phase II- Period 1|COVID-19 Related|0|||
162969954|NCT04968925|588591915|FG001|Phase II- Period 1|COVID-19 Related|0|||
162969955|NCT04968925|588591916|FG002|Phase II- Period 1|COVID-19 Related|6|||
162969956|NCT04968925|588591917|FG003|Phase II- Period 1|COVID-19 Related|6|||
162969957|NCT04968925|588591914|FG000|Phase II- Period 1|Subject enrolled in error|0|||
162969958|NCT04968925|588591915|FG001|Phase II- Period 1|Subject enrolled in error|0|||
162969959|NCT04968925|588591916|FG002|Phase II- Period 1|Subject enrolled in error|1|||
162969960|NCT04968925|588591917|FG003|Phase II- Period 1|Subject enrolled in error|0|||
162969961|NCT04968925|588591914|FG000|Phase II -Period 2|COVID-19 related|0|||
162969962|NCT04968925|588591915|FG001|Phase II -Period 2|COVID-19 related|0|||
162969963|NCT04968925|588591916|FG002|Phase II -Period 2|COVID-19 related|4|||
162969964|NCT04968925|588591917|FG003|Phase II -Period 2|COVID-19 related|3|||
162969965|NCT04968925|588591914|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
162969966|NCT04968925|588591915|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
162969967|NCT04968925|588591916|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
162969968|NCT04968925|588591917|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
162969969|NCT00835796|588591923|FG000|First Intervention|Withdrawal by Subject|0|||
162969970|NCT00835796|588591924|FG001|First Intervention|Withdrawal by Subject|1|||
162969971|NCT00396630|588591925|FG000|Overall Study|Lost to Follow-up|1|||
162969972|NCT00396630|588591926|FG001|Overall Study|Lost to Follow-up|1|||
162969973|NCT00396630|588591925|FG000|Overall Study|Withdrawal by Subject|1|||
162969974|NCT00396630|588591926|FG001|Overall Study|Withdrawal by Subject|1|||
162969975|NCT00396630|588591925|FG000|Overall Study|Not vaccinated at Visit 3|3|||
162969976|NCT00396630|588591926|FG001|Overall Study|Not vaccinated at Visit 3|3|||
162969977|NCT00876265|588591927|FG000|Overall Study|Miscellaneous reasons|4|||
162969978|NCT00876265|588591927|FG000|Overall Study|Lost to Follow-up|6|||
162969979|NCT00876265|588591927|FG000|Overall Study|Withdrawal by Subject|2|||
162969980|NCT02327325|588591928|FG000|Overall Study|Withdrawal by Subject|1|||
162969981|NCT02327325|588591929|FG001|Overall Study|Withdrawal by Subject|4|||
162969982|NCT02327325|588591930|FG002|Overall Study|Withdrawal by Subject|4|||
162969983|NCT02327325|588591928|FG000|Overall Study|Excluded by Study Team|0|||
162969984|NCT02327325|588591929|FG001|Overall Study|Excluded by Study Team|0|||
162969985|NCT02327325|588591930|FG002|Overall Study|Excluded by Study Team|1|||
162969986|NCT00651183|588591933|FG000|Overall Study|Lack of Efficacy|1|||
162969987|NCT00651183|588591934|FG001|Overall Study|Lack of Efficacy|0|||
162969988|NCT00651183|588591933|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
162969989|NCT00651183|588591934|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
162969990|NCT00651183|588591933|FG000|Overall Study|Tolerability insufficient|5|||
162969991|NCT00651183|588591934|FG001|Overall Study|Tolerability insufficient|2|||
162969992|NCT00651183|588591933|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
162969993|NCT00651183|588591934|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
162969994|NCT00651183|588591933|FG000|Overall Study|Withdrawal by Subject|6|||
162969995|NCT00651183|588591934|FG001|Overall Study|Withdrawal by Subject|3|||
162969996|NCT00651183|588591933|FG000|Overall Study|Lost to Follow-up|3|||
162969997|NCT00651183|588591934|FG001|Overall Study|Lost to Follow-up|1|||
162969998|NCT00651183|588591933|FG000|Overall Study|Other reasons|4|||
162969999|NCT00651183|588591934|FG001|Overall Study|Other reasons|2|||
162970000|NCT00651183|588591933|FG000|Overall Study|missing|1|||
163317325|NCT04800211|589873167|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
163317326|NCT04800211|589873168|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
163317327|NCT04800211|589873166|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
163317328|NCT04800211|589873167|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
163317329|NCT04800211|589873168|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
163317330|NCT04800211|589873166|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
163317331|NCT04800211|589873167|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
163317332|NCT04800211|589873168|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
163317333|NCT04800211|589873166|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
163317334|NCT04800211|589873167|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
163317335|NCT04800211|589873168|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
163317336|NCT04800211|589873166|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
163317337|NCT04800211|589873167|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
163317338|NCT04800211|589873168|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
163317339|NCT04800211|589873166|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
163317340|NCT04800211|589873167|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
163317341|NCT04800211|589873168|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
163317342|NCT05170841|589873169|FG000|Single Dose Phase|Adverse Event|1|||
163317343|NCT05170841|589873170|FG001|Single Dose Phase|Adverse Event|2|||
163317344|NCT05170841|589873171|FG002|Single Dose Phase|Adverse Event|0|||
163317345|NCT05170841|589873172|FG003|Single Dose Phase|Adverse Event|2|||
163317346|NCT05170841|589873169|FG000|Multiple Dose Phase|Adverse Event|1|||
163317347|NCT05170841|589873170|FG001|Multiple Dose Phase|Adverse Event|2|||
163317348|NCT05170841|589873171|FG002|Multiple Dose Phase|Adverse Event|1|||
163317349|NCT05170841|589873172|FG003|Multiple Dose Phase|Adverse Event|4|||
163317350|NCT05170841|589873169|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
163317351|NCT05170841|589873170|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
163317352|NCT05170841|589873171|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
163317353|NCT05170841|589873172|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
163317354|NCT05123586|589873175|FG000|Overall Study|Physician Decision|1|||
163317355|NCT05123586|589873176|FG001|Overall Study|Physician Decision|1|||
163317356|NCT05123586|589873175|FG000|Overall Study|Withdrawal by Subject|0|||
163317357|NCT05123586|589873176|FG001|Overall Study|Withdrawal by Subject|3|||
163317358|NCT02733159|589873193|FG000|Overall Study|Adverse Event|1|||
163317359|NCT02733159|589873193|FG000|Overall Study|Lack of disease progression|1|||
162970001|NCT00651183|588591934|FG001|Overall Study|missing|0|||
162970002|NCT00695110|588591937|FG000|Treatment Period 1|Adverse Event|1|||
162970003|NCT00695110|588591937|FG000|Treatment Period 1|Withdrawal by Subject|2|||
162970004|NCT00695110|588591937|FG000|Treatment Period 3|Withdrawal by Subject|1|||
162970005|NCT00695110|588591937|FG000|Treatment Period 4|Adverse Event|1|||
162970006|NCT04675775|588591944|FG000|Overall Study|Withdrawal by Subject|7|||
162970007|NCT00108082|588591947|FG000|Overall Study|Adverse Event|14|||
162970008|NCT00108082|588591948|FG001|Overall Study|Adverse Event|12|||
162970009|NCT00108082|588591949|FG002|Overall Study|Adverse Event|17|||
162970010|NCT00108082|588591947|FG000|Overall Study|Lost to Follow-up|6|||
162970011|NCT00108082|588591948|FG001|Overall Study|Lost to Follow-up|3|||
162970012|NCT00108082|588591949|FG002|Overall Study|Lost to Follow-up|7|||
162970013|NCT00108082|588591947|FG000|Overall Study|Consent Withdrawn|3|||
162970014|NCT00108082|588591948|FG001|Overall Study|Consent Withdrawn|3|||
162970015|NCT00108082|588591949|FG002|Overall Study|Consent Withdrawn|5|||
162970016|NCT00108082|588591947|FG000|Overall Study|Protocol Violation|1|||
162970017|NCT00108082|588591948|FG001|Overall Study|Protocol Violation|2|||
162970018|NCT00108082|588591949|FG002|Overall Study|Protocol Violation|0|||
162970019|NCT00108082|588591947|FG000|Overall Study|Lack of Efficacy|3|||
162970020|NCT00108082|588591948|FG001|Overall Study|Lack of Efficacy|1|||
162970021|NCT00108082|588591949|FG002|Overall Study|Lack of Efficacy|2|||
162970022|NCT00108082|588591947|FG000|Overall Study|Amendment 4: > Month 12|5|||
162970023|NCT00108082|588591948|FG001|Overall Study|Amendment 4: > Month 12|7|||
162970024|NCT00108082|588591949|FG002|Overall Study|Amendment 4: > Month 12|5|||
162970025|NCT00108082|588591947|FG000|Overall Study|Woman of Child-bearing Potential|2|||
162970026|NCT00108082|588591948|FG001|Overall Study|Woman of Child-bearing Potential|0|||
162970027|NCT00108082|588591949|FG002|Overall Study|Woman of Child-bearing Potential|2|||
162970028|NCT00108082|588591947|FG000|Overall Study|Incorrectly Randomized|0|||
162970029|NCT00108082|588591948|FG001|Overall Study|Incorrectly Randomized|0|||
162970030|NCT00108082|588591949|FG002|Overall Study|Incorrectly Randomized|2|||
162970031|NCT00108082|588591947|FG000|Overall Study|Non-compliance|1|||
162970032|NCT00108082|588591948|FG001|Overall Study|Non-compliance|0|||
163317360|NCT06122194|589873196|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
163317361|NCT06122194|589873197|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
163317362|NCT06122194|589873198|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
163317363|NCT06122194|589873199|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
162970033|NCT00108082|588591949|FG002|Overall Study|Non-compliance|2|||
163317364|NCT03088878|589873205|FG000|Overall Study|Adverse Event|0|||
163317365|NCT03088878|589873206|FG001|Overall Study|Adverse Event|0|||
163317366|NCT03088878|589873207|FG002|Overall Study|Adverse Event|0|||
163317367|NCT03088878|589873208|FG003|Overall Study|Adverse Event|0|||
162970034|NCT00108082|588591947|FG000|Overall Study|Stopped Study Medication|0|||
162970035|NCT00108082|588591948|FG001|Overall Study|Stopped Study Medication|0|||
163317368|NCT03088878|589873209|FG004|Overall Study|Adverse Event|4|||
163317369|NCT03088878|589873210|FG005|Overall Study|Adverse Event|2|||
163317370|NCT03088878|589873211|FG006|Overall Study|Adverse Event|1|||
163317371|NCT03088878|589873212|FG007|Overall Study|Adverse Event|0|||
163317372|NCT03088878|589873213|FG008|Overall Study|Adverse Event|0|||
163317373|NCT03088878|589873214|FG009|Overall Study|Adverse Event|0|||
163317374|NCT03088878|589873215|FG010|Overall Study|Adverse Event|0|||
163317375|NCT03088878|589873216|FG011|Overall Study|Adverse Event|0|||
163317376|NCT03088878|589873217|FG012|Overall Study|Adverse Event|5|||
163317377|NCT03088878|589873218|FG013|Overall Study|Adverse Event|3|||
163317378|NCT03088878|589873205|FG000|Overall Study|Clinical Progression|0|||
163317379|NCT03088878|589873206|FG001|Overall Study|Clinical Progression|0|||
163317380|NCT03088878|589873207|FG002|Overall Study|Clinical Progression|0|||
163317381|NCT03088878|589873208|FG003|Overall Study|Clinical Progression|0|||
163317382|NCT03088878|589873209|FG004|Overall Study|Clinical Progression|2|||
163317383|NCT03088878|589873210|FG005|Overall Study|Clinical Progression|0|||
163317384|NCT03088878|589873211|FG006|Overall Study|Clinical Progression|0|||
163317385|NCT03088878|589873212|FG007|Overall Study|Clinical Progression|0|||
163317386|NCT03088878|589873213|FG008|Overall Study|Clinical Progression|0|||
163317387|NCT03088878|589873214|FG009|Overall Study|Clinical Progression|0|||
163317388|NCT03088878|589873215|FG010|Overall Study|Clinical Progression|0|||
163317389|NCT03088878|589873216|FG011|Overall Study|Clinical Progression|0|||
163317390|NCT03088878|589873217|FG012|Overall Study|Clinical Progression|0|||
163317391|NCT03088878|589873218|FG013|Overall Study|Clinical Progression|0|||
163317392|NCT03088878|589873205|FG000|Overall Study|Death|0|||
163317393|NCT03088878|589873206|FG001|Overall Study|Death|0|||
163317394|NCT03088878|589873207|FG002|Overall Study|Death|0|||
163317395|NCT03088878|589873208|FG003|Overall Study|Death|0|||
163317396|NCT03088878|589873209|FG004|Overall Study|Death|2|||
163317397|NCT03088878|589873210|FG005|Overall Study|Death|0|||
163317398|NCT03088878|589873211|FG006|Overall Study|Death|0|||
163317399|NCT03088878|589873212|FG007|Overall Study|Death|0|||
163317400|NCT03088878|589873213|FG008|Overall Study|Death|0|||
163317401|NCT03088878|589873214|FG009|Overall Study|Death|0|||
163317402|NCT03088878|589873215|FG010|Overall Study|Death|0|||
163317403|NCT03088878|589873216|FG011|Overall Study|Death|1|||
163317404|NCT03088878|589873217|FG012|Overall Study|Death|0|||
163317405|NCT03088878|589873218|FG013|Overall Study|Death|0|||
163317406|NCT03088878|589873205|FG000|Overall Study|Disease Progression|1|||
163317407|NCT03088878|589873206|FG001|Overall Study|Disease Progression|2|||
163317408|NCT03088878|589873207|FG002|Overall Study|Disease Progression|3|||
163317409|NCT03088878|589873208|FG003|Overall Study|Disease Progression|0|||
163317410|NCT03088878|589873209|FG004|Overall Study|Disease Progression|3|||
163317411|NCT03088878|589873210|FG005|Overall Study|Disease Progression|0|||
163317412|NCT03088878|589873211|FG006|Overall Study|Disease Progression|0|||
163317413|NCT03088878|589873212|FG007|Overall Study|Disease Progression|0|||
163317414|NCT03088878|589873213|FG008|Overall Study|Disease Progression|0|||
163317415|NCT03088878|589873214|FG009|Overall Study|Disease Progression|0|||
163317416|NCT03088878|589873215|FG010|Overall Study|Disease Progression|0|||
163317417|NCT03088878|589873216|FG011|Overall Study|Disease Progression|0|||
163317418|NCT03088878|589873217|FG012|Overall Study|Disease Progression|1|||
163317419|NCT03088878|589873218|FG013|Overall Study|Disease Progression|1|||
163317420|NCT03088878|589873205|FG000|Overall Study|Initiation of Alternative Treatment|0|||
163317421|NCT03088878|589873206|FG001|Overall Study|Initiation of Alternative Treatment|0|||
163317422|NCT03088878|589873207|FG002|Overall Study|Initiation of Alternative Treatment|0|||
163317423|NCT03088878|589873208|FG003|Overall Study|Initiation of Alternative Treatment|1|||
163317424|NCT03088878|589873209|FG004|Overall Study|Initiation of Alternative Treatment|0|||
163317425|NCT03088878|589873210|FG005|Overall Study|Initiation of Alternative Treatment|0|||
163317426|NCT03088878|589873211|FG006|Overall Study|Initiation of Alternative Treatment|0|||
163317427|NCT03088878|589873212|FG007|Overall Study|Initiation of Alternative Treatment|1|||
163317428|NCT03088878|589873213|FG008|Overall Study|Initiation of Alternative Treatment|1|||
163317429|NCT03088878|589873214|FG009|Overall Study|Initiation of Alternative Treatment|0|||
163317430|NCT03088878|589873215|FG010|Overall Study|Initiation of Alternative Treatment|0|||
163317431|NCT03088878|589873216|FG011|Overall Study|Initiation of Alternative Treatment|0|||
163317432|NCT03088878|589873217|FG012|Overall Study|Initiation of Alternative Treatment|0|||
163317433|NCT03088878|589873218|FG013|Overall Study|Initiation of Alternative Treatment|0|||
163317434|NCT03088878|589873205|FG000|Overall Study|Withdrawal by Subject|0|||
163317435|NCT03088878|589873206|FG001|Overall Study|Withdrawal by Subject|0|||
163317436|NCT03088878|589873207|FG002|Overall Study|Withdrawal by Subject|0|||
163317437|NCT03088878|589873208|FG003|Overall Study|Withdrawal by Subject|1|||
163317438|NCT03088878|589873209|FG004|Overall Study|Withdrawal by Subject|4|||
163317439|NCT03088878|589873210|FG005|Overall Study|Withdrawal by Subject|1|||
163317440|NCT03088878|589873211|FG006|Overall Study|Withdrawal by Subject|1|||
163317441|NCT03088878|589873212|FG007|Overall Study|Withdrawal by Subject|0|||
163317442|NCT03088878|589873213|FG008|Overall Study|Withdrawal by Subject|1|||
163317443|NCT03088878|589873214|FG009|Overall Study|Withdrawal by Subject|2|||
163400564|NCT02636582|590176627|FG001|Overall Study|Surgical Pathology|0|||
163400565|NCT00573430|590176628|FG000|Overall Study|Incorrect enrollment of randomization|0|||
163400566|NCT00573430|590176629|FG001|Overall Study|Incorrect enrollment of randomization|4|||
163400567|NCT00573430|590176630|FG002|Overall Study|Incorrect enrollment of randomization|3|||
163400568|NCT00573430|590176628|FG000|Overall Study|Adverse Event|0|||
163400569|NCT00573430|590176629|FG001|Overall Study|Adverse Event|0|||
163400570|NCT00573430|590176630|FG002|Overall Study|Adverse Event|2|||
163400571|NCT00573430|590176628|FG000|Overall Study|Withdrawal by Subject|1|||
163400572|NCT00573430|590176629|FG001|Overall Study|Withdrawal by Subject|0|||
163400573|NCT00573430|590176630|FG002|Overall Study|Withdrawal by Subject|1|||
163400574|NCT00573430|590176628|FG000|Overall Study|Protocol Violation|0|||
163400575|NCT00573430|590176629|FG001|Overall Study|Protocol Violation|1|||
163400576|NCT00573430|590176630|FG002|Overall Study|Protocol Violation|1|||
163400577|NCT00573430|590176628|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163400578|NCT00573430|590176629|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
163400579|NCT00573430|590176630|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
163400580|NCT01148537|590176634|FG000|Overall Study|Withdrawal by Subject|1|||
163400581|NCT01148537|590176635|FG001|Overall Study|Withdrawal by Subject|0|||
163400582|NCT01148537|590176636|FG002|Overall Study|Withdrawal by Subject|2|||
163400583|NCT01148537|590176634|FG000|Overall Study|Adverse Event|2|||
163400584|NCT01148537|590176635|FG001|Overall Study|Adverse Event|0|||
163400585|NCT01148537|590176636|FG002|Overall Study|Adverse Event|1|||
163400586|NCT05895552|590176637|FG000|Overall Study|Adverse Event|2|||
163400587|NCT05895552|590176638|FG001|Overall Study|Adverse Event|2|||
163400588|NCT05895552|590176639|FG002|Overall Study|Adverse Event|1|||
163400589|NCT05895552|590176637|FG000|Overall Study|Lost to Follow-up|0|||
163400590|NCT05895552|590176638|FG001|Overall Study|Lost to Follow-up|1|||
163400591|NCT05895552|590176639|FG002|Overall Study|Lost to Follow-up|0|||
163400592|NCT05895552|590176637|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163400593|NCT05895552|590176638|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163400594|NCT05895552|590176639|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163400595|NCT05895552|590176637|FG000|Overall Study|Protocol Deviation|0|||
163400596|NCT05895552|590176638|FG001|Overall Study|Protocol Deviation|0|||
163400597|NCT05895552|590176639|FG002|Overall Study|Protocol Deviation|2|||
163400598|NCT05895552|590176637|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
162970036|NCT00108082|588591949|FG002|Overall Study|Stopped Study Medication|1|||
163317444|NCT03088878|589873215|FG010|Overall Study|Withdrawal by Subject|0|||
163317445|NCT03088878|589873216|FG011|Overall Study|Withdrawal by Subject|2|||
163317446|NCT03088878|589873217|FG012|Overall Study|Withdrawal by Subject|1|||
163317447|NCT03088878|589873218|FG013|Overall Study|Withdrawal by Subject|0|||
163317448|NCT03088878|589873205|FG000|Overall Study|Terminated by Sponsor|2|||
163317449|NCT03088878|589873206|FG001|Overall Study|Terminated by Sponsor|1|||
163317450|NCT03088878|589873207|FG002|Overall Study|Terminated by Sponsor|0|||
163317451|NCT03088878|589873208|FG003|Overall Study|Terminated by Sponsor|1|||
163317452|NCT03088878|589873209|FG004|Overall Study|Terminated by Sponsor|6|||
163317453|NCT03088878|589873210|FG005|Overall Study|Terminated by Sponsor|0|||
163317454|NCT03088878|589873211|FG006|Overall Study|Terminated by Sponsor|0|||
163317455|NCT03088878|589873212|FG007|Overall Study|Terminated by Sponsor|0|||
163317456|NCT03088878|589873213|FG008|Overall Study|Terminated by Sponsor|0|||
163317457|NCT03088878|589873214|FG009|Overall Study|Terminated by Sponsor|0|||
163317458|NCT03088878|589873215|FG010|Overall Study|Terminated by Sponsor|3|||
163317459|NCT03088878|589873216|FG011|Overall Study|Terminated by Sponsor|13|||
163317460|NCT03088878|589873217|FG012|Overall Study|Terminated by Sponsor|2|||
163317461|NCT03088878|589873218|FG013|Overall Study|Terminated by Sponsor|1|||
163317462|NCT03088878|589873205|FG000|Overall Study|Completed 2 years of Treatment|0|||
163317463|NCT03088878|589873206|FG001|Overall Study|Completed 2 years of Treatment|0|||
163317464|NCT03088878|589873207|FG002|Overall Study|Completed 2 years of Treatment|0|||
163317465|NCT03088878|589873208|FG003|Overall Study|Completed 2 years of Treatment|0|||
163317466|NCT03088878|589873209|FG004|Overall Study|Completed 2 years of Treatment|0|||
163317467|NCT03088878|589873210|FG005|Overall Study|Completed 2 years of Treatment|0|||
163317468|NCT03088878|589873211|FG006|Overall Study|Completed 2 years of Treatment|1|||
163317469|NCT03088878|589873212|FG007|Overall Study|Completed 2 years of Treatment|0|||
163317470|NCT03088878|589873213|FG008|Overall Study|Completed 2 years of Treatment|0|||
163317471|NCT03088878|589873214|FG009|Overall Study|Completed 2 years of Treatment|1|||
163317472|NCT03088878|589873215|FG010|Overall Study|Completed 2 years of Treatment|0|||
163400599|NCT05895552|590176638|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
163400600|NCT05895552|590176639|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
163400601|NCT05895552|590176637|FG000|Overall Study|Withdrawal by Subject|2|||
163400602|NCT05895552|590176638|FG001|Overall Study|Withdrawal by Subject|2|||
163400603|NCT05895552|590176639|FG002|Overall Study|Withdrawal by Subject|4|||
163400604|NCT01843842|590176642|FG000|Overall Study|Do not meet inclusion criteria|1|||
163400605|NCT01843842|590176643|FG001|Overall Study|Do not meet inclusion criteria|1|||
162970037|NCT00108082|588591947|FG000|Overall Study|Site Closed Study|0|||
163400606|NCT00632099|590176644|FG000|Overall Study|Lost to Follow-up|3|||
163400607|NCT00632099|590176645|FG001|Overall Study|Lost to Follow-up|3|||
163400608|NCT01517893|590176651|FG000|Overall Study|Withdrawal by Subject|3|||
163400609|NCT01517893|590176652|FG001|Overall Study|Withdrawal by Subject|0|||
163400610|NCT02018822|590176653|FG000|Overall Study|filling replaced by crown|0|||
163400611|NCT02018822|590176654|FG001|Overall Study|filling replaced by crown|1|||
163400612|NCT02018822|590176655|FG002|Overall Study|filling replaced by crown|0|||
163400613|NCT02018822|590176653|FG000|Overall Study|Physician Decision|0|||
163400614|NCT02018822|590176654|FG001|Overall Study|Physician Decision|1|||
163400615|NCT02018822|590176655|FG002|Overall Study|Physician Decision|1|||
163400616|NCT02018822|590176653|FG000|Overall Study|Lost to Follow-up|6|||
163400617|NCT02018822|590176654|FG001|Overall Study|Lost to Follow-up|6|||
163400618|NCT02018822|590176655|FG002|Overall Study|Lost to Follow-up|5|||
163400619|NCT02184195|590176664|FG000|Overall Study|Patient decision|5|||
163400620|NCT02184195|590176665|FG001|Overall Study|Patient decision|2|||
163400621|NCT02184195|590176664|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163400622|NCT02184195|590176665|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163400623|NCT02184195|590176664|FG000|Overall Study|Death|67|||
163400624|NCT02184195|590176665|FG001|Overall Study|Death|44|||
163400625|NCT02184195|590176664|FG000|Overall Study|Lost to Follow-up|1|||
163400626|NCT02184195|590176665|FG001|Overall Study|Lost to Follow-up|5|||
163400627|NCT02184195|590176664|FG000|Overall Study|Other|0|||
163400628|NCT02184195|590176665|FG001|Overall Study|Other|3|||
163400629|NCT00589420|590176666|FG000|Overall Study|screen failure|1|||
163400630|NCT00841568|590176667|FG000|Overall Study|Adverse Event|1|||
163400631|NCT00841568|590176667|FG000|Overall Study|Death|1|||
163400632|NCT00841568|590176667|FG000|Overall Study|Withdrawal by Subject|2|||
163400633|NCT00841568|590176667|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
163400634|NCT03002155|590176668|FG000|Overall Study|Lost to Follow-up|1|||
163400635|NCT03002155|590176669|FG001|Overall Study|Lost to Follow-up|2|||
163400636|NCT03002155|590176668|FG000|Overall Study|Withdrawal by Subject|1|||
163400637|NCT03002155|590176669|FG001|Overall Study|Withdrawal by Subject|0|||
163400638|NCT03002155|590176668|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
163400639|NCT03002155|590176669|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
163400640|NCT00974675|590176672|FG000|Overall Study|Adverse Event|2|||
163400641|NCT00974675|590176673|FG001|Overall Study|Adverse Event|1|||
163400642|NCT00974675|590176674|FG002|Overall Study|Adverse Event|1|||
163400643|NCT00974675|590176675|FG003|Overall Study|Adverse Event|1|||
163400644|NCT00974675|590176672|FG000|Overall Study|Physician Decision|0|||
163400645|NCT00974675|590176673|FG001|Overall Study|Physician Decision|0|||
163400646|NCT00974675|590176674|FG002|Overall Study|Physician Decision|1|||
163400647|NCT00974675|590176675|FG003|Overall Study|Physician Decision|0|||
163400648|NCT00974675|590176672|FG000|Overall Study|Participant on holiday; unable to attend|0|||
163400649|NCT00974675|590176673|FG001|Overall Study|Participant on holiday; unable to attend|0|||
163400650|NCT00974675|590176674|FG002|Overall Study|Participant on holiday; unable to attend|0|||
163400651|NCT00974675|590176675|FG003|Overall Study|Participant on holiday; unable to attend|1|||
163400652|NCT01131520|590176679|FG000|Overall Study|Computer problem|1|||
163400653|NCT01131520|590176680|FG001|Overall Study|Computer problem|0|||
163400654|NCT01131520|590176679|FG000|Overall Study|Counselor not available|0|||
163400655|NCT01131520|590176680|FG001|Overall Study|Counselor not available|3|||
163400656|NCT01131520|590176679|FG000|Overall Study|Subject changed history after enrollment|0|||
163400657|NCT01131520|590176680|FG001|Overall Study|Subject changed history after enrollment|1|||
163400658|NCT03302975|590176683|FG000|Overall Study|Lost to Follow-up|4|||
163400659|NCT01436084|590176684|FG000|Overall Study|Disease Progression|2|||
163400660|NCT01436084|590176684|FG000|Overall Study|Withdrawal by Subject|1|||
163400661|NCT01436084|590176684|FG000|Overall Study|Early Closure of Study|1|||
163400662|NCT03834519|590176685|FG000|Overall Study|Lost to Follow-up|2|||
163400663|NCT03834519|590176686|FG001|Overall Study|Lost to Follow-up|1|||
163400664|NCT03834519|590176685|FG000|Overall Study|Withdrawal by Subject|5|||
163400665|NCT03834519|590176686|FG001|Overall Study|Withdrawal by Subject|8|||
163400666|NCT03834519|590176685|FG000|Overall Study|Death|368|||
163400667|NCT03834519|590176686|FG001|Overall Study|Death|174|||
163400668|NCT03834519|590176685|FG000|Overall Study|Physician Decision|5|||
163400669|NCT03834519|590176686|FG001|Overall Study|Physician Decision|1|||
163400670|NCT03834519|590176685|FG000|Overall Study|Sponsor decision|149|||
163400671|NCT03834519|590176686|FG001|Overall Study|Sponsor decision|80|||
163400672|NCT04506086|590176687|FG000|Overall Study|Withdrawal by Subject|2|||
163400673|NCT01392677|590176690|FG000|Overall Study|Adverse Event|3|||
163400674|NCT01392677|590176691|FG001|Overall Study|Adverse Event|1|||
163400675|NCT01392677|590176690|FG000|Overall Study|Withdrawal by Subject|0|||
163400676|NCT01392677|590176691|FG001|Overall Study|Withdrawal by Subject|2|||
163400677|NCT01392677|590176690|FG000|Overall Study|Incorrect enrollment|2|||
163400678|NCT01392677|590176691|FG001|Overall Study|Incorrect enrollment|3|||
163400679|NCT01392677|590176690|FG000|Overall Study|Other reason|3|||
163400680|NCT01392677|590176691|FG001|Overall Study|Other reason|2|||
163400681|NCT05937165|590176696|FG000|Overall Study|Withdrawal by Subject|0|||
163400682|NCT05937165|590176697|FG001|Overall Study|Withdrawal by Subject|1|||
163400683|NCT06608368|590176698|FG000|Overall Study|Family Emergency|0|||
163055956|NCT00997334|588918285|FG000|Overall Study|No lesion amenable|1|||
163055957|NCT00997334|588918285|FG000|Overall Study|Ineligible|1|||
163055958|NCT01855958|588918286|FG000|Overall Study|Withdrawal by Subject|1|||
163055959|NCT01855958|588918287|FG001|Overall Study|Withdrawal by Subject|0|||
163055960|NCT00296244|588918288|FG000|Overall Study|Underwent retransplant|0|||
163055961|NCT00296244|588918289|FG001|Overall Study|Underwent retransplant|1|||
163055962|NCT00266708|588918294|FG000|Overall Study|No renal function|1|||
163055963|NCT00266708|588918295|FG001|Overall Study|No renal function|1|||
163055964|NCT00266708|588918294|FG000|Overall Study|Refused biopsy|3|||
163055965|NCT00266708|588918295|FG001|Overall Study|Refused biopsy|6|||
163055966|NCT00266708|588918294|FG000|Overall Study|Asthma|0|||
163055967|NCT00266708|588918295|FG001|Overall Study|Asthma|2|||
163055968|NCT00703534|588918296|FG000|Overall Study|Adverse Event|14|||
163055969|NCT00703534|588918297|FG001|Overall Study|Adverse Event|3|||
163055970|NCT00703534|588918296|FG000|Overall Study|Withdrawal by Subject|8|||
163055971|NCT00703534|588918297|FG001|Overall Study|Withdrawal by Subject|7|||
163055972|NCT00703534|588918296|FG000|Overall Study|Incorrect Enrollment|6|||
163055973|NCT00703534|588918297|FG001|Overall Study|Incorrect Enrollment|6|||
163055974|NCT00703534|588918296|FG000|Overall Study|Lost to Follow-up|1|||
163055975|NCT00703534|588918297|FG001|Overall Study|Lost to Follow-up|4|||
163055976|NCT00703534|588918296|FG000|Overall Study|Severe Non Compliance|1|||
163055977|NCT00703534|588918297|FG001|Overall Study|Severe Non Compliance|5|||
163055978|NCT01125930|588918298|FG000|Overall Study|Adverse Event|0|||
163055979|NCT01125930|588918299|FG001|Overall Study|Adverse Event|1|||
163055980|NCT01125930|588918298|FG000|Overall Study|Withdrawal by Subject|1|||
163055981|NCT01125930|588918299|FG001|Overall Study|Withdrawal by Subject|6|||
163055982|NCT01125930|588918298|FG000|Overall Study|Protocol Violation|0|||
163055983|NCT01125930|588918299|FG001|Overall Study|Protocol Violation|1|||
163055984|NCT01125930|588918298|FG000|Overall Study|Lost to Follow-up|0|||
163055985|NCT01125930|588918299|FG001|Overall Study|Lost to Follow-up|2|||
163055986|NCT01715831|588918304|FG000|Overall Study|Adverse Event|1|||
163055987|NCT03261401|588918305|FG000|Overall Study|Withdrawal by Subject|0|||
163055988|NCT03261401|588918306|FG001|Overall Study|Withdrawal by Subject|0|||
163055989|NCT03261401|588918307|FG002|Overall Study|Withdrawal by Subject|0|||
163055990|NCT03261401|588918308|FG003|Overall Study|Withdrawal by Subject|0|||
163055991|NCT03261401|588918309|FG004|Overall Study|Withdrawal by Subject|0|||
163055992|NCT03261401|588918310|FG005|Overall Study|Withdrawal by Subject|1|||
163055993|NCT03261401|588918311|FG006|Overall Study|Withdrawal by Subject|0|||
163055994|NCT03261401|588918312|FG007|Overall Study|Withdrawal by Subject|0|||
163055995|NCT03261401|588918313|FG008|Overall Study|Withdrawal by Subject|0|||
163055996|NCT03261401|588918314|FG009|Overall Study|Withdrawal by Subject|0|||
163055997|NCT03261401|588918315|FG010|Overall Study|Withdrawal by Subject|0|||
163055998|NCT03261401|588918316|FG011|Overall Study|Withdrawal by Subject|0|||
163055999|NCT03261401|588918317|FG012|Overall Study|Withdrawal by Subject|0|||
163056000|NCT03261401|588918305|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
163056001|NCT03261401|588918306|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
163056002|NCT03261401|588918307|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
163056003|NCT03261401|588918308|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
163056004|NCT03261401|588918309|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
163056005|NCT03261401|588918310|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
163056006|NCT03261401|588918311|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
163056007|NCT03261401|588918312|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
163056008|NCT03261401|588918313|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
163056009|NCT03261401|588918314|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
163056010|NCT03261401|588918315|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
163056011|NCT03261401|588918316|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
163056012|NCT03261401|588918317|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
163056013|NCT01516216|588918318|FG000|Overall Study|Adverse Event|2|||
163056014|NCT01516216|588918319|FG001|Overall Study|Adverse Event|4|||
163056015|NCT01516216|588918318|FG000|Overall Study|Disease Progression|38|||
163056016|NCT01516216|588918319|FG001|Overall Study|Disease Progression|34|||
163056017|NCT01516216|588918318|FG000|Overall Study|Withdrawal by Subject|9|||
163056018|NCT01516216|588918319|FG001|Overall Study|Withdrawal by Subject|11|||
163056019|NCT01516216|588918318|FG000|Overall Study|Potentially Curative Resection|6|||
163056020|NCT01516216|588918319|FG001|Overall Study|Potentially Curative Resection|12|||
163056021|NCT01516216|588918318|FG000|Overall Study|Nonadherence|2|||
163056022|NCT01516216|588918319|FG001|Overall Study|Nonadherence|3|||
163056023|NCT01516216|588918318|FG000|Overall Study|Physician Decision|6|||
163056024|NCT01516216|588918319|FG001|Overall Study|Physician Decision|3|||
163056025|NCT01516216|588918318|FG000|Overall Study|Prolonged Treatment Delay|5|||
163056026|NCT01516216|588918319|FG001|Overall Study|Prolonged Treatment Delay|1|||
163056027|NCT01516216|588918318|FG000|Overall Study|Intercurrent Illness|1|||
163208957|NCT02320149|589478705|FG001|Overall Study|Protocol Violation|1|||
163400684|NCT06608368|590176699|FG001|Overall Study|Family Emergency|1|||
163400685|NCT06608368|590176700|FG002|Overall Study|Family Emergency|0|||
163400686|NCT06608368|590176698|FG000|Overall Study|Scheduling Issues|0|||
163400687|NCT06608368|590176699|FG001|Overall Study|Scheduling Issues|1|||
163400688|NCT06608368|590176700|FG002|Overall Study|Scheduling Issues|0|||
163400689|NCT03977974|590176701|FG000|Period 2|Adverse Event|0|||
163400690|NCT03977974|590176702|FG001|Period 2|Adverse Event|0|||
163400691|NCT03977974|590176703|FG002|Period 2|Adverse Event|0|||
163400692|NCT03977974|590176704|FG003|Period 2|Adverse Event|0|||
163400693|NCT03977974|590176705|FG004|Period 2|Adverse Event|1|||
163400694|NCT03977974|590176706|FG005|Period 2|Adverse Event|0|||
163400695|NCT03977974|590176707|FG006|Period 2|Adverse Event|0|||
163400696|NCT03977974|590176708|FG007|Period 2|Adverse Event|0|||
163400697|NCT03977974|590176709|FG008|Period 2|Adverse Event|0|||
163400698|NCT03977974|590176710|FG009|Period 2|Adverse Event|0|||
163400699|NCT03977974|590176711|FG010|Period 2|Adverse Event|0|||
163400700|NCT03977974|590176712|FG011|Period 2|Adverse Event|0|||
163400701|NCT03977974|590176713|FG012|Period 2|Adverse Event|0|||
163400702|NCT00388973|590178143|FG000|Overall Study|Adverse Event|16|||
163400703|NCT00388973|590178144|FG001|Overall Study|Adverse Event|6|||
163400704|NCT00388973|590178143|FG000|Overall Study|Lack of Efficacy|1|||
163400705|NCT00388973|590178144|FG001|Overall Study|Lack of Efficacy|12|||
163400706|NCT00388973|590178143|FG000|Overall Study|Protocol Violation|3|||
163400707|NCT00388973|590178144|FG001|Overall Study|Protocol Violation|0|||
163400708|NCT00388973|590178143|FG000|Overall Study|Withdrawal by Subject|14|||
163400709|NCT00388973|590178144|FG001|Overall Study|Withdrawal by Subject|17|||
163400710|NCT00388973|590178143|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
163400711|NCT00388973|590178144|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
163400712|NCT00388973|590178143|FG000|Overall Study|Did not complete 61 days of treatment|5|||
163400713|NCT00388973|590178144|FG001|Overall Study|Did not complete 61 days of treatment|4|||
163400714|NCT00388973|590178143|FG000|Overall Study|Left region|0|||
163400715|NCT00388973|590178144|FG001|Overall Study|Left region|1|||
163400716|NCT00388973|590178143|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
163400717|NCT00388973|590178144|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
163400718|NCT00075400|590178154|FG000|Overall Study|Ineligible: wrong primary|1|||
163400719|NCT00075400|590178154|FG000|Overall Study|Never treated|2|||
163400720|NCT00666458|590178161|FG000|Overall Study|Adverse Event|8|||
163400721|NCT00666458|590178162|FG001|Overall Study|Adverse Event|7|||
163400722|NCT00666458|590178161|FG000|Overall Study|Withdrawal by Subject|5|||
163400723|NCT00666458|590178162|FG001|Overall Study|Withdrawal by Subject|4|||
163400724|NCT00666458|590178161|FG000|Overall Study|Lost to Follow-up|0|||
163400725|NCT00666458|590178162|FG001|Overall Study|Lost to Follow-up|3|||
163400726|NCT00666458|590178161|FG000|Overall Study|Administrative reason by sponsor|1|||
163400727|NCT00666458|590178162|FG001|Overall Study|Administrative reason by sponsor|1|||
163400728|NCT00666458|590178161|FG000|Overall Study|Incorrect enrollment|7|||
163400729|NCT00666458|590178162|FG001|Overall Study|Incorrect enrollment|1|||
163400730|NCT00666458|590178161|FG000|Overall Study|Study specific discontinuation criteria|14|||
163400731|NCT00666458|590178162|FG001|Overall Study|Study specific discontinuation criteria|7|||
163400732|NCT00666458|590178161|FG000|Overall Study|Severe non-compliance to the protocol|1|||
163400733|NCT00666458|590178162|FG001|Overall Study|Severe non-compliance to the protocol|1|||
163400734|NCT00666458|590178161|FG000|Overall Study|Safety reasons|1|||
163400735|NCT00666458|590178162|FG001|Overall Study|Safety reasons|0|||
163400736|NCT00666458|590178161|FG000|Overall Study|Medical history of anemia|1|||
163400737|NCT00666458|590178162|FG001|Overall Study|Medical history of anemia|0|||
163400738|NCT01999465|590178163|FG000|Overall Study|Lost to Follow-up|0|||
163400739|NCT01999465|590178164|FG001|Overall Study|Lost to Follow-up|2|||
163400740|NCT01999465|590178163|FG000|Overall Study|Protocol Violation|0|||
163400741|NCT01999465|590178164|FG001|Overall Study|Protocol Violation|1|||
163400742|NCT02554019|590178165|FG000|Overall Study|Withdrawal by Subject|1|||
163400743|NCT02554019|590178166|FG001|Overall Study|Withdrawal by Subject|0|||
163400744|NCT02554019|590178167|FG002|Overall Study|Withdrawal by Subject|2|||
163400745|NCT02554019|590178165|FG000|Overall Study|Adverse Event|1|||
163400746|NCT02554019|590178166|FG001|Overall Study|Adverse Event|0|||
163400747|NCT02554019|590178167|FG002|Overall Study|Adverse Event|0|||
163400748|NCT00390546|590178168|FG000|Overall Study|Renal impairment|1|||
163400749|NCT00390546|590178169|FG001|Overall Study|Renal impairment|0|||
163400750|NCT00390546|590178168|FG000|Overall Study|Physician Decision|5|||
163400751|NCT00390546|590178169|FG001|Overall Study|Physician Decision|5|||
163400752|NCT02463409|590178170|FG000|Overall Study|Withdrawal by Subject|1|||
163400753|NCT02463409|590178170|FG000|Overall Study|Screen failure|1|||
163400754|NCT01308008|590178171|FG000|4 Weeks|Illness, disinterest, time|9|||
163400755|NCT01308008|590178172|FG001|4 Weeks|Illness, disinterest, time|2|||
163400756|NCT02325219|590178173|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
163400757|NCT02325219|590178174|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
163400758|NCT02325219|590178175|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
163400759|NCT02325219|590178176|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
163400760|NCT02325219|590178177|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
163400761|NCT02325219|590178173|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
163400762|NCT02325219|590178174|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
163400763|NCT02325219|590178175|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163400764|NCT02325219|590178176|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163400765|NCT02325219|590178177|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163400766|NCT02325219|590178173|FG000|Controlled Period (Week 0 - 16)|Other|0|||
163400767|NCT02325219|590178174|FG001|Controlled Period (Week 0 - 16)|Other|0|||
163400768|NCT02325219|590178175|FG002|Controlled Period (Week 0 - 16)|Other|1|||
163400769|NCT02325219|590178176|FG003|Controlled Period (Week 0 - 16)|Other|0|||
163400770|NCT02325219|590178177|FG004|Controlled Period (Week 0 - 16)|Other|0|||
163400771|NCT02325219|590178173|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
163400772|NCT02325219|590178174|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
163400773|NCT02325219|590178175|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
163400774|NCT02325219|590178176|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
163400775|NCT02325219|590178177|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
163400776|NCT02325219|590178173|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
163400777|NCT02325219|590178174|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
163400778|NCT02325219|590178175|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
163400779|NCT02325219|590178176|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
163400780|NCT02325219|590178177|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
163400781|NCT02325219|590178173|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
163400782|NCT02325219|590178174|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
163400783|NCT02325219|590178175|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
163400784|NCT02325219|590178176|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
163400785|NCT02325219|590178177|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
163400786|NCT02187172|590178178|FG000|Overall Study|Lost to Follow-up|1|||
163400787|NCT02187172|590178179|FG001|Overall Study|Lost to Follow-up|2|||
163400788|NCT02187172|590178178|FG000|Overall Study|Lack of Efficacy|1|||
163400789|NCT02187172|590178179|FG001|Overall Study|Lack of Efficacy|2|||
163400790|NCT02187172|590178178|FG000|Overall Study|Adverse Event|0|||
163400791|NCT02187172|590178179|FG001|Overall Study|Adverse Event|1|||
163400792|NCT02187172|590178178|FG000|Overall Study|Physician Decision|1|||
163400793|NCT02187172|590178179|FG001|Overall Study|Physician Decision|1|||
163400794|NCT00880399|590178180|FG000|Overall Study|Adverse Event|4|||
163400795|NCT00880399|590178181|FG001|Overall Study|Adverse Event|6|||
163400796|NCT00880399|590178182|FG002|Overall Study|Adverse Event|5|||
163400797|NCT00880399|590178180|FG000|Overall Study|Lack of Efficacy|1|||
163400798|NCT00880399|590178181|FG001|Overall Study|Lack of Efficacy|4|||
163400799|NCT00880399|590178182|FG002|Overall Study|Lack of Efficacy|2|||
163400800|NCT00880399|590178180|FG000|Overall Study|Protocol Violation|4|||
163400801|NCT00880399|590178181|FG001|Overall Study|Protocol Violation|4|||
163400802|NCT00880399|590178182|FG002|Overall Study|Protocol Violation|6|||
163400803|NCT00880399|590178180|FG000|Overall Study|Study closed/terminated|3|||
163400804|NCT00880399|590178181|FG001|Overall Study|Study closed/terminated|7|||
163400805|NCT00880399|590178182|FG002|Overall Study|Study closed/terminated|4|||
163400806|NCT00880399|590178180|FG000|Overall Study|Lost to Follow-up|8|||
163400807|NCT00880399|590178181|FG001|Overall Study|Lost to Follow-up|5|||
163400808|NCT00880399|590178182|FG002|Overall Study|Lost to Follow-up|3|||
163400809|NCT00880399|590178180|FG000|Overall Study|Physician Decision|5|||
163400810|NCT00880399|590178181|FG001|Overall Study|Physician Decision|0|||
163400811|NCT00880399|590178182|FG002|Overall Study|Physician Decision|3|||
163400812|NCT00880399|590178180|FG000|Overall Study|Withdrawal by Subject|6|||
163400813|NCT00880399|590178181|FG001|Overall Study|Withdrawal by Subject|3|||
163400814|NCT00880399|590178182|FG002|Overall Study|Withdrawal by Subject|3|||
163400815|NCT02181816|590178187|FG000|Overall Study|Case Report Forms Uncollected|38|||
163400816|NCT02181816|590178187|FG000|Overall Study|Protocol Deviation|21|||
163400817|NCT00909181|590178188|FG000|Overall Study|Lost to Follow-up|39|||
163400818|NCT00909181|590178189|FG001|Overall Study|Lost to Follow-up|18|||
163400819|NCT00909181|590178190|FG002|Overall Study|Lost to Follow-up|33|||
163400820|NCT02830880|590178191|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
163400821|NCT02830880|590178191|FG000|Overall Study|Death|1|||
163400822|NCT02830880|590178191|FG000|Overall Study|Physician Decision|1|||
163400823|NCT02349048|590178196|FG000|Overall Study|Withdrawal by Subject|4|||
163400824|NCT02349048|590178197|FG001|Overall Study|Withdrawal by Subject|0|||
163400825|NCT02349048|590178196|FG000|Overall Study|Lost to Follow-up|1|||
163400826|NCT02349048|590178197|FG001|Overall Study|Lost to Follow-up|0|||
163400827|NCT01648790|590178208|FG000|Treatment 3|Withdrawal by Subject|0|||
163400828|NCT01648790|590178209|FG001|Treatment 3|Withdrawal by Subject|0|||
163400829|NCT01648790|590178210|FG002|Treatment 3|Withdrawal by Subject|0|||
163400830|NCT01648790|590178211|FG003|Treatment 3|Withdrawal by Subject|1|||
163400831|NCT01648790|590178212|FG004|Treatment 3|Withdrawal by Subject|0|||
163400832|NCT02969187|590178213|FG000|Overall Study|Physician Decision|12|||
163400833|NCT02969187|590178214|FG001|Overall Study|Physician Decision|13|||
163400834|NCT01278745|590178218|FG000|Overall Study|Death|2|||
163400835|NCT01278745|590178219|FG001|Overall Study|Death|5|||
163400836|NCT01278745|590178220|FG002|Overall Study|Death|7|||
163400837|NCT01278745|590178221|FG003|Overall Study|Death|0|||
163400838|NCT01278745|590178218|FG000|Overall Study|Physician Decision|1|||
163400839|NCT01278745|590178219|FG001|Overall Study|Physician Decision|0|||
163400840|NCT01278745|590178220|FG002|Overall Study|Physician Decision|0|||
163400841|NCT01278745|590178221|FG003|Overall Study|Physician Decision|9|||
163400842|NCT01278745|590178218|FG000|Overall Study|Withdrawal by Subject|1|||
163400843|NCT01278745|590178219|FG001|Overall Study|Withdrawal by Subject|1|||
163400844|NCT01278745|590178220|FG002|Overall Study|Withdrawal by Subject|5|||
163400845|NCT01278745|590178221|FG003|Overall Study|Withdrawal by Subject|1|||
163400846|NCT01278745|590178218|FG000|Overall Study|Sponsor Decision|1|||
163400847|NCT01278745|590178219|FG001|Overall Study|Sponsor Decision|0|||
163400848|NCT01278745|590178220|FG002|Overall Study|Sponsor Decision|62|||
163400849|NCT01278745|590178221|FG003|Overall Study|Sponsor Decision|6|||
163400850|NCT01278745|590178218|FG000|Overall Study|Ineligible|0|||
163400851|NCT01278745|590178219|FG001|Overall Study|Ineligible|0|||
162970038|NCT00108082|588591948|FG001|Overall Study|Site Closed Study|2|||
162970039|NCT00108082|588591949|FG002|Overall Study|Site Closed Study|0|||
162970040|NCT00108082|588591947|FG000|Overall Study|Protocol Amendment|0|||
162970041|NCT00108082|588591948|FG001|Overall Study|Protocol Amendment|1|||
162970042|NCT00108082|588591949|FG002|Overall Study|Protocol Amendment|0|||
162970043|NCT00108082|588591947|FG000|Overall Study|Study Medication Not Tapered|0|||
163400852|NCT01278745|590178220|FG002|Overall Study|Ineligible|42|||
163400853|NCT01278745|590178221|FG003|Overall Study|Ineligible|61|||
163400854|NCT01278745|590178218|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
163400855|NCT01278745|590178219|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
163400856|NCT01278745|590178220|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
163400857|NCT01278745|590178221|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
163400858|NCT01376778|590178222|FG000|Overall Study|Lost to Follow-up|3|||
163400859|NCT01376778|590178223|FG001|Overall Study|Lost to Follow-up|2|||
163400860|NCT03374189|590178224|FG000|Overall Study|Lost to Follow-up|1|||
163400861|NCT03374189|590178225|FG001|Overall Study|Lost to Follow-up|0|||
163400862|NCT03201458|590178226|FG000|Overall Study|No longer eligible|2|||
163400863|NCT03201458|590178227|FG001|Overall Study|No longer eligible|5|||
163400864|NCT03201458|590178226|FG000|Overall Study|Health event before starting|1|||
162970044|NCT00108082|588591948|FG001|Overall Study|Study Medication Not Tapered|1|||
162970045|NCT00108082|588591949|FG002|Overall Study|Study Medication Not Tapered|0|||
162970046|NCT00108082|588591947|FG000|Overall Study|Subject Left Site Location|1|||
162970047|NCT00108082|588591948|FG001|Overall Study|Subject Left Site Location|0|||
162970048|NCT00108082|588591949|FG002|Overall Study|Subject Left Site Location|0|||
162970049|NCT00108082|588591947|FG000|Overall Study|Investigator Not at Site|1|||
162970050|NCT00108082|588591948|FG001|Overall Study|Investigator Not at Site|0|||
162970051|NCT00108082|588591949|FG002|Overall Study|Investigator Not at Site|0|||
162970052|NCT00108082|588591947|FG000|Overall Study|Blood Pressure Not Controlled|1|||
162970053|NCT00108082|588591948|FG001|Overall Study|Blood Pressure Not Controlled|0|||
162970054|NCT00108082|588591949|FG002|Overall Study|Blood Pressure Not Controlled|0|||
162970055|NCT01091103|588591953|FG000|Overall Study|Adverse Event|1|||
162970056|NCT01091103|588591953|FG000|Overall Study|Progressive Disease|3|||
162970057|NCT02780167|588591954|FG000|Overall Study|Adverse Event|9|||
162970058|NCT02780167|588591955|FG001|Overall Study|Adverse Event|8|||
162970059|NCT02780167|588591956|FG002|Overall Study|Adverse Event|8|||
162970060|NCT02780167|588591957|FG003|Overall Study|Adverse Event|12|||
162970061|NCT02780167|588591958|FG004|Overall Study|Adverse Event|8|||
162970062|NCT02780167|588591954|FG000|Overall Study|Lack of Efficacy|6|||
162970063|NCT02780167|588591955|FG001|Overall Study|Lack of Efficacy|5|||
162970064|NCT02780167|588591956|FG002|Overall Study|Lack of Efficacy|6|||
162970065|NCT02780167|588591957|FG003|Overall Study|Lack of Efficacy|1|||
162970066|NCT02780167|588591958|FG004|Overall Study|Lack of Efficacy|0|||
162970067|NCT02780167|588591954|FG000|Overall Study|Lost to Follow-up|2|||
162970068|NCT02780167|588591955|FG001|Overall Study|Lost to Follow-up|0|||
162970069|NCT02780167|588591956|FG002|Overall Study|Lost to Follow-up|1|||
162970070|NCT02780167|588591957|FG003|Overall Study|Lost to Follow-up|0|||
163208958|NCT02320149|589478704|FG000|Overall Study|Noncompliance with Study Treatment|7|||
163208959|NCT02320149|589478705|FG001|Overall Study|Noncompliance with Study Treatment|2|||
162970071|NCT02780167|588591958|FG004|Overall Study|Lost to Follow-up|0|||
162970072|NCT02780167|588591954|FG000|Overall Study|Does not meet entrance criteria|0|||
163208960|NCT02320149|589478704|FG000|Overall Study|Lack of Efficacy|0|||
163400865|NCT03201458|590178227|FG001|Overall Study|Health event before starting|0|||
163400866|NCT03201458|590178226|FG000|Overall Study|Physician Decision|1|||
163400867|NCT03201458|590178227|FG001|Overall Study|Physician Decision|0|||
163400868|NCT00715026|590178228|FG000|Overall Study|Withdrawal by Subject|5|||
163208961|NCT02320149|589478705|FG001|Overall Study|Lack of Efficacy|1|||
163400869|NCT00715026|590178228|FG000|Overall Study|Lost to Follow-up|3|||
162970073|NCT02780167|588591955|FG001|Overall Study|Does not meet entrance criteria|0|||
162970074|NCT02780167|588591956|FG002|Overall Study|Does not meet entrance criteria|1|||
163400870|NCT00715026|590178228|FG000|Overall Study|Protocol Violation|1|||
162970075|NCT02780167|588591957|FG003|Overall Study|Does not meet entrance criteria|0|||
163400871|NCT00715026|590178228|FG000|Overall Study|Surgery done on non-study consented hip|1|||
163400872|NCT00750737|590178230|FG000|Overall Study|Withdrawal by Subject|3|||
163400873|NCT00750737|590178231|FG001|Overall Study|Withdrawal by Subject|3|||
163400874|NCT00916149|590178232|FG000|Overall Study|Lost to Follow-up|3|||
163400875|NCT00916149|590178233|FG001|Overall Study|Lost to Follow-up|2|||
163400876|NCT00916149|590178234|FG002|Overall Study|Lost to Follow-up|0|||
163400877|NCT00916149|590178232|FG000|Overall Study|Unable to place scalp EEG leads|1|||
163400878|NCT00916149|590178233|FG001|Overall Study|Unable to place scalp EEG leads|0|||
163400879|NCT00916149|590178234|FG002|Overall Study|Unable to place scalp EEG leads|0|||
163400880|NCT00978029|590178235|FG000|Overall Study|Adverse Event|1|||
163400881|NCT00978029|590178236|FG001|Overall Study|Adverse Event|2|||
163400882|NCT00978029|590178237|FG002|Overall Study|Adverse Event|5|||
163400883|NCT00978029|590178235|FG000|Overall Study|Withdrawal by Subject|0|||
163400884|NCT00978029|590178236|FG001|Overall Study|Withdrawal by Subject|0|||
163400885|NCT00978029|590178237|FG002|Overall Study|Withdrawal by Subject|1|||
162970076|NCT02780167|588591958|FG004|Overall Study|Does not meet entrance criteria|0|||
162970077|NCT02780167|588591954|FG000|Overall Study|No longer meets eligibility criteria|0|||
162970078|NCT02780167|588591955|FG001|Overall Study|No longer meets eligibility criteria|0|||
162970079|NCT02780167|588591956|FG002|Overall Study|No longer meets eligibility criteria|0|||
162970080|NCT02780167|588591957|FG003|Overall Study|No longer meets eligibility criteria|1|||
162970081|NCT02780167|588591958|FG004|Overall Study|No longer meets eligibility criteria|1|||
162970082|NCT02780167|588591954|FG000|Overall Study|Protocol Violation|5|||
162970083|NCT02780167|588591955|FG001|Overall Study|Protocol Violation|5|||
162970084|NCT02780167|588591956|FG002|Overall Study|Protocol Violation|1|||
162970085|NCT02780167|588591957|FG003|Overall Study|Protocol Violation|1|||
162970086|NCT02780167|588591958|FG004|Overall Study|Protocol Violation|2|||
162970087|NCT02780167|588591954|FG000|Overall Study|Withdrawal by Subject|6|||
162970088|NCT02780167|588591955|FG001|Overall Study|Withdrawal by Subject|4|||
162970089|NCT02780167|588591956|FG002|Overall Study|Withdrawal by Subject|4|||
162970090|NCT02780167|588591957|FG003|Overall Study|Withdrawal by Subject|3|||
162970091|NCT02780167|588591958|FG004|Overall Study|Withdrawal by Subject|4|||
162970092|NCT02780167|588591954|FG000|Overall Study|Other|0|||
162970093|NCT02780167|588591955|FG001|Overall Study|Other|0|||
162970094|NCT02780167|588591956|FG002|Overall Study|Other|3|||
162970095|NCT02780167|588591957|FG003|Overall Study|Other|1|||
162970096|NCT02780167|588591958|FG004|Overall Study|Other|2|||
162970097|NCT02315066|588591960|FG000|Overall Study|Lost to Follow-up|0|||
162970098|NCT02315066|588591961|FG001|Overall Study|Lost to Follow-up|1|||
162970099|NCT02315066|588591962|FG002|Overall Study|Lost to Follow-up|1|||
162970100|NCT02315066|588591963|FG003|Overall Study|Lost to Follow-up|0|||
162970101|NCT02315066|588591964|FG004|Overall Study|Lost to Follow-up|1|||
162970102|NCT02315066|588591965|FG005|Overall Study|Lost to Follow-up|0|||
162970103|NCT02315066|588591966|FG006|Overall Study|Lost to Follow-up|2|||
162970104|NCT02315066|588591967|FG007|Overall Study|Lost to Follow-up|1|||
162970105|NCT02315066|588591968|FG008|Overall Study|Lost to Follow-up|0|||
162970106|NCT02315066|588591969|FG009|Overall Study|Lost to Follow-up|0|||
162970107|NCT02315066|588591970|FG010|Overall Study|Lost to Follow-up|1|||
162970108|NCT02315066|588591971|FG011|Overall Study|Lost to Follow-up|2|||
162970109|NCT02315066|588591972|FG012|Overall Study|Lost to Follow-up|0|||
162970110|NCT02315066|588591973|FG013|Overall Study|Lost to Follow-up|4|||
162970111|NCT02315066|588591960|FG000|Overall Study|Death|2|||
162970112|NCT02315066|588591961|FG001|Overall Study|Death|7|||
162970113|NCT02315066|588591962|FG002|Overall Study|Death|6|||
162970114|NCT02315066|588591963|FG003|Overall Study|Death|11|||
162970115|NCT02315066|588591964|FG004|Overall Study|Death|10|||
162970116|NCT02315066|588591965|FG005|Overall Study|Death|3|||
162970117|NCT02315066|588591966|FG006|Overall Study|Death|9|||
162970118|NCT02315066|588591967|FG007|Overall Study|Death|9|||
162970119|NCT02315066|588591968|FG008|Overall Study|Death|10|||
162970120|NCT02315066|588591969|FG009|Overall Study|Death|8|||
162970121|NCT02315066|588591970|FG010|Overall Study|Death|10|||
162970122|NCT02315066|588591971|FG011|Overall Study|Death|7|||
162970123|NCT02315066|588591972|FG012|Overall Study|Death|8|||
162970124|NCT02315066|588591973|FG013|Overall Study|Death|21|||
162970125|NCT02315066|588591960|FG000|Overall Study|Other|0|||
162970126|NCT02315066|588591961|FG001|Overall Study|Other|0|||
162970127|NCT02315066|588591962|FG002|Overall Study|Other|0|||
162970128|NCT02315066|588591963|FG003|Overall Study|Other|0|||
162970129|NCT02315066|588591964|FG004|Overall Study|Other|0|||
162970130|NCT02315066|588591965|FG005|Overall Study|Other|0|||
162970131|NCT02315066|588591966|FG006|Overall Study|Other|0|||
162970132|NCT02315066|588591967|FG007|Overall Study|Other|1|||
162970133|NCT02315066|588591968|FG008|Overall Study|Other|1|||
162970134|NCT02315066|588591969|FG009|Overall Study|Other|2|||
162970135|NCT02315066|588591970|FG010|Overall Study|Other|0|||
162970136|NCT02315066|588591971|FG011|Overall Study|Other|0|||
163400886|NCT00978029|590178235|FG000|Overall Study|Protocol Violation|0|||
162970137|NCT02315066|588591972|FG012|Overall Study|Other|0|||
162970138|NCT02315066|588591973|FG013|Overall Study|Other|0|||
162970139|NCT02315066|588591960|FG000|Overall Study|Subject refused further follow-up|0|||
163400887|NCT00978029|590178236|FG001|Overall Study|Protocol Violation|1|||
163056028|NCT01516216|588918319|FG001|Overall Study|Intercurrent Illness|0|||
163056029|NCT01516216|588918318|FG000|Overall Study|Death|1|||
163056030|NCT01516216|588918319|FG001|Overall Study|Death|1|||
163056031|NCT03098979|588918320|FG000|Overall Study|Adverse Event|1|||
163056032|NCT03098979|588918321|FG001|Overall Study|Adverse Event|0|||
163056033|NCT03098979|588918322|FG002|Overall Study|Adverse Event|1|||
163056034|NCT03098979|588918323|FG003|Overall Study|Adverse Event|4|||
163056035|NCT03098979|588918324|FG004|Overall Study|Adverse Event|6|||
163056036|NCT03098979|588918325|FG005|Overall Study|Adverse Event|1|||
163056037|NCT03098979|588918320|FG000|Overall Study|Withdrawal by Subject|2|||
163056038|NCT03098979|588918321|FG001|Overall Study|Withdrawal by Subject|1|||
163056039|NCT03098979|588918322|FG002|Overall Study|Withdrawal by Subject|1|||
163056040|NCT03098979|588918323|FG003|Overall Study|Withdrawal by Subject|1|||
163056041|NCT03098979|588918324|FG004|Overall Study|Withdrawal by Subject|2|||
163056042|NCT03098979|588918325|FG005|Overall Study|Withdrawal by Subject|1|||
163056043|NCT03098979|588918320|FG000|Overall Study|Death|1|||
163056044|NCT03098979|588918321|FG001|Overall Study|Death|0|||
163056045|NCT03098979|588918322|FG002|Overall Study|Death|2|||
163056046|NCT03098979|588918323|FG003|Overall Study|Death|0|||
163056047|NCT03098979|588918324|FG004|Overall Study|Death|1|||
163056048|NCT03098979|588918325|FG005|Overall Study|Death|0|||
163056049|NCT03098979|588918320|FG000|Overall Study|Physician Decision|2|||
163056050|NCT03098979|588918321|FG001|Overall Study|Physician Decision|1|||
163056051|NCT03098979|588918322|FG002|Overall Study|Physician Decision|0|||
163056052|NCT03098979|588918323|FG003|Overall Study|Physician Decision|0|||
163317473|NCT03088878|589873216|FG011|Overall Study|Completed 2 years of Treatment|0|||
163056053|NCT03098979|588918324|FG004|Overall Study|Physician Decision|0|||
163056054|NCT03098979|588918325|FG005|Overall Study|Physician Decision|0|||
163056055|NCT03098979|588918320|FG000|Overall Study|Non-compliance|0|||
163056056|NCT03098979|588918321|FG001|Overall Study|Non-compliance|0|||
163056057|NCT03098979|588918322|FG002|Overall Study|Non-compliance|0|||
163056058|NCT03098979|588918323|FG003|Overall Study|Non-compliance|0|||
163056059|NCT03098979|588918324|FG004|Overall Study|Non-compliance|0|||
163056060|NCT03098979|588918325|FG005|Overall Study|Non-compliance|1|||
163056061|NCT03098979|588918320|FG000|Overall Study|Protocol Violation|0|||
163056062|NCT03098979|588918321|FG001|Overall Study|Protocol Violation|0|||
163056063|NCT03098979|588918322|FG002|Overall Study|Protocol Violation|0|||
163056064|NCT03098979|588918323|FG003|Overall Study|Protocol Violation|0|||
163056065|NCT03098979|588918324|FG004|Overall Study|Protocol Violation|0|||
163056066|NCT03098979|588918325|FG005|Overall Study|Protocol Violation|1|||
163056067|NCT01715298|588918326|FG000|Overall Study|Lost to Follow-up|0|||
163317474|NCT03088878|589873217|FG012|Overall Study|Completed 2 years of Treatment|8|||
163317475|NCT03088878|589873218|FG013|Overall Study|Completed 2 years of Treatment|3|||
163317476|NCT03088878|589873205|FG000|Overall Study|Physician Decision|0|||
163317477|NCT03088878|589873206|FG001|Overall Study|Physician Decision|0|||
163317478|NCT03088878|589873207|FG002|Overall Study|Physician Decision|0|||
163317479|NCT03088878|589873208|FG003|Overall Study|Physician Decision|0|||
163317480|NCT03088878|589873209|FG004|Overall Study|Physician Decision|0|||
163317481|NCT03088878|589873210|FG005|Overall Study|Physician Decision|0|||
163317482|NCT03088878|589873211|FG006|Overall Study|Physician Decision|0|||
163317483|NCT03088878|589873212|FG007|Overall Study|Physician Decision|2|||
163317484|NCT03088878|589873213|FG008|Overall Study|Physician Decision|1|||
163317485|NCT03088878|589873214|FG009|Overall Study|Physician Decision|0|||
163317486|NCT03088878|589873215|FG010|Overall Study|Physician Decision|0|||
163317487|NCT03088878|589873216|FG011|Overall Study|Physician Decision|0|||
163317488|NCT03088878|589873217|FG012|Overall Study|Physician Decision|0|||
163317489|NCT03088878|589873218|FG013|Overall Study|Physician Decision|1|||
163317490|NCT03088878|589873205|FG000|Overall Study|COVID Related noncompliance|0|||
163317491|NCT03088878|589873206|FG001|Overall Study|COVID Related noncompliance|0|||
163317492|NCT03088878|589873207|FG002|Overall Study|COVID Related noncompliance|0|||
163317493|NCT03088878|589873208|FG003|Overall Study|COVID Related noncompliance|0|||
163317494|NCT03088878|589873209|FG004|Overall Study|COVID Related noncompliance|0|||
163317495|NCT03088878|589873210|FG005|Overall Study|COVID Related noncompliance|0|||
163317496|NCT03088878|589873211|FG006|Overall Study|COVID Related noncompliance|0|||
163317497|NCT03088878|589873212|FG007|Overall Study|COVID Related noncompliance|0|||
163317498|NCT03088878|589873213|FG008|Overall Study|COVID Related noncompliance|0|||
163317499|NCT03088878|589873214|FG009|Overall Study|COVID Related noncompliance|0|||
163056068|NCT01715298|588918327|FG001|Overall Study|Lost to Follow-up|2|||
163317500|NCT03088878|589873215|FG010|Overall Study|COVID Related noncompliance|0|||
163317501|NCT03088878|589873216|FG011|Overall Study|COVID Related noncompliance|0|||
163056069|NCT01715298|588918326|FG000|Overall Study|Patient/guardian decision|7|||
163056070|NCT01715298|588918327|FG001|Overall Study|Patient/guardian decision|9|||
163056071|NCT02419807|588918328|FG000|Overall Study|Withdrawal by Subject|4|||
163056072|NCT02419807|588918328|FG000|Overall Study|Physician Decision|1|||
163056073|NCT02419807|588918328|FG000|Overall Study|Protocol Violation|5|||
163056074|NCT01499511|588918331|FG000|Overall Study|Death|1|||
163056075|NCT01499511|588918332|FG001|Overall Study|Death|0|||
163056076|NCT01006629|588918333|FG000|Overall Study|Adverse Event|1|||
163056077|NCT01006629|588918333|FG000|Overall Study|Parent refused to continue participation|1|||
163400888|NCT00978029|590178237|FG002|Overall Study|Protocol Violation|0|||
162970140|NCT02315066|588591961|FG001|Overall Study|Subject refused further follow-up|2|||
162970141|NCT02315066|588591962|FG002|Overall Study|Subject refused further follow-up|2|||
162970142|NCT02315066|588591963|FG003|Overall Study|Subject refused further follow-up|0|||
162970143|NCT02315066|588591964|FG004|Overall Study|Subject refused further follow-up|0|||
162970144|NCT02315066|588591965|FG005|Overall Study|Subject refused further follow-up|0|||
162970145|NCT02315066|588591966|FG006|Overall Study|Subject refused further follow-up|2|||
162970146|NCT02315066|588591967|FG007|Overall Study|Subject refused further follow-up|3|||
162970147|NCT02315066|588591968|FG008|Overall Study|Subject refused further follow-up|0|||
162970148|NCT02315066|588591969|FG009|Overall Study|Subject refused further follow-up|1|||
162970149|NCT02315066|588591970|FG010|Overall Study|Subject refused further follow-up|1|||
162970150|NCT02315066|588591971|FG011|Overall Study|Subject refused further follow-up|2|||
162970151|NCT02315066|588591972|FG012|Overall Study|Subject refused further follow-up|2|||
162970152|NCT02315066|588591973|FG013|Overall Study|Subject refused further follow-up|4|||
162970153|NCT02315066|588591960|FG000|Overall Study|Study ongoing at date of cut-off|0|||
162970154|NCT02315066|588591961|FG001|Overall Study|Study ongoing at date of cut-off|0|||
162970155|NCT02315066|588591962|FG002|Overall Study|Study ongoing at date of cut-off|0|||
163056078|NCT01006629|588918333|FG000|Overall Study|Parent unable to perform site visit|4|||
163056079|NCT00998946|588918335|FG000|Overall Study|Lost to Follow-up|1|||
163317502|NCT03088878|589873217|FG012|Overall Study|COVID Related noncompliance|0|||
163317503|NCT03088878|589873218|FG013|Overall Study|COVID Related noncompliance|1|||
163317504|NCT03088878|589873205|FG000|Overall Study|Drug or Study Noncompliance|0|||
163317505|NCT03088878|589873206|FG001|Overall Study|Drug or Study Noncompliance|0|||
163317506|NCT03088878|589873207|FG002|Overall Study|Drug or Study Noncompliance|0|||
163056080|NCT00998946|588918335|FG000|Overall Study|Withdrawal by Subject|1|||
163056081|NCT00998946|588918335|FG000|Overall Study|Death|2|||
163056082|NCT00998946|588918335|FG000|Overall Study|Reason Unspecified|3|||
163056083|NCT00998946|588918335|FG000|Overall Study|Enrolled but not Dosed|2|||
163056084|NCT01065818|588918337|FG000|Overall Study|Withdrawal by Subject|1|||
163056085|NCT01065818|588918337|FG000|Overall Study|Not a candidate for surgery|1|||
163056086|NCT04459338|588918338|FG000|Overall Study|Loss of IV during study|1|||
163208962|NCT02320149|589478704|FG000|Overall Study|Other Miscellaneous Reasons|2|||
163208963|NCT02320149|589478705|FG001|Overall Study|Other Miscellaneous Reasons|3|||
163208964|NCT00276159|589478706|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
163208965|NCT00333866|589478709|FG000|Overall Study|Adverse Event|23|||
163208966|NCT00333866|589478710|FG001|Overall Study|Adverse Event|37|||
163208967|NCT00333866|589478711|FG002|Overall Study|Adverse Event|38|||
163208968|NCT00333866|589478712|FG003|Overall Study|Adverse Event|47|||
163208969|NCT00333866|589478709|FG000|Overall Study|Other|3|||
163208970|NCT00333866|589478710|FG001|Overall Study|Other|2|||
163208971|NCT00333866|589478711|FG002|Overall Study|Other|2|||
163208972|NCT00333866|589478712|FG003|Overall Study|Other|2|||
163208973|NCT00333866|589478709|FG000|Overall Study|Lack of Efficacy|8|||
163208974|NCT00333866|589478710|FG001|Overall Study|Lack of Efficacy|6|||
163208975|NCT00333866|589478711|FG002|Overall Study|Lack of Efficacy|3|||
163208976|NCT00333866|589478712|FG003|Overall Study|Lack of Efficacy|5|||
163208977|NCT00333866|589478709|FG000|Overall Study|Lost to Follow-up|1|||
163208978|NCT00333866|589478710|FG001|Overall Study|Lost to Follow-up|2|||
163208979|NCT00333866|589478711|FG002|Overall Study|Lost to Follow-up|2|||
163208980|NCT00333866|589478712|FG003|Overall Study|Lost to Follow-up|2|||
163208981|NCT00333866|589478709|FG000|Overall Study|Withdrawal by Subject|8|||
163208982|NCT00333866|589478710|FG001|Overall Study|Withdrawal by Subject|14|||
163208983|NCT00333866|589478711|FG002|Overall Study|Withdrawal by Subject|4|||
163208984|NCT00333866|589478712|FG003|Overall Study|Withdrawal by Subject|9|||
163208985|NCT00333866|589478709|FG000|Overall Study|Randomized but not Treated|5|||
163208986|NCT00333866|589478710|FG001|Overall Study|Randomized but not Treated|3|||
163208987|NCT00333866|589478711|FG002|Overall Study|Randomized but not Treated|2|||
163208988|NCT00333866|589478712|FG003|Overall Study|Randomized but not Treated|1|||
163208989|NCT06073119|589478713|FG000|Overall Study|Adverse Event|1|||
163208990|NCT06073119|589478714|FG001|Overall Study|Adverse Event|3|||
163208991|NCT06073119|589478715|FG002|Overall Study|Adverse Event|0|||
163208992|NCT06073119|589478716|FG003|Overall Study|Adverse Event|0|||
163208993|NCT06073119|589478717|FG004|Overall Study|Adverse Event|1|||
163208994|NCT06073119|589478718|FG005|Overall Study|Adverse Event|0|||
163208995|NCT06073119|589478713|FG000|Overall Study|Non-compliance with study schedule|1|||
163208996|NCT06073119|589478714|FG001|Overall Study|Non-compliance with study schedule|0|||
163208997|NCT06073119|589478715|FG002|Overall Study|Non-compliance with study schedule|0|||
163208998|NCT06073119|589478716|FG003|Overall Study|Non-compliance with study schedule|0|||
163208999|NCT06073119|589478717|FG004|Overall Study|Non-compliance with study schedule|1|||
163317507|NCT03088878|589873208|FG003|Overall Study|Drug or Study Noncompliance|0|||
163317508|NCT03088878|589873209|FG004|Overall Study|Drug or Study Noncompliance|0|||
163317509|NCT03088878|589873210|FG005|Overall Study|Drug or Study Noncompliance|0|||
163317510|NCT03088878|589873211|FG006|Overall Study|Drug or Study Noncompliance|0|||
163317511|NCT03088878|589873212|FG007|Overall Study|Drug or Study Noncompliance|0|||
163317512|NCT03088878|589873213|FG008|Overall Study|Drug or Study Noncompliance|0|||
163317513|NCT03088878|589873214|FG009|Overall Study|Drug or Study Noncompliance|0|||
163317514|NCT03088878|589873215|FG010|Overall Study|Drug or Study Noncompliance|0|||
163317515|NCT03088878|589873216|FG011|Overall Study|Drug or Study Noncompliance|0|||
163317516|NCT03088878|589873217|FG012|Overall Study|Drug or Study Noncompliance|1|||
163317517|NCT03088878|589873218|FG013|Overall Study|Drug or Study Noncompliance|0|||
163317518|NCT04690582|589873224|FG000|Overall Study|Withdrawal by Subject|6|||
163317519|NCT04690582|589873225|FG001|Overall Study|Withdrawal by Subject|4|||
163317520|NCT05267470|589873228|FG000|Overall Study|Decision by sponsor|0|||
163317521|NCT05267470|589873229|FG001|Overall Study|Decision by sponsor|3|||
163317522|NCT05267470|589873230|FG002|Overall Study|Decision by sponsor|19|||
163317523|NCT05267470|589873231|FG003|Overall Study|Decision by sponsor|7|||
163317524|NCT05267470|589873232|FG004|Overall Study|Decision by sponsor|3|||
163317525|NCT05267470|589873228|FG000|Overall Study|Withdrawal by Subject|1|||
163317526|NCT05267470|589873229|FG001|Overall Study|Withdrawal by Subject|1|||
163317527|NCT05267470|589873230|FG002|Overall Study|Withdrawal by Subject|2|||
163317528|NCT05267470|589873231|FG003|Overall Study|Withdrawal by Subject|2|||
163317529|NCT05267470|589873232|FG004|Overall Study|Withdrawal by Subject|0|||
163317530|NCT05267470|589873228|FG000|Overall Study|Death|3|||
163317531|NCT05267470|589873229|FG001|Overall Study|Death|5|||
163317532|NCT05267470|589873230|FG002|Overall Study|Death|8|||
163317533|NCT05267470|589873231|FG003|Overall Study|Death|18|||
163317534|NCT05267470|589873232|FG004|Overall Study|Death|1|||
163317535|NCT05267470|589873228|FG000|Overall Study|Lost to Follow-up|0|||
163317536|NCT05267470|589873229|FG001|Overall Study|Lost to Follow-up|0|||
163317537|NCT05267470|589873230|FG002|Overall Study|Lost to Follow-up|0|||
163317538|NCT05267470|589873231|FG003|Overall Study|Lost to Follow-up|1|||
163317539|NCT05267470|589873232|FG004|Overall Study|Lost to Follow-up|0|||
163317540|NCT04428203|589873233|FG000|Overall Study|Adverse Event|1|||
163317541|NCT04428203|589873234|FG001|Overall Study|Adverse Event|0|||
163317542|NCT04428203|589873235|FG002|Overall Study|Adverse Event|0|||
163400889|NCT00545298|590178238|FG000|Overall Study|Issues with Standard of Care|2|||
163317543|NCT04428203|589873233|FG000|Overall Study|Withdrawal by Subject|1|||
163317544|NCT04428203|589873234|FG001|Overall Study|Withdrawal by Subject|0|||
163317545|NCT04428203|589873235|FG002|Overall Study|Withdrawal by Subject|1|||
163317546|NCT02823145|589873236|FG000|Enrollment|Other|1|||
163317547|NCT02823145|589873237|FG001|Enrollment|Other|0|||
163317548|NCT02823145|589873236|FG000|Treatment|Adverse Event|0|||
163317549|NCT02823145|589873237|FG001|Treatment|Adverse Event|11|||
163317550|NCT02823145|589873236|FG000|Treatment|Death|0|||
163317551|NCT02823145|589873237|FG001|Treatment|Death|3|||
163317552|NCT02823145|589873236|FG000|Treatment|Family Decision|0|||
163317553|NCT02823145|589873237|FG001|Treatment|Family Decision|1|||
163317554|NCT02823145|589873236|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
163317555|NCT02823145|589873237|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
163317556|NCT02823145|589873236|FG000|Treatment|Lack of Efficacy|0|||
163317557|NCT02823145|589873237|FG001|Treatment|Lack of Efficacy|48|||
163317558|NCT02823145|589873236|FG000|Treatment|Non-Compliance With E-Diary|0|||
163317559|NCT02823145|589873237|FG001|Treatment|Non-Compliance With E-Diary|1|||
163317560|NCT02823145|589873236|FG000|Treatment|Physician Decision|0|||
163317561|NCT02823145|589873237|FG001|Treatment|Physician Decision|2|||
163317562|NCT02823145|589873236|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
163317563|NCT02823145|589873237|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
163317564|NCT02823145|589873236|FG000|Treatment|Subject needed to take prohibited medication|0|||
163317565|NCT02823145|589873237|FG001|Treatment|Subject needed to take prohibited medication|1|||
163317566|NCT02823145|589873236|FG000|Treatment|Subject transferred to direct access programme|0|||
163317567|NCT02823145|589873237|FG001|Treatment|Subject transferred to direct access programme|1|||
163317568|NCT02823145|589873236|FG000|Treatment|Switching to commercially available drug|0|||
163317569|NCT02823145|589873237|FG001|Treatment|Switching to commercially available drug|11|||
163317570|NCT02823145|589873236|FG000|Treatment|Transitioned to commercial supply of medication|0|||
163317571|NCT02823145|589873237|FG001|Treatment|Transitioned to commercial supply of medication|1|||
163317572|NCT02823145|589873236|FG000|Treatment|Withdrawal By Caregiver|0|||
163317573|NCT02823145|589873237|FG001|Treatment|Withdrawal By Caregiver|1|||
163317574|NCT02823145|589873236|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
163317575|NCT02823145|589873237|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
163317576|NCT02823145|589873236|FG000|Treatment|Withdrawal by Subject|0|||
163317577|NCT02823145|589873237|FG001|Treatment|Withdrawal by Subject|16|||
163317578|NCT02823145|589873236|FG000|Treatment|Reason unknown|0|||
163317579|NCT02823145|589873237|FG001|Treatment|Reason unknown|1|||
163317580|NCT04622046|589873238|FG000|Intervention Period|Adverse Event|1|||
163317581|NCT04622046|589873238|FG000|Intervention Period|Withdrawal by Subject|2|||
163317582|NCT04622046|589873238|FG000|Extension Period|Ongoing in the Extension Period|21|||
163317583|NCT03314454|589874863|FG000|Overall Study|Protocol Violation|1|||
163317584|NCT04119843|589874864|FG000|Overall Study|Adverse Event|3|||
163317585|NCT04119843|589874864|FG000|Overall Study|Death|1|||
163317586|NCT02841579|589874873|FG000|Overall Study|Death|1|||
163317587|NCT02841579|589874873|FG000|Overall Study|Adverse Event|1|||
163317588|NCT02841579|589874873|FG000|Overall Study|Lack of Efficacy|9|||
163317589|NCT04233216|589874876|FG000|Overall Study|Lost to Follow-up|1|||
163317590|NCT04233216|589874877|FG001|Overall Study|Lost to Follow-up|0|||
163317591|NCT04233216|589874878|FG002|Overall Study|Lost to Follow-up|2|||
163317592|NCT04233216|589874879|FG003|Overall Study|Lost to Follow-up|0|||
163317593|NCT04233216|589874876|FG000|Overall Study|Physician Decision|0|||
163056087|NCT04459338|588918339|FG001|Overall Study|Loss of IV during study|0|||
163209000|NCT06073119|589478718|FG005|Overall Study|Non-compliance with study schedule|0|||
163209001|NCT06073119|589478713|FG000|Overall Study|Withdrawal by Subject|4|||
163209002|NCT06073119|589478714|FG001|Overall Study|Withdrawal by Subject|4|||
163209003|NCT06073119|589478715|FG002|Overall Study|Withdrawal by Subject|3|||
163209004|NCT06073119|589478716|FG003|Overall Study|Withdrawal by Subject|5|||
163400890|NCT00545298|590178239|FG001|Overall Study|Issues with Standard of Care|0|||
163400891|NCT00545298|590178240|FG002|Overall Study|Issues with Standard of Care|1|||
163400892|NCT05998148|590178244|FG000|Allocation|Did not attend any appointments|1|||
163400893|NCT05998148|590178245|FG001|Allocation|Did not attend any appointments|4|||
163400894|NCT05998148|590178244|FG000|Follow-Up|Lost to Follow-up|1|||
163400895|NCT05998148|590178245|FG001|Follow-Up|Lost to Follow-up|2|||
163400896|NCT05998148|590178244|FG000|Follow-Up|Change in insurance|1|||
163400897|NCT05998148|590178245|FG001|Follow-Up|Change in insurance|1|||
163400898|NCT02090413|590178247|FG000|Overall Study|Adverse Event|11|||
163400899|NCT02090413|590178248|FG001|Overall Study|Adverse Event|15|||
163400900|NCT02090413|590178249|FG002|Overall Study|Adverse Event|20|||
162970156|NCT02315066|588591963|FG003|Overall Study|Study ongoing at date of cut-off|0|||
162970157|NCT02315066|588591964|FG004|Overall Study|Study ongoing at date of cut-off|0|||
162970158|NCT02315066|588591965|FG005|Overall Study|Study ongoing at date of cut-off|0|||
162970159|NCT02315066|588591966|FG006|Overall Study|Study ongoing at date of cut-off|0|||
162970160|NCT02315066|588591967|FG007|Overall Study|Study ongoing at date of cut-off|0|||
163400901|NCT02090413|590178247|FG000|Overall Study|Flushing event|2|||
163400902|NCT02090413|590178248|FG001|Overall Study|Flushing event|0|||
163400903|NCT02090413|590178249|FG002|Overall Study|Flushing event|1|||
163400904|NCT02090413|590178247|FG000|Overall Study|Withdrawal by Subject|2|||
163400905|NCT02090413|590178248|FG001|Overall Study|Withdrawal by Subject|2|||
163400906|NCT02090413|590178249|FG002|Overall Study|Withdrawal by Subject|2|||
163400907|NCT02090413|590178247|FG000|Overall Study|Investigator Decision|1|||
163400908|NCT02090413|590178248|FG001|Overall Study|Investigator Decision|1|||
163400909|NCT02090413|590178249|FG002|Overall Study|Investigator Decision|0|||
163400910|NCT02090413|590178247|FG000|Overall Study|Other|2|||
163400911|NCT02090413|590178248|FG001|Overall Study|Other|1|||
162970161|NCT02315066|588591968|FG008|Overall Study|Study ongoing at date of cut-off|0|||
163400912|NCT02090413|590178249|FG002|Overall Study|Other|0|||
163400913|NCT02090413|590178247|FG000|Overall Study|Lost to Follow-up|1|||
163400914|NCT02090413|590178248|FG001|Overall Study|Lost to Follow-up|1|||
163400915|NCT02090413|590178249|FG002|Overall Study|Lost to Follow-up|0|||
163400916|NCT05248295|590178251|FG000|Overall Study|found ineligible|4|||
163400917|NCT05248295|590178252|FG001|Overall Study|found ineligible|1|||
163400918|NCT05248295|590178251|FG000|Overall Study|Withdrawal by Subject|0|||
163400919|NCT05248295|590178252|FG001|Overall Study|Withdrawal by Subject|1|||
163400920|NCT05248295|590178251|FG000|Overall Study|Data loss: audio recording error|1|||
163400921|NCT05248295|590178252|FG001|Overall Study|Data loss: audio recording error|1|||
163400922|NCT04490018|590178253|FG000|Overall Study|Protocol Violation|0|||
163400923|NCT04490018|590178254|FG001|Overall Study|Protocol Violation|2|||
163400924|NCT04490018|590178255|FG002|Overall Study|Protocol Violation|1|||
163400925|NCT04490018|590178253|FG000|Overall Study|Lost to Follow-up|2|||
163400926|NCT04490018|590178254|FG001|Overall Study|Lost to Follow-up|2|||
163400927|NCT04490018|590178255|FG002|Overall Study|Lost to Follow-up|0|||
163400928|NCT04490018|590178253|FG000|Overall Study|Withdrawal by Subject|2|||
163400929|NCT04490018|590178254|FG001|Overall Study|Withdrawal by Subject|1|||
163400930|NCT04490018|590178255|FG002|Overall Study|Withdrawal by Subject|0|||
163400931|NCT04490018|590178253|FG000|Overall Study|Withdrawal by parent/guardian|2|||
163400932|NCT04490018|590178254|FG001|Overall Study|Withdrawal by parent/guardian|3|||
163400933|NCT04490018|590178255|FG002|Overall Study|Withdrawal by parent/guardian|0|||
163400934|NCT03996876|590178258|FG000|Overall Study|Incomplete Data|2|||
163400935|NCT03996876|590178259|FG001|Overall Study|Incomplete Data|4|||
163400936|NCT00121108|590178260|FG000|Overall Study|Lost to Follow-up|10|||
163400937|NCT00121108|590178261|FG001|Overall Study|Lost to Follow-up|22|||
163400938|NCT00121108|590178260|FG000|Overall Study|Withdrawal by Subject|106|||
163400939|NCT00121108|590178261|FG001|Overall Study|Withdrawal by Subject|195|||
163400940|NCT00121108|590178260|FG000|Overall Study|Death|5|||
163400941|NCT00121108|590178261|FG001|Overall Study|Death|8|||
163400942|NCT01380379|590178262|FG000|Overall Study|Pregnancy|1|||
163400943|NCT00597753|590178267|FG000|Overall Study|Adverse Event|6|||
163400944|NCT00597753|590178268|FG001|Overall Study|Adverse Event|2|||
163400945|NCT00597753|590178267|FG000|Overall Study|Death|55|||
163400946|NCT00597753|590178268|FG001|Overall Study|Death|29|||
163400947|NCT00597753|590178267|FG000|Overall Study|Lack of Efficacy|2|||
163400948|NCT00597753|590178268|FG001|Overall Study|Lack of Efficacy|0|||
163400949|NCT00597753|590178267|FG000|Overall Study|Lost to Follow-up|10|||
163400950|NCT00597753|590178268|FG001|Overall Study|Lost to Follow-up|3|||
162970162|NCT02315066|588591969|FG009|Overall Study|Study ongoing at date of cut-off|0|||
162970163|NCT02315066|588591970|FG010|Overall Study|Study ongoing at date of cut-off|0|||
162970164|NCT02315066|588591971|FG011|Overall Study|Study ongoing at date of cut-off|0|||
162970165|NCT02315066|588591972|FG012|Overall Study|Study ongoing at date of cut-off|0|||
163400951|NCT00597753|590178267|FG000|Overall Study|Physician Decision|5|||
163400952|NCT00597753|590178268|FG001|Overall Study|Physician Decision|1|||
163400953|NCT00597753|590178267|FG000|Overall Study|Pregnancy|1|||
163400954|NCT00597753|590178268|FG001|Overall Study|Pregnancy|0|||
163400955|NCT00597753|590178267|FG000|Overall Study|Withdrawal by Subject|35|||
163400956|NCT00597753|590178268|FG001|Overall Study|Withdrawal by Subject|12|||
163400957|NCT00597753|590178267|FG000|Overall Study|Discontinued Dialysis|0|||
162970166|NCT02315066|588591973|FG013|Overall Study|Study ongoing at date of cut-off|1|||
162970167|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
163400958|NCT00597753|590178268|FG001|Overall Study|Discontinued Dialysis|1|||
163400959|NCT00597753|590178267|FG000|Overall Study|Never dosed|2|||
163400960|NCT00597753|590178268|FG001|Overall Study|Never dosed|0|||
163400961|NCT00597753|590178267|FG000|Overall Study|Noncompliance|2|||
163400962|NCT00597753|590178268|FG001|Overall Study|Noncompliance|1|||
163400963|NCT00597753|590178267|FG000|Overall Study|Relocation|17|||
163400964|NCT00597753|590178268|FG001|Overall Study|Relocation|6|||
163400965|NCT00597753|590178267|FG000|Overall Study|Renal transplant|10|||
162970168|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
162970169|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
162970170|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
162970171|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
162970172|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
163400966|NCT00597753|590178268|FG001|Overall Study|Renal transplant|3|||
162970173|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
163400967|NCT00597753|590178267|FG000|Overall Study|Site closed by sponsor|19|||
163400968|NCT00597753|590178268|FG001|Overall Study|Site closed by sponsor|7|||
162970174|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
162970175|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
162970176|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
162970177|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
162970178|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
162970179|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
162970180|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
162970181|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
162970182|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
162970183|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
162970184|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
162970185|NCT01067521|588591974|FG000|Open-Label Period|Death|3|||
162970186|NCT01067521|588591975|FG001|Open-Label Period|Death|1|||
162970187|NCT01067521|588591974|FG000|Open-Label Period|Adverse Event|30|||
162970188|NCT01067521|588591975|FG001|Open-Label Period|Adverse Event|28|||
162970189|NCT01067521|588591974|FG000|Open-Label Period|Withdrawal by Subject|160|||
162970190|NCT01067521|588591975|FG001|Open-Label Period|Withdrawal by Subject|88|||
162970191|NCT01067521|588591974|FG000|Open-Label Period|Physician Decision|13|||
162970192|NCT01067521|588591975|FG001|Open-Label Period|Physician Decision|11|||
162970193|NCT01067521|588591974|FG000|Open-Label Period|Non-compliance with study drug|5|||
162970194|NCT01067521|588591975|FG001|Open-Label Period|Non-compliance with study drug|0|||
162970195|NCT01067521|588591974|FG000|Open-Label Period|Protocol Violation|3|||
162970196|NCT01067521|588591975|FG001|Open-Label Period|Protocol Violation|0|||
162970197|NCT01067521|588591974|FG000|Open-Label Period|Pregnancy|14|||
162970198|NCT01067521|588591975|FG001|Open-Label Period|Pregnancy|8|||
162970199|NCT01067521|588591974|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
162970200|NCT01067521|588591975|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
162970201|NCT01067521|588591974|FG000|Open-Label Period|Lost to Follow-up|21|||
162970202|NCT01067521|588591975|FG001|Open-Label Period|Lost to Follow-up|20|||
163056088|NCT03157089|588918340|FG000|Overall Study|Treated only with pembrolizumab|1|||
163056089|NCT03157089|588918341|FG001|Overall Study|Treated only with pembrolizumab|0|||
163056090|NCT03157089|588918340|FG000|Overall Study|Adverse Event|5|||
163056091|NCT03157089|588918341|FG001|Overall Study|Adverse Event|4|||
163056092|NCT03157089|588918340|FG000|Overall Study|Progressive disease|6|||
163056093|NCT03157089|588918341|FG001|Overall Study|Progressive disease|8|||
162970203|NCT00057941|588591981|FG000|Overall Study|Death|1|||
162970204|NCT00057941|588591982|FG001|Overall Study|Death|2|||
162970205|NCT00057941|588591981|FG000|Overall Study|Adverse Event|7|||
163056094|NCT00958074|588918342|FG000|Overall Study|Withdrawal by Subject|0|||
162970206|NCT00057941|588591982|FG001|Overall Study|Adverse Event|9|||
162970207|NCT00057941|588591981|FG000|Overall Study|Lack of Efficacy|54|||
163209005|NCT06073119|589478717|FG004|Overall Study|Withdrawal by Subject|3|||
162970208|NCT00057941|588591982|FG001|Overall Study|Lack of Efficacy|53|||
162970209|NCT00057941|588591981|FG000|Overall Study|Withdrawal by Subject|6|||
162970210|NCT00057941|588591982|FG001|Overall Study|Withdrawal by Subject|1|||
162970211|NCT00057941|588591981|FG000|Overall Study|still on treatment|3|||
162970212|NCT00057941|588591982|FG001|Overall Study|still on treatment|1|||
162970213|NCT00057941|588591981|FG000|Overall Study|insurance, symptomatic deterioration|1|||
162970214|NCT00057941|588591982|FG001|Overall Study|insurance, symptomatic deterioration|3|||
162970215|NCT00057941|588591981|FG000|Overall Study|Ineligible|2|||
162970216|NCT00057941|588591982|FG001|Overall Study|Ineligible|5|||
162970217|NCT04142658|588591983|FG000|Overall Study|Death|2|||
162970218|NCT04142658|588591984|FG001|Overall Study|Death|1|||
162970219|NCT04142658|588591983|FG000|Overall Study|Lost to Follow-up|4|||
162970220|NCT04142658|588591984|FG001|Overall Study|Lost to Follow-up|13|||
162970221|NCT04142658|588591983|FG000|Overall Study|Withdrawal by Subject|9|||
162970222|NCT04142658|588591984|FG001|Overall Study|Withdrawal by Subject|16|||
162970223|NCT01781234|588591985|FG000|Overall Study|Adverse Event|2|||
162970224|NCT01781234|588591986|FG001|Overall Study|Adverse Event|0|||
162970225|NCT01781234|588591985|FG000|Overall Study|Protocol Violation|3|||
162970226|NCT01781234|588591986|FG001|Overall Study|Protocol Violation|0|||
162970227|NCT01781234|588591985|FG000|Overall Study|Withdrawal by Subject|4|||
162970228|NCT01781234|588591986|FG001|Overall Study|Withdrawal by Subject|3|||
162970229|NCT01685216|588591993|FG000|Overall Study|Did not receive study drug|1|||
162970230|NCT01294449|588591994|FG000|Overall Study|Death|11|||
162970231|NCT01294449|588591995|FG001|Overall Study|Death|12|||
162970232|NCT01294449|588591994|FG000|Overall Study|Withdrawal by Subject|1|||
162970233|NCT01294449|588591995|FG001|Overall Study|Withdrawal by Subject|3|||
162970234|NCT02466386|588591996|FG000|Overall Study|Adverse Event|5|||
162970235|NCT02466386|588591996|FG000|Overall Study|Protocol Violation|2|||
162970236|NCT02466386|588591996|FG000|Overall Study|Withdrawal by Subject|14|||
162970237|NCT02466386|588591996|FG000|Overall Study|Lost to Follow-up|5|||
162970238|NCT02466386|588591996|FG000|Overall Study|Lack of Efficacy|8|||
162970239|NCT02466386|588591996|FG000|Overall Study|Other|10|||
162970240|NCT05317195|588591997|FG000|Randomization|Withdrawal by Subject|1|||
162970241|NCT05317195|588591997|FG000|Randomization|Discontinued|6|||
162970242|NCT05317195|588591997|FG000|Admission|Withdrawal by Subject|2|||
162970243|NCT03259789|588591998|FG000|Overall Study|Adverse Event|3|||
162970244|NCT03259789|588591999|FG001|Overall Study|Adverse Event|2|||
162970245|NCT03259789|588592000|FG002|Overall Study|Adverse Event|1|||
162970246|NCT03259789|588591998|FG000|Overall Study|Withdrawal by Subject|9|||
162970247|NCT03259789|588591999|FG001|Overall Study|Withdrawal by Subject|5|||
162970248|NCT03259789|588592000|FG002|Overall Study|Withdrawal by Subject|1|||
162970249|NCT03259789|588591998|FG000|Overall Study|Lost to Follow-up|5|||
162970250|NCT03259789|588591999|FG001|Overall Study|Lost to Follow-up|9|||
162970251|NCT03259789|588592000|FG002|Overall Study|Lost to Follow-up|4|||
162970252|NCT03259789|588591998|FG000|Overall Study|Physician Decision|0|||
162970253|NCT03259789|588591999|FG001|Overall Study|Physician Decision|1|||
162970254|NCT03259789|588592000|FG002|Overall Study|Physician Decision|0|||
162970255|NCT00889252|588592001|FG000|Overall Study|Adverse Event|2|||
163209006|NCT06073119|589478718|FG005|Overall Study|Withdrawal by Subject|1|||
163209007|NCT06073119|589478713|FG000|Overall Study|Other|2|||
162970256|NCT00889252|588592002|FG001|Overall Study|Adverse Event|4|||
162970257|NCT00889252|588592001|FG000|Overall Study|Withdrawal by Subject|3|||
162970258|NCT00889252|588592002|FG001|Overall Study|Withdrawal by Subject|0|||
162970259|NCT00889252|588592001|FG000|Overall Study|Protocol Violation|2|||
162970260|NCT00889252|588592002|FG001|Overall Study|Protocol Violation|0|||
162970261|NCT01833169|588592003|FG000|Overall Study|Disease Progression|99|||
162970262|NCT01833169|588592003|FG000|Overall Study|Adverse Event|33|||
162970263|NCT01833169|588592003|FG000|Overall Study|Withdrawal by Subject|9|||
162970264|NCT01833169|588592003|FG000|Overall Study|Death|3|||
163400969|NCT00597753|590178267|FG000|Overall Study|Site elected to close|2|||
163400970|NCT00597753|590178268|FG001|Overall Study|Site elected to close|4|||
163400971|NCT03080883|590178269|FG000|Overall Study|Withdrawal by Subject|11|||
163400972|NCT03080883|590178270|FG001|Overall Study|Withdrawal by Subject|15|||
163400973|NCT03080883|590178269|FG000|Overall Study|Adverse Event|22|||
163400974|NCT03080883|590178270|FG001|Overall Study|Adverse Event|22|||
163400975|NCT03080883|590178269|FG000|Overall Study|Alternative Therapy|0|||
163400976|NCT03080883|590178270|FG001|Overall Study|Alternative Therapy|3|||
162970265|NCT01833169|588592003|FG000|Overall Study|Physician Decision|2|||
162970266|NCT04718129|588592011|FG000|Overall Study|Lost to Follow-up|6|||
162970267|NCT04718129|588592012|FG001|Overall Study|Lost to Follow-up|7|||
162970268|NCT02212457|588592013|FG000|Overall Study|Adverse Event|1|||
163400977|NCT03080883|590178269|FG000|Overall Study|Other Complicating Disease|9|||
162970269|NCT02212457|588592014|FG001|Overall Study|Adverse Event|2|||
162970270|NCT02212457|588592015|FG002|Overall Study|Adverse Event|2|||
162970271|NCT02212457|588592016|FG003|Overall Study|Adverse Event|2|||
163400978|NCT03080883|590178270|FG001|Overall Study|Other Complicating Disease|5|||
162970272|NCT02212457|588592017|FG004|Overall Study|Adverse Event|0|||
162970273|NCT02212457|588592018|FG005|Overall Study|Adverse Event|1|||
162970274|NCT02212457|588592013|FG000|Overall Study|Withdrawal by Subject|8|||
163209008|NCT06073119|589478714|FG001|Overall Study|Other|4|||
163209009|NCT06073119|589478715|FG002|Overall Study|Other|1|||
163209010|NCT06073119|589478716|FG003|Overall Study|Other|0|||
163209011|NCT06073119|589478717|FG004|Overall Study|Other|1|||
163209012|NCT06073119|589478718|FG005|Overall Study|Other|0|||
163209013|NCT01359449|589478721|FG000|Overall Study|Lost to Follow-up|1|||
163209014|NCT01359449|589478722|FG001|Overall Study|Lost to Follow-up|0|||
163317594|NCT04233216|589874877|FG001|Overall Study|Physician Decision|3|||
163317595|NCT04233216|589874878|FG002|Overall Study|Physician Decision|0|||
163317596|NCT04233216|589874879|FG003|Overall Study|Physician Decision|2|||
163317597|NCT04233216|589874876|FG000|Overall Study|Withdrawal by Subject|0|||
163317598|NCT04233216|589874877|FG001|Overall Study|Withdrawal by Subject|2|||
163317599|NCT04233216|589874878|FG002|Overall Study|Withdrawal by Subject|1|||
163317600|NCT04233216|589874879|FG003|Overall Study|Withdrawal by Subject|0|||
163317601|NCT03652389|589874880|FG000|Overall Study|Lost to Follow-up|1|||
162970275|NCT02212457|588592014|FG001|Overall Study|Withdrawal by Subject|10|||
163317602|NCT03652389|589874881|FG001|Overall Study|Lost to Follow-up|5|||
163317603|NCT03652389|589874880|FG000|Overall Study|Withdrawal by Subject|5|||
163317604|NCT03652389|589874881|FG001|Overall Study|Withdrawal by Subject|1|||
163317605|NCT03652389|589874880|FG000|Overall Study|New diagnosis|2|||
163317606|NCT03652389|589874881|FG001|Overall Study|New diagnosis|0|||
163056095|NCT00958074|588918343|FG001|Overall Study|Withdrawal by Subject|1|||
163056096|NCT00853385|588918344|FG000|Overall Study|Death|0|||
162970276|NCT02212457|588592015|FG002|Overall Study|Withdrawal by Subject|8|||
162970277|NCT02212457|588592016|FG003|Overall Study|Withdrawal by Subject|6|||
162970278|NCT02212457|588592017|FG004|Overall Study|Withdrawal by Subject|5|||
162970279|NCT02212457|588592018|FG005|Overall Study|Withdrawal by Subject|4|||
162970280|NCT02212457|588592013|FG000|Overall Study|Lost to Follow-up|6|||
162970281|NCT02212457|588592014|FG001|Overall Study|Lost to Follow-up|7|||
162970282|NCT02212457|588592015|FG002|Overall Study|Lost to Follow-up|4|||
162970283|NCT02212457|588592016|FG003|Overall Study|Lost to Follow-up|1|||
162970284|NCT02212457|588592017|FG004|Overall Study|Lost to Follow-up|8|||
162970285|NCT02212457|588592018|FG005|Overall Study|Lost to Follow-up|4|||
162970286|NCT02212457|588592013|FG000|Overall Study|Protocol Violation|2|||
162970287|NCT02212457|588592014|FG001|Overall Study|Protocol Violation|1|||
162970288|NCT02212457|588592015|FG002|Overall Study|Protocol Violation|0|||
162970289|NCT02212457|588592016|FG003|Overall Study|Protocol Violation|1|||
162970290|NCT02212457|588592017|FG004|Overall Study|Protocol Violation|2|||
162970291|NCT02212457|588592018|FG005|Overall Study|Protocol Violation|3|||
162970292|NCT02212457|588592013|FG000|Overall Study|Other|2|||
163209015|NCT01359449|589478721|FG000|Overall Study|Protocol Violation|0|||
162970293|NCT02212457|588592014|FG001|Overall Study|Other|1|||
162970294|NCT02212457|588592015|FG002|Overall Study|Other|2|||
163209016|NCT01359449|589478722|FG001|Overall Study|Protocol Violation|2|||
163400979|NCT03080883|590178269|FG000|Overall Study|Death|21|||
163400980|NCT03080883|590178270|FG001|Overall Study|Death|16|||
162970295|NCT02212457|588592016|FG003|Overall Study|Other|1|||
162970296|NCT02212457|588592017|FG004|Overall Study|Other|0|||
163056097|NCT00853385|588918345|FG001|Overall Study|Death|0|||
162970297|NCT02212457|588592018|FG005|Overall Study|Other|1|||
162970298|NCT01120691|588592021|FG000|Overall Study|Adverse Event|59|||
163209017|NCT01359449|589478721|FG000|Overall Study|Withdrawal by Subject|3|||
162970299|NCT01120691|588592022|FG001|Overall Study|Adverse Event|67|||
162970300|NCT01120691|588592023|FG002|Overall Study|Adverse Event|47|||
162970301|NCT01120691|588592021|FG000|Overall Study|Subject withdrew consent|33|||
162970302|NCT01120691|588592022|FG001|Overall Study|Subject withdrew consent|50|||
162970303|NCT01120691|588592023|FG002|Overall Study|Subject withdrew consent|44|||
162970304|NCT01120691|588592021|FG000|Overall Study|Death|21|||
162970305|NCT01120691|588592022|FG001|Overall Study|Death|22|||
162970306|NCT01120691|588592023|FG002|Overall Study|Death|24|||
163317607|NCT05622812|589874883|FG000|Overall Study|Withdrawal by Subject|1|||
163317608|NCT05622812|589874884|FG001|Overall Study|Withdrawal by Subject|4|||
163317609|NCT05622812|589874883|FG000|Overall Study|Lost to Follow-up|2|||
163317610|NCT05622812|589874884|FG001|Overall Study|Lost to Follow-up|1|||
163317611|NCT03916185|589874885|FG000|Overall Study|Lost to Follow-up|0|||
163317612|NCT03916185|589874886|FG001|Overall Study|Lost to Follow-up|1|||
163317613|NCT03916185|589874887|FG002|Overall Study|Lost to Follow-up|0|||
163317614|NCT03916185|589874888|FG003|Overall Study|Lost to Follow-up|0|||
163317615|NCT03916185|589874885|FG000|Overall Study|Moved|1|||
163317616|NCT03916185|589874886|FG001|Overall Study|Moved|0|||
163317617|NCT03916185|589874887|FG002|Overall Study|Moved|0|||
163317618|NCT03916185|589874888|FG003|Overall Study|Moved|1|||
163317619|NCT03916185|589874885|FG000|Overall Study|Not Able to Get to Clinic|1|||
163317620|NCT03916185|589874886|FG001|Overall Study|Not Able to Get to Clinic|0|||
163317621|NCT03916185|589874887|FG002|Overall Study|Not Able to Get to Clinic|0|||
163317622|NCT03916185|589874888|FG003|Overall Study|Not Able to Get to Clinic|0|||
163317623|NCT03766685|589874889|FG000|Overall Study|Lost to Follow-up|1|||
163317624|NCT03766685|589874890|FG001|Overall Study|Lost to Follow-up|1|||
163317625|NCT03766685|589874891|FG002|Overall Study|Lost to Follow-up|0|||
163317626|NCT03766685|589874892|FG003|Overall Study|Lost to Follow-up|0|||
163317627|NCT03766685|589874889|FG000|Overall Study|Adverse Event, not fatal|0|||
163317628|NCT03766685|589874890|FG001|Overall Study|Adverse Event, not fatal|1|||
163317629|NCT03766685|589874891|FG002|Overall Study|Adverse Event, not fatal|0|||
163317630|NCT03766685|589874892|FG003|Overall Study|Adverse Event, not fatal|1|||
163317631|NCT03766685|589874889|FG000|Overall Study|Withdrawal by Subject|0|||
163317632|NCT03766685|589874890|FG001|Overall Study|Withdrawal by Subject|2|||
163317633|NCT03766685|589874891|FG002|Overall Study|Withdrawal by Subject|0|||
163317634|NCT03766685|589874892|FG003|Overall Study|Withdrawal by Subject|0|||
163317635|NCT03766685|589874889|FG000|Overall Study|Protocol Violation|0|||
163317636|NCT03766685|589874890|FG001|Overall Study|Protocol Violation|1|||
163317637|NCT03766685|589874891|FG002|Overall Study|Protocol Violation|0|||
163317638|NCT03766685|589874892|FG003|Overall Study|Protocol Violation|0|||
163317639|NCT03766685|589874889|FG000|Overall Study|Non-compliance|0|||
163317640|NCT03766685|589874890|FG001|Overall Study|Non-compliance|2|||
163317641|NCT03766685|589874891|FG002|Overall Study|Non-compliance|0|||
163317642|NCT03766685|589874892|FG003|Overall Study|Non-compliance|0|||
163317643|NCT02844465|589874897|FG000|Overall Study|Screen Failure|36|||
163317644|NCT02844465|589874897|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
163317645|NCT02844465|589874897|FG000|Overall Study|Withdrawal by Subject|5|||
163317646|NCT02844465|589874897|FG000|Overall Study|Lost to Follow-up|1|||
163317647|NCT02844465|589874897|FG000|Overall Study|Retreatment|1|||
163317648|NCT05297565|589874898|FG000|Overall Study|Other Reasons|0|||
163317649|NCT05297565|589874899|FG001|Overall Study|Other Reasons|1|||
163317650|NCT05297565|589874898|FG000|Overall Study|Physician Decision|0|||
163056098|NCT00853385|588918346|FG002|Overall Study|Death|0|||
163317651|NCT05297565|589874899|FG001|Overall Study|Physician Decision|1|||
163317652|NCT05297565|589874898|FG000|Overall Study|Disease recurrence|1|||
163317653|NCT05297565|589874899|FG001|Overall Study|Disease recurrence|0|||
163317654|NCT05029622|589874900|FG000|Overall Study|Lost to Follow-up|1|||
163317655|NCT01197378|589874904|FG000|Overall Study|Adverse Event|3|||
163317656|NCT01197378|589874904|FG000|Overall Study|Withdrawal by Subject|1|||
163317657|NCT01197378|589874904|FG000|Overall Study|Physician Decision|1|||
163317658|NCT01197378|589874904|FG000|Overall Study|Other|2|||
163317659|NCT06232590|589874905|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
163317660|NCT06232590|589874906|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
163056099|NCT00853385|588918347|FG003|Overall Study|Death|0|||
163056100|NCT00853385|588918348|FG004|Overall Study|Death|1|||
163317661|NCT05299723|589874907|FG000|Overall Study|Withdrawal by Subject|0|||
163317662|NCT05299723|589874908|FG001|Overall Study|Withdrawal by Subject|2|||
163317663|NCT05299723|589874909|FG002|Overall Study|Withdrawal by Subject|0|||
163056101|NCT00853385|588918344|FG000|Overall Study|Adverse Event|24|||
162970307|NCT01120691|588592021|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
162970308|NCT01120691|588592022|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
162970309|NCT01120691|588592023|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
162970310|NCT01120691|588592021|FG000|Overall Study|Administrative problems|15|||
162970311|NCT01120691|588592022|FG001|Overall Study|Administrative problems|8|||
162970312|NCT01120691|588592023|FG002|Overall Study|Administrative problems|9|||
162970313|NCT01120691|588592021|FG000|Overall Study|Protocol deviation|13|||
162970314|NCT01120691|588592022|FG001|Overall Study|Protocol deviation|12|||
162970315|NCT01120691|588592023|FG002|Overall Study|Protocol deviation|12|||
162970316|NCT01120691|588592021|FG000|Overall Study|Lost to Follow-up|5|||
162970317|NCT01120691|588592022|FG001|Overall Study|Lost to Follow-up|6|||
162970318|NCT01120691|588592023|FG002|Overall Study|Lost to Follow-up|4|||
162970319|NCT01120691|588592021|FG000|Overall Study|Abnormal test procedure result(s)|3|||
162970320|NCT01120691|588592022|FG001|Overall Study|Abnormal test procedure result(s)|2|||
162970321|NCT01120691|588592023|FG002|Overall Study|Abnormal test procedure result(s)|1|||
162970322|NCT01120691|588592021|FG000|Overall Study|Patient's inability to use the device|3|||
162970323|NCT01120691|588592022|FG001|Overall Study|Patient's inability to use the device|1|||
162970324|NCT01120691|588592023|FG002|Overall Study|Patient's inability to use the device|0|||
162970325|NCT01120691|588592021|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162970326|NCT01120691|588592022|FG001|Overall Study|Abnormal laboratory value(s)|3|||
162970327|NCT01120691|588592023|FG002|Overall Study|Abnormal laboratory value(s)|4|||
162970328|NCT00772148|588592025|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
162970329|NCT00772148|588592026|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
162970330|NCT00772148|588592025|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
162970331|NCT00772148|588592026|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
162970332|NCT00772148|588592025|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
162970333|NCT00772148|588592026|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
162970334|NCT00772148|588592025|FG000|Maintenance Phase (Week 52)|Death|2|||
162970335|NCT00772148|588592026|FG001|Maintenance Phase (Week 52)|Death|2|||
162970336|NCT00772148|588592025|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
162970337|NCT00772148|588592026|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
162970338|NCT00772148|588592025|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
162970339|NCT00772148|588592026|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
162970340|NCT00772148|588592025|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
162970341|NCT00772148|588592026|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
162970342|NCT00688844|588592027|FG000|Overall Study|Lost to Follow-up|10|||
162970343|NCT01321697|588592031|FG000|Overall Study|Study Terminated|7|||
162970344|NCT00857818|588592032|FG000|Overall Study|Lack of Efficacy|1|||
162970345|NCT00857818|588592033|FG001|Overall Study|Lack of Efficacy|0|||
162970346|NCT00857818|588592032|FG000|Overall Study|Adverse Event|3|||
162970347|NCT00857818|588592033|FG001|Overall Study|Adverse Event|0|||
162970348|NCT00857818|588592032|FG000|Overall Study|Withdrawal by Subject|0|||
162970349|NCT00857818|588592033|FG001|Overall Study|Withdrawal by Subject|4|||
162970350|NCT00857818|588592032|FG000|Overall Study|Sponsor terminated study|6|||
162970351|NCT00857818|588592033|FG001|Overall Study|Sponsor terminated study|4|||
162970352|NCT00857818|588592032|FG000|Overall Study|Investigator decision|1|||
162970353|NCT00857818|588592033|FG001|Overall Study|Investigator decision|0|||
162970354|NCT02061280|588592037|FG000|Overall Study|Protocol Violation|12|||
162970355|NCT02061280|588592038|FG001|Overall Study|Protocol Violation|8|||
162970356|NCT02061280|588592037|FG000|Overall Study|moved out of state|0|||
162970357|NCT02061280|588592038|FG001|Overall Study|moved out of state|1|||
163056102|NCT00853385|588918345|FG001|Overall Study|Adverse Event|24|||
162970358|NCT02061280|588592037|FG000|Overall Study|Withdrawal by Subject|1|||
163056103|NCT00853385|588918346|FG002|Overall Study|Adverse Event|2|||
162970359|NCT02061280|588592038|FG001|Overall Study|Withdrawal by Subject|2|||
162970360|NCT02061280|588592037|FG000|Overall Study|Lost to Follow-up|5|||
162970361|NCT02061280|588592038|FG001|Overall Study|Lost to Follow-up|1|||
162970362|NCT01977456|588592039|FG000|Overall Study|Death|5|||
163400981|NCT03080883|590178269|FG000|Overall Study|Physician Decision|2|||
162970363|NCT00493792|588593836|FG000|Overall Study|Death|55|||
163209018|NCT01359449|589478722|FG001|Overall Study|Withdrawal by Subject|2|||
163209019|NCT02036294|589478724|FG000|Overall Study|Death|7|||
162970364|NCT00493792|588593837|FG001|Overall Study|Death|50|||
163209020|NCT02036294|589478725|FG001|Overall Study|Death|8|||
163209021|NCT02036294|589478724|FG000|Overall Study|Withdrawal by Subject|2|||
162970365|NCT00493792|588593836|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
163056104|NCT00853385|588918347|FG003|Overall Study|Adverse Event|5|||
163317664|NCT01959607|589874910|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
163317665|NCT01959607|589874911|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
162970366|NCT00493792|588593837|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
162970367|NCT00685035|588593838|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
162970368|NCT00685035|588593839|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
162970369|NCT02426541|588593843|FG000|Overall Study|Protocol Violation|1|||
162970370|NCT02426541|588593844|FG001|Overall Study|Protocol Violation|0|||
162970371|NCT00784979|588593847|FG000|Overall Study|incomplete data|6|||
162970372|NCT00894933|588593851|FG000|Overall Study|Lost to Follow-up|2|||
163317666|NCT01959607|589874912|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
163317667|NCT01959607|589874913|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
162970373|NCT00894933|588593851|FG000|Overall Study|Cancelled Procedure|1|||
162970374|NCT00894933|588593851|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
163317668|NCT03913442|589874914|FG000|Overall Study|Adverse Event|0|||
163317669|NCT03913442|589874915|FG001|Overall Study|Adverse Event|3|||
163317670|NCT03913442|589874914|FG000|Overall Study|Withdrawal by Subject|5|||
163317671|NCT03913442|589874915|FG001|Overall Study|Withdrawal by Subject|5|||
163317672|NCT03913442|589874914|FG000|Overall Study|Terminations|2|||
163317673|NCT03913442|589874915|FG001|Overall Study|Terminations|1|||
163317674|NCT03913442|589874914|FG000|Overall Study|Lost to Follow-up|2|||
163317675|NCT03913442|589874915|FG001|Overall Study|Lost to Follow-up|2|||
163317676|NCT02460458|589874916|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
163317677|NCT02460458|589874916|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
163317678|NCT02460458|589874916|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
163317679|NCT02460458|589874916|FG000|First Prospective Phase|Lost to Follow-up|84|||
163317680|NCT02460458|589874916|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
163317681|NCT03710603|589874920|FG000|Overall Study|Adverse Event|1|||
163317682|NCT03710603|589874921|FG001|Overall Study|Adverse Event|0|||
163317683|NCT03710603|589874920|FG000|Overall Study|Death|44|||
163317684|NCT03710603|589874921|FG001|Overall Study|Death|34|||
163317685|NCT03710603|589874920|FG000|Overall Study|Lost to Follow-up|3|||
163317686|NCT03710603|589874921|FG001|Overall Study|Lost to Follow-up|5|||
163317687|NCT03710603|589874920|FG000|Overall Study|Withdrawal by Subject|11|||
163317688|NCT03710603|589874921|FG001|Overall Study|Withdrawal by Subject|10|||
163317689|NCT02589795|589874925|FG000|Overall Study|Lost to Follow-up|1|||
163317690|NCT02589795|589874926|FG001|Overall Study|Lost to Follow-up|0|||
163317691|NCT02589795|589874927|FG002|Overall Study|Lost to Follow-up|0|||
163317692|NCT02589795|589874925|FG000|Overall Study|Withdrawal by Subject|0|||
163317693|NCT02589795|589874926|FG001|Overall Study|Withdrawal by Subject|0|||
163317694|NCT02589795|589874927|FG002|Overall Study|Withdrawal by Subject|2|||
163317695|NCT02589795|589874925|FG000|Overall Study|Protocol Violation|0|||
163317696|NCT02589795|589874926|FG001|Overall Study|Protocol Violation|0|||
163317697|NCT02589795|589874927|FG002|Overall Study|Protocol Violation|1|||
163317698|NCT03691935|589874929|FG000|Overall Study|Physician Decision|2|||
163317699|NCT03691935|589874930|FG001|Overall Study|Physician Decision|1|||
163317700|NCT03691935|589874929|FG000|Overall Study|Adverse Event|3|||
163317701|NCT03691935|589874930|FG001|Overall Study|Adverse Event|0|||
163317702|NCT03511664|589874931|FG000|Overall Study|Death|457|||
163317703|NCT03511664|589874932|FG001|Overall Study|Death|201|||
163317704|NCT03511664|589874933|FG002|Overall Study|Death|21|||
163317705|NCT03511664|589874931|FG000|Overall Study|Withdrew consent|40|||
163317706|NCT03511664|589874932|FG001|Overall Study|Withdrew consent|63|||
163317707|NCT03511664|589874933|FG002|Overall Study|Withdrew consent|3|||
163317708|NCT03511664|589874931|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
163317709|NCT03511664|589874932|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
163317710|NCT03511664|589874933|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
163317711|NCT03511664|589874931|FG000|Overall Study|Lost to Follow-up|8|||
163317712|NCT03511664|589874932|FG001|Overall Study|Lost to Follow-up|5|||
163056105|NCT00853385|588918348|FG004|Overall Study|Adverse Event|22|||
163056106|NCT00853385|588918344|FG000|Overall Study|Lack of Efficacy|6|||
163056107|NCT00853385|588918345|FG001|Overall Study|Lack of Efficacy|7|||
163056108|NCT00853385|588918346|FG002|Overall Study|Lack of Efficacy|3|||
163056109|NCT00853385|588918347|FG003|Overall Study|Lack of Efficacy|3|||
163056110|NCT00853385|588918348|FG004|Overall Study|Lack of Efficacy|6|||
163056111|NCT00853385|588918344|FG000|Overall Study|Lost to Follow-up|2|||
163056112|NCT00853385|588918345|FG001|Overall Study|Lost to Follow-up|1|||
163056113|NCT00853385|588918346|FG002|Overall Study|Lost to Follow-up|0|||
163056114|NCT00853385|588918347|FG003|Overall Study|Lost to Follow-up|0|||
163056115|NCT00853385|588918348|FG004|Overall Study|Lost to Follow-up|0|||
163056116|NCT00853385|588918344|FG000|Overall Study|Withdrawal by Subject|4|||
163056117|NCT00853385|588918345|FG001|Overall Study|Withdrawal by Subject|2|||
163056118|NCT00853385|588918346|FG002|Overall Study|Withdrawal by Subject|0|||
163056119|NCT00853385|588918347|FG003|Overall Study|Withdrawal by Subject|1|||
163056120|NCT00853385|588918348|FG004|Overall Study|Withdrawal by Subject|1|||
163056121|NCT00853385|588918344|FG000|Overall Study|Other|18|||
163056122|NCT00853385|588918345|FG001|Overall Study|Other|9|||
163056123|NCT00853385|588918346|FG002|Overall Study|Other|4|||
163056124|NCT00853385|588918347|FG003|Overall Study|Other|4|||
163056125|NCT00853385|588918348|FG004|Overall Study|Other|12|||
163056126|NCT00915525|588918349|FG000|Overall Study|Protocol Violation|9|||
163056127|NCT00915525|588918350|FG001|Overall Study|Protocol Violation|4|||
163056128|NCT00915525|588918349|FG000|Overall Study|Withdrawal by Subject|59|||
163056129|NCT00915525|588918350|FG001|Overall Study|Withdrawal by Subject|21|||
163056130|NCT00915525|588918349|FG000|Overall Study|Lost to Follow-up|27|||
163056131|NCT00915525|588918350|FG001|Overall Study|Lost to Follow-up|16|||
163056132|NCT00915525|588918349|FG000|Overall Study|Pregnancy|2|||
163056133|NCT00915525|588918350|FG001|Overall Study|Pregnancy|0|||
163056134|NCT00915525|588918349|FG000|Overall Study|Lack of Efficacy|15|||
163056135|NCT00915525|588918350|FG001|Overall Study|Lack of Efficacy|32|||
163056136|NCT00915525|588918349|FG000|Overall Study|Adverse Event|29|||
163056137|NCT00915525|588918350|FG001|Overall Study|Adverse Event|13|||
163056138|NCT00915525|588918349|FG000|Overall Study|Missing|12|||
163056139|NCT00915525|588918350|FG001|Overall Study|Missing|1|||
163056140|NCT00915525|588918349|FG000|Overall Study|Other Reason|35|||
163056141|NCT00915525|588918350|FG001|Overall Study|Other Reason|12|||
163056142|NCT00915525|588918349|FG000|Overall Study|Site Closed|27|||
163056143|NCT00915525|588918350|FG001|Overall Study|Site Closed|9|||
163056144|NCT00915525|588918349|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
163056145|NCT00915525|588918350|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
163056146|NCT00915525|588918349|FG000|Overall Study|Study Burden|28|||
163056147|NCT00915525|588918350|FG001|Overall Study|Study Burden|12|||
163056148|NCT00915525|588918349|FG000|Overall Study|Non-Compliance|3|||
163056149|NCT00915525|588918350|FG001|Overall Study|Non-Compliance|1|||
163056150|NCT00915525|588918349|FG000|Overall Study|Patient Moved|15|||
163056151|NCT00915525|588918350|FG001|Overall Study|Patient Moved|9|||
163056152|NCT00941928|588918355|FG000|Overall Study|Withdrawal by Subject|1|||
163056153|NCT00941928|588918355|FG000|Overall Study|Disease Progression|1|||
163056154|NCT00577408|588918356|FG000|Overall Study|Stopped attending study visits|9|||
163056155|NCT00577408|588918357|FG001|Overall Study|Stopped attending study visits|11|||
163056156|NCT00577408|588918356|FG000|Overall Study|Continued opioid use|3|||
163056157|NCT00577408|588918357|FG001|Overall Study|Continued opioid use|2|||
163056158|NCT00577408|588918356|FG000|Overall Study|Non-compliance with study meds|0|||
163056159|NCT00577408|588918357|FG001|Overall Study|Non-compliance with study meds|3|||
163056160|NCT00577408|588918356|FG000|Overall Study|Refused Oral Naltrexone|0|||
163056161|NCT00577408|588918357|FG001|Overall Study|Refused Oral Naltrexone|1|||
163056162|NCT00577408|588918356|FG000|Overall Study|Moved out of state|0|||
163056163|NCT00577408|588918357|FG001|Overall Study|Moved out of state|1|||
163056164|NCT00577408|588918356|FG000|Overall Study|Scheduling Issues|0|||
163056165|NCT00577408|588918357|FG001|Overall Study|Scheduling Issues|3|||
163056166|NCT00577408|588918356|FG000|Overall Study|Death|0|||
163056167|NCT00577408|588918357|FG001|Overall Study|Death|1|||
163056168|NCT00577408|588918356|FG000|Overall Study|Psychiatric hospitalization|0|||
163056169|NCT00577408|588918357|FG001|Overall Study|Psychiatric hospitalization|1|||
163056170|NCT01829347|588918358|FG000|VTI-210|Death|5|||
163056171|NCT01829347|588918359|FG001|VTI-210|Death|3|||
163056172|NCT01829347|588918358|FG000|VTI-210|Withdrawal by Subject|1|||
163056173|NCT01829347|588918359|FG001|VTI-210|Withdrawal by Subject|0|||
163056174|NCT01829347|588918358|FG000|VTI-210E|Death|2|||
163056175|NCT01829347|588918359|FG001|VTI-210E|Death|1|||
163056176|NCT01829347|588918358|FG000|VTI-210E|Study terminated prematurely|1|||
163056177|NCT01829347|588918359|FG001|VTI-210E|Study terminated prematurely|5|||
163209022|NCT02036294|589478725|FG001|Overall Study|Withdrawal by Subject|3|||
163209023|NCT01907815|589478730|FG000|Overall Study|Withdrawal by Subject|1|||
163209024|NCT01907815|589478731|FG001|Overall Study|Withdrawal by Subject|0|||
163209025|NCT01285310|589478734|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
163400982|NCT03080883|590178270|FG001|Overall Study|Physician Decision|2|||
162970375|NCT00631007|588593853|FG000|Overall Study|Adverse Event|0|||
162970376|NCT00631007|588593854|FG001|Overall Study|Adverse Event|2|||
162970377|NCT00631007|588593855|FG002|Overall Study|Adverse Event|0|||
162970378|NCT00631007|588593856|FG003|Overall Study|Adverse Event|2|||
162970379|NCT00631007|588593857|FG004|Overall Study|Adverse Event|3|||
162970380|NCT00631007|588593858|FG005|Overall Study|Adverse Event|2|||
162970381|NCT00631007|588593853|FG000|Overall Study|Lost to Follow-up|2|||
162970382|NCT00631007|588593854|FG001|Overall Study|Lost to Follow-up|1|||
162970383|NCT00631007|588593855|FG002|Overall Study|Lost to Follow-up|2|||
162970384|NCT00631007|588593856|FG003|Overall Study|Lost to Follow-up|4|||
162970385|NCT00631007|588593857|FG004|Overall Study|Lost to Follow-up|5|||
162970386|NCT00631007|588593858|FG005|Overall Study|Lost to Follow-up|3|||
162970387|NCT00631007|588593853|FG000|Overall Study|Physician Decision|1|||
162970388|NCT00631007|588593854|FG001|Overall Study|Physician Decision|0|||
162970389|NCT00631007|588593855|FG002|Overall Study|Physician Decision|1|||
162970390|NCT00631007|588593856|FG003|Overall Study|Physician Decision|0|||
162970391|NCT00631007|588593857|FG004|Overall Study|Physician Decision|0|||
162970392|NCT00631007|588593858|FG005|Overall Study|Physician Decision|2|||
162970393|NCT00631007|588593853|FG000|Overall Study|Persistent Hyperglycemia|2|||
162970394|NCT00631007|588593854|FG001|Overall Study|Persistent Hyperglycemia|2|||
162970395|NCT00631007|588593855|FG002|Overall Study|Persistent Hyperglycemia|5|||
162970396|NCT00631007|588593856|FG003|Overall Study|Persistent Hyperglycemia|1|||
162970397|NCT00631007|588593857|FG004|Overall Study|Persistent Hyperglycemia|2|||
162970398|NCT00631007|588593858|FG005|Overall Study|Persistent Hyperglycemia|5|||
162970399|NCT00631007|588593853|FG000|Overall Study|Withdrawal by Subject|4|||
162970400|NCT00631007|588593854|FG001|Overall Study|Withdrawal by Subject|5|||
162970401|NCT00631007|588593855|FG002|Overall Study|Withdrawal by Subject|2|||
162970402|NCT00631007|588593856|FG003|Overall Study|Withdrawal by Subject|2|||
162970403|NCT00631007|588593857|FG004|Overall Study|Withdrawal by Subject|1|||
162970404|NCT00631007|588593858|FG005|Overall Study|Withdrawal by Subject|3|||
162970405|NCT00631007|588593853|FG000|Overall Study|Other|2|||
162970406|NCT00631007|588593854|FG001|Overall Study|Other|1|||
162970407|NCT00631007|588593855|FG002|Overall Study|Other|0|||
162970408|NCT00631007|588593856|FG003|Overall Study|Other|0|||
162970409|NCT00631007|588593857|FG004|Overall Study|Other|1|||
162970410|NCT00631007|588593858|FG005|Overall Study|Other|0|||
162970411|NCT02674633|588593859|FG000|Overall Study|Lost to Follow-up|3|||
162970412|NCT02674633|588593860|FG001|Overall Study|Lost to Follow-up|2|||
162970413|NCT02674633|588593859|FG000|Overall Study|Physician Decision|1|||
162970414|NCT02674633|588593860|FG001|Overall Study|Physician Decision|0|||
162970415|NCT02674633|588593859|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162970416|NCT02674633|588593860|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
162970417|NCT00683787|588593861|FG000|Overall Study|Progression|3|||
162970418|NCT00683787|588593862|FG001|Overall Study|Progression|3|||
162970419|NCT00683787|588593863|FG002|Overall Study|Progression|0|||
162970420|NCT00683787|588593861|FG000|Overall Study|Adverse Event|0|||
162970421|NCT00683787|588593862|FG001|Overall Study|Adverse Event|0|||
162970422|NCT00683787|588593863|FG002|Overall Study|Adverse Event|2|||
162970423|NCT01235715|588593864|FG000|Overall Study|Physician Decision|0|||
162970424|NCT01235715|588593865|FG001|Overall Study|Physician Decision|2|||
162970425|NCT02344745|588593866|FG000|Overall Study|Data collection sheets were lost|2|||
162970426|NCT02344745|588593867|FG001|Overall Study|Data collection sheets were lost|0|||
162970427|NCT02788513|588593868|FG000|Overall Study|Withdrawal by Subject|3|||
162970428|NCT02788513|588593869|FG001|Overall Study|Withdrawal by Subject|0|||
162970429|NCT02788513|588593870|FG002|Overall Study|Withdrawal by Subject|2|||
162970430|NCT02788513|588593871|FG003|Overall Study|Withdrawal by Subject|3|||
162970431|NCT02788513|588593872|FG004|Overall Study|Withdrawal by Subject|1|||
162970432|NCT02788513|588593868|FG000|Overall Study|Lost to Follow-up|1|||
162970433|NCT02788513|588593869|FG001|Overall Study|Lost to Follow-up|0|||
162970434|NCT02788513|588593870|FG002|Overall Study|Lost to Follow-up|0|||
162970435|NCT02788513|588593871|FG003|Overall Study|Lost to Follow-up|0|||
162970436|NCT02788513|588593872|FG004|Overall Study|Lost to Follow-up|1|||
162970437|NCT02788513|588593868|FG000|Overall Study|Adverse Event|5|||
162970438|NCT02788513|588593869|FG001|Overall Study|Adverse Event|8|||
162970439|NCT02788513|588593870|FG002|Overall Study|Adverse Event|4|||
162970440|NCT02788513|588593871|FG003|Overall Study|Adverse Event|2|||
162970441|NCT02788513|588593872|FG004|Overall Study|Adverse Event|2|||
162970442|NCT02788513|588593868|FG000|Overall Study|Protocol Violation|0|||
162970443|NCT02788513|588593869|FG001|Overall Study|Protocol Violation|0|||
162970444|NCT02788513|588593870|FG002|Overall Study|Protocol Violation|1|||
162970445|NCT02788513|588593871|FG003|Overall Study|Protocol Violation|1|||
162970446|NCT02788513|588593872|FG004|Overall Study|Protocol Violation|0|||
162970447|NCT02788513|588593868|FG000|Overall Study|Subject decided to stop taking treatment|0|||
162970448|NCT02788513|588593869|FG001|Overall Study|Subject decided to stop taking treatment|0|||
162970449|NCT02788513|588593870|FG002|Overall Study|Subject decided to stop taking treatment|1|||
162970450|NCT02788513|588593871|FG003|Overall Study|Subject decided to stop taking treatment|0|||
162970451|NCT02788513|588593872|FG004|Overall Study|Subject decided to stop taking treatment|0|||
162970452|NCT02788513|588593868|FG000|Overall Study|Decision by the study team|0|||
162970453|NCT02788513|588593869|FG001|Overall Study|Decision by the study team|0|||
162970454|NCT02788513|588593870|FG002|Overall Study|Decision by the study team|0|||
162970455|NCT02788513|588593871|FG003|Overall Study|Decision by the study team|0|||
162970456|NCT02788513|588593872|FG004|Overall Study|Decision by the study team|1|||
162970457|NCT03230487|588593876|FG000|Overall Study|Adverse Event|0|||
162970458|NCT03230487|588593877|FG001|Overall Study|Adverse Event|0|||
162970459|NCT03230487|588593878|FG002|Overall Study|Adverse Event|0|||
162970460|NCT03230487|588593879|FG003|Overall Study|Adverse Event|1|||
162970461|NCT03230487|588593880|FG004|Overall Study|Adverse Event|0|||
162970462|NCT03230487|588593881|FG005|Overall Study|Adverse Event|0|||
162970463|NCT01933919|588593889|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
162970464|NCT01933919|588593890|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
162970465|NCT01933919|588593889|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
162970466|NCT01933919|588593890|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
162970467|NCT01933919|588593889|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
162970468|NCT01933919|588593890|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
162970469|NCT01933919|588593889|FG000|Open-label Long-term Phase|Adverse Event|2|||
162970470|NCT01933919|588593890|FG001|Open-label Long-term Phase|Adverse Event|0|||
162970471|NCT01933919|588593889|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
162970472|NCT01933919|588593890|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
162970473|NCT01933919|588593889|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
163400983|NCT03080883|590178269|FG000|Overall Study|Disease Progression|2|||
163056178|NCT03435055|588918360|FG000|Screening|Physician Decision|2|||
163056179|NCT03435055|588918360|FG000|Received Intervention|Did not complete nitrous administration|3|||
163056180|NCT02732639|588918366|FG000|Overall Study|Lost to Follow-up|1|||
163056181|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
163056182|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
163056183|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
163056184|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
162970474|NCT01933919|588593890|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
163056185|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
163056186|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
163056187|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
163056188|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
163056189|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
163056190|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
163056191|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
163056192|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
163056193|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
163056194|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
163056195|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
163056196|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
163056197|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
163056198|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
163056199|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
163056200|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
163056201|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
163056202|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
163056203|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
163400984|NCT03080883|590178270|FG001|Overall Study|Disease Progression|8|||
162970475|NCT01933919|588593889|FG000|Open-label Long-term Phase|Other|1|||
162970476|NCT01933919|588593890|FG001|Open-label Long-term Phase|Other|2|||
162970477|NCT01961882|588593891|FG000|Overall Study|Adverse Event|3|||
162970478|NCT01961882|588593892|FG001|Overall Study|Adverse Event|2|||
162970479|NCT01961882|588593891|FG000|Overall Study|Physician Decision|1|||
162970480|NCT01961882|588593892|FG001|Overall Study|Physician Decision|0|||
162970481|NCT01961882|588593891|FG000|Overall Study|Withdrawal by Subject|4|||
162970482|NCT01961882|588593892|FG001|Overall Study|Withdrawal by Subject|1|||
162970483|NCT01961882|588593891|FG000|Overall Study|Relapse of AML|39|||
162970484|NCT01961882|588593892|FG001|Overall Study|Relapse of AML|37|||
162970485|NCT01961882|588593891|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
162970486|NCT01961882|588593892|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
162970487|NCT01961882|588593891|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
162970488|NCT01961882|588593892|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
162970489|NCT01901848|588593893|FG000|Randomized and Treated|Lost to Follow-up|3|||
162970490|NCT01901848|588593894|FG001|Randomized and Treated|Lost to Follow-up|6|||
162970491|NCT01901848|588593893|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
162970492|NCT01901848|588593894|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
162970493|NCT02575339|588593895|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
162970494|NCT02575339|588593896|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
162970495|NCT02575339|588593897|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
162970496|NCT02575339|588593895|FG000|Study Treatment|Disease Progression|5|||
162970497|NCT02575339|588593896|FG001|Study Treatment|Disease Progression|2|||
162970498|NCT02575339|588593897|FG002|Study Treatment|Disease Progression|0|||
162970499|NCT02575339|588593895|FG000|Study Treatment|Adverse Event|1|||
162970500|NCT02575339|588593896|FG001|Study Treatment|Adverse Event|2|||
162970501|NCT02575339|588593897|FG002|Study Treatment|Adverse Event|0|||
162970502|NCT02575339|588593895|FG000|Follow up|Death|6|||
162970503|NCT02575339|588593896|FG001|Follow up|Death|2|||
162970504|NCT02575339|588593897|FG002|Follow up|Death|0|||
162970505|NCT02575339|588593895|FG000|Follow up|Study Terminated|0|||
162970506|NCT02575339|588593896|FG001|Follow up|Study Terminated|2|||
162970507|NCT02575339|588593897|FG002|Follow up|Study Terminated|0|||
163056204|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
162970508|NCT02575339|588593895|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
163056205|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
163056206|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
163056207|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
163056208|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
163056209|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
162970509|NCT02575339|588593896|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
162970510|NCT02575339|588593897|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
162970511|NCT01270620|588593898|FG000|Overall Study|Withdrawal by Subject|1|||
163056210|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
163056211|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
163056212|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
163056213|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
163056214|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
163056215|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
163056216|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
163056217|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
163056218|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
163056219|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
163056220|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
163056221|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
163056222|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
163056223|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
163056224|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
163056225|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
163056226|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
163056227|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
163056228|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
163056229|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
163056230|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
163056231|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
163056232|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
163056233|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
163056234|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
163056235|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
163056236|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
163056237|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
163056238|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
163056239|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
163056240|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
163056241|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
163056242|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
163056243|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
163056244|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
163056245|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
163056246|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
163056247|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
163056248|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
163056249|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
163056250|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
163056251|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
163056252|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
163056253|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
163056254|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
163056255|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
163056256|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
163056257|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
163056258|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
163056259|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
163056260|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
163056261|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
163056262|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
163056263|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
163056264|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
163056265|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
163056266|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
163056267|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
163056268|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
163317713|NCT03511664|589874933|FG002|Overall Study|Lost to Follow-up|0|||
163317714|NCT03511664|589874931|FG000|Overall Study|Physician Decision|2|||
163317715|NCT03511664|589874932|FG001|Overall Study|Physician Decision|1|||
163400985|NCT03080883|590178269|FG000|Overall Study|Lost to Follow-up|1|||
163400986|NCT03080883|590178270|FG001|Overall Study|Lost to Follow-up|1|||
163400987|NCT00075023|590179524|FG000|Pilot Study|Physician Decision|1|||
163400988|NCT00075023|590179525|FG001|Pilot Study|Physician Decision|2|||
163400989|NCT00075023|590179524|FG000|Pilot Study|Withdrawal by Subject|1|||
163400990|NCT00075023|590179525|FG001|Pilot Study|Withdrawal by Subject|0|||
163400991|NCT04342871|590179526|FG000|Overall Study|Death|4|||
163400992|NCT04342871|590179526|FG000|Overall Study|Clinical deterioration/illness progression|2|||
163056269|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
163056270|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
163056271|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
163056272|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
163056273|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
163056274|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
163056275|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
163056276|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
163056277|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
163056278|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
163056279|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
163056280|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
163056281|NCT00827567|588918371|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
163056282|NCT03502798|588918374|FG000|Overall Study|equipment failure|0|||
163317716|NCT03511664|589874933|FG002|Overall Study|Physician Decision|0|||
163317717|NCT03511664|589874931|FG000|Overall Study|Patient non-compliance|1|||
163317718|NCT03511664|589874932|FG001|Overall Study|Patient non-compliance|0|||
163317719|NCT03511664|589874933|FG002|Overall Study|Patient non-compliance|0|||
162970512|NCT01270620|588593899|FG001|Overall Study|Withdrawal by Subject|3|||
162970513|NCT01045707|588593900|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
162970514|NCT01045707|588593901|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
162970515|NCT01045707|588593900|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
162970516|NCT01045707|588593901|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
162970517|NCT01045707|588593900|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
162970518|NCT01045707|588593901|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
162970519|NCT01045707|588593900|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
162970520|NCT01045707|588593901|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
162970521|NCT01045707|588593900|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
162970522|NCT01045707|588593901|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
162970523|NCT01045707|588593900|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
162970524|NCT01045707|588593901|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
162970525|NCT01045707|588593900|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
162970526|NCT01045707|588593901|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
163317720|NCT01946789|589874934|FG000|Overall Study|Death|0|||
163317721|NCT01946789|589874935|FG001|Overall Study|Death|2|||
163317722|NCT01946789|589874936|FG002|Overall Study|Death|1|||
163317723|NCT01946789|589874937|FG003|Overall Study|Death|1|||
162970527|NCT01045707|588593900|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
162970528|NCT01045707|588593901|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
162970529|NCT01045707|588593900|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
162970530|NCT01045707|588593901|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
163317724|NCT01946789|589874938|FG004|Overall Study|Death|1|||
163317725|NCT01946789|589874939|FG005|Overall Study|Death|1|||
163056283|NCT03502798|588918375|FG001|Overall Study|equipment failure|7|||
163056284|NCT00062166|588918379|FG000|Overall Study|Withdrawal by Subject|6|||
163056285|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
163056286|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
163209026|NCT01285310|589478735|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
163056287|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
162970531|NCT00348816|588593902|FG000|Overall Study|Noncompliance with radiation treatment|1|||
162970532|NCT00809965|588593903|FG000|Overall Study|Death|194|||
162970533|NCT00809965|588593904|FG001|Overall Study|Death|147|||
162970534|NCT00809965|588593905|FG002|Overall Study|Death|196|||
162970535|NCT00809965|588593903|FG000|Overall Study|Lost to Follow-up|17|||
162970536|NCT00809965|588593904|FG001|Overall Study|Lost to Follow-up|10|||
162970537|NCT00809965|588593905|FG002|Overall Study|Lost to Follow-up|18|||
162970538|NCT00809965|588593903|FG000|Overall Study|Withdrawal by Subject|405|||
162970539|NCT00809965|588593904|FG001|Overall Study|Withdrawal by Subject|448|||
162970540|NCT00809965|588593905|FG002|Overall Study|Withdrawal by Subject|441|||
162970541|NCT00809965|588593903|FG000|Overall Study|Other Reason|167|||
162970542|NCT00809965|588593904|FG001|Overall Study|Other Reason|170|||
162970543|NCT00809965|588593905|FG002|Overall Study|Other Reason|189|||
162970544|NCT05552261|588593906|FG000|Overall Study|Withdrawal by Subject|1|||
162970545|NCT05552261|588593906|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
162970546|NCT04886063|588593909|FG000|Overall Study|Adverse Event|50|||
162970547|NCT04886063|588593909|FG000|Overall Study|Lack of Efficacy|31|||
162970548|NCT04886063|588593909|FG000|Overall Study|Withdrawal by Subject|45|||
162970549|NCT04886063|588593909|FG000|Overall Study|Physician Decision|3|||
162970550|NCT04886063|588593909|FG000|Overall Study|Protocol Violation|3|||
162970551|NCT04886063|588593909|FG000|Overall Study|Site closure|4|||
162970552|NCT04886063|588593909|FG000|Overall Study|Nursing home replacement|3|||
162970553|NCT04886063|588593909|FG000|Overall Study|Lost to Follow-up|5|||
162970554|NCT04886063|588593909|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
162970555|NCT04886063|588593909|FG000|Overall Study|>1 reason|20|||
162970556|NCT01628549|588593910|FG000|Overall Study|Adverse Event|1|||
162970557|NCT01628549|588593911|FG001|Overall Study|Adverse Event|1|||
162970558|NCT01628549|588593912|FG002|Overall Study|Adverse Event|0|||
162970559|NCT01628549|588593913|FG003|Overall Study|Adverse Event|4|||
162970560|NCT01628549|588593910|FG000|Overall Study|Lost to Follow-up|3|||
162970561|NCT01628549|588593911|FG001|Overall Study|Lost to Follow-up|4|||
162970562|NCT01628549|588593912|FG002|Overall Study|Lost to Follow-up|3|||
162970563|NCT01628549|588593913|FG003|Overall Study|Lost to Follow-up|3|||
162970564|NCT01628549|588593910|FG000|Overall Study|Withdrawal by Subject|3|||
162970565|NCT01628549|588593911|FG001|Overall Study|Withdrawal by Subject|4|||
163400993|NCT04342871|590179526|FG000|Overall Study|Did not complete baseline assessments|5|||
162970566|NCT01628549|588593912|FG002|Overall Study|Withdrawal by Subject|4|||
162970567|NCT01628549|588593913|FG003|Overall Study|Withdrawal by Subject|1|||
162970568|NCT01628549|588593910|FG000|Overall Study|Protocol Violation|2|||
162970569|NCT01628549|588593911|FG001|Overall Study|Protocol Violation|1|||
162970570|NCT01628549|588593912|FG002|Overall Study|Protocol Violation|1|||
162970571|NCT01628549|588593913|FG003|Overall Study|Protocol Violation|0|||
162970572|NCT01628549|588593910|FG000|Overall Study|withdrawn for noncompliance|0|||
162970573|NCT01628549|588593911|FG001|Overall Study|withdrawn for noncompliance|2|||
163317726|NCT01946789|589874940|FG006|Overall Study|Death|3|||
163209027|NCT01285310|589478736|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
162970574|NCT01628549|588593912|FG002|Overall Study|withdrawn for noncompliance|1|||
162970575|NCT01628549|588593913|FG003|Overall Study|withdrawn for noncompliance|0|||
162970576|NCT01628549|588593910|FG000|Overall Study|abnormal laboratory test results|0|||
162970577|NCT01628549|588593911|FG001|Overall Study|abnormal laboratory test results|0|||
162970578|NCT01628549|588593912|FG002|Overall Study|abnormal laboratory test results|1|||
162970579|NCT01628549|588593913|FG003|Overall Study|abnormal laboratory test results|0|||
162970580|NCT01628549|588593910|FG000|Overall Study|positive pregnancy test|0|||
162970581|NCT01628549|588593911|FG001|Overall Study|positive pregnancy test|0|||
162970582|NCT01628549|588593912|FG002|Overall Study|positive pregnancy test|0|||
162970583|NCT01628549|588593913|FG003|Overall Study|positive pregnancy test|1|||
162970584|NCT03807440|588593919|FG000|Overall Study|No documentation of index date 2|320|||
162970585|NCT03807440|588593919|FG000|Overall Study|No informed consent for index date 2|117|||
163400994|NCT04342871|590179526|FG000|Overall Study|Lost to Follow-up|13|||
163400995|NCT01429584|590179531|FG000|Overall Study|Withdrawal by Subject|1|||
163400996|NCT01429584|590179532|FG001|Overall Study|Withdrawal by Subject|0|||
163400997|NCT01429584|590179531|FG000|Overall Study|Protocol Violation|0|||
163400998|NCT01429584|590179532|FG001|Overall Study|Protocol Violation|1|||
163400999|NCT00750698|590179533|FG000|Overall Study|Withdrawal by Subject|1|||
163401000|NCT00750698|590179534|FG001|Overall Study|Withdrawal by Subject|0|||
163401001|NCT00750698|590179533|FG000|Overall Study|Progressive disease|5|||
163401002|NCT00750698|590179534|FG001|Overall Study|Progressive disease|2|||
163401003|NCT01417195|590179535|FG000|Overall Study|Stimulation failure|1|||
163401004|NCT01417195|590179536|FG001|Overall Study|Stimulation failure|0|||
163401005|NCT01417195|590179535|FG000|Overall Study|No embryos for transfer|0|||
163401006|NCT01417195|590179536|FG001|Overall Study|No embryos for transfer|1|||
163401007|NCT01417195|590179535|FG000|Overall Study|No transfer due to risk of OHSS|1|||
163401008|NCT01417195|590179536|FG001|Overall Study|No transfer due to risk of OHSS|0|||
163401009|NCT01417195|590179535|FG000|Overall Study|No transfer due to elevated progesterone|1|||
163401010|NCT01417195|590179536|FG001|Overall Study|No transfer due to elevated progesterone|0|||
163401011|NCT04766021|590179537|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
163401012|NCT04766021|590179537|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
163401013|NCT02634151|590179540|FG000|Overall Study|Withdrawal by Subject|1|||
163401014|NCT02634151|590179541|FG001|Overall Study|Withdrawal by Subject|0|||
163401015|NCT02634151|590179540|FG000|Overall Study|Non-Compliance|0|||
162970586|NCT02451358|588593920|FG000|Overall Study|Withdrawal by Subject|1|||
163401016|NCT02634151|590179541|FG001|Overall Study|Non-Compliance|1|||
163401017|NCT02634151|590179540|FG000|Overall Study|Other|0|||
163209028|NCT01285310|589478737|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
163209029|NCT01285310|589478738|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
163209030|NCT01285310|589478734|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
163209031|NCT01285310|589478735|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
163209032|NCT01285310|589478736|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
163209033|NCT01285310|589478737|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
163209034|NCT01285310|589478738|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
163209035|NCT01285310|589478734|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
163209036|NCT01285310|589478735|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
163209037|NCT01285310|589478736|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
163209038|NCT01285310|589478737|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
163209039|NCT01285310|589478738|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
163209040|NCT01285310|589478734|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
163209041|NCT01285310|589478735|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
163209042|NCT01285310|589478736|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
163209043|NCT01285310|589478737|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
163209044|NCT01285310|589478738|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
163209045|NCT01285310|589478734|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
163209046|NCT01285310|589478735|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
163209047|NCT01285310|589478736|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
163209048|NCT01285310|589478737|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
163209049|NCT01285310|589478738|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
163209050|NCT01285310|589478734|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
163209051|NCT01285310|589478735|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
163209052|NCT01285310|589478736|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
163209053|NCT01285310|589478737|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
163209054|NCT01285310|589478738|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
163209055|NCT01285310|589478734|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
163209056|NCT01285310|589478735|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
163209057|NCT01285310|589478736|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
163209058|NCT01285310|589478737|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
163209059|NCT01285310|589478738|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
163209060|NCT01285310|589478734|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
163209061|NCT01285310|589478735|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
163209062|NCT01285310|589478736|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
163209063|NCT01285310|589478737|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
163209064|NCT01285310|589478738|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
163209065|NCT01285310|589478734|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
163209066|NCT01285310|589478735|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
163209067|NCT01285310|589478736|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
163209068|NCT01285310|589478737|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
163209069|NCT01285310|589478738|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
163209070|NCT01285310|589478734|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
163209071|NCT01285310|589478735|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
163209072|NCT01285310|589478736|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
163209073|NCT01285310|589478737|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
163209074|NCT01285310|589478738|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
163209075|NCT01285310|589478734|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
163209076|NCT01285310|589478735|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
163209077|NCT01285310|589478736|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
163209078|NCT01285310|589478737|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
163209079|NCT01285310|589478738|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
163209080|NCT01285310|589478734|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
163209081|NCT01285310|589478735|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
163209082|NCT01285310|589478736|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
163209083|NCT01285310|589478737|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
163209084|NCT01285310|589478738|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
163209085|NCT00514540|589478739|FG000|First-Line Chemo|Withdrawal by Subject|1|||
163209086|NCT00514540|589478739|FG000|First-Line Chemo|Protocol Violation|7|||
163209087|NCT00514540|589478739|FG000|Second-Line|Physician/Patient Decision|31|||
163209088|NCT01996982|589478742|FG000|Overall Study|PI/team left institution|7|||
163209089|NCT00555321|589478743|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
163209090|NCT00555321|589478744|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
163209091|NCT00555321|589478745|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
163317727|NCT01946789|589874941|FG007|Overall Study|Death|1|||
163317728|NCT01946789|589874942|FG008|Overall Study|Death|2|||
163317729|NCT01946789|589874934|FG000|Overall Study|Progressive Disease|0|||
163317730|NCT01946789|589874935|FG001|Overall Study|Progressive Disease|0|||
163209092|NCT00555321|589478746|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
163209093|NCT00555321|589478747|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
163209094|NCT00555321|589478743|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
163209095|NCT00555321|589478744|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
163209096|NCT00555321|589478745|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
163209097|NCT00555321|589478746|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
163209098|NCT00555321|589478747|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
162970587|NCT02451358|588593921|FG001|Overall Study|Withdrawal by Subject|1|||
162970588|NCT02451358|588593922|FG002|Overall Study|Withdrawal by Subject|0|||
162970589|NCT02451358|588593923|FG003|Overall Study|Withdrawal by Subject|0|||
162970590|NCT02451358|588593920|FG000|Overall Study|Protocol Violation|0|||
162970591|NCT02451358|588593921|FG001|Overall Study|Protocol Violation|1|||
162970592|NCT02451358|588593922|FG002|Overall Study|Protocol Violation|1|||
163317731|NCT01946789|589874936|FG002|Overall Study|Progressive Disease|1|||
163317732|NCT01946789|589874937|FG003|Overall Study|Progressive Disease|0|||
162970593|NCT02451358|588593923|FG003|Overall Study|Protocol Violation|0|||
162970594|NCT06128525|588593924|FG000|Overall Study|Patient withdrew consent|1|||
162970595|NCT03414034|588593929|FG000|Overall Study|Adverse Event|6|||
162970596|NCT03414034|588593930|FG001|Overall Study|Adverse Event|1|||
162970597|NCT03414034|588593931|FG002|Overall Study|Adverse Event|1|||
163317733|NCT01946789|589874938|FG004|Overall Study|Progressive Disease|0|||
163317734|NCT01946789|589874939|FG005|Overall Study|Progressive Disease|2|||
162970598|NCT03414034|588593929|FG000|Overall Study|Death|0|||
163317735|NCT01946789|589874940|FG006|Overall Study|Progressive Disease|0|||
163209099|NCT00555321|589478743|FG000|Treatment Phase up to 12-months|Death|2|||
163209100|NCT00555321|589478744|FG001|Treatment Phase up to 12-months|Death|1|||
162970599|NCT03414034|588593930|FG001|Overall Study|Death|0|||
162970600|NCT03414034|588593931|FG002|Overall Study|Death|1|||
163209101|NCT00555321|589478745|FG002|Treatment Phase up to 12-months|Death|4|||
163209102|NCT00555321|589478746|FG003|Treatment Phase up to 12-months|Death|0|||
163209103|NCT00555321|589478747|FG004|Treatment Phase up to 12-months|Death|0|||
163209104|NCT00555321|589478743|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
162970601|NCT03414034|588593929|FG000|Overall Study|Non-compliance With Study Drug|0|||
162970602|NCT03414034|588593930|FG001|Overall Study|Non-compliance With Study Drug|0|||
162970603|NCT03414034|588593931|FG002|Overall Study|Non-compliance With Study Drug|1|||
162970604|NCT03414034|588593929|FG000|Overall Study|Physician Decision|1|||
162970605|NCT03414034|588593930|FG001|Overall Study|Physician Decision|3|||
162970606|NCT03414034|588593931|FG002|Overall Study|Physician Decision|2|||
162970607|NCT03414034|588593929|FG000|Overall Study|Withdrawal of Informed Consent|2|||
162970608|NCT03414034|588593930|FG001|Overall Study|Withdrawal of Informed Consent|1|||
162970609|NCT03414034|588593931|FG002|Overall Study|Withdrawal of Informed Consent|4|||
162970610|NCT03414034|588593929|FG000|Overall Study|Progressive Disease|15|||
162970611|NCT03414034|588593930|FG001|Overall Study|Progressive Disease|15|||
162970612|NCT03414034|588593931|FG002|Overall Study|Progressive Disease|17|||
162970613|NCT03414034|588593929|FG000|Overall Study|Miscellaneous|0|||
162970614|NCT03414034|588593930|FG001|Overall Study|Miscellaneous|0|||
162970615|NCT03414034|588593931|FG002|Overall Study|Miscellaneous|2|||
162970616|NCT01332968|588593933|FG000|Induction Period|Adverse Event|23|||
162970617|NCT01332968|588593934|FG001|Induction Period|Adverse Event|26|||
162970618|NCT01332968|588593935|FG002|Induction Period|Adverse Event|0|||
162970619|NCT01332968|588593936|FG003|Induction Period|Adverse Event|0|||
162970620|NCT01332968|588593937|FG004|Induction Period|Adverse Event|0|||
162970621|NCT01332968|588593938|FG005|Induction Period|Adverse Event|0|||
163056288|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
163056289|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
163056290|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
163056291|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
163056292|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
163056293|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
163056294|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
163056295|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
163056296|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
163056297|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
163056298|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
163056299|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
163056300|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
163056301|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
163056302|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
163056303|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
163056304|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
163056305|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
163056306|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
163056307|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
163056308|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
163056309|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
163056310|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
163056311|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
163056312|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
163056313|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
163056314|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
163056315|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
163056316|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
163056317|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
163056318|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
163056319|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
163056320|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
163056321|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
163056322|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
163317736|NCT01946789|589874941|FG007|Overall Study|Progressive Disease|0|||
163317737|NCT01946789|589874942|FG008|Overall Study|Progressive Disease|0|||
162970622|NCT01332968|588593939|FG006|Induction Period|Adverse Event|0|||
162970623|NCT01332968|588593940|FG007|Induction Period|Adverse Event|0|||
162970624|NCT01332968|588593933|FG000|Induction Period|Death|1|||
162970625|NCT01332968|588593934|FG001|Induction Period|Death|4|||
162970626|NCT01332968|588593935|FG002|Induction Period|Death|0|||
162970627|NCT01332968|588593936|FG003|Induction Period|Death|0|||
162970628|NCT01332968|588593937|FG004|Induction Period|Death|0|||
162970629|NCT01332968|588593938|FG005|Induction Period|Death|0|||
162970630|NCT01332968|588593939|FG006|Induction Period|Death|0|||
162970631|NCT01332968|588593940|FG007|Induction Period|Death|0|||
162970632|NCT01332968|588593933|FG000|Induction Period|Non-compliance|1|||
162970633|NCT01332968|588593934|FG001|Induction Period|Non-compliance|0|||
162970634|NCT01332968|588593935|FG002|Induction Period|Non-compliance|0|||
163209105|NCT00555321|589478744|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
163209106|NCT00555321|589478745|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
163209107|NCT00555321|589478746|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
163209108|NCT00555321|589478747|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
163209109|NCT00555321|589478743|FG000|Treatment Phase up to 12-months|Other Reason|1|||
163209110|NCT00555321|589478744|FG001|Treatment Phase up to 12-months|Other Reason|3|||
163056323|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
163056324|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
163056325|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
163056326|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
163056327|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
163056328|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
163056329|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
163056330|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
163056331|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
163056332|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
163056333|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
163056334|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
163056335|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
163056336|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
163056337|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
163056338|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
163056339|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
163056340|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
163056341|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
163056342|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
163056343|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
163056344|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
163056345|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
163209111|NCT00555321|589478745|FG002|Treatment Phase up to 12-months|Other Reason|2|||
163209112|NCT00555321|589478746|FG003|Treatment Phase up to 12-months|Other Reason|0|||
163209113|NCT00555321|589478747|FG004|Treatment Phase up to 12-months|Other Reason|0|||
163209114|NCT00555321|589478743|FG000|Treatment Phase up to 12-months|Never treated|2|||
163209115|NCT00555321|589478744|FG001|Treatment Phase up to 12-months|Never treated|3|||
163209116|NCT00555321|589478745|FG002|Treatment Phase up to 12-months|Never treated|1|||
163401018|NCT02634151|590179541|FG001|Overall Study|Other|1|||
163401019|NCT03709654|590179542|FG000|Overall Study|Lost to Follow-up|1|||
163401020|NCT03709654|590179543|FG001|Overall Study|Lost to Follow-up|1|||
163401021|NCT03709654|590179542|FG000|Overall Study|Withdrawal by Subject|1|||
163401022|NCT03709654|590179543|FG001|Overall Study|Withdrawal by Subject|1|||
163401023|NCT03709654|590179542|FG000|Overall Study|Adverse Event|1|||
163401024|NCT03709654|590179543|FG001|Overall Study|Adverse Event|0|||
163401025|NCT00530894|590179548|FG000|Overall Study|Death|84|||
163401026|NCT00530894|590179549|FG001|Overall Study|Death|89|||
163401027|NCT00530894|590179550|FG002|Overall Study|Death|55|||
163401028|NCT00530894|590179551|FG003|Overall Study|Death|89|||
163401029|NCT00530894|590179548|FG000|Overall Study|Lost to Follow-up|1|||
163401030|NCT00530894|590179549|FG001|Overall Study|Lost to Follow-up|3|||
163401031|NCT00530894|590179550|FG002|Overall Study|Lost to Follow-up|0|||
163401032|NCT00530894|590179551|FG003|Overall Study|Lost to Follow-up|0|||
163401033|NCT00530894|590179548|FG000|Overall Study|Withdrawal by Subject|1|||
163401034|NCT00530894|590179549|FG001|Overall Study|Withdrawal by Subject|23|||
163401035|NCT00530894|590179550|FG002|Overall Study|Withdrawal by Subject|0|||
163401036|NCT00530894|590179551|FG003|Overall Study|Withdrawal by Subject|5|||
163401037|NCT00530894|590179548|FG000|Overall Study|Alive and censored prior to 1 year|2|||
163401038|NCT00530894|590179549|FG001|Overall Study|Alive and censored prior to 1 year|0|||
163401039|NCT00530894|590179550|FG002|Overall Study|Alive and censored prior to 1 year|0|||
163401040|NCT00530894|590179551|FG003|Overall Study|Alive and censored prior to 1 year|0|||
163401041|NCT01230242|590179552|FG000|Overall Study|Physician Decision|2|||
163401042|NCT01230242|590179552|FG000|Overall Study|Withdrawal by Subject|1|||
163401043|NCT02256540|590179553|FG000|Overall Study|Withdrawal by Subject|0|||
163401044|NCT02256540|590179554|FG001|Overall Study|Withdrawal by Subject|1|||
162970635|NCT01332968|588593936|FG003|Induction Period|Non-compliance|0|||
162970636|NCT01332968|588593937|FG004|Induction Period|Non-compliance|0|||
162970637|NCT01332968|588593938|FG005|Induction Period|Non-compliance|0|||
162970638|NCT01332968|588593939|FG006|Induction Period|Non-compliance|0|||
162970639|NCT01332968|588593940|FG007|Induction Period|Non-compliance|0|||
162970640|NCT01332968|588593933|FG000|Induction Period|Other|2|||
162970641|NCT01332968|588593934|FG001|Induction Period|Other|2|||
162970642|NCT01332968|588593935|FG002|Induction Period|Other|0|||
163401045|NCT02256540|590179555|FG002|Overall Study|Withdrawal by Subject|1|||
162970643|NCT01332968|588593936|FG003|Induction Period|Other|0|||
162970644|NCT01332968|588593937|FG004|Induction Period|Other|0|||
162970645|NCT01332968|588593938|FG005|Induction Period|Other|0|||
162970646|NCT01332968|588593939|FG006|Induction Period|Other|0|||
162970647|NCT01332968|588593940|FG007|Induction Period|Other|0|||
162970648|NCT01332968|588593933|FG000|Induction Period|Physician Decision|6|||
162970649|NCT01332968|588593934|FG001|Induction Period|Physician Decision|1|||
162970650|NCT01332968|588593935|FG002|Induction Period|Physician Decision|0|||
162970651|NCT01332968|588593936|FG003|Induction Period|Physician Decision|0|||
162970652|NCT01332968|588593937|FG004|Induction Period|Physician Decision|0|||
162970653|NCT01332968|588593938|FG005|Induction Period|Physician Decision|0|||
162970654|NCT01332968|588593939|FG006|Induction Period|Physician Decision|0|||
162970655|NCT01332968|588593940|FG007|Induction Period|Physician Decision|0|||
162970656|NCT01332968|588593933|FG000|Induction Period|Progressive Disease|15|||
162970657|NCT01332968|588593934|FG001|Induction Period|Progressive Disease|7|||
162970658|NCT01332968|588593935|FG002|Induction Period|Progressive Disease|0|||
162970659|NCT01332968|588593936|FG003|Induction Period|Progressive Disease|0|||
162970660|NCT01332968|588593937|FG004|Induction Period|Progressive Disease|0|||
162970661|NCT01332968|588593938|FG005|Induction Period|Progressive Disease|0|||
162970662|NCT01332968|588593939|FG006|Induction Period|Progressive Disease|0|||
162970663|NCT01332968|588593940|FG007|Induction Period|Progressive Disease|0|||
162970664|NCT01332968|588593933|FG000|Induction Period|Protocol Violation|3|||
162970665|NCT01332968|588593934|FG001|Induction Period|Protocol Violation|4|||
162970666|NCT01332968|588593935|FG002|Induction Period|Protocol Violation|0|||
162970667|NCT01332968|588593936|FG003|Induction Period|Protocol Violation|0|||
162970668|NCT01332968|588593937|FG004|Induction Period|Protocol Violation|0|||
162970669|NCT01332968|588593938|FG005|Induction Period|Protocol Violation|0|||
162970670|NCT01332968|588593939|FG006|Induction Period|Protocol Violation|0|||
162970671|NCT01332968|588593940|FG007|Induction Period|Protocol Violation|0|||
162970672|NCT01332968|588593933|FG000|Induction Period|Withdrawal by Subject|3|||
162970673|NCT01332968|588593934|FG001|Induction Period|Withdrawal by Subject|5|||
162970674|NCT01332968|588593935|FG002|Induction Period|Withdrawal by Subject|0|||
162970675|NCT01332968|588593936|FG003|Induction Period|Withdrawal by Subject|0|||
162970676|NCT01332968|588593937|FG004|Induction Period|Withdrawal by Subject|0|||
162970677|NCT01332968|588593938|FG005|Induction Period|Withdrawal by Subject|0|||
162970678|NCT01332968|588593939|FG006|Induction Period|Withdrawal by Subject|0|||
162970679|NCT01332968|588593940|FG007|Induction Period|Withdrawal by Subject|0|||
162970680|NCT01332968|588593933|FG000|Induction Period|Randomised but not treated|4|||
162970681|NCT01332968|588593934|FG001|Induction Period|Randomised but not treated|7|||
162970682|NCT01332968|588593935|FG002|Induction Period|Randomised but not treated|0|||
162970683|NCT01332968|588593936|FG003|Induction Period|Randomised but not treated|0|||
162970684|NCT01332968|588593937|FG004|Induction Period|Randomised but not treated|0|||
162970685|NCT01332968|588593938|FG005|Induction Period|Randomised but not treated|0|||
162970686|NCT01332968|588593939|FG006|Induction Period|Randomised but not treated|0|||
162970687|NCT01332968|588593940|FG007|Induction Period|Randomised but not treated|0|||
162970688|NCT01332968|588593933|FG000|Maintenance/Observation Period|Adverse Event|0|||
162970689|NCT01332968|588593934|FG001|Maintenance/Observation Period|Adverse Event|0|||
162970690|NCT01332968|588593935|FG002|Maintenance/Observation Period|Adverse Event|53|||
162970691|NCT01332968|588593936|FG003|Maintenance/Observation Period|Adverse Event|66|||
162970692|NCT01332968|588593937|FG004|Maintenance/Observation Period|Adverse Event|0|||
162970693|NCT01332968|588593938|FG005|Maintenance/Observation Period|Adverse Event|0|||
162970694|NCT01332968|588593939|FG006|Maintenance/Observation Period|Adverse Event|0|||
163209117|NCT00555321|589478746|FG003|Treatment Phase up to 12-months|Never treated|0|||
163209118|NCT00555321|589478747|FG004|Treatment Phase up to 12-months|Never treated|4|||
163209119|NCT00555321|589478743|FG000|Long-term Extension Phase|Adverse Event|2|||
162970695|NCT01332968|588593940|FG007|Maintenance/Observation Period|Adverse Event|0|||
162970696|NCT01332968|588593933|FG000|Maintenance/Observation Period|Death|0|||
162970697|NCT01332968|588593934|FG001|Maintenance/Observation Period|Death|0|||
162970698|NCT01332968|588593935|FG002|Maintenance/Observation Period|Death|5|||
163317738|NCT01946789|589874934|FG000|Overall Study|Withdrawal by Subject|0|||
163317739|NCT01946789|589874935|FG001|Overall Study|Withdrawal by Subject|0|||
163317740|NCT01946789|589874936|FG002|Overall Study|Withdrawal by Subject|0|||
163317741|NCT01946789|589874937|FG003|Overall Study|Withdrawal by Subject|2|||
163317742|NCT01946789|589874938|FG004|Overall Study|Withdrawal by Subject|1|||
163317743|NCT01946789|589874939|FG005|Overall Study|Withdrawal by Subject|0|||
163317744|NCT01946789|589874940|FG006|Overall Study|Withdrawal by Subject|1|||
163317745|NCT01946789|589874941|FG007|Overall Study|Withdrawal by Subject|0|||
163401046|NCT02256540|590179553|FG000|Overall Study|Back pain preventing exercise|0|||
163401047|NCT02256540|590179554|FG001|Overall Study|Back pain preventing exercise|0|||
163401048|NCT02256540|590179555|FG002|Overall Study|Back pain preventing exercise|1|||
163401049|NCT03923426|590179556|FG000|Overall Study|Other|19|||
163401050|NCT03923426|590179556|FG000|Overall Study|Lost to Follow-up|16|||
163401051|NCT03923426|590179556|FG000|Overall Study|Death|107|||
163401052|NCT03923426|590179556|FG000|Overall Study|Incomplete response to question|13|||
163401053|NCT02953340|590179564|FG000|Overall Study|Death|0|||
163401054|NCT02953340|590179565|FG001|Overall Study|Death|1|||
163401055|NCT02953340|590179564|FG000|Overall Study|Investigator Decision|3|||
163401056|NCT02953340|590179565|FG001|Overall Study|Investigator Decision|3|||
163401057|NCT02953340|590179564|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
163401058|NCT02953340|590179565|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
163401059|NCT02953340|590179564|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
163401060|NCT02953340|590179565|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
163401061|NCT02953340|590179564|FG000|Overall Study|Withdrawal by Subject|9|||
163401062|NCT02953340|590179565|FG001|Overall Study|Withdrawal by Subject|9|||
163401063|NCT02953340|590179564|FG000|Overall Study|Sponsor decision|0|||
163401064|NCT02953340|590179565|FG001|Overall Study|Sponsor decision|2|||
163401065|NCT02953340|590179564|FG000|Overall Study|Lost to Follow-up|3|||
163401066|NCT02953340|590179565|FG001|Overall Study|Lost to Follow-up|2|||
163401067|NCT02953340|590179564|FG000|Overall Study|Reason not specified|2|||
163401068|NCT02953340|590179565|FG001|Overall Study|Reason not specified|2|||
163401069|NCT02700412|590179568|FG000|Overall Study|Adverse Event|6|||
163401070|NCT02700412|590179568|FG000|Overall Study|Death|1|||
163401071|NCT02700412|590179568|FG000|Overall Study|Lack of Efficacy|19|||
163401072|NCT02700412|590179568|FG000|Overall Study|Protocol Violation|5|||
163401073|NCT02700412|590179568|FG000|Overall Study|Withdrawal by Subject|2|||
163401074|NCT04416555|590179570|FG000|Overall Study|Withdrawal by Subject|0|||
163401075|NCT04416555|590179571|FG001|Overall Study|Withdrawal by Subject|3|||
163401076|NCT00530270|590179574|FG000|Overall Study|Protocol Violation|1|||
163401077|NCT00530270|590179575|FG001|Overall Study|Protocol Violation|0|||
163401078|NCT01923285|590179576|FG000|Overall Study|Withdrawal by Subject|7|||
163401079|NCT01923285|590179577|FG001|Overall Study|Withdrawal by Subject|6|||
163401080|NCT01309659|590179580|FG000|Overall Study|Protocol Violation|0|||
163401081|NCT01309659|590179581|FG001|Overall Study|Protocol Violation|1|||
163401082|NCT03462576|590179582|FG000|Overall Study|Protocol Violation|5|||
163401083|NCT03462576|590179583|FG001|Overall Study|Protocol Violation|11|||
163401084|NCT03462576|590179584|FG002|Overall Study|Protocol Violation|7|||
162970699|NCT01332968|588593936|FG003|Maintenance/Observation Period|Death|6|||
162970700|NCT01332968|588593937|FG004|Maintenance/Observation Period|Death|0|||
162970701|NCT01332968|588593938|FG005|Maintenance/Observation Period|Death|0|||
162970702|NCT01332968|588593939|FG006|Maintenance/Observation Period|Death|0|||
162970703|NCT01332968|588593940|FG007|Maintenance/Observation Period|Death|0|||
162970704|NCT01332968|588593933|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
162970705|NCT01332968|588593934|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
162970706|NCT01332968|588593935|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
162970707|NCT01332968|588593936|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
163401085|NCT03462576|590179582|FG000|Overall Study|Device Malfunction|0|||
163401086|NCT03462576|590179583|FG001|Overall Study|Device Malfunction|0|||
163056346|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
163056347|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
163056348|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
163056349|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
163056350|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
163056351|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
163056352|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
163056353|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
163056354|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
163056355|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
163056356|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
163056357|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
163056358|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
163056359|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
163056360|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
163056361|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
163056362|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
163056363|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
163056364|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
163056365|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
163056366|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
163056367|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
163056368|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
163056369|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
163056370|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
163056371|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
163056372|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
163056373|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
163056374|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
163056375|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
163056376|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
163056377|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
163056378|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
163056379|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
163056380|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
163056381|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
163056382|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
163056383|NCT01791595|588918380|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
163056384|NCT01791595|588918381|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
163056385|NCT01791595|588918382|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
163056386|NCT01791595|588918383|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
163056387|NCT01791595|588918384|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
163056388|NCT01791595|588918385|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
163056389|NCT01791595|588918386|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
163056390|NCT01791595|588918380|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
163056391|NCT01791595|588918381|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
163056392|NCT01791595|588918382|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
163056393|NCT01791595|588918383|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
163056394|NCT01791595|588918384|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
163056395|NCT01791595|588918385|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
163317746|NCT01946789|589874942|FG008|Overall Study|Withdrawal by Subject|0|||
163317747|NCT04076618|589874943|FG000|Overall Study|Lost to Follow-up|2|||
163056396|NCT01791595|588918386|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
162970708|NCT01332968|588593937|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
163209120|NCT00555321|589478744|FG001|Long-term Extension Phase|Adverse Event|5|||
163056397|NCT01791595|588918380|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
163056398|NCT01791595|588918381|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
163056399|NCT01791595|588918382|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
163056400|NCT01791595|588918383|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
163056401|NCT01791595|588918384|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
163056402|NCT01791595|588918385|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
163056403|NCT01791595|588918386|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
163056404|NCT01791595|588918380|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
163056405|NCT01791595|588918381|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
163056406|NCT01791595|588918382|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
163317748|NCT04076618|589874944|FG001|Overall Study|Lost to Follow-up|1|||
163317749|NCT04076618|589874945|FG002|Overall Study|Lost to Follow-up|3|||
163317750|NCT04076618|589874943|FG000|Overall Study|Withdrawal by Subject|3|||
163317751|NCT04076618|589874944|FG001|Overall Study|Withdrawal by Subject|1|||
163317752|NCT04076618|589874945|FG002|Overall Study|Withdrawal by Subject|2|||
163317753|NCT04076618|589874943|FG000|Overall Study|Relocated out of state|0|||
163317754|NCT04076618|589874944|FG001|Overall Study|Relocated out of state|2|||
163056407|NCT01791595|588918383|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
163317755|NCT04076618|589874945|FG002|Overall Study|Relocated out of state|0|||
163317756|NCT04076618|589874943|FG000|Overall Study|COVID concerns|0|||
162970709|NCT01332968|588593938|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
162970710|NCT01332968|588593939|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
162970711|NCT01332968|588593940|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
162970712|NCT01332968|588593933|FG000|Maintenance/Observation Period|Non-compliance|0|||
162970713|NCT01332968|588593934|FG001|Maintenance/Observation Period|Non-compliance|0|||
162970714|NCT01332968|588593935|FG002|Maintenance/Observation Period|Non-compliance|4|||
162970715|NCT01332968|588593936|FG003|Maintenance/Observation Period|Non-compliance|3|||
162970716|NCT01332968|588593937|FG004|Maintenance/Observation Period|Non-compliance|0|||
162970717|NCT01332968|588593938|FG005|Maintenance/Observation Period|Non-compliance|0|||
162970718|NCT01332968|588593939|FG006|Maintenance/Observation Period|Non-compliance|0|||
162970719|NCT01332968|588593940|FG007|Maintenance/Observation Period|Non-compliance|0|||
163209121|NCT00555321|589478745|FG002|Long-term Extension Phase|Adverse Event|2|||
163209122|NCT00555321|589478746|FG003|Long-term Extension Phase|Adverse Event|1|||
163209123|NCT00555321|589478747|FG004|Long-term Extension Phase|Adverse Event|0|||
163209124|NCT00555321|589478743|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
163209125|NCT00555321|589478744|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
163209126|NCT00555321|589478745|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
163209127|NCT00555321|589478746|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
163056408|NCT01791595|588918384|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
163317757|NCT04076618|589874944|FG001|Overall Study|COVID concerns|1|||
163317758|NCT04076618|589874945|FG002|Overall Study|COVID concerns|0|||
162970720|NCT01332968|588593933|FG000|Maintenance/Observation Period|Other|0|||
162970721|NCT01332968|588593934|FG001|Maintenance/Observation Period|Other|0|||
162970722|NCT01332968|588593935|FG002|Maintenance/Observation Period|Other|4|||
162970723|NCT01332968|588593936|FG003|Maintenance/Observation Period|Other|7|||
162970724|NCT01332968|588593937|FG004|Maintenance/Observation Period|Other|0|||
162970725|NCT01332968|588593938|FG005|Maintenance/Observation Period|Other|0|||
162970726|NCT01332968|588593939|FG006|Maintenance/Observation Period|Other|0|||
162970727|NCT01332968|588593940|FG007|Maintenance/Observation Period|Other|0|||
162970728|NCT01332968|588593933|FG000|Maintenance/Observation Period|Physician Decision|0|||
162970729|NCT01332968|588593934|FG001|Maintenance/Observation Period|Physician Decision|0|||
162970730|NCT01332968|588593935|FG002|Maintenance/Observation Period|Physician Decision|14|||
162970731|NCT01332968|588593936|FG003|Maintenance/Observation Period|Physician Decision|19|||
162970732|NCT01332968|588593937|FG004|Maintenance/Observation Period|Physician Decision|0|||
162970733|NCT01332968|588593938|FG005|Maintenance/Observation Period|Physician Decision|1|||
162970734|NCT01332968|588593939|FG006|Maintenance/Observation Period|Physician Decision|0|||
162970735|NCT01332968|588593940|FG007|Maintenance/Observation Period|Physician Decision|0|||
162970736|NCT01332968|588593933|FG000|Maintenance/Observation Period|Progressive Disease|0|||
162970737|NCT01332968|588593934|FG001|Maintenance/Observation Period|Progressive Disease|0|||
162970738|NCT01332968|588593935|FG002|Maintenance/Observation Period|Progressive Disease|72|||
162970739|NCT01332968|588593936|FG003|Maintenance/Observation Period|Progressive Disease|40|||
162970740|NCT01332968|588593937|FG004|Maintenance/Observation Period|Progressive Disease|0|||
162970741|NCT01332968|588593938|FG005|Maintenance/Observation Period|Progressive Disease|0|||
162970742|NCT01332968|588593939|FG006|Maintenance/Observation Period|Progressive Disease|0|||
162970743|NCT01332968|588593940|FG007|Maintenance/Observation Period|Progressive Disease|0|||
162970744|NCT01332968|588593933|FG000|Maintenance/Observation Period|Protocol Violation|0|||
162970745|NCT01332968|588593934|FG001|Maintenance/Observation Period|Protocol Violation|0|||
162970746|NCT01332968|588593935|FG002|Maintenance/Observation Period|Protocol Violation|1|||
162970747|NCT01332968|588593936|FG003|Maintenance/Observation Period|Protocol Violation|1|||
162970748|NCT01332968|588593937|FG004|Maintenance/Observation Period|Protocol Violation|0|||
162970749|NCT01332968|588593938|FG005|Maintenance/Observation Period|Protocol Violation|0|||
162970750|NCT01332968|588593939|FG006|Maintenance/Observation Period|Protocol Violation|0|||
162970751|NCT01332968|588593940|FG007|Maintenance/Observation Period|Protocol Violation|0|||
162970752|NCT01332968|588593933|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
163401087|NCT03462576|590179584|FG002|Overall Study|Device Malfunction|1|||
163401088|NCT00865904|590179595|FG000|Overall Study|Randomized but not Treated|2|||
163401089|NCT00865904|590179596|FG001|Overall Study|Randomized but not Treated|0|||
163401090|NCT00865904|590179597|FG002|Overall Study|Randomized but not Treated|0|||
163401091|NCT00865904|590179598|FG003|Overall Study|Randomized but not Treated|1|||
163401092|NCT00865904|590179599|FG004|Overall Study|Randomized but not Treated|1|||
163401093|NCT01543828|590179600|FG000|Treatment 2|Lost to Follow-up|1|||
163401094|NCT01543828|590179601|FG001|Treatment 2|Lost to Follow-up|0|||
163401095|NCT00711425|590179604|FG000|Overall Study|Protocol Violation|1|||
163401096|NCT00711425|590179604|FG000|Overall Study|Death|2|||
163401097|NCT00711425|590179604|FG000|Overall Study|Lost to Follow-up|1|||
163401098|NCT01087775|590179607|FG000|Overall Study|failed inclusion criteria|2|||
163401099|NCT00825162|590179613|FG000|Overall Study|Withdrawal by Subject|11|||
163401100|NCT00825162|590179614|FG001|Overall Study|Withdrawal by Subject|13|||
163401101|NCT00825162|590179615|FG002|Overall Study|Withdrawal by Subject|3|||
163401102|NCT00825162|590179613|FG000|Overall Study|Lost to Follow-up|9|||
163401103|NCT00825162|590179614|FG001|Overall Study|Lost to Follow-up|6|||
163401104|NCT00825162|590179615|FG002|Overall Study|Lost to Follow-up|3|||
163401105|NCT00825162|590179613|FG000|Overall Study|Physician Decision|2|||
163401106|NCT00825162|590179614|FG001|Overall Study|Physician Decision|0|||
163401107|NCT00825162|590179615|FG002|Overall Study|Physician Decision|0|||
163401108|NCT00825162|590179613|FG000|Overall Study|Move away from the study area|1|||
163401109|NCT00825162|590179614|FG001|Overall Study|Move away from the study area|0|||
163401110|NCT00825162|590179615|FG002|Overall Study|Move away from the study area|0|||
163401111|NCT00825162|590179613|FG000|Overall Study|Unable to attend the study visit|5|||
163401112|NCT00825162|590179614|FG001|Overall Study|Unable to attend the study visit|2|||
163401113|NCT00825162|590179615|FG002|Overall Study|Unable to attend the study visit|0|||
163401114|NCT00258674|590179618|FG000|Overall Study|Death|32|||
163401115|NCT00258674|590179619|FG001|Overall Study|Death|53|||
163401116|NCT00258674|590179620|FG002|Overall Study|Death|34|||
163401117|NCT01279850|590179621|FG000|Overall Study|Protocol Violation|50|||
163401118|NCT01279850|590179621|FG000|Overall Study|No Drug Administration Information|7|||
163401119|NCT01279850|590179621|FG000|Overall Study|No Visit After Treatment|34|||
163401120|NCT01147744|590179622|FG000|Overall Study|Protocol Violation|1|||
163401121|NCT01147744|590179623|FG001|Overall Study|Protocol Violation|0|||
163401122|NCT01147744|590179624|FG002|Overall Study|Protocol Violation|1|||
163401123|NCT01147744|590179625|FG003|Overall Study|Protocol Violation|0|||
163401124|NCT01147744|590179626|FG004|Overall Study|Protocol Violation|1|||
163401125|NCT01147744|590179627|FG005|Overall Study|Protocol Violation|3|||
163401126|NCT01147744|590179628|FG006|Overall Study|Protocol Violation|1|||
163401127|NCT01147744|590179622|FG000|Overall Study|Physician Decision|0|||
163401128|NCT01147744|590179623|FG001|Overall Study|Physician Decision|1|||
163401129|NCT01147744|590179624|FG002|Overall Study|Physician Decision|1|||
163401130|NCT01147744|590179625|FG003|Overall Study|Physician Decision|0|||
163401131|NCT01147744|590179626|FG004|Overall Study|Physician Decision|0|||
163401132|NCT01147744|590179627|FG005|Overall Study|Physician Decision|0|||
163401133|NCT01147744|590179628|FG006|Overall Study|Physician Decision|1|||
163401134|NCT01147744|590179622|FG000|Overall Study|Lack of Efficacy|11|||
162970753|NCT01332968|588593934|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
162970754|NCT01332968|588593935|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
162970755|NCT01332968|588593936|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
163401135|NCT01147744|590179623|FG001|Overall Study|Lack of Efficacy|11|||
163401136|NCT01147744|590179624|FG002|Overall Study|Lack of Efficacy|9|||
163401137|NCT01147744|590179625|FG003|Overall Study|Lack of Efficacy|11|||
163401138|NCT01147744|590179626|FG004|Overall Study|Lack of Efficacy|13|||
163401139|NCT01147744|590179627|FG005|Overall Study|Lack of Efficacy|8|||
163401140|NCT01147744|590179628|FG006|Overall Study|Lack of Efficacy|7|||
163401141|NCT01147744|590179622|FG000|Overall Study|Adverse Event|1|||
163401142|NCT01147744|590179623|FG001|Overall Study|Adverse Event|2|||
163401143|NCT01147744|590179624|FG002|Overall Study|Adverse Event|3|||
162970756|NCT01332968|588593937|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
163401144|NCT01147744|590179625|FG003|Overall Study|Adverse Event|0|||
163401145|NCT01147744|590179626|FG004|Overall Study|Adverse Event|2|||
163401146|NCT01147744|590179627|FG005|Overall Study|Adverse Event|1|||
163401147|NCT01147744|590179628|FG006|Overall Study|Adverse Event|2|||
163401148|NCT01147744|590179622|FG000|Overall Study|Withdrawal by Subject|8|||
163401149|NCT01147744|590179623|FG001|Overall Study|Withdrawal by Subject|4|||
162970757|NCT01332968|588593938|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
162970758|NCT01332968|588593939|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
162970759|NCT01332968|588593940|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
163317759|NCT04076618|589874943|FG000|Overall Study|Adverse Event|0|||
163317760|NCT04076618|589874944|FG001|Overall Study|Adverse Event|0|||
163317761|NCT04076618|589874945|FG002|Overall Study|Adverse Event|2|||
163317762|NCT01928394|589874946|FG000|Treatment Period|Disease progression|17|||
163317763|NCT01928394|589874947|FG001|Treatment Period|Disease progression|2|||
163317764|NCT01928394|589874948|FG002|Treatment Period|Disease progression|12|||
163317765|NCT01928394|589874949|FG003|Treatment Period|Disease progression|48|||
163317766|NCT01928394|589874950|FG004|Treatment Period|Disease progression|3|||
163317767|NCT01928394|589874951|FG005|Treatment Period|Disease progression|25|||
163317768|NCT01928394|589874952|FG006|Treatment Period|Disease progression|38|||
163317769|NCT01928394|589874953|FG007|Treatment Period|Disease progression|16|||
163317770|NCT01928394|589874954|FG008|Treatment Period|Disease progression|3|||
163317771|NCT01928394|589874955|FG009|Treatment Period|Disease progression|11|||
163317772|NCT01928394|589874956|FG010|Treatment Period|Disease progression|22|||
163317773|NCT01928394|589874957|FG011|Treatment Period|Disease progression|73|||
163317774|NCT01928394|589874958|FG012|Treatment Period|Disease progression|38|||
163317775|NCT01928394|589874959|FG013|Treatment Period|Disease progression|118|||
163317776|NCT01928394|589874960|FG014|Treatment Period|Disease progression|59|||
162970760|NCT01332968|588593933|FG000|Follow-Up Period|Adverse Event|0|||
163317777|NCT01928394|589874961|FG015|Treatment Period|Disease progression|1|||
163317778|NCT01928394|589874962|FG016|Treatment Period|Disease progression|43|||
163317779|NCT01928394|589874963|FG017|Treatment Period|Disease progression|56|||
163317780|NCT01928394|589874964|FG018|Treatment Period|Disease progression|50|||
163317781|NCT01928394|589874965|FG019|Treatment Period|Disease progression|71|||
163056409|NCT01791595|588918385|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
163056410|NCT01791595|588918386|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
163056411|NCT06494761|588918390|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
163056412|NCT06494761|588918390|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
163056413|NCT04865289|588918391|FG000|Overall Study|Death|34|||
163056414|NCT04865289|588918392|FG001|Overall Study|Death|25|||
163056415|NCT04865289|588918391|FG000|Overall Study|Physician Decision|27|||
163056416|NCT04865289|588918392|FG001|Overall Study|Physician Decision|27|||
163056417|NCT04865289|588918391|FG000|Overall Study|Sponsor Decision|11|||
163056418|NCT04865289|588918392|FG001|Overall Study|Sponsor Decision|1|||
163056419|NCT04865289|588918391|FG000|Overall Study|Withdrawal by Subject|2|||
163056420|NCT04865289|588918392|FG001|Overall Study|Withdrawal by Subject|3|||
163056421|NCT03104374|588918393|FG000|Period 1|Adverse Event|7|||
163056422|NCT03104374|588918394|FG001|Period 1|Adverse Event|7|||
163056423|NCT03104374|588918395|FG002|Period 1|Adverse Event|12|||
163056424|NCT03104374|588918396|FG003|Period 1|Adverse Event|14|||
163056425|NCT03104374|588918393|FG000|Period 1|Withdrawal by Subject|18|||
163056426|NCT03104374|588918394|FG001|Period 1|Withdrawal by Subject|9|||
163056427|NCT03104374|588918395|FG002|Period 1|Withdrawal by Subject|10|||
163056428|NCT03104374|588918396|FG003|Period 1|Withdrawal by Subject|17|||
163056429|NCT03104374|588918393|FG000|Period 1|Lost to Follow-up|4|||
163056430|NCT03104374|588918394|FG001|Period 1|Lost to Follow-up|4|||
163056431|NCT03104374|588918395|FG002|Period 1|Lost to Follow-up|6|||
163056432|NCT03104374|588918396|FG003|Period 1|Lost to Follow-up|8|||
163056433|NCT03104374|588918393|FG000|Period 1|Lack of Efficacy|6|||
163056434|NCT03104374|588918394|FG001|Period 1|Lack of Efficacy|7|||
163056435|NCT03104374|588918395|FG002|Period 1|Lack of Efficacy|12|||
163056436|NCT03104374|588918396|FG003|Period 1|Lack of Efficacy|6|||
163056437|NCT03104374|588918393|FG000|Period 1|Other|2|||
163056438|NCT03104374|588918394|FG001|Period 1|Other|2|||
163056439|NCT03104374|588918395|FG002|Period 1|Other|4|||
163056440|NCT03104374|588918396|FG003|Period 1|Other|7|||
163056441|NCT03104374|588918393|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
163056442|NCT03104374|588918394|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
163056443|NCT03104374|588918395|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
163056444|NCT03104374|588918396|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
163056445|NCT03104374|588918393|FG000|Period 2|Adverse Event|4|||
163056446|NCT03104374|588918394|FG001|Period 2|Adverse Event|7|||
163056447|NCT03104374|588918395|FG002|Period 2|Adverse Event|10|||
163056448|NCT03104374|588918396|FG003|Period 2|Adverse Event|10|||
163056449|NCT03104374|588918393|FG000|Period 2|Withdrawal by Subject|3|||
163056450|NCT03104374|588918394|FG001|Period 2|Withdrawal by Subject|7|||
163056451|NCT03104374|588918395|FG002|Period 2|Withdrawal by Subject|13|||
163056452|NCT03104374|588918396|FG003|Period 2|Withdrawal by Subject|16|||
163056453|NCT03104374|588918393|FG000|Period 2|Lost to Follow-up|2|||
163056454|NCT03104374|588918394|FG001|Period 2|Lost to Follow-up|2|||
163056455|NCT03104374|588918395|FG002|Period 2|Lost to Follow-up|3|||
163056456|NCT03104374|588918396|FG003|Period 2|Lost to Follow-up|5|||
163056457|NCT03104374|588918393|FG000|Period 2|Lack of Efficacy|2|||
163056458|NCT03104374|588918394|FG001|Period 2|Lack of Efficacy|4|||
163056459|NCT03104374|588918395|FG002|Period 2|Lack of Efficacy|7|||
163056460|NCT03104374|588918396|FG003|Period 2|Lack of Efficacy|4|||
163056461|NCT03104374|588918393|FG000|Period 2|COVID-19 Infection|0|||
163056462|NCT03104374|588918394|FG001|Period 2|COVID-19 Infection|0|||
163056463|NCT03104374|588918395|FG002|Period 2|COVID-19 Infection|1|||
163056464|NCT03104374|588918396|FG003|Period 2|COVID-19 Infection|0|||
163056465|NCT03104374|588918393|FG000|Period 2|Other|3|||
163056466|NCT03104374|588918394|FG001|Period 2|Other|2|||
163056467|NCT03104374|588918395|FG002|Period 2|Other|2|||
163056468|NCT03104374|588918396|FG003|Period 2|Other|4|||
163056469|NCT03210714|588918397|FG000|Overall Study|Adverse Event|6|||
163209128|NCT00555321|589478747|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
163056470|NCT03210714|588918397|FG000|Overall Study|Physician Decision|1|||
163056471|NCT03210714|588918397|FG000|Overall Study|Progressive disease|11|||
163209129|NCT00555321|589478743|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
163209130|NCT00555321|589478744|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
163056472|NCT03210714|588918397|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
163056473|NCT00803179|588918398|FG000|Overall Study|Lost to Follow-up|3|||
163056474|NCT04158648|588918399|FG000|Overall Study|Ongoing in the Study|69|||
163056475|NCT04158648|588918399|FG000|Overall Study|Withdrawal by Subject|4|||
163056476|NCT04609514|588918400|FG000|Overall Study|Lost to Follow-up|5|||
163056477|NCT04609514|588918401|FG001|Overall Study|Lost to Follow-up|4|||
163056478|NCT04609514|588918400|FG000|Overall Study|Withdrawal by PI|0|||
163056479|NCT04609514|588918401|FG001|Overall Study|Withdrawal by PI|2|||
163056480|NCT00885118|588918402|FG000|Overall Study|Adverse Event|1|||
163056481|NCT00885118|588918403|FG001|Overall Study|Adverse Event|0|||
163056482|NCT00885118|588918404|FG002|Overall Study|Adverse Event|0|||
163056483|NCT00885118|588918405|FG003|Overall Study|Adverse Event|0|||
163056484|NCT00885118|588918406|FG004|Overall Study|Adverse Event|0|||
163056485|NCT00885118|588918402|FG000|Overall Study|Withdrawal by Subject|0|||
163056486|NCT00885118|588918403|FG001|Overall Study|Withdrawal by Subject|0|||
163056487|NCT00885118|588918404|FG002|Overall Study|Withdrawal by Subject|0|||
163056488|NCT00885118|588918405|FG003|Overall Study|Withdrawal by Subject|0|||
163056489|NCT00885118|588918406|FG004|Overall Study|Withdrawal by Subject|1|||
163056490|NCT00885118|588918402|FG000|Overall Study|Other reason not defined above|0|||
163056491|NCT00885118|588918403|FG001|Overall Study|Other reason not defined above|0|||
163056492|NCT00885118|588918404|FG002|Overall Study|Other reason not defined above|1|||
163056493|NCT00885118|588918405|FG003|Overall Study|Other reason not defined above|0|||
163056494|NCT00885118|588918406|FG004|Overall Study|Other reason not defined above|0|||
163056495|NCT01265498|588918415|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
163056496|NCT01265498|588918416|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
163056497|NCT05399680|588919659|FG000|Overall Study|Lost to Follow-up|1|||
163056498|NCT05399680|588919660|FG001|Overall Study|Lost to Follow-up|0|||
163056499|NCT05399680|588919659|FG000|Overall Study|Death|0|||
163056500|NCT05399680|588919660|FG001|Overall Study|Death|1|||
163056501|NCT00959751|588919662|FG000|Overall Study|Lost to Follow-up|2|||
163056502|NCT00959751|588919663|FG001|Overall Study|Lost to Follow-up|3|||
163056503|NCT00959751|588919662|FG000|Overall Study|Consent Withdrawn|0|||
163056504|NCT00959751|588919663|FG001|Overall Study|Consent Withdrawn|1|||
163056505|NCT00959751|588919662|FG000|Overall Study|Non-compliance to Study Procedures|0|||
163056506|NCT00959751|588919663|FG001|Overall Study|Non-compliance to Study Procedures|1|||
163056507|NCT00959751|588919662|FG000|Overall Study|No migraine headache without aura|7|||
163056508|NCT00959751|588919663|FG001|Overall Study|No migraine headache without aura|7|||
163056509|NCT03737994|588919664|FG000|Overall Study|Withdrawal by Subject|0|||
163056510|NCT03737994|588919665|FG001|Overall Study|Withdrawal by Subject|0|||
163056511|NCT03737994|588919666|FG002|Overall Study|Withdrawal by Subject|0|||
163056512|NCT03737994|588919667|FG003|Overall Study|Withdrawal by Subject|0|||
163056513|NCT03737994|588919668|FG004|Overall Study|Withdrawal by Subject|0|||
163056514|NCT03737994|588919669|FG005|Overall Study|Withdrawal by Subject|0|||
163056515|NCT03737994|588919670|FG006|Overall Study|Withdrawal by Subject|1|||
163056516|NCT01373164|588919671|FG000|Overall Study|Lost to Follow-up|0|||
163056517|NCT01373164|588919672|FG001|Overall Study|Lost to Follow-up|0|||
163056518|NCT01373164|588919673|FG002|Overall Study|Lost to Follow-up|1|||
163056519|NCT01373164|588919674|FG003|Overall Study|Lost to Follow-up|2|||
163056520|NCT01373164|588919675|FG004|Overall Study|Lost to Follow-up|0|||
163056521|NCT01373164|588919671|FG000|Overall Study|Withdrawal by Subject|0|||
163056522|NCT01373164|588919672|FG001|Overall Study|Withdrawal by Subject|1|||
163056523|NCT01373164|588919673|FG002|Overall Study|Withdrawal by Subject|0|||
163056524|NCT01373164|588919674|FG003|Overall Study|Withdrawal by Subject|10|||
163056525|NCT01373164|588919675|FG004|Overall Study|Withdrawal by Subject|2|||
163056526|NCT00761319|588919676|FG000|Overall Study|Protocol Violation|21|||
163056527|NCT00761319|588919677|FG001|Overall Study|Protocol Violation|14|||
163056528|NCT00761319|588919676|FG000|Overall Study|Adverse Event|11|||
163056529|NCT00761319|588919677|FG001|Overall Study|Adverse Event|7|||
163056530|NCT00761319|588919676|FG000|Overall Study|Withdrawal by Subject|8|||
163056531|NCT00761319|588919677|FG001|Overall Study|Withdrawal by Subject|7|||
163056532|NCT00761319|588919676|FG000|Overall Study|Noncompliance|4|||
163056533|NCT00761319|588919677|FG001|Overall Study|Noncompliance|3|||
163056534|NCT00761319|588919676|FG000|Overall Study|Lost to Follow-up|1|||
163056535|NCT00761319|588919677|FG001|Overall Study|Lost to Follow-up|1|||
163056536|NCT00761319|588919676|FG000|Overall Study|Nonspecified|2|||
163056537|NCT00761319|588919677|FG001|Overall Study|Nonspecified|2|||
163056538|NCT00761319|588919676|FG000|Overall Study|Missing|1|||
163056539|NCT00761319|588919677|FG001|Overall Study|Missing|0|||
163056540|NCT03055013|588919682|FG000|Overall Study|Adverse Event|78|||
163056541|NCT03055013|588919683|FG001|Overall Study|Adverse Event|0|||
163056542|NCT03055013|588919682|FG000|Overall Study|Death|6|||
163056543|NCT03055013|588919683|FG001|Overall Study|Death|0|||
163056544|NCT03055013|588919682|FG000|Overall Study|Disease relapse|33|||
163056545|NCT03055013|588919683|FG001|Overall Study|Disease relapse|0|||
163056546|NCT03055013|588919682|FG000|Overall Study|Withdrawal by Subject|28|||
163056547|NCT03055013|588919683|FG001|Overall Study|Withdrawal by Subject|0|||
163056548|NCT03055013|588919682|FG000|Overall Study|Other complicating disease|5|||
163056549|NCT03055013|588919683|FG001|Overall Study|Other complicating disease|0|||
163209131|NCT00555321|589478745|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
163056550|NCT03055013|588919682|FG000|Overall Study|Physician Decision|1|||
163056551|NCT03055013|588919683|FG001|Overall Study|Physician Decision|0|||
163056552|NCT03055013|588919682|FG000|Overall Study|Benign mass/non-RCC|4|||
163056553|NCT03055013|588919683|FG001|Overall Study|Benign mass/non-RCC|0|||
163056554|NCT03055013|588919682|FG000|Overall Study|Enrolled in another trial|1|||
163209132|NCT00555321|589478746|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
163209133|NCT00555321|589478747|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
163056555|NCT03055013|588919683|FG001|Overall Study|Enrolled in another trial|0|||
163056556|NCT03055013|588919682|FG000|Overall Study|Non-protocol therapy|1|||
163056557|NCT03055013|588919683|FG001|Overall Study|Non-protocol therapy|0|||
163056558|NCT03055013|588919682|FG000|Overall Study|Incompliance|1|||
163056559|NCT03055013|588919683|FG001|Overall Study|Incompliance|0|||
163056560|NCT03055013|588919682|FG000|Overall Study|Insurance issues|1|||
163056561|NCT03055013|588919683|FG001|Overall Study|Insurance issues|0|||
163056562|NCT03055013|588919682|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
163056563|NCT03055013|588919683|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
163056564|NCT03055013|588919682|FG000|Overall Study|Did not receive nivolumab|10|||
163056565|NCT03055013|588919683|FG001|Overall Study|Did not receive nivolumab|0|||
163056566|NCT03055013|588919682|FG000|Overall Study|Did not receive surgery|0|||
163056567|NCT03055013|588919683|FG001|Overall Study|Did not receive surgery|28|||
163056568|NCT02765035|588919688|FG000|First Intervention (90 Days)|Adverse Event|1|||
163056569|NCT02765035|588919689|FG001|First Intervention (90 Days)|Adverse Event|1|||
163056570|NCT02765035|588919688|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
163056571|NCT02765035|588919689|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
163056572|NCT00671749|588919691|FG000|Overall Study|Adverse Event|2|||
163056573|NCT00671749|588919691|FG000|Overall Study|Withdrawal by Subject|4|||
163056574|NCT00671749|588919691|FG000|Overall Study|Protocol Violation|1|||
163056575|NCT00671749|588919691|FG000|Overall Study|Lost to Follow-up|1|||
163056576|NCT01259245|588919697|FG000|Overall Study|Withdrawal by Subject|27|||
163056577|NCT01259245|588919698|FG001|Overall Study|Withdrawal by Subject|24|||
163056578|NCT01259245|588919697|FG000|Overall Study|Death|1|||
163056579|NCT01259245|588919698|FG001|Overall Study|Death|2|||
163056580|NCT03937778|588919699|FG000|Overall Study|Withdrawal by Subject|1|||
163056581|NCT03937778|588919699|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
163056582|NCT01200355|588919701|FG000|Overall Study|Death|7|||
163056583|NCT01200355|588919702|FG001|Overall Study|Death|2|||
163056584|NCT00485303|588919703|FG000|Overall Study|Adverse Event|5|||
163056585|NCT00485303|588919703|FG000|Overall Study|Progressive Disease|44|||
163056586|NCT00485303|588919703|FG000|Overall Study|Other|3|||
163056587|NCT00485303|588919703|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
163056588|NCT00485303|588919703|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
163056589|NCT00296335|588919708|FG000|Overall Study|Recurrence|3|||
163056590|NCT00296335|588919709|FG001|Overall Study|Recurrence|51|||
163056591|NCT00296335|588919708|FG000|Overall Study|Adverse Event|17|||
163056592|NCT00296335|588919709|FG001|Overall Study|Adverse Event|27|||
163056593|NCT00296335|588919708|FG000|Overall Study|Lost to Follow-up|7|||
163056594|NCT00296335|588919709|FG001|Overall Study|Lost to Follow-up|33|||
163056595|NCT00296335|588919708|FG000|Overall Study|Physician Decision|3|||
163056596|NCT00296335|588919709|FG001|Overall Study|Physician Decision|11|||
163056597|NCT01027845|588919710|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
163056598|NCT01027845|588919711|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
163056599|NCT01027845|588919712|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
163056600|NCT01027845|588919713|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
163056601|NCT01027845|588919710|FG000|Primary Vaccination Phase|Adverse Event|1|||
163056602|NCT01027845|588919711|FG001|Primary Vaccination Phase|Adverse Event|0|||
163056603|NCT01027845|588919712|FG002|Primary Vaccination Phase|Adverse Event|0|||
163056604|NCT01027845|588919713|FG003|Primary Vaccination Phase|Adverse Event|0|||
163056605|NCT01027845|588919710|FG000|Primary Vaccination Phase|Protocol Violation|1|||
163056606|NCT01027845|588919711|FG001|Primary Vaccination Phase|Protocol Violation|0|||
163056607|NCT01027845|588919712|FG002|Primary Vaccination Phase|Protocol Violation|0|||
163056608|NCT01027845|588919713|FG003|Primary Vaccination Phase|Protocol Violation|0|||
163056609|NCT01027845|588919710|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
163056610|NCT01027845|588919711|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
163056611|NCT01027845|588919712|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
163056612|NCT01027845|588919713|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
163056613|NCT01027845|588919710|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
163056614|NCT01027845|588919711|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
163056615|NCT01027845|588919712|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
163056616|NCT01027845|588919713|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
163056617|NCT01027845|588919710|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
163056618|NCT01027845|588919711|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
163056619|NCT01027845|588919712|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
163056620|NCT01027845|588919713|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
163056621|NCT01281306|588919714|FG000|Overall Study|Lack of Efficacy|0|||
163056622|NCT01281306|588919715|FG001|Overall Study|Lack of Efficacy|1|||
163056623|NCT01281306|588919716|FG002|Overall Study|Lack of Efficacy|3|||
163056624|NCT01281306|588919717|FG003|Overall Study|Lack of Efficacy|0|||
163056625|NCT01281306|588919718|FG004|Overall Study|Lack of Efficacy|2|||
163401150|NCT01147744|590179624|FG002|Overall Study|Withdrawal by Subject|2|||
163401151|NCT01147744|590179625|FG003|Overall Study|Withdrawal by Subject|2|||
163209134|NCT00555321|589478743|FG000|Long-term Extension Phase|Death|2|||
163209135|NCT00555321|589478744|FG001|Long-term Extension Phase|Death|0|||
163209136|NCT00555321|589478745|FG002|Long-term Extension Phase|Death|0|||
163056626|NCT01281306|588919719|FG005|Overall Study|Lack of Efficacy|0|||
163056627|NCT01281306|588919720|FG006|Overall Study|Lack of Efficacy|1|||
163056628|NCT01281306|588919714|FG000|Overall Study|Withdrawal by Subject|1|||
163056629|NCT01281306|588919715|FG001|Overall Study|Withdrawal by Subject|0|||
163056630|NCT01281306|588919716|FG002|Overall Study|Withdrawal by Subject|2|||
163056631|NCT01281306|588919717|FG003|Overall Study|Withdrawal by Subject|4|||
163056632|NCT01281306|588919718|FG004|Overall Study|Withdrawal by Subject|1|||
163056633|NCT01281306|588919719|FG005|Overall Study|Withdrawal by Subject|3|||
163056634|NCT01281306|588919720|FG006|Overall Study|Withdrawal by Subject|1|||
163056635|NCT01281306|588919714|FG000|Overall Study|Protocol deviation|0|||
163056636|NCT01281306|588919715|FG001|Overall Study|Protocol deviation|1|||
163056637|NCT01281306|588919716|FG002|Overall Study|Protocol deviation|1|||
163056638|NCT01281306|588919717|FG003|Overall Study|Protocol deviation|1|||
163056639|NCT01281306|588919718|FG004|Overall Study|Protocol deviation|1|||
163056640|NCT01281306|588919719|FG005|Overall Study|Protocol deviation|0|||
163056641|NCT01281306|588919720|FG006|Overall Study|Protocol deviation|0|||
163056642|NCT01281306|588919714|FG000|Overall Study|Condition no longer requires study drug|1|||
163056643|NCT01281306|588919715|FG001|Overall Study|Condition no longer requires study drug|0|||
163056644|NCT01281306|588919716|FG002|Overall Study|Condition no longer requires study drug|0|||
163056645|NCT01281306|588919717|FG003|Overall Study|Condition no longer requires study drug|0|||
163317782|NCT01928394|589874966|FG020|Treatment Period|Disease progression|30|||
163056646|NCT01281306|588919718|FG004|Overall Study|Condition no longer requires study drug|0|||
163056647|NCT01281306|588919719|FG005|Overall Study|Condition no longer requires study drug|1|||
163056648|NCT01281306|588919720|FG006|Overall Study|Condition no longer requires study drug|1|||
163056649|NCT01281306|588919714|FG000|Overall Study|Lost to Follow-up|1|||
163056650|NCT01281306|588919715|FG001|Overall Study|Lost to Follow-up|0|||
163056651|NCT01281306|588919716|FG002|Overall Study|Lost to Follow-up|0|||
163056652|NCT01281306|588919717|FG003|Overall Study|Lost to Follow-up|2|||
163056653|NCT01281306|588919718|FG004|Overall Study|Lost to Follow-up|0|||
163056654|NCT01281306|588919719|FG005|Overall Study|Lost to Follow-up|0|||
163317783|NCT01928394|589874967|FG021|Treatment Period|Disease progression|31|||
162970761|NCT01332968|588593934|FG001|Follow-Up Period|Adverse Event|0|||
162970762|NCT01332968|588593935|FG002|Follow-Up Period|Adverse Event|0|||
162970763|NCT01332968|588593936|FG003|Follow-Up Period|Adverse Event|0|||
162970764|NCT01332968|588593937|FG004|Follow-Up Period|Adverse Event|0|||
162970765|NCT01332968|588593938|FG005|Follow-Up Period|Adverse Event|0|||
162970766|NCT01332968|588593939|FG006|Follow-Up Period|Adverse Event|0|||
162970767|NCT01332968|588593940|FG007|Follow-Up Period|Adverse Event|4|||
162970768|NCT01332968|588593933|FG000|Follow-Up Period|Death|0|||
162970769|NCT01332968|588593934|FG001|Follow-Up Period|Death|0|||
162970770|NCT01332968|588593935|FG002|Follow-Up Period|Death|0|||
162970771|NCT01332968|588593936|FG003|Follow-Up Period|Death|0|||
162970772|NCT01332968|588593937|FG004|Follow-Up Period|Death|0|||
162970773|NCT01332968|588593938|FG005|Follow-Up Period|Death|0|||
162970774|NCT01332968|588593939|FG006|Follow-Up Period|Death|27|||
162970775|NCT01332968|588593940|FG007|Follow-Up Period|Death|30|||
162970776|NCT01332968|588593933|FG000|Follow-Up Period|Lost to Follow-up|0|||
162970777|NCT01332968|588593934|FG001|Follow-Up Period|Lost to Follow-up|0|||
162970778|NCT01332968|588593935|FG002|Follow-Up Period|Lost to Follow-up|0|||
162970779|NCT01332968|588593936|FG003|Follow-Up Period|Lost to Follow-up|0|||
162970780|NCT01332968|588593937|FG004|Follow-Up Period|Lost to Follow-up|0|||
162970781|NCT01332968|588593938|FG005|Follow-Up Period|Lost to Follow-up|0|||
162970782|NCT01332968|588593939|FG006|Follow-Up Period|Lost to Follow-up|11|||
162970783|NCT01332968|588593940|FG007|Follow-Up Period|Lost to Follow-up|15|||
162970784|NCT01332968|588593933|FG000|Follow-Up Period|Non-compliance|0|||
162970785|NCT01332968|588593934|FG001|Follow-Up Period|Non-compliance|0|||
162970786|NCT01332968|588593935|FG002|Follow-Up Period|Non-compliance|0|||
162970787|NCT01332968|588593936|FG003|Follow-Up Period|Non-compliance|0|||
162970788|NCT01332968|588593937|FG004|Follow-Up Period|Non-compliance|0|||
162970789|NCT01332968|588593938|FG005|Follow-Up Period|Non-compliance|0|||
162970790|NCT01332968|588593939|FG006|Follow-Up Period|Non-compliance|4|||
162970791|NCT01332968|588593940|FG007|Follow-Up Period|Non-compliance|9|||
162970792|NCT01332968|588593933|FG000|Follow-Up Period|Other|0|||
162970793|NCT01332968|588593934|FG001|Follow-Up Period|Other|0|||
162970794|NCT01332968|588593935|FG002|Follow-Up Period|Other|0|||
162970795|NCT01332968|588593936|FG003|Follow-Up Period|Other|0|||
162970796|NCT01332968|588593937|FG004|Follow-Up Period|Other|0|||
162970797|NCT01332968|588593938|FG005|Follow-Up Period|Other|0|||
162970798|NCT01332968|588593939|FG006|Follow-Up Period|Other|18|||
162970799|NCT01332968|588593940|FG007|Follow-Up Period|Other|21|||
162970800|NCT01332968|588593933|FG000|Follow-Up Period|Physician Decision|0|||
162970801|NCT01332968|588593934|FG001|Follow-Up Period|Physician Decision|0|||
162970802|NCT01332968|588593935|FG002|Follow-Up Period|Physician Decision|0|||
162970803|NCT01332968|588593936|FG003|Follow-Up Period|Physician Decision|0|||
162970804|NCT01332968|588593937|FG004|Follow-Up Period|Physician Decision|0|||
162970805|NCT01332968|588593938|FG005|Follow-Up Period|Physician Decision|0|||
162970806|NCT01332968|588593939|FG006|Follow-Up Period|Physician Decision|12|||
162970807|NCT01332968|588593940|FG007|Follow-Up Period|Physician Decision|15|||
162970808|NCT01332968|588593933|FG000|Follow-Up Period|Progressive Disease|0|||
162970809|NCT01332968|588593934|FG001|Follow-Up Period|Progressive Disease|0|||
162970810|NCT01332968|588593935|FG002|Follow-Up Period|Progressive Disease|0|||
162970811|NCT01332968|588593936|FG003|Follow-Up Period|Progressive Disease|0|||
162970812|NCT01332968|588593937|FG004|Follow-Up Period|Progressive Disease|0|||
162970813|NCT01332968|588593938|FG005|Follow-Up Period|Progressive Disease|0|||
162970814|NCT01332968|588593939|FG006|Follow-Up Period|Progressive Disease|126|||
162970815|NCT01332968|588593940|FG007|Follow-Up Period|Progressive Disease|106|||
162970816|NCT01332968|588593933|FG000|Follow-Up Period|Protocol Violation|0|||
162970817|NCT01332968|588593934|FG001|Follow-Up Period|Protocol Violation|0|||
162970818|NCT01332968|588593935|FG002|Follow-Up Period|Protocol Violation|0|||
162970819|NCT01332968|588593936|FG003|Follow-Up Period|Protocol Violation|0|||
162970820|NCT01332968|588593937|FG004|Follow-Up Period|Protocol Violation|0|||
162970821|NCT01332968|588593938|FG005|Follow-Up Period|Protocol Violation|0|||
162970822|NCT01332968|588593939|FG006|Follow-Up Period|Protocol Violation|1|||
162970823|NCT01332968|588593940|FG007|Follow-Up Period|Protocol Violation|0|||
162970824|NCT01332968|588593933|FG000|Follow-Up Period|Withdrawal by Subject|0|||
162970825|NCT01332968|588593934|FG001|Follow-Up Period|Withdrawal by Subject|0|||
162970826|NCT01332968|588593935|FG002|Follow-Up Period|Withdrawal by Subject|0|||
162970827|NCT01332968|588593936|FG003|Follow-Up Period|Withdrawal by Subject|0|||
162970828|NCT01332968|588593937|FG004|Follow-Up Period|Withdrawal by Subject|0|||
162970829|NCT01332968|588593938|FG005|Follow-Up Period|Withdrawal by Subject|0|||
162970830|NCT01332968|588593939|FG006|Follow-Up Period|Withdrawal by Subject|29|||
162970831|NCT01332968|588593940|FG007|Follow-Up Period|Withdrawal by Subject|32|||
162970832|NCT01332968|588593933|FG000|Follow-Up Period|No reason provided|0|||
162970833|NCT01332968|588593934|FG001|Follow-Up Period|No reason provided|0|||
162970834|NCT01332968|588593935|FG002|Follow-Up Period|No reason provided|0|||
162970835|NCT01332968|588593936|FG003|Follow-Up Period|No reason provided|0|||
162970836|NCT01332968|588593937|FG004|Follow-Up Period|No reason provided|0|||
162970837|NCT01332968|588593938|FG005|Follow-Up Period|No reason provided|0|||
162970838|NCT01332968|588593939|FG006|Follow-Up Period|No reason provided|2|||
162970839|NCT01332968|588593940|FG007|Follow-Up Period|No reason provided|3|||
162970840|NCT00721955|588593941|FG000|Overall Study|Adverse Event|0|||
162970841|NCT00721955|588593942|FG001|Overall Study|Adverse Event|0|||
162970842|NCT00721955|588593943|FG002|Overall Study|Adverse Event|2|||
162970843|NCT04194008|588593948|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
162970844|NCT04194008|588593948|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
162970845|NCT04194008|588593948|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
162970846|NCT04194008|588593948|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
163056655|NCT01281306|588919720|FG006|Overall Study|Lost to Follow-up|1|||
163056656|NCT01281306|588919714|FG000|Overall Study|Death|1|||
163056657|NCT01281306|588919715|FG001|Overall Study|Death|0|||
163056658|NCT01281306|588919716|FG002|Overall Study|Death|0|||
163056659|NCT01281306|588919717|FG003|Overall Study|Death|0|||
163056660|NCT01281306|588919718|FG004|Overall Study|Death|0|||
163056661|NCT01281306|588919719|FG005|Overall Study|Death|0|||
163056662|NCT01281306|588919720|FG006|Overall Study|Death|0|||
163056663|NCT01281306|588919714|FG000|Overall Study|Adverse Event|3|||
163056664|NCT01281306|588919715|FG001|Overall Study|Adverse Event|2|||
163056665|NCT01281306|588919716|FG002|Overall Study|Adverse Event|2|||
163056666|NCT01281306|588919717|FG003|Overall Study|Adverse Event|3|||
163056667|NCT01281306|588919718|FG004|Overall Study|Adverse Event|5|||
163056668|NCT01281306|588919719|FG005|Overall Study|Adverse Event|3|||
163056669|NCT01281306|588919720|FG006|Overall Study|Adverse Event|3|||
163056670|NCT01281306|588919714|FG000|Overall Study|Randomized in error|1|||
163056671|NCT01281306|588919715|FG001|Overall Study|Randomized in error|0|||
163056672|NCT01281306|588919716|FG002|Overall Study|Randomized in error|0|||
163056673|NCT01281306|588919717|FG003|Overall Study|Randomized in error|1|||
163056674|NCT01281306|588919718|FG004|Overall Study|Randomized in error|0|||
163056675|NCT01281306|588919719|FG005|Overall Study|Randomized in error|0|||
163056676|NCT01281306|588919720|FG006|Overall Study|Randomized in error|0|||
163056677|NCT00368550|588919721|FG000|Overall Study|Adverse Event|7|||
163056678|NCT00368550|588919722|FG001|Overall Study|Adverse Event|4|||
163056679|NCT00368550|588919721|FG000|Overall Study|Lack of Efficacy|4|||
163056680|NCT00368550|588919722|FG001|Overall Study|Lack of Efficacy|9|||
163056681|NCT00368550|588919721|FG000|Overall Study|Withdrawal by Subject|17|||
163056682|NCT00368550|588919722|FG001|Overall Study|Withdrawal by Subject|10|||
163056683|NCT01401322|588919723|FG000|Overall Study|Withdrawal by Subject|1|||
163056684|NCT01401322|588919723|FG000|Overall Study|Physician Decision|1|||
163056685|NCT03466346|588919726|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
163056686|NCT03466346|588919727|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
163056687|NCT03466346|588919728|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
163056688|NCT03466346|588919729|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
163056689|NCT03466346|588919730|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
163056690|NCT03466346|588919726|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
163056691|NCT03466346|588919727|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
163056692|NCT03466346|588919728|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
163056693|NCT03466346|588919729|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
163056694|NCT03466346|588919730|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
163056695|NCT03466346|588919726|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
163056696|NCT03466346|588919727|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
163056697|NCT03466346|588919728|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
163056698|NCT03466346|588919729|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
163056699|NCT03466346|588919730|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
163056700|NCT03466346|588919726|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
163056701|NCT03466346|588919727|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
163056702|NCT03466346|588919728|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
163056703|NCT03466346|588919729|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
163056704|NCT03466346|588919730|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
163056705|NCT03466346|588919726|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
163056706|NCT03466346|588919727|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
163056707|NCT03466346|588919728|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
163056708|NCT03466346|588919729|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
163056709|NCT03466346|588919730|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
163056710|NCT03466346|588919726|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
163056711|NCT03466346|588919727|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
163056712|NCT03466346|588919728|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
163056713|NCT03466346|588919729|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
163056714|NCT03466346|588919730|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
163056715|NCT03466346|588919726|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
163056716|NCT03466346|588919727|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
163056717|NCT03466346|588919728|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
163056718|NCT03466346|588919729|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
163056719|NCT03466346|588919730|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
163056720|NCT02410629|588919732|FG000|Overall Study|Family cannot commit to the study|2|||
163056721|NCT02410629|588919733|FG001|Overall Study|Family cannot commit to the study|1|||
163056722|NCT02410629|588919732|FG000|Overall Study|Subject returned to work|1|||
163056723|NCT02410629|588919733|FG001|Overall Study|Subject returned to work|0|||
163056724|NCT02410629|588919732|FG000|Overall Study|Subject moved back to home country|0|||
163056725|NCT02410629|588919733|FG001|Overall Study|Subject moved back to home country|1|||
163056726|NCT02410629|588919732|FG000|Overall Study|Subject underwent heart surgery|0|||
163056727|NCT02410629|588919733|FG001|Overall Study|Subject underwent heart surgery|1|||
163056728|NCT00087178|588919734|FG000|Overall Study|No follow up data|5|||
163056729|NCT00087178|588919735|FG001|Overall Study|No follow up data|15|||
163056730|NCT00087178|588919734|FG000|Overall Study|No clinical assessment|1|||
163056731|NCT00087178|588919735|FG001|Overall Study|No clinical assessment|2|||
163056732|NCT00087178|588919734|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
163056733|NCT00087178|588919735|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
163056734|NCT03451045|588919736|FG000|Overall Study|Lack of Efficacy|3|||
163056735|NCT03451045|588919737|FG001|Overall Study|Lack of Efficacy|2|||
163056736|NCT03451045|588919738|FG002|Overall Study|Lack of Efficacy|2|||
163056737|NCT03451045|588919736|FG000|Overall Study|Physician Decision|1|||
163056738|NCT03451045|588919737|FG001|Overall Study|Physician Decision|1|||
163056739|NCT03451045|588919738|FG002|Overall Study|Physician Decision|1|||
163056740|NCT03451045|588919736|FG000|Overall Study|Withdrawal by Subject|4|||
163056741|NCT03451045|588919737|FG001|Overall Study|Withdrawal by Subject|0|||
163056742|NCT03451045|588919738|FG002|Overall Study|Withdrawal by Subject|5|||
163056743|NCT03451045|588919736|FG000|Overall Study|Pregnancy|0|||
163056744|NCT03451045|588919737|FG001|Overall Study|Pregnancy|0|||
163209137|NCT00555321|589478746|FG003|Long-term Extension Phase|Death|3|||
163209138|NCT00555321|589478747|FG004|Long-term Extension Phase|Death|0|||
163209139|NCT00555321|589478743|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
163209140|NCT00555321|589478744|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
163056745|NCT03451045|588919738|FG002|Overall Study|Pregnancy|2|||
163209141|NCT00555321|589478745|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
163056746|NCT03451045|588919736|FG000|Overall Study|Adverse Event|7|||
163056747|NCT03451045|588919737|FG001|Overall Study|Adverse Event|1|||
163056748|NCT03451045|588919738|FG002|Overall Study|Adverse Event|3|||
163056749|NCT03451045|588919736|FG000|Overall Study|Non-compliance with study|2|||
163056750|NCT03451045|588919737|FG001|Overall Study|Non-compliance with study|0|||
162970847|NCT04194008|588593948|FG000|Treatment Phase With Nerivio|Missing data|4|||
162970848|NCT04194008|588593948|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
162970849|NCT01785615|588593949|FG000|Dietary Phase|Lost to Follow-up|0|||
162970850|NCT01785615|588593950|FG001|Dietary Phase|Lost to Follow-up|0|||
162970851|NCT01785615|588593951|FG002|Dietary Phase|Lost to Follow-up|0|||
162970852|NCT01785615|588593952|FG003|Dietary Phase|Lost to Follow-up|24|||
162970853|NCT02522780|588593953|FG000|Overall Study|Consent withdrawn by subject|5|||
162970854|NCT02522780|588593954|FG001|Overall Study|Consent withdrawn by subject|7|||
162970855|NCT02522780|588593953|FG000|Overall Study|Protocol deviation|1|||
162970856|NCT02522780|588593954|FG001|Overall Study|Protocol deviation|3|||
162970857|NCT02522780|588593953|FG000|Overall Study|Subject refused endoscopic procedure|0|||
162970858|NCT02522780|588593954|FG001|Overall Study|Subject refused endoscopic procedure|1|||
162970859|NCT02522780|588593953|FG000|Overall Study|Adverse event, non-fatal|11|||
162970860|NCT02522780|588593954|FG001|Overall Study|Adverse event, non-fatal|16|||
162970861|NCT00926367|588593955|FG000|Overall Study|Withdrawal by Subject|0|||
162970862|NCT00926367|588593956|FG001|Overall Study|Withdrawal by Subject|1|||
162970863|NCT00926367|588593955|FG000|Overall Study|Lost to Follow-up|1|||
162970864|NCT00926367|588593956|FG001|Overall Study|Lost to Follow-up|0|||
162970865|NCT00926367|588593955|FG000|Overall Study|Skin Irritation|1|||
162970866|NCT00926367|588593956|FG001|Overall Study|Skin Irritation|2|||
162970867|NCT01517867|588593957|FG000|Overall Study|never started treatment|29|||
162970868|NCT01517867|588593958|FG001|Overall Study|never started treatment|32|||
162970869|NCT01517867|588593957|FG000|Overall Study|Withdrawal by Subject|34|||
162970870|NCT01517867|588593958|FG001|Overall Study|Withdrawal by Subject|30|||
162970871|NCT01517867|588593957|FG000|Overall Study|Still in treatment at study end|0|||
162970872|NCT01517867|588593958|FG001|Overall Study|Still in treatment at study end|3|||
162970873|NCT00860262|588593962|FG000|Overall Study|Adverse Event|9|||
162970874|NCT00860262|588593963|FG001|Overall Study|Adverse Event|6|||
162970875|NCT00860262|588593964|FG002|Overall Study|Adverse Event|7|||
162970876|NCT00860262|588593962|FG000|Overall Study|Protocol Violation|0|||
162970877|NCT00860262|588593963|FG001|Overall Study|Protocol Violation|1|||
162970878|NCT00860262|588593964|FG002|Overall Study|Protocol Violation|0|||
162970879|NCT00860262|588593962|FG000|Overall Study|Lost to Follow-up|2|||
162970880|NCT00860262|588593963|FG001|Overall Study|Lost to Follow-up|0|||
162970881|NCT00860262|588593964|FG002|Overall Study|Lost to Follow-up|1|||
162970882|NCT00860262|588593962|FG000|Overall Study|Withdrawal by Subject|4|||
162970883|NCT00860262|588593963|FG001|Overall Study|Withdrawal by Subject|8|||
162970884|NCT00860262|588593964|FG002|Overall Study|Withdrawal by Subject|6|||
162970885|NCT00860262|588593962|FG000|Overall Study|Lack of Efficacy|0|||
162970886|NCT00860262|588593963|FG001|Overall Study|Lack of Efficacy|4|||
162970887|NCT00860262|588593964|FG002|Overall Study|Lack of Efficacy|3|||
162970888|NCT00860262|588593962|FG000|Overall Study|Other|5|||
162970889|NCT00860262|588593963|FG001|Overall Study|Other|3|||
162970890|NCT00860262|588593964|FG002|Overall Study|Other|1|||
162970891|NCT01183884|588593965|FG000|Overall Study|Progressive Disease|26|||
162970892|NCT01183884|588593965|FG000|Overall Study|Adverse Event|3|||
162970893|NCT01183884|588593965|FG000|Overall Study|Withdrawal by Subject|1|||
162970894|NCT01183884|588593965|FG000|Overall Study|Other Complicating Disease|3|||
162970895|NCT01183884|588593965|FG000|Overall Study|Not Treated|1|||
162970896|NCT01183884|588593965|FG000|Overall Study|Other|4|||
162970897|NCT02169336|588593966|FG000|Overall Study|Lack of Efficacy|1|||
162970898|NCT02169336|588593967|FG001|Overall Study|Lack of Efficacy|1|||
162970899|NCT02169336|588593968|FG002|Overall Study|Lack of Efficacy|0|||
162970900|NCT02169336|588593966|FG000|Overall Study|Adverse Event|2|||
162970901|NCT02169336|588593967|FG001|Overall Study|Adverse Event|3|||
162970902|NCT02169336|588593968|FG002|Overall Study|Adverse Event|1|||
162970903|NCT02169336|588593966|FG000|Overall Study|Withdrawal by Subject|1|||
162970904|NCT02169336|588593967|FG001|Overall Study|Withdrawal by Subject|0|||
163056751|NCT03451045|588919738|FG002|Overall Study|Non-compliance with study|1|||
162970905|NCT02169336|588593968|FG002|Overall Study|Withdrawal by Subject|0|||
162970906|NCT02169336|588593966|FG000|Overall Study|Physician Decision|0|||
163401152|NCT01147744|590179626|FG004|Overall Study|Withdrawal by Subject|2|||
163401153|NCT01147744|590179627|FG005|Overall Study|Withdrawal by Subject|5|||
163401154|NCT01147744|590179628|FG006|Overall Study|Withdrawal by Subject|2|||
163401155|NCT01147744|590179622|FG000|Overall Study|Lost to Follow-up|0|||
163401156|NCT01147744|590179623|FG001|Overall Study|Lost to Follow-up|1|||
163401157|NCT01147744|590179624|FG002|Overall Study|Lost to Follow-up|0|||
163401158|NCT01147744|590179625|FG003|Overall Study|Lost to Follow-up|0|||
163401159|NCT01147744|590179626|FG004|Overall Study|Lost to Follow-up|0|||
163401160|NCT01147744|590179627|FG005|Overall Study|Lost to Follow-up|0|||
163401161|NCT01147744|590179628|FG006|Overall Study|Lost to Follow-up|0|||
163401162|NCT01147744|590179622|FG000|Overall Study|Sponsor decision to amend protocol|7|||
163401163|NCT01147744|590179623|FG001|Overall Study|Sponsor decision to amend protocol|4|||
163401164|NCT01147744|590179624|FG002|Overall Study|Sponsor decision to amend protocol|2|||
163401165|NCT01147744|590179625|FG003|Overall Study|Sponsor decision to amend protocol|5|||
163401166|NCT01147744|590179626|FG004|Overall Study|Sponsor decision to amend protocol|7|||
163401167|NCT01147744|590179627|FG005|Overall Study|Sponsor decision to amend protocol|2|||
163401168|NCT01147744|590179628|FG006|Overall Study|Sponsor decision to amend protocol|6|||
163401169|NCT01147744|590179622|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
163401170|NCT01147744|590179623|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
163401171|NCT01147744|590179624|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
163401172|NCT01147744|590179625|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
163401173|NCT01147744|590179626|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
163401174|NCT01147744|590179627|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
163401175|NCT01147744|590179628|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
163401176|NCT01342484|590179633|FG000|Overall Study|Other Reasons|1|||
163401177|NCT01342484|590179634|FG001|Overall Study|Other Reasons|0|||
163401178|NCT01342484|590179635|FG002|Overall Study|Other Reasons|0|||
163401179|NCT01342484|590179633|FG000|Overall Study|Protocol Violation|0|||
163401180|NCT01342484|590179634|FG001|Overall Study|Protocol Violation|0|||
163401181|NCT01342484|590179635|FG002|Overall Study|Protocol Violation|1|||
163401182|NCT01342484|590179633|FG000|Overall Study|Withdrawal by Subject|1|||
163401183|NCT01342484|590179634|FG001|Overall Study|Withdrawal by Subject|0|||
163401184|NCT01342484|590179635|FG002|Overall Study|Withdrawal by Subject|0|||
163401185|NCT00432042|590179636|FG000|Overall Study|Protocol Violation|2|||
163401186|NCT00432042|590179637|FG001|Overall Study|Protocol Violation|0|||
163401187|NCT00432042|590179638|FG002|Overall Study|Protocol Violation|0|||
163401188|NCT00432042|590179636|FG000|Overall Study|Withdrawal by Subject|0|||
163401189|NCT00432042|590179637|FG001|Overall Study|Withdrawal by Subject|0|||
163401190|NCT00432042|590179638|FG002|Overall Study|Withdrawal by Subject|2|||
163401191|NCT00432042|590179636|FG000|Overall Study|Lost to Follow-up|5|||
163401192|NCT00432042|590179637|FG001|Overall Study|Lost to Follow-up|1|||
163401193|NCT00432042|590179638|FG002|Overall Study|Lost to Follow-up|0|||
163401194|NCT01744665|590179640|FG000|Monitoring Phase|Adverse Event|4|||
163401195|NCT01744665|590179640|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
163401196|NCT01744665|590179640|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
163401197|NCT01744665|590179640|FG000|Monitoring Phase|Withdrawal by Subject|5|||
163401198|NCT01744665|590179640|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
163401199|NCT01744665|590179640|FG000|Consolidation Phase|Adverse Event|2|||
163401200|NCT01744665|590179640|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
163401201|NCT01744665|590179640|FG000|Consolidation Phase|Withdrawal by Subject|4|||
163401202|NCT01744665|590179640|FG000|Consolidation Phase|Administrative problems|9|||
163401203|NCT01744665|590179640|FG000|Re-initiation Phase|Administrative problems|10|||
163401204|NCT01744665|590179640|FG000|Re-initiation Phase|Adverse Event|1|||
163401205|NCT01744665|590179640|FG000|Re-initiation Phase|No longer required treatment|1|||
163401206|NCT01744665|590179640|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
163401207|NCT02321930|590179641|FG000|Overall Study|Lost to Follow-up|1|||
163401208|NCT01293968|590179642|FG000|Overall Study|non-cooperation|3|||
163401209|NCT01293968|590179643|FG001|Overall Study|non-cooperation|3|||
163401210|NCT01484977|590179644|FG000|Overall Study|Adverse Event|8|||
163401211|NCT01484977|590179644|FG000|Overall Study|Lack of Efficacy|4|||
163401212|NCT01484977|590179644|FG000|Overall Study|Protocol Violation|6|||
163401213|NCT01484977|590179644|FG000|Overall Study|Lost to Follow-up|1|||
163056752|NCT03451045|588919736|FG000|Overall Study|any other reason|10|||
163056753|NCT03451045|588919737|FG001|Overall Study|any other reason|2|||
163056754|NCT03451045|588919738|FG002|Overall Study|any other reason|13|||
163056755|NCT00863707|588919739|FG000|Overall Study|Randomized, but drug not received|4|||
163056756|NCT00863707|588919740|FG001|Overall Study|Randomized, but drug not received|3|||
163056757|NCT00830128|588919741|FG000|Overall Study|Adverse Event|5|||
163056758|NCT00830128|588919741|FG000|Overall Study|Lack of Efficacy|7|||
163056759|NCT00830128|588919741|FG000|Overall Study|Protocol Violation|1|||
163056760|NCT00830128|588919741|FG000|Overall Study|Withdrawal by Subject|2|||
163056761|NCT00830128|588919741|FG000|Overall Study|Family obligation|1|||
163056762|NCT00830128|588919741|FG000|Overall Study|Relocation|1|||
163056763|NCT00830128|588919741|FG000|Overall Study|Work obligation|1|||
163056764|NCT00830128|588919741|FG000|Overall Study|Operating a vehicle|1|||
162970907|NCT02169336|588593967|FG001|Overall Study|Physician Decision|0|||
162970908|NCT02169336|588593968|FG002|Overall Study|Physician Decision|1|||
162970909|NCT02169336|588593966|FG000|Overall Study|Subject declined to continue dosing|0|||
162970910|NCT02169336|588593967|FG001|Overall Study|Subject declined to continue dosing|0|||
162970911|NCT02169336|588593968|FG002|Overall Study|Subject declined to continue dosing|1|||
162970912|NCT01598896|588593969|FG000|Overall Study|Withdrawal by Subject|0|||
162970913|NCT01598896|588593970|FG001|Overall Study|Withdrawal by Subject|1|||
162970914|NCT01598896|588593969|FG000|Overall Study|Lack of Efficacy|0|||
162970915|NCT01598896|588593970|FG001|Overall Study|Lack of Efficacy|1|||
162970916|NCT00420095|588593971|FG000|Overall Study|Adverse Event|1|||
162970917|NCT00420095|588593972|FG001|Overall Study|Adverse Event|0|||
162970918|NCT00420095|588593971|FG000|Overall Study|Protocol Violation|1|||
162970919|NCT00420095|588593972|FG001|Overall Study|Protocol Violation|1|||
162970920|NCT00420095|588593971|FG000|Overall Study|Lost to Follow-up|1|||
162970921|NCT00420095|588593972|FG001|Overall Study|Lost to Follow-up|0|||
162970922|NCT00393705|588593973|FG000|Overall Study|Adverse Event|0|||
162970923|NCT00393705|588593974|FG001|Overall Study|Adverse Event|2|||
162970924|NCT00393705|588593973|FG000|Overall Study|Death|0|||
162970925|NCT00393705|588593974|FG001|Overall Study|Death|1|||
162970926|NCT00393705|588593973|FG000|Overall Study|Lost to Follow-up|2|||
162970927|NCT00393705|588593974|FG001|Overall Study|Lost to Follow-up|2|||
162970928|NCT00393705|588593973|FG000|Overall Study|Entry Criteria Not Met|10|||
162970929|NCT00393705|588593974|FG001|Overall Study|Entry Criteria Not Met|10|||
162970930|NCT00393705|588593973|FG000|Overall Study|Protocol Violation|4|||
162970931|NCT00393705|588593974|FG001|Overall Study|Protocol Violation|3|||
162970932|NCT00393705|588593973|FG000|Overall Study|Withdrawal by Subject|5|||
162970933|NCT00393705|588593974|FG001|Overall Study|Withdrawal by Subject|3|||
163056765|NCT03040726|588919742|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
163056766|NCT03040726|588919743|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
163056767|NCT03040726|588919742|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
163056768|NCT03040726|588919743|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
163056769|NCT03040726|588919742|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
162970934|NCT00393705|588593973|FG000|Overall Study|Physician Decision|2|||
163401214|NCT01484977|590179644|FG000|Overall Study|Withdrawal by Subject|4|||
163401215|NCT01484977|590179644|FG000|Overall Study|Subject Protocol Non-compliant|1|||
163401216|NCT01484977|590179644|FG000|Overall Study|Moving Overseas|1|||
162970935|NCT00393705|588593974|FG001|Overall Study|Physician Decision|2|||
162970936|NCT04553406|588593977|FG000|Overall Study|Study Discontinuation|0|||
162970937|NCT04553406|588593978|FG001|Overall Study|Study Discontinuation|1|||
162970938|NCT03370510|588593979|FG000|Overall Study|COVID-19|2|||
163056770|NCT03040726|588919743|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
163056771|NCT03040726|588919742|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
163056772|NCT03040726|588919743|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
163056773|NCT03040726|588919742|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
163056774|NCT03040726|588919743|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
163056775|NCT05063448|588919746|FG000|Overall Study|Withdrawal by Subject|1|||
162970939|NCT03370510|588593980|FG001|Overall Study|COVID-19|0|||
162970940|NCT01841060|588595585|FG000|Overall Study|Protocol Violation|10|||
162970941|NCT05258630|588595586|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
162970942|NCT05258630|588595587|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
162970943|NCT05258630|588595586|FG000|Overall Study|Lost to Follow-up|0|||
162970944|NCT05258630|588595587|FG001|Overall Study|Lost to Follow-up|2|||
162970945|NCT03431337|588595588|FG000|Overall Study|Lost to Follow-up|21|||
162970946|NCT03431337|588595589|FG001|Overall Study|Lost to Follow-up|19|||
162970947|NCT03431337|588595588|FG000|Overall Study|Withdrawal by Subject|8|||
162970948|NCT03431337|588595589|FG001|Overall Study|Withdrawal by Subject|3|||
162970949|NCT02419573|588595590|FG000|Overall Study|Lost to Follow-up|3|||
162970950|NCT02419573|588595591|FG001|Overall Study|Lost to Follow-up|0|||
162970951|NCT02419573|588595590|FG000|Overall Study|Withdrawal by Subject|1|||
162970952|NCT02419573|588595591|FG001|Overall Study|Withdrawal by Subject|0|||
162970953|NCT04167618|588595596|FG000|Overall Study|Trial terminated by sponsor|1|||
162970954|NCT04167618|588595597|FG001|Overall Study|Trial terminated by sponsor|1|||
162970955|NCT00460109|588595598|FG000|Overall Study|Death|1|||
162970956|NCT02994394|588595599|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
162970957|NCT02994394|588595600|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
162970958|NCT02994394|588595601|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
162970959|NCT02994394|588595602|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
163056776|NCT03641508|588919750|FG000|First Injection|Lost to Follow-up|2|||
163056777|NCT03641508|588919751|FG001|First Injection|Lost to Follow-up|0|||
163056778|NCT00094445|588919752|FG000|Overall Study|Withdrawal by Subject|3|||
163056779|NCT00094445|588919752|FG000|Overall Study|Lost to Follow-up|1|||
163056780|NCT00094445|588919752|FG000|Overall Study|Progressive Disease|2|||
163056781|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
163056782|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
163056783|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
163056784|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
163056785|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
163056786|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
163056787|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
163056788|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
163056789|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
163056790|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
163056791|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
162970960|NCT02994394|588595603|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
162970961|NCT02994394|588595604|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
162970962|NCT02994394|588595599|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
163209142|NCT00555321|589478746|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
163209143|NCT00555321|589478747|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
163209144|NCT00555321|589478743|FG000|Long-term Extension Phase|Other Reason|1|||
163056792|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
163056793|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
163056794|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
163056795|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
163056796|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
163056797|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
163056798|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
163056799|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
163056800|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
163056801|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
163056802|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
163056803|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
163056804|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
163056805|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
163209145|NCT00555321|589478744|FG001|Long-term Extension Phase|Other Reason|0|||
163209146|NCT00555321|589478745|FG002|Long-term Extension Phase|Other Reason|2|||
163209147|NCT00555321|589478746|FG003|Long-term Extension Phase|Other Reason|0|||
163209148|NCT00555321|589478747|FG004|Long-term Extension Phase|Other Reason|0|||
163209149|NCT01348347|589478748|FG000|Overall Study|Withdrawal by Subject|1|||
163209150|NCT01348347|589478749|FG001|Overall Study|Withdrawal by Subject|1|||
163209151|NCT01348347|589478750|FG002|Overall Study|Withdrawal by Subject|1|||
163209152|NCT01348347|589478748|FG000|Overall Study|Progressive disease|2|||
163209153|NCT01348347|589478749|FG001|Overall Study|Progressive disease|5|||
163209154|NCT01348347|589478750|FG002|Overall Study|Progressive disease|5|||
163209155|NCT00191789|589478754|FG000|Overall Study|Adverse Event|5|||
163209156|NCT00191789|589478754|FG000|Overall Study|Patient: Satisfactory Response|5|||
163209157|NCT00191789|589478754|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
163209158|NCT00191789|589478754|FG000|Overall Study|Withdrawal by Subject|4|||
163209159|NCT00191789|589478754|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
163209160|NCT00191789|589478754|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
163209161|NCT00191789|589478754|FG000|Overall Study|Death - Not Study-Drug Related|1|||
163209162|NCT03198234|589478755|FG000|Overall Study|Relapse of primary disease|0|||
163401217|NCT01484977|590179644|FG000|Overall Study|Low White Blood Cell Count|1|||
163401218|NCT01484977|590179644|FG000|Overall Study|Lack of Compliance|1|||
163209163|NCT03198234|589478756|FG001|Overall Study|Relapse of primary disease|1|||
163209164|NCT03198234|589478757|FG002|Overall Study|Relapse of primary disease|0|||
163209165|NCT00165776|589478758|FG000|Overall Study|Lack of Efficacy|0|||
163209166|NCT00165776|589478759|FG001|Overall Study|Lack of Efficacy|0|||
163209167|NCT00165776|589478760|FG002|Overall Study|Lack of Efficacy|0|||
163209168|NCT00165776|589478761|FG003|Overall Study|Lack of Efficacy|1|||
163209169|NCT00165776|589478758|FG000|Overall Study|Withdrawal by Subject|4|||
163209170|NCT00165776|589478759|FG001|Overall Study|Withdrawal by Subject|1|||
163209171|NCT00165776|589478760|FG002|Overall Study|Withdrawal by Subject|2|||
163209172|NCT00165776|589478761|FG003|Overall Study|Withdrawal by Subject|0|||
163209173|NCT00165776|589478758|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
163209174|NCT00165776|589478759|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
163209175|NCT00165776|589478760|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
163056806|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
163056807|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
163056808|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
163056809|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
163056810|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
163056811|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
163056812|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
163056813|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
163056814|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
163056815|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
163056816|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
162970963|NCT02994394|588595600|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
163056817|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
163056818|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
163056819|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
163056820|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
163056821|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
163056822|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
163056823|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
163056824|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
163056825|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
163056826|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
163056827|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
162970964|NCT02994394|588595601|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
163056828|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
163056829|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
163056830|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
163056831|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
163056832|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
163056833|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
163056834|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
163056835|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
162970965|NCT02994394|588595602|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
162970966|NCT02994394|588595603|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
162970967|NCT02994394|588595604|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
162970968|NCT03619876|588595605|FG000|Overall Study|Withdrawal by Subject|1|||
162970969|NCT03619876|588595606|FG001|Overall Study|Withdrawal by Subject|2|||
162970970|NCT03619876|588595605|FG000|Overall Study|Withdrawal due to incidental finding|0|||
162970971|NCT03619876|588595606|FG001|Overall Study|Withdrawal due to incidental finding|2|||
162970972|NCT04982445|588595608|FG000|Overall Study|Protocol Violation|1|||
162970973|NCT04982445|588595608|FG000|Overall Study|Withdrawal by Subject|4|||
162970974|NCT04982445|588595608|FG000|Overall Study|Lost to Follow-up|1|||
162970975|NCT00763555|588595609|FG000|Overall Study|Adverse Event|2|||
163317784|NCT01928394|589874968|FG022|Treatment Period|Disease progression|31|||
163317785|NCT01928394|589874946|FG000|Treatment Period|Study drug toxicity|1|||
163056836|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
163056837|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
163056838|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
163056839|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
163056840|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
163056841|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
163056842|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
163317786|NCT01928394|589874947|FG001|Treatment Period|Study drug toxicity|1|||
163317787|NCT01928394|589874948|FG002|Treatment Period|Study drug toxicity|3|||
163317788|NCT01928394|589874949|FG003|Treatment Period|Study drug toxicity|3|||
163401219|NCT01133379|590179645|FG000|Overall Study|Withdrawal by Subject|0|||
163401220|NCT01133379|590179646|FG001|Overall Study|Withdrawal by Subject|1|||
163401221|NCT01133379|590179647|FG002|Overall Study|Withdrawal by Subject|1|||
163401222|NCT01133379|590179645|FG000|Overall Study|Lost to Follow-up|1|||
163401223|NCT01133379|590179646|FG001|Overall Study|Lost to Follow-up|1|||
163401224|NCT01133379|590179647|FG002|Overall Study|Lost to Follow-up|1|||
163401225|NCT01129921|590179650|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
163401226|NCT01129921|590179651|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
163401227|NCT01129921|590179650|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
163401228|NCT01129921|590179651|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
163401229|NCT01129921|590179650|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
163401230|NCT01129921|590179651|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
163401231|NCT01129921|590179650|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
163401232|NCT01129921|590179651|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
163401233|NCT04649255|590181094|FG000|Overall Study|Death|9|||
163401234|NCT04649255|590181094|FG000|Overall Study|Withdrawal by Subject|1|||
163401235|NCT01652885|590181095|FG000|Overall Study|Adverse Event|1|||
163401236|NCT03723707|590181096|FG000|Overall Study|Death|32|||
163401237|NCT03723707|590181097|FG001|Overall Study|Death|32|||
163401238|NCT03723707|590181096|FG000|Overall Study|Admitted to long term care|12|||
163401239|NCT03723707|590181097|FG001|Overall Study|Admitted to long term care|12|||
163401240|NCT03723707|590181096|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
163401241|NCT03723707|590181097|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
163401242|NCT03723707|590181096|FG000|Overall Study|Lost to Follow-up|40|||
163401243|NCT03723707|590181097|FG001|Overall Study|Lost to Follow-up|22|||
163401244|NCT03723707|590181096|FG000|Overall Study|Discontinued after study closure|24|||
163401245|NCT03723707|590181097|FG001|Overall Study|Discontinued after study closure|12|||
163401246|NCT04682405|590181098|FG000|Overall Study|Adverse Event|0|||
163401247|NCT04682405|590181099|FG001|Overall Study|Adverse Event|1|||
163401248|NCT03357731|590181102|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
163401249|NCT03357731|590181103|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
163401250|NCT03357731|590181104|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
163401251|NCT03357731|590181105|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
163401252|NCT03357731|590181106|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
163401253|NCT03357731|590181107|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
163401254|NCT03357731|590181102|FG000|Overall Study|Acute bradycardia and hypotension|0|||
163401255|NCT03357731|590181103|FG001|Overall Study|Acute bradycardia and hypotension|0|||
163401256|NCT03357731|590181104|FG002|Overall Study|Acute bradycardia and hypotension|0|||
163401257|NCT03357731|590181105|FG003|Overall Study|Acute bradycardia and hypotension|1|||
163401258|NCT03357731|590181106|FG004|Overall Study|Acute bradycardia and hypotension|0|||
163401259|NCT03357731|590181107|FG005|Overall Study|Acute bradycardia and hypotension|0|||
163401260|NCT03357731|590181102|FG000|Overall Study|Adverse Event|0|||
163401261|NCT03357731|590181103|FG001|Overall Study|Adverse Event|0|||
163401262|NCT03357731|590181104|FG002|Overall Study|Adverse Event|0|||
163401263|NCT03357731|590181105|FG003|Overall Study|Adverse Event|0|||
163209176|NCT00165776|589478761|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
163209177|NCT04285879|589478762|FG000|Overall Study|Lost to Follow-up|1|||
163209178|NCT04285879|589478763|FG001|Overall Study|Lost to Follow-up|8|||
163209179|NCT04285879|589478762|FG000|Overall Study|medical/surgical exclusion|16|||
163209180|NCT04285879|589478763|FG001|Overall Study|medical/surgical exclusion|0|||
163209181|NCT02622321|589478770|FG000|Overall Study|Withdrawal by Subject|2|||
163209182|NCT02622321|589478771|FG001|Overall Study|Withdrawal by Subject|0|||
163209183|NCT02622321|589478772|FG002|Overall Study|Withdrawal by Subject|0|||
163209184|NCT02622321|589478773|FG003|Overall Study|Withdrawal by Subject|0|||
163209185|NCT02622321|589478770|FG000|Overall Study|Death|0|||
163209186|NCT02622321|589478771|FG001|Overall Study|Death|0|||
163209187|NCT02622321|589478772|FG002|Overall Study|Death|1|||
163209188|NCT02622321|589478773|FG003|Overall Study|Death|0|||
163209189|NCT02622321|589478770|FG000|Overall Study|Physician Decision|1|||
163209190|NCT02622321|589478771|FG001|Overall Study|Physician Decision|0|||
163209191|NCT02622321|589478772|FG002|Overall Study|Physician Decision|0|||
163209192|NCT02622321|589478773|FG003|Overall Study|Physician Decision|0|||
163209193|NCT00241280|589478774|FG000|Overall Study|Adverse Event|2|||
163209194|NCT00241280|589478775|FG001|Overall Study|Adverse Event|6|||
163209195|NCT00241280|589478774|FG000|Overall Study|Discomfort|11|||
163209196|NCT00241280|589478775|FG001|Overall Study|Discomfort|16|||
163209197|NCT00241280|589478774|FG000|Overall Study|Pregnancy|1|||
163209198|NCT00241280|589478775|FG001|Overall Study|Pregnancy|5|||
163209199|NCT00241280|589478774|FG000|Overall Study|Lost to Follow-up|5|||
162970976|NCT00763555|588595610|FG001|Overall Study|Adverse Event|1|||
162970977|NCT00763555|588595609|FG000|Overall Study|Withdrawal by Subject|2|||
162970978|NCT00763555|588595610|FG001|Overall Study|Withdrawal by Subject|6|||
162970979|NCT00763555|588595609|FG000|Overall Study|Lost to Follow-up|0|||
162970980|NCT00763555|588595610|FG001|Overall Study|Lost to Follow-up|3|||
162970981|NCT00684567|588595612|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
162970982|NCT00684567|588595612|FG000|Monotherapy Period|Adverse Event|2|||
162970983|NCT00684567|588595612|FG000|Monotherapy Period|Death|1|||
162970984|NCT00684567|588595612|FG000|Monotherapy Period|Progression of primary disease|11|||
162970985|NCT02916693|588595613|FG000|Overall Study|Lost to Follow-up|7|||
162970986|NCT00979212|588595617|FG000|Overall Study|Protocol Violation|1|||
162970987|NCT00979212|588595618|FG001|Overall Study|Protocol Violation|8|||
162970988|NCT00979212|588595617|FG000|Overall Study|No protocol therapy received|1|||
162970989|NCT00979212|588595618|FG001|Overall Study|No protocol therapy received|0|||
162970990|NCT00035555|588595619|FG000|Overall Study|Adverse Event|5|||
162970991|NCT00035555|588595620|FG001|Overall Study|Adverse Event|8|||
162970992|NCT00035555|588595621|FG002|Overall Study|Adverse Event|9|||
162970993|NCT00035555|588595619|FG000|Overall Study|Allograft loss|1|||
162970994|NCT00035555|588595620|FG001|Overall Study|Allograft loss|1|||
162970995|NCT00035555|588595621|FG002|Overall Study|Allograft loss|2|||
162970996|NCT00035555|588595619|FG000|Overall Study|Death|0|||
162970997|NCT00035555|588595620|FG001|Overall Study|Death|0|||
162970998|NCT00035555|588595621|FG002|Overall Study|Death|2|||
162970999|NCT00035555|588595619|FG000|Overall Study|Lost to Follow-up|0|||
162971000|NCT00035555|588595620|FG001|Overall Study|Lost to Follow-up|0|||
162971001|NCT00035555|588595621|FG002|Overall Study|Lost to Follow-up|1|||
162971002|NCT00035555|588595619|FG000|Overall Study|Noncompliance|0|||
162971003|NCT00035555|588595620|FG001|Overall Study|Noncompliance|1|||
162971004|NCT00035555|588595621|FG002|Overall Study|Noncompliance|1|||
162971005|NCT00035555|588595619|FG000|Overall Study|Prohibited medication|1|||
162971006|NCT00035555|588595620|FG001|Overall Study|Prohibited medication|1|||
162971007|NCT00035555|588595621|FG002|Overall Study|Prohibited medication|0|||
162971008|NCT00035555|588595619|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
162971009|NCT00035555|588595620|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
162971010|NCT00035555|588595621|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
162971011|NCT00035555|588595619|FG000|Overall Study|Withdrawal by Subject|2|||
162971012|NCT00035555|588595620|FG001|Overall Study|Withdrawal by Subject|0|||
162971013|NCT00035555|588595621|FG002|Overall Study|Withdrawal by Subject|2|||
162971014|NCT00035555|588595619|FG000|Overall Study|Investigator deemed not a good candidate|0|||
162971015|NCT00035555|588595620|FG001|Overall Study|Investigator deemed not a good candidate|0|||
162971016|NCT00035555|588595621|FG002|Overall Study|Investigator deemed not a good candidate|1|||
162971017|NCT00035555|588595619|FG000|Overall Study|Received cyclosporin in error|0|||
162971018|NCT00035555|588595620|FG001|Overall Study|Received cyclosporin in error|0|||
162971019|NCT00035555|588595621|FG002|Overall Study|Received cyclosporin in error|1|||
162971020|NCT00337428|588595622|FG000|Overall Study|Withdrawal by Subject|1|||
162971021|NCT00337428|588595623|FG001|Overall Study|Withdrawal by Subject|2|||
162971022|NCT00337428|588595622|FG000|Overall Study|Lack of Time|1|||
162971023|NCT00337428|588595623|FG001|Overall Study|Lack of Time|1|||
162971024|NCT00337428|588595622|FG000|Overall Study|Unwilling to Continue|1|||
162971025|NCT00337428|588595623|FG001|Overall Study|Unwilling to Continue|0|||
162971026|NCT00337428|588595622|FG000|Overall Study|Anorexia|1|||
163209200|NCT00241280|589478775|FG001|Overall Study|Lost to Follow-up|8|||
163209201|NCT00241280|589478774|FG000|Overall Study|Withdrawal by Subject|7|||
163209202|NCT00241280|589478775|FG001|Overall Study|Withdrawal by Subject|4|||
162971027|NCT00337428|588595623|FG001|Overall Study|Anorexia|0|||
162971028|NCT02618382|588595624|FG000|Overall Study|Physician Decision|1|||
162971029|NCT02618382|588595624|FG000|Overall Study|Withdrawal by Subject|1|||
162971030|NCT02618382|588595624|FG000|Overall Study|Protocol Violation|1|||
162971031|NCT03223909|588595625|FG000|Overall Study|Protocol Violation|48|||
163401264|NCT03357731|590181106|FG004|Overall Study|Adverse Event|0|||
163401265|NCT03357731|590181107|FG005|Overall Study|Adverse Event|1|||
163401266|NCT03357731|590181102|FG000|Overall Study|Hypotension|0|||
163401267|NCT03357731|590181103|FG001|Overall Study|Hypotension|0|||
163401268|NCT03357731|590181104|FG002|Overall Study|Hypotension|1|||
163401269|NCT03357731|590181105|FG003|Overall Study|Hypotension|1|||
163401270|NCT03357731|590181106|FG004|Overall Study|Hypotension|0|||
162971032|NCT03223909|588595626|FG001|Overall Study|Protocol Violation|45|||
162971033|NCT03223909|588595627|FG002|Overall Study|Protocol Violation|16|||
163401271|NCT03357731|590181107|FG005|Overall Study|Hypotension|0|||
162971034|NCT00177164|588595636|FG000|Overall Study|Protocol Violation|0|||
162971035|NCT00177164|588595637|FG001|Overall Study|Protocol Violation|7|||
163209203|NCT00241280|589478774|FG000|Overall Study|Protocol Violation|4|||
163401272|NCT03357731|590181102|FG000|Overall Study|Lost to Follow-up|0|||
163401273|NCT03357731|590181103|FG001|Overall Study|Lost to Follow-up|0|||
163056843|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
163056844|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
163056845|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
163056846|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
163056847|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
163056848|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
163056849|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
163056850|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
163056851|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
163056852|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
163209204|NCT00241280|589478775|FG001|Overall Study|Protocol Violation|10|||
163056853|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
163056854|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
163056855|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
163056856|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
163056857|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
163056858|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
163056859|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
163056860|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
163209205|NCT00241280|589478774|FG000|Overall Study|Relocation|4|||
163209206|NCT00241280|589478775|FG001|Overall Study|Relocation|4|||
163209207|NCT00241280|589478774|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
163209208|NCT00241280|589478775|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
163209209|NCT00241280|589478774|FG000|Overall Study|Unsatisfactory Visual Response|1|||
163056861|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
163056862|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
163056863|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
163056864|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
163056865|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
163056866|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
163056867|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
163056868|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
163056869|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
163209210|NCT00241280|589478775|FG001|Overall Study|Unsatisfactory Visual Response|1|||
163209211|NCT00241280|589478774|FG000|Overall Study|Diabetic|1|||
163209212|NCT00241280|589478775|FG001|Overall Study|Diabetic|0|||
163317789|NCT01928394|589874950|FG004|Treatment Period|Study drug toxicity|0|||
163317790|NCT01928394|589874951|FG005|Treatment Period|Study drug toxicity|9|||
163317791|NCT01928394|589874952|FG006|Treatment Period|Study drug toxicity|7|||
163317792|NCT01928394|589874953|FG007|Treatment Period|Study drug toxicity|1|||
163317793|NCT01928394|589874954|FG008|Treatment Period|Study drug toxicity|0|||
163317794|NCT01928394|589874955|FG009|Treatment Period|Study drug toxicity|5|||
163317795|NCT01928394|589874956|FG010|Treatment Period|Study drug toxicity|2|||
163317796|NCT01928394|589874957|FG011|Treatment Period|Study drug toxicity|3|||
163317797|NCT01928394|589874958|FG012|Treatment Period|Study drug toxicity|7|||
163317798|NCT01928394|589874959|FG013|Treatment Period|Study drug toxicity|5|||
163317799|NCT01928394|589874960|FG014|Treatment Period|Study drug toxicity|12|||
163317800|NCT01928394|589874961|FG015|Treatment Period|Study drug toxicity|0|||
163317801|NCT01928394|589874962|FG016|Treatment Period|Study drug toxicity|3|||
163317802|NCT01928394|589874963|FG017|Treatment Period|Study drug toxicity|3|||
163317803|NCT01928394|589874964|FG018|Treatment Period|Study drug toxicity|12|||
163317804|NCT01928394|589874965|FG019|Treatment Period|Study drug toxicity|15|||
163209213|NCT00241280|589478774|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
163317805|NCT01928394|589874966|FG020|Treatment Period|Study drug toxicity|4|||
163317806|NCT01928394|589874967|FG021|Treatment Period|Study drug toxicity|7|||
163317807|NCT01928394|589874968|FG022|Treatment Period|Study drug toxicity|4|||
163317808|NCT01928394|589874946|FG000|Treatment Period|AE unrelated to study drug|0|||
163317809|NCT01928394|589874947|FG001|Treatment Period|AE unrelated to study drug|0|||
163317810|NCT01928394|589874948|FG002|Treatment Period|AE unrelated to study drug|2|||
163317811|NCT01928394|589874949|FG003|Treatment Period|AE unrelated to study drug|3|||
163317812|NCT01928394|589874950|FG004|Treatment Period|AE unrelated to study drug|0|||
163317813|NCT01928394|589874951|FG005|Treatment Period|AE unrelated to study drug|5|||
163317814|NCT01928394|589874952|FG006|Treatment Period|AE unrelated to study drug|1|||
163401274|NCT03357731|590181104|FG002|Overall Study|Lost to Follow-up|0|||
163401275|NCT03357731|590181105|FG003|Overall Study|Lost to Follow-up|1|||
163401276|NCT03357731|590181106|FG004|Overall Study|Lost to Follow-up|0|||
163401277|NCT03357731|590181107|FG005|Overall Study|Lost to Follow-up|0|||
163401278|NCT01773109|590181108|FG000|Overall Study|Symptomatic Progression|2|||
163401279|NCT01773109|590181108|FG000|Overall Study|Death|1|||
163401280|NCT01239342|590181109|FG000|Overall Study|Adverse Event|1|||
163401281|NCT01239342|590181110|FG001|Overall Study|Adverse Event|0|||
163401282|NCT01239342|590181109|FG000|Overall Study|Withdrawal by Subject|1|||
163401283|NCT01239342|590181110|FG001|Overall Study|Withdrawal by Subject|5|||
163401284|NCT01239342|590181109|FG000|Overall Study|Reason Unknown|1|||
163401285|NCT01239342|590181110|FG001|Overall Study|Reason Unknown|1|||
163401286|NCT02257372|590181113|FG000|Overall Study|Adverse Event|3|||
163401287|NCT02257372|590181114|FG001|Overall Study|Adverse Event|7|||
163401288|NCT02257372|590181113|FG000|Overall Study|Lack of Efficacy|2|||
163401289|NCT02257372|590181114|FG001|Overall Study|Lack of Efficacy|1|||
163401290|NCT02257372|590181113|FG000|Overall Study|Protocol Violation|1|||
163401291|NCT02257372|590181114|FG001|Overall Study|Protocol Violation|1|||
163401292|NCT02257372|590181113|FG000|Overall Study|Lost to Follow-up|0|||
163401293|NCT02257372|590181114|FG001|Overall Study|Lost to Follow-up|1|||
163401294|NCT02257372|590181113|FG000|Overall Study|Withdrew consent|1|||
163401295|NCT02257372|590181114|FG001|Overall Study|Withdrew consent|0|||
163401296|NCT00003535|590181116|FG000|Overall Study|Not evaluable|5|||
163401297|NCT01849874|590181117|FG000|Overall Study|Death|89|||
163401298|NCT01849874|590181118|FG001|Overall Study|Death|42|||
163401299|NCT01849874|590181117|FG000|Overall Study|Withdrawal by Subject|17|||
163401300|NCT01849874|590181118|FG001|Overall Study|Withdrawal by Subject|16|||
163401301|NCT01849874|590181117|FG000|Overall Study|Lost to Follow-up|3|||
163401302|NCT01849874|590181118|FG001|Overall Study|Lost to Follow-up|2|||
163401303|NCT01849874|590181117|FG000|Overall Study|Study Termination By Sponsor|93|||
163401304|NCT01849874|590181118|FG001|Overall Study|Study Termination By Sponsor|48|||
163401305|NCT01849874|590181117|FG000|Overall Study|Completed as per protocol amendment 6|3|||
163401306|NCT01849874|590181118|FG001|Overall Study|Completed as per protocol amendment 6|0|||
163056870|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
163056871|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
163056872|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
163056873|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
163056874|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
163056875|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
163056876|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
163056877|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
163056878|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
163056879|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
163317815|NCT01928394|589874953|FG007|Treatment Period|AE unrelated to study drug|0|||
163317816|NCT01928394|589874954|FG008|Treatment Period|AE unrelated to study drug|0|||
163317817|NCT01928394|589874955|FG009|Treatment Period|AE unrelated to study drug|2|||
163317818|NCT01928394|589874956|FG010|Treatment Period|AE unrelated to study drug|0|||
163317819|NCT01928394|589874957|FG011|Treatment Period|AE unrelated to study drug|12|||
163317820|NCT01928394|589874958|FG012|Treatment Period|AE unrelated to study drug|6|||
163317821|NCT01928394|589874959|FG013|Treatment Period|AE unrelated to study drug|13|||
163317822|NCT01928394|589874960|FG014|Treatment Period|AE unrelated to study drug|6|||
163317823|NCT01928394|589874961|FG015|Treatment Period|AE unrelated to study drug|1|||
163317824|NCT01928394|589874962|FG016|Treatment Period|AE unrelated to study drug|1|||
163317825|NCT01928394|589874963|FG017|Treatment Period|AE unrelated to study drug|6|||
163317826|NCT01928394|589874964|FG018|Treatment Period|AE unrelated to study drug|3|||
163317827|NCT01928394|589874965|FG019|Treatment Period|AE unrelated to study drug|5|||
163401307|NCT01849874|590181117|FG000|Overall Study|Physician Decision|7|||
163401308|NCT01849874|590181118|FG001|Overall Study|Physician Decision|1|||
163401309|NCT01849874|590181117|FG000|Overall Study|Other|16|||
163056880|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
163317828|NCT01928394|589874966|FG020|Treatment Period|AE unrelated to study drug|1|||
163317829|NCT01928394|589874967|FG021|Treatment Period|AE unrelated to study drug|1|||
163317830|NCT01928394|589874968|FG022|Treatment Period|AE unrelated to study drug|0|||
163317831|NCT01928394|589874946|FG000|Treatment Period|Participant request to stop therapy|0|||
163317832|NCT01928394|589874947|FG001|Treatment Period|Participant request to stop therapy|0|||
163401310|NCT01849874|590181118|FG001|Overall Study|Other|4|||
163401311|NCT02347098|590181119|FG000|Overall Study|Death|1|||
163401312|NCT02347098|590181120|FG001|Overall Study|Death|0|||
163401313|NCT02347098|590181119|FG000|Overall Study|Withdrawal by Subject|1|||
163401314|NCT02347098|590181120|FG001|Overall Study|Withdrawal by Subject|0|||
163317833|NCT01928394|589874948|FG002|Treatment Period|Participant request to stop therapy|0|||
163401315|NCT02347098|590181119|FG000|Overall Study|Lost to Follow-up|2|||
163401316|NCT02347098|590181120|FG001|Overall Study|Lost to Follow-up|2|||
163401317|NCT02347098|590181119|FG000|Overall Study|Refuse Follow-up Visit|1|||
163317834|NCT01928394|589874949|FG003|Treatment Period|Participant request to stop therapy|0|||
163317835|NCT01928394|589874950|FG004|Treatment Period|Participant request to stop therapy|0|||
163317836|NCT01928394|589874951|FG005|Treatment Period|Participant request to stop therapy|3|||
163317837|NCT01928394|589874952|FG006|Treatment Period|Participant request to stop therapy|3|||
163317838|NCT01928394|589874953|FG007|Treatment Period|Participant request to stop therapy|0|||
163317839|NCT01928394|589874954|FG008|Treatment Period|Participant request to stop therapy|0|||
163317840|NCT01928394|589874955|FG009|Treatment Period|Participant request to stop therapy|0|||
163317841|NCT01928394|589874956|FG010|Treatment Period|Participant request to stop therapy|3|||
163317842|NCT01928394|589874957|FG011|Treatment Period|Participant request to stop therapy|2|||
163317843|NCT01928394|589874958|FG012|Treatment Period|Participant request to stop therapy|1|||
163317844|NCT01928394|589874959|FG013|Treatment Period|Participant request to stop therapy|2|||
163317845|NCT01928394|589874960|FG014|Treatment Period|Participant request to stop therapy|4|||
163317846|NCT01928394|589874961|FG015|Treatment Period|Participant request to stop therapy|0|||
163317847|NCT01928394|589874962|FG016|Treatment Period|Participant request to stop therapy|1|||
163317848|NCT01928394|589874963|FG017|Treatment Period|Participant request to stop therapy|3|||
163317849|NCT01928394|589874964|FG018|Treatment Period|Participant request to stop therapy|1|||
163317850|NCT01928394|589874965|FG019|Treatment Period|Participant request to stop therapy|1|||
163317851|NCT01928394|589874966|FG020|Treatment Period|Participant request to stop therapy|3|||
163317852|NCT01928394|589874967|FG021|Treatment Period|Participant request to stop therapy|1|||
163317853|NCT01928394|589874968|FG022|Treatment Period|Participant request to stop therapy|3|||
163317854|NCT01928394|589874946|FG000|Treatment Period|Participant withdrew consent|0|||
163317855|NCT01928394|589874947|FG001|Treatment Period|Participant withdrew consent|0|||
163317856|NCT01928394|589874948|FG002|Treatment Period|Participant withdrew consent|1|||
163317857|NCT01928394|589874949|FG003|Treatment Period|Participant withdrew consent|1|||
163317858|NCT01928394|589874950|FG004|Treatment Period|Participant withdrew consent|0|||
163317859|NCT01928394|589874951|FG005|Treatment Period|Participant withdrew consent|1|||
163317860|NCT01928394|589874952|FG006|Treatment Period|Participant withdrew consent|0|||
163317861|NCT01928394|589874953|FG007|Treatment Period|Participant withdrew consent|1|||
163317862|NCT01928394|589874954|FG008|Treatment Period|Participant withdrew consent|0|||
163317863|NCT01928394|589874955|FG009|Treatment Period|Participant withdrew consent|0|||
163317864|NCT01928394|589874956|FG010|Treatment Period|Participant withdrew consent|1|||
163317865|NCT01928394|589874957|FG011|Treatment Period|Participant withdrew consent|1|||
163317866|NCT01928394|589874958|FG012|Treatment Period|Participant withdrew consent|1|||
163317867|NCT01928394|589874959|FG013|Treatment Period|Participant withdrew consent|0|||
163317868|NCT01928394|589874960|FG014|Treatment Period|Participant withdrew consent|2|||
163317869|NCT01928394|589874961|FG015|Treatment Period|Participant withdrew consent|0|||
163317870|NCT01928394|589874962|FG016|Treatment Period|Participant withdrew consent|2|||
163317871|NCT01928394|589874963|FG017|Treatment Period|Participant withdrew consent|1|||
163317872|NCT01928394|589874964|FG018|Treatment Period|Participant withdrew consent|1|||
163317873|NCT01928394|589874965|FG019|Treatment Period|Participant withdrew consent|1|||
162971036|NCT00177164|588595636|FG000|Overall Study|Lost to Follow-up|4|||
162971037|NCT00177164|588595637|FG001|Overall Study|Lost to Follow-up|5|||
162971038|NCT00177164|588595636|FG000|Overall Study|increase in alcohol and drug use|1|||
162971039|NCT00177164|588595637|FG001|Overall Study|increase in alcohol and drug use|2|||
162971040|NCT00177164|588595636|FG000|Overall Study|Adverse Event|1|||
162971041|NCT00177164|588595637|FG001|Overall Study|Adverse Event|0|||
162971042|NCT00177164|588595636|FG000|Overall Study|discharge from hospital|1|||
162971043|NCT00177164|588595637|FG001|Overall Study|discharge from hospital|0|||
162971044|NCT00177164|588595636|FG000|Overall Study|Lack of Efficacy|2|||
162971045|NCT00177164|588595637|FG001|Overall Study|Lack of Efficacy|1|||
162971046|NCT00177164|588595636|FG000|Overall Study|Pregnancy|0|||
162971047|NCT00177164|588595637|FG001|Overall Study|Pregnancy|1|||
162971048|NCT00965757|588595638|FG000|Double-blind Phase|Progression of concomitant disease|1|||
162971049|NCT00965757|588595639|FG001|Double-blind Phase|Progression of concomitant disease|2|||
162971050|NCT00965757|588595640|FG002|Double-blind Phase|Progression of concomitant disease|0|||
162971051|NCT00965757|588595641|FG003|Double-blind Phase|Progression of concomitant disease|0|||
162971052|NCT00965757|588595638|FG000|Double-blind Phase|Adverse drug reaction|2|||
162971053|NCT00965757|588595639|FG001|Double-blind Phase|Adverse drug reaction|1|||
162971054|NCT00965757|588595640|FG002|Double-blind Phase|Adverse drug reaction|0|||
163317874|NCT01928394|589874966|FG020|Treatment Period|Participant withdrew consent|0|||
162971055|NCT00965757|588595641|FG003|Double-blind Phase|Adverse drug reaction|0|||
162971056|NCT00965757|588595638|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
163056881|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
163317875|NCT01928394|589874967|FG021|Treatment Period|Participant withdrew consent|2|||
162971057|NCT00965757|588595639|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
162971058|NCT00965757|588595640|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
162971059|NCT00965757|588595641|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
162971060|NCT00965757|588595638|FG000|Double-blind Phase|Lack of Efficacy|7|||
162971061|NCT00965757|588595639|FG001|Double-blind Phase|Lack of Efficacy|11|||
162971062|NCT00965757|588595640|FG002|Double-blind Phase|Lack of Efficacy|0|||
162971063|NCT00965757|588595641|FG003|Double-blind Phase|Lack of Efficacy|0|||
162971064|NCT00965757|588595638|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
162971065|NCT00965757|588595639|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
163401318|NCT02347098|590181120|FG001|Overall Study|Refuse Follow-up Visit|5|||
162971066|NCT00965757|588595640|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
162971067|NCT00965757|588595641|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
162971068|NCT00965757|588595638|FG000|Double-blind Phase|Lost to Follow-up|0|||
162971069|NCT00965757|588595639|FG001|Double-blind Phase|Lost to Follow-up|1|||
162971070|NCT00965757|588595640|FG002|Double-blind Phase|Lost to Follow-up|0|||
162971071|NCT00965757|588595641|FG003|Double-blind Phase|Lost to Follow-up|0|||
162971072|NCT00965757|588595638|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
162971073|NCT00965757|588595639|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
162971074|NCT00965757|588595640|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
162971075|NCT00965757|588595641|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
162971076|NCT00965757|588595638|FG000|Double-blind Phase|Other|1|||
162971077|NCT00965757|588595639|FG001|Double-blind Phase|Other|0|||
162971078|NCT00965757|588595640|FG002|Double-blind Phase|Other|0|||
162971079|NCT00965757|588595641|FG003|Double-blind Phase|Other|0|||
162971080|NCT00965757|588595638|FG000|Extension Phase|Progression of concomitant disease|0|||
162971081|NCT00965757|588595639|FG001|Extension Phase|Progression of concomitant disease|0|||
162971082|NCT00965757|588595640|FG002|Extension Phase|Progression of concomitant disease|4|||
162971083|NCT00965757|588595641|FG003|Extension Phase|Progression of concomitant disease|2|||
162971084|NCT00965757|588595638|FG000|Extension Phase|Adverse drug reaction|0|||
162971085|NCT00965757|588595639|FG001|Extension Phase|Adverse drug reaction|0|||
162971086|NCT00965757|588595640|FG002|Extension Phase|Adverse drug reaction|6|||
162971087|NCT00965757|588595641|FG003|Extension Phase|Adverse drug reaction|3|||
162971088|NCT00965757|588595638|FG000|Extension Phase|Abnormal Laboratory Value|0|||
162971089|NCT00965757|588595639|FG001|Extension Phase|Abnormal Laboratory Value|0|||
162971090|NCT00965757|588595640|FG002|Extension Phase|Abnormal Laboratory Value|6|||
162971091|NCT00965757|588595641|FG003|Extension Phase|Abnormal Laboratory Value|1|||
162971092|NCT00965757|588595638|FG000|Extension Phase|Lack of Efficacy|0|||
162971093|NCT00965757|588595639|FG001|Extension Phase|Lack of Efficacy|0|||
162971094|NCT00965757|588595640|FG002|Extension Phase|Lack of Efficacy|8|||
162971095|NCT00965757|588595641|FG003|Extension Phase|Lack of Efficacy|12|||
162971096|NCT00965757|588595638|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
162971097|NCT00965757|588595639|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
162971098|NCT00965757|588595640|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
162971099|NCT00965757|588595641|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
162971100|NCT00965757|588595638|FG000|Extension Phase|Lost to Follow-up|0|||
162971101|NCT00965757|588595639|FG001|Extension Phase|Lost to Follow-up|0|||
162971102|NCT00965757|588595640|FG002|Extension Phase|Lost to Follow-up|0|||
162971103|NCT00965757|588595641|FG003|Extension Phase|Lost to Follow-up|1|||
162971104|NCT00965757|588595638|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
162971105|NCT00965757|588595639|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
162971106|NCT00965757|588595640|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
162971107|NCT00965757|588595641|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
162971108|NCT00965757|588595638|FG000|Extension Phase|Protocol Violation|0|||
162971109|NCT00965757|588595639|FG001|Extension Phase|Protocol Violation|0|||
162971110|NCT00965757|588595640|FG002|Extension Phase|Protocol Violation|0|||
162971111|NCT00965757|588595641|FG003|Extension Phase|Protocol Violation|1|||
162971112|NCT00965757|588595638|FG000|Extension Phase|Other|0|||
162971113|NCT00965757|588595639|FG001|Extension Phase|Other|0|||
162971114|NCT00965757|588595640|FG002|Extension Phase|Other|2|||
162971115|NCT00965757|588595641|FG003|Extension Phase|Other|1|||
162971116|NCT01344018|588595645|FG000|Overall Study|Death|22|||
162971117|NCT01344018|588595646|FG001|Overall Study|Death|25|||
162971118|NCT01344018|588595645|FG000|Overall Study|Lost to Follow-up|4|||
162971119|NCT01344018|588595646|FG001|Overall Study|Lost to Follow-up|7|||
162971120|NCT02351167|588595647|FG000|Overall Study|Withdrawal by Subject|19|||
162971121|NCT02351167|588595648|FG001|Overall Study|Withdrawal by Subject|18|||
162971122|NCT02351167|588595649|FG002|Overall Study|Withdrawal by Subject|21|||
162971123|NCT04010227|588595650|FG000|Overall Study|Death|1|||
162971124|NCT04010227|588595651|FG001|Overall Study|Death|2|||
162971125|NCT04010227|588595650|FG000|Overall Study|Medical Reasons|4|||
162971126|NCT04010227|588595651|FG001|Overall Study|Medical Reasons|3|||
162971127|NCT04010227|588595650|FG000|Overall Study|Withdrawal by Subject|2|||
162971128|NCT04010227|588595651|FG001|Overall Study|Withdrawal by Subject|0|||
162971129|NCT04010227|588595650|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
162971130|NCT04010227|588595651|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
162971131|NCT00194792|588595652|FG000|Overall Study|Withdrawal by Subject|1|||
162971132|NCT02448563|588595653|FG000|Overall Study|Lost to Follow-up|16|||
162971133|NCT02448563|588595654|FG001|Overall Study|Lost to Follow-up|10|||
162971134|NCT02448563|588595653|FG000|Overall Study|Withdrawal by Subject|0|||
162971135|NCT02448563|588595654|FG001|Overall Study|Withdrawal by Subject|1|||
162971136|NCT00702507|588595656|FG000|Initial Treatment Phase|Adverse Event|2|||
162971137|NCT00702507|588595656|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
162971138|NCT00702507|588595656|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
162971139|NCT00702507|588595656|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
162971140|NCT00702507|588595656|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
162971141|NCT00702507|588595656|FG000|Follow-up Phase|Protocol Violation|2|||
162971142|NCT00702507|588595656|FG000|Follow-up Phase|Lost to Follow-up|23|||
162971143|NCT00702507|588595656|FG000|Follow-up Phase|Late Enrollment|1|||
163317876|NCT01928394|589874968|FG022|Treatment Period|Participant withdrew consent|0|||
163317877|NCT01928394|589874946|FG000|Treatment Period|Poor/non-compliance|0|||
163317878|NCT01928394|589874947|FG001|Treatment Period|Poor/non-compliance|0|||
163317879|NCT01928394|589874948|FG002|Treatment Period|Poor/non-compliance|0|||
163317880|NCT01928394|589874949|FG003|Treatment Period|Poor/non-compliance|1|||
163317881|NCT01928394|589874950|FG004|Treatment Period|Poor/non-compliance|0|||
163317882|NCT01928394|589874951|FG005|Treatment Period|Poor/non-compliance|0|||
163317883|NCT01928394|589874952|FG006|Treatment Period|Poor/non-compliance|0|||
163056882|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
163056883|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
163056884|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
163056885|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
163056886|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
163056887|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
163056888|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
163056889|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
163056890|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
163056891|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
163056892|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
163056893|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
163056894|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
163056895|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
163056896|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
163056897|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
163056898|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
163056899|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
163056900|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
163056901|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
163056902|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
163056903|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
163056904|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
163056905|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
163056906|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
163056907|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
163056908|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
163056909|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
163056910|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
163056911|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
163056912|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
163056913|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
163056914|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
163056915|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
163056916|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
163056917|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
163056918|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
163056919|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
163056920|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
163056921|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
163056922|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
163056923|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
163056924|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
163056925|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
163056926|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
163056927|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
163056928|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
163056929|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
163056930|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
163056931|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
163317884|NCT01928394|589874953|FG007|Treatment Period|Poor/non-compliance|0|||
163317885|NCT01928394|589874954|FG008|Treatment Period|Poor/non-compliance|0|||
163317886|NCT01928394|589874955|FG009|Treatment Period|Poor/non-compliance|0|||
163317887|NCT01928394|589874956|FG010|Treatment Period|Poor/non-compliance|0|||
163401319|NCT02347098|590181119|FG000|Overall Study|no visit due to illness|2|||
163056932|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
163056933|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
163056934|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
163209214|NCT00241280|589478775|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
163209215|NCT00241280|589478774|FG000|Overall Study|Dispensed incorrect test article|1|||
163209216|NCT00241280|589478775|FG001|Overall Study|Dispensed incorrect test article|2|||
163209217|NCT00241280|589478774|FG000|Overall Study|Unacceptable Fit|0|||
163317888|NCT01928394|589874957|FG011|Treatment Period|Poor/non-compliance|0|||
163209218|NCT00241280|589478775|FG001|Overall Study|Unacceptable Fit|1|||
163209219|NCT00241280|589478774|FG000|Overall Study|Scheduling Conflict|0|||
163209220|NCT00241280|589478775|FG001|Overall Study|Scheduling Conflict|2|||
163209221|NCT00241280|589478774|FG000|Overall Study|History of Ocular Surgery|0|||
163209222|NCT00241280|589478775|FG001|Overall Study|History of Ocular Surgery|1|||
163209223|NCT00241280|589478774|FG000|Overall Study|Coating on Lens|1|||
163209224|NCT00241280|589478775|FG001|Overall Study|Coating on Lens|0|||
163209225|NCT00241280|589478774|FG000|Overall Study|Excessive Dryness|0|||
163209226|NCT00241280|589478775|FG001|Overall Study|Excessive Dryness|1|||
163209227|NCT01958008|589478776|FG000|Overall Study|Worsening of disease under study|0|||
163209228|NCT01958008|589478777|FG001|Overall Study|Worsening of disease under study|0|||
163209229|NCT01958008|589478778|FG002|Overall Study|Worsening of disease under study|1|||
163209230|NCT01958008|589478779|FG003|Overall Study|Worsening of disease under study|0|||
163209231|NCT01958008|589478776|FG000|Overall Study|Other adverse event|1|||
163209232|NCT01958008|589478777|FG001|Overall Study|Other adverse event|0|||
163209233|NCT01958008|589478778|FG002|Overall Study|Other adverse event|0|||
163209234|NCT01958008|589478779|FG003|Overall Study|Other adverse event|0|||
163209235|NCT01414855|589478780|FG000|Overall Study|Death|17|||
163209236|NCT01414855|589478780|FG000|Overall Study|Lost to Follow-up|5|||
163209237|NCT01414855|589478780|FG000|Overall Study|Withdrawal by Subject|7|||
163209238|NCT01937559|589478783|FG000|Overall Study|Physician Decision|3|||
163317889|NCT01928394|589874958|FG012|Treatment Period|Poor/non-compliance|1|||
163317890|NCT01928394|589874959|FG013|Treatment Period|Poor/non-compliance|0|||
163317891|NCT01928394|589874960|FG014|Treatment Period|Poor/non-compliance|1|||
163317892|NCT01928394|589874961|FG015|Treatment Period|Poor/non-compliance|0|||
163317893|NCT01928394|589874962|FG016|Treatment Period|Poor/non-compliance|0|||
163317894|NCT01928394|589874963|FG017|Treatment Period|Poor/non-compliance|1|||
163317895|NCT01928394|589874964|FG018|Treatment Period|Poor/non-compliance|0|||
163317896|NCT01928394|589874965|FG019|Treatment Period|Poor/non-compliance|1|||
163317897|NCT01928394|589874966|FG020|Treatment Period|Poor/non-compliance|0|||
163317898|NCT01928394|589874967|FG021|Treatment Period|Poor/non-compliance|0|||
163317899|NCT01928394|589874968|FG022|Treatment Period|Poor/non-compliance|0|||
163317900|NCT01928394|589874946|FG000|Treatment Period|other reason|0|||
163317901|NCT01928394|589874947|FG001|Treatment Period|other reason|0|||
163317902|NCT01928394|589874948|FG002|Treatment Period|other reason|0|||
163317903|NCT01928394|589874949|FG003|Treatment Period|other reason|0|||
163317904|NCT01928394|589874950|FG004|Treatment Period|other reason|0|||
163317905|NCT01928394|589874951|FG005|Treatment Period|other reason|0|||
163317906|NCT01928394|589874952|FG006|Treatment Period|other reason|0|||
163317907|NCT01928394|589874953|FG007|Treatment Period|other reason|0|||
163317908|NCT01928394|589874954|FG008|Treatment Period|other reason|0|||
163317909|NCT01928394|589874955|FG009|Treatment Period|other reason|0|||
163317910|NCT01928394|589874956|FG010|Treatment Period|other reason|1|||
163317911|NCT01928394|589874957|FG011|Treatment Period|other reason|1|||
163317912|NCT01928394|589874958|FG012|Treatment Period|other reason|1|||
163317913|NCT01928394|589874959|FG013|Treatment Period|other reason|0|||
162971144|NCT02308696|588595657|FG000|Overall Study|Lost to Follow-up|28|||
162971145|NCT02308696|588595658|FG001|Overall Study|Lost to Follow-up|21|||
162971146|NCT02308696|588595657|FG000|Overall Study|Death|8|||
162971147|NCT02308696|588595658|FG001|Overall Study|Death|4|||
162971148|NCT02308696|588595657|FG000|Overall Study|Moved to a Higher Level of Care|17|||
162971149|NCT02308696|588595658|FG001|Overall Study|Moved to a Higher Level of Care|6|||
162971150|NCT00113919|588595659|FG000|Overall Study|Physician Decision|8|||
162971151|NCT00113919|588595659|FG000|Overall Study|Death|6|||
162971152|NCT02914457|588595662|FG000|Overall Study|Withdrawal by Subject|1|||
162971153|NCT02914457|588595662|FG000|Overall Study|Physician Decision|1|||
163056935|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
163209239|NCT01937559|589478784|FG001|Overall Study|Physician Decision|3|||
163209240|NCT01937559|589478785|FG002|Overall Study|Physician Decision|0|||
163209241|NCT01937559|589478783|FG000|Overall Study|Withdrawal by Subject|6|||
163317914|NCT01928394|589874960|FG014|Treatment Period|other reason|1|||
162971154|NCT02914457|588595662|FG000|Overall Study|No veins available for lead placement|1|||
162971155|NCT02914457|588595662|FG000|Overall Study|Electrical instability of patient|1|||
162971156|NCT02914457|588595662|FG000|Overall Study|ECG acquisition error due to sweating|1|||
162971157|NCT02914457|588595662|FG000|Overall Study|Protocol Violation|1|||
162971158|NCT01055886|588595668|FG000|Overall Study|Withdrawal by Subject|4|||
162971159|NCT01055886|588595669|FG001|Overall Study|Withdrawal by Subject|9|||
163317915|NCT01928394|589874961|FG015|Treatment Period|other reason|0|||
163209242|NCT01937559|589478784|FG001|Overall Study|Withdrawal by Subject|4|||
163209243|NCT01937559|589478785|FG002|Overall Study|Withdrawal by Subject|0|||
163209244|NCT01937559|589478783|FG000|Overall Study|screen fail|2|||
163317916|NCT01928394|589874962|FG016|Treatment Period|other reason|0|||
163317917|NCT01928394|589874963|FG017|Treatment Period|other reason|0|||
163209245|NCT01937559|589478784|FG001|Overall Study|screen fail|4|||
163209246|NCT01937559|589478785|FG002|Overall Study|screen fail|0|||
163209247|NCT01853826|589480525|FG000|Overall Study|Patients who switched to commercial drug|11|||
163209248|NCT01853826|589480525|FG000|Overall Study|Patient refused to continue medication|21|||
163209249|NCT01853826|589480525|FG000|Overall Study|Lost to Follow-up|2|||
163209250|NCT01853826|589480525|FG000|Overall Study|Non-compliant with protocol|4|||
163209251|NCT01853826|589480525|FG000|Overall Study|Other adverse events (AE)|62|||
163209252|NCT01853826|589480525|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
163209253|NCT01853826|589480525|FG000|Overall Study|Progressive disease|342|||
163209254|NCT01853826|589480525|FG000|Overall Study|Other than listed|13|||
163209255|NCT01853826|589480525|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
163317918|NCT01928394|589874964|FG018|Treatment Period|other reason|2|||
163317919|NCT01928394|589874965|FG019|Treatment Period|other reason|2|||
162971160|NCT01055886|588595668|FG000|Overall Study|Lost to Follow-up|1|||
163317920|NCT01928394|589874966|FG020|Treatment Period|other reason|0|||
162971161|NCT01055886|588595669|FG001|Overall Study|Lost to Follow-up|1|||
162971162|NCT01055886|588595668|FG000|Overall Study|Withdrawal by PI|0|||
162971163|NCT01055886|588595669|FG001|Overall Study|Withdrawal by PI|1|||
162971164|NCT04254809|588595672|FG000|Overall Study|Lost to Follow-up|5|||
162971165|NCT04254809|588595673|FG001|Overall Study|Lost to Follow-up|10|||
162971166|NCT02972515|588595674|FG000|Overall Study|Lost to Follow-up|78|||
162971167|NCT01928615|588595675|FG000|Overall Study|Study Terminated by Sponsor|2|||
162971168|NCT04531527|588595676|FG000|Overall Study|Found to be Ineligible|3|||
162971169|NCT01266603|588595677|FG000|Overall Study|Adverse Event|1|||
162971170|NCT01266603|588595677|FG000|Overall Study|Lack of Efficacy|14|||
162971171|NCT01266603|588595677|FG000|Overall Study|Withdrawal by Subject|1|||
162971172|NCT01266603|588595677|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
162971173|NCT02725411|588595680|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
162971174|NCT02725411|588595681|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
162971175|NCT02725411|588595682|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
162971176|NCT02725411|588595680|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
162971177|NCT02725411|588595681|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
162971178|NCT02725411|588595682|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
162971179|NCT02725411|588595680|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
162971180|NCT02725411|588595681|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
162971181|NCT02725411|588595682|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
162971182|NCT02725411|588595680|FG000|Treatment Period (56 Weeks)|Other|1|||
162971183|NCT02725411|588595681|FG001|Treatment Period (56 Weeks)|Other|4|||
162971184|NCT02725411|588595682|FG002|Treatment Period (56 Weeks)|Other|5|||
162971185|NCT02725411|588595680|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
162971186|NCT02725411|588595681|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
162971187|NCT02725411|588595682|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
162971188|NCT02725411|588595680|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
162971189|NCT02725411|588595681|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
162971190|NCT02725411|588595682|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
162971191|NCT02725411|588595680|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
162971192|NCT02725411|588595681|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
162971193|NCT02725411|588595682|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
162971194|NCT02725411|588595680|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
162971195|NCT02725411|588595681|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
162971196|NCT02725411|588595682|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
162971197|NCT02725411|588595680|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
162971198|NCT02725411|588595681|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
162971199|NCT02725411|588595682|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
162971200|NCT02725411|588595680|FG000|Follow-up Period (24 Weeks)|Other|1|||
162971201|NCT02725411|588595681|FG001|Follow-up Period (24 Weeks)|Other|4|||
162971202|NCT02725411|588595682|FG002|Follow-up Period (24 Weeks)|Other|2|||
162971203|NCT02725411|588595680|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
162971204|NCT02725411|588595681|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
162971205|NCT02725411|588595682|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
162971206|NCT04307849|588595683|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
163209256|NCT04779489|589480537|FG000|Overall Study|Physician Decision|1|||
163317921|NCT01928394|589874967|FG021|Treatment Period|other reason|0|||
163317922|NCT01928394|589874968|FG022|Treatment Period|other reason|0|||
162971207|NCT04307849|588595684|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
162971208|NCT04307849|588595685|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
163317923|NCT01928394|589874946|FG000|Treatment Period|Maximum clinical benefit|0|||
163317924|NCT01928394|589874947|FG001|Treatment Period|Maximum clinical benefit|0|||
162971209|NCT04307849|588595686|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
162971210|NCT04307849|588595687|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
162971211|NCT04307849|588595688|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
163209257|NCT05126901|589480538|FG000|Overall Study|Withdrawal by Subject|1|||
162971212|NCT04307849|588595683|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
162971213|NCT04307849|588595684|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
162971214|NCT04307849|588595685|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
162971215|NCT04307849|588595686|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
162971216|NCT04307849|588595687|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
162971217|NCT04307849|588595688|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
162971218|NCT04307849|588595683|FG000|Overall Study|Family member did not want them to continue|0|||
162971219|NCT04307849|588595684|FG001|Overall Study|Family member did not want them to continue|0|||
162971220|NCT04307849|588595685|FG002|Overall Study|Family member did not want them to continue|1|||
162971221|NCT04307849|588595686|FG003|Overall Study|Family member did not want them to continue|0|||
162971222|NCT04307849|588595687|FG004|Overall Study|Family member did not want them to continue|0|||
162971223|NCT04307849|588595688|FG005|Overall Study|Family member did not want them to continue|0|||
162971224|NCT04307849|588595683|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
162971225|NCT04307849|588595684|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
162971226|NCT04307849|588595685|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
162971227|NCT04307849|588595686|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
162971228|NCT04307849|588595687|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
162971229|NCT04307849|588595688|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
162971230|NCT02654015|588595691|FG000|Overall Study|Death|12|||
162971231|NCT02654015|588595691|FG000|Overall Study|Lost to Follow-up|3|||
162971232|NCT02418754|588595694|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
162971233|NCT02418754|588595695|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
162971234|NCT02418754|588595696|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
162971235|NCT02418754|588595697|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
162971236|NCT02418754|588595698|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
162971237|NCT02418754|588595694|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
162971238|NCT02418754|588595695|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
162971239|NCT02418754|588595696|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
162971240|NCT02418754|588595697|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
162971241|NCT02418754|588595698|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
162971242|NCT02418754|588595694|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
162971243|NCT02418754|588595695|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
162971244|NCT02418754|588595696|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
162971245|NCT02418754|588595697|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
162971246|NCT02418754|588595698|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
162971247|NCT02418754|588595694|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
162971248|NCT02418754|588595695|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
162971249|NCT02418754|588595696|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
162971250|NCT02418754|588595697|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
162971251|NCT02418754|588595698|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
162971252|NCT02418754|588595694|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
162971253|NCT02418754|588595695|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
162971254|NCT02418754|588595696|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
162971255|NCT02418754|588595697|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
162971256|NCT02418754|588595698|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
162971257|NCT02418754|588595694|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
162971258|NCT02418754|588595695|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
162971259|NCT02418754|588595696|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
162971260|NCT02418754|588595697|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
162971261|NCT02418754|588595698|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
162971262|NCT02418754|588595694|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
162971263|NCT02418754|588595695|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
162971264|NCT02418754|588595696|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
162971265|NCT02418754|588595697|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
162971266|NCT02418754|588595698|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
162971267|NCT02418754|588595694|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
163209258|NCT05126901|589480539|FG001|Overall Study|Withdrawal by Subject|1|||
163209259|NCT05126901|589480540|FG002|Overall Study|Withdrawal by Subject|4|||
163209260|NCT05126901|589480538|FG000|Overall Study|Adverse Event|0|||
163209261|NCT05126901|589480539|FG001|Overall Study|Adverse Event|0|||
163209262|NCT05126901|589480540|FG002|Overall Study|Adverse Event|1|||
163209263|NCT05126901|589480538|FG000|Overall Study|Lost to Follow-up|0|||
163209264|NCT05126901|589480539|FG001|Overall Study|Lost to Follow-up|2|||
162971268|NCT02418754|588595695|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
162971269|NCT02418754|588595696|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
162971270|NCT02418754|588595697|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
163317925|NCT01928394|589874948|FG002|Treatment Period|Maximum clinical benefit|0|||
162971271|NCT02418754|588595698|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
163209265|NCT05126901|589480540|FG002|Overall Study|Lost to Follow-up|0|||
163209266|NCT00710710|589480541|FG000|Overall Study|Consent withdrawn|2|||
163317926|NCT01928394|589874949|FG003|Treatment Period|Maximum clinical benefit|0|||
163317927|NCT01928394|589874950|FG004|Treatment Period|Maximum clinical benefit|0|||
163317928|NCT01928394|589874951|FG005|Treatment Period|Maximum clinical benefit|0|||
163317929|NCT01928394|589874952|FG006|Treatment Period|Maximum clinical benefit|0|||
163317930|NCT01928394|589874953|FG007|Treatment Period|Maximum clinical benefit|0|||
163317931|NCT01928394|589874954|FG008|Treatment Period|Maximum clinical benefit|0|||
163317932|NCT01928394|589874955|FG009|Treatment Period|Maximum clinical benefit|0|||
163317933|NCT01928394|589874956|FG010|Treatment Period|Maximum clinical benefit|1|||
163317934|NCT01928394|589874957|FG011|Treatment Period|Maximum clinical benefit|1|||
163317935|NCT01928394|589874958|FG012|Treatment Period|Maximum clinical benefit|0|||
163317936|NCT01928394|589874959|FG013|Treatment Period|Maximum clinical benefit|0|||
163317937|NCT01928394|589874960|FG014|Treatment Period|Maximum clinical benefit|1|||
163317938|NCT01928394|589874961|FG015|Treatment Period|Maximum clinical benefit|0|||
163317939|NCT01928394|589874962|FG016|Treatment Period|Maximum clinical benefit|0|||
163317940|NCT01928394|589874963|FG017|Treatment Period|Maximum clinical benefit|1|||
163317941|NCT01928394|589874964|FG018|Treatment Period|Maximum clinical benefit|1|||
163317942|NCT01928394|589874965|FG019|Treatment Period|Maximum clinical benefit|0|||
163317943|NCT01928394|589874966|FG020|Treatment Period|Maximum clinical benefit|2|||
163317944|NCT01928394|589874967|FG021|Treatment Period|Maximum clinical benefit|0|||
163317945|NCT01928394|589874968|FG022|Treatment Period|Maximum clinical benefit|0|||
163317946|NCT01928394|589874946|FG000|Treatment Period|Lost to Follow-up|0|||
163317947|NCT01928394|589874947|FG001|Treatment Period|Lost to Follow-up|0|||
163317948|NCT01928394|589874948|FG002|Treatment Period|Lost to Follow-up|0|||
163317949|NCT01928394|589874949|FG003|Treatment Period|Lost to Follow-up|0|||
163317950|NCT01928394|589874950|FG004|Treatment Period|Lost to Follow-up|0|||
163317951|NCT01928394|589874951|FG005|Treatment Period|Lost to Follow-up|0|||
163317952|NCT01928394|589874952|FG006|Treatment Period|Lost to Follow-up|0|||
162971272|NCT02418754|588595694|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
162971273|NCT02418754|588595695|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
162971274|NCT02418754|588595696|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
162971275|NCT02418754|588595697|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
162971276|NCT02418754|588595698|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
162971277|NCT02418754|588595694|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
162971278|NCT02418754|588595695|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
162971279|NCT02418754|588595696|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
162971280|NCT02418754|588595697|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
162971281|NCT02418754|588595698|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
162971282|NCT02418754|588595694|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
162971283|NCT02418754|588595695|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
162971284|NCT02418754|588595696|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
162971285|NCT02418754|588595697|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
162971286|NCT02418754|588595698|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
162971287|NCT00761176|588595703|FG000|Overall Study|Death|1|||
162971288|NCT00761176|588595704|FG001|Overall Study|Death|0|||
162971289|NCT00761176|588595703|FG000|Overall Study|Withdrawal by Subject|1|||
162971290|NCT00761176|588595704|FG001|Overall Study|Withdrawal by Subject|1|||
162971291|NCT02762994|588595705|FG000|Overall Study|Withdrawal by Subject|0|||
162971292|NCT02762994|588595706|FG001|Overall Study|Withdrawal by Subject|1|||
162971293|NCT02762994|588595707|FG002|Overall Study|Withdrawal by Subject|2|||
162971294|NCT02762994|588595708|FG003|Overall Study|Withdrawal by Subject|0|||
162971295|NCT02762994|588595705|FG000|Overall Study|Protocol Violation|1|||
162971296|NCT02762994|588595706|FG001|Overall Study|Protocol Violation|0|||
162971297|NCT02762994|588595707|FG002|Overall Study|Protocol Violation|0|||
162971298|NCT02762994|588595708|FG003|Overall Study|Protocol Violation|2|||
162971299|NCT05103657|588595711|FG000|Overall Study|Other reasons than listed|9|||
162971300|NCT05103657|588595712|FG001|Overall Study|Other reasons than listed|8|||
162971301|NCT05103657|588595711|FG000|Overall Study|Protocol deviation|2|||
162971302|NCT05103657|588595712|FG001|Overall Study|Protocol deviation|2|||
162971303|NCT05103657|588595711|FG000|Overall Study|No reason available|5|||
162971304|NCT05103657|588595712|FG001|Overall Study|No reason available|4|||
162971305|NCT05103657|588595711|FG000|Overall Study|Burden of study procedures|3|||
163317953|NCT01928394|589874953|FG007|Treatment Period|Lost to Follow-up|0|||
162971306|NCT05103657|588595712|FG001|Overall Study|Burden of study procedures|1|||
163317954|NCT01928394|589874954|FG008|Treatment Period|Lost to Follow-up|0|||
163317955|NCT01928394|589874955|FG009|Treatment Period|Lost to Follow-up|0|||
163317956|NCT01928394|589874956|FG010|Treatment Period|Lost to Follow-up|0|||
163317957|NCT01928394|589874957|FG011|Treatment Period|Lost to Follow-up|0|||
163317958|NCT01928394|589874958|FG012|Treatment Period|Lost to Follow-up|0|||
162971307|NCT05103657|588595711|FG000|Overall Study|Perceived lack of efficacy|1|||
163317959|NCT01928394|589874959|FG013|Treatment Period|Lost to Follow-up|0|||
162971308|NCT05103657|588595712|FG001|Overall Study|Perceived lack of efficacy|1|||
162971309|NCT05103657|588595711|FG000|Overall Study|Adverse Event|6|||
163401320|NCT02347098|590181120|FG001|Overall Study|no visit due to illness|1|||
163209267|NCT00710710|589480542|FG001|Overall Study|Consent withdrawn|2|||
162971310|NCT05103657|588595712|FG001|Overall Study|Adverse Event|14|||
162971311|NCT05103657|588595711|FG000|Overall Study|Not Treated|1|||
162971312|NCT05103657|588595712|FG001|Overall Study|Not Treated|1|||
162971313|NCT02020967|588595713|FG000|Overall Study|Withdrawal by Subject|51|||
162971314|NCT02387762|588595716|FG000|Overall Study|Withdrawal by Subject|1|||
162971315|NCT02387762|588595717|FG001|Overall Study|Withdrawal by Subject|0|||
162971316|NCT04203667|588595718|FG000|Overall Study|Withdrawal by Subject|1|||
162971317|NCT04203667|588595718|FG000|Overall Study|Lost to Follow-up|1|||
162971318|NCT04203667|588595718|FG000|Overall Study|Death|1|||
162971319|NCT04203667|588595718|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
162971320|NCT01160640|588595719|FG000|Overall Study|Physician Decision|3|||
162971321|NCT01160640|588595720|FG001|Overall Study|Physician Decision|3|||
162971322|NCT01160640|588595719|FG000|Overall Study|Incarceration|1|||
162971323|NCT01160640|588595720|FG001|Overall Study|Incarceration|0|||
162971324|NCT01160640|588595719|FG000|Overall Study|Withdrawal by Subject|0|||
162971325|NCT01160640|588595720|FG001|Overall Study|Withdrawal by Subject|3|||
162971326|NCT00642811|588595723|FG000|Overall Study|Adverse Event|2|||
162971327|NCT00642811|588595724|FG001|Overall Study|Adverse Event|3|||
162971328|NCT00642811|588595725|FG002|Overall Study|Adverse Event|0|||
162971329|NCT00642811|588595726|FG003|Overall Study|Adverse Event|0|||
162971330|NCT00642811|588595727|FG004|Overall Study|Adverse Event|0|||
162971331|NCT00642811|588595728|FG005|Overall Study|Adverse Event|1|||
162971332|NCT00642811|588595723|FG000|Overall Study|Developement of discontinuation criteria|0|||
162971333|NCT00642811|588595724|FG001|Overall Study|Developement of discontinuation criteria|0|||
162971334|NCT00642811|588595725|FG002|Overall Study|Developement of discontinuation criteria|0|||
162971335|NCT00642811|588595726|FG003|Overall Study|Developement of discontinuation criteria|0|||
162971336|NCT00642811|588595727|FG004|Overall Study|Developement of discontinuation criteria|1|||
162971337|NCT00642811|588595728|FG005|Overall Study|Developement of discontinuation criteria|0|||
162971338|NCT00642811|588595723|FG000|Overall Study|Severe Non-compliance to protocol|1|||
162971339|NCT00642811|588595724|FG001|Overall Study|Severe Non-compliance to protocol|0|||
162971340|NCT00642811|588595725|FG002|Overall Study|Severe Non-compliance to protocol|0|||
162971341|NCT00642811|588595726|FG003|Overall Study|Severe Non-compliance to protocol|0|||
162971342|NCT00642811|588595727|FG004|Overall Study|Severe Non-compliance to protocol|0|||
162971343|NCT00642811|588595728|FG005|Overall Study|Severe Non-compliance to protocol|0|||
162971344|NCT00642811|588595723|FG000|Overall Study|Other|0|||
162971345|NCT00642811|588595724|FG001|Overall Study|Other|1|||
162971346|NCT00642811|588595725|FG002|Overall Study|Other|0|||
162971347|NCT00642811|588595726|FG003|Overall Study|Other|1|||
162971348|NCT00642811|588595727|FG004|Overall Study|Other|0|||
162971349|NCT00642811|588595728|FG005|Overall Study|Other|0|||
162971350|NCT01525628|588595729|FG000|Overall Study|Adverse Event|1|||
162971351|NCT01525628|588595730|FG001|Overall Study|Adverse Event|1|||
162971352|NCT01525628|588595731|FG002|Overall Study|Adverse Event|2|||
162971353|NCT01525628|588595732|FG003|Overall Study|Adverse Event|0|||
162971354|NCT01525628|588595733|FG004|Overall Study|Adverse Event|1|||
162971355|NCT01525628|588595729|FG000|Overall Study|Lack of Efficacy|0|||
162971356|NCT01525628|588595730|FG001|Overall Study|Lack of Efficacy|2|||
162971357|NCT01525628|588595731|FG002|Overall Study|Lack of Efficacy|2|||
163056936|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
163056937|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
163056938|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
163056939|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
163056940|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
163056941|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
163056942|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
163056943|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
163056944|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
163056945|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
163209268|NCT00710710|589480541|FG000|Overall Study|Protocol Violation|0|||
163209269|NCT00710710|589480542|FG001|Overall Study|Protocol Violation|1|||
163209270|NCT00710710|589480541|FG000|Overall Study|Adverse Event|3|||
163209271|NCT00710710|589480542|FG001|Overall Study|Adverse Event|3|||
163209272|NCT00710710|589480541|FG000|Overall Study|Progressive disease|40|||
163209273|NCT00710710|589480542|FG001|Overall Study|Progressive disease|38|||
163209274|NCT00715078|589480543|FG000|Overall Study|Death|29|||
162971358|NCT01525628|588595732|FG003|Overall Study|Lack of Efficacy|1|||
163209275|NCT00715078|589480544|FG001|Overall Study|Death|36|||
163209276|NCT00715078|589480545|FG002|Overall Study|Death|36|||
162971359|NCT01525628|588595733|FG004|Overall Study|Lack of Efficacy|2|||
163209277|NCT00715078|589480543|FG000|Overall Study|Withdrawal by Subject|1|||
162971360|NCT01525628|588595729|FG000|Overall Study|Protocol Violation|0|||
162971361|NCT01525628|588595730|FG001|Overall Study|Protocol Violation|0|||
163056946|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
163209278|NCT00715078|589480544|FG001|Overall Study|Withdrawal by Subject|0|||
163209279|NCT00715078|589480545|FG002|Overall Study|Withdrawal by Subject|1|||
162971362|NCT01525628|588595731|FG002|Overall Study|Protocol Violation|1|||
162971363|NCT01525628|588595732|FG003|Overall Study|Protocol Violation|0|||
162971364|NCT01525628|588595733|FG004|Overall Study|Protocol Violation|0|||
162971365|NCT01525628|588595729|FG000|Overall Study|Lost to Follow-up|1|||
162971366|NCT01525628|588595730|FG001|Overall Study|Lost to Follow-up|1|||
162971367|NCT01525628|588595731|FG002|Overall Study|Lost to Follow-up|0|||
162971368|NCT01525628|588595732|FG003|Overall Study|Lost to Follow-up|0|||
162971369|NCT01525628|588595733|FG004|Overall Study|Lost to Follow-up|0|||
162971370|NCT01525628|588595729|FG000|Overall Study|Withdrawal by Subject|0|||
162971371|NCT01525628|588595730|FG001|Overall Study|Withdrawal by Subject|1|||
162971372|NCT01525628|588595731|FG002|Overall Study|Withdrawal by Subject|0|||
162971373|NCT01525628|588595732|FG003|Overall Study|Withdrawal by Subject|0|||
162971374|NCT01525628|588595733|FG004|Overall Study|Withdrawal by Subject|0|||
162971375|NCT01525628|588595729|FG000|Overall Study|Other reason not defined above|0|||
162971376|NCT01525628|588595730|FG001|Overall Study|Other reason not defined above|0|||
162971377|NCT01525628|588595731|FG002|Overall Study|Other reason not defined above|0|||
162971378|NCT01525628|588595732|FG003|Overall Study|Other reason not defined above|3|||
162971379|NCT01525628|588595733|FG004|Overall Study|Other reason not defined above|0|||
162971380|NCT02614898|588595734|FG000|Overall Study|Participated until study termination|10|||
162971381|NCT02614898|588595735|FG001|Overall Study|Participated until study termination|26|||
162971382|NCT02614898|588595734|FG000|Overall Study|Lost to Follow-up|0|||
162971383|NCT02614898|588595735|FG001|Overall Study|Lost to Follow-up|2|||
162971384|NCT02614898|588595734|FG000|Overall Study|Physician Decision|1|||
162971385|NCT02614898|588595735|FG001|Overall Study|Physician Decision|8|||
162971386|NCT02614898|588595734|FG000|Overall Study|Study Terminated by Sponsor|3|||
162971387|NCT02614898|588595735|FG001|Overall Study|Study Terminated by Sponsor|0|||
162971388|NCT02614898|588595734|FG000|Overall Study|Withdrawal by Subject|0|||
162971389|NCT02614898|588595735|FG001|Overall Study|Withdrawal by Subject|2|||
162971390|NCT02614898|588595734|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162971391|NCT02614898|588595735|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
162971392|NCT02614898|588595734|FG000|Overall Study|Other-Additional Information Unavailable|0|||
162971393|NCT02614898|588595735|FG001|Overall Study|Other-Additional Information Unavailable|11|||
162971394|NCT02614898|588595734|FG000|Overall Study|Missing|0|||
162971395|NCT02614898|588595735|FG001|Overall Study|Missing|1|||
162971396|NCT00787605|588595736|FG000|Overall Study|Administrative Problems|3|||
162971397|NCT00787605|588595737|FG001|Overall Study|Administrative Problems|0|||
162971398|NCT00787605|588595736|FG000|Overall Study|Adverse Event|14|||
162971399|NCT00787605|588595737|FG001|Overall Study|Adverse Event|25|||
162971400|NCT00787605|588595736|FG000|Overall Study|Lost to Follow-up|3|||
162971401|NCT00787605|588595737|FG001|Overall Study|Lost to Follow-up|6|||
162971402|NCT00787605|588595736|FG000|Overall Study|Protocol Violation|7|||
162971403|NCT00787605|588595737|FG001|Overall Study|Protocol Violation|3|||
162971404|NCT00787605|588595736|FG000|Overall Study|Withdrawal by Subject|6|||
162971405|NCT00787605|588595737|FG001|Overall Study|Withdrawal by Subject|13|||
162971406|NCT00787605|588595736|FG000|Overall Study|Lack of Efficacy|13|||
162971407|NCT00787605|588595737|FG001|Overall Study|Lack of Efficacy|9|||
162971408|NCT01223027|588595738|FG000|Overall Study|Adverse Event|20|||
162971409|NCT01223027|588595739|FG001|Overall Study|Adverse Event|10|||
162971410|NCT01223027|588595738|FG000|Overall Study|Death|42|||
162971411|NCT01223027|588595739|FG001|Overall Study|Death|42|||
162971412|NCT01223027|588595738|FG000|Overall Study|Lost to Follow-up|2|||
162971413|NCT01223027|588595739|FG001|Overall Study|Lost to Follow-up|1|||
162971414|NCT01223027|588595738|FG000|Overall Study|Physician Decision|4|||
162971415|NCT01223027|588595739|FG001|Overall Study|Physician Decision|8|||
162971416|NCT01223027|588595738|FG000|Overall Study|Progressive Disease|167|||
162971417|NCT01223027|588595739|FG001|Overall Study|Progressive Disease|183|||
162971418|NCT01223027|588595738|FG000|Overall Study|Protocol Violation|2|||
162971419|NCT01223027|588595739|FG001|Overall Study|Protocol Violation|1|||
162971420|NCT01223027|588595738|FG000|Overall Study|Subject/guardian decicion|18|||
162971421|NCT01223027|588595739|FG001|Overall Study|Subject/guardian decicion|16|||
162971422|NCT01223027|588595738|FG000|Overall Study|New therapy for study indication|17|||
162971423|NCT01223027|588595739|FG001|Overall Study|New therapy for study indication|8|||
162971424|NCT01223027|588595738|FG000|Overall Study|Study terminated by sponsor|2|||
162971425|NCT01223027|588595739|FG001|Overall Study|Study terminated by sponsor|8|||
162971426|NCT03493919|588595740|FG000|Overall Study|Other|2|||
162971427|NCT03493919|588595741|FG001|Overall Study|Other|0|||
162971428|NCT03493919|588595742|FG002|Overall Study|Other|1|||
162971429|NCT03493919|588595743|FG003|Overall Study|Other|0|||
162971430|NCT03493919|588595740|FG000|Overall Study|Withdrawal by Subject|9|||
163317960|NCT01928394|589874960|FG014|Treatment Period|Lost to Follow-up|0|||
163317961|NCT01928394|589874961|FG015|Treatment Period|Lost to Follow-up|0|||
163317962|NCT01928394|589874962|FG016|Treatment Period|Lost to Follow-up|0|||
162971431|NCT03493919|588595741|FG001|Overall Study|Withdrawal by Subject|3|||
162971432|NCT03493919|588595742|FG002|Overall Study|Withdrawal by Subject|1|||
162971433|NCT03493919|588595743|FG003|Overall Study|Withdrawal by Subject|1|||
162971434|NCT03493919|588595740|FG000|Overall Study|Lost to Follow-up|5|||
162971435|NCT03493919|588595741|FG001|Overall Study|Lost to Follow-up|0|||
162971436|NCT03493919|588595742|FG002|Overall Study|Lost to Follow-up|0|||
162971437|NCT03493919|588595743|FG003|Overall Study|Lost to Follow-up|3|||
162971438|NCT03493919|588595740|FG000|Overall Study|Adverse Event|0|||
162971439|NCT03493919|588595741|FG001|Overall Study|Adverse Event|1|||
162971440|NCT03493919|588595742|FG002|Overall Study|Adverse Event|0|||
162971441|NCT03493919|588595743|FG003|Overall Study|Adverse Event|0|||
162971442|NCT04428645|588595744|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
162971443|NCT00401245|588597882|FG000|Double Blind Titration Phase|Adverse Event|3|||
162971444|NCT00401245|588597883|FG001|Double Blind Titration Phase|Adverse Event|2|||
162971445|NCT00401245|588597884|FG002|Double Blind Titration Phase|Adverse Event|5|||
162971446|NCT00401245|588597885|FG003|Double Blind Titration Phase|Adverse Event|12|||
162971447|NCT00401245|588597886|FG004|Double Blind Titration Phase|Adverse Event|0|||
162971448|NCT00401245|588597887|FG005|Double Blind Titration Phase|Adverse Event|0|||
162971449|NCT00401245|588597888|FG006|Double Blind Titration Phase|Adverse Event|0|||
162971450|NCT00401245|588597889|FG007|Double Blind Titration Phase|Adverse Event|0|||
162971451|NCT00401245|588597882|FG000|Double Blind Titration Phase|Other|0|||
162971452|NCT00401245|588597883|FG001|Double Blind Titration Phase|Other|0|||
162971453|NCT00401245|588597884|FG002|Double Blind Titration Phase|Other|1|||
162971454|NCT00401245|588597885|FG003|Double Blind Titration Phase|Other|0|||
162971455|NCT00401245|588597886|FG004|Double Blind Titration Phase|Other|0|||
162971456|NCT00401245|588597887|FG005|Double Blind Titration Phase|Other|0|||
162971457|NCT00401245|588597888|FG006|Double Blind Titration Phase|Other|0|||
162971458|NCT00401245|588597889|FG007|Double Blind Titration Phase|Other|0|||
162971459|NCT00401245|588597882|FG000|Double Blind Titration Phase|Protocol Violation|0|||
162971460|NCT00401245|588597883|FG001|Double Blind Titration Phase|Protocol Violation|0|||
162971461|NCT00401245|588597884|FG002|Double Blind Titration Phase|Protocol Violation|0|||
162971462|NCT00401245|588597885|FG003|Double Blind Titration Phase|Protocol Violation|1|||
162971463|NCT00401245|588597886|FG004|Double Blind Titration Phase|Protocol Violation|0|||
162971464|NCT00401245|588597887|FG005|Double Blind Titration Phase|Protocol Violation|0|||
162971465|NCT00401245|588597888|FG006|Double Blind Titration Phase|Protocol Violation|0|||
162971466|NCT00401245|588597889|FG007|Double Blind Titration Phase|Protocol Violation|0|||
162971467|NCT00401245|588597882|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
162971468|NCT00401245|588597883|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
162971469|NCT00401245|588597884|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
162971470|NCT00401245|588597885|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
162971471|NCT00401245|588597886|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
162971472|NCT00401245|588597887|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
162971473|NCT00401245|588597888|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
162971474|NCT00401245|588597889|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
162971475|NCT00401245|588597882|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
162971476|NCT00401245|588597883|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
162971477|NCT00401245|588597884|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
162971478|NCT00401245|588597885|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
162971479|NCT00401245|588597886|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
162971480|NCT00401245|588597887|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
162971481|NCT00401245|588597888|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
162971482|NCT00401245|588597889|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
162971483|NCT00401245|588597882|FG000|Open Label Phase|Adverse Event|5|||
162971484|NCT00401245|588597883|FG001|Open Label Phase|Adverse Event|14|||
163056947|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
163056948|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
163056949|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
163056950|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
163056951|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
163056952|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
163056953|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
163056954|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
163317963|NCT01928394|589874963|FG017|Treatment Period|Lost to Follow-up|0|||
163317964|NCT01928394|589874964|FG018|Treatment Period|Lost to Follow-up|0|||
163317965|NCT01928394|589874965|FG019|Treatment Period|Lost to Follow-up|0|||
163317966|NCT01928394|589874966|FG020|Treatment Period|Lost to Follow-up|0|||
163317967|NCT01928394|589874967|FG021|Treatment Period|Lost to Follow-up|0|||
163317968|NCT01928394|589874968|FG022|Treatment Period|Lost to Follow-up|1|||
162971485|NCT00401245|588597884|FG002|Open Label Phase|Adverse Event|6|||
163317969|NCT01928394|589874946|FG000|Treatment Period|Death|0|||
163317970|NCT01928394|589874947|FG001|Treatment Period|Death|0|||
163317971|NCT01928394|589874948|FG002|Treatment Period|Death|0|||
162971486|NCT00401245|588597885|FG003|Open Label Phase|Adverse Event|7|||
163317972|NCT01928394|589874949|FG003|Treatment Period|Death|0|||
163317973|NCT01928394|589874950|FG004|Treatment Period|Death|0|||
162971487|NCT00401245|588597886|FG004|Open Label Phase|Adverse Event|0|||
162971488|NCT00401245|588597887|FG005|Open Label Phase|Adverse Event|0|||
162971489|NCT00401245|588597888|FG006|Open Label Phase|Adverse Event|0|||
162971490|NCT00401245|588597889|FG007|Open Label Phase|Adverse Event|0|||
162971491|NCT00401245|588597882|FG000|Open Label Phase|Lost to Follow-up|5|||
162971492|NCT00401245|588597883|FG001|Open Label Phase|Lost to Follow-up|7|||
162971493|NCT00401245|588597884|FG002|Open Label Phase|Lost to Follow-up|5|||
162971494|NCT00401245|588597885|FG003|Open Label Phase|Lost to Follow-up|4|||
162971495|NCT00401245|588597886|FG004|Open Label Phase|Lost to Follow-up|0|||
162971496|NCT00401245|588597887|FG005|Open Label Phase|Lost to Follow-up|0|||
162971497|NCT00401245|588597888|FG006|Open Label Phase|Lost to Follow-up|0|||
162971498|NCT00401245|588597889|FG007|Open Label Phase|Lost to Follow-up|0|||
162971499|NCT00401245|588597882|FG000|Open Label Phase|Other|4|||
162971500|NCT00401245|588597883|FG001|Open Label Phase|Other|8|||
162971501|NCT00401245|588597884|FG002|Open Label Phase|Other|7|||
162971502|NCT00401245|588597885|FG003|Open Label Phase|Other|8|||
162971503|NCT00401245|588597886|FG004|Open Label Phase|Other|0|||
162971504|NCT00401245|588597887|FG005|Open Label Phase|Other|0|||
162971505|NCT00401245|588597888|FG006|Open Label Phase|Other|0|||
162971506|NCT00401245|588597889|FG007|Open Label Phase|Other|0|||
162971507|NCT00401245|588597882|FG000|Open Label Phase|Protocol Violation|0|||
162971508|NCT00401245|588597883|FG001|Open Label Phase|Protocol Violation|1|||
162971509|NCT00401245|588597884|FG002|Open Label Phase|Protocol Violation|0|||
162971510|NCT00401245|588597885|FG003|Open Label Phase|Protocol Violation|1|||
162971511|NCT00401245|588597886|FG004|Open Label Phase|Protocol Violation|0|||
162971512|NCT00401245|588597887|FG005|Open Label Phase|Protocol Violation|0|||
162971513|NCT00401245|588597888|FG006|Open Label Phase|Protocol Violation|0|||
162971514|NCT00401245|588597889|FG007|Open Label Phase|Protocol Violation|0|||
162971515|NCT00401245|588597882|FG000|Open Label Phase|Withdrawal by Subject|3|||
162971516|NCT00401245|588597883|FG001|Open Label Phase|Withdrawal by Subject|3|||
162971517|NCT00401245|588597884|FG002|Open Label Phase|Withdrawal by Subject|2|||
162971518|NCT00401245|588597885|FG003|Open Label Phase|Withdrawal by Subject|1|||
162971519|NCT00401245|588597886|FG004|Open Label Phase|Withdrawal by Subject|0|||
162971520|NCT00401245|588597887|FG005|Open Label Phase|Withdrawal by Subject|0|||
162971521|NCT00401245|588597888|FG006|Open Label Phase|Withdrawal by Subject|0|||
162971522|NCT00401245|588597889|FG007|Open Label Phase|Withdrawal by Subject|0|||
162971523|NCT00401245|588597882|FG000|Open Label Phase|Lack of Efficacy|4|||
162971524|NCT00401245|588597883|FG001|Open Label Phase|Lack of Efficacy|2|||
162971525|NCT00401245|588597884|FG002|Open Label Phase|Lack of Efficacy|3|||
162971526|NCT00401245|588597885|FG003|Open Label Phase|Lack of Efficacy|0|||
162971527|NCT00401245|588597886|FG004|Open Label Phase|Lack of Efficacy|0|||
162971528|NCT00401245|588597887|FG005|Open Label Phase|Lack of Efficacy|0|||
162971529|NCT00401245|588597888|FG006|Open Label Phase|Lack of Efficacy|0|||
162971530|NCT00401245|588597889|FG007|Open Label Phase|Lack of Efficacy|0|||
162971531|NCT00401245|588597882|FG000|Double Blind Tapering Phase|Adverse Event|0|||
162971532|NCT00401245|588597883|FG001|Double Blind Tapering Phase|Adverse Event|0|||
162971533|NCT00401245|588597884|FG002|Double Blind Tapering Phase|Adverse Event|0|||
162971534|NCT00401245|588597885|FG003|Double Blind Tapering Phase|Adverse Event|0|||
163209280|NCT00715078|589480543|FG000|Overall Study|Unable to start due to disease prog.|0|||
163209281|NCT00715078|589480544|FG001|Overall Study|Unable to start due to disease prog.|0|||
163209282|NCT00715078|589480545|FG002|Overall Study|Unable to start due to disease prog.|1|||
163209283|NCT01529346|589480546|FG000|Overall Study|Lost to Follow-up|2|||
163209284|NCT01529346|589480547|FG001|Overall Study|Lost to Follow-up|0|||
163209285|NCT01529346|589480548|FG002|Overall Study|Lost to Follow-up|1|||
163209286|NCT01529346|589480549|FG003|Overall Study|Lost to Follow-up|0|||
163209287|NCT01529346|589480550|FG004|Overall Study|Lost to Follow-up|0|||
163209288|NCT01529346|589480546|FG000|Overall Study|Other|0|||
163209289|NCT01529346|589480547|FG001|Overall Study|Other|1|||
163209290|NCT01529346|589480548|FG002|Overall Study|Other|1|||
163209291|NCT01529346|589480549|FG003|Overall Study|Other|0|||
163209292|NCT01529346|589480550|FG004|Overall Study|Other|0|||
163209293|NCT02282020|589480557|FG000|Overall Study|Objective Disease Progression|128|||
163209294|NCT02282020|589480558|FG001|Overall Study|Objective Disease Progression|30|||
163209295|NCT02282020|589480557|FG000|Overall Study|Adverse Event|18|||
163209296|NCT02282020|589480558|FG001|Overall Study|Adverse Event|15|||
163209297|NCT02282020|589480557|FG000|Overall Study|Withdrawal by Subject|7|||
162971535|NCT00401245|588597886|FG004|Double Blind Tapering Phase|Adverse Event|1|||
162971536|NCT00401245|588597887|FG005|Double Blind Tapering Phase|Adverse Event|1|||
162971537|NCT00401245|588597888|FG006|Double Blind Tapering Phase|Adverse Event|2|||
162971538|NCT00401245|588597889|FG007|Double Blind Tapering Phase|Adverse Event|4|||
162971539|NCT00401245|588597882|FG000|Double Blind Tapering Phase|Investigator request|0|||
162971540|NCT00401245|588597883|FG001|Double Blind Tapering Phase|Investigator request|0|||
162971541|NCT00401245|588597884|FG002|Double Blind Tapering Phase|Investigator request|0|||
162971542|NCT00401245|588597885|FG003|Double Blind Tapering Phase|Investigator request|0|||
162971543|NCT00401245|588597886|FG004|Double Blind Tapering Phase|Investigator request|0|||
162971544|NCT00401245|588597887|FG005|Double Blind Tapering Phase|Investigator request|0|||
162971545|NCT00401245|588597888|FG006|Double Blind Tapering Phase|Investigator request|0|||
163056955|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
163056956|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
163056957|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
163056958|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
163056959|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
163056960|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
163056961|NCT02078817|588919758|FG000|Overall Study|Withdrawal by Subject|1|||
163056962|NCT00769561|588919759|FG000|Overall Study|Withdrawal by Subject|2|||
162971546|NCT00401245|588597889|FG007|Double Blind Tapering Phase|Investigator request|1|||
162971547|NCT00401245|588597882|FG000|Double Blind Tapering Phase|Other|0|||
162971548|NCT00401245|588597883|FG001|Double Blind Tapering Phase|Other|0|||
162971549|NCT00401245|588597884|FG002|Double Blind Tapering Phase|Other|0|||
162971550|NCT00401245|588597885|FG003|Double Blind Tapering Phase|Other|0|||
162971551|NCT00401245|588597886|FG004|Double Blind Tapering Phase|Other|1|||
162971552|NCT00401245|588597887|FG005|Double Blind Tapering Phase|Other|0|||
162971553|NCT00401245|588597888|FG006|Double Blind Tapering Phase|Other|2|||
162971554|NCT00401245|588597889|FG007|Double Blind Tapering Phase|Other|2|||
162971555|NCT00401245|588597882|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
162971556|NCT00401245|588597883|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
163056963|NCT00769561|588919760|FG001|Overall Study|Withdrawal by Subject|2|||
163056964|NCT00769561|588919759|FG000|Overall Study|Lost to Follow-up|1|||
163056965|NCT00769561|588919760|FG001|Overall Study|Lost to Follow-up|3|||
163056966|NCT01773928|588919761|FG000|Overall Study|Adverse Event|0|||
163209298|NCT02282020|589480558|FG001|Overall Study|Withdrawal by Subject|10|||
162971557|NCT00401245|588597884|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
162971558|NCT00401245|588597885|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
162971559|NCT00401245|588597886|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
162971560|NCT00401245|588597887|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
162971561|NCT00401245|588597888|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
162971562|NCT00401245|588597889|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
162971563|NCT00401245|588597882|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
162971564|NCT00401245|588597883|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
162971565|NCT00401245|588597884|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
162971566|NCT00401245|588597885|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
162971567|NCT00401245|588597886|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
162971568|NCT00401245|588597887|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
162971569|NCT00401245|588597888|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
162971570|NCT00401245|588597889|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
162971571|NCT02014441|588597891|FG000|Overall Study|Withdrawal by Subject|12|||
162971572|NCT00996437|588597893|FG000|Overall Study|Death|1|||
162971573|NCT00996437|588597894|FG001|Overall Study|Death|0|||
162971574|NCT00996437|588597893|FG000|Overall Study|Dropped|2|||
162971575|NCT00996437|588597894|FG001|Overall Study|Dropped|2|||
162971576|NCT00996437|588597893|FG000|Overall Study|Missed|2|||
162971577|NCT00996437|588597894|FG001|Overall Study|Missed|5|||
162971578|NCT02576717|588597895|FG000|Overall Study|Other Reasons|16|||
162971579|NCT02576717|588597896|FG001|Overall Study|Other Reasons|18|||
162971580|NCT02576717|588597897|FG002|Overall Study|Other Reasons|15|||
162971581|NCT02576717|588597895|FG000|Overall Study|Covid-19 Pandemic|0|||
162971582|NCT02576717|588597896|FG001|Overall Study|Covid-19 Pandemic|1|||
162971583|NCT02576717|588597897|FG002|Overall Study|Covid-19 Pandemic|1|||
162971584|NCT02576717|588597895|FG000|Overall Study|Sponsor Decision|0|||
163209299|NCT02282020|589480557|FG000|Overall Study|Miscellaneous|5|||
163056967|NCT01773928|588919762|FG001|Overall Study|Adverse Event|0|||
162971585|NCT02576717|588597896|FG001|Overall Study|Sponsor Decision|0|||
162971586|NCT02576717|588597897|FG002|Overall Study|Sponsor Decision|1|||
162971587|NCT02576717|588597895|FG000|Overall Study|Physician Decision|3|||
162971588|NCT02576717|588597896|FG001|Overall Study|Physician Decision|8|||
162971589|NCT02576717|588597897|FG002|Overall Study|Physician Decision|9|||
162971590|NCT02576717|588597895|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
162971591|NCT02576717|588597896|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
162971592|NCT02576717|588597897|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
162971593|NCT02576717|588597895|FG000|Overall Study|Death|3|||
162971594|NCT02576717|588597896|FG001|Overall Study|Death|5|||
162971595|NCT02576717|588597897|FG002|Overall Study|Death|3|||
162971596|NCT02576717|588597895|FG000|Overall Study|Lost to Follow-up|9|||
162971597|NCT02576717|588597896|FG001|Overall Study|Lost to Follow-up|10|||
162971598|NCT02576717|588597897|FG002|Overall Study|Lost to Follow-up|19|||
162971599|NCT02576717|588597895|FG000|Overall Study|Protocol Violation|4|||
162971600|NCT02576717|588597896|FG001|Overall Study|Protocol Violation|0|||
162971601|NCT02576717|588597897|FG002|Overall Study|Protocol Violation|5|||
162971602|NCT02576717|588597895|FG000|Overall Study|Lack of Efficacy|24|||
162971603|NCT02576717|588597896|FG001|Overall Study|Lack of Efficacy|28|||
162971604|NCT02576717|588597897|FG002|Overall Study|Lack of Efficacy|20|||
162971605|NCT02576717|588597895|FG000|Overall Study|Adverse Event|26|||
162971606|NCT02576717|588597896|FG001|Overall Study|Adverse Event|32|||
162971607|NCT02576717|588597897|FG002|Overall Study|Adverse Event|26|||
162971608|NCT01363011|588597898|FG000|Main Study|Adverse Event|2|||
162971609|NCT01363011|588597899|FG001|Main Study|Adverse Event|3|||
162971610|NCT01363011|588597898|FG000|Main Study|Investigator's Discretion|1|||
162971611|NCT01363011|588597899|FG001|Main Study|Investigator's Discretion|1|||
162971612|NCT01363011|588597898|FG000|Main Study|Withdrew Consent|1|||
162971613|NCT01363011|588597899|FG001|Main Study|Withdrew Consent|4|||
162971614|NCT01363011|588597898|FG000|Main Study|Protocol Violation|0|||
162971615|NCT01363011|588597899|FG001|Main Study|Protocol Violation|1|||
162971616|NCT01363011|588597898|FG000|Extension Phase|Adverse Event|1|||
162971617|NCT01363011|588597899|FG001|Extension Phase|Adverse Event|1|||
162971618|NCT01363011|588597898|FG000|Extension Phase|Lack of Efficacy|0|||
162971619|NCT01363011|588597899|FG001|Extension Phase|Lack of Efficacy|1|||
162971620|NCT01363011|588597898|FG000|Extension Phase|Investigator's Discretion|2|||
162971621|NCT01363011|588597899|FG001|Extension Phase|Investigator's Discretion|2|||
162971622|NCT01363011|588597898|FG000|Extension Phase|Withdrew Consent|0|||
162971623|NCT01363011|588597899|FG001|Extension Phase|Withdrew Consent|1|||
162971624|NCT01363011|588597898|FG000|Extension Phase|Lost to Follow-up|0|||
162971625|NCT01363011|588597899|FG001|Extension Phase|Lost to Follow-up|2|||
162971626|NCT01363011|588597898|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
162971627|NCT01363011|588597899|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
162971628|NCT00114231|588597900|FG000|Overall Study|No consent|2|||
162971629|NCT00114231|588597901|FG001|Overall Study|No consent|0|||
162971630|NCT00114231|588597900|FG000|Overall Study|QARC requirement not met|1|||
162971631|NCT00114231|588597901|FG001|Overall Study|QARC requirement not met|0|||
162971632|NCT00114231|588597900|FG000|Overall Study|Suspected metastatic disease|1|||
162971633|NCT00114231|588597901|FG001|Overall Study|Suspected metastatic disease|0|||
162971634|NCT00114231|588597900|FG000|Overall Study|No adenocarcinoma|1|||
162971635|NCT00114231|588597901|FG001|Overall Study|No adenocarcinoma|0|||
162971636|NCT00114231|588597900|FG000|Overall Study|Low creatinine clearance|0|||
162971637|NCT00114231|588597901|FG001|Overall Study|Low creatinine clearance|1|||
162971638|NCT00114231|588597900|FG000|Overall Study|Tumor size > 4cm|1|||
162971639|NCT00114231|588597901|FG001|Overall Study|Tumor size > 4cm|0|||
162971640|NCT00114231|588597900|FG000|Overall Study|Tumor fixed on digital exam|0|||
162971641|NCT00114231|588597901|FG001|Overall Study|Tumor fixed on digital exam|1|||
162971642|NCT00114231|588597900|FG000|Overall Study|No Absolute Neutrophil Count|2|||
162971643|NCT00114231|588597901|FG001|Overall Study|No Absolute Neutrophil Count|0|||
162971644|NCT00114231|588597900|FG000|Overall Study|Biopsy done after registration|1|||
162971645|NCT00114231|588597901|FG001|Overall Study|Biopsy done after registration|0|||
162971646|NCT03330236|588597906|FG000|Overall Study|Death|2|||
162971647|NCT03330236|588597907|FG001|Overall Study|Death|1|||
162971648|NCT03330236|588597906|FG000|Overall Study|Withdrawal by Subject|2|||
162971649|NCT03330236|588597907|FG001|Overall Study|Withdrawal by Subject|4|||
162971650|NCT03330236|588597906|FG000|Overall Study|Lost to Follow-up|0|||
162971651|NCT03330236|588597907|FG001|Overall Study|Lost to Follow-up|2|||
162971652|NCT03330236|588597906|FG000|Overall Study|Physician Decision|2|||
162971653|NCT03330236|588597907|FG001|Overall Study|Physician Decision|0|||
162971654|NCT03330236|588597906|FG000|Overall Study|Protocol Violation|4|||
162971655|NCT03330236|588597907|FG001|Overall Study|Protocol Violation|3|||
162971656|NCT03330236|588597906|FG000|Overall Study|SedLine malfunction/blinding|19|||
162971657|NCT03330236|588597907|FG001|Overall Study|SedLine malfunction/blinding|14|||
162971658|NCT03330236|588597906|FG000|Overall Study|Volatile anesthetics used|11|||
162971659|NCT03330236|588597907|FG001|Overall Study|Volatile anesthetics used|8|||
162971660|NCT03330236|588597906|FG000|Overall Study|Surgery aborted/converted to open|60|||
162971661|NCT03330236|588597907|FG001|Overall Study|Surgery aborted/converted to open|52|||
162971662|NCT01729026|588597913|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
162971663|NCT01729026|588597914|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
162971664|NCT01729026|588597913|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
162971665|NCT01729026|588597914|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
162971666|NCT00407745|588597921|FG000|Overall Study|Lack of Efficacy|1|||
162971667|NCT00407745|588597922|FG001|Overall Study|Lack of Efficacy|2|||
162971668|NCT00407745|588597921|FG000|Overall Study|Withdrawal by Subject|3|||
162971669|NCT00407745|588597922|FG001|Overall Study|Withdrawal by Subject|3|||
162971670|NCT00407745|588597921|FG000|Overall Study|Protocol Violation|5|||
162971671|NCT00407745|588597922|FG001|Overall Study|Protocol Violation|3|||
162971672|NCT00407745|588597921|FG000|Overall Study|Adverse Event|8|||
162971673|NCT00407745|588597922|FG001|Overall Study|Adverse Event|8|||
162971674|NCT00407745|588597921|FG000|Overall Study|Other|2|||
162971675|NCT00407745|588597922|FG001|Overall Study|Other|0|||
162971676|NCT00407745|588597921|FG000|Overall Study|Randomized, unknown if treated|0|||
162971677|NCT00407745|588597922|FG001|Overall Study|Randomized, unknown if treated|1|||
162971678|NCT02940730|588597925|FG000|Intervention 2|Physician Decision|7|||
162971679|NCT02940730|588597926|FG001|Intervention 2|Physician Decision|0|||
162971680|NCT02960438|588597927|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
162971681|NCT02960438|588597928|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
162971682|NCT02960438|588597929|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
162971683|NCT02960438|588597930|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
162971684|NCT02960438|588597927|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
162971685|NCT02960438|588597928|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
162971686|NCT02960438|588597929|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
162971687|NCT02960438|588597930|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
162971688|NCT02960438|588597927|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
162971689|NCT02960438|588597928|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
162971690|NCT02960438|588597929|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
162971691|NCT02960438|588597930|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
162971692|NCT02960438|588597927|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
162971693|NCT02960438|588597928|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
162971694|NCT02960438|588597929|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
162971695|NCT02960438|588597930|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
162971696|NCT02960438|588597927|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
162971697|NCT02960438|588597928|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
162971698|NCT02960438|588597929|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
162971699|NCT02960438|588597930|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
162971700|NCT02960438|588597927|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
162971701|NCT02960438|588597928|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
162971702|NCT02960438|588597929|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
162971703|NCT02960438|588597930|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
162971704|NCT02960438|588597927|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
162971705|NCT02960438|588597928|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
162971706|NCT02960438|588597929|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
162971707|NCT02960438|588597930|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
162971708|NCT02960438|588597927|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
162971709|NCT02960438|588597928|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
162971710|NCT02960438|588597929|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
162971711|NCT02960438|588597930|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
162971712|NCT02960438|588597927|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
162971713|NCT02960438|588597928|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
162971714|NCT02960438|588597929|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
162971715|NCT02960438|588597930|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
162971716|NCT02960438|588597927|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
162971717|NCT02960438|588597928|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
162971718|NCT02960438|588597929|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
162971719|NCT02960438|588597930|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
162971720|NCT02960438|588597927|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
162971721|NCT02960438|588597928|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
162971722|NCT02960438|588597929|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
162971723|NCT02960438|588597930|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
162971724|NCT02960438|588597927|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
162971725|NCT02960438|588597928|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
162971726|NCT02960438|588597929|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
162971727|NCT02960438|588597930|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
163056968|NCT01773928|588919763|FG002|Overall Study|Adverse Event|0|||
163209300|NCT02282020|589480558|FG001|Overall Study|Miscellaneous|19|||
162971728|NCT01522950|588597931|FG000|Overall Study|Withdrawal by Subject|3|||
162971729|NCT01522950|588597932|FG001|Overall Study|Withdrawal by Subject|2|||
162971730|NCT01522950|588597933|FG002|Overall Study|Withdrawal by Subject|1|||
162971731|NCT01522950|588597931|FG000|Overall Study|Adverse Event|3|||
162971732|NCT01522950|588597932|FG001|Overall Study|Adverse Event|1|||
162971733|NCT01522950|588597933|FG002|Overall Study|Adverse Event|1|||
162971734|NCT01522950|588597931|FG000|Overall Study|Protocol Violation|0|||
162971735|NCT01522950|588597932|FG001|Overall Study|Protocol Violation|0|||
162971736|NCT01522950|588597933|FG002|Overall Study|Protocol Violation|2|||
162971737|NCT01522950|588597931|FG000|Overall Study|Death|0|||
162971738|NCT01522950|588597932|FG001|Overall Study|Death|1|||
162971739|NCT01522950|588597933|FG002|Overall Study|Death|1|||
162971740|NCT01522950|588597931|FG000|Overall Study|Study Medication Sensitivity|0|||
162971741|NCT01522950|588597932|FG001|Overall Study|Study Medication Sensitivity|1|||
162971742|NCT01522950|588597933|FG002|Overall Study|Study Medication Sensitivity|0|||
162971743|NCT00298740|588597938|FG000|Overall Study|Lack of Efficacy|6|||
162971744|NCT00298740|588597938|FG000|Overall Study|Withdrawal by Subject|3|||
162971745|NCT03449199|588597939|FG000|Overall Study|Lost to Follow-up|1|||
162971746|NCT03449199|588597940|FG001|Overall Study|Lost to Follow-up|1|||
162971747|NCT03449199|588597941|FG002|Overall Study|Lost to Follow-up|0|||
162971748|NCT03449199|588597939|FG000|Overall Study|Protocol Deviation|0|||
162971749|NCT03449199|588597940|FG001|Overall Study|Protocol Deviation|0|||
162971750|NCT03449199|588597941|FG002|Overall Study|Protocol Deviation|1|||
162971751|NCT03449199|588597939|FG000|Overall Study|Withdrawal by Subject|0|||
162971752|NCT03449199|588597940|FG001|Overall Study|Withdrawal by Subject|0|||
162971753|NCT03449199|588597941|FG002|Overall Study|Withdrawal by Subject|1|||
162971754|NCT00848042|588597943|FG000|Overall Study|Death|1|||
162971755|NCT00848042|588597944|FG001|Overall Study|Death|2|||
162971756|NCT00848042|588597945|FG002|Overall Study|Death|0|||
162971757|NCT00848042|588597943|FG000|Overall Study|Other Therapy|3|||
162971758|NCT00848042|588597944|FG001|Overall Study|Other Therapy|0|||
162971759|NCT00848042|588597945|FG002|Overall Study|Other Therapy|0|||
162971760|NCT02744755|588597946|FG000|Study Period 1|Protocol Violation|2|||
162971761|NCT02744755|588597947|FG001|Study Period 1|Protocol Violation|1|||
162971762|NCT02744755|588597946|FG000|Study Period 1|not defined|0|||
163209301|NCT02282020|589480557|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
163209302|NCT02282020|589480558|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
163209303|NCT02282020|589480557|FG000|Overall Study|Developed Discontinuation Criteria|0|||
163209304|NCT02282020|589480558|FG001|Overall Study|Developed Discontinuation Criteria|2|||
163209305|NCT02282020|589480557|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
163209306|NCT02282020|589480558|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
163209307|NCT00588848|589480559|FG000|Overall Study|Physician Decision|0|||
163209308|NCT00588848|589480560|FG001|Overall Study|Physician Decision|3|||
163209309|NCT01499667|589480561|FG000|Overall Study|administrative problems|4|||
163209310|NCT01499667|589480562|FG001|Overall Study|administrative problems|5|||
163209311|NCT01499667|589480563|FG002|Overall Study|administrative problems|5|||
163209312|NCT01499667|589480561|FG000|Overall Study|Protocol Violation|1|||
163209313|NCT01499667|589480562|FG001|Overall Study|Protocol Violation|3|||
163209314|NCT01499667|589480563|FG002|Overall Study|Protocol Violation|2|||
163209315|NCT01499667|589480561|FG000|Overall Study|Adverse Event|0|||
163209316|NCT01499667|589480562|FG001|Overall Study|Adverse Event|2|||
163209317|NCT01499667|589480563|FG002|Overall Study|Adverse Event|2|||
163209318|NCT01499667|589480561|FG000|Overall Study|Withdrawal by Subject|2|||
163209319|NCT01499667|589480562|FG001|Overall Study|Withdrawal by Subject|1|||
163209320|NCT01499667|589480563|FG002|Overall Study|Withdrawal by Subject|1|||
163209321|NCT01499667|589480561|FG000|Overall Study|Lack of Efficacy|2|||
163209322|NCT01499667|589480562|FG001|Overall Study|Lack of Efficacy|0|||
163209323|NCT01499667|589480563|FG002|Overall Study|Lack of Efficacy|0|||
163209324|NCT02673489|589480564|FG000|Treatment Period|Lost to Follow-up|3|||
163209325|NCT02673489|589480565|FG001|Treatment Period|Lost to Follow-up|0|||
163209326|NCT02673489|589480564|FG000|Treatment Period|Participant request to discontinue|1|||
163209327|NCT02673489|589480565|FG001|Treatment Period|Participant request to discontinue|1|||
163056969|NCT01773928|588919764|FG003|Overall Study|Adverse Event|0|||
163056970|NCT01773928|588919765|FG004|Overall Study|Adverse Event|0|||
163056971|NCT01773928|588919766|FG005|Overall Study|Adverse Event|0|||
163056972|NCT01773928|588919767|FG006|Overall Study|Adverse Event|0|||
163056973|NCT01773928|588919768|FG007|Overall Study|Adverse Event|1|||
163056974|NCT01773928|588919769|FG008|Overall Study|Adverse Event|0|||
163056975|NCT01773928|588919761|FG000|Overall Study|Physician Decision|0|||
163056976|NCT01773928|588919762|FG001|Overall Study|Physician Decision|0|||
163056977|NCT01773928|588919763|FG002|Overall Study|Physician Decision|0|||
163056978|NCT01773928|588919764|FG003|Overall Study|Physician Decision|1|||
163209328|NCT02673489|589480564|FG000|Treatment Period|Participant moved to another province|1|||
163209329|NCT02673489|589480565|FG001|Treatment Period|Participant moved to another province|0|||
163209330|NCT02673489|589480564|FG000|Treatment Period|Participant was incarcerated|0|||
163209331|NCT02673489|589480565|FG001|Treatment Period|Participant was incarcerated|1|||
163209332|NCT02673489|589480564|FG000|Treatment Period|Adverse Event|0|||
163209333|NCT02673489|589480565|FG001|Treatment Period|Adverse Event|1|||
163209334|NCT02673489|589480564|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
163209335|NCT02673489|589480565|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
163209336|NCT02673489|589480564|FG000|Follow Up Period|Unable to return for follow-up|0|||
163209337|NCT02673489|589480565|FG001|Follow Up Period|Unable to return for follow-up|1|||
163209338|NCT00082355|589480566|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
163209339|NCT00082355|589480566|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
163209340|NCT00082355|589480566|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
162971763|NCT02744755|588597947|FG001|Study Period 1|not defined|1|||
162971764|NCT02744755|588597946|FG000|Study Period 1|Pregnancy|1|||
162971765|NCT02744755|588597947|FG001|Study Period 1|Pregnancy|0|||
162971766|NCT02744755|588597946|FG000|Study Period 1|Adverse Event|1|||
162971767|NCT02744755|588597947|FG001|Study Period 1|Adverse Event|1|||
162971768|NCT02744755|588597946|FG000|Study Period 1|Lost to Follow-up|1|||
162971769|NCT02744755|588597947|FG001|Study Period 1|Lost to Follow-up|1|||
162971770|NCT02744755|588597946|FG000|Study Period 1|Lack of Efficacy|1|||
162971771|NCT02744755|588597947|FG001|Study Period 1|Lack of Efficacy|0|||
163056979|NCT01773928|588919765|FG004|Overall Study|Physician Decision|0|||
163056980|NCT01773928|588919766|FG005|Overall Study|Physician Decision|0|||
163056981|NCT01773928|588919767|FG006|Overall Study|Physician Decision|0|||
163209341|NCT02233309|589480568|FG000|Overall Study|Physician Decision|5|||
163209342|NCT00311623|589480572|FG000|Overall Study|Physician Decision|0|||
163209343|NCT00311623|589480573|FG001|Overall Study|Physician Decision|0|||
163209344|NCT00311623|589480574|FG002|Overall Study|Physician Decision|2|||
163209345|NCT03998189|589480575|FG000|Overall Study|Lack of Efficacy|0|||
163056982|NCT01773928|588919768|FG007|Overall Study|Physician Decision|0|||
163209346|NCT03998189|589480576|FG001|Overall Study|Lack of Efficacy|1|||
163209347|NCT04983264|589480577|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
163209348|NCT04983264|589480578|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
163317974|NCT01928394|589874951|FG005|Treatment Period|Death|0|||
162971772|NCT02744755|588597946|FG000|Study Period 1|Withdrawal by Subject|8|||
162971773|NCT02744755|588597947|FG001|Study Period 1|Withdrawal by Subject|4|||
163056983|NCT01773928|588919769|FG008|Overall Study|Physician Decision|0|||
163056984|NCT01773928|588919761|FG000|Overall Study|Withdrawal by Subject|5|||
162971774|NCT02744755|588597946|FG000|Study Period 2|Adverse Event|5|||
162971775|NCT02744755|588597947|FG001|Study Period 2|Adverse Event|0|||
162971776|NCT02744755|588597946|FG000|Study Period 2|Protocol Violation|1|||
162971777|NCT02744755|588597947|FG001|Study Period 2|Protocol Violation|0|||
162971778|NCT02744755|588597946|FG000|Study Period 2|not defined|3|||
162971779|NCT02744755|588597947|FG001|Study Period 2|not defined|2|||
162971780|NCT02744755|588597946|FG000|Study Period 2|Lost to Follow-up|0|||
162971781|NCT02744755|588597947|FG001|Study Period 2|Lost to Follow-up|2|||
162971782|NCT02744755|588597946|FG000|Study Period 2|Withdrawal by Subject|2|||
162971783|NCT02744755|588597947|FG001|Study Period 2|Withdrawal by Subject|2|||
162971784|NCT02744755|588597946|FG000|Study Period 2|Lack of Efficacy|3|||
162971785|NCT02744755|588597947|FG001|Study Period 2|Lack of Efficacy|2|||
162971786|NCT01652729|588597948|FG000|Overall Study|Withdrawal by Subject|14|||
162971787|NCT01652729|588597949|FG001|Overall Study|Withdrawal by Subject|7|||
162971788|NCT01652729|588597950|FG002|Overall Study|Withdrawal by Subject|7|||
162971789|NCT01652729|588597948|FG000|Overall Study|Adverse Event|4|||
162971790|NCT01652729|588597949|FG001|Overall Study|Adverse Event|0|||
162971791|NCT01652729|588597950|FG002|Overall Study|Adverse Event|3|||
162971792|NCT01652729|588597948|FG000|Overall Study|Physician Decision|1|||
162971793|NCT01652729|588597949|FG001|Overall Study|Physician Decision|0|||
162971794|NCT01652729|588597950|FG002|Overall Study|Physician Decision|1|||
162971795|NCT01652729|588597948|FG000|Overall Study|Protocol Violation|1|||
162971796|NCT01652729|588597949|FG001|Overall Study|Protocol Violation|0|||
162971797|NCT01652729|588597950|FG002|Overall Study|Protocol Violation|0|||
162971798|NCT01652729|588597948|FG000|Overall Study|Lost to Follow-up|6|||
162971799|NCT01652729|588597949|FG001|Overall Study|Lost to Follow-up|6|||
162971800|NCT01652729|588597950|FG002|Overall Study|Lost to Follow-up|3|||
162971801|NCT01652729|588597948|FG000|Overall Study|Administrative|1|||
162971802|NCT01652729|588597949|FG001|Overall Study|Administrative|0|||
162971803|NCT01652729|588597950|FG002|Overall Study|Administrative|0|||
162971804|NCT00483548|588597951|FG000|Overall Study|Randomized; not treated with study drug|1|||
162971805|NCT00483548|588597952|FG001|Overall Study|Randomized; not treated with study drug|3|||
162971806|NCT00483548|588597951|FG000|Overall Study|Adverse Event|25|||
162971807|NCT00483548|588597952|FG001|Overall Study|Adverse Event|14|||
162971808|NCT00483548|588597951|FG000|Overall Study|Laboratory abnormality|1|||
162971809|NCT00483548|588597952|FG001|Overall Study|Laboratory abnormality|2|||
162971810|NCT00483548|588597951|FG000|Overall Study|Lack of Efficacy|4|||
162971811|NCT00483548|588597952|FG001|Overall Study|Lack of Efficacy|8|||
162971812|NCT00483548|588597951|FG000|Overall Study|Protocol Violation|11|||
162971813|NCT00483548|588597952|FG001|Overall Study|Protocol Violation|7|||
162971814|NCT00483548|588597951|FG000|Overall Study|Pregnancy|1|||
162971815|NCT00483548|588597952|FG001|Overall Study|Pregnancy|0|||
162971816|NCT00483548|588597951|FG000|Overall Study|Protocol required discontinuation|6|||
162971817|NCT00483548|588597952|FG001|Overall Study|Protocol required discontinuation|6|||
162971818|NCT00483548|588597951|FG000|Overall Study|Unable to comply with protocol schedule|1|||
162971819|NCT00483548|588597952|FG001|Overall Study|Unable to comply with protocol schedule|0|||
162971820|NCT00483548|588597951|FG000|Overall Study|Non-compliance with medication|2|||
162971821|NCT00483548|588597952|FG001|Overall Study|Non-compliance with medication|0|||
162971822|NCT00483548|588597951|FG000|Overall Study|Lost to Follow-up|3|||
162971823|NCT00483548|588597952|FG001|Overall Study|Lost to Follow-up|4|||
162971824|NCT00483548|588597951|FG000|Overall Study|Withdrawal by Subject|5|||
162971825|NCT00483548|588597952|FG001|Overall Study|Withdrawal by Subject|2|||
162971826|NCT04364737|588597956|FG000|Overall Study|Withdrawal by Subject|4|||
162971827|NCT04364737|588597957|FG001|Overall Study|Withdrawal by Subject|9|||
162971828|NCT04364737|588597956|FG000|Overall Study|Lost to Follow-up|1|||
162971829|NCT04364737|588597957|FG001|Overall Study|Lost to Follow-up|1|||
162971830|NCT01220609|588597958|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
162971831|NCT01220609|588597958|FG000|Overall Study|Ineligible- Wrong cell type|1|||
162971832|NCT01220609|588597958|FG000|Overall Study|Ineligible-Never treated|1|||
162971833|NCT00112294|588597959|FG000|Overall Study|Still on study|5|||
162971834|NCT00112294|588597960|FG001|Overall Study|Still on study|0|||
162971835|NCT01190930|588597964|FG000|Induction|Adverse Event|17|||
162971836|NCT01190930|588597965|FG001|Induction|Adverse Event|0|||
162971837|NCT01190930|588597966|FG002|Induction|Adverse Event|0|||
162971838|NCT01190930|588597967|FG003|Induction|Adverse Event|0|||
162971839|NCT01190930|588597968|FG004|Induction|Adverse Event|0|||
162971840|NCT01190930|588597969|FG005|Induction|Adverse Event|0|||
163056985|NCT01773928|588919762|FG001|Overall Study|Withdrawal by Subject|4|||
163401321|NCT04640272|590181121|FG000|Overall Study|Subject moved out of area|1|||
162971841|NCT01190930|588597970|FG006|Induction|Adverse Event|0|||
162971842|NCT01190930|588597971|FG007|Induction|Adverse Event|0|||
162971843|NCT01190930|588597972|FG008|Induction|Adverse Event|0|||
162971844|NCT01190930|588597973|FG009|Induction|Adverse Event|0|||
162971845|NCT01190930|588597964|FG000|Induction|Death|34|||
162971846|NCT01190930|588597965|FG001|Induction|Death|0|||
162971847|NCT01190930|588597966|FG002|Induction|Death|0|||
162971848|NCT01190930|588597967|FG003|Induction|Death|0|||
162971849|NCT01190930|588597968|FG004|Induction|Death|0|||
162971850|NCT01190930|588597969|FG005|Induction|Death|0|||
162971851|NCT01190930|588597970|FG006|Induction|Death|0|||
163209349|NCT04983264|589480579|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
163209350|NCT04983264|589480577|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
163209351|NCT04983264|589480578|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
163209352|NCT04983264|589480579|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
163209353|NCT00558025|589480582|FG000|Overall Study|Adverse Event|1|||
163209354|NCT00558025|589480583|FG001|Overall Study|Adverse Event|1|||
163209355|NCT00558025|589480582|FG000|Overall Study|Withdrawal by Subject|2|||
163209356|NCT00558025|589480583|FG001|Overall Study|Withdrawal by Subject|2|||
163209357|NCT00558025|589480582|FG000|Overall Study|Protocol Violation|1|||
163209358|NCT00558025|589480583|FG001|Overall Study|Protocol Violation|0|||
163209359|NCT01506479|589480584|FG000|Overall Study|Lost to Follow-up|1|||
163209360|NCT01506479|589480585|FG001|Overall Study|Lost to Follow-up|2|||
163209361|NCT01506479|589480586|FG002|Overall Study|Lost to Follow-up|2|||
163209362|NCT01506479|589480584|FG000|Overall Study|Withdrawal by Subject|1|||
163209363|NCT01506479|589480585|FG001|Overall Study|Withdrawal by Subject|2|||
163209364|NCT01506479|589480586|FG002|Overall Study|Withdrawal by Subject|1|||
163209365|NCT01506479|589480584|FG000|Overall Study|Missing assessment|1|||
163209366|NCT01506479|589480585|FG001|Overall Study|Missing assessment|0|||
163209367|NCT01506479|589480586|FG002|Overall Study|Missing assessment|0|||
163209368|NCT01506479|589480584|FG000|Overall Study|Adverse Event|0|||
163209369|NCT01506479|589480585|FG001|Overall Study|Adverse Event|1|||
163209370|NCT01506479|589480586|FG002|Overall Study|Adverse Event|0|||
163209371|NCT05247866|589480588|FG000|Overall Study|Adverse Event|2|||
163209372|NCT05247866|589480588|FG000|Overall Study|Lack of Efficacy|1|||
163209373|NCT05247866|589480588|FG000|Overall Study|Protocol Violation|1|||
163209374|NCT05247866|589480588|FG000|Overall Study|Withdrawal by Subject|3|||
163209375|NCT04463719|589480591|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
163209376|NCT04463719|589480592|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
163209377|NCT04463719|589480593|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
163209378|NCT03315208|589480594|FG000|Overall Study|Lost to Follow-up|11|||
163209379|NCT03315208|589480595|FG001|Overall Study|Lost to Follow-up|6|||
163209380|NCT03315208|589480594|FG000|Overall Study|Withdrawal by Subject|2|||
163209381|NCT03315208|589480595|FG001|Overall Study|Withdrawal by Subject|0|||
163209382|NCT02746874|589480596|FG000|Overall Study|Withdrawal by Subject|0|||
163209383|NCT02746874|589480597|FG001|Overall Study|Withdrawal by Subject|1|||
163209384|NCT02746874|589480596|FG000|Overall Study|Surgery Date Changed|0|||
163209385|NCT02746874|589480597|FG001|Overall Study|Surgery Date Changed|2|||
163209386|NCT01156311|589480601|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
163209387|NCT01156311|589480602|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
163209388|NCT01156311|589480603|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
163209389|NCT01156311|589480604|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
163209390|NCT01156311|589480601|FG000|2-Month Monotherapy Period|Physician Decision|0|||
163209391|NCT01156311|589480602|FG001|2-Month Monotherapy Period|Physician Decision|1|||
163209392|NCT01156311|589480603|FG002|2-Month Monotherapy Period|Physician Decision|0|||
163209393|NCT01156311|589480604|FG003|2-Month Monotherapy Period|Physician Decision|0|||
163209394|NCT01156311|589480601|FG000|2-Month Monotherapy Period|Other|1|||
163209395|NCT01156311|589480602|FG001|2-Month Monotherapy Period|Other|0|||
163209396|NCT01156311|589480603|FG002|2-Month Monotherapy Period|Other|0|||
163209397|NCT01156311|589480604|FG003|2-Month Monotherapy Period|Other|0|||
163209398|NCT01156311|589480601|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
163209399|NCT01156311|589480602|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
163209400|NCT01156311|589480603|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
163209401|NCT01156311|589480604|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
163209402|NCT01156311|589480601|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
163209403|NCT01156311|589480602|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
163209404|NCT01156311|589480603|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
163209405|NCT01156311|589480604|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
163209406|NCT01156311|589480601|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
163209407|NCT01156311|589480602|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
163209408|NCT01156311|589480603|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
163056986|NCT01773928|588919763|FG002|Overall Study|Withdrawal by Subject|4|||
163056987|NCT01773928|588919764|FG003|Overall Study|Withdrawal by Subject|4|||
163056988|NCT01773928|588919765|FG004|Overall Study|Withdrawal by Subject|7|||
163056989|NCT01773928|588919766|FG005|Overall Study|Withdrawal by Subject|1|||
163056990|NCT01773928|588919767|FG006|Overall Study|Withdrawal by Subject|0|||
163056991|NCT01773928|588919768|FG007|Overall Study|Withdrawal by Subject|0|||
163056992|NCT01773928|588919769|FG008|Overall Study|Withdrawal by Subject|1|||
163056993|NCT01773928|588919761|FG000|Overall Study|Lost to Follow-up|0|||
163209409|NCT01156311|589480604|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
163209410|NCT01156311|589480601|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
163209411|NCT01156311|589480602|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
163209412|NCT01156311|589480603|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
163056994|NCT01773928|588919762|FG001|Overall Study|Lost to Follow-up|0|||
163056995|NCT01773928|588919763|FG002|Overall Study|Lost to Follow-up|0|||
163209413|NCT01156311|589480604|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
163209414|NCT01156311|589480601|FG000|6-month Add-on Therapy Period|Other|0|||
163317975|NCT01928394|589874952|FG006|Treatment Period|Death|0|||
162971852|NCT01190930|588597971|FG007|Induction|Death|0|||
162971853|NCT01190930|588597972|FG008|Induction|Death|0|||
162971854|NCT01190930|588597973|FG009|Induction|Death|0|||
162971855|NCT01190930|588597964|FG000|Induction|Lost to Follow-up|1|||
162971856|NCT01190930|588597965|FG001|Induction|Lost to Follow-up|0|||
162971857|NCT01190930|588597966|FG002|Induction|Lost to Follow-up|0|||
162971858|NCT01190930|588597967|FG003|Induction|Lost to Follow-up|0|||
162971859|NCT01190930|588597968|FG004|Induction|Lost to Follow-up|0|||
162971860|NCT01190930|588597969|FG005|Induction|Lost to Follow-up|0|||
162971861|NCT01190930|588597970|FG006|Induction|Lost to Follow-up|0|||
162971862|NCT01190930|588597971|FG007|Induction|Lost to Follow-up|0|||
162971863|NCT01190930|588597972|FG008|Induction|Lost to Follow-up|0|||
162971864|NCT01190930|588597973|FG009|Induction|Lost to Follow-up|0|||
162971865|NCT01190930|588597964|FG000|Induction|Physician Decision|125|||
162971866|NCT01190930|588597965|FG001|Induction|Physician Decision|3|||
162971867|NCT01190930|588597966|FG002|Induction|Physician Decision|0|||
162971868|NCT01190930|588597967|FG003|Induction|Physician Decision|0|||
162971869|NCT01190930|588597968|FG004|Induction|Physician Decision|0|||
162971870|NCT01190930|588597969|FG005|Induction|Physician Decision|0|||
162971871|NCT01190930|588597970|FG006|Induction|Physician Decision|0|||
162971872|NCT01190930|588597971|FG007|Induction|Physician Decision|0|||
162971873|NCT01190930|588597972|FG008|Induction|Physician Decision|0|||
162971874|NCT01190930|588597973|FG009|Induction|Physician Decision|0|||
162971875|NCT01190930|588597964|FG000|Induction|Withdrawal by Subject|9|||
162971876|NCT01190930|588597965|FG001|Induction|Withdrawal by Subject|0|||
162971877|NCT01190930|588597966|FG002|Induction|Withdrawal by Subject|0|||
162971878|NCT01190930|588597967|FG003|Induction|Withdrawal by Subject|0|||
162971879|NCT01190930|588597968|FG004|Induction|Withdrawal by Subject|0|||
162971880|NCT01190930|588597969|FG005|Induction|Withdrawal by Subject|0|||
162971881|NCT01190930|588597970|FG006|Induction|Withdrawal by Subject|0|||
162971882|NCT01190930|588597971|FG007|Induction|Withdrawal by Subject|0|||
162971883|NCT01190930|588597972|FG008|Induction|Withdrawal by Subject|0|||
162971884|NCT01190930|588597973|FG009|Induction|Withdrawal by Subject|0|||
162971885|NCT01190930|588597964|FG000|Induction|Refusal|235|||
162971886|NCT01190930|588597965|FG001|Induction|Refusal|0|||
162971887|NCT01190930|588597966|FG002|Induction|Refusal|0|||
162971888|NCT01190930|588597967|FG003|Induction|Refusal|0|||
162971889|NCT01190930|588597968|FG004|Induction|Refusal|0|||
162971890|NCT01190930|588597969|FG005|Induction|Refusal|0|||
162971891|NCT01190930|588597970|FG006|Induction|Refusal|0|||
162971892|NCT01190930|588597971|FG007|Induction|Refusal|0|||
162971893|NCT01190930|588597972|FG008|Induction|Refusal|0|||
162971894|NCT01190930|588597973|FG009|Induction|Refusal|0|||
162971895|NCT01190930|588597964|FG000|Induction|Inevaluable|23|||
162971896|NCT01190930|588597965|FG001|Induction|Inevaluable|1|||
162971897|NCT01190930|588597966|FG002|Induction|Inevaluable|0|||
162971898|NCT01190930|588597967|FG003|Induction|Inevaluable|0|||
162971899|NCT01190930|588597968|FG004|Induction|Inevaluable|0|||
162971900|NCT01190930|588597969|FG005|Induction|Inevaluable|0|||
162971901|NCT01190930|588597970|FG006|Induction|Inevaluable|0|||
162971902|NCT01190930|588597971|FG007|Induction|Inevaluable|0|||
162971903|NCT01190930|588597972|FG008|Induction|Inevaluable|0|||
162971904|NCT01190930|588597973|FG009|Induction|Inevaluable|0|||
162971905|NCT01190930|588597964|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
162971906|NCT01190930|588597965|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971907|NCT01190930|588597966|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971908|NCT01190930|588597967|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971909|NCT01190930|588597968|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971910|NCT01190930|588597969|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971911|NCT01190930|588597970|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971912|NCT01190930|588597971|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971913|NCT01190930|588597972|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971914|NCT01190930|588597973|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971915|NCT01190930|588597964|FG000|Induction|High Risk Downs|80|||
162971916|NCT01190930|588597965|FG001|Induction|High Risk Downs|0|||
162971917|NCT01190930|588597966|FG002|Induction|High Risk Downs|0|||
162971918|NCT01190930|588597967|FG003|Induction|High Risk Downs|0|||
162971919|NCT01190930|588597968|FG004|Induction|High Risk Downs|0|||
162971920|NCT01190930|588597969|FG005|Induction|High Risk Downs|0|||
162971921|NCT01190930|588597970|FG006|Induction|High Risk Downs|0|||
162971922|NCT01190930|588597971|FG007|Induction|High Risk Downs|0|||
162971923|NCT01190930|588597972|FG008|Induction|High Risk Downs|0|||
162971924|NCT01190930|588597973|FG009|Induction|High Risk Downs|0|||
162971925|NCT01190930|588597964|FG000|Induction|Enrollment onto another COG Protocol|1|||
162971926|NCT01190930|588597965|FG001|Induction|Enrollment onto another COG Protocol|0|||
162971927|NCT01190930|588597966|FG002|Induction|Enrollment onto another COG Protocol|0|||
162971928|NCT01190930|588597967|FG003|Induction|Enrollment onto another COG Protocol|0|||
162971929|NCT01190930|588597968|FG004|Induction|Enrollment onto another COG Protocol|0|||
162971930|NCT01190930|588597969|FG005|Induction|Enrollment onto another COG Protocol|0|||
162971931|NCT01190930|588597970|FG006|Induction|Enrollment onto another COG Protocol|0|||
162971932|NCT01190930|588597971|FG007|Induction|Enrollment onto another COG Protocol|0|||
162971933|NCT01190930|588597972|FG008|Induction|Enrollment onto another COG Protocol|0|||
162971934|NCT01190930|588597973|FG009|Induction|Enrollment onto another COG Protocol|0|||
162971935|NCT01190930|588597964|FG000|Induction|Average Risk|1847|||
162971936|NCT01190930|588597965|FG001|Induction|Average Risk|0|||
162971937|NCT01190930|588597966|FG002|Induction|Average Risk|0|||
162971938|NCT01190930|588597967|FG003|Induction|Average Risk|0|||
162971939|NCT01190930|588597968|FG004|Induction|Average Risk|0|||
162971940|NCT01190930|588597969|FG005|Induction|Average Risk|0|||
162971941|NCT01190930|588597970|FG006|Induction|Average Risk|0|||
162971942|NCT01190930|588597971|FG007|Induction|Average Risk|0|||
162971943|NCT01190930|588597972|FG008|Induction|Average Risk|0|||
162971944|NCT01190930|588597973|FG009|Induction|Average Risk|0|||
162971945|NCT01190930|588597964|FG000|Induction|High Risk|1227|||
163056996|NCT01773928|588919764|FG003|Overall Study|Lost to Follow-up|0|||
162971946|NCT01190930|588597965|FG001|Induction|High Risk|0|||
162971947|NCT01190930|588597966|FG002|Induction|High Risk|0|||
162971948|NCT01190930|588597967|FG003|Induction|High Risk|0|||
162971949|NCT01190930|588597968|FG004|Induction|High Risk|0|||
162971950|NCT01190930|588597969|FG005|Induction|High Risk|0|||
162971951|NCT01190930|588597970|FG006|Induction|High Risk|0|||
162971952|NCT01190930|588597971|FG007|Induction|High Risk|0|||
162971953|NCT01190930|588597972|FG008|Induction|High Risk|0|||
162971954|NCT01190930|588597973|FG009|Induction|High Risk|0|||
162971955|NCT01190930|588597964|FG000|Induction|Low Risk|443|||
162971956|NCT01190930|588597965|FG001|Induction|Low Risk|0|||
162971957|NCT01190930|588597966|FG002|Induction|Low Risk|0|||
162971958|NCT01190930|588597967|FG003|Induction|Low Risk|0|||
162971959|NCT01190930|588597968|FG004|Induction|Low Risk|0|||
162971960|NCT01190930|588597969|FG005|Induction|Low Risk|0|||
162971961|NCT01190930|588597970|FG006|Induction|Low Risk|0|||
162971962|NCT01190930|588597971|FG007|Induction|Low Risk|0|||
162971963|NCT01190930|588597972|FG008|Induction|Low Risk|0|||
162971964|NCT01190930|588597973|FG009|Induction|Low Risk|0|||
162971965|NCT01190930|588597964|FG000|Induction|Very High Risk|1012|||
162971966|NCT01190930|588597965|FG001|Induction|Very High Risk|0|||
162971967|NCT01190930|588597966|FG002|Induction|Very High Risk|0|||
162971968|NCT01190930|588597967|FG003|Induction|Very High Risk|0|||
162971969|NCT01190930|588597968|FG004|Induction|Very High Risk|0|||
162971970|NCT01190930|588597969|FG005|Induction|Very High Risk|0|||
162971971|NCT01190930|588597970|FG006|Induction|Very High Risk|0|||
162971972|NCT01190930|588597971|FG007|Induction|Very High Risk|0|||
162971973|NCT01190930|588597972|FG008|Induction|Very High Risk|0|||
162971974|NCT01190930|588597973|FG009|Induction|Very High Risk|0|||
162971975|NCT01190930|588597964|FG000|Induction|Philadelphia chromosome-positive|99|||
162971976|NCT01190930|588597965|FG001|Induction|Philadelphia chromosome-positive|0|||
162971977|NCT01190930|588597966|FG002|Induction|Philadelphia chromosome-positive|0|||
162971978|NCT01190930|588597967|FG003|Induction|Philadelphia chromosome-positive|0|||
162971979|NCT01190930|588597968|FG004|Induction|Philadelphia chromosome-positive|0|||
162971980|NCT01190930|588597969|FG005|Induction|Philadelphia chromosome-positive|0|||
162971981|NCT01190930|588597970|FG006|Induction|Philadelphia chromosome-positive|0|||
162971982|NCT01190930|588597971|FG007|Induction|Philadelphia chromosome-positive|0|||
162971983|NCT01190930|588597972|FG008|Induction|Philadelphia chromosome-positive|0|||
162971984|NCT01190930|588597973|FG009|Induction|Philadelphia chromosome-positive|0|||
162971985|NCT01190930|588597964|FG000|Induction|Incomplete Induction data|63|||
162971986|NCT01190930|588597965|FG001|Induction|Incomplete Induction data|0|||
162971987|NCT01190930|588597966|FG002|Induction|Incomplete Induction data|0|||
162971988|NCT01190930|588597967|FG003|Induction|Incomplete Induction data|0|||
162971989|NCT01190930|588597968|FG004|Induction|Incomplete Induction data|0|||
162971990|NCT01190930|588597969|FG005|Induction|Incomplete Induction data|0|||
162971991|NCT01190930|588597970|FG006|Induction|Incomplete Induction data|0|||
162971992|NCT01190930|588597971|FG007|Induction|Incomplete Induction data|0|||
162971993|NCT01190930|588597972|FG008|Induction|Incomplete Induction data|0|||
162971994|NCT01190930|588597973|FG009|Induction|Incomplete Induction data|0|||
162971995|NCT01190930|588597964|FG000|Induction|Progressive disease|0|||
162971996|NCT01190930|588597965|FG001|Induction|Progressive disease|1|||
162971997|NCT01190930|588597966|FG002|Induction|Progressive disease|0|||
162971998|NCT01190930|588597967|FG003|Induction|Progressive disease|0|||
162971999|NCT01190930|588597968|FG004|Induction|Progressive disease|0|||
162972000|NCT01190930|588597969|FG005|Induction|Progressive disease|0|||
162972001|NCT01190930|588597970|FG006|Induction|Progressive disease|0|||
162972002|NCT01190930|588597971|FG007|Induction|Progressive disease|0|||
162972003|NCT01190930|588597972|FG008|Induction|Progressive disease|0|||
162972004|NCT01190930|588597973|FG009|Induction|Progressive disease|0|||
162972005|NCT01190930|588597964|FG000|Induction|No treatment|3|||
162972006|NCT01190930|588597965|FG001|Induction|No treatment|0|||
162972007|NCT01190930|588597966|FG002|Induction|No treatment|0|||
163056997|NCT01773928|588919765|FG004|Overall Study|Lost to Follow-up|0|||
163056998|NCT01773928|588919766|FG005|Overall Study|Lost to Follow-up|1|||
163056999|NCT01773928|588919767|FG006|Overall Study|Lost to Follow-up|0|||
163057000|NCT01773928|588919768|FG007|Overall Study|Lost to Follow-up|0|||
163057001|NCT01773928|588919769|FG008|Overall Study|Lost to Follow-up|0|||
163057002|NCT01773928|588919761|FG000|Overall Study|Subject misrepresented age|0|||
163057003|NCT01773928|588919762|FG001|Overall Study|Subject misrepresented age|1|||
163057004|NCT01773928|588919763|FG002|Overall Study|Subject misrepresented age|0|||
162972008|NCT01190930|588597967|FG003|Induction|No treatment|0|||
162972009|NCT01190930|588597968|FG004|Induction|No treatment|0|||
162972010|NCT01190930|588597969|FG005|Induction|No treatment|0|||
162972011|NCT01190930|588597970|FG006|Induction|No treatment|0|||
162972012|NCT01190930|588597971|FG007|Induction|No treatment|0|||
162972013|NCT01190930|588597972|FG008|Induction|No treatment|0|||
162972014|NCT01190930|588597973|FG009|Induction|No treatment|0|||
163057005|NCT01773928|588919764|FG003|Overall Study|Subject misrepresented age|0|||
163401322|NCT02535715|590181125|FG000|Overall Study|Withdrawal by Subject|0|||
163401323|NCT02535715|590181126|FG001|Overall Study|Withdrawal by Subject|0|||
162972015|NCT01190930|588597964|FG000|Induction|Ineligible|69|||
162972016|NCT01190930|588597965|FG001|Induction|Ineligible|4|||
162972017|NCT01190930|588597966|FG002|Induction|Ineligible|0|||
162972018|NCT01190930|588597967|FG003|Induction|Ineligible|0|||
162972019|NCT01190930|588597968|FG004|Induction|Ineligible|0|||
162972020|NCT01190930|588597969|FG005|Induction|Ineligible|0|||
163209415|NCT01156311|589480602|FG001|6-month Add-on Therapy Period|Other|0|||
163209416|NCT01156311|589480603|FG002|6-month Add-on Therapy Period|Other|1|||
163209417|NCT01156311|589480604|FG003|6-month Add-on Therapy Period|Other|2|||
163209418|NCT06133348|589480607|FG000|Overall Study|Death|3|||
163209419|NCT06133348|589480607|FG000|Overall Study|Lost to Follow-up|1|||
163209420|NCT06133348|589480607|FG000|Overall Study|Physician Decision|1|||
163209421|NCT06133348|589480607|FG000|Overall Study|Withdrawal by Subject|5|||
163209422|NCT02393547|589480610|FG000|Overall Study|Adverse Event|2|||
163209423|NCT02393547|589480610|FG000|Overall Study|Withdrawal by Subject|3|||
163209424|NCT02393547|589480610|FG000|Overall Study|Lost to Follow-up|1|||
163209425|NCT00429104|589480612|FG000|Overall Study|Protocol Violation|1|||
162972021|NCT01190930|588597970|FG006|Induction|Ineligible|0|||
162972022|NCT01190930|588597971|FG007|Induction|Ineligible|0|||
162972023|NCT01190930|588597972|FG008|Induction|Ineligible|0|||
162972024|NCT01190930|588597973|FG009|Induction|Ineligible|0|||
162972025|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
162972026|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
162972027|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
162972028|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
162972029|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
162972030|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
162972031|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
162972032|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
162972033|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
162972034|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
162972035|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Death|0|||
162972036|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Death|0|||
162972037|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Death|8|||
162972038|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Death|4|||
162972039|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Death|0|||
162972040|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Death|0|||
163057006|NCT01773928|588919765|FG004|Overall Study|Subject misrepresented age|0|||
163057007|NCT01773928|588919766|FG005|Overall Study|Subject misrepresented age|0|||
163057008|NCT01773928|588919767|FG006|Overall Study|Subject misrepresented age|0|||
163057009|NCT01773928|588919768|FG007|Overall Study|Subject misrepresented age|0|||
163057010|NCT01773928|588919769|FG008|Overall Study|Subject misrepresented age|0|||
163057011|NCT01773928|588919761|FG000|Overall Study|Subject met exclusion criteria|0|||
163057012|NCT01773928|588919762|FG001|Overall Study|Subject met exclusion criteria|0|||
163057013|NCT01773928|588919763|FG002|Overall Study|Subject met exclusion criteria|0|||
163209426|NCT04997161|589480629|FG000|Overall Study|Study terminated by sponsor|3|||
163209427|NCT00752232|589480630|FG000|Overall Study|Protocol Violation|0|||
162972041|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Death|0|||
162972042|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Death|0|||
162972043|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Death|0|||
162972044|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Death|0|||
162972045|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
162972046|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
162972047|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
162972048|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
162972049|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
162972050|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
162972051|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
162972052|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
162972053|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
162972054|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
162972055|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
162972056|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
162972057|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
162972058|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
162972059|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
163057014|NCT01773928|588919764|FG003|Overall Study|Subject met exclusion criteria|0|||
163209428|NCT00752232|589480631|FG001|Overall Study|Protocol Violation|0|||
163209429|NCT00752232|589480632|FG002|Overall Study|Protocol Violation|0|||
163209430|NCT00752232|589480633|FG003|Overall Study|Protocol Violation|0|||
162972060|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
162972061|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
162972062|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
162972063|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
162972064|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
162972065|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Refusal|0|||
162972066|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Refusal|2|||
162972067|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Refusal|694|||
162972068|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Refusal|4|||
162972069|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Refusal|0|||
162972070|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Refusal|3|||
162972071|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Refusal|0|||
162972072|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Refusal|0|||
162972073|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Refusal|0|||
162972074|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Refusal|0|||
162972075|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
162972076|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
162972077|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
162972078|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
162972079|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
162972080|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
162972081|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
162972082|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
162972083|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
162972084|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
162972085|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972086|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
162972087|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972088|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972089|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972090|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972091|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972092|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972093|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972094|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972095|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
162972096|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
162972097|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
162972098|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
162972099|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
162972100|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
162972101|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
162972102|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
162972103|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
162972104|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
162972105|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Relapse|0|||
162972106|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Relapse|0|||
162972107|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Relapse|1|||
162972108|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Relapse|0|||
162972109|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Relapse|0|||
162972110|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Relapse|0|||
162972111|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Relapse|0|||
162972112|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Relapse|0|||
162972113|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Relapse|0|||
162972114|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Relapse|0|||
162972115|NCT01190930|588597964|FG000|Maintenance|Adverse Event|0|||
162972116|NCT01190930|588597965|FG001|Maintenance|Adverse Event|0|||
163057015|NCT01773928|588919765|FG004|Overall Study|Subject met exclusion criteria|0|||
163057016|NCT01773928|588919766|FG005|Overall Study|Subject met exclusion criteria|0|||
163057017|NCT01773928|588919767|FG006|Overall Study|Subject met exclusion criteria|0|||
162972117|NCT01190930|588597966|FG002|Maintenance|Adverse Event|0|||
162972118|NCT01190930|588597967|FG003|Maintenance|Adverse Event|0|||
162972119|NCT01190930|588597968|FG004|Maintenance|Adverse Event|0|||
162972120|NCT01190930|588597969|FG005|Maintenance|Adverse Event|1|||
162972121|NCT01190930|588597970|FG006|Maintenance|Adverse Event|1|||
163057018|NCT01773928|588919768|FG007|Overall Study|Subject met exclusion criteria|0|||
162972122|NCT01190930|588597971|FG007|Maintenance|Adverse Event|3|||
162972123|NCT01190930|588597972|FG008|Maintenance|Adverse Event|3|||
163057019|NCT01773928|588919769|FG008|Overall Study|Subject met exclusion criteria|1|||
162972124|NCT01190930|588597973|FG009|Maintenance|Adverse Event|0|||
162972125|NCT01190930|588597964|FG000|Maintenance|Death|0|||
162972126|NCT01190930|588597965|FG001|Maintenance|Death|0|||
162972127|NCT01190930|588597966|FG002|Maintenance|Death|0|||
162972128|NCT01190930|588597967|FG003|Maintenance|Death|1|||
162972129|NCT01190930|588597968|FG004|Maintenance|Death|0|||
162972130|NCT01190930|588597969|FG005|Maintenance|Death|0|||
162972131|NCT01190930|588597970|FG006|Maintenance|Death|2|||
162972132|NCT01190930|588597971|FG007|Maintenance|Death|2|||
162972133|NCT01190930|588597972|FG008|Maintenance|Death|2|||
162972134|NCT01190930|588597973|FG009|Maintenance|Death|2|||
162972135|NCT01190930|588597964|FG000|Maintenance|Lost to Follow-up|0|||
162972136|NCT01190930|588597965|FG001|Maintenance|Lost to Follow-up|0|||
163057020|NCT01773928|588919761|FG000|Overall Study|Randomized, had to leave, never returned|0|||
163057021|NCT01773928|588919762|FG001|Overall Study|Randomized, had to leave, never returned|0|||
163057022|NCT01773928|588919763|FG002|Overall Study|Randomized, had to leave, never returned|0|||
163057023|NCT01773928|588919764|FG003|Overall Study|Randomized, had to leave, never returned|1|||
163057024|NCT01773928|588919765|FG004|Overall Study|Randomized, had to leave, never returned|0|||
163057025|NCT01773928|588919766|FG005|Overall Study|Randomized, had to leave, never returned|0|||
163057026|NCT01773928|588919767|FG006|Overall Study|Randomized, had to leave, never returned|0|||
163057027|NCT01773928|588919768|FG007|Overall Study|Randomized, had to leave, never returned|0|||
163057028|NCT01773928|588919769|FG008|Overall Study|Randomized, had to leave, never returned|0|||
163057029|NCT01773928|588919761|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
163057030|NCT01773928|588919762|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
163057031|NCT01773928|588919763|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
163057032|NCT01773928|588919764|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
163057033|NCT01773928|588919765|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
163057034|NCT01773928|588919766|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
163057035|NCT01773928|588919767|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
163057036|NCT01773928|588919768|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
163057037|NCT01773928|588919769|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
163057038|NCT02370511|588919770|FG000|Overall Study|Death|10|||
163057039|NCT02370511|588919771|FG001|Overall Study|Death|7|||
163057040|NCT02370511|588919772|FG002|Overall Study|Death|1|||
163057041|NCT02370511|588919770|FG000|Overall Study|Withdrawal by Subject|2|||
163057042|NCT02370511|588919771|FG001|Overall Study|Withdrawal by Subject|0|||
163057043|NCT02370511|588919772|FG002|Overall Study|Withdrawal by Subject|0|||
163057044|NCT02370511|588919770|FG000|Overall Study|Lost to Follow-up|0|||
163057045|NCT02370511|588919771|FG001|Overall Study|Lost to Follow-up|4|||
163057046|NCT02370511|588919772|FG002|Overall Study|Lost to Follow-up|0|||
163057047|NCT01149655|588919773|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
163057048|NCT01149655|588919774|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
163057049|NCT01149655|588919775|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
163057050|NCT01149655|588919776|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
163057051|NCT01149655|588919773|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
163057052|NCT01149655|588919774|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
162972137|NCT01190930|588597966|FG002|Maintenance|Lost to Follow-up|0|||
162972138|NCT01190930|588597967|FG003|Maintenance|Lost to Follow-up|0|||
162972139|NCT01190930|588597968|FG004|Maintenance|Lost to Follow-up|0|||
162972140|NCT01190930|588597969|FG005|Maintenance|Lost to Follow-up|0|||
163057053|NCT01149655|588919775|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
163057054|NCT01149655|588919776|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
163057055|NCT01149655|588919773|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
163057056|NCT01149655|588919774|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
163057057|NCT01149655|588919775|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
163057058|NCT01149655|588919776|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
163057059|NCT01149655|588919773|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
163057060|NCT01149655|588919774|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
163057061|NCT01149655|588919775|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
163057062|NCT01149655|588919776|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
163057063|NCT01149655|588919773|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
163057064|NCT01149655|588919774|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
163057065|NCT01149655|588919775|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
163057066|NCT01149655|588919776|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
163057067|NCT01149655|588919773|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
163057068|NCT01149655|588919774|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
163057069|NCT01149655|588919775|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
162972141|NCT01190930|588597970|FG006|Maintenance|Lost to Follow-up|1|||
162972142|NCT01190930|588597971|FG007|Maintenance|Lost to Follow-up|1|||
162972143|NCT01190930|588597972|FG008|Maintenance|Lost to Follow-up|1|||
163057070|NCT01149655|588919776|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
162972144|NCT01190930|588597973|FG009|Maintenance|Lost to Follow-up|0|||
162972145|NCT01190930|588597964|FG000|Maintenance|Physician Decision|0|||
162972146|NCT01190930|588597965|FG001|Maintenance|Physician Decision|1|||
162972147|NCT01190930|588597966|FG002|Maintenance|Physician Decision|0|||
163057071|NCT01149655|588919773|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
163209431|NCT00752232|589480634|FG004|Overall Study|Protocol Violation|0|||
163209432|NCT00752232|589480635|FG005|Overall Study|Protocol Violation|1|||
163209433|NCT00752232|589480636|FG006|Overall Study|Protocol Violation|0|||
163209434|NCT00752232|589480630|FG000|Overall Study|Caregiver request|2|||
163209435|NCT00752232|589480631|FG001|Overall Study|Caregiver request|0|||
163209436|NCT00752232|589480632|FG002|Overall Study|Caregiver request|0|||
163209437|NCT00752232|589480633|FG003|Overall Study|Caregiver request|0|||
163209438|NCT00752232|589480634|FG004|Overall Study|Caregiver request|1|||
163209439|NCT00752232|589480635|FG005|Overall Study|Caregiver request|0|||
163209440|NCT00752232|589480636|FG006|Overall Study|Caregiver request|0|||
163209441|NCT00752232|589480630|FG000|Overall Study|Investigator request|0|||
163209442|NCT00752232|589480631|FG001|Overall Study|Investigator request|0|||
163209443|NCT00752232|589480632|FG002|Overall Study|Investigator request|0|||
163209444|NCT00752232|589480633|FG003|Overall Study|Investigator request|0|||
163209445|NCT00752232|589480634|FG004|Overall Study|Investigator request|1|||
163209446|NCT00752232|589480635|FG005|Overall Study|Investigator request|0|||
163209447|NCT00752232|589480636|FG006|Overall Study|Investigator request|0|||
163209448|NCT00752232|589480630|FG000|Overall Study|Subject request|0|||
163209449|NCT00752232|589480631|FG001|Overall Study|Subject request|0|||
163209450|NCT00752232|589480632|FG002|Overall Study|Subject request|1|||
163209451|NCT00752232|589480633|FG003|Overall Study|Subject request|0|||
163209452|NCT00752232|589480634|FG004|Overall Study|Subject request|0|||
163209453|NCT00752232|589480635|FG005|Overall Study|Subject request|0|||
163209454|NCT00752232|589480636|FG006|Overall Study|Subject request|0|||
163209455|NCT00752232|589480630|FG000|Overall Study|Group home admission|0|||
163209456|NCT00752232|589480631|FG001|Overall Study|Group home admission|0|||
163209457|NCT00752232|589480632|FG002|Overall Study|Group home admission|0|||
163209458|NCT00752232|589480633|FG003|Overall Study|Group home admission|1|||
163209459|NCT00752232|589480634|FG004|Overall Study|Group home admission|0|||
163209460|NCT00752232|589480635|FG005|Overall Study|Group home admission|0|||
163209461|NCT00752232|589480636|FG006|Overall Study|Group home admission|0|||
163209462|NCT00752232|589480630|FG000|Overall Study|Caregiver could not attend the subject|0|||
163209463|NCT00752232|589480631|FG001|Overall Study|Caregiver could not attend the subject|0|||
163209464|NCT00752232|589480632|FG002|Overall Study|Caregiver could not attend the subject|0|||
163209465|NCT00752232|589480633|FG003|Overall Study|Caregiver could not attend the subject|0|||
163209466|NCT00752232|589480634|FG004|Overall Study|Caregiver could not attend the subject|1|||
163209467|NCT00752232|589480635|FG005|Overall Study|Caregiver could not attend the subject|0|||
163209468|NCT00752232|589480636|FG006|Overall Study|Caregiver could not attend the subject|0|||
163209469|NCT04502589|589480637|FG000|Overall Study|Physician Decision|1|||
163209470|NCT04502589|589480638|FG001|Overall Study|Physician Decision|0|||
163209471|NCT02730455|589480640|FG000|Overall Study|Death|5|||
163209472|NCT02730455|589480641|FG001|Overall Study|Death|6|||
163209473|NCT02730455|589480642|FG002|Overall Study|Death|4|||
163317976|NCT01928394|589874953|FG007|Treatment Period|Death|0|||
163317977|NCT01928394|589874954|FG008|Treatment Period|Death|0|||
163317978|NCT01928394|589874955|FG009|Treatment Period|Death|0|||
163317979|NCT01928394|589874956|FG010|Treatment Period|Death|0|||
163317980|NCT01928394|589874957|FG011|Treatment Period|Death|0|||
163317981|NCT01928394|589874958|FG012|Treatment Period|Death|0|||
163317982|NCT01928394|589874959|FG013|Treatment Period|Death|1|||
163317983|NCT01928394|589874960|FG014|Treatment Period|Death|2|||
163317984|NCT01928394|589874961|FG015|Treatment Period|Death|0|||
163317985|NCT01928394|589874962|FG016|Treatment Period|Death|0|||
163317986|NCT01928394|589874963|FG017|Treatment Period|Death|0|||
163317987|NCT01928394|589874964|FG018|Treatment Period|Death|0|||
162972148|NCT01190930|588597967|FG003|Maintenance|Physician Decision|5|||
162972149|NCT01190930|588597968|FG004|Maintenance|Physician Decision|9|||
162972150|NCT01190930|588597969|FG005|Maintenance|Physician Decision|4|||
162972151|NCT01190930|588597970|FG006|Maintenance|Physician Decision|8|||
162972152|NCT01190930|588597971|FG007|Maintenance|Physician Decision|8|||
162972153|NCT01190930|588597972|FG008|Maintenance|Physician Decision|10|||
162972154|NCT01190930|588597973|FG009|Maintenance|Physician Decision|17|||
162972155|NCT01190930|588597964|FG000|Maintenance|Withdrawal by Subject|0|||
162972156|NCT01190930|588597965|FG001|Maintenance|Withdrawal by Subject|0|||
162972157|NCT01190930|588597966|FG002|Maintenance|Withdrawal by Subject|0|||
162972158|NCT01190930|588597967|FG003|Maintenance|Withdrawal by Subject|0|||
162972159|NCT01190930|588597968|FG004|Maintenance|Withdrawal by Subject|0|||
162972160|NCT01190930|588597969|FG005|Maintenance|Withdrawal by Subject|0|||
162972161|NCT01190930|588597970|FG006|Maintenance|Withdrawal by Subject|2|||
162972162|NCT01190930|588597971|FG007|Maintenance|Withdrawal by Subject|1|||
162972163|NCT01190930|588597972|FG008|Maintenance|Withdrawal by Subject|4|||
162972164|NCT01190930|588597973|FG009|Maintenance|Withdrawal by Subject|1|||
162972165|NCT01190930|588597964|FG000|Maintenance|Refusal|0|||
162972166|NCT01190930|588597965|FG001|Maintenance|Refusal|1|||
162972167|NCT01190930|588597966|FG002|Maintenance|Refusal|0|||
162972168|NCT01190930|588597967|FG003|Maintenance|Refusal|2|||
162972169|NCT01190930|588597968|FG004|Maintenance|Refusal|0|||
162972170|NCT01190930|588597969|FG005|Maintenance|Refusal|4|||
162972171|NCT01190930|588597970|FG006|Maintenance|Refusal|5|||
162972172|NCT01190930|588597971|FG007|Maintenance|Refusal|17|||
163317988|NCT01928394|589874965|FG019|Treatment Period|Death|0|||
163317989|NCT01928394|589874966|FG020|Treatment Period|Death|0|||
163317990|NCT01928394|589874967|FG021|Treatment Period|Death|0|||
162972173|NCT01190930|588597972|FG008|Maintenance|Refusal|13|||
162972174|NCT01190930|588597973|FG009|Maintenance|Refusal|6|||
162972175|NCT01190930|588597964|FG000|Maintenance|second malignant neoplasm|0|||
163317991|NCT01928394|589874968|FG022|Treatment Period|Death|0|||
163317992|NCT01928394|589874946|FG000|Follow-up Period|Participant withdrew consent|3|||
163317993|NCT01928394|589874947|FG001|Follow-up Period|Participant withdrew consent|0|||
163057072|NCT01149655|588919774|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
163057073|NCT01149655|588919775|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
163057074|NCT01149655|588919776|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
163057075|NCT01149655|588919773|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
163057076|NCT01149655|588919774|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
163057077|NCT01149655|588919775|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
163057078|NCT01149655|588919776|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
163057079|NCT01149655|588919773|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
163057080|NCT01149655|588919774|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
163057081|NCT01149655|588919775|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
163057082|NCT01149655|588919776|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
163057083|NCT01149655|588919773|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
163057084|NCT01149655|588919774|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
163057085|NCT01149655|588919775|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
163057086|NCT01149655|588919776|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
163057087|NCT01149655|588919773|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
163057088|NCT01149655|588919774|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
163057089|NCT01149655|588919775|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
163057090|NCT01149655|588919776|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
163057091|NCT01149655|588919773|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
163057092|NCT01149655|588919774|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
163057093|NCT01149655|588919775|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
163057094|NCT01149655|588919776|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
163057095|NCT01149655|588919773|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
163057096|NCT01149655|588919774|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
163057097|NCT01149655|588919775|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
163057098|NCT01149655|588919776|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
163057099|NCT01149655|588919773|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
163057100|NCT01149655|588919774|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
163057101|NCT01149655|588919775|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
163057102|NCT01149655|588919776|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
163057103|NCT01149655|588919773|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
163057104|NCT01149655|588919774|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
163057105|NCT01149655|588919775|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
163057106|NCT01149655|588919776|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
163057107|NCT01149655|588919773|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
163057108|NCT01149655|588919774|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
163057109|NCT01149655|588919775|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
163057110|NCT01149655|588919776|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
163057111|NCT03092752|588919779|FG000|Overall Study|Aged <40 years|14209|||
163057112|NCT03092752|588919779|FG000|Overall Study|At least one claim with T2DM|61299|||
163057113|NCT03092752|588919779|FG000|Overall Study|Having no claim of study drugs|29282|||
163057114|NCT03092752|588919779|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
163057115|NCT03092752|588919779|FG000|Overall Study|<6 month history|245900|||
163057116|NCT00921024|588919783|FG000|Overall Study|Lost to Follow-up|2|||
163057117|NCT00921024|588919784|FG001|Overall Study|Lost to Follow-up|0|||
163057118|NCT00921024|588919783|FG000|Overall Study|Received concomittant therapy|2|||
163057119|NCT00921024|588919784|FG001|Overall Study|Received concomittant therapy|0|||
163057120|NCT00921024|588919783|FG000|Overall Study|Withdrawal by Subject|0|||
163057121|NCT00921024|588919784|FG001|Overall Study|Withdrawal by Subject|3|||
163057122|NCT03882918|588919785|FG000|Overall Study|Study terminated by sponsor|98|||
163057123|NCT03882918|588919785|FG000|Overall Study|Protocol Violation|1|||
163209474|NCT02730455|589480640|FG000|Overall Study|Consent withdrawn|2|||
163209475|NCT02730455|589480641|FG001|Overall Study|Consent withdrawn|4|||
163209476|NCT02730455|589480642|FG002|Overall Study|Consent withdrawn|1|||
163209477|NCT02730455|589480640|FG000|Overall Study|Lost to Follow-up|3|||
163209478|NCT02730455|589480641|FG001|Overall Study|Lost to Follow-up|1|||
163209479|NCT02730455|589480642|FG002|Overall Study|Lost to Follow-up|4|||
163209480|NCT02730455|589480640|FG000|Overall Study|Other|1|||
163209481|NCT02730455|589480641|FG001|Overall Study|Other|1|||
163209482|NCT02730455|589480642|FG002|Overall Study|Other|2|||
163209483|NCT02730455|589480640|FG000|Overall Study|Other|2|||
163209484|NCT02730455|589480641|FG001|Overall Study|Other|2|||
163209485|NCT02730455|589480642|FG002|Overall Study|Other|0|||
163209486|NCT02733367|589480643|FG000|Overall Study|Withdrawal by Subject|6|||
163209487|NCT01922089|589480646|FG000|Overall Study|Adverse Event|18|||
163209488|NCT01922089|589480647|FG001|Overall Study|Adverse Event|13|||
163209489|NCT01922089|589480646|FG000|Overall Study|Protocol Deviation|10|||
163209490|NCT01922089|589480647|FG001|Overall Study|Protocol Deviation|7|||
163057124|NCT03882918|588919785|FG000|Overall Study|Other|9|||
163057125|NCT03882918|588919785|FG000|Overall Study|Lack of Efficacy|14|||
163057126|NCT03882918|588919785|FG000|Overall Study|Adverse Event|13|||
163057127|NCT03882918|588919785|FG000|Overall Study|Withdrawal by Subject|5|||
163057128|NCT06996301|588919786|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
163057129|NCT06996301|588919787|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
163317994|NCT01928394|589874948|FG002|Follow-up Period|Participant withdrew consent|1|||
163317995|NCT01928394|589874949|FG003|Follow-up Period|Participant withdrew consent|4|||
163317996|NCT01928394|589874950|FG004|Follow-up Period|Participant withdrew consent|0|||
163057130|NCT06996301|588919786|FG000|Overall Study|Patients with discordant diagnostic results|107|||
163057131|NCT06996301|588919787|FG001|Overall Study|Patients with discordant diagnostic results|90|||
163057132|NCT06996301|588919786|FG000|Overall Study|Lost to Follow-up|31|||
163057133|NCT06996301|588919787|FG001|Overall Study|Lost to Follow-up|56|||
163317997|NCT01928394|589874951|FG005|Follow-up Period|Participant withdrew consent|2|||
163317998|NCT01928394|589874952|FG006|Follow-up Period|Participant withdrew consent|5|||
163317999|NCT01928394|589874953|FG007|Follow-up Period|Participant withdrew consent|1|||
163318000|NCT01928394|589874954|FG008|Follow-up Period|Participant withdrew consent|0|||
163318001|NCT01928394|589874955|FG009|Follow-up Period|Participant withdrew consent|0|||
163318002|NCT01928394|589874956|FG010|Follow-up Period|Participant withdrew consent|5|||
163318003|NCT01928394|589874957|FG011|Follow-up Period|Participant withdrew consent|8|||
163318004|NCT01928394|589874958|FG012|Follow-up Period|Participant withdrew consent|2|||
163057134|NCT06996301|588919786|FG000|Overall Study|Withdrawal by Subject|12|||
163057135|NCT06996301|588919787|FG001|Overall Study|Withdrawal by Subject|7|||
163057136|NCT04030598|588919788|FG000|Overall Study|Voluntary Withdrawal|0|||
163057137|NCT04030598|588919789|FG001|Overall Study|Voluntary Withdrawal|1|||
163057138|NCT04030598|588919790|FG002|Overall Study|Voluntary Withdrawal|0|||
163057139|NCT02097823|588919791|FG000|Overall Study|Withdrawal by Subject|1|||
163057140|NCT02097823|588919792|FG001|Overall Study|Withdrawal by Subject|1|||
163057141|NCT01419535|588919793|FG000|Overall Study|could not maintain iv line|1|||
163057142|NCT01419535|588919794|FG001|Overall Study|could not maintain iv line|1|||
163057143|NCT01419535|588919793|FG000|Overall Study|Withdrawal by Subject|0|||
163057144|NCT01419535|588919794|FG001|Overall Study|Withdrawal by Subject|1|||
163057145|NCT02659865|588921180|FG000|Period 1|Withdrawal by Subject|1|||
163057146|NCT02659865|588921181|FG001|Period 1|Withdrawal by Subject|0|||
163057147|NCT02659865|588921182|FG002|Period 1|Withdrawal by Subject|0|||
163057148|NCT02659865|588921183|FG003|Period 1|Withdrawal by Subject|0|||
163318005|NCT01928394|589874959|FG013|Follow-up Period|Participant withdrew consent|12|||
163318006|NCT01928394|589874960|FG014|Follow-up Period|Participant withdrew consent|7|||
163318007|NCT01928394|589874961|FG015|Follow-up Period|Participant withdrew consent|0|||
163318008|NCT01928394|589874962|FG016|Follow-up Period|Participant withdrew consent|5|||
163318009|NCT01928394|589874963|FG017|Follow-up Period|Participant withdrew consent|3|||
163318010|NCT01928394|589874964|FG018|Follow-up Period|Participant withdrew consent|2|||
163318011|NCT01928394|589874965|FG019|Follow-up Period|Participant withdrew consent|7|||
162972176|NCT01190930|588597965|FG001|Maintenance|second malignant neoplasm|0|||
162972177|NCT01190930|588597966|FG002|Maintenance|second malignant neoplasm|0|||
162972178|NCT01190930|588597967|FG003|Maintenance|second malignant neoplasm|1|||
162972179|NCT01190930|588597968|FG004|Maintenance|second malignant neoplasm|0|||
162972180|NCT01190930|588597969|FG005|Maintenance|second malignant neoplasm|1|||
162972181|NCT01190930|588597970|FG006|Maintenance|second malignant neoplasm|0|||
162972182|NCT01190930|588597971|FG007|Maintenance|second malignant neoplasm|0|||
162972183|NCT01190930|588597972|FG008|Maintenance|second malignant neoplasm|1|||
162972184|NCT01190930|588597973|FG009|Maintenance|second malignant neoplasm|0|||
162972185|NCT01190930|588597964|FG000|Maintenance|Inevaluable|0|||
162972186|NCT01190930|588597965|FG001|Maintenance|Inevaluable|0|||
162972187|NCT01190930|588597966|FG002|Maintenance|Inevaluable|0|||
162972188|NCT01190930|588597967|FG003|Maintenance|Inevaluable|0|||
163057149|NCT02659865|588921184|FG004|Period 1|Withdrawal by Subject|0|||
163057150|NCT02659865|588921180|FG000|Period 1|Adverse Event|0|||
163057151|NCT02659865|588921181|FG001|Period 1|Adverse Event|0|||
163057152|NCT02659865|588921182|FG002|Period 1|Adverse Event|0|||
163057153|NCT02659865|588921183|FG003|Period 1|Adverse Event|0|||
163057154|NCT02659865|588921184|FG004|Period 1|Adverse Event|1|||
163057155|NCT02325414|588921185|FG000|Overall Study|Withdrawal by Subject|3|||
163318012|NCT01928394|589874966|FG020|Follow-up Period|Participant withdrew consent|4|||
162972189|NCT01190930|588597968|FG004|Maintenance|Inevaluable|0|||
162972190|NCT01190930|588597969|FG005|Maintenance|Inevaluable|1|||
162972191|NCT01190930|588597970|FG006|Maintenance|Inevaluable|1|||
163057156|NCT02325414|588921186|FG001|Overall Study|Withdrawal by Subject|1|||
163057157|NCT02325414|588921185|FG000|Overall Study|Lost to Follow-up|5|||
163057158|NCT02325414|588921186|FG001|Overall Study|Lost to Follow-up|5|||
163318013|NCT01928394|589874967|FG021|Follow-up Period|Participant withdrew consent|6|||
163057159|NCT02775851|588921189|FG000|Overall Study|Adverse Event|1|||
163057160|NCT02775851|588921190|FG001|Overall Study|Adverse Event|10|||
163057161|NCT02775851|588921189|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
163057162|NCT02775851|588921190|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
163057163|NCT02775851|588921189|FG000|Overall Study|Progression/Relapse|0|||
162972192|NCT01190930|588597971|FG007|Maintenance|Inevaluable|1|||
162972193|NCT01190930|588597972|FG008|Maintenance|Inevaluable|0|||
162972194|NCT01190930|588597973|FG009|Maintenance|Inevaluable|0|||
162972195|NCT01190930|588597964|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
162972196|NCT01190930|588597965|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
162972197|NCT01190930|588597966|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
162972198|NCT01190930|588597967|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
162972199|NCT01190930|588597968|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
162972200|NCT01190930|588597969|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
162972201|NCT01190930|588597970|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
162972202|NCT01190930|588597971|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
162972203|NCT01190930|588597972|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
162972204|NCT01190930|588597973|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
162972205|NCT01190930|588597964|FG000|Maintenance|Relapse|0|||
162972206|NCT01190930|588597965|FG001|Maintenance|Relapse|0|||
162972207|NCT01190930|588597966|FG002|Maintenance|Relapse|0|||
162972208|NCT01190930|588597967|FG003|Maintenance|Relapse|2|||
162972209|NCT01190930|588597968|FG004|Maintenance|Relapse|0|||
162972210|NCT01190930|588597969|FG005|Maintenance|Relapse|1|||
162972211|NCT01190930|588597970|FG006|Maintenance|Relapse|6|||
162972212|NCT01190930|588597971|FG007|Maintenance|Relapse|13|||
162972213|NCT01190930|588597972|FG008|Maintenance|Relapse|11|||
162972214|NCT01190930|588597973|FG009|Maintenance|Relapse|11|||
162972215|NCT01190930|588597964|FG000|Maintenance|Still on therapy|0|||
162972216|NCT01190930|588597965|FG001|Maintenance|Still on therapy|8|||
162972217|NCT01190930|588597966|FG002|Maintenance|Still on therapy|0|||
162972218|NCT01190930|588597967|FG003|Maintenance|Still on therapy|29|||
162972219|NCT01190930|588597968|FG004|Maintenance|Still on therapy|0|||
162972220|NCT01190930|588597969|FG005|Maintenance|Still on therapy|0|||
162972221|NCT01190930|588597970|FG006|Maintenance|Still on therapy|0|||
162972222|NCT01190930|588597971|FG007|Maintenance|Still on therapy|0|||
162972223|NCT01190930|588597972|FG008|Maintenance|Still on therapy|0|||
162972224|NCT01190930|588597973|FG009|Maintenance|Still on therapy|0|||
162972225|NCT05070754|588597980|FG000|Overall Study|Withdrawal by Subject|0|||
162972226|NCT05070754|588597981|FG001|Overall Study|Withdrawal by Subject|0|||
162972227|NCT05070754|588597982|FG002|Overall Study|Withdrawal by Subject|0|||
162972228|NCT05070754|588597983|FG003|Overall Study|Withdrawal by Subject|1|||
162972229|NCT05070754|588597980|FG000|Overall Study|Protocol Violation|0|||
162972230|NCT05070754|588597981|FG001|Overall Study|Protocol Violation|0|||
162972231|NCT05070754|588597982|FG002|Overall Study|Protocol Violation|0|||
162972232|NCT05070754|588597983|FG003|Overall Study|Protocol Violation|1|||
162972233|NCT01398787|588597984|FG000|Overall Study|Adverse Event|1|||
162972234|NCT00529217|588597987|FG000|Overall Study|Lack of Efficacy|2|||
162972235|NCT00529217|588597987|FG000|Overall Study|Unable to adhere to study schedule|2|||
162972236|NCT00372996|588597990|FG000|Overall Study|Death|11|||
162972237|NCT00372996|588597991|FG001|Overall Study|Death|4|||
162972238|NCT00372996|588597992|FG002|Overall Study|Death|8|||
162972239|NCT00372996|588597993|FG003|Overall Study|Death|7|||
162972240|NCT00372996|588597990|FG000|Overall Study|Lost to Follow-up|0|||
162972241|NCT00372996|588597991|FG001|Overall Study|Lost to Follow-up|2|||
162972242|NCT00372996|588597992|FG002|Overall Study|Lost to Follow-up|0|||
162972243|NCT00372996|588597993|FG003|Overall Study|Lost to Follow-up|1|||
162972244|NCT00372996|588597990|FG000|Overall Study|Withdrawal by Subject|12|||
162972245|NCT00372996|588597991|FG001|Overall Study|Withdrawal by Subject|6|||
162972246|NCT00372996|588597992|FG002|Overall Study|Withdrawal by Subject|9|||
162972247|NCT00372996|588597993|FG003|Overall Study|Withdrawal by Subject|5|||
162972248|NCT00372996|588597990|FG000|Overall Study|Study Terminated by Sponsor|4|||
162972249|NCT00372996|588597991|FG001|Overall Study|Study Terminated by Sponsor|0|||
162972250|NCT00372996|588597992|FG002|Overall Study|Study Terminated by Sponsor|4|||
162972251|NCT00372996|588597993|FG003|Overall Study|Study Terminated by Sponsor|0|||
162972252|NCT00372996|588597990|FG000|Overall Study|Other|10|||
162972253|NCT00372996|588597991|FG001|Overall Study|Other|2|||
162972254|NCT00372996|588597992|FG002|Overall Study|Other|7|||
162972255|NCT00372996|588597993|FG003|Overall Study|Other|7|||
162972256|NCT01077258|588598001|FG000|Overall Study|Lost to Follow-up|1390|||
163401324|NCT02535715|590181127|FG002|Overall Study|Withdrawal by Subject|1|||
162972257|NCT01077258|588598001|FG000|Overall Study|Adverse drug reaction|218|||
162972258|NCT01077258|588598001|FG000|Overall Study|Lack of Efficacy|663|||
162972259|NCT01077258|588598001|FG000|Overall Study|Clinical remission|37|||
163057164|NCT02775851|588921190|FG001|Overall Study|Progression/Relapse|4|||
163057165|NCT02775851|588921189|FG000|Overall Study|Other - Not Protocol Specified|0|||
163401325|NCT04353284|590181128|FG000|Overall Study|Adverse Event|1|||
163057166|NCT02775851|588921190|FG001|Overall Study|Other - Not Protocol Specified|7|||
163401326|NCT04353284|590181129|FG001|Overall Study|Adverse Event|1|||
162972260|NCT01077258|588598001|FG000|Overall Study|Other reasons|260|||
162972261|NCT00726895|588598002|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
162972262|NCT00726895|588598003|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
163057167|NCT02775851|588921189|FG000|Overall Study|Withdrawal by Subject|1|||
163209491|NCT01922089|589480646|FG000|Overall Study|Withdrawal by Subject|3|||
163209492|NCT01922089|589480647|FG001|Overall Study|Withdrawal by Subject|4|||
163209493|NCT01922089|589480646|FG000|Overall Study|administrative problems|4|||
163209494|NCT01922089|589480647|FG001|Overall Study|administrative problems|1|||
163209495|NCT01922089|589480646|FG000|Overall Study|Physician Decision|2|||
163209496|NCT01922089|589480647|FG001|Overall Study|Physician Decision|3|||
163209497|NCT01922089|589480646|FG000|Overall Study|Death|2|||
163209498|NCT01922089|589480647|FG001|Overall Study|Death|1|||
163209499|NCT01922089|589480646|FG000|Overall Study|Lost to Follow-up|0|||
163209500|NCT01922089|589480647|FG001|Overall Study|Lost to Follow-up|1|||
163209501|NCT05582889|589480649|FG000|Overall Study|Health event|3|||
163209502|NCT05582889|589480650|FG001|Overall Study|Health event|2|||
163209503|NCT05582889|589480649|FG000|Overall Study|Lost to Follow-up|2|||
163209504|NCT05582889|589480650|FG001|Overall Study|Lost to Follow-up|4|||
163209505|NCT00001723|589480651|FG000|Overall Study|Lack of Efficacy|6|||
163209506|NCT00001723|589480652|FG001|Overall Study|Lack of Efficacy|7|||
163209507|NCT00001723|589480651|FG000|Overall Study|Lack of family interest|4|||
163209508|NCT00001723|589480652|FG001|Overall Study|Lack of family interest|5|||
163209509|NCT00001723|589480651|FG000|Overall Study|Lost to Follow-up|2|||
163209510|NCT00001723|589480652|FG001|Overall Study|Lost to Follow-up|2|||
163209511|NCT00001723|589480651|FG000|Overall Study|medication intolerance|1|||
162972263|NCT01881737|588598005|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
162972264|NCT01881737|588598005|FG000|Overall Study|Withdrawal by Subject|1|||
162972265|NCT01881737|588598005|FG000|Overall Study|Worsening of baseline behavior|1|||
162972266|NCT03496298|588598008|FG000|Overall Study|Adverse Event|49|||
162972267|NCT03496298|588598009|FG001|Overall Study|Adverse Event|68|||
162972268|NCT03496298|588598010|FG002|Overall Study|Adverse Event|79|||
162972269|NCT03496298|588598008|FG000|Overall Study|Study terminated by Sponsor|1050|||
162972270|NCT03496298|588598009|FG001|Overall Study|Study terminated by Sponsor|1063|||
162972271|NCT03496298|588598010|FG002|Overall Study|Study terminated by Sponsor|1071|||
162972272|NCT03496298|588598008|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
162972273|NCT03496298|588598009|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
162972274|NCT03496298|588598010|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
162972275|NCT03496298|588598008|FG000|Overall Study|Withdrawal by Subject|176|||
162972276|NCT03496298|588598009|FG001|Overall Study|Withdrawal by Subject|154|||
162972277|NCT03496298|588598010|FG002|Overall Study|Withdrawal by Subject|151|||
162972278|NCT03496298|588598008|FG000|Overall Study|Other|29|||
162972279|NCT03496298|588598009|FG001|Overall Study|Other|20|||
162972280|NCT03496298|588598010|FG002|Overall Study|Other|23|||
162972281|NCT03496298|588598008|FG000|Overall Study|Randomized and not treated|1|||
162972282|NCT03496298|588598009|FG001|Overall Study|Randomized and not treated|1|||
162972283|NCT03496298|588598010|FG002|Overall Study|Randomized and not treated|1|||
162972284|NCT00676494|588598013|FG000|Overall Study|Missed Visit|8|||
162972285|NCT00676494|588598013|FG000|Overall Study|Withdrawal by Subject|6|||
162972286|NCT02608476|588598014|FG000|Overall Study|Withdrawal by Subject|30|||
162972287|NCT02608476|588598015|FG001|Overall Study|Withdrawal by Subject|37|||
162972288|NCT02608476|588598014|FG000|Overall Study|Lost to Follow-up|24|||
162972289|NCT02608476|588598015|FG001|Overall Study|Lost to Follow-up|24|||
162972290|NCT02608476|588598014|FG000|Overall Study|Adverse Event|2|||
162972291|NCT02608476|588598015|FG001|Overall Study|Adverse Event|8|||
162972292|NCT02608476|588598014|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
162972293|NCT02608476|588598015|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
162972294|NCT02608476|588598014|FG000|Overall Study|Noncompliance with treatment|1|||
162972295|NCT02608476|588598015|FG001|Overall Study|Noncompliance with treatment|5|||
162972296|NCT02608476|588598014|FG000|Overall Study|Lack of Efficacy|3|||
162972297|NCT02608476|588598015|FG001|Overall Study|Lack of Efficacy|1|||
162972298|NCT02608476|588598014|FG000|Overall Study|Other|0|||
162972299|NCT02608476|588598015|FG001|Overall Study|Other|1|||
162972300|NCT02608476|588598014|FG000|Overall Study|Physician Decision|1|||
162972301|NCT02608476|588598015|FG001|Overall Study|Physician Decision|0|||
162972302|NCT02608476|588598014|FG000|Overall Study|Pregnancy|0|||
162972303|NCT02608476|588598015|FG001|Overall Study|Pregnancy|1|||
162972304|NCT02608476|588598014|FG000|Overall Study|Progressive disease|1|||
162972305|NCT02608476|588598015|FG001|Overall Study|Progressive disease|0|||
163209512|NCT00001723|589480652|FG001|Overall Study|medication intolerance|2|||
163209513|NCT02170051|589480653|FG000|Overall Study|Withdrawal by Subject|10|||
163209514|NCT02170051|589480654|FG001|Overall Study|Withdrawal by Subject|10|||
163209515|NCT02170051|589480653|FG000|Overall Study|Lost to Follow-up|1|||
163209516|NCT02170051|589480654|FG001|Overall Study|Lost to Follow-up|3|||
163209517|NCT04551092|589480655|FG000|Overall Study|Lost to Follow-up|7|||
162972306|NCT02058160|588598016|FG000|Overall Study|Randomized but not treated|2|||
162972307|NCT02058160|588598017|FG001|Overall Study|Randomized but not treated|4|||
162972308|NCT02058160|588598016|FG000|Overall Study|Poor compliance to protocol|4|||
162972309|NCT02058160|588598017|FG001|Overall Study|Poor compliance to protocol|1|||
162972310|NCT02058160|588598016|FG000|Overall Study|Adverse Event|12|||
162972311|NCT02058160|588598017|FG001|Overall Study|Adverse Event|3|||
163209518|NCT04551092|589480655|FG000|Overall Study|Withdrawal by Subject|4|||
163209519|NCT01324999|589480656|FG000|Overall Study|Adverse Event|3|||
163057168|NCT02775851|588921190|FG001|Overall Study|Withdrawal by Subject|0|||
163057169|NCT06125964|588921191|FG000|Overall Study|Lost to Follow-up|0|||
162972312|NCT02058160|588598016|FG000|Overall Study|Lost to Follow-up|1|||
162972313|NCT02058160|588598017|FG001|Overall Study|Lost to Follow-up|0|||
162972314|NCT02058160|588598016|FG000|Overall Study|Other than specified above|12|||
162972315|NCT02058160|588598017|FG001|Overall Study|Other than specified above|6|||
162972316|NCT01203917|588598019|FG000|Overall Study|Death|29|||
162972317|NCT01203917|588598019|FG000|Overall Study|Lost to Follow-up|2|||
162972318|NCT01203917|588598019|FG000|Overall Study|Withdrawal by Subject|3|||
162972319|NCT01203917|588598019|FG000|Overall Study|Due to objective disease progression|1|||
162972320|NCT01203917|588598019|FG000|Overall Study|Due to EGFR M+I patient|1|||
162972321|NCT04106817|588598020|FG000|Overall Study|Lost to Follow-up|1|||
162972322|NCT04106817|588598021|FG001|Overall Study|Lost to Follow-up|0|||
162972323|NCT04106817|588598022|FG002|Overall Study|Lost to Follow-up|0|||
162972324|NCT02260635|588598023|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
162972325|NCT02260635|588598024|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
162972326|NCT02260635|588598023|FG000|Open-Label Extension|Study Termination|25|||
162972327|NCT02260635|588598024|FG001|Open-Label Extension|Study Termination|25|||
162972328|NCT02260635|588598023|FG000|Open-Label Extension|Withdrawal by Subject|1|||
162972329|NCT02260635|588598024|FG001|Open-Label Extension|Withdrawal by Subject|0|||
162972330|NCT03310619|588598025|FG000|Pre-Treatment Period|Death|1|||
162972331|NCT03310619|588598026|FG001|Pre-Treatment Period|Death|0|||
162972332|NCT03310619|588598027|FG002|Pre-Treatment Period|Death|0|||
162972333|NCT03310619|588598028|FG003|Pre-Treatment Period|Death|0|||
162972334|NCT03310619|588598029|FG004|Pre-Treatment Period|Death|1|||
162972335|NCT03310619|588598030|FG005|Pre-Treatment Period|Death|0|||
162972336|NCT03310619|588598031|FG006|Pre-Treatment Period|Death|0|||
162972337|NCT03310619|588598032|FG007|Pre-Treatment Period|Death|0|||
162972338|NCT03310619|588598025|FG000|Pre-Treatment Period|Other reasons|2|||
162972339|NCT03310619|588598026|FG001|Pre-Treatment Period|Other reasons|1|||
162972340|NCT03310619|588598027|FG002|Pre-Treatment Period|Other reasons|2|||
162972341|NCT03310619|588598028|FG003|Pre-Treatment Period|Other reasons|0|||
162972342|NCT03310619|588598029|FG004|Pre-Treatment Period|Other reasons|0|||
162972343|NCT03310619|588598030|FG005|Pre-Treatment Period|Other reasons|0|||
162972344|NCT03310619|588598031|FG006|Pre-Treatment Period|Other reasons|2|||
162972345|NCT03310619|588598032|FG007|Pre-Treatment Period|Other reasons|0|||
162972346|NCT03310619|588598025|FG000|Treatment Period|Death|1|||
162972347|NCT03310619|588598026|FG001|Treatment Period|Death|2|||
162972348|NCT03310619|588598027|FG002|Treatment Period|Death|0|||
162972349|NCT03310619|588598028|FG003|Treatment Period|Death|0|||
162972350|NCT03310619|588598029|FG004|Treatment Period|Death|1|||
162972351|NCT03310619|588598030|FG005|Treatment Period|Death|0|||
162972352|NCT03310619|588598031|FG006|Treatment Period|Death|2|||
162972353|NCT03310619|588598032|FG007|Treatment Period|Death|0|||
162972354|NCT03310619|588598025|FG000|Treatment Period|Adverse Event|0|||
162972355|NCT03310619|588598026|FG001|Treatment Period|Adverse Event|1|||
162972356|NCT03310619|588598027|FG002|Treatment Period|Adverse Event|4|||
162972357|NCT03310619|588598028|FG003|Treatment Period|Adverse Event|1|||
162972358|NCT03310619|588598029|FG004|Treatment Period|Adverse Event|0|||
162972359|NCT03310619|588598030|FG005|Treatment Period|Adverse Event|0|||
162972360|NCT03310619|588598031|FG006|Treatment Period|Adverse Event|0|||
162972361|NCT03310619|588598032|FG007|Treatment Period|Adverse Event|0|||
162972362|NCT03310619|588598025|FG000|Treatment Period|Withdrawal by participant|0|||
162972363|NCT03310619|588598026|FG001|Treatment Period|Withdrawal by participant|0|||
162972364|NCT03310619|588598027|FG002|Treatment Period|Withdrawal by participant|1|||
162972365|NCT03310619|588598028|FG003|Treatment Period|Withdrawal by participant|0|||
162972366|NCT03310619|588598029|FG004|Treatment Period|Withdrawal by participant|0|||
162972367|NCT03310619|588598030|FG005|Treatment Period|Withdrawal by participant|0|||
162972368|NCT03310619|588598031|FG006|Treatment Period|Withdrawal by participant|0|||
162972369|NCT03310619|588598032|FG007|Treatment Period|Withdrawal by participant|0|||
162972370|NCT03310619|588598025|FG000|Treatment Period|Lost to Follow-up|0|||
162972371|NCT03310619|588598026|FG001|Treatment Period|Lost to Follow-up|0|||
163057170|NCT06125964|588921192|FG001|Overall Study|Lost to Follow-up|1|||
163057171|NCT06125964|588921193|FG002|Overall Study|Lost to Follow-up|0|||
163209520|NCT01324999|589480656|FG000|Overall Study|Withdrawal by Subject|2|||
163209521|NCT01712490|589480657|FG000|Overall Study|Ongoing|601|||
162972372|NCT03310619|588598027|FG002|Treatment Period|Lost to Follow-up|0|||
162972373|NCT03310619|588598028|FG003|Treatment Period|Lost to Follow-up|0|||
163209522|NCT01712490|589480658|FG001|Overall Study|Ongoing|586|||
162972374|NCT03310619|588598029|FG004|Treatment Period|Lost to Follow-up|0|||
162972375|NCT03310619|588598030|FG005|Treatment Period|Lost to Follow-up|0|||
162972376|NCT03310619|588598031|FG006|Treatment Period|Lost to Follow-up|0|||
163209523|NCT01712490|589480657|FG000|Overall Study|Other|11|||
162972377|NCT03310619|588598032|FG007|Treatment Period|Lost to Follow-up|1|||
163057172|NCT06125964|588921194|FG003|Overall Study|Lost to Follow-up|0|||
163057173|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
163209524|NCT01712490|589480658|FG001|Overall Study|Other|11|||
163401327|NCT04353284|590181128|FG000|Overall Study|Lost to Follow-up|1|||
162972378|NCT03310619|588598025|FG000|Treatment Period|Study terminated by sponsor|0|||
162972379|NCT03310619|588598026|FG001|Treatment Period|Study terminated by sponsor|0|||
162972380|NCT03310619|588598027|FG002|Treatment Period|Study terminated by sponsor|0|||
162972381|NCT03310619|588598028|FG003|Treatment Period|Study terminated by sponsor|0|||
162972382|NCT03310619|588598029|FG004|Treatment Period|Study terminated by sponsor|0|||
162972383|NCT03310619|588598030|FG005|Treatment Period|Study terminated by sponsor|0|||
162972384|NCT03310619|588598031|FG006|Treatment Period|Study terminated by sponsor|0|||
162972385|NCT03310619|588598032|FG007|Treatment Period|Study terminated by sponsor|1|||
162972386|NCT03310619|588598025|FG000|Treatment Period|Physician Decision|0|||
162972387|NCT03310619|588598026|FG001|Treatment Period|Physician Decision|0|||
162972388|NCT03310619|588598027|FG002|Treatment Period|Physician Decision|0|||
162972389|NCT03310619|588598028|FG003|Treatment Period|Physician Decision|0|||
162972390|NCT03310619|588598029|FG004|Treatment Period|Physician Decision|3|||
162972391|NCT03310619|588598030|FG005|Treatment Period|Physician Decision|0|||
162972392|NCT03310619|588598031|FG006|Treatment Period|Physician Decision|0|||
162972393|NCT03310619|588598032|FG007|Treatment Period|Physician Decision|0|||
162972394|NCT03310619|588598025|FG000|Treatment Period|Other reasons|1|||
162972395|NCT03310619|588598026|FG001|Treatment Period|Other reasons|0|||
162972396|NCT03310619|588598027|FG002|Treatment Period|Other reasons|2|||
162972397|NCT03310619|588598028|FG003|Treatment Period|Other reasons|0|||
162972398|NCT03310619|588598029|FG004|Treatment Period|Other reasons|0|||
162972399|NCT03310619|588598030|FG005|Treatment Period|Other reasons|0|||
162972400|NCT03310619|588598031|FG006|Treatment Period|Other reasons|0|||
162972401|NCT03310619|588598032|FG007|Treatment Period|Other reasons|0|||
162972402|NCT00152516|588598037|FG000|Overall Study|Adverse Event|18|||
162972403|NCT00152516|588598037|FG000|Overall Study|Lack and Loss of Efficacy|30|||
162972404|NCT00152516|588598037|FG000|Overall Study|Lost to Follow-up|5|||
162972405|NCT00152516|588598037|FG000|Overall Study|Withdrawal by Subject|8|||
162972406|NCT00152516|588598037|FG000|Overall Study|Protocol Violation|3|||
162972407|NCT00152516|588598037|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
162972408|NCT00152516|588598037|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
162972409|NCT00152516|588598037|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
162972410|NCT00152516|588598037|FG000|Overall Study|Other: Non-Compliance|2|||
162972411|NCT00152516|588598037|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
162972412|NCT00152516|588598037|FG000|Overall Study|Other: Moved Out Of State|1|||
162972413|NCT00152516|588598037|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
162972414|NCT00152516|588598037|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
162972415|NCT04660032|588598040|FG000|Overall Study|Protocol Violation|1|||
162972416|NCT04660032|588598041|FG001|Overall Study|Protocol Violation|1|||
162972417|NCT00090753|588598042|FG000|First Treatment Period|Adverse Event|20|||
162972418|NCT00090753|588598043|FG001|First Treatment Period|Adverse Event|8|||
162972419|NCT00090753|588598042|FG000|First Treatment Period|Death|88|||
162972420|NCT00090753|588598043|FG001|First Treatment Period|Death|62|||
162972421|NCT00090753|588598042|FG000|First Treatment Period|Lack of Efficacy|2|||
162972422|NCT00090753|588598043|FG001|First Treatment Period|Lack of Efficacy|1|||
162972423|NCT00090753|588598042|FG000|First Treatment Period|Refused Treatment|32|||
162972424|NCT00090753|588598043|FG001|First Treatment Period|Refused Treatment|25|||
162972425|NCT00090753|588598042|FG000|First Treatment Period|Lost to Follow-up|4|||
162972426|NCT00090753|588598043|FG001|First Treatment Period|Lost to Follow-up|4|||
162972427|NCT00090753|588598042|FG000|First Treatment Period|Renal Transplant|70|||
162972428|NCT00090753|588598043|FG001|First Treatment Period|Renal Transplant|50|||
162972429|NCT00090753|588598042|FG000|First Treatment Period|Mircera Commercialization|1|||
162972430|NCT00090753|588598043|FG001|First Treatment Period|Mircera Commercialization|0|||
162972431|NCT00090753|588598042|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
162972432|NCT00090753|588598043|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
162972433|NCT00090753|588598042|FG000|Extended Treatment Period|Adverse Event|11|||
162972434|NCT00090753|588598043|FG001|Extended Treatment Period|Adverse Event|0|||
162972435|NCT00090753|588598042|FG000|Extended Treatment Period|Death|58|||
162972436|NCT00090753|588598043|FG001|Extended Treatment Period|Death|30|||
162972437|NCT00090753|588598042|FG000|Extended Treatment Period|Lack of Efficacy|1|||
162972438|NCT00090753|588598043|FG001|Extended Treatment Period|Lack of Efficacy|0|||
162972439|NCT00090753|588598042|FG000|Extended Treatment Period|Refused Treatment|18|||
162972440|NCT00090753|588598043|FG001|Extended Treatment Period|Refused Treatment|12|||
162972441|NCT00090753|588598042|FG000|Extended Treatment Period|Lost to Follow-up|3|||
162972442|NCT00090753|588598043|FG001|Extended Treatment Period|Lost to Follow-up|1|||
162972443|NCT00090753|588598042|FG000|Extended Treatment Period|Renal Transplant|15|||
162972444|NCT00090753|588598043|FG001|Extended Treatment Period|Renal Transplant|12|||
162972445|NCT00090753|588598042|FG000|Extended Treatment Period|Mircera Commercialization|188|||
162972446|NCT00090753|588598043|FG001|Extended Treatment Period|Mircera Commercialization|93|||
162972447|NCT00090753|588598042|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
162972448|NCT00090753|588598043|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
162972449|NCT00756717|588598052|FG000|Overall Study|Withdrawal by Subject|2|||
162972450|NCT03573336|588598053|FG000|Overall Study|Study terminated|2|||
162972451|NCT03573336|588598054|FG001|Overall Study|Study terminated|4|||
162972452|NCT03573336|588598055|FG002|Overall Study|Study terminated|2|||
162972453|NCT03108820|588598056|FG000|Overall Study|Lost to Follow-up|30|||
162972454|NCT03108820|588598057|FG001|Overall Study|Lost to Follow-up|28|||
162972455|NCT03108820|588598056|FG000|Overall Study|Withdrawal by Subject|32|||
162972456|NCT03108820|588598057|FG001|Overall Study|Withdrawal by Subject|24|||
162972457|NCT03108820|588598056|FG000|Overall Study|Death|6|||
162972458|NCT03108820|588598057|FG001|Overall Study|Death|11|||
163057174|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
162972459|NCT01488448|588598059|FG000|Overall Study|Withdrawal by Subject|3|||
162972460|NCT01488448|588598060|FG001|Overall Study|Withdrawal by Subject|1|||
162972461|NCT01488448|588598059|FG000|Overall Study|Adverse Event|9|||
162972462|NCT01488448|588598060|FG001|Overall Study|Adverse Event|4|||
162972463|NCT01488448|588598059|FG000|Overall Study|Physician Decision|4|||
162972464|NCT01488448|588598060|FG001|Overall Study|Physician Decision|9|||
162972465|NCT01488448|588598059|FG000|Overall Study|Protocol Violation|4|||
162972466|NCT01488448|588598060|FG001|Overall Study|Protocol Violation|3|||
162972467|NCT01992094|588598061|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
162972468|NCT01992094|588598062|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
162972469|NCT01992094|588598063|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
162972470|NCT01992094|588598061|FG000|Overall Study|Adverse Event|1|||
162972471|NCT01992094|588598062|FG001|Overall Study|Adverse Event|0|||
162972472|NCT01992094|588598063|FG002|Overall Study|Adverse Event|0|||
162972473|NCT01992094|588598061|FG000|Overall Study|Death|5|||
162972474|NCT01992094|588598062|FG001|Overall Study|Death|5|||
162972475|NCT01992094|588598063|FG002|Overall Study|Death|2|||
162972476|NCT01992094|588598061|FG000|Overall Study|Lost to Follow-up|26|||
162972477|NCT01992094|588598062|FG001|Overall Study|Lost to Follow-up|9|||
162972478|NCT01992094|588598063|FG002|Overall Study|Lost to Follow-up|13|||
162972479|NCT01992094|588598061|FG000|Overall Study|OTHER|4|||
162972480|NCT01992094|588598062|FG001|Overall Study|OTHER|0|||
162972481|NCT01992094|588598063|FG002|Overall Study|OTHER|0|||
162972482|NCT01992094|588598061|FG000|Overall Study|Protocol Violation|1|||
162972483|NCT01992094|588598062|FG001|Overall Study|Protocol Violation|0|||
162972484|NCT01992094|588598063|FG002|Overall Study|Protocol Violation|1|||
162972485|NCT01992094|588598061|FG000|Overall Study|Withdrawal by Subject|7|||
162972486|NCT01992094|588598062|FG001|Overall Study|Withdrawal by Subject|3|||
162972487|NCT01992094|588598063|FG002|Overall Study|Withdrawal by Subject|4|||
162972488|NCT01475487|588598064|FG000|Overall Study|had to leave early for personal reasons|2|||
163057175|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
163057176|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Death|1|||
163057177|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Death|1|||
163057178|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Death|0|||
163057179|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
163057180|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
163057181|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
163057182|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
163057183|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
163057184|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
163057185|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
163057186|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
162972489|NCT01475487|588598065|FG001|Overall Study|had to leave early for personal reasons|1|||
162972490|NCT03168906|588598068|FG000|Overall Study|Lack of Efficacy|6|||
162972491|NCT03168906|588598069|FG001|Overall Study|Lack of Efficacy|6|||
162972492|NCT00434590|588598070|FG000|Overall Study|Administrative problems|5|||
162972493|NCT00434590|588598071|FG001|Overall Study|Administrative problems|5|||
162972494|NCT02839798|588599583|FG000|Overall Study|Withdrawal by Subject|2|||
162972495|NCT03180528|588599584|FG000|Overall Study|Adverse Event|1|||
162972496|NCT03180528|588599584|FG000|Overall Study|Withdrawal by Subject|1|||
162972497|NCT03180528|588599584|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
162972498|NCT02447887|588599585|FG000|Overall Study|Study was terminated|3|||
162972499|NCT03429049|588599586|FG000|Overall Study|Adverse Event|2|||
162972500|NCT03429049|588599587|FG001|Overall Study|Adverse Event|3|||
162972501|NCT03429049|588599586|FG000|Overall Study|Death|0|||
162972502|NCT03429049|588599587|FG001|Overall Study|Death|1|||
162972503|NCT03429049|588599586|FG000|Overall Study|Lack of Efficacy|4|||
162972504|NCT03429049|588599587|FG001|Overall Study|Lack of Efficacy|2|||
162972505|NCT03429049|588599586|FG000|Overall Study|Lost to Follow-up|9|||
162972506|NCT03429049|588599587|FG001|Overall Study|Lost to Follow-up|8|||
162972507|NCT03429049|588599586|FG000|Overall Study|Physician Decision|1|||
162972508|NCT03429049|588599587|FG001|Overall Study|Physician Decision|0|||
162972509|NCT03429049|588599586|FG000|Overall Study|Protocol Violation|3|||
162972510|NCT03429049|588599587|FG001|Overall Study|Protocol Violation|0|||
163401328|NCT04353284|590181129|FG001|Overall Study|Lost to Follow-up|0|||
162972511|NCT03429049|588599586|FG000|Overall Study|Sponsor Decision|2|||
162972512|NCT03429049|588599587|FG001|Overall Study|Sponsor Decision|0|||
162972513|NCT03429049|588599586|FG000|Overall Study|Withdrawal by Subject|4|||
162972514|NCT03429049|588599587|FG001|Overall Study|Withdrawal by Subject|20|||
162972515|NCT03429049|588599586|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
162972516|NCT03429049|588599587|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
162972517|NCT04703855|588599588|FG000|Overall Study|Heart Transplant|1|||
162972518|NCT00399893|588599589|FG000|Overall Study|Withdrawal by Subject|1|||
162972519|NCT00399893|588599590|FG001|Overall Study|Withdrawal by Subject|0|||
162972520|NCT04412057|588599591|FG000|Overall Study|Death|3|||
162972521|NCT04412057|588599592|FG001|Overall Study|Death|7|||
162972522|NCT04412057|588599591|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
162972523|NCT04412057|588599592|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
162972524|NCT02457819|588599593|FG000|Overall Study|reason not given|8|||
162972525|NCT02457819|588599593|FG000|Overall Study|Withdrawal by Subject|24|||
162972526|NCT02457819|588599593|FG000|Overall Study|Protocol Violation|1|||
162972527|NCT02457819|588599593|FG000|Overall Study|non compliance with study drug|4|||
162972528|NCT02457819|588599593|FG000|Overall Study|Lost to Follow-up|10|||
162972529|NCT02457819|588599593|FG000|Overall Study|Lack of Efficacy|19|||
162972530|NCT02457819|588599593|FG000|Overall Study|Adverse Event|33|||
162972531|NCT01064531|588599596|FG000|Overall Study|Lost to Follow-up|0|||
162972532|NCT01064531|588599597|FG001|Overall Study|Lost to Follow-up|2|||
162972533|NCT01064531|588599596|FG000|Overall Study|Physician Decision|0|||
162972534|NCT01064531|588599597|FG001|Overall Study|Physician Decision|1|||
162972535|NCT01064531|588599596|FG000|Overall Study|Withdrawal by Subject|2|||
162972536|NCT01064531|588599597|FG001|Overall Study|Withdrawal by Subject|2|||
162972537|NCT01064531|588599596|FG000|Overall Study|Revision due to femoral stem loosening|1|||
162972538|NCT01064531|588599597|FG001|Overall Study|Revision due to femoral stem loosening|0|||
162972539|NCT01064531|588599596|FG000|Overall Study|Revision due to dislocation|0|||
162972540|NCT01064531|588599597|FG001|Overall Study|Revision due to dislocation|1|||
162972541|NCT01064531|588599596|FG000|Overall Study|Death|0|||
162972542|NCT01064531|588599597|FG001|Overall Study|Death|1|||
162972543|NCT03136406|588599601|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
162972544|NCT01201759|588599602|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
162972545|NCT01201759|588599603|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
162972546|NCT01201759|588599602|FG000|Visit 3 - Washout|Adverse Event|0|||
162972547|NCT01201759|588599603|FG001|Visit 3 - Washout|Adverse Event|3|||
162972548|NCT01201759|588599602|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
163401329|NCT01040351|590181130|FG000|Overall Study|poor ovarian response|1|||
162972549|NCT01201759|588599603|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
162972550|NCT01201759|588599602|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
162972551|NCT01201759|588599603|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
162972552|NCT00906373|588599604|FG000|Overall Study|Withdrawal by Subject|0|||
162972553|NCT00906373|588599605|FG001|Overall Study|Withdrawal by Subject|5|||
162972554|NCT00906373|588599604|FG000|Overall Study|Other|0|||
162972555|NCT00906373|588599605|FG001|Overall Study|Other|1|||
162972556|NCT00906373|588599604|FG000|Overall Study|Still on treatment at cutoff date|0|||
162972557|NCT00906373|588599605|FG001|Overall Study|Still on treatment at cutoff date|2|||
162972558|NCT02418455|588599608|FG000|48-Week Treatment Period|Other- Not Specified|1|||
162972559|NCT02418455|588599608|FG000|Continuation Period|Sponsor Decision|7|||
162972560|NCT02001051|588599611|FG000|Overall Study|Deemed not eligible following enrollment|0|||
162972561|NCT02001051|588599612|FG001|Overall Study|Deemed not eligible following enrollment|1|||
163318014|NCT01928394|589874968|FG022|Follow-up Period|Participant withdrew consent|2|||
163318015|NCT01928394|589874946|FG000|Follow-up Period|Death|0|||
162972562|NCT04205162|588599622|FG000|Overall Study|Lost to Follow-up|1|||
162972563|NCT04205162|588599623|FG001|Overall Study|Lost to Follow-up|0|||
162972564|NCT04205162|588599622|FG000|Overall Study|Withdrawal by Subject|2|||
162972565|NCT04205162|588599623|FG001|Overall Study|Withdrawal by Subject|0|||
162972566|NCT04205162|588599622|FG000|Overall Study|University closure due to COVID-19|1|||
162972567|NCT04205162|588599623|FG001|Overall Study|University closure due to COVID-19|0|||
162972568|NCT01999894|588599624|FG000|Overall Study|Adverse Event|9|||
162972569|NCT01999894|588599624|FG000|Overall Study|Lack of Efficacy|5|||
162972570|NCT01999894|588599624|FG000|Overall Study|Protocol Violation|1|||
162972571|NCT01999894|588599624|FG000|Overall Study|Withdrawal by Subject|7|||
162972572|NCT01999894|588599624|FG000|Overall Study|Lost to Follow-up|10|||
162972573|NCT01999894|588599624|FG000|Overall Study|Other Reason|3|||
162972574|NCT01999894|588599624|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
162972575|NCT01546519|588599626|FG000|Overall Study|Adverse Event|0|||
162972576|NCT01546519|588599627|FG001|Overall Study|Adverse Event|0|||
162972577|NCT01546519|588599628|FG002|Overall Study|Adverse Event|1|||
162972578|NCT01546519|588599629|FG003|Overall Study|Adverse Event|1|||
162972579|NCT01546519|588599626|FG000|Overall Study|Death|0|||
162972580|NCT01546519|588599627|FG001|Overall Study|Death|1|||
162972581|NCT01546519|588599628|FG002|Overall Study|Death|3|||
162972582|NCT01546519|588599629|FG003|Overall Study|Death|1|||
162972583|NCT01546519|588599626|FG000|Overall Study|related to disease progression|2|||
162972584|NCT01546519|588599627|FG001|Overall Study|related to disease progression|2|||
162972585|NCT01546519|588599628|FG002|Overall Study|related to disease progression|2|||
162972586|NCT01546519|588599629|FG003|Overall Study|related to disease progression|1|||
162972587|NCT01546519|588599626|FG000|Overall Study|Physician Decision|6|||
162972588|NCT01546519|588599627|FG001|Overall Study|Physician Decision|5|||
162972589|NCT01546519|588599628|FG002|Overall Study|Physician Decision|2|||
162972590|NCT01546519|588599629|FG003|Overall Study|Physician Decision|3|||
162972591|NCT01546519|588599626|FG000|Overall Study|Withdrawal by Subject|1|||
162972592|NCT01546519|588599627|FG001|Overall Study|Withdrawal by Subject|0|||
162972593|NCT01546519|588599628|FG002|Overall Study|Withdrawal by Subject|0|||
162972594|NCT01546519|588599629|FG003|Overall Study|Withdrawal by Subject|0|||
162972595|NCT00779402|588599630|FG000|Treatment Phase 1|Disease Progression|1|||
162972596|NCT00779402|588599631|FG001|Treatment Phase 1|Disease Progression|0|||
162972597|NCT00779402|588599630|FG000|Treatment Phase 1|Adverse Event|2|||
162972598|NCT00779402|588599631|FG001|Treatment Phase 1|Adverse Event|0|||
162972599|NCT00779402|588599630|FG000|Treatment Phase 1|Protocol Violation|1|||
162972600|NCT00779402|588599631|FG001|Treatment Phase 1|Protocol Violation|0|||
162972601|NCT00779402|588599630|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
162972602|NCT00779402|588599631|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
162972603|NCT00779402|588599630|FG000|Treatment Phase 1|Lost to Follow-up|0|||
162972604|NCT00779402|588599631|FG001|Treatment Phase 1|Lost to Follow-up|1|||
162972605|NCT00779402|588599630|FG000|Treatment Phase 1|Death|0|||
162972606|NCT00779402|588599631|FG001|Treatment Phase 1|Death|1|||
162972607|NCT00779402|588599630|FG000|Treatment Phase 1|Intercurrent Illness|1|||
162972608|NCT00779402|588599631|FG001|Treatment Phase 1|Intercurrent Illness|1|||
162972609|NCT00779402|588599630|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
162972610|NCT00779402|588599631|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
162972611|NCT00779402|588599630|FG000|Treatment Phase 1|Other|4|||
162972612|NCT00779402|588599631|FG001|Treatment Phase 1|Other|2|||
162972613|NCT00779402|588599630|FG000|Treatment Phase 1|Closure of Study|3|||
162972614|NCT00779402|588599631|FG001|Treatment Phase 1|Closure of Study|2|||
162972615|NCT00779402|588599630|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
162972616|NCT00779402|588599631|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
162972617|NCT00779402|588599630|FG000|Surveillance Phase|Protocol Violation|0|||
162972618|NCT00779402|588599631|FG001|Surveillance Phase|Protocol Violation|1|||
162972619|NCT00779402|588599630|FG000|Surveillance Phase|Patient refused to continue|22|||
163318016|NCT01928394|589874947|FG001|Follow-up Period|Death|0|||
163318017|NCT01928394|589874948|FG002|Follow-up Period|Death|2|||
163318018|NCT01928394|589874949|FG003|Follow-up Period|Death|6|||
162972620|NCT00779402|588599631|FG001|Surveillance Phase|Patient refused to continue|14|||
162972621|NCT00779402|588599630|FG000|Surveillance Phase|Lost to Follow-up|2|||
162972622|NCT00779402|588599631|FG001|Surveillance Phase|Lost to Follow-up|1|||
162972623|NCT00779402|588599630|FG000|Surveillance Phase|Death|0|||
162972624|NCT00779402|588599631|FG001|Surveillance Phase|Death|1|||
162972625|NCT00779402|588599630|FG000|Surveillance Phase|Intercurrent Illness|2|||
162972626|NCT00779402|588599631|FG001|Surveillance Phase|Intercurrent Illness|0|||
162972627|NCT00779402|588599630|FG000|Surveillance Phase|Other|5|||
162972628|NCT00779402|588599631|FG001|Surveillance Phase|Other|5|||
162972629|NCT00779402|588599630|FG000|Surveillance Phase|Withdrawal by Subject|4|||
163318019|NCT01928394|589874950|FG004|Follow-up Period|Death|0|||
162972630|NCT00779402|588599631|FG001|Surveillance Phase|Withdrawal by Subject|1|||
162972631|NCT00779402|588599630|FG000|Surveillance Phase|Closure of study|5|||
162972632|NCT00779402|588599631|FG001|Surveillance Phase|Closure of study|6|||
163318020|NCT01928394|589874951|FG005|Follow-up Period|Death|6|||
163057187|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
163057188|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
163057189|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
163057190|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
163057191|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
163057192|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
163057193|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
163057194|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
163057195|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
163057196|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
163057197|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
163057198|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
163057199|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
163057200|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
163057201|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
163057202|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
163057203|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Other|10|||
163057204|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Other|4|||
163057205|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Other|0|||
163057206|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
163057207|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
163057208|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
163057209|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
163057210|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
163057211|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
163057212|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
163057213|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
163057214|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
163057215|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
163057216|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
163057217|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
163057218|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
163057219|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
163057220|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
163057221|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
163057222|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
163057223|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
163057224|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Other|2|||
163057225|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Other|3|||
163057226|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Other|0|||
163057227|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
163057228|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
163057229|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
163057230|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Ongoing|86|||
163057231|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Ongoing|96|||
163057232|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Ongoing|0|||
163057233|NCT04006457|588921195|FG000|Main Study Observation Period|Adverse Event|1|||
163057234|NCT04006457|588921196|FG001|Main Study Observation Period|Adverse Event|1|||
163057235|NCT04006457|588921197|FG002|Main Study Observation Period|Adverse Event|0|||
163057236|NCT04006457|588921195|FG000|Main Study Observation Period|Lost to Follow-up|0|||
163057237|NCT04006457|588921196|FG001|Main Study Observation Period|Lost to Follow-up|1|||
163057238|NCT04006457|588921197|FG002|Main Study Observation Period|Lost to Follow-up|0|||
163057239|NCT04006457|588921195|FG000|Main Study Observation Period|Pregnancy|1|||
163057240|NCT04006457|588921196|FG001|Main Study Observation Period|Pregnancy|0|||
163057241|NCT04006457|588921197|FG002|Main Study Observation Period|Pregnancy|0|||
163057242|NCT04006457|588921195|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
163057243|NCT04006457|588921196|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
163057244|NCT04006457|588921197|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
163057245|NCT04006457|588921195|FG000|Main Study Observation Period|Other|8|||
163057246|NCT04006457|588921196|FG001|Main Study Observation Period|Other|16|||
163057247|NCT04006457|588921197|FG002|Main Study Observation Period|Other|0|||
163209525|NCT01712490|589480657|FG000|Overall Study|Withdrawal by Subject|36|||
163057248|NCT04006457|588921195|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
163057249|NCT04006457|588921196|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
163057250|NCT04006457|588921197|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
163209526|NCT01712490|589480658|FG001|Overall Study|Withdrawal by Subject|44|||
163057251|NCT04006457|588921195|FG000|Main Study Observation Period|Ongoing|2|||
162972633|NCT00779402|588599630|FG000|Surveillance Phase|Completed Protocol Visits|3|||
162972634|NCT00779402|588599631|FG001|Surveillance Phase|Completed Protocol Visits|2|||
162972635|NCT00779402|588599630|FG000|Long-term Follow-up|Patient refused to continue|2|||
162972636|NCT00779402|588599631|FG001|Long-term Follow-up|Patient refused to continue|0|||
162972637|NCT00779402|588599630|FG000|Long-term Follow-up|Other|5|||
162972638|NCT00779402|588599631|FG001|Long-term Follow-up|Other|0|||
162972639|NCT00779402|588599630|FG000|Long-term Follow-up|Closure of Study|8|||
162972640|NCT00779402|588599631|FG001|Long-term Follow-up|Closure of Study|4|||
162972641|NCT00779402|588599630|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
162972642|NCT00779402|588599631|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
162972643|NCT01519947|588599632|FG000|Overall Study|Death|0|||
162972644|NCT01519947|588599633|FG001|Overall Study|Death|0|||
162972645|NCT01519947|588599634|FG002|Overall Study|Death|0|||
162972646|NCT01519947|588599635|FG003|Overall Study|Death|1|||
162972647|NCT01519947|588599632|FG000|Overall Study|Protocol Violation|0|||
162972648|NCT01519947|588599633|FG001|Overall Study|Protocol Violation|0|||
162972649|NCT01519947|588599634|FG002|Overall Study|Protocol Violation|2|||
162972650|NCT01519947|588599635|FG003|Overall Study|Protocol Violation|1|||
162972651|NCT01519947|588599632|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
162972652|NCT01519947|588599633|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
162972653|NCT01519947|588599634|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
162972654|NCT01519947|588599635|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
162972655|NCT01519947|588599632|FG000|Overall Study|Development of Anemia|0|||
162972656|NCT01519947|588599633|FG001|Overall Study|Development of Anemia|1|||
162972657|NCT01519947|588599634|FG002|Overall Study|Development of Anemia|0|||
162972658|NCT01519947|588599635|FG003|Overall Study|Development of Anemia|1|||
162972659|NCT01519947|588599632|FG000|Overall Study|Blood Transfusion|0|||
162972660|NCT01519947|588599633|FG001|Overall Study|Blood Transfusion|1|||
162972661|NCT01519947|588599634|FG002|Overall Study|Blood Transfusion|1|||
162972662|NCT01519947|588599635|FG003|Overall Study|Blood Transfusion|0|||
162972663|NCT01519947|588599632|FG000|Overall Study|Withdrawal by Subject|0|||
162972664|NCT01519947|588599633|FG001|Overall Study|Withdrawal by Subject|1|||
162972665|NCT01519947|588599634|FG002|Overall Study|Withdrawal by Subject|0|||
162972666|NCT01519947|588599635|FG003|Overall Study|Withdrawal by Subject|1|||
162972667|NCT01519947|588599632|FG000|Overall Study|Lost to Follow-up|0|||
162972668|NCT01519947|588599633|FG001|Overall Study|Lost to Follow-up|0|||
162972669|NCT01519947|588599634|FG002|Overall Study|Lost to Follow-up|3|||
162972670|NCT01519947|588599635|FG003|Overall Study|Lost to Follow-up|2|||
162972671|NCT01519947|588599632|FG000|Overall Study|Poor Response|1|||
162972672|NCT01519947|588599633|FG001|Overall Study|Poor Response|0|||
162972673|NCT01519947|588599634|FG002|Overall Study|Poor Response|0|||
162972674|NCT01519947|588599635|FG003|Overall Study|Poor Response|1|||
162972675|NCT01519947|588599632|FG000|Overall Study|Adverse Event|1|||
162972676|NCT01519947|588599633|FG001|Overall Study|Adverse Event|0|||
162972677|NCT01519947|588599634|FG002|Overall Study|Adverse Event|1|||
162972678|NCT01519947|588599635|FG003|Overall Study|Adverse Event|1|||
162972679|NCT00693225|588599636|FG000|Overall Study|Lost to Follow-up|1|||
162972680|NCT00693225|588599637|FG001|Overall Study|Lost to Follow-up|2|||
162972681|NCT00693225|588599636|FG000|Overall Study|Adverse Event|1|||
162972682|NCT00693225|588599637|FG001|Overall Study|Adverse Event|3|||
162972683|NCT01186016|588599640|FG000|Overall Study|Withdrawal by Subject|46|||
162972684|NCT01186016|588599641|FG001|Overall Study|Withdrawal by Subject|29|||
162972685|NCT03750695|588599643|FG000|Overall Study|Lost to Follow-up|0|||
162972686|NCT03750695|588599644|FG001|Overall Study|Lost to Follow-up|1|||
162972687|NCT03173560|588599645|FG000|Overall Study|Death|70|||
162972688|NCT03173560|588599646|FG001|Overall Study|Death|60|||
162972689|NCT03173560|588599645|FG000|Overall Study|Lost to Follow-up|1|||
162972690|NCT03173560|588599646|FG001|Overall Study|Lost to Follow-up|4|||
162972691|NCT03173560|588599645|FG000|Overall Study|Withdrawal by Subject|10|||
162972692|NCT03173560|588599646|FG001|Overall Study|Withdrawal by Subject|5|||
162972693|NCT03173560|588599645|FG000|Overall Study|Other|0|||
162972694|NCT03173560|588599646|FG001|Overall Study|Other|1|||
162972695|NCT02174276|588599647|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
162972696|NCT02174276|588599648|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
162972697|NCT02174276|588599649|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
162972698|NCT02174276|588599650|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
162972699|NCT02174276|588599647|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
162972700|NCT02174276|588599648|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
162972701|NCT02174276|588599649|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
162972702|NCT02174276|588599650|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
162972703|NCT02174276|588599647|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
162972704|NCT02174276|588599648|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
162972705|NCT02174276|588599649|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
162972706|NCT02174276|588599650|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
162972707|NCT02174276|588599647|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
162972708|NCT02174276|588599648|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
163209527|NCT01712490|589480657|FG000|Overall Study|Lost to Follow-up|16|||
162972709|NCT02174276|588599649|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
162972710|NCT02174276|588599650|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
162972711|NCT02174276|588599647|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
162972712|NCT02174276|588599648|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
162972713|NCT02174276|588599649|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
162972714|NCT02174276|588599650|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
162972715|NCT02174276|588599647|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
162972716|NCT02174276|588599648|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
162972717|NCT02174276|588599649|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
162972718|NCT02174276|588599650|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
162972719|NCT02661022|588599653|FG000|Overall Study|Withdrawal by Subject|3|||
162972720|NCT02661022|588599654|FG001|Overall Study|Withdrawal by Subject|0|||
162972721|NCT02661022|588599653|FG000|Overall Study|Adverse Event|1|||
162972722|NCT02661022|588599654|FG001|Overall Study|Adverse Event|1|||
162972723|NCT02661022|588599653|FG000|Overall Study|Physician Decision|1|||
162972724|NCT02661022|588599654|FG001|Overall Study|Physician Decision|0|||
162972725|NCT02661022|588599653|FG000|Overall Study|Progressive Disease|2|||
162972726|NCT02661022|588599654|FG001|Overall Study|Progressive Disease|1|||
162972727|NCT00725764|588599656|FG000|Overall Study|Withdrawal by Subject|2|||
162972728|NCT00725764|588599656|FG000|Overall Study|Physician Decision|1|||
162972729|NCT00725764|588599656|FG000|Overall Study|Progressive Disease|7|||
162972730|NCT00725764|588599656|FG000|Overall Study|Lost to Follow-up|1|||
162972731|NCT00725764|588599656|FG000|Overall Study|Death|1|||
162972732|NCT00725764|588599656|FG000|Overall Study|Participant non compliant with protocol|1|||
162972733|NCT00725764|588599656|FG000|Overall Study|Decline in performance status|1|||
162972734|NCT04480307|588599657|FG000|Overall Study|Withdrawal by Subject|0|||
162972735|NCT04480307|588599658|FG001|Overall Study|Withdrawal by Subject|1|||
162972736|NCT04480307|588599659|FG002|Overall Study|Withdrawal by Subject|0|||
162972737|NCT04480307|588599660|FG003|Overall Study|Withdrawal by Subject|0|||
162972738|NCT04480307|588599657|FG000|Overall Study|Adverse Event|0|||
162972739|NCT04480307|588599658|FG001|Overall Study|Adverse Event|0|||
162972740|NCT04480307|588599659|FG002|Overall Study|Adverse Event|0|||
162972741|NCT04480307|588599660|FG003|Overall Study|Adverse Event|1|||
162972742|NCT00609154|588599661|FG000|Overall Study|Protocol Violation|1|||
162972743|NCT00609154|588599662|FG001|Overall Study|Protocol Violation|2|||
162972744|NCT00609154|588599661|FG000|Overall Study|Unable to establish IV access|0|||
162972745|NCT00609154|588599662|FG001|Overall Study|Unable to establish IV access|4|||
162972746|NCT00609154|588599661|FG000|Overall Study|Adverse Event|0|||
162972747|NCT00609154|588599662|FG001|Overall Study|Adverse Event|2|||
162972748|NCT00434837|588599665|FG000|Overall Study|Lost to Follow-up|20|||
162972749|NCT00434837|588599666|FG001|Overall Study|Lost to Follow-up|23|||
162972750|NCT00434837|588599667|FG002|Overall Study|Lost to Follow-up|30|||
162972751|NCT03023137|588599669|FG000|Overall Study|Multiple pregnancy|2|||
162972752|NCT03023137|588599670|FG001|Overall Study|Multiple pregnancy|4|||
162972753|NCT03023137|588599669|FG000|Overall Study|Lost to Follow-up|1|||
162972754|NCT03023137|588599670|FG001|Overall Study|Lost to Follow-up|1|||
162972755|NCT03023137|588599669|FG000|Overall Study|Protocol Violation|0|||
162972756|NCT03023137|588599670|FG001|Overall Study|Protocol Violation|4|||
162972757|NCT03023137|588599669|FG000|Overall Study|Lost the baby in a car accident|1|||
162972758|NCT03023137|588599670|FG001|Overall Study|Lost the baby in a car accident|0|||
162972759|NCT01450800|588599671|FG000|Overall Study|Protocol Violation|1|||
162972760|NCT01450800|588599672|FG001|Overall Study|Protocol Violation|3|||
162972761|NCT00250705|588599681|FG000|Overall Study|Lack of Efficacy|2|||
162972762|NCT00587431|588599682|FG000|Overall Study|Adverse Event|1|||
162972763|NCT00587431|588599683|FG001|Overall Study|Adverse Event|0|||
162972764|NCT00587431|588599682|FG000|Overall Study|Withdrawal by Subject|0|||
162972765|NCT00587431|588599683|FG001|Overall Study|Withdrawal by Subject|1|||
162972766|NCT05467982|588599684|FG000|Overall Study|Death|0|||
162972767|NCT05467982|588599685|FG001|Overall Study|Death|1|||
162972768|NCT05467982|588599684|FG000|Overall Study|Lost to Follow-up|3|||
162972769|NCT05467982|588599685|FG001|Overall Study|Lost to Follow-up|1|||
162972770|NCT03507686|588599694|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
162972771|NCT03507686|588599695|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
162972772|NCT03507686|588599694|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
162972773|NCT03507686|588599695|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
162972774|NCT03507686|588599694|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
162972775|NCT03507686|588599695|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
162972776|NCT03507686|588599694|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
162972777|NCT03507686|588599695|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
162972778|NCT03507686|588599694|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
162972779|NCT03507686|588599695|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
162972780|NCT03507686|588599694|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
162972781|NCT03507686|588599695|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
162972782|NCT00585312|588599696|FG000|Overall Study|Adverse Event|3|||
162972783|NCT00585312|588599697|FG001|Overall Study|Adverse Event|0|||
162972784|NCT00585312|588599696|FG000|Overall Study|Lack of Efficacy|6|||
162972785|NCT00585312|588599697|FG001|Overall Study|Lack of Efficacy|11|||
162972786|NCT00585312|588599696|FG000|Overall Study|Lost to Follow-up|1|||
162972787|NCT00585312|588599697|FG001|Overall Study|Lost to Follow-up|1|||
162972788|NCT00585312|588599696|FG000|Overall Study|Reason not specified|2|||
162972789|NCT00585312|588599697|FG001|Overall Study|Reason not specified|0|||
162972790|NCT00585312|588599696|FG000|Overall Study|Withdrawal by Subject|5|||
162972791|NCT00585312|588599697|FG001|Overall Study|Withdrawal by Subject|1|||
162972792|NCT00585312|588599696|FG000|Overall Study|Study terminated by the sponsor|34|||
162972793|NCT00585312|588599697|FG001|Overall Study|Study terminated by the sponsor|31|||
162972794|NCT01263561|588599698|FG000|Overall Study|Death|1|||
162972795|NCT01263561|588599699|FG001|Overall Study|Death|2|||
162972796|NCT00879684|588599700|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
162972797|NCT00879684|588599701|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
162972798|NCT00879684|588599702|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
162972799|NCT00879684|588599703|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
162972800|NCT00879684|588599704|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
162972801|NCT00879684|588599705|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
162972802|NCT00879684|588599706|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
162972803|NCT00879684|588599700|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
162972804|NCT00879684|588599701|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
162972805|NCT00879684|588599702|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
162972806|NCT00879684|588599703|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
162972807|NCT00879684|588599704|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
162972808|NCT00879684|588599705|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
162972809|NCT00879684|588599706|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
162972810|NCT00879684|588599700|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
162972811|NCT00879684|588599701|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
162972812|NCT00879684|588599702|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
162972813|NCT00879684|588599703|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
162972814|NCT00879684|588599704|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
162972815|NCT00879684|588599705|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
162972816|NCT00879684|588599706|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
162972817|NCT00879684|588599700|FG000|Stage 1: Dose Escalation|Death|0|||
162972818|NCT00879684|588599701|FG001|Stage 1: Dose Escalation|Death|0|||
162972819|NCT00879684|588599702|FG002|Stage 1: Dose Escalation|Death|1|||
162972820|NCT00879684|588599703|FG003|Stage 1: Dose Escalation|Death|0|||
162972821|NCT00879684|588599704|FG004|Stage 1: Dose Escalation|Death|0|||
162972822|NCT00879684|588599705|FG005|Stage 1: Dose Escalation|Death|0|||
162972823|NCT00879684|588599706|FG006|Stage 1: Dose Escalation|Death|0|||
162972824|NCT00879684|588599700|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
162972825|NCT00879684|588599701|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
162972826|NCT00879684|588599702|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
162972827|NCT00879684|588599703|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
162972828|NCT00879684|588599704|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
162972829|NCT00879684|588599705|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
162972830|NCT00879684|588599706|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
162972831|NCT00879684|588599700|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
162972832|NCT00879684|588599701|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
162972833|NCT00879684|588599702|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
162972834|NCT00879684|588599703|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
162972835|NCT00879684|588599704|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
162972836|NCT00879684|588599705|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
162972837|NCT00879684|588599706|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
162972838|NCT00879684|588599700|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
162972839|NCT00879684|588599701|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
162972840|NCT00879684|588599702|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
162972841|NCT00879684|588599703|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
162972842|NCT00879684|588599704|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
162972843|NCT00879684|588599705|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
162972844|NCT00879684|588599706|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
162972845|NCT03185741|588599711|FG000|Baseline|Withdrawal by Subject|1|||
162972846|NCT03185741|588599712|FG001|Baseline|Withdrawal by Subject|3|||
162972847|NCT03185741|588599713|FG002|Baseline|Withdrawal by Subject|2|||
162972848|NCT03185741|588599711|FG000|Baseline|Lost to Follow-up|1|||
163057252|NCT04006457|588921196|FG001|Main Study Observation Period|Ongoing|1|||
163057253|NCT04006457|588921197|FG002|Main Study Observation Period|Ongoing|0|||
162972849|NCT03185741|588599712|FG001|Baseline|Lost to Follow-up|2|||
162972850|NCT03185741|588599713|FG002|Baseline|Lost to Follow-up|3|||
162972851|NCT03185741|588599711|FG000|3Month|Death|1|||
162972852|NCT03185741|588599712|FG001|3Month|Death|1|||
162972853|NCT03185741|588599713|FG002|3Month|Death|2|||
162972854|NCT03185741|588599711|FG000|3Month|Withdrawal by Subject|1|||
163057254|NCT04006457|588921195|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
162972855|NCT03185741|588599712|FG001|3Month|Withdrawal by Subject|5|||
162972856|NCT03185741|588599713|FG002|3Month|Withdrawal by Subject|1|||
162972857|NCT03185741|588599711|FG000|3Month|Lost to Follow-up|7|||
162972858|NCT03185741|588599712|FG001|3Month|Lost to Follow-up|9|||
162972859|NCT03185741|588599713|FG002|3Month|Lost to Follow-up|8|||
162972860|NCT03185741|588599711|FG000|3Month|Unavailable for 3Month|11|||
162972861|NCT03185741|588599712|FG001|3Month|Unavailable for 3Month|10|||
162972862|NCT03185741|588599713|FG002|3Month|Unavailable for 3Month|11|||
162972863|NCT03185741|588599711|FG000|3Month|Protocol Violation|0|||
162972864|NCT03185741|588599712|FG001|3Month|Protocol Violation|0|||
162972865|NCT03185741|588599713|FG002|3Month|Protocol Violation|3|||
162972866|NCT03185741|588599711|FG000|6Month|Death|1|||
162972867|NCT03185741|588599712|FG001|6Month|Death|1|||
162972868|NCT03185741|588599713|FG002|6Month|Death|2|||
162972869|NCT03185741|588599711|FG000|6Month|Withdrawal by Subject|2|||
162972870|NCT03185741|588599712|FG001|6Month|Withdrawal by Subject|3|||
162972871|NCT03185741|588599713|FG002|6Month|Withdrawal by Subject|1|||
162972872|NCT03185741|588599711|FG000|6Month|Lost to Follow-up|16|||
162972873|NCT03185741|588599712|FG001|6Month|Lost to Follow-up|15|||
162972874|NCT03185741|588599713|FG002|6Month|Lost to Follow-up|16|||
162972875|NCT00654641|588599720|FG000|Overall Study|Lost to Follow-up|2|||
162972876|NCT00654641|588599721|FG001|Overall Study|Lost to Follow-up|3|||
162972877|NCT01214239|588599722|FG000|Overall Study|Adverse Event|3|||
162972878|NCT01214239|588599723|FG001|Overall Study|Adverse Event|4|||
162972879|NCT01214239|588599722|FG000|Overall Study|Protocol Violation|2|||
162972880|NCT01214239|588599723|FG001|Overall Study|Protocol Violation|1|||
162972881|NCT01214239|588599722|FG000|Overall Study|Lost to Follow-up|1|||
162972882|NCT01214239|588599723|FG001|Overall Study|Lost to Follow-up|1|||
162972883|NCT01214239|588599722|FG000|Overall Study|Withdrawal by Subject|4|||
162972884|NCT01214239|588599723|FG001|Overall Study|Withdrawal by Subject|9|||
162972885|NCT01214239|588599722|FG000|Overall Study|Lack of Efficacy|1|||
162972886|NCT01214239|588599723|FG001|Overall Study|Lack of Efficacy|2|||
162972887|NCT01214239|588599722|FG000|Overall Study|patient's private reason|1|||
162972888|NCT01214239|588599723|FG001|Overall Study|patient's private reason|1|||
162972889|NCT00810602|588599724|FG000|Overall Study|Withdrawal by Subject|8|||
162972890|NCT00810602|588599725|FG001|Overall Study|Withdrawal by Subject|3|||
162972891|NCT03840382|588599726|FG000|Overall Study|Lost to Follow-up|11|||
162972892|NCT01142661|588599727|FG000|Overall Study|Adverse Event|2|||
162972893|NCT01142661|588599727|FG000|Overall Study|Withdrawal by Subject|1|||
162972894|NCT01142661|588599727|FG000|Overall Study|Physician Decision|1|||
162972895|NCT00965731|588599730|FG000|Overall Study|Death|0|||
162972896|NCT00965731|588599731|FG001|Overall Study|Death|4|||
162972897|NCT00965731|588599730|FG000|Overall Study|Withdrawal by Subject|0|||
162972898|NCT00965731|588599731|FG001|Overall Study|Withdrawal by Subject|1|||
162972899|NCT00965731|588599730|FG000|Overall Study|Other|7|||
162972900|NCT00965731|588599731|FG001|Overall Study|Other|15|||
162972901|NCT04773600|588599732|FG000|Overall Study|Withdrawal by Subject|15|||
162972902|NCT04773600|588599733|FG001|Overall Study|Withdrawal by Subject|9|||
162972903|NCT04773600|588599732|FG000|Overall Study|Lost to Follow-up|10|||
162972904|NCT04773600|588599733|FG001|Overall Study|Lost to Follow-up|6|||
162972905|NCT04773600|588599732|FG000|Overall Study|Adverse Event|8|||
162972906|NCT04773600|588599733|FG001|Overall Study|Adverse Event|2|||
162972907|NCT04773600|588599732|FG000|Overall Study|Lack of Efficacy|2|||
162972908|NCT04773600|588599733|FG001|Overall Study|Lack of Efficacy|3|||
162972909|NCT04773600|588599732|FG000|Overall Study|Noncompliance|2|||
162972910|NCT04773600|588599733|FG001|Overall Study|Noncompliance|0|||
162972911|NCT04773600|588599732|FG000|Overall Study|Protocol Violation|2|||
162972912|NCT04773600|588599733|FG001|Overall Study|Protocol Violation|0|||
162972913|NCT04773600|588599732|FG000|Overall Study|Physician Decision|0|||
162972914|NCT04773600|588599733|FG001|Overall Study|Physician Decision|1|||
162972915|NCT04773600|588599732|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
162972916|NCT04773600|588599733|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
162972917|NCT04773600|588599732|FG000|Overall Study|Emergency Travel Out of Country|1|||
162972918|NCT04773600|588599733|FG001|Overall Study|Emergency Travel Out of Country|0|||
162972919|NCT01923311|588601578|FG000|Overall Study|Pregnancy|1|||
162972920|NCT01923311|588601579|FG001|Overall Study|Pregnancy|0|||
162972921|NCT01923311|588601578|FG000|Overall Study|Investigator's Discretion|1|||
162972922|NCT01923311|588601579|FG001|Overall Study|Investigator's Discretion|0|||
162972923|NCT01923311|588601578|FG000|Overall Study|Non-Compliance with Study Drug|2|||
162972924|NCT01923311|588601579|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162972925|NCT01923311|588601578|FG000|Overall Study|Withdrew Consent|1|||
162972926|NCT01923311|588601579|FG001|Overall Study|Withdrew Consent|0|||
162972927|NCT01923311|588601578|FG000|Overall Study|Study Terminated by Sponsor|12|||
162972928|NCT01923311|588601579|FG001|Overall Study|Study Terminated by Sponsor|0|||
162972929|NCT04129944|588601582|FG000|Overall Study|Death|0|||
162972930|NCT04129944|588601583|FG001|Overall Study|Death|0|||
162972931|NCT04129944|588601584|FG002|Overall Study|Death|0|||
162972932|NCT04129944|588601585|FG003|Overall Study|Death|1|||
162972933|NCT04129944|588601582|FG000|Overall Study|Lost to Follow-up|1|||
162972934|NCT04129944|588601583|FG001|Overall Study|Lost to Follow-up|0|||
162972935|NCT04129944|588601584|FG002|Overall Study|Lost to Follow-up|0|||
163209528|NCT01712490|589480658|FG001|Overall Study|Lost to Follow-up|29|||
163209529|NCT01714635|589480671|FG000|Overall Study|Discontinued|1|||
163209530|NCT01714635|589480672|FG001|Overall Study|Discontinued|0|||
163209531|NCT01714635|589480673|FG002|Overall Study|Discontinued|2|||
163209532|NCT01714635|589480671|FG000|Overall Study|Missed 6-month exam|1|||
163209533|NCT01714635|589480672|FG001|Overall Study|Missed 6-month exam|0|||
163209534|NCT01714635|589480673|FG002|Overall Study|Missed 6-month exam|0|||
163209535|NCT02860169|589480674|FG000|Part A|Withdrawal by Subject|1|||
162972936|NCT04129944|588601585|FG003|Overall Study|Lost to Follow-up|0|||
163057255|NCT04006457|588921196|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
163057256|NCT04006457|588921197|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
163057257|NCT03370172|588921198|FG000|Overall Study|Withdrawal by Subject|0|||
163057258|NCT03370172|588921199|FG001|Overall Study|Withdrawal by Subject|1|||
163057259|NCT05918055|588921200|FG000|Phase I - Dose Level 1|Ineligible|0|||
163057260|NCT05918055|588921201|FG001|Phase I - Dose Level 1|Ineligible|0|||
163057261|NCT05918055|588921202|FG002|Phase I - Dose Level 1|Ineligible|1|||
163057262|NCT05918055|588921200|FG000|Phase I - Dose Level -1|Physician Decision|1|||
163057263|NCT05918055|588921201|FG001|Phase I - Dose Level -1|Physician Decision|0|||
163057264|NCT05918055|588921202|FG002|Phase I - Dose Level -1|Physician Decision|0|||
163057265|NCT02194465|588921203|FG000|Overall Study|Adverse Event|6|||
163057266|NCT02194465|588921204|FG001|Overall Study|Adverse Event|1|||
162972937|NCT04129944|588601582|FG000|Overall Study|Withdrawal by Subject|1|||
162972938|NCT04129944|588601583|FG001|Overall Study|Withdrawal by Subject|0|||
162972939|NCT04129944|588601584|FG002|Overall Study|Withdrawal by Subject|1|||
162972940|NCT04129944|588601585|FG003|Overall Study|Withdrawal by Subject|2|||
162972941|NCT01560819|588601586|FG000|Overall Study|Physician Decision|1|||
162972942|NCT01560819|588601587|FG001|Overall Study|Physician Decision|0|||
162972943|NCT02012452|588601590|FG000|Overall Study|Lost to Follow-up|2|||
162972944|NCT02012452|588601591|FG001|Overall Study|Lost to Follow-up|1|||
162972945|NCT02012452|588601590|FG000|Overall Study|Withdrawal by Subject|4|||
162972946|NCT02012452|588601591|FG001|Overall Study|Withdrawal by Subject|0|||
162972947|NCT04403399|588601592|FG000|Period 2|Physician Decision|0|||
162972948|NCT04403399|588601593|FG001|Period 2|Physician Decision|1|||
162972949|NCT00831233|588601596|FG000|Overall Study|Adverse Event|0|||
162972950|NCT00831233|588601597|FG001|Overall Study|Adverse Event|1|||
162972951|NCT00831233|588601596|FG000|Overall Study|Protocol Violation|1|||
162972952|NCT00831233|588601597|FG001|Overall Study|Protocol Violation|0|||
162972953|NCT00831233|588601596|FG000|Overall Study|Selection Criteria Not Met|2|||
162972954|NCT00831233|588601597|FG001|Overall Study|Selection Criteria Not Met|0|||
162972955|NCT00991510|588601598|FG000|Period I (Days 1-14)|Adverse Event|1|||
162972956|NCT00991510|588601599|FG001|Period I (Days 1-14)|Adverse Event|0|||
162972957|NCT00991510|588601598|FG000|Period III (Days 29-112)|Adverse Event|1|||
162972958|NCT00991510|588601599|FG001|Period III (Days 29-112)|Adverse Event|1|||
163057267|NCT02194465|588921205|FG002|Overall Study|Adverse Event|4|||
163057268|NCT02194465|588921206|FG003|Overall Study|Adverse Event|4|||
163057269|NCT02194465|588921207|FG004|Overall Study|Adverse Event|4|||
163057270|NCT02194465|588921208|FG005|Overall Study|Adverse Event|2|||
163057271|NCT02194465|588921209|FG006|Overall Study|Adverse Event|0|||
163057272|NCT02194465|588921203|FG000|Overall Study|Lost to Follow-up|0|||
163057273|NCT02194465|588921204|FG001|Overall Study|Lost to Follow-up|0|||
163057274|NCT02194465|588921205|FG002|Overall Study|Lost to Follow-up|0|||
162972959|NCT03710590|588601600|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
162972960|NCT03710590|588601601|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
162972961|NCT02488824|588601602|FG000|Overall Study|Adverse Event|1|||
162972962|NCT02488824|588601603|FG001|Overall Study|Adverse Event|1|||
162972963|NCT01976728|588601604|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
162972964|NCT01976728|588601605|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
162972965|NCT01976728|588601606|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
162972966|NCT01976728|588601607|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
162972967|NCT02356211|588601608|FG000|Overall Study|Withdrawal by Subject|2|||
162972968|NCT02356211|588601609|FG001|Overall Study|Withdrawal by Subject|2|||
162972969|NCT02356211|588601608|FG000|Overall Study|ineligible|1|||
162972970|NCT02356211|588601609|FG001|Overall Study|ineligible|8|||
162972971|NCT01563237|588601611|FG000|Overall Study|Lost to Follow-up|6|||
162972972|NCT01563237|588601612|FG001|Overall Study|Lost to Follow-up|0|||
163057275|NCT02194465|588921206|FG003|Overall Study|Lost to Follow-up|1|||
163057276|NCT02194465|588921207|FG004|Overall Study|Lost to Follow-up|0|||
163209536|NCT02860169|589480674|FG000|Part A|Other (Screening failure)|6|||
163057277|NCT02194465|588921208|FG005|Overall Study|Lost to Follow-up|1|||
162972973|NCT01563237|588601611|FG000|Overall Study|Withdrawal by Subject|1|||
162972974|NCT01563237|588601612|FG001|Overall Study|Withdrawal by Subject|0|||
163057278|NCT02194465|588921209|FG006|Overall Study|Lost to Follow-up|0|||
163057279|NCT02194465|588921203|FG000|Overall Study|Physician Decision|1|||
163057280|NCT02194465|588921204|FG001|Overall Study|Physician Decision|0|||
163057281|NCT02194465|588921205|FG002|Overall Study|Physician Decision|0|||
163057282|NCT02194465|588921206|FG003|Overall Study|Physician Decision|0|||
163209537|NCT02860169|589480674|FG000|Part A|Other (Survey not completed)|3|||
163318021|NCT01928394|589874952|FG006|Follow-up Period|Death|6|||
162972975|NCT01563237|588601611|FG000|Overall Study|Adverse Event|1|||
162972976|NCT01563237|588601612|FG001|Overall Study|Adverse Event|0|||
162972977|NCT01563237|588601611|FG000|Overall Study|Medical Reasons|1|||
162972978|NCT01563237|588601612|FG001|Overall Study|Medical Reasons|0|||
162972979|NCT01563237|588601611|FG000|Overall Study|Death|1|||
162972980|NCT01563237|588601612|FG001|Overall Study|Death|0|||
162972981|NCT02211014|588601613|FG000|Overall Study|Adverse Event|0|||
162972982|NCT02211014|588601614|FG001|Overall Study|Adverse Event|2|||
162972983|NCT02211014|588601613|FG000|Overall Study|Physician Decision|1|||
162972984|NCT02211014|588601614|FG001|Overall Study|Physician Decision|2|||
162972985|NCT02211014|588601613|FG000|Overall Study|Started another cancer therapy|1|||
162972986|NCT02211014|588601614|FG001|Overall Study|Started another cancer therapy|0|||
162972987|NCT02211014|588601613|FG000|Overall Study|Withdrawal by Subject|0|||
162972988|NCT02211014|588601614|FG001|Overall Study|Withdrawal by Subject|1|||
162972989|NCT02211014|588601613|FG000|Overall Study|In agreement with patient, no benefit|0|||
162972990|NCT02211014|588601614|FG001|Overall Study|In agreement with patient, no benefit|1|||
162972991|NCT03180801|588601616|FG000|Overall Study|Physician Decision|3|||
162972992|NCT03180801|588601617|FG001|Overall Study|Physician Decision|3|||
162972993|NCT03180801|588601618|FG002|Overall Study|Physician Decision|1|||
162972994|NCT03180801|588601616|FG000|Overall Study|Non-compliance|1|||
162972995|NCT03180801|588601617|FG001|Overall Study|Non-compliance|4|||
162972996|NCT03180801|588601618|FG002|Overall Study|Non-compliance|0|||
162972997|NCT03180801|588601616|FG000|Overall Study|Inoculation Target Reached|1|||
162972998|NCT03180801|588601617|FG001|Overall Study|Inoculation Target Reached|1|||
162972999|NCT03180801|588601618|FG002|Overall Study|Inoculation Target Reached|3|||
162973000|NCT03180801|588601616|FG000|Overall Study|Adverse Event|1|||
162973001|NCT03180801|588601617|FG001|Overall Study|Adverse Event|0|||
162973002|NCT03180801|588601618|FG002|Overall Study|Adverse Event|2|||
162973003|NCT03180801|588601616|FG000|Overall Study|Withdrawal by Subject|2|||
162973004|NCT03180801|588601617|FG001|Overall Study|Withdrawal by Subject|2|||
162973005|NCT03180801|588601618|FG002|Overall Study|Withdrawal by Subject|1|||
162973006|NCT03180801|588601616|FG000|Overall Study|Lost to Follow-up|0|||
162973007|NCT03180801|588601617|FG001|Overall Study|Lost to Follow-up|2|||
162973008|NCT03180801|588601618|FG002|Overall Study|Lost to Follow-up|3|||
162973009|NCT00573170|588601621|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
162973010|NCT00573170|588601622|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
162973011|NCT00573170|588601623|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
162973012|NCT00573170|588601624|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
162973013|NCT00573170|588601625|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
162973014|NCT00573170|588601626|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
162973015|NCT00573170|588601621|FG000|First Washout Period|Adverse Event|1|||
162973016|NCT00573170|588601622|FG001|First Washout Period|Adverse Event|1|||
162973017|NCT00573170|588601623|FG002|First Washout Period|Adverse Event|0|||
162973018|NCT00573170|588601624|FG003|First Washout Period|Adverse Event|0|||
162973019|NCT00573170|588601625|FG004|First Washout Period|Adverse Event|0|||
162973020|NCT00573170|588601626|FG005|First Washout Period|Adverse Event|1|||
162973021|NCT00573170|588601621|FG000|First Washout Period|Lack of Efficacy|0|||
162973022|NCT00573170|588601622|FG001|First Washout Period|Lack of Efficacy|0|||
162973023|NCT00573170|588601623|FG002|First Washout Period|Lack of Efficacy|0|||
162973024|NCT00573170|588601624|FG003|First Washout Period|Lack of Efficacy|0|||
162973025|NCT00573170|588601625|FG004|First Washout Period|Lack of Efficacy|0|||
162973026|NCT00573170|588601626|FG005|First Washout Period|Lack of Efficacy|1|||
162973027|NCT00573170|588601621|FG000|First Washout Period|Lost to Follow-up|1|||
162973028|NCT00573170|588601622|FG001|First Washout Period|Lost to Follow-up|1|||
162973029|NCT00573170|588601623|FG002|First Washout Period|Lost to Follow-up|0|||
162973030|NCT00573170|588601624|FG003|First Washout Period|Lost to Follow-up|2|||
162973031|NCT00573170|588601625|FG004|First Washout Period|Lost to Follow-up|0|||
162973032|NCT00573170|588601626|FG005|First Washout Period|Lost to Follow-up|2|||
162973033|NCT00573170|588601621|FG000|First Washout Period|Withdrawal by Subject|2|||
162973034|NCT00573170|588601622|FG001|First Washout Period|Withdrawal by Subject|0|||
162973035|NCT00573170|588601623|FG002|First Washout Period|Withdrawal by Subject|0|||
162973036|NCT00573170|588601624|FG003|First Washout Period|Withdrawal by Subject|2|||
162973037|NCT00573170|588601625|FG004|First Washout Period|Withdrawal by Subject|3|||
162973038|NCT00573170|588601626|FG005|First Washout Period|Withdrawal by Subject|3|||
162973039|NCT00573170|588601621|FG000|First Washout Period|Other|4|||
162973040|NCT00573170|588601622|FG001|First Washout Period|Other|0|||
162973041|NCT00573170|588601623|FG002|First Washout Period|Other|1|||
162973042|NCT00573170|588601624|FG003|First Washout Period|Other|1|||
162973043|NCT00573170|588601625|FG004|First Washout Period|Other|0|||
162973044|NCT00573170|588601626|FG005|First Washout Period|Other|0|||
162973045|NCT00573170|588601621|FG000|Second Washout Period|Adverse Event|1|||
162973046|NCT00573170|588601622|FG001|Second Washout Period|Adverse Event|0|||
162973047|NCT00573170|588601623|FG002|Second Washout Period|Adverse Event|0|||
162973048|NCT00573170|588601624|FG003|Second Washout Period|Adverse Event|0|||
162973049|NCT00573170|588601625|FG004|Second Washout Period|Adverse Event|1|||
163057283|NCT02194465|588921207|FG004|Overall Study|Physician Decision|0|||
163057284|NCT02194465|588921208|FG005|Overall Study|Physician Decision|0|||
163057285|NCT02194465|588921209|FG006|Overall Study|Physician Decision|0|||
163057286|NCT02194465|588921203|FG000|Overall Study|Protocol Violation|1|||
163057287|NCT02194465|588921204|FG001|Overall Study|Protocol Violation|1|||
163057288|NCT02194465|588921205|FG002|Overall Study|Protocol Violation|2|||
163057289|NCT02194465|588921206|FG003|Overall Study|Protocol Violation|1|||
163057290|NCT02194465|588921207|FG004|Overall Study|Protocol Violation|1|||
163209538|NCT02860169|589480674|FG000|Part A|Other (did not completed consent)|1|||
162973050|NCT00573170|588601626|FG005|Second Washout Period|Adverse Event|0|||
162973051|NCT00573170|588601621|FG000|Second Washout Period|Protocol Violation|2|||
162973052|NCT00573170|588601622|FG001|Second Washout Period|Protocol Violation|1|||
162973053|NCT00573170|588601623|FG002|Second Washout Period|Protocol Violation|1|||
162973054|NCT00573170|588601624|FG003|Second Washout Period|Protocol Violation|0|||
162973055|NCT00573170|588601625|FG004|Second Washout Period|Protocol Violation|0|||
162973056|NCT00573170|588601626|FG005|Second Washout Period|Protocol Violation|0|||
162973057|NCT00573170|588601621|FG000|Second Washout Period|Withdrawal by Subject|1|||
162973058|NCT00573170|588601622|FG001|Second Washout Period|Withdrawal by Subject|1|||
162973059|NCT00573170|588601623|FG002|Second Washout Period|Withdrawal by Subject|2|||
162973060|NCT00573170|588601624|FG003|Second Washout Period|Withdrawal by Subject|0|||
162973061|NCT00573170|588601625|FG004|Second Washout Period|Withdrawal by Subject|1|||
162973062|NCT00573170|588601626|FG005|Second Washout Period|Withdrawal by Subject|0|||
162973063|NCT00573170|588601621|FG000|Second Washout Period|Lost to Follow-up|0|||
162973064|NCT00573170|588601622|FG001|Second Washout Period|Lost to Follow-up|0|||
162973065|NCT00573170|588601623|FG002|Second Washout Period|Lost to Follow-up|0|||
162973066|NCT00573170|588601624|FG003|Second Washout Period|Lost to Follow-up|1|||
162973067|NCT00573170|588601625|FG004|Second Washout Period|Lost to Follow-up|0|||
162973068|NCT00573170|588601626|FG005|Second Washout Period|Lost to Follow-up|0|||
162973069|NCT00573170|588601621|FG000|Second Washout Period|Other|1|||
162973070|NCT00573170|588601622|FG001|Second Washout Period|Other|2|||
162973071|NCT00573170|588601623|FG002|Second Washout Period|Other|1|||
162973072|NCT00573170|588601624|FG003|Second Washout Period|Other|4|||
162973073|NCT00573170|588601625|FG004|Second Washout Period|Other|6|||
162973074|NCT00573170|588601626|FG005|Second Washout Period|Other|2|||
162973075|NCT00573170|588601621|FG000|Third Treatment Period|Withdrawal by Subject|1|||
162973076|NCT00573170|588601622|FG001|Third Treatment Period|Withdrawal by Subject|0|||
162973077|NCT00573170|588601623|FG002|Third Treatment Period|Withdrawal by Subject|0|||
162973078|NCT00573170|588601624|FG003|Third Treatment Period|Withdrawal by Subject|0|||
162973079|NCT00573170|588601625|FG004|Third Treatment Period|Withdrawal by Subject|0|||
162973080|NCT00573170|588601626|FG005|Third Treatment Period|Withdrawal by Subject|0|||
162973081|NCT00573170|588601621|FG000|Third Treatment Period|Lost to Follow-up|0|||
162973082|NCT00573170|588601622|FG001|Third Treatment Period|Lost to Follow-up|0|||
162973083|NCT00573170|588601623|FG002|Third Treatment Period|Lost to Follow-up|0|||
162973084|NCT00573170|588601624|FG003|Third Treatment Period|Lost to Follow-up|0|||
162973085|NCT00573170|588601625|FG004|Third Treatment Period|Lost to Follow-up|0|||
162973086|NCT00573170|588601626|FG005|Third Treatment Period|Lost to Follow-up|2|||
162973087|NCT05966090|588601627|FG000|Overall Study|Lost to Follow-up|6|||
162973088|NCT05966090|588601628|FG001|Overall Study|Lost to Follow-up|6|||
162973089|NCT05966090|588601627|FG000|Overall Study|Adverse Event|1|||
162973090|NCT05966090|588601628|FG001|Overall Study|Adverse Event|1|||
162973091|NCT05966090|588601627|FG000|Overall Study|Withdrawal by Subject|1|||
162973092|NCT05966090|588601628|FG001|Overall Study|Withdrawal by Subject|1|||
162973093|NCT05966090|588601627|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
162973094|NCT05966090|588601628|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
162973095|NCT05966090|588601627|FG000|Overall Study|Other|1|||
162973096|NCT05966090|588601628|FG001|Overall Study|Other|1|||
162973097|NCT03585959|588601635|FG000|Overall Study|Physician Decision|1|||
162973098|NCT03585959|588601635|FG000|Overall Study|Unsuccessful Procedure|2|||
162973099|NCT01386125|588601637|FG000|Overall Study|Lost to Follow-up|3|||
162973100|NCT01386125|588601638|FG001|Overall Study|Lost to Follow-up|9|||
162973101|NCT01386125|588601637|FG000|Overall Study|Physician Decision|0|||
162973102|NCT01386125|588601638|FG001|Overall Study|Physician Decision|1|||
162973103|NCT01386125|588601637|FG000|Overall Study|Protocol Violation|5|||
162973104|NCT01386125|588601638|FG001|Overall Study|Protocol Violation|7|||
162973105|NCT01386125|588601637|FG000|Overall Study|Disease Progress|1|||
162973106|NCT01386125|588601638|FG001|Overall Study|Disease Progress|2|||
163057291|NCT02194465|588921208|FG005|Overall Study|Protocol Violation|0|||
163057292|NCT02194465|588921209|FG006|Overall Study|Protocol Violation|0|||
163057293|NCT02194465|588921203|FG000|Overall Study|Withdrawal by Subject|1|||
163057294|NCT02194465|588921204|FG001|Overall Study|Withdrawal by Subject|3|||
162973107|NCT01386125|588601637|FG000|Overall Study|Withdrawal by Subject|13|||
162973108|NCT01386125|588601638|FG001|Overall Study|Withdrawal by Subject|12|||
162973109|NCT01386125|588601637|FG000|Overall Study|Adverse Event|2|||
162973110|NCT01386125|588601638|FG001|Overall Study|Adverse Event|5|||
162973111|NCT01386125|588601637|FG000|Overall Study|Lack of Efficacy|0|||
162973112|NCT01386125|588601638|FG001|Overall Study|Lack of Efficacy|1|||
162973113|NCT01386125|588601637|FG000|Overall Study|Participant Leaving Country|1|||
162973114|NCT01386125|588601638|FG001|Overall Study|Participant Leaving Country|0|||
162973115|NCT01098539|588601639|FG000|Overall Study|Adverse Event|26|||
163057295|NCT02194465|588921205|FG002|Overall Study|Withdrawal by Subject|1|||
162973116|NCT01098539|588601640|FG001|Overall Study|Adverse Event|26|||
162973117|NCT01098539|588601639|FG000|Overall Study|Protocol Violation|1|||
162973118|NCT01098539|588601640|FG001|Overall Study|Protocol Violation|4|||
162973119|NCT01098539|588601639|FG000|Overall Study|Noncompliance|3|||
162973120|NCT01098539|588601640|FG001|Overall Study|Noncompliance|5|||
163057296|NCT02194465|588921206|FG003|Overall Study|Withdrawal by Subject|2|||
162973121|NCT01098539|588601639|FG000|Overall Study|Lost to Follow-up|4|||
162973122|NCT01098539|588601640|FG001|Overall Study|Lost to Follow-up|4|||
162973123|NCT01098539|588601639|FG000|Overall Study|Withdrawal by Subject|12|||
162973124|NCT01098539|588601640|FG001|Overall Study|Withdrawal by Subject|26|||
162973125|NCT01098539|588601639|FG000|Overall Study|Physician Decision|5|||
162973126|NCT01098539|588601640|FG001|Overall Study|Physician Decision|3|||
162973127|NCT03843125|588601641|FG000|Overall Study|Adverse Event|17|||
162973128|NCT03843125|588601642|FG001|Overall Study|Adverse Event|13|||
162973129|NCT03843125|588601643|FG002|Overall Study|Adverse Event|5|||
162973130|NCT03843125|588601644|FG003|Overall Study|Adverse Event|9|||
162973131|NCT03843125|588601641|FG000|Overall Study|Death|0|||
162973132|NCT03843125|588601642|FG001|Overall Study|Death|6|||
162973133|NCT03843125|588601643|FG002|Overall Study|Death|2|||
162973134|NCT03843125|588601644|FG003|Overall Study|Death|0|||
162973135|NCT03843125|588601641|FG000|Overall Study|Lack of Efficacy|14|||
162973136|NCT03843125|588601642|FG001|Overall Study|Lack of Efficacy|11|||
162973137|NCT03843125|588601643|FG002|Overall Study|Lack of Efficacy|9|||
162973138|NCT03843125|588601644|FG003|Overall Study|Lack of Efficacy|4|||
162973139|NCT03843125|588601641|FG000|Overall Study|Lost to Follow-up|3|||
162973140|NCT03843125|588601642|FG001|Overall Study|Lost to Follow-up|4|||
162973141|NCT03843125|588601643|FG002|Overall Study|Lost to Follow-up|0|||
162973142|NCT03843125|588601644|FG003|Overall Study|Lost to Follow-up|2|||
162973143|NCT03843125|588601641|FG000|Overall Study|Other|12|||
162973144|NCT03843125|588601642|FG001|Overall Study|Other|14|||
162973145|NCT03843125|588601643|FG002|Overall Study|Other|3|||
162973146|NCT03843125|588601644|FG003|Overall Study|Other|4|||
162973147|NCT03843125|588601641|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
162973148|NCT03843125|588601642|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
162973149|NCT03843125|588601643|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
162973150|NCT03843125|588601644|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
162973151|NCT03843125|588601641|FG000|Overall Study|Study Terminated by Sponsor|318|||
162973152|NCT03843125|588601642|FG001|Overall Study|Study Terminated by Sponsor|318|||
162973153|NCT03843125|588601643|FG002|Overall Study|Study Terminated by Sponsor|163|||
162973154|NCT03843125|588601644|FG003|Overall Study|Study Terminated by Sponsor|163|||
162973155|NCT03843125|588601641|FG000|Overall Study|Withdrawal by Subject|23|||
162973156|NCT03843125|588601642|FG001|Overall Study|Withdrawal by Subject|12|||
162973157|NCT03843125|588601643|FG002|Overall Study|Withdrawal by Subject|6|||
162973158|NCT03843125|588601644|FG003|Overall Study|Withdrawal by Subject|9|||
162973159|NCT03843125|588601641|FG000|Overall Study|Missing data|0|||
162973160|NCT03843125|588601642|FG001|Overall Study|Missing data|1|||
162973161|NCT03843125|588601643|FG002|Overall Study|Missing data|1|||
162973162|NCT03843125|588601644|FG003|Overall Study|Missing data|0|||
162973163|NCT01292837|588601645|FG000|Overall Study|Adverse Event|1|||
162973164|NCT01292837|588601645|FG000|Overall Study|Further treatment determined|1|||
162973165|NCT02359864|588601646|FG000|Overall Study|Withdrawal by Subject|1|||
162973166|NCT02359864|588601647|FG001|Overall Study|Withdrawal by Subject|0|||
162973167|NCT00515216|588601651|FG000|Overall Study|Withdrawal by Subject|1|||
162973168|NCT00732160|588601661|FG000|Overall Study|Adverse Event|1|||
162973169|NCT00732160|588601662|FG001|Overall Study|Adverse Event|0|||
162973170|NCT00732160|588601663|FG002|Overall Study|Adverse Event|1|||
162973171|NCT00732160|588601664|FG003|Overall Study|Adverse Event|1|||
162973172|NCT00732160|588601661|FG000|Overall Study|scheduling|4|||
162973173|NCT00732160|588601662|FG001|Overall Study|scheduling|4|||
162973174|NCT00732160|588601663|FG002|Overall Study|scheduling|2|||
162973175|NCT00732160|588601664|FG003|Overall Study|scheduling|1|||
162973176|NCT02427399|588601667|FG000|Overall Study|Protocol Violation|14|||
162973177|NCT02427399|588601668|FG001|Overall Study|Protocol Violation|16|||
162973178|NCT02427399|588601669|FG002|Overall Study|Protocol Violation|12|||
162973179|NCT02427399|588601670|FG003|Overall Study|Protocol Violation|18|||
162973180|NCT02427399|588601671|FG004|Overall Study|Protocol Violation|15|||
162973181|NCT00605176|588601674|FG000|Overall Study|Adverse Event|2|||
162973182|NCT00605176|588601675|FG001|Overall Study|Adverse Event|1|||
162973183|NCT00605176|588601676|FG002|Overall Study|Adverse Event|3|||
162973184|NCT00605176|588601674|FG000|Overall Study|Withdrawal by Subject|4|||
162973185|NCT00605176|588601675|FG001|Overall Study|Withdrawal by Subject|2|||
162973186|NCT00605176|588601676|FG002|Overall Study|Withdrawal by Subject|4|||
162973187|NCT00605176|588601674|FG000|Overall Study|Lost to Follow-up|2|||
162973188|NCT00605176|588601675|FG001|Overall Study|Lost to Follow-up|2|||
162973189|NCT00605176|588601676|FG002|Overall Study|Lost to Follow-up|1|||
162973190|NCT00605176|588601674|FG000|Overall Study|Non-complicance with study procedures|1|||
162973191|NCT00605176|588601675|FG001|Overall Study|Non-complicance with study procedures|0|||
162973192|NCT00605176|588601676|FG002|Overall Study|Non-complicance with study procedures|0|||
162973193|NCT00605176|588601674|FG000|Overall Study|Use of concomitant therapy|1|||
162973194|NCT00605176|588601675|FG001|Overall Study|Use of concomitant therapy|0|||
162973195|NCT00605176|588601676|FG002|Overall Study|Use of concomitant therapy|1|||
162973196|NCT00605176|588601674|FG000|Overall Study|Other (not due to AE)|1|||
162973197|NCT00605176|588601675|FG001|Overall Study|Other (not due to AE)|1|||
162973198|NCT00605176|588601676|FG002|Overall Study|Other (not due to AE)|0|||
162973199|NCT01086969|588601677|FG000|Overall Study|Withdrawal by Subject|1|||
162973200|NCT01086969|588601678|FG001|Overall Study|Withdrawal by Subject|2|||
162973201|NCT01086969|588601679|FG002|Overall Study|Withdrawal by Subject|0|||
162973202|NCT01609582|588601684|FG000|Overall Study|Adverse Event|20|||
162973203|NCT01609582|588601685|FG001|Overall Study|Adverse Event|18|||
162973204|NCT01609582|588601684|FG000|Overall Study|Lost to Follow-up|10|||
162973205|NCT01609582|588601685|FG001|Overall Study|Lost to Follow-up|10|||
162973206|NCT01609582|588601684|FG000|Overall Study|Withdrawal by Subject|21|||
162973207|NCT01609582|588601685|FG001|Overall Study|Withdrawal by Subject|15|||
162973208|NCT01609582|588601684|FG000|Overall Study|Study Terminated by Sponsor|1543|||
162973209|NCT01609582|588601685|FG001|Overall Study|Study Terminated by Sponsor|1548|||
162973210|NCT01609582|588601684|FG000|Overall Study|Other|9|||
162973211|NCT01609582|588601685|FG001|Overall Study|Other|10|||
162973212|NCT01609582|588601684|FG000|Overall Study|Randomized, but not treated|0|||
162973213|NCT01609582|588601685|FG001|Overall Study|Randomized, but not treated|3|||
162973214|NCT00685750|588601686|FG000|Overall Study|Tumor sampling failure|0|||
162973215|NCT00685750|588601687|FG001|Overall Study|Tumor sampling failure|0|||
162973216|NCT00685750|588601688|FG002|Overall Study|Tumor sampling failure|1|||
162973217|NCT00685750|588601689|FG003|Overall Study|Tumor sampling failure|0|||
162973218|NCT00685750|588601690|FG004|Overall Study|Tumor sampling failure|0|||
162973219|NCT00685750|588601691|FG005|Overall Study|Tumor sampling failure|0|||
162973220|NCT00685750|588601692|FG006|Overall Study|Tumor sampling failure|0|||
162973221|NCT00685750|588601686|FG000|Overall Study|Patient didn't receive the treatment|0|||
162973222|NCT00685750|588601687|FG001|Overall Study|Patient didn't receive the treatment|0|||
162973223|NCT00685750|588601688|FG002|Overall Study|Patient didn't receive the treatment|0|||
162973224|NCT00685750|588601689|FG003|Overall Study|Patient didn't receive the treatment|0|||
162973225|NCT00685750|588601690|FG004|Overall Study|Patient didn't receive the treatment|0|||
162973226|NCT00685750|588601691|FG005|Overall Study|Patient didn't receive the treatment|0|||
162973227|NCT00685750|588601692|FG006|Overall Study|Patient didn't receive the treatment|1|||
162973228|NCT00685750|588601686|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162973229|NCT00685750|588601687|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162973230|NCT00685750|588601688|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
162973231|NCT00685750|588601689|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
162973232|NCT00685750|588601690|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
162973233|NCT00685750|588601691|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
162973234|NCT00685750|588601692|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
162973235|NCT04974580|588601695|FG000|Overall Study|Lost to Follow-up|33|||
162973236|NCT04974580|588601696|FG001|Overall Study|Lost to Follow-up|39|||
162973237|NCT04974580|588601697|FG002|Overall Study|Lost to Follow-up|30|||
162973238|NCT04974580|588601698|FG003|Overall Study|Lost to Follow-up|29|||
162973239|NCT00129116|588601699|FG000|Primary Phase|Lost to Follow-up|1|||
162973240|NCT00129116|588601700|FG001|Primary Phase|Lost to Follow-up|1|||
162973241|NCT00129116|588601701|FG002|Primary Phase|Lost to Follow-up|0|||
162973242|NCT00129116|588601702|FG003|Primary Phase|Lost to Follow-up|1|||
162973243|NCT00129116|588601703|FG004|Primary Phase|Lost to Follow-up|1|||
162973244|NCT00129116|588601699|FG000|Primary Phase|Protocol Violation|0|||
162973245|NCT00129116|588601700|FG001|Primary Phase|Protocol Violation|1|||
162973246|NCT00129116|588601701|FG002|Primary Phase|Protocol Violation|0|||
162973247|NCT00129116|588601702|FG003|Primary Phase|Protocol Violation|0|||
162973248|NCT00129116|588601703|FG004|Primary Phase|Protocol Violation|0|||
162973249|NCT00129116|588601699|FG000|Primary Phase|Adverse Event|1|||
162973250|NCT00129116|588601700|FG001|Primary Phase|Adverse Event|1|||
162973251|NCT00129116|588601701|FG002|Primary Phase|Adverse Event|0|||
162973252|NCT00129116|588601702|FG003|Primary Phase|Adverse Event|0|||
162973253|NCT00129116|588601703|FG004|Primary Phase|Adverse Event|0|||
162973254|NCT00129116|588601699|FG000|Primary Phase|Withdrawal by Subject|0|||
162973255|NCT00129116|588601700|FG001|Primary Phase|Withdrawal by Subject|1|||
162973256|NCT00129116|588601701|FG002|Primary Phase|Withdrawal by Subject|0|||
162973257|NCT00129116|588601702|FG003|Primary Phase|Withdrawal by Subject|0|||
162973258|NCT00129116|588601703|FG004|Primary Phase|Withdrawal by Subject|0|||
162973259|NCT00129116|588601699|FG000|Primary Phase|Other|0|||
163318022|NCT01928394|589874953|FG007|Follow-up Period|Death|2|||
163318023|NCT01928394|589874954|FG008|Follow-up Period|Death|1|||
163318024|NCT01928394|589874955|FG009|Follow-up Period|Death|2|||
162973260|NCT00129116|588601700|FG001|Primary Phase|Other|0|||
162973261|NCT00129116|588601701|FG002|Primary Phase|Other|1|||
162973262|NCT00129116|588601702|FG003|Primary Phase|Other|0|||
162973263|NCT00129116|588601703|FG004|Primary Phase|Other|0|||
162973264|NCT00129116|588601699|FG000|Booster Phase|Lost to Follow-up|2|||
162973265|NCT00129116|588601700|FG001|Booster Phase|Lost to Follow-up|0|||
162973266|NCT00129116|588601701|FG002|Booster Phase|Lost to Follow-up|0|||
162973267|NCT00129116|588601702|FG003|Booster Phase|Lost to Follow-up|0|||
162973268|NCT00129116|588601703|FG004|Booster Phase|Lost to Follow-up|1|||
162973269|NCT02539368|588601704|FG000|Overall Study|Death|4|||
162973270|NCT02539368|588601705|FG001|Overall Study|Death|2|||
162973271|NCT02539368|588601706|FG002|Overall Study|Death|1|||
162973272|NCT02539368|588601707|FG003|Overall Study|Death|0|||
162973273|NCT02539368|588601708|FG004|Overall Study|Death|0|||
163318025|NCT01928394|589874956|FG010|Follow-up Period|Death|4|||
162973274|NCT02539368|588601704|FG000|Overall Study|Withdrawal by Subject|44|||
162973275|NCT02539368|588601705|FG001|Overall Study|Withdrawal by Subject|35|||
162973276|NCT02539368|588601706|FG002|Overall Study|Withdrawal by Subject|9|||
162973277|NCT02539368|588601707|FG003|Overall Study|Withdrawal by Subject|1|||
162973278|NCT02539368|588601708|FG004|Overall Study|Withdrawal by Subject|3|||
162973279|NCT02539368|588601704|FG000|Overall Study|Physician Decision|49|||
162973280|NCT02539368|588601705|FG001|Overall Study|Physician Decision|15|||
162973281|NCT02539368|588601706|FG002|Overall Study|Physician Decision|7|||
162973282|NCT02539368|588601707|FG003|Overall Study|Physician Decision|0|||
162973283|NCT02539368|588601708|FG004|Overall Study|Physician Decision|2|||
162973284|NCT02539368|588601704|FG000|Overall Study|Lost to Follow-up|96|||
162973285|NCT02539368|588601705|FG001|Overall Study|Lost to Follow-up|21|||
162973286|NCT02539368|588601706|FG002|Overall Study|Lost to Follow-up|16|||
162973287|NCT02539368|588601707|FG003|Overall Study|Lost to Follow-up|4|||
162973288|NCT02539368|588601708|FG004|Overall Study|Lost to Follow-up|3|||
162973289|NCT02539368|588601704|FG000|Overall Study|Adverse Event|44|||
162973290|NCT02539368|588601705|FG001|Overall Study|Adverse Event|5|||
162973291|NCT02539368|588601706|FG002|Overall Study|Adverse Event|9|||
162973292|NCT02539368|588601707|FG003|Overall Study|Adverse Event|0|||
162973293|NCT02539368|588601708|FG004|Overall Study|Adverse Event|3|||
162973294|NCT02539368|588601704|FG000|Overall Study|Participant Non-compliant|13|||
162973295|NCT02539368|588601705|FG001|Overall Study|Participant Non-compliant|2|||
162973296|NCT02539368|588601706|FG002|Overall Study|Participant Non-compliant|1|||
162973297|NCT02539368|588601707|FG003|Overall Study|Participant Non-compliant|1|||
162973298|NCT02539368|588601708|FG004|Overall Study|Participant Non-compliant|0|||
162973299|NCT02539368|588601704|FG000|Overall Study|Other|145|||
162973300|NCT02539368|588601705|FG001|Overall Study|Other|18|||
162973301|NCT02539368|588601706|FG002|Overall Study|Other|24|||
162973302|NCT02539368|588601707|FG003|Overall Study|Other|1|||
162973303|NCT02539368|588601708|FG004|Overall Study|Other|3|||
162973304|NCT02539368|588601704|FG000|Overall Study|Missing|10|||
162973305|NCT02539368|588601705|FG001|Overall Study|Missing|3|||
162973306|NCT02539368|588601706|FG002|Overall Study|Missing|0|||
162973307|NCT02539368|588601707|FG003|Overall Study|Missing|0|||
162973308|NCT02539368|588601708|FG004|Overall Study|Missing|0|||
162973309|NCT03558139|588601711|FG000|Overall Study|Consent Withdrawn|1|||
162973310|NCT03558139|588601712|FG001|Overall Study|Consent Withdrawn|1|||
162973311|NCT03558139|588601713|FG002|Overall Study|Consent Withdrawn|4|||
162973312|NCT03558139|588601711|FG000|Overall Study|Death|5|||
162973313|NCT03558139|588601712|FG001|Overall Study|Death|3|||
162973314|NCT03558139|588601713|FG002|Overall Study|Death|8|||
162973315|NCT03558139|588601711|FG000|Overall Study|Lost to Follow-up|0|||
162973316|NCT03558139|588601712|FG001|Overall Study|Lost to Follow-up|0|||
162973317|NCT03558139|588601713|FG002|Overall Study|Lost to Follow-up|3|||
162973318|NCT03558139|588601711|FG000|Overall Study|Study Ended Per Protocol|0|||
162973319|NCT03558139|588601712|FG001|Overall Study|Study Ended Per Protocol|3|||
162973320|NCT03558139|588601713|FG002|Overall Study|Study Ended Per Protocol|6|||
162973321|NCT02752802|588601714|FG000|Overall Study|Contrast Volume Not Collected|1|||
162973322|NCT02752802|588601715|FG001|Overall Study|Contrast Volume Not Collected|0|||
162973323|NCT00251316|588601716|FG000|Overall Study|Physician Decision|2|||
162973324|NCT00251316|588601717|FG001|Overall Study|Physician Decision|3|||
162973325|NCT00398073|588601718|FG000|Overall Study|Withdrawal by Subject|1|||
162973326|NCT00398073|588601719|FG001|Overall Study|Withdrawal by Subject|0|||
162973327|NCT00708682|588601720|FG000|Infant Series|Adverse Event|1|||
162973328|NCT00708682|588601720|FG000|Infant Series|Lost to Follow-up|4|||
162973329|NCT00708682|588601720|FG000|Infant Series|Protocol Violation|1|||
162973330|NCT00708682|588601720|FG000|Infant Series|Parent/legal guardian request|6|||
162973331|NCT00708682|588601720|FG000|Infant Series|Failed to return|2|||
162973332|NCT00708682|588601720|FG000|Infant Series|Other|19|||
162973333|NCT00708682|588601720|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
162973334|NCT00708682|588601720|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
162973335|NCT00708682|588601720|FG000|Toddler Dose|Lost to Follow-up|3|||
162973336|NCT00708682|588601720|FG000|Toddler Dose|Failed to Return|4|||
162973337|NCT03689894|588601723|FG000|Overall Study|Adverse Event|1|||
162973338|NCT00569777|588601724|FG000|Overall Study|Withdrawal by Subject|4|||
162973339|NCT00569777|588601725|FG001|Overall Study|Withdrawal by Subject|0|||
162973340|NCT00569777|588601724|FG000|Overall Study|Adverse Event|3|||
162973341|NCT00569777|588601725|FG001|Overall Study|Adverse Event|0|||
162973342|NCT00569777|588601724|FG000|Overall Study|Lost to Follow-up|1|||
162973343|NCT00569777|588601725|FG001|Overall Study|Lost to Follow-up|0|||
162973344|NCT00569777|588601724|FG000|Overall Study|scheduled eye surgery|0|||
162973345|NCT00569777|588601725|FG001|Overall Study|scheduled eye surgery|1|||
162973346|NCT00569777|588601724|FG000|Overall Study|did not meet exclusion criteria|1|||
162973347|NCT00569777|588601725|FG001|Overall Study|did not meet exclusion criteria|2|||
162973348|NCT00569777|588601724|FG000|Overall Study|pregnant|1|||
162973349|NCT00569777|588601725|FG001|Overall Study|pregnant|0|||
162973350|NCT02056652|588601731|FG000|Overall Study|Withdrawal by Subject|1|||
162973351|NCT02056652|588601732|FG001|Overall Study|Withdrawal by Subject|0|||
162973352|NCT02056652|588601731|FG000|Overall Study|Lost to Follow-up|0|||
162973353|NCT02056652|588601732|FG001|Overall Study|Lost to Follow-up|3|||
162973354|NCT00239005|588601737|FG000|Overall Study|Adverse Event|6|||
162973355|NCT00239005|588601738|FG001|Overall Study|Adverse Event|6|||
162973356|NCT00239005|588601737|FG000|Overall Study|Withdrawal by Subject|3|||
162973357|NCT00239005|588601738|FG001|Overall Study|Withdrawal by Subject|4|||
162973358|NCT00239005|588601737|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
162973359|NCT00239005|588601738|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
162973360|NCT00239005|588601737|FG000|Overall Study|Protocol Violation|1|||
162973361|NCT00239005|588601738|FG001|Overall Study|Protocol Violation|0|||
162973362|NCT00239005|588601737|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
162973363|NCT00239005|588601738|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
162973364|NCT00239005|588601737|FG000|Overall Study|Lost to Follow-up|0|||
162973365|NCT00239005|588601738|FG001|Overall Study|Lost to Follow-up|1|||
162973366|NCT00987831|588601740|FG000|Overall Study|Never flared in 12 months|1|||
162973367|NCT00987831|588601741|FG001|Overall Study|Never flared in 12 months|0|||
162973368|NCT00987831|588601742|FG002|Overall Study|Never flared in 12 months|0|||
162973369|NCT00987831|588601740|FG000|Overall Study|Lost to Follow-up|0|||
162973370|NCT00987831|588601741|FG001|Overall Study|Lost to Follow-up|3|||
162973371|NCT00987831|588601742|FG002|Overall Study|Lost to Follow-up|0|||
162973372|NCT03253094|588601743|FG000|Overall Study|Adverse Event|2|||
162973373|NCT03253094|588601744|FG001|Overall Study|Adverse Event|0|||
162973374|NCT03253094|588601745|FG002|Overall Study|Adverse Event|0|||
162973375|NCT03253094|588601746|FG003|Overall Study|Adverse Event|0|||
162973376|NCT03253094|588601747|FG004|Overall Study|Adverse Event|0|||
162973377|NCT03253094|588601748|FG005|Overall Study|Adverse Event|0|||
162973378|NCT03253094|588601743|FG000|Overall Study|Lack of Efficacy|0|||
162973379|NCT03253094|588601744|FG001|Overall Study|Lack of Efficacy|0|||
162973380|NCT03253094|588601745|FG002|Overall Study|Lack of Efficacy|2|||
162973381|NCT03253094|588601746|FG003|Overall Study|Lack of Efficacy|1|||
162973382|NCT03253094|588601747|FG004|Overall Study|Lack of Efficacy|2|||
162973383|NCT03253094|588601748|FG005|Overall Study|Lack of Efficacy|1|||
162973384|NCT03253094|588601743|FG000|Overall Study|Lost to Follow-up|0|||
162973385|NCT03253094|588601744|FG001|Overall Study|Lost to Follow-up|0|||
162973386|NCT03253094|588601745|FG002|Overall Study|Lost to Follow-up|1|||
162973387|NCT03253094|588601746|FG003|Overall Study|Lost to Follow-up|1|||
162973388|NCT03253094|588601747|FG004|Overall Study|Lost to Follow-up|0|||
162973389|NCT03253094|588601748|FG005|Overall Study|Lost to Follow-up|1|||
162973390|NCT03253094|588601743|FG000|Overall Study|Physician Decision|1|||
162973391|NCT03253094|588601744|FG001|Overall Study|Physician Decision|0|||
162973392|NCT03253094|588601745|FG002|Overall Study|Physician Decision|0|||
162973393|NCT03253094|588601746|FG003|Overall Study|Physician Decision|1|||
162973394|NCT03253094|588601747|FG004|Overall Study|Physician Decision|0|||
162973395|NCT03253094|588601748|FG005|Overall Study|Physician Decision|2|||
162973396|NCT03253094|588601743|FG000|Overall Study|Withdrawal by Subject|1|||
162973397|NCT03253094|588601744|FG001|Overall Study|Withdrawal by Subject|2|||
162973398|NCT03253094|588601745|FG002|Overall Study|Withdrawal by Subject|1|||
162973399|NCT03253094|588601746|FG003|Overall Study|Withdrawal by Subject|0|||
162973400|NCT03253094|588601747|FG004|Overall Study|Withdrawal by Subject|3|||
162973401|NCT03253094|588601748|FG005|Overall Study|Withdrawal by Subject|0|||
162973402|NCT03253094|588601743|FG000|Overall Study|Other|0|||
162973403|NCT03253094|588601744|FG001|Overall Study|Other|1|||
162973404|NCT03253094|588601745|FG002|Overall Study|Other|2|||
162973405|NCT03253094|588601746|FG003|Overall Study|Other|1|||
162973406|NCT03253094|588601747|FG004|Overall Study|Other|0|||
162973407|NCT03253094|588601748|FG005|Overall Study|Other|0|||
162973408|NCT00824369|588601749|FG000|Overall Study|Nolonger willing to participate in study|1|||
162973409|NCT00824369|588601750|FG001|Overall Study|Nolonger willing to participate in study|0|||
162973410|NCT00824369|588601751|FG002|Overall Study|Nolonger willing to participate in study|1|||
162973411|NCT00824369|588601752|FG003|Overall Study|Nolonger willing to participate in study|2|||
162973412|NCT00824369|588601753|FG004|Overall Study|Nolonger willing to participate in study|0|||
162973413|NCT00824369|588601754|FG005|Overall Study|Nolonger willing to participate in study|1|||
162973414|NCT00824369|588601749|FG000|Overall Study|Lost to Follow-up|0|||
162973415|NCT00824369|588601750|FG001|Overall Study|Lost to Follow-up|0|||
162973416|NCT00824369|588601751|FG002|Overall Study|Lost to Follow-up|0|||
162973417|NCT00824369|588601752|FG003|Overall Study|Lost to Follow-up|0|||
162973418|NCT00824369|588601753|FG004|Overall Study|Lost to Follow-up|1|||
162973419|NCT00824369|588601754|FG005|Overall Study|Lost to Follow-up|0|||
162973420|NCT02413294|588601755|FG000|Overall Study|Withdrawal by Subject|1|||
162973421|NCT02625974|588601756|FG000|Part 1|Lost to Follow-up|9|||
162973422|NCT02625974|588601757|FG001|Part 1|Lost to Follow-up|3|||
162973423|NCT02625974|588601756|FG000|Part 2|Lost to Follow-up|4|||
163209539|NCT02860169|589480674|FG000|Part B|Other (Screening failure)|10|||
162973424|NCT02625974|588601757|FG001|Part 2|Lost to Follow-up|6|||
162973425|NCT02625974|588601756|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
162973426|NCT02625974|588601757|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
163209540|NCT02860169|589480674|FG000|Part B|Withdrawal by Subject|1|||
163209541|NCT02860169|589480674|FG000|Part C|Other (Screening failure)|1|||
162973427|NCT03941834|588603198|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
163209542|NCT01782495|589480675|FG000|Overall Study|Adverse Event|0|||
162973428|NCT03941834|588603199|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
162973429|NCT03941834|588603200|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
162973430|NCT03941834|588603198|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
162973431|NCT03941834|588603199|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
162973432|NCT03941834|588603200|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
162973433|NCT03941834|588603198|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
162973434|NCT03941834|588603199|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
162973435|NCT03941834|588603200|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
162973436|NCT03941834|588603198|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
162973437|NCT03941834|588603199|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
162973438|NCT03941834|588603200|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
162973439|NCT03941834|588603198|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
162973440|NCT03941834|588603199|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
162973441|NCT03941834|588603200|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
162973442|NCT03941834|588603198|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
162973443|NCT03941834|588603199|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
162973444|NCT03941834|588603200|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
162973445|NCT01124695|588603203|FG000|Overall Study|Disease progression|77|||
162973446|NCT01124695|588603203|FG000|Overall Study|Adverse Event|11|||
162973447|NCT01124695|588603203|FG000|Overall Study|Death|1|||
162973448|NCT01124695|588603203|FG000|Overall Study|Withdrawal by Subject|7|||
162973449|NCT01124695|588603203|FG000|Overall Study|Physician Decision|3|||
162973450|NCT01124695|588603203|FG000|Overall Study|Alternative therapy|9|||
162973451|NCT01124695|588603203|FG000|Overall Study|No documentation that patient went off treatment|4|||
162973452|NCT01124695|588603203|FG000|Overall Study|Ineligible|9|||
162973453|NCT01124695|588603203|FG000|Overall Study|Ineligible and never start treatment|2|||
162973454|NCT00097786|588603207|FG000|Overall Study|lost to follow-up for all-cause death|296|||
162973455|NCT00097786|588603208|FG001|Overall Study|lost to follow-up for all-cause death|292|||
162973456|NCT00097786|588603209|FG002|Overall Study|lost to follow-up for all-cause death|313|||
162973457|NCT00097786|588603210|FG003|Overall Study|lost to follow-up for all-cause death|310|||
162973458|NCT02668822|588603211|FG000|Overall Study|Protocol Violation|2|||
162973459|NCT02668822|588603212|FG001|Overall Study|Protocol Violation|0|||
162973460|NCT02668822|588603211|FG000|Overall Study|Study Terminated by Sponsor|7|||
162973461|NCT02668822|588603212|FG001|Overall Study|Study Terminated by Sponsor|9|||
162973462|NCT01647711|588603215|FG000|Overall Study|Progressive disease|6|||
162973463|NCT01647711|588603216|FG001|Overall Study|Progressive disease|2|||
162973464|NCT01647711|588603217|FG002|Overall Study|Progressive disease|6|||
162973465|NCT01647711|588603218|FG003|Overall Study|Progressive disease|8|||
162973466|NCT01647711|588603219|FG004|Overall Study|Progressive disease|2|||
162973467|NCT01647711|588603215|FG000|Overall Study|Other adverse event|0|||
162973468|NCT01647711|588603216|FG001|Overall Study|Other adverse event|0|||
162973469|NCT01647711|588603217|FG002|Overall Study|Other adverse event|2|||
162973470|NCT01647711|588603218|FG003|Overall Study|Other adverse event|0|||
162973471|NCT01647711|588603219|FG004|Overall Study|Other adverse event|2|||
162973472|NCT01647711|588603215|FG000|Overall Study|Protocol Violation|0|||
162973473|NCT01647711|588603216|FG001|Overall Study|Protocol Violation|0|||
162973474|NCT01647711|588603217|FG002|Overall Study|Protocol Violation|0|||
162973475|NCT01647711|588603218|FG003|Overall Study|Protocol Violation|0|||
162973476|NCT01647711|588603219|FG004|Overall Study|Protocol Violation|1|||
162973477|NCT01647711|588603215|FG000|Overall Study|Refused to continue taking medication|0|||
162973478|NCT01647711|588603216|FG001|Overall Study|Refused to continue taking medication|0|||
162973479|NCT01647711|588603217|FG002|Overall Study|Refused to continue taking medication|0|||
162973480|NCT01647711|588603218|FG003|Overall Study|Refused to continue taking medication|2|||
162973481|NCT01647711|588603219|FG004|Overall Study|Refused to continue taking medication|1|||
162973482|NCT01647711|588603215|FG000|Overall Study|Other reason not defined|0|||
163057297|NCT02194465|588921207|FG004|Overall Study|Withdrawal by Subject|2|||
162973483|NCT01647711|588603216|FG001|Overall Study|Other reason not defined|1|||
163057298|NCT02194465|588921208|FG005|Overall Study|Withdrawal by Subject|1|||
162973484|NCT01647711|588603217|FG002|Overall Study|Other reason not defined|1|||
162973485|NCT01647711|588603218|FG003|Overall Study|Other reason not defined|1|||
162973486|NCT01647711|588603219|FG004|Overall Study|Other reason not defined|0|||
162973487|NCT03036839|588603220|FG000|Overall Study|Adverse Event|0|||
162973488|NCT03036839|588603221|FG001|Overall Study|Adverse Event|0|||
162973489|NCT03036839|588603222|FG002|Overall Study|Adverse Event|1|||
162973490|NCT03036839|588603220|FG000|Overall Study|Death|3|||
162973491|NCT03036839|588603221|FG001|Overall Study|Death|0|||
162973492|NCT03036839|588603222|FG002|Overall Study|Death|3|||
162973493|NCT03036839|588603220|FG000|Overall Study|Withdrew Consent|0|||
162973494|NCT03036839|588603221|FG001|Overall Study|Withdrew Consent|0|||
162973495|NCT03036839|588603222|FG002|Overall Study|Withdrew Consent|1|||
162973496|NCT01316419|588603223|FG000|Overall Study|Not treated|103|||
162973497|NCT01316419|588603223|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
163209543|NCT01782495|589480676|FG001|Overall Study|Adverse Event|0|||
162973498|NCT01316419|588603223|FG000|Overall Study|Lost to Follow-up|19|||
162973499|NCT00412737|588603225|FG000|Overall Study|Death|1|||
162973500|NCT00412737|588603226|FG001|Overall Study|Death|0|||
162973501|NCT00412737|588603225|FG000|Overall Study|Adverse Event|3|||
162973502|NCT00412737|588603226|FG001|Overall Study|Adverse Event|2|||
162973503|NCT00412737|588603225|FG000|Overall Study|Refused Treatment|6|||
162973504|NCT00412737|588603226|FG001|Overall Study|Refused Treatment|2|||
162973505|NCT00412737|588603225|FG000|Overall Study|Failure to Return|6|||
162973506|NCT00412737|588603226|FG001|Overall Study|Failure to Return|2|||
162973507|NCT00983918|588603227|FG000|Overall Study|conversion to open cholecystectomy|0|||
162973508|NCT00983918|588603228|FG001|Overall Study|conversion to open cholecystectomy|2|||
162973509|NCT00983918|588603229|FG002|Overall Study|conversion to open cholecystectomy|2|||
162973510|NCT00983918|588603230|FG003|Overall Study|conversion to open cholecystectomy|2|||
162973511|NCT01345318|588603254|FG000|Overall Study|Adverse Event|16|||
162973512|NCT01345318|588603254|FG000|Overall Study|Lack of Efficacy|17|||
162973513|NCT01345318|588603254|FG000|Overall Study|Lost to Follow-up|2|||
162973514|NCT01345318|588603254|FG000|Overall Study|Protocol Violation|1|||
162973515|NCT01345318|588603254|FG000|Overall Study|Withdrawal by Subject|41|||
162973516|NCT01345318|588603254|FG000|Overall Study|Other|3|||
162973517|NCT01685073|588603255|FG000|Overall Study|Lost to Follow-up|6|||
162973518|NCT01685073|588603256|FG001|Overall Study|Lost to Follow-up|8|||
162973519|NCT01685073|588603255|FG000|Overall Study|Withdrawal by Subject|24|||
162973520|NCT01685073|588603256|FG001|Overall Study|Withdrawal by Subject|24|||
162973521|NCT01049412|588603259|FG000|Period I|Withdrawal by Subject|4|||
162973522|NCT01049412|588603260|FG001|Period I|Withdrawal by Subject|6|||
162973523|NCT01049412|588603259|FG000|Period I|Lost to Follow-up|2|||
162973524|NCT01049412|588603260|FG001|Period I|Lost to Follow-up|2|||
162973525|NCT01049412|588603259|FG000|Period I|Physician Decision|0|||
162973526|NCT01049412|588603260|FG001|Period I|Physician Decision|3|||
162973527|NCT01049412|588603259|FG000|Period I|Protocol Violation|1|||
162973528|NCT01049412|588603260|FG001|Period I|Protocol Violation|2|||
162973529|NCT01049412|588603259|FG000|Period I|Adverse Event|1|||
162973530|NCT01049412|588603260|FG001|Period I|Adverse Event|0|||
162973531|NCT01049412|588603259|FG000|Period II|Withdrawal by Subject|2|||
162973532|NCT01049412|588603260|FG001|Period II|Withdrawal by Subject|3|||
162973533|NCT01049412|588603259|FG000|Period II|Adverse Event|1|||
162973534|NCT01049412|588603260|FG001|Period II|Adverse Event|0|||
162973535|NCT01049412|588603259|FG000|Period II|Lost to Follow-up|1|||
162973536|NCT01049412|588603260|FG001|Period II|Lost to Follow-up|0|||
162973537|NCT00804141|588603261|FG000|Overall Study|Adverse Event|157|||
162973538|NCT00804141|588603261|FG000|Overall Study|Death|4|||
162973539|NCT00804141|588603261|FG000|Overall Study|Failed to return|96|||
162973540|NCT00804141|588603261|FG000|Overall Study|Investigator request|8|||
162973541|NCT00804141|588603261|FG000|Overall Study|Protocol Violation|85|||
162973542|NCT00804141|588603261|FG000|Overall Study|Withdrawal by Subject|131|||
162973543|NCT00804141|588603261|FG000|Overall Study|Lack of Efficacy|46|||
162973544|NCT00804141|588603261|FG000|Overall Study|Other than specified|30|||
162973545|NCT00804141|588603261|FG000|Overall Study|Enrolled but not treated|6|||
162973546|NCT01142908|588603262|FG000|Overall Study|Lost to Follow-up|19|||
162973547|NCT01142908|588603263|FG001|Overall Study|Lost to Follow-up|13|||
162973548|NCT01142908|588603262|FG000|Overall Study|Death|1|||
162973549|NCT01142908|588603263|FG001|Overall Study|Death|4|||
162973550|NCT01142908|588603262|FG000|Overall Study|Excluded - did not meet criteria|9|||
162973551|NCT01142908|588603263|FG001|Overall Study|Excluded - did not meet criteria|5|||
162973552|NCT01142908|588603262|FG000|Overall Study|Withdrawal by Subject|3|||
162973553|NCT01142908|588603263|FG001|Overall Study|Withdrawal by Subject|0|||
162973554|NCT03235479|588603265|FG000|Overall Study|Lost to Follow-up|8|||
162973555|NCT03235479|588603266|FG001|Overall Study|Lost to Follow-up|11|||
162973556|NCT03235479|588603265|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
162973557|NCT03235479|588603266|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
162973558|NCT03235479|588603265|FG000|Overall Study|Pregnancy|1|||
162973559|NCT03235479|588603266|FG001|Overall Study|Pregnancy|0|||
162973560|NCT03235479|588603265|FG000|Overall Study|Protocol Deviation|1|||
162973561|NCT03235479|588603266|FG001|Overall Study|Protocol Deviation|3|||
162973562|NCT03235479|588603265|FG000|Overall Study|Technical Problems|3|||
162973563|NCT03235479|588603266|FG001|Overall Study|Technical Problems|2|||
162973564|NCT03235479|588603265|FG000|Overall Study|Withdrawal by Subject|2|||
162973565|NCT03235479|588603266|FG001|Overall Study|Withdrawal by Subject|2|||
162973566|NCT03235479|588603265|FG000|Overall Study|Other Reasons|3|||
162973567|NCT03235479|588603266|FG001|Overall Study|Other Reasons|5|||
162973568|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
162973569|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
162973570|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
162973571|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
162973572|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
162973573|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
163209544|NCT01782495|589480677|FG002|Overall Study|Adverse Event|0|||
162973574|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
162973575|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
162973576|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
162973577|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
162973578|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
162973579|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
162973580|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
162973581|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
162973582|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
162973583|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
162973584|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Death|2|||
162973585|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Death|1|||
162973586|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Death|0|||
162973587|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Death|0|||
162973588|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
162973589|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
162973590|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
162973591|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
162973592|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
162973593|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
162973594|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
162973595|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
162973596|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
162973597|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
162973598|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
162973599|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
162973600|NCT03110380|588603272|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
162973601|NCT03110380|588603273|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
162973602|NCT03110380|588603274|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
162973603|NCT03110380|588603275|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
162973604|NCT03110380|588603272|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
162973605|NCT03110380|588603273|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
162973606|NCT03110380|588603274|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
162973607|NCT03110380|588603275|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
162973608|NCT03110380|588603272|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
162973609|NCT03110380|588603273|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
162973610|NCT03110380|588603274|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
162973611|NCT03110380|588603275|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
162973612|NCT01206439|588603278|FG000|Overall Study|subject did not meet inclusion criteria|1|||
162973613|NCT05889039|588603280|FG000|Overall Study|error in completing survey|0|||
162973614|NCT05889039|588603281|FG001|Overall Study|error in completing survey|2|||
162973615|NCT05889039|588603282|FG002|Overall Study|error in completing survey|0|||
162973616|NCT05889039|588603283|FG003|Overall Study|error in completing survey|0|||
162973617|NCT05889039|588603280|FG000|Overall Study|Lost to Follow-up|4|||
162973618|NCT05889039|588603281|FG001|Overall Study|Lost to Follow-up|0|||
162973619|NCT05889039|588603282|FG002|Overall Study|Lost to Follow-up|0|||
162973620|NCT05889039|588603283|FG003|Overall Study|Lost to Follow-up|0|||
162973621|NCT02795676|588603284|FG000|Overall Study|Adverse Event|2|||
162973622|NCT02795676|588603285|FG001|Overall Study|Adverse Event|0|||
162973623|NCT02795676|588603284|FG000|Overall Study|Withdrawal by Subject|3|||
162973624|NCT02795676|588603285|FG001|Overall Study|Withdrawal by Subject|1|||
162973625|NCT01115933|588603288|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
162973626|NCT00819767|588603289|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162973627|NCT00819767|588603290|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162973628|NCT00220727|588603314|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
162973629|NCT00220727|588603315|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
162973630|NCT00476593|588603316|FG000|Overall Study|Lost to Follow-up|10|||
162973631|NCT00476593|588603317|FG001|Overall Study|Lost to Follow-up|2|||
162973632|NCT00476593|588603318|FG002|Overall Study|Lost to Follow-up|8|||
162973633|NCT00476593|588603319|FG003|Overall Study|Lost to Follow-up|22|||
162973634|NCT03430011|588603320|FG000|Pre-Treatment|Death|1|||
162973635|NCT03430011|588603321|FG001|Pre-Treatment|Death|0|||
162973636|NCT03430011|588603322|FG002|Pre-Treatment|Death|0|||
162973637|NCT03430011|588603323|FG003|Pre-Treatment|Death|0|||
162973638|NCT03430011|588603324|FG004|Pre-Treatment|Death|1|||
162973639|NCT03430011|588603325|FG005|Pre-Treatment|Death|0|||
162973640|NCT03430011|588603326|FG006|Pre-Treatment|Death|1|||
162973641|NCT03430011|588603327|FG007|Pre-Treatment|Death|0|||
162973642|NCT03430011|588603320|FG000|Pre-Treatment|Screen Fail|0|||
162973643|NCT03430011|588603321|FG001|Pre-Treatment|Screen Fail|0|||
162973644|NCT03430011|588603322|FG002|Pre-Treatment|Screen Fail|0|||
162973645|NCT03430011|588603323|FG003|Pre-Treatment|Screen Fail|0|||
162973646|NCT03430011|588603324|FG004|Pre-Treatment|Screen Fail|1|||
162973647|NCT03430011|588603325|FG005|Pre-Treatment|Screen Fail|0|||
162973648|NCT03430011|588603326|FG006|Pre-Treatment|Screen Fail|0|||
162973649|NCT03430011|588603327|FG007|Pre-Treatment|Screen Fail|0|||
162973650|NCT03430011|588603320|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
162973651|NCT03430011|588603321|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
162973652|NCT03430011|588603322|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
162973653|NCT03430011|588603323|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
162973654|NCT03430011|588603324|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
162973655|NCT03430011|588603325|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
162973656|NCT03430011|588603326|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
162973657|NCT03430011|588603327|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
162973658|NCT03430011|588603320|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
162973659|NCT03430011|588603321|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
162973660|NCT03430011|588603322|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
162973661|NCT03430011|588603323|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
162973662|NCT03430011|588603324|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
162973663|NCT03430011|588603325|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
162973664|NCT03430011|588603326|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
162973665|NCT03430011|588603327|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
162973666|NCT03430011|588603320|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
162973667|NCT03430011|588603321|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
162973668|NCT03430011|588603322|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
162973669|NCT03430011|588603323|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
163209545|NCT01782495|589480678|FG003|Overall Study|Adverse Event|0|||
163209546|NCT01782495|589480679|FG004|Overall Study|Adverse Event|0|||
162973670|NCT03430011|588603324|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
162973671|NCT03430011|588603325|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
162973672|NCT03430011|588603326|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
162973673|NCT03430011|588603327|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
162973674|NCT03430011|588603320|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
162973675|NCT03430011|588603321|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
162973676|NCT03430011|588603322|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
162973677|NCT03430011|588603323|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
162973678|NCT03430011|588603324|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
162973679|NCT03430011|588603325|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
162973680|NCT03430011|588603326|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
162973681|NCT03430011|588603327|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
162973682|NCT03430011|588603320|FG000|JCARH125 Treatment|Death|4|||
162973683|NCT03430011|588603321|FG001|JCARH125 Treatment|Death|19|||
162973684|NCT03430011|588603322|FG002|JCARH125 Treatment|Death|10|||
162973685|NCT03430011|588603323|FG003|JCARH125 Treatment|Death|8|||
162973686|NCT03430011|588603324|FG004|JCARH125 Treatment|Death|5|||
162973687|NCT03430011|588603325|FG005|JCARH125 Treatment|Death|3|||
162973688|NCT03430011|588603326|FG006|JCARH125 Treatment|Death|4|||
162973689|NCT03430011|588603327|FG007|JCARH125 Treatment|Death|2|||
162973690|NCT03430011|588603320|FG000|JCARH125 Treatment|Other reasons|1|||
162973691|NCT03430011|588603321|FG001|JCARH125 Treatment|Other reasons|0|||
162973692|NCT03430011|588603322|FG002|JCARH125 Treatment|Other reasons|4|||
162973693|NCT03430011|588603323|FG003|JCARH125 Treatment|Other reasons|2|||
162973694|NCT03430011|588603324|FG004|JCARH125 Treatment|Other reasons|2|||
162973695|NCT03430011|588603325|FG005|JCARH125 Treatment|Other reasons|1|||
162973696|NCT03430011|588603326|FG006|JCARH125 Treatment|Other reasons|3|||
162973697|NCT03430011|588603327|FG007|JCARH125 Treatment|Other reasons|2|||
162973698|NCT00559364|588603329|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
162973699|NCT00559364|588603330|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
162973700|NCT04126343|588603331|FG000|Overall Study|Adverse Event|0|||
162973701|NCT04126343|588603332|FG001|Overall Study|Adverse Event|0|||
162973702|NCT04126343|588603333|FG002|Overall Study|Adverse Event|0|||
162973703|NCT04126343|588603334|FG003|Overall Study|Adverse Event|0|||
163209547|NCT01782495|589480680|FG005|Overall Study|Adverse Event|0|||
163401330|NCT01040351|590181131|FG001|Overall Study|poor ovarian response|2|||
163401331|NCT00766532|590181132|FG000|Overall Study|Protocol Violation|2|||
162973704|NCT04126343|588603335|FG004|Overall Study|Adverse Event|0|||
162973705|NCT04126343|588603336|FG005|Overall Study|Adverse Event|1|||
162973706|NCT04126343|588603331|FG000|Overall Study|Withdrawal by Subject|0|||
162973707|NCT04126343|588603332|FG001|Overall Study|Withdrawal by Subject|0|||
162973708|NCT04126343|588603333|FG002|Overall Study|Withdrawal by Subject|0|||
162973709|NCT04126343|588603334|FG003|Overall Study|Withdrawal by Subject|1|||
162973710|NCT04126343|588603335|FG004|Overall Study|Withdrawal by Subject|0|||
162973711|NCT04126343|588603336|FG005|Overall Study|Withdrawal by Subject|0|||
162973712|NCT04126343|588603331|FG000|Overall Study|Related to COVID-19 pandemic|3|||
162973713|NCT04126343|588603332|FG001|Overall Study|Related to COVID-19 pandemic|4|||
162973714|NCT04126343|588603333|FG002|Overall Study|Related to COVID-19 pandemic|3|||
162973715|NCT04126343|588603334|FG003|Overall Study|Related to COVID-19 pandemic|3|||
162973716|NCT04126343|588603335|FG004|Overall Study|Related to COVID-19 pandemic|3|||
162973717|NCT04126343|588603336|FG005|Overall Study|Related to COVID-19 pandemic|3|||
162973718|NCT01235442|588603337|FG000|Overall Study|Lost to Follow-up|12|||
163209548|NCT01782495|589480681|FG006|Overall Study|Adverse Event|0|||
162973719|NCT01235442|588603338|FG001|Overall Study|Lost to Follow-up|10|||
162973720|NCT01235442|588603337|FG000|Overall Study|Death|0|||
162973721|NCT01235442|588603338|FG001|Overall Study|Death|2|||
162973722|NCT01235442|588603337|FG000|Overall Study|Pregnancy|1|||
162973723|NCT01235442|588603338|FG001|Overall Study|Pregnancy|1|||
162973724|NCT01235442|588603337|FG000|Overall Study|Ineligibility determined|5|||
162973725|NCT01235442|588603338|FG001|Overall Study|Ineligibility determined|4|||
162973726|NCT01235442|588603337|FG000|Overall Study|Protocol Violation|3|||
162973727|NCT01235442|588603338|FG001|Overall Study|Protocol Violation|3|||
162973728|NCT01235442|588603337|FG000|Overall Study|Adverse Event|4|||
162973729|NCT01235442|588603338|FG001|Overall Study|Adverse Event|6|||
162973730|NCT01235442|588603337|FG000|Overall Study|Withdrawal by Subject|15|||
162973731|NCT01235442|588603338|FG001|Overall Study|Withdrawal by Subject|9|||
162973732|NCT01235442|588603337|FG000|Overall Study|Lack of Efficacy|1|||
162973733|NCT01235442|588603338|FG001|Overall Study|Lack of Efficacy|3|||
162973734|NCT01235442|588603337|FG000|Overall Study|Noncompliance|1|||
162973735|NCT01235442|588603338|FG001|Overall Study|Noncompliance|2|||
162973736|NCT01235442|588603337|FG000|Overall Study|Administrative decision|1|||
162973737|NCT01235442|588603338|FG001|Overall Study|Administrative decision|2|||
162973738|NCT01235442|588603337|FG000|Overall Study|Other unspecified|1|||
162973739|NCT01235442|588603338|FG001|Overall Study|Other unspecified|2|||
162973740|NCT01701973|588603345|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
162973741|NCT01701973|588603346|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
162973742|NCT01701973|588603347|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
162973743|NCT01701973|588603348|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
162973744|NCT01701973|588603349|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
162973745|NCT01701973|588603350|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
162973746|NCT01701973|588603351|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
162973747|NCT01701973|588603352|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
162973748|NCT02663882|588603353|FG000|Overall Study|Lost to Follow-up|4|||
162973749|NCT02663882|588603354|FG001|Overall Study|Lost to Follow-up|2|||
162973750|NCT03712124|588603355|FG000|Overall Study|Protocol Violation|1|||
162973751|NCT03712124|588603356|FG001|Overall Study|Protocol Violation|0|||
162973752|NCT00602537|588603360|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
162973753|NCT00602537|588603361|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
162973754|NCT00602537|588603360|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
162973755|NCT00602537|588603361|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
162973756|NCT00602537|588603360|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
162973757|NCT00602537|588603361|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
162973758|NCT00602537|588603360|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
162973759|NCT00602537|588603361|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
162973760|NCT00602537|588603360|FG000|Follow Up Study Comparison|Adverse Event|1|||
162973761|NCT00602537|588603361|FG001|Follow Up Study Comparison|Adverse Event|0|||
162973762|NCT00602537|588603360|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
162973763|NCT00602537|588603361|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
162973764|NCT00602537|588603360|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
162973765|NCT00602537|588603361|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
162973766|NCT02941523|588603362|FG000|Monotherapy|Withdrawal by Subject|0|||
162973767|NCT02941523|588603363|FG001|Monotherapy|Withdrawal by Subject|1|||
162973768|NCT02941523|588603362|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
162973769|NCT02941523|588603363|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
162973770|NCT02941523|588603362|FG000|Carboplatin Combination Therapy|Death|1|||
162973771|NCT02941523|588603363|FG001|Carboplatin Combination Therapy|Death|2|||
162973772|NCT02941523|588603362|FG000|Carboplatin Combination Therapy|Disease progression|2|||
162973773|NCT02941523|588603363|FG001|Carboplatin Combination Therapy|Disease progression|0|||
162973774|NCT02941523|588603362|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
162973775|NCT02941523|588603363|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
163209549|NCT01782495|589480682|FG007|Overall Study|Adverse Event|2|||
163209550|NCT01782495|589480683|FG008|Overall Study|Adverse Event|0|||
163209551|NCT01782495|589480684|FG009|Overall Study|Adverse Event|0|||
163209552|NCT01782495|589480685|FG010|Overall Study|Adverse Event|0|||
163209553|NCT01782495|589480675|FG000|Overall Study|Withdrew Consent|0|||
163209554|NCT01782495|589480676|FG001|Overall Study|Withdrew Consent|1|||
163209555|NCT01782495|589480677|FG002|Overall Study|Withdrew Consent|0|||
163209556|NCT01782495|589480678|FG003|Overall Study|Withdrew Consent|0|||
163209557|NCT01782495|589480679|FG004|Overall Study|Withdrew Consent|0|||
163209558|NCT01782495|589480680|FG005|Overall Study|Withdrew Consent|0|||
163209559|NCT01782495|589480681|FG006|Overall Study|Withdrew Consent|0|||
163209560|NCT01782495|589480682|FG007|Overall Study|Withdrew Consent|1|||
163209561|NCT01782495|589480683|FG008|Overall Study|Withdrew Consent|0|||
163209562|NCT01782495|589480684|FG009|Overall Study|Withdrew Consent|0|||
163209563|NCT01782495|589480685|FG010|Overall Study|Withdrew Consent|0|||
163209564|NCT00396591|589480690|FG000|Overall Study|Disease Progression|13|||
163209565|NCT00396591|589480690|FG000|Overall Study|Adverse Event|2|||
163209566|NCT00396591|589480690|FG000|Overall Study|Participant request|1|||
163209567|NCT01962207|589480691|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
162973776|NCT04330157|588603364|FG000|Overall Study|Protocol Violation|4|||
162973777|NCT04330157|588603364|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
162973778|NCT04314843|588603365|FG000|Overall Study|Death|2|||
162973779|NCT04314843|588603366|FG001|Overall Study|Death|2|||
162973780|NCT04314843|588603365|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
162973781|NCT04314843|588603366|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
162973782|NCT00869440|588603367|FG000|Overall Study|Withdrawal by Subject|1|||
162973783|NCT00869440|588603368|FG001|Overall Study|Withdrawal by Subject|0|||
162973784|NCT00869440|588603369|FG002|Overall Study|Withdrawal by Subject|0|||
162973785|NCT00869440|588603370|FG003|Overall Study|Withdrawal by Subject|0|||
162973786|NCT00869440|588603367|FG000|Overall Study|Physician Decision|1|||
162973787|NCT00869440|588603368|FG001|Overall Study|Physician Decision|1|||
162973788|NCT00869440|588603369|FG002|Overall Study|Physician Decision|0|||
162973789|NCT00869440|588603370|FG003|Overall Study|Physician Decision|0|||
162973790|NCT01899326|588603371|FG000|Overall Study|Withdrawal by Subject|1|||
162973791|NCT01899326|588603371|FG000|Overall Study|Adverse Event|2|||
162973792|NCT01899326|588603371|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
162973793|NCT03581188|588605592|FG000|Overall Study|Inclusion criteria not met|3|||
162973794|NCT03581188|588605593|FG001|Overall Study|Inclusion criteria not met|2|||
162973795|NCT03581188|588605592|FG000|Overall Study|Lost to Follow-up|5|||
162973796|NCT03581188|588605593|FG001|Overall Study|Lost to Follow-up|5|||
162973797|NCT03581188|588605592|FG000|Overall Study|Discontinued intervention|11|||
162973798|NCT03581188|588605593|FG001|Overall Study|Discontinued intervention|8|||
162973799|NCT00109837|588605596|FG000|Overall Study|Adverse Event|2|||
162973800|NCT00109837|588605596|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
162973801|NCT00109837|588605596|FG000|Overall Study|Death|1|||
162973802|NCT00109837|588605596|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
162973803|NCT00109837|588605596|FG000|Overall Study|Not treated|1|||
162973804|NCT00109837|588605596|FG000|Overall Study|Ineligible|1|||
162973805|NCT01989676|588605597|FG000|Overall Study|Death|52|||
162973806|NCT01989676|588605598|FG001|Overall Study|Death|60|||
162973807|NCT01989676|588605597|FG000|Overall Study|Protocol Violation|2|||
162973808|NCT01989676|588605598|FG001|Overall Study|Protocol Violation|1|||
162973809|NCT01989676|588605597|FG000|Overall Study|Lost to Follow-up|8|||
162973810|NCT01989676|588605598|FG001|Overall Study|Lost to Follow-up|18|||
162973811|NCT01989676|588605597|FG000|Overall Study|No longer willing to participate in study|26|||
162973812|NCT01989676|588605598|FG001|Overall Study|No longer willing to participate in study|26|||
162973813|NCT01989676|588605597|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
162973814|NCT01989676|588605598|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
162973815|NCT01989676|588605597|FG000|Overall Study|Other|4|||
162973816|NCT01989676|588605598|FG001|Overall Study|Other|3|||
162973817|NCT01619579|588605599|FG000|Overall Study|Withdrawal by Subject|0|||
162973818|NCT01619579|588605600|FG001|Overall Study|Withdrawal by Subject|3|||
162973819|NCT02190279|588605602|FG000|Overall Study|Withdrawal consent|1|||
162973820|NCT02190279|588605603|FG001|Overall Study|Withdrawal consent|0|||
162973821|NCT02190279|588605604|FG002|Overall Study|Withdrawal consent|1|||
162973822|NCT02190279|588605602|FG000|Overall Study|Lost to Follow-up|2|||
162973823|NCT02190279|588605603|FG001|Overall Study|Lost to Follow-up|0|||
162973824|NCT02190279|588605604|FG002|Overall Study|Lost to Follow-up|0|||
162973825|NCT02190279|588605602|FG000|Overall Study|Refused further treatment|0|||
162973826|NCT02190279|588605603|FG001|Overall Study|Refused further treatment|0|||
162973827|NCT02190279|588605604|FG002|Overall Study|Refused further treatment|1|||
162973828|NCT02190279|588605602|FG000|Overall Study|Screening failure|0|||
162973829|NCT02190279|588605603|FG001|Overall Study|Screening failure|0|||
162973830|NCT02190279|588605604|FG002|Overall Study|Screening failure|1|||
162973831|NCT02688387|588605605|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973832|NCT02688387|588605606|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973833|NCT02688387|588605607|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
162973834|NCT02688387|588605608|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
163318026|NCT01928394|589874957|FG011|Follow-up Period|Death|12|||
163318027|NCT01928394|589874958|FG012|Follow-up Period|Death|11|||
163318028|NCT01928394|589874959|FG013|Follow-up Period|Death|25|||
163318029|NCT01928394|589874960|FG014|Follow-up Period|Death|18|||
162973835|NCT02688387|588605609|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973836|NCT02688387|588605610|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973837|NCT02688387|588605611|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973838|NCT02688387|588605612|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973839|NCT02688387|588605613|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973840|NCT02688387|588605614|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973841|NCT02688387|588605615|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973842|NCT02688387|588605616|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973843|NCT02688387|588605617|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973844|NCT02688387|588605618|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973845|NCT02688387|588605619|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
163318030|NCT01928394|589874961|FG015|Follow-up Period|Death|0|||
163318031|NCT01928394|589874962|FG016|Follow-up Period|Death|6|||
162973846|NCT02688387|588605620|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973847|NCT02688387|588605621|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973848|NCT02688387|588605622|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
163209568|NCT01962207|589480692|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
162973849|NCT02688387|588605623|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973850|NCT02688387|588605624|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973851|NCT02688387|588605625|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973852|NCT02688387|588605626|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973853|NCT02688387|588605605|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973854|NCT02688387|588605606|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973855|NCT02688387|588605607|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973856|NCT02688387|588605608|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
162973857|NCT02688387|588605609|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973858|NCT02688387|588605610|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973859|NCT02688387|588605611|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973860|NCT02688387|588605612|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973861|NCT02688387|588605613|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973862|NCT02688387|588605614|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973863|NCT02688387|588605615|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973864|NCT02688387|588605616|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973865|NCT02688387|588605617|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973866|NCT02688387|588605618|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973867|NCT02688387|588605619|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973868|NCT02688387|588605620|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973869|NCT02688387|588605621|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973870|NCT02688387|588605622|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973871|NCT02688387|588605623|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973872|NCT02688387|588605624|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973873|NCT02688387|588605625|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973874|NCT02688387|588605626|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973875|NCT02688387|588605605|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973876|NCT02688387|588605606|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
162973877|NCT02688387|588605607|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973878|NCT02688387|588605608|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973879|NCT02688387|588605609|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973880|NCT02688387|588605610|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973881|NCT02688387|588605611|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973882|NCT02688387|588605612|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973883|NCT02688387|588605613|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973884|NCT02688387|588605614|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973885|NCT02688387|588605615|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973886|NCT02688387|588605616|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973887|NCT02688387|588605617|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973888|NCT02688387|588605618|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973889|NCT02688387|588605619|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973890|NCT02688387|588605620|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973891|NCT02688387|588605621|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973892|NCT02688387|588605622|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973893|NCT02688387|588605623|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973894|NCT02688387|588605624|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973895|NCT02688387|588605625|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973896|NCT02688387|588605626|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973897|NCT02688387|588605605|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973898|NCT02688387|588605606|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973899|NCT02688387|588605607|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
162973900|NCT02688387|588605608|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973901|NCT02688387|588605609|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
162973902|NCT02688387|588605610|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973903|NCT02688387|588605611|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973904|NCT02688387|588605612|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973905|NCT02688387|588605613|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973906|NCT02688387|588605614|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973907|NCT02688387|588605615|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973908|NCT02688387|588605616|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
163209569|NCT01962207|589480693|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
163209570|NCT01962207|589480694|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
163209571|NCT01962207|589480691|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
163209572|NCT01962207|589480692|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
163209573|NCT01962207|589480693|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
163209574|NCT01962207|589480694|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
163209575|NCT01962207|589480691|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
163209576|NCT01962207|589480692|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
163209577|NCT01962207|589480693|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
163209578|NCT01962207|589480694|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
163209579|NCT01962207|589480691|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
163209580|NCT01962207|589480692|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
163209581|NCT01962207|589480693|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
163209582|NCT01962207|589480694|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
163209583|NCT01962207|589480691|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
163209584|NCT01962207|589480692|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
163209585|NCT01962207|589480693|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
163209586|NCT01962207|589480694|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
163209587|NCT01962207|589480691|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
163209588|NCT01962207|589480692|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
163209589|NCT01962207|589480693|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
163209590|NCT01962207|589480694|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
163209591|NCT01535053|589480695|FG000|Overall Study|Ineligible|1|||
163209592|NCT01535053|589480696|FG001|Overall Study|Ineligible|2|||
163209593|NCT00512707|589480697|FG000|Overall Study|Lost to Follow-up|5|||
163209594|NCT00512707|589480698|FG001|Overall Study|Lost to Follow-up|11|||
163209595|NCT00512707|589480697|FG000|Overall Study|Developed skin irritation|2|||
163209596|NCT00512707|589480698|FG001|Overall Study|Developed skin irritation|1|||
163209597|NCT00512707|589480697|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
163209598|NCT00512707|589480698|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
163209599|NCT00512707|589480697|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
163209600|NCT00512707|589480698|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
163209601|NCT03653637|589482914|FG000|Overall Study|Death|1|||
163209602|NCT03653637|589482915|FG001|Overall Study|Death|3|||
163209603|NCT03653637|589482914|FG000|Overall Study|Lost to Follow-up|29|||
163209604|NCT03653637|589482915|FG001|Overall Study|Lost to Follow-up|30|||
163209605|NCT03653637|589482914|FG000|Overall Study|Physician Decision|1|||
163209606|NCT03653637|589482915|FG001|Overall Study|Physician Decision|1|||
163209607|NCT03653637|589482914|FG000|Overall Study|Withdrawal by Subject|7|||
163209608|NCT03653637|589482915|FG001|Overall Study|Withdrawal by Subject|4|||
163209609|NCT02068443|589482918|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
163209610|NCT02068443|589482919|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
163209611|NCT02068443|589482920|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
163209612|NCT02068443|589482918|FG000|Overall Study|Voluntary Withdrawal|4|||
163209613|NCT02068443|589482919|FG001|Overall Study|Voluntary Withdrawal|0|||
163209614|NCT02068443|589482920|FG002|Overall Study|Voluntary Withdrawal|1|||
163209615|NCT02068443|589482918|FG000|Overall Study|Lack of Efficacy|2|||
163209616|NCT02068443|589482919|FG001|Overall Study|Lack of Efficacy|1|||
163209617|NCT02068443|589482920|FG002|Overall Study|Lack of Efficacy|0|||
163209618|NCT02068443|589482918|FG000|Overall Study|Other Reason Not Specified|1|||
163209619|NCT02068443|589482919|FG001|Overall Study|Other Reason Not Specified|0|||
162973909|NCT02688387|588605617|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973910|NCT02688387|588605618|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973911|NCT02688387|588605619|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973912|NCT02688387|588605620|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973913|NCT02688387|588605621|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973914|NCT02688387|588605622|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973915|NCT02688387|588605623|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973916|NCT02688387|588605624|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973917|NCT02688387|588605625|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973918|NCT02688387|588605626|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973919|NCT02688387|588605605|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
163209620|NCT02068443|589482920|FG002|Overall Study|Other Reason Not Specified|0|||
163401332|NCT01438489|590181133|FG000|Overall Study|Lost to Follow-up|4|||
163209621|NCT02723084|589482922|FG000|Overall Study|Withdrawal by Subject|1|||
163209622|NCT02723084|589482923|FG001|Overall Study|Withdrawal by Subject|1|||
163209623|NCT02723084|589482922|FG000|Overall Study|Lost to Follow-up|3|||
162973920|NCT02688387|588605606|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973921|NCT02688387|588605607|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973922|NCT02688387|588605608|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973923|NCT02688387|588605609|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973924|NCT02688387|588605610|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973925|NCT02688387|588605611|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973926|NCT02688387|588605612|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973927|NCT02688387|588605613|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973928|NCT02688387|588605614|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973929|NCT02688387|588605615|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973930|NCT02688387|588605616|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973931|NCT02688387|588605617|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973932|NCT02688387|588605618|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973933|NCT02688387|588605619|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973934|NCT02688387|588605620|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973935|NCT02688387|588605621|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973936|NCT02688387|588605622|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973937|NCT02688387|588605623|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973938|NCT02688387|588605624|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973939|NCT02688387|588605625|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973940|NCT02688387|588605626|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973941|NCT02688387|588605605|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973942|NCT02688387|588605606|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973943|NCT02688387|588605607|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973944|NCT02688387|588605608|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973945|NCT02688387|588605609|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973946|NCT02688387|588605610|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973947|NCT02688387|588605611|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973948|NCT02688387|588605612|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973949|NCT02688387|588605613|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973950|NCT02688387|588605614|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973951|NCT02688387|588605615|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
162973952|NCT02688387|588605616|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973953|NCT02688387|588605617|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973954|NCT02688387|588605618|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973955|NCT02688387|588605619|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973956|NCT02688387|588605620|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973957|NCT02688387|588605621|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973958|NCT02688387|588605622|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973959|NCT02688387|588605623|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973960|NCT02688387|588605624|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973961|NCT02688387|588605625|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973962|NCT02688387|588605626|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973963|NCT02688387|588605605|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973964|NCT02688387|588605606|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973965|NCT02688387|588605607|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973966|NCT02688387|588605608|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973967|NCT02688387|588605609|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973968|NCT02688387|588605610|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973969|NCT02688387|588605611|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973970|NCT02688387|588605612|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973971|NCT02688387|588605613|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973972|NCT02688387|588605614|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973973|NCT02688387|588605615|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973974|NCT02688387|588605616|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973975|NCT02688387|588605617|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973976|NCT02688387|588605618|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973977|NCT02688387|588605619|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
162973978|NCT02688387|588605620|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973979|NCT02688387|588605621|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973980|NCT02688387|588605622|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973981|NCT02688387|588605623|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973982|NCT02688387|588605624|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973983|NCT02688387|588605625|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973984|NCT02688387|588605626|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973985|NCT02688387|588605605|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973986|NCT02688387|588605606|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
163057299|NCT02194465|588921209|FG006|Overall Study|Withdrawal by Subject|2|||
163057300|NCT02194465|588921203|FG000|Overall Study|Discontinued follow-up period|0|||
163057301|NCT02194465|588921204|FG001|Overall Study|Discontinued follow-up period|2|||
163057302|NCT02194465|588921205|FG002|Overall Study|Discontinued follow-up period|1|||
163057303|NCT02194465|588921206|FG003|Overall Study|Discontinued follow-up period|0|||
163057304|NCT02194465|588921207|FG004|Overall Study|Discontinued follow-up period|2|||
163057305|NCT02194465|588921208|FG005|Overall Study|Discontinued follow-up period|0|||
162973987|NCT02688387|588605607|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973988|NCT02688387|588605608|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973989|NCT02688387|588605609|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973990|NCT02688387|588605610|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973991|NCT02688387|588605611|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973992|NCT02688387|588605612|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973993|NCT02688387|588605613|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973994|NCT02688387|588605614|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973995|NCT02688387|588605615|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973996|NCT02688387|588605616|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973997|NCT02688387|588605617|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
163057306|NCT02194465|588921209|FG006|Overall Study|Discontinued follow-up period|0|||
163057307|NCT00420745|588921210|FG000|Overall Study|Adverse Event|2|||
163057308|NCT00420745|588921211|FG001|Overall Study|Adverse Event|2|||
163057309|NCT00420745|588921210|FG000|Overall Study|Lost to Follow-up|10|||
162973998|NCT02688387|588605618|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973999|NCT02688387|588605619|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162974000|NCT02688387|588605620|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162974001|NCT02688387|588605621|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162974002|NCT02688387|588605622|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162974003|NCT02688387|588605623|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162974004|NCT02688387|588605624|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162974005|NCT02688387|588605625|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
162974006|NCT02688387|588605626|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162974007|NCT02688387|588605605|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974008|NCT02688387|588605606|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974009|NCT02688387|588605607|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974010|NCT02688387|588605608|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974011|NCT02688387|588605609|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
163057310|NCT00420745|588921211|FG001|Overall Study|Lost to Follow-up|2|||
163057311|NCT00420745|588921210|FG000|Overall Study|Protocol Violation|1|||
163057312|NCT00420745|588921211|FG001|Overall Study|Protocol Violation|0|||
163057313|NCT00420745|588921210|FG000|Overall Study|Physician Decision|1|||
163057314|NCT00420745|588921211|FG001|Overall Study|Physician Decision|1|||
163057315|NCT00420745|588921210|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
163057316|NCT00420745|588921211|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
163057317|NCT00420745|588921210|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
163057318|NCT00420745|588921211|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
163057319|NCT02058095|588921212|FG000|Overall Study|Adverse Event|1|||
163057320|NCT02058095|588921213|FG001|Overall Study|Adverse Event|0|||
163057321|NCT00726453|588921214|FG000|Primary Enrollment Group|Death|18|||
163057322|NCT00726453|588921215|FG001|Primary Enrollment Group|Death|0|||
163057323|NCT00726453|588921214|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
163057324|NCT00726453|588921215|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
163057325|NCT00726453|588921214|FG000|38 mm Length Group|Death|0|||
163057326|NCT00726453|588921215|FG001|38 mm Length Group|Death|3|||
163057327|NCT01983930|588921218|FG000|Overall Study|Withdrawal by Subject|9|||
163057328|NCT01983930|588921219|FG001|Overall Study|Withdrawal by Subject|8|||
163057329|NCT01983930|588921218|FG000|Overall Study|Adverse Event|0|||
163318032|NCT01928394|589874963|FG017|Follow-up Period|Death|5|||
163318033|NCT01928394|589874964|FG018|Follow-up Period|Death|13|||
163318034|NCT01928394|589874965|FG019|Follow-up Period|Death|13|||
163318035|NCT01928394|589874966|FG020|Follow-up Period|Death|5|||
163318036|NCT01928394|589874967|FG021|Follow-up Period|Death|3|||
162974012|NCT02688387|588605610|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974013|NCT02688387|588605611|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974014|NCT02688387|588605612|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974015|NCT02688387|588605613|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974016|NCT02688387|588605614|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
163057330|NCT01983930|588921219|FG001|Overall Study|Adverse Event|1|||
163057331|NCT01454284|588921220|FG000|Overall Study|Adverse Event|20|||
163057332|NCT01454284|588921221|FG001|Overall Study|Adverse Event|7|||
163057333|NCT01454284|588921220|FG000|Overall Study|Death|0|||
163057334|NCT01454284|588921221|FG001|Overall Study|Death|3|||
163318037|NCT01928394|589874968|FG022|Follow-up Period|Death|2|||
163318038|NCT01928394|589874946|FG000|Follow-up Period|other reason|0|||
162974017|NCT02688387|588605615|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974018|NCT02688387|588605616|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974019|NCT02688387|588605617|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974020|NCT02688387|588605618|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974021|NCT02688387|588605619|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974022|NCT02688387|588605620|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974023|NCT02688387|588605621|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974024|NCT02688387|588605622|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974025|NCT02688387|588605623|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
162974026|NCT02688387|588605624|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974027|NCT02688387|588605625|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
162974028|NCT02688387|588605626|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974029|NCT02688387|588605605|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974030|NCT02688387|588605606|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974031|NCT02688387|588605607|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974032|NCT02688387|588605608|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974033|NCT02688387|588605609|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974034|NCT02688387|588605610|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974035|NCT02688387|588605611|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974036|NCT02688387|588605612|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974037|NCT02688387|588605613|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
163057335|NCT01454284|588921220|FG000|Overall Study|Lost to Follow-up|13|||
163057336|NCT01454284|588921221|FG001|Overall Study|Lost to Follow-up|8|||
163057337|NCT01454284|588921220|FG000|Overall Study|Protocol Violation|9|||
162974038|NCT02688387|588605614|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974039|NCT02688387|588605615|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974040|NCT02688387|588605616|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974041|NCT02688387|588605617|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974042|NCT02688387|588605618|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974043|NCT02688387|588605619|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974044|NCT02688387|588605620|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974045|NCT02688387|588605621|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974046|NCT02688387|588605622|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974047|NCT02688387|588605623|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974048|NCT02688387|588605624|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
162974049|NCT02688387|588605625|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974050|NCT02688387|588605626|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974051|NCT02938442|588605627|FG000|Overall Study|Death|0|||
162974052|NCT02938442|588605628|FG001|Overall Study|Death|1|||
162974053|NCT02938442|588605627|FG000|Overall Study|Lost to Follow-up|0|||
162974054|NCT02938442|588605628|FG001|Overall Study|Lost to Follow-up|1|||
162974055|NCT02938442|588605627|FG000|Overall Study|Physician Decision|0|||
162974056|NCT02938442|588605628|FG001|Overall Study|Physician Decision|1|||
162974057|NCT02938442|588605627|FG000|Overall Study|Withdrawal by Subject|2|||
162974058|NCT02938442|588605628|FG001|Overall Study|Withdrawal by Subject|0|||
162974059|NCT00802178|588605629|FG000|Overall Study|Lack of Efficacy|36|||
162974060|NCT00802178|588605629|FG000|Overall Study|Insufficient tolerability (IT)|17|||
162974061|NCT00802178|588605629|FG000|Overall Study|Withdrawal by Subject|18|||
162974062|NCT00802178|588605629|FG000|Overall Study|Other|32|||
162974063|NCT00802178|588605629|FG000|Overall Study|Lack of efficacy and patient wish|1|||
162974064|NCT00802178|588605629|FG000|Overall Study|IT and patient wish|8|||
162974065|NCT00802178|588605629|FG000|Overall Study|Patients wish and other reason|1|||
162974066|NCT01606228|588605630|FG000|Overall Study|Lost to Follow-up|20|||
162974067|NCT01606228|588605630|FG000|Overall Study|Withdrawal by Subject|3|||
162974068|NCT01606228|588605630|FG000|Overall Study|Non-compliant|3|||
162974069|NCT01606228|588605630|FG000|Overall Study|Lack of Efficacy|2|||
162974070|NCT01606228|588605630|FG000|Overall Study|Adverse Event|1|||
162974071|NCT01115855|588605631|FG000|Overall Study|Adverse Event|16|||
162974072|NCT01115855|588605632|FG001|Overall Study|Adverse Event|18|||
162974073|NCT01115855|588605631|FG000|Overall Study|Death|6|||
162974074|NCT01115855|588605632|FG001|Overall Study|Death|5|||
163057338|NCT01454284|588921221|FG001|Overall Study|Protocol Violation|6|||
163057339|NCT01454284|588921220|FG000|Overall Study|Withdrawal by Subject|58|||
163057340|NCT01454284|588921221|FG001|Overall Study|Withdrawal by Subject|36|||
163057341|NCT01454284|588921220|FG000|Overall Study|Physician Decision|16|||
163057342|NCT01454284|588921221|FG001|Overall Study|Physician Decision|11|||
162974075|NCT01115855|588605631|FG000|Overall Study|Lab Abnormality|1|||
162974076|NCT01115855|588605632|FG001|Overall Study|Lab Abnormality|1|||
162974077|NCT01115855|588605631|FG000|Overall Study|Protocol Violation|0|||
162974078|NCT01115855|588605632|FG001|Overall Study|Protocol Violation|1|||
162974079|NCT01115855|588605631|FG000|Overall Study|Withdrawal by Subject|5|||
163057343|NCT01454284|588921220|FG000|Overall Study|Sponsor Decision|0|||
163057344|NCT01454284|588921221|FG001|Overall Study|Sponsor Decision|2|||
162974080|NCT01115855|588605632|FG001|Overall Study|Withdrawal by Subject|5|||
162974081|NCT01115855|588605631|FG000|Overall Study|Other|8|||
162974082|NCT01115855|588605632|FG001|Overall Study|Other|6|||
162974083|NCT04100096|588605633|FG000|Overall Study|Adverse Event|19|||
162974084|NCT04100096|588605634|FG001|Overall Study|Adverse Event|7|||
162974085|NCT04100096|588605633|FG000|Overall Study|Lack of Efficacy|0|||
162974086|NCT04100096|588605634|FG001|Overall Study|Lack of Efficacy|1|||
162974087|NCT04100096|588605633|FG000|Overall Study|Lost to Follow-up|13|||
162974088|NCT04100096|588605634|FG001|Overall Study|Lost to Follow-up|11|||
162974089|NCT04100096|588605633|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162974090|NCT04100096|588605634|FG001|Overall Study|Non-Compliance With Study Drug|3|||
162974091|NCT04100096|588605633|FG000|Overall Study|Protocol Deviation|1|||
162974092|NCT04100096|588605634|FG001|Overall Study|Protocol Deviation|1|||
162974093|NCT04100096|588605633|FG000|Overall Study|Withdrawal by Participant|13|||
162974094|NCT04100096|588605634|FG001|Overall Study|Withdrawal by Participant|15|||
162974095|NCT01684215|588605635|FG000|Phase 1, Part 1|Adverse Event|1|||
162974096|NCT01684215|588605636|FG001|Phase 1, Part 1|Adverse Event|0|||
162974097|NCT01684215|588605637|FG002|Phase 1, Part 1|Adverse Event|0|||
162974098|NCT01684215|588605638|FG003|Phase 1, Part 1|Adverse Event|0|||
162974099|NCT01684215|588605635|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
162974100|NCT01684215|588605636|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
162974101|NCT01684215|588605637|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
162974102|NCT01684215|588605638|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
162974103|NCT01684215|588605635|FG000|Phase 1, Part 2|Adverse Event|0|||
162974104|NCT01684215|588605636|FG001|Phase 1, Part 2|Adverse Event|0|||
162974105|NCT01684215|588605637|FG002|Phase 1, Part 2|Adverse Event|1|||
162974106|NCT01684215|588605638|FG003|Phase 1, Part 2|Adverse Event|0|||
162974107|NCT01684215|588605635|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
162974108|NCT01684215|588605636|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
162974109|NCT01684215|588605637|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
162974110|NCT01684215|588605638|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
162974111|NCT01684215|588605635|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
162974112|NCT01684215|588605636|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
162974113|NCT01684215|588605637|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
162974114|NCT01684215|588605638|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
162974115|NCT01684215|588605635|FG000|Phase 2|Death|0|||
162974116|NCT01684215|588605636|FG001|Phase 2|Death|0|||
162974117|NCT01684215|588605637|FG002|Phase 2|Death|0|||
162974118|NCT01684215|588605638|FG003|Phase 2|Death|8|||
162974119|NCT01684215|588605635|FG000|Phase 2|Study terminated by sponsor|0|||
162974120|NCT01684215|588605636|FG001|Phase 2|Study terminated by sponsor|0|||
162974121|NCT01684215|588605637|FG002|Phase 2|Study terminated by sponsor|0|||
162974122|NCT01684215|588605638|FG003|Phase 2|Study terminated by sponsor|30|||
162974123|NCT01684215|588605635|FG000|Phase 2|Enrolled but not treated|0|||
162974124|NCT01684215|588605636|FG001|Phase 2|Enrolled but not treated|0|||
162974125|NCT01684215|588605637|FG002|Phase 2|Enrolled but not treated|0|||
162974126|NCT01684215|588605638|FG003|Phase 2|Enrolled but not treated|1|||
162974127|NCT01684215|588605635|FG000|Phase 2|Lost to Follow-up|0|||
162974128|NCT01684215|588605636|FG001|Phase 2|Lost to Follow-up|0|||
162974129|NCT01684215|588605637|FG002|Phase 2|Lost to Follow-up|0|||
162974130|NCT01684215|588605638|FG003|Phase 2|Lost to Follow-up|4|||
162974131|NCT00480324|588605639|FG000|Overall Study|Adverse Event|1|||
162974132|NCT00480324|588605640|FG001|Overall Study|Adverse Event|1|||
162974133|NCT00480324|588605639|FG000|Overall Study|Protocol Violation|0|||
162974134|NCT00480324|588605640|FG001|Overall Study|Protocol Violation|1|||
162974135|NCT00480324|588605639|FG000|Overall Study|Withdrawal by Subject|14|||
163318039|NCT01928394|589874947|FG001|Follow-up Period|other reason|0|||
163318040|NCT01928394|589874948|FG002|Follow-up Period|other reason|0|||
163318041|NCT01928394|589874949|FG003|Follow-up Period|other reason|0|||
163318042|NCT01928394|589874950|FG004|Follow-up Period|other reason|0|||
163318043|NCT01928394|589874951|FG005|Follow-up Period|other reason|0|||
163318044|NCT01928394|589874952|FG006|Follow-up Period|other reason|1|||
163318045|NCT01928394|589874953|FG007|Follow-up Period|other reason|3|||
163318046|NCT01928394|589874954|FG008|Follow-up Period|other reason|0|||
163318047|NCT01928394|589874955|FG009|Follow-up Period|other reason|0|||
163318048|NCT01928394|589874956|FG010|Follow-up Period|other reason|2|||
162974136|NCT00480324|588605640|FG001|Overall Study|Withdrawal by Subject|5|||
162974137|NCT00480324|588605639|FG000|Overall Study|Lost to Follow-up|17|||
162974138|NCT00480324|588605640|FG001|Overall Study|Lost to Follow-up|8|||
162974139|NCT00480324|588605639|FG000|Overall Study|Subject's mother pregnant|0|||
162974140|NCT00480324|588605640|FG001|Overall Study|Subject's mother pregnant|1|||
162974141|NCT00784134|588605641|FG000|Overall Study|Lost to Follow-up|3|||
162974142|NCT00784134|588605642|FG001|Overall Study|Lost to Follow-up|6|||
162974143|NCT03785145|588605643|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
162974144|NCT03785145|588605644|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
162974145|NCT03785145|588605643|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
163318049|NCT01928394|589874957|FG011|Follow-up Period|other reason|1|||
163318050|NCT01928394|589874958|FG012|Follow-up Period|other reason|0|||
163318051|NCT01928394|589874959|FG013|Follow-up Period|other reason|1|||
163209624|NCT02723084|589482923|FG001|Overall Study|Lost to Follow-up|0|||
163209625|NCT04067544|589482928|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
163209626|NCT01320085|589482929|FG000|Overall Study|Disease Progression|26|||
163209627|NCT01320085|589482930|FG001|Overall Study|Disease Progression|93|||
163209628|NCT01320085|589482931|FG002|Overall Study|Disease Progression|17|||
163209629|NCT01320085|589482929|FG000|Overall Study|Adverse Event|12|||
163209630|NCT01320085|589482930|FG001|Overall Study|Adverse Event|20|||
163209631|NCT01320085|589482931|FG002|Overall Study|Adverse Event|5|||
163209632|NCT01320085|589482929|FG000|Overall Study|Withdrawal by Subject|2|||
163209633|NCT01320085|589482930|FG001|Overall Study|Withdrawal by Subject|4|||
163209634|NCT01320085|589482931|FG002|Overall Study|Withdrawal by Subject|1|||
163209635|NCT01320085|589482929|FG000|Overall Study|Protocol Deviation|1|||
163209636|NCT01320085|589482930|FG001|Overall Study|Protocol Deviation|0|||
163209637|NCT01320085|589482931|FG002|Overall Study|Protocol Deviation|1|||
163209638|NCT01320085|589482929|FG000|Overall Study|Administrative problems|0|||
163209639|NCT01320085|589482930|FG001|Overall Study|Administrative problems|0|||
163209640|NCT01320085|589482931|FG002|Overall Study|Administrative problems|1|||
163209641|NCT00225251|589482934|FG000|Overall Study|Withdrawal by Subject|1|||
162974146|NCT03785145|588605644|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
162974147|NCT03785145|588605643|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
162974148|NCT03785145|588605644|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
162974149|NCT03785145|588605643|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
162974150|NCT03785145|588605644|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
162974151|NCT03785145|588605643|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
162974152|NCT03785145|588605644|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
162974153|NCT03785145|588605643|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
162974154|NCT03785145|588605644|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
162974155|NCT03785145|588605643|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
162974156|NCT03785145|588605644|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
162974157|NCT03785145|588605643|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
162974158|NCT03785145|588605644|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
162974159|NCT03785145|588605643|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
162974160|NCT03785145|588605644|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
162974161|NCT03785145|588605643|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
162974162|NCT03785145|588605644|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
162974163|NCT03785145|588605643|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
162974164|NCT03785145|588605644|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
162974165|NCT01796964|588605647|FG000|Overall Study|Adverse Event|1|||
162974166|NCT01796964|588605648|FG001|Overall Study|Adverse Event|1|||
162974167|NCT01796964|588605647|FG000|Overall Study|Death|1|||
162974168|NCT01796964|588605648|FG001|Overall Study|Death|0|||
162974169|NCT01796964|588605647|FG000|Overall Study|Protocol Violation|0|||
162974170|NCT01796964|588605648|FG001|Overall Study|Protocol Violation|1|||
162974171|NCT01796964|588605647|FG000|Overall Study|Withdrawal by Subject|1|||
162974172|NCT01796964|588605648|FG001|Overall Study|Withdrawal by Subject|1|||
162974173|NCT04025684|588605649|FG000|Overall Study|Withdrawal by Subject|1|||
162974174|NCT04025684|588605650|FG001|Overall Study|Withdrawal by Subject|1|||
162974175|NCT04025684|588605651|FG002|Overall Study|Withdrawal by Subject|0|||
162974176|NCT04025684|588605652|FG003|Overall Study|Withdrawal by Subject|0|||
162974177|NCT04025684|588605649|FG000|Overall Study|Multiple reasons|1|||
162974178|NCT04025684|588605650|FG001|Overall Study|Multiple reasons|3|||
162974179|NCT04025684|588605651|FG002|Overall Study|Multiple reasons|0|||
162974180|NCT04025684|588605652|FG003|Overall Study|Multiple reasons|1|||
162974181|NCT01613378|588605653|FG000|Overall Study|Lack of Efficacy|13|||
162974182|NCT01613378|588605653|FG000|Overall Study|Adverse Event|11|||
162974183|NCT01613378|588605653|FG000|Overall Study|Withdrawal by Subject|8|||
162974184|NCT01613378|588605653|FG000|Overall Study|Death|2|||
162974185|NCT01613378|588605653|FG000|Overall Study|Lost to Follow-up|1|||
162974186|NCT01613378|588605653|FG000|Overall Study|Other Reason|4|||
162974187|NCT01239472|588605654|FG000|Overall Study|Withdrawal by Subject|5|||
163209642|NCT00225251|589482935|FG001|Overall Study|Withdrawal by Subject|1|||
163209643|NCT01702454|589482936|FG000|Overall Study|Consent withdrawal|0|||
163057345|NCT02842866|588921224|FG000|Overall Study|Serious Adverse Event|0|||
163057346|NCT02842866|588921225|FG001|Overall Study|Serious Adverse Event|1|||
163057347|NCT02842866|588921224|FG000|Overall Study|Protocol Violation|4|||
163057348|NCT02842866|588921225|FG001|Overall Study|Protocol Violation|2|||
163057349|NCT02842866|588921224|FG000|Overall Study|Lost to Follow-up|2|||
163057350|NCT02842866|588921225|FG001|Overall Study|Lost to Follow-up|0|||
163057351|NCT02842866|588921224|FG000|Overall Study|Withdrawal by Subject|1|||
163057352|NCT02842866|588921225|FG001|Overall Study|Withdrawal by Subject|0|||
163057353|NCT01432327|588921226|FG000|Posttest 3 Months|depression|3|||
163057354|NCT01432327|588921227|FG001|Posttest 3 Months|depression|0|||
163057355|NCT01432327|588921228|FG002|Posttest 3 Months|depression|0|||
163057356|NCT01432327|588921229|FG003|Posttest 3 Months|depression|0|||
163057357|NCT01432327|588921226|FG000|Posttest 3 Months|Lost to Follow-up|1|||
163057358|NCT01432327|588921227|FG001|Posttest 3 Months|Lost to Follow-up|0|||
163057359|NCT01432327|588921228|FG002|Posttest 3 Months|Lost to Follow-up|2|||
163057360|NCT01432327|588921229|FG003|Posttest 3 Months|Lost to Follow-up|1|||
163057361|NCT01432327|588921226|FG000|Posttest 3 Months|Allergic reaction|0|||
163057362|NCT01432327|588921227|FG001|Posttest 3 Months|Allergic reaction|2|||
163057363|NCT01432327|588921228|FG002|Posttest 3 Months|Allergic reaction|0|||
163057364|NCT01432327|588921229|FG003|Posttest 3 Months|Allergic reaction|0|||
163057365|NCT01432327|588921226|FG000|Posttest 6 Months|Lost to Follow-up|0|||
163057366|NCT01432327|588921227|FG001|Posttest 6 Months|Lost to Follow-up|0|||
163057367|NCT01432327|588921228|FG002|Posttest 6 Months|Lost to Follow-up|3|||
163057368|NCT01432327|588921229|FG003|Posttest 6 Months|Lost to Follow-up|2|||
163057369|NCT01432327|588921226|FG000|Posttest 6 Months|Allergic reaction|0|||
163057370|NCT01432327|588921227|FG001|Posttest 6 Months|Allergic reaction|0|||
162974188|NCT01239472|588605655|FG001|Overall Study|Withdrawal by Subject|1|||
162974189|NCT01239472|588605654|FG000|Overall Study|Adverse Event|0|||
162974190|NCT01239472|588605655|FG001|Overall Study|Adverse Event|1|||
162974191|NCT01239472|588605654|FG000|Overall Study|Lack of Efficacy|0|||
162974192|NCT01239472|588605655|FG001|Overall Study|Lack of Efficacy|1|||
162974193|NCT00418522|588605659|FG000|Overall Study|Adverse Event|7|||
162974194|NCT00418522|588605660|FG001|Overall Study|Adverse Event|1|||
162974195|NCT00418522|588605659|FG000|Overall Study|Lack of Efficacy|1|||
162974196|NCT00418522|588605660|FG001|Overall Study|Lack of Efficacy|3|||
162974197|NCT00418522|588605659|FG000|Overall Study|Lost to Follow-up|10|||
162974198|NCT00418522|588605660|FG001|Overall Study|Lost to Follow-up|4|||
162974199|NCT00418522|588605659|FG000|Overall Study|Withdrawal by Subject|31|||
162974200|NCT00418522|588605660|FG001|Overall Study|Withdrawal by Subject|7|||
162974201|NCT00418522|588605659|FG000|Overall Study|Other|27|||
162974202|NCT00418522|588605660|FG001|Overall Study|Other|23|||
162974203|NCT00418522|588605659|FG000|Overall Study|Randomized but did not receive treatment|7|||
162974204|NCT00418522|588605660|FG001|Overall Study|Randomized but did not receive treatment|4|||
162974205|NCT02695719|588605661|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
162974206|NCT02695719|588605662|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
162974207|NCT02695719|588605661|FG000|Overall Study|Significant Protocol Deviation|0|||
162974208|NCT02695719|588605662|FG001|Overall Study|Significant Protocol Deviation|1|||
162974209|NCT02695719|588605661|FG000|Overall Study|Voluntary Withdrawal|1|||
162974210|NCT02695719|588605662|FG001|Overall Study|Voluntary Withdrawal|0|||
162974211|NCT00868296|588605665|FG000|Overall Study|Adverse Event|0|||
162974212|NCT00868296|588605666|FG001|Overall Study|Adverse Event|2|||
162974213|NCT00868296|588605665|FG000|Overall Study|Withdrawal by Subject|0|||
162974214|NCT00868296|588605666|FG001|Overall Study|Withdrawal by Subject|1|||
162974215|NCT01714739|588605667|FG000|Overall Study|Disease progression|3|||
162974216|NCT01714739|588605668|FG001|Overall Study|Disease progression|5|||
162974217|NCT01714739|588605669|FG002|Overall Study|Disease progression|5|||
162974218|NCT01714739|588605670|FG003|Overall Study|Disease progression|204|||
162974219|NCT01714739|588605671|FG004|Overall Study|Disease progression|1|||
162974220|NCT01714739|588605672|FG005|Overall Study|Disease progression|3|||
162974221|NCT01714739|588605673|FG006|Overall Study|Disease progression|5|||
162974222|NCT01714739|588605667|FG000|Overall Study|Study drug toxicity|1|||
162974223|NCT01714739|588605668|FG001|Overall Study|Study drug toxicity|1|||
162974224|NCT01714739|588605669|FG002|Overall Study|Study drug toxicity|1|||
162974225|NCT01714739|588605670|FG003|Overall Study|Study drug toxicity|15|||
162974226|NCT01714739|588605671|FG004|Overall Study|Study drug toxicity|0|||
162974227|NCT01714739|588605672|FG005|Overall Study|Study drug toxicity|0|||
162974228|NCT01714739|588605673|FG006|Overall Study|Study drug toxicity|5|||
162974229|NCT01714739|588605667|FG000|Overall Study|Death|0|||
162974230|NCT01714739|588605668|FG001|Overall Study|Death|0|||
162974231|NCT01714739|588605669|FG002|Overall Study|Death|0|||
162974232|NCT01714739|588605670|FG003|Overall Study|Death|1|||
162974233|NCT01714739|588605671|FG004|Overall Study|Death|0|||
163057371|NCT01432327|588921228|FG002|Posttest 6 Months|Allergic reaction|1|||
163057372|NCT01432327|588921229|FG003|Posttest 6 Months|Allergic reaction|0|||
163057373|NCT01432327|588921226|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
163057374|NCT01432327|588921227|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
163057375|NCT01432327|588921228|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
163057376|NCT01432327|588921229|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
162974234|NCT01714739|588605672|FG005|Overall Study|Death|0|||
162974235|NCT01714739|588605673|FG006|Overall Study|Death|0|||
162974236|NCT01714739|588605667|FG000|Overall Study|Adverse Event unrelated to drug|0|||
162974237|NCT01714739|588605668|FG001|Overall Study|Adverse Event unrelated to drug|0|||
162974238|NCT01714739|588605669|FG002|Overall Study|Adverse Event unrelated to drug|3|||
162974239|NCT01714739|588605670|FG003|Overall Study|Adverse Event unrelated to drug|21|||
162974240|NCT01714739|588605671|FG004|Overall Study|Adverse Event unrelated to drug|0|||
162974241|NCT01714739|588605672|FG005|Overall Study|Adverse Event unrelated to drug|0|||
162974242|NCT01714739|588605673|FG006|Overall Study|Adverse Event unrelated to drug|0|||
162974243|NCT01714739|588605667|FG000|Overall Study|Participant request to stop therapy|0|||
162974244|NCT01714739|588605668|FG001|Overall Study|Participant request to stop therapy|1|||
162974245|NCT01714739|588605669|FG002|Overall Study|Participant request to stop therapy|0|||
162974246|NCT01714739|588605670|FG003|Overall Study|Participant request to stop therapy|6|||
162974247|NCT01714739|588605671|FG004|Overall Study|Participant request to stop therapy|0|||
162974248|NCT01714739|588605672|FG005|Overall Study|Participant request to stop therapy|0|||
162974249|NCT01714739|588605673|FG006|Overall Study|Participant request to stop therapy|0|||
162974250|NCT01714739|588605667|FG000|Overall Study|Participant withdrew consent|0|||
162974251|NCT01714739|588605668|FG001|Overall Study|Participant withdrew consent|1|||
162974252|NCT01714739|588605669|FG002|Overall Study|Participant withdrew consent|0|||
162974253|NCT01714739|588605670|FG003|Overall Study|Participant withdrew consent|8|||
162974254|NCT01714739|588605671|FG004|Overall Study|Participant withdrew consent|0|||
162974255|NCT01714739|588605672|FG005|Overall Study|Participant withdrew consent|0|||
162974256|NCT01714739|588605673|FG006|Overall Study|Participant withdrew consent|0|||
162974257|NCT01714739|588605667|FG000|Overall Study|Lost to Follow-up|0|||
162974258|NCT01714739|588605668|FG001|Overall Study|Lost to Follow-up|0|||
162974259|NCT01714739|588605669|FG002|Overall Study|Lost to Follow-up|0|||
162974260|NCT01714739|588605670|FG003|Overall Study|Lost to Follow-up|1|||
162974261|NCT01714739|588605671|FG004|Overall Study|Lost to Follow-up|0|||
162974262|NCT01714739|588605672|FG005|Overall Study|Lost to Follow-up|0|||
162974263|NCT01714739|588605673|FG006|Overall Study|Lost to Follow-up|0|||
162974264|NCT01714739|588605667|FG000|Overall Study|Maximum clinical benefit|0|||
162974265|NCT01714739|588605668|FG001|Overall Study|Maximum clinical benefit|1|||
162974266|NCT01714739|588605669|FG002|Overall Study|Maximum clinical benefit|1|||
162974267|NCT01714739|588605670|FG003|Overall Study|Maximum clinical benefit|3|||
162974268|NCT01714739|588605671|FG004|Overall Study|Maximum clinical benefit|0|||
162974269|NCT01714739|588605672|FG005|Overall Study|Maximum clinical benefit|0|||
162974270|NCT01714739|588605673|FG006|Overall Study|Maximum clinical benefit|0|||
162974271|NCT01714739|588605667|FG000|Overall Study|Poor/non-comliance|0|||
162974272|NCT01714739|588605668|FG001|Overall Study|Poor/non-comliance|1|||
162974273|NCT01714739|588605669|FG002|Overall Study|Poor/non-comliance|0|||
162974274|NCT01714739|588605670|FG003|Overall Study|Poor/non-comliance|1|||
162974275|NCT01714739|588605671|FG004|Overall Study|Poor/non-comliance|0|||
162974276|NCT01714739|588605672|FG005|Overall Study|Poor/non-comliance|0|||
162974277|NCT01714739|588605673|FG006|Overall Study|Poor/non-comliance|0|||
162974278|NCT01714739|588605667|FG000|Overall Study|No longer meets study criteria|0|||
162974279|NCT01714739|588605668|FG001|Overall Study|No longer meets study criteria|0|||
162974280|NCT01714739|588605669|FG002|Overall Study|No longer meets study criteria|0|||
162974281|NCT01714739|588605670|FG003|Overall Study|No longer meets study criteria|1|||
162974282|NCT01714739|588605671|FG004|Overall Study|No longer meets study criteria|0|||
162974283|NCT01714739|588605672|FG005|Overall Study|No longer meets study criteria|0|||
162974284|NCT01714739|588605673|FG006|Overall Study|No longer meets study criteria|0|||
162974285|NCT01714739|588605667|FG000|Overall Study|Other reason|0|||
162974286|NCT01714739|588605668|FG001|Overall Study|Other reason|0|||
162974287|NCT01714739|588605669|FG002|Overall Study|Other reason|0|||
162974288|NCT01714739|588605670|FG003|Overall Study|Other reason|3|||
162974289|NCT01714739|588605671|FG004|Overall Study|Other reason|1|||
162974290|NCT01714739|588605672|FG005|Overall Study|Other reason|0|||
162974291|NCT01714739|588605673|FG006|Overall Study|Other reason|0|||
162974292|NCT02250651|588605674|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
162974293|NCT02250651|588605675|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
162974294|NCT02250651|588605676|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
162974295|NCT02250651|588605674|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
162974296|NCT02250651|588605675|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
162974297|NCT02250651|588605676|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
162974298|NCT02250651|588605674|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
162974299|NCT02250651|588605675|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
162974300|NCT02250651|588605676|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
162974301|NCT02250651|588605674|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
162974302|NCT02250651|588605675|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
162974303|NCT02250651|588605676|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
162974304|NCT02250651|588605674|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
162974305|NCT02250651|588605675|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
163209644|NCT01702454|589482937|FG001|Overall Study|Consent withdrawal|1|||
162974306|NCT02250651|588605676|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
162974307|NCT02250651|588605674|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
162974308|NCT02250651|588605675|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
162974309|NCT02250651|588605676|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
162974310|NCT02250651|588605674|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
162974311|NCT02250651|588605675|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
162974312|NCT02250651|588605676|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
162974313|NCT02250651|588605674|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
162974314|NCT02250651|588605675|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
162974315|NCT02250651|588605676|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
162974316|NCT02250651|588605674|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
162974317|NCT02250651|588605675|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
162974318|NCT02250651|588605676|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
162974319|NCT02250651|588605674|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
162974320|NCT02250651|588605675|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
162974321|NCT02250651|588605676|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
162974322|NCT02250651|588605674|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
162974323|NCT02250651|588605675|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
162974324|NCT02250651|588605676|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
162974325|NCT02250651|588605674|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
162974326|NCT02250651|588605675|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
162974327|NCT02250651|588605676|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
162974328|NCT02250651|588605674|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
162974329|NCT02250651|588605675|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
162974330|NCT02250651|588605676|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
162974331|NCT02250651|588605674|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
162974332|NCT02250651|588605675|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
162974333|NCT02250651|588605676|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
162974334|NCT02250651|588605674|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
162974335|NCT02250651|588605675|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
162974336|NCT02250651|588605676|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
162974337|NCT01557920|588605679|FG000|Overall Study|Withdrawal by Subject|2|||
162974338|NCT01557920|588605680|FG001|Overall Study|Withdrawal by Subject|3|||
162974339|NCT01557920|588605679|FG000|Overall Study|Lack of Efficacy|1|||
162974340|NCT01557920|588605680|FG001|Overall Study|Lack of Efficacy|0|||
162974341|NCT01466036|588605681|FG000|Overall Study|Death|1|||
162974342|NCT01466036|588605682|FG001|Overall Study|Death|1|||
163057377|NCT01432327|588921226|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
163209645|NCT01702454|589482936|FG000|Overall Study|Migrated/moved from study area|0|||
163209646|NCT01702454|589482937|FG001|Overall Study|Migrated/moved from study area|1|||
163209647|NCT01702454|589482936|FG000|Overall Study|Lost to Follow-up|3|||
162974343|NCT01466036|588605681|FG000|Overall Study|Physician Decision|0|||
162974344|NCT01466036|588605682|FG001|Overall Study|Physician Decision|4|||
162974345|NCT01466036|588605681|FG000|Overall Study|Adverse Event|2|||
162974346|NCT01466036|588605682|FG001|Overall Study|Adverse Event|6|||
162974347|NCT01466036|588605681|FG000|Overall Study|Withdrawal by Subject|2|||
162974348|NCT01466036|588605682|FG001|Overall Study|Withdrawal by Subject|8|||
162974349|NCT01466036|588605681|FG000|Overall Study|progression/relapse|14|||
162974350|NCT01466036|588605682|FG001|Overall Study|progression/relapse|21|||
162974351|NCT01466036|588605681|FG000|Overall Study|prolonged treatment delay|1|||
162974352|NCT01466036|588605682|FG001|Overall Study|prolonged treatment delay|1|||
162974353|NCT01808248|588605691|FG000|Overall Study|Lack of Efficacy|3|||
162974354|NCT01808248|588605691|FG000|Overall Study|Withdrawal by Subject|1|||
162974355|NCT01808248|588605691|FG000|Overall Study|Lost to Follow-up|1|||
162974356|NCT01175473|588605703|FG000|Overall Study|Adverse Event|2|||
162974357|NCT01175473|588605704|FG001|Overall Study|Adverse Event|2|||
162974358|NCT02508116|588605707|FG000|Overall Study|Lost to Follow-up|2|||
162974359|NCT02508116|588605708|FG001|Overall Study|Lost to Follow-up|3|||
162974360|NCT02508116|588605707|FG000|Overall Study|Withdrawal by Subject|3|||
162974361|NCT02508116|588605708|FG001|Overall Study|Withdrawal by Subject|2|||
162974362|NCT02508116|588605707|FG000|Overall Study|Protocol Violation|1|||
162974363|NCT02508116|588605708|FG001|Overall Study|Protocol Violation|2|||
162974364|NCT02508116|588605707|FG000|Overall Study|Physician Decision|2|||
162974365|NCT02508116|588605708|FG001|Overall Study|Physician Decision|0|||
162974366|NCT00109850|588605712|FG000|Overall Study|Adverse Event|1|||
162974367|NCT00109850|588605712|FG000|Overall Study|Death|2|||
162974368|NCT00109850|588605712|FG000|Overall Study|Ineligible|1|||
162974369|NCT04234464|588605713|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
162974370|NCT04234464|588605714|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
162974371|NCT03635983|588605715|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
162974372|NCT03635983|588605716|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
162974373|NCT03635983|588605715|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
162974374|NCT03635983|588605716|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162974375|NCT03635983|588605715|FG000|Pre-Treatment Period|Other reasons|0|||
162974376|NCT03635983|588605716|FG001|Pre-Treatment Period|Other reasons|1|||
162974377|NCT03635983|588605715|FG000|Pre-Treatment Period|Disease Progression|0|||
162974378|NCT03635983|588605716|FG001|Pre-Treatment Period|Disease Progression|1|||
162974379|NCT03635983|588605715|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
162974380|NCT03635983|588605716|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
162974381|NCT03635983|588605715|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
162974382|NCT03635983|588605716|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
162974383|NCT03635983|588605715|FG000|Treatment Period|Withdrawal by Subject|3|||
162974384|NCT03635983|588605716|FG001|Treatment Period|Withdrawal by Subject|5|||
162974385|NCT03635983|588605715|FG000|Treatment Period|Death|3|||
162974386|NCT03635983|588605716|FG001|Treatment Period|Death|5|||
162974387|NCT03635983|588605715|FG000|Treatment Period|Poor/Non-compliance|2|||
162974388|NCT03635983|588605716|FG001|Treatment Period|Poor/Non-compliance|1|||
162974389|NCT03635983|588605715|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
162974390|NCT03635983|588605716|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
162974391|NCT03635983|588605715|FG000|Treatment Period|Other reasons|7|||
162974392|NCT03635983|588605716|FG001|Treatment Period|Other reasons|4|||
162974393|NCT03635983|588605715|FG000|Treatment Period|Disease progression|230|||
162974394|NCT03635983|588605716|FG001|Treatment Period|Disease progression|201|||
162974395|NCT03635983|588605715|FG000|Treatment Period|Study drug toxicity|35|||
162974396|NCT03635983|588605716|FG001|Treatment Period|Study drug toxicity|36|||
162974397|NCT03635983|588605715|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
162974398|NCT03635983|588605716|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
162974399|NCT03635983|588605715|FG000|Treatment Period|Maximum clinical benefit|3|||
162974400|NCT03635983|588605716|FG001|Treatment Period|Maximum clinical benefit|5|||
162974401|NCT03635983|588605715|FG000|Treatment Period|Administrative reason by the sponsor|1|||
162974402|NCT03635983|588605716|FG001|Treatment Period|Administrative reason by the sponsor|2|||
162974403|NCT03635983|588605715|FG000|Treatment Period|Lost to Follow-up|0|||
162974404|NCT03635983|588605716|FG001|Treatment Period|Lost to Follow-up|1|||
162974405|NCT00330460|588605721|FG000|Overall Study|Physician Decision|1|||
162974406|NCT00330460|588605722|FG001|Overall Study|Physician Decision|0|||
162974407|NCT00330460|588605721|FG000|Overall Study|Adverse Event|10|||
162974408|NCT00330460|588605722|FG001|Overall Study|Adverse Event|8|||
162974409|NCT00330460|588605721|FG000|Overall Study|Withdrawal by Subject|18|||
162974410|NCT00330460|588605722|FG001|Overall Study|Withdrawal by Subject|17|||
162974411|NCT00330460|588605721|FG000|Overall Study|Death|1|||
162974412|NCT00330460|588605722|FG001|Overall Study|Death|1|||
162974413|NCT00330460|588605721|FG000|Overall Study|Ineligibility determined|1|||
162974414|NCT00330460|588605722|FG001|Overall Study|Ineligibility determined|3|||
163318052|NCT01928394|589874960|FG014|Follow-up Period|other reason|4|||
162974415|NCT00330460|588605721|FG000|Overall Study|Lost to Follow-up|8|||
162974416|NCT00330460|588605722|FG001|Overall Study|Lost to Follow-up|3|||
162974417|NCT00330460|588605721|FG000|Overall Study|Noncompliance|2|||
162974418|NCT00330460|588605722|FG001|Overall Study|Noncompliance|1|||
162974419|NCT00330460|588605721|FG000|Overall Study|Other|1|||
162974420|NCT00330460|588605722|FG001|Overall Study|Other|0|||
162974421|NCT01857973|588605723|FG000|Overall Study|Subject did not meet required BG range|3|||
162974422|NCT01857973|588605723|FG000|Overall Study|drop out after 3 failed attempts|1|||
162974423|NCT01857973|588605723|FG000|Overall Study|Physician Decision|1|||
162974424|NCT00388037|588605726|FG000|Overall Study|Protocol Violation|1|||
162974425|NCT01435031|588605728|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
162974426|NCT01435031|588605728|FG000|ITT at 1 Month|Death|1|||
162974427|NCT01435031|588605728|FG000|ITT at 1 Month|Lost to Follow-up|4|||
162974428|NCT01435031|588605728|FG000|ITT at 6 Months|Death|2|||
162974429|NCT01435031|588605728|FG000|ITT at 6 Months|Lost to Follow-up|3|||
162974430|NCT01435031|588605728|FG000|ITT at 1 Year|Death|1|||
162974431|NCT01435031|588605728|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
162974432|NCT01435031|588605728|FG000|ITT at 1 Year|Lost to Follow-up|6|||
162974433|NCT01435031|588605728|FG000|ITT at 2 Years|Death|7|||
162974434|NCT01435031|588605728|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
162974435|NCT01435031|588605728|FG000|ITT at 2 Years|Lost to Follow-up|4|||
162974436|NCT01435031|588605728|FG000|ITT at 3 Years|Death|5|||
162974437|NCT01435031|588605728|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
162974438|NCT01435031|588605728|FG000|ITT at 3 Years|Lost to Follow-up|4|||
162974439|NCT01435031|588605728|FG000|ITT at 4 Years|Death|4|||
162974440|NCT01435031|588605728|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
162974441|NCT01435031|588605728|FG000|ITT at 4 Years|Lost to Follow-up|1|||
162974442|NCT00104247|588605729|FG000|Overall Study|Withdrawal by Subject|1|||
162974443|NCT00104247|588605730|FG001|Overall Study|Withdrawal by Subject|0|||
162974444|NCT00104247|588605729|FG000|Overall Study|Noncompliant with dosing|0|||
162974445|NCT00104247|588605730|FG001|Overall Study|Noncompliant with dosing|1|||
162974446|NCT03718117|588605731|FG000|Overall Study|Death|12|||
162974447|NCT03718117|588605732|FG001|Overall Study|Death|11|||
162974448|NCT03718117|588605733|FG002|Overall Study|Death|0|||
162974449|NCT03718117|588605731|FG000|Overall Study|Other|0|||
162974450|NCT03718117|588605732|FG001|Overall Study|Other|1|||
162974451|NCT03718117|588605733|FG002|Overall Study|Other|0|||
162974452|NCT03718117|588605731|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
162974453|NCT03718117|588605732|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
162974454|NCT03718117|588605733|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
162974455|NCT03718117|588605731|FG000|Overall Study|Participant not met eligibility criteria|0|||
162974456|NCT03718117|588605732|FG001|Overall Study|Participant not met eligibility criteria|0|||
162974457|NCT03718117|588605733|FG002|Overall Study|Participant not met eligibility criteria|2|||
162974458|NCT01378962|588605734|FG000|Overall Study|Death|14|||
162974459|NCT01378962|588605734|FG000|Overall Study|Lost to Follow-up|1|||
162974460|NCT01378962|588605734|FG000|Overall Study|Other|2|||
162974461|NCT02030535|588605735|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
162974462|NCT01588548|588605736|FG000|Overall Study|Withdrawal by Subject|0|||
162974463|NCT01588548|588605737|FG001|Overall Study|Withdrawal by Subject|1|||
162974464|NCT01588548|588605738|FG002|Overall Study|Withdrawal by Subject|1|||
162974465|NCT01588548|588605739|FG003|Overall Study|Withdrawal by Subject|1|||
162974466|NCT01588548|588605740|FG004|Overall Study|Withdrawal by Subject|2|||
162974467|NCT01588548|588605741|FG005|Overall Study|Withdrawal by Subject|3|||
162974468|NCT01588548|588605736|FG000|Overall Study|Adverse Event|0|||
162974469|NCT01588548|588605737|FG001|Overall Study|Adverse Event|0|||
162974470|NCT01588548|588605738|FG002|Overall Study|Adverse Event|1|||
162974471|NCT01588548|588605739|FG003|Overall Study|Adverse Event|2|||
162974472|NCT01588548|588605740|FG004|Overall Study|Adverse Event|1|||
162974473|NCT01588548|588605741|FG005|Overall Study|Adverse Event|0|||
162974474|NCT01588548|588605736|FG000|Overall Study|Condition Under Investigation Worsened|3|||
162974475|NCT01588548|588605737|FG001|Overall Study|Condition Under Investigation Worsened|6|||
162974476|NCT01588548|588605738|FG002|Overall Study|Condition Under Investigation Worsened|4|||
163401333|NCT01438489|590181134|FG001|Overall Study|Lost to Follow-up|2|||
162974477|NCT01588548|588605739|FG003|Overall Study|Condition Under Investigation Worsened|4|||
162974478|NCT01588548|588605740|FG004|Overall Study|Condition Under Investigation Worsened|3|||
162974479|NCT01588548|588605741|FG005|Overall Study|Condition Under Investigation Worsened|3|||
162974480|NCT01634854|588605742|FG000|Overall Study|Cesarean delivery|2|||
162974481|NCT01634854|588605743|FG001|Overall Study|Cesarean delivery|7|||
162974482|NCT03257254|588605744|FG000|Overall Study|Withdrawal by Subject|7|||
162974483|NCT03257254|588605744|FG000|Overall Study|Lost to Follow-up|9|||
162974484|NCT03257254|588605744|FG000|Overall Study|Study discontinued by sponsor|5|||
162974485|NCT02219308|588605745|FG000|Overall Study|Withdrawal by Subject|1|||
163209648|NCT01702454|589482937|FG001|Overall Study|Lost to Follow-up|6|||
163401334|NCT01438489|590181135|FG002|Overall Study|Lost to Follow-up|2|||
162974486|NCT02219308|588605746|FG001|Overall Study|Withdrawal by Subject|2|||
162974487|NCT04149535|588605750|FG000|Overall Study|Death|11|||
162974488|NCT04149535|588605751|FG001|Overall Study|Death|7|||
162974489|NCT04149535|588605750|FG000|Overall Study|Physician Decision|10|||
162974490|NCT04149535|588605751|FG001|Overall Study|Physician Decision|4|||
162974491|NCT04149535|588605750|FG000|Overall Study|Withdrawal by Subject|6|||
162974492|NCT04149535|588605751|FG001|Overall Study|Withdrawal by Subject|7|||
162974493|NCT04149535|588605750|FG000|Overall Study|Not described|2|||
162974494|NCT04149535|588605751|FG001|Overall Study|Not described|0|||
162974495|NCT00966381|588607634|FG000|Overall Study|Withdrawal by Subject|2|||
162974496|NCT00966381|588607635|FG001|Overall Study|Withdrawal by Subject|2|||
162974497|NCT01915940|588607636|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
162974498|NCT01915940|588607637|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
162974499|NCT01915940|588607638|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
162974500|NCT01915940|588607636|FG000|Treatment Period|Decision of Participant|0|||
162974501|NCT01915940|588607637|FG001|Treatment Period|Decision of Participant|1|||
162974502|NCT01915940|588607638|FG002|Treatment Period|Decision of Participant|3|||
162974503|NCT01915940|588607636|FG000|Treatment Period|Adverse Event|0|||
162974504|NCT01915940|588607637|FG001|Treatment Period|Adverse Event|9|||
162974505|NCT01915940|588607638|FG002|Treatment Period|Adverse Event|1|||
162974506|NCT01915940|588607636|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
162974507|NCT01915940|588607637|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
162974508|NCT01915940|588607638|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
162974509|NCT03686150|588607639|FG000|Overall Study|Withdrawal by Subject|1|||
162974510|NCT03686150|588607640|FG001|Overall Study|Withdrawal by Subject|1|||
162974511|NCT03686150|588607641|FG002|Overall Study|Withdrawal by Subject|1|||
162974512|NCT03686150|588607642|FG003|Overall Study|Withdrawal by Subject|0|||
162974513|NCT03686150|588607643|FG004|Overall Study|Withdrawal by Subject|1|||
162974514|NCT03686150|588607644|FG005|Overall Study|Withdrawal by Subject|2|||
162974515|NCT03686150|588607639|FG000|Overall Study|Physician Decision|1|||
162974516|NCT03686150|588607640|FG001|Overall Study|Physician Decision|0|||
162974517|NCT03686150|588607641|FG002|Overall Study|Physician Decision|0|||
162974518|NCT03686150|588607642|FG003|Overall Study|Physician Decision|0|||
162974519|NCT03686150|588607643|FG004|Overall Study|Physician Decision|0|||
162974520|NCT03686150|588607644|FG005|Overall Study|Physician Decision|1|||
162974521|NCT03686150|588607639|FG000|Overall Study|Lost to Follow-up|0|||
162974522|NCT03686150|588607640|FG001|Overall Study|Lost to Follow-up|1|||
162974523|NCT03686150|588607641|FG002|Overall Study|Lost to Follow-up|0|||
162974524|NCT03686150|588607642|FG003|Overall Study|Lost to Follow-up|0|||
162974525|NCT03686150|588607643|FG004|Overall Study|Lost to Follow-up|0|||
162974526|NCT03686150|588607644|FG005|Overall Study|Lost to Follow-up|0|||
162974527|NCT02443324|588607645|FG000|Overall Study|Death|4|||
162974528|NCT02443324|588607646|FG001|Overall Study|Death|1|||
162974529|NCT02443324|588607647|FG002|Overall Study|Death|0|||
162974530|NCT02443324|588607648|FG003|Overall Study|Death|3|||
162974531|NCT02443324|588607649|FG004|Overall Study|Death|1|||
162974532|NCT02443324|588607650|FG005|Overall Study|Death|3|||
162974533|NCT02443324|588607651|FG006|Overall Study|Death|2|||
162974534|NCT02443324|588607645|FG000|Overall Study|Lost to Follow-up|0|||
162974535|NCT02443324|588607646|FG001|Overall Study|Lost to Follow-up|0|||
162974536|NCT02443324|588607647|FG002|Overall Study|Lost to Follow-up|0|||
162974537|NCT02443324|588607648|FG003|Overall Study|Lost to Follow-up|1|||
162974538|NCT02443324|588607649|FG004|Overall Study|Lost to Follow-up|0|||
162974539|NCT02443324|588607650|FG005|Overall Study|Lost to Follow-up|1|||
162974540|NCT02443324|588607651|FG006|Overall Study|Lost to Follow-up|0|||
162974541|NCT02443324|588607645|FG000|Overall Study|Physician Decision|0|||
162974542|NCT02443324|588607646|FG001|Overall Study|Physician Decision|3|||
162974543|NCT02443324|588607647|FG002|Overall Study|Physician Decision|5|||
162974544|NCT02443324|588607648|FG003|Overall Study|Physician Decision|1|||
162974545|NCT02443324|588607649|FG004|Overall Study|Physician Decision|1|||
162974546|NCT02443324|588607650|FG005|Overall Study|Physician Decision|0|||
162974547|NCT02443324|588607651|FG006|Overall Study|Physician Decision|2|||
162974548|NCT02443324|588607645|FG000|Overall Study|Progressive Disease|20|||
162974549|NCT02443324|588607646|FG001|Overall Study|Progressive Disease|20|||
162974550|NCT02443324|588607647|FG002|Overall Study|Progressive Disease|13|||
162974551|NCT02443324|588607648|FG003|Overall Study|Progressive Disease|10|||
162974552|NCT02443324|588607649|FG004|Overall Study|Progressive Disease|13|||
163057378|NCT01432327|588921227|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
163057379|NCT01432327|588921228|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
163057380|NCT01432327|588921229|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
163057381|NCT01432327|588921226|FG000|Posttest 1 Year|Lost to Follow-up|0|||
163318053|NCT01928394|589874961|FG015|Follow-up Period|other reason|0|||
163057382|NCT01432327|588921227|FG001|Posttest 1 Year|Lost to Follow-up|0|||
163057383|NCT01432327|588921228|FG002|Posttest 1 Year|Lost to Follow-up|4|||
163057384|NCT01432327|588921229|FG003|Posttest 1 Year|Lost to Follow-up|2|||
163057385|NCT01432327|588921226|FG000|Posttest 1 Year|Allergic reaction|0|||
163057386|NCT01432327|588921227|FG001|Posttest 1 Year|Allergic reaction|0|||
163057387|NCT01432327|588921228|FG002|Posttest 1 Year|Allergic reaction|1|||
162974553|NCT02443324|588607650|FG005|Overall Study|Progressive Disease|17|||
162974554|NCT02443324|588607651|FG006|Overall Study|Progressive Disease|10|||
162974555|NCT02443324|588607645|FG000|Overall Study|Withdrawal by Subject|0|||
163057388|NCT01432327|588921229|FG003|Posttest 1 Year|Allergic reaction|1|||
163057389|NCT03248037|588921230|FG000|Overall Study|Withdrawal by Subject|6|||
163057390|NCT03248037|588921231|FG001|Overall Study|Withdrawal by Subject|9|||
163057391|NCT03248037|588921230|FG000|Overall Study|Adverse Event|15|||
163057392|NCT03248037|588921231|FG001|Overall Study|Adverse Event|0|||
162974556|NCT02443324|588607646|FG001|Overall Study|Withdrawal by Subject|0|||
162974557|NCT02443324|588607647|FG002|Overall Study|Withdrawal by Subject|3|||
162974558|NCT02443324|588607648|FG003|Overall Study|Withdrawal by Subject|1|||
162974559|NCT02443324|588607649|FG004|Overall Study|Withdrawal by Subject|1|||
162974560|NCT02443324|588607650|FG005|Overall Study|Withdrawal by Subject|0|||
162974561|NCT02443324|588607651|FG006|Overall Study|Withdrawal by Subject|1|||
162974562|NCT02443324|588607645|FG000|Overall Study|Adverse Event|0|||
162974563|NCT02443324|588607646|FG001|Overall Study|Adverse Event|1|||
162974564|NCT02443324|588607647|FG002|Overall Study|Adverse Event|3|||
162974565|NCT02443324|588607648|FG003|Overall Study|Adverse Event|0|||
162974566|NCT02443324|588607649|FG004|Overall Study|Adverse Event|4|||
162974567|NCT02443324|588607650|FG005|Overall Study|Adverse Event|3|||
162974568|NCT02443324|588607651|FG006|Overall Study|Adverse Event|3|||
162974569|NCT02443324|588607645|FG000|Overall Study|Enrolled but Never Treated|0|||
162974570|NCT02443324|588607646|FG001|Overall Study|Enrolled but Never Treated|0|||
162974571|NCT02443324|588607647|FG002|Overall Study|Enrolled but Never Treated|1|||
162974572|NCT02443324|588607648|FG003|Overall Study|Enrolled but Never Treated|0|||
162974573|NCT02443324|588607649|FG004|Overall Study|Enrolled but Never Treated|1|||
162974574|NCT02443324|588607650|FG005|Overall Study|Enrolled but Never Treated|0|||
162974575|NCT02443324|588607651|FG006|Overall Study|Enrolled but Never Treated|1|||
162974576|NCT03346070|588607654|FG000|Overall Study|Death|0|||
162974577|NCT03346070|588607655|FG001|Overall Study|Death|0|||
162974578|NCT03346070|588607656|FG002|Overall Study|Death|0|||
162974579|NCT03346070|588607657|FG003|Overall Study|Death|0|||
162974580|NCT03346070|588607658|FG004|Overall Study|Death|1|||
162974581|NCT03346070|588607654|FG000|Overall Study|Lost to Follow-up|0|||
162974582|NCT03346070|588607655|FG001|Overall Study|Lost to Follow-up|1|||
162974583|NCT03346070|588607656|FG002|Overall Study|Lost to Follow-up|2|||
162974584|NCT03346070|588607657|FG003|Overall Study|Lost to Follow-up|0|||
162974585|NCT03346070|588607658|FG004|Overall Study|Lost to Follow-up|0|||
162974586|NCT03346070|588607654|FG000|Overall Study|Physician Decision|0|||
162974587|NCT03346070|588607655|FG001|Overall Study|Physician Decision|0|||
162974588|NCT03346070|588607656|FG002|Overall Study|Physician Decision|0|||
162974589|NCT03346070|588607657|FG003|Overall Study|Physician Decision|1|||
162974590|NCT03346070|588607658|FG004|Overall Study|Physician Decision|1|||
162974591|NCT03346070|588607654|FG000|Overall Study|Withdrawal by Subject|1|||
162974592|NCT03346070|588607655|FG001|Overall Study|Withdrawal by Subject|0|||
162974593|NCT03346070|588607656|FG002|Overall Study|Withdrawal by Subject|0|||
162974594|NCT03346070|588607657|FG003|Overall Study|Withdrawal by Subject|1|||
162974595|NCT03346070|588607658|FG004|Overall Study|Withdrawal by Subject|0|||
162974596|NCT03346070|588607654|FG000|Overall Study|Study medication not received as planned|2|||
162974597|NCT03346070|588607655|FG001|Overall Study|Study medication not received as planned|3|||
162974598|NCT03346070|588607656|FG002|Overall Study|Study medication not received as planned|2|||
162974599|NCT03346070|588607657|FG003|Overall Study|Study medication not received as planned|3|||
162974600|NCT03346070|588607658|FG004|Overall Study|Study medication not received as planned|2|||
162974601|NCT03346070|588607654|FG000|Overall Study|Screen Failure|0|||
162974602|NCT03346070|588607655|FG001|Overall Study|Screen Failure|0|||
162974603|NCT03346070|588607656|FG002|Overall Study|Screen Failure|0|||
162974604|NCT03346070|588607657|FG003|Overall Study|Screen Failure|1|||
162974605|NCT03346070|588607658|FG004|Overall Study|Screen Failure|1|||
162974606|NCT01844531|588607661|FG000|Overall Study|Withdrawal by Subject|0|||
162974607|NCT01844531|588607662|FG001|Overall Study|Withdrawal by Subject|1|||
162974608|NCT01844531|588607663|FG002|Overall Study|Withdrawal by Subject|0|||
162974609|NCT01844531|588607664|FG003|Overall Study|Withdrawal by Subject|0|||
162974610|NCT01546922|588607665|FG000|First Period of 10 Weeks|Protocol Violation|3|||
162974611|NCT01546922|588607666|FG001|First Period of 10 Weeks|Protocol Violation|1|||
162974612|NCT01546922|588607665|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
162974613|NCT01546922|588607666|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
162974614|NCT01546922|588607665|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
162974615|NCT01546922|588607666|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
162974616|NCT01546922|588607665|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
162974617|NCT01546922|588607666|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
163057393|NCT02897349|588921233|FG000|Overall Study|Lost to Follow-up|2|||
163057394|NCT02897349|588921234|FG001|Overall Study|Lost to Follow-up|2|||
163318054|NCT01928394|589874962|FG016|Follow-up Period|other reason|2|||
162974618|NCT01546922|588607665|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
162974619|NCT01546922|588607666|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
162974620|NCT00317642|588607674|FG000|Overall Study|Not Received Either Study Drug|1|||
162974621|NCT00317642|588607675|FG001|Overall Study|Not Received Either Study Drug|3|||
162974622|NCT00317642|588607674|FG000|Overall Study|Physician Decision|15|||
162974623|NCT00317642|588607675|FG001|Overall Study|Physician Decision|7|||
163057395|NCT02897349|588921233|FG000|Overall Study|Adverse Event|3|||
163318055|NCT01928394|589874963|FG017|Follow-up Period|other reason|0|||
162974624|NCT00317642|588607674|FG000|Overall Study|Participant declined treatment|14|||
162974625|NCT00317642|588607675|FG001|Overall Study|Participant declined treatment|3|||
162974626|NCT00317642|588607674|FG000|Overall Study|Adverse Event|17|||
162974627|NCT00317642|588607675|FG001|Overall Study|Adverse Event|5|||
162974628|NCT00317642|588607674|FG000|Overall Study|Treatment Failure|56|||
162974629|NCT00317642|588607675|FG001|Overall Study|Treatment Failure|102|||
162974630|NCT00317642|588607674|FG000|Overall Study|Disease Recurrence|1|||
162974631|NCT00317642|588607675|FG001|Overall Study|Disease Recurrence|2|||
162974632|NCT00317642|588607674|FG000|Overall Study|Death|14|||
162974633|NCT00317642|588607675|FG001|Overall Study|Death|7|||
162974634|NCT00317642|588607674|FG000|Overall Study|Not Continue to Consolidation|2|||
162974635|NCT00317642|588607675|FG001|Overall Study|Not Continue to Consolidation|0|||
162974636|NCT00317642|588607674|FG000|Overall Study|Withdrawal by Subject|0|||
162974637|NCT00317642|588607675|FG001|Overall Study|Withdrawal by Subject|1|||
162974638|NCT00317642|588607674|FG000|Overall Study|Referred For Transplantation|1|||
162974639|NCT00317642|588607675|FG001|Overall Study|Referred For Transplantation|0|||
162974640|NCT00317642|588607674|FG000|Overall Study|AML Not Centrally Confirmed|1|||
162974641|NCT00317642|588607675|FG001|Overall Study|AML Not Centrally Confirmed|5|||
162974642|NCT00792623|588607676|FG000|Overall Study|Adverse Event|2|||
162974643|NCT00792623|588607676|FG000|Overall Study|Withdrawal by Subject|5|||
162974644|NCT00880087|588607678|FG000|Overall Study|Lost to Follow-up|0|||
162974645|NCT00880087|588607679|FG001|Overall Study|Lost to Follow-up|2|||
162974646|NCT01005329|588607682|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
162974647|NCT00608517|588607683|FG000|Overall Study|Death|1|||
162974648|NCT00608517|588607684|FG001|Overall Study|Death|0|||
162974649|NCT00608517|588607685|FG002|Overall Study|Death|0|||
162974650|NCT00572039|588607686|FG000|Overall Study|Withdrawal by Subject|9|||
162974651|NCT00572039|588607687|FG001|Overall Study|Withdrawal by Subject|6|||
162974652|NCT00572039|588607686|FG000|Overall Study|Death|2|||
162974653|NCT00572039|588607687|FG001|Overall Study|Death|3|||
162974654|NCT00572039|588607686|FG000|Overall Study|Ill|5|||
162974655|NCT00572039|588607687|FG001|Overall Study|Ill|1|||
162974656|NCT02147587|588607688|FG000|Overall Study|Adverse Event|9|||
162974657|NCT02147587|588607689|FG001|Overall Study|Adverse Event|4|||
162974658|NCT02147587|588607688|FG000|Overall Study|Lack of Efficacy|2|||
162974659|NCT02147587|588607689|FG001|Overall Study|Lack of Efficacy|1|||
162974660|NCT01315028|588607694|FG000|Overall Study|Lost to Follow-up|1|||
162974661|NCT01315028|588607695|FG001|Overall Study|Lost to Follow-up|0|||
162974662|NCT01315028|588607694|FG000|Overall Study|Death|0|||
162974663|NCT01315028|588607695|FG001|Overall Study|Death|1|||
162974664|NCT02531594|588607696|FG000|Overall Study|Withdrawal by Subject|7|||
162974665|NCT02531594|588607697|FG001|Overall Study|Withdrawal by Subject|8|||
162974666|NCT01264835|588607702|FG000|Overall Study|Lost to Follow-up|1|||
162974667|NCT00436917|588607709|FG000|Overall Study|Withdrawal by Subject|13|||
162974668|NCT00436917|588607709|FG000|Overall Study|Adverse Event|2|||
162974669|NCT00436917|588607709|FG000|Overall Study|Physician Decision|1|||
162974670|NCT00436917|588607709|FG000|Overall Study|Death|1|||
162974671|NCT00436917|588607709|FG000|Overall Study|Lost to Follow-up|1|||
162974672|NCT00436917|588607709|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
162974673|NCT00436917|588607709|FG000|Overall Study|Increased creatinine|1|||
162974674|NCT00436917|588607709|FG000|Overall Study|Personal conflicts of patient|1|||
162974675|NCT03170869|588607710|FG000|Overall Study|Protocol Violation|5|||
162974676|NCT03170869|588607710|FG000|Overall Study|Early study termination|3|||
162974677|NCT00983528|588607713|FG000|Overall Study|Death|4|||
162974678|NCT00983528|588607713|FG000|Overall Study|Lost to Follow-up|1|||
162974679|NCT00983528|588607713|FG000|Overall Study|Study Terminated|1|||
163209649|NCT00475176|589482940|FG000|Overall Study|Adverse Event|2|||
163209650|NCT00475176|589482940|FG000|Overall Study|Withdrawal by Subject|1|||
163209651|NCT00475176|589482940|FG000|Overall Study|Protocol Violation|1|||
162974680|NCT00373425|588607715|FG000|Overall Study|Relapse of NSCLC|116|||
162974681|NCT00373425|588607716|FG001|Overall Study|Relapse of NSCLC|104|||
162974682|NCT00373425|588607717|FG002|Overall Study|Relapse of NSCLC|19|||
162974683|NCT00373425|588607718|FG003|Overall Study|Relapse of NSCLC|2|||
162974684|NCT00373425|588607719|FG004|Overall Study|Relapse of NSCLC|26|||
162974685|NCT00373425|588607715|FG000|Overall Study|Adverse Event|191|||
163209652|NCT01484873|589482941|FG000|Overall Study|Withdrawal by Subject|2|||
163209653|NCT01549392|589482942|FG000|Overall Study|Withdrawal by Subject|1|||
163209654|NCT01549392|589482943|FG001|Overall Study|Withdrawal by Subject|0|||
163209655|NCT00227903|589482944|FG000|Overall Study|Withdrawal by Subject|2|||
162974686|NCT00373425|588607716|FG001|Overall Study|Adverse Event|22|||
162974687|NCT00373425|588607717|FG002|Overall Study|Adverse Event|59|||
162974688|NCT00373425|588607718|FG003|Overall Study|Adverse Event|0|||
162974689|NCT00373425|588607719|FG004|Overall Study|Adverse Event|34|||
162974690|NCT00373425|588607715|FG000|Overall Study|Patient request|35|||
162974691|NCT00373425|588607716|FG001|Overall Study|Patient request|18|||
162974692|NCT00373425|588607717|FG002|Overall Study|Patient request|43|||
162974693|NCT00373425|588607718|FG003|Overall Study|Patient request|6|||
162974694|NCT00373425|588607719|FG004|Overall Study|Patient request|7|||
162974695|NCT00373425|588607715|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
162974696|NCT00373425|588607716|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
162974697|NCT00373425|588607717|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
162974698|NCT00373425|588607718|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
162974699|NCT00373425|588607719|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
162974700|NCT00373425|588607715|FG000|Overall Study|Death|7|||
162974701|NCT00373425|588607716|FG001|Overall Study|Death|0|||
162974702|NCT00373425|588607717|FG002|Overall Study|Death|3|||
162974703|NCT00373425|588607718|FG003|Overall Study|Death|1|||
162974704|NCT00373425|588607719|FG004|Overall Study|Death|0|||
162974705|NCT00551616|588607722|FG000|Overall Study|Lost to Follow-up|48|||
162974706|NCT00551616|588607723|FG001|Overall Study|Lost to Follow-up|40|||
162974707|NCT02808819|588607724|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
162974708|NCT02808819|588607725|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
162974709|NCT02808819|588607724|FG000|Overall Study|Withdrawal by Subject|10|||
162974710|NCT02808819|588607725|FG001|Overall Study|Withdrawal by Subject|13|||
162974711|NCT02808819|588607724|FG000|Overall Study|Site terminated by sponsor|2|||
162974712|NCT02808819|588607725|FG001|Overall Study|Site terminated by sponsor|0|||
162974713|NCT02808819|588607724|FG000|Overall Study|Pregnancy|1|||
162974714|NCT02808819|588607725|FG001|Overall Study|Pregnancy|0|||
162974715|NCT02808819|588607724|FG000|Overall Study|Lost to Follow-up|1|||
162974716|NCT02808819|588607725|FG001|Overall Study|Lost to Follow-up|6|||
162974717|NCT02808819|588607724|FG000|Overall Study|Protocol Violation|0|||
162974718|NCT02808819|588607725|FG001|Overall Study|Protocol Violation|1|||
162974719|NCT02808819|588607724|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
162974720|NCT02808819|588607725|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
162974721|NCT02808819|588607724|FG000|Overall Study|Death|1|||
162974722|NCT02808819|588607725|FG001|Overall Study|Death|0|||
162974723|NCT02808819|588607724|FG000|Overall Study|Adverse Event|3|||
162974724|NCT02808819|588607725|FG001|Overall Study|Adverse Event|4|||
162974725|NCT03297294|588607726|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
162974726|NCT03297294|588607727|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
162974727|NCT03297294|588607728|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
162974728|NCT03297294|588607729|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
162974729|NCT03297294|588607730|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
162974730|NCT03297294|588607726|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
162974731|NCT03297294|588607727|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
162974732|NCT03297294|588607728|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
162974733|NCT03297294|588607729|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
162974734|NCT03297294|588607730|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
162974735|NCT03297294|588607726|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
162974736|NCT03297294|588607727|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
162974737|NCT03297294|588607728|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
162974738|NCT03297294|588607729|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
162974739|NCT03297294|588607730|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
162974740|NCT03297294|588607726|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
162974741|NCT03297294|588607727|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
162974742|NCT03297294|588607728|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
162974743|NCT03297294|588607729|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
162974744|NCT03297294|588607730|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
162974745|NCT03297294|588607726|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
162974746|NCT03297294|588607727|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
162974747|NCT03297294|588607728|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
162974748|NCT03297294|588607729|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
162974749|NCT03297294|588607730|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
162974750|NCT02692482|588607731|FG000|Overall Study|Death|2|||
162974751|NCT02692482|588607732|FG001|Overall Study|Death|2|||
162974752|NCT02692482|588607731|FG000|Overall Study|Withdrawal by Subject|1|||
162974753|NCT02692482|588607732|FG001|Overall Study|Withdrawal by Subject|2|||
162974754|NCT00105157|588607735|FG000|Double-Blind (DB)|Never Treated|1|||
162974755|NCT00105157|588607736|FG001|Double-Blind (DB)|Never Treated|0|||
162974756|NCT00105157|588607737|FG002|Double-Blind (DB)|Never Treated|0|||
162974757|NCT00105157|588607738|FG003|Double-Blind (DB)|Never Treated|0|||
162974758|NCT00105157|588607735|FG000|Double-Blind (DB)|Adverse Event|2|||
162974759|NCT00105157|588607736|FG001|Double-Blind (DB)|Adverse Event|0|||
162974760|NCT00105157|588607737|FG002|Double-Blind (DB)|Adverse Event|1|||
162974761|NCT00105157|588607738|FG003|Double-Blind (DB)|Adverse Event|1|||
162974762|NCT00105157|588607735|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
162974763|NCT00105157|588607736|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
162974764|NCT00105157|588607737|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
162974765|NCT00105157|588607738|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
162974766|NCT00105157|588607735|FG000|Open-Label Continuation of DB|Adverse Event|3|||
162974767|NCT00105157|588607736|FG001|Open-Label Continuation of DB|Adverse Event|1|||
163057396|NCT02897349|588921234|FG001|Overall Study|Adverse Event|3|||
162974768|NCT00105157|588607737|FG002|Open-Label Continuation of DB|Adverse Event|0|||
162974769|NCT00105157|588607738|FG003|Open-Label Continuation of DB|Adverse Event|0|||
162974770|NCT00105157|588607735|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
162974771|NCT00105157|588607736|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
162974772|NCT00105157|588607737|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
162974773|NCT00105157|588607738|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
162974774|NCT00105157|588607735|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
162974775|NCT00105157|588607736|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
162974776|NCT00105157|588607737|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
162974777|NCT00105157|588607738|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
162974778|NCT00105157|588607735|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
162974779|NCT00105157|588607736|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
162974780|NCT00105157|588607737|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
162974781|NCT00105157|588607738|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
162974782|NCT00105157|588607735|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
162974783|NCT00105157|588607736|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
162974784|NCT00105157|588607737|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
162974785|NCT00105157|588607738|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
162974786|NCT00105157|588607735|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
162974787|NCT00105157|588607736|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
162974788|NCT00105157|588607737|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
162974789|NCT00105157|588607738|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
162974790|NCT00105157|588607735|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
162974791|NCT00105157|588607736|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
162974792|NCT00105157|588607737|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
162974793|NCT00105157|588607738|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
162974794|NCT00105157|588607735|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
162974795|NCT00105157|588607736|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
162974796|NCT00105157|588607737|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
162974797|NCT00105157|588607738|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
162974798|NCT00105157|588607735|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
162974799|NCT00105157|588607736|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
162974800|NCT00105157|588607737|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
162974801|NCT00105157|588607738|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
162974802|NCT00105157|588607735|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
162974803|NCT00105157|588607736|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
162974804|NCT00105157|588607737|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
162974805|NCT00105157|588607738|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
162974806|NCT00105157|588607735|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
162974807|NCT00105157|588607736|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
162974808|NCT00105157|588607737|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
162974809|NCT00105157|588607738|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
162974810|NCT03314662|588607742|FG000|Overall Study|Withdrawal by Subject|1|||
162974811|NCT03314662|588607743|FG001|Overall Study|Withdrawal by Subject|1|||
162974812|NCT03314662|588607744|FG002|Overall Study|Withdrawal by Subject|1|||
162974813|NCT03314662|588607742|FG000|Overall Study|Lost to Follow-up|5|||
162974814|NCT03314662|588607743|FG001|Overall Study|Lost to Follow-up|4|||
162974815|NCT03314662|588607744|FG002|Overall Study|Lost to Follow-up|4|||
162974816|NCT03314662|588607742|FG000|Overall Study|Death|2|||
162974817|NCT03314662|588607743|FG001|Overall Study|Death|0|||
162974818|NCT03314662|588607744|FG002|Overall Study|Death|0|||
162974819|NCT01117766|588607749|FG000|First Intervention|Adverse Event|0|||
162974820|NCT01117766|588607750|FG001|First Intervention|Adverse Event|1|||
162974821|NCT01117766|588607749|FG000|First Intervention|Protocol Violation|1|||
162974822|NCT01117766|588607750|FG001|First Intervention|Protocol Violation|0|||
162974823|NCT01117766|588607749|FG000|Washout Period|Protocol Violation|0|||
162974824|NCT01117766|588607750|FG001|Washout Period|Protocol Violation|2|||
162974825|NCT01117766|588607749|FG000|Second Intervention|Lost to Follow-up|1|||
162974826|NCT01117766|588607750|FG001|Second Intervention|Lost to Follow-up|0|||
163209656|NCT00227903|589482945|FG001|Overall Study|Withdrawal by Subject|5|||
163209657|NCT00227903|589482944|FG000|Overall Study|Subject moved out of area|1|||
163209658|NCT00227903|589482945|FG001|Overall Study|Subject moved out of area|2|||
162974827|NCT01117766|588607749|FG000|Second Intervention|Other|1|||
162974828|NCT01117766|588607750|FG001|Second Intervention|Other|2|||
162974829|NCT01117766|588607749|FG000|Second Intervention|Adverse Event|0|||
162974830|NCT01117766|588607750|FG001|Second Intervention|Adverse Event|2|||
162974831|NCT01117766|588607749|FG000|Second Intervention|Withdrawal by Subject|0|||
162974832|NCT01117766|588607750|FG001|Second Intervention|Withdrawal by Subject|1|||
163209659|NCT00227903|589482944|FG000|Overall Study|Lost to Follow-up|1|||
162974833|NCT04405739|588607751|FG000|Overall Study|Adverse Event|0|||
162974834|NCT04405739|588607752|FG001|Overall Study|Adverse Event|1|||
162974835|NCT04405739|588607753|FG002|Overall Study|Adverse Event|0|||
162974836|NCT04405739|588607754|FG003|Overall Study|Adverse Event|0|||
162974837|NCT04405739|588607751|FG000|Overall Study|Lost to Follow-up|0|||
162974838|NCT04405739|588607752|FG001|Overall Study|Lost to Follow-up|2|||
162974839|NCT04405739|588607753|FG002|Overall Study|Lost to Follow-up|1|||
162974840|NCT04405739|588607754|FG003|Overall Study|Lost to Follow-up|3|||
162974841|NCT04405739|588607751|FG000|Overall Study|Withdrawal by Subject|0|||
162974842|NCT04405739|588607752|FG001|Overall Study|Withdrawal by Subject|2|||
162974843|NCT04405739|588607753|FG002|Overall Study|Withdrawal by Subject|1|||
162974844|NCT04405739|588607754|FG003|Overall Study|Withdrawal by Subject|1|||
162974845|NCT04405739|588607751|FG000|Overall Study|Death|0|||
162974846|NCT04405739|588607752|FG001|Overall Study|Death|0|||
162974847|NCT04405739|588607753|FG002|Overall Study|Death|1|||
162974848|NCT04405739|588607754|FG003|Overall Study|Death|0|||
162974849|NCT04405739|588607751|FG000|Overall Study|Transferred to rehab|0|||
162974850|NCT04405739|588607752|FG001|Overall Study|Transferred to rehab|0|||
162974851|NCT04405739|588607753|FG002|Overall Study|Transferred to rehab|0|||
162974852|NCT04405739|588607754|FG003|Overall Study|Transferred to rehab|1|||
162974853|NCT04405739|588607751|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
162974854|NCT04405739|588607752|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
162974855|NCT04405739|588607753|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
162974856|NCT04405739|588607754|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
162974857|NCT05766787|588607755|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
162974858|NCT05766787|588607756|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
162974859|NCT05766787|588607755|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
162974860|NCT05766787|588607756|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
162974861|NCT05766787|588607755|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
162974862|NCT05766787|588607756|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
162974863|NCT00438659|588607757|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
162974864|NCT00438659|588607758|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
162974865|NCT00438659|588607757|FG000|Overall Study|Cancel|5|||
162974866|NCT00438659|588607758|FG001|Overall Study|Cancel|2|||
162974867|NCT01867606|588607759|FG000|Overall Study|Withdrawal by Subject|10|||
162974868|NCT01867606|588607760|FG001|Overall Study|Withdrawal by Subject|14|||
162974869|NCT01867606|588607759|FG000|Overall Study|Protocol Violation|0|||
162974870|NCT01867606|588607760|FG001|Overall Study|Protocol Violation|1|||
162974871|NCT00206102|588607761|FG000|Overall Study|Adverse Event|119|||
162974872|NCT00206102|588607762|FG001|Overall Study|Adverse Event|82|||
162974873|NCT00206102|588607761|FG000|Overall Study|Protocol Violation|0|||
162974874|NCT00206102|588607762|FG001|Overall Study|Protocol Violation|2|||
162974875|NCT00206102|588607761|FG000|Overall Study|Lack of therapeutic response|16|||
162974876|NCT00206102|588607762|FG001|Overall Study|Lack of therapeutic response|11|||
162974877|NCT00206102|588607761|FG000|Overall Study|Lost to Follow-up|95|||
162974878|NCT00206102|588607762|FG001|Overall Study|Lost to Follow-up|66|||
162974879|NCT00206102|588607761|FG000|Overall Study|Withdrawal by Subject|118|||
162974880|NCT00206102|588607762|FG001|Overall Study|Withdrawal by Subject|101|||
162974881|NCT00206102|588607761|FG000|Overall Study|Study-specific discontinuation criteria|18|||
162974882|NCT00206102|588607762|FG001|Overall Study|Study-specific discontinuation criteria|17|||
162974883|NCT00206102|588607761|FG000|Overall Study|None of those categories|42|||
162974884|NCT00206102|588607762|FG001|Overall Study|None of those categories|36|||
162974885|NCT01917968|588607763|FG000|Overall Study|Death|3|||
162974886|NCT01917968|588607764|FG001|Overall Study|Death|2|||
162974887|NCT01917968|588607763|FG000|Overall Study|Lost to Follow-up|21|||
162974888|NCT01917968|588607764|FG001|Overall Study|Lost to Follow-up|39|||
162974889|NCT01917968|588607763|FG000|Overall Study|Physician Decision|1|||
162974890|NCT01917968|588607764|FG001|Overall Study|Physician Decision|2|||
162974891|NCT01917968|588607763|FG000|Overall Study|Withdrawal by Subject|20|||
162974892|NCT01917968|588607764|FG001|Overall Study|Withdrawal by Subject|35|||
162974893|NCT01917968|588607763|FG000|Overall Study|Subject Relocation|5|||
162974894|NCT01917968|588607764|FG001|Overall Study|Subject Relocation|1|||
162974895|NCT01917968|588607763|FG000|Overall Study|36M Missed Visit|3|||
162974896|NCT01917968|588607764|FG001|Overall Study|36M Missed Visit|2|||
162974897|NCT01917968|588607763|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
162974898|NCT01917968|588607764|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
162974899|NCT01917968|588607763|FG000|Overall Study|Change in Family Circumstances|0|||
162974900|NCT01917968|588607764|FG001|Overall Study|Change in Family Circumstances|1|||
162974901|NCT01917968|588607763|FG000|Overall Study|No Data Available|0|||
162974902|NCT01917968|588607764|FG001|Overall Study|No Data Available|2|||
162974903|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
162974904|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
162974905|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
162974906|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
162974907|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
162974908|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
162974909|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
162974910|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
162974911|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
162974912|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
162974913|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
162974914|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
162974915|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
162974916|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
162974917|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
162974918|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
162974919|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
162974920|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
162974921|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
162974922|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
162974923|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
162974924|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
162974925|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
162974926|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
162974927|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
162974928|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
162974929|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
162974930|NCT01435928|588607766|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
162974931|NCT01435928|588607767|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
162974932|NCT01435928|588607768|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
162974933|NCT01435928|588607766|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
162974934|NCT01435928|588607767|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
162974935|NCT01435928|588607768|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
162974936|NCT01435928|588607766|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
162974937|NCT01435928|588607767|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
162974938|NCT01435928|588607768|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
162974939|NCT01435928|588607766|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
162974940|NCT01435928|588607767|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
162974941|NCT01435928|588607768|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
162974942|NCT01435928|588607766|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
162974943|NCT01435928|588607767|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
162974944|NCT01435928|588607768|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
162974945|NCT01435928|588607766|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
162974946|NCT01435928|588607767|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
162974947|NCT01435928|588607768|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
162974948|NCT01435928|588607766|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
162974949|NCT01435928|588607767|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
162974950|NCT01435928|588607768|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
162974951|NCT01835548|588607774|FG000|Dose Optimization Period|Adverse Event|0|||
162974952|NCT01835548|588607775|FG001|Dose Optimization Period|Adverse Event|0|||
162974953|NCT01835548|588607776|FG002|Dose Optimization Period|Adverse Event|1|||
162974954|NCT01835548|588607774|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
162974955|NCT01835548|588607775|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
162974956|NCT01835548|588607776|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
162974957|NCT01835548|588607774|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162974958|NCT01835548|588607775|FG001|Double-Blind Treatment Period|Adverse Event|1|||
162974959|NCT01835548|588607776|FG002|Double-Blind Treatment Period|Adverse Event|0|||
162974960|NCT01835548|588607774|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162974961|NCT01835548|588607775|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162974962|NCT01835548|588607776|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163057397|NCT02897349|588921233|FG000|Overall Study|Other than listed above|0|||
163057398|NCT02897349|588921234|FG001|Overall Study|Other than listed above|1|||
162974963|NCT01169038|588607777|FG000|Overall Study|Death|1|||
162974964|NCT01169038|588607777|FG000|Overall Study|Adverse Event|5|||
162974965|NCT01169038|588607777|FG000|Overall Study|Required antibiotic administration|1|||
162974966|NCT02490800|588607778|FG000|Overall Study|Adverse Event|0|||
162974967|NCT02490800|588607779|FG001|Overall Study|Adverse Event|0|||
162974968|NCT02490800|588607780|FG002|Overall Study|Adverse Event|0|||
162974969|NCT02490800|588607781|FG003|Overall Study|Adverse Event|2|||
162974970|NCT02490800|588607782|FG004|Overall Study|Adverse Event|3|||
162974971|NCT02490800|588607783|FG005|Overall Study|Adverse Event|2|||
162974972|NCT02490800|588607784|FG006|Overall Study|Adverse Event|0|||
162974973|NCT02490800|588607785|FG007|Overall Study|Adverse Event|0|||
163057399|NCT03817528|588921243|FG000|Overall Study|Withdrawal by Subject|1|||
162974974|NCT02490800|588607786|FG008|Overall Study|Adverse Event|0|||
162974975|NCT02490800|588607787|FG009|Overall Study|Adverse Event|0|||
162974976|NCT02490800|588607788|FG010|Overall Study|Adverse Event|0|||
162974977|NCT02490800|588607789|FG011|Overall Study|Adverse Event|2|||
162974978|NCT02490800|588607790|FG012|Overall Study|Adverse Event|2|||
162974979|NCT02490800|588607778|FG000|Overall Study|Withdrawal by Subject|0|||
162974980|NCT02490800|588607779|FG001|Overall Study|Withdrawal by Subject|0|||
162974981|NCT02490800|588607780|FG002|Overall Study|Withdrawal by Subject|0|||
162974982|NCT02490800|588607781|FG003|Overall Study|Withdrawal by Subject|1|||
162974983|NCT02490800|588607782|FG004|Overall Study|Withdrawal by Subject|0|||
162974984|NCT02490800|588607783|FG005|Overall Study|Withdrawal by Subject|0|||
162974985|NCT02490800|588607784|FG006|Overall Study|Withdrawal by Subject|0|||
162974986|NCT02490800|588607785|FG007|Overall Study|Withdrawal by Subject|0|||
162974987|NCT02490800|588607786|FG008|Overall Study|Withdrawal by Subject|1|||
162974988|NCT02490800|588607787|FG009|Overall Study|Withdrawal by Subject|0|||
162974989|NCT02490800|588607788|FG010|Overall Study|Withdrawal by Subject|0|||
162974990|NCT02490800|588607789|FG011|Overall Study|Withdrawal by Subject|0|||
162974991|NCT02490800|588607790|FG012|Overall Study|Withdrawal by Subject|0|||
162974992|NCT02490800|588607778|FG000|Overall Study|Progressive disease|3|||
162974993|NCT02490800|588607779|FG001|Overall Study|Progressive disease|3|||
162974994|NCT02490800|588607780|FG002|Overall Study|Progressive disease|3|||
162974995|NCT02490800|588607781|FG003|Overall Study|Progressive disease|4|||
162974996|NCT02490800|588607782|FG004|Overall Study|Progressive disease|4|||
162974997|NCT02490800|588607783|FG005|Overall Study|Progressive disease|1|||
162974998|NCT02490800|588607784|FG006|Overall Study|Progressive disease|4|||
162974999|NCT02490800|588607785|FG007|Overall Study|Progressive disease|3|||
162975000|NCT02490800|588607786|FG008|Overall Study|Progressive disease|6|||
162975001|NCT02490800|588607787|FG009|Overall Study|Progressive disease|2|||
162975002|NCT02490800|588607788|FG010|Overall Study|Progressive disease|7|||
162975003|NCT02490800|588607789|FG011|Overall Study|Progressive disease|1|||
162975004|NCT02490800|588607790|FG012|Overall Study|Progressive disease|10|||
162975005|NCT02490800|588607778|FG000|Overall Study|Patient enrolled in post-trial access|0|||
162975006|NCT02490800|588607779|FG001|Overall Study|Patient enrolled in post-trial access|0|||
162975007|NCT02490800|588607780|FG002|Overall Study|Patient enrolled in post-trial access|0|||
162975008|NCT02490800|588607781|FG003|Overall Study|Patient enrolled in post-trial access|0|||
162975009|NCT02490800|588607782|FG004|Overall Study|Patient enrolled in post-trial access|0|||
162975010|NCT02490800|588607783|FG005|Overall Study|Patient enrolled in post-trial access|0|||
162975011|NCT02490800|588607784|FG006|Overall Study|Patient enrolled in post-trial access|0|||
162975012|NCT02490800|588607785|FG007|Overall Study|Patient enrolled in post-trial access|0|||
162975013|NCT02490800|588607786|FG008|Overall Study|Patient enrolled in post-trial access|0|||
162975014|NCT02490800|588607787|FG009|Overall Study|Patient enrolled in post-trial access|1|||
162975015|NCT02490800|588607788|FG010|Overall Study|Patient enrolled in post-trial access|1|||
162975016|NCT02490800|588607789|FG011|Overall Study|Patient enrolled in post-trial access|0|||
162975017|NCT02490800|588607790|FG012|Overall Study|Patient enrolled in post-trial access|6|||
162975018|NCT03365791|588607791|FG000|Overall Study|Adverse Event|5|||
162975019|NCT03365791|588607791|FG000|Overall Study|Death|1|||
162975020|NCT03365791|588607791|FG000|Overall Study|Lost to Follow-up|1|||
162975021|NCT03365791|588607791|FG000|Overall Study|Physician Decision|9|||
162975022|NCT03365791|588607791|FG000|Overall Study|Progressive disease|51|||
162975023|NCT03365791|588607791|FG000|Overall Study|Subject/guardian decision|5|||
162975024|NCT00739973|588607792|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
162975025|NCT00739973|588607793|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975026|NCT00739973|588607794|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975027|NCT00739973|588607795|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975028|NCT00739973|588607796|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975029|NCT00739973|588607797|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975030|NCT00739973|588607798|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975031|NCT00739973|588607799|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975032|NCT00739973|588607800|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975033|NCT00739973|588607792|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
162975034|NCT00739973|588607793|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975035|NCT00739973|588607794|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975036|NCT00739973|588607795|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975037|NCT00739973|588607796|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975038|NCT00739973|588607797|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975039|NCT00739973|588607798|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975040|NCT00739973|588607799|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975041|NCT00739973|588607800|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975042|NCT00739973|588607792|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
162975043|NCT00739973|588607793|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975044|NCT00739973|588607794|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975045|NCT00739973|588607795|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975046|NCT00739973|588607796|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975047|NCT00739973|588607797|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975048|NCT00739973|588607798|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975049|NCT00739973|588607799|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975050|NCT00739973|588607800|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975051|NCT00739973|588607792|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
162975052|NCT00739973|588607793|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975053|NCT00739973|588607794|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975054|NCT00739973|588607795|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975055|NCT00739973|588607796|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975056|NCT00739973|588607797|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975057|NCT00739973|588607798|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975058|NCT00739973|588607799|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975059|NCT00739973|588607800|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975060|NCT00739973|588607792|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
162975061|NCT00739973|588607793|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975062|NCT00739973|588607794|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975063|NCT00739973|588607795|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975064|NCT00739973|588607796|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975065|NCT00739973|588607797|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975066|NCT00739973|588607798|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975067|NCT00739973|588607799|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975068|NCT00739973|588607800|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975069|NCT00739973|588607792|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
162975070|NCT00739973|588607793|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975071|NCT00739973|588607794|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975072|NCT00739973|588607795|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975073|NCT00739973|588607796|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975074|NCT00739973|588607797|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975075|NCT00739973|588607798|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975076|NCT00739973|588607799|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975077|NCT00739973|588607800|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975078|NCT00739973|588607792|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
162975079|NCT00739973|588607793|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975080|NCT00739973|588607794|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975081|NCT00739973|588607795|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975082|NCT00739973|588607796|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975083|NCT00739973|588607797|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975084|NCT00739973|588607798|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975085|NCT00739973|588607799|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975086|NCT00739973|588607800|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975087|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
162975088|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
162975089|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
162975090|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
162975091|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
162975092|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
162975093|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
162975094|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
162975095|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
162975096|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
162975097|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
162975098|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
162975099|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
163057400|NCT03817528|588921243|FG000|Overall Study|Adverse Event|2|||
163057401|NCT03895086|588921244|FG000|Overall Study|Early termination study|1|||
163057402|NCT03895086|588921245|FG001|Overall Study|Early termination study|0|||
163209660|NCT00227903|589482945|FG001|Overall Study|Lost to Follow-up|3|||
163209661|NCT00227903|589482944|FG000|Overall Study|Miscarriage|1|||
163209662|NCT00227903|589482945|FG001|Overall Study|Miscarriage|0|||
163209663|NCT01475331|589482946|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
163057403|NCT01192815|588921246|FG000|Overall Study|Withdrawal by Subject|1|||
163209664|NCT01475331|589482947|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
163401335|NCT01438489|590181133|FG000|Overall Study|Withdrawal by Subject|11|||
163401336|NCT01438489|590181134|FG001|Overall Study|Withdrawal by Subject|3|||
162975100|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
162975101|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
162975102|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
162975103|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
162975104|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
162975105|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
162975106|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
162975107|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
162975108|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
162975109|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
162975110|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
162975111|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
162975112|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
162975113|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
162975114|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
162975115|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
162975116|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
162975117|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
162975118|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
162975119|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
162975120|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
162975121|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
162975122|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
162975123|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
162975124|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
162975125|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
162975126|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
162975127|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
162975128|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
162975129|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
162975130|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
162975131|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
163318056|NCT01928394|589874964|FG018|Follow-up Period|other reason|1|||
163318057|NCT01928394|589874965|FG019|Follow-up Period|other reason|1|||
163318058|NCT01928394|589874966|FG020|Follow-up Period|other reason|0|||
162975132|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
162975133|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
162975134|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
162975135|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
162975136|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
162975137|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
162975138|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
162975139|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
162975140|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
162975141|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
162975142|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
162975143|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
162975144|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
162975145|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
162975146|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
162975147|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
162975148|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
162975149|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
162975150|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975151|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975152|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975153|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975154|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975155|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975156|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
162975157|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975158|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975159|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
162975160|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
162975161|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
162975162|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
162975163|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
162975164|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
162975165|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
162975166|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
162975167|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
162975168|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162975169|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
162975170|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162975171|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162975172|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162975173|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162975174|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
162975175|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162975176|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162975177|NCT00576303|588607801|FG000|Dose Titration Period|Early withdrawal|17|||
162975178|NCT00576303|588607801|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
162975179|NCT00576303|588607801|FG000|Long Term Safety Period|Early withdrawal|16|||
162975180|NCT02843659|588607805|FG000|Overall Study|Subject Withdrew Consent|0|||
162975181|NCT02843659|588607806|FG001|Overall Study|Subject Withdrew Consent|0|||
162975182|NCT02843659|588607807|FG002|Overall Study|Subject Withdrew Consent|1|||
162975183|NCT02843659|588607805|FG000|Overall Study|Administrative Reason by Sponsor|4|||
162975184|NCT02843659|588607806|FG001|Overall Study|Administrative Reason by Sponsor|5|||
162975185|NCT02843659|588607807|FG002|Overall Study|Administrative Reason by Sponsor|4|||
162975186|NCT02843659|588607805|FG000|Overall Study|Adverse Event|0|||
162975187|NCT02843659|588607806|FG001|Overall Study|Adverse Event|1|||
162975188|NCT02843659|588607807|FG002|Overall Study|Adverse Event|0|||
162975189|NCT03203642|588607808|FG000|Overall Study|Adverse Event|3|||
162975190|NCT03203642|588607809|FG001|Overall Study|Adverse Event|1|||
162975191|NCT03203642|588607808|FG000|Overall Study|Withdrawal by Subject|6|||
162975192|NCT03203642|588607809|FG001|Overall Study|Withdrawal by Subject|6|||
162975193|NCT03203642|588607808|FG000|Overall Study|Lost to Follow-up|2|||
162975194|NCT03203642|588607809|FG001|Overall Study|Lost to Follow-up|1|||
162975195|NCT03203642|588607808|FG000|Overall Study|Termination of the study by sponsor|1|||
162975196|NCT03203642|588607809|FG001|Overall Study|Termination of the study by sponsor|1|||
162975197|NCT03203642|588607808|FG000|Overall Study|Participant moved|0|||
162975198|NCT03203642|588607809|FG001|Overall Study|Participant moved|1|||
162975199|NCT03203642|588607808|FG000|Overall Study|Investigator's decision|3|||
162975200|NCT03203642|588607809|FG001|Overall Study|Investigator's decision|0|||
162975201|NCT03203642|588607808|FG000|Overall Study|Other than above specified|0|||
162975202|NCT03203642|588607809|FG001|Overall Study|Other than above specified|1|||
162975203|NCT02175368|588607810|FG000|Overall Study|Lost to Follow-up|1|||
162975204|NCT02875028|588607811|FG000|Washout Period|Withdrawal by Subject|0|||
162975205|NCT02875028|588607812|FG001|Washout Period|Withdrawal by Subject|1|||
162975206|NCT05068284|588607813|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
162975207|NCT05068284|588607814|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
162975208|NCT05068284|588607815|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
162975209|NCT05068284|588607816|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
162975210|NCT05068284|588607817|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
162975211|NCT05068284|588607818|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
162975212|NCT05068284|588607819|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
162975213|NCT05068284|588607820|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
162975214|NCT05068284|588607813|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
162975215|NCT05068284|588607814|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
162975216|NCT05068284|588607815|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
162975217|NCT05068284|588607816|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
162975218|NCT05068284|588607817|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
163318059|NCT01928394|589874967|FG021|Follow-up Period|other reason|0|||
162975219|NCT05068284|588607818|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
162975220|NCT05068284|588607819|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
163318060|NCT01928394|589874968|FG022|Follow-up Period|other reason|1|||
163318061|NCT01928394|589874946|FG000|Follow-up Period|Lost to Follow-up|0|||
162975221|NCT05068284|588607820|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
162975222|NCT05068284|588607813|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
162975223|NCT05068284|588607814|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
162975224|NCT05068284|588607815|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
162975225|NCT05068284|588607816|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
162975226|NCT05068284|588607817|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
162975227|NCT05068284|588607818|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
162975228|NCT05068284|588607819|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
162975229|NCT05068284|588607820|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
162975230|NCT05068284|588607813|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
162975231|NCT05068284|588607814|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
162975232|NCT05068284|588607815|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
162975233|NCT05068284|588607816|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
162975234|NCT05068284|588607817|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
162975235|NCT05068284|588607818|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
162975236|NCT05068284|588607819|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
162975237|NCT05068284|588607820|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
162975238|NCT05068284|588607813|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162975239|NCT05068284|588607814|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162975240|NCT05068284|588607815|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162975241|NCT05068284|588607816|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
162975242|NCT05068284|588607817|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162975243|NCT05068284|588607818|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162975244|NCT05068284|588607819|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162975245|NCT05068284|588607820|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162975246|NCT05068284|588607813|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
162975247|NCT05068284|588607814|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
162975248|NCT05068284|588607815|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
162975249|NCT05068284|588607816|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
162975250|NCT05068284|588607817|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
162975251|NCT05068284|588607818|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
162975252|NCT05068284|588607819|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
162975253|NCT05068284|588607820|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
162975254|NCT05068284|588607813|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
162975255|NCT05068284|588607814|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
162975256|NCT05068284|588607815|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
162975257|NCT05068284|588607816|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
162975258|NCT05068284|588607817|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
162975259|NCT05068284|588607818|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
162975260|NCT05068284|588607819|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
162975261|NCT05068284|588607820|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
162975262|NCT05068284|588607813|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
162975263|NCT05068284|588607814|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
162975264|NCT05068284|588607815|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
162975265|NCT05068284|588607816|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
162975266|NCT05068284|588607817|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
162975267|NCT05068284|588607818|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
162975268|NCT05068284|588607819|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
162975269|NCT05068284|588607820|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
162975270|NCT05068284|588607813|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
162975271|NCT05068284|588607814|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
162975272|NCT05068284|588607815|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
162975273|NCT05068284|588607816|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
162975274|NCT05068284|588607817|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
162975275|NCT05068284|588607818|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
162975276|NCT05068284|588607819|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
163057404|NCT01192815|588921246|FG000|Overall Study|Lack of Efficacy|1|||
163401337|NCT01438489|590181135|FG002|Overall Study|Withdrawal by Subject|8|||
163401338|NCT01438489|590181133|FG000|Overall Study|Death|0|||
163401339|NCT01438489|590181134|FG001|Overall Study|Death|0|||
163401340|NCT01438489|590181135|FG002|Overall Study|Death|1|||
163401341|NCT01438489|590181133|FG000|Overall Study|Sponsor decision|4|||
162975277|NCT05068284|588607820|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
162975278|NCT05068284|588607813|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
162975279|NCT05068284|588607814|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
162975280|NCT05068284|588607815|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
162975281|NCT05068284|588607816|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
162975282|NCT05068284|588607817|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
162975283|NCT05068284|588607818|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
162975284|NCT05068284|588607819|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
162975285|NCT05068284|588607820|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
162975286|NCT05068284|588607813|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
162975287|NCT05068284|588607814|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
162975288|NCT05068284|588607815|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
162975289|NCT05068284|588607816|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
162975290|NCT05068284|588607817|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
162975291|NCT05068284|588607818|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
162975292|NCT05068284|588607819|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
162975293|NCT05068284|588607820|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
162975294|NCT05068284|588607813|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
162975295|NCT05068284|588607814|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
162975296|NCT05068284|588607815|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
162975297|NCT05068284|588607816|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
162975298|NCT05068284|588607817|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
162975299|NCT05068284|588607818|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
162975300|NCT05068284|588607819|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
162975301|NCT05068284|588607820|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
162975302|NCT05068284|588607813|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
162975303|NCT05068284|588607814|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
162975304|NCT05068284|588607815|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
162975305|NCT05068284|588607816|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
162975306|NCT05068284|588607817|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
162975307|NCT05068284|588607818|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
162975308|NCT05068284|588607819|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
162975309|NCT05068284|588607820|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
162975310|NCT05068284|588607813|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
162975311|NCT05068284|588607814|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
162975312|NCT05068284|588607815|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
162975313|NCT05068284|588607816|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
162975314|NCT05068284|588607817|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
162975315|NCT05068284|588607818|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
162975316|NCT05068284|588607819|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
162975317|NCT05068284|588607820|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
162975318|NCT03250299|588609485|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
162975319|NCT03250299|588609486|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
162975320|NCT03250299|588609487|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
162975321|NCT03250299|588609488|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
162975322|NCT03250299|588609489|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
162975323|NCT03250299|588609485|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
162975324|NCT03250299|588609486|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
162975325|NCT03250299|588609487|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
162975326|NCT03250299|588609488|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
162975327|NCT03250299|588609489|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
162975328|NCT03250299|588609485|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
162975329|NCT03250299|588609486|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
162975330|NCT03250299|588609487|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
162975331|NCT03250299|588609488|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
162975332|NCT03250299|588609489|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
162975333|NCT03250299|588609485|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
162975334|NCT03250299|588609486|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
162975335|NCT03250299|588609487|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
162975336|NCT03250299|588609488|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
163318062|NCT01928394|589874947|FG001|Follow-up Period|Lost to Follow-up|0|||
162975337|NCT03250299|588609489|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
162975338|NCT00977548|588609491|FG000|Overall Study|Ineligible|4|||
162975339|NCT00977548|588609491|FG000|Overall Study|Adverse Event|8|||
162975340|NCT00977548|588609491|FG000|Overall Study|Withdrawal by Subject|1|||
162975341|NCT00988208|588609492|FG000|Overall Study|Adverse Event|71|||
162975342|NCT00988208|588609493|FG001|Overall Study|Adverse Event|122|||
162975343|NCT00988208|588609492|FG000|Overall Study|Disease Progression|103|||
162975344|NCT00988208|588609493|FG001|Overall Study|Disease Progression|89|||
162975345|NCT00988208|588609492|FG000|Overall Study|Withdrawal by Subject|50|||
162975346|NCT00988208|588609493|FG001|Overall Study|Withdrawal by Subject|57|||
162975347|NCT00988208|588609492|FG000|Overall Study|Death|9|||
162975348|NCT00988208|588609493|FG001|Overall Study|Death|15|||
162975349|NCT00988208|588609492|FG000|Overall Study|Lost to Follow-up|2|||
162975350|NCT00988208|588609493|FG001|Overall Study|Lost to Follow-up|3|||
162975351|NCT00988208|588609492|FG000|Overall Study|Protocol Violation|9|||
162975352|NCT00988208|588609493|FG001|Overall Study|Protocol Violation|2|||
162975353|NCT00988208|588609492|FG000|Overall Study|Sponsor Decision|102|||
162975354|NCT00988208|588609493|FG001|Overall Study|Sponsor Decision|78|||
162975355|NCT00988208|588609492|FG000|Overall Study|Clinical Progression|17|||
162975356|NCT00988208|588609493|FG001|Overall Study|Clinical Progression|16|||
162975357|NCT00988208|588609492|FG000|Overall Study|Biochemical Progression|21|||
162975358|NCT00988208|588609493|FG001|Overall Study|Biochemical Progression|7|||
162975359|NCT00988208|588609492|FG000|Overall Study|Clinical Deterioration|7|||
162975360|NCT00988208|588609493|FG001|Overall Study|Clinical Deterioration|14|||
162975361|NCT00988208|588609492|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
162975362|NCT00988208|588609493|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
162975363|NCT00988208|588609492|FG000|Overall Study|Other|8|||
162975364|NCT00988208|588609493|FG001|Overall Study|Other|3|||
162975365|NCT02000531|588609498|FG000|Overall Study|Lost to Follow-up|1|||
162975366|NCT02000531|588609499|FG001|Overall Study|Lost to Follow-up|0|||
162975367|NCT02000531|588609498|FG000|Overall Study|Discontinued due to data cut-off|3|||
162975368|NCT02000531|588609499|FG001|Overall Study|Discontinued due to data cut-off|8|||
162975369|NCT00794417|588609500|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
162975370|NCT00794417|588609501|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
162975371|NCT00794417|588609502|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
162975372|NCT00794417|588609503|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
162975373|NCT00794417|588609500|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
162975374|NCT00794417|588609501|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
162975375|NCT00794417|588609502|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
162975376|NCT00794417|588609503|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
162975377|NCT00794417|588609500|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
162975378|NCT00794417|588609501|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
162975379|NCT00794417|588609502|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
162975380|NCT00794417|588609503|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
162975381|NCT00794417|588609500|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
162975382|NCT00794417|588609501|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
162975383|NCT00794417|588609502|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
162975384|NCT00794417|588609503|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
162975385|NCT00794417|588609500|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
162975386|NCT00794417|588609501|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
162975387|NCT00794417|588609502|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
162975388|NCT00794417|588609503|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
162975389|NCT00794417|588609500|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
162975390|NCT00794417|588609501|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
162975391|NCT00794417|588609502|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
162975392|NCT00794417|588609503|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
162975393|NCT01546142|588609506|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
162975394|NCT01546142|588609507|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
162975395|NCT01546142|588609506|FG000|Overall Study|Subject Noncompliance|1|||
162975396|NCT01546142|588609507|FG001|Overall Study|Subject Noncompliance|1|||
162975397|NCT01546142|588609506|FG000|Overall Study|Adverse Event|6|||
162975398|NCT01546142|588609507|FG001|Overall Study|Adverse Event|3|||
162975399|NCT01546142|588609506|FG000|Overall Study|Lost to Follow-up|20|||
162975400|NCT01546142|588609507|FG001|Overall Study|Lost to Follow-up|15|||
162975401|NCT01546142|588609506|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
162975402|NCT01546142|588609507|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
162975403|NCT01546142|588609506|FG000|Overall Study|Subject Randomized but Not Treated|1|||
162975404|NCT01546142|588609507|FG001|Overall Study|Subject Randomized but Not Treated|0|||
162975405|NCT01213836|588609508|FG000|Period 1, First Intervention|Adverse Event|2|||
162975406|NCT01213836|588609509|FG001|Period 1, First Intervention|Adverse Event|1|||
162975407|NCT01213836|588609508|FG000|Period 1, First Intervention|Protocol Violation|0|||
162975408|NCT01213836|588609509|FG001|Period 1, First Intervention|Protocol Violation|1|||
162975409|NCT01213836|588609508|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
162975410|NCT01213836|588609509|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
162975411|NCT00255151|588609511|FG000|Overall Study|Adverse Event|10|||
162975412|NCT00255151|588609512|FG001|Overall Study|Adverse Event|6|||
162975413|NCT00255151|588609513|FG002|Overall Study|Adverse Event|9|||
162975414|NCT00255151|588609511|FG000|Overall Study|Lost to Follow-up|4|||
162975415|NCT00255151|588609512|FG001|Overall Study|Lost to Follow-up|3|||
162975416|NCT00255151|588609513|FG002|Overall Study|Lost to Follow-up|4|||
162975417|NCT00255151|588609511|FG000|Overall Study|Withdrawal by Subject|18|||
162975418|NCT00255151|588609512|FG001|Overall Study|Withdrawal by Subject|17|||
162975419|NCT00255151|588609513|FG002|Overall Study|Withdrawal by Subject|8|||
162975420|NCT00255151|588609511|FG000|Overall Study|Noncompliance|0|||
162975421|NCT00255151|588609512|FG001|Overall Study|Noncompliance|1|||
162975422|NCT00255151|588609513|FG002|Overall Study|Noncompliance|2|||
162975423|NCT00255151|588609511|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
162975424|NCT00255151|588609512|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
162975425|NCT00255151|588609513|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
162975426|NCT00255151|588609511|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
162975427|NCT00255151|588609512|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
162975428|NCT00255151|588609513|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
162975429|NCT00255151|588609511|FG000|Overall Study|Possible Barrett's Esophagus|1|||
162975430|NCT00255151|588609512|FG001|Overall Study|Possible Barrett's Esophagus|3|||
162975431|NCT00255151|588609513|FG002|Overall Study|Possible Barrett's Esophagus|8|||
162975432|NCT00255151|588609511|FG000|Overall Study|Esophageal Stricture|0|||
162975433|NCT00255151|588609512|FG001|Overall Study|Esophageal Stricture|0|||
162975434|NCT00255151|588609513|FG002|Overall Study|Esophageal Stricture|1|||
162975435|NCT00255151|588609511|FG000|Overall Study|Therapeutic Failure|11|||
162975436|NCT00255151|588609512|FG001|Overall Study|Therapeutic Failure|2|||
162975437|NCT00255151|588609513|FG002|Overall Study|Therapeutic Failure|3|||
162975438|NCT00743509|588609521|FG000|Overall Study|Withdrawal by Subject|2|||
162975439|NCT00892281|588609524|FG000|Overall Study|Adverse Event|65|||
163057405|NCT01142336|588921248|FG000|Overall Study|Adverse Event|1|||
163057406|NCT01142336|588921249|FG001|Overall Study|Adverse Event|1|||
163057407|NCT01142336|588921248|FG000|Overall Study|Lost to Follow-up|0|||
163057408|NCT01142336|588921249|FG001|Overall Study|Lost to Follow-up|1|||
163057409|NCT03025035|588921265|FG000|Overall Study|Death|2|||
163057410|NCT03025035|588921265|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
163057411|NCT01218802|588921268|FG000|Overall Study|Lost to Follow-up|5|||
163057412|NCT01218802|588921269|FG001|Overall Study|Lost to Follow-up|6|||
163057413|NCT01218802|588921268|FG000|Overall Study|Withdrawal by Subject|3|||
163057414|NCT01218802|588921269|FG001|Overall Study|Withdrawal by Subject|10|||
163057415|NCT01218802|588921268|FG000|Overall Study|Adverse Event|0|||
163057416|NCT01218802|588921269|FG001|Overall Study|Adverse Event|2|||
163057417|NCT01218802|588921268|FG000|Overall Study|Incarcerated|2|||
163057418|NCT01218802|588921269|FG001|Overall Study|Incarcerated|0|||
163057419|NCT01123655|588921274|FG000|Overall Study|Medication for RA had to be changed|1|||
163057420|NCT01123655|588921275|FG001|Overall Study|Medication for RA had to be changed|0|||
163057421|NCT01123655|588921276|FG002|Overall Study|Medication for RA had to be changed|0|||
163057422|NCT01123655|588921274|FG000|Overall Study|new illness|0|||
163057423|NCT01123655|588921275|FG001|Overall Study|new illness|1|||
162975440|NCT00892281|588609525|FG001|Overall Study|Adverse Event|8|||
162975441|NCT00892281|588609524|FG000|Overall Study|Lost to Follow-up|81|||
162975442|NCT00892281|588609525|FG001|Overall Study|Lost to Follow-up|8|||
163057424|NCT01123655|588921276|FG002|Overall Study|new illness|0|||
163057425|NCT01123655|588921274|FG000|Overall Study|began prohibitive drug|0|||
163057426|NCT01123655|588921275|FG001|Overall Study|began prohibitive drug|0|||
163318063|NCT01928394|589874948|FG002|Follow-up Period|Lost to Follow-up|0|||
162975443|NCT00892281|588609524|FG000|Overall Study|Pregnancy|1|||
162975444|NCT00892281|588609525|FG001|Overall Study|Pregnancy|0|||
162975445|NCT00892281|588609524|FG000|Overall Study|Protocol Violation|7|||
162975446|NCT00892281|588609525|FG001|Overall Study|Protocol Violation|2|||
162975447|NCT00892281|588609524|FG000|Overall Study|Withdrawal by Subject|86|||
162975448|NCT00892281|588609525|FG001|Overall Study|Withdrawal by Subject|14|||
163057427|NCT01123655|588921276|FG002|Overall Study|began prohibitive drug|1|||
163057428|NCT02475369|588921283|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
163057429|NCT02475369|588921284|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
163318064|NCT01928394|589874949|FG003|Follow-up Period|Lost to Follow-up|0|||
162975449|NCT00892281|588609524|FG000|Overall Study|Subject failed to return for final visit|2|||
163057430|NCT00471497|588921285|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
162975450|NCT00892281|588609525|FG001|Overall Study|Subject failed to return for final visit|0|||
163057431|NCT00471497|588921286|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
163057432|NCT00471497|588921287|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
163057433|NCT00471497|588921285|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
163057434|NCT00471497|588921286|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
163057435|NCT00471497|588921287|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
162975451|NCT00892281|588609524|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
162975452|NCT00892281|588609525|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
162975453|NCT00892281|588609524|FG000|Overall Study|Final visit completed 4 weeks late|0|||
162975454|NCT00892281|588609525|FG001|Overall Study|Final visit completed 4 weeks late|1|||
162975455|NCT00892281|588609524|FG000|Overall Study|Subject completed day after study closed|1|||
162975456|NCT00892281|588609525|FG001|Overall Study|Subject completed day after study closed|0|||
162975457|NCT00892281|588609524|FG000|Overall Study|Family emergency|1|||
162975458|NCT00892281|588609525|FG001|Overall Study|Family emergency|0|||
162975459|NCT00892281|588609524|FG000|Overall Study|Last visit not done - death in family|1|||
162975460|NCT00892281|588609525|FG001|Overall Study|Last visit not done - death in family|0|||
162975461|NCT00892281|588609524|FG000|Overall Study|Did not meet incl/excl criteria|1|||
162975462|NCT00892281|588609525|FG001|Overall Study|Did not meet incl/excl criteria|0|||
162975463|NCT00892281|588609524|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
162975464|NCT00892281|588609525|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
162975465|NCT00892281|588609524|FG000|Overall Study|Unable to redeem the drug voucher|1|||
162975466|NCT00892281|588609525|FG001|Overall Study|Unable to redeem the drug voucher|0|||
162975467|NCT00892281|588609524|FG000|Overall Study|Subject not good candidate for study|1|||
162975468|NCT00892281|588609525|FG001|Overall Study|Subject not good candidate for study|0|||
162975469|NCT00892281|588609524|FG000|Overall Study|Subject did not return for any visits|1|||
162975470|NCT00892281|588609525|FG001|Overall Study|Subject did not return for any visits|0|||
162975471|NCT00892281|588609524|FG000|Overall Study|Subject missed several visits/lost meds|1|||
162975472|NCT00892281|588609525|FG001|Overall Study|Subject missed several visits/lost meds|0|||
162975473|NCT00892281|588609524|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
162975474|NCT00892281|588609525|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
162975475|NCT00892281|588609524|FG000|Overall Study|Scheduled for knee replacement|0|||
162975476|NCT00892281|588609525|FG001|Overall Study|Scheduled for knee replacement|1|||
162975477|NCT00892281|588609524|FG000|Overall Study|PI complained of inadequate compensation|3|||
162975478|NCT00892281|588609525|FG001|Overall Study|PI complained of inadequate compensation|0|||
162975479|NCT00892281|588609524|FG000|Overall Study|Subject lost interest in program|0|||
162975480|NCT00892281|588609525|FG001|Overall Study|Subject lost interest in program|1|||
162975481|NCT00892281|588609524|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
162975482|NCT00892281|588609525|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
162975483|NCT00892281|588609524|FG000|Overall Study|Death in family|1|||
162975484|NCT00892281|588609525|FG001|Overall Study|Death in family|0|||
162975485|NCT00892281|588609524|FG000|Overall Study|Lack of efficacy of study product|2|||
162975486|NCT00892281|588609525|FG001|Overall Study|Lack of efficacy of study product|0|||
162975487|NCT00892281|588609524|FG000|Overall Study|Subject not seen by PI at final visit|1|||
162975488|NCT00892281|588609525|FG001|Overall Study|Subject not seen by PI at final visit|0|||
162975489|NCT00892281|588609524|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
162975490|NCT00892281|588609525|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
162975491|NCT00892281|588609524|FG000|Overall Study|Missed multiple visits|1|||
162975492|NCT00892281|588609525|FG001|Overall Study|Missed multiple visits|0|||
162975493|NCT00892281|588609524|FG000|Overall Study|Missed visits rescheduled out of window|1|||
162975494|NCT00892281|588609525|FG001|Overall Study|Missed visits rescheduled out of window|0|||
162975495|NCT00892281|588609524|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
162975496|NCT00892281|588609525|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
162975497|NCT00892281|588609524|FG000|Overall Study|Subject had history of drug abuse|1|||
162975498|NCT00892281|588609525|FG001|Overall Study|Subject had history of drug abuse|0|||
162975499|NCT00892281|588609524|FG000|Overall Study|Rash on hand|1|||
162975500|NCT00892281|588609525|FG001|Overall Study|Rash on hand|0|||
162975501|NCT00892281|588609524|FG000|Overall Study|Visit 4 date out of window|1|||
162975502|NCT00892281|588609525|FG001|Overall Study|Visit 4 date out of window|0|||
162975503|NCT01534078|588609526|FG000|Overall Study|Death|1|||
162975504|NCT01534078|588609526|FG000|Overall Study|Withdrawal by Subject|1|||
162975505|NCT01280617|588609530|FG000|Overall Study|Adverse Event|0|||
162975506|NCT01280617|588609531|FG001|Overall Study|Adverse Event|1|||
162975507|NCT00986570|588609532|FG000|Overall Study|Lost to Follow-up|6|||
162975508|NCT00986570|588609532|FG000|Overall Study|Potential bias for objective assessment|1|||
162975509|NCT02225665|588609533|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
162975510|NCT02225665|588609534|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
162975511|NCT02225665|588609533|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
162975512|NCT02225665|588609534|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
162975513|NCT01311557|588609535|FG000|Overall Study|Serious adverse event|0|||
162975514|NCT01311557|588609536|FG001|Overall Study|Serious adverse event|1|||
162975515|NCT01311557|588609535|FG000|Overall Study|Protocol Violation|4|||
162975516|NCT01311557|588609536|FG001|Overall Study|Protocol Violation|2|||
162975517|NCT01311557|588609535|FG000|Overall Study|Lost to Follow-up|0|||
162975518|NCT01311557|588609536|FG001|Overall Study|Lost to Follow-up|1|||
162975519|NCT01311557|588609535|FG000|Overall Study|Withdrawal by Subject|1|||
162975520|NCT01311557|588609536|FG001|Overall Study|Withdrawal by Subject|2|||
163057436|NCT00471497|588921285|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
163057437|NCT00471497|588921286|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
163057438|NCT00471497|588921287|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
163057439|NCT00471497|588921285|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
163057440|NCT00471497|588921286|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
163057441|NCT00471497|588921287|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
163057442|NCT00471497|588921285|FG000|Core Treatment Phase|Lost to Follow-up|6|||
163057443|NCT00471497|588921286|FG001|Core Treatment Phase|Lost to Follow-up|6|||
163057444|NCT00471497|588921287|FG002|Core Treatment Phase|Lost to Follow-up|3|||
163057445|NCT00471497|588921285|FG000|Core Treatment Phase|Death|3|||
163057446|NCT00471497|588921286|FG001|Core Treatment Phase|Death|9|||
163057447|NCT00471497|588921287|FG002|Core Treatment Phase|Death|3|||
163057448|NCT00471497|588921285|FG000|Core Treatment Phase|Disease Progression|10|||
163057449|NCT00471497|588921286|FG001|Core Treatment Phase|Disease Progression|2|||
163057450|NCT00471497|588921287|FG002|Core Treatment Phase|Disease Progression|4|||
163057451|NCT00471497|588921285|FG000|Core Treatment Phase|Protocol Violation|6|||
163057452|NCT00471497|588921286|FG001|Core Treatment Phase|Protocol Violation|15|||
163057453|NCT00471497|588921287|FG002|Core Treatment Phase|Protocol Violation|11|||
163057454|NCT00471497|588921285|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
163057455|NCT00471497|588921286|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
163057456|NCT00471497|588921287|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
163057457|NCT00471497|588921285|FG000|Core Treatment Phase|Administrative problems|14|||
163057458|NCT00471497|588921286|FG001|Core Treatment Phase|Administrative problems|14|||
163057459|NCT00471497|588921287|FG002|Core Treatment Phase|Administrative problems|12|||
163057460|NCT00471497|588921285|FG000|Core Treatment Phase|Adverse Event|43|||
163057461|NCT00471497|588921286|FG001|Core Treatment Phase|Adverse Event|53|||
163057462|NCT00471497|588921287|FG002|Core Treatment Phase|Adverse Event|89|||
163057463|NCT00471497|588921285|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
163057464|NCT00471497|588921286|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
163057465|NCT00471497|588921287|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
163057466|NCT00471497|588921285|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
163057467|NCT00471497|588921286|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
163057468|NCT00471497|588921287|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
163057469|NCT00471497|588921285|FG000|Extension Phase|Adverse Event|9|||
163057470|NCT00471497|588921286|FG001|Extension Phase|Adverse Event|5|||
163057471|NCT00471497|588921287|FG002|Extension Phase|Adverse Event|1|||
163057472|NCT00471497|588921285|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
163057473|NCT00471497|588921286|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
163057474|NCT00471497|588921287|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
163057475|NCT00471497|588921285|FG000|Extension Phase|Withdrawal by Subject|3|||
163057476|NCT00471497|588921286|FG001|Extension Phase|Withdrawal by Subject|1|||
163057477|NCT00471497|588921287|FG002|Extension Phase|Withdrawal by Subject|0|||
163057478|NCT00471497|588921285|FG000|Extension Phase|Lost to Follow-up|2|||
163057479|NCT00471497|588921286|FG001|Extension Phase|Lost to Follow-up|0|||
163057480|NCT00471497|588921287|FG002|Extension Phase|Lost to Follow-up|0|||
163057481|NCT00471497|588921285|FG000|Extension Phase|Death|1|||
163057482|NCT00471497|588921286|FG001|Extension Phase|Death|0|||
163057483|NCT00471497|588921287|FG002|Extension Phase|Death|0|||
163057484|NCT00471497|588921285|FG000|Extension Phase|Disease progression|2|||
163057485|NCT00471497|588921286|FG001|Extension Phase|Disease progression|0|||
163057486|NCT00471497|588921287|FG002|Extension Phase|Disease progression|0|||
163057487|NCT00471497|588921285|FG000|Extension Phase|Protocol Violation|2|||
163057488|NCT00471497|588921286|FG001|Extension Phase|Protocol Violation|2|||
163057489|NCT00471497|588921287|FG002|Extension Phase|Protocol Violation|0|||
163057490|NCT03329885|588921289|FG000|Overall Study|Sponsor discontinued the study early|0|||
163057491|NCT03329885|588921290|FG001|Overall Study|Sponsor discontinued the study early|0|||
163057492|NCT03329885|588921291|FG002|Overall Study|Sponsor discontinued the study early|0|||
163057493|NCT03329885|588921292|FG003|Overall Study|Sponsor discontinued the study early|0|||
163057494|NCT03329885|588921293|FG004|Overall Study|Sponsor discontinued the study early|0|||
163057495|NCT03329885|588921294|FG005|Overall Study|Sponsor discontinued the study early|0|||
163401342|NCT01438489|590181134|FG001|Overall Study|Sponsor decision|1|||
163401343|NCT01438489|590181135|FG002|Overall Study|Sponsor decision|4|||
163401344|NCT01438489|590181133|FG000|Overall Study|Subject choice/Subject moved|2|||
163401345|NCT01438489|590181134|FG001|Overall Study|Subject choice/Subject moved|1|||
163057496|NCT03329885|588921295|FG006|Overall Study|Sponsor discontinued the study early|1|||
163057497|NCT03329885|588921296|FG007|Overall Study|Sponsor discontinued the study early|1|||
163057498|NCT03329885|588921297|FG008|Overall Study|Sponsor discontinued the study early|0|||
163057499|NCT01991795|588921298|FG000|Overall Study|Lost to Follow-up|6|||
163057500|NCT01991795|588921299|FG001|Overall Study|Lost to Follow-up|4|||
163057501|NCT01991795|588921298|FG000|Overall Study|Withdrawal by Subject|117|||
163057502|NCT01991795|588921299|FG001|Overall Study|Withdrawal by Subject|94|||
163057503|NCT01991795|588921298|FG000|Overall Study|Site prematurely closed by sponsor|26|||
162975521|NCT01470417|588609539|FG000|Overall Study|Disease progression|0|||
162975522|NCT01470417|588609540|FG001|Overall Study|Disease progression|2|||
162975523|NCT02973321|588609543|FG000|Overall Study|Other than specified|0|||
162975524|NCT02973321|588609544|FG001|Overall Study|Other than specified|5|||
162975525|NCT02973321|588609545|FG002|Overall Study|Other than specified|3|||
162975526|NCT02973321|588609546|FG003|Overall Study|Other than specified|3|||
162975527|NCT02973321|588609547|FG004|Overall Study|Other than specified|1|||
162975528|NCT02973321|588609543|FG000|Overall Study|Lack of Efficacy|0|||
162975529|NCT02973321|588609544|FG001|Overall Study|Lack of Efficacy|0|||
162975530|NCT02973321|588609545|FG002|Overall Study|Lack of Efficacy|0|||
162975531|NCT02973321|588609546|FG003|Overall Study|Lack of Efficacy|0|||
162975532|NCT02973321|588609547|FG004|Overall Study|Lack of Efficacy|1|||
162975533|NCT02973321|588609543|FG000|Overall Study|Adverse Event|1|||
162975534|NCT02973321|588609544|FG001|Overall Study|Adverse Event|10|||
162975535|NCT02973321|588609545|FG002|Overall Study|Adverse Event|11|||
162975536|NCT02973321|588609546|FG003|Overall Study|Adverse Event|13|||
162975537|NCT02973321|588609547|FG004|Overall Study|Adverse Event|3|||
162975538|NCT01098110|588609551|FG000|Overall Study|Withdrawal by Subject|14|||
162975539|NCT01098110|588609552|FG001|Overall Study|Withdrawal by Subject|24|||
162975540|NCT01098110|588609553|FG002|Overall Study|Withdrawal by Subject|19|||
162975541|NCT01098110|588609551|FG000|Overall Study|Adverse Event|30|||
162975542|NCT01098110|588609552|FG001|Overall Study|Adverse Event|32|||
162975543|NCT01098110|588609553|FG002|Overall Study|Adverse Event|43|||
162975544|NCT01098110|588609551|FG000|Overall Study|Lack of Efficacy|13|||
162975545|NCT01098110|588609552|FG001|Overall Study|Lack of Efficacy|9|||
162975546|NCT01098110|588609553|FG002|Overall Study|Lack of Efficacy|27|||
162975547|NCT01098110|588609551|FG000|Overall Study|Other|4|||
162975548|NCT01098110|588609552|FG001|Overall Study|Other|7|||
162975549|NCT01098110|588609553|FG002|Overall Study|Other|5|||
162975550|NCT01098110|588609551|FG000|Overall Study|Untreated|1|||
162975551|NCT01098110|588609552|FG001|Overall Study|Untreated|1|||
162975552|NCT01098110|588609553|FG002|Overall Study|Untreated|0|||
162975553|NCT01355302|588609554|FG000|Phase 1b|Death|4|||
162975554|NCT01355302|588609555|FG001|Phase 1b|Death|0|||
162975555|NCT01355302|588609556|FG002|Phase 1b|Death|0|||
162975556|NCT01355302|588609554|FG000|Phase 1b|Study terminated by sponsor|2|||
162975557|NCT01355302|588609555|FG001|Phase 1b|Study terminated by sponsor|0|||
162975558|NCT01355302|588609556|FG002|Phase 1b|Study terminated by sponsor|0|||
162975559|NCT02274948|588609559|FG000|Overall Study|Lost to Follow-up|28|||
162975560|NCT02274948|588609560|FG001|Overall Study|Lost to Follow-up|25|||
162975561|NCT02274948|588609559|FG000|Overall Study|Withdrawal by Subject|64|||
162975562|NCT02274948|588609560|FG001|Overall Study|Withdrawal by Subject|58|||
162975563|NCT02274948|588609559|FG000|Overall Study|Stopped on family Practitioner advice|2|||
162975564|NCT02274948|588609560|FG001|Overall Study|Stopped on family Practitioner advice|5|||
162975565|NCT02274948|588609559|FG000|Overall Study|Left the area|4|||
162975566|NCT02274948|588609560|FG001|Overall Study|Left the area|3|||
162975567|NCT00707434|588609561|FG000|Overall Study|Adverse Event|1|||
162975568|NCT05212883|588609562|FG000|Overall Study|Invalid test result|125|||
162975569|NCT02502734|588609563|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
162975570|NCT02502734|588609564|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
162975571|NCT02502734|588609563|FG000|Washout Period|Adverse Event|1|||
162975572|NCT02502734|588609564|FG001|Washout Period|Adverse Event|0|||
162975573|NCT00614822|588609565|FG000|Overall Study|Adverse Event|3|||
162975574|NCT03649412|588609574|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
162975575|NCT03649412|588609575|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
162975576|NCT03649412|588609574|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
162975577|NCT03649412|588609575|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
162975578|NCT03649412|588609574|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
162975579|NCT03649412|588609575|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162975580|NCT03649412|588609574|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
162975581|NCT03649412|588609575|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
162975582|NCT03649412|588609574|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
162975583|NCT03649412|588609575|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
162975584|NCT03649412|588609574|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
162975585|NCT03649412|588609575|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
162975586|NCT00865514|588609576|FG000|Overall Study|Infusion cost exceeded funding|2|||
163401346|NCT01438489|590181135|FG002|Overall Study|Subject choice/Subject moved|1|||
162975587|NCT02865395|588609577|FG000|Overall Study|Physician Decision|6|||
162975588|NCT02865395|588609578|FG001|Overall Study|Physician Decision|10|||
162975589|NCT02865395|588609579|FG002|Overall Study|Physician Decision|7|||
162975590|NCT00530348|588609580|FG000|Overall Study|Adverse Event|5|||
162975591|NCT00530348|588609581|FG001|Overall Study|Adverse Event|1|||
163401347|NCT01438489|590181133|FG000|Overall Study|Investigator decision|0|||
163401348|NCT01438489|590181134|FG001|Overall Study|Investigator decision|1|||
162975592|NCT00530348|588609580|FG000|Overall Study|Death|0|||
162975593|NCT00530348|588609581|FG001|Overall Study|Death|1|||
162975594|NCT00530348|588609580|FG000|Overall Study|Lack of Efficacy|2|||
162975595|NCT00530348|588609581|FG001|Overall Study|Lack of Efficacy|0|||
163401349|NCT01438489|590181135|FG002|Overall Study|Investigator decision|0|||
162975596|NCT00530348|588609580|FG000|Overall Study|Lost to Follow-up|0|||
162975597|NCT00530348|588609581|FG001|Overall Study|Lost to Follow-up|2|||
162975598|NCT00530348|588609580|FG000|Overall Study|Physician Decision|1|||
162975599|NCT00530348|588609581|FG001|Overall Study|Physician Decision|2|||
162975600|NCT00530348|588609580|FG000|Overall Study|Pregnancy|1|||
162975601|NCT00530348|588609581|FG001|Overall Study|Pregnancy|0|||
162975602|NCT00530348|588609580|FG000|Overall Study|Withdrawal by Subject|12|||
162975603|NCT00530348|588609581|FG001|Overall Study|Withdrawal by Subject|12|||
162975604|NCT00530348|588609580|FG000|Overall Study|Randomised in error|1|||
162975605|NCT00530348|588609581|FG001|Overall Study|Randomised in error|0|||
162975606|NCT00530348|588609580|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
162975607|NCT00530348|588609581|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
162975608|NCT04364763|588609582|FG000|Overall Study|Death|1|||
162975609|NCT04364763|588609583|FG001|Overall Study|Death|2|||
162975610|NCT04364763|588609582|FG000|Overall Study|Lost to Follow-up|1|||
162975611|NCT04364763|588609583|FG001|Overall Study|Lost to Follow-up|0|||
162975612|NCT01256060|588609584|FG000|Overall Study|Lost to Follow-up|0|||
162975613|NCT01256060|588609585|FG001|Overall Study|Lost to Follow-up|1|||
162975614|NCT01256060|588609586|FG002|Overall Study|Lost to Follow-up|0|||
162975615|NCT01256060|588609587|FG003|Overall Study|Lost to Follow-up|0|||
162975616|NCT00985231|588609590|FG000|Overall Study|ineligible|1|||
162975617|NCT00985231|588609591|FG001|Overall Study|ineligible|0|||
162975618|NCT00985231|588609590|FG000|Overall Study|Protocol Violation|1|||
162975619|NCT00985231|588609591|FG001|Overall Study|Protocol Violation|0|||
162975620|NCT00985231|588609590|FG000|Overall Study|Withdrawal by Subject|1|||
162975621|NCT00985231|588609591|FG001|Overall Study|Withdrawal by Subject|0|||
162975622|NCT00985231|588609590|FG000|Overall Study|Lost to Follow-up|0|||
162975623|NCT00985231|588609591|FG001|Overall Study|Lost to Follow-up|1|||
162975624|NCT00985231|588609590|FG000|Overall Study|Study related symptoms & complaints|0|||
162975625|NCT00985231|588609591|FG001|Overall Study|Study related symptoms & complaints|2|||
162975626|NCT00089076|588609592|FG000|Overall Study|Alternate Therapy|1|||
162975627|NCT00089076|588609592|FG000|Overall Study|Withdrawal by Subject|2|||
162975628|NCT00089076|588609592|FG000|Overall Study|Progression|7|||
162975629|NCT00931463|588609593|FG000|Overall Study|Death|8|||
162975630|NCT00931463|588609594|FG001|Overall Study|Death|4|||
162975631|NCT00931463|588609593|FG000|Overall Study|Withdrawal by Subject|5|||
162975632|NCT00931463|588609594|FG001|Overall Study|Withdrawal by Subject|0|||
162975633|NCT00931463|588609593|FG000|Overall Study|Lost to Follow-up|4|||
162975634|NCT00931463|588609594|FG001|Overall Study|Lost to Follow-up|1|||
162975635|NCT00808509|588609595|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
162975636|NCT00808509|588609596|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
162975637|NCT00808509|588609595|FG000|Randomized Phase|Reduced methotrexate dose|1|||
162975638|NCT00808509|588609596|FG001|Randomized Phase|Reduced methotrexate dose|2|||
163401350|NCT01438489|590181133|FG000|Overall Study|AE/SAEs|2|||
162975639|NCT00808509|588609595|FG000|Randomized Phase|Patient refused rescue therapy|0|||
162975640|NCT00808509|588609596|FG001|Randomized Phase|Patient refused rescue therapy|3|||
162975641|NCT02169791|588609599|FG000|Overall Study|Death|6|||
162975642|NCT02169791|588609599|FG000|Overall Study|patient withdrew consent|1|||
162975643|NCT00127166|588609603|FG000|Period I|Protocol Violation|0|||
162975644|NCT00127166|588609604|FG001|Period I|Protocol Violation|2|||
162975645|NCT00127166|588609603|FG000|Period I|Withdrawal by Subject|2|||
162975646|NCT00127166|588609604|FG001|Period I|Withdrawal by Subject|0|||
162975647|NCT00127166|588609603|FG000|Period I|Patient did not meet inclusion criteria|1|||
162975648|NCT00127166|588609604|FG001|Period I|Patient did not meet inclusion criteria|0|||
162975649|NCT00127166|588609603|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
162975650|NCT00127166|588609604|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
162975651|NCT00127166|588609603|FG000|Period II|Withdrawal by Subject|2|||
162975652|NCT00127166|588609604|FG001|Period II|Withdrawal by Subject|0|||
162975653|NCT00127166|588609603|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
162975654|NCT00127166|588609604|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
162975655|NCT01396421|588609605|FG000|Overall Study|Lost to Follow-up|0|||
162975656|NCT01396421|588609606|FG001|Overall Study|Lost to Follow-up|0|||
162975657|NCT01396421|588609607|FG002|Overall Study|Lost to Follow-up|0|||
162975658|NCT01396421|588609608|FG003|Overall Study|Lost to Follow-up|1|||
162975659|NCT01396421|588609605|FG000|Overall Study|Adverse Event|17|||
162975660|NCT01396421|588609606|FG001|Overall Study|Adverse Event|15|||
162975661|NCT01396421|588609607|FG002|Overall Study|Adverse Event|12|||
162975662|NCT01396421|588609608|FG003|Overall Study|Adverse Event|32|||
162975663|NCT01396421|588609605|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
162975664|NCT01396421|588609606|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
162975665|NCT01396421|588609607|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
162975666|NCT01396421|588609608|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
162975667|NCT01396421|588609605|FG000|Overall Study|Physician Decision|1|||
162975668|NCT01396421|588609606|FG001|Overall Study|Physician Decision|1|||
162975669|NCT01396421|588609607|FG002|Overall Study|Physician Decision|0|||
162975670|NCT01396421|588609608|FG003|Overall Study|Physician Decision|3|||
163401351|NCT01438489|590181134|FG001|Overall Study|AE/SAEs|1|||
163057504|NCT01991795|588921299|FG001|Overall Study|Site prematurely closed by sponsor|25|||
163057505|NCT04004000|588921300|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
163057506|NCT02121210|588921301|FG000|Overall Study|Adverse Event|5|||
163057507|NCT02121210|588921302|FG001|Overall Study|Adverse Event|7|||
163057508|NCT02121210|588921301|FG000|Overall Study|Lack of Efficacy|2|||
163057509|NCT02121210|588921302|FG001|Overall Study|Lack of Efficacy|0|||
163057510|NCT02121210|588921301|FG000|Overall Study|Other than specified above|0|||
163057511|NCT02121210|588921302|FG001|Overall Study|Other than specified above|2|||
163057512|NCT01232283|588921305|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
163057513|NCT01232283|588921306|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
163057514|NCT01232283|588921307|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057515|NCT01232283|588921308|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057516|NCT01232283|588921309|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057517|NCT01232283|588921310|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057518|NCT01232283|588921311|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057519|NCT01232283|588921312|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057520|NCT01232283|588921313|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057521|NCT01232283|588921314|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057522|NCT01232283|588921305|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
163057523|NCT01232283|588921306|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
163057524|NCT01232283|588921307|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057525|NCT01232283|588921308|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057526|NCT01232283|588921309|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057527|NCT01232283|588921310|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057528|NCT01232283|588921311|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057529|NCT01232283|588921312|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057530|NCT01232283|588921313|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057531|NCT01232283|588921314|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057532|NCT01232283|588921305|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
163057533|NCT01232283|588921306|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057534|NCT01232283|588921307|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057535|NCT01232283|588921308|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057536|NCT01232283|588921309|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057537|NCT01232283|588921310|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057538|NCT01232283|588921311|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057539|NCT01232283|588921312|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057540|NCT01232283|588921313|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057541|NCT01232283|588921314|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057542|NCT01232283|588921305|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
163057543|NCT01232283|588921306|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
163057544|NCT01232283|588921307|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057545|NCT01232283|588921308|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057546|NCT01232283|588921309|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057547|NCT01232283|588921310|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057548|NCT01232283|588921311|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057549|NCT01232283|588921312|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057550|NCT01232283|588921313|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057551|NCT01232283|588921314|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057552|NCT01232283|588921305|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
163057553|NCT01232283|588921306|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
163057554|NCT01232283|588921307|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057555|NCT01232283|588921308|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057556|NCT01232283|588921309|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057557|NCT01232283|588921310|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057558|NCT01232283|588921311|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057559|NCT01232283|588921312|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057560|NCT01232283|588921313|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057561|NCT01232283|588921314|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057562|NCT01232283|588921305|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
163057563|NCT01232283|588921306|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
163057564|NCT01232283|588921307|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
163209665|NCT01475331|589482946|FG000|Overall Study|excessive main duct communication|1|||
163209666|NCT01475331|589482947|FG001|Overall Study|excessive main duct communication|1|||
163209667|NCT01475331|589482946|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
162975671|NCT01396421|588609605|FG000|Overall Study|Withdrawal by Subject|31|||
162975672|NCT01396421|588609606|FG001|Overall Study|Withdrawal by Subject|24|||
162975673|NCT01396421|588609607|FG002|Overall Study|Withdrawal by Subject|13|||
162975674|NCT01396421|588609608|FG003|Overall Study|Withdrawal by Subject|21|||
162975675|NCT01396421|588609605|FG000|Overall Study|Protocol Deviation|2|||
162975676|NCT01396421|588609606|FG001|Overall Study|Protocol Deviation|1|||
162975677|NCT01396421|588609607|FG002|Overall Study|Protocol Deviation|1|||
162975678|NCT01396421|588609608|FG003|Overall Study|Protocol Deviation|0|||
162975679|NCT01396421|588609605|FG000|Overall Study|Lack of Efficacy|7|||
162975680|NCT01396421|588609606|FG001|Overall Study|Lack of Efficacy|17|||
162975681|NCT01396421|588609607|FG002|Overall Study|Lack of Efficacy|7|||
162975682|NCT01396421|588609608|FG003|Overall Study|Lack of Efficacy|18|||
162975683|NCT01610063|588609617|FG000|Overall Study|Lost to Follow-up|42|||
162975684|NCT01610063|588609618|FG001|Overall Study|Lost to Follow-up|20|||
162975685|NCT00442546|588609619|FG000|Overall Study|Adverse Event|11|||
162975686|NCT00442546|588609620|FG001|Overall Study|Adverse Event|17|||
162975687|NCT00442546|588609621|FG002|Overall Study|Adverse Event|13|||
162975688|NCT00442546|588609619|FG000|Overall Study|Lost to Follow-up|1|||
162975689|NCT00442546|588609620|FG001|Overall Study|Lost to Follow-up|2|||
162975690|NCT00442546|588609621|FG002|Overall Study|Lost to Follow-up|1|||
162975691|NCT00442546|588609619|FG000|Overall Study|Other|4|||
162975692|NCT00442546|588609620|FG001|Overall Study|Other|9|||
162975693|NCT00442546|588609621|FG002|Overall Study|Other|6|||
162975694|NCT00442546|588609619|FG000|Overall Study|Withdrawal by Subject|5|||
162975695|NCT00442546|588609620|FG001|Overall Study|Withdrawal by Subject|5|||
162975696|NCT00442546|588609621|FG002|Overall Study|Withdrawal by Subject|7|||
162975697|NCT00442546|588609619|FG000|Overall Study|Randomized But Not Treated|5|||
162975698|NCT00442546|588609620|FG001|Overall Study|Randomized But Not Treated|4|||
162975699|NCT00442546|588609621|FG002|Overall Study|Randomized But Not Treated|6|||
162975700|NCT01301482|588611674|FG000|Overall Study|Withdrawal by Subject|1|||
162975701|NCT04039919|588611678|FG000|Treatment Period 1|Withdrawal by Subject|1|||
162975702|NCT04039919|588611679|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162975703|NCT04039919|588611680|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162975704|NCT04039919|588611681|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162975705|NCT04039919|588611682|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162975706|NCT04039919|588611678|FG000|Treatment Period 1|Sponsor's decision|0|||
162975707|NCT04039919|588611679|FG001|Treatment Period 1|Sponsor's decision|0|||
162975708|NCT04039919|588611680|FG002|Treatment Period 1|Sponsor's decision|0|||
162975709|NCT04039919|588611681|FG003|Treatment Period 1|Sponsor's decision|0|||
162975710|NCT04039919|588611682|FG004|Treatment Period 1|Sponsor's decision|16|||
162975711|NCT04039919|588611678|FG000|Treatment Period 5|Withdrawal by Subject|1|||
162975712|NCT04039919|588611679|FG001|Treatment Period 5|Withdrawal by Subject|0|||
162975713|NCT04039919|588611680|FG002|Treatment Period 5|Withdrawal by Subject|0|||
162975714|NCT04039919|588611681|FG003|Treatment Period 5|Withdrawal by Subject|0|||
162975715|NCT04039919|588611682|FG004|Treatment Period 5|Withdrawal by Subject|0|||
162975716|NCT00706095|588611683|FG000|Overall Study|Progressive Disease|4|||
162975717|NCT00706095|588611684|FG001|Overall Study|Progressive Disease|5|||
162975718|NCT00706095|588611685|FG002|Overall Study|Progressive Disease|3|||
162975719|NCT00706095|588611683|FG000|Overall Study|Clinical Progression|1|||
162975720|NCT00706095|588611684|FG001|Overall Study|Clinical Progression|2|||
162975721|NCT00706095|588611685|FG002|Overall Study|Clinical Progression|2|||
162975722|NCT00706095|588611683|FG000|Overall Study|Withdrawal by Subject|1|||
162975723|NCT00706095|588611684|FG001|Overall Study|Withdrawal by Subject|0|||
162975724|NCT00706095|588611685|FG002|Overall Study|Withdrawal by Subject|0|||
162975725|NCT00263887|588611687|FG000|Overall Study|Withdrawal by Subject|1|||
162975726|NCT00263887|588611688|FG001|Overall Study|Withdrawal by Subject|1|||
162975727|NCT00263887|588611687|FG000|Overall Study|Lung transplantation|1|||
162975728|NCT00263887|588611688|FG001|Overall Study|Lung transplantation|2|||
162975729|NCT00263887|588611687|FG000|Overall Study|Too ill to attend visit|1|||
162975730|NCT00263887|588611688|FG001|Overall Study|Too ill to attend visit|0|||
162975731|NCT00263887|588611687|FG000|Overall Study|Adverse Event|0|||
162975732|NCT00263887|588611688|FG001|Overall Study|Adverse Event|2|||
162975733|NCT00263887|588611687|FG000|Overall Study|Disease progression|0|||
162975734|NCT00263887|588611688|FG001|Overall Study|Disease progression|1|||
162975735|NCT00263887|588611687|FG000|Overall Study|Lack of Efficacy|0|||
162975736|NCT00263887|588611688|FG001|Overall Study|Lack of Efficacy|1|||
162975737|NCT03095118|588611689|FG000|Overall Study|Adverse Event|1|||
162975738|NCT03095118|588611689|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
162975739|NCT01009515|588611692|FG000|Overall Study|Withdrawal by Subject|3|||
162975740|NCT01501110|588611694|FG000|Overall Study|Death|0|||
162975741|NCT01501110|588611695|FG001|Overall Study|Death|1|||
162975742|NCT02075606|588611699|FG000|Overall Study|Adverse Event|5|||
162975743|NCT02075606|588611699|FG000|Overall Study|Withdrawal by Subject|1|||
162975744|NCT02075606|588611699|FG000|Overall Study|Death|1|||
162975745|NCT02075606|588611699|FG000|Overall Study|Investigator's decision|1|||
162975746|NCT02075606|588611699|FG000|Overall Study|Symptom management|1|||
162975747|NCT02075606|588611699|FG000|Overall Study|Increasing Symptoms|1|||
162975748|NCT00983476|588611700|FG000|Overall Study|Did not receive intervention|17|||
162975749|NCT00983476|588611701|FG001|Overall Study|Did not receive intervention|22|||
162975750|NCT00983476|588611702|FG002|Overall Study|Did not receive intervention|0|||
162975751|NCT01439724|588611704|FG000|Overall Study|missing consultation|9|||
162975752|NCT01439724|588611705|FG001|Overall Study|missing consultation|8|||
162975753|NCT00575380|588611710|FG000|Overall Study|Withdrawal by Subject|1|||
162975754|NCT00575380|588611711|FG001|Overall Study|Withdrawal by Subject|0|||
162975755|NCT00575380|588611710|FG000|Overall Study|Adverse Event|0|||
162975756|NCT00575380|588611711|FG001|Overall Study|Adverse Event|1|||
162975757|NCT00575380|588611710|FG000|Overall Study|Various|0|||
162975758|NCT00575380|588611711|FG001|Overall Study|Various|2|||
162975759|NCT04019054|588611712|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
162975760|NCT04019054|588611713|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
162975761|NCT04019054|588611712|FG000|Overall Study|Withdrawal by Subject|3|||
162975762|NCT04019054|588611713|FG001|Overall Study|Withdrawal by Subject|1|||
162975763|NCT01040793|588611714|FG000|Overall Study|Adverse Event|5|||
162975764|NCT01040793|588611715|FG001|Overall Study|Adverse Event|3|||
162975765|NCT01040793|588611716|FG002|Overall Study|Adverse Event|0|||
162975766|NCT01040793|588611717|FG003|Overall Study|Adverse Event|2|||
162975767|NCT01040793|588611718|FG004|Overall Study|Adverse Event|2|||
162975768|NCT01040793|588611719|FG005|Overall Study|Adverse Event|1|||
162975769|NCT01040793|588611714|FG000|Overall Study|Protocol Violation|1|||
162975770|NCT01040793|588611715|FG001|Overall Study|Protocol Violation|1|||
162975771|NCT01040793|588611716|FG002|Overall Study|Protocol Violation|1|||
162975772|NCT01040793|588611717|FG003|Overall Study|Protocol Violation|0|||
162975773|NCT01040793|588611718|FG004|Overall Study|Protocol Violation|1|||
162975774|NCT01040793|588611719|FG005|Overall Study|Protocol Violation|0|||
162975775|NCT01040793|588611714|FG000|Overall Study|Lost to Follow-up|0|||
162975776|NCT01040793|588611715|FG001|Overall Study|Lost to Follow-up|1|||
162975777|NCT01040793|588611716|FG002|Overall Study|Lost to Follow-up|1|||
162975778|NCT01040793|588611717|FG003|Overall Study|Lost to Follow-up|0|||
162975779|NCT01040793|588611718|FG004|Overall Study|Lost to Follow-up|0|||
162975780|NCT01040793|588611719|FG005|Overall Study|Lost to Follow-up|0|||
162975781|NCT01040793|588611714|FG000|Overall Study|Withdrawal by Subject|0|||
162975782|NCT01040793|588611715|FG001|Overall Study|Withdrawal by Subject|0|||
162975783|NCT01040793|588611716|FG002|Overall Study|Withdrawal by Subject|0|||
162975784|NCT01040793|588611717|FG003|Overall Study|Withdrawal by Subject|2|||
162975785|NCT01040793|588611718|FG004|Overall Study|Withdrawal by Subject|0|||
162975786|NCT01040793|588611719|FG005|Overall Study|Withdrawal by Subject|0|||
162975787|NCT01040793|588611714|FG000|Overall Study|Other reasons not listed above|0|||
162975788|NCT01040793|588611715|FG001|Overall Study|Other reasons not listed above|0|||
162975789|NCT01040793|588611716|FG002|Overall Study|Other reasons not listed above|1|||
162975790|NCT01040793|588611717|FG003|Overall Study|Other reasons not listed above|0|||
162975791|NCT01040793|588611718|FG004|Overall Study|Other reasons not listed above|1|||
162975792|NCT01040793|588611719|FG005|Overall Study|Other reasons not listed above|0|||
162975793|NCT02412722|588611724|FG000|Overall Study|Adverse Event|0|||
162975794|NCT02412722|588611725|FG001|Overall Study|Adverse Event|2|||
162975795|NCT02412722|588611726|FG002|Overall Study|Adverse Event|0|||
162975796|NCT02412722|588611727|FG003|Overall Study|Adverse Event|3|||
162975797|NCT02412722|588611728|FG004|Overall Study|Adverse Event|0|||
162975798|NCT02412722|588611729|FG005|Overall Study|Adverse Event|3|||
162975799|NCT02412722|588611724|FG000|Overall Study|Progressive Disease|6|||
162975800|NCT02412722|588611725|FG001|Overall Study|Progressive Disease|4|||
162975801|NCT02412722|588611726|FG002|Overall Study|Progressive Disease|4|||
162975802|NCT02412722|588611727|FG003|Overall Study|Progressive Disease|9|||
162975803|NCT02412722|588611728|FG004|Overall Study|Progressive Disease|3|||
162975804|NCT02412722|588611729|FG005|Overall Study|Progressive Disease|3|||
162975805|NCT02412722|588611724|FG000|Overall Study|Withdrawal by Subject|2|||
162975806|NCT02412722|588611725|FG001|Overall Study|Withdrawal by Subject|0|||
162975807|NCT02412722|588611726|FG002|Overall Study|Withdrawal by Subject|1|||
162975808|NCT02412722|588611727|FG003|Overall Study|Withdrawal by Subject|2|||
162975809|NCT02412722|588611728|FG004|Overall Study|Withdrawal by Subject|1|||
163318065|NCT01928394|589874950|FG004|Follow-up Period|Lost to Follow-up|0|||
163318066|NCT01928394|589874951|FG005|Follow-up Period|Lost to Follow-up|0|||
162975810|NCT02412722|588611729|FG005|Overall Study|Withdrawal by Subject|1|||
162975811|NCT02412722|588611724|FG000|Overall Study|Lost to Follow-up|0|||
162975812|NCT02412722|588611725|FG001|Overall Study|Lost to Follow-up|0|||
162975813|NCT02412722|588611726|FG002|Overall Study|Lost to Follow-up|0|||
162975814|NCT02412722|588611727|FG003|Overall Study|Lost to Follow-up|0|||
162975815|NCT02412722|588611728|FG004|Overall Study|Lost to Follow-up|1|||
162975816|NCT02412722|588611729|FG005|Overall Study|Lost to Follow-up|0|||
162975817|NCT02412722|588611724|FG000|Overall Study|Received drug in run-in and discontinued|0|||
162975818|NCT02412722|588611725|FG001|Overall Study|Received drug in run-in and discontinued|2|||
162975819|NCT02412722|588611726|FG002|Overall Study|Received drug in run-in and discontinued|0|||
162975820|NCT02412722|588611727|FG003|Overall Study|Received drug in run-in and discontinued|0|||
162975821|NCT02412722|588611728|FG004|Overall Study|Received drug in run-in and discontinued|0|||
162975822|NCT02412722|588611729|FG005|Overall Study|Received drug in run-in and discontinued|0|||
163209668|NCT01475331|589482947|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
162975823|NCT02412722|588611724|FG000|Overall Study|Reason not Specified|3|||
162975824|NCT02412722|588611725|FG001|Overall Study|Reason not Specified|0|||
162975825|NCT02412722|588611726|FG002|Overall Study|Reason not Specified|2|||
162975826|NCT02412722|588611727|FG003|Overall Study|Reason not Specified|1|||
162975827|NCT02412722|588611728|FG004|Overall Study|Reason not Specified|2|||
162975828|NCT02412722|588611729|FG005|Overall Study|Reason not Specified|6|||
162975829|NCT01083680|588611730|FG000|Overall Study|Lost to Follow-up|2758|||
162975830|NCT01083680|588611730|FG000|Overall Study|Withdrawal by Subject|1086|||
162975831|NCT03877926|588611731|FG000|Overall Study|Adverse Event|1|||
162975832|NCT03877926|588611732|FG001|Overall Study|Adverse Event|0|||
162975833|NCT03877926|588611733|FG002|Overall Study|Adverse Event|0|||
162975834|NCT03877926|588611734|FG003|Overall Study|Adverse Event|0|||
162975835|NCT03877926|588611731|FG000|Overall Study|Death|2|||
162975836|NCT03877926|588611732|FG001|Overall Study|Death|2|||
162975837|NCT03877926|588611733|FG002|Overall Study|Death|2|||
162975838|NCT03877926|588611734|FG003|Overall Study|Death|0|||
162975839|NCT03877926|588611731|FG000|Overall Study|Lost to Follow-up|41|||
162975840|NCT03877926|588611732|FG001|Overall Study|Lost to Follow-up|52|||
162975841|NCT03877926|588611733|FG002|Overall Study|Lost to Follow-up|45|||
162975842|NCT03877926|588611734|FG003|Overall Study|Lost to Follow-up|17|||
162975843|NCT03877926|588611731|FG000|Overall Study|Physician Decision|2|||
162975844|NCT03877926|588611732|FG001|Overall Study|Physician Decision|0|||
162975845|NCT03877926|588611733|FG002|Overall Study|Physician Decision|2|||
162975846|NCT03877926|588611734|FG003|Overall Study|Physician Decision|0|||
162975847|NCT03877926|588611731|FG000|Overall Study|Withdrawal by Subject|18|||
162975848|NCT03877926|588611732|FG001|Overall Study|Withdrawal by Subject|21|||
162975849|NCT03877926|588611733|FG002|Overall Study|Withdrawal by Subject|12|||
162975850|NCT03877926|588611734|FG003|Overall Study|Withdrawal by Subject|4|||
162975851|NCT03877926|588611731|FG000|Overall Study|Other - Various|4|||
162975852|NCT03877926|588611732|FG001|Overall Study|Other - Various|1|||
162975853|NCT03877926|588611733|FG002|Overall Study|Other - Various|1|||
162975854|NCT03877926|588611734|FG003|Overall Study|Other - Various|0|||
162975855|NCT03877926|588611731|FG000|Overall Study|Not Treated|3|||
162975856|NCT03877926|588611732|FG001|Overall Study|Not Treated|1|||
162975857|NCT03877926|588611733|FG002|Overall Study|Not Treated|1|||
162975858|NCT03877926|588611734|FG003|Overall Study|Not Treated|0|||
162975859|NCT03546647|588611735|FG000|Overall Study|Adverse Event|1|||
162975860|NCT03546647|588611736|FG001|Overall Study|Adverse Event|0|||
162975861|NCT02400476|588611737|FG000|Overall Study|Adverse Event|57|||
162975862|NCT02400476|588611738|FG001|Overall Study|Adverse Event|10|||
162975863|NCT02400476|588611739|FG002|Overall Study|Adverse Event|22|||
162975864|NCT02400476|588611740|FG003|Overall Study|Adverse Event|19|||
162975865|NCT02400476|588611741|FG004|Overall Study|Adverse Event|5|||
162975866|NCT02400476|588611742|FG005|Overall Study|Adverse Event|8|||
162975867|NCT02400476|588611737|FG000|Overall Study|Withdrawal by Subject|4|||
162975868|NCT02400476|588611738|FG001|Overall Study|Withdrawal by Subject|1|||
162975869|NCT02400476|588611739|FG002|Overall Study|Withdrawal by Subject|12|||
162975870|NCT02400476|588611740|FG003|Overall Study|Withdrawal by Subject|7|||
162975871|NCT02400476|588611741|FG004|Overall Study|Withdrawal by Subject|5|||
162975872|NCT02400476|588611742|FG005|Overall Study|Withdrawal by Subject|5|||
162975873|NCT02400476|588611737|FG000|Overall Study|Lost to Follow-up|0|||
162975874|NCT02400476|588611738|FG001|Overall Study|Lost to Follow-up|0|||
162975875|NCT02400476|588611739|FG002|Overall Study|Lost to Follow-up|0|||
162975876|NCT02400476|588611740|FG003|Overall Study|Lost to Follow-up|1|||
162975877|NCT02400476|588611741|FG004|Overall Study|Lost to Follow-up|3|||
162975878|NCT02400476|588611742|FG005|Overall Study|Lost to Follow-up|1|||
162975879|NCT02400476|588611737|FG000|Overall Study|Physician Decision|0|||
162975880|NCT02400476|588611738|FG001|Overall Study|Physician Decision|0|||
162975881|NCT02400476|588611739|FG002|Overall Study|Physician Decision|1|||
162975882|NCT02400476|588611740|FG003|Overall Study|Physician Decision|1|||
162975883|NCT02400476|588611741|FG004|Overall Study|Physician Decision|0|||
162975884|NCT02400476|588611742|FG005|Overall Study|Physician Decision|1|||
162975885|NCT02400476|588611737|FG000|Overall Study|Other, Disease Progression|0|||
162975886|NCT02400476|588611738|FG001|Overall Study|Other, Disease Progression|1|||
162975887|NCT02400476|588611739|FG002|Overall Study|Other, Disease Progression|2|||
162975888|NCT02400476|588611740|FG003|Overall Study|Other, Disease Progression|1|||
162975889|NCT02400476|588611741|FG004|Overall Study|Other, Disease Progression|2|||
162975890|NCT02400476|588611742|FG005|Overall Study|Other, Disease Progression|1|||
162975891|NCT02400476|588611737|FG000|Overall Study|Other, Decreased Quality of Life|0|||
162975892|NCT02400476|588611738|FG001|Overall Study|Other, Decreased Quality of Life|0|||
162975893|NCT02400476|588611739|FG002|Overall Study|Other, Decreased Quality of Life|2|||
162975894|NCT02400476|588611740|FG003|Overall Study|Other, Decreased Quality of Life|0|||
162975895|NCT02400476|588611741|FG004|Overall Study|Other, Decreased Quality of Life|0|||
162975896|NCT02400476|588611742|FG005|Overall Study|Other, Decreased Quality of Life|0|||
162975897|NCT02400476|588611737|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
162975898|NCT02400476|588611738|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
162975899|NCT02400476|588611739|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
163057565|NCT01232283|588921308|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
163057566|NCT01232283|588921309|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
163057567|NCT01232283|588921310|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
163057568|NCT01232283|588921311|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
163057569|NCT01232283|588921312|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
163057570|NCT01232283|588921313|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
162975900|NCT02400476|588611740|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
162975901|NCT02400476|588611741|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
162975902|NCT02400476|588611742|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
162975903|NCT00124462|588611743|FG000|Overall Study|Lost to Follow-up|3|||
162975904|NCT00124462|588611744|FG001|Overall Study|Lost to Follow-up|3|||
162975905|NCT00124462|588611743|FG000|Overall Study|Physician Decision|3|||
162975906|NCT00124462|588611744|FG001|Overall Study|Physician Decision|4|||
162975907|NCT00124462|588611743|FG000|Overall Study|Withdrawal by Subject|4|||
162975908|NCT00124462|588611744|FG001|Overall Study|Withdrawal by Subject|5|||
162975909|NCT00124462|588611743|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
162975910|NCT00124462|588611744|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
162975911|NCT00003531|588611745|FG000|Overall Study|Not evaluable|10|||
162975912|NCT00588731|588611746|FG000|Overall Study|Withdrawal by Subject|3|||
162975913|NCT00588731|588611747|FG001|Overall Study|Withdrawal by Subject|2|||
162975914|NCT00346164|588611748|FG000|Overall Study|Adverse Event|0|||
162975915|NCT00346164|588611749|FG001|Overall Study|Adverse Event|0|||
162975916|NCT00346164|588611750|FG002|Overall Study|Adverse Event|0|||
163057571|NCT01232283|588921314|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
163057572|NCT01232283|588921305|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
163057573|NCT01232283|588921306|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
163057574|NCT01232283|588921307|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057575|NCT01232283|588921308|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057576|NCT01232283|588921309|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057577|NCT01232283|588921310|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057578|NCT01232283|588921311|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057579|NCT01232283|588921312|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057580|NCT01232283|588921313|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057581|NCT01232283|588921314|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057582|NCT01232283|588921305|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057583|NCT01232283|588921306|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057584|NCT01232283|588921307|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
163057585|NCT01232283|588921308|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
163057586|NCT01232283|588921309|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057587|NCT01232283|588921310|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057588|NCT01232283|588921311|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057589|NCT01232283|588921312|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057590|NCT01232283|588921313|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057591|NCT01232283|588921314|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057592|NCT01232283|588921305|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
163057593|NCT01232283|588921306|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
163057594|NCT01232283|588921307|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
163057595|NCT01232283|588921308|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
163057596|NCT01232283|588921309|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
163057597|NCT01232283|588921310|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
163057598|NCT01232283|588921311|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
163057599|NCT01232283|588921312|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
162975917|NCT00346164|588611751|FG003|Overall Study|Adverse Event|1|||
163057600|NCT01232283|588921313|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
163057601|NCT01232283|588921314|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
163057602|NCT01232283|588921305|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057603|NCT01232283|588921306|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057604|NCT01232283|588921307|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
163057605|NCT01232283|588921308|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057606|NCT01232283|588921309|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057607|NCT01232283|588921310|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057608|NCT01232283|588921311|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057609|NCT01232283|588921312|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057610|NCT01232283|588921313|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057611|NCT01232283|588921314|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057612|NCT01232283|588921305|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
162975918|NCT00346164|588611748|FG000|Overall Study|Lack of Efficacy|0|||
162975919|NCT00346164|588611749|FG001|Overall Study|Lack of Efficacy|1|||
162975920|NCT00346164|588611750|FG002|Overall Study|Lack of Efficacy|7|||
163057613|NCT01232283|588921306|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
163057614|NCT01232283|588921307|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
162975921|NCT00346164|588611751|FG003|Overall Study|Lack of Efficacy|25|||
162975922|NCT00346164|588611748|FG000|Overall Study|Physician Decision|0|||
162975923|NCT00346164|588611749|FG001|Overall Study|Physician Decision|1|||
162975924|NCT00346164|588611750|FG002|Overall Study|Physician Decision|2|||
163057615|NCT01232283|588921308|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
163057616|NCT01232283|588921309|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
163057617|NCT01232283|588921310|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
163057618|NCT01232283|588921311|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
163057619|NCT01232283|588921312|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
163057620|NCT01232283|588921313|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
163057621|NCT01232283|588921314|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
163057622|NCT01232283|588921305|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057623|NCT01232283|588921306|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057624|NCT01232283|588921307|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
163057625|NCT01232283|588921308|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
163057626|NCT01232283|588921309|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057627|NCT01232283|588921310|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057628|NCT01232283|588921311|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057629|NCT01232283|588921312|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057630|NCT01232283|588921313|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057631|NCT01232283|588921314|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057632|NCT01232283|588921305|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
163057633|NCT01232283|588921306|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
163057634|NCT01232283|588921307|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
163057635|NCT01232283|588921308|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
163057636|NCT01232283|588921309|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
163057637|NCT01232283|588921310|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
162975925|NCT00346164|588611751|FG003|Overall Study|Physician Decision|27|||
162975926|NCT00346164|588611748|FG000|Overall Study|Protocol Violation|6|||
162975927|NCT00346164|588611749|FG001|Overall Study|Protocol Violation|2|||
162975928|NCT00346164|588611750|FG002|Overall Study|Protocol Violation|10|||
162975929|NCT00346164|588611751|FG003|Overall Study|Protocol Violation|4|||
162975930|NCT00346164|588611748|FG000|Overall Study|Withdrawal by Subject|0|||
162975931|NCT00346164|588611749|FG001|Overall Study|Withdrawal by Subject|0|||
162975932|NCT00346164|588611750|FG002|Overall Study|Withdrawal by Subject|2|||
162975933|NCT00346164|588611751|FG003|Overall Study|Withdrawal by Subject|0|||
162975934|NCT00346164|588611748|FG000|Overall Study|Ineligible|11|||
162975935|NCT00346164|588611749|FG001|Overall Study|Ineligible|2|||
162975936|NCT00346164|588611750|FG002|Overall Study|Ineligible|2|||
162975937|NCT00346164|588611751|FG003|Overall Study|Ineligible|23|||
162975938|NCT00346164|588611748|FG000|Overall Study|Refusal of further protocol therapy|0|||
162975939|NCT00346164|588611749|FG001|Overall Study|Refusal of further protocol therapy|1|||
162975940|NCT00346164|588611750|FG002|Overall Study|Refusal of further protocol therapy|3|||
162975941|NCT00346164|588611751|FG003|Overall Study|Refusal of further protocol therapy|15|||
162975942|NCT00346164|588611748|FG000|Overall Study|Inability to start week 16 tx on time|0|||
162975943|NCT00346164|588611749|FG001|Overall Study|Inability to start week 16 tx on time|0|||
162975944|NCT00346164|588611750|FG002|Overall Study|Inability to start week 16 tx on time|0|||
162975945|NCT00346164|588611751|FG003|Overall Study|Inability to start week 16 tx on time|11|||
162975946|NCT01684878|588611753|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
162975947|NCT01684878|588611754|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
162975948|NCT01684878|588611755|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
162975949|NCT01684878|588611756|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
162975950|NCT01684878|588611753|FG000|Part 1: Safety Run in Phase|Death|15|||
163057638|NCT01232283|588921311|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
162975951|NCT01684878|588611754|FG001|Part 1: Safety Run in Phase|Death|20|||
162975952|NCT01684878|588611755|FG002|Part 1: Safety Run in Phase|Death|0|||
162975953|NCT01684878|588611756|FG003|Part 1: Safety Run in Phase|Death|0|||
162975954|NCT01684878|588611753|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
162975955|NCT01684878|588611754|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
163057639|NCT01232283|588921312|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
163057640|NCT01232283|588921313|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
163057641|NCT01232283|588921314|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
163057642|NCT01232283|588921305|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
163057643|NCT01232283|588921306|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
162975956|NCT01684878|588611755|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
163057644|NCT01232283|588921307|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
163401352|NCT01438489|590181135|FG002|Overall Study|AE/SAEs|1|||
162975957|NCT01684878|588611756|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
162975958|NCT01684878|588611753|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
162975959|NCT01684878|588611754|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
162975960|NCT01684878|588611755|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
162975961|NCT01684878|588611756|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
162975962|NCT01684878|588611753|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
162975963|NCT01684878|588611754|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
162975964|NCT01684878|588611755|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
162975965|NCT01684878|588611756|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
162975966|NCT01684878|588611753|FG000|Part 2: Randomized Phase|Death|0|||
162975967|NCT01684878|588611754|FG001|Part 2: Randomized Phase|Death|0|||
162975968|NCT01684878|588611755|FG002|Part 2: Randomized Phase|Death|62|||
162975969|NCT01684878|588611756|FG003|Part 2: Randomized Phase|Death|68|||
162975970|NCT01684878|588611753|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
162975971|NCT01684878|588611754|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
162975972|NCT01684878|588611755|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
162975973|NCT01684878|588611756|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
162975974|NCT01684878|588611753|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
162975975|NCT01684878|588611754|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
162975976|NCT01684878|588611755|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
162975977|NCT01684878|588611756|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
162975978|NCT02087176|588611760|FG000|Overall Study|Withdrawal by Subject|1|||
162975979|NCT02087176|588611760|FG000|Overall Study|Death|10|||
162975980|NCT02087176|588611760|FG000|Overall Study|Censored|19|||
162975981|NCT02087176|588611760|FG000|Overall Study|Study Terminated by Sponsor|2|||
162975982|NCT02927834|588611761|FG000|Overall Study|Lost to Follow-up|1|||
162975983|NCT02927834|588611762|FG001|Overall Study|Lost to Follow-up|2|||
162975984|NCT02927834|588611763|FG002|Overall Study|Lost to Follow-up|2|||
162975985|NCT03812991|588611765|FG000|Overall Study|Lost to Follow-up|3|||
162975986|NCT03812991|588611766|FG001|Overall Study|Lost to Follow-up|1|||
162975987|NCT03942211|588611767|FG000|Overall Study|Death|1|||
162975988|NCT03942211|588611768|FG001|Overall Study|Death|0|||
162975989|NCT03942211|588611767|FG000|Overall Study|Study terminated by sponsor|5|||
162975990|NCT03942211|588611768|FG001|Overall Study|Study terminated by sponsor|3|||
162975991|NCT03942211|588611767|FG000|Overall Study|Adverse Event|0|||
162975992|NCT03942211|588611768|FG001|Overall Study|Adverse Event|1|||
162975993|NCT01955044|588611769|FG000|Overall Study|Death|1|||
162975994|NCT01955044|588611770|FG001|Overall Study|Death|1|||
162975995|NCT01955044|588611771|FG002|Overall Study|Death|0|||
162975996|NCT01148225|588611772|FG000|Overall Study|Other|185|||
162975997|NCT04798482|588611773|FG000|Overall Study|Physician Decision|1|||
162975998|NCT04798482|588611773|FG000|Overall Study|Lost eligibility|1|||
162975999|NCT00605917|588611778|FG000|Overall Study|Protocol Violation|79|||
162976000|NCT01506908|588611779|FG000|Overall Study|Adverse Event|1|||
162976001|NCT01506908|588611780|FG001|Overall Study|Adverse Event|0|||
162976002|NCT00925301|588611783|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
162976003|NCT00925301|588611784|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
162976004|NCT00925301|588611785|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
162976005|NCT00925301|588611786|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
162976006|NCT00925301|588611783|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
162976007|NCT00925301|588611784|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
162976008|NCT00925301|588611785|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
162976009|NCT00925301|588611786|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
162976010|NCT00925301|588611783|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
162976011|NCT00925301|588611784|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
162976012|NCT00925301|588611785|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
162976013|NCT00925301|588611786|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
162976014|NCT00925301|588611783|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
162976015|NCT00925301|588611784|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
162976016|NCT00925301|588611785|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
162976017|NCT00925301|588611786|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
162976018|NCT00925301|588611783|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
162976019|NCT00925301|588611784|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
162976020|NCT00925301|588611785|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
162976021|NCT00925301|588611786|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
163318067|NCT01928394|589874952|FG006|Follow-up Period|Lost to Follow-up|0|||
163318068|NCT01928394|589874953|FG007|Follow-up Period|Lost to Follow-up|0|||
162976022|NCT00925301|588611783|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
162976023|NCT00925301|588611784|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
162976024|NCT00925301|588611785|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
162976025|NCT00925301|588611786|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
162976026|NCT00925301|588611783|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
162976027|NCT00925301|588611784|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
162976028|NCT00925301|588611785|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
162976029|NCT00925301|588611786|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
162976030|NCT03043560|588611787|FG000|Overall Study|Discontinued Intervention|1|||
162976031|NCT03043560|588611788|FG001|Overall Study|Discontinued Intervention|2|||
162976032|NCT03043560|588611787|FG000|Overall Study|Lost to Follow-up|0|||
162976033|NCT03043560|588611788|FG001|Overall Study|Lost to Follow-up|1|||
162976034|NCT00292227|588611789|FG000|Patch Period|Adverse Event|1|||
162976035|NCT00292227|588611790|FG001|Patch Period|Adverse Event|0|||
162976036|NCT00292227|588611791|FG002|Patch Period|Adverse Event|2|||
162976037|NCT00292227|588611789|FG000|Patch Period|Withdrawal by Subject|0|||
162976038|NCT00292227|588611790|FG001|Patch Period|Withdrawal by Subject|0|||
162976039|NCT00292227|588611791|FG002|Patch Period|Withdrawal by Subject|1|||
162976040|NCT04232540|588611795|FG000|Overall Study|Lost to Follow-up|1|||
162976041|NCT04232540|588611796|FG001|Overall Study|Lost to Follow-up|0|||
162976042|NCT00537017|588611797|FG000|Treatment Phase|Adverse Event|19|||
162976043|NCT00537017|588611797|FG000|Treatment Phase|Withdrawal by Subject|13|||
162976044|NCT00537017|588611797|FG000|Treatment Phase|Protocol Violation|2|||
162976045|NCT00537017|588611797|FG000|Follow-up Phase|Withdrawal by Subject|9|||
162976046|NCT03234608|588611799|FG000|Overall Study|Lost to Follow-up|23|||
162976047|NCT03234608|588611800|FG001|Overall Study|Lost to Follow-up|21|||
162976048|NCT02105701|588611801|FG000|Overall Study|Lost to Follow-up|1|||
162976049|NCT02105701|588611802|FG001|Overall Study|Lost to Follow-up|0|||
162976050|NCT02105701|588611803|FG002|Overall Study|Lost to Follow-up|2|||
162976051|NCT02105701|588611804|FG003|Overall Study|Lost to Follow-up|1|||
162976052|NCT02105701|588611801|FG000|Overall Study|Protocol Violation|0|||
162976053|NCT02105701|588611802|FG001|Overall Study|Protocol Violation|0|||
162976054|NCT02105701|588611803|FG002|Overall Study|Protocol Violation|1|||
162976055|NCT02105701|588611804|FG003|Overall Study|Protocol Violation|0|||
162976056|NCT02105701|588611801|FG000|Overall Study|Withdrawal by Subject|2|||
162976057|NCT02105701|588611802|FG001|Overall Study|Withdrawal by Subject|1|||
162976058|NCT02105701|588611803|FG002|Overall Study|Withdrawal by Subject|0|||
162976059|NCT02105701|588611804|FG003|Overall Study|Withdrawal by Subject|1|||
162976060|NCT02105701|588611801|FG000|Overall Study|Death|1|||
162976061|NCT02105701|588611802|FG001|Overall Study|Death|0|||
162976062|NCT02105701|588611803|FG002|Overall Study|Death|0|||
162976063|NCT02105701|588611804|FG003|Overall Study|Death|0|||
162976064|NCT02329431|588611805|FG000|Overall Study|Lost to Follow-up|20|||
162976065|NCT02329431|588611806|FG001|Overall Study|Lost to Follow-up|13|||
162976066|NCT01362296|588611807|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
162976067|NCT01362296|588611808|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
162976068|NCT01362296|588611809|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
162976069|NCT01362296|588611810|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
162976070|NCT01362296|588611807|FG000|Randomized Phase (RP)|Physician Decision|1|||
162976071|NCT01362296|588611808|FG001|Randomized Phase (RP)|Physician Decision|9|||
162976072|NCT01362296|588611809|FG002|Randomized Phase (RP)|Physician Decision|0|||
162976073|NCT01362296|588611810|FG003|Randomized Phase (RP)|Physician Decision|0|||
162976074|NCT01362296|588611807|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
162976075|NCT01362296|588611808|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
162976076|NCT01362296|588611809|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
162976077|NCT01362296|588611810|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
162976078|NCT01362296|588611807|FG000|Randomized Phase (RP)|Adverse Event|20|||
162976079|NCT01362296|588611808|FG001|Randomized Phase (RP)|Adverse Event|4|||
162976080|NCT01362296|588611809|FG002|Randomized Phase (RP)|Adverse Event|0|||
162976081|NCT01362296|588611810|FG003|Randomized Phase (RP)|Adverse Event|0|||
162976082|NCT01362296|588611807|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
162976083|NCT01362296|588611808|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
162976084|NCT01362296|588611809|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
162976085|NCT01362296|588611810|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
162976086|NCT01362296|588611807|FG000|Crossover Phase|PD including Death due to PD|0|||
162976087|NCT01362296|588611808|FG001|Crossover Phase|PD including Death due to PD|0|||
162976088|NCT01362296|588611809|FG002|Crossover Phase|PD including Death due to PD|16|||
162976089|NCT01362296|588611810|FG003|Crossover Phase|PD including Death due to PD|1|||
162976090|NCT01362296|588611807|FG000|Crossover Phase|Withdrawal by Subject|0|||
162976091|NCT01362296|588611808|FG001|Crossover Phase|Withdrawal by Subject|0|||
162976092|NCT01362296|588611809|FG002|Crossover Phase|Withdrawal by Subject|2|||
162976093|NCT01362296|588611810|FG003|Crossover Phase|Withdrawal by Subject|1|||
162976094|NCT01362296|588611807|FG000|Crossover Phase|Adverse Event|0|||
162976095|NCT01362296|588611808|FG001|Crossover Phase|Adverse Event|0|||
162976096|NCT01362296|588611809|FG002|Crossover Phase|Adverse Event|4|||
162976097|NCT01362296|588611810|FG003|Crossover Phase|Adverse Event|0|||
162976098|NCT01362296|588611807|FG000|Crossover Phase|Study Closed/Terminated|0|||
162976099|NCT01362296|588611808|FG001|Crossover Phase|Study Closed/Terminated|0|||
162976100|NCT01362296|588611809|FG002|Crossover Phase|Study Closed/Terminated|1|||
162976101|NCT01362296|588611810|FG003|Crossover Phase|Study Closed/Terminated|0|||
162976102|NCT01662362|588611812|FG000|Overall Study|Lost to Follow-up|38|||
163057645|NCT01232283|588921308|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
162976103|NCT02339090|588611813|FG000|Overall Study|Adverse Event|1|||
162976104|NCT02339090|588611814|FG001|Overall Study|Adverse Event|0|||
162976105|NCT02339090|588611813|FG000|Overall Study|Lost to Follow-up|0|||
162976106|NCT02339090|588611814|FG001|Overall Study|Lost to Follow-up|1|||
162976107|NCT02339090|588611813|FG000|Overall Study|Non-compliance With Study Drug|0|||
162976108|NCT02339090|588611814|FG001|Overall Study|Non-compliance With Study Drug|1|||
162976109|NCT02339090|588611813|FG000|Overall Study|Withdrawal by Subject|2|||
162976110|NCT02339090|588611814|FG001|Overall Study|Withdrawal by Subject|1|||
162976111|NCT02339090|588611813|FG000|Overall Study|Poor Growth|3|||
162976112|NCT02339090|588611814|FG001|Overall Study|Poor Growth|0|||
162976113|NCT02339090|588611813|FG000|Overall Study|Randomized but not treated|0|||
162976114|NCT02339090|588611814|FG001|Overall Study|Randomized but not treated|2|||
162976115|NCT01253317|588611820|FG000|Overall Study|Adverse Event|2|||
162976116|NCT03183141|588611821|FG000|Overall Study|Withdrawal by Subject|2|||
162976117|NCT03183141|588611822|FG001|Overall Study|Withdrawal by Subject|4|||
162976118|NCT03183141|588611821|FG000|Overall Study|Death|0|||
162976119|NCT03183141|588611822|FG001|Overall Study|Death|8|||
162976120|NCT01507090|588611826|FG000|Overall Study|incomplete dataset|18|||
162976121|NCT02953678|588611843|FG000|Overall Study|Adverse Event|20|||
162976122|NCT02953678|588611843|FG000|Overall Study|Death|7|||
162976123|NCT02953678|588611843|FG000|Overall Study|Physician Decision|23|||
162976124|NCT02953678|588611843|FG000|Overall Study|Progressive Disease of GVHD|7|||
162976125|NCT02953678|588611843|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
162976126|NCT02953678|588611843|FG000|Overall Study|Withdrawal by participant|3|||
162976127|NCT02953678|588611843|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
162976128|NCT02953678|588611843|FG000|Overall Study|Participants were transferred to commercial product.|3|||
162976129|NCT00546910|588613970|FG000|Overall Study|Adverse Event|2|||
162976130|NCT00546910|588613971|FG001|Overall Study|Adverse Event|3|||
162976131|NCT00546910|588613970|FG000|Overall Study|Lack of Efficacy|5|||
162976132|NCT00546910|588613971|FG001|Overall Study|Lack of Efficacy|7|||
162976133|NCT00546910|588613970|FG000|Overall Study|Physician Decision|0|||
162976134|NCT00546910|588613971|FG001|Overall Study|Physician Decision|1|||
162976135|NCT00546910|588613970|FG000|Overall Study|Withdrawal by Subject|2|||
162976136|NCT00546910|588613971|FG001|Overall Study|Withdrawal by Subject|0|||
162976137|NCT01333072|588613975|FG000|Overall Study|Lost to Follow-up|3|||
162976138|NCT01333072|588613976|FG001|Overall Study|Lost to Follow-up|0|||
162976139|NCT01333072|588613975|FG000|Overall Study|Adverse Event|2|||
162976140|NCT01333072|588613976|FG001|Overall Study|Adverse Event|4|||
162976141|NCT01333072|588613975|FG000|Overall Study|Physician Decision|1|||
162976142|NCT01333072|588613976|FG001|Overall Study|Physician Decision|0|||
162976143|NCT02457611|588613977|FG000|Overall Study|Lost to Follow-up|3|||
162976144|NCT00493454|588613978|FG000|Overall Study|Withdrawal by Subject|1|||
162976145|NCT01011556|588613979|FG000|Overall Study|Adverse Event|1|||
162976146|NCT01011556|588613980|FG001|Overall Study|Adverse Event|3|||
162976147|NCT01011556|588613981|FG002|Overall Study|Adverse Event|2|||
162976148|NCT01011556|588613982|FG003|Overall Study|Adverse Event|1|||
162976149|NCT01011556|588613979|FG000|Overall Study|Lost to Follow-up|1|||
162976150|NCT01011556|588613980|FG001|Overall Study|Lost to Follow-up|0|||
162976151|NCT01011556|588613981|FG002|Overall Study|Lost to Follow-up|0|||
162976152|NCT01011556|588613982|FG003|Overall Study|Lost to Follow-up|0|||
162976153|NCT01011556|588613979|FG000|Overall Study|Physician Decision|1|||
162976154|NCT01011556|588613980|FG001|Overall Study|Physician Decision|0|||
162976155|NCT01011556|588613981|FG002|Overall Study|Physician Decision|0|||
162976156|NCT01011556|588613982|FG003|Overall Study|Physician Decision|1|||
162976157|NCT01011556|588613979|FG000|Overall Study|Protocol Violation|0|||
162976158|NCT01011556|588613980|FG001|Overall Study|Protocol Violation|1|||
162976159|NCT01011556|588613981|FG002|Overall Study|Protocol Violation|0|||
162976160|NCT01011556|588613982|FG003|Overall Study|Protocol Violation|0|||
162976161|NCT01011556|588613979|FG000|Overall Study|Withdrawal by Subject|1|||
162976162|NCT01011556|588613980|FG001|Overall Study|Withdrawal by Subject|2|||
162976163|NCT01011556|588613981|FG002|Overall Study|Withdrawal by Subject|4|||
162976164|NCT01011556|588613982|FG003|Overall Study|Withdrawal by Subject|4|||
162976165|NCT01011556|588613979|FG000|Overall Study|Sponsor decision|0|||
162976166|NCT01011556|588613980|FG001|Overall Study|Sponsor decision|1|||
162976167|NCT01011556|588613981|FG002|Overall Study|Sponsor decision|1|||
162976168|NCT01011556|588613982|FG003|Overall Study|Sponsor decision|2|||
162976169|NCT01011556|588613979|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
162976170|NCT01011556|588613980|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
162976171|NCT01011556|588613981|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
162976172|NCT01011556|588613982|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
162976173|NCT03920280|588613983|FG000|Overall Study|Adverse Event|2|||
162976174|NCT03920280|588613984|FG001|Overall Study|Adverse Event|3|||
162976175|NCT03920280|588613983|FG000|Overall Study|Lost to Follow-up|0|||
162976176|NCT03920280|588613984|FG001|Overall Study|Lost to Follow-up|1|||
162976177|NCT03920280|588613983|FG000|Overall Study|Withdrawal by Subject|1|||
162976178|NCT03920280|588613984|FG001|Overall Study|Withdrawal by Subject|1|||
162976179|NCT03920280|588613983|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
162976180|NCT03920280|588613984|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
162976181|NCT04220775|588613991|FG000|Overall Study|Adverse Event|1|||
162976182|NCT04220775|588613992|FG001|Overall Study|Adverse Event|0|||
162976183|NCT04220775|588613991|FG000|Overall Study|Disease Progression|1|||
162976184|NCT04220775|588613992|FG001|Overall Study|Disease Progression|0|||
162976185|NCT01857206|588613994|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
162976186|NCT01857206|588613995|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
162976187|NCT01857206|588613994|FG000|Overall Study|Lost to Follow-up|9|||
162976188|NCT01857206|588613995|FG001|Overall Study|Lost to Follow-up|6|||
162976189|NCT01857206|588613994|FG000|Overall Study|Unclassified|3|||
162976190|NCT01857206|588613995|FG001|Overall Study|Unclassified|3|||
162976191|NCT01857206|588613994|FG000|Overall Study|Withdrawal by Subject|1|||
162976192|NCT01857206|588613995|FG001|Overall Study|Withdrawal by Subject|0|||
162976193|NCT01483625|588613998|FG000|Overall Study|Adverse Event|1|||
162976194|NCT01483625|588613999|FG001|Overall Study|Adverse Event|1|||
162976195|NCT01483625|588613998|FG000|Overall Study|Refused to continue medication|2|||
162976196|NCT01483625|588613999|FG001|Overall Study|Refused to continue medication|1|||
162976197|NCT01483625|588613998|FG000|Overall Study|Due to other reason|1|||
162976198|NCT01483625|588613999|FG001|Overall Study|Due to other reason|0|||
162976199|NCT00084799|588614000|FG000|Overall Study|Disease Progression|1|||
162976200|NCT00084799|588614001|FG001|Overall Study|Disease Progression|0|||
162976201|NCT01261624|588614006|FG000|Week 0 to Week 12|Disease Progression|1|||
162976202|NCT01261624|588614007|FG001|Week 0 to Week 12|Disease Progression|1|||
162976203|NCT01261624|588614006|FG000|Week 0 to Week 12|Insufficient Response|0|||
162976204|NCT01261624|588614007|FG001|Week 0 to Week 12|Insufficient Response|2|||
162976205|NCT01261624|588614006|FG000|Week 13 to Week 24|Insufficient Response|0|||
162976206|NCT01261624|588614007|FG001|Week 13 to Week 24|Insufficient Response|1|||
162976207|NCT00271024|588614008|FG000|Overall Study|Lost Interest|3|||
162976208|NCT00271024|588614009|FG001|Overall Study|Lost Interest|4|||
162976209|NCT00271024|588614010|FG002|Overall Study|Lost Interest|2|||
162976210|NCT00271024|588614011|FG003|Overall Study|Lost Interest|3|||
162976211|NCT00271024|588614008|FG000|Overall Study|Unknown/Unspecified|11|||
162976212|NCT00271024|588614009|FG001|Overall Study|Unknown/Unspecified|11|||
162976213|NCT00271024|588614010|FG002|Overall Study|Unknown/Unspecified|8|||
162976214|NCT00271024|588614011|FG003|Overall Study|Unknown/Unspecified|4|||
162976215|NCT00271024|588614008|FG000|Overall Study|Protocol Violation|1|||
162976216|NCT00271024|588614009|FG001|Overall Study|Protocol Violation|6|||
162976217|NCT00271024|588614010|FG002|Overall Study|Protocol Violation|5|||
162976218|NCT00271024|588614011|FG003|Overall Study|Protocol Violation|11|||
162976219|NCT00271024|588614008|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
162976220|NCT00271024|588614009|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
162976221|NCT00271024|588614010|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
162976222|NCT00271024|588614011|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
162976223|NCT00271024|588614008|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
162976224|NCT00271024|588614009|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
162976225|NCT00271024|588614010|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
162976226|NCT00271024|588614011|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
163057646|NCT01232283|588921309|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
163057647|NCT01232283|588921310|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
163057648|NCT01232283|588921311|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
163057649|NCT01232283|588921312|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
163057650|NCT01232283|588921313|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
163057651|NCT01232283|588921314|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
163057652|NCT01232283|588921305|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
163057653|NCT01232283|588921306|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
163057654|NCT01232283|588921307|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
163057655|NCT01232283|588921308|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
163057656|NCT01232283|588921309|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
163057657|NCT01232283|588921310|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
163057658|NCT01232283|588921311|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
163057659|NCT01232283|588921312|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
163057660|NCT01232283|588921313|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
163057661|NCT01232283|588921314|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
163057662|NCT01232283|588921305|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
163057663|NCT01232283|588921306|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
163209669|NCT01475331|589482946|FG000|Overall Study|Sign of malignancy during the procedure|2|||
162976227|NCT02094261|588614015|FG000|Overall Study|Death|24|||
162976228|NCT02094261|588614015|FG000|Overall Study|Lost to Follow-up|1|||
162976229|NCT02094261|588614015|FG000|Overall Study|Withdrawal by Subject|4|||
162976230|NCT02094261|588614015|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
162976231|NCT04449341|588614016|FG000|Overall Study|Protocol Violation|1|||
162976232|NCT04449341|588614017|FG001|Overall Study|Protocol Violation|0|||
162976233|NCT04499482|588614018|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
162976234|NCT01020526|588614020|FG000|Overall Study|Withdrawal by Subject|5|||
162976235|NCT01020526|588614020|FG000|Overall Study|Other reasons|3|||
162976236|NCT01020526|588614020|FG000|Overall Study|Insufficient clinical response|3|||
162976237|NCT01020526|588614020|FG000|Overall Study|Lost to Follow-up|1|||
162976238|NCT01020526|588614020|FG000|Overall Study|Adverse Event|2|||
162976239|NCT02363439|588614021|FG000|Overall Study|Lack of Efficacy|4|||
162976240|NCT02010255|588614026|FG000|Overall Study|Death|0|||
162976241|NCT02010255|588614027|FG001|Overall Study|Death|1|||
162976242|NCT02010255|588614028|FG002|Overall Study|Death|4|||
162976243|NCT02010255|588614029|FG003|Overall Study|Death|4|||
162976244|NCT02010255|588614030|FG004|Overall Study|Death|2|||
162976245|NCT02010255|588614031|FG005|Overall Study|Death|0|||
162976246|NCT02010255|588614032|FG006|Overall Study|Death|1|||
162976247|NCT02010255|588614033|FG007|Overall Study|Death|1|||
162976248|NCT02010255|588614034|FG008|Overall Study|Death|1|||
162976249|NCT02010255|588614035|FG009|Overall Study|Death|0|||
162976250|NCT02010255|588614036|FG010|Overall Study|Death|1|||
162976251|NCT02010255|588614037|FG011|Overall Study|Death|1|||
162976252|NCT02010255|588614038|FG012|Overall Study|Death|0|||
162976253|NCT02010255|588614039|FG013|Overall Study|Death|0|||
162976254|NCT02010255|588614026|FG000|Overall Study|Lack of Efficacy|4|||
162976255|NCT02010255|588614027|FG001|Overall Study|Lack of Efficacy|1|||
162976256|NCT02010255|588614028|FG002|Overall Study|Lack of Efficacy|2|||
162976257|NCT02010255|588614029|FG003|Overall Study|Lack of Efficacy|1|||
162976258|NCT02010255|588614030|FG004|Overall Study|Lack of Efficacy|1|||
162976259|NCT02010255|588614031|FG005|Overall Study|Lack of Efficacy|0|||
162976260|NCT02010255|588614032|FG006|Overall Study|Lack of Efficacy|0|||
162976261|NCT02010255|588614033|FG007|Overall Study|Lack of Efficacy|0|||
162976262|NCT02010255|588614034|FG008|Overall Study|Lack of Efficacy|0|||
162976263|NCT02010255|588614035|FG009|Overall Study|Lack of Efficacy|0|||
162976264|NCT02010255|588614036|FG010|Overall Study|Lack of Efficacy|1|||
162976265|NCT02010255|588614037|FG011|Overall Study|Lack of Efficacy|0|||
162976266|NCT02010255|588614038|FG012|Overall Study|Lack of Efficacy|0|||
162976267|NCT02010255|588614039|FG013|Overall Study|Lack of Efficacy|0|||
162976268|NCT02010255|588614026|FG000|Overall Study|Withdrew Consent|1|||
162976269|NCT02010255|588614027|FG001|Overall Study|Withdrew Consent|0|||
162976270|NCT02010255|588614028|FG002|Overall Study|Withdrew Consent|0|||
162976271|NCT02010255|588614029|FG003|Overall Study|Withdrew Consent|1|||
162976272|NCT02010255|588614030|FG004|Overall Study|Withdrew Consent|0|||
162976273|NCT02010255|588614031|FG005|Overall Study|Withdrew Consent|0|||
162976274|NCT02010255|588614032|FG006|Overall Study|Withdrew Consent|0|||
162976275|NCT02010255|588614033|FG007|Overall Study|Withdrew Consent|0|||
162976276|NCT02010255|588614034|FG008|Overall Study|Withdrew Consent|0|||
162976277|NCT02010255|588614035|FG009|Overall Study|Withdrew Consent|0|||
162976278|NCT02010255|588614036|FG010|Overall Study|Withdrew Consent|0|||
162976279|NCT02010255|588614037|FG011|Overall Study|Withdrew Consent|0|||
162976280|NCT02010255|588614038|FG012|Overall Study|Withdrew Consent|0|||
162976281|NCT02010255|588614039|FG013|Overall Study|Withdrew Consent|0|||
162976282|NCT02010255|588614026|FG000|Overall Study|Adverse Event|1|||
162976283|NCT02010255|588614027|FG001|Overall Study|Adverse Event|0|||
162976284|NCT02010255|588614028|FG002|Overall Study|Adverse Event|0|||
162976285|NCT02010255|588614029|FG003|Overall Study|Adverse Event|0|||
162976286|NCT02010255|588614030|FG004|Overall Study|Adverse Event|0|||
162976287|NCT02010255|588614031|FG005|Overall Study|Adverse Event|0|||
162976288|NCT02010255|588614032|FG006|Overall Study|Adverse Event|0|||
162976289|NCT02010255|588614033|FG007|Overall Study|Adverse Event|0|||
162976290|NCT02010255|588614034|FG008|Overall Study|Adverse Event|0|||
162976291|NCT02010255|588614035|FG009|Overall Study|Adverse Event|0|||
162976292|NCT02010255|588614036|FG010|Overall Study|Adverse Event|0|||
162976293|NCT02010255|588614037|FG011|Overall Study|Adverse Event|0|||
162976294|NCT02010255|588614038|FG012|Overall Study|Adverse Event|0|||
162976295|NCT02010255|588614039|FG013|Overall Study|Adverse Event|0|||
163057664|NCT01232283|588921307|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
163057665|NCT01232283|588921308|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
163057666|NCT01232283|588921309|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
163057667|NCT01232283|588921310|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
162976296|NCT02010255|588614026|FG000|Overall Study|Lost to Follow-up|0|||
162976297|NCT02010255|588614027|FG001|Overall Study|Lost to Follow-up|0|||
162976298|NCT02010255|588614028|FG002|Overall Study|Lost to Follow-up|1|||
162976299|NCT02010255|588614029|FG003|Overall Study|Lost to Follow-up|0|||
162976300|NCT02010255|588614030|FG004|Overall Study|Lost to Follow-up|1|||
162976301|NCT02010255|588614031|FG005|Overall Study|Lost to Follow-up|0|||
162976302|NCT02010255|588614032|FG006|Overall Study|Lost to Follow-up|0|||
162976303|NCT02010255|588614033|FG007|Overall Study|Lost to Follow-up|0|||
162976304|NCT02010255|588614034|FG008|Overall Study|Lost to Follow-up|0|||
162976305|NCT02010255|588614035|FG009|Overall Study|Lost to Follow-up|0|||
162976306|NCT02010255|588614036|FG010|Overall Study|Lost to Follow-up|0|||
162976307|NCT02010255|588614037|FG011|Overall Study|Lost to Follow-up|0|||
162976308|NCT02010255|588614038|FG012|Overall Study|Lost to Follow-up|0|||
162976309|NCT02010255|588614039|FG013|Overall Study|Lost to Follow-up|0|||
162976310|NCT02010255|588614026|FG000|Overall Study|Randomized but Not Treated|0|||
162976311|NCT02010255|588614027|FG001|Overall Study|Randomized but Not Treated|0|||
162976312|NCT02010255|588614028|FG002|Overall Study|Randomized but Not Treated|0|||
162976313|NCT02010255|588614029|FG003|Overall Study|Randomized but Not Treated|0|||
162976314|NCT02010255|588614030|FG004|Overall Study|Randomized but Not Treated|0|||
162976315|NCT02010255|588614031|FG005|Overall Study|Randomized but Not Treated|0|||
162976316|NCT02010255|588614032|FG006|Overall Study|Randomized but Not Treated|0|||
162976317|NCT02010255|588614033|FG007|Overall Study|Randomized but Not Treated|0|||
162976318|NCT02010255|588614034|FG008|Overall Study|Randomized but Not Treated|0|||
162976319|NCT02010255|588614035|FG009|Overall Study|Randomized but Not Treated|0|||
162976320|NCT02010255|588614036|FG010|Overall Study|Randomized but Not Treated|0|||
162976321|NCT02010255|588614037|FG011|Overall Study|Randomized but Not Treated|0|||
162976322|NCT02010255|588614038|FG012|Overall Study|Randomized but Not Treated|0|||
162976323|NCT02010255|588614039|FG013|Overall Study|Randomized but Not Treated|1|||
162976324|NCT03573817|588614040|FG000|Overall Study|Adverse Event|0|||
162976325|NCT03573817|588614041|FG001|Overall Study|Adverse Event|2|||
162976326|NCT03573817|588614040|FG000|Overall Study|Protocol Violation|0|||
162976327|NCT03573817|588614041|FG001|Overall Study|Protocol Violation|1|||
162976328|NCT03573817|588614040|FG000|Overall Study|Withdrawal by Subject|1|||
162976329|NCT03573817|588614041|FG001|Overall Study|Withdrawal by Subject|1|||
162976330|NCT00508027|588614050|FG000|Dose Level 1|Lost to Follow-up|4|||
162976331|NCT00508027|588614050|FG000|Dose Level 1|Withdrawal by Subject|2|||
162976332|NCT00508027|588614050|FG000|Dose Level 1|Physician Decision|2|||
162976333|NCT00508027|588614050|FG000|Dose Level 2|Lost to Follow-up|2|||
162976334|NCT00508027|588614050|FG000|Dose Level 2|Withdrawal by Subject|2|||
162976335|NCT01719562|588614051|FG000|Overall Study|Lost to Follow-up|1|||
162976336|NCT01719562|588614052|FG001|Overall Study|Lost to Follow-up|0|||
162976337|NCT01719562|588614051|FG000|Overall Study|Death|1|||
162976338|NCT01719562|588614052|FG001|Overall Study|Death|0|||
162976339|NCT01719562|588614051|FG000|Overall Study|New cancer diagnosis|1|||
162976340|NCT01719562|588614052|FG001|Overall Study|New cancer diagnosis|0|||
162976341|NCT02013531|588614053|FG000|Overall Study|Lost to Follow-up|3|||
162976342|NCT02013531|588614053|FG000|Overall Study|Met Withdrawal Criteria|1|||
162976343|NCT02013531|588614053|FG000|Overall Study|Withdrawal by Subject|1|||
162976344|NCT03554317|588614057|FG000|Overall Study|Withdrawal by Subject|1|||
162976345|NCT03554317|588614057|FG000|Overall Study|PSA Progression|3|||
162976346|NCT03554317|588614057|FG000|Overall Study|Radiographic Progression|4|||
162976347|NCT02487082|588614060|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
162976348|NCT02487082|588614061|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
162976349|NCT02487082|588614060|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
162976350|NCT02487082|588614061|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
162976351|NCT00537199|588614062|FG000|Overall Study|Study Terminated|1|||
162976352|NCT00612677|588614063|FG000|Overall Study|study closed before treatment started|1|||
162976353|NCT03139240|588614064|FG000|Overall Study|Lost to Follow-up|0|||
162976354|NCT03139240|588614065|FG001|Overall Study|Lost to Follow-up|1|||
162976355|NCT03139240|588614066|FG002|Overall Study|Lost to Follow-up|1|||
162976356|NCT03139240|588614067|FG003|Overall Study|Lost to Follow-up|0|||
162976357|NCT00860743|588614069|FG000|Overall Study|Withdrawal by Subject|3|||
162976358|NCT00860743|588614070|FG001|Overall Study|Withdrawal by Subject|0|||
162976359|NCT00823199|588614074|FG000|Overall Study|Withdrawal by Subject|2|||
162976360|NCT02776553|588614075|FG000|Overall Study|Lost to Follow-up|1|||
162976361|NCT02776553|588614076|FG001|Overall Study|Lost to Follow-up|0|||
163401353|NCT01438489|590181133|FG000|Overall Study|Received prohibited medication|1|||
162976362|NCT02776553|588614075|FG000|Overall Study|got liver transplant|1|||
162976363|NCT02776553|588614076|FG001|Overall Study|got liver transplant|2|||
162976364|NCT02776553|588614075|FG000|Overall Study|had other surgery|1|||
162976365|NCT02776553|588614076|FG001|Overall Study|had other surgery|0|||
162976366|NCT02776553|588614075|FG000|Overall Study|Protocol Violation|0|||
162976367|NCT02776553|588614076|FG001|Overall Study|Protocol Violation|1|||
162976368|NCT00941720|588614077|FG000|Overall Study|Withdrawal by Subject|1|||
163401354|NCT01438489|590181134|FG001|Overall Study|Received prohibited medication|0|||
163401355|NCT01438489|590181135|FG002|Overall Study|Received prohibited medication|0|||
163401356|NCT01438489|590181133|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
163401357|NCT01438489|590181134|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
163401358|NCT01438489|590181135|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
163401359|NCT01438489|590181133|FG000|Overall Study|Inadequate venous access|0|||
163401360|NCT01438489|590181134|FG001|Overall Study|Inadequate venous access|2|||
163401361|NCT01438489|590181135|FG002|Overall Study|Inadequate venous access|0|||
162976369|NCT00941720|588614077|FG000|Overall Study|Insurance denied participation|11|||
162976370|NCT00941720|588614077|FG000|Overall Study|ineligible|2|||
162976371|NCT00171340|588614078|FG000|Overall Study|Adverse Event|46|||
162976372|NCT00171340|588614079|FG001|Overall Study|Adverse Event|42|||
162976373|NCT00171340|588614078|FG000|Overall Study|Lack of Efficacy|29|||
162976374|NCT00171340|588614079|FG001|Overall Study|Lack of Efficacy|41|||
162976375|NCT00171340|588614078|FG000|Overall Study|Protocol Violation|7|||
162976376|NCT00171340|588614079|FG001|Overall Study|Protocol Violation|8|||
162976377|NCT00171340|588614078|FG000|Overall Study|Withdrawal by Subject|22|||
162976378|NCT00171340|588614079|FG001|Overall Study|Withdrawal by Subject|19|||
162976379|NCT00171340|588614078|FG000|Overall Study|Lost to Follow-up|0|||
162976380|NCT00171340|588614079|FG001|Overall Study|Lost to Follow-up|5|||
162976381|NCT00171340|588614078|FG000|Overall Study|Abnormal Laboratory Results|2|||
162976382|NCT00171340|588614079|FG001|Overall Study|Abnormal Laboratory Results|0|||
162976383|NCT00171340|588614078|FG000|Overall Study|Abnormal Test Procedure Results|6|||
162976384|NCT00171340|588614079|FG001|Overall Study|Abnormal Test Procedure Results|11|||
162976385|NCT00171340|588614078|FG000|Overall Study|No Longer Required Study Drug|1|||
162976386|NCT00171340|588614079|FG001|Overall Study|No Longer Required Study Drug|1|||
162976387|NCT00171340|588614078|FG000|Overall Study|Administrative Problems|5|||
162976388|NCT00171340|588614079|FG001|Overall Study|Administrative Problems|2|||
162976389|NCT00171340|588614078|FG000|Overall Study|Death|6|||
162976390|NCT00171340|588614079|FG001|Overall Study|Death|6|||
162976391|NCT03827018|588614080|FG000|Overall Study|Adverse Event|1|||
162976392|NCT03827018|588614081|FG001|Overall Study|Adverse Event|0|||
162976393|NCT03827018|588614080|FG000|Overall Study|Withdrawal by Subject|2|||
162976394|NCT03827018|588614081|FG001|Overall Study|Withdrawal by Subject|2|||
162976395|NCT03827018|588614080|FG000|Overall Study|Lack of Efficacy|0|||
162976396|NCT03827018|588614081|FG001|Overall Study|Lack of Efficacy|1|||
162976397|NCT01998243|588614084|FG000|Overall Study|Pregnancy|0|||
162976398|NCT01998243|588614085|FG001|Overall Study|Pregnancy|1|||
162976399|NCT01998243|588614084|FG000|Overall Study|Protocol Violation|5|||
162976400|NCT01998243|588614085|FG001|Overall Study|Protocol Violation|2|||
162976401|NCT01998243|588614084|FG000|Overall Study|Withdrawal by Subject|3|||
162976402|NCT01998243|588614085|FG001|Overall Study|Withdrawal by Subject|4|||
162976403|NCT00268892|588614089|FG000|Overall Study|Adverse Event|14|||
162976404|NCT00268892|588614090|FG001|Overall Study|Adverse Event|17|||
162976405|NCT00268892|588614091|FG002|Overall Study|Adverse Event|20|||
162976406|NCT00268892|588614089|FG000|Overall Study|Lack of Efficacy|1|||
162976407|NCT00268892|588614090|FG001|Overall Study|Lack of Efficacy|3|||
162976408|NCT00268892|588614091|FG002|Overall Study|Lack of Efficacy|0|||
162976409|NCT00268892|588614089|FG000|Overall Study|Withdrawal by Subject|14|||
162976410|NCT00268892|588614090|FG001|Overall Study|Withdrawal by Subject|15|||
162976411|NCT00268892|588614091|FG002|Overall Study|Withdrawal by Subject|13|||
162976412|NCT00268892|588614089|FG000|Overall Study|Physician Decision|0|||
162976413|NCT00268892|588614090|FG001|Overall Study|Physician Decision|1|||
162976414|NCT00268892|588614091|FG002|Overall Study|Physician Decision|0|||
162976415|NCT00268892|588614089|FG000|Overall Study|Lost to Follow-up|5|||
162976416|NCT00268892|588614090|FG001|Overall Study|Lost to Follow-up|2|||
162976417|NCT00268892|588614091|FG002|Overall Study|Lost to Follow-up|4|||
162976418|NCT00268892|588614089|FG000|Overall Study|Protocol Violation|0|||
162976419|NCT00268892|588614090|FG001|Overall Study|Protocol Violation|1|||
162976420|NCT00268892|588614091|FG002|Overall Study|Protocol Violation|0|||
162976421|NCT00268892|588614089|FG000|Overall Study|Disease Progression|1|||
162976422|NCT00268892|588614090|FG001|Overall Study|Disease Progression|1|||
162976423|NCT00268892|588614091|FG002|Overall Study|Disease Progression|0|||
162976424|NCT00268892|588614089|FG000|Overall Study|Trial Site Closed|4|||
162976425|NCT00268892|588614090|FG001|Overall Study|Trial Site Closed|2|||
162976426|NCT00268892|588614091|FG002|Overall Study|Trial Site Closed|2|||
162976427|NCT04569786|588614095|FG000|Overall Study|Lost to Follow-up|1|||
162976428|NCT04569786|588614096|FG001|Overall Study|Lost to Follow-up|0|||
162976429|NCT04569786|588614097|FG002|Overall Study|Lost to Follow-up|4|||
162976430|NCT04569786|588614098|FG003|Overall Study|Lost to Follow-up|1|||
162976431|NCT04569786|588614099|FG004|Overall Study|Lost to Follow-up|0|||
162976432|NCT04569786|588614095|FG000|Overall Study|Withdrawal by Subject|0|||
162976433|NCT04569786|588614096|FG001|Overall Study|Withdrawal by Subject|0|||
162976434|NCT04569786|588614097|FG002|Overall Study|Withdrawal by Subject|0|||
162976435|NCT04569786|588614098|FG003|Overall Study|Withdrawal by Subject|5|||
162976436|NCT04569786|588614099|FG004|Overall Study|Withdrawal by Subject|1|||
162976437|NCT04569786|588614095|FG000|Overall Study|Physician Decision|0|||
162976438|NCT04569786|588614096|FG001|Overall Study|Physician Decision|0|||
162976439|NCT04569786|588614097|FG002|Overall Study|Physician Decision|0|||
162976440|NCT04569786|588614098|FG003|Overall Study|Physician Decision|1|||
162976441|NCT04569786|588614099|FG004|Overall Study|Physician Decision|0|||
162976442|NCT01640184|588614108|FG000|Overall Study|Death|1|||
162976443|NCT01640184|588614109|FG001|Overall Study|Death|0|||
162976444|NCT01640184|588614110|FG002|Overall Study|Death|0|||
162976445|NCT01640184|588614108|FG000|Overall Study|Lost to Follow-up|4|||
162976446|NCT01640184|588614109|FG001|Overall Study|Lost to Follow-up|1|||
162976447|NCT01640184|588614110|FG002|Overall Study|Lost to Follow-up|0|||
162976448|NCT01640184|588614108|FG000|Overall Study|Physician Decision|3|||
162976449|NCT01640184|588614109|FG001|Overall Study|Physician Decision|0|||
162976450|NCT01640184|588614110|FG002|Overall Study|Physician Decision|0|||
162976451|NCT01640184|588614108|FG000|Overall Study|Withdrawal by Subject|0|||
162976452|NCT01640184|588614109|FG001|Overall Study|Withdrawal by Subject|1|||
162976453|NCT01640184|588614110|FG002|Overall Study|Withdrawal by Subject|1|||
162976454|NCT01640184|588614108|FG000|Overall Study|Protocol Violation|0|||
162976455|NCT01640184|588614109|FG001|Overall Study|Protocol Violation|0|||
162976456|NCT01640184|588614110|FG002|Overall Study|Protocol Violation|1|||
162976457|NCT00680186|588614111|FG000|Overall Study|Adverse Event|47|||
162976458|NCT00680186|588614112|FG001|Overall Study|Adverse Event|44|||
163209670|NCT01475331|589482947|FG001|Overall Study|Sign of malignancy during the procedure|0|||
163209671|NCT01475331|589482946|FG000|Overall Study|cyst found to be prohibitively small|0|||
163209672|NCT01475331|589482947|FG001|Overall Study|cyst found to be prohibitively small|1|||
163209673|NCT00462761|589482948|FG000|Overall Study|Adverse Event|6|||
163209674|NCT00462761|589482948|FG000|Overall Study|Withdrawal by Subject|9|||
163209675|NCT00462761|589482948|FG000|Overall Study|Physician Decision|5|||
163209676|NCT00462761|589482948|FG000|Overall Study|Disease progression|43|||
163209677|NCT00462761|589482948|FG000|Overall Study|Death|12|||
163209678|NCT00462761|589482948|FG000|Overall Study|Other|1|||
163209679|NCT02877082|589482949|FG000|Overall Study|Trial was closed early|5|||
163209680|NCT03720470|589482954|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
163209681|NCT03720470|589482955|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
163209682|NCT03720470|589482956|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
163209683|NCT03720470|589482957|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
163209684|NCT03720470|589482958|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
163209685|NCT03720470|589482959|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
163209686|NCT03720470|589482954|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
163209687|NCT03720470|589482955|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
163209688|NCT03720470|589482956|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
163209689|NCT03720470|589482957|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
163209690|NCT03720470|589482958|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
163209691|NCT03720470|589482959|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
163209692|NCT03720470|589482954|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
163209693|NCT03720470|589482955|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
163209694|NCT03720470|589482956|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
163209695|NCT03720470|589482957|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
163209696|NCT03720470|589482958|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
163209697|NCT03720470|589482959|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
163209698|NCT03720470|589482954|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
163209699|NCT03720470|589482955|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
163209700|NCT03720470|589482956|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
163209701|NCT03720470|589482957|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
163209702|NCT03720470|589482958|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
163209703|NCT03720470|589482959|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
163209704|NCT03720470|589482954|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
163209705|NCT03720470|589482955|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
162976459|NCT00680186|588614111|FG000|Overall Study|Protocol Violation|31|||
162976460|NCT00680186|588614112|FG001|Overall Study|Protocol Violation|26|||
162976461|NCT00680186|588614111|FG000|Overall Study|Lost to Follow-up|11|||
162976462|NCT00680186|588614112|FG001|Overall Study|Lost to Follow-up|6|||
162976463|NCT00680186|588614111|FG000|Overall Study|Withdrawal by Subject|32|||
162976464|NCT00680186|588614112|FG001|Overall Study|Withdrawal by Subject|39|||
162976465|NCT00680186|588614111|FG000|Overall Study|Other|4|||
162976466|NCT00680186|588614112|FG001|Overall Study|Other|1|||
162976467|NCT01351350|588614115|FG000|Overall Study|Disease Progression|5|||
162976468|NCT01351350|588614116|FG001|Overall Study|Disease Progression|13|||
162976469|NCT01351350|588614117|FG002|Overall Study|Disease Progression|6|||
162976470|NCT01351350|588614118|FG003|Overall Study|Disease Progression|8|||
162976471|NCT01351350|588614119|FG004|Overall Study|Disease Progression|5|||
162976472|NCT01351350|588614115|FG000|Overall Study|Adverse Event|1|||
162976473|NCT01351350|588614116|FG001|Overall Study|Adverse Event|10|||
162976474|NCT01351350|588614117|FG002|Overall Study|Adverse Event|1|||
162976475|NCT01351350|588614118|FG003|Overall Study|Adverse Event|2|||
162976476|NCT01351350|588614119|FG004|Overall Study|Adverse Event|0|||
162976477|NCT01351350|588614115|FG000|Overall Study|Participant Decision|2|||
162976478|NCT01351350|588614116|FG001|Overall Study|Participant Decision|6|||
162976479|NCT01351350|588614117|FG002|Overall Study|Participant Decision|3|||
162976480|NCT01351350|588614118|FG003|Overall Study|Participant Decision|3|||
162976481|NCT01351350|588614119|FG004|Overall Study|Participant Decision|2|||
162976482|NCT01351350|588614115|FG000|Overall Study|Enrolled but not Treated|0|||
162976483|NCT01351350|588614116|FG001|Overall Study|Enrolled but not Treated|0|||
162976484|NCT01351350|588614117|FG002|Overall Study|Enrolled but not Treated|1|||
162976485|NCT01351350|588614118|FG003|Overall Study|Enrolled but not Treated|0|||
162976486|NCT01351350|588614119|FG004|Overall Study|Enrolled but not Treated|0|||
162976487|NCT04647383|588614120|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
162976488|NCT04647383|588614121|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
163057668|NCT01232283|588921311|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
163209706|NCT03720470|589482956|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
163209707|NCT03720470|589482957|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
163209708|NCT03720470|589482958|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
163209709|NCT03720470|589482959|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
163318069|NCT01928394|589874954|FG008|Follow-up Period|Lost to Follow-up|0|||
162976489|NCT04647383|588614122|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
162976490|NCT04647383|588614123|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
162976491|NCT00479388|588614128|FG000|Overall Study|Adverse Event|90|||
162976492|NCT00479388|588614129|FG001|Overall Study|Adverse Event|45|||
162976493|NCT00479388|588614128|FG000|Overall Study|Lost to Follow-up|0|||
162976494|NCT00479388|588614129|FG001|Overall Study|Lost to Follow-up|2|||
162976495|NCT00479388|588614128|FG000|Overall Study|Protocol Violation|10|||
162976496|NCT00479388|588614129|FG001|Overall Study|Protocol Violation|9|||
162976497|NCT00479388|588614128|FG000|Overall Study|Withdrawal by Subject|32|||
162976498|NCT00479388|588614129|FG001|Overall Study|Withdrawal by Subject|17|||
162976499|NCT01876368|588614135|FG000|Overall Study|Adverse Event|2|||
162976500|NCT01876368|588614136|FG001|Overall Study|Adverse Event|5|||
162976501|NCT01876368|588614135|FG000|Overall Study|Lack of Efficacy|1|||
162976502|NCT01876368|588614136|FG001|Overall Study|Lack of Efficacy|0|||
162976503|NCT01876368|588614135|FG000|Overall Study|Lost to Follow-up|0|||
162976504|NCT01876368|588614136|FG001|Overall Study|Lost to Follow-up|1|||
162976505|NCT01876368|588614135|FG000|Overall Study|Non-compliance with study treatment|0|||
162976506|NCT01876368|588614136|FG001|Overall Study|Non-compliance with study treatment|1|||
162976507|NCT01876368|588614135|FG000|Overall Study|Physician Decision|0|||
162976508|NCT01876368|588614136|FG001|Overall Study|Physician Decision|2|||
162976509|NCT01876368|588614135|FG000|Overall Study|Protocol deviation|3|||
162976510|NCT01876368|588614136|FG001|Overall Study|Protocol deviation|3|||
163057669|NCT01232283|588921312|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
163057670|NCT01232283|588921313|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
163057671|NCT01232283|588921314|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
163057672|NCT01232283|588921305|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057673|NCT01232283|588921306|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057674|NCT01232283|588921307|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057675|NCT01232283|588921308|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057676|NCT01232283|588921309|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
163057677|NCT01232283|588921310|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057678|NCT01232283|588921311|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057679|NCT01232283|588921312|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057680|NCT01232283|588921313|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057681|NCT01232283|588921314|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057682|NCT01232283|588921305|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
163057683|NCT01232283|588921306|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
163057684|NCT01232283|588921307|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
163057685|NCT01232283|588921308|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
163057686|NCT01232283|588921309|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
163057687|NCT01232283|588921310|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
163057688|NCT01232283|588921311|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
162976511|NCT01876368|588614135|FG000|Overall Study|Subject/guardian decision|3|||
162976512|NCT01876368|588614136|FG001|Overall Study|Subject/guardian decision|1|||
162976513|NCT02260258|588614140|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
162976514|NCT02260258|588614141|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
162976515|NCT01644149|588614142|FG000|Overall Study|Withdrawal by Subject|1|||
162976516|NCT01644149|588614143|FG001|Overall Study|Withdrawal by Subject|0|||
162976517|NCT01644149|588614142|FG000|Overall Study|Lost to Follow-up|3|||
162976518|NCT01644149|588614143|FG001|Overall Study|Lost to Follow-up|1|||
162976519|NCT00690482|588614144|FG000|Overall Study|Adverse Event|2|||
162976520|NCT00690482|588614145|FG001|Overall Study|Adverse Event|1|||
162976521|NCT00690482|588614144|FG000|Overall Study|Incorrect enrolment|0|||
162976522|NCT00690482|588614145|FG001|Overall Study|Incorrect enrolment|1|||
162976523|NCT00690482|588614144|FG000|Overall Study|Study-specific discontinuation criteria|1|||
162976524|NCT00690482|588614145|FG001|Overall Study|Study-specific discontinuation criteria|0|||
162976525|NCT00690482|588614144|FG000|Overall Study|Intake of prohibited medicine|1|||
162976526|NCT00690482|588614145|FG001|Overall Study|Intake of prohibited medicine|0|||
162976527|NCT00690482|588614144|FG000|Overall Study|withdrew consent at rand.day|0|||
162976528|NCT00690482|588614145|FG001|Overall Study|withdrew consent at rand.day|1|||
163318070|NCT01928394|589874955|FG009|Follow-up Period|Lost to Follow-up|0|||
162976529|NCT03693950|588614146|FG000|Overall Study|Withdrawal by Subject|1|||
162976530|NCT03693950|588614147|FG001|Overall Study|Withdrawal by Subject|0|||
162976531|NCT04230876|588614148|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
162976532|NCT04230876|588614149|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
163318071|NCT01928394|589874956|FG010|Follow-up Period|Lost to Follow-up|0|||
162976533|NCT00545688|588614151|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
162976534|NCT00545688|588614152|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
162976535|NCT00545688|588614153|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
162976536|NCT00545688|588614154|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
162976537|NCT00545688|588614151|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
162976538|NCT00545688|588614152|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
163057689|NCT01232283|588921312|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
163057690|NCT01232283|588921313|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
162976539|NCT00545688|588614153|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
162976540|NCT00545688|588614154|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
162976541|NCT00545688|588614151|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
162976542|NCT00545688|588614152|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
162976543|NCT00545688|588614153|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
162976544|NCT00545688|588614154|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
162976545|NCT00545688|588614151|FG000|Neo-Adjuvant Treatment Period|Death|0|||
162976546|NCT00545688|588614152|FG001|Neo-Adjuvant Treatment Period|Death|1|||
162976547|NCT00545688|588614153|FG002|Neo-Adjuvant Treatment Period|Death|0|||
162976548|NCT00545688|588614154|FG003|Neo-Adjuvant Treatment Period|Death|0|||
162976549|NCT00545688|588614151|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
162976550|NCT00545688|588614152|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
162976551|NCT00545688|588614153|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
162976552|NCT00545688|588614154|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
162976553|NCT00545688|588614151|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
162976554|NCT00545688|588614152|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
162976555|NCT00545688|588614153|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
162976556|NCT00545688|588614154|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
162976557|NCT00545688|588614151|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
162976558|NCT00545688|588614152|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
163057691|NCT01232283|588921314|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
163057692|NCT01232283|588921305|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057693|NCT01232283|588921306|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057694|NCT01232283|588921307|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057695|NCT01232283|588921308|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057696|NCT01232283|588921309|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057697|NCT01232283|588921310|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057698|NCT01232283|588921311|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057699|NCT01232283|588921312|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
163057700|NCT01232283|588921313|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
162976559|NCT00545688|588614153|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
162976560|NCT00545688|588614154|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
162976561|NCT00545688|588614151|FG000|Adjuvant Treatment Period|Disease Progression|3|||
162976562|NCT00545688|588614152|FG001|Adjuvant Treatment Period|Disease Progression|3|||
162976563|NCT00545688|588614153|FG002|Adjuvant Treatment Period|Disease Progression|0|||
162976564|NCT00545688|588614154|FG003|Adjuvant Treatment Period|Disease Progression|7|||
163057701|NCT01232283|588921314|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057702|NCT01232283|588921305|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057703|NCT01232283|588921306|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057704|NCT01232283|588921307|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057705|NCT01232283|588921308|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057706|NCT01232283|588921309|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057707|NCT01232283|588921310|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
163057708|NCT01232283|588921311|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057709|NCT01232283|588921312|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057710|NCT01232283|588921313|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057711|NCT01232283|588921314|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057712|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
163057713|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
162976565|NCT00545688|588614151|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
162976566|NCT00545688|588614152|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
162976567|NCT00545688|588614153|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
162976568|NCT00545688|588614154|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
162976569|NCT00545688|588614151|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
162976570|NCT00545688|588614152|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
162976571|NCT00545688|588614153|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
162976572|NCT00545688|588614154|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
162976573|NCT00545688|588614151|FG000|Adjuvant Treatment Period|Adverse Event|0|||
162976574|NCT00545688|588614152|FG001|Adjuvant Treatment Period|Adverse Event|3|||
163401362|NCT03719690|590181137|FG000|Overall Study|Withdrawal by Subject|5|||
162976575|NCT00545688|588614153|FG002|Adjuvant Treatment Period|Adverse Event|2|||
162976576|NCT00545688|588614154|FG003|Adjuvant Treatment Period|Adverse Event|2|||
162976577|NCT00545688|588614151|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
162976578|NCT00545688|588614152|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
162976579|NCT00545688|588614153|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
163209710|NCT03720470|589482954|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
163209711|NCT03720470|589482955|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
163209712|NCT03720470|589482956|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
163209713|NCT03720470|589482957|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
163209714|NCT03720470|589482958|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
162976580|NCT00545688|588614154|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
162976581|NCT00545688|588614151|FG000|Follow-Up Period|Death|4|||
162976582|NCT00545688|588614152|FG001|Follow-Up Period|Death|2|||
162976583|NCT00545688|588614153|FG002|Follow-Up Period|Death|2|||
162976584|NCT00545688|588614154|FG003|Follow-Up Period|Death|6|||
162976585|NCT00545688|588614151|FG000|Follow-Up Period|Disease Progression|6|||
162976586|NCT00545688|588614152|FG001|Follow-Up Period|Disease Progression|5|||
162976587|NCT00545688|588614153|FG002|Follow-Up Period|Disease Progression|9|||
163209715|NCT03720470|589482959|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
163209716|NCT03720470|589482954|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
163209717|NCT03720470|589482955|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
163209718|NCT03720470|589482956|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
163209719|NCT03720470|589482957|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
163209720|NCT03720470|589482958|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
163209721|NCT03720470|589482959|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
163209722|NCT03720470|589482954|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
163209723|NCT03720470|589482955|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
163209724|NCT03720470|589482956|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
163209725|NCT03720470|589482957|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
163209726|NCT03720470|589482958|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
163209727|NCT03720470|589482959|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
163209728|NCT03720470|589482954|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
163209729|NCT03720470|589482955|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
163209730|NCT03720470|589482956|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
163209731|NCT03720470|589482957|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
163209732|NCT03720470|589482958|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
163209733|NCT03720470|589482959|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
163209734|NCT03720470|589482954|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
162976588|NCT00545688|588614154|FG003|Follow-Up Period|Disease Progression|9|||
162976589|NCT00545688|588614151|FG000|Follow-Up Period|Refused Treatment|6|||
163209735|NCT03720470|589482955|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
163209736|NCT03720470|589482956|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
163209737|NCT03720470|589482957|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
163209738|NCT03720470|589482958|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
162976590|NCT00545688|588614152|FG001|Follow-Up Period|Refused Treatment|2|||
162976591|NCT00545688|588614153|FG002|Follow-Up Period|Refused Treatment|0|||
162976592|NCT00545688|588614154|FG003|Follow-Up Period|Refused Treatment|2|||
162976593|NCT00545688|588614151|FG000|Follow-Up Period|Lost to Follow-up|3|||
162976594|NCT00545688|588614152|FG001|Follow-Up Period|Lost to Follow-up|3|||
162976595|NCT00545688|588614153|FG002|Follow-Up Period|Lost to Follow-up|3|||
162976596|NCT00545688|588614154|FG003|Follow-Up Period|Lost to Follow-up|1|||
162976597|NCT00545688|588614151|FG000|Follow-Up Period|Unspecified Reason|2|||
162976598|NCT00545688|588614152|FG001|Follow-Up Period|Unspecified Reason|5|||
162976599|NCT00545688|588614153|FG002|Follow-Up Period|Unspecified Reason|6|||
162976600|NCT00545688|588614154|FG003|Follow-Up Period|Unspecified Reason|8|||
162976601|NCT00545688|588614151|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
162976602|NCT00545688|588614152|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
162976603|NCT00545688|588614153|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
162976604|NCT00545688|588614154|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
162976605|NCT02792218|588614158|FG000|Overall Study|Patient/guardian decision|15|||
162976606|NCT02792218|588614159|FG001|Overall Study|Patient/guardian decision|42|||
162976607|NCT02792218|588614158|FG000|Overall Study|Adverse Event|15|||
162976608|NCT02792218|588614159|FG001|Overall Study|Adverse Event|14|||
162976609|NCT02792218|588614158|FG000|Overall Study|Lost to Follow-up|10|||
162976610|NCT02792218|588614159|FG001|Overall Study|Lost to Follow-up|5|||
162976611|NCT02792218|588614158|FG000|Overall Study|Lack of Efficacy|1|||
162976612|NCT02792218|588614159|FG001|Overall Study|Lack of Efficacy|12|||
162976613|NCT02792218|588614158|FG000|Overall Study|Physician Decision|4|||
162976614|NCT02792218|588614159|FG001|Overall Study|Physician Decision|4|||
162976615|NCT02792218|588614158|FG000|Overall Study|Protocol deviation|3|||
162976616|NCT02792218|588614159|FG001|Overall Study|Protocol deviation|2|||
162976617|NCT02792218|588614158|FG000|Overall Study|New therapy for study indication|0|||
162976618|NCT02792218|588614159|FG001|Overall Study|New therapy for study indication|1|||
162976619|NCT02792218|588614158|FG000|Overall Study|Non-compliance with study treatment|0|||
163209739|NCT03720470|589482959|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
163209740|NCT03720470|589482954|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
163209741|NCT03720470|589482955|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
163209742|NCT03720470|589482956|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
163209743|NCT03720470|589482957|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
163209744|NCT03720470|589482958|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
163209745|NCT03720470|589482959|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
163209746|NCT03720470|589482954|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
163209747|NCT03720470|589482955|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
163209748|NCT03720470|589482956|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
163209749|NCT03720470|589482957|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
163209750|NCT03720470|589482958|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
163209751|NCT03720470|589482959|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
163209752|NCT03720470|589482954|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
163209753|NCT03720470|589482955|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
163209754|NCT03720470|589482956|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
163209755|NCT03720470|589482957|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
162976620|NCT02792218|588614159|FG001|Overall Study|Non-compliance with study treatment|1|||
162976621|NCT02792218|588614158|FG000|Overall Study|Pregnancy|1|||
162976622|NCT02792218|588614159|FG001|Overall Study|Pregnancy|0|||
162976623|NCT00248170|588614160|FG000|Overall Study|Withdrawal by Subject|71|||
162976624|NCT00248170|588614161|FG001|Overall Study|Withdrawal by Subject|79|||
162976625|NCT00248170|588614160|FG000|Overall Study|Protocol Violation|35|||
162976626|NCT00248170|588614161|FG001|Overall Study|Protocol Violation|30|||
162976627|NCT00248170|588614160|FG000|Overall Study|Lost to Follow-up|28|||
162976628|NCT00248170|588614161|FG001|Overall Study|Lost to Follow-up|35|||
162976629|NCT00248170|588614160|FG000|Overall Study|Disease progression|196|||
162976630|NCT00248170|588614161|FG001|Overall Study|Disease progression|216|||
162976631|NCT00248170|588614160|FG000|Overall Study|Death|28|||
162976632|NCT00248170|588614161|FG001|Overall Study|Death|47|||
162976633|NCT00248170|588614160|FG000|Overall Study|Adverse Event|311|||
162976634|NCT00248170|588614161|FG001|Overall Study|Adverse Event|296|||
162976635|NCT00248170|588614160|FG000|Overall Study|Administrative problems|22|||
162976636|NCT00248170|588614161|FG001|Overall Study|Administrative problems|25|||
162976637|NCT00248170|588614160|FG000|Overall Study|Abnormal test procedure(s) result|49|||
162976638|NCT00248170|588614161|FG001|Overall Study|Abnormal test procedure(s) result|61|||
162976639|NCT00248170|588614160|FG000|Overall Study|Abnormal laboratory values|4|||
162976640|NCT00248170|588614161|FG001|Overall Study|Abnormal laboratory values|0|||
162976641|NCT00248170|588614160|FG000|Overall Study|Protocol deviation|17|||
162976642|NCT00248170|588614161|FG001|Overall Study|Protocol deviation|19|||
162976643|NCT03123783|588614162|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
162976644|NCT03123783|588614163|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
162976645|NCT03123783|588614164|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
162976646|NCT03123783|588614165|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
162976647|NCT03123783|588614166|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
162976648|NCT03123783|588614167|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
162976649|NCT03123783|588614168|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
162976650|NCT03123783|588614162|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
162976651|NCT03123783|588614163|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
162976652|NCT03123783|588614164|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
162976653|NCT03123783|588614165|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
162976654|NCT03123783|588614166|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
162976655|NCT03123783|588614167|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
162976656|NCT03123783|588614168|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
162976657|NCT03123783|588614162|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
162976658|NCT03123783|588614163|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
162976659|NCT03123783|588614164|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
162976660|NCT03123783|588614165|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
162976661|NCT03123783|588614166|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
162976662|NCT03123783|588614167|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
162976663|NCT03123783|588614168|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
162976664|NCT03123783|588614162|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
162976665|NCT03123783|588614163|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
162976666|NCT03123783|588614164|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
162976667|NCT03123783|588614165|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
162976668|NCT03123783|588614166|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
163209756|NCT03720470|589482958|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
163209757|NCT03720470|589482959|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
163209758|NCT03720470|589482954|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
162976669|NCT03123783|588614167|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
162976670|NCT03123783|588614168|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
162976671|NCT01557582|588614169|FG000|Overall Study|Protocol Violation|4|||
162976672|NCT01557582|588614169|FG000|Overall Study|Operator error|2|||
162976673|NCT00749411|588614173|FG000|Overall Study|Adverse Event|0|||
162976674|NCT00749411|588614174|FG001|Overall Study|Adverse Event|2|||
163401363|NCT03719690|590181138|FG001|Overall Study|Withdrawal by Subject|10|||
162976675|NCT00749411|588614173|FG000|Overall Study|Lack of Efficacy|0|||
162976676|NCT00749411|588614174|FG001|Overall Study|Lack of Efficacy|1|||
162976677|NCT00749411|588614173|FG000|Overall Study|Protocol Violation|1|||
162976678|NCT00749411|588614174|FG001|Overall Study|Protocol Violation|1|||
162976679|NCT00749411|588614173|FG000|Overall Study|Protocol-defined stopping criteria|0|||
162976680|NCT00749411|588614174|FG001|Overall Study|Protocol-defined stopping criteria|1|||
162976681|NCT02070757|588615432|FG000|Overall Study|Adverse Event|107|||
162976682|NCT02070757|588615433|FG001|Overall Study|Adverse Event|99|||
162976683|NCT02070757|588615432|FG000|Overall Study|Lost to Follow-up|7|||
162976684|NCT02070757|588615433|FG001|Overall Study|Lost to Follow-up|4|||
162976685|NCT02070757|588615432|FG000|Overall Study|Protocol Violation|0|||
162976686|NCT02070757|588615433|FG001|Overall Study|Protocol Violation|4|||
162976687|NCT02070757|588615432|FG000|Overall Study|Withdrawal by Subject|1|||
162976688|NCT02070757|588615433|FG001|Overall Study|Withdrawal by Subject|3|||
162976689|NCT02070757|588615432|FG000|Overall Study|Investigator Decision|0|||
162976690|NCT02070757|588615433|FG001|Overall Study|Investigator Decision|2|||
162976691|NCT02070757|588615432|FG000|Overall Study|Discharged from Study Hospital|2|||
162976692|NCT02070757|588615433|FG001|Overall Study|Discharged from Study Hospital|2|||
162976693|NCT04086641|588615434|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
162976694|NCT04086641|588615435|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
162976695|NCT00126126|588615446|FG000|Overall Study|Lost to Follow-up|0|||
162976696|NCT00126126|588615447|FG001|Overall Study|Lost to Follow-up|2|||
162976697|NCT01570283|588615451|FG000|Cohort 1: Dose Level 1|Death|0|||
162976698|NCT01570283|588615452|FG001|Cohort 1: Dose Level 1|Death|1|||
162976699|NCT01570283|588615453|FG002|Cohort 1: Dose Level 1|Death|0|||
162976700|NCT01570283|588615454|FG003|Cohort 1: Dose Level 1|Death|0|||
162976701|NCT01570283|588615455|FG004|Cohort 1: Dose Level 1|Death|0|||
162976702|NCT01570283|588615456|FG005|Cohort 1: Dose Level 1|Death|0|||
162976703|NCT01570283|588615451|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
162976704|NCT01570283|588615452|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
162976705|NCT01570283|588615453|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
162976706|NCT01570283|588615454|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
162976707|NCT01570283|588615455|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
162976708|NCT01570283|588615456|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
162976709|NCT01570283|588615451|FG000|Cohort 2: Dose Level 2|Death|0|||
162976710|NCT01570283|588615452|FG001|Cohort 2: Dose Level 2|Death|0|||
162976711|NCT01570283|588615453|FG002|Cohort 2: Dose Level 2|Death|1|||
162976712|NCT01570283|588615454|FG003|Cohort 2: Dose Level 2|Death|0|||
162976713|NCT01570283|588615455|FG004|Cohort 2: Dose Level 2|Death|0|||
162976714|NCT01570283|588615456|FG005|Cohort 2: Dose Level 2|Death|0|||
162976715|NCT01570283|588615451|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
162976716|NCT01570283|588615452|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
162976717|NCT01570283|588615453|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
162976718|NCT01570283|588615454|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
162976719|NCT01570283|588615455|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
162976720|NCT01570283|588615456|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
162976721|NCT01570283|588615451|FG000|Cohort 3: Dose Level 3|Death|0|||
162976722|NCT01570283|588615452|FG001|Cohort 3: Dose Level 3|Death|0|||
162976723|NCT01570283|588615453|FG002|Cohort 3: Dose Level 3|Death|0|||
162976724|NCT01570283|588615454|FG003|Cohort 3: Dose Level 3|Death|0|||
162976725|NCT01570283|588615455|FG004|Cohort 3: Dose Level 3|Death|0|||
162976726|NCT01570283|588615456|FG005|Cohort 3: Dose Level 3|Death|1|||
162976727|NCT01570283|588615451|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
162976728|NCT01570283|588615452|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
163401364|NCT03719690|590181137|FG000|Overall Study|Death|40|||
162976729|NCT01570283|588615453|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
162976730|NCT01570283|588615454|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
162976731|NCT01570283|588615455|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
162976732|NCT01570283|588615456|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
162976733|NCT01833533|588615457|FG000|Overall Study|Adverse Event|0|||
162976734|NCT01833533|588615458|FG001|Overall Study|Adverse Event|1|||
162976735|NCT01833533|588615457|FG000|Overall Study|Lost to Follow-up|4|||
163401365|NCT03719690|590181138|FG001|Overall Study|Death|149|||
162976736|NCT01833533|588615458|FG001|Overall Study|Lost to Follow-up|9|||
162976737|NCT01833533|588615457|FG000|Overall Study|To Enter an Extension Study|0|||
162976738|NCT01833533|588615458|FG001|Overall Study|To Enter an Extension Study|4|||
163401366|NCT03719690|590181137|FG000|Overall Study|Miscellaneous|12|||
163209759|NCT03720470|589482955|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
163209760|NCT03720470|589482956|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
163209761|NCT03720470|589482957|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
163209762|NCT03720470|589482958|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
163209763|NCT03720470|589482959|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
163209764|NCT03720470|589482954|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
163209765|NCT03720470|589482955|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
163209766|NCT03720470|589482956|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
163209767|NCT03720470|589482957|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
163209768|NCT03720470|589482958|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
163209769|NCT03720470|589482959|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
163209770|NCT03720470|589482954|FG000|Treatment Period: Final 4 Weeks|Other|0|||
163209771|NCT03720470|589482955|FG001|Treatment Period: Final 4 Weeks|Other|1|||
163209772|NCT03720470|589482956|FG002|Treatment Period: Final 4 Weeks|Other|0|||
162976739|NCT01833533|588615457|FG000|Overall Study|Other|2|||
162976740|NCT01833533|588615458|FG001|Overall Study|Other|7|||
162976741|NCT02017860|588615459|FG000|Overall Study|Adverse Event|1|||
162976742|NCT02017860|588615459|FG000|Overall Study|Withdrawal by Subject|1|||
163209773|NCT03720470|589482957|FG003|Treatment Period: Final 4 Weeks|Other|2|||
163209774|NCT03720470|589482958|FG004|Treatment Period: Final 4 Weeks|Other|1|||
163209775|NCT03720470|589482959|FG005|Treatment Period: Final 4 Weeks|Other|0|||
162976743|NCT01048502|588615462|FG000|Overall Study|Lost to Follow-up|2|||
162976744|NCT01048502|588615463|FG001|Overall Study|Lost to Follow-up|0|||
162976745|NCT01048502|588615464|FG002|Overall Study|Lost to Follow-up|0|||
162976746|NCT01048502|588615465|FG003|Overall Study|Lost to Follow-up|0|||
162976747|NCT01048502|588615462|FG000|Overall Study|Adverse Event|1|||
162976748|NCT01048502|588615463|FG001|Overall Study|Adverse Event|0|||
162976749|NCT01048502|588615464|FG002|Overall Study|Adverse Event|0|||
162976750|NCT01048502|588615465|FG003|Overall Study|Adverse Event|0|||
163209776|NCT01988103|589482960|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
162976751|NCT01048502|588615462|FG000|Overall Study|Withdrawal by Subject|1|||
162976752|NCT01048502|588615463|FG001|Overall Study|Withdrawal by Subject|4|||
162976753|NCT01048502|588615464|FG002|Overall Study|Withdrawal by Subject|5|||
162976754|NCT01048502|588615465|FG003|Overall Study|Withdrawal by Subject|3|||
162976755|NCT01048502|588615462|FG000|Overall Study|Physician Decision|0|||
162976756|NCT01048502|588615463|FG001|Overall Study|Physician Decision|3|||
162976757|NCT01048502|588615464|FG002|Overall Study|Physician Decision|0|||
162976758|NCT01048502|588615465|FG003|Overall Study|Physician Decision|1|||
162976759|NCT01463982|588615467|FG000|Overall Study|Withdrawal by Subject|0|||
162976760|NCT01463982|588615468|FG001|Overall Study|Withdrawal by Subject|1|||
162976761|NCT01463982|588615469|FG002|Overall Study|Withdrawal by Subject|1|||
162976762|NCT01463982|588615470|FG003|Overall Study|Withdrawal by Subject|0|||
162976763|NCT01463982|588615467|FG000|Overall Study|Treatment delay over 5 week|0|||
162976764|NCT01463982|588615468|FG001|Overall Study|Treatment delay over 5 week|0|||
162976765|NCT01463982|588615469|FG002|Overall Study|Treatment delay over 5 week|1|||
162976766|NCT01463982|588615470|FG003|Overall Study|Treatment delay over 5 week|0|||
162976767|NCT04668274|588615471|FG000|Part 1 Study Period 1|Adverse Event|3|||
162976768|NCT04668274|588615472|FG001|Part 1 Study Period 1|Adverse Event|0|||
162976769|NCT04668274|588615473|FG002|Part 1 Study Period 1|Adverse Event|0|||
162976770|NCT04668274|588615474|FG003|Part 1 Study Period 1|Adverse Event|0|||
162976771|NCT04668274|588615471|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
162976772|NCT04668274|588615472|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
162976773|NCT04668274|588615473|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
162976774|NCT04668274|588615474|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
162976775|NCT04668274|588615471|FG000|Part 1 Study Period 2|Other|0|||
162976776|NCT04668274|588615472|FG001|Part 1 Study Period 2|Other|1|||
162976777|NCT04668274|588615473|FG002|Part 1 Study Period 2|Other|0|||
162976778|NCT04668274|588615474|FG003|Part 1 Study Period 2|Other|0|||
162976779|NCT04668274|588615471|FG000|Part 1 Study Period 3|Adverse Event|0|||
162976780|NCT04668274|588615472|FG001|Part 1 Study Period 3|Adverse Event|0|||
162976781|NCT04668274|588615473|FG002|Part 1 Study Period 3|Adverse Event|1|||
162976782|NCT04668274|588615474|FG003|Part 1 Study Period 3|Adverse Event|0|||
162976783|NCT04668274|588615471|FG000|Part 1 Study Period 3|Other|0|||
163209777|NCT01988103|589482961|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
163209778|NCT01988103|589482962|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
163209779|NCT01988103|589482963|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
162976784|NCT04668274|588615472|FG001|Part 1 Study Period 3|Other|0|||
162976785|NCT04668274|588615473|FG002|Part 1 Study Period 3|Other|2|||
162976786|NCT04668274|588615474|FG003|Part 1 Study Period 3|Other|0|||
162976787|NCT04668274|588615471|FG000|Part 2 Study Period 4|Other|0|||
162976788|NCT04668274|588615472|FG001|Part 2 Study Period 4|Other|0|||
163209780|NCT01988103|589482964|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
162976789|NCT04668274|588615473|FG002|Part 2 Study Period 4|Other|0|||
162976790|NCT04668274|588615474|FG003|Part 2 Study Period 4|Other|1|||
162976791|NCT00467831|588615479|FG000|Overall Study|Death|2|||
162976792|NCT00467831|588615479|FG000|Overall Study|Withdrawal by Subject|1|||
162976793|NCT01832402|588615482|FG000|Overall Study|Lost to Follow-up|2|||
162976794|NCT01832402|588615483|FG001|Overall Study|Lost to Follow-up|0|||
162976795|NCT01832402|588615482|FG000|Overall Study|Withdrawal by Subject|3|||
162976796|NCT01832402|588615483|FG001|Overall Study|Withdrawal by Subject|3|||
162976797|NCT01832402|588615482|FG000|Overall Study|Declining Performance status|2|||
162976798|NCT01832402|588615483|FG001|Overall Study|Declining Performance status|1|||
162976799|NCT01198873|588615484|FG000|Overall Study|Adverse Event|4|||
162976800|NCT01198873|588615485|FG001|Overall Study|Adverse Event|7|||
162976801|NCT01198873|588615484|FG000|Overall Study|Study closure|29|||
162976802|NCT01198873|588615485|FG001|Overall Study|Study closure|23|||
162976803|NCT01198873|588615484|FG000|Overall Study|Other than above|4|||
162976804|NCT01198873|588615485|FG001|Overall Study|Other than above|2|||
162976805|NCT00895037|588615494|FG000|Overall Study|Death|0|||
162976806|NCT00895037|588615495|FG001|Overall Study|Death|2|||
162976807|NCT00895037|588615496|FG002|Overall Study|Death|1|||
162976808|NCT01930175|588615506|FG000|Core Study|Lost to Follow-up|0|||
162976809|NCT01930175|588615507|FG001|Core Study|Lost to Follow-up|1|||
162976810|NCT01930175|588615508|FG002|Core Study|Lost to Follow-up|0|||
162976811|NCT01930175|588615506|FG000|Core Study|Adverse Event|0|||
162976812|NCT01930175|588615507|FG001|Core Study|Adverse Event|0|||
162976813|NCT01930175|588615508|FG002|Core Study|Adverse Event|1|||
162976814|NCT02820740|588615509|FG000|Overall Study|Did not have procedure|2|||
162976815|NCT00890552|588615510|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
162976816|NCT00890552|588615510|FG000|On-treatment|Early prog disease/ death|10|||
162976817|NCT04965389|588615511|FG000|Overall Study|Other reasons|1|||
162976818|NCT04965389|588615512|FG001|Overall Study|Other reasons|0|||
162976819|NCT04965389|588615513|FG002|Overall Study|Other reasons|0|||
162976820|NCT04965389|588615514|FG003|Overall Study|Other reasons|0|||
162976821|NCT04965389|588615511|FG000|Overall Study|Participant withdrew consent|0|||
162976822|NCT04965389|588615512|FG001|Overall Study|Participant withdrew consent|1|||
162976823|NCT04965389|588615513|FG002|Overall Study|Participant withdrew consent|0|||
162976824|NCT04965389|588615514|FG003|Overall Study|Participant withdrew consent|0|||
162976825|NCT04965389|588615511|FG000|Overall Study|Poor/Non-compliance|0|||
162976826|NCT04965389|588615512|FG001|Overall Study|Poor/Non-compliance|1|||
162976827|NCT04965389|588615513|FG002|Overall Study|Poor/Non-compliance|0|||
162976828|NCT04965389|588615514|FG003|Overall Study|Poor/Non-compliance|0|||
162976829|NCT03903159|588615515|FG000|Overall Study|Discharged with Staff Approval|2|||
162976830|NCT03903159|588615515|FG000|Overall Study|Discharged at Staff Request|2|||
162976831|NCT03903159|588615515|FG000|Overall Study|Discharged Against Staff Advice|1|||
162976832|NCT01436643|588615518|FG000|2-week Pre-treatment|Abnormal test result|0|||
162976833|NCT01436643|588615519|FG001|2-week Pre-treatment|Abnormal test result|0|||
162976834|NCT01436643|588615520|FG002|2-week Pre-treatment|Abnormal test result|0|||
162976835|NCT01436643|588615521|FG003|2-week Pre-treatment|Abnormal test result|1|||
162976836|NCT01436643|588615518|FG000|2-week Pre-treatment|Adverse Event|0|||
162976837|NCT01436643|588615519|FG001|2-week Pre-treatment|Adverse Event|0|||
162976838|NCT01436643|588615520|FG002|2-week Pre-treatment|Adverse Event|0|||
162976839|NCT01436643|588615521|FG003|2-week Pre-treatment|Adverse Event|5|||
162976840|NCT01436643|588615518|FG000|2-week Pre-treatment|Protocol Violation|0|||
162976841|NCT01436643|588615519|FG001|2-week Pre-treatment|Protocol Violation|0|||
162976842|NCT01436643|588615520|FG002|2-week Pre-treatment|Protocol Violation|0|||
162976843|NCT01436643|588615521|FG003|2-week Pre-treatment|Protocol Violation|4|||
162976844|NCT01436643|588615518|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
162976845|NCT01436643|588615519|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
162976846|NCT01436643|588615520|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
162976847|NCT01436643|588615521|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
162976848|NCT01436643|588615518|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
162976849|NCT01436643|588615519|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
162976850|NCT01436643|588615520|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
162976851|NCT01436643|588615521|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
162976852|NCT01436643|588615518|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
162976853|NCT01436643|588615519|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
162976854|NCT01436643|588615520|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
162976855|NCT01436643|588615521|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
163057714|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
162976856|NCT01382251|588615522|FG000|Overall Study|Surgeries cancelled or delayed|16|||
162976857|NCT01382251|588615523|FG001|Overall Study|Surgeries cancelled or delayed|16|||
162976858|NCT01382251|588615522|FG000|Overall Study|Lost to Follow-up|4|||
162976859|NCT01382251|588615523|FG001|Overall Study|Lost to Follow-up|4|||
162976860|NCT01382251|588615522|FG000|Overall Study|Contacted after study closed|1|||
162976861|NCT01382251|588615523|FG001|Overall Study|Contacted after study closed|1|||
162976862|NCT01117987|588615524|FG000|Overall Study|Protocol deviation|0|||
162976863|NCT01117987|588615525|FG001|Overall Study|Protocol deviation|1|||
162976864|NCT01117987|588615524|FG000|Overall Study|Subject no longer requires study drug|1|||
162976865|NCT01117987|588615525|FG001|Overall Study|Subject no longer requires study drug|0|||
162976866|NCT01117987|588615524|FG000|Overall Study|Lost to Follow-up|1|||
163057715|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
163057716|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
163057717|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
163057718|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
163057719|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
163057720|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
163057721|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
163057722|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057723|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057724|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057725|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057726|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057727|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057728|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057729|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057730|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
163057731|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
163057732|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057733|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057734|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057735|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057736|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057737|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057738|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057739|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057740|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
163057741|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
163057742|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057743|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057744|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057745|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057746|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057747|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057748|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057749|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057750|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
163057751|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
162976867|NCT01117987|588615525|FG001|Overall Study|Lost to Follow-up|1|||
162976868|NCT01117987|588615524|FG000|Overall Study|Abnormal test procedure result|2|||
162976869|NCT01117987|588615525|FG001|Overall Study|Abnormal test procedure result|0|||
162976870|NCT01117987|588615524|FG000|Overall Study|Lack of Efficacy|3|||
162976871|NCT01117987|588615525|FG001|Overall Study|Lack of Efficacy|4|||
162976872|NCT01117987|588615524|FG000|Overall Study|Death|5|||
162976873|NCT01117987|588615525|FG001|Overall Study|Death|10|||
162976874|NCT01117987|588615524|FG000|Overall Study|Withdrawal by Subject|5|||
163057752|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057753|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057754|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057755|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057756|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057757|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057758|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057759|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057760|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
163057761|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
163057762|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
163057763|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
163057764|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
162976875|NCT01117987|588615525|FG001|Overall Study|Withdrawal by Subject|10|||
162976876|NCT01117987|588615524|FG000|Overall Study|Adverse Event|19|||
162976877|NCT01117987|588615525|FG001|Overall Study|Adverse Event|26|||
162976878|NCT01117987|588615524|FG000|Overall Study|Administrative problems|25|||
163057765|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
162976879|NCT01117987|588615525|FG001|Overall Study|Administrative problems|22|||
162976880|NCT00702208|588615531|FG000|Overall Study|Lost to Follow-up|28|||
162976881|NCT00702208|588615531|FG000|Overall Study|Did not self-lavage|1|||
162976882|NCT00702208|588615531|FG000|Overall Study|Unsatisfactory colposcopy|2|||
162976883|NCT00562120|588615532|FG000|First Intervention Period|Adverse Event|1|||
162976884|NCT00562120|588615533|FG001|First Intervention Period|Adverse Event|0|||
162976885|NCT00562120|588615534|FG002|First Intervention Period|Adverse Event|0|||
162976886|NCT00562120|588615535|FG003|First Intervention Period|Adverse Event|0|||
162976887|NCT00562120|588615532|FG000|First Intervention Period|Randomized but not Treated|1|||
162976888|NCT00562120|588615533|FG001|First Intervention Period|Randomized but not Treated|0|||
162976889|NCT00562120|588615534|FG002|First Intervention Period|Randomized but not Treated|0|||
162976890|NCT00562120|588615535|FG003|First Intervention Period|Randomized but not Treated|0|||
162976891|NCT02148445|588615536|FG000|Overall Study|Death|1|||
162976892|NCT02148445|588615537|FG001|Overall Study|Death|3|||
162976893|NCT03450629|588615538|FG000|Overall Study|Adverse Event|15|||
162976894|NCT03450629|588615539|FG001|Overall Study|Adverse Event|14|||
162976895|NCT03450629|588615538|FG000|Overall Study|Physician Decision|2|||
162976896|NCT03450629|588615539|FG001|Overall Study|Physician Decision|2|||
162976897|NCT03450629|588615538|FG000|Overall Study|Lack of Efficacy|2|||
162976898|NCT03450629|588615539|FG001|Overall Study|Lack of Efficacy|0|||
162976899|NCT03450629|588615538|FG000|Overall Study|Lost to Follow-up|4|||
162976900|NCT03450629|588615539|FG001|Overall Study|Lost to Follow-up|2|||
162976901|NCT03450629|588615538|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
162976902|NCT03450629|588615539|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
162976903|NCT03450629|588615538|FG000|Overall Study|Non-Compliance With Study Drug|2|||
162976904|NCT03450629|588615539|FG001|Overall Study|Non-Compliance With Study Drug|1|||
162976905|NCT03450629|588615538|FG000|Overall Study|Protocol Violation|11|||
162976906|NCT03450629|588615539|FG001|Overall Study|Protocol Violation|8|||
162976907|NCT03450629|588615538|FG000|Overall Study|Withdrawal by Subject|12|||
162976908|NCT03450629|588615539|FG001|Overall Study|Withdrawal by Subject|6|||
162976909|NCT03366194|588615540|FG000|Overall Study|Lost to Follow-up|2|||
162976910|NCT02093923|588615541|FG000|Overall Study|Lost to Follow-up|0|||
162976911|NCT02093923|588615542|FG001|Overall Study|Lost to Follow-up|0|||
162976912|NCT02093923|588615543|FG002|Overall Study|Lost to Follow-up|0|||
162976913|NCT02093923|588615544|FG003|Overall Study|Lost to Follow-up|1|||
162976914|NCT02093923|588615545|FG004|Overall Study|Lost to Follow-up|0|||
162976915|NCT02093923|588615541|FG000|Overall Study|Screen failure after randomization|0|||
163057766|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
163057767|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
163209781|NCT01988103|589482960|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
162976916|NCT02093923|588615542|FG001|Overall Study|Screen failure after randomization|0|||
162976917|NCT02093923|588615543|FG002|Overall Study|Screen failure after randomization|0|||
162976918|NCT02093923|588615544|FG003|Overall Study|Screen failure after randomization|1|||
162976919|NCT02093923|588615545|FG004|Overall Study|Screen failure after randomization|0|||
162976920|NCT03438006|588615546|FG000|Overall Study|Adverse Event|1|||
162976921|NCT03438006|588615546|FG000|Overall Study|Lost to Follow-up|67|||
163209782|NCT01988103|589482961|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
162976922|NCT03438006|588615546|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
163209783|NCT01988103|589482962|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
163209784|NCT01988103|589482963|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
163209785|NCT01988103|589482964|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
163209786|NCT01988103|589482960|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
163209787|NCT01988103|589482961|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
163209788|NCT01988103|589482962|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
163209789|NCT01988103|589482963|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
163209790|NCT01988103|589482964|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
163209791|NCT01988103|589482960|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
163209792|NCT01988103|589482961|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
163209793|NCT01988103|589482962|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
163209794|NCT01988103|589482963|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
163209795|NCT01988103|589482964|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
163209796|NCT01988103|589482960|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
163209797|NCT01988103|589482961|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
163209798|NCT01988103|589482962|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
163209799|NCT01988103|589482963|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
163209800|NCT01988103|589482964|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
163209801|NCT01988103|589482960|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
163209802|NCT01988103|589482961|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
163209803|NCT01988103|589482962|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
163209804|NCT01988103|589482963|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
163209805|NCT01988103|589482964|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
163209806|NCT01988103|589482960|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
163209807|NCT01988103|589482961|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
163209808|NCT01988103|589482962|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
163209809|NCT01988103|589482963|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
163209810|NCT01988103|589482964|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
163209811|NCT01946425|589482966|FG000|Overall Study|Protocol Violation|1|||
163209812|NCT01946425|589482967|FG001|Overall Study|Protocol Violation|0|||
163209813|NCT01946425|589482966|FG000|Overall Study|Withdrawal by Subject|1|||
163209814|NCT01946425|589482967|FG001|Overall Study|Withdrawal by Subject|0|||
163209815|NCT05682326|589482971|FG000|Overall Study|Withdrawal by Subject|1|||
163209816|NCT05682326|589482972|FG001|Overall Study|Withdrawal by Subject|0|||
163209817|NCT01402544|589482973|FG000|Overall Study|Withdrawal by Subject|6|||
163209818|NCT01113801|589482974|FG000|Overall Study|Adverse Event|4|||
163209819|NCT01113801|589482975|FG001|Overall Study|Adverse Event|0|||
163209820|NCT01113801|589482976|FG002|Overall Study|Adverse Event|2|||
163209821|NCT01113801|589482977|FG003|Overall Study|Adverse Event|6|||
163209822|NCT01113801|589482974|FG000|Overall Study|Death|4|||
163209823|NCT01113801|589482975|FG001|Overall Study|Death|5|||
163401367|NCT03719690|590181138|FG001|Overall Study|Miscellaneous|56|||
163401368|NCT03719690|590181137|FG000|Overall Study|Lost to Follow-up|2|||
162976923|NCT03438006|588615546|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
162976924|NCT01181531|588615547|FG000|Overall Study|Other|17|||
162976925|NCT01181531|588615548|FG001|Overall Study|Other|12|||
162976926|NCT01181531|588615547|FG000|Overall Study|Partial consent by subject withdrawn|0|||
162976927|NCT01181531|588615548|FG001|Overall Study|Partial consent by subject withdrawn|1|||
162976928|NCT01181531|588615547|FG000|Overall Study|Physician Decision|3|||
162976929|NCT01181531|588615548|FG001|Overall Study|Physician Decision|1|||
162976930|NCT01181531|588615547|FG000|Overall Study|Noncompliance|2|||
162976931|NCT01181531|588615548|FG001|Overall Study|Noncompliance|2|||
162976932|NCT01181531|588615547|FG000|Overall Study|Ineligibility determined|1|||
162976933|NCT01181531|588615548|FG001|Overall Study|Ineligibility determined|2|||
162976934|NCT01181531|588615547|FG000|Overall Study|Protocol Specified Criteria|15|||
162976935|NCT01181531|588615548|FG001|Overall Study|Protocol Specified Criteria|8|||
162976936|NCT01181531|588615547|FG000|Overall Study|Pregnancy|0|||
162976937|NCT01181531|588615548|FG001|Overall Study|Pregnancy|1|||
162976938|NCT01181531|588615547|FG000|Overall Study|Withdrawal by Subject|8|||
162976939|NCT01181531|588615548|FG001|Overall Study|Withdrawal by Subject|7|||
163401369|NCT03719690|590181138|FG001|Overall Study|Lost to Follow-up|18|||
163401370|NCT03719690|590181137|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
162976940|NCT01181531|588615547|FG000|Overall Study|Protocol Violation|6|||
162976941|NCT01181531|588615548|FG001|Overall Study|Protocol Violation|6|||
162976942|NCT01181531|588615547|FG000|Overall Study|Death|9|||
162976943|NCT01181531|588615548|FG001|Overall Study|Death|12|||
162976944|NCT01181531|588615547|FG000|Overall Study|Adverse Event|0|||
162976945|NCT01181531|588615548|FG001|Overall Study|Adverse Event|1|||
162976946|NCT02737592|588615549|FG000|Overall Study|Withdrawal by Subject|1|||
162976947|NCT00955721|588615550|FG000|Overall Study|Physician Decision|1|||
163209824|NCT01113801|589482976|FG002|Overall Study|Death|3|||
163209825|NCT01113801|589482977|FG003|Overall Study|Death|4|||
163209826|NCT01113801|589482974|FG000|Overall Study|Protocol Violation|0|||
163209827|NCT01113801|589482975|FG001|Overall Study|Protocol Violation|1|||
163209828|NCT01113801|589482976|FG002|Overall Study|Protocol Violation|0|||
163209829|NCT01113801|589482977|FG003|Overall Study|Protocol Violation|0|||
163209830|NCT01113801|589482974|FG000|Overall Study|Withdrawal by Subject|9|||
163209831|NCT01113801|589482975|FG001|Overall Study|Withdrawal by Subject|7|||
163209832|NCT01113801|589482976|FG002|Overall Study|Withdrawal by Subject|7|||
163209833|NCT01113801|589482977|FG003|Overall Study|Withdrawal by Subject|8|||
163209834|NCT01113801|589482974|FG000|Overall Study|Physician Decision|2|||
163209835|NCT01113801|589482975|FG001|Overall Study|Physician Decision|2|||
163209836|NCT01113801|589482976|FG002|Overall Study|Physician Decision|3|||
163209837|NCT01113801|589482977|FG003|Overall Study|Physician Decision|3|||
163209838|NCT01113801|589482974|FG000|Overall Study|Sponsor Decision|15|||
163209839|NCT01113801|589482975|FG001|Overall Study|Sponsor Decision|21|||
163209840|NCT01113801|589482976|FG002|Overall Study|Sponsor Decision|20|||
163209841|NCT01113801|589482977|FG003|Overall Study|Sponsor Decision|15|||
163209842|NCT01113801|589482974|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
163209843|NCT01113801|589482975|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
163209844|NCT01113801|589482976|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
163209845|NCT01113801|589482977|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
163209846|NCT01949051|589482981|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
163209847|NCT01949051|589482982|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
163209848|NCT01949051|589482983|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
163209849|NCT01949051|589482984|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
163209850|NCT01949051|589482985|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
163209851|NCT01949051|589482986|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
163209852|NCT01949051|589482981|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
163209853|NCT01949051|589482982|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163209854|NCT01949051|589482983|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163209855|NCT01949051|589482984|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163209856|NCT01949051|589482985|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163209857|NCT01949051|589482986|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163209858|NCT01949051|589482981|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
163209859|NCT01949051|589482982|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
163209860|NCT01949051|589482983|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
163209861|NCT01949051|589482984|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
163209862|NCT01949051|589482985|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
163209863|NCT01949051|589482986|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
163209864|NCT01949051|589482981|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
163209865|NCT01949051|589482982|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
163209866|NCT01949051|589482983|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
163209867|NCT01949051|589482984|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
163209868|NCT01949051|589482985|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
163209869|NCT01949051|589482986|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
163209870|NCT01949051|589482981|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
163209871|NCT01949051|589482982|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
163209872|NCT01949051|589482983|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
163209873|NCT01949051|589482984|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
163209874|NCT01949051|589482985|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
163209875|NCT01949051|589482986|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
163209876|NCT04545866|589482988|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
163209877|NCT04545866|589482989|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
163209878|NCT04545866|589482988|FG000|Overall Study|Withdrawal by Physician|1|||
163318072|NCT01928394|589874957|FG011|Follow-up Period|Lost to Follow-up|1|||
163318073|NCT01928394|589874958|FG012|Follow-up Period|Lost to Follow-up|1|||
163318074|NCT01928394|589874959|FG013|Follow-up Period|Lost to Follow-up|0|||
163318075|NCT01928394|589874960|FG014|Follow-up Period|Lost to Follow-up|1|||
163318076|NCT01928394|589874961|FG015|Follow-up Period|Lost to Follow-up|0|||
163209879|NCT04545866|589482989|FG001|Overall Study|Withdrawal by Physician|0|||
163209880|NCT02436356|589482992|FG000|Overall Study|Excluded by MRI Screening|0|||
163209881|NCT02436356|589482993|FG001|Overall Study|Excluded by MRI Screening|0|||
163209882|NCT02436356|589482994|FG002|Overall Study|Excluded by MRI Screening|2|||
163209883|NCT02436356|589482992|FG000|Overall Study|Lost to Follow-up|0|||
163209884|NCT02436356|589482993|FG001|Overall Study|Lost to Follow-up|1|||
163209885|NCT02436356|589482994|FG002|Overall Study|Lost to Follow-up|0|||
163209886|NCT02436356|589482992|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
163209887|NCT02436356|589482993|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
163209888|NCT02436356|589482994|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
163209889|NCT02436356|589482992|FG000|Overall Study|Excluded due to other medical conditions|3|||
163209890|NCT02436356|589482993|FG001|Overall Study|Excluded due to other medical conditions|0|||
163209891|NCT02436356|589482994|FG002|Overall Study|Excluded due to other medical conditions|0|||
163057768|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
163057769|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
163057770|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
163057771|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
163057772|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057773|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057774|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057775|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057776|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057777|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057778|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057779|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057780|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
163057781|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057782|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057783|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057784|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057785|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057786|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057787|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057788|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057789|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057790|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
163057791|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
163057792|NCT02404545|588921315|FG000|Overall Study|Sponsor Termination|6|||
163057793|NCT02404545|588921316|FG001|Overall Study|Sponsor Termination|6|||
163057794|NCT00855218|588921319|FG000|Overall Study|Adverse Event|43|||
163057795|NCT00855218|588921320|FG001|Overall Study|Adverse Event|27|||
163057796|NCT00855218|588921319|FG000|Overall Study|Withdrawal by Subject|10|||
163057797|NCT00855218|588921320|FG001|Overall Study|Withdrawal by Subject|6|||
163057798|NCT00855218|588921319|FG000|Overall Study|Physician Decision|18|||
163057799|NCT00855218|588921320|FG001|Overall Study|Physician Decision|11|||
163057800|NCT00855218|588921319|FG000|Overall Study|Lost to Follow-up|0|||
163057801|NCT00855218|588921320|FG001|Overall Study|Lost to Follow-up|1|||
163057802|NCT00855218|588921319|FG000|Overall Study|Protocol Violation|5|||
163057803|NCT00855218|588921320|FG001|Overall Study|Protocol Violation|9|||
163057804|NCT00855218|588921319|FG000|Overall Study|non-compliant with study drug|3|||
163057805|NCT00855218|588921320|FG001|Overall Study|non-compliant with study drug|1|||
163057806|NCT00855218|588921319|FG000|Overall Study|patient convenience|2|||
163057807|NCT00855218|588921320|FG001|Overall Study|patient convenience|0|||
163057808|NCT00855218|588921319|FG000|Overall Study|technical problems|2|||
163057809|NCT00855218|588921320|FG001|Overall Study|technical problems|1|||
163057810|NCT00855218|588921319|FG000|Overall Study|Still treated with study medication|0|||
163057811|NCT00855218|588921320|FG001|Overall Study|Still treated with study medication|1|||
163057812|NCT00855218|588921319|FG000|Overall Study|Untreatable disease progression|54|||
163057813|NCT00855218|588921320|FG001|Overall Study|Untreatable disease progression|67|||
163057814|NCT00855218|588921319|FG000|Overall Study|Second malignancy|0|||
163057815|NCT00855218|588921320|FG001|Overall Study|Second malignancy|1|||
163057816|NCT00855218|588921319|FG000|Overall Study|Progression measurement proven|7|||
163057817|NCT00855218|588921320|FG001|Overall Study|Progression measurement proven|15|||
163057818|NCT00855218|588921319|FG000|Overall Study|Clinical endpoint reached|10|||
163057819|NCT00855218|588921320|FG001|Overall Study|Clinical endpoint reached|13|||
163057820|NCT03824561|588921328|FG000|Overall Study|Protocol Violation|19|||
163057821|NCT05117060|588921334|FG000|Overall Study|Adverse Event|3|||
163057822|NCT05117060|588921335|FG001|Overall Study|Adverse Event|5|||
163057823|NCT05117060|588921336|FG002|Overall Study|Adverse Event|6|||
163057824|NCT05117060|588921337|FG003|Overall Study|Adverse Event|1|||
163057825|NCT05117060|588921334|FG000|Overall Study|Lost to Follow-up|0|||
163057826|NCT05117060|588921335|FG001|Overall Study|Lost to Follow-up|0|||
163057827|NCT05117060|588921336|FG002|Overall Study|Lost to Follow-up|0|||
163057828|NCT05117060|588921337|FG003|Overall Study|Lost to Follow-up|1|||
163057829|NCT05117060|588921334|FG000|Overall Study|Lack of Efficacy|4|||
163057830|NCT05117060|588921335|FG001|Overall Study|Lack of Efficacy|5|||
163057831|NCT05117060|588921336|FG002|Overall Study|Lack of Efficacy|2|||
163057832|NCT05117060|588921337|FG003|Overall Study|Lack of Efficacy|6|||
163057833|NCT05117060|588921334|FG000|Overall Study|Withdrawal by Subject|8|||
163057834|NCT05117060|588921335|FG001|Overall Study|Withdrawal by Subject|5|||
163057835|NCT05117060|588921336|FG002|Overall Study|Withdrawal by Subject|5|||
163057836|NCT05117060|588921337|FG003|Overall Study|Withdrawal by Subject|6|||
163057837|NCT05117060|588921334|FG000|Overall Study|Other|2|||
163057838|NCT05117060|588921335|FG001|Overall Study|Other|1|||
163057839|NCT05117060|588921336|FG002|Overall Study|Other|3|||
163057840|NCT05117060|588921337|FG003|Overall Study|Other|1|||
163318077|NCT01928394|589874962|FG016|Follow-up Period|Lost to Follow-up|1|||
163318078|NCT01928394|589874963|FG017|Follow-up Period|Lost to Follow-up|0|||
163318079|NCT01928394|589874964|FG018|Follow-up Period|Lost to Follow-up|0|||
162976948|NCT00955721|588615551|FG001|Overall Study|Physician Decision|0|||
162976949|NCT00955721|588615550|FG000|Overall Study|Death|1|||
162976950|NCT00955721|588615551|FG001|Overall Study|Death|0|||
162976951|NCT00955721|588615550|FG000|Overall Study|Withdrawal by Subject|1|||
162976952|NCT00955721|588615551|FG001|Overall Study|Withdrawal by Subject|0|||
162976953|NCT04034355|588615566|FG000|Overall Study|Study terminated by Sponsor|10|||
162976954|NCT04034355|588615567|FG001|Overall Study|Study terminated by Sponsor|17|||
162976955|NCT04034355|588615566|FG000|Overall Study|Withdrawal by Subject|12|||
162976956|NCT04034355|588615567|FG001|Overall Study|Withdrawal by Subject|11|||
162976957|NCT04034355|588615566|FG000|Overall Study|Site terminated by Sponsor|4|||
162976958|NCT04034355|588615567|FG001|Overall Study|Site terminated by Sponsor|5|||
162976959|NCT04034355|588615566|FG000|Overall Study|Adverse Event|2|||
162976960|NCT04034355|588615567|FG001|Overall Study|Adverse Event|0|||
162976961|NCT04034355|588615566|FG000|Overall Study|Death|1|||
162976962|NCT04034355|588615567|FG001|Overall Study|Death|1|||
162976963|NCT04034355|588615566|FG000|Overall Study|Not reported|2|||
162976964|NCT04034355|588615567|FG001|Overall Study|Not reported|0|||
162976965|NCT04034355|588615566|FG000|Overall Study|Lost to Follow-up|1|||
162976966|NCT04034355|588615567|FG001|Overall Study|Lost to Follow-up|0|||
162976967|NCT04034355|588615566|FG000|Overall Study|Physician Decision|1|||
162976968|NCT04034355|588615567|FG001|Overall Study|Physician Decision|0|||
162976969|NCT04034355|588615566|FG000|Overall Study|Protocol Violation|0|||
162976970|NCT04034355|588615567|FG001|Overall Study|Protocol Violation|1|||
162976971|NCT04034355|588615566|FG000|Overall Study|Progressive disease|1|||
162976972|NCT04034355|588615567|FG001|Overall Study|Progressive disease|0|||
162976973|NCT04678817|588616541|FG000|Overall Study|Lost to Follow-up|28|||
162976974|NCT04678817|588616542|FG001|Overall Study|Lost to Follow-up|0|||
162976975|NCT04678817|588616543|FG002|Overall Study|Lost to Follow-up|0|||
162976976|NCT03064438|588616546|FG000|Overall Study|Lost to Follow-up|1|||
162976977|NCT03064438|588616547|FG001|Overall Study|Lost to Follow-up|0|||
162976978|NCT03064438|588616546|FG000|Overall Study|Withdrawal by Subject|0|||
162976979|NCT03064438|588616547|FG001|Overall Study|Withdrawal by Subject|1|||
162976980|NCT01937351|588616548|FG000|Overall Study|Withdrawal by Subject|4|||
162976981|NCT01937351|588616549|FG001|Overall Study|Withdrawal by Subject|2|||
162976982|NCT01937351|588616548|FG000|Overall Study|Death|1|||
162976983|NCT01937351|588616549|FG001|Overall Study|Death|0|||
162976984|NCT01937351|588616548|FG000|Overall Study|Not treated w device, per protocol fail|4|||
162976985|NCT01937351|588616549|FG001|Overall Study|Not treated w device, per protocol fail|0|||
162976986|NCT01961687|588616550|FG000|Overall Study|Lost to Follow-up|19|||
162976987|NCT01961687|588616550|FG000|Overall Study|Re-operation|17|||
162976988|NCT01961687|588616550|FG000|Overall Study|Death|7|||
162976989|NCT01961687|588616550|FG000|Overall Study|Withdrawal by Subject|6|||
162976990|NCT01961687|588616550|FG000|Overall Study|Adverse Event|6|||
162976991|NCT01961687|588616550|FG000|Overall Study|Moved to area without study site|2|||
162976992|NCT01961687|588616550|FG000|Overall Study|Sponsor decision|2|||
162976993|NCT01961687|588616550|FG000|Overall Study|Physician Decision|1|||
162976994|NCT01961687|588616550|FG000|Overall Study|Unable to meet follow-up requirements|1|||
162976995|NCT00614926|588616557|FG000|Overall Study|Burden of travel|1|||
162976996|NCT00614926|588616558|FG001|Overall Study|Burden of travel|0|||
162976997|NCT00614926|588616557|FG000|Overall Study|Adverse Event|3|||
162976998|NCT00614926|588616558|FG001|Overall Study|Adverse Event|0|||
162976999|NCT02999984|588616563|FG000|Overall Study|Treatment Failure|1|||
162977000|NCT00754013|588616567|FG000|Overall Study|Lost to Follow-up|1|||
162977001|NCT00754013|588616568|FG001|Overall Study|Lost to Follow-up|1|||
162977002|NCT00754013|588616567|FG000|Overall Study|didn't return after study termed|3|||
162977003|NCT00754013|588616568|FG001|Overall Study|didn't return after study termed|4|||
162977004|NCT02310789|588616569|FG000|Overall Study|Adverse Event|1|||
163318080|NCT01928394|589874965|FG019|Follow-up Period|Lost to Follow-up|0|||
163318081|NCT01928394|589874966|FG020|Follow-up Period|Lost to Follow-up|0|||
163318082|NCT01928394|589874967|FG021|Follow-up Period|Lost to Follow-up|0|||
163318083|NCT01928394|589874968|FG022|Follow-up Period|Lost to Follow-up|1|||
162977005|NCT01197417|588616573|FG000|Overall Study|Physician Decision|3|||
162977006|NCT01197417|588616574|FG001|Overall Study|Physician Decision|2|||
162977007|NCT01197417|588616573|FG000|Overall Study|Withdrawal by Subject|2|||
162977008|NCT01197417|588616574|FG001|Overall Study|Withdrawal by Subject|4|||
162977009|NCT01197417|588616573|FG000|Overall Study|Site miscommunication|0|||
162977010|NCT01197417|588616574|FG001|Overall Study|Site miscommunication|1|||
162977011|NCT01197417|588616573|FG000|Overall Study|Subject transferred to intensive care|0|||
163318084|NCT00321048|589874969|FG000|Overall Study|Withdrawal by Subject|6|||
162977012|NCT01197417|588616574|FG001|Overall Study|Subject transferred to intensive care|1|||
162977013|NCT01197417|588616573|FG000|Overall Study|Not consented in time to receive drug|0|||
162977014|NCT01197417|588616574|FG001|Overall Study|Not consented in time to receive drug|1|||
162977015|NCT01197417|588616573|FG000|Overall Study|Hypotension|1|||
162977016|NCT01197417|588616574|FG001|Overall Study|Hypotension|2|||
162977017|NCT01197417|588616573|FG000|Overall Study|Found to be ineligible|2|||
163057841|NCT03141359|588921338|FG000|Overall Study|Death|32|||
163057842|NCT03141359|588921338|FG000|Overall Study|Still On Study (in follow up)|29|||
163057843|NCT03675308|588922764|FG000|Overall Study|Adverse Event|3|||
163057844|NCT03675308|588922765|FG001|Overall Study|Adverse Event|2|||
163057845|NCT03675308|588922764|FG000|Overall Study|Withdrawal by Subject|6|||
163057846|NCT03675308|588922765|FG001|Overall Study|Withdrawal by Subject|4|||
163057847|NCT03675308|588922764|FG000|Overall Study|Lost to Follow-up|3|||
163057848|NCT03675308|588922765|FG001|Overall Study|Lost to Follow-up|0|||
163057849|NCT03675308|588922764|FG000|Overall Study|Lack of Efficacy|1|||
163057850|NCT03675308|588922765|FG001|Overall Study|Lack of Efficacy|1|||
163057851|NCT03675308|588922764|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
163057852|NCT03675308|588922765|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
163057853|NCT03675308|588922764|FG000|Overall Study|Other|0|||
163057854|NCT03675308|588922765|FG001|Overall Study|Other|1|||
163057855|NCT05722522|588922766|FG000|Overall Study|Adverse Event|0|||
163057856|NCT05722522|588922767|FG001|Overall Study|Adverse Event|1|||
163057857|NCT00109343|588922770|FG000|Overall Study|Adverse Event|1|||
162977018|NCT01197417|588616574|FG001|Overall Study|Found to be ineligible|5|||
162977019|NCT01197417|588616573|FG000|Overall Study|No 25-hour magnesium level|0|||
162977020|NCT01197417|588616574|FG001|Overall Study|No 25-hour magnesium level|2|||
162977021|NCT01432574|588616575|FG000|Overall Study|Moved|2|||
163057858|NCT00109343|588922771|FG001|Overall Study|Adverse Event|0|||
162977022|NCT01432574|588616575|FG000|Overall Study|Not interested|1|||
162977023|NCT02813421|588616582|FG000|Overall Study|Withdrawal by Subject|1|||
162977024|NCT02813421|588616583|FG001|Overall Study|Withdrawal by Subject|2|||
162977025|NCT02813421|588616582|FG000|Overall Study|Lost to Follow-up|1|||
162977026|NCT02813421|588616583|FG001|Overall Study|Lost to Follow-up|1|||
162977027|NCT03135899|588616584|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
162977028|NCT03135899|588616585|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
162977029|NCT03135899|588616586|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
162977030|NCT03135899|588616587|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
162977031|NCT03135899|588616588|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
162977032|NCT03135899|588616589|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
163057859|NCT00109343|588922772|FG002|Overall Study|Adverse Event|2|||
163057860|NCT00109343|588922770|FG000|Overall Study|Lack of Efficacy|1|||
163057861|NCT00109343|588922771|FG001|Overall Study|Lack of Efficacy|0|||
163057862|NCT00109343|588922772|FG002|Overall Study|Lack of Efficacy|0|||
163057863|NCT00109343|588922770|FG000|Overall Study|Lost to Follow-up|35|||
163057864|NCT00109343|588922771|FG001|Overall Study|Lost to Follow-up|20|||
163057865|NCT00109343|588922772|FG002|Overall Study|Lost to Follow-up|14|||
163057866|NCT00109343|588922770|FG000|Overall Study|Protocol Violation|1|||
163057867|NCT00109343|588922771|FG001|Overall Study|Protocol Violation|2|||
163057868|NCT00109343|588922772|FG002|Overall Study|Protocol Violation|2|||
163057869|NCT00109343|588922770|FG000|Overall Study|Withdrawal by Subject|15|||
163057870|NCT00109343|588922771|FG001|Overall Study|Withdrawal by Subject|11|||
163057871|NCT00109343|588922772|FG002|Overall Study|Withdrawal by Subject|10|||
163057872|NCT00109343|588922770|FG000|Overall Study|Subject Moved|6|||
163057873|NCT00109343|588922771|FG001|Overall Study|Subject Moved|2|||
163057874|NCT00109343|588922772|FG002|Overall Study|Subject Moved|1|||
163057875|NCT00109343|588922770|FG000|Overall Study|Other|5|||
163057876|NCT00109343|588922771|FG001|Overall Study|Other|2|||
163057877|NCT00109343|588922772|FG002|Overall Study|Other|1|||
163057878|NCT01721798|588922775|FG000|Overall Study|Death|0|||
163057879|NCT01721798|588922776|FG001|Overall Study|Death|0|||
163057880|NCT01721798|588922777|FG002|Overall Study|Death|1|||
163057881|NCT01721798|588922778|FG003|Overall Study|Death|1|||
163057882|NCT01721798|588922775|FG000|Overall Study|Lost to Follow-up|2|||
163057883|NCT01721798|588922776|FG001|Overall Study|Lost to Follow-up|2|||
163057884|NCT01721798|588922777|FG002|Overall Study|Lost to Follow-up|9|||
163057885|NCT01721798|588922778|FG003|Overall Study|Lost to Follow-up|9|||
163209892|NCT02436356|589482992|FG000|Overall Study|Withdrawal by Subject|1|||
163209893|NCT02436356|589482993|FG001|Overall Study|Withdrawal by Subject|0|||
163209894|NCT02436356|589482994|FG002|Overall Study|Withdrawal by Subject|0|||
162977033|NCT03135899|588616590|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
162977034|NCT03135899|588616591|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
162977035|NCT03135899|588616584|FG000|Overall Study|Withdrawal by Subject|0|||
162977036|NCT03135899|588616585|FG001|Overall Study|Withdrawal by Subject|0|||
162977037|NCT03135899|588616586|FG002|Overall Study|Withdrawal by Subject|0|||
163057886|NCT01721798|588922775|FG000|Overall Study|Pregnancy|0|||
163057887|NCT01721798|588922776|FG001|Overall Study|Pregnancy|0|||
163057888|NCT01721798|588922777|FG002|Overall Study|Pregnancy|1|||
163057889|NCT01721798|588922778|FG003|Overall Study|Pregnancy|1|||
163057890|NCT01721798|588922775|FG000|Overall Study|Withdrawal by Subject|1|||
163057891|NCT01721798|588922776|FG001|Overall Study|Withdrawal by Subject|0|||
163057892|NCT01721798|588922777|FG002|Overall Study|Withdrawal by Subject|2|||
163057893|NCT01721798|588922778|FG003|Overall Study|Withdrawal by Subject|1|||
163057894|NCT01721798|588922775|FG000|Overall Study|Not eligible for 24 month visit|1|||
163057895|NCT01721798|588922776|FG001|Overall Study|Not eligible for 24 month visit|0|||
162977038|NCT03135899|588616587|FG003|Overall Study|Withdrawal by Subject|0|||
162977039|NCT03135899|588616588|FG004|Overall Study|Withdrawal by Subject|0|||
162977040|NCT03135899|588616589|FG005|Overall Study|Withdrawal by Subject|2|||
162977041|NCT03135899|588616590|FG006|Overall Study|Withdrawal by Subject|0|||
162977042|NCT03135899|588616591|FG007|Overall Study|Withdrawal by Subject|0|||
162977043|NCT04373551|588616592|FG000|Overall Study|Lost to Follow-up|15|||
162977044|NCT04373551|588616592|FG000|Overall Study|Did not collect 12-month data on participants enrolled in 2024 (at Site 2)|4|||
163318085|NCT00321048|589874970|FG001|Overall Study|Withdrawal by Subject|8|||
163318086|NCT01868997|589874971|FG000|Overall Study|Adverse Event|2|||
163318087|NCT01868997|589874972|FG001|Overall Study|Adverse Event|5|||
162977045|NCT02914236|588616593|FG000|Overall Study|Lost to Follow-up|1|||
162977046|NCT01042535|588616594|FG000|Overall Study|disease progression prior to treatment|3|||
162977047|NCT01042535|588616594|FG000|Overall Study|disease progression during treatment|3|||
162977048|NCT01042535|588616594|FG000|Overall Study|complications from other disease|2|||
162977049|NCT03438539|588616601|FG000|Overall Study|Lost to Follow-up|8|||
162977050|NCT03438539|588616602|FG001|Overall Study|Lost to Follow-up|4|||
162977051|NCT03438539|588616603|FG002|Overall Study|Lost to Follow-up|10|||
162977052|NCT03438539|588616604|FG003|Overall Study|Lost to Follow-up|9|||
162977053|NCT03438539|588616605|FG004|Overall Study|Lost to Follow-up|3|||
162977054|NCT03438539|588616606|FG005|Overall Study|Lost to Follow-up|8|||
162977055|NCT00655850|588616613|FG000|Overall Study|Death|2|||
162977056|NCT00655850|588616613|FG000|Overall Study|Withdrawal by Subject|1|||
162977057|NCT02129647|588616614|FG000|Overall Study|Adverse Event|2|||
162977058|NCT02129647|588616614|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
162977059|NCT00918463|588616615|FG000|Overall Study|Death|1|||
162977060|NCT00918463|588616615|FG000|Overall Study|Lack of Efficacy|1|||
162977061|NCT01715896|588616616|FG000|Overall Study|Lost to Follow-up|0|||
162977062|NCT01715896|588616617|FG001|Overall Study|Lost to Follow-up|2|||
162977063|NCT01715896|588616616|FG000|Overall Study|Withdrawal by Subject|1|||
162977064|NCT01715896|588616617|FG001|Overall Study|Withdrawal by Subject|4|||
162977065|NCT01715896|588616616|FG000|Overall Study|Other|2|||
162977066|NCT01715896|588616617|FG001|Overall Study|Other|5|||
162977067|NCT01045993|588616619|FG000|Overall Study|Treated-later found eligibility not met|0|||
162977068|NCT01045993|588616620|FG001|Overall Study|Treated-later found eligibility not met|1|||
162977069|NCT01045993|588616621|FG002|Overall Study|Treated-later found eligibility not met|0|||
162977070|NCT01045993|588616622|FG003|Overall Study|Treated-later found eligibility not met|0|||
162977071|NCT01659736|588616623|FG000|Treatment Period|Adverse Event|1|||
162977072|NCT01659736|588616624|FG001|Treatment Period|Adverse Event|1|||
162977073|NCT01659736|588616623|FG000|Treatment Period|Protocol Violation|3|||
162977074|NCT01659736|588616624|FG001|Treatment Period|Protocol Violation|1|||
162977075|NCT01659736|588616623|FG000|Treatment Period|Withdrawal by Subject|1|||
162977076|NCT01659736|588616624|FG001|Treatment Period|Withdrawal by Subject|0|||
162977077|NCT01659736|588616623|FG000|3-month Follow-up|Lost to Follow-up|0|||
162977078|NCT01659736|588616624|FG001|3-month Follow-up|Lost to Follow-up|1|||
162977079|NCT02772562|588616629|FG000|Overall Study|Withdrawal by Subject|1|||
162977080|NCT02772562|588616629|FG000|Overall Study|Protocol Violation|1|||
162977081|NCT03336242|588616632|FG000|Overall Study|Adverse Event|0|||
162977082|NCT03336242|588616633|FG001|Overall Study|Adverse Event|1|||
162977083|NCT00384293|588616634|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
162977084|NCT00384293|588616635|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
162977085|NCT00384293|588616636|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
162977086|NCT00384293|588616634|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
162977087|NCT00384293|588616635|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
162977088|NCT00384293|588616636|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
162977089|NCT00384293|588616634|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
162977090|NCT00384293|588616635|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
162977091|NCT00384293|588616636|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
162977092|NCT00384293|588616634|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
162977093|NCT00384293|588616635|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
162977094|NCT00384293|588616636|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
162977095|NCT00384293|588616634|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
162977096|NCT00384293|588616635|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
163318088|NCT01868997|589874971|FG000|Overall Study|Lack of Efficacy|2|||
162977097|NCT00384293|588616636|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
162977098|NCT00384293|588616634|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
162977099|NCT00384293|588616635|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
162977100|NCT00384293|588616636|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
163057896|NCT01721798|588922777|FG002|Overall Study|Not eligible for 24 month visit|8|||
162977101|NCT00384293|588616634|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
162977102|NCT00384293|588616635|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
163057897|NCT01721798|588922778|FG003|Overall Study|Not eligible for 24 month visit|7|||
163057898|NCT00961064|588922779|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
163057899|NCT00961064|588922779|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
163057900|NCT00961064|588922779|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
163057901|NCT00961064|588922779|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
163057902|NCT00961064|588922779|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
163057903|NCT00961064|588922779|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
163057904|NCT00961064|588922779|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
163057905|NCT00961064|588922779|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
163057906|NCT01408641|588922780|FG000|Overall Study|Physician Decision|1|||
163057907|NCT01408641|588922781|FG001|Overall Study|Physician Decision|0|||
163057908|NCT01316614|588922782|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
163057909|NCT01316614|588922782|FG000|Overall Study|Cytology slides not available for review|4|||
163057910|NCT01316614|588922782|FG000|Overall Study|Cystic lesion|5|||
163057911|NCT01316614|588922782|FG000|Overall Study|Inadequate number of passes|2|||
163057912|NCT01316614|588922782|FG000|Overall Study|Medically unstable|1|||
163057913|NCT00076570|588922783|FG000|Overall Study|Drug intolerance|8|||
163057914|NCT00076570|588922784|FG001|Overall Study|Drug intolerance|8|||
163057915|NCT00089648|588922785|FG000|Overall Study|Adverse Event|7|||
163057916|NCT00089648|588922785|FG000|Overall Study|Withdrawal by Subject|1|||
163057917|NCT00089648|588922785|FG000|Overall Study|Lack of Efficacy|33|||
163057918|NCT03979313|588922786|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
163057919|NCT03979313|588922787|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
163057920|NCT03979313|588922786|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
163057921|NCT03979313|588922787|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
163057922|NCT03979313|588922786|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
163057923|NCT03979313|588922787|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
163057924|NCT03979313|588922786|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
163057925|NCT03979313|588922787|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
163057926|NCT03979313|588922786|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
163057927|NCT03979313|588922787|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
163057928|NCT03979313|588922786|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
163057929|NCT03979313|588922787|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
163057930|NCT03979313|588922786|FG000|All Subjects|Any Other Reason|16|||
163057931|NCT03979313|588922787|FG001|All Subjects|Any Other Reason|23|||
163057932|NCT03979313|588922786|FG000|All Subjects|Covid-19|1|||
163057933|NCT03979313|588922787|FG001|All Subjects|Covid-19|3|||
163209895|NCT02875860|589482995|FG000|Overall Study|Withdrawal by Subject|0|||
163209896|NCT02875860|589482996|FG001|Overall Study|Withdrawal by Subject|1|||
163209897|NCT03287804|589482997|FG000|Overall Study|Death|1|||
163057934|NCT03979313|588922786|FG000|All Subjects|Withdrawal by Subject|35|||
163057935|NCT03979313|588922787|FG001|All Subjects|Withdrawal by Subject|44|||
163209898|NCT03287804|589482997|FG000|Overall Study|Physician Decision|2|||
163209899|NCT03287804|589482997|FG000|Overall Study|Progressive disease|8|||
163057936|NCT03979313|588922786|FG000|All Subjects|Death|0|||
163057937|NCT03979313|588922787|FG001|All Subjects|Death|5|||
163057938|NCT03979313|588922786|FG000|All Subjects|Lost to Follow-up|28|||
163057939|NCT03979313|588922787|FG001|All Subjects|Lost to Follow-up|61|||
163057940|NCT00423605|588922788|FG000|Overall Study|Adverse Event|129|||
163057941|NCT00423605|588922788|FG000|Overall Study|Withdrawal by Subject|36|||
163057942|NCT00423605|588922788|FG000|Overall Study|Lost to Follow-up|15|||
163057943|NCT00423605|588922788|FG000|Overall Study|Lack of Efficacy|38|||
163057944|NCT00423605|588922788|FG000|Overall Study|Sponsor Decision|3|||
163057945|NCT00423605|588922788|FG000|Overall Study|Physician Decision|8|||
163057946|NCT00423605|588922788|FG000|Overall Study|Protocol Violation|7|||
163057947|NCT00423605|588922788|FG000|Overall Study|Not one of the pre-specified options|5|||
163057948|NCT03183908|588922789|FG000|Overall Study|Missing Symptom Diary Data|0|||
163057949|NCT03183908|588922790|FG001|Overall Study|Missing Symptom Diary Data|2|||
163057950|NCT01588509|588922793|FG000|Overall Study|Lost to Follow-up|1|||
163057951|NCT01588509|588922794|FG001|Overall Study|Lost to Follow-up|0|||
163057952|NCT00393367|588922795|FG000|Overall Study|Protocol Violation|2|||
163057953|NCT00393367|588922796|FG001|Overall Study|Protocol Violation|5|||
163057954|NCT00393367|588922795|FG000|Overall Study|Withdrawal by Subject|0|||
163057955|NCT00393367|588922796|FG001|Overall Study|Withdrawal by Subject|2|||
163057956|NCT01712178|588922799|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
163057957|NCT01712178|588922800|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
163209900|NCT01881776|589482998|FG000|Overall Study|Lost to Follow-up|1|||
163209901|NCT01881776|589482999|FG001|Overall Study|Lost to Follow-up|2|||
163209902|NCT01881776|589483000|FG002|Overall Study|Lost to Follow-up|1|||
163402000|NCT01840579|590182962|FG009|Overall Study|Follow-up ended by Sponsor|0|||
163057958|NCT01712178|588922799|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
163057959|NCT01712178|588922800|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
163057960|NCT01712178|588922799|FG000|Overall Study|Lost to Follow-up|0|||
163209903|NCT01881776|589482998|FG000|Overall Study|Protocol Violation|0|||
163057961|NCT01712178|588922800|FG001|Overall Study|Lost to Follow-up|1|||
163057962|NCT00856180|588922801|FG000|Overall Study|Adverse Event|4|||
163057963|NCT00856180|588922801|FG000|Overall Study|Progressive Disease|16|||
163057964|NCT00819039|588922804|FG000|Overall Study|Physician Decision|1|||
163057965|NCT00819039|588922805|FG001|Overall Study|Physician Decision|0|||
163057966|NCT00819039|588922806|FG002|Overall Study|Physician Decision|1|||
163057967|NCT00819039|588922804|FG000|Overall Study|Protocol Violation|1|||
163057968|NCT00819039|588922805|FG001|Overall Study|Protocol Violation|0|||
163057969|NCT00819039|588922806|FG002|Overall Study|Protocol Violation|0|||
163057970|NCT04796415|588922807|FG000|Overall Study|not interested|12|||
163209904|NCT01881776|589482999|FG001|Overall Study|Protocol Violation|2|||
163209905|NCT01881776|589483000|FG002|Overall Study|Protocol Violation|1|||
163209906|NCT00487747|589483001|FG000|Overall Study|Adverse Event|1|||
163209907|NCT00487747|589483001|FG000|Overall Study|Lost to Follow-up|9|||
163209908|NCT00487747|589483001|FG000|Overall Study|Lack of Efficacy|1|||
163209909|NCT04483011|589483002|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
163209910|NCT04483011|589483003|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
163209911|NCT02979522|589483026|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
163209912|NCT02979522|589483027|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
163209913|NCT02979522|589483026|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
163209914|NCT02979522|589483027|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
163209915|NCT01896531|589483030|FG000|Overall Study|Death|57|||
163209916|NCT01896531|589483031|FG001|Overall Study|Death|59|||
163209917|NCT01896531|589483030|FG000|Overall Study|Lost to Follow-up|3|||
163209918|NCT01896531|589483031|FG001|Overall Study|Lost to Follow-up|0|||
163209919|NCT01896531|589483030|FG000|Overall Study|Non-compliance|0|||
163209920|NCT01896531|589483031|FG001|Overall Study|Non-compliance|1|||
163209921|NCT01896531|589483030|FG000|Overall Study|Study Ended by Sponsor|7|||
163209922|NCT01896531|589483031|FG001|Overall Study|Study Ended by Sponsor|20|||
163209923|NCT01896531|589483030|FG000|Overall Study|Withdrawal by Subject|3|||
163209924|NCT01896531|589483031|FG001|Overall Study|Withdrawal by Subject|2|||
163209925|NCT01896531|589483030|FG000|Overall Study|Death Prior to Treatment|1|||
163209926|NCT01896531|589483031|FG001|Overall Study|Death Prior to Treatment|0|||
163209927|NCT05185089|589483032|FG000|First Intervention (4 weeks)|Adverse Event|0|||
163209928|NCT05185089|589483033|FG001|First Intervention (4 weeks)|Adverse Event|0|||
163209929|NCT05185089|589483034|FG002|First Intervention (4 weeks)|Adverse Event|0|||
163209930|NCT05185089|589483035|FG003|First Intervention (4 weeks)|Adverse Event|1|||
162977103|NCT00384293|588616636|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
162977104|NCT00384293|588616634|FG000|Post-randomization Period|Adverse Event|0|||
162977105|NCT00384293|588616635|FG001|Post-randomization Period|Adverse Event|23|||
162977106|NCT00384293|588616636|FG002|Post-randomization Period|Adverse Event|7|||
162977107|NCT00384293|588616634|FG000|Post-randomization Period|Lost to Follow-up|0|||
162977108|NCT00384293|588616635|FG001|Post-randomization Period|Lost to Follow-up|2|||
162977109|NCT00384293|588616636|FG002|Post-randomization Period|Lost to Follow-up|1|||
162977110|NCT00384293|588616634|FG000|Post-randomization Period|Protocol Violation|0|||
162977111|NCT00384293|588616635|FG001|Post-randomization Period|Protocol Violation|1|||
162977112|NCT00384293|588616636|FG002|Post-randomization Period|Protocol Violation|0|||
162977113|NCT00384293|588616634|FG000|Post-randomization Period|Withdrawal by Subject|0|||
162977114|NCT00384293|588616635|FG001|Post-randomization Period|Withdrawal by Subject|8|||
162977115|NCT00384293|588616636|FG002|Post-randomization Period|Withdrawal by Subject|6|||
162977116|NCT00384293|588616634|FG000|Post-randomization Period|Trial Termination|0|||
162977117|NCT00384293|588616635|FG001|Post-randomization Period|Trial Termination|180|||
162977118|NCT00384293|588616636|FG002|Post-randomization Period|Trial Termination|204|||
162977119|NCT00384293|588616634|FG000|Post-randomization Period|Patient Randomized in Error|0|||
162977120|NCT00384293|588616635|FG001|Post-randomization Period|Patient Randomized in Error|0|||
162977121|NCT00384293|588616636|FG002|Post-randomization Period|Patient Randomized in Error|1|||
162977122|NCT02039063|588616643|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
162977123|NCT02039063|588616644|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
162977124|NCT02039063|588616645|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
162977125|NCT02039063|588616646|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
162977126|NCT02039063|588616643|FG000|Treatment Phase|Progression of disease|0|||
162977127|NCT02039063|588616644|FG001|Treatment Phase|Progression of disease|0|||
162977128|NCT02039063|588616645|FG002|Treatment Phase|Progression of disease|1|||
162977129|NCT02039063|588616646|FG003|Treatment Phase|Progression of disease|1|||
162977130|NCT02039063|588616643|FG000|Extension Phase|Inadequate therapeutic effect|0|||
162977131|NCT02039063|588616644|FG001|Extension Phase|Inadequate therapeutic effect|1|||
162977132|NCT02039063|588616645|FG002|Extension Phase|Inadequate therapeutic effect|2|||
162977133|NCT02039063|588616646|FG003|Extension Phase|Inadequate therapeutic effect|0|||
162977134|NCT02039063|588616643|FG000|Extension Phase|Progression of disease|0|||
162977135|NCT02039063|588616644|FG001|Extension Phase|Progression of disease|0|||
162977136|NCT02039063|588616645|FG002|Extension Phase|Progression of disease|0|||
162977137|NCT02039063|588616646|FG003|Extension Phase|Progression of disease|1|||
162977138|NCT02039063|588616643|FG000|Extension Phase|Adverse Event|0|||
162977139|NCT02039063|588616644|FG001|Extension Phase|Adverse Event|0|||
162977140|NCT02039063|588616645|FG002|Extension Phase|Adverse Event|1|||
162977141|NCT02039063|588616646|FG003|Extension Phase|Adverse Event|0|||
162977142|NCT00775528|588616650|FG000|Overall Study|Protocol Violation|1|||
162977143|NCT02492841|588616651|FG000|Overall Study|Lost to Follow-up|34|||
162977144|NCT02492841|588616652|FG001|Overall Study|Lost to Follow-up|31|||
162977145|NCT02492841|588616653|FG002|Overall Study|Lost to Follow-up|35|||
162977146|NCT00613730|588616656|FG000|Overall Study|Disease progression|2|||
162977147|NCT00613730|588616656|FG000|Overall Study|Administrative decision|1|||
162977148|NCT01192399|588616657|FG000|Overall Study|Lack of Efficacy|2|||
162977149|NCT02244424|588616661|FG000|Overall Study|Lost to Follow-up|20|||
162977150|NCT02244424|588616662|FG001|Overall Study|Lost to Follow-up|10|||
163318089|NCT01868997|589874972|FG001|Overall Study|Lack of Efficacy|0|||
163318090|NCT01868997|589874971|FG000|Overall Study|Other|3|||
163318091|NCT01868997|589874972|FG001|Overall Study|Other|1|||
163318092|NCT04730739|589874975|FG000|Overall Study|Death|1|||
163318093|NCT05646355|589874984|FG000|Overall Study|Lost to Follow-up|1|||
163318094|NCT05646355|589874985|FG001|Overall Study|Lost to Follow-up|0|||
163318095|NCT05646355|589874984|FG000|Overall Study|translated materials not available for pilot|2|||
163318096|NCT05646355|589874985|FG001|Overall Study|translated materials not available for pilot|0|||
163318097|NCT05646355|589874984|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
163318098|NCT05646355|589874985|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
163318099|NCT03362476|589874986|FG000|Overall Study|Withdrawal by Subject|0|||
163318100|NCT03362476|589874987|FG001|Overall Study|Withdrawal by Subject|1|||
163318101|NCT05216406|589874988|FG000|Overall Study|Lost to Follow-up|8|||
163318102|NCT05216406|589874989|FG001|Overall Study|Lost to Follow-up|9|||
163318103|NCT04270942|589874992|FG000|Overall Study|Death|1|||
163318104|NCT01236781|589874994|FG000|Overall Study|Ineligible|2|||
162977151|NCT02377063|588616663|FG000|Overall Study|Non-compliance|5|||
162977152|NCT01524913|588616664|FG000|Overall Study|Lost to Follow-up|4|||
162977153|NCT01524913|588616665|FG001|Overall Study|Lost to Follow-up|0|||
162977154|NCT01524913|588616666|FG002|Overall Study|Lost to Follow-up|0|||
162977155|NCT02723773|588618618|FG000|Overall Study|Adverse Event|934|||
162977156|NCT02723773|588618619|FG001|Overall Study|Adverse Event|3|||
162977157|NCT02723773|588618620|FG002|Overall Study|Adverse Event|1|||
162977158|NCT02723773|588618621|FG003|Overall Study|Adverse Event|9|||
162977159|NCT02723773|588618618|FG000|Overall Study|Protocol Violation|1|||
162977160|NCT02723773|588618619|FG001|Overall Study|Protocol Violation|0|||
163318105|NCT01236781|589874995|FG001|Overall Study|Ineligible|1|||
163318106|NCT01236781|589874994|FG000|Overall Study|Did not complete study imaging|5|||
163318107|NCT01236781|589874995|FG001|Overall Study|Did not complete study imaging|0|||
163318108|NCT04862416|589875001|FG000|Overall Study|Withdrawal by Subject|0|||
163318109|NCT04862416|589875002|FG001|Overall Study|Withdrawal by Subject|1|||
163318110|NCT04862416|589875003|FG002|Overall Study|Withdrawal by Subject|0|||
163318111|NCT04862416|589875004|FG003|Overall Study|Withdrawal by Subject|1|||
163318112|NCT04862416|589875005|FG004|Overall Study|Withdrawal by Subject|0|||
163318113|NCT04862416|589875006|FG005|Overall Study|Withdrawal by Subject|0|||
163318114|NCT04862416|589875007|FG006|Overall Study|Withdrawal by Subject|0|||
163318115|NCT04862416|589875008|FG007|Overall Study|Withdrawal by Subject|0|||
163318116|NCT04059185|589875011|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
163318117|NCT04059185|589875012|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
163318118|NCT04059185|589875013|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
163318119|NCT04059185|589875011|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
163318120|NCT04059185|589875012|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
163318121|NCT04059185|589875013|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
163318122|NCT04059185|589875011|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
163318123|NCT04059185|589875012|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
163318124|NCT04059185|589875013|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
163318125|NCT04059185|589875011|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
163318126|NCT04059185|589875012|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
163318127|NCT04059185|589875013|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
163318128|NCT04059185|589875011|FG000|Longitudinal Assessment-Adults Only|Death|4|||
163318129|NCT04059185|589875012|FG001|Longitudinal Assessment-Adults Only|Death|4|||
163318130|NCT04059185|589875013|FG002|Longitudinal Assessment-Adults Only|Death|3|||
163318131|NCT01009788|589875020|FG000|Overall Study|Withdrawal by Subject|1|||
163318132|NCT01009788|589875021|FG001|Overall Study|Withdrawal by Subject|0|||
163318133|NCT04741776|589875024|FG000|Overall Study|Withdrawal by Subject|7|||
163318134|NCT04741776|589875025|FG001|Overall Study|Withdrawal by Subject|10|||
162977161|NCT02723773|588618620|FG002|Overall Study|Protocol Violation|0|||
162977162|NCT02723773|588618621|FG003|Overall Study|Protocol Violation|0|||
162977163|NCT02723773|588618618|FG000|Overall Study|Withdrawal by Subject|360|||
162977164|NCT02723773|588618619|FG001|Overall Study|Withdrawal by Subject|5|||
162977165|NCT02723773|588618620|FG002|Overall Study|Withdrawal by Subject|6|||
162977166|NCT02723773|588618621|FG003|Overall Study|Withdrawal by Subject|10|||
162977167|NCT02723773|588618618|FG000|Overall Study|Migrated/moved from study area|37|||
162977168|NCT02723773|588618619|FG001|Overall Study|Migrated/moved from study area|0|||
162977169|NCT02723773|588618620|FG002|Overall Study|Migrated/moved from study area|0|||
162977170|NCT02723773|588618621|FG003|Overall Study|Migrated/moved from study area|1|||
162977171|NCT02723773|588618618|FG000|Overall Study|Lost to Follow-up|198|||
162977172|NCT02723773|588618619|FG001|Overall Study|Lost to Follow-up|0|||
162977173|NCT02723773|588618620|FG002|Overall Study|Lost to Follow-up|0|||
162977174|NCT02723773|588618621|FG003|Overall Study|Lost to Follow-up|0|||
162977175|NCT02723773|588618618|FG000|Overall Study|Other|189|||
162977176|NCT02723773|588618619|FG001|Overall Study|Other|1|||
162977177|NCT02723773|588618620|FG002|Overall Study|Other|2|||
162977178|NCT02723773|588618621|FG003|Overall Study|Other|2|||
162977179|NCT05168774|588618622|FG000|Overall Study|Lack of Efficacy|1|||
162977180|NCT05168774|588618623|FG001|Overall Study|Lack of Efficacy|2|||
162977181|NCT05168774|588618622|FG000|Overall Study|Withdrawal by Subject|1|||
162977182|NCT05168774|588618623|FG001|Overall Study|Withdrawal by Subject|2|||
162977183|NCT05168774|588618622|FG000|Overall Study|Adverse Event|2|||
162977184|NCT05168774|588618623|FG001|Overall Study|Adverse Event|0|||
162977185|NCT02124902|588618625|FG000|Overall Study|Adverse Event|7|||
162977186|NCT02124902|588618626|FG001|Overall Study|Adverse Event|2|||
162977187|NCT02124902|588618625|FG000|Overall Study|Went to alternative treatment|4|||
162977188|NCT02124902|588618626|FG001|Overall Study|Went to alternative treatment|0|||
162977189|NCT02124902|588618625|FG000|Overall Study|Withdrawal by Subject|2|||
162977190|NCT02124902|588618626|FG001|Overall Study|Withdrawal by Subject|1|||
162977191|NCT02124902|588618625|FG000|Overall Study|Physician Decision|2|||
162977192|NCT02124902|588618626|FG001|Overall Study|Physician Decision|0|||
162977193|NCT02124902|588618625|FG000|Overall Study|Not eligible|1|||
162977194|NCT02124902|588618626|FG001|Overall Study|Not eligible|0|||
162977195|NCT02124902|588618625|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
162977196|NCT02124902|588618626|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
162977197|NCT01314118|588618627|FG000|Overall Study|Adverse Event|10|||
162977198|NCT01314118|588618627|FG000|Overall Study|Progressive disease|3|||
162977199|NCT01314118|588618627|FG000|Overall Study|Death|8|||
162977200|NCT01314118|588618627|FG000|Overall Study|Physician Decision|13|||
162977201|NCT01314118|588618627|FG000|Overall Study|Sponsor Decision|1|||
162977202|NCT01314118|588618627|FG000|Overall Study|Protocol Violation|2|||
163318135|NCT04741776|589875026|FG002|Overall Study|Withdrawal by Subject|10|||
162977203|NCT01314118|588618627|FG000|Overall Study|Withdrawal by Subject|26|||
162977204|NCT01314118|588618627|FG000|Overall Study|Other|21|||
163057971|NCT04796415|588922807|FG000|Overall Study|health issue|8|||
163057972|NCT04796415|588922807|FG000|Overall Study|Other|4|||
163057973|NCT04796415|588922807|FG000|Overall Study|discharged from home health service|3|||
163057974|NCT04796415|588922807|FG000|Overall Study|re-hospitalization|2|||
163057975|NCT04796415|588922807|FG000|Overall Study|moving to nursing home|1|||
163057976|NCT04796415|588922807|FG000|Overall Study|lost contact|1|||
163057977|NCT00486044|588922811|FG000|Overall Study|Withdrawal by Subject|2|||
163057978|NCT00486044|588922812|FG001|Overall Study|Withdrawal by Subject|1|||
163057979|NCT00486044|588922811|FG000|Overall Study|Adverse Event|0|||
163057980|NCT00486044|588922812|FG001|Overall Study|Adverse Event|1|||
163057981|NCT00486044|588922811|FG000|Overall Study|Lost to Follow-up|0|||
163057982|NCT00486044|588922812|FG001|Overall Study|Lost to Follow-up|1|||
163057983|NCT02701634|588922813|FG000|Overall Study|Adverse Event|2|||
163057984|NCT02701634|588922814|FG001|Overall Study|Adverse Event|3|||
163057985|NCT02701634|588922813|FG000|Overall Study|Death|1|||
163057986|NCT02701634|588922814|FG001|Overall Study|Death|0|||
163057987|NCT02701634|588922813|FG000|Overall Study|Investigator's Discretion|7|||
163057988|NCT02701634|588922814|FG001|Overall Study|Investigator's Discretion|4|||
163057989|NCT02701634|588922813|FG000|Overall Study|Study terminated by Sponsor|15|||
163057990|NCT02701634|588922814|FG001|Overall Study|Study terminated by Sponsor|17|||
163057991|NCT02701634|588922813|FG000|Overall Study|Withdrew Consent|6|||
163057992|NCT02701634|588922814|FG001|Overall Study|Withdrew Consent|7|||
163057993|NCT02701634|588922813|FG000|Overall Study|Randomized but not treated|1|||
163057994|NCT02701634|588922814|FG001|Overall Study|Randomized but not treated|0|||
163209931|NCT05185089|589483032|FG000|Second Intervention (4 weeks)|Death|0|||
163209932|NCT05185089|589483033|FG001|Second Intervention (4 weeks)|Death|1|||
163209933|NCT05185089|589483034|FG002|Second Intervention (4 weeks)|Death|0|||
163209934|NCT05185089|589483035|FG003|Second Intervention (4 weeks)|Death|0|||
163209935|NCT05185089|589483032|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
163209936|NCT05185089|589483033|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
163209937|NCT05185089|589483034|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
163209938|NCT05185089|589483035|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
163209939|NCT00770289|589483036|FG000|Overall Study|Other|6|||
163209940|NCT02733991|589483037|FG000|Overall Study|Adverse Event|1|||
163209941|NCT02733991|589483038|FG001|Overall Study|Adverse Event|0|||
163209942|NCT02733991|589483037|FG000|Overall Study|Withdrawal by Subject|0|||
163209943|NCT02733991|589483038|FG001|Overall Study|Withdrawal by Subject|5|||
163209944|NCT02956486|589483041|FG000|Core Phase|Adverse Event|51|||
163209945|NCT02956486|589483042|FG001|Core Phase|Adverse Event|88|||
163209946|NCT02956486|589483043|FG002|Core Phase|Adverse Event|0|||
163209947|NCT02956486|589483041|FG000|Core Phase|Lost to Follow-up|8|||
163209948|NCT02956486|589483042|FG001|Core Phase|Lost to Follow-up|6|||
163209949|NCT02956486|589483043|FG002|Core Phase|Lost to Follow-up|0|||
163209950|NCT02956486|589483041|FG000|Core Phase|Inadequate therapeutic effect|4|||
163209951|NCT02956486|589483042|FG001|Core Phase|Inadequate therapeutic effect|5|||
163209952|NCT02956486|589483043|FG002|Core Phase|Inadequate therapeutic effect|0|||
163209953|NCT02956486|589483041|FG000|Core Phase|Withdrawal by Subject|101|||
163209954|NCT02956486|589483042|FG001|Core Phase|Withdrawal by Subject|104|||
163209955|NCT02956486|589483043|FG002|Core Phase|Withdrawal by Subject|0|||
163209956|NCT02956486|589483041|FG000|Core Phase|Study terminated by sponsor|888|||
163209957|NCT02956486|589483042|FG001|Core Phase|Study terminated by sponsor|848|||
163209958|NCT02956486|589483043|FG002|Core Phase|Study terminated by sponsor|0|||
163209959|NCT02956486|589483041|FG000|Core Phase|Other|27|||
163209960|NCT02956486|589483042|FG001|Core Phase|Other|18|||
163209961|NCT02956486|589483043|FG002|Core Phase|Other|0|||
163209962|NCT02956486|589483041|FG000|Core Phase|Not treated|0|||
163209963|NCT02956486|589483042|FG001|Core Phase|Not treated|3|||
163209964|NCT02956486|589483043|FG002|Core Phase|Not treated|0|||
163209965|NCT02956486|589483041|FG000|Extension Phase|Adverse Event|0|||
163209966|NCT02956486|589483042|FG001|Extension Phase|Adverse Event|0|||
163209967|NCT02956486|589483043|FG002|Extension Phase|Adverse Event|2|||
163209968|NCT02956486|589483041|FG000|Extension Phase|Study terminated by sponsor|0|||
163209969|NCT02956486|589483042|FG001|Extension Phase|Study terminated by sponsor|0|||
163209970|NCT02956486|589483043|FG002|Extension Phase|Study terminated by sponsor|16|||
163209971|NCT02956486|589483041|FG000|Extension Phase|Not Treated|0|||
163209972|NCT02956486|589483042|FG001|Extension Phase|Not Treated|0|||
163209973|NCT02956486|589483043|FG002|Extension Phase|Not Treated|1|||
163209974|NCT02485574|589483050|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
163209975|NCT00255047|589483052|FG000|Overall Study|Serious Adverse Events|2|||
163209976|NCT00255047|589483053|FG001|Overall Study|Serious Adverse Events|1|||
163209977|NCT00255047|589483054|FG002|Overall Study|Serious Adverse Events|2|||
163209978|NCT00255047|589483055|FG003|Overall Study|Serious Adverse Events|1|||
163209979|NCT00255047|589483052|FG000|Overall Study|Adverse Event|0|||
163209980|NCT00255047|589483053|FG001|Overall Study|Adverse Event|3|||
163209981|NCT00255047|589483054|FG002|Overall Study|Adverse Event|2|||
163209982|NCT00255047|589483055|FG003|Overall Study|Adverse Event|1|||
163209983|NCT00255047|589483052|FG000|Overall Study|Protocol Violation|13|||
163209984|NCT00255047|589483053|FG001|Overall Study|Protocol Violation|13|||
163209985|NCT00255047|589483054|FG002|Overall Study|Protocol Violation|16|||
163401371|NCT03719690|590181138|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
163401372|NCT02576444|590181148|FG000|Overall Study|Death|1|||
163401373|NCT02576444|590181149|FG001|Overall Study|Death|1|||
163401374|NCT02576444|590181150|FG002|Overall Study|Death|0|||
163401375|NCT02576444|590181151|FG003|Overall Study|Death|0|||
163401376|NCT02576444|590181148|FG000|Overall Study|Withdrawal by Subject|0|||
163401377|NCT02576444|590181149|FG001|Overall Study|Withdrawal by Subject|0|||
163401378|NCT02576444|590181150|FG002|Overall Study|Withdrawal by Subject|2|||
163401379|NCT02576444|590181151|FG003|Overall Study|Withdrawal by Subject|0|||
163401380|NCT02576444|590181148|FG000|Overall Study|Adverse Event|0|||
163401381|NCT02576444|590181149|FG001|Overall Study|Adverse Event|0|||
163401382|NCT02576444|590181150|FG002|Overall Study|Adverse Event|1|||
163401383|NCT02576444|590181151|FG003|Overall Study|Adverse Event|0|||
163401384|NCT02576444|590181148|FG000|Overall Study|Physician Decision|0|||
163401385|NCT02576444|590181149|FG001|Overall Study|Physician Decision|0|||
163401386|NCT02576444|590181150|FG002|Overall Study|Physician Decision|1|||
163401387|NCT02576444|590181151|FG003|Overall Study|Physician Decision|0|||
163401388|NCT03370120|590181157|FG000|Overall Study|Adverse event, non-fatal|24|||
163401389|NCT03370120|590181157|FG000|Overall Study|Withdrawal by Subject|6|||
163401390|NCT03370120|590181157|FG000|Overall Study|Lost to Follow-up|1|||
163401391|NCT03370120|590181157|FG000|Overall Study|Lack of Efficacy|37|||
163401392|NCT03370120|590181157|FG000|Overall Study|Per sponsor's instructions|1|||
163401393|NCT03370120|590181157|FG000|Overall Study|Study was terminated by parent company UCB|2|||
163401394|NCT03370120|590181157|FG000|Overall Study|The study was ended by the promoter|3|||
163401395|NCT03370120|590181157|FG000|Overall Study|Discontinuation of drug development|3|||
163401396|NCT03370120|590181157|FG000|Overall Study|End of project|2|||
163401397|NCT03370120|590181157|FG000|Overall Study|Premature study closure|2|||
163401398|NCT03370120|590181157|FG000|Overall Study|Premature program termination|1|||
163401399|NCT03370120|590181157|FG000|Overall Study|Premature study termination|7|||
163401400|NCT03370120|590181157|FG000|Overall Study|Trial terminated by sponsor|2|||
163401401|NCT03370120|590181157|FG000|Overall Study|Trial discontinued by sponsor|2|||
163401402|NCT03370120|590181157|FG000|Overall Study|Study ended|15|||
163401403|NCT03370120|590181157|FG000|Overall Study|Clinical trial has been cancelled|1|||
163401404|NCT03370120|590181157|FG000|Overall Study|End of study per sponsor decision|2|||
163401405|NCT03370120|590181157|FG000|Overall Study|Promoter's decision|2|||
163401406|NCT03370120|590181157|FG000|Overall Study|The trial has been suspended|3|||
163401407|NCT03370120|590181157|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
163401408|NCT03370120|590181157|FG000|Overall Study|Early termination by order of sponsor|2|||
163401409|NCT03370120|590181157|FG000|Overall Study|Discontinuation of the study|5|||
163401410|NCT03370120|590181157|FG000|Overall Study|End of clinical trial discontinuation|1|||
163401411|NCT03370120|590181157|FG000|Overall Study|Because the clinical trial ended halfway|4|||
162977205|NCT01467479|588618633|FG000|Overall Study|No Study Medication|1|||
162977206|NCT01467479|588618634|FG001|Overall Study|No Study Medication|0|||
162977207|NCT01467479|588618635|FG002|Overall Study|No Study Medication|2|||
162977208|NCT01467479|588618633|FG000|Overall Study|Adverse Event|1|||
162977209|NCT01467479|588618634|FG001|Overall Study|Adverse Event|2|||
163209986|NCT00255047|589483055|FG003|Overall Study|Protocol Violation|20|||
163209987|NCT00255047|589483052|FG000|Overall Study|Lost to Follow-up|9|||
163209988|NCT00255047|589483053|FG001|Overall Study|Lost to Follow-up|8|||
163209989|NCT00255047|589483054|FG002|Overall Study|Lost to Follow-up|5|||
163209990|NCT00255047|589483055|FG003|Overall Study|Lost to Follow-up|6|||
163209991|NCT00255047|589483052|FG000|Overall Study|Withdrawal by Subject|24|||
163209992|NCT00255047|589483053|FG001|Overall Study|Withdrawal by Subject|23|||
163209993|NCT00255047|589483054|FG002|Overall Study|Withdrawal by Subject|25|||
163209994|NCT00255047|589483055|FG003|Overall Study|Withdrawal by Subject|18|||
163209995|NCT00003492|589483062|FG000|Overall Study|Not evaluable|6|||
163209996|NCT03049280|589483068|FG000|Overall Study|Physician Decision|1|||
163209997|NCT01867021|589483069|FG000|Overall Study|Adverse Event|0|||
163209998|NCT01867021|589483070|FG001|Overall Study|Adverse Event|1|||
163209999|NCT01867021|589483069|FG000|Overall Study|Not Eligible|0|||
163210000|NCT01867021|589483070|FG001|Overall Study|Not Eligible|1|||
163210001|NCT01867021|589483069|FG000|Overall Study|Death|1|||
163210002|NCT01867021|589483070|FG001|Overall Study|Death|0|||
163210003|NCT01867021|589483069|FG000|Overall Study|Lost to Follow-up|0|||
163210004|NCT01867021|589483070|FG001|Overall Study|Lost to Follow-up|2|||
163210005|NCT01867021|589483069|FG000|Overall Study|Withdrawal by Subject|1|||
163210006|NCT01867021|589483070|FG001|Overall Study|Withdrawal by Subject|6|||
163210007|NCT01129960|589483074|FG000|Overall Study|Withdrawal by Subject|3|||
163210008|NCT01129960|589483075|FG001|Overall Study|Withdrawal by Subject|0|||
163210009|NCT01129960|589483076|FG002|Overall Study|Withdrawal by Subject|3|||
163210010|NCT01129960|589483077|FG003|Overall Study|Withdrawal by Subject|2|||
163401412|NCT03370120|590181157|FG000|Overall Study|Development discontinued|5|||
163401413|NCT03370120|590181157|FG000|Overall Study|Padsenovil program closed|3|||
163401414|NCT03370120|590181157|FG000|Overall Study|End of project|2|||
163401415|NCT03370120|590181157|FG000|Overall Study|Termination of project|1|||
162977210|NCT01467479|588618635|FG002|Overall Study|Adverse Event|0|||
162977211|NCT01467479|588618633|FG000|Overall Study|Death|0|||
162977212|NCT01467479|588618634|FG001|Overall Study|Death|0|||
162977213|NCT01467479|588618635|FG002|Overall Study|Death|1|||
162977214|NCT01467479|588618633|FG000|Overall Study|Lost to Follow-up|2|||
162977215|NCT01467479|588618634|FG001|Overall Study|Lost to Follow-up|5|||
162977216|NCT01467479|588618635|FG002|Overall Study|Lost to Follow-up|3|||
162977217|NCT01467479|588618633|FG000|Overall Study|Withdrawal of Consent|3|||
162977218|NCT01467479|588618634|FG001|Overall Study|Withdrawal of Consent|7|||
162977219|NCT01467479|588618635|FG002|Overall Study|Withdrawal of Consent|7|||
162977220|NCT01467479|588618633|FG000|Overall Study|Study Terminated by Sponsor|1|||
162977221|NCT01467479|588618634|FG001|Overall Study|Study Terminated by Sponsor|3|||
162977222|NCT01467479|588618635|FG002|Overall Study|Study Terminated by Sponsor|3|||
162977223|NCT01467479|588618633|FG000|Overall Study|Other|1|||
162977224|NCT01467479|588618634|FG001|Overall Study|Other|0|||
162977225|NCT01467479|588618635|FG002|Overall Study|Other|0|||
162977226|NCT01730040|588618638|FG000|Overall Study|Randomized but not treated|0|||
162977227|NCT01730040|588618639|FG001|Overall Study|Randomized but not treated|0|||
162977228|NCT01730040|588618640|FG002|Overall Study|Randomized but not treated|0|||
162977229|NCT01730040|588618641|FG003|Overall Study|Randomized but not treated|0|||
162977230|NCT01730040|588618642|FG004|Overall Study|Randomized but not treated|0|||
162977231|NCT01730040|588618643|FG005|Overall Study|Randomized but not treated|1|||
162977232|NCT01730040|588618644|FG006|Overall Study|Randomized but not treated|0|||
162977233|NCT01730040|588618638|FG000|Overall Study|Subject moved|0|||
162977234|NCT01730040|588618639|FG001|Overall Study|Subject moved|0|||
162977235|NCT01730040|588618640|FG002|Overall Study|Subject moved|1|||
162977236|NCT01730040|588618641|FG003|Overall Study|Subject moved|0|||
163318136|NCT04741776|589875027|FG003|Overall Study|Withdrawal by Subject|17|||
163318137|NCT04741776|589875024|FG000|Overall Study|Death|0|||
163318138|NCT04741776|589875025|FG001|Overall Study|Death|0|||
163318139|NCT04741776|589875026|FG002|Overall Study|Death|1|||
163318140|NCT04741776|589875027|FG003|Overall Study|Death|0|||
163318141|NCT02852655|589875043|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
163318142|NCT02852655|589875044|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
163318143|NCT02852655|589875045|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
163318144|NCT02852655|589875043|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
163318145|NCT02852655|589875044|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
163318146|NCT02852655|589875045|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
163318147|NCT02852655|589875043|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
163318148|NCT02852655|589875044|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
163318149|NCT02852655|589875045|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
163318150|NCT02852655|589875043|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
163318151|NCT02852655|589875044|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
163318152|NCT02852655|589875045|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
163318153|NCT02852655|589875043|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
163318154|NCT02852655|589875044|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
163318155|NCT02852655|589875045|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
163318156|NCT02852655|589875043|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
163318157|NCT02852655|589875044|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
163318158|NCT02852655|589875045|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
163318159|NCT02852655|589875043|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
163318160|NCT02852655|589875044|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
163318161|NCT02852655|589875045|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
163318162|NCT02852655|589875043|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
163318163|NCT02852655|589875044|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
163318164|NCT02852655|589875045|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
163318165|NCT02852655|589875043|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
163318166|NCT02852655|589875044|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
163318167|NCT02852655|589875045|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
162977237|NCT01730040|588618642|FG004|Overall Study|Subject moved|0|||
162977238|NCT01730040|588618643|FG005|Overall Study|Subject moved|0|||
162977239|NCT01730040|588618644|FG006|Overall Study|Subject moved|1|||
163318168|NCT05809453|589876841|FG000|Overall Study|Withdrawal by Subject|1|||
163318169|NCT05809453|589876842|FG001|Overall Study|Withdrawal by Subject|0|||
163318170|NCT05809453|589876843|FG002|Overall Study|Withdrawal by Subject|0|||
163318171|NCT05809453|589876844|FG003|Overall Study|Withdrawal by Subject|0|||
163318172|NCT03257410|589876847|FG000|Overall Study|Adverse Event|2|||
163318173|NCT03257410|589876848|FG001|Overall Study|Adverse Event|3|||
163318174|NCT03257410|589876847|FG000|Overall Study|Protocol Violation|1|||
162977240|NCT01730040|588618638|FG000|Overall Study|Physician Decision|0|||
162977241|NCT01730040|588618639|FG001|Overall Study|Physician Decision|0|||
162977242|NCT01730040|588618640|FG002|Overall Study|Physician Decision|0|||
162977243|NCT01730040|588618641|FG003|Overall Study|Physician Decision|0|||
162977244|NCT01730040|588618642|FG004|Overall Study|Physician Decision|0|||
162977245|NCT01730040|588618643|FG005|Overall Study|Physician Decision|1|||
162977246|NCT01730040|588618644|FG006|Overall Study|Physician Decision|1|||
162977247|NCT01730040|588618638|FG000|Overall Study|Other than specified|7|||
162977248|NCT01730040|588618639|FG001|Overall Study|Other than specified|8|||
162977249|NCT01730040|588618640|FG002|Overall Study|Other than specified|5|||
162977250|NCT01730040|588618641|FG003|Overall Study|Other than specified|5|||
162977251|NCT01730040|588618642|FG004|Overall Study|Other than specified|5|||
162977252|NCT01730040|588618643|FG005|Overall Study|Other than specified|4|||
162977253|NCT01730040|588618644|FG006|Overall Study|Other than specified|4|||
162977254|NCT01730040|588618638|FG000|Overall Study|Adverse Event|4|||
162977255|NCT01730040|588618639|FG001|Overall Study|Adverse Event|3|||
162977256|NCT01730040|588618640|FG002|Overall Study|Adverse Event|5|||
162977257|NCT01730040|588618641|FG003|Overall Study|Adverse Event|3|||
162977258|NCT01730040|588618642|FG004|Overall Study|Adverse Event|1|||
162977259|NCT01730040|588618643|FG005|Overall Study|Adverse Event|1|||
162977260|NCT01730040|588618644|FG006|Overall Study|Adverse Event|2|||
162977261|NCT01730040|588618638|FG000|Overall Study|Poor compliance to protocol|2|||
162977262|NCT01730040|588618639|FG001|Overall Study|Poor compliance to protocol|4|||
162977263|NCT01730040|588618640|FG002|Overall Study|Poor compliance to protocol|0|||
162977264|NCT01730040|588618641|FG003|Overall Study|Poor compliance to protocol|0|||
162977265|NCT01730040|588618642|FG004|Overall Study|Poor compliance to protocol|0|||
162977266|NCT01730040|588618643|FG005|Overall Study|Poor compliance to protocol|0|||
162977267|NCT01730040|588618644|FG006|Overall Study|Poor compliance to protocol|1|||
162977268|NCT00544817|588618647|FG000|Combined Modality|Lack of Efficacy|2|||
162977269|NCT00544817|588618647|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
162977270|NCT00544817|588618647|FG000|Combined Modality|Adverse Event|2|||
162977271|NCT00544817|588618647|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
162977272|NCT00544817|588618647|FG000|No Treatment Interval|Lack of Efficacy|8|||
162977273|NCT00544817|588618647|FG000|No Treatment Interval|Physician Decision|3|||
162977274|NCT00544817|588618647|FG000|No Treatment Interval|Adverse Event|1|||
162977275|NCT00544817|588618647|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
162977276|NCT00544817|588618647|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
162977277|NCT00544817|588618647|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
162977278|NCT01552369|588618648|FG000|Overall Study|Did not consent to extended follow up|8|||
162977279|NCT01552369|588618649|FG001|Overall Study|Did not consent to extended follow up|9|||
163318175|NCT03257410|589876848|FG001|Overall Study|Protocol Violation|2|||
163318176|NCT03257410|589876847|FG000|Overall Study|Lost to Follow-up|1|||
163318177|NCT03257410|589876848|FG001|Overall Study|Lost to Follow-up|0|||
163318178|NCT03257410|589876847|FG000|Overall Study|Withdrawal by Subject|1|||
163318179|NCT03257410|589876848|FG001|Overall Study|Withdrawal by Subject|2|||
163318180|NCT03257410|589876847|FG000|Overall Study|Physician Decision|1|||
163318181|NCT03257410|589876848|FG001|Overall Study|Physician Decision|1|||
163318182|NCT03257410|589876847|FG000|Overall Study|Renal transplantation|2|||
163318183|NCT03257410|589876848|FG001|Overall Study|Renal transplantation|0|||
163318184|NCT03257410|589876847|FG000|Overall Study|Switch to peritoneal dialysis|1|||
163318185|NCT03257410|589876848|FG001|Overall Study|Switch to peritoneal dialysis|0|||
163318186|NCT03257410|589876847|FG000|Overall Study|Death|3|||
163318187|NCT03257410|589876848|FG001|Overall Study|Death|2|||
163318188|NCT03257410|589876847|FG000|Overall Study|Change to another dialysis center|2|||
163318189|NCT03257410|589876848|FG001|Overall Study|Change to another dialysis center|2|||
163318190|NCT03257410|589876847|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
163318191|NCT03257410|589876848|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
163318192|NCT03257410|589876847|FG000|Overall Study|Miscellaneous|2|||
163318193|NCT03257410|589876848|FG001|Overall Study|Miscellaneous|2|||
162977280|NCT01221090|588618651|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
162977281|NCT01221090|588618652|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
162977282|NCT01221090|588618653|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
162977283|NCT01221090|588618654|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
162977284|NCT01221090|588618651|FG000|Overall Study|Withdrawal by Subject|0|||
162977285|NCT01221090|588618652|FG001|Overall Study|Withdrawal by Subject|22|||
162977286|NCT01221090|588618653|FG002|Overall Study|Withdrawal by Subject|27|||
163318194|NCT03257410|589876847|FG000|Overall Study|Other|0|||
163318195|NCT03257410|589876848|FG001|Overall Study|Other|1|||
163318196|NCT02598388|589876849|FG000|Overall Study|Lost to Follow-up|1|||
163401416|NCT03370120|590181157|FG000|Overall Study|The study was interrupted by sponsor|4|||
163401417|NCT03370120|590181157|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
163401418|NCT03370120|590181157|FG000|Overall Study|End of sponsor decision|1|||
163318197|NCT02598388|589876850|FG001|Overall Study|Lost to Follow-up|0|||
163318198|NCT02598388|589876851|FG002|Overall Study|Lost to Follow-up|1|||
163318199|NCT02598388|589876852|FG003|Overall Study|Lost to Follow-up|0|||
163318200|NCT02598388|589876853|FG004|Overall Study|Lost to Follow-up|5|||
163318201|NCT02598388|589876854|FG005|Overall Study|Lost to Follow-up|1|||
163318202|NCT02598388|589876855|FG006|Overall Study|Lost to Follow-up|2|||
163318203|NCT02598388|589876856|FG007|Overall Study|Lost to Follow-up|1|||
163318204|NCT02598388|589876857|FG008|Overall Study|Lost to Follow-up|0|||
163318205|NCT02598388|589876858|FG009|Overall Study|Lost to Follow-up|0|||
163318206|NCT02598388|589876859|FG010|Overall Study|Lost to Follow-up|1|||
163318207|NCT02598388|589876860|FG011|Overall Study|Lost to Follow-up|0|||
163318208|NCT02598388|589876849|FG000|Overall Study|Withdrawal by Subject|0|||
163318209|NCT02598388|589876850|FG001|Overall Study|Withdrawal by Subject|0|||
163318210|NCT02598388|589876851|FG002|Overall Study|Withdrawal by Subject|0|||
163318211|NCT02598388|589876852|FG003|Overall Study|Withdrawal by Subject|0|||
163318212|NCT02598388|589876853|FG004|Overall Study|Withdrawal by Subject|2|||
163318213|NCT02598388|589876854|FG005|Overall Study|Withdrawal by Subject|0|||
163318214|NCT02598388|589876855|FG006|Overall Study|Withdrawal by Subject|2|||
163318215|NCT02598388|589876856|FG007|Overall Study|Withdrawal by Subject|0|||
163318216|NCT02598388|589876857|FG008|Overall Study|Withdrawal by Subject|0|||
163318217|NCT02598388|589876858|FG009|Overall Study|Withdrawal by Subject|1|||
163318218|NCT02598388|589876859|FG010|Overall Study|Withdrawal by Subject|0|||
163318219|NCT02598388|589876860|FG011|Overall Study|Withdrawal by Subject|0|||
163318220|NCT02598388|589876849|FG000|Overall Study|Other|0|||
163318221|NCT02598388|589876850|FG001|Overall Study|Other|0|||
163318222|NCT02598388|589876851|FG002|Overall Study|Other|1|||
163318223|NCT02598388|589876852|FG003|Overall Study|Other|0|||
163318224|NCT02598388|589876853|FG004|Overall Study|Other|3|||
163318225|NCT02598388|589876854|FG005|Overall Study|Other|0|||
163318226|NCT02598388|589876855|FG006|Overall Study|Other|1|||
163318227|NCT02598388|589876856|FG007|Overall Study|Other|0|||
163318228|NCT02598388|589876857|FG008|Overall Study|Other|0|||
163318229|NCT02598388|589876858|FG009|Overall Study|Other|0|||
163318230|NCT02598388|589876859|FG010|Overall Study|Other|0|||
163318231|NCT02598388|589876860|FG011|Overall Study|Other|0|||
163318232|NCT03668236|589876863|FG000|90-day Follow-up|Withdrawal by Subject|3|||
163318233|NCT03668236|589876864|FG001|90-day Follow-up|Withdrawal by Subject|2|||
163318234|NCT03668236|589876863|FG000|90-day Follow-up|Lost to Follow-up|3|||
163318235|NCT03668236|589876864|FG001|90-day Follow-up|Lost to Follow-up|1|||
163318236|NCT03668236|589876863|FG000|Baseline Characteristics|Lost to Follow-up|9|||
163318237|NCT03668236|589876864|FG001|Baseline Characteristics|Lost to Follow-up|5|||
163318238|NCT03668236|589876863|FG000|1-year Follow-up|Withdrawal by Subject|17|||
163318239|NCT03668236|589876864|FG001|1-year Follow-up|Withdrawal by Subject|15|||
163318240|NCT06132282|589876865|FG000|Overall Study|Lost to Follow-up|31|||
163318241|NCT04499924|589876868|FG000|Overall Study|Study termination by sponsor|4|||
163318242|NCT04499924|589876869|FG001|Overall Study|Study termination by sponsor|6|||
163318243|NCT04499924|589876868|FG000|Overall Study|Withdrawal by Subject|1|||
163318244|NCT04499924|589876869|FG001|Overall Study|Withdrawal by Subject|3|||
163318245|NCT03011333|589876870|FG000|Overall Study|Lost to Follow-up|0|||
163318246|NCT03011333|589876871|FG001|Overall Study|Lost to Follow-up|1|||
163318247|NCT03011333|589876872|FG002|Overall Study|Lost to Follow-up|0|||
163401419|NCT03370120|590181157|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
163401420|NCT03370120|590181157|FG000|Overall Study|Early termination of studies|5|||
163401421|NCT03370120|590181157|FG000|Overall Study|This study is ended early|1|||
163401422|NCT03370120|590181157|FG000|Overall Study|End of padsevonil program|2|||
163401423|NCT03370120|590181157|FG000|Overall Study|Decision of sponsor|6|||
163401424|NCT03370120|590181157|FG000|Overall Study|Asked by the sponsor|3|||
163401425|NCT03370120|590181157|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
163401426|NCT03370120|590181157|FG000|Overall Study|PI decision poor compliance from participant|1|||
163401427|NCT03370120|590181157|FG000|Overall Study|Promoter ended the study|3|||
163401428|NCT03370120|590181157|FG000|Overall Study|Premature study close by sponsor's decision|4|||
163057995|NCT01206764|588922815|FG000|Overall Study|Adverse Event|20|||
163318248|NCT03011333|589876873|FG003|Overall Study|Lost to Follow-up|1|||
163318249|NCT03011333|589876874|FG004|Overall Study|Lost to Follow-up|4|||
163318250|NCT03011333|589876875|FG005|Overall Study|Lost to Follow-up|4|||
163318251|NCT03011333|589876876|FG006|Overall Study|Lost to Follow-up|5|||
163318252|NCT03663569|589876877|FG000|Overall Study|Discontinuation of study|11|||
163318253|NCT03663569|589876877|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
163318254|NCT03663569|589876877|FG000|Overall Study|Deceased patient|6|||
163401429|NCT03370120|590181157|FG000|Overall Study|Study terminated by sponsor|33|||
163401430|NCT03370120|590181157|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
163318255|NCT03663569|589876877|FG000|Overall Study|Lost to Follow-up|18|||
163318256|NCT03663569|589876877|FG000|Overall Study|Withdrawal of consent|5|||
163318257|NCT03663569|589876877|FG000|Overall Study|Patient's request|11|||
163318258|NCT03663569|589876877|FG000|Overall Study|Adverse Event|4|||
163318259|NCT03663569|589876877|FG000|Overall Study|Not come to second visit|3|||
163318260|NCT03663569|589876877|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
163318261|NCT03663569|589876877|FG000|Overall Study|Serious adverse event|1|||
163318262|NCT04183283|589876878|FG000|Period 1|Withdrawal by Subject|0|||
163318263|NCT04183283|589876879|FG001|Period 1|Withdrawal by Subject|1|||
163318264|NCT04183283|589876880|FG002|Period 1|Withdrawal by Subject|0|||
163318265|NCT04183283|589876881|FG003|Period 1|Withdrawal by Subject|0|||
163318266|NCT04183283|589876878|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
163318267|NCT04183283|589876879|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
163318268|NCT04183283|589876880|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
163318269|NCT04183283|589876881|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
163318270|NCT00104676|589876885|FG000|Overall Study|Death|3|||
163318271|NCT00104676|589876886|FG001|Overall Study|Death|2|||
163318272|NCT00104676|589876885|FG000|Overall Study|Withdrawal by Subject|0|||
163401431|NCT03370120|590181157|FG000|Overall Study|Sponsor decision to terminate study|63|||
163401432|NCT03370120|590181157|FG000|Overall Study|Program closure|3|||
163401433|NCT03370120|590181157|FG000|Overall Study|Study ended prematurely|1|||
163401434|NCT03370120|590181157|FG000|Overall Study|Study stopped by sponsor|2|||
163401435|NCT03370120|590181157|FG000|Overall Study|Program termination|55|||
163401436|NCT03370120|590181157|FG000|Overall Study|Sponsor decision|62|||
163401437|NCT03370120|590181157|FG000|Overall Study|Sponsor study closure|10|||
163401438|NCT00928889|590181159|FG000|Overall Study|Lost to Follow-up|3|||
163401439|NCT00928889|590181160|FG001|Overall Study|Lost to Follow-up|1|||
163401440|NCT00928889|590181159|FG000|Overall Study|Protocol Violation|0|||
163401441|NCT00928889|590181160|FG001|Overall Study|Protocol Violation|1|||
163401442|NCT00928889|590181159|FG000|Overall Study|Adverse Event|1|||
163401443|NCT00928889|590181160|FG001|Overall Study|Adverse Event|0|||
163401444|NCT00928889|590181159|FG000|Overall Study|Other|1|||
163401445|NCT00928889|590181160|FG001|Overall Study|Other|0|||
163401446|NCT04712110|590181167|FG000|Overall Study|Lost to Follow-up|0|||
163318273|NCT00104676|589876886|FG001|Overall Study|Withdrawal by Subject|2|||
163318274|NCT00104676|589876885|FG000|Overall Study|treatment interruption|4|||
163318275|NCT00104676|589876886|FG001|Overall Study|treatment interruption|10|||
163318276|NCT00696111|589876897|FG000|Overall Study|Withdrawal by Subject|17|||
162977287|NCT01221090|588618654|FG003|Overall Study|Withdrawal by Subject|2|||
163318277|NCT03687086|589876904|FG000|Overall Study|Withdrawal by Subject|3|||
162977288|NCT00440466|588618656|FG000|Overall Study|Death|3|||
162977289|NCT00440466|588618657|FG001|Overall Study|Death|2|||
162977290|NCT00440466|588618658|FG002|Overall Study|Death|9|||
162977291|NCT00440466|588618656|FG000|Overall Study|Adverse Event|3|||
162977292|NCT00440466|588618657|FG001|Overall Study|Adverse Event|4|||
162977293|NCT00440466|588618658|FG002|Overall Study|Adverse Event|11|||
162977294|NCT00440466|588618656|FG000|Overall Study|Lost to Follow-up|1|||
162977295|NCT00440466|588618657|FG001|Overall Study|Lost to Follow-up|0|||
162977296|NCT00440466|588618658|FG002|Overall Study|Lost to Follow-up|2|||
162977297|NCT00440466|588618656|FG000|Overall Study|Physician Decision|2|||
162977298|NCT00440466|588618657|FG001|Overall Study|Physician Decision|0|||
162977299|NCT00440466|588618658|FG002|Overall Study|Physician Decision|1|||
162977300|NCT00440466|588618656|FG000|Overall Study|Protocol Violation|2|||
162977301|NCT00440466|588618657|FG001|Overall Study|Protocol Violation|0|||
162977302|NCT00440466|588618658|FG002|Overall Study|Protocol Violation|4|||
162977303|NCT00440466|588618656|FG000|Overall Study|Withdrawal by Subject|2|||
162977304|NCT00440466|588618657|FG001|Overall Study|Withdrawal by Subject|5|||
162977305|NCT00440466|588618658|FG002|Overall Study|Withdrawal by Subject|9|||
162977306|NCT00440466|588618656|FG000|Overall Study|Began Dialysis|0|||
162977307|NCT00440466|588618657|FG001|Overall Study|Began Dialysis|0|||
162977308|NCT00440466|588618658|FG002|Overall Study|Began Dialysis|1|||
162977309|NCT00440466|588618656|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
162977310|NCT00440466|588618657|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
162977311|NCT00440466|588618658|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
162977312|NCT01223235|588618661|FG000|Overall Study|Withdrawal by Subject|1|||
162977313|NCT03756883|588618664|FG000|Overall Study|Adverse Event|2|||
162977314|NCT03756883|588618665|FG001|Overall Study|Adverse Event|2|||
162977315|NCT03756883|588618666|FG002|Overall Study|Adverse Event|2|||
162977316|NCT03756883|588618664|FG000|Overall Study|Lack of Efficacy|0|||
163318278|NCT03687086|589876905|FG001|Overall Study|Withdrawal by Subject|4|||
163401447|NCT04712110|590181168|FG001|Overall Study|Lost to Follow-up|1|||
162977317|NCT03756883|588618665|FG001|Overall Study|Lack of Efficacy|1|||
162977318|NCT03756883|588618666|FG002|Overall Study|Lack of Efficacy|2|||
163401448|NCT04712110|590181167|FG000|Overall Study|Withdrawal by Subject|0|||
163401449|NCT04712110|590181168|FG001|Overall Study|Withdrawal by Subject|4|||
163401450|NCT04712110|590181167|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
162977319|NCT03756883|588618664|FG000|Overall Study|Lost to Follow-up|3|||
162977320|NCT03756883|588618665|FG001|Overall Study|Lost to Follow-up|3|||
163401451|NCT04712110|590181168|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
163318279|NCT03687086|589876904|FG000|Overall Study|Lost to Follow-up|1|||
163318280|NCT03687086|589876905|FG001|Overall Study|Lost to Follow-up|1|||
163318281|NCT03687086|589876904|FG000|Overall Study|Death|1|||
163210011|NCT01129960|589483074|FG000|Overall Study|Lack of Efficacy|1|||
163210012|NCT01129960|589483075|FG001|Overall Study|Lack of Efficacy|1|||
163210013|NCT01129960|589483076|FG002|Overall Study|Lack of Efficacy|1|||
163210014|NCT01129960|589483077|FG003|Overall Study|Lack of Efficacy|1|||
163210015|NCT01129960|589483074|FG000|Overall Study|Adverse Event|23|||
163210016|NCT01129960|589483075|FG001|Overall Study|Adverse Event|16|||
163210017|NCT01129960|589483076|FG002|Overall Study|Adverse Event|16|||
163210018|NCT01129960|589483077|FG003|Overall Study|Adverse Event|7|||
163210019|NCT01129960|589483074|FG000|Overall Study|Protocol Violation|1|||
163210020|NCT01129960|589483075|FG001|Overall Study|Protocol Violation|2|||
163210021|NCT01129960|589483076|FG002|Overall Study|Protocol Violation|3|||
163210022|NCT01129960|589483077|FG003|Overall Study|Protocol Violation|0|||
163210023|NCT01129960|589483074|FG000|Overall Study|Lost to Follow-up|0|||
163210024|NCT01129960|589483075|FG001|Overall Study|Lost to Follow-up|2|||
163210025|NCT01129960|589483076|FG002|Overall Study|Lost to Follow-up|3|||
163210026|NCT01129960|589483077|FG003|Overall Study|Lost to Follow-up|3|||
163210027|NCT01129960|589483074|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
163210028|NCT01129960|589483075|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
163210029|NCT01129960|589483076|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
163210030|NCT01129960|589483077|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
163210031|NCT01129960|589483074|FG000|Overall Study|Physician Decision|1|||
163210032|NCT01129960|589483075|FG001|Overall Study|Physician Decision|0|||
163210033|NCT01129960|589483076|FG002|Overall Study|Physician Decision|0|||
163210034|NCT01129960|589483077|FG003|Overall Study|Physician Decision|0|||
163210035|NCT01129960|589483074|FG000|Overall Study|Pregnancy|1|||
163210036|NCT01129960|589483075|FG001|Overall Study|Pregnancy|0|||
163210037|NCT01129960|589483076|FG002|Overall Study|Pregnancy|0|||
163210038|NCT01129960|589483077|FG003|Overall Study|Pregnancy|0|||
163210039|NCT01927367|589483080|FG000|Overall Study|Withdrawal by Subject|7|||
163210040|NCT01927367|589483081|FG001|Overall Study|Withdrawal by Subject|4|||
163318282|NCT03687086|589876905|FG001|Overall Study|Death|0|||
163318283|NCT03687086|589876904|FG000|Overall Study|Incomplete assessment|0|||
163318284|NCT03687086|589876905|FG001|Overall Study|Incomplete assessment|2|||
163318285|NCT04362254|589876909|FG000|Overall Study|Adverse Event|1|||
163318286|NCT04362254|589876909|FG000|Overall Study|Protocol Violation|1|||
163318287|NCT04362254|589876909|FG000|Overall Study|Due to early termination of the trial|10|||
163318288|NCT04707625|589876910|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
163318289|NCT02038777|589876911|FG000|Overall Study|Death|0|||
163318290|NCT02038777|589876912|FG001|Overall Study|Death|2|||
163318291|NCT02038777|589876913|FG002|Overall Study|Death|0|||
163318292|NCT02038777|589876914|FG003|Overall Study|Death|1|||
163318293|NCT02038777|589876915|FG004|Overall Study|Death|2|||
163318294|NCT02038777|589876916|FG005|Overall Study|Death|4|||
163318295|NCT02038777|589876917|FG006|Overall Study|Death|0|||
163318296|NCT02038777|589876918|FG007|Overall Study|Death|11|||
163318297|NCT02038777|589876911|FG000|Overall Study|Lost to Follow-up|0|||
163318298|NCT02038777|589876912|FG001|Overall Study|Lost to Follow-up|0|||
163318299|NCT02038777|589876913|FG002|Overall Study|Lost to Follow-up|0|||
163318300|NCT02038777|589876914|FG003|Overall Study|Lost to Follow-up|1|||
163318301|NCT02038777|589876915|FG004|Overall Study|Lost to Follow-up|0|||
163318302|NCT02038777|589876916|FG005|Overall Study|Lost to Follow-up|0|||
163318303|NCT02038777|589876917|FG006|Overall Study|Lost to Follow-up|0|||
163318304|NCT02038777|589876918|FG007|Overall Study|Lost to Follow-up|0|||
162977321|NCT03756883|588618666|FG002|Overall Study|Lost to Follow-up|0|||
163210041|NCT01927367|589483080|FG000|Overall Study|No baseline data|0|||
163210042|NCT01927367|589483081|FG001|Overall Study|No baseline data|1|||
163210043|NCT00071513|589483082|FG000|Intervention Component|Withdrawal by Subject|2|||
163210044|NCT00071513|589483083|FG001|Intervention Component|Withdrawal by Subject|3|||
163210045|NCT00071513|589483082|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
163210046|NCT00071513|589483083|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
163210047|NCT01634360|589483084|FG000|Overall Study|Adverse Event|10|||
163210048|NCT01634360|589483085|FG001|Overall Study|Adverse Event|34|||
163210049|NCT01634360|589483084|FG000|Overall Study|subject withdrew consent|13|||
163318305|NCT02038777|589876911|FG000|Overall Study|Other|0|||
163318306|NCT02038777|589876912|FG001|Overall Study|Other|1|||
163210050|NCT01634360|589483085|FG001|Overall Study|subject withdrew consent|23|||
163210051|NCT01634360|589483084|FG000|Overall Study|Protocol Violation|1|||
163210052|NCT01634360|589483085|FG001|Overall Study|Protocol Violation|1|||
163210053|NCT01634360|589483084|FG000|Overall Study|Lack of Efficacy|4|||
163210054|NCT01634360|589483085|FG001|Overall Study|Lack of Efficacy|14|||
163210055|NCT01634360|589483084|FG000|Overall Study|Other|3|||
163210056|NCT01634360|589483085|FG001|Overall Study|Other|20|||
163210057|NCT01634360|589483084|FG000|Overall Study|Study termination by sponsor|18|||
163210058|NCT01634360|589483085|FG001|Overall Study|Study termination by sponsor|44|||
163210059|NCT02743871|589483086|FG000|Overall Study|Lost to Follow-up|0|||
163318307|NCT02038777|589876913|FG002|Overall Study|Other|0|||
163318308|NCT02038777|589876914|FG003|Overall Study|Other|2|||
163318309|NCT02038777|589876915|FG004|Overall Study|Other|1|||
163318310|NCT02038777|589876916|FG005|Overall Study|Other|0|||
163318311|NCT02038777|589876917|FG006|Overall Study|Other|0|||
163318312|NCT02038777|589876918|FG007|Overall Study|Other|0|||
163318313|NCT02038777|589876911|FG000|Overall Study|Randomized but not treated|0|||
163318314|NCT02038777|589876912|FG001|Overall Study|Randomized but not treated|1|||
163318315|NCT02038777|589876913|FG002|Overall Study|Randomized but not treated|0|||
163318316|NCT02038777|589876914|FG003|Overall Study|Randomized but not treated|0|||
163318317|NCT02038777|589876915|FG004|Overall Study|Randomized but not treated|0|||
163318318|NCT02038777|589876916|FG005|Overall Study|Randomized but not treated|0|||
163318319|NCT02038777|589876917|FG006|Overall Study|Randomized but not treated|0|||
163318320|NCT02038777|589876918|FG007|Overall Study|Randomized but not treated|0|||
163318321|NCT02038777|589876911|FG000|Overall Study|Started Chemotherapy|1|||
163318322|NCT02038777|589876912|FG001|Overall Study|Started Chemotherapy|0|||
163318323|NCT02038777|589876913|FG002|Overall Study|Started Chemotherapy|3|||
163318324|NCT02038777|589876914|FG003|Overall Study|Started Chemotherapy|0|||
163318325|NCT02038777|589876915|FG004|Overall Study|Started Chemotherapy|0|||
163318326|NCT02038777|589876916|FG005|Overall Study|Started Chemotherapy|0|||
163318327|NCT02038777|589876917|FG006|Overall Study|Started Chemotherapy|0|||
163318328|NCT02038777|589876918|FG007|Overall Study|Started Chemotherapy|0|||
163318329|NCT02038777|589876911|FG000|Overall Study|participation terminated by sponsor|0|||
163318330|NCT02038777|589876912|FG001|Overall Study|participation terminated by sponsor|0|||
163318331|NCT02038777|589876913|FG002|Overall Study|participation terminated by sponsor|0|||
163318332|NCT02038777|589876914|FG003|Overall Study|participation terminated by sponsor|0|||
163210060|NCT02743871|589483087|FG001|Overall Study|Lost to Follow-up|0|||
163210061|NCT02743871|589483088|FG002|Overall Study|Lost to Follow-up|0|||
163210062|NCT02743871|589483089|FG003|Overall Study|Lost to Follow-up|1|||
163210063|NCT02743871|589483090|FG004|Overall Study|Lost to Follow-up|0|||
163210064|NCT02743871|589483091|FG005|Overall Study|Lost to Follow-up|0|||
163210065|NCT02743871|589483092|FG006|Overall Study|Lost to Follow-up|1|||
163210066|NCT02743871|589483093|FG007|Overall Study|Lost to Follow-up|0|||
163210067|NCT02743871|589483094|FG008|Overall Study|Lost to Follow-up|0|||
163210068|NCT02743871|589483095|FG009|Overall Study|Lost to Follow-up|0|||
163210069|NCT02743871|589483096|FG010|Overall Study|Lost to Follow-up|0|||
163210070|NCT02743871|589483097|FG011|Overall Study|Lost to Follow-up|2|||
163210071|NCT02743871|589483098|FG012|Overall Study|Lost to Follow-up|0|||
163210072|NCT02743871|589483099|FG013|Overall Study|Lost to Follow-up|0|||
163210073|NCT02743871|589483086|FG000|Overall Study|Withdrawal by Subject|0|||
163210074|NCT02743871|589483087|FG001|Overall Study|Withdrawal by Subject|0|||
163210075|NCT02743871|589483088|FG002|Overall Study|Withdrawal by Subject|0|||
163210076|NCT02743871|589483089|FG003|Overall Study|Withdrawal by Subject|0|||
163210077|NCT02743871|589483090|FG004|Overall Study|Withdrawal by Subject|0|||
163210078|NCT02743871|589483091|FG005|Overall Study|Withdrawal by Subject|0|||
163210079|NCT02743871|589483092|FG006|Overall Study|Withdrawal by Subject|0|||
163210080|NCT02743871|589483093|FG007|Overall Study|Withdrawal by Subject|0|||
163210081|NCT02743871|589483094|FG008|Overall Study|Withdrawal by Subject|0|||
163210082|NCT02743871|589483095|FG009|Overall Study|Withdrawal by Subject|0|||
163210083|NCT02743871|589483096|FG010|Overall Study|Withdrawal by Subject|1|||
163210084|NCT02743871|589483097|FG011|Overall Study|Withdrawal by Subject|0|||
163210085|NCT02743871|589483098|FG012|Overall Study|Withdrawal by Subject|12|||
163210086|NCT02743871|589483099|FG013|Overall Study|Withdrawal by Subject|6|||
163210087|NCT02743871|589483086|FG000|Overall Study|Adverse Event|1|||
163210088|NCT02743871|589483087|FG001|Overall Study|Adverse Event|0|||
163210089|NCT02743871|589483088|FG002|Overall Study|Adverse Event|0|||
163210090|NCT02743871|589483089|FG003|Overall Study|Adverse Event|0|||
163210091|NCT02743871|589483090|FG004|Overall Study|Adverse Event|0|||
163210092|NCT02743871|589483091|FG005|Overall Study|Adverse Event|0|||
163210093|NCT02743871|589483092|FG006|Overall Study|Adverse Event|0|||
163210094|NCT02743871|589483093|FG007|Overall Study|Adverse Event|0|||
163210095|NCT02743871|589483094|FG008|Overall Study|Adverse Event|0|||
163210096|NCT02743871|589483095|FG009|Overall Study|Adverse Event|0|||
163210097|NCT02743871|589483096|FG010|Overall Study|Adverse Event|0|||
163210098|NCT02743871|589483097|FG011|Overall Study|Adverse Event|0|||
163210099|NCT02743871|589483098|FG012|Overall Study|Adverse Event|0|||
163210100|NCT02743871|589483099|FG013|Overall Study|Adverse Event|0|||
163210101|NCT02743871|589483086|FG000|Overall Study|Other|0|||
163210102|NCT02743871|589483087|FG001|Overall Study|Other|0|||
163210103|NCT02743871|589483088|FG002|Overall Study|Other|0|||
163210104|NCT02743871|589483089|FG003|Overall Study|Other|0|||
163318333|NCT02038777|589876915|FG004|Overall Study|participation terminated by sponsor|0|||
163318334|NCT02038777|589876916|FG005|Overall Study|participation terminated by sponsor|0|||
163318335|NCT02038777|589876917|FG006|Overall Study|participation terminated by sponsor|1|||
163318336|NCT02038777|589876918|FG007|Overall Study|participation terminated by sponsor|1|||
163318337|NCT03386578|589876922|FG000|PK Component|Lost to Follow-up|0|||
163318338|NCT03386578|589876923|FG001|PK Component|Lost to Follow-up|1|||
163318339|NCT03386578|589876924|FG002|PK Component|Lost to Follow-up|0|||
162977322|NCT03756883|588618664|FG000|Overall Study|Protocol Violation|2|||
162977323|NCT03756883|588618665|FG001|Overall Study|Protocol Violation|0|||
162977324|NCT03756883|588618666|FG002|Overall Study|Protocol Violation|1|||
162977325|NCT03756883|588618664|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
162977326|NCT03756883|588618665|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
162977327|NCT03756883|588618666|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
162977328|NCT03756883|588618664|FG000|Overall Study|Withdrawal by Subject|4|||
162977329|NCT03756883|588618665|FG001|Overall Study|Withdrawal by Subject|1|||
162977330|NCT03756883|588618666|FG002|Overall Study|Withdrawal by Subject|0|||
162977331|NCT03756883|588618664|FG000|Overall Study|Other Reasons|2|||
163210105|NCT02743871|589483090|FG004|Overall Study|Other|0|||
163210106|NCT02743871|589483091|FG005|Overall Study|Other|0|||
162977332|NCT03756883|588618665|FG001|Overall Study|Other Reasons|4|||
163210107|NCT02743871|589483092|FG006|Overall Study|Other|0|||
163210108|NCT02743871|589483093|FG007|Overall Study|Other|0|||
163210109|NCT02743871|589483094|FG008|Overall Study|Other|0|||
163210110|NCT02743871|589483095|FG009|Overall Study|Other|0|||
163210111|NCT02743871|589483096|FG010|Overall Study|Other|0|||
163210112|NCT02743871|589483097|FG011|Overall Study|Other|1|||
163210113|NCT02743871|589483098|FG012|Overall Study|Other|1|||
163210114|NCT02743871|589483099|FG013|Overall Study|Other|1|||
163210115|NCT02743871|589483086|FG000|Overall Study|Protocol Violation|0|||
163210116|NCT02743871|589483087|FG001|Overall Study|Protocol Violation|0|||
163210117|NCT02743871|589483088|FG002|Overall Study|Protocol Violation|0|||
163210118|NCT02743871|589483089|FG003|Overall Study|Protocol Violation|0|||
163210119|NCT02743871|589483090|FG004|Overall Study|Protocol Violation|0|||
163210120|NCT02743871|589483091|FG005|Overall Study|Protocol Violation|0|||
162977333|NCT03756883|588618666|FG002|Overall Study|Other Reasons|0|||
162977334|NCT00685802|588618667|FG000|Washout Period of 7 Days|Protocol Violation|2|||
162977335|NCT00685802|588618668|FG001|Washout Period of 7 Days|Protocol Violation|0|||
162977336|NCT00685802|588618667|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
162977337|NCT00685802|588618668|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
162977338|NCT00754442|588618669|FG000|Overall Study|Withdrawal by Subject|5|||
162977339|NCT00754442|588618670|FG001|Overall Study|Withdrawal by Subject|3|||
162977340|NCT03005067|588618671|FG000|Overall Study|Withdrawal by Subject|3|||
163210121|NCT02743871|589483092|FG006|Overall Study|Protocol Violation|0|||
163210122|NCT02743871|589483093|FG007|Overall Study|Protocol Violation|0|||
163210123|NCT02743871|589483094|FG008|Overall Study|Protocol Violation|0|||
163210124|NCT02743871|589483095|FG009|Overall Study|Protocol Violation|0|||
163210125|NCT02743871|589483096|FG010|Overall Study|Protocol Violation|0|||
163210126|NCT02743871|589483097|FG011|Overall Study|Protocol Violation|0|||
163210127|NCT02743871|589483098|FG012|Overall Study|Protocol Violation|2|||
163210128|NCT02743871|589483099|FG013|Overall Study|Protocol Violation|0|||
163210129|NCT03171415|589483101|FG000|Overall Study|Lost to Follow-up|0|||
163210130|NCT03171415|589483102|FG001|Overall Study|Lost to Follow-up|0|||
163210131|NCT03171415|589483103|FG002|Overall Study|Lost to Follow-up|0|||
163210132|NCT03171415|589483104|FG003|Overall Study|Lost to Follow-up|0|||
163210133|NCT03171415|589483105|FG004|Overall Study|Lost to Follow-up|2|||
163210134|NCT02848651|589483106|FG000|Overall Study|Death|85|||
163210135|NCT02848651|589483106|FG000|Overall Study|Lost to Follow-up|1|||
163210136|NCT02848651|589483106|FG000|Overall Study|Non-Compliance|1|||
163210137|NCT02848651|589483106|FG000|Overall Study|Symptomatic Deterioration|1|||
163210138|NCT02848651|589483106|FG000|Overall Study|Physician Decision|4|||
163210139|NCT02848651|589483106|FG000|Overall Study|Withdrawal by Subject|14|||
163210140|NCT04140292|589483107|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
163210141|NCT04140292|589483108|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
163210142|NCT00680043|589483112|FG000|Overall Study|Withdrawal by Subject|1|||
163210143|NCT00680043|589483113|FG001|Overall Study|Withdrawal by Subject|0|||
163210144|NCT00680043|589483114|FG002|Overall Study|Withdrawal by Subject|0|||
163210145|NCT00680043|589483112|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
163210146|NCT00680043|589483113|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
163210147|NCT00680043|589483114|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
163210148|NCT00680043|589483112|FG000|Overall Study|Renal Transplant|1|||
163210149|NCT00680043|589483113|FG001|Overall Study|Renal Transplant|0|||
163210150|NCT00680043|589483114|FG002|Overall Study|Renal Transplant|4|||
163210151|NCT02480114|589483115|FG000|Overall Study|Not completing surveys|3|||
163210152|NCT02480114|589483116|FG001|Overall Study|Not completing surveys|2|||
163210153|NCT02480114|589483115|FG000|Overall Study|Withdrawal by Subject|2|||
163210154|NCT02480114|589483116|FG001|Overall Study|Withdrawal by Subject|4|||
163210155|NCT02480114|589483115|FG000|Overall Study|Disease progression|3|||
163210156|NCT02480114|589483116|FG001|Overall Study|Disease progression|0|||
163210157|NCT02480114|589483115|FG000|Overall Study|Improper completion of survey|1|||
163210158|NCT02480114|589483116|FG001|Overall Study|Improper completion of survey|1|||
163210159|NCT02480114|589483115|FG000|Overall Study|Not eligible|0|||
163210160|NCT02480114|589483116|FG001|Overall Study|Not eligible|1|||
163210161|NCT02081690|589485173|FG000|Overall Study|Death|3|||
163210162|NCT02081690|589485173|FG000|Overall Study|Physician Decision|3|||
163210163|NCT02081690|589485173|FG000|Overall Study|Withdrawal by Subject|1|||
163210164|NCT00982488|589485176|FG000|Overall Study|Administrative reason by sponsor|81|||
163210165|NCT00982488|589485177|FG001|Overall Study|Administrative reason by sponsor|3|||
163210166|NCT00982488|589485178|FG002|Overall Study|Administrative reason by sponsor|11|||
163210167|NCT00982488|589485179|FG003|Overall Study|Administrative reason by sponsor|0|||
163210168|NCT00982488|589485180|FG004|Overall Study|Administrative reason by sponsor|0|||
163210169|NCT00982488|589485176|FG000|Overall Study|Adverse event unrelated to study drug|5|||
163210170|NCT00982488|589485177|FG001|Overall Study|Adverse event unrelated to study drug|1|||
163210171|NCT00982488|589485178|FG002|Overall Study|Adverse event unrelated to study drug|0|||
163210172|NCT00982488|589485179|FG003|Overall Study|Adverse event unrelated to study drug|0|||
163210173|NCT00982488|589485180|FG004|Overall Study|Adverse event unrelated to study drug|0|||
163210174|NCT00982488|589485176|FG000|Overall Study|Death|11|||
163210175|NCT00982488|589485177|FG001|Overall Study|Death|0|||
163210176|NCT00982488|589485178|FG002|Overall Study|Death|2|||
163210177|NCT00982488|589485179|FG003|Overall Study|Death|0|||
163210178|NCT00982488|589485180|FG004|Overall Study|Death|0|||
163210179|NCT00982488|589485176|FG000|Overall Study|Disease progression|30|||
163210180|NCT00982488|589485177|FG001|Overall Study|Disease progression|5|||
163210181|NCT00982488|589485178|FG002|Overall Study|Disease progression|10|||
163210182|NCT00982488|589485179|FG003|Overall Study|Disease progression|1|||
163210183|NCT00982488|589485180|FG004|Overall Study|Disease progression|1|||
163210184|NCT00982488|589485176|FG000|Overall Study|Lost to Follow-up|1|||
163210185|NCT00982488|589485177|FG001|Overall Study|Lost to Follow-up|0|||
163210186|NCT00982488|589485178|FG002|Overall Study|Lost to Follow-up|0|||
163210187|NCT00982488|589485179|FG003|Overall Study|Lost to Follow-up|0|||
163210188|NCT00982488|589485180|FG004|Overall Study|Lost to Follow-up|0|||
163210189|NCT00982488|589485176|FG000|Overall Study|Maximum clinical benefit|1|||
163210190|NCT00982488|589485177|FG001|Overall Study|Maximum clinical benefit|1|||
163210191|NCT00982488|589485178|FG002|Overall Study|Maximum clinical benefit|1|||
163210192|NCT00982488|589485179|FG003|Overall Study|Maximum clinical benefit|0|||
163210193|NCT00982488|589485180|FG004|Overall Study|Maximum clinical benefit|0|||
163210194|NCT00982488|589485176|FG000|Overall Study|Other|15|||
163318340|NCT03386578|589876925|FG003|PK Component|Lost to Follow-up|0|||
163318341|NCT03386578|589876926|FG004|PK Component|Lost to Follow-up|0|||
163318342|NCT03386578|589876927|FG005|PK Component|Lost to Follow-up|0|||
163401452|NCT01356407|590181169|FG000|Overall Study|Lost to Follow-up|2|||
163401453|NCT01356407|590181170|FG001|Overall Study|Lost to Follow-up|0|||
163401454|NCT01356407|590181169|FG000|Overall Study|Patient Withdrew Consent|2|||
163401455|NCT01356407|590181170|FG001|Overall Study|Patient Withdrew Consent|1|||
163401456|NCT01356407|590181169|FG000|Overall Study|Could not afford IMP administration|0|||
163318343|NCT03386578|589876928|FG006|PK Component|Lost to Follow-up|1|||
163318344|NCT03386578|589876929|FG007|PK Component|Lost to Follow-up|0|||
163318345|NCT03386578|589876930|FG008|PK Component|Lost to Follow-up|0|||
163318346|NCT03386578|589876931|FG009|PK Component|Lost to Follow-up|0|||
163318347|NCT03386578|589876922|FG000|PK Component|Stillbirth/Abortion|0|||
163318348|NCT03386578|589876923|FG001|PK Component|Stillbirth/Abortion|0|||
163318349|NCT03386578|589876924|FG002|PK Component|Stillbirth/Abortion|0|||
163318350|NCT03386578|589876925|FG003|PK Component|Stillbirth/Abortion|0|||
163318351|NCT03386578|589876926|FG004|PK Component|Stillbirth/Abortion|0|||
163318352|NCT03386578|589876927|FG005|PK Component|Stillbirth/Abortion|2|||
163318353|NCT03386578|589876928|FG006|PK Component|Stillbirth/Abortion|0|||
163318354|NCT03386578|589876929|FG007|PK Component|Stillbirth/Abortion|0|||
163318355|NCT03386578|589876930|FG008|PK Component|Stillbirth/Abortion|0|||
163318356|NCT03386578|589876931|FG009|PK Component|Stillbirth/Abortion|0|||
163318357|NCT03386578|589876922|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
163318358|NCT03386578|589876923|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
163318359|NCT03386578|589876924|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
163318360|NCT03386578|589876925|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
163318361|NCT03386578|589876926|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
163318362|NCT03386578|589876927|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
163318363|NCT03386578|589876928|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
163318364|NCT03386578|589876929|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
163318365|NCT03386578|589876930|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
163318366|NCT03386578|589876931|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
163318367|NCT03386578|589876922|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
163318368|NCT03386578|589876923|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
163318369|NCT03386578|589876924|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
163318370|NCT03386578|589876925|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
163318371|NCT03386578|589876926|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
163401457|NCT01356407|590181170|FG001|Overall Study|Could not afford IMP administration|1|||
163401458|NCT01356407|590181169|FG000|Overall Study|Not complete Endoscopy|2|||
163401459|NCT01356407|590181170|FG001|Overall Study|Not complete Endoscopy|2|||
163401460|NCT01197521|590181171|FG000|Overall Study|Not reported|24|||
163401461|NCT01197521|590181172|FG001|Overall Study|Not reported|25|||
163401462|NCT01197521|590181173|FG002|Overall Study|Not reported|21|||
163401463|NCT01197521|590181171|FG000|Overall Study|Enrolment in long term extension|42|||
163401464|NCT01197521|590181172|FG001|Overall Study|Enrolment in long term extension|36|||
163401465|NCT01197521|590181173|FG002|Overall Study|Enrolment in long term extension|87|||
163401466|NCT01197521|590181171|FG000|Overall Study|Severe non-compliance to protocol|1|||
163401467|NCT01197521|590181172|FG001|Overall Study|Severe non-compliance to protocol|3|||
163401468|NCT01197521|590181173|FG002|Overall Study|Severe non-compliance to protocol|3|||
163401469|NCT01197521|590181171|FG000|Overall Study|Lack of therapeutic response|2|||
163401470|NCT01197521|590181172|FG001|Overall Study|Lack of therapeutic response|3|||
163401471|NCT01197521|590181173|FG002|Overall Study|Lack of therapeutic response|4|||
163401472|NCT01197521|590181171|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
163318372|NCT03386578|589876927|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
163318373|NCT03386578|589876928|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
163318374|NCT03386578|589876929|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
163318375|NCT03386578|589876930|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
163401473|NCT01197521|590181172|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
163401474|NCT01197521|590181173|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
163210195|NCT00982488|589485177|FG001|Overall Study|Other|1|||
163210196|NCT00982488|589485178|FG002|Overall Study|Other|3|||
163318376|NCT03386578|589876931|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
163318377|NCT03386578|589876922|FG000|PrEP Comparison Component Step 1|Death|0|||
163401475|NCT01197521|590181171|FG000|Overall Study|Lost to Follow-up|3|||
163210197|NCT00982488|589485179|FG003|Overall Study|Other|1|||
163210198|NCT00982488|589485180|FG004|Overall Study|Other|0|||
163057996|NCT01206764|588922815|FG000|Overall Study|Abnormal laboratory value|2|||
163057997|NCT01206764|588922815|FG000|Overall Study|Abnormal test procedure result|1|||
163057998|NCT01206764|588922815|FG000|Overall Study|Patient withdrew consent|5|||
163057999|NCT01206764|588922815|FG000|Overall Study|Lost to Follow-up|6|||
163058000|NCT01206764|588922815|FG000|Overall Study|Death|11|||
163058001|NCT01206764|588922815|FG000|Overall Study|New cancer therapy|2|||
163058002|NCT01206764|588922815|FG000|Overall Study|Disease progression|88|||
163058003|NCT01206764|588922815|FG000|Overall Study|Protocol deviation|3|||
163058004|NCT04494646|588922816|FG000|Overall Study|Adverse Event|0|||
163058005|NCT04494646|588922817|FG001|Overall Study|Adverse Event|1|||
163058006|NCT04494646|588922816|FG000|Overall Study|Withdrawal by Subject|0|||
163058007|NCT04494646|588922817|FG001|Overall Study|Withdrawal by Subject|1|||
163058008|NCT00997893|588922820|FG000|Overall Study|Adverse Event|1|||
163058009|NCT00997893|588922821|FG001|Overall Study|Adverse Event|0|||
163058010|NCT00997893|588922822|FG002|Overall Study|Adverse Event|0|||
163058011|NCT00997893|588922820|FG000|Overall Study|Unable to meet study timelines|1|||
163058012|NCT00997893|588922821|FG001|Overall Study|Unable to meet study timelines|0|||
163058013|NCT00997893|588922822|FG002|Overall Study|Unable to meet study timelines|0|||
163058014|NCT00997893|588922820|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
163058015|NCT00997893|588922821|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
163058016|NCT00997893|588922822|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
163058017|NCT03620162|588922823|FG000|Overall Study|Physician Decision|4|||
163058018|NCT03620162|588922824|FG001|Overall Study|Physician Decision|0|||
163058019|NCT03620162|588922825|FG002|Overall Study|Physician Decision|1|||
163058020|NCT03620162|588922826|FG003|Overall Study|Physician Decision|0|||
163058021|NCT03620162|588922827|FG004|Overall Study|Physician Decision|2|||
163058022|NCT03620162|588922823|FG000|Overall Study|Lost to Follow-up|2|||
163058023|NCT03620162|588922824|FG001|Overall Study|Lost to Follow-up|6|||
163058024|NCT03620162|588922825|FG002|Overall Study|Lost to Follow-up|7|||
163058025|NCT03620162|588922826|FG003|Overall Study|Lost to Follow-up|3|||
163210199|NCT00982488|589485176|FG000|Overall Study|Poor compliance/noncompliance|0|||
163210200|NCT00982488|589485177|FG001|Overall Study|Poor compliance/noncompliance|1|||
163210201|NCT00982488|589485178|FG002|Overall Study|Poor compliance/noncompliance|0|||
163210202|NCT00982488|589485179|FG003|Overall Study|Poor compliance/noncompliance|0|||
163210203|NCT00982488|589485180|FG004|Overall Study|Poor compliance/noncompliance|0|||
163210204|NCT00982488|589485176|FG000|Overall Study|Stem cell transplant|2|||
163210205|NCT00982488|589485177|FG001|Overall Study|Stem cell transplant|0|||
163210206|NCT00982488|589485178|FG002|Overall Study|Stem cell transplant|0|||
163210207|NCT00982488|589485179|FG003|Overall Study|Stem cell transplant|1|||
163210208|NCT00982488|589485180|FG004|Overall Study|Stem cell transplant|0|||
163210209|NCT00982488|589485176|FG000|Overall Study|Study drug toxicity|34|||
163210210|NCT00982488|589485177|FG001|Overall Study|Study drug toxicity|1|||
163210211|NCT00982488|589485178|FG002|Overall Study|Study drug toxicity|6|||
163210212|NCT00982488|589485179|FG003|Overall Study|Study drug toxicity|0|||
163210213|NCT00982488|589485180|FG004|Overall Study|Study drug toxicity|0|||
163210214|NCT00982488|589485176|FG000|Overall Study|Withdrawal by Subject|5|||
163210215|NCT00982488|589485177|FG001|Overall Study|Withdrawal by Subject|1|||
163210216|NCT00982488|589485178|FG002|Overall Study|Withdrawal by Subject|1|||
163210217|NCT00982488|589485179|FG003|Overall Study|Withdrawal by Subject|0|||
163210218|NCT00982488|589485180|FG004|Overall Study|Withdrawal by Subject|0|||
163210219|NCT03204981|589485181|FG000|Overall Study|Physician Decision|2|||
163210220|NCT03204981|589485181|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
163210221|NCT04203238|589485182|FG000|Overall Study|Withdrawal by Subject|1|||
163210222|NCT04203238|589485183|FG001|Overall Study|Withdrawal by Subject|1|||
163210223|NCT04203238|589485182|FG000|Overall Study|Covid-19|3|||
163210224|NCT04203238|589485183|FG001|Overall Study|Covid-19|0|||
163210225|NCT04244786|589485186|FG000|Overall Study|Adverse Event|0|||
163210226|NCT04244786|589485187|FG001|Overall Study|Adverse Event|0|||
163210227|NCT04244786|589485188|FG002|Overall Study|Adverse Event|2|||
163210228|NCT04244786|589485186|FG000|Overall Study|Withdrawal by Subject|0|||
163210229|NCT04244786|589485187|FG001|Overall Study|Withdrawal by Subject|0|||
163210230|NCT04244786|589485188|FG002|Overall Study|Withdrawal by Subject|5|||
163210231|NCT00415909|589485189|FG000|Overall Study|Withdrawal by Subject|2|||
163210232|NCT00415909|589485189|FG000|Overall Study|Death|1|||
163210233|NCT05024058|589485190|FG000|Treatment|Study terminated by sponsor|5|||
163210234|NCT05024058|589485191|FG001|Treatment|Study terminated by sponsor|6|||
163210235|NCT05024058|589485192|FG002|Treatment|Study terminated by sponsor|4|||
163210236|NCT05024058|589485193|FG003|Treatment|Study terminated by sponsor|2|||
163210237|NCT05024058|589485194|FG004|Treatment|Study terminated by sponsor|3|||
163210238|NCT05024058|589485195|FG005|Treatment|Study terminated by sponsor|3|||
163210239|NCT05024058|589485196|FG006|Treatment|Study terminated by sponsor|1|||
163210240|NCT05024058|589485197|FG007|Treatment|Study terminated by sponsor|3|||
163210241|NCT05024058|589485198|FG008|Treatment|Study terminated by sponsor|6|||
163210242|NCT05024058|589485199|FG009|Treatment|Study terminated by sponsor|6|||
162977341|NCT03005067|588618672|FG001|Overall Study|Withdrawal by Subject|2|||
162977342|NCT03005067|588618671|FG000|Overall Study|Adverse Event|4|||
162977343|NCT03005067|588618672|FG001|Overall Study|Adverse Event|3|||
163318378|NCT03386578|589876923|FG001|PrEP Comparison Component Step 1|Death|0|||
163318379|NCT03386578|589876924|FG002|PrEP Comparison Component Step 1|Death|1|||
163318380|NCT03386578|589876925|FG003|PrEP Comparison Component Step 1|Death|0|||
162977344|NCT03005067|588618671|FG000|Overall Study|Other (reason not specified)|3|||
162977345|NCT03005067|588618672|FG001|Overall Study|Other (reason not specified)|1|||
162977346|NCT03005067|588618671|FG000|Overall Study|Protocol Violation|0|||
162977347|NCT03005067|588618672|FG001|Overall Study|Protocol Violation|1|||
162977348|NCT00103038|588618677|FG000|Overall Study|Withdrawal by Subject|8|||
162977349|NCT00103038|588618677|FG000|Overall Study|Screen failure|3|||
162977350|NCT00103038|588618677|FG000|Overall Study|Death|1|||
162977351|NCT00103038|588618677|FG000|Overall Study|Physician Decision|1|||
162977352|NCT00355472|588618680|FG000|Overall Study|Physician Decision|1|||
162977353|NCT05445843|588618681|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
162977354|NCT05445843|588618682|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
162977355|NCT05445843|588618681|FG000|Overall Study|Progressive disease|17|||
162977356|NCT05445843|588618682|FG001|Overall Study|Progressive disease|9|||
162977357|NCT05445843|588618681|FG000|Overall Study|Physician Decision|16|||
162977358|NCT05445843|588618682|FG001|Overall Study|Physician Decision|4|||
162977359|NCT05445843|588618681|FG000|Overall Study|Death|6|||
163318381|NCT03386578|589876926|FG004|PrEP Comparison Component Step 1|Death|0|||
163318382|NCT03386578|589876927|FG005|PrEP Comparison Component Step 1|Death|0|||
163318383|NCT03386578|589876928|FG006|PrEP Comparison Component Step 1|Death|0|||
163318384|NCT03386578|589876929|FG007|PrEP Comparison Component Step 1|Death|9|||
163318385|NCT03386578|589876930|FG008|PrEP Comparison Component Step 1|Death|5|||
163318386|NCT03386578|589876931|FG009|PrEP Comparison Component Step 1|Death|0|||
163318387|NCT03386578|589876922|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
163318388|NCT03386578|589876923|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
163318389|NCT03386578|589876924|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
163318390|NCT03386578|589876925|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
163318391|NCT03386578|589876926|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
163318392|NCT03386578|589876927|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
163318393|NCT03386578|589876928|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
163318394|NCT03386578|589876929|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
163318395|NCT03386578|589876930|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
163318396|NCT03386578|589876931|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
163318397|NCT03386578|589876922|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163318398|NCT03386578|589876923|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163318399|NCT03386578|589876924|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163318400|NCT03386578|589876925|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163318401|NCT03386578|589876926|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163318402|NCT03386578|589876927|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163318403|NCT03386578|589876928|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163318404|NCT03386578|589876929|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
163318405|NCT03386578|589876930|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
163318406|NCT03386578|589876931|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163318407|NCT03386578|589876922|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163318408|NCT03386578|589876923|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163318409|NCT03386578|589876924|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163318410|NCT03386578|589876925|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163318411|NCT03386578|589876926|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163318412|NCT03386578|589876927|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163318413|NCT03386578|589876928|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163318414|NCT03386578|589876929|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
163318415|NCT03386578|589876930|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
163318416|NCT03386578|589876931|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163318417|NCT04971109|589876936|FG000|Overall Study|Adverse Event|4|||
163318418|NCT04971109|589876937|FG001|Overall Study|Adverse Event|3|||
163318419|NCT04971109|589876936|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
163318420|NCT04971109|589876937|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
163318421|NCT04971109|589876936|FG000|Overall Study|Lost to Follow-up|8|||
163318422|NCT04971109|589876937|FG001|Overall Study|Lost to Follow-up|2|||
163318423|NCT04971109|589876936|FG000|Overall Study|Physician Decision|5|||
163318424|NCT04971109|589876937|FG001|Overall Study|Physician Decision|0|||
163318425|NCT04971109|589876936|FG000|Overall Study|Protocol Violation|0|||
163318426|NCT04971109|589876937|FG001|Overall Study|Protocol Violation|1|||
163318427|NCT04971109|589876936|FG000|Overall Study|Withdrawal by Subject|18|||
163318428|NCT04971109|589876937|FG001|Overall Study|Withdrawal by Subject|3|||
163318429|NCT04971109|589876936|FG000|Overall Study|Subject was randomized in error|1|||
163318430|NCT04971109|589876937|FG001|Overall Study|Subject was randomized in error|0|||
163318431|NCT03987022|589876939|FG000|Overall Study|Lost to Follow-up|2|||
163318432|NCT03987022|589876940|FG001|Overall Study|Lost to Follow-up|2|||
163318433|NCT03987022|589876939|FG000|Overall Study|Withdrawal by Subject|1|||
163318434|NCT03987022|589876940|FG001|Overall Study|Withdrawal by Subject|0|||
163318435|NCT01627574|589876941|FG000|Overall Study|Withdrawal by Subject|8|||
163318436|NCT01627574|589876942|FG001|Overall Study|Withdrawal by Subject|5|||
163318437|NCT01627574|589876941|FG000|Overall Study|Lost to Follow-up|13|||
162977360|NCT05445843|588618682|FG001|Overall Study|Death|3|||
162977361|NCT05445843|588618681|FG000|Overall Study|Subject decision|6|||
162977362|NCT05445843|588618682|FG001|Overall Study|Subject decision|2|||
163318438|NCT01627574|589876942|FG001|Overall Study|Lost to Follow-up|13|||
163318439|NCT04314778|589876945|FG000|Overall Study|Lost to Follow-up|5|||
163318440|NCT04314778|589876946|FG001|Overall Study|Lost to Follow-up|3|||
162977363|NCT05445843|588618681|FG000|Overall Study|Adverse Event|2|||
162977364|NCT05445843|588618682|FG001|Overall Study|Adverse Event|0|||
163318441|NCT02240238|589876947|FG000|Phase 1|Adverse Event|0|||
162977365|NCT05307679|588618687|FG000|Overall Study|Study terminated by sponsor or physician decision|2|||
163318442|NCT02240238|589876948|FG001|Phase 1|Adverse Event|0|||
163318443|NCT02240238|589876949|FG002|Phase 1|Adverse Event|0|||
163318444|NCT02240238|589876950|FG003|Phase 1|Adverse Event|0|||
162977366|NCT05307679|588618688|FG001|Overall Study|Study terminated by sponsor or physician decision|5|||
162977367|NCT02310763|588618693|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
162977368|NCT02310763|588618694|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
162977369|NCT02310763|588618695|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
162977370|NCT02310763|588618693|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
162977371|NCT02310763|588618694|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
162977372|NCT02310763|588618695|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
163058026|NCT03620162|588922827|FG004|Overall Study|Lost to Follow-up|2|||
163210243|NCT05024058|589485190|FG000|Follow-up|Withdrawal by Subject|1|||
163210244|NCT05024058|589485191|FG001|Follow-up|Withdrawal by Subject|0|||
163210245|NCT05024058|589485192|FG002|Follow-up|Withdrawal by Subject|1|||
163210246|NCT05024058|589485193|FG003|Follow-up|Withdrawal by Subject|0|||
163210247|NCT05024058|589485194|FG004|Follow-up|Withdrawal by Subject|0|||
163210248|NCT05024058|589485195|FG005|Follow-up|Withdrawal by Subject|0|||
163210249|NCT05024058|589485196|FG006|Follow-up|Withdrawal by Subject|0|||
163210250|NCT05024058|589485197|FG007|Follow-up|Withdrawal by Subject|1|||
163210251|NCT05024058|589485198|FG008|Follow-up|Withdrawal by Subject|0|||
163210252|NCT05024058|589485199|FG009|Follow-up|Withdrawal by Subject|1|||
163210253|NCT02734810|589485200|FG000|Overall Study|Adverse Event|1|||
163210254|NCT02734810|589485201|FG001|Overall Study|Adverse Event|0|||
163210255|NCT02734810|589485200|FG000|Overall Study|Lack of Efficacy|1|||
163210256|NCT02734810|589485201|FG001|Overall Study|Lack of Efficacy|0|||
163210257|NCT02507505|589485202|FG000|Overall Study|Withdrawal by Subject|13|||
163210258|NCT02507505|589485203|FG001|Overall Study|Withdrawal by Subject|11|||
163210259|NCT02507505|589485202|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
163210260|NCT02507505|589485203|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
163210261|NCT02507505|589485202|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
163210262|NCT02507505|589485203|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
163210263|NCT02507505|589485202|FG000|Overall Study|Death before receipt of anesthesia|0|||
163210264|NCT02507505|589485203|FG001|Overall Study|Death before receipt of anesthesia|1|||
163210265|NCT00931762|589485204|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
163210266|NCT00931762|589485204|FG000|Overall Study|Administrative Problems|5|||
163210267|NCT00931762|589485204|FG000|Overall Study|Death|1|||
163210268|NCT00931762|589485204|FG000|Overall Study|Disease Progression|3|||
163210269|NCT00931762|589485204|FG000|Overall Study|Adverse Event (s)|11|||
163210270|NCT00931762|589485204|FG000|Overall Study|Subject withdrew consent|13|||
163210271|NCT03510884|589485205|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
163210272|NCT03510884|589485206|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
163210273|NCT03510884|589485207|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
163210274|NCT03510884|589485208|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
163210275|NCT03510884|589485205|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
163210276|NCT03510884|589485206|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
163210277|NCT03510884|589485207|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
163210278|NCT03510884|589485208|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
163210279|NCT03510884|589485205|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
163210280|NCT03510884|589485206|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
163210281|NCT03510884|589485207|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
163210282|NCT03510884|589485208|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
163210283|NCT03510884|589485205|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
163210284|NCT03510884|589485206|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
163210285|NCT03510884|589485207|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
163210286|NCT03510884|589485208|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
163210287|NCT03510884|589485205|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
163210288|NCT03510884|589485206|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
163210289|NCT03510884|589485207|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
163210290|NCT03510884|589485208|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
163210291|NCT03510884|589485205|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
163210292|NCT03510884|589485206|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
163210293|NCT03510884|589485207|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
163210294|NCT03510884|589485208|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
163210295|NCT03510884|589485205|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
163210296|NCT03510884|589485206|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
163210297|NCT03510884|589485207|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
163210298|NCT03510884|589485208|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
163210299|NCT03510884|589485205|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
163210300|NCT03510884|589485206|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
163210301|NCT03510884|589485207|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
163318445|NCT02240238|589876951|FG004|Phase 1|Adverse Event|0|||
163318446|NCT02240238|589876952|FG005|Phase 1|Adverse Event|0|||
163318447|NCT02240238|589876953|FG006|Phase 1|Adverse Event|3|||
163318448|NCT02240238|589876954|FG007|Phase 1|Adverse Event|1|||
163318449|NCT02240238|589876955|FG008|Phase 1|Adverse Event|0|||
163318450|NCT02240238|589876956|FG009|Phase 1|Adverse Event|0|||
163318451|NCT02240238|589876957|FG010|Phase 1|Adverse Event|0|||
163318452|NCT02240238|589876958|FG011|Phase 1|Adverse Event|0|||
163318453|NCT02240238|589876947|FG000|Phase 1|Death|0|||
163318454|NCT02240238|589876948|FG001|Phase 1|Death|0|||
163318455|NCT02240238|589876949|FG002|Phase 1|Death|0|||
163318456|NCT02240238|589876950|FG003|Phase 1|Death|0|||
163318457|NCT02240238|589876951|FG004|Phase 1|Death|0|||
163318458|NCT02240238|589876952|FG005|Phase 1|Death|1|||
163318459|NCT02240238|589876953|FG006|Phase 1|Death|0|||
163318460|NCT02240238|589876954|FG007|Phase 1|Death|0|||
163318461|NCT02240238|589876955|FG008|Phase 1|Death|0|||
163318462|NCT02240238|589876956|FG009|Phase 1|Death|0|||
163318463|NCT02240238|589876957|FG010|Phase 1|Death|0|||
163318464|NCT02240238|589876958|FG011|Phase 1|Death|0|||
163318465|NCT02240238|589876947|FG000|Phase 1|Sponsor termination|0|||
163318466|NCT02240238|589876948|FG001|Phase 1|Sponsor termination|0|||
163318467|NCT02240238|589876949|FG002|Phase 1|Sponsor termination|0|||
163318468|NCT02240238|589876950|FG003|Phase 1|Sponsor termination|0|||
163318469|NCT02240238|589876951|FG004|Phase 1|Sponsor termination|0|||
163318470|NCT02240238|589876952|FG005|Phase 1|Sponsor termination|1|||
163318471|NCT02240238|589876953|FG006|Phase 1|Sponsor termination|0|||
163318472|NCT02240238|589876954|FG007|Phase 1|Sponsor termination|0|||
163318473|NCT02240238|589876955|FG008|Phase 1|Sponsor termination|0|||
163318474|NCT02240238|589876956|FG009|Phase 1|Sponsor termination|0|||
163318475|NCT02240238|589876957|FG010|Phase 1|Sponsor termination|0|||
163318476|NCT02240238|589876958|FG011|Phase 1|Sponsor termination|0|||
163318477|NCT02240238|589876947|FG000|Phase 1|Withdrawal by Subject|0|||
163318478|NCT02240238|589876948|FG001|Phase 1|Withdrawal by Subject|0|||
163318479|NCT02240238|589876949|FG002|Phase 1|Withdrawal by Subject|0|||
163318480|NCT02240238|589876950|FG003|Phase 1|Withdrawal by Subject|0|||
163318481|NCT02240238|589876951|FG004|Phase 1|Withdrawal by Subject|0|||
163318482|NCT02240238|589876952|FG005|Phase 1|Withdrawal by Subject|2|||
163318483|NCT02240238|589876953|FG006|Phase 1|Withdrawal by Subject|0|||
163318484|NCT02240238|589876954|FG007|Phase 1|Withdrawal by Subject|0|||
163318485|NCT02240238|589876955|FG008|Phase 1|Withdrawal by Subject|0|||
163318486|NCT02240238|589876956|FG009|Phase 1|Withdrawal by Subject|0|||
163318487|NCT02240238|589876957|FG010|Phase 1|Withdrawal by Subject|0|||
163318488|NCT02240238|589876958|FG011|Phase 1|Withdrawal by Subject|0|||
163318489|NCT02240238|589876947|FG000|Phase 1|Physician Decision|0|||
163318490|NCT02240238|589876948|FG001|Phase 1|Physician Decision|0|||
163318491|NCT02240238|589876949|FG002|Phase 1|Physician Decision|0|||
163318492|NCT02240238|589876950|FG003|Phase 1|Physician Decision|0|||
163318493|NCT02240238|589876951|FG004|Phase 1|Physician Decision|0|||
163318494|NCT02240238|589876952|FG005|Phase 1|Physician Decision|2|||
163318495|NCT02240238|589876953|FG006|Phase 1|Physician Decision|0|||
163318496|NCT02240238|589876954|FG007|Phase 1|Physician Decision|0|||
163318497|NCT02240238|589876955|FG008|Phase 1|Physician Decision|0|||
163318498|NCT02240238|589876956|FG009|Phase 1|Physician Decision|0|||
163318499|NCT02240238|589876957|FG010|Phase 1|Physician Decision|0|||
163318500|NCT02240238|589876958|FG011|Phase 1|Physician Decision|0|||
163318501|NCT02240238|589876947|FG000|Phase 2|Adverse Event|0|||
163318502|NCT02240238|589876948|FG001|Phase 2|Adverse Event|0|||
163318503|NCT02240238|589876949|FG002|Phase 2|Adverse Event|0|||
163318504|NCT02240238|589876950|FG003|Phase 2|Adverse Event|0|||
163318505|NCT02240238|589876951|FG004|Phase 2|Adverse Event|0|||
163401476|NCT01197521|590181172|FG001|Overall Study|Lost to Follow-up|2|||
162977373|NCT02310763|588618693|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
163318506|NCT02240238|589876952|FG005|Phase 2|Adverse Event|0|||
163318507|NCT02240238|589876953|FG006|Phase 2|Adverse Event|0|||
163318508|NCT02240238|589876954|FG007|Phase 2|Adverse Event|0|||
163318509|NCT02240238|589876955|FG008|Phase 2|Adverse Event|0|||
163318510|NCT02240238|589876956|FG009|Phase 2|Adverse Event|7|||
163318511|NCT02240238|589876957|FG010|Phase 2|Adverse Event|14|||
163318512|NCT02240238|589876958|FG011|Phase 2|Adverse Event|2|||
163318513|NCT02240238|589876947|FG000|Phase 2|Death|0|||
163318514|NCT02240238|589876948|FG001|Phase 2|Death|0|||
163318515|NCT02240238|589876949|FG002|Phase 2|Death|0|||
163318516|NCT02240238|589876950|FG003|Phase 2|Death|0|||
163318517|NCT02240238|589876951|FG004|Phase 2|Death|0|||
163318518|NCT02240238|589876952|FG005|Phase 2|Death|0|||
163318519|NCT02240238|589876953|FG006|Phase 2|Death|0|||
163318520|NCT02240238|589876954|FG007|Phase 2|Death|0|||
163318521|NCT02240238|589876955|FG008|Phase 2|Death|0|||
163318522|NCT02240238|589876956|FG009|Phase 2|Death|3|||
163318523|NCT02240238|589876957|FG010|Phase 2|Death|2|||
163318524|NCT02240238|589876958|FG011|Phase 2|Death|1|||
163318525|NCT02240238|589876947|FG000|Phase 2|Disease progression|0|||
163318526|NCT02240238|589876948|FG001|Phase 2|Disease progression|0|||
163318527|NCT02240238|589876949|FG002|Phase 2|Disease progression|0|||
163318528|NCT02240238|589876950|FG003|Phase 2|Disease progression|0|||
162977374|NCT02310763|588618694|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
162977375|NCT02310763|588618695|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
162977376|NCT02310763|588618693|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
162977377|NCT02310763|588618694|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
162977378|NCT02310763|588618695|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
162977379|NCT02310763|588618693|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
163318529|NCT02240238|589876951|FG004|Phase 2|Disease progression|0|||
163318530|NCT02240238|589876952|FG005|Phase 2|Disease progression|0|||
163318531|NCT02240238|589876953|FG006|Phase 2|Disease progression|0|||
163318532|NCT02240238|589876954|FG007|Phase 2|Disease progression|0|||
163318533|NCT02240238|589876955|FG008|Phase 2|Disease progression|0|||
163318534|NCT02240238|589876956|FG009|Phase 2|Disease progression|5|||
163318535|NCT02240238|589876957|FG010|Phase 2|Disease progression|11|||
163318536|NCT02240238|589876958|FG011|Phase 2|Disease progression|1|||
163318537|NCT02240238|589876947|FG000|Phase 2|Withdrawal by Subject|0|||
163318538|NCT02240238|589876948|FG001|Phase 2|Withdrawal by Subject|0|||
163318539|NCT02240238|589876949|FG002|Phase 2|Withdrawal by Subject|0|||
163318540|NCT02240238|589876950|FG003|Phase 2|Withdrawal by Subject|0|||
163318541|NCT02240238|589876951|FG004|Phase 2|Withdrawal by Subject|0|||
163318542|NCT02240238|589876952|FG005|Phase 2|Withdrawal by Subject|0|||
163318543|NCT02240238|589876953|FG006|Phase 2|Withdrawal by Subject|0|||
163318544|NCT02240238|589876954|FG007|Phase 2|Withdrawal by Subject|0|||
163318545|NCT02240238|589876955|FG008|Phase 2|Withdrawal by Subject|0|||
163318546|NCT02240238|589876956|FG009|Phase 2|Withdrawal by Subject|1|||
163318547|NCT02240238|589876957|FG010|Phase 2|Withdrawal by Subject|1|||
163318548|NCT02240238|589876958|FG011|Phase 2|Withdrawal by Subject|0|||
163318549|NCT02240238|589876947|FG000|Phase 2|Physician Decision|0|||
163318550|NCT02240238|589876948|FG001|Phase 2|Physician Decision|0|||
163318551|NCT02240238|589876949|FG002|Phase 2|Physician Decision|0|||
163318552|NCT02240238|589876950|FG003|Phase 2|Physician Decision|0|||
163318553|NCT02240238|589876951|FG004|Phase 2|Physician Decision|0|||
163318554|NCT02240238|589876952|FG005|Phase 2|Physician Decision|0|||
163318555|NCT02240238|589876953|FG006|Phase 2|Physician Decision|0|||
163318556|NCT02240238|589876954|FG007|Phase 2|Physician Decision|0|||
163318557|NCT02240238|589876955|FG008|Phase 2|Physician Decision|0|||
163318558|NCT02240238|589876956|FG009|Phase 2|Physician Decision|1|||
163318559|NCT02240238|589876957|FG010|Phase 2|Physician Decision|3|||
163318560|NCT02240238|589876958|FG011|Phase 2|Physician Decision|0|||
163318561|NCT02240238|589876947|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163318562|NCT02240238|589876948|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163318563|NCT02240238|589876949|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163318564|NCT02240238|589876950|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163318565|NCT02240238|589876951|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163318566|NCT02240238|589876952|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163318567|NCT02240238|589876953|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163318568|NCT02240238|589876954|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163318569|NCT02240238|589876955|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163318570|NCT02240238|589876956|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
163318571|NCT02240238|589876957|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163318572|NCT02240238|589876958|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163318573|NCT02240238|589876947|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163318574|NCT02240238|589876948|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163318575|NCT02240238|589876949|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163318576|NCT02240238|589876950|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163318577|NCT02240238|589876951|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163318578|NCT02240238|589876952|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163318579|NCT02240238|589876953|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163318580|NCT02240238|589876954|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163318581|NCT02240238|589876955|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163318582|NCT02240238|589876956|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
162977380|NCT02310763|588618694|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
162977381|NCT02310763|588618695|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
163318583|NCT02240238|589876957|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162977382|NCT01731886|588618697|FG000|Overall Study|Death|1|||
162977383|NCT01731886|588618698|FG001|Overall Study|Death|0|||
162977384|NCT01731886|588618697|FG000|Overall Study|Never started treatment|0|||
163318584|NCT02240238|589876958|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162977385|NCT01731886|588618698|FG001|Overall Study|Never started treatment|1|||
162977386|NCT01731886|588618697|FG000|Overall Study|Non-compliant|1|||
162977387|NCT01731886|588618698|FG001|Overall Study|Non-compliant|0|||
162977388|NCT02280187|588618699|FG000|Overall Study|Lost to Follow-up|218|||
163210302|NCT03510884|589485208|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
163210303|NCT03510884|589485205|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
163210304|NCT03510884|589485206|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
163210305|NCT03510884|589485207|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
163210306|NCT03510884|589485208|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
163210307|NCT03510884|589485205|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
163210308|NCT03510884|589485206|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
163210309|NCT03510884|589485207|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
163210310|NCT03510884|589485208|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
163210311|NCT00157950|589485209|FG000|Overall Study|Death|1|||
163210312|NCT00157950|589485210|FG001|Overall Study|Death|0|||
163210313|NCT01287897|589485214|FG000|Overall Study|Adverse Event|5|||
163210314|NCT01287897|589485215|FG001|Overall Study|Adverse Event|3|||
163210315|NCT01287897|589485216|FG002|Overall Study|Adverse Event|6|||
163210316|NCT01287897|589485217|FG003|Overall Study|Adverse Event|4|||
163210317|NCT01287897|589485214|FG000|Overall Study|Lack of Efficacy|2|||
163210318|NCT01287897|589485215|FG001|Overall Study|Lack of Efficacy|0|||
163210319|NCT01287897|589485216|FG002|Overall Study|Lack of Efficacy|0|||
163210320|NCT01287897|589485217|FG003|Overall Study|Lack of Efficacy|0|||
163210321|NCT01287897|589485214|FG000|Overall Study|Protocol Violation|1|||
163210322|NCT01287897|589485215|FG001|Overall Study|Protocol Violation|1|||
163210323|NCT01287897|589485216|FG002|Overall Study|Protocol Violation|0|||
163210324|NCT01287897|589485217|FG003|Overall Study|Protocol Violation|1|||
163210325|NCT01287897|589485214|FG000|Overall Study|Lost to Follow-up|0|||
163210326|NCT01287897|589485215|FG001|Overall Study|Lost to Follow-up|0|||
163210327|NCT01287897|589485216|FG002|Overall Study|Lost to Follow-up|2|||
163210328|NCT01287897|589485217|FG003|Overall Study|Lost to Follow-up|0|||
163210329|NCT01287897|589485214|FG000|Overall Study|Withdrawal by Subject|1|||
163210330|NCT01287897|589485215|FG001|Overall Study|Withdrawal by Subject|5|||
163318585|NCT02240238|589876947|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163318586|NCT02240238|589876948|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162977389|NCT00939627|588618700|FG000|Overall Study|Disease Progression|16|||
162977390|NCT00939627|588618701|FG001|Overall Study|Disease Progression|12|||
162977391|NCT00939627|588618702|FG002|Overall Study|Disease Progression|0|||
162977392|NCT00939627|588618700|FG000|Overall Study|Adverse Event|6|||
163318587|NCT02240238|589876949|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163318588|NCT02240238|589876950|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163318589|NCT02240238|589876951|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163318590|NCT02240238|589876952|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163318591|NCT02240238|589876953|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163318592|NCT02240238|589876954|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163318593|NCT02240238|589876955|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163318594|NCT02240238|589876956|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163318595|NCT02240238|589876957|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
163318596|NCT02240238|589876958|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163318597|NCT02240238|589876947|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163318598|NCT02240238|589876948|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163318599|NCT02240238|589876949|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163318600|NCT02240238|589876950|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163318601|NCT02240238|589876951|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163318602|NCT02240238|589876952|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163318603|NCT02240238|589876953|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163318604|NCT02240238|589876954|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163318605|NCT02240238|589876955|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163318606|NCT02240238|589876956|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163318607|NCT02240238|589876957|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
163318608|NCT02240238|589876958|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163318609|NCT02240238|589876947|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163318610|NCT02240238|589876948|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163318611|NCT02240238|589876949|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163318612|NCT02240238|589876950|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163318613|NCT02240238|589876951|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163318614|NCT02240238|589876952|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163318615|NCT02240238|589876953|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163318616|NCT02240238|589876954|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163318617|NCT02240238|589876955|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163318618|NCT02240238|589876956|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162977393|NCT00939627|588618701|FG001|Overall Study|Adverse Event|7|||
162977394|NCT00939627|588618702|FG002|Overall Study|Adverse Event|0|||
162977395|NCT00939627|588618700|FG000|Overall Study|Death|0|||
162977396|NCT00939627|588618701|FG001|Overall Study|Death|2|||
162977397|NCT00939627|588618702|FG002|Overall Study|Death|0|||
162977398|NCT00939627|588618700|FG000|Overall Study|Withdrawal by Subject|2|||
162977399|NCT00939627|588618701|FG001|Overall Study|Withdrawal by Subject|4|||
162977400|NCT00939627|588618702|FG002|Overall Study|Withdrawal by Subject|0|||
162977401|NCT00939627|588618700|FG000|Overall Study|Other complicating disease|1|||
162977402|NCT00939627|588618701|FG001|Overall Study|Other complicating disease|1|||
162977403|NCT00939627|588618702|FG002|Overall Study|Other complicating disease|0|||
162977404|NCT00939627|588618700|FG000|Overall Study|Not compliant|2|||
162977405|NCT00939627|588618701|FG001|Overall Study|Not compliant|0|||
162977406|NCT00939627|588618702|FG002|Overall Study|Not compliant|0|||
162977407|NCT00939627|588618700|FG000|Overall Study|No off-tx reason given|0|||
162977408|NCT00939627|588618701|FG001|Overall Study|No off-tx reason given|2|||
162977409|NCT00939627|588618702|FG002|Overall Study|No off-tx reason given|0|||
162977410|NCT03417830|588618705|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
162977411|NCT03417830|588618706|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
162977412|NCT02563769|588618707|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
162977413|NCT02563769|588618708|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
162977414|NCT02563769|588618709|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
162977415|NCT00303667|588618721|FG000|Overall Study|Death|0|||
162977416|NCT00303667|588618722|FG001|Overall Study|Death|4|||
162977417|NCT00724373|588618723|FG000|Overall Study|Adverse Event|41|||
162977418|NCT00724373|588618723|FG000|Overall Study|Lack of Efficacy|82|||
163318619|NCT02240238|589876957|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
163318620|NCT02240238|589876958|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162977419|NCT00724373|588618723|FG000|Overall Study|Lost to Follow-up|7|||
162977420|NCT00724373|588618723|FG000|Overall Study|Non-compliance|2|||
162977421|NCT00724373|588618723|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
163318621|NCT02240238|589876947|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163318622|NCT02240238|589876948|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163318623|NCT02240238|589876949|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163210331|NCT01287897|589485216|FG002|Overall Study|Withdrawal by Subject|3|||
163210332|NCT01287897|589485217|FG003|Overall Study|Withdrawal by Subject|2|||
163210333|NCT01287897|589485214|FG000|Overall Study|Not consented properly|0|||
163210334|NCT01287897|589485215|FG001|Overall Study|Not consented properly|1|||
163210335|NCT01287897|589485216|FG002|Overall Study|Not consented properly|0|||
163210336|NCT01287897|589485217|FG003|Overall Study|Not consented properly|0|||
163210337|NCT01287897|589485214|FG000|Overall Study|Not meeting entrance criteria|1|||
163210338|NCT01287897|589485215|FG001|Overall Study|Not meeting entrance criteria|1|||
163210339|NCT01287897|589485216|FG002|Overall Study|Not meeting entrance criteria|0|||
163210340|NCT01287897|589485217|FG003|Overall Study|Not meeting entrance criteria|0|||
163210341|NCT01287897|589485214|FG000|Overall Study|Other|1|||
163210342|NCT01287897|589485215|FG001|Overall Study|Other|0|||
163210343|NCT01287897|589485216|FG002|Overall Study|Other|1|||
163210344|NCT01287897|589485217|FG003|Overall Study|Other|0|||
163210345|NCT02892760|589485218|FG000|Overall Study|Withdrawal by Subject|3|||
163210346|NCT00386776|589485219|FG000|Overall Study|Withdrawal by Subject|8|||
163210347|NCT01500629|589485224|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
163210348|NCT01500629|589485225|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
163210349|NCT02902965|589485226|FG000|Overall Study|Withdrawal by Subject|10|||
163210350|NCT00293254|589485227|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
163401477|NCT01197521|590181173|FG002|Overall Study|Lost to Follow-up|2|||
163401478|NCT01197521|590181171|FG000|Overall Study|Adverse Event|25|||
163401479|NCT01197521|590181172|FG001|Overall Study|Adverse Event|28|||
163401480|NCT01197521|590181173|FG002|Overall Study|Adverse Event|24|||
163401481|NCT03962101|590181174|FG000|Overall Study|Adverse Event|1|||
163401482|NCT03962101|590181174|FG000|Overall Study|Physician Decision|2|||
163401483|NCT03962101|590181174|FG000|Overall Study|Not related to medical events|1|||
163401484|NCT05879107|590181175|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
163401485|NCT05879107|590181176|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
163401486|NCT05879107|590181175|FG000|Overall Study|Migrated / moved from the study area|1|||
163401487|NCT05879107|590181176|FG001|Overall Study|Migrated / moved from the study area|1|||
163401488|NCT05879107|590181175|FG000|Overall Study|Lost to Follow-up|8|||
163401489|NCT05879107|590181176|FG001|Overall Study|Lost to Follow-up|13|||
163401490|NCT05879107|590181175|FG000|Overall Study|Death|0|||
163401491|NCT05879107|590181176|FG001|Overall Study|Death|2|||
163401492|NCT05879107|590181175|FG000|Overall Study|Other|0|||
163401493|NCT05879107|590181176|FG001|Overall Study|Other|3|||
163401494|NCT03901079|590181177|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
163401495|NCT04607148|590181178|FG000|Overall Study|Withdrawal by Subject|0|||
163401496|NCT04607148|590181179|FG001|Overall Study|Withdrawal by Subject|4|||
163401497|NCT04607148|590181180|FG002|Overall Study|Withdrawal by Subject|2|||
163401498|NCT04607148|590181181|FG003|Overall Study|Withdrawal by Subject|8|||
162977422|NCT00724373|588618723|FG000|Overall Study|Participant moved away|1|||
162977423|NCT00724373|588618723|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
162977424|NCT00724373|588618723|FG000|Overall Study|Only to have 24 week regimen|1|||
162977425|NCT00724373|588618723|FG000|Overall Study|Viral Relapse|1|||
162977426|NCT00724373|588618723|FG000|Overall Study|Acute HCV infection|1|||
162977427|NCT00724373|588618723|FG000|Overall Study|Drug Relapse|1|||
162977428|NCT00724373|588618723|FG000|Overall Study|Tolerability|23|||
162977429|NCT02083926|588618724|FG000|Overall Study|Withdrawal by Subject|1|||
162977430|NCT02083926|588618725|FG001|Overall Study|Withdrawal by Subject|0|||
162977431|NCT00384176|588618726|FG000|Overall Study|Death|239|||
162977432|NCT00384176|588618727|FG001|Overall Study|Death|247|||
162977433|NCT00384176|588618728|FG002|Overall Study|Death|105|||
162977434|NCT00384176|588618726|FG000|Overall Study|Withdrawal by Subject|52|||
162977435|NCT00384176|588618727|FG001|Overall Study|Withdrawal by Subject|48|||
162977436|NCT00384176|588618728|FG002|Overall Study|Withdrawal by Subject|22|||
162977437|NCT00384176|588618726|FG000|Overall Study|Lost to Follow-up|16|||
162977438|NCT00384176|588618727|FG001|Overall Study|Lost to Follow-up|18|||
162977439|NCT00384176|588618728|FG002|Overall Study|Lost to Follow-up|4|||
162977440|NCT00384176|588618726|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
162977441|NCT00384176|588618727|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
162977442|NCT00384176|588618728|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
162977443|NCT00384176|588618726|FG000|Overall Study|Longer QTC as Visit 1|1|||
163058027|NCT03620162|588922823|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
163210351|NCT00293254|589485228|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
163210352|NCT00293254|589485227|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
163210353|NCT00293254|589485228|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
163210354|NCT00293254|589485227|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
163210355|NCT00293254|589485228|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
163401499|NCT04607148|590181178|FG000|Overall Study|Study Terminated by Sponsor|14|||
163401500|NCT04607148|590181179|FG001|Overall Study|Study Terminated by Sponsor|59|||
163401501|NCT04607148|590181180|FG002|Overall Study|Study Terminated by Sponsor|9|||
163401502|NCT04607148|590181181|FG003|Overall Study|Study Terminated by Sponsor|39|||
163401503|NCT04607148|590181178|FG000|Overall Study|Sponsor Decision|0|||
163401504|NCT04607148|590181179|FG001|Overall Study|Sponsor Decision|0|||
162977444|NCT00384176|588618727|FG001|Overall Study|Longer QTC as Visit 1|0|||
163401505|NCT04607148|590181180|FG002|Overall Study|Sponsor Decision|1|||
163401506|NCT04607148|590181181|FG003|Overall Study|Sponsor Decision|0|||
163401507|NCT04607148|590181178|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163401508|NCT04607148|590181179|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163401509|NCT04607148|590181180|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163401510|NCT04607148|590181181|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163401511|NCT04607148|590181178|FG000|Overall Study|Lost to Follow-up|0|||
163401512|NCT04607148|590181179|FG001|Overall Study|Lost to Follow-up|2|||
163401513|NCT04607148|590181180|FG002|Overall Study|Lost to Follow-up|0|||
163401514|NCT04607148|590181181|FG003|Overall Study|Lost to Follow-up|0|||
163401515|NCT04607148|590181178|FG000|Overall Study|Death|0|||
163401516|NCT04607148|590181179|FG001|Overall Study|Death|3|||
163401517|NCT04607148|590181180|FG002|Overall Study|Death|0|||
163401518|NCT04607148|590181181|FG003|Overall Study|Death|1|||
163401519|NCT04607148|590181178|FG000|Overall Study|Adverse Event|0|||
163401520|NCT04607148|590181179|FG001|Overall Study|Adverse Event|1|||
163401521|NCT04607148|590181180|FG002|Overall Study|Adverse Event|0|||
163401522|NCT04607148|590181181|FG003|Overall Study|Adverse Event|0|||
163401523|NCT00912028|590181182|FG000|Overall Study|Lost to Follow-up|2|||
163401524|NCT00912028|590181183|FG001|Overall Study|Lost to Follow-up|3|||
163401525|NCT00912028|590181184|FG002|Overall Study|Lost to Follow-up|0|||
163401526|NCT00912028|590181185|FG003|Overall Study|Lost to Follow-up|1|||
163401527|NCT00912028|590181186|FG004|Overall Study|Lost to Follow-up|3|||
163401528|NCT00912028|590181182|FG000|Overall Study|Withdrawal by Subject|3|||
163401529|NCT00912028|590181183|FG001|Overall Study|Withdrawal by Subject|0|||
163401530|NCT00912028|590181184|FG002|Overall Study|Withdrawal by Subject|0|||
163401531|NCT00912028|590181185|FG003|Overall Study|Withdrawal by Subject|0|||
163401532|NCT00912028|590181186|FG004|Overall Study|Withdrawal by Subject|0|||
163401533|NCT01820364|590181187|FG000|Part I: LGX818|Death|1|||
163401534|NCT01820364|590181188|FG001|Part I: LGX818|Death|0|||
163401535|NCT01820364|590181187|FG000|Part I: LGX818|Administrative Problems|3|||
163401536|NCT01820364|590181188|FG001|Part I: LGX818|Administrative Problems|0|||
163401537|NCT01820364|590181187|FG000|Part I: LGX818|Adverse Event|6|||
163401538|NCT01820364|590181188|FG001|Part I: LGX818|Adverse Event|0|||
163401539|NCT01820364|590181187|FG000|Part I: LGX818|Disease Progression|4|||
163401540|NCT01820364|590181188|FG001|Part I: LGX818|Disease Progression|0|||
163401541|NCT01820364|590181187|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
163401542|NCT01820364|590181188|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
163401543|NCT03029143|590181189|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
163401544|NCT03029143|590181190|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
163401545|NCT03029143|590181191|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
163401546|NCT03029143|590181189|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
163401547|NCT03029143|590181190|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
163401548|NCT03029143|590181191|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
163401549|NCT03029143|590181189|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
163401550|NCT03029143|590181190|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
163401551|NCT03029143|590181191|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
163401552|NCT03029143|590181189|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
162977445|NCT00384176|588618728|FG002|Overall Study|Longer QTC as Visit 1|0|||
162977446|NCT00384176|588618726|FG000|Overall Study|Toxicity of treatment|1|||
162977447|NCT00384176|588618727|FG001|Overall Study|Toxicity of treatment|0|||
162977448|NCT00384176|588618728|FG002|Overall Study|Toxicity of treatment|0|||
162977449|NCT00384176|588618726|FG000|Overall Study|Did not receive study treatment|0|||
162977450|NCT00384176|588618727|FG001|Overall Study|Did not receive study treatment|1|||
162977451|NCT00384176|588618728|FG002|Overall Study|Did not receive study treatment|1|||
162977452|NCT00384176|588618726|FG000|Overall Study|Physician Decision|0|||
162977453|NCT00384176|588618727|FG001|Overall Study|Physician Decision|2|||
162977454|NCT00384176|588618728|FG002|Overall Study|Physician Decision|0|||
162977455|NCT00384176|588618726|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
162977456|NCT00384176|588618727|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
162977457|NCT00384176|588618728|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
163058028|NCT03620162|588922824|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
163401553|NCT03029143|590181190|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
163401554|NCT03029143|590181191|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
163401555|NCT03029143|590181189|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
162977458|NCT00842530|588618729|FG000|Overall Study|Serious adverse event|0|||
162977459|NCT00842530|588618730|FG001|Overall Study|Serious adverse event|6|||
163401556|NCT03029143|590181190|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
163401557|NCT03029143|590181191|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
163401558|NCT03029143|590181189|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
163401559|NCT03029143|590181190|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
163401560|NCT03029143|590181191|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
163318624|NCT02240238|589876950|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162977460|NCT00842530|588618729|FG000|Overall Study|Other adverse event|6|||
162977461|NCT00842530|588618730|FG001|Overall Study|Other adverse event|1|||
162977462|NCT00842530|588618729|FG000|Overall Study|Protocol Violation|32|||
162977463|NCT00842530|588618730|FG001|Overall Study|Protocol Violation|14|||
162977464|NCT00842530|588618729|FG000|Overall Study|Lost to Follow-up|6|||
163318625|NCT02240238|589876951|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162977465|NCT00842530|588618730|FG001|Overall Study|Lost to Follow-up|8|||
162977466|NCT00842530|588618729|FG000|Overall Study|Withdrawal by Subject|73|||
162977467|NCT00842530|588618730|FG001|Overall Study|Withdrawal by Subject|28|||
162977468|NCT02939950|588618731|FG000|Overall Study|Lost to Follow-up|13|||
162977469|NCT02939950|588618732|FG001|Overall Study|Lost to Follow-up|16|||
162977470|NCT02939950|588618731|FG000|Overall Study|Positive slit lamp findings|0|||
162977471|NCT02939950|588618732|FG001|Overall Study|Positive slit lamp findings|1|||
162977472|NCT02939950|588618731|FG000|Overall Study|Chalazion upper lid|0|||
162977473|NCT02939950|588618732|FG001|Overall Study|Chalazion upper lid|1|||
162977474|NCT02939950|588618731|FG000|Overall Study|Lack of motivation|0|||
162977475|NCT02939950|588618732|FG001|Overall Study|Lack of motivation|2|||
162977476|NCT02939950|588618731|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
162977477|NCT02939950|588618732|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
162977478|NCT02939950|588618731|FG000|Overall Study|Military orders|1|||
162977479|NCT02939950|588618732|FG001|Overall Study|Military orders|0|||
162977480|NCT02939950|588618731|FG000|Overall Study|Participant Relocated|5|||
162977481|NCT02939950|588618732|FG001|Overall Study|Participant Relocated|3|||
162977482|NCT02939950|588618731|FG000|Overall Study|Study related symptoms|8|||
162977483|NCT02939950|588618732|FG001|Overall Study|Study related symptoms|8|||
162977484|NCT02939950|588618731|FG000|Overall Study|Unacceptable lens movement|2|||
162977485|NCT02939950|588618732|FG001|Overall Study|Unacceptable lens movement|0|||
162977486|NCT02939950|588618731|FG000|Overall Study|Protocol Violation|6|||
162977487|NCT02939950|588618732|FG001|Overall Study|Protocol Violation|3|||
163318626|NCT02240238|589876952|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163318627|NCT02240238|589876953|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163318628|NCT02240238|589876954|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163318629|NCT02240238|589876955|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163318630|NCT02240238|589876956|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163318631|NCT02240238|589876957|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
163318632|NCT02240238|589876958|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163318633|NCT02240238|589876947|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163318634|NCT02240238|589876948|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163318635|NCT02240238|589876949|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163318636|NCT02240238|589876950|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163318637|NCT02240238|589876951|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163401561|NCT03029143|590181189|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
163401562|NCT03029143|590181190|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
163401563|NCT03029143|590181191|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
163401564|NCT03029143|590181189|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163401565|NCT03029143|590181190|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
163401566|NCT03029143|590181191|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
162977488|NCT02939950|588618731|FG000|Overall Study|Physician Decision|2|||
162977489|NCT02939950|588618732|FG001|Overall Study|Physician Decision|0|||
162977490|NCT02939950|588618731|FG000|Overall Study|Pregnancy|6|||
162977491|NCT02939950|588618732|FG001|Overall Study|Pregnancy|7|||
162977492|NCT02939950|588618731|FG000|Overall Study|Withdrawal by Subject|12|||
162977493|NCT02939950|588618732|FG001|Overall Study|Withdrawal by Subject|28|||
162977494|NCT02939950|588618731|FG000|Overall Study|Adverse Event|7|||
162977495|NCT02939950|588618732|FG001|Overall Study|Adverse Event|3|||
162977496|NCT02939950|588618731|FG000|Overall Study|Randomized, not dispensed|1|||
163058029|NCT03620162|588922825|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
162977497|NCT02939950|588618732|FG001|Overall Study|Randomized, not dispensed|0|||
162977498|NCT02939950|588618731|FG000|Overall Study|Ineligible at Baseline|2|||
162977499|NCT02939950|588618732|FG001|Overall Study|Ineligible at Baseline|8|||
162977500|NCT02243293|588618733|FG000|Overall Study|Adverse Event|1|||
162977501|NCT02243293|588618734|FG001|Overall Study|Adverse Event|0|||
162977502|NCT02243293|588618735|FG002|Overall Study|Adverse Event|0|||
162977503|NCT02243293|588618736|FG003|Overall Study|Adverse Event|0|||
162977504|NCT02243293|588618737|FG004|Overall Study|Adverse Event|0|||
162977505|NCT02243293|588618738|FG005|Overall Study|Adverse Event|0|||
162977506|NCT02243293|588618739|FG006|Overall Study|Adverse Event|0|||
162977507|NCT02243293|588618740|FG007|Overall Study|Adverse Event|0|||
163401567|NCT03029143|590181189|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
162977508|NCT02243293|588618741|FG008|Overall Study|Adverse Event|0|||
162977509|NCT02243293|588618742|FG009|Overall Study|Adverse Event|0|||
162977510|NCT02243293|588618743|FG010|Overall Study|Adverse Event|0|||
162977511|NCT02243293|588618744|FG011|Overall Study|Adverse Event|0|||
162977512|NCT02243293|588618745|FG012|Overall Study|Adverse Event|0|||
162977513|NCT02243293|588618746|FG013|Overall Study|Adverse Event|0|||
162977514|NCT02243293|588618747|FG014|Overall Study|Adverse Event|0|||
162977515|NCT02243293|588618748|FG015|Overall Study|Adverse Event|1|||
163210356|NCT00293254|589485227|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
163210357|NCT00293254|589485228|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
163210358|NCT00293254|589485227|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
163210359|NCT00293254|589485228|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
163210360|NCT00293254|589485227|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
163210361|NCT00293254|589485228|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
163210362|NCT00293254|589485227|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
163210363|NCT00293254|589485228|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
163210364|NCT00293254|589485227|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
163210365|NCT00293254|589485228|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
163210366|NCT00293254|589485227|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
163210367|NCT00293254|589485228|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
163210368|NCT00293254|589485227|FG000|Extension - Double-Blind Week 49-156|Death|4|||
163210369|NCT00293254|589485228|FG001|Extension - Double-Blind Week 49-156|Death|1|||
163210370|NCT00293254|589485227|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
163210371|NCT00293254|589485228|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
163210372|NCT00293254|589485227|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
163210373|NCT00293254|589485228|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
163210374|NCT00293254|589485227|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
163210375|NCT00293254|589485228|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
163210376|NCT00293254|589485227|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
163210377|NCT00293254|589485228|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
163210378|NCT00293254|589485227|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
163210379|NCT00293254|589485228|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
163210380|NCT00293254|589485227|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
163210381|NCT00293254|589485228|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
163210382|NCT00293254|589485227|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
163210383|NCT00293254|589485228|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
163210384|NCT00293254|589485227|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
163210385|NCT00293254|589485228|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
163210386|NCT00293254|589485227|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
163210387|NCT00293254|589485228|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
163210388|NCT00293254|589485227|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
163210389|NCT00293254|589485228|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
163210390|NCT00293254|589485227|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
163210391|NCT00293254|589485228|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
163210392|NCT00293254|589485227|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
163210393|NCT00293254|589485228|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
163210394|NCT00293254|589485227|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
163210395|NCT00293254|589485228|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
163210396|NCT00293254|589485227|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
163210397|NCT00293254|589485228|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
163210398|NCT00293254|589485227|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
163210399|NCT00293254|589485228|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
163210400|NCT00293254|589485227|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
163210401|NCT00293254|589485228|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
163210402|NCT00293254|589485227|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
163210403|NCT00293254|589485228|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
163210404|NCT02335489|589485229|FG000|Overall Study|Sponsor terminated study|4|||
163210405|NCT02335489|589485229|FG000|Overall Study|Lost to Follow-up|1|||
163210406|NCT02335489|589485229|FG000|Overall Study|Withdrawal by Subject|2|||
163210407|NCT02335489|589485229|FG000|Overall Study|Physician Decision|2|||
163210408|NCT02335489|589485229|FG000|Overall Study|Lack of Efficacy|1|||
163210409|NCT02259582|589485230|FG000|Overall Study|Physician Decision|0|||
163210410|NCT02259582|589485231|FG001|Overall Study|Physician Decision|1|||
163210411|NCT02259582|589485232|FG002|Overall Study|Physician Decision|0|||
163210412|NCT02259582|589485230|FG000|Overall Study|Death|0|||
163210413|NCT02259582|589485231|FG001|Overall Study|Death|0|||
163401568|NCT03029143|590181190|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
163318638|NCT02240238|589876952|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163318639|NCT02240238|589876953|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163318640|NCT02240238|589876954|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163318641|NCT02240238|589876955|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163318642|NCT02240238|589876956|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163318643|NCT02240238|589876957|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
163318644|NCT02240238|589876958|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163318645|NCT02240238|589876947|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163318646|NCT02240238|589876948|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163318647|NCT02240238|589876949|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163318648|NCT02240238|589876950|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163318649|NCT02240238|589876951|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163318650|NCT02240238|589876952|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163318651|NCT02240238|589876953|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163318652|NCT02240238|589876954|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163318653|NCT02240238|589876955|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163318654|NCT02240238|589876956|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163318655|NCT02240238|589876957|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163318656|NCT02240238|589876958|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
163318657|NCT01346540|589876970|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
163318658|NCT01346540|589876971|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
163318659|NCT01346540|589876970|FG000|Overall Study|Adverse Event|0|||
163318660|NCT01346540|589876971|FG001|Overall Study|Adverse Event|4|||
163318661|NCT05863156|589876972|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
163318662|NCT05863156|589876973|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
163318663|NCT05863156|589876974|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
163318664|NCT03625115|589876980|FG000|Overall Study|Withdrawal by Subject|4|||
163318665|NCT03625115|589876981|FG001|Overall Study|Withdrawal by Subject|7|||
163318666|NCT03625115|589876980|FG000|Overall Study|Lost to Follow-up|17|||
163318667|NCT03625115|589876981|FG001|Overall Study|Lost to Follow-up|24|||
163318668|NCT04797195|589876982|FG000|Overall Study|Death|8|||
163318669|NCT04797195|589876983|FG001|Overall Study|Death|15|||
163318670|NCT04797195|589876982|FG000|Overall Study|Change from PD|15|||
163318671|NCT04797195|589876983|FG001|Overall Study|Change from PD|15|||
163318672|NCT04797195|589876982|FG000|Overall Study|Withdrawal by Subject|3|||
163318673|NCT04797195|589876983|FG001|Overall Study|Withdrawal by Subject|2|||
163318674|NCT05868382|589876984|FG000|Overall Study|Lost to Follow-up|5|||
163318675|NCT05868382|589876985|FG001|Overall Study|Lost to Follow-up|0|||
162977516|NCT02243293|588618749|FG016|Overall Study|Adverse Event|0|||
162977517|NCT02243293|588618750|FG017|Overall Study|Adverse Event|0|||
162977518|NCT02243293|588618751|FG018|Overall Study|Adverse Event|0|||
162977519|NCT02243293|588618752|FG019|Overall Study|Adverse Event|0|||
162977520|NCT02243293|588618753|FG020|Overall Study|Adverse Event|1|||
162977521|NCT02243293|588618754|FG021|Overall Study|Adverse Event|0|||
162977522|NCT02243293|588618733|FG000|Overall Study|Withdrawal by Subject|1|||
162977523|NCT02243293|588618734|FG001|Overall Study|Withdrawal by Subject|0|||
162977524|NCT02243293|588618735|FG002|Overall Study|Withdrawal by Subject|0|||
162977525|NCT02243293|588618736|FG003|Overall Study|Withdrawal by Subject|0|||
162977526|NCT02243293|588618737|FG004|Overall Study|Withdrawal by Subject|0|||
162977527|NCT02243293|588618738|FG005|Overall Study|Withdrawal by Subject|0|||
162977528|NCT02243293|588618739|FG006|Overall Study|Withdrawal by Subject|0|||
162977529|NCT02243293|588618740|FG007|Overall Study|Withdrawal by Subject|0|||
162977530|NCT02243293|588618741|FG008|Overall Study|Withdrawal by Subject|0|||
162977531|NCT02243293|588618742|FG009|Overall Study|Withdrawal by Subject|1|||
162977532|NCT02243293|588618743|FG010|Overall Study|Withdrawal by Subject|0|||
162977533|NCT02243293|588618744|FG011|Overall Study|Withdrawal by Subject|1|||
162977534|NCT02243293|588618745|FG012|Overall Study|Withdrawal by Subject|0|||
162977535|NCT02243293|588618746|FG013|Overall Study|Withdrawal by Subject|0|||
162977536|NCT02243293|588618747|FG014|Overall Study|Withdrawal by Subject|0|||
163058030|NCT03620162|588922826|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
163058031|NCT03620162|588922827|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
163058032|NCT04009837|588922830|FG000|Overall Study|Withdrawal by Subject|5|||
163318676|NCT05868382|589876986|FG002|Overall Study|Lost to Follow-up|6|||
162977537|NCT02243293|588618748|FG015|Overall Study|Withdrawal by Subject|0|||
162977538|NCT02243293|588618749|FG016|Overall Study|Withdrawal by Subject|0|||
162977539|NCT02243293|588618750|FG017|Overall Study|Withdrawal by Subject|0|||
163058033|NCT04009837|588922831|FG001|Overall Study|Withdrawal by Subject|4|||
163318677|NCT05868382|589876987|FG003|Overall Study|Lost to Follow-up|4|||
163318678|NCT05868382|589876988|FG004|Overall Study|Lost to Follow-up|2|||
163318679|NCT05868382|589876989|FG005|Overall Study|Lost to Follow-up|6|||
163318680|NCT05868382|589876984|FG000|Overall Study|Withdrawal by Subject|1|||
163318681|NCT05868382|589876985|FG001|Overall Study|Withdrawal by Subject|0|||
162977540|NCT02243293|588618751|FG018|Overall Study|Withdrawal by Subject|0|||
162977541|NCT02243293|588618752|FG019|Overall Study|Withdrawal by Subject|0|||
162977542|NCT02243293|588618753|FG020|Overall Study|Withdrawal by Subject|0|||
162977543|NCT02243293|588618754|FG021|Overall Study|Withdrawal by Subject|1|||
162977544|NCT02243293|588618733|FG000|Overall Study|Lost to Follow-up|0|||
162977545|NCT02243293|588618734|FG001|Overall Study|Lost to Follow-up|1|||
162977546|NCT02243293|588618735|FG002|Overall Study|Lost to Follow-up|1|||
162977547|NCT02243293|588618736|FG003|Overall Study|Lost to Follow-up|1|||
162977548|NCT02243293|588618737|FG004|Overall Study|Lost to Follow-up|0|||
162977549|NCT02243293|588618738|FG005|Overall Study|Lost to Follow-up|0|||
162977550|NCT02243293|588618739|FG006|Overall Study|Lost to Follow-up|3|||
162977551|NCT02243293|588618740|FG007|Overall Study|Lost to Follow-up|0|||
162977552|NCT02243293|588618741|FG008|Overall Study|Lost to Follow-up|0|||
162977553|NCT02243293|588618742|FG009|Overall Study|Lost to Follow-up|0|||
162977554|NCT02243293|588618743|FG010|Overall Study|Lost to Follow-up|0|||
162977555|NCT02243293|588618744|FG011|Overall Study|Lost to Follow-up|2|||
162977556|NCT02243293|588618745|FG012|Overall Study|Lost to Follow-up|0|||
162977557|NCT02243293|588618746|FG013|Overall Study|Lost to Follow-up|0|||
162977558|NCT02243293|588618747|FG014|Overall Study|Lost to Follow-up|0|||
162977559|NCT02243293|588618748|FG015|Overall Study|Lost to Follow-up|0|||
162977560|NCT02243293|588618749|FG016|Overall Study|Lost to Follow-up|3|||
162977561|NCT02243293|588618750|FG017|Overall Study|Lost to Follow-up|1|||
162977562|NCT02243293|588618751|FG018|Overall Study|Lost to Follow-up|0|||
162977563|NCT02243293|588618752|FG019|Overall Study|Lost to Follow-up|0|||
162977564|NCT02243293|588618753|FG020|Overall Study|Lost to Follow-up|1|||
162977565|NCT02243293|588618754|FG021|Overall Study|Lost to Follow-up|2|||
162977566|NCT02243293|588618733|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
162977567|NCT02243293|588618734|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
162977568|NCT02243293|588618735|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
162977569|NCT02243293|588618736|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
162977570|NCT02243293|588618737|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
162977571|NCT02243293|588618738|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
162977572|NCT02243293|588618739|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
162977573|NCT02243293|588618740|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
162977574|NCT02243293|588618741|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
162977575|NCT02243293|588618742|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
162977576|NCT02243293|588618743|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
162977577|NCT02243293|588618744|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
162977578|NCT02243293|588618745|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
162977579|NCT02243293|588618746|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
162977580|NCT02243293|588618747|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
162977581|NCT02243293|588618748|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
162977582|NCT02243293|588618749|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
162977583|NCT02243293|588618750|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
162977584|NCT02243293|588618751|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
162977585|NCT02243293|588618752|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
162977586|NCT02243293|588618753|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
162977587|NCT02243293|588618754|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
163318682|NCT05868382|589876986|FG002|Overall Study|Withdrawal by Subject|0|||
163318683|NCT05868382|589876987|FG003|Overall Study|Withdrawal by Subject|0|||
163318684|NCT05868382|589876988|FG004|Overall Study|Withdrawal by Subject|1|||
163318685|NCT05868382|589876989|FG005|Overall Study|Withdrawal by Subject|0|||
163318686|NCT03655028|589876990|FG000|12-weeks Follow up|Death|1|||
163318687|NCT03655028|589876991|FG001|12-weeks Follow up|Death|0|||
163318688|NCT03655028|589876990|FG000|12-weeks Follow up|Physician Decision|3|||
163318689|NCT03655028|589876991|FG001|12-weeks Follow up|Physician Decision|3|||
163318690|NCT03655028|589876990|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
163318691|NCT03655028|589876991|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
162977588|NCT02243293|588618733|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
162977589|NCT02243293|588618734|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
162977590|NCT02243293|588618735|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
162977591|NCT02243293|588618736|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
162977592|NCT02243293|588618737|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
162977593|NCT02243293|588618738|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
162977594|NCT02243293|588618739|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
163318692|NCT03655028|589876990|FG000|12-weeks Follow up|Lost to Follow-up|4|||
163318693|NCT03655028|589876991|FG001|12-weeks Follow up|Lost to Follow-up|4|||
162977595|NCT02243293|588618740|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
162977596|NCT02243293|588618741|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
162977597|NCT02243293|588618742|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
162977598|NCT02243293|588618743|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
163318694|NCT03655028|589876990|FG000|24-weeks|Lost to Follow-up|1|||
163318695|NCT03655028|589876991|FG001|24-weeks|Lost to Follow-up|1|||
163318696|NCT03655028|589876990|FG000|24-weeks|Death|0|||
162977599|NCT02243293|588618744|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
162977600|NCT02243293|588618745|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
162977601|NCT02243293|588618746|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
162977602|NCT02243293|588618747|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
162977603|NCT02243293|588618748|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
162977604|NCT02243293|588618749|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
162977605|NCT02243293|588618750|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
162977606|NCT02243293|588618751|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
162977607|NCT02243293|588618752|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
162977608|NCT02243293|588618753|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
162977609|NCT02243293|588618754|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
162977610|NCT04117945|588618755|FG000|Overall Study|Death|1|||
162977611|NCT04117945|588618756|FG001|Overall Study|Death|0|||
162977612|NCT04117945|588618755|FG000|Overall Study|Withdrawal by Subject|3|||
162977613|NCT04117945|588618756|FG001|Overall Study|Withdrawal by Subject|1|||
162977614|NCT04117945|588618755|FG000|Overall Study|Disease Progression|0|||
162977615|NCT04117945|588618756|FG001|Overall Study|Disease Progression|2|||
162977616|NCT04117945|588618755|FG000|Overall Study|Ineligible|8|||
162977617|NCT04117945|588618756|FG001|Overall Study|Ineligible|7|||
162977618|NCT00402025|588618760|FG000|Overall Study|Adverse Event|0|||
162977619|NCT00402025|588618761|FG001|Overall Study|Adverse Event|0|||
162977620|NCT00402025|588618762|FG002|Overall Study|Adverse Event|2|||
162977621|NCT00402025|588618760|FG000|Overall Study|Death|0|||
162977622|NCT00402025|588618761|FG001|Overall Study|Death|1|||
162977623|NCT00402025|588618762|FG002|Overall Study|Death|5|||
162977624|NCT00402025|588618760|FG000|Overall Study|Disease Progression|1|||
162977625|NCT00402025|588618761|FG001|Overall Study|Disease Progression|1|||
162977626|NCT00402025|588618762|FG002|Overall Study|Disease Progression|2|||
162977627|NCT00402025|588618760|FG000|Overall Study|Physician Decision|1|||
162977628|NCT00402025|588618761|FG001|Overall Study|Physician Decision|1|||
162977629|NCT00402025|588618762|FG002|Overall Study|Physician Decision|0|||
162977630|NCT00402025|588618760|FG000|Overall Study|Participant Decision|0|||
162977631|NCT00402025|588618761|FG001|Overall Study|Participant Decision|0|||
162977632|NCT00402025|588618762|FG002|Overall Study|Participant Decision|1|||
162977633|NCT01172821|588618797|FG000|Overall Study|Adverse Event|5|||
162977634|NCT01172821|588618798|FG001|Overall Study|Adverse Event|2|||
162977635|NCT01172821|588618799|FG002|Overall Study|Adverse Event|2|||
162977636|NCT01172821|588618800|FG003|Overall Study|Adverse Event|7|||
162977637|NCT01172821|588618797|FG000|Overall Study|Protocol Violation|0|||
162977638|NCT01172821|588618798|FG001|Overall Study|Protocol Violation|2|||
162977639|NCT01172821|588618799|FG002|Overall Study|Protocol Violation|1|||
162977640|NCT01172821|588618800|FG003|Overall Study|Protocol Violation|2|||
162977641|NCT01172821|588618797|FG000|Overall Study|Lost to Follow-up|4|||
162977642|NCT01172821|588618798|FG001|Overall Study|Lost to Follow-up|1|||
162977643|NCT01172821|588618799|FG002|Overall Study|Lost to Follow-up|2|||
162977644|NCT01172821|588618800|FG003|Overall Study|Lost to Follow-up|2|||
162977645|NCT01172821|588618797|FG000|Overall Study|Withdrawal by Subject|2|||
162977646|NCT01172821|588618798|FG001|Overall Study|Withdrawal by Subject|3|||
162977647|NCT01172821|588618799|FG002|Overall Study|Withdrawal by Subject|3|||
162977648|NCT01172821|588618800|FG003|Overall Study|Withdrawal by Subject|3|||
162977649|NCT01172821|588618797|FG000|Overall Study|Other|3|||
162977650|NCT01172821|588618798|FG001|Overall Study|Other|4|||
162977651|NCT01172821|588618799|FG002|Overall Study|Other|5|||
162977652|NCT01172821|588618800|FG003|Overall Study|Other|3|||
162977653|NCT02985879|588618801|FG000|Overall Study|Adverse Event|7|||
162977654|NCT02985879|588618802|FG001|Overall Study|Adverse Event|9|||
162977655|NCT02985879|588618803|FG002|Overall Study|Adverse Event|7|||
162977656|NCT02985879|588618801|FG000|Overall Study|Withdrew consent|6|||
162977657|NCT02985879|588618802|FG001|Overall Study|Withdrew consent|8|||
162977658|NCT02985879|588618803|FG002|Overall Study|Withdrew consent|10|||
162977659|NCT02985879|588618801|FG000|Overall Study|Lost to Follow-up|1|||
162977660|NCT02985879|588618802|FG001|Overall Study|Lost to Follow-up|0|||
162977661|NCT02985879|588618803|FG002|Overall Study|Lost to Follow-up|2|||
162977662|NCT02985879|588618801|FG000|Overall Study|Other, not specified|62|||
162977663|NCT02985879|588618802|FG001|Overall Study|Other, not specified|58|||
162977664|NCT02985879|588618803|FG002|Overall Study|Other, not specified|58|||
162977665|NCT03940703|588620647|FG000|Overall Study|Still under treatment|31|||
162977666|NCT03940703|588620648|FG001|Overall Study|Still under treatment|0|||
162977667|NCT04079712|588620649|FG000|Overall Study|Disease progression before starting treatment|1|||
162977668|NCT02658487|588620650|FG000|Overall Study|Death|2|||
162977669|NCT02658487|588620650|FG000|Overall Study|Disease progression|10|||
162977670|NCT02658487|588620650|FG000|Overall Study|Alternative therapy|1|||
162977671|NCT02658487|588620650|FG000|Overall Study|Adverse Event|1|||
162977672|NCT02658487|588620650|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
162977673|NCT02658487|588620650|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
162977674|NCT02284347|588620660|FG000|Overall Study|Lost to Follow-up|2|||
162977675|NCT02284347|588620660|FG000|Overall Study|Withdrawn prior to treatment|1|||
163058034|NCT04009837|588922830|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
163058035|NCT04009837|588922831|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
163058036|NCT05569174|588922832|FG000|Overall Study|Adverse Event|0|||
163058037|NCT05569174|588922833|FG001|Overall Study|Adverse Event|1|||
163058038|NCT05569174|588922832|FG000|Overall Study|Lack of compliance|0|||
163058039|NCT05569174|588922833|FG001|Overall Study|Lack of compliance|1|||
163058040|NCT05569174|588922832|FG000|Overall Study|Withdrawal of consent|0|||
163058041|NCT05569174|588922833|FG001|Overall Study|Withdrawal of consent|1|||
163058042|NCT05569174|588922832|FG000|Overall Study|Participant wish|0|||
163058043|NCT05569174|588922833|FG001|Overall Study|Participant wish|1|||
163058044|NCT05569174|588922832|FG000|Overall Study|Lost to Follow-up|0|||
163058045|NCT05569174|588922833|FG001|Overall Study|Lost to Follow-up|1|||
163058046|NCT00112957|588922834|FG000|Overall Study|Progressive disease|18|||
163058047|NCT00112957|588922834|FG000|Overall Study|Physician Decision|1|||
163058048|NCT00961415|588922839|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
163318697|NCT03655028|589876991|FG001|24-weeks|Death|1|||
163318698|NCT03513302|589876992|FG000|First Intervention (14 Days)|Screen failure|15|||
163318699|NCT03513302|589876993|FG001|First Intervention (14 Days)|Screen failure|16|||
163318700|NCT04577963|589876994|FG000|Part 2|Death|0|||
163318701|NCT04577963|589876995|FG001|Part 2|Death|1|||
163318702|NCT04577963|589876996|FG002|Part 2|Death|8|||
163318703|NCT04577963|589876997|FG003|Part 2|Death|0|||
162977676|NCT01885182|588620661|FG000|Overall Study|Adverse Event|11|||
162977677|NCT01885182|588620662|FG001|Overall Study|Adverse Event|13|||
162977678|NCT01885182|588620661|FG000|Overall Study|Withdrawal by Subject|13|||
162977679|NCT01885182|588620662|FG001|Overall Study|Withdrawal by Subject|6|||
162977680|NCT01885182|588620661|FG000|Overall Study|Lost to Follow-up|2|||
162977681|NCT01885182|588620662|FG001|Overall Study|Lost to Follow-up|2|||
162977682|NCT01885182|588620661|FG000|Overall Study|Lack of Efficacy|8|||
162977683|NCT01885182|588620662|FG001|Overall Study|Lack of Efficacy|1|||
162977684|NCT00380692|588620665|FG000|Study Period II - Double Blind|Adverse Event|1|||
162977685|NCT00380692|588620666|FG001|Study Period II - Double Blind|Adverse Event|0|||
162977686|NCT00380692|588620665|FG000|Study Period II - Double Blind|Protocol Violation|2|||
162977687|NCT00380692|588620666|FG001|Study Period II - Double Blind|Protocol Violation|2|||
162977688|NCT00380692|588620665|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
162977689|NCT00380692|588620666|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
162977690|NCT00380692|588620665|FG000|Study Period II - Double Blind|Physician Decision|0|||
162977691|NCT00380692|588620666|FG001|Study Period II - Double Blind|Physician Decision|1|||
162977692|NCT00380692|588620665|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
162977693|NCT00380692|588620666|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
162977694|NCT00380692|588620665|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
162977695|NCT00380692|588620666|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
162977696|NCT00380692|588620665|FG000|Study Period III - Open Label|Adverse Event|5|||
162977697|NCT00380692|588620666|FG001|Study Period III - Open Label|Adverse Event|3|||
162977698|NCT00380692|588620665|FG000|Study Period III - Open Label|Protocol Violation|0|||
162977699|NCT00380692|588620666|FG001|Study Period III - Open Label|Protocol Violation|0|||
162977700|NCT00380692|588620665|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
162977701|NCT00380692|588620666|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
162977702|NCT00380692|588620665|FG000|Study Period III - Open Label|Physician Decision|0|||
162977703|NCT00380692|588620666|FG001|Study Period III - Open Label|Physician Decision|3|||
162977704|NCT00380692|588620665|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
162977705|NCT00380692|588620666|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
162977706|NCT00380692|588620665|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
162977707|NCT00380692|588620666|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
162977708|NCT04507126|588620667|FG000|Overall Study|Withdrawal by Subject|3|||
162977709|NCT04507126|588620667|FG000|Overall Study|Protocol Violation|4|||
162977710|NCT00708708|588620668|FG000|Overall Study|Another therapy instead of Enbrel|141|||
162977711|NCT00708708|588620668|FG000|Overall Study|Lost to Follow-up|52|||
162977712|NCT00708708|588620668|FG000|Overall Study|Withdrawal by Subject|51|||
162977713|NCT00708708|588620668|FG000|Overall Study|Intolerance|42|||
163058049|NCT00961415|588922840|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
163058050|NCT00961415|588922841|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
163058051|NCT00961415|588922839|FG000|Induction Treatment Phase|Death|77|||
163058052|NCT00961415|588922840|FG001|Induction Treatment Phase|Death|0|||
163058053|NCT00961415|588922841|FG002|Induction Treatment Phase|Death|0|||
163058054|NCT00961415|588922839|FG000|Induction Treatment Phase|Protocol Violation|1|||
162977714|NCT00708708|588620668|FG000|Overall Study|Another therapy along with Enbrel|15|||
162977715|NCT00708708|588620668|FG000|Overall Study|Other unspecified|11|||
162977716|NCT00708708|588620668|FG000|Overall Study|Good effectiveness|9|||
162977717|NCT00708708|588620668|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
162977718|NCT00708708|588620668|FG000|Overall Study|Administrative reasons|7|||
162977719|NCT00708708|588620668|FG000|Overall Study|Lack of effectiveness|4|||
162977720|NCT00708708|588620668|FG000|Overall Study|Lack of compliance|3|||
163318704|NCT04577963|589876998|FG004|Part 2|Death|20|||
163318705|NCT04577963|589876994|FG000|Part 2|Lost to Follow-up|0|||
162977721|NCT00708708|588620668|FG000|Overall Study|Pregnancy|3|||
162977722|NCT00708708|588620668|FG000|Overall Study|Adverse Event|3|||
162977723|NCT00708708|588620668|FG000|Overall Study|Missing values|392|||
162977724|NCT04213209|588620669|FG000|Overall Study|Protocol Violation|1|||
162977725|NCT04213209|588620670|FG001|Overall Study|Protocol Violation|0|||
162977726|NCT04213209|588620671|FG002|Overall Study|Protocol Violation|0|||
162977727|NCT04213209|588620672|FG003|Overall Study|Protocol Violation|0|||
162977728|NCT04213209|588620673|FG004|Overall Study|Protocol Violation|0|||
162977729|NCT04213209|588620674|FG005|Overall Study|Protocol Violation|0|||
162977730|NCT02065713|588620675|FG000|Overall Study|Adverse Event|0|||
162977731|NCT02065713|588620676|FG001|Overall Study|Adverse Event|1|||
162977732|NCT02065713|588620675|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162977733|NCT02065713|588620676|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162977734|NCT00140413|588620677|FG000|Overall Study|Lost to Follow-up|1|||
162977735|NCT00140413|588620678|FG001|Overall Study|Lost to Follow-up|0|||
162977736|NCT00140413|588620677|FG000|Overall Study|Withdrawal by Subject|2|||
162977737|NCT00140413|588620678|FG001|Overall Study|Withdrawal by Subject|0|||
162977738|NCT02459665|588620679|FG000|Overall Study|Withdrawal by Subject|0|||
162977739|NCT02459665|588620680|FG001|Overall Study|Withdrawal by Subject|1|||
162977740|NCT02459665|588620681|FG002|Overall Study|Withdrawal by Subject|1|||
162977741|NCT02459665|588620682|FG003|Overall Study|Withdrawal by Subject|2|||
162977742|NCT00865098|588620686|FG000|Overall Study|Progressive disease|1|||
162977743|NCT01014624|588620687|FG000|Overall Study|Adverse Event|0|||
162977744|NCT01014624|588620688|FG001|Overall Study|Adverse Event|1|||
162977745|NCT01014624|588620687|FG000|Overall Study|Protocol Violation|1|||
162977746|NCT01014624|588620688|FG001|Overall Study|Protocol Violation|0|||
162977747|NCT01014624|588620687|FG000|Overall Study|Withdrawal by Subject|1|||
162977748|NCT01014624|588620688|FG001|Overall Study|Withdrawal by Subject|0|||
162977749|NCT05560763|588620703|FG000|Overall Study|Withdrawal by Subject|4|||
162977750|NCT00296491|588620706|FG000|Overall Study|Low Pollen Counts|18|||
162977751|NCT00296491|588620707|FG001|Overall Study|Low Pollen Counts|26|||
162977752|NCT00296491|588620708|FG002|Overall Study|Low Pollen Counts|25|||
162977753|NCT00296491|588620709|FG003|Overall Study|Low Pollen Counts|16|||
162977754|NCT00296491|588620706|FG000|Overall Study|Protocol Violation|4|||
162977755|NCT00296491|588620707|FG001|Overall Study|Protocol Violation|6|||
162977756|NCT00296491|588620708|FG002|Overall Study|Protocol Violation|2|||
162977757|NCT00296491|588620709|FG003|Overall Study|Protocol Violation|3|||
162977758|NCT00296491|588620706|FG000|Overall Study|Adverse Event|1|||
162977759|NCT00296491|588620707|FG001|Overall Study|Adverse Event|3|||
162977760|NCT00296491|588620708|FG002|Overall Study|Adverse Event|1|||
162977761|NCT00296491|588620709|FG003|Overall Study|Adverse Event|4|||
162977762|NCT00296491|588620706|FG000|Overall Study|Withdrawn due to Asthma|0|||
162977763|NCT00296491|588620707|FG001|Overall Study|Withdrawn due to Asthma|0|||
162977764|NCT00296491|588620708|FG002|Overall Study|Withdrawn due to Asthma|0|||
162977765|NCT00296491|588620709|FG003|Overall Study|Withdrawn due to Asthma|4|||
162977766|NCT00296491|588620706|FG000|Overall Study|Withdrawal by Subject|7|||
162977767|NCT00296491|588620707|FG001|Overall Study|Withdrawal by Subject|3|||
162977768|NCT00296491|588620708|FG002|Overall Study|Withdrawal by Subject|3|||
162977769|NCT00296491|588620709|FG003|Overall Study|Withdrawal by Subject|2|||
162977770|NCT00296491|588620706|FG000|Overall Study|Non-Compliance|12|||
162977771|NCT00296491|588620707|FG001|Overall Study|Non-Compliance|13|||
162977772|NCT00296491|588620708|FG002|Overall Study|Non-Compliance|10|||
162977773|NCT00296491|588620709|FG003|Overall Study|Non-Compliance|14|||
162977774|NCT00296491|588620706|FG000|Overall Study|Lost to Follow-up|0|||
162977775|NCT00296491|588620707|FG001|Overall Study|Lost to Follow-up|2|||
162977776|NCT00296491|588620708|FG002|Overall Study|Lost to Follow-up|2|||
162977777|NCT00296491|588620709|FG003|Overall Study|Lost to Follow-up|0|||
162977778|NCT01929395|588620714|FG000|Overall Study|Did not complete - non-related toxicity|1|||
162977779|NCT01929395|588620715|FG001|Overall Study|Did not complete - non-related toxicity|0|||
162977780|NCT01929395|588620716|FG002|Overall Study|Did not complete - non-related toxicity|0|||
162977781|NCT01929395|588620714|FG000|Overall Study|Withdrawal by Subject|0|||
162977782|NCT01929395|588620715|FG001|Overall Study|Withdrawal by Subject|1|||
162977783|NCT01929395|588620716|FG002|Overall Study|Withdrawal by Subject|0|||
162977784|NCT01929395|588620714|FG000|Overall Study|Screen Fail|0|||
162977785|NCT01929395|588620715|FG001|Overall Study|Screen Fail|0|||
162977786|NCT01929395|588620716|FG002|Overall Study|Screen Fail|1|||
162977787|NCT00484419|588620718|FG000|Overall Study|Adverse Event|3|||
162977788|NCT00484419|588620719|FG001|Overall Study|Adverse Event|0|||
162977789|NCT00484419|588620720|FG002|Overall Study|Adverse Event|0|||
162977790|NCT00484419|588620718|FG000|Overall Study|Lost to Follow-up|1|||
162977791|NCT00484419|588620719|FG001|Overall Study|Lost to Follow-up|0|||
162977792|NCT00484419|588620720|FG002|Overall Study|Lost to Follow-up|2|||
162977793|NCT00484419|588620718|FG000|Overall Study|Withdrawal by Subject|3|||
162977794|NCT00484419|588620719|FG001|Overall Study|Withdrawal by Subject|1|||
162977795|NCT00484419|588620720|FG002|Overall Study|Withdrawal by Subject|1|||
162977796|NCT00484419|588620718|FG000|Overall Study|subject met discontinuation criteria|2|||
162977797|NCT00484419|588620719|FG001|Overall Study|subject met discontinuation criteria|2|||
162977798|NCT00484419|588620720|FG002|Overall Study|subject met discontinuation criteria|4|||
162977799|NCT00484419|588620718|FG000|Overall Study|required restricted medication|1|||
162977800|NCT00484419|588620719|FG001|Overall Study|required restricted medication|0|||
163318706|NCT04577963|589876995|FG001|Part 2|Lost to Follow-up|0|||
163318707|NCT04577963|589876996|FG002|Part 2|Lost to Follow-up|0|||
163318708|NCT04577963|589876997|FG003|Part 2|Lost to Follow-up|0|||
163318709|NCT04577963|589876998|FG004|Part 2|Lost to Follow-up|2|||
163318710|NCT04577963|589876994|FG000|Part 2|Withdrawal by Subject|0|||
163318711|NCT04577963|589876995|FG001|Part 2|Withdrawal by Subject|0|||
162977801|NCT00484419|588620720|FG002|Overall Study|required restricted medication|1|||
162977802|NCT00484419|588620718|FG000|Overall Study|Physician Decision|1|||
162977803|NCT00484419|588620719|FG001|Overall Study|Physician Decision|1|||
162977804|NCT00484419|588620720|FG002|Overall Study|Physician Decision|1|||
162977805|NCT00484419|588620718|FG000|Overall Study|subject unable to receive medication|1|||
162977806|NCT00484419|588620719|FG001|Overall Study|subject unable to receive medication|0|||
162977807|NCT00484419|588620720|FG002|Overall Study|subject unable to receive medication|0|||
162977808|NCT00484419|588620718|FG000|Overall Study|subject relocated|0|||
162977809|NCT00484419|588620719|FG001|Overall Study|subject relocated|1|||
162977810|NCT00484419|588620720|FG002|Overall Study|subject relocated|0|||
162977811|NCT00484419|588620718|FG000|Overall Study|sponsor decision, randomized in error|0|||
162977812|NCT00484419|588620719|FG001|Overall Study|sponsor decision, randomized in error|0|||
162977813|NCT00484419|588620720|FG002|Overall Study|sponsor decision, randomized in error|2|||
162977814|NCT03604341|588620721|FG000|Overall Study|Withdrawal by Subject|1|||
162977815|NCT03604341|588620722|FG001|Overall Study|Withdrawal by Subject|1|||
162977816|NCT03604341|588620721|FG000|Overall Study|Adverse Event|1|||
162977817|NCT03604341|588620722|FG001|Overall Study|Adverse Event|0|||
162977818|NCT03604341|588620721|FG000|Overall Study|Protocol Violation|0|||
162977819|NCT03604341|588620722|FG001|Overall Study|Protocol Violation|1|||
162977820|NCT01829113|588620723|FG000|Overall Study|Disease Progression|37|||
162977821|NCT01829113|588620724|FG001|Overall Study|Disease Progression|48|||
162977822|NCT01829113|588620723|FG000|Overall Study|Adverse Event|14|||
162977823|NCT01829113|588620724|FG001|Overall Study|Adverse Event|10|||
162977824|NCT01829113|588620723|FG000|Overall Study|Withdrawal by Subject|17|||
162977825|NCT01829113|588620724|FG001|Overall Study|Withdrawal by Subject|10|||
162977826|NCT01829113|588620723|FG000|Overall Study|Death|4|||
162977827|NCT01829113|588620724|FG001|Overall Study|Death|6|||
162977828|NCT01829113|588620723|FG000|Overall Study|Sponsor Decision|1|||
162977829|NCT01829113|588620724|FG001|Overall Study|Sponsor Decision|1|||
162977830|NCT01829113|588620723|FG000|Overall Study|No Study Treatment Received|3|||
162977831|NCT01829113|588620724|FG001|Overall Study|No Study Treatment Received|2|||
163058055|NCT00961415|588922840|FG001|Induction Treatment Phase|Protocol Violation|0|||
163058056|NCT00961415|588922841|FG002|Induction Treatment Phase|Protocol Violation|0|||
163058057|NCT00961415|588922839|FG000|Induction Treatment Phase|Physician Decision|2|||
163058058|NCT00961415|588922840|FG001|Induction Treatment Phase|Physician Decision|0|||
163058059|NCT00961415|588922841|FG002|Induction Treatment Phase|Physician Decision|0|||
163058060|NCT00961415|588922839|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
163058061|NCT00961415|588922840|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
163058062|NCT00961415|588922841|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
163318712|NCT04577963|589876996|FG002|Part 2|Withdrawal by Subject|0|||
163318713|NCT04577963|589876997|FG003|Part 2|Withdrawal by Subject|0|||
163318714|NCT04577963|589876998|FG004|Part 2|Withdrawal by Subject|10|||
163318715|NCT04577963|589876994|FG000|Part 2|Progressive disease|0|||
163318716|NCT04577963|589876995|FG001|Part 2|Progressive disease|0|||
163318717|NCT04577963|589876996|FG002|Part 2|Progressive disease|0|||
162977832|NCT01829113|588620723|FG000|Overall Study|Physician Decision|1|||
162977833|NCT01829113|588620724|FG001|Overall Study|Physician Decision|1|||
162977834|NCT01740791|588620725|FG000|Overall Study|Randomized but never treated|5|||
162977835|NCT01740791|588620726|FG001|Overall Study|Randomized but never treated|3|||
162977836|NCT01740791|588620727|FG002|Overall Study|Randomized but never treated|2|||
162977837|NCT01740791|588620728|FG003|Overall Study|Randomized but never treated|2|||
162977838|NCT01740791|588620729|FG004|Overall Study|Randomized but never treated|1|||
163401569|NCT03029143|590181191|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
162977839|NCT01740791|588620730|FG005|Overall Study|Randomized but never treated|3|||
162977840|NCT01740791|588620725|FG000|Overall Study|Lost to Follow-up|2|||
162977841|NCT01740791|588620726|FG001|Overall Study|Lost to Follow-up|0|||
163318718|NCT04577963|589876997|FG003|Part 2|Progressive disease|0|||
163318719|NCT04577963|589876998|FG004|Part 2|Progressive disease|2|||
162977842|NCT01740791|588620727|FG002|Overall Study|Lost to Follow-up|2|||
162977843|NCT01740791|588620728|FG003|Overall Study|Lost to Follow-up|3|||
162977844|NCT01740791|588620729|FG004|Overall Study|Lost to Follow-up|2|||
162977845|NCT01740791|588620730|FG005|Overall Study|Lost to Follow-up|3|||
162977846|NCT01740791|588620725|FG000|Overall Study|Withdrew Consent|4|||
162977847|NCT01740791|588620726|FG001|Overall Study|Withdrew Consent|0|||
162977848|NCT01740791|588620727|FG002|Overall Study|Withdrew Consent|1|||
163318720|NCT04577963|589876994|FG000|Part 2|Investigator decision|0|||
163318721|NCT04577963|589876995|FG001|Part 2|Investigator decision|0|||
163318722|NCT04577963|589876996|FG002|Part 2|Investigator decision|0|||
163210414|NCT02259582|589485232|FG002|Overall Study|Death|1|||
163210415|NCT02259582|589485230|FG000|Overall Study|Adverse Event|1|||
163210416|NCT02259582|589485231|FG001|Overall Study|Adverse Event|0|||
163210417|NCT02259582|589485232|FG002|Overall Study|Adverse Event|1|||
163210418|NCT02259582|589485230|FG000|Overall Study|Withdrawal by Subject|0|||
163210419|NCT02259582|589485231|FG001|Overall Study|Withdrawal by Subject|0|||
163210420|NCT02259582|589485232|FG002|Overall Study|Withdrawal by Subject|1|||
163210421|NCT02259582|589485230|FG000|Overall Study|Disease progression|14|||
163210422|NCT02259582|589485231|FG001|Overall Study|Disease progression|15|||
163210423|NCT02259582|589485232|FG002|Overall Study|Disease progression|17|||
163210424|NCT02259582|589485230|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
163210425|NCT02259582|589485231|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
163210426|NCT02259582|589485232|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
163210427|NCT00759863|589485235|FG000|Overall Study|Death, moved, or lost contact|20|||
163210428|NCT00759863|589485236|FG001|Overall Study|Death, moved, or lost contact|18|||
163210429|NCT00412854|589485240|FG000|Overall Study|Withdrawn due to adverse events|1|||
163210430|NCT00412854|589485241|FG001|Overall Study|Withdrawn due to adverse events|5|||
163210431|NCT00412854|589485240|FG000|Overall Study|Withdrawn for other reasons|13|||
163210432|NCT00412854|589485241|FG001|Overall Study|Withdrawn for other reasons|11|||
163210433|NCT00503308|589485243|FG000|Overall Study|Protocol Violation|2|||
163210434|NCT00503308|589485244|FG001|Overall Study|Protocol Violation|1|||
163210435|NCT00531050|589485245|FG000|Part 1: Period 1|Adverse Event|0|||
163210436|NCT00531050|589485246|FG001|Part 1: Period 1|Adverse Event|1|||
163210437|NCT00531050|589485247|FG002|Part 1: Period 1|Adverse Event|0|||
163210438|NCT00531050|589485248|FG003|Part 1: Period 1|Adverse Event|0|||
163210439|NCT00531050|589485249|FG004|Part 1: Period 1|Adverse Event|0|||
163210440|NCT00531050|589485250|FG005|Part 1: Period 1|Adverse Event|0|||
163210441|NCT00531050|589485245|FG000|Part 1: Period 1|Protocol Deviation|0|||
163210442|NCT00531050|589485246|FG001|Part 1: Period 1|Protocol Deviation|0|||
163210443|NCT00531050|589485247|FG002|Part 1: Period 1|Protocol Deviation|0|||
163210444|NCT00531050|589485248|FG003|Part 1: Period 1|Protocol Deviation|1|||
163210445|NCT00531050|589485249|FG004|Part 1: Period 1|Protocol Deviation|0|||
163210446|NCT00531050|589485250|FG005|Part 1: Period 1|Protocol Deviation|0|||
163210447|NCT00531050|589485245|FG000|Part 1: Period 3|Adverse Event|1|||
163210448|NCT00531050|589485246|FG001|Part 1: Period 3|Adverse Event|0|||
163210449|NCT00531050|589485247|FG002|Part 1: Period 3|Adverse Event|0|||
163210450|NCT00531050|589485248|FG003|Part 1: Period 3|Adverse Event|0|||
163210451|NCT00531050|589485249|FG004|Part 1: Period 3|Adverse Event|0|||
163210452|NCT00531050|589485250|FG005|Part 1: Period 3|Adverse Event|0|||
163210453|NCT00531050|589485245|FG000|Part 2: Period 1|Adverse Event|0|||
163401570|NCT03029143|590181189|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
163401571|NCT03029143|590181190|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
163401572|NCT03029143|590181191|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
163210454|NCT00531050|589485246|FG001|Part 2: Period 1|Adverse Event|0|||
163210455|NCT00531050|589485247|FG002|Part 2: Period 1|Adverse Event|0|||
163210456|NCT00531050|589485248|FG003|Part 2: Period 1|Adverse Event|0|||
163210457|NCT00531050|589485249|FG004|Part 2: Period 1|Adverse Event|0|||
163210458|NCT00531050|589485250|FG005|Part 2: Period 1|Adverse Event|1|||
163210459|NCT00531050|589485245|FG000|Part 2: Period 3|Abnormal test procedure|1|||
163210460|NCT00531050|589485246|FG001|Part 2: Period 3|Abnormal test procedure|0|||
163401573|NCT03029143|590181189|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
162977849|NCT01740791|588620728|FG003|Overall Study|Withdrew Consent|2|||
162977850|NCT01740791|588620729|FG004|Overall Study|Withdrew Consent|0|||
162977851|NCT01740791|588620730|FG005|Overall Study|Withdrew Consent|3|||
162977852|NCT01740791|588620725|FG000|Overall Study|Investigator's discretion|1|||
162977853|NCT01740791|588620726|FG001|Overall Study|Investigator's discretion|0|||
162977854|NCT01740791|588620727|FG002|Overall Study|Investigator's discretion|1|||
162977855|NCT01740791|588620728|FG003|Overall Study|Investigator's discretion|0|||
162977856|NCT01740791|588620729|FG004|Overall Study|Investigator's discretion|0|||
162977857|NCT01740791|588620730|FG005|Overall Study|Investigator's discretion|1|||
162977858|NCT01740791|588620725|FG000|Overall Study|Adverse Event|0|||
162977859|NCT01740791|588620726|FG001|Overall Study|Adverse Event|0|||
162977860|NCT01740791|588620727|FG002|Overall Study|Adverse Event|0|||
162977861|NCT01740791|588620728|FG003|Overall Study|Adverse Event|0|||
162977862|NCT01740791|588620729|FG004|Overall Study|Adverse Event|0|||
162977863|NCT01740791|588620730|FG005|Overall Study|Adverse Event|1|||
162977864|NCT02674386|588620731|FG000|Overall Study|Lost to Follow-up|0|||
162977865|NCT02674386|588620732|FG001|Overall Study|Lost to Follow-up|1|||
162977866|NCT02674386|588620733|FG002|Overall Study|Lost to Follow-up|1|||
162977867|NCT02674386|588620731|FG000|Overall Study|Withdrawal by Subject|0|||
162977868|NCT02674386|588620732|FG001|Overall Study|Withdrawal by Subject|4|||
162977869|NCT02674386|588620733|FG002|Overall Study|Withdrawal by Subject|0|||
162977870|NCT02674386|588620731|FG000|Overall Study|Other|0|||
162977871|NCT02674386|588620732|FG001|Overall Study|Other|1|||
162977872|NCT02674386|588620733|FG002|Overall Study|Other|0|||
162977873|NCT02674386|588620731|FG000|Overall Study|Enrolled but not evaluated|0|||
162977874|NCT02674386|588620732|FG001|Overall Study|Enrolled but not evaluated|4|||
162977875|NCT02674386|588620733|FG002|Overall Study|Enrolled but not evaluated|0|||
162977876|NCT02462486|588620738|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
162977877|NCT02462486|588620739|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
162977878|NCT02462486|588620740|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
162977879|NCT02462486|588620738|FG000|Overall Study|Adverse Event|53|||
162977880|NCT02462486|588620739|FG001|Overall Study|Adverse Event|48|||
162977881|NCT02462486|588620740|FG002|Overall Study|Adverse Event|21|||
162977882|NCT02462486|588620738|FG000|Overall Study|Lack of Efficacy|6|||
162977883|NCT02462486|588620739|FG001|Overall Study|Lack of Efficacy|12|||
162977884|NCT02462486|588620740|FG002|Overall Study|Lack of Efficacy|3|||
162977885|NCT02462486|588620738|FG000|Overall Study|Lost to Follow-up|3|||
162977886|NCT02462486|588620739|FG001|Overall Study|Lost to Follow-up|4|||
162977887|NCT02462486|588620740|FG002|Overall Study|Lost to Follow-up|2|||
162977888|NCT02462486|588620738|FG000|Overall Study|Withdrawal by Subject|25|||
162977889|NCT02462486|588620739|FG001|Overall Study|Withdrawal by Subject|22|||
162977890|NCT02462486|588620740|FG002|Overall Study|Withdrawal by Subject|19|||
162977891|NCT02462486|588620738|FG000|Overall Study|Protocol Violation|3|||
162977892|NCT02462486|588620739|FG001|Overall Study|Protocol Violation|1|||
162977893|NCT02462486|588620740|FG002|Overall Study|Protocol Violation|1|||
162977894|NCT02462486|588620738|FG000|Overall Study|Reason not Specified|3|||
162977895|NCT02462486|588620739|FG001|Overall Study|Reason not Specified|4|||
162977896|NCT02462486|588620740|FG002|Overall Study|Reason not Specified|3|||
162977897|NCT04706507|588620741|FG000|Overall Study|Death|45|||
162977898|NCT04706507|588620742|FG001|Overall Study|Death|22|||
162977899|NCT04706507|588620741|FG000|Overall Study|Unable to adhere|0|||
162977900|NCT04706507|588620742|FG001|Overall Study|Unable to adhere|2|||
162977901|NCT04706507|588620741|FG000|Overall Study|Lost to Follow-up|13|||
162977902|NCT04706507|588620742|FG001|Overall Study|Lost to Follow-up|12|||
162977903|NCT04706507|588620741|FG000|Overall Study|Withdrawal of consent|1|||
162977904|NCT04706507|588620742|FG001|Overall Study|Withdrawal of consent|1|||
162977905|NCT04706507|588620741|FG000|Overall Study|Patient or LAR refuses further participation|0|||
162977906|NCT04706507|588620742|FG001|Overall Study|Patient or LAR refuses further participation|3|||
162977907|NCT00873119|588620747|FG000|Overall Study|Patient request|4|||
162977908|NCT00873119|588620748|FG001|Overall Study|Patient request|2|||
162977909|NCT00873119|588620747|FG000|Overall Study|Adverse Event|8|||
162977910|NCT00873119|588620748|FG001|Overall Study|Adverse Event|0|||
162977911|NCT00873119|588620747|FG000|Overall Study|Progressive disease|26|||
162977912|NCT00873119|588620748|FG001|Overall Study|Progressive disease|18|||
162977913|NCT00873119|588620747|FG000|Overall Study|Death|2|||
162977914|NCT00873119|588620748|FG001|Overall Study|Death|1|||
162977915|NCT00873119|588620747|FG000|Overall Study|Other|2|||
162977916|NCT00873119|588620748|FG001|Overall Study|Other|5|||
162977917|NCT00873119|588620747|FG000|Overall Study|Not treated|2|||
162977918|NCT00873119|588620748|FG001|Overall Study|Not treated|0|||
162977919|NCT03648879|588620749|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
162977920|NCT00285584|588620750|FG000|Month 3|Lost to Follow-up|3|||
162977921|NCT00285584|588620751|FG001|Month 3|Lost to Follow-up|3|||
163058063|NCT00961415|588922839|FG000|Induction Treatment Phase|Other Reason|5|||
163058064|NCT00961415|588922840|FG001|Induction Treatment Phase|Other Reason|0|||
162977922|NCT00285584|588620750|FG000|Month 3|Withdrawal by Subject|1|||
162977923|NCT00285584|588620751|FG001|Month 3|Withdrawal by Subject|0|||
162977924|NCT00285584|588620750|FG000|Month 6|Lost to Follow-up|0|||
163318723|NCT04577963|589876997|FG003|Part 2|Investigator decision|0|||
163318724|NCT04577963|589876998|FG004|Part 2|Investigator decision|1|||
163318725|NCT04577963|589876994|FG000|Part 2|Sponsor terminated study|0|||
163318726|NCT04577963|589876995|FG001|Part 2|Sponsor terminated study|0|||
163318727|NCT04577963|589876996|FG002|Part 2|Sponsor terminated study|3|||
163318728|NCT04577963|589876997|FG003|Part 2|Sponsor terminated study|1|||
163318729|NCT04577963|589876998|FG004|Part 2|Sponsor terminated study|4|||
163318730|NCT05256654|589876999|FG000|Overall Study|Adverse Event|0|||
163318731|NCT05256654|589877000|FG001|Overall Study|Adverse Event|0|||
163318732|NCT05256654|589877001|FG002|Overall Study|Adverse Event|1|||
163318733|NCT05256654|589877002|FG003|Overall Study|Adverse Event|0|||
163318734|NCT05256654|589876999|FG000|Overall Study|Lost to Follow-up|0|||
163318735|NCT05256654|589877000|FG001|Overall Study|Lost to Follow-up|0|||
163318736|NCT05256654|589877001|FG002|Overall Study|Lost to Follow-up|0|||
163318737|NCT05256654|589877002|FG003|Overall Study|Lost to Follow-up|1|||
163318738|NCT05256654|589876999|FG000|Overall Study|Withdrawal by Subject|1|||
163318739|NCT05256654|589877000|FG001|Overall Study|Withdrawal by Subject|2|||
163318740|NCT05256654|589877001|FG002|Overall Study|Withdrawal by Subject|1|||
163318741|NCT05256654|589877002|FG003|Overall Study|Withdrawal by Subject|3|||
163318742|NCT05256654|589876999|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
163318743|NCT05256654|589877000|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
163318744|NCT05256654|589877001|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
163318745|NCT05256654|589877002|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
163318746|NCT05256654|589876999|FG000|Overall Study|Other|0|||
163318747|NCT05256654|589877000|FG001|Overall Study|Other|0|||
163318748|NCT05256654|589877001|FG002|Overall Study|Other|0|||
163318749|NCT05256654|589877002|FG003|Overall Study|Other|1|||
163318750|NCT02709161|589877005|FG000|Overall Study|Withdrawal by Subject|1|||
163318751|NCT02709161|589877006|FG001|Overall Study|Withdrawal by Subject|0|||
163318752|NCT04587453|589877019|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
163318753|NCT04587453|589877020|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
163318754|NCT03571581|589877021|FG000|Overall Study|Death|2|||
163318755|NCT03571581|589877021|FG000|Overall Study|Withdrawal by Subject|2|||
163318756|NCT01309672|589877022|FG000|Overall Study|Lack of Efficacy|20|||
163318757|NCT01309672|589877022|FG000|Overall Study|Other|9|||
163318758|NCT01309672|589877022|FG000|Overall Study|Adverse Event|5|||
163318759|NCT01309672|589877022|FG000|Overall Study|Withdrawal by Subject|3|||
163318760|NCT04141891|589877025|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
163318761|NCT04141891|589877026|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
163318762|NCT04141891|589877025|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
163318763|NCT04141891|589877026|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
163318764|NCT04141891|589877025|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
163318765|NCT04141891|589877026|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
163318766|NCT04141891|589877025|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
163318767|NCT04141891|589877026|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
163318768|NCT04141891|589877025|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
163318769|NCT04141891|589877026|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
163318770|NCT04141891|589877025|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
162977925|NCT00285584|588620751|FG001|Month 6|Lost to Follow-up|1|||
162977926|NCT01884688|588620752|FG000|Overall Study|Screen Failure|2|||
162977927|NCT04099641|588620753|FG000|Overall Study|Death|46|||
162977928|NCT04099641|588620754|FG001|Overall Study|Death|12|||
162977929|NCT04099641|588620753|FG000|Overall Study|Lost to Follow-up|1|||
162977930|NCT04099641|588620754|FG001|Overall Study|Lost to Follow-up|0|||
162977931|NCT04099641|588620753|FG000|Overall Study|Withdrawal by Subject|2|||
162977932|NCT04099641|588620754|FG001|Overall Study|Withdrawal by Subject|0|||
162977933|NCT02470091|588620756|FG000|Overall Study|Withdrawal by Subject|1|||
162977934|NCT02470091|588620757|FG001|Overall Study|Withdrawal by Subject|0|||
162977935|NCT02470091|588620756|FG000|Overall Study|Ineligible|0|||
162977936|NCT02470091|588620757|FG001|Overall Study|Ineligible|2|||
162977937|NCT01523587|588620758|FG000|Overall Study|Other than listed|5|||
162977938|NCT01523587|588620759|FG001|Overall Study|Other than listed|5|||
162977939|NCT01523587|588620758|FG000|Overall Study|Worsening of underlying cancer disease|19|||
162977940|NCT01523587|588620759|FG001|Overall Study|Worsening of underlying cancer disease|34|||
163318771|NCT04141891|589877026|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
163318772|NCT04141891|589877025|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
163318773|NCT04141891|589877026|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
162977941|NCT01523587|588620758|FG000|Overall Study|Adverse Event|68|||
162977942|NCT01523587|588620759|FG001|Overall Study|Adverse Event|52|||
162977943|NCT01523587|588620758|FG000|Overall Study|Protocol Violation|5|||
162977944|NCT01523587|588620759|FG001|Overall Study|Protocol Violation|3|||
162977945|NCT01523587|588620758|FG000|Overall Study|Lost to Follow-up|2|||
163318774|NCT04141891|589877025|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
163318775|NCT04141891|589877026|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
163318776|NCT04141891|589877025|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
162977946|NCT01523587|588620759|FG001|Overall Study|Lost to Follow-up|2|||
162977947|NCT01523587|588620758|FG000|Overall Study|Withdrawal by Subject|28|||
162977948|NCT01523587|588620759|FG001|Overall Study|Withdrawal by Subject|20|||
162977949|NCT01523587|588620758|FG000|Overall Study|Withdrew due to Progressive disease|265|||
162977950|NCT01523587|588620759|FG001|Overall Study|Withdrew due to Progressive disease|279|||
162977951|NCT01523587|588620758|FG000|Overall Study|Randomised but bot treated|6|||
162977952|NCT01523587|588620759|FG001|Overall Study|Randomised but bot treated|2|||
162977953|NCT02709486|588620760|FG000|Overall Study|Adverse Event|2|||
162977954|NCT02709486|588620761|FG001|Overall Study|Adverse Event|5|||
162977955|NCT02709486|588620762|FG002|Overall Study|Adverse Event|3|||
162977956|NCT02709486|588620760|FG000|Overall Study|Death|0|||
162977957|NCT02709486|588620761|FG001|Overall Study|Death|0|||
162977958|NCT02709486|588620762|FG002|Overall Study|Death|2|||
162977959|NCT02709486|588620760|FG000|Overall Study|Insufficient clinical response|7|||
162977960|NCT02709486|588620761|FG001|Overall Study|Insufficient clinical response|3|||
162977961|NCT02709486|588620762|FG002|Overall Study|Insufficient clinical response|3|||
162977962|NCT02709486|588620760|FG000|Overall Study|Lost to Follow-up|3|||
162977963|NCT02709486|588620761|FG001|Overall Study|Lost to Follow-up|2|||
162977964|NCT02709486|588620762|FG002|Overall Study|Lost to Follow-up|2|||
162977965|NCT02709486|588620760|FG000|Overall Study|Other|0|||
162977966|NCT02709486|588620761|FG001|Overall Study|Other|2|||
162977967|NCT02709486|588620762|FG002|Overall Study|Other|3|||
162977968|NCT02709486|588620760|FG000|Overall Study|Withdrawal by Subject|32|||
162977969|NCT02709486|588620761|FG001|Overall Study|Withdrawal by Subject|22|||
162977970|NCT02709486|588620762|FG002|Overall Study|Withdrawal by Subject|32|||
162977971|NCT00536484|588620767|FG000|Overall Study|Adverse Event|21|||
162977972|NCT00536484|588620768|FG001|Overall Study|Adverse Event|34|||
162977973|NCT00536484|588620767|FG000|Overall Study|Withdrawal by Subject|11|||
162977974|NCT00536484|588620768|FG001|Overall Study|Withdrawal by Subject|11|||
162977975|NCT00536484|588620767|FG000|Overall Study|Lost to Follow-up|8|||
162977976|NCT00536484|588620768|FG001|Overall Study|Lost to Follow-up|6|||
162977977|NCT00536484|588620767|FG000|Overall Study|Lack of Efficacy|16|||
162977978|NCT00536484|588620768|FG001|Overall Study|Lack of Efficacy|5|||
162977979|NCT00536484|588620767|FG000|Overall Study|Other|4|||
162977980|NCT00536484|588620768|FG001|Overall Study|Other|0|||
162977981|NCT00706355|588620769|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
162977982|NCT00706355|588620770|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
162977983|NCT00706355|588620771|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
162977984|NCT00706355|588620772|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
162977985|NCT00706355|588620769|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
162977986|NCT00706355|588620770|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
162977987|NCT00706355|588620771|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
162977988|NCT00706355|588620772|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
162977989|NCT00706355|588620769|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
162977990|NCT00706355|588620770|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
162977991|NCT00706355|588620771|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
162977992|NCT00706355|588620772|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
162977993|NCT00706355|588620769|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
162977994|NCT00706355|588620770|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
162977995|NCT00706355|588620771|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
162977996|NCT00706355|588620772|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
162977997|NCT00706355|588620769|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
162977998|NCT00706355|588620770|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
162977999|NCT00706355|588620771|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
162978000|NCT00706355|588620772|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
162978001|NCT00706355|588620769|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
162978002|NCT00706355|588620770|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
162978003|NCT00706355|588620771|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
162978004|NCT00706355|588620772|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
162978005|NCT00706355|588620769|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
162978006|NCT00706355|588620770|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
162978007|NCT00706355|588620771|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
162978008|NCT00706355|588620772|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
162978009|NCT00706355|588620769|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
162978010|NCT00706355|588620770|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
162978011|NCT00706355|588620771|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
163210461|NCT00531050|589485247|FG002|Part 2: Period 3|Abnormal test procedure|0|||
162978012|NCT00706355|588620772|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
162978013|NCT00706355|588620769|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
162978014|NCT00706355|588620770|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
162978015|NCT00706355|588620771|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
162978016|NCT00706355|588620772|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
162978017|NCT02549573|588620775|FG000|Overall Study|Withdrawal by Subject|0|||
162978018|NCT02549573|588620776|FG001|Overall Study|Withdrawal by Subject|2|||
162978019|NCT02549573|588620775|FG000|Overall Study|Protocol Violation|0|||
162978020|NCT02549573|588620776|FG001|Overall Study|Protocol Violation|1|||
162978021|NCT02610816|588620779|FG000|Phase 1|Withdrawal by Subject|2|||
162978022|NCT02610816|588620780|FG001|Phase 1|Withdrawal by Subject|6|||
162978023|NCT02610816|588620781|FG002|Phase 1|Withdrawal by Subject|0|||
162978024|NCT02610816|588620782|FG003|Phase 1|Withdrawal by Subject|0|||
162978025|NCT02610816|588620779|FG000|Phase 1|Lost to Follow-up|2|||
162978026|NCT02610816|588620780|FG001|Phase 1|Lost to Follow-up|1|||
162978027|NCT02610816|588620781|FG002|Phase 1|Lost to Follow-up|0|||
162978028|NCT02610816|588620782|FG003|Phase 1|Lost to Follow-up|0|||
162978029|NCT02610816|588620779|FG000|Phase 1|Physician Decision|0|||
162978030|NCT02610816|588620780|FG001|Phase 1|Physician Decision|1|||
162978031|NCT02610816|588620781|FG002|Phase 1|Physician Decision|0|||
162978032|NCT02610816|588620782|FG003|Phase 1|Physician Decision|0|||
162978033|NCT02610816|588620779|FG000|Phase 2|Withdrawal by Subject|0|||
162978034|NCT02610816|588620780|FG001|Phase 2|Withdrawal by Subject|0|||
162978035|NCT02610816|588620781|FG002|Phase 2|Withdrawal by Subject|9|||
162978036|NCT02610816|588620782|FG003|Phase 2|Withdrawal by Subject|3|||
162978037|NCT02610816|588620779|FG000|Phase 2|Lost to Follow-up|0|||
162978038|NCT02610816|588620780|FG001|Phase 2|Lost to Follow-up|0|||
162978039|NCT02610816|588620781|FG002|Phase 2|Lost to Follow-up|2|||
162978040|NCT02610816|588620782|FG003|Phase 2|Lost to Follow-up|0|||
162978041|NCT02610816|588620779|FG000|Phase 2|Physician Decision|0|||
162978042|NCT02610816|588620780|FG001|Phase 2|Physician Decision|0|||
162978043|NCT02610816|588620781|FG002|Phase 2|Physician Decision|0|||
162978044|NCT02610816|588620782|FG003|Phase 2|Physician Decision|2|||
162978045|NCT02610816|588620779|FG000|Phase 2|Pregnancy|0|||
162978046|NCT02610816|588620780|FG001|Phase 2|Pregnancy|0|||
162978047|NCT02610816|588620781|FG002|Phase 2|Pregnancy|0|||
162978048|NCT02610816|588620782|FG003|Phase 2|Pregnancy|1|||
162978049|NCT02691741|588620785|FG000|Overall Study|Adverse Event|0|||
162978050|NCT02691741|588620786|FG001|Overall Study|Adverse Event|2|||
162978051|NCT02691741|588620785|FG000|Overall Study|Lost to Follow-up|1|||
162978052|NCT02691741|588620786|FG001|Overall Study|Lost to Follow-up|0|||
162978053|NCT02691741|588620785|FG000|Overall Study|Physician Decision|0|||
162978054|NCT02691741|588620786|FG001|Overall Study|Physician Decision|1|||
162978055|NCT02691741|588620785|FG000|Overall Study|Withdrawal by Subject|0|||
162978056|NCT02691741|588620786|FG001|Overall Study|Withdrawal by Subject|4|||
162978057|NCT03465436|588620787|FG000|Period 1|Protocol Violation|0|||
162978058|NCT03465436|588620788|FG001|Period 1|Protocol Violation|0|||
162978059|NCT03465436|588620789|FG002|Period 1|Protocol Violation|1|||
162978060|NCT03465436|588620790|FG003|Period 1|Protocol Violation|0|||
162978061|NCT03465436|588620787|FG000|Period 2|Protocol Violation|0|||
162978062|NCT03465436|588620788|FG001|Period 2|Protocol Violation|1|||
162978063|NCT03465436|588620789|FG002|Period 2|Protocol Violation|0|||
162978064|NCT03465436|588620790|FG003|Period 2|Protocol Violation|0|||
162978065|NCT03465436|588620787|FG000|Period 3|Protocol Violation|1|||
162978066|NCT03465436|588620788|FG001|Period 3|Protocol Violation|1|||
162978067|NCT03465436|588620789|FG002|Period 3|Protocol Violation|0|||
162978068|NCT03465436|588620790|FG003|Period 3|Protocol Violation|0|||
162978069|NCT03465436|588620787|FG000|Period 4|Protocol Violation|0|||
162978070|NCT03465436|588620788|FG001|Period 4|Protocol Violation|0|||
162978071|NCT03465436|588620789|FG002|Period 4|Protocol Violation|1|||
162978072|NCT03465436|588620790|FG003|Period 4|Protocol Violation|0|||
162978073|NCT01425528|588620791|FG000|Overall Study|Withdrawal by Subject|1|||
162978074|NCT01425528|588620792|FG001|Overall Study|Withdrawal by Subject|1|||
162978075|NCT02697773|588620793|FG000|Overall Study|Adverse Event|2|||
162978076|NCT02697773|588620794|FG001|Overall Study|Adverse Event|1|||
162978077|NCT02697773|588620795|FG002|Overall Study|Adverse Event|2|||
162978078|NCT02697773|588620793|FG000|Overall Study|Death|0|||
162978079|NCT02697773|588620794|FG001|Overall Study|Death|0|||
162978080|NCT02697773|588620795|FG002|Overall Study|Death|2|||
162978081|NCT02697773|588620793|FG000|Overall Study|Lack of Efficacy|4|||
162978082|NCT02697773|588620794|FG001|Overall Study|Lack of Efficacy|6|||
162978083|NCT02697773|588620795|FG002|Overall Study|Lack of Efficacy|6|||
162978084|NCT02697773|588620793|FG000|Overall Study|Lost to Follow-up|5|||
162978085|NCT02697773|588620794|FG001|Overall Study|Lost to Follow-up|5|||
162978086|NCT02697773|588620795|FG002|Overall Study|Lost to Follow-up|7|||
162978087|NCT02697773|588620793|FG000|Overall Study|Other|15|||
162978088|NCT02697773|588620794|FG001|Overall Study|Other|11|||
162978089|NCT02697773|588620795|FG002|Overall Study|Other|10|||
162978090|NCT02697773|588620793|FG000|Overall Study|Protocol Violation|1|||
162978091|NCT02697773|588620794|FG001|Overall Study|Protocol Violation|1|||
162978092|NCT02697773|588620795|FG002|Overall Study|Protocol Violation|0|||
162978093|NCT02697773|588620793|FG000|Overall Study|Withdrawal by Subject|10|||
162978094|NCT02697773|588620794|FG001|Overall Study|Withdrawal by Subject|13|||
162978095|NCT02697773|588620795|FG002|Overall Study|Withdrawal by Subject|13|||
162978096|NCT02697773|588620793|FG000|Overall Study|Randomized but not treated|1|||
162978097|NCT02697773|588620794|FG001|Overall Study|Randomized but not treated|1|||
163318777|NCT04141891|589877026|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
163318778|NCT04141891|589877025|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
163318779|NCT04141891|589877026|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
163318780|NCT04141891|589877025|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
163318781|NCT04141891|589877026|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
163318782|NCT04141891|589877025|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
163318783|NCT04141891|589877026|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
163318784|NCT04141891|589877025|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
163318785|NCT04141891|589877026|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
163318786|NCT04141891|589877025|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
163318787|NCT04141891|589877026|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
163318788|NCT04737330|589877027|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
163318789|NCT04737330|589877028|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
163318790|NCT04737330|589877027|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
163318791|NCT04737330|589877028|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
163318792|NCT04737330|589877027|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
163318793|NCT04737330|589877028|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
163318794|NCT04737330|589877027|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
163318795|NCT04737330|589877028|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
163318796|NCT04737330|589877027|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
163318797|NCT04737330|589877028|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
163318798|NCT04737330|589877027|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
163318799|NCT04737330|589877028|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
163318800|NCT03295721|589877032|FG000|Overall Study|Adverse Event|1|||
163318801|NCT03295721|589877033|FG001|Overall Study|Adverse Event|0|||
163318802|NCT03295721|589877034|FG002|Overall Study|Adverse Event|0|||
163318803|NCT03295721|589877032|FG000|Overall Study|Lost to Follow-up|1|||
162978098|NCT02697773|588620795|FG002|Overall Study|Randomized but not treated|0|||
162978099|NCT00613834|588620796|FG000|Overall Study|Withdrawal by Subject|0|||
162978100|NCT00613834|588620797|FG001|Overall Study|Withdrawal by Subject|3|||
162978101|NCT02756637|588620798|FG000|Overall Study|Not eligible for initial SWOG study|10|||
162978102|NCT02756637|588620799|FG001|Overall Study|Not eligible for initial SWOG study|10|||
162978103|NCT02756637|588620798|FG000|Overall Study|No available NLR value|44|||
162978104|NCT02756637|588620799|FG001|Overall Study|No available NLR value|44|||
162978105|NCT02756637|588620798|FG000|Overall Study|Did not complete curative therapy|33|||
162978106|NCT02756637|588620799|FG001|Overall Study|Did not complete curative therapy|0|||
162978107|NCT01475253|588621652|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
162978108|NCT01475253|588621653|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
162978109|NCT01475253|588621654|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
162978110|NCT01475253|588621655|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
162978111|NCT01475253|588621652|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
162978112|NCT01475253|588621653|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
162978113|NCT01475253|588621654|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
162978114|NCT01475253|588621655|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
162978115|NCT03919448|588621661|FG000|Overall Study|Withdrawal by Subject|1|||
162978116|NCT03919448|588621662|FG001|Overall Study|Withdrawal by Subject|0|||
162978117|NCT03919448|588621663|FG002|Overall Study|Withdrawal by Subject|0|||
162978118|NCT01567826|588621671|FG000|Overall Study|Lost to Follow-up|3|||
162978119|NCT01567826|588621672|FG001|Overall Study|Lost to Follow-up|2|||
162978120|NCT03265288|588621675|FG000|Overall Study|Adverse Event|0|||
162978121|NCT03265288|588621676|FG001|Overall Study|Adverse Event|1|||
162978122|NCT03265288|588621675|FG000|Overall Study|Withdrawal by Subject|13|||
162978123|NCT03265288|588621676|FG001|Overall Study|Withdrawal by Subject|5|||
162978124|NCT03265288|588621675|FG000|Overall Study|Drug Withdrawn|3|||
162978125|NCT03265288|588621676|FG001|Overall Study|Drug Withdrawn|3|||
162978126|NCT03265288|588621675|FG000|Overall Study|Any Other Reason|7|||
162978127|NCT03265288|588621676|FG001|Overall Study|Any Other Reason|3|||
162978128|NCT04976621|588621693|FG000|Overall Study|Lost to Follow-up|2|||
162978129|NCT04976621|588621694|FG001|Overall Study|Lost to Follow-up|2|||
162978130|NCT04976621|588621693|FG000|Overall Study|Withdrawal by Subject|1|||
162978131|NCT04976621|588621694|FG001|Overall Study|Withdrawal by Subject|1|||
162978132|NCT01478828|588621695|FG000|Overall Study|Adverse Event|1|||
162978133|NCT01557842|588621696|FG000|Overall Study|Lost to Follow-up|0|||
162978134|NCT01557842|588621697|FG001|Overall Study|Lost to Follow-up|1|||
162978135|NCT01557842|588621696|FG000|Overall Study|Death|1|||
162978136|NCT01557842|588621697|FG001|Overall Study|Death|0|||
162978137|NCT01557842|588621696|FG000|Overall Study|Lack of Efficacy|0|||
162978138|NCT01557842|588621697|FG001|Overall Study|Lack of Efficacy|1|||
162978139|NCT01557842|588621696|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
162978140|NCT01557842|588621697|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
162978141|NCT01557842|588621696|FG000|Overall Study|Study Terminated by Sponsor|3|||
162978142|NCT01557842|588621697|FG001|Overall Study|Study Terminated by Sponsor|4|||
162978143|NCT01557842|588621696|FG000|Overall Study|Not Ablated|2|||
162978144|NCT01557842|588621697|FG001|Overall Study|Not Ablated|0|||
162978145|NCT05611996|588621698|FG000|Overall Study|Ineligible|1|||
162978146|NCT05611996|588621698|FG000|Overall Study|Withdrawal by Subject|9|||
163318804|NCT03295721|589877033|FG001|Overall Study|Lost to Follow-up|1|||
163318805|NCT03295721|589877034|FG002|Overall Study|Lost to Follow-up|1|||
163318806|NCT03295721|589877032|FG000|Overall Study|Withdrawal by Subject|1|||
163318807|NCT03295721|589877033|FG001|Overall Study|Withdrawal by Subject|0|||
163318808|NCT03295721|589877034|FG002|Overall Study|Withdrawal by Subject|1|||
162978147|NCT04479475|588621702|FG000|Overall Study|Withdrawal by Subject|7|||
162978148|NCT00619359|588621705|FG000|Overall Study|Adverse Event|32|||
162978149|NCT00619359|588621706|FG001|Overall Study|Adverse Event|36|||
162978150|NCT00619359|588621705|FG000|Overall Study|Lost to Follow-up|12|||
162978151|NCT00619359|588621706|FG001|Overall Study|Lost to Follow-up|16|||
162978152|NCT00619359|588621705|FG000|Overall Study|Physician Decision|0|||
162978153|NCT00619359|588621706|FG001|Overall Study|Physician Decision|7|||
162978154|NCT00619359|588621705|FG000|Overall Study|Protocol Violation|1|||
162978155|NCT00619359|588621706|FG001|Overall Study|Protocol Violation|1|||
162978156|NCT00619359|588621705|FG000|Overall Study|Withdrawal by Subject|19|||
162978157|NCT00619359|588621706|FG001|Overall Study|Withdrawal by Subject|20|||
162978158|NCT00619359|588621705|FG000|Overall Study|Progressive Disease|3|||
162978159|NCT00619359|588621706|FG001|Overall Study|Progressive Disease|1|||
162978160|NCT06972251|588621709|FG000|Overall Study|Withdrawal by Subject|1|||
162978161|NCT06972251|588621710|FG001|Overall Study|Withdrawal by Subject|0|||
162978162|NCT06972251|588621709|FG000|Overall Study|Lost to Follow-up|10|||
162978163|NCT06972251|588621710|FG001|Overall Study|Lost to Follow-up|2|||
162978164|NCT05575063|588621711|FG000|Overall Study|Withdrawal by Subject|1|||
162978165|NCT00949988|588621712|FG000|Overall Study|Withdrawal by Subject|3|||
162978166|NCT02654587|588621715|FG000|Overall Study|patient alive at end of study|22|||
162978167|NCT02654587|588621716|FG001|Overall Study|patient alive at end of study|8|||
162978168|NCT02654587|588621715|FG000|Overall Study|Withdrawal by Subject|1|||
162978169|NCT02654587|588621716|FG001|Overall Study|Withdrawal by Subject|7|||
162978170|NCT01825837|588621717|FG000|PART I|Withdrawal by Subject|0|||
162978171|NCT01825837|588621718|FG001|PART I|Withdrawal by Subject|0|||
162978172|NCT01825837|588621719|FG002|PART I|Withdrawal by Subject|0|||
162978173|NCT01825837|588621720|FG003|PART I|Withdrawal by Subject|6|||
162978174|NCT01825837|588621717|FG000|PART I|Patient non-compliance|0|||
162978175|NCT01825837|588621718|FG001|PART I|Patient non-compliance|0|||
162978176|NCT01825837|588621719|FG002|PART I|Patient non-compliance|0|||
162978177|NCT01825837|588621720|FG003|PART I|Patient non-compliance|1|||
162978178|NCT01825837|588621717|FG000|PART I|Treatment failure|0|||
162978179|NCT01825837|588621718|FG001|PART I|Treatment failure|0|||
162978180|NCT01825837|588621719|FG002|PART I|Treatment failure|0|||
162978181|NCT01825837|588621720|FG003|PART I|Treatment failure|7|||
162978182|NCT01825837|588621717|FG000|PART I|reason unspecified|0|||
162978183|NCT01825837|588621718|FG001|PART I|reason unspecified|0|||
162978184|NCT01825837|588621719|FG002|PART I|reason unspecified|0|||
162978185|NCT01825837|588621720|FG003|PART I|reason unspecified|3|||
162978186|NCT01825837|588621717|FG000|PART II|Withdrawal by Subject|3|||
162978187|NCT01825837|588621718|FG001|PART II|Withdrawal by Subject|3|||
162978188|NCT01825837|588621719|FG002|PART II|Withdrawal by Subject|7|||
162978189|NCT01825837|588621720|FG003|PART II|Withdrawal by Subject|0|||
162978190|NCT01825837|588621717|FG000|PART II|Patient non-compliance|5|||
162978191|NCT01825837|588621718|FG001|PART II|Patient non-compliance|2|||
162978192|NCT01825837|588621719|FG002|PART II|Patient non-compliance|4|||
162978193|NCT01825837|588621720|FG003|PART II|Patient non-compliance|0|||
162978194|NCT01825837|588621717|FG000|PART II|Adverse Event|3|||
162978195|NCT01825837|588621718|FG001|PART II|Adverse Event|3|||
162978196|NCT01825837|588621719|FG002|PART II|Adverse Event|1|||
162978197|NCT01825837|588621720|FG003|PART II|Adverse Event|0|||
162978198|NCT01825837|588621717|FG000|PART II|Treatment failure|6|||
162978199|NCT01825837|588621718|FG001|PART II|Treatment failure|4|||
162978200|NCT01825837|588621719|FG002|PART II|Treatment failure|5|||
162978201|NCT01825837|588621720|FG003|PART II|Treatment failure|0|||
162978202|NCT01825837|588621717|FG000|PART II|reason unspecified|2|||
162978203|NCT01825837|588621718|FG001|PART II|reason unspecified|2|||
162978204|NCT01825837|588621719|FG002|PART II|reason unspecified|2|||
163318809|NCT03295721|589877032|FG000|Overall Study|Death|0|||
162978205|NCT01825837|588621720|FG003|PART II|reason unspecified|0|||
162978206|NCT00904748|588621723|FG000|Overall Study|Withdrawal by Subject|1|||
162978207|NCT00904748|588621724|FG001|Overall Study|Withdrawal by Subject|1|||
162978208|NCT00904748|588621725|FG002|Overall Study|Withdrawal by Subject|1|||
162978209|NCT00904748|588621726|FG003|Overall Study|Withdrawal by Subject|2|||
162978210|NCT00904748|588621727|FG004|Overall Study|Withdrawal by Subject|0|||
162978211|NCT00904748|588621728|FG005|Overall Study|Withdrawal by Subject|0|||
162978212|NCT00904748|588621723|FG000|Overall Study|Adverse Event|0|||
162978213|NCT00904748|588621724|FG001|Overall Study|Adverse Event|0|||
162978214|NCT00904748|588621725|FG002|Overall Study|Adverse Event|0|||
163318810|NCT03295721|589877033|FG001|Overall Study|Death|0|||
162978215|NCT00904748|588621726|FG003|Overall Study|Adverse Event|0|||
162978216|NCT00904748|588621727|FG004|Overall Study|Adverse Event|1|||
162978217|NCT00904748|588621728|FG005|Overall Study|Adverse Event|0|||
162978218|NCT01682148|588621729|FG000|Overall Study|Withdrawal by Subject|2|||
162978219|NCT01682148|588621730|FG001|Overall Study|Withdrawal by Subject|0|||
162978220|NCT01682148|588621729|FG000|Overall Study|Lost to Follow-up|1|||
162978221|NCT01682148|588621730|FG001|Overall Study|Lost to Follow-up|2|||
162978222|NCT01682148|588621729|FG000|Overall Study|Protocol Violation|1|||
162978223|NCT01682148|588621730|FG001|Overall Study|Protocol Violation|1|||
162978224|NCT01202877|588621731|FG000|Overall Study|Disease Progression|0|||
162978225|NCT01202877|588621732|FG001|Overall Study|Disease Progression|1|||
162978226|NCT01202877|588621733|FG002|Overall Study|Disease Progression|2|||
162978227|NCT01202877|588621731|FG000|Overall Study|Adverse Event|0|||
162978228|NCT01202877|588621732|FG001|Overall Study|Adverse Event|0|||
162978229|NCT01202877|588621733|FG002|Overall Study|Adverse Event|2|||
162978230|NCT01202877|588621731|FG000|Overall Study|Withdrawal by Subject|0|||
162978231|NCT01202877|588621732|FG001|Overall Study|Withdrawal by Subject|0|||
162978232|NCT01202877|588621733|FG002|Overall Study|Withdrawal by Subject|1|||
162978233|NCT01202877|588621731|FG000|Overall Study|Death|0|||
162978234|NCT01202877|588621732|FG001|Overall Study|Death|0|||
162978235|NCT01202877|588621733|FG002|Overall Study|Death|1|||
162978236|NCT00396331|588621734|FG000|Overall Study|Failed to mobilize - no transplant|8|||
162978237|NCT00396331|588621734|FG000|Overall Study|Did not go on to transplant|5|||
162978238|NCT00396331|588621734|FG000|Overall Study|Lost to Follow-up|3|||
162978239|NCT00396331|588621734|FG000|Overall Study|Death|16|||
162978240|NCT01029392|588621744|FG000|Overall Study|Withdrawal by Subject|18|||
162978241|NCT01029392|588621745|FG001|Overall Study|Withdrawal by Subject|11|||
162978242|NCT01029392|588621744|FG000|Overall Study|Physician Decision|2|||
162978243|NCT01029392|588621745|FG001|Overall Study|Physician Decision|0|||
162978244|NCT01103479|588621746|FG000|Overall Study|Up to date with CRC screening|1|||
162978245|NCT01103479|588621747|FG001|Overall Study|Up to date with CRC screening|9|||
162978246|NCT01103479|588621748|FG002|Overall Study|Up to date with CRC screening|12|||
162978247|NCT01103479|588621746|FG000|Overall Study|Family history of CRC|1|||
162978248|NCT01103479|588621747|FG001|Overall Study|Family history of CRC|0|||
162978249|NCT01103479|588621748|FG002|Overall Study|Family history of CRC|2|||
162978250|NCT01103479|588621746|FG000|Overall Study|Active cancer|1|||
162978251|NCT01103479|588621747|FG001|Overall Study|Active cancer|0|||
162978252|NCT01103479|588621748|FG002|Overall Study|Active cancer|0|||
162978253|NCT01103479|588621746|FG000|Overall Study|Saw non-study physician|2|||
162978254|NCT01103479|588621747|FG001|Overall Study|Saw non-study physician|0|||
162978255|NCT01103479|588621748|FG002|Overall Study|Saw non-study physician|0|||
162978256|NCT01298778|588621749|FG000|Overall Study|Lost to Follow-up|2|||
162978257|NCT01298778|588621750|FG001|Overall Study|Lost to Follow-up|3|||
162978258|NCT01298778|588621749|FG000|Overall Study|Incorrect use of VAS|1|||
162978259|NCT01298778|588621750|FG001|Overall Study|Incorrect use of VAS|0|||
162978260|NCT01298778|588621749|FG000|Overall Study|Withdrawal by Subject|0|||
162978261|NCT01298778|588621750|FG001|Overall Study|Withdrawal by Subject|1|||
162978262|NCT01298778|588621749|FG000|Overall Study|Protocol Violation|0|||
162978263|NCT01298778|588621750|FG001|Overall Study|Protocol Violation|1|||
162978264|NCT01298778|588621749|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
162978265|NCT01298778|588621750|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
162978266|NCT02377921|588621751|FG000|Overall Study|Subject non-compliance|1|||
162978267|NCT02377921|588621752|FG001|Overall Study|Subject non-compliance|1|||
162978268|NCT02443545|588621753|FG000|Overall Study|Adverse Event|1|||
162978269|NCT02443545|588621754|FG001|Overall Study|Adverse Event|1|||
162978270|NCT02443545|588621753|FG000|Overall Study|Lost to Follow-up|0|||
162978271|NCT02443545|588621754|FG001|Overall Study|Lost to Follow-up|2|||
162978272|NCT02443545|588621753|FG000|Overall Study|Physician Decision|3|||
162978273|NCT02443545|588621754|FG001|Overall Study|Physician Decision|0|||
162978274|NCT02443545|588621753|FG000|Overall Study|Protocol Violation|8|||
162978275|NCT02443545|588621754|FG001|Overall Study|Protocol Violation|1|||
162978276|NCT02443545|588621753|FG000|Overall Study|Pregnancy|1|||
162978277|NCT02443545|588621754|FG001|Overall Study|Pregnancy|1|||
162978278|NCT02443545|588621753|FG000|Overall Study|Withdrawal by Subject|6|||
162978279|NCT02443545|588621754|FG001|Overall Study|Withdrawal by Subject|3|||
162978280|NCT02443545|588621753|FG000|Overall Study|Termination of study|20|||
162978281|NCT02443545|588621754|FG001|Overall Study|Termination of study|11|||
162978282|NCT02139124|588621757|FG000|Overall Study|Adverse Event|2|||
162978283|NCT02139124|588621758|FG001|Overall Study|Adverse Event|0|||
163058065|NCT00961415|588922841|FG002|Induction Treatment Phase|Other Reason|0|||
162978284|NCT02139124|588621759|FG002|Overall Study|Adverse Event|1|||
162978285|NCT02139124|588621760|FG003|Overall Study|Adverse Event|2|||
162978286|NCT02139124|588621761|FG004|Overall Study|Adverse Event|5|||
162978287|NCT02139124|588621757|FG000|Overall Study|Withdrawal by Subject|2|||
162978288|NCT02139124|588621758|FG001|Overall Study|Withdrawal by Subject|2|||
162978289|NCT02139124|588621759|FG002|Overall Study|Withdrawal by Subject|2|||
162978290|NCT02139124|588621760|FG003|Overall Study|Withdrawal by Subject|2|||
162978291|NCT02139124|588621761|FG004|Overall Study|Withdrawal by Subject|3|||
163318811|NCT03295721|589877034|FG002|Overall Study|Death|1|||
163318812|NCT04850898|589878764|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
163318813|NCT04850898|589878765|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
163318814|NCT04909801|589878774|FG000|Overall Study|Lack of Efficacy|2|||
163318815|NCT04909801|589878775|FG001|Overall Study|Lack of Efficacy|1|||
163318816|NCT04909801|589878774|FG000|Overall Study|Adverse Event|1|||
163318817|NCT04909801|589878775|FG001|Overall Study|Adverse Event|2|||
162978292|NCT02139124|588621757|FG000|Overall Study|Protocol Violation|0|||
162978293|NCT02139124|588621758|FG001|Overall Study|Protocol Violation|0|||
162978294|NCT02139124|588621759|FG002|Overall Study|Protocol Violation|0|||
162978295|NCT02139124|588621760|FG003|Overall Study|Protocol Violation|1|||
163318818|NCT04909801|589878774|FG000|Overall Study|Participant request to discontinue study treatment|1|||
163318819|NCT04909801|589878775|FG001|Overall Study|Participant request to discontinue study treatment|2|||
163318820|NCT04909801|589878774|FG000|Overall Study|Withdrawal by Subject|2|||
163318821|NCT04909801|589878775|FG001|Overall Study|Withdrawal by Subject|1|||
163318822|NCT04909801|589878774|FG000|Overall Study|other reasons|1|||
162978296|NCT02139124|588621761|FG004|Overall Study|Protocol Violation|1|||
162978297|NCT02139124|588621757|FG000|Overall Study|non-compliant|1|||
162978298|NCT02139124|588621758|FG001|Overall Study|non-compliant|0|||
162978299|NCT02139124|588621759|FG002|Overall Study|non-compliant|0|||
162978300|NCT02139124|588621760|FG003|Overall Study|non-compliant|2|||
162978301|NCT02139124|588621761|FG004|Overall Study|non-compliant|0|||
162978302|NCT02139124|588621757|FG000|Overall Study|incarceration|0|||
162978303|NCT02139124|588621758|FG001|Overall Study|incarceration|0|||
162978304|NCT02139124|588621759|FG002|Overall Study|incarceration|1|||
162978305|NCT02139124|588621760|FG003|Overall Study|incarceration|0|||
163318823|NCT04909801|589878775|FG001|Overall Study|other reasons|1|||
163318824|NCT04550221|589878776|FG000|Overall Study|Lost to Follow-up|0|||
163318825|NCT04550221|589878777|FG001|Overall Study|Lost to Follow-up|4|||
163318826|NCT04550221|589878776|FG000|Overall Study|Withdrawn|3|||
163318827|NCT04550221|589878777|FG001|Overall Study|Withdrawn|0|||
163318828|NCT04550221|589878776|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
163318829|NCT04550221|589878777|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
163318830|NCT05274074|589878778|FG000|Overall Study|Lost to Follow-up|2|||
163318831|NCT05274074|589878779|FG001|Overall Study|Lost to Follow-up|3|||
163318832|NCT05274074|589878778|FG000|Overall Study|Withdrawal by Subject|1|||
162978306|NCT02139124|588621761|FG004|Overall Study|incarceration|0|||
162978307|NCT02139124|588621757|FG000|Overall Study|subject moved|1|||
162978308|NCT02139124|588621758|FG001|Overall Study|subject moved|0|||
162978309|NCT02139124|588621759|FG002|Overall Study|subject moved|0|||
162978310|NCT02139124|588621760|FG003|Overall Study|subject moved|0|||
162978311|NCT02139124|588621761|FG004|Overall Study|subject moved|0|||
162978312|NCT02139124|588621757|FG000|Overall Study|Lost to Follow-up|3|||
162978313|NCT02139124|588621758|FG001|Overall Study|Lost to Follow-up|2|||
162978314|NCT02139124|588621759|FG002|Overall Study|Lost to Follow-up|0|||
162978315|NCT02139124|588621760|FG003|Overall Study|Lost to Follow-up|5|||
162978316|NCT02139124|588621761|FG004|Overall Study|Lost to Follow-up|4|||
162978317|NCT03821272|588623398|FG000|Overall Study|Death|1|||
162978318|NCT03821272|588623399|FG001|Overall Study|Death|0|||
162978319|NCT03821272|588623398|FG000|Overall Study|Physician Decision|1|||
162978320|NCT03821272|588623399|FG001|Overall Study|Physician Decision|0|||
162978321|NCT03821272|588623398|FG000|Overall Study|Withdrawal by Subject|1|||
162978322|NCT03821272|588623399|FG001|Overall Study|Withdrawal by Subject|0|||
162978323|NCT05904769|588623400|FG000|Overall Study|Physician Decision|0|||
162978324|NCT05904769|588623401|FG001|Overall Study|Physician Decision|6|||
162978325|NCT05626803|588623407|FG000|Overall Study|Lost to Follow-up|0|||
162978326|NCT05626803|588623408|FG001|Overall Study|Lost to Follow-up|1|||
162978327|NCT05626803|588623409|FG002|Overall Study|Lost to Follow-up|0|||
162978328|NCT05626803|588623410|FG003|Overall Study|Lost to Follow-up|0|||
162978329|NCT04974619|588623411|FG000|Overall Study|Lost to Follow-up|0|||
162978330|NCT04974619|588623412|FG001|Overall Study|Lost to Follow-up|0|||
162978331|NCT04974619|588623413|FG002|Overall Study|Lost to Follow-up|1|||
162978332|NCT04974619|588623411|FG000|Overall Study|Withdrawal by Subject|0|||
162978333|NCT04974619|588623412|FG001|Overall Study|Withdrawal by Subject|0|||
162978334|NCT04974619|588623413|FG002|Overall Study|Withdrawal by Subject|1|||
162978335|NCT04974619|588623411|FG000|Overall Study|Protocol Violation|0|||
162978336|NCT04974619|588623412|FG001|Overall Study|Protocol Violation|1|||
162978337|NCT04974619|588623413|FG002|Overall Study|Protocol Violation|0|||
162978338|NCT01688466|588623414|FG000|Overall Study|Withdrawal by Subject|2|||
162978339|NCT01688466|588623415|FG001|Overall Study|Withdrawal by Subject|1|||
162978340|NCT01688466|588623414|FG000|Overall Study|Death|0|||
162978341|NCT01688466|588623415|FG001|Overall Study|Death|1|||
162978342|NCT01688466|588623414|FG000|Overall Study|Adverse Event|0|||
162978343|NCT01688466|588623415|FG001|Overall Study|Adverse Event|4|||
162978344|NCT01688466|588623414|FG000|Overall Study|Not evaluable|0|||
162978345|NCT01688466|588623415|FG001|Overall Study|Not evaluable|1|||
162978346|NCT03310957|588623416|FG000|Overall Study|Withdrawal by Subject|1|||
162978347|NCT03310957|588623417|FG001|Overall Study|Withdrawal by Subject|1|||
163058066|NCT00961415|588922839|FG000|Maintenance Treatment Phase|Death|0|||
163318833|NCT05274074|589878779|FG001|Overall Study|Withdrawal by Subject|2|||
163318834|NCT04117347|589878780|FG000|Overall Study|Adverse Event|0|||
163318835|NCT04117347|589878781|FG001|Overall Study|Adverse Event|0|||
163318836|NCT04117347|589878782|FG002|Overall Study|Adverse Event|1|||
162978348|NCT03310957|588623418|FG002|Overall Study|Withdrawal by Subject|1|||
162978349|NCT03310957|588623419|FG003|Overall Study|Withdrawal by Subject|5|||
162978350|NCT03310957|588623420|FG004|Overall Study|Withdrawal by Subject|0|||
163058067|NCT00961415|588922840|FG001|Maintenance Treatment Phase|Death|42|||
162978351|NCT03310957|588623421|FG005|Overall Study|Withdrawal by Subject|4|||
162978352|NCT03310957|588623422|FG006|Overall Study|Withdrawal by Subject|3|||
162978353|NCT03310957|588623416|FG000|Overall Study|Site Terminated|0|||
162978354|NCT03310957|588623417|FG001|Overall Study|Site Terminated|1|||
162978355|NCT03310957|588623418|FG002|Overall Study|Site Terminated|1|||
162978356|NCT03310957|588623419|FG003|Overall Study|Site Terminated|1|||
162978357|NCT03310957|588623420|FG004|Overall Study|Site Terminated|0|||
162978358|NCT03310957|588623421|FG005|Overall Study|Site Terminated|2|||
163318837|NCT04117347|589878780|FG000|Overall Study|No time for study|0|||
163318838|NCT04117347|589878781|FG001|Overall Study|No time for study|2|||
163318839|NCT04117347|589878782|FG002|Overall Study|No time for study|0|||
163318840|NCT04117347|589878780|FG000|Overall Study|Family emergency|1|||
163318841|NCT04117347|589878781|FG001|Overall Study|Family emergency|0|||
163318842|NCT04117347|589878782|FG002|Overall Study|Family emergency|0|||
163318843|NCT05194956|589878783|FG000|Washout Period|Withdrawal by Subject|0|||
163318844|NCT05194956|589878784|FG001|Washout Period|Withdrawal by Subject|2|||
163318845|NCT05452460|589878785|FG000|Overall Study|Lost to Follow-up|3|||
163318846|NCT05452460|589878786|FG001|Overall Study|Lost to Follow-up|3|||
162978359|NCT03310957|588623422|FG006|Overall Study|Site Terminated|8|||
162978360|NCT03310957|588623416|FG000|Overall Study|Lost to Follow-up|1|||
162978361|NCT03310957|588623417|FG001|Overall Study|Lost to Follow-up|1|||
162978362|NCT03310957|588623418|FG002|Overall Study|Lost to Follow-up|1|||
162978363|NCT03310957|588623419|FG003|Overall Study|Lost to Follow-up|4|||
162978364|NCT03310957|588623420|FG004|Overall Study|Lost to Follow-up|0|||
162978365|NCT03310957|588623421|FG005|Overall Study|Lost to Follow-up|4|||
162978366|NCT03310957|588623422|FG006|Overall Study|Lost to Follow-up|2|||
162978367|NCT03310957|588623416|FG000|Overall Study|Death|5|||
162978368|NCT03310957|588623417|FG001|Overall Study|Death|8|||
162978369|NCT03310957|588623418|FG002|Overall Study|Death|18|||
162978370|NCT03310957|588623419|FG003|Overall Study|Death|31|||
162978371|NCT03310957|588623420|FG004|Overall Study|Death|1|||
162978372|NCT03310957|588623421|FG005|Overall Study|Death|29|||
162978373|NCT03310957|588623422|FG006|Overall Study|Death|7|||
162978374|NCT03310957|588623416|FG000|Overall Study|Discontinuation per sponsor|0|||
162978375|NCT03310957|588623417|FG001|Overall Study|Discontinuation per sponsor|1|||
162978376|NCT03310957|588623418|FG002|Overall Study|Discontinuation per sponsor|2|||
162978377|NCT03310957|588623419|FG003|Overall Study|Discontinuation per sponsor|4|||
162978378|NCT03310957|588623420|FG004|Overall Study|Discontinuation per sponsor|1|||
162978379|NCT03310957|588623421|FG005|Overall Study|Discontinuation per sponsor|9|||
162978380|NCT03310957|588623422|FG006|Overall Study|Discontinuation per sponsor|12|||
162978381|NCT03310957|588623416|FG000|Overall Study|Discontinuation per protocol amendment 11|0|||
162978382|NCT03310957|588623417|FG001|Overall Study|Discontinuation per protocol amendment 11|0|||
162978383|NCT03310957|588623418|FG002|Overall Study|Discontinuation per protocol amendment 11|0|||
162978384|NCT03310957|588623419|FG003|Overall Study|Discontinuation per protocol amendment 11|1|||
162978385|NCT03310957|588623420|FG004|Overall Study|Discontinuation per protocol amendment 11|0|||
162978386|NCT03310957|588623421|FG005|Overall Study|Discontinuation per protocol amendment 11|3|||
162978387|NCT03310957|588623422|FG006|Overall Study|Discontinuation per protocol amendment 11|5|||
162978388|NCT03310957|588623416|FG000|Overall Study|Treatment landscape|0|||
162978389|NCT03310957|588623417|FG001|Overall Study|Treatment landscape|0|||
162978390|NCT03310957|588623418|FG002|Overall Study|Treatment landscape|1|||
162978391|NCT03310957|588623419|FG003|Overall Study|Treatment landscape|1|||
162978392|NCT03310957|588623420|FG004|Overall Study|Treatment landscape|0|||
163318847|NCT05452460|589878785|FG000|Overall Study|Did not receive intervention|1|||
163318848|NCT05452460|589878786|FG001|Overall Study|Did not receive intervention|0|||
163318849|NCT04447040|589878788|FG000|Overall Study|Lost to Follow-up|2|||
163318850|NCT04447040|589878789|FG001|Overall Study|Lost to Follow-up|1|||
163318851|NCT04447040|589878790|FG002|Overall Study|Lost to Follow-up|3|||
163318852|NCT04447040|589878791|FG003|Overall Study|Lost to Follow-up|3|||
163318853|NCT04447040|589878792|FG004|Overall Study|Lost to Follow-up|1|||
163318854|NCT04447040|589878793|FG005|Overall Study|Lost to Follow-up|3|||
162978393|NCT03310957|588623421|FG005|Overall Study|Treatment landscape|1|||
162978394|NCT03310957|588623422|FG006|Overall Study|Treatment landscape|0|||
162978395|NCT03310957|588623416|FG000|Overall Study|Alanine aminotransferase (ALT) increased|0|||
162978396|NCT03310957|588623417|FG001|Overall Study|Alanine aminotransferase (ALT) increased|0|||
162978397|NCT03310957|588623418|FG002|Overall Study|Alanine aminotransferase (ALT) increased|0|||
162978398|NCT03310957|588623419|FG003|Overall Study|Alanine aminotransferase (ALT) increased|0|||
162978399|NCT03310957|588623420|FG004|Overall Study|Alanine aminotransferase (ALT) increased|1|||
162978400|NCT03310957|588623421|FG005|Overall Study|Alanine aminotransferase (ALT) increased|0|||
162978401|NCT03310957|588623422|FG006|Overall Study|Alanine aminotransferase (ALT) increased|0|||
162978402|NCT03310957|588623416|FG000|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
162978403|NCT03310957|588623417|FG001|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
162978404|NCT03310957|588623418|FG002|Overall Study|Elevated Aspartate aminotransferase (AST)|1|||
162978405|NCT03310957|588623419|FG003|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
162978406|NCT03310957|588623420|FG004|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
162978407|NCT03310957|588623421|FG005|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
162978408|NCT03310957|588623422|FG006|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
162978409|NCT03310957|588623416|FG000|Overall Study|Hospice|0|||
162978410|NCT03310957|588623417|FG001|Overall Study|Hospice|0|||
162978411|NCT03310957|588623418|FG002|Overall Study|Hospice|0|||
162978412|NCT03310957|588623419|FG003|Overall Study|Hospice|0|||
162978413|NCT03310957|588623420|FG004|Overall Study|Hospice|0|||
162978414|NCT03310957|588623421|FG005|Overall Study|Hospice|1|||
162978415|NCT03310957|588623422|FG006|Overall Study|Hospice|0|||
162978416|NCT03310957|588623416|FG000|Overall Study|Progressive|0|||
163318855|NCT04447040|589878788|FG000|Overall Study|Withdrawal by Subject|0|||
163318856|NCT04447040|589878789|FG001|Overall Study|Withdrawal by Subject|1|||
162978417|NCT03310957|588623417|FG001|Overall Study|Progressive|0|||
162978418|NCT03310957|588623418|FG002|Overall Study|Progressive|1|||
162978419|NCT03310957|588623419|FG003|Overall Study|Progressive|0|||
162978420|NCT03310957|588623420|FG004|Overall Study|Progressive|0|||
162978421|NCT03310957|588623421|FG005|Overall Study|Progressive|0|||
162978422|NCT03310957|588623422|FG006|Overall Study|Progressive|0|||
162978423|NCT02516410|588623427|FG000|Overall Study|Adverse Event|0|||
162978424|NCT02516410|588623428|FG001|Overall Study|Adverse Event|1|||
162978425|NCT02516410|588623427|FG000|Overall Study|Withdrawal by Subject|0|||
162978426|NCT02516410|588623428|FG001|Overall Study|Withdrawal by Subject|1|||
162978427|NCT04146363|588623431|FG000|Induction Period|Adverse Event|1|||
162978428|NCT04146363|588623432|FG001|Induction Period|Adverse Event|2|||
162978429|NCT04146363|588623433|FG002|Induction Period|Adverse Event|0|||
162978430|NCT04146363|588623434|FG003|Induction Period|Adverse Event|0|||
162978431|NCT04146363|588623435|FG004|Induction Period|Adverse Event|0|||
162978432|NCT04146363|588623436|FG005|Induction Period|Adverse Event|0|||
162978433|NCT04146363|588623437|FG006|Induction Period|Adverse Event|0|||
162978434|NCT04146363|588623438|FG007|Induction Period|Adverse Event|0|||
162978435|NCT04146363|588623439|FG008|Induction Period|Adverse Event|0|||
162978436|NCT04146363|588623440|FG009|Induction Period|Adverse Event|0|||
162978437|NCT04146363|588623441|FG010|Induction Period|Adverse Event|0|||
162978438|NCT04146363|588623431|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
162978439|NCT04146363|588623432|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
162978440|NCT04146363|588623433|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
162978441|NCT04146363|588623434|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
162978442|NCT04146363|588623435|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
162978443|NCT04146363|588623436|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
162978444|NCT04146363|588623437|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
162978445|NCT04146363|588623438|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
162978446|NCT04146363|588623439|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
162978447|NCT04146363|588623440|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
162978448|NCT04146363|588623441|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
162978449|NCT04146363|588623431|FG000|Induction Period|Lack of Efficacy|7|||
162978450|NCT04146363|588623432|FG001|Induction Period|Lack of Efficacy|2|||
162978451|NCT04146363|588623433|FG002|Induction Period|Lack of Efficacy|0|||
162978452|NCT04146363|588623434|FG003|Induction Period|Lack of Efficacy|0|||
162978453|NCT04146363|588623435|FG004|Induction Period|Lack of Efficacy|0|||
162978454|NCT04146363|588623436|FG005|Induction Period|Lack of Efficacy|0|||
162978455|NCT04146363|588623437|FG006|Induction Period|Lack of Efficacy|0|||
162978456|NCT04146363|588623438|FG007|Induction Period|Lack of Efficacy|0|||
162978457|NCT04146363|588623439|FG008|Induction Period|Lack of Efficacy|0|||
162978458|NCT04146363|588623440|FG009|Induction Period|Lack of Efficacy|0|||
162978459|NCT04146363|588623441|FG010|Induction Period|Lack of Efficacy|0|||
162978460|NCT04146363|588623431|FG000|Induction Period|Lost to Follow-up|1|||
162978461|NCT04146363|588623432|FG001|Induction Period|Lost to Follow-up|4|||
162978462|NCT04146363|588623433|FG002|Induction Period|Lost to Follow-up|0|||
162978463|NCT04146363|588623434|FG003|Induction Period|Lost to Follow-up|0|||
162978464|NCT04146363|588623435|FG004|Induction Period|Lost to Follow-up|0|||
162978465|NCT04146363|588623436|FG005|Induction Period|Lost to Follow-up|0|||
162978466|NCT04146363|588623437|FG006|Induction Period|Lost to Follow-up|0|||
162978467|NCT04146363|588623438|FG007|Induction Period|Lost to Follow-up|0|||
162978468|NCT04146363|588623439|FG008|Induction Period|Lost to Follow-up|0|||
162978469|NCT04146363|588623440|FG009|Induction Period|Lost to Follow-up|0|||
162978470|NCT04146363|588623441|FG010|Induction Period|Lost to Follow-up|0|||
162978471|NCT04146363|588623431|FG000|Induction Period|Positive quantiferon test|0|||
162978472|NCT04146363|588623432|FG001|Induction Period|Positive quantiferon test|1|||
162978473|NCT04146363|588623433|FG002|Induction Period|Positive quantiferon test|0|||
162978474|NCT04146363|588623434|FG003|Induction Period|Positive quantiferon test|0|||
162978475|NCT04146363|588623435|FG004|Induction Period|Positive quantiferon test|0|||
162978476|NCT04146363|588623436|FG005|Induction Period|Positive quantiferon test|0|||
162978477|NCT04146363|588623437|FG006|Induction Period|Positive quantiferon test|0|||
162978478|NCT04146363|588623438|FG007|Induction Period|Positive quantiferon test|0|||
162978479|NCT04146363|588623439|FG008|Induction Period|Positive quantiferon test|0|||
162978480|NCT04146363|588623440|FG009|Induction Period|Positive quantiferon test|0|||
162978481|NCT04146363|588623441|FG010|Induction Period|Positive quantiferon test|0|||
162978482|NCT04146363|588623431|FG000|Induction Period|Protocol Deviation|5|||
162978483|NCT04146363|588623432|FG001|Induction Period|Protocol Deviation|6|||
162978484|NCT04146363|588623433|FG002|Induction Period|Protocol Deviation|0|||
162978485|NCT04146363|588623434|FG003|Induction Period|Protocol Deviation|0|||
162978486|NCT04146363|588623435|FG004|Induction Period|Protocol Deviation|0|||
162978487|NCT04146363|588623436|FG005|Induction Period|Protocol Deviation|0|||
162978488|NCT04146363|588623437|FG006|Induction Period|Protocol Deviation|0|||
162978489|NCT04146363|588623438|FG007|Induction Period|Protocol Deviation|0|||
162978490|NCT04146363|588623439|FG008|Induction Period|Protocol Deviation|0|||
162978491|NCT04146363|588623440|FG009|Induction Period|Protocol Deviation|0|||
162978492|NCT04146363|588623441|FG010|Induction Period|Protocol Deviation|0|||
162978493|NCT04146363|588623431|FG000|Induction Period|Withdrawal by Subject|6|||
162978494|NCT04146363|588623432|FG001|Induction Period|Withdrawal by Subject|3|||
162978495|NCT04146363|588623433|FG002|Induction Period|Withdrawal by Subject|0|||
162978496|NCT04146363|588623434|FG003|Induction Period|Withdrawal by Subject|0|||
163318857|NCT04447040|589878790|FG002|Overall Study|Withdrawal by Subject|1|||
162978497|NCT04146363|588623435|FG004|Induction Period|Withdrawal by Subject|0|||
162978498|NCT04146363|588623436|FG005|Induction Period|Withdrawal by Subject|0|||
162978499|NCT04146363|588623437|FG006|Induction Period|Withdrawal by Subject|0|||
162978500|NCT04146363|588623438|FG007|Induction Period|Withdrawal by Subject|0|||
162978501|NCT04146363|588623439|FG008|Induction Period|Withdrawal by Subject|0|||
162978502|NCT04146363|588623440|FG009|Induction Period|Withdrawal by Subject|0|||
162978503|NCT04146363|588623441|FG010|Induction Period|Withdrawal by Subject|0|||
162978504|NCT04146363|588623431|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978505|NCT04146363|588623432|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978506|NCT04146363|588623433|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978507|NCT04146363|588623434|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978508|NCT04146363|588623435|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978509|NCT04146363|588623436|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978510|NCT04146363|588623437|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
162978511|NCT04146363|588623438|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
162978512|NCT04146363|588623439|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978513|NCT04146363|588623440|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978514|NCT04146363|588623441|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978515|NCT04146363|588623431|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978516|NCT04146363|588623432|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978517|NCT04146363|588623433|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978518|NCT04146363|588623434|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978519|NCT04146363|588623435|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978520|NCT04146363|588623436|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978521|NCT04146363|588623437|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978522|NCT04146363|588623438|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
162978523|NCT04146363|588623439|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978524|NCT04146363|588623440|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978525|NCT04146363|588623441|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978526|NCT04146363|588623431|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978527|NCT04146363|588623432|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978528|NCT04146363|588623433|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978529|NCT04146363|588623434|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978530|NCT04146363|588623435|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978531|NCT04146363|588623436|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978532|NCT04146363|588623437|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
162978533|NCT04146363|588623438|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
162978534|NCT04146363|588623439|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978535|NCT04146363|588623440|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978536|NCT04146363|588623441|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978537|NCT04146363|588623431|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978538|NCT04146363|588623432|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978539|NCT04146363|588623433|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
162978540|NCT04146363|588623434|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978541|NCT04146363|588623435|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978542|NCT04146363|588623436|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
162978543|NCT04146363|588623437|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978544|NCT04146363|588623438|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978545|NCT04146363|588623439|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978546|NCT04146363|588623440|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978547|NCT04146363|588623441|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978548|NCT04146363|588623431|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162978549|NCT04146363|588623432|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162978550|NCT04146363|588623433|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162978551|NCT04146363|588623434|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162978552|NCT04146363|588623435|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
162978553|NCT04146363|588623436|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
162978554|NCT04146363|588623437|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
162978555|NCT04146363|588623438|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
162978556|NCT04146363|588623439|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163318858|NCT04447040|589878791|FG003|Overall Study|Withdrawal by Subject|1|||
163318859|NCT04447040|589878792|FG004|Overall Study|Withdrawal by Subject|0|||
163318860|NCT04447040|589878793|FG005|Overall Study|Withdrawal by Subject|0|||
163401574|NCT03029143|590181190|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
163401575|NCT03029143|590181191|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
163401576|NCT04744207|590181193|FG000|Treatment|Withdrawal by Subject|2|||
163401577|NCT04744207|590181194|FG001|Treatment|Withdrawal by Subject|0|||
163401578|NCT04744207|590181193|FG000|Treatment|Adverse Event|1|||
163401579|NCT04744207|590181194|FG001|Treatment|Adverse Event|2|||
163401580|NCT04041284|590181195|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
163401581|NCT04041284|590181196|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
163401582|NCT04041284|590181195|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
163401583|NCT04041284|590181196|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
163401584|NCT04041284|590181195|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
163401585|NCT04041284|590181196|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
163401586|NCT04041284|590181195|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
163401587|NCT04041284|590181196|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
163401588|NCT04041284|590181195|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
163401589|NCT04041284|590181196|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
163401590|NCT04041284|590181195|FG000|DB Phase (12 Weeks)|Other than specified|1|||
163401591|NCT04041284|590181196|FG001|DB Phase (12 Weeks)|Other than specified|0|||
163401592|NCT04041284|590181195|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
163401593|NCT04041284|590181196|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
163401594|NCT04041284|590181195|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
163401595|NCT04041284|590181196|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
163401596|NCT04041284|590181195|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
163401597|NCT04041284|590181196|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
163401598|NCT04041284|590181195|FG000|OL Phase (12 Weeks)|Other than specified|6|||
163401599|NCT04041284|590181196|FG001|OL Phase (12 Weeks)|Other than specified|2|||
163401600|NCT02016820|590181204|FG000|Overall Study|Lost to Follow-up|2|||
163401601|NCT02016820|590181205|FG001|Overall Study|Lost to Follow-up|4|||
163401602|NCT00884273|590181206|FG000|Overall Study|Adverse Event|0|||
163401603|NCT00884273|590181207|FG001|Overall Study|Adverse Event|2|||
163401604|NCT00884273|590181206|FG000|Overall Study|Protocol Violation|1|||
163401605|NCT00884273|590181207|FG001|Overall Study|Protocol Violation|3|||
163401606|NCT00884273|590181206|FG000|Overall Study|Practical reasons|1|||
163401607|NCT00884273|590181207|FG001|Overall Study|Practical reasons|0|||
163401608|NCT02973087|590181208|FG000|Overall Study|Withdrawal by Subject|2|||
163401609|NCT02973087|590181209|FG001|Overall Study|Withdrawal by Subject|1|||
163401610|NCT02973087|590181208|FG000|Overall Study|Adverse Event|1|||
163401611|NCT02973087|590181209|FG001|Overall Study|Adverse Event|0|||
163401612|NCT02973087|590181208|FG000|Overall Study|other|1|||
163401613|NCT02973087|590181209|FG001|Overall Study|other|1|||
163401614|NCT03710486|590181210|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
163401615|NCT03710486|590181211|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
163401616|NCT03710486|590181210|FG000|Overall Study|Missing|0|||
163401617|NCT03710486|590181211|FG001|Overall Study|Missing|2|||
163401618|NCT02437864|590181220|FG000|Overall Study|Protocol Violation|4|||
163401619|NCT02437864|590181221|FG001|Overall Study|Protocol Violation|0|||
163401620|NCT00492752|590181222|FG000|Double Blind Treatment|Death|13|||
163401621|NCT00492752|590181223|FG001|Double Blind Treatment|Death|0|||
163401622|NCT00492752|590181224|FG002|Double Blind Treatment|Death|2|||
163401623|NCT00492752|590181225|FG003|Double Blind Treatment|Death|0|||
163401624|NCT00492752|590181222|FG000|Double Blind Treatment|Adverse Event|1|||
163401625|NCT00492752|590181223|FG001|Double Blind Treatment|Adverse Event|0|||
163401626|NCT00492752|590181224|FG002|Double Blind Treatment|Adverse Event|0|||
163401627|NCT00492752|590181225|FG003|Double Blind Treatment|Adverse Event|0|||
163401628|NCT00492752|590181222|FG000|Double Blind Treatment|Protocol Violation|0|||
163401629|NCT00492752|590181223|FG001|Double Blind Treatment|Protocol Violation|0|||
163401630|NCT00492752|590181224|FG002|Double Blind Treatment|Protocol Violation|1|||
163401631|NCT00492752|590181225|FG003|Double Blind Treatment|Protocol Violation|0|||
163401632|NCT00492752|590181222|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
163401633|NCT00492752|590181223|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
163401634|NCT00492752|590181224|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
163401635|NCT00492752|590181225|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
163401636|NCT00492752|590181222|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
163401637|NCT00492752|590181223|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
163401638|NCT00492752|590181224|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
163401639|NCT00492752|590181225|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
162978557|NCT04146363|588623440|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163210462|NCT00531050|589485248|FG003|Part 2: Period 3|Abnormal test procedure|0|||
163401640|NCT00492752|590181222|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
163401641|NCT00492752|590181223|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
163401642|NCT00492752|590181224|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
163401643|NCT00492752|590181225|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
163401644|NCT00492752|590181222|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
163401645|NCT00492752|590181223|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
163401646|NCT00492752|590181224|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
162978558|NCT04146363|588623441|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162978559|NCT04146363|588623431|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162978560|NCT04146363|588623432|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162978561|NCT04146363|588623433|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
162978562|NCT04146363|588623434|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162978563|NCT04146363|588623435|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162978564|NCT04146363|588623436|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
162978565|NCT04146363|588623437|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
162978566|NCT04146363|588623438|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
162978567|NCT04146363|588623439|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162978568|NCT04146363|588623440|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162978569|NCT04146363|588623441|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162978570|NCT04146363|588623431|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978571|NCT04146363|588623432|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978572|NCT04146363|588623433|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978573|NCT04146363|588623434|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978574|NCT04146363|588623435|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
163210463|NCT00531050|589485249|FG004|Part 2: Period 3|Abnormal test procedure|0|||
162978575|NCT04146363|588623436|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978576|NCT04146363|588623437|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978577|NCT04146363|588623438|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978578|NCT04146363|588623439|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
162978579|NCT04146363|588623440|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
162978580|NCT04146363|588623441|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978581|NCT04146363|588623431|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162978582|NCT04146363|588623432|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162978583|NCT04146363|588623433|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162978584|NCT04146363|588623434|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162978585|NCT04146363|588623435|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162978586|NCT04146363|588623436|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162978587|NCT04146363|588623437|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163058068|NCT00961415|588922841|FG002|Maintenance Treatment Phase|Death|34|||
162924058|NCT05378269|588423768|FG000|Overall Study|Protocol Violation|1|||
162924059|NCT05378269|588423769|FG001|Overall Study|Protocol Violation|0|||
162924060|NCT05378269|588423770|FG002|Overall Study|Protocol Violation|2|||
162924061|NCT05378269|588423771|FG003|Overall Study|Protocol Violation|0|||
162924062|NCT05378269|588423772|FG004|Overall Study|Protocol Violation|0|||
162924063|NCT00602979|588423775|FG000|Overall Study|Lost to Follow-up|3|||
162924064|NCT00602979|588423776|FG001|Overall Study|Lost to Follow-up|2|||
162924065|NCT00602979|588423777|FG002|Overall Study|Lost to Follow-up|3|||
162924066|NCT00602979|588423778|FG003|Overall Study|Lost to Follow-up|2|||
162924067|NCT00602979|588423779|FG004|Overall Study|Lost to Follow-up|3|||
162924068|NCT00602979|588423775|FG000|Overall Study|Failed Intubation|0|||
162924069|NCT00602979|588423776|FG001|Overall Study|Failed Intubation|1|||
162924070|NCT00602979|588423777|FG002|Overall Study|Failed Intubation|0|||
162924071|NCT00602979|588423778|FG003|Overall Study|Failed Intubation|1|||
162924072|NCT00602979|588423779|FG004|Overall Study|Failed Intubation|0|||
162924073|NCT01461369|588423780|FG000|Overall Study|Lack of Efficacy|2|||
162924074|NCT01461369|588423781|FG001|Overall Study|Lack of Efficacy|0|||
162924075|NCT01461369|588423782|FG002|Overall Study|Lack of Efficacy|6|||
162924076|NCT01461369|588423780|FG000|Overall Study|Lost to Follow-up|0|||
162924077|NCT01461369|588423781|FG001|Overall Study|Lost to Follow-up|0|||
162924078|NCT01461369|588423782|FG002|Overall Study|Lost to Follow-up|3|||
162924079|NCT01461369|588423780|FG000|Overall Study|Adverse Event|9|||
162924080|NCT01461369|588423781|FG001|Overall Study|Adverse Event|12|||
162924081|NCT01461369|588423782|FG002|Overall Study|Adverse Event|4|||
162924082|NCT01461369|588423780|FG000|Overall Study|Protocol Violation|1|||
162924083|NCT01461369|588423781|FG001|Overall Study|Protocol Violation|2|||
162924084|NCT01461369|588423782|FG002|Overall Study|Protocol Violation|2|||
162924085|NCT01461369|588423780|FG000|Overall Study|Withdrawal by Subject|1|||
162924086|NCT01461369|588423781|FG001|Overall Study|Withdrawal by Subject|3|||
162924087|NCT01461369|588423782|FG002|Overall Study|Withdrawal by Subject|2|||
162924088|NCT00734617|588423787|FG000|Overall Study|Adverse Event|4|||
162924089|NCT00734617|588423788|FG001|Overall Study|Adverse Event|7|||
162924090|NCT00734617|588423787|FG000|Overall Study|Withdrawal by Subject|103|||
162924091|NCT00734617|588423788|FG001|Overall Study|Withdrawal by Subject|95|||
162924092|NCT03692078|588423791|FG000|Overall Study|Adverse Event|0|||
163058069|NCT00961415|588922839|FG000|Maintenance Treatment Phase|Investigators decision|0|||
163058070|NCT00961415|588922840|FG001|Maintenance Treatment Phase|Investigators decision|2|||
163058071|NCT00961415|588922841|FG002|Maintenance Treatment Phase|Investigators decision|0|||
163058072|NCT00961415|588922839|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163058073|NCT00961415|588922840|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
163058074|NCT00961415|588922841|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
163058075|NCT00961415|588922839|FG000|Maintenance Treatment Phase|Other reason|0|||
163058076|NCT00961415|588922840|FG001|Maintenance Treatment Phase|Other reason|1|||
163058077|NCT00961415|588922841|FG002|Maintenance Treatment Phase|Other reason|3|||
163058078|NCT02309359|588922842|FG000|Overall Study|Adverse Event|4|||
163058079|NCT02309359|588922843|FG001|Overall Study|Adverse Event|5|||
163058080|NCT02309359|588922844|FG002|Overall Study|Adverse Event|5|||
163058081|NCT02309359|588922845|FG003|Overall Study|Adverse Event|4|||
163058082|NCT02309359|588922846|FG004|Overall Study|Adverse Event|4|||
163058083|NCT02309359|588922842|FG000|Overall Study|Death|1|||
163058084|NCT02309359|588922843|FG001|Overall Study|Death|0|||
163058085|NCT02309359|588922844|FG002|Overall Study|Death|0|||
162978588|NCT04146363|588623438|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162978589|NCT04146363|588623439|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
162978590|NCT04146363|588623440|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
162978591|NCT04146363|588623441|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
162978592|NCT04146363|588623431|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978593|NCT04146363|588623432|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978594|NCT04146363|588623433|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978595|NCT04146363|588623434|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978596|NCT04146363|588623435|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978597|NCT04146363|588623436|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978598|NCT04146363|588623437|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978599|NCT04146363|588623438|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978600|NCT04146363|588623439|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
162978601|NCT04146363|588623440|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
162978602|NCT04146363|588623441|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978603|NCT04146363|588623431|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978604|NCT04146363|588623432|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978605|NCT04146363|588623433|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978606|NCT04146363|588623434|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978607|NCT04146363|588623435|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978608|NCT04146363|588623436|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978609|NCT04146363|588623437|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978610|NCT04146363|588623438|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978611|NCT04146363|588623439|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
162978612|NCT04146363|588623440|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
162978613|NCT04146363|588623441|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978614|NCT04146363|588623431|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978615|NCT04146363|588623432|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978616|NCT04146363|588623433|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978617|NCT04146363|588623434|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978618|NCT04146363|588623435|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978619|NCT04146363|588623436|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978620|NCT04146363|588623437|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978621|NCT04146363|588623438|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978622|NCT04146363|588623439|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
162978623|NCT04146363|588623440|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
162978624|NCT04146363|588623441|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
162978625|NCT04146363|588623431|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978626|NCT04146363|588623432|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978627|NCT04146363|588623433|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978628|NCT04146363|588623434|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
163058086|NCT02309359|588922845|FG003|Overall Study|Death|0|||
162978629|NCT04146363|588623435|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978630|NCT04146363|588623436|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978631|NCT04146363|588623437|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978632|NCT04146363|588623438|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978633|NCT04146363|588623439|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
163058087|NCT02309359|588922846|FG004|Overall Study|Death|0|||
163058088|NCT02309359|588922842|FG000|Overall Study|Withdrawal by Subject|2|||
163058089|NCT02309359|588922843|FG001|Overall Study|Withdrawal by Subject|2|||
163058090|NCT02309359|588922844|FG002|Overall Study|Withdrawal by Subject|4|||
163058091|NCT02309359|588922845|FG003|Overall Study|Withdrawal by Subject|4|||
163401647|NCT00492752|590181225|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
163401648|NCT00492752|590181222|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
163401649|NCT00492752|590181223|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
163401650|NCT00492752|590181224|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
163401651|NCT00492752|590181225|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
163401652|NCT00492752|590181222|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
163401653|NCT00492752|590181223|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
163401654|NCT00492752|590181224|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
163401655|NCT00492752|590181225|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
163401656|NCT00492752|590181222|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
163401657|NCT00492752|590181223|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
163401658|NCT00492752|590181224|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
163401659|NCT00492752|590181225|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
163401660|NCT00492752|590181222|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
163401661|NCT00492752|590181223|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
163401662|NCT00492752|590181224|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
163401663|NCT00492752|590181225|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
163401664|NCT03803059|590181226|FG000|Overall Study|Protocol Violation|2|||
163401665|NCT03803059|590181226|FG000|Overall Study|Lost to Follow-up|1|||
163401666|NCT04857996|590181230|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
163401667|NCT04857996|590181231|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
163401668|NCT04857996|590181230|FG000|Overall Study|Lost to Follow-up|1|||
163401669|NCT04857996|590181231|FG001|Overall Study|Lost to Follow-up|3|||
163401670|NCT04857996|590181230|FG000|Overall Study|Site Closure|1|||
162978634|NCT04146363|588623440|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
162978635|NCT04146363|588623441|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978636|NCT04146363|588623431|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978637|NCT04146363|588623432|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978638|NCT04146363|588623433|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978639|NCT04146363|588623434|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978640|NCT04146363|588623435|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978641|NCT04146363|588623436|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978642|NCT04146363|588623437|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978643|NCT04146363|588623438|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978644|NCT04146363|588623439|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978645|NCT04146363|588623440|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
162978646|NCT04146363|588623441|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978647|NCT02676284|588623442|FG000|Overall Study|Withdrawal by Subject|1|||
162978648|NCT00107042|588623443|FG000|Overall Study|Lost to Follow-up|9|||
162978649|NCT00107042|588623444|FG001|Overall Study|Lost to Follow-up|7|||
162978650|NCT00107042|588623443|FG000|Overall Study|Withdrawal by Subject|6|||
162978651|NCT00107042|588623444|FG001|Overall Study|Withdrawal by Subject|1|||
163210464|NCT00531050|589485250|FG005|Part 2: Period 3|Abnormal test procedure|1|||
162978652|NCT00107042|588623443|FG000|Overall Study|Moved out of area|5|||
162978653|NCT00107042|588623444|FG001|Overall Study|Moved out of area|3|||
162978654|NCT00107042|588623443|FG000|Overall Study|Pregnancy|1|||
162978655|NCT00107042|588623444|FG001|Overall Study|Pregnancy|1|||
162978656|NCT00107042|588623443|FG000|Overall Study|Inadvertent enrollment|0|||
162978657|NCT00107042|588623444|FG001|Overall Study|Inadvertent enrollment|1|||
162978658|NCT00107042|588623443|FG000|Overall Study|vaccinated outside window|1|||
162978659|NCT00107042|588623444|FG001|Overall Study|vaccinated outside window|1|||
162978660|NCT00107042|588623443|FG000|Overall Study|Disallowed medications|0|||
162978661|NCT00107042|588623444|FG001|Overall Study|Disallowed medications|2|||
162978662|NCT04776746|588623445|FG000|Overall Study|Study terminated by sponsor|61|||
162978663|NCT04776746|588623445|FG000|Overall Study|Adverse Event|5|||
162978664|NCT04776746|588623445|FG000|Overall Study|Death|4|||
162978665|NCT04776746|588623445|FG000|Overall Study|Lack of Efficacy|3|||
162978666|NCT04776746|588623445|FG000|Overall Study|Noncompliance with study drug|2|||
162978667|NCT04776746|588623445|FG000|Overall Study|Not related to COVID-19|2|||
162978668|NCT01286558|588623448|FG000|Overall Study|Adverse Event|1|||
163401671|NCT04857996|590181231|FG001|Overall Study|Site Closure|0|||
162978669|NCT01286558|588623449|FG001|Overall Study|Adverse Event|1|||
162978670|NCT01286558|588623448|FG000|Overall Study|Withdrawal by Subject|0|||
162978671|NCT01286558|588623449|FG001|Overall Study|Withdrawal by Subject|1|||
162978672|NCT01220297|588623450|FG000|Overall Study|Death|2|||
162978673|NCT01220297|588623450|FG000|Overall Study|Lost to Follow-up|1|||
162978674|NCT01287039|588623452|FG000|Overall Study|Noncompliance with study procedures|0|||
162978675|NCT01287039|588623453|FG001|Overall Study|Noncompliance with study procedures|1|||
163210465|NCT03263442|589485251|FG000|Inpatient Phase|Death|1|||
163210466|NCT03263442|589485252|FG001|Inpatient Phase|Death|0|||
162924093|NCT03692078|588423792|FG001|Overall Study|Adverse Event|0|||
162924094|NCT03692078|588423793|FG002|Overall Study|Adverse Event|0|||
162924095|NCT03692078|588423794|FG003|Overall Study|Adverse Event|0|||
162924096|NCT03692078|588423795|FG004|Overall Study|Adverse Event|0|||
162924097|NCT03692078|588423796|FG005|Overall Study|Adverse Event|1|||
162924098|NCT03692078|588423797|FG006|Overall Study|Adverse Event|0|||
162924099|NCT03692078|588423791|FG000|Overall Study|Enrollment Closed|5|||
162924100|NCT03692078|588423792|FG001|Overall Study|Enrollment Closed|0|||
162924101|NCT03692078|588423793|FG002|Overall Study|Enrollment Closed|0|||
162924102|NCT03692078|588423794|FG003|Overall Study|Enrollment Closed|0|||
162924103|NCT03692078|588423795|FG004|Overall Study|Enrollment Closed|0|||
162924104|NCT03692078|588423796|FG005|Overall Study|Enrollment Closed|0|||
162924105|NCT03692078|588423797|FG006|Overall Study|Enrollment Closed|0|||
162924106|NCT03692078|588423791|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
162924107|NCT03692078|588423792|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
162924108|NCT03692078|588423793|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
162924109|NCT03692078|588423794|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
162924110|NCT03692078|588423795|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
162924111|NCT03692078|588423796|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
162924112|NCT03692078|588423797|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
162924113|NCT03692078|588423791|FG000|Overall Study|Withdrawal by Subject|0|||
162924114|NCT03692078|588423792|FG001|Overall Study|Withdrawal by Subject|2|||
162924115|NCT03692078|588423793|FG002|Overall Study|Withdrawal by Subject|0|||
162924116|NCT03692078|588423794|FG003|Overall Study|Withdrawal by Subject|1|||
162924117|NCT03692078|588423795|FG004|Overall Study|Withdrawal by Subject|5|||
162924118|NCT03692078|588423796|FG005|Overall Study|Withdrawal by Subject|3|||
162924119|NCT03692078|588423797|FG006|Overall Study|Withdrawal by Subject|3|||
162924120|NCT00996632|588423800|FG000|Overall Study|Physician Decision|0|||
162924121|NCT00996632|588423801|FG001|Overall Study|Physician Decision|0|||
162924122|NCT01615822|588423803|FG000|Period 1|Withdrawal by Subject|0|||
162924123|NCT01615822|588423804|FG001|Period 1|Withdrawal by Subject|1|||
162924124|NCT01615822|588423805|FG002|Period 1|Withdrawal by Subject|0|||
162924125|NCT01615822|588423803|FG000|Period 1|Adverse Event|1|||
162924126|NCT01615822|588423804|FG001|Period 1|Adverse Event|1|||
162924127|NCT01615822|588423805|FG002|Period 1|Adverse Event|0|||
162924128|NCT01615822|588423803|FG000|Period 2|Lost to Follow-up|0|||
162924129|NCT01615822|588423804|FG001|Period 2|Lost to Follow-up|1|||
162924130|NCT01615822|588423805|FG002|Period 2|Lost to Follow-up|2|||
162924131|NCT02861534|588423806|FG000|Overall Study|Death|541|||
162924132|NCT02861534|588423807|FG001|Overall Study|Death|552|||
162924133|NCT02861534|588423806|FG000|Overall Study|Lost to Follow-up|14|||
162924134|NCT02861534|588423807|FG001|Overall Study|Lost to Follow-up|14|||
162924135|NCT02861534|588423806|FG000|Overall Study|Site Terminated by Sponsor|4|||
162924136|NCT02861534|588423807|FG001|Overall Study|Site Terminated by Sponsor|3|||
162924137|NCT02861534|588423806|FG000|Overall Study|Withdrawal by Subject|15|||
162924138|NCT02861534|588423807|FG001|Overall Study|Withdrawal by Subject|18|||
162924139|NCT02886494|588423808|FG000|Overall Study|Adverse Event|1|||
162924140|NCT02886494|588423809|FG001|Overall Study|Adverse Event|0|||
162924141|NCT02886494|588423808|FG000|Overall Study|Withdrawal by Subject|12|||
162924142|NCT02886494|588423809|FG001|Overall Study|Withdrawal by Subject|3|||
162924143|NCT02886494|588423808|FG000|Overall Study|Protocol Violation|4|||
162924144|NCT02886494|588423809|FG001|Overall Study|Protocol Violation|1|||
162924145|NCT00537056|588423816|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
162924146|NCT00244881|588423817|FG000|Overall Study|Withdrawal by Subject|3|||
162924147|NCT00445458|588423818|FG000|Overall Study|Disease Progression|3|||
162924148|NCT00445458|588423819|FG001|Overall Study|Disease Progression|4|||
162924149|NCT00445458|588423820|FG002|Overall Study|Disease Progression|54|||
162924150|NCT00445458|588423821|FG003|Overall Study|Disease Progression|27|||
162924151|NCT00445458|588423818|FG000|Overall Study|Withdrawal by Subject|0|||
162924152|NCT00445458|588423819|FG001|Overall Study|Withdrawal by Subject|0|||
162924153|NCT00445458|588423820|FG002|Overall Study|Withdrawal by Subject|7|||
162924154|NCT00445458|588423821|FG003|Overall Study|Withdrawal by Subject|0|||
162924155|NCT00445458|588423818|FG000|Overall Study|Adverse Event|0|||
162924156|NCT00445458|588423819|FG001|Overall Study|Adverse Event|0|||
162924157|NCT00445458|588423820|FG002|Overall Study|Adverse Event|3|||
162924158|NCT00445458|588423821|FG003|Overall Study|Adverse Event|0|||
162924159|NCT00445458|588423818|FG000|Overall Study|Death|0|||
163058092|NCT02309359|588922846|FG004|Overall Study|Withdrawal by Subject|0|||
162924160|NCT00445458|588423819|FG001|Overall Study|Death|1|||
162924161|NCT00445458|588423820|FG002|Overall Study|Death|2|||
162924162|NCT00445458|588423821|FG003|Overall Study|Death|0|||
162924163|NCT00445458|588423818|FG000|Overall Study|Physician Decision|0|||
162924164|NCT00445458|588423819|FG001|Overall Study|Physician Decision|0|||
162924165|NCT00445458|588423820|FG002|Overall Study|Physician Decision|1|||
162924166|NCT00445458|588423821|FG003|Overall Study|Physician Decision|1|||
162924167|NCT00445458|588423818|FG000|Overall Study|Surgery|0|||
163210467|NCT03263442|589485251|FG000|Inpatient Phase|Withdrawal by Subject|1|||
162978676|NCT01287039|588623452|FG000|Overall Study|Change of location/residence|0|||
162978677|NCT01287039|588623453|FG001|Overall Study|Change of location/residence|3|||
162978678|NCT01287039|588623452|FG000|Overall Study|Elective surgery|0|||
162978679|NCT01287039|588623453|FG001|Overall Study|Elective surgery|1|||
162978680|NCT01287039|588623452|FG000|Overall Study|Protocol Violation|2|||
162978681|NCT01287039|588623453|FG001|Overall Study|Protocol Violation|3|||
162978682|NCT01287039|588623452|FG000|Overall Study|Excluded medication taken|1|||
162978683|NCT01287039|588623453|FG001|Overall Study|Excluded medication taken|0|||
162978684|NCT01287039|588623452|FG000|Overall Study|Noncompliance with study medication|0|||
162978685|NCT01287039|588623453|FG001|Overall Study|Noncompliance with study medication|1|||
162978686|NCT01287039|588623452|FG000|Overall Study|Problem with travel|0|||
162978687|NCT01287039|588623453|FG001|Overall Study|Problem with travel|1|||
162978688|NCT01287039|588623452|FG000|Overall Study|Death|1|||
162978689|NCT01287039|588623453|FG001|Overall Study|Death|0|||
162978690|NCT01287039|588623452|FG000|Overall Study|Change of residence|1|||
162978691|NCT01287039|588623453|FG001|Overall Study|Change of residence|0|||
162978692|NCT01287039|588623452|FG000|Overall Study|Adverse Event|7|||
162978693|NCT01287039|588623453|FG001|Overall Study|Adverse Event|4|||
162978694|NCT01287039|588623452|FG000|Overall Study|Withdrawal by Subject|14|||
162978695|NCT01287039|588623453|FG001|Overall Study|Withdrawal by Subject|11|||
162978696|NCT01287039|588623452|FG000|Overall Study|Lost to Follow-up|3|||
162978697|NCT01287039|588623453|FG001|Overall Study|Lost to Follow-up|2|||
162978698|NCT01117337|588623455|FG000|Overall Study|Lost to Follow-up|4|||
162978699|NCT01117337|588623456|FG001|Overall Study|Lost to Follow-up|0|||
162978700|NCT03575871|588623457|FG000|Overall Study|Adverse Event|5|||
162978701|NCT03575871|588623458|FG001|Overall Study|Adverse Event|5|||
162978702|NCT03575871|588623459|FG002|Overall Study|Adverse Event|8|||
162978703|NCT03575871|588623457|FG000|Overall Study|Death|1|||
162978704|NCT03575871|588623458|FG001|Overall Study|Death|0|||
162978705|NCT03575871|588623459|FG002|Overall Study|Death|0|||
162978706|NCT03575871|588623457|FG000|Overall Study|Lack of Efficacy|5|||
162978707|NCT03575871|588623458|FG001|Overall Study|Lack of Efficacy|4|||
162978708|NCT03575871|588623459|FG002|Overall Study|Lack of Efficacy|7|||
162978709|NCT03575871|588623457|FG000|Overall Study|Lost to Follow-up|1|||
162978710|NCT03575871|588623458|FG001|Overall Study|Lost to Follow-up|1|||
162978711|NCT03575871|588623459|FG002|Overall Study|Lost to Follow-up|1|||
162978712|NCT03575871|588623457|FG000|Overall Study|Protocol Deviation|1|||
162978713|NCT03575871|588623458|FG001|Overall Study|Protocol Deviation|1|||
162978714|NCT03575871|588623459|FG002|Overall Study|Protocol Deviation|1|||
162978715|NCT03575871|588623457|FG000|Overall Study|Withdrawal by Subject|6|||
162978716|NCT03575871|588623458|FG001|Overall Study|Withdrawal by Subject|1|||
162978717|NCT03575871|588623459|FG002|Overall Study|Withdrawal by Subject|9|||
162978718|NCT03575871|588623457|FG000|Overall Study|Other than specified|2|||
162978719|NCT03575871|588623458|FG001|Overall Study|Other than specified|2|||
162978720|NCT03575871|588623459|FG002|Overall Study|Other than specified|0|||
162978721|NCT05444556|588623460|FG000|Overall Study|Withdrawal by Subject|0|||
162978722|NCT05444556|588623461|FG001|Overall Study|Withdrawal by Subject|0|||
162978723|NCT05444556|588623462|FG002|Overall Study|Withdrawal by Subject|2|||
162978724|NCT05444556|588623463|FG003|Overall Study|Withdrawal by Subject|1|||
162978725|NCT02791893|588623465|FG000|Blinded Phase|Lost to Follow-up|2|||
162978726|NCT02791893|588623466|FG001|Blinded Phase|Lost to Follow-up|2|||
162978727|NCT02791893|588623465|FG000|Blinded Phase|Withdrawal by Subject|1|||
162978728|NCT02791893|588623466|FG001|Blinded Phase|Withdrawal by Subject|2|||
162978729|NCT02791893|588623465|FG000|Open Label Phase|Lost to Follow-up|3|||
162978730|NCT02791893|588623466|FG001|Open Label Phase|Lost to Follow-up|0|||
162978731|NCT02791893|588623465|FG000|Open Label Phase|Withdrawal by Subject|0|||
162978732|NCT02791893|588623466|FG001|Open Label Phase|Withdrawal by Subject|2|||
162978733|NCT00171301|588623468|FG000|Overall Study|Death|1|||
162978734|NCT00171301|588623469|FG001|Overall Study|Death|2|||
162978735|NCT00171301|588623468|FG000|Overall Study|Adverse Event|1|||
162978736|NCT00171301|588623469|FG001|Overall Study|Adverse Event|2|||
162978737|NCT00171301|588623468|FG000|Overall Study|Lost to Follow-up|6|||
162978738|NCT00171301|588623469|FG001|Overall Study|Lost to Follow-up|2|||
162978739|NCT00171301|588623468|FG000|Overall Study|Protocol Violation|0|||
162978740|NCT00171301|588623469|FG001|Overall Study|Protocol Violation|2|||
162978741|NCT00171301|588623468|FG000|Overall Study|Withdrawal by Subject|0|||
162978742|NCT00171301|588623469|FG001|Overall Study|Withdrawal by Subject|1|||
162978743|NCT04319159|588623471|FG000|Overall Study|Screening failure|13|||
162978744|NCT04319159|588623471|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
162978745|NCT04319159|588623471|FG000|Overall Study|Withdrawal by Subject|1|||
162978746|NCT02100319|588623474|FG000|Overall Study|Case Report Forms Uncollected|11|||
162978747|NCT02100319|588623474|FG000|Overall Study|Protocol Deviation|5|||
162978748|NCT02589522|588623477|FG000|Overall Study|Physician Decision|1|||
162978749|NCT02589522|588623478|FG001|Overall Study|Physician Decision|2|||
162978750|NCT02589522|588623479|FG002|Overall Study|Physician Decision|0|||
162978751|NCT02589522|588623477|FG000|Overall Study|Did not start treatment|1|||
162978752|NCT02589522|588623478|FG001|Overall Study|Did not start treatment|0|||
162978753|NCT02589522|588623479|FG002|Overall Study|Did not start treatment|0|||
163058093|NCT02309359|588922842|FG000|Overall Study|Lack of Efficacy|3|||
163058094|NCT02309359|588922843|FG001|Overall Study|Lack of Efficacy|1|||
163058095|NCT02309359|588922844|FG002|Overall Study|Lack of Efficacy|0|||
163058096|NCT02309359|588922845|FG003|Overall Study|Lack of Efficacy|0|||
163058097|NCT02309359|588922846|FG004|Overall Study|Lack of Efficacy|3|||
163058098|NCT02309359|588922842|FG000|Overall Study|Lost to Follow-up|0|||
163058099|NCT02309359|588922843|FG001|Overall Study|Lost to Follow-up|0|||
163058100|NCT02309359|588922844|FG002|Overall Study|Lost to Follow-up|0|||
163058101|NCT02309359|588922845|FG003|Overall Study|Lost to Follow-up|1|||
163058102|NCT02309359|588922846|FG004|Overall Study|Lost to Follow-up|0|||
163058103|NCT02309359|588922842|FG000|Overall Study|Other|2|||
163058104|NCT02309359|588922843|FG001|Overall Study|Other|0|||
163058105|NCT02309359|588922844|FG002|Overall Study|Other|2|||
163058106|NCT02309359|588922845|FG003|Overall Study|Other|3|||
163058107|NCT02309359|588922846|FG004|Overall Study|Other|2|||
163058108|NCT06129149|588922848|FG000|Overall Study|Death|1|||
163058109|NCT04649359|588922849|FG000|Overall Study|Withdrawal by Subject|7|||
163058110|NCT04649359|588922850|FG001|Overall Study|Withdrawal by Subject|7|||
163058111|NCT04649359|588922849|FG000|Overall Study|Death|41|||
163058112|NCT04649359|588922850|FG001|Overall Study|Death|26|||
163058113|NCT04649359|588922849|FG000|Overall Study|Ongoing in the study|75|||
163058114|NCT04649359|588922850|FG001|Overall Study|Ongoing in the study|31|||
163058115|NCT03307174|588922851|FG000|Overall Study|Unplanned ICU Administrion|5|||
162978754|NCT05224544|588623483|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
162978755|NCT05224544|588623484|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
162978756|NCT00351351|588623485|FG000|Overall Study|surgical access pbs; device issues|9|||
162978757|NCT00351351|588623486|FG001|Overall Study|surgical access pbs; device issues|4|||
162978758|NCT01341587|588623487|FG000|Overall Study|Lost to Follow-up|2|||
162978759|NCT01341587|588623488|FG001|Overall Study|Lost to Follow-up|0|||
162978760|NCT01341587|588623487|FG000|Overall Study|stopped using the meters|2|||
162978761|NCT01341587|588623488|FG001|Overall Study|stopped using the meters|10|||
162978762|NCT03891329|588623491|FG000|Overall Study|Death|5|||
162978763|NCT03891329|588623491|FG000|Overall Study|Lost to Follow-up|4|||
162978764|NCT03891329|588623491|FG000|Overall Study|Physician Decision|4|||
162978765|NCT03891329|588623491|FG000|Overall Study|Device explanted|3|||
162978766|NCT03891329|588623491|FG000|Overall Study|No study device implanted|3|||
162978767|NCT03176784|588623492|FG000|Overall Study|Lost to Follow-up|77|||
162978768|NCT03176784|588623493|FG001|Overall Study|Lost to Follow-up|79|||
162978769|NCT03176784|588623494|FG002|Overall Study|Lost to Follow-up|79|||
163058116|NCT03307174|588922852|FG001|Overall Study|Unplanned ICU Administrion|3|||
163058117|NCT03307174|588922851|FG000|Overall Study|Aborted Surgery|1|||
163058118|NCT03307174|588922852|FG001|Overall Study|Aborted Surgery|2|||
163058119|NCT03307174|588922851|FG000|Overall Study|Hypotension|6|||
163058120|NCT03307174|588922852|FG001|Overall Study|Hypotension|0|||
163058121|NCT03307174|588922851|FG000|Overall Study|Nonfunctional epidural|1|||
163058122|NCT03307174|588922852|FG001|Overall Study|Nonfunctional epidural|1|||
163058123|NCT03307174|588922851|FG000|Overall Study|Planned epidural removal|1|||
163058124|NCT03307174|588922852|FG001|Overall Study|Planned epidural removal|0|||
163058125|NCT03307174|588922851|FG000|Overall Study|Intrathecal catheter placement|0|||
163058126|NCT03307174|588922852|FG001|Overall Study|Intrathecal catheter placement|1|||
163058127|NCT05911841|588922853|FG000|Induction Period|Study Terminated by Sponsor|2|||
163058128|NCT05911841|588922854|FG001|Induction Period|Study Terminated by Sponsor|0|||
163058129|NCT05911841|588922855|FG002|Induction Period|Study Terminated by Sponsor|14|||
163058130|NCT05911841|588922856|FG003|Induction Period|Study Terminated by Sponsor|6|||
163058131|NCT05911841|588922857|FG004|Induction Period|Study Terminated by Sponsor|0|||
163058132|NCT05911841|588922858|FG005|Induction Period|Study Terminated by Sponsor|0|||
163058133|NCT05911841|588922859|FG006|Induction Period|Study Terminated by Sponsor|0|||
163058134|NCT05911841|588922860|FG007|Induction Period|Study Terminated by Sponsor|0|||
163058135|NCT05911841|588922861|FG008|Induction Period|Study Terminated by Sponsor|0|||
163058136|NCT05911841|588922862|FG009|Induction Period|Study Terminated by Sponsor|0|||
163058137|NCT05911841|588922853|FG000|Induction Period|Withdrawal by Subject|4|||
163058138|NCT05911841|588922854|FG001|Induction Period|Withdrawal by Subject|3|||
163058139|NCT05911841|588922855|FG002|Induction Period|Withdrawal by Subject|4|||
163058140|NCT05911841|588922856|FG003|Induction Period|Withdrawal by Subject|6|||
163058141|NCT05911841|588922857|FG004|Induction Period|Withdrawal by Subject|0|||
163210468|NCT03263442|589485252|FG001|Inpatient Phase|Withdrawal by Subject|0|||
163058142|NCT05911841|588922858|FG005|Induction Period|Withdrawal by Subject|0|||
163058143|NCT05911841|588922859|FG006|Induction Period|Withdrawal by Subject|0|||
163058144|NCT05911841|588922860|FG007|Induction Period|Withdrawal by Subject|0|||
163210469|NCT03263442|589485251|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
162978770|NCT03176784|588623495|FG003|Overall Study|Lost to Follow-up|49|||
163058145|NCT05911841|588922861|FG008|Induction Period|Withdrawal by Subject|0|||
163058146|NCT05911841|588922862|FG009|Induction Period|Withdrawal by Subject|0|||
163210470|NCT03263442|589485252|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
162978771|NCT03176784|588623492|FG000|Overall Study|Withdrawal by Subject|28|||
162978772|NCT03176784|588623493|FG001|Overall Study|Withdrawal by Subject|34|||
162978773|NCT03176784|588623494|FG002|Overall Study|Withdrawal by Subject|34|||
162978774|NCT03176784|588623495|FG003|Overall Study|Withdrawal by Subject|21|||
163058147|NCT05911841|588922853|FG000|Induction Period|Lack of Efficacy|3|||
163058148|NCT05911841|588922854|FG001|Induction Period|Lack of Efficacy|0|||
163058149|NCT05911841|588922855|FG002|Induction Period|Lack of Efficacy|3|||
163058150|NCT05911841|588922856|FG003|Induction Period|Lack of Efficacy|3|||
163058151|NCT05911841|588922857|FG004|Induction Period|Lack of Efficacy|0|||
163058152|NCT05911841|588922858|FG005|Induction Period|Lack of Efficacy|0|||
163058153|NCT05911841|588922859|FG006|Induction Period|Lack of Efficacy|0|||
163058154|NCT05911841|588922860|FG007|Induction Period|Lack of Efficacy|0|||
163058155|NCT05911841|588922861|FG008|Induction Period|Lack of Efficacy|0|||
163058156|NCT05911841|588922862|FG009|Induction Period|Lack of Efficacy|0|||
163058157|NCT05911841|588922853|FG000|Induction Period|Adverse Event|3|||
163058158|NCT05911841|588922854|FG001|Induction Period|Adverse Event|1|||
163058159|NCT05911841|588922855|FG002|Induction Period|Adverse Event|2|||
163058160|NCT05911841|588922856|FG003|Induction Period|Adverse Event|0|||
163058161|NCT05911841|588922857|FG004|Induction Period|Adverse Event|0|||
163058162|NCT05911841|588922858|FG005|Induction Period|Adverse Event|0|||
163058163|NCT05911841|588922859|FG006|Induction Period|Adverse Event|0|||
163058164|NCT05911841|588922860|FG007|Induction Period|Adverse Event|0|||
163058165|NCT05911841|588922861|FG008|Induction Period|Adverse Event|0|||
163058166|NCT05911841|588922862|FG009|Induction Period|Adverse Event|0|||
163058167|NCT05911841|588922853|FG000|Induction Period|Assigned Treatment by Mistake|0|||
163058168|NCT05911841|588922854|FG001|Induction Period|Assigned Treatment by Mistake|1|||
163058169|NCT05911841|588922855|FG002|Induction Period|Assigned Treatment by Mistake|0|||
163058170|NCT05911841|588922856|FG003|Induction Period|Assigned Treatment by Mistake|1|||
163058171|NCT05911841|588922857|FG004|Induction Period|Assigned Treatment by Mistake|0|||
163058172|NCT05911841|588922858|FG005|Induction Period|Assigned Treatment by Mistake|0|||
163058173|NCT05911841|588922859|FG006|Induction Period|Assigned Treatment by Mistake|0|||
163058174|NCT05911841|588922860|FG007|Induction Period|Assigned Treatment by Mistake|0|||
163058175|NCT05911841|588922861|FG008|Induction Period|Assigned Treatment by Mistake|0|||
163058176|NCT05911841|588922862|FG009|Induction Period|Assigned Treatment by Mistake|0|||
163058177|NCT05911841|588922853|FG000|Induction Period|Lost to Follow-up|0|||
163058178|NCT05911841|588922854|FG001|Induction Period|Lost to Follow-up|0|||
163058179|NCT05911841|588922855|FG002|Induction Period|Lost to Follow-up|1|||
163058180|NCT05911841|588922856|FG003|Induction Period|Lost to Follow-up|1|||
163058181|NCT05911841|588922857|FG004|Induction Period|Lost to Follow-up|0|||
163058182|NCT05911841|588922858|FG005|Induction Period|Lost to Follow-up|0|||
163058183|NCT05911841|588922859|FG006|Induction Period|Lost to Follow-up|0|||
163058184|NCT05911841|588922860|FG007|Induction Period|Lost to Follow-up|0|||
163058185|NCT05911841|588922861|FG008|Induction Period|Lost to Follow-up|0|||
163058186|NCT05911841|588922862|FG009|Induction Period|Lost to Follow-up|0|||
163058187|NCT05911841|588922853|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
163058188|NCT05911841|588922854|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
163058189|NCT05911841|588922855|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
163058190|NCT05911841|588922856|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
163058191|NCT05911841|588922857|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
163058192|NCT05911841|588922858|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
163058193|NCT05911841|588922859|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
163058194|NCT05911841|588922860|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
163058195|NCT05911841|588922861|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
163058196|NCT05911841|588922862|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
163058197|NCT05911841|588922853|FG000|Maintenance Period|Lack of Efficacy|0|||
163058198|NCT05911841|588922854|FG001|Maintenance Period|Lack of Efficacy|0|||
163058199|NCT05911841|588922855|FG002|Maintenance Period|Lack of Efficacy|0|||
163058200|NCT05911841|588922856|FG003|Maintenance Period|Lack of Efficacy|0|||
163058201|NCT05911841|588922857|FG004|Maintenance Period|Lack of Efficacy|1|||
162978775|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
162978776|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
162978777|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
162978778|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
162978779|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
162978780|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
162978781|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
162978782|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
162978783|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
163058202|NCT05911841|588922858|FG005|Maintenance Period|Lack of Efficacy|0|||
163058203|NCT05911841|588922859|FG006|Maintenance Period|Lack of Efficacy|1|||
163058204|NCT05911841|588922860|FG007|Maintenance Period|Lack of Efficacy|0|||
163210471|NCT03263442|589485251|FG000|1-month Follow-Up|Lost to Follow-up|1|||
162978784|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
163058205|NCT05911841|588922861|FG008|Maintenance Period|Lack of Efficacy|0|||
163058206|NCT05911841|588922862|FG009|Maintenance Period|Lack of Efficacy|0|||
163058207|NCT05911841|588922853|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
163058208|NCT05911841|588922854|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
163058209|NCT05911841|588922855|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
163058210|NCT05911841|588922856|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
163401672|NCT04857996|590181230|FG000|Overall Study|Withdrawal by Subject|1|||
163401673|NCT04857996|590181231|FG001|Overall Study|Withdrawal by Subject|0|||
163401674|NCT02988661|590181232|FG000|Overall Study|Death|2|||
163401675|NCT02988661|590181233|FG001|Overall Study|Death|18|||
163401676|NCT02988661|590181232|FG000|Overall Study|Lost to Follow-up|0|||
163401677|NCT02988661|590181233|FG001|Overall Study|Lost to Follow-up|33|||
163401678|NCT02988661|590181232|FG000|Overall Study|Withdrawal by Subject|0|||
163401679|NCT02988661|590181233|FG001|Overall Study|Withdrawal by Subject|6|||
163401680|NCT02988661|590181232|FG000|Overall Study|Unable to complete the 18-month survey|1|||
163401681|NCT02988661|590181233|FG001|Overall Study|Unable to complete the 18-month survey|27|||
163401682|NCT04050982|590181234|FG000|Overall Study|Did not meet eligibility criteria|0|||
163401683|NCT04050982|590181235|FG001|Overall Study|Did not meet eligibility criteria|1|||
163401684|NCT04050982|590181236|FG002|Overall Study|Did not meet eligibility criteria|0|||
163401685|NCT04050982|590181234|FG000|Overall Study|Withdrawal by Subject|1|||
163401686|NCT04050982|590181235|FG001|Overall Study|Withdrawal by Subject|0|||
163401687|NCT04050982|590181236|FG002|Overall Study|Withdrawal by Subject|0|||
163401688|NCT04050982|590181234|FG000|Overall Study|Unable to enroll on platform|1|||
163401689|NCT04050982|590181235|FG001|Overall Study|Unable to enroll on platform|0|||
163401690|NCT04050982|590181236|FG002|Overall Study|Unable to enroll on platform|0|||
163401691|NCT02484911|590182843|FG000|Overall Study|Withdrawal by Subject|2|||
163401692|NCT02484911|590182844|FG001|Overall Study|Withdrawal by Subject|1|||
163401693|NCT02484911|590182843|FG000|Overall Study|Protocol Violation|2|||
163401694|NCT02484911|590182844|FG001|Overall Study|Protocol Violation|1|||
163401695|NCT02222207|590182851|FG000|Overall Study|Death|1|||
163401696|NCT02222207|590182851|FG000|Overall Study|Other reasons|2|||
163401697|NCT02222207|590182851|FG000|Overall Study|Adverse Event|1|||
163401698|NCT00747643|590182852|FG000|Overall Study|Withdrawal by Subject|36|||
163401699|NCT00747643|590182853|FG001|Overall Study|Withdrawal by Subject|27|||
163401700|NCT03557281|590182854|FG000|Overall Study|Investigator discretion|0|||
163401701|NCT03557281|590182855|FG001|Overall Study|Investigator discretion|0|||
163401702|NCT03557281|590182856|FG002|Overall Study|Investigator discretion|1|||
163401703|NCT03557281|590182857|FG003|Overall Study|Investigator discretion|0|||
163401704|NCT03557281|590182858|FG004|Overall Study|Investigator discretion|0|||
163401705|NCT03557281|590182854|FG000|Overall Study|Withdrawal by Subject|0|||
163401706|NCT03557281|590182855|FG001|Overall Study|Withdrawal by Subject|1|||
163401707|NCT03557281|590182856|FG002|Overall Study|Withdrawal by Subject|1|||
163401708|NCT03557281|590182857|FG003|Overall Study|Withdrawal by Subject|1|||
163401709|NCT03557281|590182858|FG004|Overall Study|Withdrawal by Subject|2|||
163401710|NCT03557281|590182854|FG000|Overall Study|Randomized, but did not receive treatment|0|||
163058211|NCT05911841|588922857|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
163058212|NCT05911841|588922858|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
163058213|NCT05911841|588922859|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
163058214|NCT05911841|588922860|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
163058215|NCT05911841|588922861|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
163058216|NCT05911841|588922862|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
163058217|NCT05911841|588922853|FG000|Maintenance Period|Withdrawal by Subject|0|||
163058218|NCT05911841|588922854|FG001|Maintenance Period|Withdrawal by Subject|0|||
163058219|NCT05911841|588922855|FG002|Maintenance Period|Withdrawal by Subject|0|||
163058220|NCT05911841|588922856|FG003|Maintenance Period|Withdrawal by Subject|0|||
163058221|NCT05911841|588922857|FG004|Maintenance Period|Withdrawal by Subject|0|||
163058222|NCT05911841|588922858|FG005|Maintenance Period|Withdrawal by Subject|1|||
163058223|NCT05911841|588922859|FG006|Maintenance Period|Withdrawal by Subject|0|||
163058224|NCT05911841|588922860|FG007|Maintenance Period|Withdrawal by Subject|1|||
163058225|NCT05911841|588922861|FG008|Maintenance Period|Withdrawal by Subject|0|||
163058226|NCT05911841|588922862|FG009|Maintenance Period|Withdrawal by Subject|0|||
163058227|NCT05911841|588922853|FG000|Maintenance Period|Adverse Event|0|||
163058228|NCT05911841|588922854|FG001|Maintenance Period|Adverse Event|0|||
163058229|NCT05911841|588922855|FG002|Maintenance Period|Adverse Event|0|||
163058230|NCT05911841|588922856|FG003|Maintenance Period|Adverse Event|0|||
163058231|NCT05911841|588922857|FG004|Maintenance Period|Adverse Event|0|||
163058232|NCT05911841|588922858|FG005|Maintenance Period|Adverse Event|0|||
163058233|NCT05911841|588922859|FG006|Maintenance Period|Adverse Event|0|||
163058234|NCT05911841|588922860|FG007|Maintenance Period|Adverse Event|1|||
163058235|NCT05911841|588922861|FG008|Maintenance Period|Adverse Event|0|||
163058236|NCT05911841|588922862|FG009|Maintenance Period|Adverse Event|0|||
163058237|NCT05911841|588922853|FG000|Escape Period|Adverse Event|0|||
163058238|NCT05911841|588922854|FG001|Escape Period|Adverse Event|0|||
163058239|NCT05911841|588922855|FG002|Escape Period|Adverse Event|0|||
163058240|NCT05911841|588922856|FG003|Escape Period|Adverse Event|0|||
163401711|NCT03557281|590182855|FG001|Overall Study|Randomized, but did not receive treatment|0|||
163401712|NCT03557281|590182856|FG002|Overall Study|Randomized, but did not receive treatment|0|||
163401713|NCT03557281|590182857|FG003|Overall Study|Randomized, but did not receive treatment|0|||
163401714|NCT03557281|590182858|FG004|Overall Study|Randomized, but did not receive treatment|1|||
163401715|NCT01199042|590182859|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
163058241|NCT05911841|588922857|FG004|Escape Period|Adverse Event|0|||
163401716|NCT01199042|590182859|FG000|At Home (3 Months)|Lost to Follow-up|1|||
163401717|NCT04036708|590182862|FG000|Overall Study|Lost to Follow-up|14|||
163401718|NCT04036708|590182863|FG001|Overall Study|Lost to Follow-up|4|||
163401719|NCT04036708|590182864|FG002|Overall Study|Lost to Follow-up|14|||
163401720|NCT04036708|590182865|FG003|Overall Study|Lost to Follow-up|4|||
163401721|NCT02918864|590182866|FG000|Overall Study|Withdrawal by Subject|1|||
163401722|NCT02918864|590182867|FG001|Overall Study|Withdrawal by Subject|1|||
163401723|NCT02918864|590182866|FG000|Overall Study|Lost to Follow-up|3|||
163401724|NCT02918864|590182867|FG001|Overall Study|Lost to Follow-up|2|||
163401725|NCT02104583|590182869|FG000|Overall Study|New ICD or CRT-D implanted|2|||
163401726|NCT02104583|590182870|FG001|Overall Study|New ICD or CRT-D implanted|0|||
163401727|NCT02104583|590182871|FG002|Overall Study|New ICD or CRT-D implanted|1|||
163401728|NCT02104583|590182872|FG003|Overall Study|New ICD or CRT-D implanted|0|||
162978785|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
162978786|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
162978787|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
162978788|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
163401729|NCT02104583|590182873|FG004|Overall Study|New ICD or CRT-D implanted|0|||
163401730|NCT02104583|590182869|FG000|Overall Study|Death|2|||
163401731|NCT02104583|590182870|FG001|Overall Study|Death|1|||
163401732|NCT02104583|590182871|FG002|Overall Study|Death|3|||
163401733|NCT02104583|590182872|FG003|Overall Study|Death|3|||
163401734|NCT02104583|590182873|FG004|Overall Study|Death|5|||
163401735|NCT02104583|590182869|FG000|Overall Study|Subject required cardiac ablation|6|||
163401736|NCT02104583|590182870|FG001|Overall Study|Subject required cardiac ablation|4|||
163401737|NCT02104583|590182871|FG002|Overall Study|Subject required cardiac ablation|4|||
163401738|NCT02104583|590182872|FG003|Overall Study|Subject required cardiac ablation|5|||
163401739|NCT02104583|590182873|FG004|Overall Study|Subject required cardiac ablation|4|||
163401740|NCT02104583|590182869|FG000|Overall Study|Subject required prohibited medication|0|||
163401741|NCT02104583|590182870|FG001|Overall Study|Subject required prohibited medication|1|||
163401742|NCT02104583|590182871|FG002|Overall Study|Subject required prohibited medication|1|||
163401743|NCT02104583|590182872|FG003|Overall Study|Subject required prohibited medication|0|||
163401744|NCT02104583|590182873|FG004|Overall Study|Subject required prohibited medication|1|||
163401745|NCT02104583|590182869|FG000|Overall Study|Withdrew Consent|3|||
163401746|NCT02104583|590182870|FG001|Overall Study|Withdrew Consent|2|||
163401747|NCT02104583|590182871|FG002|Overall Study|Withdrew Consent|0|||
163401748|NCT02104583|590182872|FG003|Overall Study|Withdrew Consent|2|||
163401749|NCT02104583|590182873|FG004|Overall Study|Withdrew Consent|1|||
163401750|NCT02104583|590182869|FG000|Overall Study|Investigator's Discretion|1|||
163401751|NCT02104583|590182870|FG001|Overall Study|Investigator's Discretion|0|||
163401752|NCT02104583|590182871|FG002|Overall Study|Investigator's Discretion|0|||
163401753|NCT02104583|590182872|FG003|Overall Study|Investigator's Discretion|0|||
163401754|NCT02104583|590182873|FG004|Overall Study|Investigator's Discretion|0|||
162978789|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
162978790|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
162978791|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
162978792|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
162978793|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
162978794|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
162978795|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
162978796|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
162978797|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
162978798|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
162978799|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
162978800|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
162978801|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
162978802|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
162978803|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Death|0|||
162978804|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Death|1|||
162978805|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Death|0|||
162978806|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Death|0|||
162978807|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
162978808|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
162978809|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
162978810|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
163058242|NCT05911841|588922858|FG005|Escape Period|Adverse Event|0|||
163401755|NCT02104583|590182869|FG000|Overall Study|Protocol Violation|0|||
162978811|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
163058243|NCT05911841|588922859|FG006|Escape Period|Adverse Event|0|||
163401756|NCT02104583|590182870|FG001|Overall Study|Protocol Violation|0|||
163401757|NCT02104583|590182871|FG002|Overall Study|Protocol Violation|1|||
162978812|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
163401758|NCT02104583|590182872|FG003|Overall Study|Protocol Violation|0|||
163401759|NCT02104583|590182873|FG004|Overall Study|Protocol Violation|0|||
163210472|NCT03263442|589485252|FG001|1-month Follow-Up|Lost to Follow-up|0|||
162978813|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
162978814|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
162978815|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Other|1|||
162978816|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Other|3|||
162978817|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Other|0|||
162978818|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Other|0|||
162978819|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
162978820|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
162978821|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
162978822|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
162978823|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Death|1|||
162978824|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Death|0|||
162978825|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Death|0|||
162978826|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Death|0|||
162978827|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
162978828|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
162978829|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
162978830|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
162978831|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
162978832|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
162978833|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
162978834|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
162978835|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
162978836|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
162978837|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
162978838|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
162978839|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
162978840|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
162978841|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
162978842|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
162978843|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
162978844|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
162978845|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
162978846|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
162978847|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
162978848|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
162978849|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
162978850|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
162978851|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
162978852|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
162978853|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
162978854|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
162978855|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
162978856|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
162978857|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
162978858|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
162978859|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
162978860|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
162978861|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
162978862|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
162978863|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Other|3|||
162978864|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Other|0|||
162978865|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Other|4|||
162978866|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Other|1|||
162978867|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
162978868|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
162978869|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
162978870|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
162978871|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
162978872|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
162978873|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
162978874|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
162978875|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
162978876|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
162978877|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
162978878|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
162978879|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
162978880|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
162978881|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
163058244|NCT05911841|588922860|FG007|Escape Period|Adverse Event|0|||
163058245|NCT05911841|588922861|FG008|Escape Period|Adverse Event|0|||
163058246|NCT05911841|588922862|FG009|Escape Period|Adverse Event|1|||
163058247|NCT05911841|588922853|FG000|Escape Period|Lack of Efficacy|0|||
163058248|NCT05911841|588922854|FG001|Escape Period|Lack of Efficacy|0|||
163058249|NCT05911841|588922855|FG002|Escape Period|Lack of Efficacy|0|||
163058250|NCT05911841|588922856|FG003|Escape Period|Lack of Efficacy|0|||
163058251|NCT05911841|588922857|FG004|Escape Period|Lack of Efficacy|0|||
163058252|NCT05911841|588922858|FG005|Escape Period|Lack of Efficacy|0|||
163058253|NCT05911841|588922859|FG006|Escape Period|Lack of Efficacy|0|||
163058254|NCT05911841|588922860|FG007|Escape Period|Lack of Efficacy|0|||
163058255|NCT05911841|588922861|FG008|Escape Period|Lack of Efficacy|0|||
163058256|NCT05911841|588922862|FG009|Escape Period|Lack of Efficacy|31|||
163058257|NCT05911841|588922853|FG000|Escape Period|Lost to Follow-up|0|||
163058258|NCT05911841|588922854|FG001|Escape Period|Lost to Follow-up|0|||
163058259|NCT05911841|588922855|FG002|Escape Period|Lost to Follow-up|0|||
163058260|NCT05911841|588922856|FG003|Escape Period|Lost to Follow-up|0|||
163058261|NCT05911841|588922857|FG004|Escape Period|Lost to Follow-up|0|||
163058262|NCT05911841|588922858|FG005|Escape Period|Lost to Follow-up|0|||
163401760|NCT02104583|590182869|FG000|Overall Study|Adverse Event|3|||
163401761|NCT02104583|590182870|FG001|Overall Study|Adverse Event|3|||
163401762|NCT02104583|590182871|FG002|Overall Study|Adverse Event|6|||
163401763|NCT02104583|590182872|FG003|Overall Study|Adverse Event|6|||
163401764|NCT02104583|590182873|FG004|Overall Study|Adverse Event|1|||
163401765|NCT02104583|590182869|FG000|Overall Study|Lost to Follow-up|1|||
163401766|NCT02104583|590182870|FG001|Overall Study|Lost to Follow-up|0|||
163401767|NCT02104583|590182871|FG002|Overall Study|Lost to Follow-up|0|||
163401768|NCT02104583|590182872|FG003|Overall Study|Lost to Follow-up|0|||
163058263|NCT05911841|588922859|FG006|Escape Period|Lost to Follow-up|0|||
163058264|NCT05911841|588922860|FG007|Escape Period|Lost to Follow-up|0|||
163058265|NCT05911841|588922861|FG008|Escape Period|Lost to Follow-up|0|||
163058266|NCT05911841|588922862|FG009|Escape Period|Lost to Follow-up|1|||
163058267|NCT05911841|588922853|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058268|NCT05911841|588922854|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058269|NCT05911841|588922855|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058270|NCT05911841|588922856|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058271|NCT05911841|588922857|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058272|NCT05911841|588922858|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058273|NCT05911841|588922859|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058274|NCT05911841|588922860|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058275|NCT05911841|588922861|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058276|NCT05911841|588922862|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
163058277|NCT05911841|588922853|FG000|Escape Period|Site Terminated by Sponsor|0|||
163058278|NCT05911841|588922854|FG001|Escape Period|Site Terminated by Sponsor|0|||
163058279|NCT05911841|588922855|FG002|Escape Period|Site Terminated by Sponsor|0|||
163058280|NCT05911841|588922856|FG003|Escape Period|Site Terminated by Sponsor|0|||
163058281|NCT05911841|588922857|FG004|Escape Period|Site Terminated by Sponsor|0|||
163058282|NCT05911841|588922858|FG005|Escape Period|Site Terminated by Sponsor|0|||
163058283|NCT05911841|588922859|FG006|Escape Period|Site Terminated by Sponsor|0|||
163058284|NCT05911841|588922860|FG007|Escape Period|Site Terminated by Sponsor|0|||
163058285|NCT05911841|588922861|FG008|Escape Period|Site Terminated by Sponsor|0|||
163058286|NCT05911841|588922862|FG009|Escape Period|Site Terminated by Sponsor|1|||
163058287|NCT05911841|588922853|FG000|Escape Period|Study Terminated by Sponsor|0|||
163058288|NCT05911841|588922854|FG001|Escape Period|Study Terminated by Sponsor|0|||
163401769|NCT02104583|590182873|FG004|Overall Study|Lost to Follow-up|0|||
163401770|NCT02104583|590182869|FG000|Overall Study|Randomized but Never Treated|0|||
163401771|NCT02104583|590182870|FG001|Overall Study|Randomized but Never Treated|0|||
163401772|NCT02104583|590182871|FG002|Overall Study|Randomized but Never Treated|0|||
163058289|NCT05911841|588922855|FG002|Escape Period|Study Terminated by Sponsor|0|||
163058290|NCT05911841|588922856|FG003|Escape Period|Study Terminated by Sponsor|0|||
163058291|NCT05911841|588922857|FG004|Escape Period|Study Terminated by Sponsor|0|||
163058292|NCT05911841|588922858|FG005|Escape Period|Study Terminated by Sponsor|0|||
163401773|NCT02104583|590182872|FG003|Overall Study|Randomized but Never Treated|1|||
163401774|NCT02104583|590182873|FG004|Overall Study|Randomized but Never Treated|0|||
163401775|NCT00129766|590182875|FG000|Overall Study|Death|3|||
163058293|NCT05911841|588922859|FG006|Escape Period|Study Terminated by Sponsor|0|||
163058294|NCT05911841|588922860|FG007|Escape Period|Study Terminated by Sponsor|0|||
163058295|NCT05911841|588922861|FG008|Escape Period|Study Terminated by Sponsor|0|||
163058296|NCT05911841|588922862|FG009|Escape Period|Study Terminated by Sponsor|34|||
163058297|NCT05911841|588922853|FG000|Escape Period|Withdrawal by Subject|0|||
163058298|NCT05911841|588922854|FG001|Escape Period|Withdrawal by Subject|0|||
163058299|NCT05911841|588922855|FG002|Escape Period|Withdrawal by Subject|0|||
163401776|NCT00129766|590182876|FG001|Overall Study|Death|8|||
163401777|NCT00129766|590182875|FG000|Overall Study|Withdrawal of consent|31|||
163401778|NCT00129766|590182876|FG001|Overall Study|Withdrawal of consent|30|||
163401779|NCT00129766|590182875|FG000|Overall Study|Lost to Follow-up|26|||
163401780|NCT00129766|590182876|FG001|Overall Study|Lost to Follow-up|21|||
163401781|NCT01349465|590182881|FG000|Overall Study|Adverse Event|1|||
163401782|NCT01349465|590182882|FG001|Overall Study|Adverse Event|0|||
163401783|NCT01349465|590182881|FG000|Overall Study|Death|3|||
163401784|NCT01349465|590182882|FG001|Overall Study|Death|0|||
163401785|NCT01349465|590182881|FG000|Overall Study|Lost to Follow-up|10|||
163401786|NCT01349465|590182882|FG001|Overall Study|Lost to Follow-up|1|||
163401787|NCT01349465|590182881|FG000|Overall Study|Withdrawal by Subject|4|||
163401788|NCT01349465|590182882|FG001|Overall Study|Withdrawal by Subject|2|||
163401789|NCT01349465|590182881|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
163401790|NCT01349465|590182882|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
163401791|NCT04329702|590182885|FG000|Overall Study|illness|3|||
163401792|NCT04329702|590182886|FG001|Overall Study|illness|4|||
163401793|NCT04329702|590182887|FG002|Overall Study|illness|0|||
163401794|NCT04329702|590182885|FG000|Overall Study|Lost to Follow-up|0|||
163401795|NCT04329702|590182886|FG001|Overall Study|Lost to Follow-up|0|||
163401796|NCT04329702|590182887|FG002|Overall Study|Lost to Follow-up|2|||
163401797|NCT04329702|590182885|FG000|Overall Study|Death|0|||
163401798|NCT04329702|590182886|FG001|Overall Study|Death|2|||
163401799|NCT04329702|590182887|FG002|Overall Study|Death|0|||
163401800|NCT01476475|590182888|FG000|Overall Study|Adverse Event|6|||
163401801|NCT01476475|590182889|FG001|Overall Study|Adverse Event|0|||
163401802|NCT01476475|590182888|FG000|Overall Study|Poor compliance to protocol|1|||
163401803|NCT01476475|590182889|FG001|Overall Study|Poor compliance to protocol|1|||
163401804|NCT01476475|590182888|FG000|Overall Study|Other reasons|4|||
163401805|NCT01476475|590182889|FG001|Overall Study|Other reasons|2|||
163401806|NCT00751400|590182892|FG000|Overall Study|Lost to Follow-up|10|||
163401807|NCT01918007|590182894|FG000|Overall Study|Baseline oximetry not acceptable|11|||
163401808|NCT01918007|590182895|FG001|Overall Study|Baseline oximetry not acceptable|7|||
163401809|NCT01918007|590182894|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
163401810|NCT01918007|590182895|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
163401811|NCT01918007|590182894|FG000|Overall Study|Lost to Follow-up|4|||
163401812|NCT01918007|590182895|FG001|Overall Study|Lost to Follow-up|7|||
163401813|NCT01372384|590182896|FG000|Overall Study|Progression of disease|3|||
163401814|NCT00441974|590182897|FG000|Overall Study|Adverse Event|6|||
163401815|NCT00441974|590182897|FG000|Overall Study|Consent Withdrawn|35|||
163401816|NCT00441974|590182897|FG000|Overall Study|Lost to Follow-up|80|||
163401817|NCT00441974|590182897|FG000|Overall Study|Protocol Violation|7|||
163401818|NCT02375724|590182898|FG000|Overall Study|Lack of Efficacy|1|||
163401819|NCT02375724|590182899|FG001|Overall Study|Lack of Efficacy|1|||
163401820|NCT02375724|590182898|FG000|Overall Study|Withdrawal by Subject|1|||
163401821|NCT02375724|590182899|FG001|Overall Study|Withdrawal by Subject|1|||
163401822|NCT02375724|590182898|FG000|Overall Study|Lost to Follow-up|1|||
163401823|NCT02375724|590182899|FG001|Overall Study|Lost to Follow-up|0|||
163401824|NCT02375724|590182898|FG000|Overall Study|Protocol Violation|1|||
163401825|NCT02375724|590182899|FG001|Overall Study|Protocol Violation|0|||
163401826|NCT02375724|590182898|FG000|Overall Study|Adverse Event|2|||
163401827|NCT02375724|590182899|FG001|Overall Study|Adverse Event|4|||
163401828|NCT02614859|590182900|FG000|Overall Study|Physician Decision|0|||
163401829|NCT02614859|590182901|FG001|Overall Study|Physician Decision|1|||
163401830|NCT00804570|590182902|FG000|Overall Study|Adverse Event|14|||
163401831|NCT00804570|590182903|FG001|Overall Study|Adverse Event|7|||
163401832|NCT00804570|590182902|FG000|Overall Study|Lack of Efficacy|0|||
163401833|NCT00804570|590182903|FG001|Overall Study|Lack of Efficacy|1|||
163401834|NCT00804570|590182902|FG000|Overall Study|Lost to Follow-up|18|||
163401835|NCT00804570|590182903|FG001|Overall Study|Lost to Follow-up|21|||
163401836|NCT00804570|590182902|FG000|Overall Study|Entry criteria not met|5|||
163401837|NCT00804570|590182903|FG001|Overall Study|Entry criteria not met|5|||
163401838|NCT00804570|590182902|FG000|Overall Study|Protocol Violation|12|||
163401839|NCT00804570|590182903|FG001|Overall Study|Protocol Violation|16|||
163401840|NCT00804570|590182902|FG000|Overall Study|Physician Decision|1|||
163401841|NCT00804570|590182903|FG001|Overall Study|Physician Decision|2|||
163401842|NCT00804570|590182902|FG000|Overall Study|Sponsor decision|1|||
163401843|NCT00804570|590182903|FG001|Overall Study|Sponsor decision|4|||
163401844|NCT00804570|590182902|FG000|Overall Study|Withdrawal by Subject|21|||
163401845|NCT00804570|590182903|FG001|Overall Study|Withdrawal by Subject|38|||
163401846|NCT00290342|590182904|FG000|Overall Study|Other|0|||
163401847|NCT00290342|590182905|FG001|Overall Study|Other|1|||
163401848|NCT00290342|590182904|FG000|Overall Study|Withdrawal by Subject|6|||
163401849|NCT00290342|590182905|FG001|Overall Study|Withdrawal by Subject|4|||
163401850|NCT00290342|590182904|FG000|Overall Study|Lost to Follow-up|1|||
163401851|NCT00290342|590182905|FG001|Overall Study|Lost to Follow-up|0|||
163401852|NCT02285998|590182908|FG000|Overall Study|Adverse Event|9|||
163401853|NCT02285998|590182909|FG001|Overall Study|Adverse Event|8|||
163401854|NCT02285998|590182908|FG000|Overall Study|Physician Decision|1|||
163401855|NCT02285998|590182909|FG001|Overall Study|Physician Decision|2|||
163401856|NCT02285998|590182908|FG000|Overall Study|Lost to Follow-up|176|||
163401857|NCT02285998|590182909|FG001|Overall Study|Lost to Follow-up|172|||
163401858|NCT02285998|590182908|FG000|Overall Study|Withdrawal by Subject|53|||
163401859|NCT02285998|590182909|FG001|Overall Study|Withdrawal by Subject|61|||
163401860|NCT02285998|590182908|FG000|Overall Study|Other Reasons|7|||
163401861|NCT02285998|590182909|FG001|Overall Study|Other Reasons|10|||
163401862|NCT01793142|590182912|FG000|Overall Study|Randomized not treated|7|||
163401863|NCT02121262|590182915|FG000|Overall Study|Adverse Event|6|||
163401864|NCT02121262|590182916|FG001|Overall Study|Adverse Event|3|||
163401865|NCT02121262|590182915|FG000|Overall Study|Lack of Efficacy|3|||
163401866|NCT02121262|590182916|FG001|Overall Study|Lack of Efficacy|0|||
163401867|NCT02121262|590182915|FG000|Overall Study|Personal Reasons|19|||
163058300|NCT05911841|588922856|FG003|Escape Period|Withdrawal by Subject|0|||
163058301|NCT05911841|588922857|FG004|Escape Period|Withdrawal by Subject|0|||
163058302|NCT05911841|588922858|FG005|Escape Period|Withdrawal by Subject|0|||
163058303|NCT05911841|588922859|FG006|Escape Period|Withdrawal by Subject|0|||
163058304|NCT05911841|588922860|FG007|Escape Period|Withdrawal by Subject|0|||
163058305|NCT05911841|588922861|FG008|Escape Period|Withdrawal by Subject|0|||
163058306|NCT05911841|588922862|FG009|Escape Period|Withdrawal by Subject|10|||
163058307|NCT05595369|588922863|FG000|Overall Study|Adverse Event|2|||
163058308|NCT05595369|588922864|FG001|Overall Study|Adverse Event|0|||
163058309|NCT05595369|588922865|FG002|Overall Study|Adverse Event|0|||
163210473|NCT03263442|589485251|FG000|3-month Follow-Up|Lost to Follow-up|1|||
163058310|NCT05595369|588922863|FG000|Overall Study|Lost to Follow-up|11|||
163401868|NCT02121262|590182916|FG001|Overall Study|Personal Reasons|5|||
163401869|NCT02121262|590182915|FG000|Overall Study|Protocol Violation|1|||
163401870|NCT02121262|590182916|FG001|Overall Study|Protocol Violation|1|||
163401871|NCT02121262|590182915|FG000|Overall Study|Participant Dropped-out|0|||
163401872|NCT02121262|590182916|FG001|Overall Study|Participant Dropped-out|1|||
163401873|NCT02121262|590182915|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
163401874|NCT02121262|590182916|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
163401875|NCT02121262|590182915|FG000|Overall Study|Consent Withdrawn|1|||
163401876|NCT02121262|590182916|FG001|Overall Study|Consent Withdrawn|0|||
163401877|NCT02829138|590182917|FG000|Overall Study|Withdrawal by Subject|1|||
163401878|NCT02829138|590182918|FG001|Overall Study|Withdrawal by Subject|0|||
163401879|NCT01394627|590182919|FG000|First Intervention (1 Day)|poor intravenous access|0|||
163401880|NCT01394627|590182920|FG001|First Intervention (1 Day)|poor intravenous access|1|||
163401881|NCT01394627|590182919|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
163401882|NCT01394627|590182920|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
163401883|NCT01617070|590182921|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
163401884|NCT00808236|590182924|FG000|Overall Study|Was not resuscitated|50|||
163401885|NCT00808236|590182925|FG001|Overall Study|Was not resuscitated|56|||
163401886|NCT00808236|590182924|FG000|Overall Study|Pre-defined exclusion|13|||
163401887|NCT00808236|590182925|FG001|Overall Study|Pre-defined exclusion|3|||
163401888|NCT00808236|590182924|FG000|Overall Study|Lost to Follow-up|1|||
163401889|NCT00808236|590182925|FG001|Overall Study|Lost to Follow-up|1|||
163401890|NCT00808236|590182924|FG000|Overall Study|Physician Decision|0|||
163401891|NCT00808236|590182925|FG001|Overall Study|Physician Decision|1|||
163401892|NCT00808236|590182924|FG000|Overall Study|Death|18|||
163401893|NCT00808236|590182925|FG001|Overall Study|Death|30|||
163401894|NCT02230384|590182926|FG000|Phase 1|Lost to Follow-up|1|||
163401895|NCT02230384|590182927|FG001|Phase 1|Lost to Follow-up|0|||
163401896|NCT02230384|590182926|FG000|Phase 1|Physician Decision|0|||
163401897|NCT02230384|590182927|FG001|Phase 1|Physician Decision|1|||
163401898|NCT02230384|590182926|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
163058311|NCT05595369|588922864|FG001|Overall Study|Lost to Follow-up|10|||
163058312|NCT05595369|588922865|FG002|Overall Study|Lost to Follow-up|10|||
163058313|NCT05595369|588922863|FG000|Overall Study|Physician Decision|1|||
163058314|NCT05595369|588922864|FG001|Overall Study|Physician Decision|0|||
163058315|NCT05595369|588922865|FG002|Overall Study|Physician Decision|0|||
163058316|NCT05595369|588922863|FG000|Overall Study|Withdrawal by Subject|5|||
163058317|NCT05595369|588922864|FG001|Overall Study|Withdrawal by Subject|7|||
163058318|NCT05595369|588922865|FG002|Overall Study|Withdrawal by Subject|6|||
163058319|NCT05595369|588922863|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
163058320|NCT05595369|588922864|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
163058321|NCT05595369|588922865|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
163401899|NCT02230384|590182927|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
163401900|NCT02230384|590182926|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
163401901|NCT02230384|590182927|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
163401902|NCT02230384|590182926|FG000|Phase 2 - Switch|Adverse Event|2|||
163058322|NCT05595369|588922863|FG000|Overall Study|Study Drug Non-compliance|0|||
163058323|NCT05595369|588922864|FG001|Overall Study|Study Drug Non-compliance|1|||
163210474|NCT03263442|589485252|FG001|3-month Follow-Up|Lost to Follow-up|3|||
163401903|NCT02230384|590182927|FG001|Phase 2 - Switch|Adverse Event|0|||
163401904|NCT00961220|590182928|FG000|Overall Study|Adverse Event|3|||
163401905|NCT00961220|590182928|FG000|Overall Study|Lack of Efficacy|1|||
163401906|NCT00961220|590182928|FG000|Overall Study|No IV access for O6BG|1|||
163401907|NCT00961220|590182928|FG000|Overall Study|O6BG no longer supplied|1|||
163401908|NCT00961220|590182928|FG000|Overall Study|Complete Response prior to 12 courses|1|||
163401909|NCT05376215|590182929|FG000|Overall Study|Withdrawal by Subject|2|||
163058324|NCT05595369|588922865|FG002|Overall Study|Study Drug Non-compliance|0|||
163058325|NCT05595369|588922863|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
163058326|NCT05595369|588922864|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
163058327|NCT05595369|588922865|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
163058328|NCT01981616|588922872|FG000|Overall Study|Adverse Event|0|||
163058329|NCT01981616|588922873|FG001|Overall Study|Adverse Event|1|||
163058330|NCT01981616|588922872|FG000|Overall Study|Protocol Violation|1|||
163058331|NCT01981616|588922873|FG001|Overall Study|Protocol Violation|0|||
163058332|NCT05079321|588922878|FG000|Overall Study|Withdrawal by Subject|2|||
163058333|NCT05079321|588922879|FG001|Overall Study|Withdrawal by Subject|2|||
163058334|NCT05079321|588922878|FG000|Overall Study|Lost to Follow-up|0|||
163058335|NCT05079321|588922879|FG001|Overall Study|Lost to Follow-up|1|||
163058336|NCT01081626|588922880|FG000|Overall Study|Dosing error|1|||
163058337|NCT01081626|588922881|FG001|Overall Study|Dosing error|1|||
163058338|NCT01081626|588922880|FG000|Overall Study|Missing Estradiol|25|||
163058339|NCT01081626|588922881|FG001|Overall Study|Missing Estradiol|28|||
163058340|NCT01081626|588922880|FG000|Overall Study|Low antral follicle count|1|||
163058341|NCT01081626|588922881|FG001|Overall Study|Low antral follicle count|0|||
163058342|NCT01081626|588922880|FG000|Overall Study|Overstimulation|0|||
163058343|NCT01081626|588922881|FG001|Overall Study|Overstimulation|1|||
163058344|NCT01081626|588922880|FG000|Overall Study|Lost to Follow-up|0|||
163058345|NCT01081626|588922881|FG001|Overall Study|Lost to Follow-up|1|||
163058346|NCT01081626|588922880|FG000|Overall Study|Other|33|||
163058347|NCT01081626|588922881|FG001|Overall Study|Other|30|||
163058348|NCT02003144|588922882|FG000|Open Label Maintenance Phase|Other than specified|2|||
163058349|NCT02003144|588922883|FG001|Open Label Maintenance Phase|Other than specified|4|||
163058350|NCT02003144|588922882|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
163058351|NCT02003144|588922883|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
163058352|NCT02003144|588922882|FG000|Open Label Maintenance Phase|Pregnancy|0|||
163058353|NCT02003144|588922883|FG001|Open Label Maintenance Phase|Pregnancy|2|||
163058354|NCT02003144|588922882|FG000|Open Label Maintenance Phase|Physician Decision|1|||
163058355|NCT02003144|588922883|FG001|Open Label Maintenance Phase|Physician Decision|1|||
163058356|NCT02003144|588922882|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
163058357|NCT02003144|588922883|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
163058358|NCT02003144|588922882|FG000|Open Label Maintenance Phase|Adverse Event|2|||
163058359|NCT02003144|588922883|FG001|Open Label Maintenance Phase|Adverse Event|1|||
163058360|NCT02074514|588922887|FG000|Overall Study|Lack of Efficacy|3|||
163058361|NCT02074514|588922888|FG001|Overall Study|Lack of Efficacy|2|||
163058362|NCT02074514|588922887|FG000|Overall Study|Lost to Follow-up|0|||
163058363|NCT02074514|588922888|FG001|Overall Study|Lost to Follow-up|1|||
163058364|NCT02074514|588922887|FG000|Overall Study|Withdrew Consent|0|||
163058365|NCT02074514|588922888|FG001|Overall Study|Withdrew Consent|1|||
163058366|NCT00666237|588922891|FG000|Overall Study|Death|5|||
163058367|NCT00666237|588922892|FG001|Overall Study|Death|5|||
163058368|NCT00666237|588922891|FG000|Overall Study|Lost to Follow-up|29|||
163058369|NCT00666237|588922892|FG001|Overall Study|Lost to Follow-up|25|||
163058370|NCT02839707|588922894|FG000|Phase I|Not eligible for analysis|9|||
163058371|NCT02839707|588922895|FG001|Phase I|Not eligible for analysis|0|||
163058372|NCT02839707|588922896|FG002|Phase I|Not eligible for analysis|0|||
163058373|NCT02839707|588922894|FG000|Phase II|Not treated according to protocol|4|||
163058374|NCT02839707|588922895|FG001|Phase II|Not treated according to protocol|0|||
163058375|NCT02839707|588922896|FG002|Phase II|Not treated according to protocol|2|||
163058376|NCT02839707|588922894|FG000|Phase III|Not treated according to protocol|0|||
163058377|NCT02839707|588922895|FG001|Phase III|Not treated according to protocol|0|||
163058378|NCT02839707|588922896|FG002|Phase III|Not treated according to protocol|4|||
163058379|NCT05507437|588924223|FG000|Overall Study|Withdrawal by Subject|1|||
163058380|NCT05507437|588924224|FG001|Overall Study|Withdrawal by Subject|1|||
163058381|NCT05507437|588924223|FG000|Overall Study|Death|3|||
163058382|NCT05507437|588924224|FG001|Overall Study|Death|0|||
163058383|NCT06583096|588924225|FG000|Overall Study|Lost to Follow-up|4|||
163058384|NCT06583096|588924226|FG001|Overall Study|Lost to Follow-up|10|||
163058385|NCT06583096|588924225|FG000|Overall Study|Withdrawal by Subject|0|||
163058386|NCT06583096|588924226|FG001|Overall Study|Withdrawal by Subject|2|||
163058387|NCT05172609|588924227|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
163058388|NCT05172609|588924228|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
163058389|NCT05172609|588924227|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
163058390|NCT05172609|588924228|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
163401910|NCT05376215|590182930|FG001|Overall Study|Withdrawal by Subject|1|||
162924168|NCT00445458|588423819|FG001|Overall Study|Surgery|0|||
163058391|NCT05172609|588924227|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
163058392|NCT05172609|588924228|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
163058393|NCT05610605|588924231|FG000|6-month Assessment|Death|1|||
163058394|NCT05610605|588924232|FG001|6-month Assessment|Death|1|||
163058395|NCT05610605|588924231|FG000|6-month Assessment|Lost to Follow-up|20|||
163058396|NCT05610605|588924232|FG001|6-month Assessment|Lost to Follow-up|0|||
163058397|NCT05610605|588924231|FG000|6-month Assessment|Institutionalized|1|||
163058398|NCT05610605|588924232|FG001|6-month Assessment|Institutionalized|2|||
163058399|NCT05610605|588924231|FG000|12-month Assessment|Death|2|||
163058400|NCT05610605|588924232|FG001|12-month Assessment|Death|1|||
163058401|NCT05610605|588924231|FG000|12-month Assessment|Lost to Follow-up|1|||
163058402|NCT05610605|588924232|FG001|12-month Assessment|Lost to Follow-up|4|||
163210475|NCT03263442|589485251|FG000|6-month Follow-Up|Lost to Follow-up|2|||
163058403|NCT05610605|588924231|FG000|12-month Assessment|Institutionalized|2|||
163058404|NCT05610605|588924232|FG001|12-month Assessment|Institutionalized|1|||
163058405|NCT00753519|588924233|FG000|Overall Study|Withdrawal by Subject|0|||
163058406|NCT00753519|588924234|FG001|Overall Study|Withdrawal by Subject|2|||
163058407|NCT00042289|588924235|FG000|Overall Study|Lost to Follow-up|3|||
163058408|NCT00042289|588924236|FG001|Overall Study|Lost to Follow-up|0|||
163058409|NCT00042289|588924237|FG002|Overall Study|Lost to Follow-up|0|||
163058410|NCT00042289|588924238|FG003|Overall Study|Lost to Follow-up|1|||
163058411|NCT00042289|588924239|FG004|Overall Study|Lost to Follow-up|3|||
163058412|NCT00042289|588924240|FG005|Overall Study|Lost to Follow-up|3|||
163058413|NCT00042289|588924241|FG006|Overall Study|Lost to Follow-up|6|||
163058414|NCT00042289|588924242|FG007|Overall Study|Lost to Follow-up|1|||
163058415|NCT00042289|588924243|FG008|Overall Study|Lost to Follow-up|1|||
163058416|NCT00042289|588924244|FG009|Overall Study|Lost to Follow-up|0|||
163058417|NCT00042289|588924245|FG010|Overall Study|Lost to Follow-up|0|||
163058418|NCT00042289|588924246|FG011|Overall Study|Lost to Follow-up|0|||
163058419|NCT00042289|588924247|FG012|Overall Study|Lost to Follow-up|0|||
163058420|NCT00042289|588924248|FG013|Overall Study|Lost to Follow-up|0|||
163058421|NCT00042289|588924249|FG014|Overall Study|Lost to Follow-up|0|||
163058422|NCT00042289|588924250|FG015|Overall Study|Lost to Follow-up|1|||
163058423|NCT00042289|588924251|FG016|Overall Study|Lost to Follow-up|1|||
163058424|NCT00042289|588924252|FG017|Overall Study|Lost to Follow-up|0|||
163058425|NCT00042289|588924253|FG018|Overall Study|Lost to Follow-up|3|||
163058426|NCT00042289|588924254|FG019|Overall Study|Lost to Follow-up|2|||
163058427|NCT00042289|588924255|FG020|Overall Study|Lost to Follow-up|0|||
163058428|NCT00042289|588924256|FG021|Overall Study|Lost to Follow-up|0|||
163058429|NCT00042289|588924257|FG022|Overall Study|Lost to Follow-up|0|||
163058430|NCT00042289|588924258|FG023|Overall Study|Lost to Follow-up|0|||
163058431|NCT00042289|588924259|FG024|Overall Study|Lost to Follow-up|0|||
163058432|NCT00042289|588924260|FG025|Overall Study|Lost to Follow-up|0|||
163058433|NCT00042289|588924261|FG026|Overall Study|Lost to Follow-up|2|||
163058434|NCT00042289|588924262|FG027|Overall Study|Lost to Follow-up|2|||
163058435|NCT00042289|588924263|FG028|Overall Study|Lost to Follow-up|2|||
163058436|NCT00042289|588924264|FG029|Overall Study|Lost to Follow-up|0|||
163058437|NCT00042289|588924265|FG030|Overall Study|Lost to Follow-up|0|||
163058438|NCT00042289|588924266|FG031|Overall Study|Lost to Follow-up|2|||
163058439|NCT00042289|588924267|FG032|Overall Study|Lost to Follow-up|1|||
163058440|NCT00042289|588924268|FG033|Overall Study|Lost to Follow-up|1|||
163058441|NCT00042289|588924269|FG034|Overall Study|Lost to Follow-up|1|||
163058442|NCT00042289|588924270|FG035|Overall Study|Lost to Follow-up|2|||
163058443|NCT00042289|588924271|FG036|Overall Study|Lost to Follow-up|1|||
163058444|NCT00042289|588924272|FG037|Overall Study|Lost to Follow-up|1|||
163058445|NCT00042289|588924273|FG038|Overall Study|Lost to Follow-up|0|||
163058446|NCT00042289|588924274|FG039|Overall Study|Lost to Follow-up|5|||
163058447|NCT00042289|588924275|FG040|Overall Study|Lost to Follow-up|0|||
163058448|NCT00042289|588924276|FG041|Overall Study|Lost to Follow-up|2|||
163058449|NCT00042289|588924277|FG042|Overall Study|Lost to Follow-up|2|||
163058450|NCT00042289|588924278|FG043|Overall Study|Lost to Follow-up|0|||
163058451|NCT00042289|588924279|FG044|Overall Study|Lost to Follow-up|0|||
163058452|NCT00042289|588924280|FG045|Overall Study|Lost to Follow-up|1|||
163058453|NCT00042289|588924281|FG046|Overall Study|Lost to Follow-up|0|||
163058454|NCT00042289|588924235|FG000|Overall Study|Other reason|0|||
163058455|NCT00042289|588924236|FG001|Overall Study|Other reason|0|||
163401911|NCT05376215|590182929|FG000|Overall Study|Lost to Follow-up|0|||
163058456|NCT00042289|588924237|FG002|Overall Study|Other reason|0|||
163058457|NCT00042289|588924238|FG003|Overall Study|Other reason|2|||
163058458|NCT00042289|588924239|FG004|Overall Study|Other reason|0|||
163058459|NCT00042289|588924240|FG005|Overall Study|Other reason|0|||
163058460|NCT00042289|588924241|FG006|Overall Study|Other reason|0|||
163058461|NCT00042289|588924242|FG007|Overall Study|Other reason|0|||
163058462|NCT00042289|588924243|FG008|Overall Study|Other reason|0|||
163058463|NCT00042289|588924244|FG009|Overall Study|Other reason|0|||
163058464|NCT00042289|588924245|FG010|Overall Study|Other reason|0|||
163058465|NCT00042289|588924246|FG011|Overall Study|Other reason|0|||
163058466|NCT00042289|588924247|FG012|Overall Study|Other reason|0|||
163058467|NCT00042289|588924248|FG013|Overall Study|Other reason|0|||
163058468|NCT00042289|588924249|FG014|Overall Study|Other reason|0|||
163058469|NCT00042289|588924250|FG015|Overall Study|Other reason|0|||
163058470|NCT00042289|588924251|FG016|Overall Study|Other reason|0|||
163058471|NCT00042289|588924252|FG017|Overall Study|Other reason|0|||
163058472|NCT00042289|588924253|FG018|Overall Study|Other reason|1|||
163058473|NCT00042289|588924254|FG019|Overall Study|Other reason|0|||
163058474|NCT00042289|588924255|FG020|Overall Study|Other reason|0|||
163401912|NCT05376215|590182930|FG001|Overall Study|Lost to Follow-up|1|||
163401913|NCT01301950|590182931|FG000|Overall Study|Surgery was cancelled by patient|0|||
163401914|NCT01301950|590182932|FG001|Overall Study|Surgery was cancelled by patient|1|||
163401915|NCT00942175|590182933|FG000|Overall Study|Adverse Event|2|||
162978882|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
162978883|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
162978884|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
162978885|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
162978886|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
162978887|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
162978888|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
162978889|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
162978890|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
162978891|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
162978892|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
162978893|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
162978894|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
162978895|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
162978896|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
162978897|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
162978898|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
162978899|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
162978900|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
162978901|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
162978902|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
162978903|NCT04403763|588623500|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
162978904|NCT04403763|588623501|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
162978905|NCT04403763|588623502|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
162978906|NCT04403763|588623503|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
162978907|NCT04403763|588623504|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
162978908|NCT04403763|588623505|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
162978909|NCT04403763|588623506|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
162978910|NCT04403763|588623500|FG000|Stage 1|Early termination due to PK tube failure|0|||
162978911|NCT04403763|588623501|FG001|Stage 1|Early termination due to PK tube failure|0|||
162978912|NCT04403763|588623502|FG002|Stage 1|Early termination due to PK tube failure|1|||
162978913|NCT04403763|588623503|FG003|Stage 1|Early termination due to PK tube failure|0|||
162978914|NCT04403763|588623504|FG004|Stage 1|Early termination due to PK tube failure|0|||
162978915|NCT04403763|588623505|FG005|Stage 1|Early termination due to PK tube failure|0|||
162978916|NCT04403763|588623506|FG006|Stage 1|Early termination due to PK tube failure|0|||
162978917|NCT04403763|588623500|FG000|Stage 2A|Adverse Event|0|||
162978918|NCT04403763|588623501|FG001|Stage 2A|Adverse Event|0|||
162978919|NCT04403763|588623502|FG002|Stage 2A|Adverse Event|0|||
162978920|NCT04403763|588623503|FG003|Stage 2A|Adverse Event|0|||
162978921|NCT04403763|588623504|FG004|Stage 2A|Adverse Event|0|||
162978922|NCT04403763|588623505|FG005|Stage 2A|Adverse Event|0|||
162978923|NCT04403763|588623506|FG006|Stage 2A|Adverse Event|1|||
162978924|NCT00350402|588623507|FG000|Overall Study|Lost to Follow-up|1|||
162978925|NCT00350402|588623508|FG001|Overall Study|Lost to Follow-up|1|||
162978926|NCT01376310|588623509|FG000|Overall Study|Study closed/terminated|1|||
162978927|NCT01376310|588623510|FG001|Overall Study|Study closed/terminated|2|||
162978928|NCT01376310|588623509|FG000|Overall Study|Withdrawal by Subject|8|||
162978929|NCT01376310|588623510|FG001|Overall Study|Withdrawal by Subject|2|||
162978930|NCT01376310|588623509|FG000|Overall Study|Physician Decision|26|||
162978931|NCT01376310|588623510|FG001|Overall Study|Physician Decision|7|||
162978932|NCT01376310|588623509|FG000|Overall Study|Lost to Follow-up|1|||
162978933|NCT01376310|588623510|FG001|Overall Study|Lost to Follow-up|0|||
162978934|NCT00645944|588623511|FG000|Randomized|Withdrawal by Subject|1|||
162978935|NCT00645944|588623512|FG001|Randomized|Withdrawal by Subject|2|||
162978936|NCT00645944|588623511|FG000|Received Medication|Adverse Event|2|||
162978937|NCT00645944|588623512|FG001|Received Medication|Adverse Event|1|||
162978938|NCT00645944|588623511|FG000|Received Medication|Withdrawal by Subject|1|||
162978939|NCT00645944|588623512|FG001|Received Medication|Withdrawal by Subject|1|||
162978940|NCT00645944|588623511|FG000|Received Medication|Lost to Follow-up|1|||
162978941|NCT00645944|588623512|FG001|Received Medication|Lost to Follow-up|0|||
162978942|NCT00645944|588623511|FG000|Received Medication|Protocol Violation|2|||
162978943|NCT00645944|588623512|FG001|Received Medication|Protocol Violation|1|||
162978944|NCT01534637|588623513|FG000|Overall Study|Physician Decision|3|||
162978945|NCT01534637|588623513|FG000|Overall Study|Lack of Efficacy|3|||
162978946|NCT01534637|588623513|FG000|Overall Study|Withdrawal by Subject|1|||
162978947|NCT01534637|588623513|FG000|Overall Study|Adverse Event|1|||
162978948|NCT01534637|588623513|FG000|Overall Study|Liver Mets before treatment|1|||
162978949|NCT00834899|588623514|FG000|Overall Study|Withdrawal by Subject|1|||
163401916|NCT00942175|590182934|FG001|Overall Study|Adverse Event|1|||
163401917|NCT00942175|590182935|FG002|Overall Study|Adverse Event|0|||
163401918|NCT00942175|590182936|FG003|Overall Study|Adverse Event|0|||
163401919|NCT00942175|590182933|FG000|Overall Study|Protocol Violation|0|||
163401920|NCT00942175|590182934|FG001|Overall Study|Protocol Violation|1|||
163401921|NCT00942175|590182935|FG002|Overall Study|Protocol Violation|2|||
163401922|NCT00942175|590182936|FG003|Overall Study|Protocol Violation|0|||
163401923|NCT00942175|590182933|FG000|Overall Study|Pregnancy|0|||
163401924|NCT00942175|590182934|FG001|Overall Study|Pregnancy|0|||
163401925|NCT00942175|590182935|FG002|Overall Study|Pregnancy|0|||
163401926|NCT00942175|590182936|FG003|Overall Study|Pregnancy|1|||
163401927|NCT00942175|590182933|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
163401928|NCT00942175|590182934|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
163401929|NCT00942175|590182935|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
163401930|NCT00942175|590182936|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
163401931|NCT00942175|590182933|FG000|Overall Study|Low Platelet Count|0|||
163401932|NCT00942175|590182934|FG001|Overall Study|Low Platelet Count|2|||
163401933|NCT00942175|590182935|FG002|Overall Study|Low Platelet Count|0|||
163401934|NCT00942175|590182936|FG003|Overall Study|Low Platelet Count|0|||
163401935|NCT01066585|590182939|FG000|Overall Study|Protocol Violation|1|||
163058475|NCT00042289|588924256|FG021|Overall Study|Other reason|0|||
163058476|NCT00042289|588924257|FG022|Overall Study|Other reason|0|||
163058477|NCT00042289|588924258|FG023|Overall Study|Other reason|1|||
163058478|NCT00042289|588924259|FG024|Overall Study|Other reason|0|||
163058479|NCT00042289|588924260|FG025|Overall Study|Other reason|0|||
163058480|NCT00042289|588924261|FG026|Overall Study|Other reason|1|||
163058481|NCT00042289|588924262|FG027|Overall Study|Other reason|0|||
163058482|NCT00042289|588924263|FG028|Overall Study|Other reason|3|||
163058483|NCT00042289|588924264|FG029|Overall Study|Other reason|0|||
163058484|NCT00042289|588924265|FG030|Overall Study|Other reason|0|||
163058485|NCT00042289|588924266|FG031|Overall Study|Other reason|1|||
163058486|NCT00042289|588924267|FG032|Overall Study|Other reason|0|||
163058487|NCT00042289|588924268|FG033|Overall Study|Other reason|1|||
163058488|NCT00042289|588924269|FG034|Overall Study|Other reason|0|||
163058489|NCT00042289|588924270|FG035|Overall Study|Other reason|2|||
163058490|NCT00042289|588924271|FG036|Overall Study|Other reason|0|||
163058491|NCT00042289|588924272|FG037|Overall Study|Other reason|0|||
163058492|NCT00042289|588924273|FG038|Overall Study|Other reason|0|||
163058493|NCT00042289|588924274|FG039|Overall Study|Other reason|0|||
163058494|NCT00042289|588924275|FG040|Overall Study|Other reason|0|||
163058495|NCT00042289|588924276|FG041|Overall Study|Other reason|0|||
163058496|NCT00042289|588924277|FG042|Overall Study|Other reason|0|||
163058497|NCT00042289|588924278|FG043|Overall Study|Other reason|1|||
163058498|NCT00042289|588924279|FG044|Overall Study|Other reason|0|||
163058499|NCT00042289|588924280|FG045|Overall Study|Other reason|0|||
163058500|NCT00042289|588924281|FG046|Overall Study|Other reason|0|||
163058501|NCT00042289|588924235|FG000|Overall Study|Severe debilitation, unable to continue|0|||
163058502|NCT00042289|588924236|FG001|Overall Study|Severe debilitation, unable to continue|0|||
163058503|NCT00042289|588924237|FG002|Overall Study|Severe debilitation, unable to continue|0|||
163058504|NCT00042289|588924238|FG003|Overall Study|Severe debilitation, unable to continue|0|||
163058505|NCT00042289|588924239|FG004|Overall Study|Severe debilitation, unable to continue|0|||
163058506|NCT00042289|588924240|FG005|Overall Study|Severe debilitation, unable to continue|0|||
163058507|NCT00042289|588924241|FG006|Overall Study|Severe debilitation, unable to continue|0|||
163058508|NCT00042289|588924242|FG007|Overall Study|Severe debilitation, unable to continue|0|||
163058509|NCT00042289|588924243|FG008|Overall Study|Severe debilitation, unable to continue|0|||
163058510|NCT00042289|588924244|FG009|Overall Study|Severe debilitation, unable to continue|0|||
163401936|NCT01066585|590182940|FG001|Overall Study|Protocol Violation|0|||
163401937|NCT01066585|590182939|FG000|Overall Study|Withdrawal by Subject|0|||
163401938|NCT01066585|590182940|FG001|Overall Study|Withdrawal by Subject|3|||
163401939|NCT00578136|590182947|FG000|Overall Study|Not given intervention|1|||
162924169|NCT00445458|588423820|FG002|Overall Study|Surgery|1|||
163058511|NCT00042289|588924245|FG010|Overall Study|Severe debilitation, unable to continue|0|||
163058512|NCT00042289|588924246|FG011|Overall Study|Severe debilitation, unable to continue|0|||
163058513|NCT00042289|588924247|FG012|Overall Study|Severe debilitation, unable to continue|0|||
163058514|NCT00042289|588924248|FG013|Overall Study|Severe debilitation, unable to continue|0|||
163058515|NCT00042289|588924249|FG014|Overall Study|Severe debilitation, unable to continue|0|||
163058516|NCT00042289|588924250|FG015|Overall Study|Severe debilitation, unable to continue|0|||
163210476|NCT03263442|589485252|FG001|6-month Follow-Up|Lost to Follow-up|2|||
163058517|NCT00042289|588924251|FG016|Overall Study|Severe debilitation, unable to continue|0|||
163058518|NCT00042289|588924252|FG017|Overall Study|Severe debilitation, unable to continue|0|||
163401940|NCT00578136|590182948|FG001|Overall Study|Not given intervention|1|||
163401941|NCT01840579|590182953|FG000|Overall Study|Status not recorded|0|||
163401942|NCT01840579|590182954|FG001|Overall Study|Status not recorded|0|||
163401943|NCT01840579|590182955|FG002|Overall Study|Status not recorded|2|||
163401944|NCT01840579|590182956|FG003|Overall Study|Status not recorded|3|||
163401945|NCT01840579|590182957|FG004|Overall Study|Status not recorded|4|||
163401946|NCT01840579|590182958|FG005|Overall Study|Status not recorded|3|||
163401947|NCT01840579|590182959|FG006|Overall Study|Status not recorded|0|||
163401948|NCT01840579|590182960|FG007|Overall Study|Status not recorded|3|||
163401949|NCT01840579|590182961|FG008|Overall Study|Status not recorded|3|||
163401950|NCT01840579|590182962|FG009|Overall Study|Status not recorded|3|||
162924170|NCT00445458|588423821|FG003|Overall Study|Surgery|0|||
162924171|NCT01393626|588423825|FG000|Overall Study|Adverse Event|2|||
162924172|NCT01393626|588423826|FG001|Overall Study|Adverse Event|1|||
162924173|NCT01393626|588423827|FG002|Overall Study|Adverse Event|5|||
163058519|NCT00042289|588924253|FG018|Overall Study|Severe debilitation, unable to continue|0|||
163058520|NCT00042289|588924254|FG019|Overall Study|Severe debilitation, unable to continue|0|||
163058521|NCT00042289|588924255|FG020|Overall Study|Severe debilitation, unable to continue|0|||
163058522|NCT00042289|588924256|FG021|Overall Study|Severe debilitation, unable to continue|1|||
163058523|NCT00042289|588924257|FG022|Overall Study|Severe debilitation, unable to continue|0|||
163058524|NCT00042289|588924258|FG023|Overall Study|Severe debilitation, unable to continue|1|||
163058525|NCT00042289|588924259|FG024|Overall Study|Severe debilitation, unable to continue|0|||
163058526|NCT00042289|588924260|FG025|Overall Study|Severe debilitation, unable to continue|0|||
163058527|NCT00042289|588924261|FG026|Overall Study|Severe debilitation, unable to continue|0|||
162924174|NCT01393626|588423828|FG003|Overall Study|Adverse Event|0|||
162924175|NCT01393626|588423825|FG000|Overall Study|Did not meet entrance criteria|1|||
162978950|NCT00834899|588623515|FG001|Overall Study|Withdrawal by Subject|1|||
162978951|NCT00606502|588623516|FG000|Randomization|Randomized but not treated|3|||
162978952|NCT00606502|588623517|FG001|Randomization|Randomized but not treated|0|||
162978953|NCT00606502|588623516|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
162978954|NCT00606502|588623517|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
162978955|NCT02080832|588623527|FG000|Overall Study|Excluded from analysis by MRI|9|||
162978956|NCT02080832|588623528|FG001|Overall Study|Excluded from analysis by MRI|10|||
162978957|NCT02080832|588623529|FG002|Overall Study|Excluded from analysis by MRI|14|||
162978958|NCT02080832|588623527|FG000|Overall Study|Lost to Follow-up|0|||
162978959|NCT02080832|588623528|FG001|Overall Study|Lost to Follow-up|2|||
162978960|NCT02080832|588623529|FG002|Overall Study|Lost to Follow-up|2|||
162978961|NCT00560937|588623530|FG000|Overall Study|Withdrawal by Subject|0|||
162978962|NCT00560937|588623531|FG001|Overall Study|Withdrawal by Subject|1|||
162978963|NCT00560937|588623530|FG000|Overall Study|Physician Decision|1|||
162978964|NCT00560937|588623531|FG001|Overall Study|Physician Decision|1|||
162978965|NCT00440115|588623532|FG000|Overall Study|Death|7|||
162978966|NCT00440115|588623533|FG001|Overall Study|Death|9|||
162978967|NCT00440115|588623534|FG002|Overall Study|Death|5|||
162978968|NCT00440115|588623532|FG000|Overall Study|Incarceration|0|||
162978969|NCT00440115|588623533|FG001|Overall Study|Incarceration|2|||
162978970|NCT00440115|588623534|FG002|Overall Study|Incarceration|1|||
162978971|NCT03069417|588623535|FG000|Overall Study|Lost to Follow-up|2|||
162978972|NCT03069417|588623536|FG001|Overall Study|Lost to Follow-up|0|||
162978973|NCT03069417|588623535|FG000|Overall Study|Reason Unknown|4|||
162978974|NCT03069417|588623536|FG001|Overall Study|Reason Unknown|7|||
163058528|NCT00042289|588924262|FG027|Overall Study|Severe debilitation, unable to continue|1|||
163401951|NCT01840579|590182953|FG000|Overall Study|Progressive disease|3|||
163401952|NCT01840579|590182954|FG001|Overall Study|Progressive disease|5|||
162924176|NCT01393626|588423826|FG001|Overall Study|Did not meet entrance criteria|0|||
162924177|NCT01393626|588423827|FG002|Overall Study|Did not meet entrance criteria|0|||
162924178|NCT01393626|588423828|FG003|Overall Study|Did not meet entrance criteria|0|||
162924179|NCT01393626|588423825|FG000|Overall Study|Lack of Efficacy|6|||
162924180|NCT01393626|588423826|FG001|Overall Study|Lack of Efficacy|6|||
162924181|NCT01393626|588423827|FG002|Overall Study|Lack of Efficacy|4|||
162924182|NCT01393626|588423828|FG003|Overall Study|Lack of Efficacy|1|||
162924183|NCT01393626|588423825|FG000|Overall Study|Lost to Follow-up|1|||
162924184|NCT01393626|588423826|FG001|Overall Study|Lost to Follow-up|1|||
162924185|NCT01393626|588423827|FG002|Overall Study|Lost to Follow-up|1|||
162924186|NCT01393626|588423828|FG003|Overall Study|Lost to Follow-up|0|||
162924187|NCT01393626|588423825|FG000|Overall Study|Withdrawal by Subject|6|||
162924188|NCT01393626|588423826|FG001|Overall Study|Withdrawal by Subject|4|||
162924189|NCT01393626|588423827|FG002|Overall Study|Withdrawal by Subject|0|||
162924190|NCT01393626|588423828|FG003|Overall Study|Withdrawal by Subject|0|||
162924191|NCT01393626|588423825|FG000|Overall Study|Other|1|||
162924192|NCT01393626|588423826|FG001|Overall Study|Other|0|||
162924193|NCT01393626|588423827|FG002|Overall Study|Other|0|||
162924194|NCT01393626|588423828|FG003|Overall Study|Other|0|||
162924195|NCT01393626|588423825|FG000|Overall Study|Protocol Violation|1|||
162924196|NCT01393626|588423826|FG001|Overall Study|Protocol Violation|0|||
162924197|NCT01393626|588423827|FG002|Overall Study|Protocol Violation|2|||
162924198|NCT01393626|588423828|FG003|Overall Study|Protocol Violation|0|||
162924199|NCT02426125|588423829|FG000|Overall Study|Lost to Follow-up|14|||
162924200|NCT02426125|588423830|FG001|Overall Study|Lost to Follow-up|12|||
162924201|NCT02426125|588423829|FG000|Overall Study|Withdrawal by Subject|13|||
162924202|NCT02426125|588423830|FG001|Overall Study|Withdrawal by Subject|14|||
162978975|NCT01660022|588623538|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
163401953|NCT01840579|590182955|FG002|Overall Study|Progressive disease|0|||
163402001|NCT00645593|590182967|FG000|Overall Study|Later found to be ineligible|1|||
163402002|NCT00645593|590182968|FG001|Overall Study|Later found to be ineligible|0|||
163402003|NCT01585272|590182969|FG000|Overall Study|Adverse Event|22|||
163402004|NCT01585272|590182969|FG000|Overall Study|Protocol Violation|7|||
163402005|NCT01585272|590182969|FG000|Overall Study|Withdrawal by Subject|10|||
163402006|NCT04013529|590182972|FG000|Overall Study|Withdrawal by Subject|1|||
163402007|NCT04013529|590182973|FG001|Overall Study|Withdrawal by Subject|1|||
163402008|NCT05419128|590182974|FG000|Overall Study|Withdrawal by Subject|1|||
163402009|NCT05419128|590182975|FG001|Overall Study|Withdrawal by Subject|1|||
163402010|NCT05419128|590182976|FG002|Overall Study|Withdrawal by Subject|0|||
163402011|NCT05419128|590182977|FG003|Overall Study|Withdrawal by Subject|1|||
163402012|NCT05419128|590182978|FG004|Overall Study|Withdrawal by Subject|1|||
163402013|NCT05419128|590182979|FG005|Overall Study|Withdrawal by Subject|0|||
163402014|NCT05419128|590182974|FG000|Overall Study|Lost to Follow-up|0|||
163402015|NCT05419128|590182975|FG001|Overall Study|Lost to Follow-up|0|||
163402016|NCT05419128|590182976|FG002|Overall Study|Lost to Follow-up|1|||
163402017|NCT05419128|590182977|FG003|Overall Study|Lost to Follow-up|0|||
163402018|NCT05419128|590182978|FG004|Overall Study|Lost to Follow-up|0|||
163402019|NCT05419128|590182979|FG005|Overall Study|Lost to Follow-up|1|||
163402020|NCT02581202|590182985|FG000|Overall Study|Lack of Efficacy|2|||
163402021|NCT02581202|590182985|FG000|Overall Study|Withdrawal by Subject|4|||
163402022|NCT02581202|590182985|FG000|Overall Study|Lost to Follow-up|5|||
163402023|NCT02581202|590182985|FG000|Overall Study|Pregnancy|3|||
163402024|NCT05885737|590182986|FG000|DB Period|Adverse Event|4|||
163402025|NCT05885737|590182987|FG001|DB Period|Adverse Event|4|||
163402026|NCT05885737|590182986|FG000|DB Period|Lost to Follow-up|0|||
163402027|NCT05885737|590182987|FG001|DB Period|Lost to Follow-up|1|||
163402028|NCT05885737|590182986|FG000|DB Period|Physician Decision|2|||
163402029|NCT05885737|590182987|FG001|DB Period|Physician Decision|0|||
163402030|NCT05885737|590182986|FG000|DB Period|Withdrawal by Subject|12|||
163402031|NCT05885737|590182987|FG001|DB Period|Withdrawal by Subject|6|||
163402032|NCT05885737|590182986|FG000|DB Period|Other: Unspecified|2|||
163402033|NCT05885737|590182987|FG001|DB Period|Other: Unspecified|2|||
163402034|NCT05885737|590182986|FG000|OLE Period|Adverse Event|3|||
163402035|NCT05885737|590182987|FG001|OLE Period|Adverse Event|2|||
163402036|NCT05885737|590182986|FG000|OLE Period|Physician Decision|1|||
163402037|NCT05885737|590182987|FG001|OLE Period|Physician Decision|0|||
163402038|NCT05885737|590182986|FG000|OLE Period|Withdrawal by Subject|5|||
163402039|NCT05885737|590182987|FG001|OLE Period|Withdrawal by Subject|5|||
163402040|NCT05885737|590182986|FG000|OLE Period|Other: Unspecified|2|||
163402041|NCT05885737|590182987|FG001|OLE Period|Other: Unspecified|1|||
163402042|NCT00609791|590184621|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
163402043|NCT04218201|590184622|FG000|Overall Study|Death|0|||
163402044|NCT04218201|590184623|FG001|Overall Study|Death|0|||
163402045|NCT04218201|590184624|FG002|Overall Study|Death|2|||
163402046|NCT04218201|590184625|FG003|Overall Study|Death|0|||
163402047|NCT04218201|590184622|FG000|Overall Study|Unable to contact participant|4|||
163402048|NCT04218201|590184623|FG001|Overall Study|Unable to contact participant|0|||
163402049|NCT04218201|590184624|FG002|Overall Study|Unable to contact participant|3|||
163402050|NCT04218201|590184625|FG003|Overall Study|Unable to contact participant|0|||
163402051|NCT04218201|590184622|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
163402052|NCT04218201|590184623|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
163402053|NCT04218201|590184624|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
163402054|NCT04218201|590184625|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
163402055|NCT04218201|590184622|FG000|Overall Study|Withdrawal by Subject|2|||
163402056|NCT04218201|590184623|FG001|Overall Study|Withdrawal by Subject|0|||
163402057|NCT04218201|590184624|FG002|Overall Study|Withdrawal by Subject|0|||
163402058|NCT04218201|590184625|FG003|Overall Study|Withdrawal by Subject|0|||
163402059|NCT04218201|590184622|FG000|Overall Study|PCP plans to leave practice|0|||
163402060|NCT04218201|590184623|FG001|Overall Study|PCP plans to leave practice|8|||
163402061|NCT04218201|590184624|FG002|Overall Study|PCP plans to leave practice|0|||
163402062|NCT04218201|590184625|FG003|Overall Study|PCP plans to leave practice|5|||
163402063|NCT04218201|590184622|FG000|Overall Study|Reduced panel|0|||
163402064|NCT04218201|590184623|FG001|Overall Study|Reduced panel|0|||
163402065|NCT04218201|590184624|FG002|Overall Study|Reduced panel|0|||
163402066|NCT04218201|590184625|FG003|Overall Study|Reduced panel|1|||
163402067|NCT04218201|590184622|FG000|Overall Study|No longer interested in participating|0|||
163402068|NCT04218201|590184623|FG001|Overall Study|No longer interested in participating|1|||
163402069|NCT04218201|590184624|FG002|Overall Study|No longer interested in participating|0|||
163402070|NCT04218201|590184625|FG003|Overall Study|No longer interested in participating|0|||
163402071|NCT04129528|590184626|FG000|Overall Study|Adverse Event|1|||
163402072|NCT04129528|590184627|FG001|Overall Study|Adverse Event|0|||
163402073|NCT04129528|590184626|FG000|Overall Study|Physician Decision|1|||
163402074|NCT04129528|590184627|FG001|Overall Study|Physician Decision|1|||
163402075|NCT04129528|590184626|FG000|Overall Study|Withdrawal by Subject|1|||
163402076|NCT04129528|590184627|FG001|Overall Study|Withdrawal by Subject|1|||
163402077|NCT00490568|590184630|FG000|Overall Study|Adverse Event|116|||
163402078|NCT00490568|590184630|FG000|Overall Study|Lost to Follow-up|13|||
163402079|NCT00490568|590184630|FG000|Overall Study|Protocol Violation|45|||
163402080|NCT00490568|590184630|FG000|Overall Study|Withdrawal by Subject|135|||
163402081|NCT00490568|590184630|FG000|Overall Study|Still in the study at termination|974|||
163402082|NCT00490568|590184630|FG000|Overall Study|Other|1|||
163402083|NCT00490568|590184630|FG000|Overall Study|Exclusion criteria met|1|||
163402084|NCT00490568|590184630|FG000|Overall Study|Caregiver related|20|||
163402085|NCT00490568|590184630|FG000|Overall Study|Abnormal ECG|25|||
163402086|NCT00490568|590184630|FG000|Overall Study|Participant refused follow-up|9|||
163402087|NCT00490568|590184630|FG000|Overall Study|Legal representative withdrew consent|1|||
163402088|NCT00490568|590184630|FG000|Overall Study|Disease progression|4|||
163402089|NCT00490568|590184630|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
163402090|NCT00490568|590184630|FG000|Overall Study|Investigator decision|3|||
163402091|NCT00490568|590184630|FG000|Overall Study|Non-Compliance|7|||
163402092|NCT00490568|590184630|FG000|Overall Study|Efficacy related|3|||
163402093|NCT00490568|590184630|FG000|Overall Study|Participant died|1|||
163402094|NCT00490568|590184630|FG000|Overall Study|Participant withdrawal due to surgery|1|||
163402095|NCT01230307|590184635|FG000|Overall Study|LVAD Placement|0|||
163402096|NCT01230307|590184636|FG001|Overall Study|LVAD Placement|2|||
163402097|NCT04773106|590184637|FG000|Overall Study|Withdrawal by Subject|3|||
163402098|NCT04773106|590184637|FG000|Overall Study|Death|1|||
163402099|NCT02819635|590184645|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
163402100|NCT02819635|590184646|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
163402101|NCT02819635|590184647|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
163402102|NCT02819635|590184648|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
163402103|NCT02819635|590184649|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
163402104|NCT02819635|590184650|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
163402105|NCT02819635|590184651|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
163402106|NCT02819635|590184652|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
163402107|NCT02819635|590184653|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
163402108|NCT02819635|590184654|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
163402109|NCT02819635|590184655|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
163402110|NCT02819635|590184656|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
163402111|NCT02819635|590184645|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163402112|NCT02819635|590184646|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163402113|NCT02819635|590184647|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163402114|NCT02819635|590184648|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163402115|NCT02819635|590184649|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
163402116|NCT02819635|590184650|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
163402117|NCT02819635|590184651|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
163402118|NCT02819635|590184652|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163402119|NCT02819635|590184653|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163402120|NCT02819635|590184654|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163402121|NCT02819635|590184655|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163402122|NCT02819635|590184656|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163402123|NCT02819635|590184645|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163402124|NCT02819635|590184646|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163058603|NCT00042289|588924243|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
163210553|NCT03045887|589485286|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
163210554|NCT03045887|589485287|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
163210555|NCT03045887|589485288|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
163210556|NCT03045887|589485289|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
163210557|NCT03045887|589485290|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
163210558|NCT03045887|589485291|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
163210559|NCT03414424|589485292|FG000|Overall Study|Screened out after consent|0|||
163210560|NCT03414424|589485293|FG001|Overall Study|Screened out after consent|2|||
163210561|NCT03414424|589485292|FG000|Overall Study|Lost to Follow-up|0|||
163210562|NCT03414424|589485293|FG001|Overall Study|Lost to Follow-up|1|||
163210563|NCT01846507|589485294|FG000|Overall Study|Lost to Follow-up|4|||
163402125|NCT02819635|590184647|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163402126|NCT02819635|590184648|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163402127|NCT02819635|590184649|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163402128|NCT02819635|590184650|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
163402129|NCT02819635|590184651|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
163402130|NCT02819635|590184652|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163402131|NCT02819635|590184653|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163402132|NCT02819635|590184654|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163402133|NCT02819635|590184655|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163402134|NCT02819635|590184656|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163402135|NCT02819635|590184645|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163402136|NCT02819635|590184646|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163402137|NCT02819635|590184647|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163402138|NCT02819635|590184648|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163402139|NCT02819635|590184649|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163402140|NCT02819635|590184650|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163402141|NCT02819635|590184651|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
163402142|NCT02819635|590184652|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163402143|NCT02819635|590184653|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163402144|NCT02819635|590184654|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163402145|NCT02819635|590184655|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163402146|NCT02819635|590184656|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163402147|NCT02819635|590184645|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
163402148|NCT02819635|590184646|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
163402149|NCT02819635|590184647|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
163402150|NCT02819635|590184648|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
163402151|NCT02819635|590184649|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
163402152|NCT02819635|590184650|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
163402153|NCT02819635|590184651|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
163402154|NCT02819635|590184652|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
163402155|NCT02819635|590184653|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
163402156|NCT02819635|590184654|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
163402157|NCT02819635|590184655|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
163402158|NCT02819635|590184656|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
163402159|NCT02819635|590184645|FG000|Substudy 2, Part 2|Adverse Event|0|||
163402160|NCT02819635|590184646|FG001|Substudy 2, Part 2|Adverse Event|0|||
163402161|NCT02819635|590184647|FG002|Substudy 2, Part 2|Adverse Event|0|||
163402162|NCT02819635|590184648|FG003|Substudy 2, Part 2|Adverse Event|0|||
163402163|NCT02819635|590184649|FG004|Substudy 2, Part 2|Adverse Event|0|||
163402164|NCT02819635|590184650|FG005|Substudy 2, Part 2|Adverse Event|4|||
163402165|NCT02819635|590184651|FG006|Substudy 2, Part 2|Adverse Event|0|||
163402166|NCT02819635|590184652|FG007|Substudy 2, Part 2|Adverse Event|0|||
163402167|NCT02819635|590184653|FG008|Substudy 2, Part 2|Adverse Event|0|||
163402168|NCT02819635|590184654|FG009|Substudy 2, Part 2|Adverse Event|0|||
163402169|NCT02819635|590184655|FG010|Substudy 2, Part 2|Adverse Event|0|||
163402170|NCT02819635|590184656|FG011|Substudy 2, Part 2|Adverse Event|0|||
163402171|NCT02819635|590184645|FG000|Substudy 2, Part 2|Withdrew consent|0|||
163402172|NCT02819635|590184646|FG001|Substudy 2, Part 2|Withdrew consent|0|||
163402173|NCT02819635|590184647|FG002|Substudy 2, Part 2|Withdrew consent|0|||
163402174|NCT02819635|590184648|FG003|Substudy 2, Part 2|Withdrew consent|0|||
163402175|NCT02819635|590184649|FG004|Substudy 2, Part 2|Withdrew consent|0|||
163402176|NCT02819635|590184650|FG005|Substudy 2, Part 2|Withdrew consent|3|||
163402177|NCT02819635|590184651|FG006|Substudy 2, Part 2|Withdrew consent|1|||
163402178|NCT02819635|590184652|FG007|Substudy 2, Part 2|Withdrew consent|0|||
163402179|NCT02819635|590184653|FG008|Substudy 2, Part 2|Withdrew consent|0|||
163402180|NCT02819635|590184654|FG009|Substudy 2, Part 2|Withdrew consent|0|||
163402181|NCT02819635|590184655|FG010|Substudy 2, Part 2|Withdrew consent|0|||
163402182|NCT02819635|590184656|FG011|Substudy 2, Part 2|Withdrew consent|0|||
163402183|NCT02819635|590184645|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
163402184|NCT02819635|590184646|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
163402185|NCT02819635|590184647|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
163402186|NCT02819635|590184648|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
163402187|NCT02819635|590184649|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
163402188|NCT02819635|590184650|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
163402189|NCT02819635|590184651|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
163402190|NCT02819635|590184652|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
163402191|NCT02819635|590184653|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
163402192|NCT02819635|590184654|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
163402193|NCT02819635|590184655|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
163402194|NCT02819635|590184656|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
163402195|NCT02819635|590184645|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163402196|NCT02819635|590184646|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163402197|NCT02819635|590184647|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163402198|NCT02819635|590184648|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163402199|NCT02819635|590184649|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163402200|NCT02819635|590184650|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163402201|NCT02819635|590184651|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
163402202|NCT02819635|590184652|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163402203|NCT02819635|590184653|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163402204|NCT02819635|590184654|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163402205|NCT02819635|590184655|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163402206|NCT02819635|590184656|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163402207|NCT02819635|590184645|FG000|Substudy 2, Part 2|Other, not specified|0|||
163402208|NCT02819635|590184646|FG001|Substudy 2, Part 2|Other, not specified|0|||
163402209|NCT02819635|590184647|FG002|Substudy 2, Part 2|Other, not specified|0|||
163402210|NCT02819635|590184648|FG003|Substudy 2, Part 2|Other, not specified|0|||
163402211|NCT02819635|590184649|FG004|Substudy 2, Part 2|Other, not specified|0|||
163402212|NCT02819635|590184650|FG005|Substudy 2, Part 2|Other, not specified|4|||
163402213|NCT02819635|590184651|FG006|Substudy 2, Part 2|Other, not specified|8|||
163402214|NCT02819635|590184652|FG007|Substudy 2, Part 2|Other, not specified|0|||
163402215|NCT02819635|590184653|FG008|Substudy 2, Part 2|Other, not specified|0|||
163402216|NCT02819635|590184654|FG009|Substudy 2, Part 2|Other, not specified|0|||
163402217|NCT02819635|590184655|FG010|Substudy 2, Part 2|Other, not specified|0|||
163402218|NCT02819635|590184656|FG011|Substudy 2, Part 2|Other, not specified|0|||
163402219|NCT02819635|590184645|FG000|Substudy 3|Adverse Event|0|||
163402220|NCT02819635|590184646|FG001|Substudy 3|Adverse Event|0|||
163402221|NCT02819635|590184647|FG002|Substudy 3|Adverse Event|0|||
163402222|NCT02819635|590184648|FG003|Substudy 3|Adverse Event|0|||
163402223|NCT02819635|590184649|FG004|Substudy 3|Adverse Event|0|||
163402224|NCT02819635|590184650|FG005|Substudy 3|Adverse Event|0|||
163402225|NCT02819635|590184651|FG006|Substudy 3|Adverse Event|0|||
163402226|NCT02819635|590184652|FG007|Substudy 3|Adverse Event|0|||
163402227|NCT02819635|590184653|FG008|Substudy 3|Adverse Event|32|||
163402228|NCT02819635|590184654|FG009|Substudy 3|Adverse Event|3|||
163402229|NCT02819635|590184655|FG010|Substudy 3|Adverse Event|12|||
163402230|NCT02819635|590184656|FG011|Substudy 3|Adverse Event|18|||
163402231|NCT02819635|590184645|FG000|Substudy 3|Withdrew consent|0|||
163402232|NCT02819635|590184646|FG001|Substudy 3|Withdrew consent|0|||
163402233|NCT02819635|590184647|FG002|Substudy 3|Withdrew consent|0|||
163402234|NCT02819635|590184648|FG003|Substudy 3|Withdrew consent|0|||
163402235|NCT02819635|590184649|FG004|Substudy 3|Withdrew consent|0|||
163402236|NCT02819635|590184650|FG005|Substudy 3|Withdrew consent|0|||
163402237|NCT02819635|590184651|FG006|Substudy 3|Withdrew consent|0|||
163402238|NCT02819635|590184652|FG007|Substudy 3|Withdrew consent|0|||
163402239|NCT02819635|590184653|FG008|Substudy 3|Withdrew consent|11|||
163402240|NCT02819635|590184654|FG009|Substudy 3|Withdrew consent|1|||
163402241|NCT02819635|590184655|FG010|Substudy 3|Withdrew consent|4|||
163402242|NCT02819635|590184656|FG011|Substudy 3|Withdrew consent|9|||
163402243|NCT02819635|590184645|FG000|Substudy 3|Lost to Follow-up|0|||
163402244|NCT02819635|590184646|FG001|Substudy 3|Lost to Follow-up|0|||
163402245|NCT02819635|590184647|FG002|Substudy 3|Lost to Follow-up|0|||
163402246|NCT02819635|590184648|FG003|Substudy 3|Lost to Follow-up|0|||
163402247|NCT02819635|590184649|FG004|Substudy 3|Lost to Follow-up|0|||
163402248|NCT02819635|590184650|FG005|Substudy 3|Lost to Follow-up|0|||
163402249|NCT02819635|590184651|FG006|Substudy 3|Lost to Follow-up|0|||
163402250|NCT02819635|590184652|FG007|Substudy 3|Lost to Follow-up|0|||
163402251|NCT02819635|590184653|FG008|Substudy 3|Lost to Follow-up|1|||
163402252|NCT02819635|590184654|FG009|Substudy 3|Lost to Follow-up|0|||
163402253|NCT02819635|590184655|FG010|Substudy 3|Lost to Follow-up|1|||
163402254|NCT02819635|590184656|FG011|Substudy 3|Lost to Follow-up|1|||
163402255|NCT02819635|590184645|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
163402256|NCT02819635|590184646|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
163402257|NCT02819635|590184647|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
163402258|NCT02819635|590184648|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
163402259|NCT02819635|590184649|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
163402260|NCT02819635|590184650|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
163402261|NCT02819635|590184651|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
163402262|NCT02819635|590184652|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
163402263|NCT02819635|590184653|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
163402264|NCT02819635|590184654|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
163402265|NCT02819635|590184655|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
162979008|NCT01277718|588623551|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
162979009|NCT01277718|588623552|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
162979010|NCT01277718|588623551|FG000|Period 2 - Second Intervention|Physician Decision|0|||
163210564|NCT01846507|589485294|FG000|Overall Study|Protocol Violation|1|||
163402266|NCT02819635|590184656|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
163402267|NCT02819635|590184645|FG000|Substudy 3|Other, not specified|0|||
163402268|NCT02819635|590184646|FG001|Substudy 3|Other, not specified|0|||
163402269|NCT02819635|590184647|FG002|Substudy 3|Other, not specified|0|||
163402270|NCT02819635|590184648|FG003|Substudy 3|Other, not specified|0|||
163402271|NCT02819635|590184649|FG004|Substudy 3|Other, not specified|0|||
163402272|NCT02819635|590184650|FG005|Substudy 3|Other, not specified|0|||
163402273|NCT02819635|590184651|FG006|Substudy 3|Other, not specified|0|||
163402274|NCT02819635|590184652|FG007|Substudy 3|Other, not specified|0|||
163402275|NCT02819635|590184653|FG008|Substudy 3|Other, not specified|202|||
163402276|NCT02819635|590184654|FG009|Substudy 3|Other, not specified|5|||
163402277|NCT02819635|590184655|FG010|Substudy 3|Other, not specified|89|||
162979011|NCT01277718|588623552|FG001|Period 2 - Second Intervention|Physician Decision|2|||
162979012|NCT03919162|588623555|FG000|Overall Study|Adverse Event|3|||
162979013|NCT03919162|588623556|FG001|Overall Study|Adverse Event|2|||
162979014|NCT03919162|588623555|FG000|Overall Study|Death|2|||
162979015|NCT03919162|588623556|FG001|Overall Study|Death|0|||
162979016|NCT03919162|588623555|FG000|Overall Study|Lost to Follow-up|1|||
162979017|NCT03919162|588623556|FG001|Overall Study|Lost to Follow-up|0|||
162979018|NCT03919162|588623555|FG000|Overall Study|Withdrawal by Subject|12|||
162979019|NCT03919162|588623556|FG001|Overall Study|Withdrawal by Subject|12|||
162979020|NCT03919162|588623555|FG000|Overall Study|Study terminated by Sponsor|20|||
162979021|NCT03919162|588623556|FG001|Overall Study|Study terminated by Sponsor|24|||
162979022|NCT03919162|588623555|FG000|Overall Study|Screen failure|1|||
162979023|NCT03919162|588623556|FG001|Overall Study|Screen failure|0|||
163058604|NCT00042289|588924244|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
163058605|NCT00042289|588924245|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
163058606|NCT00042289|588924246|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
163058607|NCT00042289|588924247|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
163058608|NCT00042289|588924248|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
163058609|NCT00042289|588924249|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
163058610|NCT00042289|588924250|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
163058611|NCT00042289|588924251|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
163058612|NCT00042289|588924252|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
163058613|NCT00042289|588924253|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
163058614|NCT00042289|588924254|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
163058615|NCT00042289|588924255|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
163058616|NCT00042289|588924256|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
163058617|NCT00042289|588924257|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
163058618|NCT00042289|588924258|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
163058619|NCT00042289|588924259|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
163058620|NCT00042289|588924260|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
163058621|NCT00042289|588924261|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
163058622|NCT00042289|588924262|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
163058623|NCT00042289|588924263|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
163058624|NCT00042289|588924264|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
163058625|NCT00042289|588924265|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
163058626|NCT00042289|588924266|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
163058627|NCT00042289|588924267|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
163058628|NCT00042289|588924268|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
163318910|NCT05485779|589878809|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
163318911|NCT05485779|589878810|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
163318912|NCT05485779|589878811|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
163318913|NCT05485779|589878812|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
163318914|NCT05485779|589878813|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
163318915|NCT05485779|589878814|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
163318916|NCT05485779|589878815|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
163318917|NCT05485779|589878805|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
163318918|NCT05485779|589878806|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
163318919|NCT05485779|589878807|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
163318920|NCT05485779|589878808|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
163318921|NCT05485779|589878809|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
163318922|NCT05485779|589878810|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
163318923|NCT05485779|589878811|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
163318924|NCT05485779|589878812|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
163318925|NCT05485779|589878813|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
162979024|NCT03919162|588623555|FG000|Overall Study|Missing|1|||
162979025|NCT03919162|588623556|FG001|Overall Study|Missing|1|||
163058629|NCT00042289|588924269|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
163058630|NCT00042289|588924270|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
163058631|NCT00042289|588924271|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
163058632|NCT00042289|588924272|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
163058633|NCT00042289|588924273|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
163058634|NCT00042289|588924274|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
163058635|NCT00042289|588924275|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
163058636|NCT00042289|588924276|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
163058637|NCT00042289|588924277|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
163318926|NCT05485779|589878814|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
163402278|NCT02819635|590184656|FG011|Substudy 3|Other, not specified|39|||
162979026|NCT03078478|588623557|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
163402279|NCT01081912|590184657|FG000|Conversion/Titration|Adverse Event|47|||
163402280|NCT01081912|590184658|FG001|Conversion/Titration|Adverse Event|0|||
163402281|NCT01081912|590184659|FG002|Conversion/Titration|Adverse Event|0|||
163402282|NCT01081912|590184657|FG000|Conversion/Titration|Lack of Efficacy|17|||
163402283|NCT01081912|590184658|FG001|Conversion/Titration|Lack of Efficacy|0|||
163402284|NCT01081912|590184659|FG002|Conversion/Titration|Lack of Efficacy|0|||
163402285|NCT01081912|590184657|FG000|Conversion/Titration|Lost to Follow-up|5|||
163402286|NCT01081912|590184658|FG001|Conversion/Titration|Lost to Follow-up|0|||
163402287|NCT01081912|590184659|FG002|Conversion/Titration|Lost to Follow-up|0|||
163402288|NCT01081912|590184657|FG000|Conversion/Titration|Physician Decision|2|||
163402289|NCT01081912|590184658|FG001|Conversion/Titration|Physician Decision|0|||
163402290|NCT01081912|590184659|FG002|Conversion/Titration|Physician Decision|0|||
163402291|NCT01081912|590184657|FG000|Conversion/Titration|Protocol Violation|67|||
163402292|NCT01081912|590184658|FG001|Conversion/Titration|Protocol Violation|0|||
163402293|NCT01081912|590184659|FG002|Conversion/Titration|Protocol Violation|0|||
162979027|NCT03078478|588623558|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
162979028|NCT03078478|588623557|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
162979029|NCT03078478|588623558|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
162979030|NCT03078478|588623557|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
162979031|NCT03078478|588623558|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
162979032|NCT03078478|588623557|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
162979033|NCT03078478|588623558|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
162979034|NCT03078478|588623557|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
162979035|NCT03078478|588623558|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
162979036|NCT03078478|588623557|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
163402294|NCT01081912|590184657|FG000|Conversion/Titration|Withdrawal by Subject|23|||
162979037|NCT03078478|588623558|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
162979038|NCT03078478|588623557|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
162979039|NCT03078478|588623558|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
162979040|NCT03078478|588623557|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
162979041|NCT03078478|588623558|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
162979042|NCT01688726|588623559|FG000|Overall Study|Adverse Event|1|||
162979043|NCT01688726|588623560|FG001|Overall Study|Adverse Event|0|||
162979044|NCT01688726|588623559|FG000|Overall Study|Relocated abroad|0|||
162979045|NCT01688726|588623560|FG001|Overall Study|Relocated abroad|1|||
162979046|NCT03861481|588625048|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
162979047|NCT03861481|588625049|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
162979048|NCT03861481|588625048|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
162979049|NCT03861481|588625049|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
162979050|NCT03861481|588625048|FG000|Overall Study|Relapse|1|||
162979051|NCT03861481|588625049|FG001|Overall Study|Relapse|0|||
162979052|NCT03861481|588625048|FG000|Overall Study|Withdrawal by Subject|0|||
162979053|NCT03861481|588625049|FG001|Overall Study|Withdrawal by Subject|1|||
162979054|NCT03861481|588625048|FG000|Overall Study|Lack of Efficacy|4|||
162979055|NCT03861481|588625049|FG001|Overall Study|Lack of Efficacy|5|||
162979056|NCT00773734|588625050|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
162979057|NCT00773734|588625051|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
162979058|NCT00773734|588625052|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
162979059|NCT00773734|588625053|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
162979060|NCT00773734|588625054|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
162979061|NCT00773734|588625055|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
162979062|NCT00773734|588625050|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
162979063|NCT00773734|588625051|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
162979064|NCT00773734|588625052|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
162979065|NCT00773734|588625053|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
162979066|NCT00773734|588625054|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
162979067|NCT00773734|588625055|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
162979068|NCT00773734|588625050|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
162979069|NCT00773734|588625051|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
162979070|NCT00773734|588625052|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
162979071|NCT00773734|588625053|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
162979072|NCT00773734|588625054|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
162979073|NCT00773734|588625055|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
163402295|NCT01081912|590184658|FG001|Conversion/Titration|Withdrawal by Subject|0|||
162979074|NCT00773734|588625050|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
163058638|NCT00042289|588924278|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
163402296|NCT01081912|590184659|FG002|Conversion/Titration|Withdrawal by Subject|0|||
163402297|NCT01081912|590184657|FG000|Conversion/Titration|Non-Compliance|47|||
163402298|NCT01081912|590184658|FG001|Conversion/Titration|Non-Compliance|0|||
163402299|NCT01081912|590184659|FG002|Conversion/Titration|Non-Compliance|0|||
163402300|NCT01081912|590184657|FG000|Maintenance Treatment|Adverse Event|0|||
163402301|NCT01081912|590184658|FG001|Maintenance Treatment|Adverse Event|2|||
163402302|NCT01081912|590184659|FG002|Maintenance Treatment|Adverse Event|12|||
163402303|NCT01081912|590184657|FG000|Maintenance Treatment|Lack of Efficacy|0|||
163402304|NCT01081912|590184658|FG001|Maintenance Treatment|Lack of Efficacy|14|||
163402305|NCT01081912|590184659|FG002|Maintenance Treatment|Lack of Efficacy|64|||
163402306|NCT01081912|590184657|FG000|Maintenance Treatment|Lost to Follow-up|0|||
163402307|NCT01081912|590184658|FG001|Maintenance Treatment|Lost to Follow-up|1|||
163402308|NCT01081912|590184659|FG002|Maintenance Treatment|Lost to Follow-up|0|||
163402309|NCT01081912|590184657|FG000|Maintenance Treatment|Physician Decision|0|||
163402310|NCT01081912|590184658|FG001|Maintenance Treatment|Physician Decision|0|||
163402311|NCT01081912|590184659|FG002|Maintenance Treatment|Physician Decision|1|||
163402312|NCT01081912|590184657|FG000|Maintenance Treatment|Protocol Violation|0|||
163402313|NCT01081912|590184658|FG001|Maintenance Treatment|Protocol Violation|1|||
163402314|NCT01081912|590184659|FG002|Maintenance Treatment|Protocol Violation|2|||
163402315|NCT01081912|590184657|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
163402316|NCT01081912|590184658|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
163402317|NCT01081912|590184659|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
163402318|NCT01081912|590184657|FG000|Maintenance Treatment|Non-Compliance|0|||
163402319|NCT01081912|590184658|FG001|Maintenance Treatment|Non-Compliance|4|||
163402320|NCT01081912|590184659|FG002|Maintenance Treatment|Non-Compliance|7|||
163402321|NCT01081912|590184657|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
163402322|NCT01081912|590184658|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
163402323|NCT01081912|590184659|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
163402324|NCT01140451|590184660|FG000|Overall Study|Withdrawal by Subject|26|||
163402325|NCT01140451|590184661|FG001|Overall Study|Withdrawal by Subject|33|||
163402326|NCT01140451|590184660|FG000|Overall Study|Adverse Event|2|||
163402327|NCT01140451|590184661|FG001|Overall Study|Adverse Event|6|||
163402328|NCT01140451|590184660|FG000|Overall Study|Physician Decision|5|||
163402329|NCT01140451|590184661|FG001|Overall Study|Physician Decision|3|||
163402330|NCT01140451|590184660|FG000|Overall Study|Lost to Follow-up|2|||
163402331|NCT01140451|590184661|FG001|Overall Study|Lost to Follow-up|0|||
163402332|NCT01140451|590184660|FG000|Overall Study|Participants Planning Pregnancy|3|||
163402333|NCT01140451|590184661|FG001|Overall Study|Participants Planning Pregnancy|0|||
163402334|NCT01471015|590184662|FG000|Overall Study|Death|0|||
163402335|NCT01471015|590184663|FG001|Overall Study|Death|1|||
163402336|NCT01471015|590184664|FG002|Overall Study|Death|1|||
163402337|NCT04206020|590184665|FG000|Overall Study|Adverse Event|1|||
163402338|NCT04206020|590184666|FG001|Overall Study|Adverse Event|4|||
163402339|NCT04206020|590184665|FG000|Overall Study|Protocol Violation|2|||
163402340|NCT04206020|590184666|FG001|Overall Study|Protocol Violation|0|||
163402341|NCT04206020|590184665|FG000|Overall Study|Withdrawal by Subject|2|||
163402342|NCT04206020|590184666|FG001|Overall Study|Withdrawal by Subject|0|||
163402343|NCT04206020|590184665|FG000|Overall Study|Lost to Follow-up|2|||
163402344|NCT04206020|590184666|FG001|Overall Study|Lost to Follow-up|0|||
163402345|NCT04206020|590184665|FG000|Overall Study|Pregnancy|0|||
163402346|NCT04206020|590184666|FG001|Overall Study|Pregnancy|1|||
163402347|NCT04206020|590184665|FG000|Overall Study|Unable to attend visits|1|||
163402348|NCT04206020|590184666|FG001|Overall Study|Unable to attend visits|2|||
163402349|NCT04962022|590184669|FG000|Period 1|Withdrawal by Subject|1|||
163402350|NCT04962022|590184670|FG001|Period 1|Withdrawal by Subject|0|||
163402351|NCT02055820|590184675|FG000|Phase I: Dose-Finding|Death|1|||
163402352|NCT02055820|590184676|FG001|Phase I: Dose-Finding|Death|0|||
163210565|NCT01846507|589485294|FG000|Overall Study|Missing data|2|||
163210566|NCT01314443|589485295|FG000|Overall Study|Withdrawal by Subject|2|||
163210567|NCT01314443|589485296|FG001|Overall Study|Withdrawal by Subject|1|||
163210568|NCT01314443|589485297|FG002|Overall Study|Withdrawal by Subject|1|||
163210569|NCT01314443|589485298|FG003|Overall Study|Withdrawal by Subject|1|||
163210570|NCT01314443|589485295|FG000|Overall Study|Protocol Violation|2|||
163210571|NCT01314443|589485296|FG001|Overall Study|Protocol Violation|2|||
163210572|NCT01314443|589485297|FG002|Overall Study|Protocol Violation|1|||
163210573|NCT01314443|589485298|FG003|Overall Study|Protocol Violation|1|||
163210574|NCT01782859|589485299|FG000|Overall Study|Protocol Violation|6|||
163210575|NCT01782859|589485300|FG001|Overall Study|Protocol Violation|6|||
163210576|NCT01782859|589485299|FG000|Overall Study|Withdrawal by Subject|0|||
163210577|NCT01782859|589485300|FG001|Overall Study|Withdrawal by Subject|1|||
163402353|NCT02055820|590184677|FG002|Phase I: Dose-Finding|Death|1|||
163402354|NCT02055820|590184678|FG003|Phase I: Dose-Finding|Death|2|||
163402355|NCT02055820|590184679|FG004|Phase I: Dose-Finding|Death|0|||
163402356|NCT02055820|590184680|FG005|Phase I: Dose-Finding|Death|1|||
163402357|NCT02055820|590184681|FG006|Phase I: Dose-Finding|Death|1|||
163402358|NCT02055820|590184682|FG007|Phase I: Dose-Finding|Death|0|||
163402359|NCT02055820|590184683|FG008|Phase I: Dose-Finding|Death|0|||
163402360|NCT02055820|590184684|FG009|Phase I: Dose-Finding|Death|0|||
163402361|NCT02055820|590184675|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163402362|NCT02055820|590184676|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163210578|NCT00680745|589485304|FG000|Overall Study|Withdrawal by Subject|8|||
163402363|NCT02055820|590184677|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163402364|NCT02055820|590184678|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163402365|NCT02055820|590184679|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163402366|NCT02055820|590184680|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
163402367|NCT02055820|590184681|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163402368|NCT02055820|590184682|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163402369|NCT02055820|590184683|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163402370|NCT02055820|590184684|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163402371|NCT02055820|590184675|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
163402372|NCT02055820|590184676|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
163402373|NCT02055820|590184677|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
163402374|NCT02055820|590184678|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
163402375|NCT02055820|590184679|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
163402376|NCT02055820|590184680|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
163402377|NCT02055820|590184681|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
163402378|NCT02055820|590184682|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
163402379|NCT02055820|590184683|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
163402380|NCT02055820|590184684|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
163402381|NCT02055820|590184675|FG000|Phase II: Expansion|Death|0|||
163402382|NCT02055820|590184676|FG001|Phase II: Expansion|Death|0|||
163402383|NCT02055820|590184677|FG002|Phase II: Expansion|Death|0|||
163402384|NCT02055820|590184678|FG003|Phase II: Expansion|Death|0|||
163402385|NCT02055820|590184679|FG004|Phase II: Expansion|Death|33|||
163402386|NCT02055820|590184680|FG005|Phase II: Expansion|Death|0|||
163402387|NCT02055820|590184681|FG006|Phase II: Expansion|Death|0|||
163402388|NCT02055820|590184682|FG007|Phase II: Expansion|Death|0|||
163402389|NCT02055820|590184683|FG008|Phase II: Expansion|Death|0|||
163402390|NCT02055820|590184684|FG009|Phase II: Expansion|Death|0|||
163402391|NCT02055820|590184675|FG000|Phase II: Expansion|Lost to Follow-up|0|||
163402392|NCT02055820|590184676|FG001|Phase II: Expansion|Lost to Follow-up|0|||
163402393|NCT02055820|590184677|FG002|Phase II: Expansion|Lost to Follow-up|0|||
163402394|NCT02055820|590184678|FG003|Phase II: Expansion|Lost to Follow-up|0|||
163402395|NCT02055820|590184679|FG004|Phase II: Expansion|Lost to Follow-up|4|||
163402396|NCT02055820|590184680|FG005|Phase II: Expansion|Lost to Follow-up|0|||
163402397|NCT02055820|590184681|FG006|Phase II: Expansion|Lost to Follow-up|0|||
163402398|NCT02055820|590184682|FG007|Phase II: Expansion|Lost to Follow-up|0|||
163402399|NCT02055820|590184683|FG008|Phase II: Expansion|Lost to Follow-up|0|||
163402400|NCT02055820|590184684|FG009|Phase II: Expansion|Lost to Follow-up|0|||
163402401|NCT02055820|590184675|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
163402402|NCT02055820|590184676|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
163402403|NCT02055820|590184677|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
163402404|NCT02055820|590184678|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
163402405|NCT02055820|590184679|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
163402406|NCT02055820|590184680|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
163402407|NCT02055820|590184681|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
163402408|NCT02055820|590184682|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
163402409|NCT02055820|590184683|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
163402410|NCT02055820|590184684|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
163402411|NCT02285777|590184685|FG000|Overall Study|Withdrawal by Subject|1|||
163402412|NCT02285777|590184686|FG001|Overall Study|Withdrawal by Subject|1|||
163402413|NCT02285777|590184685|FG000|Overall Study|Lost to Follow-up|4|||
163402414|NCT02285777|590184686|FG001|Overall Study|Lost to Follow-up|2|||
163402415|NCT00552175|590184687|FG000|Overall Study|Lack of Efficacy|2|||
163402416|NCT00552175|590184688|FG001|Overall Study|Lack of Efficacy|0|||
163402417|NCT00552175|590184689|FG002|Overall Study|Lack of Efficacy|1|||
163402418|NCT00552175|590184687|FG000|Overall Study|Adverse Event|9|||
163402419|NCT00552175|590184688|FG001|Overall Study|Adverse Event|9|||
163402420|NCT00552175|590184689|FG002|Overall Study|Adverse Event|10|||
163402421|NCT00552175|590184687|FG000|Overall Study|Withdrawal by Subject|2|||
163402422|NCT00552175|590184688|FG001|Overall Study|Withdrawal by Subject|2|||
163402423|NCT00552175|590184689|FG002|Overall Study|Withdrawal by Subject|1|||
163402424|NCT00552175|590184687|FG000|Overall Study|Lost to Follow-up|0|||
163402425|NCT00552175|590184688|FG001|Overall Study|Lost to Follow-up|0|||
163402426|NCT00552175|590184689|FG002|Overall Study|Lost to Follow-up|1|||
163402427|NCT00552175|590184687|FG000|Overall Study|Entry Criteria Not Met|1|||
163402428|NCT00552175|590184688|FG001|Overall Study|Entry Criteria Not Met|1|||
163402429|NCT00552175|590184689|FG002|Overall Study|Entry Criteria Not Met|0|||
163402430|NCT00552175|590184687|FG000|Overall Study|Reason Not Specified|3|||
163402431|NCT00552175|590184688|FG001|Overall Study|Reason Not Specified|1|||
163402432|NCT00552175|590184689|FG002|Overall Study|Reason Not Specified|1|||
163402433|NCT00631020|590184690|FG000|Overall Study|Lost to Follow-up|7|||
163402434|NCT00631020|590184690|FG000|Overall Study|Incarcerated|1|||
163402435|NCT03548935|590184692|FG000|Overall Study|Withdrawal by Subject|26|||
163402436|NCT03548935|590184693|FG001|Overall Study|Withdrawal by Subject|17|||
163402437|NCT03548935|590184692|FG000|Overall Study|Lost to Follow-up|39|||
163402438|NCT03548935|590184693|FG001|Overall Study|Lost to Follow-up|28|||
163402439|NCT03548935|590184692|FG000|Overall Study|Death|1|||
163402440|NCT03548935|590184693|FG001|Overall Study|Death|1|||
163402441|NCT04677959|590184694|FG000|Overall Study|Adverse Event|1|||
163402442|NCT04677959|590184695|FG001|Overall Study|Adverse Event|9|||
163402443|NCT04677959|590184694|FG000|Overall Study|Withdrawal by Subject|2|||
163402444|NCT04677959|590184695|FG001|Overall Study|Withdrawal by Subject|15|||
163402445|NCT04677959|590184694|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163402446|NCT04677959|590184695|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163402447|NCT04677959|590184694|FG000|Overall Study|Non-compliance with study drug|0|||
163402448|NCT04677959|590184695|FG001|Overall Study|Non-compliance with study drug|2|||
163402449|NCT04677959|590184694|FG000|Overall Study|Protocol deviation|0|||
163402450|NCT04677959|590184695|FG001|Overall Study|Protocol deviation|11|||
163402451|NCT04677959|590184694|FG000|Overall Study|Lost to Follow-up|9|||
163402452|NCT04677959|590184695|FG001|Overall Study|Lost to Follow-up|13|||
163402453|NCT04677959|590184694|FG000|Overall Study|Other than specified|0|||
163402454|NCT04677959|590184695|FG001|Overall Study|Other than specified|8|||
163402455|NCT00732303|590184696|FG000|Overall Study|Study Terminated|2|||
163402456|NCT01074190|590184697|FG000|Overall Study|Emergency Cesarean Delivery|1|||
163402457|NCT01074190|590184698|FG001|Overall Study|Emergency Cesarean Delivery|2|||
163402458|NCT01074190|590184699|FG002|Overall Study|Emergency Cesarean Delivery|1|||
163402459|NCT01074190|590184697|FG000|Overall Study|Protocol Violation|2|||
163402460|NCT01074190|590184698|FG001|Overall Study|Protocol Violation|1|||
163402461|NCT01074190|590184699|FG002|Overall Study|Protocol Violation|0|||
163402462|NCT01074190|590184697|FG000|Overall Study|Delivered in under 90 minutes|0|||
163402463|NCT01074190|590184698|FG001|Overall Study|Delivered in under 90 minutes|2|||
163402464|NCT01074190|590184699|FG002|Overall Study|Delivered in under 90 minutes|1|||
163402465|NCT01074190|590184697|FG000|Overall Study|Subject withdrew consent|1|||
163402466|NCT01074190|590184698|FG001|Overall Study|Subject withdrew consent|1|||
163402467|NCT01074190|590184699|FG002|Overall Study|Subject withdrew consent|1|||
163402468|NCT01399788|590184706|FG000|First Intervention Period|Adverse Event|1|||
163402469|NCT01399788|590184707|FG001|First Intervention Period|Adverse Event|0|||
163402470|NCT02919436|590184708|FG000|Overall Study|Did not undergo surgery|16|||
163402471|NCT02919436|590184709|FG001|Overall Study|Did not undergo surgery|20|||
163402472|NCT02919436|590184708|FG000|Overall Study|Enrolled before trial registration|44|||
163402473|NCT02919436|590184709|FG001|Overall Study|Enrolled before trial registration|33|||
163402474|NCT01389752|590184710|FG000|Study Period 1|Sponsor decision|0|||
163402475|NCT01389752|590184711|FG001|Study Period 1|Sponsor decision|2|||
163402476|NCT01389752|590184710|FG000|Study Period 2|Sponsor decision|1|||
163402477|NCT01389752|590184711|FG001|Study Period 2|Sponsor decision|0|||
163402478|NCT01576549|590184722|FG000|Overall Study|Sponsor Decision|2|||
163402479|NCT00053417|590184723|FG000|Overall Study|Adverse Event|1|||
163402480|NCT00053417|590184724|FG001|Overall Study|Adverse Event|0|||
163402481|NCT00053417|590184725|FG002|Overall Study|Adverse Event|1|||
163402482|NCT00053417|590184726|FG003|Overall Study|Adverse Event|5|||
163402483|NCT00053417|590184723|FG000|Overall Study|Non-Compliance|0|||
163402484|NCT00053417|590184724|FG001|Overall Study|Non-Compliance|0|||
163402485|NCT00053417|590184725|FG002|Overall Study|Non-Compliance|0|||
163402486|NCT00053417|590184726|FG003|Overall Study|Non-Compliance|1|||
163402487|NCT00053417|590184723|FG000|Overall Study|Withdrawal by Subject|0|||
163402488|NCT00053417|590184724|FG001|Overall Study|Withdrawal by Subject|1|||
163402489|NCT00053417|590184725|FG002|Overall Study|Withdrawal by Subject|0|||
163402490|NCT00053417|590184726|FG003|Overall Study|Withdrawal by Subject|0|||
163402491|NCT00053417|590184723|FG000|Overall Study|Lost to Follow-up|1|||
163402492|NCT00053417|590184724|FG001|Overall Study|Lost to Follow-up|1|||
163402493|NCT00053417|590184725|FG002|Overall Study|Lost to Follow-up|0|||
163402494|NCT00053417|590184726|FG003|Overall Study|Lost to Follow-up|0|||
163402495|NCT01056510|590184727|FG000|Overall Study|Dropout Before Start of Treatment|1|||
163402496|NCT01056510|590184728|FG001|Overall Study|Dropout Before Start of Treatment|1|||
163402497|NCT01056510|590184727|FG000|Overall Study|Withdrawal by Subject|4|||
163058639|NCT00042289|588924279|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
163058640|NCT00042289|588924280|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
163058641|NCT00042289|588924281|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
163058642|NCT00042289|588924235|FG000|Overall Study|Protocol Violation|0|||
163058643|NCT00042289|588924236|FG001|Overall Study|Protocol Violation|0|||
163402498|NCT01056510|590184728|FG001|Overall Study|Withdrawal by Subject|2|||
163402499|NCT01056510|590184727|FG000|Overall Study|Death|29|||
163402500|NCT01056510|590184728|FG001|Overall Study|Death|34|||
163402501|NCT01056510|590184727|FG000|Overall Study|Noncompliance|1|||
163402502|NCT01056510|590184728|FG001|Overall Study|Noncompliance|3|||
163402503|NCT01056510|590184727|FG000|Overall Study|Physician Decision|4|||
163402504|NCT01056510|590184728|FG001|Overall Study|Physician Decision|5|||
163402505|NCT01056510|590184727|FG000|Overall Study|Lost to Follow-up|5|||
163058644|NCT00042289|588924237|FG002|Overall Study|Protocol Violation|0|||
163402506|NCT01056510|590184728|FG001|Overall Study|Lost to Follow-up|6|||
163402507|NCT01056510|590184727|FG000|Overall Study|Other|10|||
163402508|NCT01056510|590184728|FG001|Overall Study|Other|12|||
163402509|NCT01056510|590184727|FG000|Overall Study|Missing|0|||
163402510|NCT01056510|590184728|FG001|Overall Study|Missing|1|||
163210579|NCT00680745|589485305|FG001|Overall Study|Withdrawal by Subject|3|||
163210580|NCT00680745|589485306|FG002|Overall Study|Withdrawal by Subject|2|||
163210581|NCT00680745|589485307|FG003|Overall Study|Withdrawal by Subject|8|||
163210582|NCT00680745|589485304|FG000|Overall Study|Lost to Follow-up|0|||
163210583|NCT00680745|589485305|FG001|Overall Study|Lost to Follow-up|1|||
163210584|NCT00680745|589485306|FG002|Overall Study|Lost to Follow-up|1|||
163210585|NCT00680745|589485307|FG003|Overall Study|Lost to Follow-up|0|||
163210586|NCT00680745|589485304|FG000|Overall Study|Death|1|||
163210587|NCT00680745|589485305|FG001|Overall Study|Death|0|||
163210588|NCT00680745|589485306|FG002|Overall Study|Death|1|||
163210589|NCT00680745|589485307|FG003|Overall Study|Death|0|||
163210590|NCT00680745|589485304|FG000|Overall Study|Adverse Event|5|||
163210591|NCT00680745|589485305|FG001|Overall Study|Adverse Event|3|||
163210592|NCT00680745|589485306|FG002|Overall Study|Adverse Event|3|||
163210593|NCT00680745|589485307|FG003|Overall Study|Adverse Event|3|||
163210594|NCT00680745|589485304|FG000|Overall Study|Poor/Non-compliance|0|||
163210595|NCT00680745|589485305|FG001|Overall Study|Poor/Non-compliance|3|||
163210596|NCT00680745|589485306|FG002|Overall Study|Poor/Non-compliance|0|||
163210597|NCT00680745|589485307|FG003|Overall Study|Poor/Non-compliance|0|||
163210598|NCT00680745|589485304|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
163210599|NCT00680745|589485305|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
163210600|NCT00680745|589485306|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
163210601|NCT00680745|589485307|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
163210602|NCT00680745|589485304|FG000|Overall Study|False Treatment|0|||
163210603|NCT00680745|589485305|FG001|Overall Study|False Treatment|1|||
163210604|NCT00680745|589485306|FG002|Overall Study|False Treatment|3|||
163210605|NCT00680745|589485307|FG003|Overall Study|False Treatment|0|||
163210606|NCT01408914|589485308|FG000|Overall Study|Could not complete tx in protocol period|5|||
163210607|NCT01408914|589485309|FG001|Overall Study|Could not complete tx in protocol period|5|||
163210608|NCT01408914|589485310|FG002|Overall Study|Could not complete tx in protocol period|6|||
163210609|NCT01408914|589485308|FG000|Overall Study|Lost to Follow-up|4|||
163210610|NCT01408914|589485309|FG001|Overall Study|Lost to Follow-up|1|||
163210611|NCT01408914|589485310|FG002|Overall Study|Lost to Follow-up|2|||
163210612|NCT01408914|589485308|FG000|Overall Study|Physician Decision|1|||
163210613|NCT01408914|589485309|FG001|Overall Study|Physician Decision|1|||
163210614|NCT01408914|589485310|FG002|Overall Study|Physician Decision|0|||
163210615|NCT01408914|589485308|FG000|Overall Study|Withdrawal by Subject|1|||
163210616|NCT01408914|589485309|FG001|Overall Study|Withdrawal by Subject|0|||
163210617|NCT01408914|589485310|FG002|Overall Study|Withdrawal by Subject|1|||
163210618|NCT01408914|589485308|FG000|Overall Study|Moved out of study jurisdiction|1|||
163210619|NCT01408914|589485309|FG001|Overall Study|Moved out of study jurisdiction|1|||
163210620|NCT01408914|589485310|FG002|Overall Study|Moved out of study jurisdiction|0|||
163210621|NCT01408914|589485308|FG000|Overall Study|Late exclusion|0|||
163210622|NCT01408914|589485309|FG001|Overall Study|Late exclusion|3|||
162979075|NCT00773734|588625051|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
162979076|NCT00773734|588625052|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
162979077|NCT00773734|588625053|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
162979078|NCT00773734|588625054|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
162979079|NCT00773734|588625055|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
162979080|NCT00773734|588625050|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
162979081|NCT00773734|588625051|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
162979082|NCT00773734|588625052|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
162979083|NCT00773734|588625053|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
162979084|NCT00773734|588625054|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
162979085|NCT00773734|588625055|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
162979086|NCT00773734|588625050|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
162979087|NCT00773734|588625051|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
162979088|NCT00773734|588625052|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
162979089|NCT00773734|588625053|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
163058645|NCT00042289|588924238|FG003|Overall Study|Protocol Violation|0|||
163210623|NCT01408914|589485310|FG002|Overall Study|Late exclusion|3|||
163210624|NCT01408914|589485308|FG000|Overall Study|Change in local TB/HIV norms|0|||
163210625|NCT01408914|589485309|FG001|Overall Study|Change in local TB/HIV norms|1|||
163210626|NCT01408914|589485310|FG002|Overall Study|Change in local TB/HIV norms|1|||
163210627|NCT01585194|589485311|FG000|Overall Study|Withdrawal by Subject|1|||
163210628|NCT01585194|589485311|FG000|Overall Study|Physician Decision|2|||
163210629|NCT01585194|589485311|FG000|Overall Study|Lack of insurance|1|||
163210630|NCT00993291|589485312|FG000|Overall Study|Withdrawal by Subject|1|||
163210631|NCT04446377|589485314|FG000|Overall Study|Withdrawal by Subject|6|||
163210632|NCT04446377|589485315|FG001|Overall Study|Withdrawal by Subject|1|||
163210633|NCT04446377|589485314|FG000|Overall Study|Physician Decision|1|||
163210634|NCT04446377|589485315|FG001|Overall Study|Physician Decision|1|||
163210635|NCT04446377|589485314|FG000|Overall Study|Lost to Follow-up|0|||
163210636|NCT04446377|589485315|FG001|Overall Study|Lost to Follow-up|2|||
163210637|NCT04446377|589485314|FG000|Overall Study|Not eligible|0|||
163210638|NCT04446377|589485315|FG001|Overall Study|Not eligible|1|||
163210639|NCT04903626|589485318|FG000|Overall Study|Lost to Follow-up|6|||
163210640|NCT04903626|589485318|FG000|Overall Study|Withdrawal by Subject|1|||
163210641|NCT04903626|589485318|FG000|Overall Study|Other, Not Specified|1|||
163210642|NCT06112756|589485321|FG000|Overall Study|Withdrawal by Subject|0|||
163210643|NCT06112756|589485322|FG001|Overall Study|Withdrawal by Subject|2|||
163210644|NCT06112756|589485321|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
163210645|NCT06112756|589485322|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
163210646|NCT06112756|589485321|FG000|Overall Study|Adverse Event|2|||
163210647|NCT06112756|589485322|FG001|Overall Study|Adverse Event|2|||
163210648|NCT03060629|589485323|FG000|Overall Study|Death|4|||
163210649|NCT03060629|589485324|FG001|Overall Study|Death|5|||
163210650|NCT03060629|589485323|FG000|Overall Study|Withdrawal by Subject|50|||
163210651|NCT03060629|589485324|FG001|Overall Study|Withdrawal by Subject|35|||
163210652|NCT03060629|589485323|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
163210653|NCT03060629|589485324|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
163210654|NCT03060629|589485323|FG000|Overall Study|Participant Relocate|15|||
163318927|NCT05485779|589878815|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
163318928|NCT05485779|589878805|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163318929|NCT05485779|589878806|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163318930|NCT05485779|589878807|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163318931|NCT05485779|589878808|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
163318932|NCT05485779|589878809|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163318933|NCT05485779|589878810|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163318934|NCT05485779|589878811|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163318935|NCT05485779|589878812|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163318936|NCT05485779|589878813|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163318937|NCT05485779|589878814|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163318938|NCT05485779|589878815|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163318941|NCT03676192|589878820|FG000|Induction Study Period|Adverse Event|21|||
163318942|NCT03676192|589878821|FG001|Induction Study Period|Adverse Event|20|||
163318943|NCT03676192|589878820|FG000|Induction Study Period|Death|23|||
163318944|NCT03676192|589878821|FG001|Induction Study Period|Death|20|||
163318945|NCT03676192|589878820|FG000|Induction Study Period|Lost to Follow-up|3|||
163318946|NCT03676192|589878821|FG001|Induction Study Period|Lost to Follow-up|3|||
163318947|NCT03676192|589878820|FG000|Induction Study Period|Physician Decision|6|||
163318948|NCT03676192|589878821|FG001|Induction Study Period|Physician Decision|3|||
163318949|NCT03676192|589878820|FG000|Induction Study Period|Progressive Disease|32|||
163318950|NCT03676192|589878821|FG001|Induction Study Period|Progressive Disease|21|||
163318951|NCT03676192|589878820|FG000|Induction Study Period|Protocol Violation|1|||
163318952|NCT03676192|589878821|FG001|Induction Study Period|Protocol Violation|2|||
163318953|NCT03676192|589878820|FG000|Induction Study Period|Withdrawal by Subject|20|||
163318954|NCT03676192|589878821|FG001|Induction Study Period|Withdrawal by Subject|15|||
163318955|NCT02424617|589878822|FG000|Overall Study|Adverse Event|0|||
163318956|NCT02424617|589878823|FG001|Overall Study|Adverse Event|1|||
163318957|NCT02424617|589878824|FG002|Overall Study|Adverse Event|0|||
163318958|NCT02424617|589878825|FG003|Overall Study|Adverse Event|0|||
163318959|NCT02424617|589878822|FG000|Overall Study|Investigator Decision|0|||
163318960|NCT02424617|589878823|FG001|Overall Study|Investigator Decision|0|||
163318961|NCT02424617|589878824|FG002|Overall Study|Investigator Decision|0|||
163210655|NCT03060629|589485324|FG001|Overall Study|Participant Relocate|15|||
163210656|NCT03060629|589485323|FG000|Overall Study|Unable to Contact Participant|34|||
163210657|NCT03060629|589485324|FG001|Overall Study|Unable to Contact Participant|23|||
163210658|NCT03060629|589485323|FG000|Overall Study|Investigator Decision|7|||
163210659|NCT03060629|589485324|FG001|Overall Study|Investigator Decision|7|||
163210660|NCT03060629|589485323|FG000|Overall Study|Study Terminated by Sponsor|1100|||
163210661|NCT03060629|589485324|FG001|Overall Study|Study Terminated by Sponsor|1123|||
163210662|NCT03060629|589485323|FG000|Overall Study|Other|4|||
163210663|NCT03060629|589485324|FG001|Overall Study|Other|4|||
163210664|NCT01862874|589485325|FG000|Overall Study|Randomized not treated|1|||
163210665|NCT01862874|589485326|FG001|Overall Study|Randomized not treated|0|||
163210666|NCT01862874|589485325|FG000|Overall Study|Adverse Event|0|||
163210667|NCT01862874|589485326|FG001|Overall Study|Adverse Event|3|||
163210668|NCT01862874|589485325|FG000|Overall Study|Lost to Follow-up|26|||
163058646|NCT00042289|588924239|FG004|Overall Study|Protocol Violation|0|||
163058647|NCT00042289|588924240|FG005|Overall Study|Protocol Violation|1|||
163058648|NCT00042289|588924241|FG006|Overall Study|Protocol Violation|0|||
163058649|NCT00042289|588924242|FG007|Overall Study|Protocol Violation|1|||
163058650|NCT00042289|588924243|FG008|Overall Study|Protocol Violation|0|||
163058651|NCT00042289|588924244|FG009|Overall Study|Protocol Violation|0|||
163058652|NCT00042289|588924245|FG010|Overall Study|Protocol Violation|0|||
163058653|NCT00042289|588924246|FG011|Overall Study|Protocol Violation|0|||
163058654|NCT00042289|588924247|FG012|Overall Study|Protocol Violation|0|||
163210669|NCT01862874|589485326|FG001|Overall Study|Lost to Follow-up|29|||
163210670|NCT01862874|589485325|FG000|Overall Study|Physician Decision|5|||
163210671|NCT01862874|589485326|FG001|Overall Study|Physician Decision|3|||
163210672|NCT01862874|589485325|FG000|Overall Study|Withdrawn by parent/guardian|1|||
163210673|NCT01862874|589485326|FG001|Overall Study|Withdrawn by parent/guardian|1|||
163210674|NCT01862874|589485325|FG000|Overall Study|Withdrawal by Subject|46|||
163210675|NCT01862874|589485326|FG001|Overall Study|Withdrawal by Subject|40|||
163210676|NCT01862874|589485325|FG000|Overall Study|Death|0|||
163210677|NCT01862874|589485326|FG001|Overall Study|Death|1|||
163210678|NCT03681405|589485327|FG000|Overall Study|Found to be ineligible after randomized|1|||
163210679|NCT03681405|589485328|FG001|Overall Study|Found to be ineligible after randomized|0|||
163210680|NCT02056340|589485330|FG000|Overall Study|Lost to Follow-up|5|||
163210681|NCT02056340|589485331|FG001|Overall Study|Lost to Follow-up|5|||
163210682|NCT02056340|589485330|FG000|Overall Study|Withdrawal by Subject|2|||
163210683|NCT02056340|589485331|FG001|Overall Study|Withdrawal by Subject|6|||
163210684|NCT00883116|589485332|FG000|Overall Study|Adverse event unrelated to study drug|5|||
163210685|NCT00883116|589485333|FG001|Overall Study|Adverse event unrelated to study drug|10|||
163210686|NCT00883116|589485332|FG000|Overall Study|Death|6|||
163210687|NCT00883116|589485333|FG001|Overall Study|Death|2|||
163210688|NCT00883116|589485332|FG000|Overall Study|Disease progression|130|||
163210689|NCT00883116|589485333|FG001|Overall Study|Disease progression|128|||
163210690|NCT00883116|589485332|FG000|Overall Study|Lost to Follow-up|0|||
163210691|NCT00883116|589485333|FG001|Overall Study|Lost to Follow-up|1|||
163210692|NCT00883116|589485332|FG000|Overall Study|Maximum clinical benefit|13|||
163210693|NCT00883116|589485333|FG001|Overall Study|Maximum clinical benefit|46|||
163210694|NCT00883116|589485332|FG000|Overall Study|Not identified|3|||
163210695|NCT00883116|589485333|FG001|Overall Study|Not identified|6|||
163210696|NCT00883116|589485332|FG000|Overall Study|Study drug toxicity|36|||
163210697|NCT00883116|589485333|FG001|Overall Study|Study drug toxicity|16|||
163210698|NCT00883116|589485332|FG000|Overall Study|Withdrawal by Subject|14|||
163210699|NCT00883116|589485333|FG001|Overall Study|Withdrawal by Subject|8|||
163210700|NCT00883116|589485332|FG000|Overall Study|No longer meets study criteria|2|||
163210701|NCT00883116|589485333|FG001|Overall Study|No longer meets study criteria|2|||
163210702|NCT02484729|589485334|FG000|Overall Study|Failure of IntelliCap Error|0|||
163210703|NCT02484729|589485335|FG001|Overall Study|Failure of IntelliCap Error|0|||
163210704|NCT02484729|589485336|FG002|Overall Study|Failure of IntelliCap Error|0|||
163210705|NCT02484729|589485337|FG003|Overall Study|Failure of IntelliCap Error|0|||
163210706|NCT02484729|589485338|FG004|Overall Study|Failure of IntelliCap Error|0|||
163210707|NCT02484729|589485339|FG005|Overall Study|Failure of IntelliCap Error|0|||
163210708|NCT02484729|589485340|FG006|Overall Study|Failure of IntelliCap Error|0|||
163210709|NCT02484729|589485341|FG007|Overall Study|Failure of IntelliCap Error|0|||
163210710|NCT02484729|589485342|FG008|Overall Study|Failure of IntelliCap Error|0|||
163210711|NCT02484729|589485343|FG009|Overall Study|Failure of IntelliCap Error|1|||
163210712|NCT01031069|589485344|FG000|Overall Study|Serious Adverse Event|0|||
163210713|NCT01031069|589485345|FG001|Overall Study|Serious Adverse Event|1|||
163210714|NCT01031069|589485346|FG002|Overall Study|Serious Adverse Event|0|||
163210715|NCT01031069|589485347|FG003|Overall Study|Serious Adverse Event|0|||
163210716|NCT01031069|589485344|FG000|Overall Study|Withdrawal by Subject|2|||
163210717|NCT01031069|589485345|FG001|Overall Study|Withdrawal by Subject|3|||
163210718|NCT01031069|589485346|FG002|Overall Study|Withdrawal by Subject|18|||
163210719|NCT01031069|589485347|FG003|Overall Study|Withdrawal by Subject|18|||
163210720|NCT01031069|589485344|FG000|Overall Study|Migrated/moved from study area|1|||
163058655|NCT00042289|588924248|FG013|Overall Study|Protocol Violation|0|||
163210721|NCT01031069|589485345|FG001|Overall Study|Migrated/moved from study area|2|||
163210722|NCT01031069|589485346|FG002|Overall Study|Migrated/moved from study area|1|||
163210723|NCT01031069|589485347|FG003|Overall Study|Migrated/moved from study area|1|||
163210724|NCT01031069|589485344|FG000|Overall Study|Lost to Follow-up|9|||
163210725|NCT01031069|589485345|FG001|Overall Study|Lost to Follow-up|5|||
163210726|NCT01031069|589485346|FG002|Overall Study|Lost to Follow-up|21|||
163210727|NCT01031069|589485347|FG003|Overall Study|Lost to Follow-up|15|||
163210728|NCT01031069|589485344|FG000|Overall Study|Other|0|||
163210729|NCT01031069|589485345|FG001|Overall Study|Other|0|||
163210730|NCT01031069|589485346|FG002|Overall Study|Other|1|||
163210731|NCT01031069|589485347|FG003|Overall Study|Other|0|||
163210732|NCT01317160|589485348|FG000|Overall Study|Incorrect inclusion|1|||
163210733|NCT01317160|589485349|FG001|Overall Study|Incorrect inclusion|1|||
163210734|NCT01317160|589485348|FG000|Overall Study|Lost to Follow-up|3|||
163210735|NCT01317160|589485349|FG001|Overall Study|Lost to Follow-up|3|||
163402511|NCT02830776|590184729|FG000|Overall Study|Lost to Follow-up|1|||
163402512|NCT02716987|590184737|FG000|Overall Study|Ligand synthesis failure|0|||
163318962|NCT02424617|589878825|FG003|Overall Study|Investigator Decision|1|||
163318963|NCT02424617|589878822|FG000|Overall Study|Withdrawal by Subject|1|||
163318964|NCT02424617|589878823|FG001|Overall Study|Withdrawal by Subject|1|||
163318965|NCT02424617|589878824|FG002|Overall Study|Withdrawal by Subject|0|||
163318966|NCT02424617|589878825|FG003|Overall Study|Withdrawal by Subject|1|||
163318967|NCT02424617|589878822|FG000|Overall Study|Progressive Disease|7|||
163318968|NCT02424617|589878823|FG001|Overall Study|Progressive Disease|6|||
163318969|NCT02424617|589878824|FG002|Overall Study|Progressive Disease|11|||
163318970|NCT02424617|589878825|FG003|Overall Study|Progressive Disease|10|||
163318971|NCT02424617|589878822|FG000|Overall Study|Other|0|||
163318972|NCT02424617|589878823|FG001|Overall Study|Other|0|||
163318973|NCT02424617|589878824|FG002|Overall Study|Other|0|||
163318974|NCT02424617|589878825|FG003|Overall Study|Other|1|||
163318975|NCT04778397|589878828|FG000|Overall Study|Death|59|||
163318976|NCT04778397|589878829|FG001|Overall Study|Death|54|||
163318977|NCT04778397|589878830|FG002|Overall Study|Death|11|||
163318978|NCT04778397|589878831|FG003|Overall Study|Death|9|||
163318979|NCT04778397|589878828|FG000|Overall Study|Study Terminated by Sponsor|34|||
163318980|NCT04778397|589878829|FG001|Overall Study|Study Terminated by Sponsor|42|||
163318981|NCT04778397|589878830|FG002|Overall Study|Study Terminated by Sponsor|15|||
163318982|NCT04778397|589878831|FG003|Overall Study|Study Terminated by Sponsor|12|||
163318983|NCT04778397|589878828|FG000|Overall Study|Withdrew Consent|5|||
163318984|NCT04778397|589878829|FG001|Overall Study|Withdrew Consent|4|||
163318985|NCT04778397|589878830|FG002|Overall Study|Withdrew Consent|1|||
163318986|NCT04778397|589878831|FG003|Overall Study|Withdrew Consent|1|||
163318987|NCT04778397|589878828|FG000|Overall Study|Reason Not Specified|1|||
163318988|NCT04778397|589878829|FG001|Overall Study|Reason Not Specified|3|||
163318989|NCT04778397|589878830|FG002|Overall Study|Reason Not Specified|0|||
163318990|NCT04778397|589878831|FG003|Overall Study|Reason Not Specified|2|||
163318991|NCT04778397|589878828|FG000|Overall Study|Lost to Follow-up|2|||
163318992|NCT04778397|589878829|FG001|Overall Study|Lost to Follow-up|1|||
163318993|NCT04778397|589878830|FG002|Overall Study|Lost to Follow-up|0|||
163318994|NCT04778397|589878831|FG003|Overall Study|Lost to Follow-up|1|||
163318995|NCT03308877|589878832|FG000|Overall Study|Lost to Follow-up|32|||
163318996|NCT03308877|589878833|FG001|Overall Study|Lost to Follow-up|28|||
163318997|NCT03523572|589878834|FG000|Dose Escalation|Progressive disease|1|||
163318998|NCT03523572|589878835|FG001|Dose Escalation|Progressive disease|0|||
163318999|NCT03523572|589878836|FG002|Dose Escalation|Progressive disease|0|||
163319000|NCT03523572|589878837|FG003|Dose Escalation|Progressive disease|0|||
163319001|NCT03523572|589878838|FG004|Dose Escalation|Progressive disease|0|||
163319002|NCT03523572|589878839|FG005|Dose Escalation|Progressive disease|0|||
163319003|NCT03523572|589878834|FG000|Dose Escalation|Clinical Progression|0|||
163319004|NCT03523572|589878835|FG001|Dose Escalation|Clinical Progression|1|||
163319005|NCT03523572|589878836|FG002|Dose Escalation|Clinical Progression|0|||
163319006|NCT03523572|589878837|FG003|Dose Escalation|Clinical Progression|0|||
163319007|NCT03523572|589878838|FG004|Dose Escalation|Clinical Progression|0|||
163319008|NCT03523572|589878839|FG005|Dose Escalation|Clinical Progression|0|||
163319009|NCT03523572|589878834|FG000|Dose Escalation|Adverse Event|2|||
163319010|NCT03523572|589878835|FG001|Dose Escalation|Adverse Event|0|||
163319011|NCT03523572|589878836|FG002|Dose Escalation|Adverse Event|0|||
163319012|NCT03523572|589878837|FG003|Dose Escalation|Adverse Event|0|||
163319013|NCT03523572|589878838|FG004|Dose Escalation|Adverse Event|0|||
163319014|NCT03523572|589878839|FG005|Dose Escalation|Adverse Event|0|||
163319015|NCT03523572|589878834|FG000|Dose Escalation|Physician Decision|1|||
163319016|NCT03523572|589878835|FG001|Dose Escalation|Physician Decision|1|||
163319017|NCT03523572|589878836|FG002|Dose Escalation|Physician Decision|0|||
163319018|NCT03523572|589878837|FG003|Dose Escalation|Physician Decision|0|||
163319019|NCT03523572|589878838|FG004|Dose Escalation|Physician Decision|0|||
163319020|NCT03523572|589878839|FG005|Dose Escalation|Physician Decision|0|||
163319021|NCT03523572|589878834|FG000|Dose Expansion|Progressive Disease|0|||
163319022|NCT03523572|589878835|FG001|Dose Expansion|Progressive Disease|0|||
163319023|NCT03523572|589878836|FG002|Dose Expansion|Progressive Disease|9|||
163319024|NCT03523572|589878837|FG003|Dose Expansion|Progressive Disease|11|||
163319025|NCT03523572|589878838|FG004|Dose Expansion|Progressive Disease|15|||
163319026|NCT03523572|589878839|FG005|Dose Expansion|Progressive Disease|2|||
163319027|NCT03523572|589878834|FG000|Dose Expansion|Clinical Progression|0|||
163319028|NCT03523572|589878835|FG001|Dose Expansion|Clinical Progression|0|||
163319029|NCT03523572|589878836|FG002|Dose Expansion|Clinical Progression|2|||
163319030|NCT03523572|589878837|FG003|Dose Expansion|Clinical Progression|2|||
163319031|NCT03523572|589878838|FG004|Dose Expansion|Clinical Progression|2|||
163319032|NCT03523572|589878839|FG005|Dose Expansion|Clinical Progression|0|||
163319033|NCT03523572|589878834|FG000|Dose Expansion|Adverse Event|0|||
163319034|NCT03523572|589878835|FG001|Dose Expansion|Adverse Event|0|||
163319035|NCT03523572|589878836|FG002|Dose Expansion|Adverse Event|10|||
163319036|NCT03523572|589878837|FG003|Dose Expansion|Adverse Event|1|||
163319037|NCT03523572|589878838|FG004|Dose Expansion|Adverse Event|5|||
163319038|NCT03523572|589878839|FG005|Dose Expansion|Adverse Event|2|||
162979090|NCT00773734|588625054|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
162979091|NCT00773734|588625055|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
162979092|NCT00773734|588625050|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
162979093|NCT00773734|588625051|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
162979094|NCT00773734|588625052|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
162979095|NCT00773734|588625053|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
162979096|NCT00773734|588625054|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
162979097|NCT00773734|588625055|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
162979098|NCT00773734|588625050|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
162979099|NCT00773734|588625051|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
162979100|NCT00773734|588625052|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
162979101|NCT00773734|588625053|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
162979102|NCT00773734|588625054|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
162979103|NCT00773734|588625055|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
162979104|NCT00773734|588625050|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
162979105|NCT00773734|588625051|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
162979106|NCT00773734|588625052|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
162979107|NCT00773734|588625053|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
162979108|NCT00773734|588625054|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
162979109|NCT00773734|588625055|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
162979110|NCT00773734|588625050|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
162979111|NCT00773734|588625051|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
162979112|NCT00773734|588625052|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
162979113|NCT00773734|588625053|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
162979114|NCT00773734|588625054|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
162979115|NCT00773734|588625055|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
162979116|NCT00773734|588625050|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
162979117|NCT00773734|588625051|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
162979118|NCT00773734|588625052|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
163210736|NCT01317160|589485348|FG000|Overall Study|Withdrawal by Subject|0|||
163210737|NCT01317160|589485349|FG001|Overall Study|Withdrawal by Subject|2|||
163210738|NCT03578367|589485351|FG000|Overall Study|Adverse Event|0|||
163210739|NCT03578367|589485352|FG001|Overall Study|Adverse Event|3|||
163210740|NCT03578367|589485353|FG002|Overall Study|Adverse Event|0|||
163210741|NCT03578367|589485354|FG003|Overall Study|Adverse Event|5|||
163210742|NCT03578367|589485351|FG000|Overall Study|Withdrawal by Subject|2|||
163210743|NCT03578367|589485352|FG001|Overall Study|Withdrawal by Subject|2|||
163210744|NCT03578367|589485353|FG002|Overall Study|Withdrawal by Subject|1|||
163210745|NCT03578367|589485354|FG003|Overall Study|Withdrawal by Subject|3|||
163210746|NCT03578367|589485351|FG000|Overall Study|Physician Decision|0|||
163210747|NCT03578367|589485352|FG001|Overall Study|Physician Decision|0|||
163210748|NCT03578367|589485353|FG002|Overall Study|Physician Decision|14|||
163210749|NCT03578367|589485354|FG003|Overall Study|Physician Decision|0|||
163210750|NCT03578367|589485351|FG000|Overall Study|Death|1|||
163210751|NCT03578367|589485352|FG001|Overall Study|Death|0|||
163210752|NCT03578367|589485353|FG002|Overall Study|Death|0|||
163210753|NCT03578367|589485354|FG003|Overall Study|Death|0|||
163210754|NCT03578367|589485351|FG000|Overall Study|Not treated|0|||
163210755|NCT03578367|589485352|FG001|Overall Study|Not treated|0|||
163210756|NCT03578367|589485353|FG002|Overall Study|Not treated|1|||
163210757|NCT03578367|589485354|FG003|Overall Study|Not treated|0|||
163210758|NCT00670800|589486916|FG000|Overall Study|2 controls were insulin resistant|0|||
163210759|NCT00670800|589486917|FG001|Overall Study|2 controls were insulin resistant|2|||
163210760|NCT00587561|589486918|FG000|Overall Study|Lost to Follow-up|6|||
163210761|NCT00587561|589486919|FG001|Overall Study|Lost to Follow-up|4|||
163210762|NCT05661942|589486920|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
163210763|NCT05661942|589486921|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
163210764|NCT03274687|589486924|FG000|Overall Study|Protocol Violation|1|||
163210765|NCT03274687|589486925|FG001|Overall Study|Protocol Violation|1|||
163210766|NCT01572909|589486928|FG000|Overall Study|Adverse Event|7|||
163210767|NCT01572909|589486929|FG001|Overall Study|Adverse Event|2|||
163210768|NCT01572909|589486928|FG000|Overall Study|Death|3|||
163210769|NCT01572909|589486929|FG001|Overall Study|Death|1|||
163210770|NCT01572909|589486928|FG000|Overall Study|Lost to Follow-up|8|||
163210771|NCT01572909|589486929|FG001|Overall Study|Lost to Follow-up|7|||
163210772|NCT01572909|589486928|FG000|Overall Study|Physician Decision|1|||
163210773|NCT01572909|589486929|FG001|Overall Study|Physician Decision|1|||
163210774|NCT01572909|589486928|FG000|Overall Study|Technical Issues|1|||
163210775|NCT01572909|589486929|FG001|Overall Study|Technical Issues|0|||
163210776|NCT01572909|589486928|FG000|Overall Study|Withdrawal by Subject|12|||
163210777|NCT01572909|589486929|FG001|Overall Study|Withdrawal by Subject|11|||
163210778|NCT01572909|589486928|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
163319039|NCT03523572|589878834|FG000|Dose Expansion|Withdrawal by Subject|0|||
163319040|NCT03523572|589878835|FG001|Dose Expansion|Withdrawal by Subject|0|||
163319041|NCT03523572|589878836|FG002|Dose Expansion|Withdrawal by Subject|1|||
162979119|NCT00773734|588625053|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
162979120|NCT00773734|588625054|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
163210779|NCT01572909|589486929|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
163210780|NCT01199289|589486930|FG000|Overall Study|Ineligibility determined|2|||
163210781|NCT01199289|589486931|FG001|Overall Study|Ineligibility determined|1|||
163319042|NCT03523572|589878837|FG003|Dose Expansion|Withdrawal by Subject|1|||
163319043|NCT03523572|589878838|FG004|Dose Expansion|Withdrawal by Subject|0|||
163319044|NCT03523572|589878839|FG005|Dose Expansion|Withdrawal by Subject|0|||
163319045|NCT03523572|589878834|FG000|Dose Expansion|Physician Decision|0|||
163319046|NCT03523572|589878835|FG001|Dose Expansion|Physician Decision|0|||
163319047|NCT03523572|589878836|FG002|Dose Expansion|Physician Decision|1|||
163319048|NCT03523572|589878837|FG003|Dose Expansion|Physician Decision|0|||
163319049|NCT03523572|589878838|FG004|Dose Expansion|Physician Decision|1|||
163319050|NCT03523572|589878839|FG005|Dose Expansion|Physician Decision|0|||
163319051|NCT03523572|589878834|FG000|Dose Expansion|Miscellaneous|0|||
163319052|NCT03523572|589878835|FG001|Dose Expansion|Miscellaneous|0|||
163319053|NCT03523572|589878836|FG002|Dose Expansion|Miscellaneous|0|||
163319054|NCT03523572|589878837|FG003|Dose Expansion|Miscellaneous|0|||
163319055|NCT03523572|589878838|FG004|Dose Expansion|Miscellaneous|3|||
163319056|NCT03523572|589878839|FG005|Dose Expansion|Miscellaneous|0|||
163319057|NCT04685135|589878845|FG000|Overall Study|Death|126|||
163319058|NCT04685135|589878846|FG001|Overall Study|Death|53|||
163319059|NCT04685135|589878845|FG000|Overall Study|Withdrawal by Subject|12|||
163319060|NCT04685135|589878846|FG001|Overall Study|Withdrawal by Subject|16|||
163319061|NCT02315703|589878849|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
163319062|NCT02315703|589878850|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
163319063|NCT02315703|589878851|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
163319064|NCT02315703|589878852|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
163319065|NCT02315703|589878853|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
163319066|NCT02315703|589878854|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
163319067|NCT02315703|589878855|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
163319068|NCT02315703|589878856|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
163319069|NCT02315703|589878849|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
163319070|NCT02315703|589878850|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
163319071|NCT02315703|589878851|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
163319072|NCT02315703|589878852|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
163319073|NCT02315703|589878853|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
163319074|NCT02315703|589878854|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
163319075|NCT02315703|589878855|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
163319076|NCT02315703|589878856|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
163319077|NCT02315703|589878849|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
163319078|NCT02315703|589878850|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
163319079|NCT02315703|589878851|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
163319080|NCT02315703|589878852|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
163319081|NCT02315703|589878853|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
163319082|NCT02315703|589878854|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
163319083|NCT02315703|589878855|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
163210782|NCT01199289|589486932|FG002|Overall Study|Ineligibility determined|0|||
163210783|NCT01199289|589486933|FG003|Overall Study|Ineligibility determined|0|||
163210784|NCT01199289|589486930|FG000|Overall Study|Protocol Violation|1|||
163210785|NCT01199289|589486931|FG001|Overall Study|Protocol Violation|0|||
163210786|NCT01199289|589486932|FG002|Overall Study|Protocol Violation|0|||
163210787|NCT01199289|589486933|FG003|Overall Study|Protocol Violation|1|||
163210788|NCT01199289|589486930|FG000|Overall Study|Noncompliance|1|||
163210789|NCT01199289|589486931|FG001|Overall Study|Noncompliance|0|||
163210790|NCT01199289|589486932|FG002|Overall Study|Noncompliance|2|||
163210791|NCT01199289|589486933|FG003|Overall Study|Noncompliance|0|||
163210792|NCT01199289|589486930|FG000|Overall Study|Adverse Event|0|||
163210793|NCT01199289|589486931|FG001|Overall Study|Adverse Event|3|||
163210794|NCT01199289|589486932|FG002|Overall Study|Adverse Event|1|||
163210795|NCT01199289|589486933|FG003|Overall Study|Adverse Event|4|||
163210796|NCT01199289|589486930|FG000|Overall Study|Full consent withdrawn|2|||
163210797|NCT01199289|589486931|FG001|Overall Study|Full consent withdrawn|2|||
163210798|NCT01199289|589486932|FG002|Overall Study|Full consent withdrawn|2|||
163210799|NCT01199289|589486933|FG003|Overall Study|Full consent withdrawn|3|||
163210800|NCT01199289|589486930|FG000|Overall Study|Administrative decision|0|||
163210801|NCT01199289|589486931|FG001|Overall Study|Administrative decision|0|||
163210802|NCT01199289|589486932|FG002|Overall Study|Administrative decision|0|||
163210803|NCT01199289|589486933|FG003|Overall Study|Administrative decision|1|||
163210804|NCT01199289|589486930|FG000|Overall Study|Lost to Follow-up|0|||
163210805|NCT01199289|589486931|FG001|Overall Study|Lost to Follow-up|0|||
163210806|NCT01199289|589486932|FG002|Overall Study|Lost to Follow-up|0|||
163210807|NCT01199289|589486933|FG003|Overall Study|Lost to Follow-up|1|||
163210808|NCT01199289|589486930|FG000|Overall Study|Protocol-specified criteria|3|||
163210809|NCT01199289|589486931|FG001|Overall Study|Protocol-specified criteria|0|||
163210810|NCT01199289|589486932|FG002|Overall Study|Protocol-specified criteria|0|||
163210811|NCT01199289|589486933|FG003|Overall Study|Protocol-specified criteria|1|||
163210812|NCT01199289|589486930|FG000|Overall Study|Pregnancy|0|||
163210813|NCT01199289|589486931|FG001|Overall Study|Pregnancy|1|||
163210814|NCT01199289|589486932|FG002|Overall Study|Pregnancy|0|||
163210815|NCT01199289|589486933|FG003|Overall Study|Pregnancy|1|||
163210816|NCT02636868|589486934|FG000|Overall Study|Death|0|||
163210817|NCT02636868|589486935|FG001|Overall Study|Death|1|||
163210818|NCT02636868|589486936|FG002|Overall Study|Death|2|||
163210819|NCT03182829|589486942|FG000|Overall Study|Protocol Violation|12|||
163210820|NCT03182829|589486943|FG001|Overall Study|Protocol Violation|12|||
163210821|NCT03182829|589486942|FG000|Overall Study|Other|4|||
163210822|NCT03182829|589486943|FG001|Overall Study|Other|3|||
163210823|NCT03316131|589486944|FG000|Treatment Period 2|Protocol deviation|1|||
163210824|NCT03316131|589486945|FG001|Treatment Period 2|Protocol deviation|0|||
163210825|NCT02664441|589486946|FG000|Randomization|Withdrawal by Subject|0|||
163210826|NCT02664441|589486947|FG001|Randomization|Withdrawal by Subject|1|||
163210827|NCT02664441|589486946|FG000|36-week Randomized Trial|Adverse Event|2|||
163210828|NCT02664441|589486947|FG001|36-week Randomized Trial|Adverse Event|0|||
163210829|NCT02664441|589486946|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
163210830|NCT02664441|589486947|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
163210831|NCT02664441|589486946|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
163210832|NCT02664441|589486947|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
163210833|NCT02664441|589486946|FG000|18-week Open Label Extension|Adverse Event|1|||
163210834|NCT02664441|589486947|FG001|18-week Open Label Extension|Adverse Event|0|||
163210835|NCT02664441|589486946|FG000|18-week Open Label Extension|Physician Decision|1|||
163210836|NCT02664441|589486947|FG001|18-week Open Label Extension|Physician Decision|0|||
163210837|NCT02664441|589486946|FG000|18-week Open Label Extension|Death|1|||
163210838|NCT02664441|589486947|FG001|18-week Open Label Extension|Death|0|||
163210839|NCT02664441|589486946|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
163210840|NCT02664441|589486947|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
163210841|NCT05608005|589486949|FG000|Overall Study|Adverse Event|2|||
163210842|NCT05608005|589486950|FG001|Overall Study|Adverse Event|1|||
163210843|NCT05608005|589486951|FG002|Overall Study|Adverse Event|3|||
163210844|NCT05608005|589486949|FG000|Overall Study|Protocol Violation|2|||
163210845|NCT05608005|589486950|FG001|Overall Study|Protocol Violation|3|||
163210846|NCT05608005|589486951|FG002|Overall Study|Protocol Violation|0|||
163210847|NCT05608005|589486949|FG000|Overall Study|Withdrawal by Subject|10|||
163210848|NCT05608005|589486950|FG001|Overall Study|Withdrawal by Subject|12|||
163210849|NCT05608005|589486951|FG002|Overall Study|Withdrawal by Subject|4|||
163210850|NCT05608005|589486949|FG000|Overall Study|Lost to Follow-up|25|||
163210851|NCT05608005|589486950|FG001|Overall Study|Lost to Follow-up|27|||
163210852|NCT05608005|589486951|FG002|Overall Study|Lost to Follow-up|15|||
163210853|NCT05608005|589486949|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
163210854|NCT05608005|589486950|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
163210855|NCT05608005|589486951|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
163210856|NCT03518073|589486952|FG000|Overall Study|Adverse Event|2|||
163210857|NCT03518073|589486953|FG001|Overall Study|Adverse Event|4|||
163210858|NCT03518073|589486954|FG002|Overall Study|Adverse Event|2|||
163210859|NCT03518073|589486952|FG000|Overall Study|Death|2|||
163210860|NCT03518073|589486953|FG001|Overall Study|Death|1|||
163210861|NCT03518073|589486954|FG002|Overall Study|Death|3|||
163210862|NCT03518073|589486952|FG000|Overall Study|Lost to Follow-up|1|||
163058656|NCT00042289|588924249|FG014|Overall Study|Protocol Violation|0|||
163210863|NCT03518073|589486953|FG001|Overall Study|Lost to Follow-up|0|||
163210864|NCT03518073|589486954|FG002|Overall Study|Lost to Follow-up|1|||
163210865|NCT03518073|589486952|FG000|Overall Study|Physician Decision|5|||
163210866|NCT03518073|589486953|FG001|Overall Study|Physician Decision|0|||
163210867|NCT03518073|589486954|FG002|Overall Study|Physician Decision|2|||
163210868|NCT03518073|589486952|FG000|Overall Study|Progressive disease|1|||
163210869|NCT03518073|589486953|FG001|Overall Study|Progressive disease|1|||
163210870|NCT03518073|589486954|FG002|Overall Study|Progressive disease|1|||
163210871|NCT03518073|589486952|FG000|Overall Study|Protocol Violation|1|||
163210872|NCT03518073|589486953|FG001|Overall Study|Protocol Violation|0|||
163210873|NCT03518073|589486954|FG002|Overall Study|Protocol Violation|0|||
163210874|NCT03518073|589486952|FG000|Overall Study|Withdrawal by Subject|30|||
163210875|NCT03518073|589486953|FG001|Overall Study|Withdrawal by Subject|34|||
163210876|NCT03518073|589486954|FG002|Overall Study|Withdrawal by Subject|29|||
163210877|NCT03518073|589486952|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
163210878|NCT03518073|589486953|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
163210879|NCT03518073|589486954|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
163210880|NCT03518073|589486952|FG000|Overall Study|Covid-19|1|||
163319084|NCT02315703|589878856|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
163319085|NCT02315703|589878849|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
162979121|NCT00773734|588625055|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
162979122|NCT00773734|588625050|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
162979123|NCT00773734|588625051|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
162979124|NCT00773734|588625052|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
162979125|NCT00773734|588625053|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
162979126|NCT00773734|588625054|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
162979127|NCT00773734|588625055|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
162979128|NCT00773734|588625050|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
162979129|NCT00773734|588625051|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
162979130|NCT00773734|588625052|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
162979131|NCT00773734|588625053|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
163319086|NCT02315703|589878850|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
163319087|NCT02315703|589878851|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
163319088|NCT02315703|589878852|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
163319089|NCT02315703|589878853|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
163319090|NCT02315703|589878854|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
163319091|NCT02315703|589878855|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
163319092|NCT02315703|589878856|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
163319093|NCT02315703|589878849|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
163319094|NCT02315703|589878850|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
163319095|NCT02315703|589878851|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
163319096|NCT02315703|589878852|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
163319097|NCT02315703|589878853|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
163319098|NCT02315703|589878854|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
163319099|NCT02315703|589878855|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
163319100|NCT02315703|589878856|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
163319101|NCT02315703|589878849|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
163319102|NCT02315703|589878850|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
163319103|NCT02315703|589878851|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
163319104|NCT02315703|589878852|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
163319105|NCT02315703|589878853|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
163319106|NCT02315703|589878854|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
163319107|NCT02315703|589878855|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
163319108|NCT02315703|589878856|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
163319109|NCT02315703|589878849|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
163319110|NCT02315703|589878850|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
163319111|NCT02315703|589878851|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
163319112|NCT02315703|589878852|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
163319113|NCT02315703|589878853|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
163210881|NCT03518073|589486953|FG001|Overall Study|Covid-19|2|||
163210882|NCT03518073|589486954|FG002|Overall Study|Covid-19|1|||
163210883|NCT03045081|589486955|FG000|Overall Study|Withdrawal by Subject|6|||
163210884|NCT03045081|589486956|FG001|Overall Study|Withdrawal by Subject|11|||
163210885|NCT03804879|589486957|FG000|Overall Study|Adverse Event|3|||
163210886|NCT03804879|589486958|FG001|Overall Study|Adverse Event|0|||
163210887|NCT03804879|589486957|FG000|Overall Study|Study Terminated By Sponsor|10|||
163210888|NCT03804879|589486958|FG001|Overall Study|Study Terminated By Sponsor|12|||
163210889|NCT03804879|589486957|FG000|Overall Study|Withdrawal by Subject|3|||
163210890|NCT03804879|589486958|FG001|Overall Study|Withdrawal by Subject|1|||
163210891|NCT02436889|589486959|FG000|Overall Study|No improvement in symptoms|1|||
163210892|NCT02436889|589486960|FG001|Overall Study|No improvement in symptoms|0|||
163210893|NCT02436889|589486959|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
163210894|NCT02436889|589486960|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
163210895|NCT01034462|589486961|FG000|Overall Study|Adverse Event|7|||
163210896|NCT01034462|589486962|FG001|Overall Study|Adverse Event|17|||
163210897|NCT01034462|589486961|FG000|Overall Study|Lack of Efficacy|4|||
163210898|NCT01034462|589486962|FG001|Overall Study|Lack of Efficacy|4|||
163210899|NCT01034462|589486961|FG000|Overall Study|Protocol Violation|10|||
163210900|NCT01034462|589486962|FG001|Overall Study|Protocol Violation|7|||
163210901|NCT01034462|589486961|FG000|Overall Study|Withdrawal by Subject|9|||
163210902|NCT01034462|589486962|FG001|Overall Study|Withdrawal by Subject|8|||
163210903|NCT01034462|589486961|FG000|Overall Study|Lost to Follow-up|14|||
163210904|NCT01034462|589486962|FG001|Overall Study|Lost to Follow-up|16|||
163210905|NCT01034462|589486961|FG000|Overall Study|Other reasons|1|||
163210906|NCT01034462|589486962|FG001|Overall Study|Other reasons|2|||
163210907|NCT02169739|589486964|FG000|Overall Study|Lost to Follow-up|0|||
163210908|NCT02169739|589486965|FG001|Overall Study|Lost to Follow-up|4|||
163058657|NCT00042289|588924250|FG015|Overall Study|Protocol Violation|0|||
163210909|NCT00723892|589486966|FG000|Overall Study|Participant not tracked|33|||
163210910|NCT00723892|589486967|FG001|Overall Study|Participant not tracked|35|||
163210911|NCT00723892|589486966|FG000|Overall Study|Virological criterion|24|||
163210912|NCT00723892|589486967|FG001|Overall Study|Virological criterion|9|||
163210913|NCT00723892|589486966|FG000|Overall Study|Withdrawal by Subject|6|||
163210914|NCT00723892|589486967|FG001|Overall Study|Withdrawal by Subject|9|||
163210915|NCT00723892|589486966|FG000|Overall Study|End planned|11|||
163210916|NCT00723892|589486967|FG001|Overall Study|End planned|7|||
163210917|NCT00723892|589486966|FG000|Overall Study|Bad tolerance|5|||
163210918|NCT00723892|589486967|FG001|Overall Study|Bad tolerance|5|||
163210919|NCT00723892|589486966|FG000|Overall Study|Multiple reasons|17|||
163210920|NCT00723892|589486967|FG001|Overall Study|Multiple reasons|12|||
163210921|NCT00723892|589486966|FG000|Overall Study|Other|6|||
163210922|NCT00723892|589486967|FG001|Overall Study|Other|3|||
163210923|NCT00723892|589486966|FG000|Overall Study|Study end|1|||
163210924|NCT00723892|589486967|FG001|Overall Study|Study end|3|||
163210925|NCT00723892|589486966|FG000|Overall Study|Weight loss|1|||
163210926|NCT00723892|589486967|FG001|Overall Study|Weight loss|3|||
163210927|NCT00723892|589486966|FG000|Overall Study|Alcohol abuse|0|||
163210928|NCT00723892|589486967|FG001|Overall Study|Alcohol abuse|1|||
163210929|NCT00723892|589486966|FG000|Overall Study|Intercurrent infection|2|||
163210930|NCT00723892|589486967|FG001|Overall Study|Intercurrent infection|0|||
163210931|NCT00723892|589486966|FG000|Overall Study|Drug addiction|1|||
163210932|NCT00723892|589486967|FG001|Overall Study|Drug addiction|0|||
163210933|NCT03683758|589486968|FG000|Overall Study|Non-study commitment conflict|1|||
163210934|NCT03683758|589486969|FG001|Overall Study|Non-study commitment conflict|3|||
163210935|NCT03683758|589486968|FG000|Overall Study|Illness preventing participation|1|||
163210936|NCT03683758|589486969|FG001|Overall Study|Illness preventing participation|0|||
163210937|NCT03683758|589486968|FG000|Overall Study|Adverse Event|1|||
163210938|NCT03683758|589486969|FG001|Overall Study|Adverse Event|0|||
163210939|NCT00303498|589486972|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
163210940|NCT00303498|589486973|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
163210941|NCT00303498|589486972|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
163210942|NCT00303498|589486973|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
163210943|NCT00303498|589486972|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
163210944|NCT00303498|589486973|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
163210945|NCT00303498|589486972|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
163210946|NCT00303498|589486973|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
163210947|NCT00303498|589486972|FG000|Run-In-Phase (10 Weeks)|Other|4|||
163210948|NCT00303498|589486973|FG001|Run-In-Phase (10 Weeks)|Other|1|||
163210949|NCT00303498|589486972|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
163210950|NCT00303498|589486973|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
163210951|NCT00303498|589486972|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
163210952|NCT00303498|589486973|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
163210953|NCT00303498|589486972|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
163210954|NCT00303498|589486973|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
163210955|NCT00303498|589486972|FG000|Maintenance Phase (24 Weeks)|Death|1|||
163210956|NCT00303498|589486973|FG001|Maintenance Phase (24 Weeks)|Death|0|||
163210957|NCT00303498|589486972|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
163210958|NCT00303498|589486973|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
163210959|NCT00303498|589486972|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
163210960|NCT00303498|589486973|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
163210961|NCT00303498|589486972|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
163210962|NCT00303498|589486973|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
163210963|NCT00303498|589486972|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
163210964|NCT00303498|589486973|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
163210965|NCT00303498|589486972|FG000|Maintenance Phase (24 Weeks)|Other|1|||
163210966|NCT00303498|589486973|FG001|Maintenance Phase (24 Weeks)|Other|0|||
163210967|NCT00303498|589486972|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
163210968|NCT00303498|589486973|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
163210969|NCT00303498|589486972|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
163210970|NCT00303498|589486973|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
163210971|NCT00546637|589486974|FG000|Overall Study|Adverse Event|46|||
163210972|NCT00546637|589486975|FG001|Overall Study|Adverse Event|20|||
163210973|NCT00546637|589486974|FG000|Overall Study|Lack of Efficacy|5|||
163210974|NCT00546637|589486975|FG001|Overall Study|Lack of Efficacy|5|||
163210975|NCT00546637|589486974|FG000|Overall Study|Lost to Follow-up|2|||
163210976|NCT00546637|589486975|FG001|Overall Study|Lost to Follow-up|2|||
163210977|NCT00546637|589486974|FG000|Overall Study|Other|10|||
163210978|NCT00546637|589486975|FG001|Overall Study|Other|12|||
163210979|NCT00546637|589486974|FG000|Overall Study|Withdrawal by Subject|7|||
163210980|NCT00546637|589486975|FG001|Overall Study|Withdrawal by Subject|9|||
163210981|NCT00546637|589486974|FG000|Overall Study|Randomized, but not treated|3|||
163210982|NCT00546637|589486975|FG001|Overall Study|Randomized, but not treated|1|||
162979132|NCT00773734|588625054|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
162979133|NCT00773734|588625055|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
162979134|NCT00773734|588625050|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
162979135|NCT00773734|588625051|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
162979136|NCT00773734|588625052|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
162979137|NCT00773734|588625053|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
163319114|NCT02315703|589878854|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
163319115|NCT02315703|589878855|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
163319116|NCT02315703|589878856|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
163319117|NCT02315703|589878849|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
163319118|NCT02315703|589878850|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
163319119|NCT02315703|589878851|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
163319120|NCT02315703|589878852|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
163319121|NCT02315703|589878853|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
163319122|NCT02315703|589878854|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
163319123|NCT02315703|589878855|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
163319124|NCT02315703|589878856|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
163319125|NCT02315703|589878849|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
163319126|NCT02315703|589878850|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
163319127|NCT02315703|589878851|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
163319128|NCT02315703|589878852|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
163319129|NCT02315703|589878853|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
163319130|NCT02315703|589878854|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
163319131|NCT02315703|589878855|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
163319132|NCT02315703|589878856|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
163319133|NCT03476343|589878858|FG000|Overall Study|Clinical exam moved to another scanner|7|||
163319134|NCT03476343|589878858|FG000|Overall Study|Clinical order cancelled|4|||
163319135|NCT03476343|589878858|FG000|Overall Study|Neonate did not settle down for the scan|1|||
163319136|NCT02724969|589878859|FG000|Overall Study|Lost to Follow-up|12|||
163319137|NCT02724969|589878860|FG001|Overall Study|Lost to Follow-up|6|||
163319138|NCT02724969|589878859|FG000|Overall Study|Withdrawal by Subject|3|||
163319139|NCT02724969|589878860|FG001|Overall Study|Withdrawal by Subject|3|||
163319140|NCT02724969|589878859|FG000|Overall Study|Infant demise|0|||
163319141|NCT02724969|589878860|FG001|Overall Study|Infant demise|2|||
163319142|NCT05974501|589878861|FG000|Overall Study|Physician Decision|0|||
163319143|NCT05974501|589878862|FG001|Overall Study|Physician Decision|1|||
163319144|NCT02497950|589878866|FG000|Overall Study|Death|209|||
163319145|NCT02497950|589878866|FG000|Overall Study|Transplanted|85|||
163319146|NCT02497950|589878866|FG000|Overall Study|Explanted|8|||
163319147|NCT02497950|589878866|FG000|Overall Study|Device Permanently Deactivated|4|||
163319148|NCT02497950|589878866|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
163319149|NCT02497950|589878866|FG000|Overall Study|Lost to Follow-up|6|||
163319150|NCT02497950|589878866|FG000|Overall Study|Withdrawal by Subject|2|||
163319151|NCT02497950|589878866|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
163319152|NCT02497950|589878866|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
163319153|NCT01221948|589878873|FG000|Overall Study|Physician Decision|5|||
163319154|NCT01221948|589878873|FG000|Overall Study|Withdrawal by Subject|2|||
163319155|NCT01221948|589878873|FG000|Overall Study|not disclosed|2|||
163319156|NCT01221948|589878873|FG000|Overall Study|Death|1|||
163319157|NCT01221948|589878873|FG000|Overall Study|Protocol Violation|4|||
163319158|NCT00746096|589878874|FG000|Overall Study|Adverse Event|1|||
163319159|NCT00746096|589878875|FG001|Overall Study|Adverse Event|0|||
163319160|NCT00746096|589878874|FG000|Overall Study|Withdrawal by Subject|5|||
163319161|NCT00746096|589878875|FG001|Overall Study|Withdrawal by Subject|1|||
163319162|NCT00746096|589878874|FG000|Overall Study|Lost to Follow-up|2|||
163319163|NCT00746096|589878875|FG001|Overall Study|Lost to Follow-up|1|||
163319164|NCT00746096|589878874|FG000|Overall Study|Protocol Violation|1|||
163319165|NCT00746096|589878875|FG001|Overall Study|Protocol Violation|0|||
163319166|NCT00746096|589878874|FG000|Overall Study|No study drug treatment|1|||
163319167|NCT00746096|589878875|FG001|Overall Study|No study drug treatment|1|||
163319168|NCT03756662|589878876|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
163319169|NCT04295512|589878881|FG000|Overall Study|Lack of family response to schedule assessment|0|||
163319170|NCT04295512|589878882|FG001|Overall Study|Lack of family response to schedule assessment|0|||
163319171|NCT04295512|589878883|FG002|Overall Study|Lack of family response to schedule assessment|0|||
163319172|NCT04295512|589878884|FG003|Overall Study|Lack of family response to schedule assessment|2|||
163319173|NCT04295512|589878881|FG000|Overall Study|Therapist did not refer eligible family|7|||
163319174|NCT04295512|589878882|FG001|Overall Study|Therapist did not refer eligible family|7|||
163319175|NCT04295512|589878883|FG002|Overall Study|Therapist did not refer eligible family|0|||
162979138|NCT00773734|588625054|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
163319176|NCT04295512|589878884|FG003|Overall Study|Therapist did not refer eligible family|0|||
163319177|NCT05207956|589878885|FG000|Overall Study|Lost to follow up|1|||
163319178|NCT05207956|589878886|FG001|Overall Study|Lost to follow up|2|||
162979139|NCT00773734|588625055|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
162979140|NCT00773734|588625050|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
162979141|NCT00773734|588625051|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
162979142|NCT00773734|588625052|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
162979143|NCT00773734|588625053|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
162979144|NCT00773734|588625054|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
162979145|NCT00773734|588625055|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
162979146|NCT00773734|588625050|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
162979147|NCT00773734|588625051|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
162979148|NCT00773734|588625052|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
162979149|NCT00773734|588625053|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
162979150|NCT00773734|588625054|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
162979151|NCT00773734|588625055|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
162979152|NCT00773734|588625050|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
162979153|NCT00773734|588625051|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
162979154|NCT00773734|588625052|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
162979155|NCT00773734|588625053|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
163058658|NCT00042289|588924251|FG016|Overall Study|Protocol Violation|0|||
163058659|NCT00042289|588924252|FG017|Overall Study|Protocol Violation|0|||
163058660|NCT00042289|588924253|FG018|Overall Study|Protocol Violation|0|||
163058661|NCT00042289|588924254|FG019|Overall Study|Protocol Violation|0|||
163058662|NCT00042289|588924255|FG020|Overall Study|Protocol Violation|0|||
163058663|NCT00042289|588924256|FG021|Overall Study|Protocol Violation|0|||
163058664|NCT00042289|588924257|FG022|Overall Study|Protocol Violation|0|||
163058665|NCT00042289|588924258|FG023|Overall Study|Protocol Violation|1|||
163058666|NCT00042289|588924259|FG024|Overall Study|Protocol Violation|1|||
163058667|NCT00042289|588924260|FG025|Overall Study|Protocol Violation|0|||
163058668|NCT00042289|588924261|FG026|Overall Study|Protocol Violation|2|||
163210983|NCT04984993|589486979|FG000|Overall Study|Withdrawal by Subject|8|||
163210984|NCT04984993|589486980|FG001|Overall Study|Withdrawal by Subject|2|||
163210985|NCT04984993|589486979|FG000|Overall Study|Lost to Follow-up|2|||
163210986|NCT04984993|589486980|FG001|Overall Study|Lost to Follow-up|2|||
163210987|NCT04984993|589486979|FG000|Overall Study|Both patients moved to another country|4|||
163210988|NCT04984993|589486980|FG001|Overall Study|Both patients moved to another country|0|||
163210989|NCT01110707|589486981|FG000|Overall Study|Protocol Violation|0|||
163210990|NCT01110707|589486982|FG001|Overall Study|Protocol Violation|3|||
163210991|NCT03108027|589486987|FG000|Period 1|Subject/Guardian Decision|0|||
163210992|NCT03108027|589486988|FG001|Period 1|Subject/Guardian Decision|0|||
162979156|NCT00773734|588625054|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
162979157|NCT00773734|588625055|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
163058669|NCT00042289|588924262|FG027|Overall Study|Protocol Violation|0|||
163058670|NCT00042289|588924263|FG028|Overall Study|Protocol Violation|0|||
163058671|NCT00042289|588924264|FG029|Overall Study|Protocol Violation|0|||
163058672|NCT00042289|588924265|FG030|Overall Study|Protocol Violation|1|||
163058673|NCT00042289|588924266|FG031|Overall Study|Protocol Violation|0|||
163058674|NCT00042289|588924267|FG032|Overall Study|Protocol Violation|0|||
163058675|NCT00042289|588924268|FG033|Overall Study|Protocol Violation|0|||
163058676|NCT00042289|588924269|FG034|Overall Study|Protocol Violation|0|||
163058677|NCT00042289|588924270|FG035|Overall Study|Protocol Violation|0|||
163058678|NCT00042289|588924271|FG036|Overall Study|Protocol Violation|0|||
163058679|NCT00042289|588924272|FG037|Overall Study|Protocol Violation|0|||
163058680|NCT00042289|588924273|FG038|Overall Study|Protocol Violation|0|||
163058681|NCT00042289|588924274|FG039|Overall Study|Protocol Violation|0|||
163058682|NCT00042289|588924275|FG040|Overall Study|Protocol Violation|0|||
163058683|NCT00042289|588924276|FG041|Overall Study|Protocol Violation|1|||
163058684|NCT00042289|588924277|FG042|Overall Study|Protocol Violation|1|||
163058685|NCT00042289|588924278|FG043|Overall Study|Protocol Violation|1|||
163058686|NCT00042289|588924279|FG044|Overall Study|Protocol Violation|0|||
163058687|NCT00042289|588924280|FG045|Overall Study|Protocol Violation|0|||
163058688|NCT00042289|588924281|FG046|Overall Study|Protocol Violation|0|||
163058689|NCT00042289|588924235|FG000|Overall Study|Withdrawal by Subject|4|||
163058690|NCT00042289|588924236|FG001|Overall Study|Withdrawal by Subject|1|||
163058691|NCT00042289|588924237|FG002|Overall Study|Withdrawal by Subject|0|||
163058692|NCT00042289|588924238|FG003|Overall Study|Withdrawal by Subject|2|||
163058693|NCT00042289|588924239|FG004|Overall Study|Withdrawal by Subject|0|||
163058694|NCT00042289|588924240|FG005|Overall Study|Withdrawal by Subject|2|||
163058695|NCT00042289|588924241|FG006|Overall Study|Withdrawal by Subject|0|||
163058696|NCT00042289|588924242|FG007|Overall Study|Withdrawal by Subject|0|||
163058697|NCT00042289|588924243|FG008|Overall Study|Withdrawal by Subject|0|||
163058698|NCT00042289|588924244|FG009|Overall Study|Withdrawal by Subject|1|||
163058699|NCT00042289|588924245|FG010|Overall Study|Withdrawal by Subject|0|||
163058700|NCT00042289|588924246|FG011|Overall Study|Withdrawal by Subject|0|||
163058701|NCT00042289|588924247|FG012|Overall Study|Withdrawal by Subject|2|||
163058702|NCT00042289|588924248|FG013|Overall Study|Withdrawal by Subject|0|||
162979158|NCT00773734|588625050|FG000|Extension: Active Treatment Week 24-52|Other|0|||
162979159|NCT00773734|588625051|FG001|Extension: Active Treatment Week 24-52|Other|0|||
162979160|NCT00773734|588625052|FG002|Extension: Active Treatment Week 24-52|Other|1|||
162979161|NCT00773734|588625053|FG003|Extension: Active Treatment Week 24-52|Other|2|||
162979162|NCT00773734|588625054|FG004|Extension: Active Treatment Week 24-52|Other|0|||
162979163|NCT00773734|588625055|FG005|Extension: Active Treatment Week 24-52|Other|1|||
162979164|NCT00773734|588625050|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
162979165|NCT00773734|588625051|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
162979166|NCT00773734|588625052|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
162979167|NCT00773734|588625053|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
162979168|NCT00773734|588625054|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
162979169|NCT00773734|588625055|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
162979170|NCT00773734|588625050|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
163058703|NCT00042289|588924249|FG014|Overall Study|Withdrawal by Subject|0|||
163058704|NCT00042289|588924250|FG015|Overall Study|Withdrawal by Subject|0|||
163058705|NCT00042289|588924251|FG016|Overall Study|Withdrawal by Subject|0|||
163058706|NCT00042289|588924252|FG017|Overall Study|Withdrawal by Subject|0|||
163058707|NCT00042289|588924253|FG018|Overall Study|Withdrawal by Subject|0|||
163058708|NCT00042289|588924254|FG019|Overall Study|Withdrawal by Subject|0|||
163058709|NCT00042289|588924255|FG020|Overall Study|Withdrawal by Subject|0|||
163058710|NCT00042289|588924256|FG021|Overall Study|Withdrawal by Subject|1|||
163058711|NCT00042289|588924257|FG022|Overall Study|Withdrawal by Subject|1|||
163058712|NCT00042289|588924258|FG023|Overall Study|Withdrawal by Subject|1|||
163058713|NCT00042289|588924259|FG024|Overall Study|Withdrawal by Subject|0|||
163058714|NCT00042289|588924260|FG025|Overall Study|Withdrawal by Subject|0|||
163058715|NCT00042289|588924261|FG026|Overall Study|Withdrawal by Subject|1|||
163058716|NCT00042289|588924262|FG027|Overall Study|Withdrawal by Subject|0|||
163058717|NCT00042289|588924263|FG028|Overall Study|Withdrawal by Subject|2|||
163058718|NCT00042289|588924264|FG029|Overall Study|Withdrawal by Subject|0|||
163058719|NCT00042289|588924265|FG030|Overall Study|Withdrawal by Subject|0|||
163210993|NCT03108027|589486989|FG002|Period 1|Subject/Guardian Decision|0|||
163210994|NCT03108027|589486990|FG003|Period 1|Subject/Guardian Decision|2|||
163210995|NCT03108027|589486991|FG004|Period 1|Subject/Guardian Decision|0|||
163210996|NCT03108027|589486992|FG005|Period 1|Subject/Guardian Decision|0|||
163210997|NCT03108027|589486987|FG000|Period 3|Adverse Event|0|||
163210998|NCT03108027|589486988|FG001|Period 3|Adverse Event|1|||
163210999|NCT03108027|589486989|FG002|Period 3|Adverse Event|0|||
163211000|NCT03108027|589486990|FG003|Period 3|Adverse Event|0|||
163211001|NCT03108027|589486991|FG004|Period 3|Adverse Event|0|||
163211002|NCT03108027|589486992|FG005|Period 3|Adverse Event|0|||
163211003|NCT02426892|589486993|FG000|Overall Study|Adverse Event|2|||
163211004|NCT02426892|589486993|FG000|Overall Study|Lack of Efficacy|17|||
163211005|NCT02426892|589486993|FG000|Overall Study|Withdrawal by Subject|1|||
163211006|NCT03178773|589486994|FG000|Overall Study|Death|0|||
163211007|NCT03178773|589486995|FG001|Overall Study|Death|1|||
163211008|NCT03178773|589486994|FG000|Overall Study|Lost to Follow-up|29|||
163211009|NCT03178773|589486995|FG001|Overall Study|Lost to Follow-up|25|||
163211010|NCT03178773|589486994|FG000|Overall Study|Withdrawal by Subject|10|||
163211011|NCT03178773|589486995|FG001|Overall Study|Withdrawal by Subject|14|||
163211012|NCT01382446|589486996|FG000|Overall Study|Withdrawal by Subject|0|||
163211013|NCT01382446|589486997|FG001|Overall Study|Withdrawal by Subject|1|||
163211014|NCT01382446|589486996|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
163211015|NCT01382446|589486997|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
163211016|NCT00003901|589486998|FG000|Overall Study|Adverse Event|1|||
163211017|NCT00003901|589486998|FG000|Overall Study|Withdrawal by Subject|1|||
163211018|NCT00003901|589486998|FG000|Overall Study|Ineligible|6|||
163211019|NCT00003901|589486998|FG000|Overall Study|CT Scan not within protocol requirement|2|||
163211020|NCT00003901|589486998|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
163211021|NCT00003901|589486998|FG000|Overall Study|Medical problems|6|||
163211022|NCT00268996|589487001|FG000|Overall Study|Adverse Event|11|||
163211023|NCT00268996|589487002|FG001|Overall Study|Adverse Event|7|||
163211024|NCT00268996|589487001|FG000|Overall Study|Lost to Follow-up|3|||
163211025|NCT00268996|589487002|FG001|Overall Study|Lost to Follow-up|1|||
163211026|NCT00268996|589487001|FG000|Overall Study|Withdrawal by Subject|5|||
163211027|NCT00268996|589487002|FG001|Overall Study|Withdrawal by Subject|11|||
163211028|NCT00268996|589487001|FG000|Overall Study|Non-compliance|1|||
163058720|NCT00042289|588924266|FG031|Overall Study|Withdrawal by Subject|1|||
163058721|NCT00042289|588924267|FG032|Overall Study|Withdrawal by Subject|2|||
163058722|NCT00042289|588924268|FG033|Overall Study|Withdrawal by Subject|1|||
163058723|NCT00042289|588924269|FG034|Overall Study|Withdrawal by Subject|0|||
163211029|NCT00268996|589487002|FG001|Overall Study|Non-compliance|0|||
163211030|NCT00268996|589487001|FG000|Overall Study|Other|1|||
163211031|NCT00268996|589487002|FG001|Overall Study|Other|1|||
163211032|NCT03325075|589487005|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
163211033|NCT03325075|589487006|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
163211034|NCT03325075|589487007|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
162979171|NCT00773734|588625051|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
162979172|NCT00773734|588625052|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
162979173|NCT00773734|588625053|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
162979174|NCT00773734|588625054|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
162979175|NCT00773734|588625055|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
162979176|NCT00773734|588625050|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
162979177|NCT00773734|588625051|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
162979178|NCT00773734|588625052|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
162979179|NCT00773734|588625053|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
162979180|NCT00773734|588625054|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
162979181|NCT00773734|588625055|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
162979182|NCT00773734|588625050|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
162979183|NCT00773734|588625051|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
162979184|NCT00773734|588625052|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
162979185|NCT00773734|588625053|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
163058724|NCT00042289|588924270|FG035|Overall Study|Withdrawal by Subject|0|||
163319179|NCT01254864|589878888|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
163319180|NCT01254864|589878889|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
163319181|NCT01254864|589878890|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
163319182|NCT01254864|589878888|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
163319183|NCT01254864|589878889|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
163319184|NCT01254864|589878890|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
163319185|NCT01254864|589878888|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
163319186|NCT01254864|589878889|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
163319187|NCT01254864|589878890|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
163319188|NCT01254864|589878888|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
163319189|NCT01254864|589878889|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
163319190|NCT01254864|589878890|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
163319191|NCT01254864|589878888|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
163319192|NCT01254864|589878889|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
163319193|NCT01254864|589878890|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
163319194|NCT01254864|589878888|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
163319195|NCT01254864|589878889|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
163319196|NCT01254864|589878890|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
163319197|NCT01254864|589878888|FG000|Randomization Phase|Adverse Event|0|||
163319198|NCT01254864|589878889|FG001|Randomization Phase|Adverse Event|5|||
163319199|NCT01254864|589878890|FG002|Randomization Phase|Adverse Event|17|||
163319200|NCT01254864|589878888|FG000|Randomization Phase|Death|0|||
163319201|NCT01254864|589878889|FG001|Randomization Phase|Death|1|||
163319202|NCT01254864|589878890|FG002|Randomization Phase|Death|0|||
163319203|NCT01254864|589878888|FG000|Randomization Phase|Lost to Follow-up|0|||
163319204|NCT01254864|589878889|FG001|Randomization Phase|Lost to Follow-up|0|||
163319205|NCT01254864|589878890|FG002|Randomization Phase|Lost to Follow-up|1|||
163319206|NCT01254864|589878888|FG000|Randomization Phase|Physician Decision|0|||
163319207|NCT01254864|589878889|FG001|Randomization Phase|Physician Decision|20|||
163319208|NCT01254864|589878890|FG002|Randomization Phase|Physician Decision|25|||
163319209|NCT01254864|589878888|FG000|Randomization Phase|Withdrawal by Subject|0|||
163319210|NCT01254864|589878889|FG001|Randomization Phase|Withdrawal by Subject|4|||
163319211|NCT01254864|589878890|FG002|Randomization Phase|Withdrawal by Subject|2|||
163319212|NCT01254864|589878888|FG000|Randomization Phase|Non-Compliance|0|||
163319213|NCT01254864|589878889|FG001|Randomization Phase|Non-Compliance|1|||
163319214|NCT01254864|589878890|FG002|Randomization Phase|Non-Compliance|0|||
163319215|NCT01254864|589878888|FG000|Randomization Phase|Comorbidities|0|||
163319216|NCT01254864|589878889|FG001|Randomization Phase|Comorbidities|2|||
163319217|NCT01254864|589878890|FG002|Randomization Phase|Comorbidities|1|||
163319218|NCT03626220|589878891|FG000|Overall Study|Withdrawal by Subject|2|||
163319219|NCT03626220|589878892|FG001|Overall Study|Withdrawal by Subject|0|||
163319220|NCT01651403|589878898|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
163319221|NCT01651403|589878899|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
163319222|NCT01651403|589878898|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
163319223|NCT01651403|589878899|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
163319224|NCT01651403|589878898|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
163319225|NCT01651403|589878899|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
163319226|NCT01651403|589878898|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
163319227|NCT01651403|589878899|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
162979186|NCT00773734|588625054|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
162979187|NCT00773734|588625055|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
163319228|NCT01651403|589878898|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
163319229|NCT01651403|589878899|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
162979188|NCT00856830|588625059|FG000|Irinotecan & Bendamustine|Death|0|||
162979189|NCT00856830|588625060|FG001|Irinotecan & Bendamustine|Death|0|||
162979190|NCT00856830|588625061|FG002|Irinotecan & Bendamustine|Death|0|||
162979191|NCT00856830|588625062|FG003|Irinotecan & Bendamustine|Death|2|||
162979192|NCT00856830|588625059|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
162979193|NCT00856830|588625060|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
162979194|NCT00856830|588625061|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
162979195|NCT00856830|588625062|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
162979196|NCT03768726|588625063|FG000|Treatment Phase|Adverse Event|2|||
162979197|NCT03768726|588625064|FG001|Treatment Phase|Adverse Event|2|||
162979198|NCT03768726|588625063|FG000|Treatment Phase|Lost to Follow-up|1|||
162979199|NCT03768726|588625064|FG001|Treatment Phase|Lost to Follow-up|0|||
163058725|NCT00042289|588924271|FG036|Overall Study|Withdrawal by Subject|0|||
163319230|NCT01651403|589878898|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
163319231|NCT01651403|589878899|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
163319232|NCT05090683|589878900|FG000|Overall Study|Lost to Follow-up|10|||
163319233|NCT05090683|589878901|FG001|Overall Study|Lost to Follow-up|2|||
163319234|NCT05090683|589878900|FG000|Overall Study|Withdrawal by Subject|15|||
163319235|NCT05090683|589878901|FG001|Overall Study|Withdrawal by Subject|0|||
163319236|NCT03325985|589878902|FG000|Overall Study|Lost to Follow-up|122|||
163319237|NCT03325985|589878903|FG001|Overall Study|Lost to Follow-up|26|||
163319238|NCT03325985|589878904|FG002|Overall Study|Lost to Follow-up|141|||
163319239|NCT03325985|589878905|FG003|Overall Study|Lost to Follow-up|28|||
163319240|NCT03325985|589878902|FG000|Overall Study|Death|99|||
163319241|NCT03325985|589878903|FG001|Overall Study|Death|36|||
163319242|NCT03325985|589878904|FG002|Overall Study|Death|94|||
163319243|NCT03325985|589878905|FG003|Overall Study|Death|32|||
163319244|NCT03213665|589878906|FG000|Overall Study|Adverse Event|1|||
163319245|NCT03213665|589878906|FG000|Overall Study|Physician Decision|2|||
163319246|NCT03213665|589878906|FG000|Overall Study|Withdrawal by Subject|3|||
163319247|NCT03213665|589878906|FG000|Overall Study|Progressive Disease|13|||
163319248|NCT03034356|589878907|FG000|Baseline|Lost to Follow-up|2|||
163319249|NCT03034356|589878908|FG001|Baseline|Lost to Follow-up|4|||
163319250|NCT03034356|589878907|FG000|Baseline|Withdrawal by Subject|2|||
163319251|NCT03034356|589878908|FG001|Baseline|Withdrawal by Subject|0|||
163319252|NCT03034356|589878907|FG000|Baseline|Physician Decision|0|||
163319253|NCT03034356|589878908|FG001|Baseline|Physician Decision|1|||
163319254|NCT03034356|589878907|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
163319255|NCT03034356|589878908|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
163319256|NCT03034356|589878907|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
163319257|NCT03034356|589878908|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
163319258|NCT03034356|589878907|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
163319259|NCT03034356|589878908|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
163319260|NCT03034356|589878907|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
163319261|NCT03034356|589878908|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
163319262|NCT02684227|589878909|FG000|Overall Study|Adverse Event|1|||
163319263|NCT02684227|589878910|FG001|Overall Study|Adverse Event|7|||
163319264|NCT02684227|589878909|FG000|Overall Study|Death|0|||
163319265|NCT02684227|589878910|FG001|Overall Study|Death|2|||
163319266|NCT02684227|589878909|FG000|Overall Study|Withdrawal by Subject|0|||
163319267|NCT02684227|589878910|FG001|Overall Study|Withdrawal by Subject|1|||
163319268|NCT02684227|589878909|FG000|Overall Study|Progressive Disease|0|||
163319269|NCT02684227|589878910|FG001|Overall Study|Progressive Disease|2|||
163319270|NCT04571619|589878913|FG000|Phase 1|Death|22|||
163319271|NCT04571619|589878914|FG001|Phase 1|Death|18|||
163319272|NCT04571619|589878913|FG000|Phase 1|Withdrawal by Subject|7|||
163319273|NCT04571619|589878914|FG001|Phase 1|Withdrawal by Subject|2|||
163319274|NCT04571619|589878913|FG000|Phase 2|Death|13|||
163319275|NCT04571619|589878914|FG001|Phase 2|Death|16|||
163319276|NCT04571619|589878913|FG000|Phase 2|Withdrawal by Subject|6|||
163319277|NCT04571619|589878914|FG001|Phase 2|Withdrawal by Subject|4|||
163319278|NCT04580914|589878915|FG000|Overall Study|Withdrawal by Subject|6|||
163319279|NCT04580914|589878915|FG000|Overall Study|Lost to Follow-up|2|||
163319280|NCT04167553|589878919|FG000|Overall Study|Withdrawal by Subject|1|||
163319281|NCT04167553|589878920|FG001|Overall Study|Withdrawal by Subject|0|||
163319282|NCT04167553|589878921|FG002|Overall Study|Withdrawal by Subject|1|||
163319283|NCT04167553|589878922|FG003|Overall Study|Withdrawal by Subject|2|||
163319284|NCT04167553|589878923|FG004|Overall Study|Withdrawal by Subject|1|||
163319285|NCT04167553|589878924|FG005|Overall Study|Withdrawal by Subject|0|||
163319286|NCT04167553|589878925|FG006|Overall Study|Withdrawal by Subject|0|||
163319287|NCT04167553|589878919|FG000|Overall Study|Physician Decision|0|||
163319288|NCT04167553|589878920|FG001|Overall Study|Physician Decision|0|||
162979200|NCT03768726|588625063|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
163319289|NCT04167553|589878921|FG002|Overall Study|Physician Decision|0|||
163319290|NCT04167553|589878922|FG003|Overall Study|Physician Decision|0|||
163319291|NCT04167553|589878923|FG004|Overall Study|Physician Decision|2|||
162979201|NCT03768726|588625064|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
163319292|NCT04167553|589878924|FG005|Overall Study|Physician Decision|2|||
163058726|NCT00042289|588924272|FG037|Overall Study|Withdrawal by Subject|1|||
163058727|NCT00042289|588924273|FG038|Overall Study|Withdrawal by Subject|0|||
163058728|NCT00042289|588924274|FG039|Overall Study|Withdrawal by Subject|0|||
163058729|NCT00042289|588924275|FG040|Overall Study|Withdrawal by Subject|0|||
163058730|NCT00042289|588924276|FG041|Overall Study|Withdrawal by Subject|0|||
163058731|NCT00042289|588924277|FG042|Overall Study|Withdrawal by Subject|1|||
163058732|NCT00042289|588924278|FG043|Overall Study|Withdrawal by Subject|0|||
163058733|NCT00042289|588924279|FG044|Overall Study|Withdrawal by Subject|0|||
163058734|NCT00042289|588924280|FG045|Overall Study|Withdrawal by Subject|0|||
163211035|NCT03325075|589487008|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
163319293|NCT04167553|589878925|FG006|Overall Study|Physician Decision|0|||
163319294|NCT04167553|589878919|FG000|Overall Study|Lost to Follow-up|0|||
163319295|NCT04167553|589878920|FG001|Overall Study|Lost to Follow-up|0|||
163319296|NCT04167553|589878921|FG002|Overall Study|Lost to Follow-up|2|||
163319297|NCT04167553|589878922|FG003|Overall Study|Lost to Follow-up|0|||
163319298|NCT04167553|589878923|FG004|Overall Study|Lost to Follow-up|0|||
163319299|NCT04167553|589878924|FG005|Overall Study|Lost to Follow-up|0|||
163319300|NCT04167553|589878925|FG006|Overall Study|Lost to Follow-up|0|||
163319301|NCT04479761|589878928|FG000|Overall Study|could not perform the balance tasks|1|||
163319302|NCT04479761|589878929|FG001|Overall Study|could not perform the balance tasks|0|||
163319303|NCT04479761|589878930|FG002|Overall Study|could not perform the balance tasks|0|||
163319304|NCT04479761|589878928|FG000|Overall Study|Adverse Event|1|||
163319305|NCT04479761|589878929|FG001|Overall Study|Adverse Event|0|||
163319306|NCT04479761|589878930|FG002|Overall Study|Adverse Event|0|||
163319307|NCT04479761|589878928|FG000|Overall Study|one control did not meet screening criteria|0|||
163319308|NCT04479761|589878929|FG001|Overall Study|one control did not meet screening criteria|0|||
163319309|NCT04479761|589878930|FG002|Overall Study|one control did not meet screening criteria|1|||
163319310|NCT04479761|589878928|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
163319311|NCT04479761|589878929|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
163319312|NCT04479761|589878930|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
163319313|NCT05309291|589878931|FG000|Overall Study|Adverse Event|0|||
163319314|NCT05309291|589878932|FG001|Overall Study|Adverse Event|1|||
163319315|NCT05209152|589878933|FG000|Overall Study|Sponsor decision|1|||
163319316|NCT05209152|589878934|FG001|Overall Study|Sponsor decision|2|||
163319317|NCT05209152|589878933|FG000|Overall Study|Death|3|||
163319318|NCT05209152|589878934|FG001|Overall Study|Death|1|||
163319319|NCT02694822|589881088|FG000|Phase 1|Death|2|||
163319320|NCT02694822|589881089|FG001|Phase 1|Death|1|||
163319321|NCT02694822|589881090|FG002|Phase 1|Death|6|||
163319322|NCT02694822|589881091|FG003|Phase 1|Death|6|||
163319323|NCT02694822|589881092|FG004|Phase 1|Death|3|||
163319324|NCT02694822|589881093|FG005|Phase 1|Death|0|||
163319325|NCT02694822|589881088|FG000|Phase 1|Withdrawal by Subject|2|||
163319326|NCT02694822|589881089|FG001|Phase 1|Withdrawal by Subject|2|||
163319327|NCT02694822|589881090|FG002|Phase 1|Withdrawal by Subject|4|||
163319328|NCT02694822|589881091|FG003|Phase 1|Withdrawal by Subject|8|||
163319329|NCT02694822|589881092|FG004|Phase 1|Withdrawal by Subject|1|||
163319330|NCT02694822|589881093|FG005|Phase 1|Withdrawal by Subject|0|||
163319331|NCT02694822|589881088|FG000|Phase 2|Death|0|||
163319332|NCT02694822|589881089|FG001|Phase 2|Death|0|||
163319333|NCT02694822|589881090|FG002|Phase 2|Death|0|||
163319334|NCT02694822|589881091|FG003|Phase 2|Death|0|||
163319335|NCT02694822|589881092|FG004|Phase 2|Death|0|||
163319336|NCT02694822|589881093|FG005|Phase 2|Death|26|||
163319337|NCT02694822|589881088|FG000|Phase 2|Withdrawal by Subject|0|||
163319338|NCT02694822|589881089|FG001|Phase 2|Withdrawal by Subject|0|||
163319339|NCT02694822|589881090|FG002|Phase 2|Withdrawal by Subject|0|||
163319340|NCT02694822|589881091|FG003|Phase 2|Withdrawal by Subject|0|||
163319341|NCT02694822|589881092|FG004|Phase 2|Withdrawal by Subject|0|||
163319342|NCT02694822|589881093|FG005|Phase 2|Withdrawal by Subject|13|||
163402513|NCT02716987|590184738|FG001|Overall Study|Ligand synthesis failure|0|||
163058735|NCT00042289|588924281|FG046|Overall Study|Withdrawal by Subject|0|||
163058736|NCT00548327|588924286|FG000|Overall Study|Adverse Event|0|||
163058737|NCT00548327|588924287|FG001|Overall Study|Adverse Event|1|||
163211036|NCT03325075|589487005|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
163211037|NCT03325075|589487006|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
163211038|NCT03325075|589487007|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
163211039|NCT03325075|589487008|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
163211040|NCT03325075|589487005|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
163211041|NCT03325075|589487006|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
163211042|NCT03325075|589487007|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
163211043|NCT03325075|589487008|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
163211044|NCT00422591|589487009|FG000|Overall Study|Physician Decision|4|||
163211045|NCT00422591|589487009|FG000|Overall Study|Withdrawal by Subject|2|||
163211046|NCT01414075|589487014|FG000|Overall Study|Adverse Event|1|||
163211047|NCT01414075|589487015|FG001|Overall Study|Adverse Event|0|||
163402514|NCT02716987|590184739|FG002|Overall Study|Ligand synthesis failure|1|||
163402515|NCT02716987|590184740|FG003|Overall Study|Ligand synthesis failure|0|||
163402516|NCT02716987|590184741|FG004|Overall Study|Ligand synthesis failure|0|||
163402517|NCT02716987|590184742|FG005|Overall Study|Ligand synthesis failure|0|||
163402518|NCT02716987|590184737|FG000|Overall Study|Withdrawal by Subject|0|||
163402519|NCT02716987|590184738|FG001|Overall Study|Withdrawal by Subject|0|||
163402520|NCT02716987|590184739|FG002|Overall Study|Withdrawal by Subject|0|||
163402521|NCT02716987|590184740|FG003|Overall Study|Withdrawal by Subject|0|||
163402522|NCT02716987|590184741|FG004|Overall Study|Withdrawal by Subject|1|||
163402523|NCT02716987|590184742|FG005|Overall Study|Withdrawal by Subject|1|||
163402524|NCT01553188|590184743|FG000|Overall Study|Patient choice|1|||
163402525|NCT01553188|590184744|FG001|Overall Study|Patient choice|0|||
163402526|NCT01553188|590184745|FG002|Overall Study|Patient choice|0|||
163402527|NCT01553188|590184746|FG003|Overall Study|Patient choice|0|||
163402528|NCT01553188|590184743|FG000|Overall Study|Intercurrent illness and adverse event|0|||
163402529|NCT01553188|590184744|FG001|Overall Study|Intercurrent illness and adverse event|1|||
162979202|NCT03768726|588625063|FG000|Treatment Phase|Withdrawal by Subject|3|||
162979203|NCT03768726|588625064|FG001|Treatment Phase|Withdrawal by Subject|1|||
162979204|NCT03768726|588625063|FG000|Follow-Up|Adverse Event|2|||
162979205|NCT03768726|588625064|FG001|Follow-Up|Adverse Event|2|||
162979206|NCT03768726|588625063|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
162979207|NCT03768726|588625064|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
162979208|NCT03768726|588625063|FG000|Follow-Up|Withdrawal by Subject|2|||
162979209|NCT03768726|588625064|FG001|Follow-Up|Withdrawal by Subject|0|||
162979210|NCT03768726|588625063|FG000|Follow-Up|Other|1|||
162979211|NCT03768726|588625064|FG001|Follow-Up|Other|0|||
162979212|NCT01787279|588625065|FG000|Overall Study|Lost to Follow-up|2|||
162979213|NCT01787279|588625065|FG000|Overall Study|Lack of Efficacy|1|||
162979214|NCT02148913|588625066|FG000|Overall Study|Death|0|||
162979215|NCT02148913|588625067|FG001|Overall Study|Death|1|||
162979216|NCT02148913|588625068|FG002|Overall Study|Death|0|||
162979217|NCT02148913|588625069|FG003|Overall Study|Death|0|||
162979218|NCT01360866|588625071|FG000|Overall Study|Lost to Follow-up|11|||
162979219|NCT01360866|588625072|FG001|Overall Study|Lost to Follow-up|28|||
162979220|NCT01360866|588625073|FG002|Overall Study|Lost to Follow-up|41|||
162979221|NCT01360866|588625074|FG003|Overall Study|Lost to Follow-up|0|||
162979222|NCT01360866|588625071|FG000|Overall Study|Adverse Event|56|||
162979223|NCT01360866|588625072|FG001|Overall Study|Adverse Event|61|||
162979224|NCT01360866|588625073|FG002|Overall Study|Adverse Event|134|||
162979225|NCT01360866|588625074|FG003|Overall Study|Adverse Event|6|||
162979226|NCT01360866|588625071|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
162979227|NCT01360866|588625072|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
162979228|NCT01360866|588625073|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
163211048|NCT01414075|589487016|FG002|Overall Study|Adverse Event|1|||
163211049|NCT01414075|589487017|FG003|Overall Study|Adverse Event|0|||
163211050|NCT01414075|589487014|FG000|Overall Study|Death|1|||
163211051|NCT01414075|589487015|FG001|Overall Study|Death|0|||
163211052|NCT01414075|589487016|FG002|Overall Study|Death|0|||
163211053|NCT01414075|589487017|FG003|Overall Study|Death|1|||
163211054|NCT01414075|589487014|FG000|Overall Study|Withdrawal by Subject|0|||
163211055|NCT01414075|589487015|FG001|Overall Study|Withdrawal by Subject|0|||
163211056|NCT01414075|589487016|FG002|Overall Study|Withdrawal by Subject|0|||
163211057|NCT01414075|589487017|FG003|Overall Study|Withdrawal by Subject|1|||
163211058|NCT01414075|589487014|FG000|Overall Study|Other than specified|1|||
163211059|NCT01414075|589487015|FG001|Overall Study|Other than specified|0|||
163211060|NCT01414075|589487016|FG002|Overall Study|Other than specified|1|||
163211061|NCT01414075|589487017|FG003|Overall Study|Other than specified|0|||
163211062|NCT00573534|589487019|FG000|Overall Study|oppositional behavior|3|||
163211063|NCT04851314|589487024|FG000|Overall Study|Unable to complete research set-up procedures|0|||
163211064|NCT04851314|589487025|FG001|Overall Study|Unable to complete research set-up procedures|2|||
163211065|NCT04851314|589487024|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
163211066|NCT04851314|589487025|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
163211067|NCT00867009|589487026|FG000|Induction Period|Nonserious Adverse Event|5|||
163211068|NCT00867009|589487026|FG000|Induction Period|Serious Adverse Event|10|||
163211069|NCT00867009|589487026|FG000|Induction Period|Death due to serious adverse event|6|||
163211070|NCT00867009|589487026|FG000|Induction Period|Death due to Study Disease|4|||
163211071|NCT00867009|589487026|FG000|Induction Period|Protocol Violation|1|||
163211072|NCT00867009|589487026|FG000|Induction Period|Withdrawal by Subject|8|||
163211073|NCT00867009|589487026|FG000|Induction Period|Physician Decision|3|||
163211074|NCT00867009|589487026|FG000|Induction Period|Progressive Disease (PD)|25|||
163211075|NCT00867009|589487026|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
163211076|NCT03266094|589487027|FG000|Overall Study|Lost to Follow-up|1|||
163211077|NCT03266094|589487027|FG000|Overall Study|Withdrawal by Subject|1|||
163211078|NCT03241342|589487034|FG000|Overall Study|Adverse Event|5|||
163211079|NCT03241342|589487035|FG001|Overall Study|Adverse Event|8|||
163319343|NCT02694822|589881088|FG000|Phase 2|Administrative Study Closure|0|||
163319344|NCT02694822|589881089|FG001|Phase 2|Administrative Study Closure|0|||
163319345|NCT02694822|589881090|FG002|Phase 2|Administrative Study Closure|0|||
163319346|NCT02694822|589881091|FG003|Phase 2|Administrative Study Closure|0|||
163319347|NCT02694822|589881092|FG004|Phase 2|Administrative Study Closure|0|||
163319348|NCT02694822|589881093|FG005|Phase 2|Administrative Study Closure|2|||
163319349|NCT02694822|589881088|FG000|Phase 2|Lost to Follow-up|0|||
163319350|NCT02694822|589881089|FG001|Phase 2|Lost to Follow-up|0|||
163319351|NCT02694822|589881090|FG002|Phase 2|Lost to Follow-up|0|||
163319352|NCT02694822|589881091|FG003|Phase 2|Lost to Follow-up|0|||
163319353|NCT02694822|589881092|FG004|Phase 2|Lost to Follow-up|0|||
163319354|NCT02694822|589881093|FG005|Phase 2|Lost to Follow-up|1|||
163319355|NCT02694822|589881088|FG000|Phase 2|Participant Transferred to Another Site|0|||
163319356|NCT02694822|589881089|FG001|Phase 2|Participant Transferred to Another Site|0|||
163319357|NCT02694822|589881090|FG002|Phase 2|Participant Transferred to Another Site|0|||
163319358|NCT02694822|589881091|FG003|Phase 2|Participant Transferred to Another Site|0|||
163319359|NCT02694822|589881092|FG004|Phase 2|Participant Transferred to Another Site|0|||
163319360|NCT02694822|589881093|FG005|Phase 2|Participant Transferred to Another Site|1|||
163319361|NCT05370040|589881094|FG000|Overall Study|Lost to Follow-up|0|||
163319362|NCT05370040|589881095|FG001|Overall Study|Lost to Follow-up|0|||
163319363|NCT05370040|589881096|FG002|Overall Study|Lost to Follow-up|1|||
163319364|NCT05370040|589881097|FG003|Overall Study|Lost to Follow-up|0|||
163319365|NCT05370040|589881098|FG004|Overall Study|Lost to Follow-up|1|||
163319366|NCT05370040|589881099|FG005|Overall Study|Lost to Follow-up|0|||
163319367|NCT04294641|589881100|FG000|Overall Study|Screen failure|4|||
163319368|NCT05906784|589881102|FG000|Overall Study|Lost to Follow-up|2|||
163319369|NCT05906784|589881103|FG001|Overall Study|Lost to Follow-up|1|||
163319370|NCT05906784|589881104|FG002|Overall Study|Lost to Follow-up|1|||
163319371|NCT05906784|589881105|FG003|Overall Study|Lost to Follow-up|1|||
163319372|NCT03249090|589881115|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
163319373|NCT03249090|589881116|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
163319374|NCT03249090|589881115|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
163319375|NCT03249090|589881116|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
163319376|NCT03249090|589881115|FG000|3 Month Time Point|Voluntary withdrawal|6|||
163319377|NCT03249090|589881116|FG001|3 Month Time Point|Voluntary withdrawal|3|||
163319378|NCT03249090|589881115|FG000|3 Month Time Point|Changed oncology practice|4|||
163319379|NCT03249090|589881116|FG001|3 Month Time Point|Changed oncology practice|2|||
163319380|NCT03249090|589881115|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
163319381|NCT03249090|589881116|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
163319382|NCT03249090|589881115|FG000|12 Month Time Point|Voluntary withdrawal|35|||
163319383|NCT03249090|589881116|FG001|12 Month Time Point|Voluntary withdrawal|4|||
163319384|NCT03249090|589881115|FG000|12 Month Time Point|Changed oncology practice|20|||
163319385|NCT03249090|589881116|FG001|12 Month Time Point|Changed oncology practice|9|||
163319386|NCT05147116|589881133|FG000|Overall Study|Withdrawal by Subject|0|||
163319387|NCT05147116|589881134|FG001|Overall Study|Withdrawal by Subject|1|||
163319388|NCT03672916|589881135|FG000|Overall Study|Death|6|||
163319389|NCT03672916|589881135|FG000|Overall Study|Lost to Follow-up|29|||
163319390|NCT03672916|589881135|FG000|Overall Study|Adverse Event|6|||
163319391|NCT03672916|589881135|FG000|Overall Study|Withdrawal by Subject|11|||
163319392|NCT04197336|589881136|FG000|Overall Study|Withdrawal by Subject|1|||
163319393|NCT04625725|589881138|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
163319394|NCT04625725|589881139|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
163319395|NCT04625725|589881140|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
163319396|NCT04625725|589881141|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
163319397|NCT04625725|589881142|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
163319398|NCT04625725|589881143|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
163319399|NCT04625725|589881138|FG000|Provent Main Study|Withdrawal by Subject|242|||
163319400|NCT04625725|589881139|FG001|Provent Main Study|Withdrawal by Subject|144|||
163319401|NCT04625725|589881140|FG002|Provent Main Study|Withdrawal by Subject|0|||
163319402|NCT04625725|589881141|FG003|Provent Main Study|Withdrawal by Subject|0|||
163319403|NCT04625725|589881142|FG004|Provent Main Study|Withdrawal by Subject|0|||
163319404|NCT04625725|589881143|FG005|Provent Main Study|Withdrawal by Subject|0|||
163319405|NCT04625725|589881138|FG000|Provent Main Study|Physician Decision|5|||
163402530|NCT01553188|590184745|FG002|Overall Study|Intercurrent illness and adverse event|2|||
163402531|NCT01553188|590184746|FG003|Overall Study|Intercurrent illness and adverse event|0|||
163319406|NCT04625725|589881139|FG001|Provent Main Study|Physician Decision|0|||
163319407|NCT04625725|589881140|FG002|Provent Main Study|Physician Decision|0|||
163319408|NCT04625725|589881141|FG003|Provent Main Study|Physician Decision|0|||
163319409|NCT04625725|589881142|FG004|Provent Main Study|Physician Decision|0|||
163319410|NCT04625725|589881143|FG005|Provent Main Study|Physician Decision|0|||
162979229|NCT01360866|588625074|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
162979230|NCT01360866|588625071|FG000|Overall Study|Withdrawn by Investigator|9|||
162979231|NCT01360866|588625072|FG001|Overall Study|Withdrawn by Investigator|8|||
162979232|NCT01360866|588625073|FG002|Overall Study|Withdrawn by Investigator|31|||
163058738|NCT04460885|588924292|FG000|Overall Study|Withdrawal by Subject|6|||
163058739|NCT04460885|588924293|FG001|Overall Study|Withdrawal by Subject|8|||
163058740|NCT04460885|588924292|FG000|Overall Study|Site closure|1|||
163058741|NCT04460885|588924293|FG001|Overall Study|Site closure|0|||
163058742|NCT04460885|588924292|FG000|Overall Study|Death|5|||
163058743|NCT04460885|588924293|FG001|Overall Study|Death|4|||
163211080|NCT03241342|589487036|FG002|Overall Study|Adverse Event|4|||
163211081|NCT03241342|589487034|FG000|Overall Study|Lack of Efficacy|0|||
163211082|NCT03241342|589487035|FG001|Overall Study|Lack of Efficacy|0|||
163211083|NCT03241342|589487036|FG002|Overall Study|Lack of Efficacy|1|||
163211084|NCT03241342|589487034|FG000|Overall Study|noncompliance with study drug|2|||
163211085|NCT03241342|589487035|FG001|Overall Study|noncompliance with study drug|1|||
163211086|NCT03241342|589487036|FG002|Overall Study|noncompliance with study drug|1|||
163211087|NCT03241342|589487034|FG000|Overall Study|sponsor decision|0|||
163211088|NCT03241342|589487035|FG001|Overall Study|sponsor decision|1|||
163211089|NCT03241342|589487036|FG002|Overall Study|sponsor decision|2|||
163211090|NCT03241342|589487034|FG000|Overall Study|not reported|15|||
163211091|NCT03241342|589487035|FG001|Overall Study|not reported|21|||
163211092|NCT03241342|589487036|FG002|Overall Study|not reported|19|||
163211093|NCT03036072|589487040|FG000|Overall Study|Death|0|||
163211094|NCT03036072|589487041|FG001|Overall Study|Death|1|||
163211095|NCT03036072|589487040|FG000|Overall Study|Withdrawal by Subject|0|||
163211096|NCT03036072|589487041|FG001|Overall Study|Withdrawal by Subject|1|||
163211097|NCT03036072|589487040|FG000|Overall Study|Physician Decision|0|||
163211098|NCT03036072|589487041|FG001|Overall Study|Physician Decision|1|||
163211099|NCT03334903|589487042|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
163211100|NCT03334903|589487043|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
163211101|NCT03334903|589487042|FG000|Overall Study|Protocol Violation|1|||
163211102|NCT03334903|589487043|FG001|Overall Study|Protocol Violation|3|||
163211103|NCT03334903|589487042|FG000|Overall Study|Surgery postponed|1|||
163211104|NCT03334903|589487043|FG001|Overall Study|Surgery postponed|0|||
163211105|NCT03334903|589487042|FG000|Overall Study|Adverse Event|1|||
163211106|NCT03334903|589487043|FG001|Overall Study|Adverse Event|1|||
163211107|NCT03334903|589487042|FG000|Overall Study|Withdrawal by Subject|0|||
163211108|NCT03334903|589487043|FG001|Overall Study|Withdrawal by Subject|1|||
163211109|NCT00001596|589488770|FG000|Overall Study|Death|1|||
163211110|NCT00001596|589488771|FG001|Overall Study|Death|0|||
163211111|NCT00001596|589488770|FG000|Overall Study|Withdrawal by Subject|3|||
163211112|NCT00001596|589488771|FG001|Overall Study|Withdrawal by Subject|1|||
163211113|NCT00001596|589488770|FG000|Overall Study|Study Termination|12|||
163211114|NCT00001596|589488771|FG001|Overall Study|Study Termination|9|||
163211115|NCT00001596|589488770|FG000|Overall Study|Adverse Event|1|||
163211116|NCT00001596|589488771|FG001|Overall Study|Adverse Event|0|||
163211117|NCT00903617|589488776|FG000|Overall Study|Adverse Event|0|||
163211118|NCT00903617|589488777|FG001|Overall Study|Adverse Event|1|||
163211119|NCT00903617|589488778|FG002|Overall Study|Adverse Event|1|||
163211120|NCT00903617|589488779|FG003|Overall Study|Adverse Event|0|||
163211121|NCT00903617|589488776|FG000|Overall Study|Protocol-defined stopping criteria|0|||
163211122|NCT00903617|589488777|FG001|Overall Study|Protocol-defined stopping criteria|2|||
163211123|NCT00903617|589488778|FG002|Overall Study|Protocol-defined stopping criteria|0|||
163211124|NCT00903617|589488779|FG003|Overall Study|Protocol-defined stopping criteria|0|||
163211125|NCT00903617|589488776|FG000|Overall Study|Lost to Follow-up|2|||
163211126|NCT00903617|589488777|FG001|Overall Study|Lost to Follow-up|0|||
163211127|NCT00903617|589488778|FG002|Overall Study|Lost to Follow-up|1|||
163211128|NCT00903617|589488779|FG003|Overall Study|Lost to Follow-up|1|||
163211129|NCT00903617|589488776|FG000|Overall Study|Withdrawal by Subject|1|||
163211130|NCT00903617|589488777|FG001|Overall Study|Withdrawal by Subject|2|||
163211131|NCT00903617|589488778|FG002|Overall Study|Withdrawal by Subject|3|||
163211132|NCT00903617|589488779|FG003|Overall Study|Withdrawal by Subject|0|||
163211133|NCT01104636|589488780|FG000|Overall Study|Lack of Efficacy|43|||
163211134|NCT01104636|589488780|FG000|Overall Study|Lost to Follow-up|24|||
163211135|NCT01104636|589488780|FG000|Overall Study|Withdrawal by Subject|4|||
163211136|NCT01104636|589488780|FG000|Overall Study|Other|43|||
163211137|NCT01104636|589488780|FG000|Overall Study|Study terminated by sponsor|1|||
163211138|NCT01104636|589488780|FG000|Overall Study|Pregnancy|2|||
163211139|NCT01104636|589488780|FG000|Overall Study|Adverse Event|40|||
163211140|NCT01104636|589488780|FG000|Overall Study|Ongoing|21|||
163211141|NCT01706003|589488781|FG000|Overall Study|Withdrawal by Subject|2|||
163211142|NCT01706003|589488782|FG001|Overall Study|Withdrawal by Subject|0|||
163211143|NCT01706003|589488781|FG000|Overall Study|Not scheduled|3|||
163211144|NCT01706003|589488782|FG001|Overall Study|Not scheduled|0|||
163058744|NCT04460885|588924292|FG000|Overall Study|Physician Decision|2|||
163211145|NCT01706003|589488781|FG000|Overall Study|Lost to Follow-up|6|||
163211146|NCT01706003|589488782|FG001|Overall Study|Lost to Follow-up|4|||
163058745|NCT04460885|588924293|FG001|Overall Study|Physician Decision|1|||
163211147|NCT01244906|589488784|FG000|Overall Study|Death|2|||
163211148|NCT01244906|589488784|FG000|Overall Study|Progression of disease post treatment|6|||
163211149|NCT03480750|589488785|FG000|Overall Study|Withdrawal by Subject|0|||
163058746|NCT04460885|588924292|FG000|Overall Study|Lost to Follow-up|4|||
163058747|NCT04460885|588924293|FG001|Overall Study|Lost to Follow-up|4|||
163058748|NCT05001620|588924294|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
163058749|NCT05001620|588924295|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
163058750|NCT00537277|588924296|FG000|Overall Study|Adverse Event|1|||
163058751|NCT00537277|588924296|FG000|Overall Study|Lack of Efficacy|2|||
163058752|NCT00537277|588924296|FG000|Overall Study|Lost to Follow-up|12|||
163058753|NCT00537277|588924296|FG000|Overall Study|Protocol Violation|11|||
163058754|NCT00537277|588924296|FG000|Overall Study|Unclassified|4|||
163058755|NCT00537277|588924296|FG000|Overall Study|Inability to tolerate trial medication|4|||
163058756|NCT00537277|588924296|FG000|Overall Study|Non-compliance with trial procedures|15|||
163058757|NCT05282823|588924297|FG000|Overall Study|Withdrawal by Subject|9|||
163058758|NCT05282823|588924297|FG000|Overall Study|Adverse Event|1|||
163058759|NCT05282823|588924297|FG000|Overall Study|did not meet protocol criteria|2|||
163058760|NCT05282823|588924297|FG000|Overall Study|Withdrawal by Subject|7|||
163058761|NCT05352815|588924298|FG000|Overall Study|Withdrawal by Subject|28|||
163058762|NCT05352815|588924299|FG001|Overall Study|Withdrawal by Subject|24|||
163058763|NCT05352815|588924298|FG000|Overall Study|Lost to Follow-up|4|||
163058764|NCT05352815|588924299|FG001|Overall Study|Lost to Follow-up|7|||
163058765|NCT05352815|588924298|FG000|Overall Study|Death|2|||
163058766|NCT05352815|588924299|FG001|Overall Study|Death|3|||
163058767|NCT05352815|588924298|FG000|Overall Study|Site closure|1|||
163058768|NCT05352815|588924299|FG001|Overall Study|Site closure|0|||
163058769|NCT00226655|588924300|FG000|Overall Study|Death|13|||
163058770|NCT00226655|588924300|FG000|Overall Study|Withdrawal by Subject|15|||
163058771|NCT00226655|588924300|FG000|Overall Study|Adverse Event|35|||
163058772|NCT00226655|588924300|FG000|Overall Study|Physician Decision|6|||
163058773|NCT00226655|588924300|FG000|Overall Study|Clinical deterioration|10|||
163058774|NCT05144945|588924301|FG000|Overall Study|Withdrawal by Subject|1|||
163058775|NCT05144945|588924302|FG001|Overall Study|Withdrawal by Subject|0|||
163058776|NCT02592824|588924308|FG000|Overall Study|Protocol Violation|5|||
163058777|NCT02592824|588924309|FG001|Overall Study|Protocol Violation|3|||
163058778|NCT02592824|588924308|FG000|Overall Study|Lost to Follow-up|2|||
163058779|NCT02592824|588924309|FG001|Overall Study|Lost to Follow-up|1|||
163058780|NCT01704261|588924310|FG000|Overall Study|Withdrawal by Subject|12|||
163058781|NCT01704261|588924311|FG001|Overall Study|Withdrawal by Subject|15|||
163058782|NCT01704261|588924310|FG000|Overall Study|Lost to Follow-up|1|||
163058783|NCT01704261|588924311|FG001|Overall Study|Lost to Follow-up|0|||
163058784|NCT02391337|588924312|FG000|6 Months Follow-up|Death|5|||
163058785|NCT02391337|588924313|FG001|6 Months Follow-up|Death|4|||
163058786|NCT02391337|588924312|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
163058787|NCT02391337|588924313|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
163058788|NCT02391337|588924312|FG000|12 Months Follow-up|Death|2|||
163058789|NCT02391337|588924313|FG001|12 Months Follow-up|Death|0|||
163058790|NCT02391337|588924312|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
163058791|NCT02391337|588924313|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
163058792|NCT02391337|588924312|FG000|12 Months Follow-up|Lost to Follow-up|0|||
163058793|NCT02391337|588924313|FG001|12 Months Follow-up|Lost to Follow-up|2|||
163058794|NCT02855268|588924315|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
163058795|NCT02855268|588924316|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
163058796|NCT02855268|588924315|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
163058797|NCT02855268|588924316|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
163058798|NCT02855268|588924315|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
163058799|NCT02855268|588924316|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
163058800|NCT02855268|588924315|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
163058801|NCT02855268|588924316|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
163058802|NCT02855268|588924315|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
163058803|NCT02855268|588924316|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
163058804|NCT02855268|588924315|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
163058805|NCT02855268|588924316|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
163058806|NCT00465517|588924319|FG000|Overall Study|Adverse Event|7|||
163058807|NCT00465517|588924320|FG001|Overall Study|Adverse Event|3|||
163058808|NCT00465517|588924319|FG000|Overall Study|Lost to Follow-up|1|||
163058809|NCT00465517|588924320|FG001|Overall Study|Lost to Follow-up|0|||
163058810|NCT00465517|588924319|FG000|Overall Study|Withdrawal by Subject|4|||
163058811|NCT00465517|588924320|FG001|Overall Study|Withdrawal by Subject|1|||
163058812|NCT01286129|588924321|FG000|Overall Study|Withdrawal by Subject|4|||
163058813|NCT01286129|588924322|FG001|Overall Study|Withdrawal by Subject|1|||
163058814|NCT01286129|588924321|FG000|Overall Study|Could not comply with study requirements|4|||
163058815|NCT01286129|588924322|FG001|Overall Study|Could not comply with study requirements|4|||
163058816|NCT00111761|588924325|FG000|Part 1|Physician Decision|0|||
163058817|NCT00111761|588924326|FG001|Part 1|Physician Decision|1|||
163058818|NCT00111761|588924325|FG000|Part 1|Death|0|||
163058819|NCT00111761|588924326|FG001|Part 1|Death|2|||
163058820|NCT00111761|588924325|FG000|Part 1|Other|0|||
163058821|NCT00111761|588924326|FG001|Part 1|Other|1|||
163058822|NCT00111761|588924325|FG000|Part 1|Withdrawal by Subject|0|||
163058823|NCT00111761|588924326|FG001|Part 1|Withdrawal by Subject|1|||
163058824|NCT00111761|588924325|FG000|Part 2|Adverse Event|1|||
163058825|NCT00111761|588924326|FG001|Part 2|Adverse Event|0|||
163058826|NCT00111761|588924325|FG000|Part 2|Physician Decision|1|||
163058827|NCT00111761|588924326|FG001|Part 2|Physician Decision|0|||
163058828|NCT00111761|588924325|FG000|Part 2|Death|1|||
163058829|NCT00111761|588924326|FG001|Part 2|Death|0|||
163058830|NCT00111761|588924325|FG000|Part 2|Disease progression|3|||
163058831|NCT00111761|588924326|FG001|Part 2|Disease progression|0|||
163058832|NCT00111761|588924325|FG000|Part 2|Protocol-specified criteria|1|||
163319411|NCT04625725|589881138|FG000|Provent Main Study|Protocol Violation|1|||
163319412|NCT04625725|589881139|FG001|Provent Main Study|Protocol Violation|0|||
163319413|NCT04625725|589881140|FG002|Provent Main Study|Protocol Violation|0|||
163319414|NCT04625725|589881141|FG003|Provent Main Study|Protocol Violation|0|||
163319415|NCT04625725|589881142|FG004|Provent Main Study|Protocol Violation|0|||
163319416|NCT04625725|589881143|FG005|Provent Main Study|Protocol Violation|0|||
163319417|NCT04625725|589881138|FG000|Provent Main Study|Lost to Follow-up|357|||
163319418|NCT04625725|589881139|FG001|Provent Main Study|Lost to Follow-up|200|||
163319419|NCT04625725|589881140|FG002|Provent Main Study|Lost to Follow-up|0|||
163319420|NCT04625725|589881141|FG003|Provent Main Study|Lost to Follow-up|0|||
163319421|NCT04625725|589881142|FG004|Provent Main Study|Lost to Follow-up|0|||
163319422|NCT04625725|589881143|FG005|Provent Main Study|Lost to Follow-up|0|||
163319423|NCT04625725|589881138|FG000|Provent Main Study|Death|22|||
163319424|NCT04625725|589881139|FG001|Provent Main Study|Death|10|||
163319425|NCT04625725|589881140|FG002|Provent Main Study|Death|0|||
163319426|NCT04625725|589881141|FG003|Provent Main Study|Death|0|||
163319427|NCT04625725|589881142|FG004|Provent Main Study|Death|0|||
163319428|NCT04625725|589881143|FG005|Provent Main Study|Death|0|||
163319429|NCT04625725|589881138|FG000|Provent Main Study|Adverse Event|2|||
163319430|NCT04625725|589881139|FG001|Provent Main Study|Adverse Event|1|||
163319431|NCT04625725|589881140|FG002|Provent Main Study|Adverse Event|0|||
163319432|NCT04625725|589881141|FG003|Provent Main Study|Adverse Event|0|||
163319433|NCT04625725|589881142|FG004|Provent Main Study|Adverse Event|0|||
163319434|NCT04625725|589881143|FG005|Provent Main Study|Adverse Event|0|||
163319435|NCT04625725|589881138|FG000|Provent Main Study|Participants dosed in sub-study|310|||
163319436|NCT04625725|589881139|FG001|Provent Main Study|Participants dosed in sub-study|193|||
163319437|NCT04625725|589881140|FG002|Provent Main Study|Participants dosed in sub-study|0|||
163319438|NCT04625725|589881141|FG003|Provent Main Study|Participants dosed in sub-study|0|||
163319439|NCT04625725|589881142|FG004|Provent Main Study|Participants dosed in sub-study|0|||
163319440|NCT04625725|589881143|FG005|Provent Main Study|Participants dosed in sub-study|0|||
163319441|NCT04625725|589881138|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
163319442|NCT04625725|589881139|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
163319443|NCT04625725|589881140|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
163319444|NCT04625725|589881141|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
163319445|NCT04625725|589881142|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
163319446|NCT04625725|589881143|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
163319447|NCT04625725|589881138|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
163319448|NCT04625725|589881139|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
163319449|NCT04625725|589881140|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
163319450|NCT04625725|589881141|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
163319451|NCT04625725|589881142|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
163319452|NCT04625725|589881143|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
163319453|NCT04625725|589881138|FG000|Provent Main Study|INCARCERATION|3|||
163319454|NCT04625725|589881139|FG001|Provent Main Study|INCARCERATION|0|||
163319455|NCT04625725|589881140|FG002|Provent Main Study|INCARCERATION|0|||
163319456|NCT04625725|589881141|FG003|Provent Main Study|INCARCERATION|0|||
163319457|NCT04625725|589881142|FG004|Provent Main Study|INCARCERATION|0|||
163319458|NCT04625725|589881143|FG005|Provent Main Study|INCARCERATION|0|||
163058833|NCT00111761|588924326|FG001|Part 2|Protocol-specified criteria|0|||
163058834|NCT00111761|588924325|FG000|Part 2|Other|1|||
163058835|NCT00111761|588924326|FG001|Part 2|Other|0|||
163058836|NCT02029417|588924331|FG000|Overall Study|Death|1|||
163319459|NCT04625725|589881138|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
163319460|NCT04625725|589881139|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
163319461|NCT04625725|589881140|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
163319462|NCT04625725|589881141|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
163319463|NCT04625725|589881142|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
163319464|NCT04625725|589881143|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
163402532|NCT05289570|590184748|FG000|Overall Study|Physician Decision|1|||
163058837|NCT02029417|588924331|FG000|Overall Study|Adverse Event|1|||
163058838|NCT00071981|588924332|FG000|Overall Study|Lack of Efficacy|37|||
163058839|NCT00071981|588924333|FG001|Overall Study|Lack of Efficacy|29|||
163058840|NCT00071981|588924334|FG002|Overall Study|Lack of Efficacy|30|||
163058841|NCT00071981|588924335|FG003|Overall Study|Lack of Efficacy|43|||
163058842|NCT00071981|588924332|FG000|Overall Study|Adverse Event|4|||
163058843|NCT00071981|588924333|FG001|Overall Study|Adverse Event|4|||
163058844|NCT00071981|588924334|FG002|Overall Study|Adverse Event|3|||
163058845|NCT00071981|588924335|FG003|Overall Study|Adverse Event|1|||
163058846|NCT00071981|588924332|FG000|Overall Study|Death|0|||
163058847|NCT00071981|588924333|FG001|Overall Study|Death|0|||
163058848|NCT00071981|588924334|FG002|Overall Study|Death|1|||
163058849|NCT00071981|588924335|FG003|Overall Study|Death|1|||
163058850|NCT00071981|588924332|FG000|Overall Study|Withdrawal by Subject|3|||
163058851|NCT00071981|588924333|FG001|Overall Study|Withdrawal by Subject|1|||
163058852|NCT00071981|588924334|FG002|Overall Study|Withdrawal by Subject|0|||
163058853|NCT00071981|588924335|FG003|Overall Study|Withdrawal by Subject|0|||
163058854|NCT00071981|588924332|FG000|Overall Study|No protocol therapy|2|||
163058855|NCT00071981|588924333|FG001|Overall Study|No protocol therapy|5|||
163058856|NCT00071981|588924334|FG002|Overall Study|No protocol therapy|1|||
163058857|NCT00071981|588924335|FG003|Overall Study|No protocol therapy|0|||
163058858|NCT00071981|588924332|FG000|Overall Study|others (not specified in the study)|0|||
163058859|NCT00071981|588924333|FG001|Overall Study|others (not specified in the study)|2|||
163058860|NCT00071981|588924334|FG002|Overall Study|others (not specified in the study)|2|||
163058861|NCT00071981|588924335|FG003|Overall Study|others (not specified in the study)|0|||
163058862|NCT04458922|588924336|FG000|Overall Study|Withdrawal by Subject|1|||
163058863|NCT04458922|588924337|FG001|Overall Study|Withdrawal by Subject|0|||
163058864|NCT04458922|588924338|FG002|Overall Study|Withdrawal by Subject|2|||
163058865|NCT04458922|588924336|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
163058866|NCT04458922|588924337|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
163211150|NCT03480750|589488786|FG001|Overall Study|Withdrawal by Subject|1|||
163211151|NCT03480750|589488787|FG002|Overall Study|Withdrawal by Subject|0|||
163211152|NCT03480750|589488788|FG003|Overall Study|Withdrawal by Subject|0|||
163319465|NCT04625725|589881138|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
163319466|NCT04625725|589881139|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
163319467|NCT04625725|589881140|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
163319468|NCT04625725|589881141|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
163319469|NCT04625725|589881142|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
163319470|NCT04625725|589881143|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
163319471|NCT04625725|589881138|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
163211153|NCT03480750|589488789|FG004|Overall Study|Withdrawal by Subject|0|||
163211154|NCT03480750|589488790|FG005|Overall Study|Withdrawal by Subject|0|||
163211155|NCT03480750|589488785|FG000|Overall Study|The interruption in Trientine shippment|0|||
163211156|NCT03480750|589488786|FG001|Overall Study|The interruption in Trientine shippment|0|||
163211157|NCT03480750|589488787|FG002|Overall Study|The interruption in Trientine shippment|0|||
163211158|NCT03480750|589488788|FG003|Overall Study|The interruption in Trientine shippment|0|||
163211159|NCT03480750|589488789|FG004|Overall Study|The interruption in Trientine shippment|0|||
163211160|NCT03480750|589488790|FG005|Overall Study|The interruption in Trientine shippment|1|||
163211161|NCT02411292|589488795|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
163211162|NCT02411292|589488795|FG000|Overall Study|Death|2|||
163211163|NCT02411292|589488795|FG000|Overall Study|Lost to Follow-up|3|||
163211164|NCT00453921|589488796|FG000|Overall Study|Withdrawal by Subject|1|||
163211165|NCT00453921|589488797|FG001|Overall Study|Withdrawal by Subject|1|||
163211166|NCT00453921|589488798|FG002|Overall Study|Withdrawal by Subject|1|||
163211167|NCT00453921|589488799|FG003|Overall Study|Withdrawal by Subject|1|||
163211168|NCT00453921|589488796|FG000|Overall Study|Lost to Follow-up|0|||
163211169|NCT00453921|589488797|FG001|Overall Study|Lost to Follow-up|0|||
163211170|NCT00453921|589488798|FG002|Overall Study|Lost to Follow-up|1|||
163211171|NCT00453921|589488799|FG003|Overall Study|Lost to Follow-up|0|||
163211172|NCT00174915|589488800|FG000|Overall Study|Lost to Follow-up|19|||
163211173|NCT00174915|589488801|FG001|Overall Study|Lost to Follow-up|17|||
163211174|NCT00174915|589488802|FG002|Overall Study|Lost to Follow-up|9|||
163211175|NCT00174915|589488803|FG003|Overall Study|Lost to Follow-up|17|||
163319472|NCT04625725|589881139|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
163319473|NCT04625725|589881140|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
163319474|NCT04625725|589881141|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
163319475|NCT04625725|589881142|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
163319476|NCT04625725|589881143|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
163319477|NCT04625725|589881138|FG000|Provent Main Study|MISSING REASON|0|||
163319478|NCT04625725|589881139|FG001|Provent Main Study|MISSING REASON|1|||
163319479|NCT04625725|589881140|FG002|Provent Main Study|MISSING REASON|0|||
163319480|NCT04625725|589881141|FG003|Provent Main Study|MISSING REASON|0|||
163319481|NCT04625725|589881142|FG004|Provent Main Study|MISSING REASON|0|||
163319482|NCT04625725|589881143|FG005|Provent Main Study|MISSING REASON|0|||
163058867|NCT04458922|588924338|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
163058868|NCT04458922|588924336|FG000|Overall Study|Adverse Event|1|||
163058869|NCT04458922|588924337|FG001|Overall Study|Adverse Event|0|||
163058870|NCT04458922|588924338|FG002|Overall Study|Adverse Event|0|||
163058871|NCT04458922|588924336|FG000|Overall Study|Started new study|0|||
163211176|NCT00174915|589488804|FG004|Overall Study|Lost to Follow-up|10|||
163211177|NCT00174915|589488800|FG000|Overall Study|Adverse Event|18|||
163211178|NCT00174915|589488801|FG001|Overall Study|Adverse Event|16|||
163211179|NCT00174915|589488802|FG002|Overall Study|Adverse Event|11|||
163319483|NCT04625725|589881138|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
163319484|NCT04625725|589881139|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
163319485|NCT04625725|589881140|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
163402533|NCT00964743|590184753|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
163402534|NCT03317795|590184756|FG000|Overall Study|IUD Expulsion|1|||
163402535|NCT03317795|590184757|FG001|Overall Study|IUD Expulsion|0|||
163402536|NCT03317795|590184756|FG000|Overall Study|Lost to Follow-up|1|||
163319486|NCT04625725|589881141|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
163319487|NCT04625725|589881142|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
163319488|NCT04625725|589881143|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
163319489|NCT04625725|589881138|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
163319490|NCT04625725|589881139|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
163319491|NCT04625725|589881140|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
163319492|NCT04625725|589881141|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
163319493|NCT04625725|589881142|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
163319494|NCT04625725|589881143|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
163319495|NCT04625725|589881138|FG000|Provent Sub Study|Lost to Follow-up|0|||
163319496|NCT04625725|589881139|FG001|Provent Sub Study|Lost to Follow-up|0|||
163319497|NCT04625725|589881140|FG002|Provent Sub Study|Lost to Follow-up|20|||
163319498|NCT04625725|589881141|FG003|Provent Sub Study|Lost to Follow-up|10|||
163319499|NCT04625725|589881142|FG004|Provent Sub Study|Lost to Follow-up|6|||
163319500|NCT04625725|589881143|FG005|Provent Sub Study|Lost to Follow-up|4|||
163319501|NCT04625725|589881138|FG000|Provent Sub Study|Death|0|||
163319502|NCT04625725|589881139|FG001|Provent Sub Study|Death|0|||
163319503|NCT04625725|589881140|FG002|Provent Sub Study|Death|8|||
163319504|NCT04625725|589881141|FG003|Provent Sub Study|Death|5|||
163402537|NCT03317795|590184757|FG001|Overall Study|Lost to Follow-up|3|||
163319505|NCT04625725|589881142|FG004|Provent Sub Study|Death|0|||
163319506|NCT04625725|589881143|FG005|Provent Sub Study|Death|1|||
163319507|NCT04625725|589881138|FG000|Provent Sub Study|Adverse Event|0|||
163319508|NCT04625725|589881139|FG001|Provent Sub Study|Adverse Event|0|||
163319509|NCT04625725|589881140|FG002|Provent Sub Study|Adverse Event|0|||
163319510|NCT04625725|589881141|FG003|Provent Sub Study|Adverse Event|0|||
163319511|NCT04625725|589881142|FG004|Provent Sub Study|Adverse Event|0|||
163319512|NCT04625725|589881143|FG005|Provent Sub Study|Adverse Event|1|||
163319513|NCT04625725|589881138|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
163319514|NCT04625725|589881139|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
163319515|NCT04625725|589881140|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
163319516|NCT04625725|589881141|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
163319517|NCT04625725|589881142|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
163319518|NCT04625725|589881143|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
163319519|NCT04625725|589881138|FG000|Provent Sub Study|Withdrawal by Subject|0|||
163319520|NCT04625725|589881139|FG001|Provent Sub Study|Withdrawal by Subject|0|||
163319521|NCT04625725|589881140|FG002|Provent Sub Study|Withdrawal by Subject|11|||
163319522|NCT04625725|589881141|FG003|Provent Sub Study|Withdrawal by Subject|13|||
163319523|NCT04625725|589881142|FG004|Provent Sub Study|Withdrawal by Subject|5|||
163319524|NCT04625725|589881143|FG005|Provent Sub Study|Withdrawal by Subject|6|||
163319525|NCT04625725|589881138|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
163319526|NCT04625725|589881139|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
163319527|NCT04625725|589881140|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
163319528|NCT04625725|589881141|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
163319529|NCT04625725|589881142|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
163319530|NCT04625725|589881143|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
163319531|NCT04308681|589881147|FG000|Pre-Treatment|Not reported|1|||
163319532|NCT04308681|589881148|FG001|Pre-Treatment|Not reported|1|||
163319533|NCT04308681|589881149|FG002|Pre-Treatment|Not reported|0|||
163319534|NCT04308681|589881150|FG003|Pre-Treatment|Not reported|0|||
163402538|NCT03317795|590184756|FG000|Overall Study|Treatment change|0|||
163058872|NCT04458922|588924337|FG001|Overall Study|Started new study|0|||
163319535|NCT04308681|589881151|FG004|Pre-Treatment|Not reported|0|||
163319536|NCT04308681|589881152|FG005|Pre-Treatment|Not reported|2|||
163319537|NCT04308681|589881153|FG006|Pre-Treatment|Not reported|0|||
163319538|NCT04308681|589881154|FG007|Pre-Treatment|Not reported|0|||
163319539|NCT04308681|589881147|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
163319540|NCT04308681|589881148|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
163319541|NCT04308681|589881149|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
163319542|NCT04308681|589881150|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
163319543|NCT04308681|589881151|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
163319544|NCT04308681|589881152|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
163402539|NCT03317795|590184757|FG001|Overall Study|Treatment change|3|||
163319545|NCT04308681|589881153|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
163319546|NCT04308681|589881154|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
163319547|NCT04308681|589881147|FG000|Treatment up to Week 26|Other reasons|2|||
163319548|NCT04308681|589881148|FG001|Treatment up to Week 26|Other reasons|0|||
163319549|NCT04308681|589881149|FG002|Treatment up to Week 26|Other reasons|0|||
163319550|NCT04308681|589881150|FG003|Treatment up to Week 26|Other reasons|0|||
163319551|NCT04308681|589881151|FG004|Treatment up to Week 26|Other reasons|1|||
163319552|NCT04308681|589881152|FG005|Treatment up to Week 26|Other reasons|1|||
163319553|NCT04308681|589881153|FG006|Treatment up to Week 26|Other reasons|0|||
163319554|NCT04308681|589881154|FG007|Treatment up to Week 26|Other reasons|0|||
163319555|NCT04308681|589881147|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
163319556|NCT04308681|589881148|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
163319557|NCT04308681|589881149|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
163319558|NCT04308681|589881150|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
163319559|NCT04308681|589881151|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
163319560|NCT04308681|589881152|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
163319561|NCT04308681|589881153|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
163319562|NCT04308681|589881154|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
163319563|NCT04308681|589881147|FG000|Treatment up to Week 26|Adverse Event|6|||
163319564|NCT04308681|589881148|FG001|Treatment up to Week 26|Adverse Event|5|||
163319565|NCT04308681|589881149|FG002|Treatment up to Week 26|Adverse Event|5|||
163319566|NCT04308681|589881150|FG003|Treatment up to Week 26|Adverse Event|0|||
163319567|NCT04308681|589881151|FG004|Treatment up to Week 26|Adverse Event|6|||
163319568|NCT04308681|589881152|FG005|Treatment up to Week 26|Adverse Event|1|||
163319569|NCT04308681|589881153|FG006|Treatment up to Week 26|Adverse Event|0|||
163319570|NCT04308681|589881154|FG007|Treatment up to Week 26|Adverse Event|0|||
163319571|NCT04308681|589881147|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
163319572|NCT04308681|589881148|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
163319573|NCT04308681|589881149|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
163319574|NCT04308681|589881150|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
163319575|NCT04308681|589881151|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
163319576|NCT04308681|589881152|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
163319577|NCT04308681|589881153|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
163319578|NCT04308681|589881154|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
163319579|NCT04308681|589881147|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
163319580|NCT04308681|589881148|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
163319581|NCT04308681|589881149|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
163319582|NCT04308681|589881150|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
163319583|NCT04308681|589881151|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
163319584|NCT04308681|589881152|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
163319585|NCT04308681|589881153|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
163319586|NCT04308681|589881154|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
163319587|NCT04308681|589881147|FG000|OTE - 26 Weeks|Death|0|||
163319588|NCT04308681|589881148|FG001|OTE - 26 Weeks|Death|1|||
163319589|NCT04308681|589881149|FG002|OTE - 26 Weeks|Death|0|||
163319590|NCT04308681|589881150|FG003|OTE - 26 Weeks|Death|0|||
163319591|NCT04308681|589881151|FG004|OTE - 26 Weeks|Death|0|||
163319592|NCT04308681|589881152|FG005|OTE - 26 Weeks|Death|0|||
163319593|NCT04308681|589881153|FG006|OTE - 26 Weeks|Death|1|||
163319594|NCT04308681|589881154|FG007|OTE - 26 Weeks|Death|0|||
163319595|NCT04308681|589881147|FG000|OTE - 26 Weeks|Adverse Event|0|||
163319596|NCT04308681|589881148|FG001|OTE - 26 Weeks|Adverse Event|2|||
163319597|NCT04308681|589881149|FG002|OTE - 26 Weeks|Adverse Event|8|||
163319598|NCT04308681|589881150|FG003|OTE - 26 Weeks|Adverse Event|3|||
163319599|NCT04308681|589881151|FG004|OTE - 26 Weeks|Adverse Event|0|||
163319600|NCT04308681|589881152|FG005|OTE - 26 Weeks|Adverse Event|1|||
163319601|NCT04308681|589881153|FG006|OTE - 26 Weeks|Adverse Event|2|||
163058873|NCT04458922|588924338|FG002|Overall Study|Started new study|1|||
163058874|NCT04458922|588924336|FG000|Overall Study|Progressive disease|6|||
163058875|NCT04458922|588924337|FG001|Overall Study|Progressive disease|8|||
163058876|NCT04458922|588924338|FG002|Overall Study|Progressive disease|2|||
163058877|NCT04458922|588924336|FG000|Overall Study|Death|1|||
163058878|NCT04458922|588924337|FG001|Overall Study|Death|0|||
163319602|NCT04308681|589881154|FG007|OTE - 26 Weeks|Adverse Event|0|||
163319603|NCT04308681|589881147|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
163319604|NCT04308681|589881148|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
163319605|NCT04308681|589881149|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
163319606|NCT04308681|589881150|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
163319607|NCT04308681|589881151|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
163319608|NCT04308681|589881152|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
163319609|NCT04308681|589881153|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
163058879|NCT04458922|588924338|FG002|Overall Study|Death|2|||
163319610|NCT04308681|589881154|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
163319611|NCT00429364|589881157|FG000|Overall Study|Withdrawal by Subject|11|||
163319612|NCT00429364|589881158|FG001|Overall Study|Withdrawal by Subject|5|||
163319613|NCT00429364|589881157|FG000|Overall Study|Physician Decision|4|||
163319614|NCT00429364|589881158|FG001|Overall Study|Physician Decision|2|||
163319615|NCT00429364|589881157|FG000|Overall Study|Lost to Follow-up|7|||
163211180|NCT00174915|589488803|FG003|Overall Study|Adverse Event|18|||
163211181|NCT00174915|589488804|FG004|Overall Study|Adverse Event|5|||
163211182|NCT00174915|589488800|FG000|Overall Study|Personal Reason(s)|16|||
163211183|NCT00174915|589488801|FG001|Overall Study|Personal Reason(s)|16|||
163211184|NCT00174915|589488802|FG002|Overall Study|Personal Reason(s)|9|||
163319616|NCT00429364|589881158|FG001|Overall Study|Lost to Follow-up|6|||
163319617|NCT00429364|589881157|FG000|Overall Study|Death|0|||
163319618|NCT00429364|589881158|FG001|Overall Study|Death|1|||
163319619|NCT00429364|589881157|FG000|Overall Study|Underwent aortic root surgery|10|||
163319620|NCT00429364|589881158|FG001|Overall Study|Underwent aortic root surgery|18|||
163319621|NCT00429364|589881157|FG000|Overall Study|Pregnancy|0|||
163319622|NCT00429364|589881158|FG001|Overall Study|Pregnancy|1|||
163319623|NCT05873556|589881159|FG000|Overall Study|Lost to Follow-up|4|||
163319624|NCT05873556|589881160|FG001|Overall Study|Lost to Follow-up|1|||
163319625|NCT04689256|589881162|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
163058880|NCT04458922|588924336|FG000|Overall Study|Participant started chemotherapy|0|||
163211185|NCT00174915|589488803|FG003|Overall Study|Personal Reason(s)|9|||
163211186|NCT00174915|589488804|FG004|Overall Study|Personal Reason(s)|9|||
163211187|NCT00174915|589488800|FG000|Overall Study|Other|15|||
163211188|NCT00174915|589488801|FG001|Overall Study|Other|8|||
163211189|NCT00174915|589488802|FG002|Overall Study|Other|6|||
163211190|NCT00174915|589488803|FG003|Overall Study|Other|5|||
163211191|NCT00174915|589488804|FG004|Overall Study|Other|3|||
163211192|NCT00174915|589488800|FG000|Overall Study|Gout Flare|13|||
163211193|NCT00174915|589488801|FG001|Overall Study|Gout Flare|6|||
163211194|NCT00174915|589488802|FG002|Overall Study|Gout Flare|8|||
163211195|NCT00174915|589488803|FG003|Overall Study|Gout Flare|1|||
163211196|NCT00174915|589488804|FG004|Overall Study|Gout Flare|0|||
163211197|NCT00174915|589488800|FG000|Overall Study|Protocol Violation|6|||
163211198|NCT00174915|589488801|FG001|Overall Study|Protocol Violation|3|||
163211199|NCT00174915|589488802|FG002|Overall Study|Protocol Violation|3|||
163211200|NCT00174915|589488803|FG003|Overall Study|Protocol Violation|6|||
163319626|NCT04689256|589881163|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
163319627|NCT04862234|589881166|FG000|Overall Study|Surgery cancellation|1|||
163058881|NCT04458922|588924337|FG001|Overall Study|Participant started chemotherapy|1|||
163058882|NCT04458922|588924338|FG002|Overall Study|Participant started chemotherapy|0|||
163058883|NCT02867592|588924340|FG000|Overall Study|Adverse Event|3|||
163058884|NCT02867592|588924341|FG001|Overall Study|Adverse Event|0|||
163058885|NCT02867592|588924342|FG002|Overall Study|Adverse Event|2|||
163058886|NCT02867592|588924343|FG003|Overall Study|Adverse Event|1|||
163058887|NCT02867592|588924344|FG004|Overall Study|Adverse Event|1|||
163058888|NCT02867592|588924345|FG005|Overall Study|Adverse Event|5|||
163058889|NCT02867592|588924340|FG000|Overall Study|Death|0|||
163058890|NCT02867592|588924341|FG001|Overall Study|Death|0|||
163058891|NCT02867592|588924342|FG002|Overall Study|Death|0|||
163058892|NCT02867592|588924343|FG003|Overall Study|Death|1|||
163058893|NCT02867592|588924344|FG004|Overall Study|Death|0|||
163058894|NCT02867592|588924345|FG005|Overall Study|Death|1|||
163058895|NCT02867592|588924340|FG000|Overall Study|Lack of Efficacy|8|||
163058896|NCT02867592|588924341|FG001|Overall Study|Lack of Efficacy|10|||
163058897|NCT02867592|588924342|FG002|Overall Study|Lack of Efficacy|8|||
163058898|NCT02867592|588924343|FG003|Overall Study|Lack of Efficacy|8|||
163058899|NCT02867592|588924344|FG004|Overall Study|Lack of Efficacy|12|||
163058900|NCT02867592|588924345|FG005|Overall Study|Lack of Efficacy|17|||
163058901|NCT02867592|588924340|FG000|Overall Study|Physician Decision|1|||
163058902|NCT02867592|588924341|FG001|Overall Study|Physician Decision|2|||
163058903|NCT02867592|588924342|FG002|Overall Study|Physician Decision|2|||
163058904|NCT02867592|588924343|FG003|Overall Study|Physician Decision|0|||
163058905|NCT02867592|588924344|FG004|Overall Study|Physician Decision|5|||
163058906|NCT02867592|588924345|FG005|Overall Study|Physician Decision|1|||
163058907|NCT02867592|588924340|FG000|Overall Study|Protocol Violation|0|||
163058908|NCT02867592|588924341|FG001|Overall Study|Protocol Violation|0|||
163058909|NCT02867592|588924342|FG002|Overall Study|Protocol Violation|0|||
163058910|NCT02867592|588924343|FG003|Overall Study|Protocol Violation|0|||
163058911|NCT02867592|588924344|FG004|Overall Study|Protocol Violation|1|||
163058912|NCT02867592|588924345|FG005|Overall Study|Protocol Violation|1|||
163211201|NCT00174915|589488804|FG004|Overall Study|Protocol Violation|3|||
163211202|NCT00174915|589488800|FG000|Overall Study|Therapeutic Failure|6|||
163211203|NCT00174915|589488801|FG001|Overall Study|Therapeutic Failure|3|||
163211204|NCT00174915|589488802|FG002|Overall Study|Therapeutic Failure|2|||
163211205|NCT00174915|589488803|FG003|Overall Study|Therapeutic Failure|1|||
163211206|NCT00174915|589488804|FG004|Overall Study|Therapeutic Failure|3|||
163319628|NCT04862234|589881167|FG001|Overall Study|Surgery cancellation|2|||
163319629|NCT04862234|589881166|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
163319630|NCT04862234|589881167|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
163319631|NCT04862234|589881166|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
163319632|NCT04862234|589881167|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
163319633|NCT05828017|589881176|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
163319634|NCT04132518|589881177|FG000|Overall Study|Prematurely withdrawn from the study|0|||
163319635|NCT04132518|589881178|FG001|Overall Study|Prematurely withdrawn from the study|9|||
163211207|NCT02232425|589488805|FG000|Overall Study|Lost to Follow-up|6|||
163211208|NCT02232425|589488806|FG001|Overall Study|Lost to Follow-up|2|||
163211209|NCT02232425|589488805|FG000|Overall Study|Adverse Event|2|||
163211210|NCT02232425|589488806|FG001|Overall Study|Adverse Event|0|||
163211211|NCT02232425|589488805|FG000|Overall Study|Withdrawal by Subject|5|||
163211212|NCT02232425|589488806|FG001|Overall Study|Withdrawal by Subject|6|||
163211213|NCT02232425|589488805|FG000|Overall Study|Lack of Efficacy|1|||
163211214|NCT02232425|589488806|FG001|Overall Study|Lack of Efficacy|0|||
163211215|NCT03060447|589488807|FG000|Overall Study|Withdrawal by Subject|2|||
163211216|NCT03060447|589488808|FG001|Overall Study|Withdrawal by Subject|0|||
163211217|NCT01601626|589488811|FG000|Overall Study|Death|1|||
163319636|NCT04132518|589881179|FG002|Overall Study|Prematurely withdrawn from the study|1|||
163319637|NCT05425420|589881180|FG000|Overall Study|Physician Decision|1|||
163319638|NCT05425420|589881180|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
163319639|NCT03714815|589881181|FG000|Overall Study|Physician Decision|2|||
163319640|NCT03714815|589881181|FG000|Overall Study|Withdrawal by Subject|2|||
163319641|NCT03714815|589881181|FG000|Overall Study|Death|11|||
163319642|NCT04999111|589881182|FG000|Overall Study|Lost to Follow-up|21|||
163319643|NCT04999111|589881183|FG001|Overall Study|Lost to Follow-up|16|||
163319644|NCT04999111|589881184|FG002|Overall Study|Lost to Follow-up|2|||
163319645|NCT04999111|589881185|FG003|Overall Study|Lost to Follow-up|26|||
163319646|NCT04999111|589881186|FG004|Overall Study|Lost to Follow-up|30|||
163319647|NCT04999111|589881187|FG005|Overall Study|Lost to Follow-up|6|||
163319648|NCT04999111|589881182|FG000|Overall Study|Physician Decision|1|||
163319649|NCT04999111|589881183|FG001|Overall Study|Physician Decision|3|||
163319650|NCT04999111|589881184|FG002|Overall Study|Physician Decision|0|||
163319651|NCT04999111|589881185|FG003|Overall Study|Physician Decision|1|||
163319652|NCT04999111|589881186|FG004|Overall Study|Physician Decision|2|||
163319653|NCT04999111|589881187|FG005|Overall Study|Physician Decision|0|||
163319654|NCT04999111|589881182|FG000|Overall Study|Withdrawal by Subject|23|||
163319655|NCT04999111|589881183|FG001|Overall Study|Withdrawal by Subject|29|||
163319656|NCT04999111|589881184|FG002|Overall Study|Withdrawal by Subject|15|||
163211218|NCT01601626|589488812|FG001|Overall Study|Death|1|||
163211219|NCT01601626|589488813|FG002|Overall Study|Death|1|||
163211220|NCT01601626|589488811|FG000|Overall Study|Lost to Follow-up|1|||
163211221|NCT01601626|589488812|FG001|Overall Study|Lost to Follow-up|2|||
163211222|NCT01601626|589488813|FG002|Overall Study|Lost to Follow-up|0|||
163211223|NCT01601626|589488811|FG000|Overall Study|Unable to Get to Clinic|0|||
163211224|NCT01601626|589488812|FG001|Overall Study|Unable to Get to Clinic|1|||
163211225|NCT01601626|589488813|FG002|Overall Study|Unable to Get to Clinic|0|||
163211226|NCT01601626|589488811|FG000|Overall Study|Withdrawal by Subject|0|||
163211227|NCT01601626|589488812|FG001|Overall Study|Withdrawal by Subject|1|||
163211228|NCT01601626|589488813|FG002|Overall Study|Withdrawal by Subject|1|||
163211229|NCT01601626|589488811|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
163211230|NCT01601626|589488812|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
163211231|NCT01601626|589488813|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
163319657|NCT04999111|589881185|FG003|Overall Study|Withdrawal by Subject|30|||
163319658|NCT04999111|589881186|FG004|Overall Study|Withdrawal by Subject|35|||
163319659|NCT04999111|589881187|FG005|Overall Study|Withdrawal by Subject|10|||
163402540|NCT03317795|590184756|FG000|Overall Study|Intolerance of medication|0|||
162979233|NCT01360866|588625074|FG003|Overall Study|Withdrawn by Investigator|2|||
162979234|NCT01360866|588625071|FG000|Overall Study|Withdrawal by participant|79|||
162979235|NCT01360866|588625072|FG001|Overall Study|Withdrawal by participant|89|||
162979236|NCT01360866|588625073|FG002|Overall Study|Withdrawal by participant|168|||
162979237|NCT01360866|588625074|FG003|Overall Study|Withdrawal by participant|8|||
162979238|NCT01360866|588625071|FG000|Overall Study|Protocol Deviation|25|||
162979239|NCT01360866|588625072|FG001|Overall Study|Protocol Deviation|33|||
162979240|NCT01360866|588625073|FG002|Overall Study|Protocol Deviation|61|||
163211232|NCT00498602|589488814|FG000|Overall Study|Death|0|||
163211233|NCT00498602|589488815|FG001|Overall Study|Death|0|||
163211234|NCT00498602|589488816|FG002|Overall Study|Death|0|||
163211235|NCT00498602|589488817|FG003|Overall Study|Death|0|||
163211236|NCT00498602|589488818|FG004|Overall Study|Death|0|||
163211237|NCT00498602|589488819|FG005|Overall Study|Death|1|||
163211238|NCT00498602|589488820|FG006|Overall Study|Death|0|||
163211239|NCT00498602|589488814|FG000|Overall Study|Lack of Efficacy|1|||
163319660|NCT04999111|589881182|FG000|Overall Study|Other|6|||
163319661|NCT04999111|589881183|FG001|Overall Study|Other|6|||
163319662|NCT04999111|589881184|FG002|Overall Study|Other|3|||
163319663|NCT04999111|589881185|FG003|Overall Study|Other|8|||
163319664|NCT04999111|589881186|FG004|Overall Study|Other|8|||
162979241|NCT01360866|588625074|FG003|Overall Study|Protocol Deviation|2|||
162979242|NCT01360866|588625071|FG000|Overall Study|Lack of Efficacy|30|||
163319665|NCT04999111|589881187|FG005|Overall Study|Other|5|||
163319666|NCT04999111|589881182|FG000|Overall Study|Non-compliance with study schedule|1|||
163319667|NCT04999111|589881183|FG001|Overall Study|Non-compliance with study schedule|0|||
163319668|NCT04999111|589881184|FG002|Overall Study|Non-compliance with study schedule|0|||
163319669|NCT04999111|589881185|FG003|Overall Study|Non-compliance with study schedule|1|||
163319670|NCT04999111|589881186|FG004|Overall Study|Non-compliance with study schedule|1|||
163319671|NCT04999111|589881187|FG005|Overall Study|Non-compliance with study schedule|1|||
163319672|NCT04999111|589881182|FG000|Overall Study|Randomized but not vaccinated|1|||
163319673|NCT04999111|589881183|FG001|Overall Study|Randomized but not vaccinated|2|||
163319674|NCT04999111|589881184|FG002|Overall Study|Randomized but not vaccinated|0|||
163319675|NCT04999111|589881185|FG003|Overall Study|Randomized but not vaccinated|3|||
163319676|NCT04999111|589881186|FG004|Overall Study|Randomized but not vaccinated|3|||
163319677|NCT04999111|589881187|FG005|Overall Study|Randomized but not vaccinated|0|||
163319678|NCT04999111|589881182|FG000|Overall Study|Adverse Event|1|||
163319679|NCT04999111|589881183|FG001|Overall Study|Adverse Event|1|||
163319680|NCT04999111|589881184|FG002|Overall Study|Adverse Event|0|||
163319681|NCT04999111|589881185|FG003|Overall Study|Adverse Event|0|||
163319682|NCT04999111|589881186|FG004|Overall Study|Adverse Event|0|||
163319683|NCT04999111|589881187|FG005|Overall Study|Adverse Event|0|||
163319684|NCT04999111|589881182|FG000|Overall Study|Initiated prohibited medication|0|||
163319685|NCT04999111|589881183|FG001|Overall Study|Initiated prohibited medication|0|||
163319686|NCT04999111|589881184|FG002|Overall Study|Initiated prohibited medication|0|||
163319687|NCT04999111|589881185|FG003|Overall Study|Initiated prohibited medication|0|||
163319688|NCT04999111|589881186|FG004|Overall Study|Initiated prohibited medication|1|||
163319689|NCT04999111|589881187|FG005|Overall Study|Initiated prohibited medication|0|||
163319690|NCT04056611|589881194|FG000|Overall Study|Physician Decision|1|||
163319691|NCT03733925|589881197|FG000|Overall Study|Lost to Follow-up|1|||
163319692|NCT03733925|589881197|FG000|Overall Study|Withdrawal by Subject|2|||
163319693|NCT03733925|589881197|FG000|Overall Study|Adverse Event|2|||
163319694|NCT03733925|589881197|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163319695|NCT03213873|589881198|FG000|Overall Study|Withdrawal by Subject|8|||
163319696|NCT03213873|589881199|FG001|Overall Study|Withdrawal by Subject|9|||
163319697|NCT03213873|589881198|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
163319698|NCT03213873|589881199|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
163319699|NCT03213873|589881198|FG000|Overall Study|Lost to Follow-up|0|||
163319700|NCT03213873|589881199|FG001|Overall Study|Lost to Follow-up|2|||
163319701|NCT02631746|589881205|FG000|Overall Study|Lack of Efficacy|3|||
163319702|NCT02361216|589881206|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
163319703|NCT02361216|589881207|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
163319704|NCT02361216|589881206|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
163319705|NCT02361216|589881207|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
163319706|NCT02361216|589881206|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
163319707|NCT02361216|589881207|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
163319708|NCT02361216|589881206|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
163319709|NCT02361216|589881207|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
163319710|NCT02361216|589881206|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
163319711|NCT02361216|589881207|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
163319712|NCT02361216|589881206|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
163319713|NCT02361216|589881207|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
163319714|NCT04709419|589881208|FG000|Overall Study|Physician Decision|1|||
163319715|NCT04709419|589881209|FG001|Overall Study|Physician Decision|0|||
163319716|NCT05683340|589881210|FG000|Overall Study|Adverse Event|1|||
163319717|NCT05683340|589881211|FG001|Overall Study|Adverse Event|1|||
163319718|NCT05683340|589881210|FG000|Overall Study|Protocol Violation|1|||
163319719|NCT05683340|589881211|FG001|Overall Study|Protocol Violation|0|||
163319720|NCT05683340|589881210|FG000|Overall Study|Withdrawal by Subject|0|||
163319721|NCT05683340|589881211|FG001|Overall Study|Withdrawal by Subject|2|||
163319722|NCT02437136|589881212|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
163319723|NCT02437136|589881213|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
163319724|NCT02437136|589881214|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
163319725|NCT02437136|589881215|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
163319726|NCT02437136|589881216|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
163319727|NCT02437136|589881217|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
162979243|NCT01360866|588625072|FG001|Overall Study|Lack of Efficacy|40|||
162979244|NCT01360866|588625073|FG002|Overall Study|Lack of Efficacy|30|||
163319728|NCT02437136|589881218|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
163319729|NCT02437136|589881212|FG000|Expansion (Phase 2)|Death|0|||
163319730|NCT02437136|589881213|FG001|Expansion (Phase 2)|Death|0|||
163319731|NCT02437136|589881214|FG002|Expansion (Phase 2)|Death|0|||
163319732|NCT02437136|589881215|FG003|Expansion (Phase 2)|Death|6|||
163319733|NCT02437136|589881216|FG004|Expansion (Phase 2)|Death|37|||
162979245|NCT01360866|588625074|FG003|Overall Study|Lack of Efficacy|4|||
162979246|NCT05016622|588625075|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
162979247|NCT05016622|588625075|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
162979248|NCT05506358|588625083|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
162979249|NCT05506358|588625084|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
162979250|NCT05506358|588625085|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
162979251|NCT05506358|588625086|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
162979252|NCT05506358|588625087|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
162979253|NCT05506358|588625083|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
162979254|NCT05506358|588625084|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
162979255|NCT05506358|588625085|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
162979256|NCT05506358|588625086|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
162979257|NCT05506358|588625087|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
162979258|NCT05506358|588625083|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
162979259|NCT05506358|588625084|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
162979260|NCT05506358|588625085|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
162979261|NCT05506358|588625086|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
162979262|NCT05506358|588625087|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
162979263|NCT05506358|588625083|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
162979264|NCT05506358|588625084|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
162979265|NCT05506358|588625085|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
162979266|NCT05506358|588625086|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
162979267|NCT05506358|588625087|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
162979268|NCT05506358|588625083|FG000|Overall Study|HbE trait|0|||
162979269|NCT05506358|588625084|FG001|Overall Study|HbE trait|0|||
162979270|NCT05506358|588625085|FG002|Overall Study|HbE trait|0|||
162979271|NCT05506358|588625086|FG003|Overall Study|HbE trait|1|||
162979272|NCT05506358|588625087|FG004|Overall Study|HbE trait|0|||
162979273|NCT01744093|588625094|FG000|Overall Study|Withdrawal by Subject|6|||
162979274|NCT01744093|588625095|FG001|Overall Study|Withdrawal by Subject|1|||
162979275|NCT02006628|588625096|FG000|Overall Study|Adverse Event|1|||
162979276|NCT02006628|588625097|FG001|Overall Study|Adverse Event|1|||
162979277|NCT02006628|588625096|FG000|Overall Study|Withdrawal by Subject|2|||
162979278|NCT02006628|588625097|FG001|Overall Study|Withdrawal by Subject|1|||
162979279|NCT03578237|588625100|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
162979280|NCT03578237|588625101|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
162979281|NCT01173471|588625102|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162979282|NCT01173471|588625103|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162979283|NCT01173471|588625104|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
162979284|NCT01173471|588625105|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
162979285|NCT01173471|588625102|FG000|Overall Study|Condition under investigation worsened|2|||
162979286|NCT01173471|588625103|FG001|Overall Study|Condition under investigation worsened|0|||
162979287|NCT01173471|588625104|FG002|Overall Study|Condition under investigation worsened|0|||
162979288|NCT01173471|588625105|FG003|Overall Study|Condition under investigation worsened|0|||
162979289|NCT01173471|588625102|FG000|Overall Study|Lost to Follow-up|0|||
162979290|NCT01173471|588625103|FG001|Overall Study|Lost to Follow-up|0|||
162979291|NCT01173471|588625104|FG002|Overall Study|Lost to Follow-up|1|||
162979292|NCT01173471|588625105|FG003|Overall Study|Lost to Follow-up|0|||
162979293|NCT01173471|588625102|FG000|Overall Study|Reason given as Other|0|||
163402541|NCT03317795|590184757|FG001|Overall Study|Intolerance of medication|1|||
163058913|NCT02867592|588924340|FG000|Overall Study|Withdrawal by Subject|0|||
163211240|NCT00498602|589488815|FG001|Overall Study|Lack of Efficacy|0|||
163211241|NCT00498602|589488816|FG002|Overall Study|Lack of Efficacy|0|||
163211242|NCT00498602|589488817|FG003|Overall Study|Lack of Efficacy|0|||
163211243|NCT00498602|589488818|FG004|Overall Study|Lack of Efficacy|0|||
163402542|NCT00886600|590184758|FG000|Double-blind Monotherapy|Adverse Event|1|||
163211244|NCT00498602|589488819|FG005|Overall Study|Lack of Efficacy|0|||
163211245|NCT00498602|589488820|FG006|Overall Study|Lack of Efficacy|0|||
163211246|NCT00498602|589488814|FG000|Overall Study|Lost to Follow-up|0|||
163211247|NCT00498602|589488815|FG001|Overall Study|Lost to Follow-up|2|||
163211248|NCT00498602|589488816|FG002|Overall Study|Lost to Follow-up|0|||
163211249|NCT00498602|589488817|FG003|Overall Study|Lost to Follow-up|2|||
163211250|NCT00498602|589488818|FG004|Overall Study|Lost to Follow-up|0|||
163211251|NCT00498602|589488819|FG005|Overall Study|Lost to Follow-up|0|||
163211252|NCT00498602|589488820|FG006|Overall Study|Lost to Follow-up|0|||
163211253|NCT00498602|589488814|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
163211254|NCT00498602|589488815|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
163211255|NCT00498602|589488816|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
162979294|NCT01173471|588625103|FG001|Overall Study|Reason given as Other|0|||
162979295|NCT01173471|588625104|FG002|Overall Study|Reason given as Other|1|||
162979296|NCT01173471|588625105|FG003|Overall Study|Reason given as Other|0|||
162979297|NCT00584844|588625107|FG000|Overall Study|Withdrawal by Subject|59|||
162979298|NCT00584844|588625107|FG000|Overall Study|Screen Failure|20|||
162979299|NCT02370914|588625113|FG000|Overall Study|Protocol Violation|2|||
162979300|NCT05206448|588625114|FG000|Overall Study|Lost to Follow-up|2|||
162979301|NCT05206448|588625115|FG001|Overall Study|Lost to Follow-up|2|||
163402543|NCT00886600|590184759|FG001|Double-blind Monotherapy|Adverse Event|1|||
163402544|NCT00886600|590184760|FG002|Double-blind Monotherapy|Adverse Event|1|||
163402545|NCT00886600|590184761|FG003|Double-blind Monotherapy|Adverse Event|1|||
163402546|NCT00886600|590184758|FG000|Double-blind Monotherapy|Protocol Violation|0|||
163402547|NCT00886600|590184759|FG001|Double-blind Monotherapy|Protocol Violation|0|||
163402548|NCT00886600|590184760|FG002|Double-blind Monotherapy|Protocol Violation|0|||
163402549|NCT00886600|590184761|FG003|Double-blind Monotherapy|Protocol Violation|1|||
163402550|NCT00886600|590184758|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
163402551|NCT00886600|590184759|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
163402552|NCT00886600|590184760|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
163402553|NCT00886600|590184761|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
163402554|NCT00886600|590184758|FG000|Combination Therapy Period|Adverse Event|0|||
163402555|NCT00886600|590184759|FG001|Combination Therapy Period|Adverse Event|0|||
163402556|NCT00886600|590184760|FG002|Combination Therapy Period|Adverse Event|1|||
162979302|NCT05206448|588625114|FG000|Overall Study|Withdrawal by Subject|2|||
162979303|NCT05206448|588625115|FG001|Overall Study|Withdrawal by Subject|0|||
162979304|NCT05206448|588625114|FG000|Overall Study|found ineligible after randomization|1|||
163402557|NCT00886600|590184761|FG003|Combination Therapy Period|Adverse Event|0|||
163402558|NCT00886600|590184758|FG000|Combination Therapy Period|Protocol Violation|0|||
163402559|NCT00886600|590184759|FG001|Combination Therapy Period|Protocol Violation|0|||
163402560|NCT00886600|590184760|FG002|Combination Therapy Period|Protocol Violation|1|||
163402561|NCT00886600|590184761|FG003|Combination Therapy Period|Protocol Violation|0|||
163402562|NCT00501007|590184762|FG000|Overall Study|Inclusion criteria not met.|29|||
163402563|NCT00501007|590184763|FG001|Overall Study|Inclusion criteria not met.|25|||
163402564|NCT03917823|590184764|FG000|Overall Study|Lost to Follow-up|1|||
163402565|NCT03917823|590184765|FG001|Overall Study|Lost to Follow-up|1|||
163402566|NCT03917823|590184764|FG000|Overall Study|Withdrawal by Subject|0|||
163402567|NCT03917823|590184765|FG001|Overall Study|Withdrawal by Subject|1|||
163402568|NCT02424253|590184768|FG000|Overall Study|Other, unspecified|1|||
163402569|NCT02424253|590184769|FG001|Overall Study|Other, unspecified|0|||
163402570|NCT02424253|590184768|FG000|Overall Study|Compliance problems|1|||
163402571|NCT02424253|590184769|FG001|Overall Study|Compliance problems|0|||
162979305|NCT05206448|588625115|FG001|Overall Study|found ineligible after randomization|1|||
162979306|NCT05206448|588625114|FG000|Overall Study|unable to complete study due to personal constraints|1|||
162979307|NCT05206448|588625115|FG001|Overall Study|unable to complete study due to personal constraints|0|||
162979308|NCT05206448|588625114|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
162979309|NCT05206448|588625115|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
162979310|NCT04572243|588625118|FG000|Core Study: 14 Weeks|Adverse Event|1|||
162979311|NCT04572243|588625119|FG001|Core Study: 14 Weeks|Adverse Event|2|||
162979312|NCT04572243|588625120|FG002|Core Study: 14 Weeks|Adverse Event|0|||
162979313|NCT04572243|588625121|FG003|Core Study: 14 Weeks|Adverse Event|0|||
162979314|NCT04572243|588625118|FG000|Core Study: 14 Weeks|Subject choice|0|||
162979315|NCT04572243|588625119|FG001|Core Study: 14 Weeks|Subject choice|2|||
162979316|NCT04572243|588625120|FG002|Core Study: 14 Weeks|Subject choice|0|||
162979317|NCT04572243|588625121|FG003|Core Study: 14 Weeks|Subject choice|0|||
162979318|NCT04572243|588625118|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
162979319|NCT04572243|588625119|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
162979320|NCT04572243|588625120|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
162979321|NCT04572243|588625121|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
162979322|NCT04572243|588625118|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
162979323|NCT04572243|588625119|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
162979324|NCT04572243|588625120|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
162979325|NCT04572243|588625121|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
162979326|NCT03847194|588625122|FG000|Overall Study|Lost to Follow-up|2|||
162979327|NCT03847194|588625123|FG001|Overall Study|Lost to Follow-up|5|||
162979328|NCT03847194|588625122|FG000|Overall Study|Withdrawal by Subject|1|||
162979329|NCT03847194|588625123|FG001|Overall Study|Withdrawal by Subject|2|||
162979330|NCT03847194|588625122|FG000|Overall Study|Death|0|||
162979331|NCT03847194|588625123|FG001|Overall Study|Death|1|||
162979332|NCT04179019|588625128|FG000|Overall Study|Lost to Follow-up|2|||
162979333|NCT04179019|588625128|FG000|Overall Study|Physician Decision|2|||
162979334|NCT04179019|588625128|FG000|Overall Study|Withdrawal by Subject|5|||
163402572|NCT02424253|590184768|FG000|Overall Study|Physician Decision|2|||
163402573|NCT02424253|590184769|FG001|Overall Study|Physician Decision|0|||
163402574|NCT02424253|590184768|FG000|Overall Study|Lack of Efficacy|0|||
163402575|NCT02424253|590184769|FG001|Overall Study|Lack of Efficacy|7|||
162979335|NCT04179019|588625128|FG000|Overall Study|Adverse Event|4|||
162979336|NCT01560507|588625132|FG000|Overall Study|Lost to Follow-up|3|||
162979337|NCT01560507|588625133|FG001|Overall Study|Lost to Follow-up|1|||
162979338|NCT01560507|588625134|FG002|Overall Study|Lost to Follow-up|2|||
162979339|NCT01560507|588625132|FG000|Overall Study|Withdrawal by Subject|1|||
162979340|NCT01560507|588625133|FG001|Overall Study|Withdrawal by Subject|1|||
162979341|NCT01560507|588625134|FG002|Overall Study|Withdrawal by Subject|0|||
162979342|NCT02746627|588625137|FG000|Overall Study|Withdrawal by Subject|1|||
162979343|NCT02746627|588625138|FG001|Overall Study|Withdrawal by Subject|1|||
162979344|NCT02746627|588625139|FG002|Overall Study|Withdrawal by Subject|1|||
162979345|NCT02858726|588625140|FG000|Overall Study|Adverse Event|4|||
163319734|NCT02437136|589881217|FG005|Expansion (Phase 2)|Death|29|||
163319735|NCT02437136|589881218|FG006|Expansion (Phase 2)|Death|24|||
163319736|NCT02437136|589881212|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
163319737|NCT02437136|589881213|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
163319738|NCT02437136|589881214|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
163319739|NCT02437136|589881215|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
163319740|NCT02437136|589881216|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
163319741|NCT02437136|589881217|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
163319742|NCT02437136|589881218|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
163319743|NCT02437136|589881212|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
163319744|NCT02437136|589881213|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
163319745|NCT02437136|589881214|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
163319746|NCT02437136|589881215|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
163319747|NCT02437136|589881216|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
163319748|NCT02437136|589881217|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
163319749|NCT02437136|589881218|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
163319750|NCT02056834|589881221|FG000|Overall Study|Lost to Follow-up|7|||
163319751|NCT02780700|589881223|FG000|Overall Study|Progressive disease|1|||
163319752|NCT02828358|589881236|FG000|Overall Study|Physician Decision|7|||
163319753|NCT02828358|589881237|FG001|Overall Study|Physician Decision|1|||
163319754|NCT02828358|589881236|FG000|Overall Study|Treatment Failure|6|||
163319755|NCT02828358|589881237|FG001|Overall Study|Treatment Failure|0|||
163319756|NCT02828358|589881236|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
163319757|NCT02828358|589881237|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
163319758|NCT02828358|589881236|FG000|Overall Study|Refusal of further protocol therapy|2|||
163319759|NCT02828358|589881237|FG001|Overall Study|Refusal of further protocol therapy|0|||
163319760|NCT02828358|589881236|FG000|Overall Study|Relapse|25|||
163319761|NCT02828358|589881237|FG001|Overall Study|Relapse|0|||
163319762|NCT02828358|589881236|FG000|Overall Study|Still on therapy|5|||
163319763|NCT02828358|589881237|FG001|Overall Study|Still on therapy|0|||
163319764|NCT05285137|589881252|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
163319765|NCT05285137|589881253|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
163319766|NCT05285137|589881254|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
163319767|NCT05285137|589881255|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
163319768|NCT05285137|589881256|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
163319769|NCT05285137|589881257|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
163319770|NCT05285137|589881258|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
163319771|NCT05285137|589881259|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
163319772|NCT05285137|589881260|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
163319773|NCT05285137|589881252|FG000|Overall Study|Lost to Follow-up|0|||
163319774|NCT05285137|589881253|FG001|Overall Study|Lost to Follow-up|0|||
163319775|NCT05285137|589881254|FG002|Overall Study|Lost to Follow-up|1|||
163319776|NCT05285137|589881255|FG003|Overall Study|Lost to Follow-up|3|||
163319777|NCT05285137|589881256|FG004|Overall Study|Lost to Follow-up|0|||
163319778|NCT05285137|589881257|FG005|Overall Study|Lost to Follow-up|0|||
163319779|NCT05285137|589881258|FG006|Overall Study|Lost to Follow-up|1|||
163319780|NCT05285137|589881259|FG007|Overall Study|Lost to Follow-up|0|||
162979346|NCT02858726|588625141|FG001|Overall Study|Adverse Event|4|||
162979347|NCT02858726|588625142|FG002|Overall Study|Adverse Event|9|||
162979348|NCT02858726|588625143|FG003|Overall Study|Adverse Event|1|||
162979349|NCT02858726|588625140|FG000|Overall Study|Physician Decision|0|||
162979350|NCT02858726|588625141|FG001|Overall Study|Physician Decision|0|||
162979351|NCT02858726|588625142|FG002|Overall Study|Physician Decision|1|||
162979352|NCT02858726|588625143|FG003|Overall Study|Physician Decision|0|||
162979353|NCT02858726|588625140|FG000|Overall Study|Protocol Violation|0|||
162979354|NCT02858726|588625141|FG001|Overall Study|Protocol Violation|0|||
162979355|NCT02858726|588625142|FG002|Overall Study|Protocol Violation|0|||
162979356|NCT02858726|588625143|FG003|Overall Study|Protocol Violation|1|||
162979357|NCT02858726|588625140|FG000|Overall Study|Study Terminated by Sponsor|0|||
163319781|NCT05285137|589881260|FG008|Overall Study|Lost to Follow-up|0|||
163319782|NCT05285137|589881252|FG000|Overall Study|Physician Decision|0|||
163319783|NCT05285137|589881253|FG001|Overall Study|Physician Decision|1|||
163319784|NCT05285137|589881254|FG002|Overall Study|Physician Decision|0|||
163319785|NCT05285137|589881255|FG003|Overall Study|Physician Decision|0|||
163319786|NCT05285137|589881256|FG004|Overall Study|Physician Decision|0|||
163319787|NCT05285137|589881257|FG005|Overall Study|Physician Decision|0|||
162979358|NCT02858726|588625141|FG001|Overall Study|Study Terminated by Sponsor|0|||
162979359|NCT02858726|588625142|FG002|Overall Study|Study Terminated by Sponsor|0|||
162979360|NCT02858726|588625143|FG003|Overall Study|Study Terminated by Sponsor|1|||
162979361|NCT02858726|588625140|FG000|Overall Study|Withdrawal by Subject|1|||
162979362|NCT02858726|588625141|FG001|Overall Study|Withdrawal by Subject|2|||
163319788|NCT05285137|589881258|FG006|Overall Study|Physician Decision|0|||
163319789|NCT05285137|589881259|FG007|Overall Study|Physician Decision|0|||
163319790|NCT05285137|589881260|FG008|Overall Study|Physician Decision|0|||
163319791|NCT05285137|589881252|FG000|Overall Study|Pregnancy|0|||
163319792|NCT05285137|589881253|FG001|Overall Study|Pregnancy|0|||
163319793|NCT05285137|589881254|FG002|Overall Study|Pregnancy|0|||
163319794|NCT05285137|589881255|FG003|Overall Study|Pregnancy|0|||
163319795|NCT05285137|589881256|FG004|Overall Study|Pregnancy|0|||
163319796|NCT05285137|589881257|FG005|Overall Study|Pregnancy|0|||
163319797|NCT05285137|589881258|FG006|Overall Study|Pregnancy|1|||
163319798|NCT05285137|589881259|FG007|Overall Study|Pregnancy|0|||
163319799|NCT05285137|589881260|FG008|Overall Study|Pregnancy|0|||
163319800|NCT05285137|589881252|FG000|Overall Study|Withdrawal by Subject|0|||
163319801|NCT05285137|589881253|FG001|Overall Study|Withdrawal by Subject|1|||
163319802|NCT05285137|589881254|FG002|Overall Study|Withdrawal by Subject|2|||
163319803|NCT05285137|589881255|FG003|Overall Study|Withdrawal by Subject|1|||
163319804|NCT05285137|589881256|FG004|Overall Study|Withdrawal by Subject|0|||
163319805|NCT05285137|589881257|FG005|Overall Study|Withdrawal by Subject|0|||
163319806|NCT05285137|589881258|FG006|Overall Study|Withdrawal by Subject|0|||
162979363|NCT02858726|588625142|FG002|Overall Study|Withdrawal by Subject|1|||
162979364|NCT02858726|588625143|FG003|Overall Study|Withdrawal by Subject|0|||
162979365|NCT02858726|588625140|FG000|Overall Study|Noncompliance|0|||
162979366|NCT02858726|588625141|FG001|Overall Study|Noncompliance|1|||
162979367|NCT02858726|588625142|FG002|Overall Study|Noncompliance|0|||
162979368|NCT02858726|588625143|FG003|Overall Study|Noncompliance|0|||
162979369|NCT00233987|588625148|FG000|Overall Study|Withdrawal by Subject|1|||
162979370|NCT00233987|588625148|FG000|Overall Study|Lack of Efficacy|2|||
162979371|NCT00233987|588625148|FG000|Overall Study|Reason Under Review|1|||
162979372|NCT00233987|588625148|FG000|Overall Study|Other - Not Protocol Specified|5|||
162979373|NCT00233987|588625148|FG000|Overall Study|Eligible but No Treatment Received|2|||
162979374|NCT00233987|588625148|FG000|Overall Study|Ineligible|4|||
162979375|NCT04553913|588625151|FG000|Overall Study|patient's block resolved prior to PACU|1|||
162979376|NCT04553913|588625151|FG000|Overall Study|did not use the device properly|5|||
162979377|NCT01481324|588625153|FG000|Overall Study|Missing Data|0|||
162979378|NCT01481324|588625154|FG001|Overall Study|Missing Data|2|||
162979379|NCT01481324|588625155|FG002|Overall Study|Missing Data|2|||
162979380|NCT00710749|588625157|FG000|First Intervention|Withdrawal by Subject|1|||
162979381|NCT00710749|588625158|FG001|First Intervention|Withdrawal by Subject|0|||
162979382|NCT05478252|588625159|FG000|Overall Study|Withdrawal by Subject|2|||
162979383|NCT05478252|588625160|FG001|Overall Study|Withdrawal by Subject|3|||
162979384|NCT05478252|588625159|FG000|Overall Study|Lost to Follow-up|4|||
162979385|NCT05478252|588625160|FG001|Overall Study|Lost to Follow-up|2|||
162979386|NCT05478252|588625159|FG000|Overall Study|Physician Decision|1|||
162979387|NCT05478252|588625160|FG001|Overall Study|Physician Decision|1|||
162979388|NCT05478252|588625159|FG000|Overall Study|Death|1|||
162979389|NCT05478252|588625160|FG001|Overall Study|Death|0|||
162979390|NCT04846881|588625161|FG000|Overall Study|Adverse Event|14|||
162979391|NCT04846881|588625162|FG001|Overall Study|Adverse Event|15|||
162979392|NCT04846881|588625161|FG000|Overall Study|Burden of study procedures|7|||
162979393|NCT04846881|588625162|FG001|Overall Study|Burden of study procedures|3|||
162979394|NCT04846881|588625161|FG000|Overall Study|Protocol deviation|6|||
162979395|NCT04846881|588625162|FG001|Overall Study|Protocol deviation|4|||
163058914|NCT02867592|588924341|FG001|Overall Study|Withdrawal by Subject|1|||
163319807|NCT05285137|589881259|FG007|Overall Study|Withdrawal by Subject|0|||
163319808|NCT05285137|589881260|FG008|Overall Study|Withdrawal by Subject|1|||
163319809|NCT03221426|589881261|FG000|Overall Study|Ongoing in study|212|||
163319810|NCT03221426|589881262|FG001|Overall Study|Ongoing in study|193|||
163319811|NCT03221426|589881263|FG002|Overall Study|Ongoing in study|61|||
163319812|NCT03221426|589881264|FG003|Overall Study|Ongoing in study|55|||
163319813|NCT03221426|589881261|FG000|Overall Study|Withdrawal by Subject|12|||
163319814|NCT03221426|589881262|FG001|Overall Study|Withdrawal by Subject|4|||
162979396|NCT04846881|588625161|FG000|Overall Study|Perceived lack of efficacy|5|||
162979397|NCT04846881|588625162|FG001|Overall Study|Perceived lack of efficacy|2|||
162979398|NCT04846881|588625161|FG000|Overall Study|Change of residence|2|||
162979399|NCT04846881|588625162|FG001|Overall Study|Change of residence|0|||
162979400|NCT04846881|588625161|FG000|Overall Study|Technical problems|0|||
162979401|NCT04846881|588625162|FG001|Overall Study|Technical problems|1|||
162979402|NCT04846881|588625161|FG000|Overall Study|Other than listed|3|||
163319815|NCT03221426|589881263|FG002|Overall Study|Withdrawal by Subject|2|||
163319816|NCT03221426|589881264|FG003|Overall Study|Withdrawal by Subject|3|||
163319817|NCT03221426|589881261|FG000|Overall Study|Lost to Follow-up|4|||
163319818|NCT03221426|589881262|FG001|Overall Study|Lost to Follow-up|1|||
163319819|NCT03221426|589881263|FG002|Overall Study|Lost to Follow-up|1|||
163319820|NCT03221426|589881264|FG003|Overall Study|Lost to Follow-up|0|||
163319821|NCT03221426|589881261|FG000|Overall Study|Death|174|||
163319822|NCT03221426|589881262|FG001|Overall Study|Death|204|||
163319823|NCT03221426|589881263|FG002|Overall Study|Death|36|||
163319824|NCT03221426|589881264|FG003|Overall Study|Death|45|||
163319825|NCT06262477|589882769|FG000|Overall Study|Withdrawal by Subject|1|||
163319826|NCT06262477|589882770|FG001|Overall Study|Withdrawal by Subject|0|||
163319827|NCT06262477|589882769|FG000|Overall Study|Adverse Event|0|||
163319828|NCT06262477|589882770|FG001|Overall Study|Adverse Event|1|||
163319829|NCT06262477|589882769|FG000|Overall Study|Lost to Follow-up|0|||
163319830|NCT06262477|589882770|FG001|Overall Study|Lost to Follow-up|1|||
163319831|NCT03220035|589882774|FG000|Overall Study|Adverse Event|1|||
163319832|NCT03220035|589882774|FG000|Overall Study|Protocol Violation|1|||
163319833|NCT03220035|589882774|FG000|Overall Study|Progressive Disease|2|||
163319834|NCT02593773|589882775|FG000|Overall Study|Voluntary Withdrawal|3|||
163319835|NCT02593773|589882775|FG000|Overall Study|Study Terminated by Sponsor|31|||
163319836|NCT02593773|589882775|FG000|Overall Study|Death|1|||
163319837|NCT04024020|589882779|FG000|Overall Study|Withdrawal by Subject|2|||
163319838|NCT04024020|589882780|FG001|Overall Study|Withdrawal by Subject|2|||
163319839|NCT05269966|589882781|FG000|Overall Study|Adverse Event|4|||
163319840|NCT05269966|589882781|FG000|Overall Study|Withdrawal by Subject|1|||
163319841|NCT05269966|589882781|FG000|Overall Study|Lost to Follow-up|4|||
163319842|NCT05269966|589882781|FG000|Overall Study|Physician Decision|1|||
163319843|NCT06262347|589882784|FG000|Overall Study|Lost to Follow-up|4|||
163319844|NCT06262347|589882785|FG001|Overall Study|Lost to Follow-up|3|||
163319845|NCT06262347|589882784|FG000|Overall Study|Withdrawal by Subject|0|||
163319846|NCT06262347|589882785|FG001|Overall Study|Withdrawal by Subject|1|||
163319847|NCT04304144|589882786|FG000|DLT Observation Period|Physician Decision|0|||
163319848|NCT04304144|589882787|FG001|DLT Observation Period|Physician Decision|1|||
163319849|NCT04304144|589882788|FG002|DLT Observation Period|Physician Decision|0|||
163319850|NCT04304144|589882789|FG003|DLT Observation Period|Physician Decision|0|||
163319851|NCT04304144|589882786|FG000|Continued Treatment Period|Adverse Event|0|||
163319852|NCT04304144|589882787|FG001|Continued Treatment Period|Adverse Event|1|||
163319853|NCT04304144|589882788|FG002|Continued Treatment Period|Adverse Event|0|||
163319854|NCT04304144|589882789|FG003|Continued Treatment Period|Adverse Event|0|||
163319855|NCT04304144|589882786|FG000|Continued Treatment Period|Death|0|||
163319856|NCT04304144|589882787|FG001|Continued Treatment Period|Death|0|||
163319857|NCT04304144|589882788|FG002|Continued Treatment Period|Death|1|||
163319858|NCT04304144|589882789|FG003|Continued Treatment Period|Death|2|||
163319859|NCT04304144|589882786|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
163319860|NCT04304144|589882787|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
163319861|NCT04304144|589882788|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
163319862|NCT04304144|589882789|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
163319863|NCT04304144|589882786|FG000|Continued Treatment Period|Other than specified|2|||
163319864|NCT04304144|589882787|FG001|Continued Treatment Period|Other than specified|0|||
163319865|NCT04304144|589882788|FG002|Continued Treatment Period|Other than specified|1|||
163319866|NCT04304144|589882789|FG003|Continued Treatment Period|Other than specified|1|||
163319867|NCT04101357|589882790|FG000|Overall Study|Death|1|||
163319868|NCT04101357|589882791|FG001|Overall Study|Death|1|||
163319869|NCT04101357|589882792|FG002|Overall Study|Death|1|||
163319870|NCT04101357|589882793|FG003|Overall Study|Death|2|||
163319871|NCT04101357|589882794|FG004|Overall Study|Death|4|||
163319872|NCT04101357|589882795|FG005|Overall Study|Death|11|||
163319873|NCT04101357|589882796|FG006|Overall Study|Death|4|||
163319874|NCT04101357|589882797|FG007|Overall Study|Death|4|||
163319875|NCT04101357|589882798|FG008|Overall Study|Death|5|||
162979403|NCT04846881|588625162|FG001|Overall Study|Other than listed|10|||
162979404|NCT04846881|588625161|FG000|Overall Study|No reason available|1|||
162979405|NCT04846881|588625162|FG001|Overall Study|No reason available|3|||
162979406|NCT04846881|588625161|FG000|Overall Study|Patient randomised in error|1|||
162979407|NCT04846881|588625162|FG001|Overall Study|Patient randomised in error|0|||
162979408|NCT04560998|588625163|FG000|Overall Study|Withdrawal by Subject|18|||
162979409|NCT04560998|588625164|FG001|Overall Study|Withdrawal by Subject|12|||
162979410|NCT04560998|588625163|FG000|Overall Study|Lost to Follow-up|8|||
162979411|NCT04560998|588625164|FG001|Overall Study|Lost to Follow-up|5|||
163319876|NCT04101357|589882799|FG009|Overall Study|Death|2|||
163319877|NCT04101357|589882800|FG010|Overall Study|Death|3|||
163319878|NCT04101357|589882790|FG000|Overall Study|Trial closure|0|||
163319879|NCT04101357|589882791|FG001|Overall Study|Trial closure|0|||
163319880|NCT04101357|589882792|FG002|Overall Study|Trial closure|0|||
163319881|NCT04101357|589882793|FG003|Overall Study|Trial closure|0|||
163319882|NCT04101357|589882794|FG004|Overall Study|Trial closure|0|||
163319883|NCT04101357|589882795|FG005|Overall Study|Trial closure|2|||
163319884|NCT04101357|589882796|FG006|Overall Study|Trial closure|2|||
163319885|NCT04101357|589882797|FG007|Overall Study|Trial closure|0|||
163319886|NCT04101357|589882798|FG008|Overall Study|Trial closure|0|||
163319887|NCT04101357|589882799|FG009|Overall Study|Trial closure|0|||
163319888|NCT04101357|589882800|FG010|Overall Study|Trial closure|1|||
163319889|NCT04101357|589882790|FG000|Overall Study|Lost to Follow-up|0|||
163319890|NCT04101357|589882791|FG001|Overall Study|Lost to Follow-up|0|||
163319891|NCT04101357|589882792|FG002|Overall Study|Lost to Follow-up|0|||
163319892|NCT04101357|589882793|FG003|Overall Study|Lost to Follow-up|1|||
163319893|NCT04101357|589882794|FG004|Overall Study|Lost to Follow-up|0|||
163319894|NCT04101357|589882795|FG005|Overall Study|Lost to Follow-up|0|||
163319895|NCT04101357|589882796|FG006|Overall Study|Lost to Follow-up|0|||
163319896|NCT04101357|589882797|FG007|Overall Study|Lost to Follow-up|1|||
163319897|NCT04101357|589882798|FG008|Overall Study|Lost to Follow-up|0|||
163319898|NCT04101357|589882799|FG009|Overall Study|Lost to Follow-up|0|||
163319899|NCT04101357|589882800|FG010|Overall Study|Lost to Follow-up|0|||
163319900|NCT04101357|589882790|FG000|Overall Study|Withdrawal by Subject|1|||
163319901|NCT04101357|589882791|FG001|Overall Study|Withdrawal by Subject|0|||
163319902|NCT04101357|589882792|FG002|Overall Study|Withdrawal by Subject|0|||
163319903|NCT04101357|589882793|FG003|Overall Study|Withdrawal by Subject|0|||
163319904|NCT04101357|589882794|FG004|Overall Study|Withdrawal by Subject|0|||
163319905|NCT04101357|589882795|FG005|Overall Study|Withdrawal by Subject|0|||
163319906|NCT04101357|589882796|FG006|Overall Study|Withdrawal by Subject|0|||
163319907|NCT04101357|589882797|FG007|Overall Study|Withdrawal by Subject|0|||
163319908|NCT04101357|589882798|FG008|Overall Study|Withdrawal by Subject|1|||
163319909|NCT04101357|589882799|FG009|Overall Study|Withdrawal by Subject|1|||
163319910|NCT04101357|589882800|FG010|Overall Study|Withdrawal by Subject|0|||
163319911|NCT04101357|589882790|FG000|Overall Study|Other|0|||
163319912|NCT04101357|589882791|FG001|Overall Study|Other|0|||
163319913|NCT04101357|589882792|FG002|Overall Study|Other|0|||
163319914|NCT04101357|589882793|FG003|Overall Study|Other|0|||
163319915|NCT04101357|589882794|FG004|Overall Study|Other|0|||
163319916|NCT04101357|589882795|FG005|Overall Study|Other|1|||
163319917|NCT04101357|589882796|FG006|Overall Study|Other|2|||
163319918|NCT04101357|589882797|FG007|Overall Study|Other|1|||
163319919|NCT04101357|589882798|FG008|Overall Study|Other|0|||
163319920|NCT04101357|589882799|FG009|Overall Study|Other|0|||
163319921|NCT04101357|589882800|FG010|Overall Study|Other|0|||
163319922|NCT04101357|589882790|FG000|Overall Study|Enrolled but not treated|0|||
163319923|NCT04101357|589882791|FG001|Overall Study|Enrolled but not treated|0|||
163319924|NCT04101357|589882792|FG002|Overall Study|Enrolled but not treated|0|||
163319925|NCT04101357|589882793|FG003|Overall Study|Enrolled but not treated|0|||
163319926|NCT04101357|589882794|FG004|Overall Study|Enrolled but not treated|0|||
163319927|NCT04101357|589882795|FG005|Overall Study|Enrolled but not treated|1|||
163319928|NCT04101357|589882796|FG006|Overall Study|Enrolled but not treated|1|||
163319929|NCT04101357|589882797|FG007|Overall Study|Enrolled but not treated|0|||
163319930|NCT04101357|589882798|FG008|Overall Study|Enrolled but not treated|0|||
163319931|NCT04101357|589882799|FG009|Overall Study|Enrolled but not treated|0|||
163319932|NCT04101357|589882800|FG010|Overall Study|Enrolled but not treated|0|||
163319933|NCT04660539|589882803|FG000|Overall Study|Adverse Event|10|||
163319934|NCT04660539|589882803|FG000|Overall Study|Lack of Efficacy|4|||
163319935|NCT04660539|589882803|FG000|Overall Study|Lost to Follow-up|5|||
163319936|NCT04660539|589882803|FG000|Overall Study|Non-Compliance With Study Drug|3|||
163319937|NCT04660539|589882803|FG000|Overall Study|Reason not Specified|12|||
163319938|NCT04660539|589882803|FG000|Overall Study|Pregnancy|2|||
163319939|NCT04660539|589882803|FG000|Overall Study|Protocol Violation|2|||
163319940|NCT04660539|589882803|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
163319941|NCT04660539|589882803|FG000|Overall Study|Withdrawal by Subject|21|||
163319942|NCT05618587|589882804|FG000|Overall Study|Lost to Follow-up|2|||
163319943|NCT05618587|589882805|FG001|Overall Study|Lost to Follow-up|0|||
163319944|NCT05167864|589882806|FG000|Overall Study|Lost to Follow-up|7|||
163319945|NCT05167864|589882807|FG001|Overall Study|Lost to Follow-up|6|||
163319946|NCT05167864|589882808|FG002|Overall Study|Lost to Follow-up|7|||
163319947|NCT05167864|589882809|FG003|Overall Study|Lost to Follow-up|9|||
163319948|NCT03852550|589882812|FG000|Overall Study|Lost to Follow-up|4|||
163319949|NCT03852550|589882813|FG001|Overall Study|Lost to Follow-up|3|||
163319950|NCT03852550|589882812|FG000|Overall Study|Only parent outcomes completed|0|||
163319951|NCT03852550|589882813|FG001|Overall Study|Only parent outcomes completed|1|||
163319952|NCT03852550|589882812|FG000|Overall Study|Withdrawal by Subject|1|||
163319953|NCT03852550|589882813|FG001|Overall Study|Withdrawal by Subject|0|||
163319954|NCT05204654|589882814|FG000|Overall Study|Study terminated due to time restraint|2|||
163319955|NCT05204654|589882815|FG001|Overall Study|Study terminated due to time restraint|2|||
163319956|NCT01828112|589882826|FG000|Treatment Phase|Adverse Event|7|||
163319957|NCT01828112|589882827|FG001|Treatment Phase|Adverse Event|8|||
163319958|NCT01828112|589882828|FG002|Treatment Phase|Adverse Event|0|||
163319959|NCT01828112|589882826|FG000|Treatment Phase|Death|9|||
163319960|NCT01828112|589882827|FG001|Treatment Phase|Death|5|||
163319961|NCT01828112|589882828|FG002|Treatment Phase|Death|0|||
163319962|NCT01828112|589882826|FG000|Treatment Phase|No longer required treatment|0|||
163319963|NCT01828112|589882827|FG001|Treatment Phase|No longer required treatment|1|||
163319964|NCT01828112|589882828|FG002|Treatment Phase|No longer required treatment|0|||
163319965|NCT01828112|589882826|FG000|Treatment Phase|Physician Decision|6|||
163319966|NCT01828112|589882827|FG001|Treatment Phase|Physician Decision|7|||
163319967|NCT01828112|589882828|FG002|Treatment Phase|Physician Decision|0|||
163319968|NCT01828112|589882826|FG000|Treatment Phase|Pregnancy|1|||
163319969|NCT01828112|589882827|FG001|Treatment Phase|Pregnancy|0|||
163319970|NCT01828112|589882828|FG002|Treatment Phase|Pregnancy|0|||
163402576|NCT02424253|590184768|FG000|Overall Study|Adverse Event|2|||
163402577|NCT02424253|590184769|FG001|Overall Study|Adverse Event|0|||
163402578|NCT02424253|590184768|FG000|Overall Study|Consent withdrawn by subject|4|||
163402579|NCT02424253|590184769|FG001|Overall Study|Consent withdrawn by subject|1|||
163402580|NCT02424253|590184768|FG000|Overall Study|Lost to Follow-up|1|||
163402581|NCT02424253|590184769|FG001|Overall Study|Lost to Follow-up|1|||
163402582|NCT00473343|590184770|FG000|Overall Study|Adverse Event|9|||
163402583|NCT00473343|590184770|FG000|Overall Study|Lost to Follow-up|8|||
163402584|NCT00473343|590184770|FG000|Overall Study|Treatment failure|27|||
163402585|NCT00473343|590184770|FG000|Overall Study|Withdrew consent|3|||
163402586|NCT00473343|590184770|FG000|Overall Study|Other un-specified reason|3|||
163402587|NCT04126083|590184771|FG000|Overall Study|Withdrawal by Subject|1|||
163402588|NCT01892163|590184774|FG000|Overall Study|Death|1|||
163402589|NCT01892163|590184775|FG001|Overall Study|Death|1|||
163402590|NCT01892163|590184774|FG000|Overall Study|Lost to Follow-up|1|||
163402591|NCT01892163|590184775|FG001|Overall Study|Lost to Follow-up|0|||
163402592|NCT02577146|590184776|FG000|Overall Study|Lost to Follow-up|8|||
163402593|NCT02577146|590184776|FG000|Overall Study|Physician Decision|3|||
163402594|NCT02577146|590184776|FG000|Overall Study|Screen Failure|17|||
163402595|NCT02258451|590184777|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
163402596|NCT02258451|590184778|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
163402597|NCT02258451|590184777|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
163402598|NCT02258451|590184778|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
163402599|NCT02258451|590184777|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
163402600|NCT02258451|590184778|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
163402601|NCT02258451|590184777|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
163402602|NCT02258451|590184778|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
163402603|NCT02258451|590184777|FG000|Overall Study|Discontinuation all treatment due to death|4|||
163402604|NCT02258451|590184778|FG001|Overall Study|Discontinuation all treatment due to death|3|||
163402605|NCT02258451|590184777|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
163402606|NCT02258451|590184778|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
163402607|NCT02258451|590184777|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
163402608|NCT02258451|590184778|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
163402609|NCT02258451|590184777|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
163402610|NCT02258451|590184778|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
163402611|NCT02258451|590184777|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
163402612|NCT02258451|590184778|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
163402613|NCT02258451|590184777|FG000|Overall Study|Other reason|1|||
163402614|NCT02258451|590184778|FG001|Overall Study|Other reason|1|||
163402615|NCT02258451|590184777|FG000|Overall Study|Never treated|2|||
163319971|NCT01828112|589882826|FG000|Treatment Phase|Progressive disease|79|||
163319972|NCT01828112|589882827|FG001|Treatment Phase|Progressive disease|87|||
163319973|NCT01828112|589882828|FG002|Treatment Phase|Progressive disease|0|||
163319974|NCT01828112|589882826|FG000|Treatment Phase|Study terminated by sponsor|1|||
163319975|NCT01828112|589882827|FG001|Treatment Phase|Study terminated by sponsor|0|||
163319976|NCT01828112|589882828|FG002|Treatment Phase|Study terminated by sponsor|0|||
163319977|NCT01828112|589882826|FG000|Treatment Phase|Subject/guardian decision|12|||
163319978|NCT01828112|589882827|FG001|Treatment Phase|Subject/guardian decision|8|||
163319979|NCT01828112|589882828|FG002|Treatment Phase|Subject/guardian decision|0|||
163319980|NCT01828112|589882826|FG000|Extension Treatment Phase|Adverse Event|0|||
163319981|NCT01828112|589882827|FG001|Extension Treatment Phase|Adverse Event|0|||
163319982|NCT01828112|589882828|FG002|Extension Treatment Phase|Adverse Event|6|||
163319983|NCT01828112|589882826|FG000|Extension Treatment Phase|Death|0|||
163319984|NCT01828112|589882827|FG001|Extension Treatment Phase|Death|0|||
163319985|NCT01828112|589882828|FG002|Extension Treatment Phase|Death|17|||
163319986|NCT01828112|589882826|FG000|Extension Treatment Phase|Physician Decision|0|||
163402616|NCT02258451|590184778|FG001|Overall Study|Never treated|3|||
163402617|NCT00517751|590184783|FG000|Overall Study|Death|3|||
163402618|NCT00517751|590184783|FG000|Overall Study|Withdrawal by Subject|37|||
163402619|NCT00517751|590184783|FG000|Overall Study|Lost to Follow-up|4|||
163402620|NCT00517751|590184783|FG000|Overall Study|patient not over due|6|||
163402621|NCT00517751|590184783|FG000|Overall Study|Patient not due for visit|76|||
162979412|NCT04560998|588625163|FG000|Overall Study|Physician Decision|4|||
162979413|NCT04560998|588625164|FG001|Overall Study|Physician Decision|0|||
162979414|NCT01000610|588626748|FG000|Overall Study|Adverse Event|1|||
162979415|NCT01000610|588626748|FG000|Overall Study|Lost to Follow-up|4|||
163319987|NCT01828112|589882827|FG001|Extension Treatment Phase|Physician Decision|0|||
163319988|NCT01828112|589882828|FG002|Extension Treatment Phase|Physician Decision|5|||
162979416|NCT01000610|588626748|FG000|Overall Study|Treatment failure|1|||
163402622|NCT00517751|590184783|FG000|Overall Study|Missing|3|||
163402623|NCT03927105|590186974|FG000|Overall Study|Death|1|||
163402624|NCT03927105|590186974|FG000|Overall Study|In observation for potential re-treatment|2|||
162979417|NCT01010126|588626749|FG000|Overall Study|Withdrawal by Subject|1|||
162979418|NCT01010126|588626750|FG001|Overall Study|Withdrawal by Subject|0|||
162979419|NCT01010126|588626751|FG002|Overall Study|Withdrawal by Subject|1|||
162979420|NCT01010126|588626752|FG003|Overall Study|Withdrawal by Subject|0|||
162979421|NCT01010126|588626753|FG004|Overall Study|Withdrawal by Subject|3|||
162979422|NCT01010126|588626754|FG005|Overall Study|Withdrawal by Subject|0|||
162979423|NCT04495283|588626757|FG000|Overall Study|Physician Decision|0|||
162979424|NCT04495283|588626758|FG001|Overall Study|Physician Decision|0|||
162979425|NCT04495283|588626759|FG002|Overall Study|Physician Decision|1|||
162979426|NCT04495283|588626757|FG000|Overall Study|Withdrawal by Subject|0|||
162979427|NCT04495283|588626758|FG001|Overall Study|Withdrawal by Subject|1|||
162979428|NCT04495283|588626759|FG002|Overall Study|Withdrawal by Subject|1|||
162979429|NCT04495283|588626757|FG000|Overall Study|Other|1|||
162979430|NCT04495283|588626758|FG001|Overall Study|Other|0|||
162979431|NCT04495283|588626759|FG002|Overall Study|Other|1|||
162979432|NCT03341000|588626773|FG000|Overall Study|Adverse Event|1|||
162979433|NCT04718194|588626778|FG000|Overall Study|Withdrawal by Subject|3|||
162979434|NCT04718194|588626779|FG001|Overall Study|Withdrawal by Subject|0|||
162979435|NCT04718194|588626778|FG000|Overall Study|Lost to Follow-up|3|||
162979436|NCT04718194|588626779|FG001|Overall Study|Lost to Follow-up|0|||
162979437|NCT01215513|588626780|FG000|Overall Study|Not completed CS42|9|||
162979438|NCT01215513|588626780|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
162979439|NCT01215513|588626780|FG000|Overall Study|Adverse event (CS42A)|2|||
162979440|NCT01215513|588626780|FG000|Overall Study|Physician decision (CS42A)|6|||
162979441|NCT01215513|588626780|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
162979442|NCT01215513|588626780|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
162979443|NCT00821873|588626781|FG000|Overall Study|Lost to Follow-up|4|||
162979444|NCT02698865|588626786|FG000|Overall Study|Other|11|||
162979445|NCT02698865|588626787|FG001|Overall Study|Other|11|||
162979446|NCT02698865|588626786|FG000|Overall Study|Withdrawal by Subject|20|||
162979447|NCT02698865|588626787|FG001|Overall Study|Withdrawal by Subject|16|||
162979448|NCT02698865|588626786|FG000|Overall Study|Physician Decision|0|||
162979449|NCT02698865|588626787|FG001|Overall Study|Physician Decision|4|||
162979450|NCT02698865|588626786|FG000|Overall Study|Lost to Follow-up|4|||
162979451|NCT02698865|588626787|FG001|Overall Study|Lost to Follow-up|2|||
162979452|NCT01386684|588626791|FG000|Overall Study|Lost to Follow-up|51|||
162979453|NCT01386684|588626791|FG000|Overall Study|Other|51|||
162979454|NCT01386684|588626791|FG000|Overall Study|Death|47|||
162979455|NCT01386684|588626791|FG000|Overall Study|Withdrawal of Consent|44|||
162979456|NCT01386684|588626791|FG000|Overall Study|Alternative Therapy Required|37|||
162979457|NCT01386684|588626791|FG000|Overall Study|Disease Progression|28|||
162979458|NCT01386684|588626791|FG000|Overall Study|Adverse Event|20|||
162979459|NCT01386684|588626791|FG000|Overall Study|Noncompliance|8|||
162979460|NCT01386684|588626791|FG000|Overall Study|Protocol Violation|4|||
162979461|NCT01386684|588626791|FG000|Overall Study|Missing|3|||
162979462|NCT02694549|588626797|FG000|Overall Study|screen failures|2|||
162979463|NCT01996332|588626798|FG000|Overall Study|Adverse Event|117|||
162979464|NCT01996332|588626798|FG000|Overall Study|Lack of Efficacy|1245|||
162979465|NCT01996332|588626798|FG000|Overall Study|Death|264|||
162979466|NCT01996332|588626798|FG000|Overall Study|Protocol Violation|9|||
162979467|NCT01996332|588626798|FG000|Overall Study|Withdrawal by Subject|71|||
162979468|NCT01996332|588626798|FG000|Overall Study|Other|20|||
162979469|NCT01996332|588626798|FG000|Overall Study|Clinical Deterioration|28|||
162979470|NCT01996332|588626798|FG000|Overall Study|Physician Decision|17|||
162979471|NCT01996332|588626798|FG000|Overall Study|Lost to Follow-up|34|||
162979472|NCT02113189|588626799|FG000|Overall Study|Lost to follow up|2|||
162979473|NCT02113189|588626800|FG001|Overall Study|Lost to follow up|1|||
162979474|NCT02113189|588626801|FG002|Overall Study|Lost to follow up|3|||
162979475|NCT00099268|588626804|FG000|Overall Study|Withdrawal by Subject|46|||
162979476|NCT00099268|588626805|FG001|Overall Study|Withdrawal by Subject|28|||
163058915|NCT02867592|588924342|FG002|Overall Study|Withdrawal by Subject|0|||
163402625|NCT03927105|590186974|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
163402626|NCT00789529|590186975|FG000|Overall Study|Withdrawal by Subject|0|||
162979477|NCT00099268|588626804|FG000|Overall Study|Adverse Event|19|||
162979478|NCT00099268|588626805|FG001|Overall Study|Adverse Event|19|||
162979479|NCT00099268|588626804|FG000|Overall Study|Protocol Violation|9|||
162979480|NCT00099268|588626805|FG001|Overall Study|Protocol Violation|8|||
162979481|NCT00099268|588626804|FG000|Overall Study|Lost to Follow-up|6|||
162979482|NCT00099268|588626805|FG001|Overall Study|Lost to Follow-up|4|||
162979483|NCT00099268|588626804|FG000|Overall Study|Lack of Efficacy|5|||
162979484|NCT00099268|588626805|FG001|Overall Study|Lack of Efficacy|18|||
162979485|NCT00099268|588626804|FG000|Overall Study|Administrative problems|4|||
162979486|NCT00099268|588626805|FG001|Overall Study|Administrative problems|4|||
162979487|NCT00099268|588626804|FG000|Overall Study|Death|3|||
162979488|NCT00099268|588626805|FG001|Overall Study|Death|1|||
162979489|NCT03702049|588626806|FG000|Overall Study|Lost to Follow-up|4|||
163319989|NCT01828112|589882826|FG000|Extension Treatment Phase|Progressive disease|0|||
163319990|NCT01828112|589882827|FG001|Extension Treatment Phase|Progressive disease|0|||
163319991|NCT01828112|589882828|FG002|Extension Treatment Phase|Progressive disease|46|||
163319992|NCT01828112|589882826|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
163319993|NCT01828112|589882827|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
163319994|NCT01828112|589882828|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
163319995|NCT01828112|589882826|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
163319996|NCT01828112|589882827|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
163319997|NCT01828112|589882828|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
163319998|NCT05565820|589882839|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
163319999|NCT05565820|589882840|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
163320000|NCT05565820|589882839|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
163320001|NCT05565820|589882840|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
163320002|NCT04871529|589882844|FG000|Overall Study|Withdrawal by Subject|0|||
163320003|NCT04871529|589882845|FG001|Overall Study|Withdrawal by Subject|1|||
163320004|NCT04871529|589882844|FG000|Overall Study|Death|0|||
163320005|NCT04871529|589882845|FG001|Overall Study|Death|1|||
163320006|NCT04871529|589882844|FG000|Overall Study|Not protocol specified|0|||
163320007|NCT04871529|589882845|FG001|Overall Study|Not protocol specified|1|||
163320008|NCT05184452|589882846|FG000|Overall Study|Lost to Follow-up|0|||
163320009|NCT05184452|589882847|FG001|Overall Study|Lost to Follow-up|0|||
163320010|NCT05184452|589882848|FG002|Overall Study|Lost to Follow-up|0|||
163320011|NCT05184452|589882849|FG003|Overall Study|Lost to Follow-up|0|||
163320012|NCT05184452|589882850|FG004|Overall Study|Lost to Follow-up|0|||
163320013|NCT05184452|589882851|FG005|Overall Study|Lost to Follow-up|2|||
163320014|NCT05184452|589882852|FG006|Overall Study|Lost to Follow-up|0|||
163320015|NCT05184452|589882853|FG007|Overall Study|Lost to Follow-up|0|||
163320016|NCT05184452|589882854|FG008|Overall Study|Lost to Follow-up|0|||
163320017|NCT05184452|589882855|FG009|Overall Study|Lost to Follow-up|1|||
163320018|NCT05184452|589882846|FG000|Overall Study|Withdrawal by Subject|0|||
163320019|NCT05184452|589882847|FG001|Overall Study|Withdrawal by Subject|0|||
163320020|NCT05184452|589882848|FG002|Overall Study|Withdrawal by Subject|0|||
163320021|NCT05184452|589882849|FG003|Overall Study|Withdrawal by Subject|0|||
163320022|NCT05184452|589882850|FG004|Overall Study|Withdrawal by Subject|0|||
163320023|NCT05184452|589882851|FG005|Overall Study|Withdrawal by Subject|1|||
163320024|NCT05184452|589882852|FG006|Overall Study|Withdrawal by Subject|0|||
163320025|NCT05184452|589882853|FG007|Overall Study|Withdrawal by Subject|0|||
163320026|NCT05184452|589882854|FG008|Overall Study|Withdrawal by Subject|0|||
163320027|NCT05184452|589882855|FG009|Overall Study|Withdrawal by Subject|1|||
163320028|NCT05586490|589882856|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
163320029|NCT05586490|589882857|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
163320030|NCT05586490|589882858|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
163320031|NCT05586490|589882859|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
163320032|NCT05586490|589882860|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
163320033|NCT05586490|589882856|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
163320034|NCT05586490|589882857|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
163320035|NCT05586490|589882858|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
163320036|NCT05586490|589882859|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
163320037|NCT05586490|589882860|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
163320038|NCT05586490|589882856|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
163320039|NCT05586490|589882857|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
163320040|NCT05586490|589882858|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
163320041|NCT05586490|589882859|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
163320042|NCT05586490|589882860|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
163320043|NCT04136912|589882861|FG000|Overall Study|Operational reasons|0|||
163320044|NCT04136912|589882862|FG001|Overall Study|Operational reasons|0|||
163320045|NCT04136912|589882863|FG002|Overall Study|Operational reasons|2|||
163320046|NCT03606408|589882864|FG000|Overall Study|Adverse Event|13|||
163320047|NCT03606408|589882864|FG000|Overall Study|Withdrawal by Subject|7|||
163320048|NCT03606408|589882864|FG000|Overall Study|Physician Decision|4|||
163320049|NCT03606408|589882864|FG000|Overall Study|Lack of Efficacy|2|||
163320050|NCT03606408|589882864|FG000|Overall Study|Death|1|||
163320051|NCT03606408|589882864|FG000|Overall Study|new therapy for study indication|1|||
163402627|NCT00789529|590186976|FG001|Overall Study|Withdrawal by Subject|1|||
163402628|NCT00789529|590186975|FG000|Overall Study|Other Reason|1|||
163320052|NCT03556293|589882865|FG000|Overall Study|Ineligible for analysis|1904|||
163320053|NCT03556293|589882866|FG001|Overall Study|Ineligible for analysis|1471|||
163320054|NCT03556293|589882867|FG002|Overall Study|Ineligible for analysis|1091|||
163320055|NCT03556293|589882868|FG003|Overall Study|Ineligible for analysis|1269|||
163320056|NCT03292484|589882869|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
163402629|NCT00789529|590186976|FG001|Overall Study|Other Reason|0|||
163320057|NCT03292484|589882869|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
162979490|NCT03702049|588626806|FG000|Overall Study|Physician Decision|1|||
162979491|NCT02954159|588626807|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
162979492|NCT02954159|588626808|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
162979493|NCT02954159|588626807|FG000|Overall Study|Withdrawal by Subject|0|||
162979494|NCT02954159|588626808|FG001|Overall Study|Withdrawal by Subject|1|||
162979495|NCT03438396|588626809|FG000|Overall Study|Reason Not Specified|9|||
162979496|NCT03438396|588626809|FG000|Overall Study|Withdrawal by Subject|5|||
162979497|NCT03438396|588626809|FG000|Overall Study|Lost to Follow-up|2|||
162979498|NCT03438396|588626809|FG000|Overall Study|Death|85|||
162979499|NCT03438396|588626809|FG000|Overall Study|Not treated|1|||
162979500|NCT00262041|588626810|FG000|Overall Study|Withdrawal by Subject|0|||
162979501|NCT00262041|588626811|FG001|Overall Study|Withdrawal by Subject|3|||
162979502|NCT00262041|588626812|FG002|Overall Study|Withdrawal by Subject|1|||
162979503|NCT00262041|588626810|FG000|Overall Study|Lost to Follow-up|1|||
162979504|NCT00262041|588626811|FG001|Overall Study|Lost to Follow-up|1|||
162979505|NCT00262041|588626812|FG002|Overall Study|Lost to Follow-up|5|||
162979506|NCT00262041|588626810|FG000|Overall Study|Unable to classify|1|||
162979507|NCT00262041|588626811|FG001|Overall Study|Unable to classify|0|||
162979508|NCT00262041|588626812|FG002|Overall Study|Unable to classify|0|||
162979509|NCT03028740|588626813|FG000|Overall Study|Did not Receive Study Drug|4|||
162979510|NCT03028740|588626814|FG001|Overall Study|Did not Receive Study Drug|5|||
162979511|NCT03028740|588626813|FG000|Overall Study|Adverse Event|8|||
162979512|NCT03028740|588626814|FG001|Overall Study|Adverse Event|26|||
162979513|NCT03028740|588626813|FG000|Overall Study|Lack of Efficacy|0|||
162979514|NCT03028740|588626814|FG001|Overall Study|Lack of Efficacy|1|||
162979515|NCT03028740|588626813|FG000|Overall Study|Withdrawal by Subject|48|||
162979516|NCT03028740|588626814|FG001|Overall Study|Withdrawal by Subject|101|||
162979517|NCT03028740|588626813|FG000|Overall Study|Lost to Follow-up|30|||
162979518|NCT03028740|588626814|FG001|Overall Study|Lost to Follow-up|54|||
162979519|NCT03028740|588626813|FG000|Overall Study|Physician Decision|4|||
162979520|NCT03028740|588626814|FG001|Overall Study|Physician Decision|11|||
162979521|NCT03028740|588626813|FG000|Overall Study|Protocol Violation|4|||
162979522|NCT03028740|588626814|FG001|Overall Study|Protocol Violation|8|||
162979523|NCT03028740|588626813|FG000|Overall Study|Non-compliance with Study Drug|0|||
162979524|NCT03028740|588626814|FG001|Overall Study|Non-compliance with Study Drug|2|||
162979525|NCT03028740|588626813|FG000|Overall Study|Study Terminated by Sponsor|467|||
162979526|NCT03028740|588626814|FG001|Overall Study|Study Terminated by Sponsor|917|||
162979527|NCT03028740|588626813|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
162979528|NCT03028740|588626814|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
162979529|NCT03028740|588626813|FG000|Overall Study|Reason not Specified|1|||
162979530|NCT03028740|588626814|FG001|Overall Study|Reason not Specified|5|||
162979531|NCT00252174|588626815|FG000|Overall Study|Withdrawal by Subject|0|||
162979532|NCT00252174|588626816|FG001|Overall Study|Withdrawal by Subject|1|||
162979533|NCT00252174|588626817|FG002|Overall Study|Withdrawal by Subject|0|||
162979534|NCT01138826|588626818|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
162979535|NCT01138826|588626819|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
162979536|NCT01138826|588626820|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
162979537|NCT01138826|588626821|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
162979538|NCT01138826|588626822|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
162979539|NCT01138826|588626823|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
162979540|NCT02566993|588626824|FG000|Overall Study|Randomized but not treated|5|||
162979541|NCT02566993|588626825|FG001|Overall Study|Randomized but not treated|16|||
162979542|NCT02566993|588626824|FG000|Overall Study|Progressive disease|213|||
162979543|NCT02566993|588626825|FG001|Overall Study|Progressive disease|152|||
162979544|NCT02566993|588626824|FG000|Overall Study|Withdrawal by Subject|12|||
162979545|NCT02566993|588626825|FG001|Overall Study|Withdrawal by Subject|28|||
162979546|NCT02566993|588626824|FG000|Overall Study|Death|17|||
162979547|NCT02566993|588626825|FG001|Overall Study|Death|23|||
162979548|NCT02566993|588626824|FG000|Overall Study|Physician Decision|10|||
162979549|NCT02566993|588626825|FG001|Overall Study|Physician Decision|17|||
162979550|NCT02566993|588626824|FG000|Overall Study|Study drug-related adverse event|20|||
162979551|NCT02566993|588626825|FG001|Overall Study|Study drug-related adverse event|41|||
162979552|NCT02566993|588626824|FG000|Overall Study|Non study drug-related adverse event|9|||
162979553|NCT02566993|588626825|FG001|Overall Study|Non study drug-related adverse event|9|||
162979554|NCT02566993|588626824|FG000|Overall Study|Symptomatic deterioration|9|||
162979555|NCT02566993|588626825|FG001|Overall Study|Symptomatic deterioration|16|||
162979556|NCT02566993|588626824|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
162979557|NCT02566993|588626825|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
162979558|NCT02566993|588626824|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
162979559|NCT02566993|588626825|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
162979560|NCT02566993|588626824|FG000|Overall Study|Screening failure|2|||
162979561|NCT02566993|588626825|FG001|Overall Study|Screening failure|0|||
163058916|NCT02867592|588924343|FG003|Overall Study|Withdrawal by Subject|1|||
162979562|NCT02566993|588626824|FG000|Overall Study|Lost to Follow-up|0|||
163320058|NCT03292484|589882869|FG000|Overall Study|Protocol Violation|2|||
163320059|NCT03292484|589882869|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
163320060|NCT03292484|589882869|FG000|Overall Study|Sponsor decision|349|||
163320061|NCT03292484|589882869|FG000|Overall Study|Lost to Follow-up|7|||
163320062|NCT03292484|589882869|FG000|Overall Study|Coronavirus Disease 2019|1|||
163320063|NCT03292484|589882869|FG000|Overall Study|Other|20|||
163320064|NCT05012163|589882873|FG000|Overall Study|Protocol Violation|0|||
163320065|NCT05012163|589882874|FG001|Overall Study|Protocol Violation|0|||
163320066|NCT05012163|589882875|FG002|Overall Study|Protocol Violation|1|||
163320067|NCT05012163|589882876|FG003|Overall Study|Protocol Violation|1|||
163320068|NCT05524402|589882882|FG000|Overall Study|Withdrawal by Subject|3|||
163320069|NCT05524402|589882883|FG001|Overall Study|Withdrawal by Subject|1|||
163320070|NCT05524402|589882882|FG000|Overall Study|Lost to Follow-up|2|||
163320071|NCT05524402|589882883|FG001|Overall Study|Lost to Follow-up|1|||
163320072|NCT05976334|589882884|FG000|Part B|Death|0|||
163320073|NCT05976334|589882885|FG001|Part B|Death|1|||
163320074|NCT05976334|589882884|FG000|Part B|Study Terminated by Sponsor|0|||
163320075|NCT05976334|589882885|FG001|Part B|Study Terminated by Sponsor|1|||
163320076|NCT05976334|589882884|FG000|Part B|Reason Not Specified|0|||
163320077|NCT05976334|589882885|FG001|Part B|Reason Not Specified|1|||
163320078|NCT03381586|589882886|FG000|Overall Study|Adverse Event|1|||
163320079|NCT03381586|589882887|FG001|Overall Study|Adverse Event|1|||
163320080|NCT03381586|589882886|FG000|Overall Study|Protocol Violation|1|||
163320081|NCT03381586|589882887|FG001|Overall Study|Protocol Violation|0|||
163320082|NCT03381586|589882886|FG000|Overall Study|Withdrawal by Subject|1|||
163320083|NCT03381586|589882887|FG001|Overall Study|Withdrawal by Subject|2|||
163320084|NCT05280574|589882893|FG000|Overall Study|Withdrawal by Subject|0|||
163320085|NCT05280574|589882894|FG001|Overall Study|Withdrawal by Subject|2|||
162979563|NCT02566993|588626825|FG001|Overall Study|Lost to Follow-up|1|||
162979564|NCT02566993|588626824|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
162979565|NCT02566993|588626825|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
162979566|NCT01661881|588626826|FG000|Overall Study|Disease Progression|1|||
163320086|NCT05280574|589882895|FG002|Overall Study|Withdrawal by Subject|0|||
162979567|NCT01790113|588626827|FG000|Overall Study|Adverse Event|2|||
162979568|NCT01790113|588626828|FG001|Overall Study|Adverse Event|7|||
163320087|NCT05363163|589882896|FG000|Overall Study|Withdrawal by Subject|13|||
163320088|NCT02224144|589882902|FG000|Overall Study|Lost to Follow-up|3|||
163320089|NCT02224144|589882903|FG001|Overall Study|Lost to Follow-up|1|||
163320090|NCT02224144|589882902|FG000|Overall Study|Death|2|||
163320091|NCT02224144|589882903|FG001|Overall Study|Death|0|||
163320092|NCT02224144|589882902|FG000|Overall Study|Withdrawal by Subject|0|||
163320093|NCT02224144|589882903|FG001|Overall Study|Withdrawal by Subject|1|||
163320094|NCT03505008|589882904|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
163320095|NCT03505008|589882905|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
163320096|NCT03505008|589882906|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
163320097|NCT03505008|589882907|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
163320098|NCT03505008|589882904|FG000|Before Week 24 Randomization|Adverse Event|10|||
163320099|NCT03505008|589882905|FG001|Before Week 24 Randomization|Adverse Event|0|||
163320100|NCT03505008|589882906|FG002|Before Week 24 Randomization|Adverse Event|0|||
163320101|NCT03505008|589882907|FG003|Before Week 24 Randomization|Adverse Event|0|||
163320102|NCT03505008|589882904|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
163320103|NCT03505008|589882905|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
163320104|NCT03505008|589882906|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
163320105|NCT03505008|589882907|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
162979569|NCT01790113|588626827|FG000|Overall Study|Study ended due to FDA clearance|1|||
162979570|NCT01790113|588626828|FG001|Overall Study|Study ended due to FDA clearance|68|||
162979571|NCT03451006|588626829|FG000|Overall Study|Withdrawal by Subject|2|||
162979572|NCT03451006|588626830|FG001|Overall Study|Withdrawal by Subject|2|||
162979573|NCT00775606|588626831|FG000|Overall Study|Study sponsor terminated funding|3|||
162979574|NCT00775606|588626832|FG001|Overall Study|Study sponsor terminated funding|0|||
162979575|NCT02278718|588626833|FG000|Overall Study|Adverse Event|1|||
162979576|NCT02278718|588626834|FG001|Overall Study|Adverse Event|0|||
162979577|NCT02278718|588626833|FG000|Overall Study|Lost to Follow-up|2|||
163320106|NCT03505008|589882904|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
163320107|NCT03505008|589882905|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
163320108|NCT03505008|589882906|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
163320109|NCT03505008|589882907|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
163320110|NCT03505008|589882904|FG000|Before Week 24 Randomization|Physician Decision|2|||
163320111|NCT03505008|589882905|FG001|Before Week 24 Randomization|Physician Decision|0|||
163320112|NCT03505008|589882906|FG002|Before Week 24 Randomization|Physician Decision|0|||
163320113|NCT03505008|589882907|FG003|Before Week 24 Randomization|Physician Decision|0|||
163320114|NCT03505008|589882904|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
163320115|NCT03505008|589882905|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
162979578|NCT02278718|588626834|FG001|Overall Study|Lost to Follow-up|4|||
163211256|NCT00498602|589488817|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
163211257|NCT00498602|589488818|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
163211258|NCT00498602|589488819|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
163211259|NCT00498602|589488820|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
163211260|NCT00498602|589488814|FG000|Overall Study|AE not related to Study Drug|1|||
163211261|NCT00498602|589488815|FG001|Overall Study|AE not related to Study Drug|3|||
163211262|NCT00498602|589488816|FG002|Overall Study|AE not related to Study Drug|0|||
163211263|NCT00498602|589488817|FG003|Overall Study|AE not related to Study Drug|0|||
163211264|NCT00498602|589488818|FG004|Overall Study|AE not related to Study Drug|2|||
163211265|NCT00498602|589488819|FG005|Overall Study|AE not related to Study Drug|2|||
163211266|NCT00498602|589488820|FG006|Overall Study|AE not related to Study Drug|1|||
163211267|NCT00498602|589488814|FG000|Overall Study|Caregiver Request|2|||
163211268|NCT00498602|589488815|FG001|Overall Study|Caregiver Request|2|||
163211269|NCT00498602|589488816|FG002|Overall Study|Caregiver Request|2|||
163211270|NCT00498602|589488817|FG003|Overall Study|Caregiver Request|0|||
163211271|NCT00498602|589488818|FG004|Overall Study|Caregiver Request|1|||
163211272|NCT00498602|589488819|FG005|Overall Study|Caregiver Request|2|||
163211273|NCT00498602|589488820|FG006|Overall Study|Caregiver Request|0|||
163211274|NCT00498602|589488814|FG000|Overall Study|Investigator Request|0|||
163211275|NCT00498602|589488815|FG001|Overall Study|Investigator Request|0|||
163211276|NCT00498602|589488816|FG002|Overall Study|Investigator Request|1|||
163211277|NCT00498602|589488817|FG003|Overall Study|Investigator Request|0|||
163211278|NCT00498602|589488818|FG004|Overall Study|Investigator Request|0|||
163211279|NCT00498602|589488819|FG005|Overall Study|Investigator Request|0|||
163211280|NCT00498602|589488820|FG006|Overall Study|Investigator Request|0|||
163211281|NCT00498602|589488814|FG000|Overall Study|Subject Request|3|||
163211282|NCT00498602|589488815|FG001|Overall Study|Subject Request|0|||
163211283|NCT00498602|589488816|FG002|Overall Study|Subject Request|1|||
163211284|NCT00498602|589488817|FG003|Overall Study|Subject Request|1|||
163211285|NCT00498602|589488818|FG004|Overall Study|Subject Request|1|||
163211286|NCT00498602|589488819|FG005|Overall Study|Subject Request|4|||
163211287|NCT00498602|589488820|FG006|Overall Study|Subject Request|1|||
163402630|NCT01870401|590186977|FG000|Overall Study|Death|48|||
162979579|NCT02278718|588626833|FG000|Overall Study|Withdrawal by Subject|1|||
162979580|NCT02278718|588626834|FG001|Overall Study|Withdrawal by Subject|4|||
162979581|NCT02278718|588626833|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
162979582|NCT02278718|588626834|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
162979583|NCT02278718|588626833|FG000|Overall Study|Missing|0|||
162979584|NCT02278718|588626834|FG001|Overall Study|Missing|1|||
162979585|NCT04440449|588626835|FG000|Overall Study|Lost to Follow-up|2|||
162979586|NCT04440449|588626836|FG001|Overall Study|Lost to Follow-up|0|||
162979587|NCT02547766|588626837|FG000|Overall Study|Withdrawal by Subject|1|||
162979588|NCT03212794|588626838|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
162979589|NCT03212794|588626839|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
162979590|NCT03212794|588626838|FG000|Overall Study|Lost to Follow-up|5|||
162979591|NCT03212794|588626839|FG001|Overall Study|Lost to Follow-up|6|||
162979592|NCT03212794|588626838|FG000|Overall Study|Incarcerated; unable to participate|2|||
162979593|NCT03212794|588626839|FG001|Overall Study|Incarcerated; unable to participate|0|||
162979594|NCT03212794|588626838|FG000|Overall Study|Withdrawal by Subject|1|||
162979595|NCT03212794|588626839|FG001|Overall Study|Withdrawal by Subject|0|||
162979596|NCT03212794|588626838|FG000|Overall Study|Death|0|||
162979597|NCT03212794|588626839|FG001|Overall Study|Death|1|||
162979598|NCT03212794|588626838|FG000|Overall Study|Found to be ineligible after allocation|0|||
162979599|NCT03212794|588626839|FG001|Overall Study|Found to be ineligible after allocation|1|||
162979600|NCT03212794|588626838|FG000|Overall Study|Relocated out of area|2|||
162979601|NCT03212794|588626839|FG001|Overall Study|Relocated out of area|0|||
162979602|NCT01763918|588626842|FG000|Overall Study|Withdrawal by Subject|2|||
162979603|NCT01763918|588626843|FG001|Overall Study|Withdrawal by Subject|1|||
162979604|NCT01763918|588626844|FG002|Overall Study|Withdrawal by Subject|1|||
162979605|NCT01763918|588626845|FG003|Overall Study|Withdrawal by Subject|2|||
162979606|NCT01763918|588626842|FG000|Overall Study|Sponsor Decision|4|||
162979607|NCT01763918|588626843|FG001|Overall Study|Sponsor Decision|0|||
162979608|NCT01763918|588626844|FG002|Overall Study|Sponsor Decision|9|||
162979609|NCT01763918|588626845|FG003|Overall Study|Sponsor Decision|0|||
162979610|NCT00897949|588626846|FG000|Overall Study|Adverse Event|1|||
162979611|NCT00897949|588626847|FG001|Overall Study|Adverse Event|1|||
162979612|NCT00897949|588626848|FG002|Overall Study|Adverse Event|0|||
162979613|NCT00897949|588626846|FG000|Overall Study|Lost to Follow-up|0|||
162979614|NCT00897949|588626847|FG001|Overall Study|Lost to Follow-up|2|||
162979615|NCT00897949|588626848|FG002|Overall Study|Lost to Follow-up|1|||
163211288|NCT00498602|589488814|FG000|Overall Study|Other|2|||
163211289|NCT00498602|589488815|FG001|Overall Study|Other|3|||
162979616|NCT00897949|588626846|FG000|Overall Study|Protocol Violation|6|||
163211290|NCT00498602|589488816|FG002|Overall Study|Other|1|||
163211291|NCT00498602|589488817|FG003|Overall Study|Other|0|||
162979617|NCT00897949|588626847|FG001|Overall Study|Protocol Violation|3|||
162979618|NCT00897949|588626848|FG002|Overall Study|Protocol Violation|1|||
162979619|NCT00897949|588626846|FG000|Overall Study|Withdrawal by Subject|1|||
163320116|NCT03505008|589882906|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
163320117|NCT03505008|589882907|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
163320118|NCT03505008|589882904|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
163320119|NCT03505008|589882905|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
163320120|NCT03505008|589882906|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
163320121|NCT03505008|589882907|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
163320122|NCT03505008|589882904|FG000|Before Week 24 Randomization|Complication|1|||
163320123|NCT03505008|589882905|FG001|Before Week 24 Randomization|Complication|0|||
163320124|NCT03505008|589882906|FG002|Before Week 24 Randomization|Complication|0|||
163320125|NCT03505008|589882907|FG003|Before Week 24 Randomization|Complication|0|||
163320126|NCT03505008|589882904|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
163320127|NCT03505008|589882905|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
163320128|NCT03505008|589882906|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
163320129|NCT03505008|589882907|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
163320130|NCT03505008|589882904|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
163320131|NCT03505008|589882905|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
163320132|NCT03505008|589882906|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
163320133|NCT03505008|589882907|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
163320134|NCT03505008|589882904|FG000|After Week 24 Randomization|Adverse Event|0|||
163320135|NCT03505008|589882905|FG001|After Week 24 Randomization|Adverse Event|1|||
163320136|NCT03505008|589882906|FG002|After Week 24 Randomization|Adverse Event|2|||
163320137|NCT03505008|589882907|FG003|After Week 24 Randomization|Adverse Event|2|||
163320138|NCT03505008|589882904|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
163320139|NCT03505008|589882905|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
163320140|NCT03505008|589882906|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
163320141|NCT03505008|589882907|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
163320142|NCT03505008|589882904|FG000|After Week 24 Randomization|Protocol Violation|0|||
163320143|NCT03505008|589882905|FG001|After Week 24 Randomization|Protocol Violation|0|||
163320144|NCT03505008|589882906|FG002|After Week 24 Randomization|Protocol Violation|1|||
163320145|NCT03505008|589882907|FG003|After Week 24 Randomization|Protocol Violation|0|||
163320146|NCT03824366|589882913|FG000|Overall Study|Death|1|||
163320147|NCT03824366|589882913|FG000|Overall Study|Previously unidentified metal artifact|1|||
163320148|NCT03824366|589882913|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
163320149|NCT03824366|589882913|FG000|Overall Study|Withdrawal by Subject|1|||
163320150|NCT04068831|589882914|FG000|Overall Study|Disease Progression|10|||
163320151|NCT04068831|589882915|FG001|Overall Study|Disease Progression|8|||
162979620|NCT00897949|588626847|FG001|Overall Study|Withdrawal by Subject|2|||
162979621|NCT00897949|588626848|FG002|Overall Study|Withdrawal by Subject|0|||
162979622|NCT00897949|588626846|FG000|Overall Study|Patient Uncoorperative|0|||
162979623|NCT00897949|588626847|FG001|Overall Study|Patient Uncoorperative|2|||
162979624|NCT00897949|588626848|FG002|Overall Study|Patient Uncoorperative|1|||
162979625|NCT00897949|588626846|FG000|Overall Study|Lost to Follow-up|30|||
162979626|NCT00897949|588626847|FG001|Overall Study|Lost to Follow-up|23|||
162979627|NCT00897949|588626848|FG002|Overall Study|Lost to Follow-up|17|||
162979628|NCT00897949|588626846|FG000|Overall Study|Withdrawal by Subject|24|||
162979629|NCT00897949|588626847|FG001|Overall Study|Withdrawal by Subject|31|||
162979630|NCT00897949|588626848|FG002|Overall Study|Withdrawal by Subject|17|||
162979631|NCT00897949|588626846|FG000|Overall Study|Abnormal Prestudy Labs|2|||
162979632|NCT00897949|588626847|FG001|Overall Study|Abnormal Prestudy Labs|3|||
162979633|NCT00897949|588626848|FG002|Overall Study|Abnormal Prestudy Labs|4|||
162979634|NCT00897949|588626846|FG000|Overall Study|Abnormal Baseline ECG|2|||
162979635|NCT00897949|588626847|FG001|Overall Study|Abnormal Baseline ECG|2|||
162979636|NCT00897949|588626848|FG002|Overall Study|Abnormal Baseline ECG|4|||
162979637|NCT00897949|588626846|FG000|Overall Study|Need for Concom. Med.|0|||
162979638|NCT00897949|588626847|FG001|Overall Study|Need for Concom. Med.|1|||
162979639|NCT00897949|588626848|FG002|Overall Study|Need for Concom. Med.|1|||
162979640|NCT00897949|588626846|FG000|Overall Study|Lack of Migraine Attack|29|||
162979641|NCT00897949|588626847|FG001|Overall Study|Lack of Migraine Attack|30|||
162979642|NCT00897949|588626848|FG002|Overall Study|Lack of Migraine Attack|19|||
162979643|NCT00897949|588626846|FG000|Overall Study|Did not take study drug|9|||
162979644|NCT00897949|588626847|FG001|Overall Study|Did not take study drug|3|||
162979645|NCT00897949|588626848|FG002|Overall Study|Did not take study drug|4|||
162979646|NCT01553747|588626849|FG000|Overall Study|Protocol Violation|0|||
162979647|NCT01553747|588626850|FG001|Overall Study|Protocol Violation|2|||
162979648|NCT01553747|588626851|FG002|Overall Study|Protocol Violation|0|||
162979649|NCT01553747|588626849|FG000|Overall Study|Voluntarily withdrew|70|||
163320152|NCT00323856|589882916|FG000|Overall Study|Withdrawal by Subject|1|||
162979650|NCT01553747|588626850|FG001|Overall Study|Voluntarily withdrew|66|||
162979651|NCT01553747|588626851|FG002|Overall Study|Voluntarily withdrew|74|||
162979652|NCT01553747|588626849|FG000|Overall Study|Adverse event or SAE|32|||
162979653|NCT01553747|588626850|FG001|Overall Study|Adverse event or SAE|28|||
162979654|NCT01553747|588626851|FG002|Overall Study|Adverse event or SAE|19|||
162979655|NCT01553747|588626849|FG000|Overall Study|Physician decision: other|10|||
162979656|NCT01553747|588626850|FG001|Overall Study|Physician decision: other|8|||
162979657|NCT01553747|588626851|FG002|Overall Study|Physician decision: other|7|||
162979658|NCT01553747|588626849|FG000|Overall Study|Lost to Follow-up|11|||
162979659|NCT01553747|588626850|FG001|Overall Study|Lost to Follow-up|5|||
162979660|NCT01553747|588626851|FG002|Overall Study|Lost to Follow-up|6|||
162979661|NCT01553747|588626849|FG000|Overall Study|Sponsor decision, specify|7|||
162979662|NCT01553747|588626850|FG001|Overall Study|Sponsor decision, specify|5|||
162979663|NCT01553747|588626851|FG002|Overall Study|Sponsor decision, specify|0|||
162979664|NCT01553747|588626849|FG000|Overall Study|Physician decision: lack of efficacy|1|||
162979665|NCT01553747|588626850|FG001|Overall Study|Physician decision: lack of efficacy|5|||
162979666|NCT01553747|588626851|FG002|Overall Study|Physician decision: lack of efficacy|3|||
162979667|NCT00102687|588626852|FG000|Initial Period|Withdrawal by Subject|6|||
162979668|NCT00102687|588626853|FG001|Initial Period|Withdrawal by Subject|3|||
162979669|NCT00102687|588626854|FG002|Initial Period|Withdrawal by Subject|5|||
162979670|NCT00102687|588626855|FG003|Initial Period|Withdrawal by Subject|0|||
162979671|NCT00102687|588626856|FG004|Initial Period|Withdrawal by Subject|0|||
162979672|NCT00102687|588626852|FG000|Initial Period|Adverse Event|4|||
162979673|NCT00102687|588626853|FG001|Initial Period|Adverse Event|7|||
162979674|NCT00102687|588626854|FG002|Initial Period|Adverse Event|9|||
162979675|NCT00102687|588626855|FG003|Initial Period|Adverse Event|0|||
162979676|NCT00102687|588626856|FG004|Initial Period|Adverse Event|0|||
162979677|NCT00102687|588626852|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
162979678|NCT00102687|588626853|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
162979679|NCT00102687|588626854|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
162979680|NCT00102687|588626855|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
162979681|NCT00102687|588626856|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
163211292|NCT00498602|589488818|FG004|Overall Study|Other|0|||
163211293|NCT00498602|589488819|FG005|Overall Study|Other|3|||
163211294|NCT00498602|589488820|FG006|Overall Study|Other|0|||
163211295|NCT03318315|589488824|FG000|Overall Study|Lost to Follow-up|3|||
163211296|NCT03318315|589488825|FG001|Overall Study|Lost to Follow-up|2|||
163211297|NCT03318315|589488826|FG002|Overall Study|Lost to Follow-up|1|||
163211298|NCT03318315|589488824|FG000|Overall Study|Protocol Violation|1|||
163211299|NCT03318315|589488825|FG001|Overall Study|Protocol Violation|1|||
163211300|NCT03318315|589488826|FG002|Overall Study|Protocol Violation|1|||
163211301|NCT03318315|589488824|FG000|Overall Study|Withdrawal by Subject|0|||
163211302|NCT03318315|589488825|FG001|Overall Study|Withdrawal by Subject|0|||
163211303|NCT03318315|589488826|FG002|Overall Study|Withdrawal by Subject|2|||
163211304|NCT02617511|589488837|FG000|Overall Study|Withdrawal by Subject|1|||
163211305|NCT02617511|589488838|FG001|Overall Study|Withdrawal by Subject|0|||
163211306|NCT00811473|589488839|FG000|Overall Study|Adverse Event|3|||
163211307|NCT00811473|589488840|FG001|Overall Study|Adverse Event|12|||
163320153|NCT00323856|589882916|FG000|Overall Study|Was uncooperative and noncompliant|1|||
163320154|NCT00323856|589882916|FG000|Overall Study|Reason not specified|1|||
163058917|NCT02867592|588924344|FG004|Overall Study|Withdrawal by Subject|3|||
163058918|NCT02867592|588924345|FG005|Overall Study|Withdrawal by Subject|3|||
163058919|NCT02867592|588924340|FG000|Overall Study|Ineligible|1|||
163058920|NCT02867592|588924341|FG001|Overall Study|Ineligible|1|||
163058921|NCT02867592|588924342|FG002|Overall Study|Ineligible|0|||
163058922|NCT02867592|588924343|FG003|Overall Study|Ineligible|0|||
163058923|NCT02867592|588924344|FG004|Overall Study|Ineligible|2|||
163058924|NCT02867592|588924345|FG005|Overall Study|Ineligible|0|||
163058925|NCT02867592|588924340|FG000|Overall Study|No Treatment|1|||
163058926|NCT02867592|588924341|FG001|Overall Study|No Treatment|0|||
163058927|NCT02867592|588924342|FG002|Overall Study|No Treatment|0|||
163058928|NCT02867592|588924343|FG003|Overall Study|No Treatment|0|||
163058929|NCT02867592|588924344|FG004|Overall Study|No Treatment|0|||
163058930|NCT02867592|588924345|FG005|Overall Study|No Treatment|0|||
163058931|NCT02867592|588924340|FG000|Overall Study|Still on Therapy|0|||
163058932|NCT02867592|588924341|FG001|Overall Study|Still on Therapy|0|||
163058933|NCT02867592|588924342|FG002|Overall Study|Still on Therapy|0|||
163058934|NCT02867592|588924343|FG003|Overall Study|Still on Therapy|0|||
163058935|NCT02867592|588924344|FG004|Overall Study|Still on Therapy|1|||
163058936|NCT02867592|588924345|FG005|Overall Study|Still on Therapy|0|||
163058937|NCT02867592|588924340|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
163058938|NCT02867592|588924341|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
163211308|NCT00811473|589488839|FG000|Overall Study|Lost to Follow-up|5|||
163211309|NCT00811473|589488840|FG001|Overall Study|Lost to Follow-up|1|||
163058939|NCT02867592|588924342|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
163058940|NCT02867592|588924343|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
163058941|NCT02867592|588924344|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
163211310|NCT00811473|589488839|FG000|Overall Study|Withdrawal by Subject|2|||
163211311|NCT00811473|589488840|FG001|Overall Study|Withdrawal by Subject|4|||
163320155|NCT00323856|589882916|FG000|Overall Study|Missing|2|||
163320156|NCT04086121|589882918|FG000|Overall Study|Other than listed|8|||
163320157|NCT04086121|589882918|FG000|Overall Study|Withdrawal by Subject|3|||
163320158|NCT04086121|589882918|FG000|Overall Study|Lost to Follow-up|2|||
163320159|NCT04086121|589882918|FG000|Overall Study|Adverse Event|1|||
163320160|NCT02834390|589882923|FG000|Induction Phase|Progressive disease|0|||
163320161|NCT02834390|589882924|FG001|Induction Phase|Progressive disease|1|||
163320162|NCT02834390|589882923|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
163320163|NCT02834390|589882924|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
163320164|NCT02834390|589882923|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
163320165|NCT02834390|589882924|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
163320166|NCT02834390|589882923|FG000|Consolidation Phase|Physician Decision|1|||
163320167|NCT02834390|589882924|FG001|Consolidation Phase|Physician Decision|1|||
163320168|NCT03118518|589882925|FG000|Overall Study|Early Exit after treatment|2|||
163320169|NCT03118518|589882926|FG001|Overall Study|Early Exit after treatment|8|||
163320170|NCT03118518|589882925|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
163320171|NCT03118518|589882926|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
163320172|NCT03106740|589884125|FG000|Overall Study|Lost to Follow-up|2|||
163320173|NCT03106740|589884126|FG001|Overall Study|Lost to Follow-up|2|||
163320174|NCT03106740|589884125|FG000|Overall Study|Withdrawal by Subject|2|||
163320175|NCT03106740|589884126|FG001|Overall Study|Withdrawal by Subject|4|||
163320176|NCT03106740|589884125|FG000|Overall Study|Physician Decision|0|||
163320177|NCT03106740|589884126|FG001|Overall Study|Physician Decision|1|||
163320178|NCT03106740|589884125|FG000|Overall Study|Partial data|1|||
163320179|NCT03106740|589884126|FG001|Overall Study|Partial data|0|||
163320180|NCT01064440|589884127|FG000|Overall Study|Lost to Follow-up|1|||
163320181|NCT01064440|589884128|FG001|Overall Study|Lost to Follow-up|1|||
163320182|NCT01064440|589884129|FG002|Overall Study|Lost to Follow-up|1|||
163320183|NCT01064440|589884127|FG000|Overall Study|Non-compliance|0|||
163320184|NCT01064440|589884128|FG001|Overall Study|Non-compliance|1|||
163320185|NCT01064440|589884129|FG002|Overall Study|Non-compliance|0|||
163320186|NCT01064440|589884127|FG000|Overall Study|Death|1|||
163320187|NCT01064440|589884128|FG001|Overall Study|Death|0|||
163320188|NCT01064440|589884129|FG002|Overall Study|Death|1|||
163320189|NCT01064440|589884127|FG000|Overall Study|Withdrawal by Subject|0|||
163320190|NCT01064440|589884128|FG001|Overall Study|Withdrawal by Subject|1|||
163320191|NCT01064440|589884129|FG002|Overall Study|Withdrawal by Subject|1|||
163320192|NCT01064440|589884127|FG000|Overall Study|Other: amputation|1|||
163320193|NCT01064440|589884128|FG001|Overall Study|Other: amputation|0|||
163320194|NCT01064440|589884129|FG002|Overall Study|Other: amputation|0|||
163320195|NCT04797858|589884130|FG000|Overall Study|Withdrawal by Subject|0|||
163320196|NCT04797858|589884131|FG001|Overall Study|Withdrawal by Subject|1|||
163320197|NCT04797858|589884130|FG000|Overall Study|Excluded due to administrative error|7|||
162979682|NCT00102687|588626852|FG000|Initial Period|Protocol Violation|0|||
162979683|NCT00102687|588626853|FG001|Initial Period|Protocol Violation|0|||
162979684|NCT00102687|588626854|FG002|Initial Period|Protocol Violation|2|||
162979685|NCT00102687|588626855|FG003|Initial Period|Protocol Violation|0|||
162979686|NCT00102687|588626856|FG004|Initial Period|Protocol Violation|0|||
162979687|NCT00102687|588626852|FG000|Initial Period|Physician Decision|2|||
162979688|NCT00102687|588626853|FG001|Initial Period|Physician Decision|9|||
162979689|NCT00102687|588626854|FG002|Initial Period|Physician Decision|6|||
162979690|NCT00102687|588626855|FG003|Initial Period|Physician Decision|0|||
162979691|NCT00102687|588626856|FG004|Initial Period|Physician Decision|0|||
162979692|NCT00102687|588626852|FG000|Initial Period|Sponsor's decision|0|||
162979693|NCT00102687|588626853|FG001|Initial Period|Sponsor's decision|1|||
162979694|NCT00102687|588626854|FG002|Initial Period|Sponsor's decision|1|||
162979695|NCT00102687|588626855|FG003|Initial Period|Sponsor's decision|0|||
162979696|NCT00102687|588626856|FG004|Initial Period|Sponsor's decision|0|||
162979697|NCT00102687|588626852|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
162979698|NCT00102687|588626853|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
163320198|NCT04797858|589884131|FG001|Overall Study|Excluded due to administrative error|8|||
163320199|NCT01880515|589884135|FG000|Overall Study|Lost to Follow-up|3|||
163320200|NCT01880515|589884136|FG001|Overall Study|Lost to Follow-up|2|||
163320201|NCT01880515|589884135|FG000|Overall Study|Disease Progression|5|||
162979699|NCT00102687|588626854|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
162979700|NCT00102687|588626855|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
162979701|NCT00102687|588626856|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
162979702|NCT00102687|588626852|FG000|Initial Period|Death|1|||
162979703|NCT00102687|588626853|FG001|Initial Period|Death|1|||
162979704|NCT00102687|588626854|FG002|Initial Period|Death|1|||
163320202|NCT01880515|589884136|FG001|Overall Study|Disease Progression|7|||
163320203|NCT03505710|589884138|FG000|Overall Study|Progressive Disease|24|||
163320204|NCT03505710|589884139|FG001|Overall Study|Progressive Disease|17|||
163320205|NCT03505710|589884140|FG002|Overall Study|Progressive Disease|43|||
163320206|NCT03505710|589884138|FG000|Overall Study|Clinical Progression|6|||
163320207|NCT03505710|589884139|FG001|Overall Study|Clinical Progression|8|||
163320208|NCT03505710|589884140|FG002|Overall Study|Clinical Progression|3|||
163320209|NCT03505710|589884138|FG000|Overall Study|Adverse Event|12|||
163320210|NCT03505710|589884139|FG001|Overall Study|Adverse Event|6|||
163320211|NCT03505710|589884140|FG002|Overall Study|Adverse Event|28|||
163320212|NCT03505710|589884138|FG000|Overall Study|Withdrawal by Subject|1|||
163320213|NCT03505710|589884139|FG001|Overall Study|Withdrawal by Subject|3|||
163320214|NCT03505710|589884140|FG002|Overall Study|Withdrawal by Subject|7|||
163320215|NCT03505710|589884138|FG000|Overall Study|Physician Decision|1|||
163320216|NCT03505710|589884139|FG001|Overall Study|Physician Decision|1|||
163320217|NCT03505710|589884140|FG002|Overall Study|Physician Decision|2|||
163320218|NCT03505710|589884138|FG000|Overall Study|Death|4|||
163320219|NCT03505710|589884139|FG001|Overall Study|Death|5|||
163320220|NCT03505710|589884140|FG002|Overall Study|Death|6|||
163320221|NCT03505710|589884138|FG000|Overall Study|Other Reasons|1|||
163320222|NCT03505710|589884139|FG001|Overall Study|Other Reasons|1|||
163320223|NCT03505710|589884140|FG002|Overall Study|Other Reasons|1|||
163320224|NCT03505710|589884138|FG000|Overall Study|Study Terminated by Sponsor|0|||
163320225|NCT03505710|589884139|FG001|Overall Study|Study Terminated by Sponsor|0|||
163320226|NCT03505710|589884140|FG002|Overall Study|Study Terminated by Sponsor|1|||
163320227|NCT04414722|589884141|FG000|Overall Study|Lost to Follow-up|3|||
163320228|NCT04414722|589884142|FG001|Overall Study|Lost to Follow-up|4|||
163320229|NCT04414722|589884143|FG002|Overall Study|Lost to Follow-up|3|||
163320230|NCT04414722|589884144|FG003|Overall Study|Lost to Follow-up|2|||
163320231|NCT04414722|589884145|FG004|Overall Study|Lost to Follow-up|3|||
163320232|NCT04414722|589884141|FG000|Overall Study|Withdrawal by Subject|6|||
163320233|NCT04414722|589884142|FG001|Overall Study|Withdrawal by Subject|3|||
163320234|NCT04414722|589884143|FG002|Overall Study|Withdrawal by Subject|1|||
163320235|NCT04414722|589884144|FG003|Overall Study|Withdrawal by Subject|5|||
163320236|NCT04414722|589884145|FG004|Overall Study|Withdrawal by Subject|1|||
163320237|NCT04414722|589884141|FG000|Overall Study|Physician Decision|0|||
163320238|NCT04414722|589884142|FG001|Overall Study|Physician Decision|1|||
163320239|NCT04414722|589884143|FG002|Overall Study|Physician Decision|2|||
163320240|NCT04414722|589884144|FG003|Overall Study|Physician Decision|0|||
163320241|NCT04414722|589884145|FG004|Overall Study|Physician Decision|0|||
163320242|NCT04414722|589884141|FG000|Overall Study|Non-participatory|0|||
163320243|NCT04414722|589884142|FG001|Overall Study|Non-participatory|1|||
163320244|NCT04414722|589884143|FG002|Overall Study|Non-participatory|1|||
163320245|NCT04414722|589884144|FG003|Overall Study|Non-participatory|0|||
163320246|NCT04414722|589884145|FG004|Overall Study|Non-participatory|0|||
163320247|NCT04766892|589884146|FG000|Overall Study|Withdrawal by Subject|1|||
163320248|NCT04766892|589884146|FG000|Overall Study|Lost to Follow-up|1|||
163320249|NCT04766892|589884146|FG000|Overall Study|Adverse Event|3|||
163320250|NCT04766892|589884146|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
163320251|NCT05290493|589884154|FG000|Overall Study|Withdrawal by Subject|2|||
163320252|NCT05290493|589884155|FG001|Overall Study|Withdrawal by Subject|2|||
163320253|NCT05290493|589884154|FG000|Overall Study|Adverse Event|1|||
163320254|NCT05290493|589884155|FG001|Overall Study|Adverse Event|0|||
163320255|NCT04003246|589884156|FG000|Overall Study|Death|9|||
163320256|NCT03673501|589884165|FG000|Overall Study|Participants ongoing.|36|||
163320257|NCT03673501|589884166|FG001|Overall Study|Participants ongoing.|24|||
163320258|NCT05838027|589884167|FG000|Overall Study|Lost to Follow-up|5|||
162979705|NCT00102687|588626855|FG003|Initial Period|Death|0|||
162979706|NCT00102687|588626856|FG004|Initial Period|Death|0|||
162979707|NCT00102687|588626852|FG000|Maintenance Period|Withdrawal by Subject|4|||
162979708|NCT00102687|588626853|FG001|Maintenance Period|Withdrawal by Subject|0|||
162979709|NCT00102687|588626854|FG002|Maintenance Period|Withdrawal by Subject|2|||
162979710|NCT00102687|588626855|FG003|Maintenance Period|Withdrawal by Subject|3|||
162979711|NCT00102687|588626856|FG004|Maintenance Period|Withdrawal by Subject|1|||
162979712|NCT00102687|588626852|FG000|Maintenance Period|Adverse Event|1|||
162979713|NCT00102687|588626853|FG001|Maintenance Period|Adverse Event|0|||
163058942|NCT02867592|588924345|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
163058943|NCT02867592|588924340|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
162979714|NCT00102687|588626854|FG002|Maintenance Period|Adverse Event|0|||
163058944|NCT02867592|588924341|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
163320259|NCT05838027|589884168|FG001|Overall Study|Lost to Follow-up|1|||
163320260|NCT05838027|589884167|FG000|Overall Study|Withdrawal by Subject|1|||
163320261|NCT05838027|589884168|FG001|Overall Study|Withdrawal by Subject|0|||
163320262|NCT05237284|589884169|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
163320263|NCT05237284|589884170|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
162979715|NCT00102687|588626855|FG003|Maintenance Period|Adverse Event|1|||
163320264|NCT05237284|589884171|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
163320265|NCT05237284|589884172|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
163320266|NCT05237284|589884169|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
163320267|NCT05237284|589884170|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
163320268|NCT05237284|589884171|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
163402631|NCT01870401|590186978|FG001|Overall Study|Death|24|||
162979716|NCT00102687|588626856|FG004|Maintenance Period|Adverse Event|3|||
162979717|NCT00102687|588626852|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
162979718|NCT00102687|588626853|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
162979719|NCT00102687|588626854|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
162979720|NCT00102687|588626855|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
162979721|NCT00102687|588626856|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
162979722|NCT00102687|588626852|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
162979723|NCT00102687|588626853|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
162979724|NCT00102687|588626854|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
162979725|NCT00102687|588626855|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
162979726|NCT00102687|588626856|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
162979727|NCT00102687|588626852|FG000|Maintenance Period|Death|0|||
162979728|NCT00102687|588626853|FG001|Maintenance Period|Death|0|||
162979729|NCT00102687|588626854|FG002|Maintenance Period|Death|0|||
162979730|NCT00102687|588626855|FG003|Maintenance Period|Death|1|||
162979731|NCT00102687|588626856|FG004|Maintenance Period|Death|1|||
162979732|NCT00102687|588626852|FG000|Maintenance Period|Physician Decision|1|||
162979733|NCT00102687|588626853|FG001|Maintenance Period|Physician Decision|2|||
163058945|NCT02867592|588924342|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
163058946|NCT02867592|588924343|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
163058947|NCT02867592|588924344|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
163058948|NCT02867592|588924345|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
163058949|NCT00909870|588924346|FG000|Overall Study|Adverse Event|13|||
163058950|NCT00909870|588924347|FG001|Overall Study|Adverse Event|7|||
163058951|NCT00909870|588924346|FG000|Overall Study|Protocol Violation|1|||
163058952|NCT00909870|588924347|FG001|Overall Study|Protocol Violation|2|||
163058953|NCT00909870|588924346|FG000|Overall Study|Withdrawal by Subject|5|||
163058954|NCT00909870|588924347|FG001|Overall Study|Withdrawal by Subject|8|||
163058955|NCT00909870|588924346|FG000|Overall Study|Lost to Follow-up|3|||
163058956|NCT00909870|588924347|FG001|Overall Study|Lost to Follow-up|3|||
163058957|NCT00909870|588924346|FG000|Overall Study|Physician Decision|0|||
163058958|NCT00909870|588924347|FG001|Overall Study|Physician Decision|2|||
163058959|NCT00909870|588924346|FG000|Overall Study|Other|1|||
163058960|NCT00909870|588924347|FG001|Overall Study|Other|5|||
163058961|NCT01420536|588924358|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
163058962|NCT01420536|588924359|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
163058963|NCT04711005|588924360|FG000|Overall Study|Withdrawal by Subject|0|||
163058964|NCT04711005|588924361|FG001|Overall Study|Withdrawal by Subject|0|||
163058965|NCT04711005|588924362|FG002|Overall Study|Withdrawal by Subject|0|||
163058966|NCT04711005|588924363|FG003|Overall Study|Withdrawal by Subject|0|||
163058967|NCT04711005|588924364|FG004|Overall Study|Withdrawal by Subject|0|||
163058968|NCT04711005|588924365|FG005|Overall Study|Withdrawal by Subject|0|||
163058969|NCT04711005|588924366|FG006|Overall Study|Withdrawal by Subject|0|||
163058970|NCT04711005|588924367|FG007|Overall Study|Withdrawal by Subject|1|||
163058971|NCT04711005|588924368|FG008|Overall Study|Withdrawal by Subject|0|||
163058972|NCT04711005|588924369|FG009|Overall Study|Withdrawal by Subject|0|||
163058973|NCT04711005|588924360|FG000|Overall Study|Physician Decision|0|||
163058974|NCT04711005|588924361|FG001|Overall Study|Physician Decision|0|||
163058975|NCT04711005|588924362|FG002|Overall Study|Physician Decision|0|||
163058976|NCT04711005|588924363|FG003|Overall Study|Physician Decision|0|||
163058977|NCT04711005|588924364|FG004|Overall Study|Physician Decision|0|||
163058978|NCT04711005|588924365|FG005|Overall Study|Physician Decision|0|||
163058979|NCT04711005|588924366|FG006|Overall Study|Physician Decision|0|||
163058980|NCT04711005|588924367|FG007|Overall Study|Physician Decision|2|||
163058981|NCT04711005|588924368|FG008|Overall Study|Physician Decision|1|||
163058982|NCT04711005|588924369|FG009|Overall Study|Physician Decision|0|||
163058983|NCT00764790|588924370|FG000|Overall Study|Protocol Violation|0|||
163058984|NCT00764790|588924371|FG001|Overall Study|Protocol Violation|0|||
163058985|NCT00764790|588924372|FG002|Overall Study|Protocol Violation|1|||
163058986|NCT00764790|588924370|FG000|Overall Study|Withdrawal by Subject|10|||
163058987|NCT00764790|588924371|FG001|Overall Study|Withdrawal by Subject|12|||
163058988|NCT00764790|588924372|FG002|Overall Study|Withdrawal by Subject|6|||
163058989|NCT00764790|588924370|FG000|Overall Study|Lost to Follow-up|28|||
163058990|NCT00764790|588924371|FG001|Overall Study|Lost to Follow-up|29|||
163058991|NCT00764790|588924372|FG002|Overall Study|Lost to Follow-up|23|||
163058992|NCT03191552|588924373|FG000|Overall Study|Lost to Follow-up|1|||
162979734|NCT00102687|588626854|FG002|Maintenance Period|Physician Decision|3|||
162979735|NCT00102687|588626855|FG003|Maintenance Period|Physician Decision|0|||
162979736|NCT00102687|588626856|FG004|Maintenance Period|Physician Decision|4|||
162979737|NCT03253744|588626862|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
163058993|NCT03191552|588924374|FG001|Overall Study|Lost to Follow-up|0|||
163058994|NCT03191552|588924375|FG002|Overall Study|Lost to Follow-up|0|||
162979738|NCT03253744|588626863|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
162979739|NCT03253744|588626864|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
162979740|NCT03253744|588626865|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
162979741|NCT06279871|588626866|FG000|Overall Study|Death|0|||
162979742|NCT06279871|588626867|FG001|Overall Study|Death|0|||
162979743|NCT06279871|588626868|FG002|Overall Study|Death|0|||
162979744|NCT06279871|588626869|FG003|Overall Study|Death|0|||
162979745|NCT06279871|588626870|FG004|Overall Study|Death|0|||
162979746|NCT06279871|588626871|FG005|Overall Study|Death|1|||
162979747|NCT06279871|588626872|FG006|Overall Study|Death|0|||
162979748|NCT06279871|588626866|FG000|Overall Study|Other than Specified|1|||
162979749|NCT06279871|588626867|FG001|Overall Study|Other than Specified|0|||
162979750|NCT06279871|588626868|FG002|Overall Study|Other than Specified|4|||
162979751|NCT06279871|588626869|FG003|Overall Study|Other than Specified|0|||
162979752|NCT06279871|588626870|FG004|Overall Study|Other than Specified|0|||
162979753|NCT06279871|588626871|FG005|Overall Study|Other than Specified|0|||
162979754|NCT06279871|588626872|FG006|Overall Study|Other than Specified|0|||
162979755|NCT06279871|588626866|FG000|Overall Study|Withdrawal by Subject|4|||
162979756|NCT06279871|588626867|FG001|Overall Study|Withdrawal by Subject|8|||
162979757|NCT06279871|588626868|FG002|Overall Study|Withdrawal by Subject|4|||
163320269|NCT05237284|589884172|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
163320270|NCT05237284|589884169|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
163320271|NCT05237284|589884170|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
163402632|NCT01870401|590186977|FG000|Overall Study|Withdrawal by Subject|39|||
163402633|NCT01870401|590186978|FG001|Overall Study|Withdrawal by Subject|26|||
163402634|NCT01870401|590186977|FG000|Overall Study|Lost to Follow-up|19|||
163402635|NCT01870401|590186978|FG001|Overall Study|Lost to Follow-up|14|||
163402636|NCT01870401|590186977|FG000|Overall Study|Other|9|||
163402637|NCT01870401|590186978|FG001|Overall Study|Other|7|||
163402638|NCT01870401|590186977|FG000|Overall Study|On-going in the Study|35|||
163402639|NCT01870401|590186978|FG001|Overall Study|On-going in the Study|25|||
163402640|NCT01135498|590186980|FG000|Overall Study|Adverse Event|20|||
163320272|NCT05237284|589884171|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
163320273|NCT05237284|589884172|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
163402641|NCT01135498|590186980|FG000|Overall Study|Progressive disease|38|||
163402642|NCT01135498|590186980|FG000|Overall Study|Investigator judgement|25|||
163320274|NCT05237284|589884169|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
163320275|NCT05237284|589884170|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
163320276|NCT05237284|589884171|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
163320277|NCT05237284|589884172|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
163320278|NCT05237284|589884169|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
163320279|NCT05237284|589884170|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
163320280|NCT05237284|589884171|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
163320281|NCT05237284|589884172|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
163320282|NCT05237284|589884169|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
163320283|NCT05237284|589884170|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
163320284|NCT05237284|589884171|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
163320285|NCT05237284|589884172|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
163320286|NCT05237284|589884169|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
163320287|NCT05237284|589884170|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
163402643|NCT01135498|590186980|FG000|Overall Study|Withdrawal by Subject|4|||
163402644|NCT01135498|590186980|FG000|Overall Study|Death|1|||
163402645|NCT01135498|590186980|FG000|Overall Study|Ongoing at time of analysis|2|||
163402646|NCT01192022|590186981|FG000|Overall Study|Withdrawal of Consent|3|||
163402647|NCT01192022|590186982|FG001|Overall Study|Withdrawal of Consent|1|||
163402648|NCT01192022|590186983|FG002|Overall Study|Withdrawal of Consent|0|||
163402649|NCT01192022|590186984|FG003|Overall Study|Withdrawal of Consent|0|||
163402650|NCT01192022|590186985|FG004|Overall Study|Withdrawal of Consent|0|||
163402651|NCT01192022|590186981|FG000|Overall Study|Lost to Follow-up|4|||
163402652|NCT01192022|590186982|FG001|Overall Study|Lost to Follow-up|2|||
163402653|NCT01192022|590186983|FG002|Overall Study|Lost to Follow-up|1|||
163402654|NCT01192022|590186984|FG003|Overall Study|Lost to Follow-up|1|||
163402655|NCT01192022|590186985|FG004|Overall Study|Lost to Follow-up|0|||
163402656|NCT01192022|590186981|FG000|Overall Study|Adverse Event|1|||
162979758|NCT06279871|588626869|FG003|Overall Study|Withdrawal by Subject|2|||
162979759|NCT06279871|588626870|FG004|Overall Study|Withdrawal by Subject|0|||
163320288|NCT05237284|589884171|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
163320289|NCT05237284|589884172|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
163402657|NCT01192022|590186982|FG001|Overall Study|Adverse Event|0|||
163402658|NCT01192022|590186983|FG002|Overall Study|Adverse Event|0|||
163402659|NCT01192022|590186984|FG003|Overall Study|Adverse Event|0|||
162979760|NCT06279871|588626871|FG005|Overall Study|Withdrawal by Subject|0|||
162979761|NCT06279871|588626872|FG006|Overall Study|Withdrawal by Subject|0|||
162979762|NCT06279871|588626866|FG000|Overall Study|Lost to Follow-up|11|||
162979763|NCT06279871|588626867|FG001|Overall Study|Lost to Follow-up|10|||
162979764|NCT06279871|588626868|FG002|Overall Study|Lost to Follow-up|8|||
162979765|NCT06279871|588626869|FG003|Overall Study|Lost to Follow-up|0|||
162979766|NCT06279871|588626870|FG004|Overall Study|Lost to Follow-up|0|||
162979767|NCT06279871|588626871|FG005|Overall Study|Lost to Follow-up|0|||
162979768|NCT06279871|588626872|FG006|Overall Study|Lost to Follow-up|0|||
162979769|NCT06279871|588626866|FG000|Overall Study|Adverse Event|0|||
162979770|NCT06279871|588626867|FG001|Overall Study|Adverse Event|1|||
162979771|NCT06279871|588626868|FG002|Overall Study|Adverse Event|0|||
162979772|NCT06279871|588626869|FG003|Overall Study|Adverse Event|0|||
162979773|NCT06279871|588626870|FG004|Overall Study|Adverse Event|0|||
162979774|NCT06279871|588626871|FG005|Overall Study|Adverse Event|0|||
162979775|NCT06279871|588626872|FG006|Overall Study|Adverse Event|0|||
162979776|NCT01144403|588626878|FG000|Overall Study|Lost to Follow-up|3|||
162979777|NCT01144403|588626878|FG000|Overall Study|Death|1|||
162979778|NCT01144403|588626878|FG000|Overall Study|Adverse Event|1|||
162979779|NCT02339740|588626881|FG000|Overall Study|Death|1|||
162979780|NCT02339740|588626882|FG001|Overall Study|Death|0|||
162979781|NCT02339740|588626881|FG000|Overall Study|Physician Decision|0|||
162979782|NCT02339740|588626882|FG001|Overall Study|Physician Decision|2|||
162979783|NCT02339740|588626881|FG000|Overall Study|Withdrawal by Subject|5|||
162979784|NCT02339740|588626882|FG001|Overall Study|Withdrawal by Subject|1|||
162979785|NCT02339740|588626881|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
162979786|NCT02339740|588626882|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
162979787|NCT01807117|588626883|FG000|Overall Study|Physician Decision|2|||
162979788|NCT01807117|588626883|FG000|Overall Study|Disease diagnosis not a study disease|1|||
162979789|NCT02777918|588626889|FG000|Overall Study|Medical reasons|1|||
162979790|NCT02777918|588626890|FG001|Overall Study|Medical reasons|2|||
162979791|NCT02777918|588626889|FG000|Overall Study|Too busy / stressed|1|||
162979792|NCT02777918|588626890|FG001|Overall Study|Too busy / stressed|1|||
162979793|NCT02777918|588626889|FG000|Overall Study|Withdrawal by Subject|1|||
162979794|NCT02777918|588626890|FG001|Overall Study|Withdrawal by Subject|1|||
162979795|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
162979796|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
162979797|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
162979798|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
162979799|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
162979800|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
162979801|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
162979802|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
162979803|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
162979804|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
162979805|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
162979806|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
162979807|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
162979808|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
162979809|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
162979810|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
162979811|NCT02510014|588626894|FG000|Treatment Period|Adverse Event|11|||
162979812|NCT02510014|588626895|FG001|Treatment Period|Adverse Event|4|||
162979813|NCT02510014|588626894|FG000|Treatment Period|Withdrawal symptoms|3|||
162979814|NCT02510014|588626895|FG001|Treatment Period|Withdrawal symptoms|0|||
162979815|NCT02510014|588626894|FG000|Treatment Period|Lost to Follow-up|80|||
162979816|NCT02510014|588626895|FG001|Treatment Period|Lost to Follow-up|19|||
162979817|NCT02510014|588626894|FG000|Treatment Period|Physician Decision|5|||
162979818|NCT02510014|588626895|FG001|Treatment Period|Physician Decision|0|||
162979819|NCT02510014|588626894|FG000|Treatment Period|Withdrawal by Subject|67|||
162979820|NCT02510014|588626895|FG001|Treatment Period|Withdrawal by Subject|24|||
162979821|NCT02510014|588626894|FG000|Treatment Period|Withdrawn by the investigator|7|||
162979822|NCT02510014|588626895|FG001|Treatment Period|Withdrawn by the investigator|1|||
163320290|NCT05237284|589884169|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
163320291|NCT05237284|589884170|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
163320292|NCT05237284|589884171|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
162979823|NCT02510014|588626894|FG000|Treatment Period|Protocol Violation|4|||
162979824|NCT02510014|588626895|FG001|Treatment Period|Protocol Violation|4|||
163320293|NCT05237284|589884172|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
163320294|NCT05237284|589884169|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
163402660|NCT01192022|590186985|FG004|Overall Study|Adverse Event|0|||
162979825|NCT02510014|588626894|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
162979826|NCT02510014|588626895|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
162979827|NCT01949116|588626897|FG000|Overall Study|Death|2|||
162979828|NCT01949116|588626898|FG001|Overall Study|Death|0|||
162979829|NCT01949116|588626897|FG000|Overall Study|Lost to Follow-up|1|||
162979830|NCT01949116|588626898|FG001|Overall Study|Lost to Follow-up|3|||
162979831|NCT01949116|588626897|FG000|Overall Study|Withdrawal by Subject|5|||
163058995|NCT03191552|588924373|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
162979832|NCT01949116|588626898|FG001|Overall Study|Withdrawal by Subject|3|||
162979833|NCT01855048|588626909|FG000|Overall Study|Withdrawal by Subject|0|||
162979834|NCT01855048|588626910|FG001|Overall Study|Withdrawal by Subject|1|||
162979835|NCT01855048|588626911|FG002|Overall Study|Withdrawal by Subject|0|||
162979836|NCT01855048|588626912|FG003|Overall Study|Withdrawal by Subject|0|||
162979837|NCT01855048|588626913|FG004|Overall Study|Withdrawal by Subject|1|||
162979838|NCT01855048|588626914|FG005|Overall Study|Withdrawal by Subject|0|||
162979839|NCT02972502|588626919|FG000|Overall Study|Lost to Follow-up|3|||
162979840|NCT02972502|588626920|FG001|Overall Study|Lost to Follow-up|1|||
162979841|NCT02972502|588626919|FG000|Overall Study|Withdrawal by Subject|1|||
162979842|NCT02972502|588626920|FG001|Overall Study|Withdrawal by Subject|1|||
162979843|NCT03832738|588626921|FG000|Overall Study|Withdrawal by Subject|6|||
162979844|NCT03832738|588626922|FG001|Overall Study|Withdrawal by Subject|7|||
162979845|NCT03832738|588626923|FG002|Overall Study|Withdrawal by Subject|16|||
162979846|NCT03832738|588626921|FG000|Overall Study|Physician Decision|0|||
163211312|NCT00811473|589488839|FG000|Overall Study|Severe non-compliance to protocol|2|||
163211313|NCT00811473|589488840|FG001|Overall Study|Severe non-compliance to protocol|4|||
163211314|NCT00811473|589488839|FG000|Overall Study|Lack of therapeutic response|4|||
163211315|NCT00811473|589488840|FG001|Overall Study|Lack of therapeutic response|1|||
162979847|NCT03832738|588626922|FG001|Overall Study|Physician Decision|1|||
162979848|NCT03832738|588626923|FG002|Overall Study|Physician Decision|2|||
162979849|NCT03832738|588626921|FG000|Overall Study|Adverse Event|2|||
162979850|NCT03832738|588626922|FG001|Overall Study|Adverse Event|3|||
162979851|NCT03832738|588626923|FG002|Overall Study|Adverse Event|1|||
162979852|NCT03832738|588626921|FG000|Overall Study|Pregnancy|0|||
162979853|NCT03832738|588626922|FG001|Overall Study|Pregnancy|1|||
162979854|NCT03832738|588626923|FG002|Overall Study|Pregnancy|0|||
162979855|NCT03852459|588626924|FG000|Overall Study|Adverse Event|2|||
162979856|NCT03852459|588626925|FG001|Overall Study|Adverse Event|2|||
162979857|NCT03852459|588626924|FG000|Overall Study|Withdrawal by Subject|1|||
162979858|NCT03852459|588626925|FG001|Overall Study|Withdrawal by Subject|1|||
162979859|NCT00049842|588626926|FG000|Treatment Phase|Adverse Event|47|||
162979860|NCT00049842|588626927|FG001|Treatment Phase|Adverse Event|12|||
162979861|NCT00049842|588626926|FG000|Treatment Phase|Withdrawal by Subject|35|||
162979862|NCT00049842|588626927|FG001|Treatment Phase|Withdrawal by Subject|46|||
162979863|NCT00049842|588626926|FG000|Treatment Phase|Non-compliance with protocol|7|||
162979864|NCT00049842|588626927|FG001|Treatment Phase|Non-compliance with protocol|8|||
162979865|NCT00049842|588626926|FG000|Treatment Phase|Lost to Follow-up|4|||
162979866|NCT00049842|588626927|FG001|Treatment Phase|Lost to Follow-up|8|||
162979867|NCT00049842|588626926|FG000|Treatment Phase|Administrative|0|||
162979868|NCT00049842|588626927|FG001|Treatment Phase|Administrative|3|||
162979869|NCT00049842|588626926|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
162979870|NCT00049842|588626927|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
162979871|NCT00049842|588626926|FG000|Follow-up Phase|Adverse Event|6|||
162979872|NCT00049842|588626927|FG001|Follow-up Phase|Adverse Event|1|||
162979873|NCT00049842|588626926|FG000|Follow-up Phase|Other|1|||
162979874|NCT00049842|588626927|FG001|Follow-up Phase|Other|4|||
162979875|NCT05486065|588626929|FG000|Overall Study|Withdrawal by Subject|1|||
162979876|NCT05486065|588626930|FG001|Overall Study|Withdrawal by Subject|5|||
162979877|NCT05486065|588626931|FG002|Overall Study|Withdrawal by Subject|4|||
162979878|NCT05486065|588626932|FG003|Overall Study|Withdrawal by Subject|3|||
162979879|NCT05486065|588626929|FG000|Overall Study|Lost to Follow-up|4|||
162979880|NCT05486065|588626930|FG001|Overall Study|Lost to Follow-up|2|||
162979881|NCT05486065|588626931|FG002|Overall Study|Lost to Follow-up|2|||
162979882|NCT05486065|588626932|FG003|Overall Study|Lost to Follow-up|2|||
162979883|NCT05486065|588626929|FG000|Overall Study|Physician Decision|0|||
162979884|NCT05486065|588626930|FG001|Overall Study|Physician Decision|1|||
162979885|NCT05486065|588626931|FG002|Overall Study|Physician Decision|1|||
162979886|NCT05486065|588626932|FG003|Overall Study|Physician Decision|0|||
162979887|NCT05486065|588626929|FG000|Overall Study|Failure to meet randomization criteria|0|||
162979888|NCT05486065|588626930|FG001|Overall Study|Failure to meet randomization criteria|0|||
162979889|NCT05486065|588626931|FG002|Overall Study|Failure to meet randomization criteria|0|||
162979890|NCT05486065|588626932|FG003|Overall Study|Failure to meet randomization criteria|1|||
162979891|NCT00307931|588626933|FG000|Overall Study|Adverse Event|1|||
162979892|NCT00493246|588629161|FG000|Overall Study|Withdrawal by Subject|0|||
162979893|NCT00493246|588629162|FG001|Overall Study|Withdrawal by Subject|0|||
162979894|NCT00493246|588629163|FG002|Overall Study|Withdrawal by Subject|0|||
162979895|NCT00493246|588629164|FG003|Overall Study|Withdrawal by Subject|0|||
162979896|NCT00493246|588629165|FG004|Overall Study|Withdrawal by Subject|1|||
162979897|NCT00493246|588629166|FG005|Overall Study|Withdrawal by Subject|0|||
162979898|NCT00493246|588629167|FG006|Overall Study|Withdrawal by Subject|0|||
162979899|NCT00493246|588629168|FG007|Overall Study|Withdrawal by Subject|0|||
162979900|NCT00493246|588629161|FG000|Overall Study|No access to draw blood|0|||
162979901|NCT00493246|588629162|FG001|Overall Study|No access to draw blood|0|||
162979902|NCT00493246|588629163|FG002|Overall Study|No access to draw blood|0|||
162979903|NCT00493246|588629164|FG003|Overall Study|No access to draw blood|0|||
162979904|NCT00493246|588629165|FG004|Overall Study|No access to draw blood|0|||
163320295|NCT05237284|589884170|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
163320296|NCT05237284|589884171|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
163320297|NCT05237284|589884172|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
163320298|NCT04599634|589884173|FG000|Overall Study|Dose limiting toxicity|0|||
163320299|NCT04599634|589884174|FG001|Overall Study|Dose limiting toxicity|0|||
163320300|NCT04599634|589884175|FG002|Overall Study|Dose limiting toxicity|2|||
163320301|NCT04599634|589884176|FG003|Overall Study|Dose limiting toxicity|0|||
162979905|NCT00493246|588629166|FG005|Overall Study|No access to draw blood|1|||
162979906|NCT00493246|588629167|FG006|Overall Study|No access to draw blood|0|||
162979907|NCT00493246|588629168|FG007|Overall Study|No access to draw blood|0|||
162979908|NCT00493246|588629161|FG000|Overall Study|Lost to Follow-up|0|||
162979909|NCT00493246|588629162|FG001|Overall Study|Lost to Follow-up|0|||
162979910|NCT00493246|588629163|FG002|Overall Study|Lost to Follow-up|0|||
162979911|NCT00493246|588629164|FG003|Overall Study|Lost to Follow-up|0|||
162979912|NCT00493246|588629165|FG004|Overall Study|Lost to Follow-up|0|||
162979913|NCT00493246|588629166|FG005|Overall Study|Lost to Follow-up|0|||
162979914|NCT00493246|588629167|FG006|Overall Study|Lost to Follow-up|1|||
162979915|NCT00493246|588629168|FG007|Overall Study|Lost to Follow-up|0|||
162979916|NCT00595335|588629169|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
162979917|NCT00595335|588629170|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
162979918|NCT00595335|588629169|FG000|Baseline to Six Months|Disease Progression|1|||
162979919|NCT00595335|588629170|FG001|Baseline to Six Months|Disease Progression|1|||
162979920|NCT00595335|588629169|FG000|Baseline to Six Months|Adverse Event|1|||
162979921|NCT00595335|588629170|FG001|Baseline to Six Months|Adverse Event|0|||
162979922|NCT00595335|588629169|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
162979923|NCT00595335|588629170|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
162979924|NCT00595335|588629169|FG000|Six Months to Twelve Months|Disease Progression|1|||
162979925|NCT00595335|588629170|FG001|Six Months to Twelve Months|Disease Progression|0|||
162979926|NCT01013649|588629175|FG000|First Step|Withdrawal by Subject|36|||
162979927|NCT01013649|588629176|FG001|First Step|Withdrawal by Subject|19|||
162979928|NCT01013649|588629177|FG002|First Step|Withdrawal by Subject|0|||
162979929|NCT01013649|588629178|FG003|First Step|Withdrawal by Subject|0|||
162979930|NCT01013649|588629175|FG000|First Step|Progression|58|||
162979931|NCT01013649|588629176|FG001|First Step|Progression|23|||
162979932|NCT01013649|588629177|FG002|First Step|Progression|0|||
162979933|NCT01013649|588629178|FG003|First Step|Progression|0|||
162979934|NCT01013649|588629175|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
162979935|NCT01013649|588629176|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
162979936|NCT01013649|588629177|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
162979937|NCT01013649|588629178|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
162979938|NCT01013649|588629175|FG000|First Step|Death|3|||
162979939|NCT01013649|588629176|FG001|First Step|Death|4|||
162979940|NCT01013649|588629177|FG002|First Step|Death|0|||
162979941|NCT01013649|588629178|FG003|First Step|Death|0|||
162979942|NCT01013649|588629175|FG000|First Step|Adverse Event|9|||
162979943|NCT01013649|588629176|FG001|First Step|Adverse Event|5|||
162979944|NCT01013649|588629177|FG002|First Step|Adverse Event|0|||
162979945|NCT01013649|588629178|FG003|First Step|Adverse Event|0|||
162979946|NCT01013649|588629175|FG000|First Step|Other|4|||
162979947|NCT01013649|588629176|FG001|First Step|Other|6|||
162979948|NCT01013649|588629177|FG002|First Step|Other|0|||
162979949|NCT01013649|588629178|FG003|First Step|Other|0|||
162979950|NCT01647958|588629179|FG000|Initial Study|Lost to Follow-up|2|||
162979951|NCT01647958|588629180|FG001|Initial Study|Lost to Follow-up|3|||
162979952|NCT01647958|588629179|FG000|Continuation Phase|treatment received during Overall Study|39|||
162979953|NCT01647958|588629180|FG001|Continuation Phase|treatment received during Overall Study|0|||
163320302|NCT04526886|589884179|FG000|Overall Study|Physician Decision|4|||
163320303|NCT03276676|589884182|FG000|Overall Study|Withdrawal by Subject|2|||
163320304|NCT03276676|589884183|FG001|Overall Study|Withdrawal by Subject|1|||
163320305|NCT02962076|589884186|FG000|Overall Study|MHED tracer not available|5|||
162979954|NCT01647958|588629179|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
162979955|NCT01647958|588629180|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
162979956|NCT01131299|588629181|FG000|Overall Study|Withdrawal by Subject|4|||
162979957|NCT01131299|588629182|FG001|Overall Study|Withdrawal by Subject|7|||
163058996|NCT03191552|588924374|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
163058997|NCT03191552|588924375|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
162979958|NCT01207440|588629190|FG000|Overall Study|Adverse Event|46|||
162979959|NCT01207440|588629191|FG001|Overall Study|Adverse Event|11|||
162979960|NCT01207440|588629192|FG002|Overall Study|Adverse Event|7|||
162979961|NCT01207440|588629193|FG003|Overall Study|Adverse Event|2|||
162979962|NCT01207440|588629194|FG004|Overall Study|Adverse Event|6|||
162979963|NCT01207440|588629195|FG005|Overall Study|Adverse Event|6|||
163320306|NCT02962076|589884186|FG000|Overall Study|Protocol Violation|1|||
162979964|NCT01207440|588629196|FG006|Overall Study|Adverse Event|2|||
162979965|NCT01207440|588629190|FG000|Overall Study|Death|6|||
163058998|NCT05965752|588924377|FG000|Overall Study|Adverse Event|0|||
162979966|NCT01207440|588629191|FG001|Overall Study|Death|3|||
162979967|NCT01207440|588629192|FG002|Overall Study|Death|2|||
162979968|NCT01207440|588629193|FG003|Overall Study|Death|2|||
162979969|NCT01207440|588629194|FG004|Overall Study|Death|7|||
162979970|NCT01207440|588629195|FG005|Overall Study|Death|5|||
162979971|NCT01207440|588629196|FG006|Overall Study|Death|1|||
162979972|NCT01207440|588629190|FG000|Overall Study|Lack of Efficacy|13|||
163320307|NCT02962076|589884186|FG000|Overall Study|Physician Decision|1|||
163320308|NCT03580356|589884195|FG000|Treatment Period|Withdrawal by Subject|13|||
163320309|NCT03580356|589884196|FG001|Treatment Period|Withdrawal by Subject|0|||
163320310|NCT03580356|589884197|FG002|Treatment Period|Withdrawal by Subject|13|||
163320311|NCT03580356|589884198|FG003|Treatment Period|Withdrawal by Subject|1|||
163320312|NCT03580356|589884199|FG004|Treatment Period|Withdrawal by Subject|17|||
163320313|NCT03580356|589884200|FG005|Treatment Period|Withdrawal by Subject|0|||
163320314|NCT03580356|589884201|FG006|Treatment Period|Withdrawal by Subject|5|||
163320315|NCT03580356|589884202|FG007|Treatment Period|Withdrawal by Subject|0|||
163320316|NCT03580356|589884195|FG000|Treatment Period|Adverse Event|10|||
163320317|NCT03580356|589884196|FG001|Treatment Period|Adverse Event|0|||
163320318|NCT03580356|589884197|FG002|Treatment Period|Adverse Event|13|||
163320319|NCT03580356|589884198|FG003|Treatment Period|Adverse Event|0|||
163320320|NCT03580356|589884199|FG004|Treatment Period|Adverse Event|5|||
163320321|NCT03580356|589884200|FG005|Treatment Period|Adverse Event|0|||
163320322|NCT03580356|589884201|FG006|Treatment Period|Adverse Event|8|||
163320323|NCT03580356|589884202|FG007|Treatment Period|Adverse Event|0|||
163320324|NCT03580356|589884195|FG000|Treatment Period|Protocol Violation|5|||
163320325|NCT03580356|589884196|FG001|Treatment Period|Protocol Violation|0|||
163320326|NCT03580356|589884197|FG002|Treatment Period|Protocol Violation|6|||
163320327|NCT03580356|589884198|FG003|Treatment Period|Protocol Violation|1|||
163320328|NCT03580356|589884199|FG004|Treatment Period|Protocol Violation|9|||
163320329|NCT03580356|589884200|FG005|Treatment Period|Protocol Violation|1|||
163320330|NCT03580356|589884201|FG006|Treatment Period|Protocol Violation|1|||
163320331|NCT03580356|589884202|FG007|Treatment Period|Protocol Violation|0|||
163320332|NCT03580356|589884195|FG000|Treatment Period|Lack of Efficacy|6|||
163320333|NCT03580356|589884196|FG001|Treatment Period|Lack of Efficacy|0|||
163320334|NCT03580356|589884197|FG002|Treatment Period|Lack of Efficacy|2|||
163320335|NCT03580356|589884198|FG003|Treatment Period|Lack of Efficacy|0|||
163320336|NCT03580356|589884199|FG004|Treatment Period|Lack of Efficacy|3|||
163320337|NCT03580356|589884200|FG005|Treatment Period|Lack of Efficacy|0|||
163320338|NCT03580356|589884201|FG006|Treatment Period|Lack of Efficacy|3|||
163320339|NCT03580356|589884202|FG007|Treatment Period|Lack of Efficacy|0|||
163320340|NCT03580356|589884195|FG000|Treatment Period|Pregnancy|1|||
163402661|NCT01192022|590186981|FG000|Overall Study|Fatal Adverse Event|4|||
163402662|NCT01192022|590186982|FG001|Overall Study|Fatal Adverse Event|6|||
162979973|NCT01207440|588629191|FG001|Overall Study|Lack of Efficacy|2|||
162979974|NCT01207440|588629192|FG002|Overall Study|Lack of Efficacy|5|||
162979975|NCT01207440|588629193|FG003|Overall Study|Lack of Efficacy|1|||
162979976|NCT01207440|588629194|FG004|Overall Study|Lack of Efficacy|2|||
162979977|NCT01207440|588629195|FG005|Overall Study|Lack of Efficacy|3|||
162979978|NCT01207440|588629196|FG006|Overall Study|Lack of Efficacy|0|||
162979979|NCT01207440|588629190|FG000|Overall Study|Lost to Follow-up|0|||
162979980|NCT01207440|588629191|FG001|Overall Study|Lost to Follow-up|0|||
162979981|NCT01207440|588629192|FG002|Overall Study|Lost to Follow-up|2|||
162979982|NCT01207440|588629193|FG003|Overall Study|Lost to Follow-up|1|||
162979983|NCT01207440|588629194|FG004|Overall Study|Lost to Follow-up|0|||
162979984|NCT01207440|588629195|FG005|Overall Study|Lost to Follow-up|0|||
162979985|NCT01207440|588629196|FG006|Overall Study|Lost to Follow-up|0|||
162979986|NCT01207440|588629190|FG000|Overall Study|Non-compliance with Study Drug|3|||
162979987|NCT01207440|588629191|FG001|Overall Study|Non-compliance with Study Drug|0|||
162979988|NCT01207440|588629192|FG002|Overall Study|Non-compliance with Study Drug|1|||
162979989|NCT01207440|588629193|FG003|Overall Study|Non-compliance with Study Drug|0|||
162979990|NCT01207440|588629194|FG004|Overall Study|Non-compliance with Study Drug|0|||
162979991|NCT01207440|588629195|FG005|Overall Study|Non-compliance with Study Drug|0|||
163402663|NCT01192022|590186983|FG002|Overall Study|Fatal Adverse Event|0|||
163402664|NCT01192022|590186984|FG003|Overall Study|Fatal Adverse Event|0|||
162979992|NCT01207440|588629196|FG006|Overall Study|Non-compliance with Study Drug|0|||
162979993|NCT01207440|588629190|FG000|Overall Study|Physician Decision|6|||
163402665|NCT01192022|590186985|FG004|Overall Study|Fatal Adverse Event|1|||
162979994|NCT01207440|588629191|FG001|Overall Study|Physician Decision|5|||
162979995|NCT01207440|588629192|FG002|Overall Study|Physician Decision|5|||
162979996|NCT01207440|588629193|FG003|Overall Study|Physician Decision|0|||
162979997|NCT01207440|588629194|FG004|Overall Study|Physician Decision|1|||
163058999|NCT05965752|588924378|FG001|Overall Study|Adverse Event|1|||
163320341|NCT03580356|589884196|FG001|Treatment Period|Pregnancy|0|||
163320342|NCT03580356|589884197|FG002|Treatment Period|Pregnancy|7|||
163320343|NCT03580356|589884198|FG003|Treatment Period|Pregnancy|0|||
163320344|NCT03580356|589884199|FG004|Treatment Period|Pregnancy|2|||
163402666|NCT01192022|590186981|FG000|Overall Study|Physician withdrew-patient hardship|1|||
162979998|NCT01207440|588629195|FG005|Overall Study|Physician Decision|0|||
163320345|NCT03580356|589884200|FG005|Treatment Period|Pregnancy|0|||
163320346|NCT03580356|589884201|FG006|Treatment Period|Pregnancy|1|||
162979999|NCT01207440|588629196|FG006|Overall Study|Physician Decision|0|||
162980000|NCT01207440|588629190|FG000|Overall Study|Progressive Disease|19|||
162980001|NCT01207440|588629191|FG001|Overall Study|Progressive Disease|10|||
162980002|NCT01207440|588629192|FG002|Overall Study|Progressive Disease|19|||
162980003|NCT01207440|588629193|FG003|Overall Study|Progressive Disease|7|||
162980004|NCT01207440|588629194|FG004|Overall Study|Progressive Disease|23|||
162980005|NCT01207440|588629195|FG005|Overall Study|Progressive Disease|27|||
162980006|NCT01207440|588629196|FG006|Overall Study|Progressive Disease|0|||
162980007|NCT01207440|588629190|FG000|Overall Study|Protocol Violation|2|||
162980008|NCT01207440|588629191|FG001|Overall Study|Protocol Violation|0|||
162980009|NCT01207440|588629192|FG002|Overall Study|Protocol Violation|0|||
162980010|NCT01207440|588629193|FG003|Overall Study|Protocol Violation|0|||
162980011|NCT01207440|588629194|FG004|Overall Study|Protocol Violation|0|||
162980012|NCT01207440|588629195|FG005|Overall Study|Protocol Violation|0|||
162980013|NCT01207440|588629196|FG006|Overall Study|Protocol Violation|0|||
162980014|NCT01207440|588629190|FG000|Overall Study|Site Terminated by Sponsor|69|||
162980015|NCT01207440|588629191|FG001|Overall Study|Site Terminated by Sponsor|19|||
162980016|NCT01207440|588629192|FG002|Overall Study|Site Terminated by Sponsor|12|||
162980017|NCT01207440|588629193|FG003|Overall Study|Site Terminated by Sponsor|2|||
162980018|NCT01207440|588629194|FG004|Overall Study|Site Terminated by Sponsor|3|||
163320347|NCT03580356|589884202|FG007|Treatment Period|Pregnancy|0|||
163320348|NCT03580356|589884195|FG000|Treatment Period|Physician Decision|2|||
163320349|NCT03580356|589884196|FG001|Treatment Period|Physician Decision|0|||
163320350|NCT03580356|589884197|FG002|Treatment Period|Physician Decision|1|||
163320351|NCT03580356|589884198|FG003|Treatment Period|Physician Decision|0|||
163320352|NCT03580356|589884199|FG004|Treatment Period|Physician Decision|4|||
163320353|NCT03580356|589884200|FG005|Treatment Period|Physician Decision|0|||
163320354|NCT03580356|589884201|FG006|Treatment Period|Physician Decision|2|||
163320355|NCT03580356|589884202|FG007|Treatment Period|Physician Decision|0|||
163320356|NCT03580356|589884195|FG000|Treatment Period|Lost to Follow-up|1|||
163320357|NCT03580356|589884196|FG001|Treatment Period|Lost to Follow-up|1|||
163320358|NCT03580356|589884197|FG002|Treatment Period|Lost to Follow-up|1|||
163320359|NCT03580356|589884198|FG003|Treatment Period|Lost to Follow-up|0|||
163320360|NCT03580356|589884199|FG004|Treatment Period|Lost to Follow-up|3|||
163320361|NCT03580356|589884200|FG005|Treatment Period|Lost to Follow-up|0|||
163320362|NCT03580356|589884201|FG006|Treatment Period|Lost to Follow-up|1|||
163320363|NCT03580356|589884202|FG007|Treatment Period|Lost to Follow-up|0|||
163320364|NCT03580356|589884195|FG000|Treatment Period|Death|0|||
163320365|NCT03580356|589884196|FG001|Treatment Period|Death|0|||
163320366|NCT03580356|589884197|FG002|Treatment Period|Death|1|||
163320367|NCT03580356|589884198|FG003|Treatment Period|Death|0|||
163320368|NCT03580356|589884199|FG004|Treatment Period|Death|0|||
163320369|NCT03580356|589884200|FG005|Treatment Period|Death|0|||
163320370|NCT03580356|589884201|FG006|Treatment Period|Death|0|||
163320371|NCT03580356|589884202|FG007|Treatment Period|Death|0|||
163320372|NCT03580356|589884195|FG000|Treatment Period|Technical problems|0|||
163320373|NCT03580356|589884196|FG001|Treatment Period|Technical problems|0|||
163320374|NCT03580356|589884197|FG002|Treatment Period|Technical problems|0|||
163320375|NCT03580356|589884198|FG003|Treatment Period|Technical problems|0|||
163320376|NCT03580356|589884199|FG004|Treatment Period|Technical problems|1|||
163320377|NCT03580356|589884200|FG005|Treatment Period|Technical problems|0|||
163320378|NCT03580356|589884201|FG006|Treatment Period|Technical problems|0|||
163320379|NCT03580356|589884202|FG007|Treatment Period|Technical problems|0|||
163320380|NCT03580356|589884195|FG000|Treatment Period|Misrandomized, no treatment|0|||
163320381|NCT03580356|589884196|FG001|Treatment Period|Misrandomized, no treatment|0|||
163320382|NCT03580356|589884197|FG002|Treatment Period|Misrandomized, no treatment|1|||
162980019|NCT01207440|588629195|FG005|Overall Study|Site Terminated by Sponsor|0|||
162980020|NCT01207440|588629196|FG006|Overall Study|Site Terminated by Sponsor|2|||
162980021|NCT01207440|588629190|FG000|Overall Study|Withdrawal by Subject|29|||
162980022|NCT01207440|588629191|FG001|Overall Study|Withdrawal by Subject|4|||
162980023|NCT01207440|588629192|FG002|Overall Study|Withdrawal by Subject|5|||
162980024|NCT01207440|588629193|FG003|Overall Study|Withdrawal by Subject|3|||
162980025|NCT01207440|588629194|FG004|Overall Study|Withdrawal by Subject|2|||
163059000|NCT05965752|588924379|FG002|Overall Study|Adverse Event|0|||
163059001|NCT05965752|588924380|FG003|Overall Study|Adverse Event|1|||
163320383|NCT03580356|589884198|FG003|Treatment Period|Misrandomized, no treatment|0|||
163320384|NCT03580356|589884199|FG004|Treatment Period|Misrandomized, no treatment|2|||
163320385|NCT03580356|589884200|FG005|Treatment Period|Misrandomized, no treatment|0|||
163402667|NCT01192022|590186982|FG001|Overall Study|Physician withdrew-patient hardship|0|||
162980026|NCT01207440|588629195|FG005|Overall Study|Withdrawal by Subject|2|||
162980027|NCT01207440|588629196|FG006|Overall Study|Withdrawal by Subject|0|||
162980028|NCT01207440|588629190|FG000|Overall Study|Reason Not Specified|10|||
162980029|NCT01207440|588629191|FG001|Overall Study|Reason Not Specified|10|||
163320386|NCT03580356|589884201|FG006|Treatment Period|Misrandomized, no treatment|0|||
163320387|NCT03580356|589884202|FG007|Treatment Period|Misrandomized, no treatment|0|||
163320388|NCT03580356|589884195|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
163320389|NCT03580356|589884196|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
162980030|NCT01207440|588629192|FG002|Overall Study|Reason Not Specified|7|||
162980031|NCT01207440|588629193|FG003|Overall Study|Reason Not Specified|0|||
162980032|NCT01207440|588629194|FG004|Overall Study|Reason Not Specified|4|||
162980033|NCT01207440|588629195|FG005|Overall Study|Reason Not Specified|3|||
162980034|NCT01207440|588629196|FG006|Overall Study|Reason Not Specified|0|||
163320390|NCT03580356|589884197|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
163320391|NCT03580356|589884198|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
163320392|NCT03580356|589884199|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
163320393|NCT03580356|589884200|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
163320394|NCT03580356|589884201|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
163320395|NCT03580356|589884202|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
163320396|NCT03580356|589884195|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
163320397|NCT03580356|589884196|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
163320398|NCT03580356|589884197|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
163320399|NCT03580356|589884198|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
163320400|NCT03580356|589884199|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
163320401|NCT03580356|589884200|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
163320402|NCT03580356|589884201|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
163320403|NCT03580356|589884202|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
163320404|NCT03580356|589884195|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
163320405|NCT03580356|589884196|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
163320406|NCT03580356|589884197|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
163320407|NCT03580356|589884198|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
163320408|NCT03580356|589884199|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
163320409|NCT03580356|589884200|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
163320410|NCT03580356|589884201|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
163320411|NCT03580356|589884202|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
163320412|NCT03580356|589884195|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
163320413|NCT03580356|589884196|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
163320414|NCT03580356|589884197|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
163320415|NCT03580356|589884198|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
163320416|NCT03580356|589884199|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
163320417|NCT03580356|589884200|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
163320418|NCT03580356|589884201|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
163320419|NCT03580356|589884202|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
163320420|NCT03580356|589884195|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
163320421|NCT03580356|589884196|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
163320422|NCT03580356|589884197|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
163320423|NCT03580356|589884198|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
163320424|NCT03580356|589884199|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
163320425|NCT03580356|589884200|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
163320426|NCT03580356|589884201|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
163320427|NCT03580356|589884202|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
163320428|NCT03580356|589884195|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
163320429|NCT03580356|589884196|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
163320430|NCT03580356|589884197|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
163320431|NCT03580356|589884198|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
163320432|NCT03580356|589884199|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
163320433|NCT03580356|589884200|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
163320434|NCT03580356|589884201|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
163320435|NCT03580356|589884202|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
163320436|NCT03580356|589884195|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
163320437|NCT03580356|589884196|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
163320438|NCT03580356|589884197|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
163320439|NCT03580356|589884198|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
163320440|NCT03580356|589884199|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
163320441|NCT03580356|589884200|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
163320442|NCT03580356|589884201|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
163320443|NCT03580356|589884202|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
163320444|NCT05715528|589884203|FG000|Overall Study|Randomized but never treated|11|||
163320445|NCT05715528|589884204|FG001|Overall Study|Randomized but never treated|13|||
163320446|NCT05715528|589884203|FG000|Overall Study|Withdrew consent|7|||
163320447|NCT05715528|589884204|FG001|Overall Study|Withdrew consent|15|||
163320448|NCT05715528|589884203|FG000|Overall Study|Lost to Follow-up|5|||
163320449|NCT05715528|589884204|FG001|Overall Study|Lost to Follow-up|13|||
163320450|NCT05715528|589884203|FG000|Overall Study|Investigator's discretion|3|||
163402668|NCT01192022|590186983|FG002|Overall Study|Physician withdrew-patient hardship|0|||
163320451|NCT05715528|589884204|FG001|Overall Study|Investigator's discretion|1|||
162980035|NCT01592721|588629197|FG000|Long-term Follow-up|Death|1|||
162980036|NCT01408563|588629200|FG000|Overall Study|Ineligible after consent/ registration|2|||
162980037|NCT02119286|588629205|FG000|Overall Study|Adverse Event|9|||
162980038|NCT02119286|588629206|FG001|Overall Study|Adverse Event|7|||
162980039|NCT02119286|588629207|FG002|Overall Study|Adverse Event|2|||
162980040|NCT02119286|588629205|FG000|Overall Study|Lack of Efficacy|11|||
162980041|NCT02119286|588629206|FG001|Overall Study|Lack of Efficacy|3|||
162980042|NCT02119286|588629207|FG002|Overall Study|Lack of Efficacy|4|||
162980043|NCT02119286|588629205|FG000|Overall Study|Lost to Follow-up|2|||
162980044|NCT02119286|588629206|FG001|Overall Study|Lost to Follow-up|0|||
162980045|NCT02119286|588629207|FG002|Overall Study|Lost to Follow-up|1|||
162980046|NCT02119286|588629205|FG000|Overall Study|Withdrawal by Subject|4|||
162980047|NCT02119286|588629206|FG001|Overall Study|Withdrawal by Subject|1|||
162980048|NCT02119286|588629207|FG002|Overall Study|Withdrawal by Subject|0|||
162980049|NCT04109313|588629208|FG000|Overall Study|Pregnancy|1|||
162980050|NCT04109313|588629208|FG000|Overall Study|Adverse Event|11|||
162980051|NCT04109313|588629208|FG000|Overall Study|Lack of Efficacy|11|||
162980052|NCT04109313|588629208|FG000|Overall Study|Lost to Follow-up|1|||
162980053|NCT04109313|588629208|FG000|Overall Study|Physician Decision|2|||
162980054|NCT04109313|588629208|FG000|Overall Study|Subject Decision|13|||
162980055|NCT04109313|588629208|FG000|Overall Study|Covid-19 situation|2|||
162980056|NCT01272921|588629209|FG000|Overall Study|Protocol Violation|2|||
162980057|NCT01272921|588629210|FG001|Overall Study|Protocol Violation|1|||
162980058|NCT01132664|588629211|FG000|Phase lb|Adverse Event|0|||
162980059|NCT01132664|588629212|FG001|Phase lb|Adverse Event|1|||
162980060|NCT01132664|588629213|FG002|Phase lb|Adverse Event|0|||
162980061|NCT01132664|588629214|FG003|Phase lb|Adverse Event|0|||
162980062|NCT01132664|588629215|FG004|Phase lb|Adverse Event|0|||
162980063|NCT01132664|588629211|FG000|Phase lb|Withdrawal by Subject|1|||
162980064|NCT01132664|588629212|FG001|Phase lb|Withdrawal by Subject|2|||
162980065|NCT01132664|588629213|FG002|Phase lb|Withdrawal by Subject|0|||
162980066|NCT01132664|588629214|FG003|Phase lb|Withdrawal by Subject|0|||
162980067|NCT01132664|588629215|FG004|Phase lb|Withdrawal by Subject|0|||
162980068|NCT01132664|588629211|FG000|Phase lb|Disease Progression|4|||
162980069|NCT01132664|588629212|FG001|Phase lb|Disease Progression|9|||
162980070|NCT01132664|588629213|FG002|Phase lb|Disease Progression|0|||
162980071|NCT01132664|588629214|FG003|Phase lb|Disease Progression|0|||
162980072|NCT01132664|588629215|FG004|Phase lb|Disease Progression|0|||
162980073|NCT01132664|588629211|FG000|Phase ll|Death|0|||
162980074|NCT01132664|588629212|FG001|Phase ll|Death|0|||
162980075|NCT01132664|588629213|FG002|Phase ll|Death|2|||
162980076|NCT01132664|588629214|FG003|Phase ll|Death|0|||
162980077|NCT01132664|588629215|FG004|Phase ll|Death|0|||
162980078|NCT01132664|588629211|FG000|Phase ll|Adverse Event|0|||
162980079|NCT01132664|588629212|FG001|Phase ll|Adverse Event|0|||
162980080|NCT01132664|588629213|FG002|Phase ll|Adverse Event|10|||
162980081|NCT01132664|588629214|FG003|Phase ll|Adverse Event|0|||
162980082|NCT01132664|588629215|FG004|Phase ll|Adverse Event|0|||
162980083|NCT01132664|588629211|FG000|Phase ll|Withdrawal by Subject|0|||
162980084|NCT01132664|588629212|FG001|Phase ll|Withdrawal by Subject|0|||
162980085|NCT01132664|588629213|FG002|Phase ll|Withdrawal by Subject|3|||
162980086|NCT01132664|588629214|FG003|Phase ll|Withdrawal by Subject|0|||
162980087|NCT01132664|588629215|FG004|Phase ll|Withdrawal by Subject|0|||
162980088|NCT01132664|588629211|FG000|Phase ll|Disease progression|0|||
162980089|NCT01132664|588629212|FG001|Phase ll|Disease progression|0|||
162980090|NCT01132664|588629213|FG002|Phase ll|Disease progression|35|||
162980091|NCT01132664|588629214|FG003|Phase ll|Disease progression|0|||
162980092|NCT01132664|588629215|FG004|Phase ll|Disease progression|0|||
162980093|NCT01132664|588629211|FG000|BM Cohort|Disease progression|0|||
162980094|NCT01132664|588629212|FG001|BM Cohort|Disease progression|0|||
162980095|NCT01132664|588629213|FG002|BM Cohort|Disease progression|0|||
162980096|NCT01132664|588629214|FG003|BM Cohort|Disease progression|3|||
162980097|NCT01132664|588629215|FG004|BM Cohort|Disease progression|4|||
162980098|NCT01132664|588629211|FG000|BM Cohort|Adverse Event|0|||
162980099|NCT01132664|588629212|FG001|BM Cohort|Adverse Event|0|||
162980100|NCT01132664|588629213|FG002|BM Cohort|Adverse Event|0|||
162980101|NCT01132664|588629214|FG003|BM Cohort|Adverse Event|0|||
163059002|NCT05965752|588924381|FG004|Overall Study|Adverse Event|3|||
163059003|NCT05965752|588924377|FG000|Overall Study|Lost to Follow-up|2|||
162980102|NCT01132664|588629215|FG004|BM Cohort|Adverse Event|1|||
162980103|NCT01132664|588629211|FG000|BM Cohort|Withdrawal by Subject|0|||
162980104|NCT01132664|588629212|FG001|BM Cohort|Withdrawal by Subject|0|||
162980105|NCT01132664|588629213|FG002|BM Cohort|Withdrawal by Subject|0|||
162980106|NCT01132664|588629214|FG003|BM Cohort|Withdrawal by Subject|0|||
162980107|NCT01132664|588629215|FG004|BM Cohort|Withdrawal by Subject|1|||
162980108|NCT04271735|588629217|FG000|Overall Study|Physician Decision|2|||
162980109|NCT04271735|588629218|FG001|Overall Study|Physician Decision|0|||
162980110|NCT04268316|588629219|FG000|Overall Study|Withdrawal by Subject|2|||
162980111|NCT04268316|588629220|FG001|Overall Study|Withdrawal by Subject|1|||
162980112|NCT04268316|588629221|FG002|Overall Study|Withdrawal by Subject|0|||
162980113|NCT02040779|588629223|FG000|Overall Study|Adverse Event|1|||
162980114|NCT02040779|588629224|FG001|Overall Study|Adverse Event|0|||
162980115|NCT02040779|588629225|FG002|Overall Study|Adverse Event|0|||
162980116|NCT02040779|588629223|FG000|Overall Study|Withdrawal by Subject|4|||
162980117|NCT02040779|588629224|FG001|Overall Study|Withdrawal by Subject|1|||
163320452|NCT05715528|589884203|FG000|Overall Study|Protocol Violation|2|||
162980118|NCT02040779|588629225|FG002|Overall Study|Withdrawal by Subject|3|||
162980119|NCT02040779|588629223|FG000|Overall Study|Non-compliance|0|||
162980120|NCT02040779|588629224|FG001|Overall Study|Non-compliance|1|||
162980121|NCT02040779|588629225|FG002|Overall Study|Non-compliance|0|||
162980122|NCT02040779|588629223|FG000|Overall Study|Protocol Violation|2|||
162980123|NCT02040779|588629224|FG001|Overall Study|Protocol Violation|1|||
162980124|NCT02040779|588629225|FG002|Overall Study|Protocol Violation|0|||
162980125|NCT02040779|588629223|FG000|Overall Study|Lost to Follow-up|1|||
162980126|NCT02040779|588629224|FG001|Overall Study|Lost to Follow-up|2|||
162980127|NCT02040779|588629225|FG002|Overall Study|Lost to Follow-up|1|||
162980128|NCT02040779|588629223|FG000|Overall Study|Lack of Efficacy|4|||
162980129|NCT02040779|588629224|FG001|Overall Study|Lack of Efficacy|2|||
162980130|NCT02040779|588629225|FG002|Overall Study|Lack of Efficacy|0|||
162980131|NCT02132637|588629226|FG000|Study Period 1|Withdrawal by Subject|0|||
162980132|NCT02132637|588629227|FG001|Study Period 1|Withdrawal by Subject|4|||
162980133|NCT02132637|588629226|FG000|Study Period 1|Physician Decision|1|||
162980134|NCT02132637|588629227|FG001|Study Period 1|Physician Decision|0|||
162980135|NCT02132637|588629226|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
162980136|NCT02132637|588629227|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
162980137|NCT02132637|588629226|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
162980138|NCT02132637|588629227|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
162980139|NCT00922272|588629230|FG000|Open-label Phase|Adverse Event|5|||
162980140|NCT00922272|588629231|FG001|Open-label Phase|Adverse Event|0|||
162980141|NCT00922272|588629230|FG000|Open-label Phase|Protocol Violation|1|||
162980142|NCT00922272|588629231|FG001|Open-label Phase|Protocol Violation|0|||
162980143|NCT00922272|588629230|FG000|Open-label Phase|Withdrawal by Subject|11|||
162980144|NCT00922272|588629231|FG001|Open-label Phase|Withdrawal by Subject|0|||
162980145|NCT00922272|588629230|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
162980146|NCT00922272|588629231|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
162980147|NCT00922272|588629230|FG000|Open-label Phase|Withdrawal criteria met|5|||
162980148|NCT00922272|588629231|FG001|Open-label Phase|Withdrawal criteria met|0|||
162980149|NCT00922272|588629230|FG000|Double-blind Phase|Adverse Event|1|||
162980150|NCT00922272|588629231|FG001|Double-blind Phase|Adverse Event|1|||
162980151|NCT00922272|588629230|FG000|Double-blind Phase|Withdrawal by Subject|1|||
162980152|NCT00922272|588629231|FG001|Double-blind Phase|Withdrawal by Subject|1|||
162980153|NCT00922272|588629230|FG000|Double-blind Phase|Lost to Follow-up|2|||
162980154|NCT00922272|588629231|FG001|Double-blind Phase|Lost to Follow-up|1|||
162980155|NCT00922272|588629230|FG000|Double-blind Phase|Withdrawal criteria met|1|||
162980156|NCT00922272|588629231|FG001|Double-blind Phase|Withdrawal criteria met|1|||
162980157|NCT00922272|588629230|FG000|Double-blind Phase|Noncompliance|1|||
162980158|NCT00922272|588629231|FG001|Double-blind Phase|Noncompliance|1|||
162980159|NCT00922272|588629230|FG000|Double-blind Phase|Positive urine drug screen|1|||
162980160|NCT00922272|588629231|FG001|Double-blind Phase|Positive urine drug screen|1|||
162980161|NCT03197558|588629232|FG000|Overall Study|Tubes not placed|1|||
162980162|NCT02581163|588629234|FG000|Overall Study|Failure to return|15|||
162980163|NCT02581163|588629234|FG000|Overall Study|Insufficient virological response|3|||
162980164|NCT02581163|588629234|FG000|Overall Study|Withdrew consent|1|||
162980165|NCT02581163|588629234|FG000|Overall Study|Death|1|||
162980166|NCT02581163|588629234|FG000|Overall Study|Other, not specified|9|||
162980167|NCT02384941|588629244|FG000|Overall Study|Adverse Event|11|||
163059004|NCT05965752|588924378|FG001|Overall Study|Lost to Follow-up|0|||
163059005|NCT05965752|588924379|FG002|Overall Study|Lost to Follow-up|1|||
163059006|NCT05965752|588924380|FG003|Overall Study|Lost to Follow-up|1|||
163059007|NCT05965752|588924381|FG004|Overall Study|Lost to Follow-up|1|||
163059008|NCT05965752|588924377|FG000|Overall Study|Withdrawal by Subject|2|||
163059009|NCT05965752|588924378|FG001|Overall Study|Withdrawal by Subject|2|||
163320453|NCT05715528|589884204|FG001|Overall Study|Protocol Violation|0|||
163320454|NCT05715528|589884203|FG000|Overall Study|Non-compliance with study drug|0|||
163059010|NCT05965752|588924379|FG002|Overall Study|Withdrawal by Subject|1|||
163059011|NCT05965752|588924380|FG003|Overall Study|Withdrawal by Subject|5|||
163059012|NCT05965752|588924381|FG004|Overall Study|Withdrawal by Subject|0|||
163059013|NCT05965752|588924377|FG000|Overall Study|Disease Relapse|1|||
163059014|NCT05965752|588924378|FG001|Overall Study|Disease Relapse|0|||
163320455|NCT05715528|589884204|FG001|Overall Study|Non-compliance with study drug|1|||
163320456|NCT03485729|589884207|FG000|Overall Study|Withdrawal by Subject|0|||
162980168|NCT02384941|588629245|FG001|Overall Study|Adverse Event|13|||
162980169|NCT02384941|588629246|FG002|Overall Study|Adverse Event|17|||
162980170|NCT02384941|588629244|FG000|Overall Study|Lost to Follow-up|3|||
162980171|NCT02384941|588629245|FG001|Overall Study|Lost to Follow-up|2|||
162980172|NCT02384941|588629246|FG002|Overall Study|Lost to Follow-up|1|||
162980173|NCT02384941|588629244|FG000|Overall Study|Non-Compliance With Study Drug|2|||
162980174|NCT02384941|588629245|FG001|Overall Study|Non-Compliance With Study Drug|0|||
162980175|NCT02384941|588629246|FG002|Overall Study|Non-Compliance With Study Drug|1|||
162980176|NCT02384941|588629244|FG000|Overall Study|Physician Decision|1|||
162980177|NCT02384941|588629245|FG001|Overall Study|Physician Decision|1|||
162980178|NCT02384941|588629246|FG002|Overall Study|Physician Decision|0|||
162980179|NCT02384941|588629244|FG000|Overall Study|Protocol Violation|3|||
162980180|NCT02384941|588629245|FG001|Overall Study|Protocol Violation|0|||
162980181|NCT02384941|588629246|FG002|Overall Study|Protocol Violation|0|||
162980182|NCT02384941|588629244|FG000|Overall Study|Withdrawal by Subject|26|||
162980183|NCT02384941|588629245|FG001|Overall Study|Withdrawal by Subject|19|||
162980184|NCT02384941|588629246|FG002|Overall Study|Withdrawal by Subject|20|||
162980185|NCT02384941|588629244|FG000|Overall Study|Pregnancy|0|||
162980186|NCT02384941|588629245|FG001|Overall Study|Pregnancy|0|||
162980187|NCT02384941|588629246|FG002|Overall Study|Pregnancy|1|||
162980188|NCT02384941|588629244|FG000|Overall Study|Other than specified above|4|||
162980189|NCT02384941|588629245|FG001|Overall Study|Other than specified above|0|||
162980190|NCT02384941|588629246|FG002|Overall Study|Other than specified above|1|||
162980191|NCT06005597|588629247|FG000|Overall Study|Lost to Follow-up|1|||
162980192|NCT06005597|588629248|FG001|Overall Study|Lost to Follow-up|2|||
162980193|NCT06005597|588629249|FG002|Overall Study|Lost to Follow-up|1|||
162980194|NCT06005597|588629250|FG003|Overall Study|Lost to Follow-up|2|||
162980195|NCT06005597|588629247|FG000|Overall Study|Death|1|||
162980196|NCT06005597|588629248|FG001|Overall Study|Death|1|||
162980197|NCT06005597|588629249|FG002|Overall Study|Death|1|||
162980198|NCT06005597|588629250|FG003|Overall Study|Death|0|||
162980199|NCT01134627|588629255|FG000|Overall Study|Adverse Event|47|||
162980200|NCT01134627|588629256|FG001|Overall Study|Adverse Event|31|||
162980201|NCT01134627|588629255|FG000|Overall Study|Lost to Follow-up|1|||
162980202|NCT01134627|588629256|FG001|Overall Study|Lost to Follow-up|2|||
162980203|NCT01134627|588629255|FG000|Overall Study|Protocol Violation|3|||
162980204|NCT01134627|588629256|FG001|Overall Study|Protocol Violation|5|||
162980205|NCT01134627|588629255|FG000|Overall Study|Lack of Efficacy|2|||
162980206|NCT01134627|588629256|FG001|Overall Study|Lack of Efficacy|12|||
162980207|NCT01134627|588629255|FG000|Overall Study|Withdrawal by Subject|4|||
162980208|NCT01134627|588629256|FG001|Overall Study|Withdrawal by Subject|3|||
162980209|NCT01134627|588629255|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
162980210|NCT01134627|588629256|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
162980211|NCT01134627|588629255|FG000|Overall Study|Other|11|||
162980212|NCT01134627|588629256|FG001|Overall Study|Other|14|||
162980213|NCT00977431|588629257|FG000|Overall Study|Other than listed|1|||
162980214|NCT00977431|588629258|FG001|Overall Study|Other than listed|0|||
162980215|NCT00977431|588629259|FG002|Overall Study|Other than listed|0|||
162980216|NCT00977431|588629260|FG003|Overall Study|Other than listed|0|||
162980217|NCT00977431|588629261|FG004|Overall Study|Other than listed|2|||
162980218|NCT00977431|588629257|FG000|Overall Study|Protocol Violation|0|||
162980219|NCT00977431|588629258|FG001|Overall Study|Protocol Violation|0|||
162980220|NCT00977431|588629259|FG002|Overall Study|Protocol Violation|1|||
162980221|NCT00977431|588629260|FG003|Overall Study|Protocol Violation|0|||
162980222|NCT00977431|588629261|FG004|Overall Study|Protocol Violation|0|||
162980223|NCT00977431|588629257|FG000|Overall Study|Adverse Event|3|||
162980224|NCT00977431|588629258|FG001|Overall Study|Adverse Event|0|||
162980225|NCT00977431|588629259|FG002|Overall Study|Adverse Event|4|||
162980226|NCT00977431|588629260|FG003|Overall Study|Adverse Event|0|||
163059015|NCT05965752|588924379|FG002|Overall Study|Disease Relapse|1|||
163059016|NCT05965752|588924380|FG003|Overall Study|Disease Relapse|0|||
163211316|NCT00811473|589488839|FG000|Overall Study|Condition under investigation worsened|1|||
163211317|NCT00811473|589488840|FG001|Overall Study|Condition under investigation worsened|3|||
163211318|NCT00811473|589488839|FG000|Overall Study|Other 2|4|||
163211319|NCT00811473|589488840|FG001|Overall Study|Other 2|1|||
163211320|NCT00811473|589488839|FG000|Overall Study|Incorrect Enrollment|1|||
163211321|NCT00811473|589488840|FG001|Overall Study|Incorrect Enrollment|0|||
163211322|NCT00811473|589488839|FG000|Overall Study|Safety Reasons|1|||
163211323|NCT00811473|589488840|FG001|Overall Study|Safety Reasons|0|||
163211324|NCT01119131|589488844|FG000|Overall Study|Adverse Event|1|||
163211325|NCT01119131|589488845|FG001|Overall Study|Adverse Event|1|||
163211326|NCT01119131|589488846|FG002|Overall Study|Adverse Event|1|||
163211327|NCT01119131|589488844|FG000|Overall Study|Non-Compliance|1|||
163211328|NCT01119131|589488845|FG001|Overall Study|Non-Compliance|0|||
163211329|NCT01119131|589488846|FG002|Overall Study|Non-Compliance|4|||
163211330|NCT01119131|589488844|FG000|Overall Study|Physician Decision|0|||
163211331|NCT01119131|589488845|FG001|Overall Study|Physician Decision|0|||
163211332|NCT01119131|589488846|FG002|Overall Study|Physician Decision|1|||
162980227|NCT00977431|588629261|FG004|Overall Study|Adverse Event|6|||
162980228|NCT00977431|588629257|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
162980229|NCT00977431|588629258|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
162980230|NCT00977431|588629259|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
162980231|NCT00977431|588629260|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
162980232|NCT00977431|588629261|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
162980233|NCT00977431|588629257|FG000|Overall Study|Progressive disease|2|||
162980234|NCT00977431|588629258|FG001|Overall Study|Progressive disease|6|||
162980235|NCT00977431|588629259|FG002|Overall Study|Progressive disease|1|||
162980236|NCT00977431|588629260|FG003|Overall Study|Progressive disease|3|||
162980237|NCT00977431|588629261|FG004|Overall Study|Progressive disease|5|||
162980238|NCT03739138|588629268|FG000|Overall Study|Death|0|||
163211333|NCT02457910|589488847|FG000|Overall Study|Withdrawal by Subject|0|||
163402669|NCT01192022|590186984|FG003|Overall Study|Physician withdrew-patient hardship|0|||
163402670|NCT01192022|590186985|FG004|Overall Study|Physician withdrew-patient hardship|0|||
163402671|NCT01192022|590186981|FG000|Overall Study|Patient too sick from chemotherapy|0|||
163402672|NCT01192022|590186982|FG001|Overall Study|Patient too sick from chemotherapy|1|||
163402673|NCT01192022|590186983|FG002|Overall Study|Patient too sick from chemotherapy|0|||
163402674|NCT01192022|590186984|FG003|Overall Study|Patient too sick from chemotherapy|0|||
163402675|NCT01192022|590186985|FG004|Overall Study|Patient too sick from chemotherapy|0|||
163402676|NCT01192022|590186981|FG000|Overall Study|Patient needed surgery|0|||
163402677|NCT01192022|590186982|FG001|Overall Study|Patient needed surgery|1|||
163402678|NCT01192022|590186983|FG002|Overall Study|Patient needed surgery|0|||
163402679|NCT01192022|590186984|FG003|Overall Study|Patient needed surgery|0|||
163402680|NCT01192022|590186985|FG004|Overall Study|Patient needed surgery|0|||
163402681|NCT01192022|590186981|FG000|Overall Study|Parents did not allow all follow up|0|||
163402682|NCT01192022|590186982|FG001|Overall Study|Parents did not allow all follow up|0|||
163402683|NCT01192022|590186983|FG002|Overall Study|Parents did not allow all follow up|0|||
163402684|NCT01192022|590186984|FG003|Overall Study|Parents did not allow all follow up|1|||
163402685|NCT01192022|590186985|FG004|Overall Study|Parents did not allow all follow up|0|||
163402686|NCT01351389|590186986|FG000|Overall Study|Withdrawal by Subject|7|||
163402687|NCT01351389|590186987|FG001|Overall Study|Withdrawal by Subject|0|||
163402688|NCT01351389|590186986|FG000|Overall Study|did not complete intervention|23|||
163402689|NCT01351389|590186987|FG001|Overall Study|did not complete intervention|15|||
163402690|NCT04839978|590186988|FG000|Overall Study|Lost to Follow-up|135|||
163402691|NCT04839978|590186989|FG001|Overall Study|Lost to Follow-up|147|||
162980239|NCT03739138|588629269|FG001|Overall Study|Death|7|||
162980240|NCT03739138|588629270|FG002|Overall Study|Death|4|||
162980241|NCT03739138|588629271|FG003|Overall Study|Death|13|||
162980242|NCT03739138|588629272|FG004|Overall Study|Death|0|||
162980243|NCT03739138|588629268|FG000|Overall Study|Lost to Follow-up|0|||
162980244|NCT03739138|588629269|FG001|Overall Study|Lost to Follow-up|0|||
162980245|NCT03739138|588629270|FG002|Overall Study|Lost to Follow-up|1|||
162980246|NCT03739138|588629271|FG003|Overall Study|Lost to Follow-up|0|||
162980247|NCT03739138|588629272|FG004|Overall Study|Lost to Follow-up|0|||
162980248|NCT03739138|588629268|FG000|Overall Study|Study Terminated By Sponsor|0|||
162980249|NCT03739138|588629269|FG001|Overall Study|Study Terminated By Sponsor|0|||
162980250|NCT03739138|588629270|FG002|Overall Study|Study Terminated By Sponsor|0|||
162980251|NCT03739138|588629271|FG003|Overall Study|Study Terminated By Sponsor|4|||
162980252|NCT03739138|588629272|FG004|Overall Study|Study Terminated By Sponsor|0|||
162980253|NCT03739138|588629268|FG000|Overall Study|Withdrawal by Subject|0|||
162980254|NCT03739138|588629269|FG001|Overall Study|Withdrawal by Subject|0|||
162980255|NCT03739138|588629270|FG002|Overall Study|Withdrawal by Subject|0|||
162980256|NCT03739138|588629271|FG003|Overall Study|Withdrawal by Subject|1|||
162980257|NCT03739138|588629272|FG004|Overall Study|Withdrawal by Subject|0|||
162980258|NCT01056640|588629273|FG000|Overall Study|Withdrawal by Subject|11|||
162980259|NCT01056640|588629274|FG001|Overall Study|Withdrawal by Subject|8|||
162980260|NCT01056640|588629273|FG000|Overall Study|Death|15|||
162980261|NCT01056640|588629274|FG001|Overall Study|Death|4|||
162980262|NCT01803269|588629275|FG000|Overall Study|Withdrawal by Subject|3|||
162980263|NCT01803269|588629276|FG001|Overall Study|Withdrawal by Subject|0|||
162980264|NCT01803269|588629277|FG002|Overall Study|Withdrawal by Subject|0|||
162980265|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
162980266|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
162980267|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
162980268|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
162980269|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
162980270|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
162980271|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
162980272|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
162980273|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
162980274|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
162980275|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Subject decision|1|||
162980276|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Subject decision|1|||
162980277|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
162980278|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
162980279|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
162980280|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
162980281|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
162980282|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
162980283|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
162980284|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
163059017|NCT05965752|588924381|FG004|Overall Study|Disease Relapse|0|||
163402692|NCT03551509|590186994|FG000|Overall Study|Lost to Follow-up|0|||
163402693|NCT03551509|590186995|FG001|Overall Study|Lost to Follow-up|1|||
162980285|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
162980286|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
162980287|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
163059018|NCT05965752|588924377|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
163059019|NCT05965752|588924378|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
163059020|NCT05965752|588924379|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
163059021|NCT05965752|588924380|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
163059022|NCT05965752|588924381|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
163059023|NCT05965752|588924377|FG000|Overall Study|Unable to Return for Study Visits|0|||
163059024|NCT05965752|588924378|FG001|Overall Study|Unable to Return for Study Visits|1|||
163059025|NCT05965752|588924379|FG002|Overall Study|Unable to Return for Study Visits|0|||
163059026|NCT05965752|588924380|FG003|Overall Study|Unable to Return for Study Visits|3|||
163059027|NCT05965752|588924381|FG004|Overall Study|Unable to Return for Study Visits|1|||
163059028|NCT05965752|588924377|FG000|Overall Study|Early Termination|0|||
163059029|NCT05965752|588924378|FG001|Overall Study|Early Termination|0|||
163059030|NCT05965752|588924379|FG002|Overall Study|Early Termination|1|||
163059031|NCT05965752|588924380|FG003|Overall Study|Early Termination|0|||
163059032|NCT05965752|588924381|FG004|Overall Study|Early Termination|0|||
163059033|NCT05965752|588924377|FG000|Overall Study|Reported Unwanted Symptoms|0|||
163059034|NCT05965752|588924378|FG001|Overall Study|Reported Unwanted Symptoms|0|||
163059035|NCT05965752|588924379|FG002|Overall Study|Reported Unwanted Symptoms|0|||
162980288|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
162980289|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
162980290|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
162980291|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
162980292|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
162980293|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
162980294|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
162980295|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
162980296|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
162980297|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
162980298|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
162980299|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
162980300|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
162980301|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
162980302|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
162980303|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
162980304|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
162980305|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
162980306|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
162980307|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
162980308|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
162980309|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
162980310|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
163059036|NCT05965752|588924380|FG003|Overall Study|Reported Unwanted Symptoms|0|||
163059037|NCT05965752|588924381|FG004|Overall Study|Reported Unwanted Symptoms|1|||
163059038|NCT05965752|588924377|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
163059039|NCT05965752|588924378|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
163059040|NCT05965752|588924379|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
163059041|NCT05965752|588924380|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
163059042|NCT05965752|588924381|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
163059043|NCT00834041|588924383|FG000|Overall Study|Withdrawal by Subject|1|||
163059044|NCT00834041|588924384|FG001|Overall Study|Withdrawal by Subject|0|||
163059045|NCT00834041|588924383|FG000|Overall Study|Lost to Follow-up|0|||
163059046|NCT00834041|588924384|FG001|Overall Study|Lost to Follow-up|1|||
163059047|NCT02634710|588924387|FG000|Overall Study|Death|4|||
163059048|NCT04530630|588926285|FG000|Overall Study|Physician Decision|1|||
163059049|NCT01288430|588926292|FG000|Part 1|Progressive disease|2|||
163059050|NCT01288430|588926293|FG001|Part 1|Progressive disease|1|||
163059051|NCT01288430|588926294|FG002|Part 1|Progressive disease|1|||
163059052|NCT01288430|588926295|FG003|Part 1|Progressive disease|6|||
163059053|NCT01288430|588926296|FG004|Part 1|Progressive disease|2|||
163059054|NCT01288430|588926297|FG005|Part 1|Progressive disease|4|||
163059055|NCT01288430|588926298|FG006|Part 1|Progressive disease|2|||
163059056|NCT01288430|588926299|FG007|Part 1|Progressive disease|0|||
163059057|NCT01288430|588926300|FG008|Part 1|Progressive disease|0|||
163059058|NCT01288430|588926301|FG009|Part 1|Progressive disease|0|||
162980311|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
163059059|NCT01288430|588926292|FG000|Part 1|Clinical disease progression|0|||
163059060|NCT01288430|588926293|FG001|Part 1|Clinical disease progression|0|||
162980312|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
162980313|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
162980314|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
162980315|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
162980316|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
162980317|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
162980318|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
162980319|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
162980320|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
162980321|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
162980322|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
162980323|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
162980324|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
162980325|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
162980326|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
162980327|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
162980328|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
162980329|NCT04740931|588629282|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
162980330|NCT04740931|588629283|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
162980331|NCT04740931|588629282|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
162980332|NCT04740931|588629283|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
162980333|NCT04740931|588629282|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
162980334|NCT04740931|588629283|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
162980335|NCT04740931|588629282|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
162980336|NCT04740931|588629283|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
162980337|NCT04740931|588629282|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
162980338|NCT04740931|588629283|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
162980339|NCT04740931|588629282|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
162980340|NCT04740931|588629283|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
162980341|NCT04740931|588629282|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
162980342|NCT04740931|588629283|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
162980343|NCT02696031|588629285|FG000|Up to Week 24|Adverse Event|2|||
162980344|NCT02696031|588629286|FG001|Up to Week 24|Adverse Event|4|||
162980345|NCT02696031|588629287|FG002|Up to Week 24|Adverse Event|2|||
162980346|NCT02696031|588629288|FG003|Up to Week 24|Adverse Event|0|||
162980347|NCT02696031|588629289|FG004|Up to Week 24|Adverse Event|0|||
162980348|NCT02696031|588629290|FG005|Up to Week 24|Adverse Event|0|||
162980349|NCT02696031|588629285|FG000|Up to Week 24|Lack of Efficacy|2|||
162980350|NCT02696031|588629286|FG001|Up to Week 24|Lack of Efficacy|1|||
162980351|NCT02696031|588629287|FG002|Up to Week 24|Lack of Efficacy|2|||
162980352|NCT02696031|588629288|FG003|Up to Week 24|Lack of Efficacy|0|||
162980353|NCT02696031|588629289|FG004|Up to Week 24|Lack of Efficacy|0|||
162980354|NCT02696031|588629290|FG005|Up to Week 24|Lack of Efficacy|0|||
162980355|NCT02696031|588629285|FG000|Up to Week 24|Lost to Follow-up|0|||
162980356|NCT02696031|588629286|FG001|Up to Week 24|Lost to Follow-up|1|||
162980357|NCT02696031|588629287|FG002|Up to Week 24|Lost to Follow-up|1|||
162980358|NCT02696031|588629288|FG003|Up to Week 24|Lost to Follow-up|0|||
162980359|NCT02696031|588629289|FG004|Up to Week 24|Lost to Follow-up|0|||
162980360|NCT02696031|588629290|FG005|Up to Week 24|Lost to Follow-up|0|||
162980361|NCT02696031|588629285|FG000|Up to Week 24|Physician Decision|1|||
162980362|NCT02696031|588629286|FG001|Up to Week 24|Physician Decision|0|||
162980363|NCT02696031|588629287|FG002|Up to Week 24|Physician Decision|1|||
162980364|NCT02696031|588629288|FG003|Up to Week 24|Physician Decision|0|||
162980365|NCT02696031|588629289|FG004|Up to Week 24|Physician Decision|0|||
162980366|NCT02696031|588629290|FG005|Up to Week 24|Physician Decision|0|||
162980367|NCT02696031|588629285|FG000|Up to Week 24|Protocol Violation|1|||
162980368|NCT02696031|588629286|FG001|Up to Week 24|Protocol Violation|0|||
162980369|NCT02696031|588629287|FG002|Up to Week 24|Protocol Violation|0|||
162980370|NCT02696031|588629288|FG003|Up to Week 24|Protocol Violation|0|||
162980371|NCT02696031|588629289|FG004|Up to Week 24|Protocol Violation|0|||
162980372|NCT02696031|588629290|FG005|Up to Week 24|Protocol Violation|0|||
162980373|NCT02696031|588629285|FG000|Up to Week 24|Withdrawal by Subject|4|||
162980374|NCT02696031|588629286|FG001|Up to Week 24|Withdrawal by Subject|1|||
162980375|NCT02696031|588629287|FG002|Up to Week 24|Withdrawal by Subject|5|||
162980376|NCT02696031|588629288|FG003|Up to Week 24|Withdrawal by Subject|0|||
162980377|NCT02696031|588629289|FG004|Up to Week 24|Withdrawal by Subject|0|||
162980378|NCT02696031|588629290|FG005|Up to Week 24|Withdrawal by Subject|0|||
162980379|NCT02696031|588629285|FG000|Up to Week 52|Adverse Event|4|||
163402694|NCT03551509|590186996|FG002|Overall Study|Lost to Follow-up|0|||
162980380|NCT02696031|588629286|FG001|Up to Week 52|Adverse Event|5|||
162980381|NCT02696031|588629287|FG002|Up to Week 52|Adverse Event|3|||
162980382|NCT02696031|588629288|FG003|Up to Week 52|Adverse Event|0|||
162980383|NCT02696031|588629289|FG004|Up to Week 52|Adverse Event|0|||
162980384|NCT02696031|588629290|FG005|Up to Week 52|Adverse Event|0|||
162980385|NCT02696031|588629285|FG000|Up to Week 52|Lack of Efficacy|10|||
162980386|NCT02696031|588629286|FG001|Up to Week 52|Lack of Efficacy|7|||
162980387|NCT02696031|588629287|FG002|Up to Week 52|Lack of Efficacy|11|||
162980388|NCT02696031|588629288|FG003|Up to Week 52|Lack of Efficacy|0|||
162980389|NCT02696031|588629289|FG004|Up to Week 52|Lack of Efficacy|0|||
162980390|NCT02696031|588629290|FG005|Up to Week 52|Lack of Efficacy|0|||
162980391|NCT02696031|588629285|FG000|Up to Week 52|Lost to Follow-up|1|||
162980392|NCT02696031|588629286|FG001|Up to Week 52|Lost to Follow-up|1|||
162980393|NCT02696031|588629287|FG002|Up to Week 52|Lost to Follow-up|1|||
162980394|NCT02696031|588629288|FG003|Up to Week 52|Lost to Follow-up|0|||
162980395|NCT02696031|588629289|FG004|Up to Week 52|Lost to Follow-up|0|||
162980396|NCT02696031|588629290|FG005|Up to Week 52|Lost to Follow-up|0|||
162980397|NCT02696031|588629285|FG000|Up to Week 52|Physician Decision|1|||
162980398|NCT02696031|588629286|FG001|Up to Week 52|Physician Decision|1|||
162980399|NCT02696031|588629287|FG002|Up to Week 52|Physician Decision|2|||
162980400|NCT02696031|588629288|FG003|Up to Week 52|Physician Decision|0|||
162980401|NCT02696031|588629289|FG004|Up to Week 52|Physician Decision|0|||
162980402|NCT02696031|588629290|FG005|Up to Week 52|Physician Decision|0|||
162980403|NCT02696031|588629285|FG000|Up to Week 52|Pregnancy|0|||
162980404|NCT02696031|588629286|FG001|Up to Week 52|Pregnancy|2|||
162980405|NCT02696031|588629287|FG002|Up to Week 52|Pregnancy|0|||
162980406|NCT02696031|588629288|FG003|Up to Week 52|Pregnancy|0|||
162980407|NCT02696031|588629289|FG004|Up to Week 52|Pregnancy|0|||
162980408|NCT02696031|588629290|FG005|Up to Week 52|Pregnancy|0|||
162980409|NCT02696031|588629285|FG000|Up to Week 52|Protocol Violation|1|||
162980410|NCT02696031|588629286|FG001|Up to Week 52|Protocol Violation|0|||
162980411|NCT02696031|588629287|FG002|Up to Week 52|Protocol Violation|0|||
162980412|NCT02696031|588629288|FG003|Up to Week 52|Protocol Violation|0|||
162980413|NCT02696031|588629289|FG004|Up to Week 52|Protocol Violation|0|||
162980414|NCT02696031|588629290|FG005|Up to Week 52|Protocol Violation|0|||
162980415|NCT02696031|588629285|FG000|Up to Week 52|Withdrawal by Subject|12|||
162980416|NCT02696031|588629286|FG001|Up to Week 52|Withdrawal by Subject|3|||
162980417|NCT02696031|588629287|FG002|Up to Week 52|Withdrawal by Subject|9|||
162980418|NCT02696031|588629288|FG003|Up to Week 52|Withdrawal by Subject|0|||
162980419|NCT02696031|588629289|FG004|Up to Week 52|Withdrawal by Subject|0|||
162980420|NCT02696031|588629290|FG005|Up to Week 52|Withdrawal by Subject|0|||
162980421|NCT02696031|588629285|FG000|Up to Week 104|Pregnancy|0|||
162980422|NCT02696031|588629286|FG001|Up to Week 104|Pregnancy|2|||
162980423|NCT02696031|588629287|FG002|Up to Week 104|Pregnancy|1|||
162980424|NCT02696031|588629288|FG003|Up to Week 104|Pregnancy|0|||
162980425|NCT02696031|588629289|FG004|Up to Week 104|Pregnancy|0|||
162980426|NCT02696031|588629290|FG005|Up to Week 104|Pregnancy|0|||
162980427|NCT02696031|588629285|FG000|Up to Week 104|Withdrawal by Subject|15|||
162980428|NCT02696031|588629286|FG001|Up to Week 104|Withdrawal by Subject|10|||
162980429|NCT02696031|588629287|FG002|Up to Week 104|Withdrawal by Subject|16|||
162980430|NCT02696031|588629288|FG003|Up to Week 104|Withdrawal by Subject|0|||
162980431|NCT02696031|588629289|FG004|Up to Week 104|Withdrawal by Subject|0|||
162980432|NCT02696031|588629290|FG005|Up to Week 104|Withdrawal by Subject|0|||
162980433|NCT02696031|588629285|FG000|Up to Week 104|Protocol Violation|1|||
162980434|NCT02696031|588629286|FG001|Up to Week 104|Protocol Violation|0|||
162980435|NCT02696031|588629287|FG002|Up to Week 104|Protocol Violation|0|||
162980436|NCT02696031|588629288|FG003|Up to Week 104|Protocol Violation|0|||
162980437|NCT02696031|588629289|FG004|Up to Week 104|Protocol Violation|0|||
162980438|NCT02696031|588629290|FG005|Up to Week 104|Protocol Violation|0|||
162980439|NCT02696031|588629285|FG000|Up to Week 104|Physician Decision|1|||
162980440|NCT02696031|588629286|FG001|Up to Week 104|Physician Decision|2|||
162980441|NCT02696031|588629287|FG002|Up to Week 104|Physician Decision|3|||
162980442|NCT02696031|588629288|FG003|Up to Week 104|Physician Decision|0|||
162980443|NCT02696031|588629289|FG004|Up to Week 104|Physician Decision|0|||
162980444|NCT02696031|588629290|FG005|Up to Week 104|Physician Decision|0|||
162980445|NCT02696031|588629285|FG000|Up to Week 104|Lost to Follow-up|2|||
162980446|NCT02696031|588629286|FG001|Up to Week 104|Lost to Follow-up|3|||
162980447|NCT02696031|588629287|FG002|Up to Week 104|Lost to Follow-up|1|||
162980448|NCT02696031|588629288|FG003|Up to Week 104|Lost to Follow-up|0|||
162980449|NCT02696031|588629289|FG004|Up to Week 104|Lost to Follow-up|0|||
162980450|NCT02696031|588629290|FG005|Up to Week 104|Lost to Follow-up|0|||
162980451|NCT02696031|588629285|FG000|Up to Week 104|Lack of Efficacy|13|||
162980452|NCT02696031|588629286|FG001|Up to Week 104|Lack of Efficacy|12|||
162980453|NCT02696031|588629287|FG002|Up to Week 104|Lack of Efficacy|11|||
162980454|NCT02696031|588629288|FG003|Up to Week 104|Lack of Efficacy|0|||
162980455|NCT02696031|588629289|FG004|Up to Week 104|Lack of Efficacy|0|||
162980456|NCT02696031|588629290|FG005|Up to Week 104|Lack of Efficacy|0|||
162980457|NCT02696031|588629285|FG000|Up to Week 104|Adverse Event|7|||
162980458|NCT02696031|588629286|FG001|Up to Week 104|Adverse Event|11|||
162980459|NCT02696031|588629287|FG002|Up to Week 104|Adverse Event|5|||
162980460|NCT02696031|588629288|FG003|Up to Week 104|Adverse Event|0|||
163059061|NCT01288430|588926294|FG002|Part 1|Clinical disease progression|1|||
162980461|NCT02696031|588629289|FG004|Up to Week 104|Adverse Event|0|||
162980462|NCT02696031|588629290|FG005|Up to Week 104|Adverse Event|0|||
162980463|NCT02696031|588629285|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
162980464|NCT02696031|588629286|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
162980465|NCT02696031|588629287|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
162980466|NCT02696031|588629288|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
162980467|NCT02696031|588629289|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
162980468|NCT02696031|588629290|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
162980469|NCT02696031|588629285|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
162980470|NCT02696031|588629286|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
162980471|NCT02696031|588629287|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
162980472|NCT02696031|588629288|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
162980473|NCT02696031|588629289|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
162980474|NCT02696031|588629290|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
162980475|NCT02696031|588629285|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
162980476|NCT02696031|588629286|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
162980477|NCT02696031|588629287|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
162980478|NCT02696031|588629288|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
162980479|NCT02696031|588629289|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
163059062|NCT01288430|588926295|FG003|Part 1|Clinical disease progression|0|||
163059063|NCT01288430|588926296|FG004|Part 1|Clinical disease progression|0|||
163059064|NCT01288430|588926297|FG005|Part 1|Clinical disease progression|2|||
163059065|NCT01288430|588926298|FG006|Part 1|Clinical disease progression|2|||
163059066|NCT01288430|588926299|FG007|Part 1|Clinical disease progression|0|||
163059067|NCT01288430|588926300|FG008|Part 1|Clinical disease progression|0|||
163059068|NCT01288430|588926301|FG009|Part 1|Clinical disease progression|0|||
163059069|NCT01288430|588926292|FG000|Part 1|Death due to disease progression|0|||
163059070|NCT01288430|588926293|FG001|Part 1|Death due to disease progression|0|||
163059071|NCT01288430|588926294|FG002|Part 1|Death due to disease progression|0|||
163059072|NCT01288430|588926295|FG003|Part 1|Death due to disease progression|0|||
163059073|NCT01288430|588926296|FG004|Part 1|Death due to disease progression|1|||
163059074|NCT01288430|588926297|FG005|Part 1|Death due to disease progression|0|||
163211334|NCT02457910|589488848|FG001|Overall Study|Withdrawal by Subject|0|||
163211335|NCT02457910|589488849|FG002|Overall Study|Withdrawal by Subject|0|||
163211336|NCT02457910|589488850|FG003|Overall Study|Withdrawal by Subject|0|||
163211337|NCT02457910|589488851|FG004|Overall Study|Withdrawal by Subject|0|||
163211338|NCT02457910|589488852|FG005|Overall Study|Withdrawal by Subject|1|||
163211339|NCT02457910|589488847|FG000|Overall Study|Adverse Event|0|||
163211340|NCT02457910|589488848|FG001|Overall Study|Adverse Event|2|||
163211341|NCT02457910|589488849|FG002|Overall Study|Adverse Event|1|||
163211342|NCT02457910|589488850|FG003|Overall Study|Adverse Event|1|||
163211343|NCT02457910|589488851|FG004|Overall Study|Adverse Event|1|||
163211344|NCT02457910|589488852|FG005|Overall Study|Adverse Event|3|||
163211345|NCT02457910|589488847|FG000|Overall Study|Disease progression|3|||
163211346|NCT02457910|589488848|FG001|Overall Study|Disease progression|3|||
163211347|NCT02457910|589488849|FG002|Overall Study|Disease progression|1|||
163211348|NCT02457910|589488850|FG003|Overall Study|Disease progression|1|||
163320457|NCT03485729|589884208|FG001|Overall Study|Withdrawal by Subject|0|||
163320458|NCT03485729|589884209|FG002|Overall Study|Withdrawal by Subject|1|||
163320459|NCT03485729|589884207|FG000|Overall Study|Disease progression|8|||
163320460|NCT03485729|589884208|FG001|Overall Study|Disease progression|13|||
163320461|NCT03485729|589884209|FG002|Overall Study|Disease progression|1|||
163320462|NCT03485729|589884207|FG000|Overall Study|Hospice care|1|||
163320463|NCT03485729|589884208|FG001|Overall Study|Hospice care|0|||
163320464|NCT03485729|589884209|FG002|Overall Study|Hospice care|0|||
163320465|NCT03485729|589884207|FG000|Overall Study|Poor performance status|1|||
163320466|NCT03485729|589884208|FG001|Overall Study|Poor performance status|0|||
163320467|NCT03485729|589884209|FG002|Overall Study|Poor performance status|0|||
163320468|NCT03485729|589884207|FG000|Overall Study|Illness|0|||
163320469|NCT03485729|589884208|FG001|Overall Study|Illness|1|||
163320470|NCT03485729|589884209|FG002|Overall Study|Illness|0|||
163320471|NCT05035654|589884210|FG000|Overall Study|Physician Decision|0|||
163320472|NCT05035654|589884211|FG001|Overall Study|Physician Decision|1|||
163320473|NCT05035654|589884212|FG002|Overall Study|Physician Decision|0|||
163320474|NCT05035654|589884210|FG000|Overall Study|Adverse Event|0|||
163320475|NCT05035654|589884211|FG001|Overall Study|Adverse Event|1|||
163320476|NCT05035654|589884212|FG002|Overall Study|Adverse Event|0|||
163320477|NCT05035654|589884210|FG000|Overall Study|Withdrawal by Subject|0|||
163320478|NCT05035654|589884211|FG001|Overall Study|Withdrawal by Subject|0|||
163320479|NCT05035654|589884212|FG002|Overall Study|Withdrawal by Subject|4|||
163320480|NCT05035654|589884210|FG000|Overall Study|Bilateral Dislodgement|1|||
163320481|NCT05035654|589884211|FG001|Overall Study|Bilateral Dislodgement|0|||
163211349|NCT02457910|589488851|FG004|Overall Study|Disease progression|4|||
163211350|NCT02457910|589488852|FG005|Overall Study|Disease progression|6|||
163211351|NCT02457910|589488847|FG000|Overall Study|Other complicating illness|0|||
163211352|NCT02457910|589488848|FG001|Overall Study|Other complicating illness|0|||
163320482|NCT05035654|589884212|FG002|Overall Study|Bilateral Dislodgement|0|||
163211353|NCT02457910|589488849|FG002|Overall Study|Other complicating illness|0|||
163211354|NCT02457910|589488850|FG003|Overall Study|Other complicating illness|0|||
163211355|NCT02457910|589488851|FG004|Overall Study|Other complicating illness|0|||
163211356|NCT02457910|589488852|FG005|Overall Study|Other complicating illness|1|||
163320483|NCT05533190|589884215|FG000|Overall Study|Lost to Follow-up|19|||
162980480|NCT02696031|588629290|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
162980481|NCT02696031|588629285|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
162980482|NCT02696031|588629286|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
162980483|NCT02696031|588629287|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
162980484|NCT02696031|588629288|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
162980485|NCT02696031|588629289|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
162980486|NCT02696031|588629290|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
162980487|NCT02696031|588629285|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
162980488|NCT02696031|588629286|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
162980489|NCT02696031|588629287|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
162980490|NCT02696031|588629288|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
162980491|NCT02696031|588629289|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
162980492|NCT02696031|588629290|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
162980493|NCT02696031|588629285|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
162980494|NCT02696031|588629286|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
162980495|NCT02696031|588629287|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
162980496|NCT02696031|588629288|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
162980497|NCT02696031|588629289|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
162980498|NCT02696031|588629290|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
162980499|NCT02696031|588629285|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
162980500|NCT02696031|588629286|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
162980501|NCT02696031|588629287|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
162980502|NCT02696031|588629288|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
162980503|NCT02696031|588629289|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
162980504|NCT02696031|588629290|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
162980505|NCT00063882|588629293|FG000|Overall Study|Protocol Violation|3|||
162980506|NCT00063882|588629294|FG001|Overall Study|Protocol Violation|3|||
162980507|NCT00063882|588629293|FG000|Overall Study|Withdrawal by Subject|2|||
162980508|NCT00063882|588629294|FG001|Overall Study|Withdrawal by Subject|1|||
162980509|NCT02903238|588629295|FG000|Overall Study|Lost to Follow-up|4|||
162980510|NCT01813071|588629297|FG000|Overall Study|Protocol Violation|0|||
162980511|NCT01813071|588629298|FG001|Overall Study|Protocol Violation|0|||
162980512|NCT01813071|588629299|FG002|Overall Study|Protocol Violation|0|||
162980513|NCT01813071|588629300|FG003|Overall Study|Protocol Violation|0|||
163320484|NCT05533190|589884216|FG001|Overall Study|Lost to Follow-up|7|||
163320485|NCT05533190|589884215|FG000|Overall Study|Failed to download app|1|||
163320486|NCT05533190|589884216|FG001|Overall Study|Failed to download app|0|||
163320487|NCT05533190|589884215|FG000|Overall Study|Thought app was a scam|1|||
163320488|NCT05533190|589884216|FG001|Overall Study|Thought app was a scam|0|||
163320489|NCT05533190|589884215|FG000|Overall Study|Withdrawal by Subject|2|||
163320490|NCT05533190|589884216|FG001|Overall Study|Withdrawal by Subject|0|||
163320491|NCT05552508|589884217|FG000|Overall Study|Adverse Event|3|||
163320492|NCT04451772|589884220|FG000|Overall Study|Adverse Event|1|||
163320493|NCT04451772|589884221|FG001|Overall Study|Adverse Event|0|||
163320494|NCT04451772|589884222|FG002|Overall Study|Adverse Event|1|||
163320495|NCT04451772|589884223|FG003|Overall Study|Adverse Event|1|||
163320496|NCT04451772|589884224|FG004|Overall Study|Adverse Event|0|||
163320497|NCT04451772|589884225|FG005|Overall Study|Adverse Event|3|||
162980514|NCT01813071|588629301|FG004|Overall Study|Protocol Violation|1|||
162980515|NCT01813071|588629302|FG005|Overall Study|Protocol Violation|4|||
162980516|NCT01813071|588629303|FG006|Overall Study|Protocol Violation|2|||
162980517|NCT01813071|588629304|FG007|Overall Study|Protocol Violation|4|||
162980518|NCT01813071|588629305|FG008|Overall Study|Protocol Violation|2|||
162980519|NCT01813071|588629297|FG000|Overall Study|Withdrawal by Subject|0|||
162980520|NCT01813071|588629298|FG001|Overall Study|Withdrawal by Subject|0|||
162980521|NCT01813071|588629299|FG002|Overall Study|Withdrawal by Subject|0|||
162980522|NCT01813071|588629300|FG003|Overall Study|Withdrawal by Subject|0|||
162980523|NCT01813071|588629301|FG004|Overall Study|Withdrawal by Subject|0|||
162980524|NCT01813071|588629302|FG005|Overall Study|Withdrawal by Subject|1|||
162980525|NCT01813071|588629303|FG006|Overall Study|Withdrawal by Subject|0|||
162980526|NCT01813071|588629304|FG007|Overall Study|Withdrawal by Subject|0|||
162980527|NCT01813071|588629305|FG008|Overall Study|Withdrawal by Subject|0|||
162980528|NCT01813071|588629297|FG000|Overall Study|Adverse Event|0|||
162980529|NCT01813071|588629298|FG001|Overall Study|Adverse Event|0|||
162980530|NCT01813071|588629299|FG002|Overall Study|Adverse Event|0|||
162980531|NCT01813071|588629300|FG003|Overall Study|Adverse Event|0|||
162980532|NCT01813071|588629301|FG004|Overall Study|Adverse Event|0|||
162980533|NCT01813071|588629302|FG005|Overall Study|Adverse Event|1|||
163320498|NCT04451772|589884220|FG000|Overall Study|Withdrawal by Subject|2|||
163320499|NCT04451772|589884221|FG001|Overall Study|Withdrawal by Subject|7|||
163320500|NCT04451772|589884222|FG002|Overall Study|Withdrawal by Subject|2|||
163320501|NCT04451772|589884223|FG003|Overall Study|Withdrawal by Subject|1|||
163402695|NCT01902966|590186997|FG000|Overall Study|Death|1|||
163320502|NCT04451772|589884224|FG004|Overall Study|Withdrawal by Subject|1|||
163320503|NCT04451772|589884225|FG005|Overall Study|Withdrawal by Subject|0|||
163320504|NCT04451772|589884220|FG000|Overall Study|Other, not specified|1|||
163320505|NCT04451772|589884221|FG001|Overall Study|Other, not specified|2|||
163320506|NCT04451772|589884222|FG002|Overall Study|Other, not specified|1|||
163320507|NCT04451772|589884223|FG003|Overall Study|Other, not specified|0|||
163320508|NCT04451772|589884224|FG004|Overall Study|Other, not specified|0|||
163320509|NCT04451772|589884225|FG005|Overall Study|Other, not specified|1|||
163320510|NCT04451772|589884220|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
163320511|NCT04451772|589884221|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
163320512|NCT04451772|589884222|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
163320513|NCT04451772|589884223|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
163320514|NCT04451772|589884224|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
163320515|NCT04451772|589884225|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
163320516|NCT04311632|589884226|FG000|Overall Study|Withdrawal by Subject|0|||
163320517|NCT04311632|589884227|FG001|Overall Study|Withdrawal by Subject|0|||
163320518|NCT04311632|589884228|FG002|Overall Study|Withdrawal by Subject|1|||
163320519|NCT05856435|589884229|FG000|Overall Study|Lost to Follow-up|6|||
163320520|NCT04632225|589884230|FG000|Overall Study|Withdrawal by Subject|2|||
163320521|NCT04632225|589884231|FG001|Overall Study|Withdrawal by Subject|2|||
163320522|NCT05660434|589884236|FG000|Overall Study|Never obtained study materials|2|||
163320523|NCT05660434|589884237|FG001|Overall Study|Never obtained study materials|1|||
163320524|NCT01199133|589884241|FG000|Year 1|Adverse Event|16|||
163320525|NCT01199133|589884242|FG001|Year 1|Adverse Event|4|||
163320526|NCT01199133|589884241|FG000|Year 1|Withdrawal by Subject|8|||
163320527|NCT01199133|589884242|FG001|Year 1|Withdrawal by Subject|4|||
163320528|NCT01199133|589884241|FG000|Year 1|Any other reason not above-mentioned|6|||
163320529|NCT01199133|589884242|FG001|Year 1|Any other reason not above-mentioned|7|||
163320530|NCT01199133|589884241|FG000|Year 2|Adverse Event|1|||
163320531|NCT01199133|589884242|FG001|Year 2|Adverse Event|0|||
163320532|NCT01199133|589884241|FG000|Year 2|Withdrawal by Subject|1|||
163320533|NCT01199133|589884242|FG001|Year 2|Withdrawal by Subject|1|||
163320534|NCT01199133|589884241|FG000|Year 2|Any other reason not above-mentioned|1|||
163320535|NCT01199133|589884242|FG001|Year 2|Any other reason not above-mentioned|2|||
163320536|NCT02575950|589884243|FG000|Overall Study|Withdrawal by Subject|0|||
163320537|NCT02575950|589884244|FG001|Overall Study|Withdrawal by Subject|0|||
163320538|NCT02575950|589884245|FG002|Overall Study|Withdrawal by Subject|0|||
163320539|NCT02575950|589884246|FG003|Overall Study|Withdrawal by Subject|2|||
163320540|NCT02575950|589884243|FG000|Overall Study|Lost to Follow-up|0|||
163320541|NCT02575950|589884244|FG001|Overall Study|Lost to Follow-up|1|||
163320542|NCT02575950|589884245|FG002|Overall Study|Lost to Follow-up|0|||
163320543|NCT02575950|589884246|FG003|Overall Study|Lost to Follow-up|3|||
163320544|NCT03993392|589884248|FG000|Overall Study|Withdrawal by Subject|3|||
163320545|NCT03993392|589884248|FG000|Overall Study|Lost to Follow-up|2|||
163320546|NCT03993392|589884248|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
163320547|NCT05292391|589884251|FG000|Overall Study|Lost to Follow-up|0|||
163320548|NCT05292391|589884252|FG001|Overall Study|Lost to Follow-up|0|||
163320549|NCT05292391|589884253|FG002|Overall Study|Lost to Follow-up|0|||
163320550|NCT05292391|589884254|FG003|Overall Study|Lost to Follow-up|1|||
163320551|NCT05292391|589884255|FG004|Overall Study|Lost to Follow-up|0|||
163320552|NCT04857723|589884258|FG000|Overall Study|Withdrawal by Subject|2|||
163402696|NCT01902966|590186997|FG000|Overall Study|Physician Decision|1|||
163402697|NCT01902966|590186997|FG000|Overall Study|Withdrawal by Subject|1|||
162980534|NCT01813071|588629303|FG006|Overall Study|Adverse Event|0|||
162980535|NCT01813071|588629304|FG007|Overall Study|Adverse Event|0|||
162980536|NCT01813071|588629305|FG008|Overall Study|Adverse Event|0|||
162980537|NCT01813071|588629297|FG000|Overall Study|Physician Decision|0|||
162980538|NCT01813071|588629298|FG001|Overall Study|Physician Decision|0|||
162980539|NCT01813071|588629299|FG002|Overall Study|Physician Decision|0|||
162980540|NCT01813071|588629300|FG003|Overall Study|Physician Decision|0|||
162980541|NCT01813071|588629301|FG004|Overall Study|Physician Decision|0|||
163059075|NCT01288430|588926298|FG006|Part 1|Death due to disease progression|0|||
163320553|NCT04359654|589885927|FG000|Overall Study|Withdrawal by Subject|1|||
163320554|NCT04359654|589885928|FG001|Overall Study|Withdrawal by Subject|0|||
163320555|NCT04359654|589885927|FG000|Overall Study|Adverse Event|0|||
163320556|NCT04359654|589885928|FG001|Overall Study|Adverse Event|1|||
163320557|NCT03711474|589885931|FG000|Overall Study|Physician Decision|2|||
163320558|NCT03711474|589885932|FG001|Overall Study|Physician Decision|0|||
163320559|NCT02446236|589885933|FG000|Overall Study|Screen Failure|1|||
163320560|NCT02446236|589885934|FG001|Overall Study|Screen Failure|0|||
163320561|NCT02446236|589885935|FG002|Overall Study|Screen Failure|1|||
163320562|NCT02446236|589885933|FG000|Overall Study|Actively Receiving Therapy|0|||
163320563|NCT02446236|589885934|FG001|Overall Study|Actively Receiving Therapy|0|||
162980542|NCT01813071|588629302|FG005|Overall Study|Physician Decision|0|||
162980543|NCT01813071|588629303|FG006|Overall Study|Physician Decision|1|||
163320564|NCT02446236|589885935|FG002|Overall Study|Actively Receiving Therapy|1|||
162980544|NCT01813071|588629304|FG007|Overall Study|Physician Decision|0|||
162980545|NCT01813071|588629305|FG008|Overall Study|Physician Decision|0|||
162980546|NCT01813071|588629297|FG000|Overall Study|Met inc/exc criteria|0|||
162980547|NCT01813071|588629298|FG001|Overall Study|Met inc/exc criteria|0|||
162980548|NCT01813071|588629299|FG002|Overall Study|Met inc/exc criteria|0|||
162980549|NCT01813071|588629300|FG003|Overall Study|Met inc/exc criteria|0|||
162980550|NCT01813071|588629301|FG004|Overall Study|Met inc/exc criteria|0|||
162980551|NCT01813071|588629302|FG005|Overall Study|Met inc/exc criteria|1|||
162980552|NCT01813071|588629303|FG006|Overall Study|Met inc/exc criteria|0|||
162980553|NCT01813071|588629304|FG007|Overall Study|Met inc/exc criteria|1|||
162980554|NCT01813071|588629305|FG008|Overall Study|Met inc/exc criteria|1|||
162980555|NCT02442271|588629310|FG000|Overall Study|Adverse Event|1|||
162980556|NCT02442271|588629310|FG000|Overall Study|Withdrew Consent|1|||
162980557|NCT02442271|588629310|FG000|Overall Study|Lost to Follow-up|1|||
162980558|NCT02442271|588629310|FG000|Overall Study|Other|1|||
162980559|NCT00831623|588629314|FG000|Overall Study|Withdrawal by Subject|9|||
162980560|NCT00831623|588629314|FG000|Overall Study|Lost to Follow-up|1|||
162980561|NCT00831623|588629314|FG000|Overall Study|Not 2 years post-treatment|12|||
162980562|NCT01138111|588629319|FG000|Overall Study|Withdrawal by Subject|5|||
162980563|NCT01138111|588629319|FG000|Overall Study|Adverse Event|1|||
162980564|NCT01138111|588629319|FG000|Overall Study|Death|1|||
162980565|NCT01138111|588629319|FG000|Overall Study|Lost to Follow-up|2|||
162980566|NCT01118117|588629320|FG000|Overall Study|Death|8|||
162980567|NCT01118117|588629321|FG001|Overall Study|Death|0|||
162980568|NCT01118117|588629320|FG000|Overall Study|Lost to Follow-up|6|||
162980569|NCT01118117|588629321|FG001|Overall Study|Lost to Follow-up|0|||
162980570|NCT01118117|588629320|FG000|Overall Study|Missed 12 Month Visit|7|||
162980571|NCT01118117|588629321|FG001|Overall Study|Missed 12 Month Visit|0|||
162980572|NCT02149121|588629322|FG000|Main Study Period|Lack of Efficacy|2|||
162980573|NCT02149121|588629323|FG001|Main Study Period|Lack of Efficacy|2|||
162980574|NCT02149121|588629324|FG002|Main Study Period|Lack of Efficacy|1|||
162980575|NCT02149121|588629325|FG003|Main Study Period|Lack of Efficacy|0|||
162980576|NCT02149121|588629326|FG004|Main Study Period|Lack of Efficacy|0|||
162980577|NCT02149121|588629327|FG005|Main Study Period|Lack of Efficacy|0|||
162980578|NCT02149121|588629328|FG006|Main Study Period|Lack of Efficacy|0|||
162980579|NCT02149121|588629322|FG000|Main Study Period|Withdrawal by Subject|9|||
162980580|NCT02149121|588629323|FG001|Main Study Period|Withdrawal by Subject|5|||
162980581|NCT02149121|588629324|FG002|Main Study Period|Withdrawal by Subject|1|||
162980582|NCT02149121|588629325|FG003|Main Study Period|Withdrawal by Subject|0|||
162980583|NCT02149121|588629326|FG004|Main Study Period|Withdrawal by Subject|0|||
162980584|NCT02149121|588629327|FG005|Main Study Period|Withdrawal by Subject|0|||
162980585|NCT02149121|588629328|FG006|Main Study Period|Withdrawal by Subject|0|||
162980586|NCT02149121|588629322|FG000|Main Study Period|Adverse Event|2|||
162980587|NCT02149121|588629323|FG001|Main Study Period|Adverse Event|5|||
162980588|NCT02149121|588629324|FG002|Main Study Period|Adverse Event|1|||
162980589|NCT02149121|588629325|FG003|Main Study Period|Adverse Event|0|||
162980590|NCT02149121|588629326|FG004|Main Study Period|Adverse Event|0|||
162980591|NCT02149121|588629327|FG005|Main Study Period|Adverse Event|0|||
162980592|NCT02149121|588629328|FG006|Main Study Period|Adverse Event|0|||
162980593|NCT02149121|588629322|FG000|Main Study Period|Protocol Violation|2|||
162980594|NCT02149121|588629323|FG001|Main Study Period|Protocol Violation|0|||
162980595|NCT02149121|588629324|FG002|Main Study Period|Protocol Violation|0|||
162980596|NCT02149121|588629325|FG003|Main Study Period|Protocol Violation|0|||
162980597|NCT02149121|588629326|FG004|Main Study Period|Protocol Violation|0|||
162980598|NCT02149121|588629327|FG005|Main Study Period|Protocol Violation|0|||
162980599|NCT02149121|588629328|FG006|Main Study Period|Protocol Violation|0|||
162980600|NCT02149121|588629322|FG000|Main Study Period|Lost to Follow-up|2|||
162980601|NCT02149121|588629323|FG001|Main Study Period|Lost to Follow-up|1|||
162980602|NCT02149121|588629324|FG002|Main Study Period|Lost to Follow-up|0|||
162980603|NCT02149121|588629325|FG003|Main Study Period|Lost to Follow-up|0|||
162980604|NCT02149121|588629326|FG004|Main Study Period|Lost to Follow-up|0|||
162980605|NCT02149121|588629327|FG005|Main Study Period|Lost to Follow-up|0|||
162980606|NCT02149121|588629328|FG006|Main Study Period|Lost to Follow-up|0|||
162980607|NCT02149121|588629322|FG000|Main Study Period|Death|1|||
162980608|NCT02149121|588629323|FG001|Main Study Period|Death|0|||
162980609|NCT02149121|588629324|FG002|Main Study Period|Death|0|||
162980610|NCT02149121|588629325|FG003|Main Study Period|Death|0|||
162980611|NCT02149121|588629326|FG004|Main Study Period|Death|0|||
162980612|NCT02149121|588629327|FG005|Main Study Period|Death|0|||
162980613|NCT02149121|588629328|FG006|Main Study Period|Death|0|||
162980614|NCT02149121|588629322|FG000|Main Study Period|Physician Decision|1|||
162980615|NCT02149121|588629323|FG001|Main Study Period|Physician Decision|0|||
162980616|NCT02149121|588629324|FG002|Main Study Period|Physician Decision|0|||
162980617|NCT02149121|588629325|FG003|Main Study Period|Physician Decision|0|||
162980618|NCT02149121|588629326|FG004|Main Study Period|Physician Decision|0|||
162980619|NCT02149121|588629327|FG005|Main Study Period|Physician Decision|0|||
162980620|NCT02149121|588629328|FG006|Main Study Period|Physician Decision|0|||
162980621|NCT02149121|588629322|FG000|Main Study Period|Developed any malignancy|0|||
162980622|NCT02149121|588629323|FG001|Main Study Period|Developed any malignancy|1|||
162980623|NCT02149121|588629324|FG002|Main Study Period|Developed any malignancy|1|||
162980624|NCT02149121|588629325|FG003|Main Study Period|Developed any malignancy|0|||
162980625|NCT02149121|588629326|FG004|Main Study Period|Developed any malignancy|0|||
162980626|NCT02149121|588629327|FG005|Main Study Period|Developed any malignancy|0|||
162980627|NCT02149121|588629328|FG006|Main Study Period|Developed any malignancy|0|||
162980628|NCT02149121|588629322|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
162980629|NCT02149121|588629323|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
162980630|NCT02149121|588629324|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
162980631|NCT02149121|588629325|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
162980632|NCT02149121|588629326|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
162980633|NCT02149121|588629327|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
162980634|NCT02149121|588629328|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
162980635|NCT02149121|588629322|FG000|Main Study Period|Disease progression|0|||
162980636|NCT02149121|588629323|FG001|Main Study Period|Disease progression|1|||
162980637|NCT02149121|588629324|FG002|Main Study Period|Disease progression|0|||
162980638|NCT02149121|588629325|FG003|Main Study Period|Disease progression|0|||
162980639|NCT02149121|588629326|FG004|Main Study Period|Disease progression|0|||
162980640|NCT02149121|588629327|FG005|Main Study Period|Disease progression|0|||
162980641|NCT02149121|588629328|FG006|Main Study Period|Disease progression|0|||
162980642|NCT02149121|588629322|FG000|Extension Study Period|Withdrawal by Subject|0|||
162980643|NCT02149121|588629323|FG001|Extension Study Period|Withdrawal by Subject|0|||
162980644|NCT02149121|588629324|FG002|Extension Study Period|Withdrawal by Subject|0|||
162980645|NCT02149121|588629325|FG003|Extension Study Period|Withdrawal by Subject|1|||
162980646|NCT02149121|588629326|FG004|Extension Study Period|Withdrawal by Subject|0|||
162980647|NCT02149121|588629327|FG005|Extension Study Period|Withdrawal by Subject|2|||
162980648|NCT02149121|588629328|FG006|Extension Study Period|Withdrawal by Subject|0|||
162980649|NCT02177136|588630965|FG000|DB Phase|Withdrawal by Subject|2|||
162980650|NCT02177136|588630966|FG001|DB Phase|Withdrawal by Subject|0|||
162980651|NCT02177136|588630967|FG002|DB Phase|Withdrawal by Subject|0|||
162980652|NCT02177136|588630968|FG003|DB Phase|Withdrawal by Subject|0|||
162980653|NCT02177136|588630965|FG000|DB Phase|Discontinued Due to Pruritus|1|||
162980654|NCT02177136|588630966|FG001|DB Phase|Discontinued Due to Pruritus|3|||
162980655|NCT02177136|588630967|FG002|DB Phase|Discontinued Due to Pruritus|0|||
162980656|NCT02177136|588630968|FG003|DB Phase|Discontinued Due to Pruritus|0|||
162980657|NCT02177136|588630965|FG000|DB Phase|Adverse Event|3|||
162980658|NCT02177136|588630966|FG001|DB Phase|Adverse Event|2|||
162980659|NCT02177136|588630967|FG002|DB Phase|Adverse Event|3|||
162980660|NCT02177136|588630968|FG003|DB Phase|Adverse Event|0|||
162980661|NCT02177136|588630965|FG000|DB Phase|Protocol Violation|0|||
162980662|NCT02177136|588630966|FG001|DB Phase|Protocol Violation|0|||
162980663|NCT02177136|588630967|FG002|DB Phase|Protocol Violation|1|||
162980664|NCT02177136|588630968|FG003|DB Phase|Protocol Violation|0|||
162980665|NCT02177136|588630965|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
162980666|NCT02177136|588630966|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
162980667|NCT02177136|588630967|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
162980668|NCT02177136|588630968|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
162980669|NCT02177136|588630965|FG000|LTSE Phase|Withdrawal by Subject|0|||
162980670|NCT02177136|588630966|FG001|LTSE Phase|Withdrawal by Subject|0|||
162980671|NCT02177136|588630967|FG002|LTSE Phase|Withdrawal by Subject|0|||
162980672|NCT02177136|588630968|FG003|LTSE Phase|Withdrawal by Subject|6|||
162980673|NCT02177136|588630965|FG000|LTSE Phase|Adverse Event|0|||
162980674|NCT02177136|588630966|FG001|LTSE Phase|Adverse Event|0|||
162980675|NCT02177136|588630967|FG002|LTSE Phase|Adverse Event|0|||
162980676|NCT02177136|588630968|FG003|LTSE Phase|Adverse Event|10|||
162980677|NCT02177136|588630965|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
162980678|NCT02177136|588630966|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
163059076|NCT01288430|588926299|FG007|Part 1|Death due to disease progression|0|||
163059077|NCT01288430|588926300|FG008|Part 1|Death due to disease progression|0|||
163059078|NCT01288430|588926301|FG009|Part 1|Death due to disease progression|0|||
163059079|NCT01288430|588926292|FG000|Part 1|Adverse Event|0|||
163059080|NCT01288430|588926293|FG001|Part 1|Adverse Event|0|||
163059081|NCT01288430|588926294|FG002|Part 1|Adverse Event|3|||
162980679|NCT02177136|588630967|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
162980680|NCT02177136|588630968|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
162980681|NCT02177136|588630965|FG000|LTSE Phase|Physician Decision|0|||
163059082|NCT01288430|588926295|FG003|Part 1|Adverse Event|1|||
163402698|NCT01549275|590186998|FG000|Overall Study|Lost to Follow-up|1|||
163402699|NCT01549275|590186999|FG001|Overall Study|Lost to Follow-up|0|||
163059083|NCT01288430|588926296|FG004|Part 1|Adverse Event|0|||
163059084|NCT01288430|588926297|FG005|Part 1|Adverse Event|0|||
162980682|NCT02177136|588630966|FG001|LTSE Phase|Physician Decision|0|||
162980683|NCT02177136|588630967|FG002|LTSE Phase|Physician Decision|0|||
162980684|NCT02177136|588630968|FG003|LTSE Phase|Physician Decision|2|||
162980685|NCT02177136|588630965|FG000|LTSE Phase|Lost to Follow-up|0|||
163059085|NCT01288430|588926298|FG006|Part 1|Adverse Event|2|||
163402700|NCT00122681|590187000|FG000|Overall Study|Adverse Event|20|||
162980686|NCT02177136|588630966|FG001|LTSE Phase|Lost to Follow-up|0|||
162980687|NCT02177136|588630967|FG002|LTSE Phase|Lost to Follow-up|0|||
162980688|NCT02177136|588630968|FG003|LTSE Phase|Lost to Follow-up|1|||
162980689|NCT02177136|588630965|FG000|LTSE Phase|Participant Moved|0|||
162980690|NCT02177136|588630966|FG001|LTSE Phase|Participant Moved|0|||
162980691|NCT02177136|588630967|FG002|LTSE Phase|Participant Moved|0|||
162980692|NCT02177136|588630968|FG003|LTSE Phase|Participant Moved|1|||
162980693|NCT02054130|588630969|FG000|Overall Study|Withdrawal by Subject|4|||
162980694|NCT02054130|588630970|FG001|Overall Study|Withdrawal by Subject|4|||
162980695|NCT02054130|588630971|FG002|Overall Study|Withdrawal by Subject|7|||
162980696|NCT02054130|588630972|FG003|Overall Study|Withdrawal by Subject|10|||
162980697|NCT02054130|588630969|FG000|Overall Study|Death|0|||
162980698|NCT02054130|588630970|FG001|Overall Study|Death|1|||
162980699|NCT02054130|588630971|FG002|Overall Study|Death|0|||
162980700|NCT02054130|588630972|FG003|Overall Study|Death|0|||
162980701|NCT02054130|588630969|FG000|Overall Study|Lost to Follow-up|0|||
162980702|NCT02054130|588630970|FG001|Overall Study|Lost to Follow-up|0|||
162980703|NCT02054130|588630971|FG002|Overall Study|Lost to Follow-up|1|||
162980704|NCT02054130|588630972|FG003|Overall Study|Lost to Follow-up|2|||
162980705|NCT02054130|588630969|FG000|Overall Study|Missed dose|4|||
162980706|NCT02054130|588630970|FG001|Overall Study|Missed dose|6|||
162980707|NCT02054130|588630971|FG002|Overall Study|Missed dose|7|||
162980708|NCT02054130|588630972|FG003|Overall Study|Missed dose|10|||
162980709|NCT01304693|588630987|FG000|Overall Study|Adverse Event|0|||
162980710|NCT01304693|588630988|FG001|Overall Study|Adverse Event|0|||
162980711|NCT01304693|588630989|FG002|Overall Study|Adverse Event|0|||
162980712|NCT01304693|588630990|FG003|Overall Study|Adverse Event|0|||
162980713|NCT01304693|588630991|FG004|Overall Study|Adverse Event|1|||
162980714|NCT01304693|588630987|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
162980715|NCT01304693|588630988|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
162980716|NCT01304693|588630989|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
162980717|NCT01304693|588630990|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
162980718|NCT01304693|588630991|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
162980719|NCT00931268|588630992|FG000|Overall Study|Lost to Follow-up|6|||
162980720|NCT04132336|588630993|FG000|Overall Study|Investigator Decision|0|||
162980721|NCT04132336|588630994|FG001|Overall Study|Investigator Decision|1|||
162980722|NCT04132336|588630995|FG002|Overall Study|Investigator Decision|0|||
162980723|NCT04132336|588630996|FG003|Overall Study|Investigator Decision|0|||
162980724|NCT04132336|588630997|FG004|Overall Study|Investigator Decision|0|||
162980725|NCT04132336|588630998|FG005|Overall Study|Investigator Decision|0|||
162980726|NCT04132336|588630999|FG006|Overall Study|Investigator Decision|0|||
162980727|NCT02488330|588631000|FG000|Overall Study|Adverse Event|1|||
162980728|NCT02488330|588631000|FG000|Overall Study|Physician Decision|2|||
162980729|NCT02488330|588631000|FG000|Overall Study|Death|2|||
162980730|NCT02488330|588631000|FG000|Overall Study|Disease Progression|3|||
162980731|NCT02488330|588631000|FG000|Overall Study|Study Termination by Sponsor|4|||
162980732|NCT02493777|588631001|FG000|Overall Study|Lost to Follow-up|0|||
162980733|NCT02493777|588631002|FG001|Overall Study|Lost to Follow-up|1|||
162980734|NCT00468728|588631003|FG000|Treatment|criteria for mITT population|4|||
162980735|NCT00468728|588631004|FG001|Treatment|criteria for mITT population|11|||
162980736|NCT00468728|588631003|FG000|Follow-up|mITT failure|34|||
162980737|NCT00468728|588631004|FG001|Follow-up|mITT failure|31|||
162980738|NCT01705236|588631005|FG000|Overall Study|Lost to Follow-up|1|||
162980739|NCT01705236|588631005|FG000|Overall Study|Administrative problems|2|||
162980740|NCT01705236|588631005|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
162980741|NCT01705236|588631005|FG000|Overall Study|Protocol Violation|3|||
162980742|NCT01705236|588631005|FG000|Overall Study|Abnormal test procedure result(s)|4|||
162980743|NCT01705236|588631005|FG000|Overall Study|Abnormal laboratory value(s)|4|||
162980744|NCT01705236|588631005|FG000|Overall Study|Withdrawal by Subject|5|||
162980745|NCT01705236|588631005|FG000|Overall Study|Adverse Event|5|||
162980746|NCT02224573|588631006|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
162980747|NCT02224573|588631007|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
163320565|NCT03677141|589885936|FG000|Overall Study|Death|2|||
163320566|NCT03677141|589885937|FG001|Overall Study|Death|1|||
163320567|NCT03677141|589885938|FG002|Overall Study|Death|6|||
162980748|NCT02224573|588631006|FG000|Treatment Phase|Started on Other IMP|1|||
162980749|NCT02224573|588631007|FG001|Treatment Phase|Started on Other IMP|0|||
162980750|NCT02224573|588631006|FG000|Treatment Phase|Participant Discontinued IMP|0|||
162980751|NCT02224573|588631007|FG001|Treatment Phase|Participant Discontinued IMP|1|||
162980752|NCT02224573|588631006|FG000|Treatment Phase|Lack of Efficacy|15|||
163320568|NCT03677141|589885939|FG003|Overall Study|Death|9|||
163320569|NCT03677141|589885940|FG004|Overall Study|Death|5|||
162980753|NCT02224573|588631007|FG001|Treatment Phase|Lack of Efficacy|8|||
162980754|NCT02224573|588631006|FG000|Treatment Phase|Began Commercial Product|1|||
162980755|NCT02224573|588631007|FG001|Treatment Phase|Began Commercial Product|0|||
163059086|NCT01288430|588926299|FG007|Part 1|Adverse Event|0|||
163320570|NCT03677141|589885941|FG005|Overall Study|Death|3|||
163320571|NCT03677141|589885936|FG000|Overall Study|Lost to Follow-up|0|||
163320572|NCT03677141|589885937|FG001|Overall Study|Lost to Follow-up|0|||
163320573|NCT03677141|589885938|FG002|Overall Study|Lost to Follow-up|0|||
162980756|NCT02224573|588631006|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
162980757|NCT02224573|588631007|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
162980758|NCT02224573|588631006|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
162980759|NCT02224573|588631007|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
162980760|NCT02224573|588631006|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
162980761|NCT02224573|588631007|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
162980762|NCT02224573|588631006|FG000|Treatment Phase|Continued Compassionate Use|1|||
162980763|NCT02224573|588631007|FG001|Treatment Phase|Continued Compassionate Use|0|||
162980764|NCT02224573|588631006|FG000|Treatment Phase|Lack of Efficiency|2|||
162980765|NCT02224573|588631007|FG001|Treatment Phase|Lack of Efficiency|1|||
162980766|NCT02224573|588631006|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
162980767|NCT02224573|588631007|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
162980768|NCT02224573|588631006|FG000|Treatment Phase|Participant Moved|2|||
162980769|NCT02224573|588631007|FG001|Treatment Phase|Participant Moved|0|||
162980770|NCT02224573|588631006|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
162980771|NCT02224573|588631007|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
162980772|NCT02224573|588631006|FG000|Treatment Phase|Refused Medication|1|||
162980773|NCT02224573|588631007|FG001|Treatment Phase|Refused Medication|1|||
162980774|NCT02224573|588631006|FG000|Treatment Phase|Adverse Event|26|||
162980775|NCT02224573|588631007|FG001|Treatment Phase|Adverse Event|38|||
162980776|NCT02224573|588631006|FG000|Treatment Phase|Placed in Group Home|0|||
162980777|NCT02224573|588631007|FG001|Treatment Phase|Placed in Group Home|1|||
162980778|NCT02224573|588631006|FG000|Treatment Phase|Pursued Other Trials|1|||
162980779|NCT02224573|588631007|FG001|Treatment Phase|Pursued Other Trials|0|||
162980780|NCT02224573|588631006|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
162980781|NCT02224573|588631007|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
162980782|NCT02224573|588631006|FG000|Treatment Phase|Lost to Follow-up|2|||
162980783|NCT02224573|588631007|FG001|Treatment Phase|Lost to Follow-up|1|||
162980784|NCT02224573|588631006|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
162980785|NCT02224573|588631007|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
162980786|NCT02224573|588631006|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
162980787|NCT02224573|588631007|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
162980788|NCT02224573|588631006|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
162980789|NCT02224573|588631007|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
162980790|NCT02224573|588631006|FG000|Taper Phase|Adverse Event|1|||
162980791|NCT02224573|588631007|FG001|Taper Phase|Adverse Event|1|||
162980792|NCT02546362|588631008|FG000|4-week Treatment Period|Lost to Follow-up|1|||
162980793|NCT02546362|588631008|FG000|4-week Treatment Period|Change in medication|2|||
162980794|NCT02546362|588631008|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
162980795|NCT02546362|588631008|FG000|12-week Treatment Period|Lost to Follow-up|2|||
162980796|NCT02546362|588631008|FG000|12-week Treatment Period|Change in medication|1|||
162980797|NCT02025010|588631009|FG000|Overall Study|Symptomatic or radiographic progression|36|||
162980798|NCT02025010|588631009|FG000|Overall Study|Adverse Event|6|||
162980799|NCT02025010|588631009|FG000|Overall Study|Physician Decision|7|||
162980800|NCT02025010|588631009|FG000|Overall Study|Withdrawal by Subject|3|||
162980801|NCT02025010|588631009|FG000|Overall Study|Intercurrent illness|3|||
162980802|NCT02025010|588631009|FG000|Overall Study|Patients still on treatment|3|||
162980803|NCT02025010|588631009|FG000|Overall Study|Never initiate the treatment|2|||
162980804|NCT01621191|588631014|FG000|Overall Study|Adverse Event|9|||
162980805|NCT01621191|588631014|FG000|Overall Study|Withdrawal by Subject|8|||
162980806|NCT01621191|588631014|FG000|Overall Study|Lack of Efficacy|6|||
162980807|NCT01621191|588631014|FG000|Overall Study|Lost to Follow-up|1|||
162980808|NCT01621191|588631014|FG000|Overall Study|Site Removed From Study|1|||
162980809|NCT04355663|588631016|FG000|Overall Study|Physician Decision|2|||
162980810|NCT04355663|588631017|FG001|Overall Study|Physician Decision|7|||
162980811|NCT04355663|588631018|FG002|Overall Study|Physician Decision|0|||
162980812|NCT04355663|588631016|FG000|Overall Study|Adverse Event|0|||
162980813|NCT04355663|588631017|FG001|Overall Study|Adverse Event|0|||
162980814|NCT04355663|588631018|FG002|Overall Study|Adverse Event|1|||
163059087|NCT01288430|588926300|FG008|Part 1|Adverse Event|0|||
163059088|NCT01288430|588926301|FG009|Part 1|Adverse Event|0|||
163320574|NCT03677141|589885939|FG003|Overall Study|Lost to Follow-up|2|||
163320575|NCT03677141|589885940|FG004|Overall Study|Lost to Follow-up|0|||
163320576|NCT03677141|589885941|FG005|Overall Study|Lost to Follow-up|0|||
162980815|NCT04355663|588631016|FG000|Overall Study|Withdrawal by Subject|0|||
162980816|NCT04355663|588631017|FG001|Overall Study|Withdrawal by Subject|8|||
162980817|NCT04355663|588631018|FG002|Overall Study|Withdrawal by Subject|3|||
162980818|NCT02787408|588631024|FG000|Overall Study|Death|16|||
162980819|NCT02787408|588631024|FG000|Overall Study|Withdrawal by Subject|1|||
162980820|NCT02787408|588631024|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
163059089|NCT01288430|588926292|FG000|Part 1|Other|0|||
163320577|NCT03677141|589885936|FG000|Overall Study|Screen failure or enrolled in error|0|||
162980821|NCT05444543|588631027|FG000|Overall Study|Withdrawal by Subject|1|||
162980822|NCT05444543|588631028|FG001|Overall Study|Withdrawal by Subject|0|||
162980823|NCT05444543|588631027|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
162980824|NCT05444543|588631028|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
162980825|NCT05444543|588631027|FG000|Overall Study|Adverse Event|0|||
162980826|NCT05444543|588631028|FG001|Overall Study|Adverse Event|1|||
162980827|NCT05444543|588631027|FG000|Overall Study|Family relocating at a distance from study site|0|||
162980828|NCT05444543|588631028|FG001|Overall Study|Family relocating at a distance from study site|1|||
162980829|NCT02408120|588631031|FG000|Overall Study|Withdrawal by Subject|0|||
162980830|NCT02408120|588631032|FG001|Overall Study|Withdrawal by Subject|1|||
162980831|NCT02408120|588631031|FG000|Overall Study|Treatment Refusal|1|||
162980832|NCT02408120|588631032|FG001|Overall Study|Treatment Refusal|0|||
162980833|NCT02408120|588631031|FG000|Overall Study|Received Steroids|1|||
162980834|NCT02408120|588631032|FG001|Overall Study|Received Steroids|1|||
162980835|NCT02408120|588631031|FG000|Overall Study|Discharged same day|1|||
162980836|NCT02408120|588631032|FG001|Overall Study|Discharged same day|1|||
162980837|NCT02408120|588631031|FG000|Overall Study|Did not receive insulin|1|||
162980838|NCT02408120|588631032|FG001|Overall Study|Did not receive insulin|2|||
162980839|NCT01010750|588631033|FG000|Second Intervention|Adverse Event|0|||
162980840|NCT01010750|588631034|FG001|Second Intervention|Adverse Event|1|||
162980841|NCT01010750|588631035|FG002|Second Intervention|Adverse Event|0|||
162980842|NCT01010750|588631036|FG003|Second Intervention|Adverse Event|0|||
162980843|NCT01010750|588631037|FG004|Second Intervention|Adverse Event|0|||
162980844|NCT01010750|588631038|FG005|Second Intervention|Adverse Event|0|||
162980845|NCT00466726|588631039|FG000|Overall Study|Not evaluable for response|14|||
162980846|NCT00597116|588631040|FG000|Overall Study|Adverse Event|2|||
162980847|NCT00597116|588631041|FG001|Overall Study|Adverse Event|1|||
162980848|NCT00597116|588631040|FG000|Overall Study|Withdrawal by Subject|0|||
162980849|NCT00597116|588631041|FG001|Overall Study|Withdrawal by Subject|2|||
162980850|NCT00597116|588631040|FG000|Overall Study|Physician Decision|0|||
162980851|NCT00597116|588631041|FG001|Overall Study|Physician Decision|1|||
162980852|NCT00597116|588631040|FG000|Overall Study|Death|0|||
162980853|NCT00597116|588631041|FG001|Overall Study|Death|1|||
162980854|NCT00597116|588631040|FG000|Overall Study|Lost to Follow-up|1|||
162980855|NCT00597116|588631041|FG001|Overall Study|Lost to Follow-up|0|||
162980856|NCT00597116|588631040|FG000|Overall Study|Progressive disease|11|||
162980857|NCT00597116|588631041|FG001|Overall Study|Progressive disease|6|||
162980858|NCT02096588|588631042|FG000|Overall Study|Lack of Efficacy|2|||
162980859|NCT02096588|588631043|FG001|Overall Study|Lack of Efficacy|0|||
162980860|NCT02096588|588631042|FG000|Overall Study|Withdrawal by Subject|0|||
162980861|NCT02096588|588631043|FG001|Overall Study|Withdrawal by Subject|1|||
162980862|NCT01258101|588631044|FG000|Overall Study|Adverse Event|5|||
162980863|NCT01258101|588631045|FG001|Overall Study|Adverse Event|6|||
162980864|NCT01258101|588631046|FG002|Overall Study|Adverse Event|0|||
162980865|NCT01258101|588631047|FG003|Overall Study|Adverse Event|0|||
162980866|NCT01258101|588631044|FG000|Overall Study|Extra exclusion criterion amended|2|||
162980867|NCT01258101|588631045|FG001|Overall Study|Extra exclusion criterion amended|1|||
162980868|NCT01258101|588631046|FG002|Overall Study|Extra exclusion criterion amended|1|||
162980869|NCT01258101|588631047|FG003|Overall Study|Extra exclusion criterion amended|1|||
162980870|NCT01258101|588631044|FG000|Overall Study|Informed consent has been withdrawn|2|||
162980871|NCT01258101|588631045|FG001|Overall Study|Informed consent has been withdrawn|2|||
162980872|NCT01258101|588631046|FG002|Overall Study|Informed consent has been withdrawn|1|||
162980873|NCT01258101|588631047|FG003|Overall Study|Informed consent has been withdrawn|1|||
162980874|NCT01258101|588631044|FG000|Overall Study|Patient is not able to attend visits|8|||
162980875|NCT01258101|588631045|FG001|Overall Study|Patient is not able to attend visits|9|||
162980876|NCT01258101|588631046|FG002|Overall Study|Patient is not able to attend visits|7|||
162980877|NCT01258101|588631047|FG003|Overall Study|Patient is not able to attend visits|6|||
162980878|NCT01258101|588631044|FG000|Overall Study|Patient´s compliance|4|||
162980879|NCT01258101|588631045|FG001|Overall Study|Patient´s compliance|3|||
162980880|NCT01258101|588631046|FG002|Overall Study|Patient´s compliance|1|||
162980881|NCT01258101|588631047|FG003|Overall Study|Patient´s compliance|2|||
162980882|NCT01258101|588631044|FG000|Overall Study|Lost to Follow-up|5|||
163059090|NCT01288430|588926293|FG001|Part 1|Other|2|||
163320578|NCT03677141|589885937|FG001|Overall Study|Screen failure or enrolled in error|0|||
163059091|NCT01288430|588926294|FG002|Part 1|Other|0|||
163320579|NCT03677141|589885938|FG002|Overall Study|Screen failure or enrolled in error|0|||
163320580|NCT03677141|589885939|FG003|Overall Study|Screen failure or enrolled in error|0|||
163320581|NCT03677141|589885940|FG004|Overall Study|Screen failure or enrolled in error|2|||
163320582|NCT03677141|589885941|FG005|Overall Study|Screen failure or enrolled in error|0|||
163320583|NCT03677141|589885936|FG000|Overall Study|Physician Decision|0|||
162980883|NCT01258101|588631045|FG001|Overall Study|Lost to Follow-up|5|||
162980884|NCT01258101|588631046|FG002|Overall Study|Lost to Follow-up|0|||
162980885|NCT01258101|588631047|FG003|Overall Study|Lost to Follow-up|6|||
162980886|NCT01258101|588631044|FG000|Overall Study|PCR positive at week 24|0|||
162980887|NCT01258101|588631045|FG001|Overall Study|PCR positive at week 24|0|||
163059092|NCT01288430|588926295|FG003|Part 1|Other|0|||
162980888|NCT01258101|588631046|FG002|Overall Study|PCR positive at week 24|0|||
162980889|NCT01258101|588631047|FG003|Overall Study|PCR positive at week 24|1|||
162980890|NCT01258101|588631044|FG000|Overall Study|Other reason|7|||
162980891|NCT01258101|588631045|FG001|Overall Study|Other reason|8|||
162980892|NCT01258101|588631046|FG002|Overall Study|Other reason|1|||
162980893|NCT01258101|588631047|FG003|Overall Study|Other reason|8|||
162980894|NCT00958126|588631053|FG000|Overall Study|Serious Adverse Event|0|||
162980895|NCT00958126|588631054|FG001|Overall Study|Serious Adverse Event|2|||
162980896|NCT00958126|588631055|FG002|Overall Study|Serious Adverse Event|0|||
162980897|NCT00958126|588631056|FG003|Overall Study|Serious Adverse Event|0|||
162980898|NCT00958126|588631057|FG004|Overall Study|Serious Adverse Event|0|||
162980899|NCT00958126|588631058|FG005|Overall Study|Serious Adverse Event|0|||
162980900|NCT00958126|588631059|FG006|Overall Study|Serious Adverse Event|1|||
162980901|NCT00958126|588631060|FG007|Overall Study|Serious Adverse Event|0|||
162980902|NCT00958126|588631053|FG000|Overall Study|Withdrawal by Subject|0|||
162980903|NCT00958126|588631054|FG001|Overall Study|Withdrawal by Subject|2|||
162980904|NCT00958126|588631055|FG002|Overall Study|Withdrawal by Subject|0|||
162980905|NCT00958126|588631056|FG003|Overall Study|Withdrawal by Subject|0|||
162980906|NCT00958126|588631057|FG004|Overall Study|Withdrawal by Subject|0|||
162980907|NCT00958126|588631058|FG005|Overall Study|Withdrawal by Subject|0|||
162980908|NCT00958126|588631059|FG006|Overall Study|Withdrawal by Subject|0|||
162980909|NCT00958126|588631060|FG007|Overall Study|Withdrawal by Subject|0|||
162980910|NCT00958126|588631053|FG000|Overall Study|Moved away from study area|0|||
162980911|NCT00958126|588631054|FG001|Overall Study|Moved away from study area|0|||
162980912|NCT00958126|588631055|FG002|Overall Study|Moved away from study area|1|||
162980913|NCT00958126|588631056|FG003|Overall Study|Moved away from study area|1|||
162980914|NCT00958126|588631057|FG004|Overall Study|Moved away from study area|0|||
162980915|NCT00958126|588631058|FG005|Overall Study|Moved away from study area|0|||
162980916|NCT00958126|588631059|FG006|Overall Study|Moved away from study area|0|||
162980917|NCT00958126|588631060|FG007|Overall Study|Moved away from study area|0|||
162980918|NCT00958126|588631053|FG000|Overall Study|Lost to Follow-up|1|||
162980919|NCT00958126|588631054|FG001|Overall Study|Lost to Follow-up|5|||
162980920|NCT00958126|588631055|FG002|Overall Study|Lost to Follow-up|9|||
162980921|NCT00958126|588631056|FG003|Overall Study|Lost to Follow-up|8|||
162980922|NCT00958126|588631057|FG004|Overall Study|Lost to Follow-up|0|||
162980923|NCT00958126|588631058|FG005|Overall Study|Lost to Follow-up|0|||
162980924|NCT00958126|588631059|FG006|Overall Study|Lost to Follow-up|0|||
162980925|NCT00958126|588631060|FG007|Overall Study|Lost to Follow-up|0|||
162980926|NCT00958126|588631053|FG000|Overall Study|Sponsor/Investigator decision|0|||
162980927|NCT00958126|588631054|FG001|Overall Study|Sponsor/Investigator decision|0|||
162980928|NCT00958126|588631055|FG002|Overall Study|Sponsor/Investigator decision|0|||
162980929|NCT00958126|588631056|FG003|Overall Study|Sponsor/Investigator decision|1|||
162980930|NCT00958126|588631057|FG004|Overall Study|Sponsor/Investigator decision|0|||
162980931|NCT00958126|588631058|FG005|Overall Study|Sponsor/Investigator decision|0|||
162980932|NCT00958126|588631059|FG006|Overall Study|Sponsor/Investigator decision|0|||
162980933|NCT00958126|588631060|FG007|Overall Study|Sponsor/Investigator decision|0|||
162980934|NCT00958126|588631053|FG000|Overall Study|Other Reason|0|||
162980935|NCT00958126|588631054|FG001|Overall Study|Other Reason|0|||
162980936|NCT00958126|588631055|FG002|Overall Study|Other Reason|0|||
162980937|NCT00958126|588631056|FG003|Overall Study|Other Reason|1|||
162980938|NCT00958126|588631057|FG004|Overall Study|Other Reason|0|||
162980939|NCT00958126|588631058|FG005|Overall Study|Other Reason|1|||
162980940|NCT00958126|588631059|FG006|Overall Study|Other Reason|0|||
163059093|NCT01288430|588926296|FG004|Part 1|Other|0|||
163059094|NCT01288430|588926297|FG005|Part 1|Other|0|||
163059095|NCT01288430|588926298|FG006|Part 1|Other|1|||
163059096|NCT01288430|588926299|FG007|Part 1|Other|0|||
163059097|NCT01288430|588926300|FG008|Part 1|Other|0|||
163059098|NCT01288430|588926301|FG009|Part 1|Other|0|||
163059099|NCT01288430|588926292|FG000|Part 2|Progressive disease|0|||
163059100|NCT01288430|588926293|FG001|Part 2|Progressive disease|0|||
163059101|NCT01288430|588926294|FG002|Part 2|Progressive disease|0|||
163059102|NCT01288430|588926295|FG003|Part 2|Progressive disease|0|||
163211357|NCT02457910|589488847|FG000|Overall Study|Death|0|||
163211358|NCT02457910|589488848|FG001|Overall Study|Death|0|||
162980941|NCT00958126|588631060|FG007|Overall Study|Other Reason|0|||
162980942|NCT00720226|588631061|FG000|Overall Study|Withdrawal by Subject|7|||
163059103|NCT01288430|588926296|FG004|Part 2|Progressive disease|0|||
163059104|NCT01288430|588926297|FG005|Part 2|Progressive disease|0|||
163211359|NCT02457910|589488849|FG002|Overall Study|Death|1|||
162980943|NCT00720226|588631062|FG001|Overall Study|Withdrawal by Subject|4|||
163059105|NCT01288430|588926298|FG006|Part 2|Progressive disease|0|||
163211360|NCT02457910|589488850|FG003|Overall Study|Death|0|||
162980944|NCT00733369|588631063|FG000|Overall Study|Lost to Follow-up|2|||
162980945|NCT00733369|588631064|FG001|Overall Study|Lost to Follow-up|1|||
162980946|NCT00733369|588631063|FG000|Overall Study|Adverse Event|4|||
163059106|NCT01288430|588926299|FG007|Part 2|Progressive disease|8|||
163059107|NCT01288430|588926300|FG008|Part 2|Progressive disease|7|||
163059108|NCT01288430|588926301|FG009|Part 2|Progressive disease|2|||
162980947|NCT00733369|588631064|FG001|Overall Study|Adverse Event|4|||
162980948|NCT00733369|588631063|FG000|Overall Study|Protocol Violation|4|||
162980949|NCT00733369|588631064|FG001|Overall Study|Protocol Violation|4|||
162980950|NCT03401073|588631067|FG000|Overall Study|Lost to Follow-up|1|||
162980951|NCT03401073|588631068|FG001|Overall Study|Lost to Follow-up|2|||
162980952|NCT01470612|588631069|FG000|Overall Study|Adverse Event|20|||
162980953|NCT01470612|588631070|FG001|Overall Study|Adverse Event|80|||
162980954|NCT01470612|588631069|FG000|Overall Study|Death|0|||
162980955|NCT01470612|588631070|FG001|Overall Study|Death|1|||
162980956|NCT01470612|588631069|FG000|Overall Study|Lack of Efficacy|20|||
162980957|NCT01470612|588631070|FG001|Overall Study|Lack of Efficacy|326|||
162980958|NCT01470612|588631069|FG000|Overall Study|Lost to Follow-up|2|||
162980959|NCT01470612|588631070|FG001|Overall Study|Lost to Follow-up|5|||
162980960|NCT01470612|588631069|FG000|Overall Study|Did not meet entrance criteria|0|||
162980961|NCT01470612|588631070|FG001|Overall Study|Did not meet entrance criteria|1|||
162980962|NCT01470612|588631069|FG000|Overall Study|Pregnancy|2|||
162980963|NCT01470612|588631070|FG001|Overall Study|Pregnancy|10|||
162980964|NCT01470612|588631069|FG000|Overall Study|Protocol Violation|2|||
162980965|NCT01470612|588631070|FG001|Overall Study|Protocol Violation|7|||
162980966|NCT01470612|588631069|FG000|Overall Study|Withdrawal by Subject|24|||
162980967|NCT01470612|588631070|FG001|Overall Study|Withdrawal by Subject|79|||
162980968|NCT01470612|588631069|FG000|Overall Study|Other|14|||
162980969|NCT01470612|588631070|FG001|Overall Study|Other|156|||
162980970|NCT01020799|588631071|FG000|Overall Study|Adverse Event|4|||
162980971|NCT01020799|588631072|FG001|Overall Study|Adverse Event|3|||
162980972|NCT01020799|588631073|FG002|Overall Study|Adverse Event|2|||
162980973|NCT01020799|588631071|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
162980974|NCT01020799|588631072|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
162980975|NCT01020799|588631073|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
162980976|NCT01020799|588631071|FG000|Overall Study|Protocol Violation|3|||
162980977|NCT01020799|588631072|FG001|Overall Study|Protocol Violation|2|||
162980978|NCT01020799|588631073|FG002|Overall Study|Protocol Violation|0|||
162980979|NCT01020799|588631071|FG000|Overall Study|Withdrawal by Subject|2|||
162980980|NCT01020799|588631072|FG001|Overall Study|Withdrawal by Subject|2|||
162980981|NCT01020799|588631073|FG002|Overall Study|Withdrawal by Subject|3|||
162980982|NCT01020799|588631071|FG000|Overall Study|Lost to Follow-up|6|||
162980983|NCT01020799|588631072|FG001|Overall Study|Lost to Follow-up|4|||
162980984|NCT01020799|588631073|FG002|Overall Study|Lost to Follow-up|2|||
162980985|NCT02556307|588631076|FG000|Overall Study|Premature treatment interruption|11|||
162980986|NCT02556307|588631076|FG000|Overall Study|Lost to Follow-up|36|||
162980987|NCT02556307|588631076|FG000|Overall Study|Change to triple therapy|4|||
162980988|NCT02556307|588631076|FG000|Overall Study|Enrolled but not treated|2|||
162980989|NCT03438227|588631077|FG000|Overall Study|Withdrawal by Subject|10|||
162980990|NCT03438227|588631078|FG001|Overall Study|Withdrawal by Subject|5|||
162980991|NCT03977701|588631079|FG000|Overall Study|COVID-19 pandemic|0|||
162980992|NCT03977701|588631080|FG001|Overall Study|COVID-19 pandemic|0|||
162980993|NCT03977701|588631081|FG002|Overall Study|COVID-19 pandemic|0|||
162980994|NCT03977701|588631082|FG003|Overall Study|COVID-19 pandemic|0|||
162980995|NCT03977701|588631083|FG004|Overall Study|COVID-19 pandemic|0|||
162980996|NCT03977701|588631084|FG005|Overall Study|COVID-19 pandemic|1|||
162980997|NCT03977701|588631085|FG006|Overall Study|COVID-19 pandemic|0|||
162980998|NCT03977701|588631086|FG007|Overall Study|COVID-19 pandemic|1|||
162980999|NCT03977701|588631087|FG008|Overall Study|COVID-19 pandemic|0|||
162981000|NCT03977701|588631088|FG009|Overall Study|COVID-19 pandemic|0|||
162981001|NCT02429934|588631089|FG000|Overall Study|Withdrawal by Subject|0|||
162981002|NCT02429934|588631090|FG001|Overall Study|Withdrawal by Subject|2|||
162981003|NCT02429934|588631089|FG000|Overall Study|Adverse Event|2|||
162981004|NCT02429934|588631090|FG001|Overall Study|Adverse Event|0|||
162981005|NCT02429934|588631089|FG000|Overall Study|Lost to Follow-up|1|||
162981006|NCT02429934|588631090|FG001|Overall Study|Lost to Follow-up|1|||
162981007|NCT02429934|588631089|FG000|Overall Study|Physician Decision|1|||
162981008|NCT02429934|588631090|FG001|Overall Study|Physician Decision|0|||
162981009|NCT00293202|588631091|FG000|Overall Study|Withdrawal by Subject|1|||
162981010|NCT00293202|588631092|FG001|Overall Study|Withdrawal by Subject|2|||
162981011|NCT00293202|588631091|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
162981012|NCT00293202|588631092|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
162981013|NCT00293202|588631091|FG000|Overall Study|on-hold due to fistula maturation time|1|||
162981014|NCT00293202|588631092|FG001|Overall Study|on-hold due to fistula maturation time|0|||
162981015|NCT01244061|588631095|FG000|Overall Study|Death|1|||
162981016|NCT01244061|588631096|FG001|Overall Study|Death|0|||
162981017|NCT01244061|588631095|FG000|Overall Study|Did not meet entrance criteria|1|||
162981018|NCT01244061|588631096|FG001|Overall Study|Did not meet entrance criteria|0|||
162981019|NCT01244061|588631095|FG000|Overall Study|Lack of Efficacy|1|||
162981020|NCT01244061|588631096|FG001|Overall Study|Lack of Efficacy|3|||
162981021|NCT01244061|588631095|FG000|Overall Study|Lost to Follow-up|34|||
162981022|NCT01244061|588631096|FG001|Overall Study|Lost to Follow-up|30|||
162981023|NCT01244061|588631095|FG000|Overall Study|Withdrawal by Subject|29|||
162981024|NCT01244061|588631096|FG001|Overall Study|Withdrawal by Subject|46|||
162981025|NCT01244061|588631095|FG000|Overall Study|Other|8|||
162981026|NCT01244061|588631096|FG001|Overall Study|Other|19|||
162981027|NCT01244061|588631095|FG000|Overall Study|Protocol Violation|1|||
162981028|NCT01244061|588631096|FG001|Overall Study|Protocol Violation|1|||
162981029|NCT01244061|588631095|FG000|Overall Study|Adverse Event|5|||
162981030|NCT01244061|588631096|FG001|Overall Study|Adverse Event|2|||
162981031|NCT01244061|588631095|FG000|Overall Study|Randomized but not treated|2|||
162981032|NCT01244061|588631096|FG001|Overall Study|Randomized but not treated|2|||
162981033|NCT03166124|588631097|FG000|Treatment Period 1|Adverse Event|0|||
162981034|NCT03166124|588631098|FG001|Treatment Period 1|Adverse Event|0|||
162981035|NCT03166124|588631099|FG002|Treatment Period 1|Adverse Event|1|||
162981036|NCT03166124|588631100|FG003|Treatment Period 1|Adverse Event|0|||
162981037|NCT03166124|588631097|FG000|Wash-out Period|Withdrawal by Subject|0|||
162981038|NCT03166124|588631098|FG001|Wash-out Period|Withdrawal by Subject|1|||
162981039|NCT03166124|588631099|FG002|Wash-out Period|Withdrawal by Subject|0|||
162981040|NCT03166124|588631100|FG003|Wash-out Period|Withdrawal by Subject|1|||
162981041|NCT03166124|588631097|FG000|Wash-out Period|Adverse Event|0|||
162981042|NCT03166124|588631098|FG001|Wash-out Period|Adverse Event|1|||
162981043|NCT03166124|588631099|FG002|Wash-out Period|Adverse Event|1|||
162981044|NCT03166124|588631100|FG003|Wash-out Period|Adverse Event|0|||
162981045|NCT00788593|588631101|FG000|Placebo Run-in Phase|Adverse Event|2|||
162981046|NCT00788593|588631102|FG001|Placebo Run-in Phase|Adverse Event|0|||
162981047|NCT00788593|588631103|FG002|Placebo Run-in Phase|Adverse Event|0|||
162981048|NCT00788593|588631101|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
162981049|NCT00788593|588631102|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
162981050|NCT00788593|588631103|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
162981051|NCT00788593|588631101|FG000|Placebo Run-in Phase|Protocol Violation|2|||
162981052|NCT00788593|588631102|FG001|Placebo Run-in Phase|Protocol Violation|0|||
162981053|NCT00788593|588631103|FG002|Placebo Run-in Phase|Protocol Violation|0|||
162981054|NCT00788593|588631101|FG000|First Intervention Period|Adverse Event|0|||
162981055|NCT00788593|588631102|FG001|First Intervention Period|Adverse Event|1|||
162981056|NCT00788593|588631103|FG002|First Intervention Period|Adverse Event|0|||
162981057|NCT00788593|588631101|FG000|Second Intervention Period|Lost to Follow-up|0|||
162981058|NCT00788593|588631102|FG001|Second Intervention Period|Lost to Follow-up|1|||
162981059|NCT00788593|588631103|FG002|Second Intervention Period|Lost to Follow-up|0|||
162981060|NCT00788593|588631101|FG000|Second Intervention Period|Other|0|||
162981061|NCT00788593|588631102|FG001|Second Intervention Period|Other|0|||
162981062|NCT00788593|588631103|FG002|Second Intervention Period|Other|1|||
162981063|NCT01392326|588631104|FG000|Overall Study|Death|2|||
162981064|NCT01392326|588631105|FG001|Overall Study|Death|0|||
162981065|NCT01392326|588631106|FG002|Overall Study|Death|0|||
162981066|NCT01392326|588631104|FG000|Overall Study|Withdrawal by Subject|12|||
162981067|NCT01392326|588631105|FG001|Overall Study|Withdrawal by Subject|11|||
162981068|NCT01392326|588631106|FG002|Overall Study|Withdrawal by Subject|15|||
162981069|NCT01392326|588631104|FG000|Overall Study|Protocol Violation|2|||
162981070|NCT01392326|588631105|FG001|Overall Study|Protocol Violation|0|||
162981071|NCT01392326|588631106|FG002|Overall Study|Protocol Violation|0|||
162981072|NCT01392326|588631104|FG000|Overall Study|Pregnancy|0|||
162981073|NCT01392326|588631105|FG001|Overall Study|Pregnancy|0|||
162981074|NCT01392326|588631106|FG002|Overall Study|Pregnancy|1|||
162981075|NCT01392326|588631104|FG000|Overall Study|Physician Decision|7|||
162981076|NCT01392326|588631105|FG001|Overall Study|Physician Decision|5|||
162981077|NCT01392326|588631106|FG002|Overall Study|Physician Decision|2|||
162981078|NCT01392326|588631104|FG000|Overall Study|Lost to Follow-up|1|||
162981079|NCT01392326|588631105|FG001|Overall Study|Lost to Follow-up|3|||
162981080|NCT01392326|588631106|FG002|Overall Study|Lost to Follow-up|4|||
163059109|NCT01288430|588926292|FG000|Part 2|Clinical disease progression|0|||
163059110|NCT01288430|588926293|FG001|Part 2|Clinical disease progression|0|||
162981081|NCT01392326|588631104|FG000|Overall Study|Lack of Efficacy|14|||
162981082|NCT01392326|588631105|FG001|Overall Study|Lack of Efficacy|10|||
162981083|NCT01392326|588631106|FG002|Overall Study|Lack of Efficacy|15|||
162981084|NCT01392326|588631104|FG000|Overall Study|Adverse Event|9|||
162981085|NCT01392326|588631105|FG001|Overall Study|Adverse Event|6|||
163059111|NCT01288430|588926294|FG002|Part 2|Clinical disease progression|0|||
163211361|NCT02457910|589488851|FG004|Overall Study|Death|0|||
162981086|NCT01392326|588631106|FG002|Overall Study|Adverse Event|11|||
162981087|NCT00123955|588631109|FG000|Overall Study|Adverse Event|1|||
162981088|NCT00123955|588631110|FG001|Overall Study|Adverse Event|0|||
162981089|NCT00123955|588631109|FG000|Overall Study|Withdrawal by Subject|4|||
162981090|NCT00123955|588631110|FG001|Overall Study|Withdrawal by Subject|3|||
162981091|NCT00123955|588631109|FG000|Overall Study|Death|0|||
162981092|NCT00123955|588631110|FG001|Overall Study|Death|1|||
162981093|NCT04459715|588631115|FG000|Overall Study|Adverse Event|3|||
163211362|NCT02457910|589488852|FG005|Overall Study|Death|0|||
162981094|NCT04459715|588631116|FG001|Overall Study|Adverse Event|3|||
162981095|NCT04459715|588631115|FG000|Overall Study|Death|111|||
162981096|NCT04459715|588631116|FG001|Overall Study|Death|93|||
162981097|NCT04459715|588631115|FG000|Overall Study|Lost to Follow-up|10|||
163211363|NCT01339429|589488855|FG000|Overall Study|Withdrawal by Subject|1|||
162981098|NCT04459715|588631116|FG001|Overall Study|Lost to Follow-up|9|||
162981099|NCT04459715|588631115|FG000|Overall Study|Other Reasons|4|||
162981100|NCT04459715|588631116|FG001|Overall Study|Other Reasons|5|||
162981101|NCT04459715|588631115|FG000|Overall Study|PROTOCOL DEVIATION|0|||
162981102|NCT04459715|588631116|FG001|Overall Study|PROTOCOL DEVIATION|1|||
162981103|NCT04459715|588631115|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
162981104|NCT04459715|588631116|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
162981105|NCT04459715|588631115|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
162981106|NCT04459715|588631116|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
162981107|NCT04459715|588631115|FG000|Overall Study|Withdrawal by Subject|22|||
162981108|NCT04459715|588631116|FG001|Overall Study|Withdrawal by Subject|22|||
162981109|NCT02427984|588631119|FG000|Overall Study|Lost to Follow-up|13|||
163320584|NCT03677141|589885937|FG001|Overall Study|Physician Decision|0|||
163320585|NCT03677141|589885938|FG002|Overall Study|Physician Decision|0|||
162981110|NCT02427984|588631120|FG001|Overall Study|Lost to Follow-up|5|||
162981111|NCT02427984|588631121|FG002|Overall Study|Lost to Follow-up|18|||
162981112|NCT03959527|588632948|FG000|Overall Study|Withdrawal by Subject|8|||
162981113|NCT03959527|588632949|FG001|Overall Study|Withdrawal by Subject|3|||
162981114|NCT03959527|588632948|FG000|Overall Study|Lost to Follow-up|31|||
162981115|NCT03959527|588632949|FG001|Overall Study|Lost to Follow-up|15|||
162981116|NCT03959527|588632948|FG000|Overall Study|Did not meet eligibility criteria|1|||
162981117|NCT03959527|588632949|FG001|Overall Study|Did not meet eligibility criteria|1|||
162981118|NCT03959527|588632948|FG000|Overall Study|Protocol Violation|10|||
162981119|NCT03959527|588632949|FG001|Overall Study|Protocol Violation|5|||
162981120|NCT06029959|588632950|FG000|Overall Study|Physician Decision|6|||
162981121|NCT02960893|588632956|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
162981122|NCT02960893|588632957|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
162981123|NCT02960893|588632958|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
162981124|NCT02960893|588632959|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
162981125|NCT02960893|588632956|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
162981126|NCT02960893|588632957|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
162981127|NCT02960893|588632958|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
162981128|NCT02960893|588632959|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
162981129|NCT02960893|588632956|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
162981130|NCT02960893|588632957|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
162981131|NCT02960893|588632958|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
162981132|NCT02960893|588632959|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
162981133|NCT02960893|588632956|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
162981134|NCT02960893|588632957|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
162981135|NCT02960893|588632958|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
162981136|NCT02960893|588632959|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
162981137|NCT02960893|588632956|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
162981138|NCT02960893|588632957|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
162981139|NCT02960893|588632958|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
162981140|NCT02960893|588632959|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
162981141|NCT02960893|588632956|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
162981142|NCT02960893|588632957|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
162981143|NCT02960893|588632958|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
162981144|NCT02960893|588632959|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
162981145|NCT02960893|588632956|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
162981146|NCT02960893|588632957|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
162981147|NCT02960893|588632958|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
162981148|NCT02960893|588632959|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
162981149|NCT02960893|588632956|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
162981150|NCT02960893|588632957|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
162981151|NCT02960893|588632958|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
162981152|NCT02960893|588632959|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
162981153|NCT02960893|588632956|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
162981154|NCT02960893|588632957|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
162981155|NCT02960893|588632958|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
162981156|NCT02960893|588632959|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
162981157|NCT02960893|588632956|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
163320586|NCT03677141|589885939|FG003|Overall Study|Physician Decision|0|||
163320587|NCT03677141|589885940|FG004|Overall Study|Physician Decision|1|||
163320588|NCT03677141|589885941|FG005|Overall Study|Physician Decision|0|||
163320589|NCT03677141|589885936|FG000|Overall Study|Withdrawal by Subject|0|||
162981158|NCT02960893|588632957|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
162981159|NCT02960893|588632958|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
162981160|NCT02960893|588632959|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
163320590|NCT03677141|589885937|FG001|Overall Study|Withdrawal by Subject|0|||
163320591|NCT03677141|589885938|FG002|Overall Study|Withdrawal by Subject|1|||
162981161|NCT02631876|588632964|FG000|Overall Study|Death|96|||
162981162|NCT02631876|588632965|FG001|Overall Study|Death|50|||
162981163|NCT02631876|588632964|FG000|Overall Study|Investigator's discretion|1|||
163320592|NCT03677141|589885939|FG003|Overall Study|Withdrawal by Subject|1|||
162981164|NCT02631876|588632965|FG001|Overall Study|Investigator's discretion|0|||
162981165|NCT02631876|588632964|FG000|Overall Study|Lost to Follow-up|2|||
162981166|NCT02631876|588632965|FG001|Overall Study|Lost to Follow-up|0|||
162981167|NCT02631876|588632964|FG000|Overall Study|Withdrawal by Subject|16|||
162981168|NCT02631876|588632965|FG001|Overall Study|Withdrawal by Subject|9|||
162981169|NCT02631876|588632964|FG000|Overall Study|Other than specified|4|||
162981170|NCT02631876|588632965|FG001|Overall Study|Other than specified|4|||
162981171|NCT04285567|588632966|FG000|Overall Study|Death|3|||
162981172|NCT04285567|588632967|FG001|Overall Study|Death|3|||
162981173|NCT04285567|588632966|FG000|Overall Study|Lost to Follow-up|1|||
162981174|NCT04285567|588632967|FG001|Overall Study|Lost to Follow-up|1|||
162981175|NCT04285567|588632966|FG000|Overall Study|Reason Not Specified|1|||
162981176|NCT04285567|588632967|FG001|Overall Study|Reason Not Specified|1|||
162981177|NCT04285567|588632966|FG000|Overall Study|Physician Decision|2|||
162981178|NCT04285567|588632967|FG001|Overall Study|Physician Decision|1|||
162981179|NCT04285567|588632966|FG000|Overall Study|Withdrawal by Subject|2|||
162981180|NCT04285567|588632967|FG001|Overall Study|Withdrawal by Subject|6|||
162981181|NCT04285567|588632966|FG000|Overall Study|Adverse Event|1|||
162981182|NCT04285567|588632967|FG001|Overall Study|Adverse Event|0|||
162981183|NCT04285567|588632966|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
162981184|NCT04285567|588632967|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
162981185|NCT00493779|588632968|FG000|Overall Study|Logistical issue at site|1|||
162981186|NCT02091141|588632970|FG000|Overall Study|Death|280|||
162981187|NCT02091141|588632971|FG001|Overall Study|Death|118|||
162981188|NCT02091141|588632972|FG002|Overall Study|Death|46|||
162981189|NCT02091141|588632973|FG003|Overall Study|Death|13|||
162981190|NCT02091141|588632974|FG004|Overall Study|Death|31|||
162981191|NCT02091141|588632975|FG005|Overall Study|Death|16|||
162981192|NCT02091141|588632976|FG006|Overall Study|Death|12|||
162981193|NCT02091141|588632970|FG000|Overall Study|Withdrawal by Subject|21|||
162981194|NCT02091141|588632971|FG001|Overall Study|Withdrawal by Subject|13|||
162981195|NCT02091141|588632972|FG002|Overall Study|Withdrawal by Subject|3|||
162981196|NCT02091141|588632973|FG003|Overall Study|Withdrawal by Subject|2|||
162981197|NCT02091141|588632974|FG004|Overall Study|Withdrawal by Subject|2|||
162981198|NCT02091141|588632975|FG005|Overall Study|Withdrawal by Subject|3|||
162981199|NCT02091141|588632976|FG006|Overall Study|Withdrawal by Subject|0|||
162981200|NCT02091141|588632970|FG000|Overall Study|Lost to Follow-up|21|||
162981201|NCT02091141|588632971|FG001|Overall Study|Lost to Follow-up|5|||
162981202|NCT02091141|588632972|FG002|Overall Study|Lost to Follow-up|1|||
162981203|NCT02091141|588632973|FG003|Overall Study|Lost to Follow-up|0|||
162981204|NCT02091141|588632974|FG004|Overall Study|Lost to Follow-up|1|||
162981205|NCT02091141|588632975|FG005|Overall Study|Lost to Follow-up|2|||
162981206|NCT02091141|588632976|FG006|Overall Study|Lost to Follow-up|0|||
162981207|NCT02091141|588632970|FG000|Overall Study|Reason Not Specified|6|||
162981208|NCT02091141|588632971|FG001|Overall Study|Reason Not Specified|5|||
162981209|NCT02091141|588632972|FG002|Overall Study|Reason Not Specified|2|||
162981210|NCT02091141|588632973|FG003|Overall Study|Reason Not Specified|0|||
162981211|NCT02091141|588632974|FG004|Overall Study|Reason Not Specified|0|||
163320593|NCT03677141|589885940|FG004|Overall Study|Withdrawal by Subject|1|||
163320594|NCT03677141|589885941|FG005|Overall Study|Withdrawal by Subject|0|||
163320595|NCT03926130|589885948|FG000|Overall Study|Adverse Event|9|||
163320596|NCT03926130|589885949|FG001|Overall Study|Adverse Event|11|||
163320597|NCT03926130|589885950|FG002|Overall Study|Adverse Event|2|||
163320598|NCT03926130|589885951|FG003|Overall Study|Adverse Event|0|||
162981212|NCT02091141|588632975|FG005|Overall Study|Reason Not Specified|0|||
162981213|NCT02091141|588632976|FG006|Overall Study|Reason Not Specified|1|||
162981214|NCT02091141|588632970|FG000|Overall Study|Study Ended by Sponsor|1|||
163320599|NCT03926130|589885948|FG000|Overall Study|Death|2|||
163320600|NCT03926130|589885949|FG001|Overall Study|Death|0|||
163320601|NCT03926130|589885950|FG002|Overall Study|Death|1|||
163320602|NCT03926130|589885951|FG003|Overall Study|Death|0|||
163320603|NCT03926130|589885948|FG000|Overall Study|Lack of Efficacy|14|||
163320604|NCT03926130|589885949|FG001|Overall Study|Lack of Efficacy|11|||
163320605|NCT03926130|589885950|FG002|Overall Study|Lack of Efficacy|7|||
163320606|NCT03926130|589885951|FG003|Overall Study|Lack of Efficacy|1|||
163320607|NCT03926130|589885948|FG000|Overall Study|Lost to Follow-up|0|||
163320608|NCT03926130|589885949|FG001|Overall Study|Lost to Follow-up|7|||
162981215|NCT02091141|588632971|FG001|Overall Study|Study Ended by Sponsor|9|||
162981216|NCT02091141|588632972|FG002|Overall Study|Study Ended by Sponsor|0|||
162981217|NCT02091141|588632973|FG003|Overall Study|Study Ended by Sponsor|0|||
162981218|NCT02091141|588632974|FG004|Overall Study|Study Ended by Sponsor|0|||
162981219|NCT02091141|588632975|FG005|Overall Study|Study Ended by Sponsor|0|||
162981220|NCT02091141|588632976|FG006|Overall Study|Study Ended by Sponsor|0|||
162981221|NCT02091141|588632970|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
163320609|NCT03926130|589885950|FG002|Overall Study|Lost to Follow-up|1|||
163320610|NCT03926130|589885951|FG003|Overall Study|Lost to Follow-up|0|||
163320611|NCT03926130|589885948|FG000|Overall Study|As Reported by Investigator|2|||
162981222|NCT02091141|588632971|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
162981223|NCT02091141|588632972|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
162981224|NCT02091141|588632973|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
162981225|NCT02091141|588632974|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
162981226|NCT02091141|588632975|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
162981227|NCT02091141|588632976|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
162981228|NCT02246439|588632977|FG000|Overall Study|Adverse Event|3|||
162981229|NCT02246439|588632978|FG001|Overall Study|Adverse Event|0|||
162981230|NCT02246439|588632977|FG000|Overall Study|Lost to Follow-up|7|||
162981231|NCT02246439|588632978|FG001|Overall Study|Lost to Follow-up|5|||
162981232|NCT02246439|588632977|FG000|Overall Study|Protocol Violation|0|||
162981233|NCT02246439|588632978|FG001|Overall Study|Protocol Violation|2|||
162981234|NCT02246439|588632977|FG000|Overall Study|Physician Decision|0|||
162981235|NCT02246439|588632978|FG001|Overall Study|Physician Decision|1|||
162981236|NCT02246439|588632977|FG000|Overall Study|Unkonwn|1|||
162981237|NCT02246439|588632978|FG001|Overall Study|Unkonwn|3|||
162981238|NCT02246439|588632977|FG000|Overall Study|Withdrawal by Subject|1|||
162981239|NCT02246439|588632978|FG001|Overall Study|Withdrawal by Subject|0|||
162981240|NCT03439852|588632981|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
162981241|NCT03439852|588632982|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
162981242|NCT03439852|588632981|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
162981243|NCT03439852|588632982|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
162981244|NCT03439852|588632981|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
162981245|NCT03439852|588632982|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
162981246|NCT04551911|588632983|FG000|Overall Study|Lost to Follow-up|2|||
162981247|NCT04551911|588632984|FG001|Overall Study|Lost to Follow-up|1|||
162981248|NCT04551911|588632983|FG000|Overall Study|Withdrawal by Subject|10|||
162981249|NCT04551911|588632984|FG001|Overall Study|Withdrawal by Subject|10|||
162981250|NCT04551911|588632983|FG000|Overall Study|Did not receive the study drug|3|||
162981251|NCT04551911|588632984|FG001|Overall Study|Did not receive the study drug|4|||
162981252|NCT00866658|588632995|FG000|Overall Study|Adverse Event|5|||
162981253|NCT00866658|588632996|FG001|Overall Study|Adverse Event|14|||
162981254|NCT00866658|588632995|FG000|Overall Study|Lack of Efficacy|2|||
162981255|NCT00866658|588632996|FG001|Overall Study|Lack of Efficacy|1|||
162981256|NCT00866658|588632995|FG000|Overall Study|Withdrawal by Subject|1|||
162981257|NCT00866658|588632996|FG001|Overall Study|Withdrawal by Subject|0|||
162981258|NCT00866658|588632995|FG000|Overall Study|Protocol Violation|1|||
162981259|NCT00866658|588632996|FG001|Overall Study|Protocol Violation|1|||
162981260|NCT00866658|588632995|FG000|Overall Study|Familial and Personal Reasons|4|||
162981261|NCT00866658|588632996|FG001|Overall Study|Familial and Personal Reasons|5|||
162981262|NCT02072148|588632997|FG000|Overall Study|withdrew prior to surgery|23|||
162981263|NCT02072148|588632998|FG001|Overall Study|withdrew prior to surgery|0|||
162981264|NCT02072148|588632999|FG002|Overall Study|withdrew prior to surgery|0|||
162981265|NCT02072148|588632997|FG000|Overall Study|Death|0|||
162981266|NCT02072148|588632998|FG001|Overall Study|Death|0|||
162981267|NCT02072148|588632999|FG002|Overall Study|Death|1|||
162981268|NCT02072148|588632997|FG000|Overall Study|Withdrawal by Subject|0|||
162981269|NCT02072148|588632998|FG001|Overall Study|Withdrawal by Subject|13|||
162981270|NCT02072148|588632999|FG002|Overall Study|Withdrawal by Subject|12|||
162981271|NCT00430495|588633001|FG000|Overall Study|Adverse Event|2|||
162981272|NCT00430495|588633002|FG001|Overall Study|Adverse Event|3|||
163320612|NCT03926130|589885949|FG001|Overall Study|As Reported by Investigator|6|||
163320613|NCT03926130|589885950|FG002|Overall Study|As Reported by Investigator|6|||
163320614|NCT03926130|589885951|FG003|Overall Study|As Reported by Investigator|0|||
163320615|NCT03926130|589885948|FG000|Overall Study|Physician Decision|3|||
163320616|NCT03926130|589885949|FG001|Overall Study|Physician Decision|2|||
163320617|NCT03926130|589885950|FG002|Overall Study|Physician Decision|1|||
163320618|NCT03926130|589885951|FG003|Overall Study|Physician Decision|0|||
163320619|NCT03926130|589885948|FG000|Overall Study|Pregnancy|2|||
163320620|NCT03926130|589885949|FG001|Overall Study|Pregnancy|2|||
162981273|NCT00430495|588633003|FG002|Overall Study|Adverse Event|2|||
162981274|NCT00430495|588633004|FG003|Overall Study|Adverse Event|0|||
162981275|NCT00430495|588633001|FG000|Overall Study|Death|0|||
162981276|NCT00430495|588633002|FG001|Overall Study|Death|0|||
162981277|NCT00430495|588633003|FG002|Overall Study|Death|1|||
162981278|NCT00430495|588633004|FG003|Overall Study|Death|0|||
162981279|NCT00430495|588633001|FG000|Overall Study|Lost to Follow-up|0|||
163320621|NCT03926130|589885950|FG002|Overall Study|Pregnancy|1|||
162981280|NCT00430495|588633002|FG001|Overall Study|Lost to Follow-up|1|||
162981281|NCT00430495|588633003|FG002|Overall Study|Lost to Follow-up|4|||
162981282|NCT00430495|588633004|FG003|Overall Study|Lost to Follow-up|0|||
162981283|NCT00430495|588633001|FG000|Overall Study|Protocol Violation|1|||
162981284|NCT00430495|588633002|FG001|Overall Study|Protocol Violation|0|||
163320622|NCT03926130|589885951|FG003|Overall Study|Pregnancy|0|||
162981285|NCT00430495|588633003|FG002|Overall Study|Protocol Violation|1|||
162981286|NCT00430495|588633004|FG003|Overall Study|Protocol Violation|0|||
162981287|NCT00430495|588633001|FG000|Overall Study|Disease Progression|1|||
162981288|NCT00430495|588633002|FG001|Overall Study|Disease Progression|1|||
162981289|NCT00430495|588633003|FG002|Overall Study|Disease Progression|0|||
162981290|NCT00430495|588633004|FG003|Overall Study|Disease Progression|0|||
162981291|NCT00430495|588633001|FG000|Overall Study|Other|8|||
162981292|NCT00430495|588633002|FG001|Overall Study|Other|2|||
162981293|NCT00430495|588633003|FG002|Overall Study|Other|5|||
162981294|NCT00430495|588633004|FG003|Overall Study|Other|4|||
162981295|NCT00430495|588633001|FG000|Overall Study|Randomized but not Treated|2|||
162981296|NCT00430495|588633002|FG001|Overall Study|Randomized but not Treated|0|||
162981297|NCT00430495|588633003|FG002|Overall Study|Randomized but not Treated|0|||
162981298|NCT00430495|588633004|FG003|Overall Study|Randomized but not Treated|0|||
162981299|NCT00158756|588633005|FG000|Overall Study|Withdrawal by Subject|5|||
162981300|NCT00158756|588633006|FG001|Overall Study|Withdrawal by Subject|0|||
162981301|NCT00158756|588633007|FG002|Overall Study|Withdrawal by Subject|6|||
162981302|NCT00158756|588633008|FG003|Overall Study|Withdrawal by Subject|1|||
162981303|NCT00158756|588633009|FG004|Overall Study|Withdrawal by Subject|3|||
162981304|NCT00158756|588633005|FG000|Overall Study|Adverse Event|0|||
162981305|NCT00158756|588633006|FG001|Overall Study|Adverse Event|0|||
162981306|NCT00158756|588633007|FG002|Overall Study|Adverse Event|1|||
162981307|NCT00158756|588633008|FG003|Overall Study|Adverse Event|0|||
162981308|NCT00158756|588633009|FG004|Overall Study|Adverse Event|0|||
162981309|NCT00158756|588633005|FG000|Overall Study|Serious adverse event|0|||
162981310|NCT00158756|588633006|FG001|Overall Study|Serious adverse event|0|||
162981311|NCT00158756|588633007|FG002|Overall Study|Serious adverse event|1|||
162981312|NCT00158756|588633008|FG003|Overall Study|Serious adverse event|0|||
162981313|NCT00158756|588633009|FG004|Overall Study|Serious adverse event|0|||
162981314|NCT03656874|588633010|FG000|Overall Study|Lost to Follow-up|3|||
162981315|NCT03656874|588633011|FG001|Overall Study|Lost to Follow-up|17|||
162981316|NCT01206816|588633012|FG000|Overall Study|Protocol Violation|0|||
162981317|NCT01206816|588633013|FG001|Overall Study|Protocol Violation|0|||
163320623|NCT03926130|589885948|FG000|Overall Study|Withdrawal by Subject|20|||
163320624|NCT03926130|589885949|FG001|Overall Study|Withdrawal by Subject|28|||
163320625|NCT03926130|589885950|FG002|Overall Study|Withdrawal by Subject|18|||
163320626|NCT03926130|589885951|FG003|Overall Study|Withdrawal by Subject|1|||
163320627|NCT03926130|589885948|FG000|Overall Study|Non-Compliance|1|||
163320628|NCT03926130|589885949|FG001|Overall Study|Non-Compliance|1|||
162981318|NCT01206816|588633014|FG002|Overall Study|Protocol Violation|1|||
162981319|NCT01206816|588633015|FG003|Overall Study|Protocol Violation|0|||
162981320|NCT01206816|588633016|FG004|Overall Study|Protocol Violation|0|||
162981321|NCT01206816|588633017|FG005|Overall Study|Protocol Violation|0|||
162981322|NCT01206816|588633018|FG006|Overall Study|Protocol Violation|0|||
162981323|NCT01206816|588633012|FG000|Overall Study|Withdrawal by Subject|0|||
162981324|NCT01206816|588633013|FG001|Overall Study|Withdrawal by Subject|0|||
162981325|NCT01206816|588633014|FG002|Overall Study|Withdrawal by Subject|1|||
162981326|NCT01206816|588633015|FG003|Overall Study|Withdrawal by Subject|0|||
162981327|NCT01206816|588633016|FG004|Overall Study|Withdrawal by Subject|0|||
162981328|NCT01206816|588633017|FG005|Overall Study|Withdrawal by Subject|0|||
162981329|NCT01206816|588633018|FG006|Overall Study|Withdrawal by Subject|0|||
162981330|NCT01206816|588633012|FG000|Overall Study|Progressive disease|3|||
162981331|NCT01206816|588633013|FG001|Overall Study|Progressive disease|3|||
162981332|NCT01206816|588633014|FG002|Overall Study|Progressive disease|13|||
162981333|NCT01206816|588633015|FG003|Overall Study|Progressive disease|3|||
162981334|NCT01206816|588633016|FG004|Overall Study|Progressive disease|3|||
162981335|NCT01206816|588633017|FG005|Overall Study|Progressive disease|16|||
162981336|NCT01206816|588633018|FG006|Overall Study|Progressive disease|3|||
162981337|NCT01206816|588633012|FG000|Overall Study|Other AE|0|||
162981338|NCT01206816|588633013|FG001|Overall Study|Other AE|0|||
162981339|NCT01206816|588633014|FG002|Overall Study|Other AE|4|||
162981340|NCT01206816|588633015|FG003|Overall Study|Other AE|0|||
162981341|NCT01206816|588633016|FG004|Overall Study|Other AE|0|||
162981342|NCT01206816|588633017|FG005|Overall Study|Other AE|3|||
162981343|NCT01206816|588633018|FG006|Overall Study|Other AE|2|||
162981344|NCT01206816|588633012|FG000|Overall Study|other than stated above|0|||
162981345|NCT01206816|588633013|FG001|Overall Study|other than stated above|0|||
163320629|NCT03926130|589885950|FG002|Overall Study|Non-Compliance|0|||
162981346|NCT01206816|588633014|FG002|Overall Study|other than stated above|1|||
162981347|NCT01206816|588633015|FG003|Overall Study|other than stated above|0|||
162981348|NCT01206816|588633016|FG004|Overall Study|other than stated above|0|||
162981349|NCT01206816|588633017|FG005|Overall Study|other than stated above|0|||
162981350|NCT01206816|588633018|FG006|Overall Study|other than stated above|1|||
162981351|NCT02528123|588633020|FG000|Overall Study|Lost to Follow-up|1|||
162981352|NCT01939496|588633021|FG000|Overall Study|Adverse Event|2|||
162981353|NCT01939496|588633022|FG001|Overall Study|Adverse Event|0|||
162981354|NCT01939496|588633023|FG002|Overall Study|Adverse Event|0|||
162981355|NCT01939496|588633021|FG000|Overall Study|Lost to Follow-up|1|||
162981356|NCT01939496|588633022|FG001|Overall Study|Lost to Follow-up|1|||
163320630|NCT03926130|589885951|FG003|Overall Study|Non-Compliance|0|||
163320631|NCT03926130|589885948|FG000|Overall Study|Disposition Not Captured|0|||
163320632|NCT03926130|589885949|FG001|Overall Study|Disposition Not Captured|2|||
163320633|NCT03926130|589885950|FG002|Overall Study|Disposition Not Captured|1|||
162981357|NCT01939496|588633023|FG002|Overall Study|Lost to Follow-up|0|||
162981358|NCT01939496|588633021|FG000|Overall Study|Physician Decision|1|||
162981359|NCT01939496|588633022|FG001|Overall Study|Physician Decision|0|||
162981360|NCT01939496|588633023|FG002|Overall Study|Physician Decision|0|||
162981361|NCT01939496|588633021|FG000|Overall Study|Protocol Violation|3|||
162981362|NCT01939496|588633022|FG001|Overall Study|Protocol Violation|0|||
162981363|NCT01939496|588633023|FG002|Overall Study|Protocol Violation|0|||
162981364|NCT01939496|588633021|FG000|Overall Study|Withdrawal by Subject|0|||
162981365|NCT01939496|588633022|FG001|Overall Study|Withdrawal by Subject|1|||
162981366|NCT01939496|588633023|FG002|Overall Study|Withdrawal by Subject|1|||
162981367|NCT01939496|588633021|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
162981368|NCT01939496|588633022|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
162981369|NCT01939496|588633023|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
162981370|NCT01939496|588633021|FG000|Overall Study|Other|2|||
162981371|NCT01939496|588633022|FG001|Overall Study|Other|0|||
162981372|NCT01939496|588633023|FG002|Overall Study|Other|1|||
162981373|NCT00506129|588633026|FG000|Overall Study|Disease Progression/Relapse|15|||
162981374|NCT00506129|588633026|FG000|Overall Study|Death|7|||
162981375|NCT01642914|588633027|FG000|Overall Study|Adverse Event|11|||
162981376|NCT01642914|588633028|FG001|Overall Study|Adverse Event|7|||
162981377|NCT01642914|588633029|FG002|Overall Study|Adverse Event|15|||
162981378|NCT01642914|588633027|FG000|Overall Study|Lack of Efficacy|9|||
162981379|NCT01642914|588633028|FG001|Overall Study|Lack of Efficacy|4|||
162981380|NCT01642914|588633029|FG002|Overall Study|Lack of Efficacy|2|||
162981381|NCT01642914|588633027|FG000|Overall Study|Protocol Violation|15|||
162981382|NCT01642914|588633028|FG001|Overall Study|Protocol Violation|13|||
162981383|NCT01642914|588633029|FG002|Overall Study|Protocol Violation|6|||
162981384|NCT01642914|588633027|FG000|Overall Study|Withdrawal by Subject|5|||
162981385|NCT01642914|588633028|FG001|Overall Study|Withdrawal by Subject|5|||
162981386|NCT01642914|588633029|FG002|Overall Study|Withdrawal by Subject|10|||
162981387|NCT01642914|588633027|FG000|Overall Study|Lost to Follow-up|5|||
162981388|NCT01642914|588633028|FG001|Overall Study|Lost to Follow-up|3|||
162981389|NCT01642914|588633029|FG002|Overall Study|Lost to Follow-up|7|||
162981390|NCT01642914|588633027|FG000|Overall Study|Other Reason|1|||
162981391|NCT01642914|588633028|FG001|Overall Study|Other Reason|0|||
162981392|NCT01642914|588633029|FG002|Overall Study|Other Reason|0|||
162981393|NCT04295135|588633030|FG000|Overall Study|Withdrawal by Subject|2|||
162981394|NCT04295135|588633031|FG001|Overall Study|Withdrawal by Subject|1|||
162981395|NCT04295135|588633030|FG000|Overall Study|Subject left organization|8|||
162981396|NCT04295135|588633031|FG001|Overall Study|Subject left organization|4|||
162981397|NCT02923674|588633032|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
162981398|NCT02923674|588633033|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
162981399|NCT02923674|588633034|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
162981400|NCT02923674|588633032|FG000|Overall Study|Lost to Follow-up|7|||
162981401|NCT02923674|588633033|FG001|Overall Study|Lost to Follow-up|12|||
162981402|NCT02923674|588633034|FG002|Overall Study|Lost to Follow-up|7|||
162981403|NCT02923674|588633032|FG000|Overall Study|Problem with intervention|2|||
162981404|NCT02923674|588633033|FG001|Overall Study|Problem with intervention|2|||
162981405|NCT02923674|588633034|FG002|Overall Study|Problem with intervention|1|||
162981406|NCT02923674|588633032|FG000|Overall Study|Adverse Event|3|||
162981407|NCT02923674|588633033|FG001|Overall Study|Adverse Event|1|||
162981408|NCT02923674|588633034|FG002|Overall Study|Adverse Event|1|||
162981409|NCT02923674|588633032|FG000|Overall Study|Withdrawal by Subject|2|||
162981410|NCT02923674|588633033|FG001|Overall Study|Withdrawal by Subject|2|||
162981411|NCT02923674|588633034|FG002|Overall Study|Withdrawal by Subject|2|||
162981412|NCT02712333|588633038|FG000|First Period|Withdrawal by Subject|3|||
162981413|NCT02712333|588633039|FG001|First Period|Withdrawal by Subject|2|||
162981414|NCT03463993|588633040|FG000|Overall Study|Lost to Follow-up|7|||
163320634|NCT03926130|589885951|FG003|Overall Study|Disposition Not Captured|0|||
163320635|NCT03583333|589885952|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
163320636|NCT03583333|589885953|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
163320637|NCT03583333|589885952|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
163320638|NCT03583333|589885953|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
162981415|NCT03463993|588633041|FG001|Overall Study|Lost to Follow-up|8|||
162981416|NCT03463993|588633040|FG000|Overall Study|Withdrawal by Subject|2|||
162981417|NCT03463993|588633041|FG001|Overall Study|Withdrawal by Subject|0|||
162981418|NCT03463993|588633040|FG000|Overall Study|Protocol Violation|4|||
162981419|NCT03463993|588633041|FG001|Overall Study|Protocol Violation|1|||
162981420|NCT03463993|588633040|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
162981421|NCT03463993|588633041|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
162981422|NCT03463993|588633040|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
163320639|NCT03583333|589885952|FG000|Overall Study|Withdrawal by Subject|9|||
163059112|NCT01288430|588926295|FG003|Part 2|Clinical disease progression|0|||
163320640|NCT03583333|589885953|FG001|Overall Study|Withdrawal by Subject|5|||
163320641|NCT03583333|589885952|FG000|Overall Study|Physician Decision|3|||
163320642|NCT03583333|589885953|FG001|Overall Study|Physician Decision|2|||
163320643|NCT03583333|589885952|FG000|Overall Study|Death|12|||
163320644|NCT03583333|589885953|FG001|Overall Study|Death|7|||
163320645|NCT05069896|589885960|FG000|Overall Study|Adverse Event|0|||
163320646|NCT05069896|589885961|FG001|Overall Study|Adverse Event|1|||
163320647|NCT05069896|589885962|FG002|Overall Study|Adverse Event|1|||
163320648|NCT05069896|589885963|FG003|Overall Study|Adverse Event|0|||
163320649|NCT05069896|589885964|FG004|Overall Study|Adverse Event|0|||
163320650|NCT05069896|589885965|FG005|Overall Study|Adverse Event|0|||
163320651|NCT05069896|589885960|FG000|Overall Study|Lost to Follow-up|0|||
163320652|NCT05069896|589885961|FG001|Overall Study|Lost to Follow-up|0|||
163320653|NCT05069896|589885962|FG002|Overall Study|Lost to Follow-up|1|||
163320654|NCT05069896|589885963|FG003|Overall Study|Lost to Follow-up|0|||
163320655|NCT05069896|589885964|FG004|Overall Study|Lost to Follow-up|1|||
163320656|NCT05069896|589885965|FG005|Overall Study|Lost to Follow-up|2|||
163320657|NCT04605159|589885980|FG000|Overall Study|Adverse Event|6|||
163320658|NCT04605159|589885981|FG001|Overall Study|Adverse Event|3|||
163320659|NCT04605159|589885982|FG002|Overall Study|Adverse Event|21|||
163402701|NCT00122681|590187001|FG001|Overall Study|Adverse Event|16|||
163402702|NCT00122681|590187000|FG000|Overall Study|Lost to Follow-up|1080|||
163402703|NCT00122681|590187001|FG001|Overall Study|Lost to Follow-up|1097|||
162981423|NCT03463993|588633041|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
162981424|NCT01231373|588633048|FG000|Overall Study|Withdrew consent prior to randomization|2|||
162981425|NCT01231373|588633049|FG001|Overall Study|Withdrew consent prior to randomization|1|||
162981426|NCT01231373|588633050|FG002|Overall Study|Withdrew consent prior to randomization|0|||
162981427|NCT01231373|588633051|FG003|Overall Study|Withdrew consent prior to randomization|0|||
162981428|NCT01231373|588633048|FG000|Overall Study|Lost to Follow-up|0|||
162981429|NCT01231373|588633049|FG001|Overall Study|Lost to Follow-up|0|||
162981430|NCT01231373|588633050|FG002|Overall Study|Lost to Follow-up|0|||
162981431|NCT01231373|588633051|FG003|Overall Study|Lost to Follow-up|1|||
162981432|NCT01231373|588633048|FG000|Overall Study|Withdrew Consent|1|||
162981433|NCT01231373|588633049|FG001|Overall Study|Withdrew Consent|0|||
162981434|NCT01231373|588633050|FG002|Overall Study|Withdrew Consent|0|||
162981435|NCT01231373|588633051|FG003|Overall Study|Withdrew Consent|0|||
162981436|NCT01782482|588633052|FG000|Overall Study|Adverse Event|2|||
162981437|NCT01782482|588633053|FG001|Overall Study|Adverse Event|1|||
162981438|NCT01782482|588633052|FG000|Overall Study|Lost to Follow-up|2|||
162981439|NCT01782482|588633053|FG001|Overall Study|Lost to Follow-up|3|||
162981440|NCT01782482|588633052|FG000|Overall Study|Physician Decision|1|||
162981441|NCT01782482|588633053|FG001|Overall Study|Physician Decision|0|||
162981442|NCT01782482|588633052|FG000|Overall Study|Protocol Violation|1|||
162981443|NCT01782482|588633053|FG001|Overall Study|Protocol Violation|0|||
162981444|NCT01782482|588633052|FG000|Overall Study|Withdrawal by Subject|2|||
162981445|NCT01782482|588633053|FG001|Overall Study|Withdrawal by Subject|3|||
162981446|NCT01782482|588633052|FG000|Overall Study|Randomized in Error|2|||
162981447|NCT01782482|588633053|FG001|Overall Study|Randomized in Error|2|||
162981448|NCT01782482|588633052|FG000|Overall Study|Habitually wearing toric lens OS|0|||
162981449|NCT01782482|588633053|FG001|Overall Study|Habitually wearing toric lens OS|1|||
162981450|NCT00757848|588633054|FG000|Overall Study|Voluntary discontinuation|1|||
162981451|NCT00757848|588633055|FG001|Overall Study|Voluntary discontinuation|0|||
162981452|NCT00757848|588633054|FG000|Overall Study|Adverse Event|1|||
162981453|NCT00757848|588633055|FG001|Overall Study|Adverse Event|2|||
162981454|NCT00757848|588633054|FG000|Overall Study|Incorrect enrolment|1|||
162981455|NCT00757848|588633055|FG001|Overall Study|Incorrect enrolment|0|||
162981456|NCT02039414|588633058|FG000|Overall Study|Delivered|1|||
162981457|NCT02039414|588633059|FG001|Overall Study|Delivered|1|||
162981458|NCT02039414|588633058|FG000|Overall Study|Lost to Follow-up|2|||
162981459|NCT02039414|588633059|FG001|Overall Study|Lost to Follow-up|0|||
162981460|NCT02039414|588633058|FG000|Overall Study|Protocol Violation|3|||
162981461|NCT02039414|588633059|FG001|Overall Study|Protocol Violation|1|||
163059113|NCT01288430|588926296|FG004|Part 2|Clinical disease progression|0|||
163059114|NCT01288430|588926297|FG005|Part 2|Clinical disease progression|0|||
163320660|NCT04605159|589885983|FG003|Overall Study|Adverse Event|4|||
163320661|NCT04605159|589885980|FG000|Overall Study|Lost to Follow-up|74|||
163320662|NCT04605159|589885981|FG001|Overall Study|Lost to Follow-up|45|||
163320663|NCT04605159|589885982|FG002|Overall Study|Lost to Follow-up|119|||
163402704|NCT00122681|590187000|FG000|Overall Study|Protocol Violation|7|||
163402705|NCT00122681|590187001|FG001|Overall Study|Protocol Violation|10|||
162981462|NCT00430950|588633061|FG000|Overall Study|Adverse Event|7|||
162981463|NCT00430950|588633062|FG001|Overall Study|Adverse Event|6|||
162981464|NCT00430950|588633061|FG000|Overall Study|Withdrawal by Subject|1|||
162981465|NCT00430950|588633062|FG001|Overall Study|Withdrawal by Subject|0|||
163320664|NCT04605159|589885983|FG003|Overall Study|Lost to Follow-up|80|||
163320665|NCT04605159|589885980|FG000|Overall Study|Protocol Violation|4|||
163320666|NCT04605159|589885981|FG001|Overall Study|Protocol Violation|5|||
163320667|NCT04605159|589885982|FG002|Overall Study|Protocol Violation|2|||
163320668|NCT04605159|589885983|FG003|Overall Study|Protocol Violation|0|||
163320669|NCT04605159|589885980|FG000|Overall Study|Withdrawal by Subject|66|||
162981466|NCT00430950|588633061|FG000|Overall Study|concomitant medication,etc.|5|||
162981467|NCT00430950|588633062|FG001|Overall Study|concomitant medication,etc.|7|||
162981468|NCT00869024|588633063|FG000|Overall Study|Death|2|||
162981469|NCT00869024|588633064|FG001|Overall Study|Death|3|||
162981470|NCT00869024|588633063|FG000|Overall Study|Lost to Follow-up|0|||
162981471|NCT00869024|588633064|FG001|Overall Study|Lost to Follow-up|1|||
162981472|NCT00869024|588633063|FG000|Overall Study|Protocol Violation|0|||
162981473|NCT00869024|588633064|FG001|Overall Study|Protocol Violation|1|||
163320670|NCT04605159|589885981|FG001|Overall Study|Withdrawal by Subject|37|||
163320671|NCT04605159|589885982|FG002|Overall Study|Withdrawal by Subject|68|||
162981474|NCT01564459|588633065|FG000|Run-In|Adverse Event|7|||
162981475|NCT01564459|588633066|FG001|Run-In|Adverse Event|0|||
162981476|NCT01564459|588633067|FG002|Run-In|Adverse Event|0|||
162981477|NCT01564459|588633065|FG000|Run-In|Lost to Follow-up|1|||
162981478|NCT01564459|588633066|FG001|Run-In|Lost to Follow-up|0|||
162981479|NCT01564459|588633067|FG002|Run-In|Lost to Follow-up|0|||
162981480|NCT01564459|588633065|FG000|Run-In|Non-compliance with study drug|2|||
162981481|NCT01564459|588633066|FG001|Run-In|Non-compliance with study drug|0|||
162981482|NCT01564459|588633067|FG002|Run-In|Non-compliance with study drug|0|||
162981483|NCT01564459|588633065|FG000|Run-In|Protocol Violation|1|||
162981484|NCT01564459|588633066|FG001|Run-In|Protocol Violation|0|||
162981485|NCT01564459|588633067|FG002|Run-In|Protocol Violation|0|||
162981486|NCT01564459|588633065|FG000|Run-In|Withdrawal by Subject|1|||
162981487|NCT01564459|588633066|FG001|Run-In|Withdrawal by Subject|0|||
162981488|NCT01564459|588633067|FG002|Run-In|Withdrawal by Subject|0|||
162981489|NCT01564459|588633065|FG000|Double-blind Treatment|Adverse Event|0|||
162981490|NCT01564459|588633066|FG001|Double-blind Treatment|Adverse Event|0|||
162981491|NCT01564459|588633067|FG002|Double-blind Treatment|Adverse Event|1|||
162981492|NCT00706992|588633068|FG000|Overall Study|Study termination|5|||
162981493|NCT00706992|588633069|FG001|Overall Study|Study termination|5|||
162981494|NCT00706992|588633070|FG002|Overall Study|Study termination|6|||
162981495|NCT00706992|588633071|FG003|Overall Study|Study termination|2|||
162981496|NCT00706992|588633072|FG004|Overall Study|Study termination|3|||
162981497|NCT00706992|588633073|FG005|Overall Study|Study termination|2|||
162981498|NCT00706992|588633074|FG006|Overall Study|Study termination|3|||
162981499|NCT00706992|588633068|FG000|Overall Study|Disease progression before treatment|0|||
162981500|NCT00706992|588633069|FG001|Overall Study|Disease progression before treatment|0|||
162981501|NCT00706992|588633070|FG002|Overall Study|Disease progression before treatment|0|||
162981502|NCT00706992|588633071|FG003|Overall Study|Disease progression before treatment|0|||
162981503|NCT00706992|588633072|FG004|Overall Study|Disease progression before treatment|1|||
162981504|NCT00706992|588633073|FG005|Overall Study|Disease progression before treatment|0|||
162981505|NCT00706992|588633074|FG006|Overall Study|Disease progression before treatment|0|||
162981506|NCT02025751|588633080|FG000|Overall Study|Lost to Follow-up|1|||
162981507|NCT02025751|588633081|FG001|Overall Study|Lost to Follow-up|0|||
162981508|NCT02025751|588633080|FG000|Overall Study|Adverse Event|0|||
162981509|NCT02025751|588633081|FG001|Overall Study|Adverse Event|1|||
162981510|NCT02025751|588633080|FG000|Overall Study|Physician Decision|0|||
162981511|NCT02025751|588633081|FG001|Overall Study|Physician Decision|1|||
162981512|NCT02025751|588633080|FG000|Overall Study|Withdrawal by Subject|0|||
162981513|NCT02025751|588633081|FG001|Overall Study|Withdrawal by Subject|1|||
162981514|NCT02687360|588633084|FG000|Overall Study|Withdrawal by Subject|3|||
162981515|NCT02687360|588633085|FG001|Overall Study|Withdrawal by Subject|0|||
162981516|NCT00653991|588633086|FG000|3 Month Follow-up|Participant would not respond|150|||
162981517|NCT00653991|588633087|FG001|3 Month Follow-up|Participant would not respond|157|||
162981518|NCT00653991|588633086|FG000|6 Month Follow-up|Participant would not respond|133|||
162981519|NCT00653991|588633087|FG001|6 Month Follow-up|Participant would not respond|141|||
162981520|NCT01568866|588633088|FG000|Overall Study|Disease Progression|208|||
162981521|NCT01568866|588633089|FG001|Overall Study|Disease Progression|183|||
162981522|NCT01568866|588633088|FG000|Overall Study|Adverse Event|94|||
162981523|NCT01568866|588633089|FG001|Overall Study|Adverse Event|96|||
162981524|NCT01568866|588633088|FG000|Overall Study|Patient Request|55|||
162981525|NCT01568866|588633089|FG001|Overall Study|Patient Request|71|||
163320672|NCT04605159|589885983|FG003|Overall Study|Withdrawal by Subject|50|||
163320673|NCT04605159|589885980|FG000|Overall Study|Migrated / moved from the study area|32|||
162981526|NCT01568866|588633088|FG000|Overall Study|Physician Decision|40|||
162981527|NCT01568866|588633089|FG001|Overall Study|Physician Decision|32|||
162981528|NCT01568866|588633088|FG000|Overall Study|Withdrawal by Subject|19|||
162981529|NCT01568866|588633089|FG001|Overall Study|Withdrawal by Subject|11|||
162981530|NCT01568866|588633088|FG000|Overall Study|Death|10|||
162981531|NCT01568866|588633089|FG001|Overall Study|Death|18|||
162981532|NCT01568866|588633088|FG000|Overall Study|Protocol Non-compliance|2|||
162981533|NCT01568866|588633089|FG001|Overall Study|Protocol Non-compliance|4|||
162981534|NCT01568866|588633088|FG000|Overall Study|Lost to Follow-up|1|||
162981535|NCT01568866|588633089|FG001|Overall Study|Lost to Follow-up|0|||
162981536|NCT01568866|588633088|FG000|Overall Study|Randomized but Not Dosed|9|||
162981537|NCT01568866|588633089|FG001|Overall Study|Randomized but Not Dosed|1|||
162981538|NCT01698775|588633090|FG000|Phase A|Adverse Event|2|||
162981539|NCT01698775|588633091|FG001|Phase A|Adverse Event|1|||
162981540|NCT01698775|588633090|FG000|Phase A|Death|1|||
162981541|NCT01698775|588633091|FG001|Phase A|Death|1|||
162981542|NCT01698775|588633090|FG000|Phase A|Lack of Efficacy|1|||
162981543|NCT01698775|588633091|FG001|Phase A|Lack of Efficacy|0|||
162981544|NCT01698775|588633090|FG000|Phase A|Lost to Follow-up|1|||
162981545|NCT01698775|588633091|FG001|Phase A|Lost to Follow-up|2|||
162981546|NCT01698775|588633090|FG000|Phase A|Protocol Violation|1|||
162981547|NCT01698775|588633091|FG001|Phase A|Protocol Violation|0|||
162981548|NCT01698775|588633090|FG000|Phase A|Withdrawal by Subject|3|||
162981549|NCT01698775|588633091|FG001|Phase A|Withdrawal by Subject|4|||
162981550|NCT01698775|588633090|FG000|Phase A|Kidney [transplant]|0|||
162981551|NCT01698775|588633091|FG001|Phase A|Kidney [transplant]|1|||
162981552|NCT01698775|588633090|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
162981553|NCT01698775|588633091|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
162981554|NCT01698775|588633090|FG000|Phase B|Adverse Event|6|||
162981555|NCT01698775|588633091|FG001|Phase B|Adverse Event|3|||
162981556|NCT01698775|588633090|FG000|Phase B|Death|0|||
162981557|NCT01698775|588633091|FG001|Phase B|Death|1|||
162981558|NCT01698775|588633090|FG000|Phase B|Lack of Efficacy|0|||
162981559|NCT01698775|588633091|FG001|Phase B|Lack of Efficacy|1|||
162981560|NCT01698775|588633090|FG000|Phase B|Lost to Follow-up|0|||
162981561|NCT01698775|588633091|FG001|Phase B|Lost to Follow-up|1|||
162981562|NCT01698775|588633090|FG000|Phase B|Physician Decision|1|||
162981563|NCT01698775|588633091|FG001|Phase B|Physician Decision|1|||
162981564|NCT01698775|588633090|FG000|Phase B|Protocol Violation|1|||
162981565|NCT01698775|588633091|FG001|Phase B|Protocol Violation|1|||
162981566|NCT01698775|588633090|FG000|Phase B|Withdrawal by Subject|6|||
162981567|NCT01698775|588633091|FG001|Phase B|Withdrawal by Subject|2|||
162981568|NCT03864042|588633092|FG000|DDI Phase|Adverse Event|2|||
162981569|NCT03864042|588633093|FG001|DDI Phase|Adverse Event|0|||
162981570|NCT03864042|588633094|FG002|DDI Phase|Adverse Event|0|||
162981571|NCT03864042|588633092|FG000|DDI Phase|Physician Decision|1|||
162981572|NCT03864042|588633093|FG001|DDI Phase|Physician Decision|0|||
162981573|NCT03864042|588633094|FG002|DDI Phase|Physician Decision|0|||
162981574|NCT03864042|588633092|FG000|DDI Phase|Progressive Disease|1|||
162981575|NCT03864042|588633093|FG001|DDI Phase|Progressive Disease|0|||
162981576|NCT03864042|588633094|FG002|DDI Phase|Progressive Disease|0|||
162981577|NCT03864042|588633092|FG000|Post-DDI Phase|Adverse Event|5|||
162981578|NCT03864042|588633093|FG001|Post-DDI Phase|Adverse Event|3|||
162981579|NCT03864042|588633094|FG002|Post-DDI Phase|Adverse Event|2|||
162981580|NCT03864042|588633092|FG000|Post-DDI Phase|Progressive Disease|11|||
162981581|NCT03864042|588633093|FG001|Post-DDI Phase|Progressive Disease|6|||
162981582|NCT03864042|588633094|FG002|Post-DDI Phase|Progressive Disease|13|||
162981583|NCT03864042|588633092|FG000|Post-DDI Phase|Discretion of investigator|1|||
162981584|NCT03864042|588633093|FG001|Post-DDI Phase|Discretion of investigator|1|||
162981585|NCT03864042|588633094|FG002|Post-DDI Phase|Discretion of investigator|0|||
162981586|NCT03864042|588633092|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
162981587|NCT03864042|588633093|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
162981588|NCT03864042|588633094|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
162981589|NCT03864042|588633092|FG000|Post-DDI Phase|Withdrawal of consent|1|||
163059115|NCT01288430|588926298|FG006|Part 2|Clinical disease progression|0|||
163059116|NCT01288430|588926299|FG007|Part 2|Clinical disease progression|2|||
163059117|NCT01288430|588926300|FG008|Part 2|Clinical disease progression|0|||
163059118|NCT01288430|588926301|FG009|Part 2|Clinical disease progression|0|||
163059119|NCT01288430|588926292|FG000|Part 2|Withdrawal by Subject|0|||
163320674|NCT04605159|589885981|FG001|Overall Study|Migrated / moved from the study area|22|||
163320675|NCT04605159|589885982|FG002|Overall Study|Migrated / moved from the study area|41|||
163320676|NCT04605159|589885983|FG003|Overall Study|Migrated / moved from the study area|21|||
163320677|NCT04605159|589885980|FG000|Overall Study|Other|1|||
162981590|NCT03864042|588633093|FG001|Post-DDI Phase|Withdrawal of consent|2|||
162981591|NCT03864042|588633094|FG002|Post-DDI Phase|Withdrawal of consent|0|||
162981592|NCT00766831|588633099|FG000|Overall Study|Withdrawal by Subject|4|||
162981593|NCT00766831|588633099|FG000|Overall Study|Lost to Follow-up|3|||
163320678|NCT04605159|589885981|FG001|Overall Study|Other|2|||
163320679|NCT04605159|589885982|FG002|Overall Study|Other|7|||
162981594|NCT00766831|588633099|FG000|Overall Study|Adverse Event|20|||
162981595|NCT00766831|588633099|FG000|Overall Study|Protocol Violation|15|||
162981596|NCT00766831|588633099|FG000|Overall Study|Physician Decision|5|||
162981597|NCT00766831|588633099|FG000|Overall Study|Withdrawal of consent|26|||
162981598|NCT00766831|588633099|FG000|Overall Study|Non cooperation by participants|14|||
162981599|NCT00766831|588633099|FG000|Overall Study|Other|28|||
162981600|NCT00515034|588633102|FG000|Overall Study|Adverse Event|2|||
162981601|NCT00515034|588633103|FG001|Overall Study|Adverse Event|0|||
162981602|NCT00515034|588633104|FG002|Overall Study|Adverse Event|1|||
162981603|NCT00515034|588633105|FG003|Overall Study|Adverse Event|0|||
162981604|NCT00515034|588633102|FG000|Overall Study|Death|4|||
162981605|NCT00515034|588633103|FG001|Overall Study|Death|2|||
162981606|NCT00515034|588633104|FG002|Overall Study|Death|1|||
162981607|NCT00515034|588633105|FG003|Overall Study|Death|3|||
163320680|NCT04605159|589885983|FG003|Overall Study|Other|3|||
163320681|NCT02323880|589885984|FG000|Overall Study|Adverse Event|2|||
163320682|NCT02323880|589885985|FG001|Overall Study|Adverse Event|0|||
163320683|NCT02323880|589885986|FG002|Overall Study|Adverse Event|1|||
163320684|NCT02323880|589885987|FG003|Overall Study|Adverse Event|1|||
163320685|NCT02323880|589885988|FG004|Overall Study|Adverse Event|1|||
163320686|NCT02323880|589885989|FG005|Overall Study|Adverse Event|0|||
163320687|NCT02323880|589885990|FG006|Overall Study|Adverse Event|1|||
163320688|NCT02323880|589885991|FG007|Overall Study|Adverse Event|0|||
163320689|NCT02323880|589885984|FG000|Overall Study|Death|0|||
163320690|NCT02323880|589885985|FG001|Overall Study|Death|0|||
163320691|NCT02323880|589885986|FG002|Overall Study|Death|0|||
163320692|NCT02323880|589885987|FG003|Overall Study|Death|0|||
163320693|NCT02323880|589885988|FG004|Overall Study|Death|0|||
163320694|NCT02323880|589885989|FG005|Overall Study|Death|1|||
163320695|NCT02323880|589885990|FG006|Overall Study|Death|0|||
163320696|NCT02323880|589885991|FG007|Overall Study|Death|0|||
163320697|NCT02323880|589885984|FG000|Overall Study|Lack of Efficacy|4|||
163320698|NCT02323880|589885985|FG001|Overall Study|Lack of Efficacy|11|||
163320699|NCT02323880|589885986|FG002|Overall Study|Lack of Efficacy|5|||
163320700|NCT02323880|589885987|FG003|Overall Study|Lack of Efficacy|5|||
163320701|NCT02323880|589885988|FG004|Overall Study|Lack of Efficacy|4|||
163320702|NCT02323880|589885989|FG005|Overall Study|Lack of Efficacy|8|||
163320703|NCT02323880|589885990|FG006|Overall Study|Lack of Efficacy|4|||
163320704|NCT02323880|589885991|FG007|Overall Study|Lack of Efficacy|6|||
163320705|NCT02323880|589885984|FG000|Overall Study|Physician Decision|0|||
163320706|NCT02323880|589885985|FG001|Overall Study|Physician Decision|0|||
163320707|NCT02323880|589885986|FG002|Overall Study|Physician Decision|0|||
163320708|NCT02323880|589885987|FG003|Overall Study|Physician Decision|0|||
163320709|NCT02323880|589885988|FG004|Overall Study|Physician Decision|1|||
163320710|NCT02323880|589885989|FG005|Overall Study|Physician Decision|1|||
163320711|NCT02323880|589885990|FG006|Overall Study|Physician Decision|1|||
163320712|NCT02323880|589885991|FG007|Overall Study|Physician Decision|0|||
163320713|NCT02323880|589885984|FG000|Overall Study|Withdrawal by Subject|0|||
163320714|NCT02323880|589885985|FG001|Overall Study|Withdrawal by Subject|2|||
163320715|NCT02323880|589885986|FG002|Overall Study|Withdrawal by Subject|0|||
163320716|NCT02323880|589885987|FG003|Overall Study|Withdrawal by Subject|0|||
163320717|NCT02323880|589885988|FG004|Overall Study|Withdrawal by Subject|0|||
163320718|NCT02323880|589885989|FG005|Overall Study|Withdrawal by Subject|0|||
163320719|NCT02323880|589885990|FG006|Overall Study|Withdrawal by Subject|0|||
163320720|NCT02323880|589885991|FG007|Overall Study|Withdrawal by Subject|0|||
163320721|NCT04934072|589885993|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
163320722|NCT04934072|589885994|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
163320723|NCT04934072|589885995|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
163320724|NCT04934072|589885996|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
163320725|NCT04934072|589885997|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
163320726|NCT04934072|589885993|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
163320727|NCT04934072|589885994|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
163320728|NCT04934072|589885995|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
163320729|NCT04934072|589885996|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
163320730|NCT04934072|589885997|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
163320731|NCT04934072|589885993|FG000|Day 0 to Week 52|Other|3|||
163320732|NCT04934072|589885994|FG001|Day 0 to Week 52|Other|1|||
163320733|NCT04934072|589885995|FG002|Day 0 to Week 52|Other|0|||
163320734|NCT04934072|589885996|FG003|Day 0 to Week 52|Other|0|||
163320735|NCT04934072|589885997|FG004|Day 0 to Week 52|Other|0|||
163320736|NCT04934072|589885993|FG000|Day 0 to Week 52|Adverse Event|1|||
162981608|NCT00515034|588633102|FG000|Overall Study|Withdrawal by Subject|1|||
162981609|NCT00515034|588633103|FG001|Overall Study|Withdrawal by Subject|0|||
162981610|NCT00515034|588633104|FG002|Overall Study|Withdrawal by Subject|3|||
162981611|NCT00515034|588633105|FG003|Overall Study|Withdrawal by Subject|0|||
162981612|NCT00515034|588633102|FG000|Overall Study|Physician Decision|0|||
163320737|NCT04934072|589885994|FG001|Day 0 to Week 52|Adverse Event|3|||
163320738|NCT04934072|589885995|FG002|Day 0 to Week 52|Adverse Event|0|||
163320739|NCT04934072|589885996|FG003|Day 0 to Week 52|Adverse Event|0|||
163320740|NCT04934072|589885997|FG004|Day 0 to Week 52|Adverse Event|0|||
163320741|NCT04934072|589885993|FG000|Week 52 to Week 78|Adverse Event|0|||
163320742|NCT04934072|589885994|FG001|Week 52 to Week 78|Adverse Event|0|||
163320743|NCT04934072|589885995|FG002|Week 52 to Week 78|Adverse Event|0|||
163320744|NCT04934072|589885996|FG003|Week 52 to Week 78|Adverse Event|1|||
163320745|NCT04934072|589885997|FG004|Week 52 to Week 78|Adverse Event|1|||
163320746|NCT04934072|589885993|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
163320747|NCT04934072|589885994|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
163320748|NCT04934072|589885995|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
163320749|NCT04934072|589885996|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
163320750|NCT04934072|589885997|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
163320751|NCT04934072|589885993|FG000|Week 52 to Week 78|Other|0|||
163320752|NCT04934072|589885994|FG001|Week 52 to Week 78|Other|0|||
163320753|NCT04934072|589885995|FG002|Week 52 to Week 78|Other|1|||
163320754|NCT04934072|589885996|FG003|Week 52 to Week 78|Other|0|||
162981613|NCT00515034|588633103|FG001|Overall Study|Physician Decision|0|||
163320755|NCT04934072|589885997|FG004|Week 52 to Week 78|Other|0|||
163320756|NCT05424380|589886000|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
163320757|NCT05424380|589886001|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
163320758|NCT05424380|589886002|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
163320759|NCT05424380|589886003|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
163320760|NCT05424380|589886004|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
163320761|NCT05424380|589886005|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
163320762|NCT05424380|589886000|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
163320763|NCT05424380|589886001|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
163320764|NCT05424380|589886002|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
163320765|NCT05424380|589886003|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
163320766|NCT05424380|589886004|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
163320767|NCT05424380|589886005|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
163320768|NCT05424380|589886000|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
163320769|NCT05424380|589886001|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
163320770|NCT05424380|589886002|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
163320771|NCT05424380|589886003|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
163320772|NCT05424380|589886004|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
163320773|NCT05424380|589886005|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
163320774|NCT05424380|589886000|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
163320775|NCT05424380|589886001|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
163320776|NCT05424380|589886002|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
163320777|NCT05424380|589886003|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
163320778|NCT05424380|589886004|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
163320779|NCT05424380|589886005|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
163320780|NCT05424380|589886000|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
163320781|NCT05424380|589886001|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
163320782|NCT05424380|589886002|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
163320783|NCT05424380|589886003|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
163320784|NCT05424380|589886004|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
163320785|NCT05424380|589886005|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
163320786|NCT05424380|589886000|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
163320787|NCT05424380|589886001|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
163320788|NCT05424380|589886002|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
163320789|NCT05424380|589886003|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
163320790|NCT05424380|589886004|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
163320791|NCT05424380|589886005|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
163320792|NCT05424380|589886000|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
163320793|NCT05424380|589886001|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
163320794|NCT05424380|589886002|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
163320795|NCT05424380|589886003|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
163320796|NCT05424380|589886004|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
163320797|NCT05424380|589886005|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
163320798|NCT05424380|589886000|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
163320799|NCT05424380|589886001|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
163320800|NCT05424380|589886002|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
163320801|NCT05424380|589886003|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
163320802|NCT05424380|589886004|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
163320803|NCT05424380|589886005|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
163320804|NCT05424380|589886000|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163320805|NCT05424380|589886001|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163320806|NCT05424380|589886002|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163320807|NCT05424380|589886003|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
163320808|NCT05424380|589886004|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163320809|NCT05424380|589886005|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163320810|NCT05424380|589886000|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
163320811|NCT05424380|589886001|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
163320812|NCT05424380|589886002|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
163320813|NCT05424380|589886003|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
163320814|NCT05424380|589886004|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
163320815|NCT05424380|589886005|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
163320816|NCT05424380|589886000|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
163320817|NCT05424380|589886001|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
163320818|NCT05424380|589886002|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
163320819|NCT05424380|589886003|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
163402706|NCT00122681|590187000|FG000|Overall Study|Withdrawal by Subject|257|||
162981614|NCT00515034|588633104|FG002|Overall Study|Physician Decision|1|||
162981615|NCT00515034|588633105|FG003|Overall Study|Physician Decision|1|||
162981616|NCT00515034|588633102|FG000|Overall Study|Other|1|||
162981617|NCT00515034|588633103|FG001|Overall Study|Other|0|||
162981618|NCT00515034|588633104|FG002|Overall Study|Other|2|||
162981619|NCT00515034|588633105|FG003|Overall Study|Other|1|||
162981620|NCT03487848|588633106|FG000|Overall Study|Lost to Follow-up|1|||
162981621|NCT00094094|588633107|FG000|Overall Study|Death|2|||
162981622|NCT00094094|588633107|FG000|Overall Study|Lack of Efficacy|23|||
162981623|NCT00094094|588633107|FG000|Overall Study|Adverse Event|7|||
162981624|NCT04189445|588634452|FG000|Overall Study|Withdrawal of consent|8|||
162981625|NCT04189445|588634453|FG001|Overall Study|Withdrawal of consent|1|||
162981626|NCT04189445|588634454|FG002|Overall Study|Withdrawal of consent|0|||
162981627|NCT04189445|588634452|FG000|Overall Study|Study Terminated by Sponsor|25|||
162981628|NCT04189445|588634453|FG001|Overall Study|Study Terminated by Sponsor|3|||
162981629|NCT04189445|588634454|FG002|Overall Study|Study Terminated by Sponsor|0|||
162981630|NCT04189445|588634452|FG000|Overall Study|Death|54|||
162981631|NCT04189445|588634453|FG001|Overall Study|Death|24|||
162981632|NCT04189445|588634454|FG002|Overall Study|Death|0|||
162981633|NCT00003138|588634455|FG000|Step 1|Reasons off treatment not documented|60|||
162981634|NCT00003138|588634456|FG001|Step 1|Reasons off treatment not documented|57|||
162981635|NCT00003138|588634455|FG000|Step 1|Never started treatment|1|||
162981636|NCT00003138|588634456|FG001|Step 1|Never started treatment|0|||
162981637|NCT00003138|588634455|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
162981638|NCT00003138|588634456|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
162981639|NCT00003138|588634455|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
162981640|NCT00003138|588634456|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
162981641|NCT00003138|588634455|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
162981642|NCT00003138|588634456|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
162981643|NCT00003138|588634455|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
162981644|NCT00003138|588634456|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
162981645|NCT05142566|588634457|FG000|Overall Study|Protocol Violation|1|||
162981646|NCT04556552|588634458|FG000|Overall Study|Lost to Follow-up|1|||
162981647|NCT04556552|588634459|FG001|Overall Study|Lost to Follow-up|0|||
162981648|NCT04556552|588634458|FG000|Overall Study|Claustrophobia|0|||
162981649|NCT04556552|588634459|FG001|Overall Study|Claustrophobia|1|||
162981650|NCT04556552|588634458|FG000|Overall Study|Inability to continue|0|||
162981651|NCT04556552|588634459|FG001|Overall Study|Inability to continue|1|||
162981652|NCT00605865|588634460|FG000|Overall Study|Protocol Violation|115|||
162981653|NCT02856880|588634466|FG000|Overall Study|Withdrawal of consent|1|||
162981654|NCT00094458|588634467|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
162981655|NCT00094458|588634468|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
162981656|NCT00094458|588634469|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
162981657|NCT00094458|588634470|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
162981658|NCT00094458|588634471|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
162981659|NCT00094458|588634472|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
162981660|NCT00094458|588634467|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
162981661|NCT00094458|588634468|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
162981662|NCT00094458|588634469|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
162981663|NCT00094458|588634470|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
162981664|NCT00094458|588634471|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
162981665|NCT00094458|588634472|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
162981666|NCT00094458|588634467|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
162981667|NCT00094458|588634468|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
162981668|NCT00094458|588634469|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
162981669|NCT00094458|588634470|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
162981670|NCT00094458|588634471|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
162981671|NCT00094458|588634472|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
162981672|NCT00094458|588634467|FG000|Main Study: Through Week 30|Adverse Event|38|||
162981673|NCT00094458|588634468|FG001|Main Study: Through Week 30|Adverse Event|20|||
162981674|NCT00094458|588634469|FG002|Main Study: Through Week 30|Adverse Event|28|||
162981675|NCT00094458|588634470|FG003|Main Study: Through Week 30|Adverse Event|0|||
162981676|NCT00094458|588634471|FG004|Main Study: Through Week 30|Adverse Event|0|||
162981677|NCT00094458|588634472|FG005|Main Study: Through Week 30|Adverse Event|0|||
162981678|NCT00094458|588634467|FG000|Main Study: Through Week 30|Death|1|||
162981679|NCT00094458|588634468|FG001|Main Study: Through Week 30|Death|0|||
162981680|NCT00094458|588634469|FG002|Main Study: Through Week 30|Death|0|||
162981681|NCT00094458|588634470|FG003|Main Study: Through Week 30|Death|0|||
162981682|NCT00094458|588634471|FG004|Main Study: Through Week 30|Death|0|||
162981683|NCT00094458|588634472|FG005|Main Study: Through Week 30|Death|0|||
162981684|NCT00094458|588634467|FG000|Main Study: Through Week 30|Other|19|||
162981685|NCT00094458|588634468|FG001|Main Study: Through Week 30|Other|16|||
162981686|NCT00094458|588634469|FG002|Main Study: Through Week 30|Other|9|||
162981687|NCT00094458|588634470|FG003|Main Study: Through Week 30|Other|0|||
162981688|NCT00094458|588634471|FG004|Main Study: Through Week 30|Other|0|||
162981689|NCT00094458|588634472|FG005|Main Study: Through Week 30|Other|0|||
163320820|NCT05424380|589886004|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
163320821|NCT05424380|589886005|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
163320822|NCT05424380|589886000|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
163320823|NCT05424380|589886001|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
163320824|NCT05424380|589886002|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
163320825|NCT05424380|589886003|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
163320826|NCT05424380|589886004|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
163320827|NCT05424380|589886005|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
163320828|NCT05424380|589886000|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163320829|NCT05424380|589886001|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163320830|NCT05424380|589886002|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163320831|NCT05424380|589886003|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163320832|NCT05424380|589886004|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
163320833|NCT05424380|589886005|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163320834|NCT05424380|589886000|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
163320835|NCT05424380|589886001|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
163320836|NCT05424380|589886002|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
163320837|NCT05424380|589886003|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
163320838|NCT05424380|589886004|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
163320839|NCT05424380|589886005|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
163320840|NCT03213678|589886011|FG000|Overall Study|Death|1|||
163320841|NCT03213678|589886011|FG000|Overall Study|Physician Decision|1|||
163320842|NCT03213678|589886011|FG000|Overall Study|Progressive disease|16|||
163320843|NCT04218851|589886012|FG000|Overall Study|Death|1|||
163320844|NCT04218851|589886013|FG001|Overall Study|Death|3|||
163320845|NCT03174275|589886014|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
163320846|NCT03174275|589886014|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
163320847|NCT03174275|589886014|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
163320848|NCT03174275|589886014|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
163320849|NCT03174275|589886014|FG000|Adjuvant Chemotherapy|Progression|1|||
163320850|NCT03174275|589886014|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
163320851|NCT03174275|589886014|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
163320852|NCT03174275|589886014|FG000|Adjuvant Durvalumab|Progression|1|||
163320853|NCT03174275|589886014|FG000|Adjuvant Durvalumab|Adverse Event|3|||
163320854|NCT03174275|589886014|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
163320855|NCT03174275|589886014|FG000|Adjuvant Radiotherapy|Progression|1|||
163320856|NCT03174275|589886014|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
163320857|NCT02413489|589886015|FG000|Overall Study|Death|11|||
163320858|NCT02413489|589886016|FG001|Overall Study|Death|3|||
163320859|NCT02413489|589886017|FG002|Overall Study|Death|4|||
163320860|NCT02413489|589886015|FG000|Overall Study|Withdrawal by Subject|2|||
163320861|NCT02413489|589886016|FG001|Overall Study|Withdrawal by Subject|0|||
163320862|NCT02413489|589886017|FG002|Overall Study|Withdrawal by Subject|0|||
163320863|NCT02413489|589886015|FG000|Overall Study|Study Terminated By Sponsor|2|||
163320864|NCT02413489|589886016|FG001|Overall Study|Study Terminated By Sponsor|13|||
163320865|NCT02413489|589886017|FG002|Overall Study|Study Terminated By Sponsor|1|||
163320866|NCT03717935|589886018|FG000|Overall Study|Withdrawal by Subject|0|||
162981690|NCT00094458|588634467|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
162981691|NCT00094458|588634468|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
162981692|NCT00094458|588634469|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
163211364|NCT01339429|589488855|FG000|Overall Study|Physician Decision|3|||
163211365|NCT00459667|589488856|FG000|Overall Study|Adverse Event|9|||
163211366|NCT00459667|589488857|FG001|Overall Study|Adverse Event|12|||
163211367|NCT00459667|589488858|FG002|Overall Study|Adverse Event|8|||
163211368|NCT00459667|589488856|FG000|Overall Study|Lost to Follow-up|5|||
163211369|NCT00459667|589488857|FG001|Overall Study|Lost to Follow-up|9|||
163211370|NCT00459667|589488858|FG002|Overall Study|Lost to Follow-up|3|||
163211371|NCT00459667|589488856|FG000|Overall Study|Pregnancy|1|||
163211372|NCT00459667|589488857|FG001|Overall Study|Pregnancy|1|||
163211373|NCT00459667|589488858|FG002|Overall Study|Pregnancy|1|||
163211374|NCT00459667|589488856|FG000|Overall Study|Protocol Violation|1|||
163211375|NCT00459667|589488857|FG001|Overall Study|Protocol Violation|0|||
163211376|NCT00459667|589488858|FG002|Overall Study|Protocol Violation|0|||
163211377|NCT00459667|589488856|FG000|Overall Study|Withdrawal by Subject|3|||
163211378|NCT00459667|589488857|FG001|Overall Study|Withdrawal by Subject|5|||
163211379|NCT00459667|589488858|FG002|Overall Study|Withdrawal by Subject|5|||
163211380|NCT00459667|589488856|FG000|Overall Study|Other disease modifying treatment|1|||
163211381|NCT00459667|589488857|FG001|Overall Study|Other disease modifying treatment|2|||
163211382|NCT00459667|589488858|FG002|Overall Study|Other disease modifying treatment|1|||
163211383|NCT00459667|589488856|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
163320867|NCT03717935|589886019|FG001|Overall Study|Withdrawal by Subject|2|||
163320868|NCT05970861|589886020|FG000|Overall Study|Physician Decision|4|||
163320869|NCT05970861|589886021|FG001|Overall Study|Physician Decision|4|||
163320870|NCT05970861|589886020|FG000|Overall Study|Lost to Follow-up|4|||
163320871|NCT05970861|589886021|FG001|Overall Study|Lost to Follow-up|3|||
163320872|NCT04456296|589886022|FG000|Overall Study|Withdrawal by Subject|14|||
163320873|NCT04456296|589886023|FG001|Overall Study|Withdrawal by Subject|21|||
163320874|NCT04456296|589886024|FG002|Overall Study|Withdrawal by Subject|21|||
163320875|NCT04456296|589886022|FG000|Overall Study|Adverse Event|2|||
163320876|NCT04456296|589886023|FG001|Overall Study|Adverse Event|2|||
163320877|NCT04456296|589886024|FG002|Overall Study|Adverse Event|2|||
163320878|NCT04456296|589886022|FG000|Overall Study|Death|1|||
163320879|NCT04456296|589886023|FG001|Overall Study|Death|0|||
163320880|NCT04456296|589886024|FG002|Overall Study|Death|0|||
163320881|NCT04456296|589886022|FG000|Overall Study|Lost to Follow-up|3|||
163320882|NCT04456296|589886023|FG001|Overall Study|Lost to Follow-up|5|||
163320883|NCT04456296|589886024|FG002|Overall Study|Lost to Follow-up|6|||
163320884|NCT04456296|589886022|FG000|Overall Study|Other than specified|0|||
163320885|NCT04456296|589886023|FG001|Overall Study|Other than specified|1|||
163320886|NCT04456296|589886024|FG002|Overall Study|Other than specified|4|||
163320887|NCT04456296|589886022|FG000|Overall Study|Randomized, not treated|2|||
163320888|NCT04456296|589886023|FG001|Overall Study|Randomized, not treated|1|||
163320889|NCT04456296|589886024|FG002|Overall Study|Randomized, not treated|0|||
163320890|NCT05736458|589886025|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
163320891|NCT05736458|589886026|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
163320892|NCT05736458|589886027|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
163320893|NCT05736458|589886025|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
163320894|NCT05736458|589886026|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
163320895|NCT05736458|589886027|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
163320896|NCT05736458|589886025|FG000|TMS/fMRI #1|Physician Decision|0|||
163320897|NCT05736458|589886026|FG001|TMS/fMRI #1|Physician Decision|0|||
163320898|NCT05736458|589886027|FG002|TMS/fMRI #1|Physician Decision|2|||
163320899|NCT05736458|589886025|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
163320900|NCT05736458|589886026|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
163320901|NCT05736458|589886027|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
163320902|NCT02990338|589886028|FG000|Overall Study|Randomized and not treated|4|||
163320903|NCT02990338|589886029|FG001|Overall Study|Randomized and not treated|2|||
163320904|NCT02990338|589886028|FG000|Overall Study|Adverse Event|23|||
163320905|NCT02990338|589886029|FG001|Overall Study|Adverse Event|22|||
163320906|NCT02990338|589886028|FG000|Overall Study|Progressive disease|118|||
163320907|NCT02990338|589886029|FG001|Overall Study|Progressive disease|107|||
163320908|NCT02990338|589886028|FG000|Overall Study|Poor compliance to protocol|0|||
163320909|NCT02990338|589886029|FG001|Overall Study|Poor compliance to protocol|1|||
163320910|NCT02990338|589886028|FG000|Overall Study|Withdrawal by Subject|6|||
163320911|NCT02990338|589886029|FG001|Overall Study|Withdrawal by Subject|8|||
163320912|NCT02990338|589886028|FG000|Overall Study|Physician's decision|2|||
163320913|NCT02990338|589886029|FG001|Overall Study|Physician's decision|6|||
163320914|NCT02990338|589886028|FG000|Overall Study|Treatment extension study|0|||
163320915|NCT02990338|589886029|FG001|Overall Study|Treatment extension study|6|||
163320916|NCT02990338|589886028|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
163320917|NCT02990338|589886029|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
163320918|NCT02990338|589886028|FG000|Overall Study|Continue with therapy available commercially|0|||
163320919|NCT02990338|589886029|FG001|Overall Study|Continue with therapy available commercially|1|||
163320920|NCT05100628|589886035|FG000|Overall Study|Progressive Disease|1|||
163320921|NCT05100628|589886036|FG001|Overall Study|Progressive Disease|0|||
163320922|NCT05100628|589886037|FG002|Overall Study|Progressive Disease|0|||
163320923|NCT05100628|589886038|FG003|Overall Study|Progressive Disease|0|||
163320924|NCT05100628|589886035|FG000|Overall Study|Study Terminated by Sponsor|0|||
163320925|NCT05100628|589886036|FG001|Overall Study|Study Terminated by Sponsor|0|||
163320926|NCT05100628|589886037|FG002|Overall Study|Study Terminated by Sponsor|3|||
163320927|NCT05100628|589886038|FG003|Overall Study|Study Terminated by Sponsor|0|||
163320928|NCT05100628|589886035|FG000|Overall Study|unkown|0|||
163320929|NCT05100628|589886036|FG001|Overall Study|unkown|1|||
163320930|NCT05100628|589886037|FG002|Overall Study|unkown|0|||
163320931|NCT05100628|589886038|FG003|Overall Study|unkown|0|||
163320932|NCT03914469|589886039|FG000|Overall Study|Lost to Follow-up|1|||
163320933|NCT03914469|589886040|FG001|Overall Study|Lost to Follow-up|4|||
163320934|NCT03334695|589886053|FG000|Overall Study|Lost to Follow-up|3|||
163320935|NCT03334695|589886054|FG001|Overall Study|Lost to Follow-up|3|||
163320936|NCT03334695|589886053|FG000|Overall Study|Physician Decision|1|||
163320937|NCT03334695|589886054|FG001|Overall Study|Physician Decision|2|||
163320938|NCT03334695|589886053|FG000|Overall Study|Protocol Violation|0|||
163320939|NCT03334695|589886054|FG001|Overall Study|Protocol Violation|1|||
163320940|NCT00721149|589886055|FG000|Overall Study|Physician Decision|1|||
163320941|NCT04614948|589886058|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
163320942|NCT04614948|589886059|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
163320943|NCT04614948|589886060|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
163320944|NCT04614948|589886058|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
163320945|NCT04614948|589886059|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
163320946|NCT04614948|589886060|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
163320947|NCT04614948|589886058|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
163320948|NCT04614948|589886059|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
163320949|NCT04614948|589886060|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
163320950|NCT04614948|589886058|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
163320951|NCT04614948|589886059|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
163320952|NCT04614948|589886060|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
163320953|NCT04614948|589886058|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
163320954|NCT04614948|589886059|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
163320955|NCT04614948|589886060|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
163320956|NCT04614948|589886058|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
163320957|NCT04614948|589886059|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
163320958|NCT04614948|589886060|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
163320959|NCT04614948|589886058|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
163320960|NCT04614948|589886059|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
163320961|NCT04614948|589886060|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
163320962|NCT04614948|589886058|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
163320963|NCT04614948|589886059|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
163320964|NCT04614948|589886060|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
163320965|NCT04614948|589886058|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
163320966|NCT04614948|589886059|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
163320967|NCT04614948|589886060|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
163320968|NCT04614948|589886058|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
163320969|NCT04614948|589886059|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
163320970|NCT04614948|589886060|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
163320971|NCT04614948|589886058|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
163320972|NCT04614948|589886059|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
163320973|NCT04614948|589886060|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
163320974|NCT04614948|589886058|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
163320975|NCT04614948|589886059|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
163320976|NCT04614948|589886060|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
163320977|NCT04614948|589886058|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
163320978|NCT04614948|589886059|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
163320979|NCT04614948|589886060|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
163320980|NCT04614948|589886058|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
163320981|NCT04614948|589886059|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
163320982|NCT04614948|589886060|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
163320983|NCT04614948|589886058|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
163320984|NCT04614948|589886059|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
163320985|NCT04614948|589886060|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
163320986|NCT04614948|589886058|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
163320987|NCT04614948|589886059|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
163320988|NCT04614948|589886060|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
163320989|NCT04614948|589886058|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
163320990|NCT04614948|589886059|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
163320991|NCT04614948|589886060|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
163320992|NCT04614948|589886058|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
163320993|NCT04614948|589886059|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
163320994|NCT04614948|589886060|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
163320995|NCT04614948|589886058|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
163320996|NCT04614948|589886059|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
163320997|NCT04614948|589886060|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
163320998|NCT04614948|589886058|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
163320999|NCT04614948|589886059|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
163321000|NCT04614948|589886060|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
163321001|NCT04614948|589886058|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
163321002|NCT04614948|589886059|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
163321003|NCT04614948|589886060|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
163321004|NCT04614948|589886058|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
163321005|NCT04614948|589886059|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
163321006|NCT04614948|589886060|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
163321007|NCT04614948|589886058|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
163321008|NCT04614948|589886059|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
163402707|NCT00122681|590187001|FG001|Overall Study|Withdrawal by Subject|251|||
163402708|NCT00122681|590187000|FG000|Overall Study|Personal reasons|150|||
163321009|NCT04614948|589886060|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
163321010|NCT04271046|589886061|FG000|Overall Study|Death|0|||
163321011|NCT04271046|589886062|FG001|Overall Study|Death|2|||
163321012|NCT04271046|589886063|FG002|Overall Study|Death|0|||
163321013|NCT04271046|589886064|FG003|Overall Study|Death|2|||
163321014|NCT04271046|589886061|FG000|Overall Study|Lost to Follow-up|12|||
163321015|NCT04271046|589886062|FG001|Overall Study|Lost to Follow-up|12|||
163321016|NCT04271046|589886063|FG002|Overall Study|Lost to Follow-up|11|||
163321017|NCT04271046|589886064|FG003|Overall Study|Lost to Follow-up|11|||
163321018|NCT04271046|589886061|FG000|Overall Study|Patient with Dementia Died|2|||
163321019|NCT04271046|589886062|FG001|Overall Study|Patient with Dementia Died|0|||
163321020|NCT04271046|589886063|FG002|Overall Study|Patient with Dementia Died|2|||
163321021|NCT04271046|589886064|FG003|Overall Study|Patient with Dementia Died|0|||
163321022|NCT04271046|589886061|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
163321023|NCT04271046|589886062|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
163321024|NCT04271046|589886063|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
162981693|NCT00094458|588634470|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
162981694|NCT00094458|588634471|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
162981695|NCT00094458|588634472|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
162981696|NCT00094458|588634467|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
162981697|NCT00094458|588634468|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
162981698|NCT00094458|588634469|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
162981699|NCT00094458|588634470|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
162981700|NCT00094458|588634471|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
162981701|NCT00094458|588634472|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
162981702|NCT00094458|588634467|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
162981703|NCT00094458|588634468|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
162981704|NCT00094458|588634469|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
162981705|NCT00094458|588634470|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
163211384|NCT00459667|589488857|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
163211385|NCT00459667|589488858|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
163211386|NCT00459667|589488856|FG000|Overall Study|No treatment administered|6|||
163211387|NCT00459667|589488857|FG001|Overall Study|No treatment administered|3|||
163211388|NCT00459667|589488858|FG002|Overall Study|No treatment administered|1|||
163211389|NCT01013701|589488859|FG000|Overall Study|study prematurely terminated|7|||
163211390|NCT00556712|589488861|FG000|Overall Study|Adverse Event|7|||
163211391|NCT00556712|589488862|FG001|Overall Study|Adverse Event|19|||
163211392|NCT00556712|589488861|FG000|Overall Study|Death|5|||
163211393|NCT00556712|589488862|FG001|Overall Study|Death|10|||
163211394|NCT00556712|589488861|FG000|Overall Study|Progressive Disease|383|||
163211395|NCT00556712|589488862|FG001|Overall Study|Progressive Disease|320|||
163211396|NCT00556712|589488861|FG000|Overall Study|Protocol Violation|3|||
163211397|NCT00556712|589488862|FG001|Overall Study|Protocol Violation|2|||
163211398|NCT00556712|589488861|FG000|Overall Study|Refused Treatment|17|||
163211399|NCT00556712|589488862|FG001|Overall Study|Refused Treatment|16|||
163211400|NCT00556712|589488861|FG000|Overall Study|Failure to Return|2|||
163211401|NCT00556712|589488862|FG001|Overall Study|Failure to Return|3|||
163211402|NCT00556712|589488861|FG000|Overall Study|Other|2|||
163211403|NCT00556712|589488862|FG001|Overall Study|Other|2|||
163211404|NCT00556712|589488861|FG000|Overall Study|Ongoing at Data Cutoff|32|||
163211405|NCT00556712|589488862|FG001|Overall Study|Ongoing at Data Cutoff|66|||
163211406|NCT01059799|589488865|FG000|Overall Study|Adverse Event|2|||
163211407|NCT01059799|589488866|FG001|Overall Study|Adverse Event|3|||
163211408|NCT01059799|589488865|FG000|Overall Study|Lack of Efficacy|1|||
163211409|NCT01059799|589488866|FG001|Overall Study|Lack of Efficacy|0|||
163211410|NCT01059799|589488865|FG000|Overall Study|Protocol Violation|3|||
163211411|NCT01059799|589488866|FG001|Overall Study|Protocol Violation|2|||
163211412|NCT01059799|589488865|FG000|Overall Study|Withdrawal criteria|13|||
163211413|NCT01059799|589488866|FG001|Overall Study|Withdrawal criteria|2|||
163211414|NCT01059799|589488865|FG000|Overall Study|Other|12|||
163211415|NCT01059799|589488866|FG001|Overall Study|Other|3|||
163211416|NCT01361464|589488867|FG000|Overall Study|Death|1|||
163211417|NCT01361464|589488867|FG000|Overall Study|Withdrawal by Subject|2|||
163211418|NCT00818662|589488872|FG000|Overall Study|Adverse Event|5|||
163211419|NCT00818662|589488873|FG001|Overall Study|Adverse Event|14|||
163211420|NCT00818662|589488874|FG002|Overall Study|Adverse Event|4|||
163211421|NCT00818662|589488875|FG003|Overall Study|Adverse Event|3|||
163211422|NCT00818662|589488872|FG000|Overall Study|Withdrawal by Subject|5|||
163211423|NCT00818662|589488873|FG001|Overall Study|Withdrawal by Subject|4|||
163211424|NCT00818662|589488874|FG002|Overall Study|Withdrawal by Subject|2|||
163211425|NCT00818662|589488875|FG003|Overall Study|Withdrawal by Subject|2|||
163211426|NCT00818662|589488872|FG000|Overall Study|Death|1|||
163211427|NCT00818662|589488873|FG001|Overall Study|Death|3|||
163211428|NCT00818662|589488874|FG002|Overall Study|Death|0|||
163321025|NCT04271046|589886064|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
163059120|NCT01288430|588926293|FG001|Part 2|Withdrawal by Subject|0|||
163059121|NCT01288430|588926294|FG002|Part 2|Withdrawal by Subject|0|||
163059122|NCT01288430|588926295|FG003|Part 2|Withdrawal by Subject|0|||
163059123|NCT01288430|588926296|FG004|Part 2|Withdrawal by Subject|0|||
163059124|NCT01288430|588926297|FG005|Part 2|Withdrawal by Subject|0|||
163059125|NCT01288430|588926298|FG006|Part 2|Withdrawal by Subject|0|||
163059126|NCT01288430|588926299|FG007|Part 2|Withdrawal by Subject|1|||
163059127|NCT01288430|588926300|FG008|Part 2|Withdrawal by Subject|4|||
163059128|NCT01288430|588926301|FG009|Part 2|Withdrawal by Subject|0|||
163059129|NCT01288430|588926292|FG000|Part 2|Adverse Event|0|||
163059130|NCT01288430|588926293|FG001|Part 2|Adverse Event|0|||
163059131|NCT01288430|588926294|FG002|Part 2|Adverse Event|0|||
163059132|NCT01288430|588926295|FG003|Part 2|Adverse Event|0|||
163059133|NCT01288430|588926296|FG004|Part 2|Adverse Event|0|||
163059134|NCT01288430|588926297|FG005|Part 2|Adverse Event|0|||
163059135|NCT01288430|588926298|FG006|Part 2|Adverse Event|0|||
163059136|NCT01288430|588926299|FG007|Part 2|Adverse Event|1|||
163059137|NCT01288430|588926300|FG008|Part 2|Adverse Event|1|||
163059138|NCT01288430|588926301|FG009|Part 2|Adverse Event|0|||
163059139|NCT01288430|588926292|FG000|Part 2|Other|0|||
163059140|NCT01288430|588926293|FG001|Part 2|Other|0|||
163059141|NCT01288430|588926294|FG002|Part 2|Other|0|||
163059142|NCT01288430|588926295|FG003|Part 2|Other|0|||
163059143|NCT01288430|588926296|FG004|Part 2|Other|0|||
163059144|NCT01288430|588926297|FG005|Part 2|Other|0|||
163059145|NCT01288430|588926298|FG006|Part 2|Other|0|||
163059146|NCT01288430|588926299|FG007|Part 2|Other|0|||
163059147|NCT01288430|588926300|FG008|Part 2|Other|0|||
163059148|NCT01288430|588926301|FG009|Part 2|Other|1|||
163059149|NCT00788671|588926304|FG000|Overall Study|Death|2|||
163059150|NCT00788671|588926304|FG000|Overall Study|Unable to biopsy|1|||
163059151|NCT00788671|588926304|FG000|Overall Study|Withdrawal by Subject|4|||
163059152|NCT00788671|588926304|FG000|Overall Study|IUD expulsed|1|||
163059153|NCT00788671|588926304|FG000|Overall Study|Lost to follow up|2|||
163059154|NCT04780659|588926305|FG000|Overall Study|Adverse event, serious fatal|3|||
163059155|NCT04780659|588926306|FG001|Overall Study|Adverse event, serious fatal|0|||
163059156|NCT04780659|588926305|FG000|Overall Study|Withdrawal by Subject|3|||
163059157|NCT04780659|588926306|FG001|Overall Study|Withdrawal by Subject|0|||
163059158|NCT04780659|588926305|FG000|Overall Study|Physician Decision|1|||
163059159|NCT04780659|588926306|FG001|Overall Study|Physician Decision|0|||
163059160|NCT04780659|588926305|FG000|Overall Study|Died in original disease|2|||
163059161|NCT04780659|588926306|FG001|Overall Study|Died in original disease|0|||
163059162|NCT04780659|588926305|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
163059163|NCT04780659|588926306|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
163059164|NCT03729362|588926307|FG000|Overall Study|Withdrawal by Subject|2|||
163059165|NCT03729362|588926308|FG001|Overall Study|Withdrawal by Subject|0|||
163059166|NCT03729362|588926307|FG000|Overall Study|Physician Decision|1|||
163059167|NCT03729362|588926308|FG001|Overall Study|Physician Decision|0|||
163059168|NCT03729362|588926307|FG000|Overall Study|COVID-19 Pandemic|1|||
163059169|NCT03729362|588926308|FG001|Overall Study|COVID-19 Pandemic|0|||
163059170|NCT03729362|588926307|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
163059171|NCT03729362|588926308|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
163059172|NCT03729362|588926307|FG000|Overall Study|Adverse Event|0|||
163059173|NCT03729362|588926308|FG001|Overall Study|Adverse Event|1|||
163059174|NCT03729362|588926307|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
163059175|NCT03729362|588926308|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
163059176|NCT03405870|588926309|FG000|Overall Study|Withdrawal|1|||
163059177|NCT03405870|588926310|FG001|Overall Study|Withdrawal|0|||
163059178|NCT03405870|588926311|FG002|Overall Study|Withdrawal|1|||
163059179|NCT03405870|588926312|FG003|Overall Study|Withdrawal|0|||
163059180|NCT03405870|588926313|FG004|Overall Study|Withdrawal|0|||
163059181|NCT03405870|588926314|FG005|Overall Study|Withdrawal|0|||
163059182|NCT03405870|588926315|FG006|Overall Study|Withdrawal|1|||
163059183|NCT03405870|588926316|FG007|Overall Study|Withdrawal|0|||
163059184|NCT02807259|588926319|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
163059185|NCT02807259|588926320|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
163059186|NCT02807259|588926319|FG000|Midline (3 Months)|migration, refusal, not available|30|||
163059187|NCT02807259|588926320|FG001|Midline (3 Months)|migration, refusal, not available|34|||
163059188|NCT02807259|588926319|FG000|Endline (3 Months)|migration, refusal, not available|35|||
163059189|NCT02807259|588926320|FG001|Endline (3 Months)|migration, refusal, not available|87|||
163059190|NCT01171534|588926321|FG000|Overall Study|Lost to Follow-up|0|||
163059191|NCT01171534|588926322|FG001|Overall Study|Lost to Follow-up|2|||
163059192|NCT01171534|588926321|FG000|Overall Study|screen failure|0|||
163059193|NCT01171534|588926322|FG001|Overall Study|screen failure|1|||
163059194|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
163059195|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
163059196|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
163059197|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
163059198|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
163402709|NCT00122681|590187001|FG001|Overall Study|Personal reasons|147|||
163402710|NCT00783094|590187008|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
163402711|NCT00783094|590187009|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
163402712|NCT00783094|590187010|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
163402713|NCT00783094|590187008|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
163402714|NCT00783094|590187009|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
163402715|NCT00783094|590187010|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
163402716|NCT00783094|590187008|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
163402717|NCT00783094|590187009|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
163402718|NCT00783094|590187010|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
163402719|NCT00783094|590187008|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
163402720|NCT00783094|590187009|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
163402721|NCT00783094|590187010|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
163402722|NCT00783094|590187008|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
162981706|NCT00094458|588634471|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
162981707|NCT00094458|588634472|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
163211429|NCT00818662|589488875|FG003|Overall Study|Death|0|||
163211430|NCT00818662|589488872|FG000|Overall Study|Physician Decision|1|||
163321026|NCT01570361|589886065|FG000|Overall Study|Subject discontinued|1|||
163321027|NCT01570361|589886066|FG001|Overall Study|Subject discontinued|2|||
163321028|NCT01570361|589886065|FG000|Overall Study|Sponsor closing the study|51|||
163321029|NCT01570361|589886066|FG001|Overall Study|Sponsor closing the study|50|||
163321030|NCT01570361|589886065|FG000|Overall Study|Subject excluded|5|||
163321031|NCT01570361|589886066|FG001|Overall Study|Subject excluded|3|||
163321032|NCT01570361|589886065|FG000|Overall Study|Subject withdrew consent|14|||
163321033|NCT01570361|589886066|FG001|Overall Study|Subject withdrew consent|9|||
163321034|NCT01570361|589886065|FG000|Overall Study|Adverse Event|2|||
163321035|NCT01570361|589886066|FG001|Overall Study|Adverse Event|1|||
163321036|NCT01570361|589886065|FG000|Overall Study|Lost to Follow-up|4|||
163321037|NCT01570361|589886066|FG001|Overall Study|Lost to Follow-up|4|||
163321038|NCT01570361|589886065|FG000|Overall Study|Death|5|||
163321039|NCT01570361|589886066|FG001|Overall Study|Death|4|||
163321040|NCT01570361|589886065|FG000|Overall Study|Other|0|||
163321041|NCT01570361|589886066|FG001|Overall Study|Other|2|||
163402723|NCT00783094|590187009|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
163402724|NCT00783094|590187010|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
163402725|NCT00783094|590187008|FG000|Open-Label Extension Period|Adverse Event|12|||
163402726|NCT00783094|590187009|FG001|Open-Label Extension Period|Adverse Event|7|||
163402727|NCT00783094|590187010|FG002|Open-Label Extension Period|Adverse Event|16|||
163211431|NCT00818662|589488873|FG001|Overall Study|Physician Decision|0|||
163211432|NCT00818662|589488874|FG002|Overall Study|Physician Decision|0|||
163211433|NCT00818662|589488875|FG003|Overall Study|Physician Decision|0|||
163211434|NCT00818662|589488872|FG000|Overall Study|Lost to Follow-up|0|||
163211435|NCT00818662|589488873|FG001|Overall Study|Lost to Follow-up|0|||
163211436|NCT00818662|589488874|FG002|Overall Study|Lost to Follow-up|0|||
163211437|NCT00818662|589488875|FG003|Overall Study|Lost to Follow-up|1|||
163211438|NCT00818662|589488872|FG000|Overall Study|Unwilling or Unable to Participate|4|||
163211439|NCT00818662|589488873|FG001|Overall Study|Unwilling or Unable to Participate|6|||
163211440|NCT00818662|589488874|FG002|Overall Study|Unwilling or Unable to Participate|2|||
163211441|NCT00818662|589488875|FG003|Overall Study|Unwilling or Unable to Participate|4|||
163211442|NCT00818662|589488872|FG000|Overall Study|Protocol Violation|1|||
163211443|NCT00818662|589488873|FG001|Overall Study|Protocol Violation|1|||
163211444|NCT00818662|589488874|FG002|Overall Study|Protocol Violation|0|||
163211445|NCT00818662|589488875|FG003|Overall Study|Protocol Violation|0|||
163211446|NCT00818662|589488872|FG000|Overall Study|Requires a Prohibited Medication|1|||
163211447|NCT00818662|589488873|FG001|Overall Study|Requires a Prohibited Medication|0|||
163211448|NCT00818662|589488874|FG002|Overall Study|Requires a Prohibited Medication|0|||
163211449|NCT00818662|589488875|FG003|Overall Study|Requires a Prohibited Medication|0|||
163211450|NCT00818662|589488872|FG000|Overall Study|Safety Risk|1|||
163211451|NCT00818662|589488873|FG001|Overall Study|Safety Risk|1|||
163211452|NCT00818662|589488874|FG002|Overall Study|Safety Risk|0|||
163211453|NCT00818662|589488875|FG003|Overall Study|Safety Risk|1|||
163211454|NCT00818662|589488872|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
163211455|NCT00818662|589488873|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
163211456|NCT00818662|589488874|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
163211457|NCT00818662|589488875|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
163211458|NCT00818662|589488872|FG000|Overall Study|Participant's health declined|0|||
163211459|NCT00818662|589488873|FG001|Overall Study|Participant's health declined|0|||
163211460|NCT00818662|589488874|FG002|Overall Study|Participant's health declined|0|||
163211461|NCT00818662|589488875|FG003|Overall Study|Participant's health declined|1|||
163211462|NCT00818662|589488872|FG000|Overall Study|Caregiver to pursue other treatment|0|||
163211463|NCT00818662|589488873|FG001|Overall Study|Caregiver to pursue other treatment|1|||
163321042|NCT04129554|589886067|FG000|Overall Study|Withdrawal by Subject|4|||
162981708|NCT00094458|588634467|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
163321043|NCT04129554|589886068|FG001|Overall Study|Withdrawal by Subject|3|||
163321044|NCT04129554|589886067|FG000|Overall Study|Other|0|||
163321045|NCT04129554|589886068|FG001|Overall Study|Other|2|||
163321046|NCT05158504|589886069|FG000|Overall Study|Lost to Follow-up|2|||
163321047|NCT05158504|589886070|FG001|Overall Study|Lost to Follow-up|3|||
163321048|NCT03606512|589886073|FG000|Overall Study|Lost to Follow-up|0|||
163321049|NCT03606512|589886074|FG001|Overall Study|Lost to Follow-up|1|||
163321050|NCT03606512|589886073|FG000|Overall Study|'moved from study area|0|||
162981709|NCT00094458|588634468|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
162981710|NCT00094458|588634469|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
162981711|NCT00094458|588634470|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
162981712|NCT00094458|588634471|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
162981713|NCT00094458|588634472|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
162981714|NCT00094458|588634467|FG000|OLE: Open-Label Extension|Adverse Event|0|||
162981715|NCT00094458|588634468|FG001|OLE: Open-Label Extension|Adverse Event|0|||
162981716|NCT00094458|588634469|FG002|OLE: Open-Label Extension|Adverse Event|0|||
162981717|NCT00094458|588634470|FG003|OLE: Open-Label Extension|Adverse Event|0|||
162981718|NCT00094458|588634471|FG004|OLE: Open-Label Extension|Adverse Event|3|||
162981719|NCT00094458|588634472|FG005|OLE: Open-Label Extension|Adverse Event|4|||
162981720|NCT00094458|588634467|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
162981721|NCT00094458|588634468|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
162981722|NCT00094458|588634469|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
162981723|NCT00094458|588634470|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
162981724|NCT00094458|588634471|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
162981725|NCT00094458|588634472|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
162981726|NCT00094458|588634467|FG000|OLE: Open-Label Extension|Patient decision|0|||
162981727|NCT00094458|588634468|FG001|OLE: Open-Label Extension|Patient decision|0|||
162981728|NCT00094458|588634469|FG002|OLE: Open-Label Extension|Patient decision|0|||
162981729|NCT00094458|588634470|FG003|OLE: Open-Label Extension|Patient decision|0|||
162981730|NCT00094458|588634471|FG004|OLE: Open-Label Extension|Patient decision|1|||
162981731|NCT00094458|588634472|FG005|OLE: Open-Label Extension|Patient decision|0|||
162981732|NCT03247517|588634473|FG000|Overall Study|Adverse Event|0|||
162981733|NCT03247517|588634474|FG001|Overall Study|Adverse Event|4|||
162981734|NCT03247517|588634475|FG002|Overall Study|Adverse Event|2|||
162981735|NCT03247517|588634473|FG000|Overall Study|Lost to Follow-up|2|||
162981736|NCT03247517|588634474|FG001|Overall Study|Lost to Follow-up|6|||
162981737|NCT03247517|588634475|FG002|Overall Study|Lost to Follow-up|4|||
162981738|NCT03247517|588634473|FG000|Overall Study|Consent withdrawn by caregiver|1|||
162981739|NCT03247517|588634474|FG001|Overall Study|Consent withdrawn by caregiver|4|||
162981740|NCT03247517|588634475|FG002|Overall Study|Consent withdrawn by caregiver|7|||
162981741|NCT03247517|588634473|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
162981742|NCT03247517|588634474|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
162981743|NCT03247517|588634475|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
162981744|NCT03247517|588634473|FG000|Overall Study|Protocol Violation|0|||
162981745|NCT03247517|588634474|FG001|Overall Study|Protocol Violation|2|||
162981746|NCT03247517|588634475|FG002|Overall Study|Protocol Violation|0|||
162981747|NCT03247517|588634473|FG000|Overall Study|Multiple reasons|3|||
162981748|NCT03247517|588634474|FG001|Overall Study|Multiple reasons|1|||
162981749|NCT03247517|588634475|FG002|Overall Study|Multiple reasons|0|||
162981750|NCT03310411|588634476|FG000|Period 1|Adverse Event|0|||
162981751|NCT03310411|588634477|FG001|Period 1|Adverse Event|0|||
162981752|NCT03310411|588634478|FG002|Period 1|Adverse Event|0|||
162981753|NCT03310411|588634479|FG003|Period 1|Adverse Event|1|||
162981754|NCT03573505|588634480|FG000|Overall Study|Adverse Event|1|||
162981755|NCT03573505|588634481|FG001|Overall Study|Adverse Event|1|||
162981756|NCT03573505|588634480|FG000|Overall Study|Consent withdrawn|0|||
162981757|NCT03573505|588634481|FG001|Overall Study|Consent withdrawn|1|||
162981758|NCT03573505|588634480|FG000|Overall Study|Disease progression|0|||
163321051|NCT03606512|589886074|FG001|Overall Study|'moved from study area|1|||
163321052|NCT05513937|589886075|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
163402728|NCT00783094|590187008|FG000|Open-Label Extension Period|Death|0|||
162981759|NCT03573505|588634481|FG001|Overall Study|Disease progression|1|||
162981760|NCT03573505|588634480|FG000|Overall Study|Site Terminated by Sponsor|1|||
162981761|NCT03573505|588634481|FG001|Overall Study|Site Terminated by Sponsor|1|||
162981762|NCT03573505|588634480|FG000|Overall Study|Study terminated by sponsor|50|||
162981763|NCT03573505|588634481|FG001|Overall Study|Study terminated by sponsor|45|||
162981764|NCT03573505|588634480|FG000|Overall Study|Reason not specified|0|||
162981765|NCT03573505|588634481|FG001|Overall Study|Reason not specified|1|||
162981766|NCT03573505|588634480|FG000|Overall Study|Death|0|||
162981767|NCT03573505|588634481|FG001|Overall Study|Death|4|||
162981768|NCT00515541|588634482|FG000|Overall Study|Physician Decision|0|||
162981769|NCT00515541|588634483|FG001|Overall Study|Physician Decision|2|||
162981770|NCT00515541|588634484|FG002|Overall Study|Physician Decision|0|||
163321053|NCT05513937|589886076|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
163402729|NCT00783094|590187009|FG001|Open-Label Extension Period|Death|0|||
163402730|NCT00783094|590187010|FG002|Open-Label Extension Period|Death|1|||
163402731|NCT00783094|590187008|FG000|Open-Label Extension Period|Protocol Violation|4|||
163402732|NCT00783094|590187009|FG001|Open-Label Extension Period|Protocol Violation|5|||
163059199|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
163321054|NCT05513937|589886077|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
163321055|NCT05513937|589886078|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
163321056|NCT05513937|589886075|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
163321057|NCT05513937|589886076|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
163321058|NCT05513937|589886077|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
163321059|NCT05513937|589886078|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
163321060|NCT05513937|589886075|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
163321061|NCT05513937|589886076|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
163321062|NCT05513937|589886077|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
163321063|NCT05513937|589886078|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
163321064|NCT05513937|589886075|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
163321065|NCT05513937|589886076|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
163321066|NCT05513937|589886077|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
163321067|NCT05513937|589886078|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
163321068|NCT05513937|589886075|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
163321069|NCT05513937|589886076|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
163321070|NCT05513937|589886077|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
163321071|NCT05513937|589886078|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
163321072|NCT05513937|589886075|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
163321073|NCT05513937|589886076|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
163321074|NCT05513937|589886077|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
163321075|NCT05513937|589886078|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
163321076|NCT02846545|589886079|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
163321077|NCT02846545|589886080|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
163321078|NCT02846545|589886079|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
163321079|NCT02846545|589886080|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
163321080|NCT02846545|589886079|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
163321081|NCT02846545|589886080|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
163321082|NCT02846545|589886079|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
163321083|NCT02846545|589886080|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
163321084|NCT02846545|589886079|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
163321085|NCT02846545|589886080|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
163321086|NCT02326974|589886083|FG000|Overall Study|Withdrawal by Subject|2|||
163321087|NCT02326974|589886083|FG000|Overall Study|failed heterogenity evaluation|5|||
163321088|NCT04924400|589886085|FG000|Overall Study|Lost to Follow-up|3|||
163321089|NCT04924400|589886086|FG001|Overall Study|Lost to Follow-up|0|||
163321090|NCT04633538|589886089|FG000|Overall Study|Death|1|||
163321091|NCT04633538|589886089|FG000|Overall Study|Lost to Follow-up|3|||
163321092|NCT04633538|589886089|FG000|Overall Study|Withdrawal by Subject|1|||
163321093|NCT04230681|589886090|FG000|Overall Study|Physician Decision|2|||
163321094|NCT04230681|589886091|FG001|Overall Study|Physician Decision|3|||
163321095|NCT04230681|589886090|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
163321096|NCT04230681|589886091|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
163321097|NCT04230681|589886090|FG000|Overall Study|IV inadvertently removed|0|||
163321098|NCT04230681|589886091|FG001|Overall Study|IV inadvertently removed|1|||
163321099|NCT04565990|589887635|FG000|Overall Study|Death|5|||
163321100|NCT04565990|589887635|FG000|Overall Study|Lost to Follow-up|1|||
163321101|NCT04565990|589887635|FG000|Overall Study|Withdrawal by Subject|1|||
163321102|NCT05507333|589887636|FG000|Overall Study|Protocol Violation|1|||
163321103|NCT01960452|589887639|FG000|Overall Study|Withdrawal by Subject|2|||
163321104|NCT01960452|589887640|FG001|Overall Study|Withdrawal by Subject|1|||
163321105|NCT01960452|589887639|FG000|Overall Study|Sleep apnea in Night 1|1|||
163321106|NCT01960452|589887640|FG001|Overall Study|Sleep apnea in Night 1|0|||
163321107|NCT01960452|589887639|FG000|Overall Study|Poor Sleep in Night 1|0|||
163321108|NCT01960452|589887640|FG001|Overall Study|Poor Sleep in Night 1|2|||
163321109|NCT01960452|589887639|FG000|Overall Study|No Sex/Age Match Night 1|1|||
163321110|NCT01960452|589887640|FG001|Overall Study|No Sex/Age Match Night 1|0|||
163321111|NCT01960452|589887639|FG000|Overall Study|No Sex/Age Match Night 2|0|||
163321112|NCT01960452|589887640|FG001|Overall Study|No Sex/Age Match Night 2|2|||
163321113|NCT01960452|589887639|FG000|Overall Study|Technical Difficulties Night 2|2|||
163402733|NCT00783094|590187010|FG002|Open-Label Extension Period|Protocol Violation|7|||
163402734|NCT00783094|590187008|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
163321114|NCT01960452|589887640|FG001|Overall Study|Technical Difficulties Night 2|0|||
163059200|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
163059201|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
163059202|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
163059203|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
163059204|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
163059205|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
163059206|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
163059207|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
163059208|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
163059209|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
163059210|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
163059211|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
163059212|NCT00849056|588926323|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
163059213|NCT00849056|588926324|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
163059214|NCT00849056|588926323|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
163321115|NCT03981926|589887641|FG000|Overall Study|Lost to Follow-up|5|||
163321116|NCT03981926|589887642|FG001|Overall Study|Lost to Follow-up|9|||
163321117|NCT04820322|589887651|FG000|Overall Study|Adverse Event|1|||
163402735|NCT00783094|590187009|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
163402736|NCT00783094|590187010|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
163402737|NCT00783094|590187008|FG000|Open-Label Extension Period|Physician Decision|4|||
163402738|NCT00783094|590187009|FG001|Open-Label Extension Period|Physician Decision|2|||
163402739|NCT00783094|590187010|FG002|Open-Label Extension Period|Physician Decision|3|||
163402740|NCT00783094|590187008|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
163402741|NCT00783094|590187009|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
163402742|NCT00783094|590187010|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
163402743|NCT01324232|590187011|FG000|Overall Study|Protocol Violation|0|||
163402744|NCT01324232|590187012|FG001|Overall Study|Protocol Violation|0|||
163402745|NCT01324232|590187013|FG002|Overall Study|Protocol Violation|0|||
163402746|NCT01324232|590187014|FG003|Overall Study|Protocol Violation|2|||
163402747|NCT01324232|590187011|FG000|Overall Study|Missing|0|||
163402748|NCT01324232|590187012|FG001|Overall Study|Missing|0|||
163402749|NCT01324232|590187013|FG002|Overall Study|Missing|1|||
163402750|NCT01324232|590187014|FG003|Overall Study|Missing|0|||
163402751|NCT01324232|590187011|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
163402752|NCT01324232|590187012|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
163402753|NCT01324232|590187013|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
163402754|NCT01324232|590187014|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
163402755|NCT01324232|590187011|FG000|Overall Study|Lack of Efficacy|2|||
163402756|NCT01324232|590187012|FG001|Overall Study|Lack of Efficacy|1|||
163402757|NCT01324232|590187013|FG002|Overall Study|Lack of Efficacy|2|||
163402758|NCT01324232|590187014|FG003|Overall Study|Lack of Efficacy|2|||
163402759|NCT01324232|590187011|FG000|Overall Study|Participant Refused Medication|0|||
163402760|NCT01324232|590187012|FG001|Overall Study|Participant Refused Medication|1|||
163402761|NCT01324232|590187013|FG002|Overall Study|Participant Refused Medication|0|||
163321118|NCT04820322|589887652|FG001|Overall Study|Adverse Event|0|||
163321119|NCT03156465|589887658|FG000|Overall Study|Withdrawal by Subject|2|||
163321120|NCT05524116|589887666|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
163321121|NCT05524116|589887667|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
163321122|NCT05524116|589887666|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
163321123|NCT05524116|589887667|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
163321124|NCT05524116|589887666|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
163321125|NCT05524116|589887667|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
163321126|NCT05524116|589887666|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
163321127|NCT05524116|589887667|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
163321128|NCT05524116|589887666|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
163321129|NCT05524116|589887667|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
163321130|NCT03181516|589887669|FG000|Overall Study|Withdrawal by Subject|14|||
163321131|NCT03181516|589887670|FG001|Overall Study|Withdrawal by Subject|7|||
163321132|NCT03181516|589887669|FG000|Overall Study|Lost to Follow-up|2|||
163321133|NCT03181516|589887670|FG001|Overall Study|Lost to Follow-up|2|||
163321134|NCT04544007|589887673|FG000|Overall Study|Withdrawal by Subject|1|||
163321135|NCT04544007|589887673|FG000|Overall Study|Confirmed Progressive Disease|1|||
163321136|NCT02839265|589887681|FG000|Overall Study|Screen Failure|2|||
163321137|NCT02839265|589887681|FG000|Overall Study|Death|1|||
163402762|NCT01324232|590187014|FG003|Overall Study|Participant Refused Medication|0|||
163402763|NCT01324232|590187011|FG000|Overall Study|Intercurrent illness|0|||
163402764|NCT01324232|590187012|FG001|Overall Study|Intercurrent illness|0|||
163402765|NCT01324232|590187013|FG002|Overall Study|Intercurrent illness|0|||
163402766|NCT01324232|590187014|FG003|Overall Study|Intercurrent illness|1|||
163402767|NCT01324232|590187011|FG000|Overall Study|Adverse Event|2|||
163402768|NCT01324232|590187012|FG001|Overall Study|Adverse Event|5|||
163402769|NCT01324232|590187013|FG002|Overall Study|Adverse Event|6|||
163321138|NCT02839265|589887681|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
163321139|NCT00844415|589887686|FG000|Overall Study|Withdrawal by Subject|1|||
163321140|NCT04186819|589887691|FG000|Overall Study|Adverse Event|1|||
163321141|NCT04186819|589887691|FG000|Overall Study|Lost to Follow-up|1|||
163321142|NCT04186819|589887691|FG000|Overall Study|Opted for EBRT|1|||
163321143|NCT04186819|589887691|FG000|Overall Study|Opted SBRT|1|||
163321144|NCT04186819|589887691|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
163321145|NCT04186819|589887691|FG000|Overall Study|Physician Decision|1|||
163321146|NCT04186819|589887691|FG000|Overall Study|RP Delayed|1|||
163321147|NCT04186819|589887691|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
163321148|NCT04186819|589887691|FG000|Overall Study|Subject declined for financial reasons|1|||
163321149|NCT04186819|589887691|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
163321150|NCT04186819|589887691|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
163321151|NCT04186819|589887691|FG000|Overall Study|The subject opted for other treatment option|2|||
163321152|NCT04186819|589887691|FG000|Overall Study|The subject opted for other treatment options|1|||
163321153|NCT04186819|589887691|FG000|Overall Study|Withdrawal by Subject|3|||
163321154|NCT04186819|589887691|FG000|Overall Study|Reason not specified|1|||
163321155|NCT03252288|589887692|FG000|Overall Study|Death|1|||
163321156|NCT03252288|589887693|FG001|Overall Study|Death|0|||
163321157|NCT03252288|589887694|FG002|Overall Study|Death|0|||
163321158|NCT03252288|589887692|FG000|Overall Study|Death|11|||
163321159|NCT03252288|589887693|FG001|Overall Study|Death|0|||
163321160|NCT03252288|589887694|FG002|Overall Study|Death|0|||
163321161|NCT03252288|589887692|FG000|Overall Study|Withdrawal by Subject|2|||
163321162|NCT03252288|589887693|FG001|Overall Study|Withdrawal by Subject|0|||
163321163|NCT03252288|589887694|FG002|Overall Study|Withdrawal by Subject|0|||
163321164|NCT03252288|589887692|FG000|Overall Study|Lost to Follow-up|79|||
163321165|NCT03252288|589887693|FG001|Overall Study|Lost to Follow-up|0|||
163321166|NCT03252288|589887694|FG002|Overall Study|Lost to Follow-up|0|||
163321167|NCT03252288|589887692|FG000|Overall Study|Loss of baseline data on tablets|6|||
163321168|NCT03252288|589887693|FG001|Overall Study|Loss of baseline data on tablets|0|||
163321169|NCT03252288|589887694|FG002|Overall Study|Loss of baseline data on tablets|0|||
163321170|NCT00677365|589887695|FG000|Overall Study|Adverse Event|2|||
163321171|NCT00677365|589887696|FG001|Overall Study|Adverse Event|1|||
163321172|NCT00677365|589887697|FG002|Overall Study|Adverse Event|1|||
163321173|NCT00677365|589887698|FG003|Overall Study|Adverse Event|2|||
163321174|NCT00677365|589887695|FG000|Overall Study|Withdrawal by Subject|0|||
163321175|NCT00677365|589887696|FG001|Overall Study|Withdrawal by Subject|0|||
163321176|NCT00677365|589887697|FG002|Overall Study|Withdrawal by Subject|1|||
163321177|NCT00677365|589887698|FG003|Overall Study|Withdrawal by Subject|0|||
163321178|NCT00677365|589887695|FG000|Overall Study|Other reason|0|||
163321179|NCT00677365|589887696|FG001|Overall Study|Other reason|0|||
163321180|NCT00677365|589887697|FG002|Overall Study|Other reason|0|||
163321181|NCT00677365|589887698|FG003|Overall Study|Other reason|1|||
163321182|NCT05900154|589887699|FG000|Follow-Up Period|Lost to Follow-up|1|||
163321183|NCT05900154|589887700|FG001|Follow-Up Period|Lost to Follow-up|2|||
163321184|NCT05900154|589887701|FG002|Follow-Up Period|Lost to Follow-up|1|||
163402770|NCT01324232|590187014|FG003|Overall Study|Adverse Event|6|||
162981771|NCT00515541|588634485|FG003|Overall Study|Physician Decision|1|||
162981772|NCT00515541|588634482|FG000|Overall Study|No show for appointments|0|||
162981773|NCT00515541|588634483|FG001|Overall Study|No show for appointments|1|||
162981774|NCT00515541|588634484|FG002|Overall Study|No show for appointments|0|||
162981775|NCT00515541|588634485|FG003|Overall Study|No show for appointments|2|||
162981776|NCT00515541|588634482|FG000|Overall Study|Withdrawal by Subject|0|||
162981777|NCT00515541|588634483|FG001|Overall Study|Withdrawal by Subject|2|||
162981778|NCT00515541|588634484|FG002|Overall Study|Withdrawal by Subject|0|||
162981779|NCT00515541|588634485|FG003|Overall Study|Withdrawal by Subject|2|||
162981780|NCT02145026|588634487|FG000|Overall Study|Adverse Event|2|||
162981781|NCT02145026|588634487|FG000|Overall Study|Death|4|||
162981782|NCT02145026|588634487|FG000|Overall Study|Withdrawal by Subject|2|||
162981783|NCT02145026|588634487|FG000|Overall Study|Physician Decision|4|||
162981784|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
162981785|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
162981786|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
162981787|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
163321185|NCT05900154|589887702|FG003|Follow-Up Period|Lost to Follow-up|0|||
163321186|NCT05900154|589887703|FG004|Follow-Up Period|Lost to Follow-up|1|||
163402771|NCT01324232|590187011|FG000|Overall Study|Withdrawal by Subject|0|||
162981788|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
162981789|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
163321187|NCT05900154|589887704|FG005|Follow-Up Period|Lost to Follow-up|1|||
163321188|NCT04102111|589887706|FG000|Overall Study|Withdrawal by Subject|2|||
163321189|NCT04102111|589887707|FG001|Overall Study|Withdrawal by Subject|3|||
163321190|NCT04102111|589887706|FG000|Overall Study|Adverse Event|1|||
163059215|NCT00849056|588926324|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
163059216|NCT00849056|588926323|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
163059217|NCT00849056|588926324|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
163059218|NCT00849056|588926323|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
163059219|NCT00849056|588926324|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
163059220|NCT00849056|588926323|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
163059221|NCT00849056|588926324|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
163059222|NCT00849056|588926323|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
163211464|NCT00818662|589488874|FG002|Overall Study|Caregiver to pursue other treatment|0|||
163211465|NCT00818662|589488875|FG003|Overall Study|Caregiver to pursue other treatment|0|||
163211466|NCT00818662|589488872|FG000|Overall Study|Moving out of state|0|||
163211467|NCT00818662|589488873|FG001|Overall Study|Moving out of state|0|||
163321191|NCT04102111|589887707|FG001|Overall Study|Adverse Event|1|||
163321192|NCT04102111|589887706|FG000|Overall Study|Study terminated by sponsor|1|||
163321193|NCT04102111|589887707|FG001|Overall Study|Study terminated by sponsor|3|||
163211468|NCT00818662|589488874|FG002|Overall Study|Moving out of state|0|||
163211469|NCT00818662|589488875|FG003|Overall Study|Moving out of state|1|||
163211470|NCT00818662|589488872|FG000|Overall Study|Declined move to another study site|1|||
163211471|NCT00818662|589488873|FG001|Overall Study|Declined move to another study site|0|||
163211472|NCT00818662|589488874|FG002|Overall Study|Declined move to another study site|0|||
163211473|NCT00818662|589488875|FG003|Overall Study|Declined move to another study site|0|||
163211474|NCT00818662|589488872|FG000|Overall Study|Change in living situation|0|||
163211475|NCT00818662|589488873|FG001|Overall Study|Change in living situation|0|||
163211476|NCT00818662|589488874|FG002|Overall Study|Change in living situation|0|||
163211477|NCT00818662|589488875|FG003|Overall Study|Change in living situation|1|||
163211478|NCT00818662|589488872|FG000|Overall Study|Study partner decision|0|||
163211479|NCT00818662|589488873|FG001|Overall Study|Study partner decision|0|||
163211480|NCT00818662|589488874|FG002|Overall Study|Study partner decision|0|||
163211481|NCT00818662|589488875|FG003|Overall Study|Study partner decision|1|||
163211482|NCT00818662|589488872|FG000|Overall Study|Admitted to long term nursing care|0|||
163211483|NCT00818662|589488873|FG001|Overall Study|Admitted to long term nursing care|1|||
163211484|NCT00818662|589488874|FG002|Overall Study|Admitted to long term nursing care|0|||
163211485|NCT00818662|589488875|FG003|Overall Study|Admitted to long term nursing care|0|||
163211486|NCT03021265|589488876|FG000|Overall Study|Adverse Event|29|||
163211487|NCT03021265|589488876|FG000|Overall Study|Lack of Efficacy|3|||
163211488|NCT03021265|589488876|FG000|Overall Study|Improved|17|||
163211489|NCT03021265|589488876|FG000|Overall Study|Lost to Follow-up|67|||
163211490|NCT03021265|589488876|FG000|Overall Study|No reason given|2|||
163211491|NCT03021265|589488876|FG000|Overall Study|No visit since the first visit|4|||
163211492|NCT01106898|589488877|FG000|Overall Study|Adverse Event|6|||
163211493|NCT01722071|589488878|FG000|Overall Study|Protocol Violation|1|||
163211494|NCT01722071|589488879|FG001|Overall Study|Protocol Violation|0|||
163211495|NCT01338493|589488880|FG000|Enrolled|Withdrawal by Subject|1|||
163211496|NCT01338493|589488880|FG000|Enrolled|Patient not implanted|4|||
163211497|NCT01338493|589488880|FG000|Discharge|Death|1|||
163211498|NCT01338493|589488880|FG000|Discharge|Missed visit|1|||
163211499|NCT01338493|589488880|FG000|6 Months Follow up|Lost to Follow-up|11|||
163211500|NCT01338493|589488880|FG000|6 Months Follow up|Missed visit|8|||
163211501|NCT01338493|589488880|FG000|12 Months Follow up|Lost to Follow-up|9|||
163211502|NCT01846611|589488881|FG000|Overall Study|Lost to Follow-up|4|||
163211503|NCT01846611|589488882|FG001|Overall Study|Lost to Follow-up|6|||
163211504|NCT01846611|589488881|FG000|Overall Study|Withdrawal by Subject|15|||
163211505|NCT01846611|589488882|FG001|Overall Study|Withdrawal by Subject|19|||
163211506|NCT01846611|589488881|FG000|Overall Study|Other|19|||
163211507|NCT01846611|589488882|FG001|Overall Study|Other|18|||
163211508|NCT00541034|589488883|FG000|Overall Study|Non-Compliance|3|||
163211509|NCT01614067|589488884|FG000|Overall Study|Pregnancy|1|||
163211510|NCT01614067|589488885|FG001|Overall Study|Pregnancy|0|||
163211511|NCT01614067|589488884|FG000|Overall Study|Physician Decision|6|||
163211512|NCT01614067|589488885|FG001|Overall Study|Physician Decision|5|||
163211513|NCT01614067|589488884|FG000|Overall Study|Withdrawal by Subject|0|||
163211514|NCT01614067|589488885|FG001|Overall Study|Withdrawal by Subject|1|||
163211515|NCT01614067|589488884|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
163211516|NCT01614067|589488885|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
163211517|NCT00847704|589488886|FG000|Overall Study|Withdrawal by Subject|1|||
163211518|NCT02671422|589488892|FG000|Overall Study|Lost to Follow-up|1|||
163211519|NCT02671422|589488892|FG000|Overall Study|Adverse Event|68|||
163211520|NCT02671422|589488892|FG000|Overall Study|Lack of Efficacy|1|||
163211521|NCT02671422|589488892|FG000|Overall Study|Lost to Follow-up|4|||
163211522|NCT02671422|589488892|FG000|Overall Study|Withdrawal by Subject|7|||
163211523|NCT02671422|589488892|FG000|Overall Study|Progressive Disease|156|||
163211524|NCT02671422|589488892|FG000|Overall Study|Worsening of Disease|4|||
163211525|NCT02671422|589488892|FG000|Overall Study|Sponsor decision|5|||
163211526|NCT02671422|589488892|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
163211527|NCT02671422|589488892|FG000|Overall Study|Not treated with Vargatef®|3|||
163321194|NCT02542631|589887708|FG000|Overall Study|Adverse Event|1|||
163321195|NCT02542631|589887709|FG001|Overall Study|Adverse Event|1|||
163321196|NCT02542631|589887708|FG000|Overall Study|Sponsor Termination|1|||
163321197|NCT02542631|589887709|FG001|Overall Study|Sponsor Termination|0|||
163321198|NCT02542631|589887708|FG000|Overall Study|Withdrawal by Subject|11|||
163321199|NCT02542631|589887709|FG001|Overall Study|Withdrawal by Subject|16|||
163321200|NCT02542631|589887708|FG000|Overall Study|Protocol Violation|1|||
163321201|NCT02542631|589887709|FG001|Overall Study|Protocol Violation|1|||
163321202|NCT02542631|589887708|FG000|Overall Study|Physician Decision|6|||
163321203|NCT02542631|589887709|FG001|Overall Study|Physician Decision|4|||
163321204|NCT02542631|589887708|FG000|Overall Study|Lost to Follow-up|6|||
163321205|NCT02542631|589887709|FG001|Overall Study|Lost to Follow-up|5|||
163321206|NCT02542631|589887708|FG000|Overall Study|Death|1|||
163321207|NCT02542631|589887709|FG001|Overall Study|Death|2|||
163321208|NCT02542631|589887708|FG000|Overall Study|Other|2|||
163321209|NCT02542631|589887709|FG001|Overall Study|Other|1|||
163321210|NCT02542631|589887708|FG000|Overall Study|Used Prohibited Medication|2|||
163321211|NCT02542631|589887709|FG001|Overall Study|Used Prohibited Medication|1|||
163321212|NCT02641730|589887710|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
163321213|NCT02641730|589887711|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163321214|NCT02641730|589887712|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163321215|NCT02641730|589887713|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
163321216|NCT02641730|589887714|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
163321217|NCT02641730|589887710|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
163321218|NCT02641730|589887711|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
163321219|NCT02641730|589887712|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
163321220|NCT02641730|589887713|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
163321221|NCT02641730|589887714|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
162981790|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
162981791|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
162981792|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
162981793|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
162981794|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
162981795|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
162981796|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
162981797|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
162981798|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
162981799|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
162981800|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
162981801|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
162981802|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
162981803|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
162981804|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
162981805|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
162981806|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
162981807|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
162981808|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
162981809|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
162981810|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
162981811|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
162981812|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
162981813|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
162981814|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
162981815|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
162981816|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
162981817|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
162981818|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
162981819|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
162981820|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
162981821|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
162981822|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
162981823|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
162981824|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
163321222|NCT02641730|589887710|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
163321223|NCT02641730|589887711|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
163321224|NCT02641730|589887712|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
163321225|NCT02641730|589887713|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
163321226|NCT02641730|589887714|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
163321227|NCT02641730|589887710|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
163059223|NCT00849056|588926324|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
163059224|NCT00849056|588926323|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
163059225|NCT00849056|588926324|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
163059226|NCT04588259|588926325|FG000|Run-in period|Run-in failure|0|||
163059227|NCT04588259|588926326|FG001|Run-in period|Run-in failure|23|||
163059228|NCT04588259|588926325|FG000|Run-in period|Withdrawn before randomisation|0|||
163059229|NCT04588259|588926326|FG001|Run-in period|Withdrawn before randomisation|8|||
163059230|NCT04588259|588926325|FG000|Treatment period|Withdrawal by Subject|6|||
163059231|NCT04588259|588926326|FG001|Treatment period|Withdrawal by Subject|6|||
163059232|NCT01673386|588926327|FG000|Overall Study|Study terminated by sponsor|16|||
163059233|NCT01673386|588926328|FG001|Overall Study|Study terminated by sponsor|22|||
163059234|NCT01673386|588926327|FG000|Overall Study|Adverse Event|5|||
163059235|NCT01673386|588926328|FG001|Overall Study|Adverse Event|2|||
163059236|NCT01673386|588926327|FG000|Overall Study|Progressive disease|4|||
163059237|NCT01673386|588926328|FG001|Overall Study|Progressive disease|1|||
163059238|NCT01673386|588926327|FG000|Overall Study|Withdrawal by Subject|0|||
163059239|NCT01673386|588926328|FG001|Overall Study|Withdrawal by Subject|2|||
163059240|NCT00274456|588926329|FG000|Overall Study|Still on treatment|2|||
163059241|NCT00274456|588926330|FG001|Overall Study|Still on treatment|3|||
163059242|NCT00274456|588926331|FG002|Overall Study|Still on treatment|5|||
163059243|NCT00274456|588926332|FG003|Overall Study|Still on treatment|1|||
163059244|NCT00274456|588926329|FG000|Overall Study|Unacceptable toxicity|10|||
163059245|NCT00274456|588926330|FG001|Overall Study|Unacceptable toxicity|5|||
163059246|NCT00274456|588926331|FG002|Overall Study|Unacceptable toxicity|12|||
163059247|NCT00274456|588926332|FG003|Overall Study|Unacceptable toxicity|16|||
163059248|NCT00274456|588926329|FG000|Overall Study|Adverse Event|0|||
163059249|NCT00274456|588926330|FG001|Overall Study|Adverse Event|1|||
163059250|NCT00274456|588926331|FG002|Overall Study|Adverse Event|2|||
163059251|NCT00274456|588926332|FG003|Overall Study|Adverse Event|2|||
163059252|NCT00274456|588926329|FG000|Overall Study|Physician Decision|7|||
163059253|NCT00274456|588926330|FG001|Overall Study|Physician Decision|5|||
163059254|NCT00274456|588926331|FG002|Overall Study|Physician Decision|6|||
163059255|NCT00274456|588926332|FG003|Overall Study|Physician Decision|13|||
163059256|NCT00274456|588926329|FG000|Overall Study|Lost to Follow-up|0|||
163059257|NCT00274456|588926330|FG001|Overall Study|Lost to Follow-up|0|||
163059258|NCT00274456|588926331|FG002|Overall Study|Lost to Follow-up|1|||
163059259|NCT00274456|588926332|FG003|Overall Study|Lost to Follow-up|0|||
163059260|NCT00274456|588926329|FG000|Overall Study|Withdrawal by Subject|18|||
163059261|NCT00274456|588926330|FG001|Overall Study|Withdrawal by Subject|13|||
163059262|NCT00274456|588926331|FG002|Overall Study|Withdrawal by Subject|9|||
163059263|NCT00274456|588926332|FG003|Overall Study|Withdrawal by Subject|13|||
163059264|NCT04476043|588926339|FG000|Overall Study|Withdrawal by Subject|1|||
163059265|NCT04476043|588926340|FG001|Overall Study|Withdrawal by Subject|3|||
163059266|NCT04476043|588926341|FG002|Overall Study|Withdrawal by Subject|4|||
163059267|NCT04476043|588926342|FG003|Overall Study|Withdrawal by Subject|1|||
163059268|NCT04476043|588926339|FG000|Overall Study|Lost to Follow-up|1|||
163321228|NCT02641730|589887711|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
163321229|NCT02641730|589887712|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
163321230|NCT02641730|589887713|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
163321231|NCT02641730|589887714|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
163321232|NCT02641730|589887710|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
163321233|NCT02641730|589887711|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
163321234|NCT02641730|589887712|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
163321235|NCT02641730|589887713|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
163321236|NCT02641730|589887714|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
163321237|NCT02641730|589887710|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
163402772|NCT01324232|590187012|FG001|Overall Study|Withdrawal by Subject|3|||
163402773|NCT01324232|590187013|FG002|Overall Study|Withdrawal by Subject|4|||
163402774|NCT01324232|590187014|FG003|Overall Study|Withdrawal by Subject|0|||
163402775|NCT01324232|590187011|FG000|Overall Study|Lost to Follow-up|1|||
163059269|NCT04476043|588926340|FG001|Overall Study|Lost to Follow-up|1|||
163059270|NCT04476043|588926341|FG002|Overall Study|Lost to Follow-up|2|||
163059271|NCT04476043|588926342|FG003|Overall Study|Lost to Follow-up|1|||
163059272|NCT04476043|588926339|FG000|Overall Study|Adverse Event|2|||
163059273|NCT04476043|588926340|FG001|Overall Study|Adverse Event|0|||
163059274|NCT04476043|588926341|FG002|Overall Study|Adverse Event|1|||
163059275|NCT04476043|588926342|FG003|Overall Study|Adverse Event|0|||
163059276|NCT04476043|588926339|FG000|Overall Study|Protocol Violation|0|||
163059277|NCT04476043|588926340|FG001|Overall Study|Protocol Violation|1|||
163059278|NCT04476043|588926341|FG002|Overall Study|Protocol Violation|0|||
163059279|NCT04476043|588926342|FG003|Overall Study|Protocol Violation|0|||
163059280|NCT02100631|588926343|FG000|Overall Study|Withdrawal by Subject|1|||
163059281|NCT02100631|588926344|FG001|Overall Study|Withdrawal by Subject|0|||
163059282|NCT02100631|588926345|FG002|Overall Study|Withdrawal by Subject|0|||
163059283|NCT02100631|588926343|FG000|Overall Study|Lost to Follow-up|3|||
163321238|NCT02641730|589887711|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
163321239|NCT02641730|589887712|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
163321240|NCT02641730|589887713|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
163321241|NCT02641730|589887714|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
163321242|NCT05460871|589887715|FG000|Overall Study|Withdrawal by Subject|1|||
163321243|NCT05460871|589887716|FG001|Overall Study|Withdrawal by Subject|2|||
163321244|NCT02938923|589887717|FG000|Overall Study|Death|1|||
163321245|NCT02938923|589887718|FG001|Overall Study|Death|0|||
163321246|NCT02938923|589887719|FG002|Overall Study|Death|0|||
163321247|NCT02938923|589887717|FG000|Overall Study|Physician Decision|0|||
163321248|NCT02938923|589887718|FG001|Overall Study|Physician Decision|2|||
163321249|NCT02938923|589887719|FG002|Overall Study|Physician Decision|0|||
163321250|NCT02938923|589887717|FG000|Overall Study|Withdrawal by Subject|0|||
163321251|NCT02938923|589887718|FG001|Overall Study|Withdrawal by Subject|1|||
163321252|NCT02938923|589887719|FG002|Overall Study|Withdrawal by Subject|1|||
163321253|NCT03663205|589887720|FG000|Overall Study|Death|144|||
163321254|NCT03663205|589887721|FG001|Overall Study|Death|69|||
163321255|NCT03663205|589887720|FG000|Overall Study|Sponsor decision|53|||
163321256|NCT03663205|589887721|FG001|Overall Study|Sponsor decision|19|||
163321257|NCT03663205|589887720|FG000|Overall Study|Withdrawal by Subject|8|||
163321258|NCT03663205|589887721|FG001|Overall Study|Withdrawal by Subject|11|||
163321259|NCT03663205|589887720|FG000|Overall Study|Lost to Follow-up|7|||
163321260|NCT03663205|589887721|FG001|Overall Study|Lost to Follow-up|9|||
163321261|NCT03663205|589887720|FG000|Overall Study|Transferred to long term extension study|11|||
163321262|NCT03663205|589887721|FG001|Overall Study|Transferred to long term extension study|3|||
163321263|NCT03582033|589887724|FG000|Part A|Other|0|||
163321264|NCT03582033|589887725|FG001|Part A|Other|0|||
163321265|NCT03582033|589887726|FG002|Part A|Other|0|||
163321266|NCT03582033|589887727|FG003|Part A|Other|0|||
163321267|NCT03582033|589887728|FG004|Part A|Other|2|||
163321268|NCT03582033|589887729|FG005|Part A|Other|0|||
163321269|NCT03582033|589887730|FG006|Part A|Other|0|||
163321270|NCT03582033|589887731|FG007|Part A|Other|0|||
163321271|NCT03582033|589887732|FG008|Part A|Other|0|||
163321272|NCT03582033|589887733|FG009|Part A|Other|0|||
163321273|NCT03582033|589887724|FG000|Part A|Death|1|||
163321274|NCT03582033|589887725|FG001|Part A|Death|1|||
163321275|NCT03582033|589887726|FG002|Part A|Death|2|||
163321276|NCT03582033|589887727|FG003|Part A|Death|4|||
163321277|NCT03582033|589887728|FG004|Part A|Death|11|||
163321278|NCT03582033|589887729|FG005|Part A|Death|0|||
163321279|NCT03582033|589887730|FG006|Part A|Death|0|||
163321280|NCT03582033|589887731|FG007|Part A|Death|0|||
163321281|NCT03582033|589887732|FG008|Part A|Death|0|||
163321282|NCT03582033|589887733|FG009|Part A|Death|0|||
163321283|NCT03582033|589887724|FG000|Part A|Lost to Follow-up|0|||
163321284|NCT03582033|589887725|FG001|Part A|Lost to Follow-up|0|||
163321285|NCT03582033|589887726|FG002|Part A|Lost to Follow-up|0|||
163321286|NCT03582033|589887727|FG003|Part A|Lost to Follow-up|0|||
163321287|NCT03582033|589887728|FG004|Part A|Lost to Follow-up|1|||
163321288|NCT03582033|589887729|FG005|Part A|Lost to Follow-up|0|||
163321289|NCT03582033|589887730|FG006|Part A|Lost to Follow-up|0|||
163321290|NCT03582033|589887731|FG007|Part A|Lost to Follow-up|0|||
163321291|NCT03582033|589887732|FG008|Part A|Lost to Follow-up|0|||
163321292|NCT03582033|589887733|FG009|Part A|Lost to Follow-up|0|||
163321293|NCT03582033|589887724|FG000|Part A|Study terminated by sponsor|0|||
163321294|NCT03582033|589887725|FG001|Part A|Study terminated by sponsor|0|||
163321295|NCT03582033|589887726|FG002|Part A|Study terminated by sponsor|0|||
163321296|NCT03582033|589887727|FG003|Part A|Study terminated by sponsor|2|||
163321297|NCT03582033|589887728|FG004|Part A|Study terminated by sponsor|1|||
163321298|NCT03582033|589887729|FG005|Part A|Study terminated by sponsor|0|||
163321299|NCT03582033|589887730|FG006|Part A|Study terminated by sponsor|0|||
163321300|NCT03582033|589887731|FG007|Part A|Study terminated by sponsor|0|||
163321301|NCT03582033|589887732|FG008|Part A|Study terminated by sponsor|0|||
163321302|NCT03582033|589887733|FG009|Part A|Study terminated by sponsor|0|||
163321303|NCT03582033|589887724|FG000|Part A|Withdrawal by Subject|1|||
163321304|NCT03582033|589887725|FG001|Part A|Withdrawal by Subject|1|||
163321305|NCT03582033|589887726|FG002|Part A|Withdrawal by Subject|0|||
163321306|NCT03582033|589887727|FG003|Part A|Withdrawal by Subject|1|||
162981825|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
162981826|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
162981827|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
163321307|NCT03582033|589887728|FG004|Part A|Withdrawal by Subject|7|||
163321308|NCT03582033|589887729|FG005|Part A|Withdrawal by Subject|0|||
163321309|NCT03582033|589887730|FG006|Part A|Withdrawal by Subject|0|||
163321310|NCT03582033|589887731|FG007|Part A|Withdrawal by Subject|0|||
162981828|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
163321311|NCT03582033|589887732|FG008|Part A|Withdrawal by Subject|0|||
163321312|NCT03582033|589887733|FG009|Part A|Withdrawal by Subject|0|||
163321313|NCT03582033|589887724|FG000|Part B|Death|0|||
163321314|NCT03582033|589887725|FG001|Part B|Death|0|||
163321315|NCT03582033|589887726|FG002|Part B|Death|0|||
163321316|NCT03582033|589887727|FG003|Part B|Death|0|||
163321317|NCT03582033|589887728|FG004|Part B|Death|0|||
163321318|NCT03582033|589887729|FG005|Part B|Death|2|||
163321319|NCT03582033|589887730|FG006|Part B|Death|0|||
163321320|NCT03582033|589887731|FG007|Part B|Death|0|||
163321321|NCT03582033|589887732|FG008|Part B|Death|0|||
163321322|NCT03582033|589887733|FG009|Part B|Death|0|||
163321323|NCT03582033|589887724|FG000|Part B|Study terminated by sponsor|0|||
163321324|NCT03582033|589887725|FG001|Part B|Study terminated by sponsor|0|||
163321325|NCT03582033|589887726|FG002|Part B|Study terminated by sponsor|0|||
163321326|NCT03582033|589887727|FG003|Part B|Study terminated by sponsor|0|||
163321327|NCT03582033|589887728|FG004|Part B|Study terminated by sponsor|0|||
163321328|NCT03582033|589887729|FG005|Part B|Study terminated by sponsor|12|||
163321329|NCT03582033|589887730|FG006|Part B|Study terminated by sponsor|0|||
163321330|NCT03582033|589887731|FG007|Part B|Study terminated by sponsor|0|||
163321331|NCT03582033|589887732|FG008|Part B|Study terminated by sponsor|0|||
163321332|NCT03582033|589887733|FG009|Part B|Study terminated by sponsor|0|||
163321333|NCT03582033|589887724|FG000|Part B|Withdrawal by Subject|0|||
163321334|NCT03582033|589887725|FG001|Part B|Withdrawal by Subject|0|||
163321335|NCT03582033|589887726|FG002|Part B|Withdrawal by Subject|0|||
163321336|NCT03582033|589887727|FG003|Part B|Withdrawal by Subject|0|||
163321337|NCT03582033|589887728|FG004|Part B|Withdrawal by Subject|0|||
163321338|NCT03582033|589887729|FG005|Part B|Withdrawal by Subject|6|||
163321339|NCT03582033|589887730|FG006|Part B|Withdrawal by Subject|0|||
163321340|NCT03582033|589887731|FG007|Part B|Withdrawal by Subject|0|||
163321341|NCT03582033|589887732|FG008|Part B|Withdrawal by Subject|0|||
163321342|NCT03582033|589887733|FG009|Part B|Withdrawal by Subject|0|||
163321343|NCT03582033|589887724|FG000|Part C|Other|0|||
163321344|NCT03582033|589887725|FG001|Part C|Other|0|||
163321345|NCT03582033|589887726|FG002|Part C|Other|0|||
163321346|NCT03582033|589887727|FG003|Part C|Other|0|||
163321347|NCT03582033|589887728|FG004|Part C|Other|0|||
163321348|NCT03582033|589887729|FG005|Part C|Other|0|||
163321349|NCT03582033|589887730|FG006|Part C|Other|2|||
163321350|NCT03582033|589887731|FG007|Part C|Other|0|||
163321351|NCT03582033|589887732|FG008|Part C|Other|0|||
163321352|NCT03582033|589887733|FG009|Part C|Other|0|||
163321353|NCT03582033|589887724|FG000|Part C|Death|0|||
163321354|NCT03582033|589887725|FG001|Part C|Death|0|||
163321355|NCT03582033|589887726|FG002|Part C|Death|0|||
163321356|NCT03582033|589887727|FG003|Part C|Death|0|||
163321357|NCT03582033|589887728|FG004|Part C|Death|0|||
163321358|NCT03582033|589887729|FG005|Part C|Death|0|||
163321359|NCT03582033|589887730|FG006|Part C|Death|6|||
163321360|NCT03582033|589887731|FG007|Part C|Death|1|||
163321361|NCT03582033|589887732|FG008|Part C|Death|2|||
163321362|NCT03582033|589887733|FG009|Part C|Death|0|||
163321363|NCT03582033|589887724|FG000|Part C|Study terminated by sponsor|0|||
163321364|NCT03582033|589887725|FG001|Part C|Study terminated by sponsor|0|||
163321365|NCT03582033|589887726|FG002|Part C|Study terminated by sponsor|0|||
163321366|NCT03582033|589887727|FG003|Part C|Study terminated by sponsor|0|||
163321367|NCT03582033|589887728|FG004|Part C|Study terminated by sponsor|0|||
163321368|NCT03582033|589887729|FG005|Part C|Study terminated by sponsor|0|||
163321369|NCT03582033|589887730|FG006|Part C|Study terminated by sponsor|3|||
163321370|NCT03582033|589887731|FG007|Part C|Study terminated by sponsor|3|||
163321371|NCT03582033|589887732|FG008|Part C|Study terminated by sponsor|2|||
163321372|NCT03582033|589887733|FG009|Part C|Study terminated by sponsor|0|||
163321373|NCT03582033|589887724|FG000|Part C|Withdrawal by Subject|0|||
163321374|NCT03582033|589887725|FG001|Part C|Withdrawal by Subject|0|||
163321375|NCT03582033|589887726|FG002|Part C|Withdrawal by Subject|0|||
163321376|NCT03582033|589887727|FG003|Part C|Withdrawal by Subject|0|||
163321377|NCT03582033|589887728|FG004|Part C|Withdrawal by Subject|0|||
163321378|NCT03582033|589887729|FG005|Part C|Withdrawal by Subject|0|||
163321379|NCT03582033|589887730|FG006|Part C|Withdrawal by Subject|1|||
163321380|NCT03582033|589887731|FG007|Part C|Withdrawal by Subject|2|||
163321381|NCT03582033|589887732|FG008|Part C|Withdrawal by Subject|1|||
163321382|NCT03582033|589887733|FG009|Part C|Withdrawal by Subject|0|||
163321383|NCT03582033|589887724|FG000|Part D|Death|0|||
163321384|NCT03582033|589887725|FG001|Part D|Death|0|||
163321385|NCT03582033|589887726|FG002|Part D|Death|0|||
163321386|NCT03582033|589887727|FG003|Part D|Death|0|||
163321387|NCT03582033|589887728|FG004|Part D|Death|0|||
163321388|NCT03582033|589887729|FG005|Part D|Death|0|||
163321389|NCT03582033|589887730|FG006|Part D|Death|0|||
163321390|NCT03582033|589887731|FG007|Part D|Death|0|||
163321391|NCT03582033|589887732|FG008|Part D|Death|0|||
163321392|NCT03582033|589887733|FG009|Part D|Death|1|||
163321393|NCT03582033|589887724|FG000|Part D|Study terminated by sponsor|0|||
163321394|NCT03582033|589887725|FG001|Part D|Study terminated by sponsor|0|||
163321395|NCT03582033|589887726|FG002|Part D|Study terminated by sponsor|0|||
163321396|NCT03582033|589887727|FG003|Part D|Study terminated by sponsor|0|||
163321397|NCT03582033|589887728|FG004|Part D|Study terminated by sponsor|0|||
163321398|NCT03582033|589887729|FG005|Part D|Study terminated by sponsor|0|||
163321399|NCT03582033|589887730|FG006|Part D|Study terminated by sponsor|0|||
163321400|NCT03582033|589887731|FG007|Part D|Study terminated by sponsor|0|||
163321401|NCT03582033|589887732|FG008|Part D|Study terminated by sponsor|0|||
163059284|NCT02100631|588926344|FG001|Overall Study|Lost to Follow-up|4|||
163059285|NCT02100631|588926345|FG002|Overall Study|Lost to Follow-up|0|||
163059286|NCT02100631|588926343|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
163059287|NCT02100631|588926344|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
163059288|NCT02100631|588926345|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
163059289|NCT00336544|588926346|FG000|Overall Study|Lack of Efficacy|8|||
163059290|NCT00336544|588926347|FG001|Overall Study|Lack of Efficacy|5|||
163059291|NCT00336544|588926346|FG000|Overall Study|Adverse Event|4|||
163059292|NCT00336544|588926347|FG001|Overall Study|Adverse Event|9|||
163059293|NCT00336544|588926346|FG000|Overall Study|Withdrawal by Subject|4|||
163059294|NCT00336544|588926347|FG001|Overall Study|Withdrawal by Subject|3|||
163059295|NCT00336544|588926346|FG000|Overall Study|Other|3|||
163059296|NCT00336544|588926347|FG001|Overall Study|Other|5|||
163059297|NCT00576758|588926348|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
163059298|NCT00576758|588926349|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
163211528|NCT02671422|589488892|FG000|Overall Study|Other not defined above|3|||
163211529|NCT02289079|589488893|FG000|Overall Study|Physician Decision|2|||
163211530|NCT02289079|589488894|FG001|Overall Study|Physician Decision|0|||
163211531|NCT02289079|589488893|FG000|Overall Study|Lost to Follow-up|0|||
163211532|NCT02289079|589488894|FG001|Overall Study|Lost to Follow-up|1|||
163059299|NCT00576758|588926348|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
163059300|NCT00576758|588926349|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
163059301|NCT00576758|588926348|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
163059302|NCT00576758|588926349|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
163059303|NCT00576758|588926348|FG000|Induction Treatment Period|Death|1|||
163059304|NCT00576758|588926349|FG001|Induction Treatment Period|Death|0|||
163211533|NCT02111850|589488895|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
163211534|NCT02111850|589488896|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
163211535|NCT02111850|589488897|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
163211536|NCT02111850|589488898|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
163211537|NCT02111850|589488899|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
163211538|NCT02111850|589488900|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
163211539|NCT02111850|589488901|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
163211540|NCT02111850|589488902|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
163211541|NCT02111850|589488903|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
163211542|NCT02111850|589488904|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
163211543|NCT02111850|589488905|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
163211544|NCT03061331|589488906|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
163211545|NCT03061331|589488907|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
163211546|NCT02625259|589488908|FG000|First Intervention (Day 1)|Other|0|||
163211547|NCT02625259|589488909|FG001|First Intervention (Day 1)|Other|0|||
163211548|NCT02625259|589488910|FG002|First Intervention (Day 1)|Other|1|||
163211549|NCT02625259|589488911|FG003|First Intervention (Day 1)|Other|0|||
163211550|NCT02625259|589488912|FG004|First Intervention (Day 1)|Other|0|||
163211551|NCT02625259|589488908|FG000|First Intervention (Day 1)|Adverse Event|2|||
163211552|NCT02625259|589488909|FG001|First Intervention (Day 1)|Adverse Event|1|||
163211553|NCT02625259|589488910|FG002|First Intervention (Day 1)|Adverse Event|0|||
163211554|NCT02625259|589488911|FG003|First Intervention (Day 1)|Adverse Event|0|||
163211555|NCT02625259|589488912|FG004|First Intervention (Day 1)|Adverse Event|0|||
163211556|NCT02625259|589488908|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
163211557|NCT02625259|589488909|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
163211558|NCT02625259|589488910|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
163211559|NCT02625259|589488911|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
163211560|NCT02625259|589488912|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
163211561|NCT00513474|589488913|FG000|Overall Study|Death|6|||
163211562|NCT00513474|589488914|FG001|Overall Study|Death|9|||
163211563|NCT00513474|589488913|FG000|Overall Study|Participant Withdrew Consent|1|||
163211564|NCT00513474|589488914|FG001|Overall Study|Participant Withdrew Consent|0|||
163211565|NCT04772755|589488916|FG000|Overall Study|Withdrawal by Subject|1|||
163211566|NCT04772755|589488917|FG001|Overall Study|Withdrawal by Subject|0|||
163211567|NCT04772755|589488916|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
163211568|NCT04772755|589488917|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
163211569|NCT00195676|589488918|FG000|Period O - Open-label Treatment|Adverse Event|82|||
163211570|NCT00195676|589488918|FG000|Period O - Open-label Treatment|Death|6|||
163211571|NCT00195676|589488918|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
163211572|NCT00195676|589488918|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
163211573|NCT00195676|589488918|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
163211574|NCT00195676|589488918|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
163059305|NCT00576758|588926348|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
163059306|NCT00576758|588926349|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
163059307|NCT00576758|588926348|FG000|Induction Treatment Period|Withdrew consent|1|||
163059308|NCT00576758|588926349|FG001|Induction Treatment Period|Withdrew consent|0|||
163059309|NCT00576758|588926348|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
163059310|NCT00576758|588926349|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
163059311|NCT00576758|588926348|FG000|Extension Treatment Period|Death|1|||
163059312|NCT00576758|588926349|FG001|Extension Treatment Period|Death|1|||
163059313|NCT00576758|588926348|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
163059314|NCT00576758|588926349|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
163059315|NCT00576758|588926348|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
163059316|NCT00576758|588926349|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
163059317|NCT00576758|588926348|FG000|Extension Treatment Period|Administrative/Other|3|||
163059318|NCT00576758|588926349|FG001|Extension Treatment Period|Administrative/Other|1|||
163059319|NCT00576758|588926348|FG000|Follow-up Period|Administrative/Other|6|||
163059320|NCT00576758|588926349|FG001|Follow-up Period|Administrative/Other|8|||
163059321|NCT00576758|588926348|FG000|Follow-up Period|Death|3|||
163059322|NCT00576758|588926349|FG001|Follow-up Period|Death|3|||
163059323|NCT00576758|588926348|FG000|Follow-up Period|Insufficient therapeutic response|16|||
163059324|NCT00576758|588926349|FG001|Follow-up Period|Insufficient therapeutic response|5|||
163059325|NCT00576758|588926348|FG000|Follow-up Period|Withdrew consent|2|||
163059326|NCT00576758|588926349|FG001|Follow-up Period|Withdrew consent|1|||
163059327|NCT03427411|588926350|FG000|Overall Study|Screen failure - platelets too low|0|||
163059328|NCT03427411|588926351|FG001|Overall Study|Screen failure - platelets too low|1|||
163059329|NCT00903968|588926352|FG000|Overall Study|Adverse Event|0|||
163059330|NCT00903968|588926353|FG001|Overall Study|Adverse Event|0|||
163059331|NCT00903968|588926354|FG002|Overall Study|Adverse Event|0|||
163059332|NCT00903968|588926355|FG003|Overall Study|Adverse Event|0|||
163059333|NCT00903968|588926356|FG004|Overall Study|Adverse Event|0|||
163059334|NCT00903968|588926357|FG005|Overall Study|Adverse Event|0|||
163059335|NCT00903968|588926358|FG006|Overall Study|Adverse Event|1|||
163059336|NCT00903968|588926359|FG007|Overall Study|Adverse Event|8|||
163059337|NCT00903968|588926352|FG000|Overall Study|DLT|0|||
163059338|NCT00903968|588926353|FG001|Overall Study|DLT|0|||
163059339|NCT00903968|588926354|FG002|Overall Study|DLT|0|||
163211575|NCT00195676|589488918|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
163211576|NCT00195676|589488918|FG000|Period O - Open-label Treatment|Other reasons|68|||
163211577|NCT00195676|589488918|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
162981829|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
162981830|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
162981831|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
162981832|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
162981833|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
162981834|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
162981835|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
162981836|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
162981837|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
162981838|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
162981839|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
162981840|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
162981841|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
162981842|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
162981843|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
162981844|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
162981845|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
163059340|NCT00903968|588926355|FG003|Overall Study|DLT|0|||
163059341|NCT00903968|588926356|FG004|Overall Study|DLT|0|||
163059342|NCT00903968|588926357|FG005|Overall Study|DLT|0|||
163059343|NCT00903968|588926358|FG006|Overall Study|DLT|2|||
163059344|NCT00903968|588926359|FG007|Overall Study|DLT|0|||
163059345|NCT00903968|588926352|FG000|Overall Study|Withdrawal by Subject|1|||
163211578|NCT00195676|589488918|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
163211579|NCT00195676|589488918|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
163211580|NCT00195676|589488918|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
163211581|NCT00195676|589488918|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
163211582|NCT00195676|589488918|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
163211583|NCT00195676|589488918|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
163211584|NCT00195676|589488918|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
163211585|NCT00195676|589488918|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
163211586|NCT00195676|589488918|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
163402776|NCT01324232|590187012|FG001|Overall Study|Lost to Follow-up|0|||
163402777|NCT01324232|590187013|FG002|Overall Study|Lost to Follow-up|0|||
163402778|NCT01324232|590187014|FG003|Overall Study|Lost to Follow-up|0|||
163402779|NCT02513329|590187015|FG000|Overall Study|Lost to Follow-up|5|||
163402780|NCT02513329|590187016|FG001|Overall Study|Lost to Follow-up|2|||
163402781|NCT05440539|590187017|FG000|Overall Study|Lost to Follow-up|4|||
163402782|NCT05440539|590187018|FG001|Overall Study|Lost to Follow-up|4|||
163402783|NCT05440539|590187017|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
163402784|NCT05440539|590187018|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
163402785|NCT01265615|590187019|FG000|Overall Study|Protocol Violation|2|||
163402786|NCT01265615|590187020|FG001|Overall Study|Protocol Violation|2|||
163402787|NCT01265615|590187021|FG002|Overall Study|Protocol Violation|4|||
163402788|NCT01265615|590187022|FG003|Overall Study|Protocol Violation|3|||
163402789|NCT01732796|590187023|FG000|Overall Study|Adverse Event|16|||
163402790|NCT01732796|590187024|FG001|Overall Study|Adverse Event|16|||
163402791|NCT01732796|590187025|FG002|Overall Study|Adverse Event|4|||
163402792|NCT01732796|590187023|FG000|Overall Study|Lack of Efficacy|21|||
163402793|NCT01732796|590187024|FG001|Overall Study|Lack of Efficacy|18|||
163059346|NCT00903968|588926353|FG001|Overall Study|Withdrawal by Subject|0|||
163059347|NCT00903968|588926354|FG002|Overall Study|Withdrawal by Subject|1|||
163059348|NCT00903968|588926355|FG003|Overall Study|Withdrawal by Subject|0|||
163211587|NCT00195676|589488918|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
163402794|NCT01732796|590187025|FG002|Overall Study|Lack of Efficacy|5|||
163402795|NCT01732796|590187023|FG000|Overall Study|Lost to Follow-up|2|||
163211588|NCT00195676|589488918|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
163211589|NCT00195676|589488918|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
163211590|NCT01189812|589488919|FG000|Overall Study|Withdrawal by Subject|2|||
163211591|NCT01189812|589488920|FG001|Overall Study|Withdrawal by Subject|3|||
163211592|NCT01189812|589488919|FG000|Overall Study|Adverse Event|1|||
163211593|NCT01189812|589488920|FG001|Overall Study|Adverse Event|0|||
163211594|NCT01189812|589488919|FG000|Overall Study|Out of Window|4|||
163211595|NCT01189812|589488920|FG001|Overall Study|Out of Window|3|||
163211596|NCT01189812|589488919|FG000|Overall Study|Moved out of State|1|||
163211597|NCT01189812|589488920|FG001|Overall Study|Moved out of State|2|||
163211598|NCT03761147|589488921|FG000|Overall Study|Withdrawal by Subject|6|||
163211599|NCT03761147|589488922|FG001|Overall Study|Withdrawal by Subject|1|||
163211600|NCT03761147|589488921|FG000|Overall Study|Adverse Event|1|||
163211601|NCT03761147|589488922|FG001|Overall Study|Adverse Event|3|||
163211602|NCT04080297|589488923|FG000|Overall Study|Adverse Event|1|||
163211603|NCT04080297|589488924|FG001|Overall Study|Adverse Event|3|||
163211604|NCT04080297|589488923|FG000|Overall Study|concurrent illness|1|||
163211605|NCT04080297|589488924|FG001|Overall Study|concurrent illness|0|||
163211606|NCT02744391|589488925|FG000|Overall Study|Lost to Follow-up|9|||
163211607|NCT02744391|589488925|FG000|Overall Study|Physician Decision|2|||
163211608|NCT02744391|589488925|FG000|Overall Study|Withdrawal by Subject|3|||
163211609|NCT05838742|589488926|FG000|Overall Study|Adverse Event|2|||
163211610|NCT05838742|589488927|FG001|Overall Study|Adverse Event|0|||
163211611|NCT05838742|589488928|FG002|Overall Study|Adverse Event|1|||
163211612|NCT05838742|589488929|FG003|Overall Study|Adverse Event|0|||
163211613|NCT05838742|589488930|FG004|Overall Study|Adverse Event|1|||
163211614|NCT05838742|589488926|FG000|Overall Study|Lost to Follow-up|1|||
163211615|NCT05838742|589488927|FG001|Overall Study|Lost to Follow-up|1|||
163211616|NCT05838742|589488928|FG002|Overall Study|Lost to Follow-up|1|||
163211617|NCT05838742|589488929|FG003|Overall Study|Lost to Follow-up|0|||
163211618|NCT05838742|589488930|FG004|Overall Study|Lost to Follow-up|0|||
163211619|NCT05838742|589488926|FG000|Overall Study|Physician Decision|0|||
163211620|NCT05838742|589488927|FG001|Overall Study|Physician Decision|0|||
163211621|NCT05838742|589488928|FG002|Overall Study|Physician Decision|0|||
163211622|NCT05838742|589488929|FG003|Overall Study|Physician Decision|0|||
163211623|NCT05838742|589488930|FG004|Overall Study|Physician Decision|1|||
163211624|NCT05838742|589488926|FG000|Overall Study|Withdrawal by Subject|8|||
163211625|NCT05838742|589488927|FG001|Overall Study|Withdrawal by Subject|3|||
163211626|NCT05838742|589488928|FG002|Overall Study|Withdrawal by Subject|3|||
163211627|NCT05838742|589488929|FG003|Overall Study|Withdrawal by Subject|1|||
163211628|NCT05838742|589488930|FG004|Overall Study|Withdrawal by Subject|4|||
163211629|NCT05838742|589488926|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
163211630|NCT05838742|589488927|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
163211631|NCT05838742|589488928|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
163211632|NCT05838742|589488929|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
163211633|NCT05838742|589488930|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
163211634|NCT05838742|589488926|FG000|Overall Study|Lack of Efficacy|0|||
163211635|NCT05838742|589488927|FG001|Overall Study|Lack of Efficacy|0|||
163211636|NCT05838742|589488928|FG002|Overall Study|Lack of Efficacy|0|||
163211637|NCT05838742|589488929|FG003|Overall Study|Lack of Efficacy|1|||
163211638|NCT05838742|589488930|FG004|Overall Study|Lack of Efficacy|0|||
163211639|NCT05838742|589488926|FG000|Overall Study|Randomized, not treated|2|||
163211640|NCT05838742|589488927|FG001|Overall Study|Randomized, not treated|1|||
163211641|NCT05838742|589488928|FG002|Overall Study|Randomized, not treated|0|||
163402796|NCT01732796|590187024|FG001|Overall Study|Lost to Follow-up|0|||
163402797|NCT01732796|590187025|FG002|Overall Study|Lost to Follow-up|0|||
163402798|NCT01732796|590187023|FG000|Overall Study|Withdrawal by Subject|6|||
163402799|NCT01732796|590187024|FG001|Overall Study|Withdrawal by Subject|8|||
163402800|NCT01732796|590187025|FG002|Overall Study|Withdrawal by Subject|2|||
163402801|NCT01732796|590187023|FG000|Overall Study|Other reason not defined above|1|||
163402802|NCT01732796|590187024|FG001|Overall Study|Other reason not defined above|0|||
163402803|NCT01732796|590187025|FG002|Overall Study|Other reason not defined above|2|||
163402804|NCT02004262|590187036|FG000|Overall Study|Death|67|||
163402805|NCT02004262|590187037|FG001|Overall Study|Death|64|||
163402806|NCT02004262|590187038|FG002|Overall Study|Death|66|||
163402807|NCT02004262|590187039|FG003|Overall Study|Death|28|||
163402808|NCT02004262|590187040|FG004|Overall Study|Death|29|||
163402809|NCT02004262|590187041|FG005|Overall Study|Death|22|||
163402810|NCT02004262|590187036|FG000|Overall Study|Withdrawal by Subject|1|||
163402811|NCT02004262|590187037|FG001|Overall Study|Withdrawal by Subject|0|||
163402812|NCT02004262|590187038|FG002|Overall Study|Withdrawal by Subject|4|||
163402813|NCT02004262|590187039|FG003|Overall Study|Withdrawal by Subject|0|||
163402814|NCT02004262|590187040|FG004|Overall Study|Withdrawal by Subject|1|||
163402815|NCT02004262|590187041|FG005|Overall Study|Withdrawal by Subject|3|||
163402816|NCT02004262|590187036|FG000|Overall Study|Lost to Follow-up|1|||
163402817|NCT02004262|590187037|FG001|Overall Study|Lost to Follow-up|1|||
163402818|NCT02004262|590187038|FG002|Overall Study|Lost to Follow-up|0|||
163402819|NCT02004262|590187039|FG003|Overall Study|Lost to Follow-up|0|||
163402820|NCT02004262|590187040|FG004|Overall Study|Lost to Follow-up|0|||
163402821|NCT02004262|590187041|FG005|Overall Study|Lost to Follow-up|0|||
163402822|NCT02004262|590187036|FG000|Overall Study|Study Terminated by Sponsor|4|||
163402823|NCT02004262|590187037|FG001|Overall Study|Study Terminated by Sponsor|3|||
163402824|NCT02004262|590187038|FG002|Overall Study|Study Terminated by Sponsor|2|||
163402825|NCT02004262|590187039|FG003|Overall Study|Study Terminated by Sponsor|1|||
163402826|NCT02004262|590187040|FG004|Overall Study|Study Terminated by Sponsor|1|||
163402827|NCT02004262|590187041|FG005|Overall Study|Study Terminated by Sponsor|5|||
163402828|NCT01146873|590187042|FG000|Overall Study|Transfer out|0|||
163402829|NCT01146873|590187043|FG001|Overall Study|Transfer out|6|||
163402830|NCT03703102|590187044|FG000|Overall Study|Adverse Event|4|||
163402831|NCT03703102|590187045|FG001|Overall Study|Adverse Event|3|||
163402832|NCT03703102|590187046|FG002|Overall Study|Adverse Event|7|||
163402833|NCT03703102|590187047|FG003|Overall Study|Adverse Event|3|||
163402834|NCT03703102|590187048|FG004|Overall Study|Adverse Event|13|||
163402835|NCT03703102|590187044|FG000|Overall Study|Lack of Efficacy|4|||
163402836|NCT03703102|590187045|FG001|Overall Study|Lack of Efficacy|0|||
163402837|NCT03703102|590187046|FG002|Overall Study|Lack of Efficacy|1|||
163402838|NCT03703102|590187047|FG003|Overall Study|Lack of Efficacy|4|||
163402839|NCT03703102|590187048|FG004|Overall Study|Lack of Efficacy|1|||
163402840|NCT03703102|590187044|FG000|Overall Study|Lost to Follow-up|0|||
163402841|NCT03703102|590187045|FG001|Overall Study|Lost to Follow-up|0|||
163402842|NCT03703102|590187046|FG002|Overall Study|Lost to Follow-up|1|||
163402843|NCT03703102|590187047|FG003|Overall Study|Lost to Follow-up|2|||
163402844|NCT03703102|590187048|FG004|Overall Study|Lost to Follow-up|2|||
163402845|NCT03703102|590187044|FG000|Overall Study|Physician Decision|2|||
163402846|NCT03703102|590187045|FG001|Overall Study|Physician Decision|2|||
163402847|NCT03703102|590187046|FG002|Overall Study|Physician Decision|2|||
163402848|NCT03703102|590187047|FG003|Overall Study|Physician Decision|2|||
163321402|NCT03582033|589887733|FG009|Part D|Study terminated by sponsor|4|||
163321403|NCT06010836|589887734|FG000|Overall Study|Lost to Follow-up|2|||
163321404|NCT06010836|589887735|FG001|Overall Study|Lost to Follow-up|2|||
163321405|NCT06010836|589887734|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
163321406|NCT06010836|589887735|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
163321407|NCT06010836|589887734|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
163321408|NCT06010836|589887735|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
163321409|NCT06010836|589887734|FG000|Overall Study|Did not receive intervention discussion|0|||
163321410|NCT06010836|589887735|FG001|Overall Study|Did not receive intervention discussion|4|||
163321411|NCT03812614|589887736|FG000|Intervention|Withdrawal by Subject|7|||
163321412|NCT03812614|589887737|FG001|Intervention|Withdrawal by Subject|2|||
163321413|NCT03812614|589887738|FG002|Intervention|Withdrawal by Subject|7|||
163402849|NCT03703102|590187048|FG004|Overall Study|Physician Decision|4|||
163402850|NCT03703102|590187044|FG000|Overall Study|Withdrawal by Subject|7|||
163402851|NCT03703102|590187045|FG001|Overall Study|Withdrawal by Subject|5|||
163402852|NCT03703102|590187046|FG002|Overall Study|Withdrawal by Subject|5|||
163402853|NCT03703102|590187047|FG003|Overall Study|Withdrawal by Subject|5|||
163402854|NCT03703102|590187048|FG004|Overall Study|Withdrawal by Subject|9|||
163402855|NCT03703102|590187044|FG000|Overall Study|Ineligibility|0|||
163402856|NCT03703102|590187045|FG001|Overall Study|Ineligibility|0|||
163402857|NCT03703102|590187046|FG002|Overall Study|Ineligibility|1|||
163402858|NCT03703102|590187047|FG003|Overall Study|Ineligibility|0|||
163402859|NCT03703102|590187048|FG004|Overall Study|Ineligibility|0|||
163402860|NCT03703102|590187044|FG000|Overall Study|Protocol Deviation|4|||
163402861|NCT03703102|590187045|FG001|Overall Study|Protocol Deviation|4|||
163402862|NCT03703102|590187046|FG002|Overall Study|Protocol Deviation|3|||
163321414|NCT03812614|589887739|FG003|Intervention|Withdrawal by Subject|2|||
163321415|NCT03812614|589887736|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
163321416|NCT03812614|589887737|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
163321417|NCT03812614|589887738|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
163321418|NCT03812614|589887739|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
163321419|NCT03812614|589887736|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
163321420|NCT03812614|589887737|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
163321421|NCT03812614|589887738|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
163321422|NCT03812614|589887739|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
163321423|NCT03812614|589887736|FG000|6-month Follow-up|Lost to Follow-up|0|||
163321424|NCT03812614|589887737|FG001|6-month Follow-up|Lost to Follow-up|0|||
163321425|NCT03812614|589887738|FG002|6-month Follow-up|Lost to Follow-up|12|||
163321426|NCT03812614|589887739|FG003|6-month Follow-up|Lost to Follow-up|8|||
163321427|NCT03812614|589887736|FG000|12-month Follow-up|Lost to Follow-up|18|||
163321428|NCT03812614|589887737|FG001|12-month Follow-up|Lost to Follow-up|17|||
163321429|NCT03812614|589887738|FG002|12-month Follow-up|Lost to Follow-up|5|||
163321430|NCT03812614|589887739|FG003|12-month Follow-up|Lost to Follow-up|2|||
163321431|NCT03372057|589887753|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
163321432|NCT03372057|589887754|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
163321433|NCT03372057|589887755|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
163321434|NCT03372057|589887753|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
163321435|NCT03372057|589887754|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
163321436|NCT03372057|589887755|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
163321437|NCT03372057|589887753|FG000|Dose Optimization Phase|Death|16|||
163321438|NCT03372057|589887754|FG001|Dose Optimization Phase|Death|11|||
163321439|NCT03372057|589887755|FG002|Dose Optimization Phase|Death|0|||
163321440|NCT03372057|589887753|FG000|Expansion Phase|Withdrawal by Subject|0|||
163321441|NCT03372057|589887754|FG001|Expansion Phase|Withdrawal by Subject|0|||
163321442|NCT03372057|589887755|FG002|Expansion Phase|Withdrawal by Subject|4|||
163321443|NCT03372057|589887753|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
163321444|NCT03372057|589887754|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
163321445|NCT03372057|589887755|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
163321446|NCT03372057|589887753|FG000|Expansion Phase|Death|0|||
163321447|NCT03372057|589887754|FG001|Expansion Phase|Death|0|||
163321448|NCT03372057|589887755|FG002|Expansion Phase|Death|78|||
163321449|NCT03372057|589887753|FG000|Expansion Phase|Progressive Disease|0|||
163321450|NCT03372057|589887754|FG001|Expansion Phase|Progressive Disease|0|||
163321451|NCT03372057|589887755|FG002|Expansion Phase|Progressive Disease|1|||
163321452|NCT03372057|589887753|FG000|Expansion Phase|Adverse Event|0|||
163321453|NCT03372057|589887754|FG001|Expansion Phase|Adverse Event|0|||
163321454|NCT03372057|589887755|FG002|Expansion Phase|Adverse Event|1|||
163321455|NCT02518048|589887756|FG000|Overall Study|Withdrawal by Subject|1|||
163321456|NCT05890105|589887757|FG000|Overall Study|Adverse Event|1|||
163321457|NCT05890105|589887758|FG001|Overall Study|Adverse Event|0|||
163321458|NCT05890105|589887759|FG002|Overall Study|Adverse Event|0|||
163321459|NCT05890105|589887757|FG000|Overall Study|Other|1|||
163321460|NCT05890105|589887758|FG001|Overall Study|Other|2|||
163321461|NCT05890105|589887759|FG002|Overall Study|Other|0|||
163321462|NCT04505410|589887761|FG000|Overall Study|Adverse Event|2|||
163321463|NCT04505410|589887762|FG001|Overall Study|Adverse Event|0|||
163321464|NCT04505410|589887761|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
163321465|NCT04505410|589887762|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
163321466|NCT04505410|589887761|FG000|Overall Study|did not want to follow diet|1|||
163321467|NCT04505410|589887762|FG001|Overall Study|did not want to follow diet|0|||
163321468|NCT04505410|589887761|FG000|Overall Study|flare up of ulcerative colitis|0|||
163321469|NCT04505410|589887762|FG001|Overall Study|flare up of ulcerative colitis|1|||
163321470|NCT04505410|589887761|FG000|Overall Study|Lost to Follow-up|0|||
163321471|NCT04505410|589887762|FG001|Overall Study|Lost to Follow-up|2|||
163321472|NCT04505410|589887761|FG000|Overall Study|Lost to Follow-up|1|||
163321473|NCT04505410|589887762|FG001|Overall Study|Lost to Follow-up|0|||
163321474|NCT04505410|589887761|FG000|Overall Study|initiated another diet on their own|0|||
163321475|NCT04505410|589887762|FG001|Overall Study|initiated another diet on their own|2|||
163321476|NCT05123027|589887763|FG000|Overall Study|Lost to Follow-up|17|||
163321477|NCT05123027|589887764|FG001|Overall Study|Lost to Follow-up|22|||
163321478|NCT05123027|589887763|FG000|Overall Study|Incarceration|3|||
163321479|NCT05123027|589887764|FG001|Overall Study|Incarceration|4|||
163321480|NCT05123027|589887763|FG000|Overall Study|Death|2|||
163321481|NCT05123027|589887764|FG001|Overall Study|Death|2|||
163321482|NCT05123027|589887763|FG000|Overall Study|Other|2|||
163321483|NCT05123027|589887764|FG001|Overall Study|Other|0|||
163402863|NCT03703102|590187047|FG003|Overall Study|Protocol Deviation|0|||
163402864|NCT03703102|590187048|FG004|Overall Study|Protocol Deviation|0|||
163402865|NCT03703102|590187044|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163402866|NCT03703102|590187045|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163402867|NCT03703102|590187046|FG002|Overall Study|Non-Compliance with Study Drug|2|||
163402868|NCT03703102|590187047|FG003|Overall Study|Non-Compliance with Study Drug|1|||
163402869|NCT03703102|590187048|FG004|Overall Study|Non-Compliance with Study Drug|4|||
163402870|NCT00876187|590187049|FG000|Overall Study|Adverse Event|14|||
163402871|NCT00876187|590187050|FG001|Overall Study|Adverse Event|12|||
163402872|NCT00876187|590187051|FG002|Overall Study|Adverse Event|19|||
163402873|NCT00876187|590187052|FG003|Overall Study|Adverse Event|29|||
163402874|NCT00876187|590187053|FG004|Overall Study|Adverse Event|10|||
163402875|NCT00876187|590187049|FG000|Overall Study|Lack of Efficacy|59|||
163402876|NCT00876187|590187050|FG001|Overall Study|Lack of Efficacy|34|||
163402877|NCT00876187|590187051|FG002|Overall Study|Lack of Efficacy|45|||
163402878|NCT00876187|590187052|FG003|Overall Study|Lack of Efficacy|34|||
163402879|NCT00876187|590187053|FG004|Overall Study|Lack of Efficacy|59|||
163402880|NCT00876187|590187049|FG000|Overall Study|Lost to Follow-up|9|||
163402881|NCT00876187|590187050|FG001|Overall Study|Lost to Follow-up|10|||
163402882|NCT00876187|590187051|FG002|Overall Study|Lost to Follow-up|8|||
163402883|NCT00876187|590187052|FG003|Overall Study|Lost to Follow-up|8|||
163402884|NCT00876187|590187053|FG004|Overall Study|Lost to Follow-up|11|||
163402885|NCT00876187|590187049|FG000|Overall Study|Protocol Violation|6|||
163402886|NCT00876187|590187050|FG001|Overall Study|Protocol Violation|7|||
163402887|NCT00876187|590187051|FG002|Overall Study|Protocol Violation|7|||
163402888|NCT00876187|590187052|FG003|Overall Study|Protocol Violation|6|||
163402889|NCT00876187|590187053|FG004|Overall Study|Protocol Violation|3|||
163402890|NCT00876187|590187049|FG000|Overall Study|Withdrawal by Subject|16|||
163402891|NCT00876187|590187050|FG001|Overall Study|Withdrawal by Subject|26|||
163402892|NCT00876187|590187051|FG002|Overall Study|Withdrawal by Subject|32|||
163402893|NCT00876187|590187052|FG003|Overall Study|Withdrawal by Subject|38|||
163402894|NCT00876187|590187053|FG004|Overall Study|Withdrawal by Subject|37|||
162981846|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
162981847|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
162981848|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
162981849|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
162981850|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
162981851|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
162981852|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
162981853|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
162981854|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
162981855|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
162981856|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
162981857|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
162981858|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
162981859|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
162981860|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
162981861|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
162981862|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
162981863|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
162981864|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
162981865|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
162981866|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
162981867|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
162981868|NCT03052322|588634491|FG000|Overall Study|Other un-specified|1|||
162981869|NCT03052322|588634492|FG001|Overall Study|Other un-specified|2|||
162981870|NCT03052322|588634491|FG000|Overall Study|Withdrawal by Subject|10|||
162981871|NCT03052322|588634492|FG001|Overall Study|Withdrawal by Subject|9|||
162981872|NCT03052322|588634491|FG000|Overall Study|Death|0|||
162981873|NCT03052322|588634492|FG001|Overall Study|Death|2|||
162981874|NCT03052322|588634491|FG000|Overall Study|Lack of Efficacy|1|||
162981875|NCT03052322|588634492|FG001|Overall Study|Lack of Efficacy|2|||
163059349|NCT00903968|588926356|FG004|Overall Study|Withdrawal by Subject|1|||
163059350|NCT00903968|588926357|FG005|Overall Study|Withdrawal by Subject|1|||
163402895|NCT00876187|590187049|FG000|Overall Study|Entered extension study|101|||
163402896|NCT00876187|590187050|FG001|Overall Study|Entered extension study|120|||
163402897|NCT00876187|590187051|FG002|Overall Study|Entered extension study|156|||
163402898|NCT00876187|590187052|FG003|Overall Study|Entered extension study|151|||
163402899|NCT00876187|590187053|FG004|Overall Study|Entered extension study|144|||
163402900|NCT00876187|590187049|FG000|Overall Study|Randomized but not treated|3|||
163402901|NCT00876187|590187050|FG001|Overall Study|Randomized but not treated|1|||
163402902|NCT00876187|590187051|FG002|Overall Study|Randomized but not treated|3|||
162981876|NCT03052322|588634491|FG000|Overall Study|Protocol Violation|1|||
163402903|NCT00876187|590187052|FG003|Overall Study|Randomized but not treated|2|||
163211642|NCT05838742|589488929|FG003|Overall Study|Randomized, not treated|1|||
163211643|NCT05838742|589488930|FG004|Overall Study|Randomized, not treated|0|||
162981877|NCT03052322|588634492|FG001|Overall Study|Protocol Violation|0|||
162981878|NCT03052322|588634491|FG000|Overall Study|Lost to Follow-up|2|||
162981879|NCT03052322|588634492|FG001|Overall Study|Lost to Follow-up|4|||
162981880|NCT03052322|588634491|FG000|Overall Study|Adverse Event|6|||
162981881|NCT03052322|588634492|FG001|Overall Study|Adverse Event|13|||
162981882|NCT05065983|588634493|FG000|Overall Study|Lost to Follow-up|2|||
162981883|NCT04505293|588634496|FG000|Overall Study|Lost to Follow-up|2|||
162981884|NCT04505293|588634496|FG000|Overall Study|Withdrawal by Subject|6|||
162981885|NCT04505293|588634496|FG000|Overall Study|CT scan unreadable|277|||
162981886|NCT00003875|588634497|FG000|Overall Study|Screen Failed|1|||
162981887|NCT01300052|588634498|FG000|Overall Study|Adverse Event|3|||
162981888|NCT01300052|588634499|FG001|Overall Study|Adverse Event|0|||
162981889|NCT01300052|588634498|FG000|Overall Study|Withdrawal by Subject|2|||
162981890|NCT01300052|588634499|FG001|Overall Study|Withdrawal by Subject|2|||
162981891|NCT01300052|588634498|FG000|Overall Study|Protocol Violation|1|||
162981892|NCT01300052|588634499|FG001|Overall Study|Protocol Violation|1|||
162981893|NCT01546649|588634500|FG000|Overall Study|Adverse Event|4|||
162981894|NCT01546649|588634501|FG001|Overall Study|Adverse Event|5|||
162981895|NCT01546649|588634500|FG000|Overall Study|Protocol Violation|1|||
162981896|NCT01546649|588634501|FG001|Overall Study|Protocol Violation|0|||
162981897|NCT01546649|588634500|FG000|Overall Study|Lack of Efficacy|1|||
162981898|NCT01546649|588634501|FG001|Overall Study|Lack of Efficacy|0|||
162981899|NCT01546649|588634500|FG000|Overall Study|Recurrence|1|||
162981900|NCT01546649|588634501|FG001|Overall Study|Recurrence|1|||
162981901|NCT01546649|588634500|FG000|Overall Study|Discovery of secondary cancer|0|||
162981902|NCT01546649|588634501|FG001|Overall Study|Discovery of secondary cancer|1|||
162981903|NCT01546649|588634500|FG000|Overall Study|Withdrawal by Subject|1|||
162981904|NCT01546649|588634501|FG001|Overall Study|Withdrawal by Subject|2|||
162981905|NCT01550744|588634502|FG000|Open-Label|Lost to Follow-up|7|||
162981906|NCT01550744|588634503|FG001|Open-Label|Lost to Follow-up|0|||
162981907|NCT01550744|588634504|FG002|Open-Label|Lost to Follow-up|0|||
162981908|NCT01550744|588634502|FG000|Open-Label|Withdrawal by Subject|13|||
162981909|NCT01550744|588634503|FG001|Open-Label|Withdrawal by Subject|0|||
162981910|NCT01550744|588634504|FG002|Open-Label|Withdrawal by Subject|0|||
162981911|NCT01550744|588634502|FG000|Open-Label|Adverse Event|11|||
162981912|NCT01550744|588634503|FG001|Open-Label|Adverse Event|0|||
162981913|NCT01550744|588634504|FG002|Open-Label|Adverse Event|0|||
162981914|NCT01550744|588634502|FG000|Open-Label|Lack of Efficacy|4|||
163059351|NCT00903968|588926358|FG006|Overall Study|Withdrawal by Subject|0|||
163059352|NCT00903968|588926359|FG007|Overall Study|Withdrawal by Subject|4|||
163059353|NCT00903968|588926352|FG000|Overall Study|Non-Compliance|0|||
163211644|NCT02045797|589488931|FG000|Overall Study|Adverse Event|3|||
163211645|NCT02045797|589488932|FG001|Overall Study|Adverse Event|1|||
163211646|NCT02045797|589488933|FG002|Overall Study|Adverse Event|0|||
163211647|NCT02045797|589488931|FG000|Overall Study|Lack of Efficacy|1|||
163211648|NCT02045797|589488932|FG001|Overall Study|Lack of Efficacy|0|||
163211649|NCT02045797|589488933|FG002|Overall Study|Lack of Efficacy|0|||
163211650|NCT02045797|589488931|FG000|Overall Study|Lost to Follow-up|2|||
163211651|NCT02045797|589488932|FG001|Overall Study|Lost to Follow-up|3|||
163211652|NCT02045797|589488933|FG002|Overall Study|Lost to Follow-up|1|||
163211653|NCT02045797|589488931|FG000|Overall Study|Physician Decision|0|||
163211654|NCT02045797|589488932|FG001|Overall Study|Physician Decision|1|||
163211655|NCT02045797|589488933|FG002|Overall Study|Physician Decision|0|||
163211656|NCT02045797|589488931|FG000|Overall Study|Withdrawal by Subject|1|||
163211657|NCT02045797|589488932|FG001|Overall Study|Withdrawal by Subject|2|||
163211658|NCT02045797|589488933|FG002|Overall Study|Withdrawal by Subject|0|||
163211659|NCT03851302|589488934|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
163211660|NCT03851302|589488935|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
163211661|NCT03851302|589488936|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
163211662|NCT03851302|589488937|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
163211663|NCT03851302|589488938|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
163211664|NCT03851302|589488939|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
163211665|NCT03851302|589488934|FG000|Screening (1 Day)|Screened out|0|||
163211666|NCT03851302|589488935|FG001|Screening (1 Day)|Screened out|0|||
163211667|NCT03851302|589488936|FG002|Screening (1 Day)|Screened out|1|||
163211668|NCT03851302|589488937|FG003|Screening (1 Day)|Screened out|1|||
163211669|NCT03851302|589488938|FG004|Screening (1 Day)|Screened out|0|||
163211670|NCT03851302|589488939|FG005|Screening (1 Day)|Screened out|0|||
163211671|NCT03851302|589488934|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
163211672|NCT03851302|589488935|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
163211673|NCT03851302|589488936|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
163211674|NCT03851302|589488937|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
163211675|NCT03851302|589488938|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
163211676|NCT03851302|589488939|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
163211677|NCT03220217|589490569|FG000|Overall Study|Withdrawal by Subject|0|||
163211678|NCT03220217|589490570|FG001|Overall Study|Withdrawal by Subject|1|||
163211679|NCT03220217|589490571|FG002|Overall Study|Withdrawal by Subject|0|||
163211680|NCT03220217|589490569|FG000|Overall Study|Subject Missed Procedure|0|||
163211681|NCT03220217|589490570|FG001|Overall Study|Subject Missed Procedure|0|||
163211682|NCT03220217|589490571|FG002|Overall Study|Subject Missed Procedure|1|||
163211683|NCT00501293|589490572|FG000|Optimization Period|Enrolled in error|1|||
163211684|NCT00501293|589490573|FG001|Optimization Period|Enrolled in error|0|||
163211685|NCT00501293|589490572|FG000|Maintenance Period|Withdrawal by Subject|14|||
163211686|NCT00501293|589490573|FG001|Maintenance Period|Withdrawal by Subject|13|||
163211687|NCT00501293|589490572|FG000|Maintenance Period|Lost to Follow-up|12|||
163211688|NCT00501293|589490573|FG001|Maintenance Period|Lost to Follow-up|7|||
163211689|NCT00501293|589490572|FG000|Maintenance Period|Adverse Event|6|||
163211690|NCT00501293|589490573|FG001|Maintenance Period|Adverse Event|6|||
163211691|NCT00501293|589490572|FG000|Maintenance Period|Protocol Violation|2|||
163211692|NCT00501293|589490573|FG001|Maintenance Period|Protocol Violation|1|||
163211693|NCT00501293|589490572|FG000|Maintenance Period|Lack of Efficacy|4|||
163211694|NCT00501293|589490573|FG001|Maintenance Period|Lack of Efficacy|1|||
163211695|NCT00501293|589490572|FG000|Maintenance Period|Noncompliant with study medication|5|||
163211696|NCT00501293|589490573|FG001|Maintenance Period|Noncompliant with study medication|0|||
162981915|NCT01550744|588634503|FG001|Open-Label|Lack of Efficacy|0|||
162981916|NCT01550744|588634504|FG002|Open-Label|Lack of Efficacy|0|||
162981917|NCT01550744|588634502|FG000|Open-Label|Protocol Violation|4|||
162981918|NCT01550744|588634503|FG001|Open-Label|Protocol Violation|0|||
162981919|NCT01550744|588634504|FG002|Open-Label|Protocol Violation|0|||
162981920|NCT01550744|588634502|FG000|Open-Label|Not all 3 study drug injections received|2|||
162981921|NCT01550744|588634503|FG001|Open-Label|Not all 3 study drug injections received|0|||
162981922|NCT01550744|588634504|FG002|Open-Label|Not all 3 study drug injections received|0|||
163211697|NCT00501293|589490572|FG000|Maintenance Period|Went into rehabilitation|1|||
163211698|NCT00501293|589490573|FG001|Maintenance Period|Went into rehabilitation|0|||
163211699|NCT00501293|589490572|FG000|Maintenance Period|Would not wear patch|1|||
163211700|NCT00501293|589490573|FG001|Maintenance Period|Would not wear patch|0|||
163211701|NCT00501293|589490572|FG000|Maintenance Period|Application site reaction|1|||
163211702|NCT00501293|589490573|FG001|Maintenance Period|Application site reaction|0|||
163211703|NCT02355691|589490578|FG000|Overall Study|Loss of Research Personnel|7|||
163211704|NCT02355691|589490579|FG001|Overall Study|Loss of Research Personnel|9|||
163211705|NCT01042236|589490583|FG000|Treatment Period 1|Adverse Event|0|||
163211706|NCT01042236|589490584|FG001|Treatment Period 1|Adverse Event|1|||
163211707|NCT01042236|589490585|FG002|Treatment Period 1|Adverse Event|0|||
163211708|NCT01042236|589490586|FG003|Treatment Period 1|Adverse Event|0|||
163211709|NCT01042236|589490587|FG004|Treatment Period 1|Adverse Event|1|||
163211710|NCT01042236|589490588|FG005|Treatment Period 1|Adverse Event|0|||
163211711|NCT01042236|589490583|FG000|Treatment Period 3|Adverse Event|0|||
163211712|NCT01042236|589490584|FG001|Treatment Period 3|Adverse Event|0|||
163211713|NCT01042236|589490585|FG002|Treatment Period 3|Adverse Event|0|||
163211714|NCT01042236|589490586|FG003|Treatment Period 3|Adverse Event|1|||
163211715|NCT01042236|589490587|FG004|Treatment Period 3|Adverse Event|0|||
163211716|NCT01042236|589490588|FG005|Treatment Period 3|Adverse Event|0|||
163211717|NCT01042236|589490583|FG000|Treatment Period 3|Protocol Violation|0|||
163211718|NCT01042236|589490584|FG001|Treatment Period 3|Protocol Violation|0|||
163211719|NCT01042236|589490585|FG002|Treatment Period 3|Protocol Violation|0|||
163211720|NCT01042236|589490586|FG003|Treatment Period 3|Protocol Violation|1|||
163211721|NCT01042236|589490587|FG004|Treatment Period 3|Protocol Violation|0|||
163211722|NCT01042236|589490588|FG005|Treatment Period 3|Protocol Violation|0|||
163211723|NCT01172847|589490591|FG000|Overall Study|Withdrawal by Subject|3|||
163211724|NCT02132767|589490596|FG000|Overall Study|Death|3|||
163211725|NCT02132767|589490597|FG001|Overall Study|Death|2|||
163211726|NCT02132767|589490596|FG000|Overall Study|Withdrawal by Subject|10|||
163211727|NCT02132767|589490597|FG001|Overall Study|Withdrawal by Subject|9|||
163211728|NCT02132767|589490596|FG000|Overall Study|Lost to Follow-up|4|||
163211729|NCT02132767|589490597|FG001|Overall Study|Lost to Follow-up|4|||
163211730|NCT00390858|589490598|FG000|Overall Study|Adverse Event|6|||
163211731|NCT00390858|589490599|FG001|Overall Study|Adverse Event|2|||
163211732|NCT00390858|589490598|FG000|Overall Study|Lack of Efficacy|0|||
163211733|NCT00390858|589490599|FG001|Overall Study|Lack of Efficacy|1|||
163211734|NCT00390858|589490598|FG000|Overall Study|Withdrawal by Subject|3|||
163211735|NCT00390858|589490599|FG001|Overall Study|Withdrawal by Subject|4|||
163321484|NCT05654662|589887765|FG000|Overall Study|Withdrawal by Subject|1|||
163321485|NCT05654662|589887766|FG001|Overall Study|Withdrawal by Subject|0|||
163321486|NCT05654662|589887765|FG000|Overall Study|A death in the family|1|||
162981923|NCT01550744|588634502|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
162981924|NCT01550744|588634503|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
162981925|NCT01550744|588634504|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
162981926|NCT01550744|588634502|FG000|Open-Label|Other|1|||
162981927|NCT01550744|588634503|FG001|Open-Label|Other|0|||
162981928|NCT01550744|588634504|FG002|Open-Label|Other|0|||
162981929|NCT01550744|588634502|FG000|Double-Blind|Lost to Follow-up|0|||
162981930|NCT01550744|588634503|FG001|Double-Blind|Lost to Follow-up|6|||
162981931|NCT01550744|588634504|FG002|Double-Blind|Lost to Follow-up|12|||
163321487|NCT05654662|589887766|FG001|Overall Study|A death in the family|0|||
163321488|NCT04330040|589887767|FG000|Overall Study|Other: Adverse event|5|||
163321489|NCT04330040|589887768|FG001|Overall Study|Other: Adverse event|0|||
163321490|NCT04330040|589887769|FG002|Overall Study|Other: Adverse event|0|||
163321491|NCT04330040|589887767|FG000|Overall Study|Disease progression|38|||
163321492|NCT04330040|589887768|FG001|Overall Study|Disease progression|10|||
163321493|NCT04330040|589887769|FG002|Overall Study|Disease progression|0|||
163321494|NCT04330040|589887767|FG000|Overall Study|Physician Decision|5|||
163321495|NCT04330040|589887768|FG001|Overall Study|Physician Decision|3|||
163321496|NCT04330040|589887769|FG002|Overall Study|Physician Decision|0|||
163321497|NCT04330040|589887767|FG000|Overall Study|Lost to Follow-up|1|||
163321498|NCT04330040|589887768|FG001|Overall Study|Lost to Follow-up|1|||
163321499|NCT04330040|589887769|FG002|Overall Study|Lost to Follow-up|0|||
163321500|NCT04330040|589887767|FG000|Overall Study|Death|2|||
163321501|NCT04330040|589887768|FG001|Overall Study|Death|1|||
163321502|NCT04330040|589887769|FG002|Overall Study|Death|0|||
163321503|NCT04330040|589887767|FG000|Overall Study|Withdrawal by Subject|3|||
163321504|NCT04330040|589887768|FG001|Overall Study|Withdrawal by Subject|3|||
163321505|NCT04330040|589887769|FG002|Overall Study|Withdrawal by Subject|0|||
163321506|NCT04330040|589887767|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
163321507|NCT04330040|589887768|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
163321508|NCT04330040|589887769|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
163321509|NCT04330040|589887767|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
163321510|NCT04330040|589887768|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
163321511|NCT04330040|589887769|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
163321512|NCT04330040|589887767|FG000|Overall Study|Other: Disease progression|1|||
163321513|NCT04330040|589887768|FG001|Overall Study|Other: Disease progression|0|||
163321514|NCT04330040|589887769|FG002|Overall Study|Other: Disease progression|0|||
163321515|NCT04330040|589887767|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
163321516|NCT04330040|589887768|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
163321517|NCT04330040|589887769|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
163321518|NCT04330040|589887767|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
163321519|NCT04330040|589887768|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
163321520|NCT04330040|589887769|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
163321521|NCT04330040|589887767|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
163321522|NCT04330040|589887768|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
163321523|NCT04330040|589887769|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
163321524|NCT05962814|589887770|FG000|Overall Study|failed eligibility|1|||
163321525|NCT03057054|589887771|FG000|Overall Study|Death|4|||
163321526|NCT03057054|589887772|FG001|Overall Study|Death|4|||
163321527|NCT03057054|589887771|FG000|Overall Study|Withdrawal by Subject|6|||
163321528|NCT03057054|589887772|FG001|Overall Study|Withdrawal by Subject|3|||
163321529|NCT03057054|589887771|FG000|Overall Study|Ineligible|1|||
163321530|NCT03057054|589887772|FG001|Overall Study|Ineligible|1|||
163321531|NCT04427007|589888947|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
163321532|NCT04427007|589888948|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
163321533|NCT05311176|589888951|FG000|Overall Study|Death|6|||
163321534|NCT05311176|589888951|FG000|Overall Study|Sponsor discontinued the study|1|||
163321535|NCT05247034|589888952|FG000|Overall Study|Lost to Follow-up|3|||
163321536|NCT05247034|589888953|FG001|Overall Study|Lost to Follow-up|2|||
163321537|NCT05247034|589888952|FG000|Overall Study|Organizational problems when attending appointments|1|||
163321538|NCT05247034|589888953|FG001|Overall Study|Organizational problems when attending appointments|0|||
163321539|NCT03972150|589888956|FG000|Overall Study|Adverse Event|0|||
163321540|NCT03972150|589888957|FG001|Overall Study|Adverse Event|1|||
163321541|NCT03972150|589888958|FG002|Overall Study|Adverse Event|1|||
163321542|NCT03972150|589888959|FG003|Overall Study|Adverse Event|0|||
163321543|NCT03972150|589888960|FG004|Overall Study|Adverse Event|0|||
163321544|NCT03972150|589888956|FG000|Overall Study|Progressive disease|3|||
163321545|NCT03972150|589888957|FG001|Overall Study|Progressive disease|5|||
163321546|NCT03972150|589888958|FG002|Overall Study|Progressive disease|2|||
163321547|NCT03972150|589888959|FG003|Overall Study|Progressive disease|2|||
163321548|NCT03972150|589888960|FG004|Overall Study|Progressive disease|3|||
163321549|NCT02668692|589888963|FG000|Overall Study|Adverse Event|1|||
163321550|NCT02668692|589888964|FG001|Overall Study|Adverse Event|0|||
163321551|NCT05464069|589888966|FG000|Overall Study|Protocol Violation|3|||
163321552|NCT05464069|589888967|FG001|Overall Study|Protocol Violation|2|||
163321553|NCT03442309|589888968|FG000|Overall Study|Lost to Follow-up|1676|||
163321554|NCT03442309|589888969|FG001|Overall Study|Lost to Follow-up|1642|||
163321555|NCT04615273|589888975|FG000|Overall Study|Withdrawal by Subject|3|||
163321556|NCT04615273|589888976|FG001|Overall Study|Withdrawal by Subject|1|||
163321557|NCT04615273|589888977|FG002|Overall Study|Withdrawal by Subject|2|||
163321558|NCT04615273|589888975|FG000|Overall Study|Adverse Event|1|||
163059354|NCT00903968|588926353|FG001|Overall Study|Non-Compliance|0|||
163059355|NCT00903968|588926354|FG002|Overall Study|Non-Compliance|0|||
163059356|NCT00903968|588926355|FG003|Overall Study|Non-Compliance|0|||
163059357|NCT00903968|588926356|FG004|Overall Study|Non-Compliance|0|||
163059358|NCT00903968|588926357|FG005|Overall Study|Non-Compliance|1|||
163059359|NCT00903968|588926358|FG006|Overall Study|Non-Compliance|0|||
163059360|NCT00903968|588926359|FG007|Overall Study|Non-Compliance|0|||
163059361|NCT00903968|588926352|FG000|Overall Study|Physician Decision|0|||
163059362|NCT00903968|588926353|FG001|Overall Study|Physician Decision|0|||
163059363|NCT00903968|588926354|FG002|Overall Study|Physician Decision|0|||
163059364|NCT00903968|588926355|FG003|Overall Study|Physician Decision|0|||
163059365|NCT00903968|588926356|FG004|Overall Study|Physician Decision|0|||
163059366|NCT00903968|588926357|FG005|Overall Study|Physician Decision|1|||
163059367|NCT00903968|588926358|FG006|Overall Study|Physician Decision|0|||
163059368|NCT00903968|588926359|FG007|Overall Study|Physician Decision|0|||
163059369|NCT00903968|588926352|FG000|Overall Study|Progressive Disease|2|||
163059370|NCT00903968|588926353|FG001|Overall Study|Progressive Disease|3|||
163059371|NCT00903968|588926354|FG002|Overall Study|Progressive Disease|2|||
163059372|NCT00903968|588926355|FG003|Overall Study|Progressive Disease|3|||
163059373|NCT00903968|588926356|FG004|Overall Study|Progressive Disease|3|||
163059374|NCT00903968|588926357|FG005|Overall Study|Progressive Disease|3|||
163059375|NCT00903968|588926358|FG006|Overall Study|Progressive Disease|0|||
163059376|NCT00903968|588926359|FG007|Overall Study|Progressive Disease|18|||
163059377|NCT00903968|588926352|FG000|Overall Study|Lack of Efficacy|0|||
163059378|NCT00903968|588926353|FG001|Overall Study|Lack of Efficacy|0|||
163059379|NCT00903968|588926354|FG002|Overall Study|Lack of Efficacy|0|||
163059380|NCT00903968|588926355|FG003|Overall Study|Lack of Efficacy|0|||
163059381|NCT00903968|588926356|FG004|Overall Study|Lack of Efficacy|0|||
163059382|NCT00903968|588926357|FG005|Overall Study|Lack of Efficacy|0|||
163059383|NCT00903968|588926358|FG006|Overall Study|Lack of Efficacy|0|||
163059384|NCT00903968|588926359|FG007|Overall Study|Lack of Efficacy|3|||
163211736|NCT00937157|589490600|FG000|Overall Study|Pregnancy|1|||
163211737|NCT00937157|589490600|FG000|Overall Study|Lost to Follow-up|3|||
163211738|NCT02865187|589490601|FG000|Overall Study|Lost to Follow-up|12|||
163211739|NCT02865187|589490602|FG001|Overall Study|Lost to Follow-up|7|||
163211740|NCT02865187|589490601|FG000|Overall Study|Adverse Event|1|||
163211741|NCT02865187|589490602|FG001|Overall Study|Adverse Event|0|||
163211742|NCT04267133|589490603|FG000|Overall Study|Withdrawal by Subject|1|||
163211743|NCT04267133|589490603|FG000|Overall Study|Adverse Event|4|||
163211744|NCT02968563|589490604|FG000|Overall Study|Adverse Event|0|||
163211745|NCT02968563|589490605|FG001|Overall Study|Adverse Event|6|||
163211746|NCT02968563|589490604|FG000|Overall Study|Death|1|||
163211747|NCT02968563|589490605|FG001|Overall Study|Death|1|||
163211748|NCT02968563|589490604|FG000|Overall Study|Lost to Follow-up|0|||
163211749|NCT02968563|589490605|FG001|Overall Study|Lost to Follow-up|1|||
163211750|NCT00674661|589490606|FG000|Overall Study|Other|5|||
163211751|NCT00674661|589490607|FG001|Overall Study|Other|7|||
163211752|NCT00674661|589490606|FG000|Overall Study|Lost to Follow-up|6|||
163211753|NCT00674661|589490607|FG001|Overall Study|Lost to Follow-up|3|||
163211754|NCT00674661|589490606|FG000|Overall Study|Withdrawal by Subject|0|||
163211755|NCT00674661|589490607|FG001|Overall Study|Withdrawal by Subject|5|||
163211756|NCT03566823|589490610|FG000|Overall Study|Lack of Efficacy|0|||
163211757|NCT03566823|589490611|FG001|Overall Study|Lack of Efficacy|1|||
163211758|NCT03566823|589490612|FG002|Overall Study|Lack of Efficacy|0|||
163211759|NCT03566823|589490610|FG000|Overall Study|Withdrawal by Subject|1|||
163211760|NCT03566823|589490611|FG001|Overall Study|Withdrawal by Subject|2|||
163211761|NCT03566823|589490612|FG002|Overall Study|Withdrawal by Subject|0|||
163211762|NCT03566823|589490610|FG000|Overall Study|Adverse Event|1|||
163211763|NCT03566823|589490611|FG001|Overall Study|Adverse Event|0|||
163211764|NCT03566823|589490612|FG002|Overall Study|Adverse Event|2|||
163211765|NCT01909479|589490613|FG000|From Baseline to Week 26|Adverse Event|3|||
163211766|NCT01909479|589490614|FG001|From Baseline to Week 26|Adverse Event|2|||
163211767|NCT01909479|589490613|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
163211768|NCT01909479|589490614|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
163211769|NCT01909479|589490613|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
163211770|NCT01909479|589490614|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
163211771|NCT01909479|589490613|FG000|26 - 52 Weeks|Adverse Event|0|||
163211772|NCT01909479|589490614|FG001|26 - 52 Weeks|Adverse Event|1|||
163211773|NCT01909479|589490613|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
163211774|NCT01909479|589490614|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
163211775|NCT01909479|589490613|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
163211776|NCT01909479|589490614|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
163211777|NCT01909479|589490613|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
163211778|NCT01909479|589490614|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
163211779|NCT01909479|589490613|FG000|52 Weeks to End of Study|Adverse Event|2|||
163211780|NCT01909479|589490614|FG001|52 Weeks to End of Study|Adverse Event|1|||
163211781|NCT01909479|589490613|FG000|52 Weeks to End of Study|Death|0|||
163211782|NCT01909479|589490614|FG001|52 Weeks to End of Study|Death|1|||
163321559|NCT04615273|589888976|FG001|Overall Study|Adverse Event|0|||
163321560|NCT04615273|589888977|FG002|Overall Study|Adverse Event|1|||
163321561|NCT04615273|589888975|FG000|Overall Study|Lost to Follow-up|0|||
163321562|NCT04615273|589888976|FG001|Overall Study|Lost to Follow-up|1|||
163321563|NCT04615273|589888977|FG002|Overall Study|Lost to Follow-up|0|||
163321564|NCT04615273|589888975|FG000|Overall Study|Physician Decision|0|||
163321565|NCT04615273|589888976|FG001|Overall Study|Physician Decision|0|||
163321566|NCT04615273|589888977|FG002|Overall Study|Physician Decision|1|||
163321567|NCT04615273|589888975|FG000|Overall Study|Other|0|||
163321568|NCT04615273|589888976|FG001|Overall Study|Other|1|||
163321569|NCT04615273|589888977|FG002|Overall Study|Other|0|||
163321570|NCT04615273|589888975|FG000|Overall Study|Randomized but not treated|1|||
163321571|NCT04615273|589888976|FG001|Overall Study|Randomized but not treated|3|||
163321572|NCT04615273|589888977|FG002|Overall Study|Randomized but not treated|1|||
163321573|NCT01314105|589888982|FG000|Overall Study|Progressive Disease|6|||
163321574|NCT01314105|589888983|FG001|Overall Study|Progressive Disease|10|||
163321575|NCT01314105|589888982|FG000|Overall Study|Refused to continue taking medication|0|||
163321576|NCT01314105|589888983|FG001|Overall Study|Refused to continue taking medication|1|||
163321577|NCT01314105|589888982|FG000|Overall Study|Other Adverse Event|1|||
163321578|NCT01314105|589888983|FG001|Overall Study|Other Adverse Event|1|||
163321579|NCT06106022|589888984|FG000|Overall Study|Lost to Follow-up|1|||
163321580|NCT06106022|589888985|FG001|Overall Study|Lost to Follow-up|0|||
163321581|NCT06106022|589888984|FG000|Overall Study|Voluntary Withdrawal|0|||
163321582|NCT06106022|589888985|FG001|Overall Study|Voluntary Withdrawal|2|||
163321583|NCT03640286|589888986|FG000|Overall Study|Adverse Event|6|||
163321584|NCT03640286|589888987|FG001|Overall Study|Adverse Event|6|||
163321585|NCT03640286|589888986|FG000|Overall Study|Lost to Follow-up|3|||
163321586|NCT03640286|589888987|FG001|Overall Study|Lost to Follow-up|6|||
163321587|NCT03640286|589888986|FG000|Overall Study|Pregnancy|1|||
163321588|NCT03640286|589888987|FG001|Overall Study|Pregnancy|0|||
163321589|NCT03640286|589888986|FG000|Overall Study|Withdrawal by Subject|10|||
163321590|NCT03640286|589888987|FG001|Overall Study|Withdrawal by Subject|10|||
162981932|NCT01550744|588634502|FG000|Double-Blind|Withdrawal by Subject|0|||
162981933|NCT01550744|588634503|FG001|Double-Blind|Withdrawal by Subject|2|||
162981934|NCT01550744|588634504|FG002|Double-Blind|Withdrawal by Subject|15|||
162981935|NCT01550744|588634502|FG000|Double-Blind|Adverse Event|0|||
162981936|NCT01550744|588634503|FG001|Double-Blind|Adverse Event|4|||
162981937|NCT01550744|588634504|FG002|Double-Blind|Adverse Event|15|||
162981938|NCT01550744|588634502|FG000|Double-Blind|Death|0|||
162981939|NCT01550744|588634503|FG001|Double-Blind|Death|1|||
162981940|NCT01550744|588634504|FG002|Double-Blind|Death|0|||
162981941|NCT01550744|588634502|FG000|Double-Blind|Lack of Efficacy|0|||
162981942|NCT01550744|588634503|FG001|Double-Blind|Lack of Efficacy|2|||
162981943|NCT01550744|588634504|FG002|Double-Blind|Lack of Efficacy|8|||
162981944|NCT01550744|588634502|FG000|Double-Blind|Protocol Violation|0|||
162981945|NCT01550744|588634503|FG001|Double-Blind|Protocol Violation|0|||
162981946|NCT01550744|588634504|FG002|Double-Blind|Protocol Violation|4|||
162981947|NCT01550744|588634502|FG000|Double-Blind|Pregnancy|0|||
162981948|NCT01550744|588634503|FG001|Double-Blind|Pregnancy|0|||
162981949|NCT01550744|588634504|FG002|Double-Blind|Pregnancy|3|||
162981950|NCT01550744|588634502|FG000|Double-Blind|Other|0|||
162981951|NCT01550744|588634503|FG001|Double-Blind|Other|2|||
162981952|NCT01550744|588634504|FG002|Double-Blind|Other|10|||
162981953|NCT00706381|588634507|FG000|Overall Study|Lost to Follow-up|0|||
162981954|NCT00706381|588634508|FG001|Overall Study|Lost to Follow-up|1|||
162981955|NCT00706381|588634509|FG002|Overall Study|Lost to Follow-up|1|||
162981956|NCT00706381|588634510|FG003|Overall Study|Lost to Follow-up|0|||
162981957|NCT05420012|588634511|FG000|Overall Study|Lost to Follow-up|0|||
162981958|NCT05420012|588634512|FG001|Overall Study|Lost to Follow-up|1|||
162981959|NCT00767520|588634516|FG000|Overall Study|Participants still on treatment|11|||
162981960|NCT00767520|588634517|FG001|Overall Study|Participants still on treatment|15|||
162981961|NCT00767520|588634516|FG000|Overall Study|Randomized in error and Never treated|0|||
162981962|NCT00767520|588634517|FG001|Overall Study|Randomized in error and Never treated|2|||
162981963|NCT01901874|588634527|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
162981964|NCT01901874|588634527|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
162981965|NCT01901874|588634527|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
162981966|NCT01901874|588634527|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
162981967|NCT01901874|588634527|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
163321591|NCT03640286|589888986|FG000|Overall Study|Non-compliance|4|||
163321592|NCT03640286|589888987|FG001|Overall Study|Non-compliance|10|||
163321593|NCT03640286|589888986|FG000|Overall Study|Medication change|1|||
163321594|NCT03640286|589888987|FG001|Overall Study|Medication change|0|||
163321595|NCT03640286|589888986|FG000|Overall Study|Other|1|||
163321596|NCT03640286|589888987|FG001|Overall Study|Other|2|||
163321597|NCT03640286|589888986|FG000|Overall Study|Joined another lifestyle program|0|||
163321598|NCT03640286|589888987|FG001|Overall Study|Joined another lifestyle program|1|||
162981968|NCT01901874|588634527|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
162981969|NCT03078582|588634528|FG000|Overall Study|Adverse Event|0|||
163321599|NCT05405985|589888991|FG000|Overall Study|Withdrawal by Subject|1|||
163402904|NCT00876187|590187053|FG004|Overall Study|Randomized but not treated|3|||
163402905|NCT00876187|590187049|FG000|Overall Study|Other|2|||
163402906|NCT00876187|590187050|FG001|Overall Study|Other|5|||
163402907|NCT00876187|590187051|FG002|Overall Study|Other|9|||
163402908|NCT00876187|590187052|FG003|Overall Study|Other|7|||
163402909|NCT00876187|590187053|FG004|Overall Study|Other|4|||
163402910|NCT03200366|590187056|FG000|Patient Navigation Intervention Given|Death|0|||
163402911|NCT03200366|590187057|FG001|Patient Navigation Intervention Given|Death|2|||
163402912|NCT03200366|590187058|FG002|Patient Navigation Intervention Given|Death|0|||
163402913|NCT03200366|590187056|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
163402914|NCT03200366|590187057|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
163402915|NCT03200366|590187058|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
163402916|NCT03200366|590187056|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
163402917|NCT03200366|590187057|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
163402918|NCT03200366|590187058|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
163402919|NCT03200366|590187056|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
163402920|NCT03200366|590187057|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
163402921|NCT03200366|590187058|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
163402922|NCT03200366|590187056|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
163402923|NCT03200366|590187057|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
163402924|NCT03200366|590187058|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
163402925|NCT03200366|590187056|FG000|6 Month Post-Baseline Interview|Death|1|||
163402926|NCT03200366|590187057|FG001|6 Month Post-Baseline Interview|Death|1|||
163402927|NCT03200366|590187058|FG002|6 Month Post-Baseline Interview|Death|1|||
163402928|NCT03200366|590187056|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
163402929|NCT03200366|590187057|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
163402930|NCT03200366|590187058|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
163402931|NCT03200366|590187056|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
163402932|NCT03200366|590187057|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
163402933|NCT03200366|590187058|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
163402934|NCT03200366|590187056|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
163402935|NCT03200366|590187057|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
163402936|NCT03200366|590187058|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
163402937|NCT03200366|590187056|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
163402938|NCT03200366|590187057|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
163402939|NCT03200366|590187058|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
163402940|NCT03200366|590187056|FG000|9 Month Post-Baseline Interview|Death|1|||
163402941|NCT03200366|590187057|FG001|9 Month Post-Baseline Interview|Death|1|||
163402942|NCT03200366|590187058|FG002|9 Month Post-Baseline Interview|Death|1|||
163402943|NCT03200366|590187056|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
163402944|NCT03200366|590187057|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
163402945|NCT03200366|590187058|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
163402946|NCT03200366|590187056|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
163402947|NCT03200366|590187057|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
163402948|NCT03200366|590187058|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
163402949|NCT03200366|590187056|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
163402950|NCT03200366|590187057|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
163402951|NCT03200366|590187058|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
162981970|NCT03078582|588634529|FG001|Overall Study|Adverse Event|8|||
162981971|NCT01491035|588634543|FG000|Overall Study|Lost to Follow-up|0|||
162981972|NCT01491035|588634544|FG001|Overall Study|Lost to Follow-up|0|||
162981973|NCT01491035|588634545|FG002|Overall Study|Lost to Follow-up|0|||
162981974|NCT01491035|588634546|FG003|Overall Study|Lost to Follow-up|0|||
162981975|NCT01491035|588634547|FG004|Overall Study|Lost to Follow-up|1|||
162981976|NCT01491035|588634548|FG005|Overall Study|Lost to Follow-up|0|||
162981977|NCT01491035|588634549|FG006|Overall Study|Lost to Follow-up|0|||
162981978|NCT01491035|588634550|FG007|Overall Study|Lost to Follow-up|0|||
162981979|NCT02181296|588634552|FG000|Overall Study|Lost to Follow-up|7|||
162981980|NCT02181296|588634553|FG001|Overall Study|Lost to Follow-up|6|||
162981981|NCT02340221|588634558|FG000|Overall Study|Death|100|||
162981982|NCT02340221|588634559|FG001|Overall Study|Death|197|||
162981983|NCT02340221|588634558|FG000|Overall Study|Withdrawal by Participant|24|||
163402952|NCT00405067|590187059|FG000|Overall Study|Adverse Event|4|||
163402953|NCT00405067|590187060|FG001|Overall Study|Adverse Event|9|||
163402954|NCT00405067|590187061|FG002|Overall Study|Adverse Event|4|||
163402955|NCT00405067|590187059|FG000|Overall Study|Lost to Follow-up|0|||
162981984|NCT02340221|588634559|FG001|Overall Study|Withdrawal by Participant|37|||
162981985|NCT02340221|588634558|FG000|Overall Study|Lost to Follow-up|4|||
162981986|NCT02340221|588634559|FG001|Overall Study|Lost to Follow-up|15|||
162981987|NCT02340221|588634558|FG000|Overall Study|Reason Not Specified|85|||
163402956|NCT00405067|590187060|FG001|Overall Study|Lost to Follow-up|0|||
163402957|NCT00405067|590187061|FG002|Overall Study|Lost to Follow-up|1|||
163402958|NCT03571646|590187066|FG000|Overall Study|Adverse Event|1|||
163402959|NCT03571646|590187067|FG001|Overall Study|Adverse Event|0|||
163402960|NCT03571646|590187066|FG000|Overall Study|Withdrawal by Subject|1|||
163402961|NCT03571646|590187067|FG001|Overall Study|Withdrawal by Subject|1|||
163402962|NCT03972969|590187068|FG000|3-month Follow-up|Death|1|||
163402963|NCT03972969|590187069|FG001|3-month Follow-up|Death|1|||
163402964|NCT03972969|590187070|FG002|3-month Follow-up|Death|0|||
163402965|NCT03972969|590187068|FG000|6-month Follow-up|Death|1|||
163402966|NCT03972969|590187069|FG001|6-month Follow-up|Death|1|||
163402967|NCT03972969|590187070|FG002|6-month Follow-up|Death|1|||
163402968|NCT03972969|590187068|FG000|6-month Follow-up|Lost to Follow-up|2|||
163402969|NCT03972969|590187069|FG001|6-month Follow-up|Lost to Follow-up|2|||
163402970|NCT03972969|590187070|FG002|6-month Follow-up|Lost to Follow-up|2|||
163402971|NCT04718974|590187071|FG000|Overall Study|Death|0|||
163402972|NCT04718974|590187072|FG001|Overall Study|Death|2|||
163402973|NCT04718974|590187071|FG000|Overall Study|Lost to Follow-up|10|||
163402974|NCT04718974|590187072|FG001|Overall Study|Lost to Follow-up|20|||
163402975|NCT04718974|590187071|FG000|Overall Study|Transferred out|2|||
163402976|NCT04718974|590187072|FG001|Overall Study|Transferred out|4|||
163402977|NCT00845728|590187073|FG000|Overall Study|Abnormal laboratory value (s)|2|||
163402978|NCT00845728|590187074|FG001|Overall Study|Abnormal laboratory value (s)|2|||
163402979|NCT00845728|590187073|FG000|Overall Study|Patient's inability to use the device|4|||
163402980|NCT00845728|590187074|FG001|Overall Study|Patient's inability to use the device|6|||
163402981|NCT00845728|590187073|FG000|Overall Study|Abnormal test procedure result (s)|7|||
163402982|NCT00845728|590187074|FG001|Overall Study|Abnormal test procedure result (s)|2|||
163402983|NCT00845728|590187073|FG000|Overall Study|Lost to Follow-up|22|||
163402984|NCT00845728|590187074|FG001|Overall Study|Lost to Follow-up|13|||
163402985|NCT00845728|590187073|FG000|Overall Study|Death|24|||
163402986|NCT00845728|590187074|FG001|Overall Study|Death|26|||
163402987|NCT00845728|590187073|FG000|Overall Study|Administrative Problems|34|||
163402988|NCT00845728|590187074|FG001|Overall Study|Administrative Problems|26|||
163402989|NCT00845728|590187073|FG000|Overall Study|Protocol Violation|36|||
163402990|NCT00845728|590187074|FG001|Overall Study|Protocol Violation|24|||
163402991|NCT00845728|590187073|FG000|Overall Study|Lack of Efficacy|51|||
163402992|NCT00845728|590187074|FG001|Overall Study|Lack of Efficacy|39|||
163402993|NCT00845728|590187073|FG000|Overall Study|Adverse Event|101|||
163402994|NCT00845728|590187074|FG001|Overall Study|Adverse Event|96|||
163402995|NCT00845728|590187073|FG000|Overall Study|Withdrawal by Subject|105|||
163402996|NCT00845728|590187074|FG001|Overall Study|Withdrawal by Subject|108|||
163402997|NCT04081363|590187075|FG000|Overall Study|Withdrawal by Subject|1|||
163402998|NCT04081363|590187076|FG001|Overall Study|Withdrawal by Subject|0|||
163402999|NCT02409290|590187077|FG000|Overall Study|Protocol Violation|3|||
163403000|NCT02409290|590187078|FG001|Overall Study|Protocol Violation|6|||
163403001|NCT02409290|590187079|FG002|Overall Study|Protocol Violation|9|||
163403002|NCT02409290|590187080|FG003|Overall Study|Protocol Violation|4|||
163211783|NCT01909479|589490613|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
163211784|NCT01909479|589490614|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
163403003|NCT02409290|590187077|FG000|Overall Study|No positive culture/no baseline sample|3|||
163403004|NCT02409290|590187078|FG001|Overall Study|No positive culture/no baseline sample|9|||
163403005|NCT02409290|590187079|FG002|Overall Study|No positive culture/no baseline sample|6|||
163403006|NCT02409290|590187080|FG003|Overall Study|No positive culture/no baseline sample|5|||
163403007|NCT02409290|590187077|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
163403008|NCT02409290|590187078|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
163211785|NCT01909479|589490613|FG000|52 Weeks to End of Study|Protocol Violation|1|||
163211786|NCT01909479|589490614|FG001|52 Weeks to End of Study|Protocol Violation|0|||
163211787|NCT01909479|589490613|FG000|52 Weeks to End of Study|Progressive disease|1|||
163211788|NCT01909479|589490614|FG001|52 Weeks to End of Study|Progressive disease|1|||
163211789|NCT01909479|589490613|FG000|52 Weeks to End of Study|Personal reasons|2|||
163211790|NCT01909479|589490614|FG001|52 Weeks to End of Study|Personal reasons|1|||
163211791|NCT01909479|589490613|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
163211792|NCT01909479|589490614|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
163211793|NCT01909479|589490613|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
163211794|NCT01909479|589490614|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
163211795|NCT01909479|589490613|FG000|52 Weeks to End of Study|Lack of contact|1|||
163211796|NCT01909479|589490614|FG001|52 Weeks to End of Study|Lack of contact|0|||
163211797|NCT01909479|589490613|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
163211798|NCT01909479|589490614|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
163211799|NCT01909479|589490613|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
163403009|NCT02409290|590187079|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
163403010|NCT02409290|590187080|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
163403011|NCT00705783|590187083|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
163403012|NCT00705783|590187084|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
163321600|NCT05405985|589888992|FG001|Overall Study|Withdrawal by Subject|0|||
163321601|NCT01820611|589888999|FG000|Overall Study|Death|8|||
163321602|NCT01820611|589888999|FG000|Overall Study|Adverse Event|1|||
163321603|NCT01820611|589888999|FG000|Overall Study|Withdrawal by Subject|9|||
163321604|NCT03484819|589889000|FG000|Overall Study|Death|2|||
163321605|NCT03484819|589889000|FG000|Overall Study|Adverse Event|2|||
163321606|NCT03484819|589889000|FG000|Overall Study|Physician Decision|1|||
163321607|NCT03484819|589889000|FG000|Overall Study|Withdrawal by Subject|2|||
163321608|NCT03484819|589889000|FG000|Overall Study|Disease Progression|4|||
163321609|NCT03484819|589889000|FG000|Overall Study|Complicating Condition|1|||
163321610|NCT03015532|589889001|FG000|Overall Study|Adverse Event|0|||
163321611|NCT03015532|589889002|FG001|Overall Study|Adverse Event|0|||
163321612|NCT03015532|589889003|FG002|Overall Study|Adverse Event|0|||
163321613|NCT03015532|589889004|FG003|Overall Study|Adverse Event|0|||
163321614|NCT03015532|589889005|FG004|Overall Study|Adverse Event|0|||
163321615|NCT03015532|589889006|FG005|Overall Study|Adverse Event|2|||
163321616|NCT03015532|589889007|FG006|Overall Study|Adverse Event|1|||
163321617|NCT03015532|589889008|FG007|Overall Study|Adverse Event|0|||
163321618|NCT03015532|589889001|FG000|Overall Study|Withdrawal by Subject|0|||
163321619|NCT03015532|589889002|FG001|Overall Study|Withdrawal by Subject|0|||
163321620|NCT03015532|589889003|FG002|Overall Study|Withdrawal by Subject|0|||
163321621|NCT03015532|589889004|FG003|Overall Study|Withdrawal by Subject|0|||
163321622|NCT03015532|589889005|FG004|Overall Study|Withdrawal by Subject|0|||
163321623|NCT03015532|589889006|FG005|Overall Study|Withdrawal by Subject|0|||
163321624|NCT03015532|589889007|FG006|Overall Study|Withdrawal by Subject|1|||
163321625|NCT03015532|589889008|FG007|Overall Study|Withdrawal by Subject|0|||
163321626|NCT05013385|589889013|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
163321627|NCT01447719|589889014|FG000|Overall Study|Image acquisition failure|2|||
163321628|NCT01447719|589889014|FG000|Overall Study|Invalid image or not imaged|3|||
163321629|NCT01447719|589889014|FG000|Overall Study|Subject still living at end of study|79|||
163321630|NCT01447719|589889014|FG000|Overall Study|Withdrawal by Subject|2|||
163321631|NCT01447719|589889014|FG000|Overall Study|Family withdrew autopsy consent|7|||
163321632|NCT02944968|589889015|FG000|Overall Study|Subject excluded before study procedure|1|||
162981988|NCT02340221|588634559|FG001|Overall Study|Reason Not Specified|165|||
162981989|NCT02340221|588634558|FG000|Overall Study|Study Terminated by Sponsor|1|||
162981990|NCT02340221|588634559|FG001|Overall Study|Study Terminated by Sponsor|3|||
162981991|NCT00518622|588634560|FG000|Overall Study|Lost to Follow-up|0|||
162981992|NCT00518622|588634561|FG001|Overall Study|Lost to Follow-up|0|||
162981993|NCT00518622|588634562|FG002|Overall Study|Lost to Follow-up|1|||
162981994|NCT00518622|588634563|FG003|Overall Study|Lost to Follow-up|0|||
162981995|NCT00518622|588634564|FG004|Overall Study|Lost to Follow-up|0|||
162981996|NCT00518622|588634565|FG005|Overall Study|Lost to Follow-up|0|||
162981997|NCT00518622|588634566|FG006|Overall Study|Lost to Follow-up|0|||
162981998|NCT00518622|588634567|FG007|Overall Study|Lost to Follow-up|0|||
162981999|NCT00518622|588634560|FG000|Overall Study|Study medication taken incorrectly|0|||
162982000|NCT00518622|588634561|FG001|Overall Study|Study medication taken incorrectly|1|||
162982001|NCT00518622|588634562|FG002|Overall Study|Study medication taken incorrectly|0|||
162982002|NCT00518622|588634563|FG003|Overall Study|Study medication taken incorrectly|0|||
162982003|NCT00518622|588634564|FG004|Overall Study|Study medication taken incorrectly|0|||
162982004|NCT00518622|588634565|FG005|Overall Study|Study medication taken incorrectly|0|||
162982005|NCT00518622|588634566|FG006|Overall Study|Study medication taken incorrectly|0|||
162982006|NCT00518622|588634567|FG007|Overall Study|Study medication taken incorrectly|0|||
162982007|NCT03499119|588634568|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
162982008|NCT03499119|588634569|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
162982009|NCT03499119|588634570|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
162982010|NCT03499119|588634571|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
162982011|NCT03499119|588634568|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
162982012|NCT03499119|588634569|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
162982013|NCT03499119|588634570|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
162982014|NCT03499119|588634571|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
162982015|NCT03499119|588634568|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
162982016|NCT03499119|588634569|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
162982017|NCT03499119|588634570|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
163321633|NCT02944968|589889015|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
162982018|NCT03499119|588634571|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
162982019|NCT03499119|588634568|FG000|Optional Extension Phase|Lost to Follow-up|0|||
162982020|NCT03499119|588634569|FG001|Optional Extension Phase|Lost to Follow-up|0|||
162982021|NCT03499119|588634570|FG002|Optional Extension Phase|Lost to Follow-up|0|||
162982022|NCT03499119|588634571|FG003|Optional Extension Phase|Lost to Follow-up|1|||
162982023|NCT03499119|588634568|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
162982024|NCT03499119|588634569|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
163321634|NCT02874742|589889017|FG000|Overall Study|Death|0|||
163321635|NCT02874742|589889018|FG001|Overall Study|Death|1|||
163321636|NCT02874742|589889019|FG002|Overall Study|Death|0|||
163321637|NCT02874742|589889017|FG000|Overall Study|Lost to Follow-up|5|||
162982025|NCT03499119|588634570|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
162982026|NCT03499119|588634571|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
162982027|NCT03499119|588634568|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
162982028|NCT03499119|588634569|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
162982029|NCT03499119|588634570|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
162982030|NCT03499119|588634571|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
162982031|NCT01558297|588634572|FG000|Overall Study|Withdrawal by Subject|2|||
162982032|NCT01558297|588634573|FG001|Overall Study|Withdrawal by Subject|2|||
162982033|NCT01558297|588634574|FG002|Overall Study|Withdrawal by Subject|1|||
162982034|NCT02655016|588634577|FG000|Overall Study|Disease progression|6|||
162982035|NCT02655016|588634578|FG001|Overall Study|Disease progression|4|||
162982036|NCT02655016|588634577|FG000|Overall Study|Site closed|0|||
162982037|NCT02655016|588634578|FG001|Overall Study|Site closed|1|||
162982038|NCT02655016|588634577|FG000|Overall Study|Death|30|||
162982039|NCT02655016|588634578|FG001|Overall Study|Death|48|||
162982040|NCT02655016|588634577|FG000|Overall Study|Lost to Follow-up|1|||
162982041|NCT02655016|588634578|FG001|Overall Study|Lost to Follow-up|1|||
162982042|NCT02655016|588634577|FG000|Overall Study|Withdrawal by Subject|18|||
162982043|NCT02655016|588634578|FG001|Overall Study|Withdrawal by Subject|36|||
162982044|NCT00952276|588634581|FG000|Overall Study|Withdrawal by Subject|1|||
162982045|NCT00952276|588634582|FG001|Overall Study|Withdrawal by Subject|0|||
162982046|NCT00952276|588634583|FG002|Overall Study|Withdrawal by Subject|0|||
162982047|NCT00952276|588634584|FG003|Overall Study|Withdrawal by Subject|1|||
162982048|NCT00952276|588634585|FG004|Overall Study|Withdrawal by Subject|0|||
162982049|NCT02522403|588636004|FG000|Overall Study|Lost to Follow-up|2|||
162982050|NCT02522403|588636005|FG001|Overall Study|Lost to Follow-up|2|||
162982051|NCT02522403|588636004|FG000|Overall Study|Withdrawal by Subject|2|||
162982052|NCT02522403|588636005|FG001|Overall Study|Withdrawal by Subject|4|||
162982053|NCT01553279|588636006|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
162982054|NCT01553279|588636007|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
162982055|NCT01553279|588636006|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
162982056|NCT01553279|588636007|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
162982057|NCT01553279|588636006|FG000|Interim Period|Withdrawal by Subject|2|||
162982058|NCT01553279|588636007|FG001|Interim Period|Withdrawal by Subject|2|||
162982059|NCT01553279|588636006|FG000|Interim Period|Lost to Follow-up|1|||
162982060|NCT01553279|588636007|FG001|Interim Period|Lost to Follow-up|0|||
162982061|NCT01553279|588636006|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
162982062|NCT01553279|588636007|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
162982063|NCT01553279|588636006|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
162982064|NCT01553279|588636007|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
162982065|NCT00619112|588636008|FG000|Overall Study|Adverse Event|1|||
162982066|NCT00619112|588636009|FG001|Overall Study|Adverse Event|2|||
162982067|NCT00729248|588636010|FG000|Overall Study|Physician Decision|2|||
162982068|NCT02588950|588636011|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
162982069|NCT02588950|588636012|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
162982070|NCT02588950|588636013|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
162982071|NCT02588950|588636014|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
162982072|NCT02588950|588636011|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
163321638|NCT02874742|589889018|FG001|Overall Study|Lost to Follow-up|4|||
163321639|NCT02874742|589889019|FG002|Overall Study|Lost to Follow-up|1|||
163321640|NCT02874742|589889017|FG000|Overall Study|Withdrawal by Subject|17|||
163321641|NCT02874742|589889018|FG001|Overall Study|Withdrawal by Subject|8|||
163321642|NCT02874742|589889019|FG002|Overall Study|Withdrawal by Subject|0|||
163321643|NCT02874742|589889017|FG000|Overall Study|Other|4|||
163321644|NCT02874742|589889018|FG001|Overall Study|Other|1|||
163321645|NCT02874742|589889019|FG002|Overall Study|Other|0|||
163321646|NCT02874742|589889017|FG000|Overall Study|Progressive Disease|1|||
163321647|NCT02874742|589889018|FG001|Overall Study|Progressive Disease|0|||
162982073|NCT02588950|588636012|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
162982074|NCT02588950|588636013|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
163321648|NCT02874742|589889019|FG002|Overall Study|Progressive Disease|0|||
163321649|NCT02874742|589889017|FG000|Overall Study|Screen Failure|0|||
163321650|NCT02874742|589889018|FG001|Overall Study|Screen Failure|2|||
163321651|NCT02874742|589889019|FG002|Overall Study|Screen Failure|0|||
162982075|NCT02588950|588636014|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
162982076|NCT00652028|588636017|FG000|Overall Study|Adverse Event|1|||
163321652|NCT03691298|589889022|FG000|Overall Study|Lost to Follow-up|8|||
163321653|NCT03691298|589889022|FG000|Overall Study|Sponsor terminated study|2|||
162982077|NCT00652028|588636018|FG001|Overall Study|Adverse Event|0|||
162982078|NCT00652028|588636019|FG002|Overall Study|Adverse Event|0|||
162982079|NCT00652028|588636020|FG003|Overall Study|Adverse Event|0|||
162982080|NCT00652028|588636017|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
163321654|NCT04424316|589889026|FG000|Overall Study|Adverse Event|0|||
162982081|NCT00652028|588636018|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
162982082|NCT00652028|588636019|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
162982083|NCT00652028|588636020|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
162982084|NCT00652028|588636017|FG000|Overall Study|Physician Decision|0|||
162982085|NCT00652028|588636018|FG001|Overall Study|Physician Decision|0|||
162982086|NCT00652028|588636019|FG002|Overall Study|Physician Decision|1|||
162982087|NCT00652028|588636020|FG003|Overall Study|Physician Decision|0|||
162982088|NCT02072824|588636021|FG000|Overall Study|Insufficient clinical response|1|||
162982089|NCT02072824|588636022|FG001|Overall Study|Insufficient clinical response|0|||
162982090|NCT02072824|588636023|FG002|Overall Study|Insufficient clinical response|1|||
162982091|NCT02072824|588636021|FG000|Overall Study|No longer willing to participate|1|||
162982092|NCT02072824|588636022|FG001|Overall Study|No longer willing to participate|0|||
163059385|NCT01294046|588926360|FG000|Overall Study|Infection and surgical explant|1|||
163059386|NCT01294046|588926360|FG000|Overall Study|Eligibility criteria expanded|1|||
163059387|NCT01294046|588926360|FG000|Overall Study|Stimulation response inadqequate|1|||
163059388|NCT03738696|588926366|FG000|Overall Study|Withdrawal by Subject|0|||
163059389|NCT03738696|588926367|FG001|Overall Study|Withdrawal by Subject|1|||
163059390|NCT03738696|588926366|FG000|Overall Study|Lost to Follow-up|8|||
163059391|NCT03738696|588926367|FG001|Overall Study|Lost to Follow-up|14|||
163059392|NCT02690727|588926370|FG000|Overall Study|Adverse Event|2|||
163059393|NCT02690727|588926371|FG001|Overall Study|Adverse Event|2|||
163059394|NCT04757636|588926372|FG000|Overall Study|Adverse Event|25|||
163059395|NCT04757636|588926373|FG001|Overall Study|Adverse Event|8|||
163059396|NCT04757636|588926374|FG002|Overall Study|Adverse Event|11|||
163059397|NCT04757636|588926372|FG000|Overall Study|Death|9|||
163059398|NCT04757636|588926373|FG001|Overall Study|Death|12|||
163059399|NCT04757636|588926374|FG002|Overall Study|Death|6|||
163059400|NCT04757636|588926372|FG000|Overall Study|Lack of Efficacy|2|||
163059401|NCT04757636|588926373|FG001|Overall Study|Lack of Efficacy|0|||
163059402|NCT04757636|588926374|FG002|Overall Study|Lack of Efficacy|0|||
163059403|NCT04757636|588926372|FG000|Overall Study|Lost to Follow-up|1|||
163059404|NCT04757636|588926373|FG001|Overall Study|Lost to Follow-up|6|||
163059405|NCT04757636|588926374|FG002|Overall Study|Lost to Follow-up|7|||
163059406|NCT04757636|588926372|FG000|Overall Study|Physician Decision|1|||
163059407|NCT04757636|588926373|FG001|Overall Study|Physician Decision|3|||
163059408|NCT04757636|588926374|FG002|Overall Study|Physician Decision|4|||
163059409|NCT04757636|588926372|FG000|Overall Study|Withdrawal by Subject|20|||
163059410|NCT04757636|588926373|FG001|Overall Study|Withdrawal by Subject|23|||
163059411|NCT04757636|588926374|FG002|Overall Study|Withdrawal by Subject|18|||
163059412|NCT04757636|588926372|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
163059413|NCT04757636|588926373|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
163059414|NCT04757636|588926374|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
163059415|NCT04757636|588926372|FG000|Overall Study|Study Terminated by Sponsor|103|||
163059416|NCT04757636|588926373|FG001|Overall Study|Study Terminated by Sponsor|104|||
163059417|NCT04757636|588926374|FG002|Overall Study|Study Terminated by Sponsor|114|||
163059418|NCT04757636|588926372|FG000|Overall Study|Sponsor Decision|0|||
163059419|NCT04757636|588926373|FG001|Overall Study|Sponsor Decision|0|||
163059420|NCT04757636|588926374|FG002|Overall Study|Sponsor Decision|1|||
163059421|NCT04757636|588926372|FG000|Overall Study|Randomized in Error|0|||
163059422|NCT04757636|588926373|FG001|Overall Study|Randomized in Error|0|||
163059423|NCT04757636|588926374|FG002|Overall Study|Randomized in Error|2|||
163059424|NCT00091819|588926375|FG000|Overall Study|Adverse Event|1|||
163059425|NCT00091819|588926376|FG001|Overall Study|Adverse Event|1|||
163059426|NCT00091819|588926375|FG000|Overall Study|Death|4|||
163059427|NCT00091819|588926376|FG001|Overall Study|Death|5|||
163059428|NCT00091819|588926375|FG000|Overall Study|Lost to Follow-up|26|||
163059429|NCT00091819|588926376|FG001|Overall Study|Lost to Follow-up|23|||
163059430|NCT00091819|588926375|FG000|Overall Study|Withdrawal by Subject|5|||
163059431|NCT00091819|588926376|FG001|Overall Study|Withdrawal by Subject|8|||
163059432|NCT00091819|588926375|FG000|Overall Study|Protocol Violation|1|||
163059433|NCT00091819|588926376|FG001|Overall Study|Protocol Violation|2|||
163059434|NCT00091819|588926375|FG000|Overall Study|Other|2|||
163059435|NCT00091819|588926376|FG001|Overall Study|Other|3|||
163321655|NCT04424316|589889027|FG001|Overall Study|Adverse Event|1|||
163059436|NCT00091819|588926375|FG000|Overall Study|Never received study treatment|3|||
163321656|NCT04424316|589889028|FG002|Overall Study|Adverse Event|0|||
163059437|NCT00091819|588926376|FG001|Overall Study|Never received study treatment|4|||
163059438|NCT02606253|588926377|FG000|Overall Study|Adverse Event|2|||
163321657|NCT04424316|589889029|FG003|Overall Study|Adverse Event|0|||
162982093|NCT02072824|588636023|FG002|Overall Study|No longer willing to participate|1|||
162982094|NCT02072824|588636021|FG000|Overall Study|Medication error|0|||
163059439|NCT02606253|588926378|FG001|Overall Study|Adverse Event|0|||
163059440|NCT02606253|588926379|FG002|Overall Study|Adverse Event|0|||
163059441|NCT02606253|588926377|FG000|Overall Study|Protocol Violation|2|||
163059442|NCT02606253|588926378|FG001|Overall Study|Protocol Violation|1|||
163059443|NCT02606253|588926379|FG002|Overall Study|Protocol Violation|0|||
162982095|NCT02072824|588636022|FG001|Overall Study|Medication error|1|||
163059444|NCT02606253|588926377|FG000|Overall Study|Physician Decision|1|||
163059445|NCT02606253|588926378|FG001|Overall Study|Physician Decision|1|||
163059446|NCT02606253|588926379|FG002|Overall Study|Physician Decision|0|||
163059447|NCT00701363|588926380|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
162982096|NCT02072824|588636023|FG002|Overall Study|Medication error|0|||
162982097|NCT02072824|588636021|FG000|Overall Study|Adverse Event|0|||
162982098|NCT02072824|588636022|FG001|Overall Study|Adverse Event|0|||
162982099|NCT02072824|588636023|FG002|Overall Study|Adverse Event|1|||
162982100|NCT01859130|588636024|FG000|Overall Study|Death|4|||
162982101|NCT01859130|588636024|FG000|Overall Study|Lost to Follow-up|16|||
162982102|NCT01859130|588636024|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
162982103|NCT01859130|588636024|FG000|Overall Study|Physician Decision|6|||
162982104|NCT01859130|588636024|FG000|Overall Study|Withdrawal by Subject|17|||
162982105|NCT01859130|588636024|FG000|Overall Study|Adverse Event|11|||
162982106|NCT03835325|588636028|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
162982107|NCT03835325|588636028|FG000|Overall Study|Selection failure|1|||
162982108|NCT01370213|588636031|FG000|Overall Study|Early Death|1|||
162982109|NCT01370213|588636032|FG001|Overall Study|Early Death|0|||
162982110|NCT01370213|588636033|FG002|Overall Study|Early Death|0|||
162982111|NCT01370213|588636031|FG000|Overall Study|Not evaluable|0|||
162982112|NCT01370213|588636032|FG001|Overall Study|Not evaluable|2|||
162982113|NCT01370213|588636033|FG002|Overall Study|Not evaluable|0|||
162982114|NCT00038649|588636037|FG000|Overall Study|Adverse Event|9|||
162982115|NCT03395639|588636038|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
162982116|NCT03395639|588636039|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
162982117|NCT03395639|588636040|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
162982118|NCT03395639|588636038|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
162982119|NCT03395639|588636039|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
162982120|NCT03395639|588636040|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
162982121|NCT03395639|588636038|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
162982122|NCT03395639|588636039|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
162982123|NCT03395639|588636040|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
162982124|NCT03395639|588636038|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
162982125|NCT03395639|588636039|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
162982126|NCT03395639|588636040|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
162982127|NCT03395639|588636038|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
162982128|NCT03395639|588636039|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
162982129|NCT03395639|588636040|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
162982130|NCT00942331|588636041|FG000|Overall Study|Did not start treatment|15|||
162982131|NCT00942331|588636042|FG001|Overall Study|Did not start treatment|22|||
162982132|NCT00567476|588636047|FG000|Overall Study|Adverse Event|2|||
162982133|NCT00567476|588636048|FG001|Overall Study|Adverse Event|0|||
162982134|NCT00567476|588636047|FG000|Overall Study|Pregnancy|1|||
162982135|NCT00567476|588636048|FG001|Overall Study|Pregnancy|0|||
162982136|NCT00567476|588636047|FG000|Overall Study|Protocol Violation|4|||
162982137|NCT00567476|588636048|FG001|Overall Study|Protocol Violation|1|||
162982138|NCT00567476|588636047|FG000|Overall Study|Lost to Follow-up|0|||
162982139|NCT00567476|588636048|FG001|Overall Study|Lost to Follow-up|1|||
162982140|NCT00567476|588636047|FG000|Overall Study|Administrative issues|1|||
162982141|NCT00567476|588636048|FG001|Overall Study|Administrative issues|0|||
162982142|NCT00567476|588636047|FG000|Overall Study|Medical Decision|0|||
162982143|NCT00567476|588636048|FG001|Overall Study|Medical Decision|1|||
162982144|NCT00567476|588636047|FG000|Overall Study|Non-adherence to protocol|0|||
162982145|NCT00567476|588636048|FG001|Overall Study|Non-adherence to protocol|1|||
162982146|NCT00995085|588636049|FG000|Overall Study|Withdrawal by Subject|5|||
162982147|NCT01194973|588636051|FG000|Screening Period|Screen Failure|3|||
162982148|NCT01194973|588636051|FG000|26 Week Treatment Period|Adverse Event|1|||
162982149|NCT01194973|588636051|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
162982150|NCT01194973|588636051|FG000|26 Week Treatment Period|Pregnancy|1|||
162982151|NCT01338987|588636054|FG000|Overall Study|enrolled on new protocol|0|||
162982152|NCT01338987|588636055|FG001|Overall Study|enrolled on new protocol|0|||
162982153|NCT01338987|588636056|FG002|Overall Study|enrolled on new protocol|1|||
162982154|NCT01338987|588636057|FG003|Overall Study|enrolled on new protocol|0|||
162982155|NCT01338987|588636058|FG004|Overall Study|enrolled on new protocol|0|||
162982156|NCT01338987|588636054|FG000|Overall Study|Disease progression on study|2|||
162982157|NCT01338987|588636055|FG001|Overall Study|Disease progression on study|1|||
162982158|NCT01338987|588636056|FG002|Overall Study|Disease progression on study|1|||
162982159|NCT01338987|588636057|FG003|Overall Study|Disease progression on study|0|||
162982160|NCT01338987|588636058|FG004|Overall Study|Disease progression on study|0|||
162982161|NCT03856593|588636061|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
162982162|NCT03856593|588636062|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
162982163|NCT02595008|588636063|FG000|Overall Study|Enrolled In Error|1|||
162982164|NCT02595008|588636064|FG001|Overall Study|Enrolled In Error|0|||
162982165|NCT03407118|588636065|FG000|Period 2|Withdrawal by Subject|1|||
162982166|NCT03407118|588636066|FG001|Period 2|Withdrawal by Subject|0|||
162982167|NCT02999477|588636083|FG000|Overall Study|found ineligible after first dose|0|||
162982168|NCT02999477|588636084|FG001|Overall Study|found ineligible after first dose|1|||
162982169|NCT02999477|588636083|FG000|Overall Study|Withdrawal by Subject|1|||
162982170|NCT02999477|588636084|FG001|Overall Study|Withdrawal by Subject|1|||
162982171|NCT01846273|588636087|FG000|Overall Study|Adverse Event|9|||
162982172|NCT01846273|588636088|FG001|Overall Study|Adverse Event|7|||
162982173|NCT01846273|588636089|FG002|Overall Study|Adverse Event|0|||
162982174|NCT01846273|588636087|FG000|Overall Study|Subject withdrew consent|5|||
162982175|NCT01846273|588636088|FG001|Overall Study|Subject withdrew consent|8|||
162982176|NCT01846273|588636089|FG002|Overall Study|Subject withdrew consent|0|||
162982177|NCT01846273|588636087|FG000|Overall Study|Lost to Follow-up|2|||
162982178|NCT01846273|588636088|FG001|Overall Study|Lost to Follow-up|1|||
162982179|NCT01846273|588636089|FG002|Overall Study|Lost to Follow-up|0|||
162982180|NCT01846273|588636087|FG000|Overall Study|Administrative problems|1|||
162982181|NCT01846273|588636088|FG001|Overall Study|Administrative problems|0|||
162982182|NCT01846273|588636089|FG002|Overall Study|Administrative problems|0|||
162982183|NCT01846273|588636087|FG000|Overall Study|Death|2|||
162982184|NCT01846273|588636088|FG001|Overall Study|Death|1|||
162982185|NCT01846273|588636089|FG002|Overall Study|Death|0|||
162982186|NCT01846273|588636087|FG000|Overall Study|Disease Progression|0|||
162982187|NCT01846273|588636088|FG001|Overall Study|Disease Progression|4|||
162982188|NCT01846273|588636089|FG002|Overall Study|Disease Progression|0|||
162982189|NCT01846273|588636087|FG000|Overall Study|Protocol Deviation|2|||
162982190|NCT01846273|588636088|FG001|Overall Study|Protocol Deviation|3|||
162982191|NCT01846273|588636089|FG002|Overall Study|Protocol Deviation|0|||
162982192|NCT01846273|588636087|FG000|Overall Study|Physician Decision|1|||
162982193|NCT01846273|588636088|FG001|Overall Study|Physician Decision|2|||
162982194|NCT01846273|588636089|FG002|Overall Study|Physician Decision|0|||
162982195|NCT02939014|588636090|FG000|Overall Study|Lost to Follow-up|1|||
162982196|NCT02939014|588636091|FG001|Overall Study|Lost to Follow-up|0|||
162982197|NCT02939014|588636090|FG000|Overall Study|Death|4|||
162982198|NCT02939014|588636091|FG001|Overall Study|Death|3|||
162982199|NCT00851643|588636092|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
162982200|NCT00851643|588636093|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
162982201|NCT00851643|588636094|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
162982202|NCT00851643|588636095|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
162982203|NCT00851643|588636096|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
162982204|NCT00851643|588636097|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
162982205|NCT00851643|588636092|FG000|Base Study (Up to 12 Months)|Other|0|||
162982206|NCT00851643|588636093|FG001|Base Study (Up to 12 Months)|Other|0|||
162982207|NCT00851643|588636094|FG002|Base Study (Up to 12 Months)|Other|0|||
162982208|NCT00851643|588636095|FG003|Base Study (Up to 12 Months)|Other|0|||
162982209|NCT00851643|588636096|FG004|Base Study (Up to 12 Months)|Other|0|||
162982210|NCT00851643|588636097|FG005|Base Study (Up to 12 Months)|Other|1|||
162982211|NCT00851643|588636092|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
162982212|NCT00851643|588636093|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
162982213|NCT00851643|588636094|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
162982214|NCT00851643|588636095|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
162982215|NCT00851643|588636096|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
162982216|NCT00851643|588636097|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
162982217|NCT00851643|588636092|FG000|Extension Study (Up to 36 Months)|Moved|0|||
162982218|NCT00851643|588636093|FG001|Extension Study (Up to 36 Months)|Moved|2|||
162982219|NCT00851643|588636094|FG002|Extension Study (Up to 36 Months)|Moved|1|||
162982220|NCT00851643|588636095|FG003|Extension Study (Up to 36 Months)|Moved|1|||
162982221|NCT00851643|588636096|FG004|Extension Study (Up to 36 Months)|Moved|0|||
162982222|NCT00851643|588636097|FG005|Extension Study (Up to 36 Months)|Moved|1|||
162982223|NCT00359788|588636098|FG000|Overall Study|Adverse Event|11|||
162982224|NCT00359788|588636099|FG001|Overall Study|Adverse Event|10|||
162982225|NCT00359788|588636098|FG000|Overall Study|Lack of Efficacy|1|||
162982226|NCT00359788|588636099|FG001|Overall Study|Lack of Efficacy|2|||
162982227|NCT00359788|588636098|FG000|Overall Study|Lost to Follow-up|3|||
162982228|NCT00359788|588636099|FG001|Overall Study|Lost to Follow-up|2|||
162982229|NCT00359788|588636098|FG000|Overall Study|Withdrawal by Subject|4|||
162982230|NCT00359788|588636099|FG001|Overall Study|Withdrawal by Subject|1|||
162982231|NCT00359788|588636098|FG000|Overall Study|Protocol Violation|4|||
162982232|NCT00359788|588636099|FG001|Overall Study|Protocol Violation|2|||
162982233|NCT02143583|588636102|FG000|Overall Study|Withdrawal by Subject|1|||
162982234|NCT02143583|588636103|FG001|Overall Study|Withdrawal by Subject|0|||
162982235|NCT02143583|588636104|FG002|Overall Study|Withdrawal by Subject|1|||
162982236|NCT02143583|588636102|FG000|Overall Study|husband illness|0|||
162982237|NCT02143583|588636103|FG001|Overall Study|husband illness|0|||
162982238|NCT02143583|588636104|FG002|Overall Study|husband illness|1|||
162982239|NCT01641133|588636105|FG000|Overall Study|Protocol Violation|0|||
162982240|NCT01641133|588636106|FG001|Overall Study|Protocol Violation|1|||
162982241|NCT01641133|588636107|FG002|Overall Study|Protocol Violation|1|||
162982242|NCT01641133|588636105|FG000|Overall Study|Migrated/moved from study area|5|||
162982243|NCT01641133|588636106|FG001|Overall Study|Migrated/moved from study area|3|||
162982244|NCT01641133|588636107|FG002|Overall Study|Migrated/moved from study area|1|||
162982245|NCT01641133|588636105|FG000|Overall Study|Adverse Event|0|||
162982246|NCT01641133|588636106|FG001|Overall Study|Adverse Event|0|||
162982247|NCT01641133|588636107|FG002|Overall Study|Adverse Event|1|||
162982248|NCT01641133|588636105|FG000|Overall Study|Withdrawal by Subject|5|||
162982249|NCT01641133|588636106|FG001|Overall Study|Withdrawal by Subject|3|||
162982250|NCT01641133|588636107|FG002|Overall Study|Withdrawal by Subject|3|||
162982251|NCT01641133|588636105|FG000|Overall Study|Lost to Follow-up|0|||
162982252|NCT01641133|588636106|FG001|Overall Study|Lost to Follow-up|2|||
162982253|NCT01641133|588636107|FG002|Overall Study|Lost to Follow-up|2|||
162982254|NCT02220725|588636108|FG000|Overall Study|Lost to Follow-up|0|||
162982255|NCT02220725|588636109|FG001|Overall Study|Lost to Follow-up|0|||
162982256|NCT02220725|588636110|FG002|Overall Study|Lost to Follow-up|0|||
162982257|NCT02220725|588636111|FG003|Overall Study|Lost to Follow-up|1|||
162982258|NCT02220725|588636108|FG000|Overall Study|Withdrawal by Subject|0|||
162982259|NCT02220725|588636109|FG001|Overall Study|Withdrawal by Subject|0|||
162982260|NCT02220725|588636110|FG002|Overall Study|Withdrawal by Subject|0|||
162982261|NCT02220725|588636111|FG003|Overall Study|Withdrawal by Subject|1|||
162982262|NCT03351231|588636112|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
162982263|NCT03351231|588636112|FG000|Combination Therapy Period|Disease progression|2|||
162982264|NCT03351231|588636112|FG000|Combination Therapy Period|Study drug toxicity|1|||
162982265|NCT03351231|588636112|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
162982266|NCT03351231|588636112|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
162982267|NCT03351231|588636112|FG000|Safety Follow-Up Period|Other reason|2|||
162982268|NCT00103402|588636115|FG000|Overall Study|Adverse Event|3|||
162982269|NCT00103402|588636116|FG001|Overall Study|Adverse Event|4|||
162982270|NCT00103402|588636115|FG000|Overall Study|Lost to Follow-up|8|||
162982271|NCT00103402|588636116|FG001|Overall Study|Lost to Follow-up|7|||
162982272|NCT00103402|588636115|FG000|Overall Study|Dissatisfied/No longer interested|6|||
162982273|NCT00103402|588636116|FG001|Overall Study|Dissatisfied/No longer interested|6|||
162982274|NCT00103402|588636115|FG000|Overall Study|Personal constraints/Other|5|||
162982275|NCT00103402|588636116|FG001|Overall Study|Personal constraints/Other|0|||
162982276|NCT02333487|588636117|FG000|Overall Study|Adverse Event|0|||
162982277|NCT02333487|588636118|FG001|Overall Study|Adverse Event|2|||
162982278|NCT02333487|588636119|FG002|Overall Study|Adverse Event|0|||
162982279|NCT01297322|588636120|FG000|Overall Study|Lost to Follow-up|1|||
162982280|NCT01297322|588636121|FG001|Overall Study|Lost to Follow-up|0|||
162982281|NCT01297322|588636120|FG000|Overall Study|Withdrawal by Subject|0|||
162982282|NCT01297322|588636121|FG001|Overall Study|Withdrawal by Subject|1|||
162982283|NCT01297322|588636120|FG000|Overall Study|Protocol Violation|0|||
162982284|NCT01297322|588636121|FG001|Overall Study|Protocol Violation|3|||
162982285|NCT01111019|588636122|FG000|Overall Study|Withdrew Prematurely|2|||
162982286|NCT01111019|588636122|FG000|Overall Study|Other|1|||
162982287|NCT02013375|588636125|FG000|Overall Study|Did not engraft|1|||
162982288|NCT02013375|588636125|FG000|Overall Study|Did not engraft|1|||
162982289|NCT00712985|588636126|FG000|Overall Study|1 withdrew prior to start of drug|1|||
162982290|NCT00712985|588636126|FG000|Overall Study|1 patient moved out of state|1|||
162982291|NCT00712985|588636126|FG000|Overall Study|Lack of Efficacy|3|||
162982292|NCT01663727|588636127|FG000|Overall Study|Death|161|||
162982293|NCT01663727|588636128|FG001|Overall Study|Death|155|||
162982294|NCT01663727|588636127|FG000|Overall Study|Lost to Follow-up|10|||
162982295|NCT01663727|588636128|FG001|Overall Study|Lost to Follow-up|8|||
163321658|NCT04424316|589889026|FG000|Overall Study|Death|1|||
163321659|NCT04424316|589889027|FG001|Overall Study|Death|0|||
162982296|NCT01663727|588636127|FG000|Overall Study|Withdrawal by Subject|18|||
162982297|NCT01663727|588636128|FG001|Overall Study|Withdrawal by Subject|25|||
162982298|NCT01663727|588636127|FG000|Overall Study|Study Terminated|51|||
162982299|NCT01663727|588636128|FG001|Overall Study|Study Terminated|50|||
162982300|NCT01663727|588636127|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
162982301|NCT01663727|588636128|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
162982302|NCT01663727|588636127|FG000|Overall Study|Withdrawal prior to dosing.|1|||
162982303|NCT01663727|588636128|FG001|Overall Study|Withdrawal prior to dosing.|0|||
162982304|NCT01902628|588636129|FG000|Overall Study|Withdrawal of participant's consent|7|||
162982305|NCT01902628|588636129|FG000|Overall Study|Adverse Event|41|||
162982306|NCT01902628|588636129|FG000|Overall Study|Lost to Follow-up|35|||
162982307|NCT04385277|588638612|FG000|Overall Study|Physician Decision|2|||
162982308|NCT04385277|588638612|FG000|Overall Study|Ineligible|1|||
162982309|NCT04385277|588638612|FG000|Overall Study|Patient/Parent Refusal|2|||
162982310|NCT04905290|588638613|FG000|Overall Study|Adverse Event|4|||
162982311|NCT04905290|588638613|FG000|Overall Study|Death|2|||
162982312|NCT04905290|588638613|FG000|Overall Study|Withdrawal by Subject|4|||
162982313|NCT04905290|588638613|FG000|Overall Study|Physician Decision|2|||
162982314|NCT04905290|588638613|FG000|Overall Study|Lost to Follow-up|2|||
162982315|NCT04905290|588638613|FG000|Overall Study|Screen Failure|2|||
162982316|NCT04905290|588638613|FG000|Overall Study|Unsuccessful Procedure|2|||
162982317|NCT03303625|588638614|FG000|Overall Study|Withdrawal by Subject|2|||
162982318|NCT03303625|588638615|FG001|Overall Study|Withdrawal by Subject|0|||
163059448|NCT00701363|588926381|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
163059449|NCT00701363|588926382|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
163059450|NCT00701363|588926383|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
163059451|NCT00701363|588926380|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
163059452|NCT00701363|588926381|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
163059453|NCT00701363|588926382|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
163059454|NCT00701363|588926383|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
163059455|NCT00701363|588926380|FG000|Treatment Phase 1|Adverse Event|7|||
163059456|NCT00701363|588926381|FG001|Treatment Phase 1|Adverse Event|0|||
163059457|NCT00701363|588926382|FG002|Treatment Phase 1|Adverse Event|0|||
163059458|NCT00701363|588926383|FG003|Treatment Phase 1|Adverse Event|0|||
163059459|NCT00701363|588926380|FG000|Treatment Phase 1|Protocol Violation|1|||
163059460|NCT00701363|588926381|FG001|Treatment Phase 1|Protocol Violation|0|||
163059461|NCT00701363|588926382|FG002|Treatment Phase 1|Protocol Violation|0|||
163059462|NCT00701363|588926383|FG003|Treatment Phase 1|Protocol Violation|0|||
163059463|NCT00701363|588926380|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
163059464|NCT00701363|588926381|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
163059465|NCT00701363|588926382|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
163059466|NCT00701363|588926383|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
163059467|NCT00701363|588926380|FG000|Treatment Phase 1|Lack of Efficacy|1|||
162982319|NCT03303625|588638616|FG002|Overall Study|Withdrawal by Subject|0|||
162982320|NCT03303625|588638617|FG003|Overall Study|Withdrawal by Subject|0|||
163321660|NCT04424316|589889028|FG002|Overall Study|Death|8|||
162982321|NCT01045421|588638619|FG000|Phase 1|Progressive Disease|0|||
162982322|NCT01045421|588638620|FG001|Phase 1|Progressive Disease|0|||
162982323|NCT01045421|588638621|FG002|Phase 1|Progressive Disease|0|||
162982324|NCT01045421|588638622|FG003|Phase 1|Progressive Disease|0|||
162982325|NCT01045421|588638623|FG004|Phase 1|Progressive Disease|1|||
162982326|NCT01045421|588638624|FG005|Phase 1|Progressive Disease|0|||
162982327|NCT01045421|588638625|FG006|Phase 1|Progressive Disease|0|||
162982328|NCT01045421|588638626|FG007|Phase 1|Progressive Disease|0|||
162982329|NCT01045421|588638627|FG008|Phase 1|Progressive Disease|0|||
162982330|NCT01045421|588638628|FG009|Phase 1|Progressive Disease|0|||
162982331|NCT01045421|588638629|FG010|Phase 1|Progressive Disease|0|||
162982332|NCT01045421|588638619|FG000|Phase 1|Withdrawal by Subject|0|||
162982333|NCT01045421|588638620|FG001|Phase 1|Withdrawal by Subject|0|||
162982334|NCT01045421|588638621|FG002|Phase 1|Withdrawal by Subject|0|||
162982335|NCT01045421|588638622|FG003|Phase 1|Withdrawal by Subject|1|||
162982336|NCT01045421|588638623|FG004|Phase 1|Withdrawal by Subject|0|||
162982337|NCT01045421|588638624|FG005|Phase 1|Withdrawal by Subject|0|||
162982338|NCT01045421|588638625|FG006|Phase 1|Withdrawal by Subject|0|||
162982339|NCT01045421|588638626|FG007|Phase 1|Withdrawal by Subject|0|||
162982340|NCT01045421|588638627|FG008|Phase 1|Withdrawal by Subject|0|||
162982341|NCT01045421|588638628|FG009|Phase 1|Withdrawal by Subject|0|||
162982342|NCT01045421|588638629|FG010|Phase 1|Withdrawal by Subject|0|||
162982343|NCT01045421|588638619|FG000|Phase 2|Progressive Disease|0|||
162982344|NCT01045421|588638620|FG001|Phase 2|Progressive Disease|0|||
162982345|NCT01045421|588638621|FG002|Phase 2|Progressive Disease|0|||
162982346|NCT01045421|588638622|FG003|Phase 2|Progressive Disease|0|||
162982347|NCT01045421|588638623|FG004|Phase 2|Progressive Disease|0|||
162982348|NCT01045421|588638624|FG005|Phase 2|Progressive Disease|0|||
162982349|NCT01045421|588638625|FG006|Phase 2|Progressive Disease|0|||
163059468|NCT00701363|588926381|FG001|Treatment Phase 1|Lack of Efficacy|0|||
163059469|NCT00701363|588926382|FG002|Treatment Phase 1|Lack of Efficacy|0|||
163059470|NCT00701363|588926383|FG003|Treatment Phase 1|Lack of Efficacy|0|||
163059471|NCT00701363|588926380|FG000|Treatment Phase 2|Adverse Event|0|||
163059472|NCT00701363|588926381|FG001|Treatment Phase 2|Adverse Event|0|||
162982350|NCT01045421|588638626|FG007|Phase 2|Progressive Disease|1|||
162982351|NCT01045421|588638627|FG008|Phase 2|Progressive Disease|1|||
162982352|NCT01045421|588638628|FG009|Phase 2|Progressive Disease|1|||
163321661|NCT04424316|589889029|FG003|Overall Study|Death|14|||
163321662|NCT04424316|589889026|FG000|Overall Study|Lost to Follow-up|93|||
163321663|NCT04424316|589889027|FG001|Overall Study|Lost to Follow-up|88|||
163321664|NCT04424316|589889028|FG002|Overall Study|Lost to Follow-up|224|||
163321665|NCT04424316|589889029|FG003|Overall Study|Lost to Follow-up|211|||
163321666|NCT04424316|589889026|FG000|Overall Study|No longer met eligibility criteria|1|||
162982353|NCT01045421|588638629|FG010|Phase 2|Progressive Disease|1|||
162982354|NCT01045421|588638619|FG000|Phase 2|Death|0|||
162982355|NCT01045421|588638620|FG001|Phase 2|Death|0|||
162982356|NCT01045421|588638621|FG002|Phase 2|Death|0|||
162982357|NCT01045421|588638622|FG003|Phase 2|Death|0|||
162982358|NCT01045421|588638623|FG004|Phase 2|Death|0|||
162982359|NCT01045421|588638624|FG005|Phase 2|Death|0|||
162982360|NCT01045421|588638625|FG006|Phase 2|Death|0|||
162982361|NCT01045421|588638626|FG007|Phase 2|Death|1|||
162982362|NCT01045421|588638627|FG008|Phase 2|Death|1|||
163059473|NCT00701363|588926382|FG002|Treatment Phase 2|Adverse Event|1|||
163059474|NCT00701363|588926383|FG003|Treatment Phase 2|Adverse Event|0|||
163059475|NCT00701363|588926380|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
163059476|NCT00701363|588926381|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
163321667|NCT04424316|589889027|FG001|Overall Study|No longer met eligibility criteria|0|||
163321668|NCT04424316|589889028|FG002|Overall Study|No longer met eligibility criteria|0|||
163321669|NCT04424316|589889029|FG003|Overall Study|No longer met eligibility criteria|0|||
163321670|NCT04424316|589889026|FG000|Overall Study|Other|15|||
163321671|NCT04424316|589889027|FG001|Overall Study|Other|11|||
162982363|NCT01045421|588638628|FG009|Phase 2|Death|2|||
162982364|NCT01045421|588638629|FG010|Phase 2|Death|0|||
162982365|NCT01045421|588638619|FG000|Phase 2|Other|0|||
162982366|NCT01045421|588638620|FG001|Phase 2|Other|0|||
162982367|NCT01045421|588638621|FG002|Phase 2|Other|0|||
162982368|NCT01045421|588638622|FG003|Phase 2|Other|0|||
162982369|NCT01045421|588638623|FG004|Phase 2|Other|0|||
162982370|NCT01045421|588638624|FG005|Phase 2|Other|0|||
162982371|NCT01045421|588638625|FG006|Phase 2|Other|0|||
162982372|NCT01045421|588638626|FG007|Phase 2|Other|3|||
162982373|NCT01045421|588638627|FG008|Phase 2|Other|0|||
162982374|NCT01045421|588638628|FG009|Phase 2|Other|0|||
162982375|NCT01045421|588638629|FG010|Phase 2|Other|1|||
162982376|NCT01884311|588638631|FG000|Overall Study|Withdrawal by Subject|3|||
162982377|NCT01884311|588638631|FG000|Overall Study|withdrew consent due to AEs|1|||
162982378|NCT01884311|588638631|FG000|Overall Study|Precautionary measure|1|||
162982379|NCT02858492|588638632|FG000|Overall Study|Withdrawal by Subject|0|||
162982380|NCT02858492|588638633|FG001|Overall Study|Withdrawal by Subject|1|||
162982381|NCT02858492|588638634|FG002|Overall Study|Withdrawal by Subject|0|||
162982382|NCT02858492|588638635|FG003|Overall Study|Withdrawal by Subject|1|||
162982383|NCT02858492|588638632|FG000|Overall Study|Adverse Event|0|||
162982384|NCT02858492|588638633|FG001|Overall Study|Adverse Event|0|||
162982385|NCT02858492|588638634|FG002|Overall Study|Adverse Event|0|||
162982386|NCT02858492|588638635|FG003|Overall Study|Adverse Event|3|||
162982387|NCT02858492|588638632|FG000|Overall Study|Lack of Efficacy|0|||
162982388|NCT02858492|588638633|FG001|Overall Study|Lack of Efficacy|0|||
162982389|NCT02858492|588638634|FG002|Overall Study|Lack of Efficacy|0|||
162982390|NCT02858492|588638635|FG003|Overall Study|Lack of Efficacy|1|||
162982391|NCT02858492|588638632|FG000|Overall Study|Protocol defined stopping criteria|0|||
162982392|NCT02858492|588638633|FG001|Overall Study|Protocol defined stopping criteria|0|||
162982393|NCT02858492|588638634|FG002|Overall Study|Protocol defined stopping criteria|0|||
162982394|NCT02858492|588638635|FG003|Overall Study|Protocol defined stopping criteria|1|||
162982395|NCT02944383|588638636|FG000|Overall Study|Lost to Follow-up|0|||
162982396|NCT02944383|588638637|FG001|Overall Study|Lost to Follow-up|0|||
162982397|NCT02944383|588638638|FG002|Overall Study|Lost to Follow-up|1|||
162982398|NCT02944383|588638636|FG000|Overall Study|Withdrawal by Subject|1|||
162982399|NCT02944383|588638637|FG001|Overall Study|Withdrawal by Subject|0|||
162982400|NCT02944383|588638638|FG002|Overall Study|Withdrawal by Subject|0|||
162982401|NCT01995266|588638640|FG000|Overall Study|Death|1|||
162982402|NCT01995266|588638640|FG000|Overall Study|Lack of Efficacy|6|||
162982403|NCT01995266|588638640|FG000|Overall Study|Adverse Event|2|||
162982404|NCT03853148|588638641|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
162982405|NCT03853148|588638642|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
162982406|NCT03853148|588638643|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
162982407|NCT03853148|588638644|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
162982408|NCT00090610|588638645|FG000|Overall Study|Withdrawal by Subject|1|||
162982409|NCT00090610|588638646|FG001|Overall Study|Withdrawal by Subject|1|||
162982410|NCT03623386|588638649|FG000|Overall Study|Protocol Violation|3|||
162982411|NCT03623386|588638650|FG001|Overall Study|Protocol Violation|2|||
162982412|NCT03623386|588638651|FG002|Overall Study|Protocol Violation|0|||
162982413|NCT03623386|588638649|FG000|Overall Study|Physician Decision|1|||
162982414|NCT03623386|588638650|FG001|Overall Study|Physician Decision|1|||
162982415|NCT03623386|588638651|FG002|Overall Study|Physician Decision|0|||
162982416|NCT03623386|588638649|FG000|Overall Study|Lost to Follow-up|0|||
162982417|NCT03623386|588638650|FG001|Overall Study|Lost to Follow-up|2|||
163321672|NCT04424316|589889028|FG002|Overall Study|Other|34|||
163321673|NCT04424316|589889029|FG003|Overall Study|Other|45|||
163321674|NCT04424316|589889026|FG000|Overall Study|Physician Decision|1|||
163321675|NCT04424316|589889027|FG001|Overall Study|Physician Decision|0|||
162982418|NCT03623386|588638651|FG002|Overall Study|Lost to Follow-up|0|||
162982419|NCT03623386|588638649|FG000|Overall Study|COVID-19|0|||
162982420|NCT03623386|588638650|FG001|Overall Study|COVID-19|1|||
162982421|NCT03623386|588638651|FG002|Overall Study|COVID-19|0|||
162982422|NCT00599521|588638656|FG000|Overall Study|Lack of Efficacy|4|||
162982423|NCT00599521|588638657|FG001|Overall Study|Lack of Efficacy|8|||
162982424|NCT00599521|588638656|FG000|Overall Study|Adverse Event|4|||
162982425|NCT00599521|588638657|FG001|Overall Study|Adverse Event|1|||
162982426|NCT00599521|588638656|FG000|Overall Study|Withdrawal by Subject|28|||
162982427|NCT00599521|588638657|FG001|Overall Study|Withdrawal by Subject|34|||
163321676|NCT04424316|589889028|FG002|Overall Study|Physician Decision|1|||
162982428|NCT00599521|588638656|FG000|Overall Study|Protocol Violation|1|||
162982429|NCT00599521|588638657|FG001|Overall Study|Protocol Violation|1|||
162982430|NCT00599521|588638656|FG000|Overall Study|Lost to Follow-up|23|||
162982431|NCT00599521|588638657|FG001|Overall Study|Lost to Follow-up|23|||
162982432|NCT00599521|588638656|FG000|Overall Study|Pregnancy|0|||
162982433|NCT00599521|588638657|FG001|Overall Study|Pregnancy|2|||
162982434|NCT05855616|588638658|FG000|Overall Study|Lost to Follow-up|1|||
162982435|NCT05855616|588638659|FG001|Overall Study|Lost to Follow-up|2|||
162982436|NCT01388166|588638660|FG000|Overall Study|Adverse Event|16|||
162982437|NCT01388166|588638660|FG000|Overall Study|Lost to Follow-up|30|||
162982438|NCT01388166|588638660|FG000|Overall Study|Others than specified above|13|||
162982439|NCT00127036|588638662|FG000|Overall Study|Insufficient Data for Analysis|6|||
162982440|NCT00127036|588638663|FG001|Overall Study|Insufficient Data for Analysis|11|||
162982441|NCT00127036|588638662|FG000|Overall Study|Screen Failure|2|||
162982442|NCT00127036|588638663|FG001|Overall Study|Screen Failure|0|||
162982443|NCT01429051|588638666|FG000|Titration Phase|Death|1|||
162982444|NCT01429051|588638666|FG000|Titration Phase|Withdrawal by Subject|7|||
162982445|NCT01429051|588638666|FG000|Titration Phase|Physician Decision|1|||
162982446|NCT01429051|588638666|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
162982447|NCT01429051|588638666|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
162982448|NCT01429051|588638666|FG000|Efficacy Phase|Adverse Event|1|||
162982449|NCT01429051|588638666|FG000|Efficacy Phase|Death|1|||
162982450|NCT01429051|588638666|FG000|Tolerability Phase|Death|5|||
162982451|NCT01429051|588638666|FG000|Tolerability Phase|Adverse Event|2|||
162982452|NCT01429051|588638666|FG000|Tolerability Phase|Withdrawal by Subject|5|||
162982453|NCT01429051|588638666|FG000|Tolerability Phase|Physician Decision|1|||
162982454|NCT01429051|588638666|FG000|Tolerability Phase|Other|2|||
162982455|NCT03001219|588638674|FG000|Proof of Concept|Study Termination by Sponsor|0|||
162982456|NCT03001219|588638675|FG001|Proof of Concept|Study Termination by Sponsor|1|||
162982457|NCT03001219|588638674|FG000|Proof of Concept|Withdrawal by Subject|0|||
162982458|NCT03001219|588638675|FG001|Proof of Concept|Withdrawal by Subject|4|||
162982459|NCT03001219|588638674|FG000|Proof of Concept|Protocol Deviation|0|||
162982460|NCT03001219|588638675|FG001|Proof of Concept|Protocol Deviation|1|||
162982461|NCT03001219|588638674|FG000|Proof of Concept|Adverse Event|1|||
162982462|NCT03001219|588638675|FG001|Proof of Concept|Adverse Event|1|||
162982463|NCT03001219|588638674|FG000|Proof of Concept|Physician Decision|1|||
162982464|NCT03001219|588638675|FG001|Proof of Concept|Physician Decision|0|||
162982465|NCT03001219|588638674|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
162982466|NCT03001219|588638675|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
162982467|NCT03001219|588638674|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
162982468|NCT03001219|588638675|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
162982469|NCT03001219|588638674|FG000|Extension Period Analysis|Physician Decision|0|||
162982470|NCT03001219|588638675|FG001|Extension Period Analysis|Physician Decision|1|||
162982471|NCT03001219|588638674|FG000|Extension Period Analysis|Adverse Event|1|||
162982472|NCT03001219|588638675|FG001|Extension Period Analysis|Adverse Event|1|||
162982473|NCT03001219|588638674|FG000|Extension Period Analysis|Protocol Deviation|0|||
162982474|NCT03001219|588638675|FG001|Extension Period Analysis|Protocol Deviation|1|||
162982475|NCT03001219|588638674|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
162982476|NCT03001219|588638675|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
162982477|NCT01797835|588638676|FG000|Overall Study|Lost to Follow-up|31|||
162982478|NCT01797835|588638677|FG001|Overall Study|Lost to Follow-up|27|||
162982479|NCT01403064|588638678|FG000|Overall Study|Death|0|||
162982480|NCT01403064|588638679|FG001|Overall Study|Death|0|||
162982481|NCT01403064|588638680|FG002|Overall Study|Death|1|||
162982482|NCT01403064|588638681|FG003|Overall Study|Death|1|||
162982483|NCT01403064|588638678|FG000|Overall Study|Withdrawal by Subject|0|||
162982484|NCT01403064|588638679|FG001|Overall Study|Withdrawal by Subject|0|||
162982485|NCT01403064|588638680|FG002|Overall Study|Withdrawal by Subject|1|||
162982486|NCT01403064|588638681|FG003|Overall Study|Withdrawal by Subject|1|||
162982487|NCT01403064|588638678|FG000|Overall Study|Other|1|||
162982488|NCT01403064|588638679|FG001|Overall Study|Other|0|||
162982489|NCT01403064|588638680|FG002|Overall Study|Other|2|||
162982490|NCT01403064|588638681|FG003|Overall Study|Other|1|||
163059477|NCT00701363|588926382|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
163059478|NCT00701363|588926383|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
163211800|NCT01909479|589490614|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
163211801|NCT03557151|589490616|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
163321677|NCT04424316|589889029|FG003|Overall Study|Physician Decision|1|||
162982491|NCT00973765|588638682|FG000|Overall Study|Lost to Follow-up|8|||
162982492|NCT00973765|588638683|FG001|Overall Study|Lost to Follow-up|14|||
162982493|NCT02669940|588638684|FG000|Overall Study|Failure to return|0|||
162982494|NCT02669940|588638685|FG001|Overall Study|Failure to return|3|||
162982495|NCT02669940|588638684|FG000|Overall Study|Insufficient follow-up data|1|||
162982496|NCT02669940|588638685|FG001|Overall Study|Insufficient follow-up data|0|||
162982497|NCT01892657|588638686|FG000|Overall Study|Withdrawal by Subject|6|||
162982498|NCT01892657|588638686|FG000|Overall Study|Protocol Violation|12|||
162982499|NCT00986180|588638687|FG000|Overall Study|Adverse Event|21|||
163059479|NCT03426878|588926384|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
163321678|NCT04424316|589889026|FG000|Overall Study|Protocol Violation|0|||
163321679|NCT04424316|589889027|FG001|Overall Study|Protocol Violation|1|||
163059480|NCT03426878|588926384|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
163059481|NCT03426878|588926384|FG000|Overall Study|Declined to receive results|3|||
163059482|NCT03426878|588926384|FG000|Overall Study|Received negative results by mailed letter|65|||
163059483|NCT03426878|588926384|FG000|Overall Study|Lost to Follow-up|177|||
163059484|NCT03704064|588926385|FG000|Overall Study|Lost to Follow-up|8|||
163059485|NCT03704064|588926386|FG001|Overall Study|Lost to Follow-up|4|||
163059486|NCT03704064|588926385|FG000|Overall Study|Withdrawal by Subject|1|||
163059487|NCT03704064|588926386|FG001|Overall Study|Withdrawal by Subject|1|||
163059488|NCT03704064|588926385|FG000|Overall Study|No longer available for study visits|0|||
163059489|NCT03704064|588926386|FG001|Overall Study|No longer available for study visits|1|||
163059490|NCT03704064|588926385|FG000|Overall Study|Censoring event|1|||
163059491|NCT03704064|588926386|FG001|Overall Study|Censoring event|0|||
163059492|NCT00726609|588926390|FG000|Overall Study|Adverse Event|10|||
163059493|NCT00726609|588926390|FG000|Overall Study|Withdrawal by Subject|2|||
163059494|NCT00726609|588926390|FG000|Overall Study|Lack of Efficacy|25|||
163059495|NCT00726609|588926390|FG000|Overall Study|Other|16|||
163059496|NCT00726609|588926390|FG000|Overall Study|Missing|42|||
163059497|NCT00726609|588926390|FG000|Overall Study|Other|3|||
163059498|NCT00746551|588926392|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
163059499|NCT00746551|588926393|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
163059500|NCT00746551|588926392|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
163059501|NCT00746551|588926393|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
163059502|NCT00746551|588926392|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
163059503|NCT00746551|588926393|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
163059504|NCT00465179|588926397|FG000|Overall Study|Adverse Event|4|||
163059505|NCT00465179|588926397|FG000|Overall Study|Withdrawal by Subject|2|||
163059506|NCT00465179|588926397|FG000|Overall Study|Progression of Disease|47|||
163059507|NCT00833755|588926401|FG000|Overall Study|Physician Decision|4|||
163059508|NCT00833755|588926402|FG001|Overall Study|Physician Decision|4|||
163059509|NCT00833755|588926403|FG002|Overall Study|Physician Decision|2|||
163059510|NCT00833755|588926404|FG003|Overall Study|Physician Decision|6|||
163059511|NCT00833755|588926401|FG000|Overall Study|Subject had scheduling issues|0|||
163059512|NCT00833755|588926402|FG001|Overall Study|Subject had scheduling issues|1|||
163059513|NCT00833755|588926403|FG002|Overall Study|Subject had scheduling issues|0|||
163059514|NCT00833755|588926404|FG003|Overall Study|Subject had scheduling issues|0|||
162982500|NCT00986180|588638688|FG001|Overall Study|Adverse Event|23|||
162982501|NCT00986180|588638687|FG000|Overall Study|Lack of Efficacy|4|||
162982502|NCT00986180|588638688|FG001|Overall Study|Lack of Efficacy|3|||
162982503|NCT00986180|588638687|FG000|Overall Study|Lost to Follow-up|5|||
162982504|NCT00986180|588638688|FG001|Overall Study|Lost to Follow-up|7|||
162982505|NCT00986180|588638687|FG000|Overall Study|Physician Decision|1|||
162982506|NCT00986180|588638688|FG001|Overall Study|Physician Decision|3|||
162982507|NCT00986180|588638687|FG000|Overall Study|Protocol Violation|2|||
162982508|NCT00986180|588638688|FG001|Overall Study|Protocol Violation|0|||
162982509|NCT00986180|588638687|FG000|Overall Study|Withdrawal by Subject|1|||
162982510|NCT00986180|588638688|FG001|Overall Study|Withdrawal by Subject|9|||
162982511|NCT00986180|588638687|FG000|Overall Study|Miscellanies|10|||
162982512|NCT00986180|588638688|FG001|Overall Study|Miscellanies|11|||
162982513|NCT01249365|588638698|FG000|Overall Study|Lost to Follow-up|1|||
162982514|NCT03579966|588638699|FG000|Overall Study|Adverse Event|6|||
162982515|NCT03579966|588638699|FG000|Overall Study|Lost to Follow-up|4|||
162982516|NCT03579966|588638699|FG000|Overall Study|Physician Decision|10|||
162982517|NCT03579966|588638699|FG000|Overall Study|Pregnancy|1|||
162982518|NCT03579966|588638699|FG000|Overall Study|Withdrawal by Subject|16|||
162982519|NCT03579966|588638699|FG000|Overall Study|Study terminated by Sponsor|22|||
162982520|NCT03579966|588638699|FG000|Overall Study|Protocol Violation|1|||
162982521|NCT02408068|588638700|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
162982522|NCT02408068|588638701|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
162982523|NCT02408068|588638702|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
162982524|NCT02408068|588638703|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
162982525|NCT02408068|588638704|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
163059515|NCT00262925|588926405|FG000|Overall Study|Lack of Efficacy|3|||
163059516|NCT00262925|588926405|FG000|Overall Study|Adverse Event|4|||
163059517|NCT00262925|588926405|FG000|Overall Study|Death|2|||
163059518|NCT00262925|588926405|FG000|Overall Study|alternative therapy|1|||
163211802|NCT03557151|589490617|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
163059519|NCT00262925|588926405|FG000|Overall Study|Other|1|||
163059520|NCT04682301|588926407|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
163059521|NCT04682301|588926407|FG000|Overall Study|Death|2|||
162982526|NCT02408068|588638705|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
162982527|NCT03484117|588638706|FG000|Overall Study|Lost to Follow-up|1|||
162982528|NCT03484117|588638707|FG001|Overall Study|Lost to Follow-up|3|||
162982529|NCT03484117|588638706|FG000|Overall Study|Declined participation in exit assess|1|||
163321680|NCT04424316|589889028|FG002|Overall Study|Protocol Violation|0|||
162982530|NCT03484117|588638707|FG001|Overall Study|Declined participation in exit assess|1|||
162982531|NCT03551496|588638711|FG000|Overall Study|Death|11|||
162982532|NCT03551496|588638712|FG001|Overall Study|Death|7|||
163321681|NCT04424316|589889029|FG003|Overall Study|Protocol Violation|0|||
163321682|NCT04424316|589889026|FG000|Overall Study|Withdrawal by Subject|71|||
163321683|NCT04424316|589889027|FG001|Overall Study|Withdrawal by Subject|77|||
163321684|NCT04424316|589889028|FG002|Overall Study|Withdrawal by Subject|0|||
163321685|NCT04424316|589889029|FG003|Overall Study|Withdrawal by Subject|0|||
163321686|NCT04424316|589889026|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163321687|NCT04424316|589889027|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163321688|NCT04424316|589889028|FG002|Overall Study|Withdrawal by parent/guardian|74|||
163321689|NCT04424316|589889029|FG003|Overall Study|Withdrawal by parent/guardian|81|||
163321690|NCT04424316|589889026|FG000|Overall Study|Randomized but not vaccinated|13|||
163321691|NCT04424316|589889027|FG001|Overall Study|Randomized but not vaccinated|21|||
163321692|NCT04424316|589889028|FG002|Overall Study|Randomized but not vaccinated|0|||
163321693|NCT04424316|589889029|FG003|Overall Study|Randomized but not vaccinated|0|||
163321694|NCT04424316|589889026|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
163321695|NCT04424316|589889027|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
163321696|NCT04424316|589889028|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
163321697|NCT04424316|589889029|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
163321698|NCT05070741|589889030|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
163321699|NCT03245840|589889031|FG000|Overall Study|Adverse Event|6|||
163321700|NCT03245840|589889032|FG001|Overall Study|Adverse Event|0|||
163321701|NCT03245840|589889031|FG000|Overall Study|Death|2|||
163321702|NCT03245840|589889032|FG001|Overall Study|Death|0|||
163321703|NCT03245840|589889031|FG000|Overall Study|Withdrawal by Subject|31|||
162982533|NCT03551496|588638711|FG000|Overall Study|Withdrawal by Subject|4|||
163321704|NCT03245840|589889032|FG001|Overall Study|Withdrawal by Subject|1|||
163321705|NCT03245840|589889031|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
163321706|NCT03245840|589889032|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163321707|NCT03245840|589889031|FG000|Overall Study|Physician Decision|4|||
163321708|NCT03245840|589889032|FG001|Overall Study|Physician Decision|1|||
163321709|NCT03245840|589889031|FG000|Overall Study|Study Terminated by Sponsor|56|||
163321710|NCT03245840|589889032|FG001|Overall Study|Study Terminated by Sponsor|6|||
163321711|NCT03245840|589889031|FG000|Overall Study|Site Terminated by Sponsor|4|||
163321712|NCT03245840|589889032|FG001|Overall Study|Site Terminated by Sponsor|0|||
163321713|NCT03245840|589889031|FG000|Overall Study|Lost to Follow-up|12|||
163321714|NCT03245840|589889032|FG001|Overall Study|Lost to Follow-up|2|||
163321715|NCT03245840|589889031|FG000|Overall Study|Pregnancy|2|||
163321716|NCT03245840|589889032|FG001|Overall Study|Pregnancy|0|||
163321717|NCT03245840|589889031|FG000|Overall Study|Non-Compliance with Study Drug|2|||
163321718|NCT03245840|589889032|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162982534|NCT03551496|588638712|FG001|Overall Study|Withdrawal by Subject|3|||
162982535|NCT03551496|588638711|FG000|Overall Study|Other Reasons|1|||
162982536|NCT03551496|588638712|FG001|Overall Study|Other Reasons|0|||
162982537|NCT02303041|588638715|FG000|Overall Study|Adverse Event|1|||
162982538|NCT02303041|588638716|FG001|Overall Study|Adverse Event|2|||
162982539|NCT00886288|588638717|FG000|Overall Study|no respect of the 12 weeks period|657|||
162982540|NCT00886288|588638718|FG001|Overall Study|no respect of the 12 weeks period|227|||
162982541|NCT00886288|588638717|FG000|Overall Study|Lost to Follow-up|86|||
162982542|NCT00886288|588638718|FG001|Overall Study|Lost to Follow-up|0|||
162982543|NCT01070771|588638719|FG000|Overall Study|Adverse Event|2|||
163321719|NCT03245840|589889031|FG000|Overall Study|Not treated|1|||
163321720|NCT03245840|589889032|FG001|Overall Study|Not treated|1|||
163321721|NCT05652010|589889038|FG000|First Intervention|Withdrawal by Subject|0|||
163321722|NCT05652010|589889039|FG001|First Intervention|Withdrawal by Subject|1|||
163321723|NCT05652010|589889038|FG000|Second Intervention|Withdrawal by Subject|1|||
163321724|NCT05652010|589889039|FG001|Second Intervention|Withdrawal by Subject|0|||
163321725|NCT05451693|589889040|FG000|Overall Study|Withdrawal by Subject|1|||
163321726|NCT05451693|589889041|FG001|Overall Study|Withdrawal by Subject|1|||
163321727|NCT04206787|589889047|FG000|Overall Study|Other than listed|2|||
163321728|NCT04206787|589889047|FG000|Overall Study|Investigator decision|1|||
163321729|NCT04206787|589889047|FG000|Overall Study|Death|25|||
163321730|NCT04206787|589889047|FG000|Overall Study|Lost to Follow-up|9|||
163321731|NCT04206787|589889047|FG000|Overall Study|Withdrawal of consent|9|||
163321732|NCT05008055|589889048|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
163321733|NCT05008055|589889049|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
163321734|NCT05008055|589889050|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
163321735|NCT03011034|589889058|FG000|Overall Study|Adverse Event|1|||
163321736|NCT03011034|589889059|FG001|Overall Study|Adverse Event|0|||
163321737|NCT03735979|589889067|FG000|Overall Study|Lost to Follow-up|1|||
163321738|NCT03735979|589889068|FG001|Overall Study|Lost to Follow-up|12|||
163403013|NCT00705783|590187085|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
163403014|NCT00705783|590187083|FG000|Conversion Phase|Lost to Follow-up|13|||
162982544|NCT01070771|588638719|FG000|Overall Study|Protocol Violation|1|||
162982545|NCT00700817|588638724|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
162982546|NCT00700817|588638725|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
163059522|NCT00560404|588926408|FG000|Overall Study|Adverse Event|2|||
163321739|NCT03735979|589889069|FG002|Overall Study|Lost to Follow-up|14|||
163321740|NCT03735979|589889067|FG000|Overall Study|Withdrawal by Subject|1|||
163321741|NCT03735979|589889068|FG001|Overall Study|Withdrawal by Subject|5|||
163321742|NCT03735979|589889069|FG002|Overall Study|Withdrawal by Subject|2|||
163321743|NCT03735979|589889067|FG000|Overall Study|Not due to the above reasons|1|||
163321744|NCT03735979|589889068|FG001|Overall Study|Not due to the above reasons|0|||
163321745|NCT03735979|589889069|FG002|Overall Study|Not due to the above reasons|0|||
163321746|NCT03417284|589890380|FG000|Overall Study|Inadequate supply on study drug|1|||
163321747|NCT03417284|589890381|FG001|Overall Study|Inadequate supply on study drug|0|||
163321748|NCT03417284|589890382|FG002|Overall Study|Inadequate supply on study drug|0|||
163321749|NCT03417284|589890383|FG003|Overall Study|Inadequate supply on study drug|0|||
163321750|NCT03417284|589890380|FG000|Overall Study|Disease Progression|0|||
163321751|NCT03417284|589890381|FG001|Overall Study|Disease Progression|0|||
163321752|NCT03417284|589890382|FG002|Overall Study|Disease Progression|1|||
163321753|NCT03417284|589890383|FG003|Overall Study|Disease Progression|0|||
163321754|NCT04089865|589890387|FG000|Overall Study|Withdrawal by Subject|2|||
163321755|NCT04089865|589890388|FG001|Overall Study|Withdrawal by Subject|2|||
163321756|NCT04089865|589890389|FG002|Overall Study|Withdrawal by Subject|7|||
163321757|NCT04089865|589890390|FG003|Overall Study|Withdrawal by Subject|2|||
163321758|NCT04389957|589890391|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
163321759|NCT04389957|589890392|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
163321760|NCT04389957|589890393|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
163321761|NCT04389957|589890394|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
163321762|NCT04389957|589890395|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
163321763|NCT04881461|589890397|FG000|Overall Study|Adverse Event|2|||
163321764|NCT04881461|589890398|FG001|Overall Study|Adverse Event|4|||
163321765|NCT04881461|589890397|FG000|Overall Study|Withdrawal by Subject|19|||
163321766|NCT04881461|589890398|FG001|Overall Study|Withdrawal by Subject|19|||
163321767|NCT04881461|589890397|FG000|Overall Study|Lost to Follow-up|4|||
163321768|NCT04881461|589890398|FG001|Overall Study|Lost to Follow-up|4|||
163321769|NCT04881461|589890397|FG000|Overall Study|Lack of Efficacy|1|||
163321770|NCT04881461|589890398|FG001|Overall Study|Lack of Efficacy|0|||
163321771|NCT04881461|589890397|FG000|Overall Study|"Reason stated as other in CRF"|1|||
163321772|NCT04881461|589890398|FG001|Overall Study|"Reason stated as other in CRF"|2|||
163321773|NCT03988621|589890399|FG000|Overall Study|Lost to Follow-up|16|||
163321774|NCT03988621|589890400|FG001|Overall Study|Lost to Follow-up|17|||
163321775|NCT03988621|589890399|FG000|Overall Study|Withdrawal by Subject|14|||
163321776|NCT03988621|589890400|FG001|Overall Study|Withdrawal by Subject|7|||
163321777|NCT03988621|589890399|FG000|Overall Study|Patient Lost to Follow Up|15|||
163321778|NCT03988621|589890400|FG001|Overall Study|Patient Lost to Follow Up|15|||
163321779|NCT03988621|589890399|FG000|Overall Study|Patient death|1|||
163321780|NCT03988621|589890400|FG001|Overall Study|Patient death|5|||
163321781|NCT02905331|589890406|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
163321782|NCT02905331|589890407|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
163321783|NCT02905331|589890408|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
163321784|NCT02905331|589890406|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
163321785|NCT02905331|589890407|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
163321786|NCT02905331|589890408|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
163321787|NCT02905331|589890406|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
163321788|NCT02905331|589890407|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
163321789|NCT02905331|589890408|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
163321790|NCT02905331|589890406|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
163321791|NCT02905331|589890407|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
163321792|NCT02905331|589890408|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
163321793|NCT02905331|589890406|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
163321794|NCT02905331|589890407|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
163321795|NCT02905331|589890408|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
163321796|NCT05007080|589890409|FG000|Overall Study|Lost to Follow-up|0|||
163321797|NCT05007080|589890410|FG001|Overall Study|Lost to Follow-up|1|||
163403015|NCT00705783|590187084|FG001|Conversion Phase|Lost to Follow-up|0|||
163059523|NCT00560404|588926409|FG001|Overall Study|Adverse Event|3|||
163321798|NCT05007080|589890411|FG002|Overall Study|Lost to Follow-up|0|||
163321799|NCT05007080|589890412|FG003|Overall Study|Lost to Follow-up|1|||
163321800|NCT05007080|589890413|FG004|Overall Study|Lost to Follow-up|1|||
163321801|NCT05007080|589890414|FG005|Overall Study|Lost to Follow-up|1|||
163321802|NCT05007080|589890409|FG000|Overall Study|Death|0|||
163321803|NCT05007080|589890410|FG001|Overall Study|Death|1|||
163321804|NCT05007080|589890411|FG002|Overall Study|Death|0|||
163321805|NCT05007080|589890412|FG003|Overall Study|Death|0|||
163059524|NCT00560404|588926408|FG000|Overall Study|Death|3|||
163321806|NCT05007080|589890413|FG004|Overall Study|Death|0|||
163321807|NCT05007080|589890414|FG005|Overall Study|Death|0|||
163403016|NCT00705783|590187085|FG002|Conversion Phase|Lost to Follow-up|0|||
163403017|NCT00705783|590187083|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
163403018|NCT00705783|590187084|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
163403019|NCT00705783|590187085|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
163403020|NCT00705783|590187083|FG000|Conversion Phase|Withdrawn by Investigator|4|||
163403021|NCT00705783|590187084|FG001|Conversion Phase|Withdrawn by Investigator|0|||
163403022|NCT00705783|590187085|FG002|Conversion Phase|Withdrawn by Investigator|0|||
163403023|NCT00705783|590187083|FG000|Conversion Phase|Withdrew Consent|24|||
163403024|NCT00705783|590187084|FG001|Conversion Phase|Withdrew Consent|0|||
163403025|NCT00705783|590187085|FG002|Conversion Phase|Withdrew Consent|0|||
163403026|NCT00705783|590187083|FG000|Conversion Phase|Protocol Deviation|2|||
163403027|NCT00705783|590187084|FG001|Conversion Phase|Protocol Deviation|0|||
163403028|NCT00705783|590187085|FG002|Conversion Phase|Protocol Deviation|0|||
163403029|NCT00705783|590187083|FG000|Conversion Phase|Adverse Event|11|||
163403030|NCT00705783|590187084|FG001|Conversion Phase|Adverse Event|0|||
163403031|NCT00705783|590187085|FG002|Conversion Phase|Adverse Event|0|||
163403032|NCT00705783|590187083|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
163403033|NCT00705783|590187084|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
163403034|NCT00705783|590187085|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
163403035|NCT00705783|590187083|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
163403036|NCT00705783|590187084|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
163403037|NCT00705783|590187085|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
163403038|NCT00705783|590187083|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
163403039|NCT00705783|590187084|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
163403040|NCT00705783|590187085|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
163403041|NCT00705783|590187083|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
163403042|NCT00705783|590187084|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
163403043|NCT00705783|590187085|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
163403044|NCT00705783|590187083|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
163403045|NCT00705783|590187084|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
163403046|NCT00705783|590187085|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
163403047|NCT00705783|590187083|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
163403048|NCT00705783|590187084|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
163403049|NCT00705783|590187085|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
163403050|NCT00705783|590187083|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
163403051|NCT00705783|590187084|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
163403052|NCT00705783|590187085|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
163403053|NCT00705783|590187083|FG000|Oral Stabilization Phase|Adverse Event|14|||
163403054|NCT00705783|590187084|FG001|Oral Stabilization Phase|Adverse Event|0|||
163403055|NCT00705783|590187085|FG002|Oral Stabilization Phase|Adverse Event|0|||
163403056|NCT00705783|590187083|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
163403057|NCT00705783|590187084|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
163403058|NCT00705783|590187085|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
163403059|NCT00705783|590187083|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
163403060|NCT00705783|590187084|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
163403061|NCT00705783|590187085|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
163403062|NCT00705783|590187083|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
163403063|NCT00705783|590187084|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
163403064|NCT00705783|590187085|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
163403065|NCT00705783|590187083|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
163403066|NCT00705783|590187084|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
163403067|NCT00705783|590187085|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
163403068|NCT00705783|590187083|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
163403069|NCT00705783|590187084|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
163403070|NCT00705783|590187085|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
163403071|NCT00705783|590187083|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
163403072|NCT00705783|590187084|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
163403073|NCT00705783|590187085|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
163403074|NCT00705783|590187083|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
163403075|NCT00705783|590187084|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
163403076|NCT00705783|590187085|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
163403077|NCT00705783|590187083|FG000|Depot Stabilization Phase|Adverse Event|17|||
163403078|NCT00705783|590187084|FG001|Depot Stabilization Phase|Adverse Event|0|||
163403079|NCT00705783|590187085|FG002|Depot Stabilization Phase|Adverse Event|0|||
163403080|NCT00705783|590187083|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
163403081|NCT00705783|590187084|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
163403082|NCT00705783|590187085|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
163403083|NCT00705783|590187083|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
163403084|NCT00705783|590187084|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
163321808|NCT05007080|589890409|FG000|Overall Study|Withdrawal by Subject|1|||
163321809|NCT05007080|589890410|FG001|Overall Study|Withdrawal by Subject|2|||
163321810|NCT05007080|589890411|FG002|Overall Study|Withdrawal by Subject|0|||
163321811|NCT05007080|589890412|FG003|Overall Study|Withdrawal by Subject|2|||
163321812|NCT05007080|589890413|FG004|Overall Study|Withdrawal by Subject|1|||
163211803|NCT03557151|589490616|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
163211804|NCT03557151|589490617|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
163211805|NCT03557151|589490616|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
163321813|NCT05007080|589890414|FG005|Overall Study|Withdrawal by Subject|1|||
163321814|NCT05007080|589890409|FG000|Overall Study|Other|1|||
163321815|NCT05007080|589890410|FG001|Overall Study|Other|0|||
163321816|NCT05007080|589890411|FG002|Overall Study|Other|1|||
163321817|NCT05007080|589890412|FG003|Overall Study|Other|1|||
163321818|NCT05007080|589890413|FG004|Overall Study|Other|0|||
163403085|NCT00705783|590187085|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
163211806|NCT03557151|589490617|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
163211807|NCT02810392|589490618|FG000|Overall Study|Subject too ill to continue|1|||
163211808|NCT02810392|589490619|FG001|Overall Study|Subject too ill to continue|0|||
163211809|NCT02810392|589490618|FG000|Overall Study|COVID 19 research restrictions|0|||
163211810|NCT02810392|589490619|FG001|Overall Study|COVID 19 research restrictions|1|||
163211811|NCT01187043|589490621|FG000|Overall Study|Adverse Event|0|||
163211812|NCT01187043|589490622|FG001|Overall Study|Adverse Event|0|||
163211813|NCT01187043|589490623|FG002|Overall Study|Adverse Event|0|||
163211814|NCT01187043|589490624|FG003|Overall Study|Adverse Event|0|||
163211815|NCT01187043|589490625|FG004|Overall Study|Adverse Event|1|||
163211816|NCT01187043|589490621|FG000|Overall Study|Unable to make scheduled visits|1|||
163211817|NCT01187043|589490622|FG001|Overall Study|Unable to make scheduled visits|0|||
163211818|NCT01187043|589490623|FG002|Overall Study|Unable to make scheduled visits|4|||
163211819|NCT01187043|589490624|FG003|Overall Study|Unable to make scheduled visits|0|||
163211820|NCT01187043|589490625|FG004|Overall Study|Unable to make scheduled visits|1|||
163211821|NCT03035409|589490626|FG000|Overall Study|Adverse Event|5|||
163211822|NCT03035409|589490626|FG000|Overall Study|Death|2|||
163211823|NCT03035409|589490626|FG000|Overall Study|Withdrawal by Subject|2|||
163211824|NCT03035409|589490626|FG000|Overall Study|Non compliance|4|||
163211825|NCT03035409|589490626|FG000|Overall Study|Patient was jittery|1|||
163211826|NCT03035409|589490626|FG000|Overall Study|Did not like Questionnaire|1|||
163211827|NCT03035409|589490626|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
163211828|NCT03035409|589490626|FG000|Overall Study|Did not like taking drugs|1|||
163211829|NCT00927784|589490631|FG000|Overall Study|Death|1|||
163211830|NCT00927784|589490632|FG001|Overall Study|Death|0|||
163211831|NCT00927784|589490631|FG000|Overall Study|Withdrawal by Subject|1|||
163211832|NCT00927784|589490632|FG001|Overall Study|Withdrawal by Subject|0|||
163211833|NCT00467259|589490633|FG000|Overall Study|Adverse Event|24|||
163211834|NCT00467259|589490634|FG001|Overall Study|Adverse Event|90|||
163211835|NCT00467259|589490633|FG000|Overall Study|Protocol Violation|1|||
163211836|NCT00467259|589490634|FG001|Overall Study|Protocol Violation|7|||
163211837|NCT00467259|589490633|FG000|Overall Study|Withdrawal by Subject|34|||
163211838|NCT00467259|589490634|FG001|Overall Study|Withdrawal by Subject|108|||
163211839|NCT00467259|589490633|FG000|Overall Study|Physician Decision|0|||
163211840|NCT00467259|589490634|FG001|Overall Study|Physician Decision|2|||
163211841|NCT00467259|589490633|FG000|Overall Study|Lost to Follow-up|14|||
163211842|NCT00467259|589490634|FG001|Overall Study|Lost to Follow-up|34|||
163211843|NCT00467259|589490633|FG000|Overall Study|Site Closed|2|||
163211844|NCT00467259|589490634|FG001|Overall Study|Site Closed|1|||
163211845|NCT06079320|589490635|FG000|Follow up Phase|Lost to Follow-up|1|||
163211846|NCT06079320|589490636|FG001|Follow up Phase|Lost to Follow-up|0|||
163211847|NCT02196558|589490637|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
163211848|NCT02196558|589490638|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
163211849|NCT02196558|589490639|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
163211850|NCT02196558|589490637|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
163211851|NCT02196558|589490638|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
163211852|NCT02196558|589490639|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
163211853|NCT02196558|589490637|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
163211854|NCT02196558|589490638|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
163211855|NCT02196558|589490639|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
163211856|NCT02196558|589490637|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
163211857|NCT02196558|589490638|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
163211858|NCT02196558|589490639|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
163211859|NCT02196558|589490637|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
163211860|NCT02196558|589490638|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
163211861|NCT02196558|589490639|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
163211862|NCT02107482|589490644|FG000|Overall Study|inconveinence|2|||
163211863|NCT02107482|589490644|FG000|Overall Study|Lost to Follow-up|1|||
163211864|NCT02107482|589490644|FG000|Overall Study|Lack of Efficacy|1|||
163211865|NCT03128892|589490645|FG000|Overall Study|Withdrawal by Subject|2|||
163321819|NCT05007080|589890414|FG005|Overall Study|Other|2|||
163321820|NCT05007080|589890409|FG000|Overall Study|Randomized not vaccinated|0|||
163321821|NCT05007080|589890410|FG001|Overall Study|Randomized not vaccinated|0|||
163321822|NCT05007080|589890411|FG002|Overall Study|Randomized not vaccinated|0|||
163321823|NCT05007080|589890412|FG003|Overall Study|Randomized not vaccinated|0|||
163321824|NCT05007080|589890413|FG004|Overall Study|Randomized not vaccinated|0|||
163321825|NCT05007080|589890414|FG005|Overall Study|Randomized not vaccinated|1|||
163321826|NCT04583280|589890418|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
163321827|NCT04583280|589890419|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
163321828|NCT02577354|589890420|FG000|Overall Study|Lack of Efficacy|4|||
163321829|NCT02577354|589890421|FG001|Overall Study|Lack of Efficacy|4|||
163321830|NCT02577354|589890420|FG000|Overall Study|Lost to Follow-up|3|||
163321831|NCT02577354|589890421|FG001|Overall Study|Lost to Follow-up|1|||
163321832|NCT02577354|589890420|FG000|Overall Study|Missed Visit|4|||
163321833|NCT02577354|589890421|FG001|Overall Study|Missed Visit|3|||
163321834|NCT02577354|589890420|FG000|Overall Study|Adverse Event|4|||
163321835|NCT02577354|589890421|FG001|Overall Study|Adverse Event|5|||
163321836|NCT04173247|589890424|FG000|Overall Study|Withdrawal by Subject|0|||
163321837|NCT04173247|589890425|FG001|Overall Study|Withdrawal by Subject|2|||
163321838|NCT04173247|589890424|FG000|Overall Study|Death|1|||
163321839|NCT04173247|589890425|FG001|Overall Study|Death|0|||
163321840|NCT04173247|589890424|FG000|Overall Study|Physician Decision|1|||
163321841|NCT04173247|589890425|FG001|Overall Study|Physician Decision|0|||
163321842|NCT04109066|589890435|FG000|Pre-treatment|Participant withdrew consent|2|||
163321843|NCT04109066|589890436|FG001|Pre-treatment|Participant withdrew consent|0|||
163321844|NCT04109066|589890435|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
163321845|NCT04109066|589890436|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
163321846|NCT04109066|589890435|FG000|Treatment|Lack of Efficacy|2|||
163321847|NCT04109066|589890436|FG001|Treatment|Lack of Efficacy|4|||
163321848|NCT04109066|589890435|FG000|Treatment|Adverse Event|23|||
163321849|NCT04109066|589890436|FG001|Treatment|Adverse Event|7|||
163321850|NCT04109066|589890435|FG000|Treatment|Participant request to discontinue Study treatment|15|||
163321851|NCT04109066|589890436|FG001|Treatment|Participant request to discontinue Study treatment|14|||
163321852|NCT04109066|589890435|FG000|Treatment|Withdrawal by Subject|8|||
163321853|NCT04109066|589890436|FG001|Treatment|Withdrawal by Subject|8|||
163321854|NCT04109066|589890435|FG000|Treatment|Death|3|||
163321855|NCT04109066|589890436|FG001|Treatment|Death|0|||
163321856|NCT04109066|589890435|FG000|Treatment|Participant no longer meets study criteria|2|||
163321857|NCT04109066|589890436|FG001|Treatment|Participant no longer meets study criteria|2|||
163321858|NCT04109066|589890435|FG000|Treatment|Administrative reasons by sponsor|2|||
163321859|NCT04109066|589890436|FG001|Treatment|Administrative reasons by sponsor|3|||
163321860|NCT04109066|589890435|FG000|Treatment|Other reasons|17|||
163321861|NCT04109066|589890436|FG001|Treatment|Other reasons|23|||
163321862|NCT04109066|589890435|FG000|Treatment|Disease Progression|4|||
163321863|NCT04109066|589890436|FG001|Treatment|Disease Progression|7|||
163321864|NCT04109066|589890435|FG000|Treatment|Study drug toxicity|12|||
163321865|NCT04109066|589890436|FG001|Treatment|Study drug toxicity|5|||
163321866|NCT04109066|589890435|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
163321867|NCT04109066|589890436|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
163321868|NCT04109066|589890435|FG000|Treatment|Disease Recurrence|0|||
163321869|NCT04109066|589890436|FG001|Treatment|Disease Recurrence|2|||
163321870|NCT04109066|589890435|FG000|Treatment|Not reported|4|||
163321871|NCT04109066|589890436|FG001|Treatment|Not reported|8|||
163321872|NCT00319111|589890441|FG000|Overall Study|Adverse Event|20|||
163321873|NCT00319111|589890441|FG000|Overall Study|Withdrawal of consent|11|||
163321874|NCT00319111|589890441|FG000|Overall Study|Death|9|||
163321875|NCT00319111|589890441|FG000|Overall Study|Lack of clinical improvement|4|||
163321876|NCT00319111|589890441|FG000|Overall Study|Administrative|2|||
163321877|NCT00319111|589890441|FG000|Overall Study|Treatment failure|1|||
163321878|NCT01475786|589890442|FG000|Overall Study|Adverse Event|0|||
163321879|NCT01475786|589890443|FG001|Overall Study|Adverse Event|1|||
163321880|NCT01475786|589890444|FG002|Overall Study|Adverse Event|0|||
163321881|NCT01475786|589890442|FG000|Overall Study|Lost to Follow-up|1|||
163321882|NCT01475786|589890443|FG001|Overall Study|Lost to Follow-up|2|||
163321883|NCT01475786|589890444|FG002|Overall Study|Lost to Follow-up|1|||
163321884|NCT01475786|589890442|FG000|Overall Study|Withdrawal by Subject|0|||
163321885|NCT01475786|589890443|FG001|Overall Study|Withdrawal by Subject|1|||
163321886|NCT01475786|589890444|FG002|Overall Study|Withdrawal by Subject|1|||
163321887|NCT01475786|589890442|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
163321888|NCT01475786|589890443|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
163321889|NCT01475786|589890444|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
163321890|NCT03165955|589890446|FG000|Treatment|Withdrawal by Subject|3|||
163321891|NCT03165955|589890446|FG000|Treatment|Death|1|||
163321892|NCT03165955|589890446|FG000|Treatment|Adverse Event|1|||
162982547|NCT00700817|588638726|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
163321893|NCT03165955|589890446|FG000|Treatment|Progressive disease|3|||
163321894|NCT04761198|589890449|FG000|Overall Study|Progressive Disease|1|||
163321895|NCT04761198|589890450|FG001|Overall Study|Progressive Disease|0|||
163321896|NCT04761198|589890451|FG002|Overall Study|Progressive Disease|0|||
163321897|NCT04761198|589890452|FG003|Overall Study|Progressive Disease|1|||
163321898|NCT04761198|589890453|FG004|Overall Study|Progressive Disease|4|||
163321899|NCT04761198|589890454|FG005|Overall Study|Progressive Disease|1|||
163321900|NCT04761198|589890455|FG006|Overall Study|Progressive Disease|2|||
163321901|NCT04761198|589890449|FG000|Overall Study|Protocol Violation|0|||
163321902|NCT04761198|589890450|FG001|Overall Study|Protocol Violation|0|||
163321903|NCT04761198|589890451|FG002|Overall Study|Protocol Violation|0|||
163321904|NCT04761198|589890452|FG003|Overall Study|Protocol Violation|0|||
163321905|NCT04761198|589890453|FG004|Overall Study|Protocol Violation|1|||
163321906|NCT04761198|589890454|FG005|Overall Study|Protocol Violation|0|||
163321907|NCT04761198|589890455|FG006|Overall Study|Protocol Violation|0|||
163321908|NCT04761198|589890449|FG000|Overall Study|Death|2|||
163321909|NCT04761198|589890450|FG001|Overall Study|Death|1|||
163321910|NCT04761198|589890451|FG002|Overall Study|Death|2|||
163321911|NCT04761198|589890452|FG003|Overall Study|Death|5|||
163321912|NCT04761198|589890453|FG004|Overall Study|Death|14|||
163321913|NCT04761198|589890454|FG005|Overall Study|Death|2|||
163321914|NCT04761198|589890455|FG006|Overall Study|Death|5|||
163321915|NCT04761198|589890449|FG000|Overall Study|Lost to Follow-up|0|||
163321916|NCT04761198|589890450|FG001|Overall Study|Lost to Follow-up|0|||
163321917|NCT04761198|589890451|FG002|Overall Study|Lost to Follow-up|0|||
163321918|NCT04761198|589890452|FG003|Overall Study|Lost to Follow-up|0|||
163321919|NCT04761198|589890453|FG004|Overall Study|Lost to Follow-up|1|||
163321920|NCT04761198|589890454|FG005|Overall Study|Lost to Follow-up|0|||
163321921|NCT04761198|589890455|FG006|Overall Study|Lost to Follow-up|0|||
163321922|NCT04761198|589890449|FG000|Overall Study|Withdrawal by Subject|2|||
163321923|NCT04761198|589890450|FG001|Overall Study|Withdrawal by Subject|0|||
163321924|NCT04761198|589890451|FG002|Overall Study|Withdrawal by Subject|1|||
163321925|NCT04761198|589890452|FG003|Overall Study|Withdrawal by Subject|0|||
163321926|NCT04761198|589890453|FG004|Overall Study|Withdrawal by Subject|2|||
163321927|NCT04761198|589890454|FG005|Overall Study|Withdrawal by Subject|0|||
163321928|NCT04761198|589890455|FG006|Overall Study|Withdrawal by Subject|1|||
163321929|NCT04761198|589890449|FG000|Overall Study|Study Terminated by Sponsor|6|||
163321930|NCT04761198|589890450|FG001|Overall Study|Study Terminated by Sponsor|0|||
163321931|NCT04761198|589890451|FG002|Overall Study|Study Terminated by Sponsor|5|||
163321932|NCT04761198|589890452|FG003|Overall Study|Study Terminated by Sponsor|3|||
163321933|NCT04761198|589890453|FG004|Overall Study|Study Terminated by Sponsor|10|||
163321934|NCT04761198|589890454|FG005|Overall Study|Study Terminated by Sponsor|1|||
163321935|NCT04761198|589890455|FG006|Overall Study|Study Terminated by Sponsor|2|||
163321936|NCT02994927|589890456|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163321937|NCT02994927|589890457|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163321938|NCT02994927|589890456|FG000|Overall Study|Did not meet eligibility criteria|0|||
163321939|NCT02994927|589890457|FG001|Overall Study|Did not meet eligibility criteria|1|||
163321940|NCT02994927|589890456|FG000|Overall Study|Physician Decision|4|||
163321941|NCT02994927|589890457|FG001|Overall Study|Physician Decision|3|||
163321942|NCT02994927|589890456|FG000|Overall Study|Death|4|||
163321943|NCT02994927|589890457|FG001|Overall Study|Death|2|||
163321944|NCT02994927|589890456|FG000|Overall Study|Adverse Event|2|||
163321945|NCT02994927|589890457|FG001|Overall Study|Adverse Event|1|||
163321946|NCT02994927|589890456|FG000|Overall Study|Withdrawal by Subject|3|||
163321947|NCT02994927|589890457|FG001|Overall Study|Withdrawal by Subject|6|||
163321948|NCT02994927|589890456|FG000|Overall Study|Lost to Follow-up|2|||
163321949|NCT02994927|589890457|FG001|Overall Study|Lost to Follow-up|1|||
163321950|NCT03533257|589890465|FG000|Overall Study|Adverse Event|4|||
163321951|NCT03533257|589890466|FG001|Overall Study|Adverse Event|2|||
163321952|NCT03533257|589890465|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
163321953|NCT03533257|589890466|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
163321954|NCT05525104|589890470|FG000|Overall Study|Failed caudal analgesia|1|||
163321955|NCT05525104|589890471|FG001|Overall Study|Failed caudal analgesia|3|||
163321956|NCT05525104|589890470|FG000|Overall Study|Premedication needed|0|||
163321957|NCT05525104|589890471|FG001|Overall Study|Premedication needed|1|||
163321958|NCT05525104|589890470|FG000|Overall Study|Protocol Violation|10|||
163321959|NCT05525104|589890471|FG001|Overall Study|Protocol Violation|0|||
163321960|NCT05525104|589890470|FG000|Overall Study|Cancelled operation|1|||
163321961|NCT05525104|589890471|FG001|Overall Study|Cancelled operation|0|||
163321962|NCT02039401|589890472|FG000|Overall Study|Adverse Event|0|||
163321963|NCT02039401|589890473|FG001|Overall Study|Adverse Event|1|||
163321964|NCT02865538|589890476|FG000|Overall Study|Withdrawal by Subject|0|||
163321965|NCT02865538|589890477|FG001|Overall Study|Withdrawal by Subject|0|||
163321966|NCT02865538|589890478|FG002|Overall Study|Withdrawal by Subject|1|||
163321967|NCT02865538|589890479|FG003|Overall Study|Withdrawal by Subject|0|||
163321968|NCT02865538|589890480|FG004|Overall Study|Withdrawal by Subject|0|||
163321969|NCT02865538|589890476|FG000|Overall Study|Lost to Follow-up|1|||
163321970|NCT02865538|589890477|FG001|Overall Study|Lost to Follow-up|0|||
163321971|NCT02865538|589890478|FG002|Overall Study|Lost to Follow-up|0|||
163321972|NCT02865538|589890479|FG003|Overall Study|Lost to Follow-up|0|||
163321973|NCT02865538|589890480|FG004|Overall Study|Lost to Follow-up|0|||
163321974|NCT04282980|589891467|FG000|Overall Study|Remained on treatment|6|||
163321975|NCT04282980|589891467|FG000|Overall Study|Survival follow-up|11|||
163321976|NCT04282980|589891467|FG000|Overall Study|Withdrawal of informed consent|1|||
163321977|NCT04282980|589891467|FG000|Overall Study|Lost to Follow-up|1|||
163321978|NCT01917084|589891469|FG000|Overall Study|Withdrawal by Subject|1|||
163321979|NCT03571386|589891470|FG000|Overall Study|scheduling conflict|4|||
163321980|NCT03571386|589891471|FG001|Overall Study|scheduling conflict|0|||
163321981|NCT03571386|589891470|FG000|Overall Study|Withdrawal by Subject|15|||
163321982|NCT03571386|589891471|FG001|Overall Study|Withdrawal by Subject|5|||
163321983|NCT06037668|589891478|FG000|Overall Study|Lost to Follow-up|1|||
163321984|NCT06037668|589891479|FG001|Overall Study|Lost to Follow-up|1|||
163321985|NCT06037668|589891478|FG000|Overall Study|Protocol Violation|1|||
163321986|NCT06037668|589891479|FG001|Overall Study|Protocol Violation|0|||
163321987|NCT06037668|589891478|FG000|Overall Study|Withdrawal by Subject|1|||
163321988|NCT06037668|589891479|FG001|Overall Study|Withdrawal by Subject|0|||
163321989|NCT06037668|589891478|FG000|Overall Study|Other Study Discontinuation Reason|1|||
163321990|NCT06037668|589891479|FG001|Overall Study|Other Study Discontinuation Reason|0|||
163321991|NCT02473445|589891480|FG000|Overall Study|Withdrawal by Subject|2|||
163321992|NCT02473445|589891480|FG000|Overall Study|Sponsor Decision|20|||
163321993|NCT04247802|589891481|FG000|Overall Study|Withdrawal by Subject|1|||
163321994|NCT04247802|589891482|FG001|Overall Study|Withdrawal by Subject|3|||
163321995|NCT04247802|589891481|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
163321996|NCT04247802|589891482|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
163321997|NCT04629339|589891488|FG000|Overall Study|Death|1|||
163321998|NCT04629339|589891489|FG001|Overall Study|Death|0|||
163321999|NCT04629339|589891490|FG002|Overall Study|Death|2|||
163322000|NCT04629339|589891491|FG003|Overall Study|Death|2|||
163322001|NCT04629339|589891492|FG004|Overall Study|Death|0|||
163322002|NCT04629339|589891488|FG000|Overall Study|Disease Progression|0|||
163322003|NCT04629339|589891489|FG001|Overall Study|Disease Progression|0|||
163322004|NCT04629339|589891490|FG002|Overall Study|Disease Progression|1|||
163322005|NCT04629339|589891491|FG003|Overall Study|Disease Progression|1|||
163322006|NCT04629339|589891492|FG004|Overall Study|Disease Progression|0|||
163322007|NCT04629339|589891488|FG000|Overall Study|Lost to Follow-up|0|||
163322008|NCT04629339|589891489|FG001|Overall Study|Lost to Follow-up|0|||
163322009|NCT04629339|589891490|FG002|Overall Study|Lost to Follow-up|0|||
163322010|NCT04629339|589891491|FG003|Overall Study|Lost to Follow-up|1|||
163322011|NCT04629339|589891492|FG004|Overall Study|Lost to Follow-up|0|||
163322012|NCT04629339|589891488|FG000|Overall Study|Physician Decision|0|||
163322013|NCT04629339|589891489|FG001|Overall Study|Physician Decision|1|||
163322014|NCT04629339|589891490|FG002|Overall Study|Physician Decision|0|||
163322015|NCT04629339|589891491|FG003|Overall Study|Physician Decision|0|||
163322016|NCT04629339|589891492|FG004|Overall Study|Physician Decision|0|||
163322017|NCT04629339|589891488|FG000|Overall Study|Study Terminated by Sponsor|0|||
163322018|NCT04629339|589891489|FG001|Overall Study|Study Terminated by Sponsor|0|||
163322019|NCT04629339|589891490|FG002|Overall Study|Study Terminated by Sponsor|0|||
163322020|NCT04629339|589891491|FG003|Overall Study|Study Terminated by Sponsor|1|||
163322021|NCT04629339|589891492|FG004|Overall Study|Study Terminated by Sponsor|0|||
163322022|NCT04629339|589891488|FG000|Overall Study|Withdrawal by Subject|0|||
163322023|NCT04629339|589891489|FG001|Overall Study|Withdrawal by Subject|0|||
163322024|NCT04629339|589891490|FG002|Overall Study|Withdrawal by Subject|2|||
163322025|NCT04629339|589891491|FG003|Overall Study|Withdrawal by Subject|2|||
163322026|NCT04629339|589891492|FG004|Overall Study|Withdrawal by Subject|0|||
163322027|NCT04158739|589891499|FG000|Overall Study|Adverse Event|1|||
163322028|NCT04158739|589891500|FG001|Overall Study|Adverse Event|0|||
163322029|NCT04158739|589891499|FG000|Overall Study|Death|0|||
163322030|NCT04158739|589891500|FG001|Overall Study|Death|1|||
163322031|NCT04158739|589891499|FG000|Overall Study|Lack of Efficacy|3|||
163322032|NCT04158739|589891500|FG001|Overall Study|Lack of Efficacy|7|||
163322033|NCT04158739|589891499|FG000|Overall Study|Physician Decision|0|||
163322034|NCT04158739|589891500|FG001|Overall Study|Physician Decision|1|||
163059525|NCT00560404|588926409|FG001|Overall Study|Death|3|||
163322035|NCT04158739|589891499|FG000|Overall Study|Withdrawal by Subject|3|||
163322036|NCT04158739|589891500|FG001|Overall Study|Withdrawal by Subject|0|||
163322037|NCT04778410|589891501|FG000|Safety Run-in Period|Death|5|||
163322038|NCT04778410|589891502|FG001|Safety Run-in Period|Death|6|||
163322039|NCT04778410|589891503|FG002|Safety Run-in Period|Death|0|||
163322040|NCT04778410|589891504|FG003|Safety Run-in Period|Death|0|||
163322041|NCT04778410|589891505|FG004|Safety Run-in Period|Death|0|||
163322042|NCT04778410|589891506|FG005|Safety Run-in Period|Death|0|||
163322043|NCT04778410|589891501|FG000|Phase 2 Period|Death|0|||
163322044|NCT04778410|589891502|FG001|Phase 2 Period|Death|0|||
163322045|NCT04778410|589891503|FG002|Phase 2 Period|Death|0|||
163322046|NCT04778410|589891504|FG003|Phase 2 Period|Death|5|||
163322047|NCT04778410|589891505|FG004|Phase 2 Period|Death|18|||
163322048|NCT04778410|589891506|FG005|Phase 2 Period|Death|0|||
163322049|NCT04778410|589891501|FG000|Phase 2 Period|Lost to Follow-up|0|||
163322050|NCT04778410|589891502|FG001|Phase 2 Period|Lost to Follow-up|0|||
163403086|NCT00705783|590187083|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
163403087|NCT00705783|590187084|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
163403088|NCT00705783|590187085|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
163403089|NCT00705783|590187083|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
163403090|NCT00705783|590187084|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
163403091|NCT00705783|590187085|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
163403092|NCT00705783|590187083|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
163403093|NCT00705783|590187084|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
163403094|NCT00705783|590187085|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
163403095|NCT00705783|590187083|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
163403096|NCT00705783|590187084|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
163403097|NCT00705783|590187085|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
163403098|NCT00705783|590187083|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
163403099|NCT00705783|590187084|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
163403100|NCT00705783|590187085|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
163403101|NCT00705783|590187083|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
163403102|NCT00705783|590187084|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
163403103|NCT00705783|590187085|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
163403104|NCT00705783|590187083|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
163403105|NCT00705783|590187084|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
163403106|NCT00705783|590187085|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
163403107|NCT00705783|590187083|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
163403108|NCT00705783|590187084|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
163403109|NCT00705783|590187085|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
163403110|NCT00705783|590187083|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
163403111|NCT00705783|590187084|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
163403112|NCT00705783|590187085|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
163403113|NCT02182687|590187086|FG000|Overall Study|Withdrawal by Subject|4|||
163403114|NCT02182687|590187087|FG001|Overall Study|Withdrawal by Subject|0|||
163403115|NCT02182687|590187086|FG000|Overall Study|Adverse Event|1|||
163403116|NCT02182687|590187087|FG001|Overall Study|Adverse Event|0|||
163403117|NCT02182687|590187086|FG000|Overall Study|Lost to Follow-up|0|||
163403118|NCT02182687|590187087|FG001|Overall Study|Lost to Follow-up|1|||
163403119|NCT04251910|590187091|FG000|Overall Study|Covid 19 lockdown|0|||
163403120|NCT04251910|590187092|FG001|Overall Study|Covid 19 lockdown|5|||
163403121|NCT04251910|590187093|FG002|Overall Study|Covid 19 lockdown|0|||
163403122|NCT04251910|590187094|FG003|Overall Study|Covid 19 lockdown|4|||
163403123|NCT04251910|590187095|FG004|Overall Study|Covid 19 lockdown|0|||
163403124|NCT04251910|590187096|FG005|Overall Study|Covid 19 lockdown|0|||
163403125|NCT04251910|590187091|FG000|Overall Study|Assisted living facility was closed|0|||
163403126|NCT04251910|590187092|FG001|Overall Study|Assisted living facility was closed|0|||
163403127|NCT04251910|590187093|FG002|Overall Study|Assisted living facility was closed|0|||
163403128|NCT04251910|590187094|FG003|Overall Study|Assisted living facility was closed|0|||
163403129|NCT04251910|590187095|FG004|Overall Study|Assisted living facility was closed|1|||
163403130|NCT04251910|590187096|FG005|Overall Study|Assisted living facility was closed|0|||
163403131|NCT03451084|590187100|FG000|Overall Study|Withdrawal by Subject|2|||
163403132|NCT03451084|590187101|FG001|Overall Study|Withdrawal by Subject|1|||
163403133|NCT03451084|590187102|FG002|Overall Study|Withdrawal by Subject|2|||
163403134|NCT03451084|590187103|FG003|Overall Study|Withdrawal by Subject|1|||
163403135|NCT03451084|590187100|FG000|Overall Study|Disease recurrence|0|||
163403136|NCT03451084|590187101|FG001|Overall Study|Disease recurrence|2|||
163403137|NCT03451084|590187102|FG002|Overall Study|Disease recurrence|0|||
163403138|NCT03451084|590187103|FG003|Overall Study|Disease recurrence|0|||
163403139|NCT03451084|590187100|FG000|Overall Study|Lack of Efficacy|0|||
163403140|NCT03451084|590187101|FG001|Overall Study|Lack of Efficacy|3|||
163403141|NCT03451084|590187102|FG002|Overall Study|Lack of Efficacy|0|||
163403142|NCT03451084|590187103|FG003|Overall Study|Lack of Efficacy|1|||
163403143|NCT03451084|590187100|FG000|Overall Study|Death|1|||
163403144|NCT03451084|590187101|FG001|Overall Study|Death|0|||
163403145|NCT03451084|590187102|FG002|Overall Study|Death|2|||
163403146|NCT03451084|590187103|FG003|Overall Study|Death|0|||
163403147|NCT03451084|590187100|FG000|Overall Study|Physician Decision|0|||
163403148|NCT03451084|590187101|FG001|Overall Study|Physician Decision|0|||
163059526|NCT00560404|588926408|FG000|Overall Study|Protocol Violation|12|||
163403149|NCT03451084|590187102|FG002|Overall Study|Physician Decision|2|||
163403150|NCT03451084|590187103|FG003|Overall Study|Physician Decision|2|||
163403151|NCT03451084|590187100|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
163403152|NCT03451084|590187101|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
163403153|NCT03451084|590187102|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
163403154|NCT03451084|590187103|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
163403155|NCT04544475|590187108|FG000|Overall Study|Withdrawal by Subject|1|||
163403156|NCT04544475|590187109|FG001|Overall Study|Withdrawal by Subject|3|||
163059527|NCT00560404|588926409|FG001|Overall Study|Protocol Violation|7|||
163059528|NCT00560404|588926408|FG000|Overall Study|Administrative Reasons|1|||
163059529|NCT00560404|588926409|FG001|Overall Study|Administrative Reasons|1|||
163059530|NCT00560404|588926408|FG000|Overall Study|Withdrew Consent|4|||
163059531|NCT00560404|588926409|FG001|Overall Study|Withdrew Consent|0|||
163059532|NCT00560404|588926408|FG000|Overall Study|Failure to return|1|||
163059533|NCT00560404|588926409|FG001|Overall Study|Failure to return|2|||
163059534|NCT00560404|588926408|FG000|Overall Study|Other withdrawal reason|13|||
163059535|NCT00560404|588926409|FG001|Overall Study|Other withdrawal reason|5|||
163059536|NCT02642042|588926416|FG000|Overall Study|Adverse Event|22|||
163059537|NCT02642042|588926416|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
163059538|NCT02642042|588926416|FG000|Overall Study|Progression/Relapse|28|||
163059539|NCT02642042|588926416|FG000|Overall Study|Death|1|||
163059540|NCT02642042|588926416|FG000|Overall Study|Not Protocol Specified|2|||
163059541|NCT04108468|588926417|FG000|Overall Study|Physician Decision|0|||
163211866|NCT03128892|589490645|FG000|Overall Study|Physician Decision|1|||
163322051|NCT04778410|589891503|FG002|Phase 2 Period|Lost to Follow-up|0|||
163322052|NCT04778410|589891504|FG003|Phase 2 Period|Lost to Follow-up|1|||
163322053|NCT04778410|589891505|FG004|Phase 2 Period|Lost to Follow-up|1|||
163322054|NCT04778410|589891506|FG005|Phase 2 Period|Lost to Follow-up|0|||
163322055|NCT04778410|589891501|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
163322056|NCT04778410|589891502|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
163322057|NCT04778410|589891503|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
163322058|NCT04778410|589891504|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
163322059|NCT04778410|589891505|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
163322060|NCT04778410|589891506|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
163322061|NCT04778410|589891501|FG000|Phase 2 Period|Withdrew Consent|0|||
163322062|NCT04778410|589891502|FG001|Phase 2 Period|Withdrew Consent|0|||
163322063|NCT04778410|589891503|FG002|Phase 2 Period|Withdrew Consent|0|||
163322064|NCT04778410|589891504|FG003|Phase 2 Period|Withdrew Consent|0|||
163322065|NCT04778410|589891505|FG004|Phase 2 Period|Withdrew Consent|2|||
163322066|NCT04778410|589891506|FG005|Phase 2 Period|Withdrew Consent|0|||
163322067|NCT05422885|589891513|FG000|Overall Study|Lost to Follow-up|1|||
163322068|NCT05422885|589891513|FG000|Overall Study|Withdrawal by Subject|2|||
163322069|NCT04084574|589891514|FG000|Overall Study|Lost to Follow-up|1|||
163322070|NCT04084574|589891515|FG001|Overall Study|Lost to Follow-up|0|||
163322071|NCT04084574|589891514|FG000|Overall Study|Physician Decision|1|||
163322072|NCT04084574|589891515|FG001|Overall Study|Physician Decision|0|||
163322073|NCT04084574|589891514|FG000|Overall Study|Relocated out of state|1|||
163322074|NCT04084574|589891515|FG001|Overall Study|Relocated out of state|0|||
163322075|NCT01121588|589891516|FG000|Overall Study|Death|5|||
163322076|NCT01121588|589891517|FG001|Overall Study|Death|3|||
163322077|NCT01121588|589891518|FG002|Overall Study|Death|13|||
163322078|NCT01121588|589891516|FG000|Overall Study|Study Terminated by Sponsor|1|||
163322079|NCT01121588|589891517|FG001|Overall Study|Study Terminated by Sponsor|1|||
163322080|NCT01121588|589891518|FG002|Overall Study|Study Terminated by Sponsor|0|||
163322081|NCT01121588|589891516|FG000|Overall Study|Participant Refused Further Followup|2|||
163059542|NCT04108468|588926418|FG001|Overall Study|Physician Decision|1|||
163059543|NCT04108468|588926417|FG000|Overall Study|Lost to Follow-up|0|||
163059544|NCT04108468|588926418|FG001|Overall Study|Lost to Follow-up|1|||
163059545|NCT04108468|588926417|FG000|Overall Study|Non-compliance|1|||
163059546|NCT04108468|588926418|FG001|Overall Study|Non-compliance|1|||
163059547|NCT04108468|588926417|FG000|Overall Study|Unable to attend final visit|2|||
163059548|NCT04108468|588926418|FG001|Overall Study|Unable to attend final visit|0|||
163059549|NCT04108468|588926417|FG000|Overall Study|Missed study medication|0|||
163211867|NCT00368355|589490647|FG000|Overall Study|Adverse Event|1|||
163211868|NCT00368355|589490648|FG001|Overall Study|Adverse Event|0|||
163211869|NCT00368355|589490647|FG000|Overall Study|Death|2|||
163211870|NCT00368355|589490648|FG001|Overall Study|Death|4|||
163211871|NCT00368355|589490647|FG000|Overall Study|Relapse|6|||
163211872|NCT00368355|589490648|FG001|Overall Study|Relapse|10|||
163211873|NCT00368355|589490647|FG000|Overall Study|Subsequent transplant|0|||
163211874|NCT00368355|589490648|FG001|Overall Study|Subsequent transplant|3|||
163211875|NCT00368355|589490647|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
163211876|NCT00368355|589490648|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
163211877|NCT03473808|589490657|FG000|Overall Study|Withdrawal by Subject|1|||
163211878|NCT01085591|589490660|FG000|Overall Study|Adverse Event|0|||
163211879|NCT01085591|589490661|FG001|Overall Study|Adverse Event|1|||
163211880|NCT01085591|589490662|FG002|Overall Study|Adverse Event|3|||
163211881|NCT01085591|589490660|FG000|Overall Study|Physician Decision|1|||
163211882|NCT01085591|589490661|FG001|Overall Study|Physician Decision|0|||
163211883|NCT01085591|589490662|FG002|Overall Study|Physician Decision|1|||
163211884|NCT01085591|589490660|FG000|Overall Study|Withdrawal by Subject|0|||
163211885|NCT01085591|589490661|FG001|Overall Study|Withdrawal by Subject|2|||
163211886|NCT01085591|589490662|FG002|Overall Study|Withdrawal by Subject|1|||
163322082|NCT01121588|589891517|FG001|Overall Study|Participant Refused Further Followup|0|||
163322083|NCT01121588|589891518|FG002|Overall Study|Participant Refused Further Followup|2|||
163322084|NCT01121588|589891516|FG000|Overall Study|Lost to Follow-up|0|||
163322085|NCT01121588|589891517|FG001|Overall Study|Lost to Follow-up|1|||
163211887|NCT01085591|589490660|FG000|Overall Study|Lost to Follow-up|0|||
163403157|NCT01765920|590187110|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
163403158|NCT01765920|590187111|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
163403159|NCT01765920|590187110|FG000|Overall Study|Patient code disclosure|0|||
163403160|NCT01765920|590187111|FG001|Overall Study|Patient code disclosure|1|||
163403161|NCT03223428|590187112|FG000|Overall Study|No longer taking Xermelo|27|||
163403162|NCT03223428|590187112|FG000|Overall Study|Declined Consent|1|||
163403163|NCT03223428|590187112|FG000|Overall Study|Non-responders|56|||
163403164|NCT03223428|590187112|FG000|Overall Study|Withdrawal by Subject|14|||
163403165|NCT02025907|590187113|FG000|Overall Study|Lack of Efficacy|1|||
163403166|NCT02025907|590187114|FG001|Overall Study|Lack of Efficacy|0|||
163403167|NCT02025907|590187113|FG000|Overall Study|Withdrawal by Subject|15|||
163403168|NCT02025907|590187114|FG001|Overall Study|Withdrawal by Subject|8|||
163403169|NCT02025907|590187113|FG000|Overall Study|Protocol Violation|2|||
163403170|NCT02025907|590187114|FG001|Overall Study|Protocol Violation|0|||
163403171|NCT02025907|590187113|FG000|Overall Study|Physician Decision|2|||
163403172|NCT02025907|590187114|FG001|Overall Study|Physician Decision|0|||
163403173|NCT02025907|590187113|FG000|Overall Study|Lost to Follow-up|2|||
163403174|NCT02025907|590187114|FG001|Overall Study|Lost to Follow-up|2|||
163403175|NCT02025907|590187113|FG000|Overall Study|Adverse Event|3|||
163403176|NCT02025907|590187114|FG001|Overall Study|Adverse Event|1|||
163403177|NCT02025907|590187113|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
163403178|NCT02025907|590187114|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
163403179|NCT00777101|590187115|FG000|Overall Study|Death|48|||
163403180|NCT00777101|590187116|FG001|Overall Study|Death|43|||
163403181|NCT00777101|590187115|FG000|Overall Study|Withdrawal by Subject|11|||
163403182|NCT00777101|590187116|FG001|Overall Study|Withdrawal by Subject|6|||
163403183|NCT00777101|590187115|FG000|Overall Study|Lost to Follow-up|2|||
163403184|NCT00777101|590187116|FG001|Overall Study|Lost to Follow-up|1|||
163403185|NCT00777101|590187115|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
163403186|NCT00777101|590187116|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
163403187|NCT00777101|590187115|FG000|Overall Study|Failed to Return|0|||
163403188|NCT00777101|590187116|FG001|Overall Study|Failed to Return|1|||
163403189|NCT02411539|590187117|FG000|Overall Study|Lost to Follow-up|2|||
163403190|NCT02411539|590187118|FG001|Overall Study|Lost to Follow-up|0|||
163403191|NCT02411539|590187117|FG000|Overall Study|Confounding medical condition|0|||
163403192|NCT02411539|590187118|FG001|Overall Study|Confounding medical condition|1|||
163403193|NCT00282334|590187121|FG000|Overall Study|Withdrawal by Subject|8|||
163403194|NCT00282334|590187122|FG001|Overall Study|Withdrawal by Subject|5|||
163403195|NCT01422915|590187127|FG000|Overall Study|Adverse Event|1|||
163403196|NCT03631732|590187130|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
163403197|NCT03631732|590187131|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
163403198|NCT03631732|590187130|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
163403199|NCT03631732|590187131|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
163403200|NCT03631732|590187130|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
163403201|NCT03631732|590187131|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
163403202|NCT03631732|590187130|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
163403203|NCT03631732|590187131|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
163403204|NCT03631732|590187130|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
163403205|NCT03631732|590187131|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
163403206|NCT03631732|590187130|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
163403207|NCT03631732|590187131|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
163403208|NCT03631732|590187130|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
163403209|NCT03631732|590187131|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
163403210|NCT03631732|590187130|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
163403211|NCT03631732|590187131|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
163403212|NCT03631732|590187130|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
163403213|NCT03631732|590187131|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
163403214|NCT03631732|590187130|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
163403215|NCT03631732|590187131|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
163403216|NCT01439204|590187132|FG000|Overall Study|Withdrawal by Subject|0|||
163403217|NCT01439204|590187133|FG001|Overall Study|Withdrawal by Subject|1|||
163403218|NCT01439204|590187132|FG000|Overall Study|Lost to Follow-up|0|||
163403219|NCT01439204|590187133|FG001|Overall Study|Lost to Follow-up|2|||
163403220|NCT01439204|590187132|FG000|Overall Study|No longer meets study criteria|1|||
163403221|NCT01439204|590187133|FG001|Overall Study|No longer meets study criteria|0|||
163403222|NCT01439204|590187132|FG000|Overall Study|poor/non-compliance|3|||
163403223|NCT01439204|590187133|FG001|Overall Study|poor/non-compliance|0|||
163211888|NCT01085591|589490661|FG001|Overall Study|Lost to Follow-up|1|||
163211889|NCT01085591|589490662|FG002|Overall Study|Lost to Follow-up|1|||
163403224|NCT01251367|590187134|FG000|Overall Study|Protocol Violation|1|||
163403225|NCT01251367|590187134|FG000|Overall Study|Lack of Efficacy|2|||
163403226|NCT01251367|590187134|FG000|Overall Study|Adverse Event|19|||
163403227|NCT01251367|590187134|FG000|Overall Study|Withdrawal by Subject|36|||
163322086|NCT01121588|589891518|FG002|Overall Study|Lost to Follow-up|1|||
163322087|NCT01121588|589891516|FG000|Overall Study|Non-Specified Reasons|9|||
163322088|NCT01121588|589891517|FG001|Overall Study|Non-Specified Reasons|4|||
163322089|NCT01121588|589891518|FG002|Overall Study|Non-Specified Reasons|2|||
163322090|NCT00942877|589891519|FG000|Overall Study|Refused further treatment|1|||
163322091|NCT00942877|589891520|FG001|Overall Study|Refused further treatment|1|||
163322092|NCT00942877|589891519|FG000|Overall Study|Patient was not treated|1|||
163322093|NCT00942877|589891520|FG001|Overall Study|Patient was not treated|0|||
163322094|NCT00942877|589891519|FG000|Overall Study|Adverse Event|1|||
163322095|NCT00942877|589891520|FG001|Overall Study|Adverse Event|0|||
163322096|NCT00942877|589891519|FG000|Overall Study|Progressive disease|42|||
163322097|NCT00942877|589891520|FG001|Overall Study|Progressive disease|3|||
163322098|NCT01385202|589891521|FG000|Overall Study|Lost to Follow-up|6|||
163322099|NCT01385202|589891521|FG000|Overall Study|Not Eligible|11|||
163322100|NCT01385202|589891521|FG000|Overall Study|Withdrawn|1|||
163322101|NCT02095691|589891522|FG000|Overall Study|Physician Decision|1|||
163322102|NCT00964392|589891526|FG000|Overall Study|Withdrawal by Subject|4|||
163322103|NCT00964392|589891527|FG001|Overall Study|Withdrawal by Subject|6|||
163322104|NCT00964392|589891526|FG000|Overall Study|Lost to Follow-up|4|||
163322105|NCT00964392|589891527|FG001|Overall Study|Lost to Follow-up|10|||
163322106|NCT00964392|589891526|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
163322107|NCT00964392|589891527|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
163322108|NCT00964392|589891526|FG000|Overall Study|Not completed|44|||
163322109|NCT00964392|589891527|FG001|Overall Study|Not completed|168|||
163322110|NCT00631475|589891528|FG000|Overall Study|Death|18|||
163322111|NCT00631475|589891528|FG000|Overall Study|Adverse Event|14|||
163322112|NCT00631475|589891528|FG000|Overall Study|Withdrew consent|5|||
163322113|NCT00631475|589891528|FG000|Overall Study|Preparation for lung transplant|8|||
163322114|NCT04214834|589891539|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
163322115|NCT04214834|589891540|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
163322116|NCT04967599|589891543|FG000|Overall Study|Lost to Follow-up|35|||
163322117|NCT04967599|589891544|FG001|Overall Study|Lost to Follow-up|19|||
163322118|NCT04967599|589891545|FG002|Overall Study|Lost to Follow-up|23|||
163322119|NCT04369911|589891547|FG000|Overall Study|Lost to Follow-up|3|||
163322120|NCT04369911|589891548|FG001|Overall Study|Lost to Follow-up|3|||
163322121|NCT04369911|589891547|FG000|Overall Study|Withdrawal by Subject|1|||
163322122|NCT04369911|589891548|FG001|Overall Study|Withdrawal by Subject|2|||
163322123|NCT05741294|589891549|FG000|Overall Study|Lost to Follow-up|3|||
163322124|NCT05741294|589891549|FG000|Overall Study|Protocol deviation|3|||
163322125|NCT05741294|589891549|FG000|Overall Study|Withdrawal by Subject|1|||
163322126|NCT03817983|589891550|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
163322127|NCT03817983|589891551|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
163322128|NCT03817983|589891552|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
163322129|NCT03744676|589891553|FG000|Pre-Treatment Phase|Disease related complications|2|||
163322130|NCT03744676|589891553|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
163322131|NCT03744676|589891553|FG000|Pre-Treatment Phase|Death|7|||
163322132|NCT03744676|589891553|FG000|Pre-Treatment Phase|Other Reasons|7|||
163322133|NCT03744676|589891553|FG000|Treatment Phase|Participant withdrew consent|8|||
163322134|NCT03744676|589891553|FG000|Treatment Phase|Death|33|||
163322135|NCT03744676|589891553|FG000|Treatment Phase|other reasons|6|||
163322136|NCT02510235|589891554|FG000|Overall Study|Withdrawal by Subject|1|||
163322137|NCT02510235|589891555|FG001|Overall Study|Withdrawal by Subject|0|||
163322138|NCT00450216|589891556|FG000|Overall Study|Adverse Event|38|||
163322139|NCT00450216|589891557|FG001|Overall Study|Adverse Event|23|||
163322140|NCT00450216|589891556|FG000|Overall Study|Withdrawal by Subject|48|||
163322141|NCT00450216|589891557|FG001|Overall Study|Withdrawal by Subject|26|||
163322142|NCT00450216|589891556|FG000|Overall Study|Lost to Follow-up|16|||
163322143|NCT00450216|589891557|FG001|Overall Study|Lost to Follow-up|9|||
163322144|NCT00450216|589891556|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
163322145|NCT00450216|589891557|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
163322146|NCT00450216|589891556|FG000|Overall Study|misc|21|||
163322147|NCT00450216|589891557|FG001|Overall Study|misc|20|||
163322148|NCT03418740|589891560|FG000|Overall Study|Lost to Follow-up|13|||
163322149|NCT03418740|589891560|FG000|Overall Study|Scheduling Issues|7|||
163322150|NCT03418740|589891560|FG000|Overall Study|Withdrawal by Subject|2|||
163322151|NCT03418740|589891560|FG000|Overall Study|Unable to Continue Consent|1|||
163322152|NCT04108130|589892946|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
163403228|NCT01251367|590187134|FG000|Overall Study|Lost to Follow-up|5|||
162982548|NCT00700817|588638727|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
163322153|NCT04108130|589892947|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
163322154|NCT04108130|589892946|FG000|Overall Study|Consent Withdrawn|9|||
163322155|NCT04108130|589892947|FG001|Overall Study|Consent Withdrawn|6|||
163322156|NCT04108130|589892946|FG000|Overall Study|Surgery Cancelled|4|||
163322157|NCT04108130|589892947|FG001|Overall Study|Surgery Cancelled|4|||
163322158|NCT04108130|589892946|FG000|Overall Study|Found Ineligible for Study|4|||
163322159|NCT04108130|589892947|FG001|Overall Study|Found Ineligible for Study|3|||
163322160|NCT04108130|589892946|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
163322161|NCT04108130|589892947|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
163322162|NCT04108130|589892946|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
163322163|NCT04108130|589892947|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
163322164|NCT04244175|589892948|FG000|Overall Study|Adverse Event|3|||
163322165|NCT04244175|589892949|FG001|Overall Study|Adverse Event|2|||
163322166|NCT04244175|589892950|FG002|Overall Study|Adverse Event|5|||
163322167|NCT04244175|589892948|FG000|Overall Study|Lack of Efficacy|1|||
163322168|NCT04244175|589892949|FG001|Overall Study|Lack of Efficacy|0|||
163322169|NCT04244175|589892950|FG002|Overall Study|Lack of Efficacy|1|||
163322170|NCT04244175|589892948|FG000|Overall Study|Lost to Follow-up|1|||
163322171|NCT04244175|589892949|FG001|Overall Study|Lost to Follow-up|0|||
163322172|NCT04244175|589892950|FG002|Overall Study|Lost to Follow-up|0|||
163322173|NCT04244175|589892948|FG000|Overall Study|Non-compliance with study drug|1|||
163322174|NCT04244175|589892949|FG001|Overall Study|Non-compliance with study drug|0|||
163322175|NCT04244175|589892950|FG002|Overall Study|Non-compliance with study drug|1|||
163322176|NCT04244175|589892948|FG000|Overall Study|Protocol deviation|0|||
163322177|NCT04244175|589892949|FG001|Overall Study|Protocol deviation|1|||
163322178|NCT04244175|589892950|FG002|Overall Study|Protocol deviation|0|||
163322179|NCT04244175|589892948|FG000|Overall Study|Withdrawal by Subject|1|||
163322180|NCT04244175|589892949|FG001|Overall Study|Withdrawal by Subject|3|||
163322181|NCT04244175|589892950|FG002|Overall Study|Withdrawal by Subject|1|||
163322182|NCT04244175|589892948|FG000|Overall Study|Other, not specified|0|||
163322183|NCT04244175|589892949|FG001|Overall Study|Other, not specified|1|||
163322184|NCT04244175|589892950|FG002|Overall Study|Other, not specified|2|||
163322185|NCT03636490|589892953|FG000|Overall Study|Dropped out or incomplete data|141|||
163322186|NCT01130883|589892954|FG000|Overall Study|Patient Noncompliance|6|||
163322187|NCT01130883|589892954|FG000|Overall Study|Reason Unknown|1|||
163322188|NCT01130883|589892954|FG000|Overall Study|Adverse Event|3|||
163322189|NCT02585323|589892955|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
163322190|NCT02585323|589892956|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
163322191|NCT02585323|589892955|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
163322192|NCT02585323|589892956|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
163322193|NCT02585323|589892955|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
163322194|NCT02585323|589892956|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
163322195|NCT02585323|589892955|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
163322196|NCT02585323|589892956|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
163322197|NCT02278211|589892962|FG000|Overall Study|Unable to analyse PET scan|2|||
163322198|NCT02909686|589892964|FG000|Overall Study|Physician Decision|3|||
163322199|NCT02909686|589892964|FG000|Overall Study|Withdrawal by Subject|2|||
163322200|NCT03858517|589892965|FG000|Overall Study|Adverse Event|1|||
163322201|NCT03858517|589892965|FG000|Overall Study|Lost to Follow-up|1|||
163322202|NCT03858517|589892965|FG000|Overall Study|removed for being incarcerated|1|||
163322203|NCT03858517|589892965|FG000|Overall Study|Sponsor Closure|48|||
163322204|NCT04804540|589892968|FG000|Overall Study|Adverse Event|26|||
163322205|NCT04804540|589892969|FG001|Overall Study|Adverse Event|13|||
163322206|NCT05172232|589892970|FG000|Overall Study|Lost to Follow-up|3|||
163322207|NCT01828021|589892971|FG000|Overall Study|Adverse Event|5|||
163322208|NCT01828021|589892971|FG000|Overall Study|Lack of Efficacy|17|||
163322209|NCT01828021|589892971|FG000|Overall Study|Withdrawal by Subject|2|||
163322210|NCT01828021|589892971|FG000|Overall Study|Ileal obstruction, unrelated|1|||
163322211|NCT02997202|589892973|FG000|Overall Study|Miscellaneous|2|||
163322212|NCT02997202|589892974|FG001|Overall Study|Miscellaneous|2|||
163322213|NCT02997202|589892973|FG000|Overall Study|Withdrawal by Subject|8|||
163322214|NCT02997202|589892974|FG001|Overall Study|Withdrawal by Subject|12|||
163322215|NCT02997202|589892973|FG000|Overall Study|Lost to Follow-up|5|||
163322216|NCT02997202|589892974|FG001|Overall Study|Lost to Follow-up|3|||
163322217|NCT02997202|589892973|FG000|Overall Study|Death|41|||
163322218|NCT02997202|589892974|FG001|Overall Study|Death|45|||
163322219|NCT03681262|589892979|FG000|Overall Study|Continuing on study|3|||
163322220|NCT03681262|589892980|FG001|Overall Study|Continuing on study|3|||
163322221|NCT03681262|589892979|FG000|Overall Study|Lost to Follow-up|1|||
163322222|NCT03681262|589892980|FG001|Overall Study|Lost to Follow-up|0|||
163322223|NCT00887198|589892981|FG000|Randomized Period|Ongoing|42|||
163322224|NCT00887198|589892982|FG001|Randomized Period|Ongoing|0|||
163322225|NCT00887198|589892983|FG002|Randomized Period|Ongoing|0|||
163322226|NCT00887198|589892981|FG000|Randomized Period|Adverse Event|50|||
163322227|NCT00887198|589892982|FG001|Randomized Period|Adverse Event|33|||
163322228|NCT00887198|589892983|FG002|Randomized Period|Adverse Event|0|||
163322229|NCT00887198|589892981|FG000|Randomized Period|Lost to Follow-up|1|||
163322230|NCT00887198|589892982|FG001|Randomized Period|Lost to Follow-up|0|||
163322231|NCT00887198|589892983|FG002|Randomized Period|Lost to Follow-up|0|||
163322232|NCT00887198|589892981|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
163322233|NCT00887198|589892982|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
163322234|NCT00887198|589892983|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
163322235|NCT00887198|589892981|FG000|Randomized Period|Withdrawal by Subject|41|||
163322236|NCT00887198|589892982|FG001|Randomized Period|Withdrawal by Subject|56|||
162982549|NCT00700817|588638728|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
162982550|NCT00700817|588638724|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
162982551|NCT00700817|588638725|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
162982552|NCT00700817|588638726|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
162982553|NCT00700817|588638727|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
162982554|NCT00700817|588638728|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
162982555|NCT00700817|588638724|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
162982556|NCT00700817|588638725|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
162982557|NCT00700817|588638726|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
162982558|NCT00700817|588638727|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
162982559|NCT00700817|588638728|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
162982560|NCT00700817|588638724|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
162982561|NCT00700817|588638725|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
162982562|NCT00700817|588638726|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
162982563|NCT00700817|588638727|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
162982564|NCT00700817|588638728|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
162982565|NCT00700817|588638724|FG000|Week 0-26 (Main Period)|Unclassified|14|||
162982566|NCT00700817|588638725|FG001|Week 0-26 (Main Period)|Unclassified|4|||
162982567|NCT00700817|588638726|FG002|Week 0-26 (Main Period)|Unclassified|8|||
162982568|NCT00700817|588638727|FG003|Week 0-26 (Main Period)|Unclassified|0|||
162982569|NCT00700817|588638728|FG004|Week 0-26 (Main Period)|Unclassified|0|||
162982570|NCT00700817|588638724|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
162982571|NCT00700817|588638725|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
162982572|NCT00700817|588638726|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
162982573|NCT00700817|588638727|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
162982574|NCT00700817|588638728|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
162982575|NCT00700817|588638724|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
162982576|NCT00700817|588638725|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
162982577|NCT00700817|588638726|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
162982578|NCT00700817|588638727|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
162982579|NCT00700817|588638728|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
162982580|NCT00700817|588638724|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
162982581|NCT00700817|588638725|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
162982582|NCT00700817|588638726|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
162982583|NCT00700817|588638727|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
162982584|NCT00700817|588638728|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
162982585|NCT00700817|588638724|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
162982586|NCT00700817|588638725|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
162982587|NCT00700817|588638726|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
162982588|NCT00700817|588638727|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
162982589|NCT00700817|588638728|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
162982590|NCT00700817|588638724|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
162982591|NCT00700817|588638725|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
162982592|NCT00700817|588638726|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
162982593|NCT00700817|588638727|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
163322237|NCT00887198|589892983|FG002|Randomized Period|Withdrawal by Subject|0|||
163322238|NCT00887198|589892981|FG000|Randomized Period|Progressive disease|366|||
163322239|NCT00887198|589892982|FG001|Randomized Period|Progressive disease|370|||
163322240|NCT00887198|589892983|FG002|Randomized Period|Progressive disease|0|||
163322241|NCT00887198|589892981|FG000|Randomized Period|Other|42|||
163322242|NCT00887198|589892982|FG001|Randomized Period|Other|30|||
163322243|NCT00887198|589892983|FG002|Randomized Period|Other|0|||
163322244|NCT00887198|589892981|FG000|Randomized Period|Randomized, Not treated|4|||
163322245|NCT00887198|589892982|FG001|Randomized Period|Randomized, Not treated|2|||
163322246|NCT00887198|589892983|FG002|Randomized Period|Randomized, Not treated|0|||
163322247|NCT00887198|589892981|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
163322248|NCT00887198|589892982|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
163322249|NCT00887198|589892983|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
163322250|NCT00887198|589892981|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
163322251|NCT00887198|589892982|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
163322252|NCT00887198|589892983|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
163322253|NCT00887198|589892981|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
163322254|NCT00887198|589892982|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
163322255|NCT00887198|589892983|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
163322256|NCT00887198|589892981|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
162982594|NCT00700817|588638728|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
162982595|NCT00700817|588638724|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
162982596|NCT00700817|588638725|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
162982597|NCT00700817|588638726|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
163322257|NCT00887198|589892982|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
163322258|NCT00887198|589892983|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
162982598|NCT00700817|588638727|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
162982599|NCT00700817|588638728|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
162982600|NCT00700817|588638724|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
162982601|NCT00700817|588638725|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
162982602|NCT00700817|588638726|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
162982603|NCT00700817|588638727|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
162982604|NCT00700817|588638728|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
162982605|NCT00700817|588638724|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
162982606|NCT00700817|588638725|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
162982607|NCT00700817|588638726|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
162982608|NCT00700817|588638727|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
162982609|NCT00700817|588638728|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
163322259|NCT00887198|589892981|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
163322260|NCT00887198|589892982|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
163322261|NCT00887198|589892983|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
163322262|NCT00887198|589892981|FG000|Cross Over (Placebo to AA)|Other|0|||
162982610|NCT00700817|588638724|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
162982611|NCT00700817|588638725|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
162982612|NCT00700817|588638726|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
162982613|NCT00700817|588638727|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
162982614|NCT00700817|588638728|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
162982615|NCT00700817|588638724|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
162982616|NCT00700817|588638725|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
162982617|NCT00700817|588638726|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
162982618|NCT00700817|588638727|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
162982619|NCT00700817|588638728|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
162982620|NCT00058214|588638729|FG000|Overall Study|Adverse Event|1|||
162982621|NCT01347866|588638730|FG000|Overall Study|Death|0|||
162982622|NCT01347866|588638731|FG001|Overall Study|Death|0|||
162982623|NCT01347866|588638732|FG002|Overall Study|Death|0|||
162982624|NCT01347866|588638733|FG003|Overall Study|Death|1|||
162982625|NCT01347866|588638734|FG004|Overall Study|Death|2|||
162982626|NCT01347866|588638735|FG005|Overall Study|Death|2|||
162982627|NCT01347866|588638736|FG006|Overall Study|Death|1|||
162982628|NCT01347866|588638737|FG007|Overall Study|Death|0|||
162982629|NCT01347866|588638738|FG008|Overall Study|Death|4|||
162982630|NCT01347866|588638739|FG009|Overall Study|Death|1|||
162982631|NCT01347866|588638740|FG010|Overall Study|Death|3|||
162982632|NCT01347866|588638741|FG011|Overall Study|Death|1|||
162982633|NCT01347866|588638742|FG012|Overall Study|Death|2|||
162982634|NCT01347866|588638743|FG013|Overall Study|Death|0|||
162982635|NCT01347866|588638744|FG014|Overall Study|Death|0|||
162982636|NCT01347866|588638745|FG015|Overall Study|Death|1|||
162982637|NCT01347866|588638746|FG016|Overall Study|Death|0|||
162982638|NCT01347866|588638730|FG000|Overall Study|Lost to Follow-up|0|||
162982639|NCT01347866|588638731|FG001|Overall Study|Lost to Follow-up|0|||
162982640|NCT01347866|588638732|FG002|Overall Study|Lost to Follow-up|0|||
162982641|NCT01347866|588638733|FG003|Overall Study|Lost to Follow-up|0|||
162982642|NCT01347866|588638734|FG004|Overall Study|Lost to Follow-up|0|||
162982643|NCT01347866|588638735|FG005|Overall Study|Lost to Follow-up|0|||
162982644|NCT01347866|588638736|FG006|Overall Study|Lost to Follow-up|0|||
162982645|NCT01347866|588638737|FG007|Overall Study|Lost to Follow-up|1|||
162982646|NCT01347866|588638738|FG008|Overall Study|Lost to Follow-up|1|||
162982647|NCT01347866|588638739|FG009|Overall Study|Lost to Follow-up|0|||
162982648|NCT01347866|588638740|FG010|Overall Study|Lost to Follow-up|0|||
162982649|NCT01347866|588638741|FG011|Overall Study|Lost to Follow-up|0|||
162982650|NCT01347866|588638742|FG012|Overall Study|Lost to Follow-up|0|||
162982651|NCT01347866|588638743|FG013|Overall Study|Lost to Follow-up|0|||
162982652|NCT01347866|588638744|FG014|Overall Study|Lost to Follow-up|0|||
162982653|NCT01347866|588638745|FG015|Overall Study|Lost to Follow-up|0|||
162982654|NCT01347866|588638746|FG016|Overall Study|Lost to Follow-up|0|||
162982655|NCT01347866|588638730|FG000|Overall Study|Other|3|||
162982656|NCT01347866|588638731|FG001|Overall Study|Other|1|||
162982657|NCT01347866|588638732|FG002|Overall Study|Other|1|||
162982658|NCT01347866|588638733|FG003|Overall Study|Other|4|||
162982659|NCT01347866|588638734|FG004|Overall Study|Other|5|||
162982660|NCT01347866|588638735|FG005|Overall Study|Other|0|||
162982661|NCT01347866|588638736|FG006|Overall Study|Other|5|||
162982662|NCT01347866|588638737|FG007|Overall Study|Other|3|||
162982663|NCT01347866|588638738|FG008|Overall Study|Other|22|||
162982664|NCT01347866|588638739|FG009|Overall Study|Other|5|||
162982665|NCT01347866|588638740|FG010|Overall Study|Other|0|||
162982666|NCT01347866|588638741|FG011|Overall Study|Other|3|||
162982667|NCT01347866|588638742|FG012|Overall Study|Other|4|||
162982668|NCT01347866|588638743|FG013|Overall Study|Other|4|||
162982669|NCT01347866|588638744|FG014|Overall Study|Other|2|||
163322263|NCT00887198|589892982|FG001|Cross Over (Placebo to AA)|Other|0|||
162982670|NCT01347866|588638745|FG015|Overall Study|Other|3|||
162982671|NCT01347866|588638746|FG016|Overall Study|Other|0|||
163059550|NCT04108468|588926418|FG001|Overall Study|Missed study medication|1|||
163059551|NCT03260023|588926419|FG000|Overall Study|Adverse Event|0|||
163322264|NCT00887198|589892983|FG002|Cross Over (Placebo to AA)|Other|19|||
163322265|NCT02782676|589892984|FG000|Overall Study|Lost to Follow-up|0|||
163059552|NCT03260023|588926420|FG001|Overall Study|Adverse Event|0|||
163059553|NCT03260023|588926421|FG002|Overall Study|Adverse Event|4|||
163059554|NCT03260023|588926422|FG003|Overall Study|Adverse Event|4|||
163059555|NCT03260023|588926423|FG004|Overall Study|Adverse Event|4|||
163322266|NCT02782676|589892985|FG001|Overall Study|Lost to Follow-up|1|||
163322267|NCT05830799|589892988|FG000|Overall Study|Withdrawal by Subject|1|||
163322268|NCT03652272|589892989|FG000|3 Month|Withdrawal by Subject|1|||
162982672|NCT01347866|588638730|FG000|Overall Study|Subject refused further follow-up|2|||
162982673|NCT01347866|588638731|FG001|Overall Study|Subject refused further follow-up|0|||
162982674|NCT01347866|588638732|FG002|Overall Study|Subject refused further follow-up|0|||
162982675|NCT01347866|588638733|FG003|Overall Study|Subject refused further follow-up|2|||
162982676|NCT01347866|588638734|FG004|Overall Study|Subject refused further follow-up|0|||
162982677|NCT01347866|588638735|FG005|Overall Study|Subject refused further follow-up|1|||
162982678|NCT01347866|588638736|FG006|Overall Study|Subject refused further follow-up|0|||
162982679|NCT01347866|588638737|FG007|Overall Study|Subject refused further follow-up|0|||
162982680|NCT01347866|588638738|FG008|Overall Study|Subject refused further follow-up|4|||
162982681|NCT01347866|588638739|FG009|Overall Study|Subject refused further follow-up|1|||
162982682|NCT01347866|588638740|FG010|Overall Study|Subject refused further follow-up|0|||
162982683|NCT01347866|588638741|FG011|Overall Study|Subject refused further follow-up|0|||
162982684|NCT01347866|588638742|FG012|Overall Study|Subject refused further follow-up|1|||
162982685|NCT01347866|588638743|FG013|Overall Study|Subject refused further follow-up|3|||
162982686|NCT01347866|588638744|FG014|Overall Study|Subject refused further follow-up|1|||
162982687|NCT01347866|588638745|FG015|Overall Study|Subject refused further follow-up|0|||
162982688|NCT01347866|588638746|FG016|Overall Study|Subject refused further follow-up|2|||
162982689|NCT00891839|588638747|FG000|Overall Study|Adverse Event|2|||
162982690|NCT00891839|588638747|FG000|Overall Study|Withdrawal by Subject|2|||
162982691|NCT00891839|588638747|FG000|Overall Study|Disease progression|3|||
162982692|NCT01673698|588638748|FG000|Overall Study|Lost to Follow-up|51|||
162982693|NCT01673698|588638749|FG001|Overall Study|Lost to Follow-up|13|||
162982694|NCT01583218|588638750|FG000|Overall Study|Withdrawal by Subject|43|||
162982695|NCT01583218|588638751|FG001|Overall Study|Withdrawal by Subject|29|||
162982696|NCT01583218|588638750|FG000|Overall Study|Death|206|||
162982697|NCT01583218|588638751|FG001|Overall Study|Death|211|||
162982698|NCT01583218|588638750|FG000|Overall Study|Lost to Follow-up|11|||
162982699|NCT01583218|588638751|FG001|Overall Study|Lost to Follow-up|17|||
162982700|NCT01583218|588638750|FG000|Overall Study|Adverse event or serious adverse event|3|||
162982701|NCT01583218|588638751|FG001|Overall Study|Adverse event or serious adverse event|3|||
162982702|NCT01583218|588638750|FG000|Overall Study|Patient /Family decision|3|||
162982703|NCT01583218|588638751|FG001|Overall Study|Patient /Family decision|0|||
162982704|NCT01583218|588638750|FG000|Overall Study|Cannot contact patient directly|1|||
162982705|NCT01583218|588638751|FG001|Overall Study|Cannot contact patient directly|2|||
162982706|NCT01583218|588638750|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
162982707|NCT01583218|588638751|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
162982708|NCT01583218|588638750|FG000|Overall Study|Patient did not wish to attend visits|0|||
162982709|NCT01583218|588638751|FG001|Overall Study|Patient did not wish to attend visits|1|||
162982710|NCT01583218|588638750|FG000|Overall Study|Patient randomized but not dosed|17|||
162982711|NCT01583218|588638751|FG001|Overall Study|Patient randomized but not dosed|16|||
162982712|NCT01583218|588638750|FG000|Overall Study|Patient was assessed via phone in person|1|||
162982713|NCT01583218|588638751|FG001|Overall Study|Patient was assessed via phone in person|0|||
162982714|NCT01583218|588638750|FG000|Overall Study|Patient deemed ineligible after random|2|||
162982715|NCT01583218|588638751|FG001|Overall Study|Patient deemed ineligible after random|0|||
162982716|NCT01583218|588638750|FG000|Overall Study|Patient was early terminated from study|0|||
162982717|NCT01583218|588638751|FG001|Overall Study|Patient was early terminated from study|1|||
163059556|NCT03260023|588926424|FG005|Overall Study|Adverse Event|1|||
163059557|NCT03260023|588926425|FG006|Overall Study|Adverse Event|2|||
163059558|NCT03260023|588926419|FG000|Overall Study|Clinical Progression|0|||
163059559|NCT03260023|588926420|FG001|Overall Study|Clinical Progression|1|||
163211890|NCT01085591|589490660|FG000|Overall Study|Protocol Violation|1|||
163211891|NCT01085591|589490661|FG001|Overall Study|Protocol Violation|1|||
163211892|NCT01085591|589490662|FG002|Overall Study|Protocol Violation|1|||
163211893|NCT01085591|589490660|FG000|Overall Study|Other|0|||
163211894|NCT01085591|589490661|FG001|Overall Study|Other|1|||
163211895|NCT01085591|589490662|FG002|Overall Study|Other|0|||
163211896|NCT01085591|589490660|FG000|Overall Study|Not Properly Consented|1|||
163211897|NCT01085591|589490661|FG001|Overall Study|Not Properly Consented|0|||
163211898|NCT01085591|589490662|FG002|Overall Study|Not Properly Consented|0|||
163211899|NCT03715764|589490663|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
163211900|NCT03715764|589490664|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
163211901|NCT03715764|589490663|FG000|3 Month Follow-up|Lost to Follow-up|2|||
163211902|NCT03715764|589490664|FG001|3 Month Follow-up|Lost to Follow-up|2|||
163322269|NCT03652272|589892990|FG001|3 Month|Withdrawal by Subject|1|||
163322270|NCT03652272|589892989|FG000|3 Month|Lost to Follow-up|16|||
163322271|NCT03652272|589892990|FG001|3 Month|Lost to Follow-up|14|||
163322272|NCT04631016|589892991|FG000|Overall Study|Adverse Event|3|||
163322273|NCT04631016|589892992|FG001|Overall Study|Adverse Event|0|||
163322274|NCT04631016|589892991|FG000|Overall Study|Withdrawal by Subject|5|||
163322275|NCT04631016|589892992|FG001|Overall Study|Withdrawal by Subject|4|||
163322276|NCT04631016|589892991|FG000|Overall Study|Reason unspecified|1|||
163211903|NCT03715764|589490663|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
163211904|NCT03715764|589490664|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
163211905|NCT03715764|589490663|FG000|6 Month Follow-up|Lost to Follow-up|3|||
163211906|NCT03715764|589490664|FG001|6 Month Follow-up|Lost to Follow-up|0|||
163211907|NCT03715764|589490663|FG000|12 Month Follow-up|Lost to Follow-up|2|||
163211908|NCT03715764|589490664|FG001|12 Month Follow-up|Lost to Follow-up|3|||
163211909|NCT03715764|589490663|FG000|12 Month Follow-up|Pregnancy|0|||
163322277|NCT04631016|589892992|FG001|Overall Study|Reason unspecified|0|||
163322278|NCT04631016|589892991|FG000|Overall Study|Failure to meet randomization criteria|2|||
162982718|NCT01583218|588638750|FG000|Overall Study|Patient was randomized due to mistake|1|||
162982719|NCT01583218|588638751|FG001|Overall Study|Patient was randomized due to mistake|0|||
162982720|NCT01583218|588638750|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
162982721|NCT01583218|588638751|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
162982722|NCT01583218|588638750|FG000|Overall Study|Withdraw of consent on day of random|1|||
162982723|NCT01583218|588638751|FG001|Overall Study|Withdraw of consent on day of random|0|||
162982724|NCT02674061|588638752|FG000|Overall Study|Death|229|||
162982725|NCT02674061|588638753|FG001|Overall Study|Death|77|||
162982726|NCT02674061|588638752|FG000|Overall Study|Lost to Follow-up|3|||
162982727|NCT02674061|588638753|FG001|Overall Study|Lost to Follow-up|3|||
162982728|NCT02674061|588638752|FG000|Overall Study|Withdrawal by Subject|9|||
162982729|NCT02674061|588638753|FG001|Overall Study|Withdrawal by Subject|1|||
162982730|NCT02674061|588638752|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
162982731|NCT02674061|588638753|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
162982732|NCT03334721|588638756|FG000|Overall Study|Withdrawal by Subject|1|||
162982733|NCT03334721|588638757|FG001|Overall Study|Withdrawal by Subject|0|||
162982734|NCT03334721|588638756|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
162982735|NCT03334721|588638757|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
162982736|NCT01232491|588638759|FG000|Overall Study|Adverse Event|13|||
162982737|NCT01232491|588638760|FG001|Overall Study|Adverse Event|8|||
162982738|NCT01232491|588638759|FG000|Overall Study|Lack of Efficacy|1|||
162982739|NCT01232491|588638760|FG001|Overall Study|Lack of Efficacy|5|||
162982740|NCT01232491|588638759|FG000|Overall Study|Protocol Violation|13|||
162982741|NCT01232491|588638760|FG001|Overall Study|Protocol Violation|11|||
162982742|NCT01232491|588638759|FG000|Overall Study|Withdrawal Criteria|12|||
162982743|NCT01232491|588638760|FG001|Overall Study|Withdrawal Criteria|21|||
162982744|NCT01232491|588638759|FG000|Overall Study|Other|21|||
162982745|NCT01232491|588638760|FG001|Overall Study|Other|18|||
162982746|NCT02932228|588638761|FG000|Overall Study|Death|8|||
162982747|NCT02932228|588638762|FG001|Overall Study|Death|23|||
162982748|NCT02932228|588638761|FG000|Overall Study|not eligible upon chart review|2|||
162982749|NCT02932228|588638762|FG001|Overall Study|not eligible upon chart review|5|||
162982750|NCT04062448|588640358|FG000|Overall Study|Lost to Follow-up|1|||
162982751|NCT04062448|588640358|FG000|Overall Study|Withdrawal by Subject|2|||
162982752|NCT03340064|588640362|FG000|First Period|Adverse Event, non-fatal|2|||
162982753|NCT03340064|588640363|FG001|First Period|Adverse Event, non-fatal|0|||
162982754|NCT03340064|588640362|FG000|First Period|Lack of Efficacy|3|||
162982755|NCT03340064|588640363|FG001|First Period|Lack of Efficacy|0|||
162982756|NCT03340064|588640362|FG000|Second Period|Adverse Event, non-fatal|1|||
162982757|NCT03340064|588640363|FG001|Second Period|Adverse Event, non-fatal|1|||
162982758|NCT03340064|588640362|FG000|Second Period|Lack of Efficacy|11|||
162982759|NCT03340064|588640363|FG001|Second Period|Lack of Efficacy|0|||
162982760|NCT03340064|588640362|FG000|Second Period|Physician Decision|3|||
162982761|NCT03340064|588640363|FG001|Second Period|Physician Decision|0|||
162982762|NCT03340064|588640362|FG000|Second Period|Withdrawal by Subject|2|||
162982763|NCT03340064|588640363|FG001|Second Period|Withdrawal by Subject|1|||
162982764|NCT03340064|588640362|FG000|Second Period|Approved Drug Available For Indication|1|||
162982765|NCT03340064|588640363|FG001|Second Period|Approved Drug Available For Indication|0|||
162982766|NCT03340064|588640362|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
162982767|NCT03340064|588640363|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
162982768|NCT00856973|588640364|FG000|Overall Study|Adverse Event|5|||
162982769|NCT00856973|588640365|FG001|Overall Study|Adverse Event|5|||
162982770|NCT00856973|588640366|FG002|Overall Study|Adverse Event|3|||
162982771|NCT00856973|588640364|FG000|Overall Study|Lost to Follow-up|6|||
162982772|NCT00856973|588640365|FG001|Overall Study|Lost to Follow-up|3|||
162982773|NCT00856973|588640366|FG002|Overall Study|Lost to Follow-up|5|||
162982774|NCT00856973|588640364|FG000|Overall Study|Physician Decision|0|||
162982775|NCT00856973|588640365|FG001|Overall Study|Physician Decision|3|||
163211910|NCT03715764|589490664|FG001|12 Month Follow-up|Pregnancy|1|||
162982776|NCT00856973|588640366|FG002|Overall Study|Physician Decision|1|||
162982777|NCT00856973|588640364|FG000|Overall Study|Protocol Violation|1|||
162982778|NCT00856973|588640365|FG001|Overall Study|Protocol Violation|2|||
162982779|NCT00856973|588640366|FG002|Overall Study|Protocol Violation|1|||
162982780|NCT00856973|588640364|FG000|Overall Study|Withdrawal by Subject|13|||
162982781|NCT00856973|588640365|FG001|Overall Study|Withdrawal by Subject|16|||
162982782|NCT00856973|588640366|FG002|Overall Study|Withdrawal by Subject|15|||
162982783|NCT00856973|588640364|FG000|Overall Study|Other|11|||
162982784|NCT00856973|588640365|FG001|Overall Study|Other|12|||
162982785|NCT00856973|588640366|FG002|Overall Study|Other|13|||
162982786|NCT02751359|588640371|FG000|Overall Study|Lost to Follow-up|1|||
162982787|NCT01196078|588640372|FG000|Overall Study|Withdrawal by Subject|3|||
162982788|NCT01196078|588640373|FG001|Overall Study|Withdrawal by Subject|5|||
162982789|NCT01196078|588640372|FG000|Overall Study|Adverse Event|4|||
162982790|NCT01196078|588640373|FG001|Overall Study|Adverse Event|4|||
162982791|NCT01196078|588640372|FG000|Overall Study|Protocol Violation|2|||
162982792|NCT01196078|588640373|FG001|Overall Study|Protocol Violation|1|||
162982793|NCT01196078|588640372|FG000|Overall Study|Lack of Efficacy|17|||
162982794|NCT01196078|588640373|FG001|Overall Study|Lack of Efficacy|23|||
162982795|NCT01196078|588640372|FG000|Overall Study|Lost to Follow-up|1|||
162982796|NCT01196078|588640373|FG001|Overall Study|Lost to Follow-up|0|||
162982797|NCT01196078|588640372|FG000|Overall Study|Death|6|||
162982798|NCT01196078|588640373|FG001|Overall Study|Death|4|||
162982799|NCT02667288|588640374|FG000|Overall Study|Protocol Violation|5|||
162982800|NCT02667288|588640374|FG000|Overall Study|Lost to Follow-up|3|||
163322279|NCT04631016|589892992|FG001|Overall Study|Failure to meet randomization criteria|1|||
163322280|NCT05205161|589892993|FG000|Overall Study|Study terminated by sponsor|3|||
162982801|NCT02667288|588640374|FG000|Overall Study|Withdrawal by Subject|5|||
162982802|NCT02400671|588640375|FG000|Overall Study|Death|5|||
162982803|NCT02400671|588640376|FG001|Overall Study|Death|3|||
162982804|NCT02400671|588640377|FG002|Overall Study|Death|4|||
162982805|NCT02400671|588640375|FG000|Overall Study|Lost to Follow-up|20|||
162982806|NCT02400671|588640376|FG001|Overall Study|Lost to Follow-up|27|||
162982807|NCT02400671|588640377|FG002|Overall Study|Lost to Follow-up|24|||
162982808|NCT02400671|588640375|FG000|Overall Study|Withdrawal by Subject|2|||
162982809|NCT02400671|588640376|FG001|Overall Study|Withdrawal by Subject|2|||
162982810|NCT02400671|588640377|FG002|Overall Study|Withdrawal by Subject|0|||
162982811|NCT04397445|588640380|FG000|Overall Study|Withdrawal by Subject|1|||
162982812|NCT04397445|588640381|FG001|Overall Study|Withdrawal by Subject|0|||
162982813|NCT04397445|588640382|FG002|Overall Study|Withdrawal by Subject|0|||
162982814|NCT04397445|588640383|FG003|Overall Study|Withdrawal by Subject|0|||
162982815|NCT03921151|588640384|FG000|Overall Study|Withdrawal by Subject|11|||
163322281|NCT05205161|589892994|FG001|Overall Study|Study terminated by sponsor|3|||
162982816|NCT03921151|588640385|FG001|Overall Study|Withdrawal by Subject|16|||
162982817|NCT00857792|588640387|FG000|Overall Study|inadequate image quality for analysis|12|||
162982818|NCT03760250|588640388|FG000|Overall Study|Withdrawal by Subject|1|||
162982819|NCT03760250|588640388|FG000|Overall Study|Physician Decision|1|||
162982820|NCT03733210|588640390|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
162982821|NCT03733210|588640391|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
162982822|NCT00307034|588640392|FG000|Overall Study|Adverse Event|1|||
162982823|NCT00307034|588640393|FG001|Overall Study|Adverse Event|2|||
162982824|NCT00307034|588640392|FG000|Overall Study|Withdrawal by Subject|1|||
162982825|NCT00307034|588640393|FG001|Overall Study|Withdrawal by Subject|2|||
162982826|NCT00307034|588640392|FG000|Overall Study|Lost to Follow-up|0|||
162982827|NCT00307034|588640393|FG001|Overall Study|Lost to Follow-up|3|||
162982828|NCT02011113|588640402|FG000|Overall Study|Adverse Event|4|||
162982829|NCT02011113|588640402|FG000|Overall Study|Disease Progression (DP)|16|||
162982830|NCT02011113|588640402|FG000|Overall Study|Death|1|||
162982831|NCT02011113|588640402|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
163059560|NCT03260023|588926421|FG002|Overall Study|Clinical Progression|3|||
163059561|NCT03260023|588926422|FG003|Overall Study|Clinical Progression|1|||
162982832|NCT02011113|588640402|FG000|Overall Study|Investigator's judgement- DP|3|||
162982833|NCT02011113|588640402|FG000|Overall Study|Study terminated by sponsor|11|||
162982834|NCT04688931|588640405|FG000|Overall Study|Adverse Event|4|||
162982835|NCT04688931|588640406|FG001|Overall Study|Adverse Event|1|||
162982836|NCT04688931|588640405|FG000|Overall Study|Withdrawal by Subject|5|||
163059562|NCT03260023|588926423|FG004|Overall Study|Clinical Progression|0|||
163059563|NCT03260023|588926424|FG005|Overall Study|Clinical Progression|0|||
163059564|NCT03260023|588926425|FG006|Overall Study|Clinical Progression|0|||
163322282|NCT05205161|589892995|FG002|Overall Study|Study terminated by sponsor|1|||
163059565|NCT03260023|588926419|FG000|Overall Study|Physician Decision|0|||
163059566|NCT03260023|588926420|FG001|Overall Study|Physician Decision|0|||
163322283|NCT04707768|589893000|FG000|Overall Study|Adverse Event|9|||
163322284|NCT04707768|589893001|FG001|Overall Study|Adverse Event|18|||
162982837|NCT04688931|588640406|FG001|Overall Study|Withdrawal by Subject|16|||
162982838|NCT04688931|588640405|FG000|Overall Study|Physician Decision|3|||
162982839|NCT04688931|588640406|FG001|Overall Study|Physician Decision|5|||
162982840|NCT04688931|588640405|FG000|Overall Study|Noncompliance|0|||
162982841|NCT04688931|588640406|FG001|Overall Study|Noncompliance|1|||
162982842|NCT04688931|588640405|FG000|Overall Study|Lost to Follow-up|1|||
162982843|NCT04688931|588640406|FG001|Overall Study|Lost to Follow-up|3|||
162982844|NCT04688931|588640405|FG000|Overall Study|Randomization Error|3|||
162982845|NCT04688931|588640406|FG001|Overall Study|Randomization Error|0|||
162982846|NCT04688931|588640405|FG000|Overall Study|Not Eligible|1|||
162982847|NCT04688931|588640406|FG001|Overall Study|Not Eligible|3|||
162982848|NCT04688931|588640405|FG000|Overall Study|Disease Progression|0|||
162982849|NCT04688931|588640406|FG001|Overall Study|Disease Progression|2|||
162982850|NCT04688931|588640405|FG000|Overall Study|Sponsor Requirement|1|||
162982851|NCT04688931|588640406|FG001|Overall Study|Sponsor Requirement|1|||
162982852|NCT04688931|588640405|FG000|Overall Study|Other Reason|1|||
162982853|NCT04688931|588640406|FG001|Overall Study|Other Reason|2|||
162982854|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Adverse Event|9|||
162982855|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Adverse Event|4|||
162982856|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Adverse Event|5|||
162982857|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Adverse Event|9|||
162982858|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Adverse Event|8|||
162982859|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Adverse Event|0|||
162982860|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Adverse Event|0|||
162982861|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
162982862|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
162982863|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
162982864|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
162982865|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
162982866|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
162982867|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
162982868|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Death|1|||
162982869|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Death|1|||
162982870|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Death|1|||
162982871|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Death|1|||
162982872|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Death|0|||
162982873|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Death|0|||
162982874|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Death|0|||
162982875|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
162982876|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
162982877|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
162982878|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
162982879|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
162982880|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
162982881|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
162982882|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
162982883|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
162982884|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
162982885|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
162982886|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
162982887|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
162982888|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
162982889|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
162982890|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
162982891|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
162982892|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
162982893|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
162982894|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
162982895|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
162982896|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Other|2|||
162982897|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Other|9|||
162982898|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Other|9|||
162982899|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Other|3|||
163211911|NCT03715764|589490663|FG000|12 Month Follow-up|Surgery|2|||
162982900|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Other|2|||
162982901|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Other|0|||
162982902|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Other|0|||
162982903|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
162982904|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
162982905|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
162982906|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
162982907|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
162982908|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
162982909|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
162982910|NCT00361335|588640409|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
163211912|NCT03715764|589490664|FG001|12 Month Follow-up|Surgery|0|||
163211913|NCT03715764|589490663|FG000|12 Month Follow-up|Wrong address|1|||
163211914|NCT03715764|589490664|FG001|12 Month Follow-up|Wrong address|0|||
163322285|NCT04707768|589893002|FG002|Overall Study|Adverse Event|3|||
163322286|NCT04707768|589893000|FG000|Overall Study|Investigator's Discretion|8|||
163322287|NCT04707768|589893001|FG001|Overall Study|Investigator's Discretion|4|||
162982911|NCT00361335|588640410|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
162982912|NCT00361335|588640411|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
162982913|NCT00361335|588640412|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
162982914|NCT00361335|588640413|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
162982915|NCT00361335|588640414|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
162982916|NCT00361335|588640415|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
162982917|NCT00361335|588640409|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
162982918|NCT00361335|588640410|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
162982919|NCT00361335|588640411|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
162982920|NCT00361335|588640412|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
162982921|NCT00361335|588640413|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
162982922|NCT00361335|588640414|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
162982923|NCT00361335|588640415|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
162982924|NCT00361335|588640409|FG000|SC Period: Week E0 to Week E24|Death|0|||
162982925|NCT00361335|588640410|FG001|SC Period: Week E0 to Week E24|Death|0|||
162982926|NCT00361335|588640411|FG002|SC Period: Week E0 to Week E24|Death|0|||
162982927|NCT00361335|588640412|FG003|SC Period: Week E0 to Week E24|Death|0|||
162982928|NCT00361335|588640413|FG004|SC Period: Week E0 to Week E24|Death|0|||
162982929|NCT00361335|588640414|FG005|SC Period: Week E0 to Week E24|Death|0|||
162982930|NCT00361335|588640415|FG006|SC Period: Week E0 to Week E24|Death|1|||
162982931|NCT00361335|588640409|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
162982932|NCT00361335|588640410|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
162982933|NCT00361335|588640411|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
162982934|NCT00361335|588640412|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
162982935|NCT00361335|588640413|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
162982936|NCT00361335|588640414|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
162982937|NCT00361335|588640415|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
163322288|NCT04707768|589893002|FG002|Overall Study|Investigator's Discretion|3|||
163322289|NCT04707768|589893000|FG000|Overall Study|Withdrawal by Subject|6|||
163322290|NCT04707768|589893001|FG001|Overall Study|Withdrawal by Subject|8|||
163322291|NCT04707768|589893002|FG002|Overall Study|Withdrawal by Subject|2|||
163322292|NCT04707768|589893000|FG000|Overall Study|Lack of Efficacy|1|||
163322293|NCT04707768|589893001|FG001|Overall Study|Lack of Efficacy|3|||
163322294|NCT04707768|589893002|FG002|Overall Study|Lack of Efficacy|0|||
163322295|NCT04707768|589893000|FG000|Overall Study|Lost to Follow-up|0|||
163403229|NCT01251367|590187134|FG000|Overall Study|Subject Required Alternative Treatment|7|||
163403230|NCT01251367|590187134|FG000|Overall Study|No Study Drug Available|1|||
163403231|NCT01251367|590187134|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
163403232|NCT01251367|590187134|FG000|Overall Study|End of Study Visit Performed in Error|1|||
163403233|NCT02255409|590187135|FG000|Overall Study|Administrative Reason|3|||
163403234|NCT02255409|590187136|FG001|Overall Study|Administrative Reason|7|||
163403235|NCT02255409|590187135|FG000|Overall Study|Withdrawal by Subject|1|||
163403236|NCT02255409|590187136|FG001|Overall Study|Withdrawal by Subject|5|||
163403237|NCT02255409|590187135|FG000|Overall Study|Lost to Follow-up|10|||
162982938|NCT00361335|588640409|FG000|SC Period: Week E0 to Week E24|Other|1|||
162982939|NCT00361335|588640410|FG001|SC Period: Week E0 to Week E24|Other|0|||
163322296|NCT04707768|589893001|FG001|Overall Study|Lost to Follow-up|0|||
163322297|NCT04707768|589893002|FG002|Overall Study|Lost to Follow-up|3|||
163322298|NCT04707768|589893000|FG000|Overall Study|Death|13|||
163322299|NCT04707768|589893001|FG001|Overall Study|Death|11|||
163322300|NCT04707768|589893002|FG002|Overall Study|Death|13|||
163322301|NCT04707768|589893000|FG000|Overall Study|Protocol Violation|2|||
163322302|NCT04707768|589893001|FG001|Overall Study|Protocol Violation|1|||
163322303|NCT04707768|589893002|FG002|Overall Study|Protocol Violation|0|||
163403238|NCT02255409|590187136|FG001|Overall Study|Lost to Follow-up|19|||
163403239|NCT00135668|590187137|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
163403240|NCT00135668|590187138|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
162982940|NCT00361335|588640411|FG002|SC Period: Week E0 to Week E24|Other|0|||
162982941|NCT00361335|588640412|FG003|SC Period: Week E0 to Week E24|Other|1|||
162982942|NCT00361335|588640413|FG004|SC Period: Week E0 to Week E24|Other|0|||
162982943|NCT00361335|588640414|FG005|SC Period: Week E0 to Week E24|Other|1|||
162982944|NCT00361335|588640415|FG006|SC Period: Week E0 to Week E24|Other|2|||
162982945|NCT00361335|588640409|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
163322304|NCT04707768|589893000|FG000|Overall Study|Non Compliance with Study Drug|1|||
162982946|NCT00361335|588640410|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
163322305|NCT04707768|589893001|FG001|Overall Study|Non Compliance with Study Drug|0|||
163322306|NCT04707768|589893002|FG002|Overall Study|Non Compliance with Study Drug|0|||
163322307|NCT04707768|589893000|FG000|Overall Study|Transplant|4|||
163322308|NCT04707768|589893001|FG001|Overall Study|Transplant|4|||
163322309|NCT04707768|589893002|FG002|Overall Study|Transplant|8|||
163403241|NCT00135668|590187139|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
162982947|NCT00361335|588640411|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
162982948|NCT00361335|588640412|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
162982949|NCT00361335|588640413|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
162982950|NCT00361335|588640414|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
162982951|NCT00361335|588640415|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
162982952|NCT02034058|588640416|FG000|Overall Study|Death|3|||
162982953|NCT01765582|588640425|FG000|Overall Study|Other|3|||
162982954|NCT01765582|588640426|FG001|Overall Study|Other|6|||
162982955|NCT01765582|588640427|FG002|Overall Study|Other|9|||
162982956|NCT01765582|588640425|FG000|Overall Study|Lost to Follow-up|2|||
162982957|NCT01765582|588640426|FG001|Overall Study|Lost to Follow-up|2|||
162982958|NCT01765582|588640427|FG002|Overall Study|Lost to Follow-up|1|||
162982959|NCT01765582|588640425|FG000|Overall Study|Death|31|||
162982960|NCT01765582|588640426|FG001|Overall Study|Death|36|||
162982961|NCT01765582|588640427|FG002|Overall Study|Death|33|||
162982962|NCT01765582|588640425|FG000|Overall Study|Sponsor Decision|46|||
162982963|NCT01765582|588640426|FG001|Overall Study|Sponsor Decision|42|||
162982964|NCT01765582|588640427|FG002|Overall Study|Sponsor Decision|42|||
162982965|NCT01765582|588640425|FG000|Overall Study|Withdrawal of Consent|11|||
162982966|NCT01765582|588640426|FG001|Overall Study|Withdrawal of Consent|6|||
162982967|NCT01765582|588640427|FG002|Overall Study|Withdrawal of Consent|10|||
162982968|NCT03251963|588640430|FG000|Overall Study|inappropriate Xa level timing|6|||
162982969|NCT03251963|588640431|FG001|Overall Study|inappropriate Xa level timing|3|||
162982970|NCT03251963|588640430|FG000|Overall Study|no peak Xa level drawn|2|||
162982971|NCT03251963|588640431|FG001|Overall Study|no peak Xa level drawn|0|||
162982972|NCT03251963|588640430|FG000|Overall Study|bled prior to Xa level|1|||
162982973|NCT03251963|588640431|FG001|Overall Study|bled prior to Xa level|2|||
162982974|NCT00616941|588640432|FG000|Overall Study|Progressive Disease|1|||
162982975|NCT00616941|588640433|FG001|Overall Study|Progressive Disease|2|||
162982976|NCT00616941|588640434|FG002|Overall Study|Progressive Disease|1|||
162982977|NCT00616941|588640432|FG000|Overall Study|Adverse Event|0|||
162982978|NCT00616941|588640433|FG001|Overall Study|Adverse Event|1|||
162982979|NCT00616941|588640434|FG002|Overall Study|Adverse Event|1|||
162982980|NCT00616941|588640432|FG000|Overall Study|Subject Non-compliance|0|||
162982981|NCT00616941|588640433|FG001|Overall Study|Subject Non-compliance|0|||
162982982|NCT00616941|588640434|FG002|Overall Study|Subject Non-compliance|1|||
162982983|NCT00616941|588640432|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
162982984|NCT00616941|588640433|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
162982985|NCT00616941|588640434|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
162982986|NCT00616941|588640432|FG000|Overall Study|Vaccination Suspended|0|||
162982987|NCT00616941|588640433|FG001|Overall Study|Vaccination Suspended|0|||
162982988|NCT00616941|588640434|FG002|Overall Study|Vaccination Suspended|3|||
162982989|NCT00714493|588640445|FG000|Overall Study|Adverse Event|11|||
162982990|NCT00714493|588640445|FG000|Overall Study|Death|3|||
162982991|NCT00714493|588640445|FG000|Overall Study|Lack of Efficacy|10|||
162982992|NCT00714493|588640445|FG000|Overall Study|Lost to Follow-up|3|||
162982993|NCT00714493|588640445|FG000|Overall Study|Protocol Violation|12|||
162982994|NCT00714493|588640445|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
162982995|NCT00714493|588640445|FG000|Overall Study|OTHER|2|||
162982996|NCT00076804|588640446|FG000|Overall Study|Death|9|||
162982997|NCT00076804|588640447|FG001|Overall Study|Death|20|||
162982998|NCT00076804|588640446|FG000|Overall Study|Lost to Follow-up|9|||
162982999|NCT00076804|588640447|FG001|Overall Study|Lost to Follow-up|9|||
162983000|NCT00076804|588640446|FG000|Overall Study|Withdrawal by Subject|10|||
162983001|NCT00076804|588640447|FG001|Overall Study|Withdrawal by Subject|8|||
162983002|NCT00076804|588640446|FG000|Overall Study|Early study Closure|32|||
162983003|NCT00076804|588640447|FG001|Overall Study|Early study Closure|32|||
162983004|NCT00354341|588640448|FG000|Overall Study|Adverse Event|1|||
162983005|NCT00354341|588640449|FG001|Overall Study|Adverse Event|0|||
163059567|NCT03260023|588926421|FG002|Overall Study|Physician Decision|0|||
163059568|NCT03260023|588926422|FG003|Overall Study|Physician Decision|1|||
162983006|NCT00354341|588640448|FG000|Overall Study|Death|0|||
162983007|NCT00354341|588640449|FG001|Overall Study|Death|2|||
162983008|NCT00354341|588640448|FG000|Overall Study|Refused treatment|1|||
162983009|NCT00354341|588640449|FG001|Overall Study|Refused treatment|2|||
162983010|NCT00354341|588640448|FG000|Overall Study|Failure to return|0|||
163059569|NCT03260023|588926423|FG004|Overall Study|Physician Decision|1|||
163322310|NCT04707768|589893000|FG000|Overall Study|Other|9|||
162983011|NCT00354341|588640449|FG001|Overall Study|Failure to return|1|||
162983012|NCT00354341|588640448|FG000|Overall Study|Other|1|||
162983013|NCT00354341|588640449|FG001|Overall Study|Other|2|||
162983014|NCT00251719|588640450|FG000|Overall Study|Adverse Event|14|||
162983015|NCT00251719|588640451|FG001|Overall Study|Adverse Event|8|||
162983016|NCT00251719|588640452|FG002|Overall Study|Adverse Event|7|||
162983017|NCT00251719|588640450|FG000|Overall Study|Protocol Violation|1|||
163322311|NCT04707768|589893001|FG001|Overall Study|Other|5|||
162983018|NCT00251719|588640451|FG001|Overall Study|Protocol Violation|1|||
163059570|NCT03260023|588926424|FG005|Overall Study|Physician Decision|0|||
162983019|NCT00251719|588640452|FG002|Overall Study|Protocol Violation|1|||
162983020|NCT00251719|588640450|FG000|Overall Study|Lost to Follow-up|5|||
162983021|NCT00251719|588640451|FG001|Overall Study|Lost to Follow-up|11|||
162983022|NCT00251719|588640452|FG002|Overall Study|Lost to Follow-up|8|||
162983023|NCT00251719|588640450|FG000|Overall Study|Withdrawal by Subject|14|||
162983024|NCT00251719|588640451|FG001|Overall Study|Withdrawal by Subject|12|||
162983025|NCT00251719|588640452|FG002|Overall Study|Withdrawal by Subject|11|||
163059571|NCT03260023|588926425|FG006|Overall Study|Physician Decision|0|||
163211915|NCT03715764|589490663|FG000|12 Month Follow-up|No symptoms|1|||
163211916|NCT03715764|589490664|FG001|12 Month Follow-up|No symptoms|0|||
163211917|NCT03715764|589490663|FG000|12 Month Follow-up|Changed primary care centre|0|||
163211918|NCT03715764|589490664|FG001|12 Month Follow-up|Changed primary care centre|1|||
163211919|NCT01980875|589490666|FG000|Overall Study|Withdrew Consent|1|||
163211920|NCT01980875|589490667|FG001|Overall Study|Withdrew Consent|1|||
163211921|NCT01980875|589490668|FG002|Overall Study|Withdrew Consent|1|||
163211922|NCT01980875|589490666|FG000|Overall Study|Study Terminated by Sponsor|7|||
163211923|NCT01980875|589490667|FG001|Overall Study|Study Terminated by Sponsor|24|||
163211924|NCT01980875|589490668|FG002|Overall Study|Study Terminated by Sponsor|22|||
163322312|NCT04707768|589893002|FG002|Overall Study|Other|2|||
163322313|NCT04490109|589893003|FG000|Overall Study|Lost to Follow-up|3|||
163322314|NCT04490109|589893004|FG001|Overall Study|Lost to Follow-up|10|||
163322315|NCT04490109|589893005|FG002|Overall Study|Lost to Follow-up|4|||
163322316|NCT04490109|589893003|FG000|Overall Study|Withdrawal by Subject|8|||
163322317|NCT04490109|589893004|FG001|Overall Study|Withdrawal by Subject|6|||
163322318|NCT04490109|589893005|FG002|Overall Study|Withdrawal by Subject|9|||
163322319|NCT04490109|589893003|FG000|Overall Study|Physician Decision|0|||
162983026|NCT00251719|588640450|FG000|Overall Study|Lack of Efficacy|2|||
162983027|NCT00251719|588640451|FG001|Overall Study|Lack of Efficacy|1|||
162983028|NCT00251719|588640452|FG002|Overall Study|Lack of Efficacy|0|||
162983029|NCT00251719|588640450|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
162983030|NCT00251719|588640451|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
162983031|NCT00251719|588640452|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
162983032|NCT00251719|588640450|FG000|Overall Study|Investigator decision|1|||
162983033|NCT00251719|588640451|FG001|Overall Study|Investigator decision|1|||
162983034|NCT00251719|588640452|FG002|Overall Study|Investigator decision|0|||
162983035|NCT00251719|588640450|FG000|Overall Study|Noncompliance|2|||
162983036|NCT00251719|588640451|FG001|Overall Study|Noncompliance|3|||
162983037|NCT00251719|588640452|FG002|Overall Study|Noncompliance|1|||
162983038|NCT00251719|588640450|FG000|Overall Study|Barrett's esophagus|2|||
162983039|NCT00251719|588640451|FG001|Overall Study|Barrett's esophagus|2|||
162983040|NCT00251719|588640452|FG002|Overall Study|Barrett's esophagus|0|||
162983041|NCT01449279|588640453|FG000|Overall Study|Lack of Efficacy|5|||
162983042|NCT01449279|588640453|FG000|Overall Study|Toxicity|2|||
162983043|NCT01732874|588640455|FG000|Overall Study|Withdrawal by Subject|5|||
162983044|NCT01732874|588640456|FG001|Overall Study|Withdrawal by Subject|1|||
162983045|NCT01732874|588640455|FG000|Overall Study|Death of Infant|3|||
162983046|NCT01732874|588640456|FG001|Overall Study|Death of Infant|2|||
162983047|NCT03709823|588640457|FG000|Overall Study|Adverse Event|0|||
162983048|NCT03709823|588640458|FG001|Overall Study|Adverse Event|0|||
162983049|NCT03709823|588640459|FG002|Overall Study|Adverse Event|1|||
162983050|NCT03709823|588640460|FG003|Overall Study|Adverse Event|0|||
162983051|NCT03709823|588640461|FG004|Overall Study|Adverse Event|0|||
162983052|NCT03709823|588640462|FG005|Overall Study|Adverse Event|0|||
162983053|NCT03709823|588640457|FG000|Overall Study|Lost to Follow-up|2|||
162983054|NCT03709823|588640458|FG001|Overall Study|Lost to Follow-up|2|||
162983055|NCT03709823|588640459|FG002|Overall Study|Lost to Follow-up|2|||
162983056|NCT03709823|588640460|FG003|Overall Study|Lost to Follow-up|1|||
162983057|NCT03709823|588640461|FG004|Overall Study|Lost to Follow-up|1|||
162983058|NCT03709823|588640462|FG005|Overall Study|Lost to Follow-up|0|||
162983059|NCT03709823|588640457|FG000|Overall Study|Withdrawal by Subject|1|||
162983060|NCT03709823|588640458|FG001|Overall Study|Withdrawal by Subject|3|||
162983061|NCT03709823|588640459|FG002|Overall Study|Withdrawal by Subject|0|||
162983062|NCT03709823|588640460|FG003|Overall Study|Withdrawal by Subject|0|||
162983063|NCT03709823|588640461|FG004|Overall Study|Withdrawal by Subject|0|||
162983064|NCT03709823|588640462|FG005|Overall Study|Withdrawal by Subject|0|||
162983065|NCT03709823|588640457|FG000|Overall Study|Other, Not Specified|0|||
162983066|NCT03709823|588640458|FG001|Overall Study|Other, Not Specified|0|||
162983067|NCT03709823|588640459|FG002|Overall Study|Other, Not Specified|0|||
162983068|NCT03709823|588640460|FG003|Overall Study|Other, Not Specified|1|||
162983069|NCT03709823|588640461|FG004|Overall Study|Other, Not Specified|0|||
162983070|NCT03709823|588640462|FG005|Overall Study|Other, Not Specified|0|||
162983071|NCT00688376|588640465|FG000|Double-Blind Phase|Adverse Event|4|||
162983072|NCT00688376|588640466|FG001|Double-Blind Phase|Adverse Event|4|||
162983073|NCT00688376|588640465|FG000|Double-Blind Phase|Protocol Violation|1|||
162983074|NCT00688376|588640466|FG001|Double-Blind Phase|Protocol Violation|2|||
162983075|NCT00688376|588640465|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
162983076|NCT00688376|588640466|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
162983077|NCT00688376|588640465|FG000|Double-Blind Phase|Not treated|0|||
162983078|NCT00688376|588640466|FG001|Double-Blind Phase|Not treated|1|||
163322320|NCT04490109|589893004|FG001|Overall Study|Physician Decision|2|||
163322321|NCT04490109|589893005|FG002|Overall Study|Physician Decision|3|||
163322322|NCT04490109|589893003|FG000|Overall Study|Adverse Event|2|||
163322323|NCT04490109|589893004|FG001|Overall Study|Adverse Event|1|||
163322324|NCT04490109|589893005|FG002|Overall Study|Adverse Event|0|||
163322325|NCT04490109|589893003|FG000|Overall Study|Significant Non-Compliance|2|||
163322326|NCT04490109|589893004|FG001|Overall Study|Significant Non-Compliance|4|||
163322327|NCT04490109|589893005|FG002|Overall Study|Significant Non-Compliance|4|||
163322328|NCT04490109|589893003|FG000|Overall Study|Significant Clinical Event|0|||
163322329|NCT04490109|589893004|FG001|Overall Study|Significant Clinical Event|1|||
163322330|NCT04490109|589893005|FG002|Overall Study|Significant Clinical Event|0|||
163322331|NCT04490109|589893003|FG000|Overall Study|Other Reason|4|||
163322332|NCT04490109|589893004|FG001|Overall Study|Other Reason|1|||
163322333|NCT04490109|589893005|FG002|Overall Study|Other Reason|1|||
163322334|NCT04163991|589893006|FG000|Overall Study|Adverse Event|0|||
163322335|NCT04163991|589893007|FG001|Overall Study|Adverse Event|0|||
163322336|NCT04163991|589893008|FG002|Overall Study|Adverse Event|0|||
163322337|NCT04163991|589893009|FG003|Overall Study|Adverse Event|1|||
163322338|NCT04163991|589893010|FG004|Overall Study|Adverse Event|0|||
163322339|NCT04163991|589893006|FG000|Overall Study|Death|0|||
163322340|NCT04163991|589893007|FG001|Overall Study|Death|0|||
163322341|NCT04163991|589893008|FG002|Overall Study|Death|1|||
163322342|NCT04163991|589893009|FG003|Overall Study|Death|0|||
163322343|NCT04163991|589893010|FG004|Overall Study|Death|0|||
163322344|NCT04163991|589893006|FG000|Overall Study|Lost to Follow-up|0|||
163322345|NCT04163991|589893007|FG001|Overall Study|Lost to Follow-up|1|||
163322346|NCT04163991|589893008|FG002|Overall Study|Lost to Follow-up|0|||
163322347|NCT04163991|589893009|FG003|Overall Study|Lost to Follow-up|0|||
163322348|NCT04163991|589893010|FG004|Overall Study|Lost to Follow-up|0|||
163322349|NCT04163991|589893006|FG000|Overall Study|Withdrawal by Subject|1|||
163322350|NCT04163991|589893007|FG001|Overall Study|Withdrawal by Subject|1|||
163322351|NCT04163991|589893008|FG002|Overall Study|Withdrawal by Subject|3|||
163322352|NCT04163991|589893009|FG003|Overall Study|Withdrawal by Subject|1|||
163322353|NCT04163991|589893010|FG004|Overall Study|Withdrawal by Subject|1|||
163322354|NCT04163991|589893006|FG000|Overall Study|Other, Not Specified|0|||
163322355|NCT04163991|589893007|FG001|Overall Study|Other, Not Specified|1|||
163322356|NCT04163991|589893008|FG002|Overall Study|Other, Not Specified|1|||
163322357|NCT04163991|589893009|FG003|Overall Study|Other, Not Specified|1|||
163322358|NCT04163991|589893010|FG004|Overall Study|Other, Not Specified|0|||
163322359|NCT05953740|589893011|FG000|Period 1|Physician Decision|0|||
163322360|NCT05953740|589893012|FG001|Period 1|Physician Decision|1|||
163322361|NCT05953740|589893013|FG002|Period 1|Physician Decision|0|||
163322362|NCT05953740|589893014|FG003|Period 1|Physician Decision|0|||
163322363|NCT05953740|589893015|FG004|Period 1|Physician Decision|0|||
162983079|NCT00688376|588640465|FG000|Blinded Extension Phase|Adverse Event|3|||
162983080|NCT00688376|588640466|FG001|Blinded Extension Phase|Adverse Event|4|||
162983081|NCT00688376|588640465|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
162983082|NCT00688376|588640466|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
162983083|NCT00688376|588640465|FG000|Blinded Extension Phase|Physician Decision|1|||
162983084|NCT00688376|588640466|FG001|Blinded Extension Phase|Physician Decision|0|||
162983085|NCT00688376|588640465|FG000|Blinded Extension Phase|Other|1|||
162983086|NCT00688376|588640466|FG001|Blinded Extension Phase|Other|0|||
162983087|NCT00557076|588640467|FG000|Overall Study|Unblinding|0|||
162983088|NCT00557076|588640468|FG001|Overall Study|Unblinding|1|||
162983089|NCT00846521|588640469|FG000|Overall Study|Withdrawal by Subject|5|||
162983090|NCT00846521|588640469|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
162983091|NCT00846521|588640469|FG000|Overall Study|Protocol Violation|1|||
162983092|NCT02792959|588640471|FG000|Overall Study|Protocol Violation|1|||
162983093|NCT03201250|588640472|FG000|Overall Study|screen failures|3|||
163322364|NCT05953740|589893016|FG005|Period 1|Physician Decision|0|||
163322365|NCT05953740|589893017|FG006|Period 1|Physician Decision|0|||
163322366|NCT05953740|589893018|FG007|Period 1|Physician Decision|0|||
163322367|NCT05953740|589893011|FG000|Period 2|Withdrawal by Subject|0|||
163322368|NCT05953740|589893012|FG001|Period 2|Withdrawal by Subject|1|||
163322369|NCT05953740|589893013|FG002|Period 2|Withdrawal by Subject|1|||
163322370|NCT05953740|589893014|FG003|Period 2|Withdrawal by Subject|0|||
163322371|NCT05953740|589893015|FG004|Period 2|Withdrawal by Subject|0|||
163322372|NCT05953740|589893016|FG005|Period 2|Withdrawal by Subject|0|||
163322373|NCT05953740|589893017|FG006|Period 2|Withdrawal by Subject|0|||
163322374|NCT05953740|589893018|FG007|Period 2|Withdrawal by Subject|0|||
163322375|NCT05541484|589893021|FG000|Overall Study|Withdrawal by Subject|1|||
162983094|NCT03201250|588640473|FG001|Overall Study|screen failures|0|||
162983095|NCT03201250|588640474|FG002|Overall Study|screen failures|0|||
162983096|NCT02575911|588640477|FG000|Overall Study|Lost to Follow-up|1|||
163322376|NCT05541484|589893022|FG001|Overall Study|Withdrawal by Subject|0|||
163322377|NCT00626795|589893027|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
163322378|NCT00626795|589893028|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
163322379|NCT00626795|589893029|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
163059572|NCT03260023|588926419|FG000|Overall Study|Withdrawal by Subject|0|||
163059573|NCT03260023|588926420|FG001|Overall Study|Withdrawal by Subject|0|||
163059574|NCT03260023|588926421|FG002|Overall Study|Withdrawal by Subject|0|||
163059575|NCT03260023|588926422|FG003|Overall Study|Withdrawal by Subject|0|||
163059576|NCT03260023|588926423|FG004|Overall Study|Withdrawal by Subject|3|||
163059577|NCT03260023|588926424|FG005|Overall Study|Withdrawal by Subject|0|||
163059578|NCT03260023|588926425|FG006|Overall Study|Withdrawal by Subject|0|||
163059579|NCT03260023|588926419|FG000|Overall Study|Under trial intervention|0|||
163059580|NCT03260023|588926420|FG001|Overall Study|Under trial intervention|0|||
163059581|NCT03260023|588926421|FG002|Overall Study|Under trial intervention|2|||
163059582|NCT03260023|588926422|FG003|Overall Study|Under trial intervention|5|||
163059583|NCT03260023|588926423|FG004|Overall Study|Under trial intervention|3|||
163059584|NCT03260023|588926424|FG005|Overall Study|Under trial intervention|0|||
163059585|NCT03260023|588926425|FG006|Overall Study|Under trial intervention|0|||
163059586|NCT05035407|588926428|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
163059587|NCT05035407|588926429|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
163059588|NCT05035407|588926430|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
163059589|NCT05035407|588926431|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
163059590|NCT05035407|588926432|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
163059591|NCT05035407|588926433|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
163059592|NCT04220021|588926434|FG000|Overall Study|Withdrawal by Subject|11|||
163059593|NCT04220021|588926434|FG000|Overall Study|Physician Decision|2|||
163059594|NCT04220021|588926434|FG000|Overall Study|Non-study related illness|5|||
163059595|NCT06121609|588926436|FG000|Overall Study|Lack of Efficacy|0|||
163059596|NCT06121609|588926437|FG001|Overall Study|Lack of Efficacy|0|||
163059597|NCT06121609|588926438|FG002|Overall Study|Lack of Efficacy|45|||
163059598|NCT00848497|588926439|FG000|Overall Study|Screen failure|2|||
163059599|NCT00848497|588926440|FG001|Overall Study|Screen failure|0|||
163059600|NCT00848497|588926439|FG000|Overall Study|Withdrawal by Subject|0|||
163059601|NCT00848497|588926440|FG001|Overall Study|Withdrawal by Subject|1|||
163059602|NCT04935879|588926441|FG000|Overall Study|Adverse Event|2|||
163059603|NCT04935879|588926442|FG001|Overall Study|Adverse Event|1|||
163059604|NCT04935879|588926441|FG000|Overall Study|Lost to Follow-up|1|||
162983097|NCT02335983|588640478|FG000|Overall Study|Sponsor Decision|0|||
162983098|NCT02335983|588640479|FG001|Overall Study|Sponsor Decision|0|||
162983099|NCT02335983|588640480|FG002|Overall Study|Sponsor Decision|1|||
162983100|NCT02335983|588640481|FG003|Overall Study|Sponsor Decision|1|||
162983101|NCT02335983|588640482|FG004|Overall Study|Sponsor Decision|0|||
162983102|NCT02335983|588640483|FG005|Overall Study|Sponsor Decision|1|||
162983103|NCT02335983|588640478|FG000|Overall Study|Withdrawal by Subject|3|||
162983104|NCT02335983|588640479|FG001|Overall Study|Withdrawal by Subject|2|||
162983105|NCT02335983|588640480|FG002|Overall Study|Withdrawal by Subject|2|||
162983106|NCT02335983|588640481|FG003|Overall Study|Withdrawal by Subject|1|||
162983107|NCT02335983|588640482|FG004|Overall Study|Withdrawal by Subject|3|||
162983108|NCT02335983|588640483|FG005|Overall Study|Withdrawal by Subject|9|||
162983109|NCT02335983|588640478|FG000|Overall Study|Death|0|||
162983110|NCT02335983|588640479|FG001|Overall Study|Death|0|||
162983111|NCT02335983|588640480|FG002|Overall Study|Death|2|||
162983112|NCT02335983|588640481|FG003|Overall Study|Death|0|||
162983113|NCT02335983|588640482|FG004|Overall Study|Death|0|||
162983114|NCT02335983|588640483|FG005|Overall Study|Death|0|||
162983115|NCT02335983|588640478|FG000|Overall Study|Lost to Follow-up|0|||
162983116|NCT02335983|588640479|FG001|Overall Study|Lost to Follow-up|0|||
162983117|NCT02335983|588640480|FG002|Overall Study|Lost to Follow-up|0|||
162983118|NCT02335983|588640481|FG003|Overall Study|Lost to Follow-up|0|||
162983119|NCT02335983|588640482|FG004|Overall Study|Lost to Follow-up|0|||
162983120|NCT02335983|588640483|FG005|Overall Study|Lost to Follow-up|1|||
162983121|NCT02335983|588640478|FG000|Overall Study|Protocol Specified Criteria|5|||
162983122|NCT02335983|588640479|FG001|Overall Study|Protocol Specified Criteria|7|||
162983123|NCT02335983|588640480|FG002|Overall Study|Protocol Specified Criteria|27|||
162983124|NCT02335983|588640481|FG003|Overall Study|Protocol Specified Criteria|7|||
162983125|NCT02335983|588640482|FG004|Overall Study|Protocol Specified Criteria|5|||
162983126|NCT02335983|588640483|FG005|Overall Study|Protocol Specified Criteria|21|||
163059605|NCT04935879|588926442|FG001|Overall Study|Lost to Follow-up|1|||
162983127|NCT00629265|588640488|FG000|Overall Study|Lost to Follow-up|4|||
163059606|NCT04935879|588926441|FG000|Overall Study|Pregnancy|2|||
163059607|NCT04935879|588926442|FG001|Overall Study|Pregnancy|3|||
163059608|NCT04935879|588926441|FG000|Overall Study|Withdrawal by Subject|8|||
162983128|NCT00629265|588640489|FG001|Overall Study|Lost to Follow-up|5|||
162983129|NCT00629265|588640488|FG000|Overall Study|Withdrawal by Subject|11|||
162983130|NCT00629265|588640489|FG001|Overall Study|Withdrawal by Subject|8|||
162983131|NCT00629265|588640488|FG000|Overall Study|Death|1|||
162983132|NCT00629265|588640489|FG001|Overall Study|Death|0|||
162983133|NCT00629265|588640488|FG000|Overall Study|Adverse Event|2|||
163211925|NCT01980875|589490666|FG000|Overall Study|Lost to Follow-up|0|||
163211926|NCT01980875|589490667|FG001|Overall Study|Lost to Follow-up|0|||
162983134|NCT00629265|588640489|FG001|Overall Study|Adverse Event|0|||
162983135|NCT00629265|588640488|FG000|Overall Study|HNC Recurrence|4|||
162983136|NCT00629265|588640489|FG001|Overall Study|HNC Recurrence|0|||
162983137|NCT00629265|588640488|FG000|Overall Study|Other CA Requiring Treatment|1|||
162983138|NCT00629265|588640489|FG001|Overall Study|Other CA Requiring Treatment|3|||
162983139|NCT00629265|588640488|FG000|Overall Study|Needed Esophageal Dilation|4|||
162983140|NCT00629265|588640489|FG001|Overall Study|Needed Esophageal Dilation|1|||
162983141|NCT00629265|588640488|FG000|Overall Study|Unrelated Medical Complications|3|||
162983142|NCT00629265|588640489|FG001|Overall Study|Unrelated Medical Complications|1|||
162983143|NCT00629265|588640488|FG000|Overall Study|Unknown Reason|2|||
162983144|NCT00629265|588640489|FG001|Overall Study|Unknown Reason|2|||
162983145|NCT04465630|588640490|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
162983146|NCT04465630|588640490|FG000|Overall Study|Screen failure|8|||
162983147|NCT04465630|588640490|FG000|Overall Study|Baseline failure|16|||
162983148|NCT01732484|588640494|FG000|Overall Study|Death|7|||
162983149|NCT01732484|588640494|FG000|Overall Study|Lost to Follow-up|14|||
162983150|NCT01732484|588640494|FG000|Overall Study|chronical illness|5|||
162983151|NCT00289874|588640495|FG000|Overall Study|Adverse Event|1|||
162983152|NCT00289874|588640496|FG001|Overall Study|Adverse Event|5|||
162983153|NCT00289874|588640495|FG000|Overall Study|Lost to Follow-up|1|||
162983154|NCT00289874|588640496|FG001|Overall Study|Lost to Follow-up|1|||
162983155|NCT00289874|588640495|FG000|Overall Study|Protocol Violation|3|||
162983156|NCT00289874|588640496|FG001|Overall Study|Protocol Violation|2|||
162983157|NCT00289874|588640495|FG000|Overall Study|Did not meet eligibility|1|||
162983158|NCT00289874|588640496|FG001|Overall Study|Did not meet eligibility|0|||
162983159|NCT01087489|588640497|FG000|Overall Study|enrolled in another VA study|0|||
162983160|NCT01087489|588640498|FG001|Overall Study|enrolled in another VA study|1|||
162983161|NCT01087489|588640497|FG000|Overall Study|Death|0|||
162983162|NCT01087489|588640498|FG001|Overall Study|Death|1|||
162983163|NCT01087489|588640497|FG000|Overall Study|unable to survey by telephone|0|||
162983164|NCT01087489|588640498|FG001|Overall Study|unable to survey by telephone|1|||
162983165|NCT05070546|588640506|FG000|Overall Study|Death|0|||
162983166|NCT05070546|588640507|FG001|Overall Study|Death|0|||
162983167|NCT05070546|588640508|FG002|Overall Study|Death|0|||
162983168|NCT05070546|588640509|FG003|Overall Study|Death|0|||
162983169|NCT05070546|588640510|FG004|Overall Study|Death|0|||
162983170|NCT05070546|588640511|FG005|Overall Study|Death|1|||
162983171|NCT05070546|588640506|FG000|Overall Study|Lost to Follow-up|8|||
162983172|NCT05070546|588640507|FG001|Overall Study|Lost to Follow-up|2|||
162983173|NCT05070546|588640508|FG002|Overall Study|Lost to Follow-up|7|||
162983174|NCT05070546|588640509|FG003|Overall Study|Lost to Follow-up|1|||
162983175|NCT05070546|588640510|FG004|Overall Study|Lost to Follow-up|2|||
162983176|NCT05070546|588640511|FG005|Overall Study|Lost to Follow-up|0|||
162983177|NCT05070546|588640506|FG000|Overall Study|Withdrawal by Subject|1|||
162983178|NCT05070546|588640507|FG001|Overall Study|Withdrawal by Subject|1|||
162983179|NCT05070546|588640508|FG002|Overall Study|Withdrawal by Subject|3|||
162983180|NCT05070546|588640509|FG003|Overall Study|Withdrawal by Subject|0|||
162983181|NCT05070546|588640510|FG004|Overall Study|Withdrawal by Subject|0|||
162983182|NCT05070546|588640511|FG005|Overall Study|Withdrawal by Subject|0|||
162983183|NCT05070546|588640506|FG000|Overall Study|Other|0|||
162983184|NCT05070546|588640507|FG001|Overall Study|Other|0|||
162983185|NCT05070546|588640508|FG002|Overall Study|Other|0|||
162983186|NCT05070546|588640509|FG003|Overall Study|Other|0|||
162983187|NCT05070546|588640510|FG004|Overall Study|Other|3|||
162983188|NCT05070546|588640511|FG005|Overall Study|Other|0|||
162983189|NCT05070546|588640506|FG000|Overall Study|Randomized but not vaccinated|1|||
162983190|NCT05070546|588640507|FG001|Overall Study|Randomized but not vaccinated|0|||
162983191|NCT05070546|588640508|FG002|Overall Study|Randomized but not vaccinated|1|||
162983192|NCT05070546|588640509|FG003|Overall Study|Randomized but not vaccinated|1|||
162983193|NCT05070546|588640510|FG004|Overall Study|Randomized but not vaccinated|3|||
162983194|NCT05070546|588640511|FG005|Overall Study|Randomized but not vaccinated|0|||
162983195|NCT02643355|588640512|FG000|Overall Study|Withdrawal by Subject|1|||
162983196|NCT02643355|588640513|FG001|Overall Study|Withdrawal by Subject|3|||
162983197|NCT02643355|588640512|FG000|Overall Study|Protocol Violation|0|||
162983198|NCT02643355|588640513|FG001|Overall Study|Protocol Violation|2|||
162983199|NCT01615263|588640525|FG000|Overall Study|Post-randomization exclusion|0|||
162983200|NCT01615263|588640526|FG001|Overall Study|Post-randomization exclusion|2|||
162983201|NCT00988065|588640531|FG000|Overall Study|Adverse Event|4|||
162983202|NCT00988065|588640532|FG001|Overall Study|Adverse Event|10|||
162983203|NCT00988065|588640533|FG002|Overall Study|Adverse Event|2|||
163211927|NCT01980875|589490668|FG002|Overall Study|Lost to Follow-up|1|||
163211928|NCT00662363|589490669|FG000|Overall Study|Withdrawal by Subject|6|||
163211929|NCT00662363|589490670|FG001|Overall Study|Withdrawal by Subject|5|||
163211930|NCT00662363|589490669|FG000|Overall Study|Adverse Event|0|||
162983204|NCT00988065|588640531|FG000|Overall Study|Lost to Follow-up|1|||
162983205|NCT00988065|588640532|FG001|Overall Study|Lost to Follow-up|2|||
162983206|NCT00988065|588640533|FG002|Overall Study|Lost to Follow-up|2|||
162983207|NCT00988065|588640531|FG000|Overall Study|Subject withdrew consent|3|||
162983208|NCT00988065|588640532|FG001|Overall Study|Subject withdrew consent|5|||
162983209|NCT00988065|588640533|FG002|Overall Study|Subject withdrew consent|2|||
162983210|NCT00988065|588640531|FG000|Overall Study|Noncompliance with protocol|5|||
162983211|NCT00988065|588640532|FG001|Overall Study|Noncompliance with protocol|6|||
162983212|NCT00988065|588640533|FG002|Overall Study|Noncompliance with protocol|9|||
163059609|NCT04935879|588926442|FG001|Overall Study|Withdrawal by Subject|6|||
163059610|NCT04935879|588926441|FG000|Overall Study|Other|3|||
163059611|NCT04935879|588926442|FG001|Overall Study|Other|3|||
163059612|NCT03054428|588926443|FG000|Overall Study|Physician Decision|0|||
163059613|NCT03054428|588926444|FG001|Overall Study|Physician Decision|1|||
163059614|NCT03054428|588926445|FG002|Overall Study|Physician Decision|1|||
163059615|NCT03054428|588926443|FG000|Overall Study|Lack of Efficacy|3|||
163059616|NCT03054428|588926444|FG001|Overall Study|Lack of Efficacy|1|||
163059617|NCT03054428|588926445|FG002|Overall Study|Lack of Efficacy|0|||
163059618|NCT03054428|588926443|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
163059619|NCT03054428|588926444|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
163059620|NCT03054428|588926445|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
163059621|NCT03054428|588926443|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
163059622|NCT03054428|588926444|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
163059623|NCT03054428|588926445|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
163059624|NCT03054428|588926443|FG000|Overall Study|Transitioned to OLE study|76|||
163059625|NCT03054428|588926444|FG001|Overall Study|Transitioned to OLE study|76|||
163059626|NCT03054428|588926445|FG002|Overall Study|Transitioned to OLE study|73|||
163059627|NCT03054428|588926443|FG000|Overall Study|Withdrawal by Subject|3|||
163059628|NCT03054428|588926444|FG001|Overall Study|Withdrawal by Subject|2|||
163059629|NCT03054428|588926445|FG002|Overall Study|Withdrawal by Subject|3|||
163059630|NCT03054428|588926443|FG000|Overall Study|Lost to Follow-up|0|||
163059631|NCT03054428|588926444|FG001|Overall Study|Lost to Follow-up|0|||
163059632|NCT03054428|588926445|FG002|Overall Study|Lost to Follow-up|1|||
163059633|NCT01652690|588926446|FG000|Overall Study|Withdrawal by Subject|16|||
163059634|NCT01652690|588926447|FG001|Overall Study|Withdrawal by Subject|4|||
163059635|NCT01652690|588926446|FG000|Overall Study|Other|8|||
163059636|NCT01652690|588926447|FG001|Overall Study|Other|9|||
163059637|NCT01652690|588926446|FG000|Overall Study|Lost to Follow-up|6|||
163059638|NCT01652690|588926447|FG001|Overall Study|Lost to Follow-up|6|||
163059639|NCT01652690|588926446|FG000|Overall Study|Death|5|||
163059640|NCT01652690|588926447|FG001|Overall Study|Death|2|||
163059641|NCT03225287|588926450|FG000|Overall Study|Adverse Event|0|||
163059642|NCT03225287|588926451|FG001|Overall Study|Adverse Event|0|||
163059643|NCT03225287|588926452|FG002|Overall Study|Adverse Event|1|||
163059644|NCT03225287|588926450|FG000|Overall Study|Protocol non-compliance|0|||
163059645|NCT03225287|588926451|FG001|Overall Study|Protocol non-compliance|0|||
163059646|NCT03225287|588926452|FG002|Overall Study|Protocol non-compliance|1|||
163059647|NCT03225287|588926450|FG000|Overall Study|Subject withdraws consent|3|||
163059648|NCT03225287|588926451|FG001|Overall Study|Subject withdraws consent|0|||
163059649|NCT03225287|588926452|FG002|Overall Study|Subject withdraws consent|0|||
163059650|NCT03225287|588926450|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
163059651|NCT03225287|588926451|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
163059652|NCT03225287|588926452|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
163059653|NCT03225287|588926450|FG000|Overall Study|Trial drug not effective|0|||
163059654|NCT03225287|588926451|FG001|Overall Study|Trial drug not effective|1|||
163059655|NCT03225287|588926452|FG002|Overall Study|Trial drug not effective|0|||
163059656|NCT03225287|588926450|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
163059657|NCT03225287|588926451|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
163211931|NCT00662363|589490670|FG001|Overall Study|Adverse Event|3|||
163211932|NCT00662363|589490669|FG000|Overall Study|Discharged early from rehab|4|||
163059658|NCT03225287|588926452|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
163059659|NCT03225287|588926450|FG000|Overall Study|Stem cell transplantation|0|||
163059660|NCT03225287|588926451|FG001|Overall Study|Stem cell transplantation|1|||
163059661|NCT03225287|588926452|FG002|Overall Study|Stem cell transplantation|0|||
163059662|NCT06070610|588926454|FG000|Washout period|Adverse Event|1|||
163059663|NCT06070610|588926454|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
163059664|NCT01499810|588926455|FG000|Overall Study|Lost to Follow-up|10|||
163059665|NCT01499810|588926455|FG000|Overall Study|Protocol Violation|1|||
163059666|NCT01499810|588926455|FG000|Overall Study|Withdrawal by Subject|1|||
163059667|NCT01884597|588926456|FG000|Overall Study|Adverse Event|0|||
163059668|NCT01884597|588926457|FG001|Overall Study|Adverse Event|0|||
163059669|NCT01884597|588926458|FG002|Overall Study|Adverse Event|1|||
163059670|NCT01884597|588926456|FG000|Overall Study|Lack of Efficacy|1|||
163059671|NCT01884597|588926457|FG001|Overall Study|Lack of Efficacy|0|||
163211933|NCT00662363|589490670|FG001|Overall Study|Discharged early from rehab|1|||
163211934|NCT00662363|589490669|FG000|Overall Study|Protocol Violation|1|||
163211935|NCT00662363|589490670|FG001|Overall Study|Protocol Violation|1|||
163211936|NCT01905657|589490671|FG000|Overall Study|Adverse Event|23|||
162983213|NCT03295318|588642158|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
162983214|NCT03295318|588642159|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
162983215|NCT03295318|588642160|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
162983216|NCT03295318|588642158|FG000|Overall Study|Death|1|||
162983217|NCT03295318|588642159|FG001|Overall Study|Death|1|||
162983218|NCT03295318|588642160|FG002|Overall Study|Death|1|||
162983219|NCT03295318|588642158|FG000|Overall Study|Protocol Violation|4|||
162983220|NCT03295318|588642159|FG001|Overall Study|Protocol Violation|3|||
162983221|NCT03295318|588642160|FG002|Overall Study|Protocol Violation|3|||
162983222|NCT03295318|588642158|FG000|Overall Study|Withdrawal by Subject|0|||
162983223|NCT03295318|588642159|FG001|Overall Study|Withdrawal by Subject|0|||
162983224|NCT03295318|588642160|FG002|Overall Study|Withdrawal by Subject|1|||
162983225|NCT03295318|588642158|FG000|Overall Study|Subject discontinued due to travel|0|||
162983226|NCT03295318|588642159|FG001|Overall Study|Subject discontinued due to travel|1|||
162983227|NCT03295318|588642160|FG002|Overall Study|Subject discontinued due to travel|0|||
162983228|NCT04319718|588642161|FG000|Overall Study|Adverse Event|0|||
162983229|NCT04319718|588642162|FG001|Overall Study|Adverse Event|2|||
162983230|NCT04319718|588642161|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
162983231|NCT04319718|588642162|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
162983232|NCT03955471|588642164|FG000|Overall Study|Death|22|||
162983233|NCT03955471|588642164|FG000|Overall Study|Lost to Follow-up|1|||
162983234|NCT03955471|588642164|FG000|Overall Study|Withdrawal by Subject|6|||
162983235|NCT03955471|588642164|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
162983236|NCT01030341|588642165|FG000|Overall Study|Withdrawal by Subject|1|||
162983237|NCT01030341|588642165|FG000|Overall Study|Lost to Follow-up|2|||
162983238|NCT02307266|588642166|FG000|Overall Study|Adverse Event|3|||
162983239|NCT02307266|588642167|FG001|Overall Study|Adverse Event|1|||
162983240|NCT02307266|588642168|FG002|Overall Study|Adverse Event|5|||
162983241|NCT02307266|588642166|FG000|Overall Study|Withdrawal by Subject|2|||
162983242|NCT02307266|588642167|FG001|Overall Study|Withdrawal by Subject|0|||
162983243|NCT02307266|588642168|FG002|Overall Study|Withdrawal by Subject|1|||
162983244|NCT02307266|588642166|FG000|Overall Study|Lost to Follow-up|3|||
162983245|NCT02307266|588642167|FG001|Overall Study|Lost to Follow-up|0|||
162983246|NCT02307266|588642168|FG002|Overall Study|Lost to Follow-up|0|||
162983247|NCT00793780|588642169|FG000|Overall Study|Withdrawal by Subject|2|||
162983248|NCT00793780|588642170|FG001|Overall Study|Withdrawal by Subject|1|||
162983249|NCT00573157|588642171|FG000|Overall Study|Adverse Event|3|||
162983250|NCT00573157|588642172|FG001|Overall Study|Adverse Event|1|||
162983251|NCT00573157|588642171|FG000|Overall Study|Other|1|||
162983252|NCT00573157|588642172|FG001|Overall Study|Other|1|||
162983253|NCT01032018|588642173|FG000|Overall Study|Lost to Follow-up|6|||
162983254|NCT01032018|588642174|FG001|Overall Study|Lost to Follow-up|5|||
162983255|NCT01032018|588642173|FG000|Overall Study|Death|0|||
162983256|NCT01032018|588642174|FG001|Overall Study|Death|1|||
162983257|NCT00858143|588642176|FG000|Overall Study|Adverse Event|16|||
163059672|NCT01884597|588926458|FG002|Overall Study|Lack of Efficacy|0|||
163059673|NCT01884597|588926456|FG000|Overall Study|Death|0|||
163322380|NCT00626795|589893027|FG000|Blinded Treatment|Lack of Efficacy|2|||
163322381|NCT00626795|589893028|FG001|Blinded Treatment|Lack of Efficacy|0|||
163322382|NCT00626795|589893029|FG002|Blinded Treatment|Lack of Efficacy|0|||
163322383|NCT00626795|589893027|FG000|Blinded Treatment|Unacceptable adverse event|0|||
163322384|NCT00626795|589893028|FG001|Blinded Treatment|Unacceptable adverse event|0|||
163322385|NCT00626795|589893029|FG002|Blinded Treatment|Unacceptable adverse event|1|||
163322386|NCT00626795|589893027|FG000|Blinded Treatment|Protocol Violation|0|||
163322387|NCT00626795|589893028|FG001|Blinded Treatment|Protocol Violation|1|||
163322388|NCT00626795|589893029|FG002|Blinded Treatment|Protocol Violation|1|||
163322389|NCT00626795|589893027|FG000|Blinded Treatment|Withdrawal by Subject|1|||
163322390|NCT00626795|589893028|FG001|Blinded Treatment|Withdrawal by Subject|1|||
163322391|NCT00626795|589893029|FG002|Blinded Treatment|Withdrawal by Subject|0|||
163322392|NCT00626795|589893027|FG000|Blinded Treatment|Other reasons|2|||
163322393|NCT00626795|589893028|FG001|Blinded Treatment|Other reasons|0|||
163322394|NCT00626795|589893029|FG002|Blinded Treatment|Other reasons|2|||
163322395|NCT00626795|589893027|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
162983258|NCT00858143|588642176|FG000|Overall Study|Lack of Efficacy|4|||
162983259|NCT00858143|588642176|FG000|Overall Study|Death|7|||
162983260|NCT00858143|588642176|FG000|Overall Study|Other|23|||
163322396|NCT00626795|589893028|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
163322397|NCT00626795|589893029|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
163322398|NCT04499521|589893033|FG000|Overall Study|Disease Progression|1|||
162983261|NCT01293539|588642178|FG000|Overall Study|Physician Decision|1|||
162983262|NCT04032158|588642180|FG000|Overall Study|Study Termination|2|||
162983263|NCT04032158|588642181|FG001|Overall Study|Study Termination|1|||
162983264|NCT00059787|588642182|FG000|Overall Study|Adverse Event|13|||
162983265|NCT00059787|588642182|FG000|Overall Study|disease progression|2|||
162983266|NCT00059787|588642182|FG000|Overall Study|ineligible|1|||
162983267|NCT00059787|588642182|FG000|Overall Study|Other|4|||
163059674|NCT01884597|588926457|FG001|Overall Study|Death|1|||
162983268|NCT01248013|588642185|FG000|Overall Study|Withdrawal by Subject|14|||
162983269|NCT04325204|588642188|FG000|Overall Study|Death|0|||
162983270|NCT04325204|588642189|FG001|Overall Study|Death|1|||
162983271|NCT04325204|588642188|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
162983272|NCT04325204|588642189|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
162983273|NCT04325204|588642188|FG000|Overall Study|Lost to Follow-up|8|||
162983274|NCT04325204|588642189|FG001|Overall Study|Lost to Follow-up|8|||
162983275|NCT04325204|588642188|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
163322399|NCT04499521|589893034|FG001|Overall Study|Disease Progression|0|||
163322400|NCT05132400|589893811|FG000|Overall Study|Withdrawal by Subject|14|||
163322401|NCT05132400|589893812|FG001|Overall Study|Withdrawal by Subject|8|||
163322402|NCT05132400|589893811|FG000|Overall Study|Lost to Follow-up|132|||
162983276|NCT04325204|588642189|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
162983277|NCT00841906|588642190|FG000|Overall Study|Withdrawal by Subject|2|||
162983278|NCT00841906|588642191|FG001|Overall Study|Withdrawal by Subject|0|||
162983279|NCT04710979|588642194|FG000|Overall Study|Lost to Follow-up|2|||
162983280|NCT04710979|588642195|FG001|Overall Study|Lost to Follow-up|4|||
162983281|NCT04710979|588642194|FG000|Overall Study|Withdrawal by Subject|1|||
162983282|NCT04710979|588642195|FG001|Overall Study|Withdrawal by Subject|0|||
162983283|NCT00891371|588642203|FG000|Pre-assignment|Inclusion/exclusion|5|||
162983284|NCT00891371|588642203|FG000|Pre-assignment|Consent withdrawal|1|||
162983285|NCT00891371|588642203|FG000|Treatment|Lack of Efficacy|5|||
162983286|NCT00891371|588642203|FG000|Treatment|Adverse Event|2|||
162983287|NCT00891371|588642203|FG000|Treatment|Death|1|||
162983288|NCT00891371|588642203|FG000|Treatment|Lost to Follow-up|1|||
162983289|NCT04421586|588642212|FG000|Overall Study|Death|0|||
162983290|NCT04421586|588642213|FG001|Overall Study|Death|1|||
162983291|NCT04421586|588642212|FG000|Overall Study|Lost to Follow-up|2|||
162983292|NCT04421586|588642213|FG001|Overall Study|Lost to Follow-up|2|||
162983293|NCT04421586|588642212|FG000|Overall Study|Withdrawn by PI|1|||
162983294|NCT04421586|588642213|FG001|Overall Study|Withdrawn by PI|0|||
162983295|NCT04421586|588642212|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
162983296|NCT04421586|588642213|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
162983297|NCT02963441|588642214|FG000|Overall Study|Protocol violation or withdrawn|8|||
162983298|NCT02963441|588642214|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
162983299|NCT02963441|588642214|FG000|Overall Study|IDx-DR insufficient quality|33|||
162983300|NCT04920916|588642215|FG000|Phase IIa 60 Day Study|Death|2|||
162983301|NCT04920916|588642216|FG001|Phase IIa 60 Day Study|Death|5|||
162983302|NCT04920916|588642215|FG000|1 Year Follow up (Phone Call)|Death|1|||
162983303|NCT04920916|588642216|FG001|1 Year Follow up (Phone Call)|Death|3|||
162983304|NCT04920916|588642215|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
162983305|NCT04920916|588642216|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
162983306|NCT00974974|588642217|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
162983307|NCT00974974|588642218|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
162983308|NCT00974974|588642217|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
162983309|NCT00974974|588642218|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
162983310|NCT00974974|588642217|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
162983311|NCT00974974|588642218|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
162983312|NCT00974974|588642217|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
162983313|NCT00974974|588642218|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
162983314|NCT00974974|588642217|FG000|IR CD-LD Dose Adjustment|Various|0|||
162983315|NCT00974974|588642218|FG001|IR CD-LD Dose Adjustment|Various|9|||
162983316|NCT00974974|588642217|FG000|IPX066 Dose Conversion|Adverse Event|23|||
162983317|NCT00974974|588642218|FG001|IPX066 Dose Conversion|Adverse Event|0|||
162983318|NCT00974974|588642217|FG000|IPX066 Dose Conversion|Death|2|||
162983319|NCT00974974|588642218|FG001|IPX066 Dose Conversion|Death|0|||
162983320|NCT00974974|588642217|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
162983321|NCT00974974|588642218|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
162983322|NCT00974974|588642217|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
162983323|NCT00974974|588642218|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
162983324|NCT00974974|588642217|FG000|IPX066 Dose Conversion|Various|3|||
162983325|NCT00974974|588642218|FG001|IPX066 Dose Conversion|Various|0|||
162983326|NCT00974974|588642217|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
162983327|NCT00974974|588642218|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
162983328|NCT00974974|588642217|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
162983329|NCT00974974|588642218|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
162983330|NCT00974974|588642217|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
162983331|NCT00974974|588642218|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
162983332|NCT00974974|588642217|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
162983333|NCT00974974|588642218|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
162983334|NCT00974974|588642217|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
162983335|NCT00974974|588642218|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
162983336|NCT00974974|588642217|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
162983337|NCT00974974|588642218|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
162983338|NCT00974974|588642217|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
162983339|NCT00974974|588642218|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
162983340|NCT00974974|588642217|FG000|Maintenance - Double Blind Treatment|Various|4|||
162983341|NCT00974974|588642218|FG001|Maintenance - Double Blind Treatment|Various|0|||
162983342|NCT04392583|588642219|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
162983343|NCT01340768|588642220|FG000|Overall Study|Lost to Follow-up|10|||
162983344|NCT01340768|588642221|FG001|Overall Study|Lost to Follow-up|4|||
162983345|NCT01340768|588642220|FG000|Overall Study|Withdrawal by Subject|5|||
162983346|NCT01340768|588642221|FG001|Overall Study|Withdrawal by Subject|1|||
162983347|NCT01340768|588642220|FG000|Overall Study|Other|2|||
162983348|NCT01340768|588642221|FG001|Overall Study|Other|0|||
162983349|NCT03052959|588642226|FG000|Overall Study|Lost to Follow-up|4|||
162983350|NCT03052959|588642227|FG001|Overall Study|Lost to Follow-up|5|||
162983351|NCT02397408|588642228|FG000|Overall Study|Physician Decision|4|||
162983352|NCT02397408|588642228|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
162983353|NCT00985712|588642229|FG000|Overall Study|Adverse Event|0|||
162983354|NCT00985712|588642230|FG001|Overall Study|Adverse Event|1|||
162983355|NCT00985712|588642229|FG000|Overall Study|Lost to Follow-up|2|||
162983356|NCT00985712|588642230|FG001|Overall Study|Lost to Follow-up|2|||
162983357|NCT00985712|588642229|FG000|Overall Study|Protocol Violation|0|||
162983358|NCT00985712|588642230|FG001|Overall Study|Protocol Violation|1|||
162983359|NCT00985712|588642229|FG000|Overall Study|Withdrawal by Subject|4|||
162983360|NCT00985712|588642230|FG001|Overall Study|Withdrawal by Subject|1|||
162983361|NCT00985712|588642229|FG000|Overall Study|Sponsor decision|0|||
162983362|NCT00985712|588642230|FG001|Overall Study|Sponsor decision|2|||
162983363|NCT03096847|588642236|FG000|Overall Study|Other|2|||
162983364|NCT03096847|588642237|FG001|Overall Study|Other|1|||
162983365|NCT03096847|588642238|FG002|Overall Study|Other|2|||
162983366|NCT03096847|588642236|FG000|Overall Study|Lost to Follow-up|1|||
162983367|NCT03096847|588642237|FG001|Overall Study|Lost to Follow-up|0|||
162983368|NCT03096847|588642238|FG002|Overall Study|Lost to Follow-up|1|||
162983369|NCT03096847|588642236|FG000|Overall Study|Death|6|||
162983370|NCT03096847|588642237|FG001|Overall Study|Death|0|||
162983371|NCT03096847|588642238|FG002|Overall Study|Death|2|||
162983372|NCT03096847|588642236|FG000|Overall Study|Protocol Violation|3|||
162983373|NCT03096847|588642237|FG001|Overall Study|Protocol Violation|0|||
162983374|NCT03096847|588642238|FG002|Overall Study|Protocol Violation|6|||
162983375|NCT03096847|588642236|FG000|Overall Study|Physician Decision|12|||
163059675|NCT01884597|588926458|FG002|Overall Study|Death|0|||
163059676|NCT03834961|588928185|FG000|Overall Study|Lack of Efficacy|1|||
163059677|NCT03834961|588928186|FG001|Overall Study|Lack of Efficacy|1|||
163059678|NCT03834961|588928187|FG002|Overall Study|Lack of Efficacy|0|||
163059679|NCT03834961|588928185|FG000|Overall Study|Physician Decision|0|||
163059680|NCT03834961|588928186|FG001|Overall Study|Physician Decision|1|||
163059681|NCT03834961|588928187|FG002|Overall Study|Physician Decision|0|||
163059682|NCT00715208|588928190|FG000|Overall Study|Withdrawal by Subject|1|||
163059683|NCT00715208|588928191|FG001|Overall Study|Withdrawal by Subject|1|||
163059684|NCT00715208|588928190|FG000|Overall Study|Adverse Event|0|||
162983376|NCT03096847|588642237|FG001|Overall Study|Physician Decision|2|||
162983377|NCT03096847|588642238|FG002|Overall Study|Physician Decision|8|||
162983378|NCT03096847|588642236|FG000|Overall Study|Withdrawal by Subject|24|||
162983379|NCT03096847|588642237|FG001|Overall Study|Withdrawal by Subject|1|||
162983380|NCT03096847|588642238|FG002|Overall Study|Withdrawal by Subject|12|||
162983381|NCT03096847|588642236|FG000|Overall Study|Adverse Event|72|||
162983382|NCT03096847|588642237|FG001|Overall Study|Adverse Event|6|||
162983383|NCT03096847|588642238|FG002|Overall Study|Adverse Event|28|||
162983384|NCT03096847|588642236|FG000|Overall Study|Progressive disease|97|||
163059685|NCT00715208|588928191|FG001|Overall Study|Adverse Event|6|||
163059686|NCT00715208|588928190|FG000|Overall Study|Lack of Efficacy|0|||
163059687|NCT00715208|588928191|FG001|Overall Study|Lack of Efficacy|2|||
163059688|NCT01648764|588928192|FG000|Overall Study|Progressive Disease|0|||
163211937|NCT01905657|589490672|FG001|Overall Study|Adverse Event|17|||
163211938|NCT01905657|589490673|FG002|Overall Study|Adverse Event|18|||
162983385|NCT03096847|588642237|FG001|Overall Study|Progressive disease|10|||
163059689|NCT01648764|588928193|FG001|Overall Study|Progressive Disease|1|||
163059690|NCT01648764|588928194|FG002|Overall Study|Progressive Disease|0|||
163211939|NCT01905657|589490671|FG000|Overall Study|Clinical Progression|103|||
162983386|NCT03096847|588642238|FG002|Overall Study|Progressive disease|78|||
162983387|NCT03096847|588642236|FG000|Overall Study|Non-compliance with study medication|1|||
162983388|NCT03096847|588642237|FG001|Overall Study|Non-compliance with study medication|0|||
162983389|NCT03096847|588642238|FG002|Overall Study|Non-compliance with study medication|0|||
162983390|NCT03096847|588642236|FG000|Overall Study|New therapy for study indication|1|||
162983391|NCT03096847|588642237|FG001|Overall Study|New therapy for study indication|0|||
162983392|NCT03096847|588642238|FG002|Overall Study|New therapy for study indication|1|||
162983393|NCT00359632|588642242|FG000|Overall Study|Death|2|||
163211940|NCT01905657|589490672|FG001|Overall Study|Clinical Progression|78|||
163322403|NCT05132400|589893812|FG001|Overall Study|Lost to Follow-up|121|||
163322404|NCT00739908|589893815|FG000|Overall Study|Adverse Event|5|||
163322405|NCT00739908|589893816|FG001|Overall Study|Adverse Event|6|||
163322406|NCT00739908|589893815|FG000|Overall Study|Withdrawal by Subject|4|||
162983394|NCT00359632|588642243|FG001|Overall Study|Death|0|||
162983395|NCT00359632|588642242|FG000|Overall Study|Adverse Event|1|||
162983396|NCT00359632|588642243|FG001|Overall Study|Adverse Event|0|||
162983397|NCT00359632|588642242|FG000|Overall Study|Non-compliance with visit schedule|1|||
162983398|NCT00359632|588642243|FG001|Overall Study|Non-compliance with visit schedule|0|||
162983399|NCT03978091|588642246|FG000|Overall Study|Lost to Follow-up|0|||
162983400|NCT03978091|588642247|FG001|Overall Study|Lost to Follow-up|0|||
162983401|NCT03978091|588642248|FG002|Overall Study|Lost to Follow-up|1|||
162983402|NCT03978091|588642249|FG003|Overall Study|Lost to Follow-up|0|||
162983403|NCT03978091|588642250|FG004|Overall Study|Lost to Follow-up|0|||
162983404|NCT03978091|588642251|FG005|Overall Study|Lost to Follow-up|0|||
162983405|NCT03978091|588642246|FG000|Overall Study|Withdrawal by Subject|0|||
162983406|NCT03978091|588642247|FG001|Overall Study|Withdrawal by Subject|0|||
162983407|NCT03978091|588642248|FG002|Overall Study|Withdrawal by Subject|0|||
162983408|NCT03978091|588642249|FG003|Overall Study|Withdrawal by Subject|1|||
162983409|NCT03978091|588642250|FG004|Overall Study|Withdrawal by Subject|1|||
162983410|NCT03978091|588642251|FG005|Overall Study|Withdrawal by Subject|0|||
162983411|NCT04700280|588642255|FG000|Overall Study|Adverse Event|4|||
162983412|NCT04700280|588642256|FG001|Overall Study|Adverse Event|0|||
162983413|NCT04700280|588642255|FG000|Overall Study|Lack of Efficacy|1|||
162983414|NCT04700280|588642256|FG001|Overall Study|Lack of Efficacy|0|||
162983415|NCT04700280|588642255|FG000|Overall Study|Study terminated by sponsor|5|||
162983416|NCT04700280|588642256|FG001|Overall Study|Study terminated by sponsor|3|||
162983417|NCT04700280|588642255|FG000|Overall Study|Other than specified|1|||
162983418|NCT04700280|588642256|FG001|Overall Study|Other than specified|0|||
162983419|NCT01843348|588642257|FG000|Overall Study|Withdrawal by Subject|4|||
162983420|NCT01843348|588642258|FG001|Overall Study|Withdrawal by Subject|16|||
162983421|NCT01843348|588642259|FG002|Overall Study|Withdrawal by Subject|18|||
162983422|NCT01843348|588642257|FG000|Overall Study|Lost to Follow-up|5|||
162983423|NCT01843348|588642258|FG001|Overall Study|Lost to Follow-up|4|||
162983424|NCT01843348|588642259|FG002|Overall Study|Lost to Follow-up|2|||
162983425|NCT01843348|588642257|FG000|Overall Study|Death|5|||
162983426|NCT01843348|588642258|FG001|Overall Study|Death|3|||
162983427|NCT01843348|588642259|FG002|Overall Study|Death|4|||
162983428|NCT01843348|588642257|FG000|Overall Study|Graft loss/retransplantation|5|||
162983429|NCT01843348|588642258|FG001|Overall Study|Graft loss/retransplantation|8|||
162983430|NCT01843348|588642259|FG002|Overall Study|Graft loss/retransplantation|11|||
162983431|NCT01843348|588642257|FG000|Overall Study|Various reasons|4|||
162983432|NCT01843348|588642258|FG001|Overall Study|Various reasons|9|||
162983433|NCT01843348|588642259|FG002|Overall Study|Various reasons|6|||
162983434|NCT02093221|588642260|FG000|Overall Study|Adverse Event|1|||
162983435|NCT02093221|588642261|FG001|Overall Study|Adverse Event|0|||
162983436|NCT02093221|588642262|FG002|Overall Study|Adverse Event|0|||
162983437|NCT02093221|588642263|FG003|Overall Study|Adverse Event|0|||
162983438|NCT02093221|588642264|FG004|Overall Study|Adverse Event|0|||
162983439|NCT02093221|588642260|FG000|Overall Study|Withdrawal by Subject|1|||
162983440|NCT02093221|588642261|FG001|Overall Study|Withdrawal by Subject|1|||
162983441|NCT02093221|588642262|FG002|Overall Study|Withdrawal by Subject|4|||
162983442|NCT02093221|588642263|FG003|Overall Study|Withdrawal by Subject|1|||
162983443|NCT02093221|588642264|FG004|Overall Study|Withdrawal by Subject|1|||
162983444|NCT02093221|588642260|FG000|Overall Study|Lost to Follow-up|2|||
163322407|NCT00739908|589893816|FG001|Overall Study|Withdrawal by Subject|2|||
163322408|NCT00739908|589893815|FG000|Overall Study|Lost to Follow-up|14|||
163322409|NCT00739908|589893816|FG001|Overall Study|Lost to Follow-up|9|||
163322410|NCT00739908|589893815|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
163322411|NCT00739908|589893816|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
163322412|NCT00739908|589893815|FG000|Overall Study|Non-Compliance With Study Medication|0|||
163322413|NCT00739908|589893816|FG001|Overall Study|Non-Compliance With Study Medication|3|||
163322414|NCT00739908|589893815|FG000|Overall Study|Lack of Efficacy|0|||
163322415|NCT00739908|589893816|FG001|Overall Study|Lack of Efficacy|1|||
163322416|NCT00739908|589893815|FG000|Overall Study|Relocation|0|||
163322417|NCT00739908|589893816|FG001|Overall Study|Relocation|1|||
162983445|NCT02093221|588642261|FG001|Overall Study|Lost to Follow-up|0|||
162983446|NCT02093221|588642262|FG002|Overall Study|Lost to Follow-up|1|||
162983447|NCT02093221|588642263|FG003|Overall Study|Lost to Follow-up|1|||
162983448|NCT02093221|588642264|FG004|Overall Study|Lost to Follow-up|0|||
162983449|NCT02093221|588642260|FG000|Overall Study|Death|0|||
162983450|NCT02093221|588642261|FG001|Overall Study|Death|1|||
162983451|NCT02093221|588642262|FG002|Overall Study|Death|0|||
162983452|NCT02093221|588642263|FG003|Overall Study|Death|0|||
163059691|NCT01648764|588928195|FG003|Overall Study|Progressive Disease|0|||
162983453|NCT02093221|588642264|FG004|Overall Study|Death|0|||
162983454|NCT02093221|588642260|FG000|Overall Study|Protocol Violation|0|||
162983455|NCT02093221|588642261|FG001|Overall Study|Protocol Violation|1|||
163322418|NCT02076009|589893826|FG000|Overall Study|Death|172|||
163403242|NCT00135668|590187140|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
163403243|NCT02290873|590187143|FG000|Overall Study|Withdrawal by Subject|0|||
163403244|NCT02290873|590187144|FG001|Overall Study|Withdrawal by Subject|1|||
163322419|NCT02076009|589893827|FG001|Overall Study|Death|153|||
163322420|NCT02076009|589893826|FG000|Overall Study|Withdrawal by Subject|16|||
163322421|NCT02076009|589893827|FG001|Overall Study|Withdrawal by Subject|12|||
163322422|NCT02076009|589893826|FG000|Overall Study|Lost to Follow-up|4|||
163403245|NCT02290873|590187145|FG002|Overall Study|Withdrawal by Subject|1|||
163403246|NCT02290873|590187143|FG000|Overall Study|Nellcor device error|1|||
163403247|NCT02290873|590187144|FG001|Overall Study|Nellcor device error|0|||
163403248|NCT02290873|590187145|FG002|Overall Study|Nellcor device error|0|||
163403249|NCT02290873|590187143|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
163403250|NCT02290873|590187144|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
163403251|NCT02290873|590187145|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
163403252|NCT02290873|590187143|FG000|Overall Study|Protocol Violation|0|||
163403253|NCT02290873|590187144|FG001|Overall Study|Protocol Violation|0|||
163403254|NCT02290873|590187145|FG002|Overall Study|Protocol Violation|1|||
163403255|NCT02370615|590187146|FG000|Overall Study|Adverse Event|1|||
163403256|NCT02370615|590187147|FG001|Overall Study|Adverse Event|0|||
163403257|NCT03715153|590187148|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
162983456|NCT02093221|588642262|FG002|Overall Study|Protocol Violation|0|||
163211941|NCT01905657|589490673|FG002|Overall Study|Clinical Progression|59|||
163211942|NCT01905657|589490671|FG000|Overall Study|Death|40|||
163211943|NCT01905657|589490672|FG001|Overall Study|Death|43|||
163211944|NCT01905657|589490673|FG002|Overall Study|Death|47|||
163211945|NCT01905657|589490671|FG000|Overall Study|Excluded Medication|13|||
163211946|NCT01905657|589490672|FG001|Overall Study|Excluded Medication|16|||
163211947|NCT01905657|589490673|FG002|Overall Study|Excluded Medication|9|||
163322423|NCT02076009|589893827|FG001|Overall Study|Lost to Follow-up|2|||
162983457|NCT02093221|588642263|FG003|Overall Study|Protocol Violation|0|||
162983458|NCT02093221|588642264|FG004|Overall Study|Protocol Violation|0|||
162983459|NCT02093221|588642260|FG000|Overall Study|Study termination|6|||
162983460|NCT02093221|588642261|FG001|Overall Study|Study termination|5|||
162983461|NCT02093221|588642262|FG002|Overall Study|Study termination|4|||
162983462|NCT02093221|588642263|FG003|Overall Study|Study termination|6|||
162983463|NCT02093221|588642264|FG004|Overall Study|Study termination|7|||
162983464|NCT00257920|588642265|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
162983465|NCT00257920|588642266|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
162983466|NCT00257920|588642265|FG000|Period: Second Intervention|Other|2|||
162983467|NCT00257920|588642266|FG001|Period: Second Intervention|Other|1|||
162983468|NCT00770692|588642267|FG000|Overall Study|Withdrawal by Subject|7|||
162983469|NCT00770692|588642268|FG001|Overall Study|Withdrawal by Subject|9|||
162983470|NCT00770692|588642269|FG002|Overall Study|Withdrawal by Subject|9|||
162983471|NCT00770692|588642270|FG003|Overall Study|Withdrawal by Subject|6|||
162983472|NCT00770692|588642267|FG000|Overall Study|Adverse Event|3|||
162983473|NCT00770692|588642268|FG001|Overall Study|Adverse Event|0|||
162983474|NCT00770692|588642269|FG002|Overall Study|Adverse Event|4|||
162983475|NCT00770692|588642270|FG003|Overall Study|Adverse Event|4|||
162983476|NCT00770692|588642267|FG000|Overall Study|Investigator judgment|2|||
162983477|NCT00770692|588642268|FG001|Overall Study|Investigator judgment|0|||
162983478|NCT00770692|588642269|FG002|Overall Study|Investigator judgment|1|||
162983479|NCT00770692|588642270|FG003|Overall Study|Investigator judgment|1|||
162983480|NCT01230892|588642271|FG000|Overall Study|Withdrawal by Subject|1|||
162983481|NCT01230892|588642272|FG001|Overall Study|Withdrawal by Subject|1|||
162983482|NCT01230892|588642271|FG000|Overall Study|Lost to Follow-up|2|||
162983483|NCT01230892|588642272|FG001|Overall Study|Lost to Follow-up|0|||
162983484|NCT00725621|588642273|FG000|Overall Study|Adverse Event|25|||
162983485|NCT00725621|588642273|FG000|Overall Study|Lack of Efficacy|46|||
162983486|NCT00725621|588642273|FG000|Overall Study|Withdrawal by Subject|57|||
163322424|NCT02076009|589893826|FG000|Overall Study|Progressive Disease|1|||
163322425|NCT02076009|589893827|FG001|Overall Study|Progressive Disease|0|||
163322426|NCT02076009|589893826|FG000|Overall Study|Physician Decision|0|||
163322427|NCT02076009|589893827|FG001|Overall Study|Physician Decision|1|||
163322428|NCT02076009|589893826|FG000|Overall Study|End of data collection|90|||
163322429|NCT02076009|589893827|FG001|Overall Study|End of data collection|118|||
163403258|NCT03715153|590187149|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
163403259|NCT03715153|590187148|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
163403260|NCT03715153|590187149|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
162983487|NCT00725621|588642273|FG000|Overall Study|Physician Decision|19|||
162983488|NCT00725621|588642273|FG000|Overall Study|Lost to Follow-up|52|||
162983489|NCT00725621|588642273|FG000|Overall Study|Non-compliance|8|||
162983490|NCT00725621|588642273|FG000|Overall Study|Continued treatment by other physician|6|||
163059692|NCT01648764|588928196|FG004|Overall Study|Progressive Disease|0|||
163211948|NCT01905657|589490671|FG000|Overall Study|Lost to Follow-up|1|||
163211949|NCT01905657|589490672|FG001|Overall Study|Lost to Follow-up|2|||
163211950|NCT01905657|589490673|FG002|Overall Study|Lost to Follow-up|1|||
163403261|NCT03715153|590187148|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
162983491|NCT00725621|588642273|FG000|Overall Study|Switched to other study|1|||
162983492|NCT00725621|588642273|FG000|Overall Study|Switched to other drug|1|||
162983493|NCT00725621|588642273|FG000|Overall Study|Prepared for elective surgery|1|||
162983494|NCT00725621|588642273|FG000|Overall Study|Reason not specified|55|||
162983495|NCT01189500|588642274|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
162983496|NCT01189500|588642274|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
162983497|NCT00062751|588642275|FG000|Overall Study|Disease progression|24|||
162983498|NCT00062751|588642276|FG001|Overall Study|Disease progression|17|||
162983499|NCT00062751|588642277|FG002|Overall Study|Disease progression|24|||
162983500|NCT00062751|588642278|FG003|Overall Study|Disease progression|2|||
162983501|NCT00062751|588642279|FG004|Overall Study|Disease progression|2|||
162983502|NCT00062751|588642275|FG000|Overall Study|Adverse Event|4|||
162983503|NCT00062751|588642276|FG001|Overall Study|Adverse Event|7|||
162983504|NCT00062751|588642277|FG002|Overall Study|Adverse Event|2|||
162983505|NCT00062751|588642278|FG003|Overall Study|Adverse Event|2|||
162983506|NCT00062751|588642279|FG004|Overall Study|Adverse Event|2|||
162983507|NCT00062751|588642275|FG000|Overall Study|Other|2|||
162983508|NCT00062751|588642276|FG001|Overall Study|Other|3|||
162983509|NCT00062751|588642277|FG002|Overall Study|Other|1|||
162983510|NCT00062751|588642278|FG003|Overall Study|Other|0|||
162983511|NCT00062751|588642279|FG004|Overall Study|Other|1|||
162983512|NCT00062751|588642275|FG000|Overall Study|Withdrawal by Subject|1|||
162983513|NCT00062751|588642276|FG001|Overall Study|Withdrawal by Subject|2|||
162983514|NCT00062751|588642277|FG002|Overall Study|Withdrawal by Subject|2|||
162983515|NCT00062751|588642278|FG003|Overall Study|Withdrawal by Subject|1|||
162983516|NCT00062751|588642279|FG004|Overall Study|Withdrawal by Subject|0|||
162983517|NCT00062751|588642275|FG000|Overall Study|Symptomatic deterioration|1|||
162983518|NCT00062751|588642276|FG001|Overall Study|Symptomatic deterioration|1|||
162983519|NCT00062751|588642277|FG002|Overall Study|Symptomatic deterioration|0|||
162983520|NCT00062751|588642278|FG003|Overall Study|Symptomatic deterioration|0|||
162983521|NCT00062751|588642279|FG004|Overall Study|Symptomatic deterioration|1|||
162983522|NCT00062751|588642275|FG000|Overall Study|Death|1|||
162983523|NCT00062751|588642276|FG001|Overall Study|Death|0|||
162983524|NCT00062751|588642277|FG002|Overall Study|Death|1|||
162983525|NCT00062751|588642278|FG003|Overall Study|Death|0|||
162983526|NCT00062751|588642279|FG004|Overall Study|Death|0|||
162983527|NCT03097588|588642286|FG000|Overall Study|Adverse Event|1|||
162983528|NCT01144364|588642287|FG000|Induction Phase|Disease progression|14|||
162983529|NCT01144364|588642288|FG001|Induction Phase|Disease progression|0|||
162983530|NCT01144364|588642289|FG002|Induction Phase|Disease progression|0|||
162983531|NCT01144364|588642287|FG000|Induction Phase|Adverse Event|9|||
162983532|NCT01144364|588642288|FG001|Induction Phase|Adverse Event|0|||
162983533|NCT01144364|588642289|FG002|Induction Phase|Adverse Event|0|||
162983534|NCT01144364|588642287|FG000|Induction Phase|Death|1|||
162983535|NCT01144364|588642288|FG001|Induction Phase|Death|0|||
162983536|NCT01144364|588642289|FG002|Induction Phase|Death|0|||
162983537|NCT01144364|588642287|FG000|Induction Phase|Withdrawal by Subject|1|||
162983538|NCT01144364|588642288|FG001|Induction Phase|Withdrawal by Subject|0|||
162983539|NCT01144364|588642289|FG002|Induction Phase|Withdrawal by Subject|0|||
162983540|NCT01144364|588642287|FG000|Induction Phase|Lost to Follow-up|2|||
162983541|NCT01144364|588642288|FG001|Induction Phase|Lost to Follow-up|0|||
162983542|NCT01144364|588642289|FG002|Induction Phase|Lost to Follow-up|0|||
162983543|NCT01144364|588642287|FG000|Induction Phase|Physician Decision|1|||
162983544|NCT01144364|588642288|FG001|Induction Phase|Physician Decision|0|||
162983545|NCT01144364|588642289|FG002|Induction Phase|Physician Decision|0|||
162983546|NCT01144364|588642287|FG000|Induction Phase|Stable disease|2|||
162983547|NCT01144364|588642288|FG001|Induction Phase|Stable disease|0|||
162983548|NCT01144364|588642289|FG002|Induction Phase|Stable disease|0|||
162983549|NCT01144364|588642287|FG000|Induction Phase|Secondary neoplasia|1|||
162983550|NCT01144364|588642288|FG001|Induction Phase|Secondary neoplasia|0|||
162983551|NCT01144364|588642289|FG002|Induction Phase|Secondary neoplasia|0|||
162983552|NCT01144364|588642287|FG000|Induction Phase|Protocol Violation|1|||
162983553|NCT01144364|588642288|FG001|Induction Phase|Protocol Violation|0|||
163403262|NCT03715153|590187149|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
162983554|NCT01144364|588642289|FG002|Induction Phase|Protocol Violation|0|||
162983555|NCT01144364|588642287|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
162983556|NCT01144364|588642288|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
162983557|NCT01144364|588642289|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
162983558|NCT01144364|588642287|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
162983559|NCT01144364|588642288|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
162983560|NCT01144364|588642289|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
162983561|NCT01144364|588642287|FG000|Follow-Up/Maintenance Phase|Death|0|||
163059693|NCT01648764|588928197|FG005|Overall Study|Progressive Disease|1|||
163403263|NCT03715153|590187148|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
162983562|NCT01144364|588642288|FG001|Follow-Up/Maintenance Phase|Death|2|||
162983563|NCT01144364|588642289|FG002|Follow-Up/Maintenance Phase|Death|0|||
162983564|NCT01144364|588642287|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
162983565|NCT01144364|588642288|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
162983566|NCT01144364|588642289|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
162983567|NCT01144364|588642287|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
162983568|NCT01144364|588642288|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
162983569|NCT01144364|588642289|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
162983570|NCT01144364|588642287|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
162983571|NCT01144364|588642288|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
162983572|NCT01144364|588642289|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
162983573|NCT01144364|588642287|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
162983574|NCT01144364|588642288|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
162983575|NCT01144364|588642289|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
162983576|NCT02037165|588642290|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
162983577|NCT02037165|588642291|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
162983578|NCT02037165|588642292|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
162983579|NCT02037165|588642293|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
162983580|NCT02037165|588642294|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
162983581|NCT00673933|588642295|FG000|Overall Study|Withdrawal by Subject|2|||
162983582|NCT00673933|588642295|FG000|Overall Study|Lost to Follow-up|1|||
162983583|NCT04932941|588642296|FG000|Overall Study|Lost to Follow-up|3|||
162983584|NCT04932941|588642297|FG001|Overall Study|Lost to Follow-up|1|||
162983585|NCT04932941|588642296|FG000|Overall Study|Withdrawal by Subject|7|||
162983586|NCT04932941|588642297|FG001|Overall Study|Withdrawal by Subject|4|||
162983587|NCT04932941|588642296|FG000|Overall Study|Other|4|||
162983588|NCT04932941|588642297|FG001|Overall Study|Other|2|||
162983589|NCT02206620|588642298|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
162983590|NCT02206620|588642299|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
162983591|NCT02206620|588642298|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
162983592|NCT02206620|588642299|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
162983593|NCT05816200|588642300|FG000|Overall Study|Lost to Follow-up|2|||
162983594|NCT05816200|588642301|FG001|Overall Study|Lost to Follow-up|1|||
162983595|NCT02394730|588642302|FG000|Overall Study|Lost to Follow-up|1|||
162983596|NCT02394730|588642303|FG001|Overall Study|Lost to Follow-up|0|||
162983597|NCT02394730|588642302|FG000|Overall Study|Withdrawal by Subject|0|||
162983598|NCT02394730|588642303|FG001|Overall Study|Withdrawal by Subject|1|||
162983599|NCT00588640|588642304|FG000|Overall Study|Physician Decision|1|||
162983600|NCT00588640|588642304|FG000|Overall Study|Ineligible Patient|1|||
162983601|NCT01393730|588642305|FG000|Overall Study|Withdrawal by Subject|3|||
162983602|NCT01393730|588642305|FG000|Overall Study|Other|2|||
162983603|NCT01393730|588642305|FG000|Overall Study|Adverse Event|1|||
162983604|NCT03510182|588642310|FG000|Overall Study|Withdrawal by Subject|2|||
162983605|NCT00375492|588642311|FG000|Overall Study|Adverse Event|4|||
162983606|NCT00375492|588642312|FG001|Overall Study|Adverse Event|5|||
162983607|NCT00375492|588642311|FG000|Overall Study|Entry Criteria Not Met|0|||
162983608|NCT00375492|588642312|FG001|Overall Study|Entry Criteria Not Met|1|||
162983609|NCT00375492|588642311|FG000|Overall Study|Loss of Glucose Control|0|||
162983610|NCT00375492|588642312|FG001|Overall Study|Loss of Glucose Control|1|||
162983611|NCT00375492|588642311|FG000|Overall Study|Lost to Follow-up|10|||
162983612|NCT00375492|588642312|FG001|Overall Study|Lost to Follow-up|5|||
162983613|NCT00375492|588642311|FG000|Overall Study|Physician Decision|0|||
162983614|NCT00375492|588642312|FG001|Overall Study|Physician Decision|4|||
162983615|NCT00375492|588642311|FG000|Overall Study|Protocol Violation|6|||
162983616|NCT00375492|588642312|FG001|Overall Study|Protocol Violation|3|||
162983617|NCT00375492|588642311|FG000|Overall Study|Sponsor Decision|0|||
162983618|NCT00375492|588642312|FG001|Overall Study|Sponsor Decision|1|||
162983619|NCT00375492|588642311|FG000|Overall Study|Withdrawal by Subject|6|||
162983620|NCT00375492|588642312|FG001|Overall Study|Withdrawal by Subject|6|||
162983621|NCT03747601|588644006|FG000|Overall Study|COVID halt to visits|4|||
162983622|NCT02221037|588644007|FG000|Overall Study|Physician Decision|0|||
162983623|NCT02221037|588644008|FG001|Overall Study|Physician Decision|0|||
162983624|NCT02221037|588644009|FG002|Overall Study|Physician Decision|1|||
162983625|NCT02221037|588644010|FG003|Overall Study|Physician Decision|0|||
162983626|NCT00609518|588644013|FG000|Overall Study|Death from Study Disease|32|||
162983627|NCT00609518|588644014|FG001|Overall Study|Death from Study Disease|32|||
162983628|NCT00609518|588644013|FG000|Overall Study|Withdrawal by Subject|5|||
162983629|NCT00609518|588644014|FG001|Overall Study|Withdrawal by Subject|3|||
162983630|NCT00609518|588644013|FG000|Overall Study|Lost to Follow-up|3|||
162983631|NCT00609518|588644014|FG001|Overall Study|Lost to Follow-up|0|||
162983632|NCT00609518|588644013|FG000|Overall Study|Physician Decision|1|||
162983633|NCT00609518|588644014|FG001|Overall Study|Physician Decision|3|||
163059694|NCT01648764|588928198|FG006|Overall Study|Progressive Disease|1|||
162983634|NCT00609518|588644013|FG000|Overall Study|Death from Adverse Event|2|||
162983635|NCT00609518|588644014|FG001|Overall Study|Death from Adverse Event|2|||
162983636|NCT00394524|588644015|FG000|Overall Study|Protocol Violation|2|||
162983637|NCT00394524|588644016|FG001|Overall Study|Protocol Violation|3|||
162983638|NCT00394524|588644015|FG000|Overall Study|Death|1|||
162983639|NCT00394524|588644016|FG001|Overall Study|Death|0|||
162983640|NCT00394524|588644015|FG000|Overall Study|Withdrawal by Subject|0|||
163059695|NCT01648764|588928199|FG007|Overall Study|Progressive Disease|0|||
163059696|NCT01648764|588928200|FG008|Overall Study|Progressive Disease|0|||
163059697|NCT01648764|588928201|FG009|Overall Study|Progressive Disease|2|||
163059698|NCT01648764|588928202|FG010|Overall Study|Progressive Disease|0|||
163059699|NCT01648764|588928203|FG011|Overall Study|Progressive Disease|1|||
163059700|NCT01648764|588928204|FG012|Overall Study|Progressive Disease|2|||
163059701|NCT01648764|588928205|FG013|Overall Study|Progressive Disease|1|||
163059702|NCT01648764|588928192|FG000|Overall Study|Adverse Event|0|||
163059703|NCT01648764|588928193|FG001|Overall Study|Adverse Event|0|||
163059704|NCT01648764|588928194|FG002|Overall Study|Adverse Event|0|||
163059705|NCT01648764|588928195|FG003|Overall Study|Adverse Event|0|||
163059706|NCT01648764|588928196|FG004|Overall Study|Adverse Event|0|||
163059707|NCT01648764|588928197|FG005|Overall Study|Adverse Event|1|||
163059708|NCT01648764|588928198|FG006|Overall Study|Adverse Event|0|||
163059709|NCT01648764|588928199|FG007|Overall Study|Adverse Event|0|||
163059710|NCT01648764|588928200|FG008|Overall Study|Adverse Event|0|||
163059711|NCT01648764|588928201|FG009|Overall Study|Adverse Event|1|||
163059712|NCT01648764|588928202|FG010|Overall Study|Adverse Event|0|||
163059713|NCT01648764|588928203|FG011|Overall Study|Adverse Event|3|||
163059714|NCT01648764|588928204|FG012|Overall Study|Adverse Event|1|||
163059715|NCT01648764|588928205|FG013|Overall Study|Adverse Event|1|||
163403264|NCT03715153|590187149|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
162983641|NCT00394524|588644016|FG001|Overall Study|Withdrawal by Subject|1|||
162983642|NCT03827564|588644017|FG000|Overall Study|Discontinued due to Study Termination|1|||
162983643|NCT03827564|588644018|FG001|Overall Study|Discontinued due to Study Termination|0|||
162983644|NCT02238626|588644019|FG000|Overall Study|Adverse Event|3|||
162983645|NCT02238626|588644020|FG001|Overall Study|Adverse Event|5|||
162983646|NCT02238626|588644021|FG002|Overall Study|Adverse Event|0|||
162983647|NCT02238626|588644022|FG003|Overall Study|Adverse Event|3|||
162983648|NCT02238626|588644019|FG000|Overall Study|Lost to Follow-up|2|||
162983649|NCT02238626|588644020|FG001|Overall Study|Lost to Follow-up|4|||
162983650|NCT02238626|588644021|FG002|Overall Study|Lost to Follow-up|2|||
162983651|NCT02238626|588644022|FG003|Overall Study|Lost to Follow-up|2|||
162983652|NCT02238626|588644019|FG000|Overall Study|Withdrawal by Subject|0|||
162983653|NCT02238626|588644020|FG001|Overall Study|Withdrawal by Subject|3|||
162983654|NCT02238626|588644021|FG002|Overall Study|Withdrawal by Subject|0|||
162983655|NCT02238626|588644022|FG003|Overall Study|Withdrawal by Subject|1|||
162983656|NCT02238626|588644019|FG000|Overall Study|Death|0|||
162983657|NCT02238626|588644020|FG001|Overall Study|Death|0|||
162983658|NCT02238626|588644021|FG002|Overall Study|Death|1|||
162983659|NCT02238626|588644022|FG003|Overall Study|Death|1|||
162983660|NCT02238626|588644019|FG000|Overall Study|Other|0|||
162983661|NCT02238626|588644020|FG001|Overall Study|Other|2|||
162983662|NCT02238626|588644021|FG002|Overall Study|Other|0|||
162983663|NCT02238626|588644022|FG003|Overall Study|Other|0|||
162983664|NCT02621034|588644023|FG000|Overall Study|Lost to Follow-up|3|||
162983665|NCT02621034|588644024|FG001|Overall Study|Lost to Follow-up|2|||
162983666|NCT02621034|588644025|FG002|Overall Study|Lost to Follow-up|5|||
162983667|NCT01959035|588644033|FG000|Overall Study|Adverse Event|5|||
162983668|NCT01959035|588644033|FG000|Overall Study|Withdrawal by Subject|4|||
162983669|NCT01959035|588644033|FG000|Overall Study|Lost to Follow-up|1|||
162983670|NCT01959035|588644033|FG000|Overall Study|Other (no primary reason given)|1|||
162983671|NCT00450619|588644034|FG000|Overall Study|refused treatment after randomization|2|||
162983672|NCT00450619|588644035|FG001|Overall Study|refused treatment after randomization|0|||
162983673|NCT00450619|588644034|FG000|Overall Study|did not progress; refused further trmt|1|||
162983674|NCT00450619|588644035|FG001|Overall Study|did not progress; refused further trmt|1|||
163059716|NCT01648764|588928192|FG000|Overall Study|Death|0|||
163059717|NCT01648764|588928193|FG001|Overall Study|Death|0|||
163059718|NCT01648764|588928194|FG002|Overall Study|Death|0|||
163059719|NCT01648764|588928195|FG003|Overall Study|Death|0|||
163059720|NCT01648764|588928196|FG004|Overall Study|Death|0|||
163059721|NCT01648764|588928197|FG005|Overall Study|Death|0|||
163059722|NCT01648764|588928198|FG006|Overall Study|Death|1|||
163059723|NCT01648764|588928199|FG007|Overall Study|Death|0|||
163059724|NCT01648764|588928200|FG008|Overall Study|Death|0|||
163059725|NCT01648764|588928201|FG009|Overall Study|Death|0|||
162983675|NCT00450619|588644034|FG000|Overall Study|Adverse Event|1|||
162983676|NCT00450619|588644035|FG001|Overall Study|Adverse Event|0|||
163059726|NCT01648764|588928202|FG010|Overall Study|Death|0|||
163059727|NCT01648764|588928203|FG011|Overall Study|Death|0|||
163059728|NCT01648764|588928204|FG012|Overall Study|Death|0|||
162983677|NCT03254602|588644036|FG000|Overall Study|Lost to Follow-up|4|||
162983678|NCT02963311|588644039|FG000|Overall Study|Withdrawal by Subject|1|||
162983679|NCT02963311|588644039|FG000|Overall Study|Screen Failure|4|||
162983680|NCT01691820|588644040|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
163059729|NCT01648764|588928205|FG013|Overall Study|Death|1|||
163059730|NCT01648764|588928192|FG000|Overall Study|Withdrawal by Subject|0|||
163059731|NCT01648764|588928193|FG001|Overall Study|Withdrawal by Subject|0|||
163059732|NCT01648764|588928194|FG002|Overall Study|Withdrawal by Subject|0|||
163059733|NCT01648764|588928195|FG003|Overall Study|Withdrawal by Subject|0|||
162983681|NCT01691820|588644041|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
162983682|NCT01691820|588644040|FG000|Overall Study|Migrated/moved from study area|7|||
163322430|NCT04165213|589893828|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
163322431|NCT04165213|589893829|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
163322432|NCT04165213|589893828|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
163322433|NCT04165213|589893829|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
163322434|NCT04165213|589893828|FG000|Clinician Enrollment|Termination from site|0|||
163322435|NCT04165213|589893829|FG001|Clinician Enrollment|Termination from site|1|||
163322436|NCT04165213|589893828|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
162983683|NCT01691820|588644041|FG001|Overall Study|Migrated/moved from study area|4|||
162983684|NCT01691820|588644040|FG000|Overall Study|Lost to Follow-up|6|||
162983685|NCT01691820|588644041|FG001|Overall Study|Lost to Follow-up|17|||
162983686|NCT01691820|588644040|FG000|Overall Study|Other (unspecified)|4|||
162983687|NCT01691820|588644041|FG001|Overall Study|Other (unspecified)|1|||
162983688|NCT04442490|588644044|FG000|Overall Study|Withdrawal by Subject|18|||
162983689|NCT04442490|588644045|FG001|Overall Study|Withdrawal by Subject|10|||
162983690|NCT04442490|588644044|FG000|Overall Study|Lost to Follow-up|7|||
162983691|NCT04442490|588644045|FG001|Overall Study|Lost to Follow-up|7|||
162983692|NCT04442490|588644044|FG000|Overall Study|Adverse Event|2|||
162983693|NCT04442490|588644045|FG001|Overall Study|Adverse Event|6|||
162983694|NCT04442490|588644044|FG000|Overall Study|Noncompliance|3|||
162983695|NCT04442490|588644045|FG001|Overall Study|Noncompliance|1|||
162983696|NCT04442490|588644044|FG000|Overall Study|Physician Decision|2|||
162983697|NCT04442490|588644045|FG001|Overall Study|Physician Decision|1|||
162983698|NCT04442490|588644044|FG000|Overall Study|Reason not Specified|2|||
162983699|NCT04442490|588644045|FG001|Overall Study|Reason not Specified|1|||
162983700|NCT04442490|588644044|FG000|Overall Study|Randomized but not Treated|3|||
162983701|NCT04442490|588644045|FG001|Overall Study|Randomized but not Treated|3|||
162983702|NCT01968694|588644047|FG000|Washout (1 Month)|Lost to Follow-up|0|||
162983703|NCT01968694|588644048|FG001|Washout (1 Month)|Lost to Follow-up|1|||
162983704|NCT02836496|588644049|FG000|Overall Study|Adverse Event|2|||
162983705|NCT02836496|588644050|FG001|Overall Study|Adverse Event|1|||
162983706|NCT02836496|588644049|FG000|Overall Study|Withdrawal by Subject|0|||
162983707|NCT02836496|588644050|FG001|Overall Study|Withdrawal by Subject|1|||
162983708|NCT01400919|588644051|FG000|Overall Study|Withdrawal by Subject|4|||
162983709|NCT01400919|588644051|FG000|Overall Study|Lost to Follow-up|2|||
162983710|NCT01400919|588644051|FG000|Overall Study|Missed visit|2|||
162983711|NCT01246011|588644052|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
162983712|NCT01246011|588644053|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
162983713|NCT01246011|588644054|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
162983714|NCT01246011|588644052|FG000|Overall Study|Withdrawal by Subject|0|||
162983715|NCT01246011|588644053|FG001|Overall Study|Withdrawal by Subject|0|||
162983716|NCT01246011|588644054|FG002|Overall Study|Withdrawal by Subject|1|||
162983717|NCT00415194|588644058|FG000|Overall Study|Adverse Event|37|||
162983718|NCT00415194|588644059|FG001|Overall Study|Adverse Event|32|||
162983719|NCT00415194|588644058|FG000|Overall Study|Entry Criteria Not Met|4|||
162983720|NCT00415194|588644059|FG001|Overall Study|Entry Criteria Not Met|8|||
162983721|NCT00415194|588644058|FG000|Overall Study|Lost to Follow-up|1|||
162983722|NCT00415194|588644059|FG001|Overall Study|Lost to Follow-up|0|||
162983723|NCT00415194|588644058|FG000|Overall Study|Physician Decision|10|||
162983724|NCT00415194|588644059|FG001|Overall Study|Physician Decision|16|||
162983725|NCT00415194|588644058|FG000|Overall Study|Progressive Disease|180|||
162983726|NCT00415194|588644059|FG001|Overall Study|Progressive Disease|217|||
162983727|NCT00415194|588644058|FG000|Overall Study|Protocol Violation|4|||
162983728|NCT00415194|588644059|FG001|Overall Study|Protocol Violation|2|||
162983729|NCT00415194|588644058|FG000|Overall Study|Withdrawal by Subject|28|||
162983730|NCT00415194|588644059|FG001|Overall Study|Withdrawal by Subject|21|||
162983731|NCT00415194|588644058|FG000|Overall Study|Death Due to Study Disease|26|||
162983732|NCT00415194|588644059|FG001|Overall Study|Death Due to Study Disease|29|||
162983733|NCT00415194|588644058|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
162983734|NCT00415194|588644059|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
162983735|NCT00415194|588644058|FG000|Overall Study|Death Due to Procedural Related AE|0|||
162983736|NCT00415194|588644059|FG001|Overall Study|Death Due to Procedural Related AE|1|||
162983737|NCT00415194|588644058|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
162983738|NCT00415194|588644059|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
162983739|NCT01297465|588644060|FG000|Overall Study|Lack of Ovarian Response|1|||
162983740|NCT01297465|588644061|FG001|Overall Study|Lack of Ovarian Response|1|||
162983741|NCT01297465|588644060|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
162983742|NCT01297465|588644061|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
162983743|NCT01297465|588644060|FG000|Overall Study|No Oocytes Retrieved|1|||
162983744|NCT01297465|588644061|FG001|Overall Study|No Oocytes Retrieved|1|||
162983745|NCT01297465|588644060|FG000|Overall Study|Poor oocyte quality|0|||
162983746|NCT01297465|588644061|FG001|Overall Study|Poor oocyte quality|1|||
162983747|NCT01297465|588644060|FG000|Overall Study|No Fertilization|6|||
162983748|NCT01297465|588644061|FG001|Overall Study|No Fertilization|4|||
163059734|NCT01648764|588928196|FG004|Overall Study|Withdrawal by Subject|0|||
163059735|NCT01648764|588928197|FG005|Overall Study|Withdrawal by Subject|0|||
162983749|NCT01297465|588644060|FG000|Overall Study|All Embryos Discarded|0|||
162983750|NCT01297465|588644061|FG001|Overall Study|All Embryos Discarded|1|||
162983751|NCT01297465|588644060|FG000|Overall Study|Intention to Freeze all Embryos|0|||
162983752|NCT01297465|588644061|FG001|Overall Study|Intention to Freeze all Embryos|1|||
162983753|NCT00969540|588644062|FG000|Overall Study|Lost to Follow-up|1|||
162983754|NCT00969540|588644063|FG001|Overall Study|Lost to Follow-up|1|||
163059736|NCT01648764|588928198|FG006|Overall Study|Withdrawal by Subject|2|||
163059737|NCT01648764|588928199|FG007|Overall Study|Withdrawal by Subject|0|||
162983755|NCT01683838|588644064|FG000|Overall Study|Adverse Event|12|||
162983756|NCT01683838|588644065|FG001|Overall Study|Adverse Event|2|||
162983757|NCT01683838|588644064|FG000|Overall Study|Protocol Violation|3|||
162983758|NCT01683838|588644065|FG001|Overall Study|Protocol Violation|1|||
162983759|NCT01683838|588644064|FG000|Overall Study|Withdrawal by Subject|6|||
162983760|NCT01683838|588644065|FG001|Overall Study|Withdrawal by Subject|5|||
162983761|NCT01683838|588644064|FG000|Overall Study|Lost to Follow-up|1|||
162983762|NCT01683838|588644065|FG001|Overall Study|Lost to Follow-up|1|||
162983763|NCT01683838|588644064|FG000|Overall Study|Other|4|||
162983764|NCT01683838|588644065|FG001|Overall Study|Other|3|||
162983765|NCT01646138|588644066|FG000|Overall Study|Lost to Follow-up|0|||
162983766|NCT01646138|588644067|FG001|Overall Study|Lost to Follow-up|0|||
162983767|NCT01646138|588644068|FG002|Overall Study|Lost to Follow-up|0|||
162983768|NCT01646138|588644069|FG003|Overall Study|Lost to Follow-up|0|||
162983769|NCT01646138|588644070|FG004|Overall Study|Lost to Follow-up|2|||
162983770|NCT01524679|588644071|FG000|Overall Study|Lost to Follow-up|1|||
162983771|NCT01524679|588644072|FG001|Overall Study|Lost to Follow-up|4|||
162983772|NCT01524679|588644071|FG000|Overall Study|Withdrawal by Subject|4|||
162983773|NCT01524679|588644072|FG001|Overall Study|Withdrawal by Subject|4|||
162983774|NCT01524679|588644071|FG000|Overall Study|Adverse Event|9|||
162983775|NCT01524679|588644072|FG001|Overall Study|Adverse Event|0|||
162983776|NCT01524679|588644071|FG000|Overall Study|Protocol Violation|1|||
162983777|NCT01524679|588644072|FG001|Overall Study|Protocol Violation|0|||
162983778|NCT01524679|588644071|FG000|Overall Study|Lack of Efficacy|2|||
162983779|NCT01524679|588644072|FG001|Overall Study|Lack of Efficacy|0|||
162983780|NCT01524679|588644071|FG000|Overall Study|e.g.wish for children, relocation|6|||
162983781|NCT01524679|588644072|FG001|Overall Study|e.g.wish for children, relocation|1|||
162983782|NCT00801099|588644073|FG000|Overall Study|Lost to Follow-up|101|||
162983783|NCT04078126|588644076|FG000|Washout|Study put on hold due to COVID-19|0|||
162983784|NCT04078126|588644077|FG001|Washout|Study put on hold due to COVID-19|2|||
162983785|NCT04078126|588644076|FG000|Period 2|Study put on hold due to COVID-19|1|||
162983786|NCT04078126|588644077|FG001|Period 2|Study put on hold due to COVID-19|1|||
162983787|NCT03321630|588644080|FG000|Overall Study|Adverse Event|1|||
162983788|NCT03321630|588644080|FG000|Overall Study|Investigator Discretion|2|||
162983789|NCT03321630|588644080|FG000|Overall Study|Withdrawal by Subject|1|||
162983790|NCT00140426|588644081|FG000|Overall Study|Withdrawal by Subject|0|||
162983791|NCT00140426|588644082|FG001|Overall Study|Withdrawal by Subject|3|||
162983792|NCT02149108|588644083|FG000|Overall Study|Not treated|1|||
162983793|NCT02149108|588644084|FG001|Overall Study|Not treated|2|||
162983794|NCT02149108|588644083|FG000|Overall Study|Progressive Disease (PD)|324|||
162983795|NCT02149108|588644084|FG001|Overall Study|Progressive Disease (PD)|318|||
162983796|NCT02149108|588644083|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
162983797|NCT02149108|588644084|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
162983798|NCT02149108|588644083|FG000|Overall Study|Other Adverse Event (AE)|8|||
162983799|NCT02149108|588644084|FG001|Overall Study|Other Adverse Event (AE)|18|||
162983800|NCT02149108|588644083|FG000|Overall Study|Other not defined above|0|||
162983801|NCT02149108|588644084|FG001|Overall Study|Other not defined above|2|||
162983802|NCT02149108|588644083|FG000|Overall Study|Refusal to continue trial medication|15|||
163059738|NCT01648764|588928200|FG008|Overall Study|Withdrawal by Subject|0|||
163059739|NCT01648764|588928201|FG009|Overall Study|Withdrawal by Subject|0|||
163059740|NCT01648764|588928202|FG010|Overall Study|Withdrawal by Subject|0|||
163322437|NCT04165213|589893829|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
162983803|NCT02149108|588644084|FG001|Overall Study|Refusal to continue trial medication|11|||
162983804|NCT02149108|588644083|FG000|Overall Study|Lost to Follow-up|1|||
162983805|NCT02149108|588644084|FG001|Overall Study|Lost to Follow-up|0|||
162983806|NCT00950963|588644085|FG000|Overall Study|Lost to Follow-up|29|||
162983807|NCT00950963|588644086|FG001|Overall Study|Lost to Follow-up|24|||
162983808|NCT04168190|588644087|FG000|Overall Study|Lost to Follow-up|0|||
162983809|NCT04168190|588644088|FG001|Overall Study|Lost to Follow-up|1|||
162983810|NCT04168190|588644089|FG002|Overall Study|Lost to Follow-up|0|||
162983811|NCT04168190|588644090|FG003|Overall Study|Lost to Follow-up|7|||
162983812|NCT04168190|588644091|FG004|Overall Study|Lost to Follow-up|5|||
162983813|NCT04168190|588644087|FG000|Overall Study|Withdrawal by Subject|1|||
162983814|NCT04168190|588644088|FG001|Overall Study|Withdrawal by Subject|0|||
162983815|NCT04168190|588644089|FG002|Overall Study|Withdrawal by Subject|0|||
162983816|NCT04168190|588644090|FG003|Overall Study|Withdrawal by Subject|2|||
162983817|NCT04168190|588644091|FG004|Overall Study|Withdrawal by Subject|4|||
162983818|NCT04168190|588644087|FG000|Overall Study|Death|0|||
162983819|NCT04168190|588644088|FG001|Overall Study|Death|0|||
162983820|NCT04168190|588644089|FG002|Overall Study|Death|0|||
162983821|NCT04168190|588644090|FG003|Overall Study|Death|1|||
162983822|NCT04168190|588644091|FG004|Overall Study|Death|0|||
162983823|NCT02325518|588644092|FG000|Overall Study|Adverse Event|4|||
162983824|NCT02325518|588644093|FG001|Overall Study|Adverse Event|1|||
162983825|NCT02325518|588644092|FG000|Overall Study|Physician Decision|0|||
162983826|NCT02325518|588644093|FG001|Overall Study|Physician Decision|1|||
162983827|NCT02325518|588644092|FG000|Overall Study|Withdrawal by Subject|0|||
162983828|NCT02325518|588644093|FG001|Overall Study|Withdrawal by Subject|1|||
162983829|NCT01675661|588644094|FG000|Overall Study|Lost to Follow-up|22|||
162983830|NCT01675661|588644095|FG001|Overall Study|Lost to Follow-up|23|||
162983831|NCT01675661|588644094|FG000|Overall Study|Practical problems|9|||
162983832|NCT01675661|588644095|FG001|Overall Study|Practical problems|5|||
162983833|NCT01675661|588644094|FG000|Overall Study|Moved away|5|||
162983834|NCT01675661|588644095|FG001|Overall Study|Moved away|6|||
162983835|NCT01675661|588644094|FG000|Overall Study|Withdrawal by Subject|3|||
162983836|NCT01675661|588644095|FG001|Overall Study|Withdrawal by Subject|7|||
162983837|NCT01675661|588644094|FG000|Overall Study|Physician Decision|0|||
162983838|NCT01675661|588644095|FG001|Overall Study|Physician Decision|2|||
162983839|NCT01675661|588644094|FG000|Overall Study|Death|0|||
162983840|NCT01675661|588644095|FG001|Overall Study|Death|1|||
162983841|NCT01675661|588644094|FG000|Overall Study|Other reason|1|||
162983842|NCT01675661|588644095|FG001|Overall Study|Other reason|2|||
162983843|NCT04765384|588644096|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
162983844|NCT04765384|588644097|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
162983845|NCT04765384|588644098|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
162983846|NCT04765384|588644099|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
162983847|NCT04765384|588644100|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
162983848|NCT04765384|588644101|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
162983849|NCT04765384|588644096|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
162983850|NCT04765384|588644097|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
162983851|NCT04765384|588644098|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
162983852|NCT04765384|588644099|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
162983853|NCT04765384|588644100|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
162983854|NCT04765384|588644101|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
162983855|NCT04765384|588644096|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
162983856|NCT04765384|588644097|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
162983857|NCT04765384|588644098|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
162983858|NCT04765384|588644099|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
162983859|NCT04765384|588644100|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
162983860|NCT04765384|588644101|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
162983861|NCT04765384|588644096|FG000|Post-natal: Neonates and Infants|Death|0|||
162983862|NCT04765384|588644097|FG001|Post-natal: Neonates and Infants|Death|0|||
162983863|NCT04765384|588644098|FG002|Post-natal: Neonates and Infants|Death|0|||
162983864|NCT04765384|588644099|FG003|Post-natal: Neonates and Infants|Death|1|||
162983865|NCT04765384|588644100|FG004|Post-natal: Neonates and Infants|Death|0|||
162983866|NCT04765384|588644101|FG005|Post-natal: Neonates and Infants|Death|0|||
162983867|NCT04765384|588644096|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
162983868|NCT04765384|588644097|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
162983869|NCT04765384|588644098|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
162983870|NCT04765384|588644099|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
162983871|NCT04765384|588644100|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
162983872|NCT04765384|588644101|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
162983873|NCT00987389|588644102|FG000|Overall Study|Ineligible|0|||
162983874|NCT00987389|588644103|FG001|Overall Study|Ineligible|3|||
162983875|NCT00987389|588644104|FG002|Overall Study|Ineligible|0|||
162983876|NCT00987389|588644105|FG003|Overall Study|Ineligible|0|||
162983877|NCT00987389|588644102|FG000|Overall Study|Lost to Follow-up|4|||
162983878|NCT00987389|588644103|FG001|Overall Study|Lost to Follow-up|1|||
162983879|NCT00987389|588644104|FG002|Overall Study|Lost to Follow-up|3|||
162983880|NCT00987389|588644105|FG003|Overall Study|Lost to Follow-up|1|||
162983881|NCT00987389|588644102|FG000|Overall Study|Withdrawal by Subject|4|||
162983882|NCT00987389|588644103|FG001|Overall Study|Withdrawal by Subject|3|||
163211951|NCT01905657|589490671|FG000|Overall Study|Physician Decision|5|||
162983883|NCT00987389|588644104|FG002|Overall Study|Withdrawal by Subject|2|||
162983884|NCT00987389|588644105|FG003|Overall Study|Withdrawal by Subject|1|||
162983885|NCT00987389|588644102|FG000|Overall Study|Withdrawn from Treatment|0|||
162983886|NCT00987389|588644103|FG001|Overall Study|Withdrawn from Treatment|1|||
162983887|NCT00987389|588644104|FG002|Overall Study|Withdrawn from Treatment|0|||
162983888|NCT00987389|588644105|FG003|Overall Study|Withdrawn from Treatment|0|||
163211952|NCT01905657|589490672|FG001|Overall Study|Physician Decision|8|||
162983889|NCT00987389|588644102|FG000|Overall Study|Multiple different reasons|1|||
163211953|NCT01905657|589490673|FG002|Overall Study|Physician Decision|12|||
163211954|NCT01905657|589490671|FG000|Overall Study|Protocol Violation|2|||
162983890|NCT00987389|588644103|FG001|Overall Study|Multiple different reasons|0|||
162983891|NCT00987389|588644104|FG002|Overall Study|Multiple different reasons|3|||
162983892|NCT00987389|588644105|FG003|Overall Study|Multiple different reasons|1|||
162983893|NCT02992418|588644108|FG000|Overall Study|Withdrawal by Subject|11|||
162983894|NCT02992418|588644109|FG001|Overall Study|Withdrawal by Subject|12|||
162983895|NCT02992418|588644108|FG000|Overall Study|Non-compliance with the protocol|308|||
162983896|NCT02992418|588644109|FG001|Overall Study|Non-compliance with the protocol|308|||
162983897|NCT02992418|588644108|FG000|Overall Study|Lost to Follow-up|27|||
162983898|NCT02992418|588644109|FG001|Overall Study|Lost to Follow-up|22|||
162983899|NCT00289536|588644110|FG000|Period 3|Lost to Follow-up|0|||
162983900|NCT00289536|588644111|FG001|Period 3|Lost to Follow-up|0|||
162983901|NCT00289536|588644112|FG002|Period 3|Lost to Follow-up|1|||
162983902|NCT03246126|588644113|FG000|Overall Study|Withdrawal by Subject|0|||
162983903|NCT03246126|588644114|FG001|Overall Study|Withdrawal by Subject|1|||
162983904|NCT01006135|588644117|FG000|Overall Study|Adverse Event|22|||
162983905|NCT01006135|588644117|FG000|Overall Study|Protocol Violation|14|||
162983906|NCT01006135|588644117|FG000|Overall Study|Lost to Follow-up|32|||
162983907|NCT01006135|588644117|FG000|Overall Study|Other|72|||
162983908|NCT05297578|588644118|FG000|Overall Study|Lost to Follow-up|1|||
162983909|NCT05297578|588644119|FG001|Overall Study|Lost to Follow-up|1|||
162983910|NCT05297578|588644120|FG002|Overall Study|Lost to Follow-up|2|||
162983911|NCT05297578|588644121|FG003|Overall Study|Lost to Follow-up|1|||
162983912|NCT05297578|588644118|FG000|Overall Study|Death|0|||
162983913|NCT05297578|588644119|FG001|Overall Study|Death|1|||
162983914|NCT05297578|588644120|FG002|Overall Study|Death|0|||
162983915|NCT05297578|588644121|FG003|Overall Study|Death|0|||
162983916|NCT05297578|588644118|FG000|Overall Study|Withdrawal by Subject|0|||
162983917|NCT05297578|588644119|FG001|Overall Study|Withdrawal by Subject|0|||
162983918|NCT05297578|588644120|FG002|Overall Study|Withdrawal by Subject|1|||
162983919|NCT05297578|588644121|FG003|Overall Study|Withdrawal by Subject|0|||
162983920|NCT03127644|588644122|FG000|Overall Study|Study-specific withdrawal criteria|0|||
162983921|NCT03127644|588644123|FG001|Overall Study|Study-specific withdrawal criteria|0|||
162983922|NCT03127644|588644124|FG002|Overall Study|Study-specific withdrawal criteria|2|||
162983923|NCT02032706|588644127|FG000|Overall Study|Did not qualify|5|||
162983924|NCT02032706|588644127|FG000|Overall Study|Protocol Violation|1|||
162983925|NCT01156142|588644128|FG000|Overall Study|Withdrawal by Subject|8|||
162983926|NCT01156142|588644129|FG001|Overall Study|Withdrawal by Subject|6|||
162983927|NCT01156142|588644128|FG000|Overall Study|Ineligible|0|||
162983928|NCT01156142|588644129|FG001|Overall Study|Ineligible|1|||
162983929|NCT00893737|588644130|FG000|Overall Study|Adverse Event|4|||
162983930|NCT00893737|588644130|FG000|Overall Study|Withdrawal by Subject|2|||
162983931|NCT00893737|588644130|FG000|Overall Study|Lost to Follow-up|6|||
162983932|NCT00928707|588644131|FG000|Overall Study|Protocol Violation|1|||
162983933|NCT00928707|588644132|FG001|Overall Study|Protocol Violation|0|||
162983934|NCT00132028|588644133|FG000|Overall Study|Adverse Event|7|||
162983935|NCT00132028|588644133|FG000|Overall Study|Death|2|||
162983936|NCT00132028|588644133|FG000|Overall Study|Lack of Efficacy|11|||
162983937|NCT00132028|588644133|FG000|Overall Study|Withdrawal by Subject|2|||
162983938|NCT00132028|588644133|FG000|Overall Study|not eligible|2|||
162983939|NCT00132028|588644133|FG000|Overall Study|Physician Decision|3|||
162983940|NCT02140411|588644134|FG000|Overall Study|Adverse Event|1|||
162983941|NCT03981419|588644137|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
162983942|NCT03981419|588644138|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
162983943|NCT01330459|588644139|FG000|Overall Study|Physician Decision|0|||
162983944|NCT01330459|588644140|FG001|Overall Study|Physician Decision|2|||
162983945|NCT02272634|588644148|FG000|Overall Study|Adverse Event|1|||
162983946|NCT02272634|588644149|FG001|Overall Study|Adverse Event|0|||
162983947|NCT02272634|588644150|FG002|Overall Study|Adverse Event|0|||
162983948|NCT02272634|588644148|FG000|Overall Study|Protocol Violation|0|||
162983949|NCT02272634|588644149|FG001|Overall Study|Protocol Violation|0|||
162983950|NCT02272634|588644150|FG002|Overall Study|Protocol Violation|1|||
162983951|NCT02272634|588644148|FG000|Overall Study|Withdrawal by Subject|0|||
162983952|NCT02272634|588644149|FG001|Overall Study|Withdrawal by Subject|1|||
162983953|NCT02272634|588644150|FG002|Overall Study|Withdrawal by Subject|0|||
162983954|NCT01437943|588644151|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
162983955|NCT01437943|588644152|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
162983956|NCT01437943|588644151|FG000|Overall Study|Subject expressed pregnancy plans|1|||
162983957|NCT01437943|588644152|FG001|Overall Study|Subject expressed pregnancy plans|0|||
162983958|NCT01437943|588644151|FG000|Overall Study|Adverse Event|2|||
162983959|NCT01437943|588644152|FG001|Overall Study|Adverse Event|0|||
162983960|NCT04647721|588644153|FG000|Overall Study|Withdrawal by Subject|0|||
162983961|NCT04647721|588644154|FG001|Overall Study|Withdrawal by Subject|2|||
162983962|NCT04647721|588644153|FG000|Overall Study|Lost to Follow-up|2|||
162983963|NCT04647721|588644154|FG001|Overall Study|Lost to Follow-up|0|||
162983964|NCT01974440|588644157|FG000|Overall Study|Lost to Follow-up|7|||
162983965|NCT01974440|588644158|FG001|Overall Study|Lost to Follow-up|7|||
162983966|NCT01974440|588644157|FG000|Overall Study|Withdrawal by Subject|24|||
162983967|NCT01974440|588644158|FG001|Overall Study|Withdrawal by Subject|20|||
163322438|NCT04165213|589893828|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
162983968|NCT01974440|588644157|FG000|Overall Study|Sponsor decision|109|||
162983969|NCT01974440|588644158|FG001|Overall Study|Sponsor decision|110|||
162983970|NCT00136318|588644159|FG000|Overall Study|Adverse Event|5|||
162983971|NCT00136318|588644160|FG001|Overall Study|Adverse Event|5|||
162983972|NCT00136318|588644159|FG000|Overall Study|Withdrawal by Subject|2|||
162983973|NCT00136318|588644160|FG001|Overall Study|Withdrawal by Subject|2|||
162983974|NCT02005887|588644161|FG000|Overall Study|Protocol Violation|0|||
162983975|NCT02005887|588644162|FG001|Overall Study|Protocol Violation|2|||
162983976|NCT02749292|588644164|FG000|Overall Study|Physician Decision|1|||
163322439|NCT04165213|589893829|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
163322440|NCT04165213|589893828|FG000|Caregiver Enrollment|Physician Decision|1|||
163322441|NCT04165213|589893829|FG001|Caregiver Enrollment|Physician Decision|0|||
163322442|NCT04165213|589893828|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
163322443|NCT04165213|589893829|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
163322444|NCT04165213|589893828|FG000|Caregiver Enrollment|PLWD death|2|||
163322445|NCT04165213|589893829|FG001|Caregiver Enrollment|PLWD death|0|||
163322446|NCT04165213|589893828|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
163322447|NCT04165213|589893829|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
162983977|NCT02749292|588644165|FG001|Overall Study|Physician Decision|0|||
162983978|NCT02749292|588644164|FG000|Overall Study|Withdrawal by Subject|5|||
162983979|NCT02749292|588644165|FG001|Overall Study|Withdrawal by Subject|7|||
162983980|NCT02749292|588644164|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
162983981|NCT02749292|588644165|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
162983982|NCT02749292|588644164|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
162983983|NCT02749292|588644165|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
162983984|NCT02749292|588644164|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
162983985|NCT02749292|588644165|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
162983986|NCT02749292|588644164|FG000|Overall Study|Adverse Event|4|||
162983987|NCT02749292|588644165|FG001|Overall Study|Adverse Event|1|||
162983988|NCT02749292|588644164|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
162983989|NCT02749292|588644165|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
162983990|NCT02749292|588644164|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
162983991|NCT02749292|588644165|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
162983992|NCT02749292|588644164|FG000|Overall Study|Requiring glucocorticoids|0|||
162983993|NCT02749292|588644165|FG001|Overall Study|Requiring glucocorticoids|3|||
162983994|NCT02749292|588644164|FG000|Overall Study|Cancer|1|||
162983995|NCT02749292|588644165|FG001|Overall Study|Cancer|0|||
162983996|NCT00251641|588644166|FG000|Overall Study|Adverse Event|80|||
162983997|NCT00251641|588644167|FG001|Overall Study|Adverse Event|8|||
162983998|NCT00251641|588644166|FG000|Overall Study|Lack of Efficacy|2|||
162983999|NCT00251641|588644167|FG001|Overall Study|Lack of Efficacy|1|||
162984000|NCT00251641|588644166|FG000|Overall Study|Progression of Disease|0|||
162984001|NCT00251641|588644167|FG001|Overall Study|Progression of Disease|2|||
162984002|NCT00251641|588644166|FG000|Overall Study|Lost to Follow-up|3|||
162984003|NCT00251641|588644167|FG001|Overall Study|Lost to Follow-up|3|||
162984004|NCT00251641|588644166|FG000|Overall Study|Withdrawal by Subject|6|||
162984005|NCT00251641|588644167|FG001|Overall Study|Withdrawal by Subject|8|||
162984006|NCT00251641|588644166|FG000|Overall Study|Protocol Violation|10|||
162984007|NCT00251641|588644167|FG001|Overall Study|Protocol Violation|2|||
162984008|NCT00251641|588644166|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
162984009|NCT00251641|588644167|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
162984010|NCT00251641|588644166|FG000|Overall Study|Switched Treatment|9|||
162984011|NCT00251641|588644167|FG001|Overall Study|Switched Treatment|63|||
162984012|NCT00876018|588644168|FG000|Overall Study|Lost to Follow-up|0|||
162984013|NCT00876018|588644169|FG001|Overall Study|Lost to Follow-up|1|||
162984014|NCT00876018|588644170|FG002|Overall Study|Lost to Follow-up|1|||
162984015|NCT00876018|588644168|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
162984016|NCT00876018|588644169|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
163322448|NCT04165213|589893828|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
163322449|NCT04165213|589893829|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
163322450|NCT04165213|589893828|FG000|PLWD Enrollment|Lost to Follow-up|1|||
163322451|NCT04165213|589893829|FG001|PLWD Enrollment|Lost to Follow-up|1|||
163322452|NCT04165213|589893828|FG000|PLWD Enrollment|Physician Decision|1|||
163322453|NCT04165213|589893829|FG001|PLWD Enrollment|Physician Decision|0|||
162984017|NCT00876018|588644170|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
162984018|NCT01000493|588644173|FG000|Overall Study|Adverse Event|3|||
162984019|NCT01000493|588644174|FG001|Overall Study|Adverse Event|6|||
162984020|NCT01000493|588644173|FG000|Overall Study|Lack of Efficacy|1|||
162984021|NCT01000493|588644174|FG001|Overall Study|Lack of Efficacy|1|||
162984022|NCT01000493|588644173|FG000|Overall Study|Protocol Violation|1|||
162984023|NCT01000493|588644174|FG001|Overall Study|Protocol Violation|8|||
162984024|NCT01000493|588644173|FG000|Overall Study|Study closed/terminated|25|||
162984025|NCT01000493|588644174|FG001|Overall Study|Study closed/terminated|23|||
162984026|NCT01000493|588644173|FG000|Overall Study|Lost to Follow-up|5|||
162984027|NCT01000493|588644174|FG001|Overall Study|Lost to Follow-up|9|||
162984028|NCT01000493|588644173|FG000|Overall Study|Physician Decision|1|||
162984029|NCT01000493|588644174|FG001|Overall Study|Physician Decision|1|||
162984030|NCT01000493|588644173|FG000|Overall Study|Withdrawal by Subject|3|||
162984031|NCT01000493|588644174|FG001|Overall Study|Withdrawal by Subject|7|||
162984032|NCT03629028|588644175|FG000|Overall Study|Lost to Follow-up|26|||
162984033|NCT03629028|588644176|FG001|Overall Study|Lost to Follow-up|23|||
162984034|NCT03629028|588644175|FG000|Overall Study|Pregnancy|4|||
162984035|NCT03629028|588644176|FG001|Overall Study|Pregnancy|2|||
162984036|NCT03629028|588644175|FG000|Overall Study|intolerance to examination|2|||
162984037|NCT03629028|588644176|FG001|Overall Study|intolerance to examination|0|||
162984038|NCT03828448|588644178|FG000|Overall Study|Sponsor's Discretion|34|||
162984039|NCT02192164|588644182|FG000|Overall Study|Other|8|||
162984040|NCT02192164|588644182|FG000|Overall Study|Withdrawal by Subject|1|||
162984041|NCT02192164|588644182|FG000|Overall Study|Physician Decision|4|||
162984042|NCT02192164|588644182|FG000|Overall Study|Did not meet the exclusion criteria|1|||
162984043|NCT03123861|588644183|FG000|Overall Study|Protocol Violation|1|||
162984044|NCT03123861|588644184|FG001|Overall Study|Protocol Violation|1|||
162984045|NCT03123861|588644183|FG000|Overall Study|Withdrawal by Subject|2|||
162984046|NCT03123861|588644184|FG001|Overall Study|Withdrawal by Subject|2|||
162984047|NCT05011123|588645408|FG000|Overall Study|Withdrawal by Subject|4|||
162984048|NCT05011123|588645409|FG001|Overall Study|Withdrawal by Subject|2|||
162984049|NCT05011123|588645408|FG000|Overall Study|Lost to Follow-up|7|||
162984050|NCT05011123|588645409|FG001|Overall Study|Lost to Follow-up|6|||
162984051|NCT05011123|588645408|FG000|Overall Study|Ongoing at the time of DBL date|36|||
162984052|NCT05011123|588645409|FG001|Overall Study|Ongoing at the time of DBL date|10|||
162984053|NCT05011123|588645408|FG000|Overall Study|Randomized but did not receive vaccination|1|||
162984054|NCT05011123|588645409|FG001|Overall Study|Randomized but did not receive vaccination|0|||
162984055|NCT00461253|588645410|FG000|Overall Study|Death|985|||
162984056|NCT00461253|588645411|FG001|Overall Study|Death|0|||
162984057|NCT00461253|588645410|FG000|Overall Study|Protocol Violation|613|||
162984058|NCT00461253|588645411|FG001|Overall Study|Protocol Violation|236|||
162984059|NCT00461253|588645410|FG000|Overall Study|no response|2609|||
162984060|NCT00461253|588645411|FG001|Overall Study|no response|11789|||
162984061|NCT00461253|588645410|FG000|Overall Study|administrative|773|||
162984062|NCT00461253|588645411|FG001|Overall Study|administrative|7773|||
162984063|NCT01933113|588645412|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
162984064|NCT02297438|588645413|FG000|Overall Study|Death|79|||
162984065|NCT02297438|588645414|FG001|Overall Study|Death|86|||
162984066|NCT02297438|588645413|FG000|Overall Study|Lost to Follow-up|9|||
162984067|NCT02297438|588645414|FG001|Overall Study|Lost to Follow-up|7|||
162984068|NCT02297438|588645413|FG000|Overall Study|Withdrawal by Subject|7|||
162984069|NCT02297438|588645414|FG001|Overall Study|Withdrawal by Subject|0|||
162984070|NCT02297438|588645413|FG000|Overall Study|Other|9|||
162984071|NCT02297438|588645414|FG001|Overall Study|Other|5|||
162984072|NCT02297438|588645413|FG000|Overall Study|Ongoing|65|||
162984073|NCT02297438|588645414|FG001|Overall Study|Ongoing|73|||
162984074|NCT00321828|588645415|FG000|Overall Study|Ineligible|3|||
162984075|NCT00321828|588645415|FG000|Overall Study|No follow up data|1|||
162984076|NCT00678041|588645427|FG000|Overall Study|Physician Decision|5|||
162984077|NCT00678041|588645428|FG001|Overall Study|Physician Decision|5|||
162984078|NCT02358343|588645429|FG000|Screening Intervention|Death|0|||
162984079|NCT02358343|588645430|FG001|Screening Intervention|Death|2|||
163059741|NCT01648764|588928203|FG011|Overall Study|Withdrawal by Subject|0|||
163059742|NCT01648764|588928204|FG012|Overall Study|Withdrawal by Subject|1|||
163059743|NCT01648764|588928205|FG013|Overall Study|Withdrawal by Subject|0|||
163059744|NCT01648764|588928192|FG000|Overall Study|Investigator Decision|0|||
163059745|NCT01648764|588928193|FG001|Overall Study|Investigator Decision|0|||
163059746|NCT01648764|588928194|FG002|Overall Study|Investigator Decision|0|||
162984080|NCT02358343|588645431|FG002|Screening Intervention|Death|0|||
162984081|NCT02358343|588645432|FG003|Screening Intervention|Death|0|||
162984082|NCT02358343|588645433|FG004|Screening Intervention|Death|0|||
162984083|NCT02358343|588645429|FG000|Screening Intervention|Withdrawal by Subject|1|||
162984084|NCT02358343|588645430|FG001|Screening Intervention|Withdrawal by Subject|0|||
163059747|NCT01648764|588928195|FG003|Overall Study|Investigator Decision|0|||
163059748|NCT01648764|588928196|FG004|Overall Study|Investigator Decision|0|||
163211955|NCT01905657|589490672|FG001|Overall Study|Protocol Violation|1|||
163211956|NCT01905657|589490673|FG002|Overall Study|Protocol Violation|1|||
163211957|NCT01905657|589490671|FG000|Overall Study|Screen Failure|0|||
163211958|NCT01905657|589490672|FG001|Overall Study|Screen Failure|1|||
163211959|NCT01905657|589490673|FG002|Overall Study|Screen Failure|0|||
163211960|NCT01905657|589490671|FG000|Overall Study|Withdrawal by Subject|15|||
163211961|NCT01905657|589490672|FG001|Overall Study|Withdrawal by Subject|21|||
163211962|NCT01905657|589490673|FG002|Overall Study|Withdrawal by Subject|53|||
163211963|NCT01905657|589490671|FG000|Overall Study|Sponsor Decision|1|||
163211964|NCT01905657|589490672|FG001|Overall Study|Sponsor Decision|0|||
163211965|NCT01905657|589490673|FG002|Overall Study|Sponsor Decision|0|||
163211966|NCT05119569|589490678|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
163059749|NCT01648764|588928197|FG005|Overall Study|Investigator Decision|0|||
163059750|NCT01648764|588928198|FG006|Overall Study|Investigator Decision|1|||
163059751|NCT01648764|588928199|FG007|Overall Study|Investigator Decision|0|||
163059752|NCT01648764|588928200|FG008|Overall Study|Investigator Decision|0|||
163059753|NCT01648764|588928201|FG009|Overall Study|Investigator Decision|0|||
163059754|NCT01648764|588928202|FG010|Overall Study|Investigator Decision|0|||
163059755|NCT01648764|588928203|FG011|Overall Study|Investigator Decision|1|||
163059756|NCT01648764|588928204|FG012|Overall Study|Investigator Decision|0|||
163059757|NCT01648764|588928205|FG013|Overall Study|Investigator Decision|0|||
163322454|NCT04165213|589893828|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
163322455|NCT04165213|589893829|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
162984085|NCT02358343|588645431|FG002|Screening Intervention|Withdrawal by Subject|0|||
162984086|NCT02358343|588645432|FG003|Screening Intervention|Withdrawal by Subject|0|||
162984087|NCT02358343|588645433|FG004|Screening Intervention|Withdrawal by Subject|0|||
162984088|NCT02358343|588645429|FG000|Screening Intervention|Determined Ineligible|5|||
162984089|NCT02358343|588645430|FG001|Screening Intervention|Determined Ineligible|6|||
162984090|NCT02358343|588645431|FG002|Screening Intervention|Determined Ineligible|0|||
162984091|NCT02358343|588645432|FG003|Screening Intervention|Determined Ineligible|0|||
162984092|NCT02358343|588645433|FG004|Screening Intervention|Determined Ineligible|0|||
162984093|NCT02358343|588645429|FG000|Comparative Efficacy Trial / Observation|Death|0|||
162984094|NCT02358343|588645430|FG001|Comparative Efficacy Trial / Observation|Death|0|||
162984095|NCT02358343|588645431|FG002|Comparative Efficacy Trial / Observation|Death|2|||
162984096|NCT02358343|588645432|FG003|Comparative Efficacy Trial / Observation|Death|0|||
162984097|NCT02358343|588645433|FG004|Comparative Efficacy Trial / Observation|Death|0|||
162984098|NCT02358343|588645429|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
162984099|NCT02358343|588645430|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
162984100|NCT02358343|588645431|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
162984101|NCT02358343|588645432|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
162984102|NCT02358343|588645433|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
162984103|NCT02358343|588645429|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
162984104|NCT02358343|588645430|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
162984105|NCT02358343|588645431|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
162984106|NCT02358343|588645432|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
162984107|NCT02358343|588645433|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
162984108|NCT00577395|588645436|FG000|Overall Study|Study was terminated early by Sponsor|7|||
162984109|NCT00577395|588645437|FG001|Overall Study|Study was terminated early by Sponsor|6|||
162984110|NCT04322149|588645438|FG000|Overall Study|Adverse Event|1|||
162984111|NCT04322149|588645439|FG001|Overall Study|Adverse Event|1|||
162984112|NCT04322149|588645440|FG002|Overall Study|Adverse Event|0|||
162984113|NCT04322149|588645441|FG003|Overall Study|Adverse Event|0|||
162984114|NCT04322149|588645438|FG000|Overall Study|Withdrawal by Subject|0|||
162984115|NCT04322149|588645439|FG001|Overall Study|Withdrawal by Subject|0|||
162984116|NCT04322149|588645440|FG002|Overall Study|Withdrawal by Subject|0|||
162984117|NCT04322149|588645441|FG003|Overall Study|Withdrawal by Subject|2|||
162984118|NCT04322149|588645438|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
162984119|NCT04322149|588645439|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
162984120|NCT04322149|588645440|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
162984121|NCT04322149|588645441|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
162984122|NCT01700049|588645444|FG000|Overall Study|Withdrawal by Subject|1|||
162984123|NCT00792935|588645445|FG000|Overall Study|Adverse Event|2|||
162984124|NCT00792935|588645446|FG001|Overall Study|Adverse Event|1|||
162984125|NCT00792935|588645445|FG000|Overall Study|Lost to Follow-up|0|||
162984126|NCT00792935|588645446|FG001|Overall Study|Lost to Follow-up|1|||
162984127|NCT00792935|588645445|FG000|Overall Study|Protocol Violation|2|||
162984128|NCT00792935|588645446|FG001|Overall Study|Protocol Violation|0|||
162984129|NCT00792935|588645445|FG000|Overall Study|Withdrawal by Subject|0|||
162984130|NCT00792935|588645446|FG001|Overall Study|Withdrawal by Subject|1|||
162984131|NCT03084367|588645450|FG000|Overall Study|Lost to Follow-up|32|||
162984132|NCT03084367|588645450|FG000|Overall Study|Withdrawal by Subject|4|||
162984133|NCT03084367|588645450|FG000|Overall Study|Other|1|||
162984134|NCT01206101|588645451|FG000|Overall Study|Adverse Event|1|||
162984135|NCT01206101|588645452|FG001|Overall Study|Adverse Event|0|||
162984136|NCT01206101|588645451|FG000|Overall Study|Physician Decision|0|||
162984137|NCT01206101|588645452|FG001|Overall Study|Physician Decision|1|||
162984138|NCT01206101|588645451|FG000|Overall Study|Unclassified|1|||
162984139|NCT01206101|588645452|FG001|Overall Study|Unclassified|0|||
162984140|NCT00368979|588645458|FG000|Overall Study|Adverse Event|9|||
162984141|NCT00368979|588645459|FG001|Overall Study|Adverse Event|16|||
162984142|NCT00368979|588645458|FG000|Overall Study|Lack of Efficacy|5|||
163059758|NCT03801252|588928206|FG000|Overall Study|Protocol Violation|1|||
163322456|NCT04165213|589893828|FG000|PLWD Enrollment|Death|2|||
163322457|NCT04165213|589893829|FG001|PLWD Enrollment|Death|0|||
163322458|NCT04165213|589893828|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
163322459|NCT04165213|589893829|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
163322460|NCT04464564|589893830|FG000|Period A (Placebo lead-in)|Other|5|||
163322461|NCT04464564|589893831|FG001|Period A (Placebo lead-in)|Other|0|||
163322462|NCT04464564|589893832|FG002|Period A (Placebo lead-in)|Other|0|||
163322463|NCT04464564|589893833|FG003|Period A (Placebo lead-in)|Other|0|||
163322464|NCT04464564|589893830|FG000|Period B (Randomization Period)|Adverse Event|0|||
162984143|NCT00368979|588645459|FG001|Overall Study|Lack of Efficacy|3|||
162984144|NCT00368979|588645458|FG000|Overall Study|Other|3|||
162984145|NCT00368979|588645459|FG001|Overall Study|Other|1|||
162984146|NCT00368979|588645458|FG000|Overall Study|Lost to Follow-up|1|||
162984147|NCT00368979|588645459|FG001|Overall Study|Lost to Follow-up|0|||
162984148|NCT00368979|588645458|FG000|Overall Study|Protocol Violation|2|||
162984149|NCT00368979|588645459|FG001|Overall Study|Protocol Violation|1|||
162984150|NCT00368979|588645458|FG000|Overall Study|Withdrawal by Subject|5|||
162984151|NCT00368979|588645459|FG001|Overall Study|Withdrawal by Subject|9|||
162984152|NCT00103311|588645460|FG000|Overall Study|Lost to Follow-up|1|||
162984153|NCT00103311|588645461|FG001|Overall Study|Lost to Follow-up|0|||
162984154|NCT00103311|588645460|FG000|Overall Study|Withdrawal by Subject|2|||
162984155|NCT00103311|588645461|FG001|Overall Study|Withdrawal by Subject|1|||
162984156|NCT00103311|588645460|FG000|Overall Study|Adverse Event|1|||
162984157|NCT00103311|588645461|FG001|Overall Study|Adverse Event|0|||
162984158|NCT00912093|588645462|FG000|The Controlled Phase|Death|0|||
162984159|NCT00912093|588645463|FG001|The Controlled Phase|Death|1|||
162984160|NCT00912093|588645464|FG002|The Controlled Phase|Death|0|||
162984161|NCT00912093|588645465|FG003|The Controlled Phase|Death|0|||
162984162|NCT00912093|588645466|FG004|The Controlled Phase|Death|0|||
162984163|NCT00912093|588645462|FG000|The Controlled Phase|Medical Condition|0|||
162984164|NCT00912093|588645463|FG001|The Controlled Phase|Medical Condition|1|||
162984165|NCT00912093|588645464|FG002|The Controlled Phase|Medical Condition|0|||
162984166|NCT00912093|588645465|FG003|The Controlled Phase|Medical Condition|0|||
162984167|NCT00912093|588645466|FG004|The Controlled Phase|Medical Condition|0|||
162984168|NCT00912093|588645462|FG000|The Controlled Phase|Lost to Follow-up|0|||
162984169|NCT00912093|588645463|FG001|The Controlled Phase|Lost to Follow-up|0|||
162984170|NCT00912093|588645464|FG002|The Controlled Phase|Lost to Follow-up|0|||
162984171|NCT00912093|588645465|FG003|The Controlled Phase|Lost to Follow-up|0|||
162984172|NCT00912093|588645466|FG004|The Controlled Phase|Lost to Follow-up|1|||
162984173|NCT01462318|588645469|FG000|Main Study / TP-DI Study|Other|2|||
162984174|NCT01462318|588645470|FG001|Main Study / TP-DI Study|Other|0|||
162984175|NCT01462318|588645471|FG002|Main Study / TP-DI Study|Other|0|||
162984176|NCT01462318|588645469|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
162984177|NCT01462318|588645470|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
162984178|NCT01462318|588645471|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
162984179|NCT01462318|588645469|FG000|Main Study / TP-DI Study|Adverse Event|4|||
162984180|NCT01462318|588645470|FG001|Main Study / TP-DI Study|Adverse Event|0|||
162984181|NCT01462318|588645471|FG002|Main Study / TP-DI Study|Adverse Event|0|||
162984182|NCT01462318|588645469|FG000|Extension Phase|Lost to Follow-up|0|||
162984183|NCT01462318|588645470|FG001|Extension Phase|Lost to Follow-up|0|||
162984184|NCT01462318|588645471|FG002|Extension Phase|Lost to Follow-up|1|||
162984185|NCT01462318|588645469|FG000|Extension Phase|Other|0|||
162984186|NCT01462318|588645470|FG001|Extension Phase|Other|0|||
162984187|NCT01462318|588645471|FG002|Extension Phase|Other|1|||
162984188|NCT01462318|588645469|FG000|Extension Phase|Disease Progression|0|||
162984189|NCT01462318|588645470|FG001|Extension Phase|Disease Progression|0|||
162984190|NCT01462318|588645471|FG002|Extension Phase|Disease Progression|1|||
163322465|NCT04464564|589893831|FG001|Period B (Randomization Period)|Adverse Event|1|||
163322466|NCT04464564|589893832|FG002|Period B (Randomization Period)|Adverse Event|2|||
163322467|NCT04464564|589893833|FG003|Period B (Randomization Period)|Adverse Event|8|||
163322468|NCT04464564|589893830|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
163322469|NCT04464564|589893831|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
163322470|NCT04464564|589893832|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
163322471|NCT04464564|589893833|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
163322472|NCT04464564|589893830|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
163322473|NCT04464564|589893831|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
163322474|NCT04464564|589893832|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
163322475|NCT04464564|589893833|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
163322476|NCT04464564|589893830|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
163322477|NCT04464564|589893831|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
163322478|NCT04464564|589893832|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
163322479|NCT04464564|589893833|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
162984191|NCT01462318|588645469|FG000|Extension Phase|Withdrawal by Subject|0|||
162984192|NCT01462318|588645470|FG001|Extension Phase|Withdrawal by Subject|0|||
162984193|NCT01462318|588645471|FG002|Extension Phase|Withdrawal by Subject|15|||
162984194|NCT01462318|588645469|FG000|Extension Phase|Investigator Decision|0|||
162984195|NCT01462318|588645470|FG001|Extension Phase|Investigator Decision|0|||
162984196|NCT01462318|588645471|FG002|Extension Phase|Investigator Decision|5|||
162984197|NCT01462318|588645469|FG000|Extension Phase|Adverse Event|0|||
162984198|NCT01462318|588645470|FG001|Extension Phase|Adverse Event|0|||
162984199|NCT01462318|588645471|FG002|Extension Phase|Adverse Event|22|||
162984200|NCT00270257|588645472|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
162984201|NCT00270257|588645473|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
162984202|NCT01195103|588645476|FG000|Overall Study|Withdrawal by Subject|1|||
162984203|NCT01195103|588645477|FG001|Overall Study|Withdrawal by Subject|0|||
162984204|NCT01195103|588645478|FG002|Overall Study|Withdrawal by Subject|0|||
162984205|NCT01155024|588645480|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
162984206|NCT01155024|588645481|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
162984207|NCT01155024|588645480|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
162984208|NCT01155024|588645481|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
162984209|NCT01155024|588645480|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
162984210|NCT01155024|588645481|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
162984211|NCT01593696|588645482|FG000|Dose Escalation|Progressive Disease|2|||
163322480|NCT04464564|589893830|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
163322481|NCT04464564|589893831|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
163322482|NCT04464564|589893832|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
163322483|NCT04464564|589893833|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
163322484|NCT04464564|589893830|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
163322485|NCT04464564|589893831|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
163322486|NCT04464564|589893832|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
162984212|NCT01593696|588645483|FG001|Dose Escalation|Progressive Disease|0|||
162984213|NCT01593696|588645484|FG002|Dose Escalation|Progressive Disease|0|||
163322487|NCT04464564|589893833|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
163322488|NCT04464564|589893830|FG000|Period B (Randomization Period)|Reason not Specified|0|||
163322489|NCT04464564|589893831|FG001|Period B (Randomization Period)|Reason not Specified|3|||
163322490|NCT04464564|589893832|FG002|Period B (Randomization Period)|Reason not Specified|3|||
163322491|NCT04464564|589893833|FG003|Period B (Randomization Period)|Reason not Specified|3|||
163322492|NCT03786926|589893836|FG000|Overall Study|Adverse Event|0|||
163322493|NCT03786926|589893837|FG001|Overall Study|Adverse Event|0|||
163322494|NCT03786926|589893838|FG002|Overall Study|Adverse Event|0|||
163322495|NCT03786926|589893839|FG003|Overall Study|Adverse Event|0|||
163322496|NCT03786926|589893840|FG004|Overall Study|Adverse Event|0|||
163322497|NCT03786926|589893841|FG005|Overall Study|Adverse Event|0|||
163322498|NCT03786926|589893842|FG006|Overall Study|Adverse Event|0|||
163322499|NCT03786926|589893843|FG007|Overall Study|Adverse Event|1|||
163322500|NCT03786926|589893844|FG008|Overall Study|Adverse Event|1|||
163322501|NCT03786926|589893845|FG009|Overall Study|Adverse Event|0|||
163322502|NCT03786926|589893846|FG010|Overall Study|Adverse Event|1|||
163322503|NCT03786926|589893836|FG000|Overall Study|Progressive disease|3|||
163322504|NCT03786926|589893837|FG001|Overall Study|Progressive disease|0|||
163322505|NCT03786926|589893838|FG002|Overall Study|Progressive disease|3|||
163322506|NCT03786926|589893839|FG003|Overall Study|Progressive disease|1|||
163322507|NCT03786926|589893840|FG004|Overall Study|Progressive disease|2|||
163322508|NCT03786926|589893841|FG005|Overall Study|Progressive disease|2|||
163322509|NCT03786926|589893842|FG006|Overall Study|Progressive disease|1|||
163322510|NCT03786926|589893843|FG007|Overall Study|Progressive disease|6|||
163322511|NCT03786926|589893844|FG008|Overall Study|Progressive disease|1|||
163322512|NCT03786926|589893845|FG009|Overall Study|Progressive disease|1|||
163322513|NCT03786926|589893846|FG010|Overall Study|Progressive disease|1|||
163322514|NCT03786926|589893836|FG000|Overall Study|Death|0|||
163322515|NCT03786926|589893837|FG001|Overall Study|Death|1|||
163322516|NCT03786926|589893838|FG002|Overall Study|Death|1|||
163322517|NCT03786926|589893839|FG003|Overall Study|Death|0|||
163322518|NCT03786926|589893840|FG004|Overall Study|Death|0|||
163322519|NCT03786926|589893841|FG005|Overall Study|Death|0|||
163322520|NCT03786926|589893842|FG006|Overall Study|Death|0|||
163322521|NCT03786926|589893843|FG007|Overall Study|Death|0|||
163322522|NCT03786926|589893844|FG008|Overall Study|Death|0|||
163322523|NCT03786926|589893845|FG009|Overall Study|Death|1|||
163322524|NCT03786926|589893846|FG010|Overall Study|Death|2|||
163322525|NCT03786926|589893836|FG000|Overall Study|Physician Decision|0|||
163322526|NCT03786926|589893837|FG001|Overall Study|Physician Decision|1|||
163322527|NCT03786926|589893838|FG002|Overall Study|Physician Decision|0|||
163322528|NCT03786926|589893839|FG003|Overall Study|Physician Decision|1|||
163322529|NCT03786926|589893840|FG004|Overall Study|Physician Decision|2|||
162984214|NCT01593696|588645485|FG003|Dose Escalation|Progressive Disease|0|||
162984215|NCT01593696|588645482|FG000|Dose Expansion|Fungal infection|0|||
163322530|NCT03786926|589893841|FG005|Overall Study|Physician Decision|0|||
163322531|NCT03786926|589893842|FG006|Overall Study|Physician Decision|0|||
163322532|NCT03786926|589893843|FG007|Overall Study|Physician Decision|2|||
163403265|NCT03715153|590187148|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
163403266|NCT03715153|590187149|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
163403267|NCT03715153|590187148|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
163403268|NCT03715153|590187149|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
163403269|NCT03116698|590187150|FG000|Overall Study|Adverse Event|1|||
163403270|NCT03116698|590187151|FG001|Overall Study|Adverse Event|1|||
163403271|NCT03116698|590187152|FG002|Overall Study|Adverse Event|1|||
163403272|NCT03116698|590187153|FG003|Overall Study|Adverse Event|0|||
163403273|NCT03116698|590187150|FG000|Overall Study|Withdrawal by Subject|1|||
163403274|NCT03116698|590187151|FG001|Overall Study|Withdrawal by Subject|4|||
163403275|NCT03116698|590187152|FG002|Overall Study|Withdrawal by Subject|5|||
163403276|NCT03116698|590187153|FG003|Overall Study|Withdrawal by Subject|2|||
163403277|NCT03116698|590187150|FG000|Overall Study|Lost to Follow-up|2|||
163403278|NCT03116698|590187151|FG001|Overall Study|Lost to Follow-up|0|||
163403279|NCT03116698|590187152|FG002|Overall Study|Lost to Follow-up|0|||
163403280|NCT03116698|590187153|FG003|Overall Study|Lost to Follow-up|0|||
163403281|NCT03116698|590187150|FG000|Overall Study|Physician Decision|1|||
163403282|NCT03116698|590187151|FG001|Overall Study|Physician Decision|1|||
163403283|NCT03116698|590187152|FG002|Overall Study|Physician Decision|0|||
163403284|NCT03116698|590187153|FG003|Overall Study|Physician Decision|0|||
163403285|NCT03116698|590187150|FG000|Overall Study|Protocol Violation|1|||
163403286|NCT03116698|590187151|FG001|Overall Study|Protocol Violation|0|||
163403287|NCT03116698|590187152|FG002|Overall Study|Protocol Violation|0|||
163403288|NCT03116698|590187153|FG003|Overall Study|Protocol Violation|0|||
163403289|NCT03116698|590187150|FG000|Overall Study|Death|0|||
163403290|NCT03116698|590187151|FG001|Overall Study|Death|0|||
163403291|NCT03116698|590187152|FG002|Overall Study|Death|2|||
163403292|NCT03116698|590187153|FG003|Overall Study|Death|0|||
163403293|NCT03021499|590187154|FG000|Overall Study|Adverse Event|1|||
163403294|NCT03021499|590187155|FG001|Overall Study|Adverse Event|0|||
163403295|NCT03021499|590187154|FG000|Overall Study|Death|1|||
163403296|NCT03021499|590187155|FG001|Overall Study|Death|5|||
163403297|NCT03021499|590187154|FG000|Overall Study|Lack of Efficacy|0|||
163403298|NCT03021499|590187155|FG001|Overall Study|Lack of Efficacy|1|||
163403299|NCT03021499|590187154|FG000|Overall Study|Lost to Follow-up|1|||
163403300|NCT03021499|590187155|FG001|Overall Study|Lost to Follow-up|3|||
163403301|NCT03021499|590187154|FG000|Overall Study|Physician Decision|2|||
163403302|NCT03021499|590187155|FG001|Overall Study|Physician Decision|3|||
163403303|NCT03021499|590187154|FG000|Overall Study|Pregnancy|1|||
163403304|NCT03021499|590187155|FG001|Overall Study|Pregnancy|0|||
163403305|NCT03021499|590187154|FG000|Overall Study|Withdrawal by Subject|7|||
163403306|NCT03021499|590187155|FG001|Overall Study|Withdrawal by Subject|14|||
163403307|NCT03021499|590187154|FG000|Overall Study|Prohibited medication required|1|||
163403308|NCT03021499|590187155|FG001|Overall Study|Prohibited medication required|0|||
163403309|NCT03021499|590187154|FG000|Overall Study|Protocol non-compliance|1|||
163403310|NCT03021499|590187155|FG001|Overall Study|Protocol non-compliance|1|||
163403311|NCT03021499|590187154|FG000|Overall Study|None of the above|0|||
163403312|NCT03021499|590187155|FG001|Overall Study|None of the above|4|||
163403313|NCT03021499|590187154|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
163403314|NCT03021499|590187155|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
163403315|NCT00495820|590187156|FG000|Overall Study|Adverse Event|1|||
163403316|NCT00495820|590187157|FG001|Overall Study|Adverse Event|1|||
163403317|NCT00820950|590187158|FG000|Overall Study|Scheduling Conflict|0|||
163403318|NCT00820950|590187159|FG001|Overall Study|Scheduling Conflict|0|||
163403319|NCT00820950|590187160|FG002|Overall Study|Scheduling Conflict|0|||
163403320|NCT00820950|590187161|FG003|Overall Study|Scheduling Conflict|0|||
163403321|NCT00820950|590187162|FG004|Overall Study|Scheduling Conflict|0|||
163403322|NCT00820950|590187163|FG005|Overall Study|Scheduling Conflict|0|||
163403323|NCT00820950|590187164|FG006|Overall Study|Scheduling Conflict|1|||
163403324|NCT00820950|590187165|FG007|Overall Study|Scheduling Conflict|1|||
163403325|NCT00820950|590187166|FG008|Overall Study|Scheduling Conflict|0|||
163403326|NCT00820950|590187167|FG009|Overall Study|Scheduling Conflict|0|||
163403327|NCT00820950|590187158|FG000|Overall Study|Protocol Violation|1|||
163403328|NCT00820950|590187159|FG001|Overall Study|Protocol Violation|1|||
163403329|NCT00820950|590187160|FG002|Overall Study|Protocol Violation|0|||
163403330|NCT00820950|590187161|FG003|Overall Study|Protocol Violation|0|||
163403331|NCT00820950|590187162|FG004|Overall Study|Protocol Violation|0|||
163403332|NCT00820950|590187163|FG005|Overall Study|Protocol Violation|0|||
163403333|NCT00820950|590187164|FG006|Overall Study|Protocol Violation|0|||
163403334|NCT00820950|590187165|FG007|Overall Study|Protocol Violation|0|||
163403335|NCT00820950|590187166|FG008|Overall Study|Protocol Violation|0|||
163403336|NCT00820950|590187167|FG009|Overall Study|Protocol Violation|0|||
163403337|NCT00874120|590188543|FG000|First Intervention|Adverse Event|0|||
163403338|NCT00874120|590188544|FG001|First Intervention|Adverse Event|1|||
163403339|NCT00874120|590188543|FG000|First Intervention|Withdrawal by Subject|2|||
163403340|NCT00874120|590188544|FG001|First Intervention|Withdrawal by Subject|0|||
163403341|NCT00874120|590188543|FG000|First Intervention|Lost to Follow-up|0|||
163403342|NCT00874120|590188544|FG001|First Intervention|Lost to Follow-up|1|||
163403343|NCT00874120|590188543|FG000|First Intervention|Protocol Violation|3|||
162984216|NCT01593696|588645483|FG001|Dose Expansion|Fungal infection|0|||
162984217|NCT01593696|588645484|FG002|Dose Expansion|Fungal infection|1|||
162984218|NCT01593696|588645485|FG003|Dose Expansion|Fungal infection|0|||
162984219|NCT00369655|588645486|FG000|Overall Study|Refusal of further treatment|2|||
162984220|NCT04049617|588645487|FG000|Overall Study|Adverse Event|0|||
162984221|NCT04049617|588645488|FG001|Overall Study|Adverse Event|0|||
163322533|NCT03786926|589893844|FG008|Overall Study|Physician Decision|1|||
163322534|NCT03786926|589893845|FG009|Overall Study|Physician Decision|1|||
163322535|NCT03786926|589893846|FG010|Overall Study|Physician Decision|0|||
163322536|NCT03786926|589893836|FG000|Overall Study|Withdrawal by Subject|0|||
163322537|NCT03786926|589893837|FG001|Overall Study|Withdrawal by Subject|1|||
163322538|NCT03786926|589893838|FG002|Overall Study|Withdrawal by Subject|1|||
163322539|NCT03786926|589893839|FG003|Overall Study|Withdrawal by Subject|0|||
163322540|NCT03786926|589893840|FG004|Overall Study|Withdrawal by Subject|0|||
163322541|NCT03786926|589893841|FG005|Overall Study|Withdrawal by Subject|0|||
163322542|NCT03786926|589893842|FG006|Overall Study|Withdrawal by Subject|1|||
163322543|NCT03786926|589893843|FG007|Overall Study|Withdrawal by Subject|0|||
163322544|NCT03786926|589893844|FG008|Overall Study|Withdrawal by Subject|1|||
163322545|NCT03786926|589893845|FG009|Overall Study|Withdrawal by Subject|0|||
163322546|NCT03786926|589893846|FG010|Overall Study|Withdrawal by Subject|1|||
163322547|NCT03786926|589893836|FG000|Overall Study|Study terminated by Sponsor|0|||
163322548|NCT03786926|589893837|FG001|Overall Study|Study terminated by Sponsor|0|||
163322549|NCT03786926|589893838|FG002|Overall Study|Study terminated by Sponsor|0|||
163322550|NCT03786926|589893839|FG003|Overall Study|Study terminated by Sponsor|0|||
163322551|NCT03786926|589893840|FG004|Overall Study|Study terminated by Sponsor|1|||
163322552|NCT03786926|589893841|FG005|Overall Study|Study terminated by Sponsor|0|||
163322553|NCT03786926|589893842|FG006|Overall Study|Study terminated by Sponsor|0|||
163322554|NCT03786926|589893843|FG007|Overall Study|Study terminated by Sponsor|4|||
163322555|NCT03786926|589893844|FG008|Overall Study|Study terminated by Sponsor|0|||
163322556|NCT03786926|589893845|FG009|Overall Study|Study terminated by Sponsor|0|||
163322557|NCT03786926|589893846|FG010|Overall Study|Study terminated by Sponsor|0|||
163322558|NCT03786926|589893836|FG000|Overall Study|Anti-neoplasm treatment|0|||
163322559|NCT03786926|589893837|FG001|Overall Study|Anti-neoplasm treatment|0|||
163322560|NCT03786926|589893838|FG002|Overall Study|Anti-neoplasm treatment|0|||
163322561|NCT03786926|589893839|FG003|Overall Study|Anti-neoplasm treatment|0|||
163322562|NCT03786926|589893840|FG004|Overall Study|Anti-neoplasm treatment|1|||
163059759|NCT03801252|588928207|FG001|Overall Study|Protocol Violation|2|||
163059760|NCT01732692|588928211|FG000|Overall Study|Adverse Event|0|||
163059761|NCT01732692|588928212|FG001|Overall Study|Adverse Event|1|||
163059762|NCT01027949|588928213|FG000|Overall Study|Death|174|||
163059763|NCT01027949|588928213|FG000|Overall Study|Progressive Disease|163|||
163059764|NCT01027949|588928213|FG000|Overall Study|Adverse Event|172|||
163059765|NCT01027949|588928213|FG000|Overall Study|Withdrawal by Subject|113|||
163059766|NCT01027949|588928213|FG000|Overall Study|Lost to Follow-up|17|||
163059767|NCT01027949|588928213|FG000|Overall Study|Protocol Violation|13|||
163059768|NCT01027949|588928213|FG000|Overall Study|PI Decision|8|||
163059769|NCT01027949|588928213|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
163059770|NCT01027949|588928213|FG000|Overall Study|Non-compliance with Study Procedures|7|||
163059771|NCT01027949|588928213|FG000|Overall Study|Lung Transplant|5|||
163059772|NCT01027949|588928213|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
163059773|NCT01027949|588928213|FG000|Overall Study|Use of Excluded Medication|2|||
163059774|NCT01027949|588928213|FG000|Overall Study|Patient Self-discontinuation|1|||
163059775|NCT01027949|588928213|FG000|Overall Study|Pregnancy|1|||
163059776|NCT01027949|588928213|FG000|Overall Study|Surgery|1|||
163059777|NCT00656617|588928214|FG000|Overall Study|Adverse Event|1|||
163059778|NCT00656617|588928214|FG000|Overall Study|Death|2|||
163059779|NCT00656617|588928214|FG000|Overall Study|Insurance Issues|2|||
163059780|NCT00656617|588928214|FG000|Overall Study|Move to different clinical trial|2|||
163059781|NCT02030600|588928217|FG000|Treatment Period 1|Adverse Event|5|||
163059782|NCT02030600|588928218|FG001|Treatment Period 1|Adverse Event|7|||
163059783|NCT02030600|588928217|FG000|Treatment Period 1|Lack of Efficacy|0|||
162984222|NCT04049617|588645489|FG002|Overall Study|Adverse Event|0|||
163059784|NCT02030600|588928218|FG001|Treatment Period 1|Lack of Efficacy|1|||
163059785|NCT02030600|588928217|FG000|Treatment Period 1|Lost to Follow-up|11|||
163322563|NCT03786926|589893841|FG005|Overall Study|Anti-neoplasm treatment|0|||
163322564|NCT03786926|589893842|FG006|Overall Study|Anti-neoplasm treatment|1|||
163322565|NCT03786926|589893843|FG007|Overall Study|Anti-neoplasm treatment|0|||
163322566|NCT03786926|589893844|FG008|Overall Study|Anti-neoplasm treatment|0|||
163322567|NCT03786926|589893845|FG009|Overall Study|Anti-neoplasm treatment|0|||
163322568|NCT03786926|589893846|FG010|Overall Study|Anti-neoplasm treatment|0|||
162984223|NCT04049617|588645490|FG003|Overall Study|Adverse Event|1|||
162984224|NCT04049617|588645491|FG004|Overall Study|Adverse Event|0|||
163059786|NCT02030600|588928218|FG001|Treatment Period 1|Lost to Follow-up|3|||
163059787|NCT02030600|588928217|FG000|Treatment Period 1|Protocol Violation|22|||
163059788|NCT02030600|588928218|FG001|Treatment Period 1|Protocol Violation|17|||
163059789|NCT02030600|588928217|FG000|Treatment Period 1|Withdrawal by Subject|13|||
163322569|NCT03786926|589893836|FG000|Overall Study|Other|0|||
163322570|NCT03786926|589893837|FG001|Overall Study|Other|0|||
163322571|NCT03786926|589893838|FG002|Overall Study|Other|0|||
163322572|NCT03786926|589893839|FG003|Overall Study|Other|1|||
163322573|NCT03786926|589893840|FG004|Overall Study|Other|0|||
162984225|NCT04049617|588645492|FG005|Overall Study|Adverse Event|0|||
162984226|NCT04049617|588645487|FG000|Overall Study|Death|0|||
162984227|NCT04049617|588645488|FG001|Overall Study|Death|0|||
162984228|NCT04049617|588645489|FG002|Overall Study|Death|0|||
162984229|NCT04049617|588645490|FG003|Overall Study|Death|0|||
162984230|NCT04049617|588645491|FG004|Overall Study|Death|0|||
162984231|NCT04049617|588645492|FG005|Overall Study|Death|1|||
162984232|NCT04049617|588645487|FG000|Overall Study|Lost to Follow-up|0|||
162984233|NCT04049617|588645488|FG001|Overall Study|Lost to Follow-up|0|||
162984234|NCT04049617|588645489|FG002|Overall Study|Lost to Follow-up|0|||
162984235|NCT04049617|588645490|FG003|Overall Study|Lost to Follow-up|1|||
162984236|NCT04049617|588645491|FG004|Overall Study|Lost to Follow-up|0|||
162984237|NCT04049617|588645492|FG005|Overall Study|Lost to Follow-up|0|||
162984238|NCT04049617|588645487|FG000|Overall Study|Withdrew consent|0|||
162984239|NCT04049617|588645488|FG001|Overall Study|Withdrew consent|0|||
162984240|NCT04049617|588645489|FG002|Overall Study|Withdrew consent|1|||
162984241|NCT04049617|588645490|FG003|Overall Study|Withdrew consent|0|||
162984242|NCT04049617|588645491|FG004|Overall Study|Withdrew consent|0|||
162984243|NCT04049617|588645492|FG005|Overall Study|Withdrew consent|0|||
162984244|NCT01780987|588645493|FG000|Overall Study|Adverse Event|0|||
162984245|NCT01780987|588645494|FG001|Overall Study|Adverse Event|4|||
162984246|NCT01780987|588645493|FG000|Overall Study|Withdrawal by Subject|2|||
162984247|NCT01780987|588645494|FG001|Overall Study|Withdrawal by Subject|0|||
162984248|NCT01780987|588645493|FG000|Overall Study|Request of Changing Hospital|0|||
162984249|NCT01780987|588645494|FG001|Overall Study|Request of Changing Hospital|1|||
162984250|NCT01780987|588645493|FG000|Overall Study|Changing Residence|1|||
162984251|NCT01780987|588645494|FG001|Overall Study|Changing Residence|0|||
162984252|NCT01780987|588645493|FG000|Overall Study|Not Receiving any Study Medication|0|||
162984253|NCT01780987|588645494|FG001|Overall Study|Not Receiving any Study Medication|1|||
162984254|NCT03402750|588645495|FG000|Overall Study|Lost to Follow-up|2|||
162984255|NCT03402750|588645496|FG001|Overall Study|Lost to Follow-up|1|||
162984256|NCT02981303|588645497|FG000|Overall Study|Progressive Disease|17|||
162984257|NCT02981303|588645498|FG001|Overall Study|Progressive Disease|37|||
162984258|NCT02981303|588645497|FG000|Overall Study|Adverse Event|1|||
162984259|NCT02981303|588645498|FG001|Overall Study|Adverse Event|4|||
162984260|NCT02981303|588645497|FG000|Overall Study|Withdrawal by Subject|0|||
162984261|NCT02981303|588645498|FG001|Overall Study|Withdrawal by Subject|1|||
162984262|NCT00302081|588645499|FG000|Overall Study|Adverse Event|6|||
162984263|NCT00302081|588645500|FG001|Overall Study|Adverse Event|5|||
162984264|NCT00302081|588645501|FG002|Overall Study|Adverse Event|4|||
162984265|NCT00302081|588645499|FG000|Overall Study|Lost to Follow-up|21|||
162984266|NCT00302081|588645500|FG001|Overall Study|Lost to Follow-up|18|||
162984267|NCT00302081|588645501|FG002|Overall Study|Lost to Follow-up|28|||
162984268|NCT00302081|588645499|FG000|Overall Study|Withdrawal by Subject|8|||
162984269|NCT00302081|588645500|FG001|Overall Study|Withdrawal by Subject|12|||
162984270|NCT00302081|588645501|FG002|Overall Study|Withdrawal by Subject|8|||
162984271|NCT00302081|588645499|FG000|Overall Study|Protocol Violation|5|||
162984272|NCT00302081|588645500|FG001|Overall Study|Protocol Violation|1|||
162984273|NCT00302081|588645501|FG002|Overall Study|Protocol Violation|2|||
162984274|NCT00302081|588645499|FG000|Overall Study|Lack of Efficacy|1|||
162984275|NCT00302081|588645500|FG001|Overall Study|Lack of Efficacy|0|||
162984276|NCT00302081|588645501|FG002|Overall Study|Lack of Efficacy|5|||
162984277|NCT00302081|588645499|FG000|Overall Study|Death|2|||
162984278|NCT00302081|588645500|FG001|Overall Study|Death|1|||
162984279|NCT00302081|588645501|FG002|Overall Study|Death|0|||
162984280|NCT00302081|588645499|FG000|Overall Study|Other|13|||
162984281|NCT00302081|588645500|FG001|Overall Study|Other|6|||
163059790|NCT02030600|588928218|FG001|Treatment Period 1|Withdrawal by Subject|17|||
163059791|NCT02030600|588928217|FG000|Treatment Period 1|Casebook Unsigned|1|||
162984282|NCT00302081|588645501|FG002|Overall Study|Other|5|||
162984283|NCT02701413|588645502|FG000|Overall Study|Withdrawal by Subject|7|||
162984284|NCT02701413|588645503|FG001|Overall Study|Withdrawal by Subject|11|||
162984285|NCT02138136|588645504|FG000|Overall Study|Protocol Violation|4|||
162984286|NCT02138136|588645504|FG000|Overall Study|Physician Decision|7|||
163059792|NCT02030600|588928218|FG001|Treatment Period 1|Casebook Unsigned|0|||
163059793|NCT02030600|588928217|FG000|Treatment Period 1|Unclassified|1|||
162984287|NCT02138136|588645504|FG000|Overall Study|Lack of Efficacy|35|||
162984288|NCT02138136|588645504|FG000|Overall Study|Pregnancy|2|||
162984289|NCT02138136|588645504|FG000|Overall Study|Adverse Event|18|||
162984290|NCT02138136|588645504|FG000|Overall Study|Withdrawal by Subject|36|||
162984291|NCT02138136|588645504|FG000|Overall Study|Lost to Follow-up|32|||
162984292|NCT02138136|588645504|FG000|Overall Study|Withdrawn by Sponsor|5|||
162984293|NCT01660334|588645509|FG000|Overall Study|Lost to Follow-up|1|||
162984294|NCT00536263|588645510|FG000|Overall Study|Adverse Event|5|||
163059794|NCT02030600|588928218|FG001|Treatment Period 1|Unclassified|0|||
162984295|NCT00536263|588645511|FG001|Overall Study|Adverse Event|5|||
163322574|NCT03786926|589893841|FG005|Overall Study|Other|1|||
162984296|NCT00536263|588645512|FG002|Overall Study|Adverse Event|7|||
162984297|NCT00536263|588645510|FG000|Overall Study|Lost to Follow-up|3|||
162984298|NCT00536263|588645511|FG001|Overall Study|Lost to Follow-up|4|||
162984299|NCT00536263|588645512|FG002|Overall Study|Lost to Follow-up|4|||
162984300|NCT00536263|588645510|FG000|Overall Study|Subject withdrew - not treatment related|2|||
162984301|NCT00536263|588645511|FG001|Overall Study|Subject withdrew - not treatment related|0|||
162984302|NCT00536263|588645512|FG002|Overall Study|Subject withdrew - not treatment related|5|||
162984303|NCT00536263|588645510|FG000|Overall Study|Subject withdrew - treatment related|0|||
162984304|NCT00536263|588645511|FG001|Overall Study|Subject withdrew - treatment related|3|||
162984305|NCT00536263|588645512|FG002|Overall Study|Subject withdrew - treatment related|2|||
162984306|NCT00536263|588645510|FG000|Overall Study|Noncompliance with protocol|0|||
162984307|NCT00536263|588645511|FG001|Overall Study|Noncompliance with protocol|0|||
162984308|NCT00536263|588645512|FG002|Overall Study|Noncompliance with protocol|1|||
163322575|NCT03786926|589893842|FG006|Overall Study|Other|0|||
162984309|NCT00536263|588645510|FG000|Overall Study|Did not meet protocol eligibility|1|||
162984310|NCT00536263|588645511|FG001|Overall Study|Did not meet protocol eligibility|2|||
162984311|NCT00536263|588645512|FG002|Overall Study|Did not meet protocol eligibility|2|||
162984312|NCT00160641|588645519|FG000|Overall Study|Adverse Event|102|||
162984313|NCT00160641|588645519|FG000|Overall Study|Withdrawal by Subject|87|||
162984314|NCT00160641|588645519|FG000|Overall Study|Lost to Follow-up|8|||
162984315|NCT00160641|588645519|FG000|Overall Study|Lack of Efficacy|12|||
162984316|NCT00160641|588645519|FG000|Overall Study|Protocol Violation|3|||
162984317|NCT00160641|588645519|FG000|Overall Study|Other|9|||
162984318|NCT01640873|588645524|FG000|Overall Study|Protocol Violation|2|||
162984319|NCT01640873|588645525|FG001|Overall Study|Protocol Violation|1|||
162984320|NCT01321008|588645526|FG000|Overall Study|Early Study Termination|1|||
162984321|NCT02458092|588645527|FG000|Overall Study|Withdrawal by Subject|1|||
162984322|NCT02458092|588645528|FG001|Overall Study|Withdrawal by Subject|0|||
162984323|NCT00679913|588645529|FG000|Overall Study|Protocol Violation|18|||
162984324|NCT00679913|588645530|FG001|Overall Study|Protocol Violation|13|||
162984325|NCT00456495|588645535|FG000|Overall Study|Physician Decision|2|||
162984326|NCT01301508|588645536|FG000|Overall Study|Withdrawal by Subject|1|||
162984327|NCT01301508|588645537|FG001|Overall Study|Withdrawal by Subject|2|||
162984328|NCT01301508|588645536|FG000|Overall Study|Lost to Follow-up|0|||
162984329|NCT01301508|588645537|FG001|Overall Study|Lost to Follow-up|1|||
163322576|NCT03786926|589893843|FG007|Overall Study|Other|0|||
163322577|NCT03786926|589893844|FG008|Overall Study|Other|2|||
163322578|NCT03786926|589893845|FG009|Overall Study|Other|0|||
163322579|NCT03786926|589893846|FG010|Overall Study|Other|0|||
163322580|NCT00303459|589893856|FG000|Overall Study|Death|33|||
163322581|NCT00303459|589893857|FG001|Overall Study|Death|44|||
163322582|NCT00303459|589893856|FG000|Overall Study|Withdrawal of consent|32|||
163322583|NCT00303459|589893857|FG001|Overall Study|Withdrawal of consent|26|||
163322584|NCT00303459|589893856|FG000|Overall Study|Lost to Follow-up|5|||
163322585|NCT00303459|589893857|FG001|Overall Study|Lost to Follow-up|4|||
163322586|NCT00303459|589893856|FG000|Overall Study|Administrative reason|7|||
163322587|NCT00303459|589893857|FG001|Overall Study|Administrative reason|7|||
163322588|NCT00303459|589893856|FG000|Overall Study|Decision by the investigator|5|||
163322589|NCT00303459|589893857|FG001|Overall Study|Decision by the investigator|7|||
163322590|NCT00303459|589893856|FG000|Overall Study|Lung transplantation|1|||
163322591|NCT00303459|589893857|FG001|Overall Study|Lung transplantation|1|||
163322592|NCT04055012|589893858|FG000|Overall Study|Withdrawal by Subject|1|||
163322593|NCT04055012|589893859|FG001|Overall Study|Withdrawal by Subject|3|||
163322594|NCT04055012|589893860|FG002|Overall Study|Withdrawal by Subject|1|||
163322595|NCT04055012|589893861|FG003|Overall Study|Withdrawal by Subject|0|||
163403344|NCT00874120|590188544|FG001|First Intervention|Protocol Violation|0|||
163403345|NCT00874120|590188543|FG000|First Intervention|positive drug test|1|||
163403346|NCT00874120|590188544|FG001|First Intervention|positive drug test|0|||
163403347|NCT00874120|590188543|FG000|Second Intervention|Withdrawal by Subject|1|||
162984330|NCT05069155|588645542|FG000|Overall Study|Withdrawal by Subject|1|||
162984331|NCT05069155|588645543|FG001|Overall Study|Withdrawal by Subject|3|||
162984332|NCT01346774|588645544|FG000|Overall Study|Did not take a single dose|6|||
162984333|NCT01346774|588645545|FG001|Overall Study|Did not take a single dose|4|||
162984334|NCT01346774|588645544|FG000|Overall Study|Lost to Follow-up|3|||
162984335|NCT01346774|588645545|FG001|Overall Study|Lost to Follow-up|4|||
162984336|NCT01346774|588645544|FG000|Overall Study|Withdrawal by Subject|1|||
163059795|NCT02030600|588928217|FG000|Treatment Period 2|Adverse Event|4|||
163322596|NCT04055012|589893858|FG000|Overall Study|Metformin Recall|1|||
163322597|NCT04055012|589893859|FG001|Overall Study|Metformin Recall|1|||
163322598|NCT04055012|589893860|FG002|Overall Study|Metformin Recall|1|||
162984337|NCT01346774|588645545|FG001|Overall Study|Withdrawal by Subject|4|||
162984338|NCT01346774|588645544|FG000|Overall Study|Protocol Violation|2|||
162984339|NCT01346774|588645545|FG001|Overall Study|Protocol Violation|3|||
163059796|NCT02030600|588928218|FG001|Treatment Period 2|Adverse Event|4|||
163322599|NCT04055012|589893861|FG003|Overall Study|Metformin Recall|0|||
163322600|NCT02492711|589893865|FG000|Overall Study|Adverse Event|9|||
163322601|NCT02492711|589893866|FG001|Overall Study|Adverse Event|9|||
162984340|NCT01346774|588645544|FG000|Overall Study|Adverse Event|1|||
162984341|NCT01346774|588645545|FG001|Overall Study|Adverse Event|2|||
163322602|NCT02492711|589893867|FG002|Overall Study|Adverse Event|2|||
163322603|NCT02492711|589893865|FG000|Overall Study|Death|3|||
163322604|NCT02492711|589893866|FG001|Overall Study|Death|3|||
163322605|NCT02492711|589893867|FG002|Overall Study|Death|0|||
163322606|NCT02492711|589893865|FG000|Overall Study|Withdrawal by Subject|10|||
163322607|NCT02492711|589893866|FG001|Overall Study|Withdrawal by Subject|16|||
162984342|NCT01929031|588645546|FG000|Overall Study|Adverse Event|3|||
162984343|NCT01929031|588645547|FG001|Overall Study|Adverse Event|1|||
162984344|NCT01929031|588645548|FG002|Overall Study|Adverse Event|1|||
162984345|NCT01929031|588645549|FG003|Overall Study|Adverse Event|0|||
162984346|NCT01929031|588645550|FG004|Overall Study|Adverse Event|0|||
162984347|NCT01929031|588645551|FG005|Overall Study|Adverse Event|0|||
162984348|NCT01929031|588645546|FG000|Overall Study|Protocol Violation|1|||
162984349|NCT01929031|588645547|FG001|Overall Study|Protocol Violation|0|||
162984350|NCT01929031|588645548|FG002|Overall Study|Protocol Violation|0|||
162984351|NCT01929031|588645549|FG003|Overall Study|Protocol Violation|0|||
162984352|NCT01929031|588645550|FG004|Overall Study|Protocol Violation|0|||
162984353|NCT01929031|588645551|FG005|Overall Study|Protocol Violation|1|||
162984354|NCT01929031|588645546|FG000|Overall Study|Reason other than specified above|0|||
162984355|NCT01929031|588645547|FG001|Overall Study|Reason other than specified above|1|||
162984356|NCT01929031|588645548|FG002|Overall Study|Reason other than specified above|0|||
162984357|NCT01929031|588645549|FG003|Overall Study|Reason other than specified above|0|||
162984358|NCT01929031|588645550|FG004|Overall Study|Reason other than specified above|1|||
162984359|NCT01929031|588645551|FG005|Overall Study|Reason other than specified above|0|||
162984360|NCT01366443|588645552|FG000|Overall Study|Lost to Follow-up|2|||
162984361|NCT01366443|588645552|FG000|Overall Study|Under 18 yo|1|||
162984362|NCT00369382|588645558|FG000|Overall Study|Death|0|||
162984363|NCT00369382|588645559|FG001|Overall Study|Death|2|||
162984364|NCT00369382|588645558|FG000|Overall Study|Physician Decision|2|||
162984365|NCT00369382|588645559|FG001|Overall Study|Physician Decision|1|||
162984366|NCT00369382|588645558|FG000|Overall Study|Withdrawal by Subject|5|||
162984367|NCT00369382|588645559|FG001|Overall Study|Withdrawal by Subject|0|||
162984368|NCT00369382|588645558|FG000|Overall Study|Randomized, not treated|2|||
162984369|NCT00369382|588645559|FG001|Overall Study|Randomized, not treated|0|||
162984370|NCT00369382|588645558|FG000|Overall Study|Other|1|||
162984371|NCT00369382|588645559|FG001|Overall Study|Other|0|||
162984372|NCT00448136|588645562|FG000|Overall Study|Death|3|||
162984373|NCT00448136|588645563|FG001|Overall Study|Death|8|||
162984374|NCT00448136|588645562|FG000|Overall Study|Investigator's decision (progression)|1|||
162984375|NCT00448136|588645563|FG001|Overall Study|Investigator's decision (progression)|0|||
162984376|NCT03407430|588645564|FG000|Washout|Protocol Violation|1|||
162984377|NCT03407430|588645565|FG001|Washout|Protocol Violation|0|||
162984378|NCT00922987|588645567|FG000|Overall Study|Insufficient clinical response|1|||
162984379|NCT00922987|588645567|FG000|Overall Study|Protocol Violation|2|||
162984380|NCT00922987|588645567|FG000|Overall Study|Adverse Event|1|||
162984381|NCT01334710|588645574|FG000|Overall Study|Trial was terminated|3|||
162984382|NCT04221789|588647319|FG000|Overall Study|deviation from protoco|22|||
162984383|NCT04221789|588647320|FG001|Overall Study|deviation from protoco|8|||
162984384|NCT04394351|588647323|FG000|Part A (16 Weeks)|Adverse Event|1|||
162984385|NCT04394351|588647324|FG001|Part A (16 Weeks)|Adverse Event|0|||
162984386|NCT04394351|588647325|FG002|Part A (16 Weeks)|Adverse Event|0|||
162984387|NCT04394351|588647326|FG003|Part A (16 Weeks)|Adverse Event|0|||
162984388|NCT04394351|588647327|FG004|Part A (16 Weeks)|Adverse Event|0|||
162984389|NCT04394351|588647328|FG005|Part A (16 Weeks)|Adverse Event|0|||
162984390|NCT04394351|588647329|FG006|Part A (16 Weeks)|Adverse Event|0|||
162984391|NCT04394351|588647330|FG007|Part A (16 Weeks)|Adverse Event|0|||
162984392|NCT04394351|588647323|FG000|Part A (16 Weeks)|Physician Decision|0|||
162984393|NCT04394351|588647324|FG001|Part A (16 Weeks)|Physician Decision|1|||
162984394|NCT04394351|588647325|FG002|Part A (16 Weeks)|Physician Decision|0|||
162984395|NCT04394351|588647326|FG003|Part A (16 Weeks)|Physician Decision|0|||
162984396|NCT04394351|588647327|FG004|Part A (16 Weeks)|Physician Decision|0|||
162984397|NCT04394351|588647328|FG005|Part A (16 Weeks)|Physician Decision|0|||
162984398|NCT04394351|588647329|FG006|Part A (16 Weeks)|Physician Decision|0|||
162984399|NCT04394351|588647330|FG007|Part A (16 Weeks)|Physician Decision|0|||
162984400|NCT04394351|588647323|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
163322608|NCT02492711|589893867|FG002|Overall Study|Withdrawal by Subject|5|||
163322609|NCT02492711|589893865|FG000|Overall Study|Physician Decision|10|||
163322610|NCT02492711|589893866|FG001|Overall Study|Physician Decision|6|||
163322611|NCT02492711|589893867|FG002|Overall Study|Physician Decision|4|||
162984401|NCT04394351|588647324|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
162984402|NCT04394351|588647325|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
162984403|NCT04394351|588647326|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
162984404|NCT04394351|588647327|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
162984405|NCT04394351|588647328|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
162984406|NCT04394351|588647329|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
163322612|NCT02492711|589893865|FG000|Overall Study|Lost to Follow-up|0|||
162984407|NCT04394351|588647330|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
162984408|NCT04394351|588647323|FG000|Part B (36 Weeks)|Adverse Event|0|||
162984409|NCT04394351|588647324|FG001|Part B (36 Weeks)|Adverse Event|0|||
162984410|NCT04394351|588647325|FG002|Part B (36 Weeks)|Adverse Event|0|||
162984411|NCT04394351|588647326|FG003|Part B (36 Weeks)|Adverse Event|0|||
162984412|NCT04394351|588647327|FG004|Part B (36 Weeks)|Adverse Event|0|||
162984413|NCT04394351|588647328|FG005|Part B (36 Weeks)|Adverse Event|0|||
163322613|NCT02492711|589893866|FG001|Overall Study|Lost to Follow-up|0|||
163322614|NCT02492711|589893867|FG002|Overall Study|Lost to Follow-up|1|||
162984414|NCT04394351|588647329|FG006|Part B (36 Weeks)|Adverse Event|1|||
162984415|NCT04394351|588647330|FG007|Part B (36 Weeks)|Adverse Event|0|||
162984416|NCT04394351|588647323|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
162984417|NCT04394351|588647324|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
162984418|NCT04394351|588647325|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
162984419|NCT04394351|588647326|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
162984420|NCT04394351|588647327|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
162984421|NCT04394351|588647328|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
162984422|NCT04394351|588647329|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
162984423|NCT04394351|588647330|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
162984424|NCT04394351|588647323|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
162984425|NCT04394351|588647324|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
162984426|NCT04394351|588647325|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
162984427|NCT04394351|588647326|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
162984428|NCT04394351|588647327|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
162984429|NCT04394351|588647328|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
162984430|NCT04394351|588647329|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
162984431|NCT04394351|588647330|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
162984432|NCT04394351|588647323|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
162984433|NCT04394351|588647324|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
162984434|NCT04394351|588647325|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
162984435|NCT04394351|588647326|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
162984436|NCT04394351|588647327|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
162984437|NCT04394351|588647328|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
162984438|NCT04394351|588647329|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
162984439|NCT04394351|588647330|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
162984440|NCT04394351|588647323|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
162984441|NCT04394351|588647324|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
162984442|NCT04394351|588647325|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
162984443|NCT04394351|588647326|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
162984444|NCT04394351|588647327|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
162984445|NCT04394351|588647328|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
162984446|NCT04394351|588647329|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
162984447|NCT04394351|588647330|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
162984448|NCT03653507|588647331|FG000|Overall Study|Miscellaneous|28|||
162984449|NCT03653507|588647332|FG001|Overall Study|Miscellaneous|19|||
162984450|NCT03653507|588647331|FG000|Overall Study|Withdrawal by Subject|37|||
162984451|NCT03653507|588647332|FG001|Overall Study|Withdrawal by Subject|22|||
162984452|NCT03653507|588647331|FG000|Overall Study|Protocol Deviation|2|||
162984453|NCT03653507|588647332|FG001|Overall Study|Protocol Deviation|1|||
162984454|NCT03653507|588647331|FG000|Overall Study|Progressive disease|117|||
162984455|NCT03653507|588647332|FG001|Overall Study|Progressive disease|168|||
162984456|NCT03653507|588647331|FG000|Overall Study|Lost to Follow-up|1|||
162984457|NCT03653507|588647332|FG001|Overall Study|Lost to Follow-up|1|||
162984458|NCT03653507|588647331|FG000|Overall Study|Death|25|||
163322615|NCT02492711|589893865|FG000|Overall Study|study treatment delay|2|||
163322616|NCT02492711|589893866|FG001|Overall Study|study treatment delay|1|||
163322617|NCT02492711|589893867|FG002|Overall Study|study treatment delay|0|||
162984459|NCT03653507|588647332|FG001|Overall Study|Death|22|||
162984460|NCT03653507|588647331|FG000|Overall Study|Adverse Event|35|||
162984461|NCT03653507|588647332|FG001|Overall Study|Adverse Event|14|||
162984462|NCT01288053|588647339|FG000|Overall Study|Death|1|||
162984463|NCT00144781|588647340|FG000|Overall Study|Adverse Event|0|||
162984464|NCT00144781|588647341|FG001|Overall Study|Adverse Event|1|||
162984465|NCT00144781|588647342|FG002|Overall Study|Adverse Event|0|||
162984466|NCT00144781|588647343|FG003|Overall Study|Adverse Event|0|||
162984467|NCT00144781|588647340|FG000|Overall Study|Non-compliant|0|||
162984468|NCT00144781|588647341|FG001|Overall Study|Non-compliant|1|||
162984469|NCT00144781|588647342|FG002|Overall Study|Non-compliant|0|||
162984470|NCT00144781|588647343|FG003|Overall Study|Non-compliant|0|||
163322618|NCT02492711|589893865|FG000|Overall Study|change in chemotherapy|0|||
163322619|NCT02492711|589893866|FG001|Overall Study|change in chemotherapy|1|||
162984471|NCT03696953|588647344|FG000|Overall Study|Withdrawal by Subject|6|||
162984472|NCT03696953|588647345|FG001|Overall Study|Withdrawal by Subject|1|||
162984473|NCT03696953|588647344|FG000|Overall Study|missed GBS swabs|2|||
162984474|NCT03696953|588647345|FG001|Overall Study|missed GBS swabs|2|||
162984475|NCT03696953|588647344|FG000|Overall Study|lost study bottle containing capsules|2|||
162984476|NCT03696953|588647345|FG001|Overall Study|lost study bottle containing capsules|0|||
162984477|NCT03696953|588647344|FG000|Overall Study|Premature birth|1|||
162984478|NCT03696953|588647345|FG001|Overall Study|Premature birth|4|||
162984479|NCT03696953|588647344|FG000|Overall Study|Gestational hypertension|1|||
162984480|NCT03696953|588647345|FG001|Overall Study|Gestational hypertension|1|||
162984481|NCT03696953|588647344|FG000|Overall Study|Gestational diabetes|2|||
162984482|NCT03696953|588647345|FG001|Overall Study|Gestational diabetes|1|||
162984483|NCT03696953|588647344|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
162984484|NCT03696953|588647345|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
162984485|NCT03696953|588647344|FG000|Overall Study|Changed prenatal provider|1|||
162984486|NCT03696953|588647345|FG001|Overall Study|Changed prenatal provider|1|||
162984487|NCT03502707|588647346|FG000|Overall Study|Adverse Event|0|||
162984488|NCT03502707|588647347|FG001|Overall Study|Adverse Event|0|||
162984489|NCT03502707|588647348|FG002|Overall Study|Adverse Event|0|||
162984490|NCT03502707|588647349|FG003|Overall Study|Adverse Event|0|||
162984491|NCT03502707|588647350|FG004|Overall Study|Adverse Event|0|||
162984492|NCT03502707|588647351|FG005|Overall Study|Adverse Event|0|||
162984493|NCT03502707|588647352|FG006|Overall Study|Adverse Event|0|||
163322620|NCT02492711|589893867|FG002|Overall Study|change in chemotherapy|0|||
163322621|NCT02492711|589893865|FG000|Overall Study|never treated|2|||
163322622|NCT02492711|589893866|FG001|Overall Study|never treated|4|||
163322623|NCT02492711|589893867|FG002|Overall Study|never treated|0|||
163322624|NCT02492711|589893865|FG000|Overall Study|Other|0|||
163322625|NCT02492711|589893866|FG001|Overall Study|Other|0|||
163322626|NCT02492711|589893867|FG002|Overall Study|Other|1|||
163322627|NCT02163694|589893871|FG000|Overall Study|Adverse event- related to progression|4|||
163322628|NCT02163694|589893872|FG001|Overall Study|Adverse event- related to progression|10|||
163322629|NCT02163694|589893871|FG000|Overall Study|Adverse event- not related to progression|7|||
163322630|NCT02163694|589893872|FG001|Overall Study|Adverse event- not related to progression|22|||
163322631|NCT02163694|589893871|FG000|Overall Study|Withdrew consent|13|||
163322632|NCT02163694|589893872|FG001|Overall Study|Withdrew consent|28|||
163322633|NCT02163694|589893871|FG000|Overall Study|Lost to Follow-up|2|||
163322634|NCT02163694|589893872|FG001|Overall Study|Lost to Follow-up|2|||
163322635|NCT02163694|589893871|FG000|Overall Study|Sponsor discontinued study|3|||
163322636|NCT02163694|589893872|FG001|Overall Study|Sponsor discontinued study|29|||
163322637|NCT02163694|589893871|FG000|Overall Study|Progressive disease per protocol|125|||
163322638|NCT02163694|589893872|FG001|Overall Study|Progressive disease per protocol|224|||
163322639|NCT02163694|589893871|FG000|Overall Study|Other, not specified|17|||
163322640|NCT02163694|589893872|FG001|Overall Study|Other, not specified|22|||
163322641|NCT02163694|589893871|FG000|Overall Study|Randomized but Not Treated|1|||
163322642|NCT02163694|589893872|FG001|Overall Study|Randomized but Not Treated|0|||
163322643|NCT02163694|589893871|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
163322644|NCT02163694|589893872|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
163322645|NCT03884101|589893873|FG000|Overall Study|Participant Ongoing in Study|202|||
163322646|NCT03884101|589893874|FG001|Overall Study|Participant Ongoing in Study|186|||
163322647|NCT03884101|589893873|FG000|Overall Study|Death|212|||
163322648|NCT03884101|589893874|FG001|Overall Study|Death|224|||
163322649|NCT03884101|589893873|FG000|Overall Study|Lost to Follow-up|0|||
163322650|NCT03884101|589893874|FG001|Overall Study|Lost to Follow-up|1|||
163322651|NCT03884101|589893873|FG000|Overall Study|Withdrawal by Subject|6|||
163322652|NCT03884101|589893874|FG001|Overall Study|Withdrawal by Subject|11|||
163322653|NCT03880955|589893881|FG000|Overall Study|Adverse Event|1|||
163322654|NCT03880955|589893881|FG000|Overall Study|Death|1|||
163322655|NCT03880955|589893881|FG000|Overall Study|Lost to Follow-up|12|||
163322656|NCT03880955|589893881|FG000|Overall Study|Withdrawal by Subject|4|||
163322657|NCT03880955|589893881|FG000|Overall Study|Missing- Study Site Closed|27|||
163322658|NCT05112900|589893882|FG000|Overall Study|Withdrawal by Subject|960|||
162984494|NCT03502707|588647353|FG007|Overall Study|Adverse Event|0|||
162984495|NCT03502707|588647354|FG008|Overall Study|Adverse Event|0|||
162984496|NCT03502707|588647355|FG009|Overall Study|Adverse Event|0|||
162984497|NCT03502707|588647356|FG010|Overall Study|Adverse Event|0|||
162984498|NCT03502707|588647357|FG011|Overall Study|Adverse Event|0|||
163322659|NCT05112900|589893883|FG001|Overall Study|Withdrawal by Subject|921|||
163322660|NCT05112900|589893884|FG002|Overall Study|Withdrawal by Subject|968|||
163322661|NCT01438853|589893887|FG000|Overall Study|Death|0|||
163322662|NCT01438853|589893888|FG001|Overall Study|Death|0|||
163322663|NCT01438853|589893889|FG002|Overall Study|Death|0|||
162984499|NCT03502707|588647358|FG012|Overall Study|Adverse Event|0|||
162984500|NCT03502707|588647359|FG013|Overall Study|Adverse Event|0|||
162984501|NCT03502707|588647360|FG014|Overall Study|Adverse Event|0|||
162984502|NCT03502707|588647361|FG015|Overall Study|Adverse Event|1|||
163322664|NCT01438853|589893890|FG003|Overall Study|Death|1|||
163322665|NCT01438853|589893887|FG000|Overall Study|Withdrawal by Subject|0|||
162984503|NCT03502707|588647362|FG016|Overall Study|Adverse Event|5|||
162984504|NCT03502707|588647363|FG017|Overall Study|Adverse Event|0|||
162984505|NCT03502707|588647346|FG000|Overall Study|Death|0|||
162984506|NCT03502707|588647347|FG001|Overall Study|Death|0|||
162984507|NCT03502707|588647348|FG002|Overall Study|Death|0|||
162984508|NCT03502707|588647349|FG003|Overall Study|Death|1|||
162984509|NCT03502707|588647350|FG004|Overall Study|Death|0|||
162984510|NCT03502707|588647351|FG005|Overall Study|Death|0|||
162984511|NCT03502707|588647352|FG006|Overall Study|Death|0|||
162984512|NCT03502707|588647353|FG007|Overall Study|Death|0|||
162984513|NCT03502707|588647354|FG008|Overall Study|Death|1|||
162984514|NCT03502707|588647355|FG009|Overall Study|Death|1|||
162984515|NCT03502707|588647356|FG010|Overall Study|Death|0|||
162984516|NCT03502707|588647357|FG011|Overall Study|Death|0|||
162984517|NCT03502707|588647358|FG012|Overall Study|Death|1|||
162984518|NCT03502707|588647359|FG013|Overall Study|Death|0|||
162984519|NCT03502707|588647360|FG014|Overall Study|Death|0|||
162984520|NCT03502707|588647361|FG015|Overall Study|Death|1|||
162984521|NCT03502707|588647362|FG016|Overall Study|Death|0|||
162984522|NCT03502707|588647363|FG017|Overall Study|Death|0|||
162984523|NCT03502707|588647346|FG000|Overall Study|Lost to Follow-up|0|||
162984524|NCT03502707|588647347|FG001|Overall Study|Lost to Follow-up|0|||
162984525|NCT03502707|588647348|FG002|Overall Study|Lost to Follow-up|0|||
162984526|NCT03502707|588647349|FG003|Overall Study|Lost to Follow-up|0|||
162984527|NCT03502707|588647350|FG004|Overall Study|Lost to Follow-up|0|||
162984528|NCT03502707|588647351|FG005|Overall Study|Lost to Follow-up|0|||
162984529|NCT03502707|588647352|FG006|Overall Study|Lost to Follow-up|0|||
162984530|NCT03502707|588647353|FG007|Overall Study|Lost to Follow-up|5|||
162984531|NCT03502707|588647354|FG008|Overall Study|Lost to Follow-up|0|||
162984532|NCT03502707|588647355|FG009|Overall Study|Lost to Follow-up|2|||
162984533|NCT03502707|588647356|FG010|Overall Study|Lost to Follow-up|1|||
162984534|NCT03502707|588647357|FG011|Overall Study|Lost to Follow-up|2|||
162984535|NCT03502707|588647358|FG012|Overall Study|Lost to Follow-up|1|||
162984536|NCT03502707|588647359|FG013|Overall Study|Lost to Follow-up|1|||
162984537|NCT03502707|588647360|FG014|Overall Study|Lost to Follow-up|0|||
162984538|NCT03502707|588647361|FG015|Overall Study|Lost to Follow-up|4|||
162984539|NCT03502707|588647362|FG016|Overall Study|Lost to Follow-up|9|||
163322666|NCT01438853|589893888|FG001|Overall Study|Withdrawal by Subject|0|||
163322667|NCT01438853|589893889|FG002|Overall Study|Withdrawal by Subject|1|||
163322668|NCT01438853|589893890|FG003|Overall Study|Withdrawal by Subject|0|||
163322669|NCT02919917|589893891|FG000|Overall Study|Withdrawal by Subject|4|||
163322670|NCT02919917|589893892|FG001|Overall Study|Withdrawal by Subject|8|||
163322671|NCT04743973|589893893|FG000|Overall Study|Withdrawal by Subject|5|||
163322672|NCT02461134|589893898|FG000|Overall Study|Adverse Event|1|||
163322673|NCT01651000|589893899|FG000|Overall Study|Adverse Event|2|||
163322674|NCT01651000|589893900|FG001|Overall Study|Adverse Event|8|||
163322675|NCT01651000|589893899|FG000|Overall Study|Lost to Follow-up|3|||
163322676|NCT01651000|589893900|FG001|Overall Study|Lost to Follow-up|2|||
163322677|NCT01651000|589893899|FG000|Overall Study|Protocol Violation|0|||
163322678|NCT01651000|589893900|FG001|Overall Study|Protocol Violation|3|||
163322679|NCT01651000|589893899|FG000|Overall Study|Withdrawal by Subject|2|||
163322680|NCT01651000|589893900|FG001|Overall Study|Withdrawal by Subject|10|||
163322681|NCT01651000|589893899|FG000|Overall Study|Subject noncompliance|0|||
163322682|NCT01651000|589893900|FG001|Overall Study|Subject noncompliance|3|||
163322683|NCT01651000|589893899|FG000|Overall Study|Lack of Efficacy|1|||
163322684|NCT01651000|589893900|FG001|Overall Study|Lack of Efficacy|1|||
163322685|NCT01651000|589893899|FG000|Overall Study|Physician Decision|1|||
163322686|NCT01651000|589893900|FG001|Overall Study|Physician Decision|0|||
163322687|NCT01651000|589893899|FG000|Overall Study|Administrative reason|1|||
163322688|NCT01651000|589893900|FG001|Overall Study|Administrative reason|0|||
162984540|NCT03502707|588647363|FG017|Overall Study|Lost to Follow-up|2|||
162984541|NCT03502707|588647346|FG000|Overall Study|Physician Decision|0|||
162984542|NCT03502707|588647347|FG001|Overall Study|Physician Decision|0|||
162984543|NCT03502707|588647348|FG002|Overall Study|Physician Decision|0|||
162984544|NCT03502707|588647349|FG003|Overall Study|Physician Decision|0|||
162984545|NCT03502707|588647350|FG004|Overall Study|Physician Decision|0|||
162984546|NCT03502707|588647351|FG005|Overall Study|Physician Decision|0|||
162984547|NCT03502707|588647352|FG006|Overall Study|Physician Decision|0|||
162984548|NCT03502707|588647353|FG007|Overall Study|Physician Decision|0|||
162984549|NCT03502707|588647354|FG008|Overall Study|Physician Decision|2|||
162984550|NCT03502707|588647355|FG009|Overall Study|Physician Decision|1|||
162984551|NCT03502707|588647356|FG010|Overall Study|Physician Decision|0|||
162984552|NCT03502707|588647357|FG011|Overall Study|Physician Decision|0|||
162984553|NCT03502707|588647358|FG012|Overall Study|Physician Decision|0|||
162984554|NCT03502707|588647359|FG013|Overall Study|Physician Decision|0|||
163322689|NCT01651000|589893899|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
163322690|NCT01651000|589893900|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
163322691|NCT05412004|589894476|FG000|Overall Study|Adverse Event|0|||
163322692|NCT05412004|589894477|FG001|Overall Study|Adverse Event|2|||
163322693|NCT05412004|589894478|FG002|Overall Study|Adverse Event|1|||
163322694|NCT05412004|589894479|FG003|Overall Study|Adverse Event|5|||
162984555|NCT03502707|588647360|FG014|Overall Study|Physician Decision|1|||
162984556|NCT03502707|588647361|FG015|Overall Study|Physician Decision|3|||
162984557|NCT03502707|588647362|FG016|Overall Study|Physician Decision|0|||
162984558|NCT03502707|588647363|FG017|Overall Study|Physician Decision|0|||
162984559|NCT03502707|588647346|FG000|Overall Study|Protocol Violation|0|||
162984560|NCT03502707|588647347|FG001|Overall Study|Protocol Violation|0|||
162984561|NCT03502707|588647348|FG002|Overall Study|Protocol Violation|0|||
162984562|NCT03502707|588647349|FG003|Overall Study|Protocol Violation|0|||
162984563|NCT03502707|588647350|FG004|Overall Study|Protocol Violation|0|||
162984564|NCT03502707|588647351|FG005|Overall Study|Protocol Violation|0|||
162984565|NCT03502707|588647352|FG006|Overall Study|Protocol Violation|0|||
162984566|NCT03502707|588647353|FG007|Overall Study|Protocol Violation|0|||
162984567|NCT03502707|588647354|FG008|Overall Study|Protocol Violation|0|||
162984568|NCT03502707|588647355|FG009|Overall Study|Protocol Violation|0|||
162984569|NCT03502707|588647356|FG010|Overall Study|Protocol Violation|0|||
162984570|NCT03502707|588647357|FG011|Overall Study|Protocol Violation|0|||
162984571|NCT03502707|588647358|FG012|Overall Study|Protocol Violation|0|||
162984572|NCT03502707|588647359|FG013|Overall Study|Protocol Violation|0|||
162984573|NCT03502707|588647360|FG014|Overall Study|Protocol Violation|0|||
162984574|NCT03502707|588647361|FG015|Overall Study|Protocol Violation|1|||
162984575|NCT03502707|588647362|FG016|Overall Study|Protocol Violation|0|||
162984576|NCT03502707|588647363|FG017|Overall Study|Protocol Violation|0|||
163211967|NCT05119569|589490679|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
163403348|NCT00874120|590188544|FG001|Second Intervention|Withdrawal by Subject|0|||
162984577|NCT03502707|588647346|FG000|Overall Study|Withdrawal by Subject|1|||
162984578|NCT03502707|588647347|FG001|Overall Study|Withdrawal by Subject|1|||
162984579|NCT03502707|588647348|FG002|Overall Study|Withdrawal by Subject|0|||
162984580|NCT03502707|588647349|FG003|Overall Study|Withdrawal by Subject|0|||
162984581|NCT03502707|588647350|FG004|Overall Study|Withdrawal by Subject|0|||
162984582|NCT03502707|588647351|FG005|Overall Study|Withdrawal by Subject|2|||
162984583|NCT03502707|588647352|FG006|Overall Study|Withdrawal by Subject|0|||
163403349|NCT00874120|590188543|FG000|Second Intervention|Protocol Violation|1|||
163403350|NCT00874120|590188544|FG001|Second Intervention|Protocol Violation|0|||
163403351|NCT00105443|590188550|FG000|Double-Blind Treatment|Adverse Event|1|||
163403352|NCT00105443|590188551|FG001|Double-Blind Treatment|Adverse Event|0|||
163403353|NCT00105443|590188552|FG002|Double-Blind Treatment|Adverse Event|0|||
163403354|NCT00105443|590188553|FG003|Double-Blind Treatment|Adverse Event|0|||
162984584|NCT03502707|588647353|FG007|Overall Study|Withdrawal by Subject|3|||
162984585|NCT03502707|588647354|FG008|Overall Study|Withdrawal by Subject|1|||
162984586|NCT03502707|588647355|FG009|Overall Study|Withdrawal by Subject|2|||
162984587|NCT03502707|588647356|FG010|Overall Study|Withdrawal by Subject|12|||
162984588|NCT03502707|588647357|FG011|Overall Study|Withdrawal by Subject|23|||
162984589|NCT03502707|588647358|FG012|Overall Study|Withdrawal by Subject|5|||
162984590|NCT03502707|588647359|FG013|Overall Study|Withdrawal by Subject|3|||
162984591|NCT03502707|588647360|FG014|Overall Study|Withdrawal by Subject|3|||
162984592|NCT03502707|588647361|FG015|Overall Study|Withdrawal by Subject|43|||
162984593|NCT03502707|588647362|FG016|Overall Study|Withdrawal by Subject|44|||
162984594|NCT03502707|588647363|FG017|Overall Study|Withdrawal by Subject|18|||
162984595|NCT03502707|588647346|FG000|Overall Study|Sponsor's Decision|1|||
162984596|NCT03502707|588647347|FG001|Overall Study|Sponsor's Decision|0|||
162984597|NCT03502707|588647348|FG002|Overall Study|Sponsor's Decision|0|||
162984598|NCT03502707|588647349|FG003|Overall Study|Sponsor's Decision|0|||
162984599|NCT03502707|588647350|FG004|Overall Study|Sponsor's Decision|0|||
163211968|NCT05119569|589490680|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
163211969|NCT05119569|589490681|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
163211970|NCT05119569|589490678|FG000|Double Blind Treatment Phase|Adverse Event|6|||
163211971|NCT05119569|589490679|FG001|Double Blind Treatment Phase|Adverse Event|0|||
163211972|NCT05119569|589490680|FG002|Double Blind Treatment Phase|Adverse Event|0|||
163211973|NCT05119569|589490681|FG003|Double Blind Treatment Phase|Adverse Event|0|||
163211974|NCT05119569|589490678|FG000|Open Label Extension Phase|Ongoing in the study|0|||
163211975|NCT05119569|589490679|FG001|Open Label Extension Phase|Ongoing in the study|0|||
163211976|NCT05119569|589490680|FG002|Open Label Extension Phase|Ongoing in the study|65|||
163211977|NCT05119569|589490681|FG003|Open Label Extension Phase|Ongoing in the study|34|||
163211978|NCT02623439|589490684|FG000|Overall Study|Withdrawal by Subject|1|||
163211979|NCT02623439|589490684|FG000|Overall Study|Screen Failure|1|||
163211980|NCT02200445|589490688|FG000|Overall Study|Lack of Efficacy|1|||
163211981|NCT02200445|589490689|FG001|Overall Study|Lack of Efficacy|2|||
163211982|NCT02200445|589490690|FG002|Overall Study|Lack of Efficacy|2|||
163211983|NCT02200445|589490688|FG000|Overall Study|Adverse Event|0|||
163211984|NCT02200445|589490689|FG001|Overall Study|Adverse Event|2|||
163211985|NCT02200445|589490690|FG002|Overall Study|Adverse Event|0|||
163211986|NCT04484142|589490691|FG000|Overall Study|Adverse Event|13|||
163211987|NCT04484142|589490691|FG000|Overall Study|Progressive Disease|87|||
163211988|NCT04484142|589490691|FG000|Overall Study|Clinical Progression|10|||
163211989|NCT04484142|589490691|FG000|Overall Study|Withdrawal by Subject|6|||
163211990|NCT04484142|589490691|FG000|Overall Study|Physician Decision|1|||
163211991|NCT03700671|589490692|FG000|Overall Study|Lack of Efficacy|1|||
162984600|NCT03502707|588647351|FG005|Overall Study|Sponsor's Decision|0|||
162984601|NCT03502707|588647352|FG006|Overall Study|Sponsor's Decision|0|||
162984602|NCT03502707|588647353|FG007|Overall Study|Sponsor's Decision|0|||
162984603|NCT03502707|588647354|FG008|Overall Study|Sponsor's Decision|0|||
162984604|NCT03502707|588647355|FG009|Overall Study|Sponsor's Decision|1|||
162984605|NCT03502707|588647356|FG010|Overall Study|Sponsor's Decision|0|||
162984606|NCT03502707|588647357|FG011|Overall Study|Sponsor's Decision|0|||
162984607|NCT03502707|588647358|FG012|Overall Study|Sponsor's Decision|0|||
162984608|NCT03502707|588647359|FG013|Overall Study|Sponsor's Decision|0|||
162984609|NCT03502707|588647360|FG014|Overall Study|Sponsor's Decision|0|||
162984610|NCT03502707|588647361|FG015|Overall Study|Sponsor's Decision|2|||
162984611|NCT03502707|588647362|FG016|Overall Study|Sponsor's Decision|1|||
162984612|NCT03502707|588647363|FG017|Overall Study|Sponsor's Decision|0|||
162984613|NCT03502707|588647346|FG000|Overall Study|Initiated Prohibited Medication|0|||
162984614|NCT03502707|588647347|FG001|Overall Study|Initiated Prohibited Medication|0|||
162984615|NCT03502707|588647348|FG002|Overall Study|Initiated Prohibited Medication|0|||
162984616|NCT03502707|588647349|FG003|Overall Study|Initiated Prohibited Medication|0|||
162984617|NCT03502707|588647350|FG004|Overall Study|Initiated Prohibited Medication|0|||
162984618|NCT03502707|588647351|FG005|Overall Study|Initiated Prohibited Medication|0|||
162984619|NCT03502707|588647352|FG006|Overall Study|Initiated Prohibited Medication|0|||
162984620|NCT03502707|588647353|FG007|Overall Study|Initiated Prohibited Medication|0|||
162984621|NCT03502707|588647354|FG008|Overall Study|Initiated Prohibited Medication|0|||
162984622|NCT03502707|588647355|FG009|Overall Study|Initiated Prohibited Medication|0|||
162984623|NCT03502707|588647356|FG010|Overall Study|Initiated Prohibited Medication|0|||
163322695|NCT05412004|589894476|FG000|Overall Study|Assigned Treatment by Mistake|5|||
163322696|NCT05412004|589894477|FG001|Overall Study|Assigned Treatment by Mistake|10|||
163322697|NCT05412004|589894478|FG002|Overall Study|Assigned Treatment by Mistake|2|||
163322698|NCT05412004|589894479|FG003|Overall Study|Assigned Treatment by Mistake|5|||
163322699|NCT05412004|589894476|FG000|Overall Study|Lost to Follow-up|3|||
163322700|NCT05412004|589894477|FG001|Overall Study|Lost to Follow-up|0|||
163322701|NCT05412004|589894478|FG002|Overall Study|Lost to Follow-up|0|||
163322702|NCT05412004|589894479|FG003|Overall Study|Lost to Follow-up|0|||
163322703|NCT05412004|589894476|FG000|Overall Study|Patient could not travel to site|0|||
163322704|NCT05412004|589894477|FG001|Overall Study|Patient could not travel to site|1|||
163322705|NCT05412004|589894478|FG002|Overall Study|Patient could not travel to site|0|||
163322706|NCT05412004|589894479|FG003|Overall Study|Patient could not travel to site|0|||
163322707|NCT05412004|589894476|FG000|Overall Study|Physician Decision|0|||
163322708|NCT05412004|589894477|FG001|Overall Study|Physician Decision|1|||
163322709|NCT05412004|589894478|FG002|Overall Study|Physician Decision|0|||
163322710|NCT05412004|589894479|FG003|Overall Study|Physician Decision|0|||
163322711|NCT05412004|589894476|FG000|Overall Study|Pregnancy|0|||
163322712|NCT05412004|589894477|FG001|Overall Study|Pregnancy|1|||
163322713|NCT05412004|589894478|FG002|Overall Study|Pregnancy|0|||
163322714|NCT05412004|589894479|FG003|Overall Study|Pregnancy|0|||
163322715|NCT05412004|589894476|FG000|Overall Study|Protocol Violation|1|||
163322716|NCT05412004|589894477|FG001|Overall Study|Protocol Violation|0|||
163322717|NCT05412004|589894478|FG002|Overall Study|Protocol Violation|0|||
163322718|NCT05412004|589894479|FG003|Overall Study|Protocol Violation|0|||
163322719|NCT05412004|589894476|FG000|Overall Study|Withdrawal by Subject|4|||
163322720|NCT05412004|589894477|FG001|Overall Study|Withdrawal by Subject|19|||
163322721|NCT05412004|589894478|FG002|Overall Study|Withdrawal by Subject|4|||
163322722|NCT05412004|589894479|FG003|Overall Study|Withdrawal by Subject|14|||
163322723|NCT05412004|589894476|FG000|Overall Study|Screen Failure|0|||
163322724|NCT05412004|589894477|FG001|Overall Study|Screen Failure|0|||
163322725|NCT05412004|589894478|FG002|Overall Study|Screen Failure|0|||
163322726|NCT05412004|589894479|FG003|Overall Study|Screen Failure|1|||
163322727|NCT05412004|589894476|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
163322728|NCT05412004|589894477|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
163322729|NCT05412004|589894478|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
163322730|NCT05412004|589894479|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
163322731|NCT03781089|589894480|FG000|Overall Study|Constipation|1|||
163322732|NCT03781089|589894481|FG001|Overall Study|Constipation|0|||
163322733|NCT03781089|589894480|FG000|Overall Study|Positive pregnancy test|0|||
163322734|NCT03781089|589894481|FG001|Overall Study|Positive pregnancy test|1|||
162984624|NCT03502707|588647357|FG011|Overall Study|Initiated Prohibited Medication|0|||
162984625|NCT03502707|588647358|FG012|Overall Study|Initiated Prohibited Medication|0|||
162984626|NCT03502707|588647359|FG013|Overall Study|Initiated Prohibited Medication|0|||
162984627|NCT03502707|588647360|FG014|Overall Study|Initiated Prohibited Medication|0|||
162984628|NCT03502707|588647361|FG015|Overall Study|Initiated Prohibited Medication|0|||
162984629|NCT03502707|588647362|FG016|Overall Study|Initiated Prohibited Medication|1|||
163322735|NCT04644029|589894482|FG000|Overall Study|Death|1|||
163322736|NCT04644029|589894483|FG001|Overall Study|Death|0|||
163322737|NCT04644029|589894482|FG000|Overall Study|Physician Decision|1|||
163322738|NCT04644029|589894483|FG001|Overall Study|Physician Decision|2|||
162984630|NCT03502707|588647363|FG017|Overall Study|Initiated Prohibited Medication|0|||
162984631|NCT03502707|588647346|FG000|Overall Study|Other|0|||
162984632|NCT03502707|588647347|FG001|Overall Study|Other|0|||
162984633|NCT03502707|588647348|FG002|Overall Study|Other|0|||
162984634|NCT03502707|588647349|FG003|Overall Study|Other|0|||
162984635|NCT03502707|588647350|FG004|Overall Study|Other|0|||
162984636|NCT03502707|588647351|FG005|Overall Study|Other|0|||
162984637|NCT03502707|588647352|FG006|Overall Study|Other|0|||
162984638|NCT03502707|588647353|FG007|Overall Study|Other|0|||
162984639|NCT03502707|588647354|FG008|Overall Study|Other|1|||
162984640|NCT03502707|588647355|FG009|Overall Study|Other|1|||
162984641|NCT03502707|588647356|FG010|Overall Study|Other|2|||
162984642|NCT03502707|588647357|FG011|Overall Study|Other|0|||
162984643|NCT03502707|588647358|FG012|Overall Study|Other|0|||
162984644|NCT03502707|588647359|FG013|Overall Study|Other|0|||
162984645|NCT03502707|588647360|FG014|Overall Study|Other|0|||
162984646|NCT03502707|588647361|FG015|Overall Study|Other|4|||
162984647|NCT03502707|588647362|FG016|Overall Study|Other|1|||
162984648|NCT03502707|588647363|FG017|Overall Study|Other|0|||
162984649|NCT03502707|588647346|FG000|Overall Study|Randomized but not vaccinated|0|||
162984650|NCT03502707|588647347|FG001|Overall Study|Randomized but not vaccinated|0|||
162984651|NCT03502707|588647348|FG002|Overall Study|Randomized but not vaccinated|0|||
162984652|NCT03502707|588647349|FG003|Overall Study|Randomized but not vaccinated|0|||
162984653|NCT03502707|588647350|FG004|Overall Study|Randomized but not vaccinated|0|||
162984654|NCT03502707|588647351|FG005|Overall Study|Randomized but not vaccinated|0|||
162984655|NCT03502707|588647352|FG006|Overall Study|Randomized but not vaccinated|0|||
162984656|NCT03502707|588647353|FG007|Overall Study|Randomized but not vaccinated|0|||
162984657|NCT03502707|588647354|FG008|Overall Study|Randomized but not vaccinated|0|||
162984658|NCT03502707|588647355|FG009|Overall Study|Randomized but not vaccinated|0|||
162984659|NCT03502707|588647356|FG010|Overall Study|Randomized but not vaccinated|0|||
162984660|NCT03502707|588647357|FG011|Overall Study|Randomized but not vaccinated|1|||
162984661|NCT03502707|588647358|FG012|Overall Study|Randomized but not vaccinated|0|||
162984662|NCT03502707|588647359|FG013|Overall Study|Randomized but not vaccinated|0|||
163322739|NCT04644029|589894482|FG000|Overall Study|Withdrawal by Subject|21|||
163322740|NCT04644029|589894483|FG001|Overall Study|Withdrawal by Subject|19|||
163322741|NCT04644029|589894482|FG000|Overall Study|Lost to Follow-up|31|||
163322742|NCT04644029|589894483|FG001|Overall Study|Lost to Follow-up|34|||
163322743|NCT04644029|589894482|FG000|Overall Study|Study Terminated by Sponsor|308|||
163322744|NCT04644029|589894483|FG001|Overall Study|Study Terminated by Sponsor|309|||
163322745|NCT04644029|589894482|FG000|Overall Study|Randomized in Error|2|||
163322746|NCT04644029|589894483|FG001|Overall Study|Randomized in Error|1|||
163322747|NCT04644029|589894482|FG000|Overall Study|Other|0|||
163322748|NCT04644029|589894483|FG001|Overall Study|Other|1|||
163322749|NCT02246127|589894484|FG000|First Course Treatment|Adverse Event|9|||
163322750|NCT02246127|589894485|FG001|First Course Treatment|Adverse Event|7|||
163322751|NCT02246127|589894484|FG000|First Course Treatment|Withdrawal by Subject|6|||
163322752|NCT02246127|589894485|FG001|First Course Treatment|Withdrawal by Subject|7|||
163322753|NCT02246127|589894484|FG000|First Course Treatment|Physician Decision|9|||
163322754|NCT02246127|589894485|FG001|First Course Treatment|Physician Decision|9|||
163322755|NCT02246127|589894484|FG000|First Course Treatment|Death|3|||
163322756|NCT02246127|589894485|FG001|First Course Treatment|Death|3|||
163322757|NCT02246127|589894484|FG000|First Course Treatment|Not reported reasons|6|||
163322758|NCT02246127|589894485|FG001|First Course Treatment|Not reported reasons|7|||
163322759|NCT02246127|589894484|FG000|First Course Treatment|Not treated|3|||
163322760|NCT02246127|589894485|FG001|First Course Treatment|Not treated|3|||
163322761|NCT05988398|589894486|FG000|Overall Study|Lack of time|21|||
163322762|NCT05988398|589894487|FG001|Overall Study|Lack of time|0|||
163322763|NCT05988398|589894486|FG000|Overall Study|Absent from school|0|||
163322764|NCT05988398|589894487|FG001|Overall Study|Absent from school|38|||
163322765|NCT05988398|589894486|FG000|Overall Study|Chose not to participate|0|||
163322766|NCT05988398|589894487|FG001|Overall Study|Chose not to participate|42|||
163322767|NCT05988398|589894486|FG000|Overall Study|Other commitments (e.g., sports)|0|||
163322768|NCT05988398|589894487|FG001|Overall Study|Other commitments (e.g., sports)|25|||
163322769|NCT03733626|589894489|FG000|Overall Study|Physician Decision|4|||
163322770|NCT03733626|589894490|FG001|Overall Study|Physician Decision|4|||
163322771|NCT05147584|589894491|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
163322772|NCT03370913|589894492|FG000|Overall Study|Death|1|||
162984663|NCT03502707|588647360|FG014|Overall Study|Randomized but not vaccinated|0|||
162984664|NCT03502707|588647361|FG015|Overall Study|Randomized but not vaccinated|0|||
162984665|NCT03502707|588647362|FG016|Overall Study|Randomized but not vaccinated|0|||
162984666|NCT03502707|588647363|FG017|Overall Study|Randomized but not vaccinated|1|||
162984667|NCT04092894|588647364|FG000|Overall Study|Withdrawal by Subject|2|||
162984668|NCT04092894|588647365|FG001|Overall Study|Withdrawal by Subject|4|||
163322773|NCT03370913|589894492|FG000|Overall Study|Lost to Follow-up|1|||
163322774|NCT04560179|589894493|FG000|Overall Study|Physician Decision|1|||
163322775|NCT04560179|589894494|FG001|Overall Study|Physician Decision|0|||
163322776|NCT04560179|589894495|FG002|Overall Study|Physician Decision|0|||
162984669|NCT04092894|588647364|FG000|Overall Study|Discontinued EEG after randomization|10|||
162984670|NCT04092894|588647365|FG001|Overall Study|Discontinued EEG after randomization|6|||
162984671|NCT01106014|588647366|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
162984672|NCT01106014|588647367|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
162984673|NCT01106014|588647366|FG000|Overall Study|Adverse Event|78|||
162984674|NCT01106014|588647367|FG001|Overall Study|Adverse Event|42|||
162984675|NCT01106014|588647366|FG000|Overall Study|Withdrawal by Subject|43|||
162984676|NCT01106014|588647367|FG001|Overall Study|Withdrawal by Subject|37|||
162984677|NCT01106014|588647366|FG000|Overall Study|Administrative reason|7|||
162984678|NCT01106014|588647367|FG001|Overall Study|Administrative reason|6|||
162984679|NCT01106014|588647366|FG000|Overall Study|Lost to Follow-up|2|||
162984680|NCT01106014|588647367|FG001|Overall Study|Lost to Follow-up|3|||
162984681|NCT02935686|588647368|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
162984682|NCT02935686|588647369|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
162984683|NCT02935686|588647370|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
162984684|NCT02935686|588647371|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
162984685|NCT02935686|588647372|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
162984686|NCT02935686|588647368|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
162984687|NCT02935686|588647369|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
163322777|NCT04560179|589894496|FG003|Overall Study|Physician Decision|0|||
163322778|NCT04560179|589894497|FG004|Overall Study|Physician Decision|0|||
163322779|NCT04560179|589894493|FG000|Overall Study|Adverse Event|0|||
163322780|NCT04560179|589894494|FG001|Overall Study|Adverse Event|0|||
163322781|NCT04560179|589894495|FG002|Overall Study|Adverse Event|0|||
162984688|NCT02935686|588647370|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
162984689|NCT02935686|588647371|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
162984690|NCT02935686|588647372|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
162984691|NCT02935686|588647368|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
162984692|NCT02935686|588647369|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
162984693|NCT02935686|588647370|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
162984694|NCT02935686|588647371|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
162984695|NCT02935686|588647372|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
162984696|NCT02935686|588647368|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
162984697|NCT02935686|588647369|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
162984698|NCT02935686|588647370|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
162984699|NCT02935686|588647371|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
162984700|NCT02935686|588647372|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
163322782|NCT04560179|589894496|FG003|Overall Study|Adverse Event|1|||
162984701|NCT02935686|588647368|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
162984702|NCT02935686|588647369|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
162984703|NCT02935686|588647370|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
162984704|NCT02935686|588647371|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
163322783|NCT04560179|589894497|FG004|Overall Study|Adverse Event|0|||
163322784|NCT04078152|589894498|FG000|Overall Study|Other|83|||
163322785|NCT04078152|589894499|FG001|Overall Study|Other|22|||
163059797|NCT02030600|588928217|FG000|Treatment Period 2|Lack of Efficacy|2|||
163322786|NCT04078152|589894500|FG002|Overall Study|Other|25|||
163322787|NCT04078152|589894498|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
163322788|NCT04078152|589894499|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
163322789|NCT04078152|589894500|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
163322790|NCT04078152|589894498|FG000|Overall Study|Withdrawal by Subject|5|||
163322791|NCT04078152|589894499|FG001|Overall Study|Withdrawal by Subject|0|||
163322792|NCT04078152|589894500|FG002|Overall Study|Withdrawal by Subject|1|||
163322793|NCT04078152|589894498|FG000|Overall Study|Death|10|||
163322794|NCT04078152|589894499|FG001|Overall Study|Death|2|||
163322795|NCT04078152|589894500|FG002|Overall Study|Death|12|||
163322796|NCT04078152|589894498|FG000|Overall Study|Adverse Event|1|||
163322797|NCT04078152|589894499|FG001|Overall Study|Adverse Event|0|||
163322798|NCT04078152|589894500|FG002|Overall Study|Adverse Event|0|||
163322799|NCT05454514|589894506|FG000|Overall Study|Withdrawal by Subject|4|||
163322800|NCT04795245|589894507|FG000|Overall Study|Unkown reason|7|||
163322801|NCT04795245|589894507|FG000|Overall Study|Death|17|||
163322802|NCT04795245|589894507|FG000|Overall Study|Other than listed|19|||
163322803|NCT04795245|589894507|FG000|Overall Study|Adverse Event|143|||
163322804|NCT04795245|589894507|FG000|Overall Study|Progressive disease|512|||
163322805|NCT04795245|589894507|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
163322806|NCT03279978|589894509|FG000|Overall Study|Withdrawal by Subject|0|||
163322807|NCT03279978|589894510|FG001|Overall Study|Withdrawal by Subject|1|||
162984705|NCT02935686|588647372|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
162984706|NCT02935686|588647368|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
163059798|NCT02030600|588928218|FG001|Treatment Period 2|Lack of Efficacy|1|||
163322808|NCT03279978|589894511|FG002|Overall Study|Withdrawal by Subject|0|||
163322809|NCT03279978|589894512|FG003|Overall Study|Withdrawal by Subject|0|||
162984707|NCT02935686|588647369|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
162984708|NCT02935686|588647370|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
162984709|NCT02935686|588647371|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
162984710|NCT02935686|588647372|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
162984711|NCT02935686|588647368|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
162984712|NCT02935686|588647369|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
162984713|NCT02935686|588647370|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
162984714|NCT02935686|588647371|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
162984715|NCT02935686|588647372|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
162984716|NCT02935686|588647368|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
162984717|NCT02935686|588647369|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
162984718|NCT02935686|588647370|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
162984719|NCT02935686|588647371|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
162984720|NCT02935686|588647372|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
162984721|NCT02935686|588647368|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
162984722|NCT02935686|588647369|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
162984723|NCT02935686|588647370|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
162984724|NCT02935686|588647371|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
162984725|NCT02935686|588647372|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
162984726|NCT02935686|588647368|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
162984727|NCT02935686|588647369|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
162984728|NCT02935686|588647370|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
162984729|NCT02935686|588647371|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
162984730|NCT02935686|588647372|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
162984731|NCT02935686|588647368|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
162984732|NCT02935686|588647369|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
162984733|NCT02935686|588647370|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
162984734|NCT02935686|588647371|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
162984735|NCT02935686|588647372|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
162984736|NCT00062010|588647375|FG000|Overall Study|Ineligible|3|||
162984737|NCT00852969|588647378|FG000|Overall Study|Adverse Event|0|||
162984738|NCT00852969|588647379|FG001|Overall Study|Adverse Event|1|||
162984739|NCT00852969|588647378|FG000|Overall Study|Lost to Follow-up|0|||
162984740|NCT00852969|588647379|FG001|Overall Study|Lost to Follow-up|1|||
162984741|NCT01951885|588647384|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
162984742|NCT01951885|588647385|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
162984743|NCT01951885|588647384|FG000|Overall Study|Adverse Event|1|||
162984744|NCT01951885|588647385|FG001|Overall Study|Adverse Event|0|||
162984745|NCT01951885|588647384|FG000|Overall Study|Withdrawal by Subject|0|||
162984746|NCT01951885|588647385|FG001|Overall Study|Withdrawal by Subject|1|||
162984747|NCT01951885|588647384|FG000|Overall Study|ineligible due to a change in donor|0|||
162984748|NCT01951885|588647385|FG001|Overall Study|ineligible due to a change in donor|1|||
162984749|NCT01951885|588647384|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
162984750|NCT01951885|588647385|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
162984751|NCT01687478|588647386|FG000|Overall Study|Adverse Event|3|||
163322810|NCT03279978|589894513|FG004|Overall Study|Withdrawal by Subject|0|||
163322811|NCT03279978|589894514|FG005|Overall Study|Withdrawal by Subject|0|||
163322812|NCT03279978|589894515|FG006|Overall Study|Withdrawal by Subject|0|||
163322813|NCT03279978|589894516|FG007|Overall Study|Withdrawal by Subject|0|||
163322814|NCT03279978|589894517|FG008|Overall Study|Withdrawal by Subject|0|||
163322815|NCT03279978|589894518|FG009|Overall Study|Withdrawal by Subject|1|||
163322816|NCT03279978|589894509|FG000|Overall Study|Lost to Follow-up|1|||
163322817|NCT03279978|589894510|FG001|Overall Study|Lost to Follow-up|0|||
163322818|NCT03279978|589894511|FG002|Overall Study|Lost to Follow-up|1|||
163322819|NCT03279978|589894512|FG003|Overall Study|Lost to Follow-up|0|||
163322820|NCT03279978|589894513|FG004|Overall Study|Lost to Follow-up|0|||
163322821|NCT03279978|589894514|FG005|Overall Study|Lost to Follow-up|0|||
163322822|NCT03279978|589894515|FG006|Overall Study|Lost to Follow-up|0|||
163322823|NCT03279978|589894516|FG007|Overall Study|Lost to Follow-up|0|||
163322824|NCT03279978|589894517|FG008|Overall Study|Lost to Follow-up|0|||
163322825|NCT03279978|589894518|FG009|Overall Study|Lost to Follow-up|0|||
163322826|NCT03279978|589894509|FG000|Overall Study|Other than stated above|0|||
163322827|NCT03279978|589894510|FG001|Overall Study|Other than stated above|0|||
163322828|NCT03279978|589894511|FG002|Overall Study|Other than stated above|0|||
163322829|NCT03279978|589894512|FG003|Overall Study|Other than stated above|0|||
162984752|NCT01687478|588647387|FG001|Overall Study|Adverse Event|10|||
162984753|NCT01687478|588647386|FG000|Overall Study|Lost to Follow-up|1|||
162984754|NCT01687478|588647387|FG001|Overall Study|Lost to Follow-up|3|||
162984755|NCT01687478|588647386|FG000|Overall Study|Protocol Violation|0|||
162984756|NCT01687478|588647387|FG001|Overall Study|Protocol Violation|2|||
162984757|NCT01687478|588647386|FG000|Overall Study|Withdrawal by Subject|21|||
163322830|NCT03279978|589894513|FG004|Overall Study|Other than stated above|0|||
162984758|NCT01687478|588647387|FG001|Overall Study|Withdrawal by Subject|19|||
162984759|NCT01687478|588647386|FG000|Overall Study|Physician Decision|1|||
162984760|NCT01687478|588647387|FG001|Overall Study|Physician Decision|3|||
162984761|NCT01687478|588647386|FG000|Overall Study|Entry Criteria Not Met|6|||
162984762|NCT01687478|588647387|FG001|Overall Study|Entry Criteria Not Met|2|||
162984763|NCT03188718|588647388|FG000|Overall Study|Participant noncompliance|4|||
162984764|NCT03188718|588647388|FG000|Overall Study|Withdrawal by Subject|1|||
162984765|NCT03188718|588647388|FG000|Overall Study|Device failure|3|||
162984766|NCT02534844|588647398|FG000|Part B|Withdrawal by Subject|0|||
162984767|NCT02534844|588647399|FG001|Part B|Withdrawal by Subject|0|||
162984768|NCT02534844|588647400|FG002|Part B|Withdrawal by Subject|0|||
162984769|NCT02534844|588647401|FG003|Part B|Withdrawal by Subject|0|||
162984770|NCT02534844|588647402|FG004|Part B|Withdrawal by Subject|2|||
162984771|NCT02534844|588647403|FG005|Part B|Withdrawal by Subject|1|||
162984772|NCT01971970|588647404|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
162984773|NCT01971970|588647405|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
162984774|NCT01971970|588647404|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
162984775|NCT01971970|588647405|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
162984776|NCT01971970|588647404|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
162984777|NCT01971970|588647405|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
162984778|NCT01971970|588647404|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
162984779|NCT01971970|588647405|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
162984780|NCT01971970|588647404|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
162984781|NCT01971970|588647405|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
162984782|NCT01971970|588647404|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
162984783|NCT01971970|588647405|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
162984784|NCT01971970|588647404|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
162984785|NCT01971970|588647405|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
162984786|NCT00848107|588647406|FG000|Overall Study|Lost to Follow-up|2|||
162984787|NCT00848107|588647406|FG000|Overall Study|Withdrawal by Subject|8|||
162984788|NCT00848107|588647406|FG000|Overall Study|Adverse Event|9|||
162984789|NCT00848107|588647406|FG000|Overall Study|Death|1|||
162984790|NCT00848107|588647406|FG000|Overall Study|Pregnancy|1|||
162984791|NCT01831765|588647407|FG000|Overall Study|Lack of Efficacy|1|||
162984792|NCT01831765|588647408|FG001|Overall Study|Lack of Efficacy|0|||
162984793|NCT01831765|588647409|FG002|Overall Study|Lack of Efficacy|0|||
162984794|NCT01831765|588647407|FG000|Overall Study|Other, sponsor withdrew subject|0|||
162984795|NCT01831765|588647408|FG001|Overall Study|Other, sponsor withdrew subject|1|||
162984796|NCT01831765|588647409|FG002|Overall Study|Other, sponsor withdrew subject|0|||
162984797|NCT01831765|588647407|FG000|Overall Study|Pregnancy|1|||
162984798|NCT01831765|588647408|FG001|Overall Study|Pregnancy|1|||
162984799|NCT01831765|588647409|FG002|Overall Study|Pregnancy|2|||
162984800|NCT01831765|588647407|FG000|Overall Study|Death|0|||
162984801|NCT01831765|588647408|FG001|Overall Study|Death|1|||
162984802|NCT01831765|588647409|FG002|Overall Study|Death|1|||
162984803|NCT01831765|588647407|FG000|Overall Study|Other, site closed|1|||
162984804|NCT01831765|588647408|FG001|Overall Study|Other, site closed|1|||
163322831|NCT03279978|589894514|FG005|Overall Study|Other than stated above|0|||
163322832|NCT03279978|589894515|FG006|Overall Study|Other than stated above|1|||
162984805|NCT01831765|588647409|FG002|Overall Study|Other, site closed|0|||
162984806|NCT01831765|588647407|FG000|Overall Study|Adverse Event|5|||
162984807|NCT01831765|588647408|FG001|Overall Study|Adverse Event|3|||
162984808|NCT01831765|588647409|FG002|Overall Study|Adverse Event|3|||
162984809|NCT01831765|588647407|FG000|Overall Study|Withdrawal by Subject|22|||
162984810|NCT01831765|588647408|FG001|Overall Study|Withdrawal by Subject|7|||
162984811|NCT01831765|588647409|FG002|Overall Study|Withdrawal by Subject|17|||
162984812|NCT01831765|588647407|FG000|Overall Study|Withdrawal criteria|12|||
162984813|NCT01831765|588647408|FG001|Overall Study|Withdrawal criteria|10|||
162984814|NCT01831765|588647409|FG002|Overall Study|Withdrawal criteria|16|||
162984815|NCT01831765|588647407|FG000|Overall Study|Lost to Follow-up|2|||
162984816|NCT01831765|588647408|FG001|Overall Study|Lost to Follow-up|3|||
162984817|NCT01831765|588647409|FG002|Overall Study|Lost to Follow-up|3|||
162984818|NCT00859586|588647410|FG000|Overall Study|Donors|4|||
162984819|NCT00080938|588647411|FG000|Overall Study|Adverse Event|3|||
162984820|NCT00080938|588647411|FG000|Overall Study|Withdrawal by Subject|6|||
163322833|NCT03279978|589894516|FG007|Overall Study|Other than stated above|0|||
162984821|NCT00080938|588647411|FG000|Overall Study|Death|2|||
162984822|NCT00080938|588647411|FG000|Overall Study|Lack of Efficacy|7|||
162984823|NCT00080938|588647411|FG000|Overall Study|other disease|1|||
162984824|NCT00080938|588647411|FG000|Overall Study|Not started protocol therapy|1|||
162984825|NCT00080938|588647411|FG000|Overall Study|Ineligible|4|||
162984826|NCT00706511|588647414|FG000|Overall Study|Withdrawal by Subject|1|||
162984827|NCT00706511|588647415|FG001|Overall Study|Withdrawal by Subject|0|||
162984828|NCT00706511|588647416|FG002|Overall Study|Withdrawal by Subject|0|||
162984829|NCT00706511|588647417|FG003|Overall Study|Withdrawal by Subject|0|||
162984830|NCT02116608|588647420|FG000|Overall Study|Lost to Follow-up|0|||
162984831|NCT02116608|588647421|FG001|Overall Study|Lost to Follow-up|0|||
162984832|NCT02116608|588647422|FG002|Overall Study|Lost to Follow-up|1|||
162984833|NCT02116608|588647420|FG000|Overall Study|Physician Decision|0|||
162984834|NCT02116608|588647421|FG001|Overall Study|Physician Decision|1|||
162984835|NCT02116608|588647422|FG002|Overall Study|Physician Decision|0|||
162984836|NCT02116608|588647420|FG000|Overall Study|Death|0|||
162984837|NCT02116608|588647421|FG001|Overall Study|Death|1|||
162984838|NCT02116608|588647422|FG002|Overall Study|Death|0|||
162984839|NCT01169532|588647427|FG000|Overall Study|Withdrawal by Subject|1|||
162984840|NCT00117325|588647428|FG000|Overall Study|Adverse Event|3|||
162984841|NCT00117325|588647429|FG001|Overall Study|Adverse Event|3|||
162984842|NCT00117325|588647428|FG000|Overall Study|Lost to Follow-up|1|||
162984843|NCT00117325|588647429|FG001|Overall Study|Lost to Follow-up|1|||
162984844|NCT00117325|588647428|FG000|Overall Study|Protocol Violation|2|||
162984845|NCT00117325|588647429|FG001|Overall Study|Protocol Violation|3|||
162984846|NCT00117325|588647428|FG000|Overall Study|Withdrawal by Subject|3|||
162984847|NCT00117325|588647429|FG001|Overall Study|Withdrawal by Subject|2|||
162984848|NCT00117325|588647428|FG000|Overall Study|Lack of Efficacy|1|||
162984849|NCT00117325|588647429|FG001|Overall Study|Lack of Efficacy|0|||
162984850|NCT00117325|588647428|FG000|Overall Study|Use of prohibited medicine|1|||
162984851|NCT00117325|588647429|FG001|Overall Study|Use of prohibited medicine|2|||
162984852|NCT00117325|588647428|FG000|Overall Study|Early termination|1|||
162984853|NCT00117325|588647429|FG001|Overall Study|Early termination|1|||
162984854|NCT00117325|588647428|FG000|Overall Study|Admisnitrative|1|||
162984855|NCT00117325|588647429|FG001|Overall Study|Admisnitrative|0|||
162984856|NCT01468818|588647433|FG000|Overall Study|Death during treatment|2|||
162984857|NCT02266134|588647434|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
162984858|NCT02266134|588647435|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
162984859|NCT02266134|588647436|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
162984860|NCT02266134|588647437|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
162984861|NCT02266134|588647434|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
162984862|NCT02266134|588647435|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
162984863|NCT02266134|588647436|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
162984864|NCT02266134|588647437|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
162984865|NCT02266134|588647434|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
162984866|NCT02266134|588647435|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
162984867|NCT02266134|588647436|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
162984868|NCT02266134|588647437|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
162984869|NCT02266134|588647434|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
162984870|NCT02266134|588647435|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
162984871|NCT02266134|588647436|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
162984872|NCT02266134|588647437|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
162984873|NCT02266134|588647434|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
162984874|NCT02266134|588647435|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
162984875|NCT02266134|588647436|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
162984876|NCT02266134|588647437|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
162984877|NCT02266134|588647434|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
162984878|NCT02266134|588647435|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
162984879|NCT02266134|588647436|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
162984880|NCT02266134|588647437|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
162984881|NCT04771403|588647441|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
162984882|NCT04771403|588647442|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
162984883|NCT04771403|588647441|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
162984884|NCT04771403|588647442|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
162984885|NCT04771403|588647441|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
162984886|NCT04771403|588647442|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
162984887|NCT04771403|588647441|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
162984888|NCT04771403|588647442|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
162984889|NCT04771403|588647441|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
162984890|NCT04771403|588647442|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
162984891|NCT04771403|588647441|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
162984892|NCT04771403|588647442|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
162984893|NCT04771403|588647441|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
163322834|NCT03279978|589894517|FG008|Overall Study|Other than stated above|0|||
162984894|NCT04771403|588647442|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
162984895|NCT04771403|588647441|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
162984896|NCT04771403|588647442|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
162984897|NCT00857259|588647443|FG000|Overall Study|Protocol Violation|1|||
162984898|NCT00857259|588647444|FG001|Overall Study|Protocol Violation|0|||
162984899|NCT00857259|588647445|FG002|Overall Study|Protocol Violation|1|||
162984900|NCT01359644|588647446|FG000|Treatment Period|Lack of Efficacy|0|||
162984901|NCT01359644|588647447|FG001|Treatment Period|Lack of Efficacy|1|||
162984902|NCT01359644|588647448|FG002|Treatment Period|Lack of Efficacy|0|||
162984903|NCT01359644|588647449|FG003|Treatment Period|Lack of Efficacy|0|||
162984904|NCT01359644|588647450|FG004|Treatment Period|Lack of Efficacy|0|||
162984905|NCT01359644|588647451|FG005|Treatment Period|Lack of Efficacy|0|||
162984906|NCT01359644|588647452|FG006|Treatment Period|Lack of Efficacy|0|||
162984907|NCT01359644|588647453|FG007|Treatment Period|Lack of Efficacy|0|||
162984908|NCT01359644|588647454|FG008|Treatment Period|Lack of Efficacy|0|||
162984909|NCT01359644|588647455|FG009|Treatment Period|Lack of Efficacy|0|||
162984910|NCT01359644|588647446|FG000|Treatment Period|Adverse Event|0|||
162984911|NCT01359644|588647447|FG001|Treatment Period|Adverse Event|0|||
162984912|NCT01359644|588647448|FG002|Treatment Period|Adverse Event|1|||
162984913|NCT01359644|588647449|FG003|Treatment Period|Adverse Event|0|||
162984914|NCT01359644|588647450|FG004|Treatment Period|Adverse Event|0|||
162984915|NCT01359644|588647451|FG005|Treatment Period|Adverse Event|1|||
162984916|NCT01359644|588647452|FG006|Treatment Period|Adverse Event|0|||
162984917|NCT01359644|588647453|FG007|Treatment Period|Adverse Event|0|||
162984918|NCT01359644|588647454|FG008|Treatment Period|Adverse Event|0|||
162984919|NCT01359644|588647455|FG009|Treatment Period|Adverse Event|0|||
162984920|NCT01359644|588647446|FG000|Treatment Period|Lost to Follow-up|0|||
162984921|NCT01359644|588647447|FG001|Treatment Period|Lost to Follow-up|0|||
162984922|NCT01359644|588647448|FG002|Treatment Period|Lost to Follow-up|0|||
162984923|NCT01359644|588647449|FG003|Treatment Period|Lost to Follow-up|0|||
162984924|NCT01359644|588647450|FG004|Treatment Period|Lost to Follow-up|0|||
162984925|NCT01359644|588647451|FG005|Treatment Period|Lost to Follow-up|1|||
162984926|NCT01359644|588647452|FG006|Treatment Period|Lost to Follow-up|0|||
162984927|NCT01359644|588647453|FG007|Treatment Period|Lost to Follow-up|0|||
162984928|NCT01359644|588647454|FG008|Treatment Period|Lost to Follow-up|0|||
162984929|NCT01359644|588647455|FG009|Treatment Period|Lost to Follow-up|0|||
162984930|NCT01359644|588647446|FG000|Follow-up Period|Withdrawal by Subject|0|||
162984931|NCT01359644|588647447|FG001|Follow-up Period|Withdrawal by Subject|0|||
162984932|NCT01359644|588647448|FG002|Follow-up Period|Withdrawal by Subject|0|||
162984933|NCT01359644|588647449|FG003|Follow-up Period|Withdrawal by Subject|0|||
162984934|NCT01359644|588647450|FG004|Follow-up Period|Withdrawal by Subject|0|||
162984935|NCT01359644|588647451|FG005|Follow-up Period|Withdrawal by Subject|1|||
162984936|NCT01359644|588647452|FG006|Follow-up Period|Withdrawal by Subject|0|||
162984937|NCT01359644|588647453|FG007|Follow-up Period|Withdrawal by Subject|0|||
162984938|NCT01359644|588647454|FG008|Follow-up Period|Withdrawal by Subject|0|||
162984939|NCT01359644|588647455|FG009|Follow-up Period|Withdrawal by Subject|0|||
162984940|NCT01359644|588647446|FG000|Follow-up Period|Lost to Follow-up|0|||
162984941|NCT01359644|588647447|FG001|Follow-up Period|Lost to Follow-up|0|||
162984942|NCT01359644|588647448|FG002|Follow-up Period|Lost to Follow-up|0|||
162984943|NCT01359644|588647449|FG003|Follow-up Period|Lost to Follow-up|0|||
162984944|NCT01359644|588647450|FG004|Follow-up Period|Lost to Follow-up|0|||
162984945|NCT01359644|588647451|FG005|Follow-up Period|Lost to Follow-up|0|||
162984946|NCT01359644|588647452|FG006|Follow-up Period|Lost to Follow-up|1|||
162984947|NCT01359644|588647453|FG007|Follow-up Period|Lost to Follow-up|2|||
162984948|NCT01359644|588647454|FG008|Follow-up Period|Lost to Follow-up|0|||
162984949|NCT01359644|588647455|FG009|Follow-up Period|Lost to Follow-up|0|||
162984950|NCT00311311|588647457|FG000|Overall Study|Adverse Event|3|||
162984951|NCT00311311|588647458|FG001|Overall Study|Adverse Event|2|||
162984952|NCT00311311|588647457|FG000|Overall Study|Withdrawal by Subject|1|||
162984953|NCT00311311|588647458|FG001|Overall Study|Withdrawal by Subject|1|||
162984954|NCT00311311|588647457|FG000|Overall Study|Noncompliance|0|||
162984955|NCT00311311|588647458|FG001|Overall Study|Noncompliance|1|||
162984956|NCT00311311|588647457|FG000|Overall Study|Study Termination by Sponsor|3|||
162984957|NCT00311311|588647458|FG001|Overall Study|Study Termination by Sponsor|4|||
163059799|NCT02030600|588928217|FG000|Treatment Period 2|Lost to Follow-up|4|||
162984958|NCT00311311|588647457|FG000|Overall Study|Death|1|||
162984959|NCT00311311|588647458|FG001|Overall Study|Death|0|||
162984960|NCT00311311|588647457|FG000|Overall Study|Lack of ancillary assistance|0|||
162984961|NCT00311311|588647458|FG001|Overall Study|Lack of ancillary assistance|1|||
162984962|NCT00826449|588647459|FG000|Overall Study|Disease Progression|4|||
162984963|NCT00826449|588647459|FG000|Overall Study|Withdrawal by Subject|1|||
162984964|NCT01875471|588647472|FG000|Overall Study|Adverse Event|0|||
162984965|NCT01875471|588647473|FG001|Overall Study|Adverse Event|1|||
162984966|NCT01875471|588647472|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
162984967|NCT01875471|588647473|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
162984968|NCT01300923|588647480|FG000|Overall Study|Physician Decision|0|||
162984969|NCT01300923|588647481|FG001|Overall Study|Physician Decision|2|||
162984970|NCT02707861|588647482|FG000|Overall Study|Went onto commercial drug|30|||
162984971|NCT02707861|588647483|FG001|Overall Study|Went onto commercial drug|23|||
162984972|NCT02707861|588647482|FG000|Overall Study|Adverse Event|2|||
162984973|NCT02707861|588647483|FG001|Overall Study|Adverse Event|3|||
162984974|NCT02707861|588647482|FG000|Overall Study|Death|5|||
162984975|NCT02707861|588647483|FG001|Overall Study|Death|2|||
162984976|NCT02707861|588647482|FG000|Overall Study|Lack of Efficacy|0|||
162984977|NCT02707861|588647483|FG001|Overall Study|Lack of Efficacy|2|||
162984978|NCT02707861|588647482|FG000|Overall Study|Physician Decision|1|||
162984979|NCT02707861|588647483|FG001|Overall Study|Physician Decision|4|||
162984980|NCT02707861|588647482|FG000|Overall Study|Withdrawal by Subject|2|||
162984981|NCT02707861|588647483|FG001|Overall Study|Withdrawal by Subject|1|||
162984982|NCT02707861|588647482|FG000|Overall Study|Lost to Follow-up|1|||
162984983|NCT02707861|588647483|FG001|Overall Study|Lost to Follow-up|3|||
162984984|NCT00731549|588647486|FG000|Overall Study|Lost to Follow-up|19|||
162984985|NCT00731549|588647486|FG000|Overall Study|Met withdrawal criteria|24|||
162984986|NCT00731549|588647486|FG000|Overall Study|Physician Decision|16|||
162984987|NCT00731549|588647486|FG000|Overall Study|Withdrawal by Subject|89|||
162984988|NCT00731549|588647486|FG000|Overall Study|Protocol deviation|1|||
162984989|NCT00731549|588647486|FG000|Overall Study|Adverse Event|31|||
162984990|NCT00731549|588647486|FG000|Overall Study|Lack of efficacy with AE|37|||
162984991|NCT00731549|588647486|FG000|Overall Study|Lack of efficacy without AE|6|||
162984992|NCT00507546|588647487|FG000|Overall Study|Withdrawal by Subject|1|||
162984993|NCT00507546|588647488|FG001|Overall Study|Withdrawal by Subject|0|||
162984994|NCT00507546|588647487|FG000|Overall Study|Protocol Violation|1|||
162984995|NCT00507546|588647488|FG001|Overall Study|Protocol Violation|0|||
162984996|NCT00507546|588647487|FG000|Overall Study|Physician Decision|0|||
162984997|NCT00507546|588647488|FG001|Overall Study|Physician Decision|1|||
162984998|NCT00609466|588647492|FG000|Overall Study|Withdrawal by Subject|0|||
162984999|NCT00609466|588647493|FG001|Overall Study|Withdrawal by Subject|1|||
162985000|NCT00609466|588647494|FG002|Overall Study|Withdrawal by Subject|1|||
162985001|NCT00609466|588647492|FG000|Overall Study|Adverse Event|2|||
162985002|NCT00609466|588647493|FG001|Overall Study|Adverse Event|3|||
162985003|NCT00609466|588647494|FG002|Overall Study|Adverse Event|1|||
162985004|NCT00609466|588647492|FG000|Overall Study|Lack of Efficacy|0|||
162985005|NCT00609466|588647493|FG001|Overall Study|Lack of Efficacy|2|||
162985006|NCT00609466|588647494|FG002|Overall Study|Lack of Efficacy|2|||
162985007|NCT03512262|588647495|FG000|Overall Study|Adverse Event|8|||
162985008|NCT03512262|588647496|FG001|Overall Study|Adverse Event|3|||
162985009|NCT03512262|588647495|FG000|Overall Study|Death (non-treatment emergent)|1|||
162985010|NCT03512262|588647496|FG001|Overall Study|Death (non-treatment emergent)|0|||
162985011|NCT03512262|588647495|FG000|Overall Study|Withdrawal by Subject|17|||
162985012|NCT03512262|588647496|FG001|Overall Study|Withdrawal by Subject|9|||
162985013|NCT03512262|588647495|FG000|Overall Study|Lost to Follow-up|7|||
162985014|NCT03512262|588647496|FG001|Overall Study|Lost to Follow-up|1|||
162985015|NCT03512262|588647495|FG000|Overall Study|Other than Specified|2|||
162985016|NCT03512262|588647496|FG001|Overall Study|Other than Specified|2|||
162985017|NCT01299805|588647499|FG000|Overall Study|Adverse Event|2|||
162985018|NCT01299805|588647500|FG001|Overall Study|Adverse Event|0|||
162985019|NCT03188666|588649858|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
162985020|NCT03188666|588649859|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
162985021|NCT03188666|588649860|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
162985022|NCT03188666|588649861|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
162985023|NCT03188666|588649858|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
162985024|NCT03188666|588649859|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
162985025|NCT03188666|588649860|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
162985026|NCT03188666|588649861|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
162985027|NCT03188666|588649858|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
162985028|NCT03188666|588649859|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
162985029|NCT03188666|588649860|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
162985030|NCT03188666|588649861|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
162985031|NCT03188666|588649858|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
163059800|NCT02030600|588928218|FG001|Treatment Period 2|Lost to Follow-up|2|||
163059801|NCT02030600|588928217|FG000|Treatment Period 2|Protocol Violation|1|||
163322835|NCT03279978|589894518|FG009|Overall Study|Other than stated above|0|||
162985032|NCT03188666|588649859|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
162985033|NCT03188666|588649860|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
162985034|NCT03188666|588649861|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
162985035|NCT02068092|588649862|FG000|Overall Study|Physician Decision|2|||
162985036|NCT02068092|588649862|FG000|Overall Study|Adverse Event|2|||
162985037|NCT02068092|588649862|FG000|Overall Study|Lost to Follow-up|4|||
162985038|NCT02068092|588649862|FG000|Overall Study|Withdrawal by Subject|2|||
162985039|NCT02128217|588649867|FG000|Overall Study|Lost to Follow-up|0|||
162985040|NCT02128217|588649868|FG001|Overall Study|Lost to Follow-up|1|||
162985041|NCT05071313|588649871|FG000|Overall Study|Lost to Follow-up|17|||
162985042|NCT05071313|588649872|FG001|Overall Study|Lost to Follow-up|10|||
162985043|NCT05071313|588649871|FG000|Overall Study|Physician Decision|1|||
162985044|NCT05071313|588649872|FG001|Overall Study|Physician Decision|6|||
162985045|NCT05071313|588649871|FG000|Overall Study|Death|1|||
162985046|NCT05071313|588649872|FG001|Overall Study|Death|0|||
162985047|NCT05071313|588649871|FG000|Overall Study|Withdrawal by Subject|10|||
162985048|NCT05071313|588649872|FG001|Overall Study|Withdrawal by Subject|15|||
162985049|NCT05071313|588649871|FG000|Overall Study|Other|1|||
162985050|NCT05071313|588649872|FG001|Overall Study|Other|0|||
162985051|NCT05071313|588649871|FG000|Overall Study|Randomized but not vaccinated|4|||
162985052|NCT05071313|588649872|FG001|Overall Study|Randomized but not vaccinated|2|||
162985053|NCT00541970|588649873|FG000|Month 7|Protocol Violation|9|||
162985054|NCT00541970|588649874|FG001|Month 7|Protocol Violation|13|||
162985055|NCT00541970|588649875|FG002|Month 7|Protocol Violation|11|||
162985056|NCT00541970|588649876|FG003|Month 7|Protocol Violation|5|||
162985057|NCT00541970|588649873|FG000|Month 12|Adverse Event|0|||
162985058|NCT00541970|588649874|FG001|Month 12|Adverse Event|1|||
162985059|NCT00541970|588649875|FG002|Month 12|Adverse Event|1|||
162985060|NCT00541970|588649876|FG003|Month 12|Adverse Event|1|||
162985061|NCT00541970|588649873|FG000|Month 12|Protocol Violation|12|||
162985062|NCT00541970|588649874|FG001|Month 12|Protocol Violation|21|||
162985063|NCT00541970|588649875|FG002|Month 12|Protocol Violation|20|||
162985064|NCT00541970|588649876|FG003|Month 12|Protocol Violation|15|||
162985065|NCT00541970|588649873|FG000|Month 18|Adverse Event|0|||
162985066|NCT00541970|588649874|FG001|Month 18|Adverse Event|1|||
162985067|NCT00541970|588649875|FG002|Month 18|Adverse Event|1|||
162985068|NCT00541970|588649876|FG003|Month 18|Adverse Event|1|||
162985069|NCT00541970|588649873|FG000|Month 18|Protocol Violation|14|||
162985070|NCT00541970|588649874|FG001|Month 18|Protocol Violation|23|||
162985071|NCT00541970|588649875|FG002|Month 18|Protocol Violation|24|||
162985072|NCT00541970|588649876|FG003|Month 18|Protocol Violation|16|||
162985073|NCT00541970|588649873|FG000|Month 24|Adverse Event|0|||
162985074|NCT00541970|588649874|FG001|Month 24|Adverse Event|1|||
162985075|NCT00541970|588649875|FG002|Month 24|Adverse Event|1|||
162985076|NCT00541970|588649876|FG003|Month 24|Adverse Event|1|||
162985077|NCT00541970|588649873|FG000|Month 24|Protocol Violation|29|||
162985078|NCT00541970|588649874|FG001|Month 24|Protocol Violation|31|||
162985079|NCT00541970|588649875|FG002|Month 24|Protocol Violation|31|||
162985080|NCT00541970|588649876|FG003|Month 24|Protocol Violation|21|||
162985081|NCT00541970|588649873|FG000|Month 36|Protocol Violation|61|||
162985082|NCT00541970|588649874|FG001|Month 36|Protocol Violation|66|||
162985083|NCT00541970|588649875|FG002|Month 36|Protocol Violation|66|||
162985084|NCT00541970|588649876|FG003|Month 36|Protocol Violation|60|||
163322836|NCT04159519|589894519|FG000|Overall Study|Adverse Event|1|||
163322837|NCT04159519|589894520|FG001|Overall Study|Adverse Event|1|||
162985085|NCT00541970|588649873|FG000|Month 48|Withdrawal by Subject|2|||
162985086|NCT00541970|588649874|FG001|Month 48|Withdrawal by Subject|4|||
162985087|NCT00541970|588649875|FG002|Month 48|Withdrawal by Subject|4|||
162985088|NCT00541970|588649876|FG003|Month 48|Withdrawal by Subject|2|||
162985089|NCT00541970|588649873|FG000|Month 48|Other|3|||
162985090|NCT00541970|588649874|FG001|Month 48|Other|1|||
162985091|NCT00541970|588649875|FG002|Month 48|Other|1|||
162985092|NCT00541970|588649876|FG003|Month 48|Other|0|||
162985093|NCT00541970|588649873|FG000|Month 48|Lost to Follow-up|66|||
162985094|NCT00541970|588649874|FG001|Month 48|Lost to Follow-up|68|||
162985095|NCT00541970|588649875|FG002|Month 48|Lost to Follow-up|68|||
162985096|NCT00541970|588649876|FG003|Month 48|Lost to Follow-up|73|||
162985097|NCT00541970|588649873|FG000|Month 60|Protocol Violation|78|||
162985098|NCT00541970|588649874|FG001|Month 60|Protocol Violation|77|||
163322838|NCT04159519|589894519|FG000|Overall Study|Lack of Efficacy|1|||
163322839|NCT04159519|589894520|FG001|Overall Study|Lack of Efficacy|0|||
163322840|NCT04159519|589894519|FG000|Overall Study|Discontinued from study|1|||
163322841|NCT04159519|589894520|FG001|Overall Study|Discontinued from study|0|||
162985099|NCT00541970|588649875|FG002|Month 60|Protocol Violation|82|||
163322842|NCT04159519|589894519|FG000|Overall Study|Protocol Violation|1|||
163322843|NCT04159519|589894520|FG001|Overall Study|Protocol Violation|1|||
163059802|NCT02030600|588928218|FG001|Treatment Period 2|Protocol Violation|2|||
163322844|NCT04159519|589894519|FG000|Overall Study|Withdrawal by Subject|4|||
162985100|NCT00541970|588649876|FG003|Month 60|Protocol Violation|72|||
162985101|NCT03107026|588649877|FG000|Overall Study|Adverse Event|2|||
162985102|NCT03107026|588649878|FG001|Overall Study|Adverse Event|14|||
162985103|NCT03107026|588649879|FG002|Overall Study|Adverse Event|23|||
162985104|NCT03107026|588649877|FG000|Overall Study|Lost to Follow-up|12|||
162985105|NCT03107026|588649878|FG001|Overall Study|Lost to Follow-up|12|||
162985106|NCT03107026|588649879|FG002|Overall Study|Lost to Follow-up|13|||
162985107|NCT03107026|588649877|FG000|Overall Study|Protocol Violation|1|||
162985108|NCT03107026|588649878|FG001|Overall Study|Protocol Violation|2|||
162985109|NCT03107026|588649879|FG002|Overall Study|Protocol Violation|0|||
162985110|NCT03107026|588649877|FG000|Overall Study|Pregnancy|1|||
162985111|NCT03107026|588649878|FG001|Overall Study|Pregnancy|0|||
162985112|NCT03107026|588649879|FG002|Overall Study|Pregnancy|0|||
162985113|NCT03107026|588649877|FG000|Overall Study|Withdrawal by Subject|13|||
162985114|NCT03107026|588649878|FG001|Overall Study|Withdrawal by Subject|5|||
162985115|NCT03107026|588649879|FG002|Overall Study|Withdrawal by Subject|17|||
162985116|NCT03107026|588649877|FG000|Overall Study|non compliance with study visits|1|||
162985117|NCT03107026|588649878|FG001|Overall Study|non compliance with study visits|2|||
162985118|NCT03107026|588649879|FG002|Overall Study|non compliance with study visits|0|||
162985119|NCT03107026|588649877|FG000|Overall Study|non-compliance with study drug|2|||
162985120|NCT03107026|588649878|FG001|Overall Study|non-compliance with study drug|2|||
162985121|NCT03107026|588649879|FG002|Overall Study|non-compliance with study drug|3|||
162985122|NCT03107026|588649877|FG000|Overall Study|Physician Decision|0|||
162985123|NCT03107026|588649878|FG001|Overall Study|Physician Decision|1|||
162985124|NCT03107026|588649879|FG002|Overall Study|Physician Decision|0|||
162985125|NCT01183221|588649880|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
162985126|NCT01183221|588649881|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
162985127|NCT03596151|588649886|FG000|Overall Study|Withdrawal by Subject|1|||
162985128|NCT00807248|588649888|FG000|Overall Study|Adverse Event|1|||
162985129|NCT00807248|588649889|FG001|Overall Study|Adverse Event|2|||
162985130|NCT00807248|588649890|FG002|Overall Study|Adverse Event|2|||
162985131|NCT00807248|588649891|FG003|Overall Study|Adverse Event|6|||
162985132|NCT00807248|588649888|FG000|Overall Study|Lack of Efficacy|14|||
162985133|NCT00807248|588649889|FG001|Overall Study|Lack of Efficacy|4|||
162985134|NCT00807248|588649890|FG002|Overall Study|Lack of Efficacy|8|||
162985135|NCT00807248|588649891|FG003|Overall Study|Lack of Efficacy|3|||
162985136|NCT00807248|588649888|FG000|Overall Study|Protocol Violation|0|||
162985137|NCT00807248|588649889|FG001|Overall Study|Protocol Violation|1|||
162985138|NCT00807248|588649890|FG002|Overall Study|Protocol Violation|1|||
162985139|NCT00807248|588649891|FG003|Overall Study|Protocol Violation|0|||
162985140|NCT00807248|588649888|FG000|Overall Study|Withdrawal of Consent|5|||
162985141|NCT00807248|588649889|FG001|Overall Study|Withdrawal of Consent|5|||
162985142|NCT00807248|588649890|FG002|Overall Study|Withdrawal of Consent|5|||
162985143|NCT00807248|588649891|FG003|Overall Study|Withdrawal of Consent|5|||
162985144|NCT00807248|588649888|FG000|Overall Study|Lost to Follow-up|1|||
162985145|NCT00807248|588649889|FG001|Overall Study|Lost to Follow-up|0|||
162985146|NCT00807248|588649890|FG002|Overall Study|Lost to Follow-up|0|||
162985147|NCT00807248|588649891|FG003|Overall Study|Lost to Follow-up|0|||
162985148|NCT00807248|588649888|FG000|Overall Study|Other Reason|0|||
162985149|NCT00807248|588649889|FG001|Overall Study|Other Reason|0|||
162985150|NCT00807248|588649890|FG002|Overall Study|Other Reason|2|||
162985151|NCT00807248|588649891|FG003|Overall Study|Other Reason|0|||
162985152|NCT02444793|588649892|FG000|Overall Study|Lost to Follow-up|2|||
162985153|NCT02444793|588649893|FG001|Overall Study|Lost to Follow-up|2|||
162985154|NCT02444793|588649894|FG002|Overall Study|Lost to Follow-up|0|||
162985155|NCT02444793|588649895|FG003|Overall Study|Lost to Follow-up|0|||
162985156|NCT02444793|588649892|FG000|Overall Study|Death|0|||
162985157|NCT02444793|588649893|FG001|Overall Study|Death|3|||
162985158|NCT02444793|588649894|FG002|Overall Study|Death|0|||
162985159|NCT02444793|588649895|FG003|Overall Study|Death|0|||
162985160|NCT02444793|588649892|FG000|Overall Study|Other|0|||
162985161|NCT02444793|588649893|FG001|Overall Study|Other|0|||
162985162|NCT02444793|588649894|FG002|Overall Study|Other|2|||
162985163|NCT02444793|588649895|FG003|Overall Study|Other|0|||
162985164|NCT02444793|588649892|FG000|Overall Study|Objective progression or relapse|9|||
162985165|NCT02444793|588649893|FG001|Overall Study|Objective progression or relapse|1|||
163322845|NCT04159519|589894520|FG001|Overall Study|Withdrawal by Subject|4|||
163322846|NCT03493542|589894523|FG000|Base Study|Withdrawal by Subject|0|||
163322847|NCT03493542|589894524|FG001|Base Study|Withdrawal by Subject|4|||
163322848|NCT03493542|589894525|FG002|Base Study|Withdrawal by Subject|0|||
163322849|NCT03493542|589894523|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
163322850|NCT03493542|589894524|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
163322851|NCT03493542|589894525|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
163322852|NCT03493542|589894523|FG000|Extension Study|Withdrawal by Subject|0|||
163322853|NCT03493542|589894524|FG001|Extension Study|Withdrawal by Subject|0|||
163322854|NCT03493542|589894525|FG002|Extension Study|Withdrawal by Subject|25|||
163322855|NCT02765412|589894526|FG000|Overall Study|Death|482|||
163322856|NCT02765412|589894527|FG001|Overall Study|Death|855|||
163322857|NCT03734029|589894528|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
163322858|NCT03734029|589894529|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
163322859|NCT03734029|589894528|FG000|Overall Study|Adverse Event|60|||
163322860|NCT03734029|589894529|FG001|Overall Study|Adverse Event|14|||
162985166|NCT02444793|588649894|FG002|Overall Study|Objective progression or relapse|2|||
162985167|NCT02444793|588649895|FG003|Overall Study|Objective progression or relapse|3|||
162985168|NCT02504671|588649897|FG000|Overall Study|Withdrawal by Subject|1|||
162985169|NCT02504671|588649898|FG001|Overall Study|Withdrawal by Subject|5|||
162985170|NCT02504671|588649899|FG002|Overall Study|Withdrawal by Subject|4|||
162985171|NCT02504671|588649900|FG003|Overall Study|Withdrawal by Subject|4|||
162985172|NCT02504671|588649901|FG004|Overall Study|Withdrawal by Subject|5|||
162985173|NCT02504671|588649902|FG005|Overall Study|Withdrawal by Subject|3|||
162985174|NCT02504671|588649897|FG000|Overall Study|Lack of Efficacy|1|||
162985175|NCT02504671|588649898|FG001|Overall Study|Lack of Efficacy|3|||
162985176|NCT02504671|588649899|FG002|Overall Study|Lack of Efficacy|1|||
162985177|NCT02504671|588649900|FG003|Overall Study|Lack of Efficacy|0|||
162985178|NCT02504671|588649901|FG004|Overall Study|Lack of Efficacy|4|||
162985179|NCT02504671|588649902|FG005|Overall Study|Lack of Efficacy|4|||
162985180|NCT02504671|588649897|FG000|Overall Study|Adverse Event|1|||
162985181|NCT02504671|588649898|FG001|Overall Study|Adverse Event|1|||
162985182|NCT02504671|588649899|FG002|Overall Study|Adverse Event|0|||
162985183|NCT02504671|588649900|FG003|Overall Study|Adverse Event|1|||
162985184|NCT02504671|588649901|FG004|Overall Study|Adverse Event|0|||
162985185|NCT02504671|588649902|FG005|Overall Study|Adverse Event|2|||
162985186|NCT02504671|588649897|FG000|Overall Study|Protocol Violation|2|||
162985187|NCT02504671|588649898|FG001|Overall Study|Protocol Violation|1|||
162985188|NCT02504671|588649899|FG002|Overall Study|Protocol Violation|0|||
162985189|NCT02504671|588649900|FG003|Overall Study|Protocol Violation|0|||
162985190|NCT02504671|588649901|FG004|Overall Study|Protocol Violation|0|||
162985191|NCT02504671|588649902|FG005|Overall Study|Protocol Violation|1|||
162985192|NCT02504671|588649897|FG000|Overall Study|Lost to Follow-up|0|||
162985193|NCT02504671|588649898|FG001|Overall Study|Lost to Follow-up|0|||
162985194|NCT02504671|588649899|FG002|Overall Study|Lost to Follow-up|2|||
162985195|NCT02504671|588649900|FG003|Overall Study|Lost to Follow-up|0|||
162985196|NCT02504671|588649901|FG004|Overall Study|Lost to Follow-up|0|||
162985197|NCT02504671|588649902|FG005|Overall Study|Lost to Follow-up|1|||
162985198|NCT02504671|588649897|FG000|Overall Study|Protocol defined stopping criteria|7|||
162985199|NCT02504671|588649898|FG001|Overall Study|Protocol defined stopping criteria|4|||
162985200|NCT02504671|588649899|FG002|Overall Study|Protocol defined stopping criteria|3|||
162985201|NCT02504671|588649900|FG003|Overall Study|Protocol defined stopping criteria|5|||
162985202|NCT02504671|588649901|FG004|Overall Study|Protocol defined stopping criteria|3|||
162985203|NCT02504671|588649902|FG005|Overall Study|Protocol defined stopping criteria|3|||
162985204|NCT00210249|588649903|FG000|Overall Study|Lost to Follow-up|5|||
162985205|NCT00210249|588649903|FG000|Overall Study|Protocol Violation|11|||
162985206|NCT04280705|588649904|FG000|Overall Study|Enrolled but not treated|4|||
162985207|NCT04280705|588649905|FG001|Overall Study|Enrolled but not treated|10|||
162985208|NCT04280705|588649904|FG000|Overall Study|Physician Decision|1|||
162985209|NCT04280705|588649905|FG001|Overall Study|Physician Decision|0|||
162985210|NCT04280705|588649904|FG000|Overall Study|Withdrawal by Subject|7|||
162985211|NCT04280705|588649905|FG001|Overall Study|Withdrawal by Subject|9|||
162985212|NCT04280705|588649904|FG000|Overall Study|Adverse Event|0|||
162985213|NCT04280705|588649905|FG001|Overall Study|Adverse Event|4|||
162985214|NCT04280705|588649904|FG000|Overall Study|Transferred to another hospital|1|||
162985215|NCT04280705|588649905|FG001|Overall Study|Transferred to another hospital|1|||
162985216|NCT03222583|588649908|FG000|Overall Study|Withdrawal by Subject|3|||
162985217|NCT03222583|588649909|FG001|Overall Study|Withdrawal by Subject|3|||
162985218|NCT03222583|588649908|FG000|Overall Study|Lost to Follow-up|1|||
162985219|NCT03222583|588649909|FG001|Overall Study|Lost to Follow-up|0|||
162985220|NCT03222583|588649908|FG000|Overall Study|Other|1|||
162985221|NCT03222583|588649909|FG001|Overall Study|Other|3|||
162985222|NCT02518919|588649910|FG000|Overall Study|Protocol Violation|1|||
162985223|NCT02518919|588649911|FG001|Overall Study|Protocol Violation|1|||
162985224|NCT02518919|588649912|FG002|Overall Study|Protocol Violation|2|||
162985225|NCT04498403|588649913|FG000|Overall Study|Adverse Event|1|||
162985226|NCT04498403|588649914|FG001|Overall Study|Adverse Event|0|||
162985227|NCT04498403|588649913|FG000|Overall Study|Study Terminated By Sponsor|29|||
162985228|NCT04498403|588649914|FG001|Overall Study|Study Terminated By Sponsor|10|||
162985229|NCT03986138|588649915|FG000|First MRI Examination|Physician Decision|0|||
162985230|NCT03986138|588649916|FG001|First MRI Examination|Physician Decision|1|||
162985231|NCT03986138|588649915|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
162985232|NCT03986138|588649916|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
162985233|NCT03986138|588649915|FG000|Washout|Withdrawal by Subject|4|||
162985234|NCT03986138|588649916|FG001|Washout|Withdrawal by Subject|5|||
162985235|NCT03986138|588649915|FG000|Washout|Lost to Follow-up|0|||
162985236|NCT03986138|588649916|FG001|Washout|Lost to Follow-up|2|||
162985237|NCT03986138|588649915|FG000|Washout|Adverse Event|1|||
162985238|NCT03986138|588649916|FG001|Washout|Adverse Event|1|||
162985239|NCT03986138|588649915|FG000|Washout|Other reason|5|||
163211992|NCT03700671|589490693|FG001|Overall Study|Lack of Efficacy|2|||
162985240|NCT03986138|588649916|FG001|Washout|Other reason|5|||
162985241|NCT03986138|588649915|FG000|Second MRI Examination|Withdrawal by Subject|0|||
162985242|NCT03986138|588649916|FG001|Second MRI Examination|Withdrawal by Subject|2|||
162985243|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
163211993|NCT05371509|589490694|FG000|Overall Study|Physician Decision|1|||
163211994|NCT05371509|589490695|FG001|Overall Study|Physician Decision|0|||
163211995|NCT04405037|589490702|FG000|Overall Study|Withdrawal by Subject|1|||
163211996|NCT04405037|589490703|FG001|Overall Study|Withdrawal by Subject|0|||
163211997|NCT04405037|589490702|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
163211998|NCT04405037|589490703|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
163211999|NCT04434092|589490704|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
163212000|NCT04434092|589490705|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
163322861|NCT03734029|589894528|FG000|Overall Study|Withdrawal by Subject|12|||
163322862|NCT03734029|589894529|FG001|Overall Study|Withdrawal by Subject|11|||
163322863|NCT03734029|589894528|FG000|Overall Study|Clinical progression by investigator|10|||
162985244|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
162985245|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
162985246|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
162985247|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
162985248|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
162985249|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
162985250|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
162985251|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
162985252|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
162985253|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
162985254|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
162985255|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
162985256|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
162985257|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
162985258|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
162985259|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
162985260|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
162985261|NCT03182244|588649920|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
162985262|NCT03182244|588649921|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
162985263|NCT03182244|588649920|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
162985264|NCT03182244|588649921|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
162985265|NCT03182244|588649920|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
162985266|NCT03182244|588649921|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
162985267|NCT03182244|588649920|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
162985268|NCT03182244|588649921|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
162985269|NCT02049450|588649922|FG000|Overall Study|Adverse Event|2|||
162985270|NCT02049450|588649922|FG000|Overall Study|Withdrawal by Subject|1|||
162985271|NCT02049450|588649922|FG000|Overall Study|Patients/guardian decision|1|||
162985272|NCT03186781|588649923|FG000|Overall Study|Lost to Follow-up|0|||
162985273|NCT03186781|588649924|FG001|Overall Study|Lost to Follow-up|0|||
162985274|NCT03186781|588649925|FG002|Overall Study|Lost to Follow-up|1|||
162985275|NCT03186781|588649926|FG003|Overall Study|Lost to Follow-up|0|||
162985276|NCT03186781|588649927|FG004|Overall Study|Lost to Follow-up|1|||
162985277|NCT03186781|588649928|FG005|Overall Study|Lost to Follow-up|0|||
162985278|NCT03186781|588649923|FG000|Overall Study|Moved from Area|0|||
162985279|NCT03186781|588649924|FG001|Overall Study|Moved from Area|0|||
162985280|NCT03186781|588649925|FG002|Overall Study|Moved from Area|0|||
162985281|NCT03186781|588649926|FG003|Overall Study|Moved from Area|0|||
162985282|NCT03186781|588649927|FG004|Overall Study|Moved from Area|1|||
162985283|NCT03186781|588649928|FG005|Overall Study|Moved from Area|0|||
162985284|NCT03186781|588649923|FG000|Overall Study|Withdrawal by Subject|0|||
162985285|NCT03186781|588649924|FG001|Overall Study|Withdrawal by Subject|0|||
162985286|NCT03186781|588649925|FG002|Overall Study|Withdrawal by Subject|0|||
162985287|NCT03186781|588649926|FG003|Overall Study|Withdrawal by Subject|0|||
162985288|NCT03186781|588649927|FG004|Overall Study|Withdrawal by Subject|1|||
162985289|NCT03186781|588649928|FG005|Overall Study|Withdrawal by Subject|0|||
162985290|NCT04709835|588649929|FG000|Overall Study|Withdrawal by Subject|0|||
162985291|NCT04709835|588649930|FG001|Overall Study|Withdrawal by Subject|1|||
162985292|NCT04709835|588649931|FG002|Overall Study|Withdrawal by Subject|0|||
162985293|NCT01570686|588649932|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162985294|NCT01570686|588649933|FG001|Overall Study|Abnormal test procedure result(s)|1|||
162985295|NCT01570686|588649932|FG000|Overall Study|Administrative problems|0|||
162985296|NCT01570686|588649933|FG001|Overall Study|Administrative problems|1|||
162985297|NCT01570686|588649932|FG000|Overall Study|Adverse Event|8|||
162985298|NCT01570686|588649933|FG001|Overall Study|Adverse Event|6|||
163322864|NCT03734029|589894529|FG001|Overall Study|Clinical progression by investigator|8|||
163322865|NCT03734029|589894528|FG000|Overall Study|Death|5|||
162985299|NCT01570686|588649932|FG000|Overall Study|Lost to Follow-up|4|||
162985300|NCT01570686|588649933|FG001|Overall Study|Lost to Follow-up|3|||
162985301|NCT01570686|588649932|FG000|Overall Study|Protocol Deviation|3|||
162985302|NCT01570686|588649933|FG001|Overall Study|Protocol Deviation|0|||
162985303|NCT01570686|588649932|FG000|Overall Study|Withdrawal by Subject|4|||
162985304|NCT01570686|588649933|FG001|Overall Study|Withdrawal by Subject|4|||
162985305|NCT01570686|588649932|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162985306|NCT01570686|588649933|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162985307|NCT02372071|588649934|FG000|Overall Study|Protocol Violation|18|||
162985308|NCT03347422|588649938|FG000|Part A (26 Weeks)|Adverse Event|3|||
162985309|NCT03347422|588649939|FG001|Part A (26 Weeks)|Adverse Event|0|||
162985310|NCT03347422|588649938|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
163322866|NCT03734029|589894529|FG001|Overall Study|Death|2|||
163322867|NCT03734029|589894528|FG000|Overall Study|Physician Decision|4|||
162985311|NCT03347422|588649939|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
162985312|NCT03347422|588649938|FG000|Part B (149 Weeks)|Adverse Event|0|||
162985313|NCT03347422|588649939|FG001|Part B (149 Weeks)|Adverse Event|1|||
162985314|NCT03347422|588649938|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
162985315|NCT03347422|588649939|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
162985316|NCT03347422|588649938|FG000|Part B (149 Weeks)|Other|1|||
162985317|NCT03347422|588649939|FG001|Part B (149 Weeks)|Other|0|||
162985318|NCT00622466|588649947|FG000|Overall Study|Death|1|||
162985319|NCT00622466|588649947|FG000|Overall Study|Adverse Event|1|||
162985320|NCT00622466|588649947|FG000|Overall Study|Withdrawal by Subject|2|||
162985321|NCT01936623|588649961|FG000|Overall Study|Lost to Follow-up|0|||
162985322|NCT01936623|588649962|FG001|Overall Study|Lost to Follow-up|5|||
162985323|NCT01383135|588649963|FG000|Overall Study|Not Scanned / Imaged|1|||
162985324|NCT01383135|588649964|FG001|Overall Study|Not Scanned / Imaged|0|||
162985325|NCT01383135|588649965|FG002|Overall Study|Not Scanned / Imaged|1|||
162985326|NCT01383135|588649966|FG003|Overall Study|Not Scanned / Imaged|0|||
162985327|NCT03397771|588649971|FG000|Overall Study|2 erroneously randomized, never treated|3|||
162985328|NCT03397771|588649972|FG001|Overall Study|2 erroneously randomized, never treated|1|||
162985329|NCT03397771|588649971|FG000|Overall Study|Withdrawal by Subject|1|||
162985330|NCT03397771|588649972|FG001|Overall Study|Withdrawal by Subject|3|||
162985331|NCT03397771|588649971|FG000|Overall Study|Protocol Violation|2|||
162985332|NCT03397771|588649972|FG001|Overall Study|Protocol Violation|2|||
162985333|NCT03397771|588649971|FG000|Overall Study|Adverse Event|2|||
162985334|NCT03397771|588649972|FG001|Overall Study|Adverse Event|1|||
162985335|NCT02669758|588649973|FG000|Overall Study|Withdrawal by Subject|43|||
162985336|NCT02669758|588649973|FG000|Overall Study|Lost to Follow-up|19|||
162985337|NCT02669758|588649973|FG000|Overall Study|Adverse Event|16|||
162985338|NCT02669758|588649973|FG000|Overall Study|Non-Compliance with Study Drug|8|||
162985339|NCT02669758|588649973|FG000|Overall Study|Lack of Efficacy|5|||
162985340|NCT02669758|588649973|FG000|Overall Study|Pregnancy|1|||
162985341|NCT02669758|588649973|FG000|Overall Study|Study noncompliance|1|||
163059803|NCT02030600|588928217|FG000|Treatment Period 2|Withdrawal by Subject|13|||
163059804|NCT02030600|588928218|FG001|Treatment Period 2|Withdrawal by Subject|9|||
163322868|NCT03734029|589894529|FG001|Overall Study|Physician Decision|3|||
163322869|NCT03734029|589894528|FG000|Overall Study|Other|2|||
163322870|NCT03734029|589894529|FG001|Overall Study|Other|0|||
163322871|NCT03734029|589894528|FG000|Overall Study|Lost to Follow-up|0|||
163322872|NCT03734029|589894529|FG001|Overall Study|Lost to Follow-up|1|||
163322873|NCT03734029|589894528|FG000|Overall Study|Randomized, but not treated|2|||
163322874|NCT03734029|589894529|FG001|Overall Study|Randomized, but not treated|12|||
163322875|NCT04595331|589895377|FG000|Overall Study|Withdrawal by Subject|0|||
163322876|NCT04595331|589895378|FG001|Overall Study|Withdrawal by Subject|1|||
163322877|NCT04595331|589895377|FG000|Overall Study|Lost to Follow-up|0|||
163322878|NCT04595331|589895378|FG001|Overall Study|Lost to Follow-up|5|||
163322879|NCT04595331|589895377|FG000|Overall Study|Medical reason|0|||
163322880|NCT04595331|589895378|FG001|Overall Study|Medical reason|1|||
163322881|NCT05020353|589895381|FG000|Overall Study|Protocol Violation|7|||
163322882|NCT05020353|589895381|FG000|Overall Study|Withdrawal by Subject|33|||
163322883|NCT02611687|589895382|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
163322884|NCT02611687|589895383|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
163322885|NCT03934931|589895384|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
163322886|NCT03934931|589895385|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
163322887|NCT03934931|589895386|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
163322888|NCT03635567|589895389|FG000|Overall Study|Lost to Follow-up|4|||
163322889|NCT03635567|589895390|FG001|Overall Study|Lost to Follow-up|1|||
163322890|NCT03635567|589895389|FG000|Overall Study|Withdrawal by Subject|11|||
163322891|NCT03635567|589895390|FG001|Overall Study|Withdrawal by Subject|16|||
163322892|NCT03635567|589895389|FG000|Overall Study|Sponsor Decision|99|||
163322893|NCT03635567|589895390|FG001|Overall Study|Sponsor Decision|57|||
163322894|NCT03635567|589895389|FG000|Overall Study|Death|194|||
163322895|NCT03635567|589895390|FG001|Overall Study|Death|235|||
163322896|NCT05157841|589895391|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
163322897|NCT05157841|589895392|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
163322898|NCT05157841|589895393|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
163322899|NCT05157841|589895391|FG000|Part A (14 Days)|Adverse Event|1|||
163322900|NCT05157841|589895392|FG001|Part A (14 Days)|Adverse Event|0|||
163322901|NCT05157841|589895393|FG002|Part A (14 Days)|Adverse Event|0|||
163322902|NCT05157841|589895391|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
163322903|NCT05157841|589895392|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
163322904|NCT05157841|589895393|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
163322905|NCT02075554|589895395|FG000|Overall Study|Lost to Follow-up|7|||
163322906|NCT02075554|589895395|FG000|Overall Study|Withdrawal by Subject|5|||
163322907|NCT02075554|589895395|FG000|Overall Study|Physician Decision|3|||
163322908|NCT04757753|589895412|FG000|Overall Study|Lost to Follow-up|7|||
162985342|NCT02669758|588649973|FG000|Overall Study|Protocol Violation|1|||
162985343|NCT02455050|588649974|FG000|Treatment Period 1|Lost to Follow-up|1|||
162985344|NCT02455050|588649975|FG001|Treatment Period 1|Lost to Follow-up|1|||
162985345|NCT02455050|588649976|FG002|Treatment Period 1|Lost to Follow-up|1|||
162985346|NCT02455050|588649977|FG003|Treatment Period 1|Lost to Follow-up|2|||
162985347|NCT02455050|588649974|FG000|Treatment Period 2|Lost to Follow-up|1|||
162985348|NCT02455050|588649975|FG001|Treatment Period 2|Lost to Follow-up|0|||
162985349|NCT02455050|588649976|FG002|Treatment Period 2|Lost to Follow-up|2|||
162985350|NCT02455050|588649977|FG003|Treatment Period 2|Lost to Follow-up|1|||
162985351|NCT03393806|588649980|FG000|Overall Study|Physician Decision|1|||
162985352|NCT03393806|588649981|FG001|Overall Study|Physician Decision|0|||
162985353|NCT01259115|588649982|FG000|Period 1|Adverse Event|1|||
162985354|NCT01259115|588649983|FG001|Period 1|Adverse Event|0|||
162985355|NCT01259115|588649982|FG000|Period 1|Protocol Violation|2|||
162985356|NCT01259115|588649983|FG001|Period 1|Protocol Violation|0|||
162985357|NCT01259115|588649982|FG000|Period 1|Lost to Follow-up|0|||
162985358|NCT01259115|588649983|FG001|Period 1|Lost to Follow-up|1|||
162985359|NCT01259115|588649982|FG000|Period 2|Adverse Event|1|||
162985360|NCT01259115|588649983|FG001|Period 2|Adverse Event|0|||
162985361|NCT02605993|588649984|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
162985362|NCT02605993|588649985|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
162985363|NCT02605993|588649986|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
162985364|NCT02605993|588649987|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
162985365|NCT03493386|588649990|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162985366|NCT03493386|588649991|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
162985367|NCT03493386|588649992|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162985368|NCT03493386|588649993|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162985369|NCT00988442|588649999|FG000|Overall Study|Death|1|||
162985370|NCT00988442|588650000|FG001|Overall Study|Death|2|||
162985371|NCT00988442|588649999|FG000|Overall Study|Lost to Follow-up|0|||
162985372|NCT00988442|588650000|FG001|Overall Study|Lost to Follow-up|1|||
162985373|NCT00988442|588649999|FG000|Overall Study|Early Study Closure|29|||
162985374|NCT00988442|588650000|FG001|Overall Study|Early Study Closure|25|||
162985375|NCT04620135|588650003|FG000|Study Completion|Adverse Event|2|||
162985376|NCT04620135|588650004|FG001|Study Completion|Adverse Event|3|||
162985377|NCT04620135|588650003|FG000|Study Completion|Withdrawal by Subject|2|||
162985378|NCT04620135|588650004|FG001|Study Completion|Withdrawal by Subject|0|||
162985379|NCT01442688|588650006|FG000|First Intervention|Withdrawal by Subject|1|||
162985380|NCT01442688|588650007|FG001|First Intervention|Withdrawal by Subject|0|||
162985381|NCT01442688|588650006|FG000|First Intervention|subject incarcerated|1|||
162985382|NCT01442688|588650007|FG001|First Intervention|subject incarcerated|0|||
162985383|NCT01442688|588650006|FG000|Second Intervention|Adverse Event|1|||
162985384|NCT01442688|588650007|FG001|Second Intervention|Adverse Event|0|||
162985385|NCT00762437|588650008|FG000|Overall Study|Lost to Follow-up|7|||
162985386|NCT00762437|588650008|FG000|Overall Study|Missed final study visit|11|||
162985387|NCT00762437|588650008|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
162985388|NCT04480021|588650009|FG000|Overall Study|Lost to Follow-up|3|||
162985389|NCT04480021|588650010|FG001|Overall Study|Lost to Follow-up|4|||
162985390|NCT00546572|588650011|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
162985391|NCT00546572|588650012|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
162985392|NCT00546572|588650011|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
162985393|NCT00546572|588650012|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
162985394|NCT00546572|588650011|FG000|Vax 1 / Year 0|Protocol Violation|3|||
162985395|NCT00546572|588650012|FG001|Vax 1 / Year 0|Protocol Violation|4|||
162985396|NCT00546572|588650011|FG000|Vax 1 / Year 0|Death|2|||
162985397|NCT00546572|588650012|FG001|Vax 1 / Year 0|Death|2|||
162985398|NCT00546572|588650011|FG000|Vax 1 / Year 0|Adverse Event|0|||
162985399|NCT00546572|588650012|FG001|Vax 1 / Year 0|Adverse Event|1|||
162985400|NCT00546572|588650011|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
162985401|NCT00546572|588650012|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
162985402|NCT00546572|588650011|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
163322909|NCT04757753|589895413|FG001|Overall Study|Lost to Follow-up|7|||
163322910|NCT04757753|589895412|FG000|Overall Study|Withdrawal by Subject|0|||
163322911|NCT04757753|589895413|FG001|Overall Study|Withdrawal by Subject|3|||
163322912|NCT04757753|589895412|FG000|Overall Study|Endodontic treatment failure|1|||
163322913|NCT04757753|589895413|FG001|Overall Study|Endodontic treatment failure|2|||
163322914|NCT04757753|589895412|FG000|Overall Study|Tooth fracture/extraction|3|||
163322915|NCT04757753|589895413|FG001|Overall Study|Tooth fracture/extraction|0|||
163322916|NCT00942734|589895418|FG000|Overall Study|Adverse Event|2|||
162985403|NCT00546572|588650012|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
162985404|NCT00546572|588650011|FG000|Vax 2 / Year 1|Other|1|||
162985405|NCT00546572|588650012|FG001|Vax 2 / Year 1|Other|1|||
162985406|NCT00546572|588650011|FG000|Vax 2 / Year 1|Adverse Event|1|||
162985407|NCT00546572|588650012|FG001|Vax 2 / Year 1|Adverse Event|0|||
162985408|NCT00546572|588650011|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
162985409|NCT00546572|588650012|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
163059805|NCT02030600|588928217|FG000|Treatment Period 2|Unclassified|1|||
162985410|NCT03979820|588650013|FG000|Overall Study|Protocol Violation|1|||
162985411|NCT03979820|588650014|FG001|Overall Study|Protocol Violation|0|||
162985412|NCT03979820|588650015|FG002|Overall Study|Protocol Violation|0|||
162985413|NCT03979820|588650016|FG003|Overall Study|Protocol Violation|0|||
162985414|NCT03979820|588650013|FG000|Overall Study|Withdrawal by Subject|0|||
162985415|NCT03979820|588650014|FG001|Overall Study|Withdrawal by Subject|0|||
162985416|NCT03979820|588650015|FG002|Overall Study|Withdrawal by Subject|1|||
162985417|NCT03979820|588650016|FG003|Overall Study|Withdrawal by Subject|0|||
162985418|NCT03979820|588650013|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
162985419|NCT03979820|588650014|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
162985420|NCT03979820|588650015|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
162985421|NCT03979820|588650016|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
162985422|NCT02685202|588650017|FG000|Overall Study|Lost to Follow-up|9|||
162985423|NCT01229735|588650018|FG000|Overall Study|Lack of Efficacy|8|||
162985424|NCT01229735|588650019|FG001|Overall Study|Lack of Efficacy|8|||
162985425|NCT01229735|588650018|FG000|Overall Study|Protocol Violation|13|||
162985426|NCT01229735|588650019|FG001|Overall Study|Protocol Violation|8|||
162985427|NCT01229735|588650018|FG000|Overall Study|Lost to Follow-up|0|||
162985428|NCT01229735|588650019|FG001|Overall Study|Lost to Follow-up|2|||
162985429|NCT01229735|588650018|FG000|Overall Study|Withdrawal by Subject|18|||
162985430|NCT01229735|588650019|FG001|Overall Study|Withdrawal by Subject|17|||
162985431|NCT01229735|588650018|FG000|Overall Study|Other Reason|13|||
162985432|NCT01229735|588650019|FG001|Overall Study|Other Reason|10|||
162985433|NCT01229735|588650018|FG000|Overall Study|SAE, non-fatal|0|||
162985434|NCT01229735|588650019|FG001|Overall Study|SAE, non-fatal|4|||
162985435|NCT01229735|588650018|FG000|Overall Study|AE, non-serious non-fatal|13|||
162985436|NCT01229735|588650019|FG001|Overall Study|AE, non-serious non-fatal|17|||
162985437|NCT01229735|588650018|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
162985438|NCT01229735|588650019|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
162985439|NCT02130882|588650020|FG000|Overall Study|Withdrawal by Subject|0|||
162985440|NCT02130882|588650021|FG001|Overall Study|Withdrawal by Subject|1|||
162985441|NCT04453202|588650026|FG000|Overall Study|Adverse Event|0|||
162985442|NCT04453202|588650027|FG001|Overall Study|Adverse Event|0|||
162985443|NCT04453202|588650028|FG002|Overall Study|Adverse Event|0|||
162985444|NCT04453202|588650029|FG003|Overall Study|Adverse Event|0|||
163322917|NCT00942734|589895418|FG000|Overall Study|Protocol Violation|3|||
163322918|NCT00942734|589895418|FG000|Overall Study|Disease Progression|2|||
163322919|NCT00942734|589895418|FG000|Overall Study|Physician Decision|1|||
163322920|NCT00319046|589895419|FG000|Overall Study|withdrawal of subject's consent|7|||
163322921|NCT00319046|589895419|FG000|Overall Study|administrative reason|1|||
163322922|NCT03816397|589895423|FG000|Overall Study|Censored at interim analysis date.|13|||
163322923|NCT03816397|589895424|FG001|Overall Study|Censored at interim analysis date.|6|||
163322924|NCT03816397|589895423|FG000|Overall Study|Withdrawal by Subject|1|||
163322925|NCT03816397|589895424|FG001|Overall Study|Withdrawal by Subject|1|||
163322926|NCT04496752|589895427|FG000|Second Assessment|Lost to Follow-up|3|||
163322927|NCT04496752|589895428|FG001|Second Assessment|Lost to Follow-up|3|||
163322928|NCT04496752|589895427|FG000|Second Assessment|Adverse Event|2|||
163322929|NCT04496752|589895428|FG001|Second Assessment|Adverse Event|0|||
163322930|NCT04908930|589895431|FG000|Overall Study|Lost to Follow-up|1|||
163322931|NCT04908930|589895432|FG001|Overall Study|Lost to Follow-up|1|||
163322932|NCT04908930|589895433|FG002|Overall Study|Lost to Follow-up|0|||
163322933|NCT04908930|589895434|FG003|Overall Study|Lost to Follow-up|0|||
163322934|NCT04908930|589895435|FG004|Overall Study|Lost to Follow-up|0|||
163322935|NCT04908930|589895431|FG000|Overall Study|hardware in mouth|1|||
163322936|NCT04908930|589895432|FG001|Overall Study|hardware in mouth|1|||
163322937|NCT04908930|589895433|FG002|Overall Study|hardware in mouth|0|||
163322938|NCT04908930|589895434|FG003|Overall Study|hardware in mouth|0|||
163322939|NCT04908930|589895435|FG004|Overall Study|hardware in mouth|0|||
163322940|NCT04908930|589895431|FG000|Overall Study|wrong team|1|||
163322941|NCT04908930|589895432|FG001|Overall Study|wrong team|0|||
163322942|NCT04908930|589895433|FG002|Overall Study|wrong team|0|||
163322943|NCT04908930|589895434|FG003|Overall Study|wrong team|0|||
163322944|NCT04908930|589895435|FG004|Overall Study|wrong team|0|||
163322945|NCT04908930|589895431|FG000|Overall Study|quit team|2|||
162985445|NCT04453202|588650030|FG004|Overall Study|Adverse Event|0|||
162985446|NCT04453202|588650031|FG005|Overall Study|Adverse Event|0|||
162985447|NCT04453202|588650032|FG006|Overall Study|Adverse Event|1|||
162985448|NCT04453202|588650033|FG007|Overall Study|Adverse Event|0|||
163322946|NCT04908930|589895432|FG001|Overall Study|quit team|4|||
163322947|NCT04908930|589895433|FG002|Overall Study|quit team|0|||
163322948|NCT04908930|589895434|FG003|Overall Study|quit team|0|||
163322949|NCT04908930|589895435|FG004|Overall Study|quit team|0|||
163322950|NCT04908930|589895431|FG000|Overall Study|Withdrawal by Subject|1|||
163322951|NCT04908930|589895432|FG001|Overall Study|Withdrawal by Subject|2|||
162985449|NCT04453202|588650034|FG008|Overall Study|Adverse Event|0|||
162985450|NCT04453202|588650035|FG009|Overall Study|Adverse Event|0|||
163322952|NCT04908930|589895433|FG002|Overall Study|Withdrawal by Subject|0|||
163322953|NCT04908930|589895434|FG003|Overall Study|Withdrawal by Subject|0|||
162985451|NCT04453202|588650036|FG010|Overall Study|Adverse Event|0|||
162985452|NCT04453202|588650026|FG000|Overall Study|Death|0|||
162985453|NCT04453202|588650027|FG001|Overall Study|Death|0|||
162985454|NCT04453202|588650028|FG002|Overall Study|Death|0|||
162985455|NCT04453202|588650029|FG003|Overall Study|Death|0|||
162985456|NCT04453202|588650030|FG004|Overall Study|Death|0|||
162985457|NCT04453202|588650031|FG005|Overall Study|Death|0|||
162985458|NCT04453202|588650032|FG006|Overall Study|Death|0|||
162985459|NCT04453202|588650033|FG007|Overall Study|Death|0|||
162985460|NCT04453202|588650034|FG008|Overall Study|Death|0|||
162985461|NCT04453202|588650035|FG009|Overall Study|Death|1|||
162985462|NCT04453202|588650036|FG010|Overall Study|Death|0|||
162985463|NCT04453202|588650026|FG000|Overall Study|Lost to Follow-up|0|||
162985464|NCT04453202|588650027|FG001|Overall Study|Lost to Follow-up|1|||
162985465|NCT04453202|588650028|FG002|Overall Study|Lost to Follow-up|0|||
162985466|NCT04453202|588650029|FG003|Overall Study|Lost to Follow-up|1|||
162985467|NCT04453202|588650030|FG004|Overall Study|Lost to Follow-up|0|||
162985468|NCT04453202|588650031|FG005|Overall Study|Lost to Follow-up|0|||
162985469|NCT04453202|588650032|FG006|Overall Study|Lost to Follow-up|0|||
162985470|NCT04453202|588650033|FG007|Overall Study|Lost to Follow-up|0|||
162985471|NCT04453202|588650034|FG008|Overall Study|Lost to Follow-up|0|||
162985472|NCT04453202|588650035|FG009|Overall Study|Lost to Follow-up|1|||
162985473|NCT04453202|588650036|FG010|Overall Study|Lost to Follow-up|1|||
162985474|NCT04453202|588650026|FG000|Overall Study|Withdrawal by Subject|1|||
162985475|NCT04453202|588650027|FG001|Overall Study|Withdrawal by Subject|2|||
162985476|NCT04453202|588650028|FG002|Overall Study|Withdrawal by Subject|1|||
162985477|NCT04453202|588650029|FG003|Overall Study|Withdrawal by Subject|2|||
162985478|NCT04453202|588650030|FG004|Overall Study|Withdrawal by Subject|1|||
162985479|NCT04453202|588650031|FG005|Overall Study|Withdrawal by Subject|1|||
162985480|NCT04453202|588650032|FG006|Overall Study|Withdrawal by Subject|0|||
162985481|NCT04453202|588650033|FG007|Overall Study|Withdrawal by Subject|0|||
162985482|NCT04453202|588650034|FG008|Overall Study|Withdrawal by Subject|0|||
162985483|NCT04453202|588650035|FG009|Overall Study|Withdrawal by Subject|1|||
162985484|NCT04453202|588650036|FG010|Overall Study|Withdrawal by Subject|0|||
162985485|NCT04453202|588650026|FG000|Overall Study|Adverse Event|0|||
162985486|NCT04453202|588650027|FG001|Overall Study|Adverse Event|0|||
162985487|NCT04453202|588650028|FG002|Overall Study|Adverse Event|0|||
162985488|NCT04453202|588650029|FG003|Overall Study|Adverse Event|0|||
162985489|NCT04453202|588650030|FG004|Overall Study|Adverse Event|0|||
162985490|NCT04453202|588650031|FG005|Overall Study|Adverse Event|1|||
162985491|NCT04453202|588650032|FG006|Overall Study|Adverse Event|0|||
162985492|NCT04453202|588650033|FG007|Overall Study|Adverse Event|0|||
162985493|NCT04453202|588650034|FG008|Overall Study|Adverse Event|0|||
162985494|NCT04453202|588650035|FG009|Overall Study|Adverse Event|0|||
162985495|NCT04453202|588650036|FG010|Overall Study|Adverse Event|0|||
162985496|NCT01355159|588650041|FG000|Overall Study|Withdrew consent|39|||
163322954|NCT04908930|589895435|FG004|Overall Study|Withdrawal by Subject|0|||
163322955|NCT04908930|589895431|FG000|Overall Study|parent not liking program|0|||
163322956|NCT04908930|589895432|FG001|Overall Study|parent not liking program|1|||
163322957|NCT04908930|589895433|FG002|Overall Study|parent not liking program|0|||
163322958|NCT04908930|589895434|FG003|Overall Study|parent not liking program|0|||
163322959|NCT04908930|589895435|FG004|Overall Study|parent not liking program|0|||
163322960|NCT04679389|589895436|FG000|Overall Study|Adverse Event|1|||
163322961|NCT04679389|589895437|FG001|Overall Study|Adverse Event|0|||
163322962|NCT04679389|589895436|FG000|Overall Study|Protocol Violation|2|||
163322963|NCT04679389|589895437|FG001|Overall Study|Protocol Violation|0|||
163322964|NCT04679389|589895436|FG000|Overall Study|Physician Decision|3|||
163322965|NCT04679389|589895437|FG001|Overall Study|Physician Decision|5|||
163322966|NCT04679389|589895436|FG000|Overall Study|Withdrawal by Subject|5|||
163322967|NCT04679389|589895437|FG001|Overall Study|Withdrawal by Subject|7|||
163322968|NCT02777593|589895438|FG000|Overall Study|Still in study|1|||
163322969|NCT02777593|589895439|FG001|Overall Study|Still in study|32|||
163322970|NCT02777593|589895440|FG002|Overall Study|Still in study|3|||
163322971|NCT02777593|589895441|FG003|Overall Study|Still in study|6|||
163322972|NCT02777593|589895442|FG004|Overall Study|Still in study|5|||
163322973|NCT02777593|589895438|FG000|Overall Study|Death|21|||
163403355|NCT00105443|590188550|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
162985497|NCT01355159|588650042|FG001|Overall Study|Withdrew consent|47|||
162985498|NCT01355159|588650041|FG000|Overall Study|No primary outcome data|17|||
162985499|NCT01355159|588650042|FG001|Overall Study|No primary outcome data|11|||
162985500|NCT01355159|588650041|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
162985501|NCT01355159|588650042|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
163322974|NCT02777593|589895439|FG001|Overall Study|Death|28|||
163322975|NCT02777593|589895440|FG002|Overall Study|Death|0|||
163322976|NCT02777593|589895441|FG003|Overall Study|Death|5|||
163322977|NCT02777593|589895442|FG004|Overall Study|Death|0|||
163322978|NCT02777593|589895438|FG000|Overall Study|Withdrawal by Subject|8|||
162985502|NCT01355159|588650041|FG000|Overall Study|Early intrauterine fetal death|6|||
162985503|NCT01355159|588650042|FG001|Overall Study|Early intrauterine fetal death|6|||
163322979|NCT02777593|589895439|FG001|Overall Study|Withdrawal by Subject|4|||
162985504|NCT03276221|588650043|FG000|Overall Study|Lost to Follow-up|6|||
162985505|NCT03276221|588650044|FG001|Overall Study|Lost to Follow-up|2|||
162985506|NCT03276221|588650045|FG002|Overall Study|Lost to Follow-up|0|||
162985507|NCT03276221|588650043|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
162985508|NCT03276221|588650044|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
162985509|NCT03276221|588650045|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
162985510|NCT00424775|588650046|FG000|Overall Study|Adverse Event|2|||
162985511|NCT00424775|588650047|FG001|Overall Study|Adverse Event|0|||
162985512|NCT00424775|588650046|FG000|Overall Study|Lack of Efficacy|1|||
162985513|NCT00424775|588650047|FG001|Overall Study|Lack of Efficacy|0|||
162985514|NCT02615171|588650048|FG000|Overall Study|Lost to Follow-up|2|||
162985515|NCT02615171|588650049|FG001|Overall Study|Lost to Follow-up|1|||
162985516|NCT00975286|588650050|FG000|Overall Study|Adverse Event|9|||
162985517|NCT00975286|588650051|FG001|Overall Study|Adverse Event|19|||
162985518|NCT00975286|588650050|FG000|Overall Study|Protocol Violation|1|||
162985519|NCT00975286|588650051|FG001|Overall Study|Protocol Violation|2|||
162985520|NCT00975286|588650050|FG000|Overall Study|Withdrawal by Subject|0|||
162985521|NCT00975286|588650051|FG001|Overall Study|Withdrawal by Subject|2|||
162985522|NCT00975286|588650050|FG000|Overall Study|Familial and Personal Reasons|2|||
162985523|NCT00975286|588650051|FG001|Overall Study|Familial and Personal Reasons|2|||
162985524|NCT00975286|588650050|FG000|Overall Study|Poor Compliance to Protocol|0|||
162985525|NCT00975286|588650051|FG001|Overall Study|Poor Compliance to Protocol|2|||
162985526|NCT00975286|588650050|FG000|Overall Study|Sponsor Decision|0|||
162985527|NCT00975286|588650051|FG001|Overall Study|Sponsor Decision|2|||
162985528|NCT02384850|588650055|FG000|Overall Study|Withdrawal by Subject|2|||
162985529|NCT02384850|588650056|FG001|Overall Study|Withdrawal by Subject|2|||
162985530|NCT02312063|588650057|FG000|Overall Study|Withdrawal by Subject|0|||
162985531|NCT02312063|588650058|FG001|Overall Study|Withdrawal by Subject|1|||
162985532|NCT02788045|588652329|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
162985533|NCT02788045|588652330|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
162985534|NCT02788045|588652331|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
162985535|NCT02788045|588652329|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
162985536|NCT02788045|588652330|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
162985537|NCT02788045|588652331|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
162985538|NCT02788045|588652329|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
162985539|NCT02788045|588652330|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
162985540|NCT02788045|588652331|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
162985541|NCT02788045|588652329|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
162985542|NCT02788045|588652330|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
162985543|NCT02788045|588652331|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
162985544|NCT02788045|588652329|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
162985545|NCT02788045|588652330|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
162985546|NCT02788045|588652331|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
162985547|NCT02788045|588652329|FG000|Main Study (Up to Week 72)|Other|3|||
162985548|NCT02788045|588652330|FG001|Main Study (Up to Week 72)|Other|0|||
162985549|NCT02788045|588652331|FG002|Main Study (Up to Week 72)|Other|0|||
162985550|NCT02788045|588652329|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
162985551|NCT02788045|588652330|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
162985552|NCT02788045|588652331|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
162985553|NCT02788045|588652329|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
162985554|NCT02788045|588652330|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
162985555|NCT02788045|588652331|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
162985556|NCT02788045|588652329|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
162985557|NCT02788045|588652330|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
162985558|NCT02788045|588652331|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
162985559|NCT00372411|588652334|FG000|Overall Study|Withdrawal by Subject|3|||
162985560|NCT00372411|588652335|FG001|Overall Study|Withdrawal by Subject|4|||
162985561|NCT00372411|588652336|FG002|Overall Study|Withdrawal by Subject|1|||
162985562|NCT00372411|588652334|FG000|Overall Study|Death|0|||
162985563|NCT00372411|588652335|FG001|Overall Study|Death|2|||
162985564|NCT00372411|588652336|FG002|Overall Study|Death|1|||
162985565|NCT00372411|588652334|FG000|Overall Study|Lost to Follow-up|1|||
162985566|NCT00372411|588652335|FG001|Overall Study|Lost to Follow-up|1|||
163059806|NCT02030600|588928218|FG001|Treatment Period 2|Unclassified|0|||
163059807|NCT01155323|588928225|FG000|First Intervention|exclusion criteria|1|||
163322980|NCT02777593|589895440|FG002|Overall Study|Withdrawal by Subject|1|||
163322981|NCT02777593|589895441|FG003|Overall Study|Withdrawal by Subject|1|||
163322982|NCT02777593|589895442|FG004|Overall Study|Withdrawal by Subject|0|||
163322983|NCT02777593|589895438|FG000|Overall Study|Lost to Follow-up|8|||
163322984|NCT02777593|589895439|FG001|Overall Study|Lost to Follow-up|16|||
163322985|NCT02777593|589895440|FG002|Overall Study|Lost to Follow-up|5|||
163322986|NCT02777593|589895441|FG003|Overall Study|Lost to Follow-up|0|||
163322987|NCT02777593|589895442|FG004|Overall Study|Lost to Follow-up|1|||
163322988|NCT02777593|589895438|FG000|Overall Study|Physician Decision|2|||
163322989|NCT02777593|589895439|FG001|Overall Study|Physician Decision|2|||
162985567|NCT00372411|588652336|FG002|Overall Study|Lost to Follow-up|1|||
162985568|NCT00372411|588652334|FG000|Overall Study|Adverse Event|1|||
162985569|NCT00372411|588652335|FG001|Overall Study|Adverse Event|1|||
162985570|NCT00372411|588652336|FG002|Overall Study|Adverse Event|0|||
162985571|NCT00667810|588652339|FG000|Overall Study|Adverse Event|13|||
162985572|NCT00667810|588652340|FG001|Overall Study|Adverse Event|14|||
162985573|NCT00667810|588652341|FG002|Overall Study|Adverse Event|19|||
162985574|NCT00667810|588652342|FG003|Overall Study|Adverse Event|1|||
162985575|NCT00667810|588652339|FG000|Overall Study|Death|1|||
162985576|NCT00667810|588652340|FG001|Overall Study|Death|1|||
162985577|NCT00667810|588652341|FG002|Overall Study|Death|3|||
162985578|NCT00667810|588652342|FG003|Overall Study|Death|0|||
162985579|NCT00667810|588652339|FG000|Overall Study|Lack of Efficacy|1|||
162985580|NCT00667810|588652340|FG001|Overall Study|Lack of Efficacy|0|||
162985581|NCT00667810|588652341|FG002|Overall Study|Lack of Efficacy|2|||
162985582|NCT00667810|588652342|FG003|Overall Study|Lack of Efficacy|0|||
162985583|NCT00667810|588652339|FG000|Overall Study|Lost to Follow-up|1|||
162985584|NCT00667810|588652340|FG001|Overall Study|Lost to Follow-up|4|||
162985585|NCT00667810|588652341|FG002|Overall Study|Lost to Follow-up|2|||
162985586|NCT00667810|588652342|FG003|Overall Study|Lost to Follow-up|0|||
162985587|NCT00667810|588652339|FG000|Overall Study|Physician Decision|1|||
162985588|NCT00667810|588652340|FG001|Overall Study|Physician Decision|1|||
162985589|NCT00667810|588652341|FG002|Overall Study|Physician Decision|2|||
162985590|NCT00667810|588652342|FG003|Overall Study|Physician Decision|0|||
162985591|NCT00667810|588652339|FG000|Overall Study|Protocol Violation|0|||
162985592|NCT00667810|588652340|FG001|Overall Study|Protocol Violation|2|||
162985593|NCT00667810|588652341|FG002|Overall Study|Protocol Violation|0|||
162985594|NCT00667810|588652342|FG003|Overall Study|Protocol Violation|0|||
162985595|NCT00667810|588652339|FG000|Overall Study|Withdrawal by Subject|14|||
162985596|NCT00667810|588652340|FG001|Overall Study|Withdrawal by Subject|20|||
162985597|NCT00667810|588652341|FG002|Overall Study|Withdrawal by Subject|29|||
162985598|NCT00667810|588652342|FG003|Overall Study|Withdrawal by Subject|1|||
162985599|NCT00667810|588652339|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
162985600|NCT00667810|588652340|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
162985601|NCT00667810|588652341|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
162985602|NCT00667810|588652342|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
162985603|NCT00667810|588652339|FG000|Overall Study|Failed to Return|0|||
162985604|NCT00667810|588652340|FG001|Overall Study|Failed to Return|0|||
162985605|NCT00667810|588652341|FG002|Overall Study|Failed to Return|2|||
162985606|NCT00667810|588652342|FG003|Overall Study|Failed to Return|0|||
162985607|NCT00667810|588652339|FG000|Overall Study|Loss of Caregiver|0|||
162985608|NCT00667810|588652340|FG001|Overall Study|Loss of Caregiver|1|||
162985609|NCT00667810|588652341|FG002|Overall Study|Loss of Caregiver|3|||
162985610|NCT00667810|588652342|FG003|Overall Study|Loss of Caregiver|0|||
162985611|NCT00667810|588652339|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
162985612|NCT00667810|588652340|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
162985613|NCT00667810|588652341|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
162985614|NCT00667810|588652342|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
162985615|NCT00667810|588652339|FG000|Overall Study|Other|6|||
162985616|NCT00667810|588652340|FG001|Overall Study|Other|6|||
162985617|NCT00667810|588652341|FG002|Overall Study|Other|5|||
162985618|NCT00667810|588652342|FG003|Overall Study|Other|0|||
162985619|NCT00754650|588652345|FG000|Overall Study|Disease Progression|2|||
162985620|NCT02227147|588652349|FG000|Controlled Treatment Period|Adverse Event|4|||
162985621|NCT02227147|588652350|FG001|Controlled Treatment Period|Adverse Event|3|||
162985622|NCT02227147|588652349|FG000|Controlled Treatment Period|Other|2|||
162985623|NCT02227147|588652350|FG001|Controlled Treatment Period|Other|0|||
162985624|NCT02227147|588652349|FG000|Follow-up Period|Other|3|||
162985625|NCT02227147|588652350|FG001|Follow-up Period|Other|5|||
162985626|NCT03514641|588652353|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
162985627|NCT03514641|588652354|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
162985628|NCT03514641|588652355|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
162985629|NCT03514641|588652356|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
162985630|NCT03514641|588652353|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
162985631|NCT03514641|588652354|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
162985632|NCT03514641|588652355|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
162985633|NCT03514641|588652356|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
162985634|NCT03514641|588652353|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
162985635|NCT03514641|588652354|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
162985636|NCT03514641|588652355|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
162985637|NCT03514641|588652356|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
162985638|NCT03514641|588652353|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
162985639|NCT03514641|588652354|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
162985640|NCT03514641|588652355|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
162985641|NCT03514641|588652356|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
162985642|NCT03514641|588652353|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
162985643|NCT03514641|588652354|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
162985644|NCT03514641|588652355|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
162985645|NCT03514641|588652356|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
162985646|NCT03514641|588652353|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
162985647|NCT03514641|588652354|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
162985648|NCT03514641|588652355|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
162985649|NCT03514641|588652356|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
162985650|NCT03514641|588652353|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
162985651|NCT03514641|588652354|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
162985652|NCT03514641|588652355|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
162985653|NCT03514641|588652356|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
162985654|NCT03514641|588652353|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
162985655|NCT03514641|588652354|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
162985656|NCT03514641|588652355|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
162985657|NCT03514641|588652356|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
162985658|NCT03514641|588652353|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
162985659|NCT03514641|588652354|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
162985660|NCT03514641|588652355|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
162985661|NCT03514641|588652356|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
162985662|NCT03514641|588652353|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
162985663|NCT03514641|588652354|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
163322990|NCT02777593|589895440|FG002|Overall Study|Physician Decision|0|||
162985664|NCT03514641|588652355|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
162985665|NCT03514641|588652356|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
162985666|NCT03514641|588652353|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
162985667|NCT03514641|588652354|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
162985668|NCT03514641|588652355|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
162985669|NCT03514641|588652356|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
162985670|NCT03514641|588652353|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
162985671|NCT03514641|588652354|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
162985672|NCT03514641|588652355|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
162985673|NCT03514641|588652356|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
162985674|NCT01345175|588652357|FG000|Overall Study|Physician Decision|0|||
162985675|NCT01345175|588652358|FG001|Overall Study|Physician Decision|1|||
162985676|NCT01345175|588652357|FG000|Overall Study|Withdrawal by Subject|1|||
162985677|NCT01345175|588652358|FG001|Overall Study|Withdrawal by Subject|1|||
162985678|NCT01345175|588652357|FG000|Overall Study|Failed to complete BFI|3|||
162985679|NCT01345175|588652358|FG001|Overall Study|Failed to complete BFI|2|||
162985680|NCT01345175|588652357|FG000|Overall Study|Stopped taking medication|2|||
162985681|NCT01345175|588652358|FG001|Overall Study|Stopped taking medication|2|||
162985682|NCT04112173|588652360|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
162985683|NCT01561430|588652361|FG000|Overall Study|Adverse Event|0|||
162985684|NCT01561430|588652362|FG001|Overall Study|Adverse Event|0|||
162985685|NCT01561430|588652363|FG002|Overall Study|Adverse Event|3|||
162985686|NCT01561430|588652364|FG003|Overall Study|Adverse Event|1|||
163322991|NCT02777593|589895441|FG003|Overall Study|Physician Decision|0|||
163322992|NCT02777593|589895442|FG004|Overall Study|Physician Decision|0|||
163322993|NCT02777593|589895438|FG000|Overall Study|Discontinued due to Other|1|||
163322994|NCT02777593|589895439|FG001|Overall Study|Discontinued due to Other|0|||
163322995|NCT02777593|589895440|FG002|Overall Study|Discontinued due to Other|0|||
163322996|NCT02777593|589895441|FG003|Overall Study|Discontinued due to Other|0|||
163322997|NCT02777593|589895442|FG004|Overall Study|Discontinued due to Other|0|||
163322998|NCT03904576|589895449|FG000|Washout Period|Protocol Violation|1|||
163322999|NCT03904576|589895450|FG001|Washout Period|Protocol Violation|1|||
163323000|NCT05215054|589895453|FG000|Overall Study|Lost to Follow-up|1|||
163323001|NCT05215054|589895454|FG001|Overall Study|Lost to Follow-up|1|||
163323002|NCT05215054|589895453|FG000|Overall Study|Protocol Violation|1|||
163323003|NCT05215054|589895454|FG001|Overall Study|Protocol Violation|1|||
163323004|NCT05215054|589895453|FG000|Overall Study|Withdrawal by Subject|4|||
163323005|NCT05215054|589895454|FG001|Overall Study|Withdrawal by Subject|4|||
163323006|NCT01897441|589895455|FG000|Overall Study|Lost to Follow-up|0|||
163323007|NCT01897441|589895456|FG001|Overall Study|Lost to Follow-up|0|||
163323008|NCT01897441|589895457|FG002|Overall Study|Lost to Follow-up|1|||
163323009|NCT01897441|589895458|FG003|Overall Study|Lost to Follow-up|0|||
163323010|NCT01897441|589895459|FG004|Overall Study|Lost to Follow-up|0|||
163323011|NCT01897441|589895460|FG005|Overall Study|Lost to Follow-up|0|||
163323012|NCT01897441|589895455|FG000|Overall Study|Withdrawal by Subject|0|||
163323013|NCT01897441|589895456|FG001|Overall Study|Withdrawal by Subject|0|||
163323014|NCT01897441|589895457|FG002|Overall Study|Withdrawal by Subject|0|||
163323015|NCT01897441|589895458|FG003|Overall Study|Withdrawal by Subject|0|||
163323016|NCT01897441|589895459|FG004|Overall Study|Withdrawal by Subject|1|||
163323017|NCT01897441|589895460|FG005|Overall Study|Withdrawal by Subject|0|||
163323018|NCT01897441|589895455|FG000|Overall Study|Withdrawn by Provider|0|||
163403356|NCT00105443|590188551|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
162985687|NCT01561430|588652361|FG000|Overall Study|Withdrawal by Subject|0|||
162985688|NCT01561430|588652362|FG001|Overall Study|Withdrawal by Subject|0|||
162985689|NCT01561430|588652363|FG002|Overall Study|Withdrawal by Subject|1|||
162985690|NCT01561430|588652364|FG003|Overall Study|Withdrawal by Subject|0|||
162985691|NCT01561430|588652361|FG000|Overall Study|Physician Decision|0|||
162985692|NCT01561430|588652362|FG001|Overall Study|Physician Decision|1|||
162985693|NCT01561430|588652363|FG002|Overall Study|Physician Decision|0|||
162985694|NCT01561430|588652364|FG003|Overall Study|Physician Decision|0|||
162985695|NCT01561430|588652361|FG000|Overall Study|Sponsor Decision|1|||
163323019|NCT01897441|589895456|FG001|Overall Study|Withdrawn by Provider|2|||
163323020|NCT01897441|589895457|FG002|Overall Study|Withdrawn by Provider|0|||
163323021|NCT01897441|589895458|FG003|Overall Study|Withdrawn by Provider|0|||
163323022|NCT01897441|589895459|FG004|Overall Study|Withdrawn by Provider|0|||
162985696|NCT01561430|588652362|FG001|Overall Study|Sponsor Decision|14|||
162985697|NCT01561430|588652363|FG002|Overall Study|Sponsor Decision|13|||
162985698|NCT01561430|588652364|FG003|Overall Study|Sponsor Decision|12|||
162985699|NCT04234984|588652372|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
162985700|NCT04234984|588652372|FG000|Follow-up at the Second Time Point|Death|1|||
163323023|NCT01897441|589895460|FG005|Overall Study|Withdrawn by Provider|0|||
163323024|NCT02933489|589895461|FG000|Overall Study|Ineligible|3|||
163323025|NCT02933489|589895462|FG001|Overall Study|Ineligible|3|||
163323026|NCT02933489|589895461|FG000|Overall Study|Withdrawal by Subject|27|||
163323027|NCT02933489|589895462|FG001|Overall Study|Withdrawal by Subject|18|||
163323028|NCT02933489|589895461|FG000|Overall Study|Unable to complete exams (other)|14|||
163323029|NCT02933489|589895462|FG001|Overall Study|Unable to complete exams (other)|7|||
163323030|NCT01756300|589895463|FG000|Overall Study|Death|1|||
163323031|NCT01756300|589895463|FG000|Overall Study|Withdrawal by Subject|1|||
163323032|NCT04780581|589895464|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
163323033|NCT04780581|589895465|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
163323034|NCT04780581|589895464|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
163323035|NCT04780581|589895465|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
163323036|NCT03990883|589895466|FG000|Blinded Treatment Phase|Adverse Event|1|||
163323037|NCT03990883|589895467|FG001|Blinded Treatment Phase|Adverse Event|1|||
163323038|NCT03990883|589895468|FG002|Blinded Treatment Phase|Adverse Event|0|||
163323039|NCT03990883|589895466|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
163323040|NCT03990883|589895467|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
163323041|NCT03990883|589895468|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
163323042|NCT03990883|589895466|FG000|Blinded Treatment Phase|Physician Decision|1|||
163323043|NCT03990883|589895467|FG001|Blinded Treatment Phase|Physician Decision|0|||
163323044|NCT03990883|589895468|FG002|Blinded Treatment Phase|Physician Decision|0|||
163323045|NCT03990883|589895466|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
163323046|NCT03990883|589895467|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
163323047|NCT03990883|589895468|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
163323048|NCT03990883|589895466|FG000|Blinded Treatment Phase|COVID-19|3|||
163323049|NCT03990883|589895467|FG001|Blinded Treatment Phase|COVID-19|2|||
163323050|NCT03990883|589895468|FG002|Blinded Treatment Phase|COVID-19|0|||
163323051|NCT03990883|589895466|FG000|Blinded Treatment Phase|Personal Reasons|6|||
163323052|NCT03990883|589895467|FG001|Blinded Treatment Phase|Personal Reasons|3|||
163323053|NCT03990883|589895468|FG002|Blinded Treatment Phase|Personal Reasons|0|||
163323054|NCT03990883|589895466|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
163323055|NCT03990883|589895467|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
163323056|NCT03990883|589895468|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
163323057|NCT03990883|589895466|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
163323058|NCT03990883|589895467|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
163323059|NCT03990883|589895468|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
163323060|NCT03990883|589895466|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
163323061|NCT03990883|589895467|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
163323062|NCT03990883|589895468|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
163323063|NCT04678856|589895469|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
163323064|NCT04678856|589895470|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
163323065|NCT04678856|589895469|FG000|Overall Study|Withdrawal by Subject|5|||
163323066|NCT04678856|589895470|FG001|Overall Study|Withdrawal by Subject|1|||
163323067|NCT04633278|589896586|FG000|Overall Study|Adverse Event|1|||
163323068|NCT04633278|589896587|FG001|Overall Study|Adverse Event|0|||
163323069|NCT04633278|589896586|FG000|Overall Study|Withdrawal by Subject|1|||
163323070|NCT04633278|589896587|FG001|Overall Study|Withdrawal by Subject|0|||
163323071|NCT04633278|589896586|FG000|Overall Study|Death|11|||
163323072|NCT04633278|589896587|FG001|Overall Study|Death|7|||
163323073|NCT04633278|589896586|FG000|Overall Study|Sponsor Decision|3|||
163323074|NCT04633278|589896587|FG001|Overall Study|Sponsor Decision|0|||
163323075|NCT04633278|589896586|FG000|Overall Study|Not Listed|1|||
163323076|NCT04633278|589896587|FG001|Overall Study|Not Listed|0|||
163323077|NCT03705793|589896588|FG000|Overall Study|Lost to Follow-up|3|||
163323078|NCT03705793|589896589|FG001|Overall Study|Lost to Follow-up|4|||
162985701|NCT04234984|588652372|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
162985702|NCT01055132|588652375|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
162985703|NCT01055132|588652376|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
162985704|NCT01055132|588652375|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
162985705|NCT01055132|588652376|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
162985706|NCT00158600|588652377|FG000|Overall Study|unable to commit time to study|0|||
162985707|NCT00158600|588652378|FG001|Overall Study|unable to commit time to study|1|||
162985708|NCT00158600|588652377|FG000|Overall Study|Adverse Event|2|||
162985709|NCT00158600|588652378|FG001|Overall Study|Adverse Event|1|||
162985710|NCT00158600|588652377|FG000|Overall Study|Death|1|||
162985711|NCT00158600|588652378|FG001|Overall Study|Death|0|||
162985712|NCT00158600|588652377|FG000|Overall Study|Withdrawal by Subject|2|||
162985713|NCT00158600|588652378|FG001|Overall Study|Withdrawal by Subject|2|||
162985714|NCT02570113|588652379|FG000|Overall Study|Withdrawal by Subject|3|||
162985715|NCT02038907|588652380|FG000|Overall Study|Protocol Violation|0|||
162985716|NCT02038907|588652381|FG001|Overall Study|Protocol Violation|0|||
162985717|NCT02038907|588652382|FG002|Overall Study|Protocol Violation|0|||
162985718|NCT02038907|588652383|FG003|Overall Study|Protocol Violation|0|||
162985719|NCT02038907|588652384|FG004|Overall Study|Protocol Violation|0|||
162985720|NCT02038907|588652385|FG005|Overall Study|Protocol Violation|0|||
163403357|NCT00105443|590188552|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
163403358|NCT00105443|590188553|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
163403359|NCT00105443|590188550|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
163403360|NCT00105443|590188551|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
163403361|NCT00105443|590188552|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
163403362|NCT00105443|590188553|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
163403363|NCT00105443|590188550|FG000|Double-Blind Treatment|Physician Decision|1|||
163403364|NCT00105443|590188551|FG001|Double-Blind Treatment|Physician Decision|0|||
163403365|NCT00105443|590188552|FG002|Double-Blind Treatment|Physician Decision|2|||
163403366|NCT00105443|590188553|FG003|Double-Blind Treatment|Physician Decision|0|||
162985721|NCT02038907|588652386|FG006|Overall Study|Protocol Violation|0|||
162985722|NCT02038907|588652387|FG007|Overall Study|Protocol Violation|0|||
162985723|NCT02038907|588652388|FG008|Overall Study|Protocol Violation|0|||
162985724|NCT02038907|588652389|FG009|Overall Study|Protocol Violation|0|||
162985725|NCT02038907|588652390|FG010|Overall Study|Protocol Violation|1|||
162985726|NCT02038907|588652391|FG011|Overall Study|Protocol Violation|0|||
162985727|NCT02038907|588652392|FG012|Overall Study|Protocol Violation|0|||
162985728|NCT02038907|588652393|FG013|Overall Study|Protocol Violation|0|||
162985729|NCT02038907|588652380|FG000|Overall Study|Withdrawal by Subject|0|||
162985730|NCT02038907|588652381|FG001|Overall Study|Withdrawal by Subject|0|||
162985731|NCT02038907|588652382|FG002|Overall Study|Withdrawal by Subject|0|||
162985732|NCT02038907|588652383|FG003|Overall Study|Withdrawal by Subject|0|||
163059808|NCT01155323|588928226|FG001|First Intervention|exclusion criteria|1|||
163059809|NCT01155323|588928225|FG000|Second Intervention|Lost to Follow-up|1|||
163323079|NCT03705793|589896588|FG000|Overall Study|Withdrawal by Subject|2|||
163323080|NCT03705793|589896589|FG001|Overall Study|Withdrawal by Subject|1|||
163323081|NCT00447980|589896592|FG000|Overall Study|Withdrawal by Subject|1|||
163323082|NCT00447980|589896593|FG001|Overall Study|Withdrawal by Subject|1|||
163323083|NCT00447980|589896594|FG002|Overall Study|Withdrawal by Subject|4|||
163323084|NCT00447980|589896595|FG003|Overall Study|Withdrawal by Subject|4|||
163323085|NCT00447980|589896592|FG000|Overall Study|Lost to Follow-up|1|||
163323086|NCT00447980|589896593|FG001|Overall Study|Lost to Follow-up|1|||
163323087|NCT00447980|589896594|FG002|Overall Study|Lost to Follow-up|0|||
163323088|NCT00447980|589896595|FG003|Overall Study|Lost to Follow-up|0|||
163323089|NCT00447980|589896592|FG000|Overall Study|Did not proceed with surgery|3|||
163323090|NCT00447980|589896593|FG001|Overall Study|Did not proceed with surgery|3|||
163323091|NCT00447980|589896594|FG002|Overall Study|Did not proceed with surgery|2|||
163323092|NCT00447980|589896595|FG003|Overall Study|Did not proceed with surgery|2|||
163323093|NCT02720068|589896597|FG000|Overall Study|Adverse Event|0|||
163323094|NCT02720068|589896598|FG001|Overall Study|Adverse Event|0|||
163323095|NCT02720068|589896599|FG002|Overall Study|Adverse Event|0|||
163323096|NCT02720068|589896600|FG003|Overall Study|Adverse Event|0|||
162985733|NCT02038907|588652384|FG004|Overall Study|Withdrawal by Subject|0|||
162985734|NCT02038907|588652385|FG005|Overall Study|Withdrawal by Subject|0|||
162985735|NCT02038907|588652386|FG006|Overall Study|Withdrawal by Subject|0|||
162985736|NCT02038907|588652387|FG007|Overall Study|Withdrawal by Subject|0|||
163059810|NCT01155323|588928226|FG001|Second Intervention|Lost to Follow-up|1|||
163323097|NCT02720068|589896601|FG004|Overall Study|Adverse Event|0|||
163323098|NCT02720068|589896602|FG005|Overall Study|Adverse Event|0|||
163323099|NCT02720068|589896603|FG006|Overall Study|Adverse Event|0|||
163323100|NCT02720068|589896604|FG007|Overall Study|Adverse Event|0|||
163059811|NCT01208051|588928229|FG000|Total Enrollment|Withdrawal by Subject|0|||
163323101|NCT02720068|589896605|FG008|Overall Study|Adverse Event|0|||
163403367|NCT00105443|590188550|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
163403368|NCT00105443|590188551|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
162985737|NCT02038907|588652388|FG008|Overall Study|Withdrawal by Subject|0|||
163323102|NCT02720068|589896606|FG009|Overall Study|Adverse Event|0|||
163403369|NCT00105443|590188552|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
163403370|NCT00105443|590188553|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
163403371|NCT00105443|590188550|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
163403372|NCT00105443|590188551|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
163403373|NCT00105443|590188552|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
163403374|NCT00105443|590188553|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
163403375|NCT00105443|590188550|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
163403376|NCT00105443|590188551|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
163403377|NCT00105443|590188552|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
163403378|NCT00105443|590188553|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
163403379|NCT00105443|590188550|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
163403380|NCT00105443|590188551|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
163403381|NCT00105443|590188552|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
163403382|NCT00105443|590188553|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
163403383|NCT00105443|590188550|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
163403384|NCT00105443|590188551|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
163403385|NCT00105443|590188552|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
163403386|NCT00105443|590188553|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
163403387|NCT00105443|590188550|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
163403388|NCT00105443|590188551|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
163403389|NCT00105443|590188552|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
163403390|NCT00105443|590188553|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
163403391|NCT00105443|590188550|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
163403392|NCT00105443|590188551|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
163403393|NCT00105443|590188552|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
163403394|NCT00105443|590188553|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
163403395|NCT00105443|590188550|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
163403396|NCT00105443|590188551|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
163403397|NCT00105443|590188552|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
163403398|NCT00105443|590188553|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
163403399|NCT00105443|590188550|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
163403400|NCT00105443|590188551|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
163403401|NCT00105443|590188552|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
163403402|NCT00105443|590188553|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
163403403|NCT00105443|590188550|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
163403404|NCT00105443|590188551|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
163403405|NCT00105443|590188552|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
163403406|NCT00105443|590188553|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
163403407|NCT00105443|590188550|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
163403408|NCT00105443|590188551|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
163403409|NCT00105443|590188552|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
163403410|NCT00105443|590188553|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
163403411|NCT00105443|590188550|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
163403412|NCT00105443|590188551|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
163403413|NCT00105443|590188552|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
163403414|NCT00105443|590188553|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
163403415|NCT00105443|590188550|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
163403416|NCT00105443|590188551|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
163403417|NCT00105443|590188552|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
163403418|NCT00105443|590188553|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
163403419|NCT00105443|590188550|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
163403420|NCT00105443|590188551|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
163403421|NCT00105443|590188552|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
163403422|NCT00105443|590188553|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
163403423|NCT00105443|590188550|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
163403424|NCT00105443|590188551|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
163403425|NCT00105443|590188552|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
163059812|NCT01208051|588928230|FG001|Total Enrollment|Withdrawal by Subject|1|||
163059813|NCT01208051|588928231|FG002|Total Enrollment|Withdrawal by Subject|0|||
163059814|NCT01208051|588928232|FG003|Total Enrollment|Withdrawal by Subject|0|||
163403426|NCT00105443|590188553|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
163403427|NCT01623271|590188556|FG000|Overall Study|Withdrawal by Subject|2|||
163059815|NCT01208051|588928233|FG004|Total Enrollment|Withdrawal by Subject|2|||
162985738|NCT02038907|588652389|FG009|Overall Study|Withdrawal by Subject|0|||
162985739|NCT02038907|588652390|FG010|Overall Study|Withdrawal by Subject|1|||
162985740|NCT02038907|588652391|FG011|Overall Study|Withdrawal by Subject|0|||
162985741|NCT02038907|588652392|FG012|Overall Study|Withdrawal by Subject|0|||
162985742|NCT02038907|588652393|FG013|Overall Study|Withdrawal by Subject|0|||
162985743|NCT02746471|588652394|FG000|Overall Study|Death|43|||
162985744|NCT02746471|588652394|FG000|Overall Study|Exited before 36 months|1119|||
162985745|NCT02564211|588652395|FG000|Overall Study|Adverse Event|4|||
162985746|NCT00910091|588652396|FG000|Pre-assignment|Withdrawal by Subject|0|||
162985747|NCT00910091|588652397|FG001|Pre-assignment|Withdrawal by Subject|2|||
162985748|NCT00910091|588652396|FG000|Treatment and Survival|Withdrawal by Subject|3|||
162985749|NCT00910091|588652397|FG001|Treatment and Survival|Withdrawal by Subject|4|||
162985750|NCT00910091|588652396|FG000|Treatment and Survival|Adverse Event|1|||
162985751|NCT00910091|588652397|FG001|Treatment and Survival|Adverse Event|0|||
162985752|NCT01908816|588652400|FG000|Overall Study|Subject's no longer requires study drug|0|||
162985753|NCT01908816|588652401|FG001|Overall Study|Subject's no longer requires study drug|0|||
162985754|NCT01908816|588652402|FG002|Overall Study|Subject's no longer requires study drug|0|||
162985755|NCT01908816|588652403|FG003|Overall Study|Subject's no longer requires study drug|1|||
162985756|NCT01908816|588652400|FG000|Overall Study|Protocol deviation|1|||
162985757|NCT01908816|588652401|FG001|Overall Study|Protocol deviation|2|||
162985758|NCT01908816|588652402|FG002|Overall Study|Protocol deviation|1|||
162985759|NCT01908816|588652403|FG003|Overall Study|Protocol deviation|1|||
162985760|NCT01908816|588652400|FG000|Overall Study|Withdrawal by Subject|0|||
162985761|NCT01908816|588652401|FG001|Overall Study|Withdrawal by Subject|4|||
162985762|NCT01908816|588652402|FG002|Overall Study|Withdrawal by Subject|2|||
162985763|NCT01908816|588652403|FG003|Overall Study|Withdrawal by Subject|2|||
162985764|NCT01908816|588652400|FG000|Overall Study|Lost to Follow-up|3|||
162985765|NCT01908816|588652401|FG001|Overall Study|Lost to Follow-up|5|||
163059816|NCT01208051|588928229|FG000|Total Enrollment|Brain metastases|0|||
163059817|NCT01208051|588928230|FG001|Total Enrollment|Brain metastases|0|||
163059818|NCT01208051|588928231|FG002|Total Enrollment|Brain metastases|1|||
163059819|NCT01208051|588928232|FG003|Total Enrollment|Brain metastases|0|||
163059820|NCT01208051|588928233|FG004|Total Enrollment|Brain metastases|0|||
163059821|NCT02349386|588928234|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
163059822|NCT02349386|588928235|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
163059823|NCT02349386|588928236|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
163059824|NCT02349386|588928237|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
163059825|NCT02349386|588928234|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
163323103|NCT02720068|589896607|FG010|Overall Study|Adverse Event|0|||
163323104|NCT02720068|589896608|FG011|Overall Study|Adverse Event|1|||
163323105|NCT02720068|589896609|FG012|Overall Study|Adverse Event|0|||
163323106|NCT02720068|589896610|FG013|Overall Study|Adverse Event|0|||
163323107|NCT02720068|589896611|FG014|Overall Study|Adverse Event|0|||
163323108|NCT02720068|589896612|FG015|Overall Study|Adverse Event|0|||
163323109|NCT02720068|589896613|FG016|Overall Study|Adverse Event|0|||
163323110|NCT02720068|589896614|FG017|Overall Study|Adverse Event|0|||
163323111|NCT02720068|589896597|FG000|Overall Study|Death|1|||
163323112|NCT02720068|589896598|FG001|Overall Study|Death|3|||
163323113|NCT02720068|589896599|FG002|Overall Study|Death|2|||
163323114|NCT02720068|589896600|FG003|Overall Study|Death|1|||
163323115|NCT02720068|589896601|FG004|Overall Study|Death|2|||
163323116|NCT02720068|589896602|FG005|Overall Study|Death|1|||
163323117|NCT02720068|589896603|FG006|Overall Study|Death|2|||
163323118|NCT02720068|589896604|FG007|Overall Study|Death|2|||
163323119|NCT02720068|589896605|FG008|Overall Study|Death|3|||
163323120|NCT02720068|589896606|FG009|Overall Study|Death|1|||
163323121|NCT02720068|589896607|FG010|Overall Study|Death|20|||
163323122|NCT02720068|589896608|FG011|Overall Study|Death|166|||
163323123|NCT02720068|589896609|FG012|Overall Study|Death|34|||
163403428|NCT02037295|590188559|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
163403429|NCT02037295|590188560|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
162985766|NCT01908816|588652402|FG002|Overall Study|Lost to Follow-up|4|||
162985767|NCT01908816|588652403|FG003|Overall Study|Lost to Follow-up|2|||
162985768|NCT01908816|588652400|FG000|Overall Study|Death|1|||
162985769|NCT01908816|588652401|FG001|Overall Study|Death|0|||
162985770|NCT01908816|588652402|FG002|Overall Study|Death|7|||
163059826|NCT02349386|588928235|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
163323124|NCT02720068|589896610|FG013|Overall Study|Death|30|||
163323125|NCT02720068|589896611|FG014|Overall Study|Death|45|||
163323126|NCT02720068|589896612|FG015|Overall Study|Death|16|||
163323127|NCT02720068|589896613|FG016|Overall Study|Death|20|||
163323128|NCT02720068|589896614|FG017|Overall Study|Death|28|||
162985771|NCT01908816|588652403|FG003|Overall Study|Death|1|||
162985772|NCT01908816|588652400|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162985773|NCT01908816|588652401|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
162985774|NCT01908816|588652402|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
163059827|NCT02349386|588928236|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
163323129|NCT02720068|589896597|FG000|Overall Study|Lost to Follow-up|0|||
163323130|NCT02720068|589896598|FG001|Overall Study|Lost to Follow-up|0|||
163323131|NCT02720068|589896599|FG002|Overall Study|Lost to Follow-up|0|||
163323132|NCT02720068|589896600|FG003|Overall Study|Lost to Follow-up|0|||
163323133|NCT02720068|589896601|FG004|Overall Study|Lost to Follow-up|0|||
163323134|NCT02720068|589896602|FG005|Overall Study|Lost to Follow-up|0|||
163323135|NCT02720068|589896603|FG006|Overall Study|Lost to Follow-up|0|||
163323136|NCT02720068|589896604|FG007|Overall Study|Lost to Follow-up|0|||
163323137|NCT02720068|589896605|FG008|Overall Study|Lost to Follow-up|0|||
163323138|NCT02720068|589896606|FG009|Overall Study|Lost to Follow-up|0|||
162985775|NCT01908816|588652403|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
162985776|NCT01908816|588652400|FG000|Overall Study|Early termination|87|||
162985777|NCT01908816|588652401|FG001|Overall Study|Early termination|60|||
162985778|NCT01908816|588652402|FG002|Overall Study|Early termination|43|||
162985779|NCT01908816|588652403|FG003|Overall Study|Early termination|28|||
163323139|NCT02720068|589896607|FG010|Overall Study|Lost to Follow-up|0|||
163323140|NCT02720068|589896608|FG011|Overall Study|Lost to Follow-up|1|||
163323141|NCT02720068|589896609|FG012|Overall Study|Lost to Follow-up|0|||
163323142|NCT02720068|589896610|FG013|Overall Study|Lost to Follow-up|1|||
163323143|NCT02720068|589896611|FG014|Overall Study|Lost to Follow-up|2|||
163323144|NCT02720068|589896612|FG015|Overall Study|Lost to Follow-up|0|||
163323145|NCT02720068|589896613|FG016|Overall Study|Lost to Follow-up|0|||
163323146|NCT02720068|589896614|FG017|Overall Study|Lost to Follow-up|1|||
163323147|NCT02720068|589896597|FG000|Overall Study|Physician Decision|0|||
163323148|NCT02720068|589896598|FG001|Overall Study|Physician Decision|0|||
163323149|NCT02720068|589896599|FG002|Overall Study|Physician Decision|0|||
163323150|NCT02720068|589896600|FG003|Overall Study|Physician Decision|1|||
163323151|NCT02720068|589896601|FG004|Overall Study|Physician Decision|0|||
163323152|NCT02720068|589896602|FG005|Overall Study|Physician Decision|0|||
163323153|NCT02720068|589896603|FG006|Overall Study|Physician Decision|0|||
163323154|NCT02720068|589896604|FG007|Overall Study|Physician Decision|0|||
163323155|NCT02720068|589896605|FG008|Overall Study|Physician Decision|0|||
163323156|NCT02720068|589896606|FG009|Overall Study|Physician Decision|0|||
163323157|NCT02720068|589896607|FG010|Overall Study|Physician Decision|0|||
163323158|NCT02720068|589896608|FG011|Overall Study|Physician Decision|1|||
163323159|NCT02720068|589896609|FG012|Overall Study|Physician Decision|0|||
163323160|NCT02720068|589896610|FG013|Overall Study|Physician Decision|0|||
163323161|NCT02720068|589896611|FG014|Overall Study|Physician Decision|0|||
163323162|NCT02720068|589896612|FG015|Overall Study|Physician Decision|0|||
163323163|NCT02720068|589896613|FG016|Overall Study|Physician Decision|0|||
163323164|NCT02720068|589896614|FG017|Overall Study|Physician Decision|1|||
163323165|NCT02720068|589896597|FG000|Overall Study|Progressive Disease|2|||
163323166|NCT02720068|589896598|FG001|Overall Study|Progressive Disease|3|||
163323167|NCT02720068|589896599|FG002|Overall Study|Progressive Disease|1|||
163323168|NCT02720068|589896600|FG003|Overall Study|Progressive Disease|1|||
163323169|NCT02720068|589896601|FG004|Overall Study|Progressive Disease|1|||
163323170|NCT02720068|589896602|FG005|Overall Study|Progressive Disease|2|||
163323171|NCT02720068|589896603|FG006|Overall Study|Progressive Disease|1|||
163323172|NCT02720068|589896604|FG007|Overall Study|Progressive Disease|1|||
163323173|NCT02720068|589896605|FG008|Overall Study|Progressive Disease|0|||
163323174|NCT02720068|589896606|FG009|Overall Study|Progressive Disease|1|||
163323175|NCT02720068|589896607|FG010|Overall Study|Progressive Disease|0|||
163323176|NCT02720068|589896608|FG011|Overall Study|Progressive Disease|4|||
163323177|NCT02720068|589896609|FG012|Overall Study|Progressive Disease|1|||
162985780|NCT02618408|588652404|FG000|Overall Study|Withdrawal by Subject|1|||
162985781|NCT02618408|588652405|FG001|Overall Study|Withdrawal by Subject|0|||
162985782|NCT02618408|588652406|FG002|Overall Study|Withdrawal by Subject|4|||
162985783|NCT02618408|588652404|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
162985784|NCT02618408|588652405|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
162985785|NCT02618408|588652406|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
162985786|NCT02618408|588652404|FG000|Overall Study|Lost to Follow-up|4|||
162985787|NCT02618408|588652405|FG001|Overall Study|Lost to Follow-up|2|||
162985788|NCT02618408|588652406|FG002|Overall Study|Lost to Follow-up|6|||
162985789|NCT02618408|588652404|FG000|Overall Study|Adverse Event|4|||
162985790|NCT02618408|588652405|FG001|Overall Study|Adverse Event|0|||
162985791|NCT02618408|588652406|FG002|Overall Study|Adverse Event|10|||
162985792|NCT02618408|588652404|FG000|Overall Study|Physician Decision|1|||
163323178|NCT02720068|589896610|FG013|Overall Study|Progressive Disease|0|||
163323179|NCT02720068|589896611|FG014|Overall Study|Progressive Disease|0|||
163323180|NCT02720068|589896612|FG015|Overall Study|Progressive Disease|0|||
162985793|NCT02618408|588652405|FG001|Overall Study|Physician Decision|1|||
162985794|NCT02618408|588652406|FG002|Overall Study|Physician Decision|2|||
163323181|NCT02720068|589896613|FG016|Overall Study|Progressive Disease|0|||
163323182|NCT02720068|589896614|FG017|Overall Study|Progressive Disease|0|||
163323183|NCT02720068|589896597|FG000|Overall Study|Sponsor Decision|0|||
163323184|NCT02720068|589896598|FG001|Overall Study|Sponsor Decision|0|||
163323185|NCT02720068|589896599|FG002|Overall Study|Sponsor Decision|0|||
163323186|NCT02720068|589896600|FG003|Overall Study|Sponsor Decision|0|||
163323187|NCT02720068|589896601|FG004|Overall Study|Sponsor Decision|0|||
163323188|NCT02720068|589896602|FG005|Overall Study|Sponsor Decision|0|||
163323189|NCT02720068|589896603|FG006|Overall Study|Sponsor Decision|0|||
163323190|NCT02720068|589896604|FG007|Overall Study|Sponsor Decision|0|||
162985795|NCT02618408|588652404|FG000|Overall Study|Protocol Violation|1|||
162985796|NCT02618408|588652405|FG001|Overall Study|Protocol Violation|1|||
162985797|NCT02618408|588652406|FG002|Overall Study|Protocol Violation|2|||
162985798|NCT02618408|588652404|FG000|Overall Study|Other, Multiple Categories|0|||
162985799|NCT02618408|588652405|FG001|Overall Study|Other, Multiple Categories|0|||
162985800|NCT02618408|588652406|FG002|Overall Study|Other, Multiple Categories|4|||
162985801|NCT05183217|588652410|FG000|Overall Study|Withdrawal by Subject|1|||
162985802|NCT05183217|588652411|FG001|Overall Study|Withdrawal by Subject|1|||
162985803|NCT03914950|588652413|FG000|Overall Study|Physician Decision|54|||
162985804|NCT03167723|588652417|FG000|Overall Study|Protocol Violation|4|||
162985805|NCT03167723|588652418|FG001|Overall Study|Protocol Violation|6|||
162985806|NCT02524730|588652421|FG000|Overall Study|Lost to Follow-up|5|||
162985807|NCT02524730|588652421|FG000|Overall Study|Withdrawal by Subject|18|||
162985808|NCT02524730|588652421|FG000|Overall Study|Death|10|||
162985809|NCT02524730|588652421|FG000|Overall Study|Adverse Event|8|||
162985810|NCT02524730|588652421|FG000|Overall Study|Protocol Violation|1|||
162985811|NCT02524730|588652421|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
162985812|NCT00507130|588652422|FG000|Overall Study|Lost to Follow-up|0|||
162985813|NCT00507130|588652423|FG001|Overall Study|Lost to Follow-up|0|||
162985814|NCT00507130|588652424|FG002|Overall Study|Lost to Follow-up|1|||
162985815|NCT00507130|588652425|FG003|Overall Study|Lost to Follow-up|1|||
162985816|NCT00507130|588652422|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
162985817|NCT00507130|588652423|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
162985818|NCT00507130|588652424|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
162985819|NCT00507130|588652425|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
162985820|NCT03678285|588652437|FG000|Overall Study|Adverse Event|2|||
162985821|NCT03678285|588652437|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
162985822|NCT03678285|588652437|FG000|Overall Study|Dehydrated prior to start of workout|1|||
162985823|NCT02731326|588652440|FG000|Overall Study|Withdrawal by Subject|4|||
162985824|NCT02731326|588652441|FG001|Overall Study|Withdrawal by Subject|1|||
162985825|NCT02731326|588652440|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
162985826|NCT02731326|588652441|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
162985827|NCT02731326|588652440|FG000|Overall Study|Discharged without AliveCor|10|||
162985828|NCT02731326|588652441|FG001|Overall Study|Discharged without AliveCor|0|||
162985829|NCT02731326|588652440|FG000|Overall Study|Duplicate Participant|1|||
162985830|NCT02731326|588652441|FG001|Overall Study|Duplicate Participant|1|||
162985831|NCT04480710|588652444|FG000|Overall Study|Adverse Event|0|||
162985832|NCT04480710|588652445|FG001|Overall Study|Adverse Event|2|||
162985833|NCT04480710|588652446|FG002|Overall Study|Adverse Event|0|||
162985834|NCT04480710|588652447|FG003|Overall Study|Adverse Event|0|||
162985835|NCT04480710|588652444|FG000|Overall Study|Withdrawal by Subject|0|||
162985836|NCT04480710|588652445|FG001|Overall Study|Withdrawal by Subject|1|||
162985837|NCT04480710|588652446|FG002|Overall Study|Withdrawal by Subject|0|||
162985838|NCT04480710|588652447|FG003|Overall Study|Withdrawal by Subject|0|||
162985839|NCT04480710|588652444|FG000|Overall Study|Physician Decision|0|||
162985840|NCT04480710|588652445|FG001|Overall Study|Physician Decision|0|||
162985841|NCT04480710|588652446|FG002|Overall Study|Physician Decision|1|||
162985842|NCT04480710|588652447|FG003|Overall Study|Physician Decision|0|||
162985843|NCT02994940|588652448|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
162985844|NCT02994940|588652449|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
162985845|NCT02994940|588652448|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
162985846|NCT02994940|588652449|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
162985847|NCT02994940|588652448|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
162985848|NCT02994940|588652449|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
162985849|NCT01103466|588652452|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
162985850|NCT01103466|588652453|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
162985851|NCT01103466|588652454|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
162985852|NCT01103466|588652452|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
162985853|NCT01103466|588652453|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
162985854|NCT01103466|588652454|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
162985855|NCT01103466|588652452|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
162985856|NCT01103466|588652453|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
162985857|NCT01103466|588652454|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
162985858|NCT01103466|588652452|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
162985859|NCT01103466|588652453|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
162985860|NCT01103466|588652454|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
162985861|NCT01103466|588652452|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
162985862|NCT01103466|588652453|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
162985863|NCT01103466|588652454|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
162985864|NCT01103466|588652452|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
162985865|NCT01103466|588652453|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
162985866|NCT01103466|588652454|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
163323191|NCT02720068|589896605|FG008|Overall Study|Sponsor Decision|0|||
163323192|NCT02720068|589896606|FG009|Overall Study|Sponsor Decision|0|||
163323193|NCT02720068|589896607|FG010|Overall Study|Sponsor Decision|0|||
163323194|NCT02720068|589896608|FG011|Overall Study|Sponsor Decision|6|||
163323195|NCT02720068|589896609|FG012|Overall Study|Sponsor Decision|3|||
162985867|NCT02331368|588652459|FG000|Overall Study|Withdrawal by Subject|3|||
162985868|NCT02987959|588652460|FG000|Overall Study|Grantor stopped supply of drugs|6|||
162985869|NCT02302859|588652461|FG000|Overall Study|Lost Phone|1|||
162985870|NCT02302859|588652462|FG001|Overall Study|Lost Phone|1|||
162985871|NCT02302859|588652461|FG000|Overall Study|Withdrawal by Subject|0|||
162985872|NCT02302859|588652462|FG001|Overall Study|Withdrawal by Subject|1|||
162985873|NCT02989168|588652475|FG000|Overall Study|Withdrawal by Subject|2|||
162985874|NCT02989168|588652476|FG001|Overall Study|Withdrawal by Subject|0|||
162985875|NCT02989168|588652475|FG000|Overall Study|Physician Decision|0|||
162985876|NCT02989168|588652476|FG001|Overall Study|Physician Decision|1|||
162985877|NCT02989168|588652475|FG000|Overall Study|Adverse Event|1|||
162985878|NCT02989168|588652476|FG001|Overall Study|Adverse Event|2|||
162985879|NCT02989168|588652475|FG000|Overall Study|Sponsor stopped study.|1|||
162985880|NCT02989168|588652476|FG001|Overall Study|Sponsor stopped study.|0|||
162985881|NCT03456960|588652477|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
162985882|NCT03456960|588652478|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
162985883|NCT03456960|588652479|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
162985884|NCT03456960|588652480|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
162985885|NCT03456960|588652481|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
163323196|NCT02720068|589896610|FG013|Overall Study|Sponsor Decision|2|||
163323197|NCT02720068|589896611|FG014|Overall Study|Sponsor Decision|4|||
163323198|NCT02720068|589896612|FG015|Overall Study|Sponsor Decision|4|||
163323199|NCT02720068|589896613|FG016|Overall Study|Sponsor Decision|0|||
163323200|NCT02720068|589896614|FG017|Overall Study|Sponsor Decision|8|||
163323201|NCT02720068|589896597|FG000|Overall Study|Withdrawal by Subject|0|||
162985886|NCT03456960|588652482|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
162985887|NCT03456960|588652477|FG000|Period 2 (1 Day)|Adverse Event|1|||
162985888|NCT03456960|588652478|FG001|Period 2 (1 Day)|Adverse Event|0|||
162985889|NCT03456960|588652479|FG002|Period 2 (1 Day)|Adverse Event|0|||
162985890|NCT03456960|588652480|FG003|Period 2 (1 Day)|Adverse Event|1|||
162985891|NCT03456960|588652481|FG004|Period 2 (1 Day)|Adverse Event|0|||
162985892|NCT03456960|588652482|FG005|Period 2 (1 Day)|Adverse Event|0|||
162985893|NCT01940497|588652483|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
163323202|NCT02720068|589896598|FG001|Overall Study|Withdrawal by Subject|0|||
163323203|NCT02720068|589896599|FG002|Overall Study|Withdrawal by Subject|0|||
163323204|NCT02720068|589896600|FG003|Overall Study|Withdrawal by Subject|0|||
163323205|NCT02720068|589896601|FG004|Overall Study|Withdrawal by Subject|0|||
163323206|NCT02720068|589896602|FG005|Overall Study|Withdrawal by Subject|0|||
163323207|NCT02720068|589896603|FG006|Overall Study|Withdrawal by Subject|0|||
163323208|NCT02720068|589896604|FG007|Overall Study|Withdrawal by Subject|0|||
163323209|NCT02720068|589896605|FG008|Overall Study|Withdrawal by Subject|0|||
163323210|NCT02720068|589896606|FG009|Overall Study|Withdrawal by Subject|1|||
163323211|NCT02720068|589896607|FG010|Overall Study|Withdrawal by Subject|0|||
163323212|NCT02720068|589896608|FG011|Overall Study|Withdrawal by Subject|27|||
163323213|NCT02720068|589896609|FG012|Overall Study|Withdrawal by Subject|2|||
163323214|NCT02720068|589896610|FG013|Overall Study|Withdrawal by Subject|8|||
163323215|NCT02720068|589896611|FG014|Overall Study|Withdrawal by Subject|7|||
163323216|NCT02720068|589896612|FG015|Overall Study|Withdrawal by Subject|0|||
163323217|NCT02720068|589896613|FG016|Overall Study|Withdrawal by Subject|0|||
163323218|NCT02720068|589896614|FG017|Overall Study|Withdrawal by Subject|2|||
163323219|NCT02720068|589896597|FG000|Overall Study|Protocol Violation|0|||
163323220|NCT02720068|589896598|FG001|Overall Study|Protocol Violation|0|||
163323221|NCT02720068|589896599|FG002|Overall Study|Protocol Violation|0|||
163323222|NCT02720068|589896600|FG003|Overall Study|Protocol Violation|0|||
163323223|NCT02720068|589896601|FG004|Overall Study|Protocol Violation|0|||
163323224|NCT02720068|589896602|FG005|Overall Study|Protocol Violation|0|||
163323225|NCT02720068|589896603|FG006|Overall Study|Protocol Violation|0|||
163323226|NCT02720068|589896604|FG007|Overall Study|Protocol Violation|0|||
163323227|NCT02720068|589896605|FG008|Overall Study|Protocol Violation|0|||
163403430|NCT02037295|590188561|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
162985894|NCT01940497|588652484|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
163323228|NCT02720068|589896606|FG009|Overall Study|Protocol Violation|0|||
163323229|NCT02720068|589896607|FG010|Overall Study|Protocol Violation|1|||
163323230|NCT02720068|589896608|FG011|Overall Study|Protocol Violation|0|||
163323231|NCT02720068|589896609|FG012|Overall Study|Protocol Violation|0|||
163403431|NCT02037295|590188562|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
162985895|NCT01940497|588652483|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
163059828|NCT02349386|588928237|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
163323232|NCT02720068|589896610|FG013|Overall Study|Protocol Violation|0|||
163323233|NCT02720068|589896611|FG014|Overall Study|Protocol Violation|1|||
163323234|NCT02720068|589896612|FG015|Overall Study|Protocol Violation|0|||
163323235|NCT02720068|589896613|FG016|Overall Study|Protocol Violation|1|||
163323236|NCT02720068|589896614|FG017|Overall Study|Protocol Violation|0|||
162985896|NCT01940497|588652484|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
162985897|NCT01940497|588652483|FG000|Overall Study|Violation of Entry Criteria|1|||
162985898|NCT01940497|588652484|FG001|Overall Study|Violation of Entry Criteria|1|||
162985899|NCT01940497|588652483|FG000|Overall Study|Refused Treatment|1|||
162985900|NCT01940497|588652484|FG001|Overall Study|Refused Treatment|3|||
162985901|NCT01940497|588652483|FG000|Overall Study|Withdrew Consent|6|||
162985902|NCT01940497|588652484|FG001|Overall Study|Withdrew Consent|2|||
162985903|NCT01940497|588652483|FG000|Overall Study|Administrative/Other|1|||
162985904|NCT01940497|588652484|FG001|Overall Study|Administrative/Other|1|||
162985905|NCT00502801|588652485|FG000|Treatment Period|Withdrawal by Subject|3|||
162985906|NCT00502801|588652485|FG000|Treatment Period|Adverse Event|7|||
162985907|NCT00502801|588652485|FG000|Treatment Period|Death|14|||
162985908|NCT00502801|588652485|FG000|Treatment Period|OTHER|30|||
162985909|NCT00502801|588652485|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
162985910|NCT00502801|588652485|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
162985911|NCT00502801|588652485|FG000|End of Therapy to Test of Cure|Death|3|||
162985912|NCT00502801|588652485|FG000|End of Therapy to Test of Cure|OTHER|2|||
162985913|NCT00446199|588652488|FG000|Overall Study|Adverse Event|7|||
162985914|NCT00446199|588652489|FG001|Overall Study|Adverse Event|4|||
162985915|NCT00446199|588652490|FG002|Overall Study|Adverse Event|6|||
162985916|NCT00446199|588652491|FG003|Overall Study|Adverse Event|4|||
162985917|NCT00446199|588652488|FG000|Overall Study|Lost to Follow-up|4|||
162985918|NCT00446199|588652489|FG001|Overall Study|Lost to Follow-up|5|||
162985919|NCT00446199|588652490|FG002|Overall Study|Lost to Follow-up|2|||
162985920|NCT00446199|588652491|FG003|Overall Study|Lost to Follow-up|6|||
162985921|NCT00446199|588652488|FG000|Overall Study|Protocol Violation|1|||
162985922|NCT00446199|588652489|FG001|Overall Study|Protocol Violation|2|||
162985923|NCT00446199|588652490|FG002|Overall Study|Protocol Violation|1|||
162985924|NCT00446199|588652491|FG003|Overall Study|Protocol Violation|3|||
162985925|NCT00446199|588652488|FG000|Overall Study|Withdrawal by Subject|2|||
162985926|NCT00446199|588652489|FG001|Overall Study|Withdrawal by Subject|5|||
162985927|NCT00446199|588652490|FG002|Overall Study|Withdrawal by Subject|9|||
162985928|NCT00446199|588652491|FG003|Overall Study|Withdrawal by Subject|10|||
162985929|NCT00446199|588652488|FG000|Overall Study|Site termination|2|||
162985930|NCT00446199|588652489|FG001|Overall Study|Site termination|0|||
162985931|NCT00446199|588652490|FG002|Overall Study|Site termination|0|||
162985932|NCT00446199|588652491|FG003|Overall Study|Site termination|1|||
162985933|NCT00446199|588652488|FG000|Overall Study|Randomization in Error|2|||
162985934|NCT00446199|588652489|FG001|Overall Study|Randomization in Error|0|||
162985935|NCT00446199|588652490|FG002|Overall Study|Randomization in Error|1|||
162985936|NCT00446199|588652491|FG003|Overall Study|Randomization in Error|1|||
162985937|NCT00446199|588652488|FG000|Overall Study|Lack of Efficacy|1|||
162985938|NCT00446199|588652489|FG001|Overall Study|Lack of Efficacy|0|||
162985939|NCT00446199|588652490|FG002|Overall Study|Lack of Efficacy|0|||
162985940|NCT00446199|588652491|FG003|Overall Study|Lack of Efficacy|1|||
162985941|NCT00446199|588652488|FG000|Overall Study|Non-compliant with study drug|1|||
162985942|NCT00446199|588652489|FG001|Overall Study|Non-compliant with study drug|0|||
162985943|NCT00446199|588652490|FG002|Overall Study|Non-compliant with study drug|5|||
162985944|NCT00446199|588652491|FG003|Overall Study|Non-compliant with study drug|0|||
162985945|NCT00446199|588652488|FG000|Overall Study|Non-compliant with visit schedule|1|||
163323253|NCT01773993|589896620|FG000|Overall Study|No Visit After Treatment|35|||
162985946|NCT00446199|588652489|FG001|Overall Study|Non-compliant with visit schedule|1|||
162985947|NCT00446199|588652490|FG002|Overall Study|Non-compliant with visit schedule|1|||
162985948|NCT00446199|588652491|FG003|Overall Study|Non-compliant with visit schedule|2|||
162985949|NCT00446199|588652488|FG000|Overall Study|Hormone fear|0|||
162985950|NCT00446199|588652489|FG001|Overall Study|Hormone fear|0|||
162985951|NCT00446199|588652490|FG002|Overall Study|Hormone fear|0|||
162985952|NCT00446199|588652491|FG003|Overall Study|Hormone fear|1|||
162985953|NCT00446199|588652488|FG000|Overall Study|Lost interest in study participation|0|||
162985954|NCT00446199|588652489|FG001|Overall Study|Lost interest in study participation|1|||
162985955|NCT00446199|588652490|FG002|Overall Study|Lost interest in study participation|0|||
162985956|NCT00446199|588652491|FG003|Overall Study|Lost interest in study participation|0|||
162985957|NCT00446199|588652488|FG000|Overall Study|In-/Exclusion criterion violated|2|||
162985958|NCT00446199|588652489|FG001|Overall Study|In-/Exclusion criterion violated|1|||
162985959|NCT00446199|588652490|FG002|Overall Study|In-/Exclusion criterion violated|2|||
162985960|NCT00446199|588652491|FG003|Overall Study|In-/Exclusion criterion violated|1|||
162985961|NCT00446199|588652488|FG000|Overall Study|Move|0|||
162985962|NCT00446199|588652489|FG001|Overall Study|Move|1|||
162985963|NCT00446199|588652490|FG002|Overall Study|Move|0|||
162985964|NCT00446199|588652491|FG003|Overall Study|Move|0|||
162985965|NCT03071094|588652495|FG000|Overall Study|Death|1|||
162985966|NCT03071094|588652496|FG001|Overall Study|Death|1|||
162985967|NCT03071094|588652495|FG000|Overall Study|Adverse Event|1|||
162985968|NCT03071094|588652496|FG001|Overall Study|Adverse Event|0|||
162985969|NCT01079832|588652500|FG000|Overall Study|Withdrawal by Subject|1|||
162985970|NCT01195272|588652501|FG000|Overall Study|Adverse Event|1|||
162985971|NCT01195272|588652501|FG000|Overall Study|Lack of Efficacy|3|||
162985972|NCT01769339|588652504|FG000|Overall Study|Lost to Follow-up|42|||
162985973|NCT01769339|588652504|FG000|Overall Study|Adverse Event|1|||
162985974|NCT04969861|588652505|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
162985975|NCT04969861|588652506|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
162985976|NCT00290251|588652507|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
163059829|NCT02349386|588928234|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
163323254|NCT04664881|589896621|FG000|Overall Study|Withdrawal by Subject|1|||
163323255|NCT04664881|589896622|FG001|Overall Study|Withdrawal by Subject|8|||
163323256|NCT04664881|589896621|FG000|Overall Study|Physician Decision|0|||
163323257|NCT04664881|589896622|FG001|Overall Study|Physician Decision|5|||
163323258|NCT04664881|589896621|FG000|Overall Study|Lost to Follow-up|1|||
163323259|NCT04664881|589896622|FG001|Overall Study|Lost to Follow-up|0|||
163323260|NCT04408755|589896634|FG000|Period A (Placebo lead-in)|Other|11|||
163323261|NCT04408755|589896635|FG001|Period A (Placebo lead-in)|Other|0|||
163323262|NCT04408755|589896636|FG002|Period A (Placebo lead-in)|Other|0|||
163323263|NCT04408755|589896637|FG003|Period A (Placebo lead-in)|Other|0|||
163323264|NCT04408755|589896634|FG000|Period B (Randomization Period)|Adverse Event|0|||
163323265|NCT04408755|589896635|FG001|Period B (Randomization Period)|Adverse Event|3|||
163323266|NCT04408755|589896636|FG002|Period B (Randomization Period)|Adverse Event|0|||
163323267|NCT04408755|589896637|FG003|Period B (Randomization Period)|Adverse Event|1|||
163323268|NCT04408755|589896634|FG000|Period B (Randomization Period)|Death|0|||
163323269|NCT04408755|589896635|FG001|Period B (Randomization Period)|Death|0|||
163323270|NCT04408755|589896636|FG002|Period B (Randomization Period)|Death|1|||
163323271|NCT04408755|589896637|FG003|Period B (Randomization Period)|Death|0|||
163323272|NCT04408755|589896634|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
163323273|NCT04408755|589896635|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
163323274|NCT04408755|589896636|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
163323275|NCT04408755|589896637|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
163323276|NCT04408755|589896634|FG000|Period B (Randomization Period)|Physician Decision|0|||
163323277|NCT04408755|589896635|FG001|Period B (Randomization Period)|Physician Decision|0|||
163323278|NCT04408755|589896636|FG002|Period B (Randomization Period)|Physician Decision|1|||
163323279|NCT04408755|589896637|FG003|Period B (Randomization Period)|Physician Decision|0|||
163323280|NCT04408755|589896634|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
163323281|NCT04408755|589896635|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
163323282|NCT04408755|589896636|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
163323283|NCT04408755|589896637|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
163323284|NCT04408755|589896634|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
163323285|NCT04408755|589896635|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
163323286|NCT04408755|589896636|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
163323287|NCT04408755|589896637|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
163323288|NCT04408755|589896634|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
163323289|NCT04408755|589896635|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
163059830|NCT02349386|588928235|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
163059831|NCT02349386|588928236|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
163059832|NCT02349386|588928237|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
163059833|NCT02349386|588928234|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
163323290|NCT04408755|589896636|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
163323291|NCT04408755|589896637|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
163323292|NCT04408755|589896634|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
163323293|NCT04408755|589896635|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
163323294|NCT04408755|589896636|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
163323295|NCT04408755|589896637|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
162985977|NCT00290251|588652508|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
162985978|NCT00290251|588652509|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
162985979|NCT00290251|588652510|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
162985980|NCT00290251|588652511|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
162985981|NCT00290251|588652512|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
162985982|NCT00290251|588652507|FG000|Treatment 1 (Months 2-4)|headache|0|||
162985983|NCT00290251|588652508|FG001|Treatment 1 (Months 2-4)|headache|0|||
162985984|NCT00290251|588652509|FG002|Treatment 1 (Months 2-4)|headache|0|||
162985985|NCT00290251|588652510|FG003|Treatment 1 (Months 2-4)|headache|0|||
162985986|NCT00290251|588652511|FG004|Treatment 1 (Months 2-4)|headache|1|||
162985987|NCT00290251|588652512|FG005|Treatment 1 (Months 2-4)|headache|0|||
162985988|NCT00290251|588652507|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
162985989|NCT00290251|588652508|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
162985990|NCT00290251|588652509|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
162985991|NCT00290251|588652510|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
162985992|NCT00290251|588652511|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
162985993|NCT00290251|588652512|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
162985994|NCT03548064|588654727|FG000|Overall Study|Withdrawal by Subject|0|||
162985995|NCT03548064|588654728|FG001|Overall Study|Withdrawal by Subject|0|||
162985996|NCT03548064|588654729|FG002|Overall Study|Withdrawal by Subject|0|||
162985997|NCT03548064|588654730|FG003|Overall Study|Withdrawal by Subject|1|||
162985998|NCT03548064|588654731|FG004|Overall Study|Withdrawal by Subject|0|||
162985999|NCT03548064|588654732|FG005|Overall Study|Withdrawal by Subject|0|||
162986000|NCT03548064|588654733|FG006|Overall Study|Withdrawal by Subject|0|||
162986001|NCT03548064|588654734|FG007|Overall Study|Withdrawal by Subject|0|||
162986002|NCT03548064|588654727|FG000|Overall Study|Lost to Follow-up|0|||
163323296|NCT04408755|589896634|FG000|Period B (Randomization Period)|Reason not Specified|0|||
162986003|NCT03548064|588654728|FG001|Overall Study|Lost to Follow-up|0|||
162986004|NCT03548064|588654729|FG002|Overall Study|Lost to Follow-up|0|||
162986005|NCT03548064|588654730|FG003|Overall Study|Lost to Follow-up|0|||
162986006|NCT03548064|588654731|FG004|Overall Study|Lost to Follow-up|2|||
162986007|NCT03548064|588654732|FG005|Overall Study|Lost to Follow-up|0|||
162986008|NCT03548064|588654733|FG006|Overall Study|Lost to Follow-up|0|||
162986009|NCT03548064|588654734|FG007|Overall Study|Lost to Follow-up|0|||
162986010|NCT03548064|588654727|FG000|Overall Study|Covid-19 Pandemic|0|||
162986011|NCT03548064|588654728|FG001|Overall Study|Covid-19 Pandemic|0|||
162986012|NCT03548064|588654729|FG002|Overall Study|Covid-19 Pandemic|0|||
162986013|NCT03548064|588654730|FG003|Overall Study|Covid-19 Pandemic|0|||
162986014|NCT03548064|588654731|FG004|Overall Study|Covid-19 Pandemic|10|||
162986015|NCT03548064|588654732|FG005|Overall Study|Covid-19 Pandemic|3|||
162986016|NCT03548064|588654733|FG006|Overall Study|Covid-19 Pandemic|0|||
162986017|NCT03548064|588654734|FG007|Overall Study|Covid-19 Pandemic|0|||
162986018|NCT06218823|588654735|FG000|Overall Study|Death|3|||
163323297|NCT04408755|589896635|FG001|Period B (Randomization Period)|Reason not Specified|1|||
163323298|NCT04408755|589896636|FG002|Period B (Randomization Period)|Reason not Specified|0|||
163323299|NCT04408755|589896637|FG003|Period B (Randomization Period)|Reason not Specified|2|||
163323300|NCT00308997|589896638|FG000|Overall Study|Subject feigned clinical data|0|||
163323301|NCT00308997|589896639|FG001|Overall Study|Subject feigned clinical data|1|||
163323302|NCT00308997|589896638|FG000|Overall Study|Unable to tolerate intervention|1|||
163323303|NCT00308997|589896639|FG001|Overall Study|Unable to tolerate intervention|0|||
163323304|NCT06655818|589896645|FG000|Overall Study|Withdrawal by Subject|1|||
163323305|NCT04214418|589896652|FG000|Overall Study|Withdrawal by Subject|1|||
163323306|NCT04214418|589896653|FG001|Overall Study|Withdrawal by Subject|0|||
163323307|NCT04214418|589896654|FG002|Overall Study|Withdrawal by Subject|0|||
163323308|NCT04214418|589896655|FG003|Overall Study|Withdrawal by Subject|0|||
163323309|NCT04214418|589896656|FG004|Overall Study|Withdrawal by Subject|0|||
163323310|NCT04214418|589896657|FG005|Overall Study|Withdrawal by Subject|0|||
163323311|NCT04214418|589896652|FG000|Overall Study|Adverse Event|0|||
163323312|NCT04214418|589896653|FG001|Overall Study|Adverse Event|2|||
163323313|NCT04214418|589896654|FG002|Overall Study|Adverse Event|0|||
163323314|NCT04214418|589896655|FG003|Overall Study|Adverse Event|0|||
163323315|NCT04214418|589896656|FG004|Overall Study|Adverse Event|0|||
163323316|NCT04214418|589896657|FG005|Overall Study|Adverse Event|0|||
162986019|NCT06218823|588654736|FG001|Overall Study|Death|0|||
162986020|NCT06218823|588654735|FG000|Overall Study|Lost to Follow-up|0|||
163323317|NCT04214418|589896652|FG000|Overall Study|Death|1|||
163323318|NCT04214418|589896653|FG001|Overall Study|Death|0|||
163323319|NCT04214418|589896654|FG002|Overall Study|Death|0|||
163403432|NCT02770547|590188566|FG000|Overall Study|Patient non-compliant|1|||
163323320|NCT04214418|589896655|FG003|Overall Study|Death|0|||
162986021|NCT06218823|588654736|FG001|Overall Study|Lost to Follow-up|2|||
163323321|NCT04214418|589896656|FG004|Overall Study|Death|0|||
162986022|NCT04732221|588654737|FG000|Base Period|Death|2|||
162986023|NCT04732221|588654738|FG001|Base Period|Death|0|||
162986024|NCT04732221|588654739|FG002|Base Period|Death|0|||
163403433|NCT02770547|590188567|FG001|Overall Study|Patient non-compliant|0|||
163403434|NCT02770547|590188566|FG000|Overall Study|Adverse Event|0|||
163403435|NCT02770547|590188567|FG001|Overall Study|Adverse Event|1|||
163403436|NCT00661531|590188568|FG000|Overall Study|Withdrawal by Subject|3|||
163403437|NCT03134599|590188570|FG000|Week 1|Lost to Follow-up|0|||
163403438|NCT03134599|590188571|FG001|Week 1|Lost to Follow-up|0|||
163403439|NCT03134599|590188572|FG002|Week 1|Lost to Follow-up|0|||
163403440|NCT03134599|590188573|FG003|Week 1|Lost to Follow-up|0|||
163403441|NCT03134599|590188574|FG004|Week 1|Lost to Follow-up|1|||
163403442|NCT03134599|590188575|FG005|Week 1|Lost to Follow-up|0|||
163403443|NCT03134599|590188570|FG000|Week 2|Lost to Follow-up|1|||
163403444|NCT03134599|590188571|FG001|Week 2|Lost to Follow-up|0|||
163403445|NCT03134599|590188572|FG002|Week 2|Lost to Follow-up|0|||
163403446|NCT03134599|590188573|FG003|Week 2|Lost to Follow-up|1|||
163403447|NCT03134599|590188574|FG004|Week 2|Lost to Follow-up|1|||
163403448|NCT03134599|590188575|FG005|Week 2|Lost to Follow-up|0|||
163403449|NCT03134599|590188570|FG000|Week 3|Lost to Follow-up|0|||
163403450|NCT03134599|590188571|FG001|Week 3|Lost to Follow-up|0|||
163403451|NCT03134599|590188572|FG002|Week 3|Lost to Follow-up|0|||
163403452|NCT03134599|590188573|FG003|Week 3|Lost to Follow-up|1|||
163403453|NCT03134599|590188574|FG004|Week 3|Lost to Follow-up|0|||
163403454|NCT03134599|590188575|FG005|Week 3|Lost to Follow-up|1|||
163403455|NCT00393887|590188576|FG000|Overall Study|Physician Decision|5|||
163403456|NCT00393887|590188577|FG001|Overall Study|Physician Decision|0|||
163403457|NCT00393887|590188576|FG000|Overall Study|Lost to Follow-up|11|||
163403458|NCT00393887|590188577|FG001|Overall Study|Lost to Follow-up|9|||
163403459|NCT02311153|590188578|FG000|Overall Study|Lost to Follow-up|5|||
163403460|NCT02311153|590188579|FG001|Overall Study|Lost to Follow-up|7|||
163403461|NCT01967628|590188580|FG000|Overall Study|Withdrawal by Subject|2|||
163403462|NCT01967628|590188581|FG001|Overall Study|Withdrawal by Subject|0|||
163403463|NCT01967628|590188580|FG000|Overall Study|Unable to complete bronchoscopy|4|||
163403464|NCT01967628|590188581|FG001|Overall Study|Unable to complete bronchoscopy|6|||
163403465|NCT01967628|590188580|FG000|Overall Study|Lost to Follow-up|1|||
163403466|NCT01967628|590188581|FG001|Overall Study|Lost to Follow-up|0|||
163403467|NCT01967628|590188580|FG000|Overall Study|Low protein concentration in sample|20|||
163403468|NCT01967628|590188581|FG001|Overall Study|Low protein concentration in sample|25|||
163403469|NCT00838331|590188582|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
163403470|NCT01379274|590188583|FG000|Overall Study|funding withdrawn|1|||
163403471|NCT03287219|590188584|FG000|Overall Study|Protocol Violation|0|||
163403472|NCT03287219|590188585|FG001|Overall Study|Protocol Violation|2|||
163403473|NCT00957008|590188586|FG000|Overall Study|Withdrawal by Subject|13|||
163403474|NCT00957008|590188587|FG001|Overall Study|Withdrawal by Subject|10|||
163403475|NCT00957008|590188588|FG002|Overall Study|Withdrawal by Subject|12|||
163403476|NCT00957008|590188589|FG003|Overall Study|Withdrawal by Subject|16|||
163403477|NCT00957008|590188586|FG000|Overall Study|Lost to Follow-up|3|||
163403478|NCT00957008|590188587|FG001|Overall Study|Lost to Follow-up|1|||
163403479|NCT00957008|590188588|FG002|Overall Study|Lost to Follow-up|3|||
163403480|NCT00957008|590188589|FG003|Overall Study|Lost to Follow-up|4|||
163403481|NCT00957008|590188586|FG000|Overall Study|Physician Decision|1|||
163403482|NCT00957008|590188587|FG001|Overall Study|Physician Decision|0|||
163323322|NCT04214418|589896657|FG005|Overall Study|Death|0|||
163323323|NCT05785130|589896662|FG000|Overall Study|Withdrawal by Subject|1|||
163323324|NCT05785130|589896663|FG001|Overall Study|Withdrawal by Subject|0|||
163323325|NCT05785130|589896662|FG000|Overall Study|Lack of Efficacy|0|||
163323326|NCT05785130|589896663|FG001|Overall Study|Lack of Efficacy|1|||
163323327|NCT02624050|589896668|FG000|Overall Study|Physician Decision|4|||
163323328|NCT02624050|589896669|FG001|Overall Study|Physician Decision|0|||
163323329|NCT02624050|589896668|FG000|Overall Study|Protocol Violation|2|||
163323330|NCT02624050|589896669|FG001|Overall Study|Protocol Violation|0|||
163323331|NCT03547271|589896670|FG000|Overall Study|Adverse Event|1|||
163323332|NCT03547271|589896671|FG001|Overall Study|Adverse Event|1|||
163323333|NCT03547271|589896672|FG002|Overall Study|Adverse Event|0|||
163323334|NCT03547271|589896673|FG003|Overall Study|Adverse Event|0|||
163323335|NCT03547271|589896670|FG000|Overall Study|Protocol deviation|5|||
163323336|NCT03547271|589896671|FG001|Overall Study|Protocol deviation|7|||
163323337|NCT03547271|589896672|FG002|Overall Study|Protocol deviation|3|||
163403483|NCT00957008|590188588|FG002|Overall Study|Physician Decision|1|||
163403484|NCT00957008|590188589|FG003|Overall Study|Physician Decision|1|||
163403485|NCT00957008|590188586|FG000|Overall Study|Relocated; Family conflict|4|||
163403486|NCT00957008|590188587|FG001|Overall Study|Relocated; Family conflict|1|||
163403487|NCT00957008|590188588|FG002|Overall Study|Relocated; Family conflict|1|||
163403488|NCT00957008|590188589|FG003|Overall Study|Relocated; Family conflict|3|||
163403489|NCT00811135|590188590|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
163403490|NCT00811135|590188590|FG000|Overall Study|Death|3|||
163403491|NCT00811135|590188590|FG000|Overall Study|Protocol Violation|2|||
163403492|NCT00811135|590188590|FG000|Overall Study|Violation of Selection Criteria|1|||
163403493|NCT00811135|590188590|FG000|Overall Study|Refused Treatment|1|||
163403494|NCT00811135|590188590|FG000|Overall Study|Withdrawal by Subject|3|||
163403495|NCT00811135|590188590|FG000|Overall Study|Administrative/Other Unspecified|11|||
163403496|NCT00811135|590188590|FG000|Overall Study|Ongoing|59|||
163403497|NCT01118351|590188591|FG000|Overall Study|Adverse Event|3|||
163403498|NCT01118351|590188591|FG000|Overall Study|Withdrawal by Subject|1|||
163403499|NCT02192827|590188599|FG000|Overall Study|Lost to Follow-up|25|||
163403500|NCT02192827|590188600|FG001|Overall Study|Lost to Follow-up|27|||
163403501|NCT02192827|590188599|FG000|Overall Study|Given additional steroids with admission|13|||
163403502|NCT02192827|590188600|FG001|Overall Study|Given additional steroids with admission|11|||
163403503|NCT00283595|590188601|FG000|Overall Study|Withdrawal by Subject|1|||
163403504|NCT00283595|590188602|FG001|Overall Study|Withdrawal by Subject|2|||
163403505|NCT03259074|590188606|FG000|Overall Study|Adverse Event|9|||
163403506|NCT03259074|590188607|FG001|Overall Study|Adverse Event|12|||
163403507|NCT03259074|590188608|FG002|Overall Study|Adverse Event|8|||
163403508|NCT03259074|590188606|FG000|Overall Study|Death|1|||
163403509|NCT03259074|590188607|FG001|Overall Study|Death|1|||
163403510|NCT03259074|590188608|FG002|Overall Study|Death|3|||
163403511|NCT03259074|590188606|FG000|Overall Study|Lost to Follow-up|2|||
163403512|NCT03259074|590188607|FG001|Overall Study|Lost to Follow-up|4|||
163403513|NCT03259074|590188608|FG002|Overall Study|Lost to Follow-up|3|||
163403514|NCT03259074|590188606|FG000|Overall Study|New Therapy For Study Indication|1|||
163403515|NCT03259074|590188607|FG001|Overall Study|New Therapy For Study Indication|2|||
163403516|NCT03259074|590188608|FG002|Overall Study|New Therapy For Study Indication|2|||
163403517|NCT03259074|590188606|FG000|Overall Study|Physician Decision|4|||
163403518|NCT03259074|590188607|FG001|Overall Study|Physician Decision|12|||
163403519|NCT03259074|590188608|FG002|Overall Study|Physician Decision|10|||
163403520|NCT03259074|590188606|FG000|Overall Study|Pregnancy|1|||
163403521|NCT03259074|590188607|FG001|Overall Study|Pregnancy|1|||
163403522|NCT03259074|590188608|FG002|Overall Study|Pregnancy|0|||
163403523|NCT03259074|590188606|FG000|Overall Study|Progressive Disease|1|||
163403524|NCT03259074|590188607|FG001|Overall Study|Progressive Disease|0|||
163403525|NCT03259074|590188608|FG002|Overall Study|Progressive Disease|0|||
163403526|NCT03259074|590188606|FG000|Overall Study|Protocol Deviation|1|||
163403527|NCT03259074|590188607|FG001|Overall Study|Protocol Deviation|1|||
163403528|NCT03259074|590188608|FG002|Overall Study|Protocol Deviation|3|||
163403529|NCT03259074|590188606|FG000|Overall Study|Subject/Guardian Decision|13|||
163403530|NCT03259074|590188607|FG001|Overall Study|Subject/Guardian Decision|16|||
163403531|NCT03259074|590188608|FG002|Overall Study|Subject/Guardian Decision|14|||
163403532|NCT01265797|590188619|FG000|Run-in Month|Withdrawal by Subject|0|||
163403533|NCT01265797|590188620|FG001|Run-in Month|Withdrawal by Subject|4|||
163403534|NCT01265797|590188619|FG000|Run-in Month|1st seizure during run-in month|0|||
163403535|NCT01265797|590188620|FG001|Run-in Month|1st seizure during run-in month|1|||
163403536|NCT01265797|590188619|FG000|Blinded Month|Lack of Efficacy|5|||
163403537|NCT01265797|590188620|FG001|Blinded Month|Lack of Efficacy|0|||
163403538|NCT01265797|590188619|FG000|Blinded Month|Lost to Follow-up|1|||
163403539|NCT01265797|590188620|FG001|Blinded Month|Lost to Follow-up|0|||
163403540|NCT01265797|590188619|FG000|Blinded Month|Protocol Violation|2|||
163403541|NCT01265797|590188620|FG001|Blinded Month|Protocol Violation|1|||
163403542|NCT01265797|590188619|FG000|Blinded Month|Adverse Event|2|||
163403543|NCT01265797|590188620|FG001|Blinded Month|Adverse Event|0|||
163403544|NCT01265797|590188619|FG000|Blinded Month|Diary data incomplete|0|||
163403545|NCT01265797|590188620|FG001|Blinded Month|Diary data incomplete|1|||
163403546|NCT01265797|590188619|FG000|Open Label Month|Lost to Follow-up|0|||
163403547|NCT01265797|590188620|FG001|Open Label Month|Lost to Follow-up|1|||
163403548|NCT00583362|590188626|FG000|Overall Study|Adverse Event|44|||
163403549|NCT00583362|590188626|FG000|Overall Study|Lack of Efficacy|22|||
163403550|NCT00583362|590188626|FG000|Overall Study|Lost to Follow-up|4|||
163403551|NCT00583362|590188626|FG000|Overall Study|Non-compliance with study drug|28|||
163403552|NCT00583362|590188626|FG000|Overall Study|Pregnancy|7|||
163403553|NCT00583362|590188626|FG000|Overall Study|Miscommunication of visit window|5|||
163403554|NCT00583362|590188626|FG000|Overall Study|Current site closed|7|||
163403555|NCT00583362|590188626|FG000|Overall Study|Subject not dosed in LBSL99|1|||
163403556|NCT00583362|590188626|FG000|Overall Study|Subject moved out of the country/state|2|||
163403557|NCT00583362|590188626|FG000|Overall Study|Missed visits due to staff changes|1|||
163403558|NCT00583362|590188626|FG000|Overall Study|Misunderstanding of protocol|1|||
163403559|NCT00583362|590188626|FG000|Overall Study|Behavioral problems and non-compliance|1|||
163403560|NCT00583362|590188626|FG000|Overall Study|Sponsor request due to missed doses|1|||
163403561|NCT00583362|590188626|FG000|Overall Study|Physician Decision|19|||
163403562|NCT00583362|590188626|FG000|Overall Study|Protocol Violation|2|||
163403563|NCT00583362|590188626|FG000|Overall Study|Withdrawal by Subject|57|||
163403564|NCT00506883|590188632|FG000|Overall Study|Lost to Follow-up|1|||
163403565|NCT00506883|590188633|FG001|Overall Study|Lost to Follow-up|1|||
163403566|NCT00506883|590188634|FG002|Overall Study|Lost to Follow-up|1|||
163403567|NCT00506883|590188632|FG000|Overall Study|Withdrawal by Subject|1|||
163403568|NCT00506883|590188633|FG001|Overall Study|Withdrawal by Subject|0|||
163403569|NCT00506883|590188634|FG002|Overall Study|Withdrawal by Subject|1|||
163403570|NCT00506883|590188632|FG000|Overall Study|Lack of Efficacy|0|||
163403571|NCT00506883|590188633|FG001|Overall Study|Lack of Efficacy|1|||
163403572|NCT00506883|590188634|FG002|Overall Study|Lack of Efficacy|1|||
163403573|NCT00506883|590188632|FG000|Overall Study|Other|5|||
163403574|NCT00506883|590188633|FG001|Overall Study|Other|1|||
163323338|NCT03547271|589896673|FG003|Overall Study|Protocol deviation|0|||
162986025|NCT04732221|588654740|FG003|Base Period|Death|0|||
162986026|NCT04732221|588654741|FG004|Base Period|Death|0|||
162986027|NCT04732221|588654742|FG005|Base Period|Death|0|||
162986028|NCT04732221|588654743|FG006|Base Period|Death|0|||
162986029|NCT04732221|588654737|FG000|Base Period|Withdrawal by Subject|0|||
162986030|NCT04732221|588654738|FG001|Base Period|Withdrawal by Subject|1|||
162986031|NCT04732221|588654739|FG002|Base Period|Withdrawal by Subject|1|||
162986032|NCT04732221|588654740|FG003|Base Period|Withdrawal by Subject|0|||
162986033|NCT04732221|588654741|FG004|Base Period|Withdrawal by Subject|0|||
162986034|NCT04732221|588654742|FG005|Base Period|Withdrawal by Subject|0|||
162986035|NCT04732221|588654743|FG006|Base Period|Withdrawal by Subject|0|||
163323339|NCT03547271|589896670|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
163323340|NCT03547271|589896671|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
163323341|NCT03547271|589896672|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
163323342|NCT03547271|589896673|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
163323343|NCT03547271|589896670|FG000|Overall Study|Lost to Follow-up|3|||
163323344|NCT03547271|589896671|FG001|Overall Study|Lost to Follow-up|3|||
163323345|NCT03547271|589896672|FG002|Overall Study|Lost to Follow-up|1|||
163323346|NCT03547271|589896673|FG003|Overall Study|Lost to Follow-up|0|||
163323347|NCT06065735|589896678|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
163323348|NCT06065735|589896679|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
163323349|NCT06065735|589896680|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
163323350|NCT06065735|589896678|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
163323351|NCT06065735|589896679|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
163323352|NCT06065735|589896680|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
163323353|NCT06065735|589896678|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
163323354|NCT06065735|589896679|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
163323355|NCT06065735|589896680|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
163323356|NCT06065735|589896678|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
163323357|NCT06065735|589896679|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
163323358|NCT06065735|589896680|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
163323359|NCT06065735|589896678|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
163323360|NCT06065735|589896679|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
163323361|NCT06065735|589896680|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
163323362|NCT03522298|589896681|FG000|Overall Study|Adverse Event|1|||
163323363|NCT03522298|589896682|FG001|Overall Study|Adverse Event|0|||
163323364|NCT03522298|589896683|FG002|Overall Study|Adverse Event|0|||
163323365|NCT03522298|589896684|FG003|Overall Study|Adverse Event|1|||
163323366|NCT03522298|589896681|FG000|Overall Study|Death|2|||
163323367|NCT03522298|589896682|FG001|Overall Study|Death|4|||
163323368|NCT03522298|589896683|FG002|Overall Study|Death|8|||
163323369|NCT03522298|589896684|FG003|Overall Study|Death|8|||
163323370|NCT03522298|589896681|FG000|Overall Study|Patient decision|0|||
163323371|NCT03522298|589896682|FG001|Overall Study|Patient decision|2|||
162986036|NCT04732221|588654737|FG000|Extension Period|Adverse Event|0|||
162986037|NCT04732221|588654738|FG001|Extension Period|Adverse Event|0|||
162986038|NCT04732221|588654739|FG002|Extension Period|Adverse Event|0|||
162986039|NCT04732221|588654740|FG003|Extension Period|Adverse Event|0|||
162986040|NCT04732221|588654741|FG004|Extension Period|Adverse Event|0|||
162986041|NCT04732221|588654742|FG005|Extension Period|Adverse Event|1|||
162986042|NCT04732221|588654743|FG006|Extension Period|Adverse Event|0|||
162986043|NCT04732221|588654737|FG000|Extension Period|Death|0|||
162986044|NCT04732221|588654738|FG001|Extension Period|Death|0|||
162986045|NCT04732221|588654739|FG002|Extension Period|Death|0|||
163323372|NCT03522298|589896683|FG002|Overall Study|Patient decision|2|||
163323373|NCT03522298|589896684|FG003|Overall Study|Patient decision|2|||
163323374|NCT05718687|589896687|FG000|Overall Study|Withdrawal by Subject|3|||
163323375|NCT05485935|589896690|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
163323376|NCT05485935|589896691|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
163323377|NCT05485935|589896690|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
163323378|NCT05485935|589896691|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
163323379|NCT05485935|589896690|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
163323380|NCT05485935|589896691|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
163323381|NCT05485935|589896690|FG000|Period 2 (T2 and V3)|loss of contact|0|||
163323382|NCT05485935|589896691|FG001|Period 2 (T2 and V3)|loss of contact|1|||
163323383|NCT04093869|589896692|FG000|Overall Study|Death|0|||
163323384|NCT04093869|589896693|FG001|Overall Study|Death|1|||
163323385|NCT04093869|589896692|FG000|Overall Study|Withdrawal by Subject|1|||
163323386|NCT04093869|589896693|FG001|Overall Study|Withdrawal by Subject|0|||
163323387|NCT02325154|589896694|FG000|Overall Study|Physician Decision|1|||
163323388|NCT03662022|589897176|FG000|Year 1 2019|prevalent case|83|||
163323389|NCT03662022|589897177|FG001|Year 1 2019|prevalent case|116|||
162986046|NCT04732221|588654740|FG003|Extension Period|Death|0|||
162986047|NCT04732221|588654741|FG004|Extension Period|Death|1|||
162986048|NCT04732221|588654742|FG005|Extension Period|Death|0|||
162986049|NCT04732221|588654743|FG006|Extension Period|Death|2|||
162986050|NCT04732221|588654737|FG000|Extension Period|Pregnancy|0|||
163323390|NCT03662022|589897178|FG002|Year 1 2019|prevalent case|158|||
163323391|NCT03662022|589897179|FG003|Year 1 2019|prevalent case|99|||
163323392|NCT03662022|589897176|FG000|Year 2 2020|incident case|18|||
163323393|NCT03662022|589897177|FG001|Year 2 2020|incident case|18|||
163323394|NCT03662022|589897178|FG002|Year 2 2020|incident case|16|||
163323395|NCT03662022|589897179|FG003|Year 2 2020|incident case|26|||
163323396|NCT03662022|589897176|FG000|Year 2 2020|other case|18|||
163323397|NCT03662022|589897177|FG001|Year 2 2020|other case|16|||
163323398|NCT03662022|589897178|FG002|Year 2 2020|other case|16|||
163323399|NCT03662022|589897179|FG003|Year 2 2020|other case|24|||
163323400|NCT03662022|589897176|FG000|Year 2 2020|Lost to Follow-up|1633|||
163323401|NCT03662022|589897177|FG001|Year 2 2020|Lost to Follow-up|1183|||
163323402|NCT03662022|589897178|FG002|Year 2 2020|Lost to Follow-up|1381|||
163323403|NCT03662022|589897179|FG003|Year 2 2020|Lost to Follow-up|2858|||
163403575|NCT00506883|590188634|FG002|Overall Study|Other|1|||
163323404|NCT03662022|589897176|FG000|Year 3 2021|incident case|24|||
163323405|NCT03662022|589897177|FG001|Year 3 2021|incident case|27|||
163403576|NCT00455013|590188635|FG000|Short Term Period|Adverse Event|2|||
163403577|NCT00455013|590188636|FG001|Short Term Period|Adverse Event|5|||
163403578|NCT00455013|590188637|FG002|Short Term Period|Adverse Event|0|||
163403579|NCT00455013|590188635|FG000|Short Term Period|Withdrawal by Subject|0|||
163403580|NCT00455013|590188636|FG001|Short Term Period|Withdrawal by Subject|0|||
163403581|NCT00455013|590188637|FG002|Short Term Period|Withdrawal by Subject|1|||
163403582|NCT00455013|590188635|FG000|Short Term Period|Lack of Efficacy|4|||
163403583|NCT00455013|590188636|FG001|Short Term Period|Lack of Efficacy|0|||
163403584|NCT00455013|590188637|FG002|Short Term Period|Lack of Efficacy|0|||
163403585|NCT00455013|590188635|FG000|Short Term Period|Other|0|||
163403586|NCT00455013|590188636|FG001|Short Term Period|Other|0|||
163403587|NCT00455013|590188637|FG002|Short Term Period|Other|1|||
163403588|NCT00455013|590188635|FG000|Long Term Extension (LTE)|Adverse Event|0|||
163403589|NCT00455013|590188636|FG001|Long Term Extension (LTE)|Adverse Event|1|||
163403590|NCT00455013|590188637|FG002|Long Term Extension (LTE)|Adverse Event|1|||
163403591|NCT00455013|590188635|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
163403592|NCT00455013|590188636|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
163403593|NCT00455013|590188637|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
163403594|NCT00455013|590188635|FG000|Long Term Extension (LTE)|Death|1|||
163403595|NCT00455013|590188636|FG001|Long Term Extension (LTE)|Death|1|||
163403596|NCT00455013|590188637|FG002|Long Term Extension (LTE)|Death|0|||
163403597|NCT00455013|590188635|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
163403598|NCT00455013|590188636|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
163403599|NCT00455013|590188637|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
163403600|NCT00455013|590188635|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
163403601|NCT00455013|590188636|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
163403602|NCT00455013|590188637|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
163403603|NCT00455013|590188635|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
163403604|NCT00455013|590188636|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
163403605|NCT00455013|590188637|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
163403606|NCT00455013|590188635|FG000|Long Term Extension (LTE)|non-specified|0|||
163403607|NCT00455013|590188636|FG001|Long Term Extension (LTE)|non-specified|0|||
163403608|NCT00455013|590188637|FG002|Long Term Extension (LTE)|non-specified|1|||
163403609|NCT01473563|590188638|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
163403610|NCT03610724|590188639|FG000|Overall Study|Death|17|||
163403611|NCT03610724|590188639|FG000|Overall Study|Lost to Follow-up|1|||
163403612|NCT03610724|590188639|FG000|Overall Study|Physician Decision|1|||
163403613|NCT03610724|590188639|FG000|Overall Study|Died prior to infusion|1|||
163403614|NCT00078325|590188640|FG000|Overall Study|Adverse Event|15|||
163403615|NCT00078325|590188641|FG001|Overall Study|Adverse Event|10|||
163403616|NCT00078325|590188642|FG002|Overall Study|Adverse Event|5|||
163403617|NCT00078325|590188640|FG000|Overall Study|Protocol Violation|2|||
163403618|NCT00078325|590188641|FG001|Overall Study|Protocol Violation|2|||
163403619|NCT00078325|590188642|FG002|Overall Study|Protocol Violation|0|||
163403620|NCT00078325|590188640|FG000|Overall Study|Withdrawal by Subject|1|||
163403621|NCT00078325|590188641|FG001|Overall Study|Withdrawal by Subject|5|||
163403622|NCT00078325|590188642|FG002|Overall Study|Withdrawal by Subject|3|||
163403623|NCT00078325|590188640|FG000|Overall Study|Lost to Follow-up|0|||
163403624|NCT00078325|590188641|FG001|Overall Study|Lost to Follow-up|1|||
163403625|NCT00078325|590188642|FG002|Overall Study|Lost to Follow-up|1|||
163403626|NCT00078325|590188640|FG000|Overall Study|Physician Decision|2|||
163403627|NCT00078325|590188641|FG001|Overall Study|Physician Decision|0|||
162986051|NCT04732221|588654738|FG001|Extension Period|Pregnancy|0|||
162986052|NCT04732221|588654739|FG002|Extension Period|Pregnancy|0|||
163323406|NCT03662022|589897178|FG002|Year 3 2021|incident case|24|||
163323407|NCT03662022|589897179|FG003|Year 3 2021|incident case|11|||
163323408|NCT03662022|589897176|FG000|Year 3 2021|other case|4|||
163403628|NCT00078325|590188642|FG002|Overall Study|Physician Decision|1|||
163403629|NCT00078325|590188640|FG000|Overall Study|Miscellaneous|1|||
163323409|NCT03662022|589897177|FG001|Year 3 2021|other case|15|||
163323410|NCT03662022|589897178|FG002|Year 3 2021|other case|10|||
163403630|NCT00078325|590188641|FG001|Overall Study|Miscellaneous|1|||
163403631|NCT00078325|590188642|FG002|Overall Study|Miscellaneous|1|||
163403632|NCT01519765|590188643|FG000|Overall Study|Adverse Event|0|||
163403633|NCT01519765|590188644|FG001|Overall Study|Adverse Event|1|||
163403634|NCT01519765|590188643|FG000|Overall Study|Lack of Efficacy|2|||
163403635|NCT01519765|590188644|FG001|Overall Study|Lack of Efficacy|0|||
163403636|NCT01519765|590188643|FG000|Overall Study|Protocol Violation|1|||
163403637|NCT01519765|590188644|FG001|Overall Study|Protocol Violation|0|||
163403638|NCT01519765|590188643|FG000|Overall Study|Withdrawal by Subject|0|||
163403639|NCT01519765|590188644|FG001|Overall Study|Withdrawal by Subject|1|||
163403640|NCT05513625|590188650|FG000|Overall Study|Withdrawal by Subject|1|||
163403641|NCT00754793|590188651|FG000|Overall Study|voluntary withdrawn from study|0|||
163403642|NCT00754793|590188652|FG001|Overall Study|voluntary withdrawn from study|1|||
163403643|NCT02943564|590188653|FG000|Overall Study|Miscellaneous Reasons|0|||
163403644|NCT02943564|590188654|FG001|Overall Study|Miscellaneous Reasons|0|||
163403645|NCT02943564|590188655|FG002|Overall Study|Miscellaneous Reasons|3|||
163403646|NCT02943564|590188653|FG000|Overall Study|Site terminated by sponsor|0|||
163403647|NCT02943564|590188654|FG001|Overall Study|Site terminated by sponsor|1|||
163403648|NCT02943564|590188655|FG002|Overall Study|Site terminated by sponsor|0|||
163403649|NCT02943564|590188653|FG000|Overall Study|Non-compliance with study drug|0|||
163403650|NCT02943564|590188654|FG001|Overall Study|Non-compliance with study drug|1|||
163403651|NCT02943564|590188655|FG002|Overall Study|Non-compliance with study drug|0|||
163403652|NCT02943564|590188653|FG000|Overall Study|Pregnancy|0|||
163403653|NCT02943564|590188654|FG001|Overall Study|Pregnancy|1|||
163403654|NCT02943564|590188655|FG002|Overall Study|Pregnancy|1|||
163403655|NCT02943564|590188653|FG000|Overall Study|Protocol Violation|2|||
163403656|NCT02943564|590188654|FG001|Overall Study|Protocol Violation|2|||
163403657|NCT02943564|590188655|FG002|Overall Study|Protocol Violation|2|||
163403658|NCT02943564|590188653|FG000|Overall Study|Lost to Follow-up|1|||
163403659|NCT02943564|590188654|FG001|Overall Study|Lost to Follow-up|0|||
163403660|NCT02943564|590188655|FG002|Overall Study|Lost to Follow-up|0|||
162986053|NCT04732221|588654740|FG003|Extension Period|Pregnancy|0|||
162986054|NCT04732221|588654741|FG004|Extension Period|Pregnancy|1|||
163323411|NCT03662022|589897179|FG003|Year 3 2021|other case|14|||
163323412|NCT03662022|589897176|FG000|Year 3 2021|Lost to Follow-up|179|||
163323413|NCT03662022|589897177|FG001|Year 3 2021|Lost to Follow-up|244|||
163323414|NCT03662022|589897178|FG002|Year 3 2021|Lost to Follow-up|480|||
163323415|NCT03662022|589897179|FG003|Year 3 2021|Lost to Follow-up|477|||
163323416|NCT03662022|589897176|FG000|Year 4 2022|incident case|25|||
163323417|NCT03662022|589897177|FG001|Year 4 2022|incident case|41|||
163323418|NCT03662022|589897178|FG002|Year 4 2022|incident case|28|||
163323419|NCT03662022|589897179|FG003|Year 4 2022|incident case|7|||
163323420|NCT03662022|589897176|FG000|Year 4 2022|other case|8|||
163323421|NCT03662022|589897177|FG001|Year 4 2022|other case|19|||
163323422|NCT03662022|589897178|FG002|Year 4 2022|other case|13|||
163323423|NCT03662022|589897179|FG003|Year 4 2022|other case|7|||
163323424|NCT03662022|589897176|FG000|Year 4 2022|Lost to Follow-up|986|||
163323425|NCT03662022|589897177|FG001|Year 4 2022|Lost to Follow-up|1079|||
163323426|NCT03662022|589897178|FG002|Year 4 2022|Lost to Follow-up|1236|||
163323427|NCT03662022|589897179|FG003|Year 4 2022|Lost to Follow-up|1826|||
163323428|NCT05836012|589897182|FG000|Overall Study|Lost to Follow-up|1|||
163323429|NCT05836012|589897183|FG001|Overall Study|Lost to Follow-up|0|||
163323430|NCT05836012|589897182|FG000|Overall Study|Withdrawal by Subject|1|||
163323431|NCT05836012|589897183|FG001|Overall Study|Withdrawal by Subject|3|||
163323432|NCT05836012|589897182|FG000|Overall Study|Reason not included in pre-specified categories|2|||
163323433|NCT05836012|589897183|FG001|Overall Study|Reason not included in pre-specified categories|1|||
163323434|NCT03248479|589897184|FG000|Overall Study|Death|12|||
163323435|NCT03248479|589897185|FG001|Overall Study|Death|44|||
163323436|NCT03248479|589897186|FG002|Overall Study|Death|1|||
163403661|NCT02943564|590188653|FG000|Overall Study|Withdrawal by Subject|6|||
163403662|NCT02943564|590188654|FG001|Overall Study|Withdrawal by Subject|5|||
163403663|NCT02943564|590188655|FG002|Overall Study|Withdrawal by Subject|2|||
163403664|NCT02943564|590188653|FG000|Overall Study|Adverse Event|1|||
163403665|NCT02943564|590188654|FG001|Overall Study|Adverse Event|2|||
163403666|NCT02943564|590188655|FG002|Overall Study|Adverse Event|1|||
163403667|NCT02943564|590188653|FG000|Overall Study|Lack of Efficacy|0|||
163403668|NCT02943564|590188654|FG001|Overall Study|Lack of Efficacy|1|||
163403669|NCT02943564|590188655|FG002|Overall Study|Lack of Efficacy|0|||
163403670|NCT00932360|590188656|FG000|Washout (One Week)|Withdrawal by Subject|0|||
163403671|NCT00932360|590188657|FG001|Washout (One Week)|Withdrawal by Subject|0|||
163403672|NCT00932360|590188658|FG002|Washout (One Week)|Withdrawal by Subject|0|||
163323437|NCT03248479|589897187|FG003|Overall Study|Death|72|||
163323438|NCT03248479|589897188|FG004|Overall Study|Death|17|||
163323439|NCT03248479|589897189|FG005|Overall Study|Death|6|||
163323440|NCT03248479|589897190|FG006|Overall Study|Death|1|||
163403673|NCT00932360|590188659|FG003|Washout (One Week)|Withdrawal by Subject|0|||
163323441|NCT03248479|589897191|FG007|Overall Study|Death|14|||
163323442|NCT03248479|589897192|FG008|Overall Study|Death|3|||
163323443|NCT03248479|589897193|FG009|Overall Study|Death|7|||
163323444|NCT03248479|589897194|FG010|Overall Study|Death|3|||
163403674|NCT00932360|590188660|FG004|Washout (One Week)|Withdrawal by Subject|2|||
163323445|NCT03248479|589897195|FG011|Overall Study|Death|1|||
163323446|NCT03248479|589897196|FG012|Overall Study|Death|1|||
163323447|NCT03248479|589897184|FG000|Overall Study|Study terminated by sponsor|12|||
163323448|NCT03248479|589897185|FG001|Overall Study|Study terminated by sponsor|15|||
163323449|NCT03248479|589897186|FG002|Overall Study|Study terminated by sponsor|0|||
163323450|NCT03248479|589897187|FG003|Overall Study|Study terminated by sponsor|5|||
163323451|NCT03248479|589897188|FG004|Overall Study|Study terminated by sponsor|0|||
163323452|NCT03248479|589897189|FG005|Overall Study|Study terminated by sponsor|0|||
163323453|NCT03248479|589897190|FG006|Overall Study|Study terminated by sponsor|0|||
163323454|NCT03248479|589897191|FG007|Overall Study|Study terminated by sponsor|1|||
163323455|NCT03248479|589897192|FG008|Overall Study|Study terminated by sponsor|1|||
163323456|NCT03248479|589897193|FG009|Overall Study|Study terminated by sponsor|0|||
163323457|NCT03248479|589897194|FG010|Overall Study|Study terminated by sponsor|5|||
163323458|NCT03248479|589897195|FG011|Overall Study|Study terminated by sponsor|4|||
163323459|NCT03248479|589897196|FG012|Overall Study|Study terminated by sponsor|0|||
163323460|NCT03248479|589897184|FG000|Overall Study|Consent withdrawn|6|||
163323461|NCT03248479|589897185|FG001|Overall Study|Consent withdrawn|3|||
163323462|NCT03248479|589897186|FG002|Overall Study|Consent withdrawn|0|||
163323463|NCT03248479|589897187|FG003|Overall Study|Consent withdrawn|9|||
163323464|NCT03248479|589897188|FG004|Overall Study|Consent withdrawn|1|||
163323465|NCT03248479|589897189|FG005|Overall Study|Consent withdrawn|0|||
163323466|NCT03248479|589897190|FG006|Overall Study|Consent withdrawn|0|||
163323467|NCT03248479|589897191|FG007|Overall Study|Consent withdrawn|1|||
163323468|NCT03248479|589897192|FG008|Overall Study|Consent withdrawn|0|||
163323469|NCT03248479|589897193|FG009|Overall Study|Consent withdrawn|3|||
163323470|NCT03248479|589897194|FG010|Overall Study|Consent withdrawn|1|||
163323471|NCT03248479|589897195|FG011|Overall Study|Consent withdrawn|0|||
163323472|NCT03248479|589897196|FG012|Overall Study|Consent withdrawn|1|||
163323473|NCT03248479|589897184|FG000|Overall Study|Lost to Follow-up|2|||
163323474|NCT03248479|589897185|FG001|Overall Study|Lost to Follow-up|1|||
163323475|NCT03248479|589897186|FG002|Overall Study|Lost to Follow-up|0|||
163323476|NCT03248479|589897187|FG003|Overall Study|Lost to Follow-up|0|||
163323477|NCT03248479|589897188|FG004|Overall Study|Lost to Follow-up|0|||
163323478|NCT03248479|589897189|FG005|Overall Study|Lost to Follow-up|0|||
163323479|NCT03248479|589897190|FG006|Overall Study|Lost to Follow-up|0|||
163323480|NCT03248479|589897191|FG007|Overall Study|Lost to Follow-up|0|||
163323481|NCT03248479|589897192|FG008|Overall Study|Lost to Follow-up|0|||
163323482|NCT03248479|589897193|FG009|Overall Study|Lost to Follow-up|0|||
163323483|NCT03248479|589897194|FG010|Overall Study|Lost to Follow-up|0|||
163323484|NCT03248479|589897195|FG011|Overall Study|Lost to Follow-up|0|||
163323485|NCT03248479|589897196|FG012|Overall Study|Lost to Follow-up|1|||
163323486|NCT03248479|589897184|FG000|Overall Study|Not reported|0|||
163323487|NCT03248479|589897185|FG001|Overall Study|Not reported|0|||
163323488|NCT03248479|589897186|FG002|Overall Study|Not reported|0|||
163323489|NCT03248479|589897187|FG003|Overall Study|Not reported|1|||
163323490|NCT03248479|589897188|FG004|Overall Study|Not reported|1|||
163323491|NCT03248479|589897189|FG005|Overall Study|Not reported|0|||
163323492|NCT03248479|589897190|FG006|Overall Study|Not reported|0|||
163323493|NCT03248479|589897191|FG007|Overall Study|Not reported|1|||
163323494|NCT03248479|589897192|FG008|Overall Study|Not reported|1|||
163323495|NCT03248479|589897193|FG009|Overall Study|Not reported|0|||
163323496|NCT03248479|589897194|FG010|Overall Study|Not reported|0|||
163323497|NCT03248479|589897195|FG011|Overall Study|Not reported|0|||
163323498|NCT03248479|589897196|FG012|Overall Study|Not reported|0|||
163323499|NCT05129501|589897206|FG000|Overall Study|Lost to Follow-up|54|||
163323500|NCT05129501|589897207|FG001|Overall Study|Lost to Follow-up|41|||
163323501|NCT01499368|589897208|FG000|Overall Study|Did not meet I/E criteria|8|||
163323502|NCT01499368|589897209|FG001|Overall Study|Did not meet I/E criteria|4|||
163323503|NCT01499368|589897210|FG002|Overall Study|Did not meet I/E criteria|4|||
163323504|NCT01499368|589897208|FG000|Overall Study|Prohibited Concomitant medication|1|||
163323505|NCT01499368|589897209|FG001|Overall Study|Prohibited Concomitant medication|1|||
163323506|NCT01499368|589897210|FG002|Overall Study|Prohibited Concomitant medication|0|||
163323507|NCT01499368|589897208|FG000|Overall Study|Withdrawal by Subject|11|||
163323508|NCT01499368|589897209|FG001|Overall Study|Withdrawal by Subject|10|||
163323509|NCT01499368|589897210|FG002|Overall Study|Withdrawal by Subject|8|||
163323510|NCT01499368|589897208|FG000|Overall Study|Lost to Follow-up|3|||
163323511|NCT01499368|589897209|FG001|Overall Study|Lost to Follow-up|2|||
163323512|NCT01499368|589897210|FG002|Overall Study|Lost to Follow-up|5|||
163323513|NCT01499368|589897208|FG000|Overall Study|Adverse Event|4|||
163323514|NCT01499368|589897209|FG001|Overall Study|Adverse Event|0|||
163323515|NCT01499368|589897210|FG002|Overall Study|Adverse Event|2|||
163323516|NCT01499368|589897208|FG000|Overall Study|Physician Decision|0|||
163323517|NCT01499368|589897209|FG001|Overall Study|Physician Decision|1|||
163323518|NCT01499368|589897210|FG002|Overall Study|Physician Decision|0|||
163323519|NCT01499368|589897208|FG000|Overall Study|Deviation from visit window|0|||
163323520|NCT01499368|589897209|FG001|Overall Study|Deviation from visit window|0|||
163323521|NCT01499368|589897210|FG002|Overall Study|Deviation from visit window|1|||
163323522|NCT01499368|589897208|FG000|Overall Study|Error of Prescriptions|0|||
163323523|NCT01499368|589897209|FG001|Overall Study|Error of Prescriptions|0|||
162986055|NCT04732221|588654742|FG005|Extension Period|Pregnancy|0|||
162986056|NCT04732221|588654743|FG006|Extension Period|Pregnancy|0|||
162986057|NCT04732221|588654737|FG000|Extension Period|Sponsors Decision|0|||
162986058|NCT04732221|588654738|FG001|Extension Period|Sponsors Decision|0|||
162986059|NCT04732221|588654739|FG002|Extension Period|Sponsors Decision|0|||
162986060|NCT04732221|588654740|FG003|Extension Period|Sponsors Decision|0|||
162986061|NCT04732221|588654741|FG004|Extension Period|Sponsors Decision|41|||
162986062|NCT04732221|588654742|FG005|Extension Period|Sponsors Decision|40|||
162986063|NCT04732221|588654743|FG006|Extension Period|Sponsors Decision|40|||
162986064|NCT04732221|588654737|FG000|Extension Period|Withdrawal by Subject|0|||
162986065|NCT04732221|588654738|FG001|Extension Period|Withdrawal by Subject|0|||
162986066|NCT04732221|588654739|FG002|Extension Period|Withdrawal by Subject|0|||
162986067|NCT04732221|588654740|FG003|Extension Period|Withdrawal by Subject|0|||
162986068|NCT04732221|588654741|FG004|Extension Period|Withdrawal by Subject|1|||
162986069|NCT04732221|588654742|FG005|Extension Period|Withdrawal by Subject|5|||
162986070|NCT04732221|588654743|FG006|Extension Period|Withdrawal by Subject|2|||
162986071|NCT03611543|588654744|FG000|Overall Study|Withdrawal by Subject|4|||
162986072|NCT03611543|588654745|FG001|Overall Study|Withdrawal by Subject|4|||
162986073|NCT03611543|588654744|FG000|Overall Study|Physician Decision|1|||
162986074|NCT03611543|588654745|FG001|Overall Study|Physician Decision|1|||
162986075|NCT03611543|588654744|FG000|Overall Study|Protocol Violation|2|||
162986076|NCT03611543|588654745|FG001|Overall Study|Protocol Violation|2|||
162986077|NCT03611543|588654744|FG000|Overall Study|Device failure|2|||
162986078|NCT03611543|588654745|FG001|Overall Study|Device failure|2|||
162986079|NCT03611543|588654744|FG000|Overall Study|Missing information|5|||
162986080|NCT03611543|588654745|FG001|Overall Study|Missing information|5|||
162986081|NCT06077487|588654746|FG000|Overall Study|Withdrawal by Subject|0|||
162986082|NCT06077487|588654747|FG001|Overall Study|Withdrawal by Subject|1|||
162986083|NCT05101486|588654748|FG000|Overall Study|Death|1|||
162986084|NCT05101486|588654749|FG001|Overall Study|Death|0|||
162986085|NCT05101486|588654750|FG002|Overall Study|Death|1|||
162986086|NCT05101486|588654748|FG000|Overall Study|Lost to Follow-up|12|||
162986087|NCT05101486|588654749|FG001|Overall Study|Lost to Follow-up|8|||
162986088|NCT05101486|588654750|FG002|Overall Study|Lost to Follow-up|17|||
162986089|NCT05101486|588654748|FG000|Overall Study|Physician Decision|1|||
162986090|NCT05101486|588654749|FG001|Overall Study|Physician Decision|0|||
162986091|NCT05101486|588654750|FG002|Overall Study|Physician Decision|0|||
162986092|NCT05101486|588654748|FG000|Overall Study|Protocol Violation|0|||
162986093|NCT05101486|588654749|FG001|Overall Study|Protocol Violation|0|||
162986094|NCT05101486|588654750|FG002|Overall Study|Protocol Violation|1|||
162986095|NCT05101486|588654748|FG000|Overall Study|Withdrawal by Subject|5|||
162986096|NCT05101486|588654749|FG001|Overall Study|Withdrawal by Subject|2|||
162986097|NCT05101486|588654750|FG002|Overall Study|Withdrawal by Subject|4|||
162986098|NCT05101486|588654748|FG000|Overall Study|Randomized but not vaccinated|1|||
162986099|NCT05101486|588654749|FG001|Overall Study|Randomized but not vaccinated|1|||
162986100|NCT05101486|588654750|FG002|Overall Study|Randomized but not vaccinated|1|||
162986101|NCT03047473|588654758|FG000|Overall Study|Lost to Follow-up|2|||
162986102|NCT02031458|588654759|FG000|May 8, 2015 to January 11, 2019|Death|89|||
162986103|NCT02031458|588654760|FG001|May 8, 2015 to January 11, 2019|Death|193|||
162986104|NCT02031458|588654761|FG002|May 8, 2015 to January 11, 2019|Death|198|||
162986105|NCT02031458|588654759|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
162986106|NCT02031458|588654760|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
162986107|NCT02031458|588654761|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
162986108|NCT02031458|588654759|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
162986109|NCT02031458|588654760|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
162986110|NCT02031458|588654761|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
162986111|NCT02031458|588654759|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
162986112|NCT02031458|588654760|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
162986113|NCT02031458|588654761|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
162986114|NCT02031458|588654759|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
162986115|NCT02031458|588654760|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
162986116|NCT02031458|588654761|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
162986117|NCT02031458|588654759|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
162986118|NCT02031458|588654760|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
162986119|NCT02031458|588654761|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
162986120|NCT02031458|588654759|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
162986121|NCT02031458|588654760|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
163154697|NCT03938259|589281381|FG001|Overall Study|unable to establish baseline for ventilation|1|||
162986122|NCT02031458|588654761|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
162986123|NCT02031458|588654759|FG000|Baseline to May 8, 2015|Death|36|||
162986124|NCT02031458|588654760|FG001|Baseline to May 8, 2015|Death|87|||
162986125|NCT02031458|588654761|FG002|Baseline to May 8, 2015|Death|100|||
162986126|NCT02031458|588654759|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
162986127|NCT02031458|588654760|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
162986128|NCT02031458|588654761|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
162986129|NCT02031458|588654759|FG000|Baseline to May 8, 2015|Physician Decision|0|||
162986130|NCT02031458|588654760|FG001|Baseline to May 8, 2015|Physician Decision|1|||
162986131|NCT02031458|588654761|FG002|Baseline to May 8, 2015|Physician Decision|0|||
162986132|NCT02031458|588654759|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
162986133|NCT02031458|588654760|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
162986134|NCT02031458|588654761|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
162986135|NCT02031458|588654759|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
162986136|NCT02031458|588654760|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
162986137|NCT02031458|588654761|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
162986138|NCT02031458|588654759|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
162986139|NCT02031458|588654760|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
162986140|NCT02031458|588654761|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
162986141|NCT02031458|588654759|FG000|Baseline to May 8, 2015|On Treatment|43|||
162986142|NCT02031458|588654760|FG001|Baseline to May 8, 2015|On Treatment|81|||
162986143|NCT02031458|588654761|FG002|Baseline to May 8, 2015|On Treatment|73|||
162986144|NCT02031458|588654759|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
162986145|NCT02031458|588654760|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
162986146|NCT02031458|588654761|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
162986147|NCT04305587|588654762|FG000|Overall Study|Withdrawal by Subject|0|||
162986148|NCT04305587|588654763|FG001|Overall Study|Withdrawal by Subject|0|||
162986149|NCT04305587|588654764|FG002|Overall Study|Withdrawal by Subject|0|||
162986150|NCT04305587|588654765|FG003|Overall Study|Withdrawal by Subject|1|||
162986151|NCT04305587|588654766|FG004|Overall Study|Withdrawal by Subject|0|||
162986152|NCT04305587|588654767|FG005|Overall Study|Withdrawal by Subject|0|||
162986153|NCT04305587|588654768|FG006|Overall Study|Withdrawal by Subject|0|||
163323524|NCT01499368|589897210|FG002|Overall Study|Error of Prescriptions|1|||
163323525|NCT03092674|589897211|FG000|Overall Study|Adverse Event or Side Effects|1|||
163323526|NCT03092674|589897212|FG001|Overall Study|Adverse Event or Side Effects|4|||
163323527|NCT03092674|589897213|FG002|Overall Study|Adverse Event or Side Effects|4|||
163323528|NCT03092674|589897211|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
163323529|NCT03092674|589897212|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
163323530|NCT03092674|589897213|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
163323531|NCT03092674|589897211|FG000|Overall Study|Progression/Relapse|5|||
163323532|NCT03092674|589897212|FG001|Overall Study|Progression/Relapse|4|||
163323533|NCT03092674|589897213|FG002|Overall Study|Progression/Relapse|8|||
163323534|NCT03092674|589897211|FG000|Overall Study|Death|4|||
163323535|NCT03092674|589897212|FG001|Overall Study|Death|8|||
163323536|NCT03092674|589897213|FG002|Overall Study|Death|2|||
163323537|NCT03092674|589897211|FG000|Overall Study|Other - Not Protocol Specified|11|||
163323538|NCT03092674|589897212|FG001|Overall Study|Other - Not Protocol Specified|8|||
162986154|NCT04305587|588654769|FG007|Overall Study|Withdrawal by Subject|0|||
162986155|NCT04305587|588654770|FG008|Overall Study|Withdrawal by Subject|0|||
162986156|NCT02492880|588654771|FG000|Overall Study|Lost to Follow-up|1|||
163323539|NCT03092674|589897213|FG002|Overall Study|Other - Not Protocol Specified|8|||
163323540|NCT01527188|589897214|FG000|Overall Study|Adverse Event|5|||
163323541|NCT01527188|589897215|FG001|Overall Study|Adverse Event|5|||
163323542|NCT01527188|589897216|FG002|Overall Study|Adverse Event|11|||
163323543|NCT01527188|589897217|FG003|Overall Study|Adverse Event|0|||
162986157|NCT02492880|588654771|FG000|Overall Study|Protocol Violation|1|||
162986158|NCT00292188|588654775|FG000|Single-Blind|Adverse Event|14|||
162986159|NCT00292188|588654776|FG001|Single-Blind|Adverse Event|0|||
162986160|NCT00292188|588654777|FG002|Single-Blind|Adverse Event|0|||
162986161|NCT00292188|588654775|FG000|Single-Blind|Lack of Efficacy|2|||
162986162|NCT00292188|588654776|FG001|Single-Blind|Lack of Efficacy|0|||
162986163|NCT00292188|588654777|FG002|Single-Blind|Lack of Efficacy|0|||
162986164|NCT00292188|588654775|FG000|Single-Blind|Laboratory Abnormality|5|||
162986165|NCT00292188|588654776|FG001|Single-Blind|Laboratory Abnormality|0|||
162986166|NCT00292188|588654777|FG002|Single-Blind|Laboratory Abnormality|0|||
162986167|NCT00292188|588654775|FG000|Single-Blind|Lost to Follow-up|3|||
162986168|NCT00292188|588654776|FG001|Single-Blind|Lost to Follow-up|0|||
163323544|NCT01527188|589897214|FG000|Overall Study|Withdrawal by Subject|3|||
163323545|NCT01527188|589897215|FG001|Overall Study|Withdrawal by Subject|6|||
163323546|NCT01527188|589897216|FG002|Overall Study|Withdrawal by Subject|4|||
163323547|NCT01527188|589897217|FG003|Overall Study|Withdrawal by Subject|4|||
162986169|NCT00292188|588654777|FG002|Single-Blind|Lost to Follow-up|0|||
162986170|NCT00292188|588654775|FG000|Single-Blind|Other|77|||
162986171|NCT00292188|588654776|FG001|Single-Blind|Other|0|||
162986172|NCT00292188|588654777|FG002|Single-Blind|Other|0|||
162986173|NCT00292188|588654775|FG000|Single-Blind|Withdrawal by Subject|12|||
162986174|NCT00292188|588654776|FG001|Single-Blind|Withdrawal by Subject|0|||
162986175|NCT00292188|588654777|FG002|Single-Blind|Withdrawal by Subject|0|||
162986176|NCT00292188|588654775|FG000|Single-Blind|Did not receive treatment|1|||
162986177|NCT00292188|588654776|FG001|Single-Blind|Did not receive treatment|0|||
163323548|NCT01527188|589897214|FG000|Overall Study|Any other reason not above-mentioned|6|||
163323549|NCT01527188|589897215|FG001|Overall Study|Any other reason not above-mentioned|7|||
162986178|NCT00292188|588654777|FG002|Single-Blind|Did not receive treatment|0|||
162986179|NCT00292188|588654775|FG000|Double-Blind|Adverse Event|0|||
162986180|NCT00292188|588654776|FG001|Double-Blind|Adverse Event|25|||
162986181|NCT00292188|588654777|FG002|Double-Blind|Adverse Event|9|||
162986182|NCT00292188|588654775|FG000|Double-Blind|Lack of Efficacy|0|||
162986183|NCT00292188|588654776|FG001|Double-Blind|Lack of Efficacy|2|||
162986184|NCT00292188|588654777|FG002|Double-Blind|Lack of Efficacy|12|||
162986185|NCT00292188|588654775|FG000|Double-Blind|Lost to Follow-up|0|||
162986186|NCT00292188|588654776|FG001|Double-Blind|Lost to Follow-up|1|||
162986187|NCT00292188|588654777|FG002|Double-Blind|Lost to Follow-up|0|||
162986188|NCT00292188|588654775|FG000|Double-Blind|Other|0|||
162986189|NCT00292188|588654776|FG001|Double-Blind|Other|3|||
162986190|NCT00292188|588654777|FG002|Double-Blind|Other|4|||
162986191|NCT00292188|588654775|FG000|Double-Blind|Withdrawal by Subject|0|||
162986192|NCT00292188|588654776|FG001|Double-Blind|Withdrawal by Subject|0|||
162986193|NCT00292188|588654777|FG002|Double-Blind|Withdrawal by Subject|3|||
162986194|NCT00292188|588654775|FG000|Double-Blind|Laboratory Abnormality|0|||
162986195|NCT00292188|588654776|FG001|Double-Blind|Laboratory Abnormality|0|||
162986196|NCT00292188|588654777|FG002|Double-Blind|Laboratory Abnormality|1|||
162986197|NCT00824616|588654778|FG000|Overall Study|Adverse Event|2|||
162986198|NCT00824616|588654779|FG001|Overall Study|Adverse Event|1|||
162986199|NCT00824616|588654778|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
162986200|NCT00824616|588654779|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
163323550|NCT01527188|589897216|FG002|Overall Study|Any other reason not above-mentioned|8|||
163323551|NCT01527188|589897217|FG003|Overall Study|Any other reason not above-mentioned|8|||
163323552|NCT04626427|589897218|FG000|Overall Study|Death|1|||
163323553|NCT04626427|589897218|FG000|Overall Study|Withdrawal by Subject|1|||
163323554|NCT04626427|589897218|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
162986201|NCT00824616|588654778|FG000|Overall Study|Hyperglycemia|1|||
162986202|NCT00824616|588654779|FG001|Overall Study|Hyperglycemia|1|||
162986203|NCT00824616|588654778|FG000|Overall Study|Lack of Efficacy|2|||
162986204|NCT00824616|588654779|FG001|Overall Study|Lack of Efficacy|1|||
162986205|NCT00824616|588654778|FG000|Overall Study|Lost to Follow-up|0|||
162986206|NCT00824616|588654779|FG001|Overall Study|Lost to Follow-up|1|||
162986207|NCT00824616|588654778|FG000|Overall Study|Withdrawal by Subject|1|||
162986208|NCT00824616|588654779|FG001|Overall Study|Withdrawal by Subject|1|||
162986209|NCT01200992|588654780|FG000|Overall Study|Study terminated early|35|||
162986210|NCT01200992|588654781|FG001|Overall Study|Study terminated early|41|||
163323555|NCT04626427|589897218|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
162986211|NCT01200992|588654780|FG000|Overall Study|Randomized but not treated|2|||
162986212|NCT01200992|588654781|FG001|Overall Study|Randomized but not treated|0|||
162986213|NCT00721630|588654782|FG000|Overall Study|Participant found to be ineligible|1|||
163323556|NCT01553149|589897219|FG000|Overall Study|Adverse Event|0|||
163323557|NCT01553149|589897220|FG001|Overall Study|Adverse Event|9|||
163323558|NCT01553149|589897219|FG000|Overall Study|Physician Decision|5|||
163323559|NCT01553149|589897220|FG001|Overall Study|Physician Decision|10|||
163323560|NCT01553149|589897219|FG000|Overall Study|Ineligible|0|||
163323561|NCT01553149|589897220|FG001|Overall Study|Ineligible|1|||
163323562|NCT01265537|589897221|FG000|Overall Study|Adverse Event|2|||
163323563|NCT01265537|589897222|FG001|Overall Study|Adverse Event|1|||
163323564|NCT01265537|589897221|FG000|Overall Study|Physician Decision|0|||
163323565|NCT01265537|589897222|FG001|Overall Study|Physician Decision|1|||
163323566|NCT04518943|589898048|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
163323567|NCT04518943|589898049|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
163323568|NCT04518943|589898050|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
162986214|NCT04711902|588654786|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
162986215|NCT04711902|588654787|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
162986216|NCT04711902|588654788|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
163323569|NCT04518943|589898051|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
162986217|NCT04711902|588654789|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
162986218|NCT04711902|588654790|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
162986219|NCT04711902|588654791|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
163323570|NCT04518943|589898052|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
163323571|NCT04518943|589898053|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
163323572|NCT04518943|589898054|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
163323573|NCT04518943|589898055|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
163323574|NCT04518943|589898056|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
163323575|NCT04518943|589898057|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
163323576|NCT04518943|589898058|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
163323577|NCT04518943|589898059|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
163323578|NCT04518943|589898060|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
163323579|NCT04518943|589898061|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
162986220|NCT03786718|588654792|FG000|Overall Study|Lost to Follow-up|3|||
163403675|NCT00932360|590188661|FG005|Washout (One Week)|Withdrawal by Subject|0|||
163403676|NCT02536313|590188662|FG000|Overall Study|Lack of Efficacy|0|||
163403677|NCT02536313|590188663|FG001|Overall Study|Lack of Efficacy|1|||
163403678|NCT00917150|590188664|FG000|Overall Study|Adverse Event|12|||
163403679|NCT00917150|590188665|FG001|Overall Study|Adverse Event|7|||
163403680|NCT00917150|590188666|FG002|Overall Study|Adverse Event|12|||
163403681|NCT00917150|590188667|FG003|Overall Study|Adverse Event|11|||
163403682|NCT00917150|590188664|FG000|Overall Study|Death|1|||
163403683|NCT00917150|590188665|FG001|Overall Study|Death|4|||
163403684|NCT00917150|590188666|FG002|Overall Study|Death|3|||
163403685|NCT00917150|590188667|FG003|Overall Study|Death|2|||
163403686|NCT00917150|590188664|FG000|Overall Study|Lost to Follow-up|1|||
162986221|NCT03786718|588654792|FG000|Overall Study|Withdrawal by Subject|1|||
162986222|NCT03786718|588654792|FG000|Overall Study|Did not use the intervention|2|||
162986223|NCT03786718|588654792|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
162986224|NCT01398514|588654797|FG000|Overall Study|Adverse Event|1|||
162986225|NCT01398514|588654798|FG001|Overall Study|Adverse Event|0|||
162986226|NCT01398514|588654797|FG000|Overall Study|Non-compliance with study procedures|2|||
163403687|NCT00917150|590188665|FG001|Overall Study|Lost to Follow-up|0|||
163403688|NCT00917150|590188666|FG002|Overall Study|Lost to Follow-up|4|||
163403689|NCT00917150|590188667|FG003|Overall Study|Lost to Follow-up|2|||
163403690|NCT00917150|590188664|FG000|Overall Study|Physician Decision|0|||
163403691|NCT00917150|590188665|FG001|Overall Study|Physician Decision|2|||
163403692|NCT00917150|590188666|FG002|Overall Study|Physician Decision|0|||
163403693|NCT00917150|590188667|FG003|Overall Study|Physician Decision|1|||
163403694|NCT00917150|590188664|FG000|Overall Study|Protocol Violation|5|||
163403695|NCT00917150|590188665|FG001|Overall Study|Protocol Violation|5|||
163403696|NCT00917150|590188666|FG002|Overall Study|Protocol Violation|3|||
162986227|NCT01398514|588654798|FG001|Overall Study|Non-compliance with study procedures|0|||
162986228|NCT01398514|588654797|FG000|Overall Study|Physiologic non-responsiveness|1|||
162986229|NCT01398514|588654798|FG001|Overall Study|Physiologic non-responsiveness|3|||
162986230|NCT01398514|588654797|FG000|Overall Study|Failure to show a conditioned response|4|||
162986231|NCT01398514|588654798|FG001|Overall Study|Failure to show a conditioned response|3|||
162986232|NCT00123474|588654800|FG000|Randomized to Treatment|Randomized, never treated|1|||
162986233|NCT00123474|588654801|FG001|Randomized to Treatment|Randomized, never treated|4|||
162986234|NCT00123474|588654802|FG002|Randomized to Treatment|Randomized, never treated|2|||
162986235|NCT00123474|588654803|FG003|Randomized to Treatment|Randomized, never treated|1|||
162986236|NCT00123474|588654800|FG000|As Treated at Study Closure|not reported when site closed|1|||
162986237|NCT00123474|588654801|FG001|As Treated at Study Closure|not reported when site closed|0|||
162986238|NCT00123474|588654802|FG002|As Treated at Study Closure|not reported when site closed|1|||
162986239|NCT00123474|588654803|FG003|As Treated at Study Closure|not reported when site closed|0|||
162986240|NCT00123474|588654800|FG000|As Treated at Study Closure|Adverse Event|10|||
162986241|NCT00123474|588654801|FG001|As Treated at Study Closure|Adverse Event|4|||
162986242|NCT00123474|588654802|FG002|As Treated at Study Closure|Adverse Event|10|||
162986243|NCT00123474|588654803|FG003|As Treated at Study Closure|Adverse Event|8|||
162986244|NCT00123474|588654800|FG000|As Treated at Study Closure|Disease Progression|35|||
162986245|NCT00123474|588654801|FG001|As Treated at Study Closure|Disease Progression|42|||
162986246|NCT00123474|588654802|FG002|As Treated at Study Closure|Disease Progression|29|||
162986247|NCT00123474|588654803|FG003|As Treated at Study Closure|Disease Progression|27|||
162986248|NCT00123474|588654800|FG000|As Treated at Study Closure|Investigator Request|12|||
162986249|NCT00123474|588654801|FG001|As Treated at Study Closure|Investigator Request|6|||
162986250|NCT00123474|588654802|FG002|As Treated at Study Closure|Investigator Request|7|||
162986251|NCT00123474|588654803|FG003|As Treated at Study Closure|Investigator Request|5|||
162986252|NCT00123474|588654800|FG000|As Treated at Study Closure|non-specified|54|||
162986253|NCT00123474|588654801|FG001|As Treated at Study Closure|non-specified|47|||
162986254|NCT00123474|588654802|FG002|As Treated at Study Closure|non-specified|57|||
163403697|NCT00917150|590188667|FG003|Overall Study|Protocol Violation|5|||
163403698|NCT00917150|590188664|FG000|Overall Study|Withdrawal by Subject|15|||
163403699|NCT00917150|590188665|FG001|Overall Study|Withdrawal by Subject|16|||
163403700|NCT00917150|590188666|FG002|Overall Study|Withdrawal by Subject|18|||
163403701|NCT00917150|590188667|FG003|Overall Study|Withdrawal by Subject|11|||
163403702|NCT00917150|590188664|FG000|Overall Study|Other than specified|3|||
163403703|NCT00917150|590188665|FG001|Overall Study|Other than specified|3|||
163403704|NCT00917150|590188666|FG002|Overall Study|Other than specified|2|||
162986255|NCT00123474|588654803|FG003|As Treated at Study Closure|non-specified|60|||
163403705|NCT00917150|590188667|FG003|Overall Study|Other than specified|2|||
163403706|NCT04143009|590188669|FG000|Pilot Trial|Lost to Follow-up|0|||
163403707|NCT04143009|590188670|FG001|Pilot Trial|Lost to Follow-up|1|||
162986256|NCT00123474|588654800|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
162986257|NCT00123474|588654801|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
162986258|NCT00123474|588654802|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
162986259|NCT00123474|588654803|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
163403708|NCT04143009|590188671|FG002|Pilot Trial|Lost to Follow-up|1|||
163403709|NCT00993265|590188676|FG000|Overall Study|Adverse Event|1|||
162986260|NCT00123474|588654800|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
162986261|NCT00123474|588654801|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
162986262|NCT00123474|588654802|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
162986263|NCT00123474|588654803|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
162986264|NCT01059344|588654804|FG000|Overall Study|Adverse Event|12|||
162986265|NCT01059344|588654805|FG001|Overall Study|Adverse Event|30|||
162986266|NCT01059344|588654804|FG000|Overall Study|Withdrawal by Subject|6|||
162986267|NCT01059344|588654805|FG001|Overall Study|Withdrawal by Subject|9|||
162986268|NCT01059344|588654804|FG000|Overall Study|Lost to Follow-up|1|||
162986269|NCT01059344|588654805|FG001|Overall Study|Lost to Follow-up|1|||
162986270|NCT01059344|588654804|FG000|Overall Study|Other|3|||
162986271|NCT01059344|588654805|FG001|Overall Study|Other|6|||
162986272|NCT01085201|588654810|FG000|Overall Study|Scheduling conflict|1|||
162986273|NCT01085201|588654811|FG001|Overall Study|Scheduling conflict|0|||
162986274|NCT01085201|588654812|FG002|Overall Study|Scheduling conflict|1|||
162986275|NCT01085201|588654813|FG003|Overall Study|Scheduling conflict|0|||
162986276|NCT01085201|588654814|FG004|Overall Study|Scheduling conflict|0|||
162986277|NCT01085201|588654810|FG000|Overall Study|Unknown- no study drug|2|||
162986278|NCT01085201|588654811|FG001|Overall Study|Unknown- no study drug|0|||
162986279|NCT01085201|588654812|FG002|Overall Study|Unknown- no study drug|0|||
162986280|NCT01085201|588654813|FG003|Overall Study|Unknown- no study drug|0|||
162986281|NCT01085201|588654814|FG004|Overall Study|Unknown- no study drug|0|||
162986282|NCT01085201|588654810|FG000|Overall Study|Fond ineligible after consent|0|||
162986283|NCT01085201|588654811|FG001|Overall Study|Fond ineligible after consent|1|||
162986284|NCT01085201|588654812|FG002|Overall Study|Fond ineligible after consent|1|||
162986285|NCT01085201|588654813|FG003|Overall Study|Fond ineligible after consent|0|||
162986286|NCT01085201|588654814|FG004|Overall Study|Fond ineligible after consent|0|||
162986287|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
162986288|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
162986289|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
162986290|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
162986291|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
162986292|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
162986293|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
162986294|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
162986295|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
162986296|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986297|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
162986298|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986299|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986300|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986301|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986302|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986303|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986304|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986305|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986306|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
162986307|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986308|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
162986309|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986310|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986311|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986312|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986313|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986314|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
162986315|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
162986316|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
162986317|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
162986318|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
162986319|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
162986320|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
162986321|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
162986322|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
163323580|NCT04518943|589898062|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
162986323|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
162986324|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
162986325|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
163323581|NCT04518943|589898063|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
163212001|NCT04434092|589490706|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
163212002|NCT04434092|589490704|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
163212003|NCT04434092|589490705|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
163212004|NCT04434092|589490706|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
163212005|NCT04434092|589490704|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
163212006|NCT04434092|589490705|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
163212007|NCT04434092|589490706|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
163212008|NCT04434092|589490704|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
163212009|NCT04434092|589490705|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
163212010|NCT04434092|589490706|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
163212011|NCT04434092|589490704|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
163212012|NCT04434092|589490705|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
163212013|NCT04434092|589490706|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
162986326|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
163323582|NCT06408870|589898067|FG000|Washout period|Withdrawal by Subject|1|||
163323583|NCT06408870|589898068|FG001|Washout period|Withdrawal by Subject|0|||
163323584|NCT06408870|589898067|FG000|Washout period|Adverse Event|2|||
163323585|NCT06408870|589898068|FG001|Washout period|Adverse Event|0|||
162986327|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
162986328|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986329|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986330|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986331|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986332|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986333|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
162986334|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986335|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986336|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986337|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986338|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986339|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986340|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986341|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986342|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986343|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986344|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
162986345|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986346|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986347|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986348|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986349|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986350|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
162986351|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
162986352|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
162986353|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
162986354|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
162986355|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
162986356|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
162986357|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
162986358|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
162986359|NCT03893565|588654815|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
162986360|NCT03893565|588654816|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
162986361|NCT03893565|588654817|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
162986362|NCT03893565|588654818|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
162986363|NCT03893565|588654819|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
162986364|NCT03893565|588654820|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
162986365|NCT03893565|588654821|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
162986366|NCT03893565|588654822|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
162986367|NCT03893565|588654823|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
163212014|NCT04434092|589490704|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
163323586|NCT04993677|589898072|FG000|Overall Study|Lost to Follow-up|1|||
163323587|NCT04993677|589898073|FG001|Overall Study|Lost to Follow-up|0|||
163323588|NCT04993677|589898074|FG002|Overall Study|Lost to Follow-up|0|||
163323589|NCT04993677|589898075|FG003|Overall Study|Lost to Follow-up|0|||
163323590|NCT04993677|589898072|FG000|Overall Study|Death|11|||
163323591|NCT04993677|589898073|FG001|Overall Study|Death|8|||
163323592|NCT04993677|589898074|FG002|Overall Study|Death|3|||
162986368|NCT03893565|588654815|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986369|NCT03893565|588654816|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986370|NCT03893565|588654817|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986371|NCT03893565|588654818|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986372|NCT03893565|588654819|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986373|NCT03893565|588654820|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986374|NCT03893565|588654821|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
162986375|NCT03893565|588654822|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986376|NCT03893565|588654823|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986377|NCT03893565|588654815|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
162986378|NCT03893565|588654816|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
162986379|NCT03893565|588654817|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
162986380|NCT03893565|588654818|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
162986381|NCT03893565|588654819|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
162986382|NCT03893565|588654820|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
162986383|NCT03893565|588654821|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
162986384|NCT03893565|588654822|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
162986385|NCT03893565|588654823|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
162986386|NCT03893565|588654815|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
162986387|NCT03893565|588654816|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
162986388|NCT03893565|588654817|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
162986389|NCT03893565|588654818|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
162986390|NCT03893565|588654819|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
162986391|NCT03893565|588654820|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
162986392|NCT03893565|588654821|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
162986393|NCT03893565|588654822|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
162986394|NCT03893565|588654823|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
162986395|NCT03893565|588654815|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986396|NCT03893565|588654816|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986397|NCT03893565|588654817|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986398|NCT03893565|588654818|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986399|NCT03893565|588654819|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986400|NCT03893565|588654820|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986401|NCT03893565|588654821|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986402|NCT03893565|588654822|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
162986403|NCT03893565|588654823|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986404|NCT03893565|588654815|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986405|NCT03893565|588654816|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986406|NCT03893565|588654817|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986407|NCT03893565|588654818|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986408|NCT03893565|588654819|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986409|NCT03893565|588654820|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986410|NCT03893565|588654821|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986411|NCT03893565|588654822|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
162986412|NCT03893565|588654823|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986413|NCT03893565|588654815|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986414|NCT03893565|588654816|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986415|NCT03893565|588654817|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986416|NCT03893565|588654818|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986417|NCT03893565|588654819|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986418|NCT03893565|588654820|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986419|NCT03893565|588654821|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986420|NCT03893565|588654822|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
162986421|NCT03893565|588654823|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986422|NCT03893565|588654815|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
162986423|NCT03893565|588654816|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
162986424|NCT03893565|588654817|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
162986425|NCT03893565|588654818|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
163323593|NCT04993677|589898075|FG003|Overall Study|Death|1|||
163323594|NCT04993677|589898072|FG000|Overall Study|Subject withdrawal of consent|4|||
163323595|NCT04993677|589898073|FG001|Overall Study|Subject withdrawal of consent|3|||
162986426|NCT03893565|588654819|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
162986427|NCT03893565|588654820|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
162986428|NCT03893565|588654821|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
162986429|NCT03893565|588654822|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
162986430|NCT03893565|588654823|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
162986431|NCT03870477|588654824|FG000|Overall Study|Early Study Termination|1|||
162986432|NCT02256436|588654831|FG000|Overall Study|Adverse Event|9|||
162986433|NCT02256436|588654832|FG001|Overall Study|Adverse Event|14|||
162986434|NCT02256436|588654831|FG000|Overall Study|Death|216|||
162986435|NCT02256436|588654832|FG001|Overall Study|Death|208|||
162986436|NCT02256436|588654831|FG000|Overall Study|Lost to Follow-up|1|||
162986437|NCT02256436|588654832|FG001|Overall Study|Lost to Follow-up|2|||
162986438|NCT02256436|588654831|FG000|Overall Study|Physician Decision|1|||
162986439|NCT02256436|588654832|FG001|Overall Study|Physician Decision|0|||
162986440|NCT02256436|588654831|FG000|Overall Study|Protocol Violation|0|||
162986441|NCT02256436|588654832|FG001|Overall Study|Protocol Violation|1|||
162986442|NCT02256436|588654831|FG000|Overall Study|Withdrawal by Subject|26|||
163212015|NCT04434092|589490705|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
162986443|NCT02256436|588654832|FG001|Overall Study|Withdrawal by Subject|10|||
162986444|NCT02256436|588654831|FG000|Overall Study|Transferred to Extension Study|11|||
162986445|NCT02256436|588654832|FG001|Overall Study|Transferred to Extension Study|23|||
162986446|NCT02256436|588654831|FG000|Overall Study|Did Not Continue on Extension Study|8|||
162986447|NCT02256436|588654832|FG001|Overall Study|Did Not Continue on Extension Study|12|||
162986448|NCT05961215|588654833|FG000|Overall Study|Withdrawal by Subject|1|||
162986449|NCT01394952|588654834|FG000|Overall Study|Lost to Follow-up|0|||
162986450|NCT01394952|588654835|FG001|Overall Study|Lost to Follow-up|5|||
162986451|NCT01394952|588654834|FG000|Overall Study|Withdrawal by Subject|10|||
162986452|NCT01394952|588654835|FG001|Overall Study|Withdrawal by Subject|5|||
162986453|NCT01394952|588654834|FG000|Overall Study|Physician Decision|2|||
162986454|NCT01394952|588654835|FG001|Overall Study|Physician Decision|0|||
162986455|NCT01394952|588654834|FG000|Overall Study|Sponsor Decision|5|||
162986456|NCT01394952|588654835|FG001|Overall Study|Sponsor Decision|7|||
162986457|NCT01986010|588654836|FG000|Overall Study|Adverse Event|0|||
162986458|NCT01986010|588654837|FG001|Overall Study|Adverse Event|1|||
162986459|NCT01986010|588654838|FG002|Overall Study|Adverse Event|0|||
162986460|NCT01986010|588654839|FG003|Overall Study|Adverse Event|0|||
162986461|NCT01986010|588654840|FG004|Overall Study|Adverse Event|0|||
162986462|NCT01986010|588654841|FG005|Overall Study|Adverse Event|0|||
162986463|NCT01986010|588654842|FG006|Overall Study|Adverse Event|0|||
162986464|NCT01986010|588654843|FG007|Overall Study|Adverse Event|0|||
162986465|NCT01986010|588654844|FG008|Overall Study|Adverse Event|0|||
162986466|NCT01986010|588654845|FG009|Overall Study|Adverse Event|0|||
163212016|NCT04434092|589490706|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
162986467|NCT01986010|588654846|FG010|Overall Study|Adverse Event|0|||
162986468|NCT01986010|588654847|FG011|Overall Study|Adverse Event|0|||
162986469|NCT01986010|588654848|FG012|Overall Study|Adverse Event|0|||
162986470|NCT01986010|588654849|FG013|Overall Study|Adverse Event|0|||
162986471|NCT01986010|588654850|FG014|Overall Study|Adverse Event|0|||
162986472|NCT01986010|588654851|FG015|Overall Study|Adverse Event|1|||
162986473|NCT01986010|588654852|FG016|Overall Study|Adverse Event|0|||
162986474|NCT01986010|588654836|FG000|Overall Study|Lost to Follow-up|2|||
162986475|NCT01986010|588654837|FG001|Overall Study|Lost to Follow-up|1|||
163212017|NCT04434092|589490704|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
163212018|NCT04434092|589490705|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
163212019|NCT04434092|589490706|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
163323596|NCT04993677|589898074|FG002|Overall Study|Subject withdrawal of consent|0|||
163323597|NCT04993677|589898075|FG003|Overall Study|Subject withdrawal of consent|2|||
163323598|NCT04993677|589898072|FG000|Overall Study|Study termination by sponsor|3|||
163323599|NCT04993677|589898073|FG001|Overall Study|Study termination by sponsor|25|||
163323600|NCT04993677|589898074|FG002|Overall Study|Study termination by sponsor|3|||
163323601|NCT04993677|589898075|FG003|Overall Study|Study termination by sponsor|3|||
162986476|NCT01986010|588654838|FG002|Overall Study|Lost to Follow-up|2|||
162986477|NCT01986010|588654839|FG003|Overall Study|Lost to Follow-up|2|||
162986478|NCT01986010|588654840|FG004|Overall Study|Lost to Follow-up|2|||
162986479|NCT01986010|588654841|FG005|Overall Study|Lost to Follow-up|2|||
163212020|NCT02554812|589490707|FG000|Overall Study|Adverse Event|2|||
163212021|NCT02554812|589490708|FG001|Overall Study|Adverse Event|5|||
163212022|NCT02554812|589490709|FG002|Overall Study|Adverse Event|3|||
162986480|NCT01986010|588654842|FG006|Overall Study|Lost to Follow-up|0|||
162986481|NCT01986010|588654843|FG007|Overall Study|Lost to Follow-up|0|||
162986482|NCT01986010|588654844|FG008|Overall Study|Lost to Follow-up|4|||
162986483|NCT01986010|588654845|FG009|Overall Study|Lost to Follow-up|2|||
162986484|NCT01986010|588654846|FG010|Overall Study|Lost to Follow-up|0|||
162986485|NCT01986010|588654847|FG011|Overall Study|Lost to Follow-up|1|||
162986486|NCT01986010|588654848|FG012|Overall Study|Lost to Follow-up|1|||
162986487|NCT01986010|588654849|FG013|Overall Study|Lost to Follow-up|1|||
162986488|NCT01986010|588654850|FG014|Overall Study|Lost to Follow-up|2|||
162986489|NCT01986010|588654851|FG015|Overall Study|Lost to Follow-up|0|||
162986490|NCT01986010|588654852|FG016|Overall Study|Lost to Follow-up|0|||
162986491|NCT01986010|588654836|FG000|Overall Study|Physician Decision|0|||
162986492|NCT01986010|588654837|FG001|Overall Study|Physician Decision|0|||
162986493|NCT01986010|588654838|FG002|Overall Study|Physician Decision|0|||
162986494|NCT01986010|588654839|FG003|Overall Study|Physician Decision|0|||
162986495|NCT01986010|588654840|FG004|Overall Study|Physician Decision|0|||
162986496|NCT01986010|588654841|FG005|Overall Study|Physician Decision|0|||
162986497|NCT01986010|588654842|FG006|Overall Study|Physician Decision|0|||
162986498|NCT01986010|588654843|FG007|Overall Study|Physician Decision|0|||
162986499|NCT01986010|588654844|FG008|Overall Study|Physician Decision|0|||
162986500|NCT01986010|588654845|FG009|Overall Study|Physician Decision|0|||
162986501|NCT01986010|588654846|FG010|Overall Study|Physician Decision|0|||
162986502|NCT01986010|588654847|FG011|Overall Study|Physician Decision|0|||
162986503|NCT01986010|588654848|FG012|Overall Study|Physician Decision|0|||
162986504|NCT01986010|588654849|FG013|Overall Study|Physician Decision|0|||
162986505|NCT01986010|588654850|FG014|Overall Study|Physician Decision|1|||
162986506|NCT01986010|588654851|FG015|Overall Study|Physician Decision|0|||
162986507|NCT01986010|588654852|FG016|Overall Study|Physician Decision|0|||
162986508|NCT01986010|588654836|FG000|Overall Study|Withdrawal by Subject|2|||
162986509|NCT01986010|588654837|FG001|Overall Study|Withdrawal by Subject|2|||
162986510|NCT01986010|588654838|FG002|Overall Study|Withdrawal by Subject|3|||
162986511|NCT01986010|588654839|FG003|Overall Study|Withdrawal by Subject|0|||
162986512|NCT01986010|588654840|FG004|Overall Study|Withdrawal by Subject|2|||
162986513|NCT01986010|588654841|FG005|Overall Study|Withdrawal by Subject|4|||
162986514|NCT01986010|588654842|FG006|Overall Study|Withdrawal by Subject|0|||
162986515|NCT01986010|588654843|FG007|Overall Study|Withdrawal by Subject|0|||
162986516|NCT01986010|588654844|FG008|Overall Study|Withdrawal by Subject|0|||
162986517|NCT01986010|588654845|FG009|Overall Study|Withdrawal by Subject|0|||
162986518|NCT01986010|588654846|FG010|Overall Study|Withdrawal by Subject|0|||
162986519|NCT01986010|588654847|FG011|Overall Study|Withdrawal by Subject|2|||
162986520|NCT01986010|588654848|FG012|Overall Study|Withdrawal by Subject|0|||
162986521|NCT01986010|588654849|FG013|Overall Study|Withdrawal by Subject|1|||
162986522|NCT01986010|588654850|FG014|Overall Study|Withdrawal by Subject|2|||
162986523|NCT01986010|588654851|FG015|Overall Study|Withdrawal by Subject|0|||
162986524|NCT01986010|588654852|FG016|Overall Study|Withdrawal by Subject|0|||
163323602|NCT04993677|589898072|FG000|Overall Study|Other|2|||
163323603|NCT04993677|589898073|FG001|Overall Study|Other|3|||
163323604|NCT04993677|589898074|FG002|Overall Study|Other|3|||
162986525|NCT01986010|588654836|FG000|Overall Study|Status Not Recorded|2|||
162986526|NCT01986010|588654837|FG001|Overall Study|Status Not Recorded|4|||
162986527|NCT01986010|588654838|FG002|Overall Study|Status Not Recorded|2|||
162986528|NCT01986010|588654839|FG003|Overall Study|Status Not Recorded|0|||
162986529|NCT01986010|588654840|FG004|Overall Study|Status Not Recorded|1|||
162986530|NCT01986010|588654841|FG005|Overall Study|Status Not Recorded|2|||
162986531|NCT01986010|588654842|FG006|Overall Study|Status Not Recorded|0|||
162986532|NCT01986010|588654843|FG007|Overall Study|Status Not Recorded|0|||
162986533|NCT01986010|588654844|FG008|Overall Study|Status Not Recorded|2|||
162986534|NCT01986010|588654845|FG009|Overall Study|Status Not Recorded|1|||
162986535|NCT01986010|588654846|FG010|Overall Study|Status Not Recorded|7|||
162986536|NCT01986010|588654847|FG011|Overall Study|Status Not Recorded|7|||
162986537|NCT01986010|588654848|FG012|Overall Study|Status Not Recorded|9|||
162986538|NCT01986010|588654849|FG013|Overall Study|Status Not Recorded|9|||
162986539|NCT01986010|588654850|FG014|Overall Study|Status Not Recorded|5|||
163212023|NCT02554812|589490710|FG003|Overall Study|Adverse Event|0|||
163212024|NCT02554812|589490711|FG004|Overall Study|Adverse Event|5|||
163212025|NCT02554812|589490712|FG005|Overall Study|Adverse Event|0|||
163212026|NCT02554812|589490713|FG006|Overall Study|Adverse Event|1|||
163212027|NCT02554812|589490714|FG007|Overall Study|Adverse Event|6|||
163212028|NCT02554812|589490715|FG008|Overall Study|Adverse Event|2|||
163323605|NCT04993677|589898075|FG003|Overall Study|Other|2|||
163212029|NCT02554812|589490716|FG009|Overall Study|Adverse Event|2|||
163212030|NCT02554812|589490717|FG010|Overall Study|Adverse Event|1|||
163212031|NCT02554812|589490718|FG011|Overall Study|Adverse Event|2|||
163212032|NCT02554812|589490719|FG012|Overall Study|Adverse Event|0|||
163212033|NCT02554812|589490720|FG013|Overall Study|Adverse Event|3|||
163212034|NCT02554812|589490721|FG014|Overall Study|Adverse Event|2|||
163323606|NCT04174170|589898076|FG000|Placebo Run-in Period|Not Randomized|38|||
162986540|NCT01986010|588654851|FG015|Overall Study|Status Not Recorded|10|||
162986541|NCT01986010|588654852|FG016|Overall Study|Status Not Recorded|4|||
162986542|NCT01335997|588654855|FG000|Period I and II|Adverse Event|63|||
162986543|NCT01335997|588654856|FG001|Period I and II|Adverse Event|43|||
162986544|NCT01335997|588654855|FG000|Period I and II|Noncompliance with Study Drug|1|||
162986545|NCT01335997|588654856|FG001|Period I and II|Noncompliance with Study Drug|1|||
162986546|NCT01335997|588654855|FG000|Period I and II|Lost to Follow-up|3|||
162986547|NCT01335997|588654856|FG001|Period I and II|Lost to Follow-up|5|||
162986548|NCT01335997|588654855|FG000|Period I and II|Withdrawal by Subject|9|||
163212035|NCT02554812|589490722|FG015|Overall Study|Adverse Event|1|||
163323607|NCT04174170|589898077|FG001|Placebo Run-in Period|Not Randomized|0|||
162986549|NCT01335997|588654856|FG001|Period I and II|Withdrawal by Subject|4|||
162986550|NCT01335997|588654855|FG000|Period I and II|Study Terminated by Sponsor|406|||
162986551|NCT01335997|588654856|FG001|Period I and II|Study Terminated by Sponsor|415|||
162986552|NCT01335997|588654855|FG000|Period I and II|Protocol Violation|9|||
162986553|NCT01335997|588654856|FG001|Period I and II|Protocol Violation|10|||
162986554|NCT01335997|588654855|FG000|Period I and II|Physician Decision|2|||
162986555|NCT01335997|588654856|FG001|Period I and II|Physician Decision|1|||
162986556|NCT01335997|588654855|FG000|Period III|Adverse Event|0|||
162986557|NCT01335997|588654856|FG001|Period III|Adverse Event|2|||
162986558|NCT01335997|588654855|FG000|Period III|Study Terminated by Sponsor|77|||
162986559|NCT01335997|588654856|FG001|Period III|Study Terminated by Sponsor|76|||
162986560|NCT01335997|588654855|FG000|Period III|Protocol Violation|0|||
162986561|NCT01335997|588654856|FG001|Period III|Protocol Violation|1|||
162986562|NCT01335997|588654855|FG000|Period III|Lost to Follow-up|1|||
162986563|NCT01335997|588654856|FG001|Period III|Lost to Follow-up|0|||
162986564|NCT00085423|588654857|FG000|Overall Study|Withdrawal by Subject|1|||
162986565|NCT00085423|588654857|FG000|Overall Study|screen failure|1|||
162986566|NCT04740814|588654858|FG000|Overall Study|Adverse Event|3|||
162986567|NCT04740814|588654858|FG000|Overall Study|Protocol Violation|2|||
162986568|NCT04740814|588654858|FG000|Overall Study|Lost to Follow-up|2|||
162986569|NCT04740814|588654858|FG000|Overall Study|Withdrawal by Subject|3|||
162986570|NCT04126213|588654870|FG000|Overall Study|Lost to Follow-up|9|||
162986571|NCT04126213|588654871|FG001|Overall Study|Lost to Follow-up|1|||
162986572|NCT04126213|588654872|FG002|Overall Study|Lost to Follow-up|5|||
162986573|NCT04126213|588654873|FG003|Overall Study|Lost to Follow-up|10|||
162986574|NCT04126213|588654874|FG004|Overall Study|Lost to Follow-up|4|||
162986575|NCT04126213|588654875|FG005|Overall Study|Lost to Follow-up|7|||
162986576|NCT04126213|588654870|FG000|Overall Study|Withdrawal by Subject|3|||
162986577|NCT04126213|588654871|FG001|Overall Study|Withdrawal by Subject|2|||
162986578|NCT04126213|588654872|FG002|Overall Study|Withdrawal by Subject|1|||
162986579|NCT04126213|588654873|FG003|Overall Study|Withdrawal by Subject|1|||
162986580|NCT04126213|588654874|FG004|Overall Study|Withdrawal by Subject|1|||
162986581|NCT04126213|588654875|FG005|Overall Study|Withdrawal by Subject|1|||
162986582|NCT04126213|588654870|FG000|Overall Study|Other|0|||
162986583|NCT04126213|588654871|FG001|Overall Study|Other|0|||
162986584|NCT04126213|588654872|FG002|Overall Study|Other|2|||
162986585|NCT04126213|588654873|FG003|Overall Study|Other|2|||
162986586|NCT04126213|588654874|FG004|Overall Study|Other|0|||
162986587|NCT04126213|588654875|FG005|Overall Study|Other|1|||
163323608|NCT04174170|589898078|FG002|Placebo Run-in Period|Not Randomized|0|||
163323609|NCT04174170|589898079|FG003|Placebo Run-in Period|Not Randomized|0|||
163323610|NCT04174170|589898076|FG000|Double Blind Treatment Period|Adverse Event|0|||
163323611|NCT04174170|589898077|FG001|Double Blind Treatment Period|Adverse Event|9|||
163323612|NCT04174170|589898078|FG002|Double Blind Treatment Period|Adverse Event|9|||
163323613|NCT04174170|589898079|FG003|Double Blind Treatment Period|Adverse Event|8|||
163323614|NCT04174170|589898076|FG000|Double Blind Treatment Period|Death|0|||
163323615|NCT04174170|589898077|FG001|Double Blind Treatment Period|Death|1|||
163323616|NCT04174170|589898078|FG002|Double Blind Treatment Period|Death|0|||
163323617|NCT04174170|589898079|FG003|Double Blind Treatment Period|Death|0|||
163323618|NCT04174170|589898076|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
163323619|NCT04174170|589898077|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
163323620|NCT04174170|589898078|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
163323621|NCT04174170|589898079|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
163323622|NCT04174170|589898076|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
163323623|NCT04174170|589898077|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
163323624|NCT04174170|589898078|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
163323625|NCT04174170|589898079|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
163323626|NCT04174170|589898076|FG000|Double Blind Treatment Period|Physician Decision|0|||
163323627|NCT04174170|589898077|FG001|Double Blind Treatment Period|Physician Decision|1|||
163323628|NCT04174170|589898078|FG002|Double Blind Treatment Period|Physician Decision|0|||
163323629|NCT04174170|589898079|FG003|Double Blind Treatment Period|Physician Decision|1|||
163323630|NCT04174170|589898076|FG000|Double Blind Treatment Period|Pregnancy|0|||
163323631|NCT04174170|589898077|FG001|Double Blind Treatment Period|Pregnancy|1|||
163323632|NCT04174170|589898078|FG002|Double Blind Treatment Period|Pregnancy|0|||
163323633|NCT04174170|589898079|FG003|Double Blind Treatment Period|Pregnancy|1|||
163323634|NCT04174170|589898076|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
162986588|NCT04126213|588654870|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162986589|NCT04126213|588654871|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
162986590|NCT04126213|588654872|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162986591|NCT04126213|588654873|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162986592|NCT04126213|588654874|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162986593|NCT04126213|588654875|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
162986594|NCT02853370|588654876|FG000|Overall Study|Physician Decision|1|||
162986595|NCT02853370|588654876|FG000|Overall Study|Lack of Efficacy|2|||
163323635|NCT04174170|589898077|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
163323636|NCT04174170|589898078|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
163323637|NCT04174170|589898079|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
163323638|NCT04174170|589898076|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
163323639|NCT04174170|589898077|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
163323640|NCT04174170|589898078|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
163323641|NCT04174170|589898079|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
163323642|NCT04174170|589898076|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
163323643|NCT04174170|589898077|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
163323644|NCT04174170|589898078|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
163323645|NCT04174170|589898079|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
163323646|NCT04772534|589898081|FG000|Overall Study|Physician Decision|1|||
163403710|NCT00993265|590188677|FG001|Overall Study|Adverse Event|0|||
162986596|NCT02853370|588654876|FG000|Overall Study|Death|1|||
162986597|NCT02853370|588654876|FG000|Overall Study|Adverse Event|4|||
162986598|NCT02853370|588654876|FG000|Overall Study|Withdrawal by Subject|3|||
162986599|NCT03283761|588654881|FG000|Study Treatment|Patient Non-Compliance|1|||
163403711|NCT00993265|590188676|FG000|Overall Study|Changed dose of concomitant drug|2|||
163403712|NCT00993265|590188677|FG001|Overall Study|Changed dose of concomitant drug|0|||
163403713|NCT00993265|590188676|FG000|Overall Study|Non-compliant with study medication|1|||
163403714|NCT00993265|590188677|FG001|Overall Study|Non-compliant with study medication|0|||
163403715|NCT00781911|590188678|FG000|Overall Study|Adverse Event|4|||
163403716|NCT00781911|590188679|FG001|Overall Study|Adverse Event|4|||
163403717|NCT00781911|590188678|FG000|Overall Study|Withdrawal by Subject|1|||
163403718|NCT00781911|590188679|FG001|Overall Study|Withdrawal by Subject|2|||
163403719|NCT00781911|590188678|FG000|Overall Study|Physician Decision|0|||
163403720|NCT00781911|590188679|FG001|Overall Study|Physician Decision|2|||
163403721|NCT00781911|590188678|FG000|Overall Study|Sponsor Decision|1|||
163403722|NCT00781911|590188679|FG001|Overall Study|Sponsor Decision|0|||
163403723|NCT00219284|590188680|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
163403724|NCT00219284|590188681|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
163403725|NCT00219284|590188680|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
163403726|NCT00219284|590188681|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
163403727|NCT00219284|590188680|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
163403728|NCT00219284|590188681|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
163403729|NCT00219284|590188680|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
163403730|NCT00219284|590188681|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
163403731|NCT00219284|590188680|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
163403732|NCT00219284|590188681|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
163403733|NCT00219284|590188680|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
163403734|NCT00219284|590188681|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
163403735|NCT00219284|590188680|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
163403736|NCT00219284|590188681|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
163403737|NCT00219284|590188680|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
163403738|NCT00219284|590188681|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
162986600|NCT03283761|588654881|FG000|Study Treatment|Alternative Cancer Therapy|7|||
162986601|NCT03283761|588654881|FG000|Study Treatment|Disease progression|21|||
162986602|NCT03283761|588654881|FG000|Study Treatment|Adverse Event|3|||
162986603|NCT03283761|588654881|FG000|Study Treatment|Withdrawal by Subject|4|||
162986604|NCT03283761|588654881|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
162986605|NCT03283761|588654881|FG000|Study Treatment|Symptomatic Deterioration|1|||
162986606|NCT03283761|588654881|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
162986607|NCT03283761|588654881|FG000|Follow up|Lost to Follow-up|1|||
162986608|NCT03283761|588654881|FG000|Follow up|Symptomatic Deterioration|1|||
162986609|NCT03283761|588654881|FG000|Follow up|Death|29|||
162986610|NCT03283761|588654881|FG000|Follow up|study terminated|4|||
162986611|NCT03283761|588654881|FG000|Follow up|Primary Investigator Withdrawal|1|||
163403739|NCT00219284|590188680|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
163403740|NCT00219284|590188681|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
163403741|NCT01357655|590188682|FG000|Overall Study|Administrative Reason by Sponsor|45|||
163403742|NCT01357655|590188683|FG001|Overall Study|Administrative Reason by Sponsor|0|||
163323647|NCT04772534|589898082|FG001|Overall Study|Physician Decision|0|||
163403743|NCT01357655|590188682|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
163403744|NCT01357655|590188683|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163403745|NCT01357655|590188682|FG000|Overall Study|Disease Progression|1|||
163403746|NCT01357655|590188683|FG001|Overall Study|Disease Progression|0|||
163403747|NCT01357655|590188682|FG000|Overall Study|Lost to Follow-up|2|||
163403748|NCT01357655|590188683|FG001|Overall Study|Lost to Follow-up|0|||
162986612|NCT03283761|588654881|FG000|Follow up|Switched to alternative therapy|1|||
162986613|NCT03283761|588654881|FG000|Follow up|Subject is now in Hospice|1|||
162986614|NCT01910389|588654882|FG000|Overall Study|Withdrawal by Subject|2|||
162986615|NCT01910389|588654883|FG001|Overall Study|Withdrawal by Subject|0|||
162986616|NCT01910389|588654882|FG000|Overall Study|Study Closed|13|||
162986617|NCT01910389|588654883|FG001|Overall Study|Study Closed|8|||
162986618|NCT01898650|588654884|FG000|Overall Study|the subject would not lie still for imaging|1|||
162986619|NCT02912650|588654886|FG000|Overall Study|Withdrawal by Subject|1|||
162986620|NCT02912650|588654887|FG001|Overall Study|Withdrawal by Subject|0|||
162986621|NCT02912650|588654888|FG002|Overall Study|Withdrawal by Subject|1|||
162986622|NCT02912650|588654889|FG003|Overall Study|Withdrawal by Subject|5|||
162986623|NCT02912650|588654886|FG000|Overall Study|Adverse Event|0|||
162986624|NCT02912650|588654887|FG001|Overall Study|Adverse Event|0|||
162986625|NCT02912650|588654888|FG002|Overall Study|Adverse Event|1|||
162986626|NCT02912650|588654889|FG003|Overall Study|Adverse Event|0|||
162986627|NCT02357342|588654890|FG000|First 6 Months|Death|2|||
162986628|NCT02357342|588654891|FG001|First 6 Months|Death|0|||
162986629|NCT01674647|588654892|FG000|Treatment Period|Death|4|||
162986630|NCT01674647|588654893|FG001|Treatment Period|Death|1|||
163323648|NCT04772534|589898083|FG002|Overall Study|Physician Decision|0|||
163323649|NCT04772534|589898081|FG000|Overall Study|Withdrawal by Subject|3|||
163323650|NCT04772534|589898082|FG001|Overall Study|Withdrawal by Subject|0|||
163323651|NCT04772534|589898083|FG002|Overall Study|Withdrawal by Subject|1|||
163323652|NCT04194450|589898084|FG000|Overall Study|not eligible|1|||
163323653|NCT04194450|589898085|FG001|Overall Study|not eligible|0|||
163323654|NCT05875701|589898094|FG000|Overall Study|Lost to Follow-up|2|||
163323655|NCT05875701|589898095|FG001|Overall Study|Lost to Follow-up|0|||
163323656|NCT05875701|589898094|FG000|Overall Study|Withdrawal by Subject|1|||
163323657|NCT05875701|589898095|FG001|Overall Study|Withdrawal by Subject|1|||
163323658|NCT04490356|589898101|FG000|Overall Study|Lost to Follow-up|1|||
163323659|NCT00412607|589898104|FG000|Overall Study|Withdrawal by Subject|9|||
163323660|NCT00412607|589898104|FG000|Overall Study|Lost to Follow-up|19|||
163323661|NCT00412607|589898104|FG000|Overall Study|Death|61|||
163323662|NCT00412607|589898104|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
163323663|NCT04675034|589898109|FG000|Overall Study|Lost to Follow-up|1|||
163323664|NCT04675034|589898110|FG001|Overall Study|Lost to Follow-up|1|||
163323665|NCT04675034|589898111|FG002|Overall Study|Lost to Follow-up|0|||
163323666|NCT04675034|589898112|FG003|Overall Study|Lost to Follow-up|2|||
163323667|NCT04675034|589898113|FG004|Overall Study|Lost to Follow-up|0|||
163323668|NCT04675034|589898109|FG000|Overall Study|Protocol Violation|1|||
163323669|NCT04675034|589898110|FG001|Overall Study|Protocol Violation|0|||
163323670|NCT04675034|589898111|FG002|Overall Study|Protocol Violation|0|||
163323671|NCT04675034|589898112|FG003|Overall Study|Protocol Violation|1|||
163323672|NCT04675034|589898113|FG004|Overall Study|Protocol Violation|3|||
163323673|NCT04675034|589898109|FG000|Overall Study|Withdrawal by Subject|9|||
163323674|NCT04675034|589898110|FG001|Overall Study|Withdrawal by Subject|3|||
163323675|NCT04675034|589898111|FG002|Overall Study|Withdrawal by Subject|4|||
163323676|NCT04675034|589898112|FG003|Overall Study|Withdrawal by Subject|8|||
163323677|NCT04675034|589898113|FG004|Overall Study|Withdrawal by Subject|6|||
163323678|NCT03201939|589898114|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
163323679|NCT03201939|589898115|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
163323680|NCT02806726|589898124|FG000|Overall Study|Lost to Follow-up|1|||
163323681|NCT03250676|589898125|FG000|Overall Study|Adverse Event|0|||
163323682|NCT03250676|589898126|FG001|Overall Study|Adverse Event|0|||
163323683|NCT03250676|589898127|FG002|Overall Study|Adverse Event|0|||
163323684|NCT03250676|589898128|FG003|Overall Study|Adverse Event|1|||
163323685|NCT03250676|589898129|FG004|Overall Study|Adverse Event|2|||
163323686|NCT03250676|589898130|FG005|Overall Study|Adverse Event|9|||
163323687|NCT03250676|589898125|FG000|Overall Study|Withdrawal by Subject|1|||
163323688|NCT03250676|589898126|FG001|Overall Study|Withdrawal by Subject|0|||
163323689|NCT03250676|589898127|FG002|Overall Study|Withdrawal by Subject|0|||
163323690|NCT03250676|589898128|FG003|Overall Study|Withdrawal by Subject|1|||
163323691|NCT03250676|589898129|FG004|Overall Study|Withdrawal by Subject|1|||
163323692|NCT03250676|589898130|FG005|Overall Study|Withdrawal by Subject|2|||
163323693|NCT03250676|589898125|FG000|Overall Study|Physician Decision|0|||
163323694|NCT03250676|589898126|FG001|Overall Study|Physician Decision|0|||
163323695|NCT03250676|589898127|FG002|Overall Study|Physician Decision|0|||
163323696|NCT03250676|589898128|FG003|Overall Study|Physician Decision|2|||
163323697|NCT03250676|589898129|FG004|Overall Study|Physician Decision|0|||
163323698|NCT03250676|589898130|FG005|Overall Study|Physician Decision|3|||
163323699|NCT03250676|589898125|FG000|Overall Study|Withdrawal of consent|0|||
163323700|NCT03250676|589898126|FG001|Overall Study|Withdrawal of consent|0|||
163323701|NCT03250676|589898127|FG002|Overall Study|Withdrawal of consent|2|||
163323702|NCT03250676|589898128|FG003|Overall Study|Withdrawal of consent|0|||
163323703|NCT03250676|589898129|FG004|Overall Study|Withdrawal of consent|0|||
163323704|NCT03250676|589898130|FG005|Overall Study|Withdrawal of consent|2|||
162986631|NCT01674647|588654892|FG000|Treatment Period|Efficacy outcome reached|0|||
162986632|NCT01674647|588654893|FG001|Treatment Period|Efficacy outcome reached|1|||
163323705|NCT03250676|589898125|FG000|Overall Study|Other|1|||
163323706|NCT03250676|589898126|FG001|Overall Study|Other|0|||
163323707|NCT03250676|589898127|FG002|Overall Study|Other|0|||
163323708|NCT03250676|589898128|FG003|Overall Study|Other|0|||
163323709|NCT03250676|589898129|FG004|Overall Study|Other|0|||
163323710|NCT03250676|589898130|FG005|Overall Study|Other|0|||
163403749|NCT01357655|590188682|FG000|Overall Study|Maximum Clinical Benefit|2|||
163403750|NCT01357655|590188683|FG001|Overall Study|Maximum Clinical Benefit|0|||
163403751|NCT01357655|590188682|FG000|Overall Study|Reason Unspecified|1|||
163403752|NCT01357655|590188683|FG001|Overall Study|Reason Unspecified|0|||
163403753|NCT01357655|590188682|FG000|Overall Study|Study Drug Toxicity|11|||
163403754|NCT01357655|590188683|FG001|Overall Study|Study Drug Toxicity|0|||
163403755|NCT01357655|590188682|FG000|Overall Study|Subject Withdrew Consent|1|||
163403756|NCT01357655|590188683|FG001|Overall Study|Subject Withdrew Consent|0|||
163403757|NCT01624662|590188688|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
163403758|NCT01624662|590188689|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
163403759|NCT01624662|590188690|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
163403760|NCT01624662|590188691|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
163403761|NCT01624662|590188688|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
163403762|NCT01624662|590188689|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
163403763|NCT01624662|590188690|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
163403764|NCT01624662|590188691|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
163403765|NCT01624662|590188688|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
163403766|NCT01624662|590188689|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
163059834|NCT02349386|588928235|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
163059835|NCT02349386|588928236|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
163059836|NCT02349386|588928237|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
163059837|NCT02349386|588928234|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
163059838|NCT02349386|588928235|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
163059839|NCT02349386|588928236|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
163059840|NCT02349386|588928237|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
163059841|NCT02349386|588928234|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
163059842|NCT02349386|588928235|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
163059843|NCT02349386|588928236|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
163059844|NCT02349386|588928237|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
163059845|NCT00973973|588928238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
163059846|NCT00973973|588928239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
163059847|NCT00973973|588928238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
163059848|NCT00973973|588928239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
163059849|NCT00973973|588928238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
163059850|NCT00973973|588928239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
163059851|NCT00973973|588928238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
163059852|NCT00973973|588928239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
163059853|NCT00973973|588928238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
163059854|NCT00973973|588928239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
163059855|NCT00973973|588928238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
163059856|NCT00973973|588928239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
163059857|NCT00973973|588928238|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
163059858|NCT00973973|588928239|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
163059859|NCT00973973|588928238|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
163059860|NCT00973973|588928239|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
163059861|NCT00973973|588928238|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
163059862|NCT00973973|588928239|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
163059863|NCT00973973|588928238|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
163059864|NCT00973973|588928239|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
163059865|NCT00973973|588928238|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
163059866|NCT00973973|588928239|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
163059867|NCT00973973|588928238|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
163059868|NCT00973973|588928239|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
163059869|NCT02471339|588928240|FG000|Overall Study|Did not provide follow-up data|2|||
163059870|NCT02471339|588928241|FG001|Overall Study|Did not provide follow-up data|0|||
163059871|NCT06057064|588928242|FG000|Overall Study|Death|2|||
163059872|NCT06057064|588928243|FG001|Overall Study|Death|0|||
163059873|NCT06057064|588928242|FG000|Overall Study|Physician Decision|1|||
163059874|NCT06057064|588928243|FG001|Overall Study|Physician Decision|0|||
163059875|NCT06057064|588928242|FG000|Overall Study|Withdrawal by Subject|1|||
163059876|NCT06057064|588928243|FG001|Overall Study|Withdrawal by Subject|1|||
163059877|NCT00851591|588928245|FG000|Overall Study|Withdrawal by Subject|2|||
163212036|NCT02554812|589490723|FG016|Overall Study|Adverse Event|0|||
163212037|NCT02554812|589490724|FG017|Overall Study|Adverse Event|1|||
163403767|NCT01624662|590188690|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
162986633|NCT01674647|588654892|FG000|Treatment Period|Physician Decision|3|||
162986634|NCT01674647|588654893|FG001|Treatment Period|Physician Decision|1|||
162986635|NCT01674647|588654892|FG000|Treatment Period|Adverse Event|60|||
162986636|NCT01674647|588654893|FG001|Treatment Period|Adverse Event|22|||
162986637|NCT01674647|588654892|FG000|Treatment Period|Non-compliance with study drug|3|||
162986638|NCT01674647|588654893|FG001|Treatment Period|Non-compliance with study drug|0|||
162986639|NCT01674647|588654892|FG000|Treatment Period|Lost to Follow-up|1|||
162986640|NCT01674647|588654893|FG001|Treatment Period|Lost to Follow-up|1|||
162986641|NCT01674647|588654892|FG000|Treatment Period|Withdrawal by Subject|19|||
162986642|NCT01674647|588654893|FG001|Treatment Period|Withdrawal by Subject|16|||
162986643|NCT01674647|588654892|FG000|Treatment Period|Switching to other therapy|5|||
162986644|NCT01674647|588654893|FG001|Treatment Period|Switching to other therapy|2|||
162986645|NCT01674647|588654892|FG000|Treatment Period|Logistical difficulties|5|||
162986646|NCT01674647|588654893|FG001|Treatment Period|Logistical difficulties|8|||
162986647|NCT01674647|588654892|FG000|Treatment Period|Treatment failure|0|||
162986648|NCT01674647|588654893|FG001|Treatment Period|Treatment failure|14|||
162986649|NCT01674647|588654892|FG000|Treatment Period|Protocol Violation|56|||
162986650|NCT01674647|588654893|FG001|Treatment Period|Protocol Violation|36|||
162986651|NCT01674647|588654892|FG000|30-day Safety Follow-up Period|Death|3|||
162986652|NCT01674647|588654893|FG001|30-day Safety Follow-up Period|Death|2|||
162986653|NCT01674647|588654892|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
162986654|NCT01674647|588654893|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
162986655|NCT01674647|588654892|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
162986656|NCT01674647|588654893|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
162986657|NCT01674647|588654892|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
162986658|NCT01674647|588654893|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
162986659|NCT01674647|588654892|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
162986660|NCT01674647|588654893|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
162986661|NCT01674647|588654892|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
162986662|NCT01674647|588654893|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
162986663|NCT01490866|588654896|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
162986664|NCT01490866|588654896|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
162986665|NCT01490866|588654896|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
162986666|NCT01490866|588654896|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
162986667|NCT01490866|588654896|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
162986668|NCT01490866|588654896|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
162986669|NCT01490866|588654896|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
162986670|NCT01490866|588654896|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
162986671|NCT01490866|588654896|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
162986672|NCT01490866|588654896|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
162986673|NCT01490866|588654896|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
162986674|NCT03923530|588654897|FG000|Overall Study|Withdrawal by Subject|1|||
162986675|NCT03923530|588654897|FG000|Overall Study|screen failure|3|||
162986676|NCT00741936|588654898|FG000|Overall Study|Lost to Follow-up|1|||
162986677|NCT00741936|588654899|FG001|Overall Study|Lost to Follow-up|1|||
162986678|NCT00741936|588654898|FG000|Overall Study|Adverse Event|3|||
162986679|NCT00741936|588654899|FG001|Overall Study|Adverse Event|4|||
162986680|NCT00741936|588654898|FG000|Overall Study|Pregnancy|0|||
162986681|NCT00741936|588654899|FG001|Overall Study|Pregnancy|1|||
162986682|NCT00741936|588654898|FG000|Overall Study|Protocol Violation|2|||
162986683|NCT00741936|588654899|FG001|Overall Study|Protocol Violation|0|||
162986684|NCT00741936|588654898|FG000|Overall Study|Lack of Efficacy|0|||
162986685|NCT00741936|588654899|FG001|Overall Study|Lack of Efficacy|2|||
162986686|NCT00741936|588654898|FG000|Overall Study|Low compliance|3|||
162986687|NCT00741936|588654899|FG001|Overall Study|Low compliance|0|||
162986688|NCT01941940|588654900|FG000|Overall Study|Adverse Event|11|||
162986689|NCT01941940|588654900|FG000|Overall Study|Lost to Follow-up|2|||
162986690|NCT01941940|588654900|FG000|Overall Study|Physician Decision|2|||
162986691|NCT01941940|588654900|FG000|Overall Study|Withdrawal by Subject|15|||
163323711|NCT03250676|589898125|FG000|Overall Study|Disease progression|4|||
162986692|NCT01941940|588654900|FG000|Overall Study|Death|1|||
162986693|NCT01941940|588654900|FG000|Overall Study|Other|1|||
162986694|NCT01941940|588654900|FG000|Overall Study|Other|1|||
162986695|NCT04135196|588654901|FG000|Overall Study|Lost to Follow-up|8|||
163323712|NCT03250676|589898126|FG001|Overall Study|Disease progression|12|||
163323713|NCT03250676|589898127|FG002|Overall Study|Disease progression|9|||
163323714|NCT03250676|589898128|FG003|Overall Study|Disease progression|7|||
163323715|NCT03250676|589898129|FG004|Overall Study|Disease progression|4|||
163323716|NCT03250676|589898130|FG005|Overall Study|Disease progression|88|||
162986696|NCT04135196|588654902|FG001|Overall Study|Lost to Follow-up|7|||
162986697|NCT04135196|588654903|FG002|Overall Study|Lost to Follow-up|8|||
162986698|NCT04135196|588654904|FG003|Overall Study|Lost to Follow-up|9|||
162986699|NCT04135196|588654905|FG004|Overall Study|Lost to Follow-up|1|||
162986700|NCT04135196|588654901|FG000|Overall Study|Pregnancy|0|||
163323717|NCT03512301|589898970|FG000|Overall Study|Protocol Violation|2|||
163323718|NCT03512301|589898970|FG000|Overall Study|Did Not Qualify|3|||
162986701|NCT04135196|588654902|FG001|Overall Study|Pregnancy|0|||
162986702|NCT04135196|588654903|FG002|Overall Study|Pregnancy|1|||
162986703|NCT04135196|588654904|FG003|Overall Study|Pregnancy|0|||
162986704|NCT04135196|588654905|FG004|Overall Study|Pregnancy|0|||
162986705|NCT04135196|588654901|FG000|Overall Study|Withdrawal by Subject|0|||
162986706|NCT04135196|588654902|FG001|Overall Study|Withdrawal by Subject|0|||
162986707|NCT04135196|588654903|FG002|Overall Study|Withdrawal by Subject|0|||
162986708|NCT04135196|588654904|FG003|Overall Study|Withdrawal by Subject|0|||
162986709|NCT04135196|588654905|FG004|Overall Study|Withdrawal by Subject|1|||
162986710|NCT03212521|588654906|FG000|Overall Study|Adverse Event|1|||
162986711|NCT03212521|588654906|FG000|Overall Study|Lost to Follow-up|4|||
162986712|NCT03212521|588654906|FG000|Overall Study|Withdrawal by Subject|1|||
162986713|NCT03212521|588654906|FG000|Overall Study|Other|1|||
162986714|NCT00914459|588654909|FG000|Overall Study|Protocol Violation|0|||
162986715|NCT00914459|588654910|FG001|Overall Study|Protocol Violation|1|||
162986716|NCT00914459|588654909|FG000|Overall Study|Parent/Legal guardian request|1|||
162986717|NCT00914459|588654910|FG001|Overall Study|Parent/Legal guardian request|0|||
162986718|NCT01661179|588654911|FG000|Overall Study|Death|1|||
162986719|NCT01661179|588654911|FG000|Overall Study|Withdrawal by Subject|1|||
162986720|NCT01661179|588654911|FG000|Overall Study|Other Eligibility criteria|4|||
162986721|NCT01946191|588654912|FG000|Allocation|Did not complete orientation|1|||
162986722|NCT01946191|588654913|FG001|Allocation|Did not complete orientation|1|||
162986723|NCT01946191|588654912|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
162986724|NCT01946191|588654913|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
162986725|NCT01946191|588654912|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
162986726|NCT01946191|588654913|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
162986727|NCT01946191|588654912|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
162986728|NCT01946191|588654913|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
162986729|NCT01083810|588654914|FG000|Overall Study|Lost to Follow-up|23|||
162986730|NCT01083810|588654915|FG001|Overall Study|Lost to Follow-up|11|||
162986731|NCT01083810|588654916|FG002|Overall Study|Lost to Follow-up|4|||
162986732|NCT01083810|588654914|FG000|Overall Study|Adverse Event|15|||
162986733|NCT01083810|588654915|FG001|Overall Study|Adverse Event|11|||
162986734|NCT01083810|588654916|FG002|Overall Study|Adverse Event|4|||
162986735|NCT01083810|588654914|FG000|Overall Study|Withdrawal by Subject|7|||
162986736|NCT01083810|588654915|FG001|Overall Study|Withdrawal by Subject|2|||
162986737|NCT01083810|588654916|FG002|Overall Study|Withdrawal by Subject|4|||
162986738|NCT01083810|588654914|FG000|Overall Study|Reason not reported|6|||
162986739|NCT01083810|588654915|FG001|Overall Study|Reason not reported|1|||
162986740|NCT01083810|588654916|FG002|Overall Study|Reason not reported|1|||
162986741|NCT01083810|588654914|FG000|Overall Study|Non-compliance|4|||
162986742|NCT01083810|588654915|FG001|Overall Study|Non-compliance|7|||
163212038|NCT02554812|589490725|FG018|Overall Study|Adverse Event|0|||
163212039|NCT02554812|589490726|FG019|Overall Study|Adverse Event|0|||
163212040|NCT02554812|589490727|FG020|Overall Study|Adverse Event|0|||
163212041|NCT02554812|589490728|FG021|Overall Study|Adverse Event|2|||
163212042|NCT02554812|589490729|FG022|Overall Study|Adverse Event|1|||
163212043|NCT02554812|589490730|FG023|Overall Study|Adverse Event|1|||
163212044|NCT02554812|589490731|FG024|Overall Study|Adverse Event|1|||
162986743|NCT01083810|588654916|FG002|Overall Study|Non-compliance|2|||
162986744|NCT01083810|588654914|FG000|Overall Study|Simplification|4|||
162986745|NCT01083810|588654915|FG001|Overall Study|Simplification|1|||
162986746|NCT01083810|588654916|FG002|Overall Study|Simplification|0|||
162986747|NCT01083810|588654914|FG000|Overall Study|Death|2|||
162986748|NCT01083810|588654915|FG001|Overall Study|Death|2|||
162986749|NCT01083810|588654916|FG002|Overall Study|Death|3|||
162986750|NCT01083810|588654914|FG000|Overall Study|Co-morbidities|1|||
162986751|NCT01083810|588654915|FG001|Overall Study|Co-morbidities|0|||
162986752|NCT01083810|588654916|FG002|Overall Study|Co-morbidities|0|||
162986753|NCT01083810|588654914|FG000|Overall Study|Participation in study|1|||
162986754|NCT01083810|588654915|FG001|Overall Study|Participation in study|0|||
162986755|NCT01083810|588654916|FG002|Overall Study|Participation in study|0|||
162986756|NCT01083810|588654914|FG000|Overall Study|Therapy break|1|||
162986757|NCT01083810|588654915|FG001|Overall Study|Therapy break|2|||
162986758|NCT01083810|588654916|FG002|Overall Study|Therapy break|2|||
162986759|NCT01083810|588654914|FG000|Overall Study|Virologic failure|1|||
162986760|NCT01083810|588654915|FG001|Overall Study|Virologic failure|8|||
162986761|NCT01083810|588654916|FG002|Overall Study|Virologic failure|0|||
162986762|NCT04941729|588657116|FG000|Overall Study|Death|0|||
162986763|NCT04941729|588657117|FG001|Overall Study|Death|1|||
162986764|NCT04941729|588657116|FG000|Overall Study|Study terminated by sponsor|11|||
163212045|NCT02554812|589490732|FG025|Overall Study|Adverse Event|2|||
162986765|NCT04941729|588657117|FG001|Overall Study|Study terminated by sponsor|10|||
162986766|NCT00006721|588657118|FG000|Overall Study|Adverse Event|0|||
162986767|NCT00006721|588657119|FG001|Overall Study|Adverse Event|4|||
162986768|NCT00006721|588657120|FG002|Overall Study|Adverse Event|4|||
162986769|NCT00006721|588657118|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
162986770|NCT00006721|588657119|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
163212046|NCT02554812|589490733|FG026|Overall Study|Adverse Event|1|||
163059878|NCT00851591|588928246|FG001|Overall Study|Withdrawal by Subject|0|||
163059879|NCT02736617|588928247|FG000|Treatment|Adverse Event|1|||
163059880|NCT02736617|588928247|FG000|Treatment|Lack of Efficacy|1|||
163059881|NCT02736617|588928247|FG000|Treatment|Withdrawal by Subject|1|||
162986771|NCT00006721|588657120|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
162986772|NCT00006721|588657118|FG000|Overall Study|Progression/Relapse|0|||
162986773|NCT00006721|588657119|FG001|Overall Study|Progression/Relapse|1|||
162986774|NCT00006721|588657120|FG002|Overall Study|Progression/Relapse|2|||
162986775|NCT00006721|588657118|FG000|Overall Study|Death|0|||
162986776|NCT00006721|588657119|FG001|Overall Study|Death|1|||
162986777|NCT00006721|588657120|FG002|Overall Study|Death|2|||
162986778|NCT00006721|588657118|FG000|Overall Study|Other - Not Protocol Specified|0|||
162986779|NCT00006721|588657119|FG001|Overall Study|Other - Not Protocol Specified|7|||
162986780|NCT00006721|588657120|FG002|Overall Study|Other - Not Protocol Specified|7|||
162986781|NCT00006721|588657118|FG000|Overall Study|Ineligible|2|||
162986782|NCT00006721|588657119|FG001|Overall Study|Ineligible|12|||
162986783|NCT00006721|588657120|FG002|Overall Study|Ineligible|10|||
162986784|NCT00006721|588657118|FG000|Overall Study|Eligible but no Treatment Received|1|||
162986785|NCT00006721|588657119|FG001|Overall Study|Eligible but no Treatment Received|0|||
162986786|NCT00006721|588657120|FG002|Overall Study|Eligible but no Treatment Received|0|||
162986787|NCT03845296|588657121|FG000|Overall Study|On Treatment|2|||
162986788|NCT03845296|588657122|FG001|Overall Study|On Treatment|1|||
162986789|NCT03845296|588657121|FG000|Overall Study|Adverse Event|4|||
162986790|NCT03845296|588657122|FG001|Overall Study|Adverse Event|11|||
162986791|NCT03845296|588657121|FG000|Overall Study|Refusal unrelated to adverse event|0|||
162986792|NCT03845296|588657122|FG001|Overall Study|Refusal unrelated to adverse event|1|||
162986793|NCT03845296|588657121|FG000|Overall Study|Progression/relapse|14|||
162986794|NCT03845296|588657122|FG001|Overall Study|Progression/relapse|18|||
162986795|NCT03845296|588657121|FG000|Overall Study|Death|4|||
162986796|NCT03845296|588657122|FG001|Overall Study|Death|0|||
162986797|NCT03845296|588657121|FG000|Overall Study|Other - not protocol specified|1|||
162986798|NCT03845296|588657122|FG001|Overall Study|Other - not protocol specified|3|||
162986799|NCT05424042|588657123|FG000|Overall Study|Withdrawal by Subject|2|||
162986800|NCT05424042|588657124|FG001|Overall Study|Withdrawal by Subject|0|||
162986801|NCT05424042|588657125|FG002|Overall Study|Withdrawal by Subject|4|||
162986802|NCT05424042|588657123|FG000|Overall Study|Lost to Follow-up|0|||
162986803|NCT05424042|588657124|FG001|Overall Study|Lost to Follow-up|0|||
162986804|NCT05424042|588657125|FG002|Overall Study|Lost to Follow-up|1|||
162986805|NCT05091307|588657126|FG000|Overall Study|Death|0|||
162986806|NCT05091307|588657127|FG001|Overall Study|Death|0|||
162986807|NCT05091307|588657128|FG002|Overall Study|Death|1|||
162986808|NCT05091307|588657129|FG003|Overall Study|Death|0|||
162986809|NCT05091307|588657126|FG000|Overall Study|Lost to Follow-up|33|||
162986810|NCT05091307|588657127|FG001|Overall Study|Lost to Follow-up|33|||
162986811|NCT05091307|588657128|FG002|Overall Study|Lost to Follow-up|2|||
162986812|NCT05091307|588657129|FG003|Overall Study|Lost to Follow-up|0|||
162986813|NCT05091307|588657126|FG000|Overall Study|Physician Decision|1|||
162986814|NCT05091307|588657127|FG001|Overall Study|Physician Decision|0|||
162986815|NCT05091307|588657128|FG002|Overall Study|Physician Decision|0|||
162986816|NCT05091307|588657129|FG003|Overall Study|Physician Decision|0|||
162986817|NCT05091307|588657126|FG000|Overall Study|Protocol Violation|1|||
162986818|NCT05091307|588657127|FG001|Overall Study|Protocol Violation|0|||
162986819|NCT05091307|588657128|FG002|Overall Study|Protocol Violation|0|||
163059882|NCT02736617|588928247|FG000|Maintenance|Lack of Efficacy|4|||
163059883|NCT02736617|588928247|FG000|Maintenance|Physician Decision|1|||
163059884|NCT00481676|588928250|FG000|Overall Study|Adverse Event|0|||
163059885|NCT00481676|588928251|FG001|Overall Study|Adverse Event|1|||
163059886|NCT00481676|588928250|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163212047|NCT02554812|589490707|FG000|Overall Study|Death|1|||
162986820|NCT05091307|588657129|FG003|Overall Study|Protocol Violation|0|||
162986821|NCT05091307|588657126|FG000|Overall Study|Withdrawal by Subject|16|||
162986822|NCT05091307|588657127|FG001|Overall Study|Withdrawal by Subject|16|||
163059887|NCT00481676|588928251|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
163059888|NCT00481676|588928250|FG000|Overall Study|Administrative problem|1|||
163059889|NCT00481676|588928251|FG001|Overall Study|Administrative problem|0|||
162986823|NCT05091307|588657128|FG002|Overall Study|Withdrawal by Subject|0|||
162986824|NCT05091307|588657129|FG003|Overall Study|Withdrawal by Subject|1|||
162986825|NCT05091307|588657126|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
162986826|NCT05091307|588657127|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
162986827|NCT05091307|588657128|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
162986828|NCT05091307|588657129|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
162986829|NCT05091307|588657126|FG000|Overall Study|Initiated Prohibited Medication|1|||
163212048|NCT02554812|589490708|FG001|Overall Study|Death|2|||
163059890|NCT02911116|588928252|FG000|Overall Study|Insufficient Therapeutic Response|1|||
163059891|NCT02911116|588928253|FG001|Overall Study|Insufficient Therapeutic Response|0|||
163059892|NCT02911116|588928252|FG000|Overall Study|Lost to Follow-up|0|||
163212049|NCT02554812|589490709|FG002|Overall Study|Death|2|||
163212050|NCT02554812|589490710|FG003|Overall Study|Death|2|||
163212051|NCT02554812|589490711|FG004|Overall Study|Death|0|||
162986830|NCT05091307|588657127|FG001|Overall Study|Initiated Prohibited Medication|0|||
162986831|NCT05091307|588657128|FG002|Overall Study|Initiated Prohibited Medication|0|||
162986832|NCT05091307|588657129|FG003|Overall Study|Initiated Prohibited Medication|0|||
162986833|NCT05091307|588657126|FG000|Overall Study|Other|4|||
162986834|NCT05091307|588657127|FG001|Overall Study|Other|4|||
162986835|NCT05091307|588657128|FG002|Overall Study|Other|0|||
162986836|NCT05091307|588657129|FG003|Overall Study|Other|0|||
162986837|NCT05091307|588657126|FG000|Overall Study|Randomized but not vaccinated|0|||
162986838|NCT05091307|588657127|FG001|Overall Study|Randomized but not vaccinated|2|||
162986839|NCT05091307|588657128|FG002|Overall Study|Randomized but not vaccinated|0|||
162986840|NCT05091307|588657129|FG003|Overall Study|Randomized but not vaccinated|0|||
162986841|NCT00379340|588657132|FG000|Overall Study|Death|0|||
162986842|NCT00379340|588657133|FG001|Overall Study|Death|0|||
162986843|NCT00379340|588657134|FG002|Overall Study|Death|0|||
162986844|NCT00379340|588657135|FG003|Overall Study|Death|2|||
162986845|NCT00379340|588657136|FG004|Overall Study|Death|0|||
162986846|NCT00379340|588657132|FG000|Overall Study|Lack of Efficacy|6|||
162986847|NCT00379340|588657133|FG001|Overall Study|Lack of Efficacy|1|||
162986848|NCT00379340|588657134|FG002|Overall Study|Lack of Efficacy|0|||
162986849|NCT00379340|588657135|FG003|Overall Study|Lack of Efficacy|4|||
162986850|NCT00379340|588657136|FG004|Overall Study|Lack of Efficacy|3|||
162986851|NCT00379340|588657132|FG000|Overall Study|Physician Decision|6|||
162986852|NCT00379340|588657133|FG001|Overall Study|Physician Decision|2|||
162986853|NCT00379340|588657134|FG002|Overall Study|Physician Decision|1|||
162986854|NCT00379340|588657135|FG003|Overall Study|Physician Decision|2|||
162986855|NCT00379340|588657136|FG004|Overall Study|Physician Decision|3|||
162986856|NCT00379340|588657132|FG000|Overall Study|Withdrawal by Subject|0|||
162986857|NCT00379340|588657133|FG001|Overall Study|Withdrawal by Subject|0|||
162986858|NCT00379340|588657134|FG002|Overall Study|Withdrawal by Subject|0|||
162986859|NCT00379340|588657135|FG003|Overall Study|Withdrawal by Subject|1|||
162986860|NCT00379340|588657136|FG004|Overall Study|Withdrawal by Subject|0|||
162986861|NCT00379340|588657132|FG000|Overall Study|Refusal of further protocol therapy|1|||
162986862|NCT00379340|588657133|FG001|Overall Study|Refusal of further protocol therapy|0|||
162986863|NCT00379340|588657134|FG002|Overall Study|Refusal of further protocol therapy|1|||
162986864|NCT00379340|588657135|FG003|Overall Study|Refusal of further protocol therapy|1|||
162986865|NCT00379340|588657136|FG004|Overall Study|Refusal of further protocol therapy|7|||
162986866|NCT00379340|588657132|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
162986867|NCT00379340|588657133|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
162986868|NCT00379340|588657134|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
162986869|NCT00379340|588657135|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
162986870|NCT00379340|588657136|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
162986871|NCT00379340|588657132|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
162986872|NCT00379340|588657133|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
162986873|NCT00379340|588657134|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
162986874|NCT00379340|588657135|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
162986875|NCT00379340|588657136|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
162986876|NCT01167257|588657137|FG000|Overall Study|Lost to Follow-up|2|||
162986877|NCT01167257|588657138|FG001|Overall Study|Lost to Follow-up|2|||
162986878|NCT01167257|588657137|FG000|Overall Study|Withdrew consent|1|||
162986879|NCT01167257|588657138|FG001|Overall Study|Withdrew consent|1|||
162986880|NCT01367665|588657139|FG000|Overall Study|Death|102|||
162986881|NCT01367665|588657140|FG001|Overall Study|Death|19|||
162986882|NCT01367665|588657139|FG000|Overall Study|Lost to Follow-up|222|||
162986883|NCT01367665|588657140|FG001|Overall Study|Lost to Follow-up|22|||
162986884|NCT01367665|588657139|FG000|Overall Study|Not Done|118|||
162986885|NCT01367665|588657140|FG001|Overall Study|Not Done|14|||
162986886|NCT02752906|588657141|FG000|Overall Study|Protocol Violation|2|||
162986887|NCT02752906|588657142|FG001|Overall Study|Protocol Violation|1|||
162986888|NCT02752906|588657141|FG000|Overall Study|Withdrawal by Subject|2|||
162986889|NCT02752906|588657142|FG001|Overall Study|Withdrawal by Subject|2|||
162986890|NCT02752906|588657141|FG000|Overall Study|Lost to Follow-up|3|||
162986891|NCT02752906|588657142|FG001|Overall Study|Lost to Follow-up|2|||
162986892|NCT03283319|588657143|FG000|Overall Study|Lost to Follow-up|5|||
162986893|NCT03283319|588657144|FG001|Overall Study|Lost to Follow-up|4|||
162986894|NCT03283319|588657145|FG002|Overall Study|Lost to Follow-up|5|||
162986895|NCT03283319|588657146|FG003|Overall Study|Lost to Follow-up|5|||
162986896|NCT03283319|588657147|FG004|Overall Study|Lost to Follow-up|4|||
162986897|NCT03283319|588657148|FG005|Overall Study|Lost to Follow-up|3|||
162986898|NCT03283319|588657143|FG000|Overall Study|Withdrawal by Subject|2|||
162986899|NCT03283319|588657144|FG001|Overall Study|Withdrawal by Subject|2|||
162986900|NCT03283319|588657145|FG002|Overall Study|Withdrawal by Subject|2|||
162986901|NCT03283319|588657146|FG003|Overall Study|Withdrawal by Subject|1|||
162986902|NCT03283319|588657147|FG004|Overall Study|Withdrawal by Subject|0|||
162986903|NCT03283319|588657148|FG005|Overall Study|Withdrawal by Subject|1|||
162986904|NCT03283319|588657143|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
162986905|NCT03283319|588657144|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
162986906|NCT03283319|588657145|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
162986907|NCT03283319|588657146|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
162986908|NCT03283319|588657147|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
162986909|NCT03283319|588657148|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
162986910|NCT01007942|588657160|FG000|Overall Study|Adverse Event|29|||
162986911|NCT01007942|588657161|FG001|Overall Study|Adverse Event|14|||
162986912|NCT01007942|588657160|FG000|Overall Study|Abnormal test procedure|0|||
162986913|NCT01007942|588657161|FG001|Overall Study|Abnormal test procedure|1|||
162986914|NCT01007942|588657160|FG000|Overall Study|Disease progression|217|||
162986915|NCT01007942|588657161|FG001|Overall Study|Disease progression|242|||
162986916|NCT01007942|588657160|FG000|Overall Study|New cancer therapy|5|||
162986917|NCT01007942|588657161|FG001|Overall Study|New cancer therapy|1|||
162986918|NCT01007942|588657160|FG000|Overall Study|Protocol Violation|1|||
162986919|NCT01007942|588657161|FG001|Overall Study|Protocol Violation|1|||
162986920|NCT01007942|588657160|FG000|Overall Study|Withdrawal by Subject|19|||
162986921|NCT01007942|588657161|FG001|Overall Study|Withdrawal by Subject|14|||
162986922|NCT01007942|588657160|FG000|Overall Study|Lost to Follow-up|1|||
162986923|NCT01007942|588657161|FG001|Overall Study|Lost to Follow-up|0|||
162986924|NCT01007942|588657160|FG000|Overall Study|Administrative problems|2|||
162986925|NCT01007942|588657161|FG001|Overall Study|Administrative problems|0|||
162986926|NCT01007942|588657160|FG000|Overall Study|Death|3|||
162986927|NCT01007942|588657161|FG001|Overall Study|Death|2|||
162986928|NCT01007942|588657160|FG000|Overall Study|Patients untreated|4|||
162986929|NCT01007942|588657161|FG001|Overall Study|Patients untreated|3|||
162986930|NCT04492020|588657162|FG000|Overall Study|Adverse Event|1|||
162986931|NCT04492020|588657163|FG001|Overall Study|Adverse Event|3|||
162986932|NCT04492020|588657162|FG000|Overall Study|Withdrawal by Subject|4|||
162986933|NCT04492020|588657163|FG001|Overall Study|Withdrawal by Subject|3|||
162986934|NCT04492020|588657162|FG000|Overall Study|Lost to Follow-up|4|||
162986935|NCT04492020|588657163|FG001|Overall Study|Lost to Follow-up|3|||
162986936|NCT04492020|588657162|FG000|Overall Study|Protocol Violation|5|||
162986937|NCT04492020|588657163|FG001|Overall Study|Protocol Violation|2|||
162986938|NCT04492020|588657162|FG000|Overall Study|Lack of Qualifying Event|25|||
162986939|NCT04492020|588657163|FG001|Overall Study|Lack of Qualifying Event|27|||
162986940|NCT04492020|588657162|FG000|Overall Study|Non-compliance with Study Drug|2|||
162986941|NCT04492020|588657163|FG001|Overall Study|Non-compliance with Study Drug|1|||
162986942|NCT03412396|588657164|FG000|Overall Study|Withdrawal by Subject|2|||
162986943|NCT03412396|588657164|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
162986944|NCT03412396|588657164|FG000|Overall Study|Did not undergo RP|2|||
162986945|NCT01175811|588657165|FG000|Overall Study|Adverse Event|1|||
162986946|NCT01175811|588657166|FG001|Overall Study|Adverse Event|1|||
162986947|NCT01175811|588657165|FG000|Overall Study|Entry criteria not met|3|||
162986948|NCT01175811|588657166|FG001|Overall Study|Entry criteria not met|1|||
162986949|NCT01175811|588657165|FG000|Overall Study|Lack of Efficacy|1|||
162986950|NCT01175811|588657166|FG001|Overall Study|Lack of Efficacy|0|||
162986951|NCT01175811|588657165|FG000|Overall Study|Lost to Follow-up|3|||
162986952|NCT01175811|588657166|FG001|Overall Study|Lost to Follow-up|2|||
162986953|NCT01175811|588657165|FG000|Overall Study|Physician Decision|1|||
162986954|NCT01175811|588657166|FG001|Overall Study|Physician Decision|1|||
162986955|NCT01175811|588657165|FG000|Overall Study|Protocol Violation|1|||
162986956|NCT01175811|588657166|FG001|Overall Study|Protocol Violation|2|||
162986957|NCT01175811|588657165|FG000|Overall Study|Withdrawal by Subject|6|||
162986958|NCT01175811|588657166|FG001|Overall Study|Withdrawal by Subject|7|||
162986959|NCT04715932|588657169|FG000|Overall Study|Lost to Follow-up|1|||
162986960|NCT04715932|588657170|FG001|Overall Study|Lost to Follow-up|0|||
162986961|NCT03560986|588657171|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
162986962|NCT03560986|588657172|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
162986963|NCT03560986|588657171|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
162986964|NCT03560986|588657172|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
162986965|NCT03560986|588657171|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
162986966|NCT03560986|588657172|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
162986967|NCT03560986|588657171|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
163323719|NCT03512301|589898970|FG000|Overall Study|Age-ineligible|1|||
163323720|NCT03512301|589898970|FG000|Overall Study|Inadequate fluency with the English language|3|||
163323721|NCT02231749|589898984|FG000|Overall Study|Disease progression|229|||
163323722|NCT02231749|589898985|FG001|Overall Study|Disease progression|297|||
162986968|NCT03560986|588657172|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
162986969|NCT03560986|588657171|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
162986970|NCT03560986|588657172|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
162986971|NCT03560986|588657171|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
162986972|NCT03560986|588657172|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
162986973|NCT03560986|588657171|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
162986974|NCT03560986|588657172|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
162986975|NCT00655876|588657173|FG000|Overall Study|Protocol Violation|9|||
163323723|NCT02231749|589898984|FG000|Overall Study|Study Drug Toxicity|134|||
162986976|NCT00655876|588657174|FG001|Overall Study|Protocol Violation|7|||
162986977|NCT00326963|588657175|FG000|Overall Study|Adverse Event|2|||
162986978|NCT00326963|588657175|FG000|Overall Study|Injection site reaction|1|||
162986979|NCT00326963|588657175|FG000|Overall Study|Death|1|||
162986980|NCT00326963|588657175|FG000|Overall Study|Failure to return|10|||
162986981|NCT00326963|588657175|FG000|Overall Study|Withdrawal by Subject|10|||
162986982|NCT00326963|588657175|FG000|Overall Study|Refused treatment / did not cooperate|5|||
162986983|NCT00326963|588657175|FG000|Overall Study|Violation of selection criteria at entry|2|||
162986984|NCT00326963|588657175|FG000|Overall Study|Other protocol violation|1|||
162986985|NCT00326963|588657175|FG000|Overall Study|Administrative / other|1|||
162986986|NCT00699374|588657178|FG000|Overall Study|Death|93|||
162986987|NCT00699374|588657179|FG001|Overall Study|Death|83|||
162986988|NCT00699374|588657178|FG000|Overall Study|Adverse Event|70|||
162986989|NCT00699374|588657179|FG001|Overall Study|Adverse Event|67|||
162986990|NCT00699374|588657178|FG000|Overall Study|Global deterioration of health status|7|||
162986991|NCT00699374|588657179|FG001|Overall Study|Global deterioration of health status|8|||
162986992|NCT00699374|588657178|FG000|Overall Study|Lost to Follow-up|3|||
162986993|NCT00699374|588657179|FG001|Overall Study|Lost to Follow-up|5|||
162986994|NCT00699374|588657178|FG000|Overall Study|Withdrawal by Subject|34|||
162986995|NCT00699374|588657179|FG001|Overall Study|Withdrawal by Subject|44|||
162986996|NCT00699374|588657178|FG000|Overall Study|Objective progression or relapse|281|||
162986997|NCT00699374|588657179|FG001|Overall Study|Objective progression or relapse|277|||
162986998|NCT00699374|588657178|FG000|Overall Study|Other|18|||
162986999|NCT00699374|588657179|FG001|Overall Study|Other|15|||
162987000|NCT00699374|588657178|FG000|Overall Study|Protocol Violation|2|||
162987001|NCT00699374|588657179|FG001|Overall Study|Protocol Violation|6|||
162987002|NCT00699374|588657178|FG000|Overall Study|Study terminated by sponsor|13|||
162987003|NCT00699374|588657179|FG001|Overall Study|Study terminated by sponsor|28|||
162987004|NCT00699374|588657178|FG000|Overall Study|Randomized but not treated|4|||
162987005|NCT00699374|588657179|FG001|Overall Study|Randomized but not treated|2|||
162987006|NCT00699374|588657178|FG000|Overall Study|Died 28 days after last dose|5|||
162987007|NCT00699374|588657179|FG001|Overall Study|Died 28 days after last dose|9|||
162987008|NCT01783548|588657183|FG000|Overall Study|Adverse Event|8|||
162987009|NCT01783548|588657184|FG001|Overall Study|Adverse Event|4|||
162987010|NCT01783548|588657183|FG000|Overall Study|Withdrawal by Subject|11|||
162987011|NCT01783548|588657184|FG001|Overall Study|Withdrawal by Subject|8|||
162987012|NCT01783548|588657183|FG000|Overall Study|Non-compliance|4|||
162987013|NCT01783548|588657184|FG001|Overall Study|Non-compliance|0|||
162987014|NCT01783548|588657183|FG000|Overall Study|Protocol Violation|2|||
162987015|NCT01783548|588657184|FG001|Overall Study|Protocol Violation|2|||
162987016|NCT01783548|588657183|FG000|Overall Study|Lost to Follow-up|8|||
162987017|NCT01783548|588657184|FG001|Overall Study|Lost to Follow-up|3|||
162987018|NCT01783548|588657183|FG000|Overall Study|Lack of Efficacy|1|||
162987019|NCT01783548|588657184|FG001|Overall Study|Lack of Efficacy|1|||
162987020|NCT04645966|588657185|FG000|Vaccination Phase|Adverse Event|1|||
162987021|NCT04645966|588657186|FG001|Vaccination Phase|Adverse Event|0|||
162987022|NCT04645966|588657187|FG002|Vaccination Phase|Adverse Event|0|||
162987023|NCT04645966|588657188|FG003|Vaccination Phase|Adverse Event|0|||
162987024|NCT04645966|588657189|FG004|Vaccination Phase|Adverse Event|0|||
162987025|NCT04645966|588657190|FG005|Vaccination Phase|Adverse Event|0|||
162987026|NCT04645966|588657191|FG006|Vaccination Phase|Adverse Event|1|||
162987027|NCT04645966|588657192|FG007|Vaccination Phase|Adverse Event|0|||
162987028|NCT04645966|588657193|FG008|Vaccination Phase|Adverse Event|0|||
162987029|NCT04645966|588657185|FG000|Vaccination Phase|Death|0|||
162987030|NCT04645966|588657186|FG001|Vaccination Phase|Death|0|||
162987031|NCT04645966|588657187|FG002|Vaccination Phase|Death|0|||
162987032|NCT04645966|588657188|FG003|Vaccination Phase|Death|0|||
162987033|NCT04645966|588657189|FG004|Vaccination Phase|Death|0|||
162987034|NCT04645966|588657190|FG005|Vaccination Phase|Death|1|||
163403768|NCT01624662|590188691|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
163403769|NCT01624662|590188688|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
162987035|NCT04645966|588657191|FG006|Vaccination Phase|Death|0|||
162987036|NCT04645966|588657192|FG007|Vaccination Phase|Death|0|||
162987037|NCT04645966|588657193|FG008|Vaccination Phase|Death|0|||
162987038|NCT04645966|588657185|FG000|Vaccination Phase|Protocol Violation|0|||
162987039|NCT04645966|588657186|FG001|Vaccination Phase|Protocol Violation|0|||
162987040|NCT04645966|588657187|FG002|Vaccination Phase|Protocol Violation|0|||
162987041|NCT04645966|588657188|FG003|Vaccination Phase|Protocol Violation|0|||
162987042|NCT04645966|588657189|FG004|Vaccination Phase|Protocol Violation|1|||
162987043|NCT04645966|588657190|FG005|Vaccination Phase|Protocol Violation|0|||
162987044|NCT04645966|588657191|FG006|Vaccination Phase|Protocol Violation|0|||
162987045|NCT04645966|588657192|FG007|Vaccination Phase|Protocol Violation|0|||
162987046|NCT04645966|588657193|FG008|Vaccination Phase|Protocol Violation|0|||
162987047|NCT04645966|588657185|FG000|Vaccination Phase|Study terminated by sponsor|0|||
162987048|NCT04645966|588657186|FG001|Vaccination Phase|Study terminated by sponsor|0|||
162987049|NCT04645966|588657187|FG002|Vaccination Phase|Study terminated by sponsor|14|||
162987050|NCT04645966|588657188|FG003|Vaccination Phase|Study terminated by sponsor|15|||
163212052|NCT02554812|589490712|FG005|Overall Study|Death|1|||
163212053|NCT02554812|589490713|FG006|Overall Study|Death|1|||
163212054|NCT02554812|589490714|FG007|Overall Study|Death|1|||
163212055|NCT02554812|589490715|FG008|Overall Study|Death|0|||
162987051|NCT04645966|588657189|FG004|Vaccination Phase|Study terminated by sponsor|47|||
162987052|NCT04645966|588657190|FG005|Vaccination Phase|Study terminated by sponsor|43|||
162987053|NCT04645966|588657191|FG006|Vaccination Phase|Study terminated by sponsor|29|||
162987054|NCT04645966|588657192|FG007|Vaccination Phase|Study terminated by sponsor|29|||
162987055|NCT04645966|588657193|FG008|Vaccination Phase|Study terminated by sponsor|12|||
162987056|NCT04645966|588657185|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
162987057|NCT04645966|588657186|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
162987058|NCT04645966|588657187|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
162987059|NCT04645966|588657188|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
162987060|NCT04645966|588657189|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
162987061|NCT04645966|588657190|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
162987062|NCT04645966|588657191|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
162987063|NCT04645966|588657192|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
162987064|NCT04645966|588657193|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
162987065|NCT04645966|588657185|FG000|Vaccination Phase|Other|0|||
162987066|NCT04645966|588657186|FG001|Vaccination Phase|Other|0|||
162987067|NCT04645966|588657187|FG002|Vaccination Phase|Other|0|||
162987068|NCT04645966|588657188|FG003|Vaccination Phase|Other|0|||
162987069|NCT04645966|588657189|FG004|Vaccination Phase|Other|0|||
162987070|NCT04645966|588657190|FG005|Vaccination Phase|Other|2|||
162987071|NCT04645966|588657191|FG006|Vaccination Phase|Other|0|||
162987072|NCT04645966|588657192|FG007|Vaccination Phase|Other|0|||
162987073|NCT04645966|588657193|FG008|Vaccination Phase|Other|0|||
162987074|NCT04645966|588657185|FG000|Vaccination Phase|Lost to Follow-up|0|||
162987075|NCT04645966|588657186|FG001|Vaccination Phase|Lost to Follow-up|0|||
162987076|NCT04645966|588657187|FG002|Vaccination Phase|Lost to Follow-up|0|||
162987077|NCT04645966|588657188|FG003|Vaccination Phase|Lost to Follow-up|0|||
162987078|NCT04645966|588657189|FG004|Vaccination Phase|Lost to Follow-up|0|||
162987079|NCT04645966|588657190|FG005|Vaccination Phase|Lost to Follow-up|0|||
162987080|NCT04645966|588657191|FG006|Vaccination Phase|Lost to Follow-up|0|||
162987081|NCT04645966|588657192|FG007|Vaccination Phase|Lost to Follow-up|1|||
162987082|NCT04645966|588657193|FG008|Vaccination Phase|Lost to Follow-up|0|||
162987083|NCT04645966|588657185|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
162987084|NCT04645966|588657186|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
162987085|NCT04645966|588657187|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
162987086|NCT04645966|588657188|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
162987087|NCT04645966|588657189|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
162987088|NCT04645966|588657190|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
162987089|NCT04645966|588657191|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
162987090|NCT04645966|588657192|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
162987091|NCT04645966|588657193|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
162987092|NCT04645966|588657185|FG000|Follow-up Phase|Lost to Follow-up|0|||
162987093|NCT04645966|588657186|FG001|Follow-up Phase|Lost to Follow-up|0|||
162987094|NCT04645966|588657187|FG002|Follow-up Phase|Lost to Follow-up|0|||
162987095|NCT04645966|588657188|FG003|Follow-up Phase|Lost to Follow-up|0|||
162987096|NCT04645966|588657189|FG004|Follow-up Phase|Lost to Follow-up|0|||
162987097|NCT04645966|588657190|FG005|Follow-up Phase|Lost to Follow-up|0|||
162987098|NCT04645966|588657191|FG006|Follow-up Phase|Lost to Follow-up|0|||
162987099|NCT04645966|588657192|FG007|Follow-up Phase|Lost to Follow-up|1|||
162987100|NCT04645966|588657193|FG008|Follow-up Phase|Lost to Follow-up|0|||
162987101|NCT00552578|588657197|FG000|Overall Study|Lost to Follow-up|1|||
162987102|NCT00552578|588657198|FG001|Overall Study|Lost to Follow-up|1|||
162987103|NCT04729309|588657201|FG000|Period 1|Subject unable to return for Period 2|3|||
163212056|NCT02554812|589490716|FG009|Overall Study|Death|0|||
162987104|NCT04729309|588657202|FG001|Period 1|Subject unable to return for Period 2|0|||
162987105|NCT04729309|588657201|FG000|Period 1|Lost to Follow-up|1|||
162987106|NCT04729309|588657202|FG001|Period 1|Lost to Follow-up|0|||
162987107|NCT01059539|588657203|FG000|Overall Study|Adverse Event|66|||
162987108|NCT01059539|588657203|FG000|Overall Study|Insufficient Therapeutic Response|26|||
162987109|NCT01059539|588657203|FG000|Overall Study|Protocol Violation|55|||
162987110|NCT01059539|588657203|FG000|Overall Study|Withdrawal of Consent|80|||
162987111|NCT01059539|588657203|FG000|Overall Study|Lost to Follow-up|42|||
162987112|NCT01059539|588657203|FG000|Overall Study|Reason Not Specified|2|||
162987113|NCT04091659|588657207|FG000|Overall Study|Protocol Violation|3|||
162987114|NCT04091659|588657208|FG001|Overall Study|Protocol Violation|0|||
162987115|NCT04091659|588657207|FG000|Overall Study|Lost to Follow-up|0|||
162987116|NCT04091659|588657208|FG001|Overall Study|Lost to Follow-up|1|||
162987117|NCT00895947|588657209|FG000|Overall Study|Adverse Event|3|||
163212057|NCT02554812|589490717|FG010|Overall Study|Death|0|||
163212058|NCT02554812|589490718|FG011|Overall Study|Death|0|||
163212059|NCT02554812|589490719|FG012|Overall Study|Death|0|||
163212060|NCT02554812|589490720|FG013|Overall Study|Death|0|||
163212061|NCT02554812|589490721|FG014|Overall Study|Death|1|||
163403770|NCT01624662|590188689|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
162987118|NCT00895947|588657210|FG001|Overall Study|Adverse Event|4|||
162987119|NCT00895947|588657209|FG000|Overall Study|Lost to Follow-up|3|||
162987120|NCT00895947|588657210|FG001|Overall Study|Lost to Follow-up|4|||
162987121|NCT00895947|588657209|FG000|Overall Study|Protocol Violation|4|||
162987122|NCT00895947|588657210|FG001|Overall Study|Protocol Violation|2|||
162987123|NCT00895947|588657209|FG000|Overall Study|Withdrawal by Subject|2|||
162987124|NCT00895947|588657210|FG001|Overall Study|Withdrawal by Subject|0|||
162987125|NCT00616629|588657219|FG000|Overall Study|Protocol Violation|1|||
162987126|NCT00616629|588657220|FG001|Overall Study|Protocol Violation|2|||
162987127|NCT00616629|588657221|FG002|Overall Study|Protocol Violation|1|||
162987128|NCT00616629|588657222|FG003|Overall Study|Protocol Violation|0|||
162987129|NCT00616629|588657223|FG004|Overall Study|Protocol Violation|0|||
162987130|NCT00616629|588657219|FG000|Overall Study|AV-block|1|||
162987131|NCT00616629|588657220|FG001|Overall Study|AV-block|0|||
162987132|NCT00616629|588657221|FG002|Overall Study|AV-block|0|||
162987133|NCT00616629|588657222|FG003|Overall Study|AV-block|0|||
162987134|NCT00616629|588657223|FG004|Overall Study|AV-block|0|||
162987135|NCT01739348|588657224|FG000|Part I (Base Study)|Adverse Event|41|||
162987136|NCT01739348|588657225|FG001|Part I (Base Study)|Adverse Event|52|||
162987137|NCT01739348|588657226|FG002|Part I (Base Study)|Adverse Event|8|||
162987138|NCT01739348|588657227|FG003|Part I (Base Study)|Adverse Event|33|||
162987139|NCT01739348|588657224|FG000|Part I (Base Study)|Death|10|||
162987140|NCT01739348|588657225|FG001|Part I (Base Study)|Death|7|||
162987141|NCT01739348|588657226|FG002|Part I (Base Study)|Death|2|||
162987142|NCT01739348|588657227|FG003|Part I (Base Study)|Death|8|||
162987143|NCT01739348|588657224|FG000|Part I (Base Study)|Lack of Efficacy|3|||
162987144|NCT01739348|588657225|FG001|Part I (Base Study)|Lack of Efficacy|8|||
162987145|NCT01739348|588657226|FG002|Part I (Base Study)|Lack of Efficacy|0|||
162987146|NCT01739348|588657227|FG003|Part I (Base Study)|Lack of Efficacy|7|||
162987147|NCT01739348|588657224|FG000|Part I (Base Study)|Lost to Follow-up|4|||
162987148|NCT01739348|588657225|FG001|Part I (Base Study)|Lost to Follow-up|2|||
162987149|NCT01739348|588657226|FG002|Part I (Base Study)|Lost to Follow-up|4|||
162987150|NCT01739348|588657227|FG003|Part I (Base Study)|Lost to Follow-up|4|||
162987151|NCT01739348|588657224|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
162987152|NCT01739348|588657225|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
162987153|NCT01739348|588657226|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
162987154|NCT01739348|588657227|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
162987155|NCT01739348|588657224|FG000|Part I (Base Study)|Physician Decision|10|||
162987156|NCT01739348|588657225|FG001|Part I (Base Study)|Physician Decision|7|||
162987157|NCT01739348|588657226|FG002|Part I (Base Study)|Physician Decision|1|||
162987158|NCT01739348|588657227|FG003|Part I (Base Study)|Physician Decision|4|||
162987159|NCT01739348|588657224|FG000|Part I (Base Study)|Protocol Violation|2|||
162987160|NCT01739348|588657225|FG001|Part I (Base Study)|Protocol Violation|0|||
162987161|NCT01739348|588657226|FG002|Part I (Base Study)|Protocol Violation|1|||
162987162|NCT01739348|588657227|FG003|Part I (Base Study)|Protocol Violation|2|||
162987163|NCT01739348|588657224|FG000|Part I (Base Study)|Screen Failure|2|||
162987164|NCT01739348|588657225|FG001|Part I (Base Study)|Screen Failure|0|||
162987165|NCT01739348|588657226|FG002|Part I (Base Study)|Screen Failure|0|||
162987166|NCT01739348|588657227|FG003|Part I (Base Study)|Screen Failure|0|||
162987167|NCT01739348|588657224|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
162987168|NCT01739348|588657225|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
162987169|NCT01739348|588657226|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
162987170|NCT01739348|588657227|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
162987171|NCT01739348|588657224|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
163212062|NCT02554812|589490722|FG015|Overall Study|Death|1|||
163212063|NCT02554812|589490723|FG016|Overall Study|Death|1|||
163212064|NCT02554812|589490724|FG017|Overall Study|Death|0|||
163212065|NCT02554812|589490725|FG018|Overall Study|Death|1|||
163212066|NCT02554812|589490726|FG019|Overall Study|Death|2|||
163212067|NCT02554812|589490727|FG020|Overall Study|Death|0|||
163212068|NCT02554812|589490728|FG021|Overall Study|Death|1|||
163403771|NCT01624662|590188690|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
163403772|NCT01624662|590188691|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
163212069|NCT02554812|589490729|FG022|Overall Study|Death|1|||
162987172|NCT01739348|588657225|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
162987173|NCT01739348|588657226|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
162987174|NCT01739348|588657227|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
162987175|NCT01739348|588657224|FG000|Part I (Base Study)|Participant Moved|4|||
162987176|NCT01739348|588657225|FG001|Part I (Base Study)|Participant Moved|3|||
162987177|NCT01739348|588657226|FG002|Part I (Base Study)|Participant Moved|1|||
162987178|NCT01739348|588657227|FG003|Part I (Base Study)|Participant Moved|7|||
162987179|NCT01739348|588657224|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
162987180|NCT01739348|588657225|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
163059893|NCT02911116|588928253|FG001|Overall Study|Lost to Follow-up|1|||
163212070|NCT02554812|589490730|FG023|Overall Study|Death|0|||
162987181|NCT01739348|588657226|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
162987182|NCT01739348|588657227|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
162987183|NCT01739348|588657224|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
162987184|NCT01739348|588657225|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
162987185|NCT01739348|588657226|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
162987186|NCT01739348|588657227|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
162987187|NCT01739348|588657224|FG000|Part II (Extension Study)|Adverse Event|10|||
162987188|NCT01739348|588657225|FG001|Part II (Extension Study)|Adverse Event|11|||
162987189|NCT01739348|588657226|FG002|Part II (Extension Study)|Adverse Event|7|||
162987190|NCT01739348|588657227|FG003|Part II (Extension Study)|Adverse Event|26|||
162987191|NCT01739348|588657224|FG000|Part II (Extension Study)|Death|3|||
162987192|NCT01739348|588657225|FG001|Part II (Extension Study)|Death|3|||
162987193|NCT01739348|588657226|FG002|Part II (Extension Study)|Death|2|||
162987194|NCT01739348|588657227|FG003|Part II (Extension Study)|Death|6|||
162987195|NCT01739348|588657224|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
162987196|NCT01739348|588657225|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
162987197|NCT01739348|588657226|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
162987198|NCT01739348|588657227|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
162987199|NCT01739348|588657224|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
162987200|NCT01739348|588657225|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
162987201|NCT01739348|588657226|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
162987202|NCT01739348|588657227|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
162987203|NCT01739348|588657224|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
162987204|NCT01739348|588657225|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
162987205|NCT01739348|588657226|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
162987206|NCT01739348|588657227|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
162987207|NCT01739348|588657224|FG000|Part II (Extension Study)|Physician Decision|7|||
162987208|NCT01739348|588657225|FG001|Part II (Extension Study)|Physician Decision|11|||
162987209|NCT01739348|588657226|FG002|Part II (Extension Study)|Physician Decision|6|||
162987210|NCT01739348|588657227|FG003|Part II (Extension Study)|Physician Decision|12|||
162987211|NCT01739348|588657224|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
162987212|NCT01739348|588657225|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
162987213|NCT01739348|588657226|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
162987214|NCT01739348|588657227|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
162987215|NCT01739348|588657224|FG000|Part II (Extension Study)|Participant Moved|3|||
162987216|NCT01739348|588657225|FG001|Part II (Extension Study)|Participant Moved|3|||
162987217|NCT01739348|588657226|FG002|Part II (Extension Study)|Participant Moved|0|||
162987218|NCT01739348|588657227|FG003|Part II (Extension Study)|Participant Moved|3|||
162987219|NCT01739348|588657224|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
162987220|NCT01739348|588657225|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
162987221|NCT01739348|588657226|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
162987222|NCT01739348|588657227|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
162987223|NCT01739348|588657224|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
162987224|NCT01739348|588657225|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
162987225|NCT01739348|588657226|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
162987226|NCT01739348|588657227|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
162987227|NCT01447420|588657230|FG000|Overall Study|Adverse Event|2|||
162987228|NCT01447420|588657231|FG001|Overall Study|Adverse Event|4|||
162987229|NCT01447420|588657232|FG002|Overall Study|Adverse Event|2|||
162987230|NCT01447420|588657230|FG000|Overall Study|Protocol Violation|3|||
162987231|NCT01447420|588657231|FG001|Overall Study|Protocol Violation|3|||
162987232|NCT01447420|588657232|FG002|Overall Study|Protocol Violation|0|||
162987233|NCT01447420|588657230|FG000|Overall Study|Withdrawal by Subject|4|||
162987234|NCT01447420|588657231|FG001|Overall Study|Withdrawal by Subject|1|||
162987235|NCT01447420|588657232|FG002|Overall Study|Withdrawal by Subject|0|||
162987236|NCT01447420|588657230|FG000|Overall Study|Lack of Efficacy|1|||
163059894|NCT01240694|588928254|FG000|Overall Study|Adverse Event|9|||
163059895|NCT01240694|588928254|FG000|Overall Study|Lack of Efficacy|6|||
163059896|NCT01240694|588928254|FG000|Overall Study|Withdrawal by Subject|6|||
163323724|NCT02231749|589898985|FG001|Overall Study|Study Drug Toxicity|63|||
162987237|NCT01447420|588657231|FG001|Overall Study|Lack of Efficacy|19|||
162987238|NCT01447420|588657232|FG002|Overall Study|Lack of Efficacy|8|||
162987239|NCT00528411|588657237|FG000|Overall Study|Adverse Event|4|||
162987240|NCT00528411|588657238|FG001|Overall Study|Adverse Event|0|||
162987241|NCT00528411|588657239|FG002|Overall Study|Adverse Event|1|||
162987242|NCT00528411|588657237|FG000|Overall Study|Incorrect Enrolment|1|||
162987243|NCT00528411|588657238|FG001|Overall Study|Incorrect Enrolment|1|||
162987244|NCT00528411|588657239|FG002|Overall Study|Incorrect Enrolment|0|||
162987245|NCT00528411|588657237|FG000|Overall Study|Severe non-compliance to protocol|0|||
162987246|NCT00528411|588657238|FG001|Overall Study|Severe non-compliance to protocol|1|||
163059897|NCT01240694|588928254|FG000|Overall Study|Protocol Violation|2|||
163059898|NCT01240694|588928254|FG000|Overall Study|Lost to Follow-up|2|||
163323725|NCT02231749|589898984|FG000|Overall Study|Death|1|||
162987247|NCT00528411|588657239|FG002|Overall Study|Severe non-compliance to protocol|0|||
162987248|NCT00528411|588657237|FG000|Overall Study|Prior commitment medication|0|||
162987249|NCT00528411|588657238|FG001|Overall Study|Prior commitment medication|1|||
162987250|NCT00528411|588657239|FG002|Overall Study|Prior commitment medication|0|||
162987251|NCT02695537|588657249|FG000|Overall Study|Adverse Event|3|||
162987252|NCT02695537|588657249|FG000|Overall Study|Lack of Efficacy|28|||
162987253|NCT02695537|588657249|FG000|Overall Study|Withdrawal by Subject|4|||
162987254|NCT02695537|588657249|FG000|Overall Study|Protocol Violation|3|||
162987255|NCT04015908|588657250|FG000|Overall Study|Lost to Follow-up|0|||
162987256|NCT04015908|588657251|FG001|Overall Study|Lost to Follow-up|1|||
162987257|NCT02792699|588657252|FG000|Overall Study|Adverse Event|1|||
162987258|NCT02792699|588657253|FG001|Overall Study|Adverse Event|2|||
162987259|NCT02792699|588657254|FG002|Overall Study|Adverse Event|4|||
162987260|NCT02792699|588657252|FG000|Overall Study|Withdrawal by Subject|4|||
162987261|NCT02792699|588657253|FG001|Overall Study|Withdrawal by Subject|4|||
162987262|NCT02792699|588657254|FG002|Overall Study|Withdrawal by Subject|3|||
162987263|NCT02792699|588657252|FG000|Overall Study|Lost to Follow-up|0|||
162987264|NCT02792699|588657253|FG001|Overall Study|Lost to Follow-up|1|||
162987265|NCT02792699|588657254|FG002|Overall Study|Lost to Follow-up|2|||
162987266|NCT02792699|588657252|FG000|Overall Study|Physician Decision|2|||
162987267|NCT02792699|588657253|FG001|Overall Study|Physician Decision|0|||
162987268|NCT02792699|588657254|FG002|Overall Study|Physician Decision|0|||
162987269|NCT02792699|588657252|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
162987270|NCT02792699|588657253|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
162987271|NCT02792699|588657254|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
162987272|NCT02792699|588657252|FG000|Overall Study|Other|1|||
162987273|NCT02792699|588657253|FG001|Overall Study|Other|0|||
162987274|NCT02792699|588657254|FG002|Overall Study|Other|0|||
162987275|NCT01715571|588657255|FG000|Overall Study|Lost to Follow-up|8|||
162987278|NCT03569228|588657263|FG000|Overall Study|Withdrawal by PI|0|||
162987279|NCT03569228|588657264|FG001|Overall Study|Withdrawal by PI|0|||
162987280|NCT03569228|588657265|FG002|Overall Study|Withdrawal by PI|2|||
162987281|NCT03569228|588657266|FG003|Overall Study|Withdrawal by PI|2|||
162987282|NCT03569228|588657267|FG004|Overall Study|Withdrawal by PI|1|||
162987283|NCT03569228|588657268|FG005|Overall Study|Withdrawal by PI|0|||
162987284|NCT03569228|588657269|FG006|Overall Study|Withdrawal by PI|0|||
162987285|NCT03569228|588657270|FG007|Overall Study|Withdrawal by PI|0|||
162987286|NCT03569228|588657271|FG008|Overall Study|Withdrawal by PI|0|||
162987287|NCT03569228|588657263|FG000|Overall Study|Lost to Follow-up|0|||
162987288|NCT03569228|588657264|FG001|Overall Study|Lost to Follow-up|0|||
162987289|NCT03569228|588657265|FG002|Overall Study|Lost to Follow-up|0|||
162987290|NCT03569228|588657266|FG003|Overall Study|Lost to Follow-up|0|||
162987291|NCT03569228|588657267|FG004|Overall Study|Lost to Follow-up|0|||
162987292|NCT03569228|588657268|FG005|Overall Study|Lost to Follow-up|0|||
162987293|NCT03569228|588657269|FG006|Overall Study|Lost to Follow-up|0|||
162987294|NCT03569228|588657270|FG007|Overall Study|Lost to Follow-up|0|||
162987295|NCT03569228|588657271|FG008|Overall Study|Lost to Follow-up|1|||
162987296|NCT03569228|588657263|FG000|Overall Study|Screen Fail|2|||
162987297|NCT03569228|588657264|FG001|Overall Study|Screen Fail|2|||
163323726|NCT02231749|589898985|FG001|Overall Study|Death|1|||
163323727|NCT02231749|589898984|FG000|Overall Study|AE unrelated to Study drug|32|||
163323728|NCT02231749|589898985|FG001|Overall Study|AE unrelated to Study drug|31|||
163323729|NCT02231749|589898984|FG000|Overall Study|Participant's request to discontinue|10|||
163323730|NCT02231749|589898985|FG001|Overall Study|Participant's request to discontinue|21|||
163323731|NCT02231749|589898984|FG000|Overall Study|Participant withdrew Consent|8|||
163323732|NCT02231749|589898985|FG001|Overall Study|Participant withdrew Consent|15|||
163323733|NCT02231749|589898984|FG000|Overall Study|Lost to Follow-up|1|||
163323734|NCT02231749|589898985|FG001|Overall Study|Lost to Follow-up|2|||
163323735|NCT02231749|589898984|FG000|Overall Study|Maximum Clinical Benefit|5|||
163323736|NCT02231749|589898985|FG001|Overall Study|Maximum Clinical Benefit|8|||
162987298|NCT03569228|588657265|FG002|Overall Study|Screen Fail|1|||
162987299|NCT03569228|588657266|FG003|Overall Study|Screen Fail|1|||
162987300|NCT03569228|588657267|FG004|Overall Study|Screen Fail|1|||
162987301|NCT03569228|588657268|FG005|Overall Study|Screen Fail|3|||
162987302|NCT03569228|588657269|FG006|Overall Study|Screen Fail|1|||
162987303|NCT03569228|588657270|FG007|Overall Study|Screen Fail|5|||
162987304|NCT03569228|588657271|FG008|Overall Study|Screen Fail|2|||
162987305|NCT05442866|588657272|FG000|Overall Study|Death|1|||
162987306|NCT05442866|588657272|FG000|Overall Study|Lost to Follow-up|9|||
162987307|NCT05442866|588657272|FG000|Overall Study|Protocol Violation|1|||
162987308|NCT01584843|588657276|FG000|First Treatment Period|Adverse Event|0|||
162987309|NCT01584843|588657277|FG001|First Treatment Period|Adverse Event|0|||
162987310|NCT01584843|588657278|FG002|First Treatment Period|Adverse Event|1|||
163323737|NCT02231749|589898984|FG000|Overall Study|Poor/Non-Compliance|0|||
162987311|NCT01584843|588657279|FG003|First Treatment Period|Adverse Event|0|||
162987312|NCT01584843|588657280|FG004|First Treatment Period|Adverse Event|0|||
162987313|NCT01584843|588657281|FG005|First Treatment Period|Adverse Event|0|||
163323738|NCT02231749|589898985|FG001|Overall Study|Poor/Non-Compliance|3|||
163323739|NCT02231749|589898984|FG000|Overall Study|Pregnancy|1|||
163323740|NCT02231749|589898985|FG001|Overall Study|Pregnancy|0|||
163323741|NCT02231749|589898984|FG000|Overall Study|other|0|||
163323742|NCT02231749|589898985|FG001|Overall Study|other|8|||
163323743|NCT02231749|589898984|FG000|Overall Study|No longer meets Study Criteria|1|||
163323744|NCT02231749|589898985|FG001|Overall Study|No longer meets Study Criteria|0|||
163323745|NCT03884439|589898994|FG000|Overall Study|No informed consent for publication of study results|38|||
163323746|NCT03884439|589898994|FG000|Overall Study|Contract violation/deficiency|7|||
163323747|NCT04281498|589898996|FG000|Overall Study|Progression of disease|1|||
163323748|NCT04281498|589898996|FG000|Overall Study|Planned SCT|1|||
162987314|NCT01584843|588657276|FG000|First Treatment Period|Protocol Violation|0|||
162987315|NCT01584843|588657277|FG001|First Treatment Period|Protocol Violation|0|||
162987316|NCT01584843|588657278|FG002|First Treatment Period|Protocol Violation|0|||
162987317|NCT01584843|588657279|FG003|First Treatment Period|Protocol Violation|0|||
162987318|NCT01584843|588657280|FG004|First Treatment Period|Protocol Violation|0|||
162987319|NCT01584843|588657281|FG005|First Treatment Period|Protocol Violation|1|||
162987320|NCT01584843|588657276|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
162987321|NCT01584843|588657277|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
162987322|NCT01584843|588657278|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
162987323|NCT01584843|588657279|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
162987324|NCT01584843|588657280|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
162987325|NCT01584843|588657281|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
162987326|NCT01584843|588657276|FG000|Second Treatment Period|Withdrawal by Subject|0|||
162987327|NCT01584843|588657277|FG001|Second Treatment Period|Withdrawal by Subject|0|||
162987328|NCT01584843|588657278|FG002|Second Treatment Period|Withdrawal by Subject|0|||
162987329|NCT01584843|588657279|FG003|Second Treatment Period|Withdrawal by Subject|0|||
162987330|NCT01584843|588657280|FG004|Second Treatment Period|Withdrawal by Subject|0|||
162987331|NCT01584843|588657281|FG005|Second Treatment Period|Withdrawal by Subject|1|||
162987332|NCT00643565|588657282|FG000|Overall Study|Death|12|||
162987333|NCT00643565|588657283|FG001|Overall Study|Death|11|||
162987334|NCT00643565|588657282|FG000|Overall Study|Withdrawal by Subject|4|||
162987335|NCT00643565|588657283|FG001|Overall Study|Withdrawal by Subject|1|||
162987336|NCT00643565|588657282|FG000|Overall Study|Lost to Follow-up|0|||
162987337|NCT00643565|588657283|FG001|Overall Study|Lost to Follow-up|6|||
162987338|NCT00643565|588657282|FG000|Overall Study|Other|7|||
162987339|NCT00643565|588657283|FG001|Overall Study|Other|8|||
162987340|NCT00643565|588657282|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
162987341|NCT00643565|588657283|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
162987342|NCT00643565|588657282|FG000|Overall Study|Recurrence of Disease|2|||
162987343|NCT00643565|588657283|FG001|Overall Study|Recurrence of Disease|1|||
163212071|NCT02554812|589490731|FG024|Overall Study|Death|0|||
163212072|NCT02554812|589490732|FG025|Overall Study|Death|0|||
163212073|NCT02554812|589490733|FG026|Overall Study|Death|0|||
162987344|NCT00643565|588657282|FG000|Overall Study|Progression of Disease|18|||
162987345|NCT00643565|588657283|FG001|Overall Study|Progression of Disease|14|||
162987346|NCT00643565|588657282|FG000|Overall Study|Protocol Violation|3|||
162987347|NCT00643565|588657283|FG001|Overall Study|Protocol Violation|0|||
162987348|NCT00643565|588657282|FG000|Overall Study|Did Not Cooperate|0|||
162987349|NCT00643565|588657283|FG001|Overall Study|Did Not Cooperate|1|||
162987350|NCT00643565|588657282|FG000|Overall Study|Administrative|22|||
162987351|NCT00643565|588657283|FG001|Overall Study|Administrative|16|||
162987352|NCT00643565|588657282|FG000|Overall Study|Adverse Event|5|||
162987353|NCT00643565|588657283|FG001|Overall Study|Adverse Event|8|||
162987354|NCT02317614|588657284|FG000|Overall Study|Lost to Follow-up|1|||
162987355|NCT02317614|588657285|FG001|Overall Study|Lost to Follow-up|1|||
163212074|NCT02554812|589490707|FG000|Overall Study|Lost to Follow-up|0|||
163212075|NCT02554812|589490708|FG001|Overall Study|Lost to Follow-up|1|||
162987356|NCT02317614|588657284|FG000|Overall Study|Withdrawal by Subject|1|||
163212076|NCT02554812|589490709|FG002|Overall Study|Lost to Follow-up|0|||
163212077|NCT02554812|589490710|FG003|Overall Study|Lost to Follow-up|0|||
163212078|NCT02554812|589490711|FG004|Overall Study|Lost to Follow-up|0|||
162987357|NCT02317614|588657285|FG001|Overall Study|Withdrawal by Subject|0|||
162987358|NCT02317614|588657284|FG000|Overall Study|Death|1|||
162987359|NCT02317614|588657285|FG001|Overall Study|Death|1|||
162987360|NCT03285308|588657286|FG000|Overall Study|Adverse Event|3|||
163212079|NCT02554812|589490712|FG005|Overall Study|Lost to Follow-up|0|||
162987361|NCT03285308|588657287|FG001|Overall Study|Adverse Event|7|||
162987362|NCT03285308|588657286|FG000|Overall Study|Withdrawal by Subject|8|||
162987363|NCT03285308|588657287|FG001|Overall Study|Withdrawal by Subject|9|||
162987364|NCT03285308|588657286|FG000|Overall Study|Lost to Follow-up|3|||
163212080|NCT02554812|589490713|FG006|Overall Study|Lost to Follow-up|0|||
163212081|NCT02554812|589490714|FG007|Overall Study|Lost to Follow-up|0|||
163212082|NCT02554812|589490715|FG008|Overall Study|Lost to Follow-up|0|||
163323749|NCT04281498|589898996|FG000|Overall Study|Alternative Treatment|1|||
162987365|NCT03285308|588657287|FG001|Overall Study|Lost to Follow-up|1|||
163212083|NCT02554812|589490716|FG009|Overall Study|Lost to Follow-up|0|||
162987366|NCT03285308|588657286|FG000|Overall Study|Protocol Deviation|6|||
162987367|NCT03285308|588657287|FG001|Overall Study|Protocol Deviation|5|||
162987368|NCT03285308|588657286|FG000|Overall Study|Reason not Specified|0|||
162987369|NCT03285308|588657287|FG001|Overall Study|Reason not Specified|1|||
162987370|NCT02283983|588657288|FG000|Overall Study|Inclusion criteria not met|0|||
162987371|NCT02283983|588657289|FG001|Overall Study|Inclusion criteria not met|1|||
162987372|NCT02283983|588657288|FG000|Overall Study|Withdrawal by Subject|4|||
162987373|NCT02283983|588657289|FG001|Overall Study|Withdrawal by Subject|2|||
162987374|NCT02283983|588657288|FG000|Overall Study|Protocol Violation|0|||
162987375|NCT02283983|588657289|FG001|Overall Study|Protocol Violation|4|||
162987376|NCT02283983|588657288|FG000|Overall Study|Physician Decision|2|||
162987377|NCT02283983|588657289|FG001|Overall Study|Physician Decision|4|||
162987378|NCT02283983|588657288|FG000|Overall Study|Death|1|||
162987379|NCT02283983|588657289|FG001|Overall Study|Death|0|||
162987380|NCT02283983|588657288|FG000|Overall Study|Adverse Event|1|||
162987381|NCT02283983|588657289|FG001|Overall Study|Adverse Event|0|||
162987382|NCT02283983|588657288|FG000|Overall Study|Lost to Follow-up|9|||
162987383|NCT02283983|588657289|FG001|Overall Study|Lost to Follow-up|8|||
162987384|NCT02283983|588657288|FG000|Overall Study|Relapse|1|||
162987385|NCT02283983|588657289|FG001|Overall Study|Relapse|0|||
162987386|NCT03275064|588657290|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
162987387|NCT03275064|588657291|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
162987388|NCT03275064|588657292|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
162987389|NCT03275064|588657293|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
162987390|NCT03275064|588657294|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
162987391|NCT03275064|588657290|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
162987392|NCT03275064|588657291|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
162987393|NCT03275064|588657292|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
162987394|NCT03275064|588657293|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
162987395|NCT03275064|588657294|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
162987396|NCT03275064|588657290|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
162987397|NCT03275064|588657291|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
162987398|NCT03275064|588657292|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
162987399|NCT03275064|588657293|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
162987400|NCT03275064|588657294|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
162987401|NCT03275064|588657290|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
162987402|NCT03275064|588657291|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
162987403|NCT03275064|588657292|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
162987404|NCT03275064|588657293|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
162987405|NCT03275064|588657294|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
162987406|NCT03275064|588657290|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
162987407|NCT03275064|588657291|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
162987408|NCT03275064|588657292|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
162987409|NCT03275064|588657293|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
162987410|NCT03275064|588657294|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
162987411|NCT00620555|588657297|FG000|Overall Study|Adverse Event|4|||
162987412|NCT00620555|588657297|FG000|Overall Study|Protocol Violation|2|||
162987413|NCT00620555|588657297|FG000|Overall Study|Lack of Efficacy|12|||
162987414|NCT00620555|588657297|FG000|Overall Study|Withdrawal by Subject|1|||
162987415|NCT00620555|588657297|FG000|Overall Study|Choice of other treatment|1|||
162987416|NCT00620555|588657297|FG000|Overall Study|Visit failure against planned|1|||
162987417|NCT00669071|588657299|FG000|Overall Study|Lost to Follow-up|3|||
162987418|NCT00669071|588657299|FG000|Overall Study|Final visit 40 days out of window|1|||
162987419|NCT04305496|588657300|FG000|Global Cohort|Withdrawal by Subject|13|||
162987420|NCT04305496|588657301|FG001|Global Cohort|Withdrawal by Subject|6|||
162987421|NCT04305496|588657300|FG000|Global Cohort|Physician Decision|1|||
162987422|NCT04305496|588657301|FG001|Global Cohort|Physician Decision|1|||
162987423|NCT04305496|588657300|FG000|Global Cohort|Subjective disease progression|16|||
162987424|NCT04305496|588657301|FG001|Global Cohort|Subjective disease progression|17|||
162987425|NCT04305496|588657300|FG000|Global Cohort|Condition under investigation worsened|209|||
162987426|NCT04305496|588657301|FG001|Global Cohort|Condition under investigation worsened|273|||
162987427|NCT04305496|588657300|FG000|Global Cohort|Protocol Violation|2|||
162987428|NCT04305496|588657301|FG001|Global Cohort|Protocol Violation|0|||
162987429|NCT04305496|588657300|FG000|Global Cohort|Adverse Event|44|||
162987430|NCT04305496|588657301|FG001|Global Cohort|Adverse Event|6|||
162987431|NCT04305496|588657300|FG000|Global Cohort|Death|3|||
162987432|NCT04305496|588657301|FG001|Global Cohort|Death|2|||
162987433|NCT04305496|588657300|FG000|Global Cohort|Any reason not specifically recorded|4|||
162987434|NCT04305496|588657301|FG001|Global Cohort|Any reason not specifically recorded|5|||
163403773|NCT01624662|590188688|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
163403774|NCT01624662|590188689|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
162987435|NCT04305496|588657300|FG000|China Cohort|Any reason not specifically recorded|1|||
162987436|NCT04305496|588657301|FG001|China Cohort|Any reason not specifically recorded|1|||
162987437|NCT04305496|588657300|FG000|China Cohort|Adverse Event|8|||
162987438|NCT04305496|588657301|FG001|China Cohort|Adverse Event|2|||
162987439|NCT04305496|588657300|FG000|China Cohort|Condition under investigation worsened|40|||
162987440|NCT04305496|588657301|FG001|China Cohort|Condition under investigation worsened|47|||
162987441|NCT04305496|588657300|FG000|China Cohort|Subjective disease progression|2|||
162987442|NCT04305496|588657301|FG001|China Cohort|Subjective disease progression|2|||
162987443|NCT04305496|588657300|FG000|China Cohort|Withdrawal by Subject|2|||
162987444|NCT04305496|588657301|FG001|China Cohort|Withdrawal by Subject|1|||
162987445|NCT00532935|588657303|FG000|Overall Study|Adverse Event|11|||
162987446|NCT00532935|588657304|FG001|Overall Study|Adverse Event|12|||
162987447|NCT00532935|588657303|FG000|Overall Study|Lack of Efficacy|0|||
162987448|NCT00532935|588657304|FG001|Overall Study|Lack of Efficacy|3|||
162987449|NCT00532935|588657303|FG000|Overall Study|Lost to Follow-up|10|||
162987450|NCT00532935|588657304|FG001|Overall Study|Lost to Follow-up|6|||
162987451|NCT00532935|588657303|FG000|Overall Study|Physician Decision|4|||
162987452|NCT00532935|588657304|FG001|Overall Study|Physician Decision|5|||
162987453|NCT00532935|588657303|FG000|Overall Study|Pregnancy|1|||
162987454|NCT00532935|588657304|FG001|Overall Study|Pregnancy|0|||
162987455|NCT00532935|588657303|FG000|Overall Study|Protocol Violation|4|||
162987456|NCT00532935|588657304|FG001|Overall Study|Protocol Violation|2|||
162987457|NCT00532935|588657303|FG000|Overall Study|Withdrawal by Subject|10|||
162987458|NCT00532935|588657304|FG001|Overall Study|Withdrawal by Subject|9|||
162987459|NCT00532935|588657303|FG000|Overall Study|Protocol Specific Criteria|11|||
162987460|NCT00532935|588657304|FG001|Overall Study|Protocol Specific Criteria|15|||
162987461|NCT02435836|588657308|FG000|Overall Study|Lost to Follow-up|21|||
162987462|NCT02435836|588657308|FG000|Overall Study|Lack of Efficacy|1|||
162987463|NCT02435836|588657308|FG000|Overall Study|Withdrawal by Subject|236|||
162987464|NCT02435836|588657308|FG000|Overall Study|Insufficient Clinical Response|26|||
162987465|NCT02435836|588657308|FG000|Overall Study|Adverse Event|44|||
162987466|NCT02435836|588657308|FG000|Overall Study|Sponsor discontinued trial|167|||
162987467|NCT02435836|588657308|FG000|Overall Study|Noncompliance|27|||
162987468|NCT02435836|588657308|FG000|Overall Study|Protocol Violation|6|||
162987469|NCT02435836|588657308|FG000|Overall Study|Met Withdrawal Criteria|7|||
162987470|NCT02435836|588657308|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
162987471|NCT03176459|588657309|FG000|Overall Study|Lost to Follow-up|5|||
162987472|NCT03176459|588657310|FG001|Overall Study|Lost to Follow-up|7|||
162987473|NCT01602965|588657311|FG000|Overall Study|Lost to Follow-up|4|||
162987474|NCT01602965|588657312|FG001|Overall Study|Lost to Follow-up|2|||
162987475|NCT03190330|588661155|FG000|Overall Study|Adverse Event|2|||
162987476|NCT03190330|588661155|FG000|Overall Study|Death|10|||
162987477|NCT03190330|588661155|FG000|Overall Study|Lost to Follow-up|1|||
162987478|NCT03190330|588661155|FG000|Overall Study|Withdrawal by Subject|6|||
162987479|NCT03190330|588661155|FG000|Overall Study|Progressive Disease|1|||
162987480|NCT02081209|588661156|FG000|Overall Study|Withdrawal by Subject|1|||
162987481|NCT02370329|588661157|FG000|Overall Study|Alternate treatment|1|||
162987482|NCT02370329|588661157|FG000|Overall Study|Adverse Event|1|||
162987483|NCT02370329|588661157|FG000|Overall Study|Disease progression|3|||
162987484|NCT02370329|588661157|FG000|Overall Study|Physician Decision|2|||
162987485|NCT02370329|588661157|FG000|Overall Study|Study closure|4|||
162987486|NCT02022748|588661161|FG000|Overall Study|Adverse Event|1|||
162987487|NCT02022748|588661162|FG001|Overall Study|Adverse Event|1|||
162987488|NCT02022748|588661163|FG002|Overall Study|Adverse Event|0|||
162987489|NCT02022748|588661161|FG000|Overall Study|Withdrawal by Subject|0|||
162987490|NCT02022748|588661162|FG001|Overall Study|Withdrawal by Subject|1|||
162987491|NCT02022748|588661163|FG002|Overall Study|Withdrawal by Subject|0|||
162987492|NCT04347122|588661166|FG000|Overall Study|Physician Decision|0|||
162987493|NCT04347122|588661167|FG001|Overall Study|Physician Decision|3|||
163403775|NCT01624662|590188690|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
162987494|NCT04347122|588661168|FG002|Overall Study|Physician Decision|3|||
163403776|NCT01624662|590188691|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
163403777|NCT01624662|590188688|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
163403778|NCT01624662|590188689|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
162987495|NCT04347122|588661169|FG003|Overall Study|Physician Decision|6|||
162987496|NCT03510598|588661170|FG000|Overall Study|Withdrawal by Subject|1|||
162987497|NCT05327816|588661172|FG000|Overall Study|Lost to Follow-up|1|||
162987498|NCT05327816|588661173|FG001|Overall Study|Lost to Follow-up|0|||
162987499|NCT05327816|588661174|FG002|Overall Study|Lost to Follow-up|0|||
162987500|NCT05327816|588661175|FG003|Overall Study|Lost to Follow-up|0|||
162987501|NCT05327816|588661176|FG004|Overall Study|Lost to Follow-up|0|||
162987502|NCT05327816|588661177|FG005|Overall Study|Lost to Follow-up|0|||
162987503|NCT05327816|588661178|FG006|Overall Study|Lost to Follow-up|0|||
162987504|NCT05327816|588661179|FG007|Overall Study|Lost to Follow-up|0|||
162987505|NCT05327816|588661180|FG008|Overall Study|Lost to Follow-up|0|||
162987506|NCT05327816|588661181|FG009|Overall Study|Lost to Follow-up|1|||
162987507|NCT05327816|588661182|FG010|Overall Study|Lost to Follow-up|0|||
162987508|NCT05327816|588661172|FG000|Overall Study|Withdrawal by Subject|0|||
162987509|NCT05327816|588661173|FG001|Overall Study|Withdrawal by Subject|0|||
162987510|NCT05327816|588661174|FG002|Overall Study|Withdrawal by Subject|0|||
162987511|NCT05327816|588661175|FG003|Overall Study|Withdrawal by Subject|0|||
162987512|NCT05327816|588661176|FG004|Overall Study|Withdrawal by Subject|1|||
162987513|NCT05327816|588661177|FG005|Overall Study|Withdrawal by Subject|1|||
162987514|NCT05327816|588661178|FG006|Overall Study|Withdrawal by Subject|0|||
162987515|NCT05327816|588661179|FG007|Overall Study|Withdrawal by Subject|0|||
162987516|NCT05327816|588661180|FG008|Overall Study|Withdrawal by Subject|0|||
162987517|NCT05327816|588661181|FG009|Overall Study|Withdrawal by Subject|0|||
162987518|NCT05327816|588661182|FG010|Overall Study|Withdrawal by Subject|0|||
162987519|NCT05327816|588661172|FG000|Overall Study|Study Terminated by Sponsor|11|||
162987520|NCT05327816|588661173|FG001|Overall Study|Study Terminated by Sponsor|12|||
162987521|NCT05327816|588661174|FG002|Overall Study|Study Terminated by Sponsor|12|||
162987522|NCT05327816|588661175|FG003|Overall Study|Study Terminated by Sponsor|12|||
162987523|NCT05327816|588661176|FG004|Overall Study|Study Terminated by Sponsor|11|||
162987524|NCT05327816|588661177|FG005|Overall Study|Study Terminated by Sponsor|11|||
162987525|NCT05327816|588661178|FG006|Overall Study|Study Terminated by Sponsor|11|||
162987526|NCT05327816|588661179|FG007|Overall Study|Study Terminated by Sponsor|11|||
162987527|NCT05327816|588661180|FG008|Overall Study|Study Terminated by Sponsor|11|||
162987528|NCT05327816|588661181|FG009|Overall Study|Study Terminated by Sponsor|11|||
162987529|NCT05327816|588661182|FG010|Overall Study|Study Terminated by Sponsor|12|||
162987530|NCT05327816|588661172|FG000|Overall Study|Randomized but not treated|0|||
162987531|NCT05327816|588661173|FG001|Overall Study|Randomized but not treated|0|||
162987532|NCT05327816|588661174|FG002|Overall Study|Randomized but not treated|0|||
162987533|NCT05327816|588661175|FG003|Overall Study|Randomized but not treated|0|||
162987534|NCT05327816|588661176|FG004|Overall Study|Randomized but not treated|0|||
162987535|NCT05327816|588661177|FG005|Overall Study|Randomized but not treated|0|||
162987536|NCT05327816|588661178|FG006|Overall Study|Randomized but not treated|1|||
162987537|NCT05327816|588661179|FG007|Overall Study|Randomized but not treated|1|||
162987538|NCT05327816|588661180|FG008|Overall Study|Randomized but not treated|1|||
162987539|NCT05327816|588661181|FG009|Overall Study|Randomized but not treated|0|||
162987540|NCT05327816|588661182|FG010|Overall Study|Randomized but not treated|0|||
162987541|NCT00112866|588661184|FG000|Overall Study|Protocol Violation|1|||
162987542|NCT00112866|588661185|FG001|Overall Study|Protocol Violation|0|||
162987543|NCT00112866|588661184|FG000|Overall Study|did not start treatment post-op|1|||
162987544|NCT00112866|588661185|FG001|Overall Study|did not start treatment post-op|2|||
162987545|NCT00658658|588661189|FG000|Overall Study|Withdrawal by Subject|0|||
162987546|NCT00658658|588661190|FG001|Overall Study|Withdrawal by Subject|1|||
162987547|NCT00658658|588661191|FG002|Overall Study|Withdrawal by Subject|0|||
162987548|NCT00658658|588661192|FG003|Overall Study|Withdrawal by Subject|0|||
162987549|NCT00658658|588661193|FG004|Overall Study|Withdrawal by Subject|0|||
162987550|NCT00658658|588661189|FG000|Overall Study|Death|4|||
162987551|NCT00658658|588661190|FG001|Overall Study|Death|0|||
162987552|NCT00658658|588661191|FG002|Overall Study|Death|0|||
162987553|NCT00658658|588661192|FG003|Overall Study|Death|1|||
162987554|NCT00658658|588661193|FG004|Overall Study|Death|1|||
162987555|NCT00658658|588661189|FG000|Overall Study|Disease Progression|0|||
162987556|NCT00658658|588661190|FG001|Overall Study|Disease Progression|1|||
162987557|NCT00658658|588661191|FG002|Overall Study|Disease Progression|0|||
162987558|NCT00658658|588661192|FG003|Overall Study|Disease Progression|1|||
162987559|NCT00658658|588661193|FG004|Overall Study|Disease Progression|3|||
162987560|NCT00658658|588661189|FG000|Overall Study|Protocol-specified Criteria|1|||
162987561|NCT00658658|588661190|FG001|Overall Study|Protocol-specified Criteria|0|||
162987562|NCT00658658|588661191|FG002|Overall Study|Protocol-specified Criteria|0|||
162987563|NCT00658658|588661192|FG003|Overall Study|Protocol-specified Criteria|0|||
162987564|NCT00658658|588661193|FG004|Overall Study|Protocol-specified Criteria|0|||
162987565|NCT00658658|588661189|FG000|Overall Study|Other|0|||
162987566|NCT00658658|588661190|FG001|Overall Study|Other|0|||
162987567|NCT00658658|588661191|FG002|Overall Study|Other|0|||
162987568|NCT00658658|588661192|FG003|Overall Study|Other|0|||
162987569|NCT00658658|588661193|FG004|Overall Study|Other|1|||
163403779|NCT01624662|590188690|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
162987570|NCT01523457|588661194|FG000|Overall Study|Withdrawal by Subject|7|||
162987571|NCT01523457|588661195|FG001|Overall Study|Withdrawal by Subject|2|||
162987572|NCT04663295|588661197|FG000|Run-in Period|Withdrawal by Subject|3|||
162987573|NCT04663295|588661197|FG000|Overall Study Period|Pregnancy|1|||
162987574|NCT04663295|588661197|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
163212084|NCT02554812|589490717|FG010|Overall Study|Lost to Follow-up|0|||
162987575|NCT00554190|588661198|FG000|Overall Study|Termination forms not completed|10|||
162987576|NCT01502410|588661199|FG000|Overall Study|Adverse Event|1|||
162987577|NCT01502410|588661200|FG001|Overall Study|Adverse Event|2|||
162987578|NCT01502410|588661201|FG002|Overall Study|Adverse Event|0|||
162987579|NCT01502410|588661202|FG003|Overall Study|Adverse Event|0|||
163212085|NCT02554812|589490718|FG011|Overall Study|Lost to Follow-up|0|||
162987580|NCT01502410|588661199|FG000|Overall Study|Lack of Efficacy|7|||
162987581|NCT01502410|588661200|FG001|Overall Study|Lack of Efficacy|7|||
162987582|NCT01502410|588661201|FG002|Overall Study|Lack of Efficacy|0|||
162987583|NCT01502410|588661202|FG003|Overall Study|Lack of Efficacy|0|||
162987584|NCT01502410|588661199|FG000|Overall Study|Physician Decision|0|||
162987585|NCT01502410|588661200|FG001|Overall Study|Physician Decision|1|||
162987586|NCT01502410|588661201|FG002|Overall Study|Physician Decision|0|||
162987587|NCT01502410|588661202|FG003|Overall Study|Physician Decision|0|||
162987588|NCT01502410|588661199|FG000|Overall Study|Withdrawal by Subject|2|||
162987589|NCT01502410|588661200|FG001|Overall Study|Withdrawal by Subject|0|||
162987590|NCT01502410|588661201|FG002|Overall Study|Withdrawal by Subject|0|||
162987591|NCT01502410|588661202|FG003|Overall Study|Withdrawal by Subject|0|||
162987592|NCT00325195|588661204|FG000|Randomized|Not dosed|5|||
162987593|NCT00325195|588661205|FG001|Randomized|Not dosed|5|||
162987594|NCT00325195|588661206|FG002|Randomized|Not dosed|3|||
162987595|NCT00325195|588661204|FG000|Received Intervention: ITT Population|Adverse Event|15|||
162987596|NCT00325195|588661205|FG001|Received Intervention: ITT Population|Adverse Event|17|||
162987597|NCT00325195|588661206|FG002|Received Intervention: ITT Population|Adverse Event|1|||
162987598|NCT00325195|588661204|FG000|Received Intervention: ITT Population|Death|3|||
162987599|NCT00325195|588661205|FG001|Received Intervention: ITT Population|Death|1|||
162987600|NCT00325195|588661206|FG002|Received Intervention: ITT Population|Death|0|||
162987601|NCT00325195|588661204|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
162987602|NCT00325195|588661205|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
162987603|NCT00325195|588661206|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
162987604|NCT00325195|588661204|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
162987605|NCT00325195|588661205|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
162987606|NCT00325195|588661206|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
162987607|NCT00325195|588661204|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
162987608|NCT00325195|588661205|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
162987609|NCT00325195|588661206|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
162987610|NCT04594707|588661207|FG000|Overall Study|Adverse Event|0|||
162987611|NCT04594707|588661208|FG001|Overall Study|Adverse Event|0|||
162987612|NCT04594707|588661209|FG002|Overall Study|Adverse Event|1|||
162987613|NCT04594707|588661207|FG000|Overall Study|Death|0|||
162987614|NCT04594707|588661208|FG001|Overall Study|Death|2|||
162987615|NCT04594707|588661209|FG002|Overall Study|Death|2|||
162987616|NCT04594707|588661207|FG000|Overall Study|Lung Transplant|0|||
162987617|NCT04594707|588661208|FG001|Overall Study|Lung Transplant|0|||
162987618|NCT04594707|588661209|FG002|Overall Study|Lung Transplant|1|||
162987619|NCT04594707|588661207|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
162987620|NCT04594707|588661208|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
162987621|NCT04594707|588661209|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
162987622|NCT04594707|588661207|FG000|Overall Study|Study Terminated By Sponsor|19|||
162987623|NCT04594707|588661208|FG001|Overall Study|Study Terminated By Sponsor|47|||
162987624|NCT04594707|588661209|FG002|Overall Study|Study Terminated By Sponsor|41|||
162987625|NCT04594707|588661207|FG000|Overall Study|Withdrawal by Subject|1|||
162987626|NCT04594707|588661208|FG001|Overall Study|Withdrawal by Subject|0|||
162987627|NCT04594707|588661209|FG002|Overall Study|Withdrawal by Subject|2|||
162987628|NCT04585789|588661210|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
162987629|NCT04585789|588661211|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
162987630|NCT04585789|588661212|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
162987631|NCT04585789|588661210|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
162987632|NCT04585789|588661211|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
162987633|NCT04585789|588661212|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
162987634|NCT05083585|588661213|FG000|Overall Study|Death|1|||
162987635|NCT05083585|588661214|FG001|Overall Study|Death|1|||
162987636|NCT05083585|588661213|FG000|Overall Study|Lost to Follow-up|1|||
162987637|NCT05083585|588661214|FG001|Overall Study|Lost to Follow-up|1|||
162987638|NCT05083585|588661213|FG000|Overall Study|Withdrawal by Subject|2|||
162987639|NCT05083585|588661214|FG001|Overall Study|Withdrawal by Subject|0|||
162987640|NCT05083585|588661213|FG000|Overall Study|Randomized but not vaccinated|2|||
162987641|NCT05083585|588661214|FG001|Overall Study|Randomized but not vaccinated|0|||
162987642|NCT00114166|588661215|FG000|Overall Study|Wrong primary|0|||
162987643|NCT00114166|588661216|FG001|Overall Study|Wrong primary|1|||
163059899|NCT01240694|588928254|FG000|Overall Study|Other than specified|3|||
163059900|NCT01240694|588928254|FG000|Overall Study|Withdrawn due to early study termination|107|||
163059901|NCT01513590|588928255|FG000|Overall Study|Adverse Event|2|||
163059902|NCT01513590|588928256|FG001|Overall Study|Adverse Event|3|||
163059903|NCT01513590|588928255|FG000|Overall Study|Withdrawal Criteria|3|||
163059904|NCT01513590|588928256|FG001|Overall Study|Withdrawal Criteria|0|||
163212086|NCT02554812|589490719|FG012|Overall Study|Lost to Follow-up|0|||
162987644|NCT03469336|588661217|FG000|Overall Study|Adverse Event|1|||
162987645|NCT02628743|588661219|FG000|Overall Study|Other|3|||
162987646|NCT02628743|588661219|FG000|Overall Study|Withdrawal by Subject|50|||
163323750|NCT03142009|589898999|FG000|Overall Study|Lost to Follow-up|45|||
162987647|NCT02628743|588661219|FG000|Overall Study|Study Terminated by Sponsor|76|||
162987648|NCT02628743|588661219|FG000|Overall Study|Physician Decision|2|||
162987649|NCT02740699|588661221|FG000|Overall Study|Lost to Follow-up|5|||
162987650|NCT02740699|588661221|FG000|Overall Study|Withdrawal by Subject|14|||
162987651|NCT02740699|588661221|FG000|Overall Study|Physician Decision|5|||
162987652|NCT02393248|588661222|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987653|NCT02393248|588661223|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
162987654|NCT02393248|588661224|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
163323751|NCT03142009|589899000|FG001|Overall Study|Lost to Follow-up|30|||
163323752|NCT03587805|589899002|FG000|Overall Study|Adverse Event|72|||
163323753|NCT03587805|589899002|FG000|Overall Study|Death|1|||
163323754|NCT03587805|589899002|FG000|Overall Study|Lost to Follow-up|78|||
163323755|NCT03587805|589899002|FG000|Overall Study|Withdrawal by Subject|105|||
163323756|NCT03587805|589899002|FG000|Overall Study|Lack of Efficacy|119|||
163323757|NCT03587805|589899002|FG000|Overall Study|Reason unknown|26|||
163323758|NCT03587805|589899002|FG000|Overall Study|COVID_19 pandemic|4|||
163323759|NCT03587805|589899002|FG000|Overall Study|Various reasons|121|||
163323760|NCT03587805|589899002|FG000|Overall Study|Withdrawal by parent/guardian|3|||
163323761|NCT03982186|589899003|FG000|Overall Study|Lost to Follow-up|0|||
163323762|NCT03982186|589899004|FG001|Overall Study|Lost to Follow-up|1|||
163323763|NCT03982186|589899005|FG002|Overall Study|Lost to Follow-up|2|||
163323764|NCT03982186|589899006|FG003|Overall Study|Lost to Follow-up|1|||
163323765|NCT03982186|589899007|FG004|Overall Study|Lost to Follow-up|1|||
163323766|NCT03982186|589899008|FG005|Overall Study|Lost to Follow-up|0|||
163323767|NCT03982186|589899003|FG000|Overall Study|Physician Decision|0|||
163323768|NCT03982186|589899004|FG001|Overall Study|Physician Decision|1|||
163323769|NCT03982186|589899005|FG002|Overall Study|Physician Decision|0|||
163323770|NCT03982186|589899006|FG003|Overall Study|Physician Decision|0|||
163323771|NCT03982186|589899007|FG004|Overall Study|Physician Decision|0|||
163323772|NCT03982186|589899008|FG005|Overall Study|Physician Decision|0|||
163323773|NCT03982186|589899003|FG000|Overall Study|Withdrawal by Subject|3|||
163323774|NCT03982186|589899004|FG001|Overall Study|Withdrawal by Subject|4|||
163323775|NCT03982186|589899005|FG002|Overall Study|Withdrawal by Subject|1|||
163323776|NCT03982186|589899006|FG003|Overall Study|Withdrawal by Subject|7|||
163323777|NCT03982186|589899007|FG004|Overall Study|Withdrawal by Subject|2|||
163323778|NCT03982186|589899008|FG005|Overall Study|Withdrawal by Subject|0|||
163323779|NCT03982186|589899003|FG000|Overall Study|Randomized and not treated|0|||
163323780|NCT03982186|589899004|FG001|Overall Study|Randomized and not treated|0|||
163323781|NCT03982186|589899005|FG002|Overall Study|Randomized and not treated|0|||
163323782|NCT03982186|589899006|FG003|Overall Study|Randomized and not treated|1|||
163323783|NCT03982186|589899007|FG004|Overall Study|Randomized and not treated|0|||
163323784|NCT03982186|589899008|FG005|Overall Study|Randomized and not treated|0|||
163323785|NCT03008382|589899010|FG000|Overall Study|Withdrawal by Subject|2|||
163323786|NCT03008382|589899011|FG001|Overall Study|Withdrawal by Subject|5|||
163323787|NCT03008382|589899012|FG002|Overall Study|Withdrawal by Subject|2|||
163323788|NCT03008382|589899013|FG003|Overall Study|Withdrawal by Subject|0|||
163323789|NCT03008382|589899010|FG000|Overall Study|Protocol Violation|1|||
163323790|NCT03008382|589899011|FG001|Overall Study|Protocol Violation|0|||
163323791|NCT03008382|589899012|FG002|Overall Study|Protocol Violation|0|||
163323792|NCT03008382|589899013|FG003|Overall Study|Protocol Violation|0|||
163323793|NCT03008382|589899010|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
163323794|NCT03008382|589899011|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
163323795|NCT03008382|589899012|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
163323796|NCT03008382|589899013|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
163323797|NCT03008382|589899010|FG000|Overall Study|Lost to Follow-up|0|||
163323798|NCT03008382|589899011|FG001|Overall Study|Lost to Follow-up|0|||
163323799|NCT03008382|589899012|FG002|Overall Study|Lost to Follow-up|1|||
163323800|NCT03008382|589899013|FG003|Overall Study|Lost to Follow-up|0|||
163323801|NCT03008382|589899010|FG000|Overall Study|Screenfail|0|||
163323802|NCT03008382|589899011|FG001|Overall Study|Screenfail|0|||
163323803|NCT03008382|589899012|FG002|Overall Study|Screenfail|2|||
163323804|NCT03008382|589899013|FG003|Overall Study|Screenfail|0|||
163323805|NCT04039113|589899016|FG000|Overall Study|Withdrawal by Subject|8|||
163323806|NCT04039113|589899017|FG001|Overall Study|Withdrawal by Subject|11|||
163323807|NCT04039113|589899016|FG000|Overall Study|Lost to Follow-up|1|||
163323808|NCT04039113|589899017|FG001|Overall Study|Lost to Follow-up|1|||
163323809|NCT04039113|589899016|FG000|Overall Study|Adverse Event|2|||
163323810|NCT04039113|589899017|FG001|Overall Study|Adverse Event|2|||
163323811|NCT04039113|589899016|FG000|Overall Study|Death|2|||
163323812|NCT04039113|589899017|FG001|Overall Study|Death|4|||
163323813|NCT04039113|589899016|FG000|Overall Study|Site Closure|6|||
163323814|NCT04039113|589899017|FG001|Overall Study|Site Closure|0|||
162987655|NCT02393248|588661225|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
163323815|NCT04039113|589899016|FG000|Overall Study|Failure to meet randomisation criteria|4|||
163323816|NCT04039113|589899017|FG001|Overall Study|Failure to meet randomisation criteria|0|||
163323817|NCT00353496|589899018|FG000|Overall Study|Adverse Event|1|||
163323818|NCT00353496|589899019|FG001|Overall Study|Adverse Event|0|||
163059905|NCT01513590|588928255|FG000|Overall Study|Unclassified|5|||
163323819|NCT00353496|589899018|FG000|Overall Study|Protocol Violation|2|||
163323820|NCT00353496|589899019|FG001|Overall Study|Protocol Violation|2|||
163323821|NCT00353496|589899018|FG000|Overall Study|Withdrawal by Subject|3|||
163323822|NCT00353496|589899019|FG001|Overall Study|Withdrawal by Subject|4|||
163323823|NCT00353496|589899018|FG000|Overall Study|Physician Decision|6|||
163323824|NCT00353496|589899019|FG001|Overall Study|Physician Decision|9|||
163323825|NCT00353496|589899018|FG000|Overall Study|Not otherwise specified|4|||
163323826|NCT00353496|589899019|FG001|Overall Study|Not otherwise specified|2|||
163323827|NCT02180867|589899020|FG000|Overall Study|Adverse Event|3|||
163323828|NCT02180867|589899021|FG001|Overall Study|Adverse Event|4|||
163323829|NCT02180867|589899022|FG002|Overall Study|Adverse Event|1|||
163323830|NCT02180867|589899023|FG003|Overall Study|Adverse Event|5|||
163323831|NCT02180867|589899024|FG004|Overall Study|Adverse Event|0|||
163323832|NCT02180867|589899025|FG005|Overall Study|Adverse Event|0|||
163323833|NCT02180867|589899026|FG006|Overall Study|Adverse Event|0|||
163323834|NCT02180867|589899020|FG000|Overall Study|Death|0|||
163323835|NCT02180867|589899021|FG001|Overall Study|Death|0|||
163323836|NCT02180867|589899022|FG002|Overall Study|Death|0|||
163323837|NCT02180867|589899023|FG003|Overall Study|Death|0|||
163323838|NCT02180867|589899024|FG004|Overall Study|Death|1|||
163323839|NCT02180867|589899025|FG005|Overall Study|Death|0|||
163323840|NCT02180867|589899026|FG006|Overall Study|Death|0|||
163323841|NCT02180867|589899020|FG000|Overall Study|Lack of Efficacy|0|||
163323842|NCT02180867|589899021|FG001|Overall Study|Lack of Efficacy|2|||
163323843|NCT02180867|589899022|FG002|Overall Study|Lack of Efficacy|0|||
163323844|NCT02180867|589899023|FG003|Overall Study|Lack of Efficacy|1|||
163323845|NCT02180867|589899024|FG004|Overall Study|Lack of Efficacy|6|||
163323846|NCT02180867|589899025|FG005|Overall Study|Lack of Efficacy|0|||
163323847|NCT02180867|589899026|FG006|Overall Study|Lack of Efficacy|1|||
163323848|NCT02180867|589899020|FG000|Overall Study|Physician Decision|1|||
163323849|NCT02180867|589899021|FG001|Overall Study|Physician Decision|3|||
163323850|NCT02180867|589899022|FG002|Overall Study|Physician Decision|1|||
163323851|NCT02180867|589899023|FG003|Overall Study|Physician Decision|10|||
163323852|NCT02180867|589899024|FG004|Overall Study|Physician Decision|9|||
163323853|NCT02180867|589899025|FG005|Overall Study|Physician Decision|3|||
163323854|NCT02180867|589899026|FG006|Overall Study|Physician Decision|4|||
163323855|NCT02180867|589899020|FG000|Overall Study|Withdrawal by Subject|0|||
163323856|NCT02180867|589899021|FG001|Overall Study|Withdrawal by Subject|0|||
163323857|NCT02180867|589899022|FG002|Overall Study|Withdrawal by Subject|0|||
163323858|NCT02180867|589899023|FG003|Overall Study|Withdrawal by Subject|1|||
163323859|NCT02180867|589899024|FG004|Overall Study|Withdrawal by Subject|1|||
163323860|NCT02180867|589899025|FG005|Overall Study|Withdrawal by Subject|0|||
163323861|NCT02180867|589899026|FG006|Overall Study|Withdrawal by Subject|0|||
163323862|NCT02180867|589899020|FG000|Overall Study|Ineligible|1|||
163323863|NCT02180867|589899021|FG001|Overall Study|Ineligible|2|||
163323864|NCT02180867|589899022|FG002|Overall Study|Ineligible|0|||
163323865|NCT02180867|589899023|FG003|Overall Study|Ineligible|3|||
163323866|NCT02180867|589899024|FG004|Overall Study|Ineligible|5|||
163323867|NCT02180867|589899025|FG005|Overall Study|Ineligible|0|||
163323868|NCT02180867|589899026|FG006|Overall Study|Ineligible|0|||
163323869|NCT02180867|589899020|FG000|Overall Study|Repeat Eligibility Studies|0|||
163323870|NCT02180867|589899021|FG001|Overall Study|Repeat Eligibility Studies|0|||
163323871|NCT02180867|589899022|FG002|Overall Study|Repeat Eligibility Studies|0|||
163323872|NCT02180867|589899023|FG003|Overall Study|Repeat Eligibility Studies|0|||
163323873|NCT02180867|589899024|FG004|Overall Study|Repeat Eligibility Studies|1|||
163323874|NCT02180867|589899025|FG005|Overall Study|Repeat Eligibility Studies|0|||
163323875|NCT02180867|589899026|FG006|Overall Study|Repeat Eligibility Studies|0|||
163323876|NCT02180867|589899020|FG000|Overall Study|Refusal of further protocol therapy|1|||
163323877|NCT02180867|589899021|FG001|Overall Study|Refusal of further protocol therapy|0|||
163323878|NCT02180867|589899022|FG002|Overall Study|Refusal of further protocol therapy|2|||
163323879|NCT02180867|589899023|FG003|Overall Study|Refusal of further protocol therapy|6|||
163323880|NCT02180867|589899024|FG004|Overall Study|Refusal of further protocol therapy|4|||
163323881|NCT02180867|589899025|FG005|Overall Study|Refusal of further protocol therapy|0|||
163323882|NCT02180867|589899026|FG006|Overall Study|Refusal of further protocol therapy|0|||
163323883|NCT05267639|589899783|FG000|Overall Study|Withdrawal by Subject|1|||
163323884|NCT05267639|589899784|FG001|Overall Study|Withdrawal by Subject|0|||
163323885|NCT04732871|589899785|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
163323886|NCT04732871|589899786|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
163323887|NCT04732871|589899787|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
163323888|NCT04732871|589899785|FG000|Overall Study|Lost to Follow-up|7|||
163323889|NCT04732871|589899786|FG001|Overall Study|Lost to Follow-up|4|||
163323890|NCT04732871|589899787|FG002|Overall Study|Lost to Follow-up|3|||
163323891|NCT04732871|589899785|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
163323892|NCT04732871|589899786|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
163323893|NCT04732871|589899787|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
163212087|NCT02554812|589490720|FG013|Overall Study|Lost to Follow-up|0|||
163212088|NCT02554812|589490721|FG014|Overall Study|Lost to Follow-up|0|||
163212089|NCT02554812|589490722|FG015|Overall Study|Lost to Follow-up|0|||
163212090|NCT02554812|589490723|FG016|Overall Study|Lost to Follow-up|0|||
163212091|NCT02554812|589490724|FG017|Overall Study|Lost to Follow-up|0|||
163212092|NCT02554812|589490725|FG018|Overall Study|Lost to Follow-up|0|||
163212093|NCT02554812|589490726|FG019|Overall Study|Lost to Follow-up|0|||
163212094|NCT02554812|589490727|FG020|Overall Study|Lost to Follow-up|0|||
163212095|NCT02554812|589490728|FG021|Overall Study|Lost to Follow-up|0|||
163212096|NCT02554812|589490729|FG022|Overall Study|Lost to Follow-up|0|||
163212097|NCT02554812|589490730|FG023|Overall Study|Lost to Follow-up|0|||
163212098|NCT02554812|589490731|FG024|Overall Study|Lost to Follow-up|0|||
163212099|NCT02554812|589490732|FG025|Overall Study|Lost to Follow-up|0|||
163212100|NCT02554812|589490733|FG026|Overall Study|Lost to Follow-up|0|||
163212101|NCT02554812|589490707|FG000|Overall Study|Global deterioration of health status|4|||
163212102|NCT02554812|589490708|FG001|Overall Study|Global deterioration of health status|3|||
163212103|NCT02554812|589490709|FG002|Overall Study|Global deterioration of health status|3|||
163212104|NCT02554812|589490710|FG003|Overall Study|Global deterioration of health status|2|||
163212105|NCT02554812|589490711|FG004|Overall Study|Global deterioration of health status|5|||
163212106|NCT02554812|589490712|FG005|Overall Study|Global deterioration of health status|0|||
163212107|NCT02554812|589490713|FG006|Overall Study|Global deterioration of health status|2|||
163212108|NCT02554812|589490714|FG007|Overall Study|Global deterioration of health status|1|||
163212109|NCT02554812|589490715|FG008|Overall Study|Global deterioration of health status|1|||
163212110|NCT02554812|589490716|FG009|Overall Study|Global deterioration of health status|1|||
163212111|NCT02554812|589490717|FG010|Overall Study|Global deterioration of health status|2|||
163212112|NCT02554812|589490718|FG011|Overall Study|Global deterioration of health status|1|||
163212113|NCT02554812|589490719|FG012|Overall Study|Global deterioration of health status|0|||
163212114|NCT02554812|589490720|FG013|Overall Study|Global deterioration of health status|0|||
163212115|NCT02554812|589490721|FG014|Overall Study|Global deterioration of health status|0|||
163212116|NCT02554812|589490722|FG015|Overall Study|Global deterioration of health status|1|||
163212117|NCT02554812|589490723|FG016|Overall Study|Global deterioration of health status|0|||
163212118|NCT02554812|589490724|FG017|Overall Study|Global deterioration of health status|0|||
163212119|NCT02554812|589490725|FG018|Overall Study|Global deterioration of health status|0|||
163212120|NCT02554812|589490726|FG019|Overall Study|Global deterioration of health status|0|||
163212121|NCT02554812|589490727|FG020|Overall Study|Global deterioration of health status|0|||
163212122|NCT02554812|589490728|FG021|Overall Study|Global deterioration of health status|0|||
163212123|NCT02554812|589490729|FG022|Overall Study|Global deterioration of health status|0|||
163212124|NCT02554812|589490730|FG023|Overall Study|Global deterioration of health status|0|||
163212125|NCT02554812|589490731|FG024|Overall Study|Global deterioration of health status|0|||
163212126|NCT02554812|589490732|FG025|Overall Study|Global deterioration of health status|0|||
163212127|NCT02554812|589490733|FG026|Overall Study|Global deterioration of health status|0|||
163212128|NCT02554812|589490707|FG000|Overall Study|Progressive disease|20|||
163212129|NCT02554812|589490708|FG001|Overall Study|Progressive disease|16|||
163212130|NCT02554812|589490709|FG002|Overall Study|Progressive disease|19|||
163212131|NCT02554812|589490710|FG003|Overall Study|Progressive disease|18|||
163212132|NCT02554812|589490711|FG004|Overall Study|Progressive disease|21|||
163212133|NCT02554812|589490712|FG005|Overall Study|Progressive disease|15|||
163212134|NCT02554812|589490713|FG006|Overall Study|Progressive disease|6|||
163212135|NCT02554812|589490714|FG007|Overall Study|Progressive disease|13|||
163212136|NCT02554812|589490715|FG008|Overall Study|Progressive disease|6|||
163212137|NCT02554812|589490716|FG009|Overall Study|Progressive disease|6|||
163212138|NCT02554812|589490717|FG010|Overall Study|Progressive disease|8|||
163212139|NCT02554812|589490718|FG011|Overall Study|Progressive disease|8|||
163212140|NCT02554812|589490719|FG012|Overall Study|Progressive disease|6|||
163212141|NCT02554812|589490720|FG013|Overall Study|Progressive disease|10|||
163212142|NCT02554812|589490721|FG014|Overall Study|Progressive disease|20|||
163212143|NCT02554812|589490722|FG015|Overall Study|Progressive disease|6|||
163212144|NCT02554812|589490723|FG016|Overall Study|Progressive disease|3|||
163212145|NCT02554812|589490724|FG017|Overall Study|Progressive disease|3|||
163212146|NCT02554812|589490725|FG018|Overall Study|Progressive disease|11|||
163212147|NCT02554812|589490726|FG019|Overall Study|Progressive disease|7|||
163212148|NCT02554812|589490727|FG020|Overall Study|Progressive disease|11|||
163212149|NCT02554812|589490728|FG021|Overall Study|Progressive disease|6|||
163212150|NCT02554812|589490729|FG022|Overall Study|Progressive disease|9|||
163212151|NCT02554812|589490730|FG023|Overall Study|Progressive disease|9|||
163212152|NCT02554812|589490731|FG024|Overall Study|Progressive disease|4|||
163212153|NCT02554812|589490732|FG025|Overall Study|Progressive disease|5|||
163212154|NCT02554812|589490733|FG026|Overall Study|Progressive disease|5|||
163212155|NCT02554812|589490707|FG000|Overall Study|Other|0|||
163212156|NCT02554812|589490708|FG001|Overall Study|Other|0|||
163212157|NCT02554812|589490709|FG002|Overall Study|Other|2|||
163212158|NCT02554812|589490710|FG003|Overall Study|Other|3|||
163212159|NCT02554812|589490711|FG004|Overall Study|Other|2|||
163212160|NCT02554812|589490712|FG005|Overall Study|Other|1|||
163212161|NCT02554812|589490713|FG006|Overall Study|Other|0|||
163403780|NCT01624662|590188691|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
163403781|NCT01624662|590188688|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
163403782|NCT01624662|590188689|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
163403783|NCT01624662|590188690|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
163403784|NCT01624662|590188691|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
163403785|NCT00361270|590188692|FG000|Overall Study|Death|0|||
163403786|NCT00361270|590188693|FG001|Overall Study|Death|0|||
163403787|NCT00361270|590188694|FG002|Overall Study|Death|0|||
163403788|NCT00361270|590188695|FG003|Overall Study|Death|2|||
163403789|NCT00361270|590188692|FG000|Overall Study|Lost to Follow-up|4|||
163403790|NCT00361270|590188693|FG001|Overall Study|Lost to Follow-up|1|||
163403791|NCT00361270|590188694|FG002|Overall Study|Lost to Follow-up|0|||
163403792|NCT00361270|590188695|FG003|Overall Study|Lost to Follow-up|0|||
163403793|NCT00361270|590188692|FG000|Overall Study|Physician Decision|0|||
163403794|NCT00361270|590188693|FG001|Overall Study|Physician Decision|0|||
163403795|NCT00361270|590188694|FG002|Overall Study|Physician Decision|1|||
163403796|NCT00361270|590188695|FG003|Overall Study|Physician Decision|0|||
163403797|NCT00361270|590188692|FG000|Overall Study|Protocol Violation|9|||
163403798|NCT00361270|590188693|FG001|Overall Study|Protocol Violation|4|||
163403799|NCT00361270|590188694|FG002|Overall Study|Protocol Violation|5|||
163403800|NCT00361270|590188695|FG003|Overall Study|Protocol Violation|4|||
163403801|NCT00361270|590188692|FG000|Overall Study|Withdrawal by Subject|6|||
163403802|NCT00361270|590188693|FG001|Overall Study|Withdrawal by Subject|6|||
163403803|NCT00361270|590188694|FG002|Overall Study|Withdrawal by Subject|3|||
163403804|NCT00361270|590188695|FG003|Overall Study|Withdrawal by Subject|7|||
163403805|NCT00361270|590188692|FG000|Overall Study|Afraid of Hypnosis|1|||
163403806|NCT00361270|590188693|FG001|Overall Study|Afraid of Hypnosis|2|||
163403807|NCT00361270|590188694|FG002|Overall Study|Afraid of Hypnosis|0|||
163403808|NCT00361270|590188695|FG003|Overall Study|Afraid of Hypnosis|0|||
163403809|NCT00361270|590188692|FG000|Overall Study|Problems with Transportation|4|||
163403810|NCT00361270|590188693|FG001|Overall Study|Problems with Transportation|0|||
163403811|NCT00361270|590188694|FG002|Overall Study|Problems with Transportation|0|||
163403812|NCT00361270|590188695|FG003|Overall Study|Problems with Transportation|0|||
163403813|NCT00361270|590188692|FG000|Overall Study|Adverse Event|0|||
163403814|NCT00361270|590188693|FG001|Overall Study|Adverse Event|1|||
163403815|NCT00361270|590188694|FG002|Overall Study|Adverse Event|1|||
163403816|NCT00361270|590188695|FG003|Overall Study|Adverse Event|0|||
163403817|NCT01423851|590188699|FG000|Whole Study|Disease progression|2|||
163403818|NCT01423851|590188700|FG001|Whole Study|Disease progression|1|||
163403819|NCT01423851|590188701|FG002|Whole Study|Disease progression|1|||
163403820|NCT01423851|590188702|FG003|Whole Study|Disease progression|4|||
163403821|NCT01423851|590188703|FG004|Whole Study|Disease progression|1|||
163403822|NCT01423851|590188704|FG005|Whole Study|Disease progression|3|||
163403823|NCT01423851|590188705|FG006|Whole Study|Disease progression|1|||
163403824|NCT01423851|590188706|FG007|Whole Study|Disease progression|4|||
163403825|NCT01423851|590188707|FG008|Whole Study|Disease progression|0|||
163403826|NCT01423851|590188708|FG009|Whole Study|Disease progression|2|||
163403827|NCT01423851|590188709|FG010|Whole Study|Disease progression|10|||
163403828|NCT01423851|590188699|FG000|Whole Study|Physician Decision|0|||
163403829|NCT01423851|590188700|FG001|Whole Study|Physician Decision|1|||
163403830|NCT01423851|590188701|FG002|Whole Study|Physician Decision|2|||
163403831|NCT01423851|590188702|FG003|Whole Study|Physician Decision|0|||
163403832|NCT01423851|590188703|FG004|Whole Study|Physician Decision|2|||
163403833|NCT01423851|590188704|FG005|Whole Study|Physician Decision|0|||
163403834|NCT01423851|590188705|FG006|Whole Study|Physician Decision|2|||
163403835|NCT01423851|590188706|FG007|Whole Study|Physician Decision|1|||
163403836|NCT01423851|590188707|FG008|Whole Study|Physician Decision|3|||
163403837|NCT01423851|590188708|FG009|Whole Study|Physician Decision|4|||
163403838|NCT01423851|590188709|FG010|Whole Study|Physician Decision|12|||
163403839|NCT01423851|590188699|FG000|Whole Study|Withdrawal by Subject|1|||
163403840|NCT01423851|590188700|FG001|Whole Study|Withdrawal by Subject|1|||
163403841|NCT01423851|590188701|FG002|Whole Study|Withdrawal by Subject|0|||
163403842|NCT01423851|590188702|FG003|Whole Study|Withdrawal by Subject|0|||
163403843|NCT01423851|590188703|FG004|Whole Study|Withdrawal by Subject|0|||
163403844|NCT01423851|590188704|FG005|Whole Study|Withdrawal by Subject|0|||
163403845|NCT01423851|590188705|FG006|Whole Study|Withdrawal by Subject|0|||
163403846|NCT01423851|590188706|FG007|Whole Study|Withdrawal by Subject|0|||
163403847|NCT01423851|590188707|FG008|Whole Study|Withdrawal by Subject|2|||
163403848|NCT01423851|590188708|FG009|Whole Study|Withdrawal by Subject|0|||
163403849|NCT01423851|590188709|FG010|Whole Study|Withdrawal by Subject|4|||
163403850|NCT01423851|590188699|FG000|Whole Study|Adverse Event|0|||
163059906|NCT01513590|588928256|FG001|Overall Study|Unclassified|10|||
163403851|NCT01423851|590188700|FG001|Whole Study|Adverse Event|0|||
163403852|NCT01423851|590188701|FG002|Whole Study|Adverse Event|0|||
163403853|NCT01423851|590188702|FG003|Whole Study|Adverse Event|2|||
163403854|NCT01423851|590188703|FG004|Whole Study|Adverse Event|0|||
163403855|NCT01423851|590188704|FG005|Whole Study|Adverse Event|0|||
163403856|NCT01423851|590188705|FG006|Whole Study|Adverse Event|0|||
163403857|NCT01423851|590188706|FG007|Whole Study|Adverse Event|3|||
163403858|NCT01423851|590188707|FG008|Whole Study|Adverse Event|3|||
163323894|NCT04732871|589899785|FG000|Overall Study|Migrated / moved from the study area|5|||
163323895|NCT04732871|589899786|FG001|Overall Study|Migrated / moved from the study area|0|||
163323896|NCT04732871|589899787|FG002|Overall Study|Migrated / moved from the study area|0|||
163323897|NCT04732871|589899785|FG000|Overall Study|Other|1|||
163323898|NCT04732871|589899786|FG001|Overall Study|Other|0|||
163323899|NCT04732871|589899787|FG002|Overall Study|Other|1|||
163323900|NCT04732871|589899785|FG000|Overall Study|Ongoing|6|||
163323901|NCT04732871|589899786|FG001|Overall Study|Ongoing|0|||
163323902|NCT04732871|589899787|FG002|Overall Study|Ongoing|1|||
163323903|NCT04732871|589899785|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
163323904|NCT04732871|589899786|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
163323905|NCT04732871|589899787|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
163323906|NCT05180539|589899793|FG000|Overall Study|Lost to Follow-up|27|||
163323907|NCT05180539|589899794|FG001|Overall Study|Lost to Follow-up|30|||
163323908|NCT00968149|589899795|FG000|Overall Study|Adverse Event|5|||
163323909|NCT00968149|589899796|FG001|Overall Study|Adverse Event|1|||
163323910|NCT00968149|589899795|FG000|Overall Study|Lack of Efficacy|0|||
163323911|NCT00968149|589899796|FG001|Overall Study|Lack of Efficacy|4|||
163323912|NCT00968149|589899795|FG000|Overall Study|Lost to Follow-up|0|||
163323913|NCT00968149|589899796|FG001|Overall Study|Lost to Follow-up|1|||
163323914|NCT00968149|589899795|FG000|Overall Study|Protocol Violation|4|||
163323915|NCT00968149|589899796|FG001|Overall Study|Protocol Violation|0|||
163323916|NCT00968149|589899795|FG000|Overall Study|Withdrawal by Subject|2|||
163323917|NCT00968149|589899796|FG001|Overall Study|Withdrawal by Subject|0|||
163323918|NCT02502266|589899797|FG000|Overall Study|Adverse Event|0|||
163323919|NCT02502266|589899798|FG001|Overall Study|Adverse Event|0|||
163323920|NCT02502266|589899799|FG002|Overall Study|Adverse Event|0|||
163323921|NCT02502266|589899800|FG003|Overall Study|Adverse Event|0|||
163323922|NCT02502266|589899801|FG004|Overall Study|Adverse Event|1|||
163323923|NCT02502266|589899802|FG005|Overall Study|Adverse Event|1|||
163323924|NCT02502266|589899803|FG006|Overall Study|Adverse Event|1|||
163323925|NCT02502266|589899797|FG000|Overall Study|Withdrawal by Subject|30|||
163323926|NCT02502266|589899798|FG001|Overall Study|Withdrawal by Subject|15|||
163323927|NCT02502266|589899799|FG002|Overall Study|Withdrawal by Subject|16|||
163323928|NCT02502266|589899800|FG003|Overall Study|Withdrawal by Subject|0|||
163323929|NCT02502266|589899801|FG004|Overall Study|Withdrawal by Subject|0|||
163323930|NCT02502266|589899802|FG005|Overall Study|Withdrawal by Subject|0|||
163323931|NCT02502266|589899803|FG006|Overall Study|Withdrawal by Subject|0|||
163323932|NCT02502266|589899797|FG000|Overall Study|Still on Treatment|0|||
163323933|NCT02502266|589899798|FG001|Overall Study|Still on Treatment|0|||
163323934|NCT02502266|589899799|FG002|Overall Study|Still on Treatment|1|||
163323935|NCT02502266|589899800|FG003|Overall Study|Still on Treatment|0|||
163323936|NCT02502266|589899801|FG004|Overall Study|Still on Treatment|0|||
163323937|NCT02502266|589899802|FG005|Overall Study|Still on Treatment|0|||
163323938|NCT02502266|589899803|FG006|Overall Study|Still on Treatment|0|||
163323939|NCT02502266|589899797|FG000|Overall Study|Other Reasons|19|||
163323940|NCT02502266|589899798|FG001|Overall Study|Other Reasons|6|||
163323941|NCT02502266|589899799|FG002|Overall Study|Other Reasons|14|||
163323942|NCT02502266|589899800|FG003|Overall Study|Other Reasons|0|||
163323943|NCT02502266|589899801|FG004|Overall Study|Other Reasons|1|||
163323944|NCT02502266|589899802|FG005|Overall Study|Other Reasons|1|||
163323945|NCT02502266|589899803|FG006|Overall Study|Other Reasons|0|||
163323946|NCT02502266|589899797|FG000|Overall Study|Arm 4 Discontinued|0|||
163323947|NCT02502266|589899798|FG001|Overall Study|Arm 4 Discontinued|0|||
163323948|NCT02502266|589899799|FG002|Overall Study|Arm 4 Discontinued|0|||
163323949|NCT02502266|589899800|FG003|Overall Study|Arm 4 Discontinued|52|||
163323950|NCT02502266|589899801|FG004|Overall Study|Arm 4 Discontinued|0|||
163323951|NCT02502266|589899802|FG005|Overall Study|Arm 4 Discontinued|0|||
163323952|NCT02502266|589899803|FG006|Overall Study|Arm 4 Discontinued|0|||
163323953|NCT02502266|589899797|FG000|Overall Study|Never treated|0|||
163323954|NCT02502266|589899798|FG001|Overall Study|Never treated|0|||
163323955|NCT02502266|589899799|FG002|Overall Study|Never treated|0|||
163323956|NCT02502266|589899800|FG003|Overall Study|Never treated|0|||
163323957|NCT02502266|589899801|FG004|Overall Study|Never treated|0|||
163323958|NCT02502266|589899802|FG005|Overall Study|Never treated|1|||
163323959|NCT02502266|589899803|FG006|Overall Study|Never treated|0|||
163323960|NCT02719574|589899804|FG000|Phase 1 (Dose Escalation)|Other|0|||
163323961|NCT02719574|589899805|FG001|Phase 1 (Dose Escalation)|Other|2|||
163323962|NCT02719574|589899806|FG002|Phase 1 (Dose Escalation)|Other|1|||
163323963|NCT02719574|589899807|FG003|Phase 1 (Dose Escalation)|Other|2|||
163323964|NCT02719574|589899808|FG004|Phase 1 (Dose Escalation)|Other|2|||
163323965|NCT02719574|589899809|FG005|Phase 1 (Dose Escalation)|Other|0|||
163323966|NCT02719574|589899810|FG006|Phase 1 (Dose Escalation)|Other|0|||
163323967|NCT02719574|589899811|FG007|Phase 1 (Dose Escalation)|Other|0|||
163323968|NCT02719574|589899812|FG008|Phase 1 (Dose Escalation)|Other|0|||
163323969|NCT02719574|589899813|FG009|Phase 1 (Dose Escalation)|Other|0|||
163323970|NCT02719574|589899814|FG010|Phase 1 (Dose Escalation)|Other|0|||
163323971|NCT02719574|589899815|FG011|Phase 1 (Dose Escalation)|Other|0|||
163323972|NCT02719574|589899816|FG012|Phase 1 (Dose Escalation)|Other|0|||
163323973|NCT02719574|589899817|FG013|Phase 1 (Dose Escalation)|Other|0|||
163403859|NCT01423851|590188708|FG009|Whole Study|Adverse Event|2|||
163403860|NCT01423851|590188709|FG010|Whole Study|Adverse Event|3|||
163403861|NCT01395394|590190051|FG000|Baseline Study Visit|Protocol Violation|1|||
163403862|NCT01395394|590190052|FG001|Baseline Study Visit|Protocol Violation|0|||
163403863|NCT01395394|590190053|FG002|Baseline Study Visit|Protocol Violation|0|||
163403864|NCT01611974|590190060|FG000|Overall Study|Death|10|||
163403865|NCT01611974|590190061|FG001|Overall Study|Death|12|||
163403866|NCT01611974|590190062|FG002|Overall Study|Death|10|||
163403867|NCT01611974|590190060|FG000|Overall Study|Lost to Follow-up|0|||
163403868|NCT01611974|590190061|FG001|Overall Study|Lost to Follow-up|1|||
163403869|NCT01611974|590190062|FG002|Overall Study|Lost to Follow-up|0|||
163403870|NCT01611974|590190060|FG000|Overall Study|Physician Decision|5|||
163403871|NCT01611974|590190061|FG001|Overall Study|Physician Decision|1|||
163403872|NCT01611974|590190062|FG002|Overall Study|Physician Decision|2|||
163403873|NCT01611974|590190060|FG000|Overall Study|Withdrawal by Subject|0|||
163403874|NCT01611974|590190061|FG001|Overall Study|Withdrawal by Subject|1|||
163403875|NCT01611974|590190062|FG002|Overall Study|Withdrawal by Subject|4|||
163403876|NCT00132132|590190063|FG000|Overall Study|Lost to Follow-up|7|||
163403877|NCT00132132|590190064|FG001|Overall Study|Lost to Follow-up|2|||
163403878|NCT01970995|590190065|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
163403879|NCT01970995|590190066|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
163403880|NCT01970995|590190067|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
163403881|NCT01970995|590190065|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
163403882|NCT01970995|590190066|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
163403883|NCT01970995|590190067|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
163403884|NCT03699007|590190068|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
163403885|NCT03699007|590190069|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
163403886|NCT03699007|590190068|FG000|6-month Follow Up|Lost to Follow-up|2|||
163403887|NCT03699007|590190069|FG001|6-month Follow Up|Lost to Follow-up|3|||
163403888|NCT01709435|590190070|FG000|Overall Study|Adverse Event|1|||
163403889|NCT01709435|590190071|FG001|Overall Study|Adverse Event|1|||
163403890|NCT01709435|590190072|FG002|Overall Study|Adverse Event|1|||
163403891|NCT01709435|590190073|FG003|Overall Study|Adverse Event|0|||
163403892|NCT01709435|590190074|FG004|Overall Study|Adverse Event|0|||
163403893|NCT01709435|590190075|FG005|Overall Study|Adverse Event|1|||
163403894|NCT01709435|590190070|FG000|Overall Study|Lack of Efficacy|5|||
163403895|NCT01709435|590190071|FG001|Overall Study|Lack of Efficacy|7|||
163403896|NCT01709435|590190072|FG002|Overall Study|Lack of Efficacy|2|||
163403897|NCT01709435|590190073|FG003|Overall Study|Lack of Efficacy|2|||
163403898|NCT01709435|590190074|FG004|Overall Study|Lack of Efficacy|6|||
163403899|NCT01709435|590190075|FG005|Overall Study|Lack of Efficacy|3|||
163403900|NCT01709435|590190070|FG000|Overall Study|Physician Decision|0|||
163403901|NCT01709435|590190071|FG001|Overall Study|Physician Decision|1|||
163403902|NCT01709435|590190072|FG002|Overall Study|Physician Decision|0|||
163403903|NCT01709435|590190073|FG003|Overall Study|Physician Decision|1|||
163403904|NCT01709435|590190074|FG004|Overall Study|Physician Decision|2|||
163403905|NCT01709435|590190075|FG005|Overall Study|Physician Decision|0|||
163403906|NCT01709435|590190070|FG000|Overall Study|Withdrawal by Subject|0|||
163403907|NCT01709435|590190071|FG001|Overall Study|Withdrawal by Subject|0|||
163403908|NCT01709435|590190072|FG002|Overall Study|Withdrawal by Subject|3|||
163403909|NCT01709435|590190073|FG003|Overall Study|Withdrawal by Subject|0|||
163403910|NCT01709435|590190074|FG004|Overall Study|Withdrawal by Subject|2|||
163403911|NCT01709435|590190075|FG005|Overall Study|Withdrawal by Subject|2|||
163403912|NCT01780662|590190076|FG000|Overall Study|Adverse Event|1|||
163403913|NCT01780662|590190077|FG001|Overall Study|Adverse Event|0|||
163403914|NCT01780662|590190078|FG002|Overall Study|Adverse Event|2|||
163403915|NCT01780662|590190076|FG000|Overall Study|Physician Decision|0|||
163403916|NCT01780662|590190077|FG001|Overall Study|Physician Decision|5|||
163403917|NCT01780662|590190078|FG002|Overall Study|Physician Decision|7|||
163403918|NCT01780662|590190076|FG000|Overall Study|Protocol Violation|0|||
163403919|NCT01780662|590190077|FG001|Overall Study|Protocol Violation|1|||
163403920|NCT01780662|590190078|FG002|Overall Study|Protocol Violation|0|||
163403921|NCT01780662|590190076|FG000|Overall Study|Ineligible|0|||
163403922|NCT01780662|590190077|FG001|Overall Study|Ineligible|0|||
163403923|NCT01780662|590190078|FG002|Overall Study|Ineligible|1|||
163403924|NCT01263639|590190079|FG000|Overall Study|Lost to Follow-up|66|||
163403925|NCT01263639|590190080|FG001|Overall Study|Lost to Follow-up|70|||
163403926|NCT01263639|590190079|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
163403927|NCT01263639|590190080|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
163403928|NCT03975920|590190081|FG000|Overall Study|Lost to Follow-up|1|||
163212162|NCT02554812|589490714|FG007|Overall Study|Other|0|||
163212163|NCT02554812|589490715|FG008|Overall Study|Other|1|||
163212164|NCT02554812|589490716|FG009|Overall Study|Other|1|||
163212165|NCT02554812|589490717|FG010|Overall Study|Other|0|||
163212166|NCT02554812|589490718|FG011|Overall Study|Other|0|||
163212167|NCT02554812|589490719|FG012|Overall Study|Other|1|||
163212168|NCT02554812|589490720|FG013|Overall Study|Other|0|||
163212169|NCT02554812|589490721|FG014|Overall Study|Other|1|||
163212170|NCT02554812|589490722|FG015|Overall Study|Other|0|||
163323974|NCT02719574|589899818|FG014|Phase 1 (Dose Escalation)|Other|0|||
163323975|NCT02719574|589899819|FG015|Phase 1 (Dose Escalation)|Other|0|||
163323976|NCT02719574|589899820|FG016|Phase 1 (Dose Escalation)|Other|0|||
163323977|NCT02719574|589899804|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
163323978|NCT02719574|589899805|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
163323979|NCT02719574|589899806|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
163323980|NCT02719574|589899807|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
163323981|NCT02719574|589899808|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
163323982|NCT02719574|589899809|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
163323983|NCT02719574|589899810|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163323984|NCT02719574|589899811|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163323985|NCT02719574|589899812|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163323986|NCT02719574|589899813|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163323987|NCT02719574|589899814|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163323988|NCT02719574|589899815|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163323989|NCT02719574|589899816|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163323990|NCT02719574|589899817|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163323991|NCT02719574|589899818|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163323992|NCT02719574|589899819|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163323993|NCT02719574|589899820|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163323994|NCT02719574|589899804|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163323995|NCT02719574|589899805|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
163323996|NCT02719574|589899806|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
163323997|NCT02719574|589899807|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163323998|NCT02719574|589899808|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
163323999|NCT02719574|589899809|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
163324000|NCT02719574|589899810|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163324001|NCT02719574|589899811|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163324002|NCT02719574|589899812|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163324003|NCT02719574|589899813|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163324004|NCT02719574|589899814|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163324005|NCT02719574|589899815|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163324006|NCT02719574|589899816|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163324007|NCT02719574|589899817|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163324008|NCT02719574|589899818|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163324009|NCT02719574|589899819|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163324010|NCT02719574|589899820|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163324011|NCT02719574|589899804|FG000|Phase 1 (Dose Escalation)|Death|2|||
163324012|NCT02719574|589899805|FG001|Phase 1 (Dose Escalation)|Death|1|||
163324013|NCT02719574|589899806|FG002|Phase 1 (Dose Escalation)|Death|1|||
163324014|NCT02719574|589899807|FG003|Phase 1 (Dose Escalation)|Death|0|||
163324015|NCT02719574|589899808|FG004|Phase 1 (Dose Escalation)|Death|0|||
163324016|NCT02719574|589899809|FG005|Phase 1 (Dose Escalation)|Death|0|||
163324017|NCT02719574|589899810|FG006|Phase 1 (Dose Escalation)|Death|0|||
163324018|NCT02719574|589899811|FG007|Phase 1 (Dose Escalation)|Death|0|||
163324019|NCT02719574|589899812|FG008|Phase 1 (Dose Escalation)|Death|0|||
163324020|NCT02719574|589899813|FG009|Phase 1 (Dose Escalation)|Death|0|||
163324021|NCT02719574|589899814|FG010|Phase 1 (Dose Escalation)|Death|0|||
163324022|NCT02719574|589899815|FG011|Phase 1 (Dose Escalation)|Death|0|||
163324023|NCT02719574|589899816|FG012|Phase 1 (Dose Escalation)|Death|0|||
163324024|NCT02719574|589899817|FG013|Phase 1 (Dose Escalation)|Death|0|||
163324025|NCT02719574|589899818|FG014|Phase 1 (Dose Escalation)|Death|0|||
163324026|NCT02719574|589899819|FG015|Phase 1 (Dose Escalation)|Death|0|||
163324027|NCT02719574|589899820|FG016|Phase 1 (Dose Escalation)|Death|0|||
163324028|NCT02719574|589899804|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
163324029|NCT02719574|589899805|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
163324030|NCT02719574|589899806|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
163324031|NCT02719574|589899807|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
163324032|NCT02719574|589899808|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
163324033|NCT02719574|589899809|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
163324034|NCT02719574|589899810|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
163324035|NCT02719574|589899811|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
163324036|NCT02719574|589899812|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
163324037|NCT02719574|589899813|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
163324038|NCT02719574|589899814|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
163324039|NCT02719574|589899815|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
163324040|NCT02719574|589899816|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
163324041|NCT02719574|589899817|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
163324042|NCT02719574|589899818|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
163324043|NCT02719574|589899819|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
163324044|NCT02719574|589899820|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
163324045|NCT02719574|589899804|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
163324046|NCT02719574|589899805|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
163324047|NCT02719574|589899806|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
163324048|NCT02719574|589899807|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
163403929|NCT03975920|590190082|FG001|Overall Study|Lost to Follow-up|2|||
163403930|NCT03975920|590190081|FG000|Overall Study|Protocol Violation|1|||
163324049|NCT02719574|589899808|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
163324050|NCT02719574|589899809|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
163324051|NCT02719574|589899810|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
163324052|NCT02719574|589899811|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
163403931|NCT03975920|590190082|FG001|Overall Study|Protocol Violation|1|||
163403932|NCT03975920|590190081|FG000|Overall Study|Did not complete survey|2|||
163403933|NCT03975920|590190082|FG001|Overall Study|Did not complete survey|1|||
163403934|NCT03882970|590190083|FG000|Overall Study|Adverse Event|5|||
163403935|NCT03882970|590190084|FG001|Overall Study|Adverse Event|7|||
163403936|NCT03882970|590190085|FG002|Overall Study|Adverse Event|3|||
163403937|NCT03882970|590190086|FG003|Overall Study|Adverse Event|1|||
163403938|NCT03882970|590190083|FG000|Overall Study|Death|1|||
163403939|NCT03882970|590190084|FG001|Overall Study|Death|2|||
163403940|NCT03882970|590190085|FG002|Overall Study|Death|1|||
163403941|NCT03882970|590190086|FG003|Overall Study|Death|1|||
163403942|NCT03882970|590190083|FG000|Overall Study|Lost to Follow-up|8|||
163403943|NCT03882970|590190084|FG001|Overall Study|Lost to Follow-up|9|||
163324053|NCT02719574|589899812|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
163324054|NCT02719574|589899813|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
163324055|NCT02719574|589899814|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
163324056|NCT02719574|589899815|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
163324057|NCT02719574|589899816|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
163324058|NCT02719574|589899817|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
163324059|NCT02719574|589899818|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
163324060|NCT02719574|589899819|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
163324061|NCT02719574|589899820|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
163324062|NCT02719574|589899804|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324063|NCT02719574|589899805|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324064|NCT02719574|589899806|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
163324065|NCT02719574|589899807|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324066|NCT02719574|589899808|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324067|NCT02719574|589899809|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324068|NCT02719574|589899810|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324069|NCT02719574|589899811|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324070|NCT02719574|589899812|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324071|NCT02719574|589899813|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324072|NCT02719574|589899814|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324073|NCT02719574|589899815|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324074|NCT02719574|589899816|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324075|NCT02719574|589899817|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324076|NCT02719574|589899818|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324077|NCT02719574|589899819|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324078|NCT02719574|589899820|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163324079|NCT02719574|589899804|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163324080|NCT02719574|589899805|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163324081|NCT02719574|589899806|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163324082|NCT02719574|589899807|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163324083|NCT02719574|589899808|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163324084|NCT02719574|589899809|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163324085|NCT02719574|589899810|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
163324086|NCT02719574|589899811|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
163324087|NCT02719574|589899812|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
163324088|NCT02719574|589899813|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163324089|NCT02719574|589899814|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163324090|NCT02719574|589899815|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163324091|NCT02719574|589899816|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163324092|NCT02719574|589899817|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163324093|NCT02719574|589899818|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163324094|NCT02719574|589899819|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163324095|NCT02719574|589899820|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163324096|NCT02719574|589899804|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163324097|NCT02719574|589899805|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163324098|NCT02719574|589899806|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163324099|NCT02719574|589899807|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163324100|NCT02719574|589899808|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163324101|NCT02719574|589899809|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163324102|NCT02719574|589899810|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
163324103|NCT02719574|589899811|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
163324104|NCT02719574|589899812|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163324105|NCT02719574|589899813|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163324106|NCT02719574|589899814|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163324107|NCT02719574|589899815|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163324108|NCT02719574|589899816|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163324109|NCT02719574|589899817|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163324110|NCT02719574|589899818|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163324111|NCT02719574|589899819|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163324112|NCT02719574|589899820|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163324113|NCT02719574|589899804|FG000|Phase 1 (Dose Expansion)|Death|0|||
163324114|NCT02719574|589899805|FG001|Phase 1 (Dose Expansion)|Death|0|||
163324115|NCT02719574|589899806|FG002|Phase 1 (Dose Expansion)|Death|0|||
163324116|NCT02719574|589899807|FG003|Phase 1 (Dose Expansion)|Death|0|||
163324117|NCT02719574|589899808|FG004|Phase 1 (Dose Expansion)|Death|0|||
163324118|NCT02719574|589899809|FG005|Phase 1 (Dose Expansion)|Death|0|||
163324119|NCT02719574|589899810|FG006|Phase 1 (Dose Expansion)|Death|1|||
163324120|NCT02719574|589899811|FG007|Phase 1 (Dose Expansion)|Death|6|||
163324121|NCT02719574|589899812|FG008|Phase 1 (Dose Expansion)|Death|0|||
163324122|NCT02719574|589899813|FG009|Phase 1 (Dose Expansion)|Death|0|||
163324123|NCT02719574|589899814|FG010|Phase 1 (Dose Expansion)|Death|0|||
163324124|NCT02719574|589899815|FG011|Phase 1 (Dose Expansion)|Death|0|||
163324125|NCT02719574|589899816|FG012|Phase 1 (Dose Expansion)|Death|0|||
163324126|NCT02719574|589899817|FG013|Phase 1 (Dose Expansion)|Death|0|||
163324127|NCT02719574|589899818|FG014|Phase 1 (Dose Expansion)|Death|0|||
163324128|NCT02719574|589899819|FG015|Phase 1 (Dose Expansion)|Death|0|||
163324129|NCT02719574|589899820|FG016|Phase 1 (Dose Expansion)|Death|0|||
163324130|NCT02719574|589899804|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
163324131|NCT02719574|589899805|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
163324132|NCT02719574|589899806|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
163324133|NCT02719574|589899807|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
163324134|NCT02719574|589899808|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
163324135|NCT02719574|589899809|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
163324136|NCT02719574|589899810|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
163324137|NCT02719574|589899811|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
163324138|NCT02719574|589899812|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
163324139|NCT02719574|589899813|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
163324140|NCT02719574|589899814|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
163324141|NCT02719574|589899815|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
163324142|NCT02719574|589899816|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
163324143|NCT02719574|589899817|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
163324144|NCT02719574|589899818|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
163324145|NCT02719574|589899819|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
163324146|NCT02719574|589899820|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
163324147|NCT02719574|589899804|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
163324148|NCT02719574|589899805|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
163324149|NCT02719574|589899806|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
163324150|NCT02719574|589899807|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
163324151|NCT02719574|589899808|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
163324152|NCT02719574|589899809|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
163324153|NCT02719574|589899810|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
163324154|NCT02719574|589899811|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
163324155|NCT02719574|589899812|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
163324156|NCT02719574|589899813|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
163324157|NCT02719574|589899814|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
163324158|NCT02719574|589899815|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
163324159|NCT02719574|589899816|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
163324160|NCT02719574|589899817|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
163324161|NCT02719574|589899818|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
163324162|NCT02719574|589899819|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
163324163|NCT02719574|589899820|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
163324164|NCT02719574|589899804|FG000|Phase 1 (Dose Expansion)|Other|0|||
163324165|NCT02719574|589899805|FG001|Phase 1 (Dose Expansion)|Other|0|||
163324166|NCT02719574|589899806|FG002|Phase 1 (Dose Expansion)|Other|0|||
163324167|NCT02719574|589899807|FG003|Phase 1 (Dose Expansion)|Other|0|||
163324168|NCT02719574|589899808|FG004|Phase 1 (Dose Expansion)|Other|0|||
163324169|NCT02719574|589899809|FG005|Phase 1 (Dose Expansion)|Other|0|||
163324170|NCT02719574|589899810|FG006|Phase 1 (Dose Expansion)|Other|1|||
163324171|NCT02719574|589899811|FG007|Phase 1 (Dose Expansion)|Other|7|||
163324172|NCT02719574|589899812|FG008|Phase 1 (Dose Expansion)|Other|0|||
163324173|NCT02719574|589899813|FG009|Phase 1 (Dose Expansion)|Other|0|||
163324174|NCT02719574|589899814|FG010|Phase 1 (Dose Expansion)|Other|0|||
163324175|NCT02719574|589899815|FG011|Phase 1 (Dose Expansion)|Other|0|||
163324176|NCT02719574|589899816|FG012|Phase 1 (Dose Expansion)|Other|0|||
163324177|NCT02719574|589899817|FG013|Phase 1 (Dose Expansion)|Other|0|||
163324178|NCT02719574|589899818|FG014|Phase 1 (Dose Expansion)|Other|0|||
163324179|NCT02719574|589899819|FG015|Phase 1 (Dose Expansion)|Other|0|||
163324180|NCT02719574|589899820|FG016|Phase 1 (Dose Expansion)|Other|0|||
163324181|NCT02719574|589899804|FG000|Phase 2|Protocol Defined Disease Progression|0|||
163324182|NCT02719574|589899805|FG001|Phase 2|Protocol Defined Disease Progression|0|||
163059907|NCT02110693|588928257|FG000|Overall Study|Withdrawal by Subject|6|||
163324183|NCT02719574|589899806|FG002|Phase 2|Protocol Defined Disease Progression|0|||
163324184|NCT02719574|589899807|FG003|Phase 2|Protocol Defined Disease Progression|0|||
163324185|NCT02719574|589899808|FG004|Phase 2|Protocol Defined Disease Progression|0|||
163324186|NCT02719574|589899809|FG005|Phase 2|Protocol Defined Disease Progression|0|||
163324187|NCT02719574|589899810|FG006|Phase 2|Protocol Defined Disease Progression|0|||
163324188|NCT02719574|589899811|FG007|Phase 2|Protocol Defined Disease Progression|0|||
163324189|NCT02719574|589899812|FG008|Phase 2|Protocol Defined Disease Progression|0|||
163324190|NCT02719574|589899813|FG009|Phase 2|Protocol Defined Disease Progression|65|||
163324191|NCT02719574|589899814|FG010|Phase 2|Protocol Defined Disease Progression|8|||
163324192|NCT02719574|589899815|FG011|Phase 2|Protocol Defined Disease Progression|2|||
163324193|NCT02719574|589899816|FG012|Phase 2|Protocol Defined Disease Progression|4|||
163324194|NCT02719574|589899817|FG013|Phase 2|Protocol Defined Disease Progression|9|||
163324195|NCT02719574|589899818|FG014|Phase 2|Protocol Defined Disease Progression|11|||
163324196|NCT02719574|589899819|FG015|Phase 2|Protocol Defined Disease Progression|3|||
163324197|NCT02719574|589899820|FG016|Phase 2|Protocol Defined Disease Progression|4|||
163324198|NCT02719574|589899804|FG000|Phase 2|Adverse Event|0|||
163324199|NCT02719574|589899805|FG001|Phase 2|Adverse Event|0|||
163324200|NCT02719574|589899806|FG002|Phase 2|Adverse Event|0|||
163324201|NCT02719574|589899807|FG003|Phase 2|Adverse Event|0|||
163324202|NCT02719574|589899808|FG004|Phase 2|Adverse Event|0|||
163324203|NCT02719574|589899809|FG005|Phase 2|Adverse Event|0|||
163324204|NCT02719574|589899810|FG006|Phase 2|Adverse Event|0|||
163324205|NCT02719574|589899811|FG007|Phase 2|Adverse Event|0|||
163324206|NCT02719574|589899812|FG008|Phase 2|Adverse Event|0|||
163324207|NCT02719574|589899813|FG009|Phase 2|Adverse Event|27|||
163324208|NCT02719574|589899814|FG010|Phase 2|Adverse Event|0|||
163324209|NCT02719574|589899815|FG011|Phase 2|Adverse Event|1|||
163324210|NCT02719574|589899816|FG012|Phase 2|Adverse Event|1|||
163324211|NCT02719574|589899817|FG013|Phase 2|Adverse Event|1|||
163324212|NCT02719574|589899818|FG014|Phase 2|Adverse Event|2|||
163324213|NCT02719574|589899819|FG015|Phase 2|Adverse Event|2|||
163324214|NCT02719574|589899820|FG016|Phase 2|Adverse Event|3|||
163324215|NCT02719574|589899804|FG000|Phase 2|Other|0|||
163324216|NCT02719574|589899805|FG001|Phase 2|Other|0|||
163324217|NCT02719574|589899806|FG002|Phase 2|Other|0|||
163324218|NCT02719574|589899807|FG003|Phase 2|Other|0|||
163324219|NCT02719574|589899808|FG004|Phase 2|Other|0|||
163324220|NCT02719574|589899809|FG005|Phase 2|Other|0|||
163324221|NCT02719574|589899810|FG006|Phase 2|Other|0|||
163324222|NCT02719574|589899811|FG007|Phase 2|Other|0|||
163324223|NCT02719574|589899812|FG008|Phase 2|Other|0|||
163324224|NCT02719574|589899813|FG009|Phase 2|Other|20|||
163324225|NCT02719574|589899814|FG010|Phase 2|Other|7|||
163324226|NCT02719574|589899815|FG011|Phase 2|Other|0|||
163324227|NCT02719574|589899816|FG012|Phase 2|Other|5|||
163324228|NCT02719574|589899817|FG013|Phase 2|Other|7|||
163324229|NCT02719574|589899818|FG014|Phase 2|Other|0|||
163324230|NCT02719574|589899819|FG015|Phase 2|Other|1|||
163324231|NCT02719574|589899820|FG016|Phase 2|Other|4|||
163324232|NCT02719574|589899804|FG000|Phase 2|Transplant|0|||
163324233|NCT02719574|589899805|FG001|Phase 2|Transplant|0|||
163324234|NCT02719574|589899806|FG002|Phase 2|Transplant|0|||
163324235|NCT02719574|589899807|FG003|Phase 2|Transplant|0|||
163324236|NCT02719574|589899808|FG004|Phase 2|Transplant|0|||
163324237|NCT02719574|589899809|FG005|Phase 2|Transplant|0|||
163324238|NCT02719574|589899810|FG006|Phase 2|Transplant|0|||
163324239|NCT02719574|589899811|FG007|Phase 2|Transplant|0|||
163324240|NCT02719574|589899812|FG008|Phase 2|Transplant|0|||
163324241|NCT02719574|589899813|FG009|Phase 2|Transplant|15|||
163324242|NCT02719574|589899814|FG010|Phase 2|Transplant|2|||
163324243|NCT02719574|589899815|FG011|Phase 2|Transplant|0|||
163324244|NCT02719574|589899816|FG012|Phase 2|Transplant|6|||
163324245|NCT02719574|589899817|FG013|Phase 2|Transplant|1|||
163324246|NCT02719574|589899818|FG014|Phase 2|Transplant|1|||
163324247|NCT02719574|589899819|FG015|Phase 2|Transplant|0|||
163324248|NCT02719574|589899820|FG016|Phase 2|Transplant|0|||
163324249|NCT02719574|589899804|FG000|Phase 2|Death|0|||
163403944|NCT03882970|590190085|FG002|Overall Study|Lost to Follow-up|5|||
163059908|NCT02110693|588928258|FG001|Overall Study|Withdrawal by Subject|7|||
163324250|NCT02719574|589899805|FG001|Phase 2|Death|0|||
163324251|NCT02719574|589899806|FG002|Phase 2|Death|0|||
163324252|NCT02719574|589899807|FG003|Phase 2|Death|0|||
163324253|NCT02719574|589899808|FG004|Phase 2|Death|0|||
163324254|NCT02719574|589899809|FG005|Phase 2|Death|0|||
163324255|NCT02719574|589899810|FG006|Phase 2|Death|0|||
163324256|NCT02719574|589899811|FG007|Phase 2|Death|0|||
163324257|NCT02719574|589899812|FG008|Phase 2|Death|0|||
163324258|NCT02719574|589899813|FG009|Phase 2|Death|14|||
163324259|NCT02719574|589899814|FG010|Phase 2|Death|0|||
163324260|NCT02719574|589899815|FG011|Phase 2|Death|0|||
163324261|NCT02719574|589899816|FG012|Phase 2|Death|1|||
163324262|NCT02719574|589899817|FG013|Phase 2|Death|1|||
163324263|NCT02719574|589899818|FG014|Phase 2|Death|2|||
163324264|NCT02719574|589899819|FG015|Phase 2|Death|0|||
163324265|NCT02719574|589899820|FG016|Phase 2|Death|0|||
163324266|NCT02719574|589899804|FG000|Phase 2|Investigator Decision|0|||
163403945|NCT03882970|590190086|FG003|Overall Study|Lost to Follow-up|5|||
163403946|NCT03882970|590190083|FG000|Overall Study|Physician Decision|0|||
163403947|NCT03882970|590190084|FG001|Overall Study|Physician Decision|2|||
163403948|NCT03882970|590190085|FG002|Overall Study|Physician Decision|2|||
163403949|NCT03882970|590190086|FG003|Overall Study|Physician Decision|2|||
163403950|NCT03882970|590190083|FG000|Overall Study|Protocol Violation|2|||
163403951|NCT03882970|590190084|FG001|Overall Study|Protocol Violation|0|||
163403952|NCT03882970|590190085|FG002|Overall Study|Protocol Violation|0|||
163403953|NCT03882970|590190086|FG003|Overall Study|Protocol Violation|0|||
163403954|NCT03882970|590190083|FG000|Overall Study|Withdrawal by Subject|8|||
163403955|NCT03882970|590190084|FG001|Overall Study|Withdrawal by Subject|17|||
163403956|NCT03882970|590190085|FG002|Overall Study|Withdrawal by Subject|7|||
163403957|NCT03882970|590190086|FG003|Overall Study|Withdrawal by Subject|22|||
163403958|NCT03882970|590190083|FG000|Overall Study|Personal Reason|2|||
163403959|NCT03882970|590190084|FG001|Overall Study|Personal Reason|3|||
163403960|NCT03882970|590190085|FG002|Overall Study|Personal Reason|1|||
163403961|NCT03882970|590190086|FG003|Overall Study|Personal Reason|3|||
163403962|NCT02863809|590190087|FG000|Overall Study|Adverse Event|8|||
163403963|NCT02863809|590190088|FG001|Overall Study|Adverse Event|8|||
163403964|NCT02863809|590190087|FG000|Overall Study|Withdrawal by Subject|0|||
163403965|NCT02863809|590190088|FG001|Overall Study|Withdrawal by Subject|1|||
163403966|NCT02863809|590190087|FG000|Overall Study|Lost to Follow-up|1|||
163403967|NCT02863809|590190088|FG001|Overall Study|Lost to Follow-up|1|||
163403968|NCT02863809|590190087|FG000|Overall Study|Death|1|||
163403969|NCT02863809|590190088|FG001|Overall Study|Death|0|||
163403970|NCT00606320|590190091|FG000|Overall Study|Adverse Event|3|||
163403971|NCT00606320|590190091|FG000|Overall Study|Lack of Efficacy|5|||
163403972|NCT00606320|590190091|FG000|Overall Study|Physician Decision|7|||
163403973|NCT00606320|590190091|FG000|Overall Study|Protocol Violation|8|||
163403974|NCT00606320|590190091|FG000|Overall Study|Withdrawal by Subject|10|||
163403975|NCT00606320|590190091|FG000|Overall Study|Progression to depressive phase|4|||
163403976|NCT00939783|590190092|FG000|Overall Study|Death|6|||
163403977|NCT00939783|590190092|FG000|Overall Study|Adverse Event|39|||
163403978|NCT00939783|590190092|FG000|Overall Study|Study Terminated by Sponsor|498|||
163403979|NCT00939783|590190092|FG000|Overall Study|Withdrawal by Subject|78|||
163403980|NCT00939783|590190092|FG000|Overall Study|Other|16|||
163403981|NCT00939783|590190092|FG000|Overall Study|Lost to Follow-up|8|||
163403982|NCT00939783|590190092|FG000|Overall Study|Protocol Violation|3|||
163403983|NCT00939783|590190092|FG000|Overall Study|Enrolled but not treated|1|||
163403984|NCT04839380|590190094|FG000|Overall Study|Withdrawal by Subject|2|||
163403985|NCT04839380|590190094|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
163403986|NCT01549002|590190098|FG000|Overall Study|Excessive pain|0|||
163403987|NCT01549002|590190099|FG001|Overall Study|Excessive pain|2|||
163403988|NCT01549002|590190098|FG000|Overall Study|Moderate sedation required|0|||
163403989|NCT01549002|590190099|FG001|Overall Study|Moderate sedation required|2|||
163403990|NCT00749996|590190100|FG000|Overall Study|Lost to Follow-up|7|||
163403991|NCT00749996|590190101|FG001|Overall Study|Lost to Follow-up|4|||
163403992|NCT00749996|590190100|FG000|Overall Study|Withdrawal by Subject|5|||
163403993|NCT00749996|590190101|FG001|Overall Study|Withdrawal by Subject|4|||
163403994|NCT00749996|590190100|FG000|Overall Study|Protocol Violation|2|||
163403995|NCT00749996|590190101|FG001|Overall Study|Protocol Violation|3|||
163403996|NCT00749996|590190100|FG000|Overall Study|Physician Decision|2|||
163403997|NCT00749996|590190101|FG001|Overall Study|Physician Decision|0|||
163403998|NCT00749996|590190100|FG000|Overall Study|Pregnancy|0|||
163403999|NCT00749996|590190101|FG001|Overall Study|Pregnancy|2|||
163404000|NCT00749996|590190100|FG000|Overall Study|Adverse Event|1|||
163404001|NCT00749996|590190101|FG001|Overall Study|Adverse Event|0|||
163404002|NCT00749996|590190100|FG000|Overall Study|Death|1|||
163404003|NCT00749996|590190101|FG001|Overall Study|Death|0|||
163404004|NCT03775421|590190104|FG000|Overall Study|Lost to Follow-up|2|||
163404005|NCT03775421|590190104|FG000|Overall Study|Withdrawal by Subject|10|||
163404006|NCT03775421|590190104|FG000|Overall Study|Physician Decision|3|||
163404007|NCT03775421|590190104|FG000|Overall Study|Death|1|||
163404008|NCT03775421|590190104|FG000|Overall Study|Study Terminated by Sponsor|94|||
163404009|NCT01227044|590190107|FG000|Overall Study|Lost to Follow-up|5|||
163404010|NCT01227044|590190108|FG001|Overall Study|Lost to Follow-up|7|||
163404011|NCT01227044|590190107|FG000|Overall Study|Discontinued Intervention|1|||
163404012|NCT01227044|590190108|FG001|Overall Study|Discontinued Intervention|2|||
163404013|NCT02250274|590190109|FG000|Overall Study|Insufficient blood draw amount|7|||
163404014|NCT02250274|590190110|FG001|Overall Study|Insufficient blood draw amount|6|||
163404015|NCT04247061|590190111|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
163404016|NCT04247061|590190111|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
163404017|NCT04247061|590190111|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
163404018|NCT02287623|590190112|FG000|Overall Study|Protocol Violation|0|||
163404019|NCT02287623|590190113|FG001|Overall Study|Protocol Violation|1|||
163404020|NCT00205855|590190124|FG000|Overall Study|Only received temporary implants|16|||
163404021|NCT00205855|590190124|FG000|Overall Study|Withdrawal by Subject|5|||
163212171|NCT02554812|589490723|FG016|Overall Study|Other|0|||
163212172|NCT02554812|589490724|FG017|Overall Study|Other|0|||
163212173|NCT02554812|589490725|FG018|Overall Study|Other|0|||
163212174|NCT02554812|589490726|FG019|Overall Study|Other|0|||
163212175|NCT02554812|589490727|FG020|Overall Study|Other|0|||
163212176|NCT02554812|589490728|FG021|Overall Study|Other|2|||
163212177|NCT02554812|589490729|FG022|Overall Study|Other|0|||
163212178|NCT02554812|589490730|FG023|Overall Study|Other|0|||
163212179|NCT02554812|589490731|FG024|Overall Study|Other|0|||
163212180|NCT02554812|589490732|FG025|Overall Study|Other|0|||
163212181|NCT02554812|589490733|FG026|Overall Study|Other|0|||
163212182|NCT02554812|589490707|FG000|Overall Study|Withdrawal by Subject|1|||
163212183|NCT02554812|589490708|FG001|Overall Study|Withdrawal by Subject|0|||
163212184|NCT02554812|589490709|FG002|Overall Study|Withdrawal by Subject|0|||
163212185|NCT02554812|589490710|FG003|Overall Study|Withdrawal by Subject|2|||
163212186|NCT02554812|589490711|FG004|Overall Study|Withdrawal by Subject|2|||
163212187|NCT02554812|589490712|FG005|Overall Study|Withdrawal by Subject|3|||
163212188|NCT02554812|589490713|FG006|Overall Study|Withdrawal by Subject|0|||
163212189|NCT02554812|589490714|FG007|Overall Study|Withdrawal by Subject|0|||
163324267|NCT02719574|589899805|FG001|Phase 2|Investigator Decision|0|||
163324268|NCT02719574|589899806|FG002|Phase 2|Investigator Decision|0|||
163324269|NCT02719574|589899807|FG003|Phase 2|Investigator Decision|0|||
163324270|NCT02719574|589899808|FG004|Phase 2|Investigator Decision|0|||
163324271|NCT02719574|589899809|FG005|Phase 2|Investigator Decision|0|||
163324272|NCT02719574|589899810|FG006|Phase 2|Investigator Decision|0|||
163324273|NCT02719574|589899811|FG007|Phase 2|Investigator Decision|0|||
163324274|NCT02719574|589899812|FG008|Phase 2|Investigator Decision|0|||
163324275|NCT02719574|589899813|FG009|Phase 2|Investigator Decision|6|||
163324276|NCT02719574|589899814|FG010|Phase 2|Investigator Decision|1|||
163324277|NCT02719574|589899815|FG011|Phase 2|Investigator Decision|2|||
163324278|NCT02719574|589899816|FG012|Phase 2|Investigator Decision|3|||
163324279|NCT02719574|589899817|FG013|Phase 2|Investigator Decision|1|||
163324280|NCT02719574|589899818|FG014|Phase 2|Investigator Decision|3|||
163324281|NCT02719574|589899819|FG015|Phase 2|Investigator Decision|2|||
163324282|NCT02719574|589899820|FG016|Phase 2|Investigator Decision|0|||
163324283|NCT02719574|589899804|FG000|Phase 2|Withdrawal by Subject|0|||
163324284|NCT02719574|589899805|FG001|Phase 2|Withdrawal by Subject|0|||
163324285|NCT02719574|589899806|FG002|Phase 2|Withdrawal by Subject|0|||
163324286|NCT02719574|589899807|FG003|Phase 2|Withdrawal by Subject|0|||
163324287|NCT02719574|589899808|FG004|Phase 2|Withdrawal by Subject|0|||
163324288|NCT02719574|589899809|FG005|Phase 2|Withdrawal by Subject|0|||
163324289|NCT02719574|589899810|FG006|Phase 2|Withdrawal by Subject|0|||
163324290|NCT02719574|589899811|FG007|Phase 2|Withdrawal by Subject|0|||
163324291|NCT02719574|589899812|FG008|Phase 2|Withdrawal by Subject|0|||
163324292|NCT02719574|589899813|FG009|Phase 2|Withdrawal by Subject|5|||
163324293|NCT02719574|589899814|FG010|Phase 2|Withdrawal by Subject|0|||
163324294|NCT02719574|589899815|FG011|Phase 2|Withdrawal by Subject|0|||
163324295|NCT02719574|589899816|FG012|Phase 2|Withdrawal by Subject|0|||
163324296|NCT02719574|589899817|FG013|Phase 2|Withdrawal by Subject|1|||
163324297|NCT02719574|589899818|FG014|Phase 2|Withdrawal by Subject|1|||
163324298|NCT02719574|589899819|FG015|Phase 2|Withdrawal by Subject|2|||
163324299|NCT02719574|589899820|FG016|Phase 2|Withdrawal by Subject|0|||
163324300|NCT02719574|589899804|FG000|Phase 2|Protocol Violation|0|||
163324301|NCT02719574|589899805|FG001|Phase 2|Protocol Violation|0|||
163324302|NCT02719574|589899806|FG002|Phase 2|Protocol Violation|0|||
163324303|NCT02719574|589899807|FG003|Phase 2|Protocol Violation|0|||
163324304|NCT02719574|589899808|FG004|Phase 2|Protocol Violation|0|||
163324305|NCT02719574|589899809|FG005|Phase 2|Protocol Violation|0|||
163324306|NCT02719574|589899810|FG006|Phase 2|Protocol Violation|0|||
163324307|NCT02719574|589899811|FG007|Phase 2|Protocol Violation|0|||
163324308|NCT02719574|589899812|FG008|Phase 2|Protocol Violation|0|||
163324309|NCT02719574|589899813|FG009|Phase 2|Protocol Violation|1|||
163324310|NCT02719574|589899814|FG010|Phase 2|Protocol Violation|0|||
163324311|NCT02719574|589899815|FG011|Phase 2|Protocol Violation|0|||
163324312|NCT02719574|589899816|FG012|Phase 2|Protocol Violation|0|||
163324313|NCT02719574|589899817|FG013|Phase 2|Protocol Violation|0|||
163324314|NCT02719574|589899818|FG014|Phase 2|Protocol Violation|0|||
163324315|NCT02719574|589899819|FG015|Phase 2|Protocol Violation|0|||
163059909|NCT02110693|588928257|FG000|Overall Study|skipped assessment|15|||
163212190|NCT02554812|589490715|FG008|Overall Study|Withdrawal by Subject|1|||
163212191|NCT02554812|589490716|FG009|Overall Study|Withdrawal by Subject|1|||
163212192|NCT02554812|589490717|FG010|Overall Study|Withdrawal by Subject|0|||
163212193|NCT02554812|589490718|FG011|Overall Study|Withdrawal by Subject|1|||
163212194|NCT02554812|589490719|FG012|Overall Study|Withdrawal by Subject|1|||
163324316|NCT02719574|589899820|FG016|Phase 2|Protocol Violation|0|||
163324317|NCT00113360|589899821|FG000|Overall Study|Adverse Event|3|||
163324318|NCT00113360|589899821|FG000|Overall Study|Subject required surgery|1|||
163324319|NCT00113360|589899821|FG000|Overall Study|Did not meet eligibility criteria|3|||
163324320|NCT02467270|589899832|FG000|Overall Study|Participants Never Treated|0|||
163212195|NCT02554812|589490720|FG013|Overall Study|Withdrawal by Subject|1|||
163324321|NCT02467270|589899833|FG001|Overall Study|Participants Never Treated|1|||
163212196|NCT02554812|589490721|FG014|Overall Study|Withdrawal by Subject|1|||
163212197|NCT02554812|589490722|FG015|Overall Study|Withdrawal by Subject|1|||
163404022|NCT01445951|590190128|FG000|Overall Study|Adverse Event|16|||
163404023|NCT01445951|590190129|FG001|Overall Study|Adverse Event|9|||
163404024|NCT01445951|590190130|FG002|Overall Study|Adverse Event|0|||
163404025|NCT01445951|590190128|FG000|Overall Study|Protocol Violation|2|||
163404026|NCT01445951|590190129|FG001|Overall Study|Protocol Violation|2|||
163404027|NCT01445951|590190130|FG002|Overall Study|Protocol Violation|2|||
163404028|NCT01445951|590190128|FG000|Overall Study|Withdrawal by Subject|21|||
163404029|NCT01445951|590190129|FG001|Overall Study|Withdrawal by Subject|16|||
163404030|NCT01445951|590190130|FG002|Overall Study|Withdrawal by Subject|8|||
163404031|NCT01445951|590190128|FG000|Overall Study|Physician Decision|3|||
163404032|NCT01445951|590190129|FG001|Overall Study|Physician Decision|1|||
163404033|NCT01445951|590190130|FG002|Overall Study|Physician Decision|0|||
163404034|NCT01445951|590190128|FG000|Overall Study|Lost to Follow-up|1|||
163404035|NCT01445951|590190129|FG001|Overall Study|Lost to Follow-up|2|||
163404036|NCT01445951|590190130|FG002|Overall Study|Lost to Follow-up|4|||
163404037|NCT01445951|590190128|FG000|Overall Study|Pregnancy|0|||
163404038|NCT01445951|590190129|FG001|Overall Study|Pregnancy|1|||
163404039|NCT01445951|590190130|FG002|Overall Study|Pregnancy|4|||
163404040|NCT01445951|590190128|FG000|Overall Study|Death|0|||
163404041|NCT01445951|590190129|FG001|Overall Study|Death|0|||
163404042|NCT01445951|590190130|FG002|Overall Study|Death|1|||
163404043|NCT01445951|590190128|FG000|Overall Study|Non-compliance with study drug|1|||
163404044|NCT01445951|590190129|FG001|Overall Study|Non-compliance with study drug|2|||
163404045|NCT01445951|590190130|FG002|Overall Study|Non-compliance with study drug|0|||
163404046|NCT01445951|590190128|FG000|Overall Study|Non-compliance with protocol|0|||
163404047|NCT01445951|590190129|FG001|Overall Study|Non-compliance with protocol|1|||
163404048|NCT01445951|590190130|FG002|Overall Study|Non-compliance with protocol|0|||
163404049|NCT01445951|590190128|FG000|Overall Study|Sponsor decision - subject travel|0|||
163404050|NCT01445951|590190129|FG001|Overall Study|Sponsor decision - subject travel|1|||
163404051|NCT01445951|590190130|FG002|Overall Study|Sponsor decision - subject travel|0|||
163404052|NCT01445951|590190128|FG000|Overall Study|Cough|0|||
163404053|NCT01445951|590190129|FG001|Overall Study|Cough|1|||
163404054|NCT01445951|590190130|FG002|Overall Study|Cough|0|||
163404055|NCT02739620|590190133|FG000|Overall Study|Lost to Follow-up|3|||
163404056|NCT02739620|590190134|FG001|Overall Study|Lost to Follow-up|1|||
163404057|NCT02739620|590190133|FG000|Overall Study|Adverse Event|0|||
163404058|NCT02739620|590190134|FG001|Overall Study|Adverse Event|1|||
163404059|NCT00786565|590190135|FG000|Enrollment Prior to Surgery|Site Closed|3|||
163404060|NCT00786565|590190135|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
163404061|NCT00786565|590190135|FG000|Post Surgery|Abnormal macular pucker|1|||
163404062|NCT00786565|590190135|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
163404063|NCT02039375|590190144|FG000|Overall Study|Lost to Follow-up|2|||
163404064|NCT03891264|590190146|FG000|Overall Study|Adverse Event|1|||
163404065|NCT03891264|590190146|FG000|Overall Study|Withdrawal by Subject|2|||
163404066|NCT03891264|590190146|FG000|Overall Study|Physician Decision|2|||
163404067|NCT01924182|590190147|FG000|Overall Study|Withdrawal by Subject|1|||
163404068|NCT01924182|590190148|FG001|Overall Study|Withdrawal by Subject|0|||
163404069|NCT03765138|590190149|FG000|Overall Study|Lost to Follow-up|1|||
163404070|NCT05003622|590190150|FG000|Overall Study|Progressive disease|2|||
163212198|NCT02554812|589490723|FG016|Overall Study|Withdrawal by Subject|3|||
163212199|NCT02554812|589490724|FG017|Overall Study|Withdrawal by Subject|1|||
163212200|NCT02554812|589490725|FG018|Overall Study|Withdrawal by Subject|0|||
163212201|NCT02554812|589490726|FG019|Overall Study|Withdrawal by Subject|2|||
162924573|NCT02406742|588426050|FG001|Overall Study|Transition to other treatment|0|||
163212202|NCT02554812|589490727|FG020|Overall Study|Withdrawal by Subject|0|||
163212203|NCT02554812|589490728|FG021|Overall Study|Withdrawal by Subject|1|||
163212204|NCT02554812|589490729|FG022|Overall Study|Withdrawal by Subject|0|||
163212205|NCT02554812|589490730|FG023|Overall Study|Withdrawal by Subject|1|||
163212206|NCT02554812|589490731|FG024|Overall Study|Withdrawal by Subject|0|||
163212207|NCT02554812|589490732|FG025|Overall Study|Withdrawal by Subject|0|||
163212208|NCT02554812|589490733|FG026|Overall Study|Withdrawal by Subject|1|||
163404071|NCT05003622|590190150|FG000|Overall Study|Withdrawal by Subject|1|||
163404072|NCT01692275|590190151|FG000|Overall Study|Lost to Follow-up|57|||
163404073|NCT01692275|590190152|FG001|Overall Study|Lost to Follow-up|48|||
163404074|NCT01692275|590190151|FG000|Overall Study|Withdrawal by Subject|9|||
163404075|NCT01692275|590190152|FG001|Overall Study|Withdrawal by Subject|11|||
163212209|NCT02554812|589490707|FG000|Overall Study|Physician Decision|1|||
163212210|NCT02554812|589490708|FG001|Overall Study|Physician Decision|0|||
163404076|NCT00278993|590190158|FG000|Overall Study|Adverse Event|24|||
163404077|NCT00278993|590190158|FG000|Overall Study|Withdrawal by Subject|5|||
163404078|NCT00278993|590190158|FG000|Overall Study|Progressive Disease|65|||
163404079|NCT00278993|590190158|FG000|Overall Study|Physician Decision|9|||
163404080|NCT00278993|590190158|FG000|Overall Study|Not Otherwise Specified|4|||
163404081|NCT00470054|590190161|FG000|Overall Study|Ineligible|1|||
163404082|NCT01439555|590190162|FG000|Overall Study|Protocol Violation|1|||
163404083|NCT04194528|590190169|FG000|Overall Study|Adverse Event|1|||
163404084|NCT03921424|590190176|FG000|Overall Study|Lost to Follow-up|0|||
163404085|NCT03921424|590190177|FG001|Overall Study|Lost to Follow-up|1|||
163404086|NCT03921424|590190176|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
163404087|NCT03921424|590190177|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
163404088|NCT01246583|590190180|FG000|Overall Study|Lost to Follow-up|0|||
163404089|NCT01246583|590190181|FG001|Overall Study|Lost to Follow-up|0|||
163404090|NCT01246583|590190182|FG002|Overall Study|Lost to Follow-up|0|||
163404091|NCT01246583|590190183|FG003|Overall Study|Lost to Follow-up|1|||
163404092|NCT01246583|590190180|FG000|Overall Study|Protocol Violation|0|||
163404093|NCT01246583|590190181|FG001|Overall Study|Protocol Violation|0|||
163404094|NCT01246583|590190182|FG002|Overall Study|Protocol Violation|1|||
163404095|NCT01246583|590190183|FG003|Overall Study|Protocol Violation|0|||
163404096|NCT01246583|590190180|FG000|Overall Study|Withdrawal by Subject|1|||
163404097|NCT01246583|590190181|FG001|Overall Study|Withdrawal by Subject|0|||
163404098|NCT01246583|590190182|FG002|Overall Study|Withdrawal by Subject|0|||
163404099|NCT01246583|590190183|FG003|Overall Study|Withdrawal by Subject|0|||
163404100|NCT02595450|590190184|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
163404101|NCT02595450|590190184|FG000|Overall Study|Enrolled, but not treated|8|||
163404102|NCT05264740|590190186|FG000|Baseline|Withdrawal by Subject|0|||
163404103|NCT05264740|590190187|FG001|Baseline|Withdrawal by Subject|1|||
163404104|NCT05264740|590190186|FG000|Follow Up 1|Lost to Follow-up|1|||
163404105|NCT05264740|590190187|FG001|Follow Up 1|Lost to Follow-up|1|||
163404106|NCT05264740|590190186|FG000|Follow Up 1|Withdrawal by Subject|0|||
163404107|NCT05264740|590190187|FG001|Follow Up 1|Withdrawal by Subject|1|||
163404108|NCT05264740|590190186|FG000|Follow Up 2|Lost to Follow-up|1|||
163404109|NCT05264740|590190187|FG001|Follow Up 2|Lost to Follow-up|4|||
163404110|NCT05264740|590190186|FG000|Follow Up 3|Lost to Follow-up|7|||
163404111|NCT05264740|590190187|FG001|Follow Up 3|Lost to Follow-up|4|||
163404112|NCT00102960|590190190|FG000|Overall Study|Death|23|||
163404113|NCT00102960|590190191|FG001|Overall Study|Death|11|||
163404114|NCT00102960|590190192|FG002|Overall Study|Death|11|||
163404115|NCT00102960|590190190|FG000|Overall Study|Lost to Follow-up|6|||
163404116|NCT00102960|590190191|FG001|Overall Study|Lost to Follow-up|12|||
163404117|NCT00102960|590190192|FG002|Overall Study|Lost to Follow-up|16|||
163404118|NCT00102960|590190190|FG000|Overall Study|Withdrawal by Subject|1|||
163404119|NCT00102960|590190191|FG001|Overall Study|Withdrawal by Subject|0|||
163404120|NCT00102960|590190192|FG002|Overall Study|Withdrawal by Subject|1|||
163404121|NCT03040999|590191880|FG000|Overall Study|Lost to Follow-up|2|||
163404122|NCT03040999|590191881|FG001|Overall Study|Lost to Follow-up|2|||
163404123|NCT03040999|590191880|FG000|Overall Study|Withdrawal by Subject|12|||
163404124|NCT03040999|590191881|FG001|Overall Study|Withdrawal by Subject|13|||
163404125|NCT03040999|590191880|FG000|Overall Study|Death|155|||
163404126|NCT03040999|590191881|FG001|Overall Study|Death|171|||
163404127|NCT03040999|590191880|FG000|Overall Study|Physician Decision|0|||
163404128|NCT03040999|590191881|FG001|Overall Study|Physician Decision|3|||
163404129|NCT05121480|590191882|FG000|Overall Study|Lack of Efficacy|2|||
163404130|NCT05121480|590191883|FG001|Overall Study|Lack of Efficacy|2|||
163404131|NCT05121480|590191884|FG002|Overall Study|Lack of Efficacy|1|||
163404132|NCT05121480|590191885|FG003|Overall Study|Lack of Efficacy|4|||
163404133|NCT05121480|590191886|FG004|Overall Study|Lack of Efficacy|0|||
163404134|NCT05121480|590191887|FG005|Overall Study|Lack of Efficacy|1|||
163404135|NCT05121480|590191888|FG006|Overall Study|Lack of Efficacy|0|||
163404136|NCT05121480|590191889|FG007|Overall Study|Lack of Efficacy|2|||
163404137|NCT05121480|590191882|FG000|Overall Study|Treatment Failure|0|||
163404138|NCT05121480|590191883|FG001|Overall Study|Treatment Failure|2|||
163404139|NCT05121480|590191884|FG002|Overall Study|Treatment Failure|0|||
163404140|NCT05121480|590191885|FG003|Overall Study|Treatment Failure|1|||
163404141|NCT05121480|590191886|FG004|Overall Study|Treatment Failure|0|||
163404142|NCT05121480|590191887|FG005|Overall Study|Treatment Failure|0|||
163404143|NCT05121480|590191888|FG006|Overall Study|Treatment Failure|0|||
163404144|NCT05121480|590191889|FG007|Overall Study|Treatment Failure|0|||
163404145|NCT05121480|590191882|FG000|Overall Study|Adverse Event|0|||
163404146|NCT05121480|590191883|FG001|Overall Study|Adverse Event|1|||
163404147|NCT05121480|590191884|FG002|Overall Study|Adverse Event|0|||
163404148|NCT05121480|590191885|FG003|Overall Study|Adverse Event|5|||
163404149|NCT05121480|590191886|FG004|Overall Study|Adverse Event|3|||
163404150|NCT05121480|590191887|FG005|Overall Study|Adverse Event|2|||
163404151|NCT05121480|590191888|FG006|Overall Study|Adverse Event|0|||
163404152|NCT05121480|590191889|FG007|Overall Study|Adverse Event|4|||
163404153|NCT05121480|590191882|FG000|Overall Study|Withdrawal by Subject|4|||
163404154|NCT05121480|590191883|FG001|Overall Study|Withdrawal by Subject|9|||
163404155|NCT05121480|590191884|FG002|Overall Study|Withdrawal by Subject|1|||
163404156|NCT05121480|590191885|FG003|Overall Study|Withdrawal by Subject|8|||
163059910|NCT02110693|588928258|FG001|Overall Study|skipped assessment|18|||
163404157|NCT05121480|590191886|FG004|Overall Study|Withdrawal by Subject|0|||
163404158|NCT05121480|590191887|FG005|Overall Study|Withdrawal by Subject|9|||
163404159|NCT05121480|590191888|FG006|Overall Study|Withdrawal by Subject|0|||
163404160|NCT05121480|590191889|FG007|Overall Study|Withdrawal by Subject|4|||
163404161|NCT05121480|590191882|FG000|Overall Study|Non-compliance with the protocol|0|||
163404162|NCT05121480|590191883|FG001|Overall Study|Non-compliance with the protocol|0|||
163404163|NCT05121480|590191884|FG002|Overall Study|Non-compliance with the protocol|0|||
163404164|NCT05121480|590191885|FG003|Overall Study|Non-compliance with the protocol|0|||
163404165|NCT05121480|590191886|FG004|Overall Study|Non-compliance with the protocol|1|||
163404166|NCT05121480|590191887|FG005|Overall Study|Non-compliance with the protocol|6|||
163404167|NCT05121480|590191888|FG006|Overall Study|Non-compliance with the protocol|0|||
163404168|NCT05121480|590191889|FG007|Overall Study|Non-compliance with the protocol|1|||
163404169|NCT05121480|590191882|FG000|Overall Study|Lost to Follow-up|0|||
163404170|NCT05121480|590191883|FG001|Overall Study|Lost to Follow-up|4|||
163404171|NCT05121480|590191884|FG002|Overall Study|Lost to Follow-up|1|||
163404172|NCT05121480|590191885|FG003|Overall Study|Lost to Follow-up|3|||
163404173|NCT05121480|590191886|FG004|Overall Study|Lost to Follow-up|1|||
163404174|NCT05121480|590191887|FG005|Overall Study|Lost to Follow-up|1|||
163404175|NCT05121480|590191888|FG006|Overall Study|Lost to Follow-up|1|||
163404176|NCT05121480|590191889|FG007|Overall Study|Lost to Follow-up|4|||
163404177|NCT05121480|590191882|FG000|Overall Study|Physician Decision|0|||
163404178|NCT05121480|590191883|FG001|Overall Study|Physician Decision|0|||
163404179|NCT05121480|590191884|FG002|Overall Study|Physician Decision|0|||
163404180|NCT05121480|590191885|FG003|Overall Study|Physician Decision|0|||
163404181|NCT05121480|590191886|FG004|Overall Study|Physician Decision|0|||
163404182|NCT05121480|590191887|FG005|Overall Study|Physician Decision|1|||
163404183|NCT05121480|590191888|FG006|Overall Study|Physician Decision|0|||
163404184|NCT05121480|590191889|FG007|Overall Study|Physician Decision|1|||
163404185|NCT05121480|590191882|FG000|Overall Study|Other Reason|0|||
163404186|NCT05121480|590191883|FG001|Overall Study|Other Reason|0|||
163404187|NCT05121480|590191884|FG002|Overall Study|Other Reason|0|||
163404188|NCT05121480|590191885|FG003|Overall Study|Other Reason|0|||
163404189|NCT05121480|590191886|FG004|Overall Study|Other Reason|0|||
163404190|NCT05121480|590191887|FG005|Overall Study|Other Reason|1|||
163404191|NCT05121480|590191888|FG006|Overall Study|Other Reason|1|||
163404192|NCT05121480|590191889|FG007|Overall Study|Other Reason|1|||
163404193|NCT01964352|590191896|FG000|Overall Study|Adverse Event|13|||
163404194|NCT01964352|590191897|FG001|Overall Study|Adverse Event|3|||
163404195|NCT01964352|590191898|FG002|Overall Study|Adverse Event|4|||
163404196|NCT01964352|590191899|FG003|Overall Study|Adverse Event|3|||
163404197|NCT01964352|590191896|FG000|Overall Study|Lack of Efficacy|6|||
163404198|NCT01964352|590191897|FG001|Overall Study|Lack of Efficacy|0|||
163404199|NCT01964352|590191898|FG002|Overall Study|Lack of Efficacy|0|||
163404200|NCT01964352|590191899|FG003|Overall Study|Lack of Efficacy|0|||
163404201|NCT01964352|590191896|FG000|Overall Study|Protocol Violation|2|||
163404202|NCT01964352|590191897|FG001|Overall Study|Protocol Violation|4|||
163404203|NCT01964352|590191898|FG002|Overall Study|Protocol Violation|0|||
163404204|NCT01964352|590191899|FG003|Overall Study|Protocol Violation|2|||
162987656|NCT02393248|588661226|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987657|NCT02393248|588661227|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
162987658|NCT02393248|588661228|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
162987659|NCT02393248|588661229|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987660|NCT02393248|588661230|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987661|NCT02393248|588661231|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987662|NCT02393248|588661232|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987663|NCT02393248|588661233|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987664|NCT02393248|588661234|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987665|NCT02393248|588661235|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987666|NCT02393248|588661236|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987667|NCT02393248|588661237|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987668|NCT02393248|588661238|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987669|NCT02393248|588661239|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987670|NCT02393248|588661240|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987671|NCT02393248|588661241|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987672|NCT02393248|588661242|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987673|NCT02393248|588661243|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
163059911|NCT02110693|588928257|FG000|Overall Study|technical difficulties|6|||
163059912|NCT02110693|588928258|FG001|Overall Study|technical difficulties|4|||
163404205|NCT01964352|590191896|FG000|Overall Study|Lost to Follow-up|1|||
163404206|NCT01964352|590191897|FG001|Overall Study|Lost to Follow-up|0|||
163404207|NCT01964352|590191898|FG002|Overall Study|Lost to Follow-up|0|||
163404208|NCT01964352|590191899|FG003|Overall Study|Lost to Follow-up|1|||
163404209|NCT01964352|590191896|FG000|Overall Study|Withdrawal by Subject|4|||
163404210|NCT01964352|590191897|FG001|Overall Study|Withdrawal by Subject|2|||
163404211|NCT01964352|590191898|FG002|Overall Study|Withdrawal by Subject|1|||
163059913|NCT02110693|588928257|FG000|Overall Study|Other|1|||
163404212|NCT01964352|590191899|FG003|Overall Study|Withdrawal by Subject|0|||
163404213|NCT01964352|590191896|FG000|Overall Study|Other than stated above|0|||
163404214|NCT01964352|590191897|FG001|Overall Study|Other than stated above|2|||
163404215|NCT01964352|590191898|FG002|Overall Study|Other than stated above|1|||
162987674|NCT02393248|588661244|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987675|NCT02393248|588661245|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987676|NCT02393248|588661246|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987677|NCT02393248|588661222|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987678|NCT02393248|588661223|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
162987679|NCT02393248|588661224|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987680|NCT02393248|588661225|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987681|NCT02393248|588661226|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987682|NCT02393248|588661227|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987683|NCT02393248|588661228|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987684|NCT02393248|588661229|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987685|NCT02393248|588661230|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987686|NCT02393248|588661231|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987687|NCT02393248|588661232|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987688|NCT02393248|588661233|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987689|NCT02393248|588661234|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987690|NCT02393248|588661235|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987691|NCT02393248|588661236|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987692|NCT02393248|588661237|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987693|NCT02393248|588661238|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987694|NCT02393248|588661239|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987695|NCT02393248|588661240|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987696|NCT02393248|588661241|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987697|NCT02393248|588661242|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987698|NCT02393248|588661243|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987699|NCT02393248|588661244|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987700|NCT02393248|588661245|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987701|NCT02393248|588661246|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987702|NCT02393248|588661222|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
162987703|NCT02393248|588661223|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
162987704|NCT02393248|588661224|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
162987705|NCT02393248|588661225|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
162987706|NCT02393248|588661226|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
162987707|NCT02393248|588661227|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
162987708|NCT02393248|588661228|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
162987709|NCT02393248|588661229|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
162987710|NCT02393248|588661230|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
162987711|NCT02393248|588661231|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
162987712|NCT02393248|588661232|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
162987713|NCT02393248|588661233|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
162987714|NCT02393248|588661234|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
162987715|NCT02393248|588661235|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
162987716|NCT02393248|588661236|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
162987717|NCT02393248|588661237|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
162987718|NCT02393248|588661238|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
162987719|NCT02393248|588661239|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
162987720|NCT02393248|588661240|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
162987721|NCT02393248|588661241|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
162987722|NCT02393248|588661242|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
162987723|NCT02393248|588661243|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
162987724|NCT02393248|588661244|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
162987725|NCT02393248|588661245|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
162987726|NCT02393248|588661246|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
162987727|NCT02393248|588661222|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
162987728|NCT02393248|588661223|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987729|NCT02393248|588661224|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987730|NCT02393248|588661225|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987731|NCT02393248|588661226|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987732|NCT02393248|588661227|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987733|NCT02393248|588661228|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987734|NCT02393248|588661229|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987735|NCT02393248|588661230|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987736|NCT02393248|588661231|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987737|NCT02393248|588661232|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987738|NCT02393248|588661233|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
163059914|NCT02110693|588928258|FG001|Overall Study|Other|0|||
163324322|NCT02467270|589899834|FG002|Overall Study|Participants Never Treated|0|||
163324323|NCT02467270|589899832|FG000|Overall Study|Ongoing|50|||
163324324|NCT02467270|589899833|FG001|Overall Study|Ongoing|41|||
163324325|NCT02467270|589899834|FG002|Overall Study|Ongoing|43|||
163324326|NCT02467270|589899832|FG000|Overall Study|Adverse Event|16|||
163324327|NCT02467270|589899833|FG001|Overall Study|Adverse Event|15|||
163324328|NCT02467270|589899834|FG002|Overall Study|Adverse Event|14|||
163324329|NCT02467270|589899832|FG000|Overall Study|Progressive Disease|7|||
162987739|NCT02393248|588661234|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987740|NCT02393248|588661235|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987741|NCT02393248|588661236|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987742|NCT02393248|588661237|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987743|NCT02393248|588661238|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987744|NCT02393248|588661239|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987745|NCT02393248|588661240|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987746|NCT02393248|588661241|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987747|NCT02393248|588661242|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987748|NCT02393248|588661243|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987749|NCT02393248|588661244|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987750|NCT02393248|588661245|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987751|NCT02393248|588661246|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987752|NCT02393248|588661222|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987753|NCT02393248|588661223|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987754|NCT02393248|588661224|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987755|NCT02393248|588661225|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987756|NCT02393248|588661226|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987757|NCT02393248|588661227|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
162987758|NCT02393248|588661228|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
162987759|NCT02393248|588661229|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987760|NCT02393248|588661230|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987761|NCT02393248|588661231|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
162987762|NCT02393248|588661232|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987763|NCT02393248|588661233|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987764|NCT02393248|588661234|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987765|NCT02393248|588661235|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987766|NCT02393248|588661236|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987767|NCT02393248|588661237|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987768|NCT02393248|588661238|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987769|NCT02393248|588661239|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987770|NCT02393248|588661240|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987771|NCT02393248|588661241|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987772|NCT02393248|588661242|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987773|NCT02393248|588661243|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987774|NCT02393248|588661244|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987775|NCT02393248|588661245|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987776|NCT02393248|588661246|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987777|NCT02393248|588661222|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987778|NCT02393248|588661223|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987779|NCT02393248|588661224|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987780|NCT02393248|588661225|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987781|NCT02393248|588661226|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987782|NCT02393248|588661227|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
163059915|NCT01056276|588928259|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
163324330|NCT02467270|589899833|FG001|Overall Study|Progressive Disease|7|||
163324331|NCT02467270|589899834|FG002|Overall Study|Progressive Disease|4|||
163324332|NCT02467270|589899832|FG000|Overall Study|Death|2|||
163324333|NCT02467270|589899833|FG001|Overall Study|Death|0|||
163324334|NCT02467270|589899834|FG002|Overall Study|Death|2|||
163324335|NCT02467270|589899832|FG000|Overall Study|Lack of Efficacy|12|||
163404216|NCT01964352|590191899|FG003|Overall Study|Other than stated above|2|||
163404217|NCT02831673|590191900|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
163404218|NCT02831673|590191901|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
163404219|NCT02831673|590191902|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
163404220|NCT02831673|590191903|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
163404221|NCT02831673|590191904|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
163404222|NCT02831673|590191900|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
163404223|NCT02831673|590191901|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
163404224|NCT02831673|590191902|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
163404225|NCT02831673|590191903|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
163404226|NCT02831673|590191904|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
162987783|NCT02393248|588661228|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
162987784|NCT02393248|588661229|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987785|NCT02393248|588661230|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987786|NCT02393248|588661231|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987787|NCT02393248|588661232|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987788|NCT02393248|588661233|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987789|NCT02393248|588661234|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987790|NCT02393248|588661235|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987791|NCT02393248|588661236|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987792|NCT02393248|588661237|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987793|NCT02393248|588661238|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987794|NCT02393248|588661239|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987795|NCT02393248|588661240|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987796|NCT02393248|588661241|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987797|NCT02393248|588661242|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987798|NCT02393248|588661243|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987799|NCT02393248|588661244|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987800|NCT02393248|588661245|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987801|NCT02393248|588661246|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987802|NCT02393248|588661222|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987803|NCT02393248|588661223|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987804|NCT02393248|588661224|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987805|NCT02393248|588661225|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987806|NCT02393248|588661226|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987807|NCT02393248|588661227|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987808|NCT02393248|588661228|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987809|NCT02393248|588661229|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987810|NCT02393248|588661230|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987811|NCT02393248|588661231|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987812|NCT02393248|588661232|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987813|NCT02393248|588661233|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
162987814|NCT02393248|588661234|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
162987815|NCT02393248|588661235|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
162987816|NCT02393248|588661236|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
162987817|NCT02393248|588661237|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987818|NCT02393248|588661238|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987819|NCT02393248|588661239|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987820|NCT02393248|588661240|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987821|NCT02393248|588661241|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987822|NCT02393248|588661242|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987823|NCT02393248|588661243|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987824|NCT02393248|588661244|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987825|NCT02393248|588661245|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
163059916|NCT01056276|588928260|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
163059917|NCT01056276|588928259|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
163059918|NCT01056276|588928260|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
163059919|NCT01056276|588928259|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
163059920|NCT01056276|588928260|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
162987826|NCT02393248|588661246|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987827|NCT02393248|588661222|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987828|NCT02393248|588661223|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987829|NCT02393248|588661224|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987830|NCT02393248|588661225|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987831|NCT02393248|588661226|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987832|NCT02393248|588661227|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987833|NCT02393248|588661228|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987834|NCT02393248|588661229|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987835|NCT02393248|588661230|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
163059921|NCT01056276|588928259|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
162987836|NCT02393248|588661231|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987837|NCT02393248|588661232|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
162987838|NCT02393248|588661233|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
163059922|NCT01056276|588928260|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
163059923|NCT01056276|588928259|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
163059924|NCT01056276|588928260|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
163059925|NCT01056276|588928259|FG000|Treatment Period-Cycles 1-8|Death|3|||
163059926|NCT01056276|588928260|FG001|Treatment Period-Cycles 1-8|Death|1|||
163059927|NCT01056276|588928259|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
163059928|NCT01056276|588928260|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
163059929|NCT01056276|588928259|FG000|Maintenance Therapy|Toxicity|0|||
163059930|NCT01056276|588928260|FG001|Maintenance Therapy|Toxicity|2|||
163059931|NCT01056276|588928259|FG000|Maintenance Therapy|Progressive Disease|0|||
163059932|NCT01056276|588928260|FG001|Maintenance Therapy|Progressive Disease|9|||
163324336|NCT02467270|589899833|FG001|Overall Study|Lack of Efficacy|18|||
163324337|NCT02467270|589899834|FG002|Overall Study|Lack of Efficacy|23|||
163324338|NCT02467270|589899832|FG000|Overall Study|Non-compliance With Study Drug|0|||
163324339|NCT02467270|589899833|FG001|Overall Study|Non-compliance With Study Drug|2|||
163324340|NCT02467270|589899834|FG002|Overall Study|Non-compliance With Study Drug|1|||
163324341|NCT02467270|589899832|FG000|Overall Study|Lost to Follow-up|2|||
163324342|NCT02467270|589899833|FG001|Overall Study|Lost to Follow-up|1|||
163324343|NCT02467270|589899834|FG002|Overall Study|Lost to Follow-up|0|||
163324344|NCT02467270|589899832|FG000|Overall Study|Pregnancy|0|||
163324345|NCT02467270|589899833|FG001|Overall Study|Pregnancy|1|||
163324346|NCT02467270|589899834|FG002|Overall Study|Pregnancy|0|||
163324347|NCT02467270|589899832|FG000|Overall Study|Physician Decision|0|||
163324348|NCT02467270|589899833|FG001|Overall Study|Physician Decision|4|||
162987839|NCT02393248|588661234|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987840|NCT02393248|588661235|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987841|NCT02393248|588661236|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987842|NCT02393248|588661237|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987843|NCT02393248|588661238|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987844|NCT02393248|588661239|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987845|NCT02393248|588661240|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987846|NCT02393248|588661241|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987847|NCT02393248|588661242|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987848|NCT02393248|588661243|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987849|NCT02393248|588661244|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987850|NCT02393248|588661245|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987851|NCT02393248|588661246|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987852|NCT02393248|588661222|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
162987853|NCT02393248|588661223|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
162987854|NCT02393248|588661224|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
162987855|NCT02393248|588661225|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
162987856|NCT02393248|588661226|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
162987857|NCT02393248|588661227|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
162987858|NCT02393248|588661228|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
162987859|NCT02393248|588661229|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
162987860|NCT02393248|588661230|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
162987861|NCT02393248|588661231|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
162987862|NCT02393248|588661232|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
162987863|NCT02393248|588661233|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
162987864|NCT02393248|588661234|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
162987865|NCT02393248|588661235|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
162987866|NCT02393248|588661236|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
162987867|NCT02393248|588661237|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
162987868|NCT02393248|588661238|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
162987869|NCT02393248|588661239|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
162987870|NCT02393248|588661240|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
162987871|NCT02393248|588661241|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
162987872|NCT02393248|588661242|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
162987873|NCT02393248|588661243|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
162987874|NCT02393248|588661244|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
163324349|NCT02467270|589899834|FG002|Overall Study|Physician Decision|1|||
163324350|NCT02467270|589899832|FG000|Overall Study|Withdrawal by Subject|4|||
162987875|NCT02393248|588661245|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
162987876|NCT02393248|588661246|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
162987877|NCT02393248|588661222|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
163059933|NCT01056276|588928259|FG000|Maintenance Therapy|Physician Decision|0|||
163059934|NCT01056276|588928260|FG001|Maintenance Therapy|Physician Decision|1|||
163059935|NCT01056276|588928259|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
163324351|NCT02467270|589899833|FG001|Overall Study|Withdrawal by Subject|3|||
162987878|NCT02393248|588661223|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
163324352|NCT02467270|589899834|FG002|Overall Study|Withdrawal by Subject|5|||
163324353|NCT02467270|589899832|FG000|Overall Study|Reason not Specified|1|||
163324354|NCT02467270|589899833|FG001|Overall Study|Reason not Specified|2|||
163324355|NCT02467270|589899834|FG002|Overall Study|Reason not Specified|1|||
162987879|NCT02393248|588661224|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987880|NCT02393248|588661225|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987881|NCT02393248|588661226|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987882|NCT02393248|588661227|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987883|NCT02393248|588661228|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987884|NCT02393248|588661229|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987885|NCT02393248|588661230|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987886|NCT02393248|588661231|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987887|NCT02393248|588661232|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987888|NCT02393248|588661233|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
162987889|NCT02393248|588661234|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987890|NCT02393248|588661235|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
162987891|NCT02393248|588661236|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987892|NCT02393248|588661237|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987893|NCT02393248|588661238|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987894|NCT02393248|588661239|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987895|NCT02393248|588661240|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987896|NCT02393248|588661241|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987897|NCT02393248|588661242|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987898|NCT02393248|588661243|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987899|NCT02393248|588661244|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987900|NCT02393248|588661245|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987901|NCT02393248|588661246|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987902|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987903|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987904|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987905|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987906|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987907|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987908|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987909|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987910|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987911|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987912|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987913|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987914|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987915|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987916|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987917|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987918|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987919|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987920|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
162987921|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987922|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
162987923|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
162987924|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987925|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
162987926|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987927|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Death|0|||
162987928|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Death|0|||
162987929|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Death|0|||
162987930|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Death|0|||
162987931|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Death|0|||
162987932|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Death|0|||
162987933|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Death|0|||
162987934|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Death|0|||
162987935|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Death|0|||
162987936|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Death|0|||
162987937|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Death|0|||
162987938|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Death|0|||
162987939|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Death|0|||
162987940|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Death|0|||
162987941|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Death|0|||
162987942|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Death|1|||
162987943|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Death|7|||
162987944|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Death|5|||
162987945|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Death|5|||
162987946|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Death|3|||
162987947|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Death|7|||
162987948|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Death|5|||
163324356|NCT00495677|589899836|FG000|Stage 1 (25 Days)|Adverse Event|0|||
163324357|NCT00495677|589899837|FG001|Stage 1 (25 Days)|Adverse Event|0|||
163324358|NCT00495677|589899838|FG002|Stage 1 (25 Days)|Adverse Event|1|||
163324359|NCT00495677|589899839|FG003|Stage 1 (25 Days)|Adverse Event|0|||
163324360|NCT00495677|589899840|FG004|Stage 1 (25 Days)|Adverse Event|0|||
163324361|NCT00495677|589899841|FG005|Stage 1 (25 Days)|Adverse Event|0|||
163324362|NCT00495677|589899842|FG006|Stage 1 (25 Days)|Adverse Event|0|||
163324363|NCT02306161|589899846|FG000|Overall Study|Death|1|||
163324364|NCT02306161|589899847|FG001|Overall Study|Death|3|||
163324365|NCT02306161|589899846|FG000|Overall Study|Lack of Efficacy|20|||
163324366|NCT02306161|589899847|FG001|Overall Study|Lack of Efficacy|43|||
163324367|NCT02306161|589899846|FG000|Overall Study|Physician Decision|30|||
163324368|NCT02306161|589899847|FG001|Overall Study|Physician Decision|18|||
163324369|NCT02306161|589899846|FG000|Overall Study|Withdrawal by Subject|4|||
163324370|NCT02306161|589899847|FG001|Overall Study|Withdrawal by Subject|0|||
163324371|NCT02306161|589899846|FG000|Overall Study|Ineligible|9|||
162987949|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Death|6|||
162987950|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Death|3|||
162987951|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Death|0|||
162987952|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987953|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987954|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987955|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987956|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987957|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987958|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987959|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987960|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987961|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987962|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987963|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987964|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987965|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987966|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987967|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987968|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987969|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
162987970|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
162987971|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987972|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
162987973|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
162987974|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
162987975|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
162987976|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
162987977|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Disease Progression|0|||
162987978|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Disease Progression|0|||
162987979|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Disease Progression|0|||
162987980|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Disease Progression|0|||
162987981|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Disease Progression|0|||
162987982|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Disease Progression|0|||
162987983|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Disease Progression|0|||
162987984|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Disease Progression|0|||
162987985|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Disease Progression|0|||
162987986|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Disease Progression|0|||
162987987|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Disease Progression|0|||
162987988|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Disease Progression|0|||
162987989|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Disease Progression|0|||
162987990|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Disease Progression|0|||
162987991|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Disease Progression|0|||
162987992|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Disease Progression|0|||
162987993|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Disease Progression|0|||
163324372|NCT02306161|589899847|FG001|Overall Study|Ineligible|5|||
163324373|NCT05030584|589899850|FG000|Overall Study|Adverse Event|17|||
163324374|NCT05030584|589899851|FG001|Overall Study|Adverse Event|2|||
163324375|NCT05030584|589899850|FG000|Overall Study|Lack of Efficacy|0|||
163324376|NCT05030584|589899851|FG001|Overall Study|Lack of Efficacy|6|||
163324377|NCT05030584|589899850|FG000|Overall Study|Lost to Follow-up|5|||
163324378|NCT05030584|589899851|FG001|Overall Study|Lost to Follow-up|2|||
163324379|NCT05030584|589899850|FG000|Overall Study|Non-Compliance with Study Drug|2|||
162987994|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Disease Progression|0|||
163324380|NCT05030584|589899851|FG001|Overall Study|Non-Compliance with Study Drug|3|||
163324381|NCT05030584|589899850|FG000|Overall Study|Other reason|4|||
162987995|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Disease Progression|0|||
162987996|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Disease Progression|0|||
162987997|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Disease Progression|2|||
162987998|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Disease Progression|1|||
162987999|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Disease Progression|0|||
162988000|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Disease Progression|0|||
162988001|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Disease Progression|0|||
162988002|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988003|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988004|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988005|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988006|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988007|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988008|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988009|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988010|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988011|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988012|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988013|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988014|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988015|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988016|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988017|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988018|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988019|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988020|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988021|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988022|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
162988023|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
162988024|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988025|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988026|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988027|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988028|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988029|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988030|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988031|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988032|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988033|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988034|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988035|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988036|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988037|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988038|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988039|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
163324382|NCT05030584|589899851|FG001|Overall Study|Other reason|3|||
163324383|NCT05030584|589899850|FG000|Overall Study|Physician Decision|1|||
163324384|NCT05030584|589899851|FG001|Overall Study|Physician Decision|4|||
163324385|NCT05030584|589899850|FG000|Overall Study|Protocol Violation|0|||
163324386|NCT05030584|589899851|FG001|Overall Study|Protocol Violation|2|||
163324387|NCT05030584|589899850|FG000|Overall Study|Randomized by Mistake|0|||
163324388|NCT05030584|589899851|FG001|Overall Study|Randomized by Mistake|2|||
163324389|NCT05030584|589899850|FG000|Overall Study|Withdrawal by Subject|21|||
163324390|NCT05030584|589899851|FG001|Overall Study|Withdrawal by Subject|28|||
163324391|NCT05030584|589899850|FG000|Overall Study|Technical Problems|0|||
163059936|NCT01056276|588928260|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
163059937|NCT01056276|588928259|FG000|Maintenance Therapy|Intercurrent Illness|0|||
163059938|NCT01056276|588928260|FG001|Maintenance Therapy|Intercurrent Illness|1|||
163324392|NCT05030584|589899851|FG001|Overall Study|Technical Problems|1|||
163324393|NCT05030584|589899850|FG000|Overall Study|Completed post-treatment/FU visits|41|||
163324394|NCT05030584|589899851|FG001|Overall Study|Completed post-treatment/FU visits|31|||
163324395|NCT02532621|589899858|FG000|Overall Study|Death|3|||
163324396|NCT02532621|589899858|FG000|Overall Study|Lost to Follow-up|3|||
163324397|NCT02532621|589899858|FG000|Overall Study|Withdrawal by Subject|6|||
163324398|NCT02532621|589899858|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
163324399|NCT02532621|589899858|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
162988040|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988041|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988042|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988043|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988044|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988045|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988046|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988047|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
162988048|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988049|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988050|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988051|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988052|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Adverse Event|0|||
162988053|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Adverse Event|0|||
162988054|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Adverse Event|0|||
162988055|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Adverse Event|0|||
162988056|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Adverse Event|0|||
162988057|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Adverse Event|0|||
162988058|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Adverse Event|0|||
162988059|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Adverse Event|0|||
162988060|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Adverse Event|0|||
162988061|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Adverse Event|0|||
162988062|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Adverse Event|0|||
162988063|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Adverse Event|0|||
162988064|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Adverse Event|0|||
162988065|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Adverse Event|0|||
162988066|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Adverse Event|0|||
162988067|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Adverse Event|0|||
162988068|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Adverse Event|0|||
163404227|NCT02831673|590191900|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
162988069|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Adverse Event|0|||
162988070|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Adverse Event|0|||
162988071|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Adverse Event|0|||
162988072|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Adverse Event|0|||
162988073|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Adverse Event|0|||
162988074|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Adverse Event|0|||
162988075|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Adverse Event|1|||
162988076|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Adverse Event|0|||
162988077|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988078|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988079|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988080|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988081|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988082|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988083|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988084|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988085|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988086|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988087|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988088|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988089|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988090|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988091|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988092|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988093|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988094|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
163404228|NCT02831673|590191901|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
163404229|NCT02831673|590191902|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
163404230|NCT02831673|590191903|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
162988095|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
163404231|NCT02831673|590191904|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
163404232|NCT02831673|590191900|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
162988096|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988097|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988098|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988099|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988100|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
162988101|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
163404233|NCT02831673|590191901|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
163404234|NCT02831673|590191902|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
163404235|NCT02831673|590191903|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
163404236|NCT02831673|590191904|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
163404237|NCT02831673|590191900|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
163404238|NCT02831673|590191901|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
163404239|NCT02831673|590191902|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
163404240|NCT02831673|590191903|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
163404241|NCT02831673|590191904|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
163404242|NCT02831673|590191900|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
163404243|NCT02831673|590191901|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
162988102|NCT02585934|588661247|FG000|Overall Study|Lost to Follow-up|2|||
162988103|NCT02585934|588661248|FG001|Overall Study|Lost to Follow-up|2|||
162988104|NCT02585934|588661247|FG000|Overall Study|Protocol Violation|14|||
162988105|NCT02585934|588661248|FG001|Overall Study|Protocol Violation|11|||
162988106|NCT02585934|588661247|FG000|Overall Study|Adverse Event|21|||
162988107|NCT02585934|588661248|FG001|Overall Study|Adverse Event|22|||
162988108|NCT02585934|588661247|FG000|Overall Study|Physician Decision|3|||
162988109|NCT02585934|588661248|FG001|Overall Study|Physician Decision|2|||
162988110|NCT02585934|588661247|FG000|Overall Study|Withdrawal by Subject|7|||
162988111|NCT02585934|588661248|FG001|Overall Study|Withdrawal by Subject|21|||
162988112|NCT02585934|588661247|FG000|Overall Study|Lack of Efficacy|2|||
162988113|NCT02585934|588661248|FG001|Overall Study|Lack of Efficacy|1|||
162988114|NCT02585934|588661247|FG000|Overall Study|Death|2|||
162988115|NCT02585934|588661248|FG001|Overall Study|Death|0|||
162988116|NCT02585934|588661247|FG000|Overall Study|Caregiver Withdrew Consent|7|||
162988117|NCT02585934|588661248|FG001|Overall Study|Caregiver Withdrew Consent|7|||
162988118|NCT02585934|588661247|FG000|Overall Study|Sponsor Termination|1|||
162988119|NCT02585934|588661248|FG001|Overall Study|Sponsor Termination|2|||
162988120|NCT02585934|588661247|FG000|Overall Study|Another Reason|10|||
162988121|NCT02585934|588661248|FG001|Overall Study|Another Reason|5|||
162988122|NCT01359969|588661261|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
162988123|NCT00593736|588661265|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
162988124|NCT00593736|588661266|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
162988125|NCT00593736|588661267|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
162988126|NCT00593736|588661268|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
162988127|NCT00593736|588661265|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
162988128|NCT00593736|588661266|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
162988129|NCT00593736|588661267|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
162988130|NCT00593736|588661268|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
162988131|NCT00593736|588661265|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
163404244|NCT02831673|590191902|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
163404245|NCT02831673|590191903|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
162988132|NCT00593736|588661266|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
162988133|NCT00593736|588661267|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
162988134|NCT00593736|588661268|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
162988135|NCT00593736|588661265|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
162988136|NCT00593736|588661266|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
162988137|NCT00593736|588661267|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
163212211|NCT02554812|589490709|FG002|Overall Study|Physician Decision|0|||
163212212|NCT02554812|589490710|FG003|Overall Study|Physician Decision|1|||
163212213|NCT02554812|589490711|FG004|Overall Study|Physician Decision|0|||
163212214|NCT02554812|589490712|FG005|Overall Study|Physician Decision|1|||
163212215|NCT02554812|589490713|FG006|Overall Study|Physician Decision|0|||
163212216|NCT02554812|589490714|FG007|Overall Study|Physician Decision|0|||
163212217|NCT02554812|589490715|FG008|Overall Study|Physician Decision|0|||
163212218|NCT02554812|589490716|FG009|Overall Study|Physician Decision|0|||
163212219|NCT02554812|589490717|FG010|Overall Study|Physician Decision|1|||
163212220|NCT02554812|589490718|FG011|Overall Study|Physician Decision|0|||
163212221|NCT02554812|589490719|FG012|Overall Study|Physician Decision|0|||
163212222|NCT02554812|589490720|FG013|Overall Study|Physician Decision|0|||
163212223|NCT02554812|589490721|FG014|Overall Study|Physician Decision|0|||
163212224|NCT02554812|589490722|FG015|Overall Study|Physician Decision|0|||
163212225|NCT02554812|589490723|FG016|Overall Study|Physician Decision|1|||
163212226|NCT02554812|589490724|FG017|Overall Study|Physician Decision|1|||
163212227|NCT02554812|589490725|FG018|Overall Study|Physician Decision|0|||
162988138|NCT00593736|588661268|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
162988139|NCT00593736|588661265|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
162988140|NCT00593736|588661266|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
162988141|NCT00593736|588661267|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
162988142|NCT00593736|588661268|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
162988143|NCT00593736|588661265|FG000|Screening Period and Placebo Run-in|Various|0|||
162988144|NCT00593736|588661266|FG001|Screening Period and Placebo Run-in|Various|0|||
162988145|NCT00593736|588661267|FG002|Screening Period and Placebo Run-in|Various|0|||
162988146|NCT00593736|588661268|FG003|Screening Period and Placebo Run-in|Various|25|||
162988147|NCT00593736|588661265|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
162988148|NCT00593736|588661266|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
162988149|NCT00593736|588661267|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
162988150|NCT00593736|588661268|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
162988151|NCT00593736|588661265|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
162988152|NCT00593736|588661266|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
162988153|NCT00593736|588661267|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
162988154|NCT00593736|588661268|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
162988155|NCT00593736|588661265|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
162988156|NCT00593736|588661266|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
162988157|NCT00593736|588661267|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
162988158|NCT00593736|588661268|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
162988159|NCT00593736|588661265|FG000|Treatment Period and Placebo Run-out|Various|1|||
162988160|NCT00593736|588661266|FG001|Treatment Period and Placebo Run-out|Various|1|||
162988161|NCT00593736|588661267|FG002|Treatment Period and Placebo Run-out|Various|1|||
162988162|NCT00593736|588661268|FG003|Treatment Period and Placebo Run-out|Various|0|||
162988163|NCT01868893|588661269|FG000|Overall Study|Adverse Event|2|||
162988164|NCT01868893|588661269|FG000|Overall Study|Commercial availability of study drug|17|||
162988165|NCT01868893|588661269|FG000|Overall Study|Neutropenia|1|||
162988166|NCT01857271|588661270|FG000|Overall Study|Lost to Follow-up|1|||
162988167|NCT03825341|588661273|FG000|Overall Study|Withdrawal by Subject|0|||
162988168|NCT03825341|588661274|FG001|Overall Study|Withdrawal by Subject|1|||
162988169|NCT01460901|588661277|FG000|Overall Study|Withdrawal by Subject|2|||
162988170|NCT00470067|588661278|FG000|Overall Study|Death|1|||
162988171|NCT00470067|588661278|FG000|Overall Study|Disease Progression|6|||
162988172|NCT00851318|588661279|FG000|Overall Study|Withdrawal by Subject|7|||
162988173|NCT00851318|588661280|FG001|Overall Study|Withdrawal by Subject|1|||
162988174|NCT00851318|588661281|FG002|Overall Study|Withdrawal by Subject|5|||
162988175|NCT00851318|588661282|FG003|Overall Study|Withdrawal by Subject|3|||
162988176|NCT00851318|588661279|FG000|Overall Study|Adverse Event|13|||
162988177|NCT00851318|588661280|FG001|Overall Study|Adverse Event|2|||
162988178|NCT00851318|588661281|FG002|Overall Study|Adverse Event|9|||
162988179|NCT00851318|588661282|FG003|Overall Study|Adverse Event|12|||
162988180|NCT00851318|588661279|FG000|Overall Study|Pregnancy|0|||
162988181|NCT00851318|588661280|FG001|Overall Study|Pregnancy|0|||
162988182|NCT00851318|588661281|FG002|Overall Study|Pregnancy|1|||
162988183|NCT00851318|588661282|FG003|Overall Study|Pregnancy|1|||
162988184|NCT00851318|588661279|FG000|Overall Study|Lack of Efficacy|8|||
162988185|NCT00851318|588661280|FG001|Overall Study|Lack of Efficacy|2|||
162988186|NCT00851318|588661281|FG002|Overall Study|Lack of Efficacy|4|||
162988187|NCT00851318|588661282|FG003|Overall Study|Lack of Efficacy|2|||
162988188|NCT00851318|588661279|FG000|Overall Study|Non-compliance with Study Procedures|2|||
162988189|NCT00851318|588661280|FG001|Overall Study|Non-compliance with Study Procedures|0|||
162988190|NCT00851318|588661281|FG002|Overall Study|Non-compliance with Study Procedures|1|||
162988191|NCT00851318|588661282|FG003|Overall Study|Non-compliance with Study Procedures|0|||
162988192|NCT00851318|588661279|FG000|Overall Study|Physician Decision|0|||
162988193|NCT00851318|588661280|FG001|Overall Study|Physician Decision|0|||
162988194|NCT00851318|588661281|FG002|Overall Study|Physician Decision|1|||
162988195|NCT00851318|588661282|FG003|Overall Study|Physician Decision|1|||
162988196|NCT00077857|588661287|FG000|Overall Study|Adverse Event|30|||
162988197|NCT00077857|588661288|FG001|Overall Study|Adverse Event|32|||
163212228|NCT02554812|589490726|FG019|Overall Study|Physician Decision|1|||
163212229|NCT02554812|589490727|FG020|Overall Study|Physician Decision|1|||
163212230|NCT02554812|589490728|FG021|Overall Study|Physician Decision|0|||
162988198|NCT00077857|588661287|FG000|Overall Study|Death|7|||
163212231|NCT02554812|589490729|FG022|Overall Study|Physician Decision|1|||
162988199|NCT00077857|588661288|FG001|Overall Study|Death|3|||
163212232|NCT02554812|589490730|FG023|Overall Study|Physician Decision|0|||
163212233|NCT02554812|589490731|FG024|Overall Study|Physician Decision|0|||
163212234|NCT02554812|589490732|FG025|Overall Study|Physician Decision|0|||
163212235|NCT02554812|589490733|FG026|Overall Study|Physician Decision|0|||
163212236|NCT02554812|589490707|FG000|Overall Study|Study terminated by sponsor|0|||
163212237|NCT02554812|589490708|FG001|Overall Study|Study terminated by sponsor|0|||
163212238|NCT02554812|589490709|FG002|Overall Study|Study terminated by sponsor|0|||
163212239|NCT02554812|589490710|FG003|Overall Study|Study terminated by sponsor|0|||
163212240|NCT02554812|589490711|FG004|Overall Study|Study terminated by sponsor|0|||
163212241|NCT02554812|589490712|FG005|Overall Study|Study terminated by sponsor|0|||
163324400|NCT05424718|589899859|FG000|Overall Study|Lost to Follow-up|5|||
163324401|NCT05424718|589899860|FG001|Overall Study|Lost to Follow-up|4|||
163324402|NCT04046549|589899861|FG000|Overall Study|Adverse Event|1|||
162988200|NCT00077857|588661287|FG000|Overall Study|Insufficient therapeutic response|112|||
162988201|NCT00077857|588661288|FG001|Overall Study|Insufficient therapeutic response|128|||
162988202|NCT00077857|588661287|FG000|Overall Study|Violation of selection criteria at entry|3|||
162988203|NCT00077857|588661288|FG001|Overall Study|Violation of selection criteria at entry|1|||
162988204|NCT00077857|588661287|FG000|Overall Study|Other protocol violation|0|||
162988205|NCT00077857|588661288|FG001|Overall Study|Other protocol violation|1|||
162988206|NCT00077857|588661287|FG000|Overall Study|Refused treatment|29|||
162988207|NCT00077857|588661288|FG001|Overall Study|Refused treatment|21|||
162988208|NCT00077857|588661287|FG000|Overall Study|Failure to return|5|||
162988209|NCT00077857|588661288|FG001|Overall Study|Failure to return|5|||
162988210|NCT00077857|588661287|FG000|Overall Study|Other|15|||
162988211|NCT00077857|588661288|FG001|Overall Study|Other|13|||
162988212|NCT05084963|588661291|FG000|Overall Study|Withdrawal by Subject|0|||
162988213|NCT05084963|588661292|FG001|Overall Study|Withdrawal by Subject|0|||
162988214|NCT05084963|588661293|FG002|Overall Study|Withdrawal by Subject|1|||
162988215|NCT06354998|588661294|FG000|Overall Study|Withdrawal by Subject|3|||
162988216|NCT06354998|588661295|FG001|Overall Study|Withdrawal by Subject|0|||
162988217|NCT03819049|588661296|FG000|Overall Study|Lost to Follow-up|1|||
162988218|NCT03819049|588661297|FG001|Overall Study|Lost to Follow-up|2|||
162988219|NCT03819049|588661298|FG002|Overall Study|Lost to Follow-up|9|||
162988220|NCT03819049|588661299|FG003|Overall Study|Lost to Follow-up|0|||
162988221|NCT03819049|588661300|FG004|Overall Study|Lost to Follow-up|3|||
162988222|NCT03819049|588661301|FG005|Overall Study|Lost to Follow-up|1|||
162988223|NCT03819049|588661302|FG006|Overall Study|Lost to Follow-up|0|||
162988224|NCT03819049|588661296|FG000|Overall Study|Withdrawal by Subject|0|||
162988225|NCT03819049|588661297|FG001|Overall Study|Withdrawal by Subject|0|||
162988226|NCT03819049|588661298|FG002|Overall Study|Withdrawal by Subject|18|||
162988227|NCT03819049|588661299|FG003|Overall Study|Withdrawal by Subject|0|||
162988228|NCT03819049|588661300|FG004|Overall Study|Withdrawal by Subject|10|||
162988229|NCT03819049|588661301|FG005|Overall Study|Withdrawal by Subject|9|||
162988230|NCT03819049|588661302|FG006|Overall Study|Withdrawal by Subject|1|||
162988231|NCT03819049|588661296|FG000|Overall Study|Ongoing|0|||
162988232|NCT03819049|588661297|FG001|Overall Study|Ongoing|0|||
162988233|NCT03819049|588661298|FG002|Overall Study|Ongoing|75|||
162988234|NCT03819049|588661299|FG003|Overall Study|Ongoing|0|||
162988235|NCT03819049|588661300|FG004|Overall Study|Ongoing|41|||
162988236|NCT03819049|588661301|FG005|Overall Study|Ongoing|0|||
162988237|NCT03819049|588661302|FG006|Overall Study|Ongoing|0|||
162988238|NCT03819049|588661296|FG000|Overall Study|Other|0|||
162988239|NCT03819049|588661297|FG001|Overall Study|Other|0|||
163212242|NCT02554812|589490713|FG006|Overall Study|Study terminated by sponsor|0|||
163212243|NCT02554812|589490714|FG007|Overall Study|Study terminated by sponsor|0|||
163212244|NCT02554812|589490715|FG008|Overall Study|Study terminated by sponsor|0|||
162988240|NCT03819049|588661298|FG002|Overall Study|Other|2|||
162988241|NCT03819049|588661299|FG003|Overall Study|Other|0|||
162988242|NCT03819049|588661300|FG004|Overall Study|Other|0|||
162988243|NCT03819049|588661301|FG005|Overall Study|Other|0|||
162988244|NCT03819049|588661302|FG006|Overall Study|Other|0|||
162988245|NCT03819049|588661296|FG000|Overall Study|Randomized but not vaccinated|0|||
162988246|NCT03819049|588661297|FG001|Overall Study|Randomized but not vaccinated|0|||
162988247|NCT03819049|588661298|FG002|Overall Study|Randomized but not vaccinated|0|||
162988248|NCT03819049|588661299|FG003|Overall Study|Randomized but not vaccinated|1|||
162988249|NCT03819049|588661300|FG004|Overall Study|Randomized but not vaccinated|0|||
162988250|NCT03819049|588661301|FG005|Overall Study|Randomized but not vaccinated|2|||
162988251|NCT03819049|588661302|FG006|Overall Study|Randomized but not vaccinated|1|||
162988252|NCT03819049|588661296|FG000|Overall Study|Physician Decision|0|||
162988253|NCT03819049|588661297|FG001|Overall Study|Physician Decision|0|||
162988254|NCT03819049|588661298|FG002|Overall Study|Physician Decision|0|||
162988255|NCT03819049|588661299|FG003|Overall Study|Physician Decision|0|||
162988256|NCT03819049|588661300|FG004|Overall Study|Physician Decision|0|||
162988257|NCT03819049|588661301|FG005|Overall Study|Physician Decision|0|||
162988258|NCT03819049|588661302|FG006|Overall Study|Physician Decision|1|||
162988259|NCT02440568|588661304|FG000|Overall Study|Death|1|||
162988260|NCT02440568|588661305|FG001|Overall Study|Death|3|||
162988261|NCT02440568|588661306|FG002|Overall Study|Death|4|||
162988262|NCT02440568|588661307|FG003|Overall Study|Death|2|||
163212245|NCT02554812|589490716|FG009|Overall Study|Study terminated by sponsor|0|||
163212246|NCT02554812|589490717|FG010|Overall Study|Study terminated by sponsor|0|||
163324403|NCT04046549|589899861|FG000|Overall Study|Physician Decision|1|||
162988263|NCT02440568|588661304|FG000|Overall Study|Lack of Efficacy|2|||
162988264|NCT02440568|588661305|FG001|Overall Study|Lack of Efficacy|0|||
162988265|NCT02440568|588661306|FG002|Overall Study|Lack of Efficacy|1|||
162988266|NCT02440568|588661307|FG003|Overall Study|Lack of Efficacy|0|||
162988267|NCT02440568|588661304|FG000|Overall Study|Lost to Follow-up|1|||
162988268|NCT02440568|588661305|FG001|Overall Study|Lost to Follow-up|0|||
162988269|NCT02440568|588661306|FG002|Overall Study|Lost to Follow-up|0|||
162988270|NCT02440568|588661307|FG003|Overall Study|Lost to Follow-up|0|||
162988271|NCT03796039|588661310|FG000|Overall Study|Death|2|||
162988272|NCT03796039|588661311|FG001|Overall Study|Death|1|||
162988273|NCT03796039|588661310|FG000|Overall Study|Withdrawal by Subject|7|||
162988274|NCT03796039|588661311|FG001|Overall Study|Withdrawal by Subject|4|||
162988275|NCT01140503|588661312|FG000|Overall Study|Withdrawal by Subject|1|||
162988276|NCT01157897|588661314|FG000|Overall Study|Lost to Follow-up|2|||
162988277|NCT01157897|588661315|FG001|Overall Study|Lost to Follow-up|0|||
162988278|NCT01157897|588661316|FG002|Overall Study|Lost to Follow-up|0|||
162988279|NCT01157897|588661317|FG003|Overall Study|Lost to Follow-up|1|||
162988280|NCT01157897|588661314|FG000|Overall Study|Relocated|0|||
162988281|NCT01157897|588661315|FG001|Overall Study|Relocated|2|||
162988282|NCT01157897|588661316|FG002|Overall Study|Relocated|0|||
162988283|NCT01157897|588661317|FG003|Overall Study|Relocated|0|||
162988284|NCT00681590|588661318|FG000|Overall Study|Withdrawal by Subject|2|||
162988285|NCT00681590|588661319|FG001|Overall Study|Withdrawal by Subject|12|||
162988286|NCT01791153|588661322|FG000|Part 1: Blinded Period|Adverse Event|7|||
162988287|NCT01791153|588661323|FG001|Part 1: Blinded Period|Adverse Event|3|||
162988288|NCT01791153|588661324|FG002|Part 1: Blinded Period|Adverse Event|2|||
162988289|NCT01791153|588661325|FG003|Part 1: Blinded Period|Adverse Event|0|||
162988290|NCT01791153|588661326|FG004|Part 1: Blinded Period|Adverse Event|0|||
162988291|NCT01791153|588661327|FG005|Part 1: Blinded Period|Adverse Event|0|||
162988292|NCT01791153|588661328|FG006|Part 1: Blinded Period|Adverse Event|0|||
163059939|NCT01056276|588928259|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
162988293|NCT01791153|588661329|FG007|Part 1: Blinded Period|Adverse Event|0|||
162988294|NCT01791153|588661322|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
162988295|NCT01791153|588661323|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
162988296|NCT01791153|588661324|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
162988297|NCT01791153|588661325|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
162988298|NCT01791153|588661326|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
162988299|NCT01791153|588661327|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
162988300|NCT01791153|588661328|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
162988301|NCT01791153|588661329|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
162988302|NCT01791153|588661322|FG000|Part 1: Blinded Period|Non-Compliance|1|||
162988303|NCT01791153|588661323|FG001|Part 1: Blinded Period|Non-Compliance|0|||
162988304|NCT01791153|588661324|FG002|Part 1: Blinded Period|Non-Compliance|0|||
162988305|NCT01791153|588661325|FG003|Part 1: Blinded Period|Non-Compliance|0|||
162988306|NCT01791153|588661326|FG004|Part 1: Blinded Period|Non-Compliance|0|||
162988307|NCT01791153|588661327|FG005|Part 1: Blinded Period|Non-Compliance|0|||
162988308|NCT01791153|588661328|FG006|Part 1: Blinded Period|Non-Compliance|0|||
162988309|NCT01791153|588661329|FG007|Part 1: Blinded Period|Non-Compliance|0|||
162988310|NCT01791153|588661322|FG000|Part 1: Blinded Period|Physician Decision|0|||
162988311|NCT01791153|588661323|FG001|Part 1: Blinded Period|Physician Decision|0|||
162988312|NCT01791153|588661324|FG002|Part 1: Blinded Period|Physician Decision|0|||
162988313|NCT01791153|588661325|FG003|Part 1: Blinded Period|Physician Decision|1|||
162988314|NCT01791153|588661326|FG004|Part 1: Blinded Period|Physician Decision|0|||
162988315|NCT01791153|588661327|FG005|Part 1: Blinded Period|Physician Decision|0|||
162988316|NCT01791153|588661328|FG006|Part 1: Blinded Period|Physician Decision|0|||
162988317|NCT01791153|588661329|FG007|Part 1: Blinded Period|Physician Decision|0|||
162988318|NCT01791153|588661322|FG000|Part 1: Blinded Period|Protocol Violation|0|||
162988319|NCT01791153|588661323|FG001|Part 1: Blinded Period|Protocol Violation|0|||
162988320|NCT01791153|588661324|FG002|Part 1: Blinded Period|Protocol Violation|0|||
162988321|NCT01791153|588661325|FG003|Part 1: Blinded Period|Protocol Violation|1|||
162988322|NCT01791153|588661326|FG004|Part 1: Blinded Period|Protocol Violation|0|||
162988323|NCT01791153|588661327|FG005|Part 1: Blinded Period|Protocol Violation|0|||
162988324|NCT01791153|588661328|FG006|Part 1: Blinded Period|Protocol Violation|0|||
162988325|NCT01791153|588661329|FG007|Part 1: Blinded Period|Protocol Violation|0|||
162988326|NCT01791153|588661322|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
162988327|NCT01791153|588661323|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
162988328|NCT01791153|588661324|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
163059940|NCT01056276|588928260|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
163059941|NCT01881425|588928261|FG000|Overall Study|Death|5|||
163059942|NCT01881425|588928262|FG001|Overall Study|Death|1|||
163404246|NCT02831673|590191904|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
162988329|NCT01791153|588661325|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
162988330|NCT01791153|588661326|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
162988331|NCT01791153|588661327|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
162988332|NCT01791153|588661328|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
162988333|NCT01791153|588661329|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
162988334|NCT01791153|588661322|FG000|Part 2: Open-label Period|Adverse Event|0|||
162988335|NCT01791153|588661323|FG001|Part 2: Open-label Period|Adverse Event|0|||
162988336|NCT01791153|588661324|FG002|Part 2: Open-label Period|Adverse Event|0|||
163059943|NCT01881425|588928261|FG000|Overall Study|Withdrawal by Subject|8|||
162988337|NCT01791153|588661325|FG003|Part 2: Open-label Period|Adverse Event|0|||
162988338|NCT01791153|588661326|FG004|Part 2: Open-label Period|Adverse Event|0|||
162988339|NCT01791153|588661327|FG005|Part 2: Open-label Period|Adverse Event|1|||
162988340|NCT01791153|588661328|FG006|Part 2: Open-label Period|Adverse Event|1|||
162988341|NCT01791153|588661329|FG007|Part 2: Open-label Period|Adverse Event|2|||
162988342|NCT01791153|588661322|FG000|Part 2: Open-label Period|Death|0|||
162988343|NCT01791153|588661323|FG001|Part 2: Open-label Period|Death|0|||
162988344|NCT01791153|588661324|FG002|Part 2: Open-label Period|Death|0|||
162988345|NCT01791153|588661325|FG003|Part 2: Open-label Period|Death|0|||
162988346|NCT01791153|588661326|FG004|Part 2: Open-label Period|Death|0|||
162988347|NCT01791153|588661327|FG005|Part 2: Open-label Period|Death|1|||
162988348|NCT01791153|588661328|FG006|Part 2: Open-label Period|Death|1|||
162988349|NCT01791153|588661329|FG007|Part 2: Open-label Period|Death|1|||
162988350|NCT01791153|588661322|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
162988351|NCT01791153|588661323|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
162988352|NCT01791153|588661324|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
162988353|NCT01791153|588661325|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
162988354|NCT01791153|588661326|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
162988355|NCT01791153|588661327|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
162988356|NCT01791153|588661328|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
162988357|NCT01791153|588661329|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
162988358|NCT01791153|588661322|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
162988359|NCT01791153|588661323|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
162988360|NCT01791153|588661324|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
162988361|NCT01791153|588661325|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
162988362|NCT01791153|588661326|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
162988363|NCT01791153|588661327|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
162988364|NCT01791153|588661328|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
162988365|NCT01791153|588661329|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
162988366|NCT01791153|588661322|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
162988367|NCT01791153|588661323|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
162988368|NCT01791153|588661324|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
162988369|NCT01791153|588661325|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
162988370|NCT01791153|588661326|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
162988371|NCT01791153|588661327|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
162988372|NCT01791153|588661328|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
162988373|NCT01791153|588661329|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
162988374|NCT01791153|588661322|FG000|Part 2: Open-label Period|Physician Decision|0|||
162988375|NCT01791153|588661323|FG001|Part 2: Open-label Period|Physician Decision|0|||
162988376|NCT01791153|588661324|FG002|Part 2: Open-label Period|Physician Decision|0|||
162988377|NCT01791153|588661325|FG003|Part 2: Open-label Period|Physician Decision|0|||
162988378|NCT01791153|588661326|FG004|Part 2: Open-label Period|Physician Decision|1|||
162988379|NCT01791153|588661327|FG005|Part 2: Open-label Period|Physician Decision|1|||
162988380|NCT01791153|588661328|FG006|Part 2: Open-label Period|Physician Decision|0|||
162988381|NCT01791153|588661329|FG007|Part 2: Open-label Period|Physician Decision|0|||
162988382|NCT02562482|588661330|FG000|Overall Study|Enrolled, but did not receive product|4|||
162988383|NCT02562482|588661331|FG001|Overall Study|Enrolled, but did not receive product|0|||
162988384|NCT02562482|588661330|FG000|Overall Study|Lost to Follow-up|9|||
162988385|NCT02562482|588661331|FG001|Overall Study|Lost to Follow-up|6|||
162988386|NCT02562482|588661330|FG000|Overall Study|Moved from area|2|||
162988387|NCT02562482|588661331|FG001|Overall Study|Moved from area|3|||
162988388|NCT02562482|588661330|FG000|Overall Study|Withdrawal by Subject|5|||
162988389|NCT02562482|588661331|FG001|Overall Study|Withdrawal by Subject|3|||
162988390|NCT02562482|588661330|FG000|Overall Study|Physician Decision|1|||
162988391|NCT02562482|588661331|FG001|Overall Study|Physician Decision|3|||
162988392|NCT02562482|588661330|FG000|Overall Study|Illness/Injury unrelated to product|0|||
162988393|NCT02562482|588661331|FG001|Overall Study|Illness/Injury unrelated to product|1|||
162988394|NCT05896202|588661337|FG000|Overall Study|Lost to Follow-up|2|||
162988395|NCT05896202|588661338|FG001|Overall Study|Lost to Follow-up|2|||
163212247|NCT02554812|589490718|FG011|Overall Study|Study terminated by sponsor|0|||
163212248|NCT02554812|589490719|FG012|Overall Study|Study terminated by sponsor|0|||
162988396|NCT01181271|588661341|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
162988397|NCT01181271|588661341|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
162988398|NCT01181271|588661341|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
162988399|NCT01181271|588661341|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
162988400|NCT00444457|588661342|FG000|Infant Series|Other|0|||
162988401|NCT00444457|588661343|FG001|Infant Series|Other|1|||
163212249|NCT02554812|589490720|FG013|Overall Study|Study terminated by sponsor|0|||
162988402|NCT00444457|588661344|FG002|Infant Series|Other|0|||
162988403|NCT00444457|588661345|FG003|Infant Series|Other|0|||
162988404|NCT00444457|588661342|FG000|Infant Series|Parent or legal guardian request|18|||
162988405|NCT00444457|588661343|FG001|Infant Series|Parent or legal guardian request|29|||
163212250|NCT02554812|589490721|FG014|Overall Study|Study terminated by sponsor|0|||
162988406|NCT00444457|588661344|FG002|Infant Series|Parent or legal guardian request|34|||
162988407|NCT00444457|588661345|FG003|Infant Series|Parent or legal guardian request|14|||
162988408|NCT00444457|588661342|FG000|Infant Series|Lost to Follow-up|10|||
162988409|NCT00444457|588661343|FG001|Infant Series|Lost to Follow-up|11|||
162988410|NCT00444457|588661344|FG002|Infant Series|Lost to Follow-up|7|||
162988411|NCT00444457|588661345|FG003|Infant Series|Lost to Follow-up|6|||
162988412|NCT00444457|588661342|FG000|Infant Series|Protocol Violation|16|||
162988413|NCT00444457|588661343|FG001|Infant Series|Protocol Violation|8|||
162988414|NCT00444457|588661344|FG002|Infant Series|Protocol Violation|6|||
162988415|NCT00444457|588661345|FG003|Infant Series|Protocol Violation|3|||
162988416|NCT00444457|588661342|FG000|Infant Series|Failed to return|5|||
162988417|NCT00444457|588661343|FG001|Infant Series|Failed to return|4|||
163324404|NCT04046549|589899861|FG000|Overall Study|Withdrawal by Subject|3|||
163324405|NCT04046549|589899861|FG000|Overall Study|Other, Not Specified|5|||
163324406|NCT06059443|589899862|FG000|Overall Study|Withdrawal by Subject|2|||
163324407|NCT06059443|589899863|FG001|Overall Study|Withdrawal by Subject|0|||
163324408|NCT06059443|589899862|FG000|Overall Study|Lost to Follow-up|2|||
163324409|NCT06059443|589899863|FG001|Overall Study|Lost to Follow-up|2|||
163324410|NCT00709956|589899866|FG000|Overall Study|Withdrawal by Subject|1|||
163324411|NCT00709956|589899867|FG001|Overall Study|Withdrawal by Subject|1|||
163324412|NCT00709956|589899866|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
163324413|NCT00709956|589899867|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
163324414|NCT04940624|589899870|FG000|Overall Study|Adverse Event|4|||
163324415|NCT04940624|589899871|FG001|Overall Study|Adverse Event|11|||
163324416|NCT04940624|589899870|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163324417|NCT04940624|589899871|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
163404247|NCT02831673|590191900|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
163404248|NCT02831673|590191901|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
162988418|NCT00444457|588661344|FG002|Infant Series|Failed to return|4|||
162988419|NCT00444457|588661345|FG003|Infant Series|Failed to return|2|||
162988420|NCT00444457|588661342|FG000|Infant Series|Investigator request|4|||
162988421|NCT00444457|588661343|FG001|Infant Series|Investigator request|3|||
162988422|NCT00444457|588661344|FG002|Infant Series|Investigator request|3|||
162988423|NCT00444457|588661345|FG003|Infant Series|Investigator request|2|||
162988424|NCT00444457|588661342|FG000|Infant Series|Other|0|||
162988425|NCT00444457|588661343|FG001|Infant Series|Other|2|||
162988426|NCT00444457|588661344|FG002|Infant Series|Other|4|||
162988427|NCT00444457|588661345|FG003|Infant Series|Other|0|||
162988428|NCT00444457|588661342|FG000|Infant Series|Adverse Event|1|||
162988429|NCT00444457|588661343|FG001|Infant Series|Adverse Event|2|||
162988430|NCT00444457|588661344|FG002|Infant Series|Adverse Event|2|||
162988431|NCT00444457|588661345|FG003|Infant Series|Adverse Event|0|||
162988432|NCT00444457|588661342|FG000|Infant Series|Death|0|||
162988433|NCT00444457|588661343|FG001|Infant Series|Death|1|||
162988434|NCT00444457|588661344|FG002|Infant Series|Death|1|||
162988435|NCT00444457|588661345|FG003|Infant Series|Death|1|||
162988436|NCT00444457|588661342|FG000|After Infant Series|Other|0|||
162988437|NCT00444457|588661343|FG001|After Infant Series|Other|1|||
162988438|NCT00444457|588661344|FG002|After Infant Series|Other|1|||
162988439|NCT00444457|588661345|FG003|After Infant Series|Other|1|||
162988440|NCT00444457|588661342|FG000|After Infant Series|Parent or legal guardian request|4|||
162988441|NCT00444457|588661343|FG001|After Infant Series|Parent or legal guardian request|11|||
162988442|NCT00444457|588661344|FG002|After Infant Series|Parent or legal guardian request|6|||
162988443|NCT00444457|588661345|FG003|After Infant Series|Parent or legal guardian request|3|||
162988444|NCT00444457|588661342|FG000|After Infant Series|Failed to return|7|||
162988445|NCT00444457|588661343|FG001|After Infant Series|Failed to return|6|||
162988446|NCT00444457|588661344|FG002|After Infant Series|Failed to return|5|||
162988447|NCT00444457|588661345|FG003|After Infant Series|Failed to return|1|||
162988448|NCT00444457|588661342|FG000|After Infant Series|Lost to Follow-up|5|||
162988449|NCT00444457|588661343|FG001|After Infant Series|Lost to Follow-up|5|||
162988450|NCT00444457|588661344|FG002|After Infant Series|Lost to Follow-up|5|||
162988451|NCT00444457|588661345|FG003|After Infant Series|Lost to Follow-up|2|||
162988452|NCT00444457|588661342|FG000|After Infant Series|Protocol Violation|2|||
162988453|NCT00444457|588661343|FG001|After Infant Series|Protocol Violation|4|||
162988454|NCT00444457|588661344|FG002|After Infant Series|Protocol Violation|2|||
162988455|NCT00444457|588661345|FG003|After Infant Series|Protocol Violation|2|||
162988456|NCT00444457|588661342|FG000|After Infant Series|Adverse Event|2|||
162988457|NCT00444457|588661343|FG001|After Infant Series|Adverse Event|2|||
162988458|NCT00444457|588661344|FG002|After Infant Series|Adverse Event|0|||
162988459|NCT00444457|588661345|FG003|After Infant Series|Adverse Event|0|||
162988460|NCT00444457|588661342|FG000|After Infant Series|Investigator request|0|||
162988461|NCT00444457|588661343|FG001|After Infant Series|Investigator request|0|||
162988462|NCT00444457|588661344|FG002|After Infant Series|Investigator request|0|||
162988463|NCT00444457|588661345|FG003|After Infant Series|Investigator request|1|||
162988464|NCT00444457|588661342|FG000|After Infant Series|Other|0|||
162988465|NCT00444457|588661343|FG001|After Infant Series|Other|1|||
163324418|NCT04940624|589899870|FG000|Overall Study|Physician Decision|1|||
163324419|NCT04940624|589899871|FG001|Overall Study|Physician Decision|0|||
162988466|NCT00444457|588661344|FG002|After Infant Series|Other|0|||
162988467|NCT00444457|588661345|FG003|After Infant Series|Other|0|||
162988468|NCT00444457|588661342|FG000|Toddler Dose|Lost to Follow-up|4|||
162988469|NCT00444457|588661343|FG001|Toddler Dose|Lost to Follow-up|1|||
162988470|NCT00444457|588661344|FG002|Toddler Dose|Lost to Follow-up|1|||
162988471|NCT00444457|588661345|FG003|Toddler Dose|Lost to Follow-up|3|||
162988472|NCT00444457|588661342|FG000|Toddler Dose|Failed to return|2|||
162988473|NCT00444457|588661343|FG001|Toddler Dose|Failed to return|2|||
162988474|NCT00444457|588661344|FG002|Toddler Dose|Failed to return|1|||
162988475|NCT00444457|588661345|FG003|Toddler Dose|Failed to return|3|||
162988476|NCT00444457|588661342|FG000|Toddler Dose|Parent or legal guardian request|0|||
162988477|NCT00444457|588661343|FG001|Toddler Dose|Parent or legal guardian request|3|||
162988478|NCT00444457|588661344|FG002|Toddler Dose|Parent or legal guardian request|2|||
162988479|NCT00444457|588661345|FG003|Toddler Dose|Parent or legal guardian request|1|||
162988480|NCT00444457|588661342|FG000|Toddler Dose|Protocol Violation|1|||
162988481|NCT00444457|588661343|FG001|Toddler Dose|Protocol Violation|0|||
162988482|NCT00444457|588661344|FG002|Toddler Dose|Protocol Violation|0|||
162988483|NCT00444457|588661345|FG003|Toddler Dose|Protocol Violation|1|||
162988484|NCT02041091|588661346|FG000|Treatment|Adverse Event|3|||
162988485|NCT02041091|588661347|FG001|Treatment|Adverse Event|3|||
162988486|NCT02041091|588661346|FG000|Treatment|Withdrawal by Subject|2|||
162988487|NCT02041091|588661347|FG001|Treatment|Withdrawal by Subject|4|||
162988488|NCT02041091|588661346|FG000|Treatment|Physician Decision|1|||
162988489|NCT02041091|588661347|FG001|Treatment|Physician Decision|0|||
162988490|NCT02041091|588661346|FG000|Treatment|Sponsor Decision|15|||
162988491|NCT02041091|588661347|FG001|Treatment|Sponsor Decision|16|||
162988492|NCT02041091|588661346|FG000|Treatment|Lost to Follow-up|1|||
162988493|NCT02041091|588661347|FG001|Treatment|Lost to Follow-up|0|||
162988494|NCT02041091|588661346|FG000|Optional Safety Extension Period|Adverse Event|4|||
162988495|NCT02041091|588661347|FG001|Optional Safety Extension Period|Adverse Event|2|||
162988496|NCT02041091|588661346|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
162988497|NCT02041091|588661347|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
162988498|NCT02041091|588661346|FG000|Optional Safety Extension Period|Protocol Violation|2|||
162988499|NCT02041091|588661347|FG001|Optional Safety Extension Period|Protocol Violation|0|||
162988500|NCT02041091|588661346|FG000|Optional Safety Extension Period|Physician Decision|2|||
162988501|NCT02041091|588661347|FG001|Optional Safety Extension Period|Physician Decision|1|||
162988502|NCT02041091|588661346|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
162988503|NCT02041091|588661347|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
162988504|NCT02041091|588661346|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
162988505|NCT02041091|588661347|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
162988506|NCT01855074|588661348|FG000|Overall Study|Adverse Event|1|||
162988507|NCT01855074|588661348|FG000|Overall Study|Lost to Follow-up|4|||
162988508|NCT01855074|588661348|FG000|Overall Study|Withdrawal by Subject|8|||
162988509|NCT01855074|588661348|FG000|Overall Study|Started but not treated|1|||
162988510|NCT02991430|588661349|FG000|Treatment Period 1|Adverse Event|1|||
162988511|NCT02991430|588661350|FG001|Treatment Period 1|Adverse Event|0|||
162988512|NCT02991430|588661351|FG002|Treatment Period 1|Adverse Event|2|||
162988513|NCT02991430|588661349|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162988514|NCT02991430|588661350|FG001|Treatment Period 1|Withdrawal by Subject|4|||
162988515|NCT02991430|588661351|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162988516|NCT02991430|588661349|FG000|Treatment Period 2|Study Termination|6|||
162988517|NCT02991430|588661350|FG001|Treatment Period 2|Study Termination|3|||
162988518|NCT02991430|588661351|FG002|Treatment Period 2|Study Termination|3|||
162988519|NCT02991430|588661349|FG000|Treatment Period 2|Lost to Follow-up|0|||
162988520|NCT02991430|588661350|FG001|Treatment Period 2|Lost to Follow-up|0|||
162988521|NCT02991430|588661351|FG002|Treatment Period 2|Lost to Follow-up|1|||
162988522|NCT02991430|588661349|FG000|Post-treatment Observation Period|Study Termination|3|||
162988523|NCT02991430|588661350|FG001|Post-treatment Observation Period|Study Termination|6|||
162988524|NCT02991430|588661351|FG002|Post-treatment Observation Period|Study Termination|5|||
162988525|NCT03970837|588661352|FG000|Overall Study|Adverse Event|23|||
162988526|NCT03970837|588661353|FG001|Overall Study|Adverse Event|20|||
162988527|NCT03970837|588661354|FG002|Overall Study|Adverse Event|16|||
162988528|NCT03970837|588661355|FG003|Overall Study|Adverse Event|6|||
162988529|NCT03970837|588661356|FG004|Overall Study|Adverse Event|4|||
162988530|NCT03970837|588661357|FG005|Overall Study|Adverse Event|5|||
163212251|NCT02554812|589490722|FG015|Overall Study|Study terminated by sponsor|0|||
163212252|NCT02554812|589490723|FG016|Overall Study|Study terminated by sponsor|0|||
163212253|NCT02554812|589490724|FG017|Overall Study|Study terminated by sponsor|0|||
163212254|NCT02554812|589490725|FG018|Overall Study|Study terminated by sponsor|0|||
163212255|NCT02554812|589490726|FG019|Overall Study|Study terminated by sponsor|0|||
163212256|NCT02554812|589490727|FG020|Overall Study|Study terminated by sponsor|0|||
163212257|NCT02554812|589490728|FG021|Overall Study|Study terminated by sponsor|0|||
163212258|NCT02554812|589490729|FG022|Overall Study|Study terminated by sponsor|0|||
163212259|NCT02554812|589490730|FG023|Overall Study|Study terminated by sponsor|0|||
163212260|NCT02554812|589490731|FG024|Overall Study|Study terminated by sponsor|1|||
163212261|NCT02554812|589490732|FG025|Overall Study|Study terminated by sponsor|0|||
163212262|NCT02554812|589490733|FG026|Overall Study|Study terminated by sponsor|0|||
163212263|NCT02554812|589490707|FG000|Overall Study|No longer meets eligibility criteria|0|||
163212264|NCT02554812|589490708|FG001|Overall Study|No longer meets eligibility criteria|1|||
163212265|NCT02554812|589490709|FG002|Overall Study|No longer meets eligibility criteria|0|||
163212266|NCT02554812|589490710|FG003|Overall Study|No longer meets eligibility criteria|0|||
163212267|NCT02554812|589490711|FG004|Overall Study|No longer meets eligibility criteria|0|||
163212268|NCT02554812|589490712|FG005|Overall Study|No longer meets eligibility criteria|0|||
163212269|NCT02554812|589490713|FG006|Overall Study|No longer meets eligibility criteria|0|||
163212270|NCT02554812|589490714|FG007|Overall Study|No longer meets eligibility criteria|0|||
163212271|NCT02554812|589490715|FG008|Overall Study|No longer meets eligibility criteria|0|||
163212272|NCT02554812|589490716|FG009|Overall Study|No longer meets eligibility criteria|0|||
163212273|NCT02554812|589490717|FG010|Overall Study|No longer meets eligibility criteria|0|||
163212274|NCT02554812|589490718|FG011|Overall Study|No longer meets eligibility criteria|0|||
163212275|NCT02554812|589490719|FG012|Overall Study|No longer meets eligibility criteria|0|||
163212276|NCT02554812|589490720|FG013|Overall Study|No longer meets eligibility criteria|0|||
163212277|NCT02554812|589490721|FG014|Overall Study|No longer meets eligibility criteria|0|||
163212278|NCT02554812|589490722|FG015|Overall Study|No longer meets eligibility criteria|0|||
163212279|NCT02554812|589490723|FG016|Overall Study|No longer meets eligibility criteria|0|||
163212280|NCT02554812|589490724|FG017|Overall Study|No longer meets eligibility criteria|0|||
163212281|NCT02554812|589490725|FG018|Overall Study|No longer meets eligibility criteria|0|||
163212282|NCT02554812|589490726|FG019|Overall Study|No longer meets eligibility criteria|0|||
163212283|NCT02554812|589490727|FG020|Overall Study|No longer meets eligibility criteria|0|||
163212284|NCT02554812|589490728|FG021|Overall Study|No longer meets eligibility criteria|0|||
163212285|NCT02554812|589490729|FG022|Overall Study|No longer meets eligibility criteria|0|||
163212286|NCT02554812|589490730|FG023|Overall Study|No longer meets eligibility criteria|0|||
163212287|NCT02554812|589490731|FG024|Overall Study|No longer meets eligibility criteria|0|||
162988531|NCT03970837|588661358|FG006|Overall Study|Adverse Event|1|||
162988532|NCT03970837|588661359|FG007|Overall Study|Adverse Event|5|||
162988533|NCT03970837|588661360|FG008|Overall Study|Adverse Event|0|||
162988534|NCT03970837|588661361|FG009|Overall Study|Adverse Event|0|||
162988535|NCT03970837|588661362|FG010|Overall Study|Adverse Event|1|||
162988536|NCT03970837|588661363|FG011|Overall Study|Adverse Event|1|||
162988537|NCT03970837|588661352|FG000|Overall Study|Lack of Efficacy|14|||
162988538|NCT03970837|588661353|FG001|Overall Study|Lack of Efficacy|12|||
162988539|NCT03970837|588661354|FG002|Overall Study|Lack of Efficacy|1|||
162988540|NCT03970837|588661355|FG003|Overall Study|Lack of Efficacy|2|||
162988541|NCT03970837|588661356|FG004|Overall Study|Lack of Efficacy|3|||
162988542|NCT03970837|588661357|FG005|Overall Study|Lack of Efficacy|4|||
162988543|NCT03970837|588661358|FG006|Overall Study|Lack of Efficacy|6|||
162988544|NCT03970837|588661359|FG007|Overall Study|Lack of Efficacy|1|||
162988545|NCT03970837|588661360|FG008|Overall Study|Lack of Efficacy|1|||
162988546|NCT03970837|588661361|FG009|Overall Study|Lack of Efficacy|0|||
162988547|NCT03970837|588661362|FG010|Overall Study|Lack of Efficacy|0|||
162988548|NCT03970837|588661363|FG011|Overall Study|Lack of Efficacy|0|||
162988549|NCT03970837|588661352|FG000|Overall Study|Lost to Follow-up|6|||
162988550|NCT03970837|588661353|FG001|Overall Study|Lost to Follow-up|5|||
162988551|NCT03970837|588661354|FG002|Overall Study|Lost to Follow-up|5|||
162988552|NCT03970837|588661355|FG003|Overall Study|Lost to Follow-up|1|||
162988553|NCT03970837|588661356|FG004|Overall Study|Lost to Follow-up|0|||
162988554|NCT03970837|588661357|FG005|Overall Study|Lost to Follow-up|2|||
162988555|NCT03970837|588661358|FG006|Overall Study|Lost to Follow-up|0|||
163212288|NCT02554812|589490732|FG025|Overall Study|No longer meets eligibility criteria|0|||
163212289|NCT02554812|589490733|FG026|Overall Study|No longer meets eligibility criteria|0|||
163212290|NCT02879305|589490734|FG000|Overall Study|Investigator Site Closed|55|||
163212291|NCT02879305|589490735|FG001|Overall Study|Investigator Site Closed|57|||
163212292|NCT02879305|589490734|FG000|Overall Study|Withdrawal by Subject|44|||
163212293|NCT02879305|589490735|FG001|Overall Study|Withdrawal by Subject|42|||
163212294|NCT02879305|589490734|FG000|Overall Study|Lost to Follow-up|17|||
163212295|NCT02879305|589490735|FG001|Overall Study|Lost to Follow-up|12|||
163212296|NCT02879305|589490734|FG000|Overall Study|Other|1|||
163212297|NCT02879305|589490735|FG001|Overall Study|Other|0|||
163212298|NCT01786629|589492457|FG000|Overall Study|Lack of Efficacy|0|||
163212299|NCT01786629|589492458|FG001|Overall Study|Lack of Efficacy|4|||
163212300|NCT01786629|589492457|FG000|Overall Study|Adverse Event|0|||
163212301|NCT01786629|589492458|FG001|Overall Study|Adverse Event|1|||
163212302|NCT00613938|589492459|FG000|Overall Study|Withdrawal by Subject|2|||
162988556|NCT03970837|588661359|FG007|Overall Study|Lost to Follow-up|0|||
162988557|NCT03970837|588661360|FG008|Overall Study|Lost to Follow-up|0|||
162988558|NCT03970837|588661361|FG009|Overall Study|Lost to Follow-up|0|||
162988559|NCT03970837|588661362|FG010|Overall Study|Lost to Follow-up|0|||
162988560|NCT03970837|588661363|FG011|Overall Study|Lost to Follow-up|0|||
162988561|NCT03970837|588661352|FG000|Overall Study|Protocol Violation|1|||
162988562|NCT03970837|588661353|FG001|Overall Study|Protocol Violation|0|||
162988563|NCT03970837|588661354|FG002|Overall Study|Protocol Violation|0|||
162988564|NCT03970837|588661355|FG003|Overall Study|Protocol Violation|0|||
162988565|NCT03970837|588661356|FG004|Overall Study|Protocol Violation|0|||
162988566|NCT03970837|588661357|FG005|Overall Study|Protocol Violation|0|||
162988567|NCT03970837|588661358|FG006|Overall Study|Protocol Violation|0|||
162988568|NCT03970837|588661359|FG007|Overall Study|Protocol Violation|0|||
162988569|NCT03970837|588661360|FG008|Overall Study|Protocol Violation|0|||
162988570|NCT03970837|588661361|FG009|Overall Study|Protocol Violation|0|||
162988571|NCT03970837|588661362|FG010|Overall Study|Protocol Violation|0|||
162988572|NCT03970837|588661363|FG011|Overall Study|Protocol Violation|0|||
162988573|NCT03970837|588661352|FG000|Overall Study|Physician Decision|5|||
162988574|NCT03970837|588661353|FG001|Overall Study|Physician Decision|8|||
162988575|NCT03970837|588661354|FG002|Overall Study|Physician Decision|4|||
162988576|NCT03970837|588661355|FG003|Overall Study|Physician Decision|1|||
162988577|NCT03970837|588661356|FG004|Overall Study|Physician Decision|5|||
162988578|NCT03970837|588661357|FG005|Overall Study|Physician Decision|2|||
162988579|NCT03970837|588661358|FG006|Overall Study|Physician Decision|4|||
162988580|NCT03970837|588661359|FG007|Overall Study|Physician Decision|5|||
162988581|NCT03970837|588661360|FG008|Overall Study|Physician Decision|0|||
162988582|NCT03970837|588661361|FG009|Overall Study|Physician Decision|1|||
162988583|NCT03970837|588661362|FG010|Overall Study|Physician Decision|0|||
162988584|NCT03970837|588661363|FG011|Overall Study|Physician Decision|0|||
162988585|NCT03970837|588661352|FG000|Overall Study|Withdrawal by Subject|32|||
162988586|NCT03970837|588661353|FG001|Overall Study|Withdrawal by Subject|35|||
162988587|NCT03970837|588661354|FG002|Overall Study|Withdrawal by Subject|12|||
162988588|NCT03970837|588661355|FG003|Overall Study|Withdrawal by Subject|8|||
162988589|NCT03970837|588661356|FG004|Overall Study|Withdrawal by Subject|6|||
162988590|NCT03970837|588661357|FG005|Overall Study|Withdrawal by Subject|8|||
162988591|NCT03970837|588661358|FG006|Overall Study|Withdrawal by Subject|2|||
162988592|NCT03970837|588661359|FG007|Overall Study|Withdrawal by Subject|3|||
162988593|NCT03970837|588661360|FG008|Overall Study|Withdrawal by Subject|0|||
162988594|NCT03970837|588661361|FG009|Overall Study|Withdrawal by Subject|0|||
162988595|NCT03970837|588661362|FG010|Overall Study|Withdrawal by Subject|0|||
162988596|NCT03970837|588661363|FG011|Overall Study|Withdrawal by Subject|1|||
162988597|NCT03970837|588661352|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
162988598|NCT03970837|588661353|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
162988599|NCT03970837|588661354|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
162988600|NCT03970837|588661355|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
162988601|NCT03970837|588661356|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
162988602|NCT03970837|588661357|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
162988603|NCT03970837|588661358|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
162988604|NCT03970837|588661359|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
162988605|NCT03970837|588661360|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
162988606|NCT03970837|588661361|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
162988607|NCT03970837|588661362|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
162988608|NCT03970837|588661363|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
162988609|NCT03970837|588661352|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
162988610|NCT03970837|588661353|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
162988611|NCT03970837|588661354|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
162988612|NCT03970837|588661355|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
162988613|NCT03970837|588661356|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
162988614|NCT03970837|588661357|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
162988615|NCT03970837|588661358|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
162988616|NCT03970837|588661359|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
162988617|NCT03970837|588661360|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
162988618|NCT03970837|588661361|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
162988619|NCT03970837|588661362|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
162988620|NCT03970837|588661363|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
162988621|NCT02132754|588661364|FG000|Overall Study|Adverse Event|0|||
162988622|NCT02132754|588661365|FG001|Overall Study|Adverse Event|0|||
162988623|NCT02132754|588661366|FG002|Overall Study|Adverse Event|0|||
162988624|NCT02132754|588661367|FG003|Overall Study|Adverse Event|0|||
162988625|NCT02132754|588661368|FG004|Overall Study|Adverse Event|0|||
162988626|NCT02132754|588661369|FG005|Overall Study|Adverse Event|0|||
163212303|NCT00613938|589492460|FG001|Overall Study|Withdrawal by Subject|4|||
163212304|NCT00613938|589492461|FG002|Overall Study|Withdrawal by Subject|9|||
163212305|NCT00613938|589492462|FG003|Overall Study|Withdrawal by Subject|9|||
163212306|NCT00613938|589492459|FG000|Overall Study|Adverse Event|1|||
163212307|NCT00613938|589492460|FG001|Overall Study|Adverse Event|4|||
163212308|NCT00613938|589492461|FG002|Overall Study|Adverse Event|8|||
163212309|NCT00613938|589492462|FG003|Overall Study|Adverse Event|5|||
162988627|NCT02132754|588661370|FG006|Overall Study|Adverse Event|0|||
163212310|NCT00613938|589492459|FG000|Overall Study|Lack of Efficacy|16|||
162988628|NCT02132754|588661371|FG007|Overall Study|Adverse Event|0|||
163212311|NCT00613938|589492460|FG001|Overall Study|Lack of Efficacy|18|||
163212312|NCT00613938|589492461|FG002|Overall Study|Lack of Efficacy|5|||
163212313|NCT00613938|589492462|FG003|Overall Study|Lack of Efficacy|9|||
162988629|NCT02132754|588661372|FG008|Overall Study|Adverse Event|0|||
162988630|NCT02132754|588661373|FG009|Overall Study|Adverse Event|0|||
163324420|NCT04940624|589899870|FG000|Overall Study|Lost to Follow-up|1|||
163324421|NCT04940624|589899871|FG001|Overall Study|Lost to Follow-up|0|||
163324422|NCT04940624|589899870|FG000|Overall Study|Reason Not Specified|1|||
163324423|NCT04940624|589899871|FG001|Overall Study|Reason Not Specified|0|||
163324424|NCT04479787|589899872|FG000|Through 6 Months|Withdrawal by Subject|16|||
163324425|NCT04479787|589899873|FG001|Through 6 Months|Withdrawal by Subject|14|||
163324426|NCT04479787|589899872|FG000|Through 6 Months|Unsuccessful Trial|17|||
162988631|NCT02132754|588661374|FG010|Overall Study|Adverse Event|0|||
162988632|NCT02132754|588661375|FG011|Overall Study|Adverse Event|0|||
162988633|NCT02132754|588661376|FG012|Overall Study|Adverse Event|0|||
162988634|NCT02132754|588661377|FG013|Overall Study|Adverse Event|0|||
162988635|NCT02132754|588661378|FG014|Overall Study|Adverse Event|0|||
162988636|NCT02132754|588661379|FG015|Overall Study|Adverse Event|0|||
162988637|NCT02132754|588661380|FG016|Overall Study|Adverse Event|0|||
162988638|NCT02132754|588661381|FG017|Overall Study|Adverse Event|1|||
162988639|NCT02132754|588661382|FG018|Overall Study|Adverse Event|0|||
162988640|NCT02132754|588661383|FG019|Overall Study|Adverse Event|0|||
162988641|NCT02132754|588661384|FG020|Overall Study|Adverse Event|0|||
162988642|NCT02132754|588661385|FG021|Overall Study|Adverse Event|0|||
162988643|NCT02132754|588661386|FG022|Overall Study|Adverse Event|0|||
162988644|NCT02132754|588661387|FG023|Overall Study|Adverse Event|0|||
162988645|NCT02132754|588661388|FG024|Overall Study|Adverse Event|0|||
162988646|NCT02132754|588661389|FG025|Overall Study|Adverse Event|1|||
162988647|NCT02132754|588661390|FG026|Overall Study|Adverse Event|1|||
162988648|NCT02132754|588661391|FG027|Overall Study|Adverse Event|0|||
162988649|NCT02132754|588661392|FG028|Overall Study|Adverse Event|0|||
162988650|NCT02132754|588661393|FG029|Overall Study|Adverse Event|0|||
162988651|NCT02132754|588661394|FG030|Overall Study|Adverse Event|1|||
162988652|NCT02132754|588661395|FG031|Overall Study|Adverse Event|0|||
162988653|NCT02132754|588661396|FG032|Overall Study|Adverse Event|1|||
162988654|NCT02132754|588661397|FG033|Overall Study|Adverse Event|1|||
162988655|NCT02132754|588661364|FG000|Overall Study|Clinical Progression|0|||
162988656|NCT02132754|588661365|FG001|Overall Study|Clinical Progression|0|||
162988657|NCT02132754|588661366|FG002|Overall Study|Clinical Progression|0|||
162988658|NCT02132754|588661367|FG003|Overall Study|Clinical Progression|0|||
163324427|NCT04479787|589899873|FG001|Through 6 Months|Unsuccessful Trial|0|||
162988659|NCT02132754|588661368|FG004|Overall Study|Clinical Progression|0|||
162988660|NCT02132754|588661369|FG005|Overall Study|Clinical Progression|0|||
162988661|NCT02132754|588661370|FG006|Overall Study|Clinical Progression|0|||
162988662|NCT02132754|588661371|FG007|Overall Study|Clinical Progression|0|||
162988663|NCT02132754|588661372|FG008|Overall Study|Clinical Progression|0|||
162988664|NCT02132754|588661373|FG009|Overall Study|Clinical Progression|1|||
162988665|NCT02132754|588661374|FG010|Overall Study|Clinical Progression|0|||
162988666|NCT02132754|588661375|FG011|Overall Study|Clinical Progression|0|||
162988667|NCT02132754|588661376|FG012|Overall Study|Clinical Progression|0|||
162988668|NCT02132754|588661377|FG013|Overall Study|Clinical Progression|0|||
162988669|NCT02132754|588661378|FG014|Overall Study|Clinical Progression|0|||
162988670|NCT02132754|588661379|FG015|Overall Study|Clinical Progression|0|||
162988671|NCT02132754|588661380|FG016|Overall Study|Clinical Progression|1|||
162988672|NCT02132754|588661381|FG017|Overall Study|Clinical Progression|1|||
162988673|NCT02132754|588661382|FG018|Overall Study|Clinical Progression|0|||
162988674|NCT02132754|588661383|FG019|Overall Study|Clinical Progression|1|||
162988675|NCT02132754|588661384|FG020|Overall Study|Clinical Progression|0|||
162988676|NCT02132754|588661385|FG021|Overall Study|Clinical Progression|0|||
162988677|NCT02132754|588661386|FG022|Overall Study|Clinical Progression|1|||
162988678|NCT02132754|588661387|FG023|Overall Study|Clinical Progression|0|||
162988679|NCT02132754|588661388|FG024|Overall Study|Clinical Progression|1|||
163059944|NCT01881425|588928262|FG001|Overall Study|Withdrawal by Subject|3|||
163059945|NCT01881425|588928261|FG000|Overall Study|Physician Decision|2|||
163059946|NCT01881425|588928262|FG001|Overall Study|Physician Decision|1|||
162988680|NCT02132754|588661389|FG025|Overall Study|Clinical Progression|1|||
162988681|NCT02132754|588661390|FG026|Overall Study|Clinical Progression|0|||
162988682|NCT02132754|588661391|FG027|Overall Study|Clinical Progression|1|||
162988683|NCT02132754|588661392|FG028|Overall Study|Clinical Progression|1|||
162988684|NCT02132754|588661393|FG029|Overall Study|Clinical Progression|0|||
162988685|NCT02132754|588661394|FG030|Overall Study|Clinical Progression|1|||
162988686|NCT02132754|588661395|FG031|Overall Study|Clinical Progression|0|||
162988687|NCT02132754|588661396|FG032|Overall Study|Clinical Progression|0|||
162988688|NCT02132754|588661397|FG033|Overall Study|Clinical Progression|2|||
162988689|NCT02132754|588661364|FG000|Overall Study|Death|0|||
162988690|NCT02132754|588661365|FG001|Overall Study|Death|0|||
162988691|NCT02132754|588661366|FG002|Overall Study|Death|0|||
162988692|NCT02132754|588661367|FG003|Overall Study|Death|0|||
162988693|NCT02132754|588661368|FG004|Overall Study|Death|0|||
163059947|NCT01881425|588928261|FG000|Overall Study|Adverse Event|3|||
163324428|NCT04479787|589899872|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
162988694|NCT02132754|588661369|FG005|Overall Study|Death|0|||
162988695|NCT02132754|588661370|FG006|Overall Study|Death|0|||
162988696|NCT02132754|588661371|FG007|Overall Study|Death|0|||
162988697|NCT02132754|588661372|FG008|Overall Study|Death|0|||
162988698|NCT02132754|588661373|FG009|Overall Study|Death|0|||
162988699|NCT02132754|588661374|FG010|Overall Study|Death|0|||
162988700|NCT02132754|588661375|FG011|Overall Study|Death|0|||
162988701|NCT02132754|588661376|FG012|Overall Study|Death|0|||
162988702|NCT02132754|588661377|FG013|Overall Study|Death|0|||
162988703|NCT02132754|588661378|FG014|Overall Study|Death|0|||
162988704|NCT02132754|588661379|FG015|Overall Study|Death|1|||
162988705|NCT02132754|588661380|FG016|Overall Study|Death|0|||
162988706|NCT02132754|588661381|FG017|Overall Study|Death|0|||
162988707|NCT02132754|588661382|FG018|Overall Study|Death|0|||
162988708|NCT02132754|588661383|FG019|Overall Study|Death|1|||
162988709|NCT02132754|588661384|FG020|Overall Study|Death|0|||
162988710|NCT02132754|588661385|FG021|Overall Study|Death|1|||
162988711|NCT02132754|588661386|FG022|Overall Study|Death|0|||
162988712|NCT02132754|588661387|FG023|Overall Study|Death|0|||
162988713|NCT02132754|588661388|FG024|Overall Study|Death|0|||
162988714|NCT02132754|588661389|FG025|Overall Study|Death|0|||
162988715|NCT02132754|588661390|FG026|Overall Study|Death|1|||
162988716|NCT02132754|588661391|FG027|Overall Study|Death|0|||
162988717|NCT02132754|588661392|FG028|Overall Study|Death|0|||
162988718|NCT02132754|588661393|FG029|Overall Study|Death|0|||
162988719|NCT02132754|588661394|FG030|Overall Study|Death|0|||
162988720|NCT02132754|588661395|FG031|Overall Study|Death|0|||
162988721|NCT02132754|588661396|FG032|Overall Study|Death|0|||
162988722|NCT02132754|588661397|FG033|Overall Study|Death|2|||
162988723|NCT02132754|588661364|FG000|Overall Study|Excluded Medication|0|||
162988724|NCT02132754|588661365|FG001|Overall Study|Excluded Medication|0|||
162988725|NCT02132754|588661366|FG002|Overall Study|Excluded Medication|0|||
162988726|NCT02132754|588661367|FG003|Overall Study|Excluded Medication|0|||
162988727|NCT02132754|588661368|FG004|Overall Study|Excluded Medication|0|||
162988728|NCT02132754|588661369|FG005|Overall Study|Excluded Medication|0|||
162988729|NCT02132754|588661370|FG006|Overall Study|Excluded Medication|0|||
162988730|NCT02132754|588661371|FG007|Overall Study|Excluded Medication|0|||
162988731|NCT02132754|588661372|FG008|Overall Study|Excluded Medication|0|||
162988732|NCT02132754|588661373|FG009|Overall Study|Excluded Medication|0|||
162988733|NCT02132754|588661374|FG010|Overall Study|Excluded Medication|0|||
162988734|NCT02132754|588661375|FG011|Overall Study|Excluded Medication|0|||
162988735|NCT02132754|588661376|FG012|Overall Study|Excluded Medication|0|||
162988736|NCT02132754|588661377|FG013|Overall Study|Excluded Medication|0|||
162988737|NCT02132754|588661378|FG014|Overall Study|Excluded Medication|0|||
162988738|NCT02132754|588661379|FG015|Overall Study|Excluded Medication|0|||
162988739|NCT02132754|588661380|FG016|Overall Study|Excluded Medication|0|||
162988740|NCT02132754|588661381|FG017|Overall Study|Excluded Medication|0|||
162988741|NCT02132754|588661382|FG018|Overall Study|Excluded Medication|0|||
162988742|NCT02132754|588661383|FG019|Overall Study|Excluded Medication|0|||
162988743|NCT02132754|588661384|FG020|Overall Study|Excluded Medication|1|||
162988744|NCT02132754|588661385|FG021|Overall Study|Excluded Medication|0|||
162988745|NCT02132754|588661386|FG022|Overall Study|Excluded Medication|0|||
162988746|NCT02132754|588661387|FG023|Overall Study|Excluded Medication|0|||
162988747|NCT02132754|588661388|FG024|Overall Study|Excluded Medication|0|||
162988748|NCT02132754|588661389|FG025|Overall Study|Excluded Medication|0|||
162988749|NCT02132754|588661390|FG026|Overall Study|Excluded Medication|0|||
162988750|NCT02132754|588661391|FG027|Overall Study|Excluded Medication|0|||
162988751|NCT02132754|588661392|FG028|Overall Study|Excluded Medication|0|||
163212314|NCT00613938|589492459|FG000|Overall Study|Other|1|||
163212315|NCT00613938|589492460|FG001|Overall Study|Other|2|||
162988752|NCT02132754|588661393|FG029|Overall Study|Excluded Medication|0|||
162988753|NCT02132754|588661394|FG030|Overall Study|Excluded Medication|0|||
162988754|NCT02132754|588661395|FG031|Overall Study|Excluded Medication|0|||
162988755|NCT02132754|588661396|FG032|Overall Study|Excluded Medication|0|||
162988756|NCT02132754|588661397|FG033|Overall Study|Excluded Medication|1|||
162988757|NCT02132754|588661364|FG000|Overall Study|Physician Decision|0|||
162988758|NCT02132754|588661365|FG001|Overall Study|Physician Decision|0|||
162988759|NCT02132754|588661366|FG002|Overall Study|Physician Decision|0|||
162988760|NCT02132754|588661367|FG003|Overall Study|Physician Decision|0|||
162988761|NCT02132754|588661368|FG004|Overall Study|Physician Decision|0|||
162988762|NCT02132754|588661369|FG005|Overall Study|Physician Decision|0|||
163212316|NCT00613938|589492461|FG002|Overall Study|Other|1|||
162988763|NCT02132754|588661370|FG006|Overall Study|Physician Decision|0|||
162988764|NCT02132754|588661371|FG007|Overall Study|Physician Decision|0|||
162988765|NCT02132754|588661372|FG008|Overall Study|Physician Decision|0|||
162988766|NCT02132754|588661373|FG009|Overall Study|Physician Decision|1|||
162988767|NCT02132754|588661374|FG010|Overall Study|Physician Decision|0|||
162988768|NCT02132754|588661375|FG011|Overall Study|Physician Decision|1|||
162988769|NCT02132754|588661376|FG012|Overall Study|Physician Decision|1|||
162988770|NCT02132754|588661377|FG013|Overall Study|Physician Decision|0|||
162988771|NCT02132754|588661378|FG014|Overall Study|Physician Decision|0|||
162988772|NCT02132754|588661379|FG015|Overall Study|Physician Decision|1|||
162988773|NCT02132754|588661380|FG016|Overall Study|Physician Decision|0|||
162988774|NCT02132754|588661381|FG017|Overall Study|Physician Decision|0|||
162988775|NCT02132754|588661382|FG018|Overall Study|Physician Decision|0|||
162988776|NCT02132754|588661383|FG019|Overall Study|Physician Decision|0|||
162988777|NCT02132754|588661384|FG020|Overall Study|Physician Decision|0|||
162988778|NCT02132754|588661385|FG021|Overall Study|Physician Decision|0|||
162988779|NCT02132754|588661386|FG022|Overall Study|Physician Decision|0|||
162988780|NCT02132754|588661387|FG023|Overall Study|Physician Decision|0|||
162988781|NCT02132754|588661388|FG024|Overall Study|Physician Decision|1|||
162988782|NCT02132754|588661389|FG025|Overall Study|Physician Decision|0|||
162988783|NCT02132754|588661390|FG026|Overall Study|Physician Decision|0|||
162988784|NCT02132754|588661391|FG027|Overall Study|Physician Decision|0|||
162988785|NCT02132754|588661392|FG028|Overall Study|Physician Decision|0|||
162988786|NCT02132754|588661393|FG029|Overall Study|Physician Decision|0|||
162988787|NCT02132754|588661394|FG030|Overall Study|Physician Decision|0|||
162988788|NCT02132754|588661395|FG031|Overall Study|Physician Decision|1|||
162988789|NCT02132754|588661396|FG032|Overall Study|Physician Decision|0|||
162988790|NCT02132754|588661397|FG033|Overall Study|Physician Decision|3|||
162988791|NCT02132754|588661364|FG000|Overall Study|Progressive Disease|1|||
162988792|NCT02132754|588661365|FG001|Overall Study|Progressive Disease|1|||
162988793|NCT02132754|588661366|FG002|Overall Study|Progressive Disease|1|||
162988794|NCT02132754|588661367|FG003|Overall Study|Progressive Disease|1|||
162988795|NCT02132754|588661368|FG004|Overall Study|Progressive Disease|1|||
162988796|NCT02132754|588661369|FG005|Overall Study|Progressive Disease|1|||
162988797|NCT02132754|588661370|FG006|Overall Study|Progressive Disease|1|||
162988798|NCT02132754|588661371|FG007|Overall Study|Progressive Disease|1|||
162988799|NCT02132754|588661372|FG008|Overall Study|Progressive Disease|1|||
162988800|NCT02132754|588661373|FG009|Overall Study|Progressive Disease|3|||
162988801|NCT02132754|588661374|FG010|Overall Study|Progressive Disease|3|||
162988802|NCT02132754|588661375|FG011|Overall Study|Progressive Disease|2|||
162988803|NCT02132754|588661376|FG012|Overall Study|Progressive Disease|2|||
162988804|NCT02132754|588661377|FG013|Overall Study|Progressive Disease|3|||
162988805|NCT02132754|588661378|FG014|Overall Study|Progressive Disease|2|||
162988806|NCT02132754|588661379|FG015|Overall Study|Progressive Disease|1|||
162988807|NCT02132754|588661380|FG016|Overall Study|Progressive Disease|2|||
162988808|NCT02132754|588661381|FG017|Overall Study|Progressive Disease|1|||
162988809|NCT02132754|588661382|FG018|Overall Study|Progressive Disease|3|||
162988810|NCT02132754|588661383|FG019|Overall Study|Progressive Disease|1|||
162988811|NCT02132754|588661384|FG020|Overall Study|Progressive Disease|1|||
162988812|NCT02132754|588661385|FG021|Overall Study|Progressive Disease|3|||
162988813|NCT02132754|588661386|FG022|Overall Study|Progressive Disease|2|||
162988814|NCT02132754|588661387|FG023|Overall Study|Progressive Disease|3|||
162988815|NCT02132754|588661388|FG024|Overall Study|Progressive Disease|0|||
162988816|NCT02132754|588661389|FG025|Overall Study|Progressive Disease|1|||
162988817|NCT02132754|588661390|FG026|Overall Study|Progressive Disease|2|||
162988818|NCT02132754|588661391|FG027|Overall Study|Progressive Disease|1|||
162988819|NCT02132754|588661392|FG028|Overall Study|Progressive Disease|2|||
162988820|NCT02132754|588661393|FG029|Overall Study|Progressive Disease|3|||
162988821|NCT02132754|588661394|FG030|Overall Study|Progressive Disease|1|||
162988822|NCT02132754|588661395|FG031|Overall Study|Progressive Disease|1|||
162988823|NCT02132754|588661396|FG032|Overall Study|Progressive Disease|3|||
162988824|NCT02132754|588661397|FG033|Overall Study|Progressive Disease|6|||
162988825|NCT02132754|588661364|FG000|Overall Study|Screen Failure|0|||
162988826|NCT02132754|588661365|FG001|Overall Study|Screen Failure|0|||
162988827|NCT02132754|588661366|FG002|Overall Study|Screen Failure|0|||
162988828|NCT02132754|588661367|FG003|Overall Study|Screen Failure|0|||
162988829|NCT02132754|588661368|FG004|Overall Study|Screen Failure|0|||
162988830|NCT02132754|588661369|FG005|Overall Study|Screen Failure|0|||
162988831|NCT02132754|588661370|FG006|Overall Study|Screen Failure|0|||
162988832|NCT02132754|588661371|FG007|Overall Study|Screen Failure|0|||
162988833|NCT02132754|588661372|FG008|Overall Study|Screen Failure|0|||
162988834|NCT02132754|588661373|FG009|Overall Study|Screen Failure|0|||
162988835|NCT02132754|588661374|FG010|Overall Study|Screen Failure|0|||
162988836|NCT02132754|588661375|FG011|Overall Study|Screen Failure|0|||
162988837|NCT02132754|588661376|FG012|Overall Study|Screen Failure|0|||
162988838|NCT02132754|588661377|FG013|Overall Study|Screen Failure|0|||
162988839|NCT02132754|588661378|FG014|Overall Study|Screen Failure|0|||
162988840|NCT02132754|588661379|FG015|Overall Study|Screen Failure|0|||
162988841|NCT02132754|588661380|FG016|Overall Study|Screen Failure|0|||
162988842|NCT02132754|588661381|FG017|Overall Study|Screen Failure|0|||
162988843|NCT02132754|588661382|FG018|Overall Study|Screen Failure|0|||
163212317|NCT00613938|589492462|FG003|Overall Study|Other|3|||
162988844|NCT02132754|588661383|FG019|Overall Study|Screen Failure|1|||
162988845|NCT02132754|588661384|FG020|Overall Study|Screen Failure|0|||
162988846|NCT02132754|588661385|FG021|Overall Study|Screen Failure|1|||
162988847|NCT02132754|588661386|FG022|Overall Study|Screen Failure|0|||
162988848|NCT02132754|588661387|FG023|Overall Study|Screen Failure|0|||
162988849|NCT02132754|588661388|FG024|Overall Study|Screen Failure|0|||
162988850|NCT02132754|588661389|FG025|Overall Study|Screen Failure|0|||
162988851|NCT02132754|588661390|FG026|Overall Study|Screen Failure|0|||
162988852|NCT02132754|588661391|FG027|Overall Study|Screen Failure|0|||
162988853|NCT02132754|588661392|FG028|Overall Study|Screen Failure|0|||
162988854|NCT02132754|588661393|FG029|Overall Study|Screen Failure|0|||
162988855|NCT02132754|588661394|FG030|Overall Study|Screen Failure|0|||
162988856|NCT02132754|588661395|FG031|Overall Study|Screen Failure|0|||
162988857|NCT02132754|588661396|FG032|Overall Study|Screen Failure|0|||
162988858|NCT02132754|588661397|FG033|Overall Study|Screen Failure|0|||
162988859|NCT02132754|588661364|FG000|Overall Study|Transferred to Extension Study|0|||
162988860|NCT02132754|588661365|FG001|Overall Study|Transferred to Extension Study|0|||
162988861|NCT02132754|588661366|FG002|Overall Study|Transferred to Extension Study|0|||
162988862|NCT02132754|588661367|FG003|Overall Study|Transferred to Extension Study|0|||
162988863|NCT02132754|588661368|FG004|Overall Study|Transferred to Extension Study|0|||
162988864|NCT02132754|588661369|FG005|Overall Study|Transferred to Extension Study|0|||
162988865|NCT02132754|588661370|FG006|Overall Study|Transferred to Extension Study|0|||
162988866|NCT02132754|588661371|FG007|Overall Study|Transferred to Extension Study|0|||
162988867|NCT02132754|588661372|FG008|Overall Study|Transferred to Extension Study|0|||
162988868|NCT02132754|588661373|FG009|Overall Study|Transferred to Extension Study|0|||
162988869|NCT02132754|588661374|FG010|Overall Study|Transferred to Extension Study|0|||
162988870|NCT02132754|588661375|FG011|Overall Study|Transferred to Extension Study|0|||
162988871|NCT02132754|588661376|FG012|Overall Study|Transferred to Extension Study|0|||
162988872|NCT02132754|588661377|FG013|Overall Study|Transferred to Extension Study|0|||
162988873|NCT02132754|588661378|FG014|Overall Study|Transferred to Extension Study|0|||
162988874|NCT02132754|588661379|FG015|Overall Study|Transferred to Extension Study|0|||
162988875|NCT02132754|588661380|FG016|Overall Study|Transferred to Extension Study|0|||
162988876|NCT02132754|588661381|FG017|Overall Study|Transferred to Extension Study|0|||
162988877|NCT02132754|588661382|FG018|Overall Study|Transferred to Extension Study|0|||
162988878|NCT02132754|588661383|FG019|Overall Study|Transferred to Extension Study|0|||
162988879|NCT02132754|588661384|FG020|Overall Study|Transferred to Extension Study|0|||
162988880|NCT02132754|588661385|FG021|Overall Study|Transferred to Extension Study|0|||
162988881|NCT02132754|588661386|FG022|Overall Study|Transferred to Extension Study|0|||
162988882|NCT02132754|588661387|FG023|Overall Study|Transferred to Extension Study|0|||
162988883|NCT02132754|588661388|FG024|Overall Study|Transferred to Extension Study|0|||
162988884|NCT02132754|588661389|FG025|Overall Study|Transferred to Extension Study|0|||
162988885|NCT02132754|588661390|FG026|Overall Study|Transferred to Extension Study|0|||
162988886|NCT02132754|588661391|FG027|Overall Study|Transferred to Extension Study|0|||
162988887|NCT02132754|588661392|FG028|Overall Study|Transferred to Extension Study|0|||
162988888|NCT02132754|588661393|FG029|Overall Study|Transferred to Extension Study|0|||
162988889|NCT02132754|588661394|FG030|Overall Study|Transferred to Extension Study|0|||
162988890|NCT02132754|588661395|FG031|Overall Study|Transferred to Extension Study|0|||
162988891|NCT02132754|588661396|FG032|Overall Study|Transferred to Extension Study|0|||
162988892|NCT02132754|588661397|FG033|Overall Study|Transferred to Extension Study|6|||
162988893|NCT02132754|588661364|FG000|Overall Study|Withdrawal by Subject|0|||
162988894|NCT02132754|588661365|FG001|Overall Study|Withdrawal by Subject|0|||
162988895|NCT02132754|588661366|FG002|Overall Study|Withdrawal by Subject|0|||
162988896|NCT02132754|588661367|FG003|Overall Study|Withdrawal by Subject|0|||
162988897|NCT02132754|588661368|FG004|Overall Study|Withdrawal by Subject|0|||
162988898|NCT02132754|588661369|FG005|Overall Study|Withdrawal by Subject|0|||
162988899|NCT02132754|588661370|FG006|Overall Study|Withdrawal by Subject|0|||
162988900|NCT02132754|588661371|FG007|Overall Study|Withdrawal by Subject|0|||
162988901|NCT02132754|588661372|FG008|Overall Study|Withdrawal by Subject|0|||
162988902|NCT02132754|588661373|FG009|Overall Study|Withdrawal by Subject|1|||
162988903|NCT02132754|588661374|FG010|Overall Study|Withdrawal by Subject|0|||
163212318|NCT03025542|589492463|FG000|Overall Study|Adverse Event|0|||
163212319|NCT03025542|589492464|FG001|Overall Study|Adverse Event|2|||
163212320|NCT03025542|589492463|FG000|Overall Study|Lost to Follow-up|1|||
163212321|NCT03025542|589492464|FG001|Overall Study|Lost to Follow-up|0|||
162988904|NCT02132754|588661375|FG011|Overall Study|Withdrawal by Subject|0|||
162988905|NCT02132754|588661376|FG012|Overall Study|Withdrawal by Subject|1|||
162988906|NCT02132754|588661377|FG013|Overall Study|Withdrawal by Subject|0|||
163212322|NCT03025542|589492463|FG000|Overall Study|Withdrawal by Subject|1|||
163212323|NCT03025542|589492464|FG001|Overall Study|Withdrawal by Subject|0|||
163212324|NCT00312494|589492465|FG000|Overall Study|Randomized; not treated with study drug|9|||
163212325|NCT00312494|589492466|FG001|Overall Study|Randomized; not treated with study drug|10|||
163212326|NCT00312494|589492467|FG002|Overall Study|Randomized; not treated with study drug|5|||
163212327|NCT00312494|589492465|FG000|Overall Study|Adverse Event|33|||
163404249|NCT02831673|590191902|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
163404250|NCT02831673|590191903|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
163404251|NCT02831673|590191904|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
163404252|NCT02831673|590191900|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
163404253|NCT02831673|590191901|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
162988907|NCT02132754|588661378|FG014|Overall Study|Withdrawal by Subject|1|||
162988908|NCT02132754|588661379|FG015|Overall Study|Withdrawal by Subject|2|||
162988909|NCT02132754|588661380|FG016|Overall Study|Withdrawal by Subject|1|||
163212328|NCT00312494|589492466|FG001|Overall Study|Adverse Event|15|||
163212329|NCT00312494|589492467|FG002|Overall Study|Adverse Event|11|||
163324429|NCT04479787|589899873|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
163324430|NCT04479787|589899872|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
163324431|NCT04479787|589899873|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
163324432|NCT04479787|589899872|FG000|Through 6 Months|Lost to Follow-up|3|||
163324433|NCT04479787|589899873|FG001|Through 6 Months|Lost to Follow-up|2|||
163324434|NCT04479787|589899872|FG000|Through 6 Months|Death|3|||
163324435|NCT04479787|589899873|FG001|Through 6 Months|Death|0|||
163324436|NCT04479787|589899872|FG000|Through 6 Months|Inclusion/Exclusion|2|||
163404254|NCT02831673|590191902|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
163404255|NCT02831673|590191903|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
163404256|NCT02831673|590191904|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
163404257|NCT02831673|590191900|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
163404258|NCT02831673|590191901|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
162988910|NCT02132754|588661381|FG017|Overall Study|Withdrawal by Subject|0|||
162988911|NCT02132754|588661382|FG018|Overall Study|Withdrawal by Subject|0|||
162988912|NCT02132754|588661383|FG019|Overall Study|Withdrawal by Subject|0|||
162988913|NCT02132754|588661384|FG020|Overall Study|Withdrawal by Subject|1|||
162988914|NCT02132754|588661385|FG021|Overall Study|Withdrawal by Subject|0|||
162988915|NCT02132754|588661386|FG022|Overall Study|Withdrawal by Subject|0|||
162988916|NCT02132754|588661387|FG023|Overall Study|Withdrawal by Subject|0|||
162988917|NCT02132754|588661388|FG024|Overall Study|Withdrawal by Subject|1|||
162988918|NCT02132754|588661389|FG025|Overall Study|Withdrawal by Subject|0|||
162988919|NCT02132754|588661390|FG026|Overall Study|Withdrawal by Subject|0|||
162988920|NCT02132754|588661391|FG027|Overall Study|Withdrawal by Subject|1|||
162988921|NCT02132754|588661392|FG028|Overall Study|Withdrawal by Subject|0|||
162988922|NCT02132754|588661393|FG029|Overall Study|Withdrawal by Subject|0|||
162988923|NCT02132754|588661394|FG030|Overall Study|Withdrawal by Subject|0|||
162988924|NCT02132754|588661395|FG031|Overall Study|Withdrawal by Subject|1|||
162988925|NCT02132754|588661396|FG032|Overall Study|Withdrawal by Subject|0|||
162988926|NCT02132754|588661397|FG033|Overall Study|Withdrawal by Subject|2|||
162988927|NCT01193127|588661406|FG000|Randomized|Surgery Cancelled|0|||
162988928|NCT01193127|588661407|FG001|Randomized|Surgery Cancelled|0|||
162988929|NCT01193127|588661408|FG002|Randomized|Surgery Cancelled|0|||
162988930|NCT01193127|588661409|FG003|Randomized|Surgery Cancelled|1|||
162988931|NCT01193127|588661406|FG000|Treated|Withdrawal by Subject|0|||
162988932|NCT01193127|588661407|FG001|Treated|Withdrawal by Subject|0|||
162988933|NCT01193127|588661408|FG002|Treated|Withdrawal by Subject|0|||
162988934|NCT01193127|588661409|FG003|Treated|Withdrawal by Subject|1|||
162988935|NCT00761865|588661413|FG000|Overall Study|Lost to Follow-up|8|||
162988936|NCT00761865|588661414|FG001|Overall Study|Lost to Follow-up|7|||
162988937|NCT04555720|588661417|FG000|Overall Study|Lost to Follow-up|2|||
162988938|NCT04555720|588661418|FG001|Overall Study|Lost to Follow-up|0|||
162988939|NCT04555720|588661419|FG002|Overall Study|Lost to Follow-up|0|||
162988940|NCT04555720|588661420|FG003|Overall Study|Lost to Follow-up|0|||
162988941|NCT04555720|588661417|FG000|Overall Study|Withdrawal by Subject|4|||
162988942|NCT04555720|588661418|FG001|Overall Study|Withdrawal by Subject|6|||
162988943|NCT04555720|588661419|FG002|Overall Study|Withdrawal by Subject|0|||
162988944|NCT04555720|588661420|FG003|Overall Study|Withdrawal by Subject|0|||
162988945|NCT00321737|588661421|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
162988946|NCT00321737|588661422|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
162988947|NCT00321737|588661423|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
162988948|NCT00321737|588661421|FG000|Overall Study|Adverse Event|11|||
162988949|NCT00321737|588661422|FG001|Overall Study|Adverse Event|3|||
162988950|NCT00321737|588661423|FG002|Overall Study|Adverse Event|6|||
162988951|NCT00321737|588661421|FG000|Overall Study|Lost to Follow-up|5|||
162988952|NCT00321737|588661422|FG001|Overall Study|Lost to Follow-up|5|||
162988953|NCT00321737|588661423|FG002|Overall Study|Lost to Follow-up|6|||
162988954|NCT00321737|588661421|FG000|Overall Study|Withdrawal by Subject|19|||
162988955|NCT00321737|588661422|FG001|Overall Study|Withdrawal by Subject|12|||
163324437|NCT04479787|589899873|FG001|Through 6 Months|Inclusion/Exclusion|1|||
162988956|NCT00321737|588661423|FG002|Overall Study|Withdrawal by Subject|17|||
162988957|NCT00321737|588661421|FG000|Overall Study|Protocol Violation|0|||
162988958|NCT00321737|588661422|FG001|Overall Study|Protocol Violation|0|||
162988959|NCT00321737|588661423|FG002|Overall Study|Protocol Violation|1|||
162988960|NCT00321737|588661421|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
162988961|NCT00321737|588661422|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
162988962|NCT00321737|588661423|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
163324438|NCT04479787|589899872|FG000|Through 6 Months|Subject Became Pregnant|1|||
163404259|NCT02831673|590191902|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
163404260|NCT02831673|590191903|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
162988963|NCT00321737|588661421|FG000|Overall Study|Possible Barrett's Esophagus|2|||
163059948|NCT01881425|588928262|FG001|Overall Study|Adverse Event|0|||
162988964|NCT00321737|588661422|FG001|Overall Study|Possible Barrett's Esophagus|1|||
162988965|NCT00321737|588661423|FG002|Overall Study|Possible Barrett's Esophagus|1|||
163324439|NCT04479787|589899873|FG001|Through 6 Months|Subject Became Pregnant|1|||
162988966|NCT00321737|588661421|FG000|Overall Study|Therapeutic Failure|6|||
163324440|NCT04479787|589899872|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
163324441|NCT04479787|589899873|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
163324442|NCT04479787|589899872|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
163324443|NCT04479787|589899873|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
163324444|NCT04479787|589899872|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
163324445|NCT04479787|589899873|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
163324446|NCT04479787|589899872|FG000|After 6 Months|Withdrawal by Subject|3|||
163324447|NCT04479787|589899873|FG001|After 6 Months|Withdrawal by Subject|13|||
163324448|NCT04479787|589899872|FG000|After 6 Months|Unsuccessful Trial|0|||
163324449|NCT04479787|589899873|FG001|After 6 Months|Unsuccessful Trial|7|||
163324450|NCT04479787|589899872|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
163324451|NCT04479787|589899873|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
163324452|NCT04479787|589899872|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
163324453|NCT04479787|589899873|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
162988967|NCT00321737|588661422|FG001|Overall Study|Therapeutic Failure|0|||
162988968|NCT00321737|588661423|FG002|Overall Study|Therapeutic Failure|2|||
162988969|NCT00321737|588661421|FG000|Overall Study|Pregnancy|0|||
162988970|NCT00321737|588661422|FG001|Overall Study|Pregnancy|2|||
162988971|NCT00321737|588661423|FG002|Overall Study|Pregnancy|0|||
162988972|NCT00321737|588661421|FG000|Overall Study|Noncompliance|2|||
162988973|NCT00321737|588661422|FG001|Overall Study|Noncompliance|0|||
162988974|NCT00321737|588661423|FG002|Overall Study|Noncompliance|0|||
162988975|NCT00321737|588661421|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
162988976|NCT00321737|588661422|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
162988977|NCT00321737|588661423|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
162988978|NCT02283294|588661424|FG000|Overall Study|Lost to Follow-up|1|||
162988979|NCT02283294|588661425|FG001|Overall Study|Lost to Follow-up|1|||
162988980|NCT02283294|588661424|FG000|Overall Study|Withdrawal by Subject|1|||
162988981|NCT02283294|588661425|FG001|Overall Study|Withdrawal by Subject|6|||
162988982|NCT02283294|588661424|FG000|Overall Study|Protocol Violation|1|||
162988983|NCT02283294|588661425|FG001|Overall Study|Protocol Violation|0|||
162988984|NCT02283294|588661424|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
162988985|NCT02283294|588661425|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
162988986|NCT02799095|588664355|FG000|Part A|Adverse Event|1|||
162988987|NCT02799095|588664356|FG001|Part A|Adverse Event|0|||
162988988|NCT02799095|588664357|FG002|Part A|Adverse Event|1|||
162988989|NCT02799095|588664358|FG003|Part A|Adverse Event|4|||
162988990|NCT02799095|588664359|FG004|Part A|Adverse Event|1|||
162988991|NCT02799095|588664360|FG005|Part A|Adverse Event|0|||
162988992|NCT02799095|588664361|FG006|Part A|Adverse Event|0|||
162988993|NCT02799095|588664362|FG007|Part A|Adverse Event|0|||
162988994|NCT02799095|588664363|FG008|Part A|Adverse Event|0|||
162988995|NCT02799095|588664364|FG009|Part A|Adverse Event|0|||
162988996|NCT02799095|588664365|FG010|Part A|Adverse Event|0|||
162988997|NCT02799095|588664366|FG011|Part A|Adverse Event|0|||
162988998|NCT02799095|588664367|FG012|Part A|Adverse Event|0|||
162988999|NCT02799095|588664368|FG013|Part A|Adverse Event|0|||
162989000|NCT02799095|588664369|FG014|Part A|Adverse Event|0|||
162989001|NCT02799095|588664370|FG015|Part A|Adverse Event|0|||
162989002|NCT02799095|588664371|FG016|Part A|Adverse Event|0|||
162989003|NCT02799095|588664355|FG000|Part A|Death|0|||
162989004|NCT02799095|588664356|FG001|Part A|Death|0|||
162989005|NCT02799095|588664357|FG002|Part A|Death|0|||
162989006|NCT02799095|588664358|FG003|Part A|Death|0|||
162989007|NCT02799095|588664359|FG004|Part A|Death|0|||
162989008|NCT02799095|588664360|FG005|Part A|Death|0|||
162989009|NCT02799095|588664361|FG006|Part A|Death|3|||
162989010|NCT02799095|588664362|FG007|Part A|Death|0|||
163059949|NCT01881425|588928261|FG000|Overall Study|General Anesthesia panic attack|0|||
163324454|NCT04479787|589899872|FG000|After 6 Months|Death|2|||
163324455|NCT04479787|589899873|FG001|After 6 Months|Death|0|||
163324456|NCT04479787|589899872|FG000|After 6 Months|Lost to Follow-up|1|||
163324457|NCT04479787|589899873|FG001|After 6 Months|Lost to Follow-up|1|||
163324458|NCT04479787|589899872|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
162989011|NCT02799095|588664363|FG008|Part A|Death|0|||
162989012|NCT02799095|588664364|FG009|Part A|Death|0|||
162989013|NCT02799095|588664365|FG010|Part A|Death|0|||
162989014|NCT02799095|588664366|FG011|Part A|Death|0|||
162989015|NCT02799095|588664367|FG012|Part A|Death|0|||
162989016|NCT02799095|588664368|FG013|Part A|Death|0|||
162989017|NCT02799095|588664369|FG014|Part A|Death|0|||
162989018|NCT02799095|588664370|FG015|Part A|Death|0|||
162989019|NCT02799095|588664371|FG016|Part A|Death|0|||
162989020|NCT02799095|588664355|FG000|Part A|Lost to Follow-up|0|||
162989021|NCT02799095|588664356|FG001|Part A|Lost to Follow-up|1|||
162989022|NCT02799095|588664357|FG002|Part A|Lost to Follow-up|0|||
162989023|NCT02799095|588664358|FG003|Part A|Lost to Follow-up|0|||
162989024|NCT02799095|588664359|FG004|Part A|Lost to Follow-up|0|||
162989025|NCT02799095|588664360|FG005|Part A|Lost to Follow-up|0|||
162989026|NCT02799095|588664361|FG006|Part A|Lost to Follow-up|1|||
162989027|NCT02799095|588664362|FG007|Part A|Lost to Follow-up|0|||
162989028|NCT02799095|588664363|FG008|Part A|Lost to Follow-up|0|||
162989029|NCT02799095|588664364|FG009|Part A|Lost to Follow-up|0|||
162989030|NCT02799095|588664365|FG010|Part A|Lost to Follow-up|0|||
162989031|NCT02799095|588664366|FG011|Part A|Lost to Follow-up|0|||
162989032|NCT02799095|588664367|FG012|Part A|Lost to Follow-up|0|||
162989033|NCT02799095|588664368|FG013|Part A|Lost to Follow-up|0|||
162989034|NCT02799095|588664369|FG014|Part A|Lost to Follow-up|0|||
162989035|NCT02799095|588664370|FG015|Part A|Lost to Follow-up|0|||
162989036|NCT02799095|588664371|FG016|Part A|Lost to Follow-up|0|||
162989037|NCT02799095|588664355|FG000|Part A|Progressive Disease|3|||
162989038|NCT02799095|588664356|FG001|Part A|Progressive Disease|3|||
162989039|NCT02799095|588664357|FG002|Part A|Progressive Disease|3|||
162989040|NCT02799095|588664358|FG003|Part A|Progressive Disease|2|||
162989041|NCT02799095|588664359|FG004|Part A|Progressive Disease|2|||
162989042|NCT02799095|588664360|FG005|Part A|Progressive Disease|0|||
162989043|NCT02799095|588664361|FG006|Part A|Progressive Disease|0|||
162989044|NCT02799095|588664362|FG007|Part A|Progressive Disease|0|||
162989045|NCT02799095|588664363|FG008|Part A|Progressive Disease|0|||
162989046|NCT02799095|588664364|FG009|Part A|Progressive Disease|0|||
162989047|NCT02799095|588664365|FG010|Part A|Progressive Disease|0|||
162989048|NCT02799095|588664366|FG011|Part A|Progressive Disease|0|||
162989049|NCT02799095|588664367|FG012|Part A|Progressive Disease|0|||
162989050|NCT02799095|588664368|FG013|Part A|Progressive Disease|0|||
162989051|NCT02799095|588664369|FG014|Part A|Progressive Disease|0|||
162989052|NCT02799095|588664370|FG015|Part A|Progressive Disease|0|||
162989053|NCT02799095|588664371|FG016|Part A|Progressive Disease|0|||
162989054|NCT02799095|588664355|FG000|Part A|Clinical Progression|1|||
162989055|NCT02799095|588664356|FG001|Part A|Clinical Progression|0|||
162989056|NCT02799095|588664357|FG002|Part A|Clinical Progression|2|||
162989057|NCT02799095|588664358|FG003|Part A|Clinical Progression|1|||
162989058|NCT02799095|588664359|FG004|Part A|Clinical Progression|5|||
162989059|NCT02799095|588664360|FG005|Part A|Clinical Progression|0|||
162989060|NCT02799095|588664361|FG006|Part A|Clinical Progression|0|||
162989061|NCT02799095|588664362|FG007|Part A|Clinical Progression|0|||
162989062|NCT02799095|588664363|FG008|Part A|Clinical Progression|0|||
162989063|NCT02799095|588664364|FG009|Part A|Clinical Progression|0|||
162989064|NCT02799095|588664365|FG010|Part A|Clinical Progression|0|||
162989065|NCT02799095|588664366|FG011|Part A|Clinical Progression|0|||
162989066|NCT02799095|588664367|FG012|Part A|Clinical Progression|0|||
162989067|NCT02799095|588664368|FG013|Part A|Clinical Progression|0|||
162989068|NCT02799095|588664369|FG014|Part A|Clinical Progression|0|||
163324459|NCT04479787|589899873|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
162989069|NCT02799095|588664370|FG015|Part A|Clinical Progression|0|||
162989070|NCT02799095|588664371|FG016|Part A|Clinical Progression|0|||
162989071|NCT02799095|588664355|FG000|Part A|Protocol Deviation|0|||
162989072|NCT02799095|588664356|FG001|Part A|Protocol Deviation|0|||
162989073|NCT02799095|588664357|FG002|Part A|Protocol Deviation|1|||
163324460|NCT04479787|589899872|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
163324461|NCT04479787|589899873|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
163324462|NCT04479787|589899872|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
163324463|NCT04479787|589899873|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
163324464|NCT04479787|589899872|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
163324465|NCT04479787|589899873|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
163324466|NCT03699163|589900623|FG000|Overall Study|Physician Decision|12|||
163324467|NCT03699163|589900624|FG001|Overall Study|Physician Decision|0|||
163324468|NCT03699163|589900623|FG000|Overall Study|failed QC measures|205|||
163324469|NCT03699163|589900624|FG001|Overall Study|failed QC measures|206|||
163324470|NCT01976936|589900627|FG000|Overall Study|Did not receive at least 9 doses|9|||
163324471|NCT01976936|589900628|FG001|Overall Study|Did not receive at least 9 doses|4|||
163324472|NCT05162586|589900632|FG000|Overall Study|Other|0|||
163324473|NCT05162586|589900633|FG001|Overall Study|Other|0|||
163324474|NCT05162586|589900634|FG002|Overall Study|Other|0|||
162989074|NCT02799095|588664358|FG003|Part A|Protocol Deviation|0|||
162989075|NCT02799095|588664359|FG004|Part A|Protocol Deviation|0|||
162989076|NCT02799095|588664360|FG005|Part A|Protocol Deviation|0|||
162989077|NCT02799095|588664361|FG006|Part A|Protocol Deviation|0|||
162989078|NCT02799095|588664362|FG007|Part A|Protocol Deviation|0|||
162989079|NCT02799095|588664363|FG008|Part A|Protocol Deviation|0|||
162989080|NCT02799095|588664364|FG009|Part A|Protocol Deviation|0|||
162989081|NCT02799095|588664365|FG010|Part A|Protocol Deviation|0|||
162989082|NCT02799095|588664366|FG011|Part A|Protocol Deviation|0|||
162989083|NCT02799095|588664367|FG012|Part A|Protocol Deviation|0|||
162989084|NCT02799095|588664368|FG013|Part A|Protocol Deviation|0|||
162989085|NCT02799095|588664369|FG014|Part A|Protocol Deviation|0|||
162989086|NCT02799095|588664370|FG015|Part A|Protocol Deviation|0|||
162989087|NCT02799095|588664371|FG016|Part A|Protocol Deviation|0|||
162989088|NCT02799095|588664355|FG000|Part A|Withdrawal by Subject|0|||
162989089|NCT02799095|588664356|FG001|Part A|Withdrawal by Subject|0|||
162989090|NCT02799095|588664357|FG002|Part A|Withdrawal by Subject|0|||
162989091|NCT02799095|588664358|FG003|Part A|Withdrawal by Subject|1|||
163324475|NCT05162586|589900635|FG003|Overall Study|Other|0|||
163324476|NCT05162586|589900636|FG004|Overall Study|Other|1|||
163324477|NCT05162586|589900637|FG005|Overall Study|Other|0|||
162989092|NCT02799095|588664359|FG004|Part A|Withdrawal by Subject|3|||
162989093|NCT02799095|588664360|FG005|Part A|Withdrawal by Subject|1|||
162989094|NCT02799095|588664361|FG006|Part A|Withdrawal by Subject|1|||
162989095|NCT02799095|588664362|FG007|Part A|Withdrawal by Subject|0|||
162989096|NCT02799095|588664363|FG008|Part A|Withdrawal by Subject|0|||
162989097|NCT02799095|588664364|FG009|Part A|Withdrawal by Subject|0|||
162989098|NCT02799095|588664365|FG010|Part A|Withdrawal by Subject|0|||
162989099|NCT02799095|588664366|FG011|Part A|Withdrawal by Subject|0|||
162989100|NCT02799095|588664367|FG012|Part A|Withdrawal by Subject|0|||
162989101|NCT02799095|588664368|FG013|Part A|Withdrawal by Subject|0|||
162989102|NCT02799095|588664369|FG014|Part A|Withdrawal by Subject|0|||
162989103|NCT02799095|588664370|FG015|Part A|Withdrawal by Subject|0|||
162989104|NCT02799095|588664371|FG016|Part A|Withdrawal by Subject|0|||
162989105|NCT02799095|588664355|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
162989106|NCT02799095|588664356|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
162989107|NCT02799095|588664357|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
162989108|NCT02799095|588664358|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
162989109|NCT02799095|588664359|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
162989110|NCT02799095|588664360|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
162989111|NCT02799095|588664361|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
162989112|NCT02799095|588664362|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
162989113|NCT02799095|588664363|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
162989114|NCT02799095|588664364|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
162989115|NCT02799095|588664365|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
162989116|NCT02799095|588664366|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
162989117|NCT02799095|588664367|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
162989118|NCT02799095|588664368|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
162989119|NCT02799095|588664369|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
162989120|NCT02799095|588664370|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
162989121|NCT02799095|588664371|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
162989122|NCT02799095|588664355|FG000|Part B|Death|0|||
162989123|NCT02799095|588664356|FG001|Part B|Death|0|||
162989124|NCT02799095|588664357|FG002|Part B|Death|0|||
162989125|NCT02799095|588664358|FG003|Part B|Death|0|||
162989126|NCT02799095|588664359|FG004|Part B|Death|0|||
162989127|NCT02799095|588664360|FG005|Part B|Death|0|||
162989128|NCT02799095|588664361|FG006|Part B|Death|0|||
162989129|NCT02799095|588664362|FG007|Part B|Death|7|||
162989130|NCT02799095|588664363|FG008|Part B|Death|7|||
162989131|NCT02799095|588664364|FG009|Part B|Death|0|||
162989132|NCT02799095|588664365|FG010|Part B|Death|0|||
162989133|NCT02799095|588664366|FG011|Part B|Death|0|||
162989134|NCT02799095|588664367|FG012|Part B|Death|0|||
162989135|NCT02799095|588664368|FG013|Part B|Death|0|||
162989136|NCT02799095|588664369|FG014|Part B|Death|0|||
162989137|NCT02799095|588664370|FG015|Part B|Death|0|||
162989138|NCT02799095|588664371|FG016|Part B|Death|0|||
162989139|NCT02799095|588664355|FG000|Part B|Progressive Disease|0|||
162989140|NCT02799095|588664356|FG001|Part B|Progressive Disease|0|||
162989141|NCT02799095|588664357|FG002|Part B|Progressive Disease|0|||
162989142|NCT02799095|588664358|FG003|Part B|Progressive Disease|0|||
162989143|NCT02799095|588664359|FG004|Part B|Progressive Disease|0|||
162989144|NCT02799095|588664360|FG005|Part B|Progressive Disease|0|||
162989145|NCT02799095|588664361|FG006|Part B|Progressive Disease|0|||
162989146|NCT02799095|588664362|FG007|Part B|Progressive Disease|1|||
163324478|NCT05162586|589900638|FG006|Overall Study|Other|2|||
163324479|NCT05162586|589900639|FG007|Overall Study|Other|2|||
163324480|NCT05162586|589900632|FG000|Overall Study|Lack of Efficacy|0|||
163324481|NCT05162586|589900633|FG001|Overall Study|Lack of Efficacy|0|||
162989147|NCT02799095|588664363|FG008|Part B|Progressive Disease|0|||
162989148|NCT02799095|588664364|FG009|Part B|Progressive Disease|0|||
163324482|NCT05162586|589900634|FG002|Overall Study|Lack of Efficacy|0|||
163324483|NCT05162586|589900635|FG003|Overall Study|Lack of Efficacy|0|||
162989149|NCT02799095|588664365|FG010|Part B|Progressive Disease|0|||
162989150|NCT02799095|588664366|FG011|Part B|Progressive Disease|0|||
162989151|NCT02799095|588664367|FG012|Part B|Progressive Disease|0|||
162989152|NCT02799095|588664368|FG013|Part B|Progressive Disease|0|||
162989153|NCT02799095|588664369|FG014|Part B|Progressive Disease|0|||
162989154|NCT02799095|588664370|FG015|Part B|Progressive Disease|0|||
162989155|NCT02799095|588664371|FG016|Part B|Progressive Disease|0|||
162989156|NCT02799095|588664355|FG000|Part B|Withdrawal by Subject|0|||
162989157|NCT02799095|588664356|FG001|Part B|Withdrawal by Subject|0|||
162989158|NCT02799095|588664357|FG002|Part B|Withdrawal by Subject|0|||
162989159|NCT02799095|588664358|FG003|Part B|Withdrawal by Subject|0|||
162989160|NCT02799095|588664359|FG004|Part B|Withdrawal by Subject|0|||
162989161|NCT02799095|588664360|FG005|Part B|Withdrawal by Subject|0|||
162989162|NCT02799095|588664361|FG006|Part B|Withdrawal by Subject|0|||
162989163|NCT02799095|588664362|FG007|Part B|Withdrawal by Subject|10|||
163324484|NCT05162586|589900636|FG004|Overall Study|Lack of Efficacy|1|||
163324485|NCT05162586|589900637|FG005|Overall Study|Lack of Efficacy|0|||
163324486|NCT05162586|589900638|FG006|Overall Study|Lack of Efficacy|0|||
163324487|NCT05162586|589900639|FG007|Overall Study|Lack of Efficacy|1|||
163324488|NCT05162586|589900632|FG000|Overall Study|Lost to Follow-up|0|||
163324489|NCT05162586|589900633|FG001|Overall Study|Lost to Follow-up|0|||
163324490|NCT05162586|589900634|FG002|Overall Study|Lost to Follow-up|0|||
163324491|NCT05162586|589900635|FG003|Overall Study|Lost to Follow-up|0|||
163324492|NCT05162586|589900636|FG004|Overall Study|Lost to Follow-up|2|||
163324493|NCT05162586|589900637|FG005|Overall Study|Lost to Follow-up|0|||
163324494|NCT05162586|589900638|FG006|Overall Study|Lost to Follow-up|0|||
163324495|NCT05162586|589900639|FG007|Overall Study|Lost to Follow-up|2|||
163324496|NCT05162586|589900632|FG000|Overall Study|Non-Compliance|0|||
163324497|NCT05162586|589900633|FG001|Overall Study|Non-Compliance|1|||
163324498|NCT05162586|589900634|FG002|Overall Study|Non-Compliance|0|||
163324499|NCT05162586|589900635|FG003|Overall Study|Non-Compliance|0|||
163324500|NCT05162586|589900636|FG004|Overall Study|Non-Compliance|1|||
163324501|NCT05162586|589900637|FG005|Overall Study|Non-Compliance|0|||
163324502|NCT05162586|589900638|FG006|Overall Study|Non-Compliance|0|||
163324503|NCT05162586|589900639|FG007|Overall Study|Non-Compliance|1|||
163324504|NCT05162586|589900632|FG000|Overall Study|Withdrawal by Subject|2|||
163324505|NCT05162586|589900633|FG001|Overall Study|Withdrawal by Subject|0|||
163324506|NCT05162586|589900634|FG002|Overall Study|Withdrawal by Subject|0|||
163324507|NCT05162586|589900635|FG003|Overall Study|Withdrawal by Subject|0|||
163324508|NCT05162586|589900636|FG004|Overall Study|Withdrawal by Subject|7|||
163324509|NCT05162586|589900637|FG005|Overall Study|Withdrawal by Subject|6|||
163324510|NCT05162586|589900638|FG006|Overall Study|Withdrawal by Subject|2|||
163324511|NCT05162586|589900639|FG007|Overall Study|Withdrawal by Subject|2|||
162989164|NCT02799095|588664363|FG008|Part B|Withdrawal by Subject|7|||
162989165|NCT02799095|588664364|FG009|Part B|Withdrawal by Subject|0|||
162989166|NCT02799095|588664365|FG010|Part B|Withdrawal by Subject|0|||
162989167|NCT02799095|588664366|FG011|Part B|Withdrawal by Subject|0|||
162989168|NCT02799095|588664367|FG012|Part B|Withdrawal by Subject|0|||
162989169|NCT02799095|588664368|FG013|Part B|Withdrawal by Subject|0|||
162989170|NCT02799095|588664369|FG014|Part B|Withdrawal by Subject|0|||
162989171|NCT02799095|588664370|FG015|Part B|Withdrawal by Subject|0|||
162989172|NCT02799095|588664371|FG016|Part B|Withdrawal by Subject|0|||
162989173|NCT02799095|588664355|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
162989174|NCT02799095|588664356|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
162989175|NCT02799095|588664357|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
162989176|NCT02799095|588664358|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
162989177|NCT02799095|588664359|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
162989178|NCT02799095|588664360|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
162989179|NCT02799095|588664361|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
162989180|NCT02799095|588664362|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
162989181|NCT02799095|588664363|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
162989182|NCT02799095|588664364|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
162989183|NCT02799095|588664365|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
162989184|NCT02799095|588664366|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
162989185|NCT02799095|588664367|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
162989186|NCT02799095|588664368|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
162989187|NCT02799095|588664369|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
162989188|NCT02799095|588664370|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
162989189|NCT02799095|588664371|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
162989190|NCT02799095|588664355|FG000|Part C|Adverse Event|0|||
162989191|NCT02799095|588664356|FG001|Part C|Adverse Event|0|||
162989192|NCT02799095|588664357|FG002|Part C|Adverse Event|0|||
162989193|NCT02799095|588664358|FG003|Part C|Adverse Event|0|||
162989194|NCT02799095|588664359|FG004|Part C|Adverse Event|0|||
162989195|NCT02799095|588664360|FG005|Part C|Adverse Event|0|||
162989196|NCT02799095|588664361|FG006|Part C|Adverse Event|0|||
162989197|NCT02799095|588664362|FG007|Part C|Adverse Event|0|||
163324512|NCT05162586|589900632|FG000|Overall Study|Adverse Event|2|||
163324513|NCT05162586|589900633|FG001|Overall Study|Adverse Event|0|||
162989198|NCT02799095|588664363|FG008|Part C|Adverse Event|0|||
162989199|NCT02799095|588664364|FG009|Part C|Adverse Event|0|||
162989200|NCT02799095|588664365|FG010|Part C|Adverse Event|3|||
162989201|NCT02799095|588664366|FG011|Part C|Adverse Event|1|||
162989202|NCT02799095|588664367|FG012|Part C|Adverse Event|0|||
163324514|NCT05162586|589900634|FG002|Overall Study|Adverse Event|1|||
163324515|NCT05162586|589900635|FG003|Overall Study|Adverse Event|2|||
162989203|NCT02799095|588664368|FG013|Part C|Adverse Event|1|||
163324516|NCT05162586|589900636|FG004|Overall Study|Adverse Event|4|||
163324517|NCT05162586|589900637|FG005|Overall Study|Adverse Event|1|||
162989204|NCT02799095|588664369|FG014|Part C|Adverse Event|0|||
163059950|NCT01881425|588928262|FG001|Overall Study|General Anesthesia panic attack|1|||
162989205|NCT02799095|588664370|FG015|Part C|Adverse Event|0|||
162989206|NCT02799095|588664371|FG016|Part C|Adverse Event|0|||
163324518|NCT05162586|589900638|FG006|Overall Study|Adverse Event|5|||
163324519|NCT05162586|589900639|FG007|Overall Study|Adverse Event|2|||
163324520|NCT00982644|589900642|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
163324521|NCT00982644|589900643|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
162989207|NCT02799095|588664355|FG000|Part C|Death|0|||
162989208|NCT02799095|588664356|FG001|Part C|Death|0|||
162989209|NCT02799095|588664357|FG002|Part C|Death|0|||
162989210|NCT02799095|588664358|FG003|Part C|Death|0|||
162989211|NCT02799095|588664359|FG004|Part C|Death|0|||
162989212|NCT02799095|588664360|FG005|Part C|Death|0|||
162989213|NCT02799095|588664361|FG006|Part C|Death|0|||
162989214|NCT02799095|588664362|FG007|Part C|Death|0|||
162989215|NCT02799095|588664363|FG008|Part C|Death|0|||
162989216|NCT02799095|588664364|FG009|Part C|Death|0|||
162989217|NCT02799095|588664365|FG010|Part C|Death|7|||
162989218|NCT02799095|588664366|FG011|Part C|Death|5|||
162989219|NCT02799095|588664367|FG012|Part C|Death|6|||
162989220|NCT02799095|588664368|FG013|Part C|Death|8|||
162989221|NCT02799095|588664369|FG014|Part C|Death|1|||
162989222|NCT02799095|588664370|FG015|Part C|Death|8|||
162989223|NCT02799095|588664371|FG016|Part C|Death|1|||
162989224|NCT02799095|588664355|FG000|Part C|Lost to Follow-up|0|||
162989225|NCT02799095|588664356|FG001|Part C|Lost to Follow-up|0|||
162989226|NCT02799095|588664357|FG002|Part C|Lost to Follow-up|0|||
162989227|NCT02799095|588664358|FG003|Part C|Lost to Follow-up|0|||
162989228|NCT02799095|588664359|FG004|Part C|Lost to Follow-up|0|||
162989229|NCT02799095|588664360|FG005|Part C|Lost to Follow-up|0|||
162989230|NCT02799095|588664361|FG006|Part C|Lost to Follow-up|0|||
162989231|NCT02799095|588664362|FG007|Part C|Lost to Follow-up|0|||
162989232|NCT02799095|588664363|FG008|Part C|Lost to Follow-up|0|||
162989233|NCT02799095|588664364|FG009|Part C|Lost to Follow-up|0|||
163324522|NCT00982644|589900642|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
163324523|NCT00982644|589900643|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
163324524|NCT00982644|589900642|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
163324525|NCT00982644|589900643|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
163324526|NCT00982644|589900642|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
163324527|NCT00982644|589900643|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
163324528|NCT00982644|589900642|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
163324529|NCT00982644|589900643|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
163324530|NCT00982644|589900642|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
163324531|NCT00982644|589900643|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
163324532|NCT00982644|589900642|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
163324533|NCT00982644|589900643|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
163324534|NCT00982644|589900642|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
163324535|NCT00982644|589900643|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
163324536|NCT00982644|589900642|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
163324537|NCT00982644|589900643|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
163324538|NCT00982644|589900642|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
163324539|NCT00982644|589900643|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
163324540|NCT02989662|589900644|FG000|Overall Study|Lost to Follow-up|0|||
163324541|NCT02989662|589900645|FG001|Overall Study|Lost to Follow-up|0|||
163324542|NCT02989662|589900646|FG002|Overall Study|Lost to Follow-up|0|||
163324543|NCT02989662|589900647|FG003|Overall Study|Lost to Follow-up|2|||
163324544|NCT02989662|589900644|FG000|Overall Study|Physician Decision|3|||
163324545|NCT02989662|589900645|FG001|Overall Study|Physician Decision|0|||
162989234|NCT02799095|588664365|FG010|Part C|Lost to Follow-up|1|||
162989235|NCT02799095|588664366|FG011|Part C|Lost to Follow-up|1|||
162989236|NCT02799095|588664367|FG012|Part C|Lost to Follow-up|1|||
162989237|NCT02799095|588664368|FG013|Part C|Lost to Follow-up|3|||
162989238|NCT02799095|588664369|FG014|Part C|Lost to Follow-up|0|||
162989239|NCT02799095|588664370|FG015|Part C|Lost to Follow-up|0|||
162989240|NCT02799095|588664371|FG016|Part C|Lost to Follow-up|0|||
162989241|NCT02799095|588664355|FG000|Part C|Progressive Disease|0|||
162989242|NCT02799095|588664356|FG001|Part C|Progressive Disease|0|||
162989243|NCT02799095|588664357|FG002|Part C|Progressive Disease|0|||
162989244|NCT02799095|588664358|FG003|Part C|Progressive Disease|0|||
163324546|NCT02989662|589900646|FG002|Overall Study|Physician Decision|0|||
163324547|NCT02989662|589900647|FG003|Overall Study|Physician Decision|0|||
163324548|NCT02989662|589900644|FG000|Overall Study|Withdrawal by Subject|1|||
163324549|NCT02989662|589900645|FG001|Overall Study|Withdrawal by Subject|0|||
162989245|NCT02799095|588664359|FG004|Part C|Progressive Disease|0|||
162989246|NCT02799095|588664360|FG005|Part C|Progressive Disease|0|||
162989247|NCT02799095|588664361|FG006|Part C|Progressive Disease|0|||
162989248|NCT02799095|588664362|FG007|Part C|Progressive Disease|0|||
162989249|NCT02799095|588664363|FG008|Part C|Progressive Disease|0|||
162989250|NCT02799095|588664364|FG009|Part C|Progressive Disease|2|||
162989251|NCT02799095|588664365|FG010|Part C|Progressive Disease|13|||
162989252|NCT02799095|588664366|FG011|Part C|Progressive Disease|2|||
162989253|NCT02799095|588664367|FG012|Part C|Progressive Disease|0|||
162989254|NCT02799095|588664368|FG013|Part C|Progressive Disease|1|||
162989255|NCT02799095|588664369|FG014|Part C|Progressive Disease|0|||
162989256|NCT02799095|588664370|FG015|Part C|Progressive Disease|0|||
162989257|NCT02799095|588664371|FG016|Part C|Progressive Disease|0|||
162989258|NCT02799095|588664355|FG000|Part C|Clinical Progression|0|||
162989259|NCT02799095|588664356|FG001|Part C|Clinical Progression|0|||
162989260|NCT02799095|588664357|FG002|Part C|Clinical Progression|0|||
162989261|NCT02799095|588664358|FG003|Part C|Clinical Progression|0|||
162989262|NCT02799095|588664359|FG004|Part C|Clinical Progression|0|||
162989263|NCT02799095|588664360|FG005|Part C|Clinical Progression|0|||
162989264|NCT02799095|588664361|FG006|Part C|Clinical Progression|0|||
162989265|NCT02799095|588664362|FG007|Part C|Clinical Progression|0|||
162989266|NCT02799095|588664363|FG008|Part C|Clinical Progression|0|||
162989267|NCT02799095|588664364|FG009|Part C|Clinical Progression|1|||
162989268|NCT02799095|588664365|FG010|Part C|Clinical Progression|3|||
162989269|NCT02799095|588664366|FG011|Part C|Clinical Progression|0|||
162989270|NCT02799095|588664367|FG012|Part C|Clinical Progression|0|||
162989271|NCT02799095|588664368|FG013|Part C|Clinical Progression|1|||
162989272|NCT02799095|588664369|FG014|Part C|Clinical Progression|0|||
162989273|NCT02799095|588664370|FG015|Part C|Clinical Progression|0|||
162989274|NCT02799095|588664371|FG016|Part C|Clinical Progression|0|||
162989275|NCT02799095|588664355|FG000|Part C|Withdrawal by Subject|0|||
162989276|NCT02799095|588664356|FG001|Part C|Withdrawal by Subject|0|||
162989277|NCT02799095|588664357|FG002|Part C|Withdrawal by Subject|0|||
162989278|NCT02799095|588664358|FG003|Part C|Withdrawal by Subject|0|||
162989279|NCT02799095|588664359|FG004|Part C|Withdrawal by Subject|0|||
162989280|NCT02799095|588664360|FG005|Part C|Withdrawal by Subject|0|||
162989281|NCT02799095|588664361|FG006|Part C|Withdrawal by Subject|0|||
162989282|NCT02799095|588664362|FG007|Part C|Withdrawal by Subject|0|||
162989283|NCT02799095|588664363|FG008|Part C|Withdrawal by Subject|0|||
162989284|NCT02799095|588664364|FG009|Part C|Withdrawal by Subject|0|||
162989285|NCT02799095|588664365|FG010|Part C|Withdrawal by Subject|13|||
162989286|NCT02799095|588664366|FG011|Part C|Withdrawal by Subject|15|||
162989287|NCT02799095|588664367|FG012|Part C|Withdrawal by Subject|13|||
162989288|NCT02799095|588664368|FG013|Part C|Withdrawal by Subject|21|||
162989289|NCT02799095|588664369|FG014|Part C|Withdrawal by Subject|0|||
162989290|NCT02799095|588664370|FG015|Part C|Withdrawal by Subject|12|||
162989291|NCT02799095|588664371|FG016|Part C|Withdrawal by Subject|1|||
162989292|NCT02799095|588664355|FG000|Part C|Physician Decision|0|||
162989293|NCT02799095|588664356|FG001|Part C|Physician Decision|0|||
162989294|NCT02799095|588664357|FG002|Part C|Physician Decision|0|||
162989295|NCT02799095|588664358|FG003|Part C|Physician Decision|0|||
162989296|NCT02799095|588664359|FG004|Part C|Physician Decision|0|||
162989297|NCT02799095|588664360|FG005|Part C|Physician Decision|0|||
162989298|NCT02799095|588664361|FG006|Part C|Physician Decision|0|||
162989299|NCT02799095|588664362|FG007|Part C|Physician Decision|0|||
162989300|NCT02799095|588664363|FG008|Part C|Physician Decision|0|||
162989301|NCT02799095|588664364|FG009|Part C|Physician Decision|0|||
162989302|NCT02799095|588664365|FG010|Part C|Physician Decision|1|||
162989303|NCT02799095|588664366|FG011|Part C|Physician Decision|0|||
162989304|NCT02799095|588664367|FG012|Part C|Physician Decision|0|||
162989305|NCT02799095|588664368|FG013|Part C|Physician Decision|0|||
162989306|NCT02799095|588664369|FG014|Part C|Physician Decision|0|||
162989307|NCT02799095|588664370|FG015|Part C|Physician Decision|0|||
162989308|NCT02799095|588664371|FG016|Part C|Physician Decision|0|||
162989309|NCT02799095|588664355|FG000|Part C|Other|0|||
162989310|NCT02799095|588664356|FG001|Part C|Other|0|||
162989311|NCT02799095|588664357|FG002|Part C|Other|0|||
162989312|NCT02799095|588664358|FG003|Part C|Other|0|||
162989313|NCT02799095|588664359|FG004|Part C|Other|0|||
162989314|NCT02799095|588664360|FG005|Part C|Other|0|||
162989315|NCT02799095|588664361|FG006|Part C|Other|0|||
162989316|NCT02799095|588664362|FG007|Part C|Other|0|||
162989317|NCT02799095|588664363|FG008|Part C|Other|0|||
162989318|NCT02799095|588664364|FG009|Part C|Other|0|||
162989319|NCT02799095|588664365|FG010|Part C|Other|0|||
162989320|NCT02799095|588664366|FG011|Part C|Other|2|||
162989321|NCT02799095|588664367|FG012|Part C|Other|2|||
162989322|NCT02799095|588664368|FG013|Part C|Other|0|||
162989323|NCT02799095|588664369|FG014|Part C|Other|0|||
162989324|NCT02799095|588664370|FG015|Part C|Other|0|||
162989325|NCT02799095|588664371|FG016|Part C|Other|0|||
162989326|NCT04994483|588664372|FG000|Overall Study|Adverse Event|26|||
162989327|NCT04994483|588664373|FG001|Overall Study|Adverse Event|17|||
162989328|NCT04994483|588664372|FG000|Overall Study|Lost to Follow-up|6|||
162989329|NCT04994483|588664373|FG001|Overall Study|Lost to Follow-up|10|||
162989330|NCT04994483|588664372|FG000|Overall Study|Noncompliance with study drug|8|||
162989331|NCT04994483|588664373|FG001|Overall Study|Noncompliance with study drug|5|||
162989332|NCT04994483|588664372|FG000|Overall Study|Physician Decision|5|||
162989333|NCT04994483|588664373|FG001|Overall Study|Physician Decision|0|||
162989334|NCT04994483|588664372|FG000|Overall Study|Withdrawal by Subject|41|||
162989335|NCT04994483|588664373|FG001|Overall Study|Withdrawal by Subject|38|||
162989336|NCT04994483|588664372|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
162989337|NCT04994483|588664373|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
162989338|NCT04994483|588664372|FG000|Overall Study|Met stopping criteria|1|||
162989339|NCT04994483|588664373|FG001|Overall Study|Met stopping criteria|0|||
162989340|NCT04994483|588664372|FG000|Overall Study|Randomized in error, not treated|4|||
162989341|NCT04994483|588664373|FG001|Overall Study|Randomized in error, not treated|3|||
162989342|NCT04994483|588664372|FG000|Overall Study|Lack of a reliable study partner|0|||
162989343|NCT04994483|588664373|FG001|Overall Study|Lack of a reliable study partner|1|||
162989344|NCT04994483|588664372|FG000|Overall Study|Met MRI exclusion criteria|0|||
162989345|NCT04994483|588664373|FG001|Overall Study|Met MRI exclusion criteria|1|||
162989346|NCT00759902|588664374|FG000|Overall Study|Adverse Event|0|||
162989347|NCT00759902|588664375|FG001|Overall Study|Adverse Event|1|||
162989348|NCT02213510|588664376|FG000|Overall Study|Death|0|||
162989349|NCT02213510|588664377|FG001|Overall Study|Death|1|||
162989350|NCT02213510|588664376|FG000|Overall Study|Lost to Follow-up|1|||
162989351|NCT02213510|588664377|FG001|Overall Study|Lost to Follow-up|0|||
162989352|NCT03954834|588664378|FG000|Overall Study|Adverse Event|1|||
162989353|NCT03954834|588664379|FG001|Overall Study|Adverse Event|3|||
162989354|NCT03954834|588664380|FG002|Overall Study|Adverse Event|1|||
162989355|NCT03954834|588664381|FG003|Overall Study|Adverse Event|1|||
162989356|NCT03954834|588664378|FG000|Overall Study|Death|0|||
162989357|NCT03954834|588664379|FG001|Overall Study|Death|0|||
162989358|NCT03954834|588664380|FG002|Overall Study|Death|0|||
162989359|NCT03954834|588664381|FG003|Overall Study|Death|1|||
162989360|NCT03954834|588664378|FG000|Overall Study|Physician Decision|0|||
162989361|NCT03954834|588664379|FG001|Overall Study|Physician Decision|1|||
162989362|NCT03954834|588664380|FG002|Overall Study|Physician Decision|0|||
162989363|NCT03954834|588664381|FG003|Overall Study|Physician Decision|2|||
162989364|NCT03954834|588664378|FG000|Overall Study|Protocol Violation|1|||
162989365|NCT03954834|588664379|FG001|Overall Study|Protocol Violation|0|||
162989366|NCT03954834|588664380|FG002|Overall Study|Protocol Violation|0|||
162989367|NCT03954834|588664381|FG003|Overall Study|Protocol Violation|1|||
162989368|NCT03954834|588664378|FG000|Overall Study|Withdrawal by Subject|2|||
162989369|NCT03954834|588664379|FG001|Overall Study|Withdrawal by Subject|3|||
162989370|NCT03954834|588664380|FG002|Overall Study|Withdrawal by Subject|13|||
162989371|NCT03954834|588664381|FG003|Overall Study|Withdrawal by Subject|6|||
162989372|NCT03954834|588664378|FG000|Overall Study|Participant left the country|0|||
162989373|NCT03954834|588664379|FG001|Overall Study|Participant left the country|0|||
162989374|NCT03954834|588664380|FG002|Overall Study|Participant left the country|1|||
162989375|NCT03954834|588664381|FG003|Overall Study|Participant left the country|0|||
162989376|NCT03954834|588664378|FG000|Overall Study|Lost to Follow-up|3|||
162989377|NCT03954834|588664379|FG001|Overall Study|Lost to Follow-up|2|||
162989378|NCT03954834|588664380|FG002|Overall Study|Lost to Follow-up|3|||
162989379|NCT03954834|588664381|FG003|Overall Study|Lost to Follow-up|5|||
162989380|NCT02903030|588664382|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
162989381|NCT02903030|588664383|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
162989382|NCT03700385|588664390|FG000|Overall Study|Lost to Follow-up|1|||
162989383|NCT00699283|588664391|FG000|Overall Study|Lack of Efficacy|15|||
162989384|NCT00699283|588664392|FG001|Overall Study|Lack of Efficacy|5|||
162989385|NCT00699283|588664391|FG000|Overall Study|Lost to Follow-up|2|||
162989386|NCT00699283|588664392|FG001|Overall Study|Lost to Follow-up|0|||
162989387|NCT00699283|588664391|FG000|Overall Study|Withdrawal by Subject|1|||
162989388|NCT00699283|588664392|FG001|Overall Study|Withdrawal by Subject|0|||
162989389|NCT00699283|588664391|FG000|Overall Study|Other Reason|5|||
162989390|NCT00699283|588664392|FG001|Overall Study|Other Reason|1|||
162989391|NCT00699283|588664391|FG000|Overall Study|SAE, non-fatal|1|||
162989392|NCT00699283|588664392|FG001|Overall Study|SAE, non-fatal|1|||
162989393|NCT00699283|588664391|FG000|Overall Study|AE, non-serious non-fatal|8|||
162989394|NCT00699283|588664392|FG001|Overall Study|AE, non-serious non-fatal|1|||
162989395|NCT00699283|588664391|FG000|Overall Study|AE of unknown type|1|||
163059951|NCT01881425|588928261|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
163059952|NCT01881425|588928262|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
163059953|NCT01881425|588928261|FG000|Overall Study|Lost to Follow-up|7|||
163059954|NCT01881425|588928262|FG001|Overall Study|Lost to Follow-up|2|||
163059955|NCT04154956|588928267|FG000|Overall Study|Death|109|||
163059956|NCT04154956|588928268|FG001|Overall Study|Death|110|||
163059957|NCT04154956|588928267|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
163212330|NCT00312494|589492465|FG000|Overall Study|Lack of Efficacy|4|||
163212331|NCT00312494|589492466|FG001|Overall Study|Lack of Efficacy|6|||
162989396|NCT00699283|588664392|FG001|Overall Study|AE of unknown type|0|||
162989397|NCT04590040|588664398|FG000|Treatment Period|Lost to Follow-up|2|||
162989398|NCT04590040|588664399|FG001|Treatment Period|Lost to Follow-up|5|||
162989399|NCT04590040|588664400|FG002|Treatment Period|Lost to Follow-up|0|||
162989400|NCT04590040|588664398|FG000|Treatment Period|Physician Decision|0|||
162989401|NCT04590040|588664399|FG001|Treatment Period|Physician Decision|0|||
162989402|NCT04590040|588664400|FG002|Treatment Period|Physician Decision|2|||
162989403|NCT00000378|588664403|FG000|Overall Study|Lack of Efficacy|16|||
162989404|NCT00000378|588664404|FG001|Overall Study|Lack of Efficacy|14|||
162989405|NCT01284361|588664409|FG000|Overall Study|Withdrawal by Subject|1|||
163212332|NCT00312494|589492467|FG002|Overall Study|Lack of Efficacy|8|||
162989406|NCT01284361|588664409|FG000|Overall Study|Protocol Violation|5|||
162989407|NCT01284361|588664409|FG000|Overall Study|Adverse Event|1|||
163059958|NCT04154956|588928268|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
163212333|NCT00312494|589492465|FG000|Overall Study|Laboratory abnormality|1|||
163212334|NCT00312494|589492466|FG001|Overall Study|Laboratory abnormality|0|||
163212335|NCT00312494|589492467|FG002|Overall Study|Laboratory abnormality|0|||
163059959|NCT04154956|588928267|FG000|Overall Study|Withdrawal by Subject|1|||
163059960|NCT04154956|588928268|FG001|Overall Study|Withdrawal by Subject|7|||
163059961|NCT04154956|588928267|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
163059962|NCT04154956|588928268|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
163059963|NCT00147238|588928269|FG000|Overall Study|Inevaluable|8|||
163059964|NCT04424901|588928270|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
163059965|NCT04424901|588928271|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
162989408|NCT01284361|588664409|FG000|Overall Study|Lost to Follow-up|2|||
162989409|NCT00805675|588664410|FG000|Overall Study|Adverse Event|0|||
162989410|NCT00805675|588664411|FG001|Overall Study|Adverse Event|0|||
162989411|NCT00805675|588664412|FG002|Overall Study|Adverse Event|1|||
162989412|NCT02771795|588664416|FG000|Overall Study|Withdrawal by Subject|47|||
162989413|NCT02771795|588664417|FG001|Overall Study|Withdrawal by Subject|37|||
162989414|NCT02771795|588664416|FG000|Overall Study|Termination by premature discontinuation of study|168|||
162989415|NCT02771795|588664417|FG001|Overall Study|Termination by premature discontinuation of study|185|||
162989416|NCT01957397|588664419|FG000|Test Period 1|sudden leakage/small bag|1|||
162989417|NCT01957397|588664420|FG001|Test Period 1|sudden leakage/small bag|1|||
162989418|NCT01957397|588664419|FG000|Test Period 1|Withdrawal by Subject|1|||
162989419|NCT01957397|588664420|FG001|Test Period 1|Withdrawal by Subject|0|||
162989420|NCT01957397|588664419|FG000|Test Period 2|Adverse Event|0|||
162989421|NCT01957397|588664420|FG001|Test Period 2|Adverse Event|1|||
162989422|NCT01957397|588664419|FG000|Test Period 3|Adverse Event|1|||
162989423|NCT01957397|588664420|FG001|Test Period 3|Adverse Event|2|||
163324550|NCT02989662|589900646|FG002|Overall Study|Withdrawal by Subject|0|||
163324551|NCT02989662|589900647|FG003|Overall Study|Withdrawal by Subject|0|||
163324552|NCT06393127|589900648|FG000|Washout period|Withdrawal by Subject|1|||
163324553|NCT06393127|589900649|FG001|Washout period|Withdrawal by Subject|0|||
163324554|NCT06393127|589900648|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
163324555|NCT06393127|589900649|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
163324556|NCT02446600|589900650|FG000|Overall Study|Never treated|20|||
163324557|NCT02446600|589900651|FG001|Overall Study|Never treated|2|||
163324558|NCT02446600|589900652|FG002|Overall Study|Never treated|6|||
163324559|NCT02446600|589900653|FG003|Overall Study|Never treated|0|||
163324560|NCT02446600|589900650|FG000|Overall Study|Withdrawal by Subject|19|||
163324561|NCT02446600|589900651|FG001|Overall Study|Withdrawal by Subject|5|||
163324562|NCT02446600|589900652|FG002|Overall Study|Withdrawal by Subject|17|||
163324563|NCT02446600|589900653|FG003|Overall Study|Withdrawal by Subject|0|||
163324564|NCT02446600|589900650|FG000|Overall Study|Ineligible|1|||
163324565|NCT02446600|589900651|FG001|Overall Study|Ineligible|4|||
163324566|NCT02446600|589900652|FG002|Overall Study|Ineligible|4|||
162989424|NCT01957397|588664419|FG000|Test Period 3|the adhesive did not work|1|||
162989425|NCT01957397|588664420|FG001|Test Period 3|the adhesive did not work|0|||
162989426|NCT00505375|588664421|FG000|Overall Study|Death|1|||
162989427|NCT00505375|588664422|FG001|Overall Study|Death|0|||
162989428|NCT00505375|588664421|FG000|Overall Study|Withdrawal by Subject|2|||
162989429|NCT00505375|588664422|FG001|Overall Study|Withdrawal by Subject|2|||
162989430|NCT00505375|588664421|FG000|Overall Study|Lost to Follow-up|0|||
162989431|NCT00505375|588664422|FG001|Overall Study|Lost to Follow-up|2|||
162989432|NCT00505375|588664421|FG000|Overall Study|Pregnancy|1|||
162989433|NCT00505375|588664422|FG001|Overall Study|Pregnancy|0|||
162989434|NCT00505375|588664421|FG000|Overall Study|Travel issues|0|||
162989435|NCT00505375|588664422|FG001|Overall Study|Travel issues|1|||
162989436|NCT02906930|588664423|FG000|Overall Study|Withdrawal by Subject|0|||
162989437|NCT02906930|588664424|FG001|Overall Study|Withdrawal by Subject|5|||
162989438|NCT02906930|588664425|FG002|Overall Study|Withdrawal by Subject|5|||
163059966|NCT04810962|588928272|FG000|Overall Study|Adverse Event|0|||
163059967|NCT04810962|588928273|FG001|Overall Study|Adverse Event|1|||
163059968|NCT04810962|588928272|FG000|Overall Study|Lost to Follow-up|2|||
163324567|NCT02446600|589900653|FG003|Overall Study|Ineligible|1|||
163324568|NCT02446600|589900650|FG000|Overall Study|Duplicate Enrollment|0|||
162989439|NCT02906930|588664426|FG003|Overall Study|Withdrawal by Subject|4|||
162989440|NCT02906930|588664423|FG000|Overall Study|Lost to Follow-up|5|||
162989441|NCT02906930|588664424|FG001|Overall Study|Lost to Follow-up|7|||
162989442|NCT02906930|588664425|FG002|Overall Study|Lost to Follow-up|5|||
162989443|NCT02906930|588664426|FG003|Overall Study|Lost to Follow-up|2|||
162989444|NCT02906930|588664423|FG000|Overall Study|Death|0|||
162989445|NCT02906930|588664424|FG001|Overall Study|Death|0|||
162989446|NCT02906930|588664425|FG002|Overall Study|Death|1|||
162989447|NCT02906930|588664426|FG003|Overall Study|Death|0|||
162989448|NCT02906930|588664423|FG000|Overall Study|Other|1|||
162989449|NCT02906930|588664424|FG001|Overall Study|Other|2|||
163059969|NCT04810962|588928273|FG001|Overall Study|Lost to Follow-up|1|||
163059970|NCT04810962|588928272|FG000|Overall Study|Physician Decision|1|||
163324569|NCT02446600|589900651|FG001|Overall Study|Duplicate Enrollment|1|||
162989450|NCT02906930|588664425|FG002|Overall Study|Other|1|||
162989451|NCT02906930|588664426|FG003|Overall Study|Other|2|||
162989452|NCT00540293|588664427|FG000|Overall Study|Adverse event related to study drug|10|||
162989453|NCT00540293|588664427|FG000|Overall Study|Adverse event not related to study drug|7|||
162989454|NCT00540293|588664427|FG000|Overall Study|Withdrawal by Subject|6|||
162989455|NCT00540293|588664427|FG000|Overall Study|Protocol violation, & subject schedule|12|||
162989456|NCT03537599|588664428|FG000|Overall Study|Disease Progression|2|||
162989457|NCT03537599|588664429|FG001|Overall Study|Disease Progression|1|||
162989458|NCT03537599|588664428|FG000|Overall Study|Death|0|||
162989459|NCT03537599|588664429|FG001|Overall Study|Death|1|||
162989460|NCT02603393|588664431|FG000|Overall Study|Patient/guardian decision|32|||
162989461|NCT02603393|588664432|FG001|Overall Study|Patient/guardian decision|18|||
162989462|NCT02603393|588664431|FG000|Overall Study|Adverse Event|17|||
162989463|NCT02603393|588664432|FG001|Overall Study|Adverse Event|15|||
162989464|NCT02603393|588664431|FG000|Overall Study|Technical problems|4|||
162989465|NCT02603393|588664432|FG001|Overall Study|Technical problems|7|||
162989466|NCT02603393|588664431|FG000|Overall Study|Lack of Efficacy|7|||
162989467|NCT02603393|588664432|FG001|Overall Study|Lack of Efficacy|2|||
162989468|NCT02603393|588664431|FG000|Overall Study|Death|3|||
162989469|NCT02603393|588664432|FG001|Overall Study|Death|4|||
162989470|NCT02603393|588664431|FG000|Overall Study|Physician Decision|3|||
162989471|NCT02603393|588664432|FG001|Overall Study|Physician Decision|3|||
162989472|NCT02603393|588664431|FG000|Overall Study|Protocol deviation|2|||
162989473|NCT02603393|588664432|FG001|Overall Study|Protocol deviation|3|||
162989474|NCT02603393|588664431|FG000|Overall Study|Lost to Follow-up|1|||
162989475|NCT02603393|588664432|FG001|Overall Study|Lost to Follow-up|2|||
162989476|NCT02603393|588664431|FG000|Overall Study|Non-compliance with study treatment|1|||
162989477|NCT02603393|588664432|FG001|Overall Study|Non-compliance with study treatment|0|||
162989478|NCT02603393|588664431|FG000|Overall Study|Sponsor decision|1|||
162989479|NCT02603393|588664432|FG001|Overall Study|Sponsor decision|0|||
162989480|NCT04283500|588664433|FG000|Overall Study|Lost to Follow-up|8|||
162989481|NCT04283500|588664433|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
162989482|NCT04053465|588664442|FG000|Overall Study|Withdrawal by Subject|4|||
162989483|NCT04053465|588664443|FG001|Overall Study|Withdrawal by Subject|4|||
162989484|NCT02085135|588664444|FG000|Overall Study|Adverse Event|4|||
162989485|NCT02085135|588664445|FG001|Overall Study|Adverse Event|7|||
162989486|NCT02085135|588664444|FG000|Overall Study|Lost to Follow-up|2|||
162989487|NCT02085135|588664445|FG001|Overall Study|Lost to Follow-up|2|||
162989488|NCT02085135|588664444|FG000|Overall Study|Withdrawal by Subject|3|||
162989489|NCT02085135|588664445|FG001|Overall Study|Withdrawal by Subject|0|||
162989490|NCT02085135|588664444|FG000|Overall Study|Lack of Efficacy|2|||
162989491|NCT02085135|588664445|FG001|Overall Study|Lack of Efficacy|0|||
162989492|NCT00338455|588664448|FG000|Overall Study|Death|2|||
162989493|NCT00338455|588664449|FG001|Overall Study|Death|1|||
162989494|NCT00338455|588664448|FG000|Overall Study|Physician Decision|1|||
162989495|NCT00338455|588664449|FG001|Overall Study|Physician Decision|0|||
162989496|NCT01517373|588664450|FG000|Run-in Period|Death|1|||
162989497|NCT01517373|588664451|FG001|Run-in Period|Death|0|||
162989498|NCT01517373|588664452|FG002|Run-in Period|Death|0|||
162989499|NCT01517373|588664453|FG003|Run-in Period|Death|0|||
162989500|NCT01517373|588664454|FG004|Run-in Period|Death|0|||
162989501|NCT01517373|588664455|FG005|Run-in Period|Death|0|||
162989502|NCT01517373|588664450|FG000|Run-in Period|Adverse Event|5|||
162989503|NCT01517373|588664451|FG001|Run-in Period|Adverse Event|0|||
162989504|NCT01517373|588664452|FG002|Run-in Period|Adverse Event|0|||
162989505|NCT01517373|588664453|FG003|Run-in Period|Adverse Event|0|||
162989506|NCT01517373|588664454|FG004|Run-in Period|Adverse Event|0|||
162989507|NCT01517373|588664455|FG005|Run-in Period|Adverse Event|0|||
162989508|NCT01517373|588664450|FG000|Run-in Period|Did not meet eligibility criteria|34|||
162989509|NCT01517373|588664451|FG001|Run-in Period|Did not meet eligibility criteria|0|||
162989510|NCT01517373|588664452|FG002|Run-in Period|Did not meet eligibility criteria|0|||
162989511|NCT01517373|588664453|FG003|Run-in Period|Did not meet eligibility criteria|0|||
162989512|NCT01517373|588664454|FG004|Run-in Period|Did not meet eligibility criteria|0|||
163059971|NCT04810962|588928273|FG001|Overall Study|Physician Decision|0|||
163059972|NCT04810962|588928272|FG000|Overall Study|Withdrawal by Subject|1|||
162989513|NCT01517373|588664455|FG005|Run-in Period|Did not meet eligibility criteria|0|||
162989514|NCT01517373|588664450|FG000|Run-in Period|Lost to Follow-up|1|||
162989515|NCT01517373|588664451|FG001|Run-in Period|Lost to Follow-up|0|||
163059973|NCT04810962|588928273|FG001|Overall Study|Withdrawal by Subject|3|||
162989516|NCT01517373|588664452|FG002|Run-in Period|Lost to Follow-up|0|||
162989517|NCT01517373|588664453|FG003|Run-in Period|Lost to Follow-up|0|||
162989518|NCT01517373|588664454|FG004|Run-in Period|Lost to Follow-up|0|||
163059974|NCT04810962|588928272|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
162989519|NCT01517373|588664455|FG005|Run-in Period|Lost to Follow-up|0|||
162989520|NCT01517373|588664450|FG000|Run-in Period|Withdrawal by Subject|12|||
162989521|NCT01517373|588664451|FG001|Run-in Period|Withdrawal by Subject|0|||
162989522|NCT01517373|588664452|FG002|Run-in Period|Withdrawal by Subject|0|||
162989523|NCT01517373|588664453|FG003|Run-in Period|Withdrawal by Subject|0|||
163059975|NCT04810962|588928273|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
163059976|NCT01348269|588928274|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
162989524|NCT01517373|588664454|FG004|Run-in Period|Withdrawal by Subject|0|||
162989525|NCT01517373|588664455|FG005|Run-in Period|Withdrawal by Subject|0|||
162989526|NCT01517373|588664450|FG000|Run-in Period|Sponsor Decision|3|||
162989527|NCT01517373|588664451|FG001|Run-in Period|Sponsor Decision|0|||
162989528|NCT01517373|588664452|FG002|Run-in Period|Sponsor Decision|0|||
162989529|NCT01517373|588664453|FG003|Run-in Period|Sponsor Decision|0|||
162989530|NCT01517373|588664454|FG004|Run-in Period|Sponsor Decision|0|||
162989531|NCT01517373|588664455|FG005|Run-in Period|Sponsor Decision|0|||
162989532|NCT01517373|588664450|FG000|Run-in Period|Other|1|||
162989533|NCT01517373|588664451|FG001|Run-in Period|Other|0|||
162989534|NCT01517373|588664452|FG002|Run-in Period|Other|0|||
162989535|NCT01517373|588664453|FG003|Run-in Period|Other|0|||
162989536|NCT01517373|588664454|FG004|Run-in Period|Other|0|||
162989537|NCT01517373|588664455|FG005|Run-in Period|Other|0|||
162989538|NCT01517373|588664450|FG000|Treatment Period|Adverse Event|0|||
162989539|NCT01517373|588664451|FG001|Treatment Period|Adverse Event|0|||
162989540|NCT01517373|588664452|FG002|Treatment Period|Adverse Event|0|||
162989541|NCT01517373|588664453|FG003|Treatment Period|Adverse Event|0|||
162989542|NCT01517373|588664454|FG004|Treatment Period|Adverse Event|0|||
162989543|NCT01517373|588664455|FG005|Treatment Period|Adverse Event|2|||
162989544|NCT01517373|588664450|FG000|Treatment Period|Lost to Follow-up|0|||
162989545|NCT01517373|588664451|FG001|Treatment Period|Lost to Follow-up|0|||
162989546|NCT01517373|588664452|FG002|Treatment Period|Lost to Follow-up|1|||
162989547|NCT01517373|588664453|FG003|Treatment Period|Lost to Follow-up|1|||
162989548|NCT01517373|588664454|FG004|Treatment Period|Lost to Follow-up|0|||
162989549|NCT01517373|588664455|FG005|Treatment Period|Lost to Follow-up|0|||
162989550|NCT01517373|588664450|FG000|Treatment Period|Withdrawal by Subject|0|||
162989551|NCT01517373|588664451|FG001|Treatment Period|Withdrawal by Subject|3|||
162989552|NCT01517373|588664452|FG002|Treatment Period|Withdrawal by Subject|2|||
162989553|NCT01517373|588664453|FG003|Treatment Period|Withdrawal by Subject|2|||
162989554|NCT01517373|588664454|FG004|Treatment Period|Withdrawal by Subject|2|||
162989555|NCT01517373|588664455|FG005|Treatment Period|Withdrawal by Subject|3|||
162989556|NCT01517373|588664450|FG000|Treatment Period|Other|0|||
162989557|NCT01517373|588664451|FG001|Treatment Period|Other|0|||
162989558|NCT01517373|588664452|FG002|Treatment Period|Other|0|||
162989559|NCT01517373|588664453|FG003|Treatment Period|Other|0|||
162989560|NCT01517373|588664454|FG004|Treatment Period|Other|1|||
162989561|NCT01517373|588664455|FG005|Treatment Period|Other|0|||
162989562|NCT01517373|588664450|FG000|Treatment Period|Protocol Violation|0|||
162989563|NCT01517373|588664451|FG001|Treatment Period|Protocol Violation|0|||
162989564|NCT01517373|588664452|FG002|Treatment Period|Protocol Violation|0|||
162989565|NCT01517373|588664453|FG003|Treatment Period|Protocol Violation|0|||
162989566|NCT01517373|588664454|FG004|Treatment Period|Protocol Violation|1|||
162989567|NCT01517373|588664455|FG005|Treatment Period|Protocol Violation|0|||
162989568|NCT01517373|588664450|FG000|Treatment Period|Lack of Efficacy|0|||
162989569|NCT01517373|588664451|FG001|Treatment Period|Lack of Efficacy|1|||
162989570|NCT01517373|588664452|FG002|Treatment Period|Lack of Efficacy|1|||
162989571|NCT01517373|588664453|FG003|Treatment Period|Lack of Efficacy|3|||
162989572|NCT01517373|588664454|FG004|Treatment Period|Lack of Efficacy|2|||
162989573|NCT01517373|588664455|FG005|Treatment Period|Lack of Efficacy|0|||
162989574|NCT01517373|588664450|FG000|Treatment Period|Medication error without AEs|0|||
162989575|NCT01517373|588664451|FG001|Treatment Period|Medication error without AEs|0|||
162989576|NCT01517373|588664452|FG002|Treatment Period|Medication error without AEs|2|||
162989577|NCT01517373|588664453|FG003|Treatment Period|Medication error without AEs|1|||
162989578|NCT01517373|588664454|FG004|Treatment Period|Medication error without AEs|0|||
162989579|NCT01517373|588664455|FG005|Treatment Period|Medication error without AEs|2|||
162989580|NCT05005312|588664470|FG000|Overall Study|Enrolled, but not treated|0|||
162989581|NCT05005312|588664471|FG001|Overall Study|Enrolled, but not treated|1|||
162989582|NCT06077149|588664474|FG000|Overall Study|Death|1|||
162989583|NCT06077149|588664475|FG001|Overall Study|Death|0|||
162989584|NCT06077149|588664474|FG000|Overall Study|Withdrawal by Subject|2|||
162989585|NCT06077149|588664475|FG001|Overall Study|Withdrawal by Subject|0|||
162989586|NCT06077149|588664474|FG000|Overall Study|RSV infection before vaccination|3|||
163404261|NCT02831673|590191904|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
162989587|NCT06077149|588664475|FG001|Overall Study|RSV infection before vaccination|0|||
162989588|NCT04658095|588664476|FG000|Overall Study|Study terminated|5|||
162989589|NCT04658095|588664477|FG001|Overall Study|Study terminated|1|||
162989590|NCT04658095|588664478|FG002|Overall Study|Study terminated|4|||
162989591|NCT01441947|588664479|FG000|Overall Study|Withdrawal by Subject|3|||
162989592|NCT01441947|588664480|FG001|Overall Study|Withdrawal by Subject|0|||
162989593|NCT02970318|588664482|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
162989594|NCT02970318|588664483|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
162989595|NCT02970318|588664484|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
162989596|NCT02970318|588664485|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
162989597|NCT02970318|588664482|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
162989598|NCT02970318|588664483|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
163404262|NCT02831673|590191900|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
162989599|NCT02970318|588664484|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
162989600|NCT02970318|588664485|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
162989601|NCT02970318|588664482|FG000|Overall for Arm A & Main for Arm B|Death|41|||
162989602|NCT02970318|588664483|FG001|Overall for Arm A & Main for Arm B|Death|33|||
162989603|NCT02970318|588664484|FG002|Overall for Arm A & Main for Arm B|Death|0|||
162989604|NCT02970318|588664485|FG003|Overall for Arm A & Main for Arm B|Death|0|||
162989605|NCT02970318|588664482|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
162989606|NCT02970318|588664483|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
162989607|NCT02970318|588664484|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
162989608|NCT02970318|588664485|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
162989609|NCT02970318|588664482|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
162989610|NCT02970318|588664483|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
162989611|NCT02970318|588664484|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
162989612|NCT02970318|588664485|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
162989613|NCT02970318|588664482|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
162989614|NCT02970318|588664483|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
162989615|NCT02970318|588664484|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
162989616|NCT02970318|588664485|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
162989617|NCT02970318|588664482|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
162989618|NCT02970318|588664483|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
162989619|NCT02970318|588664484|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
162989620|NCT02970318|588664485|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
162989621|NCT03384654|588664486|FG000|Overall Study|Withdrawal by Subject|0|||
162989622|NCT03384654|588664487|FG001|Overall Study|Withdrawal by Subject|0|||
162989623|NCT03384654|588664488|FG002|Overall Study|Withdrawal by Subject|1|||
162989624|NCT03384654|588664489|FG003|Overall Study|Withdrawal by Subject|0|||
162989625|NCT01616953|588664490|FG000|Overall Study|Lost to Follow-up|1|||
162989626|NCT01616953|588664491|FG001|Overall Study|Lost to Follow-up|0|||
162989627|NCT01616953|588664490|FG000|Overall Study|lack of bone and soft tissue|1|||
162989628|NCT01616953|588664491|FG001|Overall Study|lack of bone and soft tissue|0|||
162989629|NCT00816361|588664492|FG000|Overall Study|Withdrawal by Subject|0|||
162989630|NCT00816361|588664493|FG001|Overall Study|Withdrawal by Subject|0|||
162989631|NCT00816361|588664494|FG002|Overall Study|Withdrawal by Subject|0|||
162989632|NCT00816361|588664495|FG003|Overall Study|Withdrawal by Subject|0|||
162989633|NCT00816361|588664496|FG004|Overall Study|Withdrawal by Subject|1|||
162989634|NCT00816361|588664497|FG005|Overall Study|Withdrawal by Subject|2|||
162989635|NCT00816361|588664498|FG006|Overall Study|Withdrawal by Subject|0|||
162989636|NCT00816361|588664499|FG007|Overall Study|Withdrawal by Subject|2|||
162989637|NCT00816361|588664500|FG008|Overall Study|Withdrawal by Subject|1|||
162989638|NCT00816361|588664492|FG000|Overall Study|Death|4|||
162989639|NCT00816361|588664493|FG001|Overall Study|Death|3|||
162989640|NCT00816361|588664494|FG002|Overall Study|Death|3|||
162989641|NCT00816361|588664495|FG003|Overall Study|Death|3|||
162989642|NCT00816361|588664496|FG004|Overall Study|Death|1|||
162989643|NCT00816361|588664497|FG005|Overall Study|Death|1|||
162989644|NCT00816361|588664498|FG006|Overall Study|Death|3|||
162989645|NCT00816361|588664499|FG007|Overall Study|Death|7|||
162989646|NCT00816361|588664500|FG008|Overall Study|Death|8|||
162989647|NCT00816361|588664492|FG000|Overall Study|Other|0|||
162989648|NCT00816361|588664493|FG001|Overall Study|Other|0|||
162989649|NCT00816361|588664494|FG002|Overall Study|Other|0|||
162989650|NCT00816361|588664495|FG003|Overall Study|Other|0|||
162989651|NCT00816361|588664496|FG004|Overall Study|Other|0|||
162989652|NCT00816361|588664497|FG005|Overall Study|Other|0|||
162989653|NCT00816361|588664498|FG006|Overall Study|Other|0|||
162989654|NCT00816361|588664499|FG007|Overall Study|Other|0|||
162989655|NCT00816361|588664500|FG008|Overall Study|Other|1|||
162989656|NCT02500641|588664501|FG000|Overall Study|Adverse Event|0|||
162989657|NCT02500641|588664502|FG001|Overall Study|Adverse Event|2|||
162989658|NCT02500641|588664501|FG000|Overall Study|Withdrawal by Subject|4|||
162989659|NCT02500641|588664502|FG001|Overall Study|Withdrawal by Subject|5|||
162989660|NCT02500641|588664501|FG000|Overall Study|Unable to follow study procedures|3|||
162989661|NCT02500641|588664502|FG001|Overall Study|Unable to follow study procedures|2|||
163059977|NCT01348269|588928275|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
163059978|NCT01348269|588928274|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
163059979|NCT01348269|588928275|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
162989662|NCT02500641|588664501|FG000|Overall Study|Protocol Violation|1|||
162989663|NCT02500641|588664502|FG001|Overall Study|Protocol Violation|2|||
162989664|NCT02500641|588664501|FG000|Overall Study|Lost to Follow-up|1|||
162989665|NCT02500641|588664502|FG001|Overall Study|Lost to Follow-up|0|||
162989666|NCT02500641|588664501|FG000|Overall Study|Sponsor decision|1|||
163212336|NCT00312494|589492465|FG000|Overall Study|Lost to Follow-up|8|||
163212337|NCT00312494|589492466|FG001|Overall Study|Lost to Follow-up|8|||
163212338|NCT00312494|589492467|FG002|Overall Study|Lost to Follow-up|8|||
162989667|NCT02500641|588664502|FG001|Overall Study|Sponsor decision|0|||
162989668|NCT02500641|588664501|FG000|Overall Study|Non compliance to study drug|0|||
162989669|NCT02500641|588664502|FG001|Overall Study|Non compliance to study drug|1|||
162989670|NCT01763684|588664503|FG000|Overall Study|Study terminated early due to low enrollment|126|||
162989671|NCT01763684|588664504|FG001|Overall Study|Study terminated early due to low enrollment|127|||
162989672|NCT01763684|588664503|FG000|Overall Study|Study surgery not performed|7|||
162989673|NCT01763684|588664504|FG001|Overall Study|Study surgery not performed|6|||
162989674|NCT02196701|588664505|FG000|Overall Study|Adverse Event|1|||
162989675|NCT02196701|588664505|FG000|Overall Study|Lost to Follow-up|1|||
162989676|NCT02196701|588664505|FG000|Overall Study|Non-adherence to Protocol|1|||
162989677|NCT01341782|588664506|FG000|Overall Study|Adverse Event|1|||
162989678|NCT01341782|588664507|FG001|Overall Study|Adverse Event|1|||
162989679|NCT01341782|588664506|FG000|Overall Study|Withdrawal by Subject|6|||
162989680|NCT01341782|588664507|FG001|Overall Study|Withdrawal by Subject|5|||
162989681|NCT01341782|588664506|FG000|Overall Study|Missed 3 consecutive doses|0|||
162989682|NCT01341782|588664507|FG001|Overall Study|Missed 3 consecutive doses|4|||
162989683|NCT01341782|588664506|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
162989684|NCT01341782|588664507|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
162989685|NCT01341782|588664506|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
162989686|NCT01341782|588664507|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
162989687|NCT01341782|588664506|FG000|Overall Study|Other|5|||
162989688|NCT01341782|588664507|FG001|Overall Study|Other|0|||
162989689|NCT02036775|588664508|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
162989690|NCT02036775|588664509|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
162989691|NCT02036775|588664510|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
162989692|NCT02036775|588664511|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
162989693|NCT02036775|588664512|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
162989694|NCT02036775|588664513|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
162989695|NCT03496610|588664517|FG000|Overall Study|Lost to Follow-up|3|||
162989696|NCT03496610|588664518|FG001|Overall Study|Lost to Follow-up|2|||
162989697|NCT03496610|588664517|FG000|Overall Study|Physician Decision|1|||
162989698|NCT03496610|588664518|FG001|Overall Study|Physician Decision|0|||
162989699|NCT03496610|588664517|FG000|Overall Study|Withdrawal by Subject|1|||
162989700|NCT03496610|588664518|FG001|Overall Study|Withdrawal by Subject|0|||
162989701|NCT00426361|588664519|FG000|Overall Study|Lost to Follow-up|3|||
162989702|NCT00426361|588664520|FG001|Overall Study|Lost to Follow-up|2|||
162989703|NCT00426361|588664521|FG002|Overall Study|Lost to Follow-up|5|||
162989704|NCT00426361|588664519|FG000|Overall Study|Withdrawal by Subject|1|||
162989705|NCT00426361|588664520|FG001|Overall Study|Withdrawal by Subject|3|||
162989706|NCT00426361|588664521|FG002|Overall Study|Withdrawal by Subject|0|||
162989707|NCT01408628|588664522|FG000|Consented|Withdrawal by Subject|12|||
162989708|NCT01408628|588664522|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
162989709|NCT01408628|588664522|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
162989710|NCT01408628|588664522|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
162989711|NCT04669691|588664523|FG000|Overall Study|Death|0|||
162989712|NCT04669691|588664524|FG001|Overall Study|Death|1|||
162989713|NCT04669691|588664525|FG002|Overall Study|Death|0|||
162989714|NCT04669691|588664526|FG003|Overall Study|Death|0|||
162989715|NCT04669691|588664527|FG004|Overall Study|Death|0|||
162989716|NCT04669691|588664528|FG005|Overall Study|Death|0|||
162989717|NCT04156620|588664529|FG000|Overall Study|Adverse event - TP 1|5|||
162989718|NCT04156620|588664530|FG001|Overall Study|Adverse event - TP 1|2|||
162989719|NCT04156620|588664529|FG000|Overall Study|Lost to follow-up TP 1|1|||
162989720|NCT04156620|588664530|FG001|Overall Study|Lost to follow-up TP 1|1|||
162989721|NCT04156620|588664529|FG000|Overall Study|Progressive disease - TP 1|0|||
162989722|NCT04156620|588664530|FG001|Overall Study|Progressive disease - TP 1|1|||
162989723|NCT04156620|588664529|FG000|Overall Study|Subject decision - TP 1|3|||
162989724|NCT04156620|588664530|FG001|Overall Study|Subject decision - TP 1|5|||
162989725|NCT04156620|588664529|FG000|Overall Study|Adverse event - TP 2|5|||
162989726|NCT04156620|588664530|FG001|Overall Study|Adverse event - TP 2|6|||
162989727|NCT04156620|588664529|FG000|Overall Study|Death - TP 2|1|||
162989728|NCT04156620|588664530|FG001|Overall Study|Death - TP 2|0|||
162989729|NCT04156620|588664529|FG000|Overall Study|Lost to follow-up - TP 2|5|||
162989730|NCT04156620|588664530|FG001|Overall Study|Lost to follow-up - TP 2|2|||
162989731|NCT04156620|588664529|FG000|Overall Study|Physician decision - TP 2|4|||
162989732|NCT04156620|588664530|FG001|Overall Study|Physician decision - TP 2|2|||
162989733|NCT04156620|588664529|FG000|Overall Study|Pregnancy - TP 2|1|||
162989734|NCT04156620|588664530|FG001|Overall Study|Pregnancy - TP 2|1|||
162989735|NCT04156620|588664529|FG000|Overall Study|Subject decision - TP 2|11|||
162989736|NCT04156620|588664530|FG001|Overall Study|Subject decision - TP 2|9|||
162989737|NCT04156620|588664529|FG000|Overall Study|New therapy for study indication - TP 2|1|||
162989738|NCT04156620|588664530|FG001|Overall Study|New therapy for study indication - TP 2|0|||
162989739|NCT01121666|588664531|FG000|Overall Study|Protocol Violation|29|||
162989740|NCT01121666|588664532|FG001|Overall Study|Protocol Violation|10|||
162989741|NCT01970865|588664535|FG000|Overall Study|Death|3|||
162989742|NCT01970865|588664536|FG001|Overall Study|Death|2|||
162989743|NCT01970865|588664537|FG002|Overall Study|Death|3|||
162989744|NCT01970865|588664538|FG003|Overall Study|Death|6|||
162989745|NCT01970865|588664539|FG004|Overall Study|Death|9|||
162989746|NCT01970865|588664540|FG005|Overall Study|Death|3|||
162989747|NCT01970865|588664541|FG006|Overall Study|Death|2|||
162989748|NCT01970865|588664542|FG007|Overall Study|Death|3|||
162989749|NCT01970865|588664543|FG008|Overall Study|Death|2|||
162989750|NCT01970865|588664544|FG009|Overall Study|Death|2|||
162989751|NCT01970865|588664545|FG010|Overall Study|Death|8|||
162989752|NCT01970865|588664546|FG011|Overall Study|Death|13|||
162989753|NCT01970865|588664547|FG012|Overall Study|Death|25|||
162989754|NCT01970865|588664548|FG013|Overall Study|Death|46|||
162989755|NCT01970865|588664549|FG014|Overall Study|Death|37|||
162989756|NCT01970865|588664550|FG015|Overall Study|Death|22|||
162989757|NCT01970865|588664551|FG016|Overall Study|Death|1|||
162989758|NCT01970865|588664552|FG017|Overall Study|Death|17|||
162989759|NCT01970865|588664535|FG000|Overall Study|Lost to Follow-up|0|||
162989760|NCT01970865|588664536|FG001|Overall Study|Lost to Follow-up|0|||
162989761|NCT01970865|588664537|FG002|Overall Study|Lost to Follow-up|0|||
162989762|NCT01970865|588664538|FG003|Overall Study|Lost to Follow-up|1|||
162989763|NCT01970865|588664539|FG004|Overall Study|Lost to Follow-up|1|||
162989764|NCT01970865|588664540|FG005|Overall Study|Lost to Follow-up|0|||
162989765|NCT01970865|588664541|FG006|Overall Study|Lost to Follow-up|0|||
162989766|NCT01970865|588664542|FG007|Overall Study|Lost to Follow-up|0|||
162989767|NCT01970865|588664543|FG008|Overall Study|Lost to Follow-up|0|||
162989768|NCT01970865|588664544|FG009|Overall Study|Lost to Follow-up|0|||
162989769|NCT01970865|588664545|FG010|Overall Study|Lost to Follow-up|1|||
162989770|NCT01970865|588664546|FG011|Overall Study|Lost to Follow-up|0|||
162989771|NCT01970865|588664547|FG012|Overall Study|Lost to Follow-up|2|||
162989772|NCT01970865|588664548|FG013|Overall Study|Lost to Follow-up|0|||
162989773|NCT01970865|588664549|FG014|Overall Study|Lost to Follow-up|1|||
162989774|NCT01970865|588664550|FG015|Overall Study|Lost to Follow-up|4|||
162989775|NCT01970865|588664551|FG016|Overall Study|Lost to Follow-up|0|||
162989776|NCT01970865|588664552|FG017|Overall Study|Lost to Follow-up|1|||
162989777|NCT01970865|588664535|FG000|Overall Study|Other|0|||
162989778|NCT01970865|588664536|FG001|Overall Study|Other|1|||
162989779|NCT01970865|588664537|FG002|Overall Study|Other|0|||
162989780|NCT01970865|588664538|FG003|Overall Study|Other|1|||
162989781|NCT01970865|588664539|FG004|Overall Study|Other|1|||
162989782|NCT01970865|588664540|FG005|Overall Study|Other|0|||
162989783|NCT01970865|588664541|FG006|Overall Study|Other|1|||
162989784|NCT01970865|588664542|FG007|Overall Study|Other|0|||
162989785|NCT01970865|588664543|FG008|Overall Study|Other|0|||
162989786|NCT01970865|588664544|FG009|Overall Study|Other|0|||
162989787|NCT01970865|588664545|FG010|Overall Study|Other|2|||
162989788|NCT01970865|588664546|FG011|Overall Study|Other|3|||
162989789|NCT01970865|588664547|FG012|Overall Study|Other|8|||
162989790|NCT01970865|588664548|FG013|Overall Study|Other|3|||
162989791|NCT01970865|588664549|FG014|Overall Study|Other|2|||
162989792|NCT01970865|588664550|FG015|Overall Study|Other|3|||
162989793|NCT01970865|588664551|FG016|Overall Study|Other|0|||
162989794|NCT01970865|588664552|FG017|Overall Study|Other|2|||
162989795|NCT01970865|588664535|FG000|Overall Study|Participant refused further follow-up|0|||
162989796|NCT01970865|588664536|FG001|Overall Study|Participant refused further follow-up|0|||
163324570|NCT02446600|589900652|FG002|Overall Study|Duplicate Enrollment|0|||
162989797|NCT01970865|588664537|FG002|Overall Study|Participant refused further follow-up|0|||
163324571|NCT02446600|589900653|FG003|Overall Study|Duplicate Enrollment|0|||
162989798|NCT01970865|588664538|FG003|Overall Study|Participant refused further follow-up|2|||
162989799|NCT01970865|588664539|FG004|Overall Study|Participant refused further follow-up|3|||
162989800|NCT01970865|588664540|FG005|Overall Study|Participant refused further follow-up|0|||
162989801|NCT01970865|588664541|FG006|Overall Study|Participant refused further follow-up|0|||
162989802|NCT01970865|588664542|FG007|Overall Study|Participant refused further follow-up|0|||
163324572|NCT00328783|589900654|FG000|Overall Study|Could not tolerate ABC|21|||
163324573|NCT00328783|589900654|FG000|Overall Study|No heart in RT field|4|||
162989803|NCT01970865|588664543|FG008|Overall Study|Participant refused further follow-up|0|||
163324574|NCT00328783|589900654|FG000|Overall Study|Withdrawal by Subject|1|||
162989804|NCT01970865|588664544|FG009|Overall Study|Participant refused further follow-up|0|||
162989805|NCT01970865|588664545|FG010|Overall Study|Participant refused further follow-up|1|||
162989806|NCT01970865|588664546|FG011|Overall Study|Participant refused further follow-up|4|||
162989807|NCT01970865|588664547|FG012|Overall Study|Participant refused further follow-up|7|||
162989808|NCT01970865|588664548|FG013|Overall Study|Participant refused further follow-up|8|||
162989809|NCT01970865|588664549|FG014|Overall Study|Participant refused further follow-up|3|||
162989810|NCT01970865|588664550|FG015|Overall Study|Participant refused further follow-up|11|||
163324575|NCT00357682|589900655|FG000|Overall Study|Did not receive allocated Treatment|10|||
162989811|NCT01970865|588664551|FG016|Overall Study|Participant refused further follow-up|0|||
162989812|NCT01970865|588664552|FG017|Overall Study|Participant refused further follow-up|6|||
162989813|NCT01629966|588664553|FG000|Overall Study|Pregnancy|0|||
162989814|NCT01629966|588664554|FG001|Overall Study|Pregnancy|1|||
162989815|NCT01629966|588664555|FG002|Overall Study|Pregnancy|0|||
162989816|NCT01629966|588664553|FG000|Overall Study|Lost to Follow-up|10|||
162989817|NCT01629966|588664554|FG001|Overall Study|Lost to Follow-up|13|||
162989818|NCT01629966|588664555|FG002|Overall Study|Lost to Follow-up|9|||
162989819|NCT01629966|588664553|FG000|Overall Study|Withdrawal by Subject|8|||
162989820|NCT01629966|588664554|FG001|Overall Study|Withdrawal by Subject|9|||
162989821|NCT01629966|588664555|FG002|Overall Study|Withdrawal by Subject|16|||
162989822|NCT01629966|588664553|FG000|Overall Study|Protocol Violation|7|||
162989823|NCT01629966|588664554|FG001|Overall Study|Protocol Violation|9|||
162989824|NCT01629966|588664555|FG002|Overall Study|Protocol Violation|7|||
162989825|NCT01629966|588664553|FG000|Overall Study|Lack of Efficacy|5|||
162989826|NCT01629966|588664554|FG001|Overall Study|Lack of Efficacy|2|||
162989827|NCT01629966|588664555|FG002|Overall Study|Lack of Efficacy|4|||
162989828|NCT01629966|588664553|FG000|Overall Study|Adverse Event|11|||
162989829|NCT01629966|588664554|FG001|Overall Study|Adverse Event|18|||
162989830|NCT01629966|588664555|FG002|Overall Study|Adverse Event|30|||
162989831|NCT01150890|588664556|FG000|Overall Study|Other|0|||
162989832|NCT01150890|588664557|FG001|Overall Study|Other|1|||
162989833|NCT01150890|588664558|FG002|Overall Study|Other|0|||
162989834|NCT01150890|588664559|FG003|Overall Study|Other|2|||
162989835|NCT01150890|588664556|FG000|Overall Study|Pregnancy|0|||
162989836|NCT01150890|588664557|FG001|Overall Study|Pregnancy|0|||
162989837|NCT01150890|588664558|FG002|Overall Study|Pregnancy|0|||
162989838|NCT01150890|588664559|FG003|Overall Study|Pregnancy|1|||
162989839|NCT01150890|588664556|FG000|Overall Study|Administrative Decision|4|||
162989840|NCT01150890|588664557|FG001|Overall Study|Administrative Decision|4|||
162989841|NCT01150890|588664558|FG002|Overall Study|Administrative Decision|5|||
162989842|NCT01150890|588664559|FG003|Overall Study|Administrative Decision|6|||
162989843|NCT01150890|588664556|FG000|Overall Study|Ineligibility determined|0|||
162989844|NCT01150890|588664557|FG001|Overall Study|Ineligibility determined|1|||
162989845|NCT01150890|588664558|FG002|Overall Study|Ineligibility determined|0|||
162989846|NCT01150890|588664559|FG003|Overall Study|Ineligibility determined|0|||
162989847|NCT01150890|588664556|FG000|Overall Study|Adverse Event|0|||
162989848|NCT01150890|588664557|FG001|Overall Study|Adverse Event|0|||
162989849|NCT01150890|588664558|FG002|Overall Study|Adverse Event|2|||
162989850|NCT01150890|588664559|FG003|Overall Study|Adverse Event|0|||
162989851|NCT01150890|588664556|FG000|Overall Study|Withdrawal by Subject|0|||
162989852|NCT01150890|588664557|FG001|Overall Study|Withdrawal by Subject|0|||
162989853|NCT01150890|588664558|FG002|Overall Study|Withdrawal by Subject|2|||
162989854|NCT01150890|588664559|FG003|Overall Study|Withdrawal by Subject|1|||
162989855|NCT01150890|588664556|FG000|Overall Study|Disease progression|0|||
162989856|NCT01150890|588664557|FG001|Overall Study|Disease progression|7|||
162989857|NCT01150890|588664558|FG002|Overall Study|Disease progression|3|||
162989858|NCT01150890|588664559|FG003|Overall Study|Disease progression|7|||
162989859|NCT03118570|588664560|FG000|Overall Study|Adverse Event|2|||
162989860|NCT03118570|588664561|FG001|Overall Study|Adverse Event|0|||
162989861|NCT03118570|588664562|FG002|Overall Study|Adverse Event|0|||
162989862|NCT03118570|588664563|FG003|Overall Study|Adverse Event|0|||
162989863|NCT03118570|588664564|FG004|Overall Study|Adverse Event|3|||
162989864|NCT03118570|588664560|FG000|Overall Study|Withdrawal by Subject|0|||
162989865|NCT03118570|588664561|FG001|Overall Study|Withdrawal by Subject|1|||
162989866|NCT03118570|588664562|FG002|Overall Study|Withdrawal by Subject|4|||
162989867|NCT03118570|588664563|FG003|Overall Study|Withdrawal by Subject|0|||
162989868|NCT03118570|588664564|FG004|Overall Study|Withdrawal by Subject|1|||
162989869|NCT03118570|588664560|FG000|Overall Study|Lost to Follow-up|2|||
162989870|NCT03118570|588664561|FG001|Overall Study|Lost to Follow-up|3|||
162989871|NCT03118570|588664562|FG002|Overall Study|Lost to Follow-up|1|||
162989872|NCT03118570|588664563|FG003|Overall Study|Lost to Follow-up|0|||
162989873|NCT03118570|588664564|FG004|Overall Study|Lost to Follow-up|1|||
162989874|NCT03118570|588664560|FG000|Overall Study|Other, Not Specified|1|||
162989875|NCT03118570|588664561|FG001|Overall Study|Other, Not Specified|3|||
162989876|NCT03118570|588664562|FG002|Overall Study|Other, Not Specified|0|||
162989877|NCT03118570|588664563|FG003|Overall Study|Other, Not Specified|0|||
162989878|NCT03118570|588664564|FG004|Overall Study|Other, Not Specified|0|||
162989879|NCT01672970|588664565|FG000|Overall Study|Lack of Efficacy|12|||
162989880|NCT01672970|588664565|FG000|Overall Study|Adverse Event|18|||
162989881|NCT01672970|588664565|FG000|Overall Study|Withdrawal by Subject|2|||
162989882|NCT01672970|588664565|FG000|Overall Study|Lost to Follow-up|5|||
162989883|NCT01672970|588664565|FG000|Overall Study|Other|9|||
163324576|NCT00357682|589900656|FG001|Overall Study|Did not receive allocated Treatment|9|||
163324577|NCT00357682|589900657|FG002|Overall Study|Did not receive allocated Treatment|9|||
162989884|NCT01672970|588664565|FG000|Overall Study|Enrolled but not treated|1|||
162989885|NCT04430855|588664566|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
162989886|NCT04430855|588664567|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
162989887|NCT04430855|588664566|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
162989888|NCT04430855|588664567|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
162989889|NCT04430855|588664566|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
162989890|NCT04430855|588664567|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
162989891|NCT04430855|588664566|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
162989892|NCT04430855|588664567|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
162989893|NCT04430855|588664566|FG000|Period 1 (Weeks 1-12)|Other|0|||
162989894|NCT04430855|588664567|FG001|Period 1 (Weeks 1-12)|Other|1|||
162989895|NCT04430855|588664566|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
162989896|NCT04430855|588664567|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
162989897|NCT04430855|588664566|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
162989898|NCT04430855|588664567|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
162989899|NCT04430855|588664566|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
162989900|NCT04430855|588664567|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
162989901|NCT00390221|588664573|FG000|Overall Study|Lost to Follow-up|0|||
162989902|NCT00390221|588664574|FG001|Overall Study|Lost to Follow-up|3|||
162989903|NCT00390221|588664575|FG002|Overall Study|Lost to Follow-up|0|||
162989904|NCT00390221|588664573|FG000|Overall Study|Adverse Event|1|||
162989905|NCT00390221|588664574|FG001|Overall Study|Adverse Event|4|||
162989906|NCT00390221|588664575|FG002|Overall Study|Adverse Event|3|||
162989907|NCT00390221|588664573|FG000|Overall Study|Investigator Decision|0|||
162989908|NCT00390221|588664574|FG001|Overall Study|Investigator Decision|0|||
162989909|NCT00390221|588664575|FG002|Overall Study|Investigator Decision|1|||
162989910|NCT00390221|588664573|FG000|Overall Study|Withdrawal by Subject|13|||
162989911|NCT00390221|588664574|FG001|Overall Study|Withdrawal by Subject|9|||
162989912|NCT00390221|588664575|FG002|Overall Study|Withdrawal by Subject|7|||
162989913|NCT00390221|588664573|FG000|Overall Study|Subject Non-compliance|1|||
162989914|NCT00390221|588664574|FG001|Overall Study|Subject Non-compliance|0|||
162989915|NCT00390221|588664575|FG002|Overall Study|Subject Non-compliance|2|||
162989916|NCT00390221|588664573|FG000|Overall Study|Other|3|||
162989917|NCT00390221|588664574|FG001|Overall Study|Other|4|||
162989918|NCT00390221|588664575|FG002|Overall Study|Other|2|||
162989919|NCT02011386|588664580|FG000|Overall Study|Non-compliance|2|||
162989920|NCT02011386|588664580|FG000|Overall Study|Lack of Efficacy|3|||
162989921|NCT00633243|588666469|FG000|Overall Study|Withdrawal by Subject|0|||
162989922|NCT00633243|588666470|FG001|Overall Study|Withdrawal by Subject|1|||
162989923|NCT00633243|588666469|FG000|Overall Study|incarceration|0|||
162989924|NCT00633243|588666470|FG001|Overall Study|incarceration|2|||
162989925|NCT00633243|588666469|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
162989926|NCT00633243|588666470|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
162989927|NCT00633243|588666469|FG000|Overall Study|Not comfortable with self-injecting|0|||
162989928|NCT00633243|588666470|FG001|Overall Study|Not comfortable with self-injecting|1|||
162989929|NCT00633243|588666469|FG000|Overall Study|Mental Health--Depression|0|||
162989930|NCT00633243|588666470|FG001|Overall Study|Mental Health--Depression|1|||
162989931|NCT00633243|588666469|FG000|Overall Study|Couldn't tolerate side-effects|1|||
162989932|NCT00633243|588666470|FG001|Overall Study|Couldn't tolerate side-effects|1|||
162989933|NCT01682863|588666471|FG000|Overall Study|Subject/guardian decision|19|||
162989934|NCT01682863|588666472|FG001|Overall Study|Subject/guardian decision|12|||
162989935|NCT01682863|588666473|FG002|Overall Study|Subject/guardian decision|10|||
162989936|NCT01682863|588666471|FG000|Overall Study|Lost to Follow-up|5|||
162989937|NCT01682863|588666472|FG001|Overall Study|Lost to Follow-up|1|||
162989938|NCT01682863|588666473|FG002|Overall Study|Lost to Follow-up|6|||
162989939|NCT01682863|588666471|FG000|Overall Study|Death|1|||
162989940|NCT01682863|588666472|FG001|Overall Study|Death|3|||
162989941|NCT01682863|588666473|FG002|Overall Study|Death|4|||
162989942|NCT01682863|588666471|FG000|Overall Study|Protocol deviation|1|||
162989943|NCT01682863|588666472|FG001|Overall Study|Protocol deviation|0|||
162989944|NCT01682863|588666473|FG002|Overall Study|Protocol deviation|1|||
162989945|NCT01682863|588666471|FG000|Overall Study|Technical problems|1|||
162989946|NCT01682863|588666472|FG001|Overall Study|Technical problems|0|||
162989947|NCT01682863|588666473|FG002|Overall Study|Technical problems|0|||
162989948|NCT01682863|588666471|FG000|Overall Study|Adverse Event|0|||
162989949|NCT01682863|588666472|FG001|Overall Study|Adverse Event|1|||
162989950|NCT01682863|588666473|FG002|Overall Study|Adverse Event|2|||
162989951|NCT01682863|588666471|FG000|Overall Study|Physician Decision|0|||
162989952|NCT01682863|588666472|FG001|Overall Study|Physician Decision|0|||
162989953|NCT01682863|588666473|FG002|Overall Study|Physician Decision|1|||
162989954|NCT00977379|588666474|FG000|Overall Study|Withdrawal by Subject|1|||
162989955|NCT00977379|588666475|FG001|Overall Study|Withdrawal by Subject|1|||
162989956|NCT00977379|588666474|FG000|Overall Study|Death|7|||
162989957|NCT00977379|588666475|FG001|Overall Study|Death|9|||
162989958|NCT00977379|588666474|FG000|Overall Study|Premature Study Termination|4|||
162989959|NCT00977379|588666475|FG001|Overall Study|Premature Study Termination|0|||
162989960|NCT00977379|588666474|FG000|Overall Study|Participant Moving House|0|||
162989961|NCT00977379|588666475|FG001|Overall Study|Participant Moving House|1|||
162989962|NCT00977379|588666474|FG000|Overall Study|Randomization Error|0|||
162989963|NCT00977379|588666475|FG001|Overall Study|Randomization Error|1|||
162989964|NCT00918138|588666476|FG000|Overall Study|Subject withdrew consent|1|||
162989965|NCT00918138|588666477|FG001|Overall Study|Subject withdrew consent|1|||
162989966|NCT00918138|588666476|FG000|Overall Study|Death|1|||
162989967|NCT00918138|588666477|FG001|Overall Study|Death|0|||
162989968|NCT03972163|588666478|FG000|Overall Study|Death|0|||
162989969|NCT03972163|588666479|FG001|Overall Study|Death|1|||
162989970|NCT01212588|588666482|FG000|Overall Study|Physician Decision|0|||
162989971|NCT01212588|588666483|FG001|Overall Study|Physician Decision|1|||
162989972|NCT01212588|588666482|FG000|Overall Study|Protocol Violation|1|||
162989973|NCT01212588|588666483|FG001|Overall Study|Protocol Violation|1|||
162989974|NCT02885181|588666484|FG000|Overall Study|Investigator's Discretion|0|||
162989975|NCT02885181|588666485|FG001|Overall Study|Investigator's Discretion|1|||
162989976|NCT02885181|588666486|FG002|Overall Study|Investigator's Discretion|0|||
162989977|NCT02885181|588666487|FG003|Overall Study|Investigator's Discretion|1|||
162989978|NCT02885181|588666484|FG000|Overall Study|Adverse Event|0|||
162989979|NCT02885181|588666485|FG001|Overall Study|Adverse Event|0|||
162989980|NCT02885181|588666486|FG002|Overall Study|Adverse Event|0|||
162989981|NCT02885181|588666487|FG003|Overall Study|Adverse Event|1|||
162989982|NCT02885181|588666484|FG000|Overall Study|Withdrawal by Subject|0|||
162989983|NCT02885181|588666485|FG001|Overall Study|Withdrawal by Subject|0|||
162989984|NCT02885181|588666486|FG002|Overall Study|Withdrawal by Subject|0|||
162989985|NCT02885181|588666487|FG003|Overall Study|Withdrawal by Subject|1|||
162989986|NCT00742924|588666490|FG000|Overall Study|Adverse Event|0|||
162989987|NCT00742924|588666491|FG001|Overall Study|Adverse Event|0|||
162989988|NCT00742924|588666492|FG002|Overall Study|Adverse Event|1|||
162989989|NCT00742924|588666493|FG003|Overall Study|Adverse Event|1|||
162989990|NCT00742924|588666490|FG000|Overall Study|Lack of Efficacy|5|||
162989991|NCT00742924|588666491|FG001|Overall Study|Lack of Efficacy|1|||
162989992|NCT00742924|588666492|FG002|Overall Study|Lack of Efficacy|2|||
162989993|NCT00742924|588666493|FG003|Overall Study|Lack of Efficacy|4|||
162989994|NCT00742924|588666490|FG000|Overall Study|Physician Decision|0|||
162989995|NCT00742924|588666491|FG001|Overall Study|Physician Decision|0|||
162989996|NCT00742924|588666492|FG002|Overall Study|Physician Decision|0|||
162989997|NCT00742924|588666493|FG003|Overall Study|Physician Decision|1|||
162989998|NCT00742924|588666490|FG000|Overall Study|Withdrawal by Subject|0|||
162989999|NCT00742924|588666491|FG001|Overall Study|Withdrawal by Subject|1|||
162990000|NCT00742924|588666492|FG002|Overall Study|Withdrawal by Subject|1|||
162990001|NCT00742924|588666493|FG003|Overall Study|Withdrawal by Subject|0|||
162990002|NCT00660400|588666494|FG000|Overall Study|Lack of insurance approval|1|||
162990003|NCT00660400|588666494|FG000|Overall Study|Suboptimal organ function|1|||
162990004|NCT00660400|588666494|FG000|Overall Study|Intracranial hemorrhage|1|||
162990005|NCT00660400|588666494|FG000|Overall Study|Withdrawal by Subject|1|||
162990006|NCT01161407|588666495|FG000|Overall Study|Protocol Violation|3|||
162990007|NCT01161407|588666496|FG001|Overall Study|Protocol Violation|1|||
162990008|NCT01777620|588666497|FG000|Overall Study|Subject Withdrawal|1|||
162990009|NCT01777620|588666498|FG001|Overall Study|Subject Withdrawal|0|||
162990010|NCT04562155|588666499|FG000|Overall Study|COVID-19 pandemic|0|||
162990011|NCT04562155|588666500|FG001|Overall Study|COVID-19 pandemic|0|||
162990012|NCT04562155|588666501|FG002|Overall Study|COVID-19 pandemic|0|||
162990013|NCT04562155|588666502|FG003|Overall Study|COVID-19 pandemic|1|||
162990014|NCT04562155|588666499|FG000|Overall Study|Adverse Event|7|||
162990015|NCT04562155|588666500|FG001|Overall Study|Adverse Event|3|||
162990016|NCT04562155|588666501|FG002|Overall Study|Adverse Event|8|||
162990017|NCT04562155|588666502|FG003|Overall Study|Adverse Event|1|||
162990018|NCT04562155|588666499|FG000|Overall Study|Withdrawal by Subject|3|||
162990019|NCT04562155|588666500|FG001|Overall Study|Withdrawal by Subject|6|||
162990020|NCT04562155|588666501|FG002|Overall Study|Withdrawal by Subject|3|||
162990021|NCT04562155|588666502|FG003|Overall Study|Withdrawal by Subject|3|||
162990022|NCT04562155|588666499|FG000|Overall Study|Participant personal reason|1|||
162990023|NCT04562155|588666500|FG001|Overall Study|Participant personal reason|0|||
162990024|NCT04562155|588666501|FG002|Overall Study|Participant personal reason|2|||
162990025|NCT04562155|588666502|FG003|Overall Study|Participant personal reason|1|||
162990026|NCT04005352|588666513|FG000|Overall Study|Adverse Event|4|||
162990027|NCT04005352|588666514|FG001|Overall Study|Adverse Event|5|||
162990028|NCT04005352|588666513|FG000|Overall Study|Death|4|||
162990029|NCT04005352|588666514|FG001|Overall Study|Death|2|||
162990030|NCT04005352|588666513|FG000|Overall Study|Lost to Follow-up|6|||
162990031|NCT04005352|588666514|FG001|Overall Study|Lost to Follow-up|2|||
162990032|NCT04005352|588666513|FG000|Overall Study|Physician Decision|7|||
162990033|NCT04005352|588666514|FG001|Overall Study|Physician Decision|13|||
162990034|NCT04005352|588666513|FG000|Overall Study|Protocol Violation|0|||
162990035|NCT04005352|588666514|FG001|Overall Study|Protocol Violation|1|||
163324578|NCT00357682|589900658|FG003|Overall Study|Did not receive allocated Treatment|10|||
163324579|NCT00357682|589900655|FG000|Overall Study|Withdrew consent|6|||
163324580|NCT00357682|589900656|FG001|Overall Study|Withdrew consent|6|||
162990036|NCT04005352|588666513|FG000|Overall Study|Withdrawal by Subject|28|||
162990037|NCT04005352|588666514|FG001|Overall Study|Withdrawal by Subject|38|||
162990038|NCT01283035|588666517|FG000|Overall Study|Subject later found ineligible|1|||
162990039|NCT03597529|588666522|FG000|Overall Study|Lost to Follow-up|10|||
162990040|NCT03597529|588666523|FG001|Overall Study|Lost to Follow-up|12|||
162990041|NCT03597529|588666522|FG000|Overall Study|Physician Decision|3|||
162990042|NCT03597529|588666523|FG001|Overall Study|Physician Decision|1|||
162990043|NCT03597529|588666522|FG000|Overall Study|Withdrawal by Subject|6|||
162990044|NCT03597529|588666523|FG001|Overall Study|Withdrawal by Subject|3|||
162990045|NCT03597529|588666522|FG000|Overall Study|Non-compliant with study activities|1|||
162990046|NCT03597529|588666523|FG001|Overall Study|Non-compliant with study activities|2|||
162990047|NCT01755767|588666524|FG000|Overall Study|Progressive Disease|8|||
162990048|NCT01755767|588666525|FG001|Overall Study|Progressive Disease|7|||
162990049|NCT01755767|588666526|FG002|Overall Study|Progressive Disease|91|||
162990050|NCT01755767|588666527|FG003|Overall Study|Progressive Disease|43|||
162990051|NCT01755767|588666524|FG000|Overall Study|Clinical Disease Progression|4|||
162990052|NCT01755767|588666525|FG001|Overall Study|Clinical Disease Progression|2|||
162990053|NCT01755767|588666526|FG002|Overall Study|Clinical Disease Progression|29|||
162990054|NCT01755767|588666527|FG003|Overall Study|Clinical Disease Progression|20|||
162990055|NCT01755767|588666524|FG000|Overall Study|Radiographic Disease Progression|9|||
162990056|NCT01755767|588666525|FG001|Overall Study|Radiographic Disease Progression|4|||
162990057|NCT01755767|588666526|FG002|Overall Study|Radiographic Disease Progression|44|||
162990058|NCT01755767|588666527|FG003|Overall Study|Radiographic Disease Progression|27|||
162990059|NCT01755767|588666524|FG000|Overall Study|Adverse Event|6|||
162990060|NCT01755767|588666525|FG001|Overall Study|Adverse Event|0|||
162990061|NCT01755767|588666526|FG002|Overall Study|Adverse Event|28|||
162990062|NCT01755767|588666527|FG003|Overall Study|Adverse Event|11|||
162990063|NCT01755767|588666524|FG000|Overall Study|Death|1|||
162990064|NCT01755767|588666525|FG001|Overall Study|Death|2|||
162990065|NCT01755767|588666526|FG002|Overall Study|Death|15|||
162990066|NCT01755767|588666527|FG003|Overall Study|Death|4|||
162990067|NCT01755767|588666524|FG000|Overall Study|Subject Decision|0|||
162990068|NCT01755767|588666525|FG001|Overall Study|Subject Decision|0|||
162990069|NCT01755767|588666526|FG002|Overall Study|Subject Decision|10|||
162990070|NCT01755767|588666527|FG003|Overall Study|Subject Decision|3|||
162990071|NCT01755767|588666524|FG000|Overall Study|Withdrawal by Subject|0|||
162990072|NCT01755767|588666525|FG001|Overall Study|Withdrawal by Subject|0|||
162990073|NCT01755767|588666526|FG002|Overall Study|Withdrawal by Subject|2|||
162990074|NCT01755767|588666527|FG003|Overall Study|Withdrawal by Subject|1|||
162990075|NCT01755767|588666524|FG000|Overall Study|Other|0|||
162990076|NCT01755767|588666525|FG001|Overall Study|Other|0|||
162990077|NCT01755767|588666526|FG002|Overall Study|Other|2|||
162990078|NCT01755767|588666527|FG003|Overall Study|Other|3|||
162990079|NCT01755767|588666524|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
162990080|NCT01755767|588666525|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
162990081|NCT01755767|588666526|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
162990082|NCT01755767|588666527|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
162990083|NCT03196635|588666528|FG000|Overall Study|Withdrawal by Subject|1|||
162990084|NCT00998309|588666529|FG000|Overall Study|Protocol Violation|4|||
162990085|NCT02865460|588666530|FG000|Overall Study|Adverse Event|1|||
162990086|NCT02865460|588666531|FG001|Overall Study|Adverse Event|0|||
162990087|NCT02865460|588666530|FG000|Overall Study|Withdrawal by Subject|1|||
162990088|NCT02865460|588666531|FG001|Overall Study|Withdrawal by Subject|1|||
162990089|NCT02865460|588666530|FG000|Overall Study|Lost to Follow-up|7|||
162990090|NCT02865460|588666531|FG001|Overall Study|Lost to Follow-up|4|||
162990091|NCT02865460|588666530|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
162990092|NCT02865460|588666531|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
162990093|NCT00901576|588666532|FG000|Second Intervention|Withdrawal by Subject|0|||
162990094|NCT00901576|588666533|FG001|Second Intervention|Withdrawal by Subject|0|||
162990095|NCT00901576|588666534|FG002|Second Intervention|Withdrawal by Subject|0|||
162990096|NCT00901576|588666535|FG003|Second Intervention|Withdrawal by Subject|1|||
162990097|NCT00901576|588666536|FG004|Second Intervention|Withdrawal by Subject|0|||
162990098|NCT00901576|588666537|FG005|Second Intervention|Withdrawal by Subject|1|||
162990099|NCT00901576|588666532|FG000|Second Intervention|Physician Decision|1|||
162990100|NCT00901576|588666533|FG001|Second Intervention|Physician Decision|0|||
162990101|NCT00901576|588666534|FG002|Second Intervention|Physician Decision|0|||
162990102|NCT00901576|588666535|FG003|Second Intervention|Physician Decision|0|||
162990103|NCT00901576|588666536|FG004|Second Intervention|Physician Decision|0|||
162990104|NCT00901576|588666537|FG005|Second Intervention|Physician Decision|0|||
162990105|NCT01696279|588666538|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
162990106|NCT01696279|588666539|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
162990107|NCT01696279|588666540|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
162990108|NCT01696279|588666541|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
162990109|NCT01696279|588666538|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
162990110|NCT01696279|588666539|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
162990111|NCT01696279|588666540|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
162990112|NCT01696279|588666541|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
162990113|NCT01696279|588666538|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
162990114|NCT01696279|588666539|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
162990115|NCT01696279|588666540|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
162990116|NCT01696279|588666541|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
162990117|NCT01696279|588666538|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
162990118|NCT01696279|588666539|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
162990119|NCT01696279|588666540|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
162990120|NCT01696279|588666541|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
162990121|NCT01696279|588666538|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
162990122|NCT01696279|588666539|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
162990123|NCT01696279|588666540|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
162990124|NCT01696279|588666541|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
162990125|NCT01696279|588666538|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
162990126|NCT01696279|588666539|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
162990127|NCT01696279|588666540|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
162990128|NCT01696279|588666541|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
162990129|NCT01696279|588666538|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
162990130|NCT01696279|588666539|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
162990131|NCT01696279|588666540|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
162990132|NCT01696279|588666541|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
162990133|NCT01696279|588666538|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
162990134|NCT01696279|588666539|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
162990135|NCT01696279|588666540|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
162990136|NCT01696279|588666541|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
162990137|NCT01696279|588666538|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
162990138|NCT01696279|588666539|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
162990139|NCT01696279|588666540|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
162990140|NCT01696279|588666541|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
162990141|NCT01696279|588666538|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
162990142|NCT01696279|588666539|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
162990143|NCT01696279|588666540|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
162990144|NCT01696279|588666541|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
162990145|NCT01696279|588666538|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
162990146|NCT01696279|588666539|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
162990147|NCT01696279|588666540|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
162990148|NCT01696279|588666541|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
162990149|NCT00171951|588666542|FG000|Overall Study|Adverse Event|1|||
162990150|NCT00171951|588666542|FG000|Overall Study|Abnormal Laboratory Values|2|||
162990151|NCT00171951|588666542|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
162990152|NCT00171951|588666542|FG000|Overall Study|Participants Withdrew Consent|3|||
162990153|NCT00171951|588666542|FG000|Overall Study|New Cancer Therapy|5|||
162990154|NCT00171951|588666542|FG000|Overall Study|Reason not Specified|2|||
162990155|NCT05788289|588666543|FG000|Overall Study|Death|3|||
162990156|NCT04154631|588666545|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
162990157|NCT04154631|588666546|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
162990158|NCT05187013|588666547|FG000|Overall Study|Withdrawal by Subject|1|||
162990159|NCT05187013|588666548|FG001|Overall Study|Withdrawal by Subject|1|||
162990160|NCT05187013|588666549|FG002|Overall Study|Withdrawal by Subject|0|||
162990161|NCT05187013|588666547|FG000|Overall Study|Death|0|||
162990162|NCT05187013|588666548|FG001|Overall Study|Death|1|||
162990163|NCT05187013|588666549|FG002|Overall Study|Death|0|||
162990164|NCT05187013|588666547|FG000|Overall Study|Lost to Follow-up|20|||
162990165|NCT05187013|588666548|FG001|Overall Study|Lost to Follow-up|17|||
162990166|NCT05187013|588666549|FG002|Overall Study|Lost to Follow-up|0|||
162990167|NCT05187013|588666547|FG000|Overall Study|Ongoing Participants|3|||
162990168|NCT05187013|588666548|FG001|Overall Study|Ongoing Participants|5|||
162990169|NCT05187013|588666549|FG002|Overall Study|Ongoing Participants|0|||
162990170|NCT01568320|588666552|FG000|Overall Study|Death|20|||
162990171|NCT01568320|588666552|FG000|Overall Study|Lost to Follow-up|9|||
162990172|NCT01568320|588666552|FG000|Overall Study|Withdrawal by Subject|10|||
162990173|NCT01568320|588666552|FG000|Overall Study|Conversion to open repair|1|||
162990174|NCT01568320|588666552|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
162990175|NCT03233230|588666553|FG000|Overall Study|Adverse Event|6|||
162990176|NCT03233230|588666554|FG001|Overall Study|Adverse Event|3|||
162990177|NCT03233230|588666555|FG002|Overall Study|Adverse Event|6|||
162990178|NCT03233230|588666556|FG003|Overall Study|Adverse Event|3|||
162990179|NCT03233230|588666553|FG000|Overall Study|Protocol Violation|1|||
162990180|NCT03233230|588666554|FG001|Overall Study|Protocol Violation|2|||
162990181|NCT03233230|588666555|FG002|Overall Study|Protocol Violation|1|||
163404263|NCT02831673|590191901|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
162990182|NCT03233230|588666556|FG003|Overall Study|Protocol Violation|1|||
162990183|NCT03233230|588666553|FG000|Overall Study|Lack of Efficacy|1|||
163404264|NCT02831673|590191902|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
162990184|NCT03233230|588666554|FG001|Overall Study|Lack of Efficacy|0|||
162990185|NCT03233230|588666555|FG002|Overall Study|Lack of Efficacy|0|||
162990186|NCT03233230|588666556|FG003|Overall Study|Lack of Efficacy|0|||
162990187|NCT03233230|588666553|FG000|Overall Study|Other|5|||
162990188|NCT03233230|588666554|FG001|Overall Study|Other|5|||
162990189|NCT03233230|588666555|FG002|Overall Study|Other|5|||
162990190|NCT03233230|588666556|FG003|Overall Study|Other|3|||
162990191|NCT03233230|588666553|FG000|Overall Study|Withdrawal by Subject|2|||
162990192|NCT03233230|588666554|FG001|Overall Study|Withdrawal by Subject|2|||
162990193|NCT03233230|588666555|FG002|Overall Study|Withdrawal by Subject|0|||
162990194|NCT03233230|588666556|FG003|Overall Study|Withdrawal by Subject|1|||
162990195|NCT03233230|588666553|FG000|Overall Study|Lost to Follow-up|0|||
162990196|NCT03233230|588666554|FG001|Overall Study|Lost to Follow-up|3|||
162990197|NCT03233230|588666555|FG002|Overall Study|Lost to Follow-up|0|||
162990198|NCT03233230|588666556|FG003|Overall Study|Lost to Follow-up|0|||
162990199|NCT04159935|588666557|FG000|Overall Study|Study terminated due to COVID-19|1|||
162990200|NCT04159935|588666558|FG001|Overall Study|Study terminated due to COVID-19|3|||
162990201|NCT02927366|588666559|FG000|Overall Study|Adverse Event|1|||
162990202|NCT02927366|588666560|FG001|Overall Study|Adverse Event|0|||
162990203|NCT02927366|588666559|FG000|Overall Study|Patient schedule|1|||
162990204|NCT02927366|588666560|FG001|Overall Study|Patient schedule|0|||
162990205|NCT00587990|588666565|FG000|Overall Study|Death|0|||
162990206|NCT00587990|588666566|FG001|Overall Study|Death|0|||
162990207|NCT00587990|588666567|FG002|Overall Study|Death|1|||
162990208|NCT00206323|588666568|FG000|Overall Study|Lack of Efficacy|4|||
162990209|NCT00206323|588666569|FG001|Overall Study|Lack of Efficacy|1|||
162990210|NCT00206323|588666568|FG000|Overall Study|Adverse Event|1|||
162990211|NCT00206323|588666569|FG001|Overall Study|Adverse Event|1|||
162990212|NCT00206323|588666568|FG000|Overall Study|Lost to Follow-up|1|||
162990213|NCT00206323|588666569|FG001|Overall Study|Lost to Follow-up|1|||
162990214|NCT02910063|588666570|FG000|Phase 2|Withdrawal by Subject|3|||
162990215|NCT02910063|588666571|FG001|Phase 2|Withdrawal by Subject|0|||
162990216|NCT02910063|588666572|FG002|Phase 2|Withdrawal by Subject|0|||
162990217|NCT02910063|588666570|FG000|Phase 2|Lost to Follow-up|1|||
162990218|NCT02910063|588666571|FG001|Phase 2|Lost to Follow-up|0|||
162990219|NCT02910063|588666572|FG002|Phase 2|Lost to Follow-up|0|||
162990220|NCT02910063|588666570|FG000|Phase 2|Death|24|||
162990221|NCT02910063|588666571|FG001|Phase 2|Death|0|||
162990222|NCT02910063|588666572|FG002|Phase 2|Death|0|||
162990223|NCT03334617|588666575|FG000|Overall Study|Adverse Event|0|||
162990224|NCT03334617|588666576|FG001|Overall Study|Adverse Event|0|||
162990225|NCT03334617|588666577|FG002|Overall Study|Adverse Event|0|||
162990226|NCT03334617|588666578|FG003|Overall Study|Adverse Event|0|||
162990227|NCT03334617|588666579|FG004|Overall Study|Adverse Event|0|||
162990228|NCT03334617|588666580|FG005|Overall Study|Adverse Event|0|||
162990229|NCT03334617|588666581|FG006|Overall Study|Adverse Event|0|||
162990230|NCT03334617|588666582|FG007|Overall Study|Adverse Event|0|||
162990231|NCT03334617|588666583|FG008|Overall Study|Adverse Event|1|||
162990232|NCT03334617|588666584|FG009|Overall Study|Adverse Event|0|||
162990233|NCT03334617|588666585|FG010|Overall Study|Adverse Event|0|||
162990234|NCT03334617|588666586|FG011|Overall Study|Adverse Event|0|||
162990235|NCT03334617|588666587|FG012|Overall Study|Adverse Event|1|||
162990236|NCT03334617|588666588|FG013|Overall Study|Adverse Event|0|||
162990237|NCT03334617|588666589|FG014|Overall Study|Adverse Event|0|||
162990238|NCT03334617|588666590|FG015|Overall Study|Adverse Event|0|||
162990239|NCT03334617|588666591|FG016|Overall Study|Adverse Event|0|||
162990240|NCT03334617|588666592|FG017|Overall Study|Adverse Event|0|||
162990241|NCT03334617|588666593|FG018|Overall Study|Adverse Event|0|||
162990242|NCT03334617|588666594|FG019|Overall Study|Adverse Event|0|||
162990243|NCT03334617|588666595|FG020|Overall Study|Adverse Event|0|||
162990244|NCT03334617|588666596|FG021|Overall Study|Adverse Event|0|||
162990245|NCT03334617|588666575|FG000|Overall Study|Death|18|||
162990246|NCT03334617|588666576|FG001|Overall Study|Death|18|||
162990247|NCT03334617|588666577|FG002|Overall Study|Death|20|||
162990248|NCT03334617|588666578|FG003|Overall Study|Death|21|||
162990249|NCT03334617|588666579|FG004|Overall Study|Death|20|||
162990250|NCT03334617|588666580|FG005|Overall Study|Death|16|||
162990251|NCT03334617|588666581|FG006|Overall Study|Death|28|||
163404265|NCT02831673|590191903|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
162990252|NCT03334617|588666582|FG007|Overall Study|Death|35|||
163404266|NCT02831673|590191904|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
162990253|NCT03334617|588666583|FG008|Overall Study|Death|47|||
162990254|NCT03334617|588666584|FG009|Overall Study|Death|0|||
162990255|NCT03334617|588666585|FG010|Overall Study|Death|19|||
163404267|NCT02831673|590191900|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
162990256|NCT03334617|588666586|FG011|Overall Study|Death|6|||
162990257|NCT03334617|588666587|FG012|Overall Study|Death|20|||
162990258|NCT03334617|588666588|FG013|Overall Study|Death|22|||
162990259|NCT03334617|588666589|FG014|Overall Study|Death|17|||
162990260|NCT03334617|588666590|FG015|Overall Study|Death|18|||
162990261|NCT03334617|588666591|FG016|Overall Study|Death|12|||
162990262|NCT03334617|588666592|FG017|Overall Study|Death|15|||
162990263|NCT03334617|588666593|FG018|Overall Study|Death|16|||
162990264|NCT03334617|588666594|FG019|Overall Study|Death|27|||
162990265|NCT03334617|588666595|FG020|Overall Study|Death|14|||
162990266|NCT03334617|588666596|FG021|Overall Study|Death|27|||
162990267|NCT03334617|588666575|FG000|Overall Study|Lost to Follow-up|0|||
162990268|NCT03334617|588666576|FG001|Overall Study|Lost to Follow-up|0|||
162990269|NCT03334617|588666577|FG002|Overall Study|Lost to Follow-up|0|||
162990270|NCT03334617|588666578|FG003|Overall Study|Lost to Follow-up|1|||
162990271|NCT03334617|588666579|FG004|Overall Study|Lost to Follow-up|0|||
162990272|NCT03334617|588666580|FG005|Overall Study|Lost to Follow-up|1|||
162990273|NCT03334617|588666581|FG006|Overall Study|Lost to Follow-up|0|||
162990274|NCT03334617|588666582|FG007|Overall Study|Lost to Follow-up|0|||
162990275|NCT03334617|588666583|FG008|Overall Study|Lost to Follow-up|1|||
162990276|NCT03334617|588666584|FG009|Overall Study|Lost to Follow-up|0|||
162990277|NCT03334617|588666585|FG010|Overall Study|Lost to Follow-up|0|||
162990278|NCT03334617|588666586|FG011|Overall Study|Lost to Follow-up|0|||
162990279|NCT03334617|588666587|FG012|Overall Study|Lost to Follow-up|0|||
162990280|NCT03334617|588666588|FG013|Overall Study|Lost to Follow-up|0|||
162990281|NCT03334617|588666589|FG014|Overall Study|Lost to Follow-up|0|||
162990282|NCT03334617|588666590|FG015|Overall Study|Lost to Follow-up|0|||
162990283|NCT03334617|588666591|FG016|Overall Study|Lost to Follow-up|0|||
162990284|NCT03334617|588666592|FG017|Overall Study|Lost to Follow-up|0|||
162990285|NCT03334617|588666593|FG018|Overall Study|Lost to Follow-up|0|||
162990286|NCT03334617|588666594|FG019|Overall Study|Lost to Follow-up|0|||
162990287|NCT03334617|588666595|FG020|Overall Study|Lost to Follow-up|0|||
162990288|NCT03334617|588666596|FG021|Overall Study|Lost to Follow-up|0|||
162990289|NCT03334617|588666575|FG000|Overall Study|Withdrawal by Subject|0|||
162990290|NCT03334617|588666576|FG001|Overall Study|Withdrawal by Subject|1|||
162990291|NCT03334617|588666577|FG002|Overall Study|Withdrawal by Subject|0|||
162990292|NCT03334617|588666578|FG003|Overall Study|Withdrawal by Subject|0|||
162990293|NCT03334617|588666579|FG004|Overall Study|Withdrawal by Subject|1|||
162990294|NCT03334617|588666580|FG005|Overall Study|Withdrawal by Subject|1|||
162990295|NCT03334617|588666581|FG006|Overall Study|Withdrawal by Subject|1|||
162990296|NCT03334617|588666582|FG007|Overall Study|Withdrawal by Subject|2|||
162990297|NCT03334617|588666583|FG008|Overall Study|Withdrawal by Subject|0|||
162990298|NCT03334617|588666584|FG009|Overall Study|Withdrawal by Subject|0|||
162990299|NCT03334617|588666585|FG010|Overall Study|Withdrawal by Subject|0|||
162990300|NCT03334617|588666586|FG011|Overall Study|Withdrawal by Subject|1|||
162990301|NCT03334617|588666587|FG012|Overall Study|Withdrawal by Subject|1|||
162990302|NCT03334617|588666588|FG013|Overall Study|Withdrawal by Subject|0|||
162990303|NCT03334617|588666589|FG014|Overall Study|Withdrawal by Subject|2|||
162990304|NCT03334617|588666590|FG015|Overall Study|Withdrawal by Subject|1|||
162990305|NCT03334617|588666591|FG016|Overall Study|Withdrawal by Subject|0|||
162990306|NCT03334617|588666592|FG017|Overall Study|Withdrawal by Subject|1|||
162990307|NCT03334617|588666593|FG018|Overall Study|Withdrawal by Subject|1|||
162990308|NCT03334617|588666594|FG019|Overall Study|Withdrawal by Subject|1|||
162990309|NCT03334617|588666595|FG020|Overall Study|Withdrawal by Subject|0|||
162990310|NCT03334617|588666596|FG021|Overall Study|Withdrawal by Subject|1|||
162990311|NCT03334617|588666575|FG000|Overall Study|Other|1|||
162990312|NCT03334617|588666576|FG001|Overall Study|Other|2|||
162990313|NCT03334617|588666577|FG002|Overall Study|Other|0|||
162990314|NCT03334617|588666578|FG003|Overall Study|Other|1|||
162990315|NCT03334617|588666579|FG004|Overall Study|Other|1|||
162990316|NCT03334617|588666580|FG005|Overall Study|Other|0|||
162990317|NCT03334617|588666581|FG006|Overall Study|Other|2|||
162990318|NCT03334617|588666582|FG007|Overall Study|Other|1|||
162990319|NCT03334617|588666583|FG008|Overall Study|Other|8|||
162990320|NCT03334617|588666584|FG009|Overall Study|Other|0|||
162990321|NCT03334617|588666585|FG010|Overall Study|Other|3|||
162990322|NCT03334617|588666586|FG011|Overall Study|Other|1|||
162990323|NCT03334617|588666587|FG012|Overall Study|Other|3|||
162990324|NCT03334617|588666588|FG013|Overall Study|Other|1|||
162990325|NCT03334617|588666589|FG014|Overall Study|Other|1|||
162990326|NCT03334617|588666590|FG015|Overall Study|Other|3|||
162990327|NCT03334617|588666591|FG016|Overall Study|Other|3|||
162990328|NCT03334617|588666592|FG017|Overall Study|Other|3|||
162990329|NCT03334617|588666593|FG018|Overall Study|Other|7|||
162990330|NCT03334617|588666594|FG019|Overall Study|Other|4|||
163059980|NCT01348269|588928274|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
163324581|NCT00357682|589900657|FG002|Overall Study|Withdrew consent|5|||
162990331|NCT03334617|588666595|FG020|Overall Study|Other|1|||
162990332|NCT03334617|588666596|FG021|Overall Study|Other|4|||
162990333|NCT03334617|588666575|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
162990334|NCT03334617|588666576|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
162990335|NCT03334617|588666577|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
162990336|NCT03334617|588666578|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
162990337|NCT03334617|588666579|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
162990338|NCT03334617|588666580|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
162990339|NCT03334617|588666581|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
162990340|NCT03334617|588666582|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
162990341|NCT03334617|588666583|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
162990342|NCT03334617|588666584|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
162990343|NCT03334617|588666585|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
162990344|NCT03334617|588666586|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
162990345|NCT03334617|588666587|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
162990346|NCT03334617|588666588|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
162990347|NCT03334617|588666589|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
162990348|NCT03334617|588666590|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
162990349|NCT03334617|588666591|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
162990350|NCT03334617|588666592|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
162990351|NCT03334617|588666593|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
162990352|NCT03334617|588666594|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
162990353|NCT03334617|588666595|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
162990354|NCT03334617|588666596|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
162990355|NCT03657342|588666598|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
162990356|NCT03657342|588666599|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
162990357|NCT03657342|588666598|FG000|Overall Study|Withdrawal by Subject|4|||
162990358|NCT03657342|588666599|FG001|Overall Study|Withdrawal by Subject|4|||
162990359|NCT03657342|588666598|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
162990360|NCT03657342|588666599|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
162990361|NCT03657342|588666598|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
162990362|NCT03657342|588666599|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
162990363|NCT00827632|588666600|FG000|Overall Study|Lost to Follow-up|8|||
162990364|NCT00827632|588666601|FG001|Overall Study|Lost to Follow-up|12|||
162990365|NCT00827632|588666600|FG000|Overall Study|Early withdrawal|14|||
162990366|NCT00827632|588666601|FG001|Overall Study|Early withdrawal|11|||
162990367|NCT01753336|588666602|FG000|Overall Study|Patient decision|12|||
162990368|NCT01753336|588666602|FG000|Overall Study|Lost to Follow-up|3|||
162990369|NCT01753336|588666602|FG000|Overall Study|Physician Decision|2|||
162990370|NCT01753336|588666602|FG000|Overall Study|Sponsor's decision|2|||
162990371|NCT01753336|588666602|FG000|Overall Study|Withdrawal by Subject|1|||
162990372|NCT03201211|588666603|FG000|Overall Study|Adverse Event|1|||
162990373|NCT03201211|588666604|FG001|Overall Study|Adverse Event|0|||
162990374|NCT03201211|588666605|FG002|Overall Study|Adverse Event|0|||
162990375|NCT03201211|588666603|FG000|Overall Study|Protocol Violation|1|||
162990376|NCT03201211|588666604|FG001|Overall Study|Protocol Violation|0|||
162990377|NCT03201211|588666605|FG002|Overall Study|Protocol Violation|0|||
162990378|NCT03201211|588666603|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
162990379|NCT03201211|588666604|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
162990380|NCT03201211|588666605|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
162990381|NCT03201211|588666603|FG000|Overall Study|OTHER unknown reasons|0|||
162990382|NCT03201211|588666604|FG001|Overall Study|OTHER unknown reasons|1|||
162990383|NCT03201211|588666605|FG002|Overall Study|OTHER unknown reasons|0|||
162990384|NCT01770392|588666606|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
162990385|NCT03401450|588666607|FG000|Overall Study|Lost to Follow-up|4|||
162990386|NCT03401450|588666608|FG001|Overall Study|Lost to Follow-up|6|||
162990387|NCT03401450|588666607|FG000|Overall Study|Anesthesia plan changed|2|||
162990388|NCT03401450|588666608|FG001|Overall Study|Anesthesia plan changed|2|||
162990389|NCT03401450|588666607|FG000|Overall Study|Did not complete medication diary|4|||
162990390|NCT03401450|588666608|FG001|Overall Study|Did not complete medication diary|2|||
162990391|NCT03401450|588666607|FG000|Overall Study|post surgery medication change|2|||
162990392|NCT03401450|588666608|FG001|Overall Study|post surgery medication change|1|||
162990393|NCT03401450|588666607|FG000|Overall Study|Cancelled surgery|0|||
162990394|NCT03401450|588666608|FG001|Overall Study|Cancelled surgery|2|||
162990395|NCT00228423|588666609|FG000|Overall Study|Adverse Event|2|||
162990396|NCT00228423|588666610|FG001|Overall Study|Adverse Event|5|||
162990397|NCT00228423|588666609|FG000|Overall Study|Withdrawal by Subject|7|||
162990398|NCT00228423|588666610|FG001|Overall Study|Withdrawal by Subject|3|||
162990399|NCT00228423|588666609|FG000|Overall Study|Protocol Violation|1|||
162990400|NCT00228423|588666610|FG001|Overall Study|Protocol Violation|3|||
162990401|NCT00228423|588666609|FG000|Overall Study|Physician Decision|0|||
162990402|NCT00228423|588666610|FG001|Overall Study|Physician Decision|1|||
162990403|NCT01709838|588666623|FG000|Overall Study|Withdrawal by Subject|21|||
162990404|NCT01709838|588666623|FG000|Overall Study|Lost to Follow-up|16|||
162990405|NCT01709838|588666623|FG000|Overall Study|Pregnancy|10|||
162990406|NCT01709838|588666623|FG000|Overall Study|Subject/guardian decision|8|||
162990407|NCT01709838|588666623|FG000|Overall Study|Adverse Event|4|||
162990408|NCT01709838|588666623|FG000|Overall Study|Physician Decision|4|||
162990409|NCT01709838|588666623|FG000|Overall Study|Death|3|||
162990410|NCT01709838|588666623|FG000|Overall Study|Protocol Violation|1|||
162990411|NCT00620659|588666624|FG000|Treatment Period 1|Adverse Event|1|||
162990412|NCT00620659|588666625|FG001|Treatment Period 1|Adverse Event|0|||
162990413|NCT00620659|588666626|FG002|Treatment Period 1|Adverse Event|0|||
162990414|NCT00620659|588666627|FG003|Treatment Period 1|Adverse Event|3|||
162990415|NCT00620659|588666628|FG004|Treatment Period 1|Adverse Event|0|||
162990416|NCT00620659|588666629|FG005|Treatment Period 1|Adverse Event|0|||
162990417|NCT00620659|588666624|FG000|Treatment Period 1|Protocol Violation|1|||
162990418|NCT00620659|588666625|FG001|Treatment Period 1|Protocol Violation|0|||
162990419|NCT00620659|588666626|FG002|Treatment Period 1|Protocol Violation|0|||
162990420|NCT00620659|588666627|FG003|Treatment Period 1|Protocol Violation|0|||
162990421|NCT00620659|588666628|FG004|Treatment Period 1|Protocol Violation|0|||
162990422|NCT00620659|588666629|FG005|Treatment Period 1|Protocol Violation|0|||
162990423|NCT00620659|588666624|FG000|Treatment Period 1|Withdrawal by Subject|1|||
162990424|NCT00620659|588666625|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162990425|NCT00620659|588666626|FG002|Treatment Period 1|Withdrawal by Subject|1|||
162990426|NCT00620659|588666627|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162990427|NCT00620659|588666628|FG004|Treatment Period 1|Withdrawal by Subject|1|||
162990428|NCT00620659|588666629|FG005|Treatment Period 1|Withdrawal by Subject|0|||
162990429|NCT00620659|588666624|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
162990430|NCT00620659|588666625|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
162990431|NCT00620659|588666626|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
162990432|NCT00620659|588666627|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
162990433|NCT00620659|588666628|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
162990434|NCT00620659|588666629|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
162990435|NCT00620659|588666624|FG000|Treatment Period 2|Adverse Event|0|||
162990436|NCT00620659|588666625|FG001|Treatment Period 2|Adverse Event|3|||
162990437|NCT00620659|588666626|FG002|Treatment Period 2|Adverse Event|0|||
162990438|NCT00620659|588666627|FG003|Treatment Period 2|Adverse Event|0|||
162990439|NCT00620659|588666628|FG004|Treatment Period 2|Adverse Event|2|||
162990440|NCT00620659|588666629|FG005|Treatment Period 2|Adverse Event|0|||
162990441|NCT00620659|588666624|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162990442|NCT00620659|588666625|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162990443|NCT00620659|588666626|FG002|Treatment Period 2|Withdrawal by Subject|1|||
162990444|NCT00620659|588666627|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162990445|NCT00620659|588666628|FG004|Treatment Period 2|Withdrawal by Subject|3|||
162990446|NCT00620659|588666629|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162990447|NCT00620659|588666624|FG000|Placebo Washout Period 2|Adverse Event|2|||
162990448|NCT00620659|588666625|FG001|Placebo Washout Period 2|Adverse Event|0|||
162990449|NCT00620659|588666626|FG002|Placebo Washout Period 2|Adverse Event|0|||
162990450|NCT00620659|588666627|FG003|Placebo Washout Period 2|Adverse Event|0|||
162990451|NCT00620659|588666628|FG004|Placebo Washout Period 2|Adverse Event|0|||
162990452|NCT00620659|588666629|FG005|Placebo Washout Period 2|Adverse Event|0|||
162990453|NCT00620659|588666624|FG000|Treatment Period 3|Adverse Event|0|||
162990454|NCT00620659|588666625|FG001|Treatment Period 3|Adverse Event|2|||
162990455|NCT00620659|588666626|FG002|Treatment Period 3|Adverse Event|0|||
162990456|NCT00620659|588666627|FG003|Treatment Period 3|Adverse Event|0|||
162990457|NCT00620659|588666628|FG004|Treatment Period 3|Adverse Event|0|||
162990458|NCT00620659|588666629|FG005|Treatment Period 3|Adverse Event|0|||
162990459|NCT00620659|588666624|FG000|Treatment Period 3|Withdrawal by Subject|0|||
162990460|NCT00620659|588666625|FG001|Treatment Period 3|Withdrawal by Subject|0|||
162990461|NCT00620659|588666626|FG002|Treatment Period 3|Withdrawal by Subject|0|||
162990462|NCT00620659|588666627|FG003|Treatment Period 3|Withdrawal by Subject|1|||
162990463|NCT00620659|588666628|FG004|Treatment Period 3|Withdrawal by Subject|0|||
162990464|NCT00620659|588666629|FG005|Treatment Period 3|Withdrawal by Subject|0|||
162990465|NCT02352779|588666630|FG000|Overall Study|Personal Issues|1|||
162990466|NCT02352779|588666631|FG001|Overall Study|Personal Issues|1|||
162990467|NCT02352779|588666632|FG002|Overall Study|Personal Issues|0|||
162990468|NCT02352779|588666630|FG000|Overall Study|Too Many Forms|2|||
162990469|NCT02352779|588666631|FG001|Overall Study|Too Many Forms|0|||
162990470|NCT02352779|588666632|FG002|Overall Study|Too Many Forms|0|||
162990471|NCT02352779|588666630|FG000|Overall Study|Feeling Overwhelmed|1|||
162990472|NCT02352779|588666631|FG001|Overall Study|Feeling Overwhelmed|0|||
162990473|NCT02352779|588666632|FG002|Overall Study|Feeling Overwhelmed|0|||
162990474|NCT02352779|588666630|FG000|Overall Study|Disliked Intervention|1|||
162990475|NCT02352779|588666631|FG001|Overall Study|Disliked Intervention|0|||
162990476|NCT02352779|588666632|FG002|Overall Study|Disliked Intervention|0|||
162990477|NCT02352779|588666630|FG000|Overall Study|Changed Mind|1|||
162990478|NCT02352779|588666631|FG001|Overall Study|Changed Mind|0|||
162990479|NCT02352779|588666632|FG002|Overall Study|Changed Mind|0|||
163059981|NCT01348269|588928275|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
163059982|NCT00805532|588928276|FG000|Overall Study|invalid data|0|||
162990480|NCT02352779|588666630|FG000|Overall Study|Study Related Symptoms|1|||
162990481|NCT02352779|588666631|FG001|Overall Study|Study Related Symptoms|0|||
162990482|NCT02352779|588666632|FG002|Overall Study|Study Related Symptoms|0|||
162990483|NCT02352779|588666630|FG000|Overall Study|Absence of Symptoms|1|||
162990484|NCT02352779|588666631|FG001|Overall Study|Absence of Symptoms|0|||
162990485|NCT02352779|588666632|FG002|Overall Study|Absence of Symptoms|0|||
162990486|NCT02352779|588666630|FG000|Overall Study|Other Medical Reason|0|||
162990487|NCT02352779|588666631|FG001|Overall Study|Other Medical Reason|0|||
162990488|NCT02352779|588666632|FG002|Overall Study|Other Medical Reason|1|||
162990489|NCT02352779|588666630|FG000|Overall Study|No Reason|0|||
162990490|NCT02352779|588666631|FG001|Overall Study|No Reason|0|||
162990491|NCT02352779|588666632|FG002|Overall Study|No Reason|1|||
162990492|NCT00968799|588666635|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
162990493|NCT00719849|588666638|FG000|Overall Study|Death|0|||
162990494|NCT00719849|588666639|FG001|Overall Study|Death|1|||
162990495|NCT00389831|588666643|FG000|Overall Study|Lack of Efficacy|0|||
162990496|NCT00389831|588666644|FG001|Overall Study|Lack of Efficacy|2|||
162990497|NCT00389831|588666643|FG000|Overall Study|Did not receive treatment.|0|||
162990498|NCT00389831|588666644|FG001|Overall Study|Did not receive treatment.|2|||
162990499|NCT00389831|588666643|FG000|Overall Study|Other reasons|0|||
162990500|NCT00389831|588666644|FG001|Overall Study|Other reasons|2|||
162990501|NCT00389831|588666643|FG000|Overall Study|Lost to Follow-up|0|||
162990502|NCT00389831|588666644|FG001|Overall Study|Lost to Follow-up|1|||
162990503|NCT00594646|588666649|FG000|Overall Study|Withdrawal by Subject|1|||
162990504|NCT00594646|588666649|FG000|Overall Study|Lost to Follow-up|15|||
162990505|NCT03907462|588666650|FG000|Overall Study|Physician Decision|1|||
162990506|NCT03907462|588666651|FG001|Overall Study|Physician Decision|3|||
162990507|NCT03907462|588666652|FG002|Overall Study|Physician Decision|1|||
162990508|NCT03907462|588666650|FG000|Overall Study|Withdrawal by Subject|6|||
162990509|NCT03907462|588666651|FG001|Overall Study|Withdrawal by Subject|3|||
162990510|NCT03907462|588666652|FG002|Overall Study|Withdrawal by Subject|3|||
162990511|NCT03907462|588666650|FG000|Overall Study|Pregnancy|4|||
162990512|NCT03907462|588666651|FG001|Overall Study|Pregnancy|2|||
162990513|NCT03907462|588666652|FG002|Overall Study|Pregnancy|6|||
162990514|NCT03907462|588666650|FG000|Overall Study|Lost to Follow-up|16|||
162990515|NCT03907462|588666651|FG001|Overall Study|Lost to Follow-up|18|||
162990516|NCT03907462|588666652|FG002|Overall Study|Lost to Follow-up|22|||
162990517|NCT00191113|588669080|FG000|Core Study|Withdrawal by Subject|25|||
162990518|NCT00191113|588669081|FG001|Core Study|Withdrawal by Subject|9|||
162990519|NCT00191113|588669080|FG000|Core Study|Protocol Violation|6|||
162990520|NCT00191113|588669081|FG001|Core Study|Protocol Violation|2|||
162990521|NCT00191113|588669080|FG000|Core Study|Lost to Follow-up|3|||
162990522|NCT00191113|588669081|FG001|Core Study|Lost to Follow-up|0|||
162990523|NCT00191113|588669080|FG000|Core Study|Adverse Event|0|||
162990524|NCT00191113|588669081|FG001|Core Study|Adverse Event|2|||
162990525|NCT00191113|588669080|FG000|Core Study|Lack of Efficacy|0|||
162990526|NCT00191113|588669081|FG001|Core Study|Lack of Efficacy|2|||
162990527|NCT00191113|588669080|FG000|Core Study|Death|1|||
162990528|NCT00191113|588669081|FG001|Core Study|Death|0|||
162990529|NCT01555671|588669084|FG000|Overall Study|Physician Decision|20|||
162990530|NCT01555671|588669085|FG001|Overall Study|Physician Decision|25|||
162990531|NCT00631657|588669086|FG000|6-Month Treatment Period|Adverse Event|47|||
162990532|NCT00631657|588669087|FG001|6-Month Treatment Period|Adverse Event|0|||
162990533|NCT00631657|588669088|FG002|6-Month Treatment Period|Adverse Event|7|||
162990534|NCT00631657|588669086|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
162990535|NCT00631657|588669087|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
162990536|NCT00631657|588669088|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
162990537|NCT00631657|588669086|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
162990538|NCT00631657|588669087|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
162990539|NCT00631657|588669088|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
162990540|NCT00631657|588669086|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
162990541|NCT00631657|588669087|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
162990542|NCT00631657|588669088|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
162990543|NCT00631657|588669086|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
162990544|NCT00631657|588669087|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
162990545|NCT00631657|588669088|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
162990546|NCT00631657|588669086|FG000|6-Month Treatment Period|Other|16|||
162990547|NCT00631657|588669087|FG001|6-Month Treatment Period|Other|0|||
162990548|NCT00631657|588669088|FG002|6-Month Treatment Period|Other|4|||
162990549|NCT00631657|588669086|FG000|6-Month Treatment Period|Not Treated|2|||
162990550|NCT00631657|588669087|FG001|6-Month Treatment Period|Not Treated|0|||
162990551|NCT00631657|588669088|FG002|6-Month Treatment Period|Not Treated|1|||
162990552|NCT00631657|588669086|FG000|7-Day Discontinuation Period|Not Treated|1|||
162990553|NCT00631657|588669087|FG001|7-Day Discontinuation Period|Not Treated|1|||
162990554|NCT00631657|588669088|FG002|7-Day Discontinuation Period|Not Treated|1|||
162990555|NCT00631657|588669086|FG000|7-Day Discontinuation Period|Other|1|||
162990556|NCT00631657|588669087|FG001|7-Day Discontinuation Period|Other|0|||
162990557|NCT00631657|588669088|FG002|7-Day Discontinuation Period|Other|0|||
162990558|NCT04003896|588669089|FG000|Overall Study|Withdrawal by Subject|3|||
162990559|NCT04003896|588669089|FG000|Overall Study|Physician Decision|1|||
162990560|NCT03929757|588669092|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
162990561|NCT03929757|588669093|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
162990562|NCT03929757|588669094|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
162990563|NCT03929757|588669092|FG000|Main Study: Up to Day 365|Other|1|||
162990564|NCT03929757|588669093|FG001|Main Study: Up to Day 365|Other|0|||
162990565|NCT03929757|588669094|FG002|Main Study: Up to Day 365|Other|0|||
162990566|NCT03929757|588669092|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
162990567|NCT03929757|588669093|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
162990568|NCT03929757|588669094|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
162990569|NCT01154816|588669095|FG000|Overall Study|Withdrawal by Subject|1|||
162990570|NCT01154816|588669096|FG001|Overall Study|Withdrawal by Subject|0|||
162990571|NCT01154816|588669097|FG002|Overall Study|Withdrawal by Subject|0|||
162990572|NCT01154816|588669098|FG003|Overall Study|Withdrawal by Subject|1|||
162990573|NCT01154816|588669099|FG004|Overall Study|Withdrawal by Subject|0|||
162990574|NCT01154816|588669100|FG005|Overall Study|Withdrawal by Subject|0|||
162990575|NCT01154816|588669101|FG006|Overall Study|Withdrawal by Subject|0|||
162990576|NCT01154816|588669102|FG007|Overall Study|Withdrawal by Subject|0|||
162990577|NCT01154816|588669103|FG008|Overall Study|Withdrawal by Subject|1|||
162990578|NCT01154816|588669104|FG009|Overall Study|Withdrawal by Subject|3|||
162990579|NCT01154816|588669105|FG010|Overall Study|Withdrawal by Subject|0|||
162990580|NCT01154816|588669106|FG011|Overall Study|Withdrawal by Subject|0|||
162990581|NCT01154816|588669095|FG000|Overall Study|Progressive Disease|13|||
162990582|NCT01154816|588669096|FG001|Overall Study|Progressive Disease|8|||
162990583|NCT01154816|588669097|FG002|Overall Study|Progressive Disease|9|||
162990584|NCT01154816|588669098|FG003|Overall Study|Progressive Disease|9|||
162990585|NCT01154816|588669099|FG004|Overall Study|Progressive Disease|8|||
162990586|NCT01154816|588669100|FG005|Overall Study|Progressive Disease|8|||
162990587|NCT01154816|588669101|FG006|Overall Study|Progressive Disease|5|||
162990588|NCT01154816|588669102|FG007|Overall Study|Progressive Disease|6|||
162990589|NCT01154816|588669103|FG008|Overall Study|Progressive Disease|8|||
162990590|NCT01154816|588669104|FG009|Overall Study|Progressive Disease|6|||
162990591|NCT01154816|588669105|FG010|Overall Study|Progressive Disease|10|||
162990592|NCT01154816|588669106|FG011|Overall Study|Progressive Disease|3|||
162990593|NCT01154816|588669095|FG000|Overall Study|Physician Decision|1|||
162990594|NCT01154816|588669096|FG001|Overall Study|Physician Decision|0|||
162990595|NCT01154816|588669097|FG002|Overall Study|Physician Decision|1|||
162990596|NCT01154816|588669098|FG003|Overall Study|Physician Decision|0|||
162990597|NCT01154816|588669099|FG004|Overall Study|Physician Decision|2|||
162990598|NCT01154816|588669100|FG005|Overall Study|Physician Decision|0|||
162990599|NCT01154816|588669101|FG006|Overall Study|Physician Decision|0|||
162990600|NCT01154816|588669102|FG007|Overall Study|Physician Decision|0|||
162990601|NCT01154816|588669103|FG008|Overall Study|Physician Decision|0|||
162990602|NCT01154816|588669104|FG009|Overall Study|Physician Decision|1|||
162990603|NCT01154816|588669105|FG010|Overall Study|Physician Decision|1|||
162990604|NCT01154816|588669106|FG011|Overall Study|Physician Decision|1|||
162990605|NCT01154816|588669095|FG000|Overall Study|Adverse Event|5|||
162990606|NCT01154816|588669096|FG001|Overall Study|Adverse Event|2|||
162990607|NCT01154816|588669097|FG002|Overall Study|Adverse Event|0|||
162990608|NCT01154816|588669098|FG003|Overall Study|Adverse Event|0|||
162990609|NCT01154816|588669099|FG004|Overall Study|Adverse Event|0|||
162990610|NCT01154816|588669100|FG005|Overall Study|Adverse Event|0|||
162990611|NCT01154816|588669101|FG006|Overall Study|Adverse Event|1|||
162990612|NCT01154816|588669102|FG007|Overall Study|Adverse Event|1|||
162990613|NCT01154816|588669103|FG008|Overall Study|Adverse Event|0|||
162990614|NCT01154816|588669104|FG009|Overall Study|Adverse Event|0|||
162990615|NCT01154816|588669105|FG010|Overall Study|Adverse Event|0|||
162990616|NCT01154816|588669106|FG011|Overall Study|Adverse Event|0|||
162990617|NCT00806286|588669107|FG000|Overall Study|Adverse Event|5|||
162990618|NCT00806286|588669108|FG001|Overall Study|Adverse Event|2|||
162990619|NCT00806286|588669109|FG002|Overall Study|Adverse Event|0|||
162990620|NCT00806286|588669107|FG000|Overall Study|Disease progression|31|||
162990621|NCT00806286|588669108|FG001|Overall Study|Disease progression|38|||
162990622|NCT00806286|588669109|FG002|Overall Study|Disease progression|1|||
162990623|NCT00806286|588669107|FG000|Overall Study|Death|1|||
162990624|NCT00806286|588669108|FG001|Overall Study|Death|6|||
162990625|NCT00806286|588669109|FG002|Overall Study|Death|0|||
162990626|NCT00806286|588669107|FG000|Overall Study|Lost to Follow-up|0|||
162990627|NCT00806286|588669108|FG001|Overall Study|Lost to Follow-up|1|||
162990628|NCT00806286|588669109|FG002|Overall Study|Lost to Follow-up|0|||
162990629|NCT00806286|588669107|FG000|Overall Study|Withdrawal by Subject|8|||
163212339|NCT00312494|589492465|FG000|Overall Study|Withdrawal by Subject|6|||
162990630|NCT00806286|588669108|FG001|Overall Study|Withdrawal by Subject|3|||
162990631|NCT00806286|588669109|FG002|Overall Study|Withdrawal by Subject|1|||
162990632|NCT00806286|588669107|FG000|Overall Study|Physician Decision|2|||
162990633|NCT00806286|588669108|FG001|Overall Study|Physician Decision|2|||
162990634|NCT00806286|588669109|FG002|Overall Study|Physician Decision|0|||
162990635|NCT00806286|588669107|FG000|Overall Study|Due to a variety of reasons|7|||
162990636|NCT00806286|588669108|FG001|Overall Study|Due to a variety of reasons|2|||
162990637|NCT00806286|588669109|FG002|Overall Study|Due to a variety of reasons|1|||
162990638|NCT00686075|588669110|FG000|Overall Study|Withdrawal by Subject|4|||
162990639|NCT00686075|588669111|FG001|Overall Study|Withdrawal by Subject|3|||
162990640|NCT00686075|588669112|FG002|Overall Study|Withdrawal by Subject|3|||
162990641|NCT00686075|588669113|FG003|Overall Study|Withdrawal by Subject|7|||
162990642|NCT00686075|588669114|FG004|Overall Study|Withdrawal by Subject|1|||
162990643|NCT00686075|588669115|FG005|Overall Study|Withdrawal by Subject|0|||
162990644|NCT00686075|588669116|FG006|Overall Study|Withdrawal by Subject|0|||
162990645|NCT00686075|588669117|FG007|Overall Study|Withdrawal by Subject|2|||
162990646|NCT00686075|588669118|FG008|Overall Study|Withdrawal by Subject|4|||
162990647|NCT00686075|588669119|FG009|Overall Study|Withdrawal by Subject|6|||
162990648|NCT00686075|588669110|FG000|Overall Study|Lost to Follow-up|3|||
162990649|NCT00686075|588669111|FG001|Overall Study|Lost to Follow-up|6|||
162990650|NCT00686075|588669112|FG002|Overall Study|Lost to Follow-up|3|||
162990651|NCT00686075|588669113|FG003|Overall Study|Lost to Follow-up|2|||
162990652|NCT00686075|588669114|FG004|Overall Study|Lost to Follow-up|3|||
162990653|NCT00686075|588669115|FG005|Overall Study|Lost to Follow-up|3|||
162990654|NCT00686075|588669116|FG006|Overall Study|Lost to Follow-up|0|||
162990655|NCT00686075|588669117|FG007|Overall Study|Lost to Follow-up|0|||
162990656|NCT00686075|588669118|FG008|Overall Study|Lost to Follow-up|2|||
162990657|NCT00686075|588669119|FG009|Overall Study|Lost to Follow-up|3|||
162990658|NCT00686075|588669110|FG000|Overall Study|Other|1|||
162990659|NCT00686075|588669111|FG001|Overall Study|Other|1|||
162990660|NCT00686075|588669112|FG002|Overall Study|Other|0|||
162990661|NCT00686075|588669113|FG003|Overall Study|Other|0|||
162990662|NCT00686075|588669114|FG004|Overall Study|Other|0|||
162990663|NCT00686075|588669115|FG005|Overall Study|Other|0|||
162990664|NCT00686075|588669116|FG006|Overall Study|Other|0|||
162990665|NCT00686075|588669117|FG007|Overall Study|Other|0|||
162990666|NCT00686075|588669118|FG008|Overall Study|Other|0|||
162990667|NCT00686075|588669119|FG009|Overall Study|Other|1|||
162990668|NCT04713553|588669120|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
162990669|NCT04713553|588669121|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
162990670|NCT04713553|588669122|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
162990671|NCT04713553|588669123|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
162990672|NCT04713553|588669124|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
162990673|NCT04713553|588669125|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
162990674|NCT04713553|588669126|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
162990675|NCT04713553|588669120|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
162990676|NCT04713553|588669121|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
162990677|NCT04713553|588669122|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
162990678|NCT04713553|588669123|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
162990679|NCT04713553|588669124|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
162990680|NCT04713553|588669125|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
162990681|NCT04713553|588669126|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
162990682|NCT04713553|588669120|FG000|Primary Study (2 Months)|Other|1|||
162990683|NCT04713553|588669121|FG001|Primary Study (2 Months)|Other|2|||
162990684|NCT04713553|588669122|FG002|Primary Study (2 Months)|Other|0|||
162990685|NCT04713553|588669123|FG003|Primary Study (2 Months)|Other|0|||
162990686|NCT04713553|588669124|FG004|Primary Study (2 Months)|Other|1|||
162990687|NCT04713553|588669125|FG005|Primary Study (2 Months)|Other|0|||
162990688|NCT04713553|588669126|FG006|Primary Study (2 Months)|Other|0|||
162990689|NCT04713553|588669120|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
162990690|NCT04713553|588669121|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
162990691|NCT04713553|588669122|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
162990692|NCT04713553|588669123|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
162990693|NCT04713553|588669124|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
162990694|NCT04713553|588669125|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
162990695|NCT04713553|588669126|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
162990696|NCT04713553|588669120|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
162990697|NCT04713553|588669121|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
162990698|NCT04713553|588669122|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
162990699|NCT04713553|588669123|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
162990700|NCT04713553|588669124|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
162990701|NCT04713553|588669125|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
162990702|NCT04713553|588669126|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
162990703|NCT01199471|588669127|FG000|Overall Study|Protocol Violation|4|||
162990704|NCT01199471|588669127|FG000|Overall Study|Withdrawal by Subject|1|||
162990705|NCT01199471|588669127|FG000|Overall Study|Physician Decision|1|||
162990706|NCT03151408|588669128|FG000|Overall Study|Adverse Event|24|||
162990707|NCT03151408|588669129|FG001|Overall Study|Adverse Event|23|||
162990708|NCT03151408|588669128|FG000|Overall Study|Death|46|||
163324582|NCT00357682|589900658|FG003|Overall Study|Withdrew consent|5|||
163324583|NCT00357682|589900655|FG000|Overall Study|Lost to Follow-up|39|||
163324584|NCT00357682|589900656|FG001|Overall Study|Lost to Follow-up|33|||
163324585|NCT00357682|589900657|FG002|Overall Study|Lost to Follow-up|26|||
162990709|NCT03151408|588669129|FG001|Overall Study|Death|26|||
162990710|NCT03151408|588669128|FG000|Overall Study|Physician Decision|13|||
162990711|NCT03151408|588669129|FG001|Overall Study|Physician Decision|19|||
162990712|NCT03151408|588669128|FG000|Overall Study|Withdrawal by Subject|16|||
162990713|NCT03151408|588669129|FG001|Overall Study|Withdrawal by Subject|20|||
162990714|NCT03151408|588669128|FG000|Overall Study|Progressive disease|45|||
162990715|NCT03151408|588669129|FG001|Overall Study|Progressive disease|61|||
162990716|NCT03151408|588669128|FG000|Overall Study|non-compliance by patient|1|||
162990717|NCT03151408|588669129|FG001|Overall Study|non-compliance by patient|0|||
162990718|NCT03151408|588669128|FG000|Overall Study|other reasons|56|||
162990719|NCT03151408|588669129|FG001|Overall Study|other reasons|52|||
162990720|NCT03151408|588669128|FG000|Overall Study|randomized and not treated|2|||
162990721|NCT03151408|588669129|FG001|Overall Study|randomized and not treated|2|||
162990722|NCT00265395|588669130|FG000|Overall Study|Adverse Event|3|||
162990723|NCT00265395|588669131|FG001|Overall Study|Adverse Event|6|||
162990724|NCT00265395|588669130|FG000|Overall Study|Lost to Follow-up|2|||
162990725|NCT00265395|588669131|FG001|Overall Study|Lost to Follow-up|1|||
162990726|NCT00265395|588669130|FG000|Overall Study|Withdrawal by Subject|1|||
162990727|NCT00265395|588669131|FG001|Overall Study|Withdrawal by Subject|6|||
162990728|NCT00265395|588669130|FG000|Overall Study|Protocol Violation|2|||
162990729|NCT00265395|588669131|FG001|Overall Study|Protocol Violation|2|||
162990730|NCT00265395|588669130|FG000|Overall Study|Lack of Efficacy|0|||
162990731|NCT00265395|588669131|FG001|Overall Study|Lack of Efficacy|1|||
162990732|NCT00265395|588669130|FG000|Overall Study|Administrative|0|||
162990733|NCT00265395|588669131|FG001|Overall Study|Administrative|1|||
162990734|NCT03400943|588669132|FG000|Treatment Period 1|Adverse Event|0|||
162990735|NCT03400943|588669133|FG001|Treatment Period 1|Adverse Event|0|||
162990736|NCT03400943|588669134|FG002|Treatment Period 1|Adverse Event|0|||
162990737|NCT03400943|588669135|FG003|Treatment Period 1|Adverse Event|1|||
162990738|NCT03400943|588669132|FG000|Treatment Period 1|Lost to Follow-up|1|||
162990739|NCT03400943|588669133|FG001|Treatment Period 1|Lost to Follow-up|0|||
162990740|NCT03400943|588669134|FG002|Treatment Period 1|Lost to Follow-up|0|||
162990741|NCT03400943|588669135|FG003|Treatment Period 1|Lost to Follow-up|0|||
162990742|NCT03400943|588669132|FG000|Treatment Period 1|Protocol Violation|0|||
162990743|NCT03400943|588669133|FG001|Treatment Period 1|Protocol Violation|1|||
162990744|NCT03400943|588669134|FG002|Treatment Period 1|Protocol Violation|1|||
162990745|NCT03400943|588669135|FG003|Treatment Period 1|Protocol Violation|0|||
162990746|NCT03400943|588669132|FG000|Treatment Period 1|Study terminated by sponsor|2|||
162990747|NCT03400943|588669133|FG001|Treatment Period 1|Study terminated by sponsor|0|||
162990748|NCT03400943|588669134|FG002|Treatment Period 1|Study terminated by sponsor|0|||
162990749|NCT03400943|588669135|FG003|Treatment Period 1|Study terminated by sponsor|1|||
162990750|NCT03400943|588669132|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162990751|NCT03400943|588669133|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162990752|NCT03400943|588669134|FG002|Treatment Period 1|Withdrawal by Subject|3|||
162990753|NCT03400943|588669135|FG003|Treatment Period 1|Withdrawal by Subject|1|||
162990754|NCT03400943|588669132|FG000|Treatment Period 1|Other|2|||
162990755|NCT03400943|588669133|FG001|Treatment Period 1|Other|1|||
162990756|NCT03400943|588669134|FG002|Treatment Period 1|Other|2|||
162990757|NCT03400943|588669135|FG003|Treatment Period 1|Other|2|||
162990758|NCT03400943|588669132|FG000|Post-treatment Period 1|Adverse Event|2|||
162990759|NCT03400943|588669133|FG001|Post-treatment Period 1|Adverse Event|0|||
162990760|NCT03400943|588669134|FG002|Post-treatment Period 1|Adverse Event|0|||
162990761|NCT03400943|588669135|FG003|Post-treatment Period 1|Adverse Event|0|||
162990762|NCT03400943|588669132|FG000|Post-treatment Period 1|Protocol Violation|1|||
162990763|NCT03400943|588669133|FG001|Post-treatment Period 1|Protocol Violation|0|||
162990764|NCT03400943|588669134|FG002|Post-treatment Period 1|Protocol Violation|0|||
162990765|NCT03400943|588669135|FG003|Post-treatment Period 1|Protocol Violation|0|||
162990766|NCT03400943|588669132|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
162990767|NCT03400943|588669133|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
162990768|NCT03400943|588669134|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
162990769|NCT03400943|588669135|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
162990770|NCT03400943|588669132|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
162990771|NCT03400943|588669133|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
162990772|NCT03400943|588669134|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
162990773|NCT03400943|588669135|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
162990774|NCT03400943|588669132|FG000|Post-treatment Period 1|Other|2|||
162990775|NCT03400943|588669133|FG001|Post-treatment Period 1|Other|0|||
162990776|NCT03400943|588669134|FG002|Post-treatment Period 1|Other|4|||
162990777|NCT03400943|588669135|FG003|Post-treatment Period 1|Other|5|||
162990778|NCT03400943|588669132|FG000|Treatment Period 2|Study terminated by sponsor|0|||
162990779|NCT03400943|588669133|FG001|Treatment Period 2|Study terminated by sponsor|1|||
162990780|NCT03400943|588669134|FG002|Treatment Period 2|Study terminated by sponsor|0|||
162990781|NCT03400943|588669135|FG003|Treatment Period 2|Study terminated by sponsor|0|||
162990782|NCT03400943|588669132|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162990783|NCT03400943|588669133|FG001|Treatment Period 2|Withdrawal by Subject|1|||
162990784|NCT03400943|588669134|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162990785|NCT03400943|588669135|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162990786|NCT03400943|588669132|FG000|Treatment Period 2|Other|1|||
162990787|NCT03400943|588669133|FG001|Treatment Period 2|Other|6|||
162990788|NCT03400943|588669134|FG002|Treatment Period 2|Other|0|||
162990789|NCT03400943|588669135|FG003|Treatment Period 2|Other|0|||
162990790|NCT03400943|588669132|FG000|Follow-up Period|Withdrawal by Subject|1|||
162990791|NCT03400943|588669133|FG001|Follow-up Period|Withdrawal by Subject|0|||
162990792|NCT03400943|588669134|FG002|Follow-up Period|Withdrawal by Subject|0|||
162990793|NCT03400943|588669135|FG003|Follow-up Period|Withdrawal by Subject|0|||
162990794|NCT01085734|588669136|FG000|Overall Study|Adverse Event|0|||
162990795|NCT01085734|588669137|FG001|Overall Study|Adverse Event|2|||
162990796|NCT01085734|588669136|FG000|Overall Study|Death|1|||
162990797|NCT01085734|588669137|FG001|Overall Study|Death|0|||
162990798|NCT01085734|588669136|FG000|Overall Study|Lost to Follow-up|0|||
162990799|NCT01085734|588669137|FG001|Overall Study|Lost to Follow-up|1|||
162990800|NCT01085734|588669136|FG000|Overall Study|Withdrawal by Subject|0|||
162990801|NCT01085734|588669137|FG001|Overall Study|Withdrawal by Subject|1|||
162990802|NCT02045147|588669140|FG000|Overall Study|Withdrawal by Subject|2|||
162990803|NCT02045147|588669141|FG001|Overall Study|Withdrawal by Subject|0|||
162990804|NCT02045147|588669142|FG002|Overall Study|Withdrawal by Subject|0|||
162990805|NCT02045147|588669143|FG003|Overall Study|Withdrawal by Subject|0|||
162990806|NCT02045147|588669144|FG004|Overall Study|Withdrawal by Subject|0|||
162990807|NCT02045147|588669145|FG005|Overall Study|Withdrawal by Subject|0|||
162990808|NCT02045147|588669146|FG006|Overall Study|Withdrawal by Subject|0|||
162990809|NCT02045147|588669147|FG007|Overall Study|Withdrawal by Subject|1|||
162990810|NCT02045147|588669140|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
162990811|NCT02045147|588669141|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
162990812|NCT02045147|588669142|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
162990813|NCT02045147|588669143|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
162990814|NCT02045147|588669144|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
162990815|NCT02045147|588669145|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
162990816|NCT02045147|588669146|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
162990817|NCT02045147|588669147|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
162990818|NCT00049530|588669148|FG000|Overall Study|Lack of Efficacy|25|||
162990819|NCT00049530|588669148|FG000|Overall Study|Adverse Event|2|||
162990820|NCT00049530|588669148|FG000|Overall Study|Death|1|||
162990821|NCT00049530|588669148|FG000|Overall Study|symptomatic deterioration|1|||
162990822|NCT00049530|588669148|FG000|Overall Study|ineligible|3|||
162990823|NCT00849186|588669152|FG000|Overall Study|Adverse Event|2|||
162990824|NCT00849186|588669152|FG000|Overall Study|Withdrawal by Subject|1|||
162990825|NCT00849186|588669152|FG000|Overall Study|not treated|6|||
162990826|NCT00849186|588669152|FG000|Overall Study|Other|1|||
162990827|NCT00936897|588669155|FG000|Overall Study|Withdrawal by Subject|9|||
162990828|NCT00936897|588669156|FG001|Overall Study|Withdrawal by Subject|19|||
162990829|NCT00936897|588669155|FG000|Overall Study|Adverse Event|4|||
162990830|NCT00936897|588669156|FG001|Overall Study|Adverse Event|13|||
162990831|NCT00936897|588669155|FG000|Overall Study|Other|3|||
162990832|NCT00936897|588669156|FG001|Overall Study|Other|9|||
162990833|NCT00936897|588669155|FG000|Overall Study|Lost to Follow-up|1|||
162990834|NCT00936897|588669156|FG001|Overall Study|Lost to Follow-up|10|||
162990835|NCT00936897|588669155|FG000|Overall Study|Administrative Decision|1|||
162990836|NCT00936897|588669156|FG001|Overall Study|Administrative Decision|2|||
162990837|NCT00936897|588669155|FG000|Overall Study|Protocol Violation|1|||
162990838|NCT00936897|588669156|FG001|Overall Study|Protocol Violation|1|||
162990839|NCT00936897|588669155|FG000|Overall Study|Ineligibility Determined|0|||
162990840|NCT00936897|588669156|FG001|Overall Study|Ineligibility Determined|3|||
162990841|NCT00936897|588669155|FG000|Overall Study|Noncompliance|0|||
162990842|NCT00936897|588669156|FG001|Overall Study|Noncompliance|2|||
162990843|NCT00936897|588669155|FG000|Overall Study|Death|0|||
162990844|NCT00936897|588669156|FG001|Overall Study|Death|1|||
162990845|NCT00417170|588669157|FG000|Overall Study|Adverse Event|1|||
162990846|NCT00417170|588669158|FG001|Overall Study|Adverse Event|1|||
162990847|NCT00417170|588669157|FG000|Overall Study|Withdrawal by Subject|1|||
162990848|NCT00417170|588669158|FG001|Overall Study|Withdrawal by Subject|1|||
162990849|NCT00417170|588669157|FG000|Overall Study|Lost to Follow-up|0|||
162990850|NCT00417170|588669158|FG001|Overall Study|Lost to Follow-up|1|||
162990851|NCT04058067|588669159|FG000|Overall Study|Adverse Event|2|||
162990852|NCT04058067|588669160|FG001|Overall Study|Adverse Event|0|||
162990853|NCT04058067|588669159|FG000|Overall Study|Death|0|||
162990854|NCT04058067|588669160|FG001|Overall Study|Death|1|||
162990855|NCT04058067|588669159|FG000|Overall Study|Physician Decision|3|||
162990856|NCT04058067|588669160|FG001|Overall Study|Physician Decision|1|||
162990857|NCT04058067|588669159|FG000|Overall Study|Protocol Violation|0|||
162990858|NCT04058067|588669160|FG001|Overall Study|Protocol Violation|1|||
162990859|NCT04058067|588669159|FG000|Overall Study|Withdrawal by Subject|7|||
162990860|NCT04058067|588669160|FG001|Overall Study|Withdrawal by Subject|8|||
162990861|NCT01001988|588669163|FG000|Overall Study|Protocol Violation|84|||
162990862|NCT01001988|588669163|FG000|Overall Study|Withdrawal by Subject|18|||
162990863|NCT01001988|588669163|FG000|Overall Study|Lost to Follow-up|15|||
162990864|NCT04628793|588669164|FG000|Overall Study|Study terminated by sponsor|0|||
162990865|NCT04628793|588669165|FG001|Overall Study|Study terminated by sponsor|0|||
162990866|NCT04628793|588669166|FG002|Overall Study|Study terminated by sponsor|8|||
162990867|NCT04628793|588669164|FG000|Overall Study|Withdrawal by Subject|2|||
162990868|NCT04628793|588669165|FG001|Overall Study|Withdrawal by Subject|3|||
162990869|NCT04628793|588669166|FG002|Overall Study|Withdrawal by Subject|0|||
162990870|NCT04628793|588669164|FG000|Overall Study|Lost to Follow-up|0|||
162990871|NCT04628793|588669165|FG001|Overall Study|Lost to Follow-up|1|||
162990872|NCT04628793|588669166|FG002|Overall Study|Lost to Follow-up|0|||
162990873|NCT01329549|588669173|FG000|Overall Study|Withdrawal by Subject|1|||
162990874|NCT01329549|588669173|FG000|Overall Study|Adverse Event|1|||
162990875|NCT00191165|588669174|FG000|Overall Study|Adverse Event|2|||
162990876|NCT00191165|588669175|FG001|Overall Study|Adverse Event|0|||
162990877|NCT00191165|588669174|FG000|Overall Study|Protocol Violation|0|||
162990878|NCT00191165|588669175|FG001|Overall Study|Protocol Violation|1|||
162990879|NCT00191165|588669174|FG000|Overall Study|Participant Moved Away|0|||
162990880|NCT00191165|588669175|FG001|Overall Study|Participant Moved Away|1|||
162990881|NCT03200912|588669176|FG000|Overall Study|Adverse Event|3|||
162990882|NCT03200912|588669177|FG001|Overall Study|Adverse Event|0|||
162990883|NCT03200912|588669178|FG002|Overall Study|Adverse Event|0|||
162990884|NCT03200912|588669176|FG000|Overall Study|Withdrawal by Subject|1|||
162990885|NCT03200912|588669177|FG001|Overall Study|Withdrawal by Subject|2|||
162990886|NCT03200912|588669178|FG002|Overall Study|Withdrawal by Subject|4|||
162990887|NCT03200912|588669176|FG000|Overall Study|Non-compliance with study drug|0|||
162990888|NCT03200912|588669177|FG001|Overall Study|Non-compliance with study drug|1|||
162990889|NCT03200912|588669178|FG002|Overall Study|Non-compliance with study drug|0|||
162990890|NCT03421730|588669181|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990891|NCT03421730|588669182|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
162990892|NCT03421730|588669183|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990893|NCT03421730|588669184|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990894|NCT03421730|588669185|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990895|NCT03421730|588669186|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990896|NCT03421730|588669187|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990897|NCT03421730|588669188|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990898|NCT03421730|588669189|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990899|NCT03421730|588669190|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990900|NCT03421730|588669191|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990901|NCT03421730|588669192|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990902|NCT03421730|588669181|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990903|NCT03421730|588669182|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990904|NCT03421730|588669183|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990905|NCT03421730|588669184|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990906|NCT03421730|588669185|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
162990907|NCT03421730|588669186|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990908|NCT03421730|588669187|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990909|NCT03421730|588669188|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990910|NCT03421730|588669189|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990911|NCT03421730|588669190|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990912|NCT03421730|588669191|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990913|NCT03421730|588669192|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990914|NCT01661062|588669199|FG000|Overall Study|Completed Treatment Off Study|3|||
162990915|NCT01661062|588669199|FG000|Overall Study|Withdrawal by Subject|2|||
162990916|NCT02238795|588669200|FG000|Overall Study|Patient without purpura fulminans|1|||
162990917|NCT01096368|588669202|FG000|Overall Study|Death|0|||
162990918|NCT01096368|588669203|FG001|Overall Study|Death|1|||
162990919|NCT01096368|588669204|FG002|Overall Study|Death|0|||
162990920|NCT01096368|588669205|FG003|Overall Study|Death|0|||
162990921|NCT01096368|588669206|FG004|Overall Study|Death|0|||
162990922|NCT01096368|588669202|FG000|Overall Study|Physician Decision|0|||
162990923|NCT01096368|588669203|FG001|Overall Study|Physician Decision|13|||
162990924|NCT01096368|588669204|FG002|Overall Study|Physician Decision|2|||
162990925|NCT01096368|588669205|FG003|Overall Study|Physician Decision|4|||
162990926|NCT01096368|588669206|FG004|Overall Study|Physician Decision|6|||
162990927|NCT01096368|588669202|FG000|Overall Study|Withdrawal by Subject|0|||
162990928|NCT01096368|588669203|FG001|Overall Study|Withdrawal by Subject|52|||
162990929|NCT01096368|588669204|FG002|Overall Study|Withdrawal by Subject|0|||
162990930|NCT01096368|588669205|FG003|Overall Study|Withdrawal by Subject|10|||
162990931|NCT01096368|588669206|FG004|Overall Study|Withdrawal by Subject|14|||
162990932|NCT01096368|588669202|FG000|Overall Study|Ineligible|0|||
162990933|NCT01096368|588669203|FG001|Overall Study|Ineligible|3|||
162990934|NCT01096368|588669204|FG002|Overall Study|Ineligible|2|||
162990935|NCT01096368|588669205|FG003|Overall Study|Ineligible|0|||
162990936|NCT01096368|588669206|FG004|Overall Study|Ineligible|25|||
162990937|NCT01096368|588669202|FG000|Overall Study|Did not start treatment|0|||
162990938|NCT01096368|588669203|FG001|Overall Study|Did not start treatment|4|||
162990939|NCT01096368|588669204|FG002|Overall Study|Did not start treatment|4|||
162990940|NCT01096368|588669205|FG003|Overall Study|Did not start treatment|0|||
162990941|NCT01096368|588669206|FG004|Overall Study|Did not start treatment|0|||
162990942|NCT01096368|588669202|FG000|Overall Study|Progressive disease|0|||
162990943|NCT01096368|588669203|FG001|Overall Study|Progressive disease|6|||
162990944|NCT01096368|588669204|FG002|Overall Study|Progressive disease|0|||
162990945|NCT01096368|588669205|FG003|Overall Study|Progressive disease|10|||
162990946|NCT01096368|588669206|FG004|Overall Study|Progressive disease|3|||
162990947|NCT01096368|588669202|FG000|Overall Study|Other|0|||
162990948|NCT01096368|588669203|FG001|Overall Study|Other|0|||
162990949|NCT01096368|588669204|FG002|Overall Study|Other|1|||
162990950|NCT01096368|588669205|FG003|Overall Study|Other|0|||
162990951|NCT01096368|588669206|FG004|Overall Study|Other|0|||
162990952|NCT01096368|588669202|FG000|Overall Study|Treated with institutional review|0|||
162990953|NCT01096368|588669203|FG001|Overall Study|Treated with institutional review|0|||
162990954|NCT01096368|588669204|FG002|Overall Study|Treated with institutional review|0|||
162990955|NCT01096368|588669205|FG003|Overall Study|Treated with institutional review|0|||
162990956|NCT01096368|588669206|FG004|Overall Study|Treated with institutional review|1|||
162990957|NCT00407758|588669221|FG000|Overall Study|ineligible -improper prior treatment|1|||
162990958|NCT00750308|588669234|FG000|First Treatment|Adverse Event|0|||
162990959|NCT00750308|588669235|FG001|First Treatment|Adverse Event|1|||
162990960|NCT00750308|588669236|FG002|First Treatment|Adverse Event|0|||
162990961|NCT00750308|588669237|FG003|First Treatment|Adverse Event|0|||
162990962|NCT00750308|588669238|FG004|First Treatment|Adverse Event|0|||
162990963|NCT00750308|588669239|FG005|First Treatment|Adverse Event|0|||
163212340|NCT00312494|589492466|FG001|Overall Study|Withdrawal by Subject|9|||
163212341|NCT00312494|589492467|FG002|Overall Study|Withdrawal by Subject|10|||
163212342|NCT00312494|589492465|FG000|Overall Study|Other|10|||
163212343|NCT00312494|589492466|FG001|Overall Study|Other|10|||
163212344|NCT00312494|589492467|FG002|Overall Study|Other|1|||
163212345|NCT00488345|589492468|FG000|Overall Study|Adverse Event|0|||
163212346|NCT00488345|589492469|FG001|Overall Study|Adverse Event|1|||
163212347|NCT00488345|589492470|FG002|Overall Study|Adverse Event|1|||
163212348|NCT00488345|589492468|FG000|Overall Study|Unable to administer antibiotics at home|0|||
163212349|NCT00488345|589492469|FG001|Overall Study|Unable to administer antibiotics at home|1|||
163212350|NCT00488345|589492470|FG002|Overall Study|Unable to administer antibiotics at home|0|||
163212351|NCT00488345|589492468|FG000|Overall Study|Institutional Review Board review|0|||
163212352|NCT00488345|589492469|FG001|Overall Study|Institutional Review Board review|0|||
163212353|NCT00488345|589492470|FG002|Overall Study|Institutional Review Board review|1|||
163212354|NCT00488345|589492468|FG000|Overall Study|Surgical team recommendation|0|||
163212355|NCT00488345|589492469|FG001|Overall Study|Surgical team recommendation|1|||
163212356|NCT00488345|589492470|FG002|Overall Study|Surgical team recommendation|0|||
163212357|NCT00488345|589492468|FG000|Overall Study|Parent/legal guardian request|0|||
163212358|NCT00488345|589492469|FG001|Overall Study|Parent/legal guardian request|1|||
163212359|NCT00488345|589492470|FG002|Overall Study|Parent/legal guardian request|1|||
163212360|NCT01585428|589492473|FG000|Overall Study|Death during treatment|1|||
163212361|NCT01585428|589492474|FG001|Overall Study|Death during treatment|0|||
163212362|NCT02057198|589492477|FG000|Overall Study|Death|0|||
163212363|NCT02057198|589492478|FG001|Overall Study|Death|0|||
163212364|NCT02057198|589492479|FG002|Overall Study|Death|1|||
163212365|NCT02057198|589492477|FG000|Overall Study|Discharged early; lost to followup|0|||
163212366|NCT02057198|589492478|FG001|Overall Study|Discharged early; lost to followup|1|||
162990964|NCT00750308|588669240|FG006|First Treatment|Adverse Event|0|||
162990965|NCT00750308|588669241|FG007|First Treatment|Adverse Event|0|||
162990966|NCT00750308|588669242|FG008|First Treatment|Adverse Event|0|||
162990967|NCT00750308|588669243|FG009|First Treatment|Adverse Event|0|||
162990968|NCT00750308|588669244|FG010|First Treatment|Adverse Event|1|||
162990969|NCT00750308|588669245|FG011|First Treatment|Adverse Event|1|||
162990970|NCT00750308|588669234|FG000|First Treatment|Withdrawal by Subject|0|||
162990971|NCT00750308|588669235|FG001|First Treatment|Withdrawal by Subject|0|||
162990972|NCT00750308|588669236|FG002|First Treatment|Withdrawal by Subject|0|||
162990973|NCT00750308|588669237|FG003|First Treatment|Withdrawal by Subject|1|||
163212367|NCT02057198|589492479|FG002|Overall Study|Discharged early; lost to followup|0|||
163212368|NCT00065507|589492481|FG000|Overall Study|Death|16|||
163212369|NCT00065507|589492482|FG001|Overall Study|Death|17|||
163212370|NCT00065507|589492481|FG000|Overall Study|Adverse Event|4|||
163212371|NCT00065507|589492482|FG001|Overall Study|Adverse Event|3|||
163324586|NCT00357682|589900658|FG003|Overall Study|Lost to Follow-up|35|||
163324587|NCT00357682|589900655|FG000|Overall Study|Adverse Event|24|||
163324588|NCT00357682|589900656|FG001|Overall Study|Adverse Event|32|||
162990974|NCT00750308|588669238|FG004|First Treatment|Withdrawal by Subject|0|||
163212372|NCT00065507|589492481|FG000|Overall Study|Lack of Efficacy|0|||
163212373|NCT00065507|589492482|FG001|Overall Study|Lack of Efficacy|6|||
163212374|NCT00065507|589492481|FG000|Overall Study|Poor/Non-compliance|3|||
162990975|NCT00750308|588669239|FG005|First Treatment|Withdrawal by Subject|0|||
162990976|NCT00750308|588669240|FG006|First Treatment|Withdrawal by Subject|0|||
162990977|NCT00750308|588669241|FG007|First Treatment|Withdrawal by Subject|1|||
163212375|NCT00065507|589492482|FG001|Overall Study|Poor/Non-compliance|2|||
163212376|NCT00065507|589492481|FG000|Overall Study|Lost to Follow-up|3|||
163212377|NCT00065507|589492482|FG001|Overall Study|Lost to Follow-up|0|||
163324589|NCT00357682|589900657|FG002|Overall Study|Adverse Event|22|||
162990978|NCT00750308|588669242|FG008|First Treatment|Withdrawal by Subject|0|||
162990979|NCT00750308|588669243|FG009|First Treatment|Withdrawal by Subject|0|||
162990980|NCT00750308|588669244|FG010|First Treatment|Withdrawal by Subject|0|||
162990981|NCT00750308|588669245|FG011|First Treatment|Withdrawal by Subject|0|||
162990982|NCT00750308|588669234|FG000|Second Treatment|Adverse Event|0|||
162990983|NCT00750308|588669235|FG001|Second Treatment|Adverse Event|0|||
162990984|NCT00750308|588669236|FG002|Second Treatment|Adverse Event|0|||
162990985|NCT00750308|588669237|FG003|Second Treatment|Adverse Event|0|||
162990986|NCT00750308|588669238|FG004|Second Treatment|Adverse Event|0|||
162990987|NCT00750308|588669239|FG005|Second Treatment|Adverse Event|1|||
162990988|NCT00750308|588669240|FG006|Second Treatment|Adverse Event|0|||
162990989|NCT00750308|588669241|FG007|Second Treatment|Adverse Event|0|||
162990990|NCT00750308|588669242|FG008|Second Treatment|Adverse Event|1|||
162990991|NCT00750308|588669243|FG009|Second Treatment|Adverse Event|0|||
162990992|NCT00750308|588669244|FG010|Second Treatment|Adverse Event|0|||
162990993|NCT00750308|588669245|FG011|Second Treatment|Adverse Event|0|||
162990994|NCT00750308|588669234|FG000|Second Treatment|Withdrawal by Subject|0|||
162990995|NCT00750308|588669235|FG001|Second Treatment|Withdrawal by Subject|0|||
162990996|NCT00750308|588669236|FG002|Second Treatment|Withdrawal by Subject|0|||
162990997|NCT00750308|588669237|FG003|Second Treatment|Withdrawal by Subject|0|||
162990998|NCT00750308|588669238|FG004|Second Treatment|Withdrawal by Subject|1|||
162990999|NCT00750308|588669239|FG005|Second Treatment|Withdrawal by Subject|0|||
162991000|NCT00750308|588669240|FG006|Second Treatment|Withdrawal by Subject|0|||
162991001|NCT00750308|588669241|FG007|Second Treatment|Withdrawal by Subject|0|||
162991002|NCT00750308|588669242|FG008|Second Treatment|Withdrawal by Subject|0|||
162991003|NCT00750308|588669243|FG009|Second Treatment|Withdrawal by Subject|0|||
162991004|NCT00750308|588669244|FG010|Second Treatment|Withdrawal by Subject|0|||
162991005|NCT00750308|588669245|FG011|Second Treatment|Withdrawal by Subject|0|||
162991006|NCT00750308|588669234|FG000|Third Treatment|Withdrawal by Subject|0|||
162991007|NCT00750308|588669235|FG001|Third Treatment|Withdrawal by Subject|1|||
162991008|NCT00750308|588669236|FG002|Third Treatment|Withdrawal by Subject|0|||
162991009|NCT00750308|588669237|FG003|Third Treatment|Withdrawal by Subject|0|||
162991010|NCT00750308|588669238|FG004|Third Treatment|Withdrawal by Subject|0|||
162991011|NCT00750308|588669239|FG005|Third Treatment|Withdrawal by Subject|0|||
162991012|NCT00750308|588669240|FG006|Third Treatment|Withdrawal by Subject|0|||
162991013|NCT00750308|588669241|FG007|Third Treatment|Withdrawal by Subject|0|||
162991014|NCT00750308|588669242|FG008|Third Treatment|Withdrawal by Subject|0|||
162991015|NCT00750308|588669243|FG009|Third Treatment|Withdrawal by Subject|0|||
162991016|NCT00750308|588669244|FG010|Third Treatment|Withdrawal by Subject|0|||
162991017|NCT00750308|588669245|FG011|Third Treatment|Withdrawal by Subject|0|||
162991018|NCT02980874|588669246|FG000|Overall Study|Adverse Event|2|||
162991019|NCT02980874|588669247|FG001|Overall Study|Adverse Event|7|||
162991020|NCT02980874|588669246|FG000|Overall Study|Withdrawal by Subject|7|||
162991021|NCT02980874|588669247|FG001|Overall Study|Withdrawal by Subject|2|||
162991022|NCT02980874|588669246|FG000|Overall Study|Lost to Follow-up|5|||
162991023|NCT02980874|588669247|FG001|Overall Study|Lost to Follow-up|5|||
162991024|NCT02980874|588669246|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
162991025|NCT02980874|588669247|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
162991026|NCT02980874|588669246|FG000|Overall Study|Unknown study completion status|1|||
162991027|NCT02980874|588669247|FG001|Overall Study|Unknown study completion status|0|||
162991028|NCT02450526|588669248|FG000|DB Period (Cycle 1)|Adverse Event|0|||
162991029|NCT02450526|588669249|FG001|DB Period (Cycle 1)|Adverse Event|0|||
162991030|NCT02450526|588669250|FG002|DB Period (Cycle 1)|Adverse Event|2|||
162991031|NCT02450526|588669251|FG003|DB Period (Cycle 1)|Adverse Event|0|||
162991032|NCT02450526|588669252|FG004|DB Period (Cycle 1)|Adverse Event|0|||
162991033|NCT02450526|588669248|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
162991034|NCT02450526|588669249|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
162991035|NCT02450526|588669250|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
162991036|NCT02450526|588669251|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
162991037|NCT02450526|588669252|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
162991038|NCT02450526|588669248|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
162991039|NCT02450526|588669249|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
162991040|NCT02450526|588669250|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
162991041|NCT02450526|588669251|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
162991042|NCT02450526|588669252|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
162991043|NCT02450526|588669248|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
162991044|NCT02450526|588669249|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
162991045|NCT02450526|588669250|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
162991046|NCT02450526|588669251|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
162991047|NCT02450526|588669252|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
162991048|NCT02450526|588669248|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
162991049|NCT02450526|588669249|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
162991050|NCT02450526|588669250|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
162991051|NCT02450526|588669251|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
162991052|NCT02450526|588669252|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
162991053|NCT02450526|588669248|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
162991054|NCT02450526|588669249|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
162991055|NCT02450526|588669250|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
162991056|NCT02450526|588669251|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
162991057|NCT02450526|588669252|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
162991058|NCT02450526|588669248|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
162991059|NCT02450526|588669249|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
162991060|NCT02450526|588669250|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
162991061|NCT02450526|588669251|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
162991062|NCT02450526|588669252|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
162991063|NCT02450526|588669248|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
162991064|NCT02450526|588669249|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
162991065|NCT02450526|588669250|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
162991066|NCT02450526|588669251|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
163324590|NCT00357682|589900658|FG003|Overall Study|Adverse Event|27|||
163324591|NCT00357682|589900655|FG000|Overall Study|Physician Decision|32|||
163324592|NCT00357682|589900656|FG001|Overall Study|Physician Decision|20|||
163324593|NCT00357682|589900657|FG002|Overall Study|Physician Decision|24|||
163324594|NCT00357682|589900658|FG003|Overall Study|Physician Decision|30|||
162991067|NCT02450526|588669252|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
162991068|NCT00911807|588669253|FG000|Overall Study|Adverse Event|2|||
162991069|NCT00911807|588669254|FG001|Overall Study|Adverse Event|1|||
162991070|NCT00911807|588669255|FG002|Overall Study|Adverse Event|5|||
162991071|NCT00911807|588669253|FG000|Overall Study|Death|0|||
162991072|NCT00911807|588669254|FG001|Overall Study|Death|0|||
162991073|NCT00911807|588669255|FG002|Overall Study|Death|1|||
162991074|NCT00911807|588669253|FG000|Overall Study|Protocol Violation|6|||
162991075|NCT00911807|588669254|FG001|Overall Study|Protocol Violation|4|||
162991076|NCT00911807|588669255|FG002|Overall Study|Protocol Violation|9|||
162991077|NCT00911807|588669253|FG000|Overall Study|Withdrawal by Subject|8|||
162991078|NCT00911807|588669254|FG001|Overall Study|Withdrawal by Subject|10|||
162991079|NCT00911807|588669255|FG002|Overall Study|Withdrawal by Subject|7|||
162991080|NCT00911807|588669253|FG000|Overall Study|Organizational reasons|1|||
162991081|NCT00911807|588669254|FG001|Overall Study|Organizational reasons|3|||
162991082|NCT00911807|588669255|FG002|Overall Study|Organizational reasons|1|||
162991083|NCT00855803|588669257|FG000|Overall Study|Death|2|||
162991084|NCT00855803|588669257|FG000|Overall Study|Lost to Follow-up|2|||
162991085|NCT00855803|588669257|FG000|Overall Study|Technical inability to undergo procedure|2|||
162991086|NCT00855803|588669257|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
162991087|NCT00855803|588669257|FG000|Overall Study|Withdrawal by Subject|3|||
162991088|NCT00855803|588669257|FG000|Overall Study|Physician Decision|3|||
162991089|NCT00809159|588669258|FG000|Part 1|Adverse Event|1|||
162991090|NCT00809159|588669259|FG001|Part 1|Adverse Event|1|||
162991091|NCT00809159|588669260|FG002|Part 1|Adverse Event|0|||
162991092|NCT00809159|588669261|FG003|Part 1|Adverse Event|0|||
162991093|NCT00809159|588669262|FG004|Part 1|Adverse Event|0|||
162991094|NCT00809159|588669263|FG005|Part 1|Adverse Event|0|||
162991095|NCT00809159|588669258|FG000|Part 1|Lost to Follow-up|1|||
162991096|NCT00809159|588669259|FG001|Part 1|Lost to Follow-up|0|||
162991097|NCT00809159|588669260|FG002|Part 1|Lost to Follow-up|0|||
162991098|NCT00809159|588669261|FG003|Part 1|Lost to Follow-up|0|||
162991099|NCT00809159|588669262|FG004|Part 1|Lost to Follow-up|0|||
162991100|NCT00809159|588669263|FG005|Part 1|Lost to Follow-up|0|||
162991101|NCT00809159|588669258|FG000|Part 1|Withdrawal by Subject|3|||
162991102|NCT00809159|588669259|FG001|Part 1|Withdrawal by Subject|1|||
162991103|NCT00809159|588669260|FG002|Part 1|Withdrawal by Subject|0|||
162991104|NCT00809159|588669261|FG003|Part 1|Withdrawal by Subject|0|||
162991105|NCT00809159|588669262|FG004|Part 1|Withdrawal by Subject|0|||
162991106|NCT00809159|588669263|FG005|Part 1|Withdrawal by Subject|0|||
162991107|NCT00809159|588669258|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
162991108|NCT00809159|588669259|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
162991109|NCT00809159|588669260|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
162991110|NCT00809159|588669261|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
163324595|NCT00357682|589900655|FG000|Overall Study|Patient decision|73|||
163324596|NCT00357682|589900656|FG001|Overall Study|Patient decision|80|||
162991111|NCT00809159|588669262|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
163324597|NCT00357682|589900657|FG002|Overall Study|Patient decision|51|||
162991112|NCT00809159|588669263|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
162991113|NCT00809159|588669258|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
163324598|NCT00357682|589900658|FG003|Overall Study|Patient decision|59|||
162991114|NCT00809159|588669259|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
163324599|NCT00357682|589900655|FG000|Overall Study|Other reason|157|||
162991115|NCT00809159|588669260|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
162991116|NCT00809159|588669261|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
162991117|NCT00809159|588669262|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
162991118|NCT00809159|588669263|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
162991119|NCT00809159|588669258|FG000|Part 1 and 2|Administrative problems|0|||
162991120|NCT00809159|588669259|FG001|Part 1 and 2|Administrative problems|0|||
162991121|NCT00809159|588669260|FG002|Part 1 and 2|Administrative problems|0|||
162991122|NCT00809159|588669261|FG003|Part 1 and 2|Administrative problems|1|||
162991123|NCT00809159|588669262|FG004|Part 1 and 2|Administrative problems|0|||
162991124|NCT00809159|588669263|FG005|Part 1 and 2|Administrative problems|0|||
162991125|NCT00809159|588669258|FG000|Part 1 and 2|Adverse Event|0|||
162991126|NCT00809159|588669259|FG001|Part 1 and 2|Adverse Event|0|||
162991127|NCT00809159|588669260|FG002|Part 1 and 2|Adverse Event|1|||
162991128|NCT00809159|588669261|FG003|Part 1 and 2|Adverse Event|0|||
162991129|NCT00809159|588669262|FG004|Part 1 and 2|Adverse Event|1|||
162991130|NCT00809159|588669263|FG005|Part 1 and 2|Adverse Event|1|||
162991131|NCT00809159|588669258|FG000|Part 1 and 2|Lost to Follow-up|0|||
162991132|NCT00809159|588669259|FG001|Part 1 and 2|Lost to Follow-up|0|||
162991133|NCT00809159|588669260|FG002|Part 1 and 2|Lost to Follow-up|1|||
162991134|NCT00809159|588669261|FG003|Part 1 and 2|Lost to Follow-up|1|||
162991135|NCT00809159|588669262|FG004|Part 1 and 2|Lost to Follow-up|0|||
162991136|NCT00809159|588669263|FG005|Part 1 and 2|Lost to Follow-up|0|||
162991137|NCT00809159|588669258|FG000|Part 1 and 2|Withdrawal by Subject|0|||
162991138|NCT00809159|588669259|FG001|Part 1 and 2|Withdrawal by Subject|0|||
162991139|NCT00809159|588669260|FG002|Part 1 and 2|Withdrawal by Subject|4|||
162991140|NCT00809159|588669261|FG003|Part 1 and 2|Withdrawal by Subject|0|||
162991141|NCT00809159|588669262|FG004|Part 1 and 2|Withdrawal by Subject|0|||
162991142|NCT00809159|588669263|FG005|Part 1 and 2|Withdrawal by Subject|1|||
162991143|NCT03918109|588669268|FG000|Overall Study|Withdrawal by Subject|0|||
162991144|NCT03918109|588669269|FG001|Overall Study|Withdrawal by Subject|0|||
162991145|NCT03918109|588669270|FG002|Overall Study|Withdrawal by Subject|2|||
162991146|NCT03918109|588669271|FG003|Overall Study|Withdrawal by Subject|1|||
163324600|NCT00357682|589900656|FG001|Overall Study|Other reason|130|||
163324601|NCT00357682|589900657|FG002|Overall Study|Other reason|114|||
163324602|NCT00357682|589900658|FG003|Overall Study|Other reason|99|||
162991147|NCT03918109|588669268|FG000|Overall Study|Lost to Follow-up|0|||
162991148|NCT03918109|588669269|FG001|Overall Study|Lost to Follow-up|0|||
162991149|NCT03918109|588669270|FG002|Overall Study|Lost to Follow-up|0|||
162991150|NCT03918109|588669271|FG003|Overall Study|Lost to Follow-up|1|||
162991151|NCT03050060|588669276|FG000|Overall Study|Adverse Event|7|||
162991152|NCT03050060|588669276|FG000|Overall Study|Withdrawal by Subject|1|||
162991153|NCT03050060|588669276|FG000|Overall Study|Progression|7|||
162991154|NCT04568031|588669277|FG000|Overall Study|Lost to Follow-up|1|||
162991155|NCT04568031|588669278|FG001|Overall Study|Lost to Follow-up|0|||
162991156|NCT04568031|588669279|FG002|Overall Study|Lost to Follow-up|0|||
162991157|NCT04568031|588669280|FG003|Overall Study|Lost to Follow-up|0|||
162991158|NCT04568031|588669277|FG000|Overall Study|Physician Decision|1|||
162991159|NCT04568031|588669278|FG001|Overall Study|Physician Decision|0|||
162991160|NCT04568031|588669279|FG002|Overall Study|Physician Decision|1|||
162991161|NCT04568031|588669280|FG003|Overall Study|Physician Decision|0|||
162991162|NCT04568031|588669277|FG000|Overall Study|Withdrawal by Subject|1|||
162991163|NCT04568031|588669278|FG001|Overall Study|Withdrawal by Subject|0|||
162991164|NCT04568031|588669279|FG002|Overall Study|Withdrawal by Subject|4|||
162991165|NCT04568031|588669280|FG003|Overall Study|Withdrawal by Subject|1|||
162991166|NCT02304458|588669281|FG000|Overall Study|Adverse Event|0|||
162991167|NCT02304458|588669282|FG001|Overall Study|Adverse Event|0|||
162991168|NCT02304458|588669283|FG002|Overall Study|Adverse Event|7|||
162991169|NCT02304458|588669284|FG003|Overall Study|Adverse Event|0|||
162991170|NCT02304458|588669285|FG004|Overall Study|Adverse Event|0|||
162991171|NCT02304458|588669286|FG005|Overall Study|Adverse Event|0|||
162991172|NCT02304458|588669287|FG006|Overall Study|Adverse Event|3|||
162991173|NCT02304458|588669288|FG007|Overall Study|Adverse Event|4|||
162991174|NCT02304458|588669281|FG000|Overall Study|Death|0|||
162991175|NCT02304458|588669282|FG001|Overall Study|Death|0|||
162991176|NCT02304458|588669283|FG002|Overall Study|Death|2|||
162991177|NCT02304458|588669284|FG003|Overall Study|Death|0|||
162991178|NCT02304458|588669285|FG004|Overall Study|Death|0|||
163324603|NCT03660930|589900659|FG000|Overall Study|Adverse Event|0|||
163324604|NCT03660930|589900660|FG001|Overall Study|Adverse Event|0|||
163324605|NCT03660930|589900661|FG002|Overall Study|Adverse Event|0|||
163324606|NCT03660930|589900662|FG003|Overall Study|Adverse Event|2|||
162991179|NCT02304458|588669286|FG005|Overall Study|Death|0|||
162991180|NCT02304458|588669287|FG006|Overall Study|Death|1|||
162991181|NCT02304458|588669288|FG007|Overall Study|Death|0|||
162991182|NCT02304458|588669281|FG000|Overall Study|Lack of Efficacy|4|||
162991183|NCT02304458|588669282|FG001|Overall Study|Lack of Efficacy|6|||
162991184|NCT02304458|588669283|FG002|Overall Study|Lack of Efficacy|38|||
162991185|NCT02304458|588669284|FG003|Overall Study|Lack of Efficacy|5|||
162991186|NCT02304458|588669285|FG004|Overall Study|Lack of Efficacy|6|||
162991187|NCT02304458|588669286|FG005|Overall Study|Lack of Efficacy|6|||
162991188|NCT02304458|588669287|FG006|Overall Study|Lack of Efficacy|21|||
162991189|NCT02304458|588669288|FG007|Overall Study|Lack of Efficacy|4|||
162991190|NCT02304458|588669281|FG000|Overall Study|Physician Decision|2|||
162991191|NCT02304458|588669282|FG001|Overall Study|Physician Decision|0|||
162991192|NCT02304458|588669283|FG002|Overall Study|Physician Decision|16|||
162991193|NCT02304458|588669284|FG003|Overall Study|Physician Decision|1|||
162991194|NCT02304458|588669285|FG004|Overall Study|Physician Decision|0|||
162991195|NCT02304458|588669286|FG005|Overall Study|Physician Decision|0|||
162991196|NCT02304458|588669287|FG006|Overall Study|Physician Decision|3|||
162991197|NCT02304458|588669288|FG007|Overall Study|Physician Decision|0|||
162991198|NCT02304458|588669281|FG000|Overall Study|Protocol Violation|0|||
162991199|NCT02304458|588669282|FG001|Overall Study|Protocol Violation|0|||
162991200|NCT02304458|588669283|FG002|Overall Study|Protocol Violation|1|||
162991201|NCT02304458|588669284|FG003|Overall Study|Protocol Violation|0|||
162991202|NCT02304458|588669285|FG004|Overall Study|Protocol Violation|0|||
162991203|NCT02304458|588669286|FG005|Overall Study|Protocol Violation|0|||
162991204|NCT02304458|588669287|FG006|Overall Study|Protocol Violation|0|||
162991205|NCT02304458|588669288|FG007|Overall Study|Protocol Violation|0|||
162991206|NCT02304458|588669281|FG000|Overall Study|Withdrawal by Subject|1|||
162991207|NCT02304458|588669282|FG001|Overall Study|Withdrawal by Subject|0|||
162991208|NCT02304458|588669283|FG002|Overall Study|Withdrawal by Subject|7|||
162991209|NCT02304458|588669284|FG003|Overall Study|Withdrawal by Subject|0|||
162991210|NCT02304458|588669285|FG004|Overall Study|Withdrawal by Subject|0|||
162991211|NCT02304458|588669286|FG005|Overall Study|Withdrawal by Subject|0|||
162991212|NCT02304458|588669287|FG006|Overall Study|Withdrawal by Subject|1|||
162991213|NCT02304458|588669288|FG007|Overall Study|Withdrawal by Subject|0|||
162991214|NCT00186043|588669289|FG000|Overall Study|Lack of Efficacy|1|||
162991215|NCT00186043|588669290|FG001|Overall Study|Lack of Efficacy|3|||
162991216|NCT00186043|588669289|FG000|Overall Study|Lost to Follow-up|4|||
162991217|NCT00186043|588669290|FG001|Overall Study|Lost to Follow-up|6|||
162991218|NCT00186043|588669289|FG000|Overall Study|Withdrawal by Subject|1|||
162991219|NCT00186043|588669290|FG001|Overall Study|Withdrawal by Subject|0|||
162991220|NCT00186043|588669289|FG000|Overall Study|Adverse Event|7|||
162991221|NCT00186043|588669290|FG001|Overall Study|Adverse Event|3|||
162991222|NCT00186043|588669289|FG000|Overall Study|Protocol Violation|2|||
162991223|NCT00186043|588669290|FG001|Overall Study|Protocol Violation|1|||
162991224|NCT04874636|588669291|FG000|Overall Study|Adverse Event|17|||
162991225|NCT04874636|588669292|FG001|Overall Study|Adverse Event|7|||
162991226|NCT04874636|588669291|FG000|Overall Study|Lost to Follow-up|1|||
162991227|NCT04874636|588669292|FG001|Overall Study|Lost to Follow-up|0|||
162991228|NCT04874636|588669291|FG000|Overall Study|Non-Compliance with Study Drug|2|||
162991229|NCT04874636|588669292|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162991230|NCT04874636|588669291|FG000|Overall Study|Physician Decision|1|||
162991231|NCT04874636|588669292|FG001|Overall Study|Physician Decision|0|||
162991232|NCT04874636|588669291|FG000|Overall Study|Withdrawal by Subject|6|||
162991233|NCT04874636|588669292|FG001|Overall Study|Withdrawal by Subject|5|||
162991234|NCT04188301|588669295|FG000|Month 3|Lost to Follow-up|0|||
162991235|NCT04188301|588669296|FG001|Month 3|Lost to Follow-up|0|||
162991236|NCT04188301|588669297|FG002|Month 3|Lost to Follow-up|1|||
162991237|NCT04188301|588669295|FG000|Month 12|Lost to Follow-up|0|||
162991238|NCT04188301|588669296|FG001|Month 12|Lost to Follow-up|0|||
162991239|NCT04188301|588669297|FG002|Month 12|Lost to Follow-up|2|||
162991240|NCT04188301|588669295|FG000|Month 12|Death|1|||
162991241|NCT04188301|588669296|FG001|Month 12|Death|1|||
162991242|NCT04188301|588669297|FG002|Month 12|Death|0|||
162991243|NCT04188301|588669295|FG000|Month 18|Lost to Follow-up|6|||
162991244|NCT04188301|588669296|FG001|Month 18|Lost to Follow-up|0|||
162991245|NCT04188301|588669297|FG002|Month 18|Lost to Follow-up|0|||
162991246|NCT02582866|588669302|FG000|Overall Study|Death|1|||
162991247|NCT02582866|588669302|FG000|Overall Study|Lack of Efficacy|2|||
162991248|NCT02582866|588669302|FG000|Overall Study|Lost to Follow-up|2|||
162991249|NCT02582866|588669302|FG000|Overall Study|Withdrawal by Subject|7|||
162991250|NCT02582866|588669302|FG000|Overall Study|Investigator decision|5|||
162991251|NCT02582866|588669302|FG000|Overall Study|Participant wants to get pregnant|1|||
162991252|NCT02582866|588669302|FG000|Overall Study|Pregnancy|2|||
162991253|NCT02582866|588669302|FG000|Overall Study|Sponsor decision|1|||
162991254|NCT02582866|588669302|FG000|Overall Study|Withdrawal due to personal reasons|1|||
162991255|NCT03567382|588669303|FG000|Overall Study|Lost to Follow-up|1|||
162991256|NCT03567382|588669304|FG001|Overall Study|Lost to Follow-up|21|||
162991257|NCT03567382|588669305|FG002|Overall Study|Lost to Follow-up|1|||
162991258|NCT03567382|588669306|FG003|Overall Study|Lost to Follow-up|21|||
162991259|NCT03567382|588669303|FG000|Overall Study|Withdrawal by Subject|2|||
162991260|NCT03567382|588669304|FG001|Overall Study|Withdrawal by Subject|14|||
162991261|NCT03567382|588669305|FG002|Overall Study|Withdrawal by Subject|1|||
162991262|NCT03567382|588669306|FG003|Overall Study|Withdrawal by Subject|12|||
162991263|NCT03246646|588669311|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
162991264|NCT03246646|588669312|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
162991265|NCT03246646|588669311|FG000|Overall Study|Withdrawal by Subject|3|||
162991266|NCT03246646|588669312|FG001|Overall Study|Withdrawal by Subject|0|||
162991267|NCT03246646|588669311|FG000|Overall Study|Lost to Follow-up|7|||
162991268|NCT03246646|588669312|FG001|Overall Study|Lost to Follow-up|0|||
162991269|NCT00319982|588669315|FG000|Overall Study|Withdrawal by Subject|1|||
162991270|NCT00319982|588669316|FG001|Overall Study|Withdrawal by Subject|0|||
162991271|NCT00758680|588669317|FG000|Overall Study|Adverse Event|0|||
162991272|NCT00758680|588669318|FG001|Overall Study|Adverse Event|0|||
162991273|NCT00758680|588669319|FG002|Overall Study|Adverse Event|0|||
162991274|NCT00758680|588669320|FG003|Overall Study|Adverse Event|0|||
162991275|NCT00758680|588669321|FG004|Overall Study|Adverse Event|0|||
162991276|NCT00758680|588669322|FG005|Overall Study|Adverse Event|0|||
162991277|NCT00758680|588669323|FG006|Overall Study|Adverse Event|0|||
162991278|NCT00758680|588669324|FG007|Overall Study|Adverse Event|1|||
162991279|NCT00758680|588669325|FG008|Overall Study|Adverse Event|0|||
162991280|NCT00758680|588669326|FG009|Overall Study|Adverse Event|1|||
162991281|NCT00758680|588669317|FG000|Overall Study|Laboratory Adverse Event|0|||
162991282|NCT00758680|588669318|FG001|Overall Study|Laboratory Adverse Event|0|||
162991283|NCT00758680|588669319|FG002|Overall Study|Laboratory Adverse Event|0|||
162991284|NCT00758680|588669320|FG003|Overall Study|Laboratory Adverse Event|0|||
162991285|NCT00758680|588669321|FG004|Overall Study|Laboratory Adverse Event|0|||
162991286|NCT00758680|588669322|FG005|Overall Study|Laboratory Adverse Event|0|||
162991287|NCT00758680|588669323|FG006|Overall Study|Laboratory Adverse Event|0|||
162991288|NCT00758680|588669324|FG007|Overall Study|Laboratory Adverse Event|0|||
162991289|NCT00758680|588669325|FG008|Overall Study|Laboratory Adverse Event|1|||
162991290|NCT00758680|588669326|FG009|Overall Study|Laboratory Adverse Event|0|||
162991291|NCT00758680|588669317|FG000|Overall Study|Withdrawal by Subject|0|||
162991292|NCT00758680|588669318|FG001|Overall Study|Withdrawal by Subject|0|||
162991293|NCT00758680|588669319|FG002|Overall Study|Withdrawal by Subject|0|||
162991294|NCT00758680|588669320|FG003|Overall Study|Withdrawal by Subject|0|||
162991295|NCT00758680|588669321|FG004|Overall Study|Withdrawal by Subject|0|||
162991296|NCT00758680|588669322|FG005|Overall Study|Withdrawal by Subject|0|||
162991297|NCT00758680|588669323|FG006|Overall Study|Withdrawal by Subject|1|||
162991298|NCT00758680|588669324|FG007|Overall Study|Withdrawal by Subject|0|||
162991299|NCT00758680|588669325|FG008|Overall Study|Withdrawal by Subject|1|||
162991300|NCT00758680|588669326|FG009|Overall Study|Withdrawal by Subject|0|||
162991301|NCT03480386|588669327|FG000|Overall Study|Did not complete measures at 3-months|17|||
162991302|NCT03480386|588669328|FG001|Overall Study|Did not complete measures at 3-months|14|||
162991303|NCT03480386|588669327|FG000|Overall Study|No baseline measures|11|||
162991304|NCT03480386|588669328|FG001|Overall Study|No baseline measures|14|||
162991305|NCT03480386|588669327|FG000|Overall Study|Death|0|||
162991306|NCT03480386|588669328|FG001|Overall Study|Death|5|||
162991307|NCT03480386|588669327|FG000|Overall Study|Withdrawal by Subject|12|||
162991308|NCT03480386|588669328|FG001|Overall Study|Withdrawal by Subject|8|||
162991309|NCT03480386|588669327|FG000|Overall Study|Lost to Follow-up|2|||
162991310|NCT03480386|588669328|FG001|Overall Study|Lost to Follow-up|1|||
162991311|NCT03480386|588669327|FG000|Overall Study|Complicating disease|0|||
162991312|NCT03480386|588669328|FG001|Overall Study|Complicating disease|1|||
162991313|NCT03480386|588669327|FG000|Overall Study|Disease progression|3|||
162991314|NCT03480386|588669328|FG001|Overall Study|Disease progression|0|||
162991315|NCT03480386|588669327|FG000|Overall Study|Became ineligible|0|||
162991316|NCT03480386|588669328|FG001|Overall Study|Became ineligible|2|||
162991317|NCT02201290|588669329|FG000|Overall Study|Withdrawal by Subject|2|||
162991318|NCT02201290|588669329|FG000|Overall Study|Lack of Efficacy|2|||
162991319|NCT02201290|588669329|FG000|Overall Study|Adverse Event|1|||
162991320|NCT04639713|588669330|FG000|Overall Study|Protocol Noncompliance|2|||
162991321|NCT04639713|588669330|FG000|Overall Study|Withdrawal by Subject|1|||
162991322|NCT03589768|588670667|FG000|Overall Study|Death|1|||
162991323|NCT03589768|588670668|FG001|Overall Study|Death|0|||
162991324|NCT03589768|588670669|FG002|Overall Study|Death|8|||
162991325|NCT03589768|588670670|FG003|Overall Study|Death|3|||
162991326|NCT03589768|588670667|FG000|Overall Study|Withdrawal by Subject|2|||
162991327|NCT03589768|588670668|FG001|Overall Study|Withdrawal by Subject|0|||
162991328|NCT03589768|588670669|FG002|Overall Study|Withdrawal by Subject|0|||
162991329|NCT03589768|588670670|FG003|Overall Study|Withdrawal by Subject|0|||
162991330|NCT03589768|588670667|FG000|Overall Study|Protocol Violation|1|||
162991331|NCT03589768|588670668|FG001|Overall Study|Protocol Violation|0|||
162991332|NCT03589768|588670669|FG002|Overall Study|Protocol Violation|0|||
162991333|NCT03589768|588670670|FG003|Overall Study|Protocol Violation|0|||
163324607|NCT03660930|589900663|FG004|Overall Study|Adverse Event|0|||
162991334|NCT04241315|588670676|FG000|Overall Study|Withdrawal by Subject|0|||
162991335|NCT04241315|588670677|FG001|Overall Study|Withdrawal by Subject|1|||
162991336|NCT03047330|588670678|FG000|Sleep Block 1|Withdrawal by Subject|3|||
162991337|NCT00663026|588670685|FG000|Overall Study|Lost to Follow-up|1|||
162991338|NCT00663026|588670686|FG001|Overall Study|Lost to Follow-up|0|||
162991339|NCT00663026|588670687|FG002|Overall Study|Lost to Follow-up|0|||
162991340|NCT00663026|588670685|FG000|Overall Study|Other|1|||
162991341|NCT00663026|588670686|FG001|Overall Study|Other|2|||
162991342|NCT00663026|588670687|FG002|Overall Study|Other|0|||
162991343|NCT00663026|588670685|FG000|Overall Study|Adverse Event|0|||
162991344|NCT00663026|588670686|FG001|Overall Study|Adverse Event|2|||
162991345|NCT00663026|588670687|FG002|Overall Study|Adverse Event|3|||
162991346|NCT00663026|588670685|FG000|Overall Study|Caregiver Request|0|||
162991347|NCT00663026|588670686|FG001|Overall Study|Caregiver Request|2|||
162991348|NCT00663026|588670687|FG002|Overall Study|Caregiver Request|0|||
162991349|NCT00663026|588670685|FG000|Overall Study|Withdrawal by Subject|0|||
162991350|NCT00663026|588670686|FG001|Overall Study|Withdrawal by Subject|0|||
162991351|NCT00663026|588670687|FG002|Overall Study|Withdrawal by Subject|1|||
162991352|NCT01392963|588670691|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
162991353|NCT01392963|588670692|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
162991354|NCT01392963|588670691|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
162991355|NCT01392963|588670692|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
162991356|NCT01392963|588670691|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
162991357|NCT01392963|588670692|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
162991358|NCT03783039|588670693|FG000|Overall Study|Death|2|||
162991359|NCT03783039|588670694|FG001|Overall Study|Death|1|||
162991360|NCT02006693|588670695|FG000|Overall Study|No Reason Specified|6|||
162991361|NCT02006693|588670696|FG001|Overall Study|No Reason Specified|8|||
162991362|NCT02006693|588670695|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
162991363|NCT02006693|588670696|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
162991364|NCT02006693|588670695|FG000|Overall Study|XEN Implant Explantation|0|||
162991365|NCT02006693|588670696|FG001|Overall Study|XEN Implant Explantation|1|||
162991366|NCT02006693|588670695|FG000|Overall Study|Death|2|||
162991367|NCT02006693|588670696|FG001|Overall Study|Death|2|||
162991368|NCT02006693|588670695|FG000|Overall Study|Lost to Follow-up|4|||
162991369|NCT02006693|588670696|FG001|Overall Study|Lost to Follow-up|1|||
162991370|NCT02006693|588670695|FG000|Overall Study|Patient Decision|4|||
162991371|NCT02006693|588670696|FG001|Overall Study|Patient Decision|0|||
162991372|NCT01119508|588670697|FG000|Overall Study|Adverse Event|56|||
162991373|NCT01119508|588670697|FG000|Overall Study|Withdrawal by Subject|2|||
162991374|NCT01119508|588670697|FG000|Overall Study|Died before tumor response evaluation|1|||
162991375|NCT00837473|588670700|FG000|Overall Study|Lost to Follow-up|1|||
162991376|NCT00837473|588670700|FG000|Overall Study|Withdrawal by Subject|2|||
162991377|NCT02563106|588670701|FG000|Overall Study|Withdrawal by Subject|7|||
162991378|NCT02563106|588670702|FG001|Overall Study|Withdrawal by Subject|8|||
162991379|NCT02563106|588670701|FG000|Overall Study|Adverse Event|17|||
162991380|NCT02563106|588670702|FG001|Overall Study|Adverse Event|15|||
162991381|NCT02563106|588670701|FG000|Overall Study|Protocol Violation|1|||
162991382|NCT02563106|588670702|FG001|Overall Study|Protocol Violation|0|||
162991383|NCT02563106|588670701|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
162991384|NCT02563106|588670702|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
162991385|NCT02563106|588670701|FG000|Overall Study|Lost to Follow-up|3|||
162991386|NCT02563106|588670702|FG001|Overall Study|Lost to Follow-up|2|||
162991387|NCT02563106|588670701|FG000|Overall Study|Physician Decision|3|||
162991388|NCT02563106|588670702|FG001|Overall Study|Physician Decision|1|||
162991389|NCT02563106|588670701|FG000|Overall Study|Other reason - not specified|2|||
162991390|NCT02563106|588670702|FG001|Overall Study|Other reason - not specified|1|||
162991391|NCT02338193|588670703|FG000|Overall Study|Withdrawal by Subject|0|||
162991392|NCT02338193|588670704|FG001|Overall Study|Withdrawal by Subject|0|||
162991393|NCT02338193|588670705|FG002|Overall Study|Withdrawal by Subject|2|||
162991394|NCT02338193|588670703|FG000|Overall Study|Pregnancy|0|||
162991395|NCT02338193|588670704|FG001|Overall Study|Pregnancy|1|||
162991396|NCT02338193|588670705|FG002|Overall Study|Pregnancy|1|||
162991397|NCT02338193|588670703|FG000|Overall Study|Noncompliant with visits|2|||
162991398|NCT02338193|588670704|FG001|Overall Study|Noncompliant with visits|2|||
162991399|NCT02338193|588670705|FG002|Overall Study|Noncompliant with visits|7|||
162991400|NCT02338193|588670703|FG000|Overall Study|moved out of state|0|||
162991401|NCT02338193|588670704|FG001|Overall Study|moved out of state|1|||
162991402|NCT02338193|588670705|FG002|Overall Study|moved out of state|0|||
162991403|NCT02338193|588670703|FG000|Overall Study|intolerant of side effects|1|||
162991404|NCT02338193|588670704|FG001|Overall Study|intolerant of side effects|0|||
162991405|NCT02338193|588670705|FG002|Overall Study|intolerant of side effects|0|||
162991406|NCT01136967|588670710|FG000|Overall Study|Adverse Event|9|||
162991407|NCT01136967|588670711|FG001|Overall Study|Adverse Event|12|||
162991408|NCT01136967|588670710|FG000|Overall Study|Participant Choice|8|||
162991409|NCT01136967|588670711|FG001|Overall Study|Participant Choice|3|||
162991410|NCT01136967|588670710|FG000|Overall Study|Lost to Follow-up|0|||
162991411|NCT01136967|588670711|FG001|Overall Study|Lost to Follow-up|1|||
162991412|NCT01136967|588670710|FG000|Overall Study|Withdrawal by Subject|1|||
162991413|NCT01136967|588670711|FG001|Overall Study|Withdrawal by Subject|2|||
163324608|NCT03660930|589900664|FG005|Overall Study|Adverse Event|1|||
162991414|NCT01136967|588670710|FG000|Overall Study|Clinical Progression|3|||
162991415|NCT01136967|588670711|FG001|Overall Study|Clinical Progression|5|||
162991416|NCT01136967|588670710|FG000|Overall Study|Radiation|1|||
162991417|NCT01136967|588670711|FG001|Overall Study|Radiation|0|||
162991418|NCT01136967|588670710|FG000|Overall Study|Non-compliance|1|||
162991419|NCT01136967|588670711|FG001|Overall Study|Non-compliance|0|||
162991420|NCT01136967|588670710|FG000|Overall Study|Investigator's Choice|1|||
162991421|NCT01136967|588670711|FG001|Overall Study|Investigator's Choice|1|||
162991422|NCT01136967|588670710|FG000|Overall Study|Increase in Lesion Size|0|||
162991423|NCT01136967|588670711|FG001|Overall Study|Increase in Lesion Size|2|||
162991424|NCT01136967|588670710|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
162991425|NCT01136967|588670711|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
162991426|NCT01735955|588670712|FG000|Overall Study|Administrative problems|1|||
162991427|NCT01735955|588670712|FG000|Overall Study|Patient/guardian decision|1|||
162991428|NCT01735955|588670712|FG000|Overall Study|Patient withdrew consent|2|||
162991429|NCT01735955|588670712|FG000|Overall Study|Physician Decision|4|||
162991430|NCT01735955|588670712|FG000|Overall Study|Disease progression|24|||
162991431|NCT01735955|588670712|FG000|Overall Study|Adverse Event|5|||
162991432|NCT03317834|588670713|FG000|Overall Study|Death|2|||
162991433|NCT03317834|588670713|FG000|Overall Study|Device Revision|5|||
162991434|NCT03317834|588670713|FG000|Overall Study|Withdrawal by Subject|13|||
162991435|NCT03317834|588670713|FG000|Overall Study|Lost to Follow-up|13|||
162991436|NCT03839823|588670717|FG000|Overall Study|Adverse Event|8|||
162991437|NCT03839823|588670718|FG001|Overall Study|Adverse Event|4|||
162991438|NCT03839823|588670717|FG000|Overall Study|Death|1|||
162991439|NCT03839823|588670718|FG001|Overall Study|Death|0|||
162991440|NCT03839823|588670717|FG000|Overall Study|Physician Decision|1|||
162991441|NCT03839823|588670718|FG001|Overall Study|Physician Decision|5|||
162991442|NCT03839823|588670717|FG000|Overall Study|Progressive Disease (PD)|65|||
162991443|NCT03839823|588670718|FG001|Overall Study|Progressive Disease (PD)|65|||
162991444|NCT03839823|588670717|FG000|Overall Study|Subject Decision|2|||
162991445|NCT03839823|588670718|FG001|Overall Study|Subject Decision|9|||
162991446|NCT03839823|588670717|FG000|Overall Study|Not Treated|0|||
162991447|NCT03839823|588670718|FG001|Overall Study|Not Treated|10|||
162991448|NCT01716715|588670719|FG000|Overall Study|Never Treated|2|||
162991449|NCT01716715|588670720|FG001|Overall Study|Never Treated|4|||
162991450|NCT04228783|588670721|FG000|Overall Study|Adverse Event|1|||
162991451|NCT04228783|588670722|FG001|Overall Study|Adverse Event|0|||
162991452|NCT04228783|588670723|FG002|Overall Study|Adverse Event|2|||
162991453|NCT04228783|588670724|FG003|Overall Study|Adverse Event|0|||
162991454|NCT04228783|588670725|FG004|Overall Study|Adverse Event|0|||
162991455|NCT04228783|588670726|FG005|Overall Study|Adverse Event|1|||
162991456|NCT04228783|588670721|FG000|Overall Study|Death|0|||
162991457|NCT04228783|588670722|FG001|Overall Study|Death|0|||
162991458|NCT04228783|588670723|FG002|Overall Study|Death|0|||
162991459|NCT04228783|588670724|FG003|Overall Study|Death|0|||
162991460|NCT04228783|588670725|FG004|Overall Study|Death|1|||
162991461|NCT04228783|588670726|FG005|Overall Study|Death|0|||
162991462|NCT04228783|588670721|FG000|Overall Study|Lost to Follow-up|36|||
162991463|NCT04228783|588670722|FG001|Overall Study|Lost to Follow-up|36|||
162991464|NCT04228783|588670723|FG002|Overall Study|Lost to Follow-up|28|||
162991465|NCT04228783|588670724|FG003|Overall Study|Lost to Follow-up|6|||
162991466|NCT04228783|588670725|FG004|Overall Study|Lost to Follow-up|14|||
162991467|NCT04228783|588670726|FG005|Overall Study|Lost to Follow-up|3|||
162991468|NCT04228783|588670721|FG000|Overall Study|Physician Decision|1|||
162991469|NCT04228783|588670722|FG001|Overall Study|Physician Decision|2|||
162991470|NCT04228783|588670723|FG002|Overall Study|Physician Decision|0|||
162991471|NCT04228783|588670724|FG003|Overall Study|Physician Decision|0|||
162991472|NCT04228783|588670725|FG004|Overall Study|Physician Decision|0|||
162991473|NCT04228783|588670726|FG005|Overall Study|Physician Decision|0|||
162991474|NCT04228783|588670721|FG000|Overall Study|Protocol Violation|0|||
162991475|NCT04228783|588670722|FG001|Overall Study|Protocol Violation|0|||
162991476|NCT04228783|588670723|FG002|Overall Study|Protocol Violation|0|||
162991477|NCT04228783|588670724|FG003|Overall Study|Protocol Violation|1|||
162991478|NCT04228783|588670725|FG004|Overall Study|Protocol Violation|0|||
162991479|NCT04228783|588670726|FG005|Overall Study|Protocol Violation|0|||
162991480|NCT04228783|588670721|FG000|Overall Study|Withdrawal by Subject|6|||
162991481|NCT04228783|588670722|FG001|Overall Study|Withdrawal by Subject|10|||
162991482|NCT04228783|588670723|FG002|Overall Study|Withdrawal by Subject|19|||
162991483|NCT04228783|588670724|FG003|Overall Study|Withdrawal by Subject|1|||
162991484|NCT04228783|588670725|FG004|Overall Study|Withdrawal by Subject|2|||
162991485|NCT04228783|588670726|FG005|Overall Study|Withdrawal by Subject|0|||
162991486|NCT04228783|588670721|FG000|Overall Study|Other|4|||
162991487|NCT04228783|588670722|FG001|Overall Study|Other|3|||
162991488|NCT04228783|588670723|FG002|Overall Study|Other|2|||
163404268|NCT02831673|590191901|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
162991489|NCT04228783|588670724|FG003|Overall Study|Other|1|||
162991490|NCT04228783|588670725|FG004|Overall Study|Other|0|||
162991491|NCT04228783|588670726|FG005|Overall Study|Other|0|||
162991492|NCT00626392|588670727|FG000|Run-in Period|Adverse Event|0|||
162991493|NCT00626392|588670728|FG001|Run-in Period|Adverse Event|0|||
162991494|NCT00626392|588670729|FG002|Run-in Period|Adverse Event|1|||
162991495|NCT00626392|588670730|FG003|Run-in Period|Adverse Event|0|||
162991496|NCT00626392|588670731|FG004|Run-in Period|Adverse Event|1|||
162991497|NCT00626392|588670732|FG005|Run-in Period|Adverse Event|0|||
162991498|NCT00626392|588670727|FG000|Run-in Period|Withdrawal by Subject|0|||
162991499|NCT00626392|588670728|FG001|Run-in Period|Withdrawal by Subject|1|||
162991500|NCT00626392|588670729|FG002|Run-in Period|Withdrawal by Subject|1|||
162991501|NCT00626392|588670730|FG003|Run-in Period|Withdrawal by Subject|1|||
162991502|NCT00626392|588670731|FG004|Run-in Period|Withdrawal by Subject|3|||
162991503|NCT00626392|588670732|FG005|Run-in Period|Withdrawal by Subject|1|||
162991504|NCT00626392|588670727|FG000|Run-in Period|Noncompliance|1|||
162991505|NCT00626392|588670728|FG001|Run-in Period|Noncompliance|0|||
162991506|NCT00626392|588670729|FG002|Run-in Period|Noncompliance|1|||
162991507|NCT00626392|588670730|FG003|Run-in Period|Noncompliance|0|||
162991508|NCT00626392|588670731|FG004|Run-in Period|Noncompliance|0|||
162991509|NCT00626392|588670732|FG005|Run-in Period|Noncompliance|0|||
162991510|NCT00626392|588670727|FG000|Coadministration Period|Adverse Event|3|||
162991511|NCT00626392|588670728|FG001|Coadministration Period|Adverse Event|1|||
162991512|NCT00626392|588670729|FG002|Coadministration Period|Adverse Event|7|||
162991513|NCT00626392|588670730|FG003|Coadministration Period|Adverse Event|4|||
162991514|NCT00626392|588670731|FG004|Coadministration Period|Adverse Event|3|||
162991515|NCT00626392|588670732|FG005|Coadministration Period|Adverse Event|4|||
162991516|NCT00626392|588670727|FG000|Coadministration Period|Withdrawal by Subject|1|||
162991517|NCT00626392|588670728|FG001|Coadministration Period|Withdrawal by Subject|1|||
162991518|NCT00626392|588670729|FG002|Coadministration Period|Withdrawal by Subject|0|||
162991519|NCT00626392|588670730|FG003|Coadministration Period|Withdrawal by Subject|1|||
162991520|NCT00626392|588670731|FG004|Coadministration Period|Withdrawal by Subject|0|||
162991521|NCT00626392|588670732|FG005|Coadministration Period|Withdrawal by Subject|1|||
162991522|NCT00626392|588670727|FG000|Coadministration Period|Protocol Violation|0|||
162991523|NCT00626392|588670728|FG001|Coadministration Period|Protocol Violation|1|||
162991524|NCT00626392|588670729|FG002|Coadministration Period|Protocol Violation|0|||
162991525|NCT00626392|588670730|FG003|Coadministration Period|Protocol Violation|1|||
162991526|NCT00626392|588670731|FG004|Coadministration Period|Protocol Violation|1|||
162991527|NCT00626392|588670732|FG005|Coadministration Period|Protocol Violation|0|||
162991528|NCT00626392|588670727|FG000|Coadministration Period|Other|0|||
162991529|NCT00626392|588670728|FG001|Coadministration Period|Other|2|||
162991530|NCT00626392|588670729|FG002|Coadministration Period|Other|3|||
162991531|NCT00626392|588670730|FG003|Coadministration Period|Other|1|||
162991532|NCT00626392|588670731|FG004|Coadministration Period|Other|1|||
162991533|NCT00626392|588670732|FG005|Coadministration Period|Other|1|||
162991534|NCT03327792|588670733|FG000|Overall Study|Adverse Event|4|||
162991535|NCT03327792|588670734|FG001|Overall Study|Adverse Event|0|||
162991536|NCT03327792|588670733|FG000|Overall Study|Family/Personal issues|3|||
162991537|NCT03327792|588670734|FG001|Overall Study|Family/Personal issues|2|||
162991538|NCT03327792|588670733|FG000|Overall Study|Lost to Follow-up|0|||
162991539|NCT03327792|588670734|FG001|Overall Study|Lost to Follow-up|1|||
162991540|NCT04576923|588670735|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
162991541|NCT03151811|588670739|FG000|Overall Study|Randomized But Not Treated|18|||
162991542|NCT03151811|588670740|FG001|Overall Study|Randomized But Not Treated|3|||
162991543|NCT03151811|588670739|FG000|Overall Study|Progressive Disease|130|||
162991544|NCT03151811|588670740|FG001|Overall Study|Progressive Disease|170|||
162991545|NCT03151811|588670739|FG000|Overall Study|Adverse Event|49|||
162991546|NCT03151811|588670740|FG001|Overall Study|Adverse Event|40|||
162991547|NCT03151811|588670739|FG000|Overall Study|Lack of Efficacy|6|||
162991548|NCT03151811|588670740|FG001|Overall Study|Lack of Efficacy|8|||
162991549|NCT03151811|588670739|FG000|Overall Study|Physician Decision|21|||
162991550|NCT03151811|588670740|FG001|Overall Study|Physician Decision|9|||
162991551|NCT03151811|588670739|FG000|Overall Study|Withdrawal by Subject|17|||
162991552|NCT03151811|588670740|FG001|Overall Study|Withdrawal by Subject|7|||
162991553|NCT03151811|588670739|FG000|Overall Study|Lost to Follow-up|0|||
162991554|NCT03151811|588670740|FG001|Overall Study|Lost to Follow-up|1|||
162991555|NCT03151811|588670739|FG000|Overall Study|Study Terminated by Sponsor|5|||
162991556|NCT03151811|588670740|FG001|Overall Study|Study Terminated by Sponsor|11|||
162991557|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
162991558|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
162991559|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
162991560|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
162991561|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
162991562|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
162991563|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
162991564|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
162991565|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
163212378|NCT00065507|589492481|FG000|Overall Study|Subject Withdrew Consent|2|||
163212379|NCT00065507|589492482|FG001|Overall Study|Subject Withdrew Consent|1|||
163212380|NCT00065507|589492481|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
163212381|NCT00065507|589492482|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
163212382|NCT00350636|589492483|FG000|Overall Study|Adverse Event|19|||
162991566|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
162991567|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Death|1|||
162991568|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Death|0|||
162991569|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Death|0|||
162991570|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Death|0|||
162991571|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Death|0|||
162991572|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
162991573|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
162991574|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
162991575|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
162991576|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
162991577|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
162991578|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
162991579|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
162991580|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
162991581|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
162991582|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
162991583|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
162991584|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
162991585|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
162991586|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
162991587|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
162991588|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
162991589|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
162991590|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
162991591|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
162991592|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
162991593|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
162991594|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
162991595|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
162991596|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
162991597|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Other|4|||
162991598|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Other|4|||
162991599|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Other|3|||
162991600|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Other|1|||
162991601|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Other|0|||
162991602|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
162991603|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
162991604|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
162991605|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
162991606|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
162991607|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
162991608|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
162991609|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
162991610|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
162991611|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
162991612|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Death|1|||
162991613|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Death|0|||
162991614|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Death|0|||
162991615|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Death|0|||
162991616|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Death|0|||
162991617|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
162991618|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
162991619|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
163212383|NCT00350636|589492484|FG001|Overall Study|Adverse Event|13|||
163404269|NCT02831673|590191902|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
163404270|NCT02831673|590191903|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
163404271|NCT02831673|590191904|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
163404272|NCT02831673|590191900|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
163404273|NCT02831673|590191901|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
163404274|NCT02831673|590191902|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
163404275|NCT02831673|590191903|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
163404276|NCT02831673|590191904|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
163404277|NCT02831673|590191900|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
163404278|NCT02831673|590191901|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
163404279|NCT02831673|590191902|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
163404280|NCT02831673|590191903|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
163404281|NCT02831673|590191904|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
163404282|NCT02831673|590191900|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
162991620|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
163059983|NCT00805532|588928277|FG001|Overall Study|invalid data|1|||
163212384|NCT00350636|589492483|FG000|Overall Study|Protocol Violation|1|||
163212385|NCT00350636|589492484|FG001|Overall Study|Protocol Violation|3|||
163404283|NCT02831673|590191901|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
163404284|NCT02831673|590191902|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
162991621|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
162991622|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
162991623|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
162991624|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
162991625|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
162991626|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
162991627|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
162991628|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
162991629|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
162991630|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
162991631|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
162991632|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
162991633|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
162991634|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
162991635|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
162991636|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
162991637|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
162991638|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
162991639|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
162991640|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
162991641|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
162991642|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Other|4|||
162991643|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Other|5|||
162991644|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Other|4|||
162991645|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Other|0|||
162991646|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Other|0|||
162991647|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
162991648|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
162991649|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
162991650|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
162991651|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
162991652|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
162991653|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
162991654|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
162991655|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
162991656|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
162991657|NCT01475097|588670750|FG000|Overall Study|Protocol Violation|1|||
162991658|NCT01475097|588670751|FG001|Overall Study|Protocol Violation|1|||
162991659|NCT04839692|588670752|FG000|Overall Study|Withdrawal by Subject|0|||
162991660|NCT04839692|588670753|FG001|Overall Study|Withdrawal by Subject|3|||
162991661|NCT04839692|588670752|FG000|Overall Study|Physician Decision|1|||
162991662|NCT04839692|588670753|FG001|Overall Study|Physician Decision|0|||
162991663|NCT03511326|588670754|FG000|Overall Study|Withdrawal by Subject|1|||
162991664|NCT00492024|588670755|FG000|Treatment|Adverse Event|3|||
162991665|NCT00492024|588670756|FG001|Treatment|Adverse Event|1|||
162991666|NCT00492024|588670755|FG000|Treatment|Lack of Efficacy|21|||
162991667|NCT00492024|588670756|FG001|Treatment|Lack of Efficacy|20|||
162991668|NCT00492024|588670755|FG000|Treatment|Lost to Follow-up|3|||
162991669|NCT00492024|588670756|FG001|Treatment|Lost to Follow-up|1|||
162991670|NCT00492024|588670755|FG000|Treatment|Withdrawal by Subject|2|||
162991671|NCT00492024|588670756|FG001|Treatment|Withdrawal by Subject|0|||
162991672|NCT00492024|588670755|FG000|Follow up|Lack of Efficacy|0|||
162991673|NCT00492024|588670756|FG001|Follow up|Lack of Efficacy|1|||
162991674|NCT00492024|588670755|FG000|Follow up|Lost to Follow-up|1|||
162991675|NCT00492024|588670756|FG001|Follow up|Lost to Follow-up|1|||
162991676|NCT03247816|588670757|FG000|Overall Study|Adverse Event|12|||
162991677|NCT03247816|588670757|FG000|Overall Study|Physician Decision|3|||
162991678|NCT03247816|588670757|FG000|Overall Study|Lack of Efficacy|1|||
163212386|NCT00350636|589492483|FG000|Overall Study|Withdrawal by Subject|13|||
163212387|NCT00350636|589492484|FG001|Overall Study|Withdrawal by Subject|17|||
163212388|NCT00350636|589492483|FG000|Overall Study|Lost to Follow-up|9|||
163212389|NCT00350636|589492484|FG001|Overall Study|Lost to Follow-up|8|||
162991679|NCT03247816|588670757|FG000|Overall Study|Lost to Follow-up|10|||
162991680|NCT03247816|588670757|FG000|Overall Study|Missing Feraccru stop date|3|||
162991681|NCT00926783|588670760|FG000|Overall Study|Incomplete CFAE Procedures|3|||
162991682|NCT00926783|588670761|FG001|Overall Study|Incomplete CFAE Procedures|3|||
162991683|NCT01439009|588670762|FG000|Overall Study|Physician Decision|5|||
162991684|NCT01439009|588670763|FG001|Overall Study|Physician Decision|3|||
163212390|NCT00350636|589492483|FG000|Overall Study|Physician Decision|0|||
162991685|NCT01439009|588670762|FG000|Overall Study|Protocol Violation|2|||
162991686|NCT01439009|588670763|FG001|Overall Study|Protocol Violation|0|||
162991687|NCT01439009|588670762|FG000|Overall Study|Deviation of exclusion criteria|1|||
162991688|NCT01439009|588670763|FG001|Overall Study|Deviation of exclusion criteria|0|||
162991689|NCT00696787|588670764|FG000|Overall Study|Adverse Event|1|||
162991690|NCT00696787|588670765|FG001|Overall Study|Adverse Event|0|||
162991691|NCT00696787|588670766|FG002|Overall Study|Adverse Event|6|||
162991692|NCT00696787|588670764|FG000|Overall Study|Discontinuation by Sponsor|9|||
162991693|NCT00696787|588670765|FG001|Overall Study|Discontinuation by Sponsor|13|||
162991694|NCT00696787|588670766|FG002|Overall Study|Discontinuation by Sponsor|14|||
162991695|NCT00696787|588670764|FG000|Overall Study|Lack of Efficacy|0|||
162991696|NCT00696787|588670765|FG001|Overall Study|Lack of Efficacy|1|||
162991697|NCT00696787|588670766|FG002|Overall Study|Lack of Efficacy|0|||
162991698|NCT00696787|588670764|FG000|Overall Study|Lost to Follow-up|4|||
162991699|NCT00696787|588670765|FG001|Overall Study|Lost to Follow-up|0|||
162991700|NCT00696787|588670766|FG002|Overall Study|Lost to Follow-up|3|||
162991701|NCT00696787|588670764|FG000|Overall Study|Withdrawal by Subject|0|||
162991702|NCT00696787|588670765|FG001|Overall Study|Withdrawal by Subject|3|||
162991703|NCT00696787|588670766|FG002|Overall Study|Withdrawal by Subject|2|||
162991704|NCT00696787|588670764|FG000|Overall Study|Failed to return|1|||
162991705|NCT00696787|588670765|FG001|Overall Study|Failed to return|3|||
162991706|NCT00696787|588670766|FG002|Overall Study|Failed to return|1|||
162991707|NCT00867503|588670768|FG000|Overall Study|Withdrawal by Subject|1|||
162991708|NCT02704403|588670769|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
162991709|NCT02704403|588670770|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
162991710|NCT02704403|588670769|FG000|Overall Study|Administrative reasons by sponsor|1251|||
162991711|NCT02704403|588670770|FG001|Overall Study|Administrative reasons by sponsor|616|||
162991712|NCT02704403|588670769|FG000|Overall Study|Death|4|||
162991713|NCT02704403|588670770|FG001|Overall Study|Death|3|||
162991714|NCT02704403|588670769|FG000|Overall Study|Endpoint event|52|||
162991715|NCT02704403|588670770|FG001|Overall Study|Endpoint event|24|||
162991716|NCT02704403|588670769|FG000|Overall Study|Lost to Follow-up|22|||
162991717|NCT02704403|588670770|FG001|Overall Study|Lost to Follow-up|11|||
162991718|NCT02704403|588670769|FG000|Overall Study|Protocol Violation|15|||
162991719|NCT02704403|588670770|FG001|Overall Study|Protocol Violation|15|||
162991720|NCT02704403|588670769|FG000|Overall Study|Adverse Event|2|||
162991721|NCT02704403|588670770|FG001|Overall Study|Adverse Event|0|||
162991722|NCT02704403|588670769|FG000|Overall Study|Withdrawal by Subject|85|||
162991723|NCT02704403|588670770|FG001|Overall Study|Withdrawal by Subject|45|||
162991724|NCT02704403|588670769|FG000|Overall Study|Investigator decision|1|||
162991725|NCT02704403|588670770|FG001|Overall Study|Investigator decision|1|||
162991726|NCT02704403|588670769|FG000|Overall Study|Follow-up not possible|1|||
162991727|NCT02704403|588670770|FG001|Overall Study|Follow-up not possible|2|||
162991728|NCT01844856|588670777|FG000|Overall Study|Lost to Follow-up|15|||
162991729|NCT01844856|588670778|FG001|Overall Study|Lost to Follow-up|3|||
162991730|NCT01844856|588670777|FG000|Overall Study|Adverse Event|3|||
162991731|NCT01844856|588670778|FG001|Overall Study|Adverse Event|6|||
162991732|NCT01844856|588670777|FG000|Overall Study|Withdrawal by Subject|3|||
162991733|NCT01844856|588670778|FG001|Overall Study|Withdrawal by Subject|2|||
162991734|NCT01844856|588670777|FG000|Overall Study|Noncompliance|2|||
162991735|NCT01844856|588670778|FG001|Overall Study|Noncompliance|3|||
162991736|NCT01844856|588670777|FG000|Overall Study|Enterococcus Resistant|0|||
162991737|NCT01844856|588670778|FG001|Overall Study|Enterococcus Resistant|1|||
162991738|NCT01844856|588670777|FG000|Overall Study|Inadvertently Not Scheduled|1|||
162991739|NCT01844856|588670778|FG001|Overall Study|Inadvertently Not Scheduled|0|||
162991740|NCT01844856|588670777|FG000|Overall Study|Randomized but was a Screen Failure|0|||
162991741|NCT01844856|588670778|FG001|Overall Study|Randomized but was a Screen Failure|1|||
162991742|NCT00927394|588670781|FG000|Overall Study|Adverse Event|14|||
162991743|NCT00927394|588670782|FG001|Overall Study|Adverse Event|9|||
162991744|NCT00927394|588670781|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
162991745|NCT00927394|588670782|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
162991746|NCT00927394|588670781|FG000|Overall Study|Withdrawal by Subject|20|||
162991747|NCT00927394|588670782|FG001|Overall Study|Withdrawal by Subject|24|||
162991748|NCT00927394|588670781|FG000|Overall Study|Lost to Follow-up|8|||
163212391|NCT00350636|589492484|FG001|Overall Study|Physician Decision|2|||
163212392|NCT00350636|589492483|FG000|Overall Study|Other|1|||
162991749|NCT00927394|588670782|FG001|Overall Study|Lost to Follow-up|14|||
162991750|NCT00927394|588670781|FG000|Overall Study|Administrative Problem|1|||
162991751|NCT00927394|588670782|FG001|Overall Study|Administrative Problem|0|||
162991752|NCT00927394|588670781|FG000|Overall Study|Death|1|||
162991753|NCT00927394|588670782|FG001|Overall Study|Death|1|||
162991754|NCT00927394|588670781|FG000|Overall Study|Protocol deviation|16|||
162991755|NCT00927394|588670782|FG001|Overall Study|Protocol deviation|13|||
162991756|NCT00927394|588670781|FG000|Overall Study|Randomized in error|0|||
162991757|NCT00927394|588670782|FG001|Overall Study|Randomized in error|1|||
162991758|NCT01221363|588670783|FG000|Overall Study|Pregnancy|1|||
163212393|NCT00350636|589492484|FG001|Overall Study|Other|2|||
163212394|NCT00100815|589492485|FG000|Overall Study|Progression|24|||
162991759|NCT01221363|588670784|FG001|Overall Study|Pregnancy|0|||
162991760|NCT01221363|588670783|FG000|Overall Study|Withdrawal by Subject|11|||
162991761|NCT01221363|588670784|FG001|Overall Study|Withdrawal by Subject|5|||
162991762|NCT01756079|588670785|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
162991763|NCT01756079|588670785|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
162991764|NCT01756079|588670785|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
162991765|NCT01756079|588670785|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
162991766|NCT01756079|588670785|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
162991767|NCT02677714|588670786|FG000|Overall Study|Withdrawal by Subject|2|||
162991768|NCT02677714|588670787|FG001|Overall Study|Withdrawal by Subject|0|||
162991769|NCT01346293|588670792|FG000|Overall Study|Protocol Violation|30|||
162991770|NCT01346293|588670793|FG001|Overall Study|Protocol Violation|9|||
162991771|NCT01346293|588670792|FG000|Overall Study|Lost to Follow-up|21|||
162991772|NCT01346293|588670793|FG001|Overall Study|Lost to Follow-up|8|||
162991773|NCT01346293|588670792|FG000|Overall Study|Withdrawal by Subject|15|||
162991774|NCT01346293|588670793|FG001|Overall Study|Withdrawal by Subject|4|||
162991775|NCT01346293|588670792|FG000|Overall Study|Other|1|||
162991776|NCT01346293|588670793|FG001|Overall Study|Other|0|||
162991777|NCT02387983|588670794|FG000|Overall Study|Adverse Event|4|||
162991778|NCT02387983|588670794|FG000|Overall Study|Protocol Violation|1|||
162991779|NCT02387983|588670794|FG000|Overall Study|Withdrawal by Subject|2|||
162991780|NCT01844505|588670798|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
162991781|NCT01844505|588670799|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
162991782|NCT01844505|588670800|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
162991783|NCT01844505|588670798|FG000|Treatment Period|Other Reasons|120|||
162991784|NCT01844505|588670799|FG001|Treatment Period|Other Reasons|136|||
162991785|NCT01844505|588670800|FG002|Treatment Period|Other Reasons|58|||
162991786|NCT01844505|588670798|FG000|Treatment Period|Lost to Follow-up|9|||
162991787|NCT01844505|588670799|FG001|Treatment Period|Lost to Follow-up|11|||
162991788|NCT01844505|588670800|FG002|Treatment Period|Lost to Follow-up|6|||
162991789|NCT01844505|588670798|FG000|Treatment Period|Death|175|||
162991790|NCT01844505|588670799|FG001|Treatment Period|Death|154|||
162991791|NCT01844505|588670800|FG002|Treatment Period|Death|228|||
162991792|NCT00128830|588670801|FG000|Overall Study|Adverse Event|10|||
162991793|NCT00128830|588670801|FG000|Overall Study|Withdrawal by Subject|14|||
162991794|NCT00128830|588670801|FG000|Overall Study|Lost to Follow-up|4|||
162991795|NCT00128830|588670801|FG000|Overall Study|Reached a virologic endpoint|29|||
162991796|NCT00128830|588670801|FG000|Overall Study|Non-compliant|4|||
162991797|NCT00128830|588670801|FG000|Overall Study|Discontinued or ineligible for study|2|||
162991798|NCT00128830|588670801|FG000|Overall Study|Other|9|||
162991799|NCT02730351|588670802|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
162991800|NCT02730351|588670803|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
162991801|NCT02730351|588670802|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
162991802|NCT02730351|588670803|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
162991803|NCT02730351|588670802|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
162991804|NCT02730351|588670803|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
162991805|NCT02730351|588670802|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
162991806|NCT02730351|588670803|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
162991807|NCT02730351|588670802|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
162991808|NCT02730351|588670803|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
162991809|NCT00311402|588670804|FG000|Overall Study|Adverse Event|118|||
162991810|NCT00311402|588670805|FG001|Overall Study|Adverse Event|105|||
162991811|NCT00311402|588670804|FG000|Overall Study|Lost to Follow-up|0|||
162991812|NCT00311402|588670805|FG001|Overall Study|Lost to Follow-up|3|||
162991813|NCT00311402|588670804|FG000|Overall Study|Withdrawal by Subject|17|||
162991814|NCT00311402|588670805|FG001|Overall Study|Withdrawal by Subject|18|||
162991815|NCT00311402|588670804|FG000|Overall Study|Lack of Efficacy|58|||
163059984|NCT01859741|588928278|FG000|Overall Study|Death|3|||
163059985|NCT01859741|588928279|FG001|Overall Study|Death|2|||
163324609|NCT03660930|589900665|FG006|Overall Study|Adverse Event|0|||
163324610|NCT03660930|589900666|FG007|Overall Study|Adverse Event|0|||
163324611|NCT03660930|589900659|FG000|Overall Study|Withdrawal by Subject|0|||
163324612|NCT03660930|589900660|FG001|Overall Study|Withdrawal by Subject|0|||
163324613|NCT03660930|589900661|FG002|Overall Study|Withdrawal by Subject|0|||
162991816|NCT00311402|588670805|FG001|Overall Study|Lack of Efficacy|42|||
162991817|NCT00311402|588670804|FG000|Overall Study|Protocol Violation|7|||
162991818|NCT00311402|588670805|FG001|Overall Study|Protocol Violation|6|||
163059986|NCT01859741|588928280|FG002|Overall Study|Death|4|||
163059987|NCT01859741|588928281|FG003|Overall Study|Death|3|||
162991819|NCT00311402|588670804|FG000|Overall Study|IRB's rejection etc.|10|||
162991820|NCT00311402|588670805|FG001|Overall Study|IRB's rejection etc.|3|||
162991821|NCT02640053|588670806|FG000|Overall Study|Withdrawal by Subject|2|||
162991822|NCT02640053|588670807|FG001|Overall Study|Withdrawal by Subject|1|||
162991823|NCT02640053|588670806|FG000|Overall Study|Adverse Event|1|||
162991824|NCT02640053|588670807|FG001|Overall Study|Adverse Event|1|||
162991825|NCT02640053|588670806|FG000|Overall Study|Alternative Therapy|1|||
163059988|NCT01859741|588928282|FG004|Overall Study|Death|5|||
162991826|NCT02640053|588670807|FG001|Overall Study|Alternative Therapy|1|||
162991827|NCT02640053|588670806|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
162991828|NCT02640053|588670807|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
162991829|NCT02754856|588670809|FG000|Overall Study|Withdrawal by Subject|1|||
162991830|NCT00530218|588670810|FG000|Overall Study|CMV Not Detected|13|||
162991831|NCT00530218|588670810|FG000|Overall Study|Death|12|||
162991832|NCT03477903|588670815|FG000|Overall Study|Study Terminated by Sponsor|1|||
162991833|NCT06281171|588670818|FG000|Timepoint 2|Lost to Follow-up|6|||
162991834|NCT06281171|588670819|FG001|Timepoint 2|Lost to Follow-up|4|||
162991835|NCT06281171|588670818|FG000|Timepoint 3|Lost to Follow-up|0|||
162991836|NCT06281171|588670819|FG001|Timepoint 3|Lost to Follow-up|5|||
162991837|NCT01822275|588670820|FG000|Overall Study|Withdrawal by Subject|3|||
162991838|NCT01822275|588670820|FG000|Overall Study|Adverse Event|3|||
162991839|NCT01822275|588670820|FG000|Overall Study|Progression|14|||
162991840|NCT01822275|588670820|FG000|Overall Study|Physician Decision|2|||
162991841|NCT00513682|588670821|FG000|Washout Phase|Adverse Event|2|||
162991842|NCT03258853|588670823|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
162991843|NCT03258853|588670824|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
162991844|NCT00070499|588672500|FG000|Overall Study|Adverse Event|6|||
162991845|NCT00070499|588672501|FG001|Overall Study|Adverse Event|6|||
162991846|NCT00070499|588672502|FG002|Overall Study|Adverse Event|19|||
162991847|NCT00070499|588672503|FG003|Overall Study|Adverse Event|15|||
162991848|NCT00070499|588672500|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
162991849|NCT00070499|588672501|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
162991850|NCT00070499|588672502|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
162991851|NCT00070499|588672503|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
162991852|NCT00070499|588672500|FG000|Overall Study|Progression/relapse|4|||
162991853|NCT00070499|588672501|FG001|Overall Study|Progression/relapse|2|||
162991854|NCT00070499|588672502|FG002|Overall Study|Progression/relapse|1|||
162991855|NCT00070499|588672503|FG003|Overall Study|Progression/relapse|4|||
162991856|NCT00070499|588672500|FG000|Overall Study|Death|1|||
162991857|NCT00070499|588672501|FG001|Overall Study|Death|1|||
162991858|NCT00070499|588672502|FG002|Overall Study|Death|1|||
162991859|NCT00070499|588672503|FG003|Overall Study|Death|2|||
162991860|NCT00070499|588672500|FG000|Overall Study|Other - not protocol specified|7|||
162991861|NCT00070499|588672501|FG001|Overall Study|Other - not protocol specified|3|||
162991862|NCT00070499|588672502|FG002|Overall Study|Other - not protocol specified|12|||
162991863|NCT00070499|588672503|FG003|Overall Study|Other - not protocol specified|20|||
162991864|NCT00070499|588672500|FG000|Overall Study|Still on protocol treatment|10|||
162991865|NCT00070499|588672501|FG001|Overall Study|Still on protocol treatment|4|||
162991866|NCT00070499|588672502|FG002|Overall Study|Still on protocol treatment|79|||
162991867|NCT00070499|588672503|FG003|Overall Study|Still on protocol treatment|57|||
162991868|NCT00070499|588672500|FG000|Overall Study|Did not start treatment|1|||
162991869|NCT00070499|588672501|FG001|Overall Study|Did not start treatment|0|||
162991870|NCT00070499|588672502|FG002|Overall Study|Did not start treatment|0|||
162991871|NCT00070499|588672503|FG003|Overall Study|Did not start treatment|2|||
162991872|NCT00070499|588672500|FG000|Overall Study|Not eligible|2|||
162991873|NCT00070499|588672501|FG001|Overall Study|Not eligible|5|||
162991874|NCT00070499|588672502|FG002|Overall Study|Not eligible|3|||
162991875|NCT00070499|588672503|FG003|Overall Study|Not eligible|2|||
162991876|NCT00805467|588672504|FG000|Overall Study|Lack of Efficacy|0|||
162991877|NCT00805467|588672505|FG001|Overall Study|Lack of Efficacy|8|||
162991878|NCT00805467|588672506|FG002|Overall Study|Lack of Efficacy|13|||
162991879|NCT00805467|588672507|FG003|Overall Study|Lack of Efficacy|86|||
162991880|NCT00805467|588672504|FG000|Overall Study|Lost to Follow-up|0|||
162991881|NCT00805467|588672505|FG001|Overall Study|Lost to Follow-up|1|||
162991882|NCT00805467|588672506|FG002|Overall Study|Lost to Follow-up|7|||
162991883|NCT00805467|588672507|FG003|Overall Study|Lost to Follow-up|21|||
162991884|NCT00805467|588672504|FG000|Overall Study|Withdrawal by Subject|0|||
162991885|NCT00805467|588672505|FG001|Overall Study|Withdrawal by Subject|6|||
163324614|NCT03660930|589900662|FG003|Overall Study|Withdrawal by Subject|0|||
163324615|NCT03660930|589900663|FG004|Overall Study|Withdrawal by Subject|0|||
163324616|NCT03660930|589900664|FG005|Overall Study|Withdrawal by Subject|1|||
162991886|NCT00805467|588672506|FG002|Overall Study|Withdrawal by Subject|45|||
162991887|NCT00805467|588672507|FG003|Overall Study|Withdrawal by Subject|50|||
162991888|NCT00805467|588672504|FG000|Overall Study|Protocol Violation|0|||
162991889|NCT00805467|588672505|FG001|Overall Study|Protocol Violation|3|||
162991890|NCT00805467|588672506|FG002|Overall Study|Protocol Violation|0|||
162991891|NCT00805467|588672507|FG003|Overall Study|Protocol Violation|5|||
162991892|NCT00805467|588672504|FG000|Overall Study|Adverse Event|0|||
162991893|NCT00805467|588672505|FG001|Overall Study|Adverse Event|13|||
162991894|NCT00805467|588672506|FG002|Overall Study|Adverse Event|26|||
162991895|NCT00805467|588672507|FG003|Overall Study|Adverse Event|57|||
162991896|NCT00805467|588672504|FG000|Overall Study|Death|0|||
162991897|NCT00805467|588672505|FG001|Overall Study|Death|2|||
162991898|NCT00805467|588672506|FG002|Overall Study|Death|7|||
162991899|NCT00805467|588672507|FG003|Overall Study|Death|5|||
162991900|NCT00805467|588672504|FG000|Overall Study|Physician Decision|0|||
162991901|NCT00805467|588672505|FG001|Overall Study|Physician Decision|1|||
162991902|NCT00805467|588672506|FG002|Overall Study|Physician Decision|2|||
162991903|NCT00805467|588672507|FG003|Overall Study|Physician Decision|6|||
162991904|NCT00805467|588672504|FG000|Overall Study|Not reported|0|||
162991905|NCT00805467|588672505|FG001|Overall Study|Not reported|0|||
162991906|NCT00805467|588672506|FG002|Overall Study|Not reported|3|||
162991907|NCT00805467|588672507|FG003|Overall Study|Not reported|7|||
162991908|NCT04240392|588672509|FG000|Overall Study|Withdrawal by Subject|13|||
162991909|NCT04240392|588672510|FG001|Overall Study|Withdrawal by Subject|4|||
162991910|NCT04240392|588672509|FG000|Overall Study|Lost to Follow-up|11|||
162991911|NCT04240392|588672510|FG001|Overall Study|Lost to Follow-up|12|||
162991912|NCT04345601|588672523|FG000|Overall Study|Death|0|||
162991913|NCT04345601|588672524|FG001|Overall Study|Death|3|||
162991914|NCT04345601|588672525|FG002|Overall Study|Death|2|||
162991915|NCT04345601|588672523|FG000|Overall Study|Lost to Follow-up|0|||
162991916|NCT04345601|588672524|FG001|Overall Study|Lost to Follow-up|0|||
162991917|NCT04345601|588672525|FG002|Overall Study|Lost to Follow-up|2|||
162991918|NCT00660907|588672527|FG000|Overall Study|Incorrect Enrollment|1|||
162991919|NCT00660907|588672528|FG001|Overall Study|Incorrect Enrollment|1|||
162991920|NCT00660907|588672527|FG000|Overall Study|Adverse Event|33|||
162991921|NCT00660907|588672528|FG001|Overall Study|Adverse Event|19|||
162991922|NCT00660907|588672527|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
162991923|NCT00660907|588672528|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
162991924|NCT00660907|588672527|FG000|Overall Study|Withdrawal by Subject|23|||
162991925|NCT00660907|588672528|FG001|Overall Study|Withdrawal by Subject|32|||
162991926|NCT00660907|588672527|FG000|Overall Study|Lost to Follow-up|3|||
162991927|NCT00660907|588672528|FG001|Overall Study|Lost to Follow-up|3|||
162991928|NCT00660907|588672527|FG000|Overall Study|Poor/Non-Compliance|5|||
162991929|NCT00660907|588672528|FG001|Overall Study|Poor/Non-Compliance|1|||
162991930|NCT00660907|588672527|FG000|Overall Study|Safety|1|||
162991931|NCT00660907|588672528|FG001|Overall Study|Safety|0|||
162991932|NCT00660907|588672527|FG000|Overall Study|Death|1|||
162991933|NCT00660907|588672528|FG001|Overall Study|Death|3|||
162991934|NCT00660907|588672527|FG000|Overall Study|Various|11|||
162991935|NCT00660907|588672528|FG001|Overall Study|Various|8|||
162991936|NCT01908907|588672529|FG000|Overall Study|Physician Decision|1|||
162991937|NCT01908907|588672530|FG001|Overall Study|Physician Decision|0|||
162991938|NCT01908907|588672529|FG000|Overall Study|Protocol Violation|1|||
162991939|NCT01908907|588672530|FG001|Overall Study|Protocol Violation|0|||
162991940|NCT04975191|588672531|FG000|Overall Study|Protocol Violation|1|||
162991941|NCT04975191|588672532|FG001|Overall Study|Protocol Violation|2|||
162991942|NCT04975191|588672533|FG002|Overall Study|Protocol Violation|2|||
162991943|NCT04975191|588672534|FG003|Overall Study|Protocol Violation|2|||
162991944|NCT04975191|588672531|FG000|Overall Study|Lost to Follow-up|13|||
162991945|NCT04975191|588672532|FG001|Overall Study|Lost to Follow-up|3|||
162991946|NCT04975191|588672533|FG002|Overall Study|Lost to Follow-up|8|||
162991947|NCT04975191|588672534|FG003|Overall Study|Lost to Follow-up|8|||
162991948|NCT02152605|588672539|FG000|Overall Study|Adverse Event|6|||
163212395|NCT00100815|589492485|FG000|Overall Study|Adverse Event|18|||
163212396|NCT00100815|589492485|FG000|Overall Study|Death|4|||
163212397|NCT00100815|589492485|FG000|Overall Study|Other|3|||
163212398|NCT01647282|589492488|FG000|Overall Study|Physician Decision|7|||
163212399|NCT01647282|589492489|FG001|Overall Study|Physician Decision|5|||
163212400|NCT00665353|589492490|FG000|Study Step 1|Adverse Event|1|||
163212401|NCT00665353|589492490|FG000|Study Step 1|Withdrawal by Subject|2|||
163212402|NCT00665353|589492490|FG000|Study Step 2|Lost to Follow-up|2|||
163212403|NCT00665353|589492490|FG000|Study Step 2|Lack of Efficacy|12|||
163212404|NCT01851720|589492491|FG000|Overall Study|Lost to Follow-up|0|||
163212405|NCT01851720|589492492|FG001|Overall Study|Lost to Follow-up|1|||
163212406|NCT02632552|589492497|FG000|Overall Study|Lost to Follow-up|14|||
163212407|NCT02632552|589492498|FG001|Overall Study|Lost to Follow-up|8|||
163212408|NCT02632552|589492497|FG000|Overall Study|Withdrawal by Subject|2|||
163212409|NCT02632552|589492498|FG001|Overall Study|Withdrawal by Subject|0|||
163212410|NCT02632552|589492497|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
162991949|NCT02152605|588672540|FG001|Overall Study|Adverse Event|8|||
162991950|NCT02152605|588672539|FG000|Overall Study|Lack of Efficacy|7|||
162991951|NCT02152605|588672540|FG001|Overall Study|Lack of Efficacy|4|||
162991952|NCT02152605|588672539|FG000|Overall Study|Protocol deviation|1|||
162991953|NCT02152605|588672540|FG001|Overall Study|Protocol deviation|4|||
163212411|NCT02632552|589492498|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
163212412|NCT02377466|589492509|FG000|Overall Study|Other: Randomized and not treated|0|||
162991954|NCT02152605|588672539|FG000|Overall Study|Lost to Follow-up|1|||
162991955|NCT02152605|588672540|FG001|Overall Study|Lost to Follow-up|0|||
162991956|NCT02152605|588672539|FG000|Overall Study|Withdrew consent|4|||
162991957|NCT02152605|588672540|FG001|Overall Study|Withdrew consent|2|||
162991958|NCT00537303|588672547|FG000|Overall Study|Adverse Event|1|||
162991959|NCT00537303|588672548|FG001|Overall Study|Adverse Event|4|||
163324617|NCT03660930|589900665|FG006|Overall Study|Withdrawal by Subject|0|||
162991960|NCT00537303|588672547|FG000|Overall Study|Lack of Efficacy|6|||
162991961|NCT00537303|588672548|FG001|Overall Study|Lack of Efficacy|7|||
162991962|NCT00537303|588672547|FG000|Overall Study|Protocol Violation|8|||
162991963|NCT00537303|588672548|FG001|Overall Study|Protocol Violation|4|||
162991964|NCT00537303|588672547|FG000|Overall Study|Withdrawal criteria|3|||
162991965|NCT00537303|588672548|FG001|Overall Study|Withdrawal criteria|3|||
162991966|NCT00537303|588672547|FG000|Overall Study|Unclassified|8|||
162991967|NCT00537303|588672548|FG001|Overall Study|Unclassified|7|||
162991968|NCT01724489|588672549|FG000|Overall Study|Adverse Event|8|||
162991969|NCT01724489|588672550|FG001|Overall Study|Adverse Event|3|||
162991970|NCT01724489|588672549|FG000|Overall Study|Surgery, medication|1|||
162991971|NCT01724489|588672550|FG001|Overall Study|Surgery, medication|1|||
162991972|NCT01724489|588672549|FG000|Overall Study|Lost to Follow-up|1|||
162991973|NCT01724489|588672550|FG001|Overall Study|Lost to Follow-up|2|||
162991974|NCT01724489|588672549|FG000|Overall Study|Withdrawal by Subject|6|||
162991975|NCT01724489|588672550|FG001|Overall Study|Withdrawal by Subject|6|||
162991976|NCT01473524|588672555|FG000|DB Phase|Adverse Event|4|||
162991977|NCT01473524|588672556|FG001|DB Phase|Adverse Event|8|||
162991978|NCT01473524|588672557|FG002|DB Phase|Adverse Event|2|||
162991979|NCT01473524|588672558|FG003|DB Phase|Adverse Event|0|||
162991980|NCT01473524|588672559|FG004|DB Phase|Adverse Event|0|||
162991981|NCT01473524|588672560|FG005|DB Phase|Adverse Event|0|||
162991982|NCT01473524|588672555|FG000|DB Phase|Death|1|||
162991983|NCT01473524|588672556|FG001|DB Phase|Death|0|||
162991984|NCT01473524|588672557|FG002|DB Phase|Death|0|||
162991985|NCT01473524|588672558|FG003|DB Phase|Death|0|||
162991986|NCT01473524|588672559|FG004|DB Phase|Death|0|||
162991987|NCT01473524|588672560|FG005|DB Phase|Death|0|||
162991988|NCT01473524|588672555|FG000|DB Phase|Withdrawal by Subject|2|||
162991989|NCT01473524|588672556|FG001|DB Phase|Withdrawal by Subject|1|||
162991990|NCT01473524|588672557|FG002|DB Phase|Withdrawal by Subject|1|||
162991991|NCT01473524|588672558|FG003|DB Phase|Withdrawal by Subject|0|||
162991992|NCT01473524|588672559|FG004|DB Phase|Withdrawal by Subject|0|||
162991993|NCT01473524|588672560|FG005|DB Phase|Withdrawal by Subject|0|||
162991994|NCT01473524|588672555|FG000|LTSE Phase|Withdrawal by Subject|0|||
162991995|NCT01473524|588672556|FG001|LTSE Phase|Withdrawal by Subject|0|||
162991996|NCT01473524|588672557|FG002|LTSE Phase|Withdrawal by Subject|0|||
162991997|NCT01473524|588672558|FG003|LTSE Phase|Withdrawal by Subject|3|||
162991998|NCT01473524|588672559|FG004|LTSE Phase|Withdrawal by Subject|3|||
162991999|NCT01473524|588672560|FG005|LTSE Phase|Withdrawal by Subject|6|||
162992000|NCT01473524|588672555|FG000|LTSE Phase|Death|0|||
162992001|NCT01473524|588672556|FG001|LTSE Phase|Death|0|||
162992002|NCT01473524|588672557|FG002|LTSE Phase|Death|0|||
162992003|NCT01473524|588672558|FG003|LTSE Phase|Death|0|||
162992004|NCT01473524|588672559|FG004|LTSE Phase|Death|1|||
162992005|NCT01473524|588672560|FG005|LTSE Phase|Death|0|||
162992006|NCT01473524|588672555|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
162992007|NCT01473524|588672556|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
162992008|NCT01473524|588672557|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
162992009|NCT01473524|588672558|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
162992010|NCT01473524|588672559|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
162992011|NCT01473524|588672560|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
162992012|NCT01473524|588672555|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
162992013|NCT01473524|588672556|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
162992014|NCT01473524|588672557|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
163059989|NCT01859741|588928283|FG005|Overall Study|Death|4|||
163059990|NCT01859741|588928284|FG006|Overall Study|Death|51|||
163059991|NCT01859741|588928285|FG007|Overall Study|Death|51|||
163059992|NCT01859741|588928278|FG000|Overall Study|Lost to Follow-up|0|||
163212413|NCT02377466|589492510|FG001|Overall Study|Other: Randomized and not treated|2|||
162992015|NCT01473524|588672558|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
163212414|NCT00495170|589492511|FG000|Overall Study|Lost to Follow-up|9|||
162992016|NCT01473524|588672559|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
162992017|NCT01473524|588672560|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
162992018|NCT01473524|588672555|FG000|LTSE Phase|Lost to Follow-up|0|||
162992019|NCT01473524|588672556|FG001|LTSE Phase|Lost to Follow-up|0|||
162992020|NCT01473524|588672557|FG002|LTSE Phase|Lost to Follow-up|0|||
162992021|NCT01473524|588672558|FG003|LTSE Phase|Lost to Follow-up|1|||
162992022|NCT01473524|588672559|FG004|LTSE Phase|Lost to Follow-up|3|||
162992023|NCT01473524|588672560|FG005|LTSE Phase|Lost to Follow-up|2|||
162992024|NCT01473524|588672555|FG000|LTSE Phase|Principal Investigator Decision|0|||
162992025|NCT01473524|588672556|FG001|LTSE Phase|Principal Investigator Decision|0|||
163059993|NCT01859741|588928279|FG001|Overall Study|Lost to Follow-up|0|||
163059994|NCT01859741|588928280|FG002|Overall Study|Lost to Follow-up|0|||
163212415|NCT00495170|589492511|FG000|Overall Study|Withdrawal by Subject|3|||
163212416|NCT00495170|589492511|FG000|Overall Study|Inappropriate staging|8|||
163212417|NCT04210310|589492512|FG000|Overall Study|Lost to Follow-up|32|||
163212418|NCT04210310|589492513|FG001|Overall Study|Lost to Follow-up|1|||
163212419|NCT00330616|589492514|FG000|Overall Study|Adverse Event|13|||
163212420|NCT00330616|589492514|FG000|Overall Study|Lack of Efficacy|1|||
163212421|NCT00330616|589492514|FG000|Overall Study|Lost to Follow-up|2|||
163212422|NCT00330616|589492514|FG000|Overall Study|Withdrawal by Subject|4|||
162992026|NCT01473524|588672557|FG002|LTSE Phase|Principal Investigator Decision|0|||
162992027|NCT01473524|588672558|FG003|LTSE Phase|Principal Investigator Decision|1|||
162992028|NCT01473524|588672559|FG004|LTSE Phase|Principal Investigator Decision|1|||
162992029|NCT01473524|588672560|FG005|LTSE Phase|Principal Investigator Decision|3|||
162992030|NCT01473524|588672555|FG000|LTSE Phase|Liver Transplantation|0|||
162992031|NCT01473524|588672556|FG001|LTSE Phase|Liver Transplantation|0|||
162992032|NCT01473524|588672557|FG002|LTSE Phase|Liver Transplantation|0|||
162992033|NCT01473524|588672558|FG003|LTSE Phase|Liver Transplantation|0|||
162992034|NCT01473524|588672559|FG004|LTSE Phase|Liver Transplantation|0|||
162992035|NCT01473524|588672560|FG005|LTSE Phase|Liver Transplantation|1|||
162992036|NCT01473524|588672555|FG000|LTSE Phase|Pregnancy|0|||
162992037|NCT01473524|588672556|FG001|LTSE Phase|Pregnancy|0|||
162992038|NCT01473524|588672557|FG002|LTSE Phase|Pregnancy|0|||
162992039|NCT01473524|588672558|FG003|LTSE Phase|Pregnancy|1|||
162992040|NCT01473524|588672559|FG004|LTSE Phase|Pregnancy|0|||
162992041|NCT01473524|588672560|FG005|LTSE Phase|Pregnancy|0|||
162992042|NCT01473524|588672555|FG000|LTSE Phase|Protocol Violation|0|||
162992043|NCT01473524|588672556|FG001|LTSE Phase|Protocol Violation|0|||
162992044|NCT01473524|588672557|FG002|LTSE Phase|Protocol Violation|0|||
162992045|NCT01473524|588672558|FG003|LTSE Phase|Protocol Violation|0|||
162992046|NCT01473524|588672559|FG004|LTSE Phase|Protocol Violation|0|||
162992047|NCT01473524|588672560|FG005|LTSE Phase|Protocol Violation|1|||
162992048|NCT01544179|588672561|FG000|Overall Study|Death|50|||
162992049|NCT01544179|588672562|FG001|Overall Study|Death|37|||
162992050|NCT01544179|588672561|FG000|Overall Study|Lost to Follow-up|0|||
162992051|NCT01544179|588672562|FG001|Overall Study|Lost to Follow-up|1|||
162992052|NCT01544179|588672561|FG000|Overall Study|Adverse Event|0|||
162992053|NCT01544179|588672562|FG001|Overall Study|Adverse Event|1|||
162992054|NCT01544179|588672561|FG000|Overall Study|Withdrawal by Subject|12|||
162992055|NCT01544179|588672562|FG001|Overall Study|Withdrawal by Subject|7|||
162992056|NCT01544179|588672561|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
162992057|NCT01544179|588672562|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162992058|NCT01305044|588672563|FG000|Overall Study|Withdrawal by Subject|3|||
162992059|NCT01305044|588672564|FG001|Overall Study|Withdrawal by Subject|6|||
162992060|NCT02861014|588672569|FG000|Primary Analysis|Adverse Event|7|||
162992061|NCT02861014|588672569|FG000|Primary Analysis|Death|1|||
162992062|NCT02861014|588672569|FG000|Primary Analysis|Lack of Efficacy|3|||
162992063|NCT02861014|588672569|FG000|Primary Analysis|Physician Decision|2|||
162992064|NCT02861014|588672569|FG000|Primary Analysis|Pregnancy|4|||
162992065|NCT02861014|588672569|FG000|Primary Analysis|Protocol Violation|2|||
162992066|NCT02861014|588672569|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
162992067|NCT02861014|588672569|FG000|Primary Analysis|Withdrawal by Subject|14|||
162992068|NCT02861014|588672569|FG000|Primary Analysis|Commercial ocrelizumab|3|||
162992069|NCT02861014|588672569|FG000|Safety Follow-up|Adverse Event|1|||
162992070|NCT02861014|588672569|FG000|Safety Follow-up|Pregnancy|1|||
162992071|NCT02861014|588672569|FG000|Safety Follow-up|Withdrawal by Subject|9|||
162992072|NCT02861014|588672569|FG000|Safety Follow-up|Study terminated by sponsor|1|||
162992073|NCT02861014|588672569|FG000|Safety Follow-up|Physician Decision|1|||
162992074|NCT02861014|588672569|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
162992075|NCT02861014|588672569|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
162992076|NCT04623086|588672571|FG000|Overall Study|Withdrawal by Subject|0|||
162992077|NCT04623086|588672572|FG001|Overall Study|Withdrawal by Subject|0|||
162992078|NCT04623086|588672573|FG002|Overall Study|Withdrawal by Subject|10|||
162992079|NCT03464630|588672574|FG000|Overall Study|Lost to Follow-up|62|||
162992080|NCT03464630|588672575|FG001|Overall Study|Lost to Follow-up|52|||
162992081|NCT03464630|588672574|FG000|Overall Study|Withdrawal by Subject|16|||
163212423|NCT00330616|589492514|FG000|Overall Study|Other|1|||
163212424|NCT02141997|589492519|FG000|Overall Study|Adverse Event|0|||
162992082|NCT03464630|588672575|FG001|Overall Study|Withdrawal by Subject|10|||
162992083|NCT03464630|588672574|FG000|Overall Study|Passive Disengagement|8|||
162992084|NCT03464630|588672575|FG001|Overall Study|Passive Disengagement|4|||
162992085|NCT00715624|588672576|FG000|Overall Study|Adverse Event|12|||
162992086|NCT00715624|588672577|FG001|Overall Study|Adverse Event|37|||
162992087|NCT00715624|588672576|FG000|Overall Study|Lack of Efficacy|11|||
162992088|NCT00715624|588672577|FG001|Overall Study|Lack of Efficacy|11|||
162992089|NCT00715624|588672576|FG000|Overall Study|Lost to Follow-up|1|||
162992090|NCT00715624|588672577|FG001|Overall Study|Lost to Follow-up|2|||
162992091|NCT00715624|588672576|FG000|Overall Study|Protocol Violation|1|||
162992092|NCT00715624|588672577|FG001|Overall Study|Protocol Violation|0|||
162992093|NCT00715624|588672576|FG000|Overall Study|Withdrawal by Subject|11|||
163212425|NCT02141997|589492520|FG001|Overall Study|Adverse Event|2|||
163212426|NCT02141997|589492521|FG002|Overall Study|Adverse Event|0|||
163212427|NCT02141997|589492522|FG003|Overall Study|Adverse Event|1|||
163212428|NCT02141997|589492519|FG000|Overall Study|Participant noncompliance|1|||
163212429|NCT02141997|589492520|FG001|Overall Study|Participant noncompliance|0|||
163212430|NCT02141997|589492521|FG002|Overall Study|Participant noncompliance|0|||
163212431|NCT02141997|589492522|FG003|Overall Study|Participant noncompliance|0|||
163212432|NCT02141997|589492519|FG000|Overall Study|Withdrew consent|1|||
163212433|NCT02141997|589492520|FG001|Overall Study|Withdrew consent|0|||
162992094|NCT00715624|588672577|FG001|Overall Study|Withdrawal by Subject|25|||
162992095|NCT00715624|588672576|FG000|Overall Study|Familial and personal reasons|10|||
162992096|NCT00715624|588672577|FG001|Overall Study|Familial and personal reasons|22|||
162992097|NCT00715624|588672576|FG000|Overall Study|Poor compliance|6|||
162992098|NCT00715624|588672577|FG001|Overall Study|Poor compliance|13|||
162992099|NCT00715624|588672576|FG000|Overall Study|Sponsor decision|0|||
162992100|NCT00715624|588672577|FG001|Overall Study|Sponsor decision|4|||
162992101|NCT00715624|588672576|FG000|Overall Study|Incorrect randomization (not treated)|0|||
162992102|NCT00715624|588672577|FG001|Overall Study|Incorrect randomization (not treated)|1|||
162992103|NCT00715624|588672576|FG000|Overall Study|Other|0|||
162992104|NCT00715624|588672577|FG001|Overall Study|Other|1|||
162992105|NCT04524364|588672580|FG000|Overall Study|Physician Decision|3|||
162992106|NCT04524364|588672581|FG001|Overall Study|Physician Decision|6|||
162992107|NCT04524364|588672580|FG000|Overall Study|Adverse Event|0|||
162992108|NCT04524364|588672581|FG001|Overall Study|Adverse Event|1|||
162992109|NCT04524364|588672580|FG000|Overall Study|Investigational device deficiency|0|||
162992110|NCT04524364|588672581|FG001|Overall Study|Investigational device deficiency|1|||
162992111|NCT04524364|588672580|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
162992112|NCT04524364|588672581|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
162992113|NCT04524364|588672580|FG000|Overall Study|Device unavailability|0|||
162992114|NCT04524364|588672581|FG001|Overall Study|Device unavailability|2|||
162992115|NCT04524364|588672580|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
162992116|NCT04524364|588672581|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
162992117|NCT04524364|588672580|FG000|Overall Study|Low International normalized ratio (INR)|1|||
162992118|NCT04524364|588672581|FG001|Overall Study|Low International normalized ratio (INR)|0|||
162992119|NCT02309138|588672582|FG000|Overall Study|Withdrawal by Subject|44|||
162992120|NCT02309138|588672583|FG001|Overall Study|Withdrawal by Subject|15|||
162992121|NCT02309138|588672582|FG000|Overall Study|Protocol Violation|4|||
162992122|NCT02309138|588672583|FG001|Overall Study|Protocol Violation|2|||
162992123|NCT02309138|588672582|FG000|Overall Study|delivered before visit 2|0|||
162992124|NCT02309138|588672583|FG001|Overall Study|delivered before visit 2|1|||
162992125|NCT00735397|588672588|FG000|Overall Study|Adverse Event|194|||
162992126|NCT00735397|588672588|FG000|Overall Study|Lost to Follow-up|33|||
162992127|NCT00735397|588672588|FG000|Overall Study|Participant choice|252|||
162992128|NCT00735397|588672588|FG000|Overall Study|Inadequate therapeutic effect|202|||
162992129|NCT00735397|588672588|FG000|Overall Study|Administrative/Other|502|||
162992130|NCT00380744|588672589|FG000|Overall Study|Death|0|||
162992131|NCT00380744|588672590|FG001|Overall Study|Death|0|||
162992132|NCT00380744|588672591|FG002|Overall Study|Death|0|||
162992133|NCT00380744|588672592|FG003|Overall Study|Death|0|||
162992134|NCT00380744|588672593|FG004|Overall Study|Death|0|||
162992135|NCT00380744|588672594|FG005|Overall Study|Death|0|||
162992136|NCT00380744|588672595|FG006|Overall Study|Death|1|||
162992137|NCT00380744|588672589|FG000|Overall Study|Withdrawal by Subject|1|||
162992138|NCT00380744|588672590|FG001|Overall Study|Withdrawal by Subject|0|||
162992139|NCT00380744|588672591|FG002|Overall Study|Withdrawal by Subject|0|||
162992140|NCT00380744|588672592|FG003|Overall Study|Withdrawal by Subject|0|||
162992141|NCT00380744|588672593|FG004|Overall Study|Withdrawal by Subject|0|||
162992142|NCT00380744|588672594|FG005|Overall Study|Withdrawal by Subject|0|||
163059995|NCT01859741|588928281|FG003|Overall Study|Lost to Follow-up|0|||
163059996|NCT01859741|588928282|FG004|Overall Study|Lost to Follow-up|0|||
163059997|NCT01859741|588928283|FG005|Overall Study|Lost to Follow-up|1|||
163059998|NCT01859741|588928284|FG006|Overall Study|Lost to Follow-up|0|||
163059999|NCT01859741|588928285|FG007|Overall Study|Lost to Follow-up|4|||
163060000|NCT01859741|588928278|FG000|Overall Study|Withdrawal by Subject|0|||
163060001|NCT01859741|588928279|FG001|Overall Study|Withdrawal by Subject|1|||
163060002|NCT01859741|588928280|FG002|Overall Study|Withdrawal by Subject|2|||
163060003|NCT01859741|588928281|FG003|Overall Study|Withdrawal by Subject|0|||
163060004|NCT01859741|588928282|FG004|Overall Study|Withdrawal by Subject|0|||
163060005|NCT01859741|588928283|FG005|Overall Study|Withdrawal by Subject|1|||
163060006|NCT01859741|588928284|FG006|Overall Study|Withdrawal by Subject|1|||
163212434|NCT02141997|589492521|FG002|Overall Study|Withdrew consent|3|||
163060007|NCT01859741|588928285|FG007|Overall Study|Withdrawal by Subject|1|||
163060008|NCT01859741|588928278|FG000|Overall Study|Study Terminated by Sponsor|0|||
162992143|NCT00380744|588672595|FG006|Overall Study|Withdrawal by Subject|0|||
162992144|NCT01955083|588672603|FG000|Overall Study|Lost to Follow-up|1|||
162992145|NCT01955083|588672604|FG001|Overall Study|Lost to Follow-up|1|||
162992146|NCT01559389|588672615|FG000|Overall Study|Withdrawal by Subject|20|||
162992147|NCT01559389|588672616|FG001|Overall Study|Withdrawal by Subject|20|||
162992148|NCT02871492|588672617|FG000|Overall Study|Lost to Follow-up|6|||
162992149|NCT02871492|588672618|FG001|Overall Study|Lost to Follow-up|3|||
162992150|NCT02871492|588672619|FG002|Overall Study|Lost to Follow-up|5|||
162992151|NCT02871492|588672617|FG000|Overall Study|Withdrawal by Subject|0|||
162992152|NCT02871492|588672618|FG001|Overall Study|Withdrawal by Subject|0|||
162992153|NCT02871492|588672619|FG002|Overall Study|Withdrawal by Subject|1|||
163060009|NCT01859741|588928279|FG001|Overall Study|Study Terminated by Sponsor|0|||
162992154|NCT04546724|588672620|FG000|Overall Study|Withdrawal by Subject|145|||
162992155|NCT04546724|588672621|FG001|Overall Study|Withdrawal by Subject|41|||
162992156|NCT04546724|588672620|FG000|Overall Study|Adverse Event|1|||
162992157|NCT04546724|588672621|FG001|Overall Study|Adverse Event|1|||
162992158|NCT04546724|588672620|FG000|Overall Study|Lost to Follow-up|186|||
162992159|NCT04546724|588672621|FG001|Overall Study|Lost to Follow-up|63|||
162992160|NCT04546724|588672620|FG000|Overall Study|Physician Decision|8|||
162992161|NCT04546724|588672621|FG001|Overall Study|Physician Decision|2|||
162992162|NCT04546724|588672620|FG000|Overall Study|Death|2|||
162992163|NCT04546724|588672621|FG001|Overall Study|Death|1|||
162992164|NCT04546724|588672620|FG000|Overall Study|subject has been out of town|1|||
162992165|NCT04546724|588672621|FG001|Overall Study|subject has been out of town|0|||
162992166|NCT04546724|588672620|FG000|Overall Study|subject is incarcerated|2|||
162992167|NCT04546724|588672621|FG001|Overall Study|subject is incarcerated|0|||
162992168|NCT04546724|588672620|FG000|Overall Study|subject is relocating|12|||
162992169|NCT04546724|588672621|FG001|Overall Study|subject is relocating|4|||
162992170|NCT04546724|588672620|FG000|Overall Study|Subject in another study|1|||
162992171|NCT04546724|588672621|FG001|Overall Study|Subject in another study|1|||
162992172|NCT03583086|588672622|FG000|Overall Study|Death|2|||
162992173|NCT03583086|588672623|FG001|Overall Study|Death|6|||
162992174|NCT03583086|588672624|FG002|Overall Study|Death|12|||
162992175|NCT03583086|588672625|FG003|Overall Study|Death|10|||
162992176|NCT03583086|588672626|FG004|Overall Study|Death|14|||
162992177|NCT03583086|588672627|FG005|Overall Study|Death|14|||
162992178|NCT03583086|588672628|FG006|Overall Study|Death|4|||
162992179|NCT03583086|588672622|FG000|Overall Study|Withdrawal by Subject|0|||
162992180|NCT03583086|588672623|FG001|Overall Study|Withdrawal by Subject|0|||
162992181|NCT03583086|588672624|FG002|Overall Study|Withdrawal by Subject|1|||
162992182|NCT03583086|588672625|FG003|Overall Study|Withdrawal by Subject|0|||
162992183|NCT03583086|588672626|FG004|Overall Study|Withdrawal by Subject|0|||
162992184|NCT03583086|588672627|FG005|Overall Study|Withdrawal by Subject|0|||
162992185|NCT03583086|588672628|FG006|Overall Study|Withdrawal by Subject|1|||
162992186|NCT03583086|588672622|FG000|Overall Study|Refused follow-up|0|||
162992187|NCT03583086|588672623|FG001|Overall Study|Refused follow-up|0|||
162992188|NCT03583086|588672624|FG002|Overall Study|Refused follow-up|1|||
162992189|NCT03583086|588672625|FG003|Overall Study|Refused follow-up|0|||
162992190|NCT03583086|588672626|FG004|Overall Study|Refused follow-up|1|||
162992191|NCT03583086|588672627|FG005|Overall Study|Refused follow-up|0|||
162992192|NCT03583086|588672628|FG006|Overall Study|Refused follow-up|0|||
162992193|NCT03583086|588672622|FG000|Overall Study|Declining Performance Status|0|||
162992194|NCT03583086|588672623|FG001|Overall Study|Declining Performance Status|0|||
162992195|NCT03583086|588672624|FG002|Overall Study|Declining Performance Status|1|||
162992196|NCT03583086|588672625|FG003|Overall Study|Declining Performance Status|0|||
162992197|NCT03583086|588672626|FG004|Overall Study|Declining Performance Status|0|||
162992198|NCT03583086|588672627|FG005|Overall Study|Declining Performance Status|0|||
162992199|NCT03583086|588672628|FG006|Overall Study|Declining Performance Status|0|||
162992200|NCT03583086|588672622|FG000|Overall Study|Still on study|0|||
162992201|NCT03583086|588672623|FG001|Overall Study|Still on study|0|||
162992202|NCT03583086|588672624|FG002|Overall Study|Still on study|0|||
162992203|NCT03583086|588672625|FG003|Overall Study|Still on study|1|||
162992204|NCT03583086|588672626|FG004|Overall Study|Still on study|0|||
163324618|NCT03660930|589900666|FG007|Overall Study|Withdrawal by Subject|0|||
162992205|NCT03583086|588672627|FG005|Overall Study|Still on study|0|||
162992206|NCT03583086|588672628|FG006|Overall Study|Still on study|1|||
162992207|NCT03583086|588672622|FG000|Overall Study|Disease progression|0|||
162992208|NCT03583086|588672623|FG001|Overall Study|Disease progression|0|||
162992209|NCT03583086|588672624|FG002|Overall Study|Disease progression|0|||
162992210|NCT03583086|588672625|FG003|Overall Study|Disease progression|0|||
162992211|NCT03583086|588672626|FG004|Overall Study|Disease progression|0|||
162992212|NCT03583086|588672627|FG005|Overall Study|Disease progression|0|||
162992213|NCT03583086|588672628|FG006|Overall Study|Disease progression|1|||
162992214|NCT03583086|588672622|FG000|Overall Study|Undergoing radiation therapy|0|||
162992215|NCT03583086|588672623|FG001|Overall Study|Undergoing radiation therapy|0|||
162992216|NCT03583086|588672624|FG002|Overall Study|Undergoing radiation therapy|0|||
163324619|NCT03725332|589900667|FG000|Overall Study|Adverse Event|5|||
162992217|NCT03583086|588672625|FG003|Overall Study|Undergoing radiation therapy|0|||
162992218|NCT03583086|588672626|FG004|Overall Study|Undergoing radiation therapy|0|||
163324620|NCT03725332|589900668|FG001|Overall Study|Adverse Event|10|||
163324621|NCT03725332|589900667|FG000|Overall Study|Death|1|||
162992219|NCT03583086|588672627|FG005|Overall Study|Undergoing radiation therapy|0|||
162992220|NCT03583086|588672628|FG006|Overall Study|Undergoing radiation therapy|1|||
162992221|NCT03583086|588672622|FG000|Overall Study|Lost to Follow-up|0|||
162992222|NCT03583086|588672623|FG001|Overall Study|Lost to Follow-up|0|||
162992223|NCT03583086|588672624|FG002|Overall Study|Lost to Follow-up|0|||
162992224|NCT03583086|588672625|FG003|Overall Study|Lost to Follow-up|0|||
162992225|NCT03583086|588672626|FG004|Overall Study|Lost to Follow-up|0|||
162992226|NCT03583086|588672627|FG005|Overall Study|Lost to Follow-up|1|||
162992227|NCT03583086|588672628|FG006|Overall Study|Lost to Follow-up|0|||
162992228|NCT03583086|588672622|FG000|Overall Study|Adverse Event|0|||
162992229|NCT03583086|588672623|FG001|Overall Study|Adverse Event|0|||
162992230|NCT03583086|588672624|FG002|Overall Study|Adverse Event|0|||
162992231|NCT03583086|588672625|FG003|Overall Study|Adverse Event|0|||
162992232|NCT03583086|588672626|FG004|Overall Study|Adverse Event|0|||
162992233|NCT03583086|588672627|FG005|Overall Study|Adverse Event|1|||
162992234|NCT03583086|588672628|FG006|Overall Study|Adverse Event|0|||
162992235|NCT00396812|588672632|FG000|Overall Study|Physician Decision|1|||
162992236|NCT03201445|588672634|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
162992237|NCT03201445|588672635|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
162992238|NCT03201445|588672634|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
162992239|NCT03201445|588672635|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
162992240|NCT03201445|588672634|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
162992241|NCT03201445|588672635|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
162992242|NCT03201445|588672634|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
162992243|NCT03201445|588672635|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
162992244|NCT03201445|588672634|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
162992245|NCT03201445|588672635|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
162992246|NCT03201445|588672634|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
162992247|NCT03201445|588672635|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
162992248|NCT03201445|588672634|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
162992249|NCT03201445|588672635|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
162992250|NCT03201445|588672634|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
162992251|NCT03201445|588672635|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
162992252|NCT03201445|588672634|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
162992253|NCT03201445|588672635|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
162992254|NCT03201445|588672634|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
162992255|NCT03201445|588672635|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
162992256|NCT03201445|588672634|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
162992257|NCT03201445|588672635|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
162992258|NCT03201445|588672634|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
162992259|NCT03201445|588672635|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
162992260|NCT03201445|588672634|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
162992261|NCT03201445|588672635|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
162992262|NCT03201445|588672634|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
162992263|NCT03201445|588672635|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
162992264|NCT03201445|588672634|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
162992265|NCT03201445|588672635|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
162992266|NCT03201445|588672634|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
162992267|NCT03201445|588672635|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
162992268|NCT03201445|588672634|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
162992269|NCT03201445|588672635|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
162992270|NCT03201445|588672634|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
162992271|NCT03201445|588672635|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
162992272|NCT03201445|588672634|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
162992273|NCT03201445|588672635|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
162992274|NCT03201445|588672634|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
162992275|NCT03201445|588672635|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
162992276|NCT03201445|588672634|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
162992277|NCT03201445|588672635|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
162992278|NCT01228019|588672636|FG000|Overall Study|Dose Violation|70|||
162992279|NCT01228019|588672636|FG000|Overall Study|Duplicate enrollment|1|||
162992280|NCT01228019|588672636|FG000|Overall Study|Missing pre-treatment data|72|||
162992281|NCT01228019|588672636|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
162992282|NCT01228019|588672636|FG000|Overall Study|Violation of Entry Criterion|9|||
162992283|NCT01268501|588672637|FG000|Overall Study|Lost to Follow-up|1|||
162992284|NCT01268501|588672637|FG000|Overall Study|Withdrawal by Subject|3|||
162992285|NCT01268501|588672637|FG000|Overall Study|Unacceptable Subjective Vision|3|||
162992286|NCT01268501|588672637|FG000|Overall Study|Handling Difficulties|2|||
162992287|NCT00724048|588672638|FG000|Overall Study|Adverse Event|1|||
162992288|NCT00724048|588672639|FG001|Overall Study|Adverse Event|1|||
163060010|NCT01859741|588928280|FG002|Overall Study|Study Terminated by Sponsor|0|||
163060011|NCT01859741|588928281|FG003|Overall Study|Study Terminated by Sponsor|0|||
162992289|NCT00724048|588672640|FG002|Overall Study|Adverse Event|1|||
162992290|NCT00724048|588672641|FG003|Overall Study|Adverse Event|0|||
162992291|NCT00724048|588672638|FG000|Overall Study|Lost to Follow-up|0|||
162992292|NCT00724048|588672639|FG001|Overall Study|Lost to Follow-up|1|||
162992293|NCT00724048|588672640|FG002|Overall Study|Lost to Follow-up|0|||
162992294|NCT00724048|588672641|FG003|Overall Study|Lost to Follow-up|0|||
162992295|NCT00724048|588672638|FG000|Overall Study|Withdrawal by Subject|1|||
162992296|NCT00724048|588672639|FG001|Overall Study|Withdrawal by Subject|2|||
162992297|NCT00724048|588672640|FG002|Overall Study|Withdrawal by Subject|1|||
162992298|NCT00724048|588672641|FG003|Overall Study|Withdrawal by Subject|2|||
162992299|NCT00724048|588672638|FG000|Overall Study|Investigator decision|0|||
162992300|NCT00724048|588672639|FG001|Overall Study|Investigator decision|0|||
162992301|NCT00724048|588672640|FG002|Overall Study|Investigator decision|1|||
162992302|NCT00724048|588672641|FG003|Overall Study|Investigator decision|0|||
162992303|NCT00724048|588672638|FG000|Overall Study|Did not tolerate study drug|0|||
162992304|NCT00724048|588672639|FG001|Overall Study|Did not tolerate study drug|0|||
162992305|NCT00724048|588672640|FG002|Overall Study|Did not tolerate study drug|0|||
162992306|NCT00724048|588672641|FG003|Overall Study|Did not tolerate study drug|1|||
162992307|NCT00724048|588672638|FG000|Overall Study|Other than specified|1|||
162992308|NCT00724048|588672639|FG001|Overall Study|Other than specified|1|||
162992309|NCT00724048|588672640|FG002|Overall Study|Other than specified|0|||
162992310|NCT00724048|588672641|FG003|Overall Study|Other than specified|0|||
162992311|NCT04874155|588672642|FG000|Overall Study|Lost to Follow-up|1|||
162992312|NCT04874155|588672643|FG001|Overall Study|Lost to Follow-up|1|||
162992313|NCT04874155|588672642|FG000|Overall Study|Withdrawal by Subject|2|||
162992314|NCT04874155|588672643|FG001|Overall Study|Withdrawal by Subject|2|||
162992315|NCT00474266|588672646|FG000|Overall Study|Withdrawal by Subject|7|||
162992316|NCT00474266|588672647|FG001|Overall Study|Withdrawal by Subject|20|||
162992317|NCT00474266|588672648|FG002|Overall Study|Withdrawal by Subject|4|||
162992318|NCT00474266|588672649|FG003|Overall Study|Withdrawal by Subject|7|||
162992319|NCT02329847|588672650|FG000|Overall Study|Death|4|||
162992320|NCT02329847|588672651|FG001|Overall Study|Death|4|||
162992321|NCT02329847|588672652|FG002|Overall Study|Death|22|||
162992322|NCT02329847|588672653|FG003|Overall Study|Death|12|||
162992323|NCT02329847|588672654|FG004|Overall Study|Death|20|||
162992324|NCT02329847|588672655|FG005|Overall Study|Death|13|||
162992325|NCT02329847|588672650|FG000|Overall Study|Lost to Follow-up|0|||
162992326|NCT02329847|588672651|FG001|Overall Study|Lost to Follow-up|0|||
162992327|NCT02329847|588672652|FG002|Overall Study|Lost to Follow-up|2|||
162992328|NCT02329847|588672653|FG003|Overall Study|Lost to Follow-up|3|||
162992329|NCT02329847|588672654|FG004|Overall Study|Lost to Follow-up|0|||
162992330|NCT02329847|588672655|FG005|Overall Study|Lost to Follow-up|1|||
162992331|NCT02329847|588672650|FG000|Overall Study|Physician Decision|0|||
162992332|NCT02329847|588672651|FG001|Overall Study|Physician Decision|0|||
162992333|NCT02329847|588672652|FG002|Overall Study|Physician Decision|0|||
162992334|NCT02329847|588672653|FG003|Overall Study|Physician Decision|0|||
162992335|NCT02329847|588672654|FG004|Overall Study|Physician Decision|1|||
162992336|NCT02329847|588672655|FG005|Overall Study|Physician Decision|0|||
162992337|NCT02329847|588672650|FG000|Overall Study|Withdrawal by Subject|2|||
162992338|NCT02329847|588672651|FG001|Overall Study|Withdrawal by Subject|1|||
162992339|NCT02329847|588672652|FG002|Overall Study|Withdrawal by Subject|5|||
162992340|NCT02329847|588672653|FG003|Overall Study|Withdrawal by Subject|7|||
162992341|NCT02329847|588672654|FG004|Overall Study|Withdrawal by Subject|8|||
162992342|NCT02329847|588672655|FG005|Overall Study|Withdrawal by Subject|3|||
162992343|NCT02329847|588672650|FG000|Overall Study|Other|1|||
162992344|NCT02329847|588672651|FG001|Overall Study|Other|2|||
162992345|NCT02329847|588672652|FG002|Overall Study|Other|6|||
162992346|NCT02329847|588672653|FG003|Overall Study|Other|13|||
162992347|NCT02329847|588672654|FG004|Overall Study|Other|10|||
162992348|NCT02329847|588672655|FG005|Overall Study|Other|3|||
162992349|NCT05330468|588672656|FG000|Overall Study|Death|6|||
162992350|NCT05330468|588672656|FG000|Overall Study|Withdrawal by Subject|4|||
162992351|NCT05330468|588672656|FG000|Overall Study|Lost to Follow-up|4|||
162992352|NCT02828241|588672659|FG000|Overall Study|Adverse Event|7|||
162992353|NCT02828241|588672660|FG001|Overall Study|Adverse Event|2|||
162992354|NCT02828241|588672659|FG000|Overall Study|Protocol Violation|1|||
162992355|NCT02828241|588672660|FG001|Overall Study|Protocol Violation|0|||
162992356|NCT04572893|588672661|FG000|Part A|Adverse Event|1|||
162992357|NCT04572893|588672662|FG001|Part A|Adverse Event|0|||
162992358|NCT04572893|588672663|FG002|Part A|Adverse Event|0|||
162992359|NCT04572893|588672664|FG003|Part A|Adverse Event|0|||
162992360|NCT04572893|588672665|FG004|Part A|Adverse Event|0|||
162992361|NCT04572893|588672666|FG005|Part A|Adverse Event|0|||
163212435|NCT02141997|589492522|FG003|Overall Study|Withdrew consent|0|||
162992362|NCT04572893|588672667|FG006|Part A|Adverse Event|0|||
162992363|NCT04572893|588672661|FG000|Part B|Withdrawal by Subject|0|||
162992364|NCT04572893|588672662|FG001|Part B|Withdrawal by Subject|0|||
162992365|NCT04572893|588672663|FG002|Part B|Withdrawal by Subject|0|||
162992366|NCT04572893|588672664|FG003|Part B|Withdrawal by Subject|0|||
162992367|NCT04572893|588672665|FG004|Part B|Withdrawal by Subject|0|||
162992368|NCT04572893|588672666|FG005|Part B|Withdrawal by Subject|1|||
162992369|NCT04572893|588672667|FG006|Part B|Withdrawal by Subject|0|||
162992370|NCT04572893|588672661|FG000|Part B|Study terminated by sponsor|0|||
162992371|NCT04572893|588672662|FG001|Part B|Study terminated by sponsor|0|||
162992372|NCT04572893|588672663|FG002|Part B|Study terminated by sponsor|0|||
162992373|NCT04572893|588672664|FG003|Part B|Study terminated by sponsor|0|||
162992374|NCT04572893|588672665|FG004|Part B|Study terminated by sponsor|7|||
162992375|NCT04572893|588672666|FG005|Part B|Study terminated by sponsor|5|||
162992376|NCT04572893|588672667|FG006|Part B|Study terminated by sponsor|3|||
162992377|NCT04572893|588672661|FG000|Part B|Lost to Follow-up|0|||
162992378|NCT04572893|588672662|FG001|Part B|Lost to Follow-up|0|||
162992379|NCT04572893|588672663|FG002|Part B|Lost to Follow-up|0|||
162992380|NCT04572893|588672664|FG003|Part B|Lost to Follow-up|0|||
162992381|NCT04572893|588672665|FG004|Part B|Lost to Follow-up|0|||
162992382|NCT04572893|588672666|FG005|Part B|Lost to Follow-up|0|||
162992383|NCT04572893|588672667|FG006|Part B|Lost to Follow-up|1|||
162992384|NCT04572893|588672661|FG000|Part B|Adverse Event|0|||
162992385|NCT04572893|588672662|FG001|Part B|Adverse Event|0|||
162992386|NCT04572893|588672663|FG002|Part B|Adverse Event|0|||
162992387|NCT04572893|588672664|FG003|Part B|Adverse Event|0|||
162992388|NCT04572893|588672665|FG004|Part B|Adverse Event|1|||
162992389|NCT04572893|588672666|FG005|Part B|Adverse Event|1|||
162992390|NCT04572893|588672667|FG006|Part B|Adverse Event|0|||
162992391|NCT00477295|588672675|FG000|Overall Study|Adverse Event|31|||
162992392|NCT00477295|588672676|FG001|Overall Study|Adverse Event|35|||
162992393|NCT00477295|588672675|FG000|Overall Study|Withdrawal by Subject|35|||
162992394|NCT00477295|588672676|FG001|Overall Study|Withdrawal by Subject|24|||
162992395|NCT00477295|588672675|FG000|Overall Study|Lack of Efficacy|23|||
162992396|NCT00477295|588672676|FG001|Overall Study|Lack of Efficacy|23|||
162992397|NCT00477295|588672675|FG000|Overall Study|Protocol Violation|3|||
162992398|NCT00477295|588672676|FG001|Overall Study|Protocol Violation|8|||
162992399|NCT00477295|588672675|FG000|Overall Study|Physician Decision|4|||
162992400|NCT00477295|588672676|FG001|Overall Study|Physician Decision|5|||
162992401|NCT00477295|588672675|FG000|Overall Study|Lost to Follow-up|21|||
162992402|NCT00477295|588672676|FG001|Overall Study|Lost to Follow-up|11|||
162992403|NCT00477295|588672675|FG000|Overall Study|Other|4|||
162992404|NCT00477295|588672676|FG001|Overall Study|Other|3|||
162992405|NCT03276780|588672679|FG000|Overall Study|Withdrawal by Subject|5|||
162992406|NCT03276780|588672680|FG001|Overall Study|Withdrawal by Subject|3|||
162992407|NCT03276780|588672679|FG000|Overall Study|Lost to Follow-up|3|||
162992408|NCT03276780|588672680|FG001|Overall Study|Lost to Follow-up|5|||
162992409|NCT03276780|588672679|FG000|Overall Study|Moved out of state|1|||
162992410|NCT03276780|588672680|FG001|Overall Study|Moved out of state|1|||
162992411|NCT03276780|588672679|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
162992412|NCT03276780|588672680|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
162992413|NCT03276780|588672679|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
162992414|NCT03276780|588672680|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
162992415|NCT00510289|588672681|FG000|Overall Study|Withdrawal by Subject|7|||
162992416|NCT00510289|588672681|FG000|Overall Study|Refused bone marrow biopsy|2|||
162992417|NCT00510289|588672681|FG000|Overall Study|Lost to Follow-up|1|||
162992418|NCT00510289|588672681|FG000|Overall Study|Progressed prior to starting drug|2|||
162992419|NCT01197755|588672685|FG000|Overall Study|Adverse Event|8|||
162992420|NCT01197755|588672686|FG001|Overall Study|Adverse Event|10|||
162992421|NCT01197755|588672687|FG002|Overall Study|Adverse Event|10|||
162992422|NCT01197755|588672685|FG000|Overall Study|Study-specific discontinuation criteria|2|||
162992423|NCT01197755|588672686|FG001|Overall Study|Study-specific discontinuation criteria|1|||
162992424|NCT01197755|588672687|FG002|Overall Study|Study-specific discontinuation criteria|0|||
162992425|NCT01197755|588672685|FG000|Overall Study|Entered the long-term extension study|18|||
162992426|NCT01197755|588672686|FG001|Overall Study|Entered the long-term extension study|21|||
162992427|NCT01197755|588672687|FG002|Overall Study|Entered the long-term extension study|35|||
162992428|NCT01197755|588672685|FG000|Overall Study|Lack of therapeutic response|0|||
162992429|NCT01197755|588672686|FG001|Overall Study|Lack of therapeutic response|7|||
162992430|NCT01197755|588672687|FG002|Overall Study|Lack of therapeutic response|4|||
162992431|NCT01197755|588672685|FG000|Overall Study|Severe non-compliance to the protocol|2|||
162992432|NCT01197755|588672686|FG001|Overall Study|Severe non-compliance to the protocol|1|||
162992433|NCT01197755|588672687|FG002|Overall Study|Severe non-compliance to the protocol|2|||
162992434|NCT01197755|588672685|FG000|Overall Study|Withdrawal by Subject|1|||
162992435|NCT01197755|588672686|FG001|Overall Study|Withdrawal by Subject|0|||
162992436|NCT01197755|588672687|FG002|Overall Study|Withdrawal by Subject|0|||
163324622|NCT03725332|589900668|FG001|Overall Study|Death|3|||
163324623|NCT03725332|589900667|FG000|Overall Study|Lost to Follow-up|43|||
162992437|NCT01197755|588672685|FG000|Overall Study|Lost to Follow-up|0|||
162992438|NCT01197755|588672686|FG001|Overall Study|Lost to Follow-up|0|||
162992439|NCT01197755|588672687|FG002|Overall Study|Lost to Follow-up|1|||
162992440|NCT01197755|588672685|FG000|Overall Study|eg, change in circumstances|7|||
163324624|NCT03725332|589900668|FG001|Overall Study|Lost to Follow-up|122|||
162992441|NCT01197755|588672686|FG001|Overall Study|eg, change in circumstances|3|||
162992442|NCT01197755|588672687|FG002|Overall Study|eg, change in circumstances|2|||
162992443|NCT03365011|588672688|FG000|Overall Study|Withdrawal by Subject|1|||
162992444|NCT03365011|588672689|FG001|Overall Study|Withdrawal by Subject|2|||
162992445|NCT03395405|588674435|FG000|Overall Study|Death|0|||
162992446|NCT03395405|588674436|FG001|Overall Study|Death|2|||
163324625|NCT03725332|589900667|FG000|Overall Study|Withdrawal by Subject|0|||
162992447|NCT03395405|588674435|FG000|Overall Study|Lost to Follow-up|0|||
162992448|NCT03395405|588674436|FG001|Overall Study|Lost to Follow-up|1|||
162992449|NCT03395405|588674435|FG000|Overall Study|Protocol Violation|0|||
162992450|NCT03395405|588674436|FG001|Overall Study|Protocol Violation|1|||
162992451|NCT03395405|588674435|FG000|Overall Study|Withdrawal by Subject|3|||
162992452|NCT03395405|588674436|FG001|Overall Study|Withdrawal by Subject|1|||
162992453|NCT03395405|588674435|FG000|Overall Study|COVID-19 Pandemic|1|||
162992454|NCT03395405|588674436|FG001|Overall Study|COVID-19 Pandemic|0|||
162992455|NCT01200069|588674442|FG000|Overall Study|Withdrawal by Subject|0|||
162992456|NCT01200069|588674443|FG001|Overall Study|Withdrawal by Subject|1|||
162992457|NCT05307510|588674446|FG000|Overall Study|Lost to Follow-up|3|||
162992458|NCT05307510|588674447|FG001|Overall Study|Lost to Follow-up|6|||
162992459|NCT05307510|588674446|FG000|Overall Study|Withdrawal by Subject|0|||
162992460|NCT05307510|588674447|FG001|Overall Study|Withdrawal by Subject|1|||
162992461|NCT00761657|588674450|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
162992462|NCT00761657|588674451|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
162992463|NCT00761657|588674452|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
162992464|NCT00761657|588674453|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
162992465|NCT00761657|588674454|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
162992466|NCT00761657|588674455|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
162992467|NCT00761657|588674456|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
163324626|NCT03725332|589900668|FG001|Overall Study|Withdrawal by Subject|1|||
163324627|NCT03725332|589900667|FG000|Overall Study|Duplicate enrollment|0|||
163324628|NCT03725332|589900668|FG001|Overall Study|Duplicate enrollment|1|||
163324629|NCT03725332|589900667|FG000|Overall Study|Did not consent|0|||
162992468|NCT00761657|588674457|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
162992469|NCT00761657|588674458|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
162992470|NCT00761657|588674450|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
162992471|NCT00761657|588674451|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
162992472|NCT00761657|588674452|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
162992473|NCT00761657|588674453|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
162992474|NCT00761657|588674454|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
162992475|NCT00761657|588674455|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
162992476|NCT00761657|588674456|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
162992477|NCT00761657|588674457|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
162992478|NCT00761657|588674458|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
162992479|NCT00761657|588674450|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
162992480|NCT00761657|588674451|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
162992481|NCT00761657|588674452|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
162992482|NCT00761657|588674453|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
162992483|NCT00761657|588674454|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
162992484|NCT00761657|588674455|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
162992485|NCT00761657|588674456|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
162992486|NCT00761657|588674457|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
162992487|NCT00761657|588674458|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
162992488|NCT00761657|588674450|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
162992489|NCT00761657|588674451|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
162992490|NCT00761657|588674452|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
162992491|NCT00761657|588674453|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
162992492|NCT00761657|588674454|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
162992493|NCT00761657|588674455|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
162992494|NCT00761657|588674456|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
162992495|NCT00761657|588674457|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
162992496|NCT00761657|588674458|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
162992497|NCT00478244|588674467|FG000|Overall Study|Did not receive transplant|1|||
162992498|NCT01564537|588674469|FG000|Overall Study|Site Terminated by Sponsor|1|||
162992499|NCT01564537|588674470|FG001|Overall Study|Site Terminated by Sponsor|0|||
162992500|NCT01564537|588674469|FG000|Overall Study|Withdrawal by Subject|12|||
162992501|NCT01564537|588674470|FG001|Overall Study|Withdrawal by Subject|14|||
163324630|NCT03725332|589900668|FG001|Overall Study|Did not consent|1|||
163324631|NCT03242915|589900673|FG000|Overall Study|Adverse Event|5|||
162992502|NCT01564537|588674469|FG000|Overall Study|Lost to Follow-up|7|||
162992503|NCT01564537|588674470|FG001|Overall Study|Lost to Follow-up|3|||
162992504|NCT01564537|588674469|FG000|Overall Study|Reason not specified|81|||
162992505|NCT01564537|588674470|FG001|Overall Study|Reason not specified|82|||
162992506|NCT01664130|588674488|FG000|Overall Study|competing secondary disease|2|||
162992507|NCT02679235|588674489|FG000|Overall Study|Withdrawal by Subject|3|||
162992508|NCT02679235|588674489|FG000|Overall Study|Adverse Event|1|||
162992509|NCT00923273|588674490|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
162992510|NCT00923273|588674491|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
162992511|NCT00923273|588674492|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
162992512|NCT00923273|588674493|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
162992513|NCT00923273|588674494|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
163060012|NCT01859741|588928282|FG004|Overall Study|Study Terminated by Sponsor|1|||
162992514|NCT00923273|588674490|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
162992515|NCT00923273|588674491|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
162992516|NCT00923273|588674492|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
162992517|NCT00923273|588674493|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
162992518|NCT00923273|588674494|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
162992519|NCT03146962|588674499|FG000|Overall Study|Lost to Follow-up|1|||
162992520|NCT03146962|588674500|FG001|Overall Study|Lost to Follow-up|1|||
162992521|NCT03146962|588674501|FG002|Overall Study|Lost to Follow-up|0|||
162992522|NCT03146962|588674502|FG003|Overall Study|Lost to Follow-up|0|||
162992523|NCT03146962|588674503|FG004|Overall Study|Lost to Follow-up|0|||
162992524|NCT03146962|588674504|FG005|Overall Study|Lost to Follow-up|0|||
162992525|NCT03146962|588674505|FG006|Overall Study|Lost to Follow-up|0|||
162992526|NCT03146962|588674506|FG007|Overall Study|Lost to Follow-up|0|||
162992527|NCT03146962|588674507|FG008|Overall Study|Lost to Follow-up|0|||
162992528|NCT03146962|588674508|FG009|Overall Study|Lost to Follow-up|0|||
162992529|NCT03146962|588674499|FG000|Overall Study|Adverse Event|0|||
162992530|NCT03146962|588674500|FG001|Overall Study|Adverse Event|3|||
162992531|NCT03146962|588674501|FG002|Overall Study|Adverse Event|0|||
162992532|NCT03146962|588674502|FG003|Overall Study|Adverse Event|0|||
162992533|NCT03146962|588674503|FG004|Overall Study|Adverse Event|0|||
162992534|NCT03146962|588674504|FG005|Overall Study|Adverse Event|0|||
162992535|NCT03146962|588674505|FG006|Overall Study|Adverse Event|0|||
162992536|NCT03146962|588674506|FG007|Overall Study|Adverse Event|1|||
162992537|NCT03146962|588674507|FG008|Overall Study|Adverse Event|0|||
162992538|NCT03146962|588674508|FG009|Overall Study|Adverse Event|0|||
162992539|NCT03146962|588674499|FG000|Overall Study|Withdrawal by Subject|0|||
162992540|NCT03146962|588674500|FG001|Overall Study|Withdrawal by Subject|0|||
162992541|NCT03146962|588674501|FG002|Overall Study|Withdrawal by Subject|0|||
162992542|NCT03146962|588674502|FG003|Overall Study|Withdrawal by Subject|0|||
162992543|NCT03146962|588674503|FG004|Overall Study|Withdrawal by Subject|1|||
162992544|NCT03146962|588674504|FG005|Overall Study|Withdrawal by Subject|0|||
162992545|NCT03146962|588674505|FG006|Overall Study|Withdrawal by Subject|0|||
162992546|NCT03146962|588674506|FG007|Overall Study|Withdrawal by Subject|0|||
162992547|NCT03146962|588674507|FG008|Overall Study|Withdrawal by Subject|0|||
162992548|NCT03146962|588674508|FG009|Overall Study|Withdrawal by Subject|0|||
162992549|NCT03146962|588674499|FG000|Overall Study|Death|0|||
162992550|NCT03146962|588674500|FG001|Overall Study|Death|1|||
162992551|NCT03146962|588674501|FG002|Overall Study|Death|0|||
162992552|NCT03146962|588674502|FG003|Overall Study|Death|0|||
162992553|NCT03146962|588674503|FG004|Overall Study|Death|0|||
162992554|NCT03146962|588674504|FG005|Overall Study|Death|0|||
162992555|NCT03146962|588674505|FG006|Overall Study|Death|0|||
162992556|NCT03146962|588674506|FG007|Overall Study|Death|0|||
162992557|NCT03146962|588674507|FG008|Overall Study|Death|0|||
162992558|NCT03146962|588674508|FG009|Overall Study|Death|0|||
162992559|NCT03146962|588674499|FG000|Overall Study|COVID Precautions|1|||
162992560|NCT03146962|588674500|FG001|Overall Study|COVID Precautions|0|||
162992561|NCT03146962|588674501|FG002|Overall Study|COVID Precautions|0|||
162992562|NCT03146962|588674502|FG003|Overall Study|COVID Precautions|0|||
162992563|NCT03146962|588674503|FG004|Overall Study|COVID Precautions|0|||
162992564|NCT03146962|588674504|FG005|Overall Study|COVID Precautions|0|||
162992565|NCT03146962|588674505|FG006|Overall Study|COVID Precautions|0|||
162992566|NCT03146962|588674506|FG007|Overall Study|COVID Precautions|0|||
162992567|NCT03146962|588674507|FG008|Overall Study|COVID Precautions|0|||
162992568|NCT03146962|588674508|FG009|Overall Study|COVID Precautions|0|||
162992569|NCT03146962|588674499|FG000|Overall Study|Physician Decision|0|||
162992570|NCT03146962|588674500|FG001|Overall Study|Physician Decision|0|||
162992571|NCT03146962|588674501|FG002|Overall Study|Physician Decision|0|||
163060013|NCT01859741|588928283|FG005|Overall Study|Study Terminated by Sponsor|0|||
162992572|NCT03146962|588674502|FG003|Overall Study|Physician Decision|0|||
162992573|NCT03146962|588674503|FG004|Overall Study|Physician Decision|0|||
162992574|NCT03146962|588674504|FG005|Overall Study|Physician Decision|0|||
162992575|NCT03146962|588674505|FG006|Overall Study|Physician Decision|0|||
162992576|NCT03146962|588674506|FG007|Overall Study|Physician Decision|0|||
163060014|NCT01859741|588928284|FG006|Overall Study|Study Terminated by Sponsor|16|||
163060015|NCT01859741|588928285|FG007|Overall Study|Study Terminated by Sponsor|14|||
163060016|NCT01859741|588928278|FG000|Overall Study|Other|0|||
163060017|NCT01859741|588928279|FG001|Overall Study|Other|0|||
163212436|NCT02141997|589492519|FG000|Overall Study|Other|1|||
162992577|NCT03146962|588674507|FG008|Overall Study|Physician Decision|0|||
162992578|NCT03146962|588674508|FG009|Overall Study|Physician Decision|1|||
162992579|NCT03146962|588674499|FG000|Overall Study|Started New Treatment|0|||
162992580|NCT03146962|588674500|FG001|Overall Study|Started New Treatment|1|||
162992581|NCT03146962|588674501|FG002|Overall Study|Started New Treatment|0|||
162992582|NCT03146962|588674502|FG003|Overall Study|Started New Treatment|0|||
162992583|NCT03146962|588674503|FG004|Overall Study|Started New Treatment|0|||
162992584|NCT03146962|588674504|FG005|Overall Study|Started New Treatment|0|||
162992585|NCT03146962|588674505|FG006|Overall Study|Started New Treatment|0|||
163060018|NCT01859741|588928280|FG002|Overall Study|Other|0|||
162992586|NCT03146962|588674506|FG007|Overall Study|Started New Treatment|0|||
162992587|NCT03146962|588674507|FG008|Overall Study|Started New Treatment|0|||
162992588|NCT03146962|588674508|FG009|Overall Study|Started New Treatment|0|||
162992589|NCT02383810|588674509|FG000|Overall Study|Physician Decision|1|||
162992590|NCT02383810|588674510|FG001|Overall Study|Physician Decision|1|||
162992591|NCT02383810|588674511|FG002|Overall Study|Physician Decision|0|||
162992592|NCT02383810|588674512|FG003|Overall Study|Physician Decision|0|||
162992593|NCT02383810|588674513|FG004|Overall Study|Physician Decision|0|||
162992594|NCT02383810|588674514|FG005|Overall Study|Physician Decision|0|||
162992595|NCT02383810|588674515|FG006|Overall Study|Physician Decision|0|||
163060019|NCT01859741|588928281|FG003|Overall Study|Other|0|||
163060020|NCT01859741|588928282|FG004|Overall Study|Other|0|||
163060021|NCT01859741|588928283|FG005|Overall Study|Other|0|||
163060022|NCT01859741|588928284|FG006|Overall Study|Other|2|||
163060023|NCT01859741|588928285|FG007|Overall Study|Other|0|||
163060024|NCT02412657|588928286|FG000|Overall Study|Lost to Follow-up|1|||
163060025|NCT02412657|588928287|FG001|Overall Study|Lost to Follow-up|0|||
163060026|NCT02412657|588928288|FG002|Overall Study|Lost to Follow-up|0|||
163060027|NCT02412657|588928286|FG000|Overall Study|Protocol Violation|0|||
163060028|NCT02412657|588928287|FG001|Overall Study|Protocol Violation|2|||
163060029|NCT02412657|588928288|FG002|Overall Study|Protocol Violation|3|||
163060030|NCT00920816|588928292|FG000|Overall Study|Death|116|||
163060031|NCT00920816|588928293|FG001|Overall Study|Death|63|||
163060032|NCT00920816|588928294|FG002|Overall Study|Death|8|||
163060033|NCT00920816|588928295|FG003|Overall Study|Death|3|||
163060034|NCT00920816|588928292|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
163060035|NCT00920816|588928293|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
163060036|NCT00920816|588928294|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
163060037|NCT00920816|588928295|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
163060038|NCT00920816|588928292|FG000|Overall Study|Global deterioration of health status|2|||
163060039|NCT00920816|588928293|FG001|Overall Study|Global deterioration of health status|0|||
163060040|NCT00920816|588928294|FG002|Overall Study|Global deterioration of health status|0|||
163060041|NCT00920816|588928295|FG003|Overall Study|Global deterioration of health status|0|||
163060042|NCT00920816|588928292|FG000|Overall Study|Objective progression or relapse|6|||
163060043|NCT00920816|588928293|FG001|Overall Study|Objective progression or relapse|2|||
163060044|NCT00920816|588928294|FG002|Overall Study|Objective progression or relapse|0|||
163060045|NCT00920816|588928295|FG003|Overall Study|Objective progression or relapse|0|||
163060046|NCT00920816|588928292|FG000|Overall Study|Other|26|||
163060047|NCT00920816|588928293|FG001|Overall Study|Other|15|||
163060048|NCT00920816|588928294|FG002|Overall Study|Other|1|||
163060049|NCT00920816|588928295|FG003|Overall Study|Other|2|||
163060050|NCT00920816|588928292|FG000|Overall Study|Lost to Follow-up|11|||
163060051|NCT00920816|588928293|FG001|Overall Study|Lost to Follow-up|2|||
163060052|NCT00920816|588928294|FG002|Overall Study|Lost to Follow-up|0|||
163060053|NCT00920816|588928295|FG003|Overall Study|Lost to Follow-up|0|||
163060054|NCT00920816|588928292|FG000|Overall Study|Adverse Event|1|||
163060055|NCT00920816|588928293|FG001|Overall Study|Adverse Event|1|||
163060056|NCT00920816|588928294|FG002|Overall Study|Adverse Event|1|||
163060057|NCT00920816|588928295|FG003|Overall Study|Adverse Event|0|||
163060058|NCT00920816|588928292|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
163060059|NCT00920816|588928293|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
163060060|NCT00920816|588928294|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
163060061|NCT00920816|588928295|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
163060062|NCT00920816|588928292|FG000|Overall Study|Randomized but not treated|3|||
163060063|NCT00920816|588928293|FG001|Overall Study|Randomized but not treated|0|||
163060064|NCT00920816|588928294|FG002|Overall Study|Randomized but not treated|0|||
163060065|NCT00920816|588928295|FG003|Overall Study|Randomized but not treated|0|||
163060066|NCT03185208|588928296|FG000|Overall Study|Did not start study medication|0|||
163324632|NCT03242915|589900674|FG001|Overall Study|Adverse Event|1|||
163324633|NCT03242915|589900673|FG000|Overall Study|Withdrawal by Subject|0|||
163324634|NCT03242915|589900674|FG001|Overall Study|Withdrawal by Subject|2|||
163324635|NCT03242915|589900673|FG000|Overall Study|Physician Decision|4|||
163060067|NCT03185208|588928297|FG001|Overall Study|Did not start study medication|3|||
163060068|NCT03834350|588928298|FG000|Overall Study|Withdrawal by Subject|1|||
163060069|NCT02765165|588928303|FG000|Treatment Period|Progressive disease|3|||
163060070|NCT02765165|588928304|FG001|Treatment Period|Progressive disease|2|||
163060071|NCT02765165|588928305|FG002|Treatment Period|Progressive disease|3|||
163060072|NCT02765165|588928306|FG003|Treatment Period|Progressive disease|3|||
163060073|NCT02765165|588928307|FG004|Treatment Period|Progressive disease|4|||
163324636|NCT03242915|589900674|FG001|Overall Study|Physician Decision|1|||
163324637|NCT02726386|589900675|FG000|Overall Study|Adverse Event|17|||
163324638|NCT02726386|589900676|FG001|Overall Study|Adverse Event|20|||
162992596|NCT02383810|588674516|FG007|Overall Study|Physician Decision|0|||
162992597|NCT02383810|588674509|FG000|Overall Study|Withdrawal by Subject|2|||
162992598|NCT02383810|588674510|FG001|Overall Study|Withdrawal by Subject|3|||
163404285|NCT02831673|590191903|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
163404286|NCT02831673|590191904|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
163404287|NCT02831673|590191900|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
162992599|NCT02383810|588674511|FG002|Overall Study|Withdrawal by Subject|3|||
162992600|NCT02383810|588674512|FG003|Overall Study|Withdrawal by Subject|3|||
162992601|NCT02383810|588674513|FG004|Overall Study|Withdrawal by Subject|0|||
162992602|NCT02383810|588674514|FG005|Overall Study|Withdrawal by Subject|0|||
162992603|NCT02383810|588674515|FG006|Overall Study|Withdrawal by Subject|0|||
162992604|NCT02383810|588674516|FG007|Overall Study|Withdrawal by Subject|0|||
162992605|NCT02383810|588674509|FG000|Overall Study|Adverse Event|0|||
162992606|NCT02383810|588674510|FG001|Overall Study|Adverse Event|2|||
162992607|NCT02383810|588674511|FG002|Overall Study|Adverse Event|4|||
162992608|NCT02383810|588674512|FG003|Overall Study|Adverse Event|5|||
162992609|NCT02383810|588674513|FG004|Overall Study|Adverse Event|0|||
162992610|NCT02383810|588674514|FG005|Overall Study|Adverse Event|1|||
162992611|NCT02383810|588674515|FG006|Overall Study|Adverse Event|1|||
162992612|NCT02383810|588674516|FG007|Overall Study|Adverse Event|0|||
162992613|NCT02383810|588674509|FG000|Overall Study|Lost to Follow-up|0|||
162992614|NCT02383810|588674510|FG001|Overall Study|Lost to Follow-up|1|||
162992615|NCT02383810|588674511|FG002|Overall Study|Lost to Follow-up|0|||
162992616|NCT02383810|588674512|FG003|Overall Study|Lost to Follow-up|1|||
162992617|NCT02383810|588674513|FG004|Overall Study|Lost to Follow-up|0|||
162992618|NCT02383810|588674514|FG005|Overall Study|Lost to Follow-up|0|||
162992619|NCT02383810|588674515|FG006|Overall Study|Lost to Follow-up|0|||
162992620|NCT02383810|588674516|FG007|Overall Study|Lost to Follow-up|0|||
162992621|NCT02383810|588674509|FG000|Overall Study|other|0|||
162992622|NCT02383810|588674510|FG001|Overall Study|other|0|||
162992623|NCT02383810|588674511|FG002|Overall Study|other|0|||
162992624|NCT02383810|588674512|FG003|Overall Study|other|2|||
162992625|NCT02383810|588674513|FG004|Overall Study|other|0|||
162992626|NCT02383810|588674514|FG005|Overall Study|other|0|||
162992627|NCT02383810|588674515|FG006|Overall Study|other|0|||
162992628|NCT02383810|588674516|FG007|Overall Study|other|0|||
162992629|NCT02383810|588674509|FG000|Overall Study|subject did not receive study treatment|0|||
162992630|NCT02383810|588674510|FG001|Overall Study|subject did not receive study treatment|1|||
162992631|NCT02383810|588674511|FG002|Overall Study|subject did not receive study treatment|0|||
162992632|NCT02383810|588674512|FG003|Overall Study|subject did not receive study treatment|0|||
162992633|NCT02383810|588674513|FG004|Overall Study|subject did not receive study treatment|0|||
162992634|NCT02383810|588674514|FG005|Overall Study|subject did not receive study treatment|0|||
162992635|NCT02383810|588674515|FG006|Overall Study|subject did not receive study treatment|0|||
162992636|NCT02383810|588674516|FG007|Overall Study|subject did not receive study treatment|0|||
162992637|NCT01635283|588674519|FG000|Overall Study|Tumor Progression|3|||
162992638|NCT01635283|588674519|FG000|Overall Study|Lost to Follow-up|1|||
162992639|NCT01438996|588674522|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
162992640|NCT01438996|588674523|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
162992641|NCT01438996|588674524|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
162992642|NCT04516759|588674525|FG000|Overall Study|Withdrawal by Subject|1|||
162992643|NCT04516759|588674526|FG001|Overall Study|Withdrawal by Subject|1|||
162992644|NCT04516759|588674525|FG000|Overall Study|Other|0|||
162992645|NCT04516759|588674526|FG001|Overall Study|Other|1|||
162992646|NCT02246114|588674527|FG000|Overall Study|miscarriage|1|||
162992647|NCT02246114|588674528|FG001|Overall Study|miscarriage|0|||
162992648|NCT00229723|588674536|FG000|Concomitant Phase|Adverse Event|4|||
162992649|NCT00229723|588674537|FG001|Concomitant Phase|Adverse Event|2|||
162992650|NCT00229723|588674538|FG002|Concomitant Phase|Adverse Event|5|||
162992651|NCT00229723|588674539|FG003|Concomitant Phase|Adverse Event|2|||
162992652|NCT00229723|588674540|FG004|Concomitant Phase|Adverse Event|0|||
162992653|NCT00229723|588674541|FG005|Concomitant Phase|Adverse Event|1|||
162992654|NCT00229723|588674542|FG006|Concomitant Phase|Adverse Event|2|||
162992655|NCT00229723|588674536|FG000|Concomitant Phase|Objective disease progression|0|||
162992656|NCT00229723|588674537|FG001|Concomitant Phase|Objective disease progression|0|||
162992657|NCT00229723|588674538|FG002|Concomitant Phase|Objective disease progression|0|||
163060074|NCT02765165|588928308|FG005|Treatment Period|Progressive disease|2|||
163404288|NCT02831673|590191901|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
162992658|NCT00229723|588674539|FG003|Concomitant Phase|Objective disease progression|0|||
162992659|NCT00229723|588674540|FG004|Concomitant Phase|Objective disease progression|0|||
162992660|NCT00229723|588674541|FG005|Concomitant Phase|Objective disease progression|0|||
162992661|NCT00229723|588674542|FG006|Concomitant Phase|Objective disease progression|0|||
162992662|NCT00229723|588674536|FG000|Concomitant Phase|Clinical progression|0|||
162992663|NCT00229723|588674537|FG001|Concomitant Phase|Clinical progression|0|||
163212437|NCT02141997|589492520|FG001|Overall Study|Other|4|||
162992664|NCT00229723|588674538|FG002|Concomitant Phase|Clinical progression|0|||
162992665|NCT00229723|588674539|FG003|Concomitant Phase|Clinical progression|0|||
162992666|NCT00229723|588674540|FG004|Concomitant Phase|Clinical progression|0|||
162992667|NCT00229723|588674541|FG005|Concomitant Phase|Clinical progression|0|||
162992668|NCT00229723|588674542|FG006|Concomitant Phase|Clinical progression|1|||
162992669|NCT00229723|588674536|FG000|Concomitant Phase|Lost to Follow-up|0|||
162992670|NCT00229723|588674537|FG001|Concomitant Phase|Lost to Follow-up|0|||
162992671|NCT00229723|588674538|FG002|Concomitant Phase|Lost to Follow-up|0|||
162992672|NCT00229723|588674539|FG003|Concomitant Phase|Lost to Follow-up|0|||
162992673|NCT00229723|588674540|FG004|Concomitant Phase|Lost to Follow-up|1|||
162992674|NCT00229723|588674541|FG005|Concomitant Phase|Lost to Follow-up|0|||
162992675|NCT00229723|588674542|FG006|Concomitant Phase|Lost to Follow-up|0|||
162992676|NCT00229723|588674536|FG000|Concomitant Phase|Informed consent withdrawn|3|||
162992677|NCT00229723|588674537|FG001|Concomitant Phase|Informed consent withdrawn|2|||
162992678|NCT00229723|588674538|FG002|Concomitant Phase|Informed consent withdrawn|0|||
162992679|NCT00229723|588674539|FG003|Concomitant Phase|Informed consent withdrawn|2|||
162992680|NCT00229723|588674540|FG004|Concomitant Phase|Informed consent withdrawn|0|||
162992681|NCT00229723|588674541|FG005|Concomitant Phase|Informed consent withdrawn|0|||
162992682|NCT00229723|588674542|FG006|Concomitant Phase|Informed consent withdrawn|0|||
162992683|NCT00229723|588674536|FG000|Concomitant Phase|Severe non-compliance|0|||
162992684|NCT00229723|588674537|FG001|Concomitant Phase|Severe non-compliance|1|||
162992685|NCT00229723|588674538|FG002|Concomitant Phase|Severe non-compliance|0|||
162992686|NCT00229723|588674539|FG003|Concomitant Phase|Severe non-compliance|0|||
162992687|NCT00229723|588674540|FG004|Concomitant Phase|Severe non-compliance|1|||
162992688|NCT00229723|588674541|FG005|Concomitant Phase|Severe non-compliance|0|||
162992689|NCT00229723|588674542|FG006|Concomitant Phase|Severe non-compliance|0|||
162992690|NCT00229723|588674536|FG000|Concomitant Phase|Other|3|||
162992691|NCT00229723|588674537|FG001|Concomitant Phase|Other|0|||
163324639|NCT02726386|589900675|FG000|Overall Study|Withdrawal by Subject|14|||
162992692|NCT00229723|588674538|FG002|Concomitant Phase|Other|1|||
162992693|NCT00229723|588674539|FG003|Concomitant Phase|Other|1|||
162992694|NCT00229723|588674540|FG004|Concomitant Phase|Other|0|||
162992695|NCT00229723|588674541|FG005|Concomitant Phase|Other|2|||
162992696|NCT00229723|588674542|FG006|Concomitant Phase|Other|0|||
162992697|NCT00229723|588674536|FG000|Maintenance Phase|Adverse Event|7|||
162992698|NCT00229723|588674537|FG001|Maintenance Phase|Adverse Event|2|||
162992699|NCT00229723|588674538|FG002|Maintenance Phase|Adverse Event|1|||
162992700|NCT00229723|588674539|FG003|Maintenance Phase|Adverse Event|4|||
162992701|NCT00229723|588674540|FG004|Maintenance Phase|Adverse Event|7|||
162992702|NCT00229723|588674541|FG005|Maintenance Phase|Adverse Event|5|||
162992703|NCT00229723|588674542|FG006|Maintenance Phase|Adverse Event|2|||
162992704|NCT00229723|588674536|FG000|Maintenance Phase|Objective disease progression|5|||
162992705|NCT00229723|588674537|FG001|Maintenance Phase|Objective disease progression|5|||
162992706|NCT00229723|588674538|FG002|Maintenance Phase|Objective disease progression|3|||
162992707|NCT00229723|588674539|FG003|Maintenance Phase|Objective disease progression|6|||
162992708|NCT00229723|588674540|FG004|Maintenance Phase|Objective disease progression|2|||
162992709|NCT00229723|588674541|FG005|Maintenance Phase|Objective disease progression|9|||
162992710|NCT00229723|588674542|FG006|Maintenance Phase|Objective disease progression|5|||
162992711|NCT00229723|588674536|FG000|Maintenance Phase|Clinical progression|4|||
162992712|NCT00229723|588674537|FG001|Maintenance Phase|Clinical progression|1|||
162992713|NCT00229723|588674538|FG002|Maintenance Phase|Clinical progression|2|||
162992714|NCT00229723|588674539|FG003|Maintenance Phase|Clinical progression|2|||
162992715|NCT00229723|588674540|FG004|Maintenance Phase|Clinical progression|1|||
162992716|NCT00229723|588674541|FG005|Maintenance Phase|Clinical progression|1|||
162992717|NCT00229723|588674542|FG006|Maintenance Phase|Clinical progression|1|||
162992718|NCT00229723|588674536|FG000|Maintenance Phase|Lost to Follow-up|0|||
162992719|NCT00229723|588674537|FG001|Maintenance Phase|Lost to Follow-up|1|||
162992720|NCT00229723|588674538|FG002|Maintenance Phase|Lost to Follow-up|2|||
162992721|NCT00229723|588674539|FG003|Maintenance Phase|Lost to Follow-up|2|||
162992722|NCT00229723|588674540|FG004|Maintenance Phase|Lost to Follow-up|0|||
163060075|NCT02765165|588928309|FG006|Treatment Period|Progressive disease|2|||
163060076|NCT02765165|588928303|FG000|Treatment Period|Physician Decision|0|||
163324640|NCT02726386|589900676|FG001|Overall Study|Withdrawal by Subject|28|||
163324641|NCT02726386|589900675|FG000|Overall Study|Other reasons|7|||
163324642|NCT02726386|589900676|FG001|Overall Study|Other reasons|8|||
163324643|NCT02101853|589900679|FG000|Block 1 Induction|Adverse Event|11|||
163324644|NCT02101853|589900680|FG001|Block 1 Induction|Adverse Event|0|||
162992723|NCT00229723|588674541|FG005|Maintenance Phase|Lost to Follow-up|0|||
162992724|NCT00229723|588674542|FG006|Maintenance Phase|Lost to Follow-up|1|||
162992725|NCT00229723|588674536|FG000|Maintenance Phase|Informed consent withdrawn|1|||
162992726|NCT00229723|588674537|FG001|Maintenance Phase|Informed consent withdrawn|0|||
162992727|NCT00229723|588674538|FG002|Maintenance Phase|Informed consent withdrawn|0|||
162992728|NCT00229723|588674539|FG003|Maintenance Phase|Informed consent withdrawn|1|||
162992729|NCT00229723|588674540|FG004|Maintenance Phase|Informed consent withdrawn|1|||
162992730|NCT00229723|588674541|FG005|Maintenance Phase|Informed consent withdrawn|1|||
162992731|NCT00229723|588674542|FG006|Maintenance Phase|Informed consent withdrawn|0|||
162992732|NCT00229723|588674536|FG000|Maintenance Phase|Severe non-compliance|3|||
162992733|NCT00229723|588674537|FG001|Maintenance Phase|Severe non-compliance|1|||
162992734|NCT00229723|588674538|FG002|Maintenance Phase|Severe non-compliance|0|||
162992735|NCT00229723|588674539|FG003|Maintenance Phase|Severe non-compliance|0|||
163404289|NCT02831673|590191902|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
162992736|NCT00229723|588674540|FG004|Maintenance Phase|Severe non-compliance|1|||
162992737|NCT00229723|588674541|FG005|Maintenance Phase|Severe non-compliance|0|||
162992738|NCT00229723|588674542|FG006|Maintenance Phase|Severe non-compliance|0|||
162992739|NCT00229723|588674536|FG000|Maintenance Phase|Other|5|||
162992740|NCT00229723|588674537|FG001|Maintenance Phase|Other|4|||
162992741|NCT00229723|588674538|FG002|Maintenance Phase|Other|1|||
162992742|NCT00229723|588674539|FG003|Maintenance Phase|Other|2|||
162992743|NCT00229723|588674540|FG004|Maintenance Phase|Other|3|||
162992744|NCT00229723|588674541|FG005|Maintenance Phase|Other|3|||
162992745|NCT00229723|588674542|FG006|Maintenance Phase|Other|1|||
163060077|NCT02765165|588928304|FG001|Treatment Period|Physician Decision|1|||
163060078|NCT02765165|588928305|FG002|Treatment Period|Physician Decision|0|||
163060079|NCT02765165|588928306|FG003|Treatment Period|Physician Decision|0|||
163060080|NCT02765165|588928307|FG004|Treatment Period|Physician Decision|0|||
163060081|NCT02765165|588928308|FG005|Treatment Period|Physician Decision|0|||
163060082|NCT02765165|588928309|FG006|Treatment Period|Physician Decision|0|||
163060083|NCT02765165|588928303|FG000|Treatment Period|Adverse Event|0|||
163060084|NCT02765165|588928304|FG001|Treatment Period|Adverse Event|1|||
163060085|NCT02765165|588928305|FG002|Treatment Period|Adverse Event|0|||
163060086|NCT02765165|588928306|FG003|Treatment Period|Adverse Event|0|||
163060087|NCT02765165|588928307|FG004|Treatment Period|Adverse Event|0|||
163060088|NCT02765165|588928308|FG005|Treatment Period|Adverse Event|0|||
163060089|NCT02765165|588928309|FG006|Treatment Period|Adverse Event|0|||
163060090|NCT02765165|588928303|FG000|Treatment Period|Withdrawal by Subject|0|||
163060091|NCT02765165|588928304|FG001|Treatment Period|Withdrawal by Subject|0|||
163060092|NCT02765165|588928305|FG002|Treatment Period|Withdrawal by Subject|0|||
163060093|NCT02765165|588928306|FG003|Treatment Period|Withdrawal by Subject|0|||
163212438|NCT02141997|589492521|FG002|Overall Study|Other|0|||
163212439|NCT02141997|589492522|FG003|Overall Study|Other|0|||
163212440|NCT00451321|589492524|FG000|Overall Study|Lost to Follow-up|3|||
163212441|NCT00451321|589492525|FG001|Overall Study|Lost to Follow-up|3|||
163212442|NCT00451321|589492526|FG002|Overall Study|Lost to Follow-up|1|||
163212443|NCT00451321|589492527|FG003|Overall Study|Lost to Follow-up|3|||
163212444|NCT00451321|589492528|FG004|Overall Study|Lost to Follow-up|0|||
163212445|NCT00451321|589492529|FG005|Overall Study|Lost to Follow-up|1|||
163212446|NCT00451321|589492530|FG006|Overall Study|Lost to Follow-up|0|||
163212447|NCT00451321|589492531|FG007|Overall Study|Lost to Follow-up|0|||
163212448|NCT00451321|589492524|FG000|Overall Study|Withdrawal by Subject|3|||
163212449|NCT00451321|589492525|FG001|Overall Study|Withdrawal by Subject|1|||
163212450|NCT00451321|589492526|FG002|Overall Study|Withdrawal by Subject|0|||
163212451|NCT00451321|589492527|FG003|Overall Study|Withdrawal by Subject|4|||
163212452|NCT00451321|589492528|FG004|Overall Study|Withdrawal by Subject|0|||
163212453|NCT00451321|589492529|FG005|Overall Study|Withdrawal by Subject|0|||
163212454|NCT00451321|589492530|FG006|Overall Study|Withdrawal by Subject|0|||
163212455|NCT00451321|589492531|FG007|Overall Study|Withdrawal by Subject|0|||
163212456|NCT00451321|589492524|FG000|Overall Study|Study closed/terminated|1|||
163212457|NCT00451321|589492525|FG001|Overall Study|Study closed/terminated|1|||
163212458|NCT00451321|589492526|FG002|Overall Study|Study closed/terminated|17|||
163212459|NCT00451321|589492527|FG003|Overall Study|Study closed/terminated|5|||
163212460|NCT00451321|589492528|FG004|Overall Study|Study closed/terminated|7|||
163212461|NCT00451321|589492529|FG005|Overall Study|Study closed/terminated|7|||
163212462|NCT00451321|589492530|FG006|Overall Study|Study closed/terminated|5|||
163212463|NCT00451321|589492531|FG007|Overall Study|Study closed/terminated|3|||
163212464|NCT00451321|589492524|FG000|Overall Study|Sponsor decision to amend protocol|0|||
163212465|NCT00451321|589492525|FG001|Overall Study|Sponsor decision to amend protocol|0|||
163212466|NCT00451321|589492526|FG002|Overall Study|Sponsor decision to amend protocol|0|||
163212467|NCT00451321|589492527|FG003|Overall Study|Sponsor decision to amend protocol|0|||
163212468|NCT00451321|589492528|FG004|Overall Study|Sponsor decision to amend protocol|0|||
163212469|NCT00451321|589492529|FG005|Overall Study|Sponsor decision to amend protocol|1|||
163212470|NCT00451321|589492530|FG006|Overall Study|Sponsor decision to amend protocol|1|||
163212471|NCT00451321|589492531|FG007|Overall Study|Sponsor decision to amend protocol|3|||
163212472|NCT00732615|589492534|FG000|Overall Study|Withdrawal by Subject|3|||
163212473|NCT00732615|589492535|FG001|Overall Study|Withdrawal by Subject|1|||
163212474|NCT00732615|589492534|FG000|Overall Study|Lost to Follow-up|0|||
163212475|NCT00732615|589492535|FG001|Overall Study|Lost to Follow-up|1|||
163212476|NCT00732615|589492534|FG000|Overall Study|Adverse Event|0|||
163212477|NCT00732615|589492535|FG001|Overall Study|Adverse Event|2|||
163212478|NCT00732615|589492534|FG000|Overall Study|Physician Decision|3|||
163212479|NCT00732615|589492535|FG001|Overall Study|Physician Decision|0|||
163212480|NCT00732615|589492534|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
163212481|NCT00732615|589492535|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
163212482|NCT00909389|589492539|FG000|Overall Study|Adverse Event|6|||
163212483|NCT00909389|589492539|FG000|Overall Study|Death|4|||
163212484|NCT00909389|589492539|FG000|Overall Study|Poor Compliance|16|||
163212485|NCT00909389|589492539|FG000|Overall Study|Lost to Follow-up|4|||
163212486|NCT00909389|589492539|FG000|Overall Study|No Information|103|||
163060094|NCT02765165|588928307|FG004|Treatment Period|Withdrawal by Subject|2|||
163060095|NCT02765165|588928308|FG005|Treatment Period|Withdrawal by Subject|0|||
163060096|NCT02765165|588928309|FG006|Treatment Period|Withdrawal by Subject|0|||
163060097|NCT02765165|588928303|FG000|Treatment Period|Study terminated|0|||
163060098|NCT02765165|588928304|FG001|Treatment Period|Study terminated|0|||
163060099|NCT02765165|588928305|FG002|Treatment Period|Study terminated|0|||
163060100|NCT02765165|588928306|FG003|Treatment Period|Study terminated|0|||
163060101|NCT02765165|588928307|FG004|Treatment Period|Study terminated|0|||
163060102|NCT02765165|588928308|FG005|Treatment Period|Study terminated|1|||
163060103|NCT02765165|588928309|FG006|Treatment Period|Study terminated|2|||
163060104|NCT02765165|588928303|FG000|Post-treatment Follow-up|Death|1|||
163060105|NCT02765165|588928304|FG001|Post-treatment Follow-up|Death|2|||
163060106|NCT02765165|588928305|FG002|Post-treatment Follow-up|Death|1|||
163324645|NCT02101853|589900681|FG002|Block 1 Induction|Adverse Event|0|||
163324646|NCT02101853|589900682|FG003|Block 1 Induction|Adverse Event|0|||
163324647|NCT02101853|589900683|FG004|Block 1 Induction|Adverse Event|0|||
163324648|NCT02101853|589900684|FG005|Block 1 Induction|Adverse Event|0|||
163324649|NCT02101853|589900679|FG000|Block 1 Induction|Death|20|||
163324650|NCT02101853|589900680|FG001|Block 1 Induction|Death|0|||
163324651|NCT02101853|589900681|FG002|Block 1 Induction|Death|0|||
163324652|NCT02101853|589900682|FG003|Block 1 Induction|Death|0|||
163324653|NCT02101853|589900683|FG004|Block 1 Induction|Death|0|||
162992746|NCT01338870|588674544|FG000|Overall Study|Lost to Follow-up|0|||
162992747|NCT01338870|588674545|FG001|Overall Study|Lost to Follow-up|0|||
162992748|NCT01338870|588674546|FG002|Overall Study|Lost to Follow-up|1|||
162992749|NCT01338870|588674547|FG003|Overall Study|Lost to Follow-up|0|||
162992750|NCT01338870|588674548|FG004|Overall Study|Lost to Follow-up|1|||
162992751|NCT01338870|588674549|FG005|Overall Study|Lost to Follow-up|0|||
162992752|NCT01338870|588674544|FG000|Overall Study|Withdrawal by Subject|2|||
162992753|NCT01338870|588674545|FG001|Overall Study|Withdrawal by Subject|3|||
162992754|NCT01338870|588674546|FG002|Overall Study|Withdrawal by Subject|4|||
162992755|NCT01338870|588674547|FG003|Overall Study|Withdrawal by Subject|0|||
162992756|NCT01338870|588674548|FG004|Overall Study|Withdrawal by Subject|0|||
162992757|NCT01338870|588674549|FG005|Overall Study|Withdrawal by Subject|2|||
162992758|NCT01338870|588674544|FG000|Overall Study|Other|3|||
162992759|NCT01338870|588674545|FG001|Overall Study|Other|3|||
162992760|NCT01338870|588674546|FG002|Overall Study|Other|3|||
162992761|NCT01338870|588674547|FG003|Overall Study|Other|2|||
162992762|NCT01338870|588674548|FG004|Overall Study|Other|0|||
162992763|NCT01338870|588674549|FG005|Overall Study|Other|2|||
162992764|NCT01338870|588674544|FG000|Overall Study|Protocol Violation|0|||
162992765|NCT01338870|588674545|FG001|Overall Study|Protocol Violation|2|||
162992766|NCT01338870|588674546|FG002|Overall Study|Protocol Violation|2|||
162992767|NCT01338870|588674547|FG003|Overall Study|Protocol Violation|2|||
162992768|NCT01338870|588674548|FG004|Overall Study|Protocol Violation|1|||
162992769|NCT01338870|588674549|FG005|Overall Study|Protocol Violation|1|||
162992770|NCT01338870|588674544|FG000|Overall Study|Adverse Event|4|||
162992771|NCT01338870|588674545|FG001|Overall Study|Adverse Event|4|||
162992772|NCT01338870|588674546|FG002|Overall Study|Adverse Event|1|||
162992773|NCT01338870|588674547|FG003|Overall Study|Adverse Event|5|||
162992774|NCT01338870|588674548|FG004|Overall Study|Adverse Event|4|||
163060107|NCT02765165|588928306|FG003|Post-treatment Follow-up|Death|1|||
163060108|NCT02765165|588928307|FG004|Post-treatment Follow-up|Death|1|||
163060109|NCT02765165|588928308|FG005|Post-treatment Follow-up|Death|1|||
163060110|NCT02765165|588928309|FG006|Post-treatment Follow-up|Death|0|||
163060111|NCT02765165|588928303|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
163324654|NCT02101853|589900684|FG005|Block 1 Induction|Death|0|||
163324655|NCT02101853|589900679|FG000|Block 1 Induction|Lack of Efficacy|6|||
163324656|NCT02101853|589900680|FG001|Block 1 Induction|Lack of Efficacy|0|||
163324657|NCT02101853|589900681|FG002|Block 1 Induction|Lack of Efficacy|0|||
163324658|NCT02101853|589900682|FG003|Block 1 Induction|Lack of Efficacy|0|||
163324659|NCT02101853|589900683|FG004|Block 1 Induction|Lack of Efficacy|0|||
163324660|NCT02101853|589900684|FG005|Block 1 Induction|Lack of Efficacy|0|||
163404290|NCT02831673|590191903|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
163060112|NCT02765165|588928304|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
163324661|NCT02101853|589900679|FG000|Block 1 Induction|Physician Decision|61|||
163324662|NCT02101853|589900680|FG001|Block 1 Induction|Physician Decision|0|||
163060113|NCT02765165|588928305|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
162992775|NCT01338870|588674549|FG005|Overall Study|Adverse Event|1|||
162992776|NCT02774642|588674550|FG000|Overall Study|Lost to Follow-up|9|||
162992777|NCT02774642|588674551|FG001|Overall Study|Lost to Follow-up|7|||
162992778|NCT03835221|588674552|FG000|Methafilcon A|Withdrawal by Subject|1|||
162992779|NCT00861198|588674553|FG000|Overall Study|SpyGlass Failed|5|||
162992780|NCT02288182|588674554|FG000|Overall Study|Adverse Event|0|||
162992781|NCT02288182|588674555|FG001|Overall Study|Adverse Event|1|||
163324663|NCT02101853|589900681|FG002|Block 1 Induction|Physician Decision|0|||
162992782|NCT02288182|588674554|FG000|Overall Study|Lost to Follow-up|0|||
162992783|NCT02288182|588674555|FG001|Overall Study|Lost to Follow-up|1|||
162992784|NCT04619992|588674557|FG000|Overall Study|Withdrawal by Subject|1|||
162992785|NCT04619992|588674558|FG001|Overall Study|Withdrawal by Subject|0|||
162992786|NCT03582826|588674559|FG000|Overall Study|Lost to Follow-up|39|||
162992787|NCT03582826|588674560|FG001|Overall Study|Lost to Follow-up|0|||
162992788|NCT03582826|588674559|FG000|Overall Study|Withdrawal by Subject|2|||
162992789|NCT03582826|588674560|FG001|Overall Study|Withdrawal by Subject|0|||
162992790|NCT00499174|588674561|FG000|Overall Study|Physician Decision|78|||
162992791|NCT00499174|588674562|FG001|Overall Study|Physician Decision|9|||
162992792|NCT01214915|588674563|FG000|Overall Study|Adverse Event|8|||
162992793|NCT01214915|588674563|FG000|Overall Study|Lack of Efficacy|3|||
162992794|NCT00574912|588674564|FG000|Overall Study|Could not place IV lines.|3|||
162992795|NCT00574912|588674564|FG000|Overall Study|scheduling conflicts|3|||
162992796|NCT00574912|588674564|FG000|Overall Study|Physician Decision|2|||
162992797|NCT04730349|588674573|FG000|Overall Study|Participant withdrew consent|1|||
162992798|NCT04730349|588674574|FG001|Overall Study|Participant withdrew consent|0|||
162992799|NCT04730349|588674573|FG000|Overall Study|Disease progression|6|||
162992800|NCT04730349|588674574|FG001|Overall Study|Disease progression|4|||
162992801|NCT04730349|588674573|FG000|Overall Study|Study drug toxicity|0|||
162992802|NCT04730349|588674574|FG001|Overall Study|Study drug toxicity|1|||
162992803|NCT00638027|588674575|FG000|Overall Study|Adverse Event|0|||
162992804|NCT00638027|588674576|FG001|Overall Study|Adverse Event|2|||
162992805|NCT00371397|588674577|FG000|Session 1|Withdrawal by Subject|1|||
162992806|NCT00371397|588674578|FG001|Session 1|Withdrawal by Subject|0|||
162992807|NCT00371397|588674579|FG002|Session 1|Withdrawal by Subject|0|||
162992808|NCT00371397|588674580|FG003|Session 1|Withdrawal by Subject|0|||
162992809|NCT00371397|588674581|FG004|Session 1|Withdrawal by Subject|0|||
162992810|NCT00371397|588674582|FG005|Session 1|Withdrawal by Subject|0|||
162992811|NCT00371397|588674583|FG006|Session 1|Withdrawal by Subject|0|||
162992812|NCT00371397|588674584|FG007|Session 1|Withdrawal by Subject|1|||
162992813|NCT00371397|588674585|FG008|Session 1|Withdrawal by Subject|0|||
162992814|NCT00371397|588674586|FG009|Session 1|Withdrawal by Subject|0|||
162992815|NCT00371397|588674587|FG010|Session 1|Withdrawal by Subject|0|||
162992816|NCT00371397|588674588|FG011|Session 1|Withdrawal by Subject|0|||
162992817|NCT03753763|588674589|FG000|Overall Study|Adverse Event|2|||
162992818|NCT03753763|588674590|FG001|Overall Study|Adverse Event|0|||
162992819|NCT03753763|588674589|FG000|Overall Study|Withdrawal by Subject|3|||
162992820|NCT03753763|588674590|FG001|Overall Study|Withdrawal by Subject|1|||
162992821|NCT03753763|588674589|FG000|Overall Study|clinical deterioration|1|||
162992822|NCT03753763|588674590|FG001|Overall Study|clinical deterioration|0|||
162992823|NCT01104779|588674591|FG000|Overall Study|Protocol Violation|1|||
162992824|NCT01104779|588674592|FG001|Overall Study|Protocol Violation|2|||
163060114|NCT02765165|588928306|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
163060115|NCT02765165|588928307|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
163324664|NCT02101853|589900682|FG003|Block 1 Induction|Physician Decision|0|||
163324665|NCT02101853|589900683|FG004|Block 1 Induction|Physician Decision|0|||
163324666|NCT02101853|589900684|FG005|Block 1 Induction|Physician Decision|0|||
163324667|NCT02101853|589900679|FG000|Block 1 Induction|Protocol Violation|2|||
163324668|NCT02101853|589900680|FG001|Block 1 Induction|Protocol Violation|0|||
163324669|NCT02101853|589900681|FG002|Block 1 Induction|Protocol Violation|0|||
163324670|NCT02101853|589900682|FG003|Block 1 Induction|Protocol Violation|0|||
163324671|NCT02101853|589900683|FG004|Block 1 Induction|Protocol Violation|0|||
163324672|NCT02101853|589900684|FG005|Block 1 Induction|Protocol Violation|0|||
162992825|NCT01104779|588674593|FG002|Overall Study|Protocol Violation|2|||
163060116|NCT02765165|588928308|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
163060117|NCT02765165|588928309|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
163060118|NCT02765165|588928303|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
163060119|NCT02765165|588928304|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
163060120|NCT02765165|588928305|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
163060121|NCT02765165|588928306|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
163060122|NCT02765165|588928307|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
163060123|NCT02765165|588928308|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
163060124|NCT02765165|588928309|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
163060125|NCT02765165|588928303|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
163324673|NCT02101853|589900679|FG000|Block 1 Induction|Withdrawal by Subject|65|||
163060126|NCT02765165|588928304|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
163060127|NCT02765165|588928305|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
163324674|NCT02101853|589900680|FG001|Block 1 Induction|Withdrawal by Subject|0|||
163324675|NCT02101853|589900681|FG002|Block 1 Induction|Withdrawal by Subject|0|||
162992826|NCT01104779|588674591|FG000|Overall Study|Lack of Efficacy|26|||
162992827|NCT01104779|588674592|FG001|Overall Study|Lack of Efficacy|12|||
162992828|NCT01104779|588674593|FG002|Overall Study|Lack of Efficacy|13|||
162992829|NCT01104779|588674591|FG000|Overall Study|Adverse Event|13|||
162992830|NCT01104779|588674592|FG001|Overall Study|Adverse Event|14|||
162992831|NCT01104779|588674593|FG002|Overall Study|Adverse Event|13|||
162992832|NCT01104779|588674591|FG000|Overall Study|Did not meet inc/exc criteria|1|||
162992833|NCT01104779|588674592|FG001|Overall Study|Did not meet inc/exc criteria|1|||
162992834|NCT01104779|588674593|FG002|Overall Study|Did not meet inc/exc criteria|1|||
162992835|NCT01104779|588674591|FG000|Overall Study|Other reasons|0|||
162992836|NCT01104779|588674592|FG001|Overall Study|Other reasons|1|||
162992837|NCT01104779|588674593|FG002|Overall Study|Other reasons|0|||
162992838|NCT01104779|588674591|FG000|Overall Study|Lost to Follow-up|2|||
162992839|NCT01104779|588674592|FG001|Overall Study|Lost to Follow-up|0|||
162992840|NCT01104779|588674593|FG002|Overall Study|Lost to Follow-up|1|||
162992841|NCT01104779|588674591|FG000|Overall Study|Withdrawal by Subject|16|||
162992842|NCT01104779|588674592|FG001|Overall Study|Withdrawal by Subject|25|||
162992843|NCT01104779|588674593|FG002|Overall Study|Withdrawal by Subject|32|||
162992844|NCT02342639|588674594|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
162992845|NCT02342639|588674595|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
162992846|NCT02342639|588674594|FG000|Overall Study|Protocol Violation|0|||
162992847|NCT02342639|588674595|FG001|Overall Study|Protocol Violation|2|||
162992848|NCT01372774|588674606|FG000|Overall Study|Withdrawal prior to treatment|4|||
162992849|NCT01372774|588674607|FG001|Overall Study|Withdrawal prior to treatment|5|||
162992850|NCT00871741|588674608|FG000|Overall Study|Premature study termination|9|||
162992851|NCT00871741|588674609|FG001|Overall Study|Premature study termination|7|||
162992852|NCT01565850|588674610|FG000|Overall Study|Adverse Event|0|||
162992853|NCT01565850|588674611|FG001|Overall Study|Adverse Event|1|||
162992854|NCT01565850|588674610|FG000|Overall Study|Lost to Follow-up|12|||
162992855|NCT01565850|588674611|FG001|Overall Study|Lost to Follow-up|4|||
162992856|NCT01565850|588674610|FG000|Overall Study|Investigator's Discretion|2|||
162992857|NCT01565850|588674611|FG001|Overall Study|Investigator's Discretion|1|||
162992858|NCT01565850|588674610|FG000|Overall Study|Participant noncompliance|2|||
162992859|NCT01565850|588674611|FG001|Overall Study|Participant noncompliance|0|||
162992860|NCT01565850|588674610|FG000|Overall Study|Withdrew Consent|4|||
162992861|NCT01565850|588674611|FG001|Overall Study|Withdrew Consent|2|||
162992862|NCT04324073|588676059|FG000|Overall Study|withdrew consent|0|||
162992863|NCT04324073|588676060|FG001|Overall Study|withdrew consent|4|||
162992864|NCT04324073|588676061|FG002|Overall Study|withdrew consent|2|||
162992865|NCT04324073|588676062|FG003|Overall Study|withdrew consent|8|||
162992866|NCT03665441|588676063|FG000|Overall Study|survival follow up ongoing|23|||
162992867|NCT03665441|588676064|FG001|Overall Study|survival follow up ongoing|0|||
162992868|NCT03665441|588676063|FG000|Overall Study|Patients ongoing on treatment|9|||
162992869|NCT03665441|588676064|FG001|Overall Study|Patients ongoing on treatment|6|||
162992870|NCT03665441|588676063|FG000|Overall Study|Randomized but not treated|7|||
162992871|NCT03665441|588676064|FG001|Overall Study|Randomized but not treated|11|||
162992872|NCT03610516|588676065|FG000|Treatment Epoch|Adverse Event|3|||
162992873|NCT03610516|588676066|FG001|Treatment Epoch|Adverse Event|1|||
162992874|NCT03610516|588676065|FG000|Treatment Epoch|Death|1|||
162992875|NCT03610516|588676066|FG001|Treatment Epoch|Death|0|||
162992876|NCT03610516|588676065|FG000|Treatment Epoch|Lack of Efficacy|0|||
162992877|NCT03610516|588676066|FG001|Treatment Epoch|Lack of Efficacy|1|||
162992878|NCT03610516|588676065|FG000|Treatment Epoch|No longer requires treatment|1|||
162992879|NCT03610516|588676066|FG001|Treatment Epoch|No longer requires treatment|0|||
162992880|NCT03610516|588676065|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
162992881|NCT03610516|588676066|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
162992882|NCT03610516|588676065|FG000|Treatment Epoch|Physician Decision|8|||
162992883|NCT03610516|588676066|FG001|Treatment Epoch|Physician Decision|5|||
162992884|NCT03610516|588676065|FG000|Treatment Epoch|Protocol Deviation|1|||
162992885|NCT03610516|588676066|FG001|Treatment Epoch|Protocol Deviation|0|||
162992886|NCT03610516|588676065|FG000|Treatment Epoch|Withdrawal by Subject|3|||
162992887|NCT03610516|588676066|FG001|Treatment Epoch|Withdrawal by Subject|1|||
162992888|NCT03610516|588676065|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
162992889|NCT03610516|588676066|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
162992890|NCT03610516|588676065|FG000|Post-Treatment Follow-up|Death|1|||
162992891|NCT03610516|588676066|FG001|Post-Treatment Follow-up|Death|0|||
162992892|NCT01396512|588676069|FG000|Overall Study|Withdrawal by Subject|0|||
162992893|NCT01396512|588676070|FG001|Overall Study|Withdrawal by Subject|1|||
162992894|NCT02500043|588676075|FG000|Overall Study|Randomized, but not Treated|2|||
162992895|NCT02500043|588676076|FG001|Overall Study|Randomized, but not Treated|2|||
162992896|NCT02500043|588676075|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
162992897|NCT02500043|588676076|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
162992898|NCT02500043|588676075|FG000|Overall Study|Adverse Event|33|||
162992899|NCT02500043|588676076|FG001|Overall Study|Adverse Event|11|||
162992900|NCT02500043|588676075|FG000|Overall Study|Clinical Progression|54|||
162992901|NCT02500043|588676076|FG001|Overall Study|Clinical Progression|35|||
162992902|NCT02500043|588676075|FG000|Overall Study|Radiological Progression|192|||
162992903|NCT02500043|588676076|FG001|Overall Study|Radiological Progression|110|||
163212487|NCT00597766|589492542|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
163404291|NCT02831673|590191904|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
162992904|NCT02500043|588676075|FG000|Overall Study|Physician's Decision|11|||
162992905|NCT02500043|588676076|FG001|Overall Study|Physician's Decision|3|||
162992906|NCT02500043|588676075|FG000|Overall Study|Withdrawal by Subject|14|||
162992907|NCT02500043|588676076|FG001|Overall Study|Withdrawal by Subject|4|||
162992908|NCT02500043|588676075|FG000|Overall Study|Death|11|||
162992909|NCT02500043|588676076|FG001|Overall Study|Death|2|||
162992910|NCT02500043|588676075|FG000|Overall Study|Protocol Deviation|1|||
162992911|NCT02500043|588676076|FG001|Overall Study|Protocol Deviation|0|||
162992912|NCT00580788|588676077|FG000|Overall Study|Adverse Event|0|||
162992913|NCT00580788|588676078|FG001|Overall Study|Adverse Event|0|||
162992914|NCT00580788|588676079|FG002|Overall Study|Adverse Event|0|||
162992915|NCT00580788|588676080|FG003|Overall Study|Adverse Event|1|||
162992916|NCT01403051|588676081|FG000|Overall Study|Protocol Violation|2|||
162992917|NCT01403051|588676082|FG001|Overall Study|Protocol Violation|0|||
162992918|NCT01403051|588676081|FG000|Overall Study|Death|1|||
162992919|NCT01403051|588676082|FG001|Overall Study|Death|0|||
162992920|NCT01403051|588676081|FG000|Overall Study|Withdrawal by Subject|2|||
162992921|NCT01403051|588676082|FG001|Overall Study|Withdrawal by Subject|1|||
162992922|NCT01403051|588676081|FG000|Overall Study|Lost to Follow-up|5|||
162992923|NCT01403051|588676082|FG001|Overall Study|Lost to Follow-up|5|||
162992924|NCT02932306|588676095|FG000|Overall Study|Withdrawal by Subject|16|||
162992925|NCT02932306|588676096|FG001|Overall Study|Withdrawal by Subject|25|||
162992926|NCT02932306|588676095|FG000|Overall Study|Adverse Event|3|||
162992927|NCT02932306|588676096|FG001|Overall Study|Adverse Event|0|||
162992928|NCT02932306|588676095|FG000|Overall Study|Pregnancy|2|||
162992929|NCT02932306|588676096|FG001|Overall Study|Pregnancy|0|||
162992930|NCT02932306|588676095|FG000|Overall Study|Protocol Violation|1|||
162992931|NCT02932306|588676096|FG001|Overall Study|Protocol Violation|1|||
162992932|NCT02932306|588676095|FG000|Overall Study|Noncompliance with Study Drug|1|||
162992933|NCT02932306|588676096|FG001|Overall Study|Noncompliance with Study Drug|1|||
162992934|NCT02932306|588676095|FG000|Overall Study|Lost to Follow-up|36|||
162992935|NCT02932306|588676096|FG001|Overall Study|Lost to Follow-up|40|||
162992936|NCT02932306|588676095|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
162992937|NCT02932306|588676096|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
162992938|NCT02932306|588676095|FG000|Overall Study|Lack of Efficacy|0|||
162992939|NCT02932306|588676096|FG001|Overall Study|Lack of Efficacy|2|||
162992940|NCT02932306|588676095|FG000|Overall Study|Worsening condition|2|||
162992941|NCT02932306|588676096|FG001|Overall Study|Worsening condition|0|||
162992942|NCT02932306|588676095|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
162992943|NCT02932306|588676096|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
162992944|NCT05776862|588676097|FG000|Overall Study|Adverse Event|0|||
162992945|NCT05776862|588676098|FG001|Overall Study|Adverse Event|1|||
162992946|NCT05776862|588676097|FG000|Overall Study|non-compliance|1|||
162992947|NCT05776862|588676098|FG001|Overall Study|non-compliance|0|||
162992948|NCT02448706|588676099|FG000|Overall Study|Withdrawal by Subject|4|||
162992949|NCT02448706|588676100|FG001|Overall Study|Withdrawal by Subject|3|||
162992950|NCT02448706|588676099|FG000|Overall Study|Protocol Violation|1|||
162992951|NCT02448706|588676100|FG001|Overall Study|Protocol Violation|1|||
162992952|NCT02065700|588676101|FG000|Overall Study|Adverse Event|165|||
162992953|NCT02065700|588676102|FG001|Overall Study|Adverse Event|101|||
162992954|NCT02065700|588676101|FG000|Overall Study|Withdrawal by Subject|90|||
162992955|NCT02065700|588676102|FG001|Overall Study|Withdrawal by Subject|29|||
162992956|NCT02065700|588676101|FG000|Overall Study|Lost to Follow-up|12|||
162992957|NCT02065700|588676102|FG001|Overall Study|Lost to Follow-up|9|||
162992958|NCT02065700|588676101|FG000|Overall Study|Physician Decision|2|||
162992959|NCT02065700|588676102|FG001|Overall Study|Physician Decision|0|||
162992960|NCT02065700|588676101|FG000|Overall Study|Sponsor Request|38|||
162992961|NCT02065700|588676102|FG001|Overall Study|Sponsor Request|15|||
162992962|NCT02065700|588676101|FG000|Overall Study|Treatment Failure|3|||
162992963|NCT02065700|588676102|FG001|Overall Study|Treatment Failure|2|||
162992964|NCT02065700|588676101|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
162992965|NCT02065700|588676102|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
162992966|NCT02065700|588676101|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
162992967|NCT02065700|588676102|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
162992968|NCT02065700|588676101|FG000|Overall Study|Non-compliance with Study Procedures|2|||
162992969|NCT02065700|588676102|FG001|Overall Study|Non-compliance with Study Procedures|0|||
162992970|NCT02065700|588676101|FG000|Overall Study|Not Defined|21|||
162992971|NCT02065700|588676102|FG001|Overall Study|Not Defined|3|||
162992972|NCT02315196|588676103|FG000|Overall Study|Withdrew consent|9|||
162992973|NCT01635218|588676104|FG000|Overall Study|Lost to Follow-up|3|||
162992974|NCT01635218|588676105|FG001|Overall Study|Lost to Follow-up|7|||
162992975|NCT01635218|588676106|FG002|Overall Study|Lost to Follow-up|6|||
163404292|NCT02831673|590191900|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
162992976|NCT03262038|588676107|FG000|Overall Study|Withdrawal by Subject|0|||
162992977|NCT03262038|588676108|FG001|Overall Study|Withdrawal by Subject|1|||
162992978|NCT04933968|588676109|FG000|Overall Study|Adverse Event|0|||
162992979|NCT04933968|588676110|FG001|Overall Study|Adverse Event|0|||
162992980|NCT04933968|588676111|FG002|Overall Study|Adverse Event|1|||
162992981|NCT04933968|588676112|FG003|Overall Study|Adverse Event|1|||
162992982|NCT04933968|588676113|FG004|Overall Study|Adverse Event|0|||
162992983|NCT04933968|588676114|FG005|Overall Study|Adverse Event|0|||
162992984|NCT04933968|588676109|FG000|Overall Study|Lost to Follow-up|1|||
163060128|NCT02765165|588928306|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
163060129|NCT02765165|588928307|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
163060130|NCT02765165|588928308|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
163060131|NCT02765165|588928309|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
163060132|NCT02765165|588928303|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
163060133|NCT02765165|588928304|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
163060134|NCT02765165|588928305|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
163060135|NCT02765165|588928306|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
163060136|NCT02765165|588928307|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
162992985|NCT04933968|588676110|FG001|Overall Study|Lost to Follow-up|0|||
162992986|NCT04933968|588676111|FG002|Overall Study|Lost to Follow-up|1|||
162992987|NCT04933968|588676112|FG003|Overall Study|Lost to Follow-up|0|||
162992988|NCT04933968|588676113|FG004|Overall Study|Lost to Follow-up|0|||
162992989|NCT04933968|588676114|FG005|Overall Study|Lost to Follow-up|0|||
162992990|NCT04933968|588676109|FG000|Overall Study|Randomized not treated|1|||
162992991|NCT04933968|588676110|FG001|Overall Study|Randomized not treated|0|||
162992992|NCT04933968|588676111|FG002|Overall Study|Randomized not treated|0|||
162992993|NCT04933968|588676112|FG003|Overall Study|Randomized not treated|0|||
162992994|NCT04933968|588676113|FG004|Overall Study|Randomized not treated|0|||
162992995|NCT04933968|588676114|FG005|Overall Study|Randomized not treated|0|||
162992996|NCT04933968|588676109|FG000|Overall Study|Sponsor terminated study|0|||
162992997|NCT04933968|588676110|FG001|Overall Study|Sponsor terminated study|0|||
162992998|NCT04933968|588676111|FG002|Overall Study|Sponsor terminated study|0|||
162992999|NCT04933968|588676112|FG003|Overall Study|Sponsor terminated study|1|||
162993000|NCT04933968|588676113|FG004|Overall Study|Sponsor terminated study|2|||
162993001|NCT04933968|588676114|FG005|Overall Study|Sponsor terminated study|0|||
162993002|NCT04933968|588676109|FG000|Overall Study|Other|0|||
162993003|NCT04933968|588676110|FG001|Overall Study|Other|0|||
162993004|NCT04933968|588676111|FG002|Overall Study|Other|0|||
162993005|NCT04933968|588676112|FG003|Overall Study|Other|1|||
162993006|NCT04933968|588676113|FG004|Overall Study|Other|0|||
162993007|NCT04933968|588676114|FG005|Overall Study|Other|0|||
162993008|NCT04933968|588676109|FG000|Overall Study|Missing|1|||
162993009|NCT04933968|588676110|FG001|Overall Study|Missing|3|||
162993010|NCT04933968|588676111|FG002|Overall Study|Missing|2|||
162993011|NCT04933968|588676112|FG003|Overall Study|Missing|1|||
162993012|NCT04933968|588676113|FG004|Overall Study|Missing|1|||
162993013|NCT04933968|588676114|FG005|Overall Study|Missing|0|||
162993014|NCT02278055|588676117|FG000|Overall Study|Adverse Event|1|||
162993015|NCT02278055|588676117|FG000|Overall Study|Lost to Follow-up|1|||
162993016|NCT02278055|588676117|FG000|Overall Study|Withdrawal by Subject|2|||
162993017|NCT02278055|588676117|FG000|Overall Study|Progressive Disease|4|||
162993018|NCT01934335|588676118|FG000|Overall Study|Withdrawal by Subject|1|||
162993019|NCT01934335|588676119|FG001|Overall Study|Withdrawal by Subject|1|||
162993020|NCT03016975|588676130|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
162993021|NCT03016975|588676131|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
162993022|NCT03016975|588676132|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
162993023|NCT03016975|588676130|FG000|At 6 Months Follow-up|Death|2|||
162993024|NCT03016975|588676131|FG001|At 6 Months Follow-up|Death|0|||
162993025|NCT03016975|588676132|FG002|At 6 Months Follow-up|Death|0|||
162993026|NCT03016975|588676130|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
162993027|NCT03016975|588676131|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
162993028|NCT03016975|588676132|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
162993029|NCT03016975|588676130|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
162993030|NCT03016975|588676131|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
162993031|NCT03016975|588676132|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
162993032|NCT03016975|588676130|FG000|At 6 Months Follow-up|Aborted implant|1|||
162993033|NCT03016975|588676131|FG001|At 6 Months Follow-up|Aborted implant|0|||
162993034|NCT03016975|588676132|FG002|At 6 Months Follow-up|Aborted implant|0|||
163060137|NCT02765165|588928308|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
162993035|NCT03016975|588676130|FG000|At 2 Year Follow-up|Death|1|||
162993036|NCT03016975|588676131|FG001|At 2 Year Follow-up|Death|0|||
162993037|NCT03016975|588676132|FG002|At 2 Year Follow-up|Death|0|||
163060138|NCT02765165|588928309|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
163060139|NCT02765165|588928303|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
163060140|NCT02765165|588928304|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
163060141|NCT02765165|588928305|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
163324676|NCT02101853|589900682|FG003|Block 1 Induction|Withdrawal by Subject|0|||
163324677|NCT02101853|589900683|FG004|Block 1 Induction|Withdrawal by Subject|0|||
163324678|NCT02101853|589900684|FG005|Block 1 Induction|Withdrawal by Subject|0|||
162993038|NCT03016975|588676130|FG000|At 3 Year Follow-up|Death|1|||
162993039|NCT03016975|588676131|FG001|At 3 Year Follow-up|Death|0|||
162993040|NCT03016975|588676132|FG002|At 3 Year Follow-up|Death|0|||
162993041|NCT03016975|588676130|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
162993042|NCT03016975|588676131|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
162993043|NCT03016975|588676132|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
162993044|NCT03016975|588676130|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
162993045|NCT03016975|588676131|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
162993046|NCT03016975|588676132|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
162993047|NCT00811928|588676133|FG000|Overall Study|AEs and SAEs Including Death|7|||
162993048|NCT00811928|588676134|FG001|Overall Study|AEs and SAEs Including Death|11|||
162993049|NCT00811928|588676133|FG000|Overall Study|Withdrawal by Subject|18|||
162993050|NCT00811928|588676134|FG001|Overall Study|Withdrawal by Subject|12|||
162993051|NCT00811928|588676133|FG000|Overall Study|Did Not Take Study Drug|3|||
162993052|NCT00811928|588676134|FG001|Overall Study|Did Not Take Study Drug|0|||
162993053|NCT00811928|588676133|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
162993054|NCT00811928|588676134|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
162993055|NCT00811928|588676133|FG000|Overall Study|Investigator Decision|2|||
162993056|NCT00811928|588676134|FG001|Overall Study|Investigator Decision|1|||
162993057|NCT00811928|588676133|FG000|Overall Study|Poor Compliance|2|||
162993058|NCT00811928|588676134|FG001|Overall Study|Poor Compliance|5|||
162993059|NCT01085357|588676135|FG000|Overall Study|Adverse Event|1|||
162993060|NCT01085357|588676136|FG001|Overall Study|Adverse Event|1|||
162993061|NCT01085357|588676135|FG000|Overall Study|Subject Decision|4|||
162993062|NCT01085357|588676136|FG001|Overall Study|Subject Decision|3|||
162993063|NCT01085357|588676135|FG000|Overall Study|Investigator Decision|1|||
162993064|NCT01085357|588676136|FG001|Overall Study|Investigator Decision|1|||
162993065|NCT01085357|588676135|FG000|Overall Study|Death|11|||
162993066|NCT01085357|588676136|FG001|Overall Study|Death|1|||
162993067|NCT01085357|588676135|FG000|Overall Study|Lost to Follow-up|2|||
162993068|NCT01085357|588676136|FG001|Overall Study|Lost to Follow-up|0|||
162993069|NCT02910011|588676137|FG000|Overall Study|Physician Decision|2|||
162993070|NCT00838435|588676138|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
162993071|NCT00838435|588676138|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
162993072|NCT00838435|588676138|FG000|Part 2 (7 Years)|Adverse Event|2|||
162993073|NCT00838435|588676138|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
162993074|NCT00838435|588676138|FG000|Part 2 (7 Years)|Physician Decision|1|||
162993075|NCT00838435|588676138|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
162993076|NCT00838435|588676138|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
162993077|NCT02348723|588676139|FG000|Overall Study|No ablation|21|||
162993078|NCT02348723|588676140|FG001|Overall Study|No ablation|20|||
162993079|NCT02348723|588676139|FG000|Overall Study|Non-compliant with Protocol|1|||
162993080|NCT02348723|588676140|FG001|Overall Study|Non-compliant with Protocol|0|||
162993081|NCT02348723|588676139|FG000|Overall Study|Lost to Follow-up|1|||
162993082|NCT02348723|588676140|FG001|Overall Study|Lost to Follow-up|1|||
162993083|NCT02348723|588676139|FG000|Overall Study|Consent withdrawn|1|||
162993084|NCT02348723|588676140|FG001|Overall Study|Consent withdrawn|3|||
162993085|NCT02348723|588676139|FG000|Overall Study|Reason other than specified|1|||
162993086|NCT02348723|588676140|FG001|Overall Study|Reason other than specified|1|||
162993087|NCT02348723|588676139|FG000|Overall Study|Adverse Event|3|||
162993088|NCT02348723|588676140|FG001|Overall Study|Adverse Event|1|||
162993089|NCT00678886|588676141|FG000|Overall Study|Withdrawal by Subject|0|||
162993090|NCT00678886|588676142|FG001|Overall Study|Withdrawal by Subject|0|||
162993091|NCT00678886|588676143|FG002|Overall Study|Withdrawal by Subject|4|||
162993092|NCT00678886|588676144|FG003|Overall Study|Withdrawal by Subject|6|||
162993093|NCT00678886|588676141|FG000|Overall Study|Physician Decision|0|||
162993094|NCT00678886|588676142|FG001|Overall Study|Physician Decision|0|||
162993095|NCT00678886|588676143|FG002|Overall Study|Physician Decision|1|||
163060142|NCT02765165|588928306|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
163060143|NCT02765165|588928307|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
163060144|NCT02765165|588928308|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
163060145|NCT02765165|588928309|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
163060146|NCT02382939|588928312|FG000|Overall Study|Adverse Event|1|||
163060147|NCT02382939|588928313|FG001|Overall Study|Adverse Event|1|||
163060148|NCT02382939|588928312|FG000|Overall Study|Withdrawal by Subject|2|||
163060149|NCT02382939|588928313|FG001|Overall Study|Withdrawal by Subject|2|||
163060150|NCT01189266|588928316|FG000|Overall Study|Adverse Event|1|||
163060151|NCT01189266|588928317|FG001|Overall Study|Adverse Event|0|||
162993096|NCT00678886|588676144|FG003|Overall Study|Physician Decision|1|||
162993097|NCT00678886|588676141|FG000|Overall Study|Lost to Follow-up|0|||
163324679|NCT02101853|589900679|FG000|Block 1 Induction|Ineligible|8|||
163324680|NCT02101853|589900680|FG001|Block 1 Induction|Ineligible|0|||
163324681|NCT02101853|589900681|FG002|Block 1 Induction|Ineligible|0|||
162993098|NCT00678886|588676142|FG001|Overall Study|Lost to Follow-up|0|||
163060152|NCT01189266|588928318|FG002|Overall Study|Adverse Event|5|||
163060153|NCT01189266|588928316|FG000|Overall Study|Death|0|||
163324682|NCT02101853|589900682|FG003|Block 1 Induction|Ineligible|0|||
163060154|NCT01189266|588928317|FG001|Overall Study|Death|0|||
162993099|NCT00678886|588676143|FG002|Overall Study|Lost to Follow-up|3|||
162993100|NCT00678886|588676144|FG003|Overall Study|Lost to Follow-up|2|||
162993101|NCT00678886|588676141|FG000|Overall Study|Other|0|||
162993102|NCT00678886|588676142|FG001|Overall Study|Other|0|||
163324683|NCT02101853|589900683|FG004|Block 1 Induction|Ineligible|0|||
162993103|NCT00678886|588676143|FG002|Overall Study|Other|1|||
162993104|NCT00678886|588676144|FG003|Overall Study|Other|0|||
162993105|NCT01147107|588676145|FG000|Overall Study|Lack of Efficacy|5|||
162993106|NCT01147107|588676146|FG001|Overall Study|Lack of Efficacy|0|||
162993107|NCT01147107|588676145|FG000|Overall Study|Withdrawal by Subject|1|||
162993108|NCT01147107|588676146|FG001|Overall Study|Withdrawal by Subject|1|||
162993109|NCT04435184|588676147|FG000|Overall Study|follow-up blood draws missing|3|||
162993110|NCT04435184|588676148|FG001|Overall Study|follow-up blood draws missing|5|||
162993111|NCT04693416|588676149|FG000|Overall Study|Lost to Follow-up|13|||
162993112|NCT04693416|588676150|FG001|Overall Study|Lost to Follow-up|0|||
162993113|NCT02290223|588676151|FG000|6 Months|Lost to Follow-up|9|||
162993114|NCT02290223|588676152|FG001|6 Months|Lost to Follow-up|6|||
162993115|NCT02290223|588676151|FG000|6 Months|Withdrawal by Subject|5|||
162993116|NCT02290223|588676152|FG001|6 Months|Withdrawal by Subject|0|||
162993117|NCT02290223|588676151|FG000|6 Months|deceased (not related to study)|2|||
162993118|NCT02290223|588676152|FG001|6 Months|deceased (not related to study)|0|||
162993119|NCT02290223|588676151|FG000|12 Months|Lost to Follow-up|16|||
162993120|NCT02290223|588676152|FG001|12 Months|Lost to Follow-up|10|||
162993121|NCT02290223|588676151|FG000|12 Months|Refusal|0|||
162993122|NCT02290223|588676152|FG001|12 Months|Refusal|1|||
162993123|NCT05293639|588676153|FG000|Overall Study|Withdrawal by Subject|1|||
162993124|NCT05293639|588676154|FG001|Overall Study|Withdrawal by Subject|1|||
162993125|NCT05293639|588676155|FG002|Overall Study|Withdrawal by Subject|2|||
162993126|NCT05293639|588676153|FG000|Overall Study|Death|0|||
162993127|NCT05293639|588676154|FG001|Overall Study|Death|1|||
162993128|NCT05293639|588676155|FG002|Overall Study|Death|0|||
162993129|NCT05293639|588676153|FG000|Overall Study|Lost to Follow-up|0|||
162993130|NCT05293639|588676154|FG001|Overall Study|Lost to Follow-up|0|||
162993131|NCT05293639|588676155|FG002|Overall Study|Lost to Follow-up|5|||
162993132|NCT05293639|588676153|FG000|Overall Study|Other|0|||
162993133|NCT05293639|588676154|FG001|Overall Study|Other|0|||
162993134|NCT05293639|588676155|FG002|Overall Study|Other|1|||
162993135|NCT01860677|588676162|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
162993136|NCT01860677|588676163|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
162993137|NCT01671332|588676169|FG000|Overall Study|Withdrawal by Subject|1|||
162993138|NCT01671332|588676170|FG001|Overall Study|Withdrawal by Subject|1|||
162993139|NCT02722148|588676176|FG000|Overall Study|Lost to Follow-up|2|||
162993140|NCT02722148|588676176|FG000|Overall Study|Non compliant with treatment regimen|3|||
162993141|NCT00073021|588676177|FG000|Overall Study|Protocol Violation|2|||
162993142|NCT00073021|588676178|FG001|Overall Study|Protocol Violation|1|||
162993143|NCT00073021|588676177|FG000|Overall Study|Adverse Event|4|||
162993144|NCT00073021|588676178|FG001|Overall Study|Adverse Event|4|||
162993145|NCT00073021|588676177|FG000|Overall Study|Withdrawal by Subject|6|||
162993146|NCT00073021|588676178|FG001|Overall Study|Withdrawal by Subject|5|||
162993147|NCT00073021|588676177|FG000|Overall Study|Physician Decision|3|||
162993148|NCT00073021|588676178|FG001|Overall Study|Physician Decision|1|||
162993149|NCT00073021|588676177|FG000|Overall Study|Lack of Efficacy|11|||
162993150|NCT00073021|588676178|FG001|Overall Study|Lack of Efficacy|5|||
162993151|NCT01458106|588676179|FG000|Overall Study|Withdrawal by Subject|2|||
162993152|NCT01458106|588676180|FG001|Overall Study|Withdrawal by Subject|0|||
162993153|NCT01458106|588676179|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
162993154|NCT01458106|588676180|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
162993155|NCT01458106|588676179|FG000|Overall Study|Withdrawn Per Protocol|0|||
162993156|NCT01458106|588676180|FG001|Overall Study|Withdrawn Per Protocol|1|||
162993157|NCT01425723|588676181|FG000|Overall Study|Lack of Efficacy|0|||
162993158|NCT01425723|588676182|FG001|Overall Study|Lack of Efficacy|1|||
162993159|NCT01425723|588676181|FG000|Overall Study|Withdrawal by Subject|1|||
162993160|NCT01425723|588676182|FG001|Overall Study|Withdrawal by Subject|4|||
162993161|NCT01425723|588676181|FG000|Overall Study|Lost to Follow-up|0|||
162993162|NCT01425723|588676182|FG001|Overall Study|Lost to Follow-up|3|||
162993163|NCT01425723|588676181|FG000|Overall Study|Physician Decision|2|||
162993164|NCT01425723|588676182|FG001|Overall Study|Physician Decision|0|||
162993165|NCT01425723|588676181|FG000|Overall Study|Other|1|||
162993166|NCT01425723|588676182|FG001|Overall Study|Other|10|||
162993167|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
162993168|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
162993169|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993170|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993171|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993172|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993173|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993174|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993175|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993176|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993177|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993178|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993179|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993180|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993181|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
162993182|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
162993183|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993184|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993185|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993186|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993187|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993188|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993189|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993190|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993191|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993192|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993193|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993194|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993195|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
162993196|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
162993197|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993198|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993199|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993200|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993201|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993202|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993203|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993204|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993205|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993206|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993207|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993208|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993209|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
162993210|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
162993211|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993212|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993213|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993214|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993215|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993216|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993217|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993218|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993219|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993220|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993221|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993222|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993223|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
162993224|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
162993225|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993226|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993227|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993228|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993229|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993230|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993231|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993232|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993233|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993234|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993235|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993236|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993237|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
162993238|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
162993239|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993240|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
163404293|NCT02831673|590191901|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
162993241|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993242|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993243|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
163404294|NCT02831673|590191902|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
163404295|NCT02831673|590191903|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
162993244|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993245|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993246|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993247|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993248|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993249|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993250|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993251|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
162993252|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
162993253|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993254|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993255|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993256|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993257|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993258|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993259|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993260|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993261|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993262|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993263|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993264|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993265|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
162993266|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
162993267|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993268|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993269|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993270|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993271|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993272|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993273|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993274|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993275|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993276|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993277|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993278|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993279|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
162993280|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
162993281|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993282|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993283|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993284|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993285|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993286|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993287|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993288|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993289|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993290|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993291|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993292|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993293|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
162993294|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
162993295|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993296|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993297|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993298|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993299|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993300|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993301|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993302|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993303|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
163060155|NCT01189266|588928318|FG002|Overall Study|Death|5|||
163060156|NCT01189266|588928316|FG000|Overall Study|Lack of Efficacy|4|||
163060157|NCT01189266|588928317|FG001|Overall Study|Lack of Efficacy|5|||
163404296|NCT02831673|590191904|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
163060158|NCT01189266|588928318|FG002|Overall Study|Lack of Efficacy|44|||
163060159|NCT01189266|588928316|FG000|Overall Study|Physician Decision|0|||
163404297|NCT02831673|590191900|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
162993304|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993305|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993306|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993307|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
162993308|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
162993309|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993310|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993311|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993312|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993313|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993314|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993315|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993316|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993317|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993318|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993319|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993320|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993321|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
162993322|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
162993323|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993324|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993325|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993326|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993327|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993328|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993329|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993330|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993331|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993332|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993333|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993334|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993335|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993336|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993337|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993338|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
163060160|NCT01189266|588928317|FG001|Overall Study|Physician Decision|0|||
163060161|NCT01189266|588928318|FG002|Overall Study|Physician Decision|1|||
163060162|NCT01189266|588928316|FG000|Overall Study|Protocol Violation|0|||
163060163|NCT01189266|588928317|FG001|Overall Study|Protocol Violation|1|||
163060164|NCT01189266|588928318|FG002|Overall Study|Protocol Violation|1|||
163060165|NCT01189266|588928316|FG000|Overall Study|Withdrawal by Subject|0|||
163060166|NCT01189266|588928317|FG001|Overall Study|Withdrawal by Subject|0|||
163060167|NCT01189266|588928318|FG002|Overall Study|Withdrawal by Subject|1|||
163060168|NCT01189266|588928316|FG000|Overall Study|Patient refuses further therapy|1|||
163060169|NCT01189266|588928317|FG001|Overall Study|Patient refuses further therapy|0|||
163060170|NCT01189266|588928318|FG002|Overall Study|Patient refuses further therapy|7|||
163060171|NCT01189266|588928316|FG000|Overall Study|No treatment|0|||
163060172|NCT01189266|588928317|FG001|Overall Study|No treatment|0|||
163060173|NCT01189266|588928318|FG002|Overall Study|No treatment|1|||
163060174|NCT00321763|588928319|FG000|Overall Study|Adverse Event|1|||
163060175|NCT00321763|588928320|FG001|Overall Study|Adverse Event|1|||
163324684|NCT02101853|589900684|FG005|Block 1 Induction|Ineligible|0|||
163324685|NCT02101853|589900679|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
163324686|NCT02101853|589900680|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
163324687|NCT02101853|589900681|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
163324688|NCT02101853|589900682|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
163060176|NCT00321763|588928321|FG002|Overall Study|Adverse Event|0|||
163060177|NCT00321763|588928322|FG003|Overall Study|Adverse Event|1|||
163060178|NCT00321763|588928319|FG000|Overall Study|Withdrawal by Subject|2|||
163060179|NCT00321763|588928320|FG001|Overall Study|Withdrawal by Subject|0|||
163060180|NCT00321763|588928321|FG002|Overall Study|Withdrawal by Subject|1|||
163060181|NCT00321763|588928322|FG003|Overall Study|Withdrawal by Subject|0|||
163060182|NCT00321763|588928319|FG000|Overall Study|Lost to Follow-up|3|||
163324689|NCT02101853|589900683|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
163060183|NCT00321763|588928320|FG001|Overall Study|Lost to Follow-up|1|||
163060184|NCT00321763|588928321|FG002|Overall Study|Lost to Follow-up|5|||
162993339|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993340|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993341|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993342|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993343|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993344|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993345|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993346|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993347|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993348|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993349|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993350|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993351|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
162993352|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993353|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993354|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993355|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993356|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993357|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993358|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993359|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993360|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993361|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993362|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993363|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993364|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993365|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
162993366|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993367|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993368|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993369|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993370|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993371|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993372|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993373|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993374|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993375|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993376|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993377|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993378|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993379|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
162993380|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
162993381|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993382|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993383|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
163324690|NCT02101853|589900684|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
163324691|NCT02101853|589900679|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
163324692|NCT02101853|589900680|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163324693|NCT02101853|589900681|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163324694|NCT02101853|589900682|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163324695|NCT02101853|589900683|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163324696|NCT02101853|589900684|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163324697|NCT02101853|589900679|FG000|Post Induction Randomization|Adverse Event|0|||
163324698|NCT02101853|589900680|FG001|Post Induction Randomization|Adverse Event|3|||
163324699|NCT02101853|589900681|FG002|Post Induction Randomization|Adverse Event|8|||
163324700|NCT02101853|589900682|FG003|Post Induction Randomization|Adverse Event|4|||
163324701|NCT02101853|589900683|FG004|Post Induction Randomization|Adverse Event|4|||
163324702|NCT02101853|589900684|FG005|Post Induction Randomization|Adverse Event|0|||
163324703|NCT02101853|589900679|FG000|Post Induction Randomization|Death|0|||
163324704|NCT02101853|589900680|FG001|Post Induction Randomization|Death|9|||
163404298|NCT02831673|590191901|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
163404299|NCT02831673|590191902|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
163404300|NCT02831673|590191903|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
162993384|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993385|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993386|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993387|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993388|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993389|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993390|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993391|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993392|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993393|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993394|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
162993395|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993396|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993397|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993398|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993399|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993400|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993401|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993402|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993403|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993404|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993405|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993406|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993407|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
162993408|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
162993409|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993410|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993411|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993412|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993413|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993414|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993415|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993416|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993417|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993418|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993419|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993420|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
163324705|NCT02101853|589900681|FG002|Post Induction Randomization|Death|2|||
163324706|NCT02101853|589900682|FG003|Post Induction Randomization|Death|2|||
163324707|NCT02101853|589900683|FG004|Post Induction Randomization|Death|0|||
163324708|NCT02101853|589900684|FG005|Post Induction Randomization|Death|0|||
163324709|NCT02101853|589900679|FG000|Post Induction Randomization|Lack of Efficacy|0|||
163324710|NCT02101853|589900680|FG001|Post Induction Randomization|Lack of Efficacy|14|||
163324711|NCT02101853|589900681|FG002|Post Induction Randomization|Lack of Efficacy|23|||
163324712|NCT02101853|589900682|FG003|Post Induction Randomization|Lack of Efficacy|18|||
163324713|NCT02101853|589900683|FG004|Post Induction Randomization|Lack of Efficacy|21|||
163324714|NCT02101853|589900684|FG005|Post Induction Randomization|Lack of Efficacy|0|||
163324715|NCT02101853|589900679|FG000|Post Induction Randomization|Physician Decision|0|||
163324716|NCT02101853|589900680|FG001|Post Induction Randomization|Physician Decision|43|||
163324717|NCT02101853|589900681|FG002|Post Induction Randomization|Physician Decision|23|||
163324718|NCT02101853|589900682|FG003|Post Induction Randomization|Physician Decision|14|||
163324719|NCT02101853|589900683|FG004|Post Induction Randomization|Physician Decision|14|||
163324720|NCT02101853|589900684|FG005|Post Induction Randomization|Physician Decision|0|||
163324721|NCT02101853|589900679|FG000|Post Induction Randomization|Protocol Violation|0|||
163324722|NCT02101853|589900680|FG001|Post Induction Randomization|Protocol Violation|3|||
163324723|NCT02101853|589900681|FG002|Post Induction Randomization|Protocol Violation|0|||
163324724|NCT02101853|589900682|FG003|Post Induction Randomization|Protocol Violation|0|||
163324725|NCT02101853|589900683|FG004|Post Induction Randomization|Protocol Violation|0|||
163324726|NCT02101853|589900684|FG005|Post Induction Randomization|Protocol Violation|0|||
163324727|NCT02101853|589900679|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
163324728|NCT02101853|589900680|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
163324729|NCT02101853|589900681|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
163324730|NCT02101853|589900682|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
163324731|NCT02101853|589900683|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
163324732|NCT02101853|589900684|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
163384888|NCT00427895|590119255|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
162993421|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993422|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993423|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993424|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993425|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993426|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993427|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
162993428|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993429|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993430|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993431|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993432|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993433|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993434|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993435|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993436|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993437|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993438|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993439|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993440|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993441|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
162993442|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993443|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993444|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993445|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993446|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993447|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993448|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993449|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993450|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993451|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993452|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993453|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993454|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993455|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
162993456|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993457|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993458|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993459|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993460|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993461|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993462|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993463|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993464|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993465|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993466|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993467|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993468|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993469|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
162993470|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
163212488|NCT00597766|589492543|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
163212489|NCT00597766|589492544|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
163212490|NCT00597766|589492542|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
163212491|NCT00597766|589492543|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
163212492|NCT00597766|589492544|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
163212493|NCT01333059|589492545|FG000|Overall Study|Physician Decision|3|||
163212494|NCT01333059|589492546|FG001|Overall Study|Physician Decision|3|||
163324733|NCT02101853|589900679|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163324734|NCT02101853|589900680|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163384889|NCT00427895|590119256|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
163212495|NCT01333059|589492545|FG000|Overall Study|Protocol Violation|3|||
163212496|NCT01333059|589492546|FG001|Overall Study|Protocol Violation|0|||
163212497|NCT01166763|589492548|FG000|Overall Study|Withdrawal by Subject|3|||
163212498|NCT00737282|589492549|FG000|Overall Study|Study prematurely terminated|175|||
162993471|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993472|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993473|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993474|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993475|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993476|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993477|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993478|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993479|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993480|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993481|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993482|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993483|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
162993484|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993485|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993486|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993487|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993488|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993489|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993490|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993491|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993492|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993493|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993494|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
162993495|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993496|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
162993497|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
162993498|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993499|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993500|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993501|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993502|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
163212499|NCT02763189|589492550|FG000|Overall Study|Device failure|0|||
162993503|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993504|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993505|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993506|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993507|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993508|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993509|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993510|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993511|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
162993512|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993513|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993514|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993515|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993516|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993517|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993518|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993519|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993520|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993521|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993522|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
162993523|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993524|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
163212500|NCT02763189|589492551|FG001|Overall Study|Device failure|2|||
163212501|NCT02049957|589492556|FG000|Overall Study|Progressive Disease|5|||
163212502|NCT02049957|589492557|FG001|Overall Study|Progressive Disease|4|||
163212503|NCT02049957|589492558|FG002|Overall Study|Progressive Disease|2|||
163212504|NCT02049957|589492559|FG003|Overall Study|Progressive Disease|2|||
163212505|NCT02049957|589492560|FG004|Overall Study|Progressive Disease|6|||
163212506|NCT02049957|589492561|FG005|Overall Study|Progressive Disease|35|||
163212507|NCT02049957|589492562|FG006|Overall Study|Progressive Disease|7|||
163212508|NCT02049957|589492563|FG007|Overall Study|Progressive Disease|26|||
163212509|NCT02049957|589492564|FG008|Overall Study|Progressive Disease|6|||
163212510|NCT02049957|589492556|FG000|Overall Study|Adverse Event|1|||
162993525|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
162993526|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993527|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993528|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993529|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993530|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993531|NCT03982199|588676185|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993532|NCT03982199|588676186|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993533|NCT03982199|588676187|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993534|NCT03982199|588676188|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993535|NCT03982199|588676189|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993536|NCT03982199|588676190|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993537|NCT03982199|588676191|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993538|NCT03982199|588676192|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993539|NCT03982199|588676193|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993540|NCT03982199|588676194|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
162993541|NCT03982199|588676195|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
162993542|NCT03982199|588676196|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
162993543|NCT03982199|588676197|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
162993544|NCT03982199|588676198|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
162993545|NCT03982199|588676185|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993546|NCT03982199|588676186|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993547|NCT03982199|588676187|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993548|NCT03982199|588676188|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993549|NCT03982199|588676189|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993550|NCT03982199|588676190|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993551|NCT03982199|588676191|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993552|NCT03982199|588676192|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993553|NCT03982199|588676193|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993554|NCT03982199|588676194|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
162993555|NCT03982199|588676195|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993556|NCT03982199|588676196|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993557|NCT03982199|588676197|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993558|NCT03982199|588676198|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993559|NCT03982199|588676185|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993560|NCT03982199|588676186|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993561|NCT03982199|588676187|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993562|NCT03982199|588676188|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993563|NCT03982199|588676189|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993564|NCT03982199|588676190|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993565|NCT03982199|588676191|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993566|NCT03982199|588676192|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
163324735|NCT02101853|589900681|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163324736|NCT02101853|589900682|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
163324737|NCT02101853|589900683|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163324738|NCT02101853|589900684|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163324739|NCT02101853|589900679|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
163324740|NCT02101853|589900680|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
163324741|NCT02101853|589900681|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
163324742|NCT02101853|589900682|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
163324743|NCT02101853|589900683|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
163324744|NCT02101853|589900684|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
163324745|NCT02101853|589900679|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
163324746|NCT02101853|589900680|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
163324747|NCT02101853|589900681|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
163324748|NCT02101853|589900682|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
163324749|NCT02101853|589900683|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
163324750|NCT02101853|589900684|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
163324751|NCT02101853|589900679|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
162993567|NCT03982199|588676193|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993568|NCT03982199|588676194|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993569|NCT03982199|588676195|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993570|NCT03982199|588676196|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993571|NCT03982199|588676197|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993572|NCT03982199|588676198|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
162993573|NCT03982199|588676185|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993574|NCT03982199|588676186|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993575|NCT03982199|588676187|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993576|NCT03982199|588676188|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993577|NCT03982199|588676189|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993578|NCT03982199|588676190|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993579|NCT03982199|588676191|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993580|NCT03982199|588676192|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993581|NCT03982199|588676193|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993582|NCT03982199|588676194|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993583|NCT03982199|588676195|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
162993584|NCT03982199|588676196|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
162993585|NCT03982199|588676197|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
162993586|NCT03982199|588676198|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993587|NCT03982199|588676185|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993588|NCT03982199|588676186|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993589|NCT03982199|588676187|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993590|NCT03982199|588676188|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993591|NCT03982199|588676189|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993592|NCT03982199|588676190|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993593|NCT03982199|588676191|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993594|NCT03982199|588676192|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993595|NCT03982199|588676193|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993596|NCT03982199|588676194|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
163060185|NCT00321763|588928322|FG003|Overall Study|Lost to Follow-up|4|||
163060186|NCT03530696|588928326|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
163060187|NCT03530696|588928327|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
163060188|NCT01129128|588928328|FG000|Overall Study|Lost to Follow-up|2|||
163060189|NCT01129128|588928329|FG001|Overall Study|Lost to Follow-up|2|||
163060190|NCT01129128|588928330|FG002|Overall Study|Lost to Follow-up|1|||
163060191|NCT01129128|588928328|FG000|Overall Study|Protocol Violation|0|||
163060192|NCT01129128|588928329|FG001|Overall Study|Protocol Violation|1|||
163060193|NCT01129128|588928330|FG002|Overall Study|Protocol Violation|0|||
163060194|NCT01129128|588928328|FG000|Overall Study|Withdrawal by Subject|0|||
163060195|NCT01129128|588928329|FG001|Overall Study|Withdrawal by Subject|1|||
163060196|NCT01129128|588928330|FG002|Overall Study|Withdrawal by Subject|3|||
163060197|NCT01129128|588928328|FG000|Overall Study|Physician Decision|1|||
163060198|NCT01129128|588928329|FG001|Overall Study|Physician Decision|0|||
163060199|NCT01129128|588928330|FG002|Overall Study|Physician Decision|0|||
163060200|NCT01311661|588928333|FG000|Overall Study|Adverse Event|2|||
163060201|NCT01311661|588928333|FG000|Overall Study|Protocol Violation|3|||
163060202|NCT01311661|588928333|FG000|Overall Study|Withdrawal by Subject|2|||
163060203|NCT01900314|588928334|FG000|Overall Study|Lost to Follow-up|1|||
163060204|NCT01900314|588928335|FG001|Overall Study|Lost to Follow-up|0|||
163060205|NCT01900314|588928334|FG000|Overall Study|Protocol Violation|0|||
163060206|NCT01900314|588928335|FG001|Overall Study|Protocol Violation|1|||
163060207|NCT01900314|588928334|FG000|Overall Study|Withdrawal by Subject|3|||
163060208|NCT01900314|588928335|FG001|Overall Study|Withdrawal by Subject|3|||
163060209|NCT04759131|588928336|FG000|Overall Study|Investigator's discretion|1|||
163060210|NCT04759131|588928337|FG001|Overall Study|Investigator's discretion|0|||
163060211|NCT04759131|588928336|FG000|Overall Study|Subject withdrawal|1|||
163060212|NCT04759131|588928337|FG001|Overall Study|Subject withdrawal|0|||
163324752|NCT02101853|589900680|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
163324753|NCT02101853|589900681|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
163060213|NCT04513366|588928341|FG000|Treatment Phase|Withdrawal by Subject|6|||
163060214|NCT04513366|588928342|FG001|Treatment Phase|Withdrawal by Subject|8|||
163060215|NCT04513366|588928343|FG002|Treatment Phase|Withdrawal by Subject|3|||
163060216|NCT04513366|588928341|FG000|Treatment Phase|Lost to Follow-up|1|||
163060217|NCT04513366|588928342|FG001|Treatment Phase|Lost to Follow-up|2|||
163060218|NCT04513366|588928343|FG002|Treatment Phase|Lost to Follow-up|5|||
163060219|NCT04513366|588928341|FG000|Treatment Phase|Other than Specified|1|||
163060220|NCT04513366|588928342|FG001|Treatment Phase|Other than Specified|0|||
163060221|NCT04513366|588928343|FG002|Treatment Phase|Other than Specified|2|||
163324754|NCT02101853|589900682|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
162993597|NCT03982199|588676195|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993598|NCT03982199|588676196|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993599|NCT03982199|588676197|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993600|NCT03982199|588676198|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
162993601|NCT03982199|588676185|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993602|NCT03982199|588676186|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993603|NCT03982199|588676187|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993604|NCT03982199|588676188|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993605|NCT03982199|588676189|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993606|NCT03982199|588676190|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993607|NCT03982199|588676191|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993608|NCT03982199|588676192|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993609|NCT03982199|588676193|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993610|NCT03982199|588676194|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993611|NCT03982199|588676195|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993612|NCT03982199|588676196|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993613|NCT03982199|588676197|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
162993614|NCT03982199|588676198|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
162993615|NCT03982199|588676185|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993616|NCT03982199|588676186|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993617|NCT03982199|588676187|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993618|NCT03982199|588676188|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993619|NCT03982199|588676189|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993620|NCT03982199|588676190|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993621|NCT03982199|588676191|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993622|NCT03982199|588676192|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993623|NCT03982199|588676193|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993624|NCT03982199|588676194|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993625|NCT03982199|588676195|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993626|NCT03982199|588676196|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993627|NCT03982199|588676197|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
162993628|NCT03982199|588676198|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993629|NCT03433755|588676199|FG000|Overall Study|Lost to Follow-up|1|||
162993630|NCT03433755|588676200|FG001|Overall Study|Lost to Follow-up|0|||
162993631|NCT03433755|588676201|FG002|Overall Study|Lost to Follow-up|0|||
162993632|NCT03433755|588676202|FG003|Overall Study|Lost to Follow-up|0|||
162993633|NCT03433755|588676199|FG000|Overall Study|Decision by Sponsor|1|||
162993634|NCT03433755|588676200|FG001|Overall Study|Decision by Sponsor|0|||
162993635|NCT03433755|588676201|FG002|Overall Study|Decision by Sponsor|0|||
162993636|NCT03433755|588676202|FG003|Overall Study|Decision by Sponsor|0|||
162993637|NCT05065567|588676204|FG000|Overall Study|Lost to Follow-up|10|||
162993638|NCT05065567|588676205|FG001|Overall Study|Lost to Follow-up|9|||
162993639|NCT05065567|588676206|FG002|Overall Study|Lost to Follow-up|6|||
162993640|NCT05323123|588676207|FG000|Overall Study|Withdrawal by Subject|2|||
162993641|NCT05323123|588676208|FG001|Overall Study|Withdrawal by Subject|1|||
162993642|NCT05323123|588676207|FG000|Overall Study|Lost to Follow-up|4|||
162993643|NCT05323123|588676208|FG001|Overall Study|Lost to Follow-up|2|||
162993644|NCT05323123|588676207|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
162993645|NCT05323123|588676208|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
162993646|NCT05529472|588676209|FG000|Overall Study|Withdrawal by Subject|1|||
162993647|NCT05529472|588676210|FG001|Overall Study|Withdrawal by Subject|1|||
162993648|NCT02886624|588677847|FG000|12-week Post Treatment Follow-up|Death|1|||
162993649|NCT02886624|588677847|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
162993650|NCT00359801|588677852|FG000|Overall Study|Lost to Follow-up|72|||
162993651|NCT00359801|588677853|FG001|Overall Study|Lost to Follow-up|58|||
162993652|NCT00359801|588677852|FG000|Overall Study|Withdrawal by Subject|143|||
162993653|NCT00359801|588677853|FG001|Overall Study|Withdrawal by Subject|96|||
162993654|NCT00359801|588677852|FG000|Overall Study|Other|66|||
162993655|NCT00359801|588677853|FG001|Overall Study|Other|46|||
162993656|NCT00359801|588677852|FG000|Overall Study|Final Status Unknown: missing data|7|||
162993657|NCT00359801|588677853|FG001|Overall Study|Final Status Unknown: missing data|4|||
162993658|NCT00359801|588677852|FG000|Overall Study|Sponsor Decision|17|||
162993659|NCT00359801|588677853|FG001|Overall Study|Sponsor Decision|16|||
162993660|NCT02929056|588677858|FG000|Overall Study|Lost to Follow-up|0|||
162993661|NCT02929056|588677859|FG001|Overall Study|Lost to Follow-up|1|||
163060222|NCT04513366|588928341|FG000|Treatment Phase|Physician Decision|2|||
163324755|NCT02101853|589900683|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
163324756|NCT02101853|589900684|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
162993662|NCT02245412|588677865|FG000|Treatment Period|Death|1|||
162993663|NCT02245412|588677866|FG001|Treatment Period|Death|1|||
162993664|NCT02245412|588677867|FG002|Treatment Period|Death|0|||
162993665|NCT02245412|588677865|FG000|Treatment Period|Physician Decision|1|||
162993666|NCT02245412|588677866|FG001|Treatment Period|Physician Decision|1|||
162993667|NCT02245412|588677867|FG002|Treatment Period|Physician Decision|0|||
162993668|NCT02245412|588677865|FG000|Treatment Period|Withdrawal by Subject|2|||
162993669|NCT02245412|588677866|FG001|Treatment Period|Withdrawal by Subject|1|||
162993670|NCT02245412|588677867|FG002|Treatment Period|Withdrawal by Subject|0|||
162993671|NCT02245412|588677865|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
162993672|NCT02245412|588677866|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
162993673|NCT02245412|588677867|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
162993674|NCT02245412|588677865|FG000|Follow-Up Period|Death|4|||
162993675|NCT02245412|588677866|FG001|Follow-Up Period|Death|2|||
162993676|NCT02245412|588677867|FG002|Follow-Up Period|Death|1|||
162993677|NCT02245412|588677865|FG000|Follow-Up Period|Physician Decision|1|||
162993678|NCT02245412|588677866|FG001|Follow-Up Period|Physician Decision|0|||
162993679|NCT02245412|588677867|FG002|Follow-Up Period|Physician Decision|0|||
162993680|NCT02245412|588677865|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
162993681|NCT02245412|588677866|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
162993682|NCT02245412|588677867|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
162993683|NCT01056289|588677868|FG000|Open-label Phase|Adverse Event|29|||
162993684|NCT01056289|588677869|FG001|Open-label Phase|Adverse Event|0|||
162993685|NCT01056289|588677870|FG002|Open-label Phase|Adverse Event|0|||
162993686|NCT01056289|588677871|FG003|Open-label Phase|Adverse Event|0|||
162993687|NCT01056289|588677868|FG000|Open-label Phase|Lost to Follow-up|30|||
162993688|NCT01056289|588677869|FG001|Open-label Phase|Lost to Follow-up|0|||
162993689|NCT01056289|588677870|FG002|Open-label Phase|Lost to Follow-up|0|||
162993690|NCT01056289|588677871|FG003|Open-label Phase|Lost to Follow-up|0|||
162993691|NCT01056289|588677868|FG000|Open-label Phase|Other|9|||
162993692|NCT01056289|588677869|FG001|Open-label Phase|Other|0|||
162993693|NCT01056289|588677870|FG002|Open-label Phase|Other|0|||
162993694|NCT01056289|588677871|FG003|Open-label Phase|Other|0|||
162993695|NCT01056289|588677868|FG000|Open-label Phase|Protocol Violation|6|||
162993696|NCT01056289|588677869|FG001|Open-label Phase|Protocol Violation|0|||
163324757|NCT02101853|589900679|FG000|Blinatumomab Salvage Therapy|Death|0|||
163324758|NCT02101853|589900680|FG001|Blinatumomab Salvage Therapy|Death|0|||
163324759|NCT02101853|589900681|FG002|Blinatumomab Salvage Therapy|Death|0|||
163324760|NCT02101853|589900682|FG003|Blinatumomab Salvage Therapy|Death|0|||
163324761|NCT02101853|589900683|FG004|Blinatumomab Salvage Therapy|Death|0|||
162993697|NCT01056289|588677870|FG002|Open-label Phase|Protocol Violation|0|||
162993698|NCT01056289|588677871|FG003|Open-label Phase|Protocol Violation|0|||
162993699|NCT01056289|588677868|FG000|Open-label Phase|Withdrawal by Subject|26|||
162993700|NCT01056289|588677869|FG001|Open-label Phase|Withdrawal by Subject|0|||
162993701|NCT01056289|588677870|FG002|Open-label Phase|Withdrawal by Subject|0|||
162993702|NCT01056289|588677871|FG003|Open-label Phase|Withdrawal by Subject|0|||
162993703|NCT01056289|588677868|FG000|Open-label Phase|Lack of Efficacy|18|||
162993704|NCT01056289|588677869|FG001|Open-label Phase|Lack of Efficacy|0|||
162993705|NCT01056289|588677870|FG002|Open-label Phase|Lack of Efficacy|0|||
162993706|NCT01056289|588677871|FG003|Open-label Phase|Lack of Efficacy|0|||
162993707|NCT01056289|588677868|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
162993708|NCT01056289|588677869|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
162993709|NCT01056289|588677870|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
162993710|NCT01056289|588677871|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
162993711|NCT01056289|588677868|FG000|Double-blind Phase|Adverse Event|0|||
162993712|NCT01056289|588677869|FG001|Double-blind Phase|Adverse Event|1|||
162993713|NCT01056289|588677870|FG002|Double-blind Phase|Adverse Event|2|||
162993714|NCT01056289|588677871|FG003|Double-blind Phase|Adverse Event|1|||
162993715|NCT01056289|588677868|FG000|Double-blind Phase|Lost to Follow-up|0|||
162993716|NCT01056289|588677869|FG001|Double-blind Phase|Lost to Follow-up|2|||
162993717|NCT01056289|588677870|FG002|Double-blind Phase|Lost to Follow-up|2|||
162993718|NCT01056289|588677871|FG003|Double-blind Phase|Lost to Follow-up|2|||
162993719|NCT01056289|588677868|FG000|Double-blind Phase|Other|0|||
162993720|NCT01056289|588677869|FG001|Double-blind Phase|Other|0|||
162993721|NCT01056289|588677870|FG002|Double-blind Phase|Other|1|||
162993722|NCT01056289|588677871|FG003|Double-blind Phase|Other|2|||
162993723|NCT01056289|588677868|FG000|Double-blind Phase|Protocol Violation|0|||
162993724|NCT01056289|588677869|FG001|Double-blind Phase|Protocol Violation|0|||
162993725|NCT01056289|588677870|FG002|Double-blind Phase|Protocol Violation|1|||
162993726|NCT01056289|588677871|FG003|Double-blind Phase|Protocol Violation|1|||
162993727|NCT01056289|588677868|FG000|Double-blind Phase|Withdrawal by Subject|0|||
162993728|NCT01056289|588677869|FG001|Double-blind Phase|Withdrawal by Subject|0|||
162993729|NCT01056289|588677870|FG002|Double-blind Phase|Withdrawal by Subject|4|||
162993730|NCT01056289|588677871|FG003|Double-blind Phase|Withdrawal by Subject|2|||
162993731|NCT01056289|588677868|FG000|Double-blind Phase|Discontinuation symptom|0|||
162993732|NCT01056289|588677869|FG001|Double-blind Phase|Discontinuation symptom|1|||
162993733|NCT01056289|588677870|FG002|Double-blind Phase|Discontinuation symptom|2|||
163324762|NCT02101853|589900684|FG005|Blinatumomab Salvage Therapy|Death|2|||
162993734|NCT01056289|588677871|FG003|Double-blind Phase|Discontinuation symptom|2|||
162993735|NCT01056289|588677868|FG000|Double-blind Phase|Physician Decision|0|||
162993736|NCT01056289|588677869|FG001|Double-blind Phase|Physician Decision|0|||
162993737|NCT01056289|588677870|FG002|Double-blind Phase|Physician Decision|1|||
162993738|NCT01056289|588677871|FG003|Double-blind Phase|Physician Decision|0|||
162993739|NCT00459043|588677878|FG000|Overall Study|Withdrawal by Subject|1|||
162993740|NCT00459043|588677879|FG001|Overall Study|Withdrawal by Subject|0|||
162993741|NCT00270855|588677880|FG000|Overall Study|Withdrawal by Subject|8|||
162993742|NCT00270855|588677881|FG001|Overall Study|Withdrawal by Subject|8|||
162993743|NCT03156504|588677889|FG000|Overall Study|Withdrawal by Subject|1|||
162993744|NCT00450801|588677890|FG000|Overall Study|Death|1|||
162993745|NCT05048329|588677891|FG000|Overall Study|Withdrawal by Subject|1|||
162993746|NCT05048329|588677891|FG000|Overall Study|Screenfail|1|||
162993747|NCT00324649|588677892|FG000|Overall Study|Adverse Event|1|||
162993748|NCT00324649|588677893|FG001|Overall Study|Adverse Event|4|||
162993749|NCT00324649|588677892|FG000|Overall Study|Withdrawal by Subject|0|||
162993750|NCT00324649|588677893|FG001|Overall Study|Withdrawal by Subject|1|||
162993751|NCT00324649|588677892|FG000|Overall Study|Noncompliance|1|||
162993752|NCT00324649|588677893|FG001|Overall Study|Noncompliance|0|||
162993753|NCT02618759|588677894|FG000|Overall Study|Lost to Follow-up|0|||
162993754|NCT02618759|588677895|FG001|Overall Study|Lost to Follow-up|1|||
162993755|NCT02618759|588677894|FG000|Overall Study|Withdrawal by Subject|1|||
162993756|NCT02618759|588677895|FG001|Overall Study|Withdrawal by Subject|0|||
162993757|NCT02618759|588677894|FG000|Overall Study|Other Reasons|1|||
162993758|NCT02618759|588677895|FG001|Overall Study|Other Reasons|4|||
162993759|NCT03301649|588677898|FG000|Overall Study|Need alternate therapy due to live lice|17|||
162993760|NCT03301649|588677899|FG001|Overall Study|Need alternate therapy due to live lice|25|||
162993761|NCT03301649|588677900|FG002|Overall Study|Need alternate therapy due to live lice|81|||
162993762|NCT03301649|588677898|FG000|Overall Study|Lost to Follow-up|11|||
162993763|NCT03301649|588677899|FG001|Overall Study|Lost to Follow-up|11|||
162993764|NCT03301649|588677900|FG002|Overall Study|Lost to Follow-up|3|||
162993765|NCT03301649|588677898|FG000|Overall Study|Protocol Violation|0|||
162993766|NCT03301649|588677899|FG001|Overall Study|Protocol Violation|1|||
162993767|NCT03301649|588677900|FG002|Overall Study|Protocol Violation|1|||
162993768|NCT03301649|588677898|FG000|Overall Study|Withdrawal by Subject|10|||
162993769|NCT03301649|588677899|FG001|Overall Study|Withdrawal by Subject|4|||
162993770|NCT03301649|588677900|FG002|Overall Study|Withdrawal by Subject|0|||
162993771|NCT03301649|588677898|FG000|Overall Study|Other than specified|5|||
162993772|NCT03301649|588677899|FG001|Overall Study|Other than specified|3|||
162993773|NCT03301649|588677900|FG002|Overall Study|Other than specified|0|||
162993774|NCT03559400|588677901|FG000|Overall Study|Lost to Follow-up|9|||
162993775|NCT03559400|588677902|FG001|Overall Study|Lost to Follow-up|7|||
162993776|NCT03559400|588677901|FG000|Overall Study|Death|0|||
162993777|NCT03559400|588677902|FG001|Overall Study|Death|2|||
162993778|NCT03323437|588677903|FG000|Overall Study|Withdrawal by Subject|0|||
162993779|NCT03323437|588677904|FG001|Overall Study|Withdrawal by Subject|4|||
162993780|NCT00282919|588677905|FG000|Overall Study|Lack of Efficacy|4|||
162993781|NCT00282919|588677905|FG000|Overall Study|Withdrawal by Subject|1|||
162993782|NCT00282919|588677905|FG000|Overall Study|Asymptomatic Parasitemia|2|||
162993783|NCT03257865|588677911|FG000|Overall Study|Adverse Event|4|||
162993784|NCT03257865|588677912|FG001|Overall Study|Adverse Event|8|||
162993785|NCT03257865|588677911|FG000|Overall Study|Lack of Efficacy|1|||
162993786|NCT03257865|588677912|FG001|Overall Study|Lack of Efficacy|2|||
162993787|NCT03257865|588677911|FG000|Overall Study|Non-compliance with Study Drug|0|||
162993788|NCT03257865|588677912|FG001|Overall Study|Non-compliance with Study Drug|2|||
162993789|NCT03257865|588677911|FG000|Overall Study|Withdrawal by Subject|23|||
162993790|NCT03257865|588677912|FG001|Overall Study|Withdrawal by Subject|17|||
162993791|NCT03257865|588677911|FG000|Overall Study|Physician Decision|3|||
163404301|NCT02831673|590191904|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
162993792|NCT03257865|588677912|FG001|Overall Study|Physician Decision|1|||
162993793|NCT03257865|588677911|FG000|Overall Study|Other|0|||
162993794|NCT03257865|588677912|FG001|Overall Study|Other|1|||
162993795|NCT03257865|588677911|FG000|Overall Study|Lost to Follow-up|4|||
162993796|NCT03257865|588677912|FG001|Overall Study|Lost to Follow-up|4|||
162993797|NCT02549027|588677915|FG000|Washout After Period 4|Withdrawal by Subject|0|||
162993798|NCT02549027|588677916|FG001|Washout After Period 4|Withdrawal by Subject|1|||
162993799|NCT02549027|588677917|FG002|Washout After Period 4|Withdrawal by Subject|1|||
162993800|NCT02549027|588677918|FG003|Washout After Period 4|Withdrawal by Subject|1|||
162993801|NCT02549027|588677919|FG004|Washout After Period 4|Withdrawal by Subject|0|||
162993802|NCT02549027|588677920|FG005|Washout After Period 4|Withdrawal by Subject|0|||
162993803|NCT02549027|588677915|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
163212511|NCT02049957|589492557|FG001|Overall Study|Adverse Event|1|||
163212512|NCT02049957|589492558|FG002|Overall Study|Adverse Event|1|||
163212513|NCT02049957|589492559|FG003|Overall Study|Adverse Event|0|||
163212514|NCT02049957|589492560|FG004|Overall Study|Adverse Event|0|||
163212515|NCT02049957|589492561|FG005|Overall Study|Adverse Event|5|||
163212516|NCT02049957|589492562|FG006|Overall Study|Adverse Event|0|||
162993804|NCT02549027|588677916|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
162993805|NCT02549027|588677917|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
162993806|NCT02549027|588677918|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
162993807|NCT02549027|588677919|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
162993808|NCT02549027|588677920|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
162993809|NCT01111825|588677921|FG000|Overall Study|Withdrawal by Subject|0|||
162993810|NCT01111825|588677922|FG001|Overall Study|Withdrawal by Subject|0|||
162993811|NCT01111825|588677923|FG002|Overall Study|Withdrawal by Subject|1|||
162993812|NCT01111825|588677924|FG003|Overall Study|Withdrawal by Subject|0|||
162993813|NCT01111825|588677921|FG000|Overall Study|Lost to Follow-up|0|||
162993814|NCT01111825|588677922|FG001|Overall Study|Lost to Follow-up|0|||
162993815|NCT01111825|588677923|FG002|Overall Study|Lost to Follow-up|3|||
162993816|NCT01111825|588677924|FG003|Overall Study|Lost to Follow-up|1|||
162993817|NCT01111825|588677921|FG000|Overall Study|Adverse Event|2|||
162993818|NCT01111825|588677922|FG001|Overall Study|Adverse Event|1|||
162993819|NCT01111825|588677923|FG002|Overall Study|Adverse Event|4|||
162993820|NCT01111825|588677924|FG003|Overall Study|Adverse Event|0|||
162993821|NCT01111825|588677921|FG000|Overall Study|Disease Progression|1|||
162993822|NCT01111825|588677922|FG001|Overall Study|Disease Progression|0|||
162993823|NCT01111825|588677923|FG002|Overall Study|Disease Progression|0|||
162993824|NCT01111825|588677924|FG003|Overall Study|Disease Progression|0|||
162993825|NCT01111825|588677921|FG000|Overall Study|Discontinuation by Sponsor|0|||
162993826|NCT01111825|588677922|FG001|Overall Study|Discontinuation by Sponsor|0|||
162993827|NCT01111825|588677923|FG002|Overall Study|Discontinuation by Sponsor|0|||
162993828|NCT01111825|588677924|FG003|Overall Study|Discontinuation by Sponsor|20|||
162993829|NCT01377987|588677925|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
162993830|NCT01377987|588677926|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
162993831|NCT00168818|588677927|FG000|Overall Study|Adverse Event|23|||
162993832|NCT00168818|588677928|FG001|Overall Study|Adverse Event|29|||
162993833|NCT00168818|588677929|FG002|Overall Study|Adverse Event|31|||
162993834|NCT00168818|588677927|FG000|Overall Study|Protocol Violation|16|||
162993835|NCT00168818|588677928|FG001|Overall Study|Protocol Violation|11|||
162993836|NCT00168818|588677929|FG002|Overall Study|Protocol Violation|11|||
162993837|NCT00168818|588677927|FG000|Overall Study|Lost to Follow-up|13|||
162993838|NCT00168818|588677928|FG001|Overall Study|Lost to Follow-up|4|||
162993839|NCT00168818|588677929|FG002|Overall Study|Lost to Follow-up|15|||
162993840|NCT00168818|588677927|FG000|Overall Study|Withdrawal by Subject|43|||
162993841|NCT00168818|588677928|FG001|Overall Study|Withdrawal by Subject|41|||
162993842|NCT00168818|588677929|FG002|Overall Study|Withdrawal by Subject|37|||
162993843|NCT00168818|588677927|FG000|Overall Study|Other|22|||
162993844|NCT00168818|588677928|FG001|Overall Study|Other|24|||
162993845|NCT00168818|588677929|FG002|Overall Study|Other|30|||
162993846|NCT00168818|588677927|FG000|Treatment|Adverse Event|77|||
162993847|NCT00168818|588677928|FG001|Treatment|Adverse Event|89|||
162993848|NCT00168818|588677929|FG002|Treatment|Adverse Event|68|||
162993849|NCT00168818|588677927|FG000|Treatment|Protocol Violation|8|||
162993850|NCT00168818|588677928|FG001|Treatment|Protocol Violation|11|||
162993851|NCT00168818|588677929|FG002|Treatment|Protocol Violation|11|||
162993852|NCT00168818|588677927|FG000|Treatment|Lost to Follow-up|0|||
162993853|NCT00168818|588677928|FG001|Treatment|Lost to Follow-up|2|||
162993854|NCT00168818|588677929|FG002|Treatment|Lost to Follow-up|1|||
162993855|NCT00168818|588677927|FG000|Treatment|Withdrawal by Subject|25|||
162993856|NCT00168818|588677928|FG001|Treatment|Withdrawal by Subject|20|||
162993857|NCT00168818|588677929|FG002|Treatment|Withdrawal by Subject|22|||
162993858|NCT00168818|588677927|FG000|Treatment|Other|23|||
162993859|NCT00168818|588677928|FG001|Treatment|Other|29|||
162993860|NCT00168818|588677929|FG002|Treatment|Other|31|||
162993861|NCT00469144|588677930|FG000|Overall Study|Death|0|||
162993862|NCT00469144|588677931|FG001|Overall Study|Death|1|||
162993863|NCT00469144|588677930|FG000|Overall Study|No Response|5|||
162993864|NCT00469144|588677931|FG001|Overall Study|No Response|5|||
162993865|NCT00469144|588677930|FG000|Overall Study|Progressive Disease|1|||
162993866|NCT00469144|588677931|FG001|Overall Study|Progressive Disease|0|||
162993867|NCT01994291|588677932|FG000|Overall Study|Adverse Event|4|||
162993868|NCT01994291|588677933|FG001|Overall Study|Adverse Event|1|||
162993869|NCT01994291|588677934|FG002|Overall Study|Adverse Event|3|||
162993870|NCT01994291|588677932|FG000|Overall Study|Lost to Follow-up|1|||
162993871|NCT01994291|588677933|FG001|Overall Study|Lost to Follow-up|1|||
162993872|NCT01994291|588677934|FG002|Overall Study|Lost to Follow-up|0|||
162993873|NCT01994291|588677932|FG000|Overall Study|Does not meet entrance criteria|1|||
162993874|NCT01994291|588677933|FG001|Overall Study|Does not meet entrance criteria|0|||
162993875|NCT01994291|588677934|FG002|Overall Study|Does not meet entrance criteria|0|||
163212517|NCT02049957|589492563|FG007|Overall Study|Adverse Event|6|||
162993876|NCT01994291|588677932|FG000|Overall Study|Medication error without associated AE|1|||
162993877|NCT01994291|588677933|FG001|Overall Study|Medication error without associated AE|0|||
162993878|NCT01994291|588677934|FG002|Overall Study|Medication error without associated AE|1|||
162993879|NCT01994291|588677932|FG000|Overall Study|Protocol Violation|1|||
162993880|NCT01994291|588677933|FG001|Overall Study|Protocol Violation|0|||
162993881|NCT01994291|588677934|FG002|Overall Study|Protocol Violation|0|||
162993882|NCT01994291|588677932|FG000|Overall Study|Withdrawal by Subject|6|||
162993883|NCT01994291|588677933|FG001|Overall Study|Withdrawal by Subject|3|||
162993884|NCT01994291|588677934|FG002|Overall Study|Withdrawal by Subject|5|||
162993885|NCT01994291|588677932|FG000|Overall Study|Other|1|||
162993886|NCT01994291|588677933|FG001|Overall Study|Other|2|||
162993887|NCT01994291|588677934|FG002|Overall Study|Other|0|||
162993888|NCT01775189|588677935|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162993889|NCT01775189|588677936|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
162993890|NCT01775189|588677937|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162993891|NCT01775189|588677938|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162993892|NCT01775189|588677939|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162993893|NCT01775189|588677940|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162993894|NCT01775189|588677941|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162993895|NCT01775189|588677935|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162993896|NCT01775189|588677936|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
162993897|NCT01775189|588677937|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162993898|NCT01775189|588677938|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162993899|NCT01775189|588677939|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162993900|NCT01775189|588677940|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162993901|NCT01775189|588677941|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162993902|NCT01775189|588677935|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
162993903|NCT01775189|588677936|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
162993904|NCT01775189|588677937|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
162993905|NCT01775189|588677938|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
162993906|NCT01775189|588677939|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
162993907|NCT01775189|588677940|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
162993908|NCT01775189|588677941|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
162993909|NCT01775189|588677935|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
162993910|NCT01775189|588677936|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
162993911|NCT01775189|588677937|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
162993912|NCT01775189|588677938|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
162993913|NCT01775189|588677939|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
162993914|NCT01775189|588677940|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
162993915|NCT01775189|588677941|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
162993916|NCT01775189|588677935|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
162993917|NCT01775189|588677936|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
162993918|NCT01775189|588677937|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
162993919|NCT01775189|588677938|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
162993920|NCT01775189|588677939|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
162993921|NCT01775189|588677940|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
162993922|NCT01775189|588677941|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
162993923|NCT01775189|588677935|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
162993924|NCT01775189|588677936|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
162993925|NCT01775189|588677937|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
162993926|NCT01775189|588677938|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
162993927|NCT01775189|588677939|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
162993928|NCT01775189|588677940|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
162993929|NCT01775189|588677941|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
162993930|NCT02227446|588677942|FG000|Overall Study|not eligible post randomization|18|||
162993931|NCT02227446|588677943|FG001|Overall Study|not eligible post randomization|29|||
162993932|NCT02227446|588677942|FG000|Overall Study|Withdrawal by Subject|4|||
162993933|NCT02227446|588677943|FG001|Overall Study|Withdrawal by Subject|5|||
162993934|NCT02901548|588677950|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
162993935|NCT03336528|588677951|FG000|Overall Study|Protocol Violation|1|||
162993936|NCT03336528|588677952|FG001|Overall Study|Protocol Violation|1|||
162993937|NCT03336528|588677951|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
162993938|NCT03336528|588677952|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
162993939|NCT03336528|588677951|FG000|Overall Study|Did not receive study medication|1|||
162993940|NCT03336528|588677952|FG001|Overall Study|Did not receive study medication|2|||
162993941|NCT00920790|588677953|FG000|Overall Study|aggravation of general condition|14|||
162993942|NCT02639052|588677954|FG000|Overall Study|Lost to Follow-up|1|||
163324763|NCT02101853|589900679|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
163324764|NCT02101853|589900680|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
163324765|NCT02101853|589900681|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
163324766|NCT02101853|589900682|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
162993943|NCT02655666|588677956|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
163324767|NCT02101853|589900683|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
163324768|NCT02101853|589900684|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
163212518|NCT02049957|589492564|FG008|Overall Study|Adverse Event|1|||
163212519|NCT02049957|589492556|FG000|Overall Study|Study Terminated by Sponsor|0|||
163212520|NCT02049957|589492557|FG001|Overall Study|Study Terminated by Sponsor|1|||
163212521|NCT02049957|589492558|FG002|Overall Study|Study Terminated by Sponsor|0|||
163212522|NCT02049957|589492559|FG003|Overall Study|Study Terminated by Sponsor|0|||
163212523|NCT02049957|589492560|FG004|Overall Study|Study Terminated by Sponsor|0|||
163212524|NCT02049957|589492561|FG005|Overall Study|Study Terminated by Sponsor|0|||
163212525|NCT02049957|589492562|FG006|Overall Study|Study Terminated by Sponsor|1|||
163212526|NCT02049957|589492563|FG007|Overall Study|Study Terminated by Sponsor|0|||
163212527|NCT02049957|589492564|FG008|Overall Study|Study Terminated by Sponsor|0|||
163212528|NCT02049957|589492556|FG000|Overall Study|Withdrawal by Subject|0|||
163212529|NCT02049957|589492557|FG001|Overall Study|Withdrawal by Subject|0|||
163212530|NCT02049957|589492558|FG002|Overall Study|Withdrawal by Subject|0|||
163212531|NCT02049957|589492559|FG003|Overall Study|Withdrawal by Subject|1|||
163212532|NCT02049957|589492560|FG004|Overall Study|Withdrawal by Subject|0|||
163212533|NCT02049957|589492561|FG005|Overall Study|Withdrawal by Subject|2|||
163212534|NCT02049957|589492562|FG006|Overall Study|Withdrawal by Subject|0|||
163212535|NCT02049957|589492563|FG007|Overall Study|Withdrawal by Subject|3|||
163212536|NCT02049957|589492564|FG008|Overall Study|Withdrawal by Subject|1|||
163212537|NCT02049957|589492556|FG000|Overall Study|Physician Decision|0|||
163324769|NCT02101853|589900679|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
163324770|NCT02101853|589900680|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
163324771|NCT02101853|589900681|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
163212538|NCT02049957|589492557|FG001|Overall Study|Physician Decision|0|||
163212539|NCT02049957|589492558|FG002|Overall Study|Physician Decision|0|||
163212540|NCT02049957|589492559|FG003|Overall Study|Physician Decision|0|||
163212541|NCT02049957|589492560|FG004|Overall Study|Physician Decision|0|||
163212542|NCT02049957|589492561|FG005|Overall Study|Physician Decision|1|||
163212543|NCT02049957|589492562|FG006|Overall Study|Physician Decision|0|||
163212544|NCT02049957|589492563|FG007|Overall Study|Physician Decision|0|||
163212545|NCT02049957|589492564|FG008|Overall Study|Physician Decision|0|||
163324772|NCT02101853|589900682|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
162993944|NCT00895414|588677957|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
162993945|NCT00895414|588677958|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
162993946|NCT00895414|588677957|FG000|First Intervention (14 Days)|Physician Decision|0|||
162993947|NCT00895414|588677958|FG001|First Intervention (14 Days)|Physician Decision|1|||
162993948|NCT00789737|588677963|FG000|Overall Study|Withdrawal by Subject|13|||
162993949|NCT00789737|588677964|FG001|Overall Study|Withdrawal by Subject|22|||
162993950|NCT00789737|588677963|FG000|Overall Study|Lost to Follow-up|10|||
162993951|NCT00789737|588677964|FG001|Overall Study|Lost to Follow-up|14|||
162993952|NCT00789737|588677963|FG000|Overall Study|Adverse Event|8|||
162993953|NCT00789737|588677964|FG001|Overall Study|Adverse Event|8|||
162993954|NCT00789737|588677963|FG000|Overall Study|Protocol Violation|3|||
162993955|NCT00789737|588677964|FG001|Overall Study|Protocol Violation|0|||
162993956|NCT00789737|588677963|FG000|Overall Study|Lack of Efficacy|3|||
162993957|NCT00789737|588677964|FG001|Overall Study|Lack of Efficacy|0|||
162993958|NCT00789737|588677963|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
162993959|NCT00789737|588677964|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
162993960|NCT00789737|588677963|FG000|Overall Study|Other|11|||
162993961|NCT00789737|588677964|FG001|Overall Study|Other|7|||
162993962|NCT02458287|588677965|FG000|Overall Study|Adverse Event|0|||
162993963|NCT02458287|588677966|FG001|Overall Study|Adverse Event|0|||
162993964|NCT02458287|588677967|FG002|Overall Study|Adverse Event|0|||
162993965|NCT02458287|588677968|FG003|Overall Study|Adverse Event|1|||
162993966|NCT02458287|588677965|FG000|Overall Study|Lost to Follow-up|0|||
163324773|NCT02101853|589900683|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
162993967|NCT02458287|588677966|FG001|Overall Study|Lost to Follow-up|1|||
163212546|NCT04447755|589492565|FG000|Overall Study|Death|9|||
163212547|NCT04447755|589492566|FG001|Overall Study|Death|16|||
163212548|NCT04447755|589492567|FG002|Overall Study|Death|8|||
163212549|NCT04447755|589492568|FG003|Overall Study|Death|9|||
163212550|NCT04447755|589492569|FG004|Overall Study|Death|8|||
163324774|NCT02101853|589900684|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
162993968|NCT02458287|588677967|FG002|Overall Study|Lost to Follow-up|1|||
162993969|NCT02458287|588677968|FG003|Overall Study|Lost to Follow-up|0|||
162993970|NCT02458287|588677965|FG000|Overall Study|Protocol Violation|0|||
162993971|NCT02458287|588677966|FG001|Overall Study|Protocol Violation|1|||
162993972|NCT02458287|588677967|FG002|Overall Study|Protocol Violation|0|||
163212551|NCT04447755|589492570|FG005|Overall Study|Death|9|||
163212552|NCT04447755|589492571|FG006|Overall Study|Death|55|||
163212553|NCT04447755|589492565|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163212554|NCT04447755|589492566|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163212555|NCT04447755|589492567|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163212556|NCT04447755|589492568|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163212557|NCT04447755|589492569|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
162993973|NCT02458287|588677968|FG003|Overall Study|Protocol Violation|0|||
162993974|NCT02458287|588677965|FG000|Overall Study|Withdrawal by Subject|0|||
162993975|NCT02458287|588677966|FG001|Overall Study|Withdrawal by Subject|2|||
162993976|NCT02458287|588677967|FG002|Overall Study|Withdrawal by Subject|2|||
162993977|NCT02458287|588677968|FG003|Overall Study|Withdrawal by Subject|1|||
162993978|NCT02458287|588677965|FG000|Overall Study|Relocated Out of State|0|||
162993979|NCT02458287|588677966|FG001|Overall Study|Relocated Out of State|0|||
162993980|NCT02458287|588677967|FG002|Overall Study|Relocated Out of State|0|||
162993981|NCT02458287|588677968|FG003|Overall Study|Relocated Out of State|1|||
162993982|NCT00369317|588677969|FG000|Overall Study|Adverse Event|3|||
162993983|NCT00369317|588677969|FG000|Overall Study|Death|1|||
162993984|NCT00369317|588677969|FG000|Overall Study|Lack of Efficacy|5|||
162993985|NCT00369317|588677969|FG000|Overall Study|Physician Decision|2|||
162993986|NCT00369317|588677969|FG000|Overall Study|Withdrawal by Subject|8|||
162993987|NCT00369317|588677969|FG000|Overall Study|Ineligible|1|||
162993988|NCT02365558|588677970|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
162993989|NCT02365558|588677971|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
162993990|NCT02365558|588677970|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
162993991|NCT02365558|588677971|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
162993992|NCT00418821|588677978|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
162993993|NCT02823652|588677979|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
162993994|NCT02823652|588677980|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
162993995|NCT02823652|588677981|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
162993996|NCT02823652|588677979|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
162993997|NCT02823652|588677980|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
162993998|NCT02823652|588677981|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
162993999|NCT02823652|588677979|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
162994000|NCT02823652|588677980|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
162994001|NCT02823652|588677981|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
162994002|NCT02823652|588677979|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
162994003|NCT02823652|588677980|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
162994004|NCT02823652|588677981|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
162994005|NCT04428333|588677982|FG000|Overall Study|Physician Decision|5|||
162994006|NCT04428333|588677983|FG001|Overall Study|Physician Decision|6|||
162994007|NCT04428333|588677982|FG000|Overall Study|Withdrawal by Subject|1|||
162994008|NCT04428333|588677983|FG001|Overall Study|Withdrawal by Subject|3|||
162994009|NCT04428333|588677982|FG000|Overall Study|Study Terminated By Sponsor|14|||
162994010|NCT04428333|588677983|FG001|Overall Study|Study Terminated By Sponsor|16|||
162994011|NCT04853992|588677984|FG000|Treatment Period A|Adverse Event|0|||
162994012|NCT04853992|588677985|FG001|Treatment Period A|Adverse Event|1|||
162994013|NCT04853992|588677984|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
162994014|NCT04853992|588677985|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
162994015|NCT02269163|588677986|FG000|Overall Study|Lost to Follow-up|1|||
162994016|NCT02269163|588677987|FG001|Overall Study|Lost to Follow-up|0|||
162994017|NCT02269163|588677986|FG000|Overall Study|Major protocol violation|0|||
162994018|NCT02269163|588677987|FG001|Overall Study|Major protocol violation|1|||
162994019|NCT02269163|588677986|FG000|Overall Study|Other|2|||
162994020|NCT02269163|588677987|FG001|Overall Study|Other|2|||
162994021|NCT02269163|588677986|FG000|Overall Study|Withdrawal by Subject|0|||
162994022|NCT02269163|588677987|FG001|Overall Study|Withdrawal by Subject|3|||
162994023|NCT02269163|588677986|FG000|Overall Study|Physician Decision|0|||
162994024|NCT02269163|588677987|FG001|Overall Study|Physician Decision|1|||
162994025|NCT02351960|588677990|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
162994026|NCT02351960|588677991|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
162994027|NCT02351960|588677990|FG000|Overall Study|Voluntary Withdrawal|5|||
162994028|NCT02351960|588677991|FG001|Overall Study|Voluntary Withdrawal|4|||
162994029|NCT02351960|588677990|FG000|Overall Study|Significant Protocol Deviation|0|||
162994030|NCT02351960|588677991|FG001|Overall Study|Significant Protocol Deviation|5|||
162994031|NCT00402116|588679995|FG000|Overall Study|Jaw infection after surgery-other|1|||
162994032|NCT00402116|588679996|FG001|Overall Study|Jaw infection after surgery-other|0|||
163060223|NCT04513366|588928342|FG001|Treatment Phase|Physician Decision|0|||
163060224|NCT04513366|588928343|FG002|Treatment Phase|Physician Decision|0|||
163212558|NCT04447755|589492570|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
163212559|NCT04447755|589492571|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
163212560|NCT04447755|589492565|FG000|Overall Study|Sponsor Decision|0|||
162994033|NCT00402116|588679997|FG002|Overall Study|Jaw infection after surgery-other|0|||
162994034|NCT00402116|588679995|FG000|Overall Study|Withdrawal by Subject|1|||
162994035|NCT00402116|588679996|FG001|Overall Study|Withdrawal by Subject|0|||
162994036|NCT00402116|588679997|FG002|Overall Study|Withdrawal by Subject|5|||
162994037|NCT00402116|588679995|FG000|Overall Study|Treatment completed per protocol|1|||
162994038|NCT00402116|588679996|FG001|Overall Study|Treatment completed per protocol|1|||
162994039|NCT00402116|588679997|FG002|Overall Study|Treatment completed per protocol|2|||
163060225|NCT04513366|588928341|FG000|Treatment Phase|Adverse Event|0|||
163212561|NCT04447755|589492566|FG001|Overall Study|Sponsor Decision|0|||
162994040|NCT00402116|588679995|FG000|Overall Study|other complicating disease|0|||
163212562|NCT04447755|589492567|FG002|Overall Study|Sponsor Decision|0|||
162994041|NCT00402116|588679996|FG001|Overall Study|other complicating disease|0|||
162994042|NCT00402116|588679997|FG002|Overall Study|other complicating disease|2|||
162994043|NCT00402116|588679995|FG000|Overall Study|Disease Progression|0|||
162994044|NCT00402116|588679996|FG001|Overall Study|Disease Progression|4|||
162994045|NCT00402116|588679997|FG002|Overall Study|Disease Progression|38|||
162994046|NCT00402116|588679995|FG000|Overall Study|mistaken thrombocytopenia|0|||
162994047|NCT00402116|588679996|FG001|Overall Study|mistaken thrombocytopenia|0|||
162994048|NCT00402116|588679997|FG002|Overall Study|mistaken thrombocytopenia|1|||
162994049|NCT00402116|588679995|FG000|Overall Study|decline related hyponatremia/tumor|0|||
162994050|NCT00402116|588679996|FG001|Overall Study|decline related hyponatremia/tumor|0|||
163404302|NCT02831673|590191900|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
163404303|NCT02831673|590191901|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
163404304|NCT02831673|590191902|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
162994051|NCT00402116|588679997|FG002|Overall Study|decline related hyponatremia/tumor|1|||
162994052|NCT00402116|588679995|FG000|Overall Study|Adverse Event|0|||
162994053|NCT00402116|588679996|FG001|Overall Study|Adverse Event|1|||
162994054|NCT00402116|588679997|FG002|Overall Study|Adverse Event|6|||
162994055|NCT02135614|588679998|FG000|Overall Study|Randomized but Not Treated|2|||
162994056|NCT02135614|588679999|FG001|Overall Study|Randomized but Not Treated|1|||
162994057|NCT02135614|588679998|FG000|Overall Study|Adverse Event|0|||
162994058|NCT02135614|588679999|FG001|Overall Study|Adverse Event|1|||
162994059|NCT02135614|588679998|FG000|Overall Study|Death|1|||
162994060|NCT02135614|588679999|FG001|Overall Study|Death|0|||
162994061|NCT02135614|588679998|FG000|Overall Study|Investigator's Discretion|0|||
162994062|NCT02135614|588679999|FG001|Overall Study|Investigator's Discretion|1|||
162994063|NCT02135614|588679998|FG000|Overall Study|Withdrew Consent|2|||
162994064|NCT02135614|588679999|FG001|Overall Study|Withdrew Consent|2|||
162994065|NCT02135614|588679998|FG000|Overall Study|Lost to Follow-up|3|||
162994066|NCT02135614|588679999|FG001|Overall Study|Lost to Follow-up|0|||
162994067|NCT00554606|588680001|FG000|Overall Study|Adverse Event|3|||
162994068|NCT00554606|588680001|FG000|Overall Study|Abnormal laboratory values|1|||
162994069|NCT00554606|588680001|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
162994070|NCT00554606|588680001|FG000|Overall Study|Subject withdrew consent|2|||
162994071|NCT00554606|588680001|FG000|Overall Study|Lost to Follow-up|2|||
162994072|NCT00554606|588680001|FG000|Overall Study|Administrative problems|60|||
162994073|NCT00554606|588680001|FG000|Overall Study|Death|1|||
162994074|NCT00554606|588680001|FG000|Overall Study|Protocol deviation|2|||
162994075|NCT01421511|588680005|FG000|Overall Study|Lost to Follow-up|11|||
162994076|NCT01421511|588680006|FG001|Overall Study|Lost to Follow-up|14|||
162994077|NCT01421511|588680005|FG000|Overall Study|Randomized but didn't receive study drug|1|||
162994078|NCT01421511|588680006|FG001|Overall Study|Randomized but didn't receive study drug|7|||
162994079|NCT01421511|588680005|FG000|Overall Study|Physician Decision|0|||
162994080|NCT01421511|588680006|FG001|Overall Study|Physician Decision|1|||
162994081|NCT01421511|588680005|FG000|Overall Study|Withdrawal by Subject|6|||
162994082|NCT01421511|588680006|FG001|Overall Study|Withdrawal by Subject|5|||
162994083|NCT01421511|588680005|FG000|Overall Study|Death|1|||
162994084|NCT01421511|588680006|FG001|Overall Study|Death|1|||
162994085|NCT02242045|588680007|FG000|Overall Study|Investigator's Discretion|1|||
162994086|NCT02242045|588680007|FG000|Overall Study|Progressive Disease|2|||
162994087|NCT02242045|588680007|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
162994088|NCT02242045|588680007|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
162994089|NCT00749892|588680008|FG000|Overall Study|Withdrawal by Subject|3|||
162994090|NCT00106964|588680010|FG000|Overall Study|Lost to Follow-up|8|||
162994091|NCT00106964|588680011|FG001|Overall Study|Lost to Follow-up|6|||
162994092|NCT00106964|588680012|FG002|Overall Study|Lost to Follow-up|2|||
162994093|NCT00106964|588680010|FG000|Overall Study|Pregnancy|2|||
162994094|NCT00106964|588680011|FG001|Overall Study|Pregnancy|3|||
162994095|NCT00106964|588680012|FG002|Overall Study|Pregnancy|2|||
162994096|NCT00106964|588680010|FG000|Overall Study|Death|1|||
162994097|NCT00106964|588680011|FG001|Overall Study|Death|1|||
162994098|NCT00106964|588680012|FG002|Overall Study|Death|0|||
162994099|NCT00106964|588680010|FG000|Overall Study|Incarceration|0|||
163060226|NCT04513366|588928342|FG001|Treatment Phase|Adverse Event|1|||
163324775|NCT02101853|589900679|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
163324776|NCT02101853|589900680|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
163324777|NCT02101853|589900681|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
163324778|NCT02101853|589900682|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
163324779|NCT02101853|589900683|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
163324780|NCT02101853|589900684|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
163324781|NCT02112916|589900688|FG000|Overall Study|Adverse Event|6|||
163324782|NCT02112916|589900689|FG001|Overall Study|Adverse Event|9|||
163324783|NCT02112916|589900690|FG002|Overall Study|Adverse Event|3|||
163324784|NCT02112916|589900691|FG003|Overall Study|Adverse Event|2|||
163324785|NCT02112916|589900688|FG000|Overall Study|Death|9|||
163324786|NCT02112916|589900689|FG001|Overall Study|Death|9|||
163324787|NCT02112916|589900690|FG002|Overall Study|Death|3|||
162994100|NCT00106964|588680011|FG001|Overall Study|Incarceration|1|||
162994101|NCT00106964|588680012|FG002|Overall Study|Incarceration|0|||
162994102|NCT00106964|588680010|FG000|Overall Study|Site Funding Terminated|0|||
162994103|NCT00106964|588680011|FG001|Overall Study|Site Funding Terminated|1|||
162994104|NCT00106964|588680012|FG002|Overall Study|Site Funding Terminated|1|||
162994105|NCT00106964|588680010|FG000|Overall Study|Failure to adhere|2|||
162994106|NCT00106964|588680011|FG001|Overall Study|Failure to adhere|0|||
162994107|NCT00106964|588680012|FG002|Overall Study|Failure to adhere|0|||
162994108|NCT00106964|588680010|FG000|Overall Study|Did not meet eligibility criteria|0|||
162994109|NCT00106964|588680011|FG001|Overall Study|Did not meet eligibility criteria|2|||
162994110|NCT00106964|588680012|FG002|Overall Study|Did not meet eligibility criteria|2|||
162994111|NCT00106964|588680010|FG000|Overall Study|Required disallowed medication|0|||
162994112|NCT00106964|588680011|FG001|Overall Study|Required disallowed medication|1|||
162994113|NCT00106964|588680012|FG002|Overall Study|Required disallowed medication|0|||
162994114|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
162994115|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
162994116|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
162994117|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
162994118|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
162994119|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
162994120|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
162994121|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
162994122|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
162994123|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
162994124|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
162994125|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
162994126|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
162994127|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
162994128|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
162994129|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
162994130|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
162994131|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
162994132|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
162994133|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
162994134|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
162994135|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
162994136|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
162994137|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
162994138|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
162994139|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
162994140|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
162994141|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
162994142|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
162994143|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
162994144|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
162994145|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
162994146|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
162994147|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
162994148|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
162994149|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
162994150|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
162994151|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
162994152|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
162994153|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
162994154|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
162994155|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
162994156|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
162994157|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
162994158|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
162994159|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
163324788|NCT02112916|589900691|FG003|Overall Study|Death|4|||
163324789|NCT02112916|589900688|FG000|Overall Study|Lost to Follow-up|1|||
162994160|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
162994161|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
163324790|NCT02112916|589900689|FG001|Overall Study|Lost to Follow-up|0|||
163324791|NCT02112916|589900690|FG002|Overall Study|Lost to Follow-up|0|||
162994162|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
162994163|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
162994164|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
162994165|NCT03207243|588680016|FG000|Overall Study|Adverse Event|2|||
162994166|NCT03207243|588680017|FG001|Overall Study|Adverse Event|2|||
162994167|NCT03207243|588680016|FG000|Overall Study|Loss of Asthma Control|47|||
162994168|NCT03207243|588680017|FG001|Overall Study|Loss of Asthma Control|31|||
162994169|NCT03207243|588680016|FG000|Overall Study|Withdrawal by Subject|2|||
162994170|NCT03207243|588680017|FG001|Overall Study|Withdrawal by Subject|4|||
162994171|NCT03207243|588680016|FG000|Overall Study|Physician Decision|1|||
162994172|NCT03207243|588680017|FG001|Overall Study|Physician Decision|1|||
162994173|NCT03207243|588680016|FG000|Overall Study|Lost to Follow-up|0|||
162994174|NCT03207243|588680017|FG001|Overall Study|Lost to Follow-up|1|||
162994175|NCT03207243|588680016|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
162994176|NCT03207243|588680017|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
162994177|NCT03207243|588680016|FG000|Overall Study|Protocol Violation|0|||
162994178|NCT03207243|588680017|FG001|Overall Study|Protocol Violation|3|||
162994179|NCT00603837|588680024|FG000|Overall Study|Physician Decision|3|||
162994180|NCT00603837|588680025|FG001|Overall Study|Physician Decision|0|||
162994181|NCT01352416|588680026|FG000|Overall Study|Physician Decision|1|||
162994182|NCT01352416|588680027|FG001|Overall Study|Physician Decision|2|||
162994183|NCT01352416|588680028|FG002|Overall Study|Physician Decision|2|||
162994184|NCT01352416|588680029|FG003|Overall Study|Physician Decision|1|||
162994185|NCT01199016|588680030|FG000|Overall Study|No longer meets eligibility criteria|4|||
162994186|NCT01199016|588680030|FG000|Overall Study|Entrance criteria|5|||
162994187|NCT01199016|588680030|FG000|Overall Study|Protocol Violation|9|||
162994188|NCT01199016|588680030|FG000|Overall Study|Other|13|||
162994189|NCT01199016|588680030|FG000|Overall Study|Withdrawal by Subject|21|||
162994190|NCT01199016|588680030|FG000|Overall Study|Lost to Follow-up|25|||
162994191|NCT02960490|588680039|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
162994192|NCT02960490|588680040|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
162994193|NCT02960490|588680041|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994194|NCT02960490|588680042|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994195|NCT02960490|588680043|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994196|NCT02960490|588680044|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994197|NCT02960490|588680045|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994198|NCT02960490|588680046|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994199|NCT02960490|588680047|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994200|NCT02960490|588680048|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994201|NCT02960490|588680039|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994202|NCT02960490|588680040|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
162994203|NCT02960490|588680041|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994204|NCT02960490|588680042|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994205|NCT02960490|588680043|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994206|NCT02960490|588680044|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994207|NCT02960490|588680045|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994208|NCT02960490|588680046|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994209|NCT02960490|588680047|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994210|NCT02960490|588680048|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994211|NCT02960490|588680039|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
162994212|NCT02960490|588680040|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
162994213|NCT02960490|588680041|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
162994214|NCT02960490|588680042|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
163212563|NCT04447755|589492568|FG003|Overall Study|Sponsor Decision|0|||
163212564|NCT04447755|589492569|FG004|Overall Study|Sponsor Decision|1|||
163212565|NCT04447755|589492570|FG005|Overall Study|Sponsor Decision|0|||
163404305|NCT02831673|590191903|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
163404306|NCT02831673|590191904|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
162994215|NCT02960490|588680043|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
162994216|NCT02960490|588680044|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
162994217|NCT02960490|588680045|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
162994218|NCT02960490|588680046|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
162994219|NCT02960490|588680047|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
162994220|NCT02960490|588680048|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
162994221|NCT02960490|588680039|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
162994222|NCT02960490|588680040|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
162994223|NCT02960490|588680041|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
162994224|NCT02960490|588680042|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
163212566|NCT04447755|589492571|FG006|Overall Study|Sponsor Decision|10|||
163212567|NCT04447755|589492565|FG000|Overall Study|Lost to Follow-up|0|||
162994225|NCT02960490|588680043|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
162994226|NCT02960490|588680044|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
162994227|NCT02960490|588680045|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
163404307|NCT02831673|590191900|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
162994228|NCT02960490|588680046|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
162994229|NCT02960490|588680047|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
162994230|NCT02960490|588680048|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
162994231|NCT02960490|588680039|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
162994232|NCT02960490|588680040|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
162994233|NCT02960490|588680041|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
162994234|NCT02960490|588680042|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
162994235|NCT02960490|588680043|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
162994236|NCT02960490|588680044|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
162994237|NCT02960490|588680045|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
162994238|NCT02960490|588680046|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
162994239|NCT02960490|588680047|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
162994240|NCT02960490|588680048|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
162994241|NCT02960490|588680039|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994242|NCT02960490|588680040|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994243|NCT02960490|588680041|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
162994244|NCT02960490|588680042|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994245|NCT02960490|588680043|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
162994246|NCT02960490|588680044|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994247|NCT02960490|588680045|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994248|NCT02960490|588680046|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994249|NCT02960490|588680047|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994250|NCT02960490|588680048|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994251|NCT02960490|588680039|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
162994252|NCT02960490|588680040|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
162994253|NCT02960490|588680041|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
162994254|NCT02960490|588680042|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
162994255|NCT02960490|588680043|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
162994256|NCT02960490|588680044|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
162994257|NCT02960490|588680045|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
162994258|NCT02960490|588680046|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
162994259|NCT02960490|588680047|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
162994260|NCT02960490|588680048|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
162994261|NCT02960490|588680039|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
162994262|NCT02960490|588680040|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
162994263|NCT02960490|588680041|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
162994264|NCT02960490|588680042|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
162994265|NCT02960490|588680043|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
162994266|NCT02960490|588680044|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
162994267|NCT02960490|588680045|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
162994268|NCT02960490|588680046|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
162994269|NCT02960490|588680047|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
162994270|NCT02960490|588680048|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
162994271|NCT02960490|588680039|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994272|NCT02960490|588680040|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994273|NCT02960490|588680041|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994274|NCT02960490|588680042|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994275|NCT02960490|588680043|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994276|NCT02960490|588680044|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994277|NCT02960490|588680045|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
163060227|NCT04513366|588928343|FG002|Treatment Phase|Adverse Event|1|||
163404308|NCT02831673|590191901|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
163404309|NCT02831673|590191902|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
162994278|NCT02960490|588680046|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
162994279|NCT02960490|588680047|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994280|NCT02960490|588680048|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994281|NCT02960490|588680039|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
162994282|NCT02960490|588680040|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
162994283|NCT02960490|588680041|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
163060228|NCT04513366|588928341|FG000|Extension Phase|Withdrawal by Subject|3|||
163060229|NCT04513366|588928342|FG001|Extension Phase|Withdrawal by Subject|1|||
163404310|NCT02831673|590191903|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
162994284|NCT02960490|588680042|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
162994285|NCT02960490|588680043|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
162994286|NCT02960490|588680044|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
162994287|NCT02960490|588680045|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
162994288|NCT02960490|588680046|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
162994289|NCT02960490|588680047|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
162994290|NCT02960490|588680048|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
162994291|NCT02960490|588680039|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994292|NCT02960490|588680040|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994293|NCT02960490|588680041|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994294|NCT02960490|588680042|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994295|NCT02960490|588680043|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994296|NCT02960490|588680044|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994297|NCT02960490|588680045|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
162994298|NCT02960490|588680046|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994299|NCT02960490|588680047|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994300|NCT02960490|588680048|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994301|NCT02960490|588680039|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994302|NCT02960490|588680040|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994303|NCT02960490|588680041|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994304|NCT02960490|588680042|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994305|NCT02960490|588680043|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994306|NCT02960490|588680044|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994307|NCT02960490|588680045|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994308|NCT02960490|588680046|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
162994309|NCT02960490|588680047|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994310|NCT02960490|588680048|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994311|NCT02368314|588680051|FG000|Overall Study|Withdrawal by Subject|2|||
162994312|NCT02368314|588680052|FG001|Overall Study|Withdrawal by Subject|1|||
162994313|NCT02368314|588680051|FG000|Overall Study|Adverse Event|1|||
162994314|NCT02368314|588680052|FG001|Overall Study|Adverse Event|2|||
162994315|NCT01266031|588680053|FG000|Overall Study|Not treated|0|||
162994316|NCT01266031|588680054|FG001|Overall Study|Not treated|3|||
162994317|NCT01266031|588680055|FG002|Overall Study|Not treated|2|||
162994318|NCT04893018|588680056|FG000|Overall Study|Lost to Follow-up|1|||
162994319|NCT04893018|588680057|FG001|Overall Study|Lost to Follow-up|0|||
162994320|NCT04893018|588680056|FG000|Overall Study|Withdrawal by Subject|2|||
162994321|NCT04893018|588680057|FG001|Overall Study|Withdrawal by Subject|0|||
162994322|NCT04893018|588680056|FG000|Overall Study|Study Terminated|1|||
162994323|NCT04893018|588680057|FG001|Overall Study|Study Terminated|2|||
162994324|NCT02842073|588680063|FG000|Overall Study|Withdrawal by Subject|1|||
162994325|NCT00195338|588680064|FG000|Overall Study|Lost to Follow-up|2|||
162994326|NCT00195338|588680064|FG000|Overall Study|Adverse Event|5|||
162994327|NCT00195338|588680064|FG000|Overall Study|Lack of Efficacy|1|||
162994328|NCT00195338|588680064|FG000|Overall Study|Early closure of the site|4|||
162994329|NCT02047734|588680067|FG000|Overall Study|Adverse Event|18|||
162994330|NCT02047734|588680068|FG001|Overall Study|Adverse Event|13|||
162994331|NCT02047734|588680069|FG002|Overall Study|Adverse Event|13|||
162994332|NCT02047734|588680067|FG000|Overall Study|Lack of Efficacy|4|||
162994333|NCT02047734|588680068|FG001|Overall Study|Lack of Efficacy|5|||
162994334|NCT02047734|588680069|FG002|Overall Study|Lack of Efficacy|1|||
162994335|NCT02047734|588680067|FG000|Overall Study|Protocol Violation|3|||
162994336|NCT02047734|588680068|FG001|Overall Study|Protocol Violation|1|||
162994337|NCT02047734|588680069|FG002|Overall Study|Protocol Violation|1|||
162994338|NCT02047734|588680067|FG000|Overall Study|Lost to Follow-up|1|||
162994339|NCT02047734|588680068|FG001|Overall Study|Lost to Follow-up|4|||
162994340|NCT02047734|588680069|FG002|Overall Study|Lost to Follow-up|0|||
163060230|NCT04513366|588928343|FG002|Extension Phase|Withdrawal by Subject|1|||
162994341|NCT02047734|588680067|FG000|Overall Study|Death|0|||
162994342|NCT02047734|588680068|FG001|Overall Study|Death|1|||
162994343|NCT02047734|588680069|FG002|Overall Study|Death|0|||
162994344|NCT02047734|588680067|FG000|Overall Study|Withdrawal by Subject|30|||
162994345|NCT02047734|588680068|FG001|Overall Study|Withdrawal by Subject|31|||
162994346|NCT02047734|588680069|FG002|Overall Study|Withdrawal by Subject|19|||
162994347|NCT02047734|588680067|FG000|Overall Study|Physician Decision|7|||
162994348|NCT02047734|588680068|FG001|Overall Study|Physician Decision|6|||
163060231|NCT04513366|588928341|FG000|Extension Phase|Other than Specified|4|||
163404311|NCT02831673|590191904|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
162994349|NCT02047734|588680069|FG002|Overall Study|Physician Decision|5|||
162994350|NCT02047734|588680067|FG000|Overall Study|Miscellaneous|2|||
162994351|NCT02047734|588680068|FG001|Overall Study|Miscellaneous|4|||
162994352|NCT02047734|588680069|FG002|Overall Study|Miscellaneous|6|||
162994353|NCT02047734|588680067|FG000|Overall Study|Did Not Receive Study Drug|2|||
162994354|NCT02047734|588680068|FG001|Overall Study|Did Not Receive Study Drug|4|||
162994355|NCT02047734|588680069|FG002|Overall Study|Did Not Receive Study Drug|1|||
162994356|NCT01333397|588680070|FG000|Overall Study|Lost to Follow-up|1|||
162994357|NCT01333397|588680071|FG001|Overall Study|Lost to Follow-up|0|||
162994358|NCT01333397|588680072|FG002|Overall Study|Lost to Follow-up|0|||
162994359|NCT01333397|588680073|FG003|Overall Study|Lost to Follow-up|1|||
162994360|NCT01333397|588680074|FG004|Overall Study|Lost to Follow-up|0|||
162994361|NCT00314951|588680077|FG000|Treatment|Didn't meet criteria for mITT population|16|||
162994362|NCT00314951|588680078|FG001|Treatment|Didn't meet criteria for mITT population|11|||
162994363|NCT00314951|588680077|FG000|Follow-up|mITT failure|44|||
162994364|NCT00314951|588680078|FG001|Follow-up|mITT failure|34|||
162994365|NCT04411914|588680079|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
162994366|NCT04411914|588680080|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
162994367|NCT04106661|588680086|FG000|Overall Study|Protocol Violation|3|||
162994368|NCT04106661|588680087|FG001|Overall Study|Protocol Violation|0|||
162994369|NCT04106661|588680086|FG000|Overall Study|Scheduling difficulties|1|||
162994370|NCT04106661|588680087|FG001|Overall Study|Scheduling difficulties|1|||
162994371|NCT00233402|588680088|FG000|Overall Study|No pathology data|12|||
162994372|NCT00233402|588680089|FG001|Overall Study|No pathology data|9|||
162994373|NCT00233402|588680088|FG000|Overall Study|No Ta/T1|89|||
162994374|NCT00233402|588680089|FG001|Overall Study|No Ta/T1|94|||
162994375|NCT00233402|588680088|FG000|Overall Study|Lost to follow up etc|3|||
162994376|NCT00233402|588680089|FG001|Overall Study|Lost to follow up etc|21|||
162994377|NCT03280381|588680090|FG000|Overall Study|Physician Decision|0|||
162994378|NCT03280381|588680091|FG001|Overall Study|Physician Decision|2|||
162994379|NCT03503864|588680092|FG000|Overall Study|Protocol Violation|6|||
162994380|NCT03503864|588680092|FG000|Overall Study|Withdrawal by Subject|7|||
162994381|NCT00423319|588680093|FG000|Overall Study|Death|2|||
162994382|NCT00423319|588680094|FG001|Overall Study|Death|0|||
162994383|NCT00423319|588680093|FG000|Overall Study|Adverse Event|93|||
162994384|NCT00423319|588680094|FG001|Overall Study|Adverse Event|112|||
162994385|NCT00423319|588680093|FG000|Overall Study|Withdrawal by Subject|86|||
162994386|NCT00423319|588680094|FG001|Overall Study|Withdrawal by Subject|99|||
162994387|NCT00423319|588680093|FG000|Overall Study|Lost to Follow-up|4|||
162994388|NCT00423319|588680094|FG001|Overall Study|Lost to Follow-up|3|||
162994389|NCT00423319|588680093|FG000|Overall Study|Poor compliance or noncompliance|1|||
162994390|NCT00423319|588680094|FG001|Overall Study|Poor compliance or noncompliance|1|||
162994391|NCT00423319|588680093|FG000|Overall Study|No longer meets study criteria|15|||
162994392|NCT00423319|588680094|FG001|Overall Study|No longer meets study criteria|15|||
162994393|NCT00423319|588680093|FG000|Overall Study|Other|23|||
162994394|NCT00423319|588680094|FG001|Overall Study|Other|22|||
162994395|NCT02087189|588680096|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
162994396|NCT00478426|588680097|FG000|Overall Study|Withdrawal by Subject|1|||
162994397|NCT01189487|588680098|FG000|Overall Study|Lack of Efficacy|2|||
162994398|NCT01189487|588680098|FG000|Overall Study|Adverse Event|1|||
162994399|NCT04630158|588680099|FG000|Overall Study|Adverse Event|1|||
162994400|NCT04630158|588680100|FG001|Overall Study|Adverse Event|1|||
162994401|NCT04630158|588680101|FG002|Overall Study|Adverse Event|1|||
162994402|NCT04630158|588680099|FG000|Overall Study|Physician Decision|0|||
162994403|NCT04630158|588680100|FG001|Overall Study|Physician Decision|2|||
162994404|NCT04630158|588680101|FG002|Overall Study|Physician Decision|0|||
162994405|NCT04630158|588680099|FG000|Overall Study|Protocol Violation|1|||
162994406|NCT04630158|588680100|FG001|Overall Study|Protocol Violation|0|||
162994407|NCT04630158|588680101|FG002|Overall Study|Protocol Violation|1|||
162994408|NCT04630158|588680099|FG000|Overall Study|Withdrawal by Subject|2|||
162994409|NCT04630158|588680100|FG001|Overall Study|Withdrawal by Subject|1|||
162994410|NCT04630158|588680101|FG002|Overall Study|Withdrawal by Subject|2|||
162994411|NCT03136965|588680105|FG000|Overall Study|Lost to Follow-up|0|||
162994412|NCT03136965|588680106|FG001|Overall Study|Lost to Follow-up|1|||
162994413|NCT03136965|588680107|FG002|Overall Study|Lost to Follow-up|0|||
162994414|NCT01210612|588680109|FG000|Overall Study|Withdrawal by Subject|0|||
162994415|NCT01210612|588680110|FG001|Overall Study|Withdrawal by Subject|2|||
162994416|NCT02752087|588680111|FG000|Washout|Physician Decision|1|||
163324792|NCT02112916|589900691|FG003|Overall Study|Lost to Follow-up|0|||
163324793|NCT02112916|589900688|FG000|Overall Study|Physician Decision|94|||
163324794|NCT02112916|589900689|FG001|Overall Study|Physician Decision|72|||
163324795|NCT02112916|589900690|FG002|Overall Study|Physician Decision|24|||
163324796|NCT02112916|589900691|FG003|Overall Study|Physician Decision|15|||
162994417|NCT02752087|588680112|FG001|Washout|Physician Decision|0|||
162994418|NCT00843635|588680113|FG000|Overall Study|Adverse Event|2|||
162994419|NCT00843635|588680114|FG001|Overall Study|Adverse Event|2|||
162994420|NCT00843635|588680115|FG002|Overall Study|Adverse Event|0|||
162994421|NCT00813800|588680118|FG000|Overall Study|Screen Failure after Consent|2|||
162994422|NCT00813800|588680118|FG000|Overall Study|Adverse Event|1|||
162994423|NCT00813800|588680118|FG000|Overall Study|Worsening of depression|2|||
162994424|NCT00813800|588680118|FG000|Overall Study|Physician Decision|1|||
162994425|NCT00642278|588680119|FG000|Overall Study|Adverse Event|2|||
162994426|NCT00642278|588680120|FG001|Overall Study|Adverse Event|1|||
162994427|NCT00642278|588680121|FG002|Overall Study|Adverse Event|3|||
162994428|NCT00642278|588680122|FG003|Overall Study|Adverse Event|1|||
162994429|NCT00642278|588680123|FG004|Overall Study|Adverse Event|2|||
162994430|NCT00642278|588680124|FG005|Overall Study|Adverse Event|2|||
162994431|NCT00642278|588680125|FG006|Overall Study|Adverse Event|0|||
162994432|NCT00642278|588680119|FG000|Overall Study|Lack of Efficacy|0|||
162994433|NCT00642278|588680120|FG001|Overall Study|Lack of Efficacy|1|||
162994434|NCT00642278|588680121|FG002|Overall Study|Lack of Efficacy|0|||
162994435|NCT00642278|588680122|FG003|Overall Study|Lack of Efficacy|0|||
162994436|NCT00642278|588680123|FG004|Overall Study|Lack of Efficacy|0|||
162994437|NCT00642278|588680124|FG005|Overall Study|Lack of Efficacy|0|||
162994438|NCT00642278|588680125|FG006|Overall Study|Lack of Efficacy|0|||
162994439|NCT00642278|588680119|FG000|Overall Study|Lost to Follow-up|5|||
162994440|NCT00642278|588680120|FG001|Overall Study|Lost to Follow-up|1|||
162994441|NCT00642278|588680121|FG002|Overall Study|Lost to Follow-up|0|||
162994442|NCT00642278|588680122|FG003|Overall Study|Lost to Follow-up|1|||
162994443|NCT00642278|588680123|FG004|Overall Study|Lost to Follow-up|0|||
162994444|NCT00642278|588680124|FG005|Overall Study|Lost to Follow-up|1|||
162994445|NCT00642278|588680125|FG006|Overall Study|Lost to Follow-up|1|||
162994446|NCT00642278|588680119|FG000|Overall Study|Physician Decision|0|||
162994447|NCT00642278|588680120|FG001|Overall Study|Physician Decision|0|||
162994448|NCT00642278|588680121|FG002|Overall Study|Physician Decision|0|||
162994449|NCT00642278|588680122|FG003|Overall Study|Physician Decision|1|||
162994450|NCT00642278|588680123|FG004|Overall Study|Physician Decision|0|||
162994451|NCT00642278|588680124|FG005|Overall Study|Physician Decision|0|||
162994452|NCT00642278|588680125|FG006|Overall Study|Physician Decision|0|||
162994453|NCT00642278|588680119|FG000|Overall Study|Protocol Violation|0|||
162994454|NCT00642278|588680120|FG001|Overall Study|Protocol Violation|0|||
162994455|NCT00642278|588680121|FG002|Overall Study|Protocol Violation|1|||
162994456|NCT00642278|588680122|FG003|Overall Study|Protocol Violation|1|||
162994457|NCT00642278|588680123|FG004|Overall Study|Protocol Violation|0|||
162994458|NCT00642278|588680124|FG005|Overall Study|Protocol Violation|1|||
162994459|NCT00642278|588680125|FG006|Overall Study|Protocol Violation|2|||
162994460|NCT00642278|588680119|FG000|Overall Study|Withdrawal by Subject|1|||
162994461|NCT00642278|588680120|FG001|Overall Study|Withdrawal by Subject|1|||
162994462|NCT00642278|588680121|FG002|Overall Study|Withdrawal by Subject|1|||
162994463|NCT00642278|588680122|FG003|Overall Study|Withdrawal by Subject|3|||
162994464|NCT00642278|588680123|FG004|Overall Study|Withdrawal by Subject|6|||
162994465|NCT00642278|588680124|FG005|Overall Study|Withdrawal by Subject|2|||
162994466|NCT00642278|588680125|FG006|Overall Study|Withdrawal by Subject|2|||
162994467|NCT00642278|588680119|FG000|Overall Study|Noncompliance with study drug regimen|0|||
162994468|NCT00642278|588680120|FG001|Overall Study|Noncompliance with study drug regimen|0|||
162994469|NCT00642278|588680121|FG002|Overall Study|Noncompliance with study drug regimen|0|||
162994470|NCT00642278|588680122|FG003|Overall Study|Noncompliance with study drug regimen|1|||
162994471|NCT00642278|588680123|FG004|Overall Study|Noncompliance with study drug regimen|0|||
162994472|NCT00642278|588680124|FG005|Overall Study|Noncompliance with study drug regimen|0|||
162994473|NCT00642278|588680125|FG006|Overall Study|Noncompliance with study drug regimen|0|||
162994474|NCT00642278|588680119|FG000|Overall Study|Other|2|||
162994475|NCT00642278|588680120|FG001|Overall Study|Other|1|||
162994476|NCT00642278|588680121|FG002|Overall Study|Other|0|||
162994477|NCT00642278|588680122|FG003|Overall Study|Other|1|||
162994478|NCT00642278|588680123|FG004|Overall Study|Other|0|||
162994479|NCT00642278|588680124|FG005|Overall Study|Other|1|||
162994480|NCT00642278|588680125|FG006|Overall Study|Other|0|||
162994481|NCT03713619|588680126|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
162994482|NCT03713619|588680127|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
162994483|NCT03713619|588680128|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
162994484|NCT03713619|588680129|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
162994485|NCT03713619|588680130|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
162994486|NCT03713619|588680126|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
162994487|NCT03713619|588680127|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
163060232|NCT04513366|588928342|FG001|Extension Phase|Other than Specified|0|||
162994488|NCT03713619|588680128|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
162994489|NCT03713619|588680129|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
162994490|NCT03713619|588680130|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
163212568|NCT04447755|589492566|FG001|Overall Study|Lost to Follow-up|0|||
162994491|NCT03713619|588680126|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
162994492|NCT03713619|588680127|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
162994493|NCT03713619|588680128|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
162994494|NCT03713619|588680129|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
162994495|NCT03713619|588680130|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
162994496|NCT03713619|588680126|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
162994497|NCT03713619|588680127|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
163212569|NCT04447755|589492567|FG002|Overall Study|Lost to Follow-up|0|||
163212570|NCT04447755|589492568|FG003|Overall Study|Lost to Follow-up|0|||
163212571|NCT04447755|589492569|FG004|Overall Study|Lost to Follow-up|0|||
163212572|NCT04447755|589492570|FG005|Overall Study|Lost to Follow-up|0|||
163212573|NCT04447755|589492571|FG006|Overall Study|Lost to Follow-up|1|||
163060233|NCT04513366|588928343|FG002|Extension Phase|Other than Specified|1|||
163060234|NCT04513366|588928341|FG000|Extension Phase|Lost to Follow-up|1|||
163060235|NCT04513366|588928342|FG001|Extension Phase|Lost to Follow-up|1|||
163060236|NCT04513366|588928343|FG002|Extension Phase|Lost to Follow-up|1|||
163060237|NCT04513366|588928341|FG000|Extension Phase|Sponsor Decision|0|||
163060238|NCT04513366|588928342|FG001|Extension Phase|Sponsor Decision|1|||
163060239|NCT04513366|588928343|FG002|Extension Phase|Sponsor Decision|0|||
163060240|NCT04513366|588928341|FG000|Extension Phase|Death|0|||
163060241|NCT04513366|588928342|FG001|Extension Phase|Death|1|||
163060242|NCT04513366|588928343|FG002|Extension Phase|Death|0|||
163060243|NCT04513366|588928341|FG000|Extension Phase|Adverse Event|0|||
163060244|NCT04513366|588928342|FG001|Extension Phase|Adverse Event|0|||
163060245|NCT04513366|588928343|FG002|Extension Phase|Adverse Event|1|||
163060246|NCT03344757|588928344|FG000|Overall Study|Withdrawal by Subject|18|||
163060247|NCT03344757|588928345|FG001|Overall Study|Withdrawal by Subject|16|||
163060248|NCT03344757|588928344|FG000|Overall Study|Lost to Follow-up|0|||
163060249|NCT03344757|588928345|FG001|Overall Study|Lost to Follow-up|2|||
163060250|NCT00269152|588928346|FG000|Overall Study|Adverse Event|9|||
162994498|NCT03713619|588680128|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
162994499|NCT03713619|588680129|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
162994500|NCT03713619|588680130|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
162994501|NCT03713619|588680126|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
162994502|NCT03713619|588680127|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
162994503|NCT03713619|588680128|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
162994504|NCT03713619|588680129|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
162994505|NCT03713619|588680130|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
162994506|NCT03713619|588680126|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
162994507|NCT03713619|588680127|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
162994508|NCT03713619|588680128|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
162994509|NCT03713619|588680129|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
162994510|NCT03713619|588680130|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
162994511|NCT03713619|588680126|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
162994512|NCT03713619|588680127|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
162994513|NCT03713619|588680128|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
162994514|NCT03713619|588680129|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
162994515|NCT03713619|588680130|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
162994516|NCT03713619|588680126|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
162994517|NCT03713619|588680127|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
162994518|NCT03713619|588680128|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
162994519|NCT03713619|588680129|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
162994520|NCT03713619|588680130|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
162994521|NCT03713619|588680126|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
162994522|NCT03713619|588680127|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
162994523|NCT03713619|588680128|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
162994524|NCT03713619|588680129|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
162994525|NCT03713619|588680130|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
162994526|NCT03713619|588680126|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
162994527|NCT03713619|588680127|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
162994528|NCT03713619|588680128|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
162994529|NCT03713619|588680129|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
162994530|NCT03713619|588680130|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
162994531|NCT03713619|588680126|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
162994532|NCT03713619|588680127|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
162994533|NCT03713619|588680128|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
162994534|NCT03713619|588680129|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
162994535|NCT03713619|588680130|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
162994536|NCT03713619|588680126|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
162994537|NCT03713619|588680127|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
162994538|NCT03713619|588680128|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
162994539|NCT03713619|588680129|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
163060251|NCT00269152|588928347|FG001|Overall Study|Adverse Event|3|||
163060252|NCT00269152|588928346|FG000|Overall Study|Withdrawal by Subject|7|||
163060253|NCT00269152|588928347|FG001|Overall Study|Withdrawal by Subject|3|||
163060254|NCT00269152|588928346|FG000|Overall Study|Physician Decision|2|||
162994540|NCT03713619|588680130|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
162994541|NCT03713619|588680126|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
162994542|NCT03713619|588680127|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
162994543|NCT03713619|588680128|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
163060255|NCT00269152|588928347|FG001|Overall Study|Physician Decision|3|||
163060256|NCT00269152|588928346|FG000|Overall Study|Protocol Violation|0|||
163060257|NCT00269152|588928347|FG001|Overall Study|Protocol Violation|1|||
162994544|NCT03713619|588680129|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
162994545|NCT03713619|588680130|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
162994546|NCT03553576|588680131|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
162994547|NCT03553576|588680132|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
162994548|NCT03553576|588680131|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
162994549|NCT03553576|588680132|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
162994550|NCT03553576|588680131|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
162994551|NCT03553576|588680132|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
162994552|NCT03553576|588680131|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
162994553|NCT03553576|588680132|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
162994554|NCT03553576|588680131|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
162994555|NCT03553576|588680132|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
162994556|NCT03553576|588680131|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
162994557|NCT03553576|588680132|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
162994558|NCT03553576|588680131|FG000|Overall Study|Physician Decision|2|||
162994559|NCT03553576|588680132|FG001|Overall Study|Physician Decision|5|||
162994560|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
162994561|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
162994562|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
162994563|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
162994564|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
162994565|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
162994566|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
162994567|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
162994568|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
162994569|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
162994570|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
162994571|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
162994572|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
162994573|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
162994574|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
162994575|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
162994576|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
162994577|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
162994578|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
162994579|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
162994580|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
162994581|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
162994582|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
162994583|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
162994584|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
162994585|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
162994586|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
162994587|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
162994588|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
162994589|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
162994590|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
162994591|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
162994592|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
162994593|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
162994594|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
162994595|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
162994596|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
162994597|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
162994598|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
163324797|NCT02112916|589900688|FG000|Overall Study|Withdrawal by Subject|5|||
163324798|NCT02112916|589900689|FG001|Overall Study|Withdrawal by Subject|3|||
163324799|NCT02112916|589900690|FG002|Overall Study|Withdrawal by Subject|1|||
163324800|NCT02112916|589900691|FG003|Overall Study|Withdrawal by Subject|1|||
163324801|NCT02112916|589900688|FG000|Overall Study|Ineligible|4|||
163324802|NCT02112916|589900689|FG001|Overall Study|Ineligible|8|||
163324803|NCT02112916|589900690|FG002|Overall Study|Ineligible|3|||
163324804|NCT02112916|589900691|FG003|Overall Study|Ineligible|8|||
163324805|NCT02112916|589900688|FG000|Overall Study|Inevaluable|6|||
163324806|NCT02112916|589900689|FG001|Overall Study|Inevaluable|4|||
163324807|NCT02112916|589900690|FG002|Overall Study|Inevaluable|5|||
162994599|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
162994600|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
162994601|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
162994602|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
162994603|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
162994604|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
162994605|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
162994606|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
162994607|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
162994608|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
162994609|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
162994610|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
162994611|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
162994612|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
162994613|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
162994614|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
162994615|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
162994616|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
162994617|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
162994618|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
162994619|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
162994620|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
162994621|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
162994622|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
162994623|NCT01094886|588680138|FG000|Overall Study|Adverse Event|2|||
162994624|NCT01094886|588680138|FG000|Overall Study|Withdrawal by Subject|5|||
162994625|NCT03866902|588680139|FG000|Overall Study|Lost to Follow-up|98|||
162994626|NCT03866902|588680140|FG001|Overall Study|Lost to Follow-up|82|||
162994627|NCT03866902|588680139|FG000|Overall Study|Pregnancy|18|||
162994628|NCT03866902|588680140|FG001|Overall Study|Pregnancy|24|||
162994629|NCT02092467|588680142|FG000|Overall Study|Death|49|||
162994630|NCT02092467|588680143|FG001|Overall Study|Death|66|||
162994631|NCT02092467|588680144|FG002|Overall Study|Death|38|||
162994632|NCT02092467|588680142|FG000|Overall Study|Lost to Follow-up|38|||
162994633|NCT02092467|588680143|FG001|Overall Study|Lost to Follow-up|35|||
162994634|NCT02092467|588680144|FG002|Overall Study|Lost to Follow-up|40|||
162994635|NCT02092467|588680142|FG000|Overall Study|Global Deterioration of Health Status|1|||
162994636|NCT02092467|588680143|FG001|Overall Study|Global Deterioration of Health Status|0|||
162994637|NCT02092467|588680144|FG002|Overall Study|Global Deterioration of Health Status|0|||
162994638|NCT02092467|588680142|FG000|Overall Study|Other|32|||
162994639|NCT02092467|588680143|FG001|Overall Study|Other|30|||
162994640|NCT02092467|588680144|FG002|Overall Study|Other|24|||
162994641|NCT02092467|588680142|FG000|Overall Study|Withdrawal by Subject|282|||
162994642|NCT02092467|588680143|FG001|Overall Study|Withdrawal by Subject|327|||
162994643|NCT02092467|588680144|FG002|Overall Study|Withdrawal by Subject|289|||
162994644|NCT02092467|588680142|FG000|Overall Study|Randomized but not treated|2|||
162994645|NCT02092467|588680143|FG001|Overall Study|Randomized but not treated|1|||
162994646|NCT02092467|588680144|FG002|Overall Study|Randomized but not treated|7|||
162994647|NCT01284621|588680145|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
162994648|NCT01284621|588680146|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
162994649|NCT01284621|588680147|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
162994650|NCT01284621|588680148|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
162994651|NCT01284621|588680149|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
162994652|NCT01284621|588680150|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
162994653|NCT02377427|588680153|FG000|Part A (Up to Week 20)|Physician Decision|1|||
162994654|NCT02377427|588680154|FG001|Part A (Up to Week 20)|Physician Decision|0|||
162994655|NCT02377427|588680155|FG002|Part A (Up to Week 20)|Physician Decision|0|||
162994656|NCT02377427|588680156|FG003|Part A (Up to Week 20)|Physician Decision|0|||
162994657|NCT02377427|588680157|FG004|Part A (Up to Week 20)|Physician Decision|0|||
162994658|NCT02377427|588680153|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
162994659|NCT02377427|588680154|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
162994660|NCT02377427|588680155|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
162994661|NCT02377427|588680156|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
162994662|NCT02377427|588680157|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
162994663|NCT02377427|588680153|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
162994664|NCT02377427|588680154|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
162994665|NCT02377427|588680155|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
162994666|NCT02377427|588680156|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
163060258|NCT01832766|588928350|FG000|Washout|Lost to Follow-up|0|||
163324808|NCT02112916|589900691|FG003|Overall Study|Inevaluable|5|||
162994667|NCT02377427|588680157|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
162994668|NCT02377427|588680153|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
162994669|NCT02377427|588680154|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
162994670|NCT02377427|588680155|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
162994671|NCT02377427|588680156|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
162994672|NCT02377427|588680157|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
162994673|NCT02293863|588680158|FG000|Overall Study|Death|4|||
162994674|NCT02293863|588680159|FG001|Overall Study|Death|6|||
162994675|NCT02293863|588680160|FG002|Overall Study|Death|4|||
162994676|NCT02293863|588680158|FG000|Overall Study|Lost to Follow-up|2|||
162994677|NCT02293863|588680159|FG001|Overall Study|Lost to Follow-up|2|||
162994678|NCT02293863|588680160|FG002|Overall Study|Lost to Follow-up|2|||
162994679|NCT02293863|588680158|FG000|Overall Study|Withdrawal by Subject|3|||
162994680|NCT02293863|588680159|FG001|Overall Study|Withdrawal by Subject|3|||
162994681|NCT02293863|588680160|FG002|Overall Study|Withdrawal by Subject|1|||
162994682|NCT02293863|588680158|FG000|Overall Study|Reason Not Specified|0|||
162994683|NCT02293863|588680159|FG001|Overall Study|Reason Not Specified|2|||
162994684|NCT02293863|588680160|FG002|Overall Study|Reason Not Specified|2|||
162994685|NCT03155945|588680161|FG000|Overall Study|Lost to Follow-up|0|||
162994686|NCT03155945|588680162|FG001|Overall Study|Lost to Follow-up|1|||
162994687|NCT03155945|588680161|FG000|Overall Study|Withdrawal by Subject|0|||
162994688|NCT03155945|588680162|FG001|Overall Study|Withdrawal by Subject|1|||
162994689|NCT03155945|588680161|FG000|Overall Study|Other Reason|0|||
162994690|NCT03155945|588680162|FG001|Overall Study|Other Reason|1|||
162994691|NCT02013674|588680163|FG000|Overall Study|Death|0|||
162994692|NCT02013674|588680164|FG001|Overall Study|Death|1|||
162994693|NCT02013674|588680163|FG000|Overall Study|Lost to Follow-up|1|||
162994694|NCT02013674|588680164|FG001|Overall Study|Lost to Follow-up|0|||
162994695|NCT00416884|588680165|FG000|Overall Study|Study terminated due to low accrual|1|||
162994696|NCT03408639|588682516|FG000|Overall Study|Death|5|||
162994697|NCT03408639|588682517|FG001|Overall Study|Death|5|||
162994698|NCT03408639|588682516|FG000|Overall Study|Lost to Follow-up|1|||
162994699|NCT03408639|588682517|FG001|Overall Study|Lost to Follow-up|4|||
162994700|NCT03408639|588682516|FG000|Overall Study|Withdrawal by Subject|2|||
162994701|NCT03408639|588682517|FG001|Overall Study|Withdrawal by Subject|7|||
162994702|NCT03408639|588682516|FG000|Overall Study|Physician Decision|3|||
162994703|NCT03408639|588682517|FG001|Overall Study|Physician Decision|6|||
162994704|NCT00213135|588682520|FG000|Overall Study|Adverse Event|9|||
162994705|NCT00213135|588682521|FG001|Overall Study|Adverse Event|5|||
162994706|NCT00213135|588682522|FG002|Overall Study|Adverse Event|5|||
162994707|NCT00213135|588682520|FG000|Overall Study|Lost to Follow-up|11|||
162994708|NCT00213135|588682521|FG001|Overall Study|Lost to Follow-up|8|||
162994709|NCT00213135|588682522|FG002|Overall Study|Lost to Follow-up|4|||
162994710|NCT00213135|588682520|FG000|Overall Study|Protocol Violation|4|||
162994711|NCT00213135|588682521|FG001|Overall Study|Protocol Violation|4|||
162994712|NCT00213135|588682522|FG002|Overall Study|Protocol Violation|10|||
162994713|NCT00213135|588682520|FG000|Overall Study|Death|1|||
162994714|NCT00213135|588682521|FG001|Overall Study|Death|1|||
162994715|NCT00213135|588682522|FG002|Overall Study|Death|2|||
163324809|NCT02112916|589900688|FG000|Overall Study|Refusal of further protocol therapy|19|||
163324810|NCT02112916|589900689|FG001|Overall Study|Refusal of further protocol therapy|16|||
163324811|NCT02112916|589900690|FG002|Overall Study|Refusal of further protocol therapy|1|||
163324812|NCT02112916|589900691|FG003|Overall Study|Refusal of further protocol therapy|7|||
163324813|NCT02112916|589900688|FG000|Overall Study|Development of SMN|1|||
162994716|NCT00213135|588682520|FG000|Overall Study|Disease progression|4|||
162994717|NCT00213135|588682521|FG001|Overall Study|Disease progression|5|||
162994718|NCT00213135|588682522|FG002|Overall Study|Disease progression|21|||
162994719|NCT00213135|588682520|FG000|Overall Study|Other|21|||
162994720|NCT00213135|588682521|FG001|Overall Study|Other|12|||
162994721|NCT00213135|588682522|FG002|Overall Study|Other|15|||
163324814|NCT02112916|589900689|FG001|Overall Study|Development of SMN|0|||
163324815|NCT02112916|589900690|FG002|Overall Study|Development of SMN|0|||
162994722|NCT01924754|588682526|FG000|Overall Study|Lost to Follow-up|1|||
162994723|NCT01924754|588682527|FG001|Overall Study|Lost to Follow-up|2|||
162994724|NCT01924754|588682528|FG002|Overall Study|Lost to Follow-up|1|||
162994725|NCT01924754|588682526|FG000|Overall Study|Pregnancy|0|||
162994726|NCT01924754|588682527|FG001|Overall Study|Pregnancy|1|||
162994727|NCT01924754|588682528|FG002|Overall Study|Pregnancy|2|||
162994728|NCT03132155|588682529|FG000|Overall Study|Lack of Efficacy|6|||
162994729|NCT03132155|588682529|FG000|Overall Study|Lost to Follow-up|1|||
163324816|NCT02112916|589900691|FG003|Overall Study|Development of SMN|1|||
162994730|NCT03132155|588682529|FG000|Overall Study|Withdrawal by Subject|1|||
162994731|NCT02925403|588682535|FG000|Overall Study|Lost to Follow-up|0|||
162994732|NCT02925403|588682536|FG001|Overall Study|Lost to Follow-up|1|||
162994733|NCT02899195|588682537|FG000|Concurrent Durvalumab|Adverse Event|4|||
162994734|NCT02899195|588682537|FG000|Concurrent Durvalumab|Physician Decision|1|||
163324817|NCT02112916|589900688|FG000|Overall Study|Relapse/Progression|10|||
162994735|NCT02899195|588682537|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
162994736|NCT02899195|588682537|FG000|Concurrent Durvalumab|Progressive Disease|5|||
162994737|NCT02899195|588682537|FG000|Maintenance Durvalumab|Adverse Event|1|||
162994738|NCT02899195|588682537|FG000|Maintenance Durvalumab|Physician Decision|1|||
162994739|NCT02899195|588682537|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
162994740|NCT02899195|588682537|FG000|Maintenance Durvalumab|Progressive Disease|31|||
162994741|NCT04778904|588682538|FG000|Overall Study|Protocol Violation|1|||
162994742|NCT04778904|588682539|FG001|Overall Study|Protocol Violation|0|||
162994743|NCT04778904|588682540|FG002|Overall Study|Protocol Violation|0|||
162994744|NCT04778904|588682541|FG003|Overall Study|Protocol Violation|0|||
162994745|NCT04778904|588682538|FG000|Overall Study|Withdrawal by Subject|0|||
162994746|NCT04778904|588682539|FG001|Overall Study|Withdrawal by Subject|0|||
162994747|NCT04778904|588682540|FG002|Overall Study|Withdrawal by Subject|1|||
162994748|NCT04778904|588682541|FG003|Overall Study|Withdrawal by Subject|0|||
162994749|NCT03452137|588682542|FG000|Overall Study|Death|67|||
162994750|NCT03452137|588682543|FG001|Overall Study|Death|70|||
162994751|NCT03452137|588682542|FG000|Overall Study|Lost to Follow-up|4|||
162994752|NCT03452137|588682543|FG001|Overall Study|Lost to Follow-up|2|||
162994753|NCT03452137|588682542|FG000|Overall Study|Physician Decision|0|||
162994754|NCT03452137|588682543|FG001|Overall Study|Physician Decision|1|||
162994755|NCT03452137|588682542|FG000|Overall Study|Study Terminated by Sponsor|120|||
162994756|NCT03452137|588682543|FG001|Overall Study|Study Terminated by Sponsor|121|||
162994757|NCT03452137|588682542|FG000|Overall Study|Withdrawal by Subject|12|||
162994758|NCT03452137|588682543|FG001|Overall Study|Withdrawal by Subject|9|||
162994759|NCT02856802|588682544|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
162994760|NCT02856802|588682545|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
162994761|NCT02856802|588682544|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
162994762|NCT02856802|588682545|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
162994763|NCT02856802|588682544|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
162994764|NCT02856802|588682545|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
162994765|NCT02856802|588682544|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
162994766|NCT02856802|588682545|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
162994767|NCT02856802|588682544|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
162994768|NCT02856802|588682545|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
162994769|NCT02856802|588682544|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
162994770|NCT02856802|588682545|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
162994771|NCT03772717|588682546|FG000|Overall Study|Withdrawal by Subject|2|||
162994772|NCT04138043|588682547|FG000|Overall Study|Withdrawal by Subject|0|||
162994773|NCT04138043|588682548|FG001|Overall Study|Withdrawal by Subject|1|||
162994774|NCT00587860|588682549|FG000|Overall Study|Lost to Follow-up|2|||
162994775|NCT00587860|588682550|FG001|Overall Study|Lost to Follow-up|2|||
162994776|NCT00587860|588682549|FG000|Overall Study|Withdrawal by Subject|3|||
162994777|NCT00587860|588682550|FG001|Overall Study|Withdrawal by Subject|3|||
162994778|NCT01659125|588682551|FG000|Overall Study|Withdrawal by Subject|2|||
162994779|NCT01659125|588682551|FG000|Overall Study|Lost to Follow-up|7|||
162994780|NCT01659125|588682551|FG000|Overall Study|Technical Problem|1|||
162994781|NCT01659125|588682551|FG000|Overall Study|Time Constraints|2|||
162994782|NCT01659125|588682551|FG000|Overall Study|Failed to Start Treatment|2|||
162994783|NCT00261443|588682552|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
162994784|NCT00261443|588682553|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
162994785|NCT00261443|588682554|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
162994786|NCT00261443|588682552|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
162994787|NCT00261443|588682553|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
162994788|NCT00261443|588682554|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
162994789|NCT00261443|588682552|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
162994790|NCT00261443|588682553|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
162994791|NCT00261443|588682554|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
162994792|NCT00261443|588682552|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
162994793|NCT00261443|588682553|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
162994794|NCT00261443|588682554|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
162994795|NCT00261443|588682552|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
162994796|NCT00261443|588682553|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
162994797|NCT00261443|588682554|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
162994798|NCT00261443|588682552|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
162994799|NCT00261443|588682553|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
162994800|NCT00261443|588682554|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
162994801|NCT00261443|588682552|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
162994802|NCT00261443|588682553|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
162994803|NCT00261443|588682554|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
162994804|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
162994805|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
162994806|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
163060259|NCT01832766|588928351|FG001|Washout|Lost to Follow-up|1|||
162994807|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
162994808|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
162994809|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
162994810|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
162994811|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
162994812|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
162994813|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
162994814|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
162994815|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
162994816|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
162994817|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
162994818|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
162994819|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
162994820|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
162994821|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
162994822|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
162994823|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
162994824|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
162994825|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
162994826|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
162994827|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
162994828|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
162994829|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
162994830|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
162994831|NCT00261443|588682552|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
162994832|NCT00261443|588682553|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
162994833|NCT00261443|588682554|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
162994834|NCT00261443|588682552|FG000|3: Assessment of Relapse|Adverse Event|0|||
162994835|NCT00261443|588682553|FG001|3: Assessment of Relapse|Adverse Event|15|||
162994836|NCT00261443|588682554|FG002|3: Assessment of Relapse|Adverse Event|19|||
162994837|NCT00261443|588682552|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
162994838|NCT00261443|588682553|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
162994839|NCT00261443|588682554|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
162994840|NCT00261443|588682552|FG000|3: Assessment of Relapse|Death|0|||
162994841|NCT00261443|588682553|FG001|3: Assessment of Relapse|Death|0|||
162994842|NCT00261443|588682554|FG002|3: Assessment of Relapse|Death|1|||
162994843|NCT00261443|588682552|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
162994844|NCT00261443|588682553|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
162994845|NCT00261443|588682554|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
162994846|NCT00261443|588682552|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
162994847|NCT00261443|588682553|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
162994848|NCT00261443|588682554|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
162994849|NCT00261443|588682552|FG000|3: Assessment of Relapse|Pregnancy|0|||
162994850|NCT00261443|588682553|FG001|3: Assessment of Relapse|Pregnancy|2|||
162994851|NCT00261443|588682554|FG002|3: Assessment of Relapse|Pregnancy|1|||
162994852|NCT00261443|588682552|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
162994853|NCT00261443|588682553|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
162994854|NCT00261443|588682554|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
162994855|NCT00261443|588682552|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
162994856|NCT00261443|588682553|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
162994857|NCT00261443|588682554|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
162994858|NCT00261443|588682552|FG000|3: Assessment of Relapse|Other Reasons|0|||
162994859|NCT00261443|588682553|FG001|3: Assessment of Relapse|Other Reasons|4|||
163212574|NCT00840294|589492572|FG000|Overall Study|Withdrawal by Subject|2|||
163212575|NCT00840294|589492573|FG001|Overall Study|Withdrawal by Subject|1|||
162994860|NCT00261443|588682554|FG002|3: Assessment of Relapse|Other Reasons|3|||
162994861|NCT00261443|588682552|FG000|4: Extension Phase|Adverse Event|0|||
162994862|NCT00261443|588682553|FG001|4: Extension Phase|Adverse Event|1|||
162994863|NCT00261443|588682554|FG002|4: Extension Phase|Adverse Event|0|||
162994864|NCT00261443|588682552|FG000|4: Extension Phase|Withdrawal by Subject|0|||
163212576|NCT00840294|589492572|FG000|Overall Study|Protocol Violation|1|||
162994865|NCT00261443|588682553|FG001|4: Extension Phase|Withdrawal by Subject|1|||
162994866|NCT00261443|588682554|FG002|4: Extension Phase|Withdrawal by Subject|2|||
162994867|NCT00261443|588682552|FG000|4: Extension Phase|Lost to Follow-up|0|||
163212577|NCT00840294|589492573|FG001|Overall Study|Protocol Violation|3|||
162994868|NCT00261443|588682553|FG001|4: Extension Phase|Lost to Follow-up|1|||
162994869|NCT00261443|588682554|FG002|4: Extension Phase|Lost to Follow-up|0|||
163212578|NCT00840294|589492572|FG000|Overall Study|Illness|0|||
163212579|NCT00840294|589492573|FG001|Overall Study|Illness|1|||
162994870|NCT02755649|588682555|FG000|Overall Study|Transitioned into OLE study|99|||
162994871|NCT02755649|588682556|FG001|Overall Study|Transitioned into OLE study|98|||
162994872|NCT02755649|588682557|FG002|Overall Study|Transitioned into OLE study|100|||
162994873|NCT02755649|588682555|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
162994874|NCT02755649|588682556|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
162994875|NCT02755649|588682557|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
162994876|NCT02755649|588682555|FG000|Overall Study|Physician Decision|0|||
162994877|NCT02755649|588682556|FG001|Overall Study|Physician Decision|0|||
162994878|NCT02755649|588682557|FG002|Overall Study|Physician Decision|2|||
162994879|NCT02755649|588682555|FG000|Overall Study|Withdrawal by Subject|0|||
162994880|NCT02755649|588682556|FG001|Overall Study|Withdrawal by Subject|1|||
162994881|NCT02755649|588682557|FG002|Overall Study|Withdrawal by Subject|0|||
162994882|NCT02755649|588682555|FG000|Overall Study|Undecided|1|||
162994883|NCT02755649|588682556|FG001|Overall Study|Undecided|0|||
162994884|NCT02755649|588682557|FG002|Overall Study|Undecided|0|||
162994885|NCT01286753|588682558|FG000|Overall Study|Adverse Event|7|||
162994886|NCT01286753|588682559|FG001|Overall Study|Adverse Event|6|||
162994887|NCT01286753|588682558|FG000|Overall Study|Progression|11|||
162994888|NCT01286753|588682559|FG001|Overall Study|Progression|13|||
162994889|NCT01286753|588682558|FG000|Overall Study|Refused Treatment|1|||
162994890|NCT01286753|588682559|FG001|Overall Study|Refused Treatment|0|||
162994891|NCT01286753|588682558|FG000|Overall Study|Withdrawal of Consent|0|||
162994892|NCT01286753|588682559|FG001|Overall Study|Withdrawal of Consent|2|||
162994893|NCT01286753|588682558|FG000|Overall Study|Discontinued to Join Extension Study|6|||
162994894|NCT01286753|588682559|FG001|Overall Study|Discontinued to Join Extension Study|4|||
162994895|NCT01286753|588682558|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
162994896|NCT01286753|588682559|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
162994897|NCT02126826|588682563|FG000|Overall Study|Withdrawal by Subject|0|||
162994898|NCT02126826|588682564|FG001|Overall Study|Withdrawal by Subject|0|||
162994899|NCT02126826|588682565|FG002|Overall Study|Withdrawal by Subject|0|||
162994900|NCT02126826|588682566|FG003|Overall Study|Withdrawal by Subject|1|||
162994901|NCT02126826|588682567|FG004|Overall Study|Withdrawal by Subject|0|||
162994902|NCT02126826|588682568|FG005|Overall Study|Withdrawal by Subject|0|||
162994903|NCT02126826|588682569|FG006|Overall Study|Withdrawal by Subject|0|||
162994904|NCT01371747|588682570|FG000|Overall Study|Adverse Event|4|||
162994905|NCT01371747|588682571|FG001|Overall Study|Adverse Event|2|||
162994906|NCT01371747|588682572|FG002|Overall Study|Adverse Event|7|||
162994907|NCT01371747|588682573|FG003|Overall Study|Adverse Event|2|||
162994908|NCT01371747|588682574|FG004|Overall Study|Adverse Event|2|||
162994909|NCT01371747|588682575|FG005|Overall Study|Adverse Event|2|||
162994910|NCT01371747|588682570|FG000|Overall Study|Death|1|||
162994911|NCT01371747|588682571|FG001|Overall Study|Death|0|||
162994912|NCT01371747|588682572|FG002|Overall Study|Death|4|||
162994913|NCT01371747|588682573|FG003|Overall Study|Death|1|||
162994914|NCT01371747|588682574|FG004|Overall Study|Death|2|||
162994915|NCT01371747|588682575|FG005|Overall Study|Death|0|||
162994916|NCT01371747|588682570|FG000|Overall Study|Abnormal Renal Function|0|||
162994917|NCT01371747|588682571|FG001|Overall Study|Abnormal Renal Function|2|||
162994918|NCT01371747|588682572|FG002|Overall Study|Abnormal Renal Function|0|||
162994919|NCT01371747|588682573|FG003|Overall Study|Abnormal Renal Function|1|||
162994920|NCT01371747|588682574|FG004|Overall Study|Abnormal Renal Function|0|||
162994921|NCT01371747|588682575|FG005|Overall Study|Abnormal Renal Function|1|||
162994922|NCT01371747|588682570|FG000|Overall Study|High Serum Potassium Results|1|||
162994923|NCT01371747|588682571|FG001|Overall Study|High Serum Potassium Results|1|||
162994924|NCT01371747|588682572|FG002|Overall Study|High Serum Potassium Results|1|||
162994925|NCT01371747|588682573|FG003|Overall Study|High Serum Potassium Results|2|||
162994926|NCT01371747|588682574|FG004|Overall Study|High Serum Potassium Results|0|||
162994927|NCT01371747|588682575|FG005|Overall Study|High Serum Potassium Results|2|||
162994928|NCT01371747|588682570|FG000|Overall Study|Low Serum Potassium Results|1|||
162994929|NCT01371747|588682571|FG001|Overall Study|Low Serum Potassium Results|1|||
162994930|NCT01371747|588682572|FG002|Overall Study|Low Serum Potassium Results|1|||
162994931|NCT01371747|588682573|FG003|Overall Study|Low Serum Potassium Results|1|||
162994932|NCT01371747|588682574|FG004|Overall Study|Low Serum Potassium Results|0|||
162994933|NCT01371747|588682575|FG005|Overall Study|Low Serum Potassium Results|3|||
162994934|NCT01371747|588682570|FG000|Overall Study|Protocol Violation|0|||
162994935|NCT01371747|588682571|FG001|Overall Study|Protocol Violation|0|||
162994936|NCT01371747|588682572|FG002|Overall Study|Protocol Violation|1|||
162994937|NCT01371747|588682573|FG003|Overall Study|Protocol Violation|0|||
162994938|NCT01371747|588682574|FG004|Overall Study|Protocol Violation|0|||
162994939|NCT01371747|588682575|FG005|Overall Study|Protocol Violation|0|||
162994940|NCT01371747|588682570|FG000|Overall Study|Non-Compliance|3|||
162994941|NCT01371747|588682571|FG001|Overall Study|Non-Compliance|4|||
162994942|NCT01371747|588682572|FG002|Overall Study|Non-Compliance|3|||
162994943|NCT01371747|588682573|FG003|Overall Study|Non-Compliance|0|||
162994944|NCT01371747|588682574|FG004|Overall Study|Non-Compliance|0|||
162994945|NCT01371747|588682575|FG005|Overall Study|Non-Compliance|1|||
162994946|NCT01371747|588682570|FG000|Overall Study|Physician Decision|0|||
162994947|NCT01371747|588682571|FG001|Overall Study|Physician Decision|0|||
163060260|NCT03533751|588928354|FG000|Overall Study|Withdrawal by Subject|12|||
163060261|NCT03533751|588928355|FG001|Overall Study|Withdrawal by Subject|6|||
163060262|NCT03533751|588928356|FG002|Overall Study|Withdrawal by Subject|11|||
163060263|NCT03533751|588928357|FG003|Overall Study|Withdrawal by Subject|9|||
163060264|NCT03533751|588928358|FG004|Overall Study|Withdrawal by Subject|10|||
163060265|NCT03533751|588928354|FG000|Overall Study|Adverse Event|4|||
163060266|NCT03533751|588928355|FG001|Overall Study|Adverse Event|7|||
163060267|NCT03533751|588928356|FG002|Overall Study|Adverse Event|2|||
162994948|NCT01371747|588682572|FG002|Overall Study|Physician Decision|0|||
162994949|NCT01371747|588682573|FG003|Overall Study|Physician Decision|0|||
162994950|NCT01371747|588682574|FG004|Overall Study|Physician Decision|1|||
162994951|NCT01371747|588682575|FG005|Overall Study|Physician Decision|0|||
162994952|NCT01371747|588682570|FG000|Overall Study|Withdrawal by Subject|6|||
162994953|NCT01371747|588682571|FG001|Overall Study|Withdrawal by Subject|12|||
162994954|NCT01371747|588682572|FG002|Overall Study|Withdrawal by Subject|5|||
162994955|NCT01371747|588682573|FG003|Overall Study|Withdrawal by Subject|2|||
162994956|NCT01371747|588682574|FG004|Overall Study|Withdrawal by Subject|2|||
162994957|NCT01371747|588682575|FG005|Overall Study|Withdrawal by Subject|4|||
162994958|NCT01371747|588682570|FG000|Overall Study|Other Reasons|2|||
162994959|NCT01371747|588682571|FG001|Overall Study|Other Reasons|1|||
162994960|NCT01371747|588682572|FG002|Overall Study|Other Reasons|2|||
162994961|NCT01371747|588682573|FG003|Overall Study|Other Reasons|0|||
162994962|NCT01371747|588682574|FG004|Overall Study|Other Reasons|0|||
162994963|NCT01371747|588682575|FG005|Overall Study|Other Reasons|1|||
162994964|NCT03092219|588682576|FG000|Overall Study|Protocol Violation|7|||
162994965|NCT03092219|588682577|FG001|Overall Study|Protocol Violation|4|||
162994966|NCT05013008|588682584|FG000|Overall Study|Exclusion from mBFAS|5|||
162994967|NCT05013008|588682585|FG001|Overall Study|Exclusion from mBFAS|25|||
162994968|NCT02094417|588682586|FG000|Overall Study|Adverse Event|0|||
162994969|NCT02094417|588682587|FG001|Overall Study|Adverse Event|0|||
162994970|NCT02094417|588682588|FG002|Overall Study|Adverse Event|0|||
162994971|NCT02094417|588682589|FG003|Overall Study|Adverse Event|1|||
162994972|NCT02094417|588682586|FG000|Overall Study|Eligibility criteria|0|||
162994973|NCT02094417|588682587|FG001|Overall Study|Eligibility criteria|1|||
162994974|NCT02094417|588682588|FG002|Overall Study|Eligibility criteria|0|||
162994975|NCT02094417|588682589|FG003|Overall Study|Eligibility criteria|0|||
162994976|NCT02094417|588682586|FG000|Overall Study|No responder|4|||
162994977|NCT02094417|588682587|FG001|Overall Study|No responder|4|||
162994978|NCT02094417|588682588|FG002|Overall Study|No responder|4|||
162994979|NCT02094417|588682589|FG003|Overall Study|No responder|3|||
162994980|NCT02094417|588682586|FG000|Overall Study|Unable to conduct observations or assess|0|||
162994981|NCT02094417|588682587|FG001|Overall Study|Unable to conduct observations or assess|1|||
162994982|NCT02094417|588682588|FG002|Overall Study|Unable to conduct observations or assess|0|||
162994983|NCT02094417|588682589|FG003|Overall Study|Unable to conduct observations or assess|0|||
162994984|NCT02094417|588682586|FG000|Overall Study|Withdrawal by Subject|1|||
162994985|NCT02094417|588682587|FG001|Overall Study|Withdrawal by Subject|2|||
162994986|NCT02094417|588682588|FG002|Overall Study|Withdrawal by Subject|1|||
162994987|NCT02094417|588682589|FG003|Overall Study|Withdrawal by Subject|3|||
162994988|NCT01443728|588682592|FG000|Overall Study|Lost to Follow-up|2|||
162994989|NCT01443728|588682593|FG001|Overall Study|Lost to Follow-up|0|||
162994990|NCT01443728|588682592|FG000|Overall Study|Withdrawal by Subject|1|||
162994991|NCT01443728|588682593|FG001|Overall Study|Withdrawal by Subject|1|||
162994992|NCT01443728|588682592|FG000|Overall Study|Adverse Event|0|||
162994993|NCT01443728|588682593|FG001|Overall Study|Adverse Event|2|||
162994994|NCT00887289|588682594|FG000|Overall Study|Lack of Efficacy|14|||
162994995|NCT00887289|588682594|FG000|Overall Study|Adverse Event|27|||
162994996|NCT00887289|588682594|FG000|Overall Study|Withdrawal by Subject|26|||
162994997|NCT00887289|588682594|FG000|Overall Study|Lost to Follow-up|8|||
162994998|NCT00887289|588682594|FG000|Overall Study|Other|20|||
162994999|NCT00591773|588682595|FG000|Overall Study|Adverse Event|9|||
162995000|NCT00591773|588682596|FG001|Overall Study|Adverse Event|9|||
162995001|NCT00591773|588682597|FG002|Overall Study|Adverse Event|6|||
162995002|NCT00591773|588682595|FG000|Overall Study|Protocol Violation|2|||
163060268|NCT03533751|588928357|FG003|Overall Study|Adverse Event|4|||
163060269|NCT03533751|588928358|FG004|Overall Study|Adverse Event|5|||
163060270|NCT03533751|588928354|FG000|Overall Study|Physician Decision|0|||
163060271|NCT03533751|588928355|FG001|Overall Study|Physician Decision|2|||
162995003|NCT00591773|588682596|FG001|Overall Study|Protocol Violation|3|||
162995004|NCT00591773|588682597|FG002|Overall Study|Protocol Violation|0|||
162995005|NCT00591773|588682595|FG000|Overall Study|Lost to Follow-up|1|||
162995006|NCT00591773|588682596|FG001|Overall Study|Lost to Follow-up|4|||
162995007|NCT00591773|588682597|FG002|Overall Study|Lost to Follow-up|1|||
163060272|NCT03533751|588928356|FG002|Overall Study|Physician Decision|1|||
162995008|NCT00591773|588682595|FG000|Overall Study|Withdrawal by Subject|2|||
162995009|NCT00591773|588682596|FG001|Overall Study|Withdrawal by Subject|5|||
162995010|NCT00591773|588682597|FG002|Overall Study|Withdrawal by Subject|3|||
163060273|NCT03533751|588928357|FG003|Overall Study|Physician Decision|2|||
163060274|NCT03533751|588928358|FG004|Overall Study|Physician Decision|1|||
162995011|NCT00591773|588682595|FG000|Overall Study|Lack of Efficacy|1|||
162995012|NCT00591773|588682596|FG001|Overall Study|Lack of Efficacy|2|||
162995013|NCT00591773|588682597|FG002|Overall Study|Lack of Efficacy|2|||
162995014|NCT00591773|588682595|FG000|Overall Study|Other|1|||
162995015|NCT00591773|588682596|FG001|Overall Study|Other|1|||
162995016|NCT00591773|588682597|FG002|Overall Study|Other|4|||
162995017|NCT03022084|588682598|FG000|Overall Study|Lost to Follow-up|2|||
162995018|NCT03022084|588682599|FG001|Overall Study|Lost to Follow-up|3|||
162995019|NCT00605540|588682600|FG000|Overall Study|Death|15|||
162995020|NCT00605540|588682600|FG000|Overall Study|Lost to Follow-up|23|||
162995021|NCT00509366|588682601|FG000|Overall Study|Not Treated (Screen Failure)|1|||
162995022|NCT00509366|588682602|FG001|Overall Study|Not Treated (Screen Failure)|1|||
162995023|NCT00509366|588682603|FG002|Overall Study|Not Treated (Screen Failure)|1|||
162995024|NCT00509366|588682604|FG003|Overall Study|Not Treated (Screen Failure)|0|||
162995025|NCT00509366|588682605|FG004|Overall Study|Not Treated (Screen Failure)|0|||
162995026|NCT02119819|588682608|FG000|Overall Study|Adverse Event|3|||
162995027|NCT02119819|588682609|FG001|Overall Study|Adverse Event|1|||
162995028|NCT02119819|588682610|FG002|Overall Study|Adverse Event|2|||
162995029|NCT02119819|588682611|FG003|Overall Study|Adverse Event|3|||
162995030|NCT02119819|588682612|FG004|Overall Study|Adverse Event|0|||
162995031|NCT02119819|588682613|FG005|Overall Study|Adverse Event|1|||
162995032|NCT02119819|588682608|FG000|Overall Study|Lack of Efficacy|0|||
162995033|NCT02119819|588682609|FG001|Overall Study|Lack of Efficacy|0|||
162995034|NCT02119819|588682610|FG002|Overall Study|Lack of Efficacy|0|||
162995035|NCT02119819|588682611|FG003|Overall Study|Lack of Efficacy|0|||
162995036|NCT02119819|588682612|FG004|Overall Study|Lack of Efficacy|0|||
162995037|NCT02119819|588682613|FG005|Overall Study|Lack of Efficacy|1|||
162995038|NCT02119819|588682608|FG000|Overall Study|Lost to Follow-up|0|||
162995039|NCT02119819|588682609|FG001|Overall Study|Lost to Follow-up|0|||
162995040|NCT02119819|588682610|FG002|Overall Study|Lost to Follow-up|1|||
162995041|NCT02119819|588682611|FG003|Overall Study|Lost to Follow-up|2|||
162995042|NCT02119819|588682612|FG004|Overall Study|Lost to Follow-up|1|||
162995043|NCT02119819|588682613|FG005|Overall Study|Lost to Follow-up|2|||
162995044|NCT02119819|588682608|FG000|Overall Study|Physician Decision|1|||
162995045|NCT02119819|588682609|FG001|Overall Study|Physician Decision|1|||
162995046|NCT02119819|588682610|FG002|Overall Study|Physician Decision|0|||
162995047|NCT02119819|588682611|FG003|Overall Study|Physician Decision|0|||
162995048|NCT02119819|588682612|FG004|Overall Study|Physician Decision|0|||
162995049|NCT02119819|588682613|FG005|Overall Study|Physician Decision|1|||
162995050|NCT02119819|588682608|FG000|Overall Study|Withdrawal by Subject|5|||
162995051|NCT02119819|588682609|FG001|Overall Study|Withdrawal by Subject|3|||
162995052|NCT02119819|588682610|FG002|Overall Study|Withdrawal by Subject|0|||
162995053|NCT02119819|588682611|FG003|Overall Study|Withdrawal by Subject|0|||
162995054|NCT02119819|588682612|FG004|Overall Study|Withdrawal by Subject|6|||
162995055|NCT02119819|588682613|FG005|Overall Study|Withdrawal by Subject|10|||
162995056|NCT02119819|588682608|FG000|Overall Study|Jury Duty|0|||
162995057|NCT02119819|588682609|FG001|Overall Study|Jury Duty|0|||
163324818|NCT02112916|589900689|FG001|Overall Study|Relapse/Progression|18|||
163324819|NCT02112916|589900690|FG002|Overall Study|Relapse/Progression|15|||
163324820|NCT02112916|589900691|FG003|Overall Study|Relapse/Progression|2|||
163324821|NCT02112916|589900688|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
162995058|NCT02119819|588682610|FG002|Overall Study|Jury Duty|1|||
162995059|NCT02119819|588682611|FG003|Overall Study|Jury Duty|0|||
162995060|NCT02119819|588682612|FG004|Overall Study|Jury Duty|0|||
162995061|NCT02119819|588682613|FG005|Overall Study|Jury Duty|0|||
162995062|NCT02119819|588682608|FG000|Overall Study|Protocol Violation|0|||
162995063|NCT02119819|588682609|FG001|Overall Study|Protocol Violation|0|||
162995064|NCT02119819|588682610|FG002|Overall Study|Protocol Violation|0|||
162995065|NCT02119819|588682611|FG003|Overall Study|Protocol Violation|1|||
162995066|NCT02119819|588682612|FG004|Overall Study|Protocol Violation|0|||
162995067|NCT02119819|588682613|FG005|Overall Study|Protocol Violation|0|||
163324822|NCT02112916|589900689|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
162995068|NCT02119819|588682608|FG000|Overall Study|Left the city to get a job|0|||
162995069|NCT02119819|588682609|FG001|Overall Study|Left the city to get a job|0|||
162995070|NCT02119819|588682610|FG002|Overall Study|Left the city to get a job|0|||
162995071|NCT02119819|588682611|FG003|Overall Study|Left the city to get a job|1|||
162995072|NCT02119819|588682612|FG004|Overall Study|Left the city to get a job|0|||
162995073|NCT02119819|588682613|FG005|Overall Study|Left the city to get a job|0|||
162995074|NCT04497948|588682616|FG000|Overall Study|Death|2|||
162995075|NCT05384171|588682619|FG000|Overall Study|Lost to Follow-up|9|||
162995076|NCT05384171|588682620|FG001|Overall Study|Lost to Follow-up|9|||
162995077|NCT05384171|588682619|FG000|Overall Study|Withdrawal by Subject|3|||
162995078|NCT05384171|588682620|FG001|Overall Study|Withdrawal by Subject|0|||
162995079|NCT04611529|588682623|FG000|2-day Follow up|Lost to Follow-up|5|||
162995080|NCT04611529|588682624|FG001|2-day Follow up|Lost to Follow-up|6|||
163324823|NCT02112916|589900690|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
162995081|NCT04611529|588682625|FG002|2-day Follow up|Lost to Follow-up|3|||
162995082|NCT02121392|588682626|FG000|Prior to Intervention|Protocol Violation|40|||
162995083|NCT02121392|588682627|FG001|Prior to Intervention|Protocol Violation|35|||
162995084|NCT02121392|588682626|FG000|Prior to Intervention|Withdrawal by Subject|8|||
162995085|NCT02121392|588682627|FG001|Prior to Intervention|Withdrawal by Subject|6|||
162995086|NCT02121392|588682626|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
162995087|NCT02121392|588682627|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
162995088|NCT02121392|588682626|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
162995089|NCT02121392|588682627|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
162995090|NCT00253448|588682630|FG000|Overall Study|Withdrawal by Subject|1|||
162995091|NCT02564887|588682632|FG000|Overall Study|Lost to Follow-up|6|||
162995092|NCT02564887|588682633|FG001|Overall Study|Lost to Follow-up|0|||
162995093|NCT02052011|588682636|FG000|Overall Study|Lost to Follow-up|3|||
162995094|NCT02052011|588682637|FG001|Overall Study|Lost to Follow-up|0|||
162995095|NCT02052011|588682636|FG000|Overall Study|Withdrawal by Subject|1|||
162995096|NCT02052011|588682637|FG001|Overall Study|Withdrawal by Subject|2|||
162995097|NCT01851330|588682638|FG000|Overall Study|Lack of Efficacy|10|||
162995098|NCT01851330|588682639|FG001|Overall Study|Lack of Efficacy|9|||
162995099|NCT01851330|588682640|FG002|Overall Study|Lack of Efficacy|2|||
162995100|NCT01851330|588682638|FG000|Overall Study|Lost to Follow-up|1|||
162995101|NCT01851330|588682639|FG001|Overall Study|Lost to Follow-up|6|||
162995102|NCT01851330|588682640|FG002|Overall Study|Lost to Follow-up|9|||
162995103|NCT01851330|588682638|FG000|Overall Study|Withdrew Consent|2|||
162995104|NCT01851330|588682639|FG001|Overall Study|Withdrew Consent|1|||
162995105|NCT01851330|588682640|FG002|Overall Study|Withdrew Consent|0|||
162995106|NCT01851330|588682638|FG000|Overall Study|Investigator's Discretion|0|||
162995107|NCT01851330|588682639|FG001|Overall Study|Investigator's Discretion|0|||
162995108|NCT01851330|588682640|FG002|Overall Study|Investigator's Discretion|1|||
162995109|NCT02648932|588682641|FG000|Overall Study|No transplant|3|||
162995110|NCT02648932|588682642|FG001|Overall Study|No transplant|1|||
162995111|NCT01590797|588682643|FG000|Overall Study|Adverse Event|4|||
162995112|NCT01590797|588682644|FG001|Overall Study|Adverse Event|3|||
162995113|NCT01590797|588682643|FG000|Overall Study|Lack of Efficacy|0|||
162995114|NCT01590797|588682644|FG001|Overall Study|Lack of Efficacy|2|||
162995115|NCT01590797|588682643|FG000|Overall Study|Lost to Follow-up|0|||
162995116|NCT01590797|588682644|FG001|Overall Study|Lost to Follow-up|1|||
162995117|NCT01590797|588682643|FG000|Overall Study|Protocol Violation|4|||
162995118|NCT01590797|588682644|FG001|Overall Study|Protocol Violation|1|||
162995119|NCT01590797|588682643|FG000|Overall Study|Withdrawal by Subject|7|||
162995120|NCT01590797|588682644|FG001|Overall Study|Withdrawal by Subject|5|||
162995121|NCT01590797|588682643|FG000|Overall Study|Other Protocol Specified Criteria|2|||
162995122|NCT01590797|588682644|FG001|Overall Study|Other Protocol Specified Criteria|4|||
162995123|NCT03106987|588682645|FG000|Overall Study|Death|37|||
162995124|NCT03106987|588682646|FG001|Overall Study|Death|22|||
162995125|NCT03106987|588682647|FG002|Overall Study|Death|12|||
162995126|NCT03106987|588682648|FG003|Overall Study|Death|8|||
162995127|NCT03106987|588682645|FG000|Overall Study|Lost to Follow-up|2|||
162995128|NCT03106987|588682646|FG001|Overall Study|Lost to Follow-up|0|||
162995129|NCT03106987|588682647|FG002|Overall Study|Lost to Follow-up|2|||
162995130|NCT03106987|588682648|FG003|Overall Study|Lost to Follow-up|2|||
162995131|NCT03106987|588682645|FG000|Overall Study|Withdrawal by Subject|5|||
162995132|NCT03106987|588682646|FG001|Overall Study|Withdrawal by Subject|1|||
162995133|NCT03106987|588682647|FG002|Overall Study|Withdrawal by Subject|4|||
162995134|NCT03106987|588682648|FG003|Overall Study|Withdrawal by Subject|1|||
162995135|NCT01307111|588682649|FG000|IUD Insertion|Lost to Follow-up|2|||
162995136|NCT01307111|588682650|FG001|IUD Insertion|Lost to Follow-up|0|||
162995137|NCT01307111|588682649|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
162995138|NCT01307111|588682650|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
162995139|NCT02114385|588682655|FG000|Overall Study|Withdrawal by Subject|3|||
162995140|NCT02114385|588682656|FG001|Overall Study|Withdrawal by Subject|2|||
162995141|NCT02114385|588682655|FG000|Overall Study|Lost to Follow-up|0|||
162995142|NCT02114385|588682656|FG001|Overall Study|Lost to Follow-up|6|||
162995143|NCT02460679|588682661|FG000|Overall Study|Investigator Decision|1|||
162995144|NCT02460679|588682661|FG000|Overall Study|Withdrawal by Subject|4|||
162995145|NCT01994850|588682670|FG000|Overall Study|Physician Decision|1|||
162995146|NCT01994850|588682670|FG000|Overall Study|Withdrawal by Subject|1|||
162995147|NCT00339144|588682705|FG000|Overall Study|Disease progression|5|||
162995148|NCT00339144|588682706|FG001|Overall Study|Disease progression|2|||
162995149|NCT00339144|588682707|FG002|Overall Study|Disease progression|2|||
162995150|NCT00339144|588682705|FG000|Overall Study|Study drug toxicity|3|||
162995151|NCT00339144|588682706|FG001|Overall Study|Study drug toxicity|1|||
162995152|NCT00339144|588682707|FG002|Overall Study|Study drug toxicity|1|||
162995153|NCT00339144|588682705|FG000|Overall Study|Participant's request to discontinuation|1|||
162995154|NCT00339144|588682706|FG001|Overall Study|Participant's request to discontinuation|0|||
162995155|NCT00339144|588682707|FG002|Overall Study|Participant's request to discontinuation|1|||
162995156|NCT01292226|588682708|FG000|Overall Study|Adverse Event|5|||
162995157|NCT01292226|588682708|FG000|Overall Study|Death|1|||
162995158|NCT01292226|588682708|FG000|Overall Study|Graft loss|1|||
162995159|NCT01292226|588682708|FG000|Overall Study|Protocol Violation|3|||
162995160|NCT01292226|588682708|FG000|Overall Study|Withdrawal by Subject|1|||
162995161|NCT01292226|588682708|FG000|Overall Study|Other|2|||
162995162|NCT00468650|588682714|FG000|Overall Study|Lost to Follow-up|4|||
162995163|NCT00468650|588682714|FG000|Overall Study|Withdrawal by Subject|2|||
162995164|NCT00468650|588682714|FG000|Overall Study|Protocol Violation|1|||
162995165|NCT01267994|588682715|FG000|Overall Study|Adverse Event|2|||
162995166|NCT01144715|588682718|FG000|Overall Study|Lost to Follow-up|2|||
162995167|NCT01144715|588682719|FG001|Overall Study|Lost to Follow-up|1|||
162995168|NCT01144715|588682718|FG000|Overall Study|Withdrawal by Subject|2|||
162995169|NCT01144715|588682719|FG001|Overall Study|Withdrawal by Subject|1|||
162995170|NCT01144715|588682718|FG000|Overall Study|Adverse Event|0|||
162995171|NCT01144715|588682719|FG001|Overall Study|Adverse Event|1|||
162995172|NCT00857584|588682720|FG000|Overall Study|Lack of Efficacy|1|||
162995173|NCT00857584|588682721|FG001|Overall Study|Lack of Efficacy|2|||
162995174|NCT00857584|588682720|FG000|Overall Study|Adverse Event|2|||
162995175|NCT00857584|588682721|FG001|Overall Study|Adverse Event|2|||
162995176|NCT00857584|588682720|FG000|Overall Study|Physician Decision|1|||
162995177|NCT00857584|588682721|FG001|Overall Study|Physician Decision|1|||
162995178|NCT02533375|588682722|FG000|Overall Study|Lack of Efficacy|3|||
162995179|NCT02533375|588682722|FG000|Overall Study|Adverse Event|2|||
162995180|NCT00673387|588682723|FG000|Overall Study|Withdrawal by Subject|15|||
162995181|NCT00673387|588682724|FG001|Overall Study|Withdrawal by Subject|16|||
162995182|NCT00673387|588682725|FG002|Overall Study|Withdrawal by Subject|20|||
162995183|NCT00673387|588682726|FG003|Overall Study|Withdrawal by Subject|16|||
162995184|NCT00673387|588682727|FG004|Overall Study|Withdrawal by Subject|18|||
162995185|NCT00673387|588682728|FG005|Overall Study|Withdrawal by Subject|21|||
162995186|NCT00673387|588682729|FG006|Overall Study|Withdrawal by Subject|15|||
162995187|NCT00673387|588682730|FG007|Overall Study|Withdrawal by Subject|21|||
162995188|NCT00673387|588682723|FG000|Overall Study|Adverse Event|3|||
162995189|NCT00673387|588682724|FG001|Overall Study|Adverse Event|1|||
162995190|NCT00673387|588682725|FG002|Overall Study|Adverse Event|5|||
162995191|NCT00673387|588682726|FG003|Overall Study|Adverse Event|2|||
162995192|NCT00673387|588682727|FG004|Overall Study|Adverse Event|6|||
162995193|NCT00673387|588682728|FG005|Overall Study|Adverse Event|2|||
162995194|NCT00673387|588682729|FG006|Overall Study|Adverse Event|5|||
162995195|NCT00673387|588682730|FG007|Overall Study|Adverse Event|5|||
162995196|NCT00673387|588682723|FG000|Overall Study|Physician Decision|0|||
162995197|NCT00673387|588682724|FG001|Overall Study|Physician Decision|0|||
162995198|NCT00673387|588682725|FG002|Overall Study|Physician Decision|0|||
162995199|NCT00673387|588682726|FG003|Overall Study|Physician Decision|0|||
162995200|NCT00673387|588682727|FG004|Overall Study|Physician Decision|0|||
162995201|NCT00673387|588682728|FG005|Overall Study|Physician Decision|5|||
162995202|NCT00673387|588682729|FG006|Overall Study|Physician Decision|1|||
162995203|NCT00673387|588682730|FG007|Overall Study|Physician Decision|1|||
162995204|NCT00673387|588682723|FG000|Overall Study|Protocol Violation|3|||
162995205|NCT00673387|588682724|FG001|Overall Study|Protocol Violation|0|||
162995206|NCT00673387|588682725|FG002|Overall Study|Protocol Violation|1|||
162995207|NCT00673387|588682726|FG003|Overall Study|Protocol Violation|2|||
162995208|NCT00673387|588682727|FG004|Overall Study|Protocol Violation|0|||
162995209|NCT00673387|588682728|FG005|Overall Study|Protocol Violation|1|||
162995210|NCT00673387|588682729|FG006|Overall Study|Protocol Violation|1|||
162995211|NCT00673387|588682730|FG007|Overall Study|Protocol Violation|3|||
162995212|NCT00673387|588682723|FG000|Overall Study|Lost to Follow-up|8|||
162995213|NCT00673387|588682724|FG001|Overall Study|Lost to Follow-up|6|||
162995214|NCT00673387|588682725|FG002|Overall Study|Lost to Follow-up|5|||
162995215|NCT00673387|588682726|FG003|Overall Study|Lost to Follow-up|6|||
162995216|NCT00673387|588682727|FG004|Overall Study|Lost to Follow-up|6|||
162995217|NCT00673387|588682728|FG005|Overall Study|Lost to Follow-up|5|||
162995218|NCT00673387|588682729|FG006|Overall Study|Lost to Follow-up|8|||
163324824|NCT02112916|589900691|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
163324825|NCT02112916|589900688|FG000|Overall Study|Still on Therapy|44|||
162995219|NCT00673387|588682730|FG007|Overall Study|Lost to Follow-up|5|||
162995220|NCT00960115|588682731|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
162995221|NCT00960115|588682732|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
162995222|NCT01102374|588682733|FG000|Overall Study|Death|9|||
162995223|NCT01102374|588682734|FG001|Overall Study|Death|13|||
162995224|NCT01102374|588682733|FG000|Overall Study|Lost to Follow-up|7|||
162995225|NCT01102374|588682734|FG001|Overall Study|Lost to Follow-up|6|||
163324826|NCT02112916|589900689|FG001|Overall Study|Still on Therapy|47|||
163324827|NCT02112916|589900690|FG002|Overall Study|Still on Therapy|3|||
162995226|NCT03996447|588684867|FG000|First MRI Examination|Adverse Event|2|||
162995227|NCT03996447|588684868|FG001|First MRI Examination|Adverse Event|0|||
162995228|NCT03996447|588684867|FG000|First MRI Examination|Withdrawal by Subject|1|||
162995229|NCT03996447|588684868|FG001|First MRI Examination|Withdrawal by Subject|2|||
162995230|NCT03996447|588684867|FG000|First MRI Examination|Protocol Violation|0|||
162995231|NCT03996447|588684868|FG001|First MRI Examination|Protocol Violation|1|||
162995232|NCT03996447|588684867|FG000|Washout|Adverse Event|2|||
163324828|NCT02112916|589900691|FG003|Overall Study|Still on Therapy|2|||
163324829|NCT02112916|589900688|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
162995233|NCT03996447|588684868|FG001|Washout|Adverse Event|0|||
162995234|NCT03996447|588684867|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
162995235|NCT03996447|588684868|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
162995236|NCT03996447|588684867|FG000|Washout|Withdrawal by Subject|0|||
162995237|NCT03996447|588684868|FG001|Washout|Withdrawal by Subject|1|||
162995238|NCT03996447|588684867|FG000|Washout|Other reason|1|||
162995239|NCT03996447|588684868|FG001|Washout|Other reason|1|||
162995240|NCT00369486|588684870|FG000|4-Week Visit|Missed visit|2|||
162995241|NCT00369486|588684871|FG001|4-Week Visit|Missed visit|2|||
162995242|NCT00369486|588684872|FG002|4-Week Visit|Missed visit|0|||
162995243|NCT00369486|588684873|FG003|4-Week Visit|Missed visit|2|||
162995244|NCT00369486|588684874|FG004|4-Week Visit|Missed visit|1|||
162995245|NCT00369486|588684870|FG000|4-Week Visit|Dropped|0|||
163324830|NCT02112916|589900689|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
163324831|NCT02112916|589900690|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
162995246|NCT00369486|588684871|FG001|4-Week Visit|Dropped|0|||
162995247|NCT00369486|588684872|FG002|4-Week Visit|Dropped|1|||
162995248|NCT00369486|588684873|FG003|4-Week Visit|Dropped|0|||
162995249|NCT00369486|588684874|FG004|4-Week Visit|Dropped|0|||
162995250|NCT00369486|588684870|FG000|8-Week Visit|Missed visit|0|||
162995251|NCT00369486|588684871|FG001|8-Week Visit|Missed visit|1|||
162995252|NCT00369486|588684872|FG002|8-Week Visit|Missed visit|0|||
162995253|NCT00369486|588684873|FG003|8-Week Visit|Missed visit|0|||
162995254|NCT00369486|588684874|FG004|8-Week Visit|Missed visit|1|||
162995255|NCT00369486|588684870|FG000|8-Week Visit|Dropped|0|||
162995256|NCT00369486|588684871|FG001|8-Week Visit|Dropped|0|||
162995257|NCT00369486|588684872|FG002|8-Week Visit|Dropped|0|||
162995258|NCT00369486|588684873|FG003|8-Week Visit|Dropped|1|||
162995259|NCT00369486|588684874|FG004|8-Week Visit|Dropped|0|||
162995260|NCT00369486|588684870|FG000|17-Week Visit|Missed visit|0|||
162995261|NCT00369486|588684871|FG001|17-Week Visit|Missed visit|0|||
162995262|NCT00369486|588684872|FG002|17-Week Visit|Missed visit|1|||
162995263|NCT00369486|588684873|FG003|17-Week Visit|Missed visit|1|||
162995264|NCT00369486|588684874|FG004|17-Week Visit|Missed visit|1|||
162995265|NCT00369486|588684870|FG000|34-Week Visit|Dropped|0|||
162995266|NCT00369486|588684871|FG001|34-Week Visit|Dropped|1|||
162995267|NCT00369486|588684872|FG002|34-Week Visit|Dropped|1|||
162995268|NCT00369486|588684873|FG003|34-Week Visit|Dropped|3|||
162995269|NCT00369486|588684874|FG004|34-Week Visit|Dropped|3|||
162995270|NCT01810302|588684881|FG000|Overall Study|Death|1|||
162995271|NCT01810302|588684882|FG001|Overall Study|Death|0|||
162995272|NCT01810302|588684881|FG000|Overall Study|Physician Decision|0|||
162995273|NCT01810302|588684882|FG001|Overall Study|Physician Decision|1|||
162995274|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #1|24|||
162995275|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #1|0|||
162995276|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
162995277|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
162995278|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
162995279|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995280|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
162995281|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
162995282|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
162995283|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
162995284|NCT03888066|588684883|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
162995285|NCT03888066|588684884|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995286|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
162995287|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
163324832|NCT02112916|589900691|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
163324833|NCT02112916|589900688|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
163324834|NCT02112916|589900689|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
163324835|NCT02112916|589900690|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
162995288|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
162995289|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
162995290|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
162995291|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995292|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
162995293|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995294|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #2|5|||
162995295|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #2|0|||
162995296|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
162995297|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
162995298|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
163060275|NCT03533751|588928354|FG000|Overall Study|Sponsor Decision|0|||
163324836|NCT02112916|589900691|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
162995299|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
162995300|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
162995301|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
162995302|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #3|11|||
162995303|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #3|0|||
162995304|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
162995305|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
162995306|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
162995307|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
162995308|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
162995309|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995310|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #4|3|||
162995311|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #4|0|||
162995312|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
162995313|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
162995314|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
162995315|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
162995316|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
162995317|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
163212580|NCT03721276|589492575|FG000|Overall Study|Lost to Follow-up|5|||
163212581|NCT03721276|589492576|FG001|Overall Study|Lost to Follow-up|3|||
163212582|NCT03721276|589492575|FG000|Overall Study|Adverse Event|0|||
163212583|NCT03721276|589492576|FG001|Overall Study|Adverse Event|1|||
163212584|NCT01405742|589492579|FG000|Overall Study|Lost to Follow-up|1|||
163212585|NCT01405742|589492580|FG001|Overall Study|Lost to Follow-up|0|||
163212586|NCT01340898|589492581|FG000|Primary Phase|Serious Adverse Events|0|||
163212587|NCT01340898|589492582|FG001|Primary Phase|Serious Adverse Events|0|||
163212588|NCT01340898|589492583|FG002|Primary Phase|Serious Adverse Events|1|||
163212589|NCT01340898|589492581|FG000|Primary Phase|Withdrawal by Subject|8|||
163212590|NCT01340898|589492582|FG001|Primary Phase|Withdrawal by Subject|7|||
163212591|NCT01340898|589492583|FG002|Primary Phase|Withdrawal by Subject|5|||
163212592|NCT01340898|589492581|FG000|Primary Phase|Migrated/moved from study area|4|||
163212593|NCT01340898|589492582|FG001|Primary Phase|Migrated/moved from study area|1|||
163212594|NCT01340898|589492583|FG002|Primary Phase|Migrated/moved from study area|0|||
163212595|NCT01340898|589492581|FG000|Primary Phase|Lost to Follow-up|4|||
163212596|NCT01340898|589492582|FG001|Primary Phase|Lost to Follow-up|1|||
163212597|NCT01340898|589492583|FG002|Primary Phase|Lost to Follow-up|0|||
163212598|NCT01340898|589492581|FG000|Booster Phase|Withdrawal by Subject|3|||
163212599|NCT01340898|589492582|FG001|Booster Phase|Withdrawal by Subject|0|||
163212600|NCT01340898|589492583|FG002|Booster Phase|Withdrawal by Subject|4|||
163212601|NCT01340898|589492581|FG000|Booster Phase|Migrated/moved from study area|3|||
163212602|NCT01340898|589492582|FG001|Booster Phase|Migrated/moved from study area|0|||
163212603|NCT01340898|589492583|FG002|Booster Phase|Migrated/moved from study area|0|||
163212604|NCT01340898|589492581|FG000|Booster Phase|Lost to Follow-up|4|||
163212605|NCT01340898|589492582|FG001|Booster Phase|Lost to Follow-up|2|||
163212606|NCT01340898|589492583|FG002|Booster Phase|Lost to Follow-up|3|||
163212607|NCT04900220|589492584|FG000|Overall Study|Lost to Follow-up|1|||
163212608|NCT04900220|589492585|FG001|Overall Study|Lost to Follow-up|1|||
163212609|NCT03428360|589492586|FG000|Overall Study|Informed consent withdrawn|5|||
163212610|NCT03428360|589492586|FG000|Overall Study|Withdrawal by Subject|4|||
163212611|NCT03428360|589492586|FG000|Overall Study|Lost to Follow-up|5|||
163212612|NCT03428360|589492586|FG000|Overall Study|Physician Decision|2|||
163212613|NCT03428360|589492586|FG000|Overall Study|Informed consent withdrawn|5|||
163212614|NCT03428360|589492586|FG000|Overall Study|Study terminated by sponsor|10|||
163212615|NCT03428360|589492586|FG000|Overall Study|Non-compliant with study|1|||
163212616|NCT03428360|589492586|FG000|Overall Study|Non-compliant with study drug|3|||
163212617|NCT03428360|589492586|FG000|Overall Study|Death|3|||
163212618|NCT03428360|589492586|FG000|Overall Study|Adverse Event|1|||
163212619|NCT03428360|589492586|FG000|Overall Study|Not on antiepileptic drug|1|||
163212620|NCT02028065|589492587|FG000|Randomization Through Start Treatment|Not treated|1|||
163212621|NCT02028065|589492588|FG001|Randomization Through Start Treatment|Not treated|3|||
163212622|NCT02028065|589492589|FG002|Randomization Through Start Treatment|Not treated|3|||
163212623|NCT02028065|589492587|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
163404312|NCT02831673|590191900|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
162995318|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
163212624|NCT02028065|589492588|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
163212625|NCT02028065|589492589|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
163212626|NCT02028065|589492587|FG000|Treatment Through Study Completion|Physician Decision|1|||
163212627|NCT02028065|589492588|FG001|Treatment Through Study Completion|Physician Decision|0|||
163212628|NCT02028065|589492589|FG002|Treatment Through Study Completion|Physician Decision|0|||
163404313|NCT02831673|590191901|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
162995319|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
162995320|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
162995321|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995322|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
162995323|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
162995324|NCT03888066|588684883|FG000|Run-in Phase|AE (Adverse Event)|17|||
162995325|NCT03888066|588684884|FG001|Run-in Phase|AE (Adverse Event)|0|||
162995326|NCT03888066|588684883|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
162995327|NCT03888066|588684884|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
162995328|NCT03888066|588684883|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
162995329|NCT03888066|588684884|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995330|NCT03888066|588684883|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
162995331|NCT03888066|588684884|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995332|NCT03888066|588684883|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
162995333|NCT03888066|588684884|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
162995334|NCT03888066|588684883|FG000|Run-in Phase|Withdrawal by Subject|43|||
162995335|NCT03888066|588684884|FG001|Run-in Phase|Withdrawal by Subject|0|||
162995336|NCT03888066|588684883|FG000|Run-in Phase|AE; Physician Decision|1|||
162995337|NCT03888066|588684884|FG001|Run-in Phase|AE; Physician Decision|0|||
162995338|NCT03888066|588684883|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
162995339|NCT03888066|588684884|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995340|NCT03888066|588684883|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
162995341|NCT03888066|588684884|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
162995342|NCT03888066|588684883|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
162995343|NCT03888066|588684884|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
162995344|NCT03888066|588684883|FG000|Run-in Phase|Death|1|||
162995345|NCT03888066|588684884|FG001|Run-in Phase|Death|0|||
162995346|NCT03888066|588684883|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
162995347|NCT03888066|588684884|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
162995348|NCT03888066|588684883|FG000|Run-in Phase|Physician Decision|1|||
162995349|NCT03888066|588684884|FG001|Run-in Phase|Physician Decision|0|||
162995350|NCT03888066|588684883|FG000|Run-in Phase|Protocol Violation|13|||
162995351|NCT03888066|588684884|FG001|Run-in Phase|Protocol Violation|0|||
162995352|NCT03888066|588684883|FG000|Run-in Phase|Sponsor Request|34|||
162995353|NCT03888066|588684884|FG001|Run-in Phase|Sponsor Request|0|||
162995354|NCT03888066|588684883|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
162995355|NCT03888066|588684884|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
162995356|NCT03888066|588684883|FG000|Run-in Phase|Withdrawal Of Consent|1|||
162995357|NCT03888066|588684884|FG001|Run-in Phase|Withdrawal Of Consent|0|||
162995358|NCT03888066|588684883|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
162995359|NCT03888066|588684884|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
162995360|NCT03888066|588684883|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
162995361|NCT03888066|588684884|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
162995362|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
162995363|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
162995364|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
162995365|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
162995366|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
162995367|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
162995368|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
162995369|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
162995370|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
162995371|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
162995372|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
162995373|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
162995374|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
162995375|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
162995376|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
162995377|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
162995378|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
163404314|NCT02831673|590191902|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
163060276|NCT03533751|588928355|FG001|Overall Study|Sponsor Decision|0|||
163404315|NCT02831673|590191903|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
163404316|NCT02831673|590191904|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
163404317|NCT02356562|590191905|FG000|Overall Study|Withdrawal by Subject|0|||
162995379|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
162995380|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
162995381|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
162995382|NCT03278626|588684885|FG000|Overall Study|Death|2|||
162995383|NCT03278626|588684885|FG000|Overall Study|Toxicity|1|||
162995384|NCT03278626|588684885|FG000|Overall Study|Disease Progression|2|||
162995385|NCT02856555|588684886|FG000|Overall Study|Adverse Event|1|||
162995386|NCT02856555|588684887|FG001|Overall Study|Adverse Event|0|||
162995387|NCT02856555|588684888|FG002|Overall Study|Adverse Event|0|||
162995388|NCT02856555|588684886|FG000|Overall Study|Lost to Follow-up|1|||
162995389|NCT02856555|588684887|FG001|Overall Study|Lost to Follow-up|3|||
162995390|NCT02856555|588684888|FG002|Overall Study|Lost to Follow-up|0|||
162995391|NCT02856555|588684886|FG000|Overall Study|Withdrawal by Subject|3|||
162995392|NCT02856555|588684887|FG001|Overall Study|Withdrawal by Subject|0|||
162995393|NCT02856555|588684888|FG002|Overall Study|Withdrawal by Subject|0|||
162995394|NCT02856555|588684886|FG000|Overall Study|Randomized but Never Treated|0|||
162995395|NCT02856555|588684887|FG001|Overall Study|Randomized but Never Treated|1|||
162995396|NCT02856555|588684888|FG002|Overall Study|Randomized but Never Treated|0|||
162995397|NCT03333941|588684889|FG000|Overall Study|Lost to Follow-up|10|||
162995398|NCT03333941|588684889|FG000|Overall Study|Death|2|||
162995399|NCT03333941|588684889|FG000|Overall Study|Adverse Event|1|||
162995400|NCT04971187|588684890|FG000|Overall Study|Screen failures|2|||
162995401|NCT04981717|588684896|FG000|Overall Study|Protocol Violation|0|||
162995402|NCT04981717|588684897|FG001|Overall Study|Protocol Violation|3|||
162995403|NCT04981717|588684896|FG000|Overall Study|Adverse Event|1|||
162995404|NCT04981717|588684897|FG001|Overall Study|Adverse Event|3|||
162995405|NCT04981717|588684896|FG000|Overall Study|Pregnancy|1|||
162995406|NCT04981717|588684897|FG001|Overall Study|Pregnancy|0|||
162995407|NCT04981717|588684896|FG000|Overall Study|Physician Decision|1|||
162995408|NCT04981717|588684897|FG001|Overall Study|Physician Decision|0|||
162995409|NCT04981717|588684896|FG000|Overall Study|Sponsor Request|157|||
162995410|NCT04981717|588684897|FG001|Overall Study|Sponsor Request|172|||
162995411|NCT04981717|588684896|FG000|Overall Study|Lost to Follow-up|4|||
162995412|NCT04981717|588684897|FG001|Overall Study|Lost to Follow-up|5|||
162995413|NCT04981717|588684896|FG000|Overall Study|Withdrawal by Subject|50|||
162995414|NCT04981717|588684897|FG001|Overall Study|Withdrawal by Subject|37|||
162995415|NCT02207634|588684898|FG000|Overall Study|Withdrawal by Subject|21|||
162995416|NCT02207634|588684899|FG001|Overall Study|Withdrawal by Subject|31|||
162995417|NCT02207634|588684898|FG000|Overall Study|Lost to Follow-up|1|||
162995418|NCT02207634|588684899|FG001|Overall Study|Lost to Follow-up|0|||
162995419|NCT02077140|588684900|FG000|Overall Study|Lost to Follow-up|4|||
162995420|NCT02077140|588684901|FG001|Overall Study|Lost to Follow-up|1|||
162995421|NCT02077140|588684902|FG002|Overall Study|Lost to Follow-up|2|||
162995422|NCT02077140|588684903|FG003|Overall Study|Lost to Follow-up|2|||
162995423|NCT02077140|588684904|FG004|Overall Study|Lost to Follow-up|3|||
162995424|NCT02077140|588684900|FG000|Overall Study|Withdrawal by Subject|0|||
162995425|NCT02077140|588684901|FG001|Overall Study|Withdrawal by Subject|1|||
162995426|NCT02077140|588684902|FG002|Overall Study|Withdrawal by Subject|0|||
162995427|NCT02077140|588684903|FG003|Overall Study|Withdrawal by Subject|2|||
162995428|NCT02077140|588684904|FG004|Overall Study|Withdrawal by Subject|2|||
162995429|NCT00974922|588684907|FG000|Overall Study|study terminated|24|||
163212629|NCT02028065|589492587|FG000|Treatment Through Study Completion|Protocol Violation|1|||
163212630|NCT02028065|589492588|FG001|Treatment Through Study Completion|Protocol Violation|4|||
162995430|NCT00287586|588684908|FG000|Overall Study|Withdrew Consent|19|||
162995431|NCT00287586|588684909|FG001|Overall Study|Withdrew Consent|30|||
162995432|NCT00287586|588684908|FG000|Overall Study|Lost to Follow-up|5|||
162995433|NCT00287586|588684909|FG001|Overall Study|Lost to Follow-up|4|||
162995434|NCT00287586|588684908|FG000|Overall Study|Death|2|||
162995435|NCT00287586|588684909|FG001|Overall Study|Death|3|||
162995436|NCT00287586|588684908|FG000|Overall Study|Elevated Hematocrit|3|||
162995437|NCT00287586|588684909|FG001|Overall Study|Elevated Hematocrit|0|||
162995438|NCT00287586|588684908|FG000|Overall Study|Rash|3|||
162995439|NCT00287586|588684909|FG001|Overall Study|Rash|0|||
162995440|NCT00287586|588684908|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
162995441|NCT00287586|588684909|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
162995442|NCT00287586|588684908|FG000|Overall Study|Stroke|2|||
162995443|NCT00287586|588684909|FG001|Overall Study|Stroke|0|||
162995444|NCT00287586|588684908|FG000|Overall Study|Myocardial Infarction|1|||
163212631|NCT02028065|589492589|FG002|Treatment Through Study Completion|Protocol Violation|0|||
163212632|NCT02028065|589492587|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
163212633|NCT02028065|589492588|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
163212634|NCT02028065|589492589|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
163212635|NCT02028065|589492587|FG000|Treatment Through Study Completion|Adverse Event|3|||
163212636|NCT02028065|589492588|FG001|Treatment Through Study Completion|Adverse Event|3|||
163212637|NCT02028065|589492589|FG002|Treatment Through Study Completion|Adverse Event|5|||
163212638|NCT04868890|589492592|FG000|Overall Study|Death|2|||
163212639|NCT04868890|589492593|FG001|Overall Study|Death|1|||
163212640|NCT04868890|589492592|FG000|Overall Study|Withdrawal by Subject|1|||
162995445|NCT00287586|588684909|FG001|Overall Study|Myocardial Infarction|0|||
162995446|NCT00287586|588684908|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
162995447|NCT00287586|588684909|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
162995448|NCT00287586|588684908|FG000|Overall Study|Cognitive Impairment|1|||
162995449|NCT00287586|588684909|FG001|Overall Study|Cognitive Impairment|0|||
162995450|NCT00287586|588684908|FG000|Overall Study|Pancreatic Cancer|1|||
162995451|NCT00287586|588684909|FG001|Overall Study|Pancreatic Cancer|3|||
162995452|NCT00287586|588684908|FG000|Overall Study|Sleep Apnea|1|||
162995453|NCT00287586|588684909|FG001|Overall Study|Sleep Apnea|0|||
162995454|NCT00287586|588684908|FG000|Overall Study|Shoulder Pain|1|||
162995455|NCT00287586|588684909|FG001|Overall Study|Shoulder Pain|0|||
162995456|NCT00287586|588684908|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
162995457|NCT00287586|588684909|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
162995458|NCT00287586|588684908|FG000|Overall Study|Nonadherence|1|||
162995459|NCT00287586|588684909|FG001|Overall Study|Nonadherence|1|||
162995460|NCT00287586|588684908|FG000|Overall Study|Enrolled in Another Study|1|||
162995461|NCT00287586|588684909|FG001|Overall Study|Enrolled in Another Study|0|||
162995462|NCT00287586|588684908|FG000|Overall Study|Major Depression|0|||
162995463|NCT00287586|588684909|FG001|Overall Study|Major Depression|2|||
162995464|NCT00287586|588684908|FG000|Overall Study|Lung Cancer|0|||
162995465|NCT00287586|588684909|FG001|Overall Study|Lung Cancer|2|||
162995466|NCT00287586|588684908|FG000|Overall Study|Elevated IPSS Score|0|||
162995467|NCT00287586|588684909|FG001|Overall Study|Elevated IPSS Score|1|||
162995468|NCT00287586|588684908|FG000|Overall Study|Retroperitoneal Cancer|0|||
162995469|NCT00287586|588684909|FG001|Overall Study|Retroperitoneal Cancer|1|||
162995470|NCT00287586|588684908|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
162995471|NCT00287586|588684909|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
162995472|NCT00287586|588684908|FG000|Overall Study|Mood Swings and Irritability|0|||
162995473|NCT00287586|588684909|FG001|Overall Study|Mood Swings and Irritability|1|||
162995474|NCT00287586|588684908|FG000|Overall Study|Bradycardia|0|||
162995475|NCT00287586|588684909|FG001|Overall Study|Bradycardia|1|||
162995476|NCT00287586|588684908|FG000|Overall Study|Itchy Swollen Eyes|0|||
162995477|NCT00287586|588684909|FG001|Overall Study|Itchy Swollen Eyes|1|||
162995478|NCT00287586|588684908|FG000|Overall Study|Recurrent Melanoma|0|||
162995479|NCT00287586|588684909|FG001|Overall Study|Recurrent Melanoma|1|||
162995480|NCT01762800|588684911|FG000|Overall Study|Adverse Event|8|||
162995481|NCT01762800|588684912|FG001|Overall Study|Adverse Event|13|||
162995482|NCT01762800|588684911|FG000|Overall Study|Lack of Efficacy|3|||
162995483|NCT01762800|588684912|FG001|Overall Study|Lack of Efficacy|2|||
162995484|NCT01762800|588684911|FG000|Overall Study|Study Closed/Terminated|0|||
162995485|NCT01762800|588684912|FG001|Overall Study|Study Closed/Terminated|1|||
162995486|NCT01762800|588684911|FG000|Overall Study|Physician Decision|1|||
162995487|NCT01762800|588684912|FG001|Overall Study|Physician Decision|1|||
162995488|NCT01762800|588684911|FG000|Overall Study|Withdrawal by Subject|7|||
162995489|NCT01762800|588684912|FG001|Overall Study|Withdrawal by Subject|4|||
162995490|NCT02640482|588684913|FG000|Overall Study|Lost to Follow-up|3|||
162995491|NCT02640482|588684914|FG001|Overall Study|Lost to Follow-up|0|||
162995492|NCT00517881|588684915|FG000|Overall Study|Protocol Violation|2|||
162995493|NCT00517881|588684915|FG000|Overall Study|Adverse Event|1|||
162995494|NCT00517881|588684915|FG000|Overall Study|Renal transplantation|2|||
162995495|NCT00113763|588684916|FG000|Overall Study|Adverse Event|5|||
162995496|NCT00113763|588684917|FG001|Overall Study|Adverse Event|2|||
163212641|NCT04868890|589492593|FG001|Overall Study|Withdrawal by Subject|5|||
163212642|NCT02669433|589492596|FG000|Overall Study|Protocol Violation|0|||
162995497|NCT00113763|588684916|FG000|Overall Study|Disease Progression|28|||
162995498|NCT00113763|588684917|FG001|Overall Study|Disease Progression|14|||
162995499|NCT00113763|588684916|FG000|Overall Study|Lost to Follow-up|10|||
162995500|NCT00113763|588684917|FG001|Overall Study|Lost to Follow-up|0|||
162995501|NCT00113763|588684916|FG000|Overall Study|Withdrawal by Subject|1|||
162995502|NCT00113763|588684917|FG001|Overall Study|Withdrawal by Subject|4|||
162995503|NCT00113763|588684916|FG000|Overall Study|Other|27|||
162995504|NCT00113763|588684917|FG001|Overall Study|Other|6|||
162995505|NCT00113763|588684916|FG000|Overall Study|Non-compliance|1|||
162995506|NCT00113763|588684917|FG001|Overall Study|Non-compliance|0|||
162995507|NCT00113763|588684916|FG000|Overall Study|Ongoing|1|||
162995508|NCT00113763|588684917|FG001|Overall Study|Ongoing|0|||
162995509|NCT01207583|588684918|FG000|Overall Study|Withdrawal by Subject|0|||
163212643|NCT02669433|589492597|FG001|Overall Study|Protocol Violation|4|||
162995510|NCT01207583|588684919|FG001|Overall Study|Withdrawal by Subject|3|||
162995511|NCT01207583|588684920|FG002|Overall Study|Withdrawal by Subject|1|||
163212644|NCT02669433|589492598|FG002|Overall Study|Protocol Violation|1|||
163212645|NCT02669433|589492596|FG000|Overall Study|Disease Progression|1|||
163212646|NCT02669433|589492597|FG001|Overall Study|Disease Progression|0|||
163212647|NCT02669433|589492598|FG002|Overall Study|Disease Progression|0|||
163212648|NCT02669433|589492596|FG000|Overall Study|Physician Decision|1|||
163212649|NCT02669433|589492597|FG001|Overall Study|Physician Decision|1|||
163212650|NCT02669433|589492598|FG002|Overall Study|Physician Decision|0|||
163212651|NCT02669433|589492596|FG000|Overall Study|Adverse Event|6|||
163212652|NCT02669433|589492597|FG001|Overall Study|Adverse Event|7|||
162995512|NCT01207583|588684918|FG000|Overall Study|Participant failed to return|1|||
162995513|NCT01207583|588684919|FG001|Overall Study|Participant failed to return|0|||
162995514|NCT01207583|588684920|FG002|Overall Study|Participant failed to return|0|||
162995515|NCT01207583|588684918|FG000|Overall Study|Lost to Follow-up|0|||
162995516|NCT01207583|588684919|FG001|Overall Study|Lost to Follow-up|2|||
162995517|NCT01207583|588684920|FG002|Overall Study|Lost to Follow-up|0|||
162995518|NCT03743415|588684921|FG000|Overall Study|Death|5|||
162995519|NCT03743415|588684922|FG001|Overall Study|Death|3|||
162995520|NCT03743415|588684923|FG002|Overall Study|Death|1|||
162995521|NCT03743415|588684924|FG003|Overall Study|Death|4|||
162995522|NCT03743415|588684925|FG004|Overall Study|Death|0|||
162995523|NCT03743415|588684926|FG005|Overall Study|Death|0|||
162995524|NCT03743415|588684927|FG006|Overall Study|Death|0|||
162995525|NCT03743415|588684928|FG007|Overall Study|Death|0|||
162995526|NCT03743415|588684929|FG008|Overall Study|Death|1|||
162995527|NCT03743415|588684930|FG009|Overall Study|Death|0|||
162995528|NCT03743415|588684921|FG000|Overall Study|Withdrawal by Subject|1|||
162995529|NCT03743415|588684922|FG001|Overall Study|Withdrawal by Subject|0|||
162995530|NCT03743415|588684923|FG002|Overall Study|Withdrawal by Subject|4|||
162995531|NCT03743415|588684924|FG003|Overall Study|Withdrawal by Subject|5|||
162995532|NCT03743415|588684925|FG004|Overall Study|Withdrawal by Subject|5|||
162995533|NCT03743415|588684926|FG005|Overall Study|Withdrawal by Subject|2|||
162995534|NCT03743415|588684927|FG006|Overall Study|Withdrawal by Subject|2|||
162995535|NCT03743415|588684928|FG007|Overall Study|Withdrawal by Subject|5|||
162995536|NCT03743415|588684929|FG008|Overall Study|Withdrawal by Subject|9|||
162995537|NCT03743415|588684930|FG009|Overall Study|Withdrawal by Subject|10|||
162995538|NCT03743415|588684921|FG000|Overall Study|Lost to Follow-up|2|||
162995539|NCT03743415|588684922|FG001|Overall Study|Lost to Follow-up|0|||
162995540|NCT03743415|588684923|FG002|Overall Study|Lost to Follow-up|2|||
162995541|NCT03743415|588684924|FG003|Overall Study|Lost to Follow-up|1|||
162995542|NCT03743415|588684925|FG004|Overall Study|Lost to Follow-up|1|||
162995543|NCT03743415|588684926|FG005|Overall Study|Lost to Follow-up|0|||
162995544|NCT03743415|588684927|FG006|Overall Study|Lost to Follow-up|1|||
162995545|NCT03743415|588684928|FG007|Overall Study|Lost to Follow-up|4|||
162995546|NCT03743415|588684929|FG008|Overall Study|Lost to Follow-up|13|||
162995547|NCT03743415|588684930|FG009|Overall Study|Lost to Follow-up|13|||
162995548|NCT01433549|588684932|FG000|Phase 2: Second Study Product|Adverse Event|0|||
162995549|NCT01433549|588684933|FG001|Phase 2: Second Study Product|Adverse Event|1|||
162995550|NCT01696058|588684935|FG000|Overall Study|Adverse Event|21|||
162995551|NCT01696058|588684936|FG001|Overall Study|Adverse Event|11|||
162995552|NCT01696058|588684935|FG000|Overall Study|Lack of Efficacy|2|||
162995553|NCT01696058|588684936|FG001|Overall Study|Lack of Efficacy|3|||
162995554|NCT01696058|588684935|FG000|Overall Study|Protocol Violation|9|||
162995555|NCT01696058|588684936|FG001|Overall Study|Protocol Violation|3|||
162995556|NCT01696058|588684935|FG000|Overall Study|Lost to Follow-up|2|||
162995557|NCT01696058|588684936|FG001|Overall Study|Lost to Follow-up|5|||
162995558|NCT01696058|588684935|FG000|Overall Study|Withdrawal by Subject|4|||
162995559|NCT01696058|588684936|FG001|Overall Study|Withdrawal by Subject|6|||
162995560|NCT01696058|588684935|FG000|Overall Study|Other reason prematurely discontinued|5|||
162995561|NCT01696058|588684936|FG001|Overall Study|Other reason prematurely discontinued|3|||
162995562|NCT02186834|588684938|FG000|Dose Escalation|Death|0|||
162995563|NCT02186834|588684939|FG001|Dose Escalation|Death|0|||
162995564|NCT02186834|588684940|FG002|Dose Escalation|Death|0|||
162995565|NCT02186834|588684941|FG003|Dose Escalation|Death|1|||
162995566|NCT02186834|588684942|FG004|Dose Escalation|Death|0|||
162995567|NCT02186834|588684943|FG005|Dose Escalation|Death|0|||
162995568|NCT02186834|588684938|FG000|Treatment at RP2D|Died prior to treatment|0|||
162995569|NCT02186834|588684939|FG001|Treatment at RP2D|Died prior to treatment|0|||
162995570|NCT02186834|588684940|FG002|Treatment at RP2D|Died prior to treatment|0|||
162995571|NCT02186834|588684941|FG003|Treatment at RP2D|Died prior to treatment|0|||
162995572|NCT02186834|588684942|FG004|Treatment at RP2D|Died prior to treatment|0|||
162995573|NCT02186834|588684943|FG005|Treatment at RP2D|Died prior to treatment|1|||
163324837|NCT03333915|589900692|FG000|Overall Study|Lost to Follow-up|0|||
163324838|NCT03333915|589900693|FG001|Overall Study|Lost to Follow-up|0|||
162995574|NCT04581369|588684944|FG000|Overall Study|Death|7|||
162995575|NCT04581369|588684945|FG001|Overall Study|Death|6|||
162995576|NCT04581369|588684946|FG002|Overall Study|Death|0|||
162995577|NCT04581369|588684944|FG000|Overall Study|Lost to Follow-up|7|||
162995578|NCT04581369|588684945|FG001|Overall Study|Lost to Follow-up|3|||
162995579|NCT04581369|588684946|FG002|Overall Study|Lost to Follow-up|0|||
162995580|NCT04581369|588684944|FG000|Overall Study|liver transplant|2|||
162995581|NCT04581369|588684945|FG001|Overall Study|liver transplant|2|||
162995582|NCT04581369|588684946|FG002|Overall Study|liver transplant|0|||
162995583|NCT04581369|588684944|FG000|Overall Study|transitioned to hospice care|0|||
162995584|NCT04581369|588684945|FG001|Overall Study|transitioned to hospice care|5|||
162995585|NCT04581369|588684946|FG002|Overall Study|transitioned to hospice care|0|||
162995586|NCT04746794|588684949|FG000|Overall Study|Did not complete any study assessment|50303|||
162995587|NCT04746794|588684950|FG001|Overall Study|Did not complete any study assessment|44997|||
162995588|NCT00856375|588685011|FG000|Overall Study|Other|0|||
162995589|NCT00856375|588685012|FG001|Overall Study|Other|1|||
162995590|NCT00856375|588685011|FG000|Overall Study|Death|32|||
162995591|NCT00856375|588685012|FG001|Overall Study|Death|30|||
162995592|NCT00856375|588685011|FG000|Overall Study|Sponsor Terminated Study|7|||
162995593|NCT00856375|588685012|FG001|Overall Study|Sponsor Terminated Study|7|||
163060277|NCT03533751|588928356|FG002|Overall Study|Sponsor Decision|1|||
163060278|NCT03533751|588928357|FG003|Overall Study|Sponsor Decision|1|||
163060279|NCT03533751|588928358|FG004|Overall Study|Sponsor Decision|0|||
163060280|NCT03533751|588928354|FG000|Overall Study|Lost to Follow-up|3|||
163060281|NCT03533751|588928355|FG001|Overall Study|Lost to Follow-up|7|||
163060282|NCT03533751|588928356|FG002|Overall Study|Lost to Follow-up|6|||
163060283|NCT03533751|588928357|FG003|Overall Study|Lost to Follow-up|4|||
163060284|NCT03533751|588928358|FG004|Overall Study|Lost to Follow-up|3|||
163060285|NCT03533751|588928354|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
163060286|NCT03533751|588928355|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
163060287|NCT03533751|588928356|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
163060288|NCT03533751|588928357|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
163060289|NCT03533751|588928358|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
163060290|NCT03533751|588928354|FG000|Overall Study|Other|0|||
163060291|NCT03533751|588928355|FG001|Overall Study|Other|2|||
163060292|NCT03533751|588928356|FG002|Overall Study|Other|1|||
163060293|NCT03533751|588928357|FG003|Overall Study|Other|0|||
163060294|NCT03533751|588928358|FG004|Overall Study|Other|3|||
163060295|NCT03454555|588929854|FG000|Overall Study|Death|6|||
163060296|NCT03454555|588929855|FG001|Overall Study|Death|6|||
163060297|NCT03454555|588929854|FG000|Overall Study|Lost to Follow-up|31|||
163060298|NCT03454555|588929855|FG001|Overall Study|Lost to Follow-up|12|||
163060299|NCT03454555|588929854|FG000|Overall Study|Physician Decision|2|||
163060300|NCT03454555|588929855|FG001|Overall Study|Physician Decision|6|||
163060301|NCT03454555|588929854|FG000|Overall Study|Withdrawal by Subject|34|||
163060302|NCT03454555|588929855|FG001|Overall Study|Withdrawal by Subject|5|||
163060303|NCT03454555|588929854|FG000|Overall Study|Ineligible|1|||
163060304|NCT03454555|588929855|FG001|Overall Study|Ineligible|5|||
163060305|NCT05493111|588929856|FG000|Overall Study|Adverse Event|3|||
163060306|NCT05493111|588929857|FG001|Overall Study|Adverse Event|4|||
162995594|NCT00856375|588685011|FG000|Overall Study|Withdrawal by Subject|2|||
162995595|NCT00856375|588685012|FG001|Overall Study|Withdrawal by Subject|1|||
162995596|NCT00856375|588685011|FG000|Overall Study|Lost to Follow-up|1|||
162995597|NCT00856375|588685012|FG001|Overall Study|Lost to Follow-up|2|||
162995598|NCT02538965|588685015|FG000|Treatment Period|Other = Death due to disease progression|1|||
162995599|NCT02538965|588685015|FG000|Treatment Period|Adverse Event|2|||
162995600|NCT02538965|588685015|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
162995601|NCT02538965|588685015|FG000|Treatment Period|Treatment Failure|9|||
162995602|NCT02538965|588685015|FG000|Treatment Period|Disease Progression|1|||
162995603|NCT02538965|588685015|FG000|Treatment Period|Physician Decision|2|||
162995604|NCT02538965|588685015|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
162995605|NCT02538965|588685015|FG000|Follow-Up Period|Withdrawal by Parent|4|||
162995606|NCT00875797|588685016|FG000|Overall Study|Protocol Violation|6|||
162995607|NCT00875797|588685017|FG001|Overall Study|Protocol Violation|3|||
162995608|NCT00000620|588685018|FG000|Overall Study|Death|86|||
162995609|NCT00000620|588685019|FG001|Overall Study|Death|67|||
162995610|NCT00000620|588685020|FG002|Overall Study|Death|112|||
162995611|NCT00000620|588685021|FG003|Overall Study|Death|126|||
162995612|NCT00000620|588685022|FG004|Overall Study|Death|64|||
162995613|NCT00000620|588685023|FG005|Overall Study|Death|77|||
162995614|NCT00000620|588685024|FG006|Overall Study|Death|91|||
162995615|NCT00000620|588685025|FG007|Overall Study|Death|95|||
162995616|NCT00000620|588685018|FG000|Overall Study|Lost to Follow-up|14|||
162995617|NCT00000620|588685019|FG001|Overall Study|Lost to Follow-up|14|||
162995618|NCT00000620|588685020|FG002|Overall Study|Lost to Follow-up|14|||
162995619|NCT00000620|588685021|FG003|Overall Study|Lost to Follow-up|14|||
163060307|NCT05493111|588929856|FG000|Overall Study|Withdrawal of Consent|19|||
163060308|NCT05493111|588929857|FG001|Overall Study|Withdrawal of Consent|10|||
162995620|NCT00000620|588685022|FG004|Overall Study|Lost to Follow-up|15|||
163060309|NCT05493111|588929856|FG000|Overall Study|Non-compliance|1|||
163212653|NCT02669433|589492598|FG002|Overall Study|Adverse Event|10|||
162995621|NCT00000620|588685023|FG005|Overall Study|Lost to Follow-up|15|||
163060310|NCT05493111|588929857|FG001|Overall Study|Non-compliance|1|||
163060311|NCT05493111|588929856|FG000|Overall Study|Lost to Follow-up|8|||
163060312|NCT05493111|588929857|FG001|Overall Study|Lost to Follow-up|1|||
162995622|NCT00000620|588685024|FG006|Overall Study|Lost to Follow-up|13|||
163060313|NCT05493111|588929856|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
163060314|NCT05493111|588929857|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
163212654|NCT02669433|589492596|FG000|Overall Study|Sponsor Termination|1|||
163212655|NCT02669433|589492597|FG001|Overall Study|Sponsor Termination|0|||
163212656|NCT02669433|589492598|FG002|Overall Study|Sponsor Termination|1|||
163212657|NCT02669433|589492596|FG000|Overall Study|Withdrawal by Subject|5|||
163212658|NCT02669433|589492597|FG001|Overall Study|Withdrawal by Subject|1|||
163212659|NCT02669433|589492598|FG002|Overall Study|Withdrawal by Subject|0|||
162995623|NCT00000620|588685025|FG007|Overall Study|Lost to Follow-up|14|||
162995624|NCT00000620|588685018|FG000|Overall Study|Withdrawal by Subject|40|||
162995625|NCT00000620|588685019|FG001|Overall Study|Withdrawal by Subject|27|||
162995626|NCT00000620|588685020|FG002|Overall Study|Withdrawal by Subject|28|||
162995627|NCT00000620|588685021|FG003|Overall Study|Withdrawal by Subject|27|||
162995628|NCT00000620|588685022|FG004|Overall Study|Withdrawal by Subject|30|||
162995629|NCT00000620|588685023|FG005|Overall Study|Withdrawal by Subject|32|||
162995630|NCT00000620|588685024|FG006|Overall Study|Withdrawal by Subject|32|||
162995631|NCT00000620|588685025|FG007|Overall Study|Withdrawal by Subject|21|||
162995632|NCT00000620|588685018|FG000|Overall Study|missed closeout visit|22|||
162995633|NCT00000620|588685019|FG001|Overall Study|missed closeout visit|28|||
162995634|NCT00000620|588685020|FG002|Overall Study|missed closeout visit|16|||
162995635|NCT00000620|588685021|FG003|Overall Study|missed closeout visit|11|||
162995636|NCT00000620|588685022|FG004|Overall Study|missed closeout visit|26|||
162995637|NCT00000620|588685023|FG005|Overall Study|missed closeout visit|28|||
162995638|NCT00000620|588685024|FG006|Overall Study|missed closeout visit|13|||
162995639|NCT00000620|588685025|FG007|Overall Study|missed closeout visit|16|||
162995640|NCT00182325|588685030|FG000|Overall Study|Lost to Follow-up|7|||
162995641|NCT00182325|588685031|FG001|Overall Study|Lost to Follow-up|7|||
163060315|NCT05493111|588929856|FG000|Overall Study|Withdrawal by Subject|1|||
163060316|NCT05493111|588929857|FG001|Overall Study|Withdrawal by Subject|1|||
162995642|NCT00182325|588685030|FG000|Overall Study|Miscarriage|5|||
162995643|NCT00182325|588685031|FG001|Overall Study|Miscarriage|3|||
162995644|NCT00182325|588685030|FG000|Overall Study|Did not complete survey|22|||
162995645|NCT00182325|588685031|FG001|Overall Study|Did not complete survey|43|||
162995646|NCT01420965|588685033|FG000|Overall Study|Withdrawal by Subject|1|||
162995647|NCT01420965|588685034|FG001|Overall Study|Withdrawal by Subject|0|||
162995648|NCT01420965|588685035|FG002|Overall Study|Withdrawal by Subject|0|||
162995649|NCT01420965|588685033|FG000|Overall Study|Adverse Event|0|||
162995650|NCT01420965|588685034|FG001|Overall Study|Adverse Event|1|||
162995651|NCT01420965|588685035|FG002|Overall Study|Adverse Event|0|||
162995652|NCT02015065|588685036|FG000|Overall Study|Death on study|1|||
162995653|NCT02015065|588685037|FG001|Overall Study|Death on study|2|||
162995654|NCT02015065|588685038|FG002|Overall Study|Death on study|1|||
162995655|NCT04642365|588685046|FG000|Overall Study|Death|3|||
162995656|NCT04642365|588685047|FG001|Overall Study|Death|2|||
162995657|NCT04642365|588685048|FG002|Overall Study|Death|4|||
162995658|NCT04642365|588685049|FG003|Overall Study|Death|5|||
162995659|NCT04642365|588685050|FG004|Overall Study|Death|5|||
162995660|NCT04642365|588685051|FG005|Overall Study|Death|3|||
162995661|NCT04642365|588685052|FG006|Overall Study|Death|2|||
162995662|NCT04642365|588685053|FG007|Overall Study|Death|1|||
162995663|NCT04642365|588685046|FG000|Overall Study|Physician Decision|1|||
162995664|NCT04642365|588685047|FG001|Overall Study|Physician Decision|0|||
162995665|NCT04642365|588685048|FG002|Overall Study|Physician Decision|0|||
162995666|NCT04642365|588685049|FG003|Overall Study|Physician Decision|0|||
162995667|NCT04642365|588685050|FG004|Overall Study|Physician Decision|0|||
162995668|NCT04642365|588685051|FG005|Overall Study|Physician Decision|0|||
162995669|NCT04642365|588685052|FG006|Overall Study|Physician Decision|0|||
162995670|NCT04642365|588685053|FG007|Overall Study|Physician Decision|0|||
162995671|NCT04642365|588685046|FG000|Overall Study|Progressive Disease|1|||
162995672|NCT04642365|588685047|FG001|Overall Study|Progressive Disease|1|||
162995673|NCT04642365|588685048|FG002|Overall Study|Progressive Disease|1|||
162995674|NCT04642365|588685049|FG003|Overall Study|Progressive Disease|0|||
162995675|NCT04642365|588685050|FG004|Overall Study|Progressive Disease|0|||
162995676|NCT04642365|588685051|FG005|Overall Study|Progressive Disease|0|||
162995677|NCT04642365|588685052|FG006|Overall Study|Progressive Disease|1|||
163060317|NCT00375752|588929858|FG000|Overall Study|Lack of Efficacy|4|||
163060318|NCT00375752|588929859|FG001|Overall Study|Lack of Efficacy|4|||
163060319|NCT00375752|588929858|FG000|Overall Study|Adverse Event|1|||
163060320|NCT00375752|588929859|FG001|Overall Study|Adverse Event|6|||
163060321|NCT00375752|588929858|FG000|Overall Study|Withdrawal by Subject|6|||
163060322|NCT00375752|588929859|FG001|Overall Study|Withdrawal by Subject|1|||
163060323|NCT00375752|588929858|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
163060324|NCT00375752|588929859|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
162995678|NCT04642365|588685053|FG007|Overall Study|Progressive Disease|0|||
162995679|NCT04642365|588685046|FG000|Overall Study|Study Terminated By Sponsor|0|||
163060325|NCT00375752|588929858|FG000|Overall Study|Protocol Violation|0|||
163060326|NCT00375752|588929859|FG001|Overall Study|Protocol Violation|2|||
162995680|NCT04642365|588685047|FG001|Overall Study|Study Terminated By Sponsor|2|||
162995681|NCT04642365|588685048|FG002|Overall Study|Study Terminated By Sponsor|1|||
162995682|NCT04642365|588685049|FG003|Overall Study|Study Terminated By Sponsor|1|||
162995683|NCT04642365|588685050|FG004|Overall Study|Study Terminated By Sponsor|1|||
162995684|NCT04642365|588685051|FG005|Overall Study|Study Terminated By Sponsor|2|||
162995685|NCT04642365|588685052|FG006|Overall Study|Study Terminated By Sponsor|2|||
162995686|NCT04642365|588685053|FG007|Overall Study|Study Terminated By Sponsor|1|||
162995687|NCT04642365|588685046|FG000|Overall Study|Symptomatic Deterioration|1|||
162995688|NCT04642365|588685047|FG001|Overall Study|Symptomatic Deterioration|1|||
162995689|NCT04642365|588685048|FG002|Overall Study|Symptomatic Deterioration|0|||
163060327|NCT00375752|588929858|FG000|Overall Study|Administrative Problems|0|||
163060328|NCT00375752|588929859|FG001|Overall Study|Administrative Problems|1|||
163060329|NCT01140906|588929864|FG000|Overall Study|Adverse Event|7|||
163060330|NCT01140906|588929865|FG001|Overall Study|Adverse Event|10|||
162995690|NCT04642365|588685049|FG003|Overall Study|Symptomatic Deterioration|0|||
162995691|NCT04642365|588685050|FG004|Overall Study|Symptomatic Deterioration|0|||
162995692|NCT04642365|588685051|FG005|Overall Study|Symptomatic Deterioration|1|||
162995693|NCT04642365|588685052|FG006|Overall Study|Symptomatic Deterioration|0|||
162995694|NCT04642365|588685053|FG007|Overall Study|Symptomatic Deterioration|0|||
162995695|NCT04642365|588685046|FG000|Overall Study|Withdrawal by Subject|0|||
162995696|NCT04642365|588685047|FG001|Overall Study|Withdrawal by Subject|0|||
162995697|NCT04642365|588685048|FG002|Overall Study|Withdrawal by Subject|1|||
162995698|NCT04642365|588685049|FG003|Overall Study|Withdrawal by Subject|1|||
162995699|NCT04642365|588685050|FG004|Overall Study|Withdrawal by Subject|0|||
162995700|NCT04642365|588685051|FG005|Overall Study|Withdrawal by Subject|0|||
162995701|NCT04642365|588685052|FG006|Overall Study|Withdrawal by Subject|2|||
162995702|NCT04642365|588685053|FG007|Overall Study|Withdrawal by Subject|0|||
162995703|NCT04642365|588685046|FG000|Overall Study|Adverse Event|0|||
162995704|NCT04642365|588685047|FG001|Overall Study|Adverse Event|0|||
162995705|NCT04642365|588685048|FG002|Overall Study|Adverse Event|0|||
162995706|NCT04642365|588685049|FG003|Overall Study|Adverse Event|0|||
162995707|NCT04642365|588685050|FG004|Overall Study|Adverse Event|0|||
162995708|NCT04642365|588685051|FG005|Overall Study|Adverse Event|0|||
162995709|NCT04642365|588685052|FG006|Overall Study|Adverse Event|0|||
162995710|NCT04642365|588685053|FG007|Overall Study|Adverse Event|1|||
162995711|NCT02728843|588685054|FG000|Overall Study|Adverse Event|0|||
162995712|NCT02728843|588685055|FG001|Overall Study|Adverse Event|2|||
162995713|NCT02728843|588685056|FG002|Overall Study|Adverse Event|3|||
162995714|NCT02728843|588685057|FG003|Overall Study|Adverse Event|1|||
162995715|NCT02728843|588685058|FG004|Overall Study|Adverse Event|2|||
162995716|NCT02728843|588685054|FG000|Overall Study|Lack of Efficacy|0|||
162995717|NCT02728843|588685055|FG001|Overall Study|Lack of Efficacy|1|||
162995718|NCT02728843|588685056|FG002|Overall Study|Lack of Efficacy|1|||
162995719|NCT02728843|588685057|FG003|Overall Study|Lack of Efficacy|0|||
162995720|NCT02728843|588685058|FG004|Overall Study|Lack of Efficacy|0|||
162995721|NCT02728843|588685054|FG000|Overall Study|Protocol Violation|2|||
162995722|NCT02728843|588685055|FG001|Overall Study|Protocol Violation|0|||
162995723|NCT02728843|588685056|FG002|Overall Study|Protocol Violation|4|||
162995724|NCT02728843|588685057|FG003|Overall Study|Protocol Violation|2|||
162995725|NCT02728843|588685058|FG004|Overall Study|Protocol Violation|2|||
162995726|NCT02728843|588685054|FG000|Overall Study|Withdrawal by Subject|1|||
162995727|NCT02728843|588685055|FG001|Overall Study|Withdrawal by Subject|0|||
162995728|NCT02728843|588685056|FG002|Overall Study|Withdrawal by Subject|0|||
162995729|NCT02728843|588685057|FG003|Overall Study|Withdrawal by Subject|1|||
162995730|NCT02728843|588685058|FG004|Overall Study|Withdrawal by Subject|0|||
162995731|NCT02728843|588685054|FG000|Overall Study|Use of rescue medication|0|||
162995732|NCT02728843|588685055|FG001|Overall Study|Use of rescue medication|2|||
162995733|NCT02728843|588685056|FG002|Overall Study|Use of rescue medication|0|||
162995734|NCT02728843|588685057|FG003|Overall Study|Use of rescue medication|2|||
162995735|NCT02728843|588685058|FG004|Overall Study|Use of rescue medication|1|||
162995736|NCT03185013|588685059|FG000|Overall Study|Withdrawal by Subject|5|||
162995737|NCT03185013|588685060|FG001|Overall Study|Withdrawal by Subject|3|||
162995738|NCT03185013|588685059|FG000|Overall Study|Adverse Event|1|||
162995739|NCT03185013|588685060|FG001|Overall Study|Adverse Event|0|||
162995740|NCT03185013|588685059|FG000|Overall Study|Progressive Disease|1|||
162995741|NCT03185013|588685060|FG001|Overall Study|Progressive Disease|0|||
162995742|NCT03185013|588685059|FG000|Overall Study|Lost to Follow-up|8|||
162995743|NCT03185013|588685060|FG001|Overall Study|Lost to Follow-up|2|||
162995744|NCT03185013|588685059|FG000|Overall Study|Physician Decision|1|||
162995745|NCT03185013|588685060|FG001|Overall Study|Physician Decision|0|||
162995746|NCT03185013|588685059|FG000|Overall Study|Protocol Deviation|2|||
162995747|NCT03185013|588685060|FG001|Overall Study|Protocol Deviation|0|||
162995748|NCT03185013|588685059|FG000|Overall Study|Reason not Specified|3|||
162995749|NCT03185013|588685060|FG001|Overall Study|Reason not Specified|2|||
162995750|NCT03185013|588685059|FG000|Overall Study|Death|1|||
162995751|NCT03185013|588685060|FG001|Overall Study|Death|0|||
162995752|NCT00197496|588685064|FG000|Baseline to Discharge|not interested|1|||
162995753|NCT00197496|588685065|FG001|Baseline to Discharge|not interested|0|||
162995754|NCT00197496|588685064|FG000|Baseline to Discharge|MRSA|1|||
162995755|NCT00197496|588685065|FG001|Baseline to Discharge|MRSA|0|||
162995756|NCT00197496|588685064|FG000|Baseline to Discharge|Physician Decision|0|||
162995757|NCT00197496|588685065|FG001|Baseline to Discharge|Physician Decision|1|||
162995758|NCT00197496|588685064|FG000|Baseline to Discharge|Protocol Violation|0|||
162995759|NCT00197496|588685065|FG001|Baseline to Discharge|Protocol Violation|1|||
162995760|NCT00197496|588685064|FG000|Follow-up|Lost to Follow-up|2|||
162995761|NCT00197496|588685065|FG001|Follow-up|Lost to Follow-up|1|||
162995762|NCT01104792|588685071|FG000|Overall Study|Adverse Event|77|||
162995763|NCT01104792|588685071|FG000|Overall Study|Insufficient Therapeutic Response|22|||
162995764|NCT01104792|588685071|FG000|Overall Study|Protocol Violation|45|||
162995765|NCT01104792|588685071|FG000|Overall Study|Withdrawal of Consent|179|||
162995766|NCT01104792|588685071|FG000|Overall Study|Lost to Follow-up|43|||
162995767|NCT01104792|588685071|FG000|Overall Study|Reasons Not Specified|27|||
162995768|NCT01104792|588685071|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
162995769|NCT02071849|588685073|FG000|6-month Primary Endpoint|Did not receive device|4|||
162995770|NCT02071849|588685073|FG000|6-month Primary Endpoint|Adverse Event|1|||
162995771|NCT02071849|588685073|FG000|2-year Extended Follow-up|Adverse Event|1|||
162995772|NCT03255655|588685074|FG000|Overall Study|Lost to Follow-up|7|||
162995773|NCT03255655|588685075|FG001|Overall Study|Lost to Follow-up|4|||
162995774|NCT02056392|588685079|FG000|Overall Study|Lost to Follow-up|0|||
162995775|NCT02056392|588685080|FG001|Overall Study|Lost to Follow-up|1|||
162995776|NCT02056392|588685081|FG002|Overall Study|Lost to Follow-up|2|||
162995777|NCT02056392|588685082|FG003|Overall Study|Lost to Follow-up|0|||
162995778|NCT02056392|588685083|FG004|Overall Study|Lost to Follow-up|0|||
162995779|NCT02056392|588685084|FG005|Overall Study|Lost to Follow-up|0|||
162995780|NCT02056392|588685079|FG000|Overall Study|Protocol Violation|1|||
162995781|NCT02056392|588685080|FG001|Overall Study|Protocol Violation|0|||
162995782|NCT02056392|588685081|FG002|Overall Study|Protocol Violation|1|||
162995783|NCT02056392|588685082|FG003|Overall Study|Protocol Violation|0|||
162995784|NCT02056392|588685083|FG004|Overall Study|Protocol Violation|0|||
162995785|NCT02056392|588685084|FG005|Overall Study|Protocol Violation|0|||
162995786|NCT02056392|588685079|FG000|Overall Study|Withdrawal by Subject|1|||
162995787|NCT02056392|588685080|FG001|Overall Study|Withdrawal by Subject|0|||
162995788|NCT02056392|588685081|FG002|Overall Study|Withdrawal by Subject|0|||
162995789|NCT02056392|588685082|FG003|Overall Study|Withdrawal by Subject|0|||
162995790|NCT02056392|588685083|FG004|Overall Study|Withdrawal by Subject|1|||
162995791|NCT02056392|588685084|FG005|Overall Study|Withdrawal by Subject|0|||
162995792|NCT00103610|588685087|FG000|Overall Study|Entered Rescue Procedure|10|||
162995793|NCT00103610|588685088|FG001|Overall Study|Entered Rescue Procedure|52|||
162995794|NCT00103610|588685087|FG000|Overall Study|Death|16|||
162995795|NCT00103610|588685088|FG001|Overall Study|Death|12|||
162995796|NCT00103610|588685087|FG000|Overall Study|Elective Withdrawal|4|||
162995797|NCT00103610|588685088|FG001|Overall Study|Elective Withdrawal|0|||
162995798|NCT00103610|588685087|FG000|Overall Study|Lost to Follow-up|3|||
162995799|NCT00103610|588685088|FG001|Overall Study|Lost to Follow-up|1|||
162995800|NCT00103610|588685087|FG000|Overall Study|Adverse Event|2|||
162995801|NCT00103610|588685088|FG001|Overall Study|Adverse Event|2|||
162995802|NCT00103610|588685087|FG000|Overall Study|Other|2|||
162995803|NCT00103610|588685088|FG001|Overall Study|Other|7|||
162995804|NCT00103610|588685087|FG000|Overall Study|Failed mobilization|1|||
162995805|NCT00103610|588685088|FG001|Overall Study|Failed mobilization|5|||
162995806|NCT00103610|588685087|FG000|Overall Study|Noncompliance|0|||
162995807|NCT00103610|588685088|FG001|Overall Study|Noncompliance|1|||
162995808|NCT00658021|588685089|FG000|28-Week Treatment Period|Adverse Event|3|||
162995809|NCT00658021|588685090|FG001|28-Week Treatment Period|Adverse Event|1|||
162995810|NCT00658021|588685091|FG002|28-Week Treatment Period|Adverse Event|0|||
162995811|NCT00658021|588685089|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
162995812|NCT00658021|588685090|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
162995813|NCT00658021|588685091|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
162995814|NCT00658021|588685089|FG000|28-Week Treatment Period|Protocol Violation|0|||
162995815|NCT00658021|588685090|FG001|28-Week Treatment Period|Protocol Violation|2|||
162995816|NCT00658021|588685091|FG002|28-Week Treatment Period|Protocol Violation|1|||
162995817|NCT00658021|588685089|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
162995818|NCT00658021|588685090|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
162995819|NCT00658021|588685091|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
162995820|NCT00658021|588685089|FG000|28-Week Treatment Period|Physician Decision|1|||
162995821|NCT00658021|588685090|FG001|28-Week Treatment Period|Physician Decision|2|||
162995822|NCT00658021|588685091|FG002|28-Week Treatment Period|Physician Decision|1|||
162995823|NCT00658021|588685089|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
162995824|NCT00658021|588685090|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
162995825|NCT00658021|588685091|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
162995826|NCT00658021|588685089|FG000|28-Week Treatment Period|Loss of glucose control|1|||
162995827|NCT00658021|588685090|FG001|28-Week Treatment Period|Loss of glucose control|1|||
162995828|NCT00658021|588685091|FG002|28-Week Treatment Period|Loss of glucose control|10|||
162995829|NCT00658021|588685089|FG000|28-Week Treatment Period|Other|2|||
162995830|NCT00658021|588685090|FG001|28-Week Treatment Period|Other|3|||
162995831|NCT00658021|588685091|FG002|28-Week Treatment Period|Other|1|||
162995832|NCT00658021|588685089|FG000|28-Week Treatment Period|Did not receive treatment|2|||
162995833|NCT00658021|588685090|FG001|28-Week Treatment Period|Did not receive treatment|0|||
162995834|NCT00658021|588685091|FG002|28-Week Treatment Period|Did not receive treatment|0|||
162995835|NCT00658021|588685089|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
162995836|NCT00658021|588685090|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
162995837|NCT00658021|588685091|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
162995838|NCT00658021|588685089|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
162995839|NCT00658021|588685090|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
162995840|NCT00658021|588685091|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
162995841|NCT01806506|588685092|FG000|Overall Study|Lost to Follow-up|2|||
162995842|NCT01806506|588685093|FG001|Overall Study|Lost to Follow-up|1|||
162995843|NCT05819203|588685098|FG000|Overall Study|Protocol Violation|1|||
162995844|NCT05819203|588685099|FG001|Overall Study|Protocol Violation|2|||
162995845|NCT05819203|588685098|FG000|Overall Study|Withdrawal by Subject|1|||
162995846|NCT05819203|588685099|FG001|Overall Study|Withdrawal by Subject|0|||
162995847|NCT02952898|588685102|FG000|Overall Study|Withdrawal by Subject|10|||
162995848|NCT02952898|588685103|FG001|Overall Study|Withdrawal by Subject|8|||
162995849|NCT02952898|588685104|FG002|Overall Study|Withdrawal by Subject|8|||
162995850|NCT02952898|588685102|FG000|Overall Study|Adverse Event|8|||
162995851|NCT02952898|588685103|FG001|Overall Study|Adverse Event|8|||
162995852|NCT02952898|588685104|FG002|Overall Study|Adverse Event|3|||
162995853|NCT02952898|588685102|FG000|Overall Study|Lost to Follow-up|3|||
162995854|NCT02952898|588685103|FG001|Overall Study|Lost to Follow-up|2|||
162995855|NCT02952898|588685104|FG002|Overall Study|Lost to Follow-up|2|||
162995856|NCT02952898|588685102|FG000|Overall Study|Non-compliance with study drug|1|||
162995857|NCT02952898|588685103|FG001|Overall Study|Non-compliance with study drug|1|||
162995858|NCT02952898|588685104|FG002|Overall Study|Non-compliance with study drug|2|||
162995859|NCT04844762|588685105|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995860|NCT04844762|588685106|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995861|NCT04844762|588685107|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
162995862|NCT04844762|588685108|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995863|NCT04844762|588685109|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995864|NCT04844762|588685110|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995865|NCT04844762|588685105|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
162995866|NCT04844762|588685106|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
162995867|NCT04844762|588685107|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
162995868|NCT04844762|588685108|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
162995869|NCT04844762|588685109|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
162995870|NCT04844762|588685110|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
162995871|NCT04844762|588685105|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995872|NCT04844762|588685106|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995873|NCT04844762|588685107|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
162995874|NCT04844762|588685108|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
162995875|NCT04844762|588685109|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995876|NCT04844762|588685110|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
162995877|NCT04844762|588685105|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995878|NCT04844762|588685106|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995879|NCT04844762|588685107|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
162995880|NCT04844762|588685108|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
162995881|NCT04844762|588685109|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
162995882|NCT04844762|588685110|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995883|NCT04844762|588685105|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
162995884|NCT04844762|588685106|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
162995885|NCT04844762|588685107|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995886|NCT04844762|588685108|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995887|NCT04844762|588685109|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995888|NCT04844762|588685110|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995889|NCT04844762|588685105|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
162995890|NCT04844762|588685106|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995891|NCT04844762|588685107|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995892|NCT04844762|588685108|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995893|NCT04844762|588685109|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995894|NCT04844762|588685110|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995895|NCT04844762|588685105|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995896|NCT04844762|588685106|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995897|NCT04844762|588685107|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995898|NCT04844762|588685108|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995899|NCT04844762|588685109|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
162995900|NCT04844762|588685110|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995901|NCT04844762|588685105|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
162995902|NCT04844762|588685106|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995903|NCT04844762|588685107|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995904|NCT04844762|588685108|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995905|NCT04844762|588685109|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
163060331|NCT01140906|588929866|FG002|Overall Study|Adverse Event|17|||
163060332|NCT01140906|588929867|FG003|Overall Study|Adverse Event|7|||
163060333|NCT01140906|588929864|FG000|Overall Study|Lack of Efficacy|6|||
163060334|NCT01140906|588929865|FG001|Overall Study|Lack of Efficacy|8|||
163060335|NCT01140906|588929866|FG002|Overall Study|Lack of Efficacy|2|||
163060336|NCT01140906|588929867|FG003|Overall Study|Lack of Efficacy|1|||
163060337|NCT01140906|588929864|FG000|Overall Study|Non-compliance|0|||
163060338|NCT01140906|588929865|FG001|Overall Study|Non-compliance|1|||
163060339|NCT01140906|588929866|FG002|Overall Study|Non-compliance|0|||
163060340|NCT01140906|588929867|FG003|Overall Study|Non-compliance|1|||
162995906|NCT04844762|588685110|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995907|NCT04844762|588685105|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
162995908|NCT04844762|588685106|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995909|NCT04844762|588685107|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995910|NCT04844762|588685108|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995911|NCT04844762|588685109|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995912|NCT04844762|588685110|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
162995913|NCT04844762|588685105|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
162995914|NCT04844762|588685106|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
162995915|NCT04844762|588685107|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
162995916|NCT04844762|588685108|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
162995917|NCT04844762|588685109|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
162995918|NCT04844762|588685110|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
162995919|NCT04844762|588685105|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
162995920|NCT04844762|588685106|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
162995921|NCT04844762|588685107|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
162995922|NCT04844762|588685108|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
162995923|NCT04844762|588685109|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
162995924|NCT04844762|588685110|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
162995925|NCT02099682|588685113|FG000|Overall Study|Data Not Available|51|||
162995926|NCT02099682|588685113|FG000|Overall Study|Lost to Follow-up|31|||
162995927|NCT02099682|588685113|FG000|Overall Study|Other|29|||
162995928|NCT02802631|588685114|FG000|Overall Study|Withdrawal by Subject|1|||
162995929|NCT02802631|588685115|FG001|Overall Study|Withdrawal by Subject|0|||
162995930|NCT02802631|588685116|FG002|Overall Study|Withdrawal by Subject|0|||
162995931|NCT02802631|588685117|FG003|Overall Study|Withdrawal by Subject|0|||
162995932|NCT02802631|588685118|FG004|Overall Study|Withdrawal by Subject|0|||
162995933|NCT02802631|588685119|FG005|Overall Study|Withdrawal by Subject|0|||
162995934|NCT02802631|588685120|FG006|Overall Study|Withdrawal by Subject|0|||
162995935|NCT02802631|588685121|FG007|Overall Study|Withdrawal by Subject|0|||
162995936|NCT02802631|588685114|FG000|Overall Study|Physician Decision|1|||
162995937|NCT02802631|588685115|FG001|Overall Study|Physician Decision|0|||
162995938|NCT02802631|588685116|FG002|Overall Study|Physician Decision|0|||
162995939|NCT02802631|588685117|FG003|Overall Study|Physician Decision|0|||
162995940|NCT02802631|588685118|FG004|Overall Study|Physician Decision|0|||
162995941|NCT02802631|588685119|FG005|Overall Study|Physician Decision|0|||
162995942|NCT02802631|588685120|FG006|Overall Study|Physician Decision|1|||
162995943|NCT02802631|588685121|FG007|Overall Study|Physician Decision|0|||
162995944|NCT02802631|588685114|FG000|Overall Study|Adverse Event|0|||
162995945|NCT02802631|588685115|FG001|Overall Study|Adverse Event|2|||
162995946|NCT02802631|588685116|FG002|Overall Study|Adverse Event|0|||
162995947|NCT02802631|588685117|FG003|Overall Study|Adverse Event|1|||
162995948|NCT02802631|588685118|FG004|Overall Study|Adverse Event|6|||
162995949|NCT02802631|588685119|FG005|Overall Study|Adverse Event|1|||
162995950|NCT02802631|588685120|FG006|Overall Study|Adverse Event|4|||
162995951|NCT02802631|588685121|FG007|Overall Study|Adverse Event|0|||
162995952|NCT02802631|588685114|FG000|Overall Study|Sponsor Decision|0|||
162995953|NCT02802631|588685115|FG001|Overall Study|Sponsor Decision|0|||
162995954|NCT02802631|588685116|FG002|Overall Study|Sponsor Decision|6|||
162995955|NCT02802631|588685117|FG003|Overall Study|Sponsor Decision|0|||
163060341|NCT01140906|588929864|FG000|Overall Study|Protocol Violation|5|||
163324839|NCT03333915|589900694|FG002|Overall Study|Lost to Follow-up|1|||
163324840|NCT03333915|589900695|FG003|Overall Study|Lost to Follow-up|0|||
162995956|NCT02802631|588685118|FG004|Overall Study|Sponsor Decision|2|||
162995957|NCT02802631|588685119|FG005|Overall Study|Sponsor Decision|0|||
162995958|NCT02802631|588685120|FG006|Overall Study|Sponsor Decision|0|||
162995959|NCT02802631|588685121|FG007|Overall Study|Sponsor Decision|4|||
162995960|NCT00477633|588685122|FG000|Overall Study|Did not receive treatment|23|||
162995961|NCT00477633|588685122|FG000|Overall Study|Adverse Event|143|||
163060342|NCT01140906|588929865|FG001|Overall Study|Protocol Violation|3|||
163060343|NCT01140906|588929866|FG002|Overall Study|Protocol Violation|2|||
163324841|NCT03333915|589900696|FG004|Overall Study|Lost to Follow-up|0|||
162995962|NCT00477633|588685122|FG000|Overall Study|Pregnancy|23|||
162995963|NCT00477633|588685122|FG000|Overall Study|Lost to Follow-up|271|||
163060344|NCT01140906|588929867|FG003|Overall Study|Protocol Violation|1|||
163324842|NCT03333915|589900692|FG000|Overall Study|Disease Progression|0|||
162995964|NCT00477633|588685122|FG000|Overall Study|Withdrawal by Subject|149|||
162995965|NCT00477633|588685122|FG000|Overall Study|Protocol Violation|25|||
162995966|NCT00477633|588685122|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
162995967|NCT02968849|588685123|FG000|Overall Study|Death|8|||
162995968|NCT02968849|588685124|FG001|Overall Study|Death|10|||
162995969|NCT02968849|588685123|FG000|Overall Study|Lost to Follow-up|31|||
162995970|NCT02968849|588685124|FG001|Overall Study|Lost to Follow-up|29|||
162995971|NCT02968849|588685123|FG000|Overall Study|Withdrawal by Subject|73|||
162995972|NCT02968849|588685124|FG001|Overall Study|Withdrawal by Subject|64|||
162995973|NCT02968849|588685123|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
162995974|NCT02968849|588685124|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
162995975|NCT02968849|588685123|FG000|Overall Study|Physician Decision|6|||
162995976|NCT02968849|588685124|FG001|Overall Study|Physician Decision|9|||
162995977|NCT02968849|588685123|FG000|Overall Study|Other|16|||
162995978|NCT02968849|588685124|FG001|Overall Study|Other|10|||
162995979|NCT02203331|588685127|FG000|Overall Study|Pregnancy|1|||
162995980|NCT02203331|588685128|FG001|Overall Study|Pregnancy|0|||
162995981|NCT02203331|588685129|FG002|Overall Study|Pregnancy|0|||
162995982|NCT02203331|588685130|FG003|Overall Study|Pregnancy|0|||
162995983|NCT02203331|588685131|FG004|Overall Study|Pregnancy|2|||
162995984|NCT02203331|588685132|FG005|Overall Study|Pregnancy|0|||
162995985|NCT02203331|588685127|FG000|Overall Study|Withdrawal by Subject|1|||
162995986|NCT02203331|588685128|FG001|Overall Study|Withdrawal by Subject|0|||
162995987|NCT02203331|588685129|FG002|Overall Study|Withdrawal by Subject|1|||
162995988|NCT02203331|588685130|FG003|Overall Study|Withdrawal by Subject|0|||
162995989|NCT02203331|588685131|FG004|Overall Study|Withdrawal by Subject|0|||
162995990|NCT02203331|588685132|FG005|Overall Study|Withdrawal by Subject|3|||
162995991|NCT02203331|588685127|FG000|Overall Study|Adverse Event|4|||
162995992|NCT02203331|588685128|FG001|Overall Study|Adverse Event|8|||
162995993|NCT02203331|588685129|FG002|Overall Study|Adverse Event|3|||
162995994|NCT02203331|588685130|FG003|Overall Study|Adverse Event|4|||
162995995|NCT02203331|588685131|FG004|Overall Study|Adverse Event|3|||
162995996|NCT02203331|588685132|FG005|Overall Study|Adverse Event|3|||
162995997|NCT02203331|588685127|FG000|Overall Study|Other Reasons|1|||
162995998|NCT02203331|588685128|FG001|Overall Study|Other Reasons|2|||
162995999|NCT02203331|588685129|FG002|Overall Study|Other Reasons|0|||
162996000|NCT02203331|588685130|FG003|Overall Study|Other Reasons|2|||
162996001|NCT02203331|588685131|FG004|Overall Study|Other Reasons|0|||
162996002|NCT02203331|588685132|FG005|Overall Study|Other Reasons|0|||
162996003|NCT02203331|588685127|FG000|Overall Study|Lack of Efficacy|0|||
162996004|NCT02203331|588685128|FG001|Overall Study|Lack of Efficacy|2|||
162996005|NCT02203331|588685129|FG002|Overall Study|Lack of Efficacy|1|||
162996006|NCT02203331|588685130|FG003|Overall Study|Lack of Efficacy|0|||
162996007|NCT02203331|588685131|FG004|Overall Study|Lack of Efficacy|0|||
162996008|NCT02203331|588685132|FG005|Overall Study|Lack of Efficacy|1|||
162996009|NCT02203331|588685127|FG000|Overall Study|Protocol Violation|0|||
162996010|NCT02203331|588685128|FG001|Overall Study|Protocol Violation|2|||
162996011|NCT02203331|588685129|FG002|Overall Study|Protocol Violation|0|||
162996012|NCT02203331|588685130|FG003|Overall Study|Protocol Violation|1|||
163212660|NCT02669433|589492596|FG000|Overall Study|Withdrawal by Caregiver|1|||
162996013|NCT02203331|588685131|FG004|Overall Study|Protocol Violation|1|||
162996014|NCT02203331|588685132|FG005|Overall Study|Protocol Violation|0|||
163212661|NCT02669433|589492597|FG001|Overall Study|Withdrawal by Caregiver|0|||
163212662|NCT02669433|589492598|FG002|Overall Study|Withdrawal by Caregiver|2|||
162996015|NCT02203331|588685127|FG000|Overall Study|Lost to Follow-up|0|||
162996016|NCT02203331|588685128|FG001|Overall Study|Lost to Follow-up|0|||
162996017|NCT02203331|588685129|FG002|Overall Study|Lost to Follow-up|0|||
162996018|NCT02203331|588685130|FG003|Overall Study|Lost to Follow-up|0|||
162996019|NCT02203331|588685131|FG004|Overall Study|Lost to Follow-up|1|||
162996020|NCT02203331|588685132|FG005|Overall Study|Lost to Follow-up|0|||
162996021|NCT02542605|588685133|FG000|Part B: Challenge Phase|Sponsor decision|1|||
162996022|NCT02542605|588685134|FG001|Part B: Challenge Phase|Sponsor decision|0|||
162996023|NCT02542605|588685135|FG002|Part B: Challenge Phase|Sponsor decision|0|||
162996024|NCT02542605|588685133|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
162996025|NCT02542605|588685134|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
162996026|NCT02542605|588685135|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
162996027|NCT00278889|588685137|FG000|Overall Study|Withdrawal by Subject|0|||
162996028|NCT00278889|588685138|FG001|Overall Study|Withdrawal by Subject|5|||
163212663|NCT02669433|589492596|FG000|Overall Study|Death|0|||
162996029|NCT00278889|588685139|FG002|Overall Study|Withdrawal by Subject|3|||
162996030|NCT00278889|588685137|FG000|Overall Study|Lost to Follow-up|1|||
162996031|NCT00278889|588685138|FG001|Overall Study|Lost to Follow-up|1|||
162996032|NCT00278889|588685139|FG002|Overall Study|Lost to Follow-up|0|||
162996033|NCT00278889|588685137|FG000|Overall Study|Death|24|||
162996034|NCT00278889|588685138|FG001|Overall Study|Death|21|||
162996035|NCT00278889|588685139|FG002|Overall Study|Death|17|||
162996036|NCT00704730|588685140|FG000|Overall Study|Adverse Event|35|||
163212664|NCT02669433|589492597|FG001|Overall Study|Death|1|||
163212665|NCT02669433|589492598|FG002|Overall Study|Death|1|||
163212666|NCT00576927|589492599|FG000|Clinical Assessment|Lack of Efficacy|24|||
162996037|NCT00704730|588685141|FG001|Overall Study|Adverse Event|9|||
162996038|NCT00704730|588685140|FG000|Overall Study|Death|11|||
162996039|NCT00704730|588685141|FG001|Overall Study|Death|5|||
162996040|NCT00704730|588685140|FG000|Overall Study|Physician Decision|2|||
162996041|NCT00704730|588685141|FG001|Overall Study|Physician Decision|0|||
162996042|NCT00704730|588685140|FG000|Overall Study|Did not receive drug|5|||
163212667|NCT00576927|589492599|FG000|Clinical Assessment|Death|1|||
163212668|NCT00576927|589492599|FG000|Clinical Assessment|Withdrawal by Subject|10|||
163212669|NCT00576927|589492599|FG000|Clinical Assessment|Physician Decision|1|||
163212670|NCT00576927|589492599|FG000|Baseline|Physician Decision|9|||
162996043|NCT00704730|588685141|FG001|Overall Study|Did not receive drug|2|||
162996044|NCT00704730|588685140|FG000|Overall Study|Disease progression per PI|58|||
162996045|NCT00704730|588685141|FG001|Overall Study|Disease progression per PI|67|||
162996046|NCT00704730|588685140|FG000|Overall Study|data unavailable|1|||
162996047|NCT00704730|588685141|FG001|Overall Study|data unavailable|0|||
162996048|NCT00704730|588685140|FG000|Overall Study|Withdrawal by Subject|9|||
162996049|NCT00704730|588685141|FG001|Overall Study|Withdrawal by Subject|13|||
162996050|NCT05292183|588686696|FG000|Overall Study|Adverse Event|1|||
162996051|NCT05833139|588686697|FG000|Study Period 2|Adverse Event|1|||
163212671|NCT00576927|589492599|FG000|Baseline|Medication Change by PCP of subject|1|||
163212672|NCT00576927|589492599|FG000|Baseline|Withdrawal by Subject|3|||
163212673|NCT00576927|589492599|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
163212674|NCT00576927|589492599|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
163212675|NCT00576927|589492599|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
163212676|NCT00576927|589492599|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
163212677|NCT00576927|589492599|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
163212678|NCT01850524|589492603|FG000|Overall Study|Lost to Follow-up|5|||
163212679|NCT01850524|589492604|FG001|Overall Study|Lost to Follow-up|10|||
163212680|NCT01850524|589492603|FG000|Overall Study|Withdrawal by Subject|24|||
163212681|NCT01850524|589492604|FG001|Overall Study|Withdrawal by Subject|22|||
163212682|NCT01850524|589492603|FG000|Overall Study|Reason not Specified|142|||
163212683|NCT01850524|589492604|FG001|Overall Study|Reason not Specified|141|||
163212684|NCT02157298|589492605|FG000|Overall Study|Adverse Event|1|||
163212685|NCT02157298|589492606|FG001|Overall Study|Adverse Event|0|||
163212686|NCT02157298|589492605|FG000|Overall Study|Subject no longer meets study criteria|1|||
163212687|NCT02157298|589492606|FG001|Overall Study|Subject no longer meets study criteria|2|||
163212688|NCT02157298|589492605|FG000|Overall Study|Poor/Non-compliance|1|||
163212689|NCT02157298|589492606|FG001|Overall Study|Poor/Non-compliance|0|||
163212690|NCT02157298|589492605|FG000|Overall Study|Withdrawal by Subject|1|||
163212691|NCT02157298|589492606|FG001|Overall Study|Withdrawal by Subject|0|||
163212692|NCT04059094|589492607|FG000|Overall Study|Adverse Event|0|||
163212693|NCT04059094|589492608|FG001|Overall Study|Adverse Event|0|||
163212694|NCT04059094|589492609|FG002|Overall Study|Adverse Event|0|||
163212695|NCT04059094|589492610|FG003|Overall Study|Adverse Event|0|||
163212696|NCT04059094|589492611|FG004|Overall Study|Adverse Event|1|||
163212697|NCT04059094|589492607|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
162996052|NCT02017015|588686702|FG000|Overall Study|Adverse Event|9|||
162996053|NCT02017015|588686702|FG000|Overall Study|Withdrawal by Subject|21|||
162996054|NCT02017015|588686702|FG000|Overall Study|Death|4|||
162996055|NCT02017015|588686702|FG000|Overall Study|Progressive Disease|31|||
162996056|NCT02017015|588686702|FG000|Overall Study|Non-compliance with study drug|2|||
162996057|NCT02017015|588686702|FG000|Overall Study|Physician Decision|2|||
162996058|NCT01277601|588686703|FG000|Overall Study|Adverse Event|5|||
162996059|NCT01277601|588686704|FG001|Overall Study|Adverse Event|3|||
162996060|NCT01277601|588686705|FG002|Overall Study|Adverse Event|0|||
162996061|NCT01277601|588686706|FG003|Overall Study|Adverse Event|7|||
163212698|NCT04059094|589492608|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
162996062|NCT01277601|588686703|FG000|Overall Study|Withdrawal by Subject|18|||
163212699|NCT04059094|589492609|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
163212700|NCT04059094|589492610|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
163212701|NCT04059094|589492611|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
163212702|NCT01698801|589492616|FG000|Treatment Phase|Adverse Event|4|||
163212703|NCT01698801|589492616|FG000|Treatment Phase|Protocol Violation|1|||
163212704|NCT01698801|589492616|FG000|Treatment Phase|Other|4|||
163212705|NCT01698801|589492616|FG000|Treatment Phase|Withdrawal by Subject|1|||
163212706|NCT01698801|589492616|FG000|Treatment Phase|Disease progression|1|||
163212707|NCT01698801|589492616|FG000|Follow Up Phase|Withdrawal by Subject|1|||
163212708|NCT01698801|589492616|FG000|Follow Up Phase|Death|4|||
163212709|NCT00656474|589492617|FG000|Overall Study|Other Reason|1|||
163212710|NCT02062879|589492618|FG000|Overall Study|Withdrawal by Subject|4|||
162996063|NCT01277601|588686704|FG001|Overall Study|Withdrawal by Subject|21|||
162996064|NCT01277601|588686705|FG002|Overall Study|Withdrawal by Subject|8|||
162996065|NCT01277601|588686706|FG003|Overall Study|Withdrawal by Subject|17|||
163212711|NCT02062879|589492619|FG001|Overall Study|Withdrawal by Subject|1|||
163212712|NCT00665847|589492623|FG000|Overall Study|Adverse Event|8|||
163212713|NCT00665847|589492623|FG000|Overall Study|Withdrawal by Subject|2|||
162996066|NCT01277601|588686703|FG000|Overall Study|Lost to Follow-up|7|||
162996067|NCT01277601|588686704|FG001|Overall Study|Lost to Follow-up|9|||
162996068|NCT01277601|588686705|FG002|Overall Study|Lost to Follow-up|4|||
162996069|NCT01277601|588686706|FG003|Overall Study|Lost to Follow-up|2|||
162996070|NCT01277601|588686703|FG000|Overall Study|Physician Decision|3|||
162996071|NCT01277601|588686704|FG001|Overall Study|Physician Decision|5|||
162996072|NCT01277601|588686705|FG002|Overall Study|Physician Decision|1|||
162996073|NCT01277601|588686706|FG003|Overall Study|Physician Decision|6|||
162996074|NCT01277601|588686703|FG000|Overall Study|Pregnancy|2|||
162996075|NCT01277601|588686704|FG001|Overall Study|Pregnancy|2|||
162996076|NCT01277601|588686705|FG002|Overall Study|Pregnancy|4|||
162996077|NCT01277601|588686706|FG003|Overall Study|Pregnancy|1|||
162996078|NCT01277601|588686703|FG000|Overall Study|Noncompliance with Study Drug|1|||
162996079|NCT01277601|588686704|FG001|Overall Study|Noncompliance with Study Drug|3|||
162996080|NCT01277601|588686705|FG002|Overall Study|Noncompliance with Study Drug|2|||
162996081|NCT01277601|588686706|FG003|Overall Study|Noncompliance with Study Drug|0|||
162996082|NCT01277601|588686703|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
162996083|NCT01277601|588686704|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
162996084|NCT01277601|588686705|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
162996085|NCT01277601|588686706|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
162996086|NCT01277601|588686703|FG000|Overall Study|Protocol Violation|0|||
162996087|NCT01277601|588686704|FG001|Overall Study|Protocol Violation|2|||
162996088|NCT01277601|588686705|FG002|Overall Study|Protocol Violation|5|||
162996089|NCT01277601|588686706|FG003|Overall Study|Protocol Violation|0|||
162996090|NCT01277601|588686703|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
162996091|NCT01277601|588686704|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
162996092|NCT01277601|588686705|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
162996093|NCT01277601|588686706|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
162996094|NCT02260570|588686708|FG000|Overall Study|Withdrawal by Subject|2|||
162996095|NCT02260570|588686709|FG001|Overall Study|Withdrawal by Subject|1|||
162996096|NCT02260570|588686708|FG000|Overall Study|Physician Decision|1|||
162996097|NCT02260570|588686709|FG001|Overall Study|Physician Decision|1|||
162996098|NCT04034927|588686710|FG000|Overall Study|Adverse Event|4|||
162996099|NCT04034927|588686711|FG001|Overall Study|Adverse Event|9|||
162996100|NCT04034927|588686710|FG000|Overall Study|Death|0|||
162996101|NCT04034927|588686711|FG001|Overall Study|Death|1|||
162996102|NCT04034927|588686710|FG000|Overall Study|Withdrawal by Subject|0|||
162996103|NCT04034927|588686711|FG001|Overall Study|Withdrawal by Subject|3|||
162996104|NCT04034927|588686710|FG000|Overall Study|Still on Treatment|2|||
162996105|NCT04034927|588686711|FG001|Overall Study|Still on Treatment|1|||
162996106|NCT04034927|588686710|FG000|Overall Study|Other|1|||
162996107|NCT04034927|588686711|FG001|Overall Study|Other|1|||
162996108|NCT00094861|588686714|FG000|Overall Study|Adverse Event|5|||
162996109|NCT00094861|588686715|FG001|Overall Study|Adverse Event|2|||
162996110|NCT00094861|588686714|FG000|Overall Study|Withdrawal by Subject|5|||
162996111|NCT00094861|588686715|FG001|Overall Study|Withdrawal by Subject|3|||
162996112|NCT00094861|588686714|FG000|Overall Study|Physician Decision|1|||
162996113|NCT00094861|588686715|FG001|Overall Study|Physician Decision|1|||
162996114|NCT00094861|588686714|FG000|Overall Study|Lost to Follow-up|0|||
162996115|NCT00094861|588686715|FG001|Overall Study|Lost to Follow-up|1|||
162996116|NCT00094861|588686714|FG000|Overall Study|Death|4|||
162996117|NCT00094861|588686715|FG001|Overall Study|Death|2|||
162996118|NCT00094861|588686714|FG000|Overall Study|Other|3|||
162996119|NCT00094861|588686715|FG001|Overall Study|Other|0|||
162996120|NCT00264550|588686716|FG000|Overall Study|Death|0|||
162996121|NCT00264550|588686717|FG001|Overall Study|Death|3|||
162996122|NCT00264550|588686718|FG002|Overall Study|Death|0|||
162996123|NCT00264550|588686719|FG003|Overall Study|Death|0|||
162996124|NCT00264550|588686716|FG000|Overall Study|Lost to Follow-up|3|||
162996125|NCT00264550|588686717|FG001|Overall Study|Lost to Follow-up|1|||
162996126|NCT00264550|588686718|FG002|Overall Study|Lost to Follow-up|1|||
162996127|NCT00264550|588686719|FG003|Overall Study|Lost to Follow-up|1|||
162996128|NCT00264550|588686716|FG000|Overall Study|Adverse Event|23|||
162996129|NCT00264550|588686717|FG001|Overall Study|Adverse Event|18|||
162996130|NCT00264550|588686718|FG002|Overall Study|Adverse Event|9|||
163060345|NCT01140906|588929864|FG000|Overall Study|Withdrawal of consent|6|||
163060346|NCT01140906|588929865|FG001|Overall Study|Withdrawal of consent|6|||
163060347|NCT01140906|588929866|FG002|Overall Study|Withdrawal of consent|2|||
163060348|NCT01140906|588929867|FG003|Overall Study|Withdrawal of consent|2|||
163060349|NCT01140906|588929864|FG000|Overall Study|Lost to Follow-up|1|||
163060350|NCT01140906|588929865|FG001|Overall Study|Lost to Follow-up|1|||
163060351|NCT01140906|588929866|FG002|Overall Study|Lost to Follow-up|0|||
163060352|NCT01140906|588929867|FG003|Overall Study|Lost to Follow-up|2|||
162996131|NCT00264550|588686719|FG003|Overall Study|Adverse Event|14|||
162996132|NCT00264550|588686716|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
162996133|NCT00264550|588686717|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
162996134|NCT00264550|588686718|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
162996135|NCT00264550|588686719|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
162996136|NCT00264550|588686716|FG000|Overall Study|Discontinued oral study agent|0|||
163060353|NCT01140906|588929864|FG000|Overall Study|Administrative or other reason|0|||
162996137|NCT00264550|588686717|FG001|Overall Study|Discontinued oral study agent|1|||
162996138|NCT00264550|588686718|FG002|Overall Study|Discontinued oral study agent|0|||
162996139|NCT00264550|588686719|FG003|Overall Study|Discontinued oral study agent|0|||
162996140|NCT00264550|588686716|FG000|Overall Study|Other|13|||
162996141|NCT00264550|588686717|FG001|Overall Study|Other|7|||
162996142|NCT00264550|588686718|FG002|Overall Study|Other|3|||
162996143|NCT00264550|588686719|FG003|Overall Study|Other|9|||
162996144|NCT02129608|588686720|FG000|Overall Study|Lost to Follow-up|0|||
162996145|NCT02129608|588686721|FG001|Overall Study|Lost to Follow-up|1|||
162996146|NCT02129608|588686722|FG002|Overall Study|Lost to Follow-up|1|||
162996147|NCT02129608|588686720|FG000|Overall Study|Withdrawal by Subject|0|||
162996148|NCT02129608|588686721|FG001|Overall Study|Withdrawal by Subject|0|||
162996149|NCT02129608|588686722|FG002|Overall Study|Withdrawal by Subject|2|||
162996150|NCT00451204|588686724|FG000|Overall Study|Adverse Event|4|||
162996151|NCT00451204|588686725|FG001|Overall Study|Adverse Event|6|||
162996152|NCT00451204|588686724|FG000|Overall Study|Lack of Efficacy|4|||
162996153|NCT00451204|588686725|FG001|Overall Study|Lack of Efficacy|4|||
162996154|NCT00451204|588686724|FG000|Overall Study|Lost to Follow-up|4|||
162996155|NCT00451204|588686725|FG001|Overall Study|Lost to Follow-up|4|||
162996156|NCT00451204|588686724|FG000|Overall Study|Protocol Violation|1|||
162996157|NCT00451204|588686725|FG001|Overall Study|Protocol Violation|0|||
162996158|NCT00451204|588686724|FG000|Overall Study|Patient refusal|8|||
162996159|NCT00451204|588686725|FG001|Overall Study|Patient refusal|4|||
162996160|NCT00451204|588686724|FG000|Overall Study|Other|1|||
162996161|NCT00451204|588686725|FG001|Overall Study|Other|2|||
162996162|NCT01422187|588686728|FG000|Overall Study|Personal reason|1|||
162996163|NCT01422187|588686729|FG001|Overall Study|Personal reason|0|||
162996164|NCT01422187|588686730|FG002|Overall Study|Personal reason|0|||
162996165|NCT01422187|588686728|FG000|Overall Study|Lost to Follow-up|0|||
162996166|NCT01422187|588686729|FG001|Overall Study|Lost to Follow-up|1|||
162996167|NCT01422187|588686730|FG002|Overall Study|Lost to Follow-up|0|||
162996168|NCT00741286|588686736|FG000|Overall Study|Lost to Follow-up|15|||
162996169|NCT00741286|588686737|FG001|Overall Study|Lost to Follow-up|10|||
162996170|NCT00741286|588686736|FG000|Overall Study|Adverse Event|1|||
162996171|NCT00741286|588686737|FG001|Overall Study|Adverse Event|6|||
162996172|NCT00741286|588686736|FG000|Overall Study|Protocol Violation|3|||
162996173|NCT00741286|588686737|FG001|Overall Study|Protocol Violation|2|||
162996174|NCT00741286|588686736|FG000|Overall Study|Primary Outcome|1|||
162996175|NCT00741286|588686737|FG001|Overall Study|Primary Outcome|1|||
162996176|NCT00425373|588686746|FG000|Overall Study|Adverse Event|2|||
162996177|NCT00425373|588686747|FG001|Overall Study|Adverse Event|2|||
162996178|NCT00425373|588686748|FG002|Overall Study|Adverse Event|0|||
162996179|NCT00425373|588686749|FG003|Overall Study|Adverse Event|1|||
162996180|NCT00425373|588686750|FG004|Overall Study|Adverse Event|4|||
162996181|NCT00425373|588686751|FG005|Overall Study|Adverse Event|6|||
162996182|NCT00425373|588686752|FG006|Overall Study|Adverse Event|2|||
162996183|NCT00425373|588686753|FG007|Overall Study|Adverse Event|3|||
162996184|NCT00425373|588686754|FG008|Overall Study|Adverse Event|8|||
162996185|NCT00425373|588686746|FG000|Overall Study|Lost to Follow-up|0|||
162996186|NCT00425373|588686747|FG001|Overall Study|Lost to Follow-up|1|||
162996187|NCT00425373|588686748|FG002|Overall Study|Lost to Follow-up|0|||
162996188|NCT00425373|588686749|FG003|Overall Study|Lost to Follow-up|0|||
162996189|NCT00425373|588686750|FG004|Overall Study|Lost to Follow-up|1|||
162996190|NCT00425373|588686751|FG005|Overall Study|Lost to Follow-up|0|||
162996191|NCT00425373|588686752|FG006|Overall Study|Lost to Follow-up|0|||
162996192|NCT00425373|588686753|FG007|Overall Study|Lost to Follow-up|0|||
162996193|NCT00425373|588686754|FG008|Overall Study|Lost to Follow-up|0|||
162996194|NCT00425373|588686746|FG000|Overall Study|Protocol Violation|1|||
162996195|NCT00425373|588686747|FG001|Overall Study|Protocol Violation|0|||
162996196|NCT00425373|588686748|FG002|Overall Study|Protocol Violation|1|||
162996197|NCT00425373|588686749|FG003|Overall Study|Protocol Violation|0|||
163060354|NCT01140906|588929865|FG001|Overall Study|Administrative or other reason|5|||
163060355|NCT01140906|588929866|FG002|Overall Study|Administrative or other reason|3|||
163060356|NCT01140906|588929867|FG003|Overall Study|Administrative or other reason|2|||
163060357|NCT01649765|588929868|FG000|Overall Study|Adverse Event|5|||
163060358|NCT01649765|588929869|FG001|Overall Study|Adverse Event|3|||
162996198|NCT00425373|588686750|FG004|Overall Study|Protocol Violation|0|||
162996199|NCT00425373|588686751|FG005|Overall Study|Protocol Violation|0|||
162996200|NCT00425373|588686752|FG006|Overall Study|Protocol Violation|0|||
163324843|NCT03333915|589900693|FG001|Overall Study|Disease Progression|1|||
162996201|NCT00425373|588686753|FG007|Overall Study|Protocol Violation|5|||
162996202|NCT00425373|588686754|FG008|Overall Study|Protocol Violation|3|||
162996203|NCT00425373|588686746|FG000|Overall Study|Withdrawal by Subject|2|||
162996204|NCT00425373|588686747|FG001|Overall Study|Withdrawal by Subject|0|||
162996205|NCT00425373|588686748|FG002|Overall Study|Withdrawal by Subject|2|||
163060359|NCT01649765|588929868|FG000|Overall Study|Lack of Efficacy|1|||
162996206|NCT00425373|588686749|FG003|Overall Study|Withdrawal by Subject|1|||
162996207|NCT00425373|588686750|FG004|Overall Study|Withdrawal by Subject|4|||
162996208|NCT00425373|588686751|FG005|Overall Study|Withdrawal by Subject|0|||
162996209|NCT00425373|588686752|FG006|Overall Study|Withdrawal by Subject|2|||
162996210|NCT00425373|588686753|FG007|Overall Study|Withdrawal by Subject|2|||
162996211|NCT00425373|588686754|FG008|Overall Study|Withdrawal by Subject|2|||
162996212|NCT00425373|588686746|FG000|Overall Study|Lack of Efficacy|0|||
162996213|NCT00425373|588686747|FG001|Overall Study|Lack of Efficacy|0|||
162996214|NCT00425373|588686748|FG002|Overall Study|Lack of Efficacy|0|||
162996215|NCT00425373|588686749|FG003|Overall Study|Lack of Efficacy|0|||
162996216|NCT00425373|588686750|FG004|Overall Study|Lack of Efficacy|1|||
162996217|NCT00425373|588686751|FG005|Overall Study|Lack of Efficacy|3|||
162996218|NCT00425373|588686752|FG006|Overall Study|Lack of Efficacy|3|||
162996219|NCT00425373|588686753|FG007|Overall Study|Lack of Efficacy|0|||
162996220|NCT00425373|588686754|FG008|Overall Study|Lack of Efficacy|5|||
162996221|NCT00582010|588686762|FG000|Overall Study|Death|0|||
162996222|NCT00582010|588686763|FG001|Overall Study|Death|1|||
162996223|NCT05320887|588686769|FG000|Overall Study|Lost to Follow-up|0|||
162996224|NCT05320887|588686770|FG001|Overall Study|Lost to Follow-up|3|||
162996225|NCT05320887|588686771|FG002|Overall Study|Lost to Follow-up|0|||
162996226|NCT05320887|588686772|FG003|Overall Study|Lost to Follow-up|0|||
162996227|NCT02463357|588686773|FG000|Overall Study|Withdrawal by Subject|1|||
162996228|NCT02463357|588686774|FG001|Overall Study|Withdrawal by Subject|0|||
162996229|NCT02463357|588686775|FG002|Overall Study|Withdrawal by Subject|0|||
162996230|NCT02463357|588686776|FG003|Overall Study|Withdrawal by Subject|0|||
162996231|NCT02463357|588686777|FG004|Overall Study|Withdrawal by Subject|0|||
162996232|NCT02463357|588686773|FG000|Overall Study|Withdrawal by Subject|0|||
162996233|NCT02463357|588686774|FG001|Overall Study|Withdrawal by Subject|0|||
162996234|NCT02463357|588686775|FG002|Overall Study|Withdrawal by Subject|0|||
162996235|NCT02463357|588686776|FG003|Overall Study|Withdrawal by Subject|0|||
162996236|NCT02463357|588686777|FG004|Overall Study|Withdrawal by Subject|1|||
162996237|NCT02620579|588686778|FG000|Overall Study|Physician Decision|0|||
162996238|NCT02620579|588686779|FG001|Overall Study|Physician Decision|0|||
162996239|NCT02620579|588686780|FG002|Overall Study|Physician Decision|0|||
162996240|NCT02620579|588686781|FG003|Overall Study|Physician Decision|1|||
162996241|NCT02620579|588686778|FG000|Overall Study|Withdrawal by Subject|0|||
162996242|NCT02620579|588686779|FG001|Overall Study|Withdrawal by Subject|1|||
162996243|NCT02620579|588686780|FG002|Overall Study|Withdrawal by Subject|1|||
162996244|NCT02620579|588686781|FG003|Overall Study|Withdrawal by Subject|0|||
162996245|NCT01721317|588686782|FG000|Overall Study|Study Closed / Terminated|2|||
162996246|NCT01721317|588686783|FG001|Overall Study|Study Closed / Terminated|2|||
162996247|NCT01721317|588686782|FG000|Overall Study|Physician Decision|0|||
162996248|NCT01721317|588686783|FG001|Overall Study|Physician Decision|1|||
162996249|NCT01721317|588686782|FG000|Overall Study|Withdrawal by Subject|0|||
162996250|NCT01721317|588686783|FG001|Overall Study|Withdrawal by Subject|1|||
162996251|NCT02661217|588686789|FG000|Overall Study|Physician Decision|12|||
162996252|NCT02661217|588686790|FG001|Overall Study|Physician Decision|15|||
162996253|NCT02661217|588686789|FG000|Overall Study|Lost to Follow-up|1|||
162996254|NCT02661217|588686790|FG001|Overall Study|Lost to Follow-up|4|||
162996255|NCT02661217|588686789|FG000|Overall Study|Protocol Deviation|0|||
162996256|NCT02661217|588686790|FG001|Overall Study|Protocol Deviation|4|||
162996257|NCT02661217|588686789|FG000|Overall Study|Non-compliance with study treatment|5|||
162996258|NCT02661217|588686790|FG001|Overall Study|Non-compliance with study treatment|5|||
162996259|NCT02661217|588686789|FG000|Overall Study|Death|21|||
162996260|NCT02661217|588686790|FG001|Overall Study|Death|15|||
162996261|NCT02661217|588686789|FG000|Overall Study|Adverse Event|10|||
162996262|NCT02661217|588686790|FG001|Overall Study|Adverse Event|8|||
162996263|NCT02661217|588686789|FG000|Overall Study|Withdrawal by Subject|15|||
162996264|NCT02661217|588686790|FG001|Overall Study|Withdrawal by Subject|19|||
162996265|NCT02661217|588686789|FG000|Overall Study|Did not enter follow-up epoch|7|||
162996266|NCT02661217|588686790|FG001|Overall Study|Did not enter follow-up epoch|10|||
162996267|NCT02661217|588686789|FG000|Overall Study|Death - no study drug received|1|||
162996268|NCT02661217|588686790|FG001|Overall Study|Death - no study drug received|2|||
162996269|NCT02661217|588686789|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
162996270|NCT02661217|588686790|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
162996271|NCT00958893|588686791|FG000|Overall Study|Study prematurely terminated|4|||
162996272|NCT00378573|588686793|FG000|Treatment Period|Adverse Event|9|||
162996273|NCT00378573|588686793|FG000|Treatment Period|Physician Decision|1|||
162996274|NCT00378573|588686793|FG000|Treatment Period|Withdrawal by Subject|2|||
162996275|NCT00378573|588686793|FG000|Treatment Period|Disease Progression|4|||
162996276|NCT00378573|588686793|FG000|Treatment Period|Sponsor decision to close study|1|||
162996277|NCT00378573|588686793|FG000|Follow-up|Death|12|||
162996278|NCT00378573|588686793|FG000|Follow-up|Lost to Follow-up|1|||
162996279|NCT00378573|588686793|FG000|Follow-up|Withdrawal by Subject|1|||
162996280|NCT02892149|588686796|FG000|Overall Study|Death|262|||
162996281|NCT02892149|588686797|FG001|Overall Study|Death|278|||
162996282|NCT02892149|588686796|FG000|Overall Study|Withdrawal by Subject|53|||
162996283|NCT02892149|588686797|FG001|Overall Study|Withdrawal by Subject|47|||
162996284|NCT02892149|588686796|FG000|Overall Study|Lost to Follow-up|37|||
162996285|NCT02892149|588686797|FG001|Overall Study|Lost to Follow-up|31|||
162996286|NCT02165735|588686802|FG000|Overall Study|Lost to Follow-up|12|||
162996287|NCT02165735|588686803|FG001|Overall Study|Lost to Follow-up|10|||
162996288|NCT02165735|588686802|FG000|Overall Study|Withdrawal by Subject|3|||
162996289|NCT02165735|588686803|FG001|Overall Study|Withdrawal by Subject|0|||
162996290|NCT02165735|588686802|FG000|Overall Study|Participant indicated lack of time|1|||
162996291|NCT02165735|588686803|FG001|Overall Study|Participant indicated lack of time|3|||
162996292|NCT02165735|588686802|FG000|Overall Study|Protocol Violation|0|||
162996293|NCT02165735|588686803|FG001|Overall Study|Protocol Violation|1|||
162996294|NCT03066258|588686804|FG000|Overall Study|Death|1|||
162996295|NCT03066258|588686805|FG001|Overall Study|Death|0|||
162996296|NCT03066258|588686806|FG002|Overall Study|Death|0|||
162996297|NCT03066258|588686807|FG003|Overall Study|Death|0|||
162996298|NCT03066258|588686808|FG004|Overall Study|Death|1|||
162996299|NCT02784795|588686809|FG000|Overall Study|Progressive Disease|2|||
162996300|NCT02784795|588686810|FG001|Overall Study|Progressive Disease|1|||
162996301|NCT02784795|588686811|FG002|Overall Study|Progressive Disease|1|||
162996302|NCT02784795|588686812|FG003|Overall Study|Progressive Disease|0|||
162996303|NCT02784795|588686813|FG004|Overall Study|Progressive Disease|2|||
162996304|NCT02784795|588686814|FG005|Overall Study|Progressive Disease|0|||
162996305|NCT02784795|588686815|FG006|Overall Study|Progressive Disease|2|||
162996306|NCT02784795|588686816|FG007|Overall Study|Progressive Disease|0|||
162996307|NCT02784795|588686817|FG008|Overall Study|Progressive Disease|0|||
162996308|NCT02784795|588686818|FG009|Overall Study|Progressive Disease|0|||
162996309|NCT02784795|588686819|FG010|Overall Study|Progressive Disease|1|||
162996310|NCT02784795|588686820|FG011|Overall Study|Progressive Disease|0|||
162996311|NCT02784795|588686809|FG000|Overall Study|Adverse Event|1|||
162996312|NCT02784795|588686810|FG001|Overall Study|Adverse Event|0|||
162996313|NCT02784795|588686811|FG002|Overall Study|Adverse Event|0|||
162996314|NCT02784795|588686812|FG003|Overall Study|Adverse Event|1|||
162996315|NCT02784795|588686813|FG004|Overall Study|Adverse Event|0|||
162996316|NCT02784795|588686814|FG005|Overall Study|Adverse Event|0|||
162996317|NCT02784795|588686815|FG006|Overall Study|Adverse Event|1|||
162996318|NCT02784795|588686816|FG007|Overall Study|Adverse Event|0|||
162996319|NCT02784795|588686817|FG008|Overall Study|Adverse Event|0|||
162996320|NCT02784795|588686818|FG009|Overall Study|Adverse Event|0|||
162996321|NCT02784795|588686819|FG010|Overall Study|Adverse Event|0|||
162996322|NCT02784795|588686820|FG011|Overall Study|Adverse Event|2|||
162996323|NCT02784795|588686809|FG000|Overall Study|Withdrawal by Subject|1|||
162996324|NCT02784795|588686810|FG001|Overall Study|Withdrawal by Subject|0|||
162996325|NCT02784795|588686811|FG002|Overall Study|Withdrawal by Subject|2|||
162996326|NCT02784795|588686812|FG003|Overall Study|Withdrawal by Subject|1|||
162996327|NCT02784795|588686813|FG004|Overall Study|Withdrawal by Subject|3|||
162996328|NCT02784795|588686814|FG005|Overall Study|Withdrawal by Subject|0|||
162996329|NCT02784795|588686815|FG006|Overall Study|Withdrawal by Subject|0|||
162996330|NCT02784795|588686816|FG007|Overall Study|Withdrawal by Subject|1|||
162996331|NCT02784795|588686817|FG008|Overall Study|Withdrawal by Subject|0|||
162996332|NCT02784795|588686818|FG009|Overall Study|Withdrawal by Subject|0|||
162996333|NCT02784795|588686819|FG010|Overall Study|Withdrawal by Subject|0|||
162996334|NCT02784795|588686820|FG011|Overall Study|Withdrawal by Subject|2|||
162996335|NCT02784795|588686809|FG000|Overall Study|Death|0|||
162996336|NCT02784795|588686810|FG001|Overall Study|Death|0|||
162996337|NCT02784795|588686811|FG002|Overall Study|Death|0|||
162996338|NCT02784795|588686812|FG003|Overall Study|Death|0|||
162996339|NCT02784795|588686813|FG004|Overall Study|Death|1|||
162996340|NCT02784795|588686814|FG005|Overall Study|Death|0|||
162996341|NCT02784795|588686815|FG006|Overall Study|Death|0|||
162996342|NCT02784795|588686816|FG007|Overall Study|Death|0|||
162996343|NCT02784795|588686817|FG008|Overall Study|Death|0|||
163324844|NCT03333915|589900694|FG002|Overall Study|Disease Progression|0|||
163324845|NCT03333915|589900695|FG003|Overall Study|Disease Progression|0|||
163324846|NCT03333915|589900696|FG004|Overall Study|Disease Progression|0|||
163324847|NCT03333915|589900692|FG000|Overall Study|Death|0|||
163324848|NCT03333915|589900693|FG001|Overall Study|Death|0|||
163324849|NCT03333915|589900694|FG002|Overall Study|Death|0|||
162996344|NCT02784795|588686818|FG009|Overall Study|Death|0|||
162996345|NCT02784795|588686819|FG010|Overall Study|Death|0|||
162996346|NCT02784795|588686820|FG011|Overall Study|Death|0|||
162996347|NCT02784795|588686809|FG000|Overall Study|Physician Decision|0|||
162996348|NCT02784795|588686810|FG001|Overall Study|Physician Decision|0|||
162996349|NCT02784795|588686811|FG002|Overall Study|Physician Decision|0|||
162996350|NCT02784795|588686812|FG003|Overall Study|Physician Decision|0|||
162996351|NCT02784795|588686813|FG004|Overall Study|Physician Decision|0|||
162996352|NCT02784795|588686814|FG005|Overall Study|Physician Decision|0|||
162996353|NCT02784795|588686815|FG006|Overall Study|Physician Decision|1|||
162996354|NCT02784795|588686816|FG007|Overall Study|Physician Decision|0|||
162996355|NCT02784795|588686817|FG008|Overall Study|Physician Decision|0|||
162996356|NCT02784795|588686818|FG009|Overall Study|Physician Decision|0|||
162996357|NCT02784795|588686819|FG010|Overall Study|Physician Decision|0|||
162996358|NCT02784795|588686820|FG011|Overall Study|Physician Decision|0|||
163324850|NCT03333915|589900695|FG003|Overall Study|Death|37|||
163324851|NCT03333915|589900696|FG004|Overall Study|Death|18|||
163324852|NCT03333915|589900692|FG000|Overall Study|Sponsor's Decision|0|||
163324853|NCT03333915|589900693|FG001|Overall Study|Sponsor's Decision|0|||
162996359|NCT00101283|588686821|FG000|Overall Study|Withdrawal by Subject|0|||
162996360|NCT00101283|588686822|FG001|Overall Study|Withdrawal by Subject|1|||
162996361|NCT00101283|588686821|FG000|Overall Study|Insurance Refusal|0|||
162996362|NCT00101283|588686822|FG001|Overall Study|Insurance Refusal|1|||
162996363|NCT00101283|588686821|FG000|Overall Study|Prostate Cancer Recurrence|0|||
162996364|NCT00101283|588686822|FG001|Overall Study|Prostate Cancer Recurrence|1|||
162996365|NCT00595309|588686823|FG000|Overall Study|Lost to Follow-up|1|||
162996366|NCT00595309|588686823|FG000|Overall Study|planned vaccination against yellow fever|1|||
162996367|NCT00595309|588686823|FG000|Overall Study|acute infection after V0|1|||
162996368|NCT00595309|588686823|FG000|Overall Study|personal reason|1|||
162996369|NCT00252239|588686829|FG000|Overall Study|Withdrawal by Subject|1|||
162996370|NCT00252239|588686830|FG001|Overall Study|Withdrawal by Subject|0|||
162996371|NCT00252239|588686831|FG002|Overall Study|Withdrawal by Subject|0|||
162996372|NCT00252239|588686832|FG003|Overall Study|Withdrawal by Subject|1|||
162996373|NCT00252239|588686829|FG000|Overall Study|Lost to Follow-up|0|||
162996374|NCT00252239|588686830|FG001|Overall Study|Lost to Follow-up|0|||
162996375|NCT00252239|588686831|FG002|Overall Study|Lost to Follow-up|2|||
162996376|NCT00252239|588686832|FG003|Overall Study|Lost to Follow-up|0|||
162996377|NCT02181790|588686837|FG000|Overall Study|study terminated|2|||
162996378|NCT02181790|588686838|FG001|Overall Study|study terminated|0|||
162996379|NCT03276078|588686839|FG000|Overall Study|Adverse Event|1|||
162996380|NCT02785952|588686840|FG000|Overall Study|Adverse Event|31|||
162996381|NCT02785952|588686841|FG001|Overall Study|Adverse Event|19|||
162996382|NCT02785952|588686840|FG000|Overall Study|Refusal unrelated to adverse events|10|||
162996383|NCT02785952|588686841|FG001|Overall Study|Refusal unrelated to adverse events|5|||
162996384|NCT02785952|588686840|FG000|Overall Study|Disease progression/relapse|61|||
162996385|NCT02785952|588686841|FG001|Overall Study|Disease progression/relapse|89|||
162996386|NCT02785952|588686840|FG000|Overall Study|Death|11|||
162996387|NCT02785952|588686841|FG001|Overall Study|Death|7|||
162996388|NCT02785952|588686840|FG000|Overall Study|Other- not protocol specified|6|||
162996389|NCT02785952|588686841|FG001|Overall Study|Other- not protocol specified|4|||
162996390|NCT02785952|588686840|FG000|Overall Study|On protocol treatment|6|||
162996391|NCT02785952|588686841|FG001|Overall Study|On protocol treatment|3|||
162996392|NCT00090363|588686842|FG000|Overall Study|Lost to Follow-up|1|||
162996393|NCT00090363|588686843|FG001|Overall Study|Lost to Follow-up|2|||
162996394|NCT00090363|588686844|FG002|Overall Study|Lost to Follow-up|1|||
162996395|NCT00090363|588686842|FG000|Overall Study|Withdrawal by Subject|7|||
162996396|NCT00090363|588686843|FG001|Overall Study|Withdrawal by Subject|7|||
162996397|NCT00090363|588686844|FG002|Overall Study|Withdrawal by Subject|6|||
162996398|NCT00090363|588686842|FG000|Overall Study|Study-specific discontinuation criteria|75|||
162996399|NCT00090363|588686843|FG001|Overall Study|Study-specific discontinuation criteria|74|||
162996400|NCT00090363|588686844|FG002|Overall Study|Study-specific discontinuation criteria|62|||
162996401|NCT00090363|588686842|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162996402|NCT00090363|588686843|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162996403|NCT00090363|588686844|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
162996404|NCT00090363|588686842|FG000|Overall Study|Consent expired|7|||
162996405|NCT00090363|588686843|FG001|Overall Study|Consent expired|10|||
162996406|NCT00090363|588686844|FG002|Overall Study|Consent expired|9|||
162996407|NCT00090363|588686842|FG000|Overall Study|Reasons not specified|2|||
162996408|NCT00090363|588686843|FG001|Overall Study|Reasons not specified|1|||
162996409|NCT00090363|588686844|FG002|Overall Study|Reasons not specified|1|||
162996410|NCT00090363|588686842|FG000|Overall Study|Continuing on study off treatment|14|||
162996411|NCT00090363|588686843|FG001|Overall Study|Continuing on study off treatment|13|||
162996412|NCT00090363|588686844|FG002|Overall Study|Continuing on study off treatment|16|||
162996413|NCT00205803|588686848|FG000|Infant Series|Lost to Follow-up|10|||
162996414|NCT00205803|588686849|FG001|Infant Series|Lost to Follow-up|4|||
162996415|NCT00205803|588686848|FG000|Infant Series|Withdrawal by Subject|2|||
162996416|NCT00205803|588686849|FG001|Infant Series|Withdrawal by Subject|5|||
162996417|NCT00205803|588686848|FG000|Infant Series|Physician Decision|3|||
162996418|NCT00205803|588686849|FG001|Infant Series|Physician Decision|1|||
162996419|NCT00205803|588686848|FG000|Infant Series|Protocol Violation|1|||
162996420|NCT00205803|588686849|FG001|Infant Series|Protocol Violation|0|||
162996421|NCT00205803|588686848|FG000|Infant Series|Lost Kaiser coverage|0|||
163212714|NCT00665847|589492623|FG000|Overall Study|Subject non-compliant|8|||
162996422|NCT00205803|588686849|FG001|Infant Series|Lost Kaiser coverage|1|||
162996423|NCT00205803|588686848|FG000|Infant Series|Non-compliant|1|||
162996424|NCT00205803|588686849|FG001|Infant Series|Non-compliant|0|||
162996425|NCT00205803|588686848|FG000|Infant Series|Sponsor request|1|||
162996426|NCT00205803|588686849|FG001|Infant Series|Sponsor request|0|||
162996427|NCT00205803|588686848|FG000|After Infant Series|Adverse Event|1|||
163212715|NCT00665847|589492623|FG000|Overall Study|Subject reached a virologic endpoint|4|||
163212716|NCT00665847|589492623|FG000|Overall Study|Resistance to TMC125|1|||
163212717|NCT00665847|589492623|FG000|Overall Study|Subject ineligible to continue the trial|1|||
162996428|NCT00205803|588686849|FG001|After Infant Series|Adverse Event|1|||
162996429|NCT00205803|588686848|FG000|After Infant Series|Protocol Violation|1|||
162996430|NCT00205803|588686849|FG001|After Infant Series|Protocol Violation|1|||
162996431|NCT00205803|588686848|FG000|After Infant Series|Lost to Follow-up|2|||
162996432|NCT00205803|588686849|FG001|After Infant Series|Lost to Follow-up|1|||
162996433|NCT00205803|588686848|FG000|After Infant Series|Physician Decision|3|||
163060360|NCT01649765|588929869|FG001|Overall Study|Lack of Efficacy|1|||
163060361|NCT01649765|588929868|FG000|Overall Study|Physician Decision|0|||
163060362|NCT01649765|588929869|FG001|Overall Study|Physician Decision|3|||
163060363|NCT01649765|588929868|FG000|Overall Study|Protocol Violation|1|||
163060364|NCT01649765|588929869|FG001|Overall Study|Protocol Violation|0|||
162996434|NCT00205803|588686849|FG001|After Infant Series|Physician Decision|2|||
162996435|NCT00205803|588686848|FG000|After Infant Series|Withdrawal by Subject|1|||
162996436|NCT00205803|588686849|FG001|After Infant Series|Withdrawal by Subject|4|||
162996437|NCT00205803|588686848|FG000|After Infant Series|Other|10|||
162996438|NCT00205803|588686849|FG001|After Infant Series|Other|4|||
162996439|NCT00205803|588686848|FG000|Toddler Dose|Lost to Follow-up|2|||
162996440|NCT00205803|588686849|FG001|Toddler Dose|Lost to Follow-up|3|||
162996441|NCT02478320|588686851|FG000|Overall Study|Adverse Event|2|||
162996442|NCT02478320|588686852|FG001|Overall Study|Adverse Event|0|||
162996443|NCT02478320|588686851|FG000|Overall Study|Death|1|||
162996444|NCT02478320|588686852|FG001|Overall Study|Death|0|||
162996445|NCT02478320|588686851|FG000|Overall Study|Lack of Efficacy|4|||
162996446|NCT02478320|588686852|FG001|Overall Study|Lack of Efficacy|0|||
162996447|NCT02478320|588686851|FG000|Overall Study|Withdrawal by Subject|2|||
162996448|NCT02478320|588686852|FG001|Overall Study|Withdrawal by Subject|0|||
162996449|NCT02478320|588686851|FG000|Overall Study|Screen Failure|3|||
162996450|NCT02478320|588686852|FG001|Overall Study|Screen Failure|0|||
162996451|NCT02847260|588688035|FG000|Overall Study|Adverse Event|3|||
162996452|NCT02847260|588688035|FG000|Overall Study|Withdrawal by Subject|2|||
162996453|NCT02847260|588688035|FG000|Overall Study|Clinical Deterioration|1|||
162996454|NCT02847260|588688035|FG000|Overall Study|Physician Decision|1|||
162996455|NCT03104400|588688036|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
162996456|NCT03104400|588688037|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
162996457|NCT03104400|588688038|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
162996458|NCT03104400|588688039|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
162996459|NCT03104400|588688040|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
162996460|NCT03104400|588688041|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
162996461|NCT03104400|588688042|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
162996462|NCT03104400|588688043|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
162996463|NCT03104400|588688044|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
162996464|NCT03104400|588688045|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
162996465|NCT03104400|588688036|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
162996466|NCT03104400|588688037|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
162996467|NCT03104400|588688038|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
162996468|NCT03104400|588688039|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
162996469|NCT03104400|588688040|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
162996470|NCT03104400|588688041|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
162996471|NCT03104400|588688042|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
162996472|NCT03104400|588688043|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
162996473|NCT03104400|588688044|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
162996474|NCT03104400|588688045|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
162996475|NCT03104400|588688036|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
162996476|NCT03104400|588688037|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
162996477|NCT03104400|588688038|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
162996478|NCT03104400|588688039|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
162996479|NCT03104400|588688040|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
162996480|NCT03104400|588688041|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
162996481|NCT03104400|588688042|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
162996482|NCT03104400|588688043|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
162996483|NCT03104400|588688044|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
162996484|NCT03104400|588688045|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
163060365|NCT01649765|588929868|FG000|Overall Study|Withdrawal by Subject|2|||
163060366|NCT01649765|588929869|FG001|Overall Study|Withdrawal by Subject|1|||
163060367|NCT02469233|588929870|FG000|Overall Study|Death|1|||
163060368|NCT02469233|588929871|FG001|Overall Study|Death|1|||
162996485|NCT03104400|588688036|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
162996486|NCT03104400|588688037|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
162996487|NCT03104400|588688038|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
162996488|NCT03104400|588688039|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
162996489|NCT03104400|588688040|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
162996490|NCT03104400|588688041|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
162996491|NCT03104400|588688042|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
162996492|NCT03104400|588688043|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
163060369|NCT02469233|588929870|FG000|Overall Study|Lost to post or 6 month follow up|7|||
163060370|NCT02469233|588929871|FG001|Overall Study|Lost to post or 6 month follow up|2|||
162996493|NCT03104400|588688044|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
162996494|NCT03104400|588688045|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
163060371|NCT04889040|588929872|FG000|Overall Study|Withdrawal by Subject|3|||
162996495|NCT03104400|588688036|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996496|NCT03104400|588688037|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996497|NCT03104400|588688038|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996498|NCT03104400|588688039|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
162996499|NCT03104400|588688040|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996500|NCT03104400|588688041|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996501|NCT03104400|588688042|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996502|NCT03104400|588688043|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996503|NCT03104400|588688044|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996504|NCT03104400|588688045|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996505|NCT03104400|588688036|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
162996506|NCT03104400|588688037|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
162996507|NCT03104400|588688038|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
162996508|NCT03104400|588688039|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
162996509|NCT03104400|588688040|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
162996510|NCT03104400|588688041|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
162996511|NCT03104400|588688042|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
162996512|NCT03104400|588688043|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
162996513|NCT03104400|588688044|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
162996514|NCT03104400|588688045|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
162996515|NCT03104400|588688036|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996516|NCT03104400|588688037|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996517|NCT03104400|588688038|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996518|NCT03104400|588688039|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
162996519|NCT03104400|588688040|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996520|NCT03104400|588688041|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996521|NCT03104400|588688042|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996522|NCT03104400|588688043|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996523|NCT03104400|588688044|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996524|NCT03104400|588688045|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996525|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
162996526|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
162996527|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
162996528|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
162996529|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
162996530|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
162996531|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
162996532|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
162996533|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
162996534|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
162996535|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
162996536|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
162996537|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
162996538|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
162996539|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
162996540|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
162996541|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
162996542|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
162996543|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
162996544|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
163324854|NCT03333915|589900694|FG002|Overall Study|Sponsor's Decision|0|||
163324855|NCT03333915|589900695|FG003|Overall Study|Sponsor's Decision|48|||
162996545|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
162996546|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
162996547|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
162996548|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
162996549|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
162996550|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
162996551|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
162996552|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
162996553|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
162996554|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
162996555|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
162996556|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
162996557|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
162996558|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
162996559|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
162996560|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
162996561|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
162996562|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
163324856|NCT03333915|589900696|FG004|Overall Study|Sponsor's Decision|4|||
163324857|NCT03333915|589900692|FG000|Overall Study|Withdrawal by Subject|0|||
162996563|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
162996564|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
162996565|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
162996566|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
162996567|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
162996568|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
162996569|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
162996570|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
162996571|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
162996572|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
162996573|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
162996574|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
162996575|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996576|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996577|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996578|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996579|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996580|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996581|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996582|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
162996583|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
162996584|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996585|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
162996586|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
162996587|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
162996588|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
162996589|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
162996590|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
162996591|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
162996592|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
162996593|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
162996594|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
162996595|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|Other|0|||
162996596|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|Other|0|||
162996597|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|Other|0|||
162996598|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|Other|0|||
162996599|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|Other|0|||
162996600|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|Other|0|||
162996601|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|Other|0|||
162996602|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|Other|0|||
162996603|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|Other|1|||
162996604|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|Other|1|||
162996605|NCT00129389|588688048|FG000|Overall Study|Adverse Event|19|||
162996606|NCT00129389|588688049|FG001|Overall Study|Adverse Event|87|||
162996607|NCT00129389|588688048|FG000|Overall Study|Death|0|||
162996608|NCT00129389|588688049|FG001|Overall Study|Death|1|||
162996609|NCT00129389|588688048|FG000|Overall Study|Lost to Follow-up|2|||
162996610|NCT00129389|588688049|FG001|Overall Study|Lost to Follow-up|1|||
162996611|NCT00129389|588688048|FG000|Overall Study|Physician Decision|0|||
162996612|NCT00129389|588688049|FG001|Overall Study|Physician Decision|4|||
162996613|NCT00129389|588688048|FG000|Overall Study|Protocol Violation|0|||
162996614|NCT00129389|588688049|FG001|Overall Study|Protocol Violation|6|||
162996615|NCT00129389|588688048|FG000|Overall Study|Withdrawal by Subject|9|||
162996616|NCT00129389|588688049|FG001|Overall Study|Withdrawal by Subject|23|||
162996617|NCT00129389|588688048|FG000|Overall Study|Relapse|1|||
162996618|NCT00129389|588688049|FG001|Overall Study|Relapse|0|||
162996619|NCT00129389|588688048|FG000|Overall Study|Not eligible|1|||
162996620|NCT00129389|588688049|FG001|Overall Study|Not eligible|2|||
162996621|NCT00129389|588688048|FG000|Overall Study|Crossed to the other arm|1|||
162996622|NCT00129389|588688049|FG001|Overall Study|Crossed to the other arm|16|||
162996623|NCT01191944|588688053|FG000|Overall Study|Adverse Event|11|||
162996624|NCT01191944|588688054|FG001|Overall Study|Adverse Event|12|||
162996625|NCT01191944|588688053|FG000|Overall Study|Protocol Violation|1|||
162996626|NCT01191944|588688054|FG001|Overall Study|Protocol Violation|2|||
162996627|NCT01191944|588688053|FG000|Overall Study|Withdrawal by Subject|4|||
162996628|NCT01191944|588688054|FG001|Overall Study|Withdrawal by Subject|2|||
162996629|NCT01191944|588688053|FG000|Overall Study|Other|1|||
162996630|NCT01191944|588688054|FG001|Overall Study|Other|3|||
162996631|NCT02794246|588688059|FG000|Overall Study|Withdrawal by Subject|2|||
162996632|NCT02794246|588688059|FG000|Overall Study|Physician Decision|4|||
162996633|NCT04602546|588688060|FG000|Overall Study|Training|2|||
162996634|NCT04602546|588688061|FG001|Overall Study|Training|2|||
162996635|NCT04602546|588688062|FG002|Overall Study|Training|1|||
162996636|NCT04602546|588688063|FG003|Overall Study|Training|2|||
162996637|NCT04602546|588688064|FG004|Overall Study|Training|0|||
162996638|NCT04602546|588688060|FG000|Overall Study|Randomized with disqualified data|2|||
162996639|NCT04602546|588688061|FG001|Overall Study|Randomized with disqualified data|0|||
162996640|NCT04602546|588688062|FG002|Overall Study|Randomized with disqualified data|2|||
162996641|NCT04602546|588688063|FG003|Overall Study|Randomized with disqualified data|5|||
162996642|NCT04602546|588688064|FG004|Overall Study|Randomized with disqualified data|3|||
162996643|NCT01831258|588688066|FG000|Overall Study|Withdrawal by Subject|2|||
162996644|NCT01831258|588688067|FG001|Overall Study|Withdrawal by Subject|1|||
162996645|NCT01831258|588688066|FG000|Overall Study|Lost to Follow-up|3|||
162996646|NCT01831258|588688067|FG001|Overall Study|Lost to Follow-up|2|||
162996647|NCT01753297|588688072|FG000|Overall Study|Lost to Follow-up|7|||
162996648|NCT01753297|588688073|FG001|Overall Study|Lost to Follow-up|2|||
162996649|NCT01753297|588688072|FG000|Overall Study|Withdrawal by Subject|26|||
162996650|NCT01753297|588688073|FG001|Overall Study|Withdrawal by Subject|23|||
162996651|NCT01753297|588688072|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
162996652|NCT01753297|588688073|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
162996653|NCT01753297|588688072|FG000|Overall Study|Death|0|||
162996654|NCT01753297|588688073|FG001|Overall Study|Death|2|||
162996655|NCT01753297|588688072|FG000|Overall Study|Did not attend end of study visit|7|||
162996656|NCT01753297|588688073|FG001|Overall Study|Did not attend end of study visit|8|||
162996657|NCT02533180|588688074|FG000|Overall Study|Death|0|||
162996658|NCT02533180|588688075|FG001|Overall Study|Death|2|||
162996659|NCT02533180|588688074|FG000|Overall Study|Lost to Follow-up|0|||
162996660|NCT02533180|588688075|FG001|Overall Study|Lost to Follow-up|1|||
162996661|NCT02533180|588688074|FG000|Overall Study|Physician Decision|0|||
162996662|NCT02533180|588688075|FG001|Overall Study|Physician Decision|1|||
162996663|NCT02533180|588688074|FG000|Overall Study|Withdrawal by Subject|2|||
162996664|NCT02533180|588688075|FG001|Overall Study|Withdrawal by Subject|5|||
162996665|NCT02533180|588688074|FG000|Overall Study|Screen Failure|37|||
162996666|NCT02533180|588688075|FG001|Overall Study|Screen Failure|0|||
162996667|NCT02533180|588688074|FG000|Overall Study|Protocol Deviation|0|||
162996668|NCT02533180|588688075|FG001|Overall Study|Protocol Deviation|1|||
162996669|NCT02533180|588688074|FG000|Overall Study|Non-compliance|0|||
162996670|NCT02533180|588688075|FG001|Overall Study|Non-compliance|1|||
162996671|NCT01174043|588688077|FG000|Overall Study|Disease progression|5|||
162996672|NCT01174043|588688077|FG000|Overall Study|Adverse Event|3|||
162996673|NCT01174043|588688077|FG000|Overall Study|Death|1|||
162996674|NCT01174043|588688077|FG000|Overall Study|Withdrawal by Subject|2|||
162996675|NCT00794339|588688082|FG000|Overall Study|Withdrawal by Subject|3|||
162996676|NCT00794339|588688082|FG000|Overall Study|Ineligible|4|||
162996677|NCT00794339|588688082|FG000|Overall Study|Tx prior to ATSM|3|||
162996678|NCT00794339|588688082|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
162996679|NCT00794339|588688082|FG000|Overall Study|Tx not per protocol|1|||
162996680|NCT01118975|588688087|FG000|Overall Study|Adverse Event|0|||
162996681|NCT01118975|588688088|FG001|Overall Study|Adverse Event|1|||
162996682|NCT01371539|588688091|FG000|Period One: One Week|Lost to Follow-up|0|||
162996683|NCT01371539|588688092|FG001|Period One: One Week|Lost to Follow-up|1|||
162996684|NCT01371539|588688091|FG000|Period Two: One Week|Lost to Follow-up|0|||
162996685|NCT01371539|588688092|FG001|Period Two: One Week|Lost to Follow-up|1|||
162996686|NCT01371539|588688091|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
162996687|NCT01371539|588688092|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
162996688|NCT01371539|588688091|FG000|Period Two: One Week|Time/job conflict|0|||
162996689|NCT01371539|588688092|FG001|Period Two: One Week|Time/job conflict|1|||
162996690|NCT01399658|588688093|FG000|Overall Study|Ineligible|1|||
162996691|NCT01399658|588688093|FG000|Overall Study|Machine Technical Issue|3|||
162996692|NCT01399658|588688093|FG000|Overall Study|Alternative therapy|1|||
162996693|NCT01399658|588688093|FG000|Overall Study|No reason given|1|||
162996694|NCT04315506|588688097|FG000|Overall Study|Lost to Follow-up|74|||
162996695|NCT04315506|588688098|FG001|Overall Study|Lost to Follow-up|82|||
162996696|NCT04315506|588688097|FG000|Overall Study|Withdrawal by Subject|8|||
162996697|NCT04315506|588688098|FG001|Overall Study|Withdrawal by Subject|8|||
162996698|NCT04315506|588688097|FG000|Overall Study|Physician Decision|0|||
162996699|NCT04315506|588688098|FG001|Overall Study|Physician Decision|1|||
162996700|NCT02756208|588688102|FG000|Overall Study|Withdrawal by Subject|1|||
162996701|NCT02756208|588688103|FG001|Overall Study|Withdrawal by Subject|0|||
162996702|NCT02756208|588688104|FG002|Overall Study|Withdrawal by Subject|1|||
162996703|NCT02756208|588688105|FG003|Overall Study|Withdrawal by Subject|3|||
162996704|NCT02756208|588688102|FG000|Overall Study|Lost to Follow-up|3|||
162996705|NCT02756208|588688103|FG001|Overall Study|Lost to Follow-up|1|||
162996706|NCT02756208|588688104|FG002|Overall Study|Lost to Follow-up|1|||
162996707|NCT02756208|588688105|FG003|Overall Study|Lost to Follow-up|1|||
162996708|NCT02756208|588688102|FG000|Overall Study|Physician Decision|1|||
162996709|NCT02756208|588688103|FG001|Overall Study|Physician Decision|0|||
162996710|NCT02756208|588688104|FG002|Overall Study|Physician Decision|0|||
162996711|NCT02756208|588688105|FG003|Overall Study|Physician Decision|0|||
162996712|NCT02756208|588688102|FG000|Overall Study|Protocol Violation|0|||
162996713|NCT02756208|588688103|FG001|Overall Study|Protocol Violation|1|||
162996714|NCT02756208|588688104|FG002|Overall Study|Protocol Violation|0|||
162996715|NCT02756208|588688105|FG003|Overall Study|Protocol Violation|0|||
162996716|NCT03485365|588688106|FG000|Overall Study|Protocol Violation|0|||
162996717|NCT03485365|588688107|FG001|Overall Study|Protocol Violation|0|||
162996718|NCT03485365|588688108|FG002|Overall Study|Protocol Violation|0|||
162996719|NCT03485365|588688109|FG003|Overall Study|Protocol Violation|1|||
162996720|NCT03485365|588688110|FG004|Overall Study|Protocol Violation|0|||
162996721|NCT03485365|588688111|FG005|Overall Study|Protocol Violation|0|||
162996722|NCT03485365|588688112|FG006|Overall Study|Protocol Violation|1|||
162996723|NCT03485365|588688113|FG007|Overall Study|Protocol Violation|0|||
162996724|NCT03485365|588688114|FG008|Overall Study|Protocol Violation|0|||
162996725|NCT01275430|588688120|FG000|Overall Study|Adverse Event|1|||
162996726|NCT01275430|588688120|FG000|Overall Study|No Contrast Injection|6|||
162996727|NCT01275430|588688120|FG000|Overall Study|Device Malfunction|1|||
162996728|NCT01275430|588688120|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
162996729|NCT04988087|588688121|FG000|Overall Study|Adverse Event|4|||
162996730|NCT04988087|588688122|FG001|Overall Study|Adverse Event|0|||
162996731|NCT04988087|588688123|FG002|Overall Study|Adverse Event|0|||
162996732|NCT04988087|588688124|FG003|Overall Study|Adverse Event|0|||
162996733|NCT04988087|588688121|FG000|Overall Study|Withdrawal by Subject|1|||
162996734|NCT04988087|588688122|FG001|Overall Study|Withdrawal by Subject|1|||
162996735|NCT04988087|588688123|FG002|Overall Study|Withdrawal by Subject|0|||
162996736|NCT04988087|588688124|FG003|Overall Study|Withdrawal by Subject|0|||
162996737|NCT04988087|588688121|FG000|Overall Study|Technical problems|7|||
162996738|NCT04988087|588688122|FG001|Overall Study|Technical problems|9|||
162996739|NCT04988087|588688123|FG002|Overall Study|Technical problems|1|||
162996740|NCT04988087|588688124|FG003|Overall Study|Technical problems|2|||
162996741|NCT02613182|588688125|FG000|Overall Study|Death|6|||
162996742|NCT02613182|588688125|FG000|Overall Study|Physician Decision|1|||
162996743|NCT02613182|588688125|FG000|Overall Study|Study Terminated by Sponsor|21|||
162996744|NCT02613182|588688125|FG000|Overall Study|Withdrawal by Subject|6|||
162996745|NCT03968978|588688126|FG000|Overall Study|Adverse Event|1|||
162996746|NCT03968978|588688127|FG001|Overall Study|Adverse Event|0|||
162996747|NCT00863772|588688128|FG000|Overall Study|Adverse Event|1|||
162996748|NCT00863772|588688129|FG001|Overall Study|Adverse Event|4|||
162996749|NCT00863772|588688130|FG002|Overall Study|Adverse Event|0|||
162996750|NCT00863772|588688128|FG000|Overall Study|Lack of Efficacy|4|||
162996751|NCT00863772|588688129|FG001|Overall Study|Lack of Efficacy|2|||
162996752|NCT00863772|588688130|FG002|Overall Study|Lack of Efficacy|4|||
162996753|NCT00863772|588688128|FG000|Overall Study|Lost to Follow-up|5|||
162996754|NCT00863772|588688129|FG001|Overall Study|Lost to Follow-up|1|||
162996755|NCT00863772|588688130|FG002|Overall Study|Lost to Follow-up|1|||
162996756|NCT00863772|588688128|FG000|Overall Study|Protocol Violation|2|||
162996757|NCT00863772|588688129|FG001|Overall Study|Protocol Violation|0|||
162996758|NCT00863772|588688130|FG002|Overall Study|Protocol Violation|2|||
162996759|NCT00863772|588688128|FG000|Overall Study|Withdrawal by Subject|4|||
162996760|NCT00863772|588688129|FG001|Overall Study|Withdrawal by Subject|7|||
162996761|NCT00863772|588688130|FG002|Overall Study|Withdrawal by Subject|5|||
162996762|NCT00863772|588688128|FG000|Overall Study|Study terminated by sponsor|44|||
162996763|NCT00863772|588688129|FG001|Overall Study|Study terminated by sponsor|45|||
162996764|NCT00863772|588688130|FG002|Overall Study|Study terminated by sponsor|36|||
162996765|NCT00863772|588688128|FG000|Overall Study|Entered extension study|6|||
162996766|NCT00863772|588688129|FG001|Overall Study|Entered extension study|4|||
162996767|NCT00863772|588688130|FG002|Overall Study|Entered extension study|9|||
162996768|NCT00863772|588688128|FG000|Overall Study|Other|1|||
162996769|NCT00863772|588688129|FG001|Overall Study|Other|2|||
162996770|NCT00863772|588688130|FG002|Overall Study|Other|4|||
163060372|NCT04889040|588929873|FG001|Overall Study|Withdrawal by Subject|3|||
162996771|NCT00863772|588688128|FG000|Overall Study|Randomized but not Treated|1|||
162996772|NCT00863772|588688129|FG001|Overall Study|Randomized but not Treated|0|||
162996773|NCT00863772|588688130|FG002|Overall Study|Randomized but not Treated|0|||
162996774|NCT05038800|588688132|FG000|Overall Study|Death|1|||
162996775|NCT05038800|588688133|FG001|Overall Study|Death|1|||
162996776|NCT05038800|588688134|FG002|Overall Study|Death|5|||
162996777|NCT05038800|588688135|FG003|Overall Study|Death|3|||
162996778|NCT05038800|588688136|FG004|Overall Study|Death|1|||
162996779|NCT05038800|588688132|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162996780|NCT05038800|588688133|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162996781|NCT05038800|588688134|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162996782|NCT05038800|588688135|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162996783|NCT05038800|588688136|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
162996784|NCT05038800|588688132|FG000|Overall Study|Lack of Efficacy|0|||
162996785|NCT05038800|588688133|FG001|Overall Study|Lack of Efficacy|0|||
162996786|NCT05038800|588688134|FG002|Overall Study|Lack of Efficacy|0|||
162996787|NCT05038800|588688135|FG003|Overall Study|Lack of Efficacy|0|||
162996788|NCT05038800|588688136|FG004|Overall Study|Lack of Efficacy|1|||
162996789|NCT00121134|588688137|FG000|Overall Study|Progression of Disease|5|||
162996790|NCT00121134|588688138|FG001|Overall Study|Progression of Disease|3|||
162996791|NCT00121134|588688139|FG002|Overall Study|Progression of Disease|4|||
162996792|NCT00121134|588688140|FG003|Overall Study|Progression of Disease|2|||
162996793|NCT00121134|588688137|FG000|Overall Study|Toxicity|4|||
163060373|NCT04889040|588929872|FG000|Overall Study|Lost to Follow-up|0|||
163060374|NCT04889040|588929873|FG001|Overall Study|Lost to Follow-up|1|||
163060375|NCT04889040|588929872|FG000|Overall Study|Adverse Event|2|||
162996794|NCT00121134|588688138|FG001|Overall Study|Toxicity|7|||
162996795|NCT00121134|588688139|FG002|Overall Study|Toxicity|13|||
162996796|NCT00121134|588688140|FG003|Overall Study|Toxicity|5|||
162996797|NCT00121134|588688137|FG000|Overall Study|Physician Decision|6|||
162996798|NCT00121134|588688138|FG001|Overall Study|Physician Decision|4|||
162996799|NCT00121134|588688139|FG002|Overall Study|Physician Decision|4|||
162996800|NCT00121134|588688140|FG003|Overall Study|Physician Decision|1|||
162996801|NCT00121134|588688137|FG000|Overall Study|Treatment Delay|1|||
162996802|NCT00121134|588688138|FG001|Overall Study|Treatment Delay|0|||
162996803|NCT00121134|588688139|FG002|Overall Study|Treatment Delay|0|||
162996804|NCT00121134|588688140|FG003|Overall Study|Treatment Delay|0|||
162996805|NCT00121134|588688137|FG000|Overall Study|Intercurrent Illness|0|||
162996806|NCT00121134|588688138|FG001|Overall Study|Intercurrent Illness|0|||
162996807|NCT00121134|588688139|FG002|Overall Study|Intercurrent Illness|0|||
163060376|NCT04889040|588929873|FG001|Overall Study|Adverse Event|1|||
162996808|NCT00121134|588688140|FG003|Overall Study|Intercurrent Illness|1|||
162996809|NCT00121134|588688137|FG000|Overall Study|Patient Personal Reasons|0|||
162996810|NCT00121134|588688138|FG001|Overall Study|Patient Personal Reasons|1|||
162996811|NCT00121134|588688139|FG002|Overall Study|Patient Personal Reasons|0|||
162996812|NCT00121134|588688140|FG003|Overall Study|Patient Personal Reasons|0|||
162996813|NCT04400682|588688148|FG000|Period 1|Withdrawal by Subject|1|||
162996814|NCT04400682|588688149|FG001|Period 1|Withdrawal by Subject|4|||
162996815|NCT02105974|588688150|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
162996816|NCT02105974|588688151|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
162996817|NCT02105974|588688152|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
162996818|NCT02105974|588688150|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
162996819|NCT02105974|588688151|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
162996820|NCT02105974|588688152|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
162996821|NCT02105974|588688150|FG000|2 Week Run-in Period|Adverse Event|6|||
162996822|NCT02105974|588688151|FG001|2 Week Run-in Period|Adverse Event|0|||
162996823|NCT02105974|588688152|FG002|2 Week Run-in Period|Adverse Event|0|||
162996824|NCT02105974|588688150|FG000|2 Week Run-in Period|Study closed/terminated|1|||
162996825|NCT02105974|588688151|FG001|2 Week Run-in Period|Study closed/terminated|0|||
162996826|NCT02105974|588688152|FG002|2 Week Run-in Period|Study closed/terminated|0|||
162996827|NCT02105974|588688150|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
162996828|NCT02105974|588688151|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
162996829|NCT02105974|588688152|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
162996830|NCT02105974|588688150|FG000|2 Week Run-in Period|Withdrew consent|23|||
162996831|NCT02105974|588688151|FG001|2 Week Run-in Period|Withdrew consent|0|||
162996832|NCT02105974|588688152|FG002|2 Week Run-in Period|Withdrew consent|0|||
162996833|NCT02105974|588688150|FG000|2 Week Run-in Period|Investigator discretion|8|||
162996834|NCT02105974|588688151|FG001|2 Week Run-in Period|Investigator discretion|0|||
162996835|NCT02105974|588688152|FG002|2 Week Run-in Period|Investigator discretion|0|||
162996836|NCT02105974|588688150|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
162996837|NCT02105974|588688151|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
162996838|NCT02105974|588688152|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
162996839|NCT02105974|588688150|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
162996840|NCT02105974|588688151|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
162996841|NCT02105974|588688152|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
162996842|NCT02105974|588688150|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
162996843|NCT02105974|588688151|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
162996844|NCT02105974|588688152|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
162996845|NCT02105974|588688150|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
162996846|NCT02105974|588688151|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
162996847|NCT02105974|588688152|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
162996848|NCT02105974|588688150|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
163324858|NCT03333915|589900693|FG001|Overall Study|Withdrawal by Subject|0|||
163324859|NCT03333915|589900694|FG002|Overall Study|Withdrawal by Subject|0|||
163324860|NCT03333915|589900695|FG003|Overall Study|Withdrawal by Subject|5|||
162996849|NCT02105974|588688151|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
162996850|NCT02105974|588688152|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
162996851|NCT02105974|588688150|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
162996852|NCT02105974|588688151|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
162996853|NCT02105974|588688152|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
162996854|NCT02105974|588688150|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
162996855|NCT02105974|588688151|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
162996856|NCT02105974|588688152|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
163060377|NCT00855582|588929878|FG000|Overall Study|Adverse Event|2|||
163324861|NCT03333915|589900696|FG004|Overall Study|Withdrawal by Subject|1|||
162996857|NCT03597464|588688153|FG000|Overall Study|Withdrawal by Subject|4|||
162996858|NCT03597464|588688154|FG001|Overall Study|Withdrawal by Subject|5|||
162996859|NCT03597464|588688153|FG000|Overall Study|Lost to Follow-up|3|||
162996860|NCT03597464|588688154|FG001|Overall Study|Lost to Follow-up|1|||
162996861|NCT03597464|588688153|FG000|Overall Study|Pregnancy|3|||
162996862|NCT03597464|588688154|FG001|Overall Study|Pregnancy|1|||
162996863|NCT03597464|588688153|FG000|Overall Study|Lack of Efficacy|2|||
162996864|NCT03597464|588688154|FG001|Overall Study|Lack of Efficacy|0|||
162996865|NCT03597464|588688153|FG000|Overall Study|Physician Decision|2|||
162996866|NCT03597464|588688154|FG001|Overall Study|Physician Decision|2|||
162996867|NCT03597464|588688153|FG000|Overall Study|Protocol Violation|1|||
162996868|NCT03597464|588688154|FG001|Overall Study|Protocol Violation|1|||
162996869|NCT03597464|588688153|FG000|Overall Study|Adverse Event|0|||
162996870|NCT03597464|588688154|FG001|Overall Study|Adverse Event|2|||
162996871|NCT03597464|588688153|FG000|Overall Study|Death|0|||
162996872|NCT03597464|588688154|FG001|Overall Study|Death|3|||
162996873|NCT03316547|588688162|FG000|Overall Study|Death|3|||
162996874|NCT03316547|588688163|FG001|Overall Study|Death|1|||
162996875|NCT03316547|588688162|FG000|Overall Study|Lost to Follow-up|6|||
162996876|NCT03316547|588688163|FG001|Overall Study|Lost to Follow-up|6|||
162996877|NCT03316547|588688162|FG000|Overall Study|Withdrawal by Subject|3|||
162996878|NCT03316547|588688163|FG001|Overall Study|Withdrawal by Subject|2|||
162996879|NCT03316547|588688162|FG000|Overall Study|Transfer to another hospital|6|||
162996880|NCT03316547|588688163|FG001|Overall Study|Transfer to another hospital|4|||
162996881|NCT00447876|588690561|FG000|Overall Study|Withdrawal by Subject|1|||
162996882|NCT00447876|588690562|FG001|Overall Study|Withdrawal by Subject|4|||
162996883|NCT00447876|588690561|FG000|Overall Study|Lost to Follow-up|1|||
162996884|NCT00447876|588690562|FG001|Overall Study|Lost to Follow-up|0|||
163060378|NCT00855582|588929879|FG001|Overall Study|Adverse Event|6|||
162996885|NCT00447876|588690561|FG000|Overall Study|Deterioration of symptomology|1|||
162996886|NCT00447876|588690562|FG001|Overall Study|Deterioration of symptomology|0|||
162996887|NCT04172597|588690563|FG000|Overall Study|Disease Progression|0|||
162996888|NCT04172597|588690564|FG001|Overall Study|Disease Progression|0|||
162996889|NCT04172597|588690565|FG002|Overall Study|Disease Progression|0|||
162996890|NCT04172597|588690566|FG003|Overall Study|Disease Progression|0|||
162996891|NCT04172597|588690567|FG004|Overall Study|Disease Progression|1|||
162996892|NCT02952586|588690571|FG000|Lead-In Phase (7 Days)|Death|0|||
162996893|NCT02952586|588690572|FG001|Lead-In Phase (7 Days)|Death|1|||
162996894|NCT02952586|588690571|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
162996895|NCT02952586|588690572|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
162996896|NCT02952586|588690571|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
162996897|NCT02952586|588690572|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
162996898|NCT02952586|588690571|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
162996899|NCT02952586|588690572|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
162996900|NCT02952586|588690571|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
162996901|NCT02952586|588690572|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
162996902|NCT02952586|588690571|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
162996903|NCT02952586|588690572|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
162996904|NCT02952586|588690571|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
162996905|NCT02952586|588690572|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
162996906|NCT02952586|588690571|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
162996907|NCT02952586|588690572|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
163060379|NCT00855582|588929880|FG002|Overall Study|Adverse Event|3|||
163060380|NCT00855582|588929878|FG000|Overall Study|Death|1|||
163060381|NCT00855582|588929879|FG001|Overall Study|Death|0|||
163060382|NCT00855582|588929880|FG002|Overall Study|Death|0|||
162996908|NCT02952586|588690571|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
162996909|NCT02952586|588690572|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
162996910|NCT02952586|588690571|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
162996911|NCT02952586|588690572|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
162996912|NCT02952586|588690571|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
162996913|NCT02952586|588690572|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
162996914|NCT02952586|588690571|FG000|CRT for Cisplatin (63 Days)|Death|3|||
162996915|NCT02952586|588690572|FG001|CRT for Cisplatin (63 Days)|Death|8|||
162996916|NCT02952586|588690571|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
162996917|NCT02952586|588690572|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
162996918|NCT02952586|588690571|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
162996919|NCT02952586|588690572|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
162996920|NCT02952586|588690571|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
162996921|NCT02952586|588690572|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
162996922|NCT02952586|588690571|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
162996923|NCT02952586|588690572|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
163060383|NCT00855582|588929878|FG000|Overall Study|Lack of Efficacy|1|||
163060384|NCT00855582|588929879|FG001|Overall Study|Lack of Efficacy|3|||
162996924|NCT02952586|588690571|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
162996925|NCT02952586|588690572|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
162996926|NCT02952586|588690571|FG000|CRT for Cisplatin (63 Days)|Other|1|||
162996927|NCT02952586|588690572|FG001|CRT for Cisplatin (63 Days)|Other|1|||
162996928|NCT02952586|588690571|FG000|CRT for IMRT (63 Days)|Death|5|||
162996929|NCT02952586|588690572|FG001|CRT for IMRT (63 Days)|Death|8|||
162996930|NCT02952586|588690571|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
162996931|NCT02952586|588690572|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
162996932|NCT02952586|588690571|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
162996933|NCT02952586|588690572|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
162996934|NCT02952586|588690571|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
162996935|NCT02952586|588690572|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
162996936|NCT02952586|588690571|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
162996937|NCT02952586|588690572|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
162996938|NCT02952586|588690571|FG000|CRT for IMRT (63 Days)|Other|1|||
163060385|NCT00855582|588929880|FG002|Overall Study|Lack of Efficacy|8|||
163060386|NCT00855582|588929878|FG000|Overall Study|Lost to Follow-up|1|||
163060387|NCT00855582|588929879|FG001|Overall Study|Lost to Follow-up|3|||
162996939|NCT02952586|588690572|FG001|CRT for IMRT (63 Days)|Other|0|||
162996940|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Death|17|||
162996941|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Death|11|||
162996942|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
162996943|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
162996944|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
162996945|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
162996946|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
162996947|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
162996948|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
162996949|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
162996950|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
162996951|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
162996952|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
162996953|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
162996954|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
162996955|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
162996956|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Other|2|||
162996957|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Other|1|||
162996958|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
162996959|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
162996960|NCT02952586|588690571|FG000|Follow-Up Phase (90 Days)|Death|12|||
162996961|NCT02952586|588690572|FG001|Follow-Up Phase (90 Days)|Death|10|||
162996962|NCT02952586|588690571|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
162996963|NCT02952586|588690572|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
162996964|NCT02952586|588690571|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
162996965|NCT02952586|588690572|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
162996966|NCT02952586|588690571|FG000|Follow-Up Phase (90 Days)|Other|7|||
162996967|NCT02952586|588690572|FG001|Follow-Up Phase (90 Days)|Other|5|||
162996968|NCT02952586|588690571|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
162996969|NCT02952586|588690572|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
162996970|NCT02952586|588690571|FG000|LT Follow-up (up to 45 Months)|Death|51|||
162996971|NCT02952586|588690572|FG001|LT Follow-up (up to 45 Months)|Death|31|||
162996972|NCT02952586|588690571|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
162996973|NCT02952586|588690572|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
162996974|NCT02952586|588690571|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
162996975|NCT02952586|588690572|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
162996976|NCT02952586|588690571|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
162996977|NCT02952586|588690572|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
163060388|NCT00855582|588929880|FG002|Overall Study|Lost to Follow-up|1|||
163060389|NCT00855582|588929878|FG000|Overall Study|Physician Decision|0|||
162996978|NCT00492778|588690575|FG000|Overall Study|Ineligible by Pathology Review|8|||
162996979|NCT00492778|588690576|FG001|Overall Study|Ineligible by Pathology Review|1|||
162996980|NCT03717012|588690591|FG000|Overall Study|Due to trial termination|1|||
162996981|NCT03717012|588690592|FG001|Overall Study|Due to trial termination|2|||
162996982|NCT03717012|588690591|FG000|Overall Study|Protocol Violation|0|||
162996983|NCT03717012|588690592|FG001|Overall Study|Protocol Violation|2|||
162996984|NCT03717012|588690591|FG000|Overall Study|Adverse Event|0|||
162996985|NCT03717012|588690592|FG001|Overall Study|Adverse Event|1|||
162996986|NCT03717012|588690591|FG000|Overall Study|Lung transplant|0|||
162996987|NCT03717012|588690592|FG001|Overall Study|Lung transplant|1|||
162996988|NCT00789035|588690593|FG000|Overall Study|Adverse Event|0|||
162996989|NCT00789035|588690594|FG001|Overall Study|Adverse Event|2|||
163060390|NCT00855582|588929879|FG001|Overall Study|Physician Decision|0|||
162996990|NCT00789035|588690595|FG002|Overall Study|Adverse Event|0|||
162996991|NCT00789035|588690596|FG003|Overall Study|Adverse Event|1|||
162996992|NCT00789035|588690597|FG004|Overall Study|Adverse Event|3|||
162996993|NCT00789035|588690593|FG000|Overall Study|Lack of Efficacy|3|||
162996994|NCT00789035|588690594|FG001|Overall Study|Lack of Efficacy|0|||
162996995|NCT00789035|588690595|FG002|Overall Study|Lack of Efficacy|0|||
162996996|NCT00789035|588690596|FG003|Overall Study|Lack of Efficacy|0|||
162996997|NCT00789035|588690597|FG004|Overall Study|Lack of Efficacy|2|||
162996998|NCT00789035|588690593|FG000|Overall Study|Protocol Violation|1|||
162996999|NCT00789035|588690594|FG001|Overall Study|Protocol Violation|0|||
162997000|NCT00789035|588690595|FG002|Overall Study|Protocol Violation|0|||
162997001|NCT00789035|588690596|FG003|Overall Study|Protocol Violation|0|||
162997002|NCT00789035|588690597|FG004|Overall Study|Protocol Violation|0|||
162997003|NCT00789035|588690593|FG000|Overall Study|Withdrawal by Subject|0|||
162997004|NCT00789035|588690594|FG001|Overall Study|Withdrawal by Subject|2|||
162997005|NCT00789035|588690595|FG002|Overall Study|Withdrawal by Subject|0|||
162997006|NCT00789035|588690596|FG003|Overall Study|Withdrawal by Subject|0|||
162997007|NCT00789035|588690597|FG004|Overall Study|Withdrawal by Subject|0|||
162997008|NCT00789035|588690593|FG000|Overall Study|Other reason not defined above|2|||
162997009|NCT00789035|588690594|FG001|Overall Study|Other reason not defined above|3|||
162997010|NCT00789035|588690595|FG002|Overall Study|Other reason not defined above|1|||
162997011|NCT00789035|588690596|FG003|Overall Study|Other reason not defined above|0|||
162997012|NCT00789035|588690597|FG004|Overall Study|Other reason not defined above|1|||
162997013|NCT04414618|588690598|FG000|Overall Study|Death|3|||
162997014|NCT04414618|588690599|FG001|Overall Study|Death|3|||
162997015|NCT04414618|588690598|FG000|Overall Study|Withdrawal by Subject|2|||
162997016|NCT04414618|588690599|FG001|Overall Study|Withdrawal by Subject|1|||
162997017|NCT04414618|588690598|FG000|Overall Study|Lost to Follow-up|2|||
162997018|NCT04414618|588690599|FG001|Overall Study|Lost to Follow-up|3|||
162997019|NCT04414618|588690598|FG000|Overall Study|Physician Decision|1|||
162997020|NCT04414618|588690599|FG001|Overall Study|Physician Decision|0|||
162997021|NCT00658879|588690600|FG000|Overall Study|Protocol Violation|1|||
162997022|NCT02640690|588690601|FG000|Overall Study|Lost to Follow-up|7|||
162997023|NCT02640690|588690602|FG001|Overall Study|Lost to Follow-up|7|||
162997024|NCT02640690|588690601|FG000|Overall Study|Withdrawal by Subject|16|||
162997025|NCT02640690|588690602|FG001|Overall Study|Withdrawal by Subject|20|||
162997026|NCT02640690|588690601|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
162997027|NCT02640690|588690602|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
162997028|NCT01645787|588690603|FG000|Washout (2 Weeks)|Adverse Event|1|||
162997029|NCT01645787|588690604|FG001|Washout (2 Weeks)|Adverse Event|0|||
162997030|NCT02806024|588690606|FG000|Overall Study|Night Delivery|1|||
162997031|NCT02806024|588690607|FG001|Overall Study|Night Delivery|1|||
162997032|NCT02806024|588690606|FG000|Overall Study|DVT during antepartum admission|0|||
162997033|NCT02806024|588690607|FG001|Overall Study|DVT during antepartum admission|1|||
162997034|NCT01098474|588690608|FG000|Active Phase|Other|0|||
162997035|NCT01098474|588690609|FG001|Active Phase|Other|0|||
162997036|NCT01098474|588690610|FG002|Active Phase|Other|3|||
162997037|NCT01098474|588690611|FG003|Active Phase|Other|0|||
162997038|NCT01098474|588690612|FG004|Active Phase|Other|0|||
162997039|NCT01098474|588690613|FG005|Active Phase|Other|0|||
162997040|NCT01098474|588690608|FG000|Active Phase|Withdrawal by Subject|1|||
162997041|NCT01098474|588690609|FG001|Active Phase|Withdrawal by Subject|1|||
162997042|NCT01098474|588690610|FG002|Active Phase|Withdrawal by Subject|2|||
162997043|NCT01098474|588690611|FG003|Active Phase|Withdrawal by Subject|0|||
162997044|NCT01098474|588690612|FG004|Active Phase|Withdrawal by Subject|0|||
162997045|NCT01098474|588690613|FG005|Active Phase|Withdrawal by Subject|0|||
162997046|NCT01098474|588690608|FG000|Active Phase|Lost to Follow-up|1|||
162997047|NCT01098474|588690609|FG001|Active Phase|Lost to Follow-up|0|||
162997048|NCT01098474|588690610|FG002|Active Phase|Lost to Follow-up|0|||
162997049|NCT01098474|588690611|FG003|Active Phase|Lost to Follow-up|0|||
162997050|NCT01098474|588690612|FG004|Active Phase|Lost to Follow-up|0|||
163404318|NCT02356562|590191906|FG001|Overall Study|Withdrawal by Subject|1|||
162997051|NCT01098474|588690613|FG005|Active Phase|Lost to Follow-up|0|||
162997052|NCT01098474|588690608|FG000|Follow Up Phase|Travelled out of study area|0|||
162997053|NCT01098474|588690609|FG001|Follow Up Phase|Travelled out of study area|0|||
162997054|NCT01098474|588690610|FG002|Follow Up Phase|Travelled out of study area|0|||
162997055|NCT01098474|588690611|FG003|Follow Up Phase|Travelled out of study area|0|||
162997056|NCT01098474|588690612|FG004|Follow Up Phase|Travelled out of study area|1|||
162997057|NCT01098474|588690613|FG005|Follow Up Phase|Travelled out of study area|0|||
162997058|NCT01098474|588690608|FG000|Follow Up Phase|Other|0|||
162997059|NCT01098474|588690609|FG001|Follow Up Phase|Other|0|||
162997060|NCT01098474|588690610|FG002|Follow Up Phase|Other|0|||
162997061|NCT01098474|588690611|FG003|Follow Up Phase|Other|0|||
162997062|NCT01098474|588690612|FG004|Follow Up Phase|Other|0|||
162997063|NCT01098474|588690613|FG005|Follow Up Phase|Other|4|||
162997064|NCT01098474|588690608|FG000|Follow Up Phase|Withdrawal by Subject|0|||
162997065|NCT01098474|588690609|FG001|Follow Up Phase|Withdrawal by Subject|0|||
162997066|NCT01098474|588690610|FG002|Follow Up Phase|Withdrawal by Subject|0|||
162997067|NCT01098474|588690611|FG003|Follow Up Phase|Withdrawal by Subject|2|||
162997068|NCT01098474|588690612|FG004|Follow Up Phase|Withdrawal by Subject|0|||
162997069|NCT01098474|588690613|FG005|Follow Up Phase|Withdrawal by Subject|1|||
162997070|NCT01098474|588690608|FG000|Follow Up Phase|Lost to Follow-up|0|||
162997071|NCT01098474|588690609|FG001|Follow Up Phase|Lost to Follow-up|0|||
162997072|NCT01098474|588690610|FG002|Follow Up Phase|Lost to Follow-up|0|||
162997073|NCT01098474|588690611|FG003|Follow Up Phase|Lost to Follow-up|0|||
162997074|NCT01098474|588690612|FG004|Follow Up Phase|Lost to Follow-up|1|||
162997075|NCT01098474|588690613|FG005|Follow Up Phase|Lost to Follow-up|0|||
162997076|NCT00711880|588690618|FG000|Overall Study|Adverse Event|11|||
162997077|NCT00711880|588690619|FG001|Overall Study|Adverse Event|2|||
162997078|NCT00711880|588690618|FG000|Overall Study|Patient non-compliance|1|||
162997079|NCT00711880|588690619|FG001|Overall Study|Patient non-compliance|0|||
162997080|NCT00711880|588690618|FG000|Overall Study|Lack of Efficacy|1|||
162997081|NCT00711880|588690619|FG001|Overall Study|Lack of Efficacy|5|||
162997082|NCT00704132|588690620|FG000|Overall Study|Clinical Adverse Experience|1|||
162997083|NCT00704132|588690621|FG001|Overall Study|Clinical Adverse Experience|0|||
162997084|NCT00704132|588690620|FG000|Overall Study|Lack of Efficacy|0|||
162997085|NCT00704132|588690621|FG001|Overall Study|Lack of Efficacy|1|||
162997086|NCT00704132|588690620|FG000|Overall Study|Withdrawal by Subject|0|||
162997087|NCT00704132|588690621|FG001|Overall Study|Withdrawal by Subject|1|||
162997088|NCT00442962|588690622|FG000|Overall Study|Pregnancy|1|||
162997089|NCT00442962|588690622|FG000|Overall Study|Lost to Follow-up|7|||
162997090|NCT04238650|588690623|FG000|Overall Study|Withdrawal by Subject|0|||
162997091|NCT04238650|588690624|FG001|Overall Study|Withdrawal by Subject|1|||
162997092|NCT03348163|588690625|FG000|Overall Study|Withdrawal by Subject|2|||
162997093|NCT03348163|588690626|FG001|Overall Study|Withdrawal by Subject|0|||
162997094|NCT02585778|588690627|FG000|Overall Study|Adverse Event|17|||
162997095|NCT02585778|588690628|FG001|Overall Study|Adverse Event|4|||
162997096|NCT02585778|588690627|FG000|Overall Study|Participant did not wish to continue|9|||
162997097|NCT02585778|588690628|FG001|Overall Study|Participant did not wish to continue|4|||
162997098|NCT02585778|588690627|FG000|Overall Study|Poor compliance to study protocol|0|||
162997099|NCT02585778|588690628|FG001|Overall Study|Poor compliance to study protocol|2|||
162997100|NCT02585778|588690627|FG000|Overall Study|Death|0|||
162997101|NCT02585778|588690628|FG001|Overall Study|Death|1|||
162997102|NCT02585778|588690627|FG000|Overall Study|Randomized but not treated|1|||
162997103|NCT02585778|588690628|FG001|Overall Study|Randomized but not treated|2|||
162997104|NCT02585778|588690627|FG000|Overall Study|Other than specified above|6|||
162997105|NCT02585778|588690628|FG001|Overall Study|Other than specified above|2|||
162997106|NCT05246670|588690631|FG000|Overall Study|Withdrawal by Subject|2|||
162997107|NCT05246670|588690632|FG001|Overall Study|Withdrawal by Subject|3|||
162997108|NCT05246670|588690633|FG002|Overall Study|Withdrawal by Subject|0|||
162997109|NCT05246670|588690634|FG003|Overall Study|Withdrawal by Subject|1|||
162997110|NCT05246670|588690631|FG000|Overall Study|Adverse Event|0|||
162997111|NCT05246670|588690632|FG001|Overall Study|Adverse Event|0|||
162997112|NCT05246670|588690633|FG002|Overall Study|Adverse Event|1|||
162997113|NCT05246670|588690634|FG003|Overall Study|Adverse Event|0|||
162997114|NCT05246670|588690631|FG000|Overall Study|Physician Decision|1|||
162997115|NCT05246670|588690632|FG001|Overall Study|Physician Decision|0|||
162997116|NCT05246670|588690633|FG002|Overall Study|Physician Decision|0|||
162997117|NCT05246670|588690634|FG003|Overall Study|Physician Decision|0|||
162997118|NCT05246670|588690631|FG000|Overall Study|Protocol Violation|1|||
162997119|NCT05246670|588690632|FG001|Overall Study|Protocol Violation|0|||
163324862|NCT05771467|589900708|FG000|Overall Study|Lost to Follow-up|6|||
163324863|NCT05771467|589900709|FG001|Overall Study|Lost to Follow-up|3|||
163060391|NCT00855582|588929880|FG002|Overall Study|Physician Decision|1|||
163324864|NCT01220531|589900712|FG000|Overall Study|Death|7|||
163324865|NCT01220531|589900712|FG000|Overall Study|Lost to Follow-up|1|||
163324866|NCT05866926|589900715|FG000|Overall Study|Death|16|||
162997120|NCT05246670|588690633|FG002|Overall Study|Protocol Violation|0|||
162997121|NCT05246670|588690634|FG003|Overall Study|Protocol Violation|0|||
162997122|NCT00356525|588690640|FG000|Overall Study|Progressive Disease|8|||
162997123|NCT00356525|588690641|FG001|Overall Study|Progressive Disease|5|||
162997124|NCT00356525|588690642|FG002|Overall Study|Progressive Disease|4|||
162997125|NCT00356525|588690643|FG003|Overall Study|Progressive Disease|2|||
162997126|NCT00356525|588690640|FG000|Overall Study|Adverse Event|1|||
162997127|NCT00356525|588690641|FG001|Overall Study|Adverse Event|3|||
162997128|NCT00356525|588690642|FG002|Overall Study|Adverse Event|1|||
162997129|NCT00356525|588690643|FG003|Overall Study|Adverse Event|1|||
163324867|NCT05866926|589900716|FG001|Overall Study|Death|9|||
162997130|NCT00356525|588690640|FG000|Overall Study|Lost to Follow-up|1|||
162997131|NCT00356525|588690641|FG001|Overall Study|Lost to Follow-up|0|||
162997132|NCT00356525|588690642|FG002|Overall Study|Lost to Follow-up|0|||
162997133|NCT00356525|588690643|FG003|Overall Study|Lost to Follow-up|0|||
162997134|NCT00356525|588690640|FG000|Overall Study|Physician Decision|2|||
162997135|NCT00356525|588690641|FG001|Overall Study|Physician Decision|2|||
162997136|NCT00356525|588690642|FG002|Overall Study|Physician Decision|2|||
162997137|NCT00356525|588690643|FG003|Overall Study|Physician Decision|1|||
162997138|NCT00356525|588690640|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
162997139|NCT00356525|588690641|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
162997140|NCT00356525|588690642|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
162997141|NCT00356525|588690643|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
162997142|NCT00356525|588690640|FG000|Overall Study|Withdrawal by Subject|1|||
162997143|NCT00356525|588690641|FG001|Overall Study|Withdrawal by Subject|1|||
162997144|NCT00356525|588690642|FG002|Overall Study|Withdrawal by Subject|0|||
162997145|NCT00356525|588690643|FG003|Overall Study|Withdrawal by Subject|3|||
162997146|NCT00356525|588690640|FG000|Overall Study|Death|0|||
162997147|NCT00356525|588690641|FG001|Overall Study|Death|0|||
162997148|NCT00356525|588690642|FG002|Overall Study|Death|0|||
162997149|NCT00356525|588690643|FG003|Overall Study|Death|1|||
162997150|NCT00356525|588690640|FG000|Overall Study|Sponsor Decision|0|||
162997151|NCT00356525|588690641|FG001|Overall Study|Sponsor Decision|0|||
162997152|NCT00356525|588690642|FG002|Overall Study|Sponsor Decision|0|||
162997153|NCT00356525|588690643|FG003|Overall Study|Sponsor Decision|1|||
162997154|NCT00652340|588690644|FG000|Overall Study|Had not progressed.|4|||
162997155|NCT00652340|588690645|FG001|Overall Study|Had not progressed.|3|||
162997156|NCT03682107|588690646|FG000|Overall Study|Withdrawal by Subject|0|||
162997157|NCT03682107|588690647|FG001|Overall Study|Withdrawal by Subject|1|||
162997158|NCT03682107|588690648|FG002|Overall Study|Withdrawal by Subject|0|||
162997159|NCT03682107|588690649|FG003|Overall Study|Withdrawal by Subject|0|||
162997160|NCT03682107|588690650|FG004|Overall Study|Withdrawal by Subject|0|||
162997161|NCT00214383|588690653|FG000|Overall Study|Lost to Follow-up|16|||
162997162|NCT00214383|588690654|FG001|Overall Study|Lost to Follow-up|26|||
162997163|NCT04152291|588690655|FG000|Overall Study|Covid-19 restrictions|27|||
162997164|NCT04152291|588690655|FG000|Overall Study|Withdrawal by Subject|3|||
162997165|NCT03597295|588690656|FG000|Overall Study|Death|70|||
162997166|NCT03597295|588690656|FG000|Overall Study|Lost to Follow-up|7|||
162997167|NCT00879411|588690657|FG000|Overall Study|lost to follow-up (non-AE)|162|||
162997168|NCT05124691|588690658|FG000|Phase II|Eligibility criteria|0|||
162997169|NCT05124691|588690659|FG001|Phase II|Eligibility criteria|1|||
162997170|NCT05124691|588690660|FG002|Phase II|Eligibility criteria|0|||
162997171|NCT05124691|588690658|FG000|Phase II|Withdrawal by Subject|6|||
162997172|NCT05124691|588690659|FG001|Phase II|Withdrawal by Subject|2|||
162997173|NCT05124691|588690660|FG002|Phase II|Withdrawal by Subject|3|||
162997174|NCT05124691|588690658|FG000|Phase III|Withdrawal by Subject|6|||
162997175|NCT05124691|588690659|FG001|Phase III|Withdrawal by Subject|4|||
162997176|NCT05124691|588690660|FG002|Phase III|Withdrawal by Subject|4|||
162997177|NCT05124691|588690658|FG000|Phase III|Lost to Follow-up|1|||
162997178|NCT05124691|588690659|FG001|Phase III|Lost to Follow-up|0|||
162997179|NCT05124691|588690660|FG002|Phase III|Lost to Follow-up|0|||
162997180|NCT05211726|588690661|FG000|Overall Study|Withdrawal by Subject|2|||
162997181|NCT05211726|588690662|FG001|Overall Study|Withdrawal by Subject|3|||
162997182|NCT05211726|588690661|FG000|Overall Study|Protocol Violation|0|||
162997183|NCT05211726|588690662|FG001|Overall Study|Protocol Violation|1|||
162997184|NCT01890434|588690663|FG000|Overall Study|Adverse Event|8|||
162997185|NCT01890434|588690663|FG000|Overall Study|PCI at external hospital|1|||
162997186|NCT01890434|588690663|FG000|Overall Study|Assessment discrepancy|1|||
162997187|NCT01890434|588690663|FG000|Overall Study|CRC didn't contact participant for FU|1|||
162997188|NCT01890434|588690663|FG000|Overall Study|Could not get whole set of images|1|||
162997189|NCT01890434|588690663|FG000|Overall Study|Decline to return for GSPECT|1|||
162997190|NCT01890434|588690663|FG000|Overall Study|GSPECT at rest was not done|1|||
162997191|NCT01890434|588690663|FG000|Overall Study|Participant didn't complete MRI|1|||
162997192|NCT01890434|588690663|FG000|Overall Study|Uncontactable by phone|1|||
162997193|NCT01890434|588690663|FG000|Overall Study|Moved out of position|1|||
162997194|NCT01890434|588690663|FG000|Overall Study|Unable to contact|1|||
162997195|NCT01890434|588690663|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
162997196|NCT00428116|588690664|FG000|Overall Study|Death|1|||
162997197|NCT00428116|588690665|FG001|Overall Study|Death|0|||
162997198|NCT00428116|588690664|FG000|Overall Study|Withdrawal by Subject|1|||
162997199|NCT00428116|588690665|FG001|Overall Study|Withdrawal by Subject|0|||
162997200|NCT00428116|588690664|FG000|Overall Study|Lost to Follow-up|1|||
162997201|NCT00428116|588690665|FG001|Overall Study|Lost to Follow-up|0|||
162997202|NCT01038297|588690666|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
162997203|NCT01038297|588690667|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
162997204|NCT01038297|588690668|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
162997205|NCT02257385|588690675|FG000|Overall Study|Adverse Event|12|||
162997206|NCT02257385|588690676|FG001|Overall Study|Adverse Event|8|||
162997207|NCT02257385|588690675|FG000|Overall Study|Lack of Efficacy|1|||
162997208|NCT02257385|588690676|FG001|Overall Study|Lack of Efficacy|2|||
162997209|NCT02257385|588690675|FG000|Overall Study|Protocol Violation|5|||
162997210|NCT02257385|588690676|FG001|Overall Study|Protocol Violation|7|||
162997211|NCT02257385|588690675|FG000|Overall Study|Lost to Follow-up|0|||
162997212|NCT02257385|588690676|FG001|Overall Study|Lost to Follow-up|1|||
162997213|NCT02257385|588690675|FG000|Overall Study|Withdrawal by Subject|4|||
162997214|NCT02257385|588690676|FG001|Overall Study|Withdrawal by Subject|4|||
163060392|NCT00855582|588929878|FG000|Overall Study|Protocol Violation|6|||
162997215|NCT02714426|588690684|FG000|Overall Study|Withdrawal by Subject|2|||
162997216|NCT02714426|588690685|FG001|Overall Study|Withdrawal by Subject|2|||
162997217|NCT01449370|588690689|FG000|Overall Study|Disease Progression|5|||
162997218|NCT01449370|588690690|FG001|Overall Study|Disease Progression|4|||
162997219|NCT01449370|588690691|FG002|Overall Study|Disease Progression|8|||
162997220|NCT01449370|588690692|FG003|Overall Study|Disease Progression|3|||
162997221|NCT01449370|588690693|FG004|Overall Study|Disease Progression|3|||
162997222|NCT01449370|588690694|FG005|Overall Study|Disease Progression|3|||
162997223|NCT01449370|588690695|FG006|Overall Study|Disease Progression|3|||
163212718|NCT00665847|589492623|FG000|Overall Study|Switch to Commercial Medication|1|||
163324868|NCT05866926|589900715|FG000|Overall Study|Lost to Follow-up|0|||
163324869|NCT05866926|589900716|FG001|Overall Study|Lost to Follow-up|1|||
163324870|NCT05866926|589900715|FG000|Overall Study|Adverse Event|1|||
163324871|NCT05866926|589900716|FG001|Overall Study|Adverse Event|0|||
163324872|NCT05866926|589900715|FG000|Overall Study|Withdrawal by Subject|5|||
163324873|NCT05866926|589900716|FG001|Overall Study|Withdrawal by Subject|1|||
163324874|NCT05866926|589900715|FG000|Overall Study|Disease progression|1|||
163324875|NCT05866926|589900716|FG001|Overall Study|Disease progression|0|||
163324876|NCT05866926|589900715|FG000|Overall Study|other causes|2|||
163324877|NCT05866926|589900716|FG001|Overall Study|other causes|1|||
163324878|NCT01105091|589900717|FG000|Overall Study|Death|2|||
163060393|NCT00855582|588929879|FG001|Overall Study|Protocol Violation|2|||
163060394|NCT00855582|588929880|FG002|Overall Study|Protocol Violation|6|||
162997224|NCT01449370|588690696|FG007|Overall Study|Disease Progression|2|||
162997225|NCT01449370|588690697|FG008|Overall Study|Disease Progression|9|||
162997226|NCT01449370|588690698|FG009|Overall Study|Disease Progression|1|||
162997227|NCT01449370|588690699|FG010|Overall Study|Disease Progression|3|||
162997228|NCT01449370|588690700|FG011|Overall Study|Disease Progression|3|||
162997229|NCT01449370|588690701|FG012|Overall Study|Disease Progression|2|||
162997230|NCT01449370|588690702|FG013|Overall Study|Disease Progression|8|||
162997231|NCT01449370|588690703|FG014|Overall Study|Disease Progression|3|||
162997232|NCT01449370|588690704|FG015|Overall Study|Disease Progression|1|||
162997233|NCT01449370|588690705|FG016|Overall Study|Disease Progression|4|||
162997234|NCT01449370|588690706|FG017|Overall Study|Disease Progression|3|||
162997235|NCT01449370|588690707|FG018|Overall Study|Disease Progression|1|||
162997236|NCT01449370|588690708|FG019|Overall Study|Disease Progression|2|||
162997237|NCT01449370|588690709|FG020|Overall Study|Disease Progression|5|||
162997238|NCT01449370|588690710|FG021|Overall Study|Disease Progression|2|||
162997239|NCT01449370|588690711|FG022|Overall Study|Disease Progression|3|||
162997240|NCT01449370|588690712|FG023|Overall Study|Disease Progression|7|||
162997241|NCT01449370|588690713|FG024|Overall Study|Disease Progression|3|||
162997242|NCT01449370|588690689|FG000|Overall Study|Adverse Event|1|||
162997243|NCT01449370|588690690|FG001|Overall Study|Adverse Event|2|||
162997244|NCT01449370|588690691|FG002|Overall Study|Adverse Event|0|||
162997245|NCT01449370|588690692|FG003|Overall Study|Adverse Event|1|||
162997246|NCT01449370|588690693|FG004|Overall Study|Adverse Event|0|||
162997247|NCT01449370|588690694|FG005|Overall Study|Adverse Event|0|||
162997248|NCT01449370|588690695|FG006|Overall Study|Adverse Event|0|||
162997249|NCT01449370|588690696|FG007|Overall Study|Adverse Event|0|||
162997250|NCT01449370|588690697|FG008|Overall Study|Adverse Event|1|||
163060395|NCT00855582|588929878|FG000|Overall Study|Entry Criteria Not Met|8|||
163060396|NCT00855582|588929879|FG001|Overall Study|Entry Criteria Not Met|6|||
163060397|NCT00855582|588929880|FG002|Overall Study|Entry Criteria Not Met|3|||
163060398|NCT00855582|588929878|FG000|Overall Study|Withdrawal by Subject|7|||
163060399|NCT00855582|588929879|FG001|Overall Study|Withdrawal by Subject|4|||
163060400|NCT00855582|588929880|FG002|Overall Study|Withdrawal by Subject|8|||
163060401|NCT02832037|588929881|FG000|Overall Study|Administrative reasons|0|||
163060402|NCT02832037|588929882|FG001|Overall Study|Administrative reasons|0|||
163060403|NCT02832037|588929883|FG002|Overall Study|Administrative reasons|1|||
163324879|NCT01105091|589900718|FG001|Overall Study|Death|0|||
163324880|NCT00557492|589901375|FG000|Overall Study|Change in health insurance|1|||
162997251|NCT01449370|588690698|FG009|Overall Study|Adverse Event|1|||
162997252|NCT01449370|588690699|FG010|Overall Study|Adverse Event|0|||
162997253|NCT01449370|588690700|FG011|Overall Study|Adverse Event|0|||
162997254|NCT01449370|588690701|FG012|Overall Study|Adverse Event|0|||
162997255|NCT01449370|588690702|FG013|Overall Study|Adverse Event|2|||
162997256|NCT01449370|588690703|FG014|Overall Study|Adverse Event|0|||
162997257|NCT01449370|588690704|FG015|Overall Study|Adverse Event|1|||
162997258|NCT01449370|588690705|FG016|Overall Study|Adverse Event|0|||
162997259|NCT01449370|588690706|FG017|Overall Study|Adverse Event|0|||
162997260|NCT01449370|588690707|FG018|Overall Study|Adverse Event|1|||
162997261|NCT01449370|588690708|FG019|Overall Study|Adverse Event|1|||
162997262|NCT01449370|588690709|FG020|Overall Study|Adverse Event|0|||
163060404|NCT02832037|588929884|FG003|Overall Study|Administrative reasons|0|||
162997263|NCT01449370|588690710|FG021|Overall Study|Adverse Event|1|||
163324881|NCT03653364|589901384|FG000|Overall Study|Withdrawal by Subject|1|||
163324882|NCT03653364|589901384|FG000|Overall Study|Enrolled in Error|1|||
163324883|NCT03653364|589901384|FG000|Overall Study|Death|1|||
163324884|NCT03983382|589901387|FG000|Overall Study|Death|1|||
163324885|NCT03983382|589901387|FG000|Overall Study|Lost to Follow-up|3|||
163060405|NCT02832037|588929885|FG004|Overall Study|Administrative reasons|0|||
162997264|NCT01449370|588690711|FG022|Overall Study|Adverse Event|0|||
162997265|NCT01449370|588690712|FG023|Overall Study|Adverse Event|1|||
162997266|NCT01449370|588690713|FG024|Overall Study|Adverse Event|3|||
162997267|NCT01449370|588690689|FG000|Overall Study|Participant Decision|0|||
162997268|NCT01449370|588690690|FG001|Overall Study|Participant Decision|0|||
162997269|NCT01449370|588690691|FG002|Overall Study|Participant Decision|0|||
162997270|NCT01449370|588690692|FG003|Overall Study|Participant Decision|0|||
162997271|NCT01449370|588690693|FG004|Overall Study|Participant Decision|0|||
162997272|NCT01449370|588690694|FG005|Overall Study|Participant Decision|0|||
162997273|NCT01449370|588690695|FG006|Overall Study|Participant Decision|0|||
162997274|NCT01449370|588690696|FG007|Overall Study|Participant Decision|1|||
162997275|NCT01449370|588690697|FG008|Overall Study|Participant Decision|1|||
162997276|NCT01449370|588690698|FG009|Overall Study|Participant Decision|0|||
162997277|NCT01449370|588690699|FG010|Overall Study|Participant Decision|0|||
162997278|NCT01449370|588690700|FG011|Overall Study|Participant Decision|0|||
162997279|NCT01449370|588690701|FG012|Overall Study|Participant Decision|1|||
162997280|NCT01449370|588690702|FG013|Overall Study|Participant Decision|1|||
162997281|NCT01449370|588690703|FG014|Overall Study|Participant Decision|0|||
162997282|NCT01449370|588690704|FG015|Overall Study|Participant Decision|1|||
162997283|NCT01449370|588690705|FG016|Overall Study|Participant Decision|3|||
162997284|NCT01449370|588690706|FG017|Overall Study|Participant Decision|0|||
162997285|NCT01449370|588690707|FG018|Overall Study|Participant Decision|1|||
162997286|NCT01449370|588690708|FG019|Overall Study|Participant Decision|0|||
162997287|NCT01449370|588690709|FG020|Overall Study|Participant Decision|0|||
162997288|NCT01449370|588690710|FG021|Overall Study|Participant Decision|1|||
162997289|NCT01449370|588690711|FG022|Overall Study|Participant Decision|0|||
162997290|NCT01449370|588690712|FG023|Overall Study|Participant Decision|0|||
162997291|NCT01449370|588690713|FG024|Overall Study|Participant Decision|1|||
162997292|NCT01449370|588690689|FG000|Overall Study|Lost to Follow-up|0|||
162997293|NCT01449370|588690690|FG001|Overall Study|Lost to Follow-up|0|||
162997294|NCT01449370|588690691|FG002|Overall Study|Lost to Follow-up|0|||
162997295|NCT01449370|588690692|FG003|Overall Study|Lost to Follow-up|0|||
162997296|NCT01449370|588690693|FG004|Overall Study|Lost to Follow-up|0|||
162997297|NCT01449370|588690694|FG005|Overall Study|Lost to Follow-up|0|||
162997298|NCT01449370|588690695|FG006|Overall Study|Lost to Follow-up|0|||
162997299|NCT01449370|588690696|FG007|Overall Study|Lost to Follow-up|0|||
162997300|NCT01449370|588690697|FG008|Overall Study|Lost to Follow-up|0|||
162997301|NCT01449370|588690698|FG009|Overall Study|Lost to Follow-up|0|||
162997302|NCT01449370|588690699|FG010|Overall Study|Lost to Follow-up|0|||
162997303|NCT01449370|588690700|FG011|Overall Study|Lost to Follow-up|0|||
162997304|NCT01449370|588690701|FG012|Overall Study|Lost to Follow-up|0|||
162997305|NCT01449370|588690702|FG013|Overall Study|Lost to Follow-up|0|||
162997306|NCT01449370|588690703|FG014|Overall Study|Lost to Follow-up|0|||
162997307|NCT01449370|588690704|FG015|Overall Study|Lost to Follow-up|0|||
162997308|NCT01449370|588690705|FG016|Overall Study|Lost to Follow-up|0|||
162997309|NCT01449370|588690706|FG017|Overall Study|Lost to Follow-up|0|||
162997310|NCT01449370|588690707|FG018|Overall Study|Lost to Follow-up|0|||
162997311|NCT01449370|588690708|FG019|Overall Study|Lost to Follow-up|0|||
163060406|NCT02832037|588929881|FG000|Overall Study|Protocol Violation|3|||
163060407|NCT02832037|588929882|FG001|Overall Study|Protocol Violation|0|||
163060408|NCT02832037|588929883|FG002|Overall Study|Protocol Violation|4|||
162997312|NCT01449370|588690709|FG020|Overall Study|Lost to Follow-up|1|||
162997313|NCT01449370|588690710|FG021|Overall Study|Lost to Follow-up|0|||
162997314|NCT01449370|588690711|FG022|Overall Study|Lost to Follow-up|0|||
162997315|NCT01449370|588690712|FG023|Overall Study|Lost to Follow-up|0|||
162997316|NCT01449370|588690713|FG024|Overall Study|Lost to Follow-up|0|||
162997317|NCT01449370|588690689|FG000|Overall Study|Other|0|||
162997318|NCT01449370|588690690|FG001|Overall Study|Other|0|||
162997319|NCT01449370|588690691|FG002|Overall Study|Other|0|||
162997320|NCT01449370|588690692|FG003|Overall Study|Other|0|||
163060409|NCT02832037|588929884|FG003|Overall Study|Protocol Violation|1|||
162997321|NCT01449370|588690693|FG004|Overall Study|Other|0|||
162997322|NCT01449370|588690694|FG005|Overall Study|Other|0|||
162997323|NCT01449370|588690695|FG006|Overall Study|Other|0|||
162997324|NCT01449370|588690696|FG007|Overall Study|Other|0|||
162997325|NCT01449370|588690697|FG008|Overall Study|Other|1|||
162997326|NCT01449370|588690698|FG009|Overall Study|Other|1|||
162997327|NCT01449370|588690699|FG010|Overall Study|Other|0|||
162997328|NCT01449370|588690700|FG011|Overall Study|Other|0|||
162997329|NCT01449370|588690701|FG012|Overall Study|Other|0|||
162997330|NCT01449370|588690702|FG013|Overall Study|Other|0|||
162997331|NCT01449370|588690703|FG014|Overall Study|Other|0|||
162997332|NCT01449370|588690704|FG015|Overall Study|Other|0|||
162997333|NCT01449370|588690705|FG016|Overall Study|Other|0|||
163060410|NCT02832037|588929885|FG004|Overall Study|Protocol Violation|2|||
162997334|NCT01449370|588690706|FG017|Overall Study|Other|0|||
162997335|NCT01449370|588690707|FG018|Overall Study|Other|0|||
162997336|NCT01449370|588690708|FG019|Overall Study|Other|0|||
162997337|NCT01449370|588690709|FG020|Overall Study|Other|0|||
163060411|NCT02832037|588929881|FG000|Overall Study|Lost to Follow-up|2|||
162997338|NCT01449370|588690710|FG021|Overall Study|Other|0|||
162997339|NCT01449370|588690711|FG022|Overall Study|Other|1|||
162997340|NCT01449370|588690712|FG023|Overall Study|Other|1|||
162997341|NCT01449370|588690713|FG024|Overall Study|Other|0|||
162997342|NCT01449370|588690689|FG000|Overall Study|Medication Prohibited by Protocol|0|||
162997343|NCT01449370|588690690|FG001|Overall Study|Medication Prohibited by Protocol|0|||
162997344|NCT01449370|588690691|FG002|Overall Study|Medication Prohibited by Protocol|0|||
162997345|NCT01449370|588690692|FG003|Overall Study|Medication Prohibited by Protocol|0|||
162997346|NCT01449370|588690693|FG004|Overall Study|Medication Prohibited by Protocol|0|||
162997347|NCT01449370|588690694|FG005|Overall Study|Medication Prohibited by Protocol|0|||
162997348|NCT01449370|588690695|FG006|Overall Study|Medication Prohibited by Protocol|0|||
162997349|NCT01449370|588690696|FG007|Overall Study|Medication Prohibited by Protocol|0|||
162997350|NCT01449370|588690697|FG008|Overall Study|Medication Prohibited by Protocol|0|||
162997351|NCT01449370|588690698|FG009|Overall Study|Medication Prohibited by Protocol|0|||
162997352|NCT01449370|588690699|FG010|Overall Study|Medication Prohibited by Protocol|0|||
162997353|NCT01449370|588690700|FG011|Overall Study|Medication Prohibited by Protocol|0|||
162997354|NCT01449370|588690701|FG012|Overall Study|Medication Prohibited by Protocol|0|||
162997355|NCT01449370|588690702|FG013|Overall Study|Medication Prohibited by Protocol|0|||
162997356|NCT01449370|588690703|FG014|Overall Study|Medication Prohibited by Protocol|0|||
162997357|NCT01449370|588690704|FG015|Overall Study|Medication Prohibited by Protocol|0|||
162997358|NCT01449370|588690705|FG016|Overall Study|Medication Prohibited by Protocol|0|||
162997359|NCT01449370|588690706|FG017|Overall Study|Medication Prohibited by Protocol|0|||
162997360|NCT01449370|588690707|FG018|Overall Study|Medication Prohibited by Protocol|0|||
162997361|NCT01449370|588690708|FG019|Overall Study|Medication Prohibited by Protocol|0|||
162997362|NCT01449370|588690709|FG020|Overall Study|Medication Prohibited by Protocol|0|||
162997363|NCT01449370|588690710|FG021|Overall Study|Medication Prohibited by Protocol|0|||
162997364|NCT01449370|588690711|FG022|Overall Study|Medication Prohibited by Protocol|0|||
162997365|NCT01449370|588690712|FG023|Overall Study|Medication Prohibited by Protocol|1|||
162997366|NCT01449370|588690713|FG024|Overall Study|Medication Prohibited by Protocol|0|||
162997367|NCT01449370|588690689|FG000|Overall Study|Death|0|||
162997368|NCT01449370|588690690|FG001|Overall Study|Death|0|||
162997369|NCT01449370|588690691|FG002|Overall Study|Death|0|||
162997370|NCT01449370|588690692|FG003|Overall Study|Death|0|||
162997371|NCT01449370|588690693|FG004|Overall Study|Death|0|||
162997372|NCT01449370|588690694|FG005|Overall Study|Death|0|||
162997373|NCT01449370|588690695|FG006|Overall Study|Death|0|||
162997374|NCT01449370|588690696|FG007|Overall Study|Death|0|||
162997375|NCT01449370|588690697|FG008|Overall Study|Death|0|||
162997376|NCT01449370|588690698|FG009|Overall Study|Death|0|||
162997377|NCT01449370|588690699|FG010|Overall Study|Death|0|||
162997378|NCT01449370|588690700|FG011|Overall Study|Death|0|||
162997379|NCT01449370|588690701|FG012|Overall Study|Death|0|||
162997380|NCT01449370|588690702|FG013|Overall Study|Death|0|||
162997381|NCT01449370|588690703|FG014|Overall Study|Death|0|||
163212719|NCT00180414|589494292|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
163212720|NCT00180414|589494293|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
162997382|NCT01449370|588690704|FG015|Overall Study|Death|0|||
162997383|NCT01449370|588690705|FG016|Overall Study|Death|0|||
162997384|NCT01449370|588690706|FG017|Overall Study|Death|0|||
162997385|NCT01449370|588690707|FG018|Overall Study|Death|0|||
162997386|NCT01449370|588690708|FG019|Overall Study|Death|0|||
162997387|NCT01449370|588690709|FG020|Overall Study|Death|0|||
162997388|NCT01449370|588690710|FG021|Overall Study|Death|0|||
162997389|NCT01449370|588690711|FG022|Overall Study|Death|0|||
163212721|NCT00623727|589494294|FG000|Double Blind (DB)|Adverse Event|1|||
162997390|NCT01449370|588690712|FG023|Overall Study|Death|0|||
162997391|NCT01449370|588690713|FG024|Overall Study|Death|1|||
162997392|NCT00086281|588690714|FG000|Phase 1|Adverse Event|0|||
162997393|NCT00086281|588690715|FG001|Phase 1|Adverse Event|0|||
162997394|NCT00086281|588690716|FG002|Phase 1|Adverse Event|0|||
162997395|NCT00086281|588690717|FG003|Phase 1|Adverse Event|0|||
162997396|NCT00086281|588690718|FG004|Phase 1|Adverse Event|0|||
162997397|NCT00086281|588690719|FG005|Phase 1|Adverse Event|0|||
162997398|NCT00086281|588690720|FG006|Phase 1|Adverse Event|0|||
162997399|NCT00086281|588690721|FG007|Phase 1|Adverse Event|0|||
162997400|NCT00086281|588690722|FG008|Phase 1|Adverse Event|0|||
162997401|NCT00086281|588690723|FG009|Phase 1|Adverse Event|1|||
162997402|NCT00086281|588690724|FG010|Phase 1|Adverse Event|2|||
162997403|NCT00086281|588690725|FG011|Phase 1|Adverse Event|1|||
162997404|NCT00086281|588690726|FG012|Phase 1|Adverse Event|1|||
162997405|NCT00086281|588690727|FG013|Phase 1|Adverse Event|1|||
162997406|NCT00086281|588690728|FG014|Phase 1|Adverse Event|2|||
162997407|NCT00086281|588690714|FG000|Phase 1|Protocol Violation|0|||
162997408|NCT00086281|588690715|FG001|Phase 1|Protocol Violation|0|||
163060412|NCT02832037|588929882|FG001|Overall Study|Lost to Follow-up|0|||
163212722|NCT00623727|589494295|FG001|Double Blind (DB)|Adverse Event|3|||
163212723|NCT00623727|589494294|FG000|Double Blind (DB)|Physician Decision|0|||
163212724|NCT00623727|589494295|FG001|Double Blind (DB)|Physician Decision|1|||
163212725|NCT00623727|589494294|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
162997409|NCT00086281|588690716|FG002|Phase 1|Protocol Violation|0|||
162997410|NCT00086281|588690717|FG003|Phase 1|Protocol Violation|0|||
162997411|NCT00086281|588690718|FG004|Phase 1|Protocol Violation|0|||
162997412|NCT00086281|588690719|FG005|Phase 1|Protocol Violation|0|||
162997413|NCT00086281|588690720|FG006|Phase 1|Protocol Violation|0|||
162997414|NCT00086281|588690721|FG007|Phase 1|Protocol Violation|0|||
162997415|NCT00086281|588690722|FG008|Phase 1|Protocol Violation|0|||
162997416|NCT00086281|588690723|FG009|Phase 1|Protocol Violation|0|||
162997417|NCT00086281|588690724|FG010|Phase 1|Protocol Violation|1|||
162997418|NCT00086281|588690725|FG011|Phase 1|Protocol Violation|0|||
162997419|NCT00086281|588690726|FG012|Phase 1|Protocol Violation|0|||
162997420|NCT00086281|588690727|FG013|Phase 1|Protocol Violation|0|||
162997421|NCT00086281|588690728|FG014|Phase 1|Protocol Violation|0|||
162997422|NCT00086281|588690714|FG000|Phase 1|Serious Adverse Event|0|||
162997423|NCT00086281|588690715|FG001|Phase 1|Serious Adverse Event|0|||
162997424|NCT00086281|588690716|FG002|Phase 1|Serious Adverse Event|0|||
162997425|NCT00086281|588690717|FG003|Phase 1|Serious Adverse Event|0|||
162997426|NCT00086281|588690718|FG004|Phase 1|Serious Adverse Event|0|||
162997427|NCT00086281|588690719|FG005|Phase 1|Serious Adverse Event|0|||
162997428|NCT00086281|588690720|FG006|Phase 1|Serious Adverse Event|0|||
162997429|NCT00086281|588690721|FG007|Phase 1|Serious Adverse Event|0|||
162997430|NCT00086281|588690722|FG008|Phase 1|Serious Adverse Event|0|||
162997431|NCT00086281|588690723|FG009|Phase 1|Serious Adverse Event|0|||
162997432|NCT00086281|588690724|FG010|Phase 1|Serious Adverse Event|0|||
162997433|NCT00086281|588690725|FG011|Phase 1|Serious Adverse Event|0|||
162997434|NCT00086281|588690726|FG012|Phase 1|Serious Adverse Event|0|||
162997435|NCT00086281|588690727|FG013|Phase 1|Serious Adverse Event|0|||
162997436|NCT00086281|588690728|FG014|Phase 1|Serious Adverse Event|1|||
162997437|NCT00086281|588690714|FG000|Phase 2|Adverse Event|0|||
162997438|NCT00086281|588690715|FG001|Phase 2|Adverse Event|0|||
162997439|NCT00086281|588690716|FG002|Phase 2|Adverse Event|0|||
162997440|NCT00086281|588690717|FG003|Phase 2|Adverse Event|0|||
162997441|NCT00086281|588690718|FG004|Phase 2|Adverse Event|0|||
162997442|NCT00086281|588690719|FG005|Phase 2|Adverse Event|0|||
162997443|NCT00086281|588690720|FG006|Phase 2|Adverse Event|0|||
162997444|NCT00086281|588690721|FG007|Phase 2|Adverse Event|0|||
162997445|NCT00086281|588690722|FG008|Phase 2|Adverse Event|0|||
162997446|NCT00086281|588690723|FG009|Phase 2|Adverse Event|0|||
162997447|NCT00086281|588690724|FG010|Phase 2|Adverse Event|0|||
162997448|NCT00086281|588690725|FG011|Phase 2|Adverse Event|0|||
162997449|NCT00086281|588690726|FG012|Phase 2|Adverse Event|1|||
162997450|NCT00086281|588690727|FG013|Phase 2|Adverse Event|1|||
162997451|NCT00086281|588690728|FG014|Phase 2|Adverse Event|0|||
162997452|NCT00908310|588690731|FG000|Overall Study|Death|37|||
162997453|NCT00908310|588690731|FG000|Overall Study|Withdrawal by Subject|7|||
162997454|NCT00908310|588690731|FG000|Overall Study|Lost to Follow-up|7|||
162997455|NCT00908310|588690731|FG000|Overall Study|Screening failure|5|||
162997456|NCT00908310|588690731|FG000|Overall Study|Other reasons|4|||
162997457|NCT00896480|588690734|FG000|Overall Study|Disease progression/recurrence|21|||
162997458|NCT00725205|588690737|FG000|Overall Study|Adverse Event|22|||
162997459|NCT00725205|588690737|FG000|Overall Study|Investigator Discontinued|1|||
162997460|NCT00725205|588690737|FG000|Overall Study|Non-compliance With Protocol|14|||
162997461|NCT00725205|588690737|FG000|Overall Study|Other|8|||
162997462|NCT00725205|588690737|FG000|Overall Study|Protocol Defined Clinical Event|1|||
162997463|NCT00725205|588690737|FG000|Overall Study|Treatment Failure|41|||
162997464|NCT03014180|588690740|FG000|Overall Study|Protocol Violation|2|||
162997465|NCT02212379|588690744|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
162997466|NCT02212379|588690744|FG000|From Baseline to Week 48|Adverse Event|7|||
162997467|NCT02212379|588690744|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
163324886|NCT03983382|589901387|FG000|Overall Study|Physician Decision|2|||
163324887|NCT03983382|589901387|FG000|Overall Study|Withdrawal by Subject|10|||
163324888|NCT03983382|589901387|FG000|Overall Study|Change in cancer treatment|2|||
163324889|NCT02567435|589901395|FG000|Overall Study|Death|1|||
163324890|NCT02567435|589901396|FG001|Overall Study|Death|1|||
163324891|NCT02567435|589901397|FG002|Overall Study|Death|0|||
162997468|NCT02212379|588690744|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
162997469|NCT02212379|588690744|FG000|From Week 48 to Week 96|Adverse Event|1|||
162997470|NCT02212379|588690744|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
162997471|NCT04784533|588690745|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
162997472|NCT04784533|588690746|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
162997473|NCT04784533|588690747|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
162997474|NCT04784533|588690748|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
162997475|NCT04784533|588690749|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
162997476|NCT04784533|588690750|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
162997477|NCT04784533|588690751|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
162997478|NCT04784533|588690752|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
162997479|NCT04784533|588690753|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
163060413|NCT02832037|588929883|FG002|Overall Study|Lost to Follow-up|3|||
162997480|NCT04784533|588690754|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
162997481|NCT04784533|588690745|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
162997482|NCT04784533|588690746|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
162997483|NCT04784533|588690747|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997484|NCT04784533|588690748|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997485|NCT04784533|588690749|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997486|NCT04784533|588690750|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997487|NCT04784533|588690751|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997488|NCT04784533|588690752|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997489|NCT04784533|588690753|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997490|NCT04784533|588690754|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997491|NCT04784533|588690745|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997492|NCT04784533|588690746|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
162997493|NCT04784533|588690747|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997494|NCT04784533|588690748|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997495|NCT04784533|588690749|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997496|NCT04784533|588690750|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997497|NCT04784533|588690751|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997498|NCT04784533|588690752|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997499|NCT04784533|588690753|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997500|NCT04784533|588690754|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997501|NCT04784533|588690745|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
162997502|NCT04784533|588690746|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997503|NCT04784533|588690747|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997504|NCT04784533|588690748|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997505|NCT04784533|588690749|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997506|NCT04784533|588690750|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997507|NCT04784533|588690751|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997508|NCT04784533|588690752|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997509|NCT04784533|588690753|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997510|NCT04784533|588690754|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997511|NCT04784533|588690745|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
162997512|NCT04784533|588690746|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
162997513|NCT04784533|588690747|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
162997514|NCT04784533|588690748|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
162997515|NCT04784533|588690749|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
162997516|NCT04784533|588690750|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
163060414|NCT02832037|588929884|FG003|Overall Study|Lost to Follow-up|0|||
163060415|NCT02832037|588929885|FG004|Overall Study|Lost to Follow-up|5|||
162997517|NCT04784533|588690751|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
162997518|NCT04784533|588690752|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
162997519|NCT04784533|588690753|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
162997520|NCT04784533|588690754|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
162997521|NCT04784533|588690745|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
162997522|NCT04784533|588690746|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
162997523|NCT04784533|588690747|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
163060416|NCT02832037|588929881|FG000|Overall Study|Withdrawal by Subject|9|||
163060417|NCT02832037|588929882|FG001|Overall Study|Withdrawal by Subject|8|||
163060418|NCT02832037|588929883|FG002|Overall Study|Withdrawal by Subject|0|||
163060419|NCT02832037|588929884|FG003|Overall Study|Withdrawal by Subject|4|||
163060420|NCT02832037|588929885|FG004|Overall Study|Withdrawal by Subject|8|||
162997524|NCT04784533|588690748|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
162997525|NCT04784533|588690749|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
162997526|NCT04784533|588690750|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
163060421|NCT02832037|588929881|FG000|Overall Study|Adverse Event|5|||
163060422|NCT02832037|588929882|FG001|Overall Study|Adverse Event|4|||
162997527|NCT04784533|588690751|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
162997528|NCT04784533|588690752|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
162997529|NCT04784533|588690753|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
162997530|NCT04784533|588690754|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
162997531|NCT04784533|588690745|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
163060423|NCT02832037|588929883|FG002|Overall Study|Adverse Event|0|||
163060424|NCT02832037|588929884|FG003|Overall Study|Adverse Event|2|||
163060425|NCT02832037|588929885|FG004|Overall Study|Adverse Event|4|||
163060426|NCT04727749|588929892|FG000|Overall Study|Lost to Follow-up|10|||
163060427|NCT04727749|588929893|FG001|Overall Study|Lost to Follow-up|3|||
162997532|NCT04784533|588690746|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997533|NCT04784533|588690747|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
162997534|NCT04784533|588690748|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997535|NCT04784533|588690749|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997536|NCT04784533|588690750|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997537|NCT04784533|588690751|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997538|NCT04784533|588690752|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997539|NCT04784533|588690753|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997540|NCT04784533|588690754|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997541|NCT04784533|588690745|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997542|NCT04784533|588690746|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997543|NCT04784533|588690747|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997544|NCT04784533|588690748|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997545|NCT04784533|588690749|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997546|NCT04784533|588690750|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997547|NCT04784533|588690751|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997548|NCT04784533|588690752|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997549|NCT04784533|588690753|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
162997550|NCT04784533|588690754|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997551|NCT04784533|588690745|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
162997552|NCT04784533|588690746|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
162997553|NCT04784533|588690747|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
162997554|NCT04784533|588690748|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
162997555|NCT04784533|588690749|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
162997556|NCT04784533|588690750|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
163324892|NCT02567435|589901398|FG003|Overall Study|Death|0|||
163324893|NCT02567435|589901395|FG000|Overall Study|Ineligible|1|||
163324894|NCT02567435|589901396|FG001|Overall Study|Ineligible|3|||
162997557|NCT04784533|588690751|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
162997558|NCT04784533|588690752|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
162997559|NCT04784533|588690753|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
162997560|NCT04784533|588690754|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
162997561|NCT02682927|588690770|FG000|Overall Study|Adverse Event|0|||
162997562|NCT02682927|588690771|FG001|Overall Study|Adverse Event|0|||
162997563|NCT02682927|588690772|FG002|Overall Study|Adverse Event|5|||
162997564|NCT02682927|588690773|FG003|Overall Study|Adverse Event|1|||
162997565|NCT02682927|588690774|FG004|Overall Study|Adverse Event|0|||
162997566|NCT02682927|588690775|FG005|Overall Study|Adverse Event|2|||
162997567|NCT02682927|588690770|FG000|Overall Study|Death|0|||
162997568|NCT02682927|588690771|FG001|Overall Study|Death|0|||
162997569|NCT02682927|588690772|FG002|Overall Study|Death|0|||
162997570|NCT02682927|588690773|FG003|Overall Study|Death|1|||
162997571|NCT02682927|588690774|FG004|Overall Study|Death|0|||
162997572|NCT02682927|588690775|FG005|Overall Study|Death|0|||
162997573|NCT02682927|588690770|FG000|Overall Study|Lack of Efficacy|1|||
162997574|NCT02682927|588690771|FG001|Overall Study|Lack of Efficacy|0|||
162997575|NCT02682927|588690772|FG002|Overall Study|Lack of Efficacy|0|||
162997576|NCT02682927|588690773|FG003|Overall Study|Lack of Efficacy|1|||
162997577|NCT02682927|588690774|FG004|Overall Study|Lack of Efficacy|0|||
163060428|NCT02378181|588929894|FG000|Overall Study|Lost to Follow-up|2|||
163060429|NCT02378181|588929895|FG001|Overall Study|Lost to Follow-up|5|||
163060430|NCT02378181|588929894|FG000|Overall Study|Withdrawal by Subject|1|||
163060431|NCT02378181|588929895|FG001|Overall Study|Withdrawal by Subject|1|||
162997578|NCT02682927|588690775|FG005|Overall Study|Lack of Efficacy|0|||
162997579|NCT02682927|588690770|FG000|Overall Study|Other|0|||
162997580|NCT02682927|588690771|FG001|Overall Study|Other|0|||
162997581|NCT02682927|588690772|FG002|Overall Study|Other|0|||
162997582|NCT02682927|588690773|FG003|Overall Study|Other|2|||
162997583|NCT02682927|588690774|FG004|Overall Study|Other|0|||
162997584|NCT02682927|588690775|FG005|Overall Study|Other|0|||
162997585|NCT02682927|588690770|FG000|Overall Study|Withdrawal by Subject|2|||
162997586|NCT02682927|588690771|FG001|Overall Study|Withdrawal by Subject|0|||
162997587|NCT02682927|588690772|FG002|Overall Study|Withdrawal by Subject|1|||
162997588|NCT02682927|588690773|FG003|Overall Study|Withdrawal by Subject|0|||
162997589|NCT02682927|588690774|FG004|Overall Study|Withdrawal by Subject|1|||
162997590|NCT02682927|588690775|FG005|Overall Study|Withdrawal by Subject|1|||
162997591|NCT03462459|588690776|FG000|Overall Study|Death|1|||
163060432|NCT02378181|588929894|FG000|Overall Study|Incarcerated|0|||
162997592|NCT03462459|588690777|FG001|Overall Study|Death|0|||
162997593|NCT03462459|588690776|FG000|Overall Study|Lack of Efficacy|2|||
162997594|NCT03462459|588690777|FG001|Overall Study|Lack of Efficacy|4|||
162997595|NCT03462459|588690776|FG000|Overall Study|Lost to Follow-up|1|||
162997596|NCT03462459|588690777|FG001|Overall Study|Lost to Follow-up|3|||
163060433|NCT02378181|588929895|FG001|Overall Study|Incarcerated|1|||
163324895|NCT02567435|589901397|FG002|Overall Study|Ineligible|0|||
163324896|NCT02567435|589901398|FG003|Overall Study|Ineligible|0|||
162997597|NCT03462459|588690776|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
162997598|NCT03462459|588690777|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
162997599|NCT03462459|588690776|FG000|Overall Study|Withdrawal by Subject|3|||
162997600|NCT03462459|588690777|FG001|Overall Study|Withdrawal by Subject|2|||
162997601|NCT03462459|588690776|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
162997602|NCT03462459|588690777|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
162997603|NCT01243775|588690778|FG000|Overall Study|Withdrawal by Subject|2|||
162997604|NCT01177059|588690779|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
162997605|NCT01177059|588690779|FG000|Overall Study|Withdrew consent|2|||
162997606|NCT01177059|588690779|FG000|Overall Study|Lost to Follow-up|18|||
162997607|NCT04051619|588690780|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
162997608|NCT04051619|588690781|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
162997609|NCT04051619|588690780|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
162997610|NCT04051619|588690781|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
162997611|NCT05938621|588691961|FG000|Overall Study|Lost to Follow-up|1|||
162997612|NCT05938621|588691962|FG001|Overall Study|Lost to Follow-up|5|||
162997613|NCT05938621|588691963|FG002|Overall Study|Lost to Follow-up|2|||
162997614|NCT05938621|588691964|FG003|Overall Study|Lost to Follow-up|2|||
162997615|NCT03922529|588691969|FG000|Overall Study|Withdrawal by Subject|13|||
162997616|NCT03922529|588691970|FG001|Overall Study|Withdrawal by Subject|12|||
162997617|NCT03922529|588691969|FG000|Overall Study|Death|7|||
162997618|NCT03922529|588691970|FG001|Overall Study|Death|12|||
162997619|NCT03922529|588691969|FG000|Overall Study|Lost to Follow-up|12|||
162997620|NCT03922529|588691970|FG001|Overall Study|Lost to Follow-up|19|||
162997621|NCT03922529|588691969|FG000|Overall Study|Adverse Event|1|||
162997622|NCT03922529|588691970|FG001|Overall Study|Adverse Event|0|||
162997623|NCT03922529|588691969|FG000|Overall Study|Death after withdrawal|1|||
162997624|NCT03922529|588691970|FG001|Overall Study|Death after withdrawal|0|||
162997625|NCT03922529|588691969|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
162997626|NCT03922529|588691970|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
162997627|NCT03922529|588691969|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
162997628|NCT03922529|588691970|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
162997629|NCT02731638|588691971|FG000|Overall Study|Lost to Follow-up|6|||
162997630|NCT02731638|588691972|FG001|Overall Study|Lost to Follow-up|9|||
162997631|NCT04158245|588691973|FG000|Overall Study|Lost to Follow-up|1|||
162997632|NCT02454608|588691974|FG000|Double-Blind Period|Lack of Efficacy|0|||
162997633|NCT02454608|588691975|FG001|Double-Blind Period|Lack of Efficacy|2|||
162997634|NCT02454608|588691976|FG002|Double-Blind Period|Lack of Efficacy|0|||
162997635|NCT02454608|588691974|FG000|Open Label Period|Lost to Follow-up|0|||
162997636|NCT02454608|588691975|FG001|Open Label Period|Lost to Follow-up|0|||
162997637|NCT02454608|588691976|FG002|Open Label Period|Lost to Follow-up|11|||
162997638|NCT02454608|588691974|FG000|Open Label Period|Withdrawal by Subject|0|||
162997639|NCT02454608|588691975|FG001|Open Label Period|Withdrawal by Subject|0|||
162997640|NCT02454608|588691976|FG002|Open Label Period|Withdrawal by Subject|8|||
162997641|NCT02465398|588691977|FG000|Overall Study|Death|7|||
162997642|NCT02465398|588691977|FG000|Overall Study|Revision|7|||
162997643|NCT02465398|588691977|FG000|Overall Study|did not receive study device|1|||
162997644|NCT02465398|588691977|FG000|Overall Study|Withdrawal by Subject|1|||
162997645|NCT02465398|588691977|FG000|Overall Study|Lost to Follow-up|14|||
162997646|NCT02540850|588691978|FG000|Overall Study|Lost to Follow-up|69|||
162997647|NCT02540850|588691979|FG001|Overall Study|Lost to Follow-up|66|||
163060434|NCT01180777|588929897|FG000|Overall Study|Protocol Violation|6|||
163060435|NCT01180777|588929897|FG000|Overall Study|Poor lens fit|4|||
163060436|NCT01180777|588929897|FG000|Overall Study|Lost to Follow-up|1|||
163060437|NCT01180777|588929897|FG000|Overall Study|Adverse Event|1|||
163060438|NCT04167462|588929898|FG000|Overall Study|Other reasons|3|||
163060439|NCT04167462|588929899|FG001|Overall Study|Other reasons|2|||
162997648|NCT02540850|588691980|FG002|Overall Study|Lost to Follow-up|34|||
162997649|NCT03760185|588691991|FG000|Overall Study|Lost to Follow-up|1|||
162997650|NCT03760185|588691992|FG001|Overall Study|Lost to Follow-up|1|||
162997651|NCT02473523|588691993|FG000|Overall Study|Death|1|||
162997652|NCT02473523|588691993|FG000|Overall Study|Lost to Follow-up|1|||
162997653|NCT02111603|588691996|FG000|Overall Study|Withdrawal by Subject|1|||
162997654|NCT00976911|588691997|FG000|Overall Study|Withdrawal by Subject|4|||
162997655|NCT00976911|588691998|FG001|Overall Study|Withdrawal by Subject|6|||
162997656|NCT00976911|588691997|FG000|Overall Study|Death|138|||
162997657|NCT00976911|588691998|FG001|Overall Study|Death|126|||
162997658|NCT00976911|588691997|FG000|Overall Study|Adverse Event|0|||
162997659|NCT00976911|588691998|FG001|Overall Study|Adverse Event|1|||
162997660|NCT00976911|588691997|FG000|Overall Study|Protocol Violation|2|||
162997661|NCT00976911|588691998|FG001|Overall Study|Protocol Violation|0|||
162997662|NCT00976911|588691997|FG000|Overall Study|Other|8|||
162997663|NCT00976911|588691998|FG001|Overall Study|Other|9|||
162997664|NCT00976911|588691997|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
163060440|NCT04167462|588929898|FG000|Overall Study|Withdrawal by Subject|6|||
162997665|NCT00976911|588691998|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
162997666|NCT02954991|588691999|FG000|Overall Study|Death|92|||
162997667|NCT02954991|588692000|FG001|Overall Study|Death|11|||
162997668|NCT02954991|588692001|FG002|Overall Study|Death|2|||
162997669|NCT02954991|588691999|FG000|Overall Study|Lost to Follow-up|3|||
162997670|NCT02954991|588692000|FG001|Overall Study|Lost to Follow-up|2|||
162997671|NCT02954991|588692001|FG002|Overall Study|Lost to Follow-up|0|||
162997672|NCT02954991|588691999|FG000|Overall Study|Withdrawal by Subject|9|||
162997673|NCT02954991|588692000|FG001|Overall Study|Withdrawal by Subject|8|||
162997674|NCT02954991|588692001|FG002|Overall Study|Withdrawal by Subject|1|||
162997675|NCT02954991|588691999|FG000|Overall Study|Study Terminated by Sponsor|18|||
162997676|NCT02954991|588692000|FG001|Overall Study|Study Terminated by Sponsor|10|||
162997677|NCT02954991|588692001|FG002|Overall Study|Study Terminated by Sponsor|1|||
162997678|NCT02954991|588691999|FG000|Overall Study|Miscellaneous|2|||
162997679|NCT02954991|588692000|FG001|Overall Study|Miscellaneous|1|||
162997680|NCT02954991|588692001|FG002|Overall Study|Miscellaneous|1|||
162997681|NCT00576316|588692002|FG000|Overall Study|Adverse Event|9|||
162997682|NCT00576316|588692002|FG000|Overall Study|Withdrawal by Subject|2|||
162997683|NCT00576316|588692002|FG000|Overall Study|Protocol Violation|9|||
162997684|NCT02552303|588692005|FG000|Allocation|Withdrawal by Subject|2|||
162997685|NCT02552303|588692006|FG001|Allocation|Withdrawal by Subject|1|||
162997686|NCT02552303|588692007|FG002|Allocation|Withdrawal by Subject|1|||
162997687|NCT02552303|588692008|FG003|Allocation|Withdrawal by Subject|1|||
162997688|NCT02552303|588692005|FG000|Allocation|ineligible|1|||
162997689|NCT02552303|588692006|FG001|Allocation|ineligible|1|||
162997690|NCT02552303|588692007|FG002|Allocation|ineligible|0|||
162997691|NCT02552303|588692008|FG003|Allocation|ineligible|0|||
162997692|NCT02552303|588692005|FG000|Follow-Up|Lost to Follow-up|0|||
162997693|NCT02552303|588692006|FG001|Follow-Up|Lost to Follow-up|0|||
162997694|NCT02552303|588692007|FG002|Follow-Up|Lost to Follow-up|1|||
162997695|NCT02552303|588692008|FG003|Follow-Up|Lost to Follow-up|0|||
162997696|NCT02552303|588692005|FG000|Follow-Up|ineligible|0|||
162997697|NCT02552303|588692006|FG001|Follow-Up|ineligible|2|||
162997698|NCT02552303|588692007|FG002|Follow-Up|ineligible|0|||
162997699|NCT02552303|588692008|FG003|Follow-Up|ineligible|0|||
162997700|NCT01582152|588692009|FG000|Overall Study|Disease Progression|4|||
162997701|NCT01582152|588692010|FG001|Overall Study|Disease Progression|5|||
162997702|NCT01582152|588692009|FG000|Overall Study|Adverse Event|2|||
162997703|NCT01582152|588692010|FG001|Overall Study|Adverse Event|1|||
162997704|NCT03055624|588692011|FG000|Overall Study|Study closed|9|||
162997705|NCT02437903|588692014|FG000|Overall Study|Adverse Event|1|||
162997706|NCT02437903|588692014|FG000|Overall Study|Withdrawal by Subject|1|||
162997707|NCT02437903|588692014|FG000|Overall Study|Lost to Follow-up|3|||
162997708|NCT00230178|588692015|FG000|Overall Study|Adverse Event|1|||
162997709|NCT00230178|588692016|FG001|Overall Study|Adverse Event|5|||
162997710|NCT00230178|588692017|FG002|Overall Study|Adverse Event|2|||
162997711|NCT00230178|588692015|FG000|Overall Study|Withdrawal by Subject|0|||
162997712|NCT00230178|588692016|FG001|Overall Study|Withdrawal by Subject|0|||
162997713|NCT00230178|588692017|FG002|Overall Study|Withdrawal by Subject|1|||
162997714|NCT00230178|588692015|FG000|Overall Study|Various other reasons|3|||
162997715|NCT00230178|588692016|FG001|Overall Study|Various other reasons|2|||
163060441|NCT04167462|588929899|FG001|Overall Study|Withdrawal by Subject|7|||
162997716|NCT00230178|588692017|FG002|Overall Study|Various other reasons|4|||
162997717|NCT01275729|588692020|FG000|Overall Study|Death|3|||
162997718|NCT01275729|588692020|FG000|Overall Study|Withdrawal by Subject|1|||
162997719|NCT02252406|588692025|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
162997720|NCT02252406|588692026|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
163060442|NCT04167462|588929898|FG000|Overall Study|Adverse Event|4|||
163324897|NCT02567435|589901395|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
162997721|NCT02252406|588692025|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
162997722|NCT02252406|588692026|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
163060443|NCT04167462|588929899|FG001|Overall Study|Adverse Event|0|||
162997723|NCT02252406|588692025|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
162997724|NCT02252406|588692026|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
162997725|NCT02252406|588692025|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
162997726|NCT02252406|588692026|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
162997727|NCT02252406|588692025|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
162997728|NCT02252406|588692026|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
162997729|NCT00005957|588692029|FG000|Overall Study|No treated|3|||
162997730|NCT00005957|588692030|FG001|Overall Study|No treated|9|||
162997731|NCT00005957|588692029|FG000|Overall Study|Crossover to the other arm|5|||
162997732|NCT00005957|588692030|FG001|Overall Study|Crossover to the other arm|19|||
162997733|NCT01609023|588692031|FG000|Overall Study|Lack of Efficacy|3|||
162997734|NCT01609023|588692031|FG000|Overall Study|Withdrawal by Subject|4|||
163060444|NCT04167462|588929898|FG000|Overall Study|Pregnancy|1|||
162997735|NCT01609023|588692031|FG000|Overall Study|Lost to Follow-up|8|||
162997736|NCT01609023|588692031|FG000|Overall Study|Toxicity|3|||
163060445|NCT04167462|588929899|FG001|Overall Study|Pregnancy|0|||
162997737|NCT01609023|588692031|FG000|Overall Study|Disease progression|10|||
162997738|NCT01609023|588692031|FG000|Overall Study|Physician Decision|2|||
162997739|NCT01609023|588692031|FG000|Overall Study|Death|2|||
162997740|NCT01609023|588692031|FG000|Overall Study|Personal reasons|1|||
162997741|NCT00799825|588692032|FG000|Overall Study|Adverse Event|1|||
162997742|NCT00799825|588692032|FG000|Overall Study|Withdrawal by Subject|6|||
162997743|NCT00799825|588692032|FG000|Overall Study|Lost to Follow-up|38|||
162997744|NCT00799825|588692032|FG000|Overall Study|Pregnancy|3|||
162997745|NCT00362336|588692033|FG000|Overall Study|Serious Adverse Event|1|||
162997746|NCT00362336|588692034|FG001|Overall Study|Serious Adverse Event|0|||
162997747|NCT00362336|588692035|FG002|Overall Study|Serious Adverse Event|1|||
162997748|NCT00362336|588692033|FG000|Overall Study|Protocol Violation|0|||
162997749|NCT00362336|588692034|FG001|Overall Study|Protocol Violation|0|||
162997750|NCT00362336|588692035|FG002|Overall Study|Protocol Violation|1|||
162997751|NCT00362336|588692033|FG000|Overall Study|Lost to Follow-up|6|||
162997752|NCT00362336|588692034|FG001|Overall Study|Lost to Follow-up|4|||
162997753|NCT00362336|588692035|FG002|Overall Study|Lost to Follow-up|0|||
162997754|NCT00362336|588692033|FG000|Overall Study|Withdrawal by Subject|3|||
162997755|NCT00362336|588692034|FG001|Overall Study|Withdrawal by Subject|3|||
162997756|NCT00362336|588692035|FG002|Overall Study|Withdrawal by Subject|1|||
162997757|NCT04974749|588692036|FG000|Overall Study|Withdrawal by Subject|2|||
162997758|NCT04974749|588692036|FG000|Overall Study|Gestation|1|||
162997759|NCT01520870|588692037|FG000|Overall Study|Withdrawal by Subject|2|||
162997760|NCT02289456|588692038|FG000|Induction Period|Death|2|||
162997761|NCT02289456|588692038|FG000|Induction Period|Adverse Event|11|||
162997762|NCT02289456|588692038|FG000|Induction Period|Progressive Disease (PD)|4|||
162997763|NCT02289456|588692038|FG000|Induction Period|Symptomatic Deterioration|4|||
162997764|NCT02289456|588692038|FG000|Induction Period|Withdrawal by Subject|2|||
162997765|NCT02289456|588692038|FG000|Induction Period|Miscellaneous|1|||
162997766|NCT02289456|588692038|FG000|Monotherapy Period|Death|1|||
162997767|NCT02289456|588692038|FG000|Monotherapy Period|Adverse Event|1|||
162997768|NCT02289456|588692038|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
162997769|NCT02289456|588692038|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
162997770|NCT02289456|588692038|FG000|Monotherapy Period|Withdrawal by Subject|2|||
162997771|NCT02289456|588692038|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
162997772|NCT02289456|588692038|FG000|Monotherapy Period|Miscellaneous|1|||
162997773|NCT00796107|588692044|FG000|Overall Study|Lack of Efficacy|1|||
162997774|NCT00796107|588692044|FG000|Overall Study|Progressive Disease|5|||
162997775|NCT02681510|588692049|FG000|Overall Study|Withdrawal by Subject|1|||
162997776|NCT02681510|588692049|FG000|Overall Study|Lost to Follow-up|9|||
162997777|NCT02797171|588692053|FG000|Overall Study|Lost to Follow-up|2|||
162997778|NCT02797171|588692054|FG001|Overall Study|Lost to Follow-up|0|||
162997779|NCT02797171|588692055|FG002|Overall Study|Lost to Follow-up|2|||
162997780|NCT02797171|588692056|FG003|Overall Study|Lost to Follow-up|1|||
162997781|NCT02797171|588692057|FG004|Overall Study|Lost to Follow-up|2|||
162997782|NCT02797171|588692058|FG005|Overall Study|Lost to Follow-up|0|||
162997783|NCT02797171|588692053|FG000|Overall Study|Withdrawal by Subject|1|||
162997784|NCT02797171|588692054|FG001|Overall Study|Withdrawal by Subject|1|||
162997785|NCT02797171|588692055|FG002|Overall Study|Withdrawal by Subject|0|||
162997786|NCT02797171|588692056|FG003|Overall Study|Withdrawal by Subject|0|||
162997787|NCT02797171|588692057|FG004|Overall Study|Withdrawal by Subject|0|||
162997788|NCT02797171|588692058|FG005|Overall Study|Withdrawal by Subject|0|||
162997789|NCT02797171|588692053|FG000|Overall Study|Protocol Violation|1|||
162997790|NCT02797171|588692054|FG001|Overall Study|Protocol Violation|0|||
162997791|NCT02797171|588692055|FG002|Overall Study|Protocol Violation|0|||
162997792|NCT02797171|588692056|FG003|Overall Study|Protocol Violation|0|||
162997793|NCT02797171|588692057|FG004|Overall Study|Protocol Violation|0|||
162997794|NCT02797171|588692058|FG005|Overall Study|Protocol Violation|0|||
162997795|NCT02797171|588692053|FG000|Overall Study|Participant unable to adhere|0|||
162997796|NCT02797171|588692054|FG001|Overall Study|Participant unable to adhere|1|||
162997797|NCT02797171|588692055|FG002|Overall Study|Participant unable to adhere|0|||
162997798|NCT02797171|588692056|FG003|Overall Study|Participant unable to adhere|0|||
162997799|NCT02797171|588692057|FG004|Overall Study|Participant unable to adhere|0|||
162997800|NCT02797171|588692058|FG005|Overall Study|Participant unable to adhere|0|||
162997801|NCT02797171|588692053|FG000|Overall Study|Not Randomized|0|||
162997802|NCT02797171|588692054|FG001|Overall Study|Not Randomized|0|||
162997803|NCT02797171|588692055|FG002|Overall Study|Not Randomized|0|||
163324898|NCT02567435|589901396|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
163324899|NCT02567435|589901397|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
163324900|NCT02567435|589901398|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
162997804|NCT02797171|588692056|FG003|Overall Study|Not Randomized|0|||
163324901|NCT02166463|589901399|FG000|Overall Study|Lost to Follow-up|0|||
163324902|NCT02166463|589901400|FG001|Overall Study|Lost to Follow-up|1|||
162997805|NCT02797171|588692057|FG004|Overall Study|Not Randomized|0|||
162997806|NCT02797171|588692058|FG005|Overall Study|Not Randomized|1|||
162997807|NCT00626561|588692059|FG000|Overall Study|Withdrawal by Subject|2|||
162997808|NCT00626561|588692059|FG000|Overall Study|Disease Progression|2|||
162997809|NCT01372748|588692060|FG000|Overall Study|Lost to Follow-up|16|||
162997810|NCT01372748|588692061|FG001|Overall Study|Lost to Follow-up|34|||
162997811|NCT01372748|588692060|FG000|Overall Study|Withdrawal by Subject|7|||
162997812|NCT01372748|588692061|FG001|Overall Study|Withdrawal by Subject|5|||
162997813|NCT00134901|588692062|FG000|Overall Study|Lost to Follow-up|5|||
162997814|NCT00134901|588692063|FG001|Overall Study|Lost to Follow-up|5|||
162997815|NCT00134901|588692062|FG000|Overall Study|discontinued intervention|12|||
162997816|NCT00134901|588692063|FG001|Overall Study|discontinued intervention|10|||
162997817|NCT00606632|588692064|FG000|Overall Study|Withdrawal by Subject|13|||
162997818|NCT00606632|588692064|FG000|Overall Study|Miscellaneous reasons|9|||
162997819|NCT03908437|588692065|FG000|Overall Study|Death|0|||
162997820|NCT03908437|588692066|FG001|Overall Study|Death|1|||
162997821|NCT03908437|588692065|FG000|Overall Study|Lost to Follow-up|31|||
162997822|NCT03908437|588692066|FG001|Overall Study|Lost to Follow-up|24|||
162997823|NCT03633825|588692067|FG000|Enrollment|Did not post on network|5066|||
162997824|NCT03633825|588692068|FG001|Enrollment|Did not post on network|5080|||
162997825|NCT03633825|588692067|FG000|Enrollment|Post not classified as crisis|13967|||
162997826|NCT03633825|588692068|FG001|Enrollment|Post not classified as crisis|13757|||
162997827|NCT03633825|588692067|FG000|Follow up|Lost to Follow-up|478|||
162997828|NCT03633825|588692068|FG001|Follow up|Lost to Follow-up|450|||
162997829|NCT04841577|588692069|FG000|Overall Study|Adverse Event|5|||
162997830|NCT04841577|588692070|FG001|Overall Study|Adverse Event|10|||
162997831|NCT04841577|588692069|FG000|Overall Study|Lost to Follow-up|8|||
162997832|NCT04841577|588692070|FG001|Overall Study|Lost to Follow-up|7|||
162997833|NCT04841577|588692069|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
162997834|NCT04841577|588692070|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
162997835|NCT04841577|588692069|FG000|Overall Study|Other|0|||
162997836|NCT04841577|588692070|FG001|Overall Study|Other|1|||
162997837|NCT03456453|588692074|FG000|Overall Study|Withdrawal by Subject|2|||
162997838|NCT03456453|588692075|FG001|Overall Study|Withdrawal by Subject|0|||
162997839|NCT03456453|588692074|FG000|Overall Study|Not released to community|1|||
162997840|NCT03456453|588692075|FG001|Overall Study|Not released to community|5|||
162997841|NCT03456453|588692074|FG000|Overall Study|Lost to Follow-up|0|||
162997842|NCT03456453|588692075|FG001|Overall Study|Lost to Follow-up|2|||
162997843|NCT01004003|588692076|FG000|Overall Study|Progressive disease|2|||
162997844|NCT01004003|588692077|FG001|Overall Study|Progressive disease|1|||
162997845|NCT01004003|588692078|FG002|Overall Study|Progressive disease|1|||
162997846|NCT01004003|588692079|FG003|Overall Study|Progressive disease|0|||
162997847|NCT01004003|588692080|FG004|Overall Study|Progressive disease|2|||
162997848|NCT01004003|588692081|FG005|Overall Study|Progressive disease|1|||
162997849|NCT01004003|588692082|FG006|Overall Study|Progressive disease|1|||
162997850|NCT01004003|588692083|FG007|Overall Study|Progressive disease|39|||
162997851|NCT01004003|588692084|FG008|Overall Study|Progressive disease|22|||
162997852|NCT01004003|588692076|FG000|Overall Study|Adverse Event|4|||
162997853|NCT01004003|588692077|FG001|Overall Study|Adverse Event|2|||
162997854|NCT01004003|588692078|FG002|Overall Study|Adverse Event|3|||
162997855|NCT01004003|588692079|FG003|Overall Study|Adverse Event|3|||
162997856|NCT01004003|588692080|FG004|Overall Study|Adverse Event|2|||
162997857|NCT01004003|588692081|FG005|Overall Study|Adverse Event|2|||
162997858|NCT01004003|588692082|FG006|Overall Study|Adverse Event|7|||
162997859|NCT01004003|588692083|FG007|Overall Study|Adverse Event|21|||
162997860|NCT01004003|588692084|FG008|Overall Study|Adverse Event|6|||
162997861|NCT01004003|588692076|FG000|Overall Study|Refused to continue taking trial med.|0|||
162997862|NCT01004003|588692077|FG001|Overall Study|Refused to continue taking trial med.|0|||
162997863|NCT01004003|588692078|FG002|Overall Study|Refused to continue taking trial med.|0|||
162997864|NCT01004003|588692079|FG003|Overall Study|Refused to continue taking trial med.|0|||
162997865|NCT01004003|588692080|FG004|Overall Study|Refused to continue taking trial med.|0|||
162997866|NCT01004003|588692081|FG005|Overall Study|Refused to continue taking trial med.|0|||
162997867|NCT01004003|588692082|FG006|Overall Study|Refused to continue taking trial med.|0|||
162997868|NCT01004003|588692083|FG007|Overall Study|Refused to continue taking trial med.|0|||
162997869|NCT01004003|588692084|FG008|Overall Study|Refused to continue taking trial med.|2|||
162997870|NCT01004003|588692076|FG000|Overall Study|Other|0|||
162997871|NCT01004003|588692077|FG001|Overall Study|Other|0|||
162997872|NCT01004003|588692078|FG002|Overall Study|Other|0|||
162997873|NCT01004003|588692079|FG003|Overall Study|Other|0|||
162997874|NCT01004003|588692080|FG004|Overall Study|Other|0|||
163324903|NCT02166463|589901399|FG000|Overall Study|Physician Decision|10|||
162997875|NCT01004003|588692081|FG005|Overall Study|Other|1|||
162997876|NCT01004003|588692082|FG006|Overall Study|Other|0|||
162997877|NCT01004003|588692083|FG007|Overall Study|Other|0|||
162997878|NCT01004003|588692084|FG008|Overall Study|Other|0|||
162997879|NCT04856930|588693760|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
162997880|NCT04856930|588693761|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
162997881|NCT04856930|588693762|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
162997882|NCT04856930|588693760|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
162997883|NCT04856930|588693761|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
162997884|NCT04856930|588693762|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
162997885|NCT04856930|588693760|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
162997886|NCT04856930|588693761|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
162997887|NCT04856930|588693762|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
162997888|NCT04856930|588693760|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
162997889|NCT04856930|588693761|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
162997890|NCT04856930|588693762|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
162997891|NCT04856930|588693760|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
162997892|NCT04856930|588693761|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
162997893|NCT04856930|588693762|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
162997894|NCT04856930|588693760|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
162997895|NCT04856930|588693761|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
162997896|NCT04856930|588693762|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
162997897|NCT04856930|588693760|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
162997898|NCT04856930|588693761|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
162997899|NCT04856930|588693762|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
162997900|NCT04856930|588693760|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
162997901|NCT04856930|588693761|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
162997902|NCT04856930|588693762|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
162997903|NCT04856930|588693760|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
162997904|NCT04856930|588693761|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
162997905|NCT04856930|588693762|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
162997906|NCT04856930|588693760|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
162997907|NCT04856930|588693761|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
162997908|NCT04856930|588693762|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
162997909|NCT04856930|588693760|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
162997910|NCT04856930|588693761|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
162997911|NCT04856930|588693762|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
162997912|NCT04856930|588693760|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
162997913|NCT04856930|588693761|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
162997914|NCT04856930|588693762|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
162997915|NCT04856930|588693760|FG000|Extension Period (16 Weeks)|Other than specified|0|||
162997916|NCT04856930|588693761|FG001|Extension Period (16 Weeks)|Other than specified|0|||
162997917|NCT04856930|588693762|FG002|Extension Period (16 Weeks)|Other than specified|1|||
162997918|NCT04856930|588693760|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
162997919|NCT04856930|588693761|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
162997920|NCT04856930|588693762|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
162997921|NCT04856930|588693760|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
162997922|NCT04856930|588693761|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
162997923|NCT04856930|588693762|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
162997924|NCT04856930|588693760|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
162997925|NCT04856930|588693761|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
162997926|NCT04856930|588693762|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
162997927|NCT04856930|588693760|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
162997928|NCT04856930|588693761|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
162997929|NCT04856930|588693762|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
162997930|NCT00678210|588693763|FG000|Overall Study|Adverse Event|1|||
162997931|NCT00678210|588693764|FG001|Overall Study|Adverse Event|2|||
162997932|NCT00678210|588693765|FG002|Overall Study|Adverse Event|3|||
162997933|NCT00678210|588693766|FG003|Overall Study|Adverse Event|3|||
162997934|NCT00678210|588693763|FG000|Overall Study|Lack of Efficacy|2|||
162997935|NCT00678210|588693764|FG001|Overall Study|Lack of Efficacy|3|||
162997936|NCT00678210|588693765|FG002|Overall Study|Lack of Efficacy|1|||
162997937|NCT00678210|588693766|FG003|Overall Study|Lack of Efficacy|9|||
162997938|NCT00678210|588693763|FG000|Overall Study|Lost to Follow-up|4|||
162997939|NCT00678210|588693764|FG001|Overall Study|Lost to Follow-up|2|||
162997940|NCT00678210|588693765|FG002|Overall Study|Lost to Follow-up|0|||
162997941|NCT00678210|588693766|FG003|Overall Study|Lost to Follow-up|1|||
162997942|NCT00678210|588693763|FG000|Overall Study|Withdrawal by Subject|3|||
162997943|NCT00678210|588693764|FG001|Overall Study|Withdrawal by Subject|4|||
162997944|NCT00678210|588693765|FG002|Overall Study|Withdrawal by Subject|1|||
162997945|NCT00678210|588693766|FG003|Overall Study|Withdrawal by Subject|7|||
162997946|NCT00678210|588693763|FG000|Overall Study|Other|1|||
162997947|NCT00678210|588693764|FG001|Overall Study|Other|0|||
162997948|NCT00678210|588693765|FG002|Overall Study|Other|1|||
162997949|NCT00678210|588693766|FG003|Overall Study|Other|0|||
162997950|NCT01383707|588693769|FG000|Overall Study|Consent withdrawal|6|||
162997951|NCT01383707|588693769|FG000|Overall Study|Death|19|||
162997952|NCT01383707|588693769|FG000|Overall Study|Other|8|||
162997953|NCT01383707|588693769|FG000|Overall Study|Sponsor's decision|2|||
162997954|NCT01383707|588693769|FG000|Overall Study|Adverse Event|14|||
162997955|NCT01383707|588693769|FG000|Overall Study|Progressive disease|23|||
162997956|NCT01625988|588693774|FG000|Overall Study|Lost to Follow-up|5|||
162997957|NCT01625988|588693775|FG001|Overall Study|Lost to Follow-up|6|||
162997958|NCT01625988|588693774|FG000|Overall Study|Withdrawal by Subject|8|||
162997959|NCT01625988|588693775|FG001|Overall Study|Withdrawal by Subject|3|||
162997960|NCT01625988|588693774|FG000|Overall Study|Adverse Event|0|||
162997961|NCT01625988|588693775|FG001|Overall Study|Adverse Event|1|||
162997962|NCT01625988|588693774|FG000|Overall Study|Lack of Efficacy|0|||
162997963|NCT01625988|588693775|FG001|Overall Study|Lack of Efficacy|1|||
162997964|NCT01625988|588693774|FG000|Overall Study|Randomized Inappropriately|1|||
162997965|NCT01625988|588693775|FG001|Overall Study|Randomized Inappropriately|0|||
162997966|NCT01625988|588693774|FG000|Overall Study|Protocol Violation|0|||
162997967|NCT01625988|588693775|FG001|Overall Study|Protocol Violation|2|||
162997968|NCT02075515|588693778|FG000|Overall Study|Serious Adverse Event|1|||
162997969|NCT02075515|588693779|FG001|Overall Study|Serious Adverse Event|1|||
162997970|NCT02075515|588693780|FG002|Overall Study|Serious Adverse Event|1|||
162997971|NCT02075515|588693778|FG000|Overall Study|Non-Serious Adverse Event|0|||
162997972|NCT02075515|588693779|FG001|Overall Study|Non-Serious Adverse Event|1|||
162997973|NCT02075515|588693780|FG002|Overall Study|Non-Serious Adverse Event|0|||
162997974|NCT02075515|588693778|FG000|Overall Study|Withdrawal by Subject|2|||
162997975|NCT02075515|588693779|FG001|Overall Study|Withdrawal by Subject|0|||
162997976|NCT02075515|588693780|FG002|Overall Study|Withdrawal by Subject|1|||
162997977|NCT02075515|588693778|FG000|Overall Study|Lost to Follow-up|1|||
162997978|NCT02075515|588693779|FG001|Overall Study|Lost to Follow-up|3|||
162997979|NCT02075515|588693780|FG002|Overall Study|Lost to Follow-up|6|||
162997980|NCT00741338|588693791|FG000|Overall Study|Adverse Event|0|||
162997981|NCT00741338|588693792|FG001|Overall Study|Adverse Event|1|||
162997982|NCT03593395|588693793|FG000|Overall Study|Lost to Follow-up|48|||
162997983|NCT03593395|588693794|FG001|Overall Study|Lost to Follow-up|3|||
162997984|NCT03593395|588693793|FG000|Overall Study|Withdrawal by Subject|5|||
162997985|NCT03593395|588693794|FG001|Overall Study|Withdrawal by Subject|24|||
162997986|NCT03593395|588693793|FG000|Overall Study|Death|2|||
162997987|NCT03593395|588693794|FG001|Overall Study|Death|3|||
162997988|NCT03593395|588693793|FG000|Overall Study|Physician Decision|0|||
162997989|NCT03593395|588693794|FG001|Overall Study|Physician Decision|6|||
162997990|NCT03593395|588693793|FG000|Overall Study|Participant Relocated|19|||
162997991|NCT03593395|588693794|FG001|Overall Study|Participant Relocated|3|||
162997992|NCT03593395|588693793|FG000|Overall Study|No Information|1|||
162997993|NCT03593395|588693794|FG001|Overall Study|No Information|7|||
162997994|NCT03713632|588693795|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
162997995|NCT03713632|588693796|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
162997996|NCT03713632|588693797|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
162997997|NCT03713632|588693798|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
162997998|NCT03713632|588693799|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
162997999|NCT03713632|588693795|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
162998000|NCT03713632|588693796|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
162998001|NCT03713632|588693797|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
162998002|NCT03713632|588693798|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
162998003|NCT03713632|588693799|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
162998004|NCT03713632|588693795|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
162998005|NCT03713632|588693796|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
163324904|NCT02166463|589901400|FG001|Overall Study|Physician Decision|10|||
162998006|NCT03713632|588693797|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
162998007|NCT03713632|588693798|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
162998008|NCT03713632|588693799|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
162998009|NCT03713632|588693795|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
162998010|NCT03713632|588693796|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
162998011|NCT03713632|588693797|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
162998012|NCT03713632|588693798|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
162998013|NCT03713632|588693799|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
162998014|NCT03713632|588693795|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
162998015|NCT03713632|588693796|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
162998016|NCT03713632|588693797|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
162998017|NCT03713632|588693798|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
162998018|NCT03713632|588693799|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
162998019|NCT03713632|588693795|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
162998020|NCT03713632|588693796|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
162998021|NCT03713632|588693797|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
162998022|NCT03713632|588693798|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
162998023|NCT03713632|588693799|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
162998024|NCT03713632|588693795|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
162998025|NCT03713632|588693796|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
162998026|NCT03713632|588693797|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
162998027|NCT03713632|588693798|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
163060446|NCT04167462|588929898|FG000|Overall Study|Lack of Efficacy|0|||
162998028|NCT03713632|588693799|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
162998029|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
162998030|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
162998031|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
162998032|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
162998033|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
162998034|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
162998035|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
162998036|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
162998037|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
162998038|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
162998039|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
162998040|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
162998041|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
162998042|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
162998043|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
162998044|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
162998045|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
162998046|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
162998047|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
162998048|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
162998049|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
162998050|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
162998051|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
162998052|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
162998053|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
162998054|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
162998055|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
162998056|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
162998057|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
162998058|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
162998059|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Death|0|||
162998060|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Death|1|||
162998061|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Death|0|||
162998062|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Death|0|||
162998063|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Death|0|||
162998064|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
162998065|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
162998066|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
162998067|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
162998068|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
162998069|NCT01524978|588693800|FG000|Overall Study|Other|16|||
162998070|NCT01524978|588693801|FG001|Overall Study|Other|2|||
162998071|NCT01524978|588693802|FG002|Overall Study|Other|1|||
162998072|NCT01524978|588693803|FG003|Overall Study|Other|2|||
162998073|NCT01524978|588693804|FG004|Overall Study|Other|1|||
162998074|NCT01524978|588693805|FG005|Overall Study|Other|3|||
162998075|NCT01524978|588693806|FG006|Overall Study|Other|17|||
162998076|NCT01524978|588693807|FG007|Overall Study|Other|1|||
162998077|NCT01524978|588693808|FG008|Overall Study|Other|2|||
162998078|NCT01524978|588693809|FG009|Overall Study|Other|2|||
162998079|NCT01524978|588693810|FG010|Overall Study|Other|5|||
162998080|NCT01524978|588693800|FG000|Overall Study|Withdrawal by Subject|12|||
162998081|NCT01524978|588693801|FG001|Overall Study|Withdrawal by Subject|0|||
162998082|NCT01524978|588693802|FG002|Overall Study|Withdrawal by Subject|1|||
162998083|NCT01524978|588693803|FG003|Overall Study|Withdrawal by Subject|1|||
162998084|NCT01524978|588693804|FG004|Overall Study|Withdrawal by Subject|3|||
162998085|NCT01524978|588693805|FG005|Overall Study|Withdrawal by Subject|1|||
162998086|NCT01524978|588693806|FG006|Overall Study|Withdrawal by Subject|6|||
162998087|NCT01524978|588693807|FG007|Overall Study|Withdrawal by Subject|2|||
162998088|NCT01524978|588693808|FG008|Overall Study|Withdrawal by Subject|4|||
162998089|NCT01524978|588693809|FG009|Overall Study|Withdrawal by Subject|0|||
162998090|NCT01524978|588693810|FG010|Overall Study|Withdrawal by Subject|5|||
162998091|NCT01524978|588693800|FG000|Overall Study|Lost to Follow-up|0|||
162998092|NCT01524978|588693801|FG001|Overall Study|Lost to Follow-up|0|||
162998093|NCT01524978|588693802|FG002|Overall Study|Lost to Follow-up|3|||
163212726|NCT00623727|589494295|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
163212727|NCT00623727|589494294|FG000|Double Blind (DB)|Lack of Efficacy|2|||
163212728|NCT00623727|589494295|FG001|Double Blind (DB)|Lack of Efficacy|2|||
163212729|NCT00623727|589494294|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
163212730|NCT00623727|589494295|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
163212731|NCT00623727|589494294|FG000|Double Blind (DB)|Lost to Follow-up|1|||
162998094|NCT01524978|588693803|FG003|Overall Study|Lost to Follow-up|0|||
162998095|NCT01524978|588693804|FG004|Overall Study|Lost to Follow-up|1|||
162998096|NCT01524978|588693805|FG005|Overall Study|Lost to Follow-up|1|||
162998097|NCT01524978|588693806|FG006|Overall Study|Lost to Follow-up|2|||
162998098|NCT01524978|588693807|FG007|Overall Study|Lost to Follow-up|0|||
162998099|NCT01524978|588693808|FG008|Overall Study|Lost to Follow-up|1|||
162998100|NCT01524978|588693809|FG009|Overall Study|Lost to Follow-up|1|||
162998101|NCT01524978|588693810|FG010|Overall Study|Lost to Follow-up|1|||
162998102|NCT01524978|588693800|FG000|Overall Study|Death|34|||
162998103|NCT01524978|588693801|FG001|Overall Study|Death|2|||
162998104|NCT01524978|588693802|FG002|Overall Study|Death|5|||
162998105|NCT01524978|588693803|FG003|Overall Study|Death|24|||
162998106|NCT01524978|588693804|FG004|Overall Study|Death|4|||
162998107|NCT01524978|588693805|FG005|Overall Study|Death|4|||
162998108|NCT01524978|588693806|FG006|Overall Study|Death|1|||
162998109|NCT01524978|588693807|FG007|Overall Study|Death|9|||
162998110|NCT01524978|588693808|FG008|Overall Study|Death|5|||
162998111|NCT01524978|588693809|FG009|Overall Study|Death|6|||
162998112|NCT01524978|588693810|FG010|Overall Study|Death|17|||
162998113|NCT02370238|588693817|FG000|Overall Study|Death|42|||
162998114|NCT02370238|588693818|FG001|Overall Study|Death|35|||
162998115|NCT02370238|588693817|FG000|Overall Study|Lost to Follow-up|1|||
162998116|NCT02370238|588693818|FG001|Overall Study|Lost to Follow-up|3|||
162998117|NCT02370238|588693817|FG000|Overall Study|Withdrawal by Subject|2|||
162998118|NCT02370238|588693818|FG001|Overall Study|Withdrawal by Subject|6|||
162998119|NCT02370238|588693817|FG000|Overall Study|Other|2|||
162998120|NCT02370238|588693818|FG001|Overall Study|Other|1|||
162998121|NCT01937871|588693819|FG000|Overall Study|Adverse Event|6|||
162998122|NCT01937871|588693820|FG001|Overall Study|Adverse Event|6|||
162998123|NCT01937871|588693821|FG002|Overall Study|Adverse Event|2|||
162998124|NCT01937871|588693819|FG000|Overall Study|Lost to Follow-up|8|||
162998125|NCT01937871|588693820|FG001|Overall Study|Lost to Follow-up|2|||
162998126|NCT01937871|588693821|FG002|Overall Study|Lost to Follow-up|4|||
162998127|NCT01937871|588693819|FG000|Overall Study|Withdrawal by Subject|9|||
162998128|NCT01937871|588693820|FG001|Overall Study|Withdrawal by Subject|6|||
162998129|NCT01937871|588693821|FG002|Overall Study|Withdrawal by Subject|4|||
162998130|NCT01937871|588693819|FG000|Overall Study|Physician Decision|0|||
162998131|NCT01937871|588693820|FG001|Overall Study|Physician Decision|1|||
162998132|NCT01937871|588693821|FG002|Overall Study|Physician Decision|0|||
162998133|NCT01937871|588693819|FG000|Overall Study|Entry Criteria Not Met|1|||
162998134|NCT01937871|588693820|FG001|Overall Study|Entry Criteria Not Met|2|||
162998135|NCT01937871|588693821|FG002|Overall Study|Entry Criteria Not Met|1|||
162998136|NCT02652949|588693822|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
162998137|NCT02652949|588693822|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
162998138|NCT02652949|588693822|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
162998139|NCT02652949|588693822|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
162998140|NCT02652949|588693822|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
162998141|NCT02652949|588693822|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
162998142|NCT02652949|588693822|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
162998143|NCT02652949|588693822|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
162998144|NCT02652949|588693822|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
162998145|NCT02652949|588693822|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
162998146|NCT02652949|588693822|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
162998147|NCT02652949|588693822|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
162998148|NCT02652949|588693822|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
162998149|NCT02652949|588693822|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
162998150|NCT02652949|588693822|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
162998151|NCT02652949|588693822|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
162998152|NCT02652949|588693822|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
162998153|NCT01973595|588693823|FG000|Washout|Withdrawal by Subject|1|||
162998154|NCT01973595|588693824|FG001|Washout|Withdrawal by Subject|0|||
162998155|NCT01973595|588693825|FG002|Washout|Withdrawal by Subject|1|||
162998156|NCT01973595|588693826|FG003|Washout|Withdrawal by Subject|0|||
162998157|NCT01141205|588693827|FG000|Overall Study|Physician Decision|1|||
162998158|NCT01141205|588693828|FG001|Overall Study|Physician Decision|1|||
162998159|NCT01141205|588693827|FG000|Overall Study|Lost to Follow-up|1|||
162998160|NCT01141205|588693828|FG001|Overall Study|Lost to Follow-up|0|||
162998161|NCT01141205|588693827|FG000|Overall Study|Withdrawal by Subject|1|||
162998162|NCT01141205|588693828|FG001|Overall Study|Withdrawal by Subject|1|||
162998163|NCT03837743|588693834|FG000|Overall Study|Adverse Event|1|||
162998164|NCT03837743|588693834|FG000|Overall Study|Withdrawal by Subject|2|||
162998165|NCT05199090|588693835|FG000|Overall Study|Adverse Event|1|||
162998166|NCT05199090|588693836|FG001|Overall Study|Adverse Event|4|||
162998167|NCT05199090|588693837|FG002|Overall Study|Adverse Event|0|||
162998168|NCT05199090|588693838|FG003|Overall Study|Adverse Event|0|||
162998169|NCT05199090|588693839|FG004|Overall Study|Adverse Event|0|||
162998170|NCT05199090|588693840|FG005|Overall Study|Adverse Event|0|||
162998171|NCT05199090|588693835|FG000|Overall Study|Lost to Follow-up|1|||
162998172|NCT05199090|588693836|FG001|Overall Study|Lost to Follow-up|0|||
162998173|NCT05199090|588693837|FG002|Overall Study|Lost to Follow-up|1|||
162998174|NCT05199090|588693838|FG003|Overall Study|Lost to Follow-up|4|||
162998175|NCT05199090|588693839|FG004|Overall Study|Lost to Follow-up|0|||
162998176|NCT05199090|588693840|FG005|Overall Study|Lost to Follow-up|5|||
162998177|NCT05199090|588693835|FG000|Overall Study|Physician Decision|0|||
162998178|NCT05199090|588693836|FG001|Overall Study|Physician Decision|0|||
162998179|NCT05199090|588693837|FG002|Overall Study|Physician Decision|0|||
162998180|NCT05199090|588693838|FG003|Overall Study|Physician Decision|0|||
162998181|NCT05199090|588693839|FG004|Overall Study|Physician Decision|0|||
162998182|NCT05199090|588693840|FG005|Overall Study|Physician Decision|1|||
162998183|NCT05199090|588693835|FG000|Overall Study|Study terminated by sponsor|0|||
162998184|NCT05199090|588693836|FG001|Overall Study|Study terminated by sponsor|6|||
162998185|NCT05199090|588693837|FG002|Overall Study|Study terminated by sponsor|0|||
162998186|NCT05199090|588693838|FG003|Overall Study|Study terminated by sponsor|0|||
162998187|NCT05199090|588693839|FG004|Overall Study|Study terminated by sponsor|0|||
162998188|NCT05199090|588693840|FG005|Overall Study|Study terminated by sponsor|5|||
162998189|NCT05199090|588693835|FG000|Overall Study|Subject decision|0|||
162998190|NCT05199090|588693836|FG001|Overall Study|Subject decision|4|||
162998191|NCT05199090|588693837|FG002|Overall Study|Subject decision|0|||
162998192|NCT05199090|588693838|FG003|Overall Study|Subject decision|2|||
162998193|NCT05199090|588693839|FG004|Overall Study|Subject decision|5|||
162998194|NCT05199090|588693840|FG005|Overall Study|Subject decision|2|||
162998195|NCT04868968|588693841|FG000|Overall Study|Lost to Follow-up|1|||
162998196|NCT00384930|588693844|FG000|Overall Study|Adverse Event|5|||
162998197|NCT00384930|588693845|FG001|Overall Study|Adverse Event|4|||
162998198|NCT00384930|588693846|FG002|Overall Study|Adverse Event|12|||
162998199|NCT00384930|588693847|FG003|Overall Study|Adverse Event|11|||
162998200|NCT00384930|588693848|FG004|Overall Study|Adverse Event|14|||
162998201|NCT00384930|588693844|FG000|Overall Study|Entry Criteria Not Met|2|||
162998202|NCT00384930|588693845|FG001|Overall Study|Entry Criteria Not Met|6|||
162998203|NCT00384930|588693846|FG002|Overall Study|Entry Criteria Not Met|7|||
162998204|NCT00384930|588693847|FG003|Overall Study|Entry Criteria Not Met|8|||
162998205|NCT00384930|588693848|FG004|Overall Study|Entry Criteria Not Met|4|||
162998206|NCT00384930|588693844|FG000|Overall Study|Lack of Efficacy|1|||
162998207|NCT00384930|588693845|FG001|Overall Study|Lack of Efficacy|1|||
162998208|NCT00384930|588693846|FG002|Overall Study|Lack of Efficacy|2|||
162998209|NCT00384930|588693847|FG003|Overall Study|Lack of Efficacy|1|||
162998210|NCT00384930|588693848|FG004|Overall Study|Lack of Efficacy|2|||
162998211|NCT00384930|588693844|FG000|Overall Study|Lost to Follow-up|5|||
162998212|NCT00384930|588693845|FG001|Overall Study|Lost to Follow-up|3|||
162998213|NCT00384930|588693846|FG002|Overall Study|Lost to Follow-up|0|||
162998214|NCT00384930|588693847|FG003|Overall Study|Lost to Follow-up|4|||
162998215|NCT00384930|588693848|FG004|Overall Study|Lost to Follow-up|6|||
162998216|NCT00384930|588693844|FG000|Overall Study|Physician Decision|0|||
162998217|NCT00384930|588693845|FG001|Overall Study|Physician Decision|1|||
162998218|NCT00384930|588693846|FG002|Overall Study|Physician Decision|1|||
162998219|NCT00384930|588693847|FG003|Overall Study|Physician Decision|0|||
162998220|NCT00384930|588693848|FG004|Overall Study|Physician Decision|1|||
162998221|NCT00384930|588693844|FG000|Overall Study|Protocol Violation|1|||
162998222|NCT00384930|588693845|FG001|Overall Study|Protocol Violation|0|||
162998223|NCT00384930|588693846|FG002|Overall Study|Protocol Violation|1|||
162998224|NCT00384930|588693847|FG003|Overall Study|Protocol Violation|6|||
162998225|NCT00384930|588693848|FG004|Overall Study|Protocol Violation|4|||
162998226|NCT00384930|588693844|FG000|Overall Study|Sponsor Decision|3|||
162998227|NCT00384930|588693845|FG001|Overall Study|Sponsor Decision|4|||
162998228|NCT00384930|588693846|FG002|Overall Study|Sponsor Decision|0|||
162998229|NCT00384930|588693847|FG003|Overall Study|Sponsor Decision|5|||
163324905|NCT02166463|589901399|FG000|Overall Study|Ineligible|11|||
162998230|NCT00384930|588693848|FG004|Overall Study|Sponsor Decision|0|||
162998231|NCT00384930|588693844|FG000|Overall Study|Withdrawal by Subject|9|||
162998232|NCT00384930|588693845|FG001|Overall Study|Withdrawal by Subject|7|||
162998233|NCT00384930|588693846|FG002|Overall Study|Withdrawal by Subject|7|||
162998234|NCT00384930|588693847|FG003|Overall Study|Withdrawal by Subject|6|||
162998235|NCT00384930|588693848|FG004|Overall Study|Withdrawal by Subject|16|||
162998236|NCT00384930|588693844|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
162998237|NCT00384930|588693845|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
162998238|NCT00384930|588693846|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
163324906|NCT02166463|589901400|FG001|Overall Study|Ineligible|2|||
162998239|NCT00384930|588693847|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
162998240|NCT00384930|588693848|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
162998241|NCT01547130|588693853|FG000|Overall Study|Lost to Follow-up|9|||
162998242|NCT01547130|588693854|FG001|Overall Study|Lost to Follow-up|5|||
162998243|NCT01685840|588693855|FG000|Overall Study|Death|77|||
162998244|NCT01685840|588693856|FG001|Overall Study|Death|66|||
162998245|NCT01685840|588693855|FG000|Overall Study|Lost to Follow-up|27|||
162998246|NCT01685840|588693856|FG001|Overall Study|Lost to Follow-up|25|||
163060447|NCT04167462|588929899|FG001|Overall Study|Lack of Efficacy|1|||
162998247|NCT01685840|588693855|FG000|Overall Study|Physician Decision|3|||
162998248|NCT01685840|588693856|FG001|Overall Study|Physician Decision|7|||
162998249|NCT01685840|588693855|FG000|Overall Study|Withdrawal by Subject|14|||
162998250|NCT01685840|588693856|FG001|Overall Study|Withdrawal by Subject|17|||
162998251|NCT01685840|588693855|FG000|Overall Study|Futility|197|||
162998252|NCT01685840|588693856|FG001|Overall Study|Futility|200|||
162998253|NCT01685840|588693855|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
162998254|NCT01685840|588693856|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
162998255|NCT00710866|588693857|FG000|Overall Study|Protocol Violation|5|||
162998256|NCT00710866|588693858|FG001|Overall Study|Protocol Violation|4|||
162998257|NCT00710866|588693857|FG000|Overall Study|Withdrawal by Subject|2|||
162998258|NCT00710866|588693858|FG001|Overall Study|Withdrawal by Subject|1|||
162998259|NCT00710866|588693857|FG000|Overall Study|Lost to Follow-up|1|||
162998260|NCT00710866|588693858|FG001|Overall Study|Lost to Follow-up|0|||
162998261|NCT00710866|588693857|FG000|Overall Study|Failed to meet eligibility|1|||
162998262|NCT00710866|588693858|FG001|Overall Study|Failed to meet eligibility|1|||
162998263|NCT01098487|588693864|FG000|Overall Study|Adverse Event|22|||
162998264|NCT01098487|588693864|FG000|Overall Study|Lack of Efficacy|11|||
162998265|NCT01098487|588693864|FG000|Overall Study|Withdrawal by Subject|7|||
162998266|NCT01098487|588693864|FG000|Overall Study|Lost to Follow-up|3|||
162998267|NCT01098487|588693864|FG000|Overall Study|Physician Decision|1|||
162998268|NCT00351533|588693866|FG000|Overall Study|Extubated before first BAL|1|||
162998269|NCT00351533|588693867|FG001|Overall Study|Extubated before first BAL|0|||
162998270|NCT00351533|588693866|FG000|Overall Study|Lost to Follow-up|1|||
162998271|NCT00351533|588693867|FG001|Overall Study|Lost to Follow-up|3|||
162998272|NCT00351533|588693866|FG000|Overall Study|Physician Decision|0|||
162998273|NCT00351533|588693867|FG001|Overall Study|Physician Decision|1|||
162998274|NCT00351533|588693866|FG000|Overall Study|Withdrawal by Subject|0|||
162998275|NCT00351533|588693867|FG001|Overall Study|Withdrawal by Subject|1|||
162998276|NCT01589497|588693868|FG000|Overall Study|Withdrawal by Subject|0|||
162998277|NCT01589497|588693869|FG001|Overall Study|Withdrawal by Subject|1|||
162998278|NCT01589497|588693870|FG002|Overall Study|Withdrawal by Subject|0|||
162998279|NCT01589497|588693871|FG003|Overall Study|Withdrawal by Subject|1|||
162998280|NCT01589497|588693868|FG000|Overall Study|Death|1|||
162998281|NCT01589497|588693869|FG001|Overall Study|Death|0|||
162998282|NCT01589497|588693870|FG002|Overall Study|Death|0|||
162998283|NCT01589497|588693871|FG003|Overall Study|Death|0|||
162998284|NCT01589497|588693868|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
162998285|NCT01589497|588693869|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
162998286|NCT01589497|588693870|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
162998287|NCT01589497|588693871|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
162998288|NCT01885195|588693872|FG000|Overall Study|Adverse Event|29|||
162998289|NCT01885195|588693872|FG000|Overall Study|Death|1|||
162998290|NCT01885195|588693872|FG000|Overall Study|Disease Progression|67|||
162998291|NCT01885195|588693872|FG000|Overall Study|Protocol Deviation|2|||
162998292|NCT01885195|588693872|FG000|Overall Study|Physician Decision|3|||
162998293|NCT01885195|588693872|FG000|Overall Study|Patient/guardian decision|8|||
162998294|NCT03390426|588693875|FG000|Overall Study|Protocol Violation|0|||
162998295|NCT03390426|588693876|FG001|Overall Study|Protocol Violation|1|||
162998296|NCT00259272|588693877|FG000|Overall Study|Adverse Event|2|||
162998297|NCT00259272|588693878|FG001|Overall Study|Adverse Event|1|||
162998298|NCT00259272|588693879|FG002|Overall Study|Adverse Event|0|||
162998299|NCT00259272|588693880|FG003|Overall Study|Adverse Event|3|||
162998300|NCT00259272|588693877|FG000|Overall Study|Lack of Efficacy|5|||
162998301|NCT00259272|588693878|FG001|Overall Study|Lack of Efficacy|1|||
162998302|NCT00259272|588693879|FG002|Overall Study|Lack of Efficacy|2|||
162998303|NCT00259272|588693880|FG003|Overall Study|Lack of Efficacy|6|||
162998304|NCT00259272|588693877|FG000|Overall Study|Physician Decision|1|||
162998305|NCT00259272|588693878|FG001|Overall Study|Physician Decision|2|||
162998306|NCT00259272|588693879|FG002|Overall Study|Physician Decision|1|||
162998307|NCT00259272|588693880|FG003|Overall Study|Physician Decision|3|||
162998308|NCT00259272|588693877|FG000|Overall Study|Protocol Violation|2|||
162998309|NCT00259272|588693878|FG001|Overall Study|Protocol Violation|0|||
162998310|NCT00259272|588693879|FG002|Overall Study|Protocol Violation|0|||
162998311|NCT00259272|588693880|FG003|Overall Study|Protocol Violation|1|||
162998312|NCT00259272|588693877|FG000|Overall Study|Sponsor Decision|0|||
162998313|NCT00259272|588693878|FG001|Overall Study|Sponsor Decision|1|||
162998314|NCT00259272|588693879|FG002|Overall Study|Sponsor Decision|0|||
162998315|NCT00259272|588693880|FG003|Overall Study|Sponsor Decision|0|||
162998316|NCT00259272|588693877|FG000|Overall Study|Withdrawal by Subject|4|||
163060448|NCT02320396|588929900|FG000|Overall Study|Adverse Event|2|||
162998317|NCT00259272|588693878|FG001|Overall Study|Withdrawal by Subject|2|||
162998318|NCT00259272|588693879|FG002|Overall Study|Withdrawal by Subject|2|||
162998319|NCT00259272|588693880|FG003|Overall Study|Withdrawal by Subject|7|||
162998320|NCT00259272|588693877|FG000|Overall Study|Lost to Follow-up|1|||
163060449|NCT02320396|588929901|FG001|Overall Study|Adverse Event|2|||
162998321|NCT00259272|588693878|FG001|Overall Study|Lost to Follow-up|0|||
162998322|NCT00259272|588693879|FG002|Overall Study|Lost to Follow-up|0|||
162998323|NCT00259272|588693880|FG003|Overall Study|Lost to Follow-up|1|||
163060450|NCT02320396|588929900|FG000|Overall Study|Pregnancy|0|||
163060451|NCT02320396|588929901|FG001|Overall Study|Pregnancy|1|||
163060452|NCT02320396|588929900|FG000|Overall Study|Protocol Violation|0|||
163060453|NCT02320396|588929901|FG001|Overall Study|Protocol Violation|1|||
163060454|NCT02320396|588929900|FG000|Overall Study|Withdrawal by Subject|2|||
163060455|NCT02320396|588929901|FG001|Overall Study|Withdrawal by Subject|0|||
163060456|NCT00142415|588929902|FG000|Overall Study|Physician Decision|0|||
163060457|NCT00142415|588929903|FG001|Overall Study|Physician Decision|0|||
163060458|NCT00142415|588929904|FG002|Overall Study|Physician Decision|0|||
162998324|NCT03301623|588693883|FG000|Overall Study|Death|3|||
163324907|NCT02166463|589901399|FG000|Overall Study|Progressive Disease|9|||
162998325|NCT03301623|588693884|FG001|Overall Study|Death|1|||
162998326|NCT03301623|588693883|FG000|Overall Study|Withdrawal by Subject|11|||
162998327|NCT03301623|588693884|FG001|Overall Study|Withdrawal by Subject|13|||
162998328|NCT03301623|588693883|FG000|Overall Study|Lost to Follow-up|3|||
162998329|NCT03301623|588693884|FG001|Overall Study|Lost to Follow-up|1|||
162998330|NCT02516553|588693885|FG000|Overall Study|Progressive disease|2|||
162998331|NCT02516553|588693886|FG001|Overall Study|Progressive disease|2|||
162998332|NCT02516553|588693887|FG002|Overall Study|Progressive disease|3|||
162998333|NCT02516553|588693888|FG003|Overall Study|Progressive disease|5|||
162998334|NCT02516553|588693889|FG004|Overall Study|Progressive disease|3|||
162998335|NCT02516553|588693890|FG005|Overall Study|Progressive disease|0|||
162998336|NCT02516553|588693891|FG006|Overall Study|Progressive disease|5|||
162998337|NCT02516553|588693892|FG007|Overall Study|Progressive disease|5|||
162998338|NCT02516553|588693893|FG008|Overall Study|Progressive disease|11|||
162998339|NCT02516553|588693894|FG009|Overall Study|Progressive disease|3|||
162998340|NCT02516553|588693895|FG010|Overall Study|Progressive disease|10|||
162998341|NCT02516553|588693896|FG011|Overall Study|Progressive disease|8|||
162998342|NCT02516553|588693897|FG012|Overall Study|Progressive disease|8|||
162998343|NCT02516553|588693898|FG013|Overall Study|Progressive disease|2|||
162998344|NCT02516553|588693899|FG014|Overall Study|Progressive disease|2|||
162998345|NCT02516553|588693900|FG015|Overall Study|Progressive disease|2|||
162998346|NCT02516553|588693901|FG016|Overall Study|Progressive disease|1|||
162998347|NCT02516553|588693902|FG017|Overall Study|Progressive disease|9|||
162998348|NCT02516553|588693903|FG018|Overall Study|Progressive disease|12|||
162998349|NCT02516553|588693904|FG019|Overall Study|Progressive disease|7|||
162998350|NCT02516553|588693905|FG020|Overall Study|Progressive disease|16|||
162998351|NCT02516553|588693906|FG021|Overall Study|Progressive disease|18|||
162998352|NCT02516553|588693885|FG000|Overall Study|Dose limiting toxicity|0|||
162998353|NCT02516553|588693886|FG001|Overall Study|Dose limiting toxicity|0|||
162998354|NCT02516553|588693887|FG002|Overall Study|Dose limiting toxicity|0|||
162998355|NCT02516553|588693888|FG003|Overall Study|Dose limiting toxicity|0|||
162998356|NCT02516553|588693889|FG004|Overall Study|Dose limiting toxicity|3|||
162998357|NCT02516553|588693890|FG005|Overall Study|Dose limiting toxicity|1|||
162998358|NCT02516553|588693891|FG006|Overall Study|Dose limiting toxicity|1|||
162998359|NCT02516553|588693892|FG007|Overall Study|Dose limiting toxicity|0|||
162998360|NCT02516553|588693893|FG008|Overall Study|Dose limiting toxicity|1|||
162998361|NCT02516553|588693894|FG009|Overall Study|Dose limiting toxicity|0|||
162998362|NCT02516553|588693895|FG010|Overall Study|Dose limiting toxicity|0|||
162998363|NCT02516553|588693896|FG011|Overall Study|Dose limiting toxicity|1|||
163060459|NCT00142415|588929905|FG003|Overall Study|Physician Decision|0|||
163060460|NCT00142415|588929906|FG004|Overall Study|Physician Decision|1|||
163060461|NCT00142415|588929907|FG005|Overall Study|Physician Decision|2|||
163324908|NCT02166463|589901400|FG001|Overall Study|Progressive Disease|6|||
163324909|NCT02166463|589901399|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
163324910|NCT02166463|589901400|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
163324911|NCT02166463|589901399|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
163324912|NCT02166463|589901400|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
162998364|NCT02516553|588693897|FG012|Overall Study|Dose limiting toxicity|0|||
162998365|NCT02516553|588693898|FG013|Overall Study|Dose limiting toxicity|1|||
162998366|NCT02516553|588693899|FG014|Overall Study|Dose limiting toxicity|0|||
162998367|NCT02516553|588693900|FG015|Overall Study|Dose limiting toxicity|0|||
162998368|NCT02516553|588693901|FG016|Overall Study|Dose limiting toxicity|1|||
162998369|NCT02516553|588693902|FG017|Overall Study|Dose limiting toxicity|1|||
162998370|NCT02516553|588693903|FG018|Overall Study|Dose limiting toxicity|0|||
163060462|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
163060463|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
163060464|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
163060465|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
163324913|NCT02166463|589901399|FG000|Overall Study|Refusal of further protocol therapy|5|||
163324914|NCT02166463|589901400|FG001|Overall Study|Refusal of further protocol therapy|6|||
163324915|NCT03767335|589901407|FG000|Overall Study|Physician Decision|1|||
162998371|NCT02516553|588693904|FG019|Overall Study|Dose limiting toxicity|2|||
162998372|NCT02516553|588693905|FG020|Overall Study|Dose limiting toxicity|0|||
162998373|NCT02516553|588693906|FG021|Overall Study|Dose limiting toxicity|0|||
162998374|NCT02516553|588693885|FG000|Overall Study|Other Adverse Events|0|||
162998375|NCT02516553|588693886|FG001|Overall Study|Other Adverse Events|0|||
162998376|NCT02516553|588693887|FG002|Overall Study|Other Adverse Events|0|||
162998377|NCT02516553|588693888|FG003|Overall Study|Other Adverse Events|1|||
162998378|NCT02516553|588693889|FG004|Overall Study|Other Adverse Events|0|||
162998379|NCT02516553|588693890|FG005|Overall Study|Other Adverse Events|1|||
162998380|NCT02516553|588693891|FG006|Overall Study|Other Adverse Events|0|||
162998381|NCT02516553|588693892|FG007|Overall Study|Other Adverse Events|0|||
162998382|NCT02516553|588693893|FG008|Overall Study|Other Adverse Events|0|||
162998383|NCT02516553|588693894|FG009|Overall Study|Other Adverse Events|1|||
162998384|NCT02516553|588693895|FG010|Overall Study|Other Adverse Events|3|||
162998385|NCT02516553|588693896|FG011|Overall Study|Other Adverse Events|2|||
162998386|NCT02516553|588693897|FG012|Overall Study|Other Adverse Events|0|||
162998387|NCT02516553|588693898|FG013|Overall Study|Other Adverse Events|1|||
162998388|NCT02516553|588693899|FG014|Overall Study|Other Adverse Events|0|||
162998389|NCT02516553|588693900|FG015|Overall Study|Other Adverse Events|0|||
162998390|NCT02516553|588693901|FG016|Overall Study|Other Adverse Events|0|||
162998391|NCT02516553|588693902|FG017|Overall Study|Other Adverse Events|2|||
162998392|NCT02516553|588693903|FG018|Overall Study|Other Adverse Events|1|||
162998393|NCT02516553|588693904|FG019|Overall Study|Other Adverse Events|2|||
162998394|NCT02516553|588693905|FG020|Overall Study|Other Adverse Events|2|||
162998395|NCT02516553|588693906|FG021|Overall Study|Other Adverse Events|1|||
162998396|NCT02516553|588693885|FG000|Overall Study|Refused to continue trial medication|0|||
162998397|NCT02516553|588693886|FG001|Overall Study|Refused to continue trial medication|0|||
162998398|NCT02516553|588693887|FG002|Overall Study|Refused to continue trial medication|0|||
162998399|NCT02516553|588693888|FG003|Overall Study|Refused to continue trial medication|0|||
162998400|NCT02516553|588693889|FG004|Overall Study|Refused to continue trial medication|0|||
162998401|NCT02516553|588693890|FG005|Overall Study|Refused to continue trial medication|0|||
162998402|NCT02516553|588693891|FG006|Overall Study|Refused to continue trial medication|0|||
162998403|NCT02516553|588693892|FG007|Overall Study|Refused to continue trial medication|0|||
162998404|NCT02516553|588693893|FG008|Overall Study|Refused to continue trial medication|0|||
162998405|NCT02516553|588693894|FG009|Overall Study|Refused to continue trial medication|0|||
162998406|NCT02516553|588693895|FG010|Overall Study|Refused to continue trial medication|1|||
162998407|NCT02516553|588693896|FG011|Overall Study|Refused to continue trial medication|0|||
162998408|NCT02516553|588693897|FG012|Overall Study|Refused to continue trial medication|0|||
162998409|NCT02516553|588693898|FG013|Overall Study|Refused to continue trial medication|0|||
162998410|NCT02516553|588693899|FG014|Overall Study|Refused to continue trial medication|0|||
162998411|NCT02516553|588693900|FG015|Overall Study|Refused to continue trial medication|0|||
162998412|NCT02516553|588693901|FG016|Overall Study|Refused to continue trial medication|0|||
162998413|NCT02516553|588693902|FG017|Overall Study|Refused to continue trial medication|0|||
162998414|NCT02516553|588693903|FG018|Overall Study|Refused to continue trial medication|1|||
162998415|NCT02516553|588693904|FG019|Overall Study|Refused to continue trial medication|0|||
162998416|NCT02516553|588693905|FG020|Overall Study|Refused to continue trial medication|0|||
162998417|NCT02516553|588693906|FG021|Overall Study|Refused to continue trial medication|1|||
162998418|NCT02516553|588693885|FG000|Overall Study|other reasons than listed|0|||
162998419|NCT02516553|588693886|FG001|Overall Study|other reasons than listed|0|||
162998420|NCT02516553|588693887|FG002|Overall Study|other reasons than listed|0|||
162998421|NCT02516553|588693888|FG003|Overall Study|other reasons than listed|0|||
162998422|NCT02516553|588693889|FG004|Overall Study|other reasons than listed|0|||
162998423|NCT02516553|588693890|FG005|Overall Study|other reasons than listed|0|||
162998424|NCT02516553|588693891|FG006|Overall Study|other reasons than listed|0|||
162998425|NCT02516553|588693892|FG007|Overall Study|other reasons than listed|1|||
162998426|NCT02516553|588693893|FG008|Overall Study|other reasons than listed|1|||
162998427|NCT02516553|588693894|FG009|Overall Study|other reasons than listed|0|||
162998428|NCT02516553|588693895|FG010|Overall Study|other reasons than listed|1|||
162998429|NCT02516553|588693896|FG011|Overall Study|other reasons than listed|1|||
162998430|NCT02516553|588693897|FG012|Overall Study|other reasons than listed|0|||
162998431|NCT02516553|588693898|FG013|Overall Study|other reasons than listed|0|||
162998432|NCT02516553|588693899|FG014|Overall Study|other reasons than listed|0|||
162998433|NCT02516553|588693900|FG015|Overall Study|other reasons than listed|0|||
162998434|NCT02516553|588693901|FG016|Overall Study|other reasons than listed|0|||
162998435|NCT02516553|588693902|FG017|Overall Study|other reasons than listed|0|||
162998436|NCT02516553|588693903|FG018|Overall Study|other reasons than listed|0|||
162998437|NCT02516553|588693904|FG019|Overall Study|other reasons than listed|0|||
162998438|NCT02516553|588693905|FG020|Overall Study|other reasons than listed|2|||
162998439|NCT02516553|588693906|FG021|Overall Study|other reasons than listed|2|||
162998440|NCT00315731|588693908|FG000|Overall Study|Lost to Follow-up|1|||
162998441|NCT00315731|588693908|FG000|Overall Study|Death|5|||
162998442|NCT01680497|588693910|FG000|Overall Study|Lost to Follow-up|2|||
162998443|NCT04123561|588693912|FG000|Overall Study|Lost to Follow-up|20|||
162998444|NCT04123561|588693913|FG001|Overall Study|Lost to Follow-up|12|||
162998445|NCT04123561|588693914|FG002|Overall Study|Lost to Follow-up|5|||
162998446|NCT04123561|588693912|FG000|Overall Study|Withdrawal by Subject|9|||
162998447|NCT04123561|588693913|FG001|Overall Study|Withdrawal by Subject|7|||
162998448|NCT04123561|588693914|FG002|Overall Study|Withdrawal by Subject|9|||
162998449|NCT04123561|588693912|FG000|Overall Study|Lack of Efficacy|7|||
162998450|NCT04123561|588693913|FG001|Overall Study|Lack of Efficacy|8|||
162998451|NCT04123561|588693914|FG002|Overall Study|Lack of Efficacy|6|||
162998452|NCT04123561|588693912|FG000|Overall Study|Adverse Event|5|||
162998453|NCT04123561|588693913|FG001|Overall Study|Adverse Event|2|||
162998454|NCT04123561|588693914|FG002|Overall Study|Adverse Event|3|||
162998455|NCT04123561|588693912|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
162998456|NCT04123561|588693913|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
162998457|NCT04123561|588693914|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
162998458|NCT04123561|588693912|FG000|Overall Study|Death|0|||
162998459|NCT04123561|588693913|FG001|Overall Study|Death|0|||
162998460|NCT04123561|588693914|FG002|Overall Study|Death|1|||
162998461|NCT04123561|588693912|FG000|Overall Study|Protocol Violation|0|||
162998462|NCT04123561|588693913|FG001|Overall Study|Protocol Violation|1|||
162998463|NCT04123561|588693914|FG002|Overall Study|Protocol Violation|0|||
162998464|NCT00708227|588693922|FG000|Overall Study|Physician Decision|0|||
162998465|NCT00708227|588693923|FG001|Overall Study|Physician Decision|3|||
162998466|NCT00708227|588693924|FG002|Overall Study|Physician Decision|1|||
162998467|NCT00708227|588693925|FG003|Overall Study|Physician Decision|2|||
162998468|NCT00708227|588693922|FG000|Overall Study|Withdrawal by Subject|1|||
162998469|NCT00708227|588693923|FG001|Overall Study|Withdrawal by Subject|2|||
162998470|NCT00708227|588693924|FG002|Overall Study|Withdrawal by Subject|0|||
162998471|NCT00708227|588693925|FG003|Overall Study|Withdrawal by Subject|1|||
163404319|NCT02356562|590191905|FG000|Overall Study|Re-entered treatment in a previous study|1|||
163404320|NCT02356562|590191906|FG001|Overall Study|Re-entered treatment in a previous study|0|||
163404321|NCT02356562|590191905|FG000|Overall Study|site closure|1|||
163404322|NCT02356562|590191906|FG001|Overall Study|site closure|0|||
162998472|NCT04007991|588693926|FG000|Overall Study|Withdrawal by Subject|1|||
162998473|NCT04007991|588693927|FG001|Overall Study|Withdrawal by Subject|1|||
162998474|NCT04007991|588693926|FG000|Overall Study|Physician Decision|1|||
162998475|NCT04007991|588693927|FG001|Overall Study|Physician Decision|1|||
162998476|NCT04007991|588693926|FG000|Overall Study|Non-compliance with Study Drug|0|||
162998477|NCT04007991|588693927|FG001|Overall Study|Non-compliance with Study Drug|1|||
162998478|NCT04007991|588693926|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
162998479|NCT04007991|588693927|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
162998480|NCT04007991|588693926|FG000|Overall Study|Adverse event, non-fatal|5|||
162998481|NCT04007991|588693927|FG001|Overall Study|Adverse event, non-fatal|0|||
162998482|NCT04007991|588693926|FG000|Overall Study|Lost to Follow-up|2|||
162998483|NCT04007991|588693927|FG001|Overall Study|Lost to Follow-up|1|||
162998484|NCT03654599|588693930|FG000|Overall Study|Lost to Follow-up|14|||
162998485|NCT03654599|588693931|FG001|Overall Study|Lost to Follow-up|12|||
162998486|NCT03654599|588693930|FG000|Overall Study|Death|8|||
163212732|NCT00623727|589494295|FG001|Double Blind (DB)|Lost to Follow-up|1|||
163212733|NCT00623727|589494294|FG000|Double Blind (DB)|Protocol Violation|2|||
163212734|NCT00623727|589494295|FG001|Double Blind (DB)|Protocol Violation|2|||
163212735|NCT00623727|589494294|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
163212736|NCT00623727|589494295|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
163212737|NCT00623727|589494294|FG000|Open Label Follow-up|Study termination|0|||
163212738|NCT00623727|589494295|FG001|Open Label Follow-up|Study termination|6|||
163212739|NCT00623727|589494294|FG000|Open Label Follow-up|Participant convenience|0|||
162998487|NCT03654599|588693931|FG001|Overall Study|Death|6|||
163212740|NCT00623727|589494295|FG001|Open Label Follow-up|Participant convenience|1|||
163404323|NCT00150592|590191907|FG000|Overall Study|Adverse Event|4|||
163404324|NCT00150592|590191908|FG001|Overall Study|Adverse Event|1|||
163404325|NCT00150592|590191907|FG000|Overall Study|Protocol Violation|1|||
162998488|NCT03654599|588693930|FG000|Overall Study|Withdrawal by Subject|6|||
162998489|NCT03654599|588693931|FG001|Overall Study|Withdrawal by Subject|4|||
163404326|NCT00150592|590191908|FG001|Overall Study|Protocol Violation|0|||
163404327|NCT00150592|590191907|FG000|Overall Study|Withdrawal by Subject|1|||
163404328|NCT00150592|590191908|FG001|Overall Study|Withdrawal by Subject|2|||
163404329|NCT00150592|590191907|FG000|Overall Study|Non-compliance|1|||
163404330|NCT00150592|590191908|FG001|Overall Study|Non-compliance|0|||
163404331|NCT00412750|590191909|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163404332|NCT00412750|590191910|FG001|Overall Study|Abnormal laboratory value(s)|0|||
162998490|NCT01290302|588695697|FG000|Overall Study|Adverse Event|2|||
162998491|NCT01290302|588695698|FG001|Overall Study|Adverse Event|0|||
162998492|NCT01290302|588695697|FG000|Overall Study|Withdrawal by Subject|1|||
163212741|NCT01852942|589494296|FG000|Overall Study|Physician Decision|1|||
163212742|NCT01852942|589494297|FG001|Overall Study|Physician Decision|0|||
163212743|NCT01852942|589494296|FG000|Overall Study|Death|1|||
162998493|NCT01290302|588695698|FG001|Overall Study|Withdrawal by Subject|0|||
162998494|NCT01290302|588695697|FG000|Overall Study|Physician Decision|0|||
162998495|NCT01290302|588695698|FG001|Overall Study|Physician Decision|2|||
162998496|NCT01290302|588695697|FG000|Overall Study|Expiration of time for screening window|1|||
163212744|NCT01852942|589494297|FG001|Overall Study|Death|1|||
163212745|NCT01852942|589494296|FG000|Overall Study|Withdrawal by Subject|2|||
163212746|NCT01852942|589494297|FG001|Overall Study|Withdrawal by Subject|3|||
163212747|NCT01852942|589494296|FG000|Overall Study|Lost to Follow-up|1|||
163212748|NCT01852942|589494297|FG001|Overall Study|Lost to Follow-up|2|||
163212749|NCT00696696|589494301|FG000|Overall Study|Adverse Event|5|||
163212750|NCT00696696|589494301|FG000|Overall Study|Withdrawal by Subject|8|||
163212751|NCT00696696|589494301|FG000|Overall Study|Physician Decision|2|||
163212752|NCT00696696|589494301|FG000|Overall Study|Death|3|||
163212753|NCT02642614|589494302|FG000|Overall Study|Adverse Event|1|||
163212754|NCT02642614|589494303|FG001|Overall Study|Adverse Event|1|||
162998497|NCT01290302|588695698|FG001|Overall Study|Expiration of time for screening window|0|||
162998498|NCT03816878|588695701|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
162998499|NCT03816878|588695702|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
162998500|NCT03816878|588695701|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
162998501|NCT03816878|588695702|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
162998502|NCT03355469|588695703|FG000|Overall Study|COVID-19|3|||
162998503|NCT03355469|588695704|FG001|Overall Study|COVID-19|2|||
162998504|NCT03355469|588695705|FG002|Overall Study|COVID-19|3|||
162998505|NCT03355469|588695706|FG003|Overall Study|COVID-19|3|||
162998506|NCT03355469|588695703|FG000|Overall Study|Lost to Follow-up|1|||
162998507|NCT03355469|588695704|FG001|Overall Study|Lost to Follow-up|0|||
162998508|NCT03355469|588695705|FG002|Overall Study|Lost to Follow-up|1|||
162998509|NCT03355469|588695706|FG003|Overall Study|Lost to Follow-up|0|||
162998510|NCT03355469|588695703|FG000|Overall Study|Withdrawal by Subject|2|||
162998511|NCT03355469|588695704|FG001|Overall Study|Withdrawal by Subject|1|||
162998512|NCT03355469|588695705|FG002|Overall Study|Withdrawal by Subject|0|||
162998513|NCT03355469|588695706|FG003|Overall Study|Withdrawal by Subject|3|||
162998514|NCT02291510|588695707|FG000|Overall Study|Adverse Event|0|||
162998515|NCT02291510|588695708|FG001|Overall Study|Adverse Event|0|||
162998516|NCT02291510|588695709|FG002|Overall Study|Adverse Event|0|||
162998517|NCT02291510|588695710|FG003|Overall Study|Adverse Event|1|||
162998518|NCT00615199|588695716|FG000|Overall Study|Adverse Event|3|||
162998519|NCT00615199|588695717|FG001|Overall Study|Adverse Event|1|||
162998520|NCT00615199|588695718|FG002|Overall Study|Adverse Event|1|||
162998521|NCT00615199|588695719|FG003|Overall Study|Adverse Event|0|||
162998522|NCT00615199|588695716|FG000|Overall Study|Lack of Efficacy|2|||
162998523|NCT00615199|588695717|FG001|Overall Study|Lack of Efficacy|0|||
162998524|NCT00615199|588695718|FG002|Overall Study|Lack of Efficacy|0|||
162998525|NCT00615199|588695719|FG003|Overall Study|Lack of Efficacy|1|||
162998526|NCT00615199|588695716|FG000|Overall Study|Lost to Follow-up|1|||
162998527|NCT00615199|588695717|FG001|Overall Study|Lost to Follow-up|0|||
162998528|NCT00615199|588695718|FG002|Overall Study|Lost to Follow-up|0|||
162998529|NCT00615199|588695719|FG003|Overall Study|Lost to Follow-up|0|||
162998530|NCT00615199|588695716|FG000|Overall Study|Other|0|||
162998531|NCT00615199|588695717|FG001|Overall Study|Other|0|||
162998532|NCT00615199|588695718|FG002|Overall Study|Other|0|||
162998533|NCT00615199|588695719|FG003|Overall Study|Other|1|||
162998534|NCT00615199|588695716|FG000|Overall Study|Withdrawal by Subject|2|||
162998535|NCT00615199|588695717|FG001|Overall Study|Withdrawal by Subject|1|||
162998536|NCT00615199|588695718|FG002|Overall Study|Withdrawal by Subject|0|||
162998537|NCT00615199|588695719|FG003|Overall Study|Withdrawal by Subject|0|||
162998538|NCT04825912|588695720|FG000|Overall Study|Death|3|||
162998539|NCT04825912|588695720|FG000|Overall Study|Withdrawal by Subject|1|||
162998540|NCT00459355|588695723|FG000|Overall Study|Subject no longer met inc criteria|20|||
162998541|NCT00459355|588695724|FG001|Overall Study|Subject no longer met inc criteria|18|||
162998542|NCT01009814|588695727|FG000|Overall Study|No longer met study criteria|1|||
162998543|NCT01009814|588695728|FG001|Overall Study|No longer met study criteria|1|||
162998544|NCT01009814|588695729|FG002|Overall Study|No longer met study criteria|0|||
162998545|NCT01009814|588695730|FG003|Overall Study|No longer met study criteria|0|||
162998546|NCT01009814|588695731|FG004|Overall Study|No longer met study criteria|0|||
162998547|NCT00618371|588695732|FG000|Overall Study|Withdrawal by Subject|2|||
162998548|NCT01173120|588695733|FG000|Overall Study|Lack of Efficacy|2|||
162998549|NCT01173120|588695733|FG000|Overall Study|Lost to Follow-up|1|||
162998550|NCT01173120|588695733|FG000|Overall Study|Participant Decision|2|||
163212755|NCT02642614|589494304|FG002|Overall Study|Adverse Event|2|||
162998551|NCT01173120|588695733|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
162998552|NCT01173120|588695733|FG000|Overall Study|Switch-Participant Decision|12|||
162998553|NCT01173120|588695733|FG000|Overall Study|Switch-Difficulty With Device|12|||
162998554|NCT01977417|588695738|FG000|Overall Study|Adverse Event|1|||
162998555|NCT01977417|588695739|FG001|Overall Study|Adverse Event|0|||
162998556|NCT01977417|588695738|FG000|Overall Study|Withdrawal by Subject|2|||
162998557|NCT01977417|588695739|FG001|Overall Study|Withdrawal by Subject|4|||
162998558|NCT01977417|588695738|FG000|Overall Study|Female enrollment goal met|0|||
163212756|NCT02642614|589494305|FG003|Overall Study|Adverse Event|2|||
163212757|NCT02642614|589494302|FG000|Overall Study|Lost to Follow-up|1|||
163212758|NCT02642614|589494303|FG001|Overall Study|Lost to Follow-up|0|||
163060466|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
163060467|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
163060468|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
163060469|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
163060470|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
162998559|NCT01977417|588695739|FG001|Overall Study|Female enrollment goal met|2|||
162998560|NCT02906358|588695740|FG000|Overall Study|Withdrawal by Subject|10|||
162998561|NCT02906358|588695741|FG001|Overall Study|Withdrawal by Subject|7|||
162998562|NCT02906358|588695740|FG000|Overall Study|Lost to Follow-up|12|||
162998563|NCT02906358|588695741|FG001|Overall Study|Lost to Follow-up|15|||
162998564|NCT02699684|588695742|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
162998565|NCT02699684|588695743|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
162998566|NCT00616421|588695746|FG000|Overall Study|Withdrawal by Subject|9|||
163060471|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
162998567|NCT00616421|588695747|FG001|Overall Study|Withdrawal by Subject|11|||
162998568|NCT00616421|588695748|FG002|Overall Study|Withdrawal by Subject|8|||
162998569|NCT00616421|588695746|FG000|Overall Study|Lost to Follow-up|12|||
162998570|NCT00616421|588695747|FG001|Overall Study|Lost to Follow-up|26|||
162998571|NCT00616421|588695748|FG002|Overall Study|Lost to Follow-up|30|||
162998572|NCT00616421|588695746|FG000|Overall Study|Inappropriate enrollment|3|||
162998573|NCT00616421|588695747|FG001|Overall Study|Inappropriate enrollment|0|||
162998574|NCT00616421|588695748|FG002|Overall Study|Inappropriate enrollment|1|||
162998575|NCT00616421|588695746|FG000|Overall Study|Administrative reason|1|||
162998576|NCT00616421|588695747|FG001|Overall Study|Administrative reason|0|||
162998577|NCT00616421|588695748|FG002|Overall Study|Administrative reason|0|||
162998578|NCT00616421|588695746|FG000|Overall Study|Protocol Violation|0|||
162998579|NCT00616421|588695747|FG001|Overall Study|Protocol Violation|1|||
162998580|NCT00616421|588695748|FG002|Overall Study|Protocol Violation|2|||
162998581|NCT00616421|588695746|FG000|Overall Study|Unable to classify|1|||
162998582|NCT00616421|588695747|FG001|Overall Study|Unable to classify|0|||
162998583|NCT00616421|588695748|FG002|Overall Study|Unable to classify|0|||
162998584|NCT01495702|588695749|FG000|Randomized Phase|Randomized But Not Treated|1|||
162998585|NCT01495702|588695750|FG001|Randomized Phase|Randomized But Not Treated|4|||
162998586|NCT01495702|588695749|FG000|Randomized Phase|Adverse Event|2|||
162998587|NCT01495702|588695750|FG001|Randomized Phase|Adverse Event|2|||
162998588|NCT01495702|588695749|FG000|Randomized Phase|Death|1|||
162998589|NCT01495702|588695750|FG001|Randomized Phase|Death|0|||
162998590|NCT01495702|588695749|FG000|Randomized Phase|Lack of Efficacy|2|||
162998591|NCT01495702|588695750|FG001|Randomized Phase|Lack of Efficacy|0|||
162998592|NCT01495702|588695749|FG000|Randomized Phase|Investigators Discretion|2|||
162998593|NCT01495702|588695750|FG001|Randomized Phase|Investigators Discretion|0|||
162998594|NCT01495702|588695749|FG000|Randomized Phase|Withdrew Consent|10|||
162998595|NCT01495702|588695750|FG001|Randomized Phase|Withdrew Consent|18|||
162998596|NCT01495702|588695749|FG000|Randomized Phase|Lost to Follow-up|4|||
162998597|NCT01495702|588695750|FG001|Randomized Phase|Lost to Follow-up|3|||
162998598|NCT01495702|588695749|FG000|Randomized Phase|Participant Noncompliance|1|||
162998599|NCT01495702|588695750|FG001|Randomized Phase|Participant Noncompliance|0|||
162998600|NCT01495702|588695749|FG000|Randomized Phase|Protocol Violation|3|||
162998601|NCT01495702|588695750|FG001|Randomized Phase|Protocol Violation|1|||
162998602|NCT04152863|588695751|FG000|Overall Study|Death|13|||
162998603|NCT04152863|588695752|FG001|Overall Study|Death|12|||
162998604|NCT04152863|588695753|FG002|Overall Study|Death|7|||
162998605|NCT04152863|588695751|FG000|Overall Study|Physician Decision|1|||
162998606|NCT04152863|588695752|FG001|Overall Study|Physician Decision|1|||
162998607|NCT04152863|588695753|FG002|Overall Study|Physician Decision|1|||
162998608|NCT04152863|588695751|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
162998609|NCT04152863|588695752|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
162998610|NCT04152863|588695753|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
163060472|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
163060473|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
163212759|NCT02642614|589494304|FG002|Overall Study|Lost to Follow-up|0|||
163212760|NCT02642614|589494305|FG003|Overall Study|Lost to Follow-up|0|||
163212761|NCT02642614|589494302|FG000|Overall Study|Withdrawal by Subject|1|||
162998611|NCT04152863|588695751|FG000|Overall Study|Withdrawal by Subject|2|||
162998612|NCT04152863|588695752|FG001|Overall Study|Withdrawal by Subject|1|||
162998613|NCT04152863|588695753|FG002|Overall Study|Withdrawal by Subject|3|||
162998614|NCT01644617|588695757|FG000|Overall Study|Withdrawal by Subject|3|||
162998615|NCT01644617|588695758|FG001|Overall Study|Withdrawal by Subject|4|||
162998616|NCT01644617|588695759|FG002|Overall Study|Withdrawal by Subject|1|||
162998617|NCT01644617|588695757|FG000|Overall Study|Lost to Follow-up|0|||
162998618|NCT01644617|588695758|FG001|Overall Study|Lost to Follow-up|1|||
162998619|NCT01644617|588695759|FG002|Overall Study|Lost to Follow-up|0|||
162998620|NCT01644617|588695757|FG000|Overall Study|Adverse Event|3|||
163212762|NCT02642614|589494303|FG001|Overall Study|Withdrawal by Subject|1|||
162998621|NCT01644617|588695758|FG001|Overall Study|Adverse Event|0|||
162998622|NCT01644617|588695759|FG002|Overall Study|Adverse Event|6|||
162998623|NCT05445492|588695768|FG000|Overall Study|Physician Decision|1|||
162998624|NCT04289363|588695770|FG000|Overall Study|Lost to Follow-up|14|||
162998625|NCT04289363|588695771|FG001|Overall Study|Lost to Follow-up|0|||
162998626|NCT03790657|588695772|FG000|Overall Study|Adverse Event|1|||
162998627|NCT03790657|588695773|FG001|Overall Study|Adverse Event|1|||
162998628|NCT03790657|588695772|FG000|Overall Study|Withdrawal by Subject|1|||
162998629|NCT03790657|588695773|FG001|Overall Study|Withdrawal by Subject|1|||
162998630|NCT03126435|588695774|FG000|Overall Study|Death|90|||
162998631|NCT03126435|588695775|FG001|Overall Study|Death|84|||
162998632|NCT03126435|588695774|FG000|Overall Study|Lost to Follow-up|4|||
162998633|NCT03126435|588695775|FG001|Overall Study|Lost to Follow-up|3|||
162998634|NCT03126435|588695774|FG000|Overall Study|Physician Decision|0|||
162998635|NCT03126435|588695775|FG001|Overall Study|Physician Decision|1|||
162998636|NCT03126435|588695774|FG000|Overall Study|Withdrawal by Subject|6|||
162998637|NCT03126435|588695775|FG001|Overall Study|Withdrawal by Subject|12|||
162998638|NCT03126435|588695774|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
162998639|NCT03126435|588695775|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
162998640|NCT03971474|588695776|FG000|Overall Study|Adverse Event|11|||
162998641|NCT03971474|588695777|FG001|Overall Study|Adverse Event|7|||
162998642|NCT03971474|588695776|FG000|Overall Study|Refusal unrelated to adverse event|5|||
162998643|NCT03971474|588695777|FG001|Overall Study|Refusal unrelated to adverse event|1|||
162998644|NCT03971474|588695776|FG000|Overall Study|Progression/relapse|40|||
162998645|NCT03971474|588695777|FG001|Overall Study|Progression/relapse|47|||
162998646|NCT03971474|588695776|FG000|Overall Study|Death|6|||
162998647|NCT03971474|588695777|FG001|Overall Study|Death|3|||
162998648|NCT03971474|588695776|FG000|Overall Study|Other - not protocol specified|5|||
162998649|NCT03971474|588695777|FG001|Overall Study|Other - not protocol specified|4|||
162998650|NCT03971474|588695776|FG000|Overall Study|On treatment|0|||
162998651|NCT03971474|588695777|FG001|Overall Study|On treatment|7|||
162998652|NCT01023035|588695779|FG000|Treatment Period|Adverse Event|27|||
163060474|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
163060475|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
163060476|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
163060477|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
162998653|NCT01023035|588695780|FG001|Treatment Period|Adverse Event|32|||
162998654|NCT01023035|588695781|FG002|Treatment Period|Adverse Event|50|||
162998655|NCT01023035|588695779|FG000|Treatment Period|Non-Medical Reasons|19|||
162998656|NCT01023035|588695780|FG001|Treatment Period|Non-Medical Reasons|22|||
162998657|NCT01023035|588695781|FG002|Treatment Period|Non-Medical Reasons|44|||
162998658|NCT01023035|588695779|FG000|Treatment Period|Treatment Failure|26|||
162998659|NCT01023035|588695780|FG001|Treatment Period|Treatment Failure|31|||
162998660|NCT01023035|588695781|FG002|Treatment Period|Treatment Failure|24|||
162998661|NCT01023035|588695779|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
162998662|NCT01023035|588695780|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
162998663|NCT01023035|588695781|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
162998664|NCT01023035|588695779|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
162998665|NCT01023035|588695780|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
162998666|NCT01023035|588695781|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
162998667|NCT01807065|588695782|FG000|Overall Study|Receive no sip-T due to IV access|1|||
162998668|NCT01807065|588695783|FG001|Overall Study|Receive no sip-T due to IV access|1|||
162998669|NCT01482312|588695785|FG000|Period 1, 90 Minutes of Wear|Other|1|||
162998670|NCT01482312|588695786|FG001|Period 1, 90 Minutes of Wear|Other|0|||
162998671|NCT01482312|588695787|FG002|Period 1, 90 Minutes of Wear|Other|0|||
162998672|NCT01482312|588695785|FG000|Period 2, 90 Minutes of Wear|Other|1|||
162998673|NCT01482312|588695786|FG001|Period 2, 90 Minutes of Wear|Other|0|||
162998674|NCT01482312|588695787|FG002|Period 2, 90 Minutes of Wear|Other|0|||
162998675|NCT01699815|588695788|FG000|Overall Study|Protocol Violation|4|||
163060478|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
162998676|NCT01699815|588695789|FG001|Overall Study|Protocol Violation|7|||
162998677|NCT01699815|588695788|FG000|Overall Study|record could not be located|1|||
163060479|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
163324916|NCT03767335|589901408|FG001|Overall Study|Physician Decision|1|||
162998678|NCT01699815|588695789|FG001|Overall Study|record could not be located|0|||
162998679|NCT01699815|588695788|FG000|Overall Study|Adverse Event|0|||
162998680|NCT01699815|588695789|FG001|Overall Study|Adverse Event|1|||
162998681|NCT01295320|588695790|FG000|Overall Study|Adverse Event|2|||
162998682|NCT01295320|588695790|FG000|Overall Study|Lost to Follow-up|4|||
162998683|NCT01295320|588695790|FG000|Overall Study|Withdrawal by Subject|2|||
162998684|NCT01295320|588695790|FG000|Overall Study|Subject was bedridden|1|||
162998685|NCT01295320|588695790|FG000|Overall Study|Unable to travel|1|||
162998686|NCT00462904|588695791|FG000|Overall Study|Lost to Follow-up|1|||
162998687|NCT00699816|588695794|FG000|Overall Study|Protocol Violation|1|||
162998688|NCT00699816|588695795|FG001|Overall Study|Protocol Violation|3|||
162998689|NCT00560391|588695796|FG000|Overall Study|Still on treatment|0|||
162998690|NCT00560391|588695797|FG001|Overall Study|Still on treatment|0|||
162998691|NCT00560391|588695798|FG002|Overall Study|Still on treatment|0|||
162998692|NCT00560391|588695799|FG003|Overall Study|Still on treatment|1|||
162998693|NCT00560391|588695800|FG004|Overall Study|Still on treatment|2|||
162998694|NCT03668808|588695801|FG000|First Intervention|Withdrawal by Subject|2|||
162998695|NCT03668808|588695802|FG001|First Intervention|Withdrawal by Subject|2|||
162998696|NCT02125877|588695804|FG000|Overall Study|Physician Decision|1|||
162998697|NCT02125877|588695805|FG001|Overall Study|Physician Decision|0|||
162998698|NCT02125877|588695804|FG000|Overall Study|Death|0|||
162998699|NCT02125877|588695805|FG001|Overall Study|Death|1|||
162998700|NCT02125877|588695804|FG000|Overall Study|Administrative problems|0|||
162998701|NCT02125877|588695805|FG001|Overall Study|Administrative problems|1|||
162998702|NCT02125877|588695804|FG000|Overall Study|Participant/guardian decision|0|||
162998703|NCT02125877|588695805|FG001|Overall Study|Participant/guardian decision|2|||
162998704|NCT02125877|588695804|FG000|Overall Study|Withdrawal by Subject|2|||
162998705|NCT02125877|588695805|FG001|Overall Study|Withdrawal by Subject|1|||
162998706|NCT02125877|588695804|FG000|Overall Study|Protocol deviation|4|||
162998707|NCT02125877|588695805|FG001|Overall Study|Protocol deviation|1|||
162998708|NCT02125877|588695804|FG000|Overall Study|Adverse Event|6|||
162998709|NCT02125877|588695805|FG001|Overall Study|Adverse Event|4|||
162998710|NCT04223752|588695806|FG000|Overall Study|Participant enrolled in error|0|||
162998711|NCT04223752|588695807|FG001|Overall Study|Participant enrolled in error|0|||
162998712|NCT04223752|588695808|FG002|Overall Study|Participant enrolled in error|0|||
162998713|NCT04223752|588695809|FG003|Overall Study|Participant enrolled in error|0|||
162998714|NCT04223752|588695810|FG004|Overall Study|Participant enrolled in error|1|||
162998715|NCT04223752|588695806|FG000|Overall Study|Death|0|||
162998716|NCT04223752|588695807|FG001|Overall Study|Death|0|||
162998717|NCT04223752|588695808|FG002|Overall Study|Death|0|||
162998718|NCT04223752|588695809|FG003|Overall Study|Death|2|||
162998719|NCT04223752|588695810|FG004|Overall Study|Death|1|||
162998720|NCT01822366|588695811|FG000|Overall Study|Lost to Follow-up|5|||
162998721|NCT01822366|588695812|FG001|Overall Study|Lost to Follow-up|1|||
162998722|NCT01822366|588695813|FG002|Overall Study|Lost to Follow-up|5|||
162998723|NCT01822366|588695814|FG003|Overall Study|Lost to Follow-up|1|||
162998724|NCT01822366|588695811|FG000|Overall Study|Withdrawal by Subject|0|||
162998725|NCT01822366|588695812|FG001|Overall Study|Withdrawal by Subject|6|||
162998726|NCT01822366|588695813|FG002|Overall Study|Withdrawal by Subject|0|||
162998727|NCT01822366|588695814|FG003|Overall Study|Withdrawal by Subject|6|||
162998728|NCT01822366|588695811|FG000|Overall Study|Partial Intervention Completion|0|||
162998729|NCT01822366|588695812|FG001|Overall Study|Partial Intervention Completion|15|||
162998730|NCT01822366|588695813|FG002|Overall Study|Partial Intervention Completion|0|||
162998731|NCT01822366|588695814|FG003|Overall Study|Partial Intervention Completion|15|||
162998732|NCT03489109|588695815|FG000|Overall Study|Lost to Follow-up|1|||
162998733|NCT03489109|588695816|FG001|Overall Study|Lost to Follow-up|2|||
162998734|NCT02552732|588695817|FG000|Overall Study|Lost to Follow-up|2|||
162998735|NCT02552732|588695817|FG000|Overall Study|Physician Decision|1|||
162998736|NCT02552732|588695817|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
162998737|NCT02552732|588695817|FG000|Overall Study|Withdrawal by Subject|6|||
162998738|NCT00025259|588695819|FG000|Overall Study|Death|1|||
162998739|NCT00025259|588695820|FG001|Overall Study|Death|3|||
162998740|NCT00025259|588695821|FG002|Overall Study|Death|0|||
162998741|NCT00025259|588695822|FG003|Overall Study|Death|3|||
162998742|NCT00025259|588695823|FG004|Overall Study|Death|0|||
162998743|NCT00025259|588695824|FG005|Overall Study|Death|1|||
162998744|NCT00025259|588695825|FG006|Overall Study|Death|2|||
162998745|NCT00025259|588695819|FG000|Overall Study|Lack of Efficacy|2|||
162998746|NCT00025259|588695820|FG001|Overall Study|Lack of Efficacy|46|||
162998747|NCT00025259|588695821|FG002|Overall Study|Lack of Efficacy|60|||
162998748|NCT00025259|588695822|FG003|Overall Study|Lack of Efficacy|78|||
162998749|NCT00025259|588695823|FG004|Overall Study|Lack of Efficacy|11|||
162998750|NCT00025259|588695824|FG005|Overall Study|Lack of Efficacy|30|||
162998751|NCT00025259|588695825|FG006|Overall Study|Lack of Efficacy|38|||
162998752|NCT00025259|588695819|FG000|Overall Study|Lost to Follow-up|2|||
162998753|NCT00025259|588695820|FG001|Overall Study|Lost to Follow-up|9|||
162998754|NCT00025259|588695821|FG002|Overall Study|Lost to Follow-up|13|||
162998755|NCT00025259|588695822|FG003|Overall Study|Lost to Follow-up|13|||
162998756|NCT00025259|588695823|FG004|Overall Study|Lost to Follow-up|1|||
162998757|NCT00025259|588695824|FG005|Overall Study|Lost to Follow-up|3|||
162998758|NCT00025259|588695825|FG006|Overall Study|Lost to Follow-up|1|||
162998759|NCT00025259|588695819|FG000|Overall Study|Physician Decision|12|||
162998760|NCT00025259|588695820|FG001|Overall Study|Physician Decision|1|||
162998761|NCT00025259|588695821|FG002|Overall Study|Physician Decision|0|||
162998762|NCT00025259|588695822|FG003|Overall Study|Physician Decision|5|||
162998763|NCT00025259|588695823|FG004|Overall Study|Physician Decision|4|||
162998764|NCT00025259|588695824|FG005|Overall Study|Physician Decision|2|||
162998765|NCT00025259|588695825|FG006|Overall Study|Physician Decision|1|||
162998766|NCT00025259|588695819|FG000|Overall Study|Protocol Violation|3|||
162998767|NCT00025259|588695820|FG001|Overall Study|Protocol Violation|2|||
162998768|NCT00025259|588695821|FG002|Overall Study|Protocol Violation|2|||
162998769|NCT00025259|588695822|FG003|Overall Study|Protocol Violation|1|||
162998770|NCT00025259|588695823|FG004|Overall Study|Protocol Violation|2|||
162998771|NCT00025259|588695824|FG005|Overall Study|Protocol Violation|1|||
162998772|NCT00025259|588695825|FG006|Overall Study|Protocol Violation|3|||
162998773|NCT00025259|588695819|FG000|Overall Study|Withdrawal by Subject|9|||
162998774|NCT00025259|588695820|FG001|Overall Study|Withdrawal by Subject|27|||
162998775|NCT00025259|588695821|FG002|Overall Study|Withdrawal by Subject|6|||
162998776|NCT00025259|588695822|FG003|Overall Study|Withdrawal by Subject|14|||
162998777|NCT00025259|588695823|FG004|Overall Study|Withdrawal by Subject|11|||
162998778|NCT00025259|588695824|FG005|Overall Study|Withdrawal by Subject|8|||
162998779|NCT00025259|588695825|FG006|Overall Study|Withdrawal by Subject|3|||
162998780|NCT00025259|588695819|FG000|Overall Study|Ineligible|14|||
162998781|NCT00025259|588695820|FG001|Overall Study|Ineligible|1|||
162998782|NCT00025259|588695821|FG002|Overall Study|Ineligible|0|||
162998783|NCT00025259|588695822|FG003|Overall Study|Ineligible|0|||
162998784|NCT00025259|588695823|FG004|Overall Study|Ineligible|6|||
162998785|NCT00025259|588695824|FG005|Overall Study|Ineligible|0|||
162998786|NCT00025259|588695825|FG006|Overall Study|Ineligible|1|||
162998787|NCT00025259|588695819|FG000|Overall Study|Randomization error|1|||
162998788|NCT00025259|588695820|FG001|Overall Study|Randomization error|0|||
162998789|NCT00025259|588695821|FG002|Overall Study|Randomization error|0|||
162998790|NCT00025259|588695822|FG003|Overall Study|Randomization error|0|||
162998791|NCT00025259|588695823|FG004|Overall Study|Randomization error|1|||
162998792|NCT00025259|588695824|FG005|Overall Study|Randomization error|7|||
162998793|NCT00025259|588695825|FG006|Overall Study|Randomization error|2|||
162998794|NCT00025259|588695819|FG000|Overall Study|Adverse Event|1|||
162998795|NCT00025259|588695820|FG001|Overall Study|Adverse Event|0|||
162998796|NCT00025259|588695821|FG002|Overall Study|Adverse Event|0|||
162998797|NCT00025259|588695822|FG003|Overall Study|Adverse Event|0|||
162998798|NCT00025259|588695823|FG004|Overall Study|Adverse Event|0|||
162998799|NCT00025259|588695824|FG005|Overall Study|Adverse Event|0|||
162998800|NCT00025259|588695825|FG006|Overall Study|Adverse Event|0|||
162998801|NCT01128543|588695830|FG000|Overall Study|Withdrawal by Subject|3|||
162998802|NCT01128543|588695830|FG000|Overall Study|Protocol Violation|1|||
162998803|NCT04487067|588695836|FG000|Overall Study|Adverse Event|3|||
162998804|NCT04487067|588695836|FG000|Overall Study|Death Other Than Progressive Disease|60|||
162998805|NCT04487067|588695836|FG000|Overall Study|Death Due To Progressive Disease|40|||
162998806|NCT04487067|588695836|FG000|Overall Study|Lost to Follow-up|3|||
162998807|NCT04487067|588695836|FG000|Overall Study|Progressive Disease|1|||
162998808|NCT04487067|588695836|FG000|Overall Study|Protocol Violation|3|||
162998809|NCT04487067|588695836|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
162998810|NCT04487067|588695836|FG000|Overall Study|Withdrawal by Subject|15|||
162998811|NCT04324021|588695837|FG000|Overall Study|Adverse Event|1|||
162998812|NCT04324021|588695838|FG001|Overall Study|Adverse Event|0|||
162998813|NCT04324021|588695839|FG002|Overall Study|Adverse Event|0|||
162998814|NCT04324021|588695837|FG000|Overall Study|Lack of Efficacy|0|||
162998815|NCT04324021|588695838|FG001|Overall Study|Lack of Efficacy|0|||
162998816|NCT04324021|588695839|FG002|Overall Study|Lack of Efficacy|1|||
162998817|NCT04324021|588695837|FG000|Overall Study|Death|1|||
162998818|NCT04324021|588695838|FG001|Overall Study|Death|1|||
162998819|NCT04324021|588695839|FG002|Overall Study|Death|0|||
162998820|NCT00246324|588695840|FG000|Overall Study|Withdrawal by Subject|1|||
162998821|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
162998822|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
163212763|NCT02642614|589494304|FG002|Overall Study|Withdrawal by Subject|0|||
163212764|NCT02642614|589494305|FG003|Overall Study|Withdrawal by Subject|0|||
163212765|NCT04708886|589494311|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
162998823|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
162998824|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Death|1|||
162998825|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Death|3|||
163212766|NCT04708886|589494311|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
162998826|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Death|1|||
162998827|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
162998828|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
162998829|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
162998830|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
162998831|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
162998832|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
162998833|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
162998834|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
162998835|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
162998836|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
162998837|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
162998838|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
163212767|NCT00936910|589494312|FG000|Overall Study|Lack of Efficacy|3|||
163212768|NCT01729754|589494313|FG000|Part 1|Adverse Event|2|||
163212769|NCT01729754|589494314|FG001|Part 1|Adverse Event|0|||
163212770|NCT01729754|589494315|FG002|Part 1|Adverse Event|0|||
163212771|NCT01729754|589494316|FG003|Part 1|Adverse Event|1|||
163212772|NCT01729754|589494317|FG004|Part 1|Adverse Event|0|||
163212773|NCT01729754|589494318|FG005|Part 1|Adverse Event|0|||
163212774|NCT01729754|589494319|FG006|Part 1|Adverse Event|2|||
163212775|NCT01729754|589494320|FG007|Part 1|Adverse Event|0|||
163212776|NCT01729754|589494321|FG008|Part 1|Adverse Event|0|||
163212777|NCT01729754|589494322|FG009|Part 1|Adverse Event|5|||
163212778|NCT01729754|589494313|FG000|Part 1|Lack of Efficacy|1|||
163212779|NCT01729754|589494314|FG001|Part 1|Lack of Efficacy|0|||
163212780|NCT01729754|589494315|FG002|Part 1|Lack of Efficacy|0|||
163212781|NCT01729754|589494316|FG003|Part 1|Lack of Efficacy|0|||
163212782|NCT01729754|589494317|FG004|Part 1|Lack of Efficacy|0|||
162998839|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
162998840|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
162998841|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
162998842|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
162998843|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
162998844|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
162998845|NCT00299130|588695841|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
162998846|NCT00299130|588695842|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
162998847|NCT00299130|588695843|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
162998848|NCT00299130|588695841|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
162998849|NCT00299130|588695842|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
162998850|NCT00299130|588695843|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
162998851|NCT00299130|588695841|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
162998852|NCT00299130|588695842|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
162998853|NCT00299130|588695843|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
162998854|NCT00299130|588695841|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
162998855|NCT00299130|588695842|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
163212783|NCT01729754|589494318|FG005|Part 1|Lack of Efficacy|0|||
162998856|NCT00299130|588695843|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
162998857|NCT00299130|588695841|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
162998858|NCT00299130|588695842|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
162998859|NCT00299130|588695843|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
162998860|NCT00299130|588695841|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
162998861|NCT00299130|588695842|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
162998862|NCT00299130|588695843|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
162998863|NCT00299130|588695841|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
162998864|NCT00299130|588695842|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
162998865|NCT00299130|588695843|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
162998866|NCT00299130|588695841|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
162998867|NCT00299130|588695842|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
162998868|NCT00299130|588695843|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
162998869|NCT00299130|588695841|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
162998870|NCT00299130|588695842|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
162998871|NCT00299130|588695843|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
162998872|NCT00345631|588695844|FG000|Overall Study|Withdrawal by Subject|1|||
162998873|NCT00345631|588695845|FG001|Overall Study|Withdrawal by Subject|0|||
162998874|NCT00345631|588695846|FG002|Overall Study|Withdrawal by Subject|1|||
162998875|NCT00345631|588695844|FG000|Overall Study|Adverse Event|0|||
162998876|NCT00345631|588695845|FG001|Overall Study|Adverse Event|1|||
162998877|NCT00345631|588695846|FG002|Overall Study|Adverse Event|0|||
162998878|NCT00345631|588695844|FG000|Overall Study|Lost to Follow-up|3|||
162998879|NCT00345631|588695845|FG001|Overall Study|Lost to Follow-up|7|||
162998880|NCT00345631|588695846|FG002|Overall Study|Lost to Follow-up|4|||
162998881|NCT00345631|588695844|FG000|Overall Study|Other reasons|0|||
162998882|NCT00345631|588695845|FG001|Overall Study|Other reasons|0|||
162998883|NCT00345631|588695846|FG002|Overall Study|Other reasons|1|||
162998884|NCT03371459|588695850|FG000|Washout|Lost to Follow-up|0|||
162998885|NCT03371459|588695851|FG001|Washout|Lost to Follow-up|1|||
162998886|NCT01374269|588695860|FG000|Overall Study|Withdrawal by Subject|4|||
162998887|NCT01374269|588695861|FG001|Overall Study|Withdrawal by Subject|0|||
162998888|NCT01374269|588695860|FG000|Overall Study|Lost to Follow-up|1|||
162998889|NCT01374269|588695861|FG001|Overall Study|Lost to Follow-up|3|||
162998890|NCT01374269|588695860|FG000|Overall Study|closed research|1|||
163324917|NCT03767335|589901409|FG002|Overall Study|Physician Decision|0|||
162998891|NCT01374269|588695861|FG001|Overall Study|closed research|2|||
162998892|NCT01653912|588695862|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
163212784|NCT01729754|589494319|FG006|Part 1|Lack of Efficacy|2|||
163324918|NCT03767335|589901407|FG000|Overall Study|Withdrawal by Subject|0|||
163212785|NCT01729754|589494320|FG007|Part 1|Lack of Efficacy|0|||
163212786|NCT01729754|589494321|FG008|Part 1|Lack of Efficacy|0|||
163212787|NCT01729754|589494322|FG009|Part 1|Lack of Efficacy|0|||
163212788|NCT01729754|589494313|FG000|Part 1|Lost to Follow-up|1|||
163212789|NCT01729754|589494314|FG001|Part 1|Lost to Follow-up|0|||
163212790|NCT01729754|589494315|FG002|Part 1|Lost to Follow-up|0|||
163212791|NCT01729754|589494316|FG003|Part 1|Lost to Follow-up|2|||
163212792|NCT01729754|589494317|FG004|Part 1|Lost to Follow-up|0|||
163212793|NCT01729754|589494318|FG005|Part 1|Lost to Follow-up|0|||
163212794|NCT01729754|589494319|FG006|Part 1|Lost to Follow-up|3|||
163212795|NCT01729754|589494320|FG007|Part 1|Lost to Follow-up|0|||
163212796|NCT01729754|589494321|FG008|Part 1|Lost to Follow-up|0|||
163212797|NCT01729754|589494322|FG009|Part 1|Lost to Follow-up|3|||
163212798|NCT01729754|589494313|FG000|Part 1|Non-compliance with Study Drug|1|||
163212799|NCT01729754|589494314|FG001|Part 1|Non-compliance with Study Drug|0|||
163212800|NCT01729754|589494315|FG002|Part 1|Non-compliance with Study Drug|0|||
163212801|NCT01729754|589494316|FG003|Part 1|Non-compliance with Study Drug|0|||
163212802|NCT01729754|589494317|FG004|Part 1|Non-compliance with Study Drug|0|||
163212803|NCT01729754|589494318|FG005|Part 1|Non-compliance with Study Drug|0|||
163212804|NCT01729754|589494319|FG006|Part 1|Non-compliance with Study Drug|0|||
163212805|NCT01729754|589494320|FG007|Part 1|Non-compliance with Study Drug|0|||
163212806|NCT01729754|589494321|FG008|Part 1|Non-compliance with Study Drug|0|||
163212807|NCT01729754|589494322|FG009|Part 1|Non-compliance with Study Drug|0|||
163212808|NCT01729754|589494313|FG000|Part 1|Physician Decision|0|||
163212809|NCT01729754|589494314|FG001|Part 1|Physician Decision|0|||
163212810|NCT01729754|589494315|FG002|Part 1|Physician Decision|0|||
163212811|NCT01729754|589494316|FG003|Part 1|Physician Decision|0|||
163212812|NCT01729754|589494317|FG004|Part 1|Physician Decision|0|||
163212813|NCT01729754|589494318|FG005|Part 1|Physician Decision|0|||
163212814|NCT01729754|589494319|FG006|Part 1|Physician Decision|0|||
163212815|NCT01729754|589494320|FG007|Part 1|Physician Decision|0|||
163212816|NCT01729754|589494321|FG008|Part 1|Physician Decision|0|||
163212817|NCT01729754|589494322|FG009|Part 1|Physician Decision|4|||
163212818|NCT01729754|589494313|FG000|Part 1|Pregnancy|0|||
163212819|NCT01729754|589494314|FG001|Part 1|Pregnancy|0|||
163212820|NCT01729754|589494315|FG002|Part 1|Pregnancy|0|||
163212821|NCT01729754|589494316|FG003|Part 1|Pregnancy|1|||
163212822|NCT01729754|589494317|FG004|Part 1|Pregnancy|0|||
163212823|NCT01729754|589494318|FG005|Part 1|Pregnancy|0|||
163212824|NCT01729754|589494319|FG006|Part 1|Pregnancy|0|||
163212825|NCT01729754|589494320|FG007|Part 1|Pregnancy|0|||
163212826|NCT01729754|589494321|FG008|Part 1|Pregnancy|0|||
163212827|NCT01729754|589494322|FG009|Part 1|Pregnancy|1|||
163212828|NCT01729754|589494313|FG000|Part 1|Progressive Disease|0|||
163212829|NCT01729754|589494314|FG001|Part 1|Progressive Disease|0|||
163212830|NCT01729754|589494315|FG002|Part 1|Progressive Disease|0|||
163212831|NCT01729754|589494316|FG003|Part 1|Progressive Disease|0|||
163212832|NCT01729754|589494317|FG004|Part 1|Progressive Disease|0|||
163212833|NCT01729754|589494318|FG005|Part 1|Progressive Disease|0|||
163212834|NCT01729754|589494319|FG006|Part 1|Progressive Disease|0|||
163212835|NCT01729754|589494320|FG007|Part 1|Progressive Disease|0|||
163212836|NCT01729754|589494321|FG008|Part 1|Progressive Disease|0|||
163212837|NCT01729754|589494322|FG009|Part 1|Progressive Disease|1|||
163212838|NCT01729754|589494313|FG000|Part 1|Protocol Violation|2|||
163212839|NCT01729754|589494314|FG001|Part 1|Protocol Violation|0|||
163212840|NCT01729754|589494315|FG002|Part 1|Protocol Violation|0|||
163212841|NCT01729754|589494316|FG003|Part 1|Protocol Violation|1|||
163212842|NCT01729754|589494317|FG004|Part 1|Protocol Violation|0|||
163212843|NCT01729754|589494318|FG005|Part 1|Protocol Violation|0|||
163212844|NCT01729754|589494319|FG006|Part 1|Protocol Violation|1|||
163212845|NCT01729754|589494320|FG007|Part 1|Protocol Violation|0|||
163212846|NCT01729754|589494321|FG008|Part 1|Protocol Violation|0|||
163212847|NCT01729754|589494322|FG009|Part 1|Protocol Violation|0|||
163324919|NCT03767335|589901408|FG001|Overall Study|Withdrawal by Subject|0|||
163324920|NCT03767335|589901409|FG002|Overall Study|Withdrawal by Subject|6|||
163324921|NCT03767335|589901407|FG000|Overall Study|Participant excluded from efficacy population|0|||
163212848|NCT01729754|589494313|FG000|Part 1|Withdrawal by Subject|5|||
163212849|NCT01729754|589494314|FG001|Part 1|Withdrawal by Subject|0|||
163212850|NCT01729754|589494315|FG002|Part 1|Withdrawal by Subject|0|||
163212851|NCT01729754|589494316|FG003|Part 1|Withdrawal by Subject|7|||
163212852|NCT01729754|589494317|FG004|Part 1|Withdrawal by Subject|0|||
163212853|NCT01729754|589494318|FG005|Part 1|Withdrawal by Subject|0|||
163212854|NCT01729754|589494319|FG006|Part 1|Withdrawal by Subject|5|||
163212855|NCT01729754|589494320|FG007|Part 1|Withdrawal by Subject|0|||
163212856|NCT01729754|589494321|FG008|Part 1|Withdrawal by Subject|0|||
163212857|NCT01729754|589494322|FG009|Part 1|Withdrawal by Subject|6|||
163212858|NCT01729754|589494313|FG000|Part 1|Other Protocol Specified Criteria|2|||
163212859|NCT01729754|589494314|FG001|Part 1|Other Protocol Specified Criteria|0|||
163212860|NCT01729754|589494315|FG002|Part 1|Other Protocol Specified Criteria|0|||
163212861|NCT01729754|589494316|FG003|Part 1|Other Protocol Specified Criteria|0|||
163212862|NCT01729754|589494317|FG004|Part 1|Other Protocol Specified Criteria|0|||
163212863|NCT01729754|589494318|FG005|Part 1|Other Protocol Specified Criteria|0|||
163212864|NCT01729754|589494319|FG006|Part 1|Other Protocol Specified Criteria|1|||
163212865|NCT01729754|589494320|FG007|Part 1|Other Protocol Specified Criteria|0|||
163212866|NCT01729754|589494321|FG008|Part 1|Other Protocol Specified Criteria|0|||
163212867|NCT01729754|589494322|FG009|Part 1|Other Protocol Specified Criteria|4|||
162998893|NCT01653912|588695863|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
162998894|NCT01653912|588695864|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
162998895|NCT01653912|588695865|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
162998896|NCT01653912|588695866|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
162998897|NCT01653912|588695867|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
162998898|NCT01653912|588695862|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
162998899|NCT01653912|588695863|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
162998900|NCT01653912|588695864|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
162998901|NCT01653912|588695865|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
162998902|NCT01653912|588695866|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
162998903|NCT01653912|588695867|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
162998904|NCT01653912|588695862|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
162998905|NCT01653912|588695863|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
162998906|NCT01653912|588695864|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
162998907|NCT01653912|588695865|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
162998908|NCT01653912|588695866|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
162998909|NCT01653912|588695867|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
162998910|NCT01653912|588695862|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998911|NCT01653912|588695863|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998912|NCT01653912|588695864|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998913|NCT01653912|588695865|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
162998914|NCT01653912|588695866|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998915|NCT01653912|588695867|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998916|NCT01653912|588695862|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
162998917|NCT01653912|588695863|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
162998918|NCT01653912|588695864|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
162998919|NCT01653912|588695865|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
162998920|NCT01653912|588695866|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
162998921|NCT01653912|588695867|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
162998922|NCT01653912|588695862|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
162998923|NCT01653912|588695863|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
162998924|NCT01653912|588695864|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
162998925|NCT01653912|588695865|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
162998926|NCT01653912|588695866|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
162998927|NCT01653912|588695867|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
162998928|NCT01653912|588695862|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998929|NCT01653912|588695863|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998930|NCT01653912|588695864|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998931|NCT01653912|588695865|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998932|NCT01653912|588695866|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998933|NCT01653912|588695867|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
162998934|NCT01987479|588695868|FG000|Overall Study|Protocol Violation|1|||
162998935|NCT01987479|588695868|FG000|Overall Study|Physician Decision|2|||
162998936|NCT01987479|588695868|FG000|Overall Study|Participant/legal guardian decision|1|||
162998937|NCT01987479|588695868|FG000|Overall Study|Other|5|||
162998938|NCT01987479|588695868|FG000|Overall Study|Lost to Follow-up|1|||
162998939|NCT01987479|588695868|FG000|Overall Study|Adverse Event|7|||
162998940|NCT01954745|588695869|FG000|Overall Study|Radiological Progression|11|||
162998941|NCT01954745|588695869|FG000|Overall Study|Clinical Progression|5|||
162998942|NCT01954745|588695869|FG000|Overall Study|Adverse Event|2|||
162998943|NCT01954745|588695869|FG000|Overall Study|Death|1|||
163212868|NCT01729754|589494313|FG000|Part 2|Adverse Event|2|||
163212869|NCT01729754|589494314|FG001|Part 2|Adverse Event|0|||
163212870|NCT01729754|589494315|FG002|Part 2|Adverse Event|0|||
163212871|NCT01729754|589494316|FG003|Part 2|Adverse Event|0|||
163404333|NCT00412750|590191911|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163404334|NCT00412750|590191909|FG000|Overall Study|Administrative problems|21|||
162998944|NCT04559347|588698152|FG000|Overall Study|Death|1|||
162998945|NCT04559347|588698153|FG001|Overall Study|Death|0|||
162998946|NCT04559347|588698152|FG000|Overall Study|Thoracotomy conversion|1|||
162998947|NCT04559347|588698153|FG001|Overall Study|Thoracotomy conversion|1|||
162998948|NCT04559347|588698152|FG000|Overall Study|Provider unavailable|2|||
162998949|NCT04559347|588698153|FG001|Overall Study|Provider unavailable|1|||
162998950|NCT04559347|588698152|FG000|Overall Study|Other|2|||
162998951|NCT04559347|588698153|FG001|Overall Study|Other|1|||
162998952|NCT02653625|588698154|FG000|Overall Study|Adverse Event|1|||
162998953|NCT02653625|588698154|FG000|Overall Study|Non-compliance with Study Drug|1|||
162998954|NCT02653625|588698154|FG000|Overall Study|Protocol Violation|1|||
162998955|NCT02653625|588698154|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
162998956|NCT03965689|588698155|FG000|Overall Study|Too sick to get study intervention|2|||
162998957|NCT02969382|588698156|FG000|Overall Study|Adverse Event|8|||
162998958|NCT02969382|588698157|FG001|Overall Study|Adverse Event|10|||
163212872|NCT01729754|589494317|FG004|Part 2|Adverse Event|0|||
163060480|NCT00410163|588929910|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
163060481|NCT00410163|588929911|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
163060482|NCT00410163|588929910|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
162998959|NCT02969382|588698156|FG000|Overall Study|Lack of Efficacy|4|||
162998960|NCT02969382|588698157|FG001|Overall Study|Lack of Efficacy|5|||
162998961|NCT02969382|588698156|FG000|Overall Study|Death|0|||
162998962|NCT02969382|588698157|FG001|Overall Study|Death|1|||
162998963|NCT02969382|588698156|FG000|Overall Study|PROTOCOL DEVIATION|0|||
162998964|NCT02969382|588698157|FG001|Overall Study|PROTOCOL DEVIATION|1|||
162998965|NCT02969382|588698156|FG000|Overall Study|Withdrawal by Subject|14|||
162998966|NCT02969382|588698157|FG001|Overall Study|Withdrawal by Subject|9|||
162998967|NCT02090725|588698159|FG000|Overall Study|Withdrawal by Subject|1|||
162998968|NCT02090725|588698159|FG000|Overall Study|participants moved from area|3|||
162998969|NCT01214655|588698160|FG000|Part A|Progressive Disease|7|||
162998970|NCT01214655|588698161|FG001|Part A|Progressive Disease|0|||
162998971|NCT01214655|588698162|FG002|Part A|Progressive Disease|0|||
162998972|NCT01214655|588698160|FG000|Part A|Physician Decision|1|||
162998973|NCT01214655|588698161|FG001|Part A|Physician Decision|0|||
162998974|NCT01214655|588698162|FG002|Part A|Physician Decision|0|||
162998975|NCT01214655|588698160|FG000|Part B|Progressive disease|0|||
162998976|NCT01214655|588698161|FG001|Part B|Progressive disease|10|||
162998977|NCT01214655|588698162|FG002|Part B|Progressive disease|0|||
162998978|NCT01214655|588698160|FG000|Part B|Death|0|||
162998979|NCT01214655|588698161|FG001|Part B|Death|1|||
162998980|NCT01214655|588698162|FG002|Part B|Death|0|||
162998981|NCT01214655|588698160|FG000|Part B|Withdrawal by Subject|0|||
162998982|NCT01214655|588698161|FG001|Part B|Withdrawal by Subject|2|||
162998983|NCT01214655|588698162|FG002|Part B|Withdrawal by Subject|0|||
162998984|NCT01214655|588698160|FG000|Part C|Progressive Disease|0|||
162998985|NCT01214655|588698161|FG001|Part C|Progressive Disease|0|||
162998986|NCT01214655|588698162|FG002|Part C|Progressive Disease|5|||
162998987|NCT01214655|588698160|FG000|Part C|Death|0|||
162998988|NCT01214655|588698161|FG001|Part C|Death|0|||
162998989|NCT01214655|588698162|FG002|Part C|Death|1|||
163060483|NCT00410163|588929911|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
163060484|NCT00410163|588929910|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
163060485|NCT00410163|588929911|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
163060486|NCT00410163|588929910|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
163060487|NCT00410163|588929911|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
163404335|NCT00412750|590191910|FG001|Overall Study|Administrative problems|17|||
163404336|NCT00412750|590191911|FG002|Overall Study|Administrative problems|14|||
163404337|NCT00412750|590191909|FG000|Overall Study|Adverse Event|8|||
163404338|NCT00412750|590191910|FG001|Overall Study|Adverse Event|3|||
163404339|NCT00412750|590191911|FG002|Overall Study|Adverse Event|3|||
163404340|NCT00412750|590191909|FG000|Overall Study|Lost to Follow-up|1|||
163404341|NCT00412750|590191910|FG001|Overall Study|Lost to Follow-up|0|||
163404342|NCT00412750|590191911|FG002|Overall Study|Lost to Follow-up|1|||
163404343|NCT00412750|590191909|FG000|Overall Study|Withdrawal by Subject|0|||
163404344|NCT00412750|590191910|FG001|Overall Study|Withdrawal by Subject|1|||
163404345|NCT00412750|590191911|FG002|Overall Study|Withdrawal by Subject|2|||
163404346|NCT00412750|590191909|FG000|Overall Study|Lack of Efficacy|0|||
163404347|NCT00412750|590191910|FG001|Overall Study|Lack of Efficacy|0|||
163404348|NCT00412750|590191911|FG002|Overall Study|Lack of Efficacy|3|||
163404349|NCT01823679|590191912|FG000|Overall Study|Death|1|||
163404350|NCT01157078|590191913|FG000|Overall Study|Withdrawal by Subject|12|||
163404351|NCT01157078|590191914|FG001|Overall Study|Withdrawal by Subject|14|||
163404352|NCT01157078|590191913|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
163404353|NCT01157078|590191914|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
163404354|NCT01157078|590191913|FG000|Overall Study|Adverse Event|6|||
163404355|NCT01157078|590191914|FG001|Overall Study|Adverse Event|6|||
163404356|NCT01157078|590191913|FG000|Overall Study|Severe non-compliance to protocol|2|||
162998990|NCT01214655|588698160|FG000|Part C|Physician Decision|0|||
162998991|NCT01214655|588698161|FG001|Part C|Physician Decision|0|||
162998992|NCT01214655|588698162|FG002|Part C|Physician Decision|1|||
162998993|NCT00764881|588698163|FG000|Overall Study|Adverse Event|5|||
162998994|NCT00764881|588698164|FG001|Overall Study|Adverse Event|1|||
162998995|NCT00764881|588698163|FG000|Overall Study|Withdrawal by Subject|1|||
162998996|NCT00764881|588698164|FG001|Overall Study|Withdrawal by Subject|3|||
162998997|NCT00764881|588698163|FG000|Overall Study|Protocol Violation|2|||
162998998|NCT00764881|588698164|FG001|Overall Study|Protocol Violation|2|||
162998999|NCT00764881|588698163|FG000|Overall Study|Lost to Follow-up|2|||
162999000|NCT00764881|588698164|FG001|Overall Study|Lost to Follow-up|0|||
162999001|NCT00764881|588698163|FG000|Overall Study|Noncompliant|1|||
162999002|NCT00764881|588698164|FG001|Overall Study|Noncompliant|0|||
162999003|NCT00764881|588698163|FG000|Overall Study|Accidentally discontinued study drug|1|||
162999004|NCT00764881|588698164|FG001|Overall Study|Accidentally discontinued study drug|0|||
162999005|NCT00764881|588698163|FG000|Overall Study|Wished to become pregnant|1|||
162999006|NCT00764881|588698164|FG001|Overall Study|Wished to become pregnant|0|||
162999007|NCT00764881|588698163|FG000|Overall Study|Carcinoma detected|1|||
162999008|NCT00764881|588698164|FG001|Overall Study|Carcinoma detected|0|||
162999009|NCT00764881|588698163|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
162999010|NCT00764881|588698164|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
162999011|NCT00764881|588698163|FG000|Overall Study|no treatment or no observation|2|||
162999012|NCT00764881|588698164|FG001|Overall Study|no treatment or no observation|2|||
162999013|NCT05256134|588698167|FG000|Overall Study|Study Terminated by Sponsor|11|||
162999014|NCT05256134|588698168|FG001|Overall Study|Study Terminated by Sponsor|10|||
162999015|NCT05256134|588698167|FG000|Overall Study|Withdrawal by Subject|1|||
162999016|NCT05256134|588698168|FG001|Overall Study|Withdrawal by Subject|3|||
162999017|NCT02013817|588698175|FG000|Overall Study|Adverse Event|12|||
162999018|NCT02013817|588698175|FG000|Overall Study|Withdrawal by Subject|4|||
162999019|NCT02013817|588698175|FG000|Overall Study|Death|2|||
162999020|NCT02013817|588698175|FG000|Overall Study|Other|9|||
162999021|NCT00855894|588698176|FG000|Overall Study|Death|31|||
162999022|NCT00855894|588698176|FG000|Overall Study|Patient's decision|1|||
162999023|NCT00855894|588698176|FG000|Overall Study|Disease progression|1|||
162999024|NCT01145508|588698177|FG000|Overall Study|Adverse Event|1|||
162999025|NCT01145508|588698178|FG001|Overall Study|Adverse Event|0|||
162999026|NCT01145508|588698177|FG000|Overall Study|Death|1|||
162999027|NCT01145508|588698178|FG001|Overall Study|Death|0|||
162999028|NCT01145508|588698177|FG000|Overall Study|Physician Decision|2|||
162999029|NCT01145508|588698178|FG001|Overall Study|Physician Decision|1|||
162999030|NCT01145508|588698177|FG000|Overall Study|Never started treatment|1|||
162999031|NCT01145508|588698178|FG001|Overall Study|Never started treatment|1|||
162999032|NCT01611857|588698182|FG000|Overall Study|Withdrawal by Subject|0|||
162999033|NCT01611857|588698183|FG001|Overall Study|Withdrawal by Subject|2|||
162999034|NCT02439970|588698184|FG000|Overall Study|Study Terminated|2|||
162999035|NCT02439970|588698185|FG001|Overall Study|Study Terminated|3|||
162999036|NCT01121562|588698186|FG000|Overall Study|Objective progression or relapse|8|||
162999037|NCT01121562|588698186|FG000|Overall Study|Withdrawal by Subject|1|||
162999038|NCT01121562|588698186|FG000|Overall Study|Adverse Event|1|||
163060488|NCT00410163|588929910|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
163060489|NCT00410163|588929911|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
163060490|NCT01572792|588929914|FG000|Lead-in Study|Lost to Follow-up|5|||
163060491|NCT01572792|588929915|FG001|Lead-in Study|Lost to Follow-up|9|||
163060492|NCT01572792|588929916|FG002|Lead-in Study|Lost to Follow-up|4|||
163060493|NCT01572792|588929917|FG003|Lead-in Study|Lost to Follow-up|2|||
163060494|NCT01572792|588929918|FG004|Lead-in Study|Lost to Follow-up|4|||
163060495|NCT01572792|588929914|FG000|Lead-in Study|Withdrawal by Subject|22|||
163060496|NCT01572792|588929915|FG001|Lead-in Study|Withdrawal by Subject|11|||
163060497|NCT01572792|588929916|FG002|Lead-in Study|Withdrawal by Subject|12|||
163060498|NCT01572792|588929917|FG003|Lead-in Study|Withdrawal by Subject|24|||
163060499|NCT01572792|588929918|FG004|Lead-in Study|Withdrawal by Subject|11|||
163060500|NCT01572792|588929914|FG000|Lead-in Study|Protocol Violation|19|||
163060501|NCT01572792|588929915|FG001|Lead-in Study|Protocol Violation|10|||
163060502|NCT01572792|588929916|FG002|Lead-in Study|Protocol Violation|12|||
163060503|NCT01572792|588929917|FG003|Lead-in Study|Protocol Violation|13|||
163060504|NCT01572792|588929918|FG004|Lead-in Study|Protocol Violation|21|||
163060505|NCT01572792|588929914|FG000|Lead-in Study|Lack of Efficacy|20|||
163060506|NCT01572792|588929915|FG001|Lead-in Study|Lack of Efficacy|5|||
163060507|NCT01572792|588929916|FG002|Lead-in Study|Lack of Efficacy|4|||
163060508|NCT01572792|588929917|FG003|Lead-in Study|Lack of Efficacy|8|||
163060509|NCT01572792|588929918|FG004|Lead-in Study|Lack of Efficacy|10|||
163060510|NCT01572792|588929914|FG000|Lead-in Study|Adverse Event|21|||
163060511|NCT01572792|588929915|FG001|Lead-in Study|Adverse Event|21|||
163404357|NCT01157078|590191914|FG001|Overall Study|Severe non-compliance to protocol|4|||
163404358|NCT01157078|590191913|FG000|Overall Study|Condition under investigation worsened|0|||
162999039|NCT01121562|588698186|FG000|Overall Study|Sponsor Decision|1|||
162999040|NCT01121562|588698186|FG000|Overall Study|Met study discontinuation criteria|1|||
162999041|NCT01569295|588698189|FG000|Overall Study|Progressive Disease|75|||
162999042|NCT01569295|588698190|FG001|Overall Study|Progressive Disease|139|||
162999043|NCT01569295|588698189|FG000|Overall Study|Adverse Event|39|||
162999044|NCT01569295|588698190|FG001|Overall Study|Adverse Event|14|||
162999045|NCT01569295|588698189|FG000|Overall Study|Withdrawal by Subject|25|||
162999046|NCT01569295|588698190|FG001|Overall Study|Withdrawal by Subject|12|||
162999047|NCT01569295|588698189|FG000|Overall Study|Death|19|||
162999048|NCT01569295|588698190|FG001|Overall Study|Death|15|||
162999049|NCT01569295|588698189|FG000|Overall Study|Physician Decision|13|||
162999050|NCT01569295|588698190|FG001|Overall Study|Physician Decision|18|||
162999051|NCT01569295|588698189|FG000|Overall Study|Study Terminated by Sponsor|24|||
162999052|NCT01569295|588698190|FG001|Overall Study|Study Terminated by Sponsor|2|||
162999053|NCT01569295|588698189|FG000|Overall Study|Other Reason not Specified|3|||
162999054|NCT01569295|588698190|FG001|Overall Study|Other Reason not Specified|5|||
162999055|NCT01569295|588698189|FG000|Overall Study|Non-Compliance with Study Drug|6|||
163060512|NCT01572792|588929916|FG002|Lead-in Study|Adverse Event|22|||
163060513|NCT01572792|588929917|FG003|Lead-in Study|Adverse Event|16|||
163060514|NCT01572792|588929918|FG004|Lead-in Study|Adverse Event|14|||
162999056|NCT01569295|588698190|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162999057|NCT01569295|588698189|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
162999058|NCT01569295|588698190|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
162999059|NCT01569295|588698189|FG000|Overall Study|Lost to Follow-up|1|||
162999060|NCT01569295|588698190|FG001|Overall Study|Lost to Follow-up|1|||
162999061|NCT00280735|588698191|FG000|Overall Study|Adverse Event|5|||
162999062|NCT00280735|588698191|FG000|Overall Study|Lack of Efficacy|3|||
163324922|NCT03767335|589901408|FG001|Overall Study|Participant excluded from efficacy population|0|||
163324923|NCT03767335|589901409|FG002|Overall Study|Participant excluded from efficacy population|1|||
163324924|NCT03767335|589901407|FG000|Overall Study|Death|0|||
163324925|NCT03767335|589901408|FG001|Overall Study|Death|0|||
163324926|NCT03767335|589901409|FG002|Overall Study|Death|2|||
163324927|NCT03767335|589901407|FG000|Overall Study|Progressive Disease|2|||
163324928|NCT03767335|589901408|FG001|Overall Study|Progressive Disease|2|||
163324929|NCT03767335|589901409|FG002|Overall Study|Progressive Disease|2|||
163324930|NCT03767335|589901407|FG000|Overall Study|Disease progression needing additional medication|0|||
163324931|NCT03767335|589901408|FG001|Overall Study|Disease progression needing additional medication|0|||
163324932|NCT03767335|589901409|FG002|Overall Study|Disease progression needing additional medication|17|||
163324933|NCT03767335|589901407|FG000|Overall Study|Sponsor decision|0|||
162999063|NCT00280735|588698191|FG000|Overall Study|Withdrawal by Subject|8|||
162999064|NCT00280735|588698191|FG000|Overall Study|Intercurrent Illness|2|||
162999065|NCT01895777|588698192|FG000|Overall Study|Adverse Event|1|||
162999066|NCT01895777|588698193|FG001|Overall Study|Adverse Event|2|||
162999067|NCT01895777|588698192|FG000|Overall Study|Lost to Follow-up|2|||
162999068|NCT01895777|588698193|FG001|Overall Study|Lost to Follow-up|0|||
162999069|NCT01895777|588698192|FG000|Overall Study|Not treated|1|||
162999070|NCT01895777|588698193|FG001|Overall Study|Not treated|0|||
162999071|NCT01895777|588698192|FG000|Overall Study|Other reasons|3|||
162999072|NCT01895777|588698193|FG001|Overall Study|Other reasons|2|||
162999073|NCT01895777|588698192|FG000|Overall Study|Non-compliance with the CTP|2|||
162999074|NCT01895777|588698193|FG001|Overall Study|Non-compliance with the CTP|1|||
162999075|NCT02064296|588698197|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
162999076|NCT02064296|588698198|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
162999077|NCT02064296|588698199|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
162999078|NCT02064296|588698197|FG000|Intervention|Withdrawal by Subject|0|||
162999079|NCT02064296|588698198|FG001|Intervention|Withdrawal by Subject|1|||
162999080|NCT02064296|588698199|FG002|Intervention|Withdrawal by Subject|2|||
162999081|NCT05061420|588698210|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
162999082|NCT05061420|588698211|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
162999083|NCT05061420|588698212|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
162999084|NCT05061420|588698210|FG000|Overall Study|Progressive disease|11|||
163324934|NCT03767335|589901408|FG001|Overall Study|Sponsor decision|0|||
162999085|NCT05061420|588698211|FG001|Overall Study|Progressive disease|15|||
162999086|NCT05061420|588698212|FG002|Overall Study|Progressive disease|14|||
162999087|NCT05061420|588698210|FG000|Overall Study|Withdrawal by Subject|2|||
162999088|NCT05061420|588698211|FG001|Overall Study|Withdrawal by Subject|0|||
163060515|NCT01572792|588929914|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
163060516|NCT01572792|588929915|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
163324935|NCT03767335|589901409|FG002|Overall Study|Sponsor decision|2|||
163324936|NCT03767335|589901407|FG000|Overall Study|Other Medical Reasons|0|||
163324937|NCT03767335|589901408|FG001|Overall Study|Other Medical Reasons|0|||
163060517|NCT01572792|588929916|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
163060518|NCT01572792|588929917|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
163060519|NCT01572792|588929918|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
163060520|NCT01572792|588929914|FG000|Extension Study|Lost to Follow-up|6|||
163060521|NCT01572792|588929915|FG001|Extension Study|Lost to Follow-up|2|||
163060522|NCT01572792|588929916|FG002|Extension Study|Lost to Follow-up|0|||
163060523|NCT01572792|588929917|FG003|Extension Study|Lost to Follow-up|3|||
163060524|NCT01572792|588929918|FG004|Extension Study|Lost to Follow-up|3|||
163060525|NCT01572792|588929914|FG000|Extension Study|Withdrawal by Subject|7|||
163060526|NCT01572792|588929915|FG001|Extension Study|Withdrawal by Subject|6|||
163060527|NCT01572792|588929916|FG002|Extension Study|Withdrawal by Subject|11|||
163060528|NCT01572792|588929917|FG003|Extension Study|Withdrawal by Subject|8|||
163060529|NCT01572792|588929918|FG004|Extension Study|Withdrawal by Subject|14|||
163060530|NCT01572792|588929914|FG000|Extension Study|Protocol Violation|0|||
163324938|NCT03767335|589901409|FG002|Overall Study|Other Medical Reasons|3|||
163324939|NCT03705390|589901410|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
162999089|NCT05061420|588698212|FG002|Overall Study|Withdrawal by Subject|1|||
162999090|NCT05061420|588698210|FG000|Overall Study|Not related to COVID-19|2|||
163060531|NCT01572792|588929915|FG001|Extension Study|Protocol Violation|4|||
162999091|NCT05061420|588698211|FG001|Overall Study|Not related to COVID-19|0|||
162999092|NCT05061420|588698212|FG002|Overall Study|Not related to COVID-19|0|||
162999093|NCT01814553|588698216|FG000|Overall Study|PD per clinical progression|6|||
162999094|NCT01814553|588698217|FG001|Overall Study|PD per clinical progression|8|||
162999095|NCT01814553|588698216|FG000|Overall Study|Other Adverse Event|4|||
162999096|NCT01814553|588698217|FG001|Overall Study|Other Adverse Event|5|||
162999097|NCT01814553|588698216|FG000|Overall Study|Withdrawal by Subject|1|||
162999098|NCT01814553|588698217|FG001|Overall Study|Withdrawal by Subject|1|||
162999099|NCT01814553|588698216|FG000|Overall Study|Other than stated|7|||
162999100|NCT01814553|588698217|FG001|Overall Study|Other than stated|8|||
162999101|NCT03138655|588698218|FG000|Overall Study|Adverse Event|2|||
162999102|NCT03138655|588698219|FG001|Overall Study|Adverse Event|1|||
162999103|NCT03138655|588698220|FG002|Overall Study|Adverse Event|2|||
162999104|NCT03138655|588698221|FG003|Overall Study|Adverse Event|1|||
162999105|NCT03138655|588698222|FG004|Overall Study|Adverse Event|1|||
162999106|NCT03138655|588698223|FG005|Overall Study|Adverse Event|4|||
162999107|NCT03138655|588698224|FG006|Overall Study|Adverse Event|2|||
162999108|NCT03138655|588698225|FG007|Overall Study|Adverse Event|2|||
162999109|NCT03138655|588698218|FG000|Overall Study|Withdrawal by Subject|0|||
163060532|NCT01572792|588929916|FG002|Extension Study|Protocol Violation|3|||
163060533|NCT01572792|588929917|FG003|Extension Study|Protocol Violation|4|||
163060534|NCT01572792|588929918|FG004|Extension Study|Protocol Violation|3|||
163060535|NCT01572792|588929914|FG000|Extension Study|Lack of Efficacy|2|||
163060536|NCT01572792|588929915|FG001|Extension Study|Lack of Efficacy|3|||
163060537|NCT01572792|588929916|FG002|Extension Study|Lack of Efficacy|3|||
163060538|NCT01572792|588929917|FG003|Extension Study|Lack of Efficacy|2|||
163060539|NCT01572792|588929918|FG004|Extension Study|Lack of Efficacy|2|||
163060540|NCT01572792|588929914|FG000|Extension Study|Adverse Event|7|||
163060541|NCT01572792|588929915|FG001|Extension Study|Adverse Event|6|||
163060542|NCT01572792|588929916|FG002|Extension Study|Adverse Event|5|||
163060543|NCT01572792|588929917|FG003|Extension Study|Adverse Event|6|||
163060544|NCT01572792|588929918|FG004|Extension Study|Adverse Event|4|||
163060545|NCT01572792|588929914|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
163060546|NCT01572792|588929915|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
163060547|NCT01572792|588929916|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
163060548|NCT01572792|588929917|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
163060549|NCT01572792|588929918|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
163060550|NCT03692949|588929924|FG000|Overall Study|Lost to Follow-up|0|||
163060551|NCT03692949|588929925|FG001|Overall Study|Lost to Follow-up|0|||
163060552|NCT03692949|588929926|FG002|Overall Study|Lost to Follow-up|0|||
163060553|NCT03692949|588929927|FG003|Overall Study|Lost to Follow-up|0|||
163060554|NCT03692949|588929928|FG004|Overall Study|Lost to Follow-up|0|||
163060555|NCT03692949|588929929|FG005|Overall Study|Lost to Follow-up|0|||
163060556|NCT03692949|588929930|FG006|Overall Study|Lost to Follow-up|0|||
163060557|NCT03692949|588929931|FG007|Overall Study|Lost to Follow-up|1|||
163060558|NCT03197129|588929937|FG000|Overall Study|did not answer the VPT: shyness|4|||
163060559|NCT03197129|588929938|FG001|Overall Study|did not answer the VPT: shyness|5|||
163060560|NCT00289276|588929939|FG000|Second Part of FAST Study (Expansion)|Death|0|||
163060561|NCT00289276|588929940|FG001|Second Part of FAST Study (Expansion)|Death|2|||
163060562|NCT00289276|588929939|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
163060563|NCT00289276|588929940|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
163060564|NCT00869960|588929941|FG000|Overall Study|Lost to Follow-up|2|||
163060565|NCT04848480|588929942|FG000|Main Phase (26 Weeks)|Death|1|||
163060566|NCT04848480|588929943|FG001|Main Phase (26 Weeks)|Death|0|||
163060567|NCT04848480|588929942|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
162999110|NCT03138655|588698219|FG001|Overall Study|Withdrawal by Subject|1|||
162999111|NCT03138655|588698220|FG002|Overall Study|Withdrawal by Subject|0|||
162999112|NCT03138655|588698221|FG003|Overall Study|Withdrawal by Subject|0|||
162999113|NCT03138655|588698222|FG004|Overall Study|Withdrawal by Subject|0|||
162999114|NCT03138655|588698223|FG005|Overall Study|Withdrawal by Subject|0|||
162999115|NCT03138655|588698224|FG006|Overall Study|Withdrawal by Subject|1|||
162999116|NCT03138655|588698225|FG007|Overall Study|Withdrawal by Subject|0|||
162999117|NCT03138655|588698218|FG000|Overall Study|Reason not Specified|1|||
162999118|NCT03138655|588698219|FG001|Overall Study|Reason not Specified|0|||
162999119|NCT03138655|588698220|FG002|Overall Study|Reason not Specified|0|||
162999120|NCT03138655|588698221|FG003|Overall Study|Reason not Specified|2|||
162999121|NCT03138655|588698222|FG004|Overall Study|Reason not Specified|1|||
162999122|NCT03138655|588698223|FG005|Overall Study|Reason not Specified|1|||
162999123|NCT03138655|588698224|FG006|Overall Study|Reason not Specified|0|||
163060568|NCT04848480|588929943|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
162999124|NCT03138655|588698225|FG007|Overall Study|Reason not Specified|0|||
162999125|NCT04759768|588698229|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
162999126|NCT04759768|588698230|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
162999127|NCT04759768|588698229|FG000|Washout (7 Days)|Physician Decision|0|||
162999128|NCT04759768|588698230|FG001|Washout (7 Days)|Physician Decision|1|||
163060569|NCT04848480|588929942|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
163060570|NCT04848480|588929943|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
163060571|NCT04848480|588929942|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
163060572|NCT04848480|588929943|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
163212873|NCT01729754|589494318|FG005|Part 2|Adverse Event|0|||
163212874|NCT01729754|589494319|FG006|Part 2|Adverse Event|0|||
163212875|NCT01729754|589494320|FG007|Part 2|Adverse Event|0|||
163212876|NCT01729754|589494321|FG008|Part 2|Adverse Event|1|||
163212877|NCT01729754|589494322|FG009|Part 2|Adverse Event|2|||
163212878|NCT01729754|589494313|FG000|Part 2|Lack of Efficacy|0|||
163212879|NCT01729754|589494314|FG001|Part 2|Lack of Efficacy|0|||
163212880|NCT01729754|589494315|FG002|Part 2|Lack of Efficacy|0|||
163212881|NCT01729754|589494316|FG003|Part 2|Lack of Efficacy|0|||
163212882|NCT01729754|589494317|FG004|Part 2|Lack of Efficacy|0|||
163212883|NCT01729754|589494318|FG005|Part 2|Lack of Efficacy|0|||
163212884|NCT01729754|589494319|FG006|Part 2|Lack of Efficacy|0|||
163212885|NCT01729754|589494320|FG007|Part 2|Lack of Efficacy|0|||
163212886|NCT01729754|589494321|FG008|Part 2|Lack of Efficacy|2|||
163212887|NCT01729754|589494322|FG009|Part 2|Lack of Efficacy|2|||
163212888|NCT01729754|589494313|FG000|Part 2|Lost to Follow-up|0|||
163212889|NCT01729754|589494314|FG001|Part 2|Lost to Follow-up|0|||
163212890|NCT01729754|589494315|FG002|Part 2|Lost to Follow-up|0|||
163212891|NCT01729754|589494316|FG003|Part 2|Lost to Follow-up|2|||
163212892|NCT01729754|589494317|FG004|Part 2|Lost to Follow-up|0|||
163212893|NCT01729754|589494318|FG005|Part 2|Lost to Follow-up|0|||
163212894|NCT01729754|589494319|FG006|Part 2|Lost to Follow-up|0|||
163212895|NCT01729754|589494320|FG007|Part 2|Lost to Follow-up|1|||
163212896|NCT01729754|589494321|FG008|Part 2|Lost to Follow-up|0|||
163212897|NCT01729754|589494322|FG009|Part 2|Lost to Follow-up|2|||
163212898|NCT01729754|589494313|FG000|Part 2|Non-Compliance with Study Drug|0|||
163212899|NCT01729754|589494314|FG001|Part 2|Non-Compliance with Study Drug|0|||
163212900|NCT01729754|589494315|FG002|Part 2|Non-Compliance with Study Drug|0|||
163212901|NCT01729754|589494316|FG003|Part 2|Non-Compliance with Study Drug|0|||
163212902|NCT01729754|589494317|FG004|Part 2|Non-Compliance with Study Drug|0|||
163212903|NCT01729754|589494318|FG005|Part 2|Non-Compliance with Study Drug|0|||
163212904|NCT01729754|589494319|FG006|Part 2|Non-Compliance with Study Drug|0|||
163212905|NCT01729754|589494320|FG007|Part 2|Non-Compliance with Study Drug|0|||
163212906|NCT01729754|589494321|FG008|Part 2|Non-Compliance with Study Drug|0|||
163212907|NCT01729754|589494322|FG009|Part 2|Non-Compliance with Study Drug|1|||
163212908|NCT01729754|589494313|FG000|Part 2|Pregnancy|0|||
163212909|NCT01729754|589494314|FG001|Part 2|Pregnancy|0|||
163212910|NCT01729754|589494315|FG002|Part 2|Pregnancy|0|||
163212911|NCT01729754|589494316|FG003|Part 2|Pregnancy|1|||
163212912|NCT01729754|589494317|FG004|Part 2|Pregnancy|0|||
163212913|NCT01729754|589494318|FG005|Part 2|Pregnancy|0|||
163212914|NCT01729754|589494319|FG006|Part 2|Pregnancy|0|||
163212915|NCT01729754|589494320|FG007|Part 2|Pregnancy|0|||
163212916|NCT01729754|589494321|FG008|Part 2|Pregnancy|0|||
163212917|NCT01729754|589494322|FG009|Part 2|Pregnancy|1|||
163212918|NCT01729754|589494313|FG000|Part 2|Withdrawal by Subject|3|||
163212919|NCT01729754|589494314|FG001|Part 2|Withdrawal by Subject|0|||
163212920|NCT01729754|589494315|FG002|Part 2|Withdrawal by Subject|0|||
163212921|NCT01729754|589494316|FG003|Part 2|Withdrawal by Subject|2|||
163212922|NCT01729754|589494317|FG004|Part 2|Withdrawal by Subject|0|||
163212923|NCT01729754|589494318|FG005|Part 2|Withdrawal by Subject|0|||
163212924|NCT01729754|589494319|FG006|Part 2|Withdrawal by Subject|0|||
163212925|NCT01729754|589494320|FG007|Part 2|Withdrawal by Subject|1|||
163212926|NCT01729754|589494321|FG008|Part 2|Withdrawal by Subject|1|||
163212927|NCT01729754|589494322|FG009|Part 2|Withdrawal by Subject|4|||
163212928|NCT01729754|589494313|FG000|Part 2|Other Protocol Specified Criteria|1|||
163212929|NCT01729754|589494314|FG001|Part 2|Other Protocol Specified Criteria|0|||
163212930|NCT01729754|589494315|FG002|Part 2|Other Protocol Specified Criteria|0|||
163212931|NCT01729754|589494316|FG003|Part 2|Other Protocol Specified Criteria|0|||
163324940|NCT03705390|589901410|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
162999129|NCT02996487|588698231|FG000|Overall Study|Lost to Follow-up|1|||
162999130|NCT02996487|588698232|FG001|Overall Study|Lost to Follow-up|1|||
163212932|NCT01729754|589494317|FG004|Part 2|Other Protocol Specified Criteria|0|||
163212933|NCT01729754|589494318|FG005|Part 2|Other Protocol Specified Criteria|0|||
163212934|NCT01729754|589494319|FG006|Part 2|Other Protocol Specified Criteria|0|||
163212935|NCT01729754|589494320|FG007|Part 2|Other Protocol Specified Criteria|1|||
163212936|NCT01729754|589494321|FG008|Part 2|Other Protocol Specified Criteria|0|||
163324941|NCT03047213|589901411|FG000|Overall Study|Withdrawal by Subject|2|||
163324942|NCT03047213|589901412|FG001|Overall Study|Withdrawal by Subject|0|||
162999131|NCT02996487|588698233|FG002|Overall Study|Lost to Follow-up|0|||
163212937|NCT01729754|589494322|FG009|Part 2|Other Protocol Specified Criteria|0|||
163212938|NCT01729754|589494313|FG000|Part 3|Adverse Event|0|||
163212939|NCT01729754|589494314|FG001|Part 3|Adverse Event|0|||
163212940|NCT01729754|589494315|FG002|Part 3|Adverse Event|1|||
163212941|NCT01729754|589494316|FG003|Part 3|Adverse Event|0|||
163212942|NCT01729754|589494317|FG004|Part 3|Adverse Event|0|||
163212943|NCT01729754|589494318|FG005|Part 3|Adverse Event|5|||
163212944|NCT01729754|589494319|FG006|Part 3|Adverse Event|0|||
163212945|NCT01729754|589494320|FG007|Part 3|Adverse Event|0|||
163212946|NCT01729754|589494321|FG008|Part 3|Adverse Event|0|||
163212947|NCT01729754|589494322|FG009|Part 3|Adverse Event|3|||
163212948|NCT01729754|589494313|FG000|Part 3|Death|0|||
163212949|NCT01729754|589494314|FG001|Part 3|Death|0|||
163212950|NCT01729754|589494315|FG002|Part 3|Death|0|||
162999132|NCT02996487|588698231|FG000|Overall Study|Death|0|||
162999133|NCT02996487|588698232|FG001|Overall Study|Death|1|||
162999134|NCT02996487|588698233|FG002|Overall Study|Death|0|||
162999135|NCT02996487|588698231|FG000|Overall Study|Withdrawal by Subject|2|||
162999136|NCT02996487|588698232|FG001|Overall Study|Withdrawal by Subject|3|||
162999137|NCT02996487|588698233|FG002|Overall Study|Withdrawal by Subject|0|||
162999138|NCT02800642|588698234|FG000|Overall Study|Death|3|||
162999139|NCT02800642|588698234|FG000|Overall Study|Other|10|||
162999140|NCT02800642|588698234|FG000|Overall Study|Physician Decision|2|||
162999141|NCT02800642|588698234|FG000|Overall Study|Adverse Event|6|||
162999142|NCT02800642|588698234|FG000|Overall Study|Withdrawal by Subject|3|||
162999143|NCT02800642|588698234|FG000|Overall Study|Lost to Follow-up|1|||
162999144|NCT02027428|588698235|FG000|Induction|Never treated|7|||
162999145|NCT02027428|588698236|FG001|Induction|Never treated|0|||
162999146|NCT02027428|588698237|FG002|Induction|Never treated|0|||
162999147|NCT02027428|588698235|FG000|Induction|Progressive disease|77|||
162999148|NCT02027428|588698236|FG001|Induction|Progressive disease|0|||
162999149|NCT02027428|588698237|FG002|Induction|Progressive disease|0|||
162999150|NCT02027428|588698235|FG000|Induction|Adverse Event|51|||
162999151|NCT02027428|588698236|FG001|Induction|Adverse Event|0|||
162999152|NCT02027428|588698237|FG002|Induction|Adverse Event|0|||
162999153|NCT02027428|588698235|FG000|Induction|Withdrawal by Subject|22|||
162999154|NCT02027428|588698236|FG001|Induction|Withdrawal by Subject|0|||
162999155|NCT02027428|588698237|FG002|Induction|Withdrawal by Subject|0|||
162999156|NCT02027428|588698235|FG000|Induction|Death|21|||
162999157|NCT02027428|588698236|FG001|Induction|Death|0|||
162999158|NCT02027428|588698237|FG002|Induction|Death|0|||
162999159|NCT02027428|588698235|FG000|Induction|Symptomatic deterioration|16|||
162999160|NCT02027428|588698236|FG001|Induction|Symptomatic deterioration|0|||
162999161|NCT02027428|588698237|FG002|Induction|Symptomatic deterioration|0|||
162999162|NCT02027428|588698235|FG000|Induction|Study terminated by sponsor|12|||
162999163|NCT02027428|588698236|FG001|Induction|Study terminated by sponsor|0|||
162999164|NCT02027428|588698237|FG002|Induction|Study terminated by sponsor|0|||
162999165|NCT02027428|588698235|FG000|Induction|Protocol Violation|1|||
162999166|NCT02027428|588698236|FG001|Induction|Protocol Violation|0|||
162999167|NCT02027428|588698237|FG002|Induction|Protocol Violation|0|||
162999168|NCT02027428|588698235|FG000|Induction|Miscellaneous|14|||
162999169|NCT02027428|588698236|FG001|Induction|Miscellaneous|0|||
162999170|NCT02027428|588698237|FG002|Induction|Miscellaneous|0|||
162999171|NCT02027428|588698235|FG000|Induction|Induction Treatment Ongoing|4|||
162999172|NCT02027428|588698236|FG001|Induction|Induction Treatment Ongoing|0|||
162999173|NCT02027428|588698237|FG002|Induction|Induction Treatment Ongoing|0|||
162999174|NCT02027428|588698235|FG000|Maintenance|Death|0|||
162999175|NCT02027428|588698236|FG001|Maintenance|Death|3|||
162999176|NCT02027428|588698237|FG002|Maintenance|Death|2|||
162999177|NCT02027428|588698235|FG000|Maintenance|Adverse Event|0|||
162999178|NCT02027428|588698236|FG001|Maintenance|Adverse Event|21|||
162999179|NCT02027428|588698237|FG002|Maintenance|Adverse Event|1|||
162999180|NCT02027428|588698235|FG000|Maintenance|Progressive disease|0|||
162999181|NCT02027428|588698236|FG001|Maintenance|Progressive disease|84|||
162999182|NCT02027428|588698237|FG002|Maintenance|Progressive disease|47|||
162999183|NCT02027428|588698235|FG000|Maintenance|Symptomatic deterioration|0|||
162999184|NCT02027428|588698236|FG001|Maintenance|Symptomatic deterioration|4|||
163060573|NCT04848480|588929942|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
163060574|NCT04848480|588929943|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
163324943|NCT03047213|589901411|FG000|Overall Study|Adverse Event|2|||
163324944|NCT03047213|589901412|FG001|Overall Study|Adverse Event|0|||
162999185|NCT02027428|588698237|FG002|Maintenance|Symptomatic deterioration|1|||
162999186|NCT02027428|588698235|FG000|Maintenance|Withdrawal by Subject|0|||
162999187|NCT02027428|588698236|FG001|Maintenance|Withdrawal by Subject|6|||
162999188|NCT02027428|588698237|FG002|Maintenance|Withdrawal by Subject|5|||
162999189|NCT02027428|588698235|FG000|Maintenance|Protocol Violation|0|||
162999190|NCT02027428|588698236|FG001|Maintenance|Protocol Violation|0|||
162999191|NCT02027428|588698237|FG002|Maintenance|Protocol Violation|1|||
162999192|NCT02027428|588698235|FG000|Maintenance|Other|0|||
162999193|NCT02027428|588698236|FG001|Maintenance|Other|6|||
162999194|NCT02027428|588698237|FG002|Maintenance|Other|3|||
162999195|NCT02027428|588698235|FG000|Survival Follow-up|Death|0|||
162999196|NCT02027428|588698236|FG001|Survival Follow-up|Death|78|||
162999197|NCT02027428|588698237|FG002|Survival Follow-up|Death|45|||
162999198|NCT02027428|588698235|FG000|Survival Follow-up|Lost to Follow-up|0|||
162999199|NCT02027428|588698236|FG001|Survival Follow-up|Lost to Follow-up|1|||
162999200|NCT02027428|588698237|FG002|Survival Follow-up|Lost to Follow-up|1|||
162999201|NCT02859142|588698238|FG000|Overall Study|Adverse Event|1|||
162999202|NCT02859142|588698239|FG001|Overall Study|Adverse Event|2|||
162999203|NCT02859142|588698238|FG000|Overall Study|Lost to Follow-up|1|||
162999204|NCT02859142|588698239|FG001|Overall Study|Lost to Follow-up|4|||
162999205|NCT02859142|588698238|FG000|Overall Study|Withdrawal by Subject|2|||
162999206|NCT02859142|588698239|FG001|Overall Study|Withdrawal by Subject|0|||
162999207|NCT02859142|588698238|FG000|Overall Study|Scheduling difficulties|0|||
162999208|NCT02859142|588698239|FG001|Overall Study|Scheduling difficulties|3|||
162999209|NCT03340974|588698240|FG000|Completion of Study -Long Term Follow up|Death|8|||
162999210|NCT03340974|588698241|FG001|Completion of Study -Long Term Follow up|Death|5|||
162999211|NCT03340974|588698242|FG002|Completion of Study -Long Term Follow up|Death|5|||
162999212|NCT03340974|588698243|FG003|Completion of Study -Long Term Follow up|Death|7|||
162999213|NCT03340974|588698240|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
162999214|NCT03340974|588698241|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
162999215|NCT03340974|588698242|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
162999216|NCT03340974|588698243|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
162999217|NCT03340974|588698240|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
162999218|NCT03340974|588698241|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
162999219|NCT03340974|588698242|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
162999220|NCT03340974|588698243|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
162999221|NCT03340974|588698240|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
162999222|NCT03340974|588698241|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
162999223|NCT03340974|588698242|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
162999224|NCT03340974|588698243|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
162999225|NCT02374346|588698247|FG000|Overall Study|operated or discharged during weekend|48|||
162999226|NCT00396565|588698250|FG000|Overall Study|Physician Decision|3|||
162999227|NCT00396565|588698251|FG001|Overall Study|Physician Decision|1|||
162999228|NCT00396565|588698252|FG002|Overall Study|Physician Decision|2|||
162999229|NCT00396565|588698250|FG000|Overall Study|Adverse Event|5|||
162999230|NCT00396565|588698251|FG001|Overall Study|Adverse Event|13|||
162999231|NCT00396565|588698252|FG002|Overall Study|Adverse Event|3|||
162999232|NCT00396565|588698250|FG000|Overall Study|Withdrawal by Subject|8|||
162999233|NCT00396565|588698251|FG001|Overall Study|Withdrawal by Subject|13|||
162999234|NCT00396565|588698252|FG002|Overall Study|Withdrawal by Subject|1|||
162999235|NCT00396565|588698250|FG000|Overall Study|Lack of Efficacy|32|||
162999236|NCT00396565|588698251|FG001|Overall Study|Lack of Efficacy|64|||
162999237|NCT00396565|588698252|FG002|Overall Study|Lack of Efficacy|11|||
162999238|NCT05299528|588698255|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
162999239|NCT05299528|588698256|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
162999240|NCT05299528|588698257|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
162999241|NCT05299528|588698258|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
162999242|NCT05299528|588698259|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
162999243|NCT05299528|588698260|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
162999244|NCT05299528|588698261|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
162999245|NCT05299528|588698255|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
162999246|NCT05299528|588698256|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
162999247|NCT05299528|588698257|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
162999248|NCT05299528|588698258|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
163060575|NCT04848480|588929942|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
163060576|NCT04848480|588929943|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
163212951|NCT01729754|589494316|FG003|Part 3|Death|0|||
162999249|NCT05299528|588698259|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
162999250|NCT05299528|588698260|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
162999251|NCT05299528|588698261|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
162999252|NCT05299528|588698255|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
162999253|NCT05299528|588698256|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
162999254|NCT05299528|588698257|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
162999255|NCT05299528|588698258|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
162999256|NCT05299528|588698259|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
162999257|NCT05299528|588698260|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
162999258|NCT05299528|588698261|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
162999259|NCT04877457|588698262|FG000|Overall Study|Early termination of study due to low enrollment|2|||
162999260|NCT04877457|588698263|FG001|Overall Study|Early termination of study due to low enrollment|1|||
162999261|NCT02211417|588698264|FG000|Overall Study|Withdrawal by Subject|11|||
162999262|NCT02211417|588698265|FG001|Overall Study|Withdrawal by Subject|8|||
162999263|NCT02211417|588698264|FG000|Overall Study|Protocol Violation|1|||
162999264|NCT02211417|588698265|FG001|Overall Study|Protocol Violation|0|||
162999265|NCT02211417|588698264|FG000|Overall Study|Pregnancy|0|||
162999266|NCT02211417|588698265|FG001|Overall Study|Pregnancy|1|||
162999267|NCT02211417|588698264|FG000|Overall Study|Lost to Follow-up|2|||
162999268|NCT02211417|588698265|FG001|Overall Study|Lost to Follow-up|3|||
162999269|NCT02211417|588698264|FG000|Overall Study|Adverse Event|1|||
162999270|NCT02211417|588698265|FG001|Overall Study|Adverse Event|4|||
162999271|NCT01198132|588698266|FG000|Overall Study|Withdrawal by Subject|4|||
163212952|NCT01729754|589494317|FG004|Part 3|Death|0|||
163212953|NCT01729754|589494318|FG005|Part 3|Death|2|||
163212954|NCT01729754|589494319|FG006|Part 3|Death|0|||
162999272|NCT01198132|588698267|FG001|Overall Study|Withdrawal by Subject|5|||
162999273|NCT01198132|588698266|FG000|Overall Study|Physician Decision|5|||
162999274|NCT01198132|588698267|FG001|Overall Study|Physician Decision|4|||
162999275|NCT01198132|588698266|FG000|Overall Study|Other Unspecified|3|||
162999276|NCT01198132|588698267|FG001|Overall Study|Other Unspecified|6|||
162999277|NCT01198132|588698266|FG000|Overall Study|Lack of Efficacy|2|||
162999278|NCT01198132|588698267|FG001|Overall Study|Lack of Efficacy|3|||
162999279|NCT01198132|588698266|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
162999280|NCT01198132|588698267|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
162999281|NCT01198132|588698266|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
162999282|NCT01198132|588698267|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
162999283|NCT01198132|588698266|FG000|Overall Study|Adverse Event|0|||
162999284|NCT01198132|588698267|FG001|Overall Study|Adverse Event|1|||
162999285|NCT01198132|588698266|FG000|Overall Study|Protocol Violation|1|||
162999286|NCT01198132|588698267|FG001|Overall Study|Protocol Violation|0|||
162999287|NCT01277211|588698268|FG000|Overall Study|Adverse Event|60|||
162999288|NCT01277211|588698269|FG001|Overall Study|Adverse Event|22|||
162999289|NCT01277211|588698268|FG000|Overall Study|Pregnancy|9|||
162999290|NCT01277211|588698269|FG001|Overall Study|Pregnancy|4|||
162999291|NCT01277211|588698268|FG000|Overall Study|Lost to Follow-up|14|||
162999292|NCT01277211|588698269|FG001|Overall Study|Lost to Follow-up|9|||
162999293|NCT01277211|588698268|FG000|Overall Study|Did not wish to continue|17|||
162999294|NCT01277211|588698269|FG001|Overall Study|Did not wish to continue|0|||
162999295|NCT01277211|588698268|FG000|Overall Study|Withdrew Consent|9|||
162999296|NCT01277211|588698269|FG001|Overall Study|Withdrew Consent|9|||
162999297|NCT01277211|588698268|FG000|Overall Study|Non-compliance with protocol|13|||
162999298|NCT01277211|588698269|FG001|Overall Study|Non-compliance with protocol|4|||
162999299|NCT01277211|588698268|FG000|Overall Study|Did not meet protocol eligibility|1|||
162999300|NCT01277211|588698269|FG001|Overall Study|Did not meet protocol eligibility|0|||
162999301|NCT01277211|588698268|FG000|Overall Study|Administrative|3|||
162999302|NCT01277211|588698269|FG001|Overall Study|Administrative|0|||
162999303|NCT01277211|588698268|FG000|Overall Study|Pregnancy wish|0|||
162999304|NCT01277211|588698269|FG001|Overall Study|Pregnancy wish|2|||
162999305|NCT01277211|588698268|FG000|Overall Study|Discontinued prior to treatment|24|||
162999306|NCT01277211|588698269|FG001|Overall Study|Discontinued prior to treatment|13|||
162999307|NCT04697069|588698270|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
162999308|NCT04697069|588698271|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
162999309|NCT04697069|588698270|FG000|Overall Study|Study termination|2|||
162999310|NCT04697069|588698271|FG001|Overall Study|Study termination|1|||
162999311|NCT05180227|588698272|FG000|Overall Study|Hypertension at screening|1|||
162999312|NCT05180227|588698272|FG000|Overall Study|Lost to Follow-up|1|||
162999313|NCT02924727|588698273|FG000|Overall Study|Withdrawal by Subject|2|||
162999314|NCT02924727|588698274|FG001|Overall Study|Withdrawal by Subject|4|||
162999315|NCT02924727|588698273|FG000|Overall Study|Lost to Follow-up|2|||
162999316|NCT02924727|588698274|FG001|Overall Study|Lost to Follow-up|5|||
162999317|NCT02924727|588698273|FG000|Overall Study|Death|221|||
162999318|NCT02924727|588698274|FG001|Overall Study|Death|247|||
162999319|NCT02924727|588698273|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
162999320|NCT02924727|588698274|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
162999321|NCT04614246|588698275|FG000|Overall Study|Adverse Event|0|||
162999322|NCT04614246|588698276|FG001|Overall Study|Adverse Event|1|||
162999323|NCT04614246|588698277|FG002|Overall Study|Adverse Event|1|||
162999324|NCT04614246|588698278|FG003|Overall Study|Adverse Event|2|||
162999325|NCT04614246|588698279|FG004|Overall Study|Adverse Event|1|||
162999326|NCT04614246|588698275|FG000|Overall Study|Lost to Follow-up|0|||
162999327|NCT04614246|588698276|FG001|Overall Study|Lost to Follow-up|1|||
162999328|NCT04614246|588698277|FG002|Overall Study|Lost to Follow-up|0|||
162999329|NCT04614246|588698278|FG003|Overall Study|Lost to Follow-up|1|||
162999330|NCT04614246|588698279|FG004|Overall Study|Lost to Follow-up|3|||
162999331|NCT04614246|588698275|FG000|Overall Study|Other reason|0|||
162999332|NCT04614246|588698276|FG001|Overall Study|Other reason|1|||
162999333|NCT04614246|588698277|FG002|Overall Study|Other reason|2|||
162999334|NCT04614246|588698278|FG003|Overall Study|Other reason|0|||
162999335|NCT04614246|588698279|FG004|Overall Study|Other reason|0|||
162999336|NCT04614246|588698275|FG000|Overall Study|Withdrawal by Subject|4|||
162999337|NCT04614246|588698276|FG001|Overall Study|Withdrawal by Subject|2|||
162999338|NCT04614246|588698277|FG002|Overall Study|Withdrawal by Subject|4|||
162999339|NCT04614246|588698278|FG003|Overall Study|Withdrawal by Subject|3|||
162999340|NCT04614246|588698279|FG004|Overall Study|Withdrawal by Subject|4|||
162999341|NCT04614246|588698275|FG000|Overall Study|Physician Decision|0|||
162999342|NCT04614246|588698276|FG001|Overall Study|Physician Decision|2|||
162999343|NCT04614246|588698277|FG002|Overall Study|Physician Decision|1|||
162999344|NCT04614246|588698278|FG003|Overall Study|Physician Decision|0|||
162999345|NCT04614246|588698279|FG004|Overall Study|Physician Decision|0|||
162999346|NCT04614246|588698275|FG000|Overall Study|Study terminated by sponsor|10|||
162999347|NCT04614246|588698276|FG001|Overall Study|Study terminated by sponsor|15|||
162999348|NCT04614246|588698277|FG002|Overall Study|Study terminated by sponsor|12|||
162999349|NCT04614246|588698278|FG003|Overall Study|Study terminated by sponsor|13|||
162999350|NCT04614246|588698279|FG004|Overall Study|Study terminated by sponsor|9|||
162999351|NCT04614246|588698275|FG000|Overall Study|Pregnancy|2|||
162999352|NCT04614246|588698276|FG001|Overall Study|Pregnancy|0|||
162999353|NCT04614246|588698277|FG002|Overall Study|Pregnancy|1|||
162999354|NCT04614246|588698278|FG003|Overall Study|Pregnancy|0|||
162999355|NCT04614246|588698279|FG004|Overall Study|Pregnancy|0|||
162999356|NCT02185053|588698280|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
162999357|NCT02185053|588698281|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
162999358|NCT02185053|588698282|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
162999359|NCT02185053|588698280|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
162999360|NCT02185053|588698281|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
162999361|NCT02185053|588698282|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
162999362|NCT02185053|588698280|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
162999363|NCT02185053|588698281|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
162999364|NCT02185053|588698282|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
162999365|NCT02185053|588698280|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
162999366|NCT02185053|588698281|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
162999367|NCT02185053|588698282|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
162999368|NCT02185053|588698280|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
162999369|NCT02185053|588698281|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
162999370|NCT02185053|588698282|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
162999371|NCT02185053|588698280|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
162999372|NCT02185053|588698281|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
162999373|NCT02185053|588698282|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
162999374|NCT02185053|588698280|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
162999375|NCT02185053|588698281|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
162999376|NCT02185053|588698282|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
162999377|NCT02185053|588698280|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
162999378|NCT02185053|588698281|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
162999379|NCT02185053|588698282|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
162999380|NCT02521376|588698290|FG000|Overall Study|Enrolled, But Not Treated|1|||
162999381|NCT02521376|588698291|FG001|Overall Study|Enrolled, But Not Treated|0|||
162999382|NCT02521376|588698292|FG002|Overall Study|Enrolled, But Not Treated|0|||
162999383|NCT02521376|588698293|FG003|Overall Study|Enrolled, But Not Treated|0|||
162999384|NCT00338728|588698294|FG000|Overall Study|Screen Failure|14|||
162999385|NCT00340678|588698297|FG000|Overall Study|Lost to Follow-up|1|||
162999386|NCT00340678|588698298|FG001|Overall Study|Lost to Follow-up|0|||
162999387|NCT00340678|588698299|FG002|Overall Study|Lost to Follow-up|0|||
162999388|NCT00340678|588698300|FG003|Overall Study|Lost to Follow-up|0|||
162999389|NCT01862484|588698301|FG000|Overall Study|Lack of Efficacy|1|||
162999390|NCT01862484|588698302|FG001|Overall Study|Lack of Efficacy|1|||
162999391|NCT01862484|588698301|FG000|Overall Study|Lost to Follow-up|1|||
162999392|NCT01862484|588698302|FG001|Overall Study|Lost to Follow-up|2|||
162999393|NCT01862484|588698301|FG000|Overall Study|Protocol Violation|0|||
162999394|NCT01862484|588698302|FG001|Overall Study|Protocol Violation|2|||
162999395|NCT01862484|588698301|FG000|Overall Study|Withdrawal by Subject|0|||
162999396|NCT01862484|588698302|FG001|Overall Study|Withdrawal by Subject|3|||
162999397|NCT00996892|588698303|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
162999398|NCT00996892|588698304|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
162999399|NCT00996892|588698305|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
162999400|NCT00996892|588698306|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
162999401|NCT00996892|588698307|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
162999402|NCT00996892|588698308|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
162999403|NCT00996892|588698309|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
162999404|NCT00996892|588698310|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
162999405|NCT00996892|588698311|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
162999406|NCT00996892|588698312|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
162999407|NCT00996892|588698313|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
162999408|NCT00996892|588698314|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
162999409|NCT00996892|588698315|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
162999410|NCT00996892|588698316|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
162999411|NCT00996892|588698317|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
162999412|NCT00996892|588698318|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
162999413|NCT00996892|588698319|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
162999414|NCT00996892|588698320|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
162999415|NCT00996892|588698321|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
162999416|NCT00996892|588698322|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
162999417|NCT00996892|588698303|FG000|Dose-Escalation Stage 1|Death|1|||
162999418|NCT00996892|588698304|FG001|Dose-Escalation Stage 1|Death|0|||
162999419|NCT00996892|588698305|FG002|Dose-Escalation Stage 1|Death|0|||
162999420|NCT00996892|588698306|FG003|Dose-Escalation Stage 1|Death|0|||
162999421|NCT00996892|588698307|FG004|Dose-Escalation Stage 1|Death|0|||
162999422|NCT00996892|588698308|FG005|Dose-Escalation Stage 1|Death|1|||
162999423|NCT00996892|588698309|FG006|Dose-Escalation Stage 1|Death|0|||
162999424|NCT00996892|588698310|FG007|Dose-Escalation Stage 1|Death|0|||
162999425|NCT00996892|588698311|FG008|Dose-Escalation Stage 1|Death|0|||
162999426|NCT00996892|588698312|FG009|Dose-Escalation Stage 1|Death|0|||
162999427|NCT00996892|588698313|FG010|Dose-Escalation Stage 1|Death|0|||
162999428|NCT00996892|588698314|FG011|Dose-Escalation Stage 1|Death|0|||
162999429|NCT00996892|588698315|FG012|Dose-Escalation Stage 1|Death|0|||
162999430|NCT00996892|588698316|FG013|Dose-Escalation Stage 1|Death|0|||
162999431|NCT00996892|588698317|FG014|Dose-Escalation Stage 1|Death|0|||
162999432|NCT00996892|588698318|FG015|Dose-Escalation Stage 1|Death|0|||
162999433|NCT00996892|588698319|FG016|Dose-Escalation Stage 1|Death|0|||
162999434|NCT00996892|588698320|FG017|Dose-Escalation Stage 1|Death|0|||
162999435|NCT00996892|588698321|FG018|Dose-Escalation Stage 1|Death|0|||
162999436|NCT00996892|588698322|FG019|Dose-Escalation Stage 1|Death|0|||
162999437|NCT00996892|588698303|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
162999438|NCT00996892|588698304|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
162999439|NCT00996892|588698305|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
162999440|NCT00996892|588698306|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
162999441|NCT00996892|588698307|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
162999442|NCT00996892|588698308|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
162999443|NCT00996892|588698309|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
162999444|NCT00996892|588698310|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
162999445|NCT00996892|588698311|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
162999446|NCT00996892|588698312|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
162999447|NCT00996892|588698313|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
162999448|NCT00996892|588698314|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
162999449|NCT00996892|588698315|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
162999450|NCT00996892|588698316|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
162999451|NCT00996892|588698317|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
162999452|NCT00996892|588698318|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
162999453|NCT00996892|588698319|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
162999454|NCT00996892|588698320|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
162999455|NCT00996892|588698321|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
162999456|NCT00996892|588698322|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
162999457|NCT00996892|588698303|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999458|NCT00996892|588698304|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
162999459|NCT00996892|588698305|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999460|NCT00996892|588698306|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
162999461|NCT00996892|588698307|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
162999462|NCT00996892|588698308|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
162999463|NCT00996892|588698309|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
162999464|NCT00996892|588698310|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999465|NCT00996892|588698311|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999466|NCT00996892|588698312|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999467|NCT00996892|588698313|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999468|NCT00996892|588698314|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999469|NCT00996892|588698315|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999470|NCT00996892|588698316|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999471|NCT00996892|588698317|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
163212955|NCT01729754|589494320|FG007|Part 3|Death|0|||
163212956|NCT01729754|589494321|FG008|Part 3|Death|0|||
163212957|NCT01729754|589494322|FG009|Part 3|Death|0|||
162999472|NCT00996892|588698318|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999473|NCT00996892|588698319|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999474|NCT00996892|588698320|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999475|NCT00996892|588698321|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999476|NCT00996892|588698322|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999477|NCT00996892|588698303|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
162999478|NCT00996892|588698304|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
162999479|NCT00996892|588698305|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
162999480|NCT00996892|588698306|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
162999481|NCT00996892|588698307|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
162999482|NCT00996892|588698308|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
162999483|NCT00996892|588698309|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
162999484|NCT00996892|588698310|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
162999485|NCT00996892|588698311|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
162999486|NCT00996892|588698312|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
162999487|NCT00996892|588698313|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
162999488|NCT00996892|588698314|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
162999489|NCT00996892|588698315|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
163212958|NCT01729754|589494313|FG000|Part 3|Lack of Efficacy|0|||
162999490|NCT00996892|588698316|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
162999491|NCT00996892|588698317|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
162999492|NCT00996892|588698318|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
162999493|NCT00996892|588698319|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
162999494|NCT00996892|588698320|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
162999495|NCT00996892|588698321|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
162999496|NCT00996892|588698322|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
162999497|NCT00996892|588698303|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
162999498|NCT00996892|588698304|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
162999499|NCT00996892|588698305|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
162999500|NCT00996892|588698306|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
162999501|NCT00996892|588698307|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
162999502|NCT00996892|588698308|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
162999503|NCT00996892|588698309|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
162999504|NCT00996892|588698310|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
162999505|NCT00996892|588698311|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
162999506|NCT00996892|588698312|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
162999507|NCT00996892|588698313|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
162999508|NCT00996892|588698314|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
162999509|NCT00996892|588698315|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
162999510|NCT00996892|588698316|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
162999511|NCT00996892|588698317|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
162999512|NCT00996892|588698318|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
162999513|NCT00996892|588698319|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
162999514|NCT00996892|588698320|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
162999515|NCT00996892|588698321|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
162999516|NCT00996892|588698322|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
162999517|NCT00996892|588698303|FG000|Dose-Escalation Stage 1A|Death|0|||
162999518|NCT00996892|588698304|FG001|Dose-Escalation Stage 1A|Death|0|||
162999519|NCT00996892|588698305|FG002|Dose-Escalation Stage 1A|Death|0|||
162999520|NCT00996892|588698306|FG003|Dose-Escalation Stage 1A|Death|0|||
162999521|NCT00996892|588698307|FG004|Dose-Escalation Stage 1A|Death|0|||
162999522|NCT00996892|588698308|FG005|Dose-Escalation Stage 1A|Death|0|||
162999523|NCT00996892|588698309|FG006|Dose-Escalation Stage 1A|Death|0|||
162999524|NCT00996892|588698310|FG007|Dose-Escalation Stage 1A|Death|0|||
162999525|NCT00996892|588698311|FG008|Dose-Escalation Stage 1A|Death|0|||
162999526|NCT00996892|588698312|FG009|Dose-Escalation Stage 1A|Death|2|||
162999527|NCT00996892|588698313|FG010|Dose-Escalation Stage 1A|Death|0|||
162999528|NCT00996892|588698314|FG011|Dose-Escalation Stage 1A|Death|1|||
162999529|NCT00996892|588698315|FG012|Dose-Escalation Stage 1A|Death|1|||
162999530|NCT00996892|588698316|FG013|Dose-Escalation Stage 1A|Death|0|||
162999531|NCT00996892|588698317|FG014|Dose-Escalation Stage 1A|Death|0|||
162999532|NCT00996892|588698318|FG015|Dose-Escalation Stage 1A|Death|0|||
162999533|NCT00996892|588698319|FG016|Dose-Escalation Stage 1A|Death|0|||
162999534|NCT00996892|588698320|FG017|Dose-Escalation Stage 1A|Death|0|||
162999535|NCT00996892|588698321|FG018|Dose-Escalation Stage 1A|Death|0|||
162999536|NCT00996892|588698322|FG019|Dose-Escalation Stage 1A|Death|0|||
162999537|NCT00996892|588698303|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
162999538|NCT00996892|588698304|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
162999539|NCT00996892|588698305|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
162999540|NCT00996892|588698306|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
162999541|NCT00996892|588698307|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
162999542|NCT00996892|588698308|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
162999543|NCT00996892|588698309|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
162999544|NCT00996892|588698310|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
162999545|NCT00996892|588698311|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
162999546|NCT00996892|588698312|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
162999547|NCT00996892|588698313|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
162999548|NCT00996892|588698314|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
162999549|NCT00996892|588698315|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
162999550|NCT00996892|588698316|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
162999551|NCT00996892|588698317|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
162999552|NCT00996892|588698318|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
162999553|NCT00996892|588698319|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
162999554|NCT00996892|588698320|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
162999555|NCT00996892|588698321|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
162999556|NCT00996892|588698322|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
162999557|NCT00996892|588698303|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999558|NCT00996892|588698304|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999559|NCT00996892|588698305|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999560|NCT00996892|588698306|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999561|NCT00996892|588698307|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999562|NCT00996892|588698308|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999563|NCT00996892|588698309|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999564|NCT00996892|588698310|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999565|NCT00996892|588698311|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999566|NCT00996892|588698312|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
162999567|NCT00996892|588698313|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
162999568|NCT00996892|588698314|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
162999569|NCT00996892|588698315|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
162999570|NCT00996892|588698316|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999571|NCT00996892|588698317|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999572|NCT00996892|588698318|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999573|NCT00996892|588698319|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999574|NCT00996892|588698320|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999575|NCT00996892|588698321|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999576|NCT00996892|588698322|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999577|NCT00996892|588698303|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
162999578|NCT00996892|588698304|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
162999579|NCT00996892|588698305|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
162999580|NCT00996892|588698306|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
162999581|NCT00996892|588698307|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
162999582|NCT00996892|588698308|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
162999583|NCT00996892|588698309|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
162999584|NCT00996892|588698310|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
162999585|NCT00996892|588698311|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
162999586|NCT00996892|588698312|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
162999587|NCT00996892|588698313|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
162999588|NCT00996892|588698314|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
162999589|NCT00996892|588698315|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
162999590|NCT00996892|588698316|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
162999591|NCT00996892|588698317|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
162999592|NCT00996892|588698318|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
162999593|NCT00996892|588698319|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
162999594|NCT00996892|588698320|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
162999595|NCT00996892|588698321|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
162999596|NCT00996892|588698322|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
162999597|NCT00996892|588698303|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
162999598|NCT00996892|588698304|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
162999599|NCT00996892|588698305|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
162999600|NCT00996892|588698306|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
162999601|NCT00996892|588698307|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
162999602|NCT00996892|588698308|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
162999603|NCT00996892|588698309|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
162999604|NCT00996892|588698310|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
162999605|NCT00996892|588698311|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
162999606|NCT00996892|588698312|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
162999607|NCT00996892|588698313|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
162999608|NCT00996892|588698314|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
162999609|NCT00996892|588698315|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
162999610|NCT00996892|588698316|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
162999611|NCT00996892|588698317|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
163212959|NCT01729754|589494314|FG001|Part 3|Lack of Efficacy|0|||
163212960|NCT01729754|589494315|FG002|Part 3|Lack of Efficacy|0|||
162999612|NCT00996892|588698318|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
162999613|NCT00996892|588698319|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
162999614|NCT00996892|588698320|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
162999615|NCT00996892|588698321|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
162999616|NCT00996892|588698322|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
162999617|NCT00996892|588698303|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
163212961|NCT01729754|589494316|FG003|Part 3|Lack of Efficacy|0|||
162999618|NCT00996892|588698304|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
162999619|NCT00996892|588698305|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
162999620|NCT00996892|588698306|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
162999621|NCT00996892|588698307|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
162999622|NCT00996892|588698308|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
162999623|NCT00996892|588698309|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
162999624|NCT00996892|588698310|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
162999625|NCT00996892|588698311|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
162999626|NCT00996892|588698312|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
163212962|NCT01729754|589494317|FG004|Part 3|Lack of Efficacy|2|||
162999627|NCT00996892|588698313|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
162999628|NCT00996892|588698314|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
162999629|NCT00996892|588698315|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
163212963|NCT01729754|589494318|FG005|Part 3|Lack of Efficacy|0|||
162999630|NCT00996892|588698316|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
162999631|NCT00996892|588698317|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
162999632|NCT00996892|588698318|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
162999633|NCT00996892|588698319|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
162999634|NCT00996892|588698320|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
162999635|NCT00996892|588698321|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
162999636|NCT00996892|588698322|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
162999637|NCT00996892|588698303|FG000|Expansion Stage 2|Adverse Event|0|||
162999638|NCT00996892|588698304|FG001|Expansion Stage 2|Adverse Event|0|||
162999639|NCT00996892|588698305|FG002|Expansion Stage 2|Adverse Event|0|||
162999640|NCT00996892|588698306|FG003|Expansion Stage 2|Adverse Event|0|||
162999641|NCT00996892|588698307|FG004|Expansion Stage 2|Adverse Event|0|||
162999642|NCT00996892|588698308|FG005|Expansion Stage 2|Adverse Event|0|||
162999643|NCT00996892|588698309|FG006|Expansion Stage 2|Adverse Event|0|||
162999644|NCT00996892|588698310|FG007|Expansion Stage 2|Adverse Event|0|||
162999645|NCT00996892|588698311|FG008|Expansion Stage 2|Adverse Event|0|||
162999646|NCT00996892|588698312|FG009|Expansion Stage 2|Adverse Event|0|||
162999647|NCT00996892|588698313|FG010|Expansion Stage 2|Adverse Event|0|||
162999648|NCT00996892|588698314|FG011|Expansion Stage 2|Adverse Event|0|||
162999649|NCT00996892|588698315|FG012|Expansion Stage 2|Adverse Event|0|||
162999650|NCT00996892|588698316|FG013|Expansion Stage 2|Adverse Event|0|||
162999651|NCT00996892|588698317|FG014|Expansion Stage 2|Adverse Event|0|||
162999652|NCT00996892|588698318|FG015|Expansion Stage 2|Adverse Event|0|||
162999653|NCT00996892|588698319|FG016|Expansion Stage 2|Adverse Event|0|||
162999654|NCT00996892|588698320|FG017|Expansion Stage 2|Adverse Event|0|||
162999655|NCT00996892|588698321|FG018|Expansion Stage 2|Adverse Event|3|||
162999656|NCT00996892|588698322|FG019|Expansion Stage 2|Adverse Event|0|||
162999657|NCT00996892|588698303|FG000|Expansion Stage 2|Death|0|||
162999658|NCT00996892|588698304|FG001|Expansion Stage 2|Death|0|||
162999659|NCT00996892|588698305|FG002|Expansion Stage 2|Death|0|||
162999660|NCT00996892|588698306|FG003|Expansion Stage 2|Death|0|||
162999661|NCT00996892|588698307|FG004|Expansion Stage 2|Death|0|||
162999662|NCT00996892|588698308|FG005|Expansion Stage 2|Death|0|||
162999663|NCT00996892|588698309|FG006|Expansion Stage 2|Death|0|||
162999664|NCT00996892|588698310|FG007|Expansion Stage 2|Death|0|||
162999665|NCT00996892|588698311|FG008|Expansion Stage 2|Death|0|||
162999666|NCT00996892|588698312|FG009|Expansion Stage 2|Death|0|||
162999667|NCT00996892|588698313|FG010|Expansion Stage 2|Death|0|||
162999668|NCT00996892|588698314|FG011|Expansion Stage 2|Death|0|||
162999669|NCT00996892|588698315|FG012|Expansion Stage 2|Death|0|||
162999670|NCT00996892|588698316|FG013|Expansion Stage 2|Death|0|||
162999671|NCT00996892|588698317|FG014|Expansion Stage 2|Death|0|||
162999672|NCT00996892|588698318|FG015|Expansion Stage 2|Death|0|||
162999673|NCT00996892|588698319|FG016|Expansion Stage 2|Death|0|||
162999674|NCT00996892|588698320|FG017|Expansion Stage 2|Death|0|||
162999675|NCT00996892|588698321|FG018|Expansion Stage 2|Death|2|||
162999676|NCT00996892|588698322|FG019|Expansion Stage 2|Death|0|||
162999677|NCT00996892|588698303|FG000|Expansion Stage 2|Physician Decision|0|||
162999678|NCT00996892|588698304|FG001|Expansion Stage 2|Physician Decision|0|||
162999679|NCT00996892|588698305|FG002|Expansion Stage 2|Physician Decision|0|||
162999680|NCT00996892|588698306|FG003|Expansion Stage 2|Physician Decision|0|||
162999681|NCT00996892|588698307|FG004|Expansion Stage 2|Physician Decision|0|||
163060577|NCT05219162|588929944|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
163060578|NCT05219162|588929944|FG000|Overall Study|Withdrawal by Subject|23|||
163324945|NCT03782116|589901440|FG000|Completed Intervetion|Lost to Follow-up|11|||
162999682|NCT00996892|588698308|FG005|Expansion Stage 2|Physician Decision|0|||
162999683|NCT00996892|588698309|FG006|Expansion Stage 2|Physician Decision|0|||
162999684|NCT00996892|588698310|FG007|Expansion Stage 2|Physician Decision|0|||
162999685|NCT00996892|588698311|FG008|Expansion Stage 2|Physician Decision|0|||
162999686|NCT00996892|588698312|FG009|Expansion Stage 2|Physician Decision|0|||
162999687|NCT00996892|588698313|FG010|Expansion Stage 2|Physician Decision|0|||
162999688|NCT00996892|588698314|FG011|Expansion Stage 2|Physician Decision|0|||
162999689|NCT00996892|588698315|FG012|Expansion Stage 2|Physician Decision|0|||
162999690|NCT00996892|588698316|FG013|Expansion Stage 2|Physician Decision|0|||
162999691|NCT00996892|588698317|FG014|Expansion Stage 2|Physician Decision|0|||
162999692|NCT00996892|588698318|FG015|Expansion Stage 2|Physician Decision|0|||
162999693|NCT00996892|588698319|FG016|Expansion Stage 2|Physician Decision|0|||
162999694|NCT00996892|588698320|FG017|Expansion Stage 2|Physician Decision|0|||
162999695|NCT00996892|588698321|FG018|Expansion Stage 2|Physician Decision|1|||
162999696|NCT00996892|588698322|FG019|Expansion Stage 2|Physician Decision|0|||
162999697|NCT00996892|588698303|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
162999698|NCT00996892|588698304|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
162999699|NCT00996892|588698305|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
163324946|NCT03782116|589901441|FG001|Completed Intervetion|Lost to Follow-up|7|||
162999700|NCT00996892|588698306|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
162999701|NCT00996892|588698307|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
162999702|NCT00996892|588698308|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
162999703|NCT00996892|588698309|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
162999704|NCT00996892|588698310|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
162999705|NCT00996892|588698311|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
162999706|NCT00996892|588698312|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
162999707|NCT00996892|588698313|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
162999708|NCT00996892|588698314|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
162999709|NCT00996892|588698315|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
162999710|NCT00996892|588698316|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
162999711|NCT00996892|588698317|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
162999712|NCT00996892|588698318|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
162999713|NCT00996892|588698319|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
162999714|NCT00996892|588698320|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
162999715|NCT00996892|588698321|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
162999716|NCT00996892|588698322|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
162999717|NCT00996892|588698303|FG000|Expansion Stage 2|Disease Progression|0|||
162999718|NCT00996892|588698304|FG001|Expansion Stage 2|Disease Progression|0|||
162999719|NCT00996892|588698305|FG002|Expansion Stage 2|Disease Progression|0|||
162999720|NCT00996892|588698306|FG003|Expansion Stage 2|Disease Progression|0|||
162999721|NCT00996892|588698307|FG004|Expansion Stage 2|Disease Progression|0|||
162999722|NCT00996892|588698308|FG005|Expansion Stage 2|Disease Progression|0|||
162999723|NCT00996892|588698309|FG006|Expansion Stage 2|Disease Progression|0|||
162999724|NCT00996892|588698310|FG007|Expansion Stage 2|Disease Progression|0|||
162999725|NCT00996892|588698311|FG008|Expansion Stage 2|Disease Progression|0|||
162999726|NCT00996892|588698312|FG009|Expansion Stage 2|Disease Progression|0|||
162999727|NCT00996892|588698313|FG010|Expansion Stage 2|Disease Progression|0|||
162999728|NCT00996892|588698314|FG011|Expansion Stage 2|Disease Progression|0|||
162999729|NCT00996892|588698315|FG012|Expansion Stage 2|Disease Progression|0|||
162999730|NCT00996892|588698316|FG013|Expansion Stage 2|Disease Progression|0|||
162999731|NCT00996892|588698317|FG014|Expansion Stage 2|Disease Progression|0|||
162999732|NCT00996892|588698318|FG015|Expansion Stage 2|Disease Progression|0|||
162999733|NCT00996892|588698319|FG016|Expansion Stage 2|Disease Progression|0|||
162999734|NCT00996892|588698320|FG017|Expansion Stage 2|Disease Progression|0|||
162999735|NCT00996892|588698321|FG018|Expansion Stage 2|Disease Progression|28|||
162999736|NCT00996892|588698322|FG019|Expansion Stage 2|Disease Progression|0|||
162999737|NCT00996892|588698303|FG000|Expansion Stage 2A|Adverse Event|0|||
162999738|NCT00996892|588698304|FG001|Expansion Stage 2A|Adverse Event|0|||
162999739|NCT00996892|588698305|FG002|Expansion Stage 2A|Adverse Event|0|||
162999740|NCT00996892|588698306|FG003|Expansion Stage 2A|Adverse Event|0|||
162999741|NCT00996892|588698307|FG004|Expansion Stage 2A|Adverse Event|0|||
162999742|NCT00996892|588698308|FG005|Expansion Stage 2A|Adverse Event|0|||
162999743|NCT00996892|588698309|FG006|Expansion Stage 2A|Adverse Event|0|||
162999744|NCT00996892|588698310|FG007|Expansion Stage 2A|Adverse Event|0|||
162999745|NCT00996892|588698311|FG008|Expansion Stage 2A|Adverse Event|0|||
162999746|NCT00996892|588698312|FG009|Expansion Stage 2A|Adverse Event|0|||
162999747|NCT00996892|588698313|FG010|Expansion Stage 2A|Adverse Event|0|||
162999748|NCT00996892|588698314|FG011|Expansion Stage 2A|Adverse Event|0|||
162999749|NCT00996892|588698315|FG012|Expansion Stage 2A|Adverse Event|0|||
162999750|NCT00996892|588698316|FG013|Expansion Stage 2A|Adverse Event|0|||
162999751|NCT00996892|588698317|FG014|Expansion Stage 2A|Adverse Event|0|||
162999752|NCT00996892|588698318|FG015|Expansion Stage 2A|Adverse Event|0|||
162999753|NCT00996892|588698319|FG016|Expansion Stage 2A|Adverse Event|0|||
162999754|NCT00996892|588698320|FG017|Expansion Stage 2A|Adverse Event|0|||
162999755|NCT00996892|588698321|FG018|Expansion Stage 2A|Adverse Event|0|||
162999756|NCT00996892|588698322|FG019|Expansion Stage 2A|Adverse Event|8|||
162999757|NCT00996892|588698303|FG000|Expansion Stage 2A|Physician Decision|0|||
162999758|NCT00996892|588698304|FG001|Expansion Stage 2A|Physician Decision|0|||
162999759|NCT00996892|588698305|FG002|Expansion Stage 2A|Physician Decision|0|||
162999760|NCT00996892|588698306|FG003|Expansion Stage 2A|Physician Decision|0|||
162999761|NCT00996892|588698307|FG004|Expansion Stage 2A|Physician Decision|0|||
162999762|NCT00996892|588698308|FG005|Expansion Stage 2A|Physician Decision|0|||
162999763|NCT00996892|588698309|FG006|Expansion Stage 2A|Physician Decision|0|||
162999764|NCT00996892|588698310|FG007|Expansion Stage 2A|Physician Decision|0|||
162999765|NCT00996892|588698311|FG008|Expansion Stage 2A|Physician Decision|0|||
162999766|NCT00996892|588698312|FG009|Expansion Stage 2A|Physician Decision|0|||
163324947|NCT03782116|589901440|FG000|Completed Intervetion|Withdrawal by Subject|6|||
163324948|NCT03782116|589901441|FG001|Completed Intervetion|Withdrawal by Subject|5|||
163324949|NCT03782116|589901440|FG000|Included in Analysis|Protocol Violation|5|||
163324950|NCT03782116|589901441|FG001|Included in Analysis|Protocol Violation|5|||
163324951|NCT04908514|589901442|FG000|Overall Study|Lost to Follow-up|2|||
162999767|NCT00996892|588698313|FG010|Expansion Stage 2A|Physician Decision|0|||
162999768|NCT00996892|588698314|FG011|Expansion Stage 2A|Physician Decision|0|||
162999769|NCT00996892|588698315|FG012|Expansion Stage 2A|Physician Decision|0|||
162999770|NCT00996892|588698316|FG013|Expansion Stage 2A|Physician Decision|0|||
162999771|NCT00996892|588698317|FG014|Expansion Stage 2A|Physician Decision|0|||
162999772|NCT00996892|588698318|FG015|Expansion Stage 2A|Physician Decision|0|||
162999773|NCT00996892|588698319|FG016|Expansion Stage 2A|Physician Decision|0|||
162999774|NCT00996892|588698320|FG017|Expansion Stage 2A|Physician Decision|0|||
162999775|NCT00996892|588698321|FG018|Expansion Stage 2A|Physician Decision|0|||
162999776|NCT00996892|588698322|FG019|Expansion Stage 2A|Physician Decision|2|||
163212964|NCT01729754|589494319|FG006|Part 3|Lack of Efficacy|0|||
163212965|NCT01729754|589494320|FG007|Part 3|Lack of Efficacy|0|||
162999777|NCT00996892|588698303|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
162999778|NCT00996892|588698304|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
162999779|NCT00996892|588698305|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
162999780|NCT00996892|588698306|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
162999781|NCT00996892|588698307|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
162999782|NCT00996892|588698308|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
162999783|NCT00996892|588698309|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
162999784|NCT00996892|588698310|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
162999785|NCT00996892|588698311|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
162999786|NCT00996892|588698312|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
162999787|NCT00996892|588698313|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
162999788|NCT00996892|588698314|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
162999789|NCT00996892|588698315|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
162999790|NCT00996892|588698316|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
162999791|NCT00996892|588698317|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
162999792|NCT00996892|588698318|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
162999793|NCT00996892|588698319|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
162999794|NCT00996892|588698320|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
162999795|NCT00996892|588698321|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
162999796|NCT00996892|588698322|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
162999797|NCT00996892|588698303|FG000|Expansion Stage 2A|Disease Progression|0|||
162999798|NCT00996892|588698304|FG001|Expansion Stage 2A|Disease Progression|0|||
162999799|NCT00996892|588698305|FG002|Expansion Stage 2A|Disease Progression|0|||
162999800|NCT00996892|588698306|FG003|Expansion Stage 2A|Disease Progression|0|||
162999801|NCT00996892|588698307|FG004|Expansion Stage 2A|Disease Progression|0|||
162999802|NCT00996892|588698308|FG005|Expansion Stage 2A|Disease Progression|0|||
162999803|NCT00996892|588698309|FG006|Expansion Stage 2A|Disease Progression|0|||
162999804|NCT00996892|588698310|FG007|Expansion Stage 2A|Disease Progression|0|||
162999805|NCT00996892|588698311|FG008|Expansion Stage 2A|Disease Progression|0|||
162999806|NCT00996892|588698312|FG009|Expansion Stage 2A|Disease Progression|0|||
162999807|NCT00996892|588698313|FG010|Expansion Stage 2A|Disease Progression|0|||
162999808|NCT00996892|588698314|FG011|Expansion Stage 2A|Disease Progression|0|||
162999809|NCT00996892|588698315|FG012|Expansion Stage 2A|Disease Progression|0|||
162999810|NCT00996892|588698316|FG013|Expansion Stage 2A|Disease Progression|0|||
162999811|NCT00996892|588698317|FG014|Expansion Stage 2A|Disease Progression|0|||
162999812|NCT00996892|588698318|FG015|Expansion Stage 2A|Disease Progression|0|||
162999813|NCT00996892|588698319|FG016|Expansion Stage 2A|Disease Progression|0|||
162999814|NCT00996892|588698320|FG017|Expansion Stage 2A|Disease Progression|0|||
162999815|NCT00996892|588698321|FG018|Expansion Stage 2A|Disease Progression|0|||
162999816|NCT00996892|588698322|FG019|Expansion Stage 2A|Disease Progression|31|||
162999817|NCT00993421|588698323|FG000|Overall Study|Adverse Event|2|||
162999818|NCT00993421|588698324|FG001|Overall Study|Adverse Event|7|||
162999819|NCT00993421|588698325|FG002|Overall Study|Adverse Event|6|||
162999820|NCT00993421|588698326|FG003|Overall Study|Adverse Event|9|||
162999821|NCT00993421|588698327|FG004|Overall Study|Adverse Event|5|||
162999822|NCT00993421|588698328|FG005|Overall Study|Adverse Event|7|||
162999823|NCT00993421|588698329|FG006|Overall Study|Adverse Event|1|||
162999824|NCT00993421|588698323|FG000|Overall Study|Sponsor Decision|36|||
162999825|NCT00993421|588698324|FG001|Overall Study|Sponsor Decision|31|||
162999826|NCT00993421|588698325|FG002|Overall Study|Sponsor Decision|28|||
163060579|NCT04428151|588929945|FG000|Overall Study|Death|100|||
163212966|NCT01729754|589494321|FG008|Part 3|Lack of Efficacy|0|||
163212967|NCT01729754|589494322|FG009|Part 3|Lack of Efficacy|4|||
163212968|NCT01729754|589494313|FG000|Part 3|Lost to Follow-up|0|||
163212969|NCT01729754|589494314|FG001|Part 3|Lost to Follow-up|1|||
163212970|NCT01729754|589494315|FG002|Part 3|Lost to Follow-up|2|||
163212971|NCT01729754|589494316|FG003|Part 3|Lost to Follow-up|0|||
163212972|NCT01729754|589494317|FG004|Part 3|Lost to Follow-up|0|||
162999827|NCT00993421|588698326|FG003|Overall Study|Sponsor Decision|30|||
162999828|NCT00993421|588698327|FG004|Overall Study|Sponsor Decision|38|||
162999829|NCT00993421|588698328|FG005|Overall Study|Sponsor Decision|30|||
162999830|NCT00993421|588698329|FG006|Overall Study|Sponsor Decision|29|||
163212973|NCT01729754|589494318|FG005|Part 3|Lost to Follow-up|3|||
163212974|NCT01729754|589494319|FG006|Part 3|Lost to Follow-up|0|||
163212975|NCT01729754|589494320|FG007|Part 3|Lost to Follow-up|0|||
163212976|NCT01729754|589494321|FG008|Part 3|Lost to Follow-up|1|||
162999831|NCT00993421|588698323|FG000|Overall Study|Lost to Follow-up|3|||
162999832|NCT00993421|588698324|FG001|Overall Study|Lost to Follow-up|5|||
162999833|NCT00993421|588698325|FG002|Overall Study|Lost to Follow-up|5|||
162999834|NCT00993421|588698326|FG003|Overall Study|Lost to Follow-up|0|||
162999835|NCT00993421|588698327|FG004|Overall Study|Lost to Follow-up|0|||
162999836|NCT00993421|588698328|FG005|Overall Study|Lost to Follow-up|0|||
162999837|NCT00993421|588698329|FG006|Overall Study|Lost to Follow-up|6|||
163324952|NCT04908514|589901442|FG000|Overall Study|Withdrawal by Subject|1|||
163324953|NCT00945724|589901443|FG000|Overall Study|Withdrawal by Subject|2|||
163324954|NCT00945724|589901443|FG000|Overall Study|Physician Decision|1|||
163212977|NCT01729754|589494322|FG009|Part 3|Lost to Follow-up|0|||
162999838|NCT00993421|588698323|FG000|Overall Study|Withdrawal by Subject|3|||
162999839|NCT00993421|588698324|FG001|Overall Study|Withdrawal by Subject|2|||
162999840|NCT00993421|588698325|FG002|Overall Study|Withdrawal by Subject|3|||
162999841|NCT00993421|588698326|FG003|Overall Study|Withdrawal by Subject|3|||
162999842|NCT00993421|588698327|FG004|Overall Study|Withdrawal by Subject|3|||
162999843|NCT00993421|588698328|FG005|Overall Study|Withdrawal by Subject|5|||
162999844|NCT00993421|588698329|FG006|Overall Study|Withdrawal by Subject|3|||
162999845|NCT00993421|588698323|FG000|Overall Study|Death|0|||
162999846|NCT00993421|588698324|FG001|Overall Study|Death|0|||
162999847|NCT00993421|588698325|FG002|Overall Study|Death|0|||
162999848|NCT00993421|588698326|FG003|Overall Study|Death|0|||
162999849|NCT00993421|588698327|FG004|Overall Study|Death|0|||
162999850|NCT00993421|588698328|FG005|Overall Study|Death|0|||
162999851|NCT00993421|588698329|FG006|Overall Study|Death|1|||
162999852|NCT00993421|588698323|FG000|Overall Study|Entry Criteria Exclusion|0|||
162999853|NCT00993421|588698324|FG001|Overall Study|Entry Criteria Exclusion|0|||
162999854|NCT00993421|588698325|FG002|Overall Study|Entry Criteria Exclusion|1|||
162999855|NCT00993421|588698326|FG003|Overall Study|Entry Criteria Exclusion|3|||
162999856|NCT00993421|588698327|FG004|Overall Study|Entry Criteria Exclusion|0|||
162999857|NCT00993421|588698328|FG005|Overall Study|Entry Criteria Exclusion|1|||
162999858|NCT00993421|588698329|FG006|Overall Study|Entry Criteria Exclusion|0|||
162999859|NCT00993421|588698323|FG000|Overall Study|Physician Decision|0|||
162999860|NCT00993421|588698324|FG001|Overall Study|Physician Decision|0|||
162999861|NCT00993421|588698325|FG002|Overall Study|Physician Decision|0|||
162999862|NCT00993421|588698326|FG003|Overall Study|Physician Decision|0|||
162999863|NCT00993421|588698327|FG004|Overall Study|Physician Decision|0|||
162999864|NCT00993421|588698328|FG005|Overall Study|Physician Decision|1|||
162999865|NCT00993421|588698329|FG006|Overall Study|Physician Decision|1|||
162999866|NCT00993421|588698323|FG000|Overall Study|Protocol Violation|0|||
162999867|NCT00993421|588698324|FG001|Overall Study|Protocol Violation|0|||
162999868|NCT00993421|588698325|FG002|Overall Study|Protocol Violation|0|||
162999869|NCT00993421|588698326|FG003|Overall Study|Protocol Violation|0|||
162999870|NCT00993421|588698327|FG004|Overall Study|Protocol Violation|0|||
162999871|NCT00993421|588698328|FG005|Overall Study|Protocol Violation|2|||
162999872|NCT00993421|588698329|FG006|Overall Study|Protocol Violation|1|||
162999873|NCT02759692|588698330|FG000|Period 1|Test article no longer available|1|||
162999874|NCT02759692|588698331|FG001|Period 1|Test article no longer available|1|||
162999875|NCT02759692|588698330|FG000|Period 1|No longer meets eligibility criteria.|1|||
162999876|NCT02759692|588698331|FG001|Period 1|No longer meets eligibility criteria.|0|||
162999877|NCT02759692|588698330|FG000|Period 1|Miss-Randomized|1|||
162999878|NCT02759692|588698331|FG001|Period 1|Miss-Randomized|1|||
162999879|NCT02759692|588698330|FG000|Period 2|Lost to Follow-up|1|||
162999880|NCT02759692|588698331|FG001|Period 2|Lost to Follow-up|0|||
162999881|NCT02759692|588698330|FG000|Period 2|Test article no longer available|0|||
162999882|NCT02759692|588698331|FG001|Period 2|Test article no longer available|1|||
162999883|NCT05314816|588698337|FG000|Overall Study|Lost to Follow-up|5|||
162999884|NCT05314816|588698338|FG001|Overall Study|Lost to Follow-up|0|||
162999885|NCT05314816|588698339|FG002|Overall Study|Lost to Follow-up|1|||
162999886|NCT05314816|588698337|FG000|Overall Study|Protocol Violation|13|||
162999887|NCT05314816|588698338|FG001|Overall Study|Protocol Violation|8|||
162999888|NCT05314816|588698339|FG002|Overall Study|Protocol Violation|0|||
162999889|NCT04042376|588698340|FG000|Overall Study|Withdrawal by Subject|1|||
162999890|NCT04042376|588698340|FG000|Overall Study|Death|3|||
162999891|NCT02551666|588698341|FG000|Overall Study|Withdrawal by Subject|1|||
162999892|NCT02551666|588698342|FG001|Overall Study|Withdrawal by Subject|3|||
162999893|NCT05422625|588698343|FG000|Overall Study|Withdrawal by Subject|1|||
162999894|NCT05422625|588698344|FG001|Overall Study|Withdrawal by Subject|0|||
162999895|NCT01059786|588700173|FG000|Overall Study|Did not receive 6 cycles.|0|||
162999896|NCT01059786|588700174|FG001|Overall Study|Did not receive 6 cycles.|0|||
162999897|NCT01059786|588700175|FG002|Overall Study|Did not receive 6 cycles.|4|||
162999898|NCT01059786|588700176|FG003|Overall Study|Did not receive 6 cycles.|1|||
162999899|NCT01059786|588700177|FG004|Overall Study|Did not receive 6 cycles.|0|||
162999900|NCT04205812|588700178|FG000|Randomized Treatment Period|Ongoing|28|||
162999901|NCT04205812|588700179|FG001|Randomized Treatment Period|Ongoing|138|||
162999902|NCT04205812|588700178|FG000|Randomized Treatment Period|Death|94|||
162999903|NCT04205812|588700179|FG001|Randomized Treatment Period|Death|226|||
162999904|NCT04205812|588700178|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
163324955|NCT00945724|589901443|FG000|Overall Study|Adverse Event|5|||
162999905|NCT04205812|588700179|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
162999906|NCT04205812|588700178|FG000|Randomized Treatment Period|Physician Decision|1|||
162999907|NCT04205812|588700179|FG001|Randomized Treatment Period|Physician Decision|4|||
162999908|NCT04205812|588700178|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
162999909|NCT04205812|588700179|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
162999910|NCT04205812|588700178|FG000|Randomized Treatment Period|Progressive Disease|0|||
162999911|NCT04205812|588700179|FG001|Randomized Treatment Period|Progressive Disease|1|||
162999912|NCT04205812|588700178|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
162999913|NCT04205812|588700179|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
163060580|NCT04428151|588929946|FG001|Overall Study|Death|86|||
162999914|NCT04205812|588700178|FG000|Monotherapy Treatment Period|Ongoing|17|||
162999915|NCT04205812|588700179|FG001|Monotherapy Treatment Period|Ongoing|0|||
162999916|NCT04205812|588700178|FG000|Monotherapy Treatment Period|Death|39|||
162999917|NCT04205812|588700179|FG001|Monotherapy Treatment Period|Death|0|||
162999918|NCT04205812|588700178|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
162999919|NCT04205812|588700179|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
162999920|NCT04205812|588700178|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
162999921|NCT04205812|588700179|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
162999922|NCT00371033|588700180|FG000|Overall Study|Lost to Follow-up|3|||
162999923|NCT00371033|588700181|FG001|Overall Study|Lost to Follow-up|2|||
162999924|NCT00371033|588700180|FG000|Overall Study|No longer interested|2|||
162999925|NCT00371033|588700181|FG001|Overall Study|No longer interested|0|||
162999926|NCT00371033|588700180|FG000|Overall Study|Uknown|3|||
162999927|NCT00371033|588700181|FG001|Overall Study|Uknown|1|||
162999928|NCT02514447|588700182|FG000|Overall Study|Withdrawal by Subject|3|||
162999929|NCT02514447|588700183|FG001|Overall Study|Withdrawal by Subject|1|||
162999930|NCT02514447|588700184|FG002|Overall Study|Withdrawal by Subject|1|||
162999931|NCT02514447|588700185|FG003|Overall Study|Withdrawal by Subject|0|||
162999932|NCT02514447|588700186|FG004|Overall Study|Withdrawal by Subject|0|||
162999933|NCT02514447|588700187|FG005|Overall Study|Withdrawal by Subject|0|||
162999934|NCT02514447|588700188|FG006|Overall Study|Withdrawal by Subject|0|||
162999935|NCT02514447|588700189|FG007|Overall Study|Withdrawal by Subject|1|||
162999936|NCT02514447|588700190|FG008|Overall Study|Withdrawal by Subject|1|||
162999937|NCT02514447|588700182|FG000|Overall Study|Death|24|||
162999938|NCT02514447|588700183|FG001|Overall Study|Death|28|||
162999939|NCT02514447|588700184|FG002|Overall Study|Death|29|||
162999940|NCT02514447|588700185|FG003|Overall Study|Death|0|||
162999941|NCT02514447|588700186|FG004|Overall Study|Death|3|||
162999942|NCT02514447|588700187|FG005|Overall Study|Death|4|||
162999943|NCT02514447|588700188|FG006|Overall Study|Death|8|||
162999944|NCT02514447|588700189|FG007|Overall Study|Death|6|||
162999945|NCT02514447|588700190|FG008|Overall Study|Death|5|||
162999946|NCT02514447|588700182|FG000|Overall Study|Lost to Follow-up|1|||
162999947|NCT02514447|588700183|FG001|Overall Study|Lost to Follow-up|0|||
162999948|NCT02514447|588700184|FG002|Overall Study|Lost to Follow-up|0|||
162999949|NCT02514447|588700185|FG003|Overall Study|Lost to Follow-up|0|||
162999950|NCT02514447|588700186|FG004|Overall Study|Lost to Follow-up|0|||
162999951|NCT02514447|588700187|FG005|Overall Study|Lost to Follow-up|0|||
162999952|NCT02514447|588700188|FG006|Overall Study|Lost to Follow-up|0|||
162999953|NCT02514447|588700189|FG007|Overall Study|Lost to Follow-up|0|||
162999954|NCT02514447|588700190|FG008|Overall Study|Lost to Follow-up|1|||
162999955|NCT02514447|588700182|FG000|Overall Study|Sponsor Termination of Study|0|||
162999956|NCT02514447|588700183|FG001|Overall Study|Sponsor Termination of Study|1|||
162999957|NCT02514447|588700184|FG002|Overall Study|Sponsor Termination of Study|1|||
162999958|NCT02514447|588700185|FG003|Overall Study|Sponsor Termination of Study|0|||
162999959|NCT02514447|588700186|FG004|Overall Study|Sponsor Termination of Study|0|||
162999960|NCT02514447|588700187|FG005|Overall Study|Sponsor Termination of Study|0|||
162999961|NCT02514447|588700188|FG006|Overall Study|Sponsor Termination of Study|0|||
162999962|NCT02514447|588700189|FG007|Overall Study|Sponsor Termination of Study|0|||
162999963|NCT02514447|588700190|FG008|Overall Study|Sponsor Termination of Study|0|||
162999964|NCT02514447|588700182|FG000|Overall Study|Study completion per Investigator|1|||
162999965|NCT02514447|588700183|FG001|Overall Study|Study completion per Investigator|0|||
162999966|NCT02514447|588700184|FG002|Overall Study|Study completion per Investigator|1|||
162999967|NCT02514447|588700185|FG003|Overall Study|Study completion per Investigator|2|||
162999968|NCT02514447|588700186|FG004|Overall Study|Study completion per Investigator|0|||
162999969|NCT02514447|588700187|FG005|Overall Study|Study completion per Investigator|0|||
162999970|NCT02514447|588700188|FG006|Overall Study|Study completion per Investigator|0|||
162999971|NCT02514447|588700189|FG007|Overall Study|Study completion per Investigator|0|||
162999972|NCT02514447|588700190|FG008|Overall Study|Study completion per Investigator|1|||
162999973|NCT03130777|588700195|FG000|Overall Study|Death|0|||
162999974|NCT03130777|588700196|FG001|Overall Study|Death|1|||
162999975|NCT03130777|588700195|FG000|Overall Study|Did not meet eligibility criteria|1|||
162999976|NCT03130777|588700196|FG001|Overall Study|Did not meet eligibility criteria|0|||
162999977|NCT05929651|588700200|FG000|Overall Study|Protocol Deviation|1|||
162999978|NCT05929651|588700200|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
163060581|NCT04428151|588929947|FG002|Overall Study|Death|57|||
162999979|NCT05026177|588700201|FG000|Overall Study|Adverse Event|33|||
163060582|NCT04428151|588929945|FG000|Overall Study|Lost to Follow-up|1|||
162999980|NCT05026177|588700202|FG001|Overall Study|Adverse Event|33|||
162999981|NCT05026177|588700203|FG002|Overall Study|Adverse Event|17|||
162999982|NCT05026177|588700201|FG000|Overall Study|Lost to Follow-up|7|||
162999983|NCT05026177|588700202|FG001|Overall Study|Lost to Follow-up|6|||
162999984|NCT05026177|588700203|FG002|Overall Study|Lost to Follow-up|8|||
162999985|NCT05026177|588700201|FG000|Overall Study|Noncompliance with study drug|6|||
162999986|NCT05026177|588700202|FG001|Overall Study|Noncompliance with study drug|2|||
162999987|NCT05026177|588700203|FG002|Overall Study|Noncompliance with study drug|1|||
163404359|NCT01157078|590191914|FG001|Overall Study|Condition under investigation worsened|1|||
162999988|NCT05026177|588700201|FG000|Overall Study|Physician Decision|4|||
162999989|NCT05026177|588700202|FG001|Overall Study|Physician Decision|1|||
162999990|NCT05026177|588700203|FG002|Overall Study|Physician Decision|0|||
162999991|NCT05026177|588700201|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
162999992|NCT05026177|588700202|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
162999993|NCT05026177|588700203|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
162999994|NCT05026177|588700201|FG000|Overall Study|Withdrawal by Subject|53|||
162999995|NCT05026177|588700202|FG001|Overall Study|Withdrawal by Subject|51|||
162999996|NCT05026177|588700203|FG002|Overall Study|Withdrawal by Subject|55|||
162999997|NCT05026177|588700201|FG000|Overall Study|Protocol Violation|0|||
162999998|NCT05026177|588700202|FG001|Overall Study|Protocol Violation|1|||
162999999|NCT05026177|588700203|FG002|Overall Study|Protocol Violation|0|||
163000000|NCT05026177|588700201|FG000|Overall Study|Study terminated by sponsor|70|||
163000001|NCT05026177|588700202|FG001|Overall Study|Study terminated by sponsor|74|||
163000002|NCT05026177|588700203|FG002|Overall Study|Study terminated by sponsor|67|||
163000003|NCT05026177|588700201|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
163000004|NCT05026177|588700202|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
163000005|NCT05026177|588700203|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
163000006|NCT05026177|588700201|FG000|Overall Study|Starting alternative treatment|0|||
163000007|NCT05026177|588700202|FG001|Overall Study|Starting alternative treatment|1|||
163000008|NCT05026177|588700203|FG002|Overall Study|Starting alternative treatment|1|||
163000009|NCT05026177|588700201|FG000|Overall Study|Noncompliance with study procedures|0|||
163000010|NCT05026177|588700202|FG001|Overall Study|Noncompliance with study procedures|1|||
163000011|NCT05026177|588700203|FG002|Overall Study|Noncompliance with study procedures|1|||
163000012|NCT05026177|588700201|FG000|Overall Study|Met stopping criteria|0|||
163000013|NCT05026177|588700202|FG001|Overall Study|Met stopping criteria|0|||
163000014|NCT05026177|588700203|FG002|Overall Study|Met stopping criteria|1|||
163000015|NCT05026177|588700201|FG000|Overall Study|Health issues preventing continuation|0|||
163000016|NCT05026177|588700202|FG001|Overall Study|Health issues preventing continuation|0|||
163000017|NCT05026177|588700203|FG002|Overall Study|Health issues preventing continuation|1|||
163000018|NCT05026177|588700201|FG000|Overall Study|Randomized in error, not treated|0|||
163000019|NCT05026177|588700202|FG001|Overall Study|Randomized in error, not treated|0|||
163000020|NCT05026177|588700203|FG002|Overall Study|Randomized in error, not treated|2|||
163000021|NCT05109611|588700206|FG000|Overall Study|Adverse Event|13|||
163000022|NCT05109611|588700207|FG001|Overall Study|Adverse Event|10|||
163000023|NCT05109611|588700206|FG000|Overall Study|Withdrawal by Subject|1|||
163000024|NCT05109611|588700207|FG001|Overall Study|Withdrawal by Subject|0|||
163000025|NCT05109611|588700206|FG000|Overall Study|Lost to Follow-up|1|||
163000026|NCT05109611|588700207|FG001|Overall Study|Lost to Follow-up|2|||
163000027|NCT05109611|588700206|FG000|Overall Study|Protocol Violation|0|||
163000028|NCT05109611|588700207|FG001|Overall Study|Protocol Violation|4|||
163000029|NCT05109611|588700206|FG000|Overall Study|Information unavailable|1|||
163000030|NCT05109611|588700207|FG001|Overall Study|Information unavailable|1|||
163000031|NCT03203850|588700211|FG000|Overall Study|Subject/guardian decision|4|||
163000032|NCT03203850|588700212|FG001|Overall Study|Subject/guardian decision|3|||
163000033|NCT03203850|588700211|FG000|Overall Study|Adverse Event|3|||
163000034|NCT03203850|588700212|FG001|Overall Study|Adverse Event|0|||
163000035|NCT03203850|588700211|FG000|Overall Study|Death|1|||
163000036|NCT03203850|588700212|FG001|Overall Study|Death|0|||
163000037|NCT02717455|588700213|FG000|Overall Study|Adverse Event|1|||
163000038|NCT02717455|588700214|FG001|Overall Study|Adverse Event|0|||
163000039|NCT02717455|588700215|FG002|Overall Study|Adverse Event|0|||
163000040|NCT02717455|588700216|FG003|Overall Study|Adverse Event|2|||
163000041|NCT02717455|588700217|FG004|Overall Study|Adverse Event|2|||
163060583|NCT04428151|588929946|FG001|Overall Study|Lost to Follow-up|1|||
163060584|NCT04428151|588929947|FG002|Overall Study|Lost to Follow-up|0|||
163404360|NCT01157078|590191913|FG000|Overall Study|Lack of Efficacy|2|||
163404361|NCT01157078|590191914|FG001|Overall Study|Lack of Efficacy|0|||
163404362|NCT01157078|590191913|FG000|Overall Study|Study-specific withdrawal criteria|2|||
163404363|NCT01157078|590191914|FG001|Overall Study|Study-specific withdrawal criteria|2|||
163000042|NCT02717455|588700218|FG005|Overall Study|Adverse Event|2|||
163000043|NCT02717455|588700213|FG000|Overall Study|Withdrawal by Subject|1|||
163000044|NCT02717455|588700214|FG001|Overall Study|Withdrawal by Subject|1|||
163000045|NCT02717455|588700215|FG002|Overall Study|Withdrawal by Subject|0|||
163000046|NCT02717455|588700216|FG003|Overall Study|Withdrawal by Subject|2|||
163000047|NCT02717455|588700217|FG004|Overall Study|Withdrawal by Subject|2|||
163000048|NCT02717455|588700218|FG005|Overall Study|Withdrawal by Subject|1|||
163000049|NCT02717455|588700213|FG000|Overall Study|Death|1|||
163000050|NCT02717455|588700214|FG001|Overall Study|Death|0|||
163000051|NCT02717455|588700215|FG002|Overall Study|Death|0|||
163000052|NCT02717455|588700216|FG003|Overall Study|Death|0|||
163000053|NCT02717455|588700217|FG004|Overall Study|Death|1|||
163000054|NCT02717455|588700218|FG005|Overall Study|Death|0|||
163000055|NCT02717455|588700213|FG000|Overall Study|Did not receive study drug|0|||
163404364|NCT01157078|590191913|FG000|Overall Study|Lost to Follow-up|7|||
163000056|NCT02717455|588700214|FG001|Overall Study|Did not receive study drug|0|||
163000057|NCT02717455|588700215|FG002|Overall Study|Did not receive study drug|0|||
163000058|NCT02717455|588700216|FG003|Overall Study|Did not receive study drug|1|||
163000059|NCT02717455|588700217|FG004|Overall Study|Did not receive study drug|0|||
163212978|NCT01729754|589494313|FG000|Part 3|Physician Decision|0|||
163212979|NCT01729754|589494314|FG001|Part 3|Physician Decision|0|||
163212980|NCT01729754|589494315|FG002|Part 3|Physician Decision|1|||
163212981|NCT01729754|589494316|FG003|Part 3|Physician Decision|0|||
163212982|NCT01729754|589494317|FG004|Part 3|Physician Decision|0|||
163212983|NCT01729754|589494318|FG005|Part 3|Physician Decision|0|||
163212984|NCT01729754|589494319|FG006|Part 3|Physician Decision|0|||
163212985|NCT01729754|589494320|FG007|Part 3|Physician Decision|0|||
163212986|NCT01729754|589494321|FG008|Part 3|Physician Decision|0|||
163212987|NCT01729754|589494322|FG009|Part 3|Physician Decision|0|||
163212988|NCT01729754|589494313|FG000|Part 3|Withdrawal by Subject|0|||
163212989|NCT01729754|589494314|FG001|Part 3|Withdrawal by Subject|4|||
163212990|NCT01729754|589494315|FG002|Part 3|Withdrawal by Subject|1|||
163212991|NCT01729754|589494316|FG003|Part 3|Withdrawal by Subject|0|||
163212992|NCT01729754|589494317|FG004|Part 3|Withdrawal by Subject|2|||
163212993|NCT01729754|589494318|FG005|Part 3|Withdrawal by Subject|1|||
163212994|NCT01729754|589494319|FG006|Part 3|Withdrawal by Subject|0|||
163212995|NCT01729754|589494320|FG007|Part 3|Withdrawal by Subject|2|||
163212996|NCT01729754|589494321|FG008|Part 3|Withdrawal by Subject|0|||
163212997|NCT01729754|589494322|FG009|Part 3|Withdrawal by Subject|0|||
163212998|NCT01729754|589494313|FG000|Part 3|Other Protocol Specified Criteria|0|||
163212999|NCT01729754|589494314|FG001|Part 3|Other Protocol Specified Criteria|0|||
163213000|NCT01729754|589494315|FG002|Part 3|Other Protocol Specified Criteria|0|||
163213001|NCT01729754|589494316|FG003|Part 3|Other Protocol Specified Criteria|0|||
163213002|NCT01729754|589494317|FG004|Part 3|Other Protocol Specified Criteria|0|||
163213003|NCT01729754|589494318|FG005|Part 3|Other Protocol Specified Criteria|2|||
163213004|NCT01729754|589494319|FG006|Part 3|Other Protocol Specified Criteria|0|||
163213005|NCT01729754|589494320|FG007|Part 3|Other Protocol Specified Criteria|1|||
163213006|NCT01729754|589494321|FG008|Part 3|Other Protocol Specified Criteria|0|||
163213007|NCT01729754|589494322|FG009|Part 3|Other Protocol Specified Criteria|0|||
163213008|NCT01853046|589494323|FG000|Overall Study|Withdrawal by Subject|1|||
163213009|NCT01853046|589494324|FG001|Overall Study|Withdrawal by Subject|1|||
163213010|NCT01853046|589494323|FG000|Overall Study|Adverse Event|4|||
163213011|NCT01853046|589494324|FG001|Overall Study|Adverse Event|2|||
163213012|NCT01853046|589494323|FG000|Overall Study|Disease progression|13|||
163213013|NCT01853046|589494324|FG001|Overall Study|Disease progression|3|||
163213014|NCT03020407|589494326|FG000|Overall Study|Withdrawal by Subject|2|||
163213015|NCT03020407|589494327|FG001|Overall Study|Withdrawal by Subject|1|||
163213016|NCT03020407|589494326|FG000|Overall Study|Lost to Follow-up|2|||
163213017|NCT03020407|589494327|FG001|Overall Study|Lost to Follow-up|3|||
163213018|NCT03020407|589494326|FG000|Overall Study|Protocol Violation|0|||
163213019|NCT03020407|589494327|FG001|Overall Study|Protocol Violation|1|||
163213020|NCT02699554|589494328|FG000|Overall Study|Lost to Follow-up|9|||
163213021|NCT00788151|589494329|FG000|Overall Study|Other adverse event|0|||
163213022|NCT00788151|589494330|FG001|Overall Study|Other adverse event|2|||
163213023|NCT00788151|589494329|FG000|Overall Study|Protocol Violation|0|||
163213024|NCT00788151|589494330|FG001|Overall Study|Protocol Violation|1|||
163213025|NCT00788151|589494329|FG000|Overall Study|Withdrawal by Subject|13|||
163213026|NCT00788151|589494330|FG001|Overall Study|Withdrawal by Subject|6|||
163213027|NCT00788151|589494329|FG000|Overall Study|Enrolled but not treated|1|||
163213028|NCT00788151|589494330|FG001|Overall Study|Enrolled but not treated|1|||
163213029|NCT00503009|589494331|FG000|Overall Study|Protocol Violation|1|||
163213030|NCT00503009|589494332|FG001|Overall Study|Protocol Violation|0|||
163213031|NCT00503009|589494333|FG002|Overall Study|Protocol Violation|1|||
163213032|NCT00503009|589494331|FG000|Overall Study|Withdrawal by Subject|0|||
163213033|NCT00503009|589494332|FG001|Overall Study|Withdrawal by Subject|1|||
163213034|NCT00503009|589494333|FG002|Overall Study|Withdrawal by Subject|1|||
163213035|NCT00503009|589494331|FG000|Overall Study|Physician Decision|0|||
163213036|NCT00503009|589494332|FG001|Overall Study|Physician Decision|1|||
163213037|NCT00503009|589494333|FG002|Overall Study|Physician Decision|1|||
163213038|NCT01870583|589494334|FG000|Overall Study|Protocol Violation|0|||
163213039|NCT01870583|589494335|FG001|Overall Study|Protocol Violation|5|||
163213040|NCT01870583|589494336|FG002|Overall Study|Protocol Violation|3|||
163213041|NCT01870583|589494334|FG000|Overall Study|Lost to Follow-up|11|||
163213042|NCT01870583|589494335|FG001|Overall Study|Lost to Follow-up|13|||
163213043|NCT01870583|589494336|FG002|Overall Study|Lost to Follow-up|5|||
163213044|NCT01394523|589494337|FG000|Overall Study|Unable to place block|1|||
163000060|NCT02717455|588700218|FG005|Overall Study|Did not receive study drug|1|||
163000061|NCT02717455|588700213|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
163213045|NCT01394523|589494338|FG001|Overall Study|Unable to place block|0|||
163213046|NCT01394523|589494339|FG002|Overall Study|Unable to place block|0|||
163213047|NCT02389998|589494343|FG000|Overall Study|car accident|1|||
163213048|NCT02389998|589494344|FG001|Overall Study|car accident|0|||
163213049|NCT04741074|589494347|FG000|Overall Study|Withdrawal by Subject|1|||
163213050|NCT04741074|589494348|FG001|Overall Study|Withdrawal by Subject|1|||
163213051|NCT04741074|589494347|FG000|Overall Study|Study terminated prematurely|1|||
163213052|NCT04741074|589494348|FG001|Overall Study|Study terminated prematurely|0|||
163213053|NCT01770379|589494350|FG000|Overall Study|Technical issues|1|||
163213054|NCT01770379|589494351|FG001|Overall Study|Technical issues|0|||
163213055|NCT01770379|589494352|FG002|Overall Study|Technical issues|0|||
163213056|NCT01770379|589494350|FG000|Overall Study|Withdrawal by Subject|7|||
163213057|NCT01770379|589494351|FG001|Overall Study|Withdrawal by Subject|10|||
163213058|NCT01770379|589494352|FG002|Overall Study|Withdrawal by Subject|7|||
163213059|NCT01770379|589494350|FG000|Overall Study|study terminated by sponsor|22|||
163213060|NCT01770379|589494351|FG001|Overall Study|study terminated by sponsor|23|||
163213061|NCT01770379|589494352|FG002|Overall Study|study terminated by sponsor|22|||
163213062|NCT01770379|589494350|FG000|Overall Study|Protocol Violation|0|||
163213063|NCT01770379|589494351|FG001|Overall Study|Protocol Violation|1|||
163213064|NCT01770379|589494352|FG002|Overall Study|Protocol Violation|1|||
163213065|NCT01770379|589494350|FG000|Overall Study|Physician Decision|0|||
163213066|NCT01770379|589494351|FG001|Overall Study|Physician Decision|1|||
163213067|NCT01770379|589494352|FG002|Overall Study|Physician Decision|2|||
163213068|NCT01770379|589494350|FG000|Overall Study|Lost to Follow-up|0|||
163213069|NCT01770379|589494351|FG001|Overall Study|Lost to Follow-up|0|||
163213070|NCT01770379|589494352|FG002|Overall Study|Lost to Follow-up|2|||
163213071|NCT01770379|589494350|FG000|Overall Study|Lack of Efficacy|8|||
163213072|NCT01770379|589494351|FG001|Overall Study|Lack of Efficacy|6|||
163213073|NCT01770379|589494352|FG002|Overall Study|Lack of Efficacy|6|||
163213074|NCT01770379|589494350|FG000|Overall Study|Adverse Event|1|||
163213075|NCT01770379|589494351|FG001|Overall Study|Adverse Event|3|||
163213076|NCT01770379|589494352|FG002|Overall Study|Adverse Event|2|||
163000062|NCT02717455|588700214|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
163000063|NCT02717455|588700215|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
163000064|NCT02717455|588700216|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
163000065|NCT02717455|588700217|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
163000066|NCT02717455|588700218|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
163000067|NCT02717455|588700213|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
163000068|NCT02717455|588700214|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
163000069|NCT02717455|588700215|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
163000070|NCT02717455|588700216|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
163000071|NCT02717455|588700217|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
163000072|NCT02717455|588700218|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
163000073|NCT01433055|588700219|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
163000074|NCT01433055|588700220|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
163000075|NCT01433055|588700219|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
163000076|NCT01433055|588700220|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
163000077|NCT00733005|588700226|FG000|Overall Study|Adverse Event|0|||
163000078|NCT00733005|588700227|FG001|Overall Study|Adverse Event|1|||
163000079|NCT00733005|588700226|FG000|Overall Study|Treatment Failure|0|||
163000080|NCT00733005|588700227|FG001|Overall Study|Treatment Failure|1|||
163000081|NCT00733005|588700226|FG000|Overall Study|Withdrawal by Subject|0|||
163000082|NCT00733005|588700227|FG001|Overall Study|Withdrawal by Subject|1|||
163000083|NCT00733005|588700226|FG000|Overall Study|Protocol Violation|2|||
163000084|NCT00733005|588700227|FG001|Overall Study|Protocol Violation|0|||
163000085|NCT01769456|588700228|FG000|Overall Study|Lost to Follow-up|19|||
163000086|NCT01769456|588700228|FG000|Overall Study|Withdrawal by Subject|3|||
163000087|NCT01769456|588700228|FG000|Overall Study|Did not receive PCC intervention|6|||
163000088|NCT01769456|588700228|FG000|Overall Study|Moved out of the area|3|||
163000089|NCT01769456|588700228|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
163000090|NCT01769456|588700228|FG000|Overall Study|Parental request to youth to withdraw|1|||
163000091|NCT05244122|588700239|FG000|Overall Study|Withdrawal by Subject|318|||
163213077|NCT00778700|589494353|FG000|Overall Study|Adverse Event|6|||
163213078|NCT00778700|589494354|FG001|Overall Study|Adverse Event|1|||
163213079|NCT00778700|589494355|FG002|Overall Study|Adverse Event|3|||
163213080|NCT00778700|589494356|FG003|Overall Study|Adverse Event|5|||
163213081|NCT00778700|589494353|FG000|Overall Study|Protocol Violation|1|||
163213082|NCT00778700|589494354|FG001|Overall Study|Protocol Violation|1|||
163000092|NCT05377749|588700242|FG000|3 Weeks|Lost to Follow-up|2|||
163000093|NCT05377749|588700243|FG001|3 Weeks|Lost to Follow-up|4|||
163000094|NCT05377749|588700242|FG000|3 Weeks|Withdrawal by Subject|1|||
163000095|NCT05377749|588700243|FG001|3 Weeks|Withdrawal by Subject|1|||
163213083|NCT00778700|589494355|FG002|Overall Study|Protocol Violation|0|||
163213084|NCT00778700|589494356|FG003|Overall Study|Protocol Violation|0|||
163213085|NCT00778700|589494353|FG000|Overall Study|Subject Withdrew Consent|6|||
163000096|NCT00886015|588700244|FG000|Overall Study|Death|0|||
163000097|NCT00886015|588700245|FG001|Overall Study|Death|2|||
163213086|NCT00778700|589494354|FG001|Overall Study|Subject Withdrew Consent|4|||
163213087|NCT00778700|589494355|FG002|Overall Study|Subject Withdrew Consent|1|||
163060585|NCT04428151|588929945|FG000|Overall Study|Withdrawal by Subject|2|||
163000098|NCT01692626|588700246|FG000|Overall Study|Death|0|||
163000099|NCT01692626|588700247|FG001|Overall Study|Death|1|||
163000100|NCT01692626|588700246|FG000|Overall Study|Adverse Event|2|||
163000101|NCT01692626|588700247|FG001|Overall Study|Adverse Event|3|||
163000102|NCT01692626|588700246|FG000|Overall Study|Protocol Violation|1|||
163000103|NCT01692626|588700247|FG001|Overall Study|Protocol Violation|2|||
163000104|NCT01692626|588700246|FG000|Overall Study|Withdrawal by Subject|1|||
163000105|NCT01692626|588700247|FG001|Overall Study|Withdrawal by Subject|0|||
163000106|NCT01434810|588700261|FG000|Overall Study|Did not receive treatment|11|||
163000107|NCT01434810|588700262|FG001|Overall Study|Did not receive treatment|3|||
163000108|NCT01434810|588700261|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
163000109|NCT01434810|588700262|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
163000110|NCT02794870|588700264|FG000|Overall Study|Withdrawal by Subject|2|||
163000111|NCT02794870|588700265|FG001|Overall Study|Withdrawal by Subject|0|||
163000112|NCT02540083|588700272|FG000|Overall Study|Withdrawal by Subject|16|||
163000113|NCT02301390|588700273|FG000|Overall Study|Withdrawal by Subject|3|||
163000114|NCT02301390|588700274|FG001|Overall Study|Withdrawal by Subject|5|||
163000115|NCT02301390|588700273|FG000|Overall Study|Protocol Violation|1|||
163000116|NCT02301390|588700274|FG001|Overall Study|Protocol Violation|0|||
163000117|NCT02301390|588700273|FG000|Overall Study|Physician Decision|1|||
163000118|NCT02301390|588700274|FG001|Overall Study|Physician Decision|0|||
163000119|NCT02301390|588700273|FG000|Overall Study|Lost to Follow-up|0|||
163000120|NCT02301390|588700274|FG001|Overall Study|Lost to Follow-up|1|||
163000121|NCT02301390|588700273|FG000|Overall Study|Death|2|||
163000122|NCT02301390|588700274|FG001|Overall Study|Death|2|||
163000123|NCT02301390|588700273|FG000|Overall Study|Procedure not completed|0|||
163000124|NCT02301390|588700274|FG001|Overall Study|Procedure not completed|4|||
163000125|NCT02301390|588700273|FG000|Overall Study|Missed multiple visits|1|||
163000126|NCT02301390|588700274|FG001|Overall Study|Missed multiple visits|1|||
163000127|NCT02301390|588700273|FG000|Overall Study|study terminated|2|||
163000128|NCT02301390|588700274|FG001|Overall Study|study terminated|0|||
163000129|NCT00185588|588700275|FG000|Overall Study|Adverse Event|3|||
163000130|NCT00185588|588700276|FG001|Overall Study|Adverse Event|1|||
163000131|NCT00185588|588700277|FG002|Overall Study|Adverse Event|4|||
163000132|NCT00185588|588700278|FG003|Overall Study|Adverse Event|2|||
163000133|NCT00185588|588700275|FG000|Overall Study|Lost to Follow-up|0|||
163000134|NCT00185588|588700276|FG001|Overall Study|Lost to Follow-up|0|||
163000135|NCT00185588|588700277|FG002|Overall Study|Lost to Follow-up|1|||
163000136|NCT00185588|588700278|FG003|Overall Study|Lost to Follow-up|2|||
163000137|NCT00185588|588700275|FG000|Overall Study|Withdrawal by Subject|0|||
163000138|NCT00185588|588700276|FG001|Overall Study|Withdrawal by Subject|1|||
163000139|NCT00185588|588700277|FG002|Overall Study|Withdrawal by Subject|0|||
163000140|NCT00185588|588700278|FG003|Overall Study|Withdrawal by Subject|0|||
163000141|NCT00185588|588700275|FG000|Overall Study|Physician Decision|0|||
163000142|NCT00185588|588700276|FG001|Overall Study|Physician Decision|0|||
163000143|NCT00185588|588700277|FG002|Overall Study|Physician Decision|1|||
163000144|NCT00185588|588700278|FG003|Overall Study|Physician Decision|0|||
163000145|NCT00398866|588700279|FG000|Overall Study|Adverse Event|1|||
163000146|NCT00398866|588700280|FG001|Overall Study|Adverse Event|0|||
163000147|NCT00398866|588700281|FG002|Overall Study|Adverse Event|0|||
163000148|NCT00398866|588700279|FG000|Overall Study|Lack of Efficacy|0|||
163000149|NCT00398866|588700280|FG001|Overall Study|Lack of Efficacy|0|||
163000150|NCT00398866|588700281|FG002|Overall Study|Lack of Efficacy|1|||
163060586|NCT04428151|588929946|FG001|Overall Study|Withdrawal by Subject|2|||
163060587|NCT04428151|588929947|FG002|Overall Study|Withdrawal by Subject|3|||
163060588|NCT04428151|588929945|FG000|Overall Study|Participant Ongoing in Study|41|||
163404365|NCT01157078|590191914|FG001|Overall Study|Lost to Follow-up|5|||
163000151|NCT00398866|588700279|FG000|Overall Study|Lost to Follow-up|7|||
163000152|NCT00398866|588700280|FG001|Overall Study|Lost to Follow-up|6|||
163000153|NCT00398866|588700281|FG002|Overall Study|Lost to Follow-up|4|||
163000154|NCT00398866|588700279|FG000|Overall Study|Withdrawal by Subject|5|||
163000155|NCT00398866|588700280|FG001|Overall Study|Withdrawal by Subject|1|||
163000156|NCT00398866|588700281|FG002|Overall Study|Withdrawal by Subject|2|||
163000157|NCT00398866|588700279|FG000|Overall Study|Unable to complete requirements of study|1|||
163000158|NCT00398866|588700280|FG001|Overall Study|Unable to complete requirements of study|1|||
163000159|NCT00398866|588700281|FG002|Overall Study|Unable to complete requirements of study|1|||
163000160|NCT02481869|588700286|FG000|Overall Study|Lost to Follow-up|3|||
163000161|NCT02481869|588700287|FG001|Overall Study|Lost to Follow-up|4|||
163060589|NCT04428151|588929946|FG001|Overall Study|Participant Ongoing in Study|53|||
163404366|NCT01157078|590191913|FG000|Overall Study|Other|2|||
163000162|NCT02481869|588700286|FG000|Overall Study|Withdrawal by Subject|2|||
163000163|NCT02481869|588700287|FG001|Overall Study|Withdrawal by Subject|0|||
163000164|NCT01153425|588700293|FG000|Overall Study|Withdrawal by Subject|3|||
163000165|NCT01153425|588700294|FG001|Overall Study|Withdrawal by Subject|3|||
163000166|NCT03154125|588700295|FG000|Overall Study|Lost to Follow-up|11|||
163000167|NCT03154125|588700296|FG001|Overall Study|Lost to Follow-up|11|||
163404367|NCT01157078|590191914|FG001|Overall Study|Other|4|||
163324956|NCT00945724|589901443|FG000|Overall Study|Second malignancy|1|||
163324957|NCT05039021|589902011|FG000|Overall Study|Death|1|||
163324958|NCT05039021|589902011|FG000|Overall Study|Lost to Follow-up|3|||
163324959|NCT00994643|589902012|FG000|Overall Study|Withdrawal by Subject|1|||
163324960|NCT02566889|589902013|FG000|Overall Study|Withdrawal by Subject|3|||
163324961|NCT02566889|589902014|FG001|Overall Study|Withdrawal by Subject|1|||
163324962|NCT02566889|589902013|FG000|Overall Study|Adverse Event|4|||
163324963|NCT02566889|589902014|FG001|Overall Study|Adverse Event|2|||
163324964|NCT02566889|589902013|FG000|Overall Study|Other|6|||
163324965|NCT02566889|589902014|FG001|Overall Study|Other|2|||
163324966|NCT01964300|589902032|FG000|Overall Study|Ineligible after enrollment|0|||
163324967|NCT01964300|589902033|FG001|Overall Study|Ineligible after enrollment|1|||
163324968|NCT01964300|589902032|FG000|Overall Study|Adverse Event|1|||
163324969|NCT01964300|589902033|FG001|Overall Study|Adverse Event|1|||
163324970|NCT01964300|589902032|FG000|Overall Study|Lack of Efficacy|3|||
163324971|NCT01964300|589902033|FG001|Overall Study|Lack of Efficacy|5|||
163324972|NCT01964300|589902032|FG000|Overall Study|Withdrawal by Subject|0|||
163324973|NCT01964300|589902033|FG001|Overall Study|Withdrawal by Subject|1|||
163324974|NCT01964300|589902032|FG000|Overall Study|To receive alternative therapy|1|||
163324975|NCT01964300|589902033|FG001|Overall Study|To receive alternative therapy|2|||
163324976|NCT01964300|589902032|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
163324977|NCT01964300|589902033|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
163324978|NCT01964300|589902032|FG000|Overall Study|Weight criteria not met|0|||
163324979|NCT01964300|589902033|FG001|Overall Study|Weight criteria not met|1|||
163324980|NCT03286114|589902037|FG000|Overall Study|Adverse Event|6|||
163324981|NCT03286114|589902037|FG000|Overall Study|Death|3|||
163324982|NCT01260896|589902041|FG000|First Intervention|Withdrawn Due to Emesis|2|||
163324983|NCT01260896|589902042|FG001|First Intervention|Withdrawn Due to Emesis|0|||
163000168|NCT03154125|588700297|FG002|Overall Study|Lost to Follow-up|0|||
163000169|NCT03154125|588700295|FG000|Overall Study|Withdrawal by Subject|49|||
163000170|NCT03154125|588700296|FG001|Overall Study|Withdrawal by Subject|55|||
163000171|NCT03154125|588700297|FG002|Overall Study|Withdrawal by Subject|8|||
163000172|NCT03154125|588700295|FG000|Overall Study|Physician Decision|13|||
163000173|NCT03154125|588700296|FG001|Overall Study|Physician Decision|6|||
163000174|NCT03154125|588700297|FG002|Overall Study|Physician Decision|0|||
163000175|NCT03154125|588700295|FG000|Overall Study|Protocol Violation|3|||
163000176|NCT03154125|588700296|FG001|Overall Study|Protocol Violation|5|||
163000177|NCT03154125|588700297|FG002|Overall Study|Protocol Violation|0|||
163000178|NCT00810511|588700298|FG000|Overall Study|Protocol Violation|0|||
163000179|NCT00810511|588700299|FG001|Overall Study|Protocol Violation|1|||
163000180|NCT00810511|588700298|FG000|Overall Study|Lack of Efficacy|9|||
163000181|NCT00810511|588700299|FG001|Overall Study|Lack of Efficacy|1|||
163000182|NCT00810511|588700298|FG000|Overall Study|death in the family|0|||
163000183|NCT00810511|588700299|FG001|Overall Study|death in the family|1|||
163000184|NCT00810511|588700298|FG000|Overall Study|Lost to Follow-up|1|||
163000185|NCT00810511|588700299|FG001|Overall Study|Lost to Follow-up|0|||
163000186|NCT00810511|588700298|FG000|Overall Study|deposits on contact lens|0|||
163000187|NCT00810511|588700299|FG001|Overall Study|deposits on contact lens|1|||
163000188|NCT00911300|588700301|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
163324984|NCT02754596|589902049|FG000|Overall Study|Withdrawal by Subject|3|||
163324985|NCT02754596|589902050|FG001|Overall Study|Withdrawal by Subject|4|||
163324986|NCT02754596|589902051|FG002|Overall Study|Withdrawal by Subject|0|||
163324987|NCT02754596|589902049|FG000|Overall Study|Physician Decision|1|||
163324988|NCT02754596|589902050|FG001|Overall Study|Physician Decision|1|||
163324989|NCT02754596|589902051|FG002|Overall Study|Physician Decision|1|||
163324990|NCT02754596|589902049|FG000|Overall Study|Lost to Follow-up|1|||
163324991|NCT02754596|589902050|FG001|Overall Study|Lost to Follow-up|1|||
163324992|NCT02754596|589902051|FG002|Overall Study|Lost to Follow-up|2|||
163324993|NCT02754596|589902049|FG000|Overall Study|Death|0|||
163324994|NCT02754596|589902050|FG001|Overall Study|Death|2|||
163404368|NCT00522431|590191915|FG000|Overall Study|Adverse Event|5|||
163000189|NCT00911300|588700302|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
163000190|NCT00911300|588700301|FG000|Overall Study|Death|1|||
163000191|NCT00911300|588700302|FG001|Overall Study|Death|0|||
163000192|NCT00911300|588700301|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
163000193|NCT00911300|588700302|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
163000194|NCT00911300|588700301|FG000|Overall Study|Adverse Event|14|||
163000195|NCT00911300|588700302|FG001|Overall Study|Adverse Event|6|||
163000196|NCT00911300|588700301|FG000|Overall Study|Protocol Violation|3|||
163000197|NCT00911300|588700302|FG001|Overall Study|Protocol Violation|2|||
163000198|NCT00911300|588700301|FG000|Overall Study|Consent Withdrawn|4|||
163000199|NCT00911300|588700302|FG001|Overall Study|Consent Withdrawn|12|||
163000200|NCT00911300|588700301|FG000|Overall Study|Coronary Angiography Performed|1|||
163000201|NCT00911300|588700302|FG001|Overall Study|Coronary Angiography Performed|0|||
163000202|NCT00911300|588700301|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
163000203|NCT00911300|588700302|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
163000204|NCT00911300|588700301|FG000|Overall Study|Received Commercial Treatment|1|||
163324995|NCT02754596|589902051|FG002|Overall Study|Death|0|||
163000205|NCT00911300|588700302|FG001|Overall Study|Received Commercial Treatment|0|||
163000206|NCT00911300|588700301|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
163000207|NCT00911300|588700302|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
163000208|NCT00911300|588700301|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
163000209|NCT00911300|588700302|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
163000210|NCT00911300|588700301|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
163000211|NCT00911300|588700302|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
163000212|NCT00911300|588700301|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
163000213|NCT00911300|588700302|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
163000214|NCT00911300|588700301|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
163000215|NCT00911300|588700302|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
163000216|NCT00911300|588700301|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
163000217|NCT00911300|588700302|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
163000218|NCT00911300|588700301|FG000|Overall Study|International Normalized Ratio Too High|0|||
163000219|NCT00911300|588700302|FG001|Overall Study|International Normalized Ratio Too High|1|||
163000220|NCT00911300|588700301|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
163000221|NCT00911300|588700302|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
163000222|NCT00911300|588700301|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
163000223|NCT00911300|588700302|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
163000224|NCT00911300|588700301|FG000|Overall Study|Physician Decision|0|||
163000225|NCT00911300|588700302|FG001|Overall Study|Physician Decision|1|||
163000226|NCT00911300|588700301|FG000|Overall Study|Treatment Stopped by Mistake|0|||
163000227|NCT00911300|588700302|FG001|Overall Study|Treatment Stopped by Mistake|1|||
163000228|NCT00911300|588700301|FG000|Overall Study|Randomized; No Study Medication Received|0|||
163000229|NCT00911300|588700302|FG001|Overall Study|Randomized; No Study Medication Received|2|||
163000230|NCT00666328|588700306|FG000|Overall Study|Death|2|||
163000231|NCT00666328|588700306|FG000|Overall Study|Lost to Follow-up|2|||
163000232|NCT00666328|588700306|FG000|Overall Study|No longer met eligibility criteria|1|||
163000233|NCT02288325|588700307|FG000|Run-in Period|Adverse Event|48|||
163000234|NCT02288325|588700308|FG001|Run-in Period|Adverse Event|0|||
163000235|NCT02288325|588700309|FG002|Run-in Period|Adverse Event|0|||
163000236|NCT02288325|588700307|FG000|Run-in Period|Lack of Efficacy|16|||
163000237|NCT02288325|588700308|FG001|Run-in Period|Lack of Efficacy|0|||
163000238|NCT02288325|588700309|FG002|Run-in Period|Lack of Efficacy|0|||
163000239|NCT02288325|588700307|FG000|Run-in Period|Withdrawal of Consent|28|||
163000240|NCT02288325|588700308|FG001|Run-in Period|Withdrawal of Consent|0|||
163000241|NCT02288325|588700309|FG002|Run-in Period|Withdrawal of Consent|0|||
163000242|NCT02288325|588700307|FG000|Run-in Period|Lost to Follow-up|25|||
163000243|NCT02288325|588700308|FG001|Run-in Period|Lost to Follow-up|0|||
163000244|NCT02288325|588700309|FG002|Run-in Period|Lost to Follow-up|0|||
163000245|NCT02288325|588700307|FG000|Run-in Period|Protocol Violation|17|||
163000246|NCT02288325|588700308|FG001|Run-in Period|Protocol Violation|0|||
163000247|NCT02288325|588700309|FG002|Run-in Period|Protocol Violation|0|||
163000248|NCT02288325|588700307|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
163000249|NCT02288325|588700308|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
163000250|NCT02288325|588700309|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
163000251|NCT02288325|588700307|FG000|Run-in Period|Reason not Specified|8|||
163000252|NCT02288325|588700308|FG001|Run-in Period|Reason not Specified|0|||
163000253|NCT02288325|588700309|FG002|Run-in Period|Reason not Specified|0|||
163000254|NCT02288325|588700307|FG000|Stabilization Period|Adverse Event|13|||
163000255|NCT02288325|588700308|FG001|Stabilization Period|Adverse Event|0|||
163000256|NCT02288325|588700309|FG002|Stabilization Period|Adverse Event|0|||
163000257|NCT02288325|588700307|FG000|Stabilization Period|Lack of Efficacy|22|||
163000258|NCT02288325|588700308|FG001|Stabilization Period|Lack of Efficacy|0|||
163000259|NCT02288325|588700309|FG002|Stabilization Period|Lack of Efficacy|0|||
163060590|NCT04428151|588929947|FG002|Overall Study|Participant Ongoing in Study|28|||
163324996|NCT02754596|589902049|FG000|Overall Study|Adverse Event|1|||
163324997|NCT02754596|589902050|FG001|Overall Study|Adverse Event|0|||
163324998|NCT02754596|589902051|FG002|Overall Study|Adverse Event|1|||
163324999|NCT02754596|589902049|FG000|Overall Study|Other|1|||
163325000|NCT02754596|589902050|FG001|Overall Study|Other|0|||
163000260|NCT02288325|588700307|FG000|Stabilization Period|Withdrawal of Consent|23|||
163000261|NCT02288325|588700308|FG001|Stabilization Period|Withdrawal of Consent|0|||
163000262|NCT02288325|588700309|FG002|Stabilization Period|Withdrawal of Consent|0|||
163060591|NCT02187783|588929948|FG000|Overall Study|Adverse Event|8|||
163325001|NCT02754596|589902051|FG002|Overall Study|Other|0|||
163000263|NCT02288325|588700307|FG000|Stabilization Period|Lost to Follow-up|12|||
163000264|NCT02288325|588700308|FG001|Stabilization Period|Lost to Follow-up|0|||
163000265|NCT02288325|588700309|FG002|Stabilization Period|Lost to Follow-up|0|||
163000266|NCT02288325|588700307|FG000|Stabilization Period|Protocol Violation|8|||
163000267|NCT02288325|588700308|FG001|Stabilization Period|Protocol Violation|0|||
163000268|NCT02288325|588700309|FG002|Stabilization Period|Protocol Violation|0|||
163060592|NCT02187783|588929948|FG000|Overall Study|Death|3|||
163325002|NCT04018495|589902056|FG000|Overall Study|Physician Decision|1|||
163000269|NCT02288325|588700307|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
163000270|NCT02288325|588700308|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
163000271|NCT02288325|588700309|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
163000272|NCT02288325|588700307|FG000|Stabilization Period|Reason not Specified|15|||
163000273|NCT02288325|588700308|FG001|Stabilization Period|Reason not Specified|0|||
163000274|NCT02288325|588700309|FG002|Stabilization Period|Reason not Specified|0|||
163000275|NCT02288325|588700307|FG000|Double-blind Treatment Period|Adverse Event|0|||
163000276|NCT02288325|588700308|FG001|Double-blind Treatment Period|Adverse Event|2|||
163000277|NCT02288325|588700309|FG002|Double-blind Treatment Period|Adverse Event|5|||
163325003|NCT05934292|589902065|FG000|Overall Study|Lost to Follow-up|0|||
163325004|NCT05934292|589902066|FG001|Overall Study|Lost to Follow-up|0|||
163325005|NCT05934292|589902067|FG002|Overall Study|Lost to Follow-up|1|||
163000278|NCT02288325|588700307|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
163000279|NCT02288325|588700308|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
163000280|NCT02288325|588700309|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
163000281|NCT02288325|588700307|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
163000282|NCT02288325|588700308|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
163000283|NCT02288325|588700309|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
163000284|NCT02288325|588700307|FG000|Double-blind Treatment Period|Protocol Violation|0|||
163000285|NCT02288325|588700308|FG001|Double-blind Treatment Period|Protocol Violation|1|||
163000286|NCT02288325|588700309|FG002|Double-blind Treatment Period|Protocol Violation|2|||
163000287|NCT02288325|588700307|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
163000288|NCT02288325|588700308|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
163000289|NCT02288325|588700309|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
163000290|NCT02288325|588700307|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
163000291|NCT02288325|588700308|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
163000292|NCT02288325|588700309|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
163000293|NCT03607487|588700313|FG000|Overall Study|Withdrawal by Subject|2|||
163000294|NCT03607487|588700314|FG001|Overall Study|Withdrawal by Subject|0|||
163000295|NCT03607487|588700315|FG002|Overall Study|Withdrawal by Subject|0|||
163000296|NCT03607487|588700316|FG003|Overall Study|Withdrawal by Subject|1|||
163000297|NCT04759703|588700317|FG000|Overall Study|Withdrawal by Subject|4|||
163000298|NCT04759703|588700318|FG001|Overall Study|Withdrawal by Subject|9|||
163000299|NCT04759703|588700317|FG000|Overall Study|Adverse Event|1|||
163000300|NCT04759703|588700318|FG001|Overall Study|Adverse Event|0|||
163000301|NCT04759703|588700317|FG000|Overall Study|Lost to Follow-up|2|||
163000302|NCT04759703|588700318|FG001|Overall Study|Lost to Follow-up|0|||
163000303|NCT04186845|588700326|FG000|Overall Study|Death|2|||
163000304|NCT04186845|588700326|FG000|Overall Study|Lost to Follow-up|1|||
163000305|NCT04186845|588700326|FG000|Overall Study|Physician Decision|1|||
163000306|NCT04186845|588700326|FG000|Overall Study|Protocol Violation|1|||
163000307|NCT04186845|588700326|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
163000308|NCT04186845|588700326|FG000|Overall Study|Biopsy ordered but not done|1|||
163000309|NCT04186845|588700326|FG000|Overall Study|It was previously confirmed|1|||
163000310|NCT04186845|588700326|FG000|Overall Study|Patient cancelled scheduled scans|2|||
163000311|NCT04186845|588700326|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
163000312|NCT04186845|588700326|FG000|Overall Study|Subject refused confirmatory imaging|1|||
163000313|NCT04186845|588700326|FG000|Overall Study|Too small to biopsy|1|||
163000314|NCT03151304|588700327|FG000|Overall Study|Termination of study by Sponsor|23|||
163000315|NCT03151304|588700327|FG000|Overall Study|missing|3|||
163000316|NCT03151304|588700327|FG000|Overall Study|Withdrawal by Subject|8|||
163000317|NCT03151304|588700327|FG000|Overall Study|multiple reasons|30|||
163000318|NCT04036110|588700330|FG000|Overall Study|Lost to Follow-up|3|||
163000319|NCT04036110|588700331|FG001|Overall Study|Lost to Follow-up|2|||
163325006|NCT05934292|589902068|FG003|Overall Study|Lost to Follow-up|0|||
163325007|NCT02890355|589902069|FG000|Overall Study|Adverse Event|5|||
163325008|NCT02890355|589902070|FG001|Overall Study|Adverse Event|5|||
163325009|NCT02890355|589902069|FG000|Overall Study|Refusal unrelated to adverse event|5|||
163325010|NCT02890355|589902070|FG001|Overall Study|Refusal unrelated to adverse event|10|||
163000320|NCT04036110|588700332|FG002|Overall Study|Lost to Follow-up|1|||
163000321|NCT04036110|588700330|FG000|Overall Study|Study Suspended|4|||
163000322|NCT04036110|588700331|FG001|Overall Study|Study Suspended|5|||
163000323|NCT04036110|588700332|FG002|Overall Study|Study Suspended|1|||
163000324|NCT00534404|588700335|FG000|Overall Study|Death|0|||
163000325|NCT00534404|588700336|FG001|Overall Study|Death|0|||
163325011|NCT02890355|589902069|FG000|Overall Study|Progression/relapse|46|||
163325012|NCT02890355|589902070|FG001|Overall Study|Progression/relapse|39|||
163325013|NCT02890355|589902069|FG000|Overall Study|Not protocol specified|3|||
163325014|NCT02890355|589902070|FG001|Overall Study|Not protocol specified|4|||
163000326|NCT00534404|588700337|FG002|Overall Study|Death|2|||
163000327|NCT00534404|588700335|FG000|Overall Study|Withdrawal by Subject|8|||
163000328|NCT00534404|588700336|FG001|Overall Study|Withdrawal by Subject|2|||
163000329|NCT00534404|588700337|FG002|Overall Study|Withdrawal by Subject|38|||
163000330|NCT00534404|588700335|FG000|Overall Study|Removed by study staff|2|||
163000331|NCT00534404|588700336|FG001|Overall Study|Removed by study staff|3|||
163000332|NCT00534404|588700337|FG002|Overall Study|Removed by study staff|1|||
163000333|NCT00534404|588700335|FG000|Overall Study|Lost to Follow-up|170|||
163000334|NCT00534404|588700336|FG001|Overall Study|Lost to Follow-up|138|||
163000335|NCT00534404|588700337|FG002|Overall Study|Lost to Follow-up|201|||
163000336|NCT02676765|588700338|FG000|Overall Study|Lost to Follow-up|0|||
163000337|NCT02676765|588700339|FG001|Overall Study|Lost to Follow-up|1|||
163000338|NCT00490841|588700340|FG000|Overall Study|Death|5|||
163000339|NCT00490841|588700340|FG000|Overall Study|Withdrawal by Subject|4|||
163000340|NCT00490841|588700340|FG000|Overall Study|Lost to Follow-up|1|||
163000341|NCT00490841|588700340|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
163000342|NCT03452943|588700341|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
163000343|NCT03452943|588700342|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
163000344|NCT03452943|588700341|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
163000345|NCT03452943|588700342|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
163000346|NCT03452943|588700341|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
163000347|NCT03452943|588700342|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
163000348|NCT03452943|588700341|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
163000349|NCT03452943|588700342|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
163000350|NCT03452943|588700341|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
163000351|NCT03452943|588700342|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
163000352|NCT03452943|588700341|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
163000353|NCT03452943|588700342|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
163000354|NCT01107197|588700345|FG000|Overall Study|Death|12|||
163000355|NCT01107197|588700346|FG001|Overall Study|Death|10|||
163000356|NCT01107197|588700345|FG000|Overall Study|Lost to Follow-up|5|||
163000357|NCT01107197|588700346|FG001|Overall Study|Lost to Follow-up|8|||
163000358|NCT01107197|588700345|FG000|Overall Study|Withdrawal by Subject|3|||
163000359|NCT01107197|588700346|FG001|Overall Study|Withdrawal by Subject|5|||
163000360|NCT01301729|588700348|FG000|Overall Study|Withdrawal by Subject|2|||
163000361|NCT01301729|588700348|FG000|Overall Study|Participant did not Return for Treatment|1|||
163000362|NCT01301729|588700348|FG000|Overall Study|Violated Selection Criteria|1|||
163000363|NCT00447993|588700349|FG000|Overall Study|Lost to Follow-up|0|||
163000364|NCT00447993|588700350|FG001|Overall Study|Lost to Follow-up|0|||
163000365|NCT00447993|588700351|FG002|Overall Study|Lost to Follow-up|2|||
163000366|NCT00447993|588700352|FG003|Overall Study|Lost to Follow-up|2|||
163060593|NCT02187783|588929948|FG000|Overall Study|Progressive disease|80|||
163060594|NCT02187783|588929948|FG000|Overall Study|Protocol Violation|3|||
163060595|NCT02187783|588929948|FG000|Overall Study|Physician Decision|2|||
163060596|NCT02187783|588929948|FG000|Overall Study|Withdrawal by Subject|9|||
163060597|NCT02187783|588929948|FG000|Overall Study|Study terminated by sponsor|1|||
163060598|NCT00392223|588929949|FG000|Overall Study|Adverse Event|5|||
163060599|NCT00392223|588929950|FG001|Overall Study|Adverse Event|4|||
163060600|NCT00392223|588929949|FG000|Overall Study|Lost to Follow-up|1|||
163060601|NCT00392223|588929950|FG001|Overall Study|Lost to Follow-up|4|||
163060602|NCT00392223|588929949|FG000|Overall Study|Protocol Violation|0|||
163060603|NCT00392223|588929950|FG001|Overall Study|Protocol Violation|3|||
163060604|NCT00392223|588929949|FG000|Overall Study|Withdrawal by Subject|3|||
163060605|NCT00392223|588929950|FG001|Overall Study|Withdrawal by Subject|2|||
163060606|NCT02908347|588929951|FG000|Overall Study|Adverse Event|0|||
163060607|NCT02908347|588929952|FG001|Overall Study|Adverse Event|1|||
163060608|NCT02908347|588929951|FG000|Overall Study|Lost to Follow-up|1|||
163000367|NCT00447993|588700349|FG000|Overall Study|Withdrawal by Subject|0|||
163000368|NCT00447993|588700350|FG001|Overall Study|Withdrawal by Subject|0|||
163000369|NCT00447993|588700351|FG002|Overall Study|Withdrawal by Subject|2|||
163000370|NCT00447993|588700352|FG003|Overall Study|Withdrawal by Subject|2|||
163000371|NCT04380961|588700355|FG000|Overall Study|Lost to Follow-up|17|||
163000372|NCT04380961|588700356|FG001|Overall Study|Lost to Follow-up|11|||
163000373|NCT04380961|588700355|FG000|Overall Study|Withdrawal by Subject|3|||
163000374|NCT04380961|588700356|FG001|Overall Study|Withdrawal by Subject|0|||
163060609|NCT02908347|588929952|FG001|Overall Study|Lost to Follow-up|0|||
163060610|NCT05516758|588929958|FG000|Overall Study|Adverse Event|5|||
163060611|NCT05516758|588929959|FG001|Overall Study|Adverse Event|1|||
163000375|NCT04380961|588700355|FG000|Overall Study|Death|22|||
163000376|NCT04380961|588700356|FG001|Overall Study|Death|16|||
163000377|NCT04380961|588700355|FG000|Overall Study|Other|1|||
163000378|NCT04380961|588700356|FG001|Overall Study|Other|0|||
163000379|NCT04380961|588700355|FG000|Overall Study|Randomized but Not Treated|1|||
163000380|NCT04380961|588700356|FG001|Overall Study|Randomized but Not Treated|2|||
163060612|NCT05516758|588929960|FG002|Overall Study|Adverse Event|3|||
163060613|NCT05516758|588929961|FG003|Overall Study|Adverse Event|0|||
163060614|NCT05516758|588929962|FG004|Overall Study|Adverse Event|1|||
163000381|NCT04803305|588700357|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
163000382|NCT04803305|588700358|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
163000383|NCT04803305|588700357|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
163060615|NCT05516758|588929963|FG005|Overall Study|Adverse Event|3|||
163060616|NCT05516758|588929964|FG006|Overall Study|Adverse Event|5|||
163000384|NCT04803305|588700358|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
163000385|NCT04803305|588700357|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
163000386|NCT04803305|588700358|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
163000387|NCT04803305|588700357|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
163000388|NCT04803305|588700358|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
163000389|NCT04803305|588700357|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
163000390|NCT04803305|588700358|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
163000391|NCT04803305|588700357|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
163000392|NCT04803305|588700358|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
163000393|NCT04803305|588700357|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
163000394|NCT04803305|588700358|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
163000395|NCT04803305|588700357|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
163000396|NCT04803305|588700358|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
163000397|NCT02121652|588701804|FG000|Overall Study|Lost to Follow-up|2|||
163000398|NCT02121652|588701805|FG001|Overall Study|Lost to Follow-up|1|||
163000399|NCT02121652|588701804|FG000|Overall Study|Death|1|||
163000400|NCT02121652|588701805|FG001|Overall Study|Death|0|||
163000401|NCT02121652|588701804|FG000|Overall Study|Withdrawal by Subject|3|||
163000402|NCT02121652|588701805|FG001|Overall Study|Withdrawal by Subject|3|||
163000403|NCT01090414|588701806|FG000|Study 101-99|Progressive Disease|28|||
163000404|NCT01090414|588701807|FG001|Study 101-99|Progressive Disease|48|||
163000405|NCT01090414|588701808|FG002|Study 101-99|Progressive Disease|10|||
163000406|NCT01090414|588701809|FG003|Study 101-99|Progressive Disease|4|||
163000407|NCT01090414|588701806|FG000|Study 101-99|Adverse Event|10|||
163000408|NCT01090414|588701807|FG001|Study 101-99|Adverse Event|28|||
163000409|NCT01090414|588701808|FG002|Study 101-99|Adverse Event|18|||
163000410|NCT01090414|588701809|FG003|Study 101-99|Adverse Event|0|||
163000411|NCT01090414|588701806|FG000|Study 101-99|Investigator Request|1|||
163000412|NCT01090414|588701807|FG001|Study 101-99|Investigator Request|11|||
163000413|NCT01090414|588701808|FG002|Study 101-99|Investigator Request|4|||
163000414|NCT01090414|588701809|FG003|Study 101-99|Investigator Request|0|||
163000415|NCT01090414|588701806|FG000|Study 101-99|Death|3|||
163000416|NCT01090414|588701807|FG001|Study 101-99|Death|8|||
163000417|NCT01090414|588701808|FG002|Study 101-99|Death|1|||
163000418|NCT01090414|588701809|FG003|Study 101-99|Death|0|||
163000419|NCT01090414|588701806|FG000|Study 101-99|Sponsor Discontinued Study|0|||
163000420|NCT01090414|588701807|FG001|Study 101-99|Sponsor Discontinued Study|7|||
163000421|NCT01090414|588701808|FG002|Study 101-99|Sponsor Discontinued Study|5|||
163000422|NCT01090414|588701809|FG003|Study 101-99|Sponsor Discontinued Study|0|||
163000423|NCT01090414|588701806|FG000|Study 101-99|Other (Unknown Reasons)|3|||
163000424|NCT01090414|588701807|FG001|Study 101-99|Other (Unknown Reasons)|3|||
163000425|NCT01090414|588701808|FG002|Study 101-99|Other (Unknown Reasons)|0|||
163000426|NCT01090414|588701809|FG003|Study 101-99|Other (Unknown Reasons)|0|||
163000427|NCT01090414|588701806|FG000|Study 101-99|Withdrew Consent|0|||
163000428|NCT01090414|588701807|FG001|Study 101-99|Withdrew Consent|2|||
163000429|NCT01090414|588701808|FG002|Study 101-99|Withdrew Consent|3|||
163000430|NCT01090414|588701809|FG003|Study 101-99|Withdrew Consent|1|||
163000431|NCT01090414|588701806|FG000|Study 101-99|Participant Request|3|||
163000432|NCT01090414|588701807|FG001|Study 101-99|Participant Request|1|||
163000433|NCT01090414|588701808|FG002|Study 101-99|Participant Request|0|||
163000434|NCT01090414|588701809|FG003|Study 101-99|Participant Request|0|||
163000435|NCT04342819|588701810|FG000|Overall Study|Declined|4|||
163000436|NCT04342819|588701810|FG000|Overall Study|Not meeeting selection criteria|1|||
163000437|NCT01965860|588701811|FG000|Overall Study|Pregnancy|1|||
163000438|NCT01965860|588701812|FG001|Overall Study|Pregnancy|0|||
163000439|NCT01965860|588701813|FG002|Overall Study|Pregnancy|1|||
163000440|NCT01965860|588701811|FG000|Overall Study|Logistics|1|||
163000441|NCT01965860|588701812|FG001|Overall Study|Logistics|0|||
163000442|NCT01965860|588701813|FG002|Overall Study|Logistics|0|||
163000443|NCT00769379|588701814|FG000|Overall Study|No follow up data mapped to Other.|3|||
163000444|NCT00769379|588701815|FG001|Overall Study|No follow up data mapped to Other.|13|||
163000445|NCT04138823|588701824|FG000|Overall Study|Clinical disease progression|0|||
163000446|NCT04138823|588701825|FG001|Overall Study|Clinical disease progression|0|||
163000447|NCT04138823|588701826|FG002|Overall Study|Clinical disease progression|1|||
163000448|NCT04138823|588701824|FG000|Overall Study|Objective disease progression|3|||
163000449|NCT04138823|588701825|FG001|Overall Study|Objective disease progression|2|||
163000450|NCT04138823|588701826|FG002|Overall Study|Objective disease progression|5|||
163000451|NCT04868500|588701827|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
163000452|NCT04868500|588701828|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
163000453|NCT04868500|588701827|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
163000454|NCT04868500|588701828|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
163000455|NCT02466685|588701830|FG000|Overall Study|Adverse Event|5|||
163000456|NCT02466685|588701831|FG001|Overall Study|Adverse Event|2|||
163000457|NCT02466685|588701830|FG000|Overall Study|Lost to Follow-up|1|||
163000458|NCT02466685|588701831|FG001|Overall Study|Lost to Follow-up|1|||
163000459|NCT02466685|588701830|FG000|Overall Study|Withdrawal by Subject|1|||
163000460|NCT02466685|588701831|FG001|Overall Study|Withdrawal by Subject|0|||
163000461|NCT02466685|588701830|FG000|Overall Study|Physician Decision|1|||
163000462|NCT02466685|588701831|FG001|Overall Study|Physician Decision|1|||
163000463|NCT02565511|588701832|FG000|Overall Study|Study terminated by Sponsor|35|||
163000464|NCT02565511|588701833|FG001|Overall Study|Study terminated by Sponsor|22|||
163000465|NCT02565511|588701834|FG002|Overall Study|Study terminated by Sponsor|235|||
163000466|NCT02565511|588701835|FG003|Overall Study|Study terminated by Sponsor|156|||
163000467|NCT02565511|588701832|FG000|Overall Study|Withdrawal by Subject|3|||
163000468|NCT02565511|588701833|FG001|Overall Study|Withdrawal by Subject|0|||
163000469|NCT02565511|588701834|FG002|Overall Study|Withdrawal by Subject|12|||
163000470|NCT02565511|588701835|FG003|Overall Study|Withdrawal by Subject|5|||
163000471|NCT02565511|588701832|FG000|Overall Study|Adverse Event|0|||
163000472|NCT02565511|588701833|FG001|Overall Study|Adverse Event|0|||
163000473|NCT02565511|588701834|FG002|Overall Study|Adverse Event|1|||
163000474|NCT02565511|588701835|FG003|Overall Study|Adverse Event|1|||
163000475|NCT02565511|588701832|FG000|Overall Study|Lost to Follow-up|4|||
163000476|NCT02565511|588701833|FG001|Overall Study|Lost to Follow-up|1|||
163000477|NCT02565511|588701834|FG002|Overall Study|Lost to Follow-up|0|||
163000478|NCT02565511|588701835|FG003|Overall Study|Lost to Follow-up|1|||
163000479|NCT02565511|588701832|FG000|Overall Study|Physician Decision|0|||
163000480|NCT02565511|588701833|FG001|Overall Study|Physician Decision|0|||
163000481|NCT02565511|588701834|FG002|Overall Study|Physician Decision|0|||
163000482|NCT02565511|588701835|FG003|Overall Study|Physician Decision|1|||
163000483|NCT02565511|588701832|FG000|Overall Study|Protocol deviation|0|||
163000484|NCT02565511|588701833|FG001|Overall Study|Protocol deviation|0|||
163000485|NCT02565511|588701834|FG002|Overall Study|Protocol deviation|3|||
163000486|NCT02565511|588701835|FG003|Overall Study|Protocol deviation|0|||
163000487|NCT01941498|588701836|FG000|Overall Study|Relocated out of state|1|||
163000488|NCT00104572|588701838|FG000|Overall Study|Withdrawal by Subject|3|||
163000489|NCT00104572|588701839|FG001|Overall Study|Withdrawal by Subject|3|||
163000490|NCT00104572|588701840|FG002|Overall Study|Withdrawal by Subject|0|||
163000491|NCT00098774|588701841|FG000|Overall Study|Adverse Event|2|||
163000492|NCT00098774|588701841|FG000|Overall Study|Disease Progression|9|||
163000493|NCT00098774|588701841|FG000|Overall Study|Withdrawal by Subject|1|||
163000494|NCT00098774|588701841|FG000|Overall Study|Failed (to respond) during induction|4|||
163000495|NCT00098774|588701841|FG000|Overall Study|Physician Decision|2|||
163000496|NCT03097991|588701842|FG000|Overall Study|Didn't meet study criteria|8|||
163000497|NCT03097991|588701843|FG001|Overall Study|Didn't meet study criteria|0|||
163000498|NCT03097991|588701842|FG000|Overall Study|Withdrawal by Subject|12|||
163000499|NCT03097991|588701843|FG001|Overall Study|Withdrawal by Subject|6|||
163000500|NCT03097991|588701842|FG000|Overall Study|Death of Baby|3|||
163000501|NCT03097991|588701843|FG001|Overall Study|Death of Baby|1|||
163000502|NCT03097991|588701842|FG000|Overall Study|Lost to Follow-up|24|||
163000503|NCT03097991|588701843|FG001|Overall Study|Lost to Follow-up|38|||
163000504|NCT03097991|588701842|FG000|Overall Study|Adverse Event|3|||
163000505|NCT03097991|588701843|FG001|Overall Study|Adverse Event|5|||
163000506|NCT01755091|588701844|FG000|Overall Study|Withdrawal by Subject|6|||
163000507|NCT01755091|588701845|FG001|Overall Study|Withdrawal by Subject|1|||
163000508|NCT01755091|588701846|FG002|Overall Study|Withdrawal by Subject|3|||
163000509|NCT01755091|588701844|FG000|Overall Study|Adverse Event|1|||
163000510|NCT01755091|588701845|FG001|Overall Study|Adverse Event|1|||
163000511|NCT01755091|588701846|FG002|Overall Study|Adverse Event|1|||
163000512|NCT01755091|588701844|FG000|Overall Study|Lost to Follow-up|1|||
163000513|NCT01755091|588701845|FG001|Overall Study|Lost to Follow-up|0|||
163000514|NCT01755091|588701846|FG002|Overall Study|Lost to Follow-up|1|||
163000515|NCT01755091|588701844|FG000|Overall Study|Physician Decision|1|||
163000516|NCT01755091|588701845|FG001|Overall Study|Physician Decision|1|||
163000517|NCT01755091|588701846|FG002|Overall Study|Physician Decision|2|||
163000518|NCT01330303|588701851|FG000|Period 1|Adverse Event|1|||
163000519|NCT01330303|588701852|FG001|Period 1|Adverse Event|0|||
163000520|NCT01330303|588701851|FG000|Period 1|Protocol Violation|0|||
163000521|NCT01330303|588701852|FG001|Period 1|Protocol Violation|1|||
163000522|NCT01330303|588701851|FG000|Period 1|Withdrawal by Subject|0|||
163000523|NCT01330303|588701852|FG001|Period 1|Withdrawal by Subject|1|||
163000524|NCT00796757|588701853|FG000|Overall Study|Withdrawal by Subject|14|||
163060617|NCT05516758|588929958|FG000|Overall Study|Assigned treatment by mistake|1|||
163060618|NCT05516758|588929959|FG001|Overall Study|Assigned treatment by mistake|0|||
163060619|NCT05516758|588929960|FG002|Overall Study|Assigned treatment by mistake|0|||
163000525|NCT00796757|588701853|FG000|Overall Study|Death|61|||
163060620|NCT05516758|588929961|FG003|Overall Study|Assigned treatment by mistake|0|||
163060621|NCT05516758|588929962|FG004|Overall Study|Assigned treatment by mistake|1|||
163000526|NCT00796757|588701853|FG000|Overall Study|Protocol Violation|1|||
163000527|NCT00796757|588701853|FG000|Overall Study|Participant noncompliance|1|||
163000528|NCT00796757|588701853|FG000|Overall Study|Investigator's decision|2|||
163000529|NCT00796757|588701853|FG000|Overall Study|Other|7|||
163000530|NCT03516513|588701854|FG000|Overall Study|Withdrawal by Subject|2|||
163000531|NCT03516513|588701855|FG001|Overall Study|Withdrawal by Subject|2|||
163000532|NCT03516513|588701856|FG002|Overall Study|Withdrawal by Subject|0|||
163325015|NCT02206828|589902071|FG000|Overall Study|Lost to Follow-up|7|||
163000533|NCT03516513|588701857|FG003|Overall Study|Withdrawal by Subject|0|||
163000534|NCT02593110|588701858|FG000|Overall Study|Withdrawal by Subject|0|||
163000535|NCT02593110|588701859|FG001|Overall Study|Withdrawal by Subject|3|||
163000536|NCT02593110|588701860|FG002|Overall Study|Withdrawal by Subject|3|||
163000537|NCT02593110|588701861|FG003|Overall Study|Withdrawal by Subject|2|||
163000538|NCT02593110|588701858|FG000|Overall Study|Death|0|||
163000539|NCT02593110|588701859|FG001|Overall Study|Death|0|||
163000540|NCT02593110|588701860|FG002|Overall Study|Death|1|||
163000541|NCT02593110|588701861|FG003|Overall Study|Death|0|||
163000542|NCT01130597|588701862|FG000|Overall Study|Protocol-specified (High K+)|1|||
163000543|NCT01130597|588701862|FG000|Overall Study|Adverse Event|4|||
163000544|NCT01130597|588701862|FG000|Overall Study|Death|1|||
163000545|NCT01130597|588701862|FG000|Overall Study|Protocol Violation|1|||
163000546|NCT03071276|588701863|FG000|Overall Study|Adverse Event|1|||
163000547|NCT03071276|588701863|FG000|Overall Study|Lack of Efficacy|14|||
163000548|NCT05794503|588701868|FG000|Overall Study|Operation Cancelled|2|||
163000549|NCT05794503|588701869|FG001|Overall Study|Operation Cancelled|0|||
163000550|NCT05794503|588701868|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
163000551|NCT05794503|588701869|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
163000552|NCT05794503|588701868|FG000|Overall Study|Protocol Violation|1|||
163000553|NCT05794503|588701869|FG001|Overall Study|Protocol Violation|0|||
163000554|NCT03052127|588701870|FG000|Overall Study|Withdrawal by Subject|0|||
163000555|NCT03052127|588701871|FG001|Overall Study|Withdrawal by Subject|0|||
163000556|NCT03052127|588701872|FG002|Overall Study|Withdrawal by Subject|0|||
163000557|NCT03052127|588701873|FG003|Overall Study|Withdrawal by Subject|0|||
163000558|NCT03052127|588701874|FG004|Overall Study|Withdrawal by Subject|0|||
163325016|NCT03391466|589902857|FG000|Overall Study|Death|84|||
163325017|NCT03391466|589902858|FG001|Overall Study|Death|91|||
163325018|NCT03391466|589902857|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
163325019|NCT03391466|589902858|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
163325020|NCT03391466|589902857|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
163000559|NCT03052127|588701875|FG005|Overall Study|Withdrawal by Subject|0|||
163000560|NCT03052127|588701876|FG006|Overall Study|Withdrawal by Subject|0|||
163000561|NCT03052127|588701877|FG007|Overall Study|Withdrawal by Subject|1|||
163000562|NCT03052127|588701878|FG008|Overall Study|Withdrawal by Subject|1|||
163000563|NCT03052127|588701879|FG009|Overall Study|Withdrawal by Subject|1|||
163000564|NCT03052127|588701880|FG010|Overall Study|Withdrawal by Subject|0|||
163000565|NCT03052127|588701881|FG011|Overall Study|Withdrawal by Subject|0|||
163000566|NCT03052127|588701870|FG000|Overall Study|Discontinuation by Sponsor|0|||
163000567|NCT03052127|588701871|FG001|Overall Study|Discontinuation by Sponsor|0|||
163000568|NCT03052127|588701872|FG002|Overall Study|Discontinuation by Sponsor|0|||
163000569|NCT03052127|588701873|FG003|Overall Study|Discontinuation by Sponsor|0|||
163000570|NCT03052127|588701874|FG004|Overall Study|Discontinuation by Sponsor|0|||
163000571|NCT03052127|588701875|FG005|Overall Study|Discontinuation by Sponsor|0|||
163000572|NCT03052127|588701876|FG006|Overall Study|Discontinuation by Sponsor|0|||
163000573|NCT03052127|588701877|FG007|Overall Study|Discontinuation by Sponsor|0|||
163000574|NCT03052127|588701878|FG008|Overall Study|Discontinuation by Sponsor|4|||
163000575|NCT03052127|588701879|FG009|Overall Study|Discontinuation by Sponsor|2|||
163000576|NCT03052127|588701880|FG010|Overall Study|Discontinuation by Sponsor|5|||
163000577|NCT03052127|588701881|FG011|Overall Study|Discontinuation by Sponsor|13|||
163000578|NCT03052127|588701870|FG000|Overall Study|Inability to comply with trial requirements|0|||
163000579|NCT03052127|588701871|FG001|Overall Study|Inability to comply with trial requirements|0|||
163000580|NCT03052127|588701872|FG002|Overall Study|Inability to comply with trial requirements|1|||
163000581|NCT03052127|588701873|FG003|Overall Study|Inability to comply with trial requirements|0|||
163000582|NCT03052127|588701874|FG004|Overall Study|Inability to comply with trial requirements|0|||
163000583|NCT03052127|588701875|FG005|Overall Study|Inability to comply with trial requirements|0|||
163000584|NCT03052127|588701876|FG006|Overall Study|Inability to comply with trial requirements|0|||
163000585|NCT03052127|588701877|FG007|Overall Study|Inability to comply with trial requirements|0|||
163000586|NCT03052127|588701878|FG008|Overall Study|Inability to comply with trial requirements|0|||
163000587|NCT03052127|588701879|FG009|Overall Study|Inability to comply with trial requirements|0|||
163000588|NCT03052127|588701880|FG010|Overall Study|Inability to comply with trial requirements|0|||
163000589|NCT03052127|588701881|FG011|Overall Study|Inability to comply with trial requirements|0|||
163000590|NCT03052127|588701870|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
163000591|NCT03052127|588701871|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000592|NCT03052127|588701872|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000593|NCT03052127|588701873|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000594|NCT03052127|588701874|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
163000595|NCT03052127|588701875|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
163000596|NCT03052127|588701876|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
163000597|NCT03052127|588701877|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000598|NCT03052127|588701878|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000599|NCT03052127|588701879|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000600|NCT03052127|588701880|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000601|NCT03052127|588701881|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000602|NCT03694327|588701882|FG000|Overall Study|Lost to Follow-up|13|||
163000603|NCT03694327|588701883|FG001|Overall Study|Lost to Follow-up|23|||
163000604|NCT01464931|588701884|FG000|Overall Study|Withdrawal by Subject|1|||
163000605|NCT01464931|588701885|FG001|Overall Study|Withdrawal by Subject|0|||
163000606|NCT01982812|588701888|FG000|Overall Study|Death|1|||
163000607|NCT01982812|588701889|FG001|Overall Study|Death|5|||
163000608|NCT01982812|588701888|FG000|Overall Study|Adverse Event|0|||
163000609|NCT01982812|588701889|FG001|Overall Study|Adverse Event|5|||
163000610|NCT00307437|588701893|FG000|Controlled Period|Adverse Event|7|||
163000611|NCT00307437|588701894|FG001|Controlled Period|Adverse Event|2|||
163000612|NCT00307437|588701895|FG002|Controlled Period|Adverse Event|5|||
163000613|NCT00307437|588701896|FG003|Controlled Period|Adverse Event|0|||
163000614|NCT00307437|588701897|FG004|Controlled Period|Adverse Event|0|||
163000615|NCT00307437|588701898|FG005|Controlled Period|Adverse Event|0|||
163000616|NCT00307437|588701899|FG006|Controlled Period|Adverse Event|0|||
163000617|NCT00307437|588701893|FG000|Controlled Period|Death|0|||
163000618|NCT00307437|588701894|FG001|Controlled Period|Death|0|||
163000619|NCT00307437|588701895|FG002|Controlled Period|Death|1|||
163000620|NCT00307437|588701896|FG003|Controlled Period|Death|0|||
163000621|NCT00307437|588701897|FG004|Controlled Period|Death|0|||
163000622|NCT00307437|588701898|FG005|Controlled Period|Death|0|||
163000623|NCT00307437|588701899|FG006|Controlled Period|Death|0|||
163000624|NCT00307437|588701893|FG000|Controlled Period|Lack of Efficacy|2|||
163000625|NCT00307437|588701894|FG001|Controlled Period|Lack of Efficacy|0|||
163000626|NCT00307437|588701895|FG002|Controlled Period|Lack of Efficacy|0|||
163000627|NCT00307437|588701896|FG003|Controlled Period|Lack of Efficacy|0|||
163000628|NCT00307437|588701897|FG004|Controlled Period|Lack of Efficacy|0|||
163000629|NCT00307437|588701898|FG005|Controlled Period|Lack of Efficacy|0|||
163000630|NCT00307437|588701899|FG006|Controlled Period|Lack of Efficacy|0|||
163000631|NCT00307437|588701893|FG000|Controlled Period|Lost to Follow-up|2|||
163000632|NCT00307437|588701894|FG001|Controlled Period|Lost to Follow-up|3|||
163000633|NCT00307437|588701895|FG002|Controlled Period|Lost to Follow-up|0|||
163000634|NCT00307437|588701896|FG003|Controlled Period|Lost to Follow-up|0|||
163000635|NCT00307437|588701897|FG004|Controlled Period|Lost to Follow-up|0|||
163000636|NCT00307437|588701898|FG005|Controlled Period|Lost to Follow-up|0|||
163000637|NCT00307437|588701899|FG006|Controlled Period|Lost to Follow-up|0|||
163000638|NCT00307437|588701893|FG000|Controlled Period|Other|5|||
163000639|NCT00307437|588701894|FG001|Controlled Period|Other|1|||
163000640|NCT00307437|588701895|FG002|Controlled Period|Other|3|||
163000641|NCT00307437|588701896|FG003|Controlled Period|Other|0|||
163000642|NCT00307437|588701897|FG004|Controlled Period|Other|0|||
163000643|NCT00307437|588701898|FG005|Controlled Period|Other|0|||
163000644|NCT00307437|588701899|FG006|Controlled Period|Other|0|||
163000645|NCT00307437|588701893|FG000|After Controlled Period|Adverse Event|0|||
163000646|NCT00307437|588701894|FG001|After Controlled Period|Adverse Event|0|||
163000647|NCT00307437|588701895|FG002|After Controlled Period|Adverse Event|0|||
163000648|NCT00307437|588701896|FG003|After Controlled Period|Adverse Event|18|||
163000649|NCT00307437|588701897|FG004|After Controlled Period|Adverse Event|16|||
163000650|NCT00307437|588701898|FG005|After Controlled Period|Adverse Event|31|||
163000651|NCT00307437|588701899|FG006|After Controlled Period|Adverse Event|40|||
163000652|NCT00307437|588701893|FG000|After Controlled Period|Death|0|||
163000653|NCT00307437|588701894|FG001|After Controlled Period|Death|0|||
163000654|NCT00307437|588701895|FG002|After Controlled Period|Death|0|||
163000655|NCT00307437|588701896|FG003|After Controlled Period|Death|3|||
163000656|NCT00307437|588701897|FG004|After Controlled Period|Death|1|||
163000657|NCT00307437|588701898|FG005|After Controlled Period|Death|1|||
163325021|NCT03391466|589902858|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
163000658|NCT00307437|588701899|FG006|After Controlled Period|Death|3|||
163000659|NCT00307437|588701893|FG000|After Controlled Period|Lack of Efficacy|0|||
163000660|NCT00307437|588701894|FG001|After Controlled Period|Lack of Efficacy|0|||
163000661|NCT00307437|588701895|FG002|After Controlled Period|Lack of Efficacy|0|||
163000662|NCT00307437|588701896|FG003|After Controlled Period|Lack of Efficacy|15|||
163000663|NCT00307437|588701897|FG004|After Controlled Period|Lack of Efficacy|17|||
163000664|NCT00307437|588701898|FG005|After Controlled Period|Lack of Efficacy|37|||
163000665|NCT00307437|588701899|FG006|After Controlled Period|Lack of Efficacy|24|||
163000666|NCT00307437|588701893|FG000|After Controlled Period|Lost to Follow-up|0|||
163000667|NCT00307437|588701894|FG001|After Controlled Period|Lost to Follow-up|0|||
163000668|NCT00307437|588701895|FG002|After Controlled Period|Lost to Follow-up|0|||
163325022|NCT03391466|589902857|FG000|Overall Study|Lost to Follow-up|9|||
163000669|NCT00307437|588701896|FG003|After Controlled Period|Lost to Follow-up|7|||
163000670|NCT00307437|588701897|FG004|After Controlled Period|Lost to Follow-up|12|||
163325023|NCT03391466|589902858|FG001|Overall Study|Lost to Follow-up|5|||
163000671|NCT00307437|588701898|FG005|After Controlled Period|Lost to Follow-up|13|||
163000672|NCT00307437|588701899|FG006|After Controlled Period|Lost to Follow-up|18|||
163000673|NCT00307437|588701893|FG000|After Controlled Period|Other|0|||
163213088|NCT00778700|589494356|FG003|Overall Study|Subject Withdrew Consent|4|||
163213089|NCT00778700|589494353|FG000|Overall Study|Lost to Follow-up|3|||
163213090|NCT00778700|589494354|FG001|Overall Study|Lost to Follow-up|1|||
163213091|NCT00778700|589494355|FG002|Overall Study|Lost to Follow-up|0|||
163213092|NCT00778700|589494356|FG003|Overall Study|Lost to Follow-up|1|||
163213093|NCT00778700|589494353|FG000|Overall Study|Reason not Specified|2|||
163213094|NCT00778700|589494354|FG001|Overall Study|Reason not Specified|0|||
163213095|NCT00778700|589494355|FG002|Overall Study|Reason not Specified|1|||
163213096|NCT00778700|589494356|FG003|Overall Study|Reason not Specified|3|||
163000674|NCT00307437|588701894|FG001|After Controlled Period|Other|0|||
163000675|NCT00307437|588701895|FG002|After Controlled Period|Other|0|||
163000676|NCT00307437|588701896|FG003|After Controlled Period|Other|15|||
163000677|NCT00307437|588701897|FG004|After Controlled Period|Other|9|||
163000678|NCT00307437|588701898|FG005|After Controlled Period|Other|40|||
163000679|NCT00307437|588701899|FG006|After Controlled Period|Other|28|||
163000680|NCT03017612|588701902|FG000|Overall Study|Adverse Event|2|||
163000681|NCT00985491|588701904|FG000|Overall Study|Adverse Event|8|||
163000682|NCT00985491|588701904|FG000|Overall Study|device migration|7|||
163000683|NCT00985491|588701904|FG000|Overall Study|Withdrawal by Subject|1|||
163000684|NCT00985491|588701904|FG000|Overall Study|implant failure|3|||
163000685|NCT01893346|588701905|FG000|Overall Study|Lost to Follow-up|0|||
163000686|NCT01893346|588701906|FG001|Overall Study|Lost to Follow-up|1|||
163000687|NCT01893346|588701907|FG002|Overall Study|Lost to Follow-up|0|||
163000688|NCT01893346|588701908|FG003|Overall Study|Lost to Follow-up|0|||
163000689|NCT01893346|588701905|FG000|Overall Study|Protocol Violation|1|||
163000690|NCT01893346|588701906|FG001|Overall Study|Protocol Violation|0|||
163000691|NCT01893346|588701907|FG002|Overall Study|Protocol Violation|0|||
163000692|NCT01893346|588701908|FG003|Overall Study|Protocol Violation|0|||
163000693|NCT01893346|588701905|FG000|Overall Study|Withdrawal by Subject|2|||
163000694|NCT01893346|588701906|FG001|Overall Study|Withdrawal by Subject|0|||
163000695|NCT01893346|588701907|FG002|Overall Study|Withdrawal by Subject|0|||
163000696|NCT01893346|588701908|FG003|Overall Study|Withdrawal by Subject|0|||
163000697|NCT00352417|588701911|FG000|Overall Study|Adverse Event|1|||
163000698|NCT00352417|588701912|FG001|Overall Study|Adverse Event|0|||
163000699|NCT00352417|588701911|FG000|Overall Study|Protocol Violation|0|||
163000700|NCT00352417|588701912|FG001|Overall Study|Protocol Violation|2|||
163000701|NCT00352417|588701911|FG000|Overall Study|Withdrawal by Subject|1|||
163000702|NCT00352417|588701912|FG001|Overall Study|Withdrawal by Subject|2|||
163000703|NCT00352417|588701911|FG000|Overall Study|Lost to Follow-up|1|||
163000704|NCT00352417|588701912|FG001|Overall Study|Lost to Follow-up|0|||
163000705|NCT00352417|588701911|FG000|Overall Study|Schedule Change|2|||
163000706|NCT00352417|588701912|FG001|Overall Study|Schedule Change|1|||
163000707|NCT00912912|588701913|FG000|Overall Study|Withdrawal by Subject|1|||
163000708|NCT00912912|588701913|FG000|Overall Study|Disease Progression|3|||
163000709|NCT02447744|588701914|FG000|Overall Study|Withdrawal by Subject|3|||
163000710|NCT02447744|588701915|FG001|Overall Study|Withdrawal by Subject|1|||
163000711|NCT02447744|588701914|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
163000712|NCT02447744|588701915|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
163000713|NCT00306995|588701916|FG000|Study Part I|Withdrawal by Subject|0|||
163000714|NCT00306995|588701917|FG001|Study Part I|Withdrawal by Subject|0|||
163000715|NCT00306995|588701918|FG002|Study Part I|Withdrawal by Subject|0|||
163213097|NCT00778700|589494353|FG000|Overall Study|Other|0|||
163213098|NCT00778700|589494354|FG001|Overall Study|Other|0|||
163213099|NCT00778700|589494355|FG002|Overall Study|Other|1|||
163404369|NCT00522431|590191915|FG000|Overall Study|Protocol Violation|2|||
163000716|NCT00306995|588701919|FG003|Study Part I|Withdrawal by Subject|0|||
163000717|NCT00306995|588701920|FG004|Study Part I|Withdrawal by Subject|0|||
163000718|NCT00306995|588701921|FG005|Study Part I|Withdrawal by Subject|0|||
163000719|NCT00306995|588701922|FG006|Study Part I|Withdrawal by Subject|1|||
163000720|NCT00306995|588701916|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
163000721|NCT00306995|588701917|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
163000722|NCT00306995|588701918|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
163000723|NCT00306995|588701919|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
163000724|NCT00306995|588701920|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
163000725|NCT00306995|588701921|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
163000726|NCT00306995|588701922|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
163000727|NCT06419907|588703646|FG000|Overall Study|Protocol Violation|0|||
163213100|NCT00778700|589494356|FG003|Overall Study|Other|0|||
163213101|NCT03274440|589494359|FG000|Overall Study|Time commitment too great|1|||
163213102|NCT03274440|589494360|FG001|Overall Study|Time commitment too great|0|||
163213103|NCT03274440|589494361|FG002|Overall Study|Time commitment too great|0|||
163000728|NCT06419907|588703647|FG001|Overall Study|Protocol Violation|3|||
163000729|NCT06419907|588703648|FG002|Overall Study|Protocol Violation|0|||
163000730|NCT06419907|588703649|FG003|Overall Study|Protocol Violation|1|||
163000731|NCT06419907|588703646|FG000|Overall Study|Lost to Follow-up|0|||
163000732|NCT06419907|588703647|FG001|Overall Study|Lost to Follow-up|0|||
163000733|NCT06419907|588703648|FG002|Overall Study|Lost to Follow-up|2|||
163213104|NCT03274440|589494362|FG003|Overall Study|Time commitment too great|1|||
163000734|NCT06419907|588703649|FG003|Overall Study|Lost to Follow-up|1|||
163000735|NCT03573830|588703650|FG000|Overall Study|Dropped without completing treatment|0|||
163000736|NCT03573830|588703651|FG001|Overall Study|Dropped without completing treatment|7|||
163000737|NCT03573830|588703650|FG000|Overall Study|Lost to Follow-up|4|||
163000738|NCT03573830|588703651|FG001|Overall Study|Lost to Follow-up|0|||
163000739|NCT00266630|588703652|FG000|Overall Study|Adverse Event|8|||
163000740|NCT00266630|588703653|FG001|Overall Study|Adverse Event|6|||
163000741|NCT00266630|588703652|FG000|Overall Study|Lack of Efficacy|1|||
163000742|NCT00266630|588703653|FG001|Overall Study|Lack of Efficacy|4|||
163000743|NCT00266630|588703652|FG000|Overall Study|Entry Criteria not met|1|||
163000744|NCT00266630|588703653|FG001|Overall Study|Entry Criteria not met|0|||
163000745|NCT00266630|588703652|FG000|Overall Study|Protocol Violation|1|||
163000746|NCT00266630|588703653|FG001|Overall Study|Protocol Violation|3|||
163000747|NCT00266630|588703652|FG000|Overall Study|Physician Decision|1|||
163000748|NCT00266630|588703653|FG001|Overall Study|Physician Decision|2|||
163000749|NCT00266630|588703652|FG000|Overall Study|Withdrawal by Subject|10|||
163000750|NCT00266630|588703653|FG001|Overall Study|Withdrawal by Subject|2|||
163000751|NCT00266630|588703652|FG000|Overall Study|Lost to Follow-up|1|||
163000752|NCT00266630|588703653|FG001|Overall Study|Lost to Follow-up|0|||
163000753|NCT00266630|588703652|FG000|Overall Study|Other|19|||
163000754|NCT00266630|588703653|FG001|Overall Study|Other|11|||
163000755|NCT03284723|588703658|FG000|Overall Study|Death|0|||
163000756|NCT03284723|588703659|FG001|Overall Study|Death|0|||
163000757|NCT03284723|588703660|FG002|Overall Study|Death|0|||
163000758|NCT03284723|588703661|FG003|Overall Study|Death|1|||
163000759|NCT03284723|588703662|FG004|Overall Study|Death|0|||
163000760|NCT03284723|588703663|FG005|Overall Study|Death|0|||
163000761|NCT03284723|588703664|FG006|Overall Study|Death|1|||
163000762|NCT03284723|588703665|FG007|Overall Study|Death|0|||
163000763|NCT03284723|588703666|FG008|Overall Study|Death|0|||
163000764|NCT03284723|588703667|FG009|Overall Study|Death|2|||
163000765|NCT03284723|588703668|FG010|Overall Study|Death|1|||
163000766|NCT03284723|588703669|FG011|Overall Study|Death|0|||
163000767|NCT03284723|588703658|FG000|Overall Study|Lost to Follow-up|0|||
163000768|NCT03284723|588703659|FG001|Overall Study|Lost to Follow-up|0|||
163000769|NCT03284723|588703660|FG002|Overall Study|Lost to Follow-up|0|||
163000770|NCT03284723|588703661|FG003|Overall Study|Lost to Follow-up|0|||
163000771|NCT03284723|588703662|FG004|Overall Study|Lost to Follow-up|0|||
163000772|NCT03284723|588703663|FG005|Overall Study|Lost to Follow-up|2|||
163000773|NCT03284723|588703664|FG006|Overall Study|Lost to Follow-up|1|||
163000774|NCT03284723|588703665|FG007|Overall Study|Lost to Follow-up|0|||
163000775|NCT03284723|588703666|FG008|Overall Study|Lost to Follow-up|0|||
163000776|NCT03284723|588703667|FG009|Overall Study|Lost to Follow-up|2|||
163000777|NCT03284723|588703668|FG010|Overall Study|Lost to Follow-up|0|||
163000778|NCT03284723|588703669|FG011|Overall Study|Lost to Follow-up|0|||
163000779|NCT03284723|588703658|FG000|Overall Study|Study Terminated By Sponsor|0|||
163000780|NCT03284723|588703659|FG001|Overall Study|Study Terminated By Sponsor|0|||
163000781|NCT03284723|588703660|FG002|Overall Study|Study Terminated By Sponsor|0|||
163000782|NCT03284723|588703661|FG003|Overall Study|Study Terminated By Sponsor|0|||
163000783|NCT03284723|588703662|FG004|Overall Study|Study Terminated By Sponsor|1|||
163000784|NCT03284723|588703663|FG005|Overall Study|Study Terminated By Sponsor|0|||
163000785|NCT03284723|588703664|FG006|Overall Study|Study Terminated By Sponsor|0|||
163000786|NCT03284723|588703665|FG007|Overall Study|Study Terminated By Sponsor|0|||
163213105|NCT03274440|589494363|FG004|Overall Study|Time commitment too great|0|||
163213106|NCT03274440|589494364|FG005|Overall Study|Time commitment too great|0|||
163213107|NCT00450450|589494365|FG000|Overall Study|Death|1|||
163213108|NCT00450450|589494366|FG001|Overall Study|Death|3|||
163000787|NCT03284723|588703666|FG008|Overall Study|Study Terminated By Sponsor|1|||
163000788|NCT03284723|588703667|FG009|Overall Study|Study Terminated By Sponsor|1|||
163000789|NCT03284723|588703668|FG010|Overall Study|Study Terminated By Sponsor|1|||
163000790|NCT03284723|588703669|FG011|Overall Study|Study Terminated By Sponsor|1|||
163000791|NCT03284723|588703658|FG000|Overall Study|Withdrawal by Subject|0|||
163000792|NCT03284723|588703659|FG001|Overall Study|Withdrawal by Subject|0|||
163000793|NCT03284723|588703660|FG002|Overall Study|Withdrawal by Subject|0|||
163000794|NCT03284723|588703661|FG003|Overall Study|Withdrawal by Subject|0|||
163000795|NCT03284723|588703662|FG004|Overall Study|Withdrawal by Subject|5|||
163000796|NCT03284723|588703663|FG005|Overall Study|Withdrawal by Subject|3|||
163000797|NCT03284723|588703664|FG006|Overall Study|Withdrawal by Subject|1|||
163000798|NCT03284723|588703665|FG007|Overall Study|Withdrawal by Subject|0|||
163000799|NCT03284723|588703666|FG008|Overall Study|Withdrawal by Subject|6|||
163000800|NCT03284723|588703667|FG009|Overall Study|Withdrawal by Subject|0|||
163000801|NCT03284723|588703668|FG010|Overall Study|Withdrawal by Subject|3|||
163000802|NCT03284723|588703669|FG011|Overall Study|Withdrawal by Subject|1|||
163000803|NCT03284723|588703658|FG000|Overall Study|Other|1|||
163000804|NCT03284723|588703659|FG001|Overall Study|Other|0|||
163000805|NCT03284723|588703660|FG002|Overall Study|Other|1|||
163000806|NCT03284723|588703661|FG003|Overall Study|Other|0|||
163000807|NCT03284723|588703662|FG004|Overall Study|Other|1|||
163000808|NCT03284723|588703663|FG005|Overall Study|Other|0|||
163213109|NCT00450450|589494365|FG000|Overall Study|Relapse|2|||
163000809|NCT03284723|588703664|FG006|Overall Study|Other|0|||
163000810|NCT03284723|588703665|FG007|Overall Study|Other|0|||
163000811|NCT03284723|588703666|FG008|Overall Study|Other|0|||
163000812|NCT03284723|588703667|FG009|Overall Study|Other|0|||
163000813|NCT03284723|588703668|FG010|Overall Study|Other|1|||
163000814|NCT03284723|588703669|FG011|Overall Study|Other|0|||
163000815|NCT03284723|588703658|FG000|Overall Study|Adverse Event|0|||
163000816|NCT03284723|588703659|FG001|Overall Study|Adverse Event|0|||
163000817|NCT03284723|588703660|FG002|Overall Study|Adverse Event|0|||
163000818|NCT03284723|588703661|FG003|Overall Study|Adverse Event|0|||
163000819|NCT03284723|588703662|FG004|Overall Study|Adverse Event|0|||
163213110|NCT00450450|589494366|FG001|Overall Study|Relapse|0|||
163213111|NCT00450450|589494365|FG000|Overall Study|Missing Data|2|||
163213112|NCT00450450|589494366|FG001|Overall Study|Missing Data|0|||
163213113|NCT02150954|589494369|FG000|Overall Study|Protocol Violation|1|||
163213114|NCT02150954|589494370|FG001|Overall Study|Protocol Violation|0|||
163213115|NCT02611778|589494376|FG000|Overall Study|Withdrawal by Subject|2|||
163213116|NCT02611778|589494377|FG001|Overall Study|Withdrawal by Subject|8|||
163000820|NCT03284723|588703663|FG005|Overall Study|Adverse Event|0|||
163000821|NCT03284723|588703664|FG006|Overall Study|Adverse Event|0|||
163000822|NCT03284723|588703665|FG007|Overall Study|Adverse Event|0|||
163000823|NCT03284723|588703666|FG008|Overall Study|Adverse Event|1|||
163000824|NCT03284723|588703667|FG009|Overall Study|Adverse Event|0|||
163000825|NCT03284723|588703668|FG010|Overall Study|Adverse Event|0|||
163000826|NCT03284723|588703669|FG011|Overall Study|Adverse Event|0|||
163000827|NCT00064987|588703674|FG000|Overall Study|Physician Decision|3|||
163000828|NCT00064987|588703675|FG001|Overall Study|Physician Decision|0|||
163000829|NCT01499095|588703676|FG000|Overall Study|Randomized But Not Treated|1|||
163213117|NCT02611778|589494376|FG000|Overall Study|Adverse Event|1|||
163213118|NCT02611778|589494377|FG001|Overall Study|Adverse Event|2|||
163213119|NCT02611778|589494376|FG000|Overall Study|Death|2|||
163213120|NCT02611778|589494377|FG001|Overall Study|Death|1|||
163213121|NCT02611778|589494376|FG000|Overall Study|Protocol Violation|1|||
163213122|NCT02611778|589494377|FG001|Overall Study|Protocol Violation|0|||
163213123|NCT02611778|589494376|FG000|Overall Study|Lost to Follow-up|3|||
163213124|NCT02611778|589494377|FG001|Overall Study|Lost to Follow-up|1|||
163213125|NCT02611778|589494376|FG000|Overall Study|Need for alternative treatment|1|||
163213126|NCT02611778|589494377|FG001|Overall Study|Need for alternative treatment|0|||
163213127|NCT02611778|589494376|FG000|Overall Study|Other Reason|2|||
163213128|NCT02611778|589494377|FG001|Overall Study|Other Reason|1|||
163213129|NCT04008030|589494379|FG000|Pre-Treatment|Withdrawal by Subject|0|||
163213130|NCT04008030|589494380|FG001|Pre-Treatment|Withdrawal by Subject|0|||
163213131|NCT04008030|589494381|FG002|Pre-Treatment|Withdrawal by Subject|9|||
163213132|NCT04008030|589494379|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
163213133|NCT04008030|589494380|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
163213134|NCT04008030|589494381|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
163213135|NCT04008030|589494379|FG000|Pre-Treatment|Other reasons|0|||
163213136|NCT04008030|589494380|FG001|Pre-Treatment|Other reasons|1|||
163213137|NCT04008030|589494381|FG002|Pre-Treatment|Other reasons|6|||
163213138|NCT04008030|589494379|FG000|Treatment|Withdrawal by Subject|1|||
163213139|NCT04008030|589494380|FG001|Treatment|Withdrawal by Subject|1|||
163213140|NCT04008030|589494381|FG002|Treatment|Withdrawal by Subject|1|||
163213141|NCT04008030|589494379|FG000|Treatment|Death|2|||
163213142|NCT04008030|589494380|FG001|Treatment|Death|4|||
163213143|NCT04008030|589494381|FG002|Treatment|Death|0|||
163213144|NCT04008030|589494379|FG000|Treatment|Pregnancy|0|||
163213145|NCT04008030|589494380|FG001|Treatment|Pregnancy|1|||
163213146|NCT04008030|589494381|FG002|Treatment|Pregnancy|0|||
163000830|NCT01499095|588703677|FG001|Overall Study|Randomized But Not Treated|1|||
163000831|NCT01499095|588703676|FG000|Overall Study|Adverse Event|12|||
163000832|NCT01499095|588703677|FG001|Overall Study|Adverse Event|7|||
163000833|NCT01499095|588703676|FG000|Overall Study|Lack of Efficacy|2|||
163000834|NCT01499095|588703677|FG001|Overall Study|Lack of Efficacy|1|||
163325024|NCT03391466|589902857|FG000|Overall Study|Reason Not Specified|2|||
163325025|NCT03391466|589902858|FG001|Overall Study|Reason Not Specified|2|||
163325026|NCT03391466|589902857|FG000|Overall Study|Investigator Decision|0|||
163000835|NCT01499095|588703676|FG000|Overall Study|Protocol Violation|6|||
163000836|NCT01499095|588703677|FG001|Overall Study|Protocol Violation|7|||
163325027|NCT03391466|589902858|FG001|Overall Study|Investigator Decision|1|||
163000837|NCT01499095|588703676|FG000|Overall Study|Received Rescue Therapy|32|||
163000838|NCT01499095|588703677|FG001|Overall Study|Received Rescue Therapy|40|||
163213147|NCT04008030|589494379|FG000|Treatment|Participant no longer meets study criteria|0|||
163213148|NCT04008030|589494380|FG001|Treatment|Participant no longer meets study criteria|1|||
163213149|NCT04008030|589494381|FG002|Treatment|Participant no longer meets study criteria|0|||
163000839|NCT01499095|588703676|FG000|Overall Study|Diverse Reasons|22|||
163000840|NCT01499095|588703677|FG001|Overall Study|Diverse Reasons|25|||
163213150|NCT04008030|589494379|FG000|Treatment|Other reasons|5|||
163213151|NCT04008030|589494380|FG001|Treatment|Other reasons|13|||
163213152|NCT04008030|589494381|FG002|Treatment|Other reasons|6|||
163325028|NCT03140670|589902859|FG000|Overall Study|Withdrawal by Subject|2|||
163000841|NCT01499095|588703676|FG000|Overall Study|Lost to Follow-up|6|||
163000842|NCT01499095|588703677|FG001|Overall Study|Lost to Follow-up|4|||
163000843|NCT01499095|588703676|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
163000844|NCT01499095|588703677|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
163000845|NCT01499095|588703676|FG000|Overall Study|Hypoglycemia|3|||
163000846|NCT01499095|588703677|FG001|Overall Study|Hypoglycemia|1|||
163000847|NCT01499095|588703676|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
163000848|NCT01499095|588703677|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
163000849|NCT01499095|588703676|FG000|Overall Study|Change in Injection Schedule|2|||
163000850|NCT01499095|588703677|FG001|Overall Study|Change in Injection Schedule|0|||
163000851|NCT01499095|588703676|FG000|Overall Study|Perceived Lack of Efficacy|1|||
163000852|NCT01499095|588703677|FG001|Overall Study|Perceived Lack of Efficacy|1|||
163000853|NCT01368497|588703678|FG000|Overall Study|Lost to Follow-up|2|||
163000854|NCT00443729|588703682|FG000|Overall Study|Never Treated|0|||
163000855|NCT00443729|588703683|FG001|Overall Study|Never Treated|1|||
163000856|NCT00443729|588703682|FG000|Overall Study|Lack of Efficacy|4|||
163000857|NCT00443729|588703683|FG001|Overall Study|Lack of Efficacy|2|||
163000858|NCT00443729|588703682|FG000|Overall Study|Lost to Follow-up|0|||
163000859|NCT00443729|588703683|FG001|Overall Study|Lost to Follow-up|1|||
163000860|NCT00443729|588703682|FG000|Overall Study|Physician Decision|2|||
163000861|NCT00443729|588703683|FG001|Overall Study|Physician Decision|1|||
163000862|NCT00443729|588703682|FG000|Overall Study|Protocol Violation|1|||
163000863|NCT00443729|588703683|FG001|Overall Study|Protocol Violation|1|||
163000864|NCT00443729|588703682|FG000|Overall Study|Withdrawal by Subject|3|||
163000865|NCT00443729|588703683|FG001|Overall Study|Withdrawal by Subject|1|||
163000866|NCT00782626|588703687|FG000|Overall Study|Adverse Event|1|||
163000867|NCT00782626|588703687|FG000|Overall Study|Progressive Disease|5|||
163000868|NCT00782626|588703687|FG000|Overall Study|Other Complicating Disease|1|||
163000869|NCT00077207|588703690|FG000|Overall Study|Adverse Event|5|||
163000870|NCT00077207|588703690|FG000|Overall Study|Lack of Efficacy|12|||
163000871|NCT00077207|588703690|FG000|Overall Study|Physician Decision|6|||
163000872|NCT00077207|588703690|FG000|Overall Study|Withdrawal by Subject|6|||
163000873|NCT00077207|588703690|FG000|Overall Study|Ineligible|1|||
163000874|NCT03052751|588703693|FG000|Dosing Period 1|Adverse Event|0|||
163000875|NCT03052751|588703694|FG001|Dosing Period 1|Adverse Event|1|||
163000876|NCT03052751|588703695|FG002|Dosing Period 1|Adverse Event|0|||
163000877|NCT03052751|588703696|FG003|Dosing Period 1|Adverse Event|0|||
163000878|NCT03052751|588703697|FG004|Dosing Period 1|Adverse Event|0|||
163000879|NCT03052751|588703698|FG005|Dosing Period 1|Adverse Event|0|||
163000880|NCT03052751|588703693|FG000|Dosing Period 2|Adverse Event|0|||
163000881|NCT03052751|588703694|FG001|Dosing Period 2|Adverse Event|0|||
163000882|NCT03052751|588703695|FG002|Dosing Period 2|Adverse Event|3|||
163000883|NCT03052751|588703696|FG003|Dosing Period 2|Adverse Event|0|||
163000884|NCT03052751|588703697|FG004|Dosing Period 2|Adverse Event|0|||
163000885|NCT03052751|588703698|FG005|Dosing Period 2|Adverse Event|0|||
163000886|NCT03052751|588703693|FG000|Observation Period|Adverse Event|0|||
163000887|NCT03052751|588703694|FG001|Observation Period|Adverse Event|0|||
163000888|NCT03052751|588703695|FG002|Observation Period|Adverse Event|0|||
163000889|NCT03052751|588703696|FG003|Observation Period|Adverse Event|0|||
163000890|NCT03052751|588703697|FG004|Observation Period|Adverse Event|1|||
163000891|NCT03052751|588703698|FG005|Observation Period|Adverse Event|0|||
163000892|NCT01427608|588703703|FG000|Overall Study|Death|1|||
163000893|NCT01427608|588703704|FG001|Overall Study|Death|0|||
163000894|NCT01427608|588703703|FG000|Overall Study|Withdrawal by Subject|7|||
163000895|NCT01427608|588703704|FG001|Overall Study|Withdrawal by Subject|3|||
163000896|NCT01427608|588703703|FG000|Overall Study|Relapsed-all cause|13|||
163000897|NCT01427608|588703704|FG001|Overall Study|Relapsed-all cause|34|||
163000898|NCT01427608|588703703|FG000|Overall Study|Events not attributed to study meds|0|||
163000899|NCT01427608|588703704|FG001|Overall Study|Events not attributed to study meds|1|||
163000900|NCT01027702|588703707|FG000|Overall Study|Received subsequent therapy|1|||
163000901|NCT01027702|588703708|FG001|Overall Study|Received subsequent therapy|2|||
163000902|NCT01027702|588703709|FG002|Overall Study|Received subsequent therapy|0|||
163000903|NCT01027702|588703710|FG003|Overall Study|Received subsequent therapy|4|||
163000904|NCT01027702|588703711|FG004|Overall Study|Received subsequent therapy|1|||
163000905|NCT01027702|588703712|FG005|Overall Study|Received subsequent therapy|0|||
163000906|NCT01027702|588703713|FG006|Overall Study|Received subsequent therapy|1|||
163000907|NCT01027702|588703707|FG000|Overall Study|Death|0|||
163000908|NCT01027702|588703708|FG001|Overall Study|Death|0|||
163000909|NCT01027702|588703709|FG002|Overall Study|Death|1|||
163000910|NCT01027702|588703710|FG003|Overall Study|Death|0|||
163000911|NCT01027702|588703711|FG004|Overall Study|Death|0|||
163000912|NCT01027702|588703712|FG005|Overall Study|Death|0|||
163000913|NCT01027702|588703713|FG006|Overall Study|Death|0|||
163000914|NCT00403585|588703714|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
163000915|NCT00403585|588703714|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
163000916|NCT00403585|588703714|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
163000917|NCT02862730|588703717|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
163000918|NCT02862730|588703718|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
163213153|NCT04008030|589494379|FG000|Treatment|Disease Progression|137|||
163213154|NCT04008030|589494380|FG001|Treatment|Disease Progression|82|||
163213155|NCT04008030|589494381|FG002|Treatment|Disease Progression|85|||
163213156|NCT04008030|589494379|FG000|Treatment|Study drug toxicity|28|||
163213157|NCT04008030|589494380|FG001|Treatment|Study drug toxicity|48|||
163213158|NCT04008030|589494381|FG002|Treatment|Study drug toxicity|8|||
163213159|NCT04008030|589494379|FG000|Treatment|Adverse Event unrelated to study drug|28|||
163213160|NCT04008030|589494380|FG001|Treatment|Adverse Event unrelated to study drug|22|||
163213161|NCT04008030|589494381|FG002|Treatment|Adverse Event unrelated to study drug|6|||
163213162|NCT04008030|589494379|FG000|Treatment|Maximum Clinical Benefit|0|||
163213163|NCT04008030|589494380|FG001|Treatment|Maximum Clinical Benefit|1|||
163213164|NCT04008030|589494381|FG002|Treatment|Maximum Clinical Benefit|9|||
163213165|NCT04008030|589494379|FG000|Treatment|On-going treatment|13|||
163213166|NCT04008030|589494380|FG001|Treatment|On-going treatment|20|||
163213167|NCT04008030|589494381|FG002|Treatment|On-going treatment|0|||
163213168|NCT02574247|589494388|FG000|Overall Study|Withdrawal by Subject|1|||
163213169|NCT02574247|589494389|FG001|Overall Study|Withdrawal by Subject|0|||
163213170|NCT02574247|589494390|FG002|Overall Study|Withdrawal by Subject|0|||
163213171|NCT02574247|589494388|FG000|Overall Study|Did not meet inclusion criteria|4|||
163213172|NCT02574247|589494389|FG001|Overall Study|Did not meet inclusion criteria|3|||
163213173|NCT02574247|589494390|FG002|Overall Study|Did not meet inclusion criteria|5|||
163213174|NCT02268864|589494391|FG000|Overall Study|Withdrawal by Subject|2|||
163213175|NCT02268864|589494392|FG001|Overall Study|Withdrawal by Subject|0|||
163213176|NCT02268864|589494393|FG002|Overall Study|Withdrawal by Subject|0|||
163213177|NCT02268864|589494391|FG000|Overall Study|Death|0|||
163213178|NCT02268864|589494392|FG001|Overall Study|Death|1|||
163213179|NCT02268864|589494393|FG002|Overall Study|Death|0|||
163213180|NCT01528254|589494398|FG000|Overall Study|Administrative problems|96|||
163213181|NCT01528254|589494399|FG001|Overall Study|Administrative problems|94|||
163213182|NCT01528254|589494398|FG000|Overall Study|Adverse Event|28|||
163213183|NCT01528254|589494399|FG001|Overall Study|Adverse Event|44|||
163213184|NCT01528254|589494398|FG000|Overall Study|Lost to Follow-up|17|||
163325029|NCT03140670|589902859|FG000|Overall Study|Lost to Follow-up|1|||
163325030|NCT03140670|589902859|FG000|Overall Study|Physician Decision|1|||
163325031|NCT00220805|589902860|FG000|Overall Study|Adverse Event|1|||
163325032|NCT00220805|589902861|FG001|Overall Study|Adverse Event|3|||
163325033|NCT00220805|589902860|FG000|Overall Study|Withdrawal by Subject|3|||
163325034|NCT00220805|589902861|FG001|Overall Study|Withdrawal by Subject|0|||
163325035|NCT00220805|589902860|FG000|Overall Study|Lack of Efficacy|1|||
163325036|NCT00220805|589902861|FG001|Overall Study|Lack of Efficacy|0|||
163325037|NCT00220805|589902860|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
163325038|NCT00220805|589902861|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
163325039|NCT02325466|589902862|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
163000919|NCT02862730|588703719|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
163000920|NCT02862730|588703720|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
163000921|NCT02862730|588703721|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
163000922|NCT02862730|588703722|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
163000923|NCT02862730|588703723|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
163000924|NCT02862730|588703717|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
163000925|NCT02862730|588703718|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
163000926|NCT02862730|588703719|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
163000927|NCT02862730|588703720|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
163000928|NCT02862730|588703721|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
163000929|NCT02862730|588703722|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
163000930|NCT02862730|588703723|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
163000931|NCT02862730|588703717|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
163000932|NCT02862730|588703718|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
163000933|NCT02862730|588703719|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
163000934|NCT02862730|588703720|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
163000935|NCT02862730|588703721|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
163325040|NCT02325466|589902863|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
163000936|NCT02862730|588703722|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
163000937|NCT02862730|588703723|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
163213185|NCT01528254|589494399|FG001|Overall Study|Lost to Follow-up|24|||
163213186|NCT01528254|589494398|FG000|Overall Study|Death|13|||
163213187|NCT01528254|589494399|FG001|Overall Study|Death|9|||
163213188|NCT01528254|589494398|FG000|Overall Study|Protocol deviation|9|||
163213189|NCT01528254|589494399|FG001|Overall Study|Protocol deviation|19|||
163213190|NCT01528254|589494398|FG000|Overall Study|New therapy for study indication|8|||
163213191|NCT01528254|589494399|FG001|Overall Study|New therapy for study indication|6|||
163213192|NCT01528254|589494398|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
163213193|NCT01528254|589494399|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
163325041|NCT02325466|589902864|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
163404370|NCT00522431|590191915|FG000|Overall Study|Withdrawal by Subject|2|||
163000938|NCT02862730|588703717|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
163000939|NCT02862730|588703718|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
163000940|NCT02862730|588703719|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
163000941|NCT02862730|588703720|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
163000942|NCT02862730|588703721|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
163000943|NCT02862730|588703722|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
163000944|NCT02862730|588703723|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
163000945|NCT03022370|588703724|FG000|Overall Study|Death|6|||
163000946|NCT03022370|588703725|FG001|Overall Study|Death|12|||
163000947|NCT03022370|588703724|FG000|Overall Study|Lost to Follow-up|174|||
163000948|NCT03022370|588703725|FG001|Overall Study|Lost to Follow-up|109|||
163000949|NCT00668317|588703726|FG000|Overall Study|Adverse Event|2|||
163000950|NCT01526655|588703727|FG000|Overall Study|Withdrawal by Subject|0|||
163000951|NCT01526655|588703728|FG001|Overall Study|Withdrawal by Subject|1|||
163000952|NCT04753216|588703729|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
163000953|NCT04753216|588703729|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
163000954|NCT04753216|588703729|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
163000955|NCT02001987|588703731|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
163000956|NCT02001987|588703731|FG000|Core Study Period (24 Weeks)|Death|1|||
163000957|NCT02001987|588703731|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
163000958|NCT02001987|588703731|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
163000959|NCT02001987|588703731|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
163000960|NCT02001987|588703731|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
163000961|NCT02001987|588703731|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
163000962|NCT02001987|588703731|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
163000963|NCT02001987|588703731|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
163000964|NCT02001987|588703731|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
163000965|NCT02001987|588703731|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
163000966|NCT02001987|588703731|FG000|LTE Period (52 Weeks)|Other|3|||
163000967|NCT03571828|588703738|FG000|Overall Study|Withdrawal by Subject|1|||
163000968|NCT03571828|588703739|FG001|Overall Study|Withdrawal by Subject|0|||
163000969|NCT03571828|588703738|FG000|Overall Study|Decision by sponsor|5|||
163000970|NCT03571828|588703739|FG001|Overall Study|Decision by sponsor|1|||
163000971|NCT03571828|588703738|FG000|Overall Study|Death|2|||
163000972|NCT03571828|588703739|FG001|Overall Study|Death|0|||
163000973|NCT02232984|588703742|FG000|Overall Study|Withdrawal by Subject|5|||
163000974|NCT02232984|588703742|FG000|Overall Study|Death|1|||
163000975|NCT02232984|588703742|FG000|Overall Study|Investigator withdrawal|10|||
163000976|NCT02232984|588703742|FG000|Overall Study|Device implant unsuccessful|53|||
163000977|NCT02232984|588703742|FG000|Overall Study|not disclosed by site|7|||
163000978|NCT02232984|588703742|FG000|Overall Study|Protocol Violation|1|||
163000979|NCT01884337|588703745|FG000|Treatment|Adverse Event|2|||
163000980|NCT01884337|588703746|FG001|Treatment|Adverse Event|2|||
163000981|NCT01884337|588703745|FG000|Treatment|Subj. request to discont. treatment|2|||
163000982|NCT01884337|588703746|FG001|Treatment|Subj. request to discont. treatment|0|||
163000983|NCT01884337|588703745|FG000|Follow-up Period|Lost to Follow-up|1|||
163000984|NCT01884337|588703746|FG001|Follow-up Period|Lost to Follow-up|1|||
163000985|NCT02455518|588703747|FG000|Overall Study|Protocol Violation|0|||
163000986|NCT02455518|588703748|FG001|Overall Study|Protocol Violation|1|||
163000987|NCT02455518|588703749|FG002|Overall Study|Protocol Violation|1|||
163000988|NCT02455518|588703750|FG003|Overall Study|Protocol Violation|3|||
163404371|NCT00522431|590191915|FG000|Overall Study|Subject non-compliance|1|||
163000989|NCT02508935|588703751|FG000|Overall Study|Withdrawal by Subject|1|||
163404372|NCT00522431|590191915|FG000|Overall Study|Other/unknown|1|||
163404373|NCT02145741|590191917|FG000|Overall Study|Progressive disease|3|||
163404374|NCT02145741|590191918|FG001|Overall Study|Progressive disease|6|||
163000990|NCT02508935|588703751|FG000|Overall Study|Withdrawal by Caregiver|8|||
163000991|NCT02508935|588703751|FG000|Overall Study|Pain Score <4|1|||
163000992|NCT02508935|588703751|FG000|Overall Study|Emesis|3|||
163000993|NCT02508935|588703751|FG000|Overall Study|Adverse Event|3|||
163000994|NCT02508935|588703751|FG000|Overall Study|Protocol Violation|1|||
163000995|NCT02508935|588703751|FG000|Overall Study|Physician Decision|1|||
163000996|NCT02508935|588703751|FG000|Overall Study|Trial terminated by sponsor|5|||
163000997|NCT01332292|588703759|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
163000998|NCT01332292|588703760|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
163000999|NCT01332292|588703759|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
163001000|NCT01332292|588703760|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
163001001|NCT01332292|588703759|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
163001002|NCT01332292|588703760|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
163001003|NCT02006732|588703761|FG000|Overall Study|Adverse Event|10|||
163404375|NCT02145741|590191919|FG002|Overall Study|Progressive disease|6|||
163404376|NCT02145741|590191917|FG000|Overall Study|quality issue with the administered drug|3|||
163001004|NCT02006732|588703762|FG001|Overall Study|Adverse Event|7|||
163404377|NCT02145741|590191918|FG001|Overall Study|quality issue with the administered drug|0|||
163001005|NCT02006732|588703763|FG002|Overall Study|Adverse Event|4|||
163001006|NCT02006732|588703764|FG003|Overall Study|Adverse Event|2|||
163001007|NCT02006732|588703761|FG000|Overall Study|Lack of Efficacy|6|||
163001008|NCT02006732|588703762|FG001|Overall Study|Lack of Efficacy|3|||
163213194|NCT01528254|589494398|FG000|Overall Study|Withdrawal by Subject|5|||
163213195|NCT01528254|589494399|FG001|Overall Study|Withdrawal by Subject|4|||
163213196|NCT01528254|589494398|FG000|Overall Study|Abnormal laboratory value(s)|3|||
163001009|NCT02006732|588703763|FG002|Overall Study|Lack of Efficacy|1|||
163001010|NCT02006732|588703764|FG003|Overall Study|Lack of Efficacy|1|||
163001011|NCT02006732|588703761|FG000|Overall Study|Protocol Violation|1|||
163001012|NCT02006732|588703762|FG001|Overall Study|Protocol Violation|1|||
163001013|NCT02006732|588703763|FG002|Overall Study|Protocol Violation|0|||
163001014|NCT02006732|588703764|FG003|Overall Study|Protocol Violation|0|||
163001015|NCT02006732|588703761|FG000|Overall Study|Lost to Follow-up|0|||
163001016|NCT02006732|588703762|FG001|Overall Study|Lost to Follow-up|1|||
163001017|NCT02006732|588703763|FG002|Overall Study|Lost to Follow-up|0|||
163001018|NCT02006732|588703764|FG003|Overall Study|Lost to Follow-up|0|||
163001019|NCT02006732|588703761|FG000|Overall Study|Withdrawal by Subject|3|||
163001020|NCT02006732|588703762|FG001|Overall Study|Withdrawal by Subject|0|||
163001021|NCT02006732|588703763|FG002|Overall Study|Withdrawal by Subject|4|||
163001022|NCT02006732|588703764|FG003|Overall Study|Withdrawal by Subject|1|||
163001023|NCT02969044|588703767|FG000|Overall Study|Withdrawal by Subject|2|||
163001024|NCT02969044|588703768|FG001|Overall Study|Withdrawal by Subject|6|||
163001025|NCT02969044|588703767|FG000|Overall Study|Adverse Event|3|||
163001026|NCT02969044|588703768|FG001|Overall Study|Adverse Event|0|||
163001027|NCT03548337|588703770|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
163001028|NCT03548337|588703771|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
163001029|NCT03548337|588703770|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
163001030|NCT03548337|588703771|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
163001031|NCT03548337|588703770|FG000|Infant Series|Lost to Follow-up|2|||
163001032|NCT03548337|588703771|FG001|Infant Series|Lost to Follow-up|1|||
163001033|NCT03548337|588703770|FG000|Infant Series|Adverse Event|0|||
163001034|NCT03548337|588703771|FG001|Infant Series|Adverse Event|2|||
163001035|NCT03548337|588703770|FG000|Infant Series|Randomized but Not Vaccinated|1|||
163001036|NCT03548337|588703771|FG001|Infant Series|Randomized but Not Vaccinated|0|||
163001037|NCT03548337|588703770|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
163001038|NCT03548337|588703771|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
163001039|NCT04502212|588703772|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
163001040|NCT04502212|588703772|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
163001041|NCT02359994|588703774|FG000|Overall Population Study|Adverse Event|1|||
163001042|NCT02359994|588703775|FG001|Overall Population Study|Adverse Event|1|||
163001043|NCT02359994|588703774|FG000|Overall Population Study|Death|1|||
163001044|NCT02359994|588703775|FG001|Overall Population Study|Death|5|||
163001045|NCT02359994|588703774|FG000|Overall Population Study|Lost to Follow-up|1|||
163001046|NCT02359994|588703775|FG001|Overall Population Study|Lost to Follow-up|1|||
163001047|NCT02359994|588703774|FG000|Overall Population Study|Withdrawal by Subject|1|||
163001048|NCT02359994|588703775|FG001|Overall Population Study|Withdrawal by Subject|0|||
163001049|NCT02359994|588703774|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
163001050|NCT02359994|588703775|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
163001051|NCT02359994|588703774|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
163001052|NCT02359994|588703775|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
163001053|NCT02359994|588703774|FG000|Extended Oncology 24-Month Survival|Death|19|||
163001054|NCT02359994|588703775|FG001|Extended Oncology 24-Month Survival|Death|21|||
163001055|NCT02359994|588703774|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
163001056|NCT02359994|588703775|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
163001057|NCT01320150|588703776|FG000|Overall Study|Protocol Violation|15|||
163001058|NCT01320150|588703776|FG000|Overall Study|Withdrawal by Subject|5|||
163001059|NCT01320150|588703776|FG000|Overall Study|Death|2|||
163001060|NCT01320150|588703776|FG000|Overall Study|Lost to Follow-up|44|||
163001061|NCT00489827|588703780|FG000|Overall Study|Intraoperative exclusion criteria|1|||
163001062|NCT00489827|588703781|FG001|Overall Study|Intraoperative exclusion criteria|1|||
163001063|NCT00489827|588703780|FG000|Overall Study|Intraoperative exclusion criteria|1|||
163001064|NCT00489827|588703781|FG001|Overall Study|Intraoperative exclusion criteria|1|||
163001065|NCT02766283|588703782|FG000|Overall Study|Lost to Follow-up|27|||
163001066|NCT00721227|588703783|FG000|Overall Study|Lost to Follow-up|3|||
163001067|NCT00721227|588703784|FG001|Overall Study|Lost to Follow-up|0|||
163001068|NCT00721227|588703783|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
163001069|NCT00721227|588703784|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
163001070|NCT01632280|588703798|FG000|Overall Study|Withdrawal by Subject|1|||
163213197|NCT01528254|589494399|FG001|Overall Study|Abnormal laboratory value(s)|7|||
163213198|NCT01528254|589494398|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163325042|NCT02325466|589902862|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
163325043|NCT02325466|589902863|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
163325044|NCT02325466|589902864|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
163325045|NCT02325466|589902862|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
163325046|NCT02325466|589902863|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
163325047|NCT02325466|589902864|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
163001071|NCT01632280|588703799|FG001|Overall Study|Withdrawal by Subject|0|||
163001072|NCT03086551|588703800|FG000|First Intervention|Failure to meet inclusion criterion|1|||
163001073|NCT03086551|588703801|FG001|First Intervention|Failure to meet inclusion criterion|0|||
163001074|NCT03086551|588703800|FG000|First Intervention|Lost to Follow-up|0|||
163001075|NCT03086551|588703801|FG001|First Intervention|Lost to Follow-up|1|||
163001076|NCT03086551|588703800|FG000|Washout|Lost to Follow-up|1|||
163001077|NCT03086551|588703801|FG001|Washout|Lost to Follow-up|2|||
163001078|NCT03086551|588703800|FG000|Washout|Withdrawal by Subject|2|||
163001079|NCT03086551|588703801|FG001|Washout|Withdrawal by Subject|1|||
163001080|NCT03736031|588703805|FG000|Overall Study|Death|2|||
163001081|NCT03736031|588703806|FG001|Overall Study|Death|4|||
163001082|NCT03736031|588703805|FG000|Overall Study|Lost to Follow-up|21|||
163001083|NCT03736031|588703806|FG001|Overall Study|Lost to Follow-up|2|||
163001084|NCT03736031|588703805|FG000|Overall Study|Withdrawal by Subject|9|||
163001085|NCT03736031|588703806|FG001|Overall Study|Withdrawal by Subject|0|||
163001086|NCT00451178|588703807|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
163001087|NCT00451178|588703808|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
163001088|NCT00451178|588703807|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
163001089|NCT00451178|588703808|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
163001090|NCT00451178|588703807|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
163001091|NCT00451178|588703808|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
163001092|NCT00451178|588703807|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
163001093|NCT00451178|588703808|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
163001094|NCT00451178|588703807|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
163001095|NCT00451178|588703808|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
163001096|NCT00451178|588703807|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
163001097|NCT00451178|588703808|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
163001098|NCT00451178|588703807|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
163001099|NCT00451178|588703808|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
163001100|NCT00451178|588703807|FG000|Prior to Maintenance Therapy|PD|2|||
163001101|NCT00451178|588703808|FG001|Prior to Maintenance Therapy|PD|0|||
163001102|NCT00451178|588703807|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
163001103|NCT00451178|588703808|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
163001104|NCT00451178|588703807|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
163001105|NCT00451178|588703808|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
163001106|NCT00451178|588703807|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
163060622|NCT05516758|588929963|FG005|Overall Study|Assigned treatment by mistake|0|||
163060623|NCT05516758|588929964|FG006|Overall Study|Assigned treatment by mistake|0|||
163060624|NCT05516758|588929958|FG000|Overall Study|Lack of Efficacy|6|||
163060625|NCT05516758|588929959|FG001|Overall Study|Lack of Efficacy|0|||
163060626|NCT05516758|588929960|FG002|Overall Study|Lack of Efficacy|2|||
163060627|NCT05516758|588929961|FG003|Overall Study|Lack of Efficacy|0|||
163060628|NCT05516758|588929962|FG004|Overall Study|Lack of Efficacy|3|||
163060629|NCT05516758|588929963|FG005|Overall Study|Lack of Efficacy|6|||
163060630|NCT05516758|588929964|FG006|Overall Study|Lack of Efficacy|3|||
163060631|NCT05516758|588929958|FG000|Overall Study|Lost to Follow-up|2|||
163060632|NCT05516758|588929959|FG001|Overall Study|Lost to Follow-up|0|||
163060633|NCT05516758|588929960|FG002|Overall Study|Lost to Follow-up|2|||
163060634|NCT05516758|588929961|FG003|Overall Study|Lost to Follow-up|0|||
163060635|NCT05516758|588929962|FG004|Overall Study|Lost to Follow-up|3|||
163060636|NCT05516758|588929963|FG005|Overall Study|Lost to Follow-up|2|||
163060637|NCT05516758|588929964|FG006|Overall Study|Lost to Follow-up|1|||
163060638|NCT05516758|588929958|FG000|Overall Study|Other- As reported by the site|2|||
163060639|NCT05516758|588929959|FG001|Overall Study|Other- As reported by the site|1|||
163060640|NCT05516758|588929960|FG002|Overall Study|Other- As reported by the site|8|||
163325048|NCT02325466|589902862|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
163001107|NCT00451178|588703808|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
163001108|NCT00451178|588703807|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
163001109|NCT00451178|588703808|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
163001110|NCT00451178|588703807|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
163060641|NCT05516758|588929961|FG003|Overall Study|Other- As reported by the site|1|||
163060642|NCT05516758|588929962|FG004|Overall Study|Other- As reported by the site|2|||
163060643|NCT05516758|588929963|FG005|Overall Study|Other- As reported by the site|3|||
163060644|NCT05516758|588929964|FG006|Overall Study|Other- As reported by the site|8|||
163060645|NCT05516758|588929958|FG000|Overall Study|Physician Decision|1|||
163325049|NCT02325466|589902863|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
163001111|NCT00451178|588703808|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
163001112|NCT00451178|588703807|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
163001113|NCT00451178|588703808|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
163001114|NCT00451178|588703807|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
163001115|NCT00451178|588703808|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
163001116|NCT02586688|588706213|FG000|Overall Study|Lost to Follow-up|2|||
163001117|NCT02586688|588706214|FG001|Overall Study|Lost to Follow-up|1|||
163001118|NCT02586688|588706213|FG000|Overall Study|Withdrawal by Subject|1|||
163001119|NCT02586688|588706214|FG001|Overall Study|Withdrawal by Subject|1|||
163001120|NCT02586688|588706213|FG000|Overall Study|Adverse Event|3|||
163001121|NCT02586688|588706214|FG001|Overall Study|Adverse Event|1|||
163001122|NCT04856917|588706215|FG000|Overall Study|Withdrawal by Subject|4|||
163001123|NCT04856917|588706216|FG001|Overall Study|Withdrawal by Subject|3|||
163001124|NCT04856917|588706217|FG002|Overall Study|Withdrawal by Subject|1|||
163001125|NCT04856917|588706215|FG000|Overall Study|Lost to Follow-up|3|||
163001126|NCT04856917|588706216|FG001|Overall Study|Lost to Follow-up|1|||
163001127|NCT04856917|588706217|FG002|Overall Study|Lost to Follow-up|1|||
163001128|NCT04856917|588706215|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
163001129|NCT04856917|588706216|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
163001130|NCT04856917|588706217|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
163001131|NCT04856917|588706215|FG000|Overall Study|Other|1|||
163001132|NCT04856917|588706216|FG001|Overall Study|Other|1|||
163213199|NCT01528254|589494399|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163213200|NCT01528254|589494398|FG000|Overall Study|No longer requires study drug|1|||
163001133|NCT04856917|588706217|FG002|Overall Study|Other|0|||
163001134|NCT05168202|588706218|FG000|Overall Study|Progressive Disease|4|||
163001135|NCT05168202|588706219|FG001|Overall Study|Progressive Disease|4|||
163001136|NCT05168202|588706220|FG002|Overall Study|Progressive Disease|2|||
163001137|NCT05168202|588706221|FG003|Overall Study|Progressive Disease|3|||
163001138|NCT05168202|588706222|FG004|Overall Study|Progressive Disease|2|||
163001139|NCT05168202|588706223|FG005|Overall Study|Progressive Disease|3|||
163001140|NCT05168202|588706224|FG006|Overall Study|Progressive Disease|2|||
163001141|NCT05168202|588706218|FG000|Overall Study|Adverse Event|2|||
163001142|NCT05168202|588706219|FG001|Overall Study|Adverse Event|1|||
163001143|NCT05168202|588706220|FG002|Overall Study|Adverse Event|4|||
163001144|NCT05168202|588706221|FG003|Overall Study|Adverse Event|4|||
163001145|NCT05168202|588706222|FG004|Overall Study|Adverse Event|3|||
163001146|NCT05168202|588706223|FG005|Overall Study|Adverse Event|2|||
163001147|NCT05168202|588706224|FG006|Overall Study|Adverse Event|0|||
163001148|NCT05168202|588706218|FG000|Overall Study|Lack of Efficacy|0|||
163001149|NCT05168202|588706219|FG001|Overall Study|Lack of Efficacy|1|||
163001150|NCT05168202|588706220|FG002|Overall Study|Lack of Efficacy|1|||
163001151|NCT05168202|588706221|FG003|Overall Study|Lack of Efficacy|0|||
163001152|NCT05168202|588706222|FG004|Overall Study|Lack of Efficacy|1|||
163001153|NCT05168202|588706223|FG005|Overall Study|Lack of Efficacy|2|||
163001154|NCT05168202|588706224|FG006|Overall Study|Lack of Efficacy|2|||
163001155|NCT05168202|588706218|FG000|Overall Study|Withdrawal by Subject|0|||
163001156|NCT05168202|588706219|FG001|Overall Study|Withdrawal by Subject|0|||
163001157|NCT05168202|588706220|FG002|Overall Study|Withdrawal by Subject|1|||
163001158|NCT05168202|588706221|FG003|Overall Study|Withdrawal by Subject|1|||
163001159|NCT05168202|588706222|FG004|Overall Study|Withdrawal by Subject|1|||
163001160|NCT05168202|588706223|FG005|Overall Study|Withdrawal by Subject|1|||
163001161|NCT05168202|588706224|FG006|Overall Study|Withdrawal by Subject|0|||
163001162|NCT05168202|588706218|FG000|Overall Study|Disease Relapse|0|||
163001163|NCT05168202|588706219|FG001|Overall Study|Disease Relapse|1|||
163001164|NCT05168202|588706220|FG002|Overall Study|Disease Relapse|0|||
163001165|NCT05168202|588706221|FG003|Overall Study|Disease Relapse|1|||
163213201|NCT01528254|589494399|FG001|Overall Study|No longer requires study drug|1|||
163213202|NCT00383149|589494400|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
163213203|NCT00383149|589494400|FG000|Overall Study|Death|2|||
163213204|NCT00383149|589494400|FG000|Overall Study|Disease Progression|38|||
163213205|NCT00383149|589494400|FG000|Overall Study|Lost to Follow-up|1|||
163001166|NCT05168202|588706222|FG004|Overall Study|Disease Relapse|1|||
163001167|NCT05168202|588706223|FG005|Overall Study|Disease Relapse|0|||
163001168|NCT05168202|588706224|FG006|Overall Study|Disease Relapse|0|||
163001169|NCT05168202|588706218|FG000|Overall Study|Other Reasons|0|||
163001170|NCT05168202|588706219|FG001|Overall Study|Other Reasons|0|||
163001171|NCT05168202|588706220|FG002|Overall Study|Other Reasons|0|||
163001172|NCT05168202|588706221|FG003|Overall Study|Other Reasons|0|||
163001173|NCT05168202|588706222|FG004|Overall Study|Other Reasons|0|||
163001174|NCT05168202|588706223|FG005|Overall Study|Other Reasons|2|||
163001175|NCT05168202|588706224|FG006|Overall Study|Other Reasons|1|||
163001176|NCT05168202|588706218|FG000|Overall Study|Physician Decision|0|||
163001177|NCT05168202|588706219|FG001|Overall Study|Physician Decision|1|||
163001178|NCT05168202|588706220|FG002|Overall Study|Physician Decision|1|||
163001179|NCT05168202|588706221|FG003|Overall Study|Physician Decision|0|||
163001180|NCT05168202|588706222|FG004|Overall Study|Physician Decision|0|||
163001181|NCT05168202|588706223|FG005|Overall Study|Physician Decision|0|||
163001182|NCT05168202|588706224|FG006|Overall Study|Physician Decision|0|||
163001183|NCT05168202|588706218|FG000|Overall Study|Study Terminated by Sponsor|0|||
163001184|NCT05168202|588706219|FG001|Overall Study|Study Terminated by Sponsor|0|||
163001185|NCT05168202|588706220|FG002|Overall Study|Study Terminated by Sponsor|0|||
163001186|NCT05168202|588706221|FG003|Overall Study|Study Terminated by Sponsor|1|||
163001187|NCT05168202|588706222|FG004|Overall Study|Study Terminated by Sponsor|0|||
163001188|NCT05168202|588706223|FG005|Overall Study|Study Terminated by Sponsor|0|||
163001189|NCT05168202|588706224|FG006|Overall Study|Study Terminated by Sponsor|0|||
163001190|NCT04011722|588706228|FG000|30 Days|Death|5|||
163001191|NCT04011722|588706229|FG001|30 Days|Death|1|||
163001192|NCT04011722|588706228|FG000|1 Year|Death|13|||
163001193|NCT04011722|588706229|FG001|1 Year|Death|5|||
163001194|NCT04011722|588706228|FG000|1 Year|Withdrawal by Subject|8|||
163001195|NCT04011722|588706229|FG001|1 Year|Withdrawal by Subject|2|||
163001196|NCT04011722|588706228|FG000|1 Year|Missed Visit|6|||
163001197|NCT04011722|588706229|FG001|1 Year|Missed Visit|1|||
163001198|NCT04011722|588706228|FG000|1 Year|Pending Visit|0|||
163001199|NCT04011722|588706229|FG001|1 Year|Pending Visit|11|||
163001200|NCT04011722|588706228|FG000|1 Year|Not Yet Due|0|||
163001201|NCT04011722|588706229|FG001|1 Year|Not Yet Due|9|||
163001202|NCT04011722|588706228|FG000|2 Year|Death|16|||
163001203|NCT04011722|588706229|FG001|2 Year|Death|1|||
163001204|NCT04011722|588706228|FG000|2 Year|Withdrawal by Subject|10|||
163001205|NCT04011722|588706229|FG001|2 Year|Withdrawal by Subject|1|||
163001206|NCT04011722|588706228|FG000|2 Year|Missed Visit|9|||
163001207|NCT04011722|588706229|FG001|2 Year|Missed Visit|0|||
163001208|NCT04011722|588706228|FG000|2 Year|Visit Pending|1|||
163001209|NCT04011722|588706229|FG001|2 Year|Visit Pending|3|||
163001210|NCT04011722|588706228|FG000|2 Year|Not Yet Due|43|||
163001211|NCT04011722|588706229|FG001|2 Year|Not Yet Due|54|||
163001212|NCT04011722|588706228|FG000|3 Year|Death|10|||
163001213|NCT04011722|588706229|FG001|3 Year|Death|0|||
163001214|NCT04011722|588706228|FG000|3 Year|Withdrawal by Subject|2|||
163001215|NCT04011722|588706229|FG001|3 Year|Withdrawal by Subject|0|||
163001216|NCT04011722|588706228|FG000|3 Year|Missed Visit|2|||
163001217|NCT04011722|588706229|FG001|3 Year|Missed Visit|0|||
163001218|NCT04011722|588706228|FG000|3 Year|Pending Visit|34|||
163325050|NCT02325466|589902864|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
163325051|NCT02325466|589902862|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
163325052|NCT02325466|589902863|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
163325053|NCT02325466|589902864|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
163325054|NCT02325466|589902862|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
163325055|NCT02325466|589902863|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
163001219|NCT04011722|588706229|FG001|3 Year|Pending Visit|0|||
163001220|NCT04011722|588706228|FG000|3 Year|Not Yet Due|99|||
163001221|NCT04011722|588706229|FG001|3 Year|Not Yet Due|0|||
163001222|NCT05626231|588706232|FG000|Provider Enrollment|Worked part-time|4|||
163001223|NCT05626231|588706232|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
163001224|NCT05626231|588706232|FG000|Provider Enrollment|Non-clinical employee|1|||
163001225|NCT05626231|588706232|FG000|Provider Enrollment|Provider does not see clients|3|||
163001226|NCT05626231|588706232|FG000|Provider Enrollment|Other|5|||
163001227|NCT06195930|588706233|FG000|Overall Study|Adverse Event|4|||
163001228|NCT00233948|588706242|FG000|Overall Study|Adverse Event|1|||
163001229|NCT00233948|588706243|FG001|Overall Study|Adverse Event|0|||
163001230|NCT00233948|588706244|FG002|Overall Study|Adverse Event|0|||
163001231|NCT00233948|588706245|FG003|Overall Study|Adverse Event|0|||
163001232|NCT00233948|588706246|FG004|Overall Study|Adverse Event|0|||
163060646|NCT05516758|588929959|FG001|Overall Study|Physician Decision|0|||
163060647|NCT05516758|588929960|FG002|Overall Study|Physician Decision|7|||
163060648|NCT05516758|588929961|FG003|Overall Study|Physician Decision|0|||
163060649|NCT05516758|588929962|FG004|Overall Study|Physician Decision|1|||
163325056|NCT02325466|589902864|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
163325057|NCT02325466|589902862|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
163404378|NCT02145741|590191919|FG002|Overall Study|quality issue with the administered drug|0|||
163404379|NCT03776175|590191920|FG000|Treatment Period (42 Days)|Adverse Event|0|||
163404380|NCT03776175|590191921|FG001|Treatment Period (42 Days)|Adverse Event|1|||
163404381|NCT03776175|590191922|FG002|Treatment Period (42 Days)|Adverse Event|1|||
163001233|NCT00233948|588706247|FG005|Overall Study|Adverse Event|0|||
163001234|NCT01567462|588706248|FG000|Overall Study|Withdrawal by Subject|4|||
163001235|NCT01567462|588706249|FG001|Overall Study|Withdrawal by Subject|7|||
163001236|NCT02548156|588706250|FG000|Washout Period 1|Lost to Follow-up|0|||
163001237|NCT02548156|588706251|FG001|Washout Period 1|Lost to Follow-up|0|||
163001238|NCT02548156|588706252|FG002|Washout Period 1|Lost to Follow-up|0|||
163001239|NCT02548156|588706253|FG003|Washout Period 1|Lost to Follow-up|0|||
163001240|NCT02548156|588706254|FG004|Washout Period 1|Lost to Follow-up|1|||
163001241|NCT02548156|588706255|FG005|Washout Period 1|Lost to Follow-up|0|||
163001242|NCT00444587|588706262|FG000|Overall Study|Death|2|||
163325058|NCT02325466|589902863|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
163404382|NCT03776175|590191923|FG003|Treatment Period (42 Days)|Adverse Event|0|||
163001243|NCT00444587|588706263|FG001|Overall Study|Death|1|||
163001244|NCT00444587|588706262|FG000|Overall Study|Progression of the disease|73|||
163001245|NCT00444587|588706263|FG001|Overall Study|Progression of the disease|8|||
163001246|NCT00444587|588706262|FG000|Overall Study|Refused treatment/did not cooperate|4|||
163001247|NCT00444587|588706263|FG001|Overall Study|Refused treatment/did not cooperate|1|||
163001248|NCT00444587|588706262|FG000|Overall Study|Investigator decision|3|||
163001249|NCT00444587|588706263|FG001|Overall Study|Investigator decision|0|||
163001250|NCT00444587|588706262|FG000|Overall Study|Protocol Violation|1|||
163001251|NCT00444587|588706263|FG001|Overall Study|Protocol Violation|0|||
163001252|NCT00444587|588706262|FG000|Overall Study|Missing|0|||
163001253|NCT00444587|588706263|FG001|Overall Study|Missing|5|||
163001254|NCT00196326|588706264|FG000|Overall Study|Did not meet protocol requirements|64|||
163001255|NCT00196326|588706264|FG000|Overall Study|Non-compliance with the protocol|81|||
163001256|NCT00196326|588706264|FG000|Overall Study|Physician Decision|3|||
163001257|NCT00196326|588706264|FG000|Overall Study|Withdrawal by Subject|225|||
163001258|NCT00196326|588706264|FG000|Overall Study|Adverse Event|253|||
163001259|NCT00196326|588706264|FG000|Overall Study|Pregnancy|34|||
163001260|NCT00196326|588706264|FG000|Overall Study|Lost to Follow-up|304|||
163001261|NCT00196326|588706264|FG000|Overall Study|Other|22|||
163001262|NCT01473407|588706273|FG000|Overall Study|Physician Decision|1|||
163001263|NCT01473407|588706274|FG001|Overall Study|Physician Decision|4|||
163001264|NCT01473407|588706273|FG000|Overall Study|Lost to Follow-up|10|||
163001265|NCT01473407|588706274|FG001|Overall Study|Lost to Follow-up|4|||
163001266|NCT01473407|588706273|FG000|Overall Study|Adverse Event|8|||
163001267|NCT01473407|588706274|FG001|Overall Study|Adverse Event|8|||
163001268|NCT01473407|588706273|FG000|Overall Study|Randomization Error|3|||
163001269|NCT01473407|588706274|FG001|Overall Study|Randomization Error|1|||
163001270|NCT01473407|588706273|FG000|Overall Study|Withdrawal by Subject|4|||
163001271|NCT01473407|588706274|FG001|Overall Study|Withdrawal by Subject|7|||
163001272|NCT01473407|588706273|FG000|Overall Study|Kidney Transplant|7|||
163001273|NCT01473407|588706274|FG001|Overall Study|Kidney Transplant|6|||
163001274|NCT01473407|588706273|FG000|Overall Study|Vacation/Travel|1|||
163001275|NCT01473407|588706274|FG001|Overall Study|Vacation/Travel|1|||
163001276|NCT01473407|588706273|FG000|Overall Study|Elevated Hemoglobin|1|||
163001277|NCT01473407|588706274|FG001|Overall Study|Elevated Hemoglobin|0|||
163001278|NCT01473407|588706273|FG000|Overall Study|Patient Received Aranesp|1|||
163001279|NCT01473407|588706274|FG001|Overall Study|Patient Received Aranesp|0|||
163001280|NCT01473407|588706273|FG000|Overall Study|Patient Lost Green Card Status|1|||
163001281|NCT01473407|588706274|FG001|Overall Study|Patient Lost Green Card Status|0|||
163001282|NCT01473407|588706273|FG000|Overall Study|Temperature Excursion|2|||
163001283|NCT01473407|588706274|FG001|Overall Study|Temperature Excursion|3|||
163001284|NCT01473407|588706273|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
163001285|NCT01473407|588706274|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
163001286|NCT01473407|588706273|FG000|Overall Study|Sponsor's Decision|10|||
163001287|NCT01473407|588706274|FG001|Overall Study|Sponsor's Decision|10|||
163001288|NCT01473407|588706273|FG000|Overall Study|Site Closure|1|||
163001289|NCT01473407|588706274|FG001|Overall Study|Site Closure|0|||
163001290|NCT02422797|588706275|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
163001291|NCT02422797|588706276|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
163001292|NCT02422797|588706275|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
163001293|NCT02422797|588706276|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
163001294|NCT02422797|588706275|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
163001295|NCT02422797|588706276|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
163001296|NCT02422797|588706275|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
163001297|NCT02422797|588706276|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
163001298|NCT02422797|588706275|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
163001299|NCT02422797|588706276|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
163213206|NCT00383149|589494400|FG000|Overall Study|Other|1|||
163213207|NCT00383149|589494400|FG000|Overall Study|Study Drug Toxicity|4|||
163213208|NCT00383149|589494400|FG000|Overall Study|Request to Discontinue Treatment|4|||
163213209|NCT00383149|589494400|FG000|Overall Study|Participant Withdrew Consent|1|||
163213210|NCT00416078|589494407|FG000|Overall Study|Death|3|||
163213211|NCT00416078|589494408|FG001|Overall Study|Death|4|||
163213212|NCT00416078|589494407|FG000|Overall Study|Withdrawal by Subject|3|||
163213213|NCT00416078|589494408|FG001|Overall Study|Withdrawal by Subject|2|||
163213214|NCT00416078|589494407|FG000|Overall Study|Physician Decision|1|||
163213215|NCT00416078|589494408|FG001|Overall Study|Physician Decision|0|||
163213216|NCT00416078|589494407|FG000|Overall Study|Lost to Follow-up|4|||
163213217|NCT00416078|589494408|FG001|Overall Study|Lost to Follow-up|2|||
163213218|NCT02998840|589494417|FG000|Overall Study|Lost to Follow-up|1|||
163213219|NCT02998840|589494418|FG001|Overall Study|Lost to Follow-up|1|||
163213220|NCT02998840|589494419|FG002|Overall Study|Lost to Follow-up|2|||
163213221|NCT02998840|589494420|FG003|Overall Study|Lost to Follow-up|3|||
163213222|NCT02998840|589494417|FG000|Overall Study|Withdrawal by Subject|1|||
163213223|NCT02998840|589494418|FG001|Overall Study|Withdrawal by Subject|1|||
163213224|NCT02998840|589494419|FG002|Overall Study|Withdrawal by Subject|0|||
163213225|NCT02998840|589494420|FG003|Overall Study|Withdrawal by Subject|1|||
163001300|NCT02422797|588706275|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
163001301|NCT02422797|588706276|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
163001302|NCT02422797|588706275|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
163001303|NCT02422797|588706276|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
163001304|NCT02422797|588706275|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
163001305|NCT02422797|588706276|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
163001306|NCT02422797|588706275|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
163001307|NCT02422797|588706276|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
163001308|NCT02422797|588706275|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
163001309|NCT02422797|588706276|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
163001310|NCT02422797|588706275|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
163001311|NCT02422797|588706276|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
163001312|NCT02422797|588706275|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
163001313|NCT02422797|588706276|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
163001314|NCT02422797|588706275|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
163001315|NCT02422797|588706276|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
163001316|NCT02422797|588706275|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
163001317|NCT02422797|588706276|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
163001318|NCT02422797|588706275|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
163001319|NCT02422797|588706276|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
163001320|NCT02422797|588706275|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
163001321|NCT02422797|588706276|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
163001322|NCT02422797|588706275|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
163001323|NCT02422797|588706276|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
163001324|NCT02422797|588706275|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
163001325|NCT02422797|588706276|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
163001326|NCT02422797|588706275|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
163001327|NCT02422797|588706276|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
163001328|NCT02422797|588706275|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
163001329|NCT02422797|588706276|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
163001330|NCT02422797|588706275|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
163001331|NCT02422797|588706276|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
163001332|NCT05223920|588706277|FG000|Overall Study|Adverse Event|6|||
163001333|NCT05223920|588706278|FG001|Overall Study|Adverse Event|3|||
163001334|NCT05223920|588706277|FG000|Overall Study|Death|2|||
163001335|NCT05223920|588706278|FG001|Overall Study|Death|0|||
163001336|NCT05223920|588706277|FG000|Overall Study|Disease Progression|1|||
163001337|NCT05223920|588706278|FG001|Overall Study|Disease Progression|2|||
163001338|NCT05223920|588706277|FG000|Overall Study|Physician Decision|1|||
163001339|NCT05223920|588706278|FG001|Overall Study|Physician Decision|2|||
163001340|NCT05223920|588706277|FG000|Overall Study|Sponsor decision|11|||
163001341|NCT05223920|588706278|FG001|Overall Study|Sponsor decision|9|||
163001342|NCT05223920|588706277|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
163001343|NCT05223920|588706278|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
163001344|NCT05223920|588706277|FG000|Overall Study|Subject decision|1|||
163001345|NCT05223920|588706278|FG001|Overall Study|Subject decision|0|||
163001346|NCT05223920|588706277|FG000|Overall Study|Withdrawal by Subject|1|||
163001347|NCT05223920|588706278|FG001|Overall Study|Withdrawal by Subject|6|||
163001348|NCT04071405|588706279|FG000|Overall Study|Protocol Violation|3|||
163001349|NCT00369941|588706282|FG000|Overall Study|Never Treated|1|||
163001350|NCT00369941|588706283|FG001|Overall Study|Never Treated|2|||
163001351|NCT00369941|588706282|FG000|Overall Study|Adverse Event|14|||
163001352|NCT00369941|588706283|FG001|Overall Study|Adverse Event|28|||
163001353|NCT00369941|588706282|FG000|Overall Study|Lack of Efficacy|6|||
163001354|NCT00369941|588706283|FG001|Overall Study|Lack of Efficacy|10|||
163001355|NCT00369941|588706282|FG000|Overall Study|Lost to Follow-up|12|||
163001356|NCT00369941|588706283|FG001|Overall Study|Lost to Follow-up|22|||
163001357|NCT00369941|588706282|FG000|Overall Study|Protocol Violation|5|||
163001358|NCT00369941|588706283|FG001|Overall Study|Protocol Violation|3|||
163001359|NCT00369941|588706282|FG000|Overall Study|Withdrawal by Subject|5|||
163001360|NCT00369941|588706283|FG001|Overall Study|Withdrawal by Subject|18|||
163001361|NCT00369941|588706282|FG000|Overall Study|Pregnancy|4|||
163001362|NCT00369941|588706283|FG001|Overall Study|Pregnancy|2|||
163001363|NCT00369941|588706282|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
163001364|NCT00369941|588706283|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
163001365|NCT00369941|588706282|FG000|Overall Study|Moved|11|||
163001366|NCT00369941|588706283|FG001|Overall Study|Moved|5|||
163001367|NCT00369941|588706282|FG000|Overall Study|Treatment with Prohibited Medication|3|||
163001368|NCT00369941|588706283|FG001|Overall Study|Treatment with Prohibited Medication|1|||
163001369|NCT00369941|588706282|FG000|Overall Study|Employment Interfered with Study Visits|1|||
163001370|NCT00369941|588706283|FG001|Overall Study|Employment Interfered with Study Visits|0|||
163001371|NCT00369941|588706282|FG000|Overall Study|Study Site Terminated|2|||
163001372|NCT00369941|588706283|FG001|Overall Study|Study Site Terminated|0|||
163001373|NCT00369941|588706282|FG000|Overall Study|Miscellaneous|3|||
163001374|NCT00369941|588706283|FG001|Overall Study|Miscellaneous|3|||
163001375|NCT03685344|588706284|FG000|Overall Study|Withdrawal by Subject|1|||
163001376|NCT03685344|588706285|FG001|Overall Study|Withdrawal by Subject|1|||
163001377|NCT03685344|588706286|FG002|Overall Study|Withdrawal by Subject|2|||
163001378|NCT03685344|588706287|FG003|Overall Study|Withdrawal by Subject|0|||
163001379|NCT03685344|588706284|FG000|Overall Study|Physician Decision|1|||
163001380|NCT03685344|588706285|FG001|Overall Study|Physician Decision|1|||
163001381|NCT03685344|588706286|FG002|Overall Study|Physician Decision|5|||
163001382|NCT03685344|588706287|FG003|Overall Study|Physician Decision|0|||
163001383|NCT03685344|588706284|FG000|Overall Study|Death|1|||
163001384|NCT03685344|588706285|FG001|Overall Study|Death|1|||
163001385|NCT03685344|588706286|FG002|Overall Study|Death|0|||
163001386|NCT03685344|588706287|FG003|Overall Study|Death|0|||
163001387|NCT02276807|588706288|FG000|Overall Study|Withdrawal by Subject|8|||
163001388|NCT02276807|588706289|FG001|Overall Study|Withdrawal by Subject|7|||
163001389|NCT02276807|588706288|FG000|Overall Study|Lost to Follow-up|10|||
163001390|NCT02276807|588706289|FG001|Overall Study|Lost to Follow-up|10|||
163001391|NCT00261950|588706290|FG000|Overall Study|Lost to Follow-up|2|||
163001392|NCT00261950|588706290|FG000|Overall Study|Death|6|||
163001393|NCT00261950|588706290|FG000|Overall Study|Withdrawal by Subject|5|||
163001394|NCT00261950|588706290|FG000|Overall Study|Other|1|||
163001395|NCT00261950|588706290|FG000|Overall Study|Physician Decision|1|||
163001396|NCT00261950|588706290|FG000|Overall Study|Protocol specified Criteria|11|||
163001397|NCT03288714|588706291|FG000|Overall Study|Lost to Follow-up|2|||
163001398|NCT03288714|588706292|FG001|Overall Study|Lost to Follow-up|1|||
163001399|NCT03288714|588706291|FG000|Overall Study|Non-compliance with study schedule|2|||
163001400|NCT03288714|588706292|FG001|Overall Study|Non-compliance with study schedule|0|||
163001401|NCT03288714|588706291|FG000|Overall Study|Withdrawal by Subject|3|||
163001402|NCT03288714|588706292|FG001|Overall Study|Withdrawal by Subject|1|||
163001403|NCT03288714|588706291|FG000|Overall Study|Clinical Worsening|2|||
163001404|NCT03288714|588706292|FG001|Overall Study|Clinical Worsening|1|||
163001405|NCT03288714|588706291|FG000|Overall Study|Adverse Event|1|||
163001406|NCT03288714|588706292|FG001|Overall Study|Adverse Event|0|||
163001407|NCT02789137|588706298|FG000|Overall Study|Dropped out/Died|58|||
163001408|NCT00445432|588706299|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
163001409|NCT00445432|588706300|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
163001410|NCT00445432|588706301|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
163001411|NCT00445432|588706302|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
163001412|NCT00445432|588706299|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
163001413|NCT00445432|588706300|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
163001414|NCT00445432|588706301|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
163001415|NCT00445432|588706302|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
163001416|NCT00445432|588706299|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
163001417|NCT00445432|588706300|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
163001418|NCT00445432|588706301|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
163001419|NCT00445432|588706302|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
163001420|NCT00445432|588706299|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
163001421|NCT00445432|588706300|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
163001422|NCT00445432|588706301|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
163001423|NCT00445432|588706302|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
163001424|NCT00445432|588706299|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
163001425|NCT00445432|588706300|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
163001426|NCT00445432|588706301|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
163001427|NCT00445432|588706302|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
163001428|NCT00445432|588706299|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
163001429|NCT00445432|588706300|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
163001430|NCT00445432|588706301|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
163001431|NCT00445432|588706302|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
163001432|NCT00445432|588706299|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
163001433|NCT00445432|588706300|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
163001434|NCT00445432|588706301|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
163001435|NCT00445432|588706302|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
163001436|NCT00799058|588706309|FG000|Overall Study|Withdrawal by Subject|2|||
163001437|NCT00799058|588706310|FG001|Overall Study|Withdrawal by Subject|2|||
163001438|NCT00799058|588706311|FG002|Overall Study|Withdrawal by Subject|2|||
163001439|NCT00799058|588706309|FG000|Overall Study|Lost to Follow-up|1|||
163001440|NCT00799058|588706310|FG001|Overall Study|Lost to Follow-up|2|||
163001441|NCT00799058|588706311|FG002|Overall Study|Lost to Follow-up|1|||
163001442|NCT00799058|588706309|FG000|Overall Study|Adverse Event|0|||
163001443|NCT00799058|588706310|FG001|Overall Study|Adverse Event|2|||
163001444|NCT00799058|588706311|FG002|Overall Study|Adverse Event|0|||
163001445|NCT00799058|588706309|FG000|Overall Study|Pregnancy|1|||
163001446|NCT00799058|588706310|FG001|Overall Study|Pregnancy|0|||
163001447|NCT00799058|588706311|FG002|Overall Study|Pregnancy|0|||
163001448|NCT00799058|588706309|FG000|Overall Study|Not adherent|3|||
163001449|NCT00799058|588706310|FG001|Overall Study|Not adherent|2|||
163001450|NCT00799058|588706311|FG002|Overall Study|Not adherent|1|||
163001451|NCT00799058|588706309|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
163001452|NCT00799058|588706310|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
163001453|NCT00799058|588706311|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
163001454|NCT00799058|588706309|FG000|Overall Study|IP dispensing error|1|||
163001455|NCT00799058|588706310|FG001|Overall Study|IP dispensing error|0|||
163001456|NCT00799058|588706311|FG002|Overall Study|IP dispensing error|0|||
163001457|NCT00799058|588706309|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
163001458|NCT00799058|588706310|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
163001459|NCT00799058|588706311|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
163001460|NCT00799058|588706309|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
163001461|NCT00799058|588706310|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
163001462|NCT00799058|588706311|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
163001463|NCT00799058|588706309|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
163001464|NCT00799058|588706310|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
163001465|NCT00799058|588706311|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
163001466|NCT00799058|588706309|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
163001467|NCT00799058|588706310|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
163001468|NCT00799058|588706311|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
163001469|NCT02088697|588706316|FG000|Period I|Physician Decision|1|||
163001470|NCT02088697|588706317|FG001|Period I|Physician Decision|4|||
163001471|NCT02088697|588706316|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
163001472|NCT02088697|588706317|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
163001473|NCT01995513|588706320|FG000|Period 1: First Open Label Treatment|Other|34|||
163001474|NCT01995513|588706321|FG001|Period 1: First Open Label Treatment|Other|0|||
163001475|NCT01995513|588706322|FG002|Period 1: First Open Label Treatment|Other|0|||
163001476|NCT01995513|588706323|FG003|Period 1: First Open Label Treatment|Other|0|||
163001477|NCT01995513|588706320|FG000|Period 1: First Open Label Treatment|Death|14|||
163001478|NCT01995513|588706321|FG001|Period 1: First Open Label Treatment|Death|0|||
163001479|NCT01995513|588706322|FG002|Period 1: First Open Label Treatment|Death|0|||
163001480|NCT01995513|588706323|FG003|Period 1: First Open Label Treatment|Death|0|||
163001481|NCT01995513|588706320|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
163001482|NCT01995513|588706321|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
163001483|NCT01995513|588706322|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
163001484|NCT01995513|588706323|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
163001485|NCT01995513|588706320|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
163001486|NCT01995513|588706321|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
163001487|NCT01995513|588706322|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
163001488|NCT01995513|588706323|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
163001489|NCT01995513|588706320|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
163001490|NCT01995513|588706321|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
163001491|NCT01995513|588706322|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
163001492|NCT01995513|588706323|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
163001493|NCT01995513|588706320|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
163001494|NCT01995513|588706321|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
163001495|NCT01995513|588706322|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
163001496|NCT01995513|588706323|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
163001497|NCT01995513|588706320|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
163001498|NCT01995513|588706321|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
163001499|NCT01995513|588706322|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
163001500|NCT01995513|588706323|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
163001501|NCT01995513|588706320|FG000|Period 1: Second Open Label Treatment|Other|0|||
163001502|NCT01995513|588706321|FG001|Period 1: Second Open Label Treatment|Other|2|||
163001503|NCT01995513|588706322|FG002|Period 1: Second Open Label Treatment|Other|0|||
163001504|NCT01995513|588706323|FG003|Period 1: Second Open Label Treatment|Other|0|||
163001505|NCT01995513|588706320|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
163001506|NCT01995513|588706321|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
163001507|NCT01995513|588706322|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
163001508|NCT01995513|588706323|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
163325059|NCT02325466|589902864|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
163325060|NCT02325466|589902862|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
163001509|NCT01995513|588706320|FG000|Period 2: Double Blind Treatment|Death|0|||
163001510|NCT01995513|588706321|FG001|Period 2: Double Blind Treatment|Death|0|||
163001511|NCT01995513|588706322|FG002|Period 2: Double Blind Treatment|Death|0|||
163325061|NCT02325466|589902863|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
163325062|NCT02325466|589902864|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
163325063|NCT02325466|589902862|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
163325064|NCT02325466|589902863|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
163325065|NCT02325466|589902864|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
163325066|NCT00692913|589902865|FG000|Overall Study|Adverse Event|8|||
163325067|NCT00692913|589902866|FG001|Overall Study|Adverse Event|4|||
163325068|NCT00692913|589902865|FG000|Overall Study|Lost to Follow-up|3|||
163325069|NCT00692913|589902866|FG001|Overall Study|Lost to Follow-up|5|||
163325070|NCT00692913|589902865|FG000|Overall Study|Physician Decision|2|||
163325071|NCT00692913|589902866|FG001|Overall Study|Physician Decision|0|||
163325072|NCT00692913|589902865|FG000|Overall Study|Protocol Violation|1|||
163325073|NCT00692913|589902866|FG001|Overall Study|Protocol Violation|1|||
163325074|NCT00692913|589902865|FG000|Overall Study|Withdrawal by Subject|15|||
163325075|NCT00692913|589902866|FG001|Overall Study|Withdrawal by Subject|20|||
163325076|NCT01637402|589902867|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
163325077|NCT01637402|589902868|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
163325078|NCT01637402|589902867|FG000|Standard Dose Regimen|Adverse Event|1|||
163325079|NCT01637402|589902868|FG001|Standard Dose Regimen|Adverse Event|0|||
163325080|NCT01637402|589902867|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
163325081|NCT01637402|589902868|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
163325082|NCT01637402|589902867|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
163325083|NCT01637402|589902868|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
163325084|NCT01637402|589902867|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
163325085|NCT01637402|589902868|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
163325086|NCT01637402|589902867|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
163325087|NCT01637402|589902868|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
163325088|NCT02285270|589902871|FG000|Overall Study|Lost to Follow-up|1|||
163325089|NCT02285270|589902871|FG000|Overall Study|Physician Decision|3|||
163325090|NCT02285270|589902871|FG000|Overall Study|Determined to be ineligible|1|||
163001512|NCT01995513|588706323|FG003|Period 2: Double Blind Treatment|Death|1|||
163001513|NCT01995513|588706320|FG000|Period 2: Double Blind Treatment|Other|0|||
163001514|NCT01995513|588706321|FG001|Period 2: Double Blind Treatment|Other|0|||
163001515|NCT01995513|588706322|FG002|Period 2: Double Blind Treatment|Other|3|||
163001516|NCT01995513|588706323|FG003|Period 2: Double Blind Treatment|Other|3|||
163001517|NCT01995513|588706320|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
163001518|NCT01995513|588706321|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
163001519|NCT01995513|588706322|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
163001520|NCT01995513|588706323|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
163001521|NCT01995513|588706320|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
163213226|NCT02998840|589494417|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
163213227|NCT02998840|589494418|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
163213228|NCT02998840|589494419|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
163213229|NCT02998840|589494420|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
163213230|NCT01686633|589494421|FG000|Overall Study|Lack of Efficacy|33|||
163001522|NCT01995513|588706321|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
163001523|NCT01995513|588706322|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
163001524|NCT01995513|588706323|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
163001525|NCT01995513|588706320|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
163001526|NCT01995513|588706321|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
163001527|NCT01995513|588706322|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
163001528|NCT01995513|588706323|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
163001529|NCT01995513|588706320|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
163001530|NCT01995513|588706321|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
163001531|NCT01995513|588706322|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
163213231|NCT01686633|589494422|FG001|Overall Study|Lack of Efficacy|13|||
163325091|NCT02111096|589902872|FG000|Overall Study|Adverse Event|4|||
163325092|NCT02111096|589902873|FG001|Overall Study|Adverse Event|1|||
163325093|NCT02111096|589902874|FG002|Overall Study|Adverse Event|2|||
163325094|NCT02111096|589902872|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163213232|NCT01686633|589494423|FG002|Overall Study|Lack of Efficacy|11|||
163325095|NCT02111096|589902873|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163325096|NCT02111096|589902874|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163325097|NCT02111096|589902872|FG000|Overall Study|Lost to Follow Up|1|||
163325098|NCT02111096|589902873|FG001|Overall Study|Lost to Follow Up|1|||
163325099|NCT02111096|589902874|FG002|Overall Study|Lost to Follow Up|1|||
163325100|NCT02111096|589902872|FG000|Overall Study|Physician Decision|0|||
163325101|NCT02111096|589902873|FG001|Overall Study|Physician Decision|1|||
163325102|NCT02111096|589902874|FG002|Overall Study|Physician Decision|0|||
163325103|NCT02111096|589902872|FG000|Overall Study|Protocol Violation|1|||
163325104|NCT02111096|589902873|FG001|Overall Study|Protocol Violation|0|||
163325105|NCT02111096|589902874|FG002|Overall Study|Protocol Violation|1|||
163325106|NCT02111096|589902872|FG000|Overall Study|Terminated by Sponsor|53|||
163325107|NCT02111096|589902873|FG001|Overall Study|Terminated by Sponsor|35|||
163325108|NCT02111096|589902874|FG002|Overall Study|Terminated by Sponsor|54|||
163325109|NCT02111096|589902872|FG000|Overall Study|Withdrawal by Subject|4|||
163325110|NCT02111096|589902873|FG001|Overall Study|Withdrawal by Subject|2|||
163325111|NCT02111096|589902874|FG002|Overall Study|Withdrawal by Subject|8|||
163001532|NCT01995513|588706323|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
163001533|NCT01232452|588706324|FG000|Overall Study|Adverse Event|17|||
163001534|NCT01232452|588706325|FG001|Overall Study|Adverse Event|15|||
163001535|NCT01232452|588706324|FG000|Overall Study|Withdrawal by Subject|11|||
163001536|NCT01232452|588706325|FG001|Overall Study|Withdrawal by Subject|8|||
163001537|NCT01232452|588706324|FG000|Overall Study|Physician Decision|8|||
163001538|NCT01232452|588706325|FG001|Overall Study|Physician Decision|12|||
163001539|NCT01232452|588706324|FG000|Overall Study|Protocol entry criterion not met|0|||
163001540|NCT01232452|588706325|FG001|Overall Study|Protocol entry criterion not met|2|||
163001541|NCT01232452|588706324|FG000|Overall Study|Sponsor Decision|3|||
163001542|NCT01232452|588706325|FG001|Overall Study|Sponsor Decision|1|||
163001543|NCT01232452|588706324|FG000|Overall Study|Protocol Violation|0|||
163001544|NCT01232452|588706325|FG001|Overall Study|Protocol Violation|1|||
163001545|NCT00247676|588706330|FG000|Overall Study|Death|5|||
163001546|NCT00247676|588706330|FG000|Overall Study|Adverse Event|11|||
163001547|NCT00247676|588706330|FG000|Overall Study|Lack of Efficacy|15|||
163001548|NCT00247676|588706330|FG000|Overall Study|Other|3|||
163001549|NCT00247676|588706330|FG000|Overall Study|Withdrawal by Subject|2|||
163001550|NCT03594071|588706331|FG000|Overall Study|Re-operation|3|||
163001551|NCT03594071|588706331|FG000|Overall Study|Missed visit|2|||
163001552|NCT05219448|588706332|FG000|Overall Study|Lost to Follow-up|9|||
163001553|NCT05219448|588706333|FG001|Overall Study|Lost to Follow-up|0|||
163001554|NCT01750190|588706334|FG000|Overall Study|Adverse Event|47|||
163001555|NCT01750190|588706335|FG001|Overall Study|Adverse Event|19|||
163001556|NCT01750190|588706334|FG000|Overall Study|Death|38|||
163001557|NCT01750190|588706335|FG001|Overall Study|Death|11|||
163001558|NCT01750190|588706334|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
163001559|NCT01750190|588706335|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
163001560|NCT01750190|588706334|FG000|Overall Study|Lost to Follow-up|28|||
163001561|NCT01750190|588706335|FG001|Overall Study|Lost to Follow-up|7|||
163001562|NCT01750190|588706334|FG000|Overall Study|Physician Decision|16|||
163001563|NCT01750190|588706335|FG001|Overall Study|Physician Decision|17|||
163001564|NCT01750190|588706334|FG000|Overall Study|Protocol Violation|6|||
163001565|NCT01750190|588706335|FG001|Overall Study|Protocol Violation|5|||
163325112|NCT00439270|589902877|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
163325113|NCT00439270|589902878|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
163325114|NCT00439270|589902879|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
163325115|NCT00439270|589902880|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
163001566|NCT01750190|588706334|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
163001567|NCT01750190|588706335|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
163001568|NCT01750190|588706334|FG000|Overall Study|Withdrawal by Subject|83|||
163001569|NCT01750190|588706335|FG001|Overall Study|Withdrawal by Subject|89|||
163001570|NCT01750190|588706334|FG000|Overall Study|Kidney Transplant|8|||
163001571|NCT01750190|588706335|FG001|Overall Study|Kidney Transplant|4|||
163001572|NCT01750190|588706334|FG000|Overall Study|Dialysis|22|||
163001573|NCT01750190|588706335|FG001|Overall Study|Dialysis|8|||
163001574|NCT01750190|588706334|FG000|Overall Study|Other than Specified|13|||
163001575|NCT01750190|588706335|FG001|Overall Study|Other than Specified|4|||
163001576|NCT02287922|588706336|FG000|Overall Study|Adverse Event|1|||
163001577|NCT02287922|588706337|FG001|Overall Study|Adverse Event|1|||
163001578|NCT02287922|588706338|FG002|Overall Study|Adverse Event|3|||
163001579|NCT02287922|588706339|FG003|Overall Study|Adverse Event|4|||
163001580|NCT02287922|588706336|FG000|Overall Study|Withdrawal by Subject|1|||
163001581|NCT02287922|588706337|FG001|Overall Study|Withdrawal by Subject|1|||
163001582|NCT02287922|588706338|FG002|Overall Study|Withdrawal by Subject|1|||
163001583|NCT02287922|588706339|FG003|Overall Study|Withdrawal by Subject|2|||
163001584|NCT02287922|588706336|FG000|Overall Study|Lost to Follow-up|0|||
163001585|NCT02287922|588706337|FG001|Overall Study|Lost to Follow-up|0|||
163001586|NCT02287922|588706338|FG002|Overall Study|Lost to Follow-up|1|||
163325116|NCT00439270|589902881|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
163325117|NCT00439270|589902877|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
163001587|NCT02287922|588706339|FG003|Overall Study|Lost to Follow-up|0|||
163001588|NCT02287922|588706336|FG000|Overall Study|Sponsor's decision|0|||
163325118|NCT00439270|589902878|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
163325119|NCT00439270|589902879|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
163001589|NCT02287922|588706337|FG001|Overall Study|Sponsor's decision|0|||
163001590|NCT02287922|588706338|FG002|Overall Study|Sponsor's decision|0|||
163001591|NCT02287922|588706339|FG003|Overall Study|Sponsor's decision|1|||
163001592|NCT02287922|588706336|FG000|Overall Study|Other|1|||
163001593|NCT02287922|588706337|FG001|Overall Study|Other|0|||
163001594|NCT02287922|588706338|FG002|Overall Study|Other|2|||
163001595|NCT02287922|588706339|FG003|Overall Study|Other|0|||
163001596|NCT03762239|588706344|FG000|Overall Study|Appointment to the doctor|1|||
163001597|NCT03762239|588706345|FG001|Overall Study|Appointment to the doctor|1|||
163001598|NCT00535405|588706346|FG000|Overall Study|Adverse Event|6|||
163001599|NCT00535405|588706347|FG001|Overall Study|Adverse Event|8|||
163001600|NCT00535405|588706348|FG002|Overall Study|Adverse Event|3|||
163001601|NCT00535405|588706349|FG003|Overall Study|Adverse Event|8|||
163001602|NCT00535405|588706350|FG004|Overall Study|Adverse Event|6|||
163001603|NCT00535405|588706346|FG000|Overall Study|Lost to Follow-up|1|||
163001604|NCT00535405|588706347|FG001|Overall Study|Lost to Follow-up|3|||
163001605|NCT00535405|588706348|FG002|Overall Study|Lost to Follow-up|3|||
163001606|NCT00535405|588706349|FG003|Overall Study|Lost to Follow-up|2|||
163001607|NCT00535405|588706350|FG004|Overall Study|Lost to Follow-up|1|||
163001608|NCT00535405|588706346|FG000|Overall Study|Physician Decision|3|||
163001609|NCT00535405|588706347|FG001|Overall Study|Physician Decision|2|||
163001610|NCT00535405|588706348|FG002|Overall Study|Physician Decision|0|||
163001611|NCT00535405|588706349|FG003|Overall Study|Physician Decision|1|||
163001612|NCT00535405|588706350|FG004|Overall Study|Physician Decision|1|||
163001613|NCT00535405|588706346|FG000|Overall Study|Protocol Violation|2|||
163001614|NCT00535405|588706347|FG001|Overall Study|Protocol Violation|2|||
163001615|NCT00535405|588706348|FG002|Overall Study|Protocol Violation|2|||
163001616|NCT00535405|588706349|FG003|Overall Study|Protocol Violation|1|||
163001617|NCT00535405|588706350|FG004|Overall Study|Protocol Violation|0|||
163001618|NCT00535405|588706346|FG000|Overall Study|Withdrawal by Subject|5|||
163001619|NCT00535405|588706347|FG001|Overall Study|Withdrawal by Subject|11|||
163001620|NCT00535405|588706348|FG002|Overall Study|Withdrawal by Subject|10|||
163001621|NCT00535405|588706349|FG003|Overall Study|Withdrawal by Subject|10|||
163001622|NCT00535405|588706350|FG004|Overall Study|Withdrawal by Subject|8|||
163001623|NCT03910673|588706354|FG000|Overall Study|Adverse Event|0|||
163001624|NCT03910673|588706355|FG001|Overall Study|Adverse Event|0|||
163001625|NCT03910673|588706356|FG002|Overall Study|Adverse Event|0|||
163001626|NCT03910673|588706357|FG003|Overall Study|Adverse Event|2|||
163001627|NCT03910673|588706358|FG004|Overall Study|Adverse Event|0|||
163001628|NCT04650204|588706374|FG000|Overall Study|Study was Terminated|2|||
163001629|NCT04650204|588706375|FG001|Overall Study|Study was Terminated|1|||
163001630|NCT03164616|588706376|FG000|Overall Study|Death|250|||
163001631|NCT03164616|588706377|FG001|Overall Study|Death|264|||
163001632|NCT03164616|588706378|FG002|Overall Study|Death|279|||
163001633|NCT03164616|588706376|FG000|Overall Study|Lost to Follow-up|2|||
163001634|NCT03164616|588706377|FG001|Overall Study|Lost to Follow-up|2|||
163001635|NCT03164616|588706378|FG002|Overall Study|Lost to Follow-up|2|||
163001636|NCT03164616|588706376|FG000|Overall Study|Withdrawal by Subject|6|||
163001637|NCT03164616|588706377|FG001|Overall Study|Withdrawal by Subject|7|||
163001638|NCT03164616|588706378|FG002|Overall Study|Withdrawal by Subject|16|||
163001639|NCT01911273|588706381|FG000|Overall Study|Progression of Disease|1|||
163001640|NCT01911273|588706382|FG001|Overall Study|Progression of Disease|0|||
163001641|NCT01911273|588706381|FG000|Overall Study|Withdrawal by Subject|0|||
163001642|NCT01911273|588706382|FG001|Overall Study|Withdrawal by Subject|2|||
163001643|NCT02503787|588706387|FG000|Enrollment|Withdrawal by Subject|6|||
163001644|NCT02503787|588706387|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
163001645|NCT02503787|588706387|FG000|Enrollment|Physician Decision|2|||
163001646|NCT02503787|588706387|FG000|Enrollment|Insurance issue|2|||
163001647|NCT02503787|588706387|FG000|Enrollment|Lost to Follow-up|1|||
163001648|NCT02503787|588706387|FG000|Enrollment|Study closure|1|||
163001649|NCT02503787|588706387|FG000|Enrollment|Adverse Event|1|||
163001650|NCT02503787|588706387|FG000|Enrollment|Protocol Violation|1|||
163001651|NCT02503787|588706387|FG000|Enrollment|Inability to implant system|1|||
163001652|NCT02503787|588706387|FG000|Enrollment|Unable to be programmed|1|||
163001653|NCT02503787|588706387|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
163213233|NCT01686633|589494421|FG000|Overall Study|Withdrawal by Subject|8|||
163213234|NCT01686633|589494422|FG001|Overall Study|Withdrawal by Subject|8|||
163213235|NCT01686633|589494423|FG002|Overall Study|Withdrawal by Subject|5|||
163213236|NCT01686633|589494421|FG000|Overall Study|Physician Decision|3|||
163213237|NCT01686633|589494422|FG001|Overall Study|Physician Decision|4|||
163213238|NCT01686633|589494423|FG002|Overall Study|Physician Decision|4|||
163213239|NCT01686633|589494421|FG000|Overall Study|Adverse Event|4|||
163213240|NCT01686633|589494422|FG001|Overall Study|Adverse Event|3|||
163213241|NCT01686633|589494423|FG002|Overall Study|Adverse Event|3|||
163213242|NCT01686633|589494421|FG000|Overall Study|Protocol Violation|2|||
163213243|NCT01686633|589494422|FG001|Overall Study|Protocol Violation|3|||
163213244|NCT01686633|589494423|FG002|Overall Study|Protocol Violation|0|||
163213245|NCT01686633|589494421|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
163213246|NCT01686633|589494422|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
163213247|NCT01686633|589494423|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
163213248|NCT01686633|589494421|FG000|Overall Study|Lost to Follow-up|0|||
163213249|NCT01686633|589494422|FG001|Overall Study|Lost to Follow-up|1|||
163213250|NCT01686633|589494423|FG002|Overall Study|Lost to Follow-up|1|||
163213251|NCT00511667|589494428|FG000|Overall Study|Adverse Event|1|||
163213252|NCT00511667|589494429|FG001|Overall Study|Adverse Event|0|||
163213253|NCT00511667|589494428|FG000|Overall Study|Protocol Violation|1|||
163213254|NCT00511667|589494429|FG001|Overall Study|Protocol Violation|1|||
163001654|NCT02503787|588706387|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
163001655|NCT02503787|588706387|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
163001656|NCT02503787|588706387|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
163001657|NCT02503787|588706387|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
163001658|NCT02503787|588706387|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
163001659|NCT04787627|588706388|FG000|Overall Study|Withdrawal by Subject|3|||
163001660|NCT04787627|588706389|FG001|Overall Study|Withdrawal by Subject|0|||
163001661|NCT04787627|588706388|FG000|Overall Study|Physician Decision|2|||
163001662|NCT04787627|588706389|FG001|Overall Study|Physician Decision|0|||
163001663|NCT04787627|588706388|FG000|Overall Study|Excluded|0|||
163001664|NCT04787627|588706389|FG001|Overall Study|Excluded|1|||
163001665|NCT00548093|588706390|FG000|Overall Study|Death|33|||
163001666|NCT00548093|588706391|FG001|Overall Study|Death|13|||
163001667|NCT00548093|588706390|FG000|Overall Study|Lost to Follow-up|3|||
163001668|NCT00548093|588706391|FG001|Overall Study|Lost to Follow-up|1|||
163001669|NCT00548093|588706390|FG000|Overall Study|Objective progression or relapse|1|||
163001670|NCT00548093|588706391|FG001|Overall Study|Objective progression or relapse|1|||
163001671|NCT00548093|588706390|FG000|Overall Study|Other|11|||
163001672|NCT00548093|588706391|FG001|Overall Study|Other|1|||
163001673|NCT00548093|588706390|FG000|Overall Study|Withdrawal by Subject|1|||
163001674|NCT00548093|588706391|FG001|Overall Study|Withdrawal by Subject|0|||
163001675|NCT00548093|588706390|FG000|Overall Study|Completed post-treatment follow-up|1|||
163001676|NCT00548093|588706391|FG001|Overall Study|Completed post-treatment follow-up|0|||
163001677|NCT00919854|588706394|FG000|Overall Study|Adverse Event|1|||
163001678|NCT00143247|588706402|FG000|Overall Study|Death|8|||
163001679|NCT00143247|588706402|FG000|Overall Study|Adverse Event|19|||
163001680|NCT00143247|588706402|FG000|Overall Study|Lack of Efficacy|3|||
163001681|NCT00143247|588706402|FG000|Overall Study|Withdrawal by Subject|55|||
163001682|NCT00143247|588706402|FG000|Overall Study|Study terminated by sponsor|31|||
163001683|NCT00143247|588706402|FG000|Overall Study|Protocol Violation|15|||
163001684|NCT00143247|588706402|FG000|Overall Study|Lost to Follow-up|12|||
163001685|NCT00143247|588706402|FG000|Overall Study|following inaccurate lab adverse event|1|||
163001686|NCT00143247|588706402|FG000|Overall Study|Other|12|||
163001687|NCT02933255|588706403|FG000|Overall Study|Discontinued due to study closure.|1|||
163001688|NCT02933255|588706404|FG001|Overall Study|Discontinued due to study closure.|0|||
163001689|NCT02215967|588706409|FG000|Overall Study|Patient became ineligible for treatment|0|||
163001690|NCT02215967|588706410|FG001|Overall Study|Patient became ineligible for treatment|0|||
163001691|NCT02215967|588706411|FG002|Overall Study|Patient became ineligible for treatment|0|||
163001692|NCT02215967|588706412|FG003|Overall Study|Patient became ineligible for treatment|3|||
163001693|NCT02215967|588706409|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
163001694|NCT02215967|588706410|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
163001695|NCT02215967|588706411|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
163001696|NCT02215967|588706412|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
163001697|NCT03207867|588706413|FG000|Overall Study|Adverse Event|1|||
163001698|NCT03207867|588706414|FG001|Overall Study|Adverse Event|0|||
163001699|NCT03207867|588706415|FG002|Overall Study|Adverse Event|1|||
163001700|NCT03207867|588706416|FG003|Overall Study|Adverse Event|0|||
163001701|NCT03207867|588706417|FG004|Overall Study|Adverse Event|0|||
163001702|NCT03207867|588706418|FG005|Overall Study|Adverse Event|2|||
163001703|NCT03207867|588706419|FG006|Overall Study|Adverse Event|1|||
163001704|NCT03207867|588706420|FG007|Overall Study|Adverse Event|1|||
163001705|NCT03207867|588706421|FG008|Overall Study|Adverse Event|2|||
163001706|NCT03207867|588706422|FG009|Overall Study|Adverse Event|2|||
163213255|NCT00511667|589494428|FG000|Overall Study|Withdrawal by Subject|2|||
163213256|NCT00511667|589494429|FG001|Overall Study|Withdrawal by Subject|0|||
163213257|NCT00511667|589494428|FG000|Overall Study|Site terminated|6|||
163213258|NCT00511667|589494429|FG001|Overall Study|Site terminated|1|||
163325120|NCT00439270|589902880|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
163325121|NCT00439270|589902881|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
163213259|NCT00511667|589494428|FG000|Overall Study|Other|2|||
163001707|NCT03207867|588706423|FG010|Overall Study|Adverse Event|0|||
163001708|NCT03207867|588706424|FG011|Overall Study|Adverse Event|0|||
163001709|NCT03207867|588706425|FG012|Overall Study|Adverse Event|0|||
163001710|NCT03207867|588706426|FG013|Overall Study|Adverse Event|0|||
163001711|NCT03207867|588706427|FG014|Overall Study|Adverse Event|0|||
163213260|NCT00511667|589494429|FG001|Overall Study|Other|1|||
163001712|NCT03207867|588706428|FG015|Overall Study|Adverse Event|0|||
163001713|NCT03207867|588706429|FG016|Overall Study|Adverse Event|3|||
163213261|NCT03564145|589494430|FG000|Overall Study|Adverse Event|4|||
163001714|NCT03207867|588706430|FG017|Overall Study|Adverse Event|1|||
163001715|NCT03207867|588706431|FG018|Overall Study|Adverse Event|2|||
163001716|NCT03207867|588706432|FG019|Overall Study|Adverse Event|1|||
163001717|NCT03207867|588706433|FG020|Overall Study|Adverse Event|0|||
163001718|NCT03207867|588706434|FG021|Overall Study|Adverse Event|0|||
163001719|NCT03207867|588706435|FG022|Overall Study|Adverse Event|0|||
163001720|NCT03207867|588706436|FG023|Overall Study|Adverse Event|0|||
163001721|NCT03207867|588706413|FG000|Overall Study|Death|0|||
163001722|NCT03207867|588706414|FG001|Overall Study|Death|0|||
163001723|NCT03207867|588706415|FG002|Overall Study|Death|0|||
163001724|NCT03207867|588706416|FG003|Overall Study|Death|0|||
163001725|NCT03207867|588706417|FG004|Overall Study|Death|0|||
163001726|NCT03207867|588706418|FG005|Overall Study|Death|1|||
163001727|NCT03207867|588706419|FG006|Overall Study|Death|0|||
163001728|NCT03207867|588706420|FG007|Overall Study|Death|3|||
163001729|NCT03207867|588706421|FG008|Overall Study|Death|1|||
163001730|NCT03207867|588706422|FG009|Overall Study|Death|2|||
163001731|NCT03207867|588706423|FG010|Overall Study|Death|0|||
163001732|NCT03207867|588706424|FG011|Overall Study|Death|1|||
163001733|NCT03207867|588706425|FG012|Overall Study|Death|0|||
163001734|NCT03207867|588706426|FG013|Overall Study|Death|1|||
163001735|NCT03207867|588706427|FG014|Overall Study|Death|0|||
163001736|NCT03207867|588706428|FG015|Overall Study|Death|0|||
163001737|NCT03207867|588706429|FG016|Overall Study|Death|0|||
163001738|NCT03207867|588706430|FG017|Overall Study|Death|2|||
163001739|NCT03207867|588706431|FG018|Overall Study|Death|0|||
163001740|NCT03207867|588706432|FG019|Overall Study|Death|1|||
163001741|NCT03207867|588706433|FG020|Overall Study|Death|0|||
163001742|NCT03207867|588706434|FG021|Overall Study|Death|0|||
163001743|NCT03207867|588706435|FG022|Overall Study|Death|0|||
163001744|NCT03207867|588706436|FG023|Overall Study|Death|0|||
163001745|NCT03207867|588706413|FG000|Overall Study|Physician Decision|3|||
163001746|NCT03207867|588706414|FG001|Overall Study|Physician Decision|5|||
163001747|NCT03207867|588706415|FG002|Overall Study|Physician Decision|0|||
163001748|NCT03207867|588706416|FG003|Overall Study|Physician Decision|3|||
163001749|NCT03207867|588706417|FG004|Overall Study|Physician Decision|2|||
163001750|NCT03207867|588706418|FG005|Overall Study|Physician Decision|0|||
163001751|NCT03207867|588706419|FG006|Overall Study|Physician Decision|0|||
163001752|NCT03207867|588706420|FG007|Overall Study|Physician Decision|0|||
163001753|NCT03207867|588706421|FG008|Overall Study|Physician Decision|4|||
163001754|NCT03207867|588706422|FG009|Overall Study|Physician Decision|2|||
163001755|NCT03207867|588706423|FG010|Overall Study|Physician Decision|0|||
163001756|NCT03207867|588706424|FG011|Overall Study|Physician Decision|4|||
163001757|NCT03207867|588706425|FG012|Overall Study|Physician Decision|0|||
163001758|NCT03207867|588706426|FG013|Overall Study|Physician Decision|0|||
163001759|NCT03207867|588706427|FG014|Overall Study|Physician Decision|2|||
163001760|NCT03207867|588706428|FG015|Overall Study|Physician Decision|1|||
163001761|NCT03207867|588706429|FG016|Overall Study|Physician Decision|1|||
163001762|NCT03207867|588706430|FG017|Overall Study|Physician Decision|2|||
163001763|NCT03207867|588706431|FG018|Overall Study|Physician Decision|1|||
163001764|NCT03207867|588706432|FG019|Overall Study|Physician Decision|3|||
163001765|NCT03207867|588706433|FG020|Overall Study|Physician Decision|0|||
163001766|NCT03207867|588706434|FG021|Overall Study|Physician Decision|0|||
163001767|NCT03207867|588706435|FG022|Overall Study|Physician Decision|0|||
163001768|NCT03207867|588706436|FG023|Overall Study|Physician Decision|0|||
163001769|NCT03207867|588706413|FG000|Overall Study|Progressive Disease|7|||
163001770|NCT03207867|588706414|FG001|Overall Study|Progressive Disease|7|||
163001771|NCT03207867|588706415|FG002|Overall Study|Progressive Disease|9|||
163001772|NCT03207867|588706416|FG003|Overall Study|Progressive Disease|10|||
163001773|NCT03207867|588706417|FG004|Overall Study|Progressive Disease|11|||
163001774|NCT03207867|588706418|FG005|Overall Study|Progressive Disease|10|||
163001775|NCT03207867|588706419|FG006|Overall Study|Progressive Disease|9|||
163001776|NCT03207867|588706420|FG007|Overall Study|Progressive Disease|8|||
163001777|NCT03207867|588706421|FG008|Overall Study|Progressive Disease|19|||
163001778|NCT03207867|588706422|FG009|Overall Study|Progressive Disease|23|||
163001779|NCT03207867|588706423|FG010|Overall Study|Progressive Disease|2|||
163001780|NCT03207867|588706424|FG011|Overall Study|Progressive Disease|24|||
163001781|NCT03207867|588706425|FG012|Overall Study|Progressive Disease|3|||
163001782|NCT03207867|588706426|FG013|Overall Study|Progressive Disease|11|||
163001783|NCT03207867|588706427|FG014|Overall Study|Progressive Disease|9|||
163001784|NCT03207867|588706428|FG015|Overall Study|Progressive Disease|5|||
163001785|NCT03207867|588706429|FG016|Overall Study|Progressive Disease|10|||
163001786|NCT03207867|588706430|FG017|Overall Study|Progressive Disease|14|||
163001787|NCT03207867|588706431|FG018|Overall Study|Progressive Disease|13|||
163001788|NCT03207867|588706432|FG019|Overall Study|Progressive Disease|14|||
163001789|NCT03207867|588706433|FG020|Overall Study|Progressive Disease|6|||
163001790|NCT03207867|588706434|FG021|Overall Study|Progressive Disease|3|||
163001791|NCT03207867|588706435|FG022|Overall Study|Progressive Disease|3|||
163001792|NCT03207867|588706436|FG023|Overall Study|Progressive Disease|3|||
163001793|NCT03207867|588706413|FG000|Overall Study|Patient/guardian Decision|0|||
163001794|NCT03207867|588706414|FG001|Overall Study|Patient/guardian Decision|0|||
163001795|NCT03207867|588706415|FG002|Overall Study|Patient/guardian Decision|1|||
163001796|NCT03207867|588706416|FG003|Overall Study|Patient/guardian Decision|1|||
163325122|NCT00439270|589902877|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
163001797|NCT03207867|588706417|FG004|Overall Study|Patient/guardian Decision|1|||
163001798|NCT03207867|588706418|FG005|Overall Study|Patient/guardian Decision|2|||
163001799|NCT03207867|588706419|FG006|Overall Study|Patient/guardian Decision|1|||
163001800|NCT03207867|588706420|FG007|Overall Study|Patient/guardian Decision|0|||
163001801|NCT03207867|588706421|FG008|Overall Study|Patient/guardian Decision|1|||
163001802|NCT03207867|588706422|FG009|Overall Study|Patient/guardian Decision|0|||
163001803|NCT03207867|588706423|FG010|Overall Study|Patient/guardian Decision|0|||
163001804|NCT03207867|588706424|FG011|Overall Study|Patient/guardian Decision|1|||
163001805|NCT03207867|588706425|FG012|Overall Study|Patient/guardian Decision|0|||
163001806|NCT03207867|588706426|FG013|Overall Study|Patient/guardian Decision|1|||
163325123|NCT00439270|589902878|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
163325124|NCT00439270|589902879|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
163325125|NCT00439270|589902880|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
163325126|NCT00439270|589902881|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
163001807|NCT03207867|588706427|FG014|Overall Study|Patient/guardian Decision|2|||
163325127|NCT00439270|589902877|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
163325128|NCT00439270|589902878|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
163325129|NCT00439270|589902879|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
163325130|NCT00439270|589902880|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
163325131|NCT00439270|589902881|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
163325132|NCT00439270|589902877|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
163325133|NCT00439270|589902878|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
163325134|NCT00439270|589902879|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
163325135|NCT00439270|589902880|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
163325136|NCT00439270|589902881|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
163325137|NCT00439270|589902877|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
163325138|NCT00439270|589902878|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
163325139|NCT00439270|589902879|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
163325140|NCT00439270|589902880|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
163325141|NCT00439270|589902881|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
163325142|NCT00439270|589902877|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
163325143|NCT00439270|589902878|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
163325144|NCT00439270|589902879|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
163325145|NCT00439270|589902880|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
163325146|NCT00439270|589902881|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
163325147|NCT00439270|589902877|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
163325148|NCT00439270|589902878|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
163325149|NCT00439270|589902879|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
163325150|NCT00439270|589902880|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
163325151|NCT00439270|589902881|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
163325152|NCT00439270|589902877|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
163325153|NCT00439270|589902878|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
163325154|NCT00439270|589902879|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
163325155|NCT00439270|589902880|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
163325156|NCT00439270|589902881|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
163325157|NCT00439270|589902877|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
163325158|NCT00439270|589902878|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
163325159|NCT00439270|589902879|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
163001808|NCT03207867|588706428|FG015|Overall Study|Patient/guardian Decision|0|||
163001809|NCT03207867|588706429|FG016|Overall Study|Patient/guardian Decision|1|||
163001810|NCT03207867|588706430|FG017|Overall Study|Patient/guardian Decision|3|||
163001811|NCT03207867|588706431|FG018|Overall Study|Patient/guardian Decision|4|||
163001812|NCT03207867|588706432|FG019|Overall Study|Patient/guardian Decision|1|||
163001813|NCT03207867|588706433|FG020|Overall Study|Patient/guardian Decision|0|||
163001814|NCT03207867|588706434|FG021|Overall Study|Patient/guardian Decision|0|||
163001815|NCT03207867|588706435|FG022|Overall Study|Patient/guardian Decision|0|||
163001816|NCT03207867|588706436|FG023|Overall Study|Patient/guardian Decision|0|||
163001817|NCT02603146|588708875|FG000|Overall Study|Lost to Follow-up|5|||
163001818|NCT02603146|588708876|FG001|Overall Study|Lost to Follow-up|6|||
163001819|NCT02603146|588708875|FG000|Overall Study|Withdrawal by Subject|8|||
163001820|NCT02603146|588708876|FG001|Overall Study|Withdrawal by Subject|10|||
163001821|NCT02603146|588708875|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
163325160|NCT00439270|589902880|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
163325161|NCT00439270|589902881|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
163325162|NCT01268306|589902882|FG000|Overall Study|Lost to Follow-up|1|||
163001822|NCT02603146|588708876|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
163001823|NCT02603146|588708875|FG000|Overall Study|Participant moved|2|||
163001824|NCT02603146|588708876|FG001|Overall Study|Participant moved|0|||
163001825|NCT02603146|588708875|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
163325163|NCT04121546|589902883|FG000|Overall Study|Lost to Follow-up|1|||
163001826|NCT02603146|588708876|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
163001827|NCT05221320|588708877|FG000|Overall Study|Lack of Efficacy|3|||
163001828|NCT05221320|588708878|FG001|Overall Study|Lack of Efficacy|7|||
163001829|NCT05221320|588708879|FG002|Overall Study|Lack of Efficacy|10|||
163001830|NCT05221320|588708880|FG003|Overall Study|Lack of Efficacy|1|||
163001831|NCT05221320|588708881|FG004|Overall Study|Lack of Efficacy|0|||
163001832|NCT05221320|588708882|FG005|Overall Study|Lack of Efficacy|0|||
163001833|NCT05221320|588708877|FG000|Overall Study|Physician Decision|1|||
163001834|NCT05221320|588708878|FG001|Overall Study|Physician Decision|0|||
163001835|NCT05221320|588708879|FG002|Overall Study|Physician Decision|3|||
163001836|NCT05221320|588708880|FG003|Overall Study|Physician Decision|1|||
163001837|NCT05221320|588708881|FG004|Overall Study|Physician Decision|0|||
163001838|NCT05221320|588708882|FG005|Overall Study|Physician Decision|0|||
163001839|NCT05221320|588708877|FG000|Overall Study|Withdrawal by Subject|0|||
163001840|NCT05221320|588708878|FG001|Overall Study|Withdrawal by Subject|3|||
163001841|NCT05221320|588708879|FG002|Overall Study|Withdrawal by Subject|1|||
163001842|NCT05221320|588708880|FG003|Overall Study|Withdrawal by Subject|0|||
163001843|NCT05221320|588708881|FG004|Overall Study|Withdrawal by Subject|0|||
163001844|NCT05221320|588708882|FG005|Overall Study|Withdrawal by Subject|0|||
163001845|NCT05221320|588708877|FG000|Overall Study|Death|0|||
163001846|NCT05221320|588708878|FG001|Overall Study|Death|5|||
163001847|NCT05221320|588708879|FG002|Overall Study|Death|6|||
163001848|NCT05221320|588708880|FG003|Overall Study|Death|0|||
163001849|NCT05221320|588708881|FG004|Overall Study|Death|1|||
163001850|NCT05221320|588708882|FG005|Overall Study|Death|0|||
163001851|NCT06473519|588708883|FG000|Overall Study|Lost to Follow-up|2|||
163001852|NCT06473519|588708884|FG001|Overall Study|Lost to Follow-up|5|||
163001853|NCT06473519|588708883|FG000|Overall Study|Withdrawal by Subject|1|||
163001854|NCT06473519|588708884|FG001|Overall Study|Withdrawal by Subject|4|||
163001855|NCT06473519|588708883|FG000|Overall Study|Randomized but not vaccinated|1|||
163001856|NCT06473519|588708884|FG001|Overall Study|Randomized but not vaccinated|2|||
163001859|NCT03729596|588708888|FG000|Overall Study|Death|3|||
163001860|NCT03729596|588708889|FG001|Overall Study|Death|5|||
163001861|NCT03729596|588708890|FG002|Overall Study|Death|4|||
163001862|NCT03729596|588708891|FG003|Overall Study|Death|1|||
163001863|NCT03729596|588708892|FG004|Overall Study|Death|0|||
163001864|NCT03729596|588708893|FG005|Overall Study|Death|34|||
163001865|NCT03729596|588708894|FG006|Overall Study|Death|18|||
163001866|NCT03729596|588708895|FG007|Overall Study|Death|14|||
163001867|NCT03729596|588708896|FG008|Overall Study|Death|19|||
163001868|NCT03729596|588708897|FG009|Overall Study|Death|9|||
163001869|NCT03729596|588708888|FG000|Overall Study|Lost to Follow-up|0|||
163001870|NCT03729596|588708889|FG001|Overall Study|Lost to Follow-up|0|||
163001871|NCT03729596|588708890|FG002|Overall Study|Lost to Follow-up|0|||
163001872|NCT03729596|588708891|FG003|Overall Study|Lost to Follow-up|0|||
163001873|NCT03729596|588708892|FG004|Overall Study|Lost to Follow-up|0|||
163001874|NCT03729596|588708893|FG005|Overall Study|Lost to Follow-up|0|||
163001875|NCT03729596|588708894|FG006|Overall Study|Lost to Follow-up|1|||
163001876|NCT03729596|588708895|FG007|Overall Study|Lost to Follow-up|0|||
163001877|NCT03729596|588708896|FG008|Overall Study|Lost to Follow-up|0|||
163001878|NCT03729596|588708897|FG009|Overall Study|Lost to Follow-up|1|||
163001879|NCT03729596|588708888|FG000|Overall Study|protocol amendment|0|||
163001880|NCT03729596|588708889|FG001|Overall Study|protocol amendment|1|||
163001881|NCT03729596|588708890|FG002|Overall Study|protocol amendment|3|||
163001882|NCT03729596|588708891|FG003|Overall Study|protocol amendment|6|||
163001883|NCT03729596|588708892|FG004|Overall Study|protocol amendment|5|||
163001884|NCT03729596|588708893|FG005|Overall Study|protocol amendment|0|||
163001885|NCT03729596|588708894|FG006|Overall Study|protocol amendment|0|||
163001886|NCT03729596|588708895|FG007|Overall Study|protocol amendment|0|||
163001887|NCT03729596|588708896|FG008|Overall Study|protocol amendment|0|||
163001888|NCT03729596|588708897|FG009|Overall Study|protocol amendment|0|||
163001889|NCT03729596|588708888|FG000|Overall Study|Withdrawal by Subject|0|||
163001890|NCT03729596|588708889|FG001|Overall Study|Withdrawal by Subject|0|||
163001891|NCT03729596|588708890|FG002|Overall Study|Withdrawal by Subject|0|||
163001892|NCT03729596|588708891|FG003|Overall Study|Withdrawal by Subject|0|||
163001893|NCT03729596|588708892|FG004|Overall Study|Withdrawal by Subject|0|||
163001894|NCT03729596|588708893|FG005|Overall Study|Withdrawal by Subject|4|||
163001895|NCT03729596|588708894|FG006|Overall Study|Withdrawal by Subject|2|||
163001896|NCT03729596|588708895|FG007|Overall Study|Withdrawal by Subject|3|||
163001897|NCT03729596|588708896|FG008|Overall Study|Withdrawal by Subject|2|||
163001898|NCT03729596|588708897|FG009|Overall Study|Withdrawal by Subject|3|||
163001899|NCT03729596|588708888|FG000|Overall Study|study terminated by sponsor|0|||
163001900|NCT03729596|588708889|FG001|Overall Study|study terminated by sponsor|0|||
163001901|NCT03729596|588708890|FG002|Overall Study|study terminated by sponsor|0|||
163001902|NCT03729596|588708891|FG003|Overall Study|study terminated by sponsor|0|||
163001903|NCT03729596|588708892|FG004|Overall Study|study terminated by sponsor|1|||
163001904|NCT03729596|588708893|FG005|Overall Study|study terminated by sponsor|3|||
163001905|NCT03729596|588708894|FG006|Overall Study|study terminated by sponsor|0|||
163001906|NCT03729596|588708895|FG007|Overall Study|study terminated by sponsor|1|||
163001907|NCT03729596|588708896|FG008|Overall Study|study terminated by sponsor|0|||
163001908|NCT03729596|588708897|FG009|Overall Study|study terminated by sponsor|0|||
163001909|NCT03713593|588708898|FG000|Overall Study|Sponsor Decision|73|||
163001910|NCT03713593|588708899|FG001|Overall Study|Sponsor Decision|41|||
163001911|NCT03713593|588708898|FG000|Overall Study|Lost to Follow-up|2|||
163001912|NCT03713593|588708899|FG001|Overall Study|Lost to Follow-up|1|||
163001913|NCT03713593|588708898|FG000|Overall Study|Death|314|||
163001914|NCT03713593|588708899|FG001|Overall Study|Death|349|||
163001915|NCT03713593|588708898|FG000|Overall Study|Withdrawal by Subject|6|||
163001916|NCT03713593|588708899|FG001|Overall Study|Withdrawal by Subject|8|||
163001917|NCT03560037|588708901|FG000|Overall Study|Protocol Violation|1|||
163001918|NCT03560037|588708902|FG001|Overall Study|Protocol Violation|0|||
163001919|NCT03560037|588708901|FG000|Overall Study|Physician Decision|0|||
163001920|NCT03560037|588708902|FG001|Overall Study|Physician Decision|1|||
163001921|NCT03620708|588708903|FG000|Overall Study|Lost to Follow-up|1|||
163001922|NCT03620708|588708904|FG001|Overall Study|Lost to Follow-up|1|||
163001923|NCT03620708|588708905|FG002|Overall Study|Lost to Follow-up|2|||
163001924|NCT03620708|588708903|FG000|Overall Study|Withdrawal by Subject|0|||
163001925|NCT03620708|588708904|FG001|Overall Study|Withdrawal by Subject|0|||
163001926|NCT03620708|588708905|FG002|Overall Study|Withdrawal by Subject|1|||
163001927|NCT02498613|588708906|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
163001928|NCT02498613|588708907|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
163001929|NCT02498613|588708908|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
163001930|NCT02498613|588708909|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
163001931|NCT02498613|588708906|FG000|Overall Study|Withdrawal by Subject|3|||
163001932|NCT02498613|588708907|FG001|Overall Study|Withdrawal by Subject|1|||
163001933|NCT02498613|588708908|FG002|Overall Study|Withdrawal by Subject|0|||
163001934|NCT02498613|588708909|FG003|Overall Study|Withdrawal by Subject|0|||
163001935|NCT05126693|588708910|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
163001936|NCT05126693|588708911|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
163001937|NCT05126693|588708910|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
163001938|NCT05126693|588708911|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
163001939|NCT05126693|588708910|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
163001940|NCT05126693|588708911|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
163001941|NCT03631199|588708916|FG000|Overall Study|Progressive disease|9|||
163001942|NCT03631199|588708917|FG001|Overall Study|Progressive disease|5|||
163001943|NCT03631199|588708918|FG002|Overall Study|Progressive disease|5|||
163001944|NCT03631199|588708919|FG003|Overall Study|Progressive disease|149|||
163001945|NCT03631199|588708920|FG004|Overall Study|Progressive disease|148|||
163001946|NCT03631199|588708916|FG000|Overall Study|Physician Decision|0|||
163001947|NCT03631199|588708917|FG001|Overall Study|Physician Decision|2|||
163001948|NCT03631199|588708918|FG002|Overall Study|Physician Decision|3|||
163001949|NCT03631199|588708919|FG003|Overall Study|Physician Decision|19|||
163001950|NCT03631199|588708920|FG004|Overall Study|Physician Decision|13|||
163001951|NCT03631199|588708916|FG000|Overall Study|Adverse Event|1|||
163001952|NCT03631199|588708917|FG001|Overall Study|Adverse Event|1|||
163001953|NCT03631199|588708918|FG002|Overall Study|Adverse Event|0|||
163001954|NCT03631199|588708919|FG003|Overall Study|Adverse Event|28|||
163001955|NCT03631199|588708920|FG004|Overall Study|Adverse Event|29|||
163001956|NCT03631199|588708916|FG000|Overall Study|Death|0|||
163001957|NCT03631199|588708917|FG001|Overall Study|Death|1|||
163001958|NCT03631199|588708918|FG002|Overall Study|Death|0|||
163001959|NCT03631199|588708919|FG003|Overall Study|Death|35|||
163001960|NCT03631199|588708920|FG004|Overall Study|Death|48|||
163001961|NCT03631199|588708916|FG000|Overall Study|Subject decision|0|||
163001962|NCT03631199|588708917|FG001|Overall Study|Subject decision|1|||
163001963|NCT03631199|588708918|FG002|Overall Study|Subject decision|0|||
163001964|NCT03631199|588708919|FG003|Overall Study|Subject decision|12|||
163001965|NCT03631199|588708920|FG004|Overall Study|Subject decision|12|||
163001966|NCT03631199|588708916|FG000|Overall Study|No treated|0|||
163001967|NCT03631199|588708917|FG001|Overall Study|No treated|0|||
163001968|NCT03631199|588708918|FG002|Overall Study|No treated|0|||
163001969|NCT03631199|588708919|FG003|Overall Study|No treated|0|||
163001970|NCT03631199|588708920|FG004|Overall Study|No treated|1|||
163001971|NCT03631199|588708916|FG000|Overall Study|Treatment ongoing|0|||
163001972|NCT03631199|588708917|FG001|Overall Study|Treatment ongoing|1|||
163001973|NCT03631199|588708918|FG002|Overall Study|Treatment ongoing|1|||
163001974|NCT03631199|588708919|FG003|Overall Study|Treatment ongoing|76|||
163001975|NCT03631199|588708920|FG004|Overall Study|Treatment ongoing|71|||
163001976|NCT03631199|588708916|FG000|Overall Study|Guardian decision|0|||
163001977|NCT03631199|588708917|FG001|Overall Study|Guardian decision|0|||
163213262|NCT03564145|589494430|FG000|Overall Study|Lost to Follow-up|21|||
163213263|NCT03564145|589494430|FG000|Overall Study|Protocol Violation|2|||
163213264|NCT03564145|589494430|FG000|Overall Study|Withdrawal by Subject|48|||
163213265|NCT03564145|589494430|FG000|Overall Study|Study Terminated by Sponsor|146|||
163001978|NCT03631199|588708918|FG002|Overall Study|Guardian decision|0|||
163001979|NCT03631199|588708919|FG003|Overall Study|Guardian decision|1|||
163001980|NCT03631199|588708920|FG004|Overall Study|Guardian decision|1|||
163001981|NCT03690388|588708921|FG000|Overall Study|Adverse Event|8|||
163001982|NCT03690388|588708922|FG001|Overall Study|Adverse Event|1|||
163001983|NCT03690388|588708921|FG000|Overall Study|Radiographic Progression|14|||
163001984|NCT03690388|588708922|FG001|Overall Study|Radiographic Progression|29|||
163001985|NCT03690388|588708921|FG000|Overall Study|Clinical deterioration|10|||
163001986|NCT03690388|588708922|FG001|Overall Study|Clinical deterioration|6|||
163001987|NCT03690388|588708921|FG000|Overall Study|Withdrawal by Subject|2|||
163001988|NCT03690388|588708922|FG001|Overall Study|Withdrawal by Subject|0|||
163001989|NCT03690388|588708921|FG000|Overall Study|Lack of Efficacy|1|||
163001990|NCT03690388|588708922|FG001|Overall Study|Lack of Efficacy|0|||
163001991|NCT03690388|588708921|FG000|Overall Study|Lost to Follow-up|1|||
163001992|NCT03690388|588708922|FG001|Overall Study|Lost to Follow-up|0|||
163001993|NCT03041311|588708923|FG000|Overall Study|Death|39|||
163001994|NCT03041311|588708924|FG001|Overall Study|Death|42|||
163001995|NCT03041311|588708923|FG000|Overall Study|Lost to Follow-up|0|||
163001996|NCT03041311|588708924|FG001|Overall Study|Lost to Follow-up|1|||
163001997|NCT03041311|588708923|FG000|Overall Study|Withdrawal by Subject|8|||
163001998|NCT03041311|588708924|FG001|Overall Study|Withdrawal by Subject|5|||
163001999|NCT03041311|588708923|FG000|Overall Study|Sponsor Terminated Study|2|||
163002000|NCT03041311|588708924|FG001|Overall Study|Sponsor Terminated Study|4|||
163002001|NCT03041311|588708923|FG000|Overall Study|Disease Progression|3|||
163002002|NCT03041311|588708924|FG001|Overall Study|Disease Progression|1|||
163002003|NCT03041311|588708923|FG000|Overall Study|Randomized in error, did not receive drug|2|||
163002004|NCT03041311|588708924|FG001|Overall Study|Randomized in error, did not receive drug|0|||
163002005|NCT01720225|588708926|FG000|Overall Study|Withdrawal by Subject|0|||
163002006|NCT01720225|588708927|FG001|Overall Study|Withdrawal by Subject|1|||
163002007|NCT01720225|588708926|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
163002008|NCT01720225|588708927|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
163002009|NCT02604407|588708928|FG000|Overall Study|Adverse Event|0|||
163002010|NCT02604407|588708929|FG001|Overall Study|Adverse Event|7|||
163002011|NCT02604407|588708930|FG002|Overall Study|Adverse Event|5|||
163002012|NCT02604407|588708928|FG000|Overall Study|Protocol Violation|2|||
163002013|NCT02604407|588708929|FG001|Overall Study|Protocol Violation|0|||
163002014|NCT02604407|588708930|FG002|Overall Study|Protocol Violation|0|||
163002015|NCT02604407|588708928|FG000|Overall Study|Withdrawal by Subject|3|||
163002016|NCT02604407|588708929|FG001|Overall Study|Withdrawal by Subject|3|||
163002017|NCT02604407|588708930|FG002|Overall Study|Withdrawal by Subject|5|||
163002018|NCT02604407|588708928|FG000|Overall Study|Lost to Follow-up|2|||
163002019|NCT02604407|588708929|FG001|Overall Study|Lost to Follow-up|1|||
163002020|NCT02604407|588708930|FG002|Overall Study|Lost to Follow-up|2|||
163002021|NCT02604407|588708928|FG000|Overall Study|Lack of Efficacy|1|||
163002022|NCT02604407|588708929|FG001|Overall Study|Lack of Efficacy|0|||
163002023|NCT02604407|588708930|FG002|Overall Study|Lack of Efficacy|0|||
163002024|NCT02604407|588708928|FG000|Overall Study|Other|3|||
163002025|NCT02604407|588708929|FG001|Overall Study|Other|1|||
163002026|NCT02604407|588708930|FG002|Overall Study|Other|4|||
163002027|NCT00661193|588708931|FG000|Overall Study|Adverse Event|2|||
163002028|NCT00661193|588708932|FG001|Overall Study|Adverse Event|1|||
163002029|NCT00661193|588708931|FG000|Overall Study|Withdrawal by Subject|3|||
163002030|NCT00661193|588708932|FG001|Overall Study|Withdrawal by Subject|1|||
163002031|NCT00661193|588708931|FG000|Overall Study|Progression|27|||
163002032|NCT00661193|588708932|FG001|Overall Study|Progression|24|||
163002033|NCT00661193|588708931|FG000|Overall Study|Not protocol specified|1|||
163002034|NCT00661193|588708932|FG001|Overall Study|Not protocol specified|0|||
163002035|NCT02964312|588708939|FG000|Overall Study|Lost to Follow-up|28|||
163002036|NCT02964312|588708939|FG000|Overall Study|Withdrawal by Subject|11|||
163002037|NCT02964312|588708939|FG000|Overall Study|Lack of Efficacy|10|||
163002038|NCT02964312|588708939|FG000|Overall Study|Did not consent to long-term FU|14|||
163002039|NCT02964312|588708939|FG000|Overall Study|Death|1|||
163002040|NCT00191191|588708942|FG000|Overall Study|Entry Criteria Exclusion|2|||
163002041|NCT00191191|588708943|FG001|Overall Study|Entry Criteria Exclusion|0|||
163002042|NCT00191191|588708942|FG000|Overall Study|Treated with Another Systemic Agent|1|||
163002043|NCT00191191|588708943|FG001|Overall Study|Treated with Another Systemic Agent|1|||
163002044|NCT00191191|588708942|FG000|Overall Study|Adverse Event|11|||
163002045|NCT00191191|588708943|FG001|Overall Study|Adverse Event|21|||
163002046|NCT00191191|588708942|FG000|Overall Study|Progressive Disease|84|||
163213266|NCT03564145|589494430|FG000|Overall Study|Physician Decision|1|||
163002047|NCT00191191|588708943|FG001|Overall Study|Progressive Disease|72|||
163002048|NCT00191191|588708942|FG000|Overall Study|Toxicity After Dose Reduction|7|||
163213267|NCT03564145|589494430|FG000|Overall Study|Other Than Specified|1|||
163213268|NCT03564145|589494430|FG000|Overall Study|Pregnancy|1|||
163213269|NCT04219891|589494433|FG000|Overall Study|Lost to Follow-up|3|||
163002049|NCT00191191|588708943|FG001|Overall Study|Toxicity After Dose Reduction|8|||
163002050|NCT00191191|588708942|FG000|Overall Study|Family/Caregiver Decision|5|||
163002051|NCT00191191|588708943|FG001|Overall Study|Family/Caregiver Decision|7|||
163002052|NCT00191191|588708942|FG000|Overall Study|Lost to Follow-up|1|||
163002053|NCT00191191|588708943|FG001|Overall Study|Lost to Follow-up|0|||
163213270|NCT04219891|589494433|FG000|Overall Study|Withdrawal by Subject|2|||
163213271|NCT00410761|589495928|FG000|Randomized Treatment Period|Adverse Event|34|||
163002054|NCT00191191|588708942|FG000|Overall Study|Physician Decision|3|||
163002055|NCT00191191|588708943|FG001|Overall Study|Physician Decision|2|||
163002056|NCT00191191|588708942|FG000|Overall Study|Good Clinical Practice Violation|0|||
163002057|NCT00191191|588708943|FG001|Overall Study|Good Clinical Practice Violation|1|||
163002058|NCT03280264|588708949|FG000|Overall Study|Adverse Event|1|||
163002059|NCT03280264|588708949|FG000|Overall Study|Physician Decision|1|||
163002060|NCT03280264|588708949|FG000|Overall Study|Withdrawal by Subject|1|||
163002061|NCT00524420|588708956|FG000|Overall Study|Lack of Efficacy|1|||
163002062|NCT00524420|588708957|FG001|Overall Study|Lack of Efficacy|0|||
163002063|NCT00577863|588708958|FG000|Overall Study|Adverse Event|4|||
163002064|NCT00577863|588708959|FG001|Overall Study|Adverse Event|2|||
163002065|NCT00577863|588708958|FG000|Overall Study|Death|1|||
163002066|NCT00577863|588708959|FG001|Overall Study|Death|0|||
163002067|NCT00577863|588708958|FG000|Overall Study|Lost to Follow-up|2|||
163002068|NCT00577863|588708959|FG001|Overall Study|Lost to Follow-up|2|||
163002069|NCT00577863|588708958|FG000|Overall Study|Entry Criteria Exclusion|1|||
163002070|NCT00577863|588708959|FG001|Overall Study|Entry Criteria Exclusion|0|||
163002071|NCT00577863|588708958|FG000|Overall Study|Withdrawal by Subject|0|||
163002072|NCT00577863|588708959|FG001|Overall Study|Withdrawal by Subject|2|||
163002073|NCT00577863|588708958|FG000|Overall Study|Sponsor Decision|2|||
163002074|NCT00577863|588708959|FG001|Overall Study|Sponsor Decision|7|||
163002075|NCT00577863|588708958|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
163002076|NCT00577863|588708959|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
163002077|NCT02738138|588708961|FG000|Overall Study|Adverse Event|0|||
163002078|NCT02738138|588708962|FG001|Overall Study|Adverse Event|1|||
163002079|NCT02738138|588708961|FG000|Overall Study|Lost to Follow-up|2|||
163213272|NCT00410761|589495929|FG001|Randomized Treatment Period|Adverse Event|3|||
163213273|NCT00410761|589495928|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
163213274|NCT00410761|589495929|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
163213275|NCT00410761|589495928|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
163213276|NCT00410761|589495929|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
163213277|NCT00410761|589495928|FG000|Randomized Treatment Period|Other|69|||
163213278|NCT00410761|589495929|FG001|Randomized Treatment Period|Other|21|||
163213279|NCT00410761|589495928|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
163213280|NCT00410761|589495929|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
163213281|NCT00410761|589495928|FG000|Open-Label Treatment Period|Adverse Event|13|||
163213282|NCT00410761|589495929|FG001|Open-Label Treatment Period|Adverse Event|15|||
163213283|NCT00410761|589495928|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
163213284|NCT00410761|589495929|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
163213285|NCT00410761|589495928|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
163213286|NCT00410761|589495929|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
163213287|NCT00410761|589495928|FG000|Open-Label Treatment Period|Other|18|||
163213288|NCT00410761|589495929|FG001|Open-Label Treatment Period|Other|9|||
163213289|NCT00773292|589495933|FG000|Treatment 48 Weeks|Adverse Event|1|||
163213290|NCT00773292|589495933|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
163213291|NCT00708162|589495934|FG000|Randomized Phase|Randomized but Not Treated|7|||
163213292|NCT00708162|589495935|FG001|Randomized Phase|Randomized but Not Treated|5|||
163325164|NCT04121546|589902884|FG001|Overall Study|Lost to Follow-up|3|||
163325165|NCT04129164|589902885|FG000|Overall Study|Non-compliance with procedures|0|||
163002080|NCT02738138|588708962|FG001|Overall Study|Lost to Follow-up|0|||
163002081|NCT02738138|588708961|FG000|Overall Study|Other - not further specified|1|||
163002082|NCT02738138|588708962|FG001|Overall Study|Other - not further specified|0|||
163002083|NCT05024747|588708973|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
163002084|NCT05024747|588708974|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
163002085|NCT05024747|588708973|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
163002086|NCT05024747|588708974|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
163213293|NCT00708162|589495934|FG000|Randomized Phase|Participant Noncompliance|40|||
163213294|NCT00708162|589495935|FG001|Randomized Phase|Participant Noncompliance|32|||
163213295|NCT00708162|589495934|FG000|Randomized Phase|Lost to Follow-up|34|||
163213296|NCT00708162|589495935|FG001|Randomized Phase|Lost to Follow-up|34|||
163213297|NCT00708162|589495934|FG000|Randomized Phase|Withdrew Consent|31|||
163213298|NCT00708162|589495935|FG001|Randomized Phase|Withdrew Consent|22|||
163325166|NCT04129164|589902886|FG001|Overall Study|Non-compliance with procedures|0|||
163325167|NCT04129164|589902887|FG002|Overall Study|Non-compliance with procedures|2|||
163213299|NCT00708162|589495934|FG000|Randomized Phase|Lack of Efficacy|14|||
163213300|NCT00708162|589495935|FG001|Randomized Phase|Lack of Efficacy|19|||
163213301|NCT00708162|589495934|FG000|Randomized Phase|Protocol Violation|10|||
163325168|NCT04129164|589902888|FG003|Overall Study|Non-compliance with procedures|0|||
163002087|NCT05024747|588708973|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
163002088|NCT05024747|588708974|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
163002089|NCT00662649|588708976|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
163002090|NCT00662649|588708977|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
163002091|NCT00662649|588708978|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
163325169|NCT04129164|589902885|FG000|Overall Study|Adverse Event|0|||
163325170|NCT04129164|589902886|FG001|Overall Study|Adverse Event|0|||
163325171|NCT04129164|589902887|FG002|Overall Study|Adverse Event|2|||
163325172|NCT04129164|589902888|FG003|Overall Study|Adverse Event|0|||
163325173|NCT04129164|589902885|FG000|Overall Study|Pregnancy|0|||
163325174|NCT04129164|589902886|FG001|Overall Study|Pregnancy|0|||
163325175|NCT04129164|589902887|FG002|Overall Study|Pregnancy|0|||
163325176|NCT04129164|589902888|FG003|Overall Study|Pregnancy|1|||
163325177|NCT04129164|589902885|FG000|Overall Study|Withdrawal by Subject|3|||
163325178|NCT04129164|589902886|FG001|Overall Study|Withdrawal by Subject|2|||
163325179|NCT04129164|589902887|FG002|Overall Study|Withdrawal by Subject|4|||
163325180|NCT04129164|589902888|FG003|Overall Study|Withdrawal by Subject|6|||
163325181|NCT04129164|589902885|FG000|Overall Study|Death|0|||
163002092|NCT00662649|588708979|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
163002093|NCT00662649|588708980|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
163002094|NCT00662649|588708976|FG000|Core Study (24 Months)|Adverse Event|22|||
163002095|NCT00662649|588708977|FG001|Core Study (24 Months)|Adverse Event|13|||
163002096|NCT00662649|588708978|FG002|Core Study (24 Months)|Adverse Event|18|||
163002097|NCT00662649|588708979|FG003|Core Study (24 Months)|Adverse Event|0|||
163002098|NCT00662649|588708980|FG004|Core Study (24 Months)|Adverse Event|0|||
163002099|NCT00662649|588708976|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
163002100|NCT00662649|588708977|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
163002101|NCT00662649|588708978|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
163002102|NCT00662649|588708979|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
163002103|NCT00662649|588708980|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
163002104|NCT00662649|588708976|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
163002105|NCT00662649|588708977|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
163002106|NCT00662649|588708978|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
163002107|NCT00662649|588708979|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
163002108|NCT00662649|588708980|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
163002109|NCT00662649|588708976|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
163002110|NCT00662649|588708977|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
163002111|NCT00662649|588708978|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
163002112|NCT00662649|588708979|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
163002113|NCT00662649|588708980|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
163002114|NCT00662649|588708976|FG000|Core Study (24 Months)|Protocol Violation|5|||
163002115|NCT00662649|588708977|FG001|Core Study (24 Months)|Protocol Violation|5|||
163002116|NCT00662649|588708978|FG002|Core Study (24 Months)|Protocol Violation|4|||
163002117|NCT00662649|588708979|FG003|Core Study (24 Months)|Protocol Violation|0|||
163002118|NCT00662649|588708980|FG004|Core Study (24 Months)|Protocol Violation|0|||
163002119|NCT00662649|588708976|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
163002120|NCT00662649|588708977|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
163002121|NCT00662649|588708978|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
163002122|NCT00662649|588708979|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
163002123|NCT00662649|588708980|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
163002124|NCT00662649|588708976|FG000|Core Study (24 Months)|Death|1|||
163002125|NCT00662649|588708977|FG001|Core Study (24 Months)|Death|0|||
163002126|NCT00662649|588708978|FG002|Core Study (24 Months)|Death|2|||
163325182|NCT04129164|589902886|FG001|Overall Study|Death|1|||
163325183|NCT04129164|589902887|FG002|Overall Study|Death|0|||
163325184|NCT04129164|589902888|FG003|Overall Study|Death|0|||
163325185|NCT04129164|589902885|FG000|Overall Study|Lost to Follow-up|0|||
163325186|NCT04129164|589902886|FG001|Overall Study|Lost to Follow-up|1|||
163325187|NCT04129164|589902887|FG002|Overall Study|Lost to Follow-up|0|||
163325188|NCT04129164|589902888|FG003|Overall Study|Lost to Follow-up|0|||
163325189|NCT00943917|589902897|FG000|Stage I|Adverse Event|1|||
163325190|NCT00943917|589902898|FG001|Stage I|Adverse Event|2|||
163325191|NCT00943917|589902899|FG002|Stage I|Adverse Event|2|||
163002127|NCT00662649|588708979|FG003|Core Study (24 Months)|Death|0|||
163002128|NCT00662649|588708980|FG004|Core Study (24 Months)|Death|0|||
163002129|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
163002130|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
163002131|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
163002132|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
163002133|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
163002134|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
163002135|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
163325192|NCT00943917|589902900|FG003|Stage I|Adverse Event|0|||
163325193|NCT00943917|589902901|FG004|Stage I|Adverse Event|0|||
163325194|NCT00943917|589902902|FG005|Stage I|Adverse Event|0|||
163325195|NCT00943917|589902903|FG006|Stage I|Adverse Event|0|||
163325196|NCT00943917|589902904|FG007|Stage I|Adverse Event|0|||
163325197|NCT00943917|589902905|FG008|Stage I|Adverse Event|0|||
163325198|NCT00943917|589902906|FG009|Stage I|Adverse Event|0|||
163325199|NCT00943917|589902907|FG010|Stage I|Adverse Event|0|||
163002136|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
163002137|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
163002138|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
163060650|NCT05516758|588929963|FG005|Overall Study|Physician Decision|1|||
163060651|NCT05516758|588929964|FG006|Overall Study|Physician Decision|2|||
163060652|NCT05516758|588929958|FG000|Overall Study|Protocol Deviation|1|||
163060653|NCT05516758|588929959|FG001|Overall Study|Protocol Deviation|0|||
163060654|NCT05516758|588929960|FG002|Overall Study|Protocol Deviation|0|||
163060655|NCT05516758|588929961|FG003|Overall Study|Protocol Deviation|0|||
163060656|NCT05516758|588929962|FG004|Overall Study|Protocol Deviation|0|||
163060657|NCT05516758|588929963|FG005|Overall Study|Protocol Deviation|1|||
163060658|NCT05516758|588929964|FG006|Overall Study|Protocol Deviation|5|||
163060659|NCT05516758|588929958|FG000|Overall Study|Withdrawal by Subject|11|||
163060660|NCT05516758|588929959|FG001|Overall Study|Withdrawal by Subject|1|||
163060661|NCT05516758|588929960|FG002|Overall Study|Withdrawal by Subject|15|||
163060662|NCT05516758|588929961|FG003|Overall Study|Withdrawal by Subject|2|||
163060663|NCT05516758|588929962|FG004|Overall Study|Withdrawal by Subject|7|||
163060664|NCT05516758|588929963|FG005|Overall Study|Withdrawal by Subject|7|||
163060665|NCT05516758|588929964|FG006|Overall Study|Withdrawal by Subject|6|||
163060666|NCT05516758|588929958|FG000|Overall Study|Death|1|||
163060667|NCT05516758|588929959|FG001|Overall Study|Death|0|||
163060668|NCT05516758|588929960|FG002|Overall Study|Death|0|||
163060669|NCT05516758|588929961|FG003|Overall Study|Death|0|||
163060670|NCT05516758|588929962|FG004|Overall Study|Death|0|||
163060671|NCT05516758|588929963|FG005|Overall Study|Death|0|||
163060672|NCT05516758|588929964|FG006|Overall Study|Death|0|||
163060673|NCT05516758|588929958|FG000|Overall Study|Non-compliance With Study Drug|0|||
163060674|NCT05516758|588929959|FG001|Overall Study|Non-compliance With Study Drug|0|||
163060675|NCT05516758|588929960|FG002|Overall Study|Non-compliance With Study Drug|1|||
163060676|NCT05516758|588929961|FG003|Overall Study|Non-compliance With Study Drug|0|||
163060677|NCT05516758|588929962|FG004|Overall Study|Non-compliance With Study Drug|0|||
163060678|NCT05516758|588929963|FG005|Overall Study|Non-compliance With Study Drug|0|||
163060679|NCT05516758|588929964|FG006|Overall Study|Non-compliance With Study Drug|0|||
163060680|NCT05516758|588929958|FG000|Overall Study|Site Terminated by Sponsor|2|||
163060681|NCT05516758|588929959|FG001|Overall Study|Site Terminated by Sponsor|0|||
163060682|NCT05516758|588929960|FG002|Overall Study|Site Terminated by Sponsor|0|||
163060683|NCT05516758|588929961|FG003|Overall Study|Site Terminated by Sponsor|0|||
163060684|NCT05516758|588929962|FG004|Overall Study|Site Terminated by Sponsor|0|||
163060685|NCT05516758|588929963|FG005|Overall Study|Site Terminated by Sponsor|0|||
163060686|NCT05516758|588929964|FG006|Overall Study|Site Terminated by Sponsor|0|||
163060687|NCT05516758|588929958|FG000|Overall Study|Study Terminated by Sponsor|4|||
163213302|NCT00708162|589495935|FG001|Randomized Phase|Protocol Violation|11|||
163213303|NCT00708162|589495934|FG000|Randomized Phase|Adverse Event|8|||
163213304|NCT00708162|589495935|FG001|Randomized Phase|Adverse Event|12|||
163213305|NCT00708162|589495934|FG000|Randomized Phase|Investigator's Discretion|7|||
163213306|NCT00708162|589495935|FG001|Randomized Phase|Investigator's Discretion|10|||
163213307|NCT00708162|589495934|FG000|Randomized Phase|Death|2|||
163213308|NCT00708162|589495935|FG001|Randomized Phase|Death|9|||
163213309|NCT00708162|589495934|FG000|Randomized Phase|Pregnancy|3|||
163213310|NCT00708162|589495935|FG001|Randomized Phase|Pregnancy|0|||
163002139|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
163002140|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
163002141|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
163002142|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
163002143|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
163002144|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
163002145|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
163002146|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
163002147|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
163002148|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
163002149|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
163002150|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
163002151|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
163213311|NCT00708162|589495934|FG000|Open-Label Phase|Lost to Follow-up|10|||
163213312|NCT00708162|589495935|FG001|Open-Label Phase|Lost to Follow-up|8|||
163060688|NCT05516758|588929959|FG001|Overall Study|Study Terminated by Sponsor|0|||
163060689|NCT05516758|588929960|FG002|Overall Study|Study Terminated by Sponsor|3|||
163060690|NCT05516758|588929961|FG003|Overall Study|Study Terminated by Sponsor|0|||
163060691|NCT05516758|588929962|FG004|Overall Study|Study Terminated by Sponsor|2|||
163060692|NCT05516758|588929963|FG005|Overall Study|Study Terminated by Sponsor|3|||
163060693|NCT05516758|588929964|FG006|Overall Study|Study Terminated by Sponsor|0|||
163060694|NCT05516758|588929958|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
163213313|NCT00708162|589495934|FG000|Open-Label Phase|Withdrew Consent|12|||
163213314|NCT00708162|589495935|FG001|Open-Label Phase|Withdrew Consent|6|||
163002152|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
163002153|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
163002154|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
163002155|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
163002156|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
163002157|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
163002158|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
163002159|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
163002160|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
163002161|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
163002162|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
163002163|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
163002164|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
163002165|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
163002166|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
163002167|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
163002168|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
163002169|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
163002170|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
163002171|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
163002172|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
163002173|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
163002174|NCT01960257|588708981|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
163002175|NCT01960257|588708982|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
163002176|NCT01960257|588708983|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
163002177|NCT01960257|588708981|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
163002178|NCT01960257|588708982|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
163002179|NCT01960257|588708983|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
163002180|NCT01960257|588708981|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
163002181|NCT01960257|588708982|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
163002182|NCT01960257|588708983|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
163002183|NCT01942993|588708984|FG000|Overall Study|Lost to Follow-up|1|||
163002184|NCT01942993|588708984|FG000|Overall Study|Physician Decision|1|||
163002185|NCT02906670|588708988|FG000|Cohort 1, QW|Radiological Progression|1|||
163002186|NCT02906670|588708989|FG001|Cohort 1, QW|Radiological Progression|0|||
163002187|NCT02906670|588708990|FG002|Cohort 1, QW|Radiological Progression|0|||
163002188|NCT02906670|588708991|FG003|Cohort 1, QW|Radiological Progression|0|||
163002189|NCT02906670|588708992|FG004|Cohort 1, QW|Radiological Progression|0|||
163002190|NCT02906670|588708993|FG005|Cohort 1, QW|Radiological Progression|0|||
163002191|NCT02906670|588708994|FG006|Cohort 1, QW|Radiological Progression|0|||
163002192|NCT02906670|588708995|FG007|Cohort 1, QW|Radiological Progression|0|||
163002193|NCT02906670|588708996|FG008|Cohort 1, QW|Radiological Progression|0|||
163002194|NCT02906670|588708997|FG009|Cohort 1, QW|Radiological Progression|0|||
163002195|NCT02906670|588708988|FG000|Cohort 2, QW|Radiological Progression|0|||
163404383|NCT03776175|590191920|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
163404384|NCT03776175|590191921|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
163404385|NCT03776175|590191922|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
163404386|NCT03776175|590191923|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
163404387|NCT03776175|590191920|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
163404388|NCT03776175|590191921|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
163404389|NCT03776175|590191922|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
163404390|NCT03776175|590191923|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
163404391|NCT03776175|590191920|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
163404392|NCT03776175|590191921|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
163060695|NCT05516758|588929959|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
163404393|NCT03776175|590191922|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
163404394|NCT03776175|590191923|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
163404395|NCT03776175|590191920|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
163404396|NCT03776175|590191921|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
163404397|NCT03776175|590191922|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
163002196|NCT02906670|588708989|FG001|Cohort 2, QW|Radiological Progression|1|||
163002197|NCT02906670|588708990|FG002|Cohort 2, QW|Radiological Progression|0|||
163002198|NCT02906670|588708991|FG003|Cohort 2, QW|Radiological Progression|0|||
163002199|NCT02906670|588708992|FG004|Cohort 2, QW|Radiological Progression|0|||
163002200|NCT02906670|588708993|FG005|Cohort 2, QW|Radiological Progression|0|||
163002201|NCT02906670|588708994|FG006|Cohort 2, QW|Radiological Progression|0|||
163404398|NCT03776175|590191923|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
163404399|NCT03776175|590191920|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
163002202|NCT02906670|588708995|FG007|Cohort 2, QW|Radiological Progression|0|||
163002203|NCT02906670|588708996|FG008|Cohort 2, QW|Radiological Progression|0|||
163002204|NCT02906670|588708997|FG009|Cohort 2, QW|Radiological Progression|0|||
163002205|NCT02906670|588708988|FG000|Cohort 3, QW|Radiological Progression|0|||
163002206|NCT02906670|588708989|FG001|Cohort 3, QW|Radiological Progression|0|||
163002207|NCT02906670|588708990|FG002|Cohort 3, QW|Radiological Progression|2|||
163002208|NCT02906670|588708991|FG003|Cohort 3, QW|Radiological Progression|0|||
163002209|NCT02906670|588708992|FG004|Cohort 3, QW|Radiological Progression|0|||
163002210|NCT02906670|588708993|FG005|Cohort 3, QW|Radiological Progression|0|||
163002211|NCT02906670|588708994|FG006|Cohort 3, QW|Radiological Progression|0|||
163002212|NCT02906670|588708995|FG007|Cohort 3, QW|Radiological Progression|0|||
163002213|NCT02906670|588708996|FG008|Cohort 3, QW|Radiological Progression|0|||
163002214|NCT02906670|588708997|FG009|Cohort 3, QW|Radiological Progression|0|||
163002215|NCT02906670|588708988|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002216|NCT02906670|588708989|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002217|NCT02906670|588708990|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
163002218|NCT02906670|588708991|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002219|NCT02906670|588708992|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002220|NCT02906670|588708993|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002221|NCT02906670|588708994|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002222|NCT02906670|588708995|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002223|NCT02906670|588708996|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002224|NCT02906670|588708997|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002225|NCT02906670|588708988|FG000|Cohort 4, Q2W|Radiological Progression|0|||
163002226|NCT02906670|588708989|FG001|Cohort 4, Q2W|Radiological Progression|0|||
163002227|NCT02906670|588708990|FG002|Cohort 4, Q2W|Radiological Progression|0|||
163002228|NCT02906670|588708991|FG003|Cohort 4, Q2W|Radiological Progression|0|||
163002229|NCT02906670|588708992|FG004|Cohort 4, Q2W|Radiological Progression|0|||
163002230|NCT02906670|588708993|FG005|Cohort 4, Q2W|Radiological Progression|1|||
163002231|NCT02906670|588708994|FG006|Cohort 4, Q2W|Radiological Progression|0|||
163002232|NCT02906670|588708995|FG007|Cohort 4, Q2W|Radiological Progression|0|||
163002233|NCT02906670|588708996|FG008|Cohort 4, Q2W|Radiological Progression|0|||
163002234|NCT02906670|588708997|FG009|Cohort 4, Q2W|Radiological Progression|0|||
163002235|NCT02906670|588708988|FG000|Cohort 4, Q2W|Clinical Progression|0|||
163002236|NCT02906670|588708989|FG001|Cohort 4, Q2W|Clinical Progression|0|||
163002237|NCT02906670|588708990|FG002|Cohort 4, Q2W|Clinical Progression|0|||
163002238|NCT02906670|588708991|FG003|Cohort 4, Q2W|Clinical Progression|0|||
163002239|NCT02906670|588708992|FG004|Cohort 4, Q2W|Clinical Progression|0|||
163002240|NCT02906670|588708993|FG005|Cohort 4, Q2W|Clinical Progression|2|||
163002241|NCT02906670|588708994|FG006|Cohort 4, Q2W|Clinical Progression|0|||
163002242|NCT02906670|588708995|FG007|Cohort 4, Q2W|Clinical Progression|0|||
163002243|NCT02906670|588708996|FG008|Cohort 4, Q2W|Clinical Progression|0|||
163002244|NCT02906670|588708997|FG009|Cohort 4, Q2W|Clinical Progression|0|||
163002245|NCT02906670|588708988|FG000|Cohort 5, Q2W|Radiological Progression|0|||
163002246|NCT02906670|588708989|FG001|Cohort 5, Q2W|Radiological Progression|0|||
163002247|NCT02906670|588708990|FG002|Cohort 5, Q2W|Radiological Progression|0|||
163002248|NCT02906670|588708991|FG003|Cohort 5, Q2W|Radiological Progression|0|||
163002249|NCT02906670|588708992|FG004|Cohort 5, Q2W|Radiological Progression|0|||
163002250|NCT02906670|588708993|FG005|Cohort 5, Q2W|Radiological Progression|0|||
163002251|NCT02906670|588708994|FG006|Cohort 5, Q2W|Radiological Progression|4|||
163002252|NCT02906670|588708995|FG007|Cohort 5, Q2W|Radiological Progression|0|||
163002253|NCT02906670|588708996|FG008|Cohort 5, Q2W|Radiological Progression|0|||
163002254|NCT02906670|588708997|FG009|Cohort 5, Q2W|Radiological Progression|0|||
163002255|NCT02906670|588708988|FG000|Cohort 5, Q2W|Clinical Progression|0|||
163002256|NCT02906670|588708989|FG001|Cohort 5, Q2W|Clinical Progression|0|||
163002257|NCT02906670|588708990|FG002|Cohort 5, Q2W|Clinical Progression|0|||
163002258|NCT02906670|588708991|FG003|Cohort 5, Q2W|Clinical Progression|0|||
163060696|NCT05516758|588929960|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
163060697|NCT05516758|588929961|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
163002259|NCT02906670|588708992|FG004|Cohort 5, Q2W|Clinical Progression|0|||
163002260|NCT02906670|588708993|FG005|Cohort 5, Q2W|Clinical Progression|0|||
163002261|NCT02906670|588708994|FG006|Cohort 5, Q2W|Clinical Progression|1|||
163002262|NCT02906670|588708995|FG007|Cohort 5, Q2W|Clinical Progression|0|||
163002263|NCT02906670|588708996|FG008|Cohort 5, Q2W|Clinical Progression|0|||
163002264|NCT02906670|588708997|FG009|Cohort 5, Q2W|Clinical Progression|0|||
163002265|NCT02906670|588708988|FG000|Cohort 5, Q2W|Adverse Event|0|||
163002266|NCT02906670|588708989|FG001|Cohort 5, Q2W|Adverse Event|0|||
163002267|NCT02906670|588708990|FG002|Cohort 5, Q2W|Adverse Event|0|||
163002268|NCT02906670|588708991|FG003|Cohort 5, Q2W|Adverse Event|0|||
163002269|NCT02906670|588708992|FG004|Cohort 5, Q2W|Adverse Event|0|||
163002270|NCT02906670|588708993|FG005|Cohort 5, Q2W|Adverse Event|0|||
163002271|NCT02906670|588708994|FG006|Cohort 5, Q2W|Adverse Event|1|||
163002272|NCT02906670|588708995|FG007|Cohort 5, Q2W|Adverse Event|0|||
163002273|NCT02906670|588708996|FG008|Cohort 5, Q2W|Adverse Event|0|||
163002274|NCT02906670|588708997|FG009|Cohort 5, Q2W|Adverse Event|0|||
163002275|NCT02906670|588708988|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002276|NCT02906670|588708989|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002277|NCT02906670|588708990|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002278|NCT02906670|588708991|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002279|NCT02906670|588708992|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002280|NCT02906670|588708993|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002281|NCT02906670|588708994|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
163002282|NCT02906670|588708995|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002283|NCT02906670|588708996|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002284|NCT02906670|588708997|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002285|NCT02906670|588708988|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
163002286|NCT02906670|588708989|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
163002287|NCT02906670|588708990|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
163002288|NCT02906670|588708991|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
163002289|NCT02906670|588708992|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
163002290|NCT02906670|588708993|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
163002291|NCT02906670|588708994|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
163002292|NCT02906670|588708995|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
163060698|NCT05516758|588929962|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
163060699|NCT05516758|588929963|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
163060700|NCT05516758|588929964|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
163060701|NCT05516758|588929958|FG000|Overall Study|Other|0|||
163060702|NCT05516758|588929959|FG001|Overall Study|Other|0|||
163060703|NCT05516758|588929960|FG002|Overall Study|Other|0|||
163060704|NCT05516758|588929961|FG003|Overall Study|Other|0|||
163060705|NCT05516758|588929962|FG004|Overall Study|Other|0|||
163060706|NCT05516758|588929963|FG005|Overall Study|Other|0|||
163060707|NCT05516758|588929964|FG006|Overall Study|Other|1|||
163060708|NCT01316575|588929965|FG000|Overall Study|Withdrawal by Subject|2|||
163060709|NCT01316575|588929966|FG001|Overall Study|Withdrawal by Subject|0|||
163060710|NCT01316575|588929965|FG000|Overall Study|Required alternate treatment|0|||
163060711|NCT01316575|588929966|FG001|Overall Study|Required alternate treatment|1|||
163060712|NCT00402831|588929967|FG000|Overall Study|Lost to Follow-up|1|||
163060713|NCT00402831|588929968|FG001|Overall Study|Lost to Follow-up|2|||
163060714|NCT00402831|588929967|FG000|Overall Study|Non-compliance with protocol|0|||
163060715|NCT00402831|588929968|FG001|Overall Study|Non-compliance with protocol|1|||
163060716|NCT02792504|588929969|FG000|Overall Study|Lost to Follow-up|24|||
163060717|NCT02792504|588929969|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
163060718|NCT02814526|588929976|FG000|Overall Study|Adverse Event|4|||
163060719|NCT02814526|588929977|FG001|Overall Study|Adverse Event|3|||
163060720|NCT02814526|588929976|FG000|Overall Study|Death|1|||
163060721|NCT02814526|588929977|FG001|Overall Study|Death|1|||
163060722|NCT02814526|588929976|FG000|Overall Study|Lost to Follow-up|3|||
163060723|NCT02814526|588929977|FG001|Overall Study|Lost to Follow-up|4|||
163060724|NCT02814526|588929976|FG000|Overall Study|non site physician decision|1|||
163060725|NCT02814526|588929977|FG001|Overall Study|non site physician decision|0|||
163060726|NCT02814526|588929976|FG000|Overall Study|participant noncompliance|1|||
163060727|NCT02814526|588929977|FG001|Overall Study|participant noncompliance|1|||
163060728|NCT02814526|588929976|FG000|Overall Study|Withdrawal by Subject|20|||
163060729|NCT02814526|588929977|FG001|Overall Study|Withdrawal by Subject|14|||
163060730|NCT02814526|588929976|FG000|Overall Study|safety risk|2|||
163060731|NCT02814526|588929977|FG001|Overall Study|safety risk|1|||
163060732|NCT02814526|588929976|FG000|Overall Study|early termination-study terminated|1|||
163060733|NCT02814526|588929977|FG001|Overall Study|early termination-study terminated|2|||
163060734|NCT02814526|588929976|FG000|Overall Study|Other|0|||
163060735|NCT02814526|588929977|FG001|Overall Study|Other|4|||
163060736|NCT02485860|588929978|FG000|Overall Study|Lost to Follow-up|4|||
163404400|NCT03776175|590191921|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
163002293|NCT02906670|588708996|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
163002294|NCT02906670|588708997|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
163060737|NCT02485860|588929979|FG001|Overall Study|Lost to Follow-up|1|||
163060738|NCT02485860|588929978|FG000|Overall Study|Physician Decision|1|||
163060739|NCT02485860|588929979|FG001|Overall Study|Physician Decision|2|||
163060740|NCT02485860|588929978|FG000|Overall Study|Health context (COVID-19)|1|||
163060741|NCT02485860|588929979|FG001|Overall Study|Health context (COVID-19)|0|||
163060742|NCT03836053|588931281|FG000|Overall Study|Protocol-specified criteria|0|||
163060743|NCT03836053|588931282|FG001|Overall Study|Protocol-specified criteria|2|||
163002295|NCT02906670|588708988|FG000|Cohort 5P, Q2W|Adverse Event|0|||
163002296|NCT02906670|588708989|FG001|Cohort 5P, Q2W|Adverse Event|0|||
163002297|NCT02906670|588708990|FG002|Cohort 5P, Q2W|Adverse Event|0|||
163060744|NCT03836053|588931283|FG002|Overall Study|Protocol-specified criteria|1|||
163060745|NCT03836053|588931281|FG000|Overall Study|Death|1|||
163060746|NCT03836053|588931282|FG001|Overall Study|Death|6|||
163060747|NCT03836053|588931283|FG002|Overall Study|Death|4|||
163060748|NCT03836053|588931281|FG000|Overall Study|Withdrawal of consent from study|0|||
163060749|NCT03836053|588931282|FG001|Overall Study|Withdrawal of consent from study|0|||
163060750|NCT03836053|588931283|FG002|Overall Study|Withdrawal of consent from study|1|||
163002298|NCT02906670|588708991|FG003|Cohort 5P, Q2W|Adverse Event|0|||
163002299|NCT02906670|588708992|FG004|Cohort 5P, Q2W|Adverse Event|0|||
163002300|NCT02906670|588708993|FG005|Cohort 5P, Q2W|Adverse Event|0|||
163002301|NCT02906670|588708994|FG006|Cohort 5P, Q2W|Adverse Event|0|||
163002302|NCT02906670|588708995|FG007|Cohort 5P, Q2W|Adverse Event|1|||
163002303|NCT02906670|588708996|FG008|Cohort 5P, Q2W|Adverse Event|0|||
163002304|NCT02906670|588708997|FG009|Cohort 5P, Q2W|Adverse Event|0|||
163002305|NCT02906670|588708988|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
163002306|NCT02906670|588708989|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
163002307|NCT02906670|588708990|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
163002308|NCT02906670|588708991|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
163002309|NCT02906670|588708992|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
163002310|NCT02906670|588708993|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
163002311|NCT02906670|588708994|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
163002312|NCT02906670|588708995|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
163002313|NCT02906670|588708996|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
163002314|NCT02906670|588708997|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
163002315|NCT02906670|588708988|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
163002316|NCT02906670|588708989|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
163002317|NCT02906670|588708990|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
163002318|NCT02906670|588708991|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
163002319|NCT02906670|588708992|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
163002320|NCT02906670|588708993|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
163002321|NCT02906670|588708994|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
163002322|NCT02906670|588708995|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
163002323|NCT02906670|588708996|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
163002324|NCT02906670|588708997|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
163002325|NCT02906670|588708988|FG000|Cohort 4P, QW|Radiological Progression|0|||
163002326|NCT02906670|588708989|FG001|Cohort 4P, QW|Radiological Progression|0|||
163002327|NCT02906670|588708990|FG002|Cohort 4P, QW|Radiological Progression|0|||
163002328|NCT02906670|588708991|FG003|Cohort 4P, QW|Radiological Progression|3|||
163002329|NCT02906670|588708992|FG004|Cohort 4P, QW|Radiological Progression|0|||
163002330|NCT02906670|588708993|FG005|Cohort 4P, QW|Radiological Progression|0|||
163002331|NCT02906670|588708994|FG006|Cohort 4P, QW|Radiological Progression|0|||
163002332|NCT02906670|588708995|FG007|Cohort 4P, QW|Radiological Progression|0|||
163002333|NCT02906670|588708996|FG008|Cohort 4P, QW|Radiological Progression|0|||
163002334|NCT02906670|588708997|FG009|Cohort 4P, QW|Radiological Progression|0|||
163002335|NCT02906670|588708988|FG000|Cohort 7P, Q2W|Adverse Event|0|||
163002336|NCT02906670|588708989|FG001|Cohort 7P, Q2W|Adverse Event|0|||
163002337|NCT02906670|588708990|FG002|Cohort 7P, Q2W|Adverse Event|0|||
163002338|NCT02906670|588708991|FG003|Cohort 7P, Q2W|Adverse Event|0|||
163002339|NCT02906670|588708992|FG004|Cohort 7P, Q2W|Adverse Event|0|||
163002340|NCT02906670|588708993|FG005|Cohort 7P, Q2W|Adverse Event|0|||
163002341|NCT02906670|588708994|FG006|Cohort 7P, Q2W|Adverse Event|0|||
163002342|NCT02906670|588708995|FG007|Cohort 7P, Q2W|Adverse Event|0|||
163002343|NCT02906670|588708996|FG008|Cohort 7P, Q2W|Adverse Event|0|||
163002344|NCT02906670|588708997|FG009|Cohort 7P, Q2W|Adverse Event|1|||
163002345|NCT02906670|588708988|FG000|Cohort 7P, Q2W|Physician Decision|0|||
163002346|NCT02906670|588708989|FG001|Cohort 7P, Q2W|Physician Decision|0|||
163002347|NCT02906670|588708990|FG002|Cohort 7P, Q2W|Physician Decision|0|||
163002348|NCT02906670|588708991|FG003|Cohort 7P, Q2W|Physician Decision|0|||
163002349|NCT02906670|588708992|FG004|Cohort 7P, Q2W|Physician Decision|0|||
163002350|NCT02906670|588708993|FG005|Cohort 7P, Q2W|Physician Decision|0|||
163002351|NCT02906670|588708994|FG006|Cohort 7P, Q2W|Physician Decision|0|||
163002352|NCT02906670|588708995|FG007|Cohort 7P, Q2W|Physician Decision|0|||
163002353|NCT02906670|588708996|FG008|Cohort 7P, Q2W|Physician Decision|0|||
163002354|NCT02906670|588708997|FG009|Cohort 7P, Q2W|Physician Decision|1|||
163002355|NCT02906670|588708988|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002356|NCT02906670|588708989|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002357|NCT02906670|588708990|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002358|NCT02906670|588708991|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002359|NCT02906670|588708992|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002360|NCT02906670|588708993|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002361|NCT02906670|588708994|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002362|NCT02906670|588708995|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002363|NCT02906670|588708996|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002364|NCT02906670|588708997|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
163002365|NCT02906670|588708988|FG000|Cohort 5P, QW|Radiological Progression|0|||
163002366|NCT02906670|588708989|FG001|Cohort 5P, QW|Radiological Progression|0|||
163002367|NCT02906670|588708990|FG002|Cohort 5P, QW|Radiological Progression|0|||
163002368|NCT02906670|588708991|FG003|Cohort 5P, QW|Radiological Progression|0|||
163002369|NCT02906670|588708992|FG004|Cohort 5P, QW|Radiological Progression|3|||
163002370|NCT02906670|588708993|FG005|Cohort 5P, QW|Radiological Progression|0|||
163002371|NCT02906670|588708994|FG006|Cohort 5P, QW|Radiological Progression|0|||
163002372|NCT02906670|588708995|FG007|Cohort 5P, QW|Radiological Progression|0|||
163002373|NCT02906670|588708996|FG008|Cohort 5P, QW|Radiological Progression|0|||
163325200|NCT00943917|589902908|FG011|Stage I|Adverse Event|0|||
163325201|NCT00943917|589902909|FG012|Stage I|Adverse Event|0|||
163325202|NCT00943917|589902910|FG013|Stage I|Adverse Event|0|||
163325203|NCT00943917|589902911|FG014|Stage I|Adverse Event|0|||
163325204|NCT00943917|589902897|FG000|Stage I|Lost to Follow-up|0|||
163325205|NCT00943917|589902898|FG001|Stage I|Lost to Follow-up|0|||
163325206|NCT00943917|589902899|FG002|Stage I|Lost to Follow-up|1|||
163325207|NCT00943917|589902900|FG003|Stage I|Lost to Follow-up|0|||
163325208|NCT00943917|589902901|FG004|Stage I|Lost to Follow-up|0|||
163325209|NCT00943917|589902902|FG005|Stage I|Lost to Follow-up|0|||
163325210|NCT00943917|589902903|FG006|Stage I|Lost to Follow-up|0|||
163325211|NCT00943917|589902904|FG007|Stage I|Lost to Follow-up|0|||
163325212|NCT00943917|589902905|FG008|Stage I|Lost to Follow-up|0|||
163325213|NCT00943917|589902906|FG009|Stage I|Lost to Follow-up|0|||
163325214|NCT00943917|589902907|FG010|Stage I|Lost to Follow-up|0|||
163325215|NCT00943917|589902908|FG011|Stage I|Lost to Follow-up|0|||
163325216|NCT00943917|589902909|FG012|Stage I|Lost to Follow-up|0|||
163325217|NCT00943917|589902910|FG013|Stage I|Lost to Follow-up|0|||
163325218|NCT00943917|589902911|FG014|Stage I|Lost to Follow-up|0|||
163325219|NCT00943917|589902897|FG000|Stage I|hyperglycemia|0|||
163325220|NCT00943917|589902898|FG001|Stage I|hyperglycemia|0|||
163325221|NCT00943917|589902899|FG002|Stage I|hyperglycemia|1|||
163325222|NCT00943917|589902900|FG003|Stage I|hyperglycemia|0|||
163325223|NCT00943917|589902901|FG004|Stage I|hyperglycemia|0|||
163325224|NCT00943917|589902902|FG005|Stage I|hyperglycemia|0|||
163325225|NCT00943917|589902903|FG006|Stage I|hyperglycemia|0|||
163002374|NCT02906670|588708997|FG009|Cohort 5P, QW|Radiological Progression|0|||
163002375|NCT01349192|588708998|FG000|Overall Study|Protocol Violation|0|||
163002376|NCT01349192|588708999|FG001|Overall Study|Protocol Violation|1|||
163002377|NCT01349192|588708998|FG000|Overall Study|Withdrawal by Subject|0|||
163002378|NCT01349192|588708999|FG001|Overall Study|Withdrawal by Subject|2|||
163325226|NCT00943917|589902904|FG007|Stage I|hyperglycemia|0|||
163325227|NCT00943917|589902905|FG008|Stage I|hyperglycemia|0|||
163325228|NCT00943917|589902906|FG009|Stage I|hyperglycemia|0|||
163325229|NCT00943917|589902907|FG010|Stage I|hyperglycemia|0|||
163325230|NCT00943917|589902908|FG011|Stage I|hyperglycemia|0|||
163325231|NCT00943917|589902909|FG012|Stage I|hyperglycemia|0|||
163325232|NCT00943917|589902910|FG013|Stage I|hyperglycemia|0|||
163325233|NCT00943917|589902911|FG014|Stage I|hyperglycemia|0|||
163325234|NCT00943917|589902897|FG000|Stage I|A1C elevation|1|||
163325235|NCT00943917|589902898|FG001|Stage I|A1C elevation|0|||
163325236|NCT00943917|589902899|FG002|Stage I|A1C elevation|0|||
163325237|NCT00943917|589902900|FG003|Stage I|A1C elevation|0|||
163325238|NCT00943917|589902901|FG004|Stage I|A1C elevation|0|||
163325239|NCT00943917|589902902|FG005|Stage I|A1C elevation|0|||
163325240|NCT00943917|589902903|FG006|Stage I|A1C elevation|0|||
163325241|NCT00943917|589902904|FG007|Stage I|A1C elevation|0|||
163325242|NCT00943917|589902905|FG008|Stage I|A1C elevation|0|||
163002379|NCT01349192|588708998|FG000|Overall Study|Lost to Follow-up|1|||
163325243|NCT00943917|589902906|FG009|Stage I|A1C elevation|0|||
163325244|NCT00943917|589902907|FG010|Stage I|A1C elevation|0|||
163404401|NCT03776175|590191922|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
163404402|NCT03776175|590191923|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
163404403|NCT01496885|590191924|FG000|Overall Study|Lost to Follow-up|13|||
163404404|NCT01496885|590191924|FG000|Overall Study|Withdrawal by Subject|7|||
163002380|NCT01349192|588708999|FG001|Overall Study|Lost to Follow-up|3|||
163002381|NCT01349192|588708998|FG000|Overall Study|Failure to adhere to Protocol|2|||
163002382|NCT01349192|588708999|FG001|Overall Study|Failure to adhere to Protocol|0|||
163002383|NCT03749330|588709000|FG000|Overall Study|Clinicians left work in the CICU|0|||
163002384|NCT03749330|588709001|FG001|Overall Study|Clinicians left work in the CICU|2|||
163002385|NCT03749330|588709002|FG002|Overall Study|Clinicians left work in the CICU|0|||
163002386|NCT03749330|588709003|FG003|Overall Study|Clinicians left work in the CICU|0|||
163002387|NCT03749330|588709004|FG004|Overall Study|Clinicians left work in the CICU|0|||
163002388|NCT03749330|588709005|FG005|Overall Study|Clinicians left work in the CICU|0|||
163002389|NCT02038010|588709006|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
163060751|NCT03836053|588931281|FG000|Overall Study|Decision by sponsor|0|||
163325245|NCT00943917|589902908|FG011|Stage I|A1C elevation|0|||
163325246|NCT00943917|589902909|FG012|Stage I|A1C elevation|0|||
163325247|NCT00943917|589902910|FG013|Stage I|A1C elevation|0|||
163325248|NCT00943917|589902911|FG014|Stage I|A1C elevation|0|||
163325249|NCT00943917|589902897|FG000|Stage I|Withdrawal by Subject|2|||
163325250|NCT00943917|589902898|FG001|Stage I|Withdrawal by Subject|1|||
163325251|NCT00943917|589902899|FG002|Stage I|Withdrawal by Subject|2|||
163325252|NCT00943917|589902900|FG003|Stage I|Withdrawal by Subject|0|||
163325253|NCT00943917|589902901|FG004|Stage I|Withdrawal by Subject|0|||
163325254|NCT00943917|589902902|FG005|Stage I|Withdrawal by Subject|0|||
163325255|NCT00943917|589902903|FG006|Stage I|Withdrawal by Subject|0|||
163325256|NCT00943917|589902904|FG007|Stage I|Withdrawal by Subject|0|||
163325257|NCT00943917|589902905|FG008|Stage I|Withdrawal by Subject|0|||
163325258|NCT00943917|589902906|FG009|Stage I|Withdrawal by Subject|0|||
163325259|NCT00943917|589902907|FG010|Stage I|Withdrawal by Subject|0|||
163404405|NCT01496885|590191924|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
163002390|NCT02038010|588709007|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
163002391|NCT02038010|588709008|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
163002392|NCT02038010|588709009|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
163002393|NCT02038010|588709006|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
163002394|NCT02038010|588709007|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
163002395|NCT02038010|588709008|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
163002396|NCT02038010|588709009|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
163002397|NCT02038010|588709006|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
163002398|NCT02038010|588709007|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
163002399|NCT02038010|588709008|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
163002400|NCT02038010|588709009|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
163002401|NCT02038010|588709006|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
163002402|NCT02038010|588709007|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
163002403|NCT02038010|588709008|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
163002404|NCT02038010|588709009|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
163002405|NCT02038010|588709006|FG000|Follow Up|Death|4|||
163002406|NCT02038010|588709007|FG001|Follow Up|Death|3|||
163002407|NCT02038010|588709008|FG002|Follow Up|Death|0|||
163002408|NCT02038010|588709009|FG003|Follow Up|Death|0|||
163002409|NCT02038010|588709006|FG000|Follow Up|Other|3|||
163002410|NCT02038010|588709007|FG001|Follow Up|Other|0|||
163002411|NCT02038010|588709008|FG002|Follow Up|Other|0|||
163002412|NCT02038010|588709009|FG003|Follow Up|Other|0|||
163002413|NCT02105467|588709016|FG000|Period 1|Lost to Follow-up|1|||
163002414|NCT02105467|588709017|FG001|Period 1|Lost to Follow-up|0|||
163002415|NCT02105467|588709016|FG000|Period 1|Death|1|||
163002416|NCT02105467|588709017|FG001|Period 1|Death|0|||
163002417|NCT02105467|588709016|FG000|Period 2|Lost to Follow-up|1|||
163002418|NCT02105467|588709017|FG001|Period 2|Lost to Follow-up|0|||
163002419|NCT02105467|588709016|FG000|Period 2|Death|1|||
163002420|NCT02105467|588709017|FG001|Period 2|Death|0|||
163002421|NCT02105467|588709016|FG000|Period 2|Withdrawal by Subject|0|||
163002422|NCT02105467|588709017|FG001|Period 2|Withdrawal by Subject|2|||
163002423|NCT02105467|588709016|FG000|Period 3|Lost to Follow-up|0|||
163002424|NCT02105467|588709017|FG001|Period 3|Lost to Follow-up|1|||
163002425|NCT03908125|588709018|FG000|Overall Study|Withdrawal by Subject|92|||
163002426|NCT03908125|588709018|FG000|Overall Study|Lost to Follow-up|8|||
163002427|NCT02262325|588709019|FG000|Overall Study|Death|16|||
163002428|NCT02262325|588709019|FG000|Overall Study|Lost to Follow-up|1|||
163002429|NCT02815995|588709020|FG000|Overall Study|Disease Progression|3|||
163002430|NCT02815995|588709021|FG001|Overall Study|Disease Progression|7|||
163002431|NCT02815995|588709022|FG002|Overall Study|Disease Progression|2|||
163002432|NCT02815995|588709023|FG003|Overall Study|Disease Progression|4|||
163002433|NCT02815995|588709024|FG004|Overall Study|Disease Progression|3|||
163002434|NCT02815995|588709025|FG005|Overall Study|Disease Progression|9|||
163002435|NCT02815995|588709026|FG006|Overall Study|Disease Progression|3|||
163002436|NCT02815995|588709027|FG007|Overall Study|Disease Progression|1|||
163002437|NCT02815995|588709020|FG000|Overall Study|Adverse Event|1|||
163002438|NCT02815995|588709021|FG001|Overall Study|Adverse Event|2|||
163002439|NCT02815995|588709022|FG002|Overall Study|Adverse Event|2|||
163002440|NCT02815995|588709023|FG003|Overall Study|Adverse Event|0|||
163002441|NCT02815995|588709024|FG004|Overall Study|Adverse Event|0|||
163002442|NCT02815995|588709025|FG005|Overall Study|Adverse Event|1|||
163002443|NCT02815995|588709026|FG006|Overall Study|Adverse Event|0|||
163002444|NCT02815995|588709027|FG007|Overall Study|Adverse Event|0|||
163002445|NCT02815995|588709020|FG000|Overall Study|Pregnancy|0|||
163002446|NCT02815995|588709021|FG001|Overall Study|Pregnancy|0|||
163002447|NCT02815995|588709022|FG002|Overall Study|Pregnancy|0|||
163002448|NCT02815995|588709023|FG003|Overall Study|Pregnancy|0|||
163002449|NCT02815995|588709024|FG004|Overall Study|Pregnancy|0|||
163325260|NCT00943917|589902908|FG011|Stage I|Withdrawal by Subject|0|||
163325261|NCT00943917|589902909|FG012|Stage I|Withdrawal by Subject|0|||
163325262|NCT00943917|589902910|FG013|Stage I|Withdrawal by Subject|0|||
163325263|NCT00943917|589902911|FG014|Stage I|Withdrawal by Subject|0|||
163325264|NCT00943917|589902897|FG000|Stage II|Adverse Event|0|||
163002450|NCT02815995|588709025|FG005|Overall Study|Pregnancy|0|||
163002451|NCT02815995|588709026|FG006|Overall Study|Pregnancy|1|||
163002452|NCT02815995|588709027|FG007|Overall Study|Pregnancy|0|||
163002453|NCT01071915|588709032|FG000|Overall Study|Adverse Event|3|||
163002454|NCT01071915|588709032|FG000|Overall Study|Physician Decision|2|||
163002455|NCT01071915|588709032|FG000|Overall Study|Withdrawal by Subject|2|||
163002456|NCT01071915|588709032|FG000|Overall Study|Miscellaneous Reasons|2|||
163002457|NCT00958828|588709033|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
163002458|NCT00958828|588709034|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
163002459|NCT00958828|588709033|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
163002460|NCT00958828|588709034|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
163002461|NCT02673775|588709045|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
163002462|NCT02673775|588709046|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
163002463|NCT02673775|588709045|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
163002464|NCT02673775|588709046|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
163325265|NCT00943917|589902898|FG001|Stage II|Adverse Event|0|||
163325266|NCT00943917|589902899|FG002|Stage II|Adverse Event|0|||
163325267|NCT00943917|589902900|FG003|Stage II|Adverse Event|0|||
163002465|NCT02673775|588709045|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
163002466|NCT02673775|588709046|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
163002467|NCT02673775|588709045|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
163002468|NCT02673775|588709046|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
163002469|NCT02016183|588709047|FG000|Overall Study|Case Report Forms Uncollected|13|||
163002470|NCT02016183|588709047|FG000|Overall Study|Protocol Violation|52|||
163002471|NCT00770328|588709048|FG000|Overall Study|Adverse Event|11|||
163002472|NCT00770328|588709049|FG001|Overall Study|Adverse Event|2|||
163002473|NCT00770328|588709048|FG000|Overall Study|Lost to Follow-up|2|||
163002474|NCT00770328|588709049|FG001|Overall Study|Lost to Follow-up|2|||
163002475|NCT02286843|588709052|FG000|Overall Study|Not Treated|4|||
163002476|NCT02286843|588709052|FG000|Overall Study|Protocol Violation|1|||
163002477|NCT02286843|588709052|FG000|Overall Study|Withdrawal by Subject|1|||
163002478|NCT02536846|588709053|FG000|Overall Study|Withdrawal by Subject|1|||
163002479|NCT04388553|588709054|FG000|Overall Study|Protocol Violation|1|||
163002480|NCT04388553|588709055|FG001|Overall Study|Protocol Violation|0|||
163002481|NCT04604795|588709056|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
163002482|NCT04604795|588709057|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
163002483|NCT04604795|588709058|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002484|NCT04604795|588709059|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002485|NCT04604795|588709060|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002486|NCT04604795|588709061|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002487|NCT04604795|588709062|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002488|NCT04604795|588709063|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002489|NCT04604795|588709064|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002490|NCT04604795|588709065|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002491|NCT04604795|588709056|FG000|Part B: Up to Day 14|Adverse Event|0|||
163002492|NCT04604795|588709057|FG001|Part B: Up to Day 14|Adverse Event|0|||
163002493|NCT04604795|588709058|FG002|Part B: Up to Day 14|Adverse Event|0|||
163002494|NCT04604795|588709059|FG003|Part B: Up to Day 14|Adverse Event|0|||
163002495|NCT04604795|588709060|FG004|Part B: Up to Day 14|Adverse Event|2|||
163002496|NCT04604795|588709061|FG005|Part B: Up to Day 14|Adverse Event|1|||
163002497|NCT04604795|588709062|FG006|Part B: Up to Day 14|Adverse Event|0|||
163002498|NCT04604795|588709063|FG007|Part B: Up to Day 14|Adverse Event|0|||
163002499|NCT04604795|588709064|FG008|Part B: Up to Day 14|Adverse Event|0|||
163002500|NCT04604795|588709065|FG009|Part B: Up to Day 14|Adverse Event|0|||
163002501|NCT04604795|588709056|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002502|NCT04604795|588709057|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002503|NCT04604795|588709058|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002504|NCT04604795|588709059|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002505|NCT04604795|588709060|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002506|NCT04604795|588709061|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002507|NCT04604795|588709062|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002508|NCT04604795|588709063|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002509|NCT04604795|588709064|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002510|NCT04604795|588709065|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
163002511|NCT04604795|588709056|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002512|NCT04604795|588709057|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002513|NCT04604795|588709058|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002514|NCT04604795|588709059|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002515|NCT04604795|588709060|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002516|NCT04604795|588709061|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002517|NCT04604795|588709062|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163325268|NCT00943917|589902901|FG004|Stage II|Adverse Event|0|||
163325269|NCT00943917|589902902|FG005|Stage II|Adverse Event|1|||
163325270|NCT00943917|589902903|FG006|Stage II|Adverse Event|3|||
163325271|NCT00943917|589902904|FG007|Stage II|Adverse Event|0|||
163325272|NCT00943917|589902905|FG008|Stage II|Adverse Event|1|||
163325273|NCT00943917|589902906|FG009|Stage II|Adverse Event|0|||
163325274|NCT00943917|589902907|FG010|Stage II|Adverse Event|0|||
163002518|NCT04604795|588709063|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002519|NCT04604795|588709064|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
163002520|NCT04604795|588709065|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002521|NCT04604795|588709056|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163325275|NCT00943917|589902908|FG011|Stage II|Adverse Event|0|||
163325276|NCT00943917|589902909|FG012|Stage II|Adverse Event|0|||
163002522|NCT04604795|588709057|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002523|NCT04604795|588709058|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002524|NCT04604795|588709059|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002525|NCT04604795|588709060|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002526|NCT04604795|588709061|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002527|NCT04604795|588709062|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002528|NCT04604795|588709063|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002529|NCT04604795|588709064|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
163002530|NCT04604795|588709065|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002531|NCT04604795|588709056|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002532|NCT04604795|588709057|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002533|NCT04604795|588709058|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002534|NCT04604795|588709059|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002535|NCT04604795|588709060|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002536|NCT04604795|588709061|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002537|NCT04604795|588709062|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002538|NCT04604795|588709063|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002539|NCT04604795|588709064|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
163002540|NCT04604795|588709065|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002541|NCT00174954|588709070|FG000|Overall Study|Adverse Event|2|||
163002542|NCT00174954|588709070|FG000|Overall Study|No tophi found in MRI|1|||
163002543|NCT00174954|588709070|FG000|Overall Study|Physician Decision|1|||
163002544|NCT00839254|588709071|FG000|Overall Study|Protocol Violation|0|||
163002545|NCT00839254|588709072|FG001|Overall Study|Protocol Violation|1|||
163002546|NCT00839254|588709073|FG002|Overall Study|Protocol Violation|1|||
163002547|NCT00839254|588709074|FG003|Overall Study|Protocol Violation|1|||
163002548|NCT00839254|588709075|FG004|Overall Study|Protocol Violation|0|||
163002549|NCT00839254|588709076|FG005|Overall Study|Protocol Violation|0|||
163002550|NCT00839254|588709077|FG006|Overall Study|Protocol Violation|1|||
163002551|NCT00839254|588709078|FG007|Overall Study|Protocol Violation|2|||
163002552|NCT00839254|588709071|FG000|Overall Study|Physician Decision|0|||
163002553|NCT00839254|588709072|FG001|Overall Study|Physician Decision|1|||
163002554|NCT00839254|588709073|FG002|Overall Study|Physician Decision|0|||
163213315|NCT00708162|589495934|FG000|Open-Label Phase|Participant Noncompliance|7|||
163213316|NCT00708162|589495935|FG001|Open-Label Phase|Participant Noncompliance|7|||
163002555|NCT00839254|588709074|FG003|Overall Study|Physician Decision|0|||
163002556|NCT00839254|588709075|FG004|Overall Study|Physician Decision|0|||
163002557|NCT00839254|588709076|FG005|Overall Study|Physician Decision|0|||
163002558|NCT00839254|588709077|FG006|Overall Study|Physician Decision|0|||
163002559|NCT00839254|588709078|FG007|Overall Study|Physician Decision|1|||
163002560|NCT00839254|588709071|FG000|Overall Study|Wrong treatment number allocation|0|||
163002561|NCT00839254|588709072|FG001|Overall Study|Wrong treatment number allocation|1|||
163002562|NCT00839254|588709073|FG002|Overall Study|Wrong treatment number allocation|0|||
163002563|NCT00839254|588709074|FG003|Overall Study|Wrong treatment number allocation|0|||
163002564|NCT00839254|588709075|FG004|Overall Study|Wrong treatment number allocation|0|||
163002565|NCT00839254|588709076|FG005|Overall Study|Wrong treatment number allocation|1|||
163002566|NCT00839254|588709077|FG006|Overall Study|Wrong treatment number allocation|0|||
163002567|NCT00839254|588709078|FG007|Overall Study|Wrong treatment number allocation|0|||
163002568|NCT00839254|588709071|FG000|Overall Study|Adverse Event|12|||
163002569|NCT00839254|588709072|FG001|Overall Study|Adverse Event|6|||
163002570|NCT00839254|588709073|FG002|Overall Study|Adverse Event|3|||
163002571|NCT00839254|588709074|FG003|Overall Study|Adverse Event|5|||
163002572|NCT00839254|588709075|FG004|Overall Study|Adverse Event|2|||
163002573|NCT00839254|588709076|FG005|Overall Study|Adverse Event|1|||
163002574|NCT00839254|588709077|FG006|Overall Study|Adverse Event|0|||
163002575|NCT00839254|588709078|FG007|Overall Study|Adverse Event|1|||
163002576|NCT00839254|588709071|FG000|Overall Study|Withdrawal by Subject|87|||
163002577|NCT00839254|588709072|FG001|Overall Study|Withdrawal by Subject|53|||
163002578|NCT00839254|588709073|FG002|Overall Study|Withdrawal by Subject|54|||
163002579|NCT00839254|588709074|FG003|Overall Study|Withdrawal by Subject|32|||
163002580|NCT00839254|588709075|FG004|Overall Study|Withdrawal by Subject|27|||
163002581|NCT00839254|588709076|FG005|Overall Study|Withdrawal by Subject|15|||
163002582|NCT00839254|588709077|FG006|Overall Study|Withdrawal by Subject|22|||
163002583|NCT00839254|588709078|FG007|Overall Study|Withdrawal by Subject|9|||
163002584|NCT00839254|588709071|FG000|Overall Study|Wrong group allocation|0|||
163002585|NCT00839254|588709072|FG001|Overall Study|Wrong group allocation|0|||
163002586|NCT00839254|588709073|FG002|Overall Study|Wrong group allocation|0|||
163002587|NCT00839254|588709074|FG003|Overall Study|Wrong group allocation|0|||
163002588|NCT00839254|588709075|FG004|Overall Study|Wrong group allocation|0|||
163213317|NCT00708162|589495934|FG000|Open-Label Phase|Lack of Efficacy|7|||
163002589|NCT00839254|588709076|FG005|Overall Study|Wrong group allocation|0|||
163002590|NCT00839254|588709077|FG006|Overall Study|Wrong group allocation|1|||
163002591|NCT00839254|588709078|FG007|Overall Study|Wrong group allocation|0|||
163213318|NCT00708162|589495935|FG001|Open-Label Phase|Lack of Efficacy|4|||
163060752|NCT03836053|588931282|FG001|Overall Study|Decision by sponsor|2|||
163002592|NCT00839254|588709071|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
163002593|NCT00839254|588709072|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
163002594|NCT00839254|588709073|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
163002595|NCT00839254|588709074|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
163002596|NCT00839254|588709075|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
163002597|NCT00839254|588709076|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
163002598|NCT00839254|588709077|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
163002599|NCT00839254|588709078|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
163002600|NCT00839254|588709071|FG000|Overall Study|Withdrawn due to non-compliance|2|||
163002601|NCT00839254|588709072|FG001|Overall Study|Withdrawn due to non-compliance|0|||
163002602|NCT00839254|588709073|FG002|Overall Study|Withdrawn due to non-compliance|0|||
163002603|NCT00839254|588709074|FG003|Overall Study|Withdrawn due to non-compliance|0|||
163002604|NCT00839254|588709075|FG004|Overall Study|Withdrawn due to non-compliance|0|||
163002605|NCT00839254|588709076|FG005|Overall Study|Withdrawn due to non-compliance|0|||
163002606|NCT00839254|588709077|FG006|Overall Study|Withdrawn due to non-compliance|0|||
163002607|NCT00839254|588709078|FG007|Overall Study|Withdrawn due to non-compliance|0|||
163002608|NCT00839254|588709071|FG000|Overall Study|Lost to Follow-up|51|||
163002609|NCT00839254|588709072|FG001|Overall Study|Lost to Follow-up|30|||
163002610|NCT00839254|588709073|FG002|Overall Study|Lost to Follow-up|32|||
163002611|NCT00839254|588709074|FG003|Overall Study|Lost to Follow-up|24|||
163002612|NCT00839254|588709075|FG004|Overall Study|Lost to Follow-up|8|||
163002613|NCT00839254|588709076|FG005|Overall Study|Lost to Follow-up|8|||
163002614|NCT00839254|588709077|FG006|Overall Study|Lost to Follow-up|4|||
163002615|NCT00839254|588709078|FG007|Overall Study|Lost to Follow-up|2|||
163002616|NCT04597632|588709079|FG000|Overall Study|Withdrawal by Subject|10|||
163002617|NCT04597632|588709079|FG000|Overall Study|Lost to Follow-up|1|||
163002618|NCT04597632|588709079|FG000|Overall Study|Death|1|||
163002619|NCT04597632|588709079|FG000|Overall Study|Adverse Event|5|||
163002620|NCT01823835|588709080|FG000|Overall Study|Adverse Event|0|||
163002621|NCT01823835|588709081|FG001|Overall Study|Adverse Event|0|||
163002622|NCT01823835|588709082|FG002|Overall Study|Adverse Event|0|||
163002623|NCT01823835|588709083|FG003|Overall Study|Adverse Event|0|||
163002624|NCT01823835|588709084|FG004|Overall Study|Adverse Event|1|||
163002625|NCT01823835|588709085|FG005|Overall Study|Adverse Event|0|||
163002626|NCT01823835|588709086|FG006|Overall Study|Adverse Event|1|||
163002627|NCT01823835|588709087|FG007|Overall Study|Adverse Event|0|||
163002628|NCT01823835|588709088|FG008|Overall Study|Adverse Event|0|||
163002629|NCT01823835|588709089|FG009|Overall Study|Adverse Event|0|||
163002630|NCT01823835|588709090|FG010|Overall Study|Adverse Event|1|||
163002631|NCT01823835|588709091|FG011|Overall Study|Adverse Event|2|||
163213319|NCT00708162|589495934|FG000|Open-Label Phase|Investigator's Discretion|3|||
163002632|NCT01823835|588709092|FG012|Overall Study|Adverse Event|0|||
163002633|NCT01823835|588709093|FG013|Overall Study|Adverse Event|0|||
163002634|NCT01823835|588709094|FG014|Overall Study|Adverse Event|0|||
163002635|NCT01823835|588709080|FG000|Overall Study|Physician Decision|0|||
163002636|NCT01823835|588709081|FG001|Overall Study|Physician Decision|0|||
163002637|NCT01823835|588709082|FG002|Overall Study|Physician Decision|0|||
163002638|NCT01823835|588709083|FG003|Overall Study|Physician Decision|0|||
163002639|NCT01823835|588709084|FG004|Overall Study|Physician Decision|0|||
163002640|NCT01823835|588709085|FG005|Overall Study|Physician Decision|0|||
163002641|NCT01823835|588709086|FG006|Overall Study|Physician Decision|0|||
163002642|NCT01823835|588709087|FG007|Overall Study|Physician Decision|0|||
163002643|NCT01823835|588709088|FG008|Overall Study|Physician Decision|0|||
163002644|NCT01823835|588709089|FG009|Overall Study|Physician Decision|0|||
163002645|NCT01823835|588709090|FG010|Overall Study|Physician Decision|0|||
163002646|NCT01823835|588709091|FG011|Overall Study|Physician Decision|2|||
163002647|NCT01823835|588709092|FG012|Overall Study|Physician Decision|0|||
163002648|NCT01823835|588709093|FG013|Overall Study|Physician Decision|0|||
163002649|NCT01823835|588709094|FG014|Overall Study|Physician Decision|0|||
163002650|NCT01823835|588709080|FG000|Overall Study|Progressive Disease|3|||
163002651|NCT01823835|588709081|FG001|Overall Study|Progressive Disease|4|||
163002652|NCT01823835|588709082|FG002|Overall Study|Progressive Disease|3|||
163002653|NCT01823835|588709083|FG003|Overall Study|Progressive Disease|6|||
163002654|NCT01823835|588709084|FG004|Overall Study|Progressive Disease|4|||
163213320|NCT00708162|589495935|FG001|Open-Label Phase|Investigator's Discretion|2|||
163404406|NCT01496885|590191924|FG000|Overall Study|Death|1|||
163002655|NCT01823835|588709085|FG005|Overall Study|Progressive Disease|6|||
163002656|NCT01823835|588709086|FG006|Overall Study|Progressive Disease|5|||
163002657|NCT01823835|588709087|FG007|Overall Study|Progressive Disease|3|||
163002658|NCT01823835|588709088|FG008|Overall Study|Progressive Disease|3|||
163002659|NCT01823835|588709089|FG009|Overall Study|Progressive Disease|18|||
163002660|NCT01823835|588709090|FG010|Overall Study|Progressive Disease|8|||
163002661|NCT01823835|588709091|FG011|Overall Study|Progressive Disease|46|||
163002662|NCT01823835|588709092|FG012|Overall Study|Progressive Disease|18|||
163002663|NCT01823835|588709093|FG013|Overall Study|Progressive Disease|4|||
163002664|NCT01823835|588709094|FG014|Overall Study|Progressive Disease|6|||
163002665|NCT01823835|588709080|FG000|Overall Study|Study Termination|0|||
163002666|NCT01823835|588709081|FG001|Overall Study|Study Termination|0|||
163002667|NCT01823835|588709082|FG002|Overall Study|Study Termination|0|||
163002668|NCT01823835|588709083|FG003|Overall Study|Study Termination|0|||
163002669|NCT01823835|588709084|FG004|Overall Study|Study Termination|1|||
163002670|NCT01823835|588709085|FG005|Overall Study|Study Termination|0|||
163002671|NCT01823835|588709086|FG006|Overall Study|Study Termination|0|||
163002672|NCT01823835|588709087|FG007|Overall Study|Study Termination|0|||
163002673|NCT01823835|588709088|FG008|Overall Study|Study Termination|0|||
163002674|NCT01823835|588709089|FG009|Overall Study|Study Termination|0|||
163002675|NCT01823835|588709090|FG010|Overall Study|Study Termination|0|||
163002676|NCT01823835|588709091|FG011|Overall Study|Study Termination|1|||
163002677|NCT01823835|588709092|FG012|Overall Study|Study Termination|0|||
163002678|NCT01823835|588709093|FG013|Overall Study|Study Termination|0|||
163002679|NCT01823835|588709094|FG014|Overall Study|Study Termination|0|||
163002680|NCT01823835|588709080|FG000|Overall Study|Withdrawal by Subject|0|||
163002681|NCT01823835|588709081|FG001|Overall Study|Withdrawal by Subject|0|||
163002682|NCT01823835|588709082|FG002|Overall Study|Withdrawal by Subject|1|||
163002683|NCT01823835|588709083|FG003|Overall Study|Withdrawal by Subject|0|||
163002684|NCT01823835|588709084|FG004|Overall Study|Withdrawal by Subject|0|||
163002685|NCT01823835|588709085|FG005|Overall Study|Withdrawal by Subject|0|||
163002686|NCT01823835|588709086|FG006|Overall Study|Withdrawal by Subject|0|||
163002687|NCT01823835|588709087|FG007|Overall Study|Withdrawal by Subject|0|||
163002688|NCT01823835|588709088|FG008|Overall Study|Withdrawal by Subject|0|||
163002689|NCT01823835|588709089|FG009|Overall Study|Withdrawal by Subject|1|||
163002690|NCT01823835|588709090|FG010|Overall Study|Withdrawal by Subject|1|||
163002691|NCT01823835|588709091|FG011|Overall Study|Withdrawal by Subject|2|||
163002692|NCT01823835|588709092|FG012|Overall Study|Withdrawal by Subject|1|||
163002693|NCT01823835|588709093|FG013|Overall Study|Withdrawal by Subject|0|||
163002694|NCT01823835|588709094|FG014|Overall Study|Withdrawal by Subject|0|||
163002695|NCT00509795|588709095|FG000|Overall Study|Adverse Event|4|||
163002696|NCT00509795|588709096|FG001|Overall Study|Adverse Event|3|||
163002697|NCT00509795|588709097|FG002|Overall Study|Adverse Event|5|||
163002698|NCT00509795|588709098|FG003|Overall Study|Adverse Event|4|||
163002699|NCT00509795|588709095|FG000|Overall Study|Death|3|||
163002700|NCT00509795|588709096|FG001|Overall Study|Death|1|||
163002701|NCT00509795|588709097|FG002|Overall Study|Death|2|||
163002702|NCT00509795|588709098|FG003|Overall Study|Death|7|||
163002703|NCT00509795|588709095|FG000|Overall Study|Lack of Efficacy|0|||
163002704|NCT00509795|588709096|FG001|Overall Study|Lack of Efficacy|0|||
163002705|NCT00509795|588709097|FG002|Overall Study|Lack of Efficacy|2|||
163002706|NCT00509795|588709098|FG003|Overall Study|Lack of Efficacy|2|||
163002707|NCT00509795|588709095|FG000|Overall Study|Lost to Follow-up|1|||
163002708|NCT00509795|588709096|FG001|Overall Study|Lost to Follow-up|2|||
163002709|NCT00509795|588709097|FG002|Overall Study|Lost to Follow-up|4|||
163002710|NCT00509795|588709098|FG003|Overall Study|Lost to Follow-up|4|||
163002711|NCT00509795|588709095|FG000|Overall Study|OTHER|1|||
163002712|NCT00509795|588709096|FG001|Overall Study|OTHER|0|||
163002713|NCT00509795|588709097|FG002|Overall Study|OTHER|4|||
163002714|NCT00509795|588709098|FG003|Overall Study|OTHER|1|||
163002715|NCT00509795|588709095|FG000|Overall Study|Protocol Violation|3|||
163002716|NCT00509795|588709096|FG001|Overall Study|Protocol Violation|0|||
163002717|NCT00509795|588709097|FG002|Overall Study|Protocol Violation|3|||
163002718|NCT00509795|588709098|FG003|Overall Study|Protocol Violation|1|||
163002719|NCT00509795|588709095|FG000|Overall Study|Withdrawal by Subject|10|||
163002720|NCT00509795|588709096|FG001|Overall Study|Withdrawal by Subject|5|||
163002721|NCT00509795|588709097|FG002|Overall Study|Withdrawal by Subject|7|||
163002722|NCT00509795|588709098|FG003|Overall Study|Withdrawal by Subject|8|||
163002723|NCT04895982|588709099|FG000|Overall Study|Withdrawal by Subject|0|||
163002724|NCT04895982|588709100|FG001|Overall Study|Withdrawal by Subject|0|||
163002725|NCT04895982|588709101|FG002|Overall Study|Withdrawal by Subject|0|||
163002726|NCT04895982|588709102|FG003|Overall Study|Withdrawal by Subject|0|||
163002727|NCT04895982|588709103|FG004|Overall Study|Withdrawal by Subject|0|||
163002728|NCT04895982|588709104|FG005|Overall Study|Withdrawal by Subject|1|||
163002729|NCT04895982|588709105|FG006|Overall Study|Withdrawal by Subject|1|||
163002730|NCT04895982|588709106|FG007|Overall Study|Withdrawal by Subject|0|||
163002731|NCT04895982|588709107|FG008|Overall Study|Withdrawal by Subject|0|||
163002732|NCT04895982|588709108|FG009|Overall Study|Withdrawal by Subject|1|||
163002733|NCT04895982|588709109|FG010|Overall Study|Withdrawal by Subject|0|||
163002734|NCT04895982|588709110|FG011|Overall Study|Withdrawal by Subject|1|||
163002735|NCT04895982|588709099|FG000|Overall Study|Withdrawal by parent/guardian|2|||
163002736|NCT04895982|588709100|FG001|Overall Study|Withdrawal by parent/guardian|3|||
163002737|NCT04895982|588709101|FG002|Overall Study|Withdrawal by parent/guardian|3|||
163002738|NCT04895982|588709102|FG003|Overall Study|Withdrawal by parent/guardian|1|||
163002739|NCT04895982|588709103|FG004|Overall Study|Withdrawal by parent/guardian|3|||
163002740|NCT04895982|588709104|FG005|Overall Study|Withdrawal by parent/guardian|2|||
163002741|NCT04895982|588709105|FG006|Overall Study|Withdrawal by parent/guardian|1|||
163002742|NCT04895982|588709106|FG007|Overall Study|Withdrawal by parent/guardian|0|||
163002743|NCT04895982|588709107|FG008|Overall Study|Withdrawal by parent/guardian|3|||
163002744|NCT04895982|588709108|FG009|Overall Study|Withdrawal by parent/guardian|0|||
163002745|NCT04895982|588709109|FG010|Overall Study|Withdrawal by parent/guardian|0|||
163002746|NCT04895982|588709110|FG011|Overall Study|Withdrawal by parent/guardian|0|||
163002747|NCT04895982|588709099|FG000|Overall Study|Other|0|||
163002748|NCT04895982|588709100|FG001|Overall Study|Other|0|||
163002749|NCT04895982|588709101|FG002|Overall Study|Other|1|||
163002750|NCT04895982|588709102|FG003|Overall Study|Other|1|||
163002751|NCT04895982|588709103|FG004|Overall Study|Other|0|||
163002752|NCT04895982|588709104|FG005|Overall Study|Other|0|||
163002753|NCT04895982|588709105|FG006|Overall Study|Other|0|||
163002754|NCT04895982|588709106|FG007|Overall Study|Other|0|||
163002755|NCT04895982|588709107|FG008|Overall Study|Other|0|||
163002756|NCT04895982|588709108|FG009|Overall Study|Other|1|||
163002757|NCT04895982|588709109|FG010|Overall Study|Other|0|||
163002758|NCT04895982|588709110|FG011|Overall Study|Other|0|||
163002759|NCT04895982|588709099|FG000|Overall Study|Protocol Violation|0|||
163002760|NCT04895982|588709100|FG001|Overall Study|Protocol Violation|0|||
163002761|NCT04895982|588709101|FG002|Overall Study|Protocol Violation|1|||
163002762|NCT04895982|588709102|FG003|Overall Study|Protocol Violation|1|||
163002763|NCT04895982|588709103|FG004|Overall Study|Protocol Violation|1|||
163002764|NCT04895982|588709104|FG005|Overall Study|Protocol Violation|0|||
163002765|NCT04895982|588709105|FG006|Overall Study|Protocol Violation|0|||
163002766|NCT04895982|588709106|FG007|Overall Study|Protocol Violation|1|||
163002767|NCT04895982|588709107|FG008|Overall Study|Protocol Violation|0|||
163002768|NCT04895982|588709108|FG009|Overall Study|Protocol Violation|0|||
163002769|NCT04895982|588709109|FG010|Overall Study|Protocol Violation|0|||
163002770|NCT04895982|588709110|FG011|Overall Study|Protocol Violation|0|||
163002771|NCT04895982|588709099|FG000|Overall Study|Lost to Follow-up|0|||
163002772|NCT04895982|588709100|FG001|Overall Study|Lost to Follow-up|0|||
163002773|NCT04895982|588709101|FG002|Overall Study|Lost to Follow-up|1|||
163002774|NCT04895982|588709102|FG003|Overall Study|Lost to Follow-up|0|||
163002775|NCT04895982|588709103|FG004|Overall Study|Lost to Follow-up|0|||
163002776|NCT04895982|588709104|FG005|Overall Study|Lost to Follow-up|1|||
163002777|NCT04895982|588709105|FG006|Overall Study|Lost to Follow-up|0|||
163002778|NCT04895982|588709106|FG007|Overall Study|Lost to Follow-up|0|||
163002779|NCT04895982|588709107|FG008|Overall Study|Lost to Follow-up|1|||
163002780|NCT04895982|588709108|FG009|Overall Study|Lost to Follow-up|0|||
163002781|NCT04895982|588709109|FG010|Overall Study|Lost to Follow-up|0|||
163002782|NCT04895982|588709110|FG011|Overall Study|Lost to Follow-up|0|||
163002783|NCT04895982|588709099|FG000|Overall Study|Refused further study procedures|0|||
163002784|NCT04895982|588709100|FG001|Overall Study|Refused further study procedures|0|||
163002785|NCT04895982|588709101|FG002|Overall Study|Refused further study procedures|1|||
163002786|NCT04895982|588709102|FG003|Overall Study|Refused further study procedures|0|||
163002787|NCT04895982|588709103|FG004|Overall Study|Refused further study procedures|0|||
163002788|NCT04895982|588709104|FG005|Overall Study|Refused further study procedures|0|||
163002789|NCT04895982|588709105|FG006|Overall Study|Refused further study procedures|0|||
163002790|NCT04895982|588709106|FG007|Overall Study|Refused further study procedures|0|||
163002791|NCT04895982|588709107|FG008|Overall Study|Refused further study procedures|0|||
163002792|NCT04895982|588709108|FG009|Overall Study|Refused further study procedures|0|||
163002793|NCT04895982|588709109|FG010|Overall Study|Refused further study procedures|0|||
163002794|NCT04895982|588709110|FG011|Overall Study|Refused further study procedures|0|||
163002795|NCT03300817|588711375|FG000|Overall Study|Withdrawal by Subject|1|||
163002796|NCT03300817|588711375|FG000|Overall Study|Adverse Event|1|||
163002797|NCT03300817|588711375|FG000|Overall Study|Subject Found to be Ineligible|2|||
163002798|NCT05061134|588711377|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
163002799|NCT05061134|588711378|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
163002800|NCT05061134|588711379|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
163002801|NCT05061134|588711377|FG000|Overall Study|Subject not treated|0|||
163002802|NCT05061134|588711378|FG001|Overall Study|Subject not treated|0|||
163002803|NCT05061134|588711379|FG002|Overall Study|Subject not treated|2|||
163002804|NCT05061134|588711377|FG000|Overall Study|Other|0|||
163002805|NCT05061134|588711378|FG001|Overall Study|Other|0|||
163002806|NCT05061134|588711379|FG002|Overall Study|Other|9|||
163002807|NCT05061134|588711377|FG000|Overall Study|Withdrawal by Subject|9|||
163002808|NCT05061134|588711378|FG001|Overall Study|Withdrawal by Subject|8|||
163002809|NCT05061134|588711379|FG002|Overall Study|Withdrawal by Subject|5|||
163002810|NCT05061134|588711377|FG000|Overall Study|Study Terminated by Sponsor|22|||
163002811|NCT05061134|588711378|FG001|Overall Study|Study Terminated by Sponsor|14|||
163002812|NCT05061134|588711379|FG002|Overall Study|Study Terminated by Sponsor|7|||
163002813|NCT05061134|588711377|FG000|Overall Study|Progressive Disease|1|||
163002814|NCT05061134|588711378|FG001|Overall Study|Progressive Disease|2|||
163002815|NCT05061134|588711379|FG002|Overall Study|Progressive Disease|0|||
163002816|NCT05061134|588711377|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
163213321|NCT00708162|589495934|FG000|Open-Label Phase|Death|3|||
163213322|NCT00708162|589495935|FG001|Open-Label Phase|Death|1|||
163213323|NCT00708162|589495934|FG000|Open-Label Phase|Adverse Event|1|||
163213324|NCT00708162|589495935|FG001|Open-Label Phase|Adverse Event|2|||
163213325|NCT00708162|589495934|FG000|Open-Label Phase|Other|1|||
163213326|NCT00708162|589495935|FG001|Open-Label Phase|Other|0|||
163002817|NCT05061134|588711378|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
163002818|NCT05061134|588711379|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
163002819|NCT05061134|588711377|FG000|Overall Study|Lost to Follow-up|1|||
163002820|NCT05061134|588711378|FG001|Overall Study|Lost to Follow-up|0|||
163002821|NCT05061134|588711379|FG002|Overall Study|Lost to Follow-up|0|||
163002822|NCT05061134|588711377|FG000|Overall Study|Physician Decision|1|||
163002823|NCT05061134|588711378|FG001|Overall Study|Physician Decision|1|||
163002824|NCT05061134|588711379|FG002|Overall Study|Physician Decision|0|||
163002825|NCT05061134|588711377|FG000|Overall Study|Disease progression|1|||
163002826|NCT05061134|588711378|FG001|Overall Study|Disease progression|0|||
163002827|NCT05061134|588711379|FG002|Overall Study|Disease progression|0|||
163002828|NCT05061134|588711377|FG000|Overall Study|Death|43|||
163002829|NCT05061134|588711378|FG001|Overall Study|Death|23|||
163002830|NCT05061134|588711379|FG002|Overall Study|Death|14|||
163002831|NCT05061134|588711377|FG000|Overall Study|Database lock|2|||
163002832|NCT05061134|588711378|FG001|Overall Study|Database lock|0|||
163002833|NCT05061134|588711379|FG002|Overall Study|Database lock|0|||
163002834|NCT03999996|588711380|FG000|Prior to Booster|Adverse Event|2|||
163002835|NCT03999996|588711381|FG001|Prior to Booster|Adverse Event|0|||
163002836|NCT03999996|588711382|FG002|Prior to Booster|Adverse Event|0|||
163002837|NCT03999996|588711383|FG003|Prior to Booster|Adverse Event|0|||
163002838|NCT03999996|588711380|FG000|Prior to Booster|Lost to Follow-up|17|||
163002839|NCT03999996|588711381|FG001|Prior to Booster|Lost to Follow-up|22|||
163002840|NCT03999996|588711382|FG002|Prior to Booster|Lost to Follow-up|0|||
163002841|NCT03999996|588711383|FG003|Prior to Booster|Lost to Follow-up|0|||
163002842|NCT03999996|588711380|FG000|Prior to Booster|Withdrawal of Consent|51|||
163002843|NCT03999996|588711381|FG001|Prior to Booster|Withdrawal of Consent|8|||
163002844|NCT03999996|588711382|FG002|Prior to Booster|Withdrawal of Consent|0|||
163002845|NCT03999996|588711383|FG003|Prior to Booster|Withdrawal of Consent|0|||
163002846|NCT03999996|588711380|FG000|Prior to Booster|Death|0|||
163002847|NCT03999996|588711381|FG001|Prior to Booster|Death|1|||
163002848|NCT03999996|588711382|FG002|Prior to Booster|Death|0|||
163002849|NCT03999996|588711383|FG003|Prior to Booster|Death|0|||
163002850|NCT03999996|588711380|FG000|Prior to Booster|Reason Not Specified|27|||
163002851|NCT03999996|588711381|FG001|Prior to Booster|Reason Not Specified|4|||
163002852|NCT03999996|588711382|FG002|Prior to Booster|Reason Not Specified|0|||
163002853|NCT03999996|588711383|FG003|Prior to Booster|Reason Not Specified|0|||
163002854|NCT03999996|588711380|FG000|Booster Phase|Lost to Follow-up|0|||
163002855|NCT03999996|588711381|FG001|Booster Phase|Lost to Follow-up|0|||
163002856|NCT03999996|588711382|FG002|Booster Phase|Lost to Follow-up|3|||
163002857|NCT03999996|588711383|FG003|Booster Phase|Lost to Follow-up|3|||
163002858|NCT03999996|588711380|FG000|Booster Phase|Withdrawal of Consent|0|||
163002859|NCT03999996|588711381|FG001|Booster Phase|Withdrawal of Consent|0|||
163002860|NCT03999996|588711382|FG002|Booster Phase|Withdrawal of Consent|0|||
163002861|NCT03999996|588711383|FG003|Booster Phase|Withdrawal of Consent|1|||
163002862|NCT03999996|588711380|FG000|Booster Phase|Reason Not Specified|0|||
163002863|NCT03999996|588711381|FG001|Booster Phase|Reason Not Specified|0|||
163002864|NCT03999996|588711382|FG002|Booster Phase|Reason Not Specified|0|||
163002865|NCT03999996|588711383|FG003|Booster Phase|Reason Not Specified|1|||
163002866|NCT03765788|588711384|FG000|Overall Study|Subject decision|2|||
163002867|NCT03765788|588711385|FG001|Overall Study|Subject decision|3|||
163002868|NCT03765788|588711384|FG000|Overall Study|Physician Decision|2|||
163002869|NCT03765788|588711385|FG001|Overall Study|Physician Decision|4|||
163060753|NCT03836053|588931283|FG002|Overall Study|Decision by sponsor|4|||
163060754|NCT03846479|588931284|FG000|Overall Study|Death|8|||
163060755|NCT03846479|588931284|FG000|Overall Study|Lost to Follow-up|1|||
163060756|NCT02332707|588931285|FG000|Overall Study|Adverse Event|0|||
163060757|NCT02332707|588931286|FG001|Overall Study|Adverse Event|0|||
163002870|NCT03765788|588711384|FG000|Overall Study|Death|0|||
163002871|NCT03765788|588711385|FG001|Overall Study|Death|1|||
163002872|NCT03765788|588711384|FG000|Overall Study|Lost to Follow-up|1|||
163060758|NCT02332707|588931287|FG002|Overall Study|Adverse Event|0|||
163213327|NCT01349803|589495937|FG000|Overall Study|Adverse Event|0|||
163002873|NCT03765788|588711385|FG001|Overall Study|Lost to Follow-up|0|||
163002874|NCT00001521|588711386|FG000|Overall Study|Withdrawal by Subject|3|||
163002875|NCT00001521|588711387|FG001|Overall Study|Withdrawal by Subject|3|||
163002876|NCT00001521|588711386|FG000|Overall Study|Physician Decision|1|||
163213328|NCT01349803|589495938|FG001|Overall Study|Adverse Event|0|||
163060759|NCT02332707|588931288|FG003|Overall Study|Adverse Event|0|||
163213329|NCT01349803|589495939|FG002|Overall Study|Adverse Event|0|||
163002877|NCT00001521|588711387|FG001|Overall Study|Physician Decision|1|||
163002878|NCT00001521|588711386|FG000|Overall Study|Noncompliant|6|||
163002879|NCT00001521|588711387|FG001|Overall Study|Noncompliant|3|||
163002880|NCT03176134|588711388|FG000|Overall Study|Lost to Follow-up|0|||
163002881|NCT03176134|588711389|FG001|Overall Study|Lost to Follow-up|2|||
163002882|NCT03176134|588711390|FG002|Overall Study|Lost to Follow-up|0|||
163002883|NCT03176134|588711391|FG003|Overall Study|Lost to Follow-up|0|||
163002884|NCT03176134|588711392|FG004|Overall Study|Lost to Follow-up|0|||
163060760|NCT02332707|588931289|FG004|Overall Study|Adverse Event|0|||
163060761|NCT02332707|588931290|FG005|Overall Study|Adverse Event|0|||
163002885|NCT03176134|588711393|FG005|Overall Study|Lost to Follow-up|0|||
163002886|NCT03176134|588711394|FG006|Overall Study|Lost to Follow-up|0|||
163002887|NCT03176134|588711395|FG007|Overall Study|Lost to Follow-up|0|||
163002888|NCT03176134|588711388|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
163002889|NCT03176134|588711389|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163002890|NCT03176134|588711390|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
163002891|NCT03176134|588711391|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163002892|NCT03176134|588711392|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
163002893|NCT03176134|588711393|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
163002894|NCT03176134|588711394|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
163002895|NCT03176134|588711395|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
163002896|NCT03410056|588711400|FG000|Overall Study|Decision by Sponsor|0|||
163002897|NCT03410056|588711401|FG001|Overall Study|Decision by Sponsor|0|||
163002898|NCT03410056|588711402|FG002|Overall Study|Decision by Sponsor|3|||
163002899|NCT03410056|588711403|FG003|Overall Study|Decision by Sponsor|0|||
163002900|NCT03410056|588711404|FG004|Overall Study|Decision by Sponsor|0|||
163002901|NCT03410056|588711405|FG005|Overall Study|Decision by Sponsor|0|||
163002902|NCT03410056|588711406|FG006|Overall Study|Decision by Sponsor|0|||
163002903|NCT03410056|588711400|FG000|Overall Study|Withdrawal by Subject|0|||
163002904|NCT03410056|588711401|FG001|Overall Study|Withdrawal by Subject|2|||
163002905|NCT03410056|588711402|FG002|Overall Study|Withdrawal by Subject|5|||
163002906|NCT03410056|588711403|FG003|Overall Study|Withdrawal by Subject|5|||
163002907|NCT03410056|588711404|FG004|Overall Study|Withdrawal by Subject|0|||
163002908|NCT03410056|588711405|FG005|Overall Study|Withdrawal by Subject|0|||
163002909|NCT03410056|588711406|FG006|Overall Study|Withdrawal by Subject|0|||
163002910|NCT01130532|588711410|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
163002911|NCT01130532|588711411|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
163060762|NCT02332707|588931291|FG006|Overall Study|Adverse Event|0|||
163060763|NCT02332707|588931292|FG007|Overall Study|Adverse Event|0|||
163060764|NCT02332707|588931293|FG008|Overall Study|Adverse Event|0|||
163060765|NCT02332707|588931294|FG009|Overall Study|Adverse Event|0|||
163060766|NCT02332707|588931295|FG010|Overall Study|Adverse Event|0|||
163060767|NCT02332707|588931296|FG011|Overall Study|Adverse Event|0|||
163060768|NCT02332707|588931297|FG012|Overall Study|Adverse Event|1|||
163060769|NCT02332707|588931298|FG013|Overall Study|Adverse Event|0|||
163060770|NCT02332707|588931299|FG014|Overall Study|Adverse Event|0|||
163213330|NCT01349803|589495940|FG003|Overall Study|Adverse Event|2|||
163213331|NCT01349803|589495937|FG000|Overall Study|Withdrawal by Subject|1|||
163213332|NCT01349803|589495938|FG001|Overall Study|Withdrawal by Subject|0|||
163213333|NCT01349803|589495939|FG002|Overall Study|Withdrawal by Subject|0|||
163213334|NCT01349803|589495940|FG003|Overall Study|Withdrawal by Subject|0|||
163213335|NCT01349803|589495937|FG000|Overall Study|Protocol-specified criteria|0|||
163213336|NCT01349803|589495938|FG001|Overall Study|Protocol-specified criteria|1|||
163213337|NCT01349803|589495939|FG002|Overall Study|Protocol-specified criteria|3|||
163213338|NCT01349803|589495940|FG003|Overall Study|Protocol-specified criteria|0|||
163213339|NCT02345811|589495941|FG000|First Intervention|Withdrawal by Subject|1|||
163325277|NCT00943917|589902910|FG013|Stage II|Adverse Event|0|||
163325278|NCT00943917|589902911|FG014|Stage II|Adverse Event|0|||
163325279|NCT00943917|589902897|FG000|Stage II|Withdrawal by Subject|0|||
163325280|NCT00943917|589902898|FG001|Stage II|Withdrawal by Subject|0|||
163325281|NCT00943917|589902899|FG002|Stage II|Withdrawal by Subject|0|||
163325282|NCT00943917|589902900|FG003|Stage II|Withdrawal by Subject|0|||
163325283|NCT00943917|589902901|FG004|Stage II|Withdrawal by Subject|0|||
163325284|NCT00943917|589902902|FG005|Stage II|Withdrawal by Subject|1|||
163325285|NCT00943917|589902903|FG006|Stage II|Withdrawal by Subject|0|||
163325286|NCT00943917|589902904|FG007|Stage II|Withdrawal by Subject|0|||
163213340|NCT02345811|589495942|FG001|First Intervention|Withdrawal by Subject|1|||
163213341|NCT02522286|589495943|FG000|Overall Study|Withdrawal by Subject|3|||
163213342|NCT02522286|589495944|FG001|Overall Study|Withdrawal by Subject|0|||
163325287|NCT00943917|589902905|FG008|Stage II|Withdrawal by Subject|0|||
163325288|NCT00943917|589902906|FG009|Stage II|Withdrawal by Subject|0|||
163325289|NCT00943917|589902907|FG010|Stage II|Withdrawal by Subject|0|||
163325290|NCT00943917|589902908|FG011|Stage II|Withdrawal by Subject|0|||
163325291|NCT00943917|589902909|FG012|Stage II|Withdrawal by Subject|0|||
163325292|NCT00943917|589902910|FG013|Stage II|Withdrawal by Subject|0|||
163325293|NCT00943917|589902911|FG014|Stage II|Withdrawal by Subject|0|||
163325294|NCT00943917|589902897|FG000|Stage II|Pregnancy|0|||
163325295|NCT00943917|589902898|FG001|Stage II|Pregnancy|0|||
163325296|NCT00943917|589902899|FG002|Stage II|Pregnancy|0|||
163325297|NCT00943917|589902900|FG003|Stage II|Pregnancy|0|||
163325298|NCT00943917|589902901|FG004|Stage II|Pregnancy|0|||
163325299|NCT00943917|589902902|FG005|Stage II|Pregnancy|1|||
163325300|NCT00943917|589902903|FG006|Stage II|Pregnancy|0|||
163325301|NCT00943917|589902904|FG007|Stage II|Pregnancy|0|||
163325302|NCT00943917|589902905|FG008|Stage II|Pregnancy|0|||
163325303|NCT00943917|589902906|FG009|Stage II|Pregnancy|0|||
163325304|NCT00943917|589902907|FG010|Stage II|Pregnancy|0|||
163325305|NCT00943917|589902908|FG011|Stage II|Pregnancy|0|||
163325306|NCT00943917|589902909|FG012|Stage II|Pregnancy|0|||
163325307|NCT00943917|589902910|FG013|Stage II|Pregnancy|0|||
163325308|NCT00943917|589902911|FG014|Stage II|Pregnancy|0|||
163325309|NCT00943917|589902897|FG000|Stage II Continuation|Adverse Event|0|||
163325310|NCT00943917|589902898|FG001|Stage II Continuation|Adverse Event|0|||
163325311|NCT00943917|589902899|FG002|Stage II Continuation|Adverse Event|0|||
163325312|NCT00943917|589902900|FG003|Stage II Continuation|Adverse Event|0|||
163325313|NCT00943917|589902901|FG004|Stage II Continuation|Adverse Event|0|||
163325314|NCT00943917|589902902|FG005|Stage II Continuation|Adverse Event|0|||
163325315|NCT00943917|589902903|FG006|Stage II Continuation|Adverse Event|0|||
163325316|NCT00943917|589902904|FG007|Stage II Continuation|Adverse Event|0|||
163325317|NCT00943917|589902905|FG008|Stage II Continuation|Adverse Event|0|||
163325318|NCT00943917|589902906|FG009|Stage II Continuation|Adverse Event|0|||
163325319|NCT00943917|589902907|FG010|Stage II Continuation|Adverse Event|0|||
163325320|NCT00943917|589902908|FG011|Stage II Continuation|Adverse Event|1|||
163325321|NCT00943917|589902909|FG012|Stage II Continuation|Adverse Event|2|||
163325322|NCT00943917|589902910|FG013|Stage II Continuation|Adverse Event|1|||
163325323|NCT00943917|589902911|FG014|Stage II Continuation|Adverse Event|1|||
163325324|NCT00943917|589902897|FG000|Stage II Continuation|Withdrawal by Subject|0|||
163325325|NCT00943917|589902898|FG001|Stage II Continuation|Withdrawal by Subject|0|||
163325326|NCT00943917|589902899|FG002|Stage II Continuation|Withdrawal by Subject|0|||
163325327|NCT00943917|589902900|FG003|Stage II Continuation|Withdrawal by Subject|0|||
163325328|NCT00943917|589902901|FG004|Stage II Continuation|Withdrawal by Subject|0|||
163002912|NCT01130532|588711412|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
163002913|NCT01130532|588711413|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
163002914|NCT01130532|588711410|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
163002915|NCT01130532|588711411|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
163002916|NCT01130532|588711412|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
163002917|NCT01130532|588711413|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
163002918|NCT01130532|588711410|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
163002919|NCT01130532|588711411|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
163325329|NCT00943917|589902902|FG005|Stage II Continuation|Withdrawal by Subject|0|||
163325330|NCT00943917|589902903|FG006|Stage II Continuation|Withdrawal by Subject|0|||
163325331|NCT00943917|589902904|FG007|Stage II Continuation|Withdrawal by Subject|0|||
163325332|NCT00943917|589902905|FG008|Stage II Continuation|Withdrawal by Subject|0|||
163325333|NCT00943917|589902906|FG009|Stage II Continuation|Withdrawal by Subject|0|||
163325334|NCT00943917|589902907|FG010|Stage II Continuation|Withdrawal by Subject|0|||
163325335|NCT00943917|589902908|FG011|Stage II Continuation|Withdrawal by Subject|0|||
163325336|NCT00943917|589902909|FG012|Stage II Continuation|Withdrawal by Subject|0|||
163325337|NCT00943917|589902910|FG013|Stage II Continuation|Withdrawal by Subject|1|||
163325338|NCT00943917|589902911|FG014|Stage II Continuation|Withdrawal by Subject|3|||
163325339|NCT00943917|589902897|FG000|Stage II Continuation|Protocol Violation|0|||
163325340|NCT00943917|589902898|FG001|Stage II Continuation|Protocol Violation|0|||
163325341|NCT00943917|589902899|FG002|Stage II Continuation|Protocol Violation|0|||
163325342|NCT00943917|589902900|FG003|Stage II Continuation|Protocol Violation|0|||
163325343|NCT00943917|589902901|FG004|Stage II Continuation|Protocol Violation|0|||
163325344|NCT00943917|589902902|FG005|Stage II Continuation|Protocol Violation|0|||
163002920|NCT01130532|588711412|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
163060771|NCT02332707|588931300|FG015|Overall Study|Adverse Event|0|||
163060772|NCT02332707|588931301|FG016|Overall Study|Adverse Event|0|||
163060773|NCT02332707|588931302|FG017|Overall Study|Adverse Event|0|||
163060774|NCT02332707|588931285|FG000|Overall Study|Lost to Follow-up|0|||
163060775|NCT02332707|588931286|FG001|Overall Study|Lost to Follow-up|0|||
163060776|NCT02332707|588931287|FG002|Overall Study|Lost to Follow-up|0|||
163060777|NCT02332707|588931288|FG003|Overall Study|Lost to Follow-up|0|||
163060778|NCT02332707|588931289|FG004|Overall Study|Lost to Follow-up|0|||
163060779|NCT02332707|588931290|FG005|Overall Study|Lost to Follow-up|1|||
163060780|NCT02332707|588931291|FG006|Overall Study|Lost to Follow-up|0|||
163060781|NCT02332707|588931292|FG007|Overall Study|Lost to Follow-up|0|||
163060782|NCT02332707|588931293|FG008|Overall Study|Lost to Follow-up|0|||
163060783|NCT02332707|588931294|FG009|Overall Study|Lost to Follow-up|0|||
163060784|NCT02332707|588931295|FG010|Overall Study|Lost to Follow-up|2|||
163060785|NCT02332707|588931296|FG011|Overall Study|Lost to Follow-up|0|||
163060786|NCT02332707|588931297|FG012|Overall Study|Lost to Follow-up|3|||
163060787|NCT02332707|588931298|FG013|Overall Study|Lost to Follow-up|0|||
163325345|NCT00943917|589902903|FG006|Stage II Continuation|Protocol Violation|0|||
163325346|NCT00943917|589902904|FG007|Stage II Continuation|Protocol Violation|0|||
163325347|NCT00943917|589902905|FG008|Stage II Continuation|Protocol Violation|0|||
163325348|NCT00943917|589902906|FG009|Stage II Continuation|Protocol Violation|1|||
163325349|NCT00943917|589902907|FG010|Stage II Continuation|Protocol Violation|0|||
163060788|NCT02332707|588931299|FG014|Overall Study|Lost to Follow-up|0|||
163060789|NCT02332707|588931300|FG015|Overall Study|Lost to Follow-up|0|||
163060790|NCT02332707|588931301|FG016|Overall Study|Lost to Follow-up|0|||
163325350|NCT00943917|589902908|FG011|Stage II Continuation|Protocol Violation|1|||
163002921|NCT01130532|588711413|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
163060791|NCT02332707|588931302|FG017|Overall Study|Lost to Follow-up|0|||
163060792|NCT02332707|588931285|FG000|Overall Study|Physician Decision|0|||
163002922|NCT01130532|588711410|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
163002923|NCT01130532|588711411|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
163002924|NCT01130532|588711412|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
163002925|NCT01130532|588711413|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
163002926|NCT01130532|588711410|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
163002927|NCT01130532|588711411|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
163002928|NCT01130532|588711412|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
163002929|NCT01130532|588711413|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
163002930|NCT01130532|588711410|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
163002931|NCT01130532|588711411|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
163002932|NCT01130532|588711412|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
163002933|NCT01130532|588711413|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
163002934|NCT01130532|588711410|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
163002935|NCT01130532|588711411|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
163002936|NCT01130532|588711412|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
163002937|NCT01130532|588711413|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
163002938|NCT01130532|588711410|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
163002939|NCT01130532|588711411|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
163002940|NCT01130532|588711412|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
163002941|NCT01130532|588711413|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
163002942|NCT01130532|588711410|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
163002943|NCT01130532|588711411|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
163002944|NCT01130532|588711412|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
163002945|NCT01130532|588711413|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
163002946|NCT01130532|588711410|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
163002947|NCT01130532|588711411|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
163002948|NCT01130532|588711412|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
163002949|NCT01130532|588711413|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
163002950|NCT01130532|588711410|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
163002951|NCT01130532|588711411|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
163002952|NCT01130532|588711412|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
163002953|NCT01130532|588711413|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
163002954|NCT02762929|588711414|FG000|Overall Study|Adverse Event|0|||
163002955|NCT02762929|588711415|FG001|Overall Study|Adverse Event|0|||
163325351|NCT00943917|589902909|FG012|Stage II Continuation|Protocol Violation|0|||
163325352|NCT00943917|589902910|FG013|Stage II Continuation|Protocol Violation|0|||
163325353|NCT00943917|589902911|FG014|Stage II Continuation|Protocol Violation|0|||
163325354|NCT00943917|589902897|FG000|Stage II Continuation|hypoglycemia|0|||
163325355|NCT00943917|589902898|FG001|Stage II Continuation|hypoglycemia|0|||
163325356|NCT00943917|589902899|FG002|Stage II Continuation|hypoglycemia|0|||
163325357|NCT00943917|589902900|FG003|Stage II Continuation|hypoglycemia|0|||
163325358|NCT00943917|589902901|FG004|Stage II Continuation|hypoglycemia|0|||
163325359|NCT00943917|589902902|FG005|Stage II Continuation|hypoglycemia|0|||
163325360|NCT00943917|589902903|FG006|Stage II Continuation|hypoglycemia|0|||
163325361|NCT00943917|589902904|FG007|Stage II Continuation|hypoglycemia|0|||
163325362|NCT00943917|589902905|FG008|Stage II Continuation|hypoglycemia|0|||
163325363|NCT00943917|589902906|FG009|Stage II Continuation|hypoglycemia|0|||
163325364|NCT00943917|589902907|FG010|Stage II Continuation|hypoglycemia|0|||
163325365|NCT00943917|589902908|FG011|Stage II Continuation|hypoglycemia|0|||
163325366|NCT00943917|589902909|FG012|Stage II Continuation|hypoglycemia|1|||
163325367|NCT00943917|589902910|FG013|Stage II Continuation|hypoglycemia|0|||
163325368|NCT00943917|589902911|FG014|Stage II Continuation|hypoglycemia|0|||
163325369|NCT00943917|589902897|FG000|Stage II Continuation|A1C elevation|0|||
163325370|NCT00943917|589902898|FG001|Stage II Continuation|A1C elevation|0|||
163325371|NCT00943917|589902899|FG002|Stage II Continuation|A1C elevation|0|||
163325372|NCT00943917|589902900|FG003|Stage II Continuation|A1C elevation|0|||
163325373|NCT00943917|589902901|FG004|Stage II Continuation|A1C elevation|0|||
163325374|NCT00943917|589902902|FG005|Stage II Continuation|A1C elevation|0|||
163325375|NCT00943917|589902903|FG006|Stage II Continuation|A1C elevation|0|||
163325376|NCT00943917|589902904|FG007|Stage II Continuation|A1C elevation|0|||
163325377|NCT00943917|589902905|FG008|Stage II Continuation|A1C elevation|0|||
163002956|NCT02762929|588711416|FG002|Overall Study|Adverse Event|0|||
163002957|NCT02762929|588711417|FG003|Overall Study|Adverse Event|1|||
163002958|NCT02762929|588711418|FG004|Overall Study|Adverse Event|0|||
163002959|NCT02762929|588711419|FG005|Overall Study|Adverse Event|0|||
163002960|NCT02762929|588711414|FG000|Overall Study|Lost to Follow-up|1|||
163002961|NCT02762929|588711415|FG001|Overall Study|Lost to Follow-up|2|||
163002962|NCT02762929|588711416|FG002|Overall Study|Lost to Follow-up|0|||
163325378|NCT00943917|589902906|FG009|Stage II Continuation|A1C elevation|0|||
163325379|NCT00943917|589902907|FG010|Stage II Continuation|A1C elevation|0|||
163325380|NCT00943917|589902908|FG011|Stage II Continuation|A1C elevation|0|||
163325381|NCT00943917|589902909|FG012|Stage II Continuation|A1C elevation|0|||
163325382|NCT00943917|589902910|FG013|Stage II Continuation|A1C elevation|1|||
163002963|NCT02762929|588711417|FG003|Overall Study|Lost to Follow-up|1|||
163002964|NCT02762929|588711418|FG004|Overall Study|Lost to Follow-up|0|||
163002965|NCT02762929|588711419|FG005|Overall Study|Lost to Follow-up|0|||
163325383|NCT00943917|589902911|FG014|Stage II Continuation|A1C elevation|0|||
163325384|NCT01171976|589902912|FG000|Overall Study|Protocol Violation|0|||
163325385|NCT01171976|589902913|FG001|Overall Study|Protocol Violation|0|||
163325386|NCT01171976|589902914|FG002|Overall Study|Protocol Violation|1|||
163325387|NCT01171976|589902912|FG000|Overall Study|Death|2|||
163325388|NCT01171976|589902913|FG001|Overall Study|Death|4|||
163325389|NCT01171976|589902914|FG002|Overall Study|Death|1|||
163325390|NCT01171976|589902912|FG000|Overall Study|Lost to Follow-up|4|||
163325391|NCT01171976|589902913|FG001|Overall Study|Lost to Follow-up|0|||
163325392|NCT01171976|589902914|FG002|Overall Study|Lost to Follow-up|2|||
163325393|NCT01171976|589902912|FG000|Overall Study|Withdrawal by Subject|1|||
163325394|NCT01171976|589902913|FG001|Overall Study|Withdrawal by Subject|5|||
163325395|NCT01171976|589902914|FG002|Overall Study|Withdrawal by Subject|6|||
163325396|NCT01171976|589902912|FG000|Overall Study|Abnormal test result|1|||
163325397|NCT01171976|589902913|FG001|Overall Study|Abnormal test result|0|||
163325398|NCT01171976|589902914|FG002|Overall Study|Abnormal test result|0|||
163325399|NCT01171976|589902912|FG000|Overall Study|Adverse Event|6|||
163325400|NCT01171976|589902913|FG001|Overall Study|Adverse Event|2|||
163325401|NCT01171976|589902914|FG002|Overall Study|Adverse Event|5|||
163325402|NCT00003222|589902915|FG000|Overall Study|Physician Decision|0|||
163325403|NCT00003222|589902916|FG001|Overall Study|Physician Decision|1|||
163325404|NCT01313559|589902918|FG000|Overall Study|Withdrawal by Subject|1|||
163325405|NCT01313559|589902919|FG001|Overall Study|Withdrawal by Subject|2|||
163325406|NCT01313559|589902918|FG000|Overall Study|Disease progression|1|||
163325407|NCT01313559|589902919|FG001|Overall Study|Disease progression|0|||
163325408|NCT01313559|589902918|FG000|Overall Study|Rising PSA|2|||
163325409|NCT01313559|589902919|FG001|Overall Study|Rising PSA|0|||
163325410|NCT02466971|589902920|FG000|Overall Study|eligible and never treated|14|||
163325411|NCT02466971|589902921|FG001|Overall Study|eligible and never treated|20|||
163325412|NCT02466971|589902920|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
163325413|NCT02466971|589902921|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
163325414|NCT02466971|589902920|FG000|Overall Study|ineligible and treated|1|||
163325415|NCT02466971|589902921|FG001|Overall Study|ineligible and treated|0|||
163325416|NCT02466971|589902920|FG000|Overall Study|ineligible and never treated|0|||
163325417|NCT02466971|589902921|FG001|Overall Study|ineligible and never treated|1|||
163325418|NCT05707351|589902922|FG000|Overall Study|Withdrawal by Subject|2|||
163002966|NCT02762929|588711414|FG000|Overall Study|Withdrawal by Subject|0|||
163002967|NCT02762929|588711415|FG001|Overall Study|Withdrawal by Subject|1|||
163002968|NCT02762929|588711416|FG002|Overall Study|Withdrawal by Subject|0|||
163002969|NCT02762929|588711417|FG003|Overall Study|Withdrawal by Subject|0|||
163002970|NCT02762929|588711418|FG004|Overall Study|Withdrawal by Subject|0|||
163002971|NCT02762929|588711419|FG005|Overall Study|Withdrawal by Subject|0|||
163002972|NCT02762929|588711414|FG000|Overall Study|exclusionary medication disclosed late|0|||
163002973|NCT02762929|588711415|FG001|Overall Study|exclusionary medication disclosed late|0|||
163002974|NCT02762929|588711416|FG002|Overall Study|exclusionary medication disclosed late|0|||
163002975|NCT02762929|588711417|FG003|Overall Study|exclusionary medication disclosed late|1|||
163002976|NCT02762929|588711418|FG004|Overall Study|exclusionary medication disclosed late|0|||
163002977|NCT02762929|588711419|FG005|Overall Study|exclusionary medication disclosed late|0|||
163002978|NCT02656303|588711420|FG000|Overall Study|Adverse Event|3|||
163002979|NCT02656303|588711421|FG001|Overall Study|Adverse Event|2|||
163002980|NCT02656303|588711422|FG002|Overall Study|Adverse Event|0|||
163002981|NCT02656303|588711420|FG000|Overall Study|Death|12|||
163002982|NCT02656303|588711421|FG001|Overall Study|Death|4|||
163002983|NCT02656303|588711422|FG002|Overall Study|Death|1|||
163002984|NCT02656303|588711420|FG000|Overall Study|Lack of Efficacy|1|||
163002985|NCT02656303|588711421|FG001|Overall Study|Lack of Efficacy|0|||
163002986|NCT02656303|588711422|FG002|Overall Study|Lack of Efficacy|0|||
163002987|NCT02656303|588711420|FG000|Overall Study|Non-Compliance with Study|1|||
163002988|NCT02656303|588711421|FG001|Overall Study|Non-Compliance with Study|1|||
163002989|NCT02656303|588711422|FG002|Overall Study|Non-Compliance with Study|0|||
163002990|NCT02656303|588711420|FG000|Overall Study|Investigator Decision|2|||
163325419|NCT05707351|589902922|FG000|Overall Study|Reason Not Specified|1|||
163325420|NCT04174560|589902926|FG000|Overall Study|Lost to Follow-up|1|||
163325421|NCT04174560|589902927|FG001|Overall Study|Lost to Follow-up|0|||
163325422|NCT04174560|589902928|FG002|Overall Study|Lost to Follow-up|0|||
163325423|NCT04174560|589902929|FG003|Overall Study|Lost to Follow-up|0|||
163002991|NCT02656303|588711421|FG001|Overall Study|Investigator Decision|1|||
163002992|NCT02656303|588711422|FG002|Overall Study|Investigator Decision|0|||
163002993|NCT02656303|588711420|FG000|Overall Study|Progressive Disease|25|||
163002994|NCT02656303|588711421|FG001|Overall Study|Progressive Disease|14|||
163002995|NCT02656303|588711422|FG002|Overall Study|Progressive Disease|10|||
163002996|NCT02656303|588711420|FG000|Overall Study|Study Terminated by Sponsor|20|||
163325424|NCT04174560|589902926|FG000|Overall Study|Withdrawal by Subject|0|||
163325425|NCT04174560|589902927|FG001|Overall Study|Withdrawal by Subject|0|||
163325426|NCT04174560|589902928|FG002|Overall Study|Withdrawal by Subject|2|||
163002997|NCT02656303|588711421|FG001|Overall Study|Study Terminated by Sponsor|7|||
163325427|NCT04174560|589902929|FG003|Overall Study|Withdrawal by Subject|0|||
163325428|NCT03872466|589902930|FG000|Overall Study|Withdrawal by Subject|1|||
163325429|NCT03872466|589902931|FG001|Overall Study|Withdrawal by Subject|0|||
163325430|NCT03872466|589902930|FG000|Overall Study|Physician Decision|2|||
163325431|NCT03872466|589902931|FG001|Overall Study|Physician Decision|0|||
163325432|NCT01778686|589902932|FG000|Overall Study|Adverse Event|0|||
163325433|NCT01778686|589902933|FG001|Overall Study|Adverse Event|0|||
163325434|NCT01778686|589902934|FG002|Overall Study|Adverse Event|1|||
163325435|NCT04012567|589902935|FG000|Overall Study|Lost to Follow-up|0|||
163325436|NCT04012567|589902936|FG001|Overall Study|Lost to Follow-up|1|||
163325437|NCT04012567|589902935|FG000|Overall Study|Withdrawal by Subject|1|||
163325438|NCT04012567|589902936|FG001|Overall Study|Withdrawal by Subject|0|||
163325439|NCT05714059|589902941|FG000|Overall Study|Withdrawal by Subject|2|||
163325440|NCT05714059|589902942|FG001|Overall Study|Withdrawal by Subject|2|||
163325441|NCT05714059|589902941|FG000|Overall Study|Adverse Event|0|||
163325442|NCT05714059|589902942|FG001|Overall Study|Adverse Event|1|||
163325443|NCT05714059|589902941|FG000|Overall Study|Lost to Follow-up|0|||
163325444|NCT05714059|589902942|FG001|Overall Study|Lost to Follow-up|1|||
163325445|NCT05714059|589902941|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
163325446|NCT05714059|589902942|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
163325447|NCT05714059|589902941|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
163325448|NCT05714059|589902942|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
163325449|NCT04899674|589902943|FG000|Test|Adverse Event|1|||
163325450|NCT04305327|589902948|FG000|Overall Study|Study early termination|2|||
163325451|NCT04305327|589902949|FG001|Overall Study|Study early termination|5|||
163325452|NCT04305327|589902950|FG002|Overall Study|Study early termination|2|||
163325453|NCT04305327|589902951|FG003|Overall Study|Study early termination|2|||
163325454|NCT04305327|589902948|FG000|Overall Study|Withdrawal by Subject|0|||
163325455|NCT04305327|589902949|FG001|Overall Study|Withdrawal by Subject|1|||
163325456|NCT04305327|589902950|FG002|Overall Study|Withdrawal by Subject|0|||
163325457|NCT04305327|589902951|FG003|Overall Study|Withdrawal by Subject|0|||
163325458|NCT05864209|589903834|FG000|Overall Study|Lost to Follow-up|2|||
163325459|NCT05864209|589903835|FG001|Overall Study|Lost to Follow-up|3|||
163325460|NCT04530487|589903836|FG000|Overall Study|Death|1|||
163002998|NCT02656303|588711422|FG002|Overall Study|Study Terminated by Sponsor|5|||
163002999|NCT02656303|588711420|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
163003000|NCT02656303|588711421|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
163003001|NCT02656303|588711422|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
163003002|NCT02656303|588711420|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
163003003|NCT02656303|588711421|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
163003004|NCT02656303|588711422|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
163003005|NCT02656303|588711420|FG000|Overall Study|Reason not Specified|1|||
163003006|NCT02656303|588711421|FG001|Overall Study|Reason not Specified|1|||
163003007|NCT02656303|588711422|FG002|Overall Study|Reason not Specified|2|||
163003008|NCT01842438|588711425|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
163003009|NCT01842438|588711426|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
163003010|NCT01842438|588711425|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
163003011|NCT01842438|588711426|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
163003012|NCT01842438|588711425|FG000|T2: 6month Follow-up|Death|0|||
163003013|NCT01842438|588711426|FG001|T2: 6month Follow-up|Death|1|||
163003014|NCT04909853|588711427|FG000|Part 1|Assigned but not treated|0|||
163003015|NCT04909853|588711428|FG001|Part 1|Assigned but not treated|0|||
163003016|NCT04909853|588711429|FG002|Part 1|Assigned but not treated|1|||
163003017|NCT04909853|588711430|FG003|Part 1|Assigned but not treated|0|||
163003018|NCT04909853|588711427|FG000|Part 2|Adverse Event|0|||
163003019|NCT04909853|588711428|FG001|Part 2|Adverse Event|0|||
163003020|NCT04909853|588711429|FG002|Part 2|Adverse Event|0|||
163003021|NCT04909853|588711430|FG003|Part 2|Adverse Event|1|||
163003022|NCT02366689|588711439|FG000|Overall Study|Withdrawal by Subject|1|||
163003023|NCT02366689|588711440|FG001|Overall Study|Withdrawal by Subject|0|||
163003024|NCT02366689|588711441|FG002|Overall Study|Withdrawal by Subject|1|||
163003025|NCT02366689|588711439|FG000|Overall Study|Lost to Follow-up|3|||
163003026|NCT02366689|588711440|FG001|Overall Study|Lost to Follow-up|2|||
163003027|NCT02366689|588711441|FG002|Overall Study|Lost to Follow-up|0|||
163003028|NCT02366689|588711439|FG000|Overall Study|Pregnancy|0|||
163003029|NCT02366689|588711440|FG001|Overall Study|Pregnancy|1|||
163003030|NCT02366689|588711441|FG002|Overall Study|Pregnancy|1|||
163003031|NCT03718832|588711442|FG000|Analysis Sample|Withdrawal by Subject|18|||
163003032|NCT03718832|588711443|FG001|Analysis Sample|Withdrawal by Subject|15|||
163003033|NCT03718832|588711442|FG000|Analysis Sample|Legal hold on data|1|||
163003034|NCT03718832|588711443|FG001|Analysis Sample|Legal hold on data|0|||
163003035|NCT03718832|588711442|FG000|Analysis Sample|Participant from treated household|0|||
163325461|NCT04977583|589903837|FG000|Overall Study|Lost to Follow-up|8|||
163325462|NCT04977583|589903838|FG001|Overall Study|Lost to Follow-up|4|||
163325463|NCT04977583|589903839|FG002|Overall Study|Lost to Follow-up|13|||
163325464|NCT04977583|589903837|FG000|Overall Study|Withdrawal by Subject|3|||
163325465|NCT04977583|589903838|FG001|Overall Study|Withdrawal by Subject|2|||
163325466|NCT04977583|589903839|FG002|Overall Study|Withdrawal by Subject|1|||
163325467|NCT04974047|589903844|FG000|Overall Study|Sponsor Ended Study|20|||
163325468|NCT04974047|589903845|FG001|Overall Study|Sponsor Ended Study|22|||
163325469|NCT04974047|589903844|FG000|Overall Study|Death|8|||
163325470|NCT04974047|589903845|FG001|Overall Study|Death|17|||
163325471|NCT04974047|589903844|FG000|Overall Study|Lost to Follow-up|2|||
163325472|NCT04974047|589903845|FG001|Overall Study|Lost to Follow-up|0|||
163325473|NCT04974047|589903844|FG000|Overall Study|Withdrawal by Subject|0|||
163325474|NCT04974047|589903845|FG001|Overall Study|Withdrawal by Subject|1|||
163325475|NCT00655499|589903846|FG000|Overall Study|not eligible|4|||
163325476|NCT00146172|589903848|FG000|Overall Study|Adverse Event|0|||
163325477|NCT00146172|589903849|FG001|Overall Study|Adverse Event|0|||
163325478|NCT00146172|589903850|FG002|Overall Study|Adverse Event|1|||
163325479|NCT00146172|589903851|FG003|Overall Study|Adverse Event|1|||
163325480|NCT00146172|589903852|FG004|Overall Study|Adverse Event|0|||
163325481|NCT00146172|589903853|FG005|Overall Study|Adverse Event|2|||
163325482|NCT00146172|589903854|FG006|Overall Study|Adverse Event|3|||
163325483|NCT00146172|589903855|FG007|Overall Study|Adverse Event|10|||
163325484|NCT00146172|589903848|FG000|Overall Study|Lost to Follow-up|0|||
163325485|NCT00146172|589903849|FG001|Overall Study|Lost to Follow-up|0|||
163325486|NCT00146172|589903850|FG002|Overall Study|Lost to Follow-up|0|||
163325487|NCT00146172|589903851|FG003|Overall Study|Lost to Follow-up|0|||
163325488|NCT00146172|589903852|FG004|Overall Study|Lost to Follow-up|0|||
163325489|NCT00146172|589903853|FG005|Overall Study|Lost to Follow-up|0|||
163325490|NCT00146172|589903854|FG006|Overall Study|Lost to Follow-up|0|||
163325491|NCT00146172|589903855|FG007|Overall Study|Lost to Follow-up|1|||
163325492|NCT00146172|589903848|FG000|Overall Study|Disease Progression|2|||
163325493|NCT00146172|589903849|FG001|Overall Study|Disease Progression|4|||
163325494|NCT00146172|589903850|FG002|Overall Study|Disease Progression|2|||
163325495|NCT00146172|589903851|FG003|Overall Study|Disease Progression|5|||
163325496|NCT00146172|589903852|FG004|Overall Study|Disease Progression|2|||
163325497|NCT00146172|589903853|FG005|Overall Study|Disease Progression|2|||
163325498|NCT00146172|589903854|FG006|Overall Study|Disease Progression|1|||
163325499|NCT00146172|589903855|FG007|Overall Study|Disease Progression|22|||
163325500|NCT00146172|589903848|FG000|Overall Study|Death|0|||
163325501|NCT00146172|589903849|FG001|Overall Study|Death|0|||
163003036|NCT03718832|588711443|FG001|Analysis Sample|Participant from treated household|1|||
163003037|NCT03718832|588711442|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
163060793|NCT02332707|588931286|FG001|Overall Study|Physician Decision|0|||
163060794|NCT02332707|588931287|FG002|Overall Study|Physician Decision|0|||
163060795|NCT02332707|588931288|FG003|Overall Study|Physician Decision|1|||
163060796|NCT02332707|588931289|FG004|Overall Study|Physician Decision|0|||
163060797|NCT02332707|588931290|FG005|Overall Study|Physician Decision|0|||
163060798|NCT02332707|588931291|FG006|Overall Study|Physician Decision|0|||
163060799|NCT02332707|588931292|FG007|Overall Study|Physician Decision|0|||
163060800|NCT02332707|588931293|FG008|Overall Study|Physician Decision|0|||
163060801|NCT02332707|588931294|FG009|Overall Study|Physician Decision|0|||
163325502|NCT00146172|589903850|FG002|Overall Study|Death|0|||
163325503|NCT00146172|589903851|FG003|Overall Study|Death|0|||
163325504|NCT00146172|589903852|FG004|Overall Study|Death|0|||
163325505|NCT00146172|589903853|FG005|Overall Study|Death|0|||
163325506|NCT00146172|589903854|FG006|Overall Study|Death|1|||
163003038|NCT03718832|588711443|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
163003039|NCT01996241|588711445|FG000|Overall Study|Lost to Follow-up|252|||
163003040|NCT01996241|588711446|FG001|Overall Study|Lost to Follow-up|235|||
163003041|NCT04882241|588711451|FG000|Overall Study|Ongoing in study|46|||
163003042|NCT04882241|588711452|FG001|Overall Study|Ongoing in study|48|||
163003043|NCT04882241|588711453|FG002|Overall Study|Ongoing in study|0|||
163003044|NCT04882241|588711454|FG003|Overall Study|Ongoing in study|0|||
163003045|NCT04882241|588711451|FG000|Overall Study|Death|13|||
163003046|NCT04882241|588711452|FG001|Overall Study|Death|13|||
163003047|NCT04882241|588711453|FG002|Overall Study|Death|0|||
163003048|NCT04882241|588711454|FG003|Overall Study|Death|0|||
163003049|NCT03639779|588711457|FG000|Overall Study|Lost to Follow-up|1|||
163003050|NCT02932462|588711458|FG000|Overall Study|Adverse Event|1|||
163003051|NCT02932462|588711459|FG001|Overall Study|Adverse Event|2|||
163060802|NCT02332707|588931295|FG010|Overall Study|Physician Decision|0|||
163060803|NCT02332707|588931296|FG011|Overall Study|Physician Decision|0|||
163060804|NCT02332707|588931297|FG012|Overall Study|Physician Decision|1|||
163325507|NCT00146172|589903855|FG007|Overall Study|Death|0|||
163325508|NCT00146172|589903848|FG000|Overall Study|Physician Decision|0|||
163325509|NCT00146172|589903849|FG001|Overall Study|Physician Decision|0|||
163003052|NCT02932462|588711458|FG000|Overall Study|Lost to Follow-up|4|||
163003053|NCT02932462|588711459|FG001|Overall Study|Lost to Follow-up|1|||
163060805|NCT02332707|588931298|FG013|Overall Study|Physician Decision|0|||
163325510|NCT00146172|589903850|FG002|Overall Study|Physician Decision|0|||
163325511|NCT00146172|589903851|FG003|Overall Study|Physician Decision|0|||
163325512|NCT00146172|589903852|FG004|Overall Study|Physician Decision|0|||
163325513|NCT00146172|589903853|FG005|Overall Study|Physician Decision|0|||
163325514|NCT00146172|589903854|FG006|Overall Study|Physician Decision|0|||
163325515|NCT00146172|589903855|FG007|Overall Study|Physician Decision|1|||
163325516|NCT00146172|589903848|FG000|Overall Study|Withdrawal by Subject|0|||
163003054|NCT02932462|588711458|FG000|Overall Study|Protocol Violation|0|||
163003055|NCT02932462|588711459|FG001|Overall Study|Protocol Violation|5|||
163003056|NCT02932462|588711458|FG000|Overall Study|Withdrawal by Subject|1|||
163003057|NCT02932462|588711459|FG001|Overall Study|Withdrawal by Subject|4|||
163003058|NCT02932462|588711458|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163003059|NCT02932462|588711459|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163003060|NCT02932462|588711458|FG000|Overall Study|Progressive Disease|1|||
163003061|NCT02932462|588711459|FG001|Overall Study|Progressive Disease|0|||
163003062|NCT02413229|588711460|FG000|Overall Study|Adverse Event|0|||
163003063|NCT02413229|588711461|FG001|Overall Study|Adverse Event|0|||
163003064|NCT02413229|588711462|FG002|Overall Study|Adverse Event|0|||
163003065|NCT02413229|588711463|FG003|Overall Study|Adverse Event|1|||
163003066|NCT02413229|588711464|FG004|Overall Study|Adverse Event|0|||
163003067|NCT02413229|588711465|FG005|Overall Study|Adverse Event|0|||
163325517|NCT00146172|589903849|FG001|Overall Study|Withdrawal by Subject|0|||
163325518|NCT00146172|589903850|FG002|Overall Study|Withdrawal by Subject|0|||
163325519|NCT00146172|589903851|FG003|Overall Study|Withdrawal by Subject|0|||
163325520|NCT00146172|589903852|FG004|Overall Study|Withdrawal by Subject|0|||
163325521|NCT00146172|589903853|FG005|Overall Study|Withdrawal by Subject|1|||
163325522|NCT00146172|589903854|FG006|Overall Study|Withdrawal by Subject|1|||
163325523|NCT00146172|589903855|FG007|Overall Study|Withdrawal by Subject|4|||
163325524|NCT00146172|589903848|FG000|Overall Study|Symptomatic Deterioration|1|||
163325525|NCT00146172|589903849|FG001|Overall Study|Symptomatic Deterioration|0|||
163325526|NCT00146172|589903850|FG002|Overall Study|Symptomatic Deterioration|1|||
163325527|NCT00146172|589903851|FG003|Overall Study|Symptomatic Deterioration|0|||
163325528|NCT00146172|589903852|FG004|Overall Study|Symptomatic Deterioration|1|||
163325529|NCT00146172|589903853|FG005|Overall Study|Symptomatic Deterioration|2|||
163325530|NCT00146172|589903854|FG006|Overall Study|Symptomatic Deterioration|0|||
163325531|NCT00146172|589903855|FG007|Overall Study|Symptomatic Deterioration|2|||
163325532|NCT00210106|589903856|FG000|Overall Study|Death|1|||
163325533|NCT00210106|589903856|FG000|Overall Study|Protocol Violation|13|||
163325534|NCT00786864|589903857|FG000|Overall Study|Lost to Follow-up|0|||
163325535|NCT00786864|589903858|FG001|Overall Study|Lost to Follow-up|1|||
163325536|NCT00786864|589903857|FG000|Overall Study|Sustained serious back injury|1|||
163325537|NCT00786864|589903858|FG001|Overall Study|Sustained serious back injury|0|||
163325538|NCT02422615|589903859|FG000|Treatment Period|Progressive disease|314|||
163325539|NCT02422615|589903860|FG001|Treatment Period|Progressive disease|200|||
163325540|NCT02422615|589903859|FG000|Treatment Period|Adverse Event|51|||
163325541|NCT02422615|589903860|FG001|Treatment Period|Adverse Event|9|||
163325542|NCT02422615|589903859|FG000|Treatment Period|Physician Decision|32|||
163325543|NCT02422615|589903860|FG001|Treatment Period|Physician Decision|8|||
163325544|NCT02422615|589903859|FG000|Treatment Period|Subject/guardian decision|38|||
163325545|NCT02422615|589903860|FG001|Treatment Period|Subject/guardian decision|8|||
163325546|NCT02422615|589903859|FG000|Treatment Period|Death|2|||
163325547|NCT02422615|589903860|FG001|Treatment Period|Death|1|||
163325548|NCT02422615|589903859|FG000|Treatment Period|Technical problems|0|||
163003068|NCT02413229|588711466|FG006|Overall Study|Adverse Event|0|||
163003069|NCT02413229|588711467|FG007|Overall Study|Adverse Event|1|||
163003070|NCT02413229|588711460|FG000|Overall Study|Lost to Follow-up|0|||
163003071|NCT02413229|588711461|FG001|Overall Study|Lost to Follow-up|0|||
163003072|NCT02413229|588711462|FG002|Overall Study|Lost to Follow-up|1|||
163003073|NCT02413229|588711463|FG003|Overall Study|Lost to Follow-up|0|||
163003074|NCT02413229|588711464|FG004|Overall Study|Lost to Follow-up|2|||
163003075|NCT02413229|588711465|FG005|Overall Study|Lost to Follow-up|0|||
163003076|NCT02413229|588711466|FG006|Overall Study|Lost to Follow-up|0|||
163003077|NCT02413229|588711467|FG007|Overall Study|Lost to Follow-up|0|||
163003078|NCT02413229|588711460|FG000|Overall Study|Withdrawal by Subject|1|||
163003079|NCT02413229|588711461|FG001|Overall Study|Withdrawal by Subject|1|||
163003080|NCT02413229|588711462|FG002|Overall Study|Withdrawal by Subject|0|||
163003081|NCT02413229|588711463|FG003|Overall Study|Withdrawal by Subject|0|||
163003082|NCT02413229|588711464|FG004|Overall Study|Withdrawal by Subject|1|||
163003083|NCT02413229|588711465|FG005|Overall Study|Withdrawal by Subject|0|||
163003084|NCT02413229|588711466|FG006|Overall Study|Withdrawal by Subject|0|||
163003085|NCT02413229|588711467|FG007|Overall Study|Withdrawal by Subject|2|||
163003086|NCT02413229|588711460|FG000|Overall Study|Progressive Disease|0|||
163003087|NCT02413229|588711461|FG001|Overall Study|Progressive Disease|0|||
163003088|NCT02413229|588711462|FG002|Overall Study|Progressive Disease|0|||
163003089|NCT02413229|588711463|FG003|Overall Study|Progressive Disease|0|||
163003090|NCT02413229|588711464|FG004|Overall Study|Progressive Disease|0|||
163003091|NCT02413229|588711465|FG005|Overall Study|Progressive Disease|0|||
163003092|NCT02413229|588711466|FG006|Overall Study|Progressive Disease|0|||
163003093|NCT02413229|588711467|FG007|Overall Study|Progressive Disease|1|||
163003094|NCT02009722|588711477|FG000|Overall Study|Protocol Violation|1|||
163003095|NCT02009722|588711478|FG001|Overall Study|Protocol Violation|2|||
163003096|NCT02009722|588711477|FG000|Overall Study|Did not receive intervention|0|||
163003097|NCT02009722|588711478|FG001|Overall Study|Did not receive intervention|1|||
163325549|NCT02422615|589903860|FG001|Treatment Period|Technical problems|1|||
163325550|NCT02422615|589903859|FG000|Treatment Period|Protocol deviation|1|||
163003098|NCT02955212|588711479|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
163003099|NCT02955212|588711480|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
163003100|NCT02955212|588711479|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
163003101|NCT02955212|588711480|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
163003102|NCT02955212|588711479|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
163003103|NCT02955212|588711480|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
163003104|NCT02955212|588711479|FG000|Period 1: Double-blind Treatment Period|Other|3|||
163003105|NCT02955212|588711480|FG001|Period 1: Double-blind Treatment Period|Other|2|||
163060806|NCT02332707|588931299|FG014|Overall Study|Physician Decision|0|||
163060807|NCT02332707|588931300|FG015|Overall Study|Physician Decision|0|||
163060808|NCT02332707|588931301|FG016|Overall Study|Physician Decision|0|||
163060809|NCT02332707|588931302|FG017|Overall Study|Physician Decision|0|||
163060810|NCT02332707|588931285|FG000|Overall Study|Withdrawal by Subject|0|||
163060811|NCT02332707|588931286|FG001|Overall Study|Withdrawal by Subject|0|||
163060812|NCT02332707|588931287|FG002|Overall Study|Withdrawal by Subject|1|||
163325551|NCT02422615|589903860|FG001|Treatment Period|Protocol deviation|1|||
163325552|NCT02422615|589903859|FG000|Treatment Period|Study terminated as per protocol|46|||
163325553|NCT02422615|589903860|FG001|Treatment Period|Study terminated as per protocol|14|||
163325554|NCT02422615|589903859|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
163325555|NCT02422615|589903860|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
163325556|NCT02422615|589903859|FG000|Post-treatment Efficacy Follow-up|Death|2|||
163325557|NCT02422615|589903860|FG001|Post-treatment Efficacy Follow-up|Death|1|||
163325558|NCT02422615|589903859|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
163325559|NCT02422615|589903860|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
163325560|NCT02422615|589903859|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
163325561|NCT02422615|589903860|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
163325562|NCT02422615|589903859|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
163325563|NCT02422615|589903860|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
163325564|NCT02422615|589903859|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
163325565|NCT02422615|589903860|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
163325566|NCT01288443|589903861|FG000|Overall Study|Adverse Event|0|||
163325567|NCT01288443|589903862|FG001|Overall Study|Adverse Event|0|||
163325568|NCT01288443|589903863|FG002|Overall Study|Adverse Event|1|||
163325569|NCT01288443|589903864|FG003|Overall Study|Adverse Event|1|||
163325570|NCT01288443|589903865|FG004|Overall Study|Adverse Event|3|||
163325571|NCT01288443|589903866|FG005|Overall Study|Adverse Event|1|||
163325572|NCT01288443|589903861|FG000|Overall Study|Poor compliance to protocol|0|||
163325573|NCT01288443|589903862|FG001|Overall Study|Poor compliance to protocol|0|||
163325574|NCT01288443|589903863|FG002|Overall Study|Poor compliance to protocol|0|||
163325575|NCT01288443|589903864|FG003|Overall Study|Poor compliance to protocol|0|||
163325576|NCT01288443|589903865|FG004|Overall Study|Poor compliance to protocol|0|||
163325577|NCT01288443|589903866|FG005|Overall Study|Poor compliance to protocol|1|||
163325578|NCT01288443|589903861|FG000|Overall Study|Participant Moved|0|||
163325579|NCT01288443|589903862|FG001|Overall Study|Participant Moved|0|||
163003106|NCT02955212|588711479|FG000|Period 2: Open-label Extension|Adverse Event|11|||
163003107|NCT02955212|588711480|FG001|Period 2: Open-label Extension|Adverse Event|7|||
163003108|NCT02955212|588711479|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
163003109|NCT02955212|588711480|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
163003110|NCT02955212|588711479|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
163003111|NCT02955212|588711480|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
163003112|NCT02955212|588711479|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
163003113|NCT02955212|588711480|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
163003114|NCT02955212|588711479|FG000|Period 2: Open-label Extension|Other|2|||
163003115|NCT02955212|588711480|FG001|Period 2: Open-label Extension|Other|4|||
163060813|NCT02332707|588931288|FG003|Overall Study|Withdrawal by Subject|0|||
163060814|NCT02332707|588931289|FG004|Overall Study|Withdrawal by Subject|0|||
163060815|NCT02332707|588931290|FG005|Overall Study|Withdrawal by Subject|0|||
163060816|NCT02332707|588931291|FG006|Overall Study|Withdrawal by Subject|0|||
163060817|NCT02332707|588931292|FG007|Overall Study|Withdrawal by Subject|0|||
163060818|NCT02332707|588931293|FG008|Overall Study|Withdrawal by Subject|0|||
163060819|NCT02332707|588931294|FG009|Overall Study|Withdrawal by Subject|3|||
163060820|NCT02332707|588931295|FG010|Overall Study|Withdrawal by Subject|0|||
163060821|NCT02332707|588931296|FG011|Overall Study|Withdrawal by Subject|0|||
163060822|NCT02332707|588931297|FG012|Overall Study|Withdrawal by Subject|0|||
163060823|NCT02332707|588931298|FG013|Overall Study|Withdrawal by Subject|0|||
163325580|NCT01288443|589903863|FG002|Overall Study|Participant Moved|0|||
163060824|NCT02332707|588931299|FG014|Overall Study|Withdrawal by Subject|0|||
163060825|NCT02332707|588931300|FG015|Overall Study|Withdrawal by Subject|0|||
163325581|NCT01288443|589903864|FG003|Overall Study|Participant Moved|1|||
163325582|NCT01288443|589903865|FG004|Overall Study|Participant Moved|2|||
163325583|NCT01288443|589903866|FG005|Overall Study|Participant Moved|1|||
163003116|NCT02454933|588711485|FG000|Overall Study|Progressive disease|10|||
163003117|NCT02454933|588711486|FG001|Overall Study|Progressive disease|7|||
163003118|NCT02454933|588711485|FG000|Overall Study|Adverse Event|1|||
163003119|NCT02454933|588711486|FG001|Overall Study|Adverse Event|1|||
163003120|NCT02454933|588711485|FG000|Overall Study|Withdrawal by Subject|0|||
163003121|NCT02454933|588711486|FG001|Overall Study|Withdrawal by Subject|3|||
163003122|NCT02454933|588711485|FG000|Overall Study|Lost to Follow-up|1|||
163003123|NCT02454933|588711486|FG001|Overall Study|Lost to Follow-up|0|||
163003124|NCT02071225|588711494|FG000|Overall Study|Withdrawal of Consent|2|||
163003125|NCT02071225|588711494|FG000|Overall Study|Protocol Deviation|1|||
163003126|NCT02071225|588711494|FG000|Overall Study|Lost to Follow-up|2|||
163003127|NCT02071225|588711494|FG000|Overall Study|Death|25|||
163003128|NCT01342081|588711497|FG000|Overall Study|Did not receive allocated intervention|0|||
163003129|NCT01342081|588711498|FG001|Overall Study|Did not receive allocated intervention|0|||
163003130|NCT01342081|588711499|FG002|Overall Study|Did not receive allocated intervention|1|||
163003131|NCT01342081|588711497|FG000|Overall Study|Adverse Event|1|||
163003132|NCT01342081|588711498|FG001|Overall Study|Adverse Event|0|||
163003133|NCT01342081|588711499|FG002|Overall Study|Adverse Event|0|||
163003134|NCT01342081|588711497|FG000|Overall Study|Physician Decision|0|||
163003135|NCT01342081|588711498|FG001|Overall Study|Physician Decision|1|||
163003136|NCT01342081|588711499|FG002|Overall Study|Physician Decision|0|||
163003137|NCT01342081|588711497|FG000|Overall Study|Withdrawal by Subject|1|||
163003138|NCT01342081|588711498|FG001|Overall Study|Withdrawal by Subject|1|||
163003139|NCT01342081|588711499|FG002|Overall Study|Withdrawal by Subject|0|||
163003140|NCT04720053|588711504|FG000|Overall Study|Lost to Follow-up|12|||
163003141|NCT03519087|588711505|FG000|Clinic Evaluation|Physician Decision|15|||
163003142|NCT03519087|588711506|FG001|Clinic Evaluation|Physician Decision|18|||
163003143|NCT03519087|588711507|FG002|Clinic Evaluation|Physician Decision|0|||
163003144|NCT03519087|588711508|FG003|Clinic Evaluation|Physician Decision|0|||
163003145|NCT03519087|588711509|FG004|Clinic Evaluation|Physician Decision|0|||
163003146|NCT03519087|588711505|FG000|Clinic Evaluation|Protocol Violation|1|||
163003147|NCT03519087|588711506|FG001|Clinic Evaluation|Protocol Violation|0|||
163003148|NCT03519087|588711507|FG002|Clinic Evaluation|Protocol Violation|0|||
163003149|NCT03519087|588711508|FG003|Clinic Evaluation|Protocol Violation|0|||
163003150|NCT03519087|588711509|FG004|Clinic Evaluation|Protocol Violation|0|||
163003151|NCT03519087|588711505|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
163003152|NCT03519087|588711506|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
163003153|NCT03519087|588711507|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
163003154|NCT03519087|588711508|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
163003155|NCT03519087|588711509|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
163003156|NCT03519087|588711505|FG000|Re-randomization for Treatment|Not appropriate|2|||
163003157|NCT03519087|588711506|FG001|Re-randomization for Treatment|Not appropriate|3|||
163003158|NCT03519087|588711507|FG002|Re-randomization for Treatment|Not appropriate|0|||
163003159|NCT03519087|588711508|FG003|Re-randomization for Treatment|Not appropriate|0|||
163003160|NCT03519087|588711509|FG004|Re-randomization for Treatment|Not appropriate|0|||
163003161|NCT03519087|588711505|FG000|Laboratory Testing|Lost to Follow-up|0|||
163003162|NCT03519087|588711506|FG001|Laboratory Testing|Lost to Follow-up|0|||
163003163|NCT03519087|588711507|FG002|Laboratory Testing|Lost to Follow-up|2|||
163003164|NCT03519087|588711508|FG003|Laboratory Testing|Lost to Follow-up|3|||
163003165|NCT03519087|588711509|FG004|Laboratory Testing|Lost to Follow-up|6|||
163003166|NCT03519087|588711505|FG000|Laboratory Testing|Protocol Violation|0|||
163003167|NCT03519087|588711506|FG001|Laboratory Testing|Protocol Violation|0|||
163003168|NCT03519087|588711507|FG002|Laboratory Testing|Protocol Violation|0|||
163003169|NCT03519087|588711508|FG003|Laboratory Testing|Protocol Violation|1|||
163003170|NCT03519087|588711509|FG004|Laboratory Testing|Protocol Violation|0|||
163003171|NCT01137071|588711510|FG000|Overall Study|Disease Progression|11|||
163003172|NCT01137071|588711510|FG000|Overall Study|Withdrawal by Subject|2|||
163003173|NCT01137071|588711510|FG000|Overall Study|Wrongly Included|1|||
163060826|NCT02332707|588931301|FG016|Overall Study|Withdrawal by Subject|0|||
163060827|NCT02332707|588931302|FG017|Overall Study|Withdrawal by Subject|0|||
163003174|NCT04807400|588711513|FG000|Overall Study|Adverse Event|2|||
163003175|NCT04807400|588711514|FG001|Overall Study|Adverse Event|3|||
163003176|NCT04807400|588711515|FG002|Overall Study|Adverse Event|3|||
163003177|NCT04807400|588711513|FG000|Overall Study|Death|2|||
163003178|NCT04807400|588711514|FG001|Overall Study|Death|0|||
163003179|NCT04807400|588711515|FG002|Overall Study|Death|0|||
163003180|NCT04807400|588711513|FG000|Overall Study|Lost to Follow-up|8|||
163003181|NCT04807400|588711514|FG001|Overall Study|Lost to Follow-up|6|||
163003182|NCT04807400|588711515|FG002|Overall Study|Lost to Follow-up|6|||
163003183|NCT04807400|588711513|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163060828|NCT01473134|588931303|FG000|Overall Study|Lost to Follow-up|21|||
163003184|NCT04807400|588711514|FG001|Overall Study|Non-Compliance With Study Drug|4|||
163003185|NCT04807400|588711515|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163003186|NCT04807400|588711513|FG000|Overall Study|Participant Decision|20|||
163003187|NCT04807400|588711514|FG001|Overall Study|Participant Decision|19|||
163003188|NCT04807400|588711515|FG002|Overall Study|Participant Decision|26|||
163060829|NCT01473134|588931304|FG001|Overall Study|Lost to Follow-up|13|||
163060830|NCT01473134|588931303|FG000|Overall Study|Protocol Violation|32|||
163060831|NCT01473134|588931304|FG001|Overall Study|Protocol Violation|19|||
163060832|NCT01473134|588931303|FG000|Overall Study|Withdrawal by Subject|1|||
163060833|NCT01473134|588931304|FG001|Overall Study|Withdrawal by Subject|2|||
163060834|NCT01473134|588931303|FG000|Overall Study|Death|0|||
163060835|NCT01473134|588931304|FG001|Overall Study|Death|1|||
163060836|NCT01473134|588931303|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
163060837|NCT01473134|588931304|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
163060838|NCT04761822|588931307|FG000|Overall Study|Adverse Event|3|||
163060839|NCT04761822|588931308|FG001|Overall Study|Adverse Event|1|||
163060840|NCT04761822|588931309|FG002|Overall Study|Adverse Event|1|||
163213343|NCT02522286|589495945|FG002|Overall Study|Withdrawal by Subject|0|||
163213344|NCT02522286|589495946|FG003|Overall Study|Withdrawal by Subject|3|||
163060841|NCT04761822|588931310|FG003|Overall Study|Adverse Event|3|||
163060842|NCT04761822|588931307|FG000|Overall Study|Lost to Follow-up|1|||
163060843|NCT04761822|588931308|FG001|Overall Study|Lost to Follow-up|0|||
163060844|NCT04761822|588931309|FG002|Overall Study|Lost to Follow-up|2|||
163060845|NCT04761822|588931310|FG003|Overall Study|Lost to Follow-up|3|||
163060846|NCT04761822|588931307|FG000|Overall Study|Physician Decision|0|||
163060847|NCT04761822|588931308|FG001|Overall Study|Physician Decision|1|||
163060848|NCT04761822|588931309|FG002|Overall Study|Physician Decision|0|||
163060849|NCT04761822|588931310|FG003|Overall Study|Physician Decision|0|||
163060850|NCT04761822|588931307|FG000|Overall Study|Withdrawal by Subject|3|||
163060851|NCT04761822|588931308|FG001|Overall Study|Withdrawal by Subject|8|||
163060852|NCT04761822|588931309|FG002|Overall Study|Withdrawal by Subject|1|||
163325584|NCT01288443|589903861|FG000|Overall Study|Consent withdrawn by Participant|0|||
163325585|NCT01288443|589903862|FG001|Overall Study|Consent withdrawn by Participant|0|||
163325586|NCT01288443|589903863|FG002|Overall Study|Consent withdrawn by Participant|0|||
163325587|NCT01288443|589903864|FG003|Overall Study|Consent withdrawn by Participant|0|||
163325588|NCT01288443|589903865|FG004|Overall Study|Consent withdrawn by Participant|0|||
163325589|NCT01288443|589903866|FG005|Overall Study|Consent withdrawn by Participant|1|||
163325590|NCT01288443|589903861|FG000|Overall Study|Lost to Follow-up|0|||
163325591|NCT01288443|589903862|FG001|Overall Study|Lost to Follow-up|1|||
163325592|NCT01288443|589903863|FG002|Overall Study|Lost to Follow-up|0|||
163325593|NCT01288443|589903864|FG003|Overall Study|Lost to Follow-up|0|||
163325594|NCT01288443|589903865|FG004|Overall Study|Lost to Follow-up|0|||
163325595|NCT01288443|589903866|FG005|Overall Study|Lost to Follow-up|0|||
163325596|NCT01288443|589903861|FG000|Overall Study|Study drug auto-injector administration|0|||
163325597|NCT01288443|589903862|FG001|Overall Study|Study drug auto-injector administration|0|||
163325598|NCT01288443|589903863|FG002|Overall Study|Study drug auto-injector administration|0|||
163325599|NCT01288443|589903864|FG003|Overall Study|Study drug auto-injector administration|0|||
163325600|NCT01288443|589903865|FG004|Overall Study|Study drug auto-injector administration|1|||
163325601|NCT01288443|589903866|FG005|Overall Study|Study drug auto-injector administration|1|||
163325602|NCT01288443|589903861|FG000|Overall Study|Other than above|0|||
163325603|NCT01288443|589903862|FG001|Overall Study|Other than above|0|||
163325604|NCT01288443|589903863|FG002|Overall Study|Other than above|0|||
163325605|NCT01288443|589903864|FG003|Overall Study|Other than above|2|||
163325606|NCT01288443|589903865|FG004|Overall Study|Other than above|1|||
163325607|NCT01288443|589903866|FG005|Overall Study|Other than above|0|||
163325608|NCT01596972|589903867|FG000|Overall Study|Physician Decision|1|||
163325609|NCT01596972|589903868|FG001|Overall Study|Physician Decision|9|||
163325610|NCT01596972|589903867|FG000|Overall Study|Lost to Follow-up|0|||
163325611|NCT01596972|589903868|FG001|Overall Study|Lost to Follow-up|4|||
163060853|NCT04761822|588931310|FG003|Overall Study|Withdrawal by Subject|11|||
163213345|NCT00605813|589495948|FG000|Overall Study|Protocol Violation|25|||
163213346|NCT01163279|589495949|FG000|Overall Study|Withdrawal by Subject|2|||
163213347|NCT01163279|589495950|FG001|Overall Study|Withdrawal by Subject|0|||
163213348|NCT03525574|589495955|FG000|Overall Study|Adverse Event|15|||
163213349|NCT03525574|589495956|FG001|Overall Study|Adverse Event|0|||
163213350|NCT03525574|589495955|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
163325612|NCT01596972|589903867|FG000|Overall Study|Withdrawal by Subject|0|||
163325613|NCT01596972|589903868|FG001|Overall Study|Withdrawal by Subject|1|||
163325614|NCT01639131|589903870|FG000|Overall Study|Disease Progression|6|||
163060854|NCT04761822|588931307|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
163060855|NCT04761822|588931308|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
163060856|NCT04761822|588931309|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
163213351|NCT03525574|589495956|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
163213352|NCT03525574|589495955|FG000|Overall Study|Lost to Follow-up|4|||
163213353|NCT03525574|589495956|FG001|Overall Study|Lost to Follow-up|0|||
163060857|NCT04761822|588931310|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
163060858|NCT04761822|588931307|FG000|Overall Study|Participant requested unblinding|0|||
163060859|NCT04761822|588931308|FG001|Overall Study|Participant requested unblinding|0|||
163213354|NCT03525574|589495955|FG000|Overall Study|Commercial drug is Available for participant|48|||
163325615|NCT02438137|589903874|FG000|Overall Study|Lost to Follow-up|3|||
163003189|NCT04807400|588711513|FG000|Overall Study|Physician Decision|0|||
163003190|NCT04807400|588711514|FG001|Overall Study|Physician Decision|1|||
163003191|NCT04807400|588711515|FG002|Overall Study|Physician Decision|0|||
163003192|NCT04807400|588711513|FG000|Overall Study|Protocol Violation|4|||
163003193|NCT04807400|588711514|FG001|Overall Study|Protocol Violation|3|||
163003194|NCT04807400|588711515|FG002|Overall Study|Protocol Violation|7|||
163003195|NCT04807400|588711513|FG000|Overall Study|Withdrawal by Subject|13|||
163003196|NCT04807400|588711514|FG001|Overall Study|Withdrawal by Subject|9|||
163060860|NCT04761822|588931309|FG002|Overall Study|Participant requested unblinding|0|||
163060861|NCT04761822|588931310|FG003|Overall Study|Participant requested unblinding|1|||
163060862|NCT06217380|588931313|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
163060863|NCT06217380|588931313|FG000|Overall Study|Physician Decision|1|||
163060864|NCT06217380|588931313|FG000|Overall Study|Withdrawal by Subject|2|||
163060865|NCT03286504|588931322|FG000|Overall Study|Lost to Follow-up|19|||
163060866|NCT03286504|588931323|FG001|Overall Study|Lost to Follow-up|16|||
163060867|NCT00141921|588931326|FG000|Overall Study|Remain on Study|28|||
163060868|NCT00141921|588931326|FG000|Overall Study|Withdrawal by Subject|42|||
163060869|NCT00141921|588931326|FG000|Overall Study|Lost to Follow-up|19|||
163060870|NCT00141921|588931326|FG000|Overall Study|Noncompliance|17|||
163060871|NCT00141921|588931326|FG000|Overall Study|Disease Progression|7|||
163060872|NCT00141921|588931326|FG000|Overall Study|Protocol Deviation|7|||
163060873|NCT00141921|588931326|FG000|Overall Study|Adverse Event|5|||
163060874|NCT00141921|588931326|FG000|Overall Study|Administrative Decision|2|||
163060875|NCT00141921|588931326|FG000|Overall Study|Pregnancy|4|||
163060876|NCT00141921|588931326|FG000|Overall Study|Ineligibility Determined|2|||
163060877|NCT00141921|588931326|FG000|Overall Study|Other|8|||
163060878|NCT03320369|588931327|FG000|Overall Study|Adverse Event|1|||
163060879|NCT03320369|588931327|FG000|Overall Study|Withdrawal by Subject|2|||
163060880|NCT03813654|588931328|FG000|Overall Study|Protocol Violation|0|||
163060881|NCT03813654|588931329|FG001|Overall Study|Protocol Violation|1|||
163060882|NCT03813654|588931330|FG002|Overall Study|Protocol Violation|2|||
163060883|NCT03813654|588931328|FG000|Overall Study|Withdrawal by Subject|1|||
163060884|NCT03813654|588931329|FG001|Overall Study|Withdrawal by Subject|0|||
163060885|NCT03813654|588931330|FG002|Overall Study|Withdrawal by Subject|0|||
163060886|NCT00297167|588931343|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
163060887|NCT00297167|588931344|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
163060888|NCT00297167|588931345|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
163060889|NCT00297167|588931343|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
163060890|NCT00297167|588931344|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
163060891|NCT00297167|588931345|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
163060892|NCT00171249|588931348|FG000|Overall Study|Withdrawal by Subject|2|||
163060893|NCT00171249|588931349|FG001|Overall Study|Withdrawal by Subject|0|||
163060894|NCT00171249|588931350|FG002|Overall Study|Withdrawal by Subject|0|||
163060895|NCT00171249|588931351|FG003|Overall Study|Withdrawal by Subject|6|||
163060896|NCT00171249|588931352|FG004|Overall Study|Withdrawal by Subject|0|||
163060897|NCT00171249|588931353|FG005|Overall Study|Withdrawal by Subject|0|||
163060898|NCT00171249|588931354|FG006|Overall Study|Withdrawal by Subject|0|||
163060899|NCT00171249|588931348|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
163060900|NCT00171249|588931349|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
163060901|NCT00171249|588931350|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
163060902|NCT00171249|588931351|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
163060903|NCT00171249|588931352|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
163060904|NCT00171249|588931353|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
163060905|NCT00171249|588931354|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
163060906|NCT00171249|588931348|FG000|Overall Study|Death|7|||
163060907|NCT00171249|588931349|FG001|Overall Study|Death|1|||
163060908|NCT00171249|588931350|FG002|Overall Study|Death|0|||
163060909|NCT00171249|588931351|FG003|Overall Study|Death|4|||
163060910|NCT00171249|588931352|FG004|Overall Study|Death|0|||
163213355|NCT03525574|589495956|FG001|Overall Study|Commercial drug is Available for participant|0|||
163003197|NCT04807400|588711515|FG002|Overall Study|Withdrawal by Subject|20|||
163060911|NCT00171249|588931353|FG005|Overall Study|Death|3|||
163060912|NCT00171249|588931354|FG006|Overall Study|Death|1|||
163060913|NCT00171249|588931348|FG000|Overall Study|Other|10|||
163060914|NCT00171249|588931349|FG001|Overall Study|Other|0|||
163060915|NCT00171249|588931350|FG002|Overall Study|Other|0|||
163060916|NCT00171249|588931351|FG003|Overall Study|Other|43|||
163060917|NCT00171249|588931352|FG004|Overall Study|Other|0|||
163060918|NCT00171249|588931353|FG005|Overall Study|Other|2|||
163060919|NCT00171249|588931354|FG006|Overall Study|Other|0|||
163060920|NCT00171249|588931348|FG000|Overall Study|No Longer Requires Study Drug|4|||
163060921|NCT00171249|588931349|FG001|Overall Study|No Longer Requires Study Drug|0|||
163213356|NCT03525574|589495955|FG000|Overall Study|Death|1|||
163213357|NCT03525574|589495956|FG001|Overall Study|Death|0|||
163213358|NCT03525574|589495955|FG000|Overall Study|Other non-compliance|2|||
163213359|NCT03525574|589495956|FG001|Overall Study|Other non-compliance|0|||
163003198|NCT04807400|588711513|FG000|Overall Study|Mis-randomized|1|||
163003199|NCT04807400|588711514|FG001|Overall Study|Mis-randomized|0|||
163003200|NCT04807400|588711515|FG002|Overall Study|Mis-randomized|0|||
163003201|NCT04194645|588711516|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003202|NCT04194645|588711517|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003203|NCT04194645|588711518|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003204|NCT04194645|588711519|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003205|NCT04194645|588711520|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003206|NCT04194645|588711521|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003207|NCT04194645|588711522|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003208|NCT04194645|588711523|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003209|NCT04194645|588711524|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003210|NCT04194645|588711525|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
163003211|NCT04194645|588711526|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003212|NCT04194645|588711527|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003213|NCT04194645|588711528|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003214|NCT04194645|588711529|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003215|NCT04194645|588711530|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003216|NCT03656744|588711531|FG000|Overall Study|Adverse Event|1|||
163325616|NCT02438137|589903875|FG001|Overall Study|Lost to Follow-up|2|||
163325617|NCT02438137|589903874|FG000|Overall Study|Adverse Event|1|||
163325618|NCT02438137|589903875|FG001|Overall Study|Adverse Event|0|||
163325619|NCT02438137|589903874|FG000|Overall Study|Withdrawal by Subject|4|||
163325620|NCT02438137|589903875|FG001|Overall Study|Withdrawal by Subject|3|||
163325621|NCT02438137|589903874|FG000|Overall Study|Physician Decision|0|||
163325622|NCT02438137|589903875|FG001|Overall Study|Physician Decision|1|||
163325623|NCT00945321|589903876|FG000|Period 1|Adverse Event|0|||
163325624|NCT00945321|589903877|FG001|Period 1|Adverse Event|0|||
163325625|NCT00945321|589903878|FG002|Period 1|Adverse Event|0|||
163325626|NCT00945321|589903879|FG003|Period 1|Adverse Event|0|||
163325627|NCT00945321|589903880|FG004|Period 1|Adverse Event|1|||
163325628|NCT00945321|589903881|FG005|Period 1|Adverse Event|0|||
163325629|NCT00945321|589903876|FG000|Period 4|Lost to Follow-up|0|||
163325630|NCT00945321|589903877|FG001|Period 4|Lost to Follow-up|0|||
163325631|NCT00945321|589903878|FG002|Period 4|Lost to Follow-up|0|||
163325632|NCT00945321|589903879|FG003|Period 4|Lost to Follow-up|0|||
163325633|NCT00945321|589903880|FG004|Period 4|Lost to Follow-up|0|||
163325634|NCT00945321|589903881|FG005|Period 4|Lost to Follow-up|1|||
163325635|NCT03248492|589903889|FG000|Overall Study|Progressive Disease|24|||
163325636|NCT03248492|589903890|FG001|Overall Study|Progressive Disease|23|||
163325637|NCT03248492|589903891|FG002|Overall Study|Progressive Disease|11|||
163325638|NCT03248492|589903892|FG003|Overall Study|Progressive Disease|66|||
163325639|NCT03248492|589903893|FG004|Overall Study|Progressive Disease|1|||
163325640|NCT03248492|589903889|FG000|Overall Study|Adverse Event|14|||
163325641|NCT03248492|589903890|FG001|Overall Study|Adverse Event|13|||
163325642|NCT03248492|589903891|FG002|Overall Study|Adverse Event|9|||
163325643|NCT03248492|589903892|FG003|Overall Study|Adverse Event|22|||
163325644|NCT03248492|589903893|FG004|Overall Study|Adverse Event|2|||
163325645|NCT03248492|589903889|FG000|Overall Study|Withdrawal by Subject|5|||
163325646|NCT03248492|589903890|FG001|Overall Study|Withdrawal by Subject|4|||
163325647|NCT03248492|589903891|FG002|Overall Study|Withdrawal by Subject|0|||
163325648|NCT03248492|589903892|FG003|Overall Study|Withdrawal by Subject|8|||
163325649|NCT03248492|589903893|FG004|Overall Study|Withdrawal by Subject|1|||
163325650|NCT03248492|589903889|FG000|Overall Study|Physician Decision|1|||
163325651|NCT03248492|589903890|FG001|Overall Study|Physician Decision|1|||
163325652|NCT03248492|589903891|FG002|Overall Study|Physician Decision|1|||
163325653|NCT03248492|589903892|FG003|Overall Study|Physician Decision|7|||
163325654|NCT03248492|589903893|FG004|Overall Study|Physician Decision|0|||
163325655|NCT03248492|589903889|FG000|Overall Study|Death|1|||
163325656|NCT03248492|589903890|FG001|Overall Study|Death|1|||
163003217|NCT03656744|588711532|FG001|Overall Study|Adverse Event|4|||
163003218|NCT03656744|588711533|FG002|Overall Study|Adverse Event|1|||
163325657|NCT03248492|589903891|FG002|Overall Study|Death|0|||
163325658|NCT03248492|589903892|FG003|Overall Study|Death|6|||
163325659|NCT03248492|589903893|FG004|Overall Study|Death|0|||
163404407|NCT03273166|590191925|FG000|Overall Study|Withdrawn prior to Completion|31|||
163003219|NCT03656744|588711531|FG000|Overall Study|Protocol Violation|1|||
163003220|NCT03656744|588711532|FG001|Overall Study|Protocol Violation|0|||
163060922|NCT00171249|588931350|FG002|Overall Study|No Longer Requires Study Drug|0|||
163060923|NCT00171249|588931351|FG003|Overall Study|No Longer Requires Study Drug|3|||
163325660|NCT03248492|589903889|FG000|Overall Study|Study Terminated by Sponsor|3|||
163325661|NCT03248492|589903890|FG001|Overall Study|Study Terminated by Sponsor|1|||
163325662|NCT03248492|589903891|FG002|Overall Study|Study Terminated by Sponsor|0|||
163325663|NCT03248492|589903892|FG003|Overall Study|Study Terminated by Sponsor|7|||
163325664|NCT03248492|589903893|FG004|Overall Study|Study Terminated by Sponsor|0|||
163325665|NCT03248492|589903889|FG000|Overall Study|Other|2|||
163325666|NCT03248492|589903890|FG001|Overall Study|Other|5|||
163325667|NCT03248492|589903891|FG002|Overall Study|Other|0|||
163404408|NCT01294670|590191926|FG000|Overall Study|Not treated|1|||
163404409|NCT01294670|590191927|FG001|Overall Study|Not treated|0|||
163404410|NCT01294670|590191928|FG002|Overall Study|Not treated|0|||
163404411|NCT01294670|590191929|FG003|Overall Study|Not treated|0|||
163404412|NCT01294670|590191930|FG004|Overall Study|Not treated|0|||
163404413|NCT03808077|590191931|FG000|Overall Study|Physician Decision|2|||
163404414|NCT03808077|590191932|FG001|Overall Study|Physician Decision|3|||
163404415|NCT03808077|590191931|FG000|Overall Study|Withdrawal by Subject|1|||
163325668|NCT03248492|589903892|FG003|Overall Study|Other|14|||
163325669|NCT03248492|589903893|FG004|Overall Study|Other|0|||
163325670|NCT04495621|589903894|FG000|Overall Study|Withdrawal by Subject|0|||
163325671|NCT04495621|589903895|FG001|Overall Study|Withdrawal by Subject|3|||
163325672|NCT04495621|589903894|FG000|Overall Study|Death|7|||
163325673|NCT04495621|589903895|FG001|Overall Study|Death|11|||
163325674|NCT04495621|589903894|FG000|Overall Study|Investigator Decision|0|||
163325675|NCT04495621|589903895|FG001|Overall Study|Investigator Decision|7|||
163325676|NCT04495621|589903894|FG000|Overall Study|Lost to Follow-up|0|||
163325677|NCT04495621|589903895|FG001|Overall Study|Lost to Follow-up|1|||
163325678|NCT03774472|589903898|FG000|Overall Study|Physician Decision|1|||
163325679|NCT03774472|589903899|FG001|Overall Study|Physician Decision|0|||
163325680|NCT03774472|589903900|FG002|Overall Study|Physician Decision|0|||
163325681|NCT03774472|589903898|FG000|Overall Study|Progression prior to 4 weeks|0|||
163325682|NCT03774472|589903899|FG001|Overall Study|Progression prior to 4 weeks|1|||
163325683|NCT03774472|589903900|FG002|Overall Study|Progression prior to 4 weeks|0|||
163325684|NCT03774472|589903898|FG000|Overall Study|Withdrawal by Subject|0|||
163325685|NCT03774472|589903899|FG001|Overall Study|Withdrawal by Subject|1|||
163325686|NCT03774472|589903900|FG002|Overall Study|Withdrawal by Subject|0|||
163325687|NCT04059406|589903901|FG000|Overall Study|Early Treatment Termination|5|||
163325688|NCT04059406|589903902|FG001|Overall Study|Early Treatment Termination|5|||
163325689|NCT04059406|589903903|FG002|Overall Study|Early Treatment Termination|15|||
163325690|NCT05155306|589903908|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
163325691|NCT05155306|589903909|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
163325692|NCT05155306|589903910|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
163325693|NCT05155306|589903911|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
163325694|NCT05155306|589903908|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
163325695|NCT05155306|589903909|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
163325696|NCT05155306|589903910|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
163325697|NCT05155306|589903911|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
163325698|NCT04121741|589903912|FG000|Overall Study|Protocol Violation|1|||
163325699|NCT04121741|589903913|FG001|Overall Study|Protocol Violation|0|||
163325700|NCT04121741|589903914|FG002|Overall Study|Protocol Violation|0|||
163325701|NCT04121741|589903915|FG003|Overall Study|Protocol Violation|0|||
163325702|NCT04121741|589903916|FG004|Overall Study|Protocol Violation|0|||
163325703|NCT04121741|589903917|FG005|Overall Study|Protocol Violation|0|||
163325704|NCT01084863|589903918|FG000|Main Study Treatment Period|Disease progression|11|||
163325705|NCT01084863|589903919|FG001|Main Study Treatment Period|Disease progression|7|||
163325706|NCT01084863|589903918|FG000|Main Study Treatment Period|Adverse Event|5|||
163325707|NCT01084863|589903919|FG001|Main Study Treatment Period|Adverse Event|3|||
163325708|NCT01084863|589903918|FG000|Main Study Treatment Period|Other Reason|0|||
163325709|NCT01084863|589903919|FG001|Main Study Treatment Period|Other Reason|1|||
163325710|NCT01084863|589903918|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
163325711|NCT01084863|589903919|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
163003221|NCT03656744|588711533|FG002|Overall Study|Protocol Violation|0|||
163003222|NCT03656744|588711531|FG000|Overall Study|Lost to Follow-up|2|||
163003223|NCT03656744|588711532|FG001|Overall Study|Lost to Follow-up|2|||
163404416|NCT03808077|590191932|FG001|Overall Study|Withdrawal by Subject|0|||
163404417|NCT03808077|590191931|FG000|Overall Study|Equipment Issues|2|||
163404418|NCT03808077|590191932|FG001|Overall Study|Equipment Issues|1|||
163404419|NCT02412787|590191933|FG000|Overall Study|Withdrawal by Subject|9|||
163003224|NCT03656744|588711533|FG002|Overall Study|Lost to Follow-up|0|||
163003225|NCT03656744|588711531|FG000|Overall Study|Withdrawal by Subject|0|||
163003226|NCT03656744|588711532|FG001|Overall Study|Withdrawal by Subject|1|||
163003227|NCT03656744|588711533|FG002|Overall Study|Withdrawal by Subject|0|||
163003228|NCT03656744|588711531|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
163003229|NCT03656744|588711532|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
163003230|NCT03656744|588711533|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
163003231|NCT03076775|588711534|FG000|Overall Study|Lost to Follow-up|1|||
163003232|NCT03076775|588711535|FG001|Overall Study|Lost to Follow-up|0|||
163003233|NCT01783886|588711536|FG000|Overall Study|Lost to Follow-up|0|||
163003234|NCT01783886|588711537|FG001|Overall Study|Lost to Follow-up|3|||
163003235|NCT01783886|588711538|FG002|Overall Study|Lost to Follow-up|0|||
163003236|NCT01783886|588711536|FG000|Overall Study|Protocol deviation|0|||
163003237|NCT01783886|588711537|FG001|Overall Study|Protocol deviation|0|||
163003238|NCT01783886|588711538|FG002|Overall Study|Protocol deviation|2|||
163003239|NCT01783886|588711536|FG000|Overall Study|Withdrawal of consent by participant|1|||
163003240|NCT01783886|588711537|FG001|Overall Study|Withdrawal of consent by participant|3|||
163003241|NCT01783886|588711538|FG002|Overall Study|Withdrawal of consent by participant|4|||
163003242|NCT01783886|588711536|FG000|Overall Study|Adverse Event|4|||
163003243|NCT01783886|588711537|FG001|Overall Study|Adverse Event|5|||
163003244|NCT01783886|588711538|FG002|Overall Study|Adverse Event|4|||
163003245|NCT00940316|588711539|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
163003246|NCT00940316|588711540|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
163003247|NCT00940316|588711541|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
163003248|NCT00940316|588711539|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
163003249|NCT00940316|588711540|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
163003250|NCT00940316|588711541|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
163003251|NCT00940316|588711539|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
163003252|NCT00940316|588711540|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
163003253|NCT00940316|588711541|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
163003254|NCT00940316|588711539|FG000|Treated After Cycle 5|Adverse Event|0|||
163003255|NCT00940316|588711540|FG001|Treated After Cycle 5|Adverse Event|0|||
163003256|NCT00940316|588711541|FG002|Treated After Cycle 5|Adverse Event|1|||
163003257|NCT00940316|588711539|FG000|Treated After Cycle 5|Progressive disease|0|||
163003258|NCT00940316|588711540|FG001|Treated After Cycle 5|Progressive disease|1|||
163003259|NCT00940316|588711541|FG002|Treated After Cycle 5|Progressive disease|0|||
163003260|NCT02290405|588711542|FG000|Overall Study|Withdrawal by Subject|1|||
163003261|NCT02290405|588711543|FG001|Overall Study|Withdrawal by Subject|0|||
163003262|NCT00996489|588711544|FG000|Overall Study|Device failure|45|||
163003263|NCT00996489|588711544|FG000|Overall Study|Discontinued|116|||
163003264|NCT03142191|588711545|FG000|Placebo Controlled Period|Death|0|||
163003265|NCT03142191|588711546|FG001|Placebo Controlled Period|Death|1|||
163003266|NCT03142191|588711547|FG002|Placebo Controlled Period|Death|1|||
163003267|NCT03142191|588711548|FG003|Placebo Controlled Period|Death|0|||
163003268|NCT03142191|588711549|FG004|Placebo Controlled Period|Death|0|||
163003269|NCT03142191|588711545|FG000|Placebo Controlled Period|Adverse Event|4|||
163003270|NCT03142191|588711546|FG001|Placebo Controlled Period|Adverse Event|5|||
163003271|NCT03142191|588711547|FG002|Placebo Controlled Period|Adverse Event|1|||
163003272|NCT03142191|588711548|FG003|Placebo Controlled Period|Adverse Event|0|||
163003273|NCT03142191|588711549|FG004|Placebo Controlled Period|Adverse Event|0|||
163003274|NCT03142191|588711545|FG000|Placebo Controlled Period|Progressive Disease|1|||
163003275|NCT03142191|588711546|FG001|Placebo Controlled Period|Progressive Disease|0|||
163003276|NCT03142191|588711547|FG002|Placebo Controlled Period|Progressive Disease|1|||
163003277|NCT03142191|588711548|FG003|Placebo Controlled Period|Progressive Disease|0|||
163003278|NCT03142191|588711549|FG004|Placebo Controlled Period|Progressive Disease|0|||
163003279|NCT03142191|588711545|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
163003280|NCT03142191|588711546|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
163003281|NCT03142191|588711547|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
163003282|NCT03142191|588711548|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
163003283|NCT03142191|588711549|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
163003284|NCT03142191|588711545|FG000|Placebo Controlled Period|Other Reasons|1|||
163003285|NCT03142191|588711546|FG001|Placebo Controlled Period|Other Reasons|0|||
163003286|NCT03142191|588711547|FG002|Placebo Controlled Period|Other Reasons|0|||
163003287|NCT03142191|588711548|FG003|Placebo Controlled Period|Other Reasons|0|||
163003288|NCT03142191|588711549|FG004|Placebo Controlled Period|Other Reasons|0|||
163003289|NCT03142191|588711545|FG000|Active Treatment Extension Period|Death|2|||
163003290|NCT03142191|588711546|FG001|Active Treatment Extension Period|Death|1|||
163003291|NCT03142191|588711547|FG002|Active Treatment Extension Period|Death|1|||
163003292|NCT03142191|588711548|FG003|Active Treatment Extension Period|Death|1|||
163003293|NCT03142191|588711549|FG004|Active Treatment Extension Period|Death|0|||
163003294|NCT03142191|588711545|FG000|Active Treatment Extension Period|Adverse Event|6|||
163003295|NCT03142191|588711546|FG001|Active Treatment Extension Period|Adverse Event|5|||
163003296|NCT03142191|588711547|FG002|Active Treatment Extension Period|Adverse Event|4|||
163003297|NCT03142191|588711548|FG003|Active Treatment Extension Period|Adverse Event|1|||
163003298|NCT03142191|588711549|FG004|Active Treatment Extension Period|Adverse Event|0|||
163003299|NCT03142191|588711545|FG000|Active Treatment Extension Period|Progressive Disease|10|||
163003300|NCT03142191|588711546|FG001|Active Treatment Extension Period|Progressive Disease|5|||
163003301|NCT03142191|588711547|FG002|Active Treatment Extension Period|Progressive Disease|4|||
163003302|NCT03142191|588711548|FG003|Active Treatment Extension Period|Progressive Disease|1|||
163003303|NCT03142191|588711549|FG004|Active Treatment Extension Period|Progressive Disease|2|||
163003304|NCT03142191|588711545|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
163003305|NCT03142191|588711546|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
163003306|NCT03142191|588711547|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
163003307|NCT03142191|588711548|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
163003308|NCT03142191|588711549|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
163003309|NCT03142191|588711545|FG000|Active Treatment Extension Period|Physician Decision|2|||
163003310|NCT03142191|588711546|FG001|Active Treatment Extension Period|Physician Decision|0|||
163003311|NCT03142191|588711547|FG002|Active Treatment Extension Period|Physician Decision|0|||
163003312|NCT03142191|588711548|FG003|Active Treatment Extension Period|Physician Decision|0|||
163003313|NCT03142191|588711549|FG004|Active Treatment Extension Period|Physician Decision|0|||
163003314|NCT03142191|588711545|FG000|Active Treatment Extension Period|Other Reasons|3|||
163003315|NCT03142191|588711546|FG001|Active Treatment Extension Period|Other Reasons|3|||
163003316|NCT03142191|588711547|FG002|Active Treatment Extension Period|Other Reasons|3|||
163003317|NCT03142191|588711548|FG003|Active Treatment Extension Period|Other Reasons|8|||
163003318|NCT03142191|588711549|FG004|Active Treatment Extension Period|Other Reasons|3|||
163003319|NCT03142191|588711545|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
163003320|NCT03142191|588711546|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
163003321|NCT03142191|588711547|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
163003322|NCT03142191|588711548|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
163003323|NCT03142191|588711549|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
163003324|NCT01130493|588711554|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
163003325|NCT01130493|588711555|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
163003326|NCT01130493|588711556|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
163003327|NCT01130493|588711554|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
163003328|NCT01130493|588711555|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
163003329|NCT01130493|588711556|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
163003330|NCT01130493|588711554|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
163003331|NCT01130493|588711555|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
163003332|NCT01130493|588711556|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
163003333|NCT01130493|588711554|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
163003334|NCT01130493|588711555|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
163003335|NCT01130493|588711556|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
163003336|NCT01130493|588711554|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
163003337|NCT01130493|588711555|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
163003338|NCT01130493|588711556|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
163003339|NCT01130493|588711554|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
163003340|NCT01130493|588711555|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
163003341|NCT01130493|588711556|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
163003342|NCT01130493|588711554|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
163404420|NCT02412787|590191933|FG000|Overall Study|Participation Terminated by Investigator|1|||
163404421|NCT02412787|590191933|FG000|Overall Study|Site Terminated by Sponsor|21|||
163003343|NCT01130493|588711555|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
163003344|NCT01130493|588711556|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
163003345|NCT01130493|588711554|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
163003346|NCT01130493|588711555|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
163003347|NCT01130493|588711556|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
163003348|NCT01130493|588711554|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
163003349|NCT01130493|588711555|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
163003350|NCT01130493|588711556|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
163003351|NCT01130493|588711554|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
163003352|NCT01130493|588711555|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
163003353|NCT01130493|588711556|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
163003354|NCT01130493|588711554|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
163003355|NCT01130493|588711555|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
163003356|NCT01130493|588711556|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
163003357|NCT01130493|588711554|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
163003358|NCT01130493|588711555|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
163003359|NCT01130493|588711556|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
163003360|NCT01130493|588711554|FG000|Part 2: OLE|Adverse Event|0|||
163003361|NCT01130493|588711555|FG001|Part 2: OLE|Adverse Event|2|||
163003362|NCT01130493|588711556|FG002|Part 2: OLE|Adverse Event|1|||
163003363|NCT01130493|588711554|FG000|Part 2: OLE|Withdrawal by Subject|0|||
163003364|NCT01130493|588711555|FG001|Part 2: OLE|Withdrawal by Subject|1|||
163003365|NCT01130493|588711556|FG002|Part 2: OLE|Withdrawal by Subject|4|||
163060924|NCT00171249|588931352|FG004|Overall Study|No Longer Requires Study Drug|0|||
163213360|NCT03525574|589495955|FG000|Overall Study|Physician Decision|6|||
163404422|NCT02412787|590191933|FG000|Overall Study|Technical Problems|1|||
163404423|NCT02412787|590191933|FG000|Overall Study|Reason Not Specified|1|||
163404424|NCT03246958|590191934|FG000|Overall Study|Withdrawal by Subject|0|||
163003366|NCT03541317|588711559|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
163003367|NCT03541317|588711560|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
163003368|NCT03541317|588711561|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
163003369|NCT03541317|588711562|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
163003370|NCT03541317|588711563|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
163404425|NCT03246958|590191935|FG001|Overall Study|Withdrawal by Subject|1|||
163003371|NCT03541317|588711564|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
163003372|NCT00879086|588711565|FG000|Overall Study|Adverse Event|3|||
163003373|NCT00879086|588711566|FG001|Overall Study|Adverse Event|15|||
163003374|NCT00879086|588711565|FG000|Overall Study|Participant choice|2|||
163003375|NCT00879086|588711566|FG001|Overall Study|Participant choice|2|||
163003376|NCT00879086|588711565|FG000|Overall Study|Progression of disease|40|||
163003377|NCT00879086|588711566|FG001|Overall Study|Progression of disease|26|||
163003378|NCT00879086|588711565|FG000|Overall Study|Withdrawal of consent|2|||
163003379|NCT00879086|588711566|FG001|Overall Study|Withdrawal of consent|1|||
163003380|NCT00879086|588711565|FG000|Overall Study|Other|4|||
163003381|NCT00879086|588711566|FG001|Overall Study|Other|6|||
163003382|NCT00879086|588711565|FG000|Overall Study|Death|1|||
163003383|NCT00879086|588711566|FG001|Overall Study|Death|2|||
163003384|NCT04728802|588711567|FG000|Overall Study|Withdrawal by Subject|4|||
163003385|NCT04728802|588711568|FG001|Overall Study|Withdrawal by Subject|20|||
163003386|NCT04728802|588711567|FG000|Overall Study|Physician Decision|7|||
163003387|NCT04728802|588711568|FG001|Overall Study|Physician Decision|7|||
163213361|NCT03525574|589495956|FG001|Overall Study|Physician Decision|0|||
163213362|NCT03525574|589495955|FG000|Overall Study|Other|58|||
163003388|NCT04728802|588711567|FG000|Overall Study|Protocol Violation|10|||
163003389|NCT04728802|588711568|FG001|Overall Study|Protocol Violation|4|||
163003390|NCT04728802|588711567|FG000|Overall Study|Transfer|1|||
163003391|NCT04728802|588711568|FG001|Overall Study|Transfer|0|||
163003392|NCT04728802|588711567|FG000|Overall Study|Death|4|||
163003393|NCT04728802|588711568|FG001|Overall Study|Death|5|||
163003394|NCT04728802|588711567|FG000|Overall Study|Other|3|||
163003395|NCT04728802|588711568|FG001|Overall Study|Other|0|||
163003396|NCT02517463|588711569|FG000|Overall Study|Lost to Follow-up|5|||
163003397|NCT02517463|588711570|FG001|Overall Study|Lost to Follow-up|2|||
163003398|NCT02296931|588711573|FG000|Overall Study|Protocol Violation|0|||
163003399|NCT02296931|588711574|FG001|Overall Study|Protocol Violation|2|||
163003400|NCT01590277|588711575|FG000|Overall Study|Withdrawal by Subject|3|||
163003401|NCT01590277|588711575|FG000|Overall Study|Withdrawal by Subject|2|||
163003402|NCT01590277|588711575|FG000|Overall Study|Withdrawal by Subject|1|||
163003403|NCT01590277|588711575|FG000|Overall Study|Withdrawal by Subject|1|||
163003404|NCT04386616|588711576|FG000|Overall Study|Death|22|||
163003405|NCT04386616|588711577|FG001|Overall Study|Death|22|||
163003406|NCT04386616|588711578|FG002|Overall Study|Death|21|||
163003407|NCT04386616|588711576|FG000|Overall Study|Lost to Follow-up|5|||
163003408|NCT04386616|588711577|FG001|Overall Study|Lost to Follow-up|8|||
163003409|NCT04386616|588711578|FG002|Overall Study|Lost to Follow-up|6|||
163003410|NCT04386616|588711576|FG000|Overall Study|Withdrawal by Subject|2|||
163003411|NCT04386616|588711577|FG001|Overall Study|Withdrawal by Subject|4|||
163003412|NCT04386616|588711578|FG002|Overall Study|Withdrawal by Subject|1|||
163003413|NCT04386616|588711576|FG000|Overall Study|Adverse Event|1|||
163003414|NCT04386616|588711577|FG001|Overall Study|Adverse Event|1|||
163003415|NCT04386616|588711578|FG002|Overall Study|Adverse Event|0|||
163003416|NCT01377012|588711579|FG000|Core Study|Study terminated by Sponsor|47|||
163003417|NCT01377012|588711580|FG001|Core Study|Study terminated by Sponsor|54|||
163003418|NCT01377012|588711581|FG002|Core Study|Study terminated by Sponsor|46|||
163003419|NCT01377012|588711579|FG000|Core Study|Technical problems|1|||
163003420|NCT01377012|588711580|FG001|Core Study|Technical problems|0|||
163003421|NCT01377012|588711581|FG002|Core Study|Technical problems|0|||
163003422|NCT01377012|588711579|FG000|Core Study|Withdrawal by Subject|15|||
163003423|NCT01377012|588711580|FG001|Core Study|Withdrawal by Subject|23|||
163003424|NCT01377012|588711581|FG002|Core Study|Withdrawal by Subject|18|||
163003425|NCT01377012|588711579|FG000|Core Study|Protocol Violation|7|||
163003426|NCT01377012|588711580|FG001|Core Study|Protocol Violation|3|||
163003427|NCT01377012|588711581|FG002|Core Study|Protocol Violation|2|||
163003428|NCT01377012|588711579|FG000|Core Study|Pregnancy|0|||
163003429|NCT01377012|588711580|FG001|Core Study|Pregnancy|0|||
163003430|NCT01377012|588711581|FG002|Core Study|Pregnancy|1|||
163003431|NCT01377012|588711579|FG000|Core Study|Physician Decision|5|||
163003432|NCT01377012|588711580|FG001|Core Study|Physician Decision|4|||
163003433|NCT01377012|588711581|FG002|Core Study|Physician Decision|10|||
163003434|NCT01377012|588711579|FG000|Core Study|Non-Compliant with study treatment|0|||
163003435|NCT01377012|588711580|FG001|Core Study|Non-Compliant with study treatment|0|||
163003436|NCT01377012|588711581|FG002|Core Study|Non-Compliant with study treatment|1|||
163003437|NCT01377012|588711579|FG000|Core Study|No Longer require treatment|0|||
163003438|NCT01377012|588711580|FG001|Core Study|No Longer require treatment|0|||
163003439|NCT01377012|588711581|FG002|Core Study|No Longer require treatment|1|||
163003440|NCT01377012|588711579|FG000|Core Study|Lost to Follow-up|7|||
163213363|NCT03525574|589495956|FG001|Overall Study|Other|0|||
163213364|NCT03525574|589495955|FG000|Overall Study|Enrolled but never dosed|1|||
163003441|NCT01377012|588711580|FG001|Core Study|Lost to Follow-up|5|||
163003442|NCT01377012|588711581|FG002|Core Study|Lost to Follow-up|4|||
163003443|NCT01377012|588711579|FG000|Core Study|Lack of Efficacy|41|||
163003444|NCT01377012|588711580|FG001|Core Study|Lack of Efficacy|28|||
163003445|NCT01377012|588711581|FG002|Core Study|Lack of Efficacy|37|||
163003446|NCT01377012|588711579|FG000|Core Study|Death|1|||
163003447|NCT01377012|588711580|FG001|Core Study|Death|1|||
163003448|NCT01377012|588711581|FG002|Core Study|Death|1|||
163003449|NCT01377012|588711579|FG000|Core Study|Adverse Event|10|||
163003450|NCT01377012|588711580|FG001|Core Study|Adverse Event|14|||
163003451|NCT01377012|588711581|FG002|Core Study|Adverse Event|13|||
163003452|NCT01377012|588711579|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
163003453|NCT01377012|588711580|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
163003454|NCT01377012|588711581|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
163003455|NCT01377012|588711579|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
163003456|NCT01377012|588711580|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
163003457|NCT01377012|588711581|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
163003458|NCT01377012|588711579|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
163003459|NCT01377012|588711580|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
163003460|NCT01377012|588711581|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
163003461|NCT01377012|588711579|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
163003462|NCT01377012|588711580|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
163003463|NCT01377012|588711581|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
163003464|NCT01377012|588711579|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
163003465|NCT01377012|588711580|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
163003466|NCT01377012|588711581|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
163003467|NCT01377012|588711579|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
163003468|NCT01377012|588711580|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
163003469|NCT01377012|588711581|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
163003470|NCT00805961|588711582|FG000|Modality Therapy|Withdrawal by Subject|1|||
163003471|NCT00805961|588711582|FG000|Modality Therapy|Adverse Event|1|||
163003472|NCT00805961|588711582|FG000|Modality Therapy|Disease Progression|2|||
163003473|NCT00805961|588711582|FG000|Treatment-Free Interval|Adverse Event|3|||
163003474|NCT00805961|588711582|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
163003475|NCT00805961|588711582|FG000|Treatment-Free Interval|Physician Decision|1|||
163003476|NCT00805961|588711582|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
163003477|NCT00805961|588711582|FG000|Maintenance Treatment|Lack of Efficacy|13|||
163003478|NCT00805961|588711582|FG000|Maintenance Treatment|Intercurrent Illness|7|||
163003479|NCT00805961|588711582|FG000|Maintenance Treatment|Adverse Event|6|||
163003480|NCT00805961|588711582|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
163003481|NCT00805961|588711582|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
163003482|NCT00805961|588711582|FG000|Maintenance Treatment|Withdrawn Consent|1|||
163003483|NCT05022212|588711590|FG000|Overall Study|Lost to Follow-up|0|||
163003484|NCT05022212|588711591|FG001|Overall Study|Lost to Follow-up|2|||
163003485|NCT02905032|588711592|FG000|Overall Study|Withdrawal by Subject|2|||
163003486|NCT02905032|588711593|FG001|Overall Study|Withdrawal by Subject|0|||
163003487|NCT02905032|588711594|FG002|Overall Study|Withdrawal by Subject|0|||
163003488|NCT02905032|588711592|FG000|Overall Study|Protocol Violation|6|||
163003489|NCT02905032|588711593|FG001|Overall Study|Protocol Violation|12|||
163003490|NCT02905032|588711594|FG002|Overall Study|Protocol Violation|0|||
163003491|NCT00739063|588711595|FG000|Overall Study|Screen failures|8|||
163003492|NCT01068262|588713289|FG000|Overall Study|Adverse Event|2|||
163003493|NCT01068262|588713290|FG001|Overall Study|Adverse Event|0|||
163003494|NCT01068262|588713291|FG002|Overall Study|Adverse Event|1|||
163003495|NCT01068262|588713292|FG003|Overall Study|Adverse Event|0|||
163003496|NCT01068262|588713289|FG000|Overall Study|Protocol Violation|1|||
163003497|NCT01068262|588713290|FG001|Overall Study|Protocol Violation|0|||
163003498|NCT01068262|588713291|FG002|Overall Study|Protocol Violation|0|||
163003499|NCT01068262|588713292|FG003|Overall Study|Protocol Violation|0|||
163003500|NCT01068262|588713289|FG000|Overall Study|Withdrawal by Subject|0|||
163003501|NCT01068262|588713290|FG001|Overall Study|Withdrawal by Subject|1|||
163003502|NCT01068262|588713291|FG002|Overall Study|Withdrawal by Subject|0|||
163003503|NCT01068262|588713292|FG003|Overall Study|Withdrawal by Subject|0|||
163003504|NCT04182490|588713293|FG000|Overall Study|Withdrawal by Subject|3|||
163003505|NCT04182490|588713294|FG001|Overall Study|Withdrawal by Subject|3|||
163003506|NCT04182490|588713293|FG000|Overall Study|Lost to Follow-up|0|||
163003507|NCT04182490|588713294|FG001|Overall Study|Lost to Follow-up|1|||
163003508|NCT04182490|588713293|FG000|Overall Study|Physician Decision|0|||
163003509|NCT04182490|588713294|FG001|Overall Study|Physician Decision|1|||
163003510|NCT01811472|588713300|FG000|Overall Study|Adverse Event|1|||
163003511|NCT01811472|588713301|FG001|Overall Study|Adverse Event|0|||
163003512|NCT01811472|588713302|FG002|Overall Study|Adverse Event|4|||
163003513|NCT01811472|588713300|FG000|Overall Study|Lost to Follow-up|0|||
163003514|NCT01811472|588713301|FG001|Overall Study|Lost to Follow-up|0|||
163003515|NCT01811472|588713302|FG002|Overall Study|Lost to Follow-up|1|||
163003516|NCT01811472|588713300|FG000|Overall Study|Subject/guardian decision|1|||
163003517|NCT01811472|588713301|FG001|Overall Study|Subject/guardian decision|0|||
163003518|NCT01811472|588713302|FG002|Overall Study|Subject/guardian decision|0|||
163003519|NCT04108299|588713311|FG000|Overall Study|Not interested in participating|2|||
163003520|NCT04108299|588713312|FG001|Overall Study|Not interested in participating|1|||
163003521|NCT04108299|588713313|FG002|Overall Study|Not interested in participating|2|||
163003522|NCT04108299|588713314|FG003|Overall Study|Not interested in participating|1|||
163003523|NCT02515331|588713323|FG000|Overall Study|Withdrawal by Subject|0|||
163003524|NCT02515331|588713324|FG001|Overall Study|Withdrawal by Subject|0|||
163003525|NCT02515331|588713325|FG002|Overall Study|Withdrawal by Subject|1|||
163003526|NCT02515331|588713323|FG000|Overall Study|Protocol deviation|0|||
163003527|NCT02515331|588713324|FG001|Overall Study|Protocol deviation|0|||
163003528|NCT02515331|588713325|FG002|Overall Study|Protocol deviation|3|||
163003529|NCT02515331|588713323|FG000|Overall Study|Adverse Event|2|||
163003530|NCT02515331|588713324|FG001|Overall Study|Adverse Event|0|||
163325712|NCT01084863|589903918|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
163325713|NCT01084863|589903919|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
163325714|NCT01084863|589903918|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
163325715|NCT01084863|589903919|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
163325716|NCT01084863|589903918|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
163325717|NCT01084863|589903919|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
163325718|NCT01084863|589903918|FG000|Treatment Period Beyond Cycle 8|Other|0|||
163325719|NCT01084863|589903919|FG001|Treatment Period Beyond Cycle 8|Other|1|||
163325720|NCT01084863|589903918|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
163325721|NCT01084863|589903919|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
163325722|NCT03473223|589903921|FG000|Overall Study|Lost to Follow-up|1|||
163325723|NCT03473223|589903922|FG001|Overall Study|Lost to Follow-up|1|||
163325724|NCT03473223|589903921|FG000|Overall Study|Withdrawal by Subject|47|||
163325725|NCT03473223|589903922|FG001|Overall Study|Withdrawal by Subject|42|||
163325726|NCT03473223|589903921|FG000|Overall Study|Indirect contact|32|||
163325727|NCT03473223|589903922|FG001|Overall Study|Indirect contact|29|||
163325728|NCT03473223|589903921|FG000|Overall Study|Other (Not specified)|32|||
163325729|NCT03473223|589903922|FG001|Overall Study|Other (Not specified)|20|||
163325730|NCT04505722|589903923|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
163325731|NCT04505722|589903924|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
163325732|NCT04505722|589903925|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
163325733|NCT04505722|589903923|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
163325734|NCT04505722|589903924|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
163325735|NCT04505722|589903925|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
163325736|NCT04505722|589903923|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
163325737|NCT04505722|589903924|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
163325738|NCT04505722|589903925|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
163325739|NCT04505722|589903923|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
163325740|NCT04505722|589903924|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
163325741|NCT04505722|589903925|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
163325742|NCT04505722|589903923|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
163325743|NCT04505722|589903924|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
163325744|NCT04505722|589903925|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
163325745|NCT04505722|589903923|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
163325746|NCT04505722|589903924|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
163325747|NCT04505722|589903925|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
163325748|NCT04505722|589903923|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
163325749|NCT04505722|589903924|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
163325750|NCT04505722|589903925|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
163325751|NCT04505722|589903923|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
163325752|NCT04505722|589903924|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
163325753|NCT04505722|589903925|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
163325754|NCT04505722|589903923|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
163325755|NCT04505722|589903924|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
163325756|NCT04505722|589903925|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
163325757|NCT04505722|589903923|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
163325758|NCT04505722|589903924|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
163325759|NCT04505722|589903925|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
163325760|NCT04505722|589903923|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
163325761|NCT04505722|589903924|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
163325762|NCT04505722|589903925|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
163003531|NCT02515331|588713325|FG002|Overall Study|Adverse Event|0|||
163003532|NCT00124748|588713326|FG000|Overall Study|Adverse Event|8|||
163003533|NCT00124748|588713327|FG001|Overall Study|Adverse Event|39|||
163325763|NCT04505722|589903923|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
163325764|NCT04505722|589903924|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
163325765|NCT04505722|589903925|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
163325766|NCT04505722|589903923|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
163325767|NCT04505722|589903924|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
163325768|NCT04505722|589903925|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
163003534|NCT00124748|588713326|FG000|Overall Study|Abnormal laboratory Value|2|||
163003535|NCT00124748|588713327|FG001|Overall Study|Abnormal laboratory Value|2|||
163325769|NCT04505722|589903923|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
163325770|NCT04505722|589903924|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
163325771|NCT04505722|589903925|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
163325772|NCT04505722|589903923|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
163325773|NCT04505722|589903924|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
163325774|NCT04505722|589903925|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
163325775|NCT04755595|589903926|FG000|Overall Study|Lost to Follow-up|1|||
163325776|NCT02549352|589903930|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
163325777|NCT02549352|589903931|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
163325778|NCT02549352|589903930|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
163325779|NCT02549352|589903931|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
163325780|NCT02549352|589903930|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
163325781|NCT02549352|589903931|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
163325782|NCT02549352|589903930|FG000|12-month Follow-up|Withdrawal by Subject|4|||
163325783|NCT02549352|589903931|FG001|12-month Follow-up|Withdrawal by Subject|5|||
163325784|NCT02549352|589903930|FG000|12-month Follow-up|Lost to Follow-up|3|||
163325785|NCT02549352|589903931|FG001|12-month Follow-up|Lost to Follow-up|2|||
163325786|NCT02549352|589903930|FG000|12-month Follow-up|Death|0|||
163325787|NCT02549352|589903931|FG001|12-month Follow-up|Death|1|||
163325788|NCT02549352|589903930|FG000|12-month Follow-up|Protocol Violation|0|||
163325789|NCT02549352|589903931|FG001|12-month Follow-up|Protocol Violation|1|||
163325790|NCT02549352|589903930|FG000|12-month Follow-up|Other|1|||
163325791|NCT02549352|589903931|FG001|12-month Follow-up|Other|3|||
163325792|NCT04129450|589903933|FG000|Overall Study|Lost to Follow-up|20|||
163325793|NCT04129450|589903934|FG001|Overall Study|Lost to Follow-up|10|||
163325794|NCT04129450|589903933|FG000|Overall Study|Withdrawal by Subject|9|||
163325795|NCT04129450|589903934|FG001|Overall Study|Withdrawal by Subject|5|||
163325796|NCT04129450|589903933|FG000|Overall Study|Work Family Obligations|2|||
163325797|NCT04129450|589903934|FG001|Overall Study|Work Family Obligations|0|||
163325798|NCT04129450|589903933|FG000|Overall Study|Other|3|||
163325799|NCT04129450|589903934|FG001|Overall Study|Other|0|||
163325800|NCT02291913|589904598|FG000|Overall Study|Progressive Disease|32|||
163325801|NCT02291913|589904598|FG000|Overall Study|Adverse Event|11|||
163325802|NCT02291913|589904598|FG000|Overall Study|Death|2|||
163325803|NCT02291913|589904598|FG000|Overall Study|Physician Decision|1|||
163003536|NCT00124748|588713326|FG000|Overall Study|Abnormal Procedure|0|||
163003537|NCT00124748|588713327|FG001|Overall Study|Abnormal Procedure|1|||
163003538|NCT00124748|588713326|FG000|Overall Study|Lack of Efficacy|20|||
163003539|NCT00124748|588713327|FG001|Overall Study|Lack of Efficacy|41|||
163003540|NCT00124748|588713326|FG000|Overall Study|No longer requires study drug|1|||
163003541|NCT00124748|588713327|FG001|Overall Study|No longer requires study drug|1|||
163003542|NCT00124748|588713326|FG000|Overall Study|Protocol Violation|3|||
163003543|NCT00124748|588713327|FG001|Overall Study|Protocol Violation|1|||
163003544|NCT00124748|588713326|FG000|Overall Study|Withdrawal by Subject|5|||
163003545|NCT00124748|588713327|FG001|Overall Study|Withdrawal by Subject|15|||
163003546|NCT00124748|588713326|FG000|Overall Study|Lost to Follow-up|2|||
163003547|NCT00124748|588713327|FG001|Overall Study|Lost to Follow-up|7|||
163003548|NCT00124748|588713326|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
163003549|NCT00124748|588713327|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
163003550|NCT00124748|588713326|FG000|Overall Study|Death|1|||
163003551|NCT00124748|588713327|FG001|Overall Study|Death|3|||
163003552|NCT00322712|588713328|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
163003553|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
163003554|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
163003555|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
163003556|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003557|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
163003558|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
163003559|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163060925|NCT00171249|588931353|FG005|Overall Study|No Longer Requires Study Drug|5|||
163003560|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003561|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163060926|NCT00171249|588931354|FG006|Overall Study|No Longer Requires Study Drug|0|||
163003562|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003563|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163060927|NCT00171249|588931348|FG000|Overall Study|Administrative Problems|1|||
163060928|NCT00171249|588931349|FG001|Overall Study|Administrative Problems|0|||
163325804|NCT02291913|589904598|FG000|Overall Study|Withdrawal by Subject|1|||
163325805|NCT02291913|589904598|FG000|Overall Study|Protocol Violation|1|||
163003564|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163060929|NCT00171249|588931350|FG002|Overall Study|Administrative Problems|0|||
163325806|NCT04876417|589904599|FG000|Overall Study|Lost to Follow-up|5|||
163325807|NCT04876417|589904600|FG001|Overall Study|Lost to Follow-up|8|||
163325808|NCT04876417|589904601|FG002|Overall Study|Lost to Follow-up|0|||
163325809|NCT04876417|589904602|FG003|Overall Study|Lost to Follow-up|0|||
163003565|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003566|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003567|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003568|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003569|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003570|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
163003571|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003572|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
163003573|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
163003574|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
163003575|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
163003576|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003577|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003578|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003579|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003580|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003581|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003582|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003583|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003584|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003585|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003586|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003587|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
163003588|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
163003589|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
163003590|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
163003591|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
163003592|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
163003593|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003594|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003595|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003596|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003597|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003598|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003599|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003600|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003601|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003602|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003603|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003604|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003605|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
163003606|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
163003607|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003608|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
163060930|NCT00171249|588931351|FG003|Overall Study|Administrative Problems|2|||
163060931|NCT00171249|588931352|FG004|Overall Study|Administrative Problems|0|||
163060932|NCT00171249|588931353|FG005|Overall Study|Administrative Problems|0|||
163060933|NCT00171249|588931354|FG006|Overall Study|Administrative Problems|0|||
163213365|NCT03525574|589495956|FG001|Overall Study|Enrolled but never dosed|0|||
163213366|NCT03525574|589495955|FG000|Overall Study|Not enrolled in 105 study|0|||
163213367|NCT03525574|589495956|FG001|Overall Study|Not enrolled in 105 study|3|||
163213368|NCT03227029|589495962|FG000|Overall Study|Child Wheezed (no treatment)|0|||
163213369|NCT03227029|589495963|FG001|Overall Study|Child Wheezed (no treatment)|1|||
163213370|NCT03227029|589495964|FG002|Overall Study|Child Wheezed (no treatment)|0|||
163213371|NCT03227029|589495962|FG000|Overall Study|No post RSV season visit due to COVID|3|||
163213372|NCT03227029|589495963|FG001|Overall Study|No post RSV season visit due to COVID|3|||
163213373|NCT03227029|589495964|FG002|Overall Study|No post RSV season visit due to COVID|2|||
163213374|NCT03227029|589495962|FG000|Overall Study|Not able to get to clinic|0|||
163213375|NCT03227029|589495963|FG001|Overall Study|Not able to get to clinic|0|||
163213376|NCT03227029|589495964|FG002|Overall Study|Not able to get to clinic|1|||
163213377|NCT03227029|589495962|FG000|Overall Study|Withdrawal by Subject|1|||
163003609|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
163060934|NCT00171249|588931348|FG000|Overall Study|Adverse Event|3|||
163060935|NCT00171249|588931349|FG001|Overall Study|Adverse Event|1|||
163213378|NCT03227029|589495963|FG001|Overall Study|Withdrawal by Subject|0|||
163213379|NCT03227029|589495964|FG002|Overall Study|Withdrawal by Subject|0|||
163213380|NCT03227029|589495962|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
163213381|NCT03227029|589495963|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
163003610|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163060936|NCT00171249|588931350|FG002|Overall Study|Adverse Event|0|||
163003611|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003612|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003613|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003614|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003615|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003616|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003617|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003618|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003619|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163213382|NCT03227029|589495964|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
163213383|NCT01291173|589495965|FG000|Overall Study|Adverse Event|0|||
163213384|NCT01291173|589495966|FG001|Overall Study|Adverse Event|3|||
163213385|NCT01291173|589495967|FG002|Overall Study|Adverse Event|1|||
163213386|NCT01291173|589495968|FG003|Overall Study|Adverse Event|3|||
163213387|NCT01291173|589495965|FG000|Overall Study|Protocol Violation|7|||
163213388|NCT01291173|589495966|FG001|Overall Study|Protocol Violation|2|||
163213389|NCT01291173|589495967|FG002|Overall Study|Protocol Violation|2|||
163213390|NCT01291173|589495968|FG003|Overall Study|Protocol Violation|5|||
163213391|NCT01291173|589495965|FG000|Overall Study|Withdrawal by Subject|6|||
163213392|NCT01291173|589495966|FG001|Overall Study|Withdrawal by Subject|4|||
163213393|NCT01291173|589495967|FG002|Overall Study|Withdrawal by Subject|4|||
163213394|NCT01291173|589495968|FG003|Overall Study|Withdrawal by Subject|2|||
163213395|NCT01291173|589495965|FG000|Overall Study|Lost to Follow-up|4|||
163213396|NCT01291173|589495966|FG001|Overall Study|Lost to Follow-up|6|||
163213397|NCT01291173|589495967|FG002|Overall Study|Lost to Follow-up|3|||
163213398|NCT01291173|589495968|FG003|Overall Study|Lost to Follow-up|2|||
163213399|NCT01291173|589495965|FG000|Overall Study|Unable to meet visit schedule|0|||
163213400|NCT01291173|589495966|FG001|Overall Study|Unable to meet visit schedule|0|||
163213401|NCT01291173|589495967|FG002|Overall Study|Unable to meet visit schedule|1|||
163213402|NCT01291173|589495968|FG003|Overall Study|Unable to meet visit schedule|0|||
163213403|NCT01291173|589495965|FG000|Overall Study|Lack of compliance|0|||
163213404|NCT01291173|589495966|FG001|Overall Study|Lack of compliance|0|||
163213405|NCT01291173|589495967|FG002|Overall Study|Lack of compliance|0|||
163213406|NCT01291173|589495968|FG003|Overall Study|Lack of compliance|1|||
163213407|NCT01291173|589495965|FG000|Overall Study|Subject was unblinded|0|||
163213408|NCT01291173|589495966|FG001|Overall Study|Subject was unblinded|0|||
163213409|NCT01291173|589495967|FG002|Overall Study|Subject was unblinded|1|||
163213410|NCT01291173|589495968|FG003|Overall Study|Subject was unblinded|0|||
163213411|NCT01291173|589495965|FG000|Overall Study|Excluded therapy|0|||
163213412|NCT01291173|589495966|FG001|Overall Study|Excluded therapy|0|||
163213413|NCT01291173|589495967|FG002|Overall Study|Excluded therapy|1|||
163213414|NCT01291173|589495968|FG003|Overall Study|Excluded therapy|0|||
163213415|NCT01074450|589495974|FG000|First Intervention|Emesis in Dosing Interval|0|||
163213416|NCT01074450|589495975|FG001|First Intervention|Emesis in Dosing Interval|2|||
163213417|NCT01074450|589495974|FG000|Second Intervention|Protocol Violation|1|||
163213418|NCT01074450|589495975|FG001|Second Intervention|Protocol Violation|0|||
163213419|NCT01074450|589495974|FG000|Second Intervention|Physician Decision|0|||
163213420|NCT01074450|589495975|FG001|Second Intervention|Physician Decision|1|||
163213421|NCT02728895|589495976|FG000|Overall Study|Other|1|||
163213422|NCT02728895|589495977|FG001|Overall Study|Other|2|||
163213423|NCT02728895|589495976|FG000|Overall Study|Withdrawal by Subject|0|||
163213424|NCT02728895|589495977|FG001|Overall Study|Withdrawal by Subject|3|||
163213425|NCT02769247|589495978|FG000|Overall Study|Withdrawal by Subject|1|||
163213426|NCT02769247|589495979|FG001|Overall Study|Withdrawal by Subject|0|||
163213427|NCT02769247|589495980|FG002|Overall Study|Withdrawal by Subject|0|||
163213428|NCT02769247|589495981|FG003|Overall Study|Withdrawal by Subject|1|||
163213429|NCT02769247|589495978|FG000|Overall Study|Protocol Violation|0|||
163213430|NCT02769247|589495979|FG001|Overall Study|Protocol Violation|0|||
163213431|NCT02769247|589495980|FG002|Overall Study|Protocol Violation|1|||
163325810|NCT04334317|589904603|FG000|Overall Study|Adverse Event|1|||
163325811|NCT04334317|589904604|FG001|Overall Study|Adverse Event|2|||
163325812|NCT04334317|589904605|FG002|Overall Study|Adverse Event|0|||
163325813|NCT04334317|589904606|FG003|Overall Study|Adverse Event|0|||
163325814|NCT04334317|589904603|FG000|Overall Study|Protocol Deviation|0|||
163325815|NCT04334317|589904604|FG001|Overall Study|Protocol Deviation|1|||
163213432|NCT02769247|589495981|FG003|Overall Study|Protocol Violation|0|||
163213433|NCT02769247|589495978|FG000|Overall Study|Physician Decision|1|||
163213434|NCT02769247|589495979|FG001|Overall Study|Physician Decision|0|||
163213435|NCT02769247|589495980|FG002|Overall Study|Physician Decision|0|||
163213436|NCT02769247|589495981|FG003|Overall Study|Physician Decision|0|||
163213437|NCT04788953|589495982|FG000|Overall Study|Adverse Event|1|||
163003620|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163213438|NCT04788953|589495983|FG001|Overall Study|Adverse Event|1|||
163213439|NCT04788953|589495982|FG000|Overall Study|Withdrawal by Subject|1|||
163213440|NCT04788953|589495983|FG001|Overall Study|Withdrawal by Subject|0|||
163213441|NCT04788953|589495982|FG000|Overall Study|Protocol Violation|0|||
163325816|NCT04334317|589904605|FG002|Overall Study|Protocol Deviation|0|||
163003621|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163325817|NCT04334317|589904606|FG003|Overall Study|Protocol Deviation|0|||
163325818|NCT04334317|589904603|FG000|Overall Study|Withdrawal by Subject|2|||
163325819|NCT04334317|589904604|FG001|Overall Study|Withdrawal by Subject|2|||
163325820|NCT04334317|589904605|FG002|Overall Study|Withdrawal by Subject|0|||
163325821|NCT04334317|589904606|FG003|Overall Study|Withdrawal by Subject|0|||
163325822|NCT03621735|589904607|FG000|Overall Study|Withdrawal by Subject|13|||
163325823|NCT03621735|589904608|FG001|Overall Study|Withdrawal by Subject|13|||
163325824|NCT00605306|589904611|FG000|Overall Study|Adverse Event|0|||
163325825|NCT00605306|589904612|FG001|Overall Study|Adverse Event|1|||
163325826|NCT03875313|589904615|FG000|Overall Study|Withdrawal by Subject|1|||
163325827|NCT03875313|589904616|FG001|Overall Study|Withdrawal by Subject|3|||
163325828|NCT03875313|589904617|FG002|Overall Study|Withdrawal by Subject|0|||
163325829|NCT03875313|589904618|FG003|Overall Study|Withdrawal by Subject|0|||
163325830|NCT03875313|589904619|FG004|Overall Study|Withdrawal by Subject|0|||
163325831|NCT03875313|589904615|FG000|Overall Study|Death|0|||
163325832|NCT03875313|589904616|FG001|Overall Study|Death|0|||
163325833|NCT03875313|589904617|FG002|Overall Study|Death|0|||
163325834|NCT03875313|589904618|FG003|Overall Study|Death|0|||
163325835|NCT03875313|589904619|FG004|Overall Study|Death|1|||
163325836|NCT03875313|589904615|FG000|Overall Study|Lost to Follow-up|0|||
163325837|NCT03875313|589904616|FG001|Overall Study|Lost to Follow-up|0|||
163325838|NCT03875313|589904617|FG002|Overall Study|Lost to Follow-up|0|||
163325839|NCT03875313|589904618|FG003|Overall Study|Lost to Follow-up|0|||
163325840|NCT03875313|589904619|FG004|Overall Study|Lost to Follow-up|1|||
163325841|NCT03875313|589904615|FG000|Overall Study|Study Termination by Sponsor|0|||
163325842|NCT03875313|589904616|FG001|Overall Study|Study Termination by Sponsor|1|||
163325843|NCT03875313|589904617|FG002|Overall Study|Study Termination by Sponsor|1|||
163325844|NCT03875313|589904618|FG003|Overall Study|Study Termination by Sponsor|0|||
163325845|NCT03875313|589904619|FG004|Overall Study|Study Termination by Sponsor|1|||
163325846|NCT03875313|589904615|FG000|Overall Study|New Anticancer Treatment|0|||
163325847|NCT03875313|589904616|FG001|Overall Study|New Anticancer Treatment|1|||
163325848|NCT03875313|589904617|FG002|Overall Study|New Anticancer Treatment|2|||
163325849|NCT03875313|589904618|FG003|Overall Study|New Anticancer Treatment|1|||
163325850|NCT03875313|589904619|FG004|Overall Study|New Anticancer Treatment|0|||
163325851|NCT03875313|589904615|FG000|Overall Study|Other, Not Specified|2|||
163325852|NCT03875313|589904616|FG001|Overall Study|Other, Not Specified|11|||
163325853|NCT03875313|589904617|FG002|Overall Study|Other, Not Specified|3|||
163325854|NCT03875313|589904618|FG003|Overall Study|Other, Not Specified|3|||
163325855|NCT03875313|589904619|FG004|Overall Study|Other, Not Specified|1|||
163325856|NCT01092416|589904620|FG000|Enrollment|Atherectomy device not inserted|3|||
163325857|NCT01092416|589904620|FG000|30-Day Follow-up|Death|2|||
163325858|NCT01092416|589904620|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
163325859|NCT01092416|589904620|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
163325860|NCT01092416|589904620|FG000|12-Month Follow-up|Death|16|||
163325861|NCT01092416|589904620|FG000|12-Month Follow-up|Lost to Follow-up|4|||
163325862|NCT01092416|589904620|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
163325863|NCT01092416|589904620|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
163325864|NCT01092416|589904620|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
163325865|NCT03709706|589904621|FG000|Overall Study|Adverse Event|0|||
163325866|NCT03709706|589904622|FG001|Overall Study|Adverse Event|1|||
163325867|NCT03709706|589904621|FG000|Overall Study|Physician Decision|14|||
163325868|NCT03709706|589904622|FG001|Overall Study|Physician Decision|8|||
163325869|NCT03709706|589904621|FG000|Overall Study|Withdrawal by Subject|2|||
163325870|NCT03709706|589904622|FG001|Overall Study|Withdrawal by Subject|1|||
163325871|NCT03709706|589904621|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
163325872|NCT03709706|589904622|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
163325873|NCT01105975|589904623|FG000|Overall Study|Adverse Event|2|||
163325874|NCT01105975|589904624|FG001|Overall Study|Adverse Event|1|||
163003622|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003623|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
163003624|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
163003625|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003626|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163325875|NCT01105975|589904625|FG002|Overall Study|Adverse Event|5|||
163325876|NCT01105975|589904626|FG003|Overall Study|Adverse Event|1|||
163325877|NCT01105975|589904627|FG004|Overall Study|Adverse Event|0|||
163325878|NCT01105975|589904628|FG005|Overall Study|Adverse Event|1|||
163325879|NCT01105975|589904629|FG006|Overall Study|Adverse Event|2|||
163325880|NCT01105975|589904630|FG007|Overall Study|Adverse Event|4|||
163325881|NCT01105975|589904631|FG008|Overall Study|Adverse Event|1|||
163003627|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163325882|NCT01105975|589904632|FG009|Overall Study|Adverse Event|4|||
163325883|NCT01105975|589904623|FG000|Overall Study|Withdrawal by Subject|2|||
163325884|NCT01105975|589904624|FG001|Overall Study|Withdrawal by Subject|2|||
163003628|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003629|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163213442|NCT04788953|589495983|FG001|Overall Study|Protocol Violation|1|||
163213443|NCT00469092|589495984|FG000|Overall Study|Adverse Event|5|||
163213444|NCT00469092|589495985|FG001|Overall Study|Adverse Event|4|||
163213445|NCT00469092|589495984|FG000|Overall Study|Lack of Efficacy|1|||
163213446|NCT00469092|589495985|FG001|Overall Study|Lack of Efficacy|0|||
163213447|NCT00469092|589495984|FG000|Overall Study|Lost to Follow-up|1|||
163213448|NCT00469092|589495985|FG001|Overall Study|Lost to Follow-up|2|||
163213449|NCT00469092|589495984|FG000|Overall Study|Protocol Violation|3|||
163213450|NCT00469092|589495985|FG001|Overall Study|Protocol Violation|3|||
163003630|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003631|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003632|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003633|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003634|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003635|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003636|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003637|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003638|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003639|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003640|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003641|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163213451|NCT00469092|589495984|FG000|Overall Study|Withdrawal by Subject|4|||
163213452|NCT00469092|589495985|FG001|Overall Study|Withdrawal by Subject|4|||
163213453|NCT00469092|589495984|FG000|Overall Study|Withdrawal Criteria|3|||
163213454|NCT00469092|589495985|FG001|Overall Study|Withdrawal Criteria|4|||
163213455|NCT00469092|589495984|FG000|Overall Study|Incorrectly Randomised|4|||
163213456|NCT00469092|589495985|FG001|Overall Study|Incorrectly Randomised|3|||
163213457|NCT00469092|589495984|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
163213458|NCT00469092|589495985|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
163213459|NCT00469092|589495984|FG000|Overall Study|Use of lipid lowering drug|1|||
163213460|NCT00469092|589495985|FG001|Overall Study|Use of lipid lowering drug|0|||
163213461|NCT00469092|589495984|FG000|Overall Study|Hypoglycaemic Episodes|1|||
163213462|NCT00469092|589495985|FG001|Overall Study|Hypoglycaemic Episodes|1|||
163213463|NCT00469092|589495984|FG000|Overall Study|Abnormal lab value|1|||
163213464|NCT00469092|589495985|FG001|Overall Study|Abnormal lab value|0|||
163213465|NCT00469092|589495984|FG000|Overall Study|Use of Corticosteroid|1|||
163213466|NCT00469092|589495985|FG001|Overall Study|Use of Corticosteroid|0|||
163213467|NCT01086540|589495987|FG000|Overall Study|Death|3|||
163213468|NCT01086540|589495988|FG001|Overall Study|Death|1|||
163213469|NCT01086540|589495987|FG000|Overall Study|Physician Decision|2|||
163213470|NCT01086540|589495988|FG001|Overall Study|Physician Decision|1|||
163213471|NCT01086540|589495987|FG000|Overall Study|Addition of new therapy for PAH|1|||
163213472|NCT01086540|589495988|FG001|Overall Study|Addition of new therapy for PAH|0|||
163213473|NCT02707991|589495989|FG000|Overall Study|Protocol Violation|1|||
163213474|NCT02707991|589495990|FG001|Overall Study|Protocol Violation|0|||
163213475|NCT02707991|589495989|FG000|Overall Study|Became ineligible|0|||
163213476|NCT02707991|589495990|FG001|Overall Study|Became ineligible|1|||
163213477|NCT02659631|589495993|FG000|Overall Study|Lost to Follow-up|0|||
163213478|NCT02659631|589495994|FG001|Overall Study|Lost to Follow-up|0|||
163003642|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
163003643|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003644|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003645|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003646|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003647|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003648|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003649|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003650|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003651|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003652|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003653|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163060937|NCT00171249|588931351|FG003|Overall Study|Adverse Event|15|||
163060938|NCT00171249|588931352|FG004|Overall Study|Adverse Event|0|||
163213479|NCT02659631|589495995|FG002|Overall Study|Lost to Follow-up|2|||
163213480|NCT02659631|589495996|FG003|Overall Study|Lost to Follow-up|0|||
163213481|NCT02659631|589495997|FG004|Overall Study|Lost to Follow-up|0|||
163213482|NCT02659631|589495998|FG005|Overall Study|Lost to Follow-up|1|||
163213483|NCT02659631|589495999|FG006|Overall Study|Lost to Follow-up|0|||
163213484|NCT02659631|589496000|FG007|Overall Study|Lost to Follow-up|0|||
163213485|NCT02659631|589496001|FG008|Overall Study|Lost to Follow-up|0|||
163213486|NCT02659631|589496002|FG009|Overall Study|Lost to Follow-up|0|||
163060939|NCT00171249|588931353|FG005|Overall Study|Adverse Event|2|||
163060940|NCT00171249|588931354|FG006|Overall Study|Adverse Event|0|||
163060941|NCT00171249|588931348|FG000|Overall Study|Lost to Follow-up|5|||
163060942|NCT00171249|588931349|FG001|Overall Study|Lost to Follow-up|0|||
163060943|NCT00171249|588931350|FG002|Overall Study|Lost to Follow-up|0|||
163325885|NCT01105975|589904625|FG002|Overall Study|Withdrawal by Subject|2|||
163325886|NCT01105975|589904626|FG003|Overall Study|Withdrawal by Subject|0|||
163325887|NCT01105975|589904627|FG004|Overall Study|Withdrawal by Subject|4|||
163325888|NCT01105975|589904628|FG005|Overall Study|Withdrawal by Subject|1|||
163325889|NCT01105975|589904629|FG006|Overall Study|Withdrawal by Subject|2|||
163325890|NCT01105975|589904630|FG007|Overall Study|Withdrawal by Subject|1|||
163325891|NCT01105975|589904631|FG008|Overall Study|Withdrawal by Subject|0|||
163325892|NCT01105975|589904632|FG009|Overall Study|Withdrawal by Subject|3|||
163325893|NCT01105975|589904623|FG000|Overall Study|Lost to Follow-up|1|||
163325894|NCT01105975|589904624|FG001|Overall Study|Lost to Follow-up|0|||
163325895|NCT01105975|589904625|FG002|Overall Study|Lost to Follow-up|0|||
163325896|NCT01105975|589904626|FG003|Overall Study|Lost to Follow-up|1|||
163325897|NCT01105975|589904627|FG004|Overall Study|Lost to Follow-up|1|||
163325898|NCT01105975|589904628|FG005|Overall Study|Lost to Follow-up|0|||
163325899|NCT01105975|589904629|FG006|Overall Study|Lost to Follow-up|0|||
163325900|NCT01105975|589904630|FG007|Overall Study|Lost to Follow-up|0|||
163325901|NCT01105975|589904631|FG008|Overall Study|Lost to Follow-up|1|||
163325902|NCT01105975|589904632|FG009|Overall Study|Lost to Follow-up|0|||
163003654|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003655|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003656|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
163003657|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003658|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003659|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003660|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003661|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003662|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003663|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003664|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003665|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003666|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003667|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003668|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003669|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003670|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003671|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003672|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003673|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
163003674|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003675|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003676|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003677|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003678|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003679|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003680|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003681|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003682|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003683|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003684|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003685|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003686|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003687|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003688|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003689|NCT00758524|588713331|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003690|NCT00758524|588713332|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003691|NCT00758524|588713333|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003692|NCT00758524|588713334|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003693|NCT00758524|588713335|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003694|NCT00758524|588713336|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163060944|NCT00171249|588931351|FG003|Overall Study|Lost to Follow-up|9|||
163325903|NCT01105975|589904623|FG000|Overall Study|Physician Decision|0|||
163325904|NCT01105975|589904624|FG001|Overall Study|Physician Decision|0|||
163325905|NCT01105975|589904625|FG002|Overall Study|Physician Decision|0|||
163003695|NCT00758524|588713337|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003696|NCT00758524|588713338|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003697|NCT00758524|588713339|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
163003698|NCT00758524|588713340|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003699|NCT00758524|588713341|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003700|NCT00758524|588713342|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003701|NCT00758524|588713343|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003702|NCT00758524|588713344|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003703|NCT00758524|588713345|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003704|NCT00758524|588713346|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003705|NCT00758524|588713347|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003706|NCT00758524|588713331|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003707|NCT00758524|588713332|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003708|NCT00758524|588713333|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003709|NCT00758524|588713334|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003710|NCT00758524|588713335|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163060945|NCT00171249|588931352|FG004|Overall Study|Lost to Follow-up|0|||
163060946|NCT00171249|588931353|FG005|Overall Study|Lost to Follow-up|0|||
163060947|NCT00171249|588931354|FG006|Overall Study|Lost to Follow-up|0|||
163060948|NCT02783690|588931357|FG000|Overall Study|Withdrawal by Subject|3|||
163060949|NCT02783690|588931358|FG001|Overall Study|Withdrawal by Subject|3|||
163060950|NCT01114724|588931359|FG000|Overall Study|Death|8|||
163060951|NCT01114724|588931359|FG000|Overall Study|Lost to Follow-up|1|||
163060952|NCT01114724|588931359|FG000|Overall Study|Withdrawal by Subject|1|||
163060953|NCT04585893|588931360|FG000|Overall Study|Death|1|||
163060954|NCT04585893|588931361|FG001|Overall Study|Death|0|||
163060955|NCT06178991|588931364|FG000|Overall Study|Withdrawal by Subject|2|||
163060956|NCT06178991|588931365|FG001|Overall Study|Withdrawal by Subject|6|||
163060957|NCT06178991|588931366|FG002|Overall Study|Withdrawal by Subject|44|||
163060958|NCT06178991|588931367|FG003|Overall Study|Withdrawal by Subject|23|||
163060959|NCT06178991|588931368|FG004|Overall Study|Withdrawal by Subject|7|||
163060960|NCT06178991|588931369|FG005|Overall Study|Withdrawal by Subject|7|||
163060961|NCT06178991|588931370|FG006|Overall Study|Withdrawal by Subject|7|||
163060962|NCT06178991|588931371|FG007|Overall Study|Withdrawal by Subject|5|||
163060963|NCT06178991|588931364|FG000|Overall Study|Lost to Follow-up|2|||
163060964|NCT06178991|588931365|FG001|Overall Study|Lost to Follow-up|4|||
163060965|NCT06178991|588931366|FG002|Overall Study|Lost to Follow-up|133|||
163325906|NCT01105975|589904626|FG003|Overall Study|Physician Decision|0|||
163325907|NCT01105975|589904627|FG004|Overall Study|Physician Decision|0|||
163325908|NCT01105975|589904628|FG005|Overall Study|Physician Decision|0|||
163325909|NCT01105975|589904629|FG006|Overall Study|Physician Decision|2|||
163325910|NCT01105975|589904630|FG007|Overall Study|Physician Decision|0|||
163325911|NCT01105975|589904631|FG008|Overall Study|Physician Decision|0|||
163325912|NCT01105975|589904632|FG009|Overall Study|Physician Decision|0|||
163325913|NCT01105975|589904623|FG000|Overall Study|Protocol Violation|0|||
163325914|NCT01105975|589904624|FG001|Overall Study|Protocol Violation|2|||
163325915|NCT01105975|589904625|FG002|Overall Study|Protocol Violation|2|||
163325916|NCT01105975|589904626|FG003|Overall Study|Protocol Violation|0|||
163325917|NCT01105975|589904627|FG004|Overall Study|Protocol Violation|1|||
163325918|NCT01105975|589904628|FG005|Overall Study|Protocol Violation|1|||
163325919|NCT01105975|589904629|FG006|Overall Study|Protocol Violation|1|||
163325920|NCT01105975|589904630|FG007|Overall Study|Protocol Violation|1|||
163325921|NCT01105975|589904631|FG008|Overall Study|Protocol Violation|2|||
163325922|NCT01105975|589904632|FG009|Overall Study|Protocol Violation|2|||
163325923|NCT01105975|589904623|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
163325924|NCT01105975|589904624|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
163325925|NCT01105975|589904625|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
163325926|NCT01105975|589904626|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
163325927|NCT01105975|589904627|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
163325928|NCT01105975|589904628|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
163060966|NCT06178991|588931367|FG003|Overall Study|Lost to Follow-up|65|||
163060967|NCT06178991|588931368|FG004|Overall Study|Lost to Follow-up|68|||
163325929|NCT01105975|589904629|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
163325930|NCT01105975|589904630|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
163325931|NCT01105975|589904631|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
163325932|NCT01105975|589904632|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
163325933|NCT04868617|589904633|FG000|Overall Study|Death|1|||
163325934|NCT04868617|589904634|FG001|Overall Study|Death|0|||
163060968|NCT06178991|588931369|FG005|Overall Study|Lost to Follow-up|57|||
163060969|NCT06178991|588931370|FG006|Overall Study|Lost to Follow-up|25|||
163325935|NCT04868617|589904633|FG000|Overall Study|Adverse Event|1|||
163325936|NCT04868617|589904634|FG001|Overall Study|Adverse Event|0|||
163325937|NCT04868617|589904633|FG000|Overall Study|Withdrawal by Subject|1|||
163003711|NCT00758524|588713336|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003712|NCT00758524|588713337|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
163003713|NCT00758524|588713338|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003714|NCT00758524|588713339|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003715|NCT00758524|588713340|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003716|NCT00758524|588713341|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003717|NCT00758524|588713342|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003718|NCT00758524|588713343|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003719|NCT00758524|588713344|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003720|NCT00758524|588713345|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003721|NCT00758524|588713346|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003722|NCT00758524|588713347|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003723|NCT04176250|588713348|FG000|Overall Study|Adverse Event|0|||
163003724|NCT04176250|588713349|FG001|Overall Study|Adverse Event|1|||
163003725|NCT04176250|588713350|FG002|Overall Study|Adverse Event|0|||
163003726|NCT04176250|588713351|FG003|Overall Study|Adverse Event|1|||
163003727|NCT04176250|588713352|FG004|Overall Study|Adverse Event|0|||
163003728|NCT04176250|588713353|FG005|Overall Study|Adverse Event|1|||
163003729|NCT04176250|588713348|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
163003730|NCT04176250|588713349|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
163003731|NCT04176250|588713350|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
163003732|NCT04176250|588713351|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
163003733|NCT04176250|588713352|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
163003734|NCT04176250|588713353|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
163003735|NCT04176250|588713348|FG000|Overall Study|Withdrawal by Subject|0|||
163003736|NCT04176250|588713349|FG001|Overall Study|Withdrawal by Subject|0|||
163003737|NCT04176250|588713350|FG002|Overall Study|Withdrawal by Subject|0|||
163003738|NCT04176250|588713351|FG003|Overall Study|Withdrawal by Subject|0|||
163003739|NCT04176250|588713352|FG004|Overall Study|Withdrawal by Subject|0|||
163003740|NCT04176250|588713353|FG005|Overall Study|Withdrawal by Subject|1|||
163003741|NCT04176250|588713348|FG000|Overall Study|Randomized in error|0|||
163003742|NCT04176250|588713349|FG001|Overall Study|Randomized in error|0|||
163003743|NCT04176250|588713350|FG002|Overall Study|Randomized in error|0|||
163003744|NCT04176250|588713351|FG003|Overall Study|Randomized in error|0|||
163003745|NCT04176250|588713352|FG004|Overall Study|Randomized in error|1|||
163003746|NCT04176250|588713353|FG005|Overall Study|Randomized in error|0|||
163003747|NCT04688671|588713354|FG000|Overall Study|Adverse Event|3|||
163003748|NCT04688671|588713355|FG001|Overall Study|Adverse Event|1|||
163003749|NCT04688671|588713354|FG000|Overall Study|Withdrawal by Subject|3|||
163003750|NCT04688671|588713355|FG001|Overall Study|Withdrawal by Subject|1|||
163003751|NCT04688671|588713354|FG000|Overall Study|Lack of Efficacy|1|||
163003752|NCT04688671|588713355|FG001|Overall Study|Lack of Efficacy|1|||
163003753|NCT04688671|588713354|FG000|Overall Study|Protocol Violation|1|||
163003754|NCT04688671|588713355|FG001|Overall Study|Protocol Violation|0|||
163003755|NCT04688671|588713354|FG000|Overall Study|Lost to Follow-up|0|||
163003756|NCT04688671|588713355|FG001|Overall Study|Lost to Follow-up|1|||
163003757|NCT01350271|588713356|FG000|Overall Study|Lost to Follow-up|21|||
163003758|NCT01350271|588713357|FG001|Overall Study|Lost to Follow-up|17|||
163003759|NCT01350271|588713358|FG002|Overall Study|Lost to Follow-up|26|||
163003760|NCT01973439|588713359|FG000|Overall Study|Lost samples from one PK Day|2|||
163003761|NCT01973439|588713359|FG000|Overall Study|Vomiting after commencing once daily|1|||
163003762|NCT01973439|588713359|FG000|Overall Study|PK curve incomplete|2|||
163003763|NCT00344448|588713360|FG000|Screening|Withdrawal by Subject|0|||
163003764|NCT00344448|588713361|FG001|Screening|Withdrawal by Subject|1|||
163003765|NCT00344448|588713360|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
163003766|NCT00344448|588713361|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
163003767|NCT00344448|588713360|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
163003768|NCT00344448|588713361|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
163003769|NCT00344448|588713360|FG000|Open Label|Withdrawal by Subject|1|||
163003770|NCT00344448|588713361|FG001|Open Label|Withdrawal by Subject|1|||
163003771|NCT00344448|588713360|FG000|Open Label|Study terminated|1|||
163003772|NCT00344448|588713361|FG001|Open Label|Study terminated|0|||
163003773|NCT02096744|588713384|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
163213487|NCT02659631|589495993|FG000|Overall Study|Withdrawal prior to treatment|0|||
163213488|NCT02659631|589495994|FG001|Overall Study|Withdrawal prior to treatment|0|||
163213489|NCT02659631|589495995|FG002|Overall Study|Withdrawal prior to treatment|0|||
163213490|NCT02659631|589495996|FG003|Overall Study|Withdrawal prior to treatment|0|||
163213491|NCT02659631|589495997|FG004|Overall Study|Withdrawal prior to treatment|1|||
163213492|NCT02659631|589495998|FG005|Overall Study|Withdrawal prior to treatment|0|||
163213493|NCT02659631|589495999|FG006|Overall Study|Withdrawal prior to treatment|0|||
163325938|NCT04868617|589904634|FG001|Overall Study|Withdrawal by Subject|0|||
163325939|NCT04868617|589904633|FG000|Overall Study|Device deficiency|1|||
163325940|NCT04868617|589904634|FG001|Overall Study|Device deficiency|0|||
163325941|NCT00686595|589904637|FG000|Overall Study|Adverse Event|3|||
163325942|NCT00686595|589904637|FG000|Overall Study|Protocol Violation|1|||
163325943|NCT00686595|589904637|FG000|Overall Study|Lost to Follow-up|1|||
163325944|NCT00686595|589904637|FG000|Overall Study|Lack of Efficacy|1|||
163325945|NCT00686595|589904637|FG000|Overall Study|Poor Compliance|1|||
163325946|NCT01315132|589904640|FG000|Overall Study|not treated due to disease progression|1|||
163325947|NCT04158141|589904648|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
163325948|NCT04158141|589904649|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
163325949|NCT04158141|589904650|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
163325950|NCT04158141|589904648|FG000|Step 1: Registration|Adverse Event|1|||
163325951|NCT04158141|589904649|FG001|Step 1: Registration|Adverse Event|0|||
163325952|NCT04158141|589904650|FG002|Step 1: Registration|Adverse Event|0|||
163325953|NCT04158141|589904648|FG000|Step 1: Registration|Withdrawal by Subject|1|||
163325954|NCT04158141|589904649|FG001|Step 1: Registration|Withdrawal by Subject|0|||
163325955|NCT04158141|589904650|FG002|Step 1: Registration|Withdrawal by Subject|0|||
163325956|NCT04158141|589904648|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
163325957|NCT04158141|589904649|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
163325958|NCT04158141|589904650|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
163325959|NCT00319696|589904654|FG000|Overall Study|Adverse Event|36|||
163325960|NCT00319696|589904654|FG000|Overall Study|withdrawal of consent|14|||
163325961|NCT00319696|589904654|FG000|Overall Study|administrative|7|||
163325962|NCT00319696|589904654|FG000|Overall Study|Lost to Follow-up|3|||
163325963|NCT03777657|589904655|FG000|Overall Study|Death|397|||
163325964|NCT03777657|589904656|FG001|Overall Study|Death|431|||
163003774|NCT02096744|588713385|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
163003775|NCT02096744|588713384|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
163003776|NCT02096744|588713385|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
163003777|NCT02096744|588713384|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
163003778|NCT02096744|588713385|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
163003779|NCT05724589|588713391|FG000|Overall Study|Lost to Follow-up|1|||
163003780|NCT01070953|588713394|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
163003781|NCT01070953|588713394|FG000|Participants for Safety Evaluation|Off-label use|283|||
163003782|NCT01070953|588713394|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
163003783|NCT01070953|588713394|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
163003784|NCT01070953|588713394|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
163003785|NCT01070953|588713394|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
163003786|NCT01070953|588713394|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
163003787|NCT01070953|588713394|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
163003788|NCT01070953|588713394|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
163003789|NCT01070953|588713394|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
163003790|NCT04700137|588713395|FG000|Overall Study|Lost to Follow-up|1|||
163003791|NCT04700137|588713396|FG001|Overall Study|Lost to Follow-up|6|||
163003792|NCT04700137|588713397|FG002|Overall Study|Lost to Follow-up|1|||
163003793|NCT04700137|588713398|FG003|Overall Study|Lost to Follow-up|1|||
163003794|NCT04700137|588713395|FG000|Overall Study|Withdrawal by Subject|0|||
163003795|NCT04700137|588713396|FG001|Overall Study|Withdrawal by Subject|0|||
163003796|NCT04700137|588713397|FG002|Overall Study|Withdrawal by Subject|1|||
163003797|NCT04700137|588713398|FG003|Overall Study|Withdrawal by Subject|0|||
163003798|NCT04700137|588713395|FG000|Overall Study|Death|0|||
163003799|NCT04700137|588713396|FG001|Overall Study|Death|0|||
163003800|NCT04700137|588713397|FG002|Overall Study|Death|1|||
163003801|NCT04700137|588713398|FG003|Overall Study|Death|0|||
163003802|NCT03449446|588713404|FG000|Overall Study|Randomized but Never Treated|0|||
163003803|NCT03449446|588713405|FG001|Overall Study|Randomized but Never Treated|0|||
163003804|NCT03449446|588713406|FG002|Overall Study|Randomized but Never Treated|1|||
163003805|NCT03449446|588713407|FG003|Overall Study|Randomized but Never Treated|1|||
163003806|NCT03449446|588713408|FG004|Overall Study|Randomized but Never Treated|1|||
163003807|NCT03449446|588713409|FG005|Overall Study|Randomized but Never Treated|0|||
163003808|NCT03449446|588713410|FG006|Overall Study|Randomized but Never Treated|0|||
163003809|NCT03449446|588713404|FG000|Overall Study|Unknown Reason|33|||
163003810|NCT03449446|588713405|FG001|Overall Study|Unknown Reason|1|||
163003811|NCT03449446|588713406|FG002|Overall Study|Unknown Reason|1|||
163003812|NCT03449446|588713407|FG003|Overall Study|Unknown Reason|1|||
163325965|NCT03777657|589904655|FG000|Overall Study|Study Closed by Sponsor|77|||
163003813|NCT03449446|588713408|FG004|Overall Study|Unknown Reason|2|||
163003814|NCT03449446|588713409|FG005|Overall Study|Unknown Reason|2|||
163003815|NCT03449446|588713410|FG006|Overall Study|Unknown Reason|0|||
163325966|NCT03777657|589904656|FG001|Overall Study|Study Closed by Sponsor|38|||
163325967|NCT03777657|589904655|FG000|Overall Study|Withdrawal by Subject|20|||
163003816|NCT03449446|588713404|FG000|Overall Study|Withdrew Consent|1|||
163003817|NCT03449446|588713405|FG001|Overall Study|Withdrew Consent|3|||
163003818|NCT03449446|588713406|FG002|Overall Study|Withdrew Consent|1|||
163003819|NCT03449446|588713407|FG003|Overall Study|Withdrew Consent|4|||
163003820|NCT03449446|588713408|FG004|Overall Study|Withdrew Consent|4|||
163003821|NCT03449446|588713409|FG005|Overall Study|Withdrew Consent|4|||
163003822|NCT03449446|588713410|FG006|Overall Study|Withdrew Consent|1|||
163003823|NCT03449446|588713404|FG000|Overall Study|Adverse Event|1|||
163003824|NCT03449446|588713405|FG001|Overall Study|Adverse Event|2|||
163003825|NCT03449446|588713406|FG002|Overall Study|Adverse Event|1|||
163003826|NCT03449446|588713407|FG003|Overall Study|Adverse Event|0|||
163003827|NCT03449446|588713408|FG004|Overall Study|Adverse Event|0|||
163003828|NCT03449446|588713409|FG005|Overall Study|Adverse Event|2|||
163003829|NCT03449446|588713410|FG006|Overall Study|Adverse Event|0|||
163003830|NCT03449446|588713404|FG000|Overall Study|Lost to Follow-up|0|||
163003831|NCT03449446|588713405|FG001|Overall Study|Lost to Follow-up|0|||
163003832|NCT03449446|588713406|FG002|Overall Study|Lost to Follow-up|2|||
163003833|NCT03449446|588713407|FG003|Overall Study|Lost to Follow-up|1|||
163003834|NCT03449446|588713408|FG004|Overall Study|Lost to Follow-up|3|||
163003835|NCT03449446|588713409|FG005|Overall Study|Lost to Follow-up|0|||
163003836|NCT03449446|588713410|FG006|Overall Study|Lost to Follow-up|0|||
163003837|NCT03449446|588713404|FG000|Overall Study|Investigator's Discretion|0|||
163003838|NCT03449446|588713405|FG001|Overall Study|Investigator's Discretion|1|||
163003839|NCT03449446|588713406|FG002|Overall Study|Investigator's Discretion|1|||
163003840|NCT03449446|588713407|FG003|Overall Study|Investigator's Discretion|2|||
163003841|NCT03449446|588713408|FG004|Overall Study|Investigator's Discretion|0|||
163003842|NCT03449446|588713409|FG005|Overall Study|Investigator's Discretion|0|||
163003843|NCT03449446|588713410|FG006|Overall Study|Investigator's Discretion|0|||
163003844|NCT03449446|588713404|FG000|Overall Study|Non Compliance with Study Drug|1|||
163003845|NCT03449446|588713405|FG001|Overall Study|Non Compliance with Study Drug|0|||
163003846|NCT03449446|588713406|FG002|Overall Study|Non Compliance with Study Drug|0|||
163003847|NCT03449446|588713407|FG003|Overall Study|Non Compliance with Study Drug|0|||
163003848|NCT03449446|588713408|FG004|Overall Study|Non Compliance with Study Drug|0|||
163003849|NCT03449446|588713409|FG005|Overall Study|Non Compliance with Study Drug|0|||
163003850|NCT03449446|588713410|FG006|Overall Study|Non Compliance with Study Drug|0|||
163003851|NCT03449446|588713404|FG000|Overall Study|Protocol Violation|0|||
163003852|NCT03449446|588713405|FG001|Overall Study|Protocol Violation|0|||
163003853|NCT03449446|588713406|FG002|Overall Study|Protocol Violation|0|||
163003854|NCT03449446|588713407|FG003|Overall Study|Protocol Violation|0|||
163003855|NCT03449446|588713408|FG004|Overall Study|Protocol Violation|1|||
163003856|NCT03449446|588713409|FG005|Overall Study|Protocol Violation|1|||
163003857|NCT03449446|588713410|FG006|Overall Study|Protocol Violation|0|||
163003858|NCT03449446|588713404|FG000|Overall Study|Death|0|||
163003859|NCT03449446|588713405|FG001|Overall Study|Death|0|||
163003860|NCT03449446|588713406|FG002|Overall Study|Death|0|||
163003861|NCT03449446|588713407|FG003|Overall Study|Death|0|||
163003862|NCT03449446|588713408|FG004|Overall Study|Death|1|||
163003863|NCT03449446|588713409|FG005|Overall Study|Death|0|||
163003864|NCT03449446|588713410|FG006|Overall Study|Death|0|||
163003865|NCT03180645|588713423|FG000|Overall Study|Adverse Event|0|||
163003866|NCT03180645|588713424|FG001|Overall Study|Adverse Event|1|||
163003867|NCT03180645|588713425|FG002|Overall Study|Adverse Event|2|||
163003868|NCT04208750|588713426|FG000|Overall Study|Lost to Follow-up|16|||
163003869|NCT04208750|588713427|FG001|Overall Study|Lost to Follow-up|15|||
163003870|NCT02201277|588713428|FG000|Overall Study|Death|3|||
163003871|NCT02201277|588713429|FG001|Overall Study|Death|4|||
163003872|NCT02201277|588713428|FG000|Overall Study|Lost to Follow-up|2|||
163003873|NCT02201277|588713429|FG001|Overall Study|Lost to Follow-up|1|||
163003874|NCT02201277|588713428|FG000|Overall Study|Failed retrieval|1|||
163003875|NCT02201277|588713429|FG001|Overall Study|Failed retrieval|0|||
163003876|NCT02201277|588713428|FG000|Overall Study|Physician Decision|1|||
163003877|NCT02201277|588713429|FG001|Overall Study|Physician Decision|0|||
163003878|NCT00866359|588713431|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
163003879|NCT00866359|588713432|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
163003880|NCT00866359|588713433|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
163003881|NCT00866359|588713434|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
163003882|NCT00866359|588713431|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
163003883|NCT00866359|588713432|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
163003884|NCT00866359|588713433|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
163003885|NCT00866359|588713434|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
163003886|NCT00866359|588713431|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
163003887|NCT00866359|588713432|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
163003888|NCT00866359|588713433|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
163003889|NCT00866359|588713434|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
163003890|NCT00866359|588713431|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
163003891|NCT00866359|588713432|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
163003892|NCT00866359|588713433|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
163060970|NCT06178991|588931371|FG007|Overall Study|Lost to Follow-up|18|||
163003893|NCT00866359|588713434|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
163003894|NCT00866359|588713431|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
163003895|NCT00866359|588713432|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
163003896|NCT00866359|588713433|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
163003897|NCT00866359|588713434|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
163003898|NCT00866359|588713431|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
163003899|NCT00866359|588713432|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
163003900|NCT00866359|588713433|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
163003901|NCT00866359|588713434|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
163003902|NCT01625091|588713435|FG000|Intervention|Death|1|||
163003903|NCT01625091|588713436|FG001|Intervention|Death|1|||
163003904|NCT01625091|588713435|FG000|Intervention|Withdrawal by Subject|4|||
163003905|NCT01625091|588713436|FG001|Intervention|Withdrawal by Subject|1|||
163003906|NCT01625091|588713435|FG000|Intervention|Adverse Event|0|||
163003907|NCT01625091|588713436|FG001|Intervention|Adverse Event|2|||
163003908|NCT01625091|588713435|FG000|Intervention|Lost to Follow-up|4|||
163003909|NCT01625091|588713436|FG001|Intervention|Lost to Follow-up|4|||
163003910|NCT01625091|588713435|FG000|Intervention|Study termination|2|||
163003911|NCT01625091|588713436|FG001|Intervention|Study termination|3|||
163003912|NCT01625091|588713435|FG000|Post-intervention|Death|0|||
163003913|NCT01625091|588713436|FG001|Post-intervention|Death|1|||
163003914|NCT01625091|588713435|FG000|Post-intervention|Lost to Follow-up|2|||
163003915|NCT01625091|588713436|FG001|Post-intervention|Lost to Follow-up|0|||
163003916|NCT01625091|588713435|FG000|Post-intervention|Study termination|2|||
163003917|NCT01625091|588713436|FG001|Post-intervention|Study termination|1|||
163003918|NCT02163057|588713437|FG000|Overall Study|Participant Refusal to Continue|2|||
163003919|NCT02163057|588713438|FG001|Overall Study|Participant Refusal to Continue|2|||
163003920|NCT02163057|588713437|FG000|Overall Study|Participant Significant Noncompliance|0|||
163003921|NCT02163057|588713438|FG001|Overall Study|Participant Significant Noncompliance|1|||
163003922|NCT02163057|588713437|FG000|Overall Study|Progression of Disease|1|||
163003923|NCT02163057|588713438|FG001|Overall Study|Progression of Disease|2|||
163003924|NCT01547390|588713445|FG000|Overall Study|Withdrawal by Subject|10|||
163003925|NCT01547390|588713446|FG001|Overall Study|Withdrawal by Subject|7|||
163003926|NCT01547390|588713445|FG000|Overall Study|termination of pregnancy|0|||
163003927|NCT01547390|588713446|FG001|Overall Study|termination of pregnancy|1|||
163003928|NCT01547390|588713445|FG000|Overall Study|Lost to Follow-up|0|||
163003929|NCT01547390|588713446|FG001|Overall Study|Lost to Follow-up|2|||
163003930|NCT01547390|588713445|FG000|Overall Study|Adverse Event|3|||
163060971|NCT06178991|588931364|FG000|Overall Study|Death|1|||
163060972|NCT06178991|588931365|FG001|Overall Study|Death|0|||
163060973|NCT06178991|588931366|FG002|Overall Study|Death|2|||
163060974|NCT06178991|588931367|FG003|Overall Study|Death|1|||
163060975|NCT06178991|588931368|FG004|Overall Study|Death|1|||
163060976|NCT06178991|588931369|FG005|Overall Study|Death|0|||
163060977|NCT06178991|588931370|FG006|Overall Study|Death|1|||
163060978|NCT06178991|588931371|FG007|Overall Study|Death|1|||
163060979|NCT06178991|588931364|FG000|Overall Study|Randomized but not Vaccinated|4|||
163060980|NCT06178991|588931365|FG001|Overall Study|Randomized but not Vaccinated|1|||
163060981|NCT06178991|588931366|FG002|Overall Study|Randomized but not Vaccinated|15|||
163060982|NCT06178991|588931367|FG003|Overall Study|Randomized but not Vaccinated|9|||
163060983|NCT06178991|588931368|FG004|Overall Study|Randomized but not Vaccinated|8|||
163060984|NCT06178991|588931369|FG005|Overall Study|Randomized but not Vaccinated|4|||
163060985|NCT06178991|588931370|FG006|Overall Study|Randomized but not Vaccinated|2|||
163060986|NCT06178991|588931371|FG007|Overall Study|Randomized but not Vaccinated|2|||
163060987|NCT06178991|588931364|FG000|Overall Study|Other: Unspecified|0|||
163003931|NCT01547390|588713446|FG001|Overall Study|Adverse Event|0|||
163003932|NCT04917861|588713451|FG000|Main Study (196 Days)|Adverse Event|0|||
163003933|NCT04917861|588713452|FG001|Main Study (196 Days)|Adverse Event|1|||
163003934|NCT04917861|588713453|FG002|Main Study (196 Days)|Adverse Event|0|||
163003935|NCT04917861|588713454|FG003|Main Study (196 Days)|Adverse Event|0|||
163003936|NCT04917861|588713451|FG000|Main Study (196 Days)|Death|0|||
163003937|NCT04917861|588713452|FG001|Main Study (196 Days)|Death|0|||
163060988|NCT06178991|588931365|FG001|Overall Study|Other: Unspecified|1|||
163060989|NCT06178991|588931366|FG002|Overall Study|Other: Unspecified|7|||
163060990|NCT06178991|588931367|FG003|Overall Study|Other: Unspecified|6|||
163060991|NCT06178991|588931368|FG004|Overall Study|Other: Unspecified|1|||
163060992|NCT06178991|588931369|FG005|Overall Study|Other: Unspecified|1|||
163213494|NCT02659631|589496000|FG007|Overall Study|Withdrawal prior to treatment|0|||
163213495|NCT02659631|589496001|FG008|Overall Study|Withdrawal prior to treatment|0|||
163213496|NCT02659631|589496002|FG009|Overall Study|Withdrawal prior to treatment|0|||
163213497|NCT02659631|589495993|FG000|Overall Study|Participant refused further follow-up|0|||
163213498|NCT02659631|589495994|FG001|Overall Study|Participant refused further follow-up|0|||
163213499|NCT02659631|589495995|FG002|Overall Study|Participant refused further follow-up|0|||
163213500|NCT02659631|589495996|FG003|Overall Study|Participant refused further follow-up|1|||
163213501|NCT02659631|589495997|FG004|Overall Study|Participant refused further follow-up|0|||
163213502|NCT02659631|589495998|FG005|Overall Study|Participant refused further follow-up|0|||
163003938|NCT04917861|588713453|FG002|Main Study (196 Days)|Death|0|||
163003939|NCT04917861|588713454|FG003|Main Study (196 Days)|Death|1|||
163003940|NCT04917861|588713451|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
163003941|NCT04917861|588713452|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
163003942|NCT04917861|588713453|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
163003943|NCT04917861|588713454|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
163003944|NCT04917861|588713451|FG000|Main Study (196 Days)|Physician Decision|0|||
163003945|NCT04917861|588713452|FG001|Main Study (196 Days)|Physician Decision|0|||
163003946|NCT04917861|588713453|FG002|Main Study (196 Days)|Physician Decision|0|||
163003947|NCT04917861|588713454|FG003|Main Study (196 Days)|Physician Decision|1|||
163003948|NCT04917861|588713451|FG000|Main Study (196 Days)|Pregnancy|1|||
163003949|NCT04917861|588713452|FG001|Main Study (196 Days)|Pregnancy|1|||
163003950|NCT04917861|588713453|FG002|Main Study (196 Days)|Pregnancy|0|||
163003951|NCT04917861|588713454|FG003|Main Study (196 Days)|Pregnancy|0|||
163213503|NCT02659631|589495999|FG006|Overall Study|Participant refused further follow-up|0|||
163003952|NCT04917861|588713451|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
163213504|NCT02659631|589496000|FG007|Overall Study|Participant refused further follow-up|0|||
163003953|NCT04917861|588713452|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
163003954|NCT04917861|588713453|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
163003955|NCT04917861|588713454|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
163003956|NCT04917861|588713451|FG000|Main Study (196 Days)|Other Than Specified|1|||
163003957|NCT04917861|588713452|FG001|Main Study (196 Days)|Other Than Specified|0|||
163003958|NCT04917861|588713453|FG002|Main Study (196 Days)|Other Than Specified|1|||
163003959|NCT04917861|588713454|FG003|Main Study (196 Days)|Other Than Specified|2|||
163003960|NCT04917861|588713451|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
163003961|NCT04917861|588713452|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
163003962|NCT04917861|588713453|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
163003963|NCT04917861|588713454|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
163003964|NCT04917861|588713451|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
163003965|NCT04917861|588713452|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
163003966|NCT04917861|588713453|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
163003967|NCT04917861|588713454|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
163003968|NCT04917861|588713451|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
163003969|NCT04917861|588713452|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
163003970|NCT04917861|588713453|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
163003971|NCT04917861|588713454|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
163003972|NCT04917861|588713451|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
163003973|NCT04917861|588713452|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
163003974|NCT04917861|588713453|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
163003975|NCT04917861|588713454|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
163003976|NCT04917861|588713451|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
163003977|NCT04917861|588713452|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
163003978|NCT04917861|588713453|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
163003979|NCT04917861|588713454|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
163003980|NCT04917861|588713451|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
163003981|NCT04917861|588713452|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
163003982|NCT04917861|588713453|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
163003983|NCT04917861|588713454|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
163003984|NCT01260701|588713455|FG000|Overall Study|Adverse Event|9|||
163003985|NCT01260701|588713455|FG000|Overall Study|Withdrawal by Subject|2|||
163003986|NCT01260701|588713455|FG000|Overall Study|Progression|53|||
163003987|NCT01260701|588713455|FG000|Overall Study|Death|2|||
163003988|NCT01260701|588713455|FG000|Overall Study|Not protocol specified|3|||
163003989|NCT01260701|588713455|FG000|Overall Study|Under review|1|||
163003990|NCT01260701|588713455|FG000|Overall Study|Ineligible|4|||
163003991|NCT01260701|588713455|FG000|Overall Study|Did not begin protocol therapy|1|||
163003992|NCT00720382|588713457|FG000|Overall Study|Adverse Event|54|||
163003993|NCT00720382|588713458|FG001|Overall Study|Adverse Event|17|||
163003994|NCT00720382|588713457|FG000|Overall Study|Lack of Efficacy|18|||
163003995|NCT00720382|588713458|FG001|Overall Study|Lack of Efficacy|7|||
163003996|NCT00720382|588713457|FG000|Overall Study|Non-Compliance|15|||
163003997|NCT00720382|588713458|FG001|Overall Study|Non-Compliance|5|||
163003998|NCT00720382|588713457|FG000|Overall Study|Withdrawal by Subject|47|||
163003999|NCT00720382|588713458|FG001|Overall Study|Withdrawal by Subject|11|||
163004000|NCT00720382|588713457|FG000|Overall Study|Lost to Follow-up|28|||
163004001|NCT00720382|588713458|FG001|Overall Study|Lost to Follow-up|14|||
163004002|NCT00720382|588713457|FG000|Overall Study|administrative|14|||
163004003|NCT00720382|588713458|FG001|Overall Study|administrative|5|||
163004004|NCT05192889|588713459|FG000|Block 1: All Eligible Patients|Death|2|||
163004005|NCT05192889|588713460|FG001|Block 1: All Eligible Patients|Death|0|||
163004006|NCT05192889|588713461|FG002|Block 1: All Eligible Patients|Death|0|||
163213505|NCT02659631|589496001|FG008|Overall Study|Participant refused further follow-up|1|||
163004007|NCT05192889|588713459|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
163004008|NCT05192889|588713460|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
163004009|NCT05192889|588713461|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
163004010|NCT05192889|588713459|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
163004011|NCT05192889|588713460|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
163004012|NCT05192889|588713461|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
163004013|NCT04467840|588714497|FG000|Overall Study|Death|35|||
163004014|NCT04467840|588714498|FG001|Overall Study|Death|39|||
163004015|NCT04467840|588714497|FG000|Overall Study|Withdrawal by Subject|8|||
163004016|NCT04467840|588714498|FG001|Overall Study|Withdrawal by Subject|4|||
163004017|NCT04467840|588714497|FG000|Overall Study|Adverse Event|2|||
163004018|NCT04467840|588714498|FG001|Overall Study|Adverse Event|0|||
163004019|NCT04467840|588714497|FG000|Overall Study|Lost to Follow-up|1|||
163004020|NCT04467840|588714498|FG001|Overall Study|Lost to Follow-up|3|||
163004021|NCT04467840|588714497|FG000|Overall Study|Physician Decision|1|||
163004022|NCT04467840|588714498|FG001|Overall Study|Physician Decision|0|||
163004023|NCT04467840|588714497|FG000|Overall Study|Other|1|||
163004024|NCT04467840|588714498|FG001|Overall Study|Other|5|||
163004025|NCT04467840|588714497|FG000|Overall Study|Missing study completion status|3|||
163004026|NCT04467840|588714498|FG001|Overall Study|Missing study completion status|1|||
163004027|NCT06082843|588714505|FG000|Overall Study|Withdrawal by Subject|0|||
163004028|NCT06082843|588714506|FG001|Overall Study|Withdrawal by Subject|2|||
163004029|NCT06082843|588714505|FG000|Overall Study|Study terminated by sponsor|12|||
163004030|NCT06082843|588714506|FG001|Overall Study|Study terminated by sponsor|8|||
163004031|NCT00696423|588714509|FG000|Overall Study|Lost to Follow-up|0|||
163004032|NCT00696423|588714510|FG001|Overall Study|Lost to Follow-up|5|||
163004033|NCT03989102|588714511|FG000|Year 1|Withdrawal by Subject|6|||
163004034|NCT03989102|588714512|FG001|Year 1|Withdrawal by Subject|2|||
163004035|NCT03989102|588714513|FG002|Year 1|Withdrawal by Subject|7|||
163004036|NCT03989102|588714511|FG000|Year 1|Lost to Follow-up|5|||
163004037|NCT03989102|588714512|FG001|Year 1|Lost to Follow-up|2|||
163004038|NCT03989102|588714513|FG002|Year 1|Lost to Follow-up|5|||
163004039|NCT03989102|588714511|FG000|Year 1|Subject met withdrawal criteria|1|||
163004040|NCT03989102|588714512|FG001|Year 1|Subject met withdrawal criteria|0|||
163004041|NCT03989102|588714513|FG002|Year 1|Subject met withdrawal criteria|1|||
163004042|NCT03989102|588714511|FG000|Year 2|Lost to Follow-up|7|||
163004043|NCT03989102|588714512|FG001|Year 2|Lost to Follow-up|3|||
163004044|NCT03989102|588714513|FG002|Year 2|Lost to Follow-up|4|||
163004045|NCT03989102|588714511|FG000|Year 2|Withdrawal by Subject|3|||
163004046|NCT03989102|588714512|FG001|Year 2|Withdrawal by Subject|1|||
163004047|NCT03989102|588714513|FG002|Year 2|Withdrawal by Subject|2|||
163004048|NCT03989102|588714511|FG000|Year 2|Subject non-compliant|3|||
163004049|NCT03989102|588714512|FG001|Year 2|Subject non-compliant|2|||
163004050|NCT03989102|588714513|FG002|Year 2|Subject non-compliant|0|||
163004051|NCT03989102|588714511|FG000|Year 2|Travel|1|||
163004052|NCT03989102|588714512|FG001|Year 2|Travel|0|||
163004053|NCT03989102|588714513|FG002|Year 2|Travel|1|||
163004054|NCT03989102|588714511|FG000|Year 2|P16 missing|4|||
163004055|NCT03989102|588714512|FG001|Year 2|P16 missing|2|||
163004056|NCT03989102|588714513|FG002|Year 2|P16 missing|1|||
163004057|NCT03989102|588714511|FG000|Year 2|P11 missing|1|||
163004058|NCT03989102|588714512|FG001|Year 2|P11 missing|3|||
163004059|NCT03989102|588714513|FG002|Year 2|P11 missing|7|||
163004060|NCT03989102|588714511|FG000|Year 2|Definitive displacement outside the study site|0|||
163004061|NCT03989102|588714512|FG001|Year 2|Definitive displacement outside the study site|1|||
163004062|NCT03989102|588714513|FG002|Year 2|Definitive displacement outside the study site|0|||
163004063|NCT03989102|588714511|FG000|Year 2|Subject missed last study visit|0|||
163004064|NCT03989102|588714512|FG001|Year 2|Subject missed last study visit|1|||
163004065|NCT03989102|588714513|FG002|Year 2|Subject missed last study visit|0|||
163004066|NCT03989102|588714511|FG000|Year 2|Death|0|||
163004067|NCT03989102|588714512|FG001|Year 2|Death|1|||
163004068|NCT03989102|588714513|FG002|Year 2|Death|0|||
163004069|NCT03989102|588714511|FG000|Year 2|Subject not reachable|0|||
163004070|NCT03989102|588714512|FG001|Year 2|Subject not reachable|0|||
163004071|NCT03989102|588714513|FG002|Year 2|Subject not reachable|1|||
163004072|NCT03989102|588714511|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
163004073|NCT03989102|588714512|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
163004074|NCT03989102|588714513|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
163004075|NCT03989102|588714511|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
163004076|NCT03989102|588714512|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
163004077|NCT03989102|588714513|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
163004078|NCT03989102|588714511|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
163004079|NCT03989102|588714512|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
163004080|NCT03989102|588714513|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
163004081|NCT03989102|588714511|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
163004082|NCT03989102|588714512|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
163004083|NCT03989102|588714513|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
163213506|NCT02659631|589496002|FG009|Overall Study|Participant refused further follow-up|0|||
163004084|NCT03989102|588714511|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
163004085|NCT03989102|588714512|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
163004086|NCT03989102|588714513|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
163004087|NCT03989102|588714511|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
163004088|NCT03989102|588714512|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
163004089|NCT03989102|588714513|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
163004090|NCT04054765|588714514|FG000|Baseline|Withdrawal by Subject|5|||
163004091|NCT04054765|588714515|FG001|Baseline|Withdrawal by Subject|3|||
163004092|NCT04054765|588714514|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
163004093|NCT04054765|588714515|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
163004094|NCT04054765|588714514|FG000|3-month Follow up|Withdrawal by Subject|0|||
163004095|NCT04054765|588714515|FG001|3-month Follow up|Withdrawal by Subject|3|||
163004096|NCT04054765|588714514|FG000|6-month Follow up|Lost to Follow-up|32|||
163004097|NCT04054765|588714515|FG001|6-month Follow up|Lost to Follow-up|32|||
163004098|NCT01290068|588714516|FG000|Overall Study|Adverse Event|1|||
163004099|NCT01290068|588714517|FG001|Overall Study|Adverse Event|3|||
163004100|NCT01290068|588714516|FG000|Overall Study|Lost to Follow-up|3|||
163004101|NCT01290068|588714517|FG001|Overall Study|Lost to Follow-up|0|||
163004102|NCT01290068|588714516|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
163004103|NCT01290068|588714517|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
163004104|NCT01290068|588714516|FG000|Overall Study|Other|3|||
163004105|NCT01290068|588714517|FG001|Overall Study|Other|1|||
163004106|NCT02719184|588714520|FG000|Overall Study|Other than listed|1|||
163004107|NCT02719184|588714521|FG001|Overall Study|Other than listed|12|||
163004108|NCT02719184|588714522|FG002|Overall Study|Other than listed|13|||
163004109|NCT02719184|588714523|FG003|Overall Study|Other than listed|22|||
163004110|NCT02719184|588714524|FG004|Overall Study|Other than listed|9|||
163004111|NCT02719184|588714520|FG000|Overall Study|Withdrawal by Subject|5|||
163004112|NCT02719184|588714521|FG001|Overall Study|Withdrawal by Subject|3|||
163004113|NCT02719184|588714522|FG002|Overall Study|Withdrawal by Subject|6|||
163004114|NCT02719184|588714523|FG003|Overall Study|Withdrawal by Subject|6|||
163004115|NCT02719184|588714524|FG004|Overall Study|Withdrawal by Subject|0|||
163004116|NCT02719184|588714520|FG000|Overall Study|Lost to Follow-up|0|||
163004117|NCT02719184|588714521|FG001|Overall Study|Lost to Follow-up|4|||
163004118|NCT02719184|588714522|FG002|Overall Study|Lost to Follow-up|1|||
163004119|NCT02719184|588714523|FG003|Overall Study|Lost to Follow-up|3|||
163004120|NCT02719184|588714524|FG004|Overall Study|Lost to Follow-up|0|||
163004121|NCT02719184|588714520|FG000|Overall Study|Protocol Violation|0|||
163004122|NCT02719184|588714521|FG001|Overall Study|Protocol Violation|3|||
163004123|NCT02719184|588714522|FG002|Overall Study|Protocol Violation|0|||
163004124|NCT02719184|588714523|FG003|Overall Study|Protocol Violation|2|||
163004125|NCT02719184|588714524|FG004|Overall Study|Protocol Violation|0|||
163004126|NCT02719184|588714520|FG000|Overall Study|Adverse Event|0|||
163004127|NCT02719184|588714521|FG001|Overall Study|Adverse Event|0|||
163004128|NCT02719184|588714522|FG002|Overall Study|Adverse Event|0|||
163004129|NCT02719184|588714523|FG003|Overall Study|Adverse Event|3|||
163004130|NCT02719184|588714524|FG004|Overall Study|Adverse Event|0|||
163004131|NCT04428034|588714527|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
163004132|NCT02556801|588714530|FG000|Overall Study|Lost to Follow-up|1|||
163004133|NCT02556801|588714531|FG001|Overall Study|Lost to Follow-up|0|||
163004134|NCT02556801|588714532|FG002|Overall Study|Lost to Follow-up|2|||
163004135|NCT02556801|588714533|FG003|Overall Study|Lost to Follow-up|0|||
163060993|NCT06178991|588931370|FG006|Overall Study|Other: Unspecified|1|||
163060994|NCT06178991|588931371|FG007|Overall Study|Other: Unspecified|0|||
163060995|NCT06178991|588931364|FG000|Overall Study|Physician Decision|0|||
163060996|NCT06178991|588931365|FG001|Overall Study|Physician Decision|0|||
163060997|NCT06178991|588931366|FG002|Overall Study|Physician Decision|2|||
163004136|NCT02556801|588714530|FG000|Overall Study|Withdrawal by Subject|1|||
163060998|NCT06178991|588931367|FG003|Overall Study|Physician Decision|0|||
163060999|NCT06178991|588931368|FG004|Overall Study|Physician Decision|2|||
163061000|NCT06178991|588931369|FG005|Overall Study|Physician Decision|1|||
163061001|NCT06178991|588931370|FG006|Overall Study|Physician Decision|0|||
163061002|NCT06178991|588931371|FG007|Overall Study|Physician Decision|0|||
163061003|NCT06178991|588931364|FG000|Overall Study|Protocol Violation|0|||
163004137|NCT02556801|588714531|FG001|Overall Study|Withdrawal by Subject|1|||
163004138|NCT02556801|588714532|FG002|Overall Study|Withdrawal by Subject|1|||
163004139|NCT02556801|588714533|FG003|Overall Study|Withdrawal by Subject|0|||
163004140|NCT02556801|588714530|FG000|Overall Study|Protocol Violation|0|||
163004141|NCT02556801|588714531|FG001|Overall Study|Protocol Violation|3|||
163004142|NCT02556801|588714532|FG002|Overall Study|Protocol Violation|1|||
163004143|NCT02556801|588714533|FG003|Overall Study|Protocol Violation|1|||
163061004|NCT06178991|588931365|FG001|Overall Study|Protocol Violation|0|||
163061005|NCT06178991|588931366|FG002|Overall Study|Protocol Violation|1|||
163061006|NCT06178991|588931367|FG003|Overall Study|Protocol Violation|0|||
163004144|NCT02556801|588714530|FG000|Overall Study|Adverse Event|0|||
163004145|NCT02556801|588714531|FG001|Overall Study|Adverse Event|2|||
163004146|NCT02556801|588714532|FG002|Overall Study|Adverse Event|0|||
163004147|NCT02556801|588714533|FG003|Overall Study|Adverse Event|3|||
163004148|NCT02556801|588714530|FG000|Overall Study|Pregnancy|0|||
163004149|NCT02556801|588714531|FG001|Overall Study|Pregnancy|1|||
163004150|NCT02556801|588714532|FG002|Overall Study|Pregnancy|0|||
163004151|NCT02556801|588714533|FG003|Overall Study|Pregnancy|0|||
163004152|NCT02556801|588714530|FG000|Overall Study|Personal reasons patient|0|||
163004153|NCT02556801|588714531|FG001|Overall Study|Personal reasons patient|0|||
163004154|NCT02556801|588714532|FG002|Overall Study|Personal reasons patient|0|||
163004155|NCT02556801|588714533|FG003|Overall Study|Personal reasons patient|1|||
163004156|NCT02676882|588714545|FG000|Overall Study|Adverse Event|1|||
163004157|NCT02676882|588714546|FG001|Overall Study|Adverse Event|0|||
163004158|NCT02676882|588714545|FG000|Overall Study|Lost to Follow-up|1|||
163004159|NCT02676882|588714546|FG001|Overall Study|Lost to Follow-up|0|||
163004160|NCT02676882|588714545|FG000|Overall Study|Withdrawal by Subject|1|||
163004161|NCT02676882|588714546|FG001|Overall Study|Withdrawal by Subject|2|||
163004162|NCT00114140|588714547|FG000|Overall Study|Protocol Violation|7|||
163004163|NCT00110396|588714552|FG000|Overall Study|Adverse Event|15|||
163004164|NCT00110396|588714552|FG000|Overall Study|Lost to Follow-up|1|||
163004165|NCT00110396|588714552|FG000|Overall Study|Administration of plasmapheresis|1|||
163004166|NCT00110396|588714552|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
163004167|NCT00110396|588714552|FG000|Overall Study|Lack of Efficacy|1|||
163004168|NCT00110396|588714552|FG000|Overall Study|Decided not to continue treatment|1|||
163061007|NCT06178991|588931368|FG004|Overall Study|Protocol Violation|0|||
163061008|NCT06178991|588931369|FG005|Overall Study|Protocol Violation|0|||
163061009|NCT06178991|588931370|FG006|Overall Study|Protocol Violation|0|||
163061010|NCT06178991|588931371|FG007|Overall Study|Protocol Violation|0|||
163061011|NCT01366092|588931377|FG000|Overall Study|Progressive cGVHD|2|||
163061012|NCT01366092|588931377|FG000|Overall Study|Physician Decision|1|||
163061013|NCT01366092|588931377|FG000|Overall Study|Withdrawal by Subject|1|||
163061014|NCT02273167|588931378|FG000|Overall Study|Adverse Event|1|||
163061015|NCT02273167|588931379|FG001|Overall Study|Adverse Event|0|||
163061016|NCT02273167|588931380|FG002|Overall Study|Adverse Event|0|||
163061017|NCT02273167|588931378|FG000|Overall Study|Protocol Violation|3|||
163061018|NCT02273167|588931379|FG001|Overall Study|Protocol Violation|1|||
163061019|NCT02273167|588931380|FG002|Overall Study|Protocol Violation|1|||
163061020|NCT02273167|588931378|FG000|Overall Study|Lost to Follow-up|0|||
163061021|NCT02273167|588931379|FG001|Overall Study|Lost to Follow-up|1|||
163061022|NCT02273167|588931380|FG002|Overall Study|Lost to Follow-up|1|||
163061023|NCT02273167|588931378|FG000|Overall Study|Withdrawal by Subject|10|||
163061024|NCT02273167|588931379|FG001|Overall Study|Withdrawal by Subject|12|||
163061025|NCT02273167|588931380|FG002|Overall Study|Withdrawal by Subject|11|||
163061026|NCT02273167|588931378|FG000|Overall Study|Various|10|||
163061027|NCT02273167|588931379|FG001|Overall Study|Various|9|||
163061028|NCT02273167|588931380|FG002|Overall Study|Various|8|||
163061029|NCT03082729|588931384|FG000|Overall Study|Lost to Follow-up|7|||
163061030|NCT03082729|588931384|FG000|Overall Study|Physician Decision|2|||
163061031|NCT03082729|588931384|FG000|Overall Study|Withdrawal by Subject|1|||
163061032|NCT03082729|588931384|FG000|Overall Study|Lack of Efficacy|9|||
163061033|NCT03082729|588931384|FG000|Overall Study|Adverse Event|4|||
163061034|NCT03082729|588931384|FG000|Overall Study|Protocol Violation|6|||
163061035|NCT03082729|588931384|FG000|Overall Study|Fear of study procedure|1|||
163061036|NCT03082729|588931384|FG000|Overall Study|Scheduling conflict|1|||
163061037|NCT01416571|588931389|FG000|Overall Study|Lost to Follow-up|2|||
163061038|NCT03608163|588931390|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
163061039|NCT03608163|588931391|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
163061040|NCT03353220|588931397|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
163061041|NCT03353220|588931398|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
163061042|NCT03586479|588931399|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
163061043|NCT03586479|588931400|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
163061044|NCT03586479|588931401|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
163061045|NCT03586479|588931399|FG000|Overall Study|Protocol Violation|2|||
163061046|NCT03586479|588931400|FG001|Overall Study|Protocol Violation|0|||
163061047|NCT03586479|588931401|FG002|Overall Study|Protocol Violation|0|||
163061048|NCT03586479|588931399|FG000|Overall Study|Lost to Follow-up|1|||
163061049|NCT03586479|588931400|FG001|Overall Study|Lost to Follow-up|1|||
163061050|NCT03586479|588931401|FG002|Overall Study|Lost to Follow-up|2|||
163325968|NCT03777657|589904656|FG001|Overall Study|Withdrawal by Subject|17|||
163004169|NCT00110396|588714552|FG000|Overall Study|Patient non-compliance|1|||
163004170|NCT00110396|588714552|FG000|Overall Study|Patient refused to continue|1|||
163061051|NCT03586479|588931399|FG000|Overall Study|Behavioral Issues|1|||
163061052|NCT03586479|588931400|FG001|Overall Study|Behavioral Issues|0|||
163061053|NCT03586479|588931401|FG002|Overall Study|Behavioral Issues|0|||
163061054|NCT00661388|588931410|FG000|Overall Study|Adverse Event|14|||
163061055|NCT00661388|588931410|FG000|Overall Study|Protocol Violation|7|||
163061056|NCT00661388|588931410|FG000|Overall Study|Renal transplantation|1|||
163325969|NCT03777657|589904655|FG000|Overall Study|Lost to Follow-up|6|||
163004171|NCT00110396|588714552|FG000|Overall Study|Patient refused to participate|1|||
163061057|NCT00661388|588931410|FG000|Overall Study|Dialysis initiation|1|||
163004172|NCT00110396|588714552|FG000|Overall Study|Patient will|1|||
163004173|NCT00110396|588714552|FG000|Overall Study|Patient's decision|1|||
163004174|NCT00110396|588714552|FG000|Overall Study|Participation in MS vaccine study|1|||
163004175|NCT00110396|588714552|FG000|Overall Study|Pregnancy|1|||
163004176|NCT00110396|588714552|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
163004177|NCT00110396|588714552|FG000|Overall Study|Protocol Violation|2|||
163004178|NCT00110396|588714552|FG000|Overall Study|Patient refused to come back|1|||
163004179|NCT00110396|588714552|FG000|Overall Study|The patient has refused|2|||
163004180|NCT00110396|588714552|FG000|Overall Study|The patient has refused to visit site|1|||
163004181|NCT00110396|588714552|FG000|Overall Study|Patient is to be administered copaxone|1|||
163004182|NCT00811733|588714554|FG000|Overall Study|Investigator Discretion|10|||
163004183|NCT00811733|588714555|FG001|Overall Study|Investigator Discretion|8|||
163004184|NCT00811733|588714554|FG000|Overall Study|Withdrawal by Subject|1|||
163004185|NCT00811733|588714555|FG001|Overall Study|Withdrawal by Subject|2|||
163004186|NCT00793871|588714556|FG000|Overall Study|Death|50|||
163004187|NCT00793871|588714556|FG000|Overall Study|Lost to Follow-up|3|||
163004188|NCT00793871|588714556|FG000|Overall Study|Study terminated by the Sponsor|7|||
163004189|NCT02500589|588714557|FG000|Overall Study|Withdrawal by Subject|11|||
163004190|NCT02500589|588714558|FG001|Overall Study|Withdrawal by Subject|14|||
163004191|NCT02500589|588714557|FG000|Overall Study|Lost to Follow-up|10|||
163004192|NCT02500589|588714558|FG001|Overall Study|Lost to Follow-up|12|||
163004193|NCT02500589|588714557|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
163004194|NCT02500589|588714558|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
163004195|NCT02500589|588714557|FG000|Overall Study|Death|7|||
163004196|NCT02500589|588714558|FG001|Overall Study|Death|5|||
163004197|NCT00245466|588714559|FG000|Overall Study|Adverse Event|2|||
163004198|NCT00245466|588714560|FG001|Overall Study|Adverse Event|8|||
163004199|NCT00245466|588714561|FG002|Overall Study|Adverse Event|4|||
163004200|NCT00245466|588714559|FG000|Overall Study|Low prostate specific antigen suppr|16|||
163004201|NCT00245466|588714560|FG001|Overall Study|Low prostate specific antigen suppr|14|||
163004202|NCT00245466|588714561|FG002|Overall Study|Low prostate specific antigen suppr|5|||
163004203|NCT00245466|588714559|FG000|Overall Study|Insufficient testosterone suppr|12|||
163004204|NCT00245466|588714560|FG001|Overall Study|Insufficient testosterone suppr|12|||
163004205|NCT00245466|588714561|FG002|Overall Study|Insufficient testosterone suppr|21|||
163004206|NCT00245466|588714559|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
163004207|NCT00245466|588714560|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
163004208|NCT00245466|588714561|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
163004209|NCT00245466|588714559|FG000|Overall Study|Withdrawal by Subject|2|||
163004210|NCT00245466|588714560|FG001|Overall Study|Withdrawal by Subject|2|||
163004211|NCT00245466|588714561|FG002|Overall Study|Withdrawal by Subject|1|||
163004212|NCT00245466|588714559|FG000|Overall Study|Lost to Follow-up|3|||
163004213|NCT00245466|588714560|FG001|Overall Study|Lost to Follow-up|0|||
163004214|NCT00245466|588714561|FG002|Overall Study|Lost to Follow-up|0|||
163004215|NCT00245466|588714559|FG000|Overall Study|Disease progression|0|||
163004216|NCT00245466|588714560|FG001|Overall Study|Disease progression|3|||
163004217|NCT00245466|588714561|FG002|Overall Study|Disease progression|1|||
163004218|NCT00245466|588714559|FG000|Overall Study|Protocol Violation|1|||
163004219|NCT00245466|588714560|FG001|Overall Study|Protocol Violation|2|||
163004220|NCT00245466|588714561|FG002|Overall Study|Protocol Violation|2|||
163004221|NCT00245466|588714559|FG000|Overall Study|Death|0|||
163004222|NCT00245466|588714560|FG001|Overall Study|Death|2|||
163004223|NCT00245466|588714561|FG002|Overall Study|Death|0|||
163004224|NCT00245466|588714559|FG000|Overall Study|Administrative reasons|0|||
163004225|NCT00245466|588714560|FG001|Overall Study|Administrative reasons|1|||
163004226|NCT00245466|588714561|FG002|Overall Study|Administrative reasons|0|||
163004227|NCT00856193|588714562|FG000|Period 2|Abnormal test procedure results|0|||
163004228|NCT00856193|588714563|FG001|Period 2|Abnormal test procedure results|1|||
163004229|NCT00856193|588714562|FG000|Period 2|Lost to Follow-up|0|||
163004230|NCT00856193|588714563|FG001|Period 2|Lost to Follow-up|1|||
163004231|NCT03885661|588714564|FG000|Overall Study|Withdrawal by Subject|0|||
163004232|NCT03885661|588714565|FG001|Overall Study|Withdrawal by Subject|1|||
163004233|NCT03885661|588714564|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
163004234|NCT03885661|588714565|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
163004235|NCT05064397|588714566|FG000|Overall Study|Adverse Event|4|||
163004236|NCT05064397|588714566|FG000|Overall Study|Lack of Efficacy|12|||
163004237|NCT05064397|588714566|FG000|Overall Study|Withdrawal by Subject|3|||
163004238|NCT05064397|588714566|FG000|Overall Study|Lost to Follow-up|1|||
163004239|NCT05064397|588714566|FG000|Overall Study|Other reasons|3|||
163004240|NCT02324582|588714569|FG000|Overall Study|Screen Failures|0|||
163004241|NCT02324582|588714570|FG001|Overall Study|Screen Failures|5|||
163004242|NCT00129545|588714574|FG000|Overall Study|Death|5|||
163004243|NCT00129545|588714575|FG001|Overall Study|Death|60|||
163004244|NCT00129545|588714576|FG002|Overall Study|Death|44|||
163004245|NCT00129545|588714574|FG000|Overall Study|Withdrawal by Subject|3|||
163004246|NCT00129545|588714575|FG001|Overall Study|Withdrawal by Subject|18|||
163004247|NCT00129545|588714576|FG002|Overall Study|Withdrawal by Subject|44|||
163404426|NCT03246958|590191936|FG002|Overall Study|Withdrawal by Subject|0|||
163404427|NCT03246958|590191937|FG003|Overall Study|Withdrawal by Subject|0|||
163404428|NCT03246958|590191938|FG004|Overall Study|Withdrawal by Subject|0|||
163404429|NCT03246958|590191939|FG005|Overall Study|Withdrawal by Subject|1|||
163404430|NCT03246958|590191940|FG006|Overall Study|Withdrawal by Subject|0|||
163404431|NCT03246958|590191934|FG000|Overall Study|Progression|13|||
163404432|NCT03246958|590191935|FG001|Overall Study|Progression|9|||
163404433|NCT03246958|590191936|FG002|Overall Study|Progression|3|||
163404434|NCT03246958|590191937|FG003|Overall Study|Progression|2|||
163404435|NCT03246958|590191938|FG004|Overall Study|Progression|1|||
163404436|NCT03246958|590191939|FG005|Overall Study|Progression|2|||
163404437|NCT03246958|590191940|FG006|Overall Study|Progression|1|||
163404438|NCT03246958|590191934|FG000|Overall Study|Adverse Event|2|||
163404439|NCT03246958|590191935|FG001|Overall Study|Adverse Event|2|||
163404440|NCT03246958|590191936|FG002|Overall Study|Adverse Event|0|||
163404441|NCT03246958|590191937|FG003|Overall Study|Adverse Event|1|||
163404442|NCT03246958|590191938|FG004|Overall Study|Adverse Event|1|||
163404443|NCT03246958|590191939|FG005|Overall Study|Adverse Event|0|||
163404444|NCT03246958|590191940|FG006|Overall Study|Adverse Event|2|||
163404445|NCT03246958|590191934|FG000|Overall Study|Death|0|||
163404446|NCT03246958|590191935|FG001|Overall Study|Death|1|||
163004248|NCT00129545|588714574|FG000|Overall Study|Lost to Follow-up|2|||
163004249|NCT00129545|588714575|FG001|Overall Study|Lost to Follow-up|22|||
163004250|NCT00129545|588714576|FG002|Overall Study|Lost to Follow-up|13|||
163004251|NCT00129545|588714574|FG000|Overall Study|Physician Decision|0|||
163004252|NCT00129545|588714575|FG001|Overall Study|Physician Decision|3|||
163004253|NCT00129545|588714576|FG002|Overall Study|Physician Decision|10|||
163004254|NCT00129545|588714574|FG000|Overall Study|Device not implanted|16|||
163004255|NCT00129545|588714575|FG001|Overall Study|Device not implanted|61|||
163004256|NCT00129545|588714576|FG002|Overall Study|Device not implanted|0|||
163004257|NCT04660331|588714577|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
163004258|NCT04660331|588714578|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
163004259|NCT04660331|588714579|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
163004260|NCT00111241|588714581|FG000|Overall Study|Lost to Follow-up|1|||
163004261|NCT00111241|588714582|FG001|Overall Study|Lost to Follow-up|0|||
163004262|NCT00111241|588714581|FG000|Overall Study|Withdrawal by Subject|4|||
163004263|NCT00111241|588714582|FG001|Overall Study|Withdrawal by Subject|0|||
163004264|NCT00111241|588714581|FG000|Overall Study|Protocol Violation|9|||
163004265|NCT00111241|588714582|FG001|Overall Study|Protocol Violation|8|||
163004266|NCT00111241|588714581|FG000|Overall Study|Adverse Event|1|||
163004267|NCT00111241|588714582|FG001|Overall Study|Adverse Event|0|||
163004268|NCT01449812|588714583|FG000|Overall Study|Migrated/moved from study area|1|||
163004269|NCT01449812|588714584|FG001|Overall Study|Migrated/moved from study area|0|||
163004270|NCT01449812|588714585|FG002|Overall Study|Migrated/moved from study area|0|||
163004271|NCT01449812|588714583|FG000|Overall Study|Withdrawal by Subject|0|||
163004272|NCT01449812|588714584|FG001|Overall Study|Withdrawal by Subject|0|||
163004273|NCT01449812|588714585|FG002|Overall Study|Withdrawal by Subject|1|||
163004274|NCT01449812|588714583|FG000|Overall Study|Lost to Follow-up|1|||
163004275|NCT01449812|588714584|FG001|Overall Study|Lost to Follow-up|0|||
163004276|NCT01449812|588714585|FG002|Overall Study|Lost to Follow-up|0|||
163004277|NCT00265759|588717050|FG000|Overall Study|Withdrawal by Subject|0|||
163004278|NCT00265759|588717051|FG001|Overall Study|Withdrawal by Subject|1|||
163004279|NCT00265759|588717052|FG002|Overall Study|Withdrawal by Subject|2|||
163061058|NCT00661388|588931410|FG000|Overall Study|Administrative reasons|1|||
163061059|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
163061060|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
163061061|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Death|1|||
163061062|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Death|3|||
163061063|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
163061064|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
163061065|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
163404447|NCT03246958|590191936|FG002|Overall Study|Death|0|||
163404448|NCT03246958|590191937|FG003|Overall Study|Death|0|||
163404449|NCT03246958|590191938|FG004|Overall Study|Death|0|||
163404450|NCT03246958|590191939|FG005|Overall Study|Death|0|||
163404451|NCT03246958|590191940|FG006|Overall Study|Death|0|||
163404452|NCT03246958|590191934|FG000|Overall Study|Physician Decision|0|||
163404453|NCT03246958|590191935|FG001|Overall Study|Physician Decision|0|||
163004280|NCT00265759|588717053|FG003|Overall Study|Withdrawal by Subject|2|||
163004281|NCT00265759|588717050|FG000|Overall Study|Cancel|0|||
163004282|NCT00265759|588717051|FG001|Overall Study|Cancel|0|||
163004283|NCT00265759|588717052|FG002|Overall Study|Cancel|0|||
163004284|NCT00265759|588717053|FG003|Overall Study|Cancel|3|||
163061066|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
163404454|NCT03246958|590191936|FG002|Overall Study|Physician Decision|0|||
163404455|NCT03246958|590191937|FG003|Overall Study|Physician Decision|1|||
163404456|NCT03246958|590191938|FG004|Overall Study|Physician Decision|0|||
163404457|NCT03246958|590191939|FG005|Overall Study|Physician Decision|0|||
163404458|NCT03246958|590191940|FG006|Overall Study|Physician Decision|0|||
163004285|NCT00265759|588717050|FG000|Overall Study|Ineligible|0|||
163004286|NCT00265759|588717051|FG001|Overall Study|Ineligible|0|||
163004287|NCT00265759|588717052|FG002|Overall Study|Ineligible|0|||
163004288|NCT00265759|588717053|FG003|Overall Study|Ineligible|1|||
163004289|NCT00265759|588717050|FG000|Overall Study|Bilateral disease|0|||
163004290|NCT00265759|588717051|FG001|Overall Study|Bilateral disease|0|||
163004291|NCT00265759|588717052|FG002|Overall Study|Bilateral disease|0|||
163004292|NCT00265759|588717053|FG003|Overall Study|Bilateral disease|2|||
163004293|NCT00265759|588717050|FG000|Overall Study|Discontinued due to intolerability|0|||
163004294|NCT00265759|588717051|FG001|Overall Study|Discontinued due to intolerability|0|||
163004295|NCT00265759|588717052|FG002|Overall Study|Discontinued due to intolerability|0|||
163004296|NCT00265759|588717053|FG003|Overall Study|Discontinued due to intolerability|1|||
163004297|NCT04515147|588717054|FG000|Overall Study|Withdrawal by Subject|1|||
163004298|NCT04515147|588717055|FG001|Overall Study|Withdrawal by Subject|0|||
163004299|NCT04515147|588717056|FG002|Overall Study|Withdrawal by Subject|10|||
163004300|NCT04515147|588717057|FG003|Overall Study|Withdrawal by Subject|18|||
163004301|NCT04515147|588717058|FG004|Overall Study|Withdrawal by Subject|1|||
163004302|NCT04515147|588717059|FG005|Overall Study|Withdrawal by Subject|8|||
163004303|NCT04515147|588717054|FG000|Overall Study|Lost to Follow-up|0|||
163004304|NCT04515147|588717055|FG001|Overall Study|Lost to Follow-up|1|||
163004305|NCT04515147|588717056|FG002|Overall Study|Lost to Follow-up|5|||
163004306|NCT04515147|588717057|FG003|Overall Study|Lost to Follow-up|6|||
163004307|NCT04515147|588717058|FG004|Overall Study|Lost to Follow-up|2|||
163004308|NCT04515147|588717059|FG005|Overall Study|Lost to Follow-up|1|||
163004309|NCT04515147|588717054|FG000|Overall Study|Adverse Event|0|||
163004310|NCT04515147|588717055|FG001|Overall Study|Adverse Event|0|||
163004311|NCT04515147|588717056|FG002|Overall Study|Adverse Event|0|||
163004312|NCT04515147|588717057|FG003|Overall Study|Adverse Event|2|||
163004313|NCT04515147|588717058|FG004|Overall Study|Adverse Event|0|||
163004314|NCT04515147|588717059|FG005|Overall Study|Adverse Event|0|||
163004315|NCT04515147|588717054|FG000|Overall Study|Miscellaneous|0|||
163004316|NCT04515147|588717055|FG001|Overall Study|Miscellaneous|0|||
163004317|NCT04515147|588717056|FG002|Overall Study|Miscellaneous|0|||
163004318|NCT04515147|588717057|FG003|Overall Study|Miscellaneous|1|||
163004319|NCT04515147|588717058|FG004|Overall Study|Miscellaneous|0|||
163004320|NCT04515147|588717059|FG005|Overall Study|Miscellaneous|1|||
163004321|NCT04123405|588717060|FG000|Overall Study|Adverse Event|1|||
163004322|NCT04123405|588717061|FG001|Overall Study|Adverse Event|2|||
163004323|NCT04123405|588717062|FG002|Overall Study|Adverse Event|3|||
163004324|NCT04123405|588717063|FG003|Overall Study|Adverse Event|3|||
163004325|NCT04123405|588717060|FG000|Overall Study|Exclusion criteria met|1|||
163004326|NCT04123405|588717061|FG001|Overall Study|Exclusion criteria met|2|||
163004327|NCT04123405|588717062|FG002|Overall Study|Exclusion criteria met|0|||
163004328|NCT04123405|588717063|FG003|Overall Study|Exclusion criteria met|2|||
163004329|NCT04123405|588717060|FG000|Overall Study|Withdrawal by Subject|1|||
163004330|NCT04123405|588717061|FG001|Overall Study|Withdrawal by Subject|3|||
163004331|NCT04123405|588717062|FG002|Overall Study|Withdrawal by Subject|0|||
163004332|NCT04123405|588717063|FG003|Overall Study|Withdrawal by Subject|2|||
163004333|NCT04123405|588717060|FG000|Overall Study|Contact to subject lost|0|||
163004334|NCT04123405|588717061|FG001|Overall Study|Contact to subject lost|0|||
163004335|NCT04123405|588717062|FG002|Overall Study|Contact to subject lost|0|||
163004336|NCT04123405|588717063|FG003|Overall Study|Contact to subject lost|1|||
163004337|NCT04123405|588717060|FG000|Overall Study|screening failure|1|||
163004338|NCT04123405|588717061|FG001|Overall Study|screening failure|0|||
163004339|NCT04123405|588717062|FG002|Overall Study|screening failure|0|||
163004340|NCT04123405|588717063|FG003|Overall Study|screening failure|0|||
163004341|NCT01050530|588717064|FG000|Overall Study|Adverse Event|6|||
163004342|NCT01050530|588717065|FG001|Overall Study|Adverse Event|3|||
163004343|NCT01050530|588717064|FG000|Overall Study|Lack of Efficacy|1|||
163004344|NCT01050530|588717065|FG001|Overall Study|Lack of Efficacy|4|||
163004345|NCT01050530|588717064|FG000|Overall Study|Withdrawal by Subject|0|||
163061067|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
163061068|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
163061069|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
163061070|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
163061071|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
163004346|NCT01050530|588717065|FG001|Overall Study|Withdrawal by Subject|3|||
163004347|NCT01050530|588717064|FG000|Overall Study|Protocol Violation|1|||
163004348|NCT01050530|588717065|FG001|Overall Study|Protocol Violation|0|||
163004349|NCT00545714|588717066|FG000|Induction Phase (6 Months)|Physician Decision|3|||
163004350|NCT00545714|588717066|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
163004351|NCT00545714|588717066|FG000|Induction Phase (6 Months)|Disease Progression|1|||
163004352|NCT00545714|588717066|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
163004353|NCT00545714|588717066|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
163004354|NCT00545714|588717066|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
163004355|NCT00545714|588717066|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
163004356|NCT00545714|588717066|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
162924574|NCT02406742|588426051|FG002|Overall Study|Transition to other treatment|1|||
162924575|NCT02406742|588426049|FG000|Overall Study|Other Reasons|1|||
162924576|NCT02406742|588426050|FG001|Overall Study|Other Reasons|11|||
162924577|NCT02406742|588426051|FG002|Overall Study|Other Reasons|5|||
162924578|NCT02367729|588426052|FG000|Overall Study|Organic disorder diagnosed|2|||
162924579|NCT02367729|588426053|FG001|Overall Study|Organic disorder diagnosed|1|||
162924580|NCT02367729|588426052|FG000|Overall Study|Adverse Event|1|||
162924581|NCT02367729|588426053|FG001|Overall Study|Adverse Event|2|||
162924582|NCT02367729|588426052|FG000|Overall Study|Withdrawal by Subject|0|||
162924583|NCT02367729|588426053|FG001|Overall Study|Withdrawal by Subject|5|||
162924584|NCT00759174|588426054|FG000|Overall Study|Other|0|||
162924585|NCT00759174|588426055|FG001|Overall Study|Other|2|||
162924586|NCT01890109|588426056|FG000|Overall Study|Withdrawal by Subject|0|||
162924587|NCT01890109|588426057|FG001|Overall Study|Withdrawal by Subject|3|||
162924588|NCT01890109|588426056|FG000|Overall Study|Lost to Follow-up|1|||
162924589|NCT01890109|588426057|FG001|Overall Study|Lost to Follow-up|2|||
162924590|NCT01643928|588426058|FG000|Overall Study|Lost to Follow-up|1|||
162924591|NCT01643928|588426059|FG001|Overall Study|Lost to Follow-up|0|||
162924592|NCT01643928|588426060|FG002|Overall Study|Lost to Follow-up|2|||
162924593|NCT01643928|588426061|FG003|Overall Study|Lost to Follow-up|0|||
162924594|NCT01643928|588426062|FG004|Overall Study|Lost to Follow-up|0|||
162924595|NCT01643928|588426058|FG000|Overall Study|Withdrawal by Subject|2|||
162924596|NCT01643928|588426059|FG001|Overall Study|Withdrawal by Subject|0|||
162924597|NCT01643928|588426060|FG002|Overall Study|Withdrawal by Subject|0|||
162924598|NCT01643928|588426061|FG003|Overall Study|Withdrawal by Subject|1|||
162924599|NCT01643928|588426062|FG004|Overall Study|Withdrawal by Subject|0|||
162924600|NCT01643928|588426058|FG000|Overall Study|Pregnancy|0|||
162924601|NCT01643928|588426059|FG001|Overall Study|Pregnancy|0|||
162924602|NCT01643928|588426060|FG002|Overall Study|Pregnancy|0|||
162924603|NCT01643928|588426061|FG003|Overall Study|Pregnancy|1|||
162924604|NCT01643928|588426062|FG004|Overall Study|Pregnancy|0|||
162924605|NCT01643928|588426058|FG000|Overall Study|Other|5|||
162924606|NCT01643928|588426059|FG001|Overall Study|Other|1|||
162924607|NCT01643928|588426060|FG002|Overall Study|Other|1|||
162924608|NCT01643928|588426061|FG003|Overall Study|Other|0|||
162924609|NCT01643928|588426062|FG004|Overall Study|Other|0|||
162924610|NCT01643928|588426058|FG000|Overall Study|Adverse Event|2|||
162924611|NCT01643928|588426059|FG001|Overall Study|Adverse Event|1|||
162924612|NCT01643928|588426060|FG002|Overall Study|Adverse Event|0|||
162924613|NCT01643928|588426061|FG003|Overall Study|Adverse Event|1|||
162924614|NCT01643928|588426062|FG004|Overall Study|Adverse Event|2|||
162924615|NCT00916617|588426069|FG000|Overall Study|Adverse Event|3|||
162924616|NCT00916617|588426070|FG001|Overall Study|Adverse Event|2|||
162924617|NCT00916617|588426071|FG002|Overall Study|Adverse Event|6|||
162924618|NCT00916617|588426072|FG003|Overall Study|Adverse Event|3|||
162924619|NCT00916617|588426069|FG000|Overall Study|Withdrawal by Subject|3|||
162924620|NCT00916617|588426070|FG001|Overall Study|Withdrawal by Subject|2|||
162924621|NCT00916617|588426071|FG002|Overall Study|Withdrawal by Subject|0|||
162924622|NCT00916617|588426072|FG003|Overall Study|Withdrawal by Subject|1|||
162924623|NCT00916617|588426069|FG000|Overall Study|Caregiver Request|3|||
162924624|NCT00916617|588426070|FG001|Overall Study|Caregiver Request|2|||
162924625|NCT00916617|588426071|FG002|Overall Study|Caregiver Request|1|||
162924626|NCT00916617|588426072|FG003|Overall Study|Caregiver Request|0|||
162924627|NCT00916617|588426069|FG000|Overall Study|Physician Decision|1|||
162924628|NCT00916617|588426070|FG001|Overall Study|Physician Decision|1|||
162924629|NCT00916617|588426071|FG002|Overall Study|Physician Decision|0|||
162924630|NCT00916617|588426072|FG003|Overall Study|Physician Decision|0|||
162924631|NCT00916617|588426069|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
162924632|NCT00916617|588426070|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
162924633|NCT00916617|588426071|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
162924634|NCT00916617|588426072|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
162924635|NCT00916617|588426069|FG000|Overall Study|Lost to Follow-up|2|||
162924636|NCT00916617|588426070|FG001|Overall Study|Lost to Follow-up|1|||
162924637|NCT00916617|588426071|FG002|Overall Study|Lost to Follow-up|0|||
162924638|NCT00916617|588426072|FG003|Overall Study|Lost to Follow-up|0|||
162924639|NCT00916617|588426069|FG000|Overall Study|Lack of Efficacy|1|||
162924640|NCT00916617|588426070|FG001|Overall Study|Lack of Efficacy|0|||
162924641|NCT00916617|588426071|FG002|Overall Study|Lack of Efficacy|0|||
162924642|NCT00916617|588426072|FG003|Overall Study|Lack of Efficacy|0|||
162924643|NCT00916617|588426069|FG000|Overall Study|Other|2|||
162924644|NCT00916617|588426070|FG001|Overall Study|Other|0|||
162924645|NCT00916617|588426071|FG002|Overall Study|Other|0|||
162924646|NCT00916617|588426072|FG003|Overall Study|Other|2|||
162924647|NCT00499252|588426074|FG000|Overall Study|Adverse Event|3|||
162924648|NCT00499252|588426074|FG000|Overall Study|Refused further treatment|2|||
162924649|NCT00499252|588426074|FG000|Overall Study|Ineligible|4|||
162924650|NCT00499252|588426074|FG000|Overall Study|<no further label>|3|||
163061072|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
162924651|NCT02230332|588426075|FG000|Overall Study|Adverse Event|2|||
162924652|NCT02230332|588426076|FG001|Overall Study|Adverse Event|1|||
163004357|NCT00545714|588717066|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
163004358|NCT00545714|588717066|FG000|Maintenance Phase (36 Months)|Death|2|||
163004359|NCT01431079|588717069|FG000|Overall Study|Lost to Follow-up|35|||
163004360|NCT01431079|588717070|FG001|Overall Study|Lost to Follow-up|39|||
163004361|NCT01202175|588717071|FG000|Overall Study|Lost to Follow-up|2|||
163004362|NCT01202175|588717071|FG000|Overall Study|Withdrawal by Subject|1|||
163004363|NCT01202175|588717071|FG000|Overall Study|Adverse Event|2|||
163004364|NCT04747470|588717072|FG000|Overall Study|Death|0|||
163004365|NCT04747470|588717073|FG001|Overall Study|Death|3|||
163004366|NCT04747470|588717074|FG002|Overall Study|Death|2|||
163004367|NCT04747470|588717075|FG003|Overall Study|Death|2|||
163004368|NCT04747470|588717076|FG004|Overall Study|Death|2|||
163004369|NCT04747470|588717077|FG005|Overall Study|Death|0|||
163004370|NCT04747470|588717078|FG006|Overall Study|Death|0|||
163004371|NCT04747470|588717079|FG007|Overall Study|Death|0|||
163004372|NCT04747470|588717080|FG008|Overall Study|Death|0|||
163004373|NCT04747470|588717081|FG009|Overall Study|Death|0|||
163004374|NCT04747470|588717082|FG010|Overall Study|Death|0|||
163004375|NCT04747470|588717072|FG000|Overall Study|Withdrew Consent|0|||
163004376|NCT04747470|588717073|FG001|Overall Study|Withdrew Consent|0|||
163004377|NCT04747470|588717074|FG002|Overall Study|Withdrew Consent|0|||
163004378|NCT04747470|588717075|FG003|Overall Study|Withdrew Consent|1|||
163004379|NCT04747470|588717076|FG004|Overall Study|Withdrew Consent|0|||
163004380|NCT04747470|588717077|FG005|Overall Study|Withdrew Consent|0|||
163004381|NCT04747470|588717078|FG006|Overall Study|Withdrew Consent|0|||
163004382|NCT04747470|588717079|FG007|Overall Study|Withdrew Consent|0|||
163004383|NCT04747470|588717080|FG008|Overall Study|Withdrew Consent|0|||
163004384|NCT04747470|588717081|FG009|Overall Study|Withdrew Consent|0|||
163004385|NCT04747470|588717082|FG010|Overall Study|Withdrew Consent|0|||
163004386|NCT04747470|588717072|FG000|Overall Study|Study Terminated by Sponsor|0|||
163004387|NCT04747470|588717073|FG001|Overall Study|Study Terminated by Sponsor|0|||
163004388|NCT04747470|588717074|FG002|Overall Study|Study Terminated by Sponsor|1|||
163004389|NCT04747470|588717075|FG003|Overall Study|Study Terminated by Sponsor|0|||
163004390|NCT04747470|588717076|FG004|Overall Study|Study Terminated by Sponsor|2|||
163004391|NCT04747470|588717077|FG005|Overall Study|Study Terminated by Sponsor|0|||
163004392|NCT04747470|588717078|FG006|Overall Study|Study Terminated by Sponsor|0|||
163004393|NCT04747470|588717079|FG007|Overall Study|Study Terminated by Sponsor|0|||
163004394|NCT04747470|588717080|FG008|Overall Study|Study Terminated by Sponsor|0|||
163004395|NCT04747470|588717081|FG009|Overall Study|Study Terminated by Sponsor|0|||
163004396|NCT04747470|588717082|FG010|Overall Study|Study Terminated by Sponsor|0|||
163004397|NCT02790437|588717083|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
163004398|NCT02790437|588717084|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
163004399|NCT02790437|588717083|FG000|Overall Study|Adverse Event|1|||
163004400|NCT02790437|588717084|FG001|Overall Study|Adverse Event|0|||
163004401|NCT02790437|588717083|FG000|Overall Study|Withdrawal by Subject|1|||
163004402|NCT02790437|588717084|FG001|Overall Study|Withdrawal by Subject|0|||
163004403|NCT01626690|588717087|FG000|Overall Study|Protocol Violation|1|||
163004404|NCT01626690|588717088|FG001|Overall Study|Protocol Violation|0|||
163004405|NCT01626690|588717087|FG000|Overall Study|Adverse Event|1|||
163004406|NCT01626690|588717088|FG001|Overall Study|Adverse Event|0|||
163004407|NCT01125189|588717089|FG000|Treatment Period|Lack of Efficacy|15|||
163004408|NCT01125189|588717090|FG001|Treatment Period|Lack of Efficacy|18|||
163004409|NCT01125189|588717091|FG002|Treatment Period|Lack of Efficacy|25|||
163004410|NCT01125189|588717089|FG000|Treatment Period|Adverse Event|7|||
163004411|NCT01125189|588717090|FG001|Treatment Period|Adverse Event|8|||
163004412|NCT01125189|588717091|FG002|Treatment Period|Adverse Event|8|||
163004413|NCT01125189|588717089|FG000|Treatment Period|Withdrawal by Subject|3|||
163004414|NCT01125189|588717090|FG001|Treatment Period|Withdrawal by Subject|1|||
163004415|NCT01125189|588717091|FG002|Treatment Period|Withdrawal by Subject|1|||
163004416|NCT01125189|588717089|FG000|Treatment Period|Death|1|||
163004417|NCT01125189|588717090|FG001|Treatment Period|Death|0|||
163004418|NCT01125189|588717091|FG002|Treatment Period|Death|0|||
163004419|NCT01125189|588717089|FG000|Treatment Period|Lost to Follow-up|1|||
163004420|NCT01125189|588717090|FG001|Treatment Period|Lost to Follow-up|2|||
163004421|NCT01125189|588717091|FG002|Treatment Period|Lost to Follow-up|1|||
163004422|NCT01125189|588717089|FG000|Treatment Period|Poor compliance/noncompliance|0|||
163004423|NCT01125189|588717090|FG001|Treatment Period|Poor compliance/noncompliance|1|||
163004424|NCT01125189|588717091|FG002|Treatment Period|Poor compliance/noncompliance|0|||
163004425|NCT01125189|588717089|FG000|Treatment Period|Participants requested to discontinue|1|||
163004426|NCT01125189|588717090|FG001|Treatment Period|Participants requested to discontinue|3|||
163004427|NCT01125189|588717091|FG002|Treatment Period|Participants requested to discontinue|4|||
163004428|NCT01125189|588717089|FG000|Treatment Period|Other reasons|1|||
163004429|NCT01125189|588717090|FG001|Treatment Period|Other reasons|1|||
163004430|NCT01125189|588717091|FG002|Treatment Period|Other reasons|0|||
163004431|NCT01125189|588717089|FG000|Treatment Period|Completed 24 week treatment period only|2|||
163004432|NCT01125189|588717090|FG001|Treatment Period|Completed 24 week treatment period only|1|||
163004433|NCT01125189|588717091|FG002|Treatment Period|Completed 24 week treatment period only|2|||
163004434|NCT01125189|588717089|FG000|Follow up Period|Withdrawal by Subject|3|||
163061073|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
163061074|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
163325970|NCT03777657|589904656|FG001|Overall Study|Lost to Follow-up|10|||
163325971|NCT04559698|589905404|FG000|Overall Study|Lost to Follow-up|14|||
163325972|NCT04559698|589905405|FG001|Overall Study|Lost to Follow-up|15|||
163325973|NCT04559698|589905404|FG000|Overall Study|Withdrawal by Subject|0|||
163325974|NCT04559698|589905405|FG001|Overall Study|Withdrawal by Subject|1|||
163325975|NCT01982682|589905406|FG000|Overall Study|Physician Decision|1|||
163325976|NCT02760654|589905407|FG000|Overall Study|Lost to Follow-up|3|||
163004435|NCT01125189|588717090|FG001|Follow up Period|Withdrawal by Subject|2|||
163004436|NCT01125189|588717091|FG002|Follow up Period|Withdrawal by Subject|5|||
163004437|NCT01125189|588717089|FG000|Follow up Period|Death|1|||
163004438|NCT01125189|588717090|FG001|Follow up Period|Death|0|||
163004439|NCT01125189|588717091|FG002|Follow up Period|Death|0|||
163004440|NCT01125189|588717089|FG000|Follow up Period|Lost to Follow-up|12|||
163004441|NCT01125189|588717090|FG001|Follow up Period|Lost to Follow-up|9|||
163004442|NCT01125189|588717091|FG002|Follow up Period|Lost to Follow-up|6|||
163004443|NCT01125189|588717089|FG000|Follow up Period|Other reasons|4|||
163004444|NCT01125189|588717090|FG001|Follow up Period|Other reasons|4|||
163004445|NCT01125189|588717091|FG002|Follow up Period|Other reasons|5|||
163004446|NCT02414958|588717092|FG000|Overall Study|Adverse Event|6|||
163004447|NCT02414958|588717093|FG001|Overall Study|Adverse Event|6|||
163004448|NCT02414958|588717094|FG002|Overall Study|Adverse Event|3|||
163004449|NCT02414958|588717092|FG000|Overall Study|Protocol Violation|10|||
163004450|NCT02414958|588717093|FG001|Overall Study|Protocol Violation|3|||
163004451|NCT02414958|588717094|FG002|Overall Study|Protocol Violation|1|||
163004452|NCT02414958|588717092|FG000|Overall Study|Lost to Follow-up|7|||
163004453|NCT02414958|588717093|FG001|Overall Study|Lost to Follow-up|4|||
163004454|NCT02414958|588717094|FG002|Overall Study|Lost to Follow-up|0|||
163004455|NCT02414958|588717092|FG000|Overall Study|Withdrawal by Subject|5|||
163004456|NCT02414958|588717093|FG001|Overall Study|Withdrawal by Subject|3|||
163004457|NCT02414958|588717094|FG002|Overall Study|Withdrawal by Subject|5|||
163004458|NCT02414958|588717092|FG000|Overall Study|Other than specified|4|||
163004459|NCT02414958|588717093|FG001|Overall Study|Other than specified|4|||
163004460|NCT02414958|588717094|FG002|Overall Study|Other than specified|5|||
163004461|NCT01269918|588717095|FG000|Overall Study|Did not receive study drug|0|||
163004462|NCT01269918|588717096|FG001|Overall Study|Did not receive study drug|3|||
163004463|NCT04542057|588717097|FG000|Overall Study|Death|3|||
163004464|NCT04542057|588717098|FG001|Overall Study|Death|1|||
163004465|NCT04542057|588717097|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
163004466|NCT04542057|588717098|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
163004467|NCT04542057|588717097|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
163004468|NCT04542057|588717098|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
163004469|NCT04542057|588717097|FG000|Overall Study|Adverse Event|15|||
163004470|NCT04542057|588717098|FG001|Overall Study|Adverse Event|6|||
163004471|NCT04542057|588717097|FG000|Overall Study|COVID-19 adverse event|6|||
163004472|NCT04542057|588717098|FG001|Overall Study|COVID-19 adverse event|4|||
163004473|NCT04542057|588717097|FG000|Overall Study|Lack of Efficacy|2|||
163004474|NCT04542057|588717098|FG001|Overall Study|Lack of Efficacy|5|||
163004475|NCT04542057|588717097|FG000|Overall Study|Study terminated by sponsor|1|||
163004476|NCT04542057|588717098|FG001|Overall Study|Study terminated by sponsor|0|||
163004477|NCT04542057|588717097|FG000|Overall Study|Investigator discretion|2|||
163004478|NCT04542057|588717098|FG001|Overall Study|Investigator discretion|1|||
163004479|NCT04542057|588717097|FG000|Overall Study|Withdrawal by Subject|52|||
163004480|NCT04542057|588717098|FG001|Overall Study|Withdrawal by Subject|30|||
163325977|NCT02760654|589905408|FG001|Overall Study|Lost to Follow-up|3|||
163325978|NCT02760654|589905407|FG000|Overall Study|Withdrawal by Subject|4|||
163325979|NCT02760654|589905408|FG001|Overall Study|Withdrawal by Subject|3|||
163325980|NCT01574716|589905409|FG000|Part 1|Death|3|||
163325981|NCT01574716|589905410|FG001|Part 1|Death|1|||
163325982|NCT01574716|589905411|FG002|Part 1|Death|8|||
163325983|NCT01574716|589905412|FG003|Part 1|Death|0|||
163004481|NCT04542057|588717097|FG000|Overall Study|Lost to Follow-up|8|||
163004482|NCT04542057|588717098|FG001|Overall Study|Lost to Follow-up|11|||
163325984|NCT01574716|589905413|FG004|Part 1|Death|0|||
163004483|NCT04542057|588717097|FG000|Overall Study|Other|2|||
163004484|NCT04542057|588717098|FG001|Overall Study|Other|2|||
163004485|NCT03624192|588717099|FG000|Overall Study|Lost to Follow-up|1|||
163004486|NCT03624192|588717100|FG001|Overall Study|Lost to Follow-up|1|||
163004487|NCT01640249|588717101|FG000|Period 1|Withdrawal by Subject|1|||
163004488|NCT01640249|588717102|FG001|Period 1|Withdrawal by Subject|0|||
163004489|NCT01640249|588717103|FG002|Period 1|Withdrawal by Subject|0|||
163004490|NCT01640249|588717104|FG003|Period 1|Withdrawal by Subject|0|||
163004491|NCT01640249|588717105|FG004|Period 1|Withdrawal by Subject|0|||
163004492|NCT01640249|588717106|FG005|Period 1|Withdrawal by Subject|1|||
163004493|NCT01640249|588717107|FG006|Period 1|Withdrawal by Subject|0|||
163004494|NCT00065156|588717108|FG000|Overall Study|Adverse Event|37|||
163325985|NCT01574716|589905409|FG000|Part 1|Discontinuation of study by sponsor|0|||
163004495|NCT00065156|588717108|FG000|Overall Study|Lack of Efficacy|52|||
163004496|NCT00065156|588717108|FG000|Overall Study|Withdrawal by Subject|8|||
163004497|NCT00065156|588717108|FG000|Overall Study|Lost to Follow-up|1|||
163004498|NCT00065156|588717108|FG000|Overall Study|Death|11|||
163004499|NCT00065156|588717108|FG000|Overall Study|Study Closed by Sponsor|2|||
163004500|NCT00065156|588717108|FG000|Overall Study|Disease Progression|7|||
163004501|NCT00065156|588717108|FG000|Overall Study|Investigator Decision|2|||
163004502|NCT00065156|588717108|FG000|Overall Study|Non-Compliance|2|||
163004503|NCT00065156|588717108|FG000|Overall Study|Loss of Response|1|||
163004504|NCT00065156|588717108|FG000|Overall Study|Secondary Malign Disease|1|||
163004505|NCT00312338|588717109|FG000|Overall Study|Adverse Event|7|||
163004506|NCT00312338|588717110|FG001|Overall Study|Adverse Event|2|||
163004507|NCT00312338|588717109|FG000|Overall Study|Lost to Follow-up|9|||
163004508|NCT00312338|588717110|FG001|Overall Study|Lost to Follow-up|1|||
163004509|NCT00312338|588717109|FG000|Overall Study|Withdrawal by Subject|4|||
163004510|NCT00312338|588717110|FG001|Overall Study|Withdrawal by Subject|0|||
163004511|NCT00312338|588717109|FG000|Overall Study|Subsequent infection|2|||
163004512|NCT00312338|588717110|FG001|Overall Study|Subsequent infection|0|||
163004513|NCT00100828|588717111|FG000|Overall Study|Physician Decision|6|||
163004514|NCT04583735|588717112|FG000|Double-masked Treatment Period|Adverse Event|0|||
163004515|NCT04583735|588717113|FG001|Double-masked Treatment Period|Adverse Event|1|||
163004516|NCT04583735|588717112|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
163004517|NCT04583735|588717113|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
163061075|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
163061076|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
163061077|NCT00362232|588933015|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
163061078|NCT00362232|588933016|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
163061079|NCT00362232|588933015|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
163061080|NCT00362232|588933016|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
163004518|NCT04583735|588717112|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
163004519|NCT04583735|588717113|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
163061081|NCT00362232|588933015|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
163061082|NCT00362232|588933016|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
163061083|NCT00362232|588933015|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
163061084|NCT00362232|588933016|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
163061085|NCT02233413|588933019|FG000|Overall Study|Lost to Follow-up|7|||
163061086|NCT02233413|588933020|FG001|Overall Study|Lost to Follow-up|9|||
163325986|NCT01574716|589905410|FG001|Part 1|Discontinuation of study by sponsor|0|||
163325987|NCT01574716|589905411|FG002|Part 1|Discontinuation of study by sponsor|1|||
163325988|NCT01574716|589905412|FG003|Part 1|Discontinuation of study by sponsor|0|||
163325989|NCT01574716|589905413|FG004|Part 1|Discontinuation of study by sponsor|0|||
163325990|NCT01574716|589905409|FG000|Part 1|Withdrawal by Subject|0|||
163325991|NCT01574716|589905410|FG001|Part 1|Withdrawal by Subject|2|||
163325992|NCT01574716|589905411|FG002|Part 1|Withdrawal by Subject|0|||
163325993|NCT01574716|589905412|FG003|Part 1|Withdrawal by Subject|0|||
163325994|NCT01574716|589905413|FG004|Part 1|Withdrawal by Subject|0|||
163325995|NCT01574716|589905409|FG000|Part 1|Lost to Follow-up|0|||
163061087|NCT02233413|588933019|FG000|Overall Study|Withdrawal by Subject|4|||
163061088|NCT02233413|588933020|FG001|Overall Study|Withdrawal by Subject|5|||
163061089|NCT01799889|588933021|FG000|Overall Study|Adverse Event|4|||
163061090|NCT01799889|588933022|FG001|Overall Study|Adverse Event|4|||
163061091|NCT01799889|588933023|FG002|Overall Study|Adverse Event|5|||
163061092|NCT01799889|588933024|FG003|Overall Study|Adverse Event|1|||
163061093|NCT01799889|588933025|FG004|Overall Study|Adverse Event|11|||
163061094|NCT01799889|588933026|FG005|Overall Study|Adverse Event|1|||
163061095|NCT01799889|588933027|FG006|Overall Study|Adverse Event|5|||
163325996|NCT01574716|589905410|FG001|Part 1|Lost to Follow-up|1|||
163325997|NCT01574716|589905411|FG002|Part 1|Lost to Follow-up|0|||
163325998|NCT01574716|589905412|FG003|Part 1|Lost to Follow-up|0|||
163325999|NCT01574716|589905413|FG004|Part 1|Lost to Follow-up|0|||
163326000|NCT01574716|589905409|FG000|Part 2|Progressive disease|0|||
163326001|NCT01574716|589905410|FG001|Part 2|Progressive disease|0|||
163004520|NCT04583735|588717112|FG000|Open-label Treatment Period|Adverse Event|1|||
163004521|NCT04583735|588717113|FG001|Open-label Treatment Period|Adverse Event|1|||
163004522|NCT04583735|588717112|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
163004523|NCT04583735|588717113|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
163004524|NCT04583735|588717112|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
163004525|NCT04583735|588717113|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
163004526|NCT01176513|588717114|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
163004527|NCT01215136|588717115|FG000|Overall Study|Adverse Event|2|||
163004528|NCT01215136|588717116|FG001|Overall Study|Adverse Event|9|||
163004529|NCT01215136|588717115|FG000|Overall Study|Disease Progression|3|||
163061096|NCT01799889|588933028|FG007|Overall Study|Adverse Event|2|||
163061097|NCT01799889|588933029|FG008|Overall Study|Adverse Event|3|||
163061098|NCT01799889|588933030|FG009|Overall Study|Adverse Event|1|||
163061099|NCT01799889|588933031|FG010|Overall Study|Adverse Event|1|||
163061100|NCT01799889|588933032|FG011|Overall Study|Adverse Event|0|||
163061101|NCT01799889|588933021|FG000|Overall Study|Death|1|||
163004530|NCT01215136|588717116|FG001|Overall Study|Disease Progression|14|||
163004531|NCT01215136|588717115|FG000|Overall Study|Symptomatic Deterioration|1|||
163004532|NCT01215136|588717116|FG001|Overall Study|Symptomatic Deterioration|1|||
163004533|NCT01215136|588717115|FG000|Overall Study|Death|0|||
163004534|NCT01215136|588717116|FG001|Overall Study|Death|2|||
163004535|NCT01215136|588717115|FG000|Overall Study|Withdrawal by Subject|0|||
163004536|NCT01215136|588717116|FG001|Overall Study|Withdrawal by Subject|1|||
163004537|NCT01125917|588717121|FG000|Overall Study|Adverse Event|43|||
163004538|NCT01125917|588717121|FG000|Overall Study|Lost to Follow-up|23|||
163004539|NCT01125917|588717121|FG000|Overall Study|Withdrawal by Subject|31|||
163004540|NCT01125917|588717121|FG000|Overall Study|Administrative|223|||
163004541|NCT01125917|588717121|FG000|Overall Study|Lack of Efficacy|19|||
163004542|NCT04421131|588717123|FG000|Overall Study|Lost to Follow-up|1|||
163004543|NCT04421131|588717123|FG000|Overall Study|Protocol Violation|2|||
163004544|NCT04421131|588717123|FG000|Overall Study|App crashed|5|||
163004545|NCT02308124|588717124|FG000|Overall Study|Lost to Follow-up|6|||
163004546|NCT02308124|588717125|FG001|Overall Study|Lost to Follow-up|6|||
163004547|NCT02308124|588717126|FG002|Overall Study|Lost to Follow-up|6|||
163004548|NCT02308124|588717124|FG000|Overall Study|Adverse Event|0|||
163004549|NCT02308124|588717125|FG001|Overall Study|Adverse Event|2|||
163004550|NCT02308124|588717126|FG002|Overall Study|Adverse Event|2|||
163004551|NCT00838526|588717131|FG000|Overall Study|Adverse Event|3|||
163004552|NCT00838526|588717132|FG001|Overall Study|Adverse Event|12|||
163004553|NCT00838526|588717131|FG000|Overall Study|Lost to Follow-up|4|||
163004554|NCT00838526|588717132|FG001|Overall Study|Lost to Follow-up|12|||
163004555|NCT00838526|588717131|FG000|Overall Study|Withdrawal by Subject|4|||
163004556|NCT00838526|588717132|FG001|Overall Study|Withdrawal by Subject|5|||
163004557|NCT00838526|588717131|FG000|Overall Study|Lack of Efficacy|2|||
163004558|NCT00838526|588717132|FG001|Overall Study|Lack of Efficacy|3|||
163004559|NCT00838526|588717131|FG000|Overall Study|Other|11|||
163004560|NCT00838526|588717132|FG001|Overall Study|Other|7|||
163004561|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
163004562|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
163004563|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
163004564|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
163004565|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
163004566|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
163004567|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
163004568|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
163004569|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
163004570|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
163004571|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
163004572|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
163004573|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
163004574|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
163004575|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
163004576|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
163004577|NCT04338022|588717134|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
163004578|NCT04338022|588717135|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
163004579|NCT04338022|588717134|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
163004580|NCT04338022|588717135|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
163004581|NCT04338022|588717134|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
163004582|NCT04338022|588717135|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
163004583|NCT04338022|588717134|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
163004584|NCT04338022|588717135|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
163004585|NCT04338022|588717134|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
163004586|NCT04338022|588717135|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
163004587|NCT04338022|588717134|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
163004588|NCT04338022|588717135|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
163004589|NCT00786409|588717136|FG000|Overall Study|Withdrawal by Subject|2|||
163004590|NCT00786409|588717136|FG000|Overall Study|Adverse Event|2|||
163004591|NCT00786409|588717136|FG000|Overall Study|Pregnancy|2|||
163004592|NCT00786409|588717136|FG000|Overall Study|Lost to Follow-up|1|||
163004593|NCT00610129|588717137|FG000|Overall Study|Not treated since patients ineligible|3|||
163061102|NCT01799889|588933022|FG001|Overall Study|Death|0|||
163004594|NCT02273388|588717141|FG000|Overall Study|Adverse Event|0|||
163004595|NCT02273388|588717142|FG001|Overall Study|Adverse Event|0|||
163004596|NCT02273388|588717143|FG002|Overall Study|Adverse Event|0|||
163004597|NCT02273388|588717144|FG003|Overall Study|Adverse Event|0|||
163004598|NCT02273388|588717145|FG004|Overall Study|Adverse Event|0|||
163004599|NCT02273388|588717146|FG005|Overall Study|Adverse Event|0|||
163004600|NCT02273388|588717147|FG006|Overall Study|Adverse Event|1|||
163004601|NCT02273388|588717148|FG007|Overall Study|Adverse Event|2|||
163061103|NCT01799889|588933023|FG002|Overall Study|Death|5|||
163004602|NCT02273388|588717149|FG008|Overall Study|Adverse Event|0|||
163004603|NCT02273388|588717150|FG009|Overall Study|Adverse Event|0|||
163004604|NCT02273388|588717151|FG010|Overall Study|Adverse Event|0|||
163004605|NCT02273388|588717152|FG011|Overall Study|Adverse Event|0|||
163004606|NCT02273388|588717141|FG000|Overall Study|Adverse Event study disease worse|4|||
163004607|NCT02273388|588717142|FG001|Overall Study|Adverse Event study disease worse|3|||
163004608|NCT02273388|588717143|FG002|Overall Study|Adverse Event study disease worse|3|||
163004609|NCT02273388|588717144|FG003|Overall Study|Adverse Event study disease worse|2|||
163004610|NCT02273388|588717145|FG004|Overall Study|Adverse Event study disease worse|4|||
163004611|NCT02273388|588717146|FG005|Overall Study|Adverse Event study disease worse|3|||
163004612|NCT02273388|588717147|FG006|Overall Study|Adverse Event study disease worse|14|||
163004613|NCT02273388|588717148|FG007|Overall Study|Adverse Event study disease worse|6|||
163004614|NCT02273388|588717149|FG008|Overall Study|Adverse Event study disease worse|6|||
163004615|NCT02273388|588717150|FG009|Overall Study|Adverse Event study disease worse|5|||
163004616|NCT02273388|588717151|FG010|Overall Study|Adverse Event study disease worse|10|||
163004617|NCT02273388|588717152|FG011|Overall Study|Adverse Event study disease worse|1|||
163004618|NCT02273388|588717141|FG000|Overall Study|Sponsor decision|0|||
163004619|NCT02273388|588717142|FG001|Overall Study|Sponsor decision|0|||
163004620|NCT02273388|588717143|FG002|Overall Study|Sponsor decision|0|||
163004621|NCT02273388|588717144|FG003|Overall Study|Sponsor decision|0|||
163004622|NCT02273388|588717145|FG004|Overall Study|Sponsor decision|0|||
163004623|NCT02273388|588717146|FG005|Overall Study|Sponsor decision|0|||
163004624|NCT02273388|588717147|FG006|Overall Study|Sponsor decision|0|||
163004625|NCT02273388|588717148|FG007|Overall Study|Sponsor decision|0|||
163004626|NCT02273388|588717149|FG008|Overall Study|Sponsor decision|0|||
163004627|NCT02273388|588717150|FG009|Overall Study|Sponsor decision|0|||
163004628|NCT02273388|588717151|FG010|Overall Study|Sponsor decision|0|||
163004629|NCT02273388|588717152|FG011|Overall Study|Sponsor decision|1|||
163004630|NCT04331808|588717153|FG000|Overall Study|Withdrew consent|1|||
163061104|NCT01799889|588933024|FG003|Overall Study|Death|3|||
163061105|NCT01799889|588933025|FG004|Overall Study|Death|1|||
163061106|NCT01799889|588933026|FG005|Overall Study|Death|0|||
163061107|NCT01799889|588933027|FG006|Overall Study|Death|0|||
163061108|NCT01799889|588933028|FG007|Overall Study|Death|0|||
163061109|NCT01799889|588933029|FG008|Overall Study|Death|1|||
163061110|NCT01799889|588933030|FG009|Overall Study|Death|0|||
163061111|NCT01799889|588933031|FG010|Overall Study|Death|1|||
163061112|NCT01799889|588933032|FG011|Overall Study|Death|0|||
163061113|NCT01799889|588933021|FG000|Overall Study|Lack of Efficacy|1|||
163061114|NCT01799889|588933022|FG001|Overall Study|Lack of Efficacy|1|||
163061115|NCT01799889|588933023|FG002|Overall Study|Lack of Efficacy|0|||
163061116|NCT01799889|588933024|FG003|Overall Study|Lack of Efficacy|1|||
163061117|NCT01799889|588933025|FG004|Overall Study|Lack of Efficacy|2|||
163061118|NCT01799889|588933026|FG005|Overall Study|Lack of Efficacy|2|||
163061119|NCT01799889|588933027|FG006|Overall Study|Lack of Efficacy|0|||
163061120|NCT01799889|588933028|FG007|Overall Study|Lack of Efficacy|0|||
163061121|NCT01799889|588933029|FG008|Overall Study|Lack of Efficacy|2|||
163061122|NCT01799889|588933030|FG009|Overall Study|Lack of Efficacy|0|||
163061123|NCT01799889|588933031|FG010|Overall Study|Lack of Efficacy|1|||
163061124|NCT01799889|588933032|FG011|Overall Study|Lack of Efficacy|0|||
163061125|NCT01799889|588933021|FG000|Overall Study|Lost to Follow-up|0|||
163061126|NCT01799889|588933022|FG001|Overall Study|Lost to Follow-up|1|||
163061127|NCT01799889|588933023|FG002|Overall Study|Lost to Follow-up|0|||
163061128|NCT01799889|588933024|FG003|Overall Study|Lost to Follow-up|0|||
163061129|NCT01799889|588933025|FG004|Overall Study|Lost to Follow-up|0|||
163061130|NCT01799889|588933026|FG005|Overall Study|Lost to Follow-up|0|||
163061131|NCT01799889|588933027|FG006|Overall Study|Lost to Follow-up|0|||
163061132|NCT01799889|588933028|FG007|Overall Study|Lost to Follow-up|0|||
163061133|NCT01799889|588933029|FG008|Overall Study|Lost to Follow-up|0|||
163061134|NCT01799889|588933030|FG009|Overall Study|Lost to Follow-up|0|||
163061135|NCT01799889|588933031|FG010|Overall Study|Lost to Follow-up|0|||
163061136|NCT01799889|588933032|FG011|Overall Study|Lost to Follow-up|0|||
163061137|NCT01799889|588933021|FG000|Overall Study|Physician Decision|3|||
163061138|NCT01799889|588933022|FG001|Overall Study|Physician Decision|2|||
163061139|NCT01799889|588933023|FG002|Overall Study|Physician Decision|4|||
163004631|NCT04331808|588717154|FG001|Overall Study|Withdrew consent|0|||
163004632|NCT04331808|588717155|FG002|Overall Study|Withdrew consent|2|||
163004633|NCT04331808|588717156|FG003|Overall Study|Withdrew consent|3|||
163004634|NCT02445963|588717157|FG000|Overall Study|Lost to Follow-up|1|||
163004635|NCT02445963|588717158|FG001|Overall Study|Lost to Follow-up|0|||
163004636|NCT02445963|588717159|FG002|Overall Study|Lost to Follow-up|0|||
163061140|NCT01799889|588933024|FG003|Overall Study|Physician Decision|4|||
163004637|NCT02445963|588717160|FG003|Overall Study|Lost to Follow-up|0|||
163004638|NCT02445963|588717157|FG000|Overall Study|Change in employment|1|||
163061141|NCT01799889|588933025|FG004|Overall Study|Physician Decision|5|||
163061142|NCT01799889|588933026|FG005|Overall Study|Physician Decision|5|||
163061143|NCT01799889|588933027|FG006|Overall Study|Physician Decision|5|||
163061144|NCT01799889|588933028|FG007|Overall Study|Physician Decision|2|||
163061145|NCT01799889|588933029|FG008|Overall Study|Physician Decision|6|||
163061146|NCT01799889|588933030|FG009|Overall Study|Physician Decision|0|||
163004639|NCT02445963|588717158|FG001|Overall Study|Change in employment|0|||
163004640|NCT02445963|588717159|FG002|Overall Study|Change in employment|0|||
163004641|NCT02445963|588717160|FG003|Overall Study|Change in employment|0|||
163004642|NCT02445963|588717157|FG000|Overall Study|Symptoms post-vaccination|0|||
163004643|NCT02445963|588717158|FG001|Overall Study|Symptoms post-vaccination|0|||
163004644|NCT02445963|588717159|FG002|Overall Study|Symptoms post-vaccination|1|||
163004645|NCT02445963|588717160|FG003|Overall Study|Symptoms post-vaccination|0|||
163004646|NCT01957176|588717164|FG000|Overall Study|Adverse Event|2|||
163004647|NCT01957176|588717165|FG001|Overall Study|Adverse Event|0|||
163004648|NCT01957176|588717164|FG000|Overall Study|Physician Decision|2|||
163004649|NCT01957176|588717165|FG001|Overall Study|Physician Decision|1|||
163004650|NCT01957176|588717164|FG000|Overall Study|Withdrawal by Subject|1|||
163004651|NCT01957176|588717165|FG001|Overall Study|Withdrawal by Subject|0|||
163004652|NCT00952731|588717166|FG000|Overall Study|Drug supply expired|1|||
163004653|NCT00952731|588717167|FG001|Overall Study|Drug supply expired|0|||
163004654|NCT03172494|588717168|FG000|Overall Study|Adverse Event|5|||
163004655|NCT03172494|588717169|FG001|Overall Study|Adverse Event|1|||
163004656|NCT03172494|588717170|FG002|Overall Study|Adverse Event|15|||
163004657|NCT03172494|588717168|FG000|Overall Study|Protocol Violation|3|||
163004658|NCT03172494|588717169|FG001|Overall Study|Protocol Violation|2|||
163004659|NCT03172494|588717170|FG002|Overall Study|Protocol Violation|1|||
163004660|NCT03172494|588717168|FG000|Overall Study|Lack of Efficacy|0|||
163004661|NCT03172494|588717169|FG001|Overall Study|Lack of Efficacy|0|||
163004662|NCT03172494|588717170|FG002|Overall Study|Lack of Efficacy|4|||
163004663|NCT03172494|588717168|FG000|Overall Study|Pregnancy|0|||
163004664|NCT03172494|588717169|FG001|Overall Study|Pregnancy|1|||
163004665|NCT03172494|588717170|FG002|Overall Study|Pregnancy|0|||
163004666|NCT03172494|588717168|FG000|Overall Study|Withdrawal by Subject|10|||
163004667|NCT03172494|588717169|FG001|Overall Study|Withdrawal by Subject|8|||
163004668|NCT03172494|588717170|FG002|Overall Study|Withdrawal by Subject|8|||
163004669|NCT03172494|588717168|FG000|Overall Study|Severe hypoglycaemic episode|0|||
163004670|NCT03172494|588717169|FG001|Overall Study|Severe hypoglycaemic episode|0|||
163004671|NCT03172494|588717170|FG002|Overall Study|Severe hypoglycaemic episode|1|||
163004672|NCT03172494|588717168|FG000|Overall Study|Non-compliance towards treatment|2|||
163004673|NCT03172494|588717169|FG001|Overall Study|Non-compliance towards treatment|0|||
163004674|NCT03172494|588717170|FG002|Overall Study|Non-compliance towards treatment|0|||
163326002|NCT01574716|589905411|FG002|Part 2|Progressive disease|0|||
163326003|NCT01574716|589905412|FG003|Part 2|Progressive disease|1|||
163326004|NCT01574716|589905413|FG004|Part 2|Progressive disease|0|||
163326005|NCT01574716|589905409|FG000|Part 2|Death|0|||
163326006|NCT01574716|589905410|FG001|Part 2|Death|0|||
163326007|NCT01574716|589905411|FG002|Part 2|Death|0|||
163326008|NCT01574716|589905412|FG003|Part 2|Death|76|||
163326009|NCT01574716|589905413|FG004|Part 2|Death|35|||
163326010|NCT01574716|589905409|FG000|Part 2|Discontinuation of study by sponsor|0|||
163326011|NCT01574716|589905410|FG001|Part 2|Discontinuation of study by sponsor|0|||
163326012|NCT01574716|589905411|FG002|Part 2|Discontinuation of study by sponsor|0|||
163326013|NCT01574716|589905412|FG003|Part 2|Discontinuation of study by sponsor|51|||
163004675|NCT04233073|588717171|FG000|Overall Study|Death|5|||
163004676|NCT00143390|588717172|FG000|Overall Study|Death|2|||
163004677|NCT00143390|588717173|FG001|Overall Study|Death|0|||
163004678|NCT00143390|588717172|FG000|Overall Study|Not meeting entry criteria|2|||
163004679|NCT00143390|588717173|FG001|Overall Study|Not meeting entry criteria|5|||
163004680|NCT00143390|588717172|FG000|Overall Study|Withdrawal by Subject|4|||
163004681|NCT00143390|588717173|FG001|Overall Study|Withdrawal by Subject|4|||
163004682|NCT00143390|588717172|FG000|Overall Study|Progressive disease|119|||
163004683|NCT00143390|588717173|FG001|Overall Study|Progressive disease|115|||
163004684|NCT00143390|588717172|FG000|Overall Study|Protocol Violation|2|||
163004685|NCT00143390|588717173|FG001|Overall Study|Protocol Violation|0|||
163004686|NCT00143390|588717172|FG000|Overall Study|Study termination|10|||
163004687|NCT00143390|588717173|FG001|Overall Study|Study termination|15|||
163004688|NCT00143390|588717172|FG000|Overall Study|Adverse Event|9|||
163004689|NCT00143390|588717173|FG001|Overall Study|Adverse Event|8|||
163004690|NCT00143390|588717172|FG000|Overall Study|Other|1|||
163004691|NCT00143390|588717173|FG001|Overall Study|Other|2|||
163326014|NCT01574716|589905413|FG004|Part 2|Discontinuation of study by sponsor|31|||
163004692|NCT00243412|588717174|FG000|Overall Study|Death|0|||
163004693|NCT00243412|588717175|FG001|Overall Study|Death|1|||
163004694|NCT00243412|588717174|FG000|Overall Study|Adverse Event|4|||
163004695|NCT00243412|588717175|FG001|Overall Study|Adverse Event|2|||
163061147|NCT01799889|588933031|FG010|Overall Study|Physician Decision|0|||
163326015|NCT01574716|589905409|FG000|Part 2|Withdrawal by Subject|0|||
163326016|NCT01574716|589905410|FG001|Part 2|Withdrawal by Subject|0|||
163326017|NCT01574716|589905411|FG002|Part 2|Withdrawal by Subject|0|||
163004696|NCT00243412|588717174|FG000|Overall Study|Lost to Follow-up|0|||
163004697|NCT00243412|588717175|FG001|Overall Study|Lost to Follow-up|1|||
163004698|NCT00243412|588717174|FG000|Overall Study|Physician Decision|1|||
163004699|NCT00243412|588717175|FG001|Overall Study|Physician Decision|1|||
163004700|NCT00243412|588717174|FG000|Overall Study|Withdrawal by Subject|4|||
163326018|NCT01574716|589905412|FG003|Part 2|Withdrawal by Subject|5|||
163326019|NCT01574716|589905413|FG004|Part 2|Withdrawal by Subject|4|||
163326020|NCT01574716|589905409|FG000|Part 2|Brain metastases|0|||
163326021|NCT01574716|589905410|FG001|Part 2|Brain metastases|0|||
163004701|NCT00243412|588717175|FG001|Overall Study|Withdrawal by Subject|5|||
163004702|NCT00243412|588717174|FG000|Overall Study|Other|1|||
163004703|NCT00243412|588717175|FG001|Overall Study|Other|1|||
163004704|NCT00041132|588717177|FG000|Overall Study|Adverse Event|19|||
163004705|NCT00041132|588717177|FG000|Overall Study|Death|1|||
163004706|NCT00041132|588717177|FG000|Overall Study|Not Eligible|7|||
163004707|NCT00041132|588717177|FG000|Overall Study|Withdrawal by Subject|1|||
163004708|NCT00041132|588717177|FG000|Overall Study|Physician Decision|2|||
163004709|NCT02764151|588717178|FG000|Overall Study|Subject refused further follow-up|0|||
163004710|NCT02764151|588717179|FG001|Overall Study|Subject refused further follow-up|0|||
163004711|NCT02764151|588717180|FG002|Overall Study|Subject refused further follow-up|0|||
163004712|NCT02764151|588717181|FG003|Overall Study|Subject refused further follow-up|1|||
163004713|NCT02764151|588717178|FG000|Overall Study|Other|0|||
163004714|NCT02764151|588717179|FG001|Overall Study|Other|0|||
163004715|NCT02764151|588717180|FG002|Overall Study|Other|0|||
163004716|NCT02764151|588717181|FG003|Overall Study|Other|2|||
163004717|NCT01450683|588717185|FG000|Overall Study|Adverse Event|2|||
163004718|NCT00625872|588717187|FG000|Overall Study|Withdrawal by Subject|1|||
163004719|NCT00625872|588717188|FG001|Overall Study|Withdrawal by Subject|0|||
163004720|NCT00625872|588717187|FG000|Overall Study|Does not meet inclusion criteria|1|||
163004721|NCT00625872|588717188|FG001|Overall Study|Does not meet inclusion criteria|0|||
163004722|NCT00625872|588717187|FG000|Overall Study|Terminated by sponsor|2|||
163004723|NCT00625872|588717188|FG001|Overall Study|Terminated by sponsor|5|||
163004724|NCT00625872|588717187|FG000|Overall Study|Randomized but not treated|0|||
163004725|NCT00625872|588717188|FG001|Overall Study|Randomized but not treated|1|||
163004726|NCT01512160|588717189|FG000|Overall Study|Lost to Follow-up|1|||
163004727|NCT01512160|588717190|FG001|Overall Study|Lost to Follow-up|0|||
163004728|NCT01512160|588717191|FG002|Overall Study|Lost to Follow-up|0|||
163004729|NCT01512160|588717192|FG003|Overall Study|Lost to Follow-up|0|||
163004730|NCT01512160|588717189|FG000|Overall Study|Withdrawal by Subject|1|||
163004731|NCT01512160|588717190|FG001|Overall Study|Withdrawal by Subject|0|||
163004732|NCT01512160|588717191|FG002|Overall Study|Withdrawal by Subject|0|||
163004733|NCT01512160|588717192|FG003|Overall Study|Withdrawal by Subject|1|||
163004734|NCT02729909|588717193|FG000|Overall Study|Lost to Follow-up|0|||
163004735|NCT02729909|588717194|FG001|Overall Study|Lost to Follow-up|1|||
163004736|NCT02729909|588717193|FG000|Overall Study|Lack of Efficacy|0|||
163004737|NCT02729909|588717194|FG001|Overall Study|Lack of Efficacy|2|||
163004738|NCT02729909|588717193|FG000|Overall Study|Significant Protocol Deviation|0|||
163004739|NCT02729909|588717194|FG001|Overall Study|Significant Protocol Deviation|2|||
163004740|NCT02729909|588717193|FG000|Overall Study|Voluntary Withdrawal|1|||
163004741|NCT02729909|588717194|FG001|Overall Study|Voluntary Withdrawal|0|||
163004742|NCT04779879|588717198|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
163004743|NCT04779879|588717199|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
163004744|NCT04779879|588717200|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
163004745|NCT04779879|588717201|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
163004746|NCT04779879|588717202|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
163004747|NCT04779879|588717203|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
163004748|NCT04779879|588717198|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
163004749|NCT04779879|588717199|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
163004750|NCT04779879|588717200|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
163004751|NCT04779879|588717201|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
163004752|NCT04779879|588717202|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
163004753|NCT04779879|588717203|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
163004754|NCT04779879|588717198|FG000|Part C: Up to Week 36|Death|0|||
163004755|NCT04779879|588717199|FG001|Part C: Up to Week 36|Death|0|||
163004756|NCT04779879|588717200|FG002|Part C: Up to Week 36|Death|0|||
163004757|NCT04779879|588717201|FG003|Part C: Up to Week 36|Death|0|||
163326022|NCT01574716|589905411|FG002|Part 2|Brain metastases|0|||
163326023|NCT01574716|589905412|FG003|Part 2|Brain metastases|1|||
163004758|NCT04779879|588717202|FG004|Part C: Up to Week 36|Death|0|||
163004759|NCT04779879|588717203|FG005|Part C: Up to Week 36|Death|1|||
163004760|NCT04779879|588717198|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
163004761|NCT04779879|588717199|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
163004762|NCT04779879|588717200|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
163326024|NCT01574716|589905413|FG004|Part 2|Brain metastases|0|||
163004763|NCT04779879|588717201|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
163004764|NCT04779879|588717202|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
163004765|NCT04779879|588717203|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
163004766|NCT05101343|588717204|FG000|Overall Study|Withdrawal by Subject|2|||
163004767|NCT05101343|588717205|FG001|Overall Study|Withdrawal by Subject|1|||
163326025|NCT01574716|589905409|FG000|Part 2|Lost to Follow-up|0|||
163004768|NCT02854527|588717206|FG000|Overall Study|Adverse Event|0|||
163326026|NCT01574716|589905410|FG001|Part 2|Lost to Follow-up|0|||
163004769|NCT02854527|588717207|FG001|Overall Study|Adverse Event|0|||
163004770|NCT02854527|588717208|FG002|Overall Study|Adverse Event|0|||
163061148|NCT01799889|588933032|FG011|Overall Study|Physician Decision|1|||
163061149|NCT01799889|588933021|FG000|Overall Study|Progressive Disease|30|||
163061150|NCT01799889|588933022|FG001|Overall Study|Progressive Disease|26|||
163061151|NCT01799889|588933023|FG002|Overall Study|Progressive Disease|25|||
163061152|NCT01799889|588933024|FG003|Overall Study|Progressive Disease|30|||
163061153|NCT01799889|588933025|FG004|Overall Study|Progressive Disease|23|||
163061154|NCT01799889|588933026|FG005|Overall Study|Progressive Disease|9|||
163061155|NCT01799889|588933027|FG006|Overall Study|Progressive Disease|8|||
163061156|NCT01799889|588933028|FG007|Overall Study|Progressive Disease|13|||
163061157|NCT01799889|588933029|FG008|Overall Study|Progressive Disease|18|||
163061158|NCT01799889|588933030|FG009|Overall Study|Progressive Disease|5|||
163061159|NCT01799889|588933031|FG010|Overall Study|Progressive Disease|3|||
163061160|NCT01799889|588933032|FG011|Overall Study|Progressive Disease|1|||
163061161|NCT01799889|588933021|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
163061162|NCT01799889|588933022|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
163061163|NCT01799889|588933023|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
163061164|NCT01799889|588933024|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
163061165|NCT01799889|588933025|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
163061166|NCT01799889|588933026|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
163061167|NCT01799889|588933027|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
163061168|NCT01799889|588933028|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
163061169|NCT01799889|588933029|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
163061170|NCT01799889|588933030|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
163061171|NCT01799889|588933031|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
163061172|NCT01799889|588933032|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
163061173|NCT01799889|588933021|FG000|Overall Study|Study Terminated By Sponsor|1|||
163061174|NCT01799889|588933022|FG001|Overall Study|Study Terminated By Sponsor|0|||
163061175|NCT01799889|588933023|FG002|Overall Study|Study Terminated By Sponsor|0|||
163004771|NCT02854527|588717209|FG003|Overall Study|Adverse Event|0|||
163004772|NCT02854527|588717210|FG004|Overall Study|Adverse Event|1|||
163004773|NCT02854527|588717211|FG005|Overall Study|Adverse Event|0|||
163004774|NCT02854527|588717212|FG006|Overall Study|Adverse Event|0|||
163004775|NCT02854527|588717213|FG007|Overall Study|Adverse Event|0|||
163004776|NCT02854527|588717214|FG008|Overall Study|Adverse Event|0|||
163004777|NCT02854527|588717215|FG009|Overall Study|Adverse Event|0|||
163004778|NCT02854527|588717206|FG000|Overall Study|Lost to Follow-up|0|||
163004779|NCT02854527|588717207|FG001|Overall Study|Lost to Follow-up|0|||
163004780|NCT02854527|588717208|FG002|Overall Study|Lost to Follow-up|0|||
163004781|NCT02854527|588717209|FG003|Overall Study|Lost to Follow-up|1|||
163004782|NCT02854527|588717210|FG004|Overall Study|Lost to Follow-up|0|||
163004783|NCT02854527|588717211|FG005|Overall Study|Lost to Follow-up|0|||
163004784|NCT02854527|588717212|FG006|Overall Study|Lost to Follow-up|0|||
163004785|NCT02854527|588717213|FG007|Overall Study|Lost to Follow-up|0|||
163004786|NCT02854527|588717214|FG008|Overall Study|Lost to Follow-up|0|||
163004787|NCT02854527|588717215|FG009|Overall Study|Lost to Follow-up|0|||
163004788|NCT01959295|588717216|FG000|Overall Study|Adverse Event|2|||
163004789|NCT01959295|588717217|FG001|Overall Study|Adverse Event|0|||
163004790|NCT01959295|588717216|FG000|Overall Study|Lost to Follow-up|0|||
163004791|NCT01959295|588717217|FG001|Overall Study|Lost to Follow-up|2|||
163004792|NCT01959295|588717216|FG000|Overall Study|Physician Decision|2|||
163004793|NCT01959295|588717217|FG001|Overall Study|Physician Decision|3|||
163004794|NCT01959295|588717216|FG000|Overall Study|Protocol Violation|16|||
163004795|NCT01959295|588717217|FG001|Overall Study|Protocol Violation|5|||
163004796|NCT01959295|588717216|FG000|Overall Study|Withdrawal by Subject|3|||
163004797|NCT01959295|588717217|FG001|Overall Study|Withdrawal by Subject|1|||
163004798|NCT01959295|588717216|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
163004799|NCT01959295|588717217|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
163004800|NCT01128179|588717219|FG000|Overall Study|Death|1|||
163061176|NCT01799889|588933024|FG003|Overall Study|Study Terminated By Sponsor|0|||
163061177|NCT01799889|588933025|FG004|Overall Study|Study Terminated By Sponsor|2|||
163061178|NCT01799889|588933026|FG005|Overall Study|Study Terminated By Sponsor|1|||
163004801|NCT01128179|588717220|FG001|Overall Study|Death|0|||
163004802|NCT01128179|588717219|FG000|Overall Study|Protocol Violation|1|||
163061179|NCT01799889|588933027|FG006|Overall Study|Study Terminated By Sponsor|0|||
163061180|NCT01799889|588933028|FG007|Overall Study|Study Terminated By Sponsor|2|||
163061181|NCT01799889|588933029|FG008|Overall Study|Study Terminated By Sponsor|1|||
163326027|NCT01574716|589905411|FG002|Part 2|Lost to Follow-up|0|||
163004803|NCT01128179|588717220|FG001|Overall Study|Protocol Violation|0|||
163004804|NCT01682811|588717221|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
163061182|NCT01799889|588933030|FG009|Overall Study|Study Terminated By Sponsor|1|||
163061183|NCT01799889|588933031|FG010|Overall Study|Study Terminated By Sponsor|0|||
163061184|NCT01799889|588933032|FG011|Overall Study|Study Terminated By Sponsor|0|||
163061185|NCT01799889|588933021|FG000|Overall Study|Withdrawal by Subject|1|||
163004805|NCT01682811|588717222|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
163004806|NCT01682811|588717223|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
163004807|NCT01682811|588717224|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
163004808|NCT01682811|588717225|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
163004809|NCT01682811|588717226|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
163004810|NCT01682811|588717227|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
163004811|NCT01682811|588717221|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
163004812|NCT01682811|588717222|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
163004813|NCT01682811|588717223|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
163004814|NCT01682811|588717224|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
163004815|NCT01682811|588717225|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
163004816|NCT01682811|588717226|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
163004817|NCT01682811|588717227|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
163004818|NCT01682811|588717221|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
163004819|NCT01682811|588717222|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
163004820|NCT01682811|588717223|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
163004821|NCT01682811|588717224|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
163004822|NCT01682811|588717225|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
163004823|NCT01682811|588717226|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
163004824|NCT01682811|588717227|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
163004825|NCT01682811|588717221|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
163004826|NCT01682811|588717222|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
163004827|NCT01682811|588717223|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
163004828|NCT01682811|588717224|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
163004829|NCT01682811|588717225|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
163004830|NCT01682811|588717226|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
163004831|NCT01682811|588717227|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
163004832|NCT02694328|588717232|FG000|Overall Study|Adverse Event|27|||
163004833|NCT02694328|588717233|FG001|Overall Study|Adverse Event|33|||
163004834|NCT02694328|588717232|FG000|Overall Study|Withdrawal by Subject|27|||
163004835|NCT02694328|588717233|FG001|Overall Study|Withdrawal by Subject|23|||
163004836|NCT02694328|588717232|FG000|Overall Study|Lost to Follow-up|26|||
163004837|NCT02694328|588717233|FG001|Overall Study|Lost to Follow-up|22|||
163004838|NCT02694328|588717232|FG000|Overall Study|Noncompliant with study drug|11|||
163004839|NCT02694328|588717233|FG001|Overall Study|Noncompliant with study drug|8|||
163004840|NCT02694328|588717232|FG000|Overall Study|Incarceration|1|||
163004841|NCT02694328|588717233|FG001|Overall Study|Incarceration|1|||
163004842|NCT02694328|588717232|FG000|Overall Study|Lack of Efficacy|1|||
163004843|NCT02694328|588717233|FG001|Overall Study|Lack of Efficacy|2|||
163004844|NCT02694328|588717232|FG000|Overall Study|Pregnancy|1|||
163004845|NCT02694328|588717233|FG001|Overall Study|Pregnancy|1|||
163004846|NCT02694328|588717232|FG000|Overall Study|Protocol Violation|6|||
163004847|NCT02694328|588717233|FG001|Overall Study|Protocol Violation|5|||
163004848|NCT02694328|588717232|FG000|Overall Study|Abnormal Laboratory Value|0|||
163004849|NCT02694328|588717233|FG001|Overall Study|Abnormal Laboratory Value|3|||
163004850|NCT04075487|588719675|FG000|Overall Study|Withdrawal by Subject|1|||
163004851|NCT04653454|588719678|FG000|Overall Study|Withdrawal by Subject|1|||
163004852|NCT04653454|588719678|FG000|Overall Study|Physician Decision|40|||
163004853|NCT05525520|588719680|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
163004854|NCT05525520|588719681|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
163004855|NCT05525520|588719680|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
163004856|NCT05525520|588719681|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
163004857|NCT05878093|588719682|FG000|Overall Study|Withdrawal by Subject|3|||
163004858|NCT05878093|588719683|FG001|Overall Study|Withdrawal by Subject|1|||
163004859|NCT02721732|588719684|FG000|Overall Study|Adverse Event|2|||
163004860|NCT02721732|588719685|FG001|Overall Study|Adverse Event|0|||
163004861|NCT02721732|588719686|FG002|Overall Study|Adverse Event|2|||
163004862|NCT02721732|588719687|FG003|Overall Study|Adverse Event|0|||
163004863|NCT02721732|588719688|FG004|Overall Study|Adverse Event|1|||
163004864|NCT02721732|588719689|FG005|Overall Study|Adverse Event|0|||
163004865|NCT02721732|588719690|FG006|Overall Study|Adverse Event|1|||
163004866|NCT02721732|588719691|FG007|Overall Study|Adverse Event|0|||
163004867|NCT02721732|588719692|FG008|Overall Study|Adverse Event|1|||
163326028|NCT01574716|589905412|FG003|Part 2|Lost to Follow-up|3|||
163326029|NCT01574716|589905413|FG004|Part 2|Lost to Follow-up|0|||
163004868|NCT02721732|588719693|FG009|Overall Study|Adverse Event|1|||
163004869|NCT02721732|588719684|FG000|Overall Study|Death|0|||
163004870|NCT02721732|588719685|FG001|Overall Study|Death|0|||
163004871|NCT02721732|588719686|FG002|Overall Study|Death|0|||
163004872|NCT02721732|588719687|FG003|Overall Study|Death|0|||
163004873|NCT02721732|588719688|FG004|Overall Study|Death|1|||
163004874|NCT02721732|588719689|FG005|Overall Study|Death|0|||
163004875|NCT02721732|588719690|FG006|Overall Study|Death|1|||
163326030|NCT03183050|589905414|FG000|Overall Study|Lost to Follow-up|23|||
163004876|NCT02721732|588719691|FG007|Overall Study|Death|0|||
163004877|NCT02721732|588719692|FG008|Overall Study|Death|0|||
163004878|NCT02721732|588719693|FG009|Overall Study|Death|1|||
163004879|NCT02721732|588719684|FG000|Overall Study|Lack of Efficacy|12|||
163004880|NCT02721732|588719685|FG001|Overall Study|Lack of Efficacy|11|||
163004881|NCT02721732|588719686|FG002|Overall Study|Lack of Efficacy|18|||
163326031|NCT02797132|589905416|FG000|Part A (15 Days)|Adverse Event|1|||
163326032|NCT02797132|589905416|FG000|Part B (24 Weeks)|Adverse Event|3|||
163326033|NCT02502526|589905417|FG000|Overall Study|Lost to Follow-up|2|||
163326034|NCT02502526|589905418|FG001|Overall Study|Lost to Follow-up|2|||
163326035|NCT02502526|589905419|FG002|Overall Study|Lost to Follow-up|3|||
163326036|NCT02502526|589905417|FG000|Overall Study|Withdrawal by Subject|0|||
163004882|NCT02721732|588719687|FG003|Overall Study|Lack of Efficacy|5|||
163004883|NCT02721732|588719688|FG004|Overall Study|Lack of Efficacy|21|||
163004884|NCT02721732|588719689|FG005|Overall Study|Lack of Efficacy|2|||
163004885|NCT02721732|588719690|FG006|Overall Study|Lack of Efficacy|8|||
163004886|NCT02721732|588719691|FG007|Overall Study|Lack of Efficacy|11|||
163004887|NCT02721732|588719692|FG008|Overall Study|Lack of Efficacy|10|||
163004888|NCT02721732|588719693|FG009|Overall Study|Lack of Efficacy|20|||
163004889|NCT02721732|588719684|FG000|Overall Study|Physician Decision|0|||
163004890|NCT02721732|588719685|FG001|Overall Study|Physician Decision|0|||
163004891|NCT02721732|588719686|FG002|Overall Study|Physician Decision|1|||
163004892|NCT02721732|588719687|FG003|Overall Study|Physician Decision|0|||
163004893|NCT02721732|588719688|FG004|Overall Study|Physician Decision|0|||
163004894|NCT02721732|588719689|FG005|Overall Study|Physician Decision|0|||
163004895|NCT02721732|588719690|FG006|Overall Study|Physician Decision|0|||
163004896|NCT02721732|588719691|FG007|Overall Study|Physician Decision|0|||
163004897|NCT02721732|588719692|FG008|Overall Study|Physician Decision|0|||
163004898|NCT02721732|588719693|FG009|Overall Study|Physician Decision|0|||
163004899|NCT02721732|588719684|FG000|Overall Study|Withdrawal by Subject|1|||
163004900|NCT02721732|588719685|FG001|Overall Study|Withdrawal by Subject|0|||
163004901|NCT02721732|588719686|FG002|Overall Study|Withdrawal by Subject|0|||
163004902|NCT02721732|588719687|FG003|Overall Study|Withdrawal by Subject|0|||
163004903|NCT02721732|588719688|FG004|Overall Study|Withdrawal by Subject|3|||
163004904|NCT02721732|588719689|FG005|Overall Study|Withdrawal by Subject|0|||
163004905|NCT02721732|588719690|FG006|Overall Study|Withdrawal by Subject|1|||
163004906|NCT02721732|588719691|FG007|Overall Study|Withdrawal by Subject|1|||
163004907|NCT02721732|588719692|FG008|Overall Study|Withdrawal by Subject|0|||
163004908|NCT02721732|588719693|FG009|Overall Study|Withdrawal by Subject|1|||
163004909|NCT02721732|588719684|FG000|Overall Study|Participant Choice|1|||
163004910|NCT02721732|588719685|FG001|Overall Study|Participant Choice|0|||
163004911|NCT02721732|588719686|FG002|Overall Study|Participant Choice|0|||
163004912|NCT02721732|588719687|FG003|Overall Study|Participant Choice|0|||
163004913|NCT02721732|588719688|FG004|Overall Study|Participant Choice|0|||
163004914|NCT02721732|588719689|FG005|Overall Study|Participant Choice|0|||
163004915|NCT02721732|588719690|FG006|Overall Study|Participant Choice|0|||
163004916|NCT02721732|588719691|FG007|Overall Study|Participant Choice|0|||
163004917|NCT02721732|588719692|FG008|Overall Study|Participant Choice|0|||
163004918|NCT02721732|588719693|FG009|Overall Study|Participant Choice|1|||
163004919|NCT02721732|588719684|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004920|NCT02721732|588719685|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004921|NCT02721732|588719686|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
163004922|NCT02721732|588719687|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004923|NCT02721732|588719688|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004924|NCT02721732|588719689|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004925|NCT02721732|588719690|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004926|NCT02721732|588719691|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004927|NCT02721732|588719692|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004928|NCT02721732|588719693|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004929|NCT02721732|588719684|FG000|Overall Study|Progression and withdrew consent|1|||
163004930|NCT02721732|588719685|FG001|Overall Study|Progression and withdrew consent|1|||
163004931|NCT02721732|588719686|FG002|Overall Study|Progression and withdrew consent|0|||
163061186|NCT01799889|588933022|FG001|Overall Study|Withdrawal by Subject|6|||
163061187|NCT01799889|588933023|FG002|Overall Study|Withdrawal by Subject|4|||
163061188|NCT01799889|588933024|FG003|Overall Study|Withdrawal by Subject|0|||
163326037|NCT02502526|589905418|FG001|Overall Study|Withdrawal by Subject|1|||
163326038|NCT02502526|589905419|FG002|Overall Study|Withdrawal by Subject|1|||
163326039|NCT02502526|589905417|FG000|Overall Study|Disqualified due to cataract grading|0|||
163404459|NCT03246958|590191934|FG000|Overall Study|Never start treatment|1|||
163404460|NCT03246958|590191935|FG001|Overall Study|Never start treatment|0|||
163004932|NCT02721732|588719687|FG003|Overall Study|Progression and withdrew consent|0|||
163004933|NCT02721732|588719688|FG004|Overall Study|Progression and withdrew consent|0|||
163004934|NCT02721732|588719689|FG005|Overall Study|Progression and withdrew consent|0|||
163004935|NCT02721732|588719690|FG006|Overall Study|Progression and withdrew consent|0|||
163004936|NCT02721732|588719691|FG007|Overall Study|Progression and withdrew consent|0|||
163004937|NCT02721732|588719692|FG008|Overall Study|Progression and withdrew consent|0|||
163004938|NCT02721732|588719693|FG009|Overall Study|Progression and withdrew consent|1|||
163326040|NCT02502526|589905418|FG001|Overall Study|Disqualified due to cataract grading|0|||
163404461|NCT03246958|590191936|FG002|Overall Study|Never start treatment|0|||
163004939|NCT02721732|588719684|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
163004940|NCT02721732|588719685|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
163004941|NCT02721732|588719686|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
163004942|NCT02721732|588719687|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
163004943|NCT02721732|588719688|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
163004944|NCT02721732|588719689|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
163004945|NCT02721732|588719690|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
163004946|NCT02721732|588719691|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
163004947|NCT02721732|588719692|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
163004948|NCT02721732|588719693|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
163004949|NCT04100018|588719699|FG000|Pre-Treatment Period|Not Reported|0|||
163004950|NCT04100018|588719700|FG001|Pre-Treatment Period|Not Reported|4|||
163004951|NCT04100018|588719699|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
163004952|NCT04100018|588719700|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
163004953|NCT04100018|588719699|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
163004954|NCT04100018|588719700|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
163004955|NCT04100018|588719699|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
163004956|NCT04100018|588719700|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
163004957|NCT04100018|588719699|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
163004958|NCT04100018|588719700|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
163004959|NCT04100018|588719699|FG000|Treatment Period|Ongoing Treatment|1|||
163004960|NCT04100018|588719700|FG001|Treatment Period|Ongoing Treatment|0|||
163004961|NCT04100018|588719699|FG000|Treatment Period|Other Reason|26|||
163004962|NCT04100018|588719700|FG001|Treatment Period|Other Reason|37|||
163004963|NCT04100018|588719699|FG000|Treatment Period|Completed treatment as per protocol|1|||
163004964|NCT04100018|588719700|FG001|Treatment Period|Completed treatment as per protocol|2|||
163004965|NCT04100018|588719699|FG000|Treatment Period|Maximum clinical benefit|3|||
163004966|NCT04100018|588719700|FG001|Treatment Period|Maximum clinical benefit|0|||
163004967|NCT04100018|588719699|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
163004968|NCT04100018|588719700|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
163004969|NCT04100018|588719699|FG000|Treatment Period|Study drug toxicity|67|||
163004970|NCT04100018|588719700|FG001|Treatment Period|Study drug toxicity|28|||
163004971|NCT04100018|588719699|FG000|Treatment Period|Disease Progression|284|||
163004972|NCT04100018|588719700|FG001|Treatment Period|Disease Progression|327|||
163004973|NCT04100018|588719699|FG000|Treatment Period|Administrative reasons by sponsor|16|||
163004974|NCT04100018|588719700|FG001|Treatment Period|Administrative reasons by sponsor|30|||
163004975|NCT04100018|588719699|FG000|Treatment Period|Poor/Non-Compliance|1|||
163004976|NCT04100018|588719700|FG001|Treatment Period|Poor/Non-Compliance|0|||
163004977|NCT04100018|588719699|FG000|Treatment Period|Lost to Follow-up|2|||
163004978|NCT04100018|588719700|FG001|Treatment Period|Lost to Follow-up|2|||
163004979|NCT04100018|588719699|FG000|Treatment Period|Death|16|||
163004980|NCT04100018|588719700|FG001|Treatment Period|Death|11|||
163004981|NCT04100018|588719699|FG000|Treatment Period|Participant withdrew consent|10|||
163004982|NCT04100018|588719700|FG001|Treatment Period|Participant withdrew consent|10|||
163004983|NCT04100018|588719699|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
163004984|NCT04100018|588719700|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
163004985|NCT04100018|588719699|FG000|Treatment Period|Adverse Event|14|||
163004986|NCT04100018|588719700|FG001|Treatment Period|Adverse Event|6|||
163004987|NCT04100018|588719699|FG000|Treatment Period|Lack of Efficacy|4|||
163004988|NCT04100018|588719700|FG001|Treatment Period|Lack of Efficacy|2|||
163004989|NCT02848001|588719701|FG000|Overall Study|other reasons|0|||
163004990|NCT02848001|588719702|FG001|Overall Study|other reasons|0|||
163004991|NCT02848001|588719703|FG002|Overall Study|other reasons|1|||
163004992|NCT02848001|588719704|FG003|Overall Study|other reasons|0|||
163004993|NCT02848001|588719705|FG004|Overall Study|other reasons|4|||
163004994|NCT02848001|588719706|FG005|Overall Study|other reasons|1|||
163004995|NCT02848001|588719707|FG006|Overall Study|other reasons|0|||
163004996|NCT02848001|588719708|FG007|Overall Study|other reasons|2|||
163004997|NCT02848001|588719709|FG008|Overall Study|other reasons|2|||
163004998|NCT02848001|588719710|FG009|Overall Study|other reasons|3|||
163004999|NCT02848001|588719711|FG010|Overall Study|other reasons|0|||
163005000|NCT02848001|588719712|FG011|Overall Study|other reasons|1|||
163005001|NCT02848001|588719713|FG012|Overall Study|other reasons|1|||
163005002|NCT02848001|588719714|FG013|Overall Study|other reasons|0|||
163005003|NCT02848001|588719715|FG014|Overall Study|other reasons|0|||
163005004|NCT02848001|588719716|FG015|Overall Study|other reasons|2|||
163005005|NCT02848001|588719717|FG016|Overall Study|other reasons|1|||
163005006|NCT02848001|588719701|FG000|Overall Study|Lack of Efficacy|0|||
163005007|NCT02848001|588719702|FG001|Overall Study|Lack of Efficacy|1|||
163005008|NCT02848001|588719703|FG002|Overall Study|Lack of Efficacy|1|||
163005009|NCT02848001|588719704|FG003|Overall Study|Lack of Efficacy|2|||
163005010|NCT02848001|588719705|FG004|Overall Study|Lack of Efficacy|3|||
163005011|NCT02848001|588719706|FG005|Overall Study|Lack of Efficacy|0|||
163005012|NCT02848001|588719707|FG006|Overall Study|Lack of Efficacy|1|||
163005013|NCT02848001|588719708|FG007|Overall Study|Lack of Efficacy|0|||
163005014|NCT02848001|588719709|FG008|Overall Study|Lack of Efficacy|0|||
163005015|NCT02848001|588719710|FG009|Overall Study|Lack of Efficacy|1|||
163005016|NCT02848001|588719711|FG010|Overall Study|Lack of Efficacy|0|||
163005017|NCT02848001|588719712|FG011|Overall Study|Lack of Efficacy|2|||
163005018|NCT02848001|588719713|FG012|Overall Study|Lack of Efficacy|0|||
163005019|NCT02848001|588719714|FG013|Overall Study|Lack of Efficacy|2|||
163005020|NCT02848001|588719715|FG014|Overall Study|Lack of Efficacy|2|||
163005021|NCT02848001|588719716|FG015|Overall Study|Lack of Efficacy|0|||
163005022|NCT02848001|588719717|FG016|Overall Study|Lack of Efficacy|0|||
163005023|NCT02848001|588719701|FG000|Overall Study|Progressive Disease|2|||
163005024|NCT02848001|588719702|FG001|Overall Study|Progressive Disease|1|||
163005025|NCT02848001|588719703|FG002|Overall Study|Progressive Disease|0|||
163005026|NCT02848001|588719704|FG003|Overall Study|Progressive Disease|4|||
163005027|NCT02848001|588719705|FG004|Overall Study|Progressive Disease|3|||
163005028|NCT02848001|588719706|FG005|Overall Study|Progressive Disease|0|||
163005029|NCT02848001|588719707|FG006|Overall Study|Progressive Disease|4|||
163005030|NCT02848001|588719708|FG007|Overall Study|Progressive Disease|1|||
163005031|NCT02848001|588719709|FG008|Overall Study|Progressive Disease|0|||
163005032|NCT02848001|588719710|FG009|Overall Study|Progressive Disease|2|||
163005033|NCT02848001|588719711|FG010|Overall Study|Progressive Disease|3|||
163005034|NCT02848001|588719712|FG011|Overall Study|Progressive Disease|2|||
163005035|NCT02848001|588719713|FG012|Overall Study|Progressive Disease|1|||
163005036|NCT02848001|588719714|FG013|Overall Study|Progressive Disease|0|||
163005037|NCT02848001|588719715|FG014|Overall Study|Progressive Disease|2|||
163005038|NCT02848001|588719716|FG015|Overall Study|Progressive Disease|4|||
163005039|NCT02848001|588719717|FG016|Overall Study|Progressive Disease|0|||
163005040|NCT02848001|588719701|FG000|Overall Study|Adverse Event|0|||
163005041|NCT02848001|588719702|FG001|Overall Study|Adverse Event|0|||
163005042|NCT02848001|588719703|FG002|Overall Study|Adverse Event|0|||
163005043|NCT02848001|588719704|FG003|Overall Study|Adverse Event|0|||
163005044|NCT02848001|588719705|FG004|Overall Study|Adverse Event|2|||
163005045|NCT02848001|588719706|FG005|Overall Study|Adverse Event|0|||
163005046|NCT02848001|588719707|FG006|Overall Study|Adverse Event|0|||
163005047|NCT02848001|588719708|FG007|Overall Study|Adverse Event|0|||
163005048|NCT02848001|588719709|FG008|Overall Study|Adverse Event|0|||
163005049|NCT02848001|588719710|FG009|Overall Study|Adverse Event|1|||
163005050|NCT02848001|588719711|FG010|Overall Study|Adverse Event|0|||
163005051|NCT02848001|588719712|FG011|Overall Study|Adverse Event|1|||
163005052|NCT02848001|588719713|FG012|Overall Study|Adverse Event|1|||
163005053|NCT02848001|588719714|FG013|Overall Study|Adverse Event|0|||
163005054|NCT02848001|588719715|FG014|Overall Study|Adverse Event|2|||
163005055|NCT02848001|588719716|FG015|Overall Study|Adverse Event|0|||
163005056|NCT02848001|588719717|FG016|Overall Study|Adverse Event|0|||
163005057|NCT02848001|588719701|FG000|Overall Study|Death|0|||
163005058|NCT02848001|588719702|FG001|Overall Study|Death|0|||
163005059|NCT02848001|588719703|FG002|Overall Study|Death|0|||
163005060|NCT02848001|588719704|FG003|Overall Study|Death|1|||
163005061|NCT02848001|588719705|FG004|Overall Study|Death|3|||
163326041|NCT02502526|589905419|FG002|Overall Study|Disqualified due to cataract grading|1|||
163326042|NCT02502526|589905417|FG000|Overall Study|Enrollment suspension|4|||
163005062|NCT02848001|588719706|FG005|Overall Study|Death|1|||
163005063|NCT02848001|588719707|FG006|Overall Study|Death|2|||
163005064|NCT02848001|588719708|FG007|Overall Study|Death|3|||
163005065|NCT02848001|588719709|FG008|Overall Study|Death|4|||
163005066|NCT02848001|588719710|FG009|Overall Study|Death|1|||
163005067|NCT02848001|588719711|FG010|Overall Study|Death|0|||
163326043|NCT02502526|589905418|FG001|Overall Study|Enrollment suspension|1|||
163326044|NCT02502526|589905419|FG002|Overall Study|Enrollment suspension|1|||
163326045|NCT02964741|589905421|FG000|Overall Study|Protocol Violation|1|||
163326046|NCT02964741|589905422|FG001|Overall Study|Protocol Violation|0|||
163005068|NCT02848001|588719712|FG011|Overall Study|Death|1|||
163005069|NCT02848001|588719713|FG012|Overall Study|Death|3|||
163005070|NCT02848001|588719714|FG013|Overall Study|Death|0|||
163005071|NCT02848001|588719715|FG014|Overall Study|Death|2|||
163005072|NCT02848001|588719716|FG015|Overall Study|Death|3|||
163326047|NCT02964741|589905423|FG002|Overall Study|Protocol Violation|0|||
163326048|NCT02964741|589905421|FG000|Overall Study|Withdrawal by Subject|0|||
163005073|NCT02848001|588719717|FG016|Overall Study|Death|0|||
163005074|NCT02848001|588719701|FG000|Overall Study|Physician Decision|0|||
163005075|NCT02848001|588719702|FG001|Overall Study|Physician Decision|0|||
163005076|NCT02848001|588719703|FG002|Overall Study|Physician Decision|0|||
163005077|NCT02848001|588719704|FG003|Overall Study|Physician Decision|0|||
163005078|NCT02848001|588719705|FG004|Overall Study|Physician Decision|0|||
163005079|NCT02848001|588719706|FG005|Overall Study|Physician Decision|0|||
163005080|NCT02848001|588719707|FG006|Overall Study|Physician Decision|0|||
163005081|NCT02848001|588719708|FG007|Overall Study|Physician Decision|0|||
163005082|NCT02848001|588719709|FG008|Overall Study|Physician Decision|1|||
163005083|NCT02848001|588719710|FG009|Overall Study|Physician Decision|1|||
163005084|NCT02848001|588719711|FG010|Overall Study|Physician Decision|0|||
163005085|NCT02848001|588719712|FG011|Overall Study|Physician Decision|0|||
163005086|NCT02848001|588719713|FG012|Overall Study|Physician Decision|2|||
163005087|NCT02848001|588719714|FG013|Overall Study|Physician Decision|0|||
163005088|NCT02848001|588719715|FG014|Overall Study|Physician Decision|0|||
163005089|NCT02848001|588719716|FG015|Overall Study|Physician Decision|0|||
163005090|NCT02848001|588719717|FG016|Overall Study|Physician Decision|0|||
163005091|NCT02848001|588719701|FG000|Overall Study|Withdrawal by Subject|0|||
163005092|NCT02848001|588719702|FG001|Overall Study|Withdrawal by Subject|0|||
163005093|NCT02848001|588719703|FG002|Overall Study|Withdrawal by Subject|0|||
163005094|NCT02848001|588719704|FG003|Overall Study|Withdrawal by Subject|0|||
163005095|NCT02848001|588719705|FG004|Overall Study|Withdrawal by Subject|0|||
163005096|NCT02848001|588719706|FG005|Overall Study|Withdrawal by Subject|1|||
163005097|NCT02848001|588719707|FG006|Overall Study|Withdrawal by Subject|1|||
163005098|NCT02848001|588719708|FG007|Overall Study|Withdrawal by Subject|1|||
163005099|NCT02848001|588719709|FG008|Overall Study|Withdrawal by Subject|0|||
163005100|NCT02848001|588719710|FG009|Overall Study|Withdrawal by Subject|0|||
163005101|NCT02848001|588719711|FG010|Overall Study|Withdrawal by Subject|0|||
163005102|NCT02848001|588719712|FG011|Overall Study|Withdrawal by Subject|0|||
163005103|NCT02848001|588719713|FG012|Overall Study|Withdrawal by Subject|0|||
163005104|NCT02848001|588719714|FG013|Overall Study|Withdrawal by Subject|0|||
163005105|NCT02848001|588719715|FG014|Overall Study|Withdrawal by Subject|0|||
163005106|NCT02848001|588719716|FG015|Overall Study|Withdrawal by Subject|0|||
163005107|NCT02848001|588719717|FG016|Overall Study|Withdrawal by Subject|0|||
163005108|NCT04358081|588719718|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
163005109|NCT04358081|588719719|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
163005110|NCT04358081|588719720|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
163005111|NCT04358081|588719718|FG000|Treatment Phase of Study|Adverse Event|1|||
163005112|NCT04358081|588719719|FG001|Treatment Phase of Study|Adverse Event|0|||
163005113|NCT04358081|588719720|FG002|Treatment Phase of Study|Adverse Event|1|||
163005114|NCT04358081|588719718|FG000|Treatment Phase of Study|Physician Decision|2|||
163005115|NCT04358081|588719719|FG001|Treatment Phase of Study|Physician Decision|0|||
163005116|NCT04358081|588719720|FG002|Treatment Phase of Study|Physician Decision|1|||
163005117|NCT04358081|588719718|FG000|Treatment Phase of Study|Protocol Violation|1|||
163005118|NCT04358081|588719719|FG001|Treatment Phase of Study|Protocol Violation|0|||
163005119|NCT04358081|588719720|FG002|Treatment Phase of Study|Protocol Violation|0|||
163005120|NCT04358081|588719718|FG000|Study Completion Phase|Death|0|||
163005121|NCT04358081|588719719|FG001|Study Completion Phase|Death|0|||
163005122|NCT04358081|588719720|FG002|Study Completion Phase|Death|1|||
163005123|NCT04358081|588719718|FG000|Study Completion Phase|Lost to Follow-up|1|||
163005124|NCT04358081|588719719|FG001|Study Completion Phase|Lost to Follow-up|0|||
163005125|NCT04358081|588719720|FG002|Study Completion Phase|Lost to Follow-up|1|||
163005126|NCT00725283|588719724|FG000|Overall Study|Missing Code|3|||
163005127|NCT00725283|588719724|FG000|Overall Study|Death|5|||
163005128|NCT00725283|588719724|FG000|Overall Study|Other|6|||
163005129|NCT00725283|588719724|FG000|Overall Study|Withdrawal by Subject|10|||
163005130|NCT03103087|588719725|FG000|Overall Study|Did not receive any study drug|1|||
163005131|NCT03103087|588719726|FG001|Overall Study|Did not receive any study drug|0|||
163005132|NCT03103087|588719727|FG002|Overall Study|Did not receive any study drug|0|||
163005133|NCT03103087|588719725|FG000|Overall Study|Protocol Violation|1|||
163005134|NCT03103087|588719726|FG001|Overall Study|Protocol Violation|2|||
163005135|NCT03103087|588719727|FG002|Overall Study|Protocol Violation|1|||
163005136|NCT03103087|588719725|FG000|Overall Study|Lack of Efficacy|2|||
163005137|NCT03103087|588719726|FG001|Overall Study|Lack of Efficacy|1|||
163005138|NCT03103087|588719727|FG002|Overall Study|Lack of Efficacy|1|||
163005139|NCT03103087|588719725|FG000|Overall Study|Pregnancy|0|||
163005140|NCT03103087|588719726|FG001|Overall Study|Pregnancy|0|||
163005141|NCT03103087|588719727|FG002|Overall Study|Pregnancy|1|||
163005142|NCT03103087|588719725|FG000|Overall Study|Adverse Event|2|||
163005143|NCT03103087|588719726|FG001|Overall Study|Adverse Event|15|||
163005144|NCT03103087|588719727|FG002|Overall Study|Adverse Event|6|||
163005145|NCT03103087|588719725|FG000|Overall Study|Withdrawal by Subject|13|||
163005146|NCT03103087|588719726|FG001|Overall Study|Withdrawal by Subject|6|||
163005147|NCT03103087|588719727|FG002|Overall Study|Withdrawal by Subject|6|||
163005148|NCT03103087|588719725|FG000|Overall Study|Lost to Follow-up|4|||
163061189|NCT01799889|588933025|FG004|Overall Study|Withdrawal by Subject|5|||
163005149|NCT03103087|588719726|FG001|Overall Study|Lost to Follow-up|2|||
163005150|NCT03103087|588719727|FG002|Overall Study|Lost to Follow-up|7|||
163005151|NCT03103087|588719725|FG000|Overall Study|Other reason not reported|1|||
163005152|NCT03103087|588719726|FG001|Overall Study|Other reason not reported|3|||
163005153|NCT03103087|588719727|FG002|Overall Study|Other reason not reported|5|||
163005154|NCT00118157|588719728|FG000|Overall Study|Adverse Event|2|||
163061190|NCT01799889|588933026|FG005|Overall Study|Withdrawal by Subject|1|||
163005155|NCT00118157|588719728|FG000|Overall Study|Death|8|||
163005156|NCT00118157|588719728|FG000|Overall Study|Withdrawal by Subject|2|||
163005157|NCT03283566|588719729|FG000|Overall Study|Lost to Follow-up|1|||
163005158|NCT03283566|588719730|FG001|Overall Study|Lost to Follow-up|2|||
163005159|NCT02760004|588719731|FG000|Overall Study|Lost to Follow-up|13|||
163326049|NCT02964741|589905422|FG001|Overall Study|Withdrawal by Subject|1|||
163326050|NCT02964741|589905423|FG002|Overall Study|Withdrawal by Subject|0|||
163005160|NCT02760004|588719732|FG001|Overall Study|Lost to Follow-up|22|||
163005161|NCT01495000|588719733|FG000|Overall Study|Lost to Follow-up|2|||
163005162|NCT01495000|588719734|FG001|Overall Study|Lost to Follow-up|2|||
163005163|NCT01495000|588719733|FG000|Overall Study|Protocol Violation|1|||
163005164|NCT01495000|588719734|FG001|Overall Study|Protocol Violation|0|||
163005165|NCT01495000|588719733|FG000|Overall Study|Withdrawal by Subject|10|||
163005166|NCT01495000|588719734|FG001|Overall Study|Withdrawal by Subject|10|||
163005167|NCT02070965|588719735|FG000|Overall Study|Lost to Follow-up|0|||
163005168|NCT02070965|588719736|FG001|Overall Study|Lost to Follow-up|1|||
163005169|NCT02070965|588719737|FG002|Overall Study|Lost to Follow-up|0|||
163005170|NCT02070965|588719735|FG000|Overall Study|Withdrawal by Subject|1|||
163005171|NCT02070965|588719736|FG001|Overall Study|Withdrawal by Subject|1|||
163005172|NCT02070965|588719737|FG002|Overall Study|Withdrawal by Subject|1|||
163005173|NCT02070965|588719735|FG000|Overall Study|Subject moved|1|||
163005174|NCT02070965|588719736|FG001|Overall Study|Subject moved|0|||
163005175|NCT02070965|588719737|FG002|Overall Study|Subject moved|0|||
163005176|NCT03889886|588719739|FG000|Overall Study|Other|0|||
163005177|NCT03889886|588719740|FG001|Overall Study|Other|1|||
163005178|NCT03889886|588719741|FG002|Overall Study|Other|0|||
163005179|NCT03889886|588719742|FG003|Overall Study|Other|1|||
163005180|NCT03889886|588719739|FG000|Overall Study|Withdrawal by Subject|0|||
163005181|NCT03889886|588719740|FG001|Overall Study|Withdrawal by Subject|0|||
163005182|NCT03889886|588719741|FG002|Overall Study|Withdrawal by Subject|1|||
163005183|NCT03889886|588719742|FG003|Overall Study|Withdrawal by Subject|0|||
163005184|NCT03889886|588719739|FG000|Overall Study|Adverse Event|0|||
163005185|NCT03889886|588719740|FG001|Overall Study|Adverse Event|0|||
163005186|NCT03889886|588719741|FG002|Overall Study|Adverse Event|0|||
163005187|NCT03889886|588719742|FG003|Overall Study|Adverse Event|6|||
163005188|NCT00276484|588719743|FG000|Overall Study|Adverse Event|4|||
163005189|NCT00276484|588719744|FG001|Overall Study|Adverse Event|7|||
163005190|NCT00276484|588719743|FG000|Overall Study|Lost to Follow-up|1|||
163005191|NCT00276484|588719744|FG001|Overall Study|Lost to Follow-up|1|||
163005192|NCT00276484|588719743|FG000|Overall Study|Protocol Violation|0|||
163005193|NCT00276484|588719744|FG001|Overall Study|Protocol Violation|1|||
163005194|NCT00276484|588719743|FG000|Overall Study|Withdrawal by Subject|4|||
163005195|NCT00276484|588719744|FG001|Overall Study|Withdrawal by Subject|3|||
163005196|NCT00276484|588719743|FG000|Overall Study|Could not take time off work|0|||
163005197|NCT00276484|588719744|FG001|Overall Study|Could not take time off work|1|||
163005198|NCT00116779|588719756|FG000|Overall Study|Adverse Event|4|||
163005199|NCT00116779|588719757|FG001|Overall Study|Adverse Event|2|||
163005200|NCT00116779|588719756|FG000|Overall Study|Protocol Violation|1|||
163005201|NCT00116779|588719757|FG001|Overall Study|Protocol Violation|4|||
163005202|NCT00116779|588719756|FG000|Overall Study|Withdrawal by Subject|4|||
163005203|NCT00116779|588719757|FG001|Overall Study|Withdrawal by Subject|1|||
163005204|NCT00116779|588719756|FG000|Overall Study|Inadequate testosterone suppression|7|||
163005205|NCT00116779|588719757|FG001|Overall Study|Inadequate testosterone suppression|9|||
163005206|NCT00116779|588719756|FG000|Overall Study|Physician Decision|3|||
163005207|NCT00116779|588719757|FG001|Overall Study|Physician Decision|1|||
163005208|NCT00116779|588719756|FG000|Overall Study|Elevated PSA levels|2|||
163005209|NCT00116779|588719757|FG001|Overall Study|Elevated PSA levels|2|||
163005210|NCT03934541|588719772|FG000|Overall Study|Study Terminated by Sponsor|0|||
163005211|NCT03934541|588719773|FG001|Overall Study|Study Terminated by Sponsor|1|||
163005212|NCT03934541|588719774|FG002|Overall Study|Study Terminated by Sponsor|0|||
163005213|NCT03934541|588719775|FG003|Overall Study|Study Terminated by Sponsor|0|||
163005214|NCT01928472|588719778|FG000|Overall Study|Death|0|||
163005215|NCT01928472|588719779|FG001|Overall Study|Death|0|||
163005216|NCT01928472|588719780|FG002|Overall Study|Death|1|||
163005217|NCT01928472|588719781|FG003|Overall Study|Death|0|||
163005218|NCT01928472|588719778|FG000|Overall Study|Withdrawal by Subject|4|||
163005219|NCT01928472|588719779|FG001|Overall Study|Withdrawal by Subject|4|||
163005220|NCT01928472|588719780|FG002|Overall Study|Withdrawal by Subject|1|||
163005221|NCT01928472|588719781|FG003|Overall Study|Withdrawal by Subject|2|||
163005222|NCT01928472|588719778|FG000|Overall Study|Lost to Follow-up|2|||
163005223|NCT01928472|588719779|FG001|Overall Study|Lost to Follow-up|3|||
163005224|NCT01928472|588719780|FG002|Overall Study|Lost to Follow-up|4|||
163005225|NCT01928472|588719781|FG003|Overall Study|Lost to Follow-up|0|||
163005226|NCT01928472|588719778|FG000|Overall Study|Administrative Reason|2|||
163005227|NCT01928472|588719779|FG001|Overall Study|Administrative Reason|1|||
163005228|NCT01928472|588719780|FG002|Overall Study|Administrative Reason|0|||
163005229|NCT01928472|588719781|FG003|Overall Study|Administrative Reason|0|||
163005230|NCT01928472|588719778|FG000|Overall Study|Unclassified|0|||
163005231|NCT01928472|588719779|FG001|Overall Study|Unclassified|0|||
163005232|NCT01928472|588719780|FG002|Overall Study|Unclassified|1|||
163005233|NCT01928472|588719781|FG003|Overall Study|Unclassified|0|||
163326051|NCT02964741|589905421|FG000|Overall Study|claustrophobia|1|||
163005234|NCT04620746|588719782|FG000|Overall Study|Adverse Event|2|||
163005235|NCT04620746|588719783|FG001|Overall Study|Adverse Event|0|||
163005236|NCT04620746|588719782|FG000|Overall Study|Uniterpretable skin test|1|||
163005237|NCT04620746|588719783|FG001|Overall Study|Uniterpretable skin test|0|||
163005238|NCT04620746|588719782|FG000|Overall Study|Withdrawal by Subject|0|||
163005239|NCT04620746|588719783|FG001|Overall Study|Withdrawal by Subject|1|||
163005240|NCT05767905|588719788|FG000|Overall Study|Adverse Event|0|||
163005241|NCT05767905|588719789|FG001|Overall Study|Adverse Event|0|||
163005242|NCT05767905|588719790|FG002|Overall Study|Adverse Event|1|||
163005243|NCT03404674|588719796|FG000|Overall Study|Inability to Attend Future Visits|0|||
163005244|NCT03404674|588719797|FG001|Overall Study|Inability to Attend Future Visits|1|||
163005245|NCT03404674|588719798|FG002|Overall Study|Inability to Attend Future Visits|1|||
163005246|NCT03404674|588719799|FG003|Overall Study|Inability to Attend Future Visits|0|||
163005247|NCT03404674|588719800|FG004|Overall Study|Inability to Attend Future Visits|0|||
163005248|NCT03404674|588719801|FG005|Overall Study|Inability to Attend Future Visits|0|||
163005249|NCT03404674|588719796|FG000|Overall Study|Behavioral Problems|0|||
163005250|NCT03404674|588719797|FG001|Overall Study|Behavioral Problems|0|||
163005251|NCT03404674|588719798|FG002|Overall Study|Behavioral Problems|1|||
163005252|NCT03404674|588719799|FG003|Overall Study|Behavioral Problems|0|||
163005253|NCT03404674|588719800|FG004|Overall Study|Behavioral Problems|0|||
163005254|NCT03404674|588719801|FG005|Overall Study|Behavioral Problems|0|||
163005255|NCT03404674|588719796|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
163005256|NCT03404674|588719797|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
163005257|NCT03404674|588719798|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
163005258|NCT03404674|588719799|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
163005259|NCT03404674|588719800|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
163005260|NCT03404674|588719801|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
163005261|NCT01841593|588719807|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
163005262|NCT01841593|588719808|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
163005263|NCT01841593|588719807|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
163005264|NCT01841593|588719808|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
163005265|NCT02635984|588719809|FG000|Overall Study|Lost to Follow-up|2|||
163005266|NCT02635984|588719810|FG001|Overall Study|Lost to Follow-up|4|||
163005267|NCT02635984|588719809|FG000|Overall Study|Study Arm Closed|1|||
163005268|NCT02635984|588719810|FG001|Overall Study|Study Arm Closed|0|||
163005269|NCT00307086|588719813|FG000|Overall Study|ineligible|5|||
163005270|NCT01487525|588719814|FG000|Overall Study|Withdrawal by Subject|0|||
163005271|NCT01487525|588719815|FG001|Overall Study|Withdrawal by Subject|1|||
163005272|NCT03518008|588719816|FG000|Period 2, Second Week of Wear|Family emergency|0|||
163005273|NCT03518008|588719817|FG001|Period 2, Second Week of Wear|Family emergency|1|||
163005274|NCT02501928|588719818|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
163005275|NCT02501928|588719819|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
163005276|NCT02501928|588719820|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
163005277|NCT02501928|588719821|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
163005278|NCT02501928|588719822|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
163005279|NCT02501928|588719823|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
163005280|NCT01197911|588719824|FG000|Overall Study|Adverse Event|0|||
163005281|NCT01197911|588719825|FG001|Overall Study|Adverse Event|0|||
163005282|NCT01197911|588719826|FG002|Overall Study|Adverse Event|1|||
163005283|NCT01526057|588719830|FG000|Overall Study|Withdrawal by Subject|3|||
163005284|NCT01526057|588719831|FG001|Overall Study|Withdrawal by Subject|2|||
163005285|NCT01526057|588719832|FG002|Overall Study|Withdrawal by Subject|2|||
163005286|NCT01526057|588719830|FG000|Overall Study|Adverse Event|3|||
163005287|NCT01526057|588719831|FG001|Overall Study|Adverse Event|1|||
163005288|NCT01526057|588719832|FG002|Overall Study|Adverse Event|1|||
163005289|NCT01526057|588719830|FG000|Overall Study|Death|1|||
163005290|NCT01526057|588719831|FG001|Overall Study|Death|0|||
163005291|NCT01526057|588719832|FG002|Overall Study|Death|0|||
163005292|NCT01526057|588719830|FG000|Overall Study|Lost to Follow-up|1|||
163005293|NCT01526057|588719831|FG001|Overall Study|Lost to Follow-up|0|||
163005294|NCT01526057|588719832|FG002|Overall Study|Lost to Follow-up|1|||
163005295|NCT01526057|588719830|FG000|Overall Study|Other|1|||
163005296|NCT01526057|588719831|FG001|Overall Study|Other|0|||
163005297|NCT01526057|588719832|FG002|Overall Study|Other|1|||
163005298|NCT01526057|588719830|FG000|Overall Study|Protocol Violation|0|||
163005299|NCT01526057|588719831|FG001|Overall Study|Protocol Violation|0|||
163005300|NCT01526057|588719832|FG002|Overall Study|Protocol Violation|1|||
163005301|NCT02123446|588719833|FG000|Washout Period (1 Day)|Physician Decision|1|||
163005302|NCT02123446|588719834|FG001|Washout Period (1 Day)|Physician Decision|0|||
163005303|NCT02553772|588719836|FG000|Overall Study|Adverse Event|2|||
163005304|NCT02553772|588719837|FG001|Overall Study|Adverse Event|3|||
163005305|NCT02553772|588719836|FG000|Overall Study|Lost to Follow-up|2|||
163005306|NCT02553772|588719837|FG001|Overall Study|Lost to Follow-up|1|||
163005307|NCT02553772|588719836|FG000|Overall Study|Withdrawal of Consent|1|||
163005308|NCT02553772|588719837|FG001|Overall Study|Withdrawal of Consent|1|||
163005309|NCT02553772|588719836|FG000|Overall Study|Lack of Efficacy|1|||
163005310|NCT02553772|588719837|FG001|Overall Study|Lack of Efficacy|0|||
163326052|NCT02964741|589905422|FG001|Overall Study|claustrophobia|0|||
163061191|NCT01799889|588933027|FG006|Overall Study|Withdrawal by Subject|3|||
163061192|NCT01799889|588933028|FG007|Overall Study|Withdrawal by Subject|1|||
163061193|NCT01799889|588933029|FG008|Overall Study|Withdrawal by Subject|2|||
163061194|NCT01799889|588933030|FG009|Overall Study|Withdrawal by Subject|1|||
163061195|NCT01799889|588933031|FG010|Overall Study|Withdrawal by Subject|1|||
163061196|NCT01799889|588933032|FG011|Overall Study|Withdrawal by Subject|1|||
163061197|NCT01799889|588933021|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163061198|NCT01799889|588933022|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163061199|NCT01799889|588933023|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163061200|NCT01799889|588933024|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163061201|NCT01799889|588933025|FG004|Overall Study|Non-Compliance With Study Drug|0|||
163061202|NCT01799889|588933026|FG005|Overall Study|Non-Compliance With Study Drug|1|||
163061203|NCT01799889|588933027|FG006|Overall Study|Non-Compliance With Study Drug|0|||
163061204|NCT01799889|588933028|FG007|Overall Study|Non-Compliance With Study Drug|0|||
163061205|NCT01799889|588933029|FG008|Overall Study|Non-Compliance With Study Drug|0|||
163061206|NCT01799889|588933030|FG009|Overall Study|Non-Compliance With Study Drug|0|||
163061207|NCT01799889|588933031|FG010|Overall Study|Non-Compliance With Study Drug|0|||
163061208|NCT01799889|588933032|FG011|Overall Study|Non-Compliance With Study Drug|0|||
163061209|NCT06633965|588933033|FG000|Overall Study|Withdrawal by Subject|0|||
163061210|NCT06633965|588933034|FG001|Overall Study|Withdrawal by Subject|1|||
163326053|NCT02964741|589905423|FG002|Overall Study|claustrophobia|0|||
163326054|NCT01074294|589905427|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
163061211|NCT00300053|588933040|FG000|Overall Study|Patient/Caregiver Preference|2|||
163061212|NCT00300053|588933041|FG001|Overall Study|Patient/Caregiver Preference|2|||
163061213|NCT00300053|588933042|FG002|Overall Study|Patient/Caregiver Preference|3|||
163061214|NCT00300053|588933040|FG000|Overall Study|Death|0|||
163061215|NCT00300053|588933041|FG001|Overall Study|Death|0|||
163061216|NCT00300053|588933042|FG002|Overall Study|Death|3|||
163061217|NCT00300053|588933040|FG000|Overall Study|Lost to Follow-up|0|||
163061218|NCT00300053|588933041|FG001|Overall Study|Lost to Follow-up|1|||
163061219|NCT00300053|588933042|FG002|Overall Study|Lost to Follow-up|0|||
163061220|NCT02472405|588933043|FG000|Overall Study|Lost to Follow-up|9|||
163061221|NCT02472405|588933043|FG000|Overall Study|Adverse Event|1|||
163061222|NCT03095287|588933044|FG000|Overall Study|Treatment Failure|1|||
163061223|NCT03095287|588933044|FG000|Overall Study|Adverse Event|1|||
163326055|NCT01074294|589905428|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
163326056|NCT01074294|589905429|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
163326057|NCT01074294|589905430|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
162924653|NCT02230332|588426075|FG000|Overall Study|Lost to Follow-up|1|||
162924654|NCT02230332|588426076|FG001|Overall Study|Lost to Follow-up|0|||
162924655|NCT02230332|588426075|FG000|Overall Study|Protocol Violation|1|||
162924656|NCT02230332|588426076|FG001|Overall Study|Protocol Violation|0|||
162924657|NCT01260194|588426079|FG000|Overall Study|Withdrawal of Consent|1|||
162924658|NCT02086968|588426080|FG000|Overall Study|Adverse Event|1|||
162924659|NCT02086968|588426081|FG001|Overall Study|Adverse Event|5|||
162924660|NCT02086968|588426080|FG000|Overall Study|Lost to Follow-up|2|||
162924661|NCT02086968|588426081|FG001|Overall Study|Lost to Follow-up|3|||
162924662|NCT02086968|588426080|FG000|Overall Study|Study drug received outside protocol|0|||
162924663|NCT02086968|588426081|FG001|Overall Study|Study drug received outside protocol|1|||
162924664|NCT02086968|588426080|FG000|Overall Study|Physician Decision|4|||
162924665|NCT02086968|588426081|FG001|Overall Study|Physician Decision|0|||
162924666|NCT02086968|588426080|FG000|Overall Study|Withdrawal by Subject|1|||
162924667|NCT02086968|588426081|FG001|Overall Study|Withdrawal by Subject|4|||
162924668|NCT00556166|588426087|FG000|Overall Study|Withdrawal by Subject|1|||
162924669|NCT03359473|588426088|FG000|Overall Study|Adverse Event|0|||
162924670|NCT03359473|588426089|FG001|Overall Study|Adverse Event|2|||
162924671|NCT03359473|588426090|FG002|Overall Study|Adverse Event|5|||
162924672|NCT03359473|588426091|FG003|Overall Study|Adverse Event|3|||
162924673|NCT03359473|588426088|FG000|Overall Study|Lost to Follow-up|0|||
162924674|NCT03359473|588426089|FG001|Overall Study|Lost to Follow-up|1|||
162924675|NCT03359473|588426090|FG002|Overall Study|Lost to Follow-up|0|||
162924676|NCT03359473|588426091|FG003|Overall Study|Lost to Follow-up|0|||
162924677|NCT03359473|588426088|FG000|Overall Study|Physician Decision|0|||
162924678|NCT03359473|588426089|FG001|Overall Study|Physician Decision|1|||
162924679|NCT03359473|588426090|FG002|Overall Study|Physician Decision|0|||
162924680|NCT03359473|588426091|FG003|Overall Study|Physician Decision|1|||
162924681|NCT03359473|588426088|FG000|Overall Study|Withdrawal by Subject|1|||
162924682|NCT03359473|588426089|FG001|Overall Study|Withdrawal by Subject|2|||
162924683|NCT03359473|588426090|FG002|Overall Study|Withdrawal by Subject|1|||
162924684|NCT03359473|588426091|FG003|Overall Study|Withdrawal by Subject|0|||
162924685|NCT03359473|588426088|FG000|Overall Study|Protocol-defined stopping criteria|1|||
162924686|NCT03359473|588426089|FG001|Overall Study|Protocol-defined stopping criteria|0|||
162924687|NCT03359473|588426090|FG002|Overall Study|Protocol-defined stopping criteria|0|||
162924688|NCT03359473|588426091|FG003|Overall Study|Protocol-defined stopping criteria|1|||
163005311|NCT02553772|588719836|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163005312|NCT02553772|588719837|FG001|Overall Study|Other Miscellaneous Reasons|1|||
163005313|NCT02860546|588719838|FG000|Overall Study|Clinical Progression|6|||
163005314|NCT02860546|588719838|FG000|Overall Study|Radiological Progression|12|||
163005315|NCT02466321|588719839|FG000|Overall Study|Death|26|||
163005316|NCT02466321|588719839|FG000|Overall Study|Revision|6|||
163005317|NCT02466321|588719839|FG000|Overall Study|Lost to Follow-up|60|||
163005318|NCT02466321|588719839|FG000|Overall Study|Did not receive study device|1|||
163005319|NCT01855828|588719840|FG000|Overall Study|Adverse Event|1|||
163005320|NCT01855828|588719840|FG000|Overall Study|Withdrawal by Subject|1|||
163005321|NCT05655546|588721773|FG000|Overall Study|Withdrawal by Subject|2|||
163005322|NCT05655546|588721774|FG001|Overall Study|Withdrawal by Subject|4|||
163005323|NCT03493685|588721775|FG000|Overall Study|Death|4|||
163005324|NCT03493685|588721776|FG001|Overall Study|Death|3|||
163005325|NCT03493685|588721775|FG000|Overall Study|Lost to Follow-up|3|||
163005326|NCT03493685|588721776|FG001|Overall Study|Lost to Follow-up|2|||
163005327|NCT03493685|588721775|FG000|Overall Study|Physician Decision|2|||
163005328|NCT03493685|588721776|FG001|Overall Study|Physician Decision|0|||
163213507|NCT02659631|589495993|FG000|Overall Study|Death (follow-up phase)|1|||
163213508|NCT02659631|589495994|FG001|Overall Study|Death (follow-up phase)|2|||
163005329|NCT03493685|588721775|FG000|Overall Study|Withdrawal by Subject|7|||
163005330|NCT03493685|588721776|FG001|Overall Study|Withdrawal by Subject|11|||
163005331|NCT04452669|588721777|FG000|Overall Study|Death|1|||
163005332|NCT04452669|588721778|FG001|Overall Study|Death|4|||
163005333|NCT04576507|588721782|FG000|Overall Study|Adverse Event|4|||
163005334|NCT04576507|588721782|FG000|Overall Study|Withdrawal by Subject|1|||
163005335|NCT00413699|588721783|FG000|Initial Period|Death|25|||
163005336|NCT00413699|588721784|FG001|Initial Period|Death|30|||
163005337|NCT00413699|588721785|FG002|Initial Period|Death|0|||
163005338|NCT00413699|588721783|FG000|Initial Period|Lack of Efficacy|59|||
163005339|NCT00413699|588721784|FG001|Initial Period|Lack of Efficacy|115|||
163005340|NCT00413699|588721785|FG002|Initial Period|Lack of Efficacy|0|||
163005341|NCT00413699|588721783|FG000|Initial Period|Lost to Follow-up|31|||
163005342|NCT00413699|588721784|FG001|Initial Period|Lost to Follow-up|101|||
163005343|NCT00413699|588721785|FG002|Initial Period|Lost to Follow-up|0|||
163005344|NCT00413699|588721783|FG000|Initial Period|Protocol Violation|38|||
163005345|NCT00413699|588721784|FG001|Initial Period|Protocol Violation|89|||
163005346|NCT00413699|588721785|FG002|Initial Period|Protocol Violation|0|||
163005347|NCT00413699|588721783|FG000|Initial Period|Pregnancy|10|||
163005348|NCT00413699|588721784|FG001|Initial Period|Pregnancy|8|||
163005349|NCT00413699|588721785|FG002|Initial Period|Pregnancy|0|||
163005350|NCT00413699|588721783|FG000|Initial Period|Did not meet entrance criteria|2|||
163005351|NCT00413699|588721784|FG001|Initial Period|Did not meet entrance criteria|2|||
163005352|NCT00413699|588721785|FG002|Initial Period|Did not meet entrance criteria|0|||
163005353|NCT00413699|588721783|FG000|Initial Period|Medication error without adverse event|0|||
163005354|NCT00413699|588721784|FG001|Initial Period|Medication error without adverse event|1|||
163005355|NCT00413699|588721785|FG002|Initial Period|Medication error without adverse event|0|||
163005356|NCT00413699|588721783|FG000|Initial Period|Study terminated by Sponsor|0|||
163005357|NCT00413699|588721784|FG001|Initial Period|Study terminated by Sponsor|1|||
163005358|NCT00413699|588721785|FG002|Initial Period|Study terminated by Sponsor|0|||
163005359|NCT00413699|588721783|FG000|Initial Period|Other|67|||
163005360|NCT00413699|588721784|FG001|Initial Period|Other|211|||
163005361|NCT00413699|588721785|FG002|Initial Period|Other|0|||
163005362|NCT00413699|588721783|FG000|Initial Period|Adverse event related to study drug|178|||
163005363|NCT00413699|588721784|FG001|Initial Period|Adverse event related to study drug|527|||
163005364|NCT00413699|588721785|FG002|Initial Period|Adverse event related to study drug|0|||
163005365|NCT00413699|588721783|FG000|Initial Period|Adverse event not related to study drug|113|||
163005366|NCT00413699|588721784|FG001|Initial Period|Adverse event not related to study drug|248|||
163005367|NCT00413699|588721785|FG002|Initial Period|Adverse event not related to study drug|0|||
163005368|NCT00413699|588721783|FG000|Initial Period|Missing end of study page|0|||
163005369|NCT00413699|588721784|FG001|Initial Period|Missing end of study page|4|||
163005370|NCT00413699|588721785|FG002|Initial Period|Missing end of study page|0|||
163213509|NCT02659631|589495995|FG002|Overall Study|Death (follow-up phase)|1|||
163005371|NCT00413699|588721783|FG000|Initial Period|No longer willing to participate|116|||
163005372|NCT00413699|588721784|FG001|Initial Period|No longer willing to participate|368|||
163005373|NCT00413699|588721785|FG002|Initial Period|No longer willing to participate|0|||
163005374|NCT00413699|588721783|FG000|Extension Period|No Longer Willing to Participate|0|||
163005375|NCT00413699|588721784|FG001|Extension Period|No Longer Willing to Participate|0|||
163005376|NCT00413699|588721785|FG002|Extension Period|No Longer Willing to Participate|2|||
163005377|NCT00413699|588721783|FG000|Extension Period|Protocol Violation|0|||
163005378|NCT00413699|588721784|FG001|Extension Period|Protocol Violation|0|||
163005379|NCT00413699|588721785|FG002|Extension Period|Protocol Violation|1|||
163005380|NCT00413699|588721783|FG000|Extension Period|Adverse Event|0|||
163005381|NCT00413699|588721784|FG001|Extension Period|Adverse Event|0|||
163005382|NCT00413699|588721785|FG002|Extension Period|Adverse Event|2|||
163213510|NCT02659631|589495996|FG003|Overall Study|Death (follow-up phase)|1|||
163005383|NCT02115269|588721786|FG000|Overall Study|Lost to Follow-up|43|||
163005384|NCT02115269|588721786|FG000|Overall Study|Did not complete patient diary|3|||
163005385|NCT02115269|588721786|FG000|Overall Study|Moved to another city|7|||
163005386|NCT02115269|588721786|FG000|Overall Study|Withdrawal by Subject|2|||
163005387|NCT02115269|588721786|FG000|Overall Study|Didn't take study drug|2|||
163005388|NCT05989672|588721788|FG000|Overall Study|Adverse Event|3|||
163005389|NCT05989672|588721789|FG001|Overall Study|Adverse Event|0|||
163005390|NCT05989672|588721790|FG002|Overall Study|Adverse Event|0|||
163005391|NCT03511105|588721791|FG000|Overall Study|Adverse Event|1|||
163005392|NCT03511105|588721792|FG001|Overall Study|Adverse Event|0|||
163005393|NCT03511105|588721791|FG000|Overall Study|Withdrew consent|1|||
163005394|NCT03511105|588721792|FG001|Overall Study|Withdrew consent|0|||
163005395|NCT02810457|588721793|FG000|Overall Study|Randomised but no treatment received|2|||
163005396|NCT02810457|588721794|FG001|Overall Study|Randomised but no treatment received|1|||
163005397|NCT02810457|588721793|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
163005398|NCT02810457|588721794|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
163005399|NCT02810457|588721793|FG000|Overall Study|Adverse Event|37|||
163005400|NCT02810457|588721794|FG001|Overall Study|Adverse Event|43|||
163005401|NCT02810457|588721793|FG000|Overall Study|Patient decision|31|||
163005402|NCT02810457|588721794|FG001|Overall Study|Patient decision|35|||
163005403|NCT02810457|588721793|FG000|Overall Study|Patient lost to follow-up|2|||
163005404|NCT02810457|588721794|FG001|Overall Study|Patient lost to follow-up|2|||
163005405|NCT02810457|588721793|FG000|Overall Study|Death|39|||
163005406|NCT02810457|588721794|FG001|Overall Study|Death|28|||
163005407|NCT02810457|588721793|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
163005408|NCT02810457|588721794|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
163005409|NCT02810457|588721793|FG000|Overall Study|Clinical progression|15|||
163005410|NCT02810457|588721794|FG001|Overall Study|Clinical progression|16|||
163005411|NCT02810457|588721793|FG000|Overall Study|Investigator decision|3|||
163005412|NCT02810457|588721794|FG001|Overall Study|Investigator decision|2|||
163005413|NCT02810457|588721793|FG000|Overall Study|Patient ineligibility|3|||
163005414|NCT02810457|588721794|FG001|Overall Study|Patient ineligibility|0|||
163005415|NCT02810457|588721793|FG000|Overall Study|Miscalculated PD|1|||
163005416|NCT02810457|588721794|FG001|Overall Study|Miscalculated PD|0|||
163005417|NCT02810457|588721793|FG000|Overall Study|Physician Decision|0|||
163005418|NCT02810457|588721794|FG001|Overall Study|Physician Decision|1|||
163005419|NCT01962103|588721795|FG000|Phase 1|Adverse Event|4|||
163005420|NCT01962103|588721796|FG001|Phase 1|Adverse Event|0|||
163005421|NCT01962103|588721797|FG002|Phase 1|Adverse Event|2|||
163005422|NCT01962103|588721798|FG003|Phase 1|Adverse Event|1|||
163005423|NCT01962103|588721799|FG004|Phase 1|Adverse Event|2|||
163005424|NCT01962103|588721800|FG005|Phase 1|Adverse Event|2|||
163005425|NCT01962103|588721801|FG006|Phase 1|Adverse Event|0|||
163005426|NCT01962103|588721802|FG007|Phase 1|Adverse Event|0|||
163005427|NCT01962103|588721803|FG008|Phase 1|Adverse Event|0|||
163005428|NCT01962103|588721795|FG000|Phase 1|Progressive Disease|8|||
163005429|NCT01962103|588721796|FG001|Phase 1|Progressive Disease|6|||
163005430|NCT01962103|588721797|FG002|Phase 1|Progressive Disease|8|||
163005431|NCT01962103|588721798|FG003|Phase 1|Progressive Disease|4|||
163005432|NCT01962103|588721799|FG004|Phase 1|Progressive Disease|5|||
163005433|NCT01962103|588721800|FG005|Phase 1|Progressive Disease|4|||
163005434|NCT01962103|588721801|FG006|Phase 1|Progressive Disease|0|||
163005435|NCT01962103|588721802|FG007|Phase 1|Progressive Disease|0|||
163005436|NCT01962103|588721803|FG008|Phase 1|Progressive Disease|0|||
163005437|NCT01962103|588721795|FG000|Phase 1|Withdrawal by Subject|0|||
163005438|NCT01962103|588721796|FG001|Phase 1|Withdrawal by Subject|0|||
163005439|NCT01962103|588721797|FG002|Phase 1|Withdrawal by Subject|0|||
163005440|NCT01962103|588721798|FG003|Phase 1|Withdrawal by Subject|2|||
163005441|NCT01962103|588721799|FG004|Phase 1|Withdrawal by Subject|0|||
163005442|NCT01962103|588721800|FG005|Phase 1|Withdrawal by Subject|0|||
163005443|NCT01962103|588721801|FG006|Phase 1|Withdrawal by Subject|0|||
163005444|NCT01962103|588721802|FG007|Phase 1|Withdrawal by Subject|0|||
163005445|NCT01962103|588721803|FG008|Phase 1|Withdrawal by Subject|0|||
163005446|NCT01962103|588721795|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
163005447|NCT01962103|588721796|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
163005448|NCT01962103|588721797|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
163005449|NCT01962103|588721798|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
163005450|NCT01962103|588721799|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
163005451|NCT01962103|588721800|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
163005452|NCT01962103|588721801|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
163005453|NCT01962103|588721802|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
163005454|NCT01962103|588721803|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
163005455|NCT01962103|588721795|FG000|Phase 1|Physician Decision|0|||
163005456|NCT01962103|588721796|FG001|Phase 1|Physician Decision|0|||
163005457|NCT01962103|588721797|FG002|Phase 1|Physician Decision|0|||
163005458|NCT01962103|588721798|FG003|Phase 1|Physician Decision|1|||
163005459|NCT01962103|588721799|FG004|Phase 1|Physician Decision|0|||
163005460|NCT01962103|588721800|FG005|Phase 1|Physician Decision|0|||
163005461|NCT01962103|588721801|FG006|Phase 1|Physician Decision|0|||
163005462|NCT01962103|588721802|FG007|Phase 1|Physician Decision|0|||
163005463|NCT01962103|588721803|FG008|Phase 1|Physician Decision|0|||
163005464|NCT01962103|588721795|FG000|Phase 1|Symptomatic Deterioration|3|||
163005465|NCT01962103|588721796|FG001|Phase 1|Symptomatic Deterioration|2|||
163005466|NCT01962103|588721797|FG002|Phase 1|Symptomatic Deterioration|2|||
163005467|NCT01962103|588721798|FG003|Phase 1|Symptomatic Deterioration|2|||
163005468|NCT01962103|588721799|FG004|Phase 1|Symptomatic Deterioration|1|||
163005469|NCT01962103|588721800|FG005|Phase 1|Symptomatic Deterioration|1|||
163005470|NCT01962103|588721801|FG006|Phase 1|Symptomatic Deterioration|0|||
163005471|NCT01962103|588721802|FG007|Phase 1|Symptomatic Deterioration|0|||
163005472|NCT01962103|588721803|FG008|Phase 1|Symptomatic Deterioration|0|||
163005473|NCT01962103|588721795|FG000|Phase 1|Miscellaneous|1|||
163005474|NCT01962103|588721796|FG001|Phase 1|Miscellaneous|0|||
163005475|NCT01962103|588721797|FG002|Phase 1|Miscellaneous|0|||
163005476|NCT01962103|588721798|FG003|Phase 1|Miscellaneous|0|||
163005477|NCT01962103|588721799|FG004|Phase 1|Miscellaneous|0|||
163005478|NCT01962103|588721800|FG005|Phase 1|Miscellaneous|0|||
163005479|NCT01962103|588721801|FG006|Phase 1|Miscellaneous|0|||
163005480|NCT01962103|588721802|FG007|Phase 1|Miscellaneous|0|||
163005481|NCT01962103|588721803|FG008|Phase 1|Miscellaneous|0|||
163005482|NCT01962103|588721795|FG000|Phase 2|Adverse Event|0|||
163005483|NCT01962103|588721796|FG001|Phase 2|Adverse Event|0|||
163005484|NCT01962103|588721797|FG002|Phase 2|Adverse Event|0|||
163005485|NCT01962103|588721798|FG003|Phase 2|Adverse Event|0|||
163005486|NCT01962103|588721799|FG004|Phase 2|Adverse Event|0|||
163005487|NCT01962103|588721800|FG005|Phase 2|Adverse Event|0|||
163005488|NCT01962103|588721801|FG006|Phase 2|Adverse Event|1|||
163005489|NCT01962103|588721802|FG007|Phase 2|Adverse Event|0|||
163005490|NCT01962103|588721803|FG008|Phase 2|Adverse Event|3|||
163005491|NCT01962103|588721795|FG000|Phase 2|Progressive Disease|0|||
163005492|NCT01962103|588721796|FG001|Phase 2|Progressive Disease|0|||
163005493|NCT01962103|588721797|FG002|Phase 2|Progressive Disease|0|||
163005494|NCT01962103|588721798|FG003|Phase 2|Progressive Disease|0|||
163005495|NCT01962103|588721799|FG004|Phase 2|Progressive Disease|0|||
163005496|NCT01962103|588721800|FG005|Phase 2|Progressive Disease|0|||
163005497|NCT01962103|588721801|FG006|Phase 2|Progressive Disease|11|||
163005498|NCT01962103|588721802|FG007|Phase 2|Progressive Disease|12|||
163005499|NCT01962103|588721803|FG008|Phase 2|Progressive Disease|11|||
163005500|NCT01962103|588721795|FG000|Phase 2|Symptomatic Deterioration|0|||
163005501|NCT01962103|588721796|FG001|Phase 2|Symptomatic Deterioration|0|||
163005502|NCT01962103|588721797|FG002|Phase 2|Symptomatic Deterioration|0|||
163005503|NCT01962103|588721798|FG003|Phase 2|Symptomatic Deterioration|0|||
163005504|NCT01962103|588721799|FG004|Phase 2|Symptomatic Deterioration|0|||
163005505|NCT01962103|588721800|FG005|Phase 2|Symptomatic Deterioration|0|||
163005506|NCT01962103|588721801|FG006|Phase 2|Symptomatic Deterioration|2|||
163005507|NCT01962103|588721802|FG007|Phase 2|Symptomatic Deterioration|2|||
163005508|NCT01962103|588721803|FG008|Phase 2|Symptomatic Deterioration|0|||
163005509|NCT02750618|588721804|FG000|Overall Study|Withdrawal by Subject|1|||
163005510|NCT02094300|588721811|FG000|Overall Study|Death|7|||
163005511|NCT02094300|588721811|FG000|Overall Study|Lost to Follow-up|10|||
163005512|NCT02094300|588721811|FG000|Overall Study|Still be eligible for follow-up|3|||
163005513|NCT03347110|588721814|FG000|Overall Study|Other (Participant is incarcerated)|1|||
163005514|NCT03347110|588721814|FG000|Overall Study|Withdrawal by Subject|9|||
163005515|NCT03347110|588721814|FG000|Overall Study|Lost to Follow-up|1|||
163005516|NCT03347110|588721814|FG000|Overall Study|Lack of Efficacy|2|||
163005517|NCT03347110|588721814|FG000|Overall Study|Adverse Event, non-fatal|9|||
163005518|NCT01321879|588721815|FG000|Overall Study|Lack of Efficacy|5|||
163005519|NCT01321879|588721815|FG000|Overall Study|Adverse Event|5|||
163005520|NCT01321879|588721815|FG000|Overall Study|Death|3|||
163005521|NCT01321879|588721815|FG000|Overall Study|Withdrawal by Subject|1|||
163005522|NCT02687451|588721816|FG000|Overall Study|Withdrawal by Subject|1|||
163005523|NCT02687451|588721817|FG001|Overall Study|Withdrawal by Subject|0|||
163005524|NCT02687451|588721818|FG002|Overall Study|Withdrawal by Subject|0|||
163005525|NCT02687451|588721819|FG003|Overall Study|Withdrawal by Subject|0|||
163005526|NCT02687451|588721820|FG004|Overall Study|Withdrawal by Subject|0|||
163005527|NCT02687451|588721821|FG005|Overall Study|Withdrawal by Subject|1|||
163005528|NCT01518322|588721822|FG000|Overall Study|FeNO measurement was missing|13|||
163005529|NCT00707239|588721823|FG000|Overall Study|Adverse Event|5|||
163005530|NCT00707239|588721824|FG001|Overall Study|Adverse Event|3|||
163005531|NCT00707239|588721825|FG002|Overall Study|Adverse Event|2|||
163005532|NCT00707239|588721823|FG000|Overall Study|Death|3|||
163005533|NCT00707239|588721824|FG001|Overall Study|Death|1|||
163005534|NCT00707239|588721825|FG002|Overall Study|Death|3|||
163005535|NCT00707239|588721823|FG000|Overall Study|Physician Decision|1|||
163005536|NCT00707239|588721824|FG001|Overall Study|Physician Decision|1|||
163005537|NCT00707239|588721825|FG002|Overall Study|Physician Decision|2|||
163005538|NCT00707239|588721823|FG000|Overall Study|Protocol Violation|0|||
163005539|NCT00707239|588721824|FG001|Overall Study|Protocol Violation|0|||
163005540|NCT00707239|588721825|FG002|Overall Study|Protocol Violation|1|||
163005541|NCT00707239|588721823|FG000|Overall Study|Lack of Efficacy|1|||
163005542|NCT00707239|588721824|FG001|Overall Study|Lack of Efficacy|2|||
163005543|NCT00707239|588721825|FG002|Overall Study|Lack of Efficacy|0|||
163005544|NCT00707239|588721823|FG000|Overall Study|Randomized, but not treated|1|||
163005545|NCT00707239|588721824|FG001|Overall Study|Randomized, but not treated|1|||
163005546|NCT00707239|588721825|FG002|Overall Study|Randomized, but not treated|1|||
163005547|NCT00707239|588721823|FG000|Overall Study|Other|8|||
163005548|NCT00707239|588721824|FG001|Overall Study|Other|3|||
163005549|NCT00707239|588721825|FG002|Overall Study|Other|5|||
163005550|NCT03472014|588721826|FG000|Overall Study|Lost to Follow-up|4|||
163005551|NCT03652051|588721827|FG000|Stage 1|Adverse Event|0|||
163005552|NCT03652051|588721828|FG001|Stage 1|Adverse Event|5|||
163005553|NCT03652051|588721829|FG002|Stage 1|Adverse Event|7|||
163005554|NCT03652051|588721830|FG003|Stage 1|Adverse Event|1|||
163005555|NCT03652051|588721827|FG000|Stage 1|Withdrawal by Subject|0|||
163005556|NCT03652051|588721828|FG001|Stage 1|Withdrawal by Subject|0|||
163005557|NCT03652051|588721829|FG002|Stage 1|Withdrawal by Subject|1|||
163005558|NCT03652051|588721830|FG003|Stage 1|Withdrawal by Subject|0|||
163005559|NCT03652051|588721827|FG000|Stage 2|Adverse Event|0|||
163005560|NCT03652051|588721828|FG001|Stage 2|Adverse Event|2|||
163005561|NCT03652051|588721829|FG002|Stage 2|Adverse Event|1|||
163005562|NCT03652051|588721830|FG003|Stage 2|Adverse Event|0|||
163005563|NCT03652051|588721827|FG000|Stage 2|Protocol Violation|0|||
163005564|NCT03652051|588721828|FG001|Stage 2|Protocol Violation|1|||
163005565|NCT03652051|588721829|FG002|Stage 2|Protocol Violation|6|||
163005566|NCT03652051|588721830|FG003|Stage 2|Protocol Violation|0|||
163005567|NCT03652051|588721827|FG000|Stage 2|Lost to Follow-up|0|||
163005568|NCT03652051|588721828|FG001|Stage 2|Lost to Follow-up|2|||
163005569|NCT03652051|588721829|FG002|Stage 2|Lost to Follow-up|0|||
163005570|NCT03652051|588721830|FG003|Stage 2|Lost to Follow-up|3|||
163005571|NCT03652051|588721827|FG000|Stage 2|Withdrawal by Subject|0|||
163005572|NCT03652051|588721828|FG001|Stage 2|Withdrawal by Subject|11|||
163005573|NCT03652051|588721829|FG002|Stage 2|Withdrawal by Subject|9|||
163005574|NCT03652051|588721830|FG003|Stage 2|Withdrawal by Subject|3|||
163005575|NCT01930162|588721831|FG000|Overall Study|Abnormal test procedure result(s)|4|||
163005576|NCT01930162|588721831|FG000|Overall Study|Death|1|||
163005577|NCT02394600|588721834|FG000|Overall Study|Adverse Event|3|||
163005578|NCT02394600|588721835|FG001|Overall Study|Adverse Event|0|||
163005579|NCT02394600|588721834|FG000|Overall Study|Lost to Follow-up|0|||
163005580|NCT02394600|588721835|FG001|Overall Study|Lost to Follow-up|1|||
163005581|NCT02394600|588721834|FG000|Overall Study|Withdrawal by Subject|0|||
163005582|NCT02394600|588721835|FG001|Overall Study|Withdrawal by Subject|1|||
163005583|NCT02394600|588721834|FG000|Overall Study|Protocol Violation|1|||
163005584|NCT02394600|588721835|FG001|Overall Study|Protocol Violation|0|||
163005585|NCT02569801|588721836|FG000|Overall Study|Withdrawal by Subject|9|||
163005586|NCT02569801|588721837|FG001|Overall Study|Withdrawal by Subject|9|||
163005587|NCT02569801|588721836|FG000|Overall Study|Sponsor Decision|13|||
163005588|NCT02569801|588721837|FG001|Overall Study|Sponsor Decision|14|||
163005589|NCT02569801|588721836|FG000|Overall Study|Progressive Disease|2|||
163005590|NCT02569801|588721837|FG001|Overall Study|Progressive Disease|7|||
163005591|NCT02569801|588721836|FG000|Overall Study|Lost to Follow-up|0|||
163005592|NCT02569801|588721837|FG001|Overall Study|Lost to Follow-up|1|||
163005593|NCT02569801|588721836|FG000|Overall Study|Death|12|||
163005594|NCT02569801|588721837|FG001|Overall Study|Death|4|||
163005595|NCT03442751|588721840|FG000|Overall Study|Withdrawal by Subject|3|||
163005596|NCT03442751|588721841|FG001|Overall Study|Withdrawal by Subject|1|||
163005597|NCT03442751|588721840|FG000|Overall Study|Lost to Follow-up|3|||
163005598|NCT03442751|588721841|FG001|Overall Study|Lost to Follow-up|0|||
163005599|NCT01308424|588721842|FG000|Baseline Eligibility|Screen Failures|71|||
163005600|NCT01308424|588721843|FG001|Baseline Eligibility|Screen Failures|0|||
163005601|NCT01308424|588721844|FG002|Baseline Eligibility|Screen Failures|0|||
163005602|NCT01308424|588721842|FG000|Randomization|Adverse Event|0|||
163005603|NCT01308424|588721843|FG001|Randomization|Adverse Event|1|||
163005604|NCT01308424|588721844|FG002|Randomization|Adverse Event|1|||
163005605|NCT01308424|588721842|FG000|Randomization|Lost to Follow-up|0|||
163005606|NCT01308424|588721843|FG001|Randomization|Lost to Follow-up|1|||
163005607|NCT01308424|588721844|FG002|Randomization|Lost to Follow-up|0|||
163005608|NCT01308424|588721842|FG000|Randomization|Physician Decision|0|||
163061224|NCT01431976|588933047|FG000|Overall Study|Adverse Event|6|||
163404462|NCT03246958|590191937|FG003|Overall Study|Never start treatment|0|||
163005609|NCT01308424|588721843|FG001|Randomization|Physician Decision|1|||
163005610|NCT01308424|588721844|FG002|Randomization|Physician Decision|1|||
163005611|NCT00948155|588721845|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
163005612|NCT00948155|588721846|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
163005613|NCT00948155|588721845|FG000|Washout 14 Days|Lost to Follow-up|1|||
163005614|NCT00948155|588721846|FG001|Washout 14 Days|Lost to Follow-up|2|||
163005615|NCT01870778|588721848|FG000|Overall Study|Withdrawal by Subject|8|||
163005616|NCT01870778|588721849|FG001|Overall Study|Withdrawal by Subject|7|||
163005617|NCT01870778|588721848|FG000|Overall Study|Lost to Follow-up|0|||
163005618|NCT01870778|588721849|FG001|Overall Study|Lost to Follow-up|2|||
163005619|NCT01169350|588721852|FG000|Overall Study|Physician Decision|3|||
163005620|NCT01169350|588721852|FG000|Overall Study|Lost to Follow-up|2|||
163005621|NCT04870710|588721856|FG000|Overall Study|Lost to Follow-up|3|||
163005622|NCT01329900|588721857|FG000|Overall Study|Elevated creatinine/renal function|1|||
163005623|NCT01866098|588721858|FG000|Overall Study|Lost to Follow-up|11|||
163005624|NCT01866098|588721859|FG001|Overall Study|Lost to Follow-up|18|||
163005625|NCT01866098|588721860|FG002|Overall Study|Lost to Follow-up|13|||
163005626|NCT01866098|588721858|FG000|Overall Study|Physician Decision|0|||
163005627|NCT01866098|588721859|FG001|Overall Study|Physician Decision|1|||
163005628|NCT01866098|588721860|FG002|Overall Study|Physician Decision|2|||
163005629|NCT01866098|588721858|FG000|Overall Study|Adverse Event|1|||
163005630|NCT01866098|588721859|FG001|Overall Study|Adverse Event|5|||
163005631|NCT01866098|588721860|FG002|Overall Study|Adverse Event|4|||
163005632|NCT01866098|588721858|FG000|Overall Study|Protocol Violation|1|||
163005633|NCT01866098|588721859|FG001|Overall Study|Protocol Violation|0|||
163005634|NCT01866098|588721860|FG002|Overall Study|Protocol Violation|0|||
163005635|NCT01866098|588721858|FG000|Overall Study|Withdrawal by Subject|1|||
163005636|NCT01866098|588721859|FG001|Overall Study|Withdrawal by Subject|2|||
163005637|NCT01866098|588721860|FG002|Overall Study|Withdrawal by Subject|0|||
163005638|NCT01866098|588721858|FG000|Overall Study|Unrelated Hospitalization|2|||
163005639|NCT01866098|588721859|FG001|Overall Study|Unrelated Hospitalization|0|||
163005640|NCT01866098|588721860|FG002|Overall Study|Unrelated Hospitalization|1|||
163005641|NCT01866098|588721858|FG000|Overall Study|Non-compliance|1|||
163005642|NCT01866098|588721859|FG001|Overall Study|Non-compliance|0|||
163005643|NCT01866098|588721860|FG002|Overall Study|Non-compliance|1|||
163005644|NCT01866098|588721858|FG000|Overall Study|Pregnancy|2|||
163005645|NCT01866098|588721859|FG001|Overall Study|Pregnancy|0|||
163005646|NCT01866098|588721860|FG002|Overall Study|Pregnancy|0|||
163005647|NCT01866098|588721858|FG000|Overall Study|Death|0|||
163005648|NCT01866098|588721859|FG001|Overall Study|Death|1|||
163005649|NCT01866098|588721860|FG002|Overall Study|Death|0|||
163005650|NCT04239027|588721861|FG000|Overall Study|Adverse Event|4|||
163005651|NCT04239027|588721861|FG000|Overall Study|Withdrawal by Subject|9|||
163005652|NCT04239027|588721861|FG000|Overall Study|Death|1|||
163061225|NCT01431976|588933047|FG000|Overall Study|Lack of Efficacy|2|||
163061226|NCT01431976|588933047|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
163061227|NCT01431976|588933047|FG000|Overall Study|Physician Decision|1|||
163061228|NCT01431976|588933047|FG000|Overall Study|Withdrawal by Subject|1|||
163061229|NCT01294514|588933048|FG000|Overall Study|Excluded due to Arrhythmia|1|||
163061230|NCT01963611|588933049|FG000|Overall Study|Adverse Event|1|||
163061231|NCT01963611|588933050|FG001|Overall Study|Adverse Event|1|||
163061232|NCT01963611|588933051|FG002|Overall Study|Adverse Event|3|||
163061233|NCT01963611|588933052|FG003|Overall Study|Adverse Event|4|||
163061234|NCT01963611|588933053|FG004|Overall Study|Adverse Event|3|||
163061235|NCT01963611|588933049|FG000|Overall Study|Protocol Violation|0|||
163061236|NCT01963611|588933050|FG001|Overall Study|Protocol Violation|0|||
163061237|NCT01963611|588933051|FG002|Overall Study|Protocol Violation|0|||
163061238|NCT01963611|588933052|FG003|Overall Study|Protocol Violation|1|||
163061239|NCT01963611|588933053|FG004|Overall Study|Protocol Violation|0|||
163061240|NCT01963611|588933049|FG000|Overall Study|Lack of Efficacy|0|||
163061241|NCT01963611|588933050|FG001|Overall Study|Lack of Efficacy|0|||
163061242|NCT01963611|588933051|FG002|Overall Study|Lack of Efficacy|0|||
163061243|NCT01963611|588933052|FG003|Overall Study|Lack of Efficacy|1|||
163061244|NCT01963611|588933053|FG004|Overall Study|Lack of Efficacy|0|||
163061245|NCT01963611|588933049|FG000|Overall Study|Withdrawal by Subject|3|||
163061246|NCT01963611|588933050|FG001|Overall Study|Withdrawal by Subject|2|||
163061247|NCT01963611|588933051|FG002|Overall Study|Withdrawal by Subject|1|||
163061248|NCT01963611|588933052|FG003|Overall Study|Withdrawal by Subject|1|||
163061249|NCT01963611|588933053|FG004|Overall Study|Withdrawal by Subject|3|||
163061250|NCT01963611|588933049|FG000|Overall Study|Other|47|||
163061251|NCT01963611|588933050|FG001|Overall Study|Other|46|||
163061252|NCT01963611|588933051|FG002|Overall Study|Other|48|||
163061253|NCT01963611|588933052|FG003|Overall Study|Other|45|||
163061254|NCT01963611|588933053|FG004|Overall Study|Other|45|||
163061255|NCT01126424|588933059|FG000|Overall Study|Adverse Event|0|||
163061256|NCT01126424|588933060|FG001|Overall Study|Adverse Event|0|||
163061257|NCT01126424|588933061|FG002|Overall Study|Adverse Event|0|||
163005653|NCT04239027|588721861|FG000|Overall Study|Physician Decision|9|||
163005654|NCT04239027|588721861|FG000|Overall Study|Lost to Follow-up|2|||
163005655|NCT04239027|588721861|FG000|Overall Study|Lack of Efficacy|1|||
163005656|NCT01184079|588721868|FG000|Overall Study|Lost to Follow-up|14|||
163005657|NCT01184079|588721869|FG001|Overall Study|Lost to Follow-up|2|||
163005658|NCT01876446|588721872|FG000|Overall Study|Death|0|||
163005659|NCT01876446|588721873|FG001|Overall Study|Death|1|||
163061258|NCT01126424|588933062|FG003|Overall Study|Adverse Event|0|||
163061259|NCT01126424|588933063|FG004|Overall Study|Adverse Event|1|||
163061260|NCT01126424|588933064|FG005|Overall Study|Adverse Event|0|||
163061261|NCT01126424|588933059|FG000|Overall Study|Withdrawal by Subject|0|||
163061262|NCT01126424|588933060|FG001|Overall Study|Withdrawal by Subject|0|||
163005660|NCT01876446|588721872|FG000|Overall Study|Withdrawal by Subject|1|||
163005661|NCT01876446|588721873|FG001|Overall Study|Withdrawal by Subject|2|||
163005662|NCT01876446|588721872|FG000|Overall Study|Physician Decision|1|||
163005663|NCT01876446|588721873|FG001|Overall Study|Physician Decision|3|||
163005664|NCT02108912|588721874|FG000|Overall Study|Lost to Follow-up|1|||
163061263|NCT01126424|588933061|FG002|Overall Study|Withdrawal by Subject|1|||
163005665|NCT02108912|588721875|FG001|Overall Study|Lost to Follow-up|1|||
163005666|NCT02108912|588721874|FG000|Overall Study|lack of transportation|1|||
163005667|NCT02108912|588721875|FG001|Overall Study|lack of transportation|0|||
163005668|NCT02108912|588721874|FG000|Overall Study|high blood pressure|1|||
163005669|NCT02108912|588721875|FG001|Overall Study|high blood pressure|0|||
163005670|NCT01808573|588721881|FG000|Overall Study|Death|212|||
163005671|NCT01808573|588721882|FG001|Overall Study|Death|240|||
163005672|NCT01808573|588721881|FG000|Overall Study|Withdrawal by Subject|12|||
163005673|NCT01808573|588721882|FG001|Overall Study|Withdrawal by Subject|10|||
163005674|NCT01808573|588721881|FG000|Overall Study|Lost to Follow-up|3|||
163005675|NCT01808573|588721882|FG001|Overall Study|Lost to Follow-up|0|||
163005676|NCT01808573|588721881|FG000|Overall Study|Discontinuation of study by sponsor|79|||
163005677|NCT01808573|588721882|FG001|Overall Study|Discontinuation of study by sponsor|64|||
163005678|NCT01808573|588721881|FG000|Overall Study|Randomized in Error|1|||
163326058|NCT01074294|589905427|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
163005679|NCT01808573|588721882|FG001|Overall Study|Randomized in Error|0|||
163005680|NCT01523002|588721885|FG000|Period 1|Withdrawal by Subject|1|||
163005681|NCT01523002|588721886|FG001|Period 1|Withdrawal by Subject|3|||
163005682|NCT01523002|588721885|FG000|Period 1|Lost to Follow-up|1|||
163005683|NCT01523002|588721886|FG001|Period 1|Lost to Follow-up|0|||
163005684|NCT01523002|588721885|FG000|Period 1|Adverse Event|0|||
163005685|NCT01523002|588721886|FG001|Period 1|Adverse Event|8|||
163005686|NCT01523002|588721885|FG000|Period 2|Withdrawal by Subject|4|||
163005687|NCT01523002|588721886|FG001|Period 2|Withdrawal by Subject|1|||
163005688|NCT01523002|588721885|FG000|Period 2|Adverse Event|2|||
163005689|NCT01523002|588721886|FG001|Period 2|Adverse Event|5|||
163005690|NCT01523002|588721885|FG000|Period 3|Withdrawal by Subject|1|||
163005691|NCT01523002|588721886|FG001|Period 3|Withdrawal by Subject|0|||
163005692|NCT01523002|588721885|FG000|Period 3|Adverse Event|3|||
163005693|NCT01523002|588721886|FG001|Period 3|Adverse Event|0|||
163005694|NCT01256502|588721887|FG000|Overall Study|Had scaffold removed|4|||
163005695|NCT01256502|588721887|FG000|Overall Study|Personal reasons|5|||
163005696|NCT01256502|588721887|FG000|Overall Study|Protocol deviation|1|||
163005697|NCT00489255|588721888|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
163326059|NCT01074294|589905428|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
163326060|NCT01074294|589905429|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
163326061|NCT01074294|589905430|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
163326062|NCT01074294|589905427|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
163005698|NCT00489255|588721889|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
163005699|NCT00489255|588721888|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
163005700|NCT00489255|588721889|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
163005701|NCT00489255|588721888|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
163005702|NCT00489255|588721889|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
163005703|NCT00489255|588721888|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
163005704|NCT00489255|588721889|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
163005705|NCT00489255|588721888|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
163005706|NCT00489255|588721889|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
163005707|NCT00489255|588721888|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
163005708|NCT00489255|588721889|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
163005709|NCT00489255|588721888|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
163005710|NCT00489255|588721889|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
163005711|NCT00489255|588721888|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
163005712|NCT00489255|588721889|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
163005713|NCT00489255|588721888|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
163005714|NCT00489255|588721889|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
163005715|NCT00489255|588721888|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
163005716|NCT00489255|588721889|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
163005717|NCT03953612|588721890|FG000|Overall Study|Randomized but did not start|1|||
163005718|NCT03953612|588721891|FG001|Overall Study|Randomized but did not start|1|||
163005719|NCT03953612|588721892|FG002|Overall Study|Randomized but did not start|1|||
163005720|NCT03953612|588721890|FG000|Overall Study|Withdrawal by Subject|2|||
163005721|NCT03953612|588721891|FG001|Overall Study|Withdrawal by Subject|1|||
163005722|NCT03953612|588721892|FG002|Overall Study|Withdrawal by Subject|0|||
163005723|NCT03485352|588721893|FG000|Overall Study|Lost to Follow-up|9|||
163005724|NCT00852202|588721904|FG000|Overall Study|Adverse Event|2|||
163005725|NCT00852202|588721905|FG001|Overall Study|Adverse Event|3|||
163005726|NCT00852202|588721906|FG002|Overall Study|Adverse Event|7|||
163005727|NCT00852202|588721904|FG000|Overall Study|Lack of Efficacy|4|||
163005728|NCT00852202|588721905|FG001|Overall Study|Lack of Efficacy|1|||
163005729|NCT00852202|588721906|FG002|Overall Study|Lack of Efficacy|2|||
163005730|NCT00852202|588721904|FG000|Overall Study|Protocol Violation|2|||
163005731|NCT00852202|588721905|FG001|Overall Study|Protocol Violation|2|||
163005732|NCT00852202|588721906|FG002|Overall Study|Protocol Violation|7|||
163005733|NCT00852202|588721904|FG000|Overall Study|Withdrawal by Subject|3|||
163005734|NCT00852202|588721905|FG001|Overall Study|Withdrawal by Subject|1|||
163005735|NCT00852202|588721906|FG002|Overall Study|Withdrawal by Subject|2|||
163005736|NCT00852202|588721904|FG000|Overall Study|Lost to Follow-up|5|||
163005737|NCT00852202|588721905|FG001|Overall Study|Lost to Follow-up|5|||
163005738|NCT00852202|588721906|FG002|Overall Study|Lost to Follow-up|6|||
163005739|NCT00852202|588721904|FG000|Overall Study|pregnancy,moving away and surgery|1|||
163005740|NCT00852202|588721905|FG001|Overall Study|pregnancy,moving away and surgery|0|||
163005741|NCT00852202|588721906|FG002|Overall Study|pregnancy,moving away and surgery|2|||
163005742|NCT02552121|588721909|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
163005743|NCT02552121|588721910|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
163005744|NCT02552121|588721911|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
163005745|NCT02552121|588721912|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
163005746|NCT02552121|588721913|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
163005747|NCT02552121|588721914|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
163005748|NCT02552121|588721915|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
163005749|NCT02552121|588721916|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
163005750|NCT02552121|588721909|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
163005751|NCT02552121|588721910|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
163005752|NCT02552121|588721911|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
163005753|NCT02552121|588721912|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
163005754|NCT02552121|588721913|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
163005755|NCT02552121|588721914|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
163005756|NCT02552121|588721915|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
163005757|NCT02552121|588721916|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
163005758|NCT02552121|588721909|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
163005759|NCT02552121|588721910|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
163005760|NCT02552121|588721911|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
163005761|NCT02552121|588721912|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
163005762|NCT02552121|588721913|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
163005763|NCT02552121|588721914|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
163005764|NCT02552121|588721915|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
163005765|NCT02552121|588721916|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
163005766|NCT02552121|588721909|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
163005767|NCT02552121|588721910|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
163061264|NCT01126424|588933062|FG003|Overall Study|Withdrawal by Subject|3|||
163061265|NCT01126424|588933063|FG004|Overall Study|Withdrawal by Subject|1|||
163061266|NCT01126424|588933064|FG005|Overall Study|Withdrawal by Subject|0|||
163061267|NCT02127671|588933065|FG000|Overall Study|Death|2|||
163061268|NCT02127671|588933066|FG001|Overall Study|Death|2|||
163061269|NCT02127671|588933065|FG000|Overall Study|Lost to Follow-up|4|||
163061270|NCT02127671|588933066|FG001|Overall Study|Lost to Follow-up|2|||
163061271|NCT02127671|588933065|FG000|Overall Study|Physician Decision|1|||
163061272|NCT02127671|588933066|FG001|Overall Study|Physician Decision|0|||
163061273|NCT02127671|588933065|FG000|Overall Study|incarceration|0|||
163061274|NCT02127671|588933066|FG001|Overall Study|incarceration|1|||
163061275|NCT02127671|588933065|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
163061276|NCT02127671|588933066|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
163061277|NCT02394275|588933067|FG000|Overall Study|Adverse Event|22|||
163061278|NCT02394275|588933067|FG000|Overall Study|Lost to Follow-up|7|||
163061279|NCT00782067|588933068|FG000|Overall Study|Adverse Event|35|||
163061280|NCT00782067|588933068|FG000|Overall Study|Subject withdrew consent|11|||
163061281|NCT00782067|588933068|FG000|Overall Study|Lost to Follow-up|2|||
163061282|NCT00782067|588933068|FG000|Overall Study|Administrative problems|14|||
163061283|NCT00782067|588933068|FG000|Overall Study|Death|9|||
163061284|NCT00782067|588933068|FG000|Overall Study|Disease progression|43|||
163061285|NCT00782067|588933068|FG000|Overall Study|Protocol deviation|2|||
163061286|NCT02471183|588933069|FG000|Main Treatment Period|Adverse Event|1|||
163061287|NCT02471183|588933069|FG000|Main Treatment Period|Withdrawal by Subject|1|||
163061288|NCT02471183|588933069|FG000|Extended Treatment Period|Lack of Efficacy|1|||
163061289|NCT00614393|588933071|FG000|Overall Study|Adverse Event|20|||
163061290|NCT00614393|588933072|FG001|Overall Study|Adverse Event|2|||
163061291|NCT00614393|588933073|FG002|Overall Study|Adverse Event|3|||
163061292|NCT00614393|588933074|FG003|Overall Study|Adverse Event|13|||
163061293|NCT00614393|588933075|FG004|Overall Study|Adverse Event|21|||
163061294|NCT00614393|588933071|FG000|Overall Study|Lost to Follow-up|0|||
163061295|NCT00614393|588933072|FG001|Overall Study|Lost to Follow-up|0|||
163404463|NCT03246958|590191938|FG004|Overall Study|Never start treatment|0|||
163005768|NCT02552121|588721911|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
163005769|NCT02552121|588721912|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
163005770|NCT02552121|588721913|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
163005771|NCT02552121|588721914|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
163005772|NCT02552121|588721915|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
163061296|NCT00614393|588933073|FG002|Overall Study|Lost to Follow-up|0|||
163061297|NCT00614393|588933074|FG003|Overall Study|Lost to Follow-up|1|||
163061298|NCT00614393|588933075|FG004|Overall Study|Lost to Follow-up|2|||
163326063|NCT01074294|589905428|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
163326064|NCT01074294|589905429|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
163326065|NCT01074294|589905430|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
163326066|NCT01074294|589905427|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
163326067|NCT01074294|589905428|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
163326068|NCT01074294|589905429|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
163326069|NCT01074294|589905430|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
163326070|NCT01074294|589905427|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
163326071|NCT01074294|589905428|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
163326072|NCT01074294|589905429|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
163326073|NCT01074294|589905430|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
163326074|NCT01074294|589905427|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
163326075|NCT01074294|589905428|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
163326076|NCT01074294|589905429|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
163326077|NCT01074294|589905430|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
163326078|NCT01074294|589905427|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
163326079|NCT01074294|589905428|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
163326080|NCT01074294|589905429|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
163326081|NCT01074294|589905430|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
163326082|NCT01074294|589905427|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
163326083|NCT01074294|589905428|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
163326084|NCT01074294|589905429|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
163326085|NCT01074294|589905430|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
163326086|NCT01074294|589905427|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
163326087|NCT01074294|589905428|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
163326088|NCT01074294|589905429|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
163326089|NCT01074294|589905430|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
163326090|NCT01074294|589905427|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
163326091|NCT01074294|589905428|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
163326092|NCT01074294|589905429|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
163326093|NCT01074294|589905430|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
163326094|NCT01074294|589905427|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
163326095|NCT01074294|589905428|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
163326096|NCT01074294|589905429|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
163326097|NCT01074294|589905430|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
163326098|NCT01074294|589905427|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
163326099|NCT01074294|589905428|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
163326100|NCT01074294|589905429|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
163326101|NCT01074294|589905430|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
163326102|NCT01074294|589905427|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
163326103|NCT01074294|589905428|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
163005773|NCT02552121|588721916|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
163005774|NCT02552121|588721909|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
163005775|NCT02552121|588721910|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
163005776|NCT02552121|588721911|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
163005777|NCT02552121|588721912|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
163005778|NCT02552121|588721913|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
163005779|NCT02552121|588721914|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
163005780|NCT02552121|588721915|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
163005781|NCT02552121|588721916|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
163005782|NCT02552121|588721909|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
163005783|NCT02552121|588721910|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
163005784|NCT02552121|588721911|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
163005785|NCT02552121|588721912|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
163005786|NCT02552121|588721913|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
163005787|NCT02552121|588721914|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
163326104|NCT01074294|589905429|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
163005788|NCT02552121|588721915|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
163005789|NCT02552121|588721916|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
163005790|NCT02552121|588721909|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
163005791|NCT02552121|588721910|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
163005792|NCT02552121|588721911|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
163326105|NCT01074294|589905430|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
163326106|NCT01500200|589905431|FG000|Stage 1|Adverse Event|1|||
163005793|NCT02552121|588721912|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
163005794|NCT02552121|588721913|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
163005795|NCT02552121|588721914|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
163326107|NCT01500200|589905432|FG001|Stage 1|Adverse Event|4|||
163326108|NCT01500200|589905433|FG002|Stage 1|Adverse Event|5|||
163326109|NCT01500200|589905434|FG003|Stage 1|Adverse Event|0|||
163005796|NCT02552121|588721915|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
163005797|NCT02552121|588721916|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
163005798|NCT02552121|588721909|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
163005799|NCT02552121|588721910|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
163005800|NCT02552121|588721911|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
163005801|NCT02552121|588721912|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
163005802|NCT02552121|588721913|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
163005803|NCT02552121|588721914|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
163005804|NCT02552121|588721915|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
163005805|NCT02552121|588721916|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
163005806|NCT02552121|588721909|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
163005807|NCT02552121|588721910|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
163005808|NCT02552121|588721911|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
163005809|NCT02552121|588721912|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
163005810|NCT02552121|588721913|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
163005811|NCT02552121|588721914|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
163005812|NCT02552121|588721915|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
163005813|NCT02552121|588721916|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
163005814|NCT02552121|588721909|FG000|Part 2: Cohort Expansion|Death|0|||
163005815|NCT02552121|588721910|FG001|Part 2: Cohort Expansion|Death|0|||
163005816|NCT02552121|588721911|FG002|Part 2: Cohort Expansion|Death|1|||
163005817|NCT02552121|588721912|FG003|Part 2: Cohort Expansion|Death|0|||
163005818|NCT02552121|588721913|FG004|Part 2: Cohort Expansion|Death|0|||
163005819|NCT02552121|588721914|FG005|Part 2: Cohort Expansion|Death|0|||
163326110|NCT01500200|589905435|FG004|Stage 1|Adverse Event|0|||
163326111|NCT01500200|589905436|FG005|Stage 1|Adverse Event|0|||
163326112|NCT01500200|589905431|FG000|Stage 1|Lost to Follow-up|2|||
163326113|NCT01500200|589905432|FG001|Stage 1|Lost to Follow-up|2|||
163326114|NCT01500200|589905433|FG002|Stage 1|Lost to Follow-up|1|||
163005820|NCT02552121|588721915|FG006|Part 2: Cohort Expansion|Death|0|||
163005821|NCT02552121|588721916|FG007|Part 2: Cohort Expansion|Death|0|||
163005822|NCT03629184|588721917|FG000|Overall Study|Withdrawal by Subject|2|||
163005823|NCT03629184|588721918|FG001|Overall Study|Withdrawal by Subject|1|||
163005824|NCT03629184|588721917|FG000|Overall Study|Physician Decision|1|||
163005825|NCT03629184|588721918|FG001|Overall Study|Physician Decision|0|||
163005826|NCT01982955|588721920|FG000|Overall Study|Randomized but not treated|0|||
163005827|NCT01982955|588721921|FG001|Overall Study|Randomized but not treated|0|||
163005828|NCT01982955|588721922|FG002|Overall Study|Randomized but not treated|0|||
163005829|NCT01982955|588721923|FG003|Overall Study|Randomized but not treated|1|||
163005830|NCT01982955|588721924|FG004|Overall Study|Randomized but not treated|0|||
163005831|NCT02548143|588721926|FG000|Overall Study|Adverse Event|1|||
163005832|NCT02548143|588721927|FG001|Overall Study|Adverse Event|0|||
163005833|NCT02548143|588721926|FG000|Overall Study|Withdrawal by Subject|0|||
163005834|NCT02548143|588721927|FG001|Overall Study|Withdrawal by Subject|1|||
163005835|NCT04179838|588723172|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
163005836|NCT04179838|588723173|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
163005837|NCT04179838|588723172|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
163061299|NCT00614393|588933071|FG000|Overall Study|Physician Decision|17|||
163326115|NCT01500200|589905434|FG003|Stage 1|Lost to Follow-up|0|||
163326116|NCT01500200|589905435|FG004|Stage 1|Lost to Follow-up|0|||
163326117|NCT01500200|589905436|FG005|Stage 1|Lost to Follow-up|0|||
163326118|NCT01500200|589905431|FG000|Stage 1|Withdrawal by Subject|3|||
163326119|NCT01500200|589905432|FG001|Stage 1|Withdrawal by Subject|0|||
163005838|NCT04179838|588723173|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
163005839|NCT02763046|588723174|FG000|Overall Study|Adverse Event|5|||
163005840|NCT02763046|588723175|FG001|Overall Study|Adverse Event|4|||
163005841|NCT02763046|588723176|FG002|Overall Study|Adverse Event|0|||
163005842|NCT02763046|588723174|FG000|Overall Study|Lack of Efficacy|1|||
163326120|NCT01500200|589905433|FG002|Stage 1|Withdrawal by Subject|0|||
163326121|NCT01500200|589905434|FG003|Stage 1|Withdrawal by Subject|0|||
163326122|NCT01500200|589905435|FG004|Stage 1|Withdrawal by Subject|0|||
163326123|NCT01500200|589905436|FG005|Stage 1|Withdrawal by Subject|0|||
163005843|NCT02763046|588723175|FG001|Overall Study|Lack of Efficacy|1|||
163005844|NCT02763046|588723176|FG002|Overall Study|Lack of Efficacy|3|||
163005845|NCT02763046|588723174|FG000|Overall Study|Physician Decision|1|||
163005846|NCT02763046|588723175|FG001|Overall Study|Physician Decision|0|||
163005847|NCT02763046|588723176|FG002|Overall Study|Physician Decision|1|||
163005848|NCT02763046|588723174|FG000|Overall Study|Subject/guardian decision|2|||
163005849|NCT02763046|588723175|FG001|Overall Study|Subject/guardian decision|0|||
163005850|NCT02763046|588723176|FG002|Overall Study|Subject/guardian decision|4|||
163005851|NCT00818766|588723181|FG000|Overall Study|Could not be Contacted on Day 28|11|||
163061300|NCT00614393|588933072|FG001|Overall Study|Physician Decision|0|||
163326124|NCT01500200|589905431|FG000|Stage 1|Noncompliance with Study Drug|1|||
163005852|NCT00818766|588723182|FG001|Overall Study|Could not be Contacted on Day 28|10|||
163005853|NCT00818766|588723181|FG000|Overall Study|Death|1|||
163005854|NCT00818766|588723182|FG001|Overall Study|Death|0|||
163005855|NCT00818766|588723181|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
163005856|NCT00818766|588723182|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
163005857|NCT00086684|588723183|FG000|Overall Study|Adverse Event|12|||
163005858|NCT00086684|588723184|FG001|Overall Study|Adverse Event|17|||
163005859|NCT00086684|588723185|FG002|Overall Study|Adverse Event|14|||
163005860|NCT00086684|588723183|FG000|Overall Study|Lack of Efficacy|6|||
163005861|NCT00086684|588723184|FG001|Overall Study|Lack of Efficacy|6|||
163005862|NCT00086684|588723185|FG002|Overall Study|Lack of Efficacy|5|||
163005863|NCT00086684|588723183|FG000|Overall Study|Lost to Follow-up|15|||
163005864|NCT00086684|588723184|FG001|Overall Study|Lost to Follow-up|8|||
163005865|NCT00086684|588723185|FG002|Overall Study|Lost to Follow-up|10|||
163005866|NCT00086684|588723183|FG000|Overall Study|Protocol Violation|8|||
163005867|NCT00086684|588723184|FG001|Overall Study|Protocol Violation|3|||
163005868|NCT00086684|588723185|FG002|Overall Study|Protocol Violation|0|||
163005869|NCT00086684|588723183|FG000|Overall Study|Withdrawal by Subject|0|||
163005870|NCT00086684|588723184|FG001|Overall Study|Withdrawal by Subject|4|||
163005871|NCT00086684|588723185|FG002|Overall Study|Withdrawal by Subject|10|||
163005872|NCT00086684|588723183|FG000|Overall Study|NONCOMPLIANCE|5|||
163005873|NCT00086684|588723184|FG001|Overall Study|NONCOMPLIANCE|7|||
163005874|NCT00086684|588723185|FG002|Overall Study|NONCOMPLIANCE|6|||
163005875|NCT00086684|588723183|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
163005876|NCT00086684|588723184|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
163005877|NCT00086684|588723185|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
163005878|NCT00086684|588723183|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
163005879|NCT00086684|588723184|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
163005880|NCT00086684|588723185|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
163005881|NCT00086684|588723183|FG000|Overall Study|Other|4|||
163005882|NCT00086684|588723184|FG001|Overall Study|Other|2|||
163005883|NCT00086684|588723185|FG002|Overall Study|Other|3|||
163005884|NCT01103180|588723188|FG000|Overall Study|Withdrawal by Subject|8|||
163005885|NCT01103180|588723189|FG001|Overall Study|Withdrawal by Subject|13|||
163005886|NCT01103180|588723188|FG000|Overall Study|Lost to Follow-up|13|||
163005887|NCT01103180|588723189|FG001|Overall Study|Lost to Follow-up|7|||
163005888|NCT01103180|588723188|FG000|Overall Study|Physician Decision|1|||
163005889|NCT01103180|588723189|FG001|Overall Study|Physician Decision|0|||
163005890|NCT01103180|588723188|FG000|Overall Study|Protocol Violation|0|||
163005891|NCT01103180|588723189|FG001|Overall Study|Protocol Violation|1|||
163005892|NCT01173523|588723190|FG000|Overall Study|Clinical Progression|1|||
163005893|NCT01173523|588723191|FG001|Overall Study|Clinical Progression|1|||
163005894|NCT01173523|588723190|FG000|Overall Study|Progressive Disease|10|||
163005895|NCT01173523|588723191|FG001|Overall Study|Progressive Disease|8|||
163005896|NCT01173523|588723190|FG000|Overall Study|Other|2|||
163005897|NCT01173523|588723191|FG001|Overall Study|Other|3|||
163005898|NCT01067105|588723192|FG000|Overall Study|Adverse Event|14|||
163005899|NCT01067105|588723192|FG000|Overall Study|Protocol Violation|48|||
163005900|NCT01067105|588723192|FG000|Overall Study|Withdrawal by Subject|36|||
163005901|NCT01067105|588723192|FG000|Overall Study|Lost to Follow-up|6|||
163005902|NCT01067105|588723192|FG000|Overall Study|Physician Decision|6|||
163005903|NCT01067105|588723192|FG000|Overall Study|Other|31|||
163005904|NCT00853099|588723193|FG000|Double-blind Period|Adverse Event|7|||
163005905|NCT00853099|588723194|FG001|Double-blind Period|Adverse Event|9|||
163005906|NCT00853099|588723195|FG002|Double-blind Period|Adverse Event|13|||
163005907|NCT00853099|588723196|FG003|Double-blind Period|Adverse Event|0|||
163005908|NCT00853099|588723193|FG000|Double-blind Period|Withdrawal by Subject|2|||
163213511|NCT02659631|589495997|FG004|Overall Study|Death (follow-up phase)|3|||
163213512|NCT02659631|589495998|FG005|Overall Study|Death (follow-up phase)|2|||
163213513|NCT02659631|589495999|FG006|Overall Study|Death (follow-up phase)|0|||
163213514|NCT02659631|589496000|FG007|Overall Study|Death (follow-up phase)|3|||
163213515|NCT02659631|589496001|FG008|Overall Study|Death (follow-up phase)|1|||
163005909|NCT00853099|588723194|FG001|Double-blind Period|Withdrawal by Subject|3|||
163213516|NCT02659631|589496002|FG009|Overall Study|Death (follow-up phase)|0|||
163213517|NCT02659631|589495993|FG000|Overall Study|Death (treatment phase)|0|||
163213518|NCT02659631|589495994|FG001|Overall Study|Death (treatment phase)|0|||
163005910|NCT00853099|588723195|FG002|Double-blind Period|Withdrawal by Subject|0|||
163005911|NCT00853099|588723196|FG003|Double-blind Period|Withdrawal by Subject|0|||
163005912|NCT00853099|588723193|FG000|Double-blind Period|Lack of Efficacy|14|||
163005913|NCT00853099|588723194|FG001|Double-blind Period|Lack of Efficacy|17|||
163005914|NCT00853099|588723195|FG002|Double-blind Period|Lack of Efficacy|16|||
163005915|NCT00853099|588723196|FG003|Double-blind Period|Lack of Efficacy|0|||
163005916|NCT00853099|588723193|FG000|Double-blind Period|Other|0|||
163005917|NCT00853099|588723194|FG001|Double-blind Period|Other|0|||
163005918|NCT00853099|588723195|FG002|Double-blind Period|Other|1|||
163005919|NCT00853099|588723196|FG003|Double-blind Period|Other|0|||
163005920|NCT00853099|588723193|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
163005921|NCT00853099|588723194|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
163061301|NCT00614393|588933073|FG002|Overall Study|Physician Decision|1|||
163005922|NCT00853099|588723195|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
163005923|NCT00853099|588723196|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
163005924|NCT00853099|588723193|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
163005925|NCT00853099|588723194|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
163005926|NCT00853099|588723195|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
163005927|NCT00853099|588723196|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
163005928|NCT00853099|588723193|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
163005929|NCT00853099|588723194|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
163005930|NCT00853099|588723195|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
163005931|NCT00853099|588723196|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
163005932|NCT00853099|588723193|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
163005933|NCT00853099|588723194|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
163005934|NCT00853099|588723195|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
163005935|NCT00853099|588723196|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
163005936|NCT00853099|588723193|FG000|Double-blind + Open-label Periods|Other|0|||
163005937|NCT00853099|588723194|FG001|Double-blind + Open-label Periods|Other|0|||
163005938|NCT00853099|588723195|FG002|Double-blind + Open-label Periods|Other|0|||
163005939|NCT00853099|588723196|FG003|Double-blind + Open-label Periods|Other|6|||
163005940|NCT02439216|588723200|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
163005941|NCT02439216|588723201|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005942|NCT02439216|588723202|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005943|NCT02439216|588723203|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005944|NCT02439216|588723204|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005945|NCT02439216|588723205|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005946|NCT02439216|588723206|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005947|NCT02439216|588723207|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005948|NCT02439216|588723208|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005949|NCT02439216|588723200|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005950|NCT02439216|588723201|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005951|NCT02439216|588723202|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005952|NCT02439216|588723203|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005953|NCT02439216|588723204|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005954|NCT02439216|588723205|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005955|NCT02439216|588723206|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005956|NCT02439216|588723207|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
163005957|NCT02439216|588723208|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005958|NCT02439216|588723200|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
163005959|NCT02439216|588723201|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
163005960|NCT02439216|588723202|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
163005961|NCT02439216|588723203|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
163005962|NCT02439216|588723204|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
163005963|NCT02439216|588723205|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
163005964|NCT02439216|588723206|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
163005965|NCT02439216|588723207|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
163005966|NCT02439216|588723208|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
163005967|NCT02439216|588723200|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005968|NCT02439216|588723201|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005969|NCT02439216|588723202|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005970|NCT02439216|588723203|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005971|NCT02439216|588723204|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005972|NCT02439216|588723205|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005973|NCT02439216|588723206|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005974|NCT02439216|588723207|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005975|NCT02439216|588723208|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
163005976|NCT02439216|588723200|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
163005977|NCT02439216|588723201|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
163005978|NCT02439216|588723202|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
163005979|NCT02439216|588723203|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
163005980|NCT02439216|588723204|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
163061302|NCT00614393|588933074|FG003|Overall Study|Physician Decision|8|||
163061303|NCT00614393|588933075|FG004|Overall Study|Physician Decision|9|||
163061304|NCT00614393|588933071|FG000|Overall Study|Progressive Disease|118|||
163061305|NCT00614393|588933072|FG001|Overall Study|Progressive Disease|5|||
163213519|NCT02659631|589495995|FG002|Overall Study|Death (treatment phase)|0|||
163213520|NCT02659631|589495996|FG003|Overall Study|Death (treatment phase)|0|||
163213521|NCT02659631|589495997|FG004|Overall Study|Death (treatment phase)|1|||
163005981|NCT02439216|588723205|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
163005982|NCT02439216|588723206|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
163005983|NCT02439216|588723207|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
163005984|NCT02439216|588723208|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
163005985|NCT00470535|588723212|FG000|Overall Study|Disease Progression|13|||
163005986|NCT00470535|588723212|FG000|Overall Study|Withdrawal by Subject|1|||
163005987|NCT00470535|588723212|FG000|Overall Study|Adverse Event|1|||
163005988|NCT00470535|588723212|FG000|Overall Study|Death|1|||
163005989|NCT00470535|588723212|FG000|Overall Study|Other|2|||
163005990|NCT00725491|588723219|FG000|Overall Study|Adverse Event|3|||
163005991|NCT00725491|588723220|FG001|Overall Study|Adverse Event|2|||
163005992|NCT00725491|588723219|FG000|Overall Study|Pregnancy|0|||
163005993|NCT00725491|588723220|FG001|Overall Study|Pregnancy|3|||
163005994|NCT00725491|588723219|FG000|Overall Study|Risk for hyperstimulation|2|||
163005995|NCT00725491|588723220|FG001|Overall Study|Risk for hyperstimulation|9|||
163005996|NCT00725491|588723219|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
163005997|NCT00725491|588723220|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
163005998|NCT00725491|588723219|FG000|Overall Study|Fertilization failure|0|||
163005999|NCT00725491|588723220|FG001|Overall Study|Fertilization failure|1|||
163006000|NCT00725491|588723219|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
163006001|NCT00725491|588723220|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
163006002|NCT00942357|588723223|FG000|Overall Study|Ineligible|37|||
163006003|NCT00942357|588723224|FG001|Overall Study|Ineligible|40|||
163006004|NCT01998919|588723225|FG000|Overall Study|Death|2|||
163006005|NCT01998919|588723226|FG001|Overall Study|Death|2|||
163006006|NCT01998919|588723225|FG000|Overall Study|Adverse Event|0|||
163006007|NCT01998919|588723226|FG001|Overall Study|Adverse Event|5|||
163006008|NCT01998919|588723225|FG000|Overall Study|Disease progression|31|||
163006009|NCT01998919|588723226|FG001|Overall Study|Disease progression|22|||
163006010|NCT01998919|588723225|FG000|Overall Study|Withdrawal by Subject|2|||
163006011|NCT01998919|588723226|FG001|Overall Study|Withdrawal by Subject|4|||
163006012|NCT01998919|588723225|FG000|Overall Study|Lost to Follow-up|2|||
163006013|NCT01998919|588723226|FG001|Overall Study|Lost to Follow-up|0|||
163006014|NCT01998919|588723225|FG000|Overall Study|Other|5|||
163006015|NCT01998919|588723226|FG001|Overall Study|Other|2|||
163006016|NCT00897715|588723227|FG000|Overall Study|Lost to Follow-up|0|||
163006017|NCT00897715|588723228|FG001|Overall Study|Lost to Follow-up|1|||
163006018|NCT00897715|588723227|FG000|Overall Study|Physician Decision|1|||
163006019|NCT00897715|588723228|FG001|Overall Study|Physician Decision|0|||
163006020|NCT00897715|588723227|FG000|Overall Study|increased risk of infection|1|||
163006021|NCT00897715|588723228|FG001|Overall Study|increased risk of infection|0|||
163006022|NCT00927589|588723230|FG000|Overall Study|Death|1|||
163006023|NCT00927589|588723230|FG000|Overall Study|Physician Decision|1|||
163006024|NCT00927589|588723230|FG000|Overall Study|Withdrawal by Subject|3|||
163006025|NCT00927589|588723230|FG000|Overall Study|Adverse Event|2|||
163006026|NCT00927589|588723230|FG000|Overall Study|Disease Progression|8|||
163006027|NCT00927589|588723230|FG000|Overall Study|Non-compliance|1|||
163006028|NCT01641640|588723231|FG000|Overall Study|Enrolled but not treated|1|||
163006029|NCT01641640|588723231|FG000|Overall Study|Efficacy failure|29|||
163006030|NCT01641640|588723231|FG000|Overall Study|Lost to Follow-up|3|||
163006031|NCT01641640|588723231|FG000|Overall Study|Withdrawal by Subject|2|||
163006032|NCT01641640|588723231|FG000|Overall Study|Adverse Event|1|||
163006033|NCT01778530|588723233|FG000|Overall Study|Progression on study|1|||
163006034|NCT01778530|588723233|FG000|Overall Study|Adverse event/side effect|1|||
163326125|NCT01500200|589905432|FG001|Stage 1|Noncompliance with Study Drug|0|||
163326126|NCT01500200|589905433|FG002|Stage 1|Noncompliance with Study Drug|0|||
163326127|NCT01500200|589905434|FG003|Stage 1|Noncompliance with Study Drug|0|||
163326128|NCT01500200|589905435|FG004|Stage 1|Noncompliance with Study Drug|0|||
163326129|NCT01500200|589905436|FG005|Stage 1|Noncompliance with Study Drug|0|||
163326130|NCT01500200|589905431|FG000|Stage 1|Physician Decision|1|||
163326131|NCT01500200|589905432|FG001|Stage 1|Physician Decision|0|||
163326132|NCT01500200|589905433|FG002|Stage 1|Physician Decision|0|||
163326133|NCT01500200|589905434|FG003|Stage 1|Physician Decision|0|||
163326134|NCT01500200|589905435|FG004|Stage 1|Physician Decision|0|||
163326135|NCT01500200|589905436|FG005|Stage 1|Physician Decision|0|||
163326136|NCT01500200|589905431|FG000|Stage 2|Adverse Event|0|||
163006035|NCT01199939|588723236|FG000|Overall Study|Adverse Event|4|||
163006036|NCT01199939|588723236|FG000|Overall Study|Protocol Violation|3|||
163006037|NCT01199939|588723236|FG000|Overall Study|Lost to Follow-up|2|||
163006038|NCT01199939|588723236|FG000|Overall Study|Reached a virologic endpoint|4|||
163006039|NCT02792517|588723244|FG000|Overall Study|Withdrawal by Subject|10|||
163006040|NCT02792517|588723244|FG000|Overall Study|Decision by Sponsor|7|||
163006041|NCT02792517|588723244|FG000|Overall Study|Lost to Follow-up|3|||
163006042|NCT00882518|588723245|FG000|Overall Study|Adverse Event|9|||
163061306|NCT00614393|588933073|FG002|Overall Study|Progressive Disease|5|||
163006043|NCT00882518|588723246|FG001|Overall Study|Adverse Event|18|||
163006044|NCT00882518|588723245|FG000|Overall Study|Withdrawal by Subject|9|||
163006045|NCT00882518|588723246|FG001|Overall Study|Withdrawal by Subject|13|||
163006046|NCT00882518|588723245|FG000|Overall Study|Lack of Efficacy|12|||
163006047|NCT00882518|588723246|FG001|Overall Study|Lack of Efficacy|9|||
163006048|NCT00882518|588723245|FG000|Overall Study|Severe non-compliance to protocol|3|||
163006049|NCT00882518|588723246|FG001|Overall Study|Severe non-compliance to protocol|1|||
163006050|NCT00882518|588723245|FG000|Overall Study|Incorrect enrolment|4|||
163006051|NCT00882518|588723246|FG001|Overall Study|Incorrect enrolment|2|||
163006052|NCT00882518|588723245|FG000|Overall Study|Central lab closure for National day|1|||
163006053|NCT00882518|588723246|FG001|Overall Study|Central lab closure for National day|0|||
163006054|NCT00882518|588723245|FG000|Overall Study|Allocating random number by mistake|0|||
163006055|NCT00882518|588723246|FG001|Overall Study|Allocating random number by mistake|1|||
163006056|NCT03238651|588723247|FG000|Overall Study|Other|0|||
163006057|NCT03238651|588723248|FG001|Overall Study|Other|0|||
163006058|NCT03238651|588723249|FG002|Overall Study|Other|0|||
163006059|NCT03238651|588723250|FG003|Overall Study|Other|0|||
163006060|NCT03238651|588723251|FG004|Overall Study|Other|1|||
163006061|NCT03238651|588723247|FG000|Overall Study|Progressive Disease|2|||
163006062|NCT03238651|588723248|FG001|Overall Study|Progressive Disease|2|||
163006063|NCT03238651|588723249|FG002|Overall Study|Progressive Disease|2|||
163006064|NCT03238651|588723250|FG003|Overall Study|Progressive Disease|2|||
163006065|NCT03238651|588723251|FG004|Overall Study|Progressive Disease|0|||
163006066|NCT03238651|588723247|FG000|Overall Study|Withdrawal by Subject|0|||
163006067|NCT03238651|588723248|FG001|Overall Study|Withdrawal by Subject|1|||
163006068|NCT03238651|588723249|FG002|Overall Study|Withdrawal by Subject|0|||
163006069|NCT03238651|588723250|FG003|Overall Study|Withdrawal by Subject|1|||
163006070|NCT03238651|588723251|FG004|Overall Study|Withdrawal by Subject|0|||
163006071|NCT03238651|588723247|FG000|Overall Study|Adverse Event|1|||
163006072|NCT03238651|588723248|FG001|Overall Study|Adverse Event|3|||
163006073|NCT03238651|588723249|FG002|Overall Study|Adverse Event|2|||
163006074|NCT03238651|588723250|FG003|Overall Study|Adverse Event|0|||
163006075|NCT03238651|588723251|FG004|Overall Study|Adverse Event|0|||
163006076|NCT03875508|588723252|FG000|Overall Study|Adverse Event|1|||
163213522|NCT02659631|589495998|FG005|Overall Study|Death (treatment phase)|0|||
163213523|NCT02659631|589495999|FG006|Overall Study|Death (treatment phase)|1|||
163213524|NCT02659631|589496000|FG007|Overall Study|Death (treatment phase)|0|||
163213525|NCT02659631|589496001|FG008|Overall Study|Death (treatment phase)|0|||
163213526|NCT02659631|589496002|FG009|Overall Study|Death (treatment phase)|0|||
163213527|NCT05407675|589496003|FG000|Overall Study|Withdrawal by Subject|0|||
163213528|NCT05407675|589496004|FG001|Overall Study|Withdrawal by Subject|2|||
163213529|NCT05407675|589496005|FG002|Overall Study|Withdrawal by Subject|3|||
163213530|NCT05407675|589496006|FG003|Overall Study|Withdrawal by Subject|5|||
163213531|NCT05407675|589496007|FG004|Overall Study|Withdrawal by Subject|0|||
163213532|NCT05407675|589496008|FG005|Overall Study|Withdrawal by Subject|2|||
163213533|NCT05407675|589496009|FG006|Overall Study|Withdrawal by Subject|0|||
163213534|NCT05407675|589496010|FG007|Overall Study|Withdrawal by Subject|0|||
163213535|NCT05407675|589496011|FG008|Overall Study|Withdrawal by Subject|2|||
163213536|NCT05407675|589496012|FG009|Overall Study|Withdrawal by Subject|0|||
163213537|NCT05407675|589496013|FG010|Overall Study|Withdrawal by Subject|1|||
163213538|NCT05407675|589496014|FG011|Overall Study|Withdrawal by Subject|0|||
163213539|NCT05407675|589496015|FG012|Overall Study|Withdrawal by Subject|0|||
163404464|NCT03246958|590191939|FG005|Overall Study|Never start treatment|0|||
163006077|NCT03875508|588723252|FG000|Overall Study|Lost to Follow-up|8|||
163006078|NCT03875508|588723252|FG000|Overall Study|Lack of Efficacy|1|||
163006079|NCT03875508|588723252|FG000|Overall Study|Other, not specified|2|||
163006080|NCT00711087|588723253|FG000|Overall Study|Lost to Follow-up|1|||
163006081|NCT00711087|588723254|FG001|Overall Study|Lost to Follow-up|0|||
163006082|NCT02137252|588723255|FG000|Overall Study|trial terminated early|2|||
163006083|NCT02137252|588723256|FG001|Overall Study|trial terminated early|1|||
163006084|NCT01958437|588723258|FG000|Overall Study|Incidental MRI findings|0|||
163006085|NCT01958437|588723259|FG001|Overall Study|Incidental MRI findings|0|||
163006086|NCT01958437|588723260|FG002|Overall Study|Incidental MRI findings|1|||
163006087|NCT01958437|588723261|FG003|Overall Study|Incidental MRI findings|1|||
163006088|NCT00428246|588723262|FG000|Overall Study|Withdrawal by Subject|0|||
163006089|NCT00428246|588723263|FG001|Overall Study|Withdrawal by Subject|0|||
163006090|NCT00428246|588723264|FG002|Overall Study|Withdrawal by Subject|1|||
163006091|NCT00428246|588723262|FG000|Overall Study|Adverse Event|1|||
163006092|NCT00428246|588723263|FG001|Overall Study|Adverse Event|0|||
163006093|NCT00428246|588723264|FG002|Overall Study|Adverse Event|0|||
163006094|NCT02603887|588723268|FG000|Stage 1|Adverse Event|4|||
163006095|NCT02603887|588723268|FG000|Stage 1|Disease progression|1|||
163006096|NCT02603887|588723268|FG000|Stage 2|FDA guidance|1|||
163006097|NCT03535740|588723271|FG000|Overall Study|Death|44|||
163006098|NCT03535740|588723271|FG000|Overall Study|Lost to Follow-up|1|||
163006099|NCT03535740|588723271|FG000|Overall Study|Withdrawal by Subject|13|||
163006100|NCT03535740|588723271|FG000|Overall Study|Site terminated by Sponsor|45|||
163006101|NCT05198518|588723274|FG000|Screening Visit|Deemed unable to participate|58|||
163213540|NCT05407675|589496003|FG000|Overall Study|Site terminated by sponsor|0|||
163213541|NCT05407675|589496004|FG001|Overall Study|Site terminated by sponsor|0|||
163006102|NCT05198518|588723275|FG001|Screening Visit|Deemed unable to participate|0|||
163006103|NCT05198518|588723276|FG002|Screening Visit|Deemed unable to participate|0|||
163006104|NCT05317312|588723282|FG000|Overall Study|Withdrawal by Subject|0|||
163006105|NCT05317312|588723283|FG001|Overall Study|Withdrawal by Subject|1|||
163006106|NCT05317312|588723284|FG002|Overall Study|Withdrawal by Subject|0|||
163006107|NCT05317312|588723285|FG003|Overall Study|Withdrawal by Subject|0|||
163006108|NCT05317312|588723282|FG000|Overall Study|Lost to Follow-up|0|||
163006109|NCT05317312|588723283|FG001|Overall Study|Lost to Follow-up|0|||
163006110|NCT05317312|588723284|FG002|Overall Study|Lost to Follow-up|0|||
163006111|NCT05317312|588723285|FG003|Overall Study|Lost to Follow-up|1|||
163006112|NCT05317312|588723282|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
163006113|NCT05317312|588723283|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
163006114|NCT05317312|588723284|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
163006115|NCT05317312|588723285|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
163006116|NCT00124917|588723286|FG000|Overall Study|Physician Decision|3|||
163006117|NCT00613171|588723289|FG000|Overall Study|Adverse Event|7|||
163006118|NCT00613171|588723289|FG000|Overall Study|Withdrawal by Subject|3|||
163006119|NCT00613171|588723289|FG000|Overall Study|Reason not Specified|4|||
163006120|NCT00951496|588723294|FG000|Overall Study|Did not initiate study treatment|10|||
163006121|NCT00951496|588723295|FG001|Overall Study|Did not initiate study treatment|8|||
163006122|NCT00951496|588723296|FG002|Overall Study|Did not initiate study treatment|13|||
163006123|NCT01042093|588723297|FG000|Overall Study|Protocol Violation|2|||
163006124|NCT01042093|588723298|FG001|Overall Study|Protocol Violation|2|||
163006125|NCT01042093|588723299|FG002|Overall Study|Protocol Violation|2|||
163006126|NCT01042093|588723300|FG003|Overall Study|Protocol Violation|3|||
163006127|NCT01042093|588723297|FG000|Overall Study|Withdrawal by Subject|0|||
163006128|NCT01042093|588723298|FG001|Overall Study|Withdrawal by Subject|0|||
163006129|NCT01042093|588723299|FG002|Overall Study|Withdrawal by Subject|0|||
163006130|NCT01042093|588723300|FG003|Overall Study|Withdrawal by Subject|1|||
163006131|NCT03447743|588723307|FG000|Overall Study|Withdrawal by Subject|2|||
163006132|NCT03447743|588723307|FG000|Overall Study|Lost to Follow-up|3|||
163006133|NCT03447743|588723307|FG000|Overall Study|Adverse Event|1|||
163006134|NCT03447743|588723307|FG000|Overall Study|Did not meet criteria to continue|1|||
163006135|NCT01610492|588723312|FG000|Overall Study|Adverse Event|1|||
163006136|NCT01610492|588723312|FG000|Overall Study|Lack of Efficacy|3|||
163006137|NCT01610492|588723312|FG000|Overall Study|Other: Reached stopping criteria|1|||
163006138|NCT01610492|588723312|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
163006139|NCT02575833|588723313|FG000|Overall Study|Withdrawal by Subject|0|||
163006140|NCT02575833|588723314|FG001|Overall Study|Withdrawal by Subject|1|||
163006141|NCT02575833|588723313|FG000|Overall Study|Lost to Follow-up|1|||
163006142|NCT02575833|588723314|FG001|Overall Study|Lost to Follow-up|0|||
163006143|NCT01757275|588723315|FG000|Overall Study|Lost to Follow-up|1|||
163006144|NCT01757275|588723316|FG001|Overall Study|Lost to Follow-up|2|||
163006145|NCT01757275|588723315|FG000|Overall Study|Adverse Event|3|||
163006146|NCT01757275|588723316|FG001|Overall Study|Adverse Event|3|||
163006147|NCT01757275|588723315|FG000|Overall Study|Withdrawal by Subject|2|||
163006148|NCT01757275|588723316|FG001|Overall Study|Withdrawal by Subject|4|||
163006149|NCT01757275|588723315|FG000|Overall Study|Not treated|3|||
163006150|NCT01757275|588723316|FG001|Overall Study|Not treated|4|||
163006151|NCT01821807|588723317|FG000|Overall Study|Lost to Follow-up|3|||
163006152|NCT01821807|588723318|FG001|Overall Study|Lost to Follow-up|1|||
163006153|NCT00768248|588723319|FG000|Overall Study|Research coordinator didn't collect data|1|||
163006154|NCT00768248|588723320|FG001|Overall Study|Research coordinator didn't collect data|1|||
163006155|NCT04211831|588723321|FG000|Overall Study|Withdrawal by Subject|4|||
163061307|NCT00614393|588933074|FG003|Overall Study|Progressive Disease|138|||
163326137|NCT01500200|589905432|FG001|Stage 2|Adverse Event|0|||
163326138|NCT01500200|589905433|FG002|Stage 2|Adverse Event|0|||
163326139|NCT01500200|589905434|FG003|Stage 2|Adverse Event|0|||
163326140|NCT01500200|589905435|FG004|Stage 2|Adverse Event|5|||
163326141|NCT01500200|589905436|FG005|Stage 2|Adverse Event|4|||
163326142|NCT00112359|589905437|FG000|Overall Study|Unrelated adverse event|16|||
163006156|NCT04211831|588723322|FG001|Overall Study|Withdrawal by Subject|1|||
163006157|NCT04211831|588723323|FG002|Overall Study|Withdrawal by Subject|1|||
163006158|NCT04211831|588723321|FG000|Overall Study|Protocol Violation|0|||
163061308|NCT00614393|588933075|FG004|Overall Study|Progressive Disease|130|||
163326143|NCT00112359|589905438|FG001|Overall Study|Unrelated adverse event|8|||
163061309|NCT00614393|588933071|FG000|Overall Study|Protocol Violation|1|||
163326144|NCT00112359|589905437|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
163006159|NCT04211831|588723322|FG001|Overall Study|Protocol Violation|0|||
163006160|NCT04211831|588723323|FG002|Overall Study|Protocol Violation|1|||
163006161|NCT04211831|588723321|FG000|Overall Study|Adverse Event|0|||
163006162|NCT04211831|588723322|FG001|Overall Study|Adverse Event|1|||
163006163|NCT04211831|588723323|FG002|Overall Study|Adverse Event|0|||
163061310|NCT00614393|588933072|FG001|Overall Study|Protocol Violation|0|||
163326145|NCT00112359|589905438|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
163006164|NCT04211831|588723321|FG000|Overall Study|Lack of Efficacy|0|||
163006165|NCT04211831|588723322|FG001|Overall Study|Lack of Efficacy|0|||
163006166|NCT04211831|588723323|FG002|Overall Study|Lack of Efficacy|1|||
163006167|NCT04211831|588723321|FG000|Overall Study|Lost to Follow-up|0|||
163006168|NCT04211831|588723322|FG001|Overall Study|Lost to Follow-up|0|||
163006169|NCT04211831|588723323|FG002|Overall Study|Lost to Follow-up|2|||
163006170|NCT04211831|588723321|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
163006171|NCT04211831|588723322|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
163006172|NCT04211831|588723323|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
163006173|NCT04211831|588723321|FG000|Overall Study|Other|0|||
163006174|NCT04211831|588723322|FG001|Overall Study|Other|1|||
163006175|NCT04211831|588723323|FG002|Overall Study|Other|0|||
163006176|NCT00967330|588723324|FG000|Overall Study|Protocol Violation|3|||
163006177|NCT00967330|588723325|FG001|Overall Study|Protocol Violation|4|||
163006178|NCT00967330|588723324|FG000|Overall Study|Regular|10|||
163006179|NCT00967330|588723325|FG001|Overall Study|Regular|3|||
163006180|NCT00967330|588723324|FG000|Overall Study|Withdrawal by Subject|6|||
163006181|NCT00967330|588723325|FG001|Overall Study|Withdrawal by Subject|0|||
163006182|NCT00967330|588723324|FG000|Overall Study|Lost to Follow-up|1|||
163006183|NCT00967330|588723325|FG001|Overall Study|Lost to Follow-up|1|||
163006184|NCT00967330|588723324|FG000|Overall Study|Death|102|||
163006185|NCT00967330|588723325|FG001|Overall Study|Death|51|||
163006186|NCT00967330|588723324|FG000|Overall Study|Severe protocol deviation|0|||
163006187|NCT00967330|588723325|FG001|Overall Study|Severe protocol deviation|1|||
163006188|NCT04796961|588725292|FG000|Overall Study|Lost to Follow-up|10|||
163006189|NCT04796961|588725292|FG000|Overall Study|Withdrawal by Subject|3|||
163006190|NCT04796961|588725292|FG000|Overall Study|Left Organization|10|||
163006191|NCT05825404|588725295|FG000|First Intervention (Weeks 2-5)|Death|0|||
163006192|NCT05825404|588725296|FG001|First Intervention (Weeks 2-5)|Death|1|||
163006193|NCT05825404|588725295|FG000|Second Intervention (Weeks 8-11)|Death|0|||
163006194|NCT05825404|588725296|FG001|Second Intervention (Weeks 8-11)|Death|1|||
163006195|NCT01922037|588725297|FG000|Overall Study|Withdrawal by Subject|2|||
163006196|NCT01922037|588725298|FG001|Overall Study|Withdrawal by Subject|44|||
163006197|NCT01922037|588725297|FG000|Overall Study|Adverse Event|1|||
163006198|NCT01922037|588725298|FG001|Overall Study|Adverse Event|7|||
163006199|NCT01922037|588725297|FG000|Overall Study|Death|0|||
163006200|NCT01922037|588725298|FG001|Overall Study|Death|5|||
163006201|NCT01922037|588725297|FG000|Overall Study|Pregnancy|0|||
163006202|NCT01922037|588725298|FG001|Overall Study|Pregnancy|2|||
163006203|NCT01922037|588725297|FG000|Overall Study|Participant non-compliance|4|||
163006204|NCT01922037|588725298|FG001|Overall Study|Participant non-compliance|46|||
163006205|NCT01922037|588725297|FG000|Overall Study|Investigator/Sponsor decision|1|||
163006206|NCT01922037|588725298|FG001|Overall Study|Investigator/Sponsor decision|4|||
163006207|NCT01922037|588725297|FG000|Overall Study|Other unspecified|2|||
163006208|NCT01922037|588725298|FG001|Overall Study|Other unspecified|66|||
163006209|NCT00679211|588725299|FG000|Overall Study|Progressive disease|82|||
163006210|NCT00679211|588725299|FG000|Overall Study|Adverse Event|7|||
163006211|NCT00679211|588725299|FG000|Overall Study|Withdrawal by Subject|2|||
163006212|NCT00679211|588725299|FG000|Overall Study|Physician Decision|5|||
163006213|NCT00679211|588725299|FG000|Overall Study|Refused to undergo protocol procedures|1|||
163006214|NCT00679211|588725299|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
163006215|NCT00679211|588725299|FG000|Overall Study|Other|1|||
163006216|NCT00931528|588725300|FG000|Overall Study|Protocol Violation|9|||
163006217|NCT00931528|588725301|FG001|Overall Study|Protocol Violation|12|||
163006218|NCT00931528|588725300|FG000|Overall Study|Withdrawal by Subject|4|||
163006219|NCT00931528|588725301|FG001|Overall Study|Withdrawal by Subject|12|||
163006220|NCT00931528|588725300|FG000|Overall Study|Lost to Follow-up|6|||
163006221|NCT00931528|588725301|FG001|Overall Study|Lost to Follow-up|13|||
163006222|NCT00931528|588725300|FG000|Overall Study|Assessment outside of Time Frame|22|||
163006223|NCT00931528|588725301|FG001|Overall Study|Assessment outside of Time Frame|23|||
163006224|NCT01470248|588725302|FG000|Overall Study|Withdrawal by Subject|1|||
163006225|NCT02243605|588725305|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
163006226|NCT02243605|588725306|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
163006227|NCT02243605|588725305|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
163006228|NCT02243605|588725306|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
163213542|NCT05407675|589496005|FG002|Overall Study|Site terminated by sponsor|1|||
163213543|NCT05407675|589496006|FG003|Overall Study|Site terminated by sponsor|0|||
163006229|NCT02243605|588725305|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
163006230|NCT02243605|588725306|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
163006231|NCT02243605|588725305|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
163213544|NCT05407675|589496007|FG004|Overall Study|Site terminated by sponsor|2|||
163213545|NCT05407675|589496008|FG005|Overall Study|Site terminated by sponsor|0|||
163213546|NCT05407675|589496009|FG006|Overall Study|Site terminated by sponsor|1|||
163006232|NCT02243605|588725306|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
163006233|NCT02243605|588725305|FG000|Stage 2 - Final Analysis Population|Progression|0|||
163006234|NCT02243605|588725306|FG001|Stage 2 - Final Analysis Population|Progression|1|||
163006235|NCT05842967|588725307|FG000|Period 1: SSA|Adverse Event|1|||
163006236|NCT05842967|588725308|FG001|Period 1: SSA|Adverse Event|1|||
163006237|NCT05842967|588725309|FG002|Period 1: SSA|Adverse Event|0|||
163006238|NCT05842967|588725310|FG003|Period 1: SSA|Adverse Event|0|||
163006239|NCT05842967|588725307|FG000|Period 1: SSA|Death|1|||
163006240|NCT05842967|588725308|FG001|Period 1: SSA|Death|0|||
163006241|NCT05842967|588725309|FG002|Period 1: SSA|Death|0|||
163006242|NCT05842967|588725310|FG003|Period 1: SSA|Death|0|||
163006243|NCT05842967|588725307|FG000|Period 1: SSA|Lost to Follow-up|16|||
163006244|NCT05842967|588725308|FG001|Period 1: SSA|Lost to Follow-up|4|||
163006245|NCT05842967|588725309|FG002|Period 1: SSA|Lost to Follow-up|0|||
163006246|NCT05842967|588725310|FG003|Period 1: SSA|Lost to Follow-up|0|||
163006247|NCT05842967|588725307|FG000|Period 1: SSA|Physician Decision|1|||
163006248|NCT05842967|588725308|FG001|Period 1: SSA|Physician Decision|0|||
163006249|NCT05842967|588725309|FG002|Period 1: SSA|Physician Decision|0|||
163006250|NCT05842967|588725310|FG003|Period 1: SSA|Physician Decision|0|||
163006251|NCT05842967|588725307|FG000|Period 1: SSA|Withdrawal by Subject|2|||
163006252|NCT05842967|588725308|FG001|Period 1: SSA|Withdrawal by Subject|2|||
163006253|NCT05842967|588725309|FG002|Period 1: SSA|Withdrawal by Subject|0|||
163006254|NCT05842967|588725310|FG003|Period 1: SSA|Withdrawal by Subject|0|||
163006255|NCT05842967|588725307|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
163006256|NCT05842967|588725308|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
163006257|NCT05842967|588725309|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
163006258|NCT05842967|588725310|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
163006259|NCT05842967|588725307|FG000|Period 2: SSB|Adverse Event|0|||
163006260|NCT05842967|588725308|FG001|Period 2: SSB|Adverse Event|0|||
163006261|NCT05842967|588725309|FG002|Period 2: SSB|Adverse Event|2|||
163006262|NCT05842967|588725310|FG003|Period 2: SSB|Adverse Event|0|||
163006263|NCT05842967|588725307|FG000|Period 2: SSB|Lost to Follow-up|0|||
163006264|NCT05842967|588725308|FG001|Period 2: SSB|Lost to Follow-up|0|||
163006265|NCT05842967|588725309|FG002|Period 2: SSB|Lost to Follow-up|4|||
163006266|NCT05842967|588725310|FG003|Period 2: SSB|Lost to Follow-up|3|||
163006267|NCT05842967|588725307|FG000|Period 2: SSB|Withdrawal by Subject|0|||
163006268|NCT05842967|588725308|FG001|Period 2: SSB|Withdrawal by Subject|0|||
163006269|NCT05842967|588725309|FG002|Period 2: SSB|Withdrawal by Subject|1|||
163006270|NCT05842967|588725310|FG003|Period 2: SSB|Withdrawal by Subject|0|||
163006271|NCT05842967|588725307|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
163006272|NCT05842967|588725308|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
163006273|NCT05842967|588725309|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
163006274|NCT05842967|588725310|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
163006275|NCT05842967|588725307|FG000|Period 2: SSB|Protocol Violation|0|||
163006276|NCT05842967|588725308|FG001|Period 2: SSB|Protocol Violation|0|||
163006277|NCT05842967|588725309|FG002|Period 2: SSB|Protocol Violation|0|||
163006278|NCT05842967|588725310|FG003|Period 2: SSB|Protocol Violation|1|||
163006279|NCT01557504|588725318|FG000|Overall Study|Physician Decision|1|||
163006280|NCT01557504|588725319|FG001|Overall Study|Physician Decision|0|||
163006281|NCT01321749|588725325|FG000|Overall Study|Lost to Follow-up|4|||
163006282|NCT01321749|588725326|FG001|Overall Study|Lost to Follow-up|11|||
163006283|NCT01321749|588725325|FG000|Overall Study|Protocol Violation|4|||
163006284|NCT01321749|588725326|FG001|Overall Study|Protocol Violation|7|||
163006285|NCT01321749|588725325|FG000|Overall Study|Withdrawal by Subject|5|||
163006286|NCT01321749|588725326|FG001|Overall Study|Withdrawal by Subject|4|||
163006287|NCT00970593|588725327|FG000|Overall Study|Adverse Event|1|||
163006288|NCT00970593|588725328|FG001|Overall Study|Adverse Event|1|||
163006289|NCT00970593|588725329|FG002|Overall Study|Adverse Event|0|||
163006290|NCT00970593|588725330|FG003|Overall Study|Adverse Event|0|||
163006291|NCT00970593|588725331|FG004|Overall Study|Adverse Event|0|||
163006292|NCT00970593|588725332|FG005|Overall Study|Adverse Event|0|||
163006293|NCT00970593|588725333|FG006|Overall Study|Adverse Event|0|||
163006294|NCT00970593|588725327|FG000|Overall Study|Discontinuation of study by sponsor|0|||
163006295|NCT00970593|588725328|FG001|Overall Study|Discontinuation of study by sponsor|0|||
163006296|NCT00970593|588725329|FG002|Overall Study|Discontinuation of study by sponsor|5|||
163326146|NCT00112359|589905437|FG000|Overall Study|Related adverse event|5|||
163326147|NCT00112359|589905438|FG001|Overall Study|Related adverse event|3|||
163006297|NCT00970593|588725330|FG003|Overall Study|Discontinuation of study by sponsor|0|||
163006298|NCT00970593|588725331|FG004|Overall Study|Discontinuation of study by sponsor|0|||
163006299|NCT00970593|588725332|FG005|Overall Study|Discontinuation of study by sponsor|0|||
163006300|NCT00970593|588725333|FG006|Overall Study|Discontinuation of study by sponsor|2|||
163006301|NCT00970593|588725327|FG000|Overall Study|Withdrawal by Subject|0|||
163006302|NCT00970593|588725328|FG001|Overall Study|Withdrawal by Subject|0|||
163006303|NCT00970593|588725329|FG002|Overall Study|Withdrawal by Subject|1|||
163006304|NCT00970593|588725330|FG003|Overall Study|Withdrawal by Subject|0|||
163006305|NCT00970593|588725331|FG004|Overall Study|Withdrawal by Subject|0|||
163006306|NCT00970593|588725332|FG005|Overall Study|Withdrawal by Subject|0|||
163006307|NCT00970593|588725333|FG006|Overall Study|Withdrawal by Subject|0|||
163006308|NCT02203357|588725334|FG000|Overall Study|Lost to Follow-up|58|||
163006309|NCT02203357|588725335|FG001|Overall Study|Lost to Follow-up|66|||
163006310|NCT02203357|588725336|FG002|Overall Study|Lost to Follow-up|70|||
163006311|NCT01866826|588725343|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
163006312|NCT01866826|588725344|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
163006313|NCT01866826|588725343|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
163006314|NCT01866826|588725344|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
163006315|NCT01866826|588725343|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
163006316|NCT01866826|588725344|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
163006317|NCT02288312|588725345|FG000|Overall Study|Pregnancy|1|||
163006318|NCT02288312|588725346|FG001|Overall Study|Pregnancy|0|||
163006319|NCT02288312|588725347|FG002|Overall Study|Pregnancy|0|||
163006320|NCT01276041|588725348|FG000|Overall Study|Adverse Event|2|||
163006321|NCT01276041|588725348|FG000|Overall Study|Protocol Violation|1|||
163006322|NCT02968576|588725349|FG000|Overall Study|Pregnancy|0|||
163006323|NCT02968576|588725350|FG001|Overall Study|Pregnancy|1|||
163006324|NCT02058069|588725353|FG000|Overall Study|Exclusion due to implant size|5|||
163006325|NCT02058069|588725353|FG000|Overall Study|Withdrawal by Subject|6|||
163006326|NCT02222922|588725354|FG000|Overall Study|Death|0|||
163006327|NCT02222922|588725355|FG001|Overall Study|Death|0|||
163006328|NCT02222922|588725356|FG002|Overall Study|Death|0|||
163006329|NCT02222922|588725357|FG003|Overall Study|Death|0|||
163006330|NCT02222922|588725358|FG004|Overall Study|Death|13|||
163006331|NCT02222922|588725359|FG005|Overall Study|Death|0|||
163006332|NCT02222922|588725360|FG006|Overall Study|Death|0|||
163006333|NCT02222922|588725361|FG007|Overall Study|Death|0|||
163006334|NCT02222922|588725362|FG008|Overall Study|Death|2|||
163006335|NCT02222922|588725354|FG000|Overall Study|Lost to Follow-up|0|||
163006336|NCT02222922|588725355|FG001|Overall Study|Lost to Follow-up|0|||
163006337|NCT02222922|588725356|FG002|Overall Study|Lost to Follow-up|1|||
163006338|NCT02222922|588725357|FG003|Overall Study|Lost to Follow-up|0|||
163006339|NCT02222922|588725358|FG004|Overall Study|Lost to Follow-up|9|||
163326148|NCT00112359|589905437|FG000|Overall Study|Lost to Follow-up|0|||
163326149|NCT00112359|589905438|FG001|Overall Study|Lost to Follow-up|1|||
163326150|NCT00112359|589905437|FG000|Overall Study|Personal/administrative|1|||
163326151|NCT00112359|589905438|FG001|Overall Study|Personal/administrative|1|||
163006340|NCT02222922|588725359|FG005|Overall Study|Lost to Follow-up|1|||
163006341|NCT02222922|588725360|FG006|Overall Study|Lost to Follow-up|0|||
163006342|NCT02222922|588725361|FG007|Overall Study|Lost to Follow-up|0|||
163006343|NCT02222922|588725362|FG008|Overall Study|Lost to Follow-up|0|||
163006344|NCT02222922|588725354|FG000|Overall Study|Other|0|||
163006345|NCT02222922|588725355|FG001|Overall Study|Other|0|||
163006346|NCT02222922|588725356|FG002|Overall Study|Other|0|||
163006347|NCT02222922|588725357|FG003|Overall Study|Other|2|||
163006348|NCT02222922|588725358|FG004|Overall Study|Other|10|||
163006349|NCT02222922|588725359|FG005|Overall Study|Other|2|||
163006350|NCT02222922|588725360|FG006|Overall Study|Other|2|||
163006351|NCT02222922|588725361|FG007|Overall Study|Other|4|||
163006352|NCT02222922|588725362|FG008|Overall Study|Other|1|||
163006353|NCT02222922|588725354|FG000|Overall Study|Participant refused further follow-up|1|||
163006354|NCT02222922|588725355|FG001|Overall Study|Participant refused further follow-up|0|||
163006355|NCT02222922|588725356|FG002|Overall Study|Participant refused further follow-up|0|||
163006356|NCT02222922|588725357|FG003|Overall Study|Participant refused further follow-up|1|||
163006357|NCT02222922|588725358|FG004|Overall Study|Participant refused further follow-up|6|||
163006358|NCT02222922|588725359|FG005|Overall Study|Participant refused further follow-up|0|||
163006359|NCT02222922|588725360|FG006|Overall Study|Participant refused further follow-up|0|||
163006360|NCT02222922|588725361|FG007|Overall Study|Participant refused further follow-up|0|||
163006361|NCT02222922|588725362|FG008|Overall Study|Participant refused further follow-up|3|||
163006362|NCT02002221|588725363|FG000|Overall Study|Adverse Event|2|||
163006363|NCT02002221|588725364|FG001|Overall Study|Adverse Event|1|||
163006364|NCT02002221|588725363|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163006365|NCT02002221|588725364|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163006366|NCT02002221|588725363|FG000|Overall Study|Patient withdrew consent|0|||
163006367|NCT02002221|588725364|FG001|Overall Study|Patient withdrew consent|1|||
163006368|NCT01068860|588725365|FG000|Overall Study|Withdrawal by Subject|0|||
163326152|NCT00112359|589905437|FG000|Overall Study|Other|3|||
163326153|NCT00112359|589905438|FG001|Overall Study|Other|0|||
163326154|NCT00312208|589905439|FG000|Overall Study|Adverse Event|97|||
163006369|NCT01068860|588725366|FG001|Overall Study|Withdrawal by Subject|0|||
163006370|NCT01068860|588725367|FG002|Overall Study|Withdrawal by Subject|0|||
163006371|NCT01068860|588725368|FG003|Overall Study|Withdrawal by Subject|0|||
163326155|NCT00312208|589905440|FG001|Overall Study|Adverse Event|61|||
163006372|NCT01068860|588725369|FG004|Overall Study|Withdrawal by Subject|0|||
163006373|NCT01068860|588725370|FG005|Overall Study|Withdrawal by Subject|2|||
163326156|NCT00312208|589905439|FG000|Overall Study|Protocol Violation|5|||
163006374|NCT01068860|588725371|FG006|Overall Study|Withdrawal by Subject|0|||
163006375|NCT01068860|588725372|FG007|Overall Study|Withdrawal by Subject|0|||
163006376|NCT01068860|588725373|FG008|Overall Study|Withdrawal by Subject|0|||
163006377|NCT01068860|588725374|FG009|Overall Study|Withdrawal by Subject|3|||
163006378|NCT01068860|588725365|FG000|Overall Study|Administrative problems; misrandomized|0|||
163326157|NCT00312208|589905440|FG001|Overall Study|Protocol Violation|3|||
163326158|NCT00312208|589905439|FG000|Overall Study|Death|2|||
163326159|NCT00312208|589905440|FG001|Overall Study|Death|1|||
163326160|NCT00312208|589905439|FG000|Overall Study|Lack of Efficacy|7|||
163326161|NCT00312208|589905440|FG001|Overall Study|Lack of Efficacy|4|||
163326162|NCT00312208|589905439|FG000|Overall Study|Lost to Follow-up|3|||
163326163|NCT00312208|589905440|FG001|Overall Study|Lost to Follow-up|5|||
163326164|NCT00312208|589905439|FG000|Overall Study|Withdrawal by Subject|53|||
163326165|NCT00312208|589905440|FG001|Overall Study|Withdrawal by Subject|42|||
163326166|NCT00312208|589905439|FG000|Overall Study|Other|5|||
163326167|NCT00312208|589905440|FG001|Overall Study|Other|7|||
163006379|NCT01068860|588725366|FG001|Overall Study|Administrative problems; misrandomized|0|||
163006380|NCT01068860|588725367|FG002|Overall Study|Administrative problems; misrandomized|0|||
163006381|NCT01068860|588725368|FG003|Overall Study|Administrative problems; misrandomized|1|||
163006382|NCT01068860|588725369|FG004|Overall Study|Administrative problems; misrandomized|0|||
163006383|NCT01068860|588725370|FG005|Overall Study|Administrative problems; misrandomized|0|||
163006384|NCT01068860|588725371|FG006|Overall Study|Administrative problems; misrandomized|0|||
163006385|NCT01068860|588725372|FG007|Overall Study|Administrative problems; misrandomized|0|||
163006386|NCT01068860|588725373|FG008|Overall Study|Administrative problems; misrandomized|0|||
163006387|NCT01068860|588725374|FG009|Overall Study|Administrative problems; misrandomized|1|||
163006388|NCT01068860|588725365|FG000|Overall Study|Lost to Follow-up|0|||
163006389|NCT01068860|588725366|FG001|Overall Study|Lost to Follow-up|1|||
163006390|NCT01068860|588725367|FG002|Overall Study|Lost to Follow-up|0|||
163006391|NCT01068860|588725368|FG003|Overall Study|Lost to Follow-up|0|||
163006392|NCT01068860|588725369|FG004|Overall Study|Lost to Follow-up|0|||
163006393|NCT01068860|588725370|FG005|Overall Study|Lost to Follow-up|0|||
163006394|NCT01068860|588725371|FG006|Overall Study|Lost to Follow-up|0|||
163006395|NCT01068860|588725372|FG007|Overall Study|Lost to Follow-up|0|||
163006396|NCT01068860|588725373|FG008|Overall Study|Lost to Follow-up|0|||
163006397|NCT01068860|588725374|FG009|Overall Study|Lost to Follow-up|0|||
163006398|NCT03743051|588725378|FG000|Overall Study|Adverse Event|5|||
163006399|NCT03743051|588725379|FG001|Overall Study|Adverse Event|9|||
163006400|NCT03743051|588725378|FG000|Overall Study|Death|27|||
163006401|NCT03743051|588725379|FG001|Overall Study|Death|26|||
163006402|NCT03743051|588725378|FG000|Overall Study|Lost to Follow-up|4|||
163006403|NCT03743051|588725379|FG001|Overall Study|Lost to Follow-up|8|||
163006404|NCT03743051|588725378|FG000|Overall Study|Withdrawal by Subject|32|||
163006405|NCT03743051|588725379|FG001|Overall Study|Withdrawal by Subject|19|||
163006406|NCT03743051|588725378|FG000|Overall Study|Physician Decision|10|||
163006407|NCT03743051|588725379|FG001|Overall Study|Physician Decision|15|||
163006408|NCT03743051|588725378|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
163006409|NCT03743051|588725379|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
163006410|NCT02550561|588725380|FG000|Overall Study|Lost to Follow-up|5|||
163006411|NCT02550561|588725380|FG000|Overall Study|Withdrawal by Subject|1|||
163006412|NCT03411863|588725381|FG000|Overall Study|Withdrawal by Subject|3|||
163006413|NCT03411863|588725382|FG001|Overall Study|Withdrawal by Subject|1|||
163006414|NCT03411863|588725381|FG000|Overall Study|Physician Decision|0|||
163006415|NCT03411863|588725382|FG001|Overall Study|Physician Decision|1|||
163006416|NCT02766335|588725383|FG000|Initial Registration|Adverse Event|6|||
163006417|NCT02766335|588725384|FG001|Initial Registration|Adverse Event|3|||
163006418|NCT02766335|588725385|FG002|Initial Registration|Adverse Event|0|||
163006419|NCT02766335|588725383|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
163006420|NCT02766335|588725384|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
163006421|NCT02766335|588725385|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
163006422|NCT02766335|588725383|FG000|Initial Registration|Progression/relapse|49|||
163006423|NCT02766335|588725384|FG001|Initial Registration|Progression/relapse|15|||
163006424|NCT02766335|588725385|FG002|Initial Registration|Progression/relapse|0|||
163006425|NCT02766335|588725383|FG000|Initial Registration|Death|1|||
163006426|NCT02766335|588725384|FG001|Initial Registration|Death|3|||
163006427|NCT02766335|588725385|FG002|Initial Registration|Death|0|||
163006428|NCT02766335|588725383|FG000|Initial Registration|not protocol specified|1|||
163006429|NCT02766335|588725384|FG001|Initial Registration|not protocol specified|9|||
163006430|NCT02766335|588725385|FG002|Initial Registration|not protocol specified|0|||
163006431|NCT02766335|588725383|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
163006432|NCT02766335|588725384|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
163006433|NCT02766335|588725385|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
163006434|NCT02766335|588725383|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
163326168|NCT01218659|589905442|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
163326169|NCT01218659|589905443|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
163326170|NCT01218659|589905444|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
163006435|NCT02766335|588725384|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
163006436|NCT02766335|588725385|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
163326171|NCT01218659|589905442|FG000|18-Month Randomized Period|Did not receive study drug|0|||
163006437|NCT00262028|588725390|FG000|Overall Study|Withdrawal by Subject|6|||
163006438|NCT00262028|588725391|FG001|Overall Study|Withdrawal by Subject|3|||
163006439|NCT00262028|588725392|FG002|Overall Study|Withdrawal by Subject|6|||
163326172|NCT01218659|589905443|FG001|18-Month Randomized Period|Did not receive study drug|3|||
163326173|NCT01218659|589905444|FG002|18-Month Randomized Period|Did not receive study drug|0|||
163326174|NCT01218659|589905442|FG000|12-Month OLE|Withdrawal by Subject|0|||
163326175|NCT01218659|589905443|FG001|12-Month OLE|Withdrawal by Subject|0|||
163326176|NCT01218659|589905444|FG002|12-Month OLE|Withdrawal by Subject|2|||
163326177|NCT01218659|589905442|FG000|12-Month OLE|Physician Decision|0|||
163326178|NCT01218659|589905443|FG001|12-Month OLE|Physician Decision|0|||
163326179|NCT01218659|589905444|FG002|12-Month OLE|Physician Decision|1|||
163326180|NCT01218659|589905442|FG000|12-Month OLE|Lost to Follow-up|0|||
163326181|NCT01218659|589905443|FG001|12-Month OLE|Lost to Follow-up|0|||
163326182|NCT01218659|589905444|FG002|12-Month OLE|Lost to Follow-up|1|||
163326183|NCT01218659|589905442|FG000|12-Month OLE|Pregnancy|0|||
163326184|NCT01218659|589905443|FG001|12-Month OLE|Pregnancy|0|||
163326185|NCT01218659|589905444|FG002|12-Month OLE|Pregnancy|1|||
163326186|NCT01218659|589905442|FG000|12-Month OLE|Lack of Efficacy|0|||
163326187|NCT01218659|589905443|FG001|12-Month OLE|Lack of Efficacy|0|||
163326188|NCT01218659|589905444|FG002|12-Month OLE|Lack of Efficacy|1|||
163326189|NCT01218659|589905442|FG000|12-Month OLE|Declined to participate in the OLE|0|||
163326190|NCT01218659|589905443|FG001|12-Month OLE|Declined to participate in the OLE|0|||
163326191|NCT01218659|589905444|FG002|12-Month OLE|Declined to participate in the OLE|4|||
163326192|NCT03066609|589905447|FG000|INDUCTION|Pregnancy|0|||
163326193|NCT03066609|589905448|FG001|INDUCTION|Pregnancy|0|||
163326194|NCT03066609|589905449|FG002|INDUCTION|Pregnancy|1|||
163326195|NCT03066609|589905450|FG003|INDUCTION|Pregnancy|0|||
163326196|NCT03066609|589905447|FG000|INDUCTION|Lack of Efficacy|0|||
163326197|NCT03066609|589905448|FG001|INDUCTION|Lack of Efficacy|0|||
163326198|NCT03066609|589905449|FG002|INDUCTION|Lack of Efficacy|1|||
163326199|NCT03066609|589905450|FG003|INDUCTION|Lack of Efficacy|0|||
163326200|NCT03066609|589905447|FG000|INDUCTION|Adverse Event|2|||
163326201|NCT03066609|589905448|FG001|INDUCTION|Adverse Event|2|||
163326202|NCT03066609|589905449|FG002|INDUCTION|Adverse Event|0|||
163326203|NCT03066609|589905450|FG003|INDUCTION|Adverse Event|0|||
163326204|NCT03066609|589905447|FG000|MAINTENANCE|Adverse Event|0|||
163326205|NCT03066609|589905448|FG001|MAINTENANCE|Adverse Event|0|||
163326206|NCT03066609|589905449|FG002|MAINTENANCE|Adverse Event|0|||
163326207|NCT03066609|589905450|FG003|MAINTENANCE|Adverse Event|1|||
163326208|NCT03066609|589905447|FG000|MAINTENANCE|Withdrawal by Subject|4|||
163326209|NCT03066609|589905448|FG001|MAINTENANCE|Withdrawal by Subject|2|||
163326210|NCT03066609|589905449|FG002|MAINTENANCE|Withdrawal by Subject|1|||
163326211|NCT03066609|589905450|FG003|MAINTENANCE|Withdrawal by Subject|1|||
163326212|NCT03066609|589905447|FG000|MAINTENANCE|Lost to Follow-up|0|||
163326213|NCT03066609|589905448|FG001|MAINTENANCE|Lost to Follow-up|1|||
163326214|NCT03066609|589905449|FG002|MAINTENANCE|Lost to Follow-up|1|||
163326215|NCT03066609|589905450|FG003|MAINTENANCE|Lost to Follow-up|0|||
163326216|NCT03066609|589905447|FG000|MAINTENANCE|Pregnancy|1|||
163326217|NCT03066609|589905448|FG001|MAINTENANCE|Pregnancy|0|||
163326218|NCT03066609|589905449|FG002|MAINTENANCE|Pregnancy|0|||
163326219|NCT03066609|589905450|FG003|MAINTENANCE|Pregnancy|0|||
163326220|NCT03066609|589905447|FG000|MAINTENANCE|Lack of Efficacy|2|||
163326221|NCT03066609|589905448|FG001|MAINTENANCE|Lack of Efficacy|1|||
163326222|NCT03066609|589905449|FG002|MAINTENANCE|Lack of Efficacy|0|||
163326223|NCT03066609|589905450|FG003|MAINTENANCE|Lack of Efficacy|1|||
163326224|NCT03066609|589905447|FG000|OVERALL STUDY|Adverse Event|2|||
163326225|NCT03066609|589905448|FG001|OVERALL STUDY|Adverse Event|2|||
163326226|NCT03066609|589905449|FG002|OVERALL STUDY|Adverse Event|0|||
163326227|NCT03066609|589905450|FG003|OVERALL STUDY|Adverse Event|1|||
163326228|NCT03066609|589905447|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
163326229|NCT03066609|589905448|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
163326230|NCT03066609|589905449|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
163326231|NCT03066609|589905450|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
163326232|NCT03066609|589905447|FG000|OVERALL STUDY|Lost to Follow-up|1|||
163326233|NCT03066609|589905448|FG001|OVERALL STUDY|Lost to Follow-up|1|||
163326234|NCT03066609|589905449|FG002|OVERALL STUDY|Lost to Follow-up|1|||
163326235|NCT03066609|589905450|FG003|OVERALL STUDY|Lost to Follow-up|1|||
163326236|NCT03066609|589905447|FG000|OVERALL STUDY|Pregnancy|1|||
163326237|NCT03066609|589905448|FG001|OVERALL STUDY|Pregnancy|0|||
163326238|NCT03066609|589905449|FG002|OVERALL STUDY|Pregnancy|1|||
163326239|NCT03066609|589905450|FG003|OVERALL STUDY|Pregnancy|0|||
163326240|NCT03066609|589905447|FG000|OVERALL STUDY|Lack of Efficacy|2|||
163326241|NCT03066609|589905448|FG001|OVERALL STUDY|Lack of Efficacy|1|||
163326242|NCT03066609|589905449|FG002|OVERALL STUDY|Lack of Efficacy|1|||
163326243|NCT03066609|589905450|FG003|OVERALL STUDY|Lack of Efficacy|1|||
163326244|NCT03066609|589905447|FG000|OVERALL STUDY|discontinued follow up|0|||
163326245|NCT03066609|589905448|FG001|OVERALL STUDY|discontinued follow up|2|||
163326246|NCT03066609|589905449|FG002|OVERALL STUDY|discontinued follow up|0|||
163326247|NCT03066609|589905450|FG003|OVERALL STUDY|discontinued follow up|0|||
163326248|NCT02284113|589905451|FG000|Overall Study|Adverse Event|1|||
163326249|NCT02284113|589905452|FG001|Overall Study|Adverse Event|0|||
163326250|NCT02284113|589905451|FG000|Overall Study|non-compliance|0|||
163326251|NCT02284113|589905452|FG001|Overall Study|non-compliance|1|||
163326252|NCT02284113|589905451|FG000|Overall Study|Withdrawal by Subject|0|||
163213547|NCT05407675|589496010|FG007|Overall Study|Site terminated by sponsor|0|||
163213548|NCT05407675|589496011|FG008|Overall Study|Site terminated by sponsor|0|||
163213549|NCT05407675|589496012|FG009|Overall Study|Site terminated by sponsor|2|||
163213550|NCT05407675|589496013|FG010|Overall Study|Site terminated by sponsor|2|||
163213551|NCT05407675|589496014|FG011|Overall Study|Site terminated by sponsor|2|||
163213552|NCT05407675|589496015|FG012|Overall Study|Site terminated by sponsor|1|||
163213553|NCT05407675|589496003|FG000|Overall Study|Disease Progression|0|||
163213554|NCT05407675|589496004|FG001|Overall Study|Disease Progression|0|||
163213555|NCT05407675|589496005|FG002|Overall Study|Disease Progression|0|||
163213556|NCT05407675|589496006|FG003|Overall Study|Disease Progression|0|||
163213557|NCT05407675|589496007|FG004|Overall Study|Disease Progression|0|||
163213558|NCT05407675|589496008|FG005|Overall Study|Disease Progression|0|||
163213559|NCT05407675|589496009|FG006|Overall Study|Disease Progression|0|||
163213560|NCT05407675|589496010|FG007|Overall Study|Disease Progression|0|||
163213561|NCT05407675|589496011|FG008|Overall Study|Disease Progression|0|||
163213562|NCT05407675|589496012|FG009|Overall Study|Disease Progression|0|||
163213563|NCT05407675|589496013|FG010|Overall Study|Disease Progression|1|||
163213564|NCT05407675|589496014|FG011|Overall Study|Disease Progression|0|||
163213565|NCT05407675|589496015|FG012|Overall Study|Disease Progression|0|||
163213566|NCT05407675|589496003|FG000|Overall Study|Physician Decision|0|||
163213567|NCT05407675|589496004|FG001|Overall Study|Physician Decision|0|||
163326253|NCT02284113|589905452|FG001|Overall Study|Withdrawal by Subject|1|||
163326254|NCT02284113|589905451|FG000|Overall Study|not provided|0|||
163326255|NCT02284113|589905452|FG001|Overall Study|not provided|1|||
163006440|NCT00262028|588725393|FG003|Overall Study|Withdrawal by Subject|5|||
163006441|NCT00262028|588725394|FG004|Overall Study|Withdrawal by Subject|2|||
163006442|NCT00262028|588725395|FG005|Overall Study|Withdrawal by Subject|3|||
163006443|NCT00262028|588725396|FG006|Overall Study|Withdrawal by Subject|5|||
163006444|NCT00262028|588725397|FG007|Overall Study|Withdrawal by Subject|7|||
163006445|NCT00262028|588725398|FG008|Overall Study|Withdrawal by Subject|2|||
163006446|NCT00262028|588725390|FG000|Overall Study|Lost to Follow-up|7|||
163006447|NCT00262028|588725391|FG001|Overall Study|Lost to Follow-up|7|||
163006448|NCT00262028|588725392|FG002|Overall Study|Lost to Follow-up|5|||
163006449|NCT00262028|588725393|FG003|Overall Study|Lost to Follow-up|5|||
163006450|NCT00262028|588725394|FG004|Overall Study|Lost to Follow-up|4|||
163006451|NCT00262028|588725395|FG005|Overall Study|Lost to Follow-up|3|||
163006452|NCT00262028|588725396|FG006|Overall Study|Lost to Follow-up|3|||
163006453|NCT00262028|588725397|FG007|Overall Study|Lost to Follow-up|5|||
163006454|NCT00262028|588725398|FG008|Overall Study|Lost to Follow-up|6|||
163006455|NCT00262028|588725390|FG000|Overall Study|Administrative Reason|11|||
163006456|NCT00262028|588725391|FG001|Overall Study|Administrative Reason|14|||
163006457|NCT00262028|588725392|FG002|Overall Study|Administrative Reason|9|||
163006458|NCT00262028|588725393|FG003|Overall Study|Administrative Reason|12|||
163006459|NCT00262028|588725394|FG004|Overall Study|Administrative Reason|6|||
163006460|NCT00262028|588725395|FG005|Overall Study|Administrative Reason|7|||
163006461|NCT00262028|588725396|FG006|Overall Study|Administrative Reason|4|||
163006462|NCT00262028|588725397|FG007|Overall Study|Administrative Reason|6|||
163006463|NCT00262028|588725398|FG008|Overall Study|Administrative Reason|10|||
163006464|NCT00262028|588725390|FG000|Overall Study|Protocol Violation|0|||
163006465|NCT00262028|588725391|FG001|Overall Study|Protocol Violation|0|||
163006466|NCT00262028|588725392|FG002|Overall Study|Protocol Violation|0|||
163006467|NCT00262028|588725393|FG003|Overall Study|Protocol Violation|1|||
163061311|NCT00614393|588933073|FG002|Overall Study|Protocol Violation|0|||
163061312|NCT00614393|588933074|FG003|Overall Study|Protocol Violation|0|||
163061313|NCT00614393|588933075|FG004|Overall Study|Protocol Violation|0|||
163061314|NCT00614393|588933071|FG000|Overall Study|Terminated by Sponsor|0|||
163061315|NCT00614393|588933072|FG001|Overall Study|Terminated by Sponsor|0|||
163061316|NCT00614393|588933073|FG002|Overall Study|Terminated by Sponsor|0|||
163061317|NCT00614393|588933074|FG003|Overall Study|Terminated by Sponsor|0|||
163061318|NCT00614393|588933075|FG004|Overall Study|Terminated by Sponsor|1|||
163061319|NCT00614393|588933071|FG000|Overall Study|Withdrawal by Subject|20|||
163326256|NCT02284113|589905451|FG000|Overall Study|surgery cancelled|2|||
163326257|NCT02284113|589905452|FG001|Overall Study|surgery cancelled|0|||
163061320|NCT00614393|588933072|FG001|Overall Study|Withdrawal by Subject|1|||
163326258|NCT04191824|589905453|FG000|Overall Study|Death|13|||
163006468|NCT00262028|588725394|FG004|Overall Study|Protocol Violation|0|||
163006469|NCT00262028|588725395|FG005|Overall Study|Protocol Violation|0|||
163006470|NCT00262028|588725396|FG006|Overall Study|Protocol Violation|0|||
163061321|NCT00614393|588933073|FG002|Overall Study|Withdrawal by Subject|1|||
163213568|NCT05407675|589496005|FG002|Overall Study|Physician Decision|0|||
163213569|NCT05407675|589496006|FG003|Overall Study|Physician Decision|0|||
163213570|NCT05407675|589496007|FG004|Overall Study|Physician Decision|0|||
163213571|NCT05407675|589496008|FG005|Overall Study|Physician Decision|0|||
163213572|NCT05407675|589496009|FG006|Overall Study|Physician Decision|0|||
163326259|NCT04191824|589905454|FG001|Overall Study|Death|12|||
163326260|NCT04191824|589905453|FG000|Overall Study|Lost to Follow-up|456|||
163006471|NCT00262028|588725397|FG007|Overall Study|Protocol Violation|0|||
163006472|NCT00262028|588725398|FG008|Overall Study|Protocol Violation|0|||
163006473|NCT00262028|588725390|FG000|Overall Study|Unable to classify|0|||
163006474|NCT00262028|588725391|FG001|Overall Study|Unable to classify|3|||
163006475|NCT00262028|588725392|FG002|Overall Study|Unable to classify|0|||
163006476|NCT00262028|588725393|FG003|Overall Study|Unable to classify|0|||
163006477|NCT00262028|588725394|FG004|Overall Study|Unable to classify|0|||
163006478|NCT00262028|588725395|FG005|Overall Study|Unable to classify|0|||
163006479|NCT00262028|588725396|FG006|Overall Study|Unable to classify|0|||
163006480|NCT00262028|588725397|FG007|Overall Study|Unable to classify|0|||
163061322|NCT00614393|588933074|FG003|Overall Study|Withdrawal by Subject|16|||
163061323|NCT00614393|588933075|FG004|Overall Study|Withdrawal by Subject|13|||
163061324|NCT00614393|588933071|FG000|Overall Study|Other|4|||
163061325|NCT00614393|588933072|FG001|Overall Study|Other|0|||
163061326|NCT00614393|588933073|FG002|Overall Study|Other|0|||
163061327|NCT00614393|588933074|FG003|Overall Study|Other|4|||
163061328|NCT00614393|588933075|FG004|Overall Study|Other|2|||
163061329|NCT00614393|588933071|FG000|Overall Study|Not Treated|0|||
163061330|NCT00614393|588933072|FG001|Overall Study|Not Treated|0|||
163061331|NCT00614393|588933073|FG002|Overall Study|Not Treated|0|||
163061332|NCT00614393|588933074|FG003|Overall Study|Not Treated|0|||
163061333|NCT00614393|588933075|FG004|Overall Study|Not Treated|2|||
163061334|NCT02328105|588933076|FG000|Overall Study|Death|6|||
163061335|NCT02328105|588933076|FG000|Overall Study|Withdrawal by Subject|1|||
163061336|NCT02328105|588933076|FG000|Overall Study|Still On Study in Follow-Up|4|||
163061337|NCT01013753|588933081|FG000|Overall Study|Adverse Event|8|||
163061338|NCT01013753|588933081|FG000|Overall Study|Protocol Violation|3|||
163061339|NCT01013753|588933081|FG000|Overall Study|Lost to Follow-up|1|||
163061340|NCT01013753|588933081|FG000|Overall Study|Withdrawal by Subject|2|||
163061341|NCT01013753|588933081|FG000|Overall Study|Other|2|||
163061342|NCT05350423|588933082|FG000|Overall Study|Lost to Follow-up|3|||
163061343|NCT05350423|588933083|FG001|Overall Study|Lost to Follow-up|3|||
163061344|NCT05350423|588933082|FG000|Overall Study|screen failure|5|||
163061345|NCT05350423|588933083|FG001|Overall Study|screen failure|6|||
163061346|NCT02097277|588933084|FG000|Overall Study|Subject no longer meets study criteria|0|||
163061347|NCT02097277|588933085|FG001|Overall Study|Subject no longer meets study criteria|1|||
163061348|NCT02097277|588933086|FG002|Overall Study|Subject no longer meets study criteria|0|||
163061349|NCT02097277|588933087|FG003|Overall Study|Subject no longer meets study criteria|1|||
163061350|NCT02097277|588933088|FG004|Overall Study|Subject no longer meets study criteria|0|||
163006481|NCT00262028|588725398|FG008|Overall Study|Unable to classify|1|||
163006482|NCT03164551|588725399|FG000|Overall Study|Imaging discontinued prior completion|8|||
163006483|NCT03164551|588725400|FG001|Overall Study|Imaging discontinued prior completion|0|||
163061351|NCT02097277|588933084|FG000|Overall Study|Subject request to discontinue treatment|0|||
163061352|NCT02097277|588933085|FG001|Overall Study|Subject request to discontinue treatment|0|||
163061353|NCT02097277|588933086|FG002|Overall Study|Subject request to discontinue treatment|0|||
163061354|NCT02097277|588933087|FG003|Overall Study|Subject request to discontinue treatment|0|||
163061355|NCT02097277|588933088|FG004|Overall Study|Subject request to discontinue treatment|1|||
163061356|NCT02097277|588933084|FG000|Overall Study|Lost to Follow-up|0|||
163061357|NCT02097277|588933085|FG001|Overall Study|Lost to Follow-up|1|||
163061358|NCT02097277|588933086|FG002|Overall Study|Lost to Follow-up|1|||
163061359|NCT02097277|588933087|FG003|Overall Study|Lost to Follow-up|0|||
163061360|NCT02097277|588933088|FG004|Overall Study|Lost to Follow-up|0|||
163061361|NCT02097277|588933084|FG000|Overall Study|Withdrawal by Subject|2|||
163061362|NCT02097277|588933085|FG001|Overall Study|Withdrawal by Subject|1|||
163061363|NCT02097277|588933086|FG002|Overall Study|Withdrawal by Subject|0|||
163061364|NCT02097277|588933087|FG003|Overall Study|Withdrawal by Subject|1|||
163061365|NCT02097277|588933088|FG004|Overall Study|Withdrawal by Subject|0|||
163061366|NCT02097277|588933084|FG000|Overall Study|Adverse Event|0|||
163061367|NCT02097277|588933085|FG001|Overall Study|Adverse Event|0|||
163061368|NCT02097277|588933086|FG002|Overall Study|Adverse Event|1|||
163061369|NCT02097277|588933087|FG003|Overall Study|Adverse Event|2|||
163061370|NCT02097277|588933088|FG004|Overall Study|Adverse Event|0|||
163061371|NCT01461551|588933100|FG000|Overall Study|Physician Decision|2|||
163061372|NCT01461551|588933101|FG001|Overall Study|Physician Decision|1|||
163061373|NCT01461551|588933102|FG002|Overall Study|Physician Decision|2|||
163061374|NCT00303186|588933103|FG000|Overall Study|Other|52|||
163061375|NCT02326883|588933104|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
163061376|NCT02326883|588933105|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
163061377|NCT02326883|588933106|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
163061378|NCT01385176|588933107|FG000|Randomization Phase|Death|1|||
163061379|NCT01385176|588933108|FG001|Randomization Phase|Death|2|||
163061380|NCT01385176|588933107|FG000|6-18 Month All VNS Active|Death|1|||
163061381|NCT01385176|588933108|FG001|6-18 Month All VNS Active|Death|2|||
163061382|NCT01385176|588933107|FG000|6-18 Month All VNS Active|Physician Decision|0|||
163061383|NCT01385176|588933108|FG001|6-18 Month All VNS Active|Physician Decision|1|||
163061384|NCT01385176|588933107|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
163006484|NCT03164551|588725399|FG000|Overall Study|Participant was non-compliant|1|||
163061385|NCT01385176|588933108|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
163213573|NCT05407675|589496010|FG007|Overall Study|Physician Decision|0|||
163006485|NCT03164551|588725400|FG001|Overall Study|Participant was non-compliant|0|||
163006486|NCT03164551|588725399|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
163006487|NCT03164551|588725400|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
163006488|NCT03164551|588725399|FG000|Overall Study|Other|8|||
163006489|NCT03164551|588725400|FG001|Overall Study|Other|2|||
163006490|NCT01515423|588725401|FG000|Open Label Phase|Adverse Event|57|||
163006491|NCT01515423|588725402|FG001|Open Label Phase|Adverse Event|0|||
163006492|NCT01515423|588725403|FG002|Open Label Phase|Adverse Event|0|||
163006493|NCT01515423|588725401|FG000|Open Label Phase|Death|2|||
163006494|NCT01515423|588725402|FG001|Open Label Phase|Death|0|||
163006495|NCT01515423|588725403|FG002|Open Label Phase|Death|0|||
163006496|NCT01515423|588725401|FG000|Open Label Phase|Lack of Efficacy|117|||
163006497|NCT01515423|588725402|FG001|Open Label Phase|Lack of Efficacy|0|||
163006498|NCT01515423|588725403|FG002|Open Label Phase|Lack of Efficacy|0|||
163006499|NCT01515423|588725401|FG000|Open Label Phase|Lost to Follow-up|21|||
163006500|NCT01515423|588725402|FG001|Open Label Phase|Lost to Follow-up|0|||
163006501|NCT01515423|588725403|FG002|Open Label Phase|Lost to Follow-up|0|||
163006502|NCT01515423|588725401|FG000|Open Label Phase|Withdrawal by Subject|118|||
163006503|NCT01515423|588725402|FG001|Open Label Phase|Withdrawal by Subject|0|||
163006504|NCT01515423|588725403|FG002|Open Label Phase|Withdrawal by Subject|0|||
163006505|NCT01515423|588725401|FG000|Open Label Phase|excluded from DB Phase|70|||
163006506|NCT01515423|588725402|FG001|Open Label Phase|excluded from DB Phase|0|||
163006507|NCT01515423|588725403|FG002|Open Label Phase|excluded from DB Phase|0|||
163006508|NCT01515423|588725401|FG000|Open Label Phase|Other|28|||
163326261|NCT04191824|589905454|FG001|Overall Study|Lost to Follow-up|435|||
163326262|NCT04191824|589905453|FG000|Overall Study|Physician Decision|2|||
163326263|NCT04191824|589905454|FG001|Overall Study|Physician Decision|1|||
163326264|NCT04191824|589905453|FG000|Overall Study|Protocol Violation|0|||
163326265|NCT04191824|589905454|FG001|Overall Study|Protocol Violation|2|||
163326266|NCT04191824|589905453|FG000|Overall Study|Withdrawal by Subject|16|||
163326267|NCT04191824|589905454|FG001|Overall Study|Withdrawal by Subject|18|||
163326268|NCT04191824|589905453|FG000|Overall Study|Early site closure|24|||
163326269|NCT04191824|589905454|FG001|Overall Study|Early site closure|22|||
163326270|NCT01324310|589905457|FG000|Overall Study|Adverse Event|1|||
163326271|NCT01324310|589905457|FG000|Overall Study|Disease Progression|1|||
163326272|NCT03170882|589905458|FG000|Overall Study|Death|17|||
163326273|NCT03170882|589905459|FG001|Overall Study|Death|29|||
163326274|NCT03170882|589905458|FG000|Overall Study|Lost to Follow-up|0|||
163326275|NCT03170882|589905459|FG001|Overall Study|Lost to Follow-up|1|||
163326276|NCT03170882|589905458|FG000|Overall Study|Withdrawal by Subject|4|||
163326277|NCT03170882|589905459|FG001|Overall Study|Withdrawal by Subject|7|||
163326278|NCT03170882|589905458|FG000|Overall Study|Reason not Specified|28|||
163326279|NCT03170882|589905459|FG001|Overall Study|Reason not Specified|36|||
163326280|NCT03213457|589905460|FG000|Screening Period|Withdrawal by Subject|0|||
163326281|NCT03213457|589905461|FG001|Screening Period|Withdrawal by Subject|1|||
163326282|NCT03213457|589905462|FG002|Screening Period|Withdrawal by Subject|0|||
163326283|NCT03213457|589905460|FG000|Screening Period|Other|1|||
163326284|NCT03213457|589905461|FG001|Screening Period|Other|0|||
163326285|NCT03213457|589905462|FG002|Screening Period|Other|0|||
163006509|NCT01515423|588725402|FG001|Open Label Phase|Other|0|||
163006510|NCT01515423|588725403|FG002|Open Label Phase|Other|0|||
163006511|NCT01515423|588725401|FG000|DOUBLE BLIND|Adverse Event|0|||
163006512|NCT01515423|588725402|FG001|DOUBLE BLIND|Adverse Event|15|||
163006513|NCT01515423|588725403|FG002|DOUBLE BLIND|Adverse Event|13|||
163006514|NCT01515423|588725401|FG000|DOUBLE BLIND|Death|0|||
163006515|NCT01515423|588725402|FG001|DOUBLE BLIND|Death|1|||
163006516|NCT01515423|588725403|FG002|DOUBLE BLIND|Death|2|||
163006517|NCT01515423|588725401|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
163006518|NCT01515423|588725402|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
163006519|NCT01515423|588725403|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
163006520|NCT01515423|588725401|FG000|DOUBLE BLIND|Pregnancy|0|||
163006521|NCT01515423|588725402|FG001|DOUBLE BLIND|Pregnancy|2|||
163006522|NCT01515423|588725403|FG002|DOUBLE BLIND|Pregnancy|0|||
163326286|NCT03213457|589905460|FG000|Double-Blind Period|Adverse Event|3|||
163326287|NCT03213457|589905461|FG001|Double-Blind Period|Adverse Event|2|||
163006523|NCT01515423|588725401|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
163326288|NCT03213457|589905462|FG002|Double-Blind Period|Adverse Event|7|||
163326289|NCT03213457|589905460|FG000|Double-Blind Period|Withdrawal by Subject|14|||
163006524|NCT01515423|588725402|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
163006525|NCT01515423|588725403|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
163006526|NCT01515423|588725401|FG000|DOUBLE BLIND|Other|0|||
163006527|NCT01515423|588725402|FG001|DOUBLE BLIND|Other|6|||
163006528|NCT01515423|588725403|FG002|DOUBLE BLIND|Other|12|||
163006529|NCT01515423|588725401|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
163006530|NCT01515423|588725402|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
163006531|NCT01515423|588725403|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
163006532|NCT00995774|588725414|FG000|Training Period 2|Withdrawal by Subject|2|||
163006533|NCT00995774|588725415|FG001|Training Period 2|Withdrawal by Subject|0|||
163006534|NCT01998841|588725420|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
163326290|NCT03213457|589905461|FG001|Double-Blind Period|Withdrawal by Subject|2|||
163006535|NCT01998841|588725421|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
163006536|NCT01998841|588725422|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
163006537|NCT01998841|588725423|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
163006538|NCT01998841|588725424|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
163006539|NCT01998841|588725420|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
163006540|NCT01998841|588725421|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
163006541|NCT01998841|588725422|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
163006542|NCT01998841|588725423|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
163006543|NCT01998841|588725424|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
163006544|NCT00972595|588725425|FG000|Period 1|Adverse Event|1|||
163006545|NCT00972595|588725426|FG001|Period 1|Adverse Event|0|||
163006546|NCT01461538|588725427|FG000|Overall Study|Death|15|||
163006547|NCT01461538|588725428|FG001|Overall Study|Death|6|||
163006548|NCT01461538|588725429|FG002|Overall Study|Death|2|||
163006549|NCT01461538|588725427|FG000|Overall Study|Study Stopped by Sponsor|2|||
163006550|NCT01461538|588725428|FG001|Overall Study|Study Stopped by Sponsor|1|||
163006551|NCT01461538|588725429|FG002|Overall Study|Study Stopped by Sponsor|0|||
163006552|NCT01461538|588725427|FG000|Overall Study|Withdrawal by Subject|1|||
163006553|NCT01461538|588725428|FG001|Overall Study|Withdrawal by Subject|1|||
163006554|NCT01461538|588725429|FG002|Overall Study|Withdrawal by Subject|0|||
163006555|NCT00141778|588725430|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
163006556|NCT00141778|588725431|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
163006557|NCT00141778|588725432|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
163006558|NCT00141778|588725430|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
163006559|NCT00141778|588725431|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
163006560|NCT00141778|588725432|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
163006561|NCT00141778|588725430|FG000|Started Study Medication|Withdrawal by Subject|0|||
163006562|NCT00141778|588725431|FG001|Started Study Medication|Withdrawal by Subject|2|||
163006563|NCT00141778|588725432|FG002|Started Study Medication|Withdrawal by Subject|0|||
163006564|NCT00141778|588725430|FG000|Started Study Medication|Difficulty Swallowing|0|||
163006565|NCT00141778|588725431|FG001|Started Study Medication|Difficulty Swallowing|1|||
163006566|NCT00141778|588725432|FG002|Started Study Medication|Difficulty Swallowing|0|||
163006567|NCT00141778|588725430|FG000|Started Study Medication|Chest Discomfort|0|||
163006568|NCT00141778|588725431|FG001|Started Study Medication|Chest Discomfort|0|||
163006569|NCT00141778|588725432|FG002|Started Study Medication|Chest Discomfort|1|||
163006570|NCT01406574|588725434|FG000|Overall Study|Adverse Event|0|||
163006571|NCT01406574|588725435|FG001|Overall Study|Adverse Event|0|||
163006572|NCT01406574|588725436|FG002|Overall Study|Adverse Event|1|||
163006573|NCT01406574|588725437|FG003|Overall Study|Adverse Event|3|||
163006574|NCT01406574|588725434|FG000|Overall Study|Physician Decision|0|||
163006575|NCT01406574|588725435|FG001|Overall Study|Physician Decision|0|||
163006576|NCT01406574|588725436|FG002|Overall Study|Physician Decision|0|||
163006577|NCT01406574|588725437|FG003|Overall Study|Physician Decision|1|||
163006578|NCT01406574|588725434|FG000|Overall Study|Withdrawal by Subject|0|||
163006579|NCT01406574|588725435|FG001|Overall Study|Withdrawal by Subject|1|||
163006580|NCT01406574|588725436|FG002|Overall Study|Withdrawal by Subject|0|||
163006581|NCT01406574|588725437|FG003|Overall Study|Withdrawal by Subject|0|||
163006582|NCT01406574|588725434|FG000|Overall Study|Definite progression of primary disease|1|||
163006583|NCT01406574|588725435|FG001|Overall Study|Definite progression of primary disease|0|||
163006584|NCT01406574|588725436|FG002|Overall Study|Definite progression of primary disease|0|||
163006585|NCT01406574|588725437|FG003|Overall Study|Definite progression of primary disease|0|||
163006586|NCT04052620|588725438|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
163006587|NCT04052620|588725439|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
163006588|NCT04052620|588725438|FG000|Overall Study|Withdrawal by Subject|1|||
163006589|NCT04052620|588725439|FG001|Overall Study|Withdrawal by Subject|0|||
163006590|NCT04052620|588725438|FG000|Overall Study|Lost to Follow-up|1|||
163006591|NCT04052620|588725439|FG001|Overall Study|Lost to Follow-up|1|||
163006592|NCT04052620|588725438|FG000|Overall Study|Adverse Event|1|||
163006593|NCT04052620|588725439|FG001|Overall Study|Adverse Event|0|||
163006594|NCT04052620|588725438|FG000|Overall Study|Subject did not meet study Criteria|0|||
163006595|NCT04052620|588725439|FG001|Overall Study|Subject did not meet study Criteria|1|||
163006596|NCT04052620|588725438|FG000|Overall Study|Screened failure, randomized by mistake|0|||
163006597|NCT04052620|588725439|FG001|Overall Study|Screened failure, randomized by mistake|1|||
163006598|NCT04052620|588725438|FG000|Overall Study|Personal reasons|2|||
163006599|NCT04052620|588725439|FG001|Overall Study|Personal reasons|4|||
163006600|NCT04052620|588725438|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
163006601|NCT04052620|588725439|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
163006602|NCT03552380|588725441|FG000|Study Treatment|Disease Progression|3|||
163006603|NCT03552380|588725442|FG001|Study Treatment|Disease Progression|4|||
163006604|NCT03552380|588725441|FG000|Study Treatment|Adverse Event|2|||
163006605|NCT03552380|588725442|FG001|Study Treatment|Adverse Event|2|||
163213574|NCT05407675|589496011|FG008|Overall Study|Physician Decision|0|||
163213575|NCT05407675|589496012|FG009|Overall Study|Physician Decision|0|||
163213576|NCT05407675|589496013|FG010|Overall Study|Physician Decision|1|||
163213577|NCT05407675|589496014|FG011|Overall Study|Physician Decision|0|||
163213578|NCT05407675|589496015|FG012|Overall Study|Physician Decision|0|||
163213579|NCT05407675|589496003|FG000|Overall Study|Other reasons|0|||
163213580|NCT05407675|589496004|FG001|Overall Study|Other reasons|0|||
163006606|NCT03552380|588725441|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
163213581|NCT05407675|589496005|FG002|Overall Study|Other reasons|0|||
163213582|NCT05407675|589496006|FG003|Overall Study|Other reasons|0|||
163213583|NCT05407675|589496007|FG004|Overall Study|Other reasons|0|||
163213584|NCT05407675|589496008|FG005|Overall Study|Other reasons|0|||
163213585|NCT05407675|589496009|FG006|Overall Study|Other reasons|0|||
163006607|NCT03552380|588725442|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
163006608|NCT03552380|588725441|FG000|Follow up|Death|3|||
163006609|NCT03552380|588725442|FG001|Follow up|Death|4|||
163006610|NCT03552380|588725441|FG000|Follow up|Site IRB terminated|0|||
163006611|NCT03552380|588725442|FG001|Follow up|Site IRB terminated|1|||
163006612|NCT01112059|588725443|FG000|Overall Study|Withdrawal by Subject|1|||
163006613|NCT01112059|588725444|FG001|Overall Study|Withdrawal by Subject|0|||
163006614|NCT01245283|588725445|FG000|Overall Study|Lost to Follow-up|14|||
163006615|NCT01245283|588725446|FG001|Overall Study|Lost to Follow-up|11|||
163006616|NCT01245283|588725447|FG002|Overall Study|Lost to Follow-up|11|||
163006617|NCT03567980|588725454|FG000|Overall Study|Adverse Event|1|||
163006618|NCT03093259|588725458|FG000|Overall Study|Adverse Event|1|||
163006619|NCT03093259|588725459|FG001|Overall Study|Adverse Event|0|||
163006620|NCT03093259|588725458|FG000|Overall Study|Withdrawal by Subject|1|||
163006621|NCT03093259|588725459|FG001|Overall Study|Withdrawal by Subject|0|||
163213586|NCT05407675|589496010|FG007|Overall Study|Other reasons|0|||
163213587|NCT05407675|589496011|FG008|Overall Study|Other reasons|1|||
163213588|NCT05407675|589496012|FG009|Overall Study|Other reasons|1|||
163213589|NCT05407675|589496013|FG010|Overall Study|Other reasons|1|||
163213590|NCT05407675|589496014|FG011|Overall Study|Other reasons|1|||
163213591|NCT05407675|589496015|FG012|Overall Study|Other reasons|0|||
163213592|NCT05407675|589496003|FG000|Overall Study|Death|3|||
163213593|NCT05407675|589496004|FG001|Overall Study|Death|4|||
163213594|NCT05407675|589496005|FG002|Overall Study|Death|3|||
163213595|NCT05407675|589496006|FG003|Overall Study|Death|6|||
163213596|NCT05407675|589496007|FG004|Overall Study|Death|0|||
163213597|NCT05407675|589496008|FG005|Overall Study|Death|2|||
163213598|NCT05407675|589496009|FG006|Overall Study|Death|4|||
163213599|NCT05407675|589496010|FG007|Overall Study|Death|2|||
163213600|NCT05407675|589496011|FG008|Overall Study|Death|2|||
163061386|NCT01385176|588933107|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
163061387|NCT01385176|588933108|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
163061388|NCT01056536|588933109|FG000|Overall Study|Lost to Follow-up|202|||
163213601|NCT05407675|589496012|FG009|Overall Study|Death|4|||
163213602|NCT05407675|589496013|FG010|Overall Study|Death|2|||
163006622|NCT00550459|588725462|FG000|Overall Study|Adverse Event|0|||
163006623|NCT00550459|588725463|FG001|Overall Study|Adverse Event|2|||
163006624|NCT00550459|588725462|FG000|Overall Study|Withdrawal by Subject|1|||
163006625|NCT00550459|588725463|FG001|Overall Study|Withdrawal by Subject|1|||
163006626|NCT01401452|588725464|FG000|Overall Study|Adverse reaction|9|||
163006627|NCT01401452|588725464|FG000|Overall Study|Lost to Follow-up|12|||
163006628|NCT01401452|588725464|FG000|Overall Study|Lack of Efficacy|30|||
163006629|NCT01401452|588725464|FG000|Overall Study|Participant developed breast cancer|1|||
163006630|NCT01401452|588725464|FG000|Overall Study|Tx stopped due to financial reasons|1|||
163006631|NCT01401452|588725464|FG000|Overall Study|Tx stopped by psychiatrist|1|||
163006632|NCT01401452|588725464|FG000|Overall Study|No more visits within the 36 wk followup|4|||
163006633|NCT01401452|588725464|FG000|Overall Study|Subject did not come to follow up visits|2|||
163006634|NCT01401452|588725464|FG000|Overall Study|Subject didn't return for routine visits|1|||
163061389|NCT01056536|588933110|FG001|Overall Study|Lost to Follow-up|116|||
163213603|NCT05407675|589496014|FG011|Overall Study|Death|1|||
163213604|NCT05407675|589496015|FG012|Overall Study|Death|0|||
163326291|NCT03213457|589905462|FG002|Double-Blind Period|Withdrawal by Subject|14|||
163006635|NCT01401452|588725464|FG000|Overall Study|Subject moved to another city|1|||
163006636|NCT01401452|588725464|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
163006637|NCT01401452|588725464|FG000|Overall Study|Psoriatic arthritis|1|||
163006638|NCT01401452|588725464|FG000|Overall Study|Participant stopped Tx|2|||
163006639|NCT01401452|588725464|FG000|Overall Study|Discontinuation for personal reasons|1|||
163006640|NCT01401452|588725464|FG000|Overall Study|Treatment failure|1|||
163061390|NCT01056536|588933111|FG002|Overall Study|Lost to Follow-up|248|||
163213605|NCT05407675|589496003|FG000|Overall Study|Adverse Event|0|||
163213606|NCT05407675|589496004|FG001|Overall Study|Adverse Event|0|||
163213607|NCT05407675|589496005|FG002|Overall Study|Adverse Event|0|||
163213608|NCT05407675|589496006|FG003|Overall Study|Adverse Event|0|||
163213609|NCT05407675|589496007|FG004|Overall Study|Adverse Event|1|||
163213610|NCT05407675|589496008|FG005|Overall Study|Adverse Event|0|||
163213611|NCT05407675|589496009|FG006|Overall Study|Adverse Event|0|||
163006641|NCT01401452|588725464|FG000|Overall Study|Unsatisfactory output|1|||
163006642|NCT01401452|588725464|FG000|Overall Study|Subject withdrew because of Tx success|1|||
163006643|NCT01401452|588725464|FG000|Overall Study|Subject chose to discontinue treatment|1|||
163006644|NCT01401452|588725464|FG000|Overall Study|Participant withdrew consent|1|||
163006645|NCT02633787|588725465|FG000|Overall Study|Withdrawal by Subject|1|||
163006646|NCT00584454|588725466|FG000|Overall Study|Adverse Event|1|||
163006647|NCT00584454|588725466|FG000|Overall Study|Relocation|1|||
163006648|NCT00584454|588725466|FG000|Overall Study|Clinical Hold|2|||
163006649|NCT01742897|588725467|FG000|Overall Study|Adverse Event|3|||
163006650|NCT01742897|588725467|FG000|Overall Study|Withdrawal by Subject|1|||
163006651|NCT01742897|588725467|FG000|Overall Study|Other|1|||
163006652|NCT02404805|588725468|FG000|Overall Study|Withdrawal by Subject|1|||
163006653|NCT02404805|588725469|FG001|Overall Study|Withdrawal by Subject|0|||
163006654|NCT02404805|588725470|FG002|Overall Study|Withdrawal by Subject|0|||
163006655|NCT02404805|588725471|FG003|Overall Study|Withdrawal by Subject|0|||
163006656|NCT02404805|588725472|FG004|Overall Study|Withdrawal by Subject|0|||
163006657|NCT02404805|588725473|FG005|Overall Study|Withdrawal by Subject|0|||
163006658|NCT01459783|588725477|FG000|Baseline to 6 Months|Death|1|||
163006659|NCT01459783|588725478|FG001|Baseline to 6 Months|Death|0|||
163006660|NCT01459783|588725477|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
163006661|NCT01459783|588725478|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
163006662|NCT01459783|588725477|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
163006663|NCT01459783|588725478|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
163006664|NCT01459783|588725477|FG000|6 Months to 12 Months|Death|0|||
163006665|NCT01459783|588725478|FG001|6 Months to 12 Months|Death|1|||
163006666|NCT01459783|588725477|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
163006667|NCT01459783|588725478|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
163006668|NCT01459783|588725477|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
163006669|NCT01459783|588725478|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
163006670|NCT01459783|588725477|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
163006671|NCT01459783|588725478|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
163006672|NCT04199104|588727633|FG000|Overall Study|Death|148|||
163006673|NCT04199104|588727634|FG001|Overall Study|Death|134|||
163006674|NCT04199104|588727633|FG000|Overall Study|Lost to Follow-up|1|||
163006675|NCT04199104|588727634|FG001|Overall Study|Lost to Follow-up|1|||
163006676|NCT04199104|588727633|FG000|Overall Study|Withdrawal by Subject|4|||
163006677|NCT04199104|588727634|FG001|Overall Study|Withdrawal by Subject|4|||
163006678|NCT04199104|588727633|FG000|Overall Study|Participants Ongoing|103|||
163006679|NCT04199104|588727634|FG001|Overall Study|Participants Ongoing|116|||
163006680|NCT04563754|588727636|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
163006681|NCT04563754|588727637|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
163006682|NCT04563754|588727638|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
163006683|NCT04563754|588727636|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
163006684|NCT04563754|588727637|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
163006685|NCT04563754|588727638|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
163006686|NCT04563754|588727636|FG000|Follow up|Lost to Follow-up|61|||
163006687|NCT04563754|588727637|FG001|Follow up|Lost to Follow-up|23|||
163006688|NCT04563754|588727638|FG002|Follow up|Lost to Follow-up|5|||
163006689|NCT04563754|588727636|FG000|Follow up|Death|0|||
163006690|NCT04563754|588727637|FG001|Follow up|Death|2|||
163006691|NCT04563754|588727638|FG002|Follow up|Death|0|||
163006692|NCT04563754|588727636|FG000|Follow up|Ongoing|0|||
163006693|NCT04563754|588727637|FG001|Follow up|Ongoing|28|||
163006694|NCT04563754|588727638|FG002|Follow up|Ongoing|0|||
163006695|NCT00070564|588727639|FG000|Overall Study|Progression|2|||
163006696|NCT00070564|588727640|FG001|Overall Study|Progression|4|||
163006697|NCT00070564|588727641|FG002|Overall Study|Progression|7|||
163006698|NCT00070564|588727642|FG003|Overall Study|Progression|7|||
163006699|NCT00070564|588727643|FG004|Overall Study|Progression|1|||
163006700|NCT00070564|588727644|FG005|Overall Study|Progression|0|||
163006701|NCT00070564|588727639|FG000|Overall Study|Delinquent|1|||
163006702|NCT00070564|588727640|FG001|Overall Study|Delinquent|4|||
163006703|NCT00070564|588727641|FG002|Overall Study|Delinquent|2|||
163006704|NCT00070564|588727642|FG003|Overall Study|Delinquent|0|||
163006705|NCT00070564|588727643|FG004|Overall Study|Delinquent|0|||
163006706|NCT00070564|588727644|FG005|Overall Study|Delinquent|0|||
163326292|NCT03213457|589905460|FG000|Double-Blind Period|Lost to Follow-up|2|||
163326293|NCT03213457|589905461|FG001|Double-Blind Period|Lost to Follow-up|3|||
163006707|NCT00070564|588727639|FG000|Overall Study|Adverse Event|150|||
163006708|NCT00070564|588727640|FG001|Overall Study|Adverse Event|142|||
163006709|NCT00070564|588727641|FG002|Overall Study|Adverse Event|120|||
163006710|NCT00070564|588727642|FG003|Overall Study|Adverse Event|108|||
163006711|NCT00070564|588727643|FG004|Overall Study|Adverse Event|63|||
163006712|NCT00070564|588727644|FG005|Overall Study|Adverse Event|36|||
163006713|NCT00070564|588727639|FG000|Overall Study|Death|4|||
163006714|NCT00070564|588727640|FG001|Overall Study|Death|1|||
163006715|NCT00070564|588727641|FG002|Overall Study|Death|5|||
163006716|NCT00070564|588727642|FG003|Overall Study|Death|3|||
163006717|NCT00070564|588727643|FG004|Overall Study|Death|0|||
163006718|NCT00070564|588727644|FG005|Overall Study|Death|1|||
163006719|NCT00070564|588727639|FG000|Overall Study|Other, not protocol specified|17|||
163006720|NCT00070564|588727640|FG001|Overall Study|Other, not protocol specified|15|||
163006721|NCT00070564|588727641|FG002|Overall Study|Other, not protocol specified|14|||
163006722|NCT00070564|588727642|FG003|Overall Study|Other, not protocol specified|19|||
163006723|NCT00070564|588727643|FG004|Overall Study|Other, not protocol specified|6|||
163006724|NCT00070564|588727644|FG005|Overall Study|Other, not protocol specified|7|||
163006725|NCT00070564|588727639|FG000|Overall Study|Withdrawal by Subject|26|||
163006726|NCT00070564|588727640|FG001|Overall Study|Withdrawal by Subject|37|||
163006727|NCT00070564|588727641|FG002|Overall Study|Withdrawal by Subject|23|||
163006728|NCT00070564|588727642|FG003|Overall Study|Withdrawal by Subject|30|||
163006729|NCT00070564|588727643|FG004|Overall Study|Withdrawal by Subject|8|||
163006730|NCT00070564|588727644|FG005|Overall Study|Withdrawal by Subject|8|||
163006731|NCT00070564|588727639|FG000|Overall Study|Not reported|0|||
163006732|NCT00070564|588727640|FG001|Overall Study|Not reported|0|||
163006733|NCT00070564|588727641|FG002|Overall Study|Not reported|0|||
163006734|NCT00070564|588727642|FG003|Overall Study|Not reported|0|||
163006735|NCT00070564|588727643|FG004|Overall Study|Not reported|1|||
163006736|NCT00070564|588727644|FG005|Overall Study|Not reported|0|||
163006737|NCT04023396|588727645|FG000|Overall Study|Adverse Event|16|||
163006738|NCT04023396|588727645|FG000|Overall Study|Death|1|||
163006739|NCT04023396|588727645|FG000|Overall Study|Lost to Follow-up|1|||
163006740|NCT04023396|588727645|FG000|Overall Study|Withdrawal by Subject|14|||
163006741|NCT04023396|588727645|FG000|Overall Study|Pregnancy|4|||
163006742|NCT04023396|588727645|FG000|Overall Study|Lack of Efficacy|3|||
163006743|NCT04023396|588727645|FG000|Overall Study|Physician Decision|4|||
163006744|NCT04023396|588727645|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
163006745|NCT02325973|588727648|FG000|Overall Study|Death|5|||
163006746|NCT02325973|588727648|FG000|Overall Study|Withdrawal by subject or investigator|16|||
163006747|NCT04075825|588727649|FG000|Overall Study|Withdrawal by Subject|6|||
163006748|NCT04075825|588727650|FG001|Overall Study|Withdrawal by Subject|8|||
163006749|NCT04075825|588727649|FG000|Overall Study|Physician Decision|3|||
163006750|NCT04075825|588727650|FG001|Overall Study|Physician Decision|1|||
163006751|NCT04075825|588727649|FG000|Overall Study|Lost to Follow-up|5|||
163006752|NCT04075825|588727650|FG001|Overall Study|Lost to Follow-up|1|||
163006753|NCT04075825|588727649|FG000|Overall Study|Participation in New Clinical Trial|1|||
163006754|NCT04075825|588727650|FG001|Overall Study|Participation in New Clinical Trial|1|||
163006755|NCT04075825|588727649|FG000|Overall Study|Reason Not Specified|2|||
163006756|NCT04075825|588727650|FG001|Overall Study|Reason Not Specified|2|||
163006757|NCT01168232|588727651|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
163006758|NCT01168232|588727651|FG000|Overall Study|Ineligible- Wrong cell type|6|||
163006759|NCT01168232|588727651|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
163006760|NCT03879135|588727658|FG000|Overall Study|Physician Decision|0|||
163006761|NCT03879135|588727659|FG001|Overall Study|Physician Decision|0|||
163006762|NCT03879135|588727660|FG002|Overall Study|Physician Decision|0|||
163006763|NCT03879135|588727661|FG003|Overall Study|Physician Decision|1|||
163006764|NCT03879135|588727662|FG004|Overall Study|Physician Decision|0|||
163006765|NCT03879135|588727663|FG005|Overall Study|Physician Decision|0|||
163006766|NCT03879135|588727658|FG000|Overall Study|Withdrawal by Subject|0|||
163006767|NCT03879135|588727659|FG001|Overall Study|Withdrawal by Subject|0|||
163006768|NCT03879135|588727660|FG002|Overall Study|Withdrawal by Subject|0|||
163006769|NCT03879135|588727661|FG003|Overall Study|Withdrawal by Subject|0|||
163006770|NCT03879135|588727662|FG004|Overall Study|Withdrawal by Subject|0|||
163006771|NCT03879135|588727663|FG005|Overall Study|Withdrawal by Subject|1|||
163006772|NCT03879135|588727658|FG000|Overall Study|Site Closed by Sponsor|0|||
163006773|NCT03879135|588727659|FG001|Overall Study|Site Closed by Sponsor|0|||
163006774|NCT03879135|588727660|FG002|Overall Study|Site Closed by Sponsor|0|||
163061391|NCT00284856|588933112|FG000|Overall Study|Adverse Event|3|||
163061392|NCT00284856|588933113|FG001|Overall Study|Adverse Event|3|||
163061393|NCT00284856|588933114|FG002|Overall Study|Adverse Event|3|||
163326294|NCT03213457|589905462|FG002|Double-Blind Period|Lost to Follow-up|9|||
163326295|NCT03213457|589905460|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
163006775|NCT03879135|588727661|FG003|Overall Study|Site Closed by Sponsor|1|||
163006776|NCT03879135|588727662|FG004|Overall Study|Site Closed by Sponsor|1|||
163006777|NCT03879135|588727663|FG005|Overall Study|Site Closed by Sponsor|0|||
163006778|NCT05201794|588727664|FG000|Overall Study|Withdrawal by Subject|13|||
163006779|NCT05201794|588727665|FG001|Overall Study|Withdrawal by Subject|12|||
163006780|NCT05201794|588727666|FG002|Overall Study|Withdrawal by Subject|14|||
163006781|NCT05201794|588727667|FG003|Overall Study|Withdrawal by Subject|0|||
163006782|NCT05201794|588727664|FG000|Overall Study|Adverse Event|5|||
163006783|NCT05201794|588727665|FG001|Overall Study|Adverse Event|5|||
163006784|NCT05201794|588727666|FG002|Overall Study|Adverse Event|4|||
163006785|NCT05201794|588727667|FG003|Overall Study|Adverse Event|0|||
163061394|NCT00284856|588933112|FG000|Overall Study|Lack of Efficacy|2|||
163006786|NCT05201794|588727664|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
163006787|NCT05201794|588727665|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
163006788|NCT05201794|588727666|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
163006789|NCT05201794|588727667|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163006790|NCT05201794|588727664|FG000|Overall Study|Non-Compliance With Study Drug|2|||
163006791|NCT05201794|588727665|FG001|Overall Study|Non-Compliance With Study Drug|3|||
163006792|NCT05201794|588727666|FG002|Overall Study|Non-Compliance With Study Drug|3|||
163006793|NCT05201794|588727667|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163006794|NCT05201794|588727664|FG000|Overall Study|Physician Decision|1|||
163006795|NCT05201794|588727665|FG001|Overall Study|Physician Decision|3|||
163006796|NCT05201794|588727666|FG002|Overall Study|Physician Decision|2|||
163006797|NCT05201794|588727667|FG003|Overall Study|Physician Decision|0|||
163006798|NCT05201794|588727664|FG000|Overall Study|Lost to Follow-up|2|||
163006799|NCT05201794|588727665|FG001|Overall Study|Lost to Follow-up|2|||
163006800|NCT05201794|588727666|FG002|Overall Study|Lost to Follow-up|0|||
163006801|NCT05201794|588727667|FG003|Overall Study|Lost to Follow-up|0|||
163006802|NCT05201794|588727664|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
163006803|NCT05201794|588727665|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
163006804|NCT05201794|588727666|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
163006805|NCT05201794|588727667|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
163006806|NCT05201794|588727664|FG000|Overall Study|Protocol Violation|2|||
163006807|NCT05201794|588727665|FG001|Overall Study|Protocol Violation|0|||
163006808|NCT05201794|588727666|FG002|Overall Study|Protocol Violation|1|||
163006809|NCT05201794|588727667|FG003|Overall Study|Protocol Violation|0|||
163006810|NCT05201794|588727664|FG000|Overall Study|Death|1|||
163006811|NCT05201794|588727665|FG001|Overall Study|Death|0|||
163006812|NCT05201794|588727666|FG002|Overall Study|Death|0|||
163006813|NCT05201794|588727667|FG003|Overall Study|Death|0|||
163006814|NCT05201794|588727664|FG000|Overall Study|Site Terminated By Sponsor|0|||
163006815|NCT05201794|588727665|FG001|Overall Study|Site Terminated By Sponsor|1|||
163006816|NCT05201794|588727666|FG002|Overall Study|Site Terminated By Sponsor|0|||
163006817|NCT05201794|588727667|FG003|Overall Study|Site Terminated By Sponsor|0|||
163006818|NCT05201794|588727664|FG000|Overall Study|Other|3|||
163006819|NCT05201794|588727665|FG001|Overall Study|Other|3|||
163006820|NCT05201794|588727666|FG002|Overall Study|Other|3|||
163006821|NCT05201794|588727667|FG003|Overall Study|Other|0|||
163006822|NCT05201794|588727664|FG000|Overall Study|Randomized But Not Treated|1|||
163006823|NCT05201794|588727665|FG001|Overall Study|Randomized But Not Treated|2|||
163006824|NCT05201794|588727666|FG002|Overall Study|Randomized But Not Treated|1|||
163006825|NCT05201794|588727667|FG003|Overall Study|Randomized But Not Treated|0|||
163006826|NCT03428958|588727668|FG000|Overall Study|Adverse Event|0|||
163006827|NCT03428958|588727669|FG001|Overall Study|Adverse Event|0|||
163006828|NCT03428958|588727670|FG002|Overall Study|Adverse Event|0|||
163006829|NCT03428958|588727671|FG003|Overall Study|Adverse Event|1|||
163006830|NCT03428958|588727672|FG004|Overall Study|Adverse Event|0|||
163326296|NCT03213457|589905461|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
163006831|NCT03428958|588727673|FG005|Overall Study|Adverse Event|2|||
163006832|NCT03428958|588727674|FG006|Overall Study|Adverse Event|1|||
163006833|NCT03428958|588727675|FG007|Overall Study|Adverse Event|0|||
163006834|NCT03428958|588727676|FG008|Overall Study|Adverse Event|0|||
163006835|NCT03428958|588727677|FG009|Overall Study|Adverse Event|0|||
163006836|NCT03428958|588727678|FG010|Overall Study|Adverse Event|0|||
163006837|NCT03428958|588727679|FG011|Overall Study|Adverse Event|0|||
163006838|NCT03428958|588727680|FG012|Overall Study|Adverse Event|0|||
163006839|NCT03428958|588727681|FG013|Overall Study|Adverse Event|0|||
163006840|NCT03428958|588727682|FG014|Overall Study|Adverse Event|0|||
163061395|NCT00284856|588933113|FG001|Overall Study|Lack of Efficacy|1|||
163061396|NCT00284856|588933114|FG002|Overall Study|Lack of Efficacy|8|||
163326297|NCT03213457|589905462|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
163326298|NCT03213457|589905460|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
163006841|NCT03428958|588727683|FG015|Overall Study|Adverse Event|0|||
163006842|NCT03428958|588727684|FG016|Overall Study|Adverse Event|0|||
163006843|NCT03428958|588727668|FG000|Overall Study|Clinical Progression|2|||
163006844|NCT03428958|588727669|FG001|Overall Study|Clinical Progression|3|||
163006845|NCT03428958|588727670|FG002|Overall Study|Clinical Progression|2|||
163006846|NCT03428958|588727671|FG003|Overall Study|Clinical Progression|1|||
163006847|NCT03428958|588727672|FG004|Overall Study|Clinical Progression|0|||
163006848|NCT03428958|588727673|FG005|Overall Study|Clinical Progression|2|||
163006849|NCT03428958|588727674|FG006|Overall Study|Clinical Progression|0|||
163006850|NCT03428958|588727675|FG007|Overall Study|Clinical Progression|0|||
163006851|NCT03428958|588727676|FG008|Overall Study|Clinical Progression|0|||
163006852|NCT03428958|588727677|FG009|Overall Study|Clinical Progression|0|||
163006853|NCT03428958|588727678|FG010|Overall Study|Clinical Progression|0|||
163006854|NCT03428958|588727679|FG011|Overall Study|Clinical Progression|0|||
163006855|NCT03428958|588727680|FG012|Overall Study|Clinical Progression|0|||
163061397|NCT00284856|588933112|FG000|Overall Study|Lost to Follow-up|25|||
163006856|NCT03428958|588727681|FG013|Overall Study|Clinical Progression|0|||
163006857|NCT03428958|588727682|FG014|Overall Study|Clinical Progression|0|||
163006858|NCT03428958|588727683|FG015|Overall Study|Clinical Progression|0|||
163006859|NCT03428958|588727684|FG016|Overall Study|Clinical Progression|0|||
163006860|NCT03428958|588727668|FG000|Overall Study|Progression per RECIST|6|||
163006861|NCT03428958|588727669|FG001|Overall Study|Progression per RECIST|6|||
163006862|NCT03428958|588727670|FG002|Overall Study|Progression per RECIST|7|||
163006863|NCT03428958|588727671|FG003|Overall Study|Progression per RECIST|4|||
163006864|NCT03428958|588727672|FG004|Overall Study|Progression per RECIST|0|||
163006865|NCT03428958|588727673|FG005|Overall Study|Progression per RECIST|7|||
163006866|NCT03428958|588727674|FG006|Overall Study|Progression per RECIST|8|||
163006867|NCT03428958|588727675|FG007|Overall Study|Progression per RECIST|0|||
163006868|NCT03428958|588727676|FG008|Overall Study|Progression per RECIST|0|||
163006869|NCT03428958|588727677|FG009|Overall Study|Progression per RECIST|0|||
163006870|NCT03428958|588727678|FG010|Overall Study|Progression per RECIST|0|||
163006871|NCT03428958|588727679|FG011|Overall Study|Progression per RECIST|0|||
163006872|NCT03428958|588727680|FG012|Overall Study|Progression per RECIST|1|||
163006873|NCT03428958|588727681|FG013|Overall Study|Progression per RECIST|0|||
163006874|NCT03428958|588727682|FG014|Overall Study|Progression per RECIST|0|||
163006875|NCT03428958|588727683|FG015|Overall Study|Progression per RECIST|0|||
163006876|NCT03428958|588727684|FG016|Overall Study|Progression per RECIST|0|||
163006877|NCT03428958|588727668|FG000|Overall Study|Death|2|||
163006878|NCT03428958|588727669|FG001|Overall Study|Death|2|||
163006879|NCT03428958|588727670|FG002|Overall Study|Death|0|||
163006880|NCT03428958|588727671|FG003|Overall Study|Death|0|||
163006881|NCT03428958|588727672|FG004|Overall Study|Death|0|||
163006882|NCT03428958|588727673|FG005|Overall Study|Death|7|||
163006883|NCT03428958|588727674|FG006|Overall Study|Death|9|||
163006884|NCT03428958|588727675|FG007|Overall Study|Death|6|||
163006885|NCT03428958|588727676|FG008|Overall Study|Death|0|||
163006886|NCT03428958|588727677|FG009|Overall Study|Death|0|||
163006887|NCT03428958|588727678|FG010|Overall Study|Death|3|||
163006888|NCT03428958|588727679|FG011|Overall Study|Death|0|||
163006889|NCT03428958|588727680|FG012|Overall Study|Death|4|||
163006890|NCT03428958|588727681|FG013|Overall Study|Death|0|||
163006891|NCT03428958|588727682|FG014|Overall Study|Death|0|||
163006892|NCT03428958|588727683|FG015|Overall Study|Death|0|||
163006893|NCT03428958|588727684|FG016|Overall Study|Death|0|||
163006894|NCT03428958|588727668|FG000|Overall Study|Lost to Follow-up|0|||
163006895|NCT03428958|588727669|FG001|Overall Study|Lost to Follow-up|0|||
163006896|NCT03428958|588727670|FG002|Overall Study|Lost to Follow-up|0|||
163006897|NCT03428958|588727671|FG003|Overall Study|Lost to Follow-up|0|||
163006898|NCT03428958|588727672|FG004|Overall Study|Lost to Follow-up|0|||
163006899|NCT03428958|588727673|FG005|Overall Study|Lost to Follow-up|1|||
163006900|NCT03428958|588727674|FG006|Overall Study|Lost to Follow-up|1|||
163006901|NCT03428958|588727675|FG007|Overall Study|Lost to Follow-up|0|||
163006902|NCT03428958|588727676|FG008|Overall Study|Lost to Follow-up|0|||
163006903|NCT03428958|588727677|FG009|Overall Study|Lost to Follow-up|0|||
163006904|NCT03428958|588727678|FG010|Overall Study|Lost to Follow-up|0|||
163006905|NCT03428958|588727679|FG011|Overall Study|Lost to Follow-up|0|||
163006906|NCT03428958|588727680|FG012|Overall Study|Lost to Follow-up|0|||
163006907|NCT03428958|588727681|FG013|Overall Study|Lost to Follow-up|0|||
163006908|NCT03428958|588727682|FG014|Overall Study|Lost to Follow-up|0|||
163006909|NCT03428958|588727683|FG015|Overall Study|Lost to Follow-up|0|||
163006910|NCT03428958|588727684|FG016|Overall Study|Lost to Follow-up|0|||
163006911|NCT03428958|588727668|FG000|Overall Study|Physician/Sponsor Decision|1|||
163006912|NCT03428958|588727669|FG001|Overall Study|Physician/Sponsor Decision|0|||
163006913|NCT03428958|588727670|FG002|Overall Study|Physician/Sponsor Decision|1|||
163006914|NCT03428958|588727671|FG003|Overall Study|Physician/Sponsor Decision|0|||
163006915|NCT03428958|588727672|FG004|Overall Study|Physician/Sponsor Decision|0|||
163006916|NCT03428958|588727673|FG005|Overall Study|Physician/Sponsor Decision|2|||
163006917|NCT03428958|588727674|FG006|Overall Study|Physician/Sponsor Decision|2|||
163006918|NCT03428958|588727675|FG007|Overall Study|Physician/Sponsor Decision|2|||
163006919|NCT03428958|588727676|FG008|Overall Study|Physician/Sponsor Decision|0|||
163006920|NCT03428958|588727677|FG009|Overall Study|Physician/Sponsor Decision|0|||
163006921|NCT03428958|588727678|FG010|Overall Study|Physician/Sponsor Decision|2|||
163006922|NCT03428958|588727679|FG011|Overall Study|Physician/Sponsor Decision|0|||
163006923|NCT03428958|588727680|FG012|Overall Study|Physician/Sponsor Decision|4|||
163006924|NCT03428958|588727681|FG013|Overall Study|Physician/Sponsor Decision|0|||
163006925|NCT03428958|588727682|FG014|Overall Study|Physician/Sponsor Decision|0|||
163006926|NCT03428958|588727683|FG015|Overall Study|Physician/Sponsor Decision|0|||
163006927|NCT03428958|588727684|FG016|Overall Study|Physician/Sponsor Decision|0|||
163006928|NCT03428958|588727668|FG000|Overall Study|Withdrawal by Subject|0|||
163006929|NCT03428958|588727669|FG001|Overall Study|Withdrawal by Subject|0|||
163006930|NCT03428958|588727670|FG002|Overall Study|Withdrawal by Subject|2|||
163006931|NCT03428958|588727671|FG003|Overall Study|Withdrawal by Subject|0|||
163006932|NCT03428958|588727672|FG004|Overall Study|Withdrawal by Subject|0|||
163006933|NCT03428958|588727673|FG005|Overall Study|Withdrawal by Subject|2|||
163006934|NCT03428958|588727674|FG006|Overall Study|Withdrawal by Subject|4|||
163326299|NCT03213457|589905461|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
163006935|NCT03428958|588727675|FG007|Overall Study|Withdrawal by Subject|1|||
163006936|NCT03428958|588727676|FG008|Overall Study|Withdrawal by Subject|0|||
163006937|NCT03428958|588727677|FG009|Overall Study|Withdrawal by Subject|0|||
163006938|NCT03428958|588727678|FG010|Overall Study|Withdrawal by Subject|0|||
163006939|NCT03428958|588727679|FG011|Overall Study|Withdrawal by Subject|0|||
163006940|NCT03428958|588727680|FG012|Overall Study|Withdrawal by Subject|0|||
163006941|NCT03428958|588727681|FG013|Overall Study|Withdrawal by Subject|0|||
163006942|NCT03428958|588727682|FG014|Overall Study|Withdrawal by Subject|0|||
163006943|NCT03428958|588727683|FG015|Overall Study|Withdrawal by Subject|0|||
163006944|NCT03428958|588727684|FG016|Overall Study|Withdrawal by Subject|0|||
163006945|NCT03874117|588727685|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
163006946|NCT03874117|588727686|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
163006947|NCT03874117|588727685|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
163006948|NCT03874117|588727686|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
163006949|NCT03874117|588727685|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
163006950|NCT03874117|588727686|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163006951|NCT03874117|588727685|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
163006952|NCT03874117|588727686|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
163006953|NCT03874117|588727685|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
163006954|NCT03874117|588727686|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
163006955|NCT01490086|588727688|FG000|Overall Study|Consent withdrawn|4|||
163006956|NCT01490086|588727689|FG001|Overall Study|Consent withdrawn|4|||
163006957|NCT01490086|588727690|FG002|Overall Study|Consent withdrawn|3|||
163006958|NCT01490086|588727691|FG003|Overall Study|Consent withdrawn|0|||
163006959|NCT01490086|588727692|FG004|Overall Study|Consent withdrawn|1|||
163006960|NCT01490086|588727688|FG000|Overall Study|Non-compliance|0|||
163006961|NCT01490086|588727689|FG001|Overall Study|Non-compliance|1|||
163006962|NCT01490086|588727690|FG002|Overall Study|Non-compliance|0|||
163006963|NCT01490086|588727691|FG003|Overall Study|Non-compliance|0|||
163006964|NCT01490086|588727692|FG004|Overall Study|Non-compliance|0|||
163006965|NCT01490086|588727688|FG000|Overall Study|Abnormal laboratory findings|1|||
163006966|NCT01490086|588727689|FG001|Overall Study|Abnormal laboratory findings|0|||
163006967|NCT01490086|588727690|FG002|Overall Study|Abnormal laboratory findings|0|||
163006968|NCT01490086|588727691|FG003|Overall Study|Abnormal laboratory findings|0|||
163006969|NCT01490086|588727692|FG004|Overall Study|Abnormal laboratory findings|0|||
163006970|NCT01490086|588727688|FG000|Overall Study|Lost to Follow-up|0|||
163006971|NCT01490086|588727689|FG001|Overall Study|Lost to Follow-up|0|||
163006972|NCT01490086|588727690|FG002|Overall Study|Lost to Follow-up|0|||
163006973|NCT01490086|588727691|FG003|Overall Study|Lost to Follow-up|0|||
163006974|NCT01490086|588727692|FG004|Overall Study|Lost to Follow-up|1|||
163006975|NCT01490086|588727688|FG000|Overall Study|Physician Decision|3|||
163006976|NCT01490086|588727689|FG001|Overall Study|Physician Decision|4|||
163006977|NCT01490086|588727690|FG002|Overall Study|Physician Decision|2|||
163006978|NCT01490086|588727691|FG003|Overall Study|Physician Decision|3|||
163006979|NCT01490086|588727692|FG004|Overall Study|Physician Decision|1|||
163006980|NCT01490086|588727688|FG000|Overall Study|Adverse Event|0|||
163006981|NCT01490086|588727689|FG001|Overall Study|Adverse Event|0|||
163006982|NCT01490086|588727690|FG002|Overall Study|Adverse Event|1|||
163006983|NCT01490086|588727691|FG003|Overall Study|Adverse Event|2|||
163006984|NCT01490086|588727692|FG004|Overall Study|Adverse Event|0|||
163006985|NCT01490086|588727688|FG000|Overall Study|Lack of Efficacy|0|||
163006986|NCT01490086|588727689|FG001|Overall Study|Lack of Efficacy|3|||
163006987|NCT01490086|588727690|FG002|Overall Study|Lack of Efficacy|1|||
163006988|NCT01490086|588727691|FG003|Overall Study|Lack of Efficacy|0|||
163006989|NCT01490086|588727692|FG004|Overall Study|Lack of Efficacy|8|||
163006990|NCT01490086|588727688|FG000|Overall Study|Worsening of symptoms|0|||
163006991|NCT01490086|588727689|FG001|Overall Study|Worsening of symptoms|1|||
163006992|NCT01490086|588727690|FG002|Overall Study|Worsening of symptoms|0|||
163006993|NCT01490086|588727691|FG003|Overall Study|Worsening of symptoms|1|||
163006994|NCT01490086|588727692|FG004|Overall Study|Worsening of symptoms|0|||
163006995|NCT01490086|588727688|FG000|Overall Study|Subject uncontrollable and abusive|0|||
163061398|NCT00284856|588933113|FG001|Overall Study|Lost to Follow-up|21|||
163061399|NCT00284856|588933114|FG002|Overall Study|Lost to Follow-up|22|||
163326300|NCT03213457|589905462|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
163006996|NCT01490086|588727689|FG001|Overall Study|Subject uncontrollable and abusive|1|||
163006997|NCT01490086|588727690|FG002|Overall Study|Subject uncontrollable and abusive|0|||
163006998|NCT01490086|588727691|FG003|Overall Study|Subject uncontrollable and abusive|0|||
163006999|NCT01490086|588727692|FG004|Overall Study|Subject uncontrollable and abusive|0|||
163007000|NCT01490086|588727688|FG000|Overall Study|Subject left hospital|0|||
163007001|NCT01490086|588727689|FG001|Overall Study|Subject left hospital|1|||
163007002|NCT01490086|588727690|FG002|Overall Study|Subject left hospital|0|||
163007003|NCT01490086|588727691|FG003|Overall Study|Subject left hospital|1|||
163007004|NCT01490086|588727692|FG004|Overall Study|Subject left hospital|0|||
163007005|NCT04510090|588727695|FG000|FE-HS|Withdrawal by Subject|0|||
163007006|NCT04510090|588727696|FG001|FE-HS|Withdrawal by Subject|0|||
163007007|NCT04510090|588727697|FG002|FE-HS|Withdrawal by Subject|0|||
163007008|NCT04510090|588727698|FG003|FE-HS|Withdrawal by Subject|0|||
163007009|NCT04510090|588727699|FG004|FE-HS|Withdrawal by Subject|1|||
163007010|NCT04510090|588727700|FG005|FE-HS|Withdrawal by Subject|0|||
163007011|NCT04510090|588727701|FG006|FE-HS|Withdrawal by Subject|0|||
163007012|NCT04510090|588727702|FG007|FE-HS|Withdrawal by Subject|0|||
163007013|NCT01127256|588727703|FG000|Overall Study|Adverse Event|13|||
163007014|NCT01127256|588727704|FG001|Overall Study|Adverse Event|13|||
163007015|NCT01127256|588727703|FG000|Overall Study|Lack of Efficacy|4|||
163007016|NCT01127256|588727704|FG001|Overall Study|Lack of Efficacy|0|||
163007017|NCT01127256|588727703|FG000|Overall Study|Lost to Follow-up|16|||
163007018|NCT01127256|588727704|FG001|Overall Study|Lost to Follow-up|17|||
163007019|NCT01127256|588727703|FG000|Overall Study|Withdrawal by Subject|5|||
163007020|NCT01127256|588727704|FG001|Overall Study|Withdrawal by Subject|9|||
163007021|NCT01127256|588727703|FG000|Overall Study|Protocol Violation|1|||
163007022|NCT01127256|588727704|FG001|Overall Study|Protocol Violation|0|||
163007023|NCT03657797|588727720|FG000|Overall Study|Lost to Follow-up|0|||
163007024|NCT03657797|588727721|FG001|Overall Study|Lost to Follow-up|1|||
163007025|NCT03657797|588727722|FG002|Overall Study|Lost to Follow-up|1|||
163007026|NCT03657797|588727723|FG003|Overall Study|Lost to Follow-up|0|||
163007027|NCT03657797|588727720|FG000|Overall Study|Physician Decision|0|||
163007028|NCT03657797|588727721|FG001|Overall Study|Physician Decision|1|||
163007029|NCT03657797|588727722|FG002|Overall Study|Physician Decision|0|||
163007030|NCT03657797|588727723|FG003|Overall Study|Physician Decision|0|||
163007031|NCT03657797|588727720|FG000|Overall Study|Withdrawal by Subject|0|||
163007032|NCT03657797|588727721|FG001|Overall Study|Withdrawal by Subject|1|||
163007033|NCT03657797|588727722|FG002|Overall Study|Withdrawal by Subject|2|||
163007034|NCT03657797|588727723|FG003|Overall Study|Withdrawal by Subject|0|||
163007035|NCT03657797|588727720|FG000|Overall Study|Adverse Event|0|||
163007036|NCT03657797|588727721|FG001|Overall Study|Adverse Event|0|||
163007037|NCT03657797|588727722|FG002|Overall Study|Adverse Event|2|||
163007038|NCT03657797|588727723|FG003|Overall Study|Adverse Event|0|||
163007039|NCT00711243|588727724|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
163007040|NCT00711243|588727725|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
163007041|NCT00711243|588727726|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
163007042|NCT00711243|588727727|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
163007043|NCT00711243|588727728|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
163007044|NCT00711243|588727729|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
163007045|NCT00711243|588727724|FG000|Reached First Response/4 Cycles|Death|0|||
163007046|NCT00711243|588727725|FG001|Reached First Response/4 Cycles|Death|0|||
163007047|NCT00711243|588727726|FG002|Reached First Response/4 Cycles|Death|0|||
163007048|NCT00711243|588727727|FG003|Reached First Response/4 Cycles|Death|0|||
163007049|NCT00711243|588727728|FG004|Reached First Response/4 Cycles|Death|0|||
163007050|NCT00711243|588727729|FG005|Reached First Response/4 Cycles|Death|2|||
163007051|NCT00711243|588727724|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
163007052|NCT00711243|588727725|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
163007053|NCT00711243|588727726|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
163007054|NCT00711243|588727727|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
163007055|NCT00711243|588727728|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
163007056|NCT00711243|588727729|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
163007057|NCT00711243|588727724|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
163007058|NCT00711243|588727725|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
163007059|NCT00711243|588727726|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
163007060|NCT00711243|588727727|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
163007061|NCT00711243|588727728|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
163007062|NCT00711243|588727729|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
163007063|NCT00711243|588727724|FG000|Treated Cycle 5 After First Response|Death|0|||
163007064|NCT00711243|588727725|FG001|Treated Cycle 5 After First Response|Death|0|||
163007065|NCT00711243|588727726|FG002|Treated Cycle 5 After First Response|Death|0|||
163007066|NCT00711243|588727727|FG003|Treated Cycle 5 After First Response|Death|0|||
163007067|NCT00711243|588727728|FG004|Treated Cycle 5 After First Response|Death|0|||
163007068|NCT00711243|588727729|FG005|Treated Cycle 5 After First Response|Death|2|||
163007069|NCT00711243|588727724|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
163007070|NCT00711243|588727725|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
163007071|NCT00711243|588727726|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
163007072|NCT00711243|588727727|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
163007073|NCT00711243|588727728|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
163007074|NCT00711243|588727729|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
163007075|NCT00711243|588727724|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
163213612|NCT05407675|589496010|FG007|Overall Study|Adverse Event|0|||
163213613|NCT05407675|589496011|FG008|Overall Study|Adverse Event|0|||
163213614|NCT05407675|589496012|FG009|Overall Study|Adverse Event|0|||
163213615|NCT05407675|589496013|FG010|Overall Study|Adverse Event|0|||
163213616|NCT05407675|589496014|FG011|Overall Study|Adverse Event|1|||
163213617|NCT05407675|589496015|FG012|Overall Study|Adverse Event|0|||
163213618|NCT05407675|589496003|FG000|Overall Study|Ongoing Treatment|0|||
163213619|NCT05407675|589496004|FG001|Overall Study|Ongoing Treatment|0|||
163213620|NCT05407675|589496005|FG002|Overall Study|Ongoing Treatment|0|||
163007076|NCT00711243|588727725|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
163007077|NCT00711243|588727726|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
163007078|NCT00711243|588727727|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
163007079|NCT00711243|588727728|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
163007080|NCT00711243|588727729|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
163007081|NCT01402570|588727730|FG000|Overall Study|Adverse Event|1|||
163007082|NCT03642262|588727733|FG000|Period 1|Withdrawal by Subject|1|||
163007083|NCT03642262|588727734|FG001|Period 1|Withdrawal by Subject|1|||
163007084|NCT03642262|588727733|FG000|Period 1|Adverse Event|0|||
163007085|NCT03642262|588727734|FG001|Period 1|Adverse Event|1|||
163007086|NCT02572570|588727735|FG000|Overall Study|Study Terminated|27|||
163007087|NCT02019472|588727736|FG000|Overall Study|Adverse Event|14|||
163007088|NCT02019472|588727737|FG001|Overall Study|Adverse Event|23|||
163007089|NCT02019472|588727738|FG002|Overall Study|Adverse Event|17|||
163007090|NCT02019472|588727736|FG000|Overall Study|Death|0|||
163007091|NCT02019472|588727737|FG001|Overall Study|Death|1|||
163007092|NCT02019472|588727738|FG002|Overall Study|Death|1|||
163007093|NCT02019472|588727736|FG000|Overall Study|Lack of Efficacy|7|||
163007094|NCT02019472|588727737|FG001|Overall Study|Lack of Efficacy|4|||
163007095|NCT02019472|588727738|FG002|Overall Study|Lack of Efficacy|4|||
163007096|NCT02019472|588727736|FG000|Overall Study|Lost to Follow-up|0|||
163007097|NCT02019472|588727737|FG001|Overall Study|Lost to Follow-up|2|||
163007098|NCT02019472|588727738|FG002|Overall Study|Lost to Follow-up|1|||
163007099|NCT02019472|588727736|FG000|Overall Study|Physician Decision|1|||
163007100|NCT02019472|588727737|FG001|Overall Study|Physician Decision|2|||
163213621|NCT05407675|589496006|FG003|Overall Study|Ongoing Treatment|0|||
163213622|NCT05407675|589496007|FG004|Overall Study|Ongoing Treatment|0|||
163213623|NCT05407675|589496008|FG005|Overall Study|Ongoing Treatment|0|||
163213624|NCT05407675|589496009|FG006|Overall Study|Ongoing Treatment|0|||
163213625|NCT05407675|589496010|FG007|Overall Study|Ongoing Treatment|0|||
163213626|NCT05407675|589496011|FG008|Overall Study|Ongoing Treatment|1|||
163213627|NCT05407675|589496012|FG009|Overall Study|Ongoing Treatment|0|||
163213628|NCT05407675|589496013|FG010|Overall Study|Ongoing Treatment|0|||
163213629|NCT05407675|589496014|FG011|Overall Study|Ongoing Treatment|0|||
163213630|NCT05407675|589496015|FG012|Overall Study|Ongoing Treatment|0|||
163213631|NCT02612428|589496016|FG000|VTL-308|Death|14|||
163213632|NCT02612428|589496017|FG001|VTL-308|Death|16|||
163213633|NCT02612428|589496016|FG000|VTL-308|Withdrawal by Subject|0|||
163213634|NCT02612428|589496017|FG001|VTL-308|Withdrawal by Subject|1|||
163213635|NCT02612428|589496016|FG000|VTL-308E|Death|9|||
163213636|NCT02612428|589496017|FG001|VTL-308E|Death|7|||
163213637|NCT02612428|589496016|FG000|VTL-308E|Lost to Follow-up|2|||
163213638|NCT02612428|589496017|FG001|VTL-308E|Lost to Follow-up|0|||
163213639|NCT00742001|589496018|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
163213640|NCT00742001|589496019|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
163007101|NCT02019472|588727738|FG002|Overall Study|Physician Decision|0|||
163007102|NCT02019472|588727736|FG000|Overall Study|Pregnancy|1|||
163007103|NCT02019472|588727737|FG001|Overall Study|Pregnancy|2|||
163007104|NCT02019472|588727738|FG002|Overall Study|Pregnancy|2|||
163007105|NCT02019472|588727736|FG000|Overall Study|Withdrawal by Subject|11|||
163007106|NCT02019472|588727737|FG001|Overall Study|Withdrawal by Subject|10|||
163007107|NCT02019472|588727738|FG002|Overall Study|Withdrawal by Subject|11|||
163007108|NCT02019472|588727736|FG000|Overall Study|Other|3|||
163007109|NCT02019472|588727737|FG001|Overall Study|Other|8|||
163007110|NCT02019472|588727738|FG002|Overall Study|Other|6|||
163007111|NCT00513695|588727739|FG000|Overall Study|Discontinued therapy|2|||
163213641|NCT00742001|589496020|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
163213642|NCT01928329|589496023|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
163213643|NCT01928329|589496024|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
163007112|NCT00513695|588727739|FG000|Overall Study|Progression prior to surgery|3|||
163007113|NCT02157935|588727742|FG000|Overall Study|Withdrawal by Subject|25|||
163007114|NCT02157935|588727743|FG001|Overall Study|Withdrawal by Subject|39|||
163007115|NCT02157935|588727742|FG000|Overall Study|Screen failure|1|||
163007116|NCT02157935|588727743|FG001|Overall Study|Screen failure|2|||
163007117|NCT02157935|588727742|FG000|Overall Study|Protocol Violation|1|||
163007118|NCT02157935|588727743|FG001|Overall Study|Protocol Violation|0|||
163007119|NCT02157935|588727742|FG000|Overall Study|Progressive disease|0|||
163007120|NCT02157935|588727743|FG001|Overall Study|Progressive disease|2|||
163007121|NCT02157935|588727742|FG000|Overall Study|Other|5|||
163213644|NCT01928329|589496023|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
163213645|NCT01928329|589496024|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
163213646|NCT01928329|589496023|FG000|Overall Study|Adverse Event|5|||
163007122|NCT02157935|588727743|FG001|Overall Study|Other|12|||
163007123|NCT02157935|588727742|FG000|Overall Study|Lack of Efficacy|0|||
163007124|NCT02157935|588727743|FG001|Overall Study|Lack of Efficacy|1|||
163007125|NCT02157935|588727742|FG000|Overall Study|Death|4|||
163007126|NCT02157935|588727743|FG001|Overall Study|Death|4|||
163007127|NCT02157935|588727742|FG000|Overall Study|Adverse Event|3|||
163007128|NCT02157935|588727743|FG001|Overall Study|Adverse Event|5|||
163007129|NCT01417156|588727744|FG000|Overall Study|Adverse Event|12|||
163007130|NCT01417156|588727744|FG000|Overall Study|Protocol Violation|2|||
163007131|NCT03192488|588727745|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
163007132|NCT03192488|588727746|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
163007133|NCT03192488|588727747|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
163007134|NCT03192488|588727748|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
163007135|NCT03192488|588727749|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
163007136|NCT03192488|588727750|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
163007137|NCT03192488|588727745|FG000|Third Intervention (d1)|Adverse Event|0|||
163007138|NCT03192488|588727746|FG001|Third Intervention (d1)|Adverse Event|0|||
163007139|NCT03192488|588727747|FG002|Third Intervention (d1)|Adverse Event|0|||
163007140|NCT03192488|588727748|FG003|Third Intervention (d1)|Adverse Event|0|||
163007141|NCT03192488|588727749|FG004|Third Intervention (d1)|Adverse Event|1|||
163007142|NCT03192488|588727750|FG005|Third Intervention (d1)|Adverse Event|0|||
163007143|NCT00611923|588727752|FG000|Overall Study|Withdrawal by Subject|2|||
163007144|NCT00611923|588727753|FG001|Overall Study|Withdrawal by Subject|2|||
163007145|NCT02302833|588727767|FG000|Overall Study|Lost to Follow-up|3|||
163007146|NCT04429503|588727768|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
163007147|NCT04429503|588727769|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
163007148|NCT04429503|588727770|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
163007149|NCT04429503|588727771|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
163007150|NCT04429503|588727772|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
163007151|NCT04429503|588727773|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
163007152|NCT04429503|588727768|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
163007153|NCT04429503|588727769|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
163007154|NCT04429503|588727770|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
163007155|NCT04429503|588727771|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
163007156|NCT04429503|588727772|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
163007157|NCT04429503|588727773|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
163007158|NCT04429503|588727768|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
163007159|NCT04429503|588727769|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
163007160|NCT04429503|588727770|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
163007161|NCT04429503|588727771|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
163007162|NCT04429503|588727772|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
163007163|NCT04429503|588727773|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
163007164|NCT04429503|588727768|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
163007165|NCT04429503|588727769|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
163007166|NCT04429503|588727770|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
163007167|NCT04429503|588727771|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
163007168|NCT04429503|588727772|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
163007169|NCT04429503|588727773|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
163007170|NCT04429503|588727768|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
163007171|NCT04429503|588727769|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
163007172|NCT04429503|588727770|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
163007173|NCT04429503|588727771|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
163007174|NCT04429503|588727772|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
163007175|NCT04429503|588727773|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
163007176|NCT04429503|588727768|FG000|Main Study (Up to Wk 96)|Death|9|||
163007177|NCT04429503|588727769|FG001|Main Study (Up to Wk 96)|Death|18|||
163007178|NCT04429503|588727770|FG002|Main Study (Up to Wk 96)|Death|5|||
163007179|NCT04429503|588727771|FG003|Main Study (Up to Wk 96)|Death|0|||
163007180|NCT04429503|588727772|FG004|Main Study (Up to Wk 96)|Death|0|||
163007181|NCT04429503|588727773|FG005|Main Study (Up to Wk 96)|Death|0|||
163007182|NCT04429503|588727768|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
163007183|NCT04429503|588727769|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
163007184|NCT04429503|588727770|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
163007185|NCT04429503|588727771|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
163007186|NCT04429503|588727772|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
163061400|NCT00284856|588933112|FG000|Overall Study|Protocol Violation|5|||
163007187|NCT04429503|588727773|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
163007188|NCT04429503|588727768|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
163007189|NCT04429503|588727769|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
163007190|NCT04429503|588727770|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
163007191|NCT04429503|588727771|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
163061401|NCT00284856|588933113|FG001|Overall Study|Protocol Violation|4|||
163007192|NCT04429503|588727772|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
163007193|NCT04429503|588727773|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
163007194|NCT04429503|588727768|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
163007195|NCT04429503|588727769|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
163007196|NCT04429503|588727770|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
163007197|NCT04429503|588727771|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
163007198|NCT04429503|588727772|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
163007199|NCT04429503|588727773|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
163007200|NCT04429503|588727768|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
163007201|NCT04429503|588727769|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
163007202|NCT04429503|588727770|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
163007203|NCT04429503|588727771|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
163007204|NCT04429503|588727772|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
163007205|NCT04429503|588727773|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
163007206|NCT04429503|588727768|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
163007207|NCT04429503|588727769|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
163007208|NCT04429503|588727770|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
163007209|NCT04429503|588727771|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
163007210|NCT04429503|588727772|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
163007211|NCT04429503|588727773|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
163007212|NCT04429503|588727768|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
163007213|NCT04429503|588727769|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
163007214|NCT04429503|588727770|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
163007215|NCT04429503|588727771|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
163007216|NCT04429503|588727772|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
163007217|NCT04429503|588727773|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
163007218|NCT05516108|588727774|FG000|Overall Study|Time Commitment|3|||
163007219|NCT05516108|588727775|FG001|Overall Study|Time Commitment|1|||
163007220|NCT05516108|588727774|FG000|Overall Study|Reason Unknown|2|||
163007221|NCT05516108|588727775|FG001|Overall Study|Reason Unknown|4|||
163007222|NCT03664232|588727776|FG000|Overall Study|Withdrawal by Subject|0|||
163007223|NCT03664232|588727777|FG001|Overall Study|Withdrawal by Subject|1|||
163007224|NCT03664232|588727778|FG002|Overall Study|Withdrawal by Subject|0|||
163007225|NCT03664232|588727779|FG003|Overall Study|Withdrawal by Subject|1|||
163007226|NCT03664232|588727776|FG000|Overall Study|Adverse Event|0|||
163007227|NCT03664232|588727777|FG001|Overall Study|Adverse Event|0|||
163007228|NCT03664232|588727778|FG002|Overall Study|Adverse Event|1|||
163007229|NCT03664232|588727779|FG003|Overall Study|Adverse Event|0|||
163007230|NCT03664232|588727776|FG000|Overall Study|Other-Non-compliance with study drug|0|||
163007231|NCT03664232|588727777|FG001|Overall Study|Other-Non-compliance with study drug|1|||
163007232|NCT03664232|588727778|FG002|Overall Study|Other-Non-compliance with study drug|0|||
163007233|NCT03664232|588727779|FG003|Overall Study|Other-Non-compliance with study drug|2|||
163007234|NCT03664232|588727776|FG000|Overall Study|Other-Unspecified|0|||
163007235|NCT03664232|588727777|FG001|Overall Study|Other-Unspecified|3|||
163007236|NCT03664232|588727778|FG002|Overall Study|Other-Unspecified|0|||
163007237|NCT03664232|588727779|FG003|Overall Study|Other-Unspecified|1|||
163007238|NCT03664232|588727776|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
163007239|NCT03664232|588727777|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
163007240|NCT03664232|588727778|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
163007241|NCT03664232|588727779|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
163007242|NCT02717507|588727780|FG000|Overall Study|Lost to Follow-up|5|||
163007243|NCT02717507|588727781|FG001|Overall Study|Lost to Follow-up|8|||
163007244|NCT02717507|588727780|FG000|Overall Study|Pregnancy|1|||
163007245|NCT02717507|588727781|FG001|Overall Study|Pregnancy|1|||
163007246|NCT02717507|588727780|FG000|Overall Study|Protocol Violation|2|||
163007247|NCT02717507|588727781|FG001|Overall Study|Protocol Violation|2|||
163007248|NCT02717507|588727780|FG000|Overall Study|Withdrawal by Subject|20|||
163007249|NCT02717507|588727781|FG001|Overall Study|Withdrawal by Subject|20|||
163007250|NCT02717507|588727780|FG000|Overall Study|Relapse|1|||
163007251|NCT02717507|588727781|FG001|Overall Study|Relapse|1|||
163007252|NCT02717507|588727780|FG000|Overall Study|Cardiac Event|2|||
163007253|NCT02717507|588727781|FG001|Overall Study|Cardiac Event|6|||
163007254|NCT05017246|588727782|FG000|Overall Study|Withdrawal by Subject|5|||
163007255|NCT05017246|588727783|FG001|Overall Study|Withdrawal by Subject|3|||
163007256|NCT05017246|588727782|FG000|Overall Study|Determined to be ineligible|0|||
163061402|NCT00284856|588933114|FG002|Overall Study|Protocol Violation|5|||
163213647|NCT01928329|589496024|FG001|Overall Study|Adverse Event|3|||
163007257|NCT05017246|588727783|FG001|Overall Study|Determined to be ineligible|1|||
163007258|NCT05017246|588727782|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
163007259|NCT05017246|588727783|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
163007260|NCT05017246|588727782|FG000|Overall Study|Technical failure|1|||
163007261|NCT05017246|588727783|FG001|Overall Study|Technical failure|3|||
163326301|NCT03213457|589905460|FG000|Double-Blind Period|Pregnancy|5|||
163326302|NCT03213457|589905461|FG001|Double-Blind Period|Pregnancy|0|||
163326303|NCT03213457|589905462|FG002|Double-Blind Period|Pregnancy|0|||
163326304|NCT03213457|589905460|FG000|Double-Blind Period|Other|10|||
163326305|NCT03213457|589905461|FG001|Double-Blind Period|Other|3|||
163326306|NCT03213457|589905462|FG002|Double-Blind Period|Other|17|||
163326307|NCT03213457|589905460|FG000|Open-Label Period|Adverse Event|1|||
163326308|NCT03213457|589905461|FG001|Open-Label Period|Adverse Event|2|||
163326309|NCT03213457|589905462|FG002|Open-Label Period|Adverse Event|2|||
163326310|NCT03213457|589905460|FG000|Open-Label Period|Withdrawal by Subject|12|||
163326311|NCT03213457|589905461|FG001|Open-Label Period|Withdrawal by Subject|5|||
163326312|NCT03213457|589905462|FG002|Open-Label Period|Withdrawal by Subject|24|||
163326313|NCT03213457|589905460|FG000|Open-Label Period|Lost to Follow-up|1|||
163326314|NCT03213457|589905461|FG001|Open-Label Period|Lost to Follow-up|2|||
163326315|NCT03213457|589905462|FG002|Open-Label Period|Lost to Follow-up|8|||
163326316|NCT03213457|589905460|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
163326317|NCT03213457|589905461|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
163007262|NCT02493660|588727784|FG000|Overall Study|Physician Decision|0|||
163007263|NCT02493660|588727785|FG001|Overall Study|Physician Decision|1|||
163007264|NCT02493660|588727784|FG000|Overall Study|Adverse Event|4|||
163007265|NCT02493660|588727785|FG001|Overall Study|Adverse Event|2|||
163007266|NCT02493660|588727784|FG000|Overall Study|Withdrawal by Subject|2|||
163007267|NCT02493660|588727785|FG001|Overall Study|Withdrawal by Subject|3|||
163007268|NCT02493660|588727784|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
163007269|NCT02493660|588727785|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
163007270|NCT02493660|588727784|FG000|Overall Study|Protocol Violation|0|||
163007271|NCT02493660|588727785|FG001|Overall Study|Protocol Violation|1|||
163007272|NCT02493660|588727784|FG000|Overall Study|Death|0|||
163007273|NCT02493660|588727785|FG001|Overall Study|Death|1|||
163007274|NCT02493660|588727784|FG000|Overall Study|Lost to Follow-up|2|||
163007275|NCT02493660|588727785|FG001|Overall Study|Lost to Follow-up|4|||
163007276|NCT00709995|588727788|FG000|Overall Study|Adverse Event|4|||
163007277|NCT00709995|588727789|FG001|Overall Study|Adverse Event|2|||
163007278|NCT00709995|588727788|FG000|Overall Study|Withdrawal by Subject|1|||
163007279|NCT00709995|588727789|FG001|Overall Study|Withdrawal by Subject|3|||
163007280|NCT00638508|588727790|FG000|Overall Study|Physician Decision|5|||
163007281|NCT00638508|588727791|FG001|Overall Study|Physician Decision|2|||
163007282|NCT03500198|588727792|FG000|Overall Study|Lost to Follow-up|0|||
163007283|NCT03500198|588727793|FG001|Overall Study|Lost to Follow-up|1|||
163007284|NCT00654095|588727794|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
163007285|NCT00654095|588727794|FG000|Overall Study|Elevated triglyceride level (2)|1|||
163007286|NCT00654095|588727794|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
163007287|NCT00654095|588727794|FG000|Overall Study|Adverse Event|11|||
163007288|NCT00654095|588727794|FG000|Overall Study|Withdrawal by Subject|5|||
163007289|NCT00654095|588727794|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
163007290|NCT00654095|588727794|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
163007291|NCT00654095|588727794|FG000|Overall Study|Did not meet inclusion criteria|1|||
163007292|NCT00595621|588727800|FG000|Open Label Run in|Adverse Event|1|||
163007293|NCT00595621|588727801|FG001|Open Label Run in|Adverse Event|0|||
163007294|NCT00595621|588727800|FG000|Open Label Run in|Physician Decision|1|||
163007295|NCT00595621|588727801|FG001|Open Label Run in|Physician Decision|0|||
163007296|NCT00595621|588727800|FG000|Open Label Run in|Withdrawal by Subject|1|||
163007297|NCT00595621|588727801|FG001|Open Label Run in|Withdrawal by Subject|0|||
163007298|NCT00595621|588727800|FG000|Randomization and Study|Adverse Event|2|||
163007299|NCT00595621|588727801|FG001|Randomization and Study|Adverse Event|0|||
163007300|NCT00595621|588727800|FG000|Randomization and Study|Withdrawal by Subject|0|||
163007301|NCT00595621|588727801|FG001|Randomization and Study|Withdrawal by Subject|1|||
163007302|NCT02440464|588727802|FG000|Overall Study|Withdrawal by Subject|3|||
163007303|NCT02440464|588727803|FG001|Overall Study|Withdrawal by Subject|2|||
163007304|NCT00324987|588727804|FG000|Overall Study|Adverse Event|2|||
163007305|NCT00324987|588727805|FG001|Overall Study|Adverse Event|1|||
163007306|NCT00324987|588727804|FG000|Overall Study|Withdrawal by Subject|1|||
163007307|NCT00324987|588727805|FG001|Overall Study|Withdrawal by Subject|1|||
163326318|NCT03213457|589905462|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
163326319|NCT03213457|589905460|FG000|Open-Label Period|Non-compliance with study procedures|1|||
163326320|NCT03213457|589905461|FG001|Open-Label Period|Non-compliance with study procedures|1|||
163326321|NCT03213457|589905462|FG002|Open-Label Period|Non-compliance with study procedures|2|||
163007308|NCT00324987|588727804|FG000|Overall Study|Progression|1|||
163007309|NCT00324987|588727805|FG001|Overall Study|Progression|1|||
163007310|NCT00324987|588727804|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
163007311|NCT00324987|588727805|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
163326322|NCT03213457|589905460|FG000|Open-Label Period|Exclusionary medications|0|||
163326323|NCT03213457|589905461|FG001|Open-Label Period|Exclusionary medications|0|||
163007312|NCT02568072|588727807|FG000|Overall Study|Unavailable for appointment|23|||
163061403|NCT00284856|588933112|FG000|Overall Study|Withdrawal by Subject|12|||
163061404|NCT00284856|588933113|FG001|Overall Study|Withdrawal by Subject|16|||
163061405|NCT00284856|588933114|FG002|Overall Study|Withdrawal by Subject|18|||
163061406|NCT00284856|588933112|FG000|Overall Study|Other|4|||
163061407|NCT00284856|588933113|FG001|Overall Study|Other|5|||
163061408|NCT00284856|588933114|FG002|Overall Study|Other|4|||
163061409|NCT05853120|588933115|FG000|Overall Study|Lost to Follow-up|4|||
163061410|NCT05853120|588933116|FG001|Overall Study|Lost to Follow-up|4|||
163061411|NCT05853120|588933115|FG000|Overall Study|Physician Decision|3|||
163326324|NCT03213457|589905462|FG002|Open-Label Period|Exclusionary medications|1|||
163326325|NCT03213457|589905460|FG000|Open-Label Period|Other|1|||
163326326|NCT03213457|589905461|FG001|Open-Label Period|Other|1|||
163007313|NCT02568072|588727807|FG000|Overall Study|Unable to contact|3|||
163007314|NCT02568072|588727807|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
163007315|NCT02568072|588727807|FG000|Overall Study|Withdrawal by Subject|1|||
163007316|NCT02568072|588727807|FG000|Overall Study|Sustained injury, marathon not run|24|||
163007317|NCT05263908|588727808|FG000|Overall Study|No informed consent for publication of study results|397|||
163007318|NCT05263908|588727808|FG000|Overall Study|CRF not collected|1|||
163007319|NCT02714218|588727809|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163007320|NCT02714218|588727810|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
163007321|NCT02714218|588727811|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163007322|NCT02714218|588727809|FG000|Pre-Treatment Period|Other reasons|0|||
163007323|NCT02714218|588727810|FG001|Pre-Treatment Period|Other reasons|1|||
163007324|NCT02714218|588727811|FG002|Pre-Treatment Period|Other reasons|0|||
163007325|NCT02714218|588727809|FG000|Treatment Period|Disease Progression|55|||
163007326|NCT02714218|588727810|FG001|Treatment Period|Disease Progression|52|||
163007327|NCT02714218|588727811|FG002|Treatment Period|Disease Progression|14|||
163007328|NCT02714218|588727809|FG000|Treatment Period|Study drug toxicity|46|||
163007329|NCT02714218|588727810|FG001|Treatment Period|Study drug toxicity|70|||
163007330|NCT02714218|588727811|FG002|Treatment Period|Study drug toxicity|6|||
163007331|NCT02714218|588727809|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
163007332|NCT02714218|588727810|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
163007333|NCT02714218|588727811|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
163007334|NCT02714218|588727809|FG000|Treatment Period|Request to discontinue treatment|1|||
163007335|NCT02714218|588727810|FG001|Treatment Period|Request to discontinue treatment|4|||
163007336|NCT02714218|588727811|FG002|Treatment Period|Request to discontinue treatment|1|||
163007337|NCT02714218|588727809|FG000|Treatment Period|Participant withdrew consent|2|||
163007338|NCT02714218|588727810|FG001|Treatment Period|Participant withdrew consent|2|||
163007339|NCT02714218|588727811|FG002|Treatment Period|Participant withdrew consent|0|||
163007340|NCT02714218|588727809|FG000|Treatment Period|Maximum clinical benefit|4|||
163007341|NCT02714218|588727810|FG001|Treatment Period|Maximum clinical benefit|2|||
163007342|NCT02714218|588727811|FG002|Treatment Period|Maximum clinical benefit|0|||
163007343|NCT02714218|588727809|FG000|Treatment Period|Administrative reason by sponsor|2|||
163007344|NCT02714218|588727810|FG001|Treatment Period|Administrative reason by sponsor|1|||
163007345|NCT02714218|588727811|FG002|Treatment Period|Administrative reason by sponsor|0|||
163007346|NCT02714218|588727809|FG000|Treatment Period|Other reasons|6|||
163007347|NCT02714218|588727810|FG001|Treatment Period|Other reasons|6|||
163007348|NCT02714218|588727811|FG002|Treatment Period|Other reasons|0|||
163007349|NCT02714218|588727809|FG000|Treatment Period|Completed treatment as per protocol|36|||
163007350|NCT02714218|588727810|FG001|Treatment Period|Completed treatment as per protocol|27|||
163007351|NCT02714218|588727811|FG002|Treatment Period|Completed treatment as per protocol|3|||
163007352|NCT02714218|588727809|FG000|Treatment Period|Not reported|9|||
163007353|NCT02714218|588727810|FG001|Treatment Period|Not reported|6|||
163007354|NCT02714218|588727811|FG002|Treatment Period|Not reported|0|||
163007355|NCT00840749|588727814|FG000|Overall Study|Death|1|||
163326327|NCT03213457|589905462|FG002|Open-Label Period|Other|6|||
163326328|NCT03213457|589905460|FG000|Follow-Up Period|Adverse Event|16|||
163007356|NCT00840749|588727815|FG001|Overall Study|Death|2|||
163007357|NCT00840749|588727814|FG000|Overall Study|not treated on study arm|11|||
163326329|NCT03213457|589905461|FG001|Follow-Up Period|Adverse Event|8|||
163326330|NCT03213457|589905462|FG002|Follow-Up Period|Adverse Event|37|||
163326331|NCT03213457|589905460|FG000|Follow-Up Period|Withdrawal by Subject|18|||
163007358|NCT00840749|588727815|FG001|Overall Study|not treated on study arm|11|||
163007359|NCT00840749|588727814|FG000|Overall Study|study closed|19|||
163007360|NCT00840749|588727815|FG001|Overall Study|study closed|14|||
163007361|NCT01113892|588727820|FG000|Overall Study|Lost to Follow-up|2|||
163007362|NCT01113892|588727821|FG001|Overall Study|Lost to Follow-up|2|||
163007363|NCT01113892|588727820|FG000|Overall Study|Withdrawal by Subject|1|||
163007364|NCT01113892|588727821|FG001|Overall Study|Withdrawal by Subject|1|||
163061412|NCT05853120|588933116|FG001|Overall Study|Physician Decision|0|||
163061413|NCT05853120|588933115|FG000|Overall Study|Withdrawal by Subject|5|||
163061414|NCT05853120|588933116|FG001|Overall Study|Withdrawal by Subject|2|||
163007365|NCT01113892|588727820|FG000|Overall Study|Death|2|||
163007366|NCT01113892|588727821|FG001|Overall Study|Death|4|||
163061415|NCT00790036|588933117|FG000|Overall Study|Abnormal lab values|3|||
163007367|NCT01113892|588727820|FG000|Overall Study|Graft no longer evaluable|9|||
163007368|NCT01113892|588727821|FG001|Overall Study|Graft no longer evaluable|9|||
163007369|NCT00789854|588727824|FG000|Overall Study|Adverse Event|28|||
163007370|NCT00789854|588727825|FG001|Overall Study|Adverse Event|23|||
163007371|NCT00789854|588727826|FG002|Overall Study|Adverse Event|18|||
163007372|NCT00789854|588727824|FG000|Overall Study|Lost to Follow-up|1|||
163007373|NCT00789854|588727825|FG001|Overall Study|Lost to Follow-up|1|||
163007374|NCT00789854|588727826|FG002|Overall Study|Lost to Follow-up|4|||
163007375|NCT00789854|588727824|FG000|Overall Study|Withdrawal by Subject|9|||
163007376|NCT00789854|588727825|FG001|Overall Study|Withdrawal by Subject|6|||
163007377|NCT00789854|588727826|FG002|Overall Study|Withdrawal by Subject|17|||
163007378|NCT00789854|588727824|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
163007379|NCT00789854|588727825|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
163007380|NCT00789854|588727826|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
163007381|NCT00789854|588727824|FG000|Overall Study|Severe non-compliance to the protocol|3|||
163007382|NCT00789854|588727825|FG001|Overall Study|Severe non-compliance to the protocol|0|||
163007383|NCT00789854|588727826|FG002|Overall Study|Severe non-compliance to the protocol|0|||
163007384|NCT00789854|588727824|FG000|Overall Study|Safety reasons|0|||
163007385|NCT00789854|588727825|FG001|Overall Study|Safety reasons|0|||
163007386|NCT00789854|588727826|FG002|Overall Study|Safety reasons|2|||
163007387|NCT00789854|588727824|FG000|Overall Study|Other|6|||
163007388|NCT00789854|588727825|FG001|Overall Study|Other|0|||
163007389|NCT00789854|588727826|FG002|Overall Study|Other|5|||
163007390|NCT03473925|588727827|FG000|Overall Study|Death|48|||
163007391|NCT03473925|588727828|FG001|Overall Study|Death|44|||
163007392|NCT03473925|588727827|FG000|Overall Study|Sponsor Decision|2|||
163007393|NCT03473925|588727828|FG001|Overall Study|Sponsor Decision|7|||
163007394|NCT03473925|588727827|FG000|Overall Study|Withdrawal by Subject|1|||
163007395|NCT03473925|588727828|FG001|Overall Study|Withdrawal by Subject|3|||
163007396|NCT03473925|588727827|FG000|Overall Study|Not Treated|1|||
163007397|NCT03473925|588727828|FG001|Overall Study|Not Treated|1|||
163007398|NCT02756611|588727830|FG000|Overall Study|Death|70|||
163007399|NCT02756611|588727830|FG000|Overall Study|Withdrawal by Subject|2|||
163007400|NCT02756611|588727830|FG000|Overall Study|Lost to Follow-up|3|||
163007401|NCT02756611|588727830|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
163007402|NCT02756611|588727830|FG000|Overall Study|Other|10|||
163007403|NCT03125798|588727831|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
163007404|NCT03125798|588727832|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
163007405|NCT03125798|588727831|FG000|Overall Study|Conversion to thoracotomy|7|||
163007406|NCT03125798|588727832|FG001|Overall Study|Conversion to thoracotomy|7|||
163007407|NCT01422213|588727839|FG000|Overall Study|Adverse Event|8|||
163007408|NCT01422213|588727840|FG001|Overall Study|Adverse Event|7|||
163007409|NCT01422213|588727841|FG002|Overall Study|Adverse Event|11|||
163007410|NCT01422213|588727839|FG000|Overall Study|Lack of Efficacy|10|||
163007411|NCT01422213|588727840|FG001|Overall Study|Lack of Efficacy|2|||
163007412|NCT01422213|588727841|FG002|Overall Study|Lack of Efficacy|2|||
163007413|NCT01422213|588727839|FG000|Overall Study|Non-compliance with study drug|0|||
163007414|NCT01422213|588727840|FG001|Overall Study|Non-compliance with study drug|1|||
163007415|NCT01422213|588727841|FG002|Overall Study|Non-compliance with study drug|0|||
163007416|NCT01422213|588727839|FG000|Overall Study|Protocol Violation|0|||
163007417|NCT01422213|588727840|FG001|Overall Study|Protocol Violation|2|||
163007418|NCT01422213|588727841|FG002|Overall Study|Protocol Violation|4|||
163007419|NCT01422213|588727839|FG000|Overall Study|Withdrawal of Consent|7|||
163007420|NCT01422213|588727840|FG001|Overall Study|Withdrawal of Consent|3|||
163007421|NCT01422213|588727841|FG002|Overall Study|Withdrawal of Consent|5|||
163007422|NCT01422213|588727839|FG000|Overall Study|Lost to Follow-up|3|||
163007423|NCT01422213|588727840|FG001|Overall Study|Lost to Follow-up|3|||
163007424|NCT01422213|588727841|FG002|Overall Study|Lost to Follow-up|5|||
163007425|NCT01422213|588727839|FG000|Overall Study|Administrative or Other Reason(s)|5|||
163007426|NCT01422213|588727840|FG001|Overall Study|Administrative or Other Reason(s)|4|||
163007427|NCT01422213|588727841|FG002|Overall Study|Administrative or Other Reason(s)|2|||
163007428|NCT00476190|588727845|FG000|Overall Study|Ineligible|1|||
163007429|NCT00476190|588727846|FG001|Overall Study|Ineligible|1|||
163007430|NCT00476190|588727845|FG000|Overall Study|Induction Death|2|||
163213648|NCT01928329|589496023|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
163007431|NCT00476190|588727846|FG001|Overall Study|Induction Death|0|||
163007432|NCT00476190|588727845|FG000|Overall Study|Induction Failure|2|||
163007433|NCT00476190|588727846|FG001|Overall Study|Induction Failure|4|||
163007434|NCT00476190|588727845|FG000|Overall Study|Lost to Follow-up|1|||
163007435|NCT00476190|588727846|FG001|Overall Study|Lost to Follow-up|0|||
163007436|NCT00476190|588727845|FG000|Overall Study|Relapse/Progression|5|||
163007437|NCT00476190|588727846|FG001|Overall Study|Relapse/Progression|2|||
163007438|NCT00476190|588727845|FG000|Overall Study|Remission Death|0|||
163007439|NCT00476190|588727846|FG001|Overall Study|Remission Death|1|||
163007440|NCT00476190|588727845|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
163007441|NCT00476190|588727846|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
163213649|NCT01928329|589496024|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
163326332|NCT03213457|589905461|FG001|Follow-Up Period|Withdrawal by Subject|11|||
163326333|NCT03213457|589905462|FG002|Follow-Up Period|Withdrawal by Subject|55|||
163326334|NCT03213457|589905460|FG000|Follow-Up Period|Lost to Follow-up|28|||
163326335|NCT03213457|589905461|FG001|Follow-Up Period|Lost to Follow-up|15|||
163326336|NCT03213457|589905462|FG002|Follow-Up Period|Lost to Follow-up|50|||
163326337|NCT03213457|589905460|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
163326338|NCT03213457|589905461|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
163326339|NCT03213457|589905462|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
163326340|NCT03213457|589905460|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
163007442|NCT00476190|588727845|FG000|Overall Study|Withdrawal by Subject|6|||
163007443|NCT00476190|588727846|FG001|Overall Study|Withdrawal by Subject|2|||
163007444|NCT00476190|588727845|FG000|Overall Study|Other|9|||
163007445|NCT00476190|588727846|FG001|Overall Study|Other|10|||
163007446|NCT04782076|588727847|FG000|Overall Study|Family Emergency|1|||
163007447|NCT04565145|588729988|FG000|Overall Study|Withdrawal by Subject|1|||
163007448|NCT04565145|588729989|FG001|Overall Study|Withdrawal by Subject|1|||
163007449|NCT02547428|588729990|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
163007450|NCT02547428|588729991|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
163007451|NCT02547428|588729990|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
163007452|NCT02547428|588729991|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
163007453|NCT02547428|588729990|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
163007454|NCT02547428|588729991|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
163007455|NCT02547428|588729990|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
163007456|NCT02547428|588729991|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
163007457|NCT02547428|588729990|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
163007458|NCT02547428|588729991|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
163007459|NCT02547428|588729990|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
163007460|NCT02547428|588729991|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
163007461|NCT02547428|588729990|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
163007462|NCT02547428|588729991|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
163007463|NCT02547428|588729990|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
163007464|NCT02547428|588729991|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
163007465|NCT00742209|588730004|FG000|Overall Study|Adverse Event|11|||
163007466|NCT00742209|588730005|FG001|Overall Study|Adverse Event|4|||
163007467|NCT00742209|588730006|FG002|Overall Study|Adverse Event|17|||
163007468|NCT00742209|588730007|FG003|Overall Study|Adverse Event|16|||
163007469|NCT00742209|588730008|FG004|Overall Study|Adverse Event|13|||
163007470|NCT00742209|588730004|FG000|Overall Study|Participant Withdrew Consent|8|||
163007471|NCT00742209|588730005|FG001|Overall Study|Participant Withdrew Consent|4|||
163007472|NCT00742209|588730006|FG002|Overall Study|Participant Withdrew Consent|14|||
163007473|NCT00742209|588730007|FG003|Overall Study|Participant Withdrew Consent|7|||
163007474|NCT00742209|588730008|FG004|Overall Study|Participant Withdrew Consent|4|||
163007475|NCT00742209|588730004|FG000|Overall Study|Protocol Violation|6|||
163061416|NCT00790036|588933118|FG001|Overall Study|Abnormal lab values|2|||
163061417|NCT00790036|588933117|FG000|Overall Study|Administrative problems|5|||
163061418|NCT00790036|588933118|FG001|Overall Study|Administrative problems|9|||
163061419|NCT00790036|588933117|FG000|Overall Study|Adverse Event|113|||
163061420|NCT00790036|588933118|FG001|Overall Study|Adverse Event|44|||
163061421|NCT00790036|588933117|FG000|Overall Study|Death|1|||
163061422|NCT00790036|588933118|FG001|Overall Study|Death|0|||
163061423|NCT00790036|588933117|FG000|Overall Study|Disease progression|24|||
163061424|NCT00790036|588933118|FG001|Overall Study|Disease progression|48|||
163061425|NCT00790036|588933117|FG000|Overall Study|Lost to Follow-up|1|||
163326341|NCT03213457|589905461|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
163326342|NCT03213457|589905462|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
163326343|NCT03213457|589905460|FG000|Follow-Up Period|Pregnancy|7|||
163326344|NCT03213457|589905461|FG001|Follow-Up Period|Pregnancy|0|||
163007476|NCT00742209|588730005|FG001|Overall Study|Protocol Violation|5|||
163007477|NCT00742209|588730006|FG002|Overall Study|Protocol Violation|4|||
163007478|NCT00742209|588730007|FG003|Overall Study|Protocol Violation|5|||
163007479|NCT00742209|588730008|FG004|Overall Study|Protocol Violation|3|||
163007480|NCT00742209|588730004|FG000|Overall Study|Lost to Follow-up|3|||
163007481|NCT00742209|588730005|FG001|Overall Study|Lost to Follow-up|4|||
163007482|NCT00742209|588730006|FG002|Overall Study|Lost to Follow-up|5|||
163007483|NCT00742209|588730007|FG003|Overall Study|Lost to Follow-up|5|||
163007484|NCT00742209|588730008|FG004|Overall Study|Lost to Follow-up|3|||
163061426|NCT00790036|588933118|FG001|Overall Study|Lost to Follow-up|2|||
163061427|NCT00790036|588933117|FG000|Overall Study|Protocol Violation|10|||
163007485|NCT00742209|588730004|FG000|Overall Study|Lack of Efficacy|6|||
163007486|NCT00742209|588730005|FG001|Overall Study|Lack of Efficacy|1|||
163061428|NCT00790036|588933118|FG001|Overall Study|Protocol Violation|2|||
163061429|NCT00790036|588933117|FG000|Overall Study|Withdrawal by Subject|18|||
163326345|NCT03213457|589905462|FG002|Follow-Up Period|Pregnancy|18|||
163007487|NCT00742209|588730006|FG002|Overall Study|Lack of Efficacy|1|||
163007488|NCT00742209|588730007|FG003|Overall Study|Lack of Efficacy|3|||
163007489|NCT00742209|588730008|FG004|Overall Study|Lack of Efficacy|1|||
163007490|NCT00742209|588730004|FG000|Overall Study|Investigator Discretion|0|||
163007491|NCT00742209|588730005|FG001|Overall Study|Investigator Discretion|0|||
163007492|NCT00742209|588730006|FG002|Overall Study|Investigator Discretion|5|||
163007493|NCT00742209|588730007|FG003|Overall Study|Investigator Discretion|1|||
163007494|NCT00742209|588730008|FG004|Overall Study|Investigator Discretion|1|||
163007495|NCT02003209|588730009|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
163007496|NCT02003209|588730010|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
163007497|NCT00485264|588730013|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
163007498|NCT00485264|588730014|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
163007499|NCT00485264|588730015|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
163007500|NCT00485264|588730016|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
163007501|NCT00485264|588730017|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
163007502|NCT00485264|588730018|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
163007503|NCT00485264|588730013|FG000|Overall Study|Death|1|||
163007504|NCT00485264|588730014|FG001|Overall Study|Death|0|||
163007505|NCT00485264|588730015|FG002|Overall Study|Death|0|||
163007506|NCT00485264|588730016|FG003|Overall Study|Death|0|||
163007507|NCT00485264|588730017|FG004|Overall Study|Death|1|||
163007508|NCT00485264|588730018|FG005|Overall Study|Death|0|||
163007509|NCT00485264|588730013|FG000|Overall Study|Adverse Event|1|||
163007510|NCT00485264|588730014|FG001|Overall Study|Adverse Event|0|||
163007511|NCT00485264|588730015|FG002|Overall Study|Adverse Event|2|||
163007512|NCT00485264|588730016|FG003|Overall Study|Adverse Event|3|||
163007513|NCT00485264|588730017|FG004|Overall Study|Adverse Event|1|||
163007514|NCT00485264|588730018|FG005|Overall Study|Adverse Event|3|||
163007515|NCT00485264|588730013|FG000|Overall Study|Pregnancy|4|||
163007516|NCT00485264|588730014|FG001|Overall Study|Pregnancy|0|||
163007517|NCT00485264|588730015|FG002|Overall Study|Pregnancy|0|||
163007518|NCT00485264|588730016|FG003|Overall Study|Pregnancy|0|||
163007519|NCT00485264|588730017|FG004|Overall Study|Pregnancy|0|||
163007520|NCT00485264|588730018|FG005|Overall Study|Pregnancy|0|||
163007521|NCT00485264|588730013|FG000|Overall Study|Disallowed Medication|0|||
163007522|NCT00485264|588730014|FG001|Overall Study|Disallowed Medication|0|||
163007523|NCT00485264|588730015|FG002|Overall Study|Disallowed Medication|0|||
163007524|NCT00485264|588730016|FG003|Overall Study|Disallowed Medication|0|||
163007525|NCT00485264|588730017|FG004|Overall Study|Disallowed Medication|0|||
163007526|NCT00485264|588730018|FG005|Overall Study|Disallowed Medication|1|||
163007527|NCT00485264|588730013|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
163007528|NCT00485264|588730014|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
163007529|NCT00485264|588730015|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
163007530|NCT00485264|588730016|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
163007531|NCT00485264|588730017|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
163007532|NCT00485264|588730018|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
163007533|NCT00485264|588730013|FG000|Overall Study|Lack of Efficacy|0|||
163007534|NCT00485264|588730014|FG001|Overall Study|Lack of Efficacy|1|||
163007535|NCT00485264|588730015|FG002|Overall Study|Lack of Efficacy|0|||
163007536|NCT00485264|588730016|FG003|Overall Study|Lack of Efficacy|0|||
163007537|NCT00485264|588730017|FG004|Overall Study|Lack of Efficacy|0|||
163007538|NCT00485264|588730018|FG005|Overall Study|Lack of Efficacy|0|||
163007539|NCT00485264|588730013|FG000|Overall Study|Guardian Consent Withdrawn|1|||
163007540|NCT00485264|588730014|FG001|Overall Study|Guardian Consent Withdrawn|0|||
163007541|NCT00485264|588730015|FG002|Overall Study|Guardian Consent Withdrawn|0|||
163007542|NCT00485264|588730016|FG003|Overall Study|Guardian Consent Withdrawn|0|||
163007543|NCT00485264|588730017|FG004|Overall Study|Guardian Consent Withdrawn|1|||
163007544|NCT00485264|588730018|FG005|Overall Study|Guardian Consent Withdrawn|0|||
163007545|NCT00485264|588730013|FG000|Overall Study|Physician Decision|0|||
163007546|NCT00485264|588730014|FG001|Overall Study|Physician Decision|2|||
163007547|NCT00485264|588730015|FG002|Overall Study|Physician Decision|0|||
163007548|NCT00485264|588730016|FG003|Overall Study|Physician Decision|0|||
163007549|NCT00485264|588730017|FG004|Overall Study|Physician Decision|0|||
163007550|NCT00485264|588730018|FG005|Overall Study|Physician Decision|0|||
163007551|NCT00485264|588730013|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
163007552|NCT00485264|588730014|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
163007553|NCT00485264|588730015|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
163007554|NCT00485264|588730016|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
163007555|NCT00485264|588730017|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
163007556|NCT00485264|588730018|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
163007557|NCT00485264|588730013|FG000|Overall Study|Not Able to Attend Clinic|5|||
163007558|NCT00485264|588730014|FG001|Overall Study|Not Able to Attend Clinic|0|||
163007559|NCT00485264|588730015|FG002|Overall Study|Not Able to Attend Clinic|0|||
163007560|NCT00485264|588730016|FG003|Overall Study|Not Able to Attend Clinic|1|||
163007561|NCT00485264|588730017|FG004|Overall Study|Not Able to Attend Clinic|1|||
163007562|NCT00485264|588730018|FG005|Overall Study|Not Able to Attend Clinic|2|||
163007563|NCT00485264|588730013|FG000|Overall Study|Non-Compliant|17|||
163326346|NCT03213457|589905460|FG000|Follow-Up Period|Exclusionary medications|1|||
163326347|NCT03213457|589905461|FG001|Follow-Up Period|Exclusionary medications|1|||
163326348|NCT03213457|589905462|FG002|Follow-Up Period|Exclusionary medications|5|||
163326349|NCT03213457|589905460|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
163326350|NCT03213457|589905461|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
163326351|NCT03213457|589905462|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
163326352|NCT03213457|589905460|FG000|Follow-Up Period|Other|14|||
163326353|NCT03213457|589905461|FG001|Follow-Up Period|Other|10|||
163326354|NCT03213457|589905462|FG002|Follow-Up Period|Other|31|||
163326355|NCT05116774|589905463|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
163326356|NCT05116774|589905464|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
163326357|NCT05116774|589905463|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
163326358|NCT05116774|589905464|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
163326359|NCT05116774|589905463|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
163326360|NCT05116774|589905464|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
163326361|NCT05116774|589905463|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
163326362|NCT05116774|589905464|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
163326363|NCT03150862|589905465|FG000|Overall Study|Death|2|||
163326364|NCT03150862|589905466|FG001|Overall Study|Death|7|||
163326365|NCT03150862|589905467|FG002|Overall Study|Death|8|||
163326366|NCT03150862|589905468|FG003|Overall Study|Death|27|||
163326367|NCT03150862|589905469|FG004|Overall Study|Death|4|||
163326368|NCT03150862|589905470|FG005|Overall Study|Death|8|||
163326369|NCT03150862|589905471|FG006|Overall Study|Death|6|||
163326370|NCT03150862|589905472|FG007|Overall Study|Death|21|||
163326371|NCT03150862|589905465|FG000|Overall Study|Withdrawal by Subject|1|||
163326372|NCT03150862|589905466|FG001|Overall Study|Withdrawal by Subject|1|||
163326373|NCT03150862|589905467|FG002|Overall Study|Withdrawal by Subject|0|||
163326374|NCT03150862|589905468|FG003|Overall Study|Withdrawal by Subject|3|||
163326375|NCT03150862|589905469|FG004|Overall Study|Withdrawal by Subject|1|||
163326376|NCT03150862|589905470|FG005|Overall Study|Withdrawal by Subject|1|||
163326377|NCT03150862|589905471|FG006|Overall Study|Withdrawal by Subject|1|||
163326378|NCT03150862|589905472|FG007|Overall Study|Withdrawal by Subject|3|||
163326379|NCT03150862|589905465|FG000|Overall Study|Lost to Follow-up|0|||
163326380|NCT03150862|589905466|FG001|Overall Study|Lost to Follow-up|0|||
163326381|NCT03150862|589905467|FG002|Overall Study|Lost to Follow-up|1|||
163326382|NCT03150862|589905468|FG003|Overall Study|Lost to Follow-up|0|||
163326383|NCT03150862|589905469|FG004|Overall Study|Lost to Follow-up|0|||
163326384|NCT03150862|589905470|FG005|Overall Study|Lost to Follow-up|0|||
163326385|NCT03150862|589905471|FG006|Overall Study|Lost to Follow-up|0|||
163326386|NCT03150862|589905472|FG007|Overall Study|Lost to Follow-up|2|||
163326387|NCT03150862|589905465|FG000|Overall Study|Sponsor's decision|0|||
163326388|NCT03150862|589905466|FG001|Overall Study|Sponsor's decision|0|||
163326389|NCT03150862|589905467|FG002|Overall Study|Sponsor's decision|0|||
163326390|NCT03150862|589905468|FG003|Overall Study|Sponsor's decision|10|||
163326391|NCT03150862|589905469|FG004|Overall Study|Sponsor's decision|3|||
163326392|NCT03150862|589905470|FG005|Overall Study|Sponsor's decision|0|||
163326393|NCT03150862|589905471|FG006|Overall Study|Sponsor's decision|1|||
163326394|NCT03150862|589905472|FG007|Overall Study|Sponsor's decision|1|||
163326395|NCT03150862|589905465|FG000|Overall Study|Change in Methylation status|0|||
163326396|NCT03150862|589905466|FG001|Overall Study|Change in Methylation status|0|||
163326397|NCT03150862|589905467|FG002|Overall Study|Change in Methylation status|0|||
163326398|NCT03150862|589905468|FG003|Overall Study|Change in Methylation status|0|||
163326399|NCT03150862|589905469|FG004|Overall Study|Change in Methylation status|1|||
163326400|NCT03150862|589905470|FG005|Overall Study|Change in Methylation status|0|||
163326401|NCT03150862|589905471|FG006|Overall Study|Change in Methylation status|0|||
163326402|NCT03150862|589905472|FG007|Overall Study|Change in Methylation status|0|||
163326403|NCT03150862|589905465|FG000|Overall Study|Roll over in to Long Term Extension|0|||
163326404|NCT03150862|589905466|FG001|Overall Study|Roll over in to Long Term Extension|0|||
163326405|NCT03150862|589905467|FG002|Overall Study|Roll over in to Long Term Extension|0|||
163326406|NCT03150862|589905468|FG003|Overall Study|Roll over in to Long Term Extension|0|||
163326407|NCT03150862|589905469|FG004|Overall Study|Roll over in to Long Term Extension|0|||
163326408|NCT03150862|589905470|FG005|Overall Study|Roll over in to Long Term Extension|0|||
163326409|NCT03150862|589905471|FG006|Overall Study|Roll over in to Long Term Extension|0|||
163326410|NCT03150862|589905472|FG007|Overall Study|Roll over in to Long Term Extension|1|||
163326411|NCT03150862|589905465|FG000|Overall Study|Progressive Disease|0|||
163326412|NCT03150862|589905466|FG001|Overall Study|Progressive Disease|0|||
163326413|NCT03150862|589905467|FG002|Overall Study|Progressive Disease|0|||
163326414|NCT03150862|589905468|FG003|Overall Study|Progressive Disease|0|||
163326415|NCT03150862|589905469|FG004|Overall Study|Progressive Disease|0|||
163326416|NCT03150862|589905470|FG005|Overall Study|Progressive Disease|0|||
163326417|NCT03150862|589905471|FG006|Overall Study|Progressive Disease|0|||
163326418|NCT03150862|589905472|FG007|Overall Study|Progressive Disease|2|||
163326419|NCT05139992|589905473|FG000|Overall Study|Withdrawal by Subject|12|||
163326420|NCT05139992|589905473|FG000|Overall Study|Lost to Follow-up|6|||
163326421|NCT05521516|589905474|FG000|Overall Study|Withdrawal by Subject|1|||
163326422|NCT05521516|589905475|FG001|Overall Study|Withdrawal by Subject|1|||
163007564|NCT00485264|588730014|FG001|Overall Study|Non-Compliant|2|||
163007565|NCT00485264|588730015|FG002|Overall Study|Non-Compliant|1|||
163007566|NCT00485264|588730016|FG003|Overall Study|Non-Compliant|0|||
163007567|NCT00485264|588730017|FG004|Overall Study|Non-Compliant|1|||
163007568|NCT00485264|588730018|FG005|Overall Study|Non-Compliant|0|||
163007569|NCT00485264|588730013|FG000|Overall Study|Lost to Follow-up|2|||
163007570|NCT00485264|588730014|FG001|Overall Study|Lost to Follow-up|1|||
163007571|NCT00485264|588730015|FG002|Overall Study|Lost to Follow-up|1|||
163007572|NCT00485264|588730016|FG003|Overall Study|Lost to Follow-up|0|||
163007573|NCT00485264|588730017|FG004|Overall Study|Lost to Follow-up|0|||
163007574|NCT00485264|588730018|FG005|Overall Study|Lost to Follow-up|1|||
163007575|NCT00485264|588730013|FG000|Overall Study|Other Reason|3|||
163007576|NCT00485264|588730014|FG001|Overall Study|Other Reason|0|||
163007577|NCT00485264|588730015|FG002|Overall Study|Other Reason|0|||
163007578|NCT00485264|588730016|FG003|Overall Study|Other Reason|0|||
163007579|NCT00485264|588730017|FG004|Overall Study|Other Reason|0|||
163007580|NCT00485264|588730018|FG005|Overall Study|Other Reason|0|||
163007581|NCT01514461|588730019|FG000|Overall Study|Adverse Event|2|||
163007582|NCT01514461|588730020|FG001|Overall Study|Adverse Event|1|||
163007583|NCT01514461|588730021|FG002|Overall Study|Adverse Event|3|||
163007584|NCT01514461|588730019|FG000|Overall Study|Physician Decision|1|||
163007585|NCT01514461|588730020|FG001|Overall Study|Physician Decision|1|||
163007586|NCT01514461|588730021|FG002|Overall Study|Physician Decision|0|||
163007587|NCT01514461|588730019|FG000|Overall Study|Patient/guardian decision|1|||
163007588|NCT01514461|588730020|FG001|Overall Study|Patient/guardian decision|1|||
163007589|NCT01514461|588730021|FG002|Overall Study|Patient/guardian decision|1|||
163007590|NCT01514461|588730019|FG000|Overall Study|Death|1|||
163007591|NCT01514461|588730020|FG001|Overall Study|Death|0|||
163007592|NCT01514461|588730021|FG002|Overall Study|Death|0|||
163007593|NCT02548832|588730022|FG000|Overall Study|Lost to Follow-up|2|||
163007594|NCT02548832|588730023|FG001|Overall Study|Lost to Follow-up|2|||
163007595|NCT02548832|588730024|FG002|Overall Study|Lost to Follow-up|2|||
163061430|NCT00790036|588933118|FG001|Overall Study|Withdrawal by Subject|7|||
163061431|NCT00790036|588933117|FG000|Overall Study|Subject/guardian decision|20|||
163061432|NCT00790036|588933118|FG001|Overall Study|Subject/guardian decision|7|||
163061433|NCT01285518|588933119|FG000|Overall Study|Lost to Follow-up|0|||
163061434|NCT01285518|588933120|FG001|Overall Study|Lost to Follow-up|0|||
163061435|NCT01285518|588933121|FG002|Overall Study|Lost to Follow-up|0|||
163061436|NCT01285518|588933122|FG003|Overall Study|Lost to Follow-up|0|||
163061437|NCT01285518|588933123|FG004|Overall Study|Lost to Follow-up|0|||
163061438|NCT01285518|588933124|FG005|Overall Study|Lost to Follow-up|1|||
163061439|NCT01285518|588933125|FG006|Overall Study|Lost to Follow-up|0|||
163061440|NCT01285518|588933126|FG007|Overall Study|Lost to Follow-up|0|||
163061441|NCT00639509|588933133|FG000|Overall Study|Death|1|||
163061442|NCT02921256|588933134|FG000|Arm 1a v. Arm II|Adverse Event|6|||
163326423|NCT00747565|589905476|FG000|Overall Study|Withdrawal by Subject|10|||
163326424|NCT00747565|589905477|FG001|Overall Study|Withdrawal by Subject|6|||
163326425|NCT00747565|589905476|FG000|Overall Study|Lost to Follow-up|4|||
163326426|NCT00747565|589905477|FG001|Overall Study|Lost to Follow-up|1|||
163326427|NCT03437733|589906135|FG000|Overall Study|Eligibility criteria not met|0|||
163326428|NCT03437733|589906136|FG001|Overall Study|Eligibility criteria not met|3|||
163326429|NCT04017611|589906142|FG000|Overall Study|Withdrawn prior to completion|1|||
163326430|NCT01128595|589906153|FG000|Treatment Period 3|Withdrawal by Subject|0|||
163326431|NCT01128595|589906154|FG001|Treatment Period 3|Withdrawal by Subject|1|||
163326432|NCT01128595|589906155|FG002|Treatment Period 3|Withdrawal by Subject|0|||
163326433|NCT01128595|589906156|FG003|Treatment Period 3|Withdrawal by Subject|0|||
163326434|NCT00366249|589906159|FG000|Overall Study|Adverse Event|53|||
163326435|NCT00366249|589906160|FG001|Overall Study|Adverse Event|28|||
163326436|NCT00366249|589906159|FG000|Overall Study|Death|0|||
163326437|NCT00366249|589906160|FG001|Overall Study|Death|1|||
163326438|NCT00366249|589906159|FG000|Overall Study|Physician Decision|5|||
163326439|NCT00366249|589906160|FG001|Overall Study|Physician Decision|2|||
163326440|NCT00366249|589906159|FG000|Overall Study|Lost to Follow-up|2|||
163007596|NCT03565900|588730025|FG000|Overall Study|Disposition Unknown|4|||
163007597|NCT03565900|588730026|FG001|Overall Study|Disposition Unknown|1|||
163007598|NCT03565900|588730025|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
163007599|NCT03565900|588730026|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
163007600|NCT03565900|588730025|FG000|Overall Study|Withdrawal by Subject|4|||
163007601|NCT03565900|588730026|FG001|Overall Study|Withdrawal by Subject|5|||
163007602|NCT03565900|588730025|FG000|Overall Study|Randomized By Mistake|0|||
163007603|NCT03565900|588730026|FG001|Overall Study|Randomized By Mistake|2|||
163007604|NCT03565900|588730025|FG000|Overall Study|Physician Decision|7|||
163007605|NCT03565900|588730026|FG001|Overall Study|Physician Decision|11|||
163007606|NCT03565900|588730025|FG000|Overall Study|Death|9|||
163007607|NCT03565900|588730026|FG001|Overall Study|Death|7|||
163007608|NCT01254643|588730027|FG000|Overall Study|Withdrawal by Subject|1|||
163007609|NCT03359850|588730033|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
163326441|NCT00366249|589906160|FG001|Overall Study|Lost to Follow-up|0|||
163326442|NCT00366249|589906159|FG000|Overall Study|Protocol Violation|1|||
163326443|NCT00366249|589906160|FG001|Overall Study|Protocol Violation|2|||
163326444|NCT00366249|589906159|FG000|Overall Study|Withdrawal by Subject|18|||
163326445|NCT00366249|589906160|FG001|Overall Study|Withdrawal by Subject|4|||
163326446|NCT00366249|589906159|FG000|Overall Study|Lack of Efficacy|21|||
163326447|NCT00366249|589906160|FG001|Overall Study|Lack of Efficacy|21|||
163326448|NCT00366249|589906159|FG000|Overall Study|Most due to osteomylitis status|31|||
163326449|NCT00366249|589906160|FG001|Overall Study|Most due to osteomylitis status|20|||
163326450|NCT00246805|589906161|FG000|Phase 1|Lost to Follow-up|1|||
163326451|NCT00246805|589906162|FG001|Phase 1|Lost to Follow-up|0|||
163007610|NCT03359850|588730034|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
163007611|NCT03359850|588730033|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
163007612|NCT03359850|588730034|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
163007613|NCT03359850|588730033|FG000|Extension Phase (Up to 28 Months)|Death|2|||
163007614|NCT03359850|588730034|FG001|Extension Phase (Up to 28 Months)|Death|4|||
163007615|NCT03359850|588730033|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
163007616|NCT03359850|588730034|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
163007617|NCT03359850|588730033|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
163007618|NCT03359850|588730034|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
163007619|NCT03817125|588730052|FG000|Overall Study|Adverse Event|1|||
163007620|NCT03817125|588730053|FG001|Overall Study|Adverse Event|0|||
163007621|NCT03817125|588730052|FG000|Overall Study|Physician Decision|0|||
163007622|NCT03817125|588730053|FG001|Overall Study|Physician Decision|1|||
163007623|NCT03817125|588730052|FG000|Overall Study|Lack of Efficacy|1|||
163007624|NCT03817125|588730053|FG001|Overall Study|Lack of Efficacy|5|||
163007625|NCT00942084|588730054|FG000|Overall Study|Death|2|||
163007626|NCT01062425|588730055|FG000|Overall Study|Protocol Violation|3|||
163007627|NCT01062425|588730056|FG001|Overall Study|Protocol Violation|6|||
163007628|NCT01037218|588730057|FG000|Overall Study|Adverse Event|4|||
163007629|NCT01037218|588730058|FG001|Overall Study|Adverse Event|2|||
163007630|NCT01037218|588730059|FG002|Overall Study|Adverse Event|2|||
163007631|NCT01037218|588730060|FG003|Overall Study|Adverse Event|1|||
163007632|NCT01037218|588730057|FG000|Overall Study|Lack of Efficacy|0|||
163007633|NCT01037218|588730058|FG001|Overall Study|Lack of Efficacy|2|||
163007634|NCT01037218|588730059|FG002|Overall Study|Lack of Efficacy|1|||
163007635|NCT01037218|588730060|FG003|Overall Study|Lack of Efficacy|5|||
163007636|NCT01037218|588730057|FG000|Overall Study|Lost to Follow-up|3|||
163007637|NCT01037218|588730058|FG001|Overall Study|Lost to Follow-up|5|||
163007638|NCT01037218|588730059|FG002|Overall Study|Lost to Follow-up|4|||
163007639|NCT01037218|588730060|FG003|Overall Study|Lost to Follow-up|2|||
163007640|NCT01037218|588730057|FG000|Overall Study|Withdrawal by Subject|6|||
163007641|NCT01037218|588730058|FG001|Overall Study|Withdrawal by Subject|7|||
163007642|NCT01037218|588730059|FG002|Overall Study|Withdrawal by Subject|7|||
163007643|NCT01037218|588730060|FG003|Overall Study|Withdrawal by Subject|4|||
163007644|NCT01037218|588730057|FG000|Overall Study|Partner Withdrew Consent|0|||
163007645|NCT01037218|588730058|FG001|Overall Study|Partner Withdrew Consent|3|||
163007646|NCT01037218|588730059|FG002|Overall Study|Partner Withdrew Consent|2|||
163007647|NCT01037218|588730060|FG003|Overall Study|Partner Withdrew Consent|1|||
163007648|NCT01037218|588730057|FG000|Overall Study|Protocol Violation|0|||
163007649|NCT01037218|588730058|FG001|Overall Study|Protocol Violation|0|||
163007650|NCT01037218|588730059|FG002|Overall Study|Protocol Violation|2|||
163007651|NCT01037218|588730060|FG003|Overall Study|Protocol Violation|2|||
163007652|NCT01037218|588730057|FG000|Overall Study|Various|3|||
163007653|NCT01037218|588730058|FG001|Overall Study|Various|2|||
163007654|NCT01037218|588730059|FG002|Overall Study|Various|3|||
163007655|NCT01037218|588730060|FG003|Overall Study|Various|1|||
163007656|NCT00513240|588730062|FG000|Overall Study|Did not have intended surgery|3|||
163007657|NCT00513240|588730063|FG001|Overall Study|Did not have intended surgery|0|||
163007658|NCT00513240|588730062|FG000|Overall Study|Death|3|||
163326452|NCT00609869|589906163|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
163326453|NCT00609869|589906163|FG000|Overall Study|Severe hematologic toxicity|1|||
163326454|NCT00609869|589906163|FG000|Overall Study|Withdrawal by Subject|1|||
163326455|NCT00609869|589906163|FG000|Overall Study|Seizures|1|||
163007659|NCT00513240|588730063|FG001|Overall Study|Death|3|||
163007660|NCT00513240|588730062|FG000|Overall Study|Withdrawal by Subject|7|||
163007661|NCT00513240|588730063|FG001|Overall Study|Withdrawal by Subject|4|||
163007662|NCT01949662|588730066|FG000|Overall Study|Death|9|||
163007663|NCT01949662|588730067|FG001|Overall Study|Death|7|||
163007664|NCT01949662|588730066|FG000|Overall Study|Discharged before an agitation event|8|||
163007665|NCT01949662|588730067|FG001|Overall Study|Discharged before an agitation event|3|||
163007666|NCT01949662|588730066|FG000|Overall Study|Dropped out|1|||
163007667|NCT01949662|588730067|FG001|Overall Study|Dropped out|3|||
163007668|NCT01949662|588730066|FG000|Overall Study|Ineligible|0|||
163007669|NCT01949662|588730067|FG001|Overall Study|Ineligible|1|||
163007670|NCT02291237|588730068|FG000|Overall Study|Study Terminated by Sponsor|72|||
163007671|NCT02291237|588730069|FG001|Overall Study|Study Terminated by Sponsor|67|||
163007672|NCT02291237|588730068|FG000|Overall Study|Adverse Event|1|||
163007673|NCT02291237|588730069|FG001|Overall Study|Adverse Event|3|||
163326456|NCT00609869|589906163|FG000|Overall Study|Severe tumor flare reaction|1|||
163007674|NCT02291237|588730068|FG000|Overall Study|Investigator's Discretion|0|||
163213650|NCT01928329|589496023|FG000|Overall Study|Withdrawal by Subject|1|||
163213651|NCT01928329|589496024|FG001|Overall Study|Withdrawal by Subject|5|||
163213652|NCT01928329|589496023|FG000|Overall Study|Physician Decision|1|||
163213653|NCT01928329|589496024|FG001|Overall Study|Physician Decision|1|||
163213654|NCT01496313|589496025|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
163213655|NCT01496313|589496026|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
163213656|NCT01496313|589496027|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
163213657|NCT01496313|589496028|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
163213658|NCT01496313|589496029|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
163213659|NCT01496313|589496030|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
163213660|NCT01496313|589496025|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
163213661|NCT01496313|589496026|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
163213662|NCT01496313|589496027|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
163213663|NCT01496313|589496028|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
163213664|NCT01496313|589496029|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
163213665|NCT01496313|589496030|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
163213666|NCT01496313|589496025|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
163213667|NCT01496313|589496026|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
163213668|NCT01496313|589496027|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
163213669|NCT01496313|589496028|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
163213670|NCT01496313|589496029|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
163213671|NCT01496313|589496030|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
163213672|NCT01496313|589496025|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
163213673|NCT01496313|589496026|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
163213674|NCT01496313|589496027|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
163213675|NCT01496313|589496028|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
163213676|NCT01496313|589496029|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
163213677|NCT01496313|589496030|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
163213678|NCT01496313|589496025|FG000|Randomized Period (up to 14 Months)|Other|1|||
163213679|NCT01496313|589496026|FG001|Randomized Period (up to 14 Months)|Other|2|||
163213680|NCT01496313|589496027|FG002|Randomized Period (up to 14 Months)|Other|0|||
163213681|NCT01496313|589496028|FG003|Randomized Period (up to 14 Months)|Other|0|||
163213682|NCT01496313|589496029|FG004|Randomized Period (up to 14 Months)|Other|0|||
163213683|NCT01496313|589496030|FG005|Randomized Period (up to 14 Months)|Other|0|||
163213684|NCT01496313|589496025|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
163213685|NCT01496313|589496026|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
163213686|NCT01496313|589496027|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
163213687|NCT01496313|589496028|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
163213688|NCT01496313|589496029|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
163213689|NCT01496313|589496030|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
163213690|NCT01496313|589496025|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
163213691|NCT01496313|589496026|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
163213692|NCT01496313|589496027|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
163213693|NCT01496313|589496028|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
163213694|NCT01496313|589496029|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
163213695|NCT01496313|589496030|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
163213696|NCT01496313|589496025|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
163213697|NCT01496313|589496026|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
163213698|NCT01496313|589496027|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
163213699|NCT01496313|589496028|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
163213700|NCT01496313|589496029|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
163213701|NCT01496313|589496030|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
163213702|NCT01050257|589496038|FG000|Overall Study|Adverse Event|4|||
163213703|NCT01050257|589496039|FG001|Overall Study|Adverse Event|4|||
163213704|NCT01050257|589496040|FG002|Overall Study|Adverse Event|2|||
163213705|NCT01050257|589496038|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
163213706|NCT01050257|589496039|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
163213707|NCT01050257|589496040|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
163213708|NCT01050257|589496038|FG000|Overall Study|Withdrawal by Subject|0|||
163213709|NCT01050257|589496039|FG001|Overall Study|Withdrawal by Subject|3|||
163007675|NCT02291237|588730069|FG001|Overall Study|Investigator's Discretion|3|||
163213710|NCT01050257|589496040|FG002|Overall Study|Withdrawal by Subject|0|||
163007676|NCT02291237|588730068|FG000|Overall Study|Withdrew Consent|11|||
163007677|NCT02291237|588730069|FG001|Overall Study|Withdrew Consent|11|||
163007678|NCT02291237|588730068|FG000|Overall Study|Lost to Follow-up|0|||
163007679|NCT02291237|588730069|FG001|Overall Study|Lost to Follow-up|2|||
163007680|NCT02291237|588730068|FG000|Overall Study|Subject Required Prohibited Medication|2|||
163007681|NCT02291237|588730069|FG001|Overall Study|Subject Required Prohibited Medication|0|||
163007682|NCT02189837|588730072|FG000|Overall Study|Withdrawal by Subject|2|||
163007683|NCT02189837|588730073|FG001|Overall Study|Withdrawal by Subject|1|||
163007684|NCT02189837|588730074|FG002|Overall Study|Withdrawal by Subject|3|||
163007685|NCT02189837|588730075|FG003|Overall Study|Withdrawal by Subject|1|||
163007686|NCT02189837|588730072|FG000|Overall Study|Sponsor Decision|0|||
163007687|NCT02189837|588730073|FG001|Overall Study|Sponsor Decision|0|||
163007688|NCT02189837|588730074|FG002|Overall Study|Sponsor Decision|0|||
163061443|NCT02921256|588933135|FG001|Arm 1a v. Arm II|Adverse Event|15|||
163061444|NCT02921256|588933136|FG002|Arm 1a v. Arm II|Adverse Event|0|||
163061445|NCT02921256|588933134|FG000|Arm 1a v. Arm II|Death|0|||
163061446|NCT02921256|588933135|FG001|Arm 1a v. Arm II|Death|2|||
163061447|NCT02921256|588933136|FG002|Arm 1a v. Arm II|Death|0|||
163061448|NCT02921256|588933134|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
163061449|NCT02921256|588933135|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
163061450|NCT02921256|588933136|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
163061451|NCT02921256|588933134|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
163061452|NCT02921256|588933135|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
163061453|NCT02921256|588933136|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
163061454|NCT02921256|588933134|FG000|Arm 1a v. Arm II|Physician Decision|1|||
163061455|NCT02921256|588933135|FG001|Arm 1a v. Arm II|Physician Decision|1|||
163061456|NCT02921256|588933136|FG002|Arm 1a v. Arm II|Physician Decision|0|||
163061457|NCT02921256|588933134|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
163061458|NCT02921256|588933135|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
163061459|NCT02921256|588933136|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
163061460|NCT02921256|588933134|FG000|Arm Ib v Arm III|Adverse Event|9|||
163061461|NCT02921256|588933135|FG001|Arm Ib v Arm III|Adverse Event|0|||
163061462|NCT02921256|588933136|FG002|Arm Ib v Arm III|Adverse Event|4|||
163061463|NCT02921256|588933134|FG000|Arm Ib v Arm III|Death|1|||
163061464|NCT02921256|588933135|FG001|Arm Ib v Arm III|Death|0|||
163061465|NCT02921256|588933136|FG002|Arm Ib v Arm III|Death|1|||
163061466|NCT02921256|588933134|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
163061467|NCT02921256|588933135|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
163061468|NCT02921256|588933136|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
163061469|NCT02921256|588933134|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
163061470|NCT02921256|588933135|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
163061471|NCT02921256|588933136|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
163061472|NCT02921256|588933134|FG000|Arm Ib v Arm III|Physician Decision|4|||
163061473|NCT02921256|588933135|FG001|Arm Ib v Arm III|Physician Decision|0|||
163061474|NCT02921256|588933136|FG002|Arm Ib v Arm III|Physician Decision|1|||
163061475|NCT02921256|588933134|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
163061476|NCT02921256|588933135|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
163061477|NCT02921256|588933136|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
163061478|NCT03507790|588933137|FG000|Overall Study|Adverse Event|0|||
163061479|NCT03507790|588933138|FG001|Overall Study|Adverse Event|11|||
163061480|NCT03507790|588933139|FG002|Overall Study|Adverse Event|3|||
163061481|NCT03507790|588933137|FG000|Overall Study|Withdrawal by Subject|2|||
163061482|NCT03507790|588933138|FG001|Overall Study|Withdrawal by Subject|0|||
163061483|NCT03507790|588933139|FG002|Overall Study|Withdrawal by Subject|0|||
163061484|NCT03507790|588933137|FG000|Overall Study|Subject moved to another location|1|||
163061485|NCT03507790|588933138|FG001|Overall Study|Subject moved to another location|2|||
163061486|NCT03507790|588933139|FG002|Overall Study|Subject moved to another location|0|||
163061487|NCT03507790|588933137|FG000|Overall Study|Non-compliance with study drug|0|||
163061488|NCT03507790|588933138|FG001|Overall Study|Non-compliance with study drug|0|||
163061489|NCT03507790|588933139|FG002|Overall Study|Non-compliance with study drug|1|||
163061490|NCT03507790|588933137|FG000|Overall Study|COVID 19 Pandemic|0|||
163061491|NCT03507790|588933138|FG001|Overall Study|COVID 19 Pandemic|1|||
163061492|NCT03507790|588933139|FG002|Overall Study|COVID 19 Pandemic|0|||
163213711|NCT01050257|589496038|FG000|Overall Study|No reason specified|0|||
163007689|NCT02189837|588730075|FG003|Overall Study|Sponsor Decision|1|||
163007690|NCT00729937|588730076|FG000|Overall Study|Lost to Follow-up|49|||
163213712|NCT01050257|589496039|FG001|Overall Study|No reason specified|0|||
163007691|NCT00729937|588730077|FG001|Overall Study|Lost to Follow-up|58|||
163007692|NCT00729937|588730078|FG002|Overall Study|Lost to Follow-up|18|||
163007693|NCT00729937|588730079|FG003|Overall Study|Lost to Follow-up|33|||
163061493|NCT03507790|588933137|FG000|Overall Study|Lost to Follow-up|0|||
163061494|NCT03507790|588933138|FG001|Overall Study|Lost to Follow-up|1|||
163061495|NCT03507790|588933139|FG002|Overall Study|Lost to Follow-up|0|||
163061496|NCT03507790|588933137|FG000|Overall Study|Discontinuation of the trial at the site|1|||
163213713|NCT01050257|589496040|FG002|Overall Study|No reason specified|2|||
163213714|NCT01050257|589496038|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
163007694|NCT00729937|588730080|FG004|Overall Study|Lost to Follow-up|18|||
163007695|NCT00729937|588730081|FG005|Overall Study|Lost to Follow-up|23|||
163007696|NCT00729937|588730076|FG000|Overall Study|Physician Decision|7|||
163061497|NCT03507790|588933138|FG001|Overall Study|Discontinuation of the trial at the site|1|||
163326457|NCT00609869|589906163|FG000|Overall Study|Hepatitis B infection|1|||
163326458|NCT00609869|589906163|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
163007697|NCT00729937|588730077|FG001|Overall Study|Physician Decision|16|||
163007698|NCT00729937|588730078|FG002|Overall Study|Physician Decision|2|||
163007699|NCT00729937|588730079|FG003|Overall Study|Physician Decision|0|||
163007700|NCT00729937|588730080|FG004|Overall Study|Physician Decision|5|||
163007701|NCT00729937|588730081|FG005|Overall Study|Physician Decision|8|||
163007702|NCT00729937|588730076|FG000|Overall Study|Death|1|||
163007703|NCT00729937|588730077|FG001|Overall Study|Death|0|||
163007704|NCT00729937|588730078|FG002|Overall Study|Death|1|||
163007705|NCT00729937|588730079|FG003|Overall Study|Death|0|||
163326459|NCT00609869|589906163|FG000|Overall Study|Mantle cell: not evaluable|4|||
163326460|NCT01342367|589906164|FG000|Overall Study|Death|1|||
163326461|NCT01342367|589906165|FG001|Overall Study|Death|0|||
163326462|NCT01342367|589906164|FG000|Overall Study|Withdrawal by Subject|1|||
163326463|NCT01342367|589906165|FG001|Overall Study|Withdrawal by Subject|2|||
163326464|NCT00640159|589906166|FG000|Overall Study|Lost to Follow-up|2|||
163326465|NCT03355573|589906167|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
163326466|NCT03355573|589906167|FG000|Overall Study|Sponsor's decision|1|||
163326467|NCT03355573|589906167|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
163326468|NCT03355573|589906167|FG000|Overall Study|PI's decision|2|||
163326469|NCT03355573|589906167|FG000|Overall Study|Withdrawal by Subject|23|||
163326470|NCT03355573|589906167|FG000|Overall Study|Lost to Follow-up|4|||
163326471|NCT03355573|589906167|FG000|Overall Study|Lack of Efficacy|2|||
163326472|NCT03355573|589906167|FG000|Overall Study|Adverse Event, non-fatal|17|||
163326473|NCT03355573|589906167|FG000|Overall Study|Adverse Event, serious fatal|2|||
163326474|NCT01218009|589906168|FG000|Overall Study|Protocol Violation|2|||
163326475|NCT01218009|589906169|FG001|Overall Study|Protocol Violation|1|||
163326476|NCT01218009|589906168|FG000|Overall Study|Withdrawal by Subject|3|||
163326477|NCT01218009|589906169|FG001|Overall Study|Withdrawal by Subject|1|||
163326478|NCT01218009|589906168|FG000|Overall Study|Sponsor terminated study|161|||
163326479|NCT01218009|589906169|FG001|Overall Study|Sponsor terminated study|163|||
163326480|NCT01371994|589906173|FG000|Overall Study|Adverse Event|3|||
163326481|NCT01371994|589906174|FG001|Overall Study|Adverse Event|6|||
163326482|NCT01371994|589906173|FG000|Overall Study|Lack of Efficacy|3|||
163326483|NCT01371994|589906174|FG001|Overall Study|Lack of Efficacy|0|||
163326484|NCT01371994|589906173|FG000|Overall Study|Withdrawal by Subject|13|||
163326485|NCT01371994|589906174|FG001|Overall Study|Withdrawal by Subject|7|||
163326486|NCT01371994|589906173|FG000|Overall Study|Lost to Follow-up|1|||
163326487|NCT01371994|589906174|FG001|Overall Study|Lost to Follow-up|1|||
163326488|NCT01371994|589906173|FG000|Overall Study|Protocol Violation|24|||
163007706|NCT00729937|588730080|FG004|Overall Study|Death|0|||
163007707|NCT00729937|588730081|FG005|Overall Study|Death|1|||
163007708|NCT00729937|588730076|FG000|Overall Study|Withdrawal by Subject|3|||
163007709|NCT00729937|588730077|FG001|Overall Study|Withdrawal by Subject|5|||
163007710|NCT00729937|588730078|FG002|Overall Study|Withdrawal by Subject|6|||
163007711|NCT00729937|588730079|FG003|Overall Study|Withdrawal by Subject|0|||
163007712|NCT00729937|588730080|FG004|Overall Study|Withdrawal by Subject|4|||
163007713|NCT00729937|588730081|FG005|Overall Study|Withdrawal by Subject|2|||
163007714|NCT00729937|588730076|FG000|Overall Study|Randomized but not treated|12|||
163007715|NCT00729937|588730077|FG001|Overall Study|Randomized but not treated|6|||
163007716|NCT00729937|588730078|FG002|Overall Study|Randomized but not treated|1|||
163007717|NCT00729937|588730079|FG003|Overall Study|Randomized but not treated|0|||
163007718|NCT00729937|588730080|FG004|Overall Study|Randomized but not treated|1|||
163007719|NCT00729937|588730081|FG005|Overall Study|Randomized but not treated|3|||
163007720|NCT00729937|588730076|FG000|Overall Study|Did not meet eligibility criteria|2|||
163007721|NCT00729937|588730077|FG001|Overall Study|Did not meet eligibility criteria|1|||
163007722|NCT00729937|588730078|FG002|Overall Study|Did not meet eligibility criteria|0|||
163007723|NCT00729937|588730079|FG003|Overall Study|Did not meet eligibility criteria|0|||
163007724|NCT00729937|588730080|FG004|Overall Study|Did not meet eligibility criteria|0|||
163007725|NCT00729937|588730081|FG005|Overall Study|Did not meet eligibility criteria|0|||
163007726|NCT00729937|588730076|FG000|Overall Study|Incarcerated|0|||
163007727|NCT00729937|588730077|FG001|Overall Study|Incarcerated|2|||
163007728|NCT00729937|588730078|FG002|Overall Study|Incarcerated|1|||
163007729|NCT00729937|588730079|FG003|Overall Study|Incarcerated|1|||
163007730|NCT00729937|588730080|FG004|Overall Study|Incarcerated|0|||
163007731|NCT00729937|588730081|FG005|Overall Study|Incarcerated|0|||
163007732|NCT02198963|588730085|FG000|Overall Study|Adverse Event|1|||
163007733|NCT02198963|588730085|FG000|Overall Study|Withdrawal by Subject|6|||
163007734|NCT00281957|588730086|FG000|Overall Study|Adverse Event|7|||
163326489|NCT01371994|589906174|FG001|Overall Study|Protocol Violation|17|||
163007735|NCT00281957|588730087|FG001|Overall Study|Adverse Event|2|||
163007736|NCT00281957|588730086|FG000|Overall Study|Death|1|||
163007737|NCT00281957|588730087|FG001|Overall Study|Death|0|||
163007738|NCT00281957|588730086|FG000|Overall Study|Progression/relapse|47|||
163007739|NCT00281957|588730087|FG001|Overall Study|Progression/relapse|35|||
163007740|NCT00281957|588730086|FG000|Overall Study|Not protocol specified|8|||
163326490|NCT01371994|589906173|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
163007741|NCT00281957|588730087|FG001|Overall Study|Not protocol specified|1|||
163007742|NCT00281957|588730086|FG000|Overall Study|Not eligible|1|||
163007743|NCT00281957|588730087|FG001|Overall Study|Not eligible|2|||
163007744|NCT00281957|588730086|FG000|Overall Study|Did not start treatment|3|||
163007745|NCT00281957|588730087|FG001|Overall Study|Did not start treatment|1|||
163007746|NCT00281957|588730086|FG000|Overall Study|Refusal unrelated to adverse events|0|||
163007747|NCT00281957|588730087|FG001|Overall Study|Refusal unrelated to adverse events|1|||
163007748|NCT03281876|588730095|FG000|Overall Study|Adverse Event|4|||
163007749|NCT03281876|588730096|FG001|Overall Study|Adverse Event|15|||
163007750|NCT03281876|588730095|FG000|Overall Study|Lost to Follow-up|1|||
163007751|NCT03281876|588730096|FG001|Overall Study|Lost to Follow-up|4|||
163007752|NCT03281876|588730095|FG000|Overall Study|Withdrawal by Subject|11|||
163007753|NCT03281876|588730096|FG001|Overall Study|Withdrawal by Subject|15|||
163007754|NCT03281876|588730095|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
163007755|NCT03281876|588730096|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163007756|NCT03281876|588730095|FG000|Overall Study|OTHER|5|||
163007757|NCT03281876|588730096|FG001|Overall Study|OTHER|5|||
163007758|NCT02208089|588730097|FG000|Overall Study|Withdrawal by Subject|1|||
163007759|NCT02208089|588730098|FG001|Overall Study|Withdrawal by Subject|0|||
163007760|NCT02208089|588730097|FG000|Overall Study|Lost to Follow-up|6|||
163007761|NCT02208089|588730098|FG001|Overall Study|Lost to Follow-up|0|||
163007762|NCT00456300|588730099|FG000|Overall Study|Adverse Event|1|||
163007763|NCT00456300|588730100|FG001|Overall Study|Adverse Event|0|||
163007764|NCT01478373|588730101|FG000|Treatment Phase|Protocol Violation|1|||
163007765|NCT01478373|588730101|FG000|Survival Phase|Adverse Event|8|||
163007766|NCT01478373|588730101|FG000|Survival Phase|Protocol Violation|1|||
163007767|NCT01478373|588730101|FG000|Survival Phase|crossover to another study|2|||
163007768|NCT01478373|588730101|FG000|Survival Phase|Progressive Disease|27|||
163007769|NCT00683657|588730106|FG000|Overall Study|Adverse Event|0|||
163007770|NCT00683657|588730107|FG001|Overall Study|Adverse Event|1|||
163007771|NCT00683657|588730106|FG000|Overall Study|Subject Withdrew Consent|1|||
163007772|NCT00683657|588730107|FG001|Overall Study|Subject Withdrew Consent|0|||
163007773|NCT01074944|588730113|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
163007774|NCT01074944|588730114|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
163007775|NCT01074944|588730115|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
163007776|NCT01074944|588730116|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
163007777|NCT01074944|588730117|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
163007778|NCT01074944|588730113|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
163007779|NCT01074944|588730114|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
163007780|NCT01074944|588730115|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
163007781|NCT01074944|588730116|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
163007782|NCT01074944|588730117|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
163007783|NCT01074944|588730113|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
163007784|NCT01074944|588730114|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
163007785|NCT01074944|588730115|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
163007786|NCT01074944|588730116|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
163007787|NCT01074944|588730117|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
163007788|NCT01074944|588730113|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
163007789|NCT01074944|588730114|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
163007790|NCT01074944|588730115|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
163007791|NCT01074944|588730116|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
163007792|NCT01074944|588730117|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
163007793|NCT01074944|588730113|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
163007794|NCT01074944|588730114|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
163007795|NCT01074944|588730115|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
163007796|NCT01074944|588730116|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
163061498|NCT03507790|588933139|FG002|Overall Study|Discontinuation of the trial at the site|0|||
163007797|NCT01074944|588730117|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
163007798|NCT01074944|588730113|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
163007799|NCT01074944|588730114|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
163007800|NCT01074944|588730115|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
163007801|NCT01074944|588730116|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
163007802|NCT01074944|588730117|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
163007803|NCT01074944|588730113|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
163007804|NCT01074944|588730114|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
163007805|NCT01074944|588730115|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
163007806|NCT01074944|588730116|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
163007807|NCT01074944|588730117|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
163007808|NCT01074944|588730113|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
163007809|NCT01074944|588730114|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
163007810|NCT01074944|588730115|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
163007811|NCT01074944|588730116|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
163007812|NCT01074944|588730117|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
163007813|NCT01074944|588730113|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
163007814|NCT01074944|588730114|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
163007815|NCT01074944|588730115|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
163007816|NCT01074944|588730116|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
163007817|NCT01074944|588730117|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
163007818|NCT01074944|588730113|FG000|Long Term Treatment|Adverse Event|0|||
163007819|NCT01074944|588730114|FG001|Long Term Treatment|Adverse Event|0|||
163007820|NCT01074944|588730115|FG002|Long Term Treatment|Adverse Event|0|||
163007821|NCT01074944|588730116|FG003|Long Term Treatment|Adverse Event|3|||
163007822|NCT01074944|588730117|FG004|Long Term Treatment|Adverse Event|0|||
163007823|NCT01074944|588730113|FG000|Long Term Treatment|Lost to Follow-up|0|||
163007824|NCT01074944|588730114|FG001|Long Term Treatment|Lost to Follow-up|0|||
163007825|NCT01074944|588730115|FG002|Long Term Treatment|Lost to Follow-up|0|||
163007826|NCT01074944|588730116|FG003|Long Term Treatment|Lost to Follow-up|2|||
163007827|NCT01074944|588730117|FG004|Long Term Treatment|Lost to Follow-up|0|||
163007828|NCT01074944|588730113|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
163007829|NCT01074944|588730114|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
163007830|NCT01074944|588730115|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
163007831|NCT01074944|588730116|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
163007832|NCT01074944|588730117|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
163007833|NCT01074944|588730113|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
163007834|NCT01074944|588730114|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
163007835|NCT01074944|588730115|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
163007836|NCT01074944|588730116|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
163007837|NCT01074944|588730117|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
163007838|NCT01074944|588730113|FG000|Long Term Treatment|Withdrawal by Subject|0|||
163007839|NCT01074944|588730114|FG001|Long Term Treatment|Withdrawal by Subject|0|||
163007840|NCT01074944|588730115|FG002|Long Term Treatment|Withdrawal by Subject|0|||
163007841|NCT01074944|588730116|FG003|Long Term Treatment|Withdrawal by Subject|2|||
163007842|NCT01074944|588730117|FG004|Long Term Treatment|Withdrawal by Subject|0|||
163007843|NCT01074944|588730113|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
163007844|NCT01074944|588730114|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
163007845|NCT01074944|588730115|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
163007846|NCT01074944|588730116|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
163007847|NCT01074944|588730117|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
163007848|NCT01074944|588730113|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
163007849|NCT01074944|588730114|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
163007850|NCT01074944|588730115|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
163007851|NCT01074944|588730116|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
163007852|NCT01074944|588730117|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
163007853|NCT03200717|588730126|FG000|Overall Study|Progressive disease|24|||
163007854|NCT03200717|588730127|FG001|Overall Study|Progressive disease|5|||
163007855|NCT03200717|588730126|FG000|Overall Study|Adverse Event|11|||
163007856|NCT03200717|588730127|FG001|Overall Study|Adverse Event|8|||
163007857|NCT03200717|588730126|FG000|Overall Study|Physician Decision|3|||
163007858|NCT03200717|588730127|FG001|Overall Study|Physician Decision|2|||
163007859|NCT03200717|588730126|FG000|Overall Study|Death|2|||
163007860|NCT03200717|588730127|FG001|Overall Study|Death|0|||
163007861|NCT03200717|588730126|FG000|Overall Study|Subject/Guardian Decision|1|||
163007862|NCT03200717|588730127|FG001|Overall Study|Subject/Guardian Decision|0|||
163007863|NCT02586155|588730128|FG000|Overall Study|Adverse Event|2|||
163007864|NCT02586155|588730129|FG001|Overall Study|Adverse Event|3|||
163007865|NCT02586155|588730128|FG000|Overall Study|Withdrawal by Subject|31|||
163007866|NCT02586155|588730129|FG001|Overall Study|Withdrawal by Subject|24|||
163007867|NCT02586155|588730128|FG000|Overall Study|Lost to Follow-up|7|||
163007868|NCT02586155|588730129|FG001|Overall Study|Lost to Follow-up|13|||
163007869|NCT02586155|588730128|FG000|Overall Study|Death|61|||
163007870|NCT02586155|588730129|FG001|Overall Study|Death|72|||
163007871|NCT02586155|588730128|FG000|Overall Study|Other reasons|26|||
163061499|NCT03507790|588933137|FG000|Overall Study|Randomized in error|0|||
163061500|NCT03507790|588933138|FG001|Overall Study|Randomized in error|0|||
163213715|NCT01050257|589496039|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
163213716|NCT01050257|589496040|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
163213717|NCT01050257|589496038|FG000|Overall Study|Violation criteria|0|||
163213718|NCT01050257|589496039|FG001|Overall Study|Violation criteria|1|||
163213719|NCT01050257|589496040|FG002|Overall Study|Violation criteria|0|||
163213720|NCT01050257|589496038|FG000|Overall Study|Failure to return|0|||
163213721|NCT01050257|589496039|FG001|Overall Study|Failure to return|2|||
163213722|NCT01050257|589496040|FG002|Overall Study|Failure to return|0|||
163007872|NCT02586155|588730129|FG001|Overall Study|Other reasons|15|||
163007873|NCT01522456|588730130|FG000|Overall Study|Adverse Event|2|||
163007874|NCT01522456|588730130|FG000|Overall Study|Lost to Follow-up|2|||
163007875|NCT01522456|588730130|FG000|Overall Study|Withdrawal by Subject|2|||
163007876|NCT01522456|588730130|FG000|Overall Study|Pregnancy|1|||
163007877|NCT01522456|588730130|FG000|Overall Study|Tolerability Assessment|1|||
163007878|NCT02201784|588730131|FG000|Overall Study|Failure to achieve adequate block|2|||
163007879|NCT02201784|588730132|FG001|Overall Study|Failure to achieve adequate block|0|||
163007880|NCT02072980|588730133|FG000|Period 2, Second Wear|Adverse Event|0|||
163007881|NCT02072980|588730134|FG001|Period 2, Second Wear|Adverse Event|1|||
163007882|NCT00916383|588730135|FG000|Overall Study|Adverse Event|1|||
163007883|NCT00916383|588730135|FG000|Overall Study|Death|1|||
163007884|NCT00916383|588730135|FG000|Overall Study|Protocol Violation|1|||
163007885|NCT02899962|588730136|FG000|Open-label Phase|Adverse Event|2|||
163007886|NCT02899962|588730137|FG001|Open-label Phase|Adverse Event|0|||
163007887|NCT02899962|588730138|FG002|Open-label Phase|Adverse Event|0|||
163007888|NCT02899962|588730136|FG000|Open-label Phase|Lost to Follow-up|9|||
163007889|NCT02899962|588730137|FG001|Open-label Phase|Lost to Follow-up|0|||
163007890|NCT02899962|588730138|FG002|Open-label Phase|Lost to Follow-up|0|||
163007891|NCT02899962|588730136|FG000|Open-label Phase|Other reasons|9|||
163007892|NCT02899962|588730137|FG001|Open-label Phase|Other reasons|0|||
163007893|NCT02899962|588730138|FG002|Open-label Phase|Other reasons|0|||
163007894|NCT02899962|588730136|FG000|Open-label Phase|Withdrawal by Subject|7|||
163007895|NCT02899962|588730137|FG001|Open-label Phase|Withdrawal by Subject|0|||
163007896|NCT02899962|588730138|FG002|Open-label Phase|Withdrawal by Subject|0|||
163007897|NCT02899962|588730136|FG000|Maintenance Phase|Adverse Event|0|||
163007898|NCT02899962|588730137|FG001|Maintenance Phase|Adverse Event|2|||
163007899|NCT02899962|588730138|FG002|Maintenance Phase|Adverse Event|1|||
163007900|NCT02899962|588730136|FG000|Maintenance Phase|Death|0|||
163007901|NCT02899962|588730137|FG001|Maintenance Phase|Death|0|||
163007902|NCT02899962|588730138|FG002|Maintenance Phase|Death|1|||
163007903|NCT02899962|588730136|FG000|Maintenance Phase|Lack of Efficacy|0|||
163007904|NCT02899962|588730137|FG001|Maintenance Phase|Lack of Efficacy|20|||
163007905|NCT02899962|588730138|FG002|Maintenance Phase|Lack of Efficacy|16|||
163007906|NCT02899962|588730136|FG000|Maintenance Phase|Lost to Follow-up|0|||
163007907|NCT02899962|588730137|FG001|Maintenance Phase|Lost to Follow-up|12|||
163007908|NCT02899962|588730138|FG002|Maintenance Phase|Lost to Follow-up|14|||
163007909|NCT02899962|588730136|FG000|Maintenance Phase|Other reasons|0|||
163007910|NCT02899962|588730137|FG001|Maintenance Phase|Other reasons|9|||
163007911|NCT02899962|588730138|FG002|Maintenance Phase|Other reasons|13|||
163007912|NCT02899962|588730136|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
163007913|NCT02899962|588730137|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
163007914|NCT02899962|588730138|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
163007915|NCT02899962|588730136|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
163007916|NCT02899962|588730137|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
163007917|NCT02899962|588730138|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
163007918|NCT02899962|588730136|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163007919|NCT02899962|588730137|FG001|Maintenance Phase|Withdrawal by Subject|30|||
163007920|NCT02899962|588730138|FG002|Maintenance Phase|Withdrawal by Subject|36|||
163007921|NCT00258960|588730139|FG000|Overall Study|Death|2|||
163007922|NCT00258960|588730139|FG000|Overall Study|Disease Progression|7|||
163007923|NCT00258960|588730139|FG000|Overall Study|Adverse Event|4|||
163007924|NCT00258960|588730139|FG000|Overall Study|Physician Decision|1|||
163061501|NCT03507790|588933139|FG002|Overall Study|Randomized in error|1|||
163061502|NCT00671788|588933140|FG000|Overall Study|Adverse Event|8|||
163061503|NCT00671788|588933140|FG000|Overall Study|Refused further treatment|3|||
163061504|NCT00671788|588933140|FG000|Overall Study|Ineligible|1|||
163061505|NCT00671788|588933140|FG000|Overall Study|MD Decision|1|||
163061506|NCT00671788|588933140|FG000|Overall Study|Other|1|||
163061507|NCT03415178|588933141|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
163061508|NCT03415178|588933142|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
163007925|NCT00258960|588730139|FG000|Overall Study|Withdrawal by Subject|1|||
163007926|NCT00258960|588730139|FG000|Overall Study|Mistake|2|||
163007927|NCT00473590|588730140|FG000|Overall Study|Adverse Event|3|||
163007928|NCT00473590|588730141|FG001|Overall Study|Adverse Event|3|||
163061509|NCT03415178|588933141|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
163007929|NCT00473590|588730140|FG000|Overall Study|Death|4|||
163007930|NCT00473590|588730141|FG001|Overall Study|Death|2|||
163007931|NCT00473590|588730140|FG000|Overall Study|Progression not resulting in death|24|||
163061510|NCT03415178|588933142|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
163007932|NCT00473590|588730141|FG001|Overall Study|Progression not resulting in death|20|||
163007933|NCT00473590|588730140|FG000|Overall Study|Non-protocol-specified therapy|7|||
163007934|NCT00473590|588730141|FG001|Overall Study|Non-protocol-specified therapy|5|||
163007935|NCT00473590|588730140|FG000|Overall Study|Physician Decision|2|||
163007936|NCT00473590|588730141|FG001|Overall Study|Physician Decision|4|||
163061511|NCT01093846|588933143|FG000|Overall Study|Adverse Event|0|||
163061512|NCT01093846|588933144|FG001|Overall Study|Adverse Event|0|||
163326491|NCT01371994|589906174|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
163326492|NCT01371994|589906173|FG000|Overall Study|Physician Decision|1|||
163326493|NCT01371994|589906174|FG001|Overall Study|Physician Decision|1|||
163326494|NCT01371994|589906173|FG000|Overall Study|Miscellaneous Reasons|6|||
163326495|NCT01371994|589906174|FG001|Overall Study|Miscellaneous Reasons|4|||
163326496|NCT00087685|589906175|FG000|Overall Study|Adverse Event|5|||
163326497|NCT00087685|589906175|FG000|Overall Study|Non-Compliance|1|||
163326498|NCT00087685|589906175|FG000|Overall Study|Progressive Disease|5|||
163326499|NCT00087685|589906175|FG000|Overall Study|Withdrawal by Subject|3|||
163326500|NCT01830595|589906176|FG000|First Period|Withdrawal by Subject|1|||
163007937|NCT00473590|588730140|FG000|Overall Study|Withdrawal by Subject|5|||
163326501|NCT01830595|589906177|FG001|First Period|Withdrawal by Subject|3|||
163326502|NCT01830595|589906176|FG000|Washout|Withdrawal by Subject|2|||
163326503|NCT01830595|589906177|FG001|Washout|Withdrawal by Subject|2|||
163326504|NCT03280030|589906185|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
163326505|NCT03280030|589906186|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
163326506|NCT03280030|589906187|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
163326507|NCT03280030|589906185|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
163326508|NCT03280030|589906186|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
163326509|NCT03280030|589906187|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
163326510|NCT03280030|589906185|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
163326511|NCT03280030|589906186|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
163326512|NCT03280030|589906187|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
163326513|NCT03280030|589906185|FG000|Part 2 - Efficacy|Adverse Event|0|||
163326514|NCT03280030|589906186|FG001|Part 2 - Efficacy|Adverse Event|4|||
163326515|NCT03280030|589906187|FG002|Part 2 - Efficacy|Adverse Event|6|||
163326516|NCT03280030|589906185|FG000|Part 2 - Efficacy|Death|0|||
163326517|NCT03280030|589906186|FG001|Part 2 - Efficacy|Death|3|||
163326518|NCT03280030|589906187|FG002|Part 2 - Efficacy|Death|0|||
163326519|NCT03280030|589906185|FG000|Part 2 - Efficacy|Physician Decision|0|||
163326520|NCT03280030|589906186|FG001|Part 2 - Efficacy|Physician Decision|10|||
163326521|NCT03280030|589906187|FG002|Part 2 - Efficacy|Physician Decision|16|||
163326522|NCT03280030|589906185|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
163326523|NCT03280030|589906186|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
163326524|NCT03280030|589906187|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
163326525|NCT03280030|589906185|FG000|Part 2 - Efficacy|Progressive disease|0|||
163326526|NCT03280030|589906186|FG001|Part 2 - Efficacy|Progressive disease|7|||
163326527|NCT03280030|589906187|FG002|Part 2 - Efficacy|Progressive disease|5|||
163326528|NCT01983683|589906189|FG000|Overall Study|Withdrawal by Subject|14|||
163326529|NCT01983683|589906190|FG001|Overall Study|Withdrawal by Subject|18|||
163326530|NCT01983683|589906189|FG000|Overall Study|Death|11|||
163326531|NCT01983683|589906190|FG001|Overall Study|Death|15|||
163326532|NCT01983683|589906189|FG000|Overall Study|Physician Decision|8|||
163326533|NCT01983683|589906190|FG001|Overall Study|Physician Decision|9|||
163326534|NCT01983683|589906189|FG000|Overall Study|Lost to Follow-up|4|||
163007938|NCT00473590|588730141|FG001|Overall Study|Withdrawal by Subject|3|||
163007939|NCT00473590|588730140|FG000|Overall Study|Other|0|||
163007940|NCT00473590|588730141|FG001|Overall Study|Other|1|||
163007941|NCT02601014|588730145|FG000|Overall Study|Adverse Event|3|||
163007942|NCT02601014|588730146|FG001|Overall Study|Adverse Event|3|||
163007943|NCT02601014|588730145|FG000|Overall Study|Death|3|||
163007944|NCT02601014|588730146|FG001|Overall Study|Death|1|||
163007945|NCT02601014|588730145|FG000|Overall Study|Disease progression|4|||
163007946|NCT02601014|588730146|FG001|Overall Study|Disease progression|8|||
163007947|NCT02623725|588730148|FG000|Overall Study|Non compliance with protocol|9|||
163007948|NCT02623725|588730149|FG001|Overall Study|Non compliance with protocol|3|||
163007949|NCT02623725|588730148|FG000|Overall Study|Serious adverse event|0|||
163326535|NCT01983683|589906190|FG001|Overall Study|Lost to Follow-up|8|||
163326536|NCT01983683|589906189|FG000|Overall Study|Sponsor Decision|1|||
163326537|NCT01983683|589906190|FG001|Overall Study|Sponsor Decision|1|||
163326538|NCT04882917|589906193|FG000|Overall Study|Adverse Event|0|||
163326539|NCT04882917|589906194|FG001|Overall Study|Adverse Event|1|||
163326540|NCT04882917|589906195|FG002|Overall Study|Adverse Event|2|||
163007950|NCT02623725|588730149|FG001|Overall Study|Serious adverse event|2|||
163007951|NCT02623725|588730148|FG000|Overall Study|Withdrawal by Subject|7|||
163007952|NCT02623725|588730149|FG001|Overall Study|Withdrawal by Subject|1|||
163007953|NCT03918629|588730150|FG000|Overall Study|Adverse Event|19|||
163007954|NCT03918629|588730151|FG001|Overall Study|Adverse Event|20|||
163007955|NCT03918629|588730150|FG000|Overall Study|Death|14|||
163007956|NCT03918629|588730151|FG001|Overall Study|Death|7|||
163007957|NCT03918629|588730150|FG000|Overall Study|Lost to Follow-up|36|||
163007958|NCT03918629|588730151|FG001|Overall Study|Lost to Follow-up|28|||
163007959|NCT03918629|588730150|FG000|Overall Study|Physician Decision|1|||
163007960|NCT03918629|588730151|FG001|Overall Study|Physician Decision|0|||
163007961|NCT03918629|588730150|FG000|Overall Study|Protocol Violation|7|||
163007962|NCT03918629|588730151|FG001|Overall Study|Protocol Violation|4|||
163326541|NCT04882917|589906196|FG003|Overall Study|Adverse Event|2|||
163061513|NCT01093846|588933145|FG002|Overall Study|Adverse Event|1|||
163007963|NCT03918629|588730150|FG000|Overall Study|Withdrawal by Subject|47|||
163007964|NCT03918629|588730151|FG001|Overall Study|Withdrawal by Subject|47|||
163007965|NCT03918629|588730150|FG000|Overall Study|Other|7|||
163007966|NCT03918629|588730151|FG001|Overall Study|Other|11|||
163007967|NCT03918629|588730150|FG000|Overall Study|Randomized but not vaccinated|2|||
163007968|NCT03918629|588730151|FG001|Overall Study|Randomized but not vaccinated|1|||
163007969|NCT01891864|588730153|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
163007970|NCT01891864|588730154|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
163007971|NCT01891864|588730155|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
163007972|NCT01891864|588730156|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
163007973|NCT01891864|588730157|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
163007974|NCT01891864|588730158|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
163007975|NCT01891864|588730153|FG000|Treatment Period 1|Physician Decision|0|||
163007976|NCT01891864|588730154|FG001|Treatment Period 1|Physician Decision|1|||
163326542|NCT04882917|589906193|FG000|Overall Study|Withdrawal by Subject|1|||
163326543|NCT04882917|589906194|FG001|Overall Study|Withdrawal by Subject|0|||
163326544|NCT04882917|589906195|FG002|Overall Study|Withdrawal by Subject|2|||
163326545|NCT04882917|589906196|FG003|Overall Study|Withdrawal by Subject|1|||
163326546|NCT04882917|589906193|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
163007977|NCT01891864|588730155|FG002|Treatment Period 1|Physician Decision|0|||
163007978|NCT01891864|588730156|FG003|Treatment Period 1|Physician Decision|0|||
163007979|NCT01891864|588730157|FG004|Treatment Period 1|Physician Decision|0|||
163007980|NCT01891864|588730158|FG005|Treatment Period 1|Physician Decision|0|||
163007981|NCT01891864|588730153|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
163007982|NCT01891864|588730154|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
163007983|NCT01891864|588730155|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
163007984|NCT01891864|588730156|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
163007985|NCT01891864|588730157|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
163007986|NCT01891864|588730158|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
163007987|NCT01891864|588730153|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
163007988|NCT01891864|588730154|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
163007989|NCT01891864|588730155|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
163007990|NCT01891864|588730156|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
163061514|NCT01093846|588933143|FG000|Overall Study|Lack of Efficacy|0|||
163061515|NCT01093846|588933144|FG001|Overall Study|Lack of Efficacy|0|||
163061516|NCT01093846|588933145|FG002|Overall Study|Lack of Efficacy|4|||
163213723|NCT01050257|589496038|FG000|Overall Study|Death|0|||
163213724|NCT01050257|589496039|FG001|Overall Study|Death|0|||
163213725|NCT01050257|589496040|FG002|Overall Study|Death|1|||
163213726|NCT00171223|589496041|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
163213727|NCT00171223|589496042|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
163213728|NCT00171223|589496043|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
163213729|NCT00171223|589496041|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
163213730|NCT00171223|589496042|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
163213731|NCT00171223|589496043|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
163213732|NCT00171223|589496041|FG000|Overall Study|Abnormal Procedure|1|||
163213733|NCT00171223|589496042|FG001|Overall Study|Abnormal Procedure|0|||
163213734|NCT00171223|589496043|FG002|Overall Study|Abnormal Procedure|0|||
163213735|NCT00171223|589496041|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
163213736|NCT00171223|589496042|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
163213737|NCT00171223|589496043|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
163213738|NCT00171223|589496041|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
163213739|NCT00171223|589496042|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
163213740|NCT00171223|589496043|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
163213741|NCT00171223|589496041|FG000|Overall Study|Protocol Violation|2|||
163213742|NCT00171223|589496042|FG001|Overall Study|Protocol Violation|2|||
163213743|NCT00171223|589496043|FG002|Overall Study|Protocol Violation|3|||
163213744|NCT00171223|589496041|FG000|Overall Study|Participant Withdrew Consent|12|||
163213745|NCT00171223|589496042|FG001|Overall Study|Participant Withdrew Consent|21|||
163213746|NCT00171223|589496043|FG002|Overall Study|Participant Withdrew Consent|15|||
163213747|NCT00171223|589496041|FG000|Overall Study|Lost to Follow-up|5|||
163213748|NCT00171223|589496042|FG001|Overall Study|Lost to Follow-up|2|||
163213749|NCT00171223|589496043|FG002|Overall Study|Lost to Follow-up|3|||
163213750|NCT00171223|589496041|FG000|Overall Study|Administrative Problems|4|||
163213751|NCT00171223|589496042|FG001|Overall Study|Administrative Problems|7|||
163213752|NCT00171223|589496043|FG002|Overall Study|Administrative Problems|6|||
163213753|NCT00171223|589496041|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
163213754|NCT00171223|589496042|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
163213755|NCT00171223|589496043|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
163213756|NCT00171223|589496041|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
163213757|NCT00171223|589496042|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
163213758|NCT00171223|589496043|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
163213759|NCT02064166|589496044|FG000|Overall Study|Adverse Event|1|||
163213760|NCT02064166|589496045|FG001|Overall Study|Adverse Event|0|||
163213761|NCT03742037|589496047|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
163213762|NCT03742037|589496048|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
163213763|NCT03742037|589496049|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
163213764|NCT03742037|589496050|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
163213765|NCT03742037|589496051|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
163213766|NCT03742037|589496052|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
163213767|NCT03742037|589496053|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
163213768|NCT03742037|589496047|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
163213769|NCT03742037|589496048|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
163213770|NCT03742037|589496049|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
163213771|NCT03742037|589496050|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
163213772|NCT03742037|589496051|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
163213773|NCT03742037|589496052|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
163213774|NCT03742037|589496053|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
163213775|NCT03742037|589496047|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
163007991|NCT01891864|588730157|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
163007992|NCT01891864|588730158|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
163007993|NCT01891864|588730153|FG000|Treatment Period 1|Withdrawal by Subject|2|||
163007994|NCT01891864|588730154|FG001|Treatment Period 1|Withdrawal by Subject|5|||
163007995|NCT01891864|588730155|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163007996|NCT01891864|588730156|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163007997|NCT01891864|588730157|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163007998|NCT01891864|588730158|FG005|Treatment Period 1|Withdrawal by Subject|0|||
163007999|NCT01891864|588730153|FG000|Treatment Period 1|Lost to Follow-up|1|||
163008000|NCT01891864|588730154|FG001|Treatment Period 1|Lost to Follow-up|0|||
163008001|NCT01891864|588730155|FG002|Treatment Period 1|Lost to Follow-up|0|||
163008002|NCT01891864|588730156|FG003|Treatment Period 1|Lost to Follow-up|0|||
163213776|NCT03742037|589496048|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
163213777|NCT03742037|589496049|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
163008003|NCT01891864|588730157|FG004|Treatment Period 1|Lost to Follow-up|0|||
163008004|NCT01891864|588730158|FG005|Treatment Period 1|Lost to Follow-up|0|||
163008005|NCT01891864|588730153|FG000|Treatment Period 2|Protocol Violation|0|||
163008006|NCT01891864|588730154|FG001|Treatment Period 2|Protocol Violation|0|||
163008007|NCT01891864|588730155|FG002|Treatment Period 2|Protocol Violation|0|||
163213778|NCT03742037|589496050|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
163213779|NCT03742037|589496051|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
163213780|NCT03742037|589496052|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
163213781|NCT03742037|589496053|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
163213782|NCT03742037|589496047|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
163213783|NCT03742037|589496048|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
163213784|NCT03742037|589496049|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
163213785|NCT03742037|589496050|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
163213786|NCT03742037|589496051|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
163213787|NCT03742037|589496052|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
163213788|NCT03742037|589496053|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
163213789|NCT03742037|589496047|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
163213790|NCT03742037|589496048|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
163213791|NCT03742037|589496049|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
163213792|NCT03742037|589496050|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
163213793|NCT03742037|589496051|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
163213794|NCT03742037|589496052|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
163213795|NCT03742037|589496053|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
163213796|NCT03742037|589496047|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
163213797|NCT03742037|589496048|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
163213798|NCT03742037|589496049|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
163213799|NCT03742037|589496050|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
163213800|NCT03742037|589496051|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
163326547|NCT04882917|589906194|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
163326548|NCT04882917|589906195|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
163008008|NCT01891864|588730156|FG003|Treatment Period 2|Protocol Violation|1|||
163008009|NCT01891864|588730157|FG004|Treatment Period 2|Protocol Violation|0|||
163008010|NCT01891864|588730158|FG005|Treatment Period 2|Protocol Violation|0|||
163061517|NCT01093846|588933143|FG000|Overall Study|Condition no longer required study drug|1|||
163008011|NCT01891864|588730153|FG000|Treatment Period 2|Physician Decision|0|||
163008012|NCT01891864|588730154|FG001|Treatment Period 2|Physician Decision|0|||
163008013|NCT01891864|588730155|FG002|Treatment Period 2|Physician Decision|1|||
163008014|NCT01891864|588730156|FG003|Treatment Period 2|Physician Decision|0|||
163008015|NCT01891864|588730157|FG004|Treatment Period 2|Physician Decision|0|||
163008016|NCT01891864|588730158|FG005|Treatment Period 2|Physician Decision|0|||
163008017|NCT01891864|588730153|FG000|Treatment Period 2|Site Termination|0|||
163008018|NCT01891864|588730154|FG001|Treatment Period 2|Site Termination|0|||
163008019|NCT01891864|588730155|FG002|Treatment Period 2|Site Termination|1|||
163008020|NCT01891864|588730156|FG003|Treatment Period 2|Site Termination|2|||
163008021|NCT01891864|588730157|FG004|Treatment Period 2|Site Termination|0|||
163008022|NCT01891864|588730158|FG005|Treatment Period 2|Site Termination|0|||
163326549|NCT04882917|589906196|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
163326550|NCT00319020|589906197|FG000|Overall Study|Death|2|||
163326551|NCT00319020|589906198|FG001|Overall Study|Death|2|||
163326552|NCT00319020|589906197|FG000|Overall Study|Withdrawal by Subject|4|||
163326553|NCT00319020|589906198|FG001|Overall Study|Withdrawal by Subject|1|||
163326554|NCT00319020|589906197|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
163326555|NCT00319020|589906198|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
163326556|NCT00319020|589906197|FG000|Overall Study|Administrative reason|0|||
163326557|NCT00319020|589906198|FG001|Overall Study|Administrative reason|5|||
163326558|NCT00319020|589906197|FG000|Overall Study|Disease progression|0|||
163326559|NCT00319020|589906198|FG001|Overall Study|Disease progression|2|||
163326560|NCT00319020|589906197|FG000|Overall Study|Transplant|0|||
163008023|NCT01891864|588730153|FG000|Treatment Period 2|Lack of Efficacy|0|||
163008024|NCT01891864|588730154|FG001|Treatment Period 2|Lack of Efficacy|0|||
163008025|NCT01891864|588730155|FG002|Treatment Period 2|Lack of Efficacy|1|||
163008026|NCT01891864|588730156|FG003|Treatment Period 2|Lack of Efficacy|0|||
163008027|NCT01891864|588730157|FG004|Treatment Period 2|Lack of Efficacy|1|||
163008028|NCT01891864|588730158|FG005|Treatment Period 2|Lack of Efficacy|0|||
163008029|NCT01891864|588730153|FG000|Treatment Period 2|Adverse Event|0|||
163008030|NCT01891864|588730154|FG001|Treatment Period 2|Adverse Event|0|||
163008031|NCT01891864|588730155|FG002|Treatment Period 2|Adverse Event|1|||
163008032|NCT01891864|588730156|FG003|Treatment Period 2|Adverse Event|2|||
163008033|NCT01891864|588730157|FG004|Treatment Period 2|Adverse Event|0|||
163008034|NCT01891864|588730158|FG005|Treatment Period 2|Adverse Event|4|||
163008035|NCT01891864|588730153|FG000|Treatment Period 2|Termination of Site|0|||
163008036|NCT01891864|588730154|FG001|Treatment Period 2|Termination of Site|0|||
163008037|NCT01891864|588730155|FG002|Treatment Period 2|Termination of Site|0|||
163008038|NCT01891864|588730156|FG003|Treatment Period 2|Termination of Site|0|||
163008039|NCT01891864|588730157|FG004|Treatment Period 2|Termination of Site|2|||
163008040|NCT01891864|588730158|FG005|Treatment Period 2|Termination of Site|0|||
163008041|NCT01891864|588730153|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163008042|NCT01891864|588730154|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163008043|NCT01891864|588730155|FG002|Treatment Period 2|Withdrawal by Subject|3|||
163008044|NCT01891864|588730156|FG003|Treatment Period 2|Withdrawal by Subject|4|||
163008045|NCT01891864|588730157|FG004|Treatment Period 2|Withdrawal by Subject|1|||
163008046|NCT01891864|588730158|FG005|Treatment Period 2|Withdrawal by Subject|1|||
163008047|NCT01891864|588730153|FG000|Extension Period|Lack of Efficacy|0|||
163008048|NCT01891864|588730154|FG001|Extension Period|Lack of Efficacy|0|||
163008049|NCT01891864|588730155|FG002|Extension Period|Lack of Efficacy|0|||
163008050|NCT01891864|588730156|FG003|Extension Period|Lack of Efficacy|1|||
163008051|NCT01891864|588730157|FG004|Extension Period|Lack of Efficacy|1|||
163008052|NCT01891864|588730158|FG005|Extension Period|Lack of Efficacy|0|||
163008053|NCT01891864|588730153|FG000|Extension Period|Pregnancy|0|||
163008054|NCT01891864|588730154|FG001|Extension Period|Pregnancy|0|||
163008055|NCT01891864|588730155|FG002|Extension Period|Pregnancy|1|||
163008056|NCT01891864|588730156|FG003|Extension Period|Pregnancy|0|||
163008057|NCT01891864|588730157|FG004|Extension Period|Pregnancy|0|||
163008058|NCT01891864|588730158|FG005|Extension Period|Pregnancy|0|||
163326561|NCT00319020|589906198|FG001|Overall Study|Transplant|1|||
163326562|NCT00319020|589906197|FG000|Overall Study|Treatment failure|0|||
163008059|NCT01891864|588730153|FG000|Extension Period|Adverse Event|0|||
163008060|NCT01891864|588730154|FG001|Extension Period|Adverse Event|0|||
163008061|NCT01891864|588730155|FG002|Extension Period|Adverse Event|4|||
163008062|NCT01891864|588730156|FG003|Extension Period|Adverse Event|2|||
163326563|NCT00319020|589906198|FG001|Overall Study|Treatment failure|1|||
163326564|NCT00319020|589906197|FG000|Overall Study|Adverse Event|0|||
163008063|NCT01891864|588730157|FG004|Extension Period|Adverse Event|2|||
163008064|NCT01891864|588730158|FG005|Extension Period|Adverse Event|0|||
163008065|NCT01891864|588730153|FG000|Extension Period|Withdrawal by Subject|0|||
163008066|NCT01891864|588730154|FG001|Extension Period|Withdrawal by Subject|0|||
163008067|NCT01891864|588730155|FG002|Extension Period|Withdrawal by Subject|1|||
163008068|NCT01891864|588730156|FG003|Extension Period|Withdrawal by Subject|2|||
163008069|NCT01891864|588730157|FG004|Extension Period|Withdrawal by Subject|4|||
163008070|NCT01891864|588730158|FG005|Extension Period|Withdrawal by Subject|0|||
163008071|NCT01891864|588730153|FG000|Extension Period|Lost to Follow-up|0|||
163326565|NCT00319020|589906198|FG001|Overall Study|Adverse Event|1|||
163326566|NCT04926740|589906199|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
163326567|NCT04926740|589906200|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
163326568|NCT04926740|589906199|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
163326569|NCT04926740|589906200|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
163326570|NCT04980300|589906201|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
163326571|NCT04980300|589906202|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
163326572|NCT04980300|589906201|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
163326573|NCT04980300|589906202|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
163326574|NCT04980300|589906201|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
163326575|NCT04980300|589906202|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
163326576|NCT04980300|589906201|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
163326577|NCT04980300|589906202|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
163326578|NCT06056310|589907351|FG000|Overall Study|Other Reasons|2|||
163326579|NCT06056310|589907351|FG000|Overall Study|Sponsor Request|16|||
163326580|NCT00536120|589907362|FG000|Overall Study|Lost to Follow-up|1|||
163326581|NCT00536120|589907363|FG001|Overall Study|Lost to Follow-up|0|||
163326582|NCT00536120|589907362|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
163326583|NCT00536120|589907363|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
163326584|NCT00536120|589907362|FG000|Overall Study|Non-compliance|1|||
163326585|NCT00536120|589907363|FG001|Overall Study|Non-compliance|0|||
163326586|NCT00536120|589907362|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
163326587|NCT00536120|589907363|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
163326588|NCT00536120|589907362|FG000|Overall Study|Steroid Use|0|||
163326589|NCT00536120|589907363|FG001|Overall Study|Steroid Use|2|||
163326590|NCT00536120|589907362|FG000|Overall Study|Missed Study Visit|0|||
163326591|NCT00536120|589907363|FG001|Overall Study|Missed Study Visit|1|||
163326592|NCT02722434|589907364|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
163326593|NCT02722434|589907365|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
163326594|NCT02722434|589907364|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
163326595|NCT02722434|589907365|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
163326596|NCT03876457|589907370|FG000|Overall Study|Lost to Follow-up|1|||
163326597|NCT03876457|589907371|FG001|Overall Study|Lost to Follow-up|3|||
163326598|NCT01084694|589907372|FG000|Overall Study|Withdrawal by Subject|2|||
163326599|NCT01084694|589907373|FG001|Overall Study|Withdrawal by Subject|1|||
163326600|NCT01084694|589907372|FG000|Overall Study|Death|2|||
163326601|NCT01084694|589907373|FG001|Overall Study|Death|12|||
163326602|NCT01084694|589907372|FG000|Overall Study|eligibility not maintained|2|||
163326603|NCT01084694|589907373|FG001|Overall Study|eligibility not maintained|7|||
163326604|NCT02185794|589907378|FG000|Overall Study|Enrolled but Never Dosed|1|||
163326605|NCT02185794|589907379|FG001|Overall Study|Enrolled but Never Dosed|6|||
163326606|NCT02185794|589907380|FG002|Overall Study|Enrolled but Never Dosed|3|||
163326607|NCT02185794|589907381|FG003|Overall Study|Enrolled but Never Dosed|1|||
163326608|NCT02185794|589907382|FG004|Overall Study|Enrolled but Never Dosed|1|||
163326609|NCT02185794|589907383|FG005|Overall Study|Enrolled but Never Dosed|0|||
163326610|NCT02185794|589907378|FG000|Overall Study|Investigator's Discretion|1|||
163326611|NCT02185794|589907379|FG001|Overall Study|Investigator's Discretion|0|||
163326612|NCT02185794|589907380|FG002|Overall Study|Investigator's Discretion|1|||
163326613|NCT02185794|589907381|FG003|Overall Study|Investigator's Discretion|2|||
163326614|NCT02185794|589907382|FG004|Overall Study|Investigator's Discretion|2|||
163326615|NCT02185794|589907383|FG005|Overall Study|Investigator's Discretion|15|||
163326616|NCT02185794|589907378|FG000|Overall Study|Withdrew Consent|2|||
163326617|NCT02185794|589907379|FG001|Overall Study|Withdrew Consent|5|||
163326618|NCT02185794|589907380|FG002|Overall Study|Withdrew Consent|10|||
163326619|NCT02185794|589907381|FG003|Overall Study|Withdrew Consent|2|||
163326620|NCT02185794|589907382|FG004|Overall Study|Withdrew Consent|0|||
163326621|NCT02185794|589907383|FG005|Overall Study|Withdrew Consent|0|||
163008072|NCT01891864|588730154|FG001|Extension Period|Lost to Follow-up|0|||
163008073|NCT01891864|588730155|FG002|Extension Period|Lost to Follow-up|2|||
163008074|NCT01891864|588730156|FG003|Extension Period|Lost to Follow-up|0|||
163008075|NCT01891864|588730157|FG004|Extension Period|Lost to Follow-up|0|||
163326622|NCT02185794|589907378|FG000|Overall Study|Lost to Follow-up|1|||
163326623|NCT02185794|589907379|FG001|Overall Study|Lost to Follow-up|2|||
163326624|NCT02185794|589907380|FG002|Overall Study|Lost to Follow-up|2|||
163008076|NCT01891864|588730158|FG005|Extension Period|Lost to Follow-up|0|||
163008077|NCT02698163|588730159|FG000|Overall Study|Lost to Follow-up|0|||
163008078|NCT02698163|588730160|FG001|Overall Study|Lost to Follow-up|1|||
163326625|NCT02185794|589907381|FG003|Overall Study|Lost to Follow-up|3|||
163326626|NCT02185794|589907382|FG004|Overall Study|Lost to Follow-up|0|||
163326627|NCT02185794|589907383|FG005|Overall Study|Lost to Follow-up|1|||
163326628|NCT00336505|589907384|FG000|Overall Study|Adverse Event|10|||
163326629|NCT00336505|589907385|FG001|Overall Study|Adverse Event|9|||
163326630|NCT00336505|589907384|FG000|Overall Study|Lack of Efficacy|8|||
163326631|NCT00336505|589907385|FG001|Overall Study|Lack of Efficacy|4|||
163008079|NCT01133067|588730161|FG000|Overall Study|Death|136|||
163008080|NCT01133067|588730161|FG000|Overall Study|Lost to Follow-up|3|||
163008081|NCT00752128|588730162|FG000|Overall Study|Withdrawal by Subject|4|||
163008082|NCT00349973|588730163|FG000|Overall Study|Adverse Event|3|||
163008083|NCT00349973|588730164|FG001|Overall Study|Adverse Event|3|||
163008084|NCT00349973|588730163|FG000|Overall Study|Withdrawal by Subject|1|||
163008085|NCT00349973|588730164|FG001|Overall Study|Withdrawal by Subject|0|||
163008086|NCT04135937|588730165|FG000|Overall Study|Lost to Follow-up|2|||
163008087|NCT04135937|588730165|FG000|Overall Study|Withdrawal by Subject|1|||
163008088|NCT05620082|588730166|FG000|Overall Study|Discharged before study end|1|||
163008089|NCT05620082|588730167|FG001|Overall Study|Discharged before study end|4|||
163008090|NCT05620082|588730168|FG002|Overall Study|Discharged before study end|0|||
163008091|NCT05620082|588730166|FG000|Overall Study|Moved to a different ward|1|||
163008092|NCT05620082|588730167|FG001|Overall Study|Moved to a different ward|0|||
163008093|NCT05620082|588730168|FG002|Overall Study|Moved to a different ward|0|||
163008094|NCT05620082|588730166|FG000|Overall Study|Feeling too unwell|1|||
163008095|NCT05620082|588730167|FG001|Overall Study|Feeling too unwell|0|||
163008096|NCT05620082|588730168|FG002|Overall Study|Feeling too unwell|0|||
163008097|NCT02141438|588732249|FG000|Overall Study|Death|1308|||
163008098|NCT02141438|588732249|FG000|Overall Study|Lost to Follow-up|84|||
163008099|NCT02141438|588732249|FG000|Overall Study|Withdrawal by Subject|52|||
163008100|NCT02141438|588732249|FG000|Overall Study|Physician Decision|1|||
163008101|NCT02141438|588732249|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
163008102|NCT02513160|588732252|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
163008103|NCT02513160|588732253|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
163008104|NCT02513160|588732254|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
163008105|NCT02513160|588732255|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
163008106|NCT02513160|588732252|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
163008107|NCT02513160|588732253|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
163008108|NCT02513160|588732254|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
163008109|NCT02513160|588732255|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
163008110|NCT02513160|588732252|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
163008111|NCT02513160|588732253|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
163008112|NCT02513160|588732254|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
163008113|NCT02513160|588732255|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
163008114|NCT02513160|588732252|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
163008115|NCT02513160|588732253|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
163008116|NCT02513160|588732254|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
163008117|NCT02513160|588732255|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
163008118|NCT02513160|588732252|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
163008119|NCT02513160|588732253|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
163008120|NCT02513160|588732254|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
163008121|NCT02513160|588732255|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
163008122|NCT02513160|588732252|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
163008123|NCT02513160|588732253|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
163008124|NCT02513160|588732254|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
163008125|NCT02513160|588732255|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
163008126|NCT02513160|588732252|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
163008127|NCT02513160|588732253|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
163008128|NCT02513160|588732254|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
163008129|NCT02513160|588732255|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
163008130|NCT02513160|588732252|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
163008131|NCT02513160|588732253|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
163008132|NCT02513160|588732254|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
163008133|NCT02513160|588732255|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
163008134|NCT02513160|588732252|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
163008135|NCT02513160|588732253|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
163008136|NCT02513160|588732254|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
163008137|NCT02513160|588732255|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
163008138|NCT02513160|588732252|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
163008139|NCT02513160|588732253|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
163008140|NCT02513160|588732254|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
163008141|NCT02513160|588732255|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
163008142|NCT02513160|588732252|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
163008143|NCT02513160|588732253|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
163008144|NCT02513160|588732254|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
163213801|NCT03742037|589496052|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
163008145|NCT02513160|588732255|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
163008146|NCT02513160|588732252|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
163326632|NCT00336505|589907384|FG000|Overall Study|Lost to Follow-up|7|||
163326633|NCT00336505|589907385|FG001|Overall Study|Lost to Follow-up|4|||
163326634|NCT00336505|589907384|FG000|Overall Study|Withdrawal by Subject|5|||
163326635|NCT00336505|589907385|FG001|Overall Study|Withdrawal by Subject|3|||
163326636|NCT00336505|589907384|FG000|Overall Study|Other|7|||
163326637|NCT00336505|589907385|FG001|Overall Study|Other|7|||
163326638|NCT03478969|589907386|FG000|Overall Study|Withdrawal by Subject|4|||
163326639|NCT03478969|589907387|FG001|Overall Study|Withdrawal by Subject|7|||
163326640|NCT03478969|589907388|FG002|Overall Study|Withdrawal by Subject|6|||
163326641|NCT03478969|589907386|FG000|Overall Study|Adverse Event|2|||
163326642|NCT03478969|589907387|FG001|Overall Study|Adverse Event|0|||
163326643|NCT03478969|589907388|FG002|Overall Study|Adverse Event|1|||
163326644|NCT03478969|589907386|FG000|Overall Study|Pregnancy|1|||
163326645|NCT03478969|589907387|FG001|Overall Study|Pregnancy|0|||
163326646|NCT03478969|589907388|FG002|Overall Study|Pregnancy|0|||
163326647|NCT03478969|589907386|FG000|Overall Study|Personal Reasons|1|||
163326648|NCT03478969|589907387|FG001|Overall Study|Personal Reasons|0|||
163326649|NCT03478969|589907388|FG002|Overall Study|Personal Reasons|1|||
163326650|NCT03478969|589907386|FG000|Overall Study|Covid-19|1|||
163326651|NCT03478969|589907387|FG001|Overall Study|Covid-19|4|||
163326652|NCT03478969|589907388|FG002|Overall Study|Covid-19|3|||
163326653|NCT03478969|589907386|FG000|Overall Study|Multiple Reasons|0|||
163326654|NCT03478969|589907387|FG001|Overall Study|Multiple Reasons|1|||
163326655|NCT03478969|589907388|FG002|Overall Study|Multiple Reasons|1|||
163326656|NCT03478969|589907386|FG000|Overall Study|Eligibility Criteria|0|||
163326657|NCT03478969|589907387|FG001|Overall Study|Eligibility Criteria|0|||
163326658|NCT03478969|589907388|FG002|Overall Study|Eligibility Criteria|5|||
163326659|NCT03478969|589907386|FG000|Overall Study|Lost to Follow-up|0|||
163326660|NCT03478969|589907387|FG001|Overall Study|Lost to Follow-up|0|||
163326661|NCT03478969|589907388|FG002|Overall Study|Lost to Follow-up|1|||
163326662|NCT01185600|589907389|FG000|Overall Study|Adverse Event|1|||
163326663|NCT01185600|589907390|FG001|Overall Study|Adverse Event|1|||
163326664|NCT01185600|589907389|FG000|Overall Study|Death|0|||
163326665|NCT01185600|589907390|FG001|Overall Study|Death|1|||
163326666|NCT01185600|589907389|FG000|Overall Study|Lost to Follow-up|0|||
163326667|NCT01185600|589907390|FG001|Overall Study|Lost to Follow-up|5|||
163326668|NCT01185600|589907389|FG000|Overall Study|Physician Decision|29|||
163008147|NCT02513160|588732253|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
163008148|NCT02513160|588732254|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
163008149|NCT02513160|588732255|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
163008150|NCT04021914|588732258|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
163008151|NCT00803790|588732262|FG000|Period 1|Adverse Event|0|||
163008152|NCT00803790|588732263|FG001|Period 1|Adverse Event|1|||
163008153|NCT00803790|588732264|FG002|Period 1|Adverse Event|0|||
163008154|NCT00803790|588732265|FG003|Period 1|Adverse Event|0|||
163008155|NCT00803790|588732262|FG000|Period 1|Lost to Follow-up|1|||
163008156|NCT00803790|588732263|FG001|Period 1|Lost to Follow-up|2|||
163008157|NCT00803790|588732264|FG002|Period 1|Lost to Follow-up|0|||
163008158|NCT00803790|588732265|FG003|Period 1|Lost to Follow-up|0|||
163008159|NCT00803790|588732262|FG000|Period 1|Withdrawal by Subject|8|||
163008160|NCT00803790|588732263|FG001|Period 1|Withdrawal by Subject|6|||
163008161|NCT00803790|588732264|FG002|Period 1|Withdrawal by Subject|0|||
163008162|NCT00803790|588732265|FG003|Period 1|Withdrawal by Subject|0|||
163008163|NCT00803790|588732262|FG000|Period 1|positive drug screen or personal reasons|0|||
163008164|NCT00803790|588732263|FG001|Period 1|positive drug screen or personal reasons|3|||
163008165|NCT00803790|588732264|FG002|Period 1|positive drug screen or personal reasons|0|||
163008166|NCT00803790|588732265|FG003|Period 1|positive drug screen or personal reasons|4|||
163008167|NCT00803790|588732262|FG000|Period 1|Protocol Violation|0|||
163008168|NCT00803790|588732263|FG001|Period 1|Protocol Violation|0|||
163008169|NCT00803790|588732264|FG002|Period 1|Protocol Violation|1|||
163008170|NCT00803790|588732265|FG003|Period 1|Protocol Violation|0|||
163326669|NCT01185600|589907390|FG001|Overall Study|Physician Decision|35|||
163326670|NCT01185600|589907389|FG000|Overall Study|Withdrawal by Subject|1|||
163326671|NCT01185600|589907390|FG001|Overall Study|Withdrawal by Subject|1|||
163008171|NCT00803790|588732262|FG000|Period 2|Adverse Event|0|||
163061518|NCT01093846|588933144|FG001|Overall Study|Condition no longer required study drug|1|||
163061519|NCT01093846|588933145|FG002|Overall Study|Condition no longer required study drug|1|||
163061520|NCT01093846|588933143|FG000|Overall Study|Administrative Problems|18|||
163326672|NCT01185600|589907389|FG000|Overall Study|Hold by DSMB|1|||
163008172|NCT00803790|588732263|FG001|Period 2|Adverse Event|0|||
163061521|NCT01093846|588933144|FG001|Overall Study|Administrative Problems|17|||
163326673|NCT01185600|589907390|FG001|Overall Study|Hold by DSMB|2|||
163326674|NCT05405244|589907391|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
163326675|NCT05405244|589907392|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
163326676|NCT05405244|589907391|FG000|Washout (2 Weeks)|Adverse Event|2|||
163008173|NCT00803790|588732264|FG002|Period 2|Adverse Event|1|||
163326677|NCT05405244|589907392|FG001|Washout (2 Weeks)|Adverse Event|0|||
163326678|NCT05405244|589907391|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
163326679|NCT05405244|589907392|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
163008174|NCT00803790|588732265|FG003|Period 2|Adverse Event|1|||
163008175|NCT00803790|588732262|FG000|Period 2|Withdrawal by Subject|1|||
163008176|NCT00803790|588732263|FG001|Period 2|Withdrawal by Subject|0|||
163008177|NCT00803790|588732264|FG002|Period 2|Withdrawal by Subject|0|||
163008178|NCT00803790|588732265|FG003|Period 2|Withdrawal by Subject|0|||
163008179|NCT00803790|588732262|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
163008180|NCT00803790|588732263|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
163008181|NCT00803790|588732264|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
163008182|NCT00803790|588732265|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
163008183|NCT04581824|588732267|FG000|Overall Study|Lost to Follow-up|1|||
163008184|NCT04581824|588732268|FG001|Overall Study|Lost to Follow-up|0|||
163008185|NCT04581824|588732267|FG000|Overall Study|Withdrawal by Subject|2|||
163008186|NCT04581824|588732268|FG001|Overall Study|Withdrawal by Subject|7|||
163008187|NCT04581824|588732267|FG000|Overall Study|Study terminated by sponsor|37|||
163008188|NCT04581824|588732268|FG001|Overall Study|Study terminated by sponsor|23|||
163008189|NCT05012098|588732269|FG000|Overall Study|Disease progression|5|||
163008190|NCT05012098|588732270|FG001|Overall Study|Disease progression|2|||
163008191|NCT05012098|588732269|FG000|Overall Study|Adverse Event|1|||
163008192|NCT05012098|588732270|FG001|Overall Study|Adverse Event|0|||
163008193|NCT05012098|588732269|FG000|Overall Study|Withdrawal by Subject|1|||
163008194|NCT05012098|588732270|FG001|Overall Study|Withdrawal by Subject|0|||
163008195|NCT05012098|588732269|FG000|Overall Study|Discontinuation per protocol|1|||
163008196|NCT05012098|588732270|FG001|Overall Study|Discontinuation per protocol|0|||
163008197|NCT01749826|588732273|FG000|Overall Study|Study Terminated|20|||
163008198|NCT01749826|588732274|FG001|Overall Study|Study Terminated|0|||
163008199|NCT00813150|588732275|FG000|Treatment Period|Adverse Event|16|||
163008200|NCT00813150|588732276|FG001|Treatment Period|Adverse Event|15|||
163008201|NCT00813150|588732275|FG000|Treatment Period|Death|2|||
163008202|NCT00813150|588732276|FG001|Treatment Period|Death|0|||
163008203|NCT00813150|588732275|FG000|Treatment Period|Progressive disease|1|||
163008204|NCT00813150|588732276|FG001|Treatment Period|Progressive disease|0|||
163008205|NCT00813150|588732275|FG000|Treatment Period|Complete response|0|||
163008206|NCT00813150|588732276|FG001|Treatment Period|Complete response|1|||
163008207|NCT00813150|588732275|FG000|Treatment Period|Stable disease|1|||
163008208|NCT00813150|588732276|FG001|Treatment Period|Stable disease|2|||
163008209|NCT00813150|588732275|FG000|Treatment Period|Protocol Violation|3|||
163008210|NCT00813150|588732276|FG001|Treatment Period|Protocol Violation|4|||
163008211|NCT00813150|588732275|FG000|Treatment Period|Withdrawal by Subject|5|||
163008212|NCT00813150|588732276|FG001|Treatment Period|Withdrawal by Subject|3|||
163008213|NCT00813150|588732275|FG000|Treatment Period|Non compliance|0|||
163008214|NCT00813150|588732276|FG001|Treatment Period|Non compliance|1|||
163008215|NCT00813150|588732275|FG000|Treatment Period|Reason not specified|3|||
163008216|NCT00813150|588732276|FG001|Treatment Period|Reason not specified|4|||
163008217|NCT00813150|588732275|FG000|Treatment Period|Data not available|1|||
163008218|NCT00813150|588732276|FG001|Treatment Period|Data not available|2|||
163008219|NCT00813150|588732275|FG000|Long Term Follow-up|Death|0|||
163008220|NCT00813150|588732276|FG001|Long Term Follow-up|Death|4|||
163008221|NCT00813150|588732275|FG000|Long Term Follow-up|Other|0|||
163008222|NCT00813150|588732276|FG001|Long Term Follow-up|Other|3|||
163061522|NCT01093846|588933145|FG002|Overall Study|Administrative Problems|15|||
163061523|NCT02781324|588933146|FG000|Overall Study|Withdrawal by Subject|1|||
163061524|NCT02781324|588933147|FG001|Overall Study|Withdrawal by Subject|0|||
163061525|NCT02781324|588933146|FG000|Overall Study|Physician Decision|1|||
163061526|NCT02781324|588933147|FG001|Overall Study|Physician Decision|2|||
163061527|NCT05020015|588934978|FG000|Overall Study|Ongoing on study|1|||
163061528|NCT05020015|588934979|FG001|Overall Study|Ongoing on study|3|||
163061529|NCT05020015|588934980|FG002|Overall Study|Ongoing on study|4|||
163061530|NCT05020015|588934981|FG003|Overall Study|Ongoing on study|7|||
163213802|NCT03742037|589496053|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
163213803|NCT03742037|589496047|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
163213804|NCT03742037|589496048|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
163213805|NCT03742037|589496049|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
163213806|NCT03742037|589496050|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
163213807|NCT03742037|589496051|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
163213808|NCT03742037|589496052|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
163213809|NCT03742037|589496053|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
163213810|NCT03742037|589496047|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
163213811|NCT03742037|589496048|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
163213812|NCT03742037|589496049|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
163213813|NCT03742037|589496050|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
163213814|NCT03742037|589496051|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
163213815|NCT03742037|589496052|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
163213816|NCT03742037|589496053|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
163213817|NCT03742037|589496047|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
163213818|NCT03742037|589496048|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
163061531|NCT05020015|588934978|FG000|Overall Study|Death|2|||
163061532|NCT05020015|588934979|FG001|Overall Study|Death|3|||
163061533|NCT05020015|588934980|FG002|Overall Study|Death|4|||
163061534|NCT05020015|588934981|FG003|Overall Study|Death|0|||
163061535|NCT05020015|588934978|FG000|Overall Study|Withdrawal by Subject|0|||
163061536|NCT05020015|588934979|FG001|Overall Study|Withdrawal by Subject|0|||
163061537|NCT05020015|588934980|FG002|Overall Study|Withdrawal by Subject|1|||
163061538|NCT05020015|588934981|FG003|Overall Study|Withdrawal by Subject|0|||
163061539|NCT05020015|588934978|FG000|Overall Study|Reason Not Specified|0|||
163061540|NCT05020015|588934979|FG001|Overall Study|Reason Not Specified|0|||
163061541|NCT05020015|588934980|FG002|Overall Study|Reason Not Specified|2|||
163061542|NCT05020015|588934981|FG003|Overall Study|Reason Not Specified|0|||
163061543|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
163061544|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
163061545|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
163061546|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
163061547|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
163061548|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
163061549|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
163061550|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
163061551|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
163061552|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
163061553|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
163061554|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
163061555|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
163061556|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
163061557|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
163008223|NCT00813150|588732275|FG000|Long Term Follow-up|Lost to Follow-up|2|||
163008224|NCT00813150|588732276|FG001|Long Term Follow-up|Lost to Follow-up|0|||
163008225|NCT00813150|588732275|FG000|Long Term Follow-up|Progression/Relapse|22|||
163008226|NCT00813150|588732276|FG001|Long Term Follow-up|Progression/Relapse|24|||
163008227|NCT05085834|588732277|FG000|Overall Study|Lost to Follow-up|9|||
163008228|NCT05085834|588732278|FG001|Overall Study|Lost to Follow-up|2|||
163008229|NCT05085834|588732277|FG000|Overall Study|Adverse Event|6|||
163008230|NCT05085834|588732278|FG001|Overall Study|Adverse Event|0|||
163008231|NCT05085834|588732277|FG000|Overall Study|Death|1|||
163008232|NCT05085834|588732278|FG001|Overall Study|Death|0|||
163008233|NCT05085834|588732277|FG000|Overall Study|Inability to swallow the pill|0|||
163061558|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
163061559|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
163061560|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
163061561|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
163061562|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
163008234|NCT05085834|588732278|FG001|Overall Study|Inability to swallow the pill|1|||
163008235|NCT01823328|588732283|FG000|Overall Study|Withdrawal by Subject|8|||
163008236|NCT01823328|588732284|FG001|Overall Study|Withdrawal by Subject|6|||
163008237|NCT01662635|588732285|FG000|Overall Study|scarce samples for evaluation|30|||
163008238|NCT01217112|588732286|FG000|Overall Study|Adverse Event|0|||
163061563|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
163213819|NCT03742037|589496049|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
163213820|NCT03742037|589496050|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
163213821|NCT03742037|589496051|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
163213822|NCT03742037|589496052|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
163213823|NCT03742037|589496053|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
163213824|NCT03742037|589496047|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
163213825|NCT03742037|589496048|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
163213826|NCT03742037|589496049|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
163213827|NCT03742037|589496050|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
163213828|NCT03742037|589496051|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
163213829|NCT03742037|589496052|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
163213830|NCT03742037|589496053|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
163213831|NCT03742037|589496047|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
163213832|NCT03742037|589496048|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
163213833|NCT03742037|589496049|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
163213834|NCT03742037|589496050|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
163213835|NCT03742037|589496051|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
163213836|NCT03742037|589496052|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
163213837|NCT03742037|589496053|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
163326680|NCT00739934|589907393|FG000|Voriconazole IV|Adverse Event|6|||
163008239|NCT01217112|588732287|FG001|Overall Study|Adverse Event|2|||
163008240|NCT01217112|588732288|FG002|Overall Study|Adverse Event|0|||
163008241|NCT01217112|588732289|FG003|Overall Study|Adverse Event|2|||
163008242|NCT01217112|588732290|FG004|Overall Study|Adverse Event|0|||
163008243|NCT01217112|588732286|FG000|Overall Study|Withdrawal by Subject|0|||
163008244|NCT01217112|588732287|FG001|Overall Study|Withdrawal by Subject|0|||
163008245|NCT01217112|588732288|FG002|Overall Study|Withdrawal by Subject|1|||
163008246|NCT01217112|588732289|FG003|Overall Study|Withdrawal by Subject|0|||
163008247|NCT01217112|588732290|FG004|Overall Study|Withdrawal by Subject|0|||
163008248|NCT01217112|588732286|FG000|Overall Study|Physician Decision|0|||
163008249|NCT01217112|588732287|FG001|Overall Study|Physician Decision|0|||
163008250|NCT01217112|588732288|FG002|Overall Study|Physician Decision|0|||
163008251|NCT01217112|588732289|FG003|Overall Study|Physician Decision|0|||
163008252|NCT01217112|588732290|FG004|Overall Study|Physician Decision|1|||
163008253|NCT01401361|588732291|FG000|Overall Study|Withdrawal by Subject|16|||
163008254|NCT01401361|588732291|FG000|Overall Study|Lack of Efficacy|6|||
163008255|NCT01401361|588732291|FG000|Overall Study|Physician Decision|1|||
163008256|NCT01401361|588732291|FG000|Overall Study|Lost to Follow-up|3|||
163008257|NCT01401361|588732291|FG000|Overall Study|Subject/family decision post procedure|2|||
163008258|NCT00595920|588732294|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
163008259|NCT00351468|588732295|FG000|Overall Study|Adverse Event|42|||
163008260|NCT00351468|588732295|FG000|Overall Study|Withdrawal by Subject|39|||
163008261|NCT00351468|588732295|FG000|Overall Study|Various -follow up w clinical team|39|||
163008262|NCT00351468|588732295|FG000|Overall Study|Lack of Efficacy|32|||
163008263|NCT00351468|588732295|FG000|Overall Study|Non-compliance|8|||
163008264|NCT00351468|588732295|FG000|Overall Study|Lost to Follow-up|4|||
163008265|NCT00351468|588732295|FG000|Overall Study|Protocol Violation|3|||
163008266|NCT03588910|588732296|FG000|Overall Study|Withdrawal by Subject|1|||
163008267|NCT03588910|588732297|FG001|Overall Study|Withdrawal by Subject|0|||
163008268|NCT03588910|588732296|FG000|Overall Study|Allergy|2|||
163008269|NCT03588910|588732297|FG001|Overall Study|Allergy|0|||
163008270|NCT03588910|588732296|FG000|Overall Study|Protocol Violation|0|||
163008271|NCT03588910|588732297|FG001|Overall Study|Protocol Violation|3|||
163008272|NCT03588910|588732296|FG000|Overall Study|Did not complete Day 1 Survey|5|||
163008273|NCT03588910|588732297|FG001|Overall Study|Did not complete Day 1 Survey|10|||
163008274|NCT03588910|588732296|FG000|Overall Study|Did not complete Day 7 Survey|5|||
163008275|NCT03588910|588732297|FG001|Overall Study|Did not complete Day 7 Survey|2|||
163008276|NCT03096314|588732298|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
163008277|NCT03096314|588732299|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
163008278|NCT00471822|588732300|FG000|Overall Study|Protocol Violation|2|||
163008279|NCT03318861|588732301|FG000|Overall Study|Death|2|||
163008280|NCT03318861|588732302|FG001|Overall Study|Death|3|||
163008281|NCT03318861|588732303|FG002|Overall Study|Death|3|||
163008282|NCT03318861|588732304|FG003|Overall Study|Death|2|||
163008283|NCT03318861|588732305|FG004|Overall Study|Death|2|||
163008284|NCT03318861|588732301|FG000|Overall Study|Enrolled But Never Treated|0|||
163008285|NCT03318861|588732302|FG001|Overall Study|Enrolled But Never Treated|1|||
163008286|NCT03318861|588732303|FG002|Overall Study|Enrolled But Never Treated|0|||
163008287|NCT03318861|588732304|FG003|Overall Study|Enrolled But Never Treated|1|||
163008288|NCT03318861|588732305|FG004|Overall Study|Enrolled But Never Treated|1|||
163008289|NCT03318861|588732301|FG000|Overall Study|Informed Consent Withdraw|0|||
163008290|NCT03318861|588732302|FG001|Overall Study|Informed Consent Withdraw|0|||
163008291|NCT03318861|588732303|FG002|Overall Study|Informed Consent Withdraw|0|||
163008292|NCT03318861|588732304|FG003|Overall Study|Informed Consent Withdraw|1|||
163008293|NCT03318861|588732305|FG004|Overall Study|Informed Consent Withdraw|0|||
163008294|NCT03318861|588732301|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
163008295|NCT03318861|588732302|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
163008296|NCT03318861|588732303|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
163008297|NCT03318861|588732304|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
163008298|NCT03318861|588732305|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
163008299|NCT02844933|588732306|FG000|Overall Study|Discontinued due to premature termination of study|3|||
163008300|NCT02844933|588732307|FG001|Overall Study|Discontinued due to premature termination of study|2|||
163008301|NCT01479465|588732308|FG000|Overall Study|Disease Progression|9|||
163008302|NCT01479465|588732309|FG001|Overall Study|Disease Progression|61|||
163008303|NCT01479465|588732310|FG002|Overall Study|Disease Progression|65|||
163008304|NCT01479465|588732311|FG003|Overall Study|Disease Progression|70|||
163008305|NCT01479465|588732308|FG000|Overall Study|Study Discontinued by Sponsor|0|||
163008306|NCT01479465|588732309|FG001|Overall Study|Study Discontinued by Sponsor|7|||
163008307|NCT01479465|588732310|FG002|Overall Study|Study Discontinued by Sponsor|5|||
163008308|NCT01479465|588732311|FG003|Overall Study|Study Discontinued by Sponsor|3|||
163008309|NCT01479465|588732308|FG000|Overall Study|Adverse Event|0|||
163213838|NCT03742037|589496047|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
163008310|NCT01479465|588732309|FG001|Overall Study|Adverse Event|3|||
163061564|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
163213839|NCT03742037|589496048|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
163326681|NCT00739934|589907393|FG000|Voriconazole Oral|Other|3|||
163326682|NCT00754065|589907396|FG000|Overall Study|Never received treatment|12|||
163008311|NCT01479465|588732310|FG002|Overall Study|Adverse Event|6|||
163008312|NCT01479465|588732311|FG003|Overall Study|Adverse Event|4|||
163008313|NCT01479465|588732308|FG000|Overall Study|Investigator Discretion|1|||
163008314|NCT01479465|588732309|FG001|Overall Study|Investigator Discretion|4|||
163008315|NCT01479465|588732310|FG002|Overall Study|Investigator Discretion|2|||
163008316|NCT01479465|588732311|FG003|Overall Study|Investigator Discretion|4|||
163008317|NCT01479465|588732308|FG000|Overall Study|Subject Request|1|||
163008318|NCT01479465|588732309|FG001|Overall Study|Subject Request|3|||
163008319|NCT01479465|588732310|FG002|Overall Study|Subject Request|4|||
163008320|NCT01479465|588732311|FG003|Overall Study|Subject Request|2|||
163008321|NCT01479465|588732308|FG000|Overall Study|Subject Withdrew Consent|0|||
163008322|NCT01479465|588732309|FG001|Overall Study|Subject Withdrew Consent|5|||
163008323|NCT01479465|588732310|FG002|Overall Study|Subject Withdrew Consent|2|||
163008324|NCT01479465|588732311|FG003|Overall Study|Subject Withdrew Consent|1|||
163008325|NCT01479465|588732308|FG000|Overall Study|Protocol Violation|0|||
163008326|NCT01479465|588732309|FG001|Overall Study|Protocol Violation|1|||
163008327|NCT01479465|588732310|FG002|Overall Study|Protocol Violation|1|||
163008328|NCT01479465|588732311|FG003|Overall Study|Protocol Violation|0|||
163008329|NCT01479465|588732308|FG000|Overall Study|Death|0|||
163008330|NCT01479465|588732309|FG001|Overall Study|Death|0|||
163008331|NCT01479465|588732310|FG002|Overall Study|Death|0|||
163008332|NCT01479465|588732311|FG003|Overall Study|Death|1|||
163008333|NCT01479465|588732308|FG000|Overall Study|Lost to Follow-up|0|||
163008334|NCT01479465|588732309|FG001|Overall Study|Lost to Follow-up|0|||
163008335|NCT01479465|588732310|FG002|Overall Study|Lost to Follow-up|1|||
163008336|NCT01479465|588732311|FG003|Overall Study|Lost to Follow-up|0|||
163008337|NCT01892501|588732312|FG000|Overall Study|Protocol Violation|2|||
163008338|NCT01892501|588732312|FG000|Overall Study|Puncture not carried out|9|||
163008339|NCT01892501|588732312|FG000|Overall Study|Radiological monitoring not carried out|5|||
163008340|NCT01892501|588732312|FG000|Overall Study|Non-contributory histological result|12|||
163008341|NCT04335123|588732316|FG000|Overall Study|Withdrawal by Subject|2|||
163008342|NCT04335123|588732317|FG001|Overall Study|Withdrawal by Subject|0|||
163008343|NCT04335123|588732316|FG000|Overall Study|Physician Decision|2|||
163008344|NCT04335123|588732317|FG001|Overall Study|Physician Decision|0|||
163008345|NCT01439802|588732318|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
163008346|NCT01439802|588732318|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
163008347|NCT02088177|588732324|FG000|Overall Study|Lost to Follow-up|3|||
163008348|NCT01234350|588732325|FG000|Overall Study|Adverse Event|277|||
163008349|NCT01234350|588732326|FG001|Overall Study|Adverse Event|92|||
163008350|NCT01234350|588732325|FG000|Overall Study|Withdrawal by Subject|61|||
163008351|NCT01234350|588732326|FG001|Overall Study|Withdrawal by Subject|36|||
163008352|NCT01234350|588732325|FG000|Overall Study|Lost to Follow-up|115|||
163008353|NCT01234350|588732326|FG001|Overall Study|Lost to Follow-up|47|||
163008354|NCT01234350|588732325|FG000|Overall Study|Covers a diverse set of reasons|234|||
163008355|NCT01234350|588732326|FG001|Overall Study|Covers a diverse set of reasons|92|||
163008356|NCT00289848|588732327|FG000|Overall Study|Adverse Event|6|||
163008357|NCT00289848|588732328|FG001|Overall Study|Adverse Event|4|||
163008358|NCT00289848|588732327|FG000|Overall Study|Death|1|||
163008359|NCT00289848|588732328|FG001|Overall Study|Death|0|||
163008360|NCT00289848|588732327|FG000|Overall Study|Lack of Efficacy|20|||
163061565|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
163061566|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
163061567|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
163061568|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
163326683|NCT00754065|589907397|FG001|Overall Study|Never received treatment|2|||
163326684|NCT00754065|589907396|FG000|Overall Study|Adverse Event|19|||
163326685|NCT00754065|589907397|FG001|Overall Study|Adverse Event|25|||
163326686|NCT00754065|589907396|FG000|Overall Study|Lost to Follow-up|7|||
163326687|NCT00754065|589907397|FG001|Overall Study|Lost to Follow-up|11|||
163326688|NCT00754065|589907396|FG000|Overall Study|Protocol Violation|12|||
163326689|NCT00754065|589907397|FG001|Overall Study|Protocol Violation|10|||
163326690|NCT00754065|589907396|FG000|Overall Study|Withdrawal by Subject|4|||
163326691|NCT00754065|589907397|FG001|Overall Study|Withdrawal by Subject|5|||
163008361|NCT00289848|588732328|FG001|Overall Study|Lack of Efficacy|24|||
163008362|NCT00289848|588732327|FG000|Overall Study|Lost to Follow-up|3|||
163008363|NCT00289848|588732328|FG001|Overall Study|Lost to Follow-up|1|||
163008364|NCT00289848|588732327|FG000|Overall Study|Protocol Violation|5|||
163008365|NCT00289848|588732328|FG001|Overall Study|Protocol Violation|2|||
163008366|NCT00289848|588732327|FG000|Overall Study|Withdrawal by Subject|5|||
163326692|NCT00754065|589907396|FG000|Overall Study|Pregnancy|6|||
163008367|NCT00289848|588732328|FG001|Overall Study|Withdrawal by Subject|11|||
163008368|NCT00289848|588732327|FG000|Overall Study|Patient Moved|6|||
163008369|NCT00289848|588732328|FG001|Overall Study|Patient Moved|2|||
163008370|NCT00289848|588732327|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
163326693|NCT00754065|589907397|FG001|Overall Study|Pregnancy|0|||
163008371|NCT00289848|588732328|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
163008372|NCT01433471|588732331|FG000|Overall Study|Withdrawal by Subject|0|||
163008373|NCT01433471|588732332|FG001|Overall Study|Withdrawal by Subject|1|||
163008374|NCT03428152|588732337|FG000|Overall Study|Physician Decision|4|||
163008375|NCT03428152|588732338|FG001|Overall Study|Physician Decision|2|||
163008376|NCT03428152|588732337|FG000|Overall Study|Protocol Violation|3|||
163008377|NCT03428152|588732338|FG001|Overall Study|Protocol Violation|5|||
163008378|NCT03428152|588732337|FG000|Overall Study|Lack of Efficacy|0|||
163008379|NCT03428152|588732338|FG001|Overall Study|Lack of Efficacy|4|||
163008380|NCT00395629|588732339|FG000|Core Study|Adverse Event|0|||
163008381|NCT00395629|588732340|FG001|Core Study|Adverse Event|3|||
163008382|NCT00395629|588732341|FG002|Core Study|Adverse Event|4|||
163008383|NCT00395629|588732339|FG000|Core Study|Abnormal laboratory value(s)|0|||
163008384|NCT00395629|588732340|FG001|Core Study|Abnormal laboratory value(s)|0|||
163008385|NCT00395629|588732341|FG002|Core Study|Abnormal laboratory value(s)|1|||
163008386|NCT00395629|588732339|FG000|Core Study|Protocol Violation|1|||
163008387|NCT00395629|588732340|FG001|Core Study|Protocol Violation|0|||
163008388|NCT00395629|588732341|FG002|Core Study|Protocol Violation|0|||
163008389|NCT00395629|588732339|FG000|Core Study|Withdrawal by Subject|0|||
163008390|NCT00395629|588732340|FG001|Core Study|Withdrawal by Subject|1|||
163008391|NCT00395629|588732341|FG002|Core Study|Withdrawal by Subject|1|||
163008392|NCT00395629|588732339|FG000|Core Study|Lost to Follow-up|0|||
163008393|NCT00395629|588732340|FG001|Core Study|Lost to Follow-up|0|||
163008394|NCT00395629|588732341|FG002|Core Study|Lost to Follow-up|1|||
163008395|NCT00395629|588732339|FG000|Extension Study|Adverse Event|0|||
163008396|NCT00395629|588732340|FG001|Extension Study|Adverse Event|0|||
163008397|NCT00395629|588732341|FG002|Extension Study|Adverse Event|2|||
163008398|NCT00395629|588732339|FG000|Extension Study|Administrative problems|0|||
163008399|NCT00395629|588732340|FG001|Extension Study|Administrative problems|0|||
163008400|NCT00395629|588732341|FG002|Extension Study|Administrative problems|1|||
163008401|NCT01686373|588732342|FG000|Overall Study|Lost to Follow-up|3|||
163008402|NCT01686373|588732343|FG001|Overall Study|Lost to Follow-up|0|||
163008403|NCT01686373|588732342|FG000|Overall Study|Withdrawal by Subject|0|||
163008404|NCT01686373|588732343|FG001|Overall Study|Withdrawal by Subject|1|||
163008405|NCT01686373|588732342|FG000|Overall Study|Adverse Event|0|||
163008406|NCT01686373|588732343|FG001|Overall Study|Adverse Event|1|||
163008407|NCT02285361|588732353|FG000|Overall Study|Protocol Violation|43|||
163008408|NCT02285361|588732353|FG000|Overall Study|Lost to Follow-up|5|||
163008409|NCT02285361|588732353|FG000|Overall Study|Not taken GIOTRIF|2|||
163008410|NCT02285361|588732353|FG000|Overall Study|Consented prior to the contract date|1|||
163008411|NCT00191477|588732354|FG000|Overall Study|Tumor Recurrence|49|||
163008412|NCT00191477|588732355|FG001|Overall Study|Tumor Recurrence|48|||
163008413|NCT00191477|588732354|FG000|Overall Study|Death, Study Disease|1|||
163008414|NCT00191477|588732355|FG001|Overall Study|Death, Study Disease|1|||
163213840|NCT03742037|589496049|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
163213841|NCT03742037|589496050|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
163008415|NCT00191477|588732354|FG000|Overall Study|Death, Other Cause|3|||
163008416|NCT00191477|588732355|FG001|Overall Study|Death, Other Cause|6|||
163008417|NCT00191477|588732354|FG000|Overall Study|Lost to Follow-up|23|||
163008418|NCT00191477|588732355|FG001|Overall Study|Lost to Follow-up|21|||
163008419|NCT00191477|588732354|FG000|Overall Study|Protocol Violation|1|||
163008420|NCT00191477|588732355|FG001|Overall Study|Protocol Violation|1|||
163008421|NCT00191477|588732354|FG000|Overall Study|Treatment Change|2|||
163008422|NCT00191477|588732355|FG001|Overall Study|Treatment Change|0|||
163008423|NCT00191477|588732354|FG000|Overall Study|Withdrawal by Subject|2|||
163008424|NCT00191477|588732355|FG001|Overall Study|Withdrawal by Subject|0|||
163008425|NCT00191477|588732354|FG000|Overall Study|Other|2|||
163008426|NCT00191477|588732355|FG001|Overall Study|Other|0|||
163008427|NCT00191477|588732354|FG000|Overall Study|Not Eligible|41|||
163008428|NCT00191477|588732355|FG001|Overall Study|Not Eligible|38|||
163008429|NCT00191477|588732354|FG000|Overall Study|Pathological Specimen Lost|1|||
163008430|NCT00191477|588732355|FG001|Overall Study|Pathological Specimen Lost|0|||
163008431|NCT00191477|588732354|FG000|Overall Study|Discontinued Prior to Instillation|13|||
163008432|NCT00191477|588732355|FG001|Overall Study|Discontinued Prior to Instillation|14|||
163008433|NCT02411656|588732356|FG000|Overall Study|Adverse Event|4|||
163008434|NCT02411656|588732356|FG000|Overall Study|Clinical Progression|33|||
163008435|NCT06481709|588732357|FG000|Overall Study|Withdrawal by Subject|0|||
163008436|NCT06481709|588732358|FG001|Overall Study|Withdrawal by Subject|0|||
163008437|NCT06481709|588732359|FG002|Overall Study|Withdrawal by Subject|2|||
163008438|NCT06481709|588732360|FG003|Overall Study|Withdrawal by Subject|0|||
163008439|NCT05366010|588732362|FG000|Overall Study|Withdrawal by Subject|1|||
163008440|NCT05366010|588732362|FG000|Overall Study|Protocol Violation|1|||
163008441|NCT05366010|588732362|FG000|Overall Study|Lost to Follow-up|2|||
163008442|NCT05366010|588732362|FG000|Overall Study|Screen Failure|2|||
163008443|NCT02224157|588732363|FG000|Overall Study|Severe non-compliance to protocol|2|||
163008444|NCT02224157|588732364|FG001|Overall Study|Severe non-compliance to protocol|2|||
163008445|NCT02224157|588732363|FG000|Overall Study|Other|13|||
163008446|NCT02224157|588732364|FG001|Overall Study|Other|10|||
163008447|NCT02224157|588732363|FG000|Overall Study|Subject decision|58|||
163008448|NCT02224157|588732364|FG001|Overall Study|Subject decision|50|||
163008449|NCT02224157|588732363|FG000|Overall Study|Prematurely closed site|4|||
163008450|NCT02224157|588732364|FG001|Overall Study|Prematurely closed site|2|||
163008451|NCT02224157|588732363|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
163008452|NCT02224157|588732364|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
163008453|NCT02224157|588732363|FG000|Overall Study|Lost to Follow-up|27|||
163008454|NCT02224157|588732364|FG001|Overall Study|Lost to Follow-up|35|||
163008455|NCT02224157|588732363|FG000|Overall Study|Death|1|||
163008456|NCT02224157|588732364|FG001|Overall Study|Death|1|||
163008457|NCT02224157|588732363|FG000|Overall Study|Adverse Event|1|||
163008458|NCT02224157|588732364|FG001|Overall Study|Adverse Event|3|||
163008459|NCT05906628|588732365|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
163008460|NCT05906628|588732366|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
163008461|NCT05906628|588732365|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
163008462|NCT05906628|588732366|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
163326694|NCT00754065|589907396|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
163326695|NCT00754065|589907397|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
163326696|NCT04353492|589907400|FG000|Overall Study|Subject decision|24|||
163326697|NCT04353492|589907400|FG000|Overall Study|Physician Decision|5|||
163326698|NCT04353492|589907400|FG000|Overall Study|Adverse Event|3|||
163326699|NCT04353492|589907400|FG000|Overall Study|Pregnancy|3|||
163326700|NCT04353492|589907400|FG000|Overall Study|Lost to Follow-up|2|||
163326701|NCT04353492|589907400|FG000|Overall Study|Protocol deviation|1|||
163326702|NCT04353492|589907400|FG000|Overall Study|Technical problems|1|||
163326703|NCT01952366|589907403|FG000|Overall Study|Death|22|||
163326704|NCT01952366|589907403|FG000|Overall Study|Withdrawal by Subject|9|||
163326705|NCT00623194|589907404|FG000|Overall Study|Lack of Efficacy|1|||
163326706|NCT00623194|589907404|FG000|Overall Study|Protocol Violation|3|||
163326707|NCT00623194|589907404|FG000|Overall Study|Unclassified|1|||
163326708|NCT00857766|589907405|FG000|Overall Study|Adverse Event|13|||
163326709|NCT00857766|589907406|FG001|Overall Study|Adverse Event|12|||
163326710|NCT00857766|589907405|FG000|Overall Study|Protocol Violation|11|||
163326711|NCT00857766|589907406|FG001|Overall Study|Protocol Violation|11|||
163326712|NCT00857766|589907405|FG000|Overall Study|Lost to Follow-up|1|||
163326713|NCT00857766|589907406|FG001|Overall Study|Lost to Follow-up|0|||
163326714|NCT00857766|589907405|FG000|Overall Study|Investigator Discretion|2|||
163326715|NCT00857766|589907406|FG001|Overall Study|Investigator Discretion|3|||
163326716|NCT00857766|589907405|FG000|Overall Study|Participant Withdrew Consent|4|||
163326717|NCT00857766|589907406|FG001|Overall Study|Participant Withdrew Consent|4|||
163326718|NCT01961609|589907407|FG000|Initiation|Missing|3|||
163326719|NCT01961609|589907408|FG001|Initiation|Missing|2|||
163326720|NCT01961609|589907409|FG002|Initiation|Missing|0|||
163326721|NCT01961609|589907410|FG003|Initiation|Missing|0|||
163326722|NCT01961609|589907407|FG000|Initiation|Protocol deviation|1|||
163326723|NCT01961609|589907408|FG001|Initiation|Protocol deviation|0|||
163326724|NCT01961609|589907409|FG002|Initiation|Protocol deviation|0|||
163326725|NCT01961609|589907410|FG003|Initiation|Protocol deviation|0|||
163326726|NCT01961609|589907407|FG000|Initiation|Death|0|||
163326727|NCT01961609|589907408|FG001|Initiation|Death|1|||
163326728|NCT01961609|589907409|FG002|Initiation|Death|0|||
163326729|NCT01961609|589907410|FG003|Initiation|Death|0|||
163326730|NCT01961609|589907407|FG000|Initiation|Administrative problems|1|||
163326731|NCT01961609|589907408|FG001|Initiation|Administrative problems|0|||
163326732|NCT01961609|589907409|FG002|Initiation|Administrative problems|0|||
163326733|NCT01961609|589907410|FG003|Initiation|Administrative problems|0|||
163326734|NCT01961609|589907407|FG000|Initiation|Withdrawal by Subject|1|||
163326735|NCT01961609|589907408|FG001|Initiation|Withdrawal by Subject|2|||
163326736|NCT01961609|589907409|FG002|Initiation|Withdrawal by Subject|0|||
163326737|NCT01961609|589907410|FG003|Initiation|Withdrawal by Subject|0|||
163326738|NCT01961609|589907407|FG000|Initiation|Lack of Efficacy|2|||
163326739|NCT01961609|589907408|FG001|Initiation|Lack of Efficacy|1|||
163326740|NCT01961609|589907409|FG002|Initiation|Lack of Efficacy|0|||
163326741|NCT01961609|589907410|FG003|Initiation|Lack of Efficacy|0|||
163326742|NCT01961609|589907407|FG000|Initiation|Abnormal lab values|0|||
163326743|NCT01961609|589907408|FG001|Initiation|Abnormal lab values|1|||
163326744|NCT01961609|589907409|FG002|Initiation|Abnormal lab values|0|||
163326745|NCT01961609|589907410|FG003|Initiation|Abnormal lab values|0|||
163326746|NCT01961609|589907407|FG000|Initiation|Adverse Event|3|||
163326747|NCT01961609|589907408|FG001|Initiation|Adverse Event|5|||
163326748|NCT01961609|589907409|FG002|Initiation|Adverse Event|0|||
163326749|NCT01961609|589907410|FG003|Initiation|Adverse Event|0|||
163008463|NCT05906628|588732365|FG000|16-Week DBVC Period|Protocol Violation|4|||
163008464|NCT05906628|588732366|FG001|16-Week DBVC Period|Protocol Violation|2|||
163326750|NCT01961609|589907407|FG000|Initiation|Randomized but not treated|1|||
163326751|NCT01961609|589907408|FG001|Initiation|Randomized but not treated|1|||
163008465|NCT05906628|588732365|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
163008466|NCT05906628|588732366|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
163326752|NCT01961609|589907409|FG002|Initiation|Randomized but not treated|0|||
163326753|NCT01961609|589907410|FG003|Initiation|Randomized but not treated|0|||
163326754|NCT01961609|589907407|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
163326755|NCT01961609|589907408|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
163326756|NCT01961609|589907409|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
163326757|NCT01961609|589907410|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
163326758|NCT01961609|589907407|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
163326759|NCT01961609|589907408|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
163326760|NCT01961609|589907409|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
163326761|NCT01961609|589907410|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
163326762|NCT01961609|589907407|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
163326763|NCT01961609|589907408|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
163326764|NCT01961609|589907409|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
163326765|NCT01961609|589907410|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
163326766|NCT01961609|589907407|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
163326767|NCT01961609|589907408|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
163326768|NCT01961609|589907409|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
163326769|NCT01961609|589907410|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
163326770|NCT01961609|589907407|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
163326771|NCT01961609|589907408|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
163326772|NCT01961609|589907409|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
163326773|NCT01961609|589907410|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
163326774|NCT01961609|589907407|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
163326775|NCT01961609|589907408|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
163326776|NCT01961609|589907409|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
163326777|NCT01961609|589907410|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
163326778|NCT01961609|589907407|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
163326779|NCT01961609|589907408|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
163326780|NCT01961609|589907409|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
163326781|NCT01961609|589907410|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
163326782|NCT01961609|589907407|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
163326783|NCT01961609|589907408|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
163326784|NCT01961609|589907409|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
163326785|NCT01961609|589907410|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
163326786|NCT01961609|589907407|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
163326787|NCT01961609|589907408|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
163326788|NCT01961609|589907409|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
163326789|NCT01961609|589907410|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
163326790|NCT01961609|589907407|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
163326791|NCT01961609|589907408|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
163326792|NCT01961609|589907409|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
163326793|NCT01961609|589907410|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
163326794|NCT01961609|589907407|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
163326795|NCT01961609|589907408|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
163326796|NCT01961609|589907409|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
163326797|NCT01961609|589907410|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
163326798|NCT01961609|589907407|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
163326799|NCT01961609|589907408|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
163326800|NCT01961609|589907409|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
163326801|NCT01961609|589907410|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
163326802|NCT01988402|589907411|FG000|Overall Study|Adverse Event|1|||
163326803|NCT01988402|589907412|FG001|Overall Study|Adverse Event|2|||
163326804|NCT01988402|589907411|FG000|Overall Study|Withdrawal by Subject|1|||
163326805|NCT01988402|589907412|FG001|Overall Study|Withdrawal by Subject|0|||
163326806|NCT01212744|589907415|FG000|Overall Study|Withdrawal by Subject|1|||
163326807|NCT02167451|589907416|FG000|Overall Study|Withdrawal by Subject|1|||
163008467|NCT05906628|588732365|FG000|16-Week OLE Period|Death|1|||
163008468|NCT05906628|588732366|FG001|16-Week OLE Period|Death|0|||
163008469|NCT05906628|588732365|FG000|16-Week OLE Period|Lost to Follow-up|1|||
163008470|NCT05906628|588732366|FG001|16-Week OLE Period|Lost to Follow-up|1|||
163008471|NCT05906628|588732365|FG000|16-Week OLE Period|Protocol Violation|0|||
163008472|NCT05906628|588732366|FG001|16-Week OLE Period|Protocol Violation|1|||
163008473|NCT05906628|588732365|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
163008474|NCT05906628|588732366|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
163008475|NCT01108718|588732367|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
163008476|NCT01108718|588732368|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
163008477|NCT02857816|588732371|FG000|Overall Study|Screen Failure|33|||
163008478|NCT02857816|588732371|FG000|Overall Study|Withdrawal by Subject|4|||
163326808|NCT00571649|589907417|FG000|Treatment Period|Adverse Event|438|||
163326809|NCT00571649|589907418|FG001|Treatment Period|Adverse Event|385|||
163008479|NCT02857816|588732371|FG000|Overall Study|Lost to Follow-up|1|||
163008480|NCT02443740|588732372|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008481|NCT02443740|588732373|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008482|NCT02443740|588732374|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008483|NCT02443740|588732375|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008484|NCT02443740|588732376|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008485|NCT02443740|588732377|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
163008486|NCT02443740|588732378|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008487|NCT02443740|588732379|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008488|NCT02443740|588732380|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008489|NCT02443740|588732381|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008490|NCT02443740|588732382|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008491|NCT02443740|588732372|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
163008492|NCT02443740|588732373|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163326810|NCT00571649|589907417|FG000|Treatment Period|Clinical endpoint reached|50|||
163326811|NCT00571649|589907418|FG001|Treatment Period|Clinical endpoint reached|56|||
163326812|NCT00571649|589907417|FG000|Treatment Period|Withdrawal by Subject|285|||
163326813|NCT00571649|589907418|FG001|Treatment Period|Withdrawal by Subject|255|||
163326814|NCT00571649|589907417|FG000|Treatment Period|Death|76|||
163008493|NCT02443740|588732374|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008494|NCT02443740|588732375|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008495|NCT02443740|588732376|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008496|NCT02443740|588732377|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008497|NCT02443740|588732378|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
163008498|NCT02443740|588732379|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008499|NCT02443740|588732380|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008500|NCT02443740|588732381|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008501|NCT02443740|588732382|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008502|NCT02443740|588732372|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008503|NCT02443740|588732373|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008504|NCT02443740|588732374|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008505|NCT02443740|588732375|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008506|NCT02443740|588732376|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008507|NCT02443740|588732377|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
163008508|NCT02443740|588732378|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008509|NCT02443740|588732379|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008510|NCT02443740|588732380|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008511|NCT02443740|588732381|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008512|NCT02443740|588732382|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008513|NCT02046603|588732383|FG000|Overall Study|Other|11|||
163008514|NCT02046603|588732384|FG001|Overall Study|Other|66|||
163008515|NCT02046603|588732383|FG000|Overall Study|Protocol Violation|0|||
163008516|NCT02046603|588732384|FG001|Overall Study|Protocol Violation|1|||
163008517|NCT02046603|588732383|FG000|Overall Study|Participant/legal guardian decision|1|||
163008518|NCT02046603|588732384|FG001|Overall Study|Participant/legal guardian decision|3|||
163008519|NCT02046603|588732383|FG000|Overall Study|Physician Decision|2|||
163008520|NCT02046603|588732384|FG001|Overall Study|Physician Decision|1|||
163008521|NCT02046603|588732383|FG000|Overall Study|Lost to Follow-up|1|||
163008522|NCT02046603|588732384|FG001|Overall Study|Lost to Follow-up|2|||
163008523|NCT02046603|588732383|FG000|Overall Study|Death|0|||
163008524|NCT02046603|588732384|FG001|Overall Study|Death|1|||
163008525|NCT02046603|588732383|FG000|Overall Study|Adverse Event|0|||
163008526|NCT02046603|588732384|FG001|Overall Study|Adverse Event|1|||
163008527|NCT02461160|588732385|FG000|Overall Study|Lost to Follow-up|0|||
163008528|NCT02461160|588732386|FG001|Overall Study|Lost to Follow-up|0|||
163008529|NCT02461160|588732387|FG002|Overall Study|Lost to Follow-up|0|||
163008530|NCT02461160|588732388|FG003|Overall Study|Lost to Follow-up|0|||
163008531|NCT02461160|588732389|FG004|Overall Study|Lost to Follow-up|0|||
163008532|NCT02461160|588732390|FG005|Overall Study|Lost to Follow-up|0|||
163008533|NCT02461160|588732391|FG006|Overall Study|Lost to Follow-up|0|||
163008534|NCT02461160|588732392|FG007|Overall Study|Lost to Follow-up|1|||
163326815|NCT00571649|589907418|FG001|Treatment Period|Death|59|||
163326816|NCT00571649|589907417|FG000|Treatment Period|Physician Decision|8|||
163326817|NCT00571649|589907418|FG001|Treatment Period|Physician Decision|9|||
163326818|NCT00571649|589907417|FG000|Treatment Period|Lost to Follow-up|43|||
163008535|NCT02461160|588732393|FG008|Overall Study|Lost to Follow-up|0|||
163008536|NCT02461160|588732394|FG009|Overall Study|Lost to Follow-up|0|||
163008537|NCT02461160|588732395|FG010|Overall Study|Lost to Follow-up|0|||
163008538|NCT02461160|588732396|FG011|Overall Study|Lost to Follow-up|0|||
163008539|NCT02461160|588732397|FG012|Overall Study|Lost to Follow-up|0|||
163326819|NCT00571649|589907418|FG001|Treatment Period|Lost to Follow-up|41|||
163326820|NCT00571649|589907417|FG000|Treatment Period|Non-compliant with study medication|88|||
163326821|NCT00571649|589907418|FG001|Treatment Period|Non-compliant with study medication|89|||
163008540|NCT00193050|588732398|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
163008541|NCT00193050|588732398|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
163326822|NCT00571649|589907417|FG000|Treatment Period|Patient convenience|11|||
163326823|NCT00571649|589907418|FG001|Treatment Period|Patient convenience|13|||
163326824|NCT00571649|589907417|FG000|Treatment Period|Protocol Violation|90|||
163326825|NCT00571649|589907418|FG001|Treatment Period|Protocol Violation|92|||
163326826|NCT00571649|589907417|FG000|Treatment Period|Technical problems|3|||
163326827|NCT00571649|589907418|FG001|Treatment Period|Technical problems|5|||
163326828|NCT00571649|589907417|FG000|Follow-up Period|Adverse Event|46|||
163326829|NCT00571649|589907418|FG001|Follow-up Period|Adverse Event|40|||
163326830|NCT00571649|589907417|FG000|Follow-up Period|Clinical endpoint reached|5|||
163326831|NCT00571649|589907418|FG001|Follow-up Period|Clinical endpoint reached|2|||
163326832|NCT00571649|589907417|FG000|Follow-up Period|Withdrawal by Subject|119|||
163326833|NCT00571649|589907418|FG001|Follow-up Period|Withdrawal by Subject|115|||
163326834|NCT00571649|589907417|FG000|Follow-up Period|Death|132|||
163326835|NCT00571649|589907418|FG001|Follow-up Period|Death|133|||
163326836|NCT00571649|589907417|FG000|Follow-up Period|Physician Decision|7|||
163326837|NCT00571649|589907418|FG001|Follow-up Period|Physician Decision|13|||
163326838|NCT00571649|589907417|FG000|Follow-up Period|Lost to Follow-up|95|||
163326839|NCT00571649|589907418|FG001|Follow-up Period|Lost to Follow-up|92|||
163326840|NCT00571649|589907417|FG000|Follow-up Period|Patient convenience|136|||
163326841|NCT00571649|589907418|FG001|Follow-up Period|Patient convenience|121|||
163326842|NCT00571649|589907417|FG000|Follow-up Period|Protocol Violation|5|||
163326843|NCT00571649|589907418|FG001|Follow-up Period|Protocol Violation|12|||
163326844|NCT01566890|589907423|FG000|Overall Study|Adverse Event|1|||
163326845|NCT01566890|589907424|FG001|Overall Study|Adverse Event|0|||
163326846|NCT01566890|589907425|FG002|Overall Study|Adverse Event|0|||
163326847|NCT01566890|589907426|FG003|Overall Study|Adverse Event|0|||
163008542|NCT00193050|588732398|FG000|Neoadjuvant Treatment|Physician Decision|2|||
163008543|NCT00193050|588732398|FG000|Neoadjuvant Treatment|Adverse Event|2|||
163008544|NCT00193050|588732398|FG000|Adjuvant|Physician Decision|5|||
163008545|NCT00193050|588732398|FG000|Adjuvant|Intercurrent Hospitalization|3|||
163213842|NCT03742037|589496051|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
163213843|NCT03742037|589496052|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
163213844|NCT03742037|589496053|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
163213845|NCT03742037|589496047|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
163213846|NCT03742037|589496048|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
163213847|NCT03742037|589496049|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
163213848|NCT03742037|589496050|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
163213849|NCT03742037|589496051|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
163213850|NCT03742037|589496052|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
163008546|NCT00193050|588732398|FG000|Adjuvant|Lack of Efficacy|2|||
163008547|NCT02431364|588732399|FG000|Overall Study|Adverse Event|0|||
163008548|NCT02431364|588732400|FG001|Overall Study|Adverse Event|1|||
163008549|NCT02431364|588732401|FG002|Overall Study|Adverse Event|0|||
163008550|NCT02431364|588732402|FG003|Overall Study|Adverse Event|0|||
163008551|NCT02431364|588732403|FG004|Overall Study|Adverse Event|0|||
163008552|NCT02431364|588732399|FG000|Overall Study|Randomized but never treated|0|||
163008553|NCT02431364|588732400|FG001|Overall Study|Randomized but never treated|0|||
163008554|NCT02431364|588732401|FG002|Overall Study|Randomized but never treated|0|||
163213851|NCT03742037|589496053|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
163326848|NCT01566890|589907427|FG004|Overall Study|Adverse Event|0|||
163326849|NCT01566890|589907423|FG000|Overall Study|Withdrawal by Subject|3|||
163326850|NCT01566890|589907424|FG001|Overall Study|Withdrawal by Subject|1|||
163326851|NCT01566890|589907425|FG002|Overall Study|Withdrawal by Subject|1|||
163326852|NCT01566890|589907426|FG003|Overall Study|Withdrawal by Subject|1|||
163326853|NCT01566890|589907427|FG004|Overall Study|Withdrawal by Subject|0|||
163326854|NCT01566890|589907423|FG000|Overall Study|Screen failure|6|||
163326855|NCT01566890|589907424|FG001|Overall Study|Screen failure|0|||
163326856|NCT01566890|589907425|FG002|Overall Study|Screen failure|1|||
163326857|NCT01566890|589907426|FG003|Overall Study|Screen failure|1|||
163008555|NCT02431364|588732402|FG003|Overall Study|Randomized but never treated|1|||
163008556|NCT02431364|588732403|FG004|Overall Study|Randomized but never treated|0|||
163008557|NCT00061932|588732404|FG000|Overall Study|Withdrawal by Subject|13|||
163008558|NCT00061932|588732405|FG001|Overall Study|Withdrawal by Subject|4|||
163008559|NCT03367819|588732406|FG000|Overall Study|Adverse Event|4|||
163008560|NCT03367819|588732407|FG001|Overall Study|Adverse Event|4|||
163326858|NCT01566890|589907427|FG004|Overall Study|Screen failure|0|||
163326859|NCT01566890|589907423|FG000|Overall Study|Incomplete CEU data|1|||
163326860|NCT01566890|589907424|FG001|Overall Study|Incomplete CEU data|3|||
163326861|NCT01566890|589907425|FG002|Overall Study|Incomplete CEU data|5|||
163008561|NCT03367819|588732406|FG000|Overall Study|Progressive Disease|15|||
163008562|NCT03367819|588732407|FG001|Overall Study|Progressive Disease|13|||
163326862|NCT01566890|589907426|FG003|Overall Study|Incomplete CEU data|8|||
163008563|NCT03367819|588732406|FG000|Overall Study|Withdrawal by Subject|1|||
163008564|NCT03367819|588732407|FG001|Overall Study|Withdrawal by Subject|0|||
163008565|NCT03367819|588732406|FG000|Overall Study|Other|4|||
163326863|NCT01566890|589907427|FG004|Overall Study|Incomplete CEU data|0|||
163008566|NCT03367819|588732407|FG001|Overall Study|Other|2|||
163008567|NCT00445146|588732410|FG000|Overall Study|Withdrew Consent|29|||
163008568|NCT00445146|588732410|FG000|Overall Study|Lack of Efficacy|28|||
163008569|NCT00445146|588732410|FG000|Overall Study|Investigator's Discretion|22|||
163008570|NCT00445146|588732410|FG000|Overall Study|Adverse Event|13|||
163008571|NCT00445146|588732410|FG000|Overall Study|Lost to Follow-up|13|||
163008572|NCT00445146|588732410|FG000|Overall Study|Death|9|||
163008573|NCT00445146|588732410|FG000|Overall Study|Protocol Violation|4|||
163008574|NCT00445146|588732410|FG000|Overall Study|Pregnancy|1|||
163008575|NCT02456740|588732411|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
163008576|NCT02456740|588732412|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
163008577|NCT02456740|588732413|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
163008578|NCT02456740|588732414|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
163008579|NCT02456740|588732415|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
163008580|NCT02456740|588732416|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
163008581|NCT02456740|588732417|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
163008582|NCT02456740|588732418|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
163008583|NCT02456740|588732419|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
163008584|NCT02456740|588732411|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
163008585|NCT02456740|588732412|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
163008586|NCT02456740|588732413|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
163008587|NCT02456740|588732414|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
163008588|NCT02456740|588732415|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
163008589|NCT02456740|588732416|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
163008590|NCT02456740|588732417|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
163008591|NCT02456740|588732418|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
163008592|NCT02456740|588732419|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
163008593|NCT02456740|588732411|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
163008594|NCT02456740|588732412|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
163008595|NCT02456740|588732413|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
163008596|NCT02456740|588732414|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
163008597|NCT02456740|588732415|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
163008598|NCT02456740|588732416|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
163008599|NCT02456740|588732417|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
163008600|NCT02456740|588732418|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
163008601|NCT02456740|588732419|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
163008602|NCT02456740|588732411|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
163008603|NCT02456740|588732412|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
163008604|NCT02456740|588732413|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
163008605|NCT02456740|588732414|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
163008606|NCT02456740|588732415|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
163008607|NCT02456740|588732416|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
163008608|NCT02456740|588732417|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
163326864|NCT01566890|589907423|FG000|Overall Study|Lost to Follow-up|0|||
163326865|NCT01566890|589907424|FG001|Overall Study|Lost to Follow-up|0|||
163008609|NCT02456740|588732418|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
163008610|NCT02456740|588732419|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
163008611|NCT02456740|588732411|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
163008612|NCT02456740|588732412|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
163008613|NCT02456740|588732413|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
163008614|NCT02456740|588732414|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
163008615|NCT02456740|588732415|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
163008616|NCT02456740|588732416|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
163008617|NCT02456740|588732417|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
163008618|NCT02456740|588732418|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
163008619|NCT02456740|588732419|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
163008620|NCT02456740|588732411|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
163008621|NCT02456740|588732412|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
163008622|NCT02456740|588732413|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
163008623|NCT02456740|588732414|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
163326866|NCT01566890|589907425|FG002|Overall Study|Lost to Follow-up|4|||
163326867|NCT01566890|589907426|FG003|Overall Study|Lost to Follow-up|4|||
163008624|NCT02456740|588732415|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
163326868|NCT01566890|589907427|FG004|Overall Study|Lost to Follow-up|0|||
163326869|NCT01566890|589907423|FG000|Overall Study|Other|0|||
163008625|NCT02456740|588732416|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
163008626|NCT02456740|588732417|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
163008627|NCT02456740|588732418|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
163008628|NCT02456740|588732419|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
163008629|NCT02456740|588732411|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163008630|NCT02456740|588732412|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163008631|NCT02456740|588732413|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163008632|NCT02456740|588732414|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
163008633|NCT02456740|588732415|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
163008634|NCT02456740|588732416|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
163008635|NCT02456740|588732417|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
163008636|NCT02456740|588732418|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
163008637|NCT02456740|588732419|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
163008638|NCT04720105|588732423|FG000|Overall Study|Lack of Efficacy|1|||
163008639|NCT04720105|588732423|FG000|Overall Study|Lost to Follow-up|1|||
163008640|NCT04720105|588732423|FG000|Overall Study|Withdrawal by Subject|3|||
163008641|NCT00625820|588732428|FG000|Overall Study|Withdrawal by Subject|1|||
163008642|NCT02546986|588734198|FG000|Treatment Period|Progressive Disease|20|||
163008643|NCT02546986|588734199|FG001|Treatment Period|Progressive Disease|22|||
163008644|NCT02546986|588734198|FG000|Treatment Period|Adverse Event|14|||
163008645|NCT02546986|588734199|FG001|Treatment Period|Adverse Event|6|||
163008646|NCT02546986|588734198|FG000|Treatment Period|Symptomatic Deterioration|4|||
163008647|NCT02546986|588734199|FG001|Treatment Period|Symptomatic Deterioration|3|||
163008648|NCT02546986|588734198|FG000|Treatment Period|Death|3|||
163008649|NCT02546986|588734199|FG001|Treatment Period|Death|4|||
163008650|NCT02546986|588734198|FG000|Treatment Period|Physician Decision|1|||
163008651|NCT02546986|588734199|FG001|Treatment Period|Physician Decision|2|||
163008652|NCT02546986|588734198|FG000|Treatment Period|Protocol Violation|1|||
163008653|NCT02546986|588734199|FG001|Treatment Period|Protocol Violation|0|||
163008654|NCT02546986|588734198|FG000|Treatment Period|Withdrawal by Subject|1|||
163008655|NCT02546986|588734199|FG001|Treatment Period|Withdrawal by Subject|1|||
163008656|NCT02546986|588734198|FG000|Treatment Period|Non-compliance with Study Drug|0|||
163008657|NCT02546986|588734199|FG001|Treatment Period|Non-compliance with Study Drug|1|||
163008658|NCT02546986|588734198|FG000|Treatment Period|Study Terminated by Sponsor|0|||
163008659|NCT02546986|588734199|FG001|Treatment Period|Study Terminated by Sponsor|1|||
163008660|NCT02546986|588734198|FG000|Treatment Period|Miscellaneous|7|||
163008661|NCT02546986|588734199|FG001|Treatment Period|Miscellaneous|9|||
163008662|NCT02546986|588734198|FG000|Survival Follow-Up Phase|Missing Status|3|||
163008663|NCT02546986|588734199|FG001|Survival Follow-Up Phase|Missing Status|5|||
163008664|NCT02546986|588734198|FG000|Survival Follow-Up Phase|Death|18|||
163008665|NCT02546986|588734199|FG001|Survival Follow-Up Phase|Death|12|||
163008666|NCT02546986|588734198|FG000|Survival Follow-Up Phase|Alive|13|||
163008667|NCT02546986|588734199|FG001|Survival Follow-Up Phase|Alive|16|||
163008668|NCT02546986|588734198|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
163008669|NCT02546986|588734199|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
163008670|NCT02844543|588734200|FG000|Overall Study|Withdrawal by Subject|4|||
163008671|NCT02844543|588734200|FG000|Overall Study|Did not meet eligibility criteria|1|||
163008672|NCT03349060|588734201|FG000|Overall Study|Adverse Event|9|||
163008673|NCT03349060|588734202|FG001|Overall Study|Adverse Event|9|||
163008674|NCT03349060|588734203|FG002|Overall Study|Adverse Event|7|||
163008675|NCT03349060|588734201|FG000|Overall Study|Lack of Efficacy|1|||
163008676|NCT03349060|588734202|FG001|Overall Study|Lack of Efficacy|0|||
163008677|NCT03349060|588734203|FG002|Overall Study|Lack of Efficacy|2|||
163008678|NCT03349060|588734201|FG000|Overall Study|Lost to Follow-up|2|||
163008679|NCT03349060|588734202|FG001|Overall Study|Lost to Follow-up|1|||
163008680|NCT03349060|588734203|FG002|Overall Study|Lost to Follow-up|1|||
163008681|NCT03349060|588734201|FG000|Overall Study|Protocol Violation|2|||
163008682|NCT03349060|588734202|FG001|Overall Study|Protocol Violation|2|||
163008683|NCT03349060|588734203|FG002|Overall Study|Protocol Violation|1|||
163008684|NCT03349060|588734201|FG000|Overall Study|Withdrawal by Subject|5|||
163008685|NCT03349060|588734202|FG001|Overall Study|Withdrawal by Subject|3|||
163326870|NCT01566890|589907424|FG001|Overall Study|Other|0|||
163326871|NCT01566890|589907425|FG002|Overall Study|Other|0|||
163008686|NCT03349060|588734203|FG002|Overall Study|Withdrawal by Subject|4|||
163008687|NCT03349060|588734201|FG000|Overall Study|Medication error,no linked adverse event|0|||
163008688|NCT03349060|588734202|FG001|Overall Study|Medication error,no linked adverse event|0|||
163008689|NCT03349060|588734203|FG002|Overall Study|Medication error,no linked adverse event|1|||
163008690|NCT03349060|588734201|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
163008691|NCT03349060|588734202|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
163008692|NCT03349060|588734203|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
163008693|NCT03349060|588734201|FG000|Overall Study|Other|2|||
163008694|NCT03349060|588734202|FG001|Overall Study|Other|1|||
163008695|NCT03349060|588734203|FG002|Overall Study|Other|0|||
163008696|NCT02861586|588734204|FG000|Overall Study|Withdrawal by Subject|1|||
163326872|NCT01566890|589907426|FG003|Overall Study|Other|0|||
163008697|NCT02861586|588734205|FG001|Overall Study|Withdrawal by Subject|2|||
163008698|NCT02861586|588734206|FG002|Overall Study|Withdrawal by Subject|0|||
163008699|NCT02861586|588734207|FG003|Overall Study|Withdrawal by Subject|0|||
163008700|NCT02861586|588734208|FG004|Overall Study|Withdrawal by Subject|0|||
163008701|NCT02861586|588734209|FG005|Overall Study|Withdrawal by Subject|1|||
163008702|NCT02861586|588734210|FG006|Overall Study|Withdrawal by Subject|1|||
163008703|NCT02861586|588734211|FG007|Overall Study|Withdrawal by Subject|0|||
163008704|NCT02861586|588734204|FG000|Overall Study|Lost to Follow-up|3|||
163008705|NCT02861586|588734205|FG001|Overall Study|Lost to Follow-up|1|||
163008706|NCT02861586|588734206|FG002|Overall Study|Lost to Follow-up|1|||
163008707|NCT02861586|588734207|FG003|Overall Study|Lost to Follow-up|0|||
163008708|NCT02861586|588734208|FG004|Overall Study|Lost to Follow-up|0|||
163008709|NCT02861586|588734209|FG005|Overall Study|Lost to Follow-up|3|||
163008710|NCT02861586|588734210|FG006|Overall Study|Lost to Follow-up|0|||
163008711|NCT02861586|588734211|FG007|Overall Study|Lost to Follow-up|0|||
163008712|NCT02861586|588734204|FG000|Overall Study|Adverse Event|0|||
163008713|NCT02861586|588734205|FG001|Overall Study|Adverse Event|0|||
163008714|NCT02861586|588734206|FG002|Overall Study|Adverse Event|0|||
163008715|NCT02861586|588734207|FG003|Overall Study|Adverse Event|0|||
163008716|NCT02861586|588734208|FG004|Overall Study|Adverse Event|0|||
163008717|NCT02861586|588734209|FG005|Overall Study|Adverse Event|1|||
163008718|NCT02861586|588734210|FG006|Overall Study|Adverse Event|0|||
163008719|NCT02861586|588734211|FG007|Overall Study|Adverse Event|0|||
163008720|NCT04710576|588734212|FG000|Overall Study|Participants still in the study|73|||
163008721|NCT04710576|588734213|FG001|Overall Study|Participants still in the study|70|||
163008722|NCT04710576|588734214|FG002|Overall Study|Participants still in the study|60|||
163008723|NCT04710576|588734212|FG000|Overall Study|Death|2|||
163008724|NCT04710576|588734213|FG001|Overall Study|Death|7|||
163008725|NCT04710576|588734214|FG002|Overall Study|Death|12|||
163008726|NCT04710576|588734212|FG000|Overall Study|Withdrawal by Subject|4|||
163008727|NCT04710576|588734213|FG001|Overall Study|Withdrawal by Subject|3|||
163008728|NCT04710576|588734214|FG002|Overall Study|Withdrawal by Subject|7|||
163008729|NCT04710576|588734212|FG000|Overall Study|Sponsor decision|1|||
163008730|NCT04710576|588734213|FG001|Overall Study|Sponsor decision|0|||
163008731|NCT04710576|588734214|FG002|Overall Study|Sponsor decision|0|||
163326873|NCT01566890|589907427|FG004|Overall Study|Other|7|||
163326874|NCT02397096|589907430|FG000|Day 1 to Week 24|Adverse Event|7|||
163326875|NCT02397096|589907431|FG001|Day 1 to Week 24|Adverse Event|1|||
163326876|NCT02397096|589907430|FG000|Day 1 to Week 24|Death|1|||
163326877|NCT02397096|589907431|FG001|Day 1 to Week 24|Death|0|||
163326878|NCT02397096|589907430|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
163326879|NCT02397096|589907431|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
163326880|NCT02397096|589907430|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
163326881|NCT02397096|589907431|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
163326882|NCT02397096|589907430|FG000|Day 1 to Week 24|Physician Decision|2|||
163213852|NCT03742037|589496047|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
163213853|NCT03742037|589496048|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
163326883|NCT02397096|589907431|FG001|Day 1 to Week 24|Physician Decision|3|||
163326884|NCT02397096|589907430|FG000|Day 1 to Week 24|Protocol Violation|1|||
163008732|NCT04796909|588734215|FG000|Overall Study|Withdrawal by Subject|1|||
163213854|NCT03742037|589496049|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
163326885|NCT02397096|589907431|FG001|Day 1 to Week 24|Protocol Violation|4|||
163213855|NCT03742037|589496050|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
163213856|NCT03742037|589496051|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
163213857|NCT03742037|589496052|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
163213858|NCT03742037|589496053|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
163213859|NCT03742037|589496047|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
163213860|NCT03742037|589496048|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
163213861|NCT03742037|589496049|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
163213862|NCT03742037|589496050|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
163213863|NCT03742037|589496051|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
163326886|NCT02397096|589907430|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
163326887|NCT02397096|589907431|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
163326888|NCT02397096|589907430|FG000|Day 1 to Week 24|Randomized, not treated|3|||
163326889|NCT02397096|589907431|FG001|Day 1 to Week 24|Randomized, not treated|0|||
163008733|NCT04796909|588734216|FG001|Overall Study|Withdrawal by Subject|1|||
163008734|NCT00437021|588734217|FG000|Overall Study|Adverse Event|0|||
163008735|NCT00437021|588734218|FG001|Overall Study|Adverse Event|0|||
163008736|NCT00437021|588734219|FG002|Overall Study|Adverse Event|0|||
163008737|NCT00437021|588734220|FG003|Overall Study|Adverse Event|0|||
163008738|NCT00437021|588734221|FG004|Overall Study|Adverse Event|0|||
163008739|NCT00437021|588734222|FG005|Overall Study|Adverse Event|0|||
163008740|NCT00437021|588734223|FG006|Overall Study|Adverse Event|1|||
163008741|NCT00437021|588734224|FG007|Overall Study|Adverse Event|0|||
163008742|NCT00437021|588734225|FG008|Overall Study|Adverse Event|0|||
163008743|NCT00437021|588734226|FG009|Overall Study|Adverse Event|0|||
163008744|NCT00437021|588734227|FG010|Overall Study|Adverse Event|0|||
163213864|NCT03742037|589496052|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
163213865|NCT03742037|589496053|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
163213866|NCT04128267|589496054|FG000|Overall Study|Withdrawal by Subject|6|||
163213867|NCT04128267|589496054|FG000|Overall Study|Death|2|||
163213868|NCT04128267|589496054|FG000|Overall Study|Disease progression|1|||
163213869|NCT04128267|589496054|FG000|Overall Study|Participant had other medical issues|4|||
163213870|NCT04128267|589496054|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
163213871|NCT01705652|589496058|FG000|Overall Study|Adverse Event|1|||
163213872|NCT01705652|589496059|FG001|Overall Study|Adverse Event|0|||
163213873|NCT01705652|589496058|FG000|Overall Study|Withdrawal by Subject|1|||
163213874|NCT01705652|589496059|FG001|Overall Study|Withdrawal by Subject|2|||
163213875|NCT01705652|589496058|FG000|Overall Study|non-compliance|1|||
163213876|NCT01705652|589496059|FG001|Overall Study|non-compliance|1|||
163213877|NCT00056407|589496061|FG000|Overall Study|Adverse Event|282|||
163213878|NCT00056407|589496062|FG001|Overall Study|Adverse Event|364|||
163213879|NCT00056407|589496061|FG000|Overall Study|Withdrawal by Subject|377|||
163213880|NCT00056407|589496062|FG001|Overall Study|Withdrawal by Subject|361|||
163213881|NCT00056407|589496061|FG000|Overall Study|Lost to Follow-up|123|||
163213882|NCT00056407|589496062|FG001|Overall Study|Lost to Follow-up|113|||
163213883|NCT00056407|589496061|FG000|Overall Study|Protocol Violation|104|||
163213884|NCT00056407|589496062|FG001|Overall Study|Protocol Violation|95|||
163213885|NCT00056407|589496061|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
163213886|NCT00056407|589496062|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
163213887|NCT00056407|589496061|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
163213888|NCT00056407|589496062|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
163213889|NCT00056407|589496061|FG000|Overall Study|Missing|25|||
163213890|NCT00056407|589496062|FG001|Overall Study|Missing|34|||
163213891|NCT00616655|589496063|FG000|Overall Study|Adverse Event|10|||
163213892|NCT00616655|589496064|FG001|Overall Study|Adverse Event|7|||
163213893|NCT00616655|589496065|FG002|Overall Study|Adverse Event|12|||
163213894|NCT00616655|589496063|FG000|Overall Study|Lack of Efficacy|5|||
163213895|NCT00616655|589496064|FG001|Overall Study|Lack of Efficacy|5|||
163213896|NCT00616655|589496065|FG002|Overall Study|Lack of Efficacy|5|||
163213897|NCT00616655|589496063|FG000|Overall Study|Lost to Follow-up|3|||
163213898|NCT00616655|589496064|FG001|Overall Study|Lost to Follow-up|12|||
163213899|NCT00616655|589496065|FG002|Overall Study|Lost to Follow-up|10|||
163213900|NCT00616655|589496063|FG000|Overall Study|Protocol Violation|2|||
163326890|NCT02397096|589907430|FG000|Week 24 to Week 48|Adverse Event|6|||
163326891|NCT02397096|589907431|FG001|Week 24 to Week 48|Adverse Event|2|||
163326892|NCT02397096|589907430|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
163326893|NCT02397096|589907431|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
163326894|NCT02397096|589907430|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
163326895|NCT02397096|589907431|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
163326896|NCT02397096|589907430|FG000|Week 24 to Week 48|Physician Decision|2|||
163326897|NCT02397096|589907431|FG001|Week 24 to Week 48|Physician Decision|1|||
163326898|NCT02397096|589907430|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
163326899|NCT02397096|589907431|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
163326900|NCT02397096|589907430|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
163326901|NCT02397096|589907431|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
163326902|NCT02397096|589907430|FG000|Study Extension 1|Adverse Event|7|||
163326903|NCT02397096|589907431|FG001|Study Extension 1|Adverse Event|5|||
163326904|NCT02397096|589907430|FG000|Study Extension 1|Death|1|||
163326905|NCT02397096|589907431|FG001|Study Extension 1|Death|0|||
163326906|NCT02397096|589907430|FG000|Study Extension 1|Lack of Efficacy|2|||
163326907|NCT02397096|589907431|FG001|Study Extension 1|Lack of Efficacy|5|||
163326908|NCT02397096|589907430|FG000|Study Extension 1|Lost to Follow-up|2|||
163008745|NCT00437021|588734228|FG011|Overall Study|Adverse Event|0|||
163008746|NCT00437021|588734217|FG000|Overall Study|Lost to Follow-up|0|||
163213901|NCT00616655|589496064|FG001|Overall Study|Protocol Violation|4|||
163213902|NCT00616655|589496065|FG002|Overall Study|Protocol Violation|3|||
163213903|NCT00616655|589496063|FG000|Overall Study|Withdrawal by Subject|9|||
163326909|NCT02397096|589907431|FG001|Study Extension 1|Lost to Follow-up|3|||
163326910|NCT02397096|589907430|FG000|Study Extension 1|Non-compliance with study drug|3|||
163213904|NCT00616655|589496064|FG001|Overall Study|Withdrawal by Subject|7|||
163213905|NCT00616655|589496065|FG002|Overall Study|Withdrawal by Subject|11|||
163213906|NCT00616655|589496063|FG000|Overall Study|Does not meet in/ex criteria|0|||
163213907|NCT00616655|589496064|FG001|Overall Study|Does not meet in/ex criteria|0|||
163213908|NCT00616655|589496065|FG002|Overall Study|Does not meet in/ex criteria|2|||
163326911|NCT02397096|589907431|FG001|Study Extension 1|Non-compliance with study drug|0|||
163008747|NCT00437021|588734218|FG001|Overall Study|Lost to Follow-up|3|||
163213909|NCT00616655|589496063|FG000|Overall Study|Other|6|||
163213910|NCT00616655|589496064|FG001|Overall Study|Other|6|||
163061569|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
163061570|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
163061571|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
163061572|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
163061573|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
163061574|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
163061575|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
163061576|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
163061577|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
163061578|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
163061579|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
163061580|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
163061581|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
163061582|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
163061583|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
163061584|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
163061585|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
163061586|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
163061587|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
163061588|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
163061589|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
163061590|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
163061591|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
163061592|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
163061593|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
163061594|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
163061595|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
163061596|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
163213911|NCT00616655|589496065|FG002|Overall Study|Other|5|||
163213912|NCT01026792|589496066|FG000|Overall Study|Protocol Violation|1|||
163213913|NCT00309842|589496067|FG000|Overall Study|Lost to Follow-up|1|||
163213914|NCT02335099|589496070|FG000|Treatment|Withdrawal by Subject|1|||
163213915|NCT02335099|589496071|FG001|Treatment|Withdrawal by Subject|3|||
163213916|NCT02335099|589496070|FG000|Treatment|Lost to Follow-up|2|||
163213917|NCT02335099|589496071|FG001|Treatment|Lost to Follow-up|0|||
163213918|NCT02335099|589496070|FG000|Treatment|Death|1|||
163213919|NCT02335099|589496071|FG001|Treatment|Death|0|||
163213920|NCT02335099|589496070|FG000|Treatment|Adverse Event|1|||
163213921|NCT02335099|589496071|FG001|Treatment|Adverse Event|2|||
163213922|NCT02335099|589496070|FG000|Follow-up|Death|0|||
163213923|NCT02335099|589496071|FG001|Follow-up|Death|1|||
163213924|NCT01472081|589496072|FG000|Overall Study|Continuing treatment at time of analysis|1|||
163213925|NCT01472081|589496073|FG001|Overall Study|Continuing treatment at time of analysis|4|||
163213926|NCT01472081|589496074|FG002|Overall Study|Continuing treatment at time of analysis|1|||
163213927|NCT01472081|589496075|FG003|Overall Study|Continuing treatment at time of analysis|8|||
163213928|NCT01472081|589496076|FG004|Overall Study|Continuing treatment at time of analysis|9|||
163213929|NCT01472081|589496077|FG005|Overall Study|Continuing treatment at time of analysis|0|||
163213930|NCT01472081|589496072|FG000|Overall Study|Disease Progression|4|||
163213931|NCT01472081|589496073|FG001|Overall Study|Disease Progression|10|||
163213932|NCT01472081|589496074|FG002|Overall Study|Disease Progression|12|||
163213933|NCT01472081|589496075|FG003|Overall Study|Disease Progression|31|||
163213934|NCT01472081|589496076|FG004|Overall Study|Disease Progression|22|||
163213935|NCT01472081|589496077|FG005|Overall Study|Disease Progression|3|||
163213936|NCT01472081|589496072|FG000|Overall Study|Study drug toxicity|2|||
163213937|NCT01472081|589496073|FG001|Overall Study|Study drug toxicity|9|||
163213938|NCT01472081|589496074|FG002|Overall Study|Study drug toxicity|4|||
163213939|NCT01472081|589496075|FG003|Overall Study|Study drug toxicity|6|||
163213940|NCT01472081|589496076|FG004|Overall Study|Study drug toxicity|13|||
163213941|NCT01472081|589496077|FG005|Overall Study|Study drug toxicity|2|||
163213942|NCT01472081|589496072|FG000|Overall Study|Death|0|||
163213943|NCT01472081|589496073|FG001|Overall Study|Death|0|||
163213944|NCT01472081|589496074|FG002|Overall Study|Death|0|||
163213945|NCT01472081|589496075|FG003|Overall Study|Death|0|||
163213946|NCT01472081|589496076|FG004|Overall Study|Death|1|||
163213947|NCT01472081|589496077|FG005|Overall Study|Death|0|||
163213948|NCT01472081|589496072|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
163213949|NCT01472081|589496073|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
163213950|NCT01472081|589496074|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
163213951|NCT01472081|589496075|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
163061597|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
163061598|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
163061599|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
163061600|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
163061601|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
163061602|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
163061603|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
163061604|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
163061605|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
163061606|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
163061607|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
163061608|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
163326912|NCT02397096|589907430|FG000|Study Extension 1|Physician Decision|4|||
163326913|NCT02397096|589907431|FG001|Study Extension 1|Physician Decision|2|||
163326914|NCT02397096|589907430|FG000|Study Extension 1|Pregnancy|1|||
163326915|NCT02397096|589907431|FG001|Study Extension 1|Pregnancy|0|||
163326916|NCT02397096|589907430|FG000|Study Extension 1|Protocol Violation|0|||
163326917|NCT02397096|589907431|FG001|Study Extension 1|Protocol Violation|1|||
163326918|NCT02397096|589907430|FG000|Study Extension 1|Withdrawal by Subject|21|||
163326919|NCT02397096|589907431|FG001|Study Extension 1|Withdrawal by Subject|7|||
163326920|NCT02397096|589907430|FG000|Study Extension 2|Adverse Event|3|||
163326921|NCT02397096|589907431|FG001|Study Extension 2|Adverse Event|3|||
163326922|NCT02397096|589907430|FG000|Study Extension 2|Availability of study medication locally|152|||
163326923|NCT02397096|589907431|FG001|Study Extension 2|Availability of study medication locally|64|||
163326924|NCT02397096|589907430|FG000|Study Extension 2|Death|2|||
163326925|NCT02397096|589907431|FG001|Study Extension 2|Death|0|||
163326926|NCT02397096|589907430|FG000|Study Extension 2|Lack of Efficacy|1|||
163326927|NCT02397096|589907431|FG001|Study Extension 2|Lack of Efficacy|0|||
163326928|NCT02397096|589907430|FG000|Study Extension 2|Lost to Follow-up|2|||
163326929|NCT02397096|589907431|FG001|Study Extension 2|Lost to Follow-up|1|||
163326930|NCT02397096|589907430|FG000|Study Extension 2|Non-compliance with study drug|1|||
163326931|NCT02397096|589907431|FG001|Study Extension 2|Non-compliance with study drug|0|||
163326932|NCT02397096|589907430|FG000|Study Extension 2|Physician Decision|2|||
163326933|NCT02397096|589907431|FG001|Study Extension 2|Physician Decision|5|||
163326934|NCT02397096|589907430|FG000|Study Extension 2|Pregnancy|1|||
163008748|NCT00437021|588734219|FG002|Overall Study|Lost to Follow-up|0|||
163008749|NCT00437021|588734220|FG003|Overall Study|Lost to Follow-up|0|||
163008750|NCT00437021|588734221|FG004|Overall Study|Lost to Follow-up|0|||
163008751|NCT00437021|588734222|FG005|Overall Study|Lost to Follow-up|2|||
163008752|NCT00437021|588734223|FG006|Overall Study|Lost to Follow-up|0|||
163008753|NCT00437021|588734224|FG007|Overall Study|Lost to Follow-up|1|||
163008754|NCT00437021|588734225|FG008|Overall Study|Lost to Follow-up|0|||
163008755|NCT00437021|588734226|FG009|Overall Study|Lost to Follow-up|0|||
163008756|NCT00437021|588734227|FG010|Overall Study|Lost to Follow-up|0|||
163008757|NCT00437021|588734228|FG011|Overall Study|Lost to Follow-up|0|||
163008758|NCT00437021|588734217|FG000|Overall Study|Withdrawal by Subject|2|||
163008759|NCT00437021|588734218|FG001|Overall Study|Withdrawal by Subject|1|||
163008760|NCT00437021|588734219|FG002|Overall Study|Withdrawal by Subject|0|||
163008761|NCT00437021|588734220|FG003|Overall Study|Withdrawal by Subject|0|||
163008762|NCT00437021|588734221|FG004|Overall Study|Withdrawal by Subject|0|||
163008763|NCT00437021|588734222|FG005|Overall Study|Withdrawal by Subject|0|||
163008764|NCT00437021|588734223|FG006|Overall Study|Withdrawal by Subject|0|||
163008765|NCT00437021|588734224|FG007|Overall Study|Withdrawal by Subject|0|||
163008766|NCT00437021|588734225|FG008|Overall Study|Withdrawal by Subject|0|||
163008767|NCT00437021|588734226|FG009|Overall Study|Withdrawal by Subject|0|||
163008768|NCT00437021|588734227|FG010|Overall Study|Withdrawal by Subject|0|||
163008769|NCT00437021|588734228|FG011|Overall Study|Withdrawal by Subject|0|||
163008770|NCT04162847|588734229|FG000|Overall Study|Withdrawal by Subject|7|||
163008771|NCT04162847|588734230|FG001|Overall Study|Withdrawal by Subject|1|||
163008772|NCT03985800|588734231|FG000|Overall Study|Death|1|||
163008773|NCT03985800|588734232|FG001|Overall Study|Death|2|||
163008774|NCT03985800|588734231|FG000|Overall Study|Withdrawal by Subject|3|||
163008775|NCT03985800|588734232|FG001|Overall Study|Withdrawal by Subject|6|||
163008776|NCT03985800|588734231|FG000|Overall Study|Protocol Violation|2|||
163008777|NCT03985800|588734232|FG001|Overall Study|Protocol Violation|0|||
163008778|NCT05258773|588734233|FG000|Overall Study|Screen Failure|1|||
163008779|NCT05258773|588734234|FG001|Overall Study|Screen Failure|1|||
163008780|NCT05258773|588734233|FG000|Overall Study|Adverse Event|1|||
163008781|NCT05258773|588734234|FG001|Overall Study|Adverse Event|0|||
163008782|NCT05258773|588734233|FG000|Overall Study|Withdrawal by Subject|0|||
163008783|NCT05258773|588734234|FG001|Overall Study|Withdrawal by Subject|1|||
163008784|NCT03018288|588734237|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
163326935|NCT02397096|589907431|FG001|Study Extension 2|Pregnancy|0|||
163326936|NCT02397096|589907430|FG000|Study Extension 2|Withdrawal by Subject|10|||
163008785|NCT03018288|588734238|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
163008786|NCT03018288|588734239|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
163008787|NCT03018288|588734240|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
163008788|NCT03018288|588734237|FG000|Overall Study|Participant withdrew consent.|0|||
163008789|NCT03018288|588734238|FG001|Overall Study|Participant withdrew consent.|0|||
163008790|NCT03018288|588734239|FG002|Overall Study|Participant withdrew consent.|1|||
163008791|NCT03018288|588734240|FG003|Overall Study|Participant withdrew consent.|0|||
163008792|NCT03018288|588734237|FG000|Overall Study|Switched to alternative treatment.|0|||
163008793|NCT03018288|588734238|FG001|Overall Study|Switched to alternative treatment.|0|||
163008794|NCT03018288|588734239|FG002|Overall Study|Switched to alternative treatment.|1|||
163326937|NCT02397096|589907431|FG001|Study Extension 2|Withdrawal by Subject|3|||
163326938|NCT02397096|589907430|FG000|Study Extension 3|Adverse Event|1|||
163326939|NCT02397096|589907431|FG001|Study Extension 3|Adverse Event|0|||
163326940|NCT02397096|589907430|FG000|Study Extension 3|Availability of study medication locally|11|||
163326941|NCT02397096|589907431|FG001|Study Extension 3|Availability of study medication locally|3|||
163326942|NCT02397096|589907430|FG000|Study Extension 3|Lost to Follow-up|1|||
163326943|NCT02397096|589907431|FG001|Study Extension 3|Lost to Follow-up|0|||
163326944|NCT02397096|589907430|FG000|Study Extension 3|Withdrawal by Subject|2|||
163326945|NCT02397096|589907431|FG001|Study Extension 3|Withdrawal by Subject|1|||
163326946|NCT03275285|589907436|FG000|Overall Study|Ongoing|45|||
163326947|NCT03275285|589907437|FG001|Overall Study|Ongoing|69|||
163326948|NCT00115934|589907438|FG000|Overall Study|Lost to Follow-up|1|||
163326949|NCT00115934|589907439|FG001|Overall Study|Lost to Follow-up|0|||
163326950|NCT00115934|589907438|FG000|Overall Study|Did not receive intervention|3|||
163326951|NCT00115934|589907439|FG001|Overall Study|Did not receive intervention|2|||
163008795|NCT03018288|588734240|FG003|Overall Study|Switched to alternative treatment.|0|||
163008796|NCT03018288|588734237|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
163008797|NCT03018288|588734238|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
163008798|NCT03018288|588734239|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
163008799|NCT03018288|588734240|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
163008800|NCT03018288|588734237|FG000|Overall Study|Screen failures|0|||
163008801|NCT03018288|588734238|FG001|Overall Study|Screen failures|0|||
163008802|NCT03018288|588734239|FG002|Overall Study|Screen failures|0|||
163008803|NCT03018288|588734240|FG003|Overall Study|Screen failures|51|||
163008804|NCT03018288|588734237|FG000|Overall Study|Chose treatment outside of UNC|0|||
163326952|NCT03789110|589907440|FG000|Overall Study|Adverse Event|2|||
163326953|NCT03789110|589907440|FG000|Overall Study|Physician Decision|1|||
163326954|NCT03789110|589907440|FG000|Overall Study|Withdrawal by Subject|2|||
163326955|NCT03789110|589907440|FG000|Overall Study|Lack of Efficacy|22|||
163326956|NCT03789110|589907440|FG000|Overall Study|still on treatment|3|||
163326957|NCT03959423|589907444|FG000|Overall Study|Withdrawal by Subject|2|||
163326958|NCT03959423|589907445|FG001|Overall Study|Withdrawal by Subject|3|||
163326959|NCT03959423|589907444|FG000|Overall Study|Physician Decision|0|||
163326960|NCT03959423|589907445|FG001|Overall Study|Physician Decision|1|||
163326961|NCT03959423|589907444|FG000|Overall Study|Lost to Follow-up|1|||
163326962|NCT03959423|589907445|FG001|Overall Study|Lost to Follow-up|0|||
163326963|NCT03959423|589907444|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
163326964|NCT03959423|589907445|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163326965|NCT00593840|589907448|FG000|Overall Study|Withdrawal by Subject|1|||
163326966|NCT05802173|589908572|FG000|Overall Study|Withdrawal by Subject|2|||
163326967|NCT05802173|589908573|FG001|Overall Study|Withdrawal by Subject|0|||
163326968|NCT05802173|589908574|FG002|Overall Study|Withdrawal by Subject|0|||
163326969|NCT05802173|589908572|FG000|Overall Study|Protocol Violation|1|||
163326970|NCT05802173|589908573|FG001|Overall Study|Protocol Violation|0|||
163326971|NCT05802173|589908574|FG002|Overall Study|Protocol Violation|0|||
163326972|NCT05802173|589908572|FG000|Overall Study|Lost to Follow-up|0|||
163326973|NCT05802173|589908573|FG001|Overall Study|Lost to Follow-up|6|||
163326974|NCT05802173|589908574|FG002|Overall Study|Lost to Follow-up|4|||
163326975|NCT05802173|589908572|FG000|Overall Study|non-compliance|0|||
163326976|NCT05802173|589908573|FG001|Overall Study|non-compliance|1|||
163326977|NCT05802173|589908574|FG002|Overall Study|non-compliance|0|||
163326978|NCT04503681|589908575|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
163326979|NCT04503681|589908576|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
163326980|NCT03352713|589908577|FG000|Overall Study|Lost to Follow-up|8|||
163326981|NCT03352713|589908577|FG000|Overall Study|Withdrawn by investigator|5|||
163008805|NCT03018288|588734238|FG001|Overall Study|Chose treatment outside of UNC|0|||
163008806|NCT03018288|588734239|FG002|Overall Study|Chose treatment outside of UNC|0|||
163008807|NCT03018288|588734240|FG003|Overall Study|Chose treatment outside of UNC|1|||
163008808|NCT03018288|588734237|FG000|Overall Study|Unable to comply with protocol requirements|1|||
163326982|NCT03352713|589908577|FG000|Overall Study|Completed 0 EMAs|8|||
163326983|NCT03352713|589908577|FG000|Overall Study|Device incompatible/stolen|5|||
163326984|NCT01812759|589908578|FG000|Overall Study|Physician Decision|0|||
163326985|NCT01812759|589908579|FG001|Overall Study|Physician Decision|0|||
163326986|NCT01812759|589908580|FG002|Overall Study|Physician Decision|1|||
163008809|NCT03018288|588734238|FG001|Overall Study|Unable to comply with protocol requirements|1|||
163008810|NCT03018288|588734239|FG002|Overall Study|Unable to comply with protocol requirements|0|||
163008811|NCT03018288|588734240|FG003|Overall Study|Unable to comply with protocol requirements|1|||
163008812|NCT03018288|588734237|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
163008813|NCT03018288|588734238|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
163008814|NCT03018288|588734239|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
163008815|NCT03018288|588734240|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
163008816|NCT03018288|588734237|FG000|Overall Study|Physician Decision|0|||
163008817|NCT03018288|588734238|FG001|Overall Study|Physician Decision|0|||
163008818|NCT03018288|588734239|FG002|Overall Study|Physician Decision|0|||
163008819|NCT03018288|588734240|FG003|Overall Study|Physician Decision|1|||
163008820|NCT05573464|588734241|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
163008821|NCT05573464|588734242|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
163008822|NCT05573464|588734241|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
163008823|NCT05573464|588734242|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
163008824|NCT05573464|588734241|FG000|12-week Treatment Period|Protocol Violation|3|||
163008825|NCT05573464|588734242|FG001|12-week Treatment Period|Protocol Violation|1|||
163008826|NCT05573464|588734241|FG000|12-week Treatment Period|Physician Decision|1|||
163008827|NCT05573464|588734242|FG001|12-week Treatment Period|Physician Decision|2|||
163008828|NCT05573464|588734241|FG000|12-week Treatment Period|Lost to Follow-up|2|||
163008829|NCT05573464|588734242|FG001|12-week Treatment Period|Lost to Follow-up|0|||
163008830|NCT05573464|588734241|FG000|12-week Treatment Period|Adverse Event|20|||
163008831|NCT05573464|588734242|FG001|12-week Treatment Period|Adverse Event|9|||
163008832|NCT05573464|588734241|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
163008833|NCT05573464|588734242|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
163008834|NCT05573464|588734241|FG000|12-week Treatment Period|Randomised, not treated|0|||
163008835|NCT05573464|588734242|FG001|12-week Treatment Period|Randomised, not treated|1|||
163008836|NCT05573464|588734241|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
163008837|NCT05573464|588734242|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
163008838|NCT05573464|588734241|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
163008839|NCT05573464|588734242|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
163008840|NCT05573464|588734241|FG000|52-week Treatment Period|Protocol Violation|1|||
163008841|NCT05573464|588734242|FG001|52-week Treatment Period|Protocol Violation|1|||
163008842|NCT05573464|588734241|FG000|52-week Treatment Period|Physician Decision|2|||
163008843|NCT05573464|588734242|FG001|52-week Treatment Period|Physician Decision|2|||
163008844|NCT05573464|588734241|FG000|52-week Treatment Period|Lost to Follow-up|1|||
163008845|NCT05573464|588734242|FG001|52-week Treatment Period|Lost to Follow-up|1|||
163008846|NCT05573464|588734241|FG000|52-week Treatment Period|Adverse Event|11|||
163008847|NCT05573464|588734242|FG001|52-week Treatment Period|Adverse Event|8|||
163008848|NCT05573464|588734241|FG000|52-week Treatment Period|Death|1|||
163008849|NCT05573464|588734242|FG001|52-week Treatment Period|Death|1|||
163008850|NCT05734157|588734243|FG000|Overall Study|Death|3|||
163008851|NCT05734157|588734243|FG000|Overall Study|Withdrawal by Subject|2|||
163008852|NCT05734157|588734243|FG000|Overall Study|Lost to Follow-up|1|||
163008853|NCT05734157|588734243|FG000|Overall Study|Telephone call|3|||
163008854|NCT04815083|588734244|FG000|Overall Study|Physician Decision|1|||
163008855|NCT04815083|588734244|FG000|Overall Study|Study pause|2|||
163008856|NCT04815083|588734244|FG000|Overall Study|Screening failure|4|||
163008857|NCT06025721|588734245|FG000|Overall Study|Physician Decision|1|||
163008858|NCT06025721|588734245|FG000|Overall Study|Protocol Violation|1|||
163008859|NCT06025721|588734245|FG000|Overall Study|Incarceration|1|||
163008860|NCT01730053|588734248|FG000|Overall Study|Participant moved|0|||
163008861|NCT01730053|588734249|FG001|Overall Study|Participant moved|0|||
163008862|NCT01730053|588734250|FG002|Overall Study|Participant moved|1|||
163008863|NCT01730053|588734251|FG003|Overall Study|Participant moved|0|||
163008864|NCT01730053|588734252|FG004|Overall Study|Participant moved|0|||
163213952|NCT01472081|589496076|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
163008865|NCT01730053|588734253|FG005|Overall Study|Participant moved|0|||
163008866|NCT01730053|588734248|FG000|Overall Study|Physician Decision|0|||
163008867|NCT01730053|588734249|FG001|Overall Study|Physician Decision|0|||
163008868|NCT01730053|588734250|FG002|Overall Study|Physician Decision|0|||
163213953|NCT01472081|589496077|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
163213954|NCT01472081|589496072|FG000|Overall Study|Withdrawal by Subject|0|||
163213955|NCT01472081|589496073|FG001|Overall Study|Withdrawal by Subject|0|||
163008869|NCT01730053|588734251|FG003|Overall Study|Physician Decision|1|||
163008870|NCT01730053|588734252|FG004|Overall Study|Physician Decision|0|||
163008871|NCT01730053|588734253|FG005|Overall Study|Physician Decision|0|||
163008872|NCT01730053|588734248|FG000|Overall Study|Adverse Event|2|||
163008873|NCT01730053|588734249|FG001|Overall Study|Adverse Event|6|||
163008874|NCT01730053|588734250|FG002|Overall Study|Adverse Event|3|||
163008875|NCT01730053|588734251|FG003|Overall Study|Adverse Event|3|||
163213956|NCT01472081|589496074|FG002|Overall Study|Withdrawal by Subject|0|||
163008876|NCT01730053|588734252|FG004|Overall Study|Adverse Event|2|||
163008877|NCT01730053|588734253|FG005|Overall Study|Adverse Event|2|||
163008878|NCT01730053|588734248|FG000|Overall Study|Poor compliance to protocol|1|||
163008879|NCT01730053|588734249|FG001|Overall Study|Poor compliance to protocol|2|||
163008880|NCT01730053|588734250|FG002|Overall Study|Poor compliance to protocol|2|||
163008881|NCT01730053|588734251|FG003|Overall Study|Poor compliance to protocol|0|||
163008882|NCT01730053|588734252|FG004|Overall Study|Poor compliance to protocol|0|||
163008883|NCT01730053|588734253|FG005|Overall Study|Poor compliance to protocol|2|||
163326987|NCT00360269|589908581|FG000|Overall Study|Lost to Follow-up|7|||
163326988|NCT00360269|589908582|FG001|Overall Study|Lost to Follow-up|9|||
163326989|NCT00360269|589908581|FG000|Overall Study|Physician Decision|1|||
163326990|NCT00360269|589908582|FG001|Overall Study|Physician Decision|2|||
163326991|NCT00360269|589908581|FG000|Overall Study|Adverse Event|1|||
163326992|NCT00360269|589908582|FG001|Overall Study|Adverse Event|0|||
163326993|NCT00360269|589908581|FG000|Overall Study|Withdrawal by Subject|1|||
163326994|NCT00360269|589908582|FG001|Overall Study|Withdrawal by Subject|1|||
163326995|NCT04989816|589908585|FG000|Overall Study|Death|77|||
163326996|NCT04989816|589908585|FG000|Overall Study|Lost to Follow-up|3|||
163326997|NCT03758638|589908586|FG000|Overall Study|Pregnancy|17|||
163326998|NCT03758638|589908587|FG001|Overall Study|Pregnancy|25|||
163326999|NCT03758638|589908586|FG000|Overall Study|Lost to Follow-up|60|||
163327000|NCT03758638|589908587|FG001|Overall Study|Lost to Follow-up|54|||
163327001|NCT03758638|589908586|FG000|Overall Study|Protocol Violation|2|||
163327002|NCT03758638|589908587|FG001|Overall Study|Protocol Violation|0|||
163327003|NCT03758638|589908586|FG000|Overall Study|Withdrawal by Subject|8|||
163327004|NCT03758638|589908587|FG001|Overall Study|Withdrawal by Subject|2|||
163327005|NCT03758638|589908586|FG000|Overall Study|Providers not included in the primary outcome.|183|||
163327006|NCT03758638|589908587|FG001|Overall Study|Providers not included in the primary outcome.|128|||
163327007|NCT01184326|589908588|FG000|Overall Study|Adverse Event|1|||
163327008|NCT01184326|589908589|FG001|Overall Study|Adverse Event|2|||
163327009|NCT01184326|589908590|FG002|Overall Study|Adverse Event|0|||
163327010|NCT01184326|589908588|FG000|Overall Study|Death|0|||
163327011|NCT01184326|589908589|FG001|Overall Study|Death|0|||
163327012|NCT01184326|589908590|FG002|Overall Study|Death|1|||
163327013|NCT01184326|589908588|FG000|Overall Study|Withdrawal by Subject|0|||
163327014|NCT01184326|589908589|FG001|Overall Study|Withdrawal by Subject|0|||
163327015|NCT01184326|589908590|FG002|Overall Study|Withdrawal by Subject|1|||
163327016|NCT01184326|589908588|FG000|Overall Study|Physician Decision|1|||
163327017|NCT01184326|589908589|FG001|Overall Study|Physician Decision|1|||
163327018|NCT01184326|589908590|FG002|Overall Study|Physician Decision|0|||
163327019|NCT01184326|589908588|FG000|Overall Study|Disease Progression|1|||
163327020|NCT01184326|589908589|FG001|Overall Study|Disease Progression|3|||
163327021|NCT01184326|589908590|FG002|Overall Study|Disease Progression|12|||
163327022|NCT01036724|589908591|FG000|Overall Study|Adverse Event|1|||
163327023|NCT01036724|589908592|FG001|Overall Study|Adverse Event|2|||
163327024|NCT01036724|589908591|FG000|Overall Study|Lack of Efficacy|1|||
163327025|NCT01036724|589908592|FG001|Overall Study|Lack of Efficacy|1|||
163327026|NCT01036724|589908591|FG000|Overall Study|Protocol Violation|4|||
163327027|NCT01036724|589908592|FG001|Overall Study|Protocol Violation|5|||
163327028|NCT03442777|589908595|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
163327029|NCT03442777|589908596|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
163008884|NCT01730053|588734248|FG000|Overall Study|Other than specified|2|||
163008885|NCT01730053|588734249|FG001|Overall Study|Other than specified|6|||
163008886|NCT01730053|588734250|FG002|Overall Study|Other than specified|5|||
163008887|NCT01730053|588734251|FG003|Overall Study|Other than specified|4|||
163008888|NCT01730053|588734252|FG004|Overall Study|Other than specified|7|||
163008889|NCT01730053|588734253|FG005|Overall Study|Other than specified|9|||
163327030|NCT03442777|589908597|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
163327031|NCT02866942|589908598|FG000|Overall Study|Invalid consent|1|||
163327032|NCT00372775|589908599|FG000|Overall Study|Adverse Event|8|||
163327033|NCT00372775|589908599|FG000|Overall Study|Death|15|||
163327034|NCT00372775|589908599|FG000|Overall Study|Objective progression or relapse|30|||
163327035|NCT00372775|589908599|FG000|Overall Study|Global deterioration of health status|6|||
163327036|NCT00372775|589908599|FG000|Overall Study|Withdrawal by Subject|1|||
163327037|NCT00372775|589908599|FG000|Overall Study|Other|1|||
163327038|NCT00372775|589908599|FG000|Overall Study|Not Treated|2|||
163327039|NCT01750684|589908600|FG000|Overall Study|Death|1|||
163327040|NCT01750684|589908601|FG001|Overall Study|Death|0|||
163327041|NCT01750684|589908600|FG000|Overall Study|Non-compliance with Study Drug|0|||
163327042|NCT01750684|589908601|FG001|Overall Study|Non-compliance with Study Drug|1|||
163327043|NCT01750684|589908600|FG000|Overall Study|Withdrawn by Sponsor|0|||
163327044|NCT01750684|589908601|FG001|Overall Study|Withdrawn by Sponsor|1|||
163327045|NCT01750684|589908600|FG000|Overall Study|Protocol Violation|1|||
163327046|NCT01750684|589908601|FG001|Overall Study|Protocol Violation|0|||
163327047|NCT01561300|589908602|FG000|Run in on Placebo|Adverse Event|1|||
163327048|NCT01561300|589908603|FG001|Run in on Placebo|Adverse Event|0|||
163327049|NCT00777049|589908604|FG000|Overall Study|Withdrawal by Subject|1|||
163008890|NCT02068508|588734254|FG000|Overall Study|Case report forms uncollected|27|||
163008891|NCT02068508|588734254|FG000|Overall Study|Patient did not visit the study site|1|||
163008892|NCT02068508|588734254|FG000|Overall Study|Protocol Violation|4|||
163008893|NCT00075816|588734262|FG000|Overall Study|Did not undergo transplantation|14|||
163008894|NCT00075816|588734263|FG001|Overall Study|Did not undergo transplantation|11|||
163008895|NCT04173507|588734264|FG000|Overall Study|On Treatment|3|||
163008896|NCT04173507|588734264|FG000|Overall Study|Adverse Event|3|||
163008897|NCT04173507|588734264|FG000|Overall Study|Progression/Relapse|34|||
163008898|NCT04173507|588734264|FG000|Overall Study|Death|2|||
163008899|NCT02832687|588734265|FG000|Overall Study|Adverse Event|0|||
163008900|NCT02832687|588734266|FG001|Overall Study|Adverse Event|2|||
163008901|NCT04231825|588734267|FG000|Overall Study|Protocol Violation|3|||
163008902|NCT04231825|588734268|FG001|Overall Study|Protocol Violation|3|||
163008903|NCT04231825|588734267|FG000|Overall Study|Lost to Follow-up|0|||
163008904|NCT04231825|588734268|FG001|Overall Study|Lost to Follow-up|1|||
163008905|NCT02392481|588734269|FG000|Overall Study|Adverse Event|0|||
163008906|NCT02392481|588734270|FG001|Overall Study|Adverse Event|0|||
163008907|NCT02392481|588734271|FG002|Overall Study|Adverse Event|1|||
163008908|NCT02392481|588734272|FG003|Overall Study|Adverse Event|2|||
163008909|NCT02392481|588734269|FG000|Overall Study|Withdrawal by Subject|0|||
163008910|NCT02392481|588734270|FG001|Overall Study|Withdrawal by Subject|0|||
163008911|NCT02392481|588734271|FG002|Overall Study|Withdrawal by Subject|1|||
163327050|NCT00777049|589908605|FG001|Overall Study|Withdrawal by Subject|0|||
163008912|NCT02392481|588734272|FG003|Overall Study|Withdrawal by Subject|0|||
163008913|NCT04341363|588734275|FG000|Overall Study|Adverse Event|1|||
163008914|NCT04341363|588734275|FG000|Overall Study|Withdrawal by Subject|1|||
163008915|NCT00063934|588734276|FG000|Overall Study|Ineligible|1|||
163008916|NCT01836471|588734277|FG000|Overall Study|Pregnancy|1|||
163008917|NCT01836471|588734278|FG001|Overall Study|Pregnancy|0|||
163008918|NCT01836471|588734279|FG002|Overall Study|Pregnancy|0|||
163008919|NCT01836471|588734280|FG003|Overall Study|Pregnancy|0|||
163327051|NCT00777049|589908604|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
163008920|NCT01836471|588734281|FG004|Overall Study|Pregnancy|0|||
163008921|NCT01836471|588734277|FG000|Overall Study|Withdrawal by Subject|3|||
163008922|NCT01836471|588734278|FG001|Overall Study|Withdrawal by Subject|4|||
163008923|NCT01836471|588734279|FG002|Overall Study|Withdrawal by Subject|1|||
163008924|NCT01836471|588734280|FG003|Overall Study|Withdrawal by Subject|0|||
163008925|NCT01836471|588734281|FG004|Overall Study|Withdrawal by Subject|2|||
163008926|NCT01836471|588734277|FG000|Overall Study|Physician Decision|0|||
163327052|NCT00777049|589908605|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
163327053|NCT00790569|589908606|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
163327054|NCT00790569|589908607|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
163327055|NCT00790569|589908608|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
163327056|NCT00790569|589908606|FG000|End of Treatment (6 Month Interview)|Death|0|||
163327057|NCT00790569|589908607|FG001|End of Treatment (6 Month Interview)|Death|2|||
163327058|NCT00790569|589908608|FG002|End of Treatment (6 Month Interview)|Death|1|||
163327059|NCT00790569|589908606|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
163327060|NCT00790569|589908607|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
163327061|NCT00790569|589908608|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
163327062|NCT00790569|589908606|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
163327063|NCT00790569|589908607|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
163327064|NCT00790569|589908608|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
163327065|NCT00790569|589908606|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
163327066|NCT00790569|589908607|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
163327067|NCT00790569|589908608|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
163327068|NCT00790569|589908606|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
163327069|NCT00790569|589908607|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
163327070|NCT00790569|589908608|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
163327071|NCT01627561|589908609|FG000|Overall Study|Lost to Follow-up|1|||
163008927|NCT01836471|588734278|FG001|Overall Study|Physician Decision|1|||
163008928|NCT01836471|588734279|FG002|Overall Study|Physician Decision|0|||
163008929|NCT01836471|588734280|FG003|Overall Study|Physician Decision|0|||
163008930|NCT01836471|588734281|FG004|Overall Study|Physician Decision|0|||
163008931|NCT01836471|588734277|FG000|Overall Study|Lost to Follow-up|0|||
163008932|NCT01836471|588734278|FG001|Overall Study|Lost to Follow-up|0|||
163008933|NCT01836471|588734279|FG002|Overall Study|Lost to Follow-up|0|||
163008934|NCT01836471|588734280|FG003|Overall Study|Lost to Follow-up|1|||
163008935|NCT01836471|588734281|FG004|Overall Study|Lost to Follow-up|1|||
163008936|NCT01836471|588734277|FG000|Overall Study|Adverse Event|6|||
163008937|NCT01836471|588734278|FG001|Overall Study|Adverse Event|3|||
163008938|NCT01836471|588734279|FG002|Overall Study|Adverse Event|1|||
163008939|NCT01836471|588734280|FG003|Overall Study|Adverse Event|1|||
163327072|NCT01627561|589908610|FG001|Overall Study|Lost to Follow-up|0|||
163327073|NCT01627561|589908609|FG000|Overall Study|Withdrawal by Subject|0|||
163327074|NCT01627561|589908610|FG001|Overall Study|Withdrawal by Subject|1|||
163008940|NCT01836471|588734281|FG004|Overall Study|Adverse Event|2|||
163327075|NCT01627561|589908609|FG000|Overall Study|Migrated/moved from study area|0|||
163327076|NCT01627561|589908610|FG001|Overall Study|Migrated/moved from study area|2|||
163327077|NCT00724126|589908611|FG000|Overall Study|Adverse Event|2|||
163327078|NCT00724126|589908612|FG001|Overall Study|Adverse Event|0|||
163327079|NCT00724126|589908611|FG000|Overall Study|Withdrawal by Subject|8|||
163327080|NCT00724126|589908612|FG001|Overall Study|Withdrawal by Subject|6|||
163327081|NCT00724126|589908611|FG000|Overall Study|Lost to Follow-up|6|||
163327082|NCT00724126|589908612|FG001|Overall Study|Lost to Follow-up|6|||
163327083|NCT00724126|589908611|FG000|Overall Study|Noncompliance|2|||
163327084|NCT00724126|589908612|FG001|Overall Study|Noncompliance|1|||
163327085|NCT00724126|589908611|FG000|Overall Study|Subject randomized although ineligible|1|||
163327086|NCT00724126|589908612|FG001|Overall Study|Subject randomized although ineligible|1|||
163327087|NCT00724126|589908611|FG000|Overall Study|Subject had to leave vicinity of site|0|||
163327088|NCT00724126|589908612|FG001|Overall Study|Subject had to leave vicinity of site|1|||
163327089|NCT01436175|589908613|FG000|Overall Study|Adverse Event|111|||
163327090|NCT01436175|589908613|FG000|Overall Study|Protocol Violation|49|||
163327091|NCT01436175|589908613|FG000|Overall Study|Withdrawal by Subject|108|||
163327092|NCT01436175|589908613|FG000|Overall Study|Lost to Follow-up|89|||
163327093|NCT01436175|589908613|FG000|Overall Study|Lack of Efficacy|24|||
163327094|NCT01436175|589908613|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
163327095|NCT01436175|589908613|FG000|Overall Study|Other|826|||
163327096|NCT03577106|589908617|FG000|Overall Study|Withdrawal by Subject|3|||
163327097|NCT01579318|589908618|FG000|Overall Study|Disease Progression|1|||
163327098|NCT03601715|589908621|FG000|Second Intervention|Lost to Follow-up|1|||
162924689|NCT04101721|588426095|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
163327099|NCT03601715|589908622|FG001|Second Intervention|Lost to Follow-up|1|||
163327100|NCT03601715|589908623|FG002|Second Intervention|Lost to Follow-up|0|||
163327101|NCT01478594|589908625|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
163327102|NCT01478594|589908626|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
163327103|NCT01478594|589908625|FG000|Overall Study|Death|45|||
163327104|NCT01478594|589908626|FG001|Overall Study|Death|18|||
163327105|NCT01478594|589908625|FG000|Overall Study|Lost to Follow-up|3|||
163327106|NCT01478594|589908626|FG001|Overall Study|Lost to Follow-up|1|||
163404465|NCT03246958|590191940|FG006|Overall Study|Never start treatment|0|||
163404466|NCT03246958|590191934|FG000|Overall Study|Over enrollment|0|||
162924690|NCT04101721|588426096|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
162924691|NCT04101721|588426095|FG000|Overall Study|Death|0|||
162924692|NCT04101721|588426096|FG001|Overall Study|Death|1|||
162924693|NCT04101721|588426095|FG000|Overall Study|Lost to Follow-up|0|||
162924694|NCT04101721|588426096|FG001|Overall Study|Lost to Follow-up|3|||
162924695|NCT01215955|588426097|FG000|Overall Study|Adverse Event|1|||
162924696|NCT01215955|588426098|FG001|Overall Study|Adverse Event|4|||
162924697|NCT01215955|588426099|FG002|Overall Study|Adverse Event|2|||
162924698|NCT01215955|588426100|FG003|Overall Study|Adverse Event|3|||
162924699|NCT01215955|588426097|FG000|Overall Study|Death|2|||
162924700|NCT01215955|588426098|FG001|Overall Study|Death|0|||
162924701|NCT01215955|588426099|FG002|Overall Study|Death|1|||
162924702|NCT01215955|588426100|FG003|Overall Study|Death|3|||
162924703|NCT01215955|588426097|FG000|Overall Study|Entry Criteria Not Met|1|||
162924704|NCT01215955|588426098|FG001|Overall Study|Entry Criteria Not Met|3|||
162924705|NCT01215955|588426099|FG002|Overall Study|Entry Criteria Not Met|4|||
162924706|NCT01215955|588426100|FG003|Overall Study|Entry Criteria Not Met|7|||
162924707|NCT01215955|588426097|FG000|Overall Study|Lack of Efficacy|1|||
162924708|NCT01215955|588426098|FG001|Overall Study|Lack of Efficacy|2|||
162924709|NCT01215955|588426099|FG002|Overall Study|Lack of Efficacy|1|||
162924710|NCT01215955|588426100|FG003|Overall Study|Lack of Efficacy|0|||
162924711|NCT01215955|588426097|FG000|Overall Study|Lost to Follow-up|4|||
162924712|NCT01215955|588426098|FG001|Overall Study|Lost to Follow-up|4|||
162924713|NCT01215955|588426099|FG002|Overall Study|Lost to Follow-up|8|||
162924714|NCT01215955|588426100|FG003|Overall Study|Lost to Follow-up|9|||
162924715|NCT01215955|588426097|FG000|Overall Study|Physician Decision|4|||
162924716|NCT01215955|588426098|FG001|Overall Study|Physician Decision|10|||
162924717|NCT01215955|588426099|FG002|Overall Study|Physician Decision|8|||
162924718|NCT01215955|588426100|FG003|Overall Study|Physician Decision|11|||
162924719|NCT01215955|588426097|FG000|Overall Study|Protocol Violation|17|||
162924720|NCT01215955|588426098|FG001|Overall Study|Protocol Violation|13|||
163327107|NCT01478594|589908625|FG000|Overall Study|Withdrawal by Subject|9|||
163327108|NCT01478594|589908626|FG001|Overall Study|Withdrawal by Subject|3|||
163327109|NCT01478594|589908625|FG000|Overall Study|Study Closed by Sponsor|8|||
163327110|NCT01478594|589908626|FG001|Overall Study|Study Closed by Sponsor|5|||
162924721|NCT01215955|588426099|FG002|Overall Study|Protocol Violation|8|||
162924722|NCT01215955|588426100|FG003|Overall Study|Protocol Violation|8|||
162924723|NCT01215955|588426097|FG000|Overall Study|Sponsor Decision|1|||
163327111|NCT01313884|589908628|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
163327112|NCT01970007|589908629|FG000|Overall Study|Death|5|||
162924724|NCT01215955|588426098|FG001|Overall Study|Sponsor Decision|2|||
162924725|NCT01215955|588426099|FG002|Overall Study|Sponsor Decision|0|||
162924726|NCT01215955|588426100|FG003|Overall Study|Sponsor Decision|1|||
163327113|NCT01970007|589908629|FG000|Overall Study|Withdrawal by Subject|23|||
163327114|NCT01970007|589908629|FG000|Overall Study|Lost to Follow-up|24|||
163327115|NCT01970007|589908629|FG000|Overall Study|"Other endpoint"|3|||
163327116|NCT04250194|589908633|FG000|Overall Study|Declined to schedule biopsy|6|||
163327117|NCT04250194|589908634|FG001|Overall Study|Declined to schedule biopsy|10|||
163327118|NCT04250194|589908633|FG000|Overall Study|Medically Unfit for Biopsy|2|||
163327119|NCT04250194|589908634|FG001|Overall Study|Medically Unfit for Biopsy|1|||
163327120|NCT04250194|589908633|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
163327121|NCT04250194|589908634|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
163327122|NCT04250194|589908633|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
163327123|NCT04250194|589908634|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
163327124|NCT04250194|589908633|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
163327125|NCT04250194|589908634|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
163327126|NCT00274261|589908635|FG000|Overall Study|Adverse Event|19|||
163327127|NCT00274261|589908636|FG001|Overall Study|Adverse Event|11|||
163327128|NCT00274261|589908635|FG000|Overall Study|Pregnancy|114|||
163327129|NCT00274261|589908636|FG001|Overall Study|Pregnancy|83|||
163327130|NCT00274261|589908635|FG000|Overall Study|Withdrawal by Subject|179|||
163327131|NCT00274261|589908636|FG001|Overall Study|Withdrawal by Subject|126|||
163327132|NCT00274261|589908635|FG000|Overall Study|Protocol Violation|71|||
163327133|NCT00274261|589908636|FG001|Overall Study|Protocol Violation|42|||
163327134|NCT00274261|589908635|FG000|Overall Study|Lost to Follow-up|106|||
163327135|NCT00274261|589908636|FG001|Overall Study|Lost to Follow-up|75|||
163327136|NCT03500549|589908637|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
163327137|NCT03500549|589908638|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
163327138|NCT03500549|589908637|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
163327139|NCT03500549|589908638|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
163327140|NCT02016872|589908641|FG000|Overall Study|Withdrawal by Subject|10|||
163327141|NCT02016872|589908641|FG000|Overall Study|Death Progression|2|||
163327142|NCT02016872|589908641|FG000|Overall Study|No FMISO scan|1|||
163327143|NCT02016872|589908641|FG000|Overall Study|Ineligible|2|||
163327144|NCT05018143|589908642|FG000|Overall Study|Lost to Follow-up|5|||
163327145|NCT05018143|589908643|FG001|Overall Study|Lost to Follow-up|4|||
163327146|NCT05018143|589908642|FG000|Overall Study|Withdrawal by Subject|0|||
163327147|NCT05018143|589908643|FG001|Overall Study|Withdrawal by Subject|1|||
163327148|NCT06688357|589908644|FG000|Overall Study|Adverse Event|0|||
163327149|NCT06688357|589908645|FG001|Overall Study|Adverse Event|1|||
163327150|NCT00545545|589908646|FG000|Overall Study|Progressive Neoplastic Disease|1|||
163327151|NCT00545545|589908647|FG001|Overall Study|Progressive Neoplastic Disease|5|||
163327152|NCT00545545|589908648|FG002|Overall Study|Progressive Neoplastic Disease|0|||
163327153|NCT00545545|589908649|FG003|Overall Study|Progressive Neoplastic Disease|4|||
163327154|NCT00545545|589908650|FG004|Overall Study|Progressive Neoplastic Disease|8|||
163327155|NCT00545545|589908651|FG005|Overall Study|Progressive Neoplastic Disease|7|||
163327156|NCT00545545|589908646|FG000|Overall Study|Withdrawal by Subject|0|||
163327157|NCT00545545|589908647|FG001|Overall Study|Withdrawal by Subject|1|||
163327158|NCT00545545|589908648|FG002|Overall Study|Withdrawal by Subject|0|||
163327159|NCT00545545|589908649|FG003|Overall Study|Withdrawal by Subject|0|||
163327160|NCT00545545|589908650|FG004|Overall Study|Withdrawal by Subject|0|||
163327161|NCT00545545|589908651|FG005|Overall Study|Withdrawal by Subject|0|||
163327162|NCT00545545|589908646|FG000|Overall Study|Physician Decision|1|||
163327163|NCT00545545|589908647|FG001|Overall Study|Physician Decision|0|||
163327164|NCT00545545|589908648|FG002|Overall Study|Physician Decision|0|||
163327165|NCT00545545|589908649|FG003|Overall Study|Physician Decision|0|||
163327166|NCT00545545|589908650|FG004|Overall Study|Physician Decision|0|||
163327167|NCT00545545|589908651|FG005|Overall Study|Physician Decision|1|||
163327168|NCT00545545|589908646|FG000|Overall Study|Irinotecan intolerance|1|||
163327169|NCT00545545|589908647|FG001|Overall Study|Irinotecan intolerance|1|||
163327170|NCT00545545|589908648|FG002|Overall Study|Irinotecan intolerance|0|||
163327171|NCT00545545|589908649|FG003|Overall Study|Irinotecan intolerance|0|||
163327172|NCT00545545|589908650|FG004|Overall Study|Irinotecan intolerance|0|||
163327173|NCT00545545|589908651|FG005|Overall Study|Irinotecan intolerance|0|||
163327174|NCT00545545|589908646|FG000|Overall Study|No target lesions to track post surgery|0|||
163327175|NCT00545545|589908647|FG001|Overall Study|No target lesions to track post surgery|0|||
163327176|NCT00545545|589908648|FG002|Overall Study|No target lesions to track post surgery|0|||
163061609|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
163061610|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
163061611|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
163327177|NCT00545545|589908649|FG003|Overall Study|No target lesions to track post surgery|0|||
163327178|NCT00545545|589908650|FG004|Overall Study|No target lesions to track post surgery|1|||
163327179|NCT00545545|589908651|FG005|Overall Study|No target lesions to track post surgery|1|||
163327180|NCT00227266|589908655|FG000|Overall Study|Withdrawal by Subject|0|||
163008941|NCT01836471|588734277|FG000|Overall Study|Non compliance with tx|1|||
163008942|NCT01836471|588734278|FG001|Overall Study|Non compliance with tx|1|||
163008943|NCT01836471|588734279|FG002|Overall Study|Non compliance with tx|0|||
163008944|NCT01836471|588734280|FG003|Overall Study|Non compliance with tx|0|||
163008945|NCT01836471|588734281|FG004|Overall Study|Non compliance with tx|0|||
163008946|NCT02570308|588734284|FG000|Overall Study|Death|1|||
163008947|NCT02570308|588734285|FG001|Overall Study|Death|5|||
163008948|NCT02570308|588734286|FG002|Overall Study|Death|4|||
163008949|NCT02570308|588734287|FG003|Overall Study|Death|4|||
163008950|NCT02570308|588734288|FG004|Overall Study|Death|69|||
163008951|NCT02570308|588734284|FG000|Overall Study|Lost to Follow-up|0|||
163008952|NCT02570308|588734285|FG001|Overall Study|Lost to Follow-up|0|||
163008953|NCT02570308|588734286|FG002|Overall Study|Lost to Follow-up|0|||
163008954|NCT02570308|588734287|FG003|Overall Study|Lost to Follow-up|0|||
163008955|NCT02570308|588734288|FG004|Overall Study|Lost to Follow-up|2|||
163008956|NCT02570308|588734284|FG000|Overall Study|Withdrawal by Subject|0|||
163008957|NCT02570308|588734285|FG001|Overall Study|Withdrawal by Subject|0|||
163008958|NCT02570308|588734286|FG002|Overall Study|Withdrawal by Subject|0|||
163008959|NCT02570308|588734287|FG003|Overall Study|Withdrawal by Subject|0|||
163008960|NCT02570308|588734288|FG004|Overall Study|Withdrawal by Subject|1|||
163008961|NCT02570308|588734284|FG000|Overall Study|Other|0|||
163008962|NCT02570308|588734285|FG001|Overall Study|Other|0|||
163008963|NCT02570308|588734286|FG002|Overall Study|Other|0|||
163008964|NCT02570308|588734287|FG003|Overall Study|Other|0|||
163008965|NCT02570308|588734288|FG004|Overall Study|Other|2|||
163008966|NCT01960413|588734289|FG000|Overall Study|Withdrawal by Subject|1|||
163008967|NCT01960413|588734290|FG001|Overall Study|Withdrawal by Subject|1|||
163008968|NCT01960413|588734289|FG000|Overall Study|Physician Decision|1|||
163008969|NCT01960413|588734290|FG001|Overall Study|Physician Decision|0|||
163008970|NCT01960413|588734289|FG000|Overall Study|Lost to Follow-up|2|||
163008971|NCT01960413|588734290|FG001|Overall Study|Lost to Follow-up|0|||
163008972|NCT02069015|588734291|FG000|Overall Study|Lost to Follow-up|39|||
163008973|NCT02069015|588734292|FG001|Overall Study|Lost to Follow-up|32|||
163008974|NCT02069015|588734291|FG000|Overall Study|Withdrawal by Subject|1|||
163008975|NCT02069015|588734292|FG001|Overall Study|Withdrawal by Subject|1|||
163008976|NCT02059135|588734293|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
163008977|NCT02059135|588734294|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
163008978|NCT02059135|588734293|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
163008979|NCT02059135|588734294|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
163008980|NCT02059135|588734293|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
163008981|NCT02059135|588734294|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
163008982|NCT02059135|588734293|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
163008983|NCT02059135|588734294|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
163008984|NCT02059135|588734293|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
163008985|NCT02059135|588734294|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
163008986|NCT02059135|588734293|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
163008987|NCT02059135|588734294|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
163008988|NCT02059135|588734293|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
163008989|NCT02059135|588734294|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
163008990|NCT02059135|588734293|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
163008991|NCT02059135|588734294|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
163008992|NCT05921903|588734299|FG000|Overall Study|Unsolicited non-SAE|0|||
163008993|NCT05921903|588734300|FG001|Overall Study|Unsolicited non-SAE|1|||
163008994|NCT05921903|588734301|FG002|Overall Study|Unsolicited non-SAE|0|||
163008995|NCT05921903|588734299|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
163008996|NCT05921903|588734300|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
163008997|NCT05921903|588734301|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
163008998|NCT05921903|588734299|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
163008999|NCT05921903|588734300|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
163009000|NCT05921903|588734301|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
163009001|NCT03305848|588734302|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
163009002|NCT03305848|588734302|FG000|Overall Study|Physician Decision|2|||
163009003|NCT02301169|588734304|FG000|Overall Study|Adverse Event|1|||
163009004|NCT02301169|588734305|FG001|Overall Study|Adverse Event|0|||
163009005|NCT03762265|588734306|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
163009006|NCT03762265|588734307|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
163009007|NCT03762265|588734306|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
163009008|NCT03762265|588734307|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
163009009|NCT03762265|588734306|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
163009010|NCT03762265|588734307|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
163009011|NCT03762265|588734306|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
163009012|NCT03762265|588734307|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
163009013|NCT03762265|588734306|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
163009014|NCT03762265|588734307|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
163009015|NCT03762265|588734306|FG000|BT Period: Weeks 1 to 37|Other|0|||
163009016|NCT03762265|588734307|FG001|BT Period: Weeks 1 to 37|Other|1|||
163009017|NCT03762265|588734306|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
163009018|NCT03762265|588734307|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
163009019|NCT03762265|588734306|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
163009020|NCT03762265|588734307|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
163009021|NCT03762265|588734306|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
163009022|NCT03762265|588734307|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
163009023|NCT03762265|588734306|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
163009024|NCT03762265|588734307|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
163009025|NCT03762265|588734306|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
163009026|NCT03762265|588734307|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
163009027|NCT03762265|588734306|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
163009028|NCT03762265|588734307|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
163009029|NCT03762265|588734306|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
163009030|NCT03762265|588734307|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
163327181|NCT00227266|589908656|FG001|Overall Study|Withdrawal by Subject|0|||
163327182|NCT00227266|589908657|FG002|Overall Study|Withdrawal by Subject|1|||
163327183|NCT00227266|589908655|FG000|Overall Study|Protocol Violation|1|||
163327184|NCT00227266|589908656|FG001|Overall Study|Protocol Violation|0|||
163327185|NCT00227266|589908657|FG002|Overall Study|Protocol Violation|1|||
163327186|NCT00227266|589908655|FG000|Overall Study|Excessive weight gain|0|||
163327187|NCT00227266|589908656|FG001|Overall Study|Excessive weight gain|0|||
163327188|NCT00227266|589908657|FG002|Overall Study|Excessive weight gain|2|||
163327189|NCT02761187|589908661|FG000|Overall Study|Too ill to Participate|13|||
163327190|NCT02761187|589908662|FG001|Overall Study|Too ill to Participate|8|||
163327191|NCT02761187|589908661|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
163327192|NCT02761187|589908662|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
163327193|NCT02761187|589908661|FG000|Overall Study|Patient withdrew consent|64|||
163327194|NCT02761187|589908662|FG001|Overall Study|Patient withdrew consent|58|||
163327195|NCT02761187|589908661|FG000|Overall Study|Physician discretion|4|||
163327196|NCT02761187|589908662|FG001|Overall Study|Physician discretion|8|||
163327197|NCT02761187|589908661|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
163327198|NCT02761187|589908662|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
163327199|NCT02761187|589908661|FG000|Overall Study|On Hospice|20|||
163327200|NCT02761187|589908662|FG001|Overall Study|On Hospice|26|||
163327201|NCT02761187|589908661|FG000|Overall Study|Deceased|474|||
163327202|NCT02761187|589908662|FG001|Overall Study|Deceased|642|||
163327203|NCT02761187|589908661|FG000|Overall Study|Lost to Follow-up|73|||
163327204|NCT02761187|589908662|FG001|Overall Study|Lost to Follow-up|63|||
163327205|NCT02761187|589908661|FG000|Overall Study|Due to study discontinued at site|100|||
163327206|NCT02761187|589908662|FG001|Overall Study|Due to study discontinued at site|85|||
163327207|NCT02761187|589908661|FG000|Overall Study|Reason not Specified|1484|||
163327208|NCT02761187|589908662|FG001|Overall Study|Reason not Specified|937|||
163327209|NCT05786612|589908665|FG000|Overall Study|Adverse Event|1|||
163327210|NCT05786612|589908666|FG001|Overall Study|Adverse Event|2|||
163327211|NCT05786612|589908665|FG000|Overall Study|one screening failure|0|||
163327212|NCT05786612|589908666|FG001|Overall Study|one screening failure|2|||
163327213|NCT05704725|589908671|FG000|Overall Study|Lost to Follow-up|0|||
163327214|NCT05704725|589908672|FG001|Overall Study|Lost to Follow-up|1|||
163327215|NCT05704725|589908671|FG000|Overall Study|Withdrawal by Subject|1|||
163327216|NCT05704725|589908672|FG001|Overall Study|Withdrawal by Subject|0|||
163327217|NCT01470144|589908673|FG000|Overall Study|Adverse Event|2|||
163327218|NCT01470144|589908673|FG000|Overall Study|Death|1|||
163327219|NCT01470144|589908673|FG000|Overall Study|Lung transplant|6|||
163327220|NCT01470144|589908673|FG000|Overall Study|Patient's and investigator's decision|1|||
163327221|NCT02798471|589908677|FG000|Overall Study|Adverse Event|7|||
163327222|NCT02798471|589908678|FG001|Overall Study|Adverse Event|2|||
163327223|NCT02798471|589908677|FG000|Overall Study|Physician Decision|3|||
163327224|NCT02798471|589908678|FG001|Overall Study|Physician Decision|7|||
163327225|NCT02798471|589908677|FG000|Overall Study|Death|2|||
163327226|NCT02798471|589908678|FG001|Overall Study|Death|3|||
163327227|NCT02798471|589908677|FG000|Overall Study|Lost to Follow-up|0|||
163327228|NCT02798471|589908678|FG001|Overall Study|Lost to Follow-up|1|||
163327229|NCT02798471|589908677|FG000|Overall Study|Other|5|||
163327230|NCT02798471|589908678|FG001|Overall Study|Other|3|||
163009031|NCT03762265|588734306|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
163009032|NCT03762265|588734307|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
163009033|NCT03762265|588734306|FG000|LTE Period: Weeks 61 to 109|Other|1|||
163009034|NCT03762265|588734307|FG001|LTE Period: Weeks 61 to 109|Other|0|||
163327231|NCT02798471|589908677|FG000|Overall Study|Subject withdrew consent|0|||
163327232|NCT02798471|589908678|FG001|Overall Study|Subject withdrew consent|6|||
163327233|NCT02798471|589908677|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
163327234|NCT02798471|589908678|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
163327235|NCT02798471|589908677|FG000|Overall Study|Randomized, but not treated|0|||
163327236|NCT02798471|589908678|FG001|Overall Study|Randomized, but not treated|2|||
163327237|NCT03752684|589909768|FG000|Overall Study|Lost to Follow-up|4|||
163327238|NCT00048932|589909771|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
163327239|NCT00048932|589909772|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
163327240|NCT00048932|589909773|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
163327241|NCT00048932|589909771|FG000|Double Blind Period (DB)|Adverse Event|51|||
163327242|NCT00048932|589909772|FG001|Double Blind Period (DB)|Adverse Event|19|||
163327243|NCT00048932|589909773|FG002|Double Blind Period (DB)|Adverse Event|0|||
163327244|NCT00048932|589909771|FG000|Double Blind Period (DB)|Death|5|||
163327245|NCT00048932|589909772|FG001|Double Blind Period (DB)|Death|3|||
163327246|NCT00048932|589909773|FG002|Double Blind Period (DB)|Death|0|||
163327247|NCT00048932|589909771|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
163327248|NCT00048932|589909772|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
163327249|NCT00048932|589909773|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
163327250|NCT00048932|589909771|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
163327251|NCT00048932|589909772|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
163327252|NCT00048932|589909773|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
163327253|NCT00048932|589909771|FG000|Double Blind Period (DB)|Relocation|1|||
163327254|NCT00048932|589909772|FG001|Double Blind Period (DB)|Relocation|0|||
163327255|NCT00048932|589909773|FG002|Double Blind Period (DB)|Relocation|0|||
163327256|NCT00048932|589909771|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
163327257|NCT00048932|589909772|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
163327258|NCT00048932|589909773|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
163327259|NCT00048932|589909771|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
163327260|NCT00048932|589909772|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
163327261|NCT00048932|589909773|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
163327262|NCT00048932|589909771|FG000|Double Blind Period (DB)|Pregnancy|1|||
163327263|NCT00048932|589909772|FG001|Double Blind Period (DB)|Pregnancy|0|||
163327264|NCT00048932|589909773|FG002|Double Blind Period (DB)|Pregnancy|0|||
163327265|NCT00048932|589909771|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
163327266|NCT00048932|589909772|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
163327267|NCT00048932|589909773|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
163327268|NCT00048932|589909771|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
163327269|NCT00048932|589909772|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
163327270|NCT00048932|589909773|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
163327271|NCT00048932|589909771|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
163327272|NCT00048932|589909772|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
163327273|NCT00048932|589909773|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
163327274|NCT00048932|589909771|FG000|Open Label Period (OL)|Death|0|||
163327275|NCT00048932|589909772|FG001|Open Label Period (OL)|Death|0|||
163327276|NCT00048932|589909773|FG002|Open Label Period (OL)|Death|25|||
163327277|NCT00048932|589909771|FG000|Open Label Period (OL)|Adverse Event|0|||
163327278|NCT00048932|589909772|FG001|Open Label Period (OL)|Adverse Event|0|||
163327279|NCT00048932|589909773|FG002|Open Label Period (OL)|Adverse Event|103|||
163327280|NCT00048932|589909771|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
163404467|NCT03246958|590191935|FG001|Overall Study|Over enrollment|2|||
163404468|NCT03246958|590191936|FG002|Overall Study|Over enrollment|0|||
163404469|NCT03246958|590191937|FG003|Overall Study|Over enrollment|0|||
163404470|NCT03246958|590191938|FG004|Overall Study|Over enrollment|0|||
163404471|NCT03246958|590191939|FG005|Overall Study|Over enrollment|0|||
163404472|NCT03246958|590191940|FG006|Overall Study|Over enrollment|0|||
163404473|NCT01650636|590191947|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
163009035|NCT00765102|588734308|FG000|Overall Study|Progressive disease|18|||
163009036|NCT00765102|588734308|FG000|Overall Study|Adverse Event|6|||
163009037|NCT00765102|588734308|FG000|Overall Study|Physician Decision|4|||
163009038|NCT00765102|588734308|FG000|Overall Study|Withdrawal by Subject|2|||
163009039|NCT00765102|588734308|FG000|Overall Study|Protocol Violation|1|||
163009040|NCT02289729|588734311|FG000|Overall Study|Lack of Efficacy|3|||
163009041|NCT02289729|588734311|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
163009042|NCT02289729|588734311|FG000|Overall Study|Withdrawal by Subject|1|||
163009043|NCT02289729|588734311|FG000|Overall Study|Death|1|||
163009044|NCT00470470|588734312|FG000|Overall Study|Adverse Event|2|||
163009045|NCT00470470|588734312|FG000|Overall Study|Death|2|||
163009046|NCT00470470|588734312|FG000|Overall Study|Not treated|1|||
163009047|NCT01149863|588734316|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
163009048|NCT02452476|588734321|FG000|Overall Study|Death|4|||
163009049|NCT02452476|588734322|FG001|Overall Study|Death|7|||
163009050|NCT02452476|588734321|FG000|Overall Study|Lost to Follow-up|1|||
163009051|NCT02452476|588734322|FG001|Overall Study|Lost to Follow-up|1|||
163009052|NCT02452476|588734321|FG000|Overall Study|Physician Decision|1|||
163009053|NCT02452476|588734322|FG001|Overall Study|Physician Decision|1|||
163061612|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
163061613|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
163061614|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
163061615|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
163061616|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
163061617|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
163061618|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
163061619|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
163061620|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
163061621|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
163061622|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
163061623|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
163061624|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
163061625|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
163061626|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
163061627|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
163061628|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
163061629|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
163061630|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
163061631|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
163061632|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
163061633|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
163061634|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
163061635|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
163061636|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
163061637|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
163061638|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
163061639|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
163061640|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
163061641|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
163061642|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
163061643|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
163061644|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
163061645|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
163061646|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
163061647|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
163061648|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
163061649|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
163061650|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
163061651|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
163061652|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
163061653|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
163061654|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
163061655|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
163061656|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
163061657|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
163061658|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
163061659|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
163061660|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
163213957|NCT01472081|589496075|FG003|Overall Study|Withdrawal by Subject|0|||
163213958|NCT01472081|589496076|FG004|Overall Study|Withdrawal by Subject|0|||
163213959|NCT01472081|589496077|FG005|Overall Study|Withdrawal by Subject|1|||
163213960|NCT01472081|589496072|FG000|Overall Study|Poor/non-compliance|0|||
163213961|NCT01472081|589496073|FG001|Overall Study|Poor/non-compliance|0|||
163213962|NCT01472081|589496074|FG002|Overall Study|Poor/non-compliance|1|||
163213963|NCT01472081|589496075|FG003|Overall Study|Poor/non-compliance|0|||
163213964|NCT01472081|589496076|FG004|Overall Study|Poor/non-compliance|1|||
163213965|NCT01472081|589496077|FG005|Overall Study|Poor/non-compliance|0|||
163213966|NCT01472081|589496072|FG000|Overall Study|No longer meets study criteria|0|||
163213967|NCT01472081|589496073|FG001|Overall Study|No longer meets study criteria|0|||
163213968|NCT01472081|589496074|FG002|Overall Study|No longer meets study criteria|1|||
163213969|NCT01472081|589496075|FG003|Overall Study|No longer meets study criteria|0|||
163213970|NCT01472081|589496076|FG004|Overall Study|No longer meets study criteria|0|||
163213971|NCT01472081|589496077|FG005|Overall Study|No longer meets study criteria|0|||
163213972|NCT01472081|589496072|FG000|Overall Study|Subject request to discontinue treatment|0|||
162924727|NCT01215955|588426097|FG000|Overall Study|Withdrawal by Subject|14|||
163327281|NCT00048932|589909772|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
163327282|NCT00048932|589909773|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
163327283|NCT00048932|589909771|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
163327284|NCT00048932|589909772|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
163327285|NCT00048932|589909773|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
163327286|NCT00048932|589909771|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
163327287|NCT00048932|589909772|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
163327288|NCT00048932|589909773|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
163327289|NCT00048932|589909771|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
163327290|NCT00048932|589909772|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
163327291|NCT00048932|589909773|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
163327292|NCT00048932|589909771|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
163327293|NCT00048932|589909772|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
163327294|NCT00048932|589909773|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
163327295|NCT00048932|589909771|FG000|Open Label Period (OL)|Pregnancy|0|||
163327296|NCT00048932|589909772|FG001|Open Label Period (OL)|Pregnancy|0|||
163327297|NCT00048932|589909773|FG002|Open Label Period (OL)|Pregnancy|6|||
163327298|NCT00048932|589909771|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
163327299|NCT00048932|589909772|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
163327300|NCT00048932|589909773|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
163327301|NCT00048932|589909771|FG000|Open Label Period (OL)|Investigator Retiring|0|||
163327302|NCT00048932|589909772|FG001|Open Label Period (OL)|Investigator Retiring|0|||
163327303|NCT00048932|589909773|FG002|Open Label Period (OL)|Investigator Retiring|2|||
163327304|NCT00048932|589909771|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
163327305|NCT00048932|589909772|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
163327306|NCT00048932|589909773|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
163327307|NCT00048932|589909771|FG000|Open Label Period (OL)|Participant Relocated|0|||
163327308|NCT00048932|589909772|FG001|Open Label Period (OL)|Participant Relocated|0|||
163327309|NCT00048932|589909773|FG002|Open Label Period (OL)|Participant Relocated|6|||
163327310|NCT00048932|589909771|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
163327311|NCT00048932|589909772|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
163327312|NCT00048932|589909773|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
163327313|NCT00048932|589909771|FG000|Open Label Period (OL)|Site Closure|0|||
163327314|NCT00048932|589909772|FG001|Open Label Period (OL)|Site Closure|0|||
163327315|NCT00048932|589909773|FG002|Open Label Period (OL)|Site Closure|3|||
163327316|NCT00048932|589909771|FG000|Open Label Period (OL)|Trial Terminated|0|||
163327317|NCT00048932|589909772|FG001|Open Label Period (OL)|Trial Terminated|0|||
163327318|NCT00048932|589909773|FG002|Open Label Period (OL)|Trial Terminated|1|||
163327319|NCT00048932|589909771|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
163327320|NCT00048932|589909772|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
163327321|NCT00048932|589909773|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
163327322|NCT00048932|589909771|FG000|Open Label Period (OL)|Patient Decision|0|||
163327323|NCT00048932|589909772|FG001|Open Label Period (OL)|Patient Decision|0|||
163327324|NCT00048932|589909773|FG002|Open Label Period (OL)|Patient Decision|4|||
163327325|NCT00048932|589909771|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
163327326|NCT00048932|589909772|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
163327327|NCT00048932|589909773|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
163327328|NCT00048932|589909771|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
163327329|NCT00048932|589909772|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
163327330|NCT00048932|589909773|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
163327331|NCT00048932|589909771|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
163327332|NCT00048932|589909772|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
163327333|NCT00048932|589909773|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
163327334|NCT00048932|589909771|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
163327335|NCT00048932|589909772|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
163327336|NCT00048932|589909773|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
163327337|NCT00048932|589909771|FG000|Open Label Period (OL)|Investigator Decision|0|||
163327338|NCT00048932|589909772|FG001|Open Label Period (OL)|Investigator Decision|0|||
163009054|NCT02452476|588734321|FG000|Overall Study|Not treated|5|||
163009055|NCT02452476|588734322|FG001|Overall Study|Not treated|1|||
163327339|NCT00048932|589909773|FG002|Open Label Period (OL)|Investigator Decision|4|||
163327340|NCT00048932|589909771|FG000|Open Label Period (OL)|Site Staff Issues|0|||
163327341|NCT00048932|589909772|FG001|Open Label Period (OL)|Site Staff Issues|0|||
163009056|NCT01408043|588734323|FG000|Overall Study|unable to collect cells|1|||
163009057|NCT00946920|588734324|FG000|Overall Study|Withdrawal by Subject|28|||
163009058|NCT00946920|588734325|FG001|Overall Study|Withdrawal by Subject|15|||
163327342|NCT00048932|589909773|FG002|Open Label Period (OL)|Site Staff Issues|2|||
163009059|NCT00946920|588734324|FG000|Overall Study|Lost to Follow-up|2|||
163009060|NCT00946920|588734325|FG001|Overall Study|Lost to Follow-up|2|||
163009061|NCT00946920|588734324|FG000|Overall Study|Physician Decision|5|||
163061661|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
163061662|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
163061663|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
163061664|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
163061665|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
163061666|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
163061667|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
163061668|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
163061669|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
163061670|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
163327343|NCT00048932|589909771|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
163327344|NCT00048932|589909772|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
163327345|NCT00048932|589909773|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
163327346|NCT00048932|589909771|FG000|Open Label Period (OL)|Participant Surgery|0|||
163327347|NCT00048932|589909772|FG001|Open Label Period (OL)|Participant Surgery|0|||
163327348|NCT00048932|589909773|FG002|Open Label Period (OL)|Participant Surgery|1|||
163327349|NCT04213807|589909776|FG000|Overall Study|Physician Decision|0|||
163327350|NCT04213807|589909777|FG001|Overall Study|Physician Decision|0|||
163327351|NCT04213807|589909778|FG002|Overall Study|Physician Decision|1|||
163327352|NCT03418922|589909779|FG000|Overall Study|Withdrawal by Subject|0|||
163327353|NCT03418922|589909780|FG001|Overall Study|Withdrawal by Subject|2|||
163327354|NCT03418922|589909779|FG000|Overall Study|Adverse Event|2|||
163327355|NCT03418922|589909780|FG001|Overall Study|Adverse Event|2|||
163327356|NCT03418922|589909779|FG000|Overall Study|Death|0|||
163327357|NCT03418922|589909780|FG001|Overall Study|Death|1|||
163327358|NCT03418922|589909779|FG000|Overall Study|Physician Decision|0|||
163327359|NCT03418922|589909780|FG001|Overall Study|Physician Decision|1|||
163327360|NCT03451422|589909781|FG000|Overall Study|Lost to Follow-up|0|||
163327361|NCT03451422|589909782|FG001|Overall Study|Lost to Follow-up|0|||
163327362|NCT03451422|589909783|FG002|Overall Study|Lost to Follow-up|0|||
163327363|NCT03451422|589909784|FG003|Overall Study|Lost to Follow-up|0|||
163327364|NCT03451422|589909785|FG004|Overall Study|Lost to Follow-up|0|||
163327365|NCT03451422|589909786|FG005|Overall Study|Lost to Follow-up|1|||
163327366|NCT03451422|589909781|FG000|Overall Study|Decision by sponsor|1|||
163327367|NCT03451422|589909782|FG001|Overall Study|Decision by sponsor|0|||
163327368|NCT03451422|589909783|FG002|Overall Study|Decision by sponsor|1|||
163327369|NCT03451422|589909784|FG003|Overall Study|Decision by sponsor|0|||
163327370|NCT03451422|589909785|FG004|Overall Study|Decision by sponsor|0|||
163327371|NCT03451422|589909786|FG005|Overall Study|Decision by sponsor|0|||
163327372|NCT03451422|589909781|FG000|Overall Study|Withdrawal by Subject|0|||
163327373|NCT03451422|589909782|FG001|Overall Study|Withdrawal by Subject|0|||
163327374|NCT03451422|589909783|FG002|Overall Study|Withdrawal by Subject|2|||
163327375|NCT03451422|589909784|FG003|Overall Study|Withdrawal by Subject|3|||
163327376|NCT03451422|589909785|FG004|Overall Study|Withdrawal by Subject|2|||
163327377|NCT03451422|589909786|FG005|Overall Study|Withdrawal by Subject|1|||
163327378|NCT02347332|589909787|FG000|Overall Study|Not treated|5|||
163327379|NCT02347332|589909788|FG001|Overall Study|Not treated|2|||
163327380|NCT02347332|589909787|FG000|Overall Study|Progressive disease|141|||
163327381|NCT02347332|589909788|FG001|Overall Study|Progressive disease|159|||
163327382|NCT02347332|589909787|FG000|Overall Study|Adverse Event|50|||
163327383|NCT02347332|589909788|FG001|Overall Study|Adverse Event|41|||
163327384|NCT02347332|589909787|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
163327385|NCT02347332|589909788|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
163327386|NCT02347332|589909787|FG000|Overall Study|Protocol Violation|1|||
163327387|NCT02347332|589909788|FG001|Overall Study|Protocol Violation|1|||
163327388|NCT02347332|589909787|FG000|Overall Study|Lost to Follow-up|2|||
163061671|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
163327389|NCT02347332|589909788|FG001|Overall Study|Lost to Follow-up|1|||
163327390|NCT02347332|589909787|FG000|Overall Study|Physician Decision|4|||
163327391|NCT02347332|589909788|FG001|Overall Study|Physician Decision|3|||
163327392|NCT02347332|589909787|FG000|Overall Study|Withdrawal by Subject|20|||
163327393|NCT02347332|589909788|FG001|Overall Study|Withdrawal by Subject|14|||
163327394|NCT02347332|589909787|FG000|Overall Study|Protocol requirement|1|||
163061672|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
163061673|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
163061674|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
163327395|NCT02347332|589909788|FG001|Overall Study|Protocol requirement|1|||
163327396|NCT02347332|589909787|FG000|Overall Study|Switch Post-Trial program|0|||
163327397|NCT02347332|589909788|FG001|Overall Study|Switch Post-Trial program|1|||
163327398|NCT04384172|589909790|FG000|Overall Study|Lost to Follow-up|0|||
163327399|NCT04384172|589909791|FG001|Overall Study|Lost to Follow-up|2|||
163327400|NCT04384172|589909790|FG000|Overall Study|Pregnancy|1|||
163404474|NCT01650636|590191948|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
163404475|NCT01650636|590191947|FG000|Washout up to 5 Months|Physician Decision|2|||
163404476|NCT01650636|590191948|FG001|Washout up to 5 Months|Physician Decision|2|||
163009062|NCT00946920|588734325|FG001|Overall Study|Physician Decision|2|||
163009063|NCT00946920|588734324|FG000|Overall Study|Adverse Event|41|||
163009064|NCT00946920|588734325|FG001|Overall Study|Adverse Event|14|||
163009065|NCT00946920|588734324|FG000|Overall Study|Protocol Violation|16|||
163213973|NCT01472081|589496073|FG001|Overall Study|Subject request to discontinue treatment|3|||
163213974|NCT01472081|589496074|FG002|Overall Study|Subject request to discontinue treatment|1|||
163213975|NCT01472081|589496075|FG003|Overall Study|Subject request to discontinue treatment|1|||
163009066|NCT00946920|588734325|FG001|Overall Study|Protocol Violation|8|||
163009067|NCT00946920|588734324|FG000|Overall Study|Miscellaneous reasons|18|||
163009068|NCT00946920|588734325|FG001|Overall Study|Miscellaneous reasons|3|||
163009069|NCT00397514|588734326|FG000|Overall Study|Withdrawal by Subject|1|||
163009070|NCT00397514|588734326|FG000|Overall Study|Pacing wire malfunction|1|||
163009071|NCT00397514|588734326|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
163009072|NCT00397514|588734326|FG000|Overall Study|early extubation|2|||
163009073|NCT00397514|588734326|FG000|Overall Study|poor echocardiographic windows|1|||
163009074|NCT05373108|588734327|FG000|Overall Study|Withdrawal by Subject|2|||
163009075|NCT02892331|588734329|FG000|Overall Study|Withdrawal by Subject|0|||
163009076|NCT02892331|588734330|FG001|Overall Study|Withdrawal by Subject|1|||
163009077|NCT02892331|588734331|FG002|Overall Study|Withdrawal by Subject|1|||
163009078|NCT02892331|588734329|FG000|Overall Study|Sick family member|0|||
163009079|NCT02892331|588734330|FG001|Overall Study|Sick family member|0|||
163009080|NCT02892331|588734331|FG002|Overall Study|Sick family member|1|||
163009081|NCT02892331|588734329|FG000|Overall Study|Corona virus pandemic|1|||
163009082|NCT02892331|588734330|FG001|Overall Study|Corona virus pandemic|0|||
163009083|NCT02892331|588734331|FG002|Overall Study|Corona virus pandemic|1|||
163009084|NCT02892331|588734329|FG000|Overall Study|Lost to Follow-up|1|||
163009085|NCT02892331|588734330|FG001|Overall Study|Lost to Follow-up|0|||
163009086|NCT02892331|588734331|FG002|Overall Study|Lost to Follow-up|1|||
163009087|NCT02892331|588734329|FG000|Overall Study|Blood pressure was too elevated|0|||
163009088|NCT02892331|588734330|FG001|Overall Study|Blood pressure was too elevated|1|||
163009089|NCT02892331|588734331|FG002|Overall Study|Blood pressure was too elevated|0|||
163009090|NCT02892331|588734329|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
163009091|NCT02892331|588734330|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
163009092|NCT02892331|588734331|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
163009093|NCT02654054|588734336|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
163009094|NCT02654054|588734337|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
163009095|NCT02654054|588734338|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
163009096|NCT02654054|588734336|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
163009097|NCT02654054|588734337|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163009098|NCT02654054|588734338|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
163009099|NCT02654054|588734336|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
163009100|NCT02654054|588734337|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
163009101|NCT02654054|588734338|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
163009102|NCT02654054|588734336|FG000|Post-Treatment Follow-Up Period|Other|1|||
163009103|NCT02654054|588734337|FG001|Post-Treatment Follow-Up Period|Other|0|||
163213976|NCT01472081|589496076|FG004|Overall Study|Subject request to discontinue treatment|0|||
163213977|NCT01472081|589496077|FG005|Overall Study|Subject request to discontinue treatment|0|||
163213978|NCT04702997|589496078|FG000|Overall Study|Withdrawal by Subject|1|||
163213979|NCT04702997|589496079|FG001|Overall Study|Withdrawal by Subject|1|||
163213980|NCT03915496|589496080|FG000|Overall Study|Adverse Event|2|||
163213981|NCT03915496|589496081|FG001|Overall Study|Adverse Event|1|||
163213982|NCT03915496|589496082|FG002|Overall Study|Adverse Event|2|||
163213983|NCT02759471|589496083|FG000|Overall Study|discomfort|2|||
163213984|NCT01103284|589496084|FG000|Overall Study|Death|2|||
163213985|NCT01103284|589496085|FG001|Overall Study|Death|0|||
163213986|NCT01103284|589496084|FG000|Overall Study|Lost to Follow-up|9|||
163327401|NCT04384172|589909791|FG001|Overall Study|Pregnancy|0|||
163327402|NCT04384172|589909790|FG000|Overall Study|Withdrawal by Subject|0|||
163009104|NCT02654054|588734338|FG002|Post-Treatment Follow-Up Period|Other|4|||
163009105|NCT02654054|588734336|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
163009106|NCT02654054|588734337|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
163009107|NCT02654054|588734338|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
163061675|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
163213987|NCT01103284|589496085|FG001|Overall Study|Lost to Follow-up|10|||
163213988|NCT01103284|589496084|FG000|Overall Study|Pregnancy|3|||
163213989|NCT01103284|589496085|FG001|Overall Study|Pregnancy|1|||
163213990|NCT01103284|589496084|FG000|Overall Study|Protocol Violation|12|||
163213991|NCT01103284|589496085|FG001|Overall Study|Protocol Violation|5|||
163213992|NCT01103284|589496084|FG000|Overall Study|Adverse Event|0|||
163327403|NCT04384172|589909791|FG001|Overall Study|Withdrawal by Subject|1|||
163213993|NCT01103284|589496085|FG001|Overall Study|Adverse Event|5|||
163213994|NCT01103284|589496084|FG000|Overall Study|Withdrawal by Subject|14|||
163327404|NCT04860505|589909792|FG000|Overall Study|Lost to Follow-up|2|||
163213995|NCT01103284|589496085|FG001|Overall Study|Withdrawal by Subject|18|||
163213996|NCT01103284|589496084|FG000|Overall Study|Dermal Hypersensitivity|0|||
163213997|NCT01103284|589496085|FG001|Overall Study|Dermal Hypersensitivity|1|||
163213998|NCT01103284|589496084|FG000|Overall Study|Termination by the Sponsor|0|||
163213999|NCT01103284|589496085|FG001|Overall Study|Termination by the Sponsor|1|||
163214000|NCT01103284|589496084|FG000|Overall Study|Not described|2|||
163214001|NCT01103284|589496085|FG001|Overall Study|Not described|1|||
163214002|NCT01103284|589496084|FG000|Overall Study|Missing CRF entries for study completion|0|||
163214003|NCT01103284|589496085|FG001|Overall Study|Missing CRF entries for study completion|2|||
163009108|NCT04871776|588734339|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
163009109|NCT04871776|588734340|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
163009110|NCT04871776|588734341|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
163009111|NCT04871776|588734339|FG000|Overall Study|Did not meet eligibility criteria|1|||
163009112|NCT04871776|588734340|FG001|Overall Study|Did not meet eligibility criteria|1|||
163009113|NCT04871776|588734341|FG002|Overall Study|Did not meet eligibility criteria|1|||
163009114|NCT06389487|588734346|FG000|Overall Study|Lost to Follow-up|9|||
163009115|NCT06389487|588734347|FG001|Overall Study|Lost to Follow-up|5|||
163009116|NCT06389487|588734348|FG002|Overall Study|Lost to Follow-up|13|||
163009117|NCT06389487|588734346|FG000|Overall Study|Protocol Violation|0|||
163009118|NCT06389487|588734347|FG001|Overall Study|Protocol Violation|0|||
163009119|NCT06389487|588734348|FG002|Overall Study|Protocol Violation|2|||
163009120|NCT06389487|588734346|FG000|Overall Study|Withdrawal by Subject|2|||
163214004|NCT03712904|589497620|FG000|Overall Study|Death|0|||
163214005|NCT03712904|589497621|FG001|Overall Study|Death|1|||
163214006|NCT03712904|589497620|FG000|Overall Study|Withdrawal by Subject|0|||
163214007|NCT03712904|589497621|FG001|Overall Study|Withdrawal by Subject|1|||
163214008|NCT03712904|589497620|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
163214009|NCT03712904|589497621|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
163009121|NCT06389487|588734347|FG001|Overall Study|Withdrawal by Subject|2|||
163009122|NCT06389487|588734348|FG002|Overall Study|Withdrawal by Subject|1|||
163009123|NCT06389487|588734346|FG000|Overall Study|Other|1|||
163009124|NCT06389487|588734347|FG001|Overall Study|Other|0|||
163009125|NCT06389487|588734348|FG002|Overall Study|Other|1|||
163009126|NCT05423093|588736219|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
163009127|NCT05423093|588736219|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
163009128|NCT05423093|588736219|FG000|Attended Intervention Session|Lost to Follow-up|3|||
163009129|NCT05423093|588736219|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
163009130|NCT05423093|588736219|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
163009131|NCT03593525|588736220|FG000|Overall Study|Withdrawal by Subject|1|||
163009132|NCT03593525|588736221|FG001|Overall Study|Withdrawal by Subject|0|||
163009133|NCT03593525|588736220|FG000|Overall Study|Lost to Follow-up|7|||
163009134|NCT03593525|588736221|FG001|Overall Study|Lost to Follow-up|5|||
163009135|NCT00210210|588736229|FG000|Overall Study|Withdrawal by Subject|3|||
163009136|NCT00210210|588736230|FG001|Overall Study|Withdrawal by Subject|2|||
163009137|NCT00210210|588736229|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
163009138|NCT00210210|588736230|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
163009139|NCT02502149|588736235|FG000|Intermediate|Discontinued prematurely|1|||
163009140|NCT02502149|588736236|FG001|Intermediate|Discontinued prematurely|0|||
163009141|NCT02502149|588736237|FG002|Intermediate|Discontinued prematurely|0|||
163009142|NCT02502149|588736238|FG003|Intermediate|Discontinued prematurely|0|||
163009143|NCT02502149|588736239|FG004|Intermediate|Discontinued prematurely|0|||
163009144|NCT04067050|588736247|FG000|One Month|Lost to Follow-up|4|||
163009145|NCT04067050|588736248|FG001|One Month|Lost to Follow-up|0|||
163009146|NCT04067050|588736247|FG000|Two Month|Lost to Follow-up|1|||
163009147|NCT04067050|588736248|FG001|Two Month|Lost to Follow-up|0|||
163009148|NCT04067050|588736247|FG000|Two Month|Adverse Event|1|||
163009149|NCT04067050|588736248|FG001|Two Month|Adverse Event|0|||
163009150|NCT02383017|588736256|FG000|Overall Study|Injury Sustained Outside Study|1|||
163214010|NCT03745937|589497622|FG000|Overall Study|Withdrawal by Subject|0|||
163009151|NCT02383017|588736257|FG001|Overall Study|Injury Sustained Outside Study|0|||
163009152|NCT02383017|588736256|FG000|Overall Study|Compliance|3|||
163009153|NCT02383017|588736257|FG001|Overall Study|Compliance|2|||
163214011|NCT03745937|589497623|FG001|Overall Study|Withdrawal by Subject|0|||
163214012|NCT03745937|589497624|FG002|Overall Study|Withdrawal by Subject|0|||
163214013|NCT03745937|589497625|FG003|Overall Study|Withdrawal by Subject|1|||
163214014|NCT03745937|589497622|FG000|Overall Study|Not-specifed|0|||
163214015|NCT03745937|589497623|FG001|Overall Study|Not-specifed|1|||
163214016|NCT03745937|589497624|FG002|Overall Study|Not-specifed|0|||
163214017|NCT03745937|589497625|FG003|Overall Study|Not-specifed|1|||
163009154|NCT02383017|588736256|FG000|Overall Study|Found to be Hypogonadal|1|||
163009155|NCT02383017|588736257|FG001|Overall Study|Found to be Hypogonadal|0|||
163009156|NCT03871543|588736265|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
163009157|NCT03871543|588736265|FG000|Period 1|Investigator Error|1|||
163404477|NCT01650636|590191947|FG000|Washout up to 5 Months|Death|1|||
163009158|NCT03871543|588736265|FG000|Period 1|Protocol Violation|2|||
163009159|NCT03871543|588736265|FG000|Period 1|COVID-19 Related|1|||
163009160|NCT03871543|588736265|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
163009161|NCT03871543|588736265|FG000|Period 1|Withdrawal by Subject|10|||
163009162|NCT03871543|588736265|FG000|Period 2|Adverse Event|1|||
163009163|NCT03871543|588736265|FG000|Period 2|Withdrawal by Subject|1|||
163009164|NCT01894919|588736266|FG000|Overall Study|Withdrawal by Subject|1|||
163009165|NCT01894919|588736267|FG001|Overall Study|Withdrawal by Subject|0|||
163009166|NCT01894919|588736268|FG002|Overall Study|Withdrawal by Subject|0|||
163009167|NCT01894919|588736269|FG003|Overall Study|Withdrawal by Subject|0|||
163009168|NCT01894919|588736270|FG004|Overall Study|Withdrawal by Subject|1|||
163009169|NCT01894919|588736271|FG005|Overall Study|Withdrawal by Subject|0|||
163009170|NCT01894919|588736272|FG006|Overall Study|Withdrawal by Subject|0|||
163009171|NCT01894919|588736273|FG007|Overall Study|Withdrawal by Subject|0|||
163009172|NCT01894919|588736274|FG008|Overall Study|Withdrawal by Subject|0|||
163009173|NCT01894919|588736275|FG009|Overall Study|Withdrawal by Subject|1|||
163009174|NCT01894919|588736276|FG010|Overall Study|Withdrawal by Subject|1|||
163009175|NCT01894919|588736277|FG011|Overall Study|Withdrawal by Subject|0|||
163009176|NCT01894919|588736278|FG012|Overall Study|Withdrawal by Subject|0|||
163009177|NCT01894919|588736266|FG000|Overall Study|Adverse Event|0|||
163009178|NCT01894919|588736267|FG001|Overall Study|Adverse Event|0|||
163009179|NCT01894919|588736268|FG002|Overall Study|Adverse Event|0|||
163009180|NCT01894919|588736269|FG003|Overall Study|Adverse Event|0|||
163009181|NCT01894919|588736270|FG004|Overall Study|Adverse Event|0|||
163009182|NCT01894919|588736271|FG005|Overall Study|Adverse Event|0|||
163009183|NCT01894919|588736272|FG006|Overall Study|Adverse Event|0|||
163009184|NCT01894919|588736273|FG007|Overall Study|Adverse Event|0|||
163009185|NCT01894919|588736274|FG008|Overall Study|Adverse Event|0|||
163009186|NCT01894919|588736275|FG009|Overall Study|Adverse Event|0|||
163009187|NCT01894919|588736276|FG010|Overall Study|Adverse Event|1|||
163009188|NCT01894919|588736277|FG011|Overall Study|Adverse Event|0|||
163009189|NCT01894919|588736278|FG012|Overall Study|Adverse Event|0|||
163009190|NCT01894919|588736266|FG000|Overall Study|Other-Unspecified|1|||
163009191|NCT01894919|588736267|FG001|Overall Study|Other-Unspecified|0|||
163009192|NCT01894919|588736268|FG002|Overall Study|Other-Unspecified|0|||
163009193|NCT01894919|588736269|FG003|Overall Study|Other-Unspecified|0|||
163009194|NCT01894919|588736270|FG004|Overall Study|Other-Unspecified|0|||
163009195|NCT01894919|588736271|FG005|Overall Study|Other-Unspecified|0|||
163009196|NCT01894919|588736272|FG006|Overall Study|Other-Unspecified|0|||
163009197|NCT01894919|588736273|FG007|Overall Study|Other-Unspecified|0|||
163009198|NCT01894919|588736274|FG008|Overall Study|Other-Unspecified|0|||
163009199|NCT01894919|588736275|FG009|Overall Study|Other-Unspecified|0|||
163009200|NCT01894919|588736276|FG010|Overall Study|Other-Unspecified|0|||
163009201|NCT01894919|588736277|FG011|Overall Study|Other-Unspecified|0|||
163214018|NCT01190254|589497628|FG000|Overall Study|Adverse Event|3|||
163214019|NCT01190254|589497629|FG001|Overall Study|Adverse Event|6|||
163214020|NCT01190254|589497630|FG002|Overall Study|Adverse Event|8|||
163214021|NCT01190254|589497628|FG000|Overall Study|Lack of Efficacy|7|||
163214022|NCT01190254|589497629|FG001|Overall Study|Lack of Efficacy|4|||
163214023|NCT01190254|589497630|FG002|Overall Study|Lack of Efficacy|5|||
163214024|NCT01190254|589497628|FG000|Overall Study|Lost to Follow-up|4|||
163214025|NCT01190254|589497629|FG001|Overall Study|Lost to Follow-up|2|||
163214026|NCT01190254|589497630|FG002|Overall Study|Lost to Follow-up|0|||
163214027|NCT01190254|589497628|FG000|Overall Study|Withdrawal by Subject|4|||
163214028|NCT01190254|589497629|FG001|Overall Study|Withdrawal by Subject|5|||
163214029|NCT01190254|589497630|FG002|Overall Study|Withdrawal by Subject|7|||
163214030|NCT01190254|589497628|FG000|Overall Study|Protocol Violation|2|||
163214031|NCT01190254|589497629|FG001|Overall Study|Protocol Violation|0|||
163214032|NCT01190254|589497630|FG002|Overall Study|Protocol Violation|2|||
163214033|NCT01190254|589497628|FG000|Overall Study|Did not meet protocol eligibility|1|||
163214034|NCT01190254|589497629|FG001|Overall Study|Did not meet protocol eligibility|0|||
163214035|NCT01190254|589497630|FG002|Overall Study|Did not meet protocol eligibility|0|||
163214036|NCT02356783|589497631|FG000|Overall Study|Lost to Follow-up|1|||
163214037|NCT02356783|589497632|FG001|Overall Study|Lost to Follow-up|3|||
163214038|NCT01485640|589497633|FG000|Overall Study|Adverse Event|10|||
163214039|NCT01485640|589497633|FG000|Overall Study|Lack of Efficacy|2|||
163214040|NCT01485640|589497633|FG000|Overall Study|Protocol Violation|1|||
163214041|NCT01485640|589497633|FG000|Overall Study|Withdrawal by Subject|14|||
163214042|NCT01485640|589497633|FG000|Overall Study|Terminated by Sponsor|95|||
163214043|NCT00202644|589497636|FG000|Overall Study|Adverse Event|12|||
163214044|NCT00202644|589497637|FG001|Overall Study|Adverse Event|13|||
163214045|NCT00202644|589497636|FG000|Overall Study|Withdrawal by Subject|8|||
163214046|NCT00202644|589497637|FG001|Overall Study|Withdrawal by Subject|6|||
163214047|NCT00202644|589497636|FG000|Overall Study|Lack of Efficacy|6|||
163214048|NCT00202644|589497637|FG001|Overall Study|Lack of Efficacy|6|||
163214049|NCT00202644|589497636|FG000|Overall Study|Lost to Follow-up|0|||
163214050|NCT00202644|589497637|FG001|Overall Study|Lost to Follow-up|1|||
163214051|NCT00202644|589497636|FG000|Overall Study|Other|9|||
163009202|NCT01894919|588736278|FG012|Overall Study|Other-Unspecified|0|||
163009203|NCT01894919|588736266|FG000|Overall Study|Lost to Follow-up|0|||
163009204|NCT01894919|588736267|FG001|Overall Study|Lost to Follow-up|0|||
163009205|NCT01894919|588736268|FG002|Overall Study|Lost to Follow-up|0|||
163009206|NCT01894919|588736269|FG003|Overall Study|Lost to Follow-up|0|||
163009207|NCT01894919|588736270|FG004|Overall Study|Lost to Follow-up|2|||
163009208|NCT01894919|588736271|FG005|Overall Study|Lost to Follow-up|0|||
163009209|NCT01894919|588736272|FG006|Overall Study|Lost to Follow-up|0|||
163009210|NCT01894919|588736273|FG007|Overall Study|Lost to Follow-up|0|||
163009211|NCT01894919|588736274|FG008|Overall Study|Lost to Follow-up|0|||
163009212|NCT01894919|588736275|FG009|Overall Study|Lost to Follow-up|0|||
163009213|NCT01894919|588736276|FG010|Overall Study|Lost to Follow-up|0|||
163009214|NCT01894919|588736277|FG011|Overall Study|Lost to Follow-up|0|||
163009215|NCT01894919|588736278|FG012|Overall Study|Lost to Follow-up|0|||
163009216|NCT03711188|588736279|FG000|Overall Study|Disease progression|11|||
163009217|NCT03711188|588736279|FG000|Overall Study|Adverse Event|1|||
163009218|NCT03534687|588736282|FG000|Overall Study|Lost to Follow-up|7|||
163009219|NCT03534687|588736283|FG001|Overall Study|Lost to Follow-up|2|||
163009220|NCT00314340|588736285|FG000|Overall Study|lost interest|1|||
163009221|NCT00957801|588736286|FG000|Overall Study|Withdrawal by Subject|0|||
163009222|NCT00957801|588736287|FG001|Overall Study|Withdrawal by Subject|0|||
163009223|NCT00957801|588736288|FG002|Overall Study|Withdrawal by Subject|0|||
163009224|NCT00957801|588736289|FG003|Overall Study|Withdrawal by Subject|1|||
163009225|NCT01283464|588736290|FG000|Overall Study|Lost to Follow-up|0|||
163009226|NCT01283464|588736291|FG001|Overall Study|Lost to Follow-up|1|||
163009227|NCT01283464|588736290|FG000|Overall Study|Withdrawal by Subject|1|||
163009228|NCT01283464|588736291|FG001|Overall Study|Withdrawal by Subject|0|||
163009229|NCT01283464|588736290|FG000|Overall Study|Physician Decision|1|||
163009230|NCT01283464|588736291|FG001|Overall Study|Physician Decision|0|||
163009231|NCT03051100|588736293|FG000|Overall Study|Withdrawal by Subject|1|||
163009232|NCT03051100|588736294|FG001|Overall Study|Withdrawal by Subject|0|||
163009233|NCT02626026|588736295|FG000|Overall Study|Randomized but Never Treated|0|||
163009234|NCT02626026|588736296|FG001|Overall Study|Randomized but Never Treated|0|||
163009235|NCT02626026|588736297|FG002|Overall Study|Randomized but Never Treated|0|||
163009236|NCT02626026|588736298|FG003|Overall Study|Randomized but Never Treated|0|||
163009237|NCT02626026|588736299|FG004|Overall Study|Randomized but Never Treated|1|||
163009238|NCT02626026|588736300|FG005|Overall Study|Randomized but Never Treated|0|||
163009239|NCT01778855|588736301|FG000|Overall Study|Death|0|||
163009240|NCT01778855|588736302|FG001|Overall Study|Death|1|||
163009241|NCT01286467|588736305|FG000|Overall Study|Death|1|||
163009242|NCT01286467|588736306|FG001|Overall Study|Death|1|||
163009243|NCT01286467|588736307|FG002|Overall Study|Death|1|||
163009244|NCT01286467|588736308|FG003|Overall Study|Death|0|||
163009245|NCT01286467|588736305|FG000|Overall Study|Lost to Follow-up|0|||
163009246|NCT01286467|588736306|FG001|Overall Study|Lost to Follow-up|0|||
163009247|NCT01286467|588736307|FG002|Overall Study|Lost to Follow-up|0|||
163009248|NCT01286467|588736308|FG003|Overall Study|Lost to Follow-up|1|||
163009249|NCT01286467|588736305|FG000|Overall Study|Withdrawal by Subject|0|||
163009250|NCT01286467|588736306|FG001|Overall Study|Withdrawal by Subject|0|||
163009251|NCT01286467|588736307|FG002|Overall Study|Withdrawal by Subject|1|||
163009252|NCT01286467|588736308|FG003|Overall Study|Withdrawal by Subject|0|||
163009253|NCT01286467|588736305|FG000|Overall Study|Physician Decision|0|||
163009254|NCT01286467|588736306|FG001|Overall Study|Physician Decision|0|||
163009255|NCT01286467|588736307|FG002|Overall Study|Physician Decision|0|||
163009256|NCT01286467|588736308|FG003|Overall Study|Physician Decision|1|||
163009257|NCT01286467|588736305|FG000|Overall Study|Disease progression|3|||
163009258|NCT01286467|588736306|FG001|Overall Study|Disease progression|2|||
163009259|NCT01286467|588736307|FG002|Overall Study|Disease progression|2|||
163009260|NCT01286467|588736308|FG003|Overall Study|Disease progression|3|||
163009261|NCT01286467|588736305|FG000|Overall Study|Adverse Event|0|||
163009262|NCT01286467|588736306|FG001|Overall Study|Adverse Event|1|||
163009263|NCT01286467|588736307|FG002|Overall Study|Adverse Event|2|||
163009264|NCT01286467|588736308|FG003|Overall Study|Adverse Event|3|||
163009265|NCT01286467|588736305|FG000|Overall Study|Study drug stop longer than 14 days|0|||
163061676|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
163009266|NCT01286467|588736306|FG001|Overall Study|Study drug stop longer than 14 days|0|||
163009267|NCT01286467|588736307|FG002|Overall Study|Study drug stop longer than 14 days|1|||
163009268|NCT01286467|588736308|FG003|Overall Study|Study drug stop longer than 14 days|0|||
163009269|NCT03335475|588736309|FG000|Overall Study|Did not wear accelerometer|4|||
163009270|NCT03335475|588736310|FG001|Overall Study|Did not wear accelerometer|0|||
163009271|NCT03335475|588736309|FG000|Overall Study|Withdrawal by Subject|0|||
163009272|NCT03335475|588736310|FG001|Overall Study|Withdrawal by Subject|1|||
163009273|NCT04886596|588736311|FG000|Overall Study|Adverse Event|442|||
163009274|NCT04886596|588736312|FG001|Overall Study|Adverse Event|441|||
163009275|NCT04886596|588736311|FG000|Overall Study|Lost to Follow-up|448|||
163009276|NCT04886596|588736312|FG001|Overall Study|Lost to Follow-up|465|||
163009277|NCT04886596|588736311|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
163009278|NCT04886596|588736312|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
163009279|NCT04886596|588736311|FG000|Overall Study|Migrated/moved from the study area|201|||
163009280|NCT04886596|588736312|FG001|Overall Study|Migrated/moved from the study area|184|||
163009281|NCT04886596|588736311|FG000|Overall Study|Other|298|||
163009282|NCT04886596|588736312|FG001|Overall Study|Other|326|||
163009283|NCT03751098|588736315|FG000|Overall Study|Withdrawal by Subject|0|||
163009284|NCT03751098|588736316|FG001|Overall Study|Withdrawal by Subject|1|||
163009285|NCT00923013|588736317|FG000|Overall Study|Refused further treatment|0|||
163009286|NCT00923013|588736318|FG001|Overall Study|Refused further treatment|1|||
163009287|NCT00923013|588736319|FG002|Overall Study|Refused further treatment|2|||
163009288|NCT00923013|588736320|FG003|Overall Study|Refused further treatment|0|||
163061677|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
163327405|NCT01640951|589909793|FG000|Overall Study|Adverse Event|8|||
163327406|NCT01640951|589909794|FG001|Overall Study|Adverse Event|3|||
163327407|NCT01640951|589909795|FG002|Overall Study|Adverse Event|10|||
163327408|NCT01640951|589909796|FG003|Overall Study|Adverse Event|6|||
163327409|NCT01640951|589909797|FG004|Overall Study|Adverse Event|1|||
163327410|NCT01640951|589909798|FG005|Overall Study|Adverse Event|11|||
163327411|NCT01640951|589909799|FG006|Overall Study|Adverse Event|1|||
163327412|NCT01640951|589909800|FG007|Overall Study|Adverse Event|3|||
163327413|NCT01640951|589909793|FG000|Overall Study|Lack of Efficacy|20|||
163327414|NCT01640951|589909794|FG001|Overall Study|Lack of Efficacy|1|||
163327415|NCT01640951|589909795|FG002|Overall Study|Lack of Efficacy|7|||
163327416|NCT01640951|589909796|FG003|Overall Study|Lack of Efficacy|14|||
163327417|NCT01640951|589909797|FG004|Overall Study|Lack of Efficacy|0|||
163327418|NCT01640951|589909798|FG005|Overall Study|Lack of Efficacy|6|||
163327419|NCT01640951|589909799|FG006|Overall Study|Lack of Efficacy|5|||
163327420|NCT01640951|589909800|FG007|Overall Study|Lack of Efficacy|6|||
163327421|NCT01640951|589909793|FG000|Overall Study|Lost to Follow-up|1|||
163327422|NCT01640951|589909794|FG001|Overall Study|Lost to Follow-up|0|||
163327423|NCT01640951|589909795|FG002|Overall Study|Lost to Follow-up|6|||
163327424|NCT01640951|589909796|FG003|Overall Study|Lost to Follow-up|2|||
163327425|NCT01640951|589909797|FG004|Overall Study|Lost to Follow-up|2|||
163327426|NCT01640951|589909798|FG005|Overall Study|Lost to Follow-up|3|||
163327427|NCT01640951|589909799|FG006|Overall Study|Lost to Follow-up|1|||
163327428|NCT01640951|589909800|FG007|Overall Study|Lost to Follow-up|1|||
163327429|NCT01640951|589909793|FG000|Overall Study|Non-compliance with study treatment|0|||
163327430|NCT01640951|589909794|FG001|Overall Study|Non-compliance with study treatment|0|||
163327431|NCT01640951|589909795|FG002|Overall Study|Non-compliance with study treatment|1|||
163327432|NCT01640951|589909796|FG003|Overall Study|Non-compliance with study treatment|1|||
163327433|NCT01640951|589909797|FG004|Overall Study|Non-compliance with study treatment|1|||
163327434|NCT01640951|589909798|FG005|Overall Study|Non-compliance with study treatment|4|||
163327435|NCT01640951|589909799|FG006|Overall Study|Non-compliance with study treatment|1|||
163327436|NCT01640951|589909800|FG007|Overall Study|Non-compliance with study treatment|0|||
163327437|NCT01640951|589909793|FG000|Overall Study|Physician Decision|2|||
163327438|NCT01640951|589909794|FG001|Overall Study|Physician Decision|5|||
163327439|NCT01640951|589909795|FG002|Overall Study|Physician Decision|2|||
163327440|NCT01640951|589909796|FG003|Overall Study|Physician Decision|2|||
163327441|NCT01640951|589909797|FG004|Overall Study|Physician Decision|2|||
163327442|NCT01640951|589909798|FG005|Overall Study|Physician Decision|3|||
163327443|NCT01640951|589909799|FG006|Overall Study|Physician Decision|3|||
163327444|NCT01640951|589909800|FG007|Overall Study|Physician Decision|0|||
163327445|NCT01640951|589909793|FG000|Overall Study|Pregnancy|3|||
163327446|NCT01640951|589909794|FG001|Overall Study|Pregnancy|0|||
163327447|NCT01640951|589909795|FG002|Overall Study|Pregnancy|0|||
163327448|NCT01640951|589909796|FG003|Overall Study|Pregnancy|4|||
163327449|NCT01640951|589909797|FG004|Overall Study|Pregnancy|0|||
163327450|NCT01640951|589909798|FG005|Overall Study|Pregnancy|0|||
163327451|NCT01640951|589909799|FG006|Overall Study|Pregnancy|2|||
163327452|NCT01640951|589909800|FG007|Overall Study|Pregnancy|0|||
163327453|NCT01640951|589909793|FG000|Overall Study|Protocol Deviation|0|||
163009289|NCT00923013|588736321|FG004|Overall Study|Refused further treatment|0|||
163009290|NCT00923013|588736322|FG005|Overall Study|Refused further treatment|0|||
163009291|NCT00923013|588736317|FG000|Overall Study|Switched to alternative treatment|0|||
163009292|NCT00923013|588736318|FG001|Overall Study|Switched to alternative treatment|1|||
163009293|NCT00923013|588736319|FG002|Overall Study|Switched to alternative treatment|0|||
163009294|NCT00923013|588736320|FG003|Overall Study|Switched to alternative treatment|0|||
163009295|NCT00923013|588736321|FG004|Overall Study|Switched to alternative treatment|0|||
163327454|NCT01640951|589909794|FG001|Overall Study|Protocol Deviation|1|||
163327455|NCT01640951|589909795|FG002|Overall Study|Protocol Deviation|2|||
163404478|NCT01650636|590191948|FG001|Washout up to 5 Months|Death|0|||
163327456|NCT01640951|589909796|FG003|Overall Study|Protocol Deviation|1|||
163327457|NCT01640951|589909797|FG004|Overall Study|Protocol Deviation|0|||
163327458|NCT01640951|589909798|FG005|Overall Study|Protocol Deviation|1|||
163009296|NCT00923013|588736322|FG005|Overall Study|Switched to alternative treatment|0|||
163327459|NCT01640951|589909799|FG006|Overall Study|Protocol Deviation|0|||
163327460|NCT01640951|589909800|FG007|Overall Study|Protocol Deviation|0|||
163327461|NCT01640951|589909793|FG000|Overall Study|Subject/Guardian decision|12|||
163327462|NCT01640951|589909794|FG001|Overall Study|Subject/Guardian decision|4|||
163214052|NCT00202644|589497637|FG001|Overall Study|Other|1|||
163214053|NCT03232281|589497643|FG000|Overall Study|Adverse Event|1|||
163009297|NCT00923013|588736317|FG000|Overall Study|Death on study|2|||
163009298|NCT00923013|588736318|FG001|Overall Study|Death on study|2|||
163009299|NCT00923013|588736319|FG002|Overall Study|Death on study|0|||
163009300|NCT00923013|588736320|FG003|Overall Study|Death on study|1|||
163009301|NCT00923013|588736321|FG004|Overall Study|Death on study|0|||
163009302|NCT00923013|588736322|FG005|Overall Study|Death on study|0|||
163009303|NCT01060072|588736325|FG000|Overall Study|Adverse Event|1|||
163009304|NCT01060072|588736326|FG001|Overall Study|Adverse Event|1|||
163009305|NCT01060072|588736325|FG000|Overall Study|Physician Decision|0|||
163009306|NCT01060072|588736326|FG001|Overall Study|Physician Decision|2|||
163009307|NCT01060072|588736325|FG000|Overall Study|Protocol Violation|0|||
163009308|NCT01060072|588736326|FG001|Overall Study|Protocol Violation|1|||
163009309|NCT01060072|588736325|FG000|Overall Study|Acute cholecystitis|1|||
163009310|NCT01060072|588736326|FG001|Overall Study|Acute cholecystitis|0|||
163009311|NCT01060072|588736325|FG000|Overall Study|Excluded Medications|0|||
163009312|NCT01060072|588736326|FG001|Overall Study|Excluded Medications|1|||
163009313|NCT03326193|588736336|FG000|Overall Study|Sponsor decision|35|||
163009314|NCT00822692|588736337|FG000|Overall Study|Lost to Follow-up|17|||
163009315|NCT00822692|588736338|FG001|Overall Study|Lost to Follow-up|25|||
163009316|NCT02348112|588736339|FG000|Overall Study|Withdrawal by Subject|32|||
163009317|NCT02348112|588736340|FG001|Overall Study|Withdrawal by Subject|29|||
163009318|NCT02348112|588736339|FG000|Overall Study|Lost to Follow-up|24|||
163009319|NCT02348112|588736340|FG001|Overall Study|Lost to Follow-up|20|||
163009320|NCT02348112|588736339|FG000|Overall Study|Physician Decision|17|||
163009321|NCT02348112|588736340|FG001|Overall Study|Physician Decision|15|||
163009322|NCT02348112|588736339|FG000|Overall Study|Site closed due to PI leaving|0|||
163009323|NCT02348112|588736340|FG001|Overall Study|Site closed due to PI leaving|30|||
163009324|NCT02348112|588736339|FG000|Overall Study|Sponsor withdrawal|0|||
163009325|NCT02348112|588736340|FG001|Overall Study|Sponsor withdrawal|7|||
163009326|NCT02348112|588736339|FG000|Overall Study|Death|0|||
163009327|NCT02348112|588736340|FG001|Overall Study|Death|1|||
163009328|NCT01168427|588736342|FG000|Overall Study|Patient exited prior to implant|1|||
163009329|NCT00640315|588736343|FG000|Overall Study|Withdrawal by Subject|0|||
163009330|NCT00640315|588736344|FG001|Overall Study|Withdrawal by Subject|1|||
163009331|NCT01530464|588736345|FG000|Washout (24h)|Withdrawal by Subject|1|||
163009332|NCT01530464|588736346|FG001|Washout (24h)|Withdrawal by Subject|0|||
163009333|NCT01530464|588736345|FG000|Washout (24h)|Withdrawal by Subject|0|||
163009334|NCT01530464|588736346|FG001|Washout (24h)|Withdrawal by Subject|1|||
163009335|NCT01709500|588736347|FG000|Overall Study|Randomized but not treated|0|||
163009336|NCT01709500|588736348|FG001|Overall Study|Randomized but not treated|1|||
163009337|NCT01709500|588736347|FG000|Overall Study|Adverse Event|5|||
163009338|NCT01709500|588736348|FG001|Overall Study|Adverse Event|1|||
163009339|NCT01709500|588736347|FG000|Overall Study|Poor compliance to protocol|2|||
163009340|NCT01709500|588736348|FG001|Overall Study|Poor compliance to protocol|1|||
163009341|NCT01709500|588736347|FG000|Overall Study|Other|3|||
163009342|NCT01709500|588736348|FG001|Overall Study|Other|1|||
163009343|NCT01709500|588736347|FG000|Overall Study|Related to IMP administration|1|||
163009344|NCT01709500|588736348|FG001|Overall Study|Related to IMP administration|0|||
163009345|NCT01709500|588736347|FG000|Overall Study|Treatment ongoing|156|||
163009346|NCT01709500|588736348|FG001|Overall Study|Treatment ongoing|78|||
163009347|NCT02107131|588736349|FG000|Overall Study|Lost to Follow-up|4|||
163009348|NCT02107131|588736350|FG001|Overall Study|Lost to Follow-up|4|||
163009349|NCT02107131|588736349|FG000|Overall Study|Physician Decision|1|||
163009350|NCT02107131|588736350|FG001|Overall Study|Physician Decision|0|||
163009351|NCT02107131|588736349|FG000|Overall Study|Withdrawal by Subject|2|||
163009352|NCT02107131|588736350|FG001|Overall Study|Withdrawal by Subject|0|||
163009353|NCT02107131|588736349|FG000|Overall Study|mental instability|1|||
163009354|NCT02107131|588736350|FG001|Overall Study|mental instability|0|||
163009355|NCT02107131|588736349|FG000|Overall Study|Death|0|||
163009356|NCT02107131|588736350|FG001|Overall Study|Death|1|||
163009357|NCT02107131|588736349|FG000|Overall Study|Protocol Violation|0|||
163061678|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
163009358|NCT02107131|588736350|FG001|Overall Study|Protocol Violation|4|||
163009359|NCT02286713|588736351|FG000|One Week Follow-Up|Death|1|||
163009360|NCT02286713|588736352|FG001|One Week Follow-Up|Death|0|||
163009361|NCT02286713|588736351|FG000|One Week Follow-Up|Lost to Follow-up|17|||
163009362|NCT02286713|588736352|FG001|One Week Follow-Up|Lost to Follow-up|21|||
163009363|NCT02286713|588736351|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
163009364|NCT02286713|588736352|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
163009365|NCT02286713|588736351|FG000|Three Month Follow-Up|Death|1|||
163009366|NCT02286713|588736352|FG001|Three Month Follow-Up|Death|1|||
163009367|NCT02286713|588736351|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
163214054|NCT03232281|589497644|FG001|Overall Study|Adverse Event|1|||
163009368|NCT02286713|588736352|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
163009369|NCT02286713|588736351|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
163061679|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
163009370|NCT02286713|588736352|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
163009371|NCT02286713|588736351|FG000|Six Month Follow-Up|Death|2|||
163009372|NCT02286713|588736352|FG001|Six Month Follow-Up|Death|0|||
163009373|NCT02286713|588736351|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
163009374|NCT02286713|588736352|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
163009375|NCT04314037|588736353|FG000|Treatment Period 2|Adverse Event|1|||
163009376|NCT04314037|588736354|FG001|Treatment Period 2|Adverse Event|0|||
163009377|NCT04314037|588736353|FG000|Treatment Period 3|Protocol Violation|1|||
163009378|NCT04314037|588736354|FG001|Treatment Period 3|Protocol Violation|0|||
163009379|NCT04314037|588736353|FG000|Treatment Period 3|Adverse Event|0|||
163009380|NCT04314037|588736354|FG001|Treatment Period 3|Adverse Event|1|||
163009381|NCT00856492|588736357|FG000|Overall Study|Ineligible or withdrew consent|1|||
163009382|NCT00856492|588736358|FG001|Overall Study|Ineligible or withdrew consent|1|||
163009383|NCT00856492|588736359|FG002|Overall Study|Ineligible or withdrew consent|2|||
163009384|NCT00955409|588737936|FG000|Overall Study|Lack of Efficacy|1|||
163009385|NCT00955409|588737937|FG001|Overall Study|Lack of Efficacy|0|||
163009386|NCT00955409|588737938|FG002|Overall Study|Lack of Efficacy|0|||
163009387|NCT00955409|588737939|FG003|Overall Study|Lack of Efficacy|0|||
163009388|NCT00955409|588737940|FG004|Overall Study|Lack of Efficacy|0|||
163009389|NCT00955409|588737941|FG005|Overall Study|Lack of Efficacy|0|||
163009390|NCT00955409|588737942|FG006|Overall Study|Lack of Efficacy|0|||
163009391|NCT00955409|588737943|FG007|Overall Study|Lack of Efficacy|0|||
163009392|NCT00955409|588737944|FG008|Overall Study|Lack of Efficacy|0|||
163009393|NCT00955409|588737945|FG009|Overall Study|Lack of Efficacy|0|||
163009394|NCT00955409|588737936|FG000|Overall Study|Withdrawal by Subject|1|||
163009395|NCT00955409|588737937|FG001|Overall Study|Withdrawal by Subject|0|||
163009396|NCT00955409|588737938|FG002|Overall Study|Withdrawal by Subject|5|||
163009397|NCT00955409|588737939|FG003|Overall Study|Withdrawal by Subject|2|||
163009398|NCT00955409|588737940|FG004|Overall Study|Withdrawal by Subject|0|||
163009399|NCT00955409|588737941|FG005|Overall Study|Withdrawal by Subject|0|||
163009400|NCT00955409|588737942|FG006|Overall Study|Withdrawal by Subject|2|||
163009401|NCT00955409|588737943|FG007|Overall Study|Withdrawal by Subject|0|||
163009402|NCT00955409|588737944|FG008|Overall Study|Withdrawal by Subject|1|||
163009403|NCT00955409|588737945|FG009|Overall Study|Withdrawal by Subject|0|||
163009404|NCT00955409|588737936|FG000|Overall Study|Caregiver Request|2|||
163009405|NCT00955409|588737937|FG001|Overall Study|Caregiver Request|0|||
163009406|NCT00955409|588737938|FG002|Overall Study|Caregiver Request|6|||
163009407|NCT00955409|588737939|FG003|Overall Study|Caregiver Request|5|||
163009408|NCT00955409|588737940|FG004|Overall Study|Caregiver Request|0|||
163009409|NCT00955409|588737941|FG005|Overall Study|Caregiver Request|2|||
163009410|NCT00955409|588737942|FG006|Overall Study|Caregiver Request|3|||
163009411|NCT00955409|588737943|FG007|Overall Study|Caregiver Request|1|||
163009412|NCT00955409|588737944|FG008|Overall Study|Caregiver Request|3|||
163009413|NCT00955409|588737945|FG009|Overall Study|Caregiver Request|0|||
163009414|NCT00955409|588737936|FG000|Overall Study|Investigator Request|0|||
163009415|NCT00955409|588737937|FG001|Overall Study|Investigator Request|0|||
163009416|NCT00955409|588737938|FG002|Overall Study|Investigator Request|1|||
163009417|NCT00955409|588737939|FG003|Overall Study|Investigator Request|0|||
163009418|NCT00955409|588737940|FG004|Overall Study|Investigator Request|0|||
163009419|NCT00955409|588737941|FG005|Overall Study|Investigator Request|0|||
163009420|NCT00955409|588737942|FG006|Overall Study|Investigator Request|0|||
163009421|NCT00955409|588737943|FG007|Overall Study|Investigator Request|0|||
163009422|NCT00955409|588737944|FG008|Overall Study|Investigator Request|0|||
163009423|NCT00955409|588737945|FG009|Overall Study|Investigator Request|0|||
163009424|NCT00955409|588737936|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
163009425|NCT00955409|588737937|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
163009426|NCT00955409|588737938|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
163009427|NCT00955409|588737939|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
163009428|NCT00955409|588737940|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
163061680|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
163061681|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
163061682|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
163009429|NCT00955409|588737941|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
163009430|NCT00955409|588737942|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
163009431|NCT00955409|588737943|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
163009432|NCT00955409|588737944|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
163009433|NCT00955409|588737945|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
163009434|NCT00955409|588737936|FG000|Overall Study|Lost to Follow-up|0|||
163009435|NCT00955409|588737937|FG001|Overall Study|Lost to Follow-up|0|||
163009436|NCT00955409|588737938|FG002|Overall Study|Lost to Follow-up|1|||
163009437|NCT00955409|588737939|FG003|Overall Study|Lost to Follow-up|0|||
163009438|NCT00955409|588737940|FG004|Overall Study|Lost to Follow-up|0|||
163009439|NCT00955409|588737941|FG005|Overall Study|Lost to Follow-up|0|||
163009440|NCT00955409|588737942|FG006|Overall Study|Lost to Follow-up|1|||
163009441|NCT00955409|588737943|FG007|Overall Study|Lost to Follow-up|0|||
163009442|NCT00955409|588737944|FG008|Overall Study|Lost to Follow-up|0|||
163009443|NCT00955409|588737945|FG009|Overall Study|Lost to Follow-up|0|||
163009444|NCT00955409|588737936|FG000|Overall Study|Failed to Return|2|||
163009445|NCT00955409|588737937|FG001|Overall Study|Failed to Return|0|||
163009446|NCT00955409|588737938|FG002|Overall Study|Failed to Return|0|||
163009447|NCT00955409|588737939|FG003|Overall Study|Failed to Return|0|||
163009448|NCT00955409|588737940|FG004|Overall Study|Failed to Return|0|||
163009449|NCT00955409|588737941|FG005|Overall Study|Failed to Return|0|||
163009450|NCT00955409|588737942|FG006|Overall Study|Failed to Return|0|||
163009451|NCT00955409|588737943|FG007|Overall Study|Failed to Return|2|||
163009452|NCT00955409|588737944|FG008|Overall Study|Failed to Return|0|||
163009453|NCT00955409|588737945|FG009|Overall Study|Failed to Return|0|||
163009454|NCT00955409|588737936|FG000|Overall Study|Adverse Event (AE)|2|||
163009455|NCT00955409|588737937|FG001|Overall Study|Adverse Event (AE)|0|||
163009456|NCT00955409|588737938|FG002|Overall Study|Adverse Event (AE)|0|||
163009457|NCT00955409|588737939|FG003|Overall Study|Adverse Event (AE)|0|||
163009458|NCT00955409|588737940|FG004|Overall Study|Adverse Event (AE)|0|||
163009459|NCT00955409|588737941|FG005|Overall Study|Adverse Event (AE)|1|||
163009460|NCT00955409|588737942|FG006|Overall Study|Adverse Event (AE)|2|||
163009461|NCT00955409|588737943|FG007|Overall Study|Adverse Event (AE)|0|||
163009462|NCT00955409|588737944|FG008|Overall Study|Adverse Event (AE)|2|||
163009463|NCT00955409|588737945|FG009|Overall Study|Adverse Event (AE)|0|||
163009464|NCT00955409|588737936|FG000|Overall Study|Reason not Specified|2|||
163009465|NCT00955409|588737937|FG001|Overall Study|Reason not Specified|1|||
163009466|NCT00955409|588737938|FG002|Overall Study|Reason not Specified|13|||
163009467|NCT00955409|588737939|FG003|Overall Study|Reason not Specified|1|||
163009468|NCT00955409|588737940|FG004|Overall Study|Reason not Specified|2|||
163009469|NCT00955409|588737941|FG005|Overall Study|Reason not Specified|0|||
163009470|NCT00955409|588737942|FG006|Overall Study|Reason not Specified|16|||
163009471|NCT00955409|588737943|FG007|Overall Study|Reason not Specified|0|||
163009472|NCT00955409|588737944|FG008|Overall Study|Reason not Specified|8|||
163009473|NCT00955409|588737945|FG009|Overall Study|Reason not Specified|1|||
163009474|NCT00485732|588737946|FG000|Overall Study|Protocol Violation|1|||
163009475|NCT00485732|588737947|FG001|Overall Study|Protocol Violation|3|||
163009476|NCT00485732|588737946|FG000|Overall Study|Withdrawal by Subject|5|||
163009477|NCT00485732|588737947|FG001|Overall Study|Withdrawal by Subject|4|||
163061683|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
163061684|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Death|1|||
163061685|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Death|0|||
163327463|NCT01640951|589909795|FG002|Overall Study|Subject/Guardian decision|13|||
163327464|NCT01640951|589909796|FG003|Overall Study|Subject/Guardian decision|15|||
163327465|NCT01640951|589909797|FG004|Overall Study|Subject/Guardian decision|7|||
163327466|NCT01640951|589909798|FG005|Overall Study|Subject/Guardian decision|19|||
163327467|NCT01640951|589909799|FG006|Overall Study|Subject/Guardian decision|5|||
163327468|NCT01640951|589909800|FG007|Overall Study|Subject/Guardian decision|4|||
163404479|NCT01650636|590191947|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
163404480|NCT01650636|590191948|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
163404481|NCT01650636|590191947|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
163327469|NCT01640951|589909793|FG000|Overall Study|Death|0|||
163327470|NCT01640951|589909794|FG001|Overall Study|Death|1|||
163327471|NCT01640951|589909795|FG002|Overall Study|Death|1|||
163327472|NCT01640951|589909796|FG003|Overall Study|Death|0|||
163327473|NCT01640951|589909797|FG004|Overall Study|Death|0|||
163327474|NCT01640951|589909798|FG005|Overall Study|Death|0|||
163327475|NCT01640951|589909799|FG006|Overall Study|Death|0|||
163327476|NCT01640951|589909800|FG007|Overall Study|Death|2|||
163327477|NCT00582972|589909801|FG000|Overall Study|Protocol Violation|2|||
163327478|NCT00293397|589909804|FG000|Overall Study|Death|2|||
163327479|NCT00523419|589909806|FG000|Overall Study|Adverse Event|1|||
163327480|NCT00523419|589909806|FG000|Overall Study|Withdrawal by Subject|1|||
163327481|NCT00523419|589909806|FG000|Overall Study|Physician Decision|2|||
163327482|NCT00523419|589909806|FG000|Overall Study|Progressive Disease|22|||
163404482|NCT01650636|590191948|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
163404483|NCT01650636|590191947|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
163404484|NCT01650636|590191948|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
163009478|NCT00485732|588737946|FG000|Overall Study|Lost to Follow-up|2|||
163009479|NCT00485732|588737947|FG001|Overall Study|Lost to Follow-up|2|||
163327483|NCT00523419|589909806|FG000|Overall Study|Death due to Study Disease|4|||
163009480|NCT02445248|588737949|FG000|Overall Study|Death|45|||
163009481|NCT02445248|588737950|FG001|Overall Study|Death|12|||
163009482|NCT02445248|588737949|FG000|Overall Study|Progressive disease|13|||
163009483|NCT02445248|588737950|FG001|Overall Study|Progressive disease|1|||
163009484|NCT02445248|588737949|FG000|Overall Study|Subject decision|8|||
163009485|NCT02445248|588737950|FG001|Overall Study|Subject decision|0|||
163009486|NCT02445248|588737949|FG000|Overall Study|Physician Decision|5|||
163009487|NCT02445248|588737950|FG001|Overall Study|Physician Decision|0|||
163009488|NCT02445248|588737949|FG000|Overall Study|Adverse Event|1|||
163009489|NCT02445248|588737950|FG001|Overall Study|Adverse Event|0|||
163009490|NCT02445248|588737949|FG000|Overall Study|Lost to Follow-up|1|||
163327484|NCT00523419|589909806|FG000|Overall Study|Death due to Adverse Event|2|||
163404485|NCT01560780|590191949|FG000|Overall Study|Death|2|||
163009491|NCT02445248|588737950|FG001|Overall Study|Lost to Follow-up|0|||
163009492|NCT01120184|588737951|FG000|Overall Study|Adverse Event|0|||
163009493|NCT01120184|588737952|FG001|Overall Study|Adverse Event|1|||
163009494|NCT01120184|588737953|FG002|Overall Study|Adverse Event|0|||
163009495|NCT01120184|588737951|FG000|Overall Study|Lost to Follow-up|13|||
163009496|NCT01120184|588737952|FG001|Overall Study|Lost to Follow-up|13|||
163009497|NCT01120184|588737953|FG002|Overall Study|Lost to Follow-up|11|||
163009498|NCT01120184|588737951|FG000|Overall Study|Physician Decision|9|||
163009499|NCT01120184|588737952|FG001|Overall Study|Physician Decision|1|||
163009500|NCT01120184|588737953|FG002|Overall Study|Physician Decision|3|||
163009501|NCT01120184|588737951|FG000|Overall Study|Reason not Specified|8|||
163009502|NCT01120184|588737952|FG001|Overall Study|Reason not Specified|3|||
163009503|NCT01120184|588737953|FG002|Overall Study|Reason not Specified|12|||
163009504|NCT01120184|588737951|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
163009505|NCT01120184|588737952|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
163009506|NCT01120184|588737953|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
163009507|NCT01120184|588737951|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
163009508|NCT01120184|588737952|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
163009509|NCT01120184|588737953|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
163009510|NCT01120184|588737951|FG000|Overall Study|Death|170|||
163009511|NCT01120184|588737952|FG001|Overall Study|Death|176|||
163009512|NCT01120184|588737953|FG002|Overall Study|Death|169|||
163009513|NCT02596971|588737954|FG000|Overall Study|Death|5|||
163009514|NCT02596971|588737955|FG001|Overall Study|Death|1|||
163009515|NCT02596971|588737956|FG002|Overall Study|Death|5|||
163009516|NCT02596971|588737954|FG000|Overall Study|Withdrawal by Subject|5|||
163009517|NCT02596971|588737955|FG001|Overall Study|Withdrawal by Subject|1|||
163009518|NCT02596971|588737956|FG002|Overall Study|Withdrawal by Subject|4|||
163009519|NCT00824772|588737959|FG000|Overall Study|Withdrawal by Subject|8|||
163009520|NCT00683618|588737960|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
163009521|NCT00683618|588737961|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
163327485|NCT00822120|589909807|FG000|Initial Registration|Adverse Event|1|||
163327486|NCT00822120|589909808|FG001|Initial Registration|Adverse Event|0|||
163327487|NCT00822120|589909809|FG002|Initial Registration|Adverse Event|0|||
163327488|NCT00822120|589909810|FG003|Initial Registration|Adverse Event|0|||
163327489|NCT00822120|589909811|FG004|Initial Registration|Adverse Event|0|||
163327490|NCT00822120|589909812|FG005|Initial Registration|Adverse Event|0|||
163327491|NCT00822120|589909807|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
163327492|NCT00822120|589909808|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
163327493|NCT00822120|589909809|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
163327494|NCT00822120|589909810|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
163327495|NCT00822120|589909811|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
163327496|NCT00822120|589909812|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
163327497|NCT00822120|589909807|FG000|Initial Registration|Reasons not Protocol Specified|2|||
163327498|NCT00822120|589909808|FG001|Initial Registration|Reasons not Protocol Specified|0|||
163327499|NCT00822120|589909809|FG002|Initial Registration|Reasons not Protocol Specified|0|||
163327500|NCT00822120|589909810|FG003|Initial Registration|Reasons not Protocol Specified|0|||
163327501|NCT00822120|589909811|FG004|Initial Registration|Reasons not Protocol Specified|0|||
163327502|NCT00822120|589909812|FG005|Initial Registration|Reasons not Protocol Specified|0|||
163327503|NCT00822120|589909807|FG000|Initial Registration|Ineligible|22|||
163327504|NCT00822120|589909808|FG001|Initial Registration|Ineligible|1|||
163327505|NCT00822120|589909809|FG002|Initial Registration|Ineligible|0|||
163327506|NCT00822120|589909810|FG003|Initial Registration|Ineligible|0|||
163327507|NCT00822120|589909811|FG004|Initial Registration|Ineligible|0|||
163327508|NCT00822120|589909812|FG005|Initial Registration|Ineligible|0|||
163327509|NCT00822120|589909807|FG000|PET-directed Therapy|Adverse Event|0|||
163327510|NCT00822120|589909808|FG001|PET-directed Therapy|Adverse Event|0|||
163327511|NCT00822120|589909809|FG002|PET-directed Therapy|Adverse Event|0|||
163327512|NCT00822120|589909810|FG003|PET-directed Therapy|Adverse Event|1|||
163327513|NCT00822120|589909811|FG004|PET-directed Therapy|Adverse Event|0|||
163327514|NCT00822120|589909812|FG005|PET-directed Therapy|Adverse Event|0|||
163404486|NCT01560780|590191950|FG001|Overall Study|Death|1|||
163009522|NCT00683618|588737962|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
163009523|NCT00683618|588737960|FG000|Randomised Treatment Period|Protocol Violation|0|||
163327515|NCT00822120|589909807|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
163327516|NCT00822120|589909808|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
163327517|NCT00822120|589909809|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
163404487|NCT01560780|590191949|FG000|Overall Study|Patient Preference|11|||
163009524|NCT00683618|588737961|FG001|Randomised Treatment Period|Protocol Violation|1|||
163009525|NCT00683618|588737962|FG002|Randomised Treatment Period|Protocol Violation|0|||
163009526|NCT00683618|588737960|FG000|Randomised Treatment Period|Adverse Event|2|||
163009527|NCT00683618|588737961|FG001|Randomised Treatment Period|Adverse Event|0|||
163009528|NCT00683618|588737962|FG002|Randomised Treatment Period|Adverse Event|2|||
163009529|NCT00683618|588737960|FG000|Randomised Treatment Period|Reason not provided|0|||
163009530|NCT00683618|588737961|FG001|Randomised Treatment Period|Reason not provided|0|||
163009531|NCT00683618|588737962|FG002|Randomised Treatment Period|Reason not provided|2|||
163009532|NCT00683618|588737960|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
163009533|NCT00683618|588737961|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
163009534|NCT00683618|588737962|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
163009535|NCT00683618|588737960|FG000|Extension Treatment Period|Adverse Event|1|||
163214055|NCT03232281|589497643|FG000|Overall Study|Withdrawal by Subject|5|||
163214056|NCT03232281|589497644|FG001|Overall Study|Withdrawal by Subject|4|||
163214057|NCT03232281|589497643|FG000|Overall Study|Protocol Deviation|1|||
163214058|NCT03232281|589497644|FG001|Overall Study|Protocol Deviation|1|||
163214059|NCT01372501|589497648|FG000|Overall Study|Adverse Event|4|||
163214060|NCT01372501|589497648|FG000|Overall Study|Device migration|1|||
163214061|NCT05333900|589497649|FG000|Overall Study|Protocol Violation|0|||
163214062|NCT05333900|589497650|FG001|Overall Study|Protocol Violation|1|||
163214063|NCT05333900|589497649|FG000|Overall Study|Withdrawal by Subject|0|||
163214064|NCT05333900|589497650|FG001|Overall Study|Withdrawal by Subject|1|||
163214065|NCT05333900|589497649|FG000|Overall Study|COVID-19 Pandemic|1|||
163214066|NCT05333900|589497650|FG001|Overall Study|COVID-19 Pandemic|1|||
163214067|NCT00573755|589497651|FG000|Overall Study|Still receiving treatment|1|||
163214068|NCT00573755|589497652|FG001|Overall Study|Still receiving treatment|0|||
163214069|NCT03724812|589497653|FG000|Overall Study|Missed Visit|1|||
163214070|NCT03724812|589497653|FG000|Overall Study|Death|2|||
163214071|NCT03724812|589497653|FG000|Overall Study|Withdrawal by Subject|1|||
163214072|NCT02024867|589497654|FG000|Overall Study|Protocol Violation|3|||
163214073|NCT02024867|589497655|FG001|Overall Study|Protocol Violation|3|||
163214074|NCT02024867|589497654|FG000|Overall Study|Lost to Follow-up|6|||
163214075|NCT02024867|589497655|FG001|Overall Study|Lost to Follow-up|4|||
163214076|NCT01462084|589497657|FG000|Overall Study|Withdrawal by Subject|1|||
163214077|NCT01462084|589497658|FG001|Overall Study|Withdrawal by Subject|0|||
163214078|NCT01462084|589497657|FG000|Overall Study|Protocol Violation|1|||
163214079|NCT01462084|589497658|FG001|Overall Study|Protocol Violation|1|||
163214080|NCT02369341|589497659|FG000|Overall Study|Migrated/moved from study area|1|||
163214081|NCT02369341|589497660|FG001|Overall Study|Migrated/moved from study area|0|||
163214082|NCT02278263|589497663|FG000|Overall Study|Protocol Violation|7|||
163214083|NCT02278263|589497664|FG001|Overall Study|Protocol Violation|0|||
163214084|NCT02278263|589497665|FG002|Overall Study|Protocol Violation|9|||
163214085|NCT01998737|589497666|FG000|Overall Study|Corrupted database|23|||
163214086|NCT01998737|589497667|FG001|Overall Study|Corrupted database|0|||
163214087|NCT02092662|589497668|FG000|Overall Study|Lost to Follow-up|13|||
163214088|NCT02092662|589497669|FG001|Overall Study|Lost to Follow-up|0|||
163214089|NCT00772707|589497671|FG000|Overall Study|Withdrawn|3|||
163214090|NCT01266460|589497673|FG000|Overall Study|Adverse Event|3|||
163214091|NCT01266460|589497673|FG000|Overall Study|Withdrawal by Subject|5|||
163214092|NCT01266460|589497673|FG000|Overall Study|Disease Progression|18|||
163214093|NCT01266460|589497673|FG000|Overall Study|Not otherwise specified|8|||
163214094|NCT01132547|589497674|FG000|Overall Study|Withdrawal by Subject|3|||
163404488|NCT01560780|590191950|FG001|Overall Study|Patient Preference|11|||
162924728|NCT01215955|588426098|FG001|Overall Study|Withdrawal by Subject|15|||
162924729|NCT01215955|588426099|FG002|Overall Study|Withdrawal by Subject|13|||
162924730|NCT01215955|588426100|FG003|Overall Study|Withdrawal by Subject|9|||
162924731|NCT01215955|588426097|FG000|Overall Study|Quality Issues|0|||
162924732|NCT01215955|588426098|FG001|Overall Study|Quality Issues|0|||
162924733|NCT01215955|588426099|FG002|Overall Study|Quality Issues|3|||
162924734|NCT01215955|588426100|FG003|Overall Study|Quality Issues|2|||
162924735|NCT05013749|588426101|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
162924736|NCT05013749|588426102|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
162924737|NCT05013749|588426101|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
162924738|NCT05013749|588426102|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
162924739|NCT02858076|588426103|FG000|Overall Study|Death|6|||
162924740|NCT02858076|588426104|FG001|Overall Study|Death|3|||
162924741|NCT02858076|588426103|FG000|Overall Study|Withdrawal by Subject|1|||
162924742|NCT02858076|588426104|FG001|Overall Study|Withdrawal by Subject|5|||
162924743|NCT02858076|588426103|FG000|Overall Study|Lost to Follow-up|2|||
162924744|NCT02858076|588426104|FG001|Overall Study|Lost to Follow-up|7|||
162924745|NCT02858076|588426103|FG000|Overall Study|Completed Out of Window|1|||
162924746|NCT02858076|588426104|FG001|Overall Study|Completed Out of Window|3|||
162924747|NCT02643394|588426105|FG000|Overall Study|Protocol Violation|4|||
162924748|NCT02643394|588426106|FG001|Overall Study|Protocol Violation|5|||
162924749|NCT00943384|588426107|FG000|Overall Study|Dispositioned prior to treatment|23|||
162924750|NCT00943384|588426107|FG000|Overall Study|Treated off protocol-protocol violation|5|||
162924751|NCT00943384|588426107|FG000|Overall Study|Lost to Follow-up|16|||
162924752|NCT00943384|588426107|FG000|Overall Study|Withdrawal by Subject|5|||
162924753|NCT00096200|588426108|FG000|Overall Study|Adverse Event|0|||
162924754|NCT00096200|588426109|FG001|Overall Study|Adverse Event|4|||
163009536|NCT00683618|588737961|FG001|Extension Treatment Period|Adverse Event|0|||
163214095|NCT01132547|589497675|FG001|Overall Study|Withdrawal by Subject|1|||
163404489|NCT00930761|590191951|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
163404490|NCT00930761|590191952|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
163404491|NCT00930761|590191951|FG000|Overall Study|less than 3 music therapy sessions|0|||
163009537|NCT00683618|588737962|FG002|Extension Treatment Period|Adverse Event|0|||
163009538|NCT00683618|588737960|FG000|Extension Treatment Period|Protocol Violation|1|||
163009539|NCT00683618|588737961|FG001|Extension Treatment Period|Protocol Violation|0|||
163009540|NCT00683618|588737962|FG002|Extension Treatment Period|Protocol Violation|0|||
163009541|NCT04570670|588737963|FG000|Overall Study|Withdrawal by Subject|1|||
163009542|NCT04570670|588737964|FG001|Overall Study|Withdrawal by Subject|0|||
163009543|NCT02764762|588737968|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
163009544|NCT02764762|588737968|FG000|Overall Study|Lost to Follow-up|4|||
163009545|NCT02764762|588737968|FG000|Overall Study|Voluntary Withdrawal|8|||
163009546|NCT02764762|588737968|FG000|Overall Study|Site Termination|1|||
163009547|NCT02764762|588737968|FG000|Overall Study|Lack of Efficacy|16|||
163009548|NCT02764762|588737968|FG000|Overall Study|Reason not Specified|1|||
163009549|NCT01002989|588737969|FG000|Overall Study|exclusion criteria, no consent|5|||
163009550|NCT02954601|588737970|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
163009551|NCT02954601|588737971|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
163009552|NCT02954601|588737972|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
163009553|NCT02954601|588737973|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
163009554|NCT00318474|588737974|FG000|Overall Study|Adverse Event|1|||
163009555|NCT00318474|588737975|FG001|Overall Study|Adverse Event|1|||
163009556|NCT00318474|588737974|FG000|Overall Study|Lost to Follow-up|0|||
163009557|NCT00318474|588737975|FG001|Overall Study|Lost to Follow-up|1|||
163061686|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Death|1|||
163061687|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
163061688|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
163061689|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
163061690|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
163061691|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
163061692|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
163061693|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
163009558|NCT00318474|588737974|FG000|Overall Study|Pregnancy|0|||
163009559|NCT00318474|588737975|FG001|Overall Study|Pregnancy|2|||
163009560|NCT00318474|588737974|FG000|Overall Study|Protocol Violation|1|||
163009561|NCT00318474|588737975|FG001|Overall Study|Protocol Violation|0|||
163009562|NCT00318474|588737974|FG000|Overall Study|Withdrawal by Subject|3|||
163009563|NCT00318474|588737975|FG001|Overall Study|Withdrawal by Subject|2|||
163009564|NCT00318474|588737974|FG000|Overall Study|Fall in GFR|3|||
163009565|NCT00318474|588737975|FG001|Overall Study|Fall in GFR|3|||
163009566|NCT00318474|588737974|FG000|Overall Study|Post-therapy hyperflycemia|0|||
163214096|NCT01132547|589497674|FG000|Overall Study|Death|1|||
163214097|NCT01132547|589497675|FG001|Overall Study|Death|0|||
163214098|NCT05811234|589497676|FG000|Overall Study|Loss of Effectiveness|2|||
163009567|NCT00318474|588737975|FG001|Overall Study|Post-therapy hyperflycemia|1|||
163009568|NCT00318474|588737974|FG000|Overall Study|Trial terminated|10|||
163009569|NCT00318474|588737975|FG001|Overall Study|Trial terminated|7|||
163009570|NCT00917852|588737979|FG000|Overall Study|Death|6|||
163214099|NCT05811234|589497676|FG000|Overall Study|Adverse Event|4|||
163214100|NCT05811234|589497676|FG000|Overall Study|Pregnancy|1|||
163214101|NCT05811234|589497676|FG000|Overall Study|Disease progression|1|||
163214102|NCT05811234|589497676|FG000|Overall Study|Withdrawal by Subject|4|||
163214103|NCT05811234|589497676|FG000|Overall Study|Lost to Follow-up|13|||
163214104|NCT05811234|589497676|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
163214105|NCT02710045|589497677|FG000|Overall Study|Death|1|||
163214106|NCT02710045|589497678|FG001|Overall Study|Death|2|||
163214107|NCT02710045|589497679|FG002|Overall Study|Death|0|||
163214108|NCT02710045|589497677|FG000|Overall Study|Withdrawal by Subject|6|||
163214109|NCT02710045|589497678|FG001|Overall Study|Withdrawal by Subject|6|||
163214110|NCT02710045|589497679|FG002|Overall Study|Withdrawal by Subject|2|||
163214111|NCT02710045|589497677|FG000|Overall Study|Protocol Violation|1|||
163214112|NCT02710045|589497678|FG001|Overall Study|Protocol Violation|2|||
163214113|NCT02710045|589497679|FG002|Overall Study|Protocol Violation|3|||
163214114|NCT02710045|589497677|FG000|Overall Study|Lost to Follow-up|3|||
163214115|NCT02710045|589497678|FG001|Overall Study|Lost to Follow-up|6|||
163214116|NCT02710045|589497679|FG002|Overall Study|Lost to Follow-up|7|||
163214117|NCT02710045|589497677|FG000|Overall Study|Physician Decision|0|||
163214118|NCT02710045|589497678|FG001|Overall Study|Physician Decision|0|||
163214119|NCT02710045|589497679|FG002|Overall Study|Physician Decision|1|||
163214120|NCT02710045|589497677|FG000|Overall Study|Poor Attendance|0|||
163214121|NCT02710045|589497678|FG001|Overall Study|Poor Attendance|1|||
163214122|NCT02710045|589497679|FG002|Overall Study|Poor Attendance|0|||
163214123|NCT00227305|589497680|FG000|Overall Study|Adverse Event|40|||
163214124|NCT00227305|589497680|FG000|Overall Study|Withdrawal by Subject|42|||
163214125|NCT00227305|589497680|FG000|Overall Study|Lost to Follow-up|33|||
163327518|NCT00822120|589909810|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
163327519|NCT00822120|589909811|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
163327520|NCT00822120|589909812|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
163327521|NCT00822120|589909807|FG000|PET-directed Therapy|Death|0|||
163327522|NCT00822120|589909808|FG001|PET-directed Therapy|Death|0|||
163327523|NCT00822120|589909809|FG002|PET-directed Therapy|Death|0|||
163327524|NCT00822120|589909810|FG003|PET-directed Therapy|Death|2|||
163327525|NCT00822120|589909811|FG004|PET-directed Therapy|Death|0|||
163327526|NCT00822120|589909812|FG005|PET-directed Therapy|Death|0|||
163327527|NCT00822120|589909807|FG000|PET-directed Therapy|Protocol Violation|0|||
163327528|NCT00822120|589909808|FG001|PET-directed Therapy|Protocol Violation|0|||
163327529|NCT00822120|589909809|FG002|PET-directed Therapy|Protocol Violation|0|||
163327530|NCT00822120|589909810|FG003|PET-directed Therapy|Protocol Violation|6|||
163327531|NCT00822120|589909811|FG004|PET-directed Therapy|Protocol Violation|0|||
163327532|NCT00822120|589909812|FG005|PET-directed Therapy|Protocol Violation|0|||
163327533|NCT01759862|589909813|FG000|Overall Study|Physician Decision|3|||
163327534|NCT01759862|589909814|FG001|Overall Study|Physician Decision|1|||
163327535|NCT01759862|589909813|FG000|Overall Study|Adverse Event|0|||
163327536|NCT01759862|589909814|FG001|Overall Study|Adverse Event|1|||
163327537|NCT04060212|589909816|FG000|Overall Study|Withdrawal by Subject|7|||
163327538|NCT01499849|589909817|FG000|Overall Study|Adverse Event|28|||
163327539|NCT01499849|589909818|FG001|Overall Study|Adverse Event|32|||
163327540|NCT01499849|589909817|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
163327541|NCT01499849|589909818|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
163327542|NCT01499849|589909817|FG000|Overall Study|Withdrawal by Subject|43|||
163327543|NCT01499849|589909818|FG001|Overall Study|Withdrawal by Subject|43|||
163327544|NCT01499849|589909817|FG000|Overall Study|Death|5|||
163327545|NCT01499849|589909818|FG001|Overall Study|Death|7|||
163327546|NCT01499849|589909817|FG000|Overall Study|Disease Progression|11|||
163327547|NCT01499849|589909818|FG001|Overall Study|Disease Progression|10|||
163327548|NCT01499849|589909817|FG000|Overall Study|Protocol Violation|11|||
163327549|NCT01499849|589909818|FG001|Overall Study|Protocol Violation|11|||
163327550|NCT01499849|589909817|FG000|Overall Study|Physician Decision|20|||
163009571|NCT00471081|588737980|FG000|Active Phase|Protocol Violation|1|||
163009572|NCT00471081|588737981|FG001|Active Phase|Protocol Violation|1|||
163009573|NCT00471081|588737980|FG000|Active Phase|Withdrawal by Subject|0|||
163009574|NCT00471081|588737981|FG001|Active Phase|Withdrawal by Subject|3|||
163009575|NCT00471081|588737980|FG000|Active Phase|Lost to Follow-up|0|||
163009576|NCT00471081|588737981|FG001|Active Phase|Lost to Follow-up|1|||
163009577|NCT00471081|588737980|FG000|Active Phase|Lost health plan/insurance|1|||
163009578|NCT00471081|588737981|FG001|Active Phase|Lost health plan/insurance|8|||
163009579|NCT00471081|588737980|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
163009580|NCT00471081|588737981|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
163009581|NCT00471081|588737980|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
163009582|NCT00471081|588737981|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
163009583|NCT00471081|588737980|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
163009584|NCT00471081|588737981|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
163009585|NCT02393950|588737986|FG000|Overall Study|Adverse Event|1|||
163009586|NCT02393950|588737987|FG001|Overall Study|Adverse Event|0|||
163009587|NCT02393950|588737986|FG000|Overall Study|Withdrawal by Subject|0|||
163009588|NCT02393950|588737987|FG001|Overall Study|Withdrawal by Subject|1|||
163009589|NCT05486091|588737988|FG000|Overall Study|Withdrawal by Subject|1|||
163009590|NCT05486091|588737988|FG000|Overall Study|Lost to Follow-up|2|||
163009591|NCT00370552|588737989|FG000|Overall Study|Adverse Event|2|||
163009592|NCT00370552|588737990|FG001|Overall Study|Adverse Event|2|||
163009593|NCT00370552|588737991|FG002|Overall Study|Adverse Event|2|||
163009594|NCT00370552|588737989|FG000|Overall Study|Disease progression|23|||
163009595|NCT00370552|588737990|FG001|Overall Study|Disease progression|23|||
163009596|NCT00370552|588737991|FG002|Overall Study|Disease progression|15|||
163009597|NCT00370552|588737989|FG000|Overall Study|Maximum clinical benefit|3|||
163009598|NCT00370552|588737990|FG001|Overall Study|Maximum clinical benefit|5|||
163009599|NCT00370552|588737991|FG002|Overall Study|Maximum clinical benefit|5|||
163009600|NCT00370552|588737989|FG000|Overall Study|Poor or noncompliance|0|||
163009601|NCT00370552|588737990|FG001|Overall Study|Poor or noncompliance|0|||
163009602|NCT00370552|588737991|FG002|Overall Study|Poor or noncompliance|1|||
163009603|NCT00370552|588737989|FG000|Overall Study|Study drug toxicity|11|||
163009604|NCT00370552|588737990|FG001|Overall Study|Study drug toxicity|8|||
163009605|NCT00370552|588737991|FG002|Overall Study|Study drug toxicity|6|||
163009606|NCT00370552|588737989|FG000|Overall Study|Withdrawal by Subject|2|||
163327551|NCT01499849|589909818|FG001|Overall Study|Physician Decision|19|||
163327552|NCT01499849|589909817|FG000|Overall Study|Lack of Efficacy|3|||
163009607|NCT00370552|588737990|FG001|Overall Study|Withdrawal by Subject|0|||
163009608|NCT00370552|588737991|FG002|Overall Study|Withdrawal by Subject|1|||
163009609|NCT00370552|588737989|FG000|Overall Study|Still on treatment|1|||
163327553|NCT01499849|589909818|FG001|Overall Study|Lack of Efficacy|4|||
163327554|NCT01499849|589909817|FG000|Overall Study|Lost to Follow-up|6|||
163327555|NCT01499849|589909818|FG001|Overall Study|Lost to Follow-up|3|||
163327556|NCT01499849|589909817|FG000|Overall Study|Other Reasons|27|||
163327557|NCT01499849|589909818|FG001|Overall Study|Other Reasons|30|||
163327558|NCT02646618|589909819|FG000|Overall Study|Lost to Follow-up|10|||
163404492|NCT00930761|590191952|FG001|Overall Study|less than 3 music therapy sessions|3|||
163404493|NCT01500278|590191955|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
163404494|NCT01500278|590191956|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
163404495|NCT01500278|590191955|FG000|Week 0 - Week 12|Protocol Violation|10|||
163404496|NCT01500278|590191956|FG001|Week 0 - Week 12|Protocol Violation|16|||
163404497|NCT01500278|590191955|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
163404498|NCT01500278|590191956|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
163404499|NCT01500278|590191955|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
163404500|NCT01500278|590191956|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
163404501|NCT01500278|590191955|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
163404502|NCT01500278|590191956|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
163404503|NCT01500278|590191955|FG000|Week 0 - Week 12|Patient decision|1|||
163404504|NCT01500278|590191956|FG001|Week 0 - Week 12|Patient decision|0|||
163404505|NCT01500278|590191955|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
163404506|NCT01500278|590191956|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
163404507|NCT01500278|590191955|FG000|Week 0 - Week 12|Investigator decision|1|||
163404508|NCT01500278|590191956|FG001|Week 0 - Week 12|Investigator decision|0|||
163404509|NCT01500278|590191955|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
163404510|NCT01500278|590191956|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
163404511|NCT01500278|590191955|FG000|Week 0 - Week 12|Sponsor decision|1|||
163404512|NCT01500278|590191956|FG001|Week 0 - Week 12|Sponsor decision|0|||
163327559|NCT02646618|589909820|FG001|Overall Study|Lost to Follow-up|14|||
163327560|NCT03885232|589909821|FG000|Overall Study|Lost to Follow-up|74|||
163327561|NCT03885232|589909822|FG001|Overall Study|Lost to Follow-up|32|||
163327562|NCT03885232|589909821|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
163327563|NCT03885232|589909822|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
163327564|NCT03333109|589909824|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
163327565|NCT03333109|589909825|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
163327566|NCT03333109|589909826|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
163327567|NCT03333109|589909824|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163327568|NCT03333109|589909825|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163327569|NCT03333109|589909826|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
163327570|NCT03333109|589909824|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
163327571|NCT03333109|589909825|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
163327572|NCT03333109|589909826|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
163327573|NCT03333109|589909824|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
163327574|NCT03333109|589909825|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
163327575|NCT03333109|589909826|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
163327576|NCT03333109|589909824|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
163327577|NCT03333109|589909825|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
163327578|NCT03333109|589909826|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
163327579|NCT03333109|589909824|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
163327580|NCT03333109|589909825|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
163327581|NCT03333109|589909826|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
163327582|NCT03333109|589909824|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
163327583|NCT03333109|589909825|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
163327584|NCT03333109|589909826|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
163327585|NCT03333109|589909824|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
163327586|NCT03333109|589909825|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
163327587|NCT03333109|589909826|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
163327588|NCT00918203|589909829|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
163327589|NCT00918203|589909830|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
163327590|NCT00918203|589909831|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
163327591|NCT00918203|589909829|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
163327592|NCT00918203|589909830|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
163327593|NCT00918203|589909831|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
163404513|NCT01500278|590191955|FG000|Week 0 - Week 12|Personal reason|0|||
163404514|NCT01500278|590191956|FG001|Week 0 - Week 12|Personal reason|1|||
163404515|NCT01500278|590191955|FG000|Week 0 - Week 12|Other serious disease|0|||
163404516|NCT01500278|590191956|FG001|Week 0 - Week 12|Other serious disease|1|||
163404517|NCT01500278|590191955|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
163327594|NCT00918203|589909829|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
163404518|NCT01500278|590191956|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
163404519|NCT01500278|590191955|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
163404520|NCT01500278|590191956|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
163404521|NCT01500278|590191955|FG000|Week 13 - Week 104|Protocol Violation|6|||
162924755|NCT00096200|588426110|FG002|Overall Study|Adverse Event|0|||
163404522|NCT01500278|590191956|FG001|Week 13 - Week 104|Protocol Violation|6|||
163327595|NCT00918203|589909830|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
163327596|NCT00918203|589909831|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
163327597|NCT00918203|589909829|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
163327598|NCT00918203|589909830|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
163327599|NCT00918203|589909831|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
163327600|NCT04066075|589909832|FG000|Overall Study|Lost to Follow-up|3|||
163009610|NCT00370552|588737990|FG001|Overall Study|Still on treatment|3|||
163009611|NCT00370552|588737991|FG002|Overall Study|Still on treatment|2|||
163009612|NCT00370552|588737989|FG000|Overall Study|Never treated|1|||
163009613|NCT00370552|588737990|FG001|Overall Study|Never treated|0|||
163009614|NCT00370552|588737991|FG002|Overall Study|Never treated|0|||
163009615|NCT00370552|588737989|FG000|Overall Study|Physician Decision|1|||
163009616|NCT00370552|588737990|FG001|Overall Study|Physician Decision|1|||
163009617|NCT00370552|588737991|FG002|Overall Study|Physician Decision|0|||
163009618|NCT00370552|588737989|FG000|Overall Study|Investigator decision|2|||
163009619|NCT00370552|588737990|FG001|Overall Study|Investigator decision|1|||
163009620|NCT00370552|588737991|FG002|Overall Study|Investigator decision|0|||
163327601|NCT04066075|589909833|FG001|Overall Study|Lost to Follow-up|3|||
163327602|NCT04066075|589909832|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
163327603|NCT04066075|589909833|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
163327604|NCT04066075|589909832|FG000|Overall Study|Withdrawal by Subject|2|||
163327605|NCT04066075|589909833|FG001|Overall Study|Withdrawal by Subject|2|||
163327606|NCT00309166|589909834|FG000|Overall Study|Adverse event, non-fatal|1|||
163327607|NCT00309166|589909835|FG001|Overall Study|Adverse event, non-fatal|0|||
163327608|NCT00309166|589909834|FG000|Overall Study|Withdrawal by Subject|4|||
163327609|NCT00309166|589909835|FG001|Overall Study|Withdrawal by Subject|3|||
163327610|NCT00701701|589909838|FG000|Overall Study|Withdrawal by Subject|0|||
163327611|NCT00701701|589909839|FG001|Overall Study|Withdrawal by Subject|1|||
163327612|NCT00701701|589909838|FG000|Overall Study|Adverse Event|0|||
163327613|NCT00701701|589909839|FG001|Overall Study|Adverse Event|1|||
163327614|NCT05601882|589909840|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
163327615|NCT05601882|589909841|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
163327616|NCT05601882|589909842|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
163327617|NCT05601882|589909843|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
163327618|NCT05601882|589909840|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
163327619|NCT05601882|589909841|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
163327620|NCT05601882|589909842|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
163327621|NCT05601882|589909843|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
163327622|NCT05601882|589909840|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
163327623|NCT05601882|589909841|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
163327624|NCT05601882|589909842|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
163327625|NCT05601882|589909843|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
163327626|NCT05601882|589909840|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
163327627|NCT05601882|589909841|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
163327628|NCT05601882|589909842|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
163327629|NCT05601882|589909843|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
163327630|NCT05601882|589909840|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
163327631|NCT05601882|589909841|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
163327632|NCT05601882|589909842|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
163327633|NCT05601882|589909843|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
163327634|NCT05601882|589909840|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
163327635|NCT05601882|589909841|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
163327636|NCT05601882|589909842|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
163327637|NCT05601882|589909843|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
163327638|NCT03834740|589909844|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
163327639|NCT03834740|589909845|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
163327640|NCT03834740|589909846|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
163327641|NCT01208974|589909847|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
163327642|NCT01208974|589909848|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
163327643|NCT01208974|589909849|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
163327644|NCT01208974|589909850|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
163327645|NCT01208974|589909847|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
163327646|NCT01208974|589909848|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
163327647|NCT01208974|589909849|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
163327648|NCT01208974|589909850|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
163327649|NCT01208974|589909847|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
163327650|NCT01208974|589909848|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
163327651|NCT01208974|589909849|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
163327652|NCT01208974|589909850|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
163214126|NCT00227305|589497680|FG000|Overall Study|Study specific discontinuation|13|||
163327653|NCT03593226|589909851|FG000|Overall Study|Disease progression|6|||
163327654|NCT03593226|589909852|FG001|Overall Study|Disease progression|13|||
163327655|NCT03593226|589909853|FG002|Overall Study|Disease progression|5|||
163327656|NCT03593226|589909854|FG003|Overall Study|Disease progression|6|||
163327657|NCT03593226|589909851|FG000|Overall Study|Adverse Event|0|||
163327658|NCT03593226|589909852|FG001|Overall Study|Adverse Event|1|||
163327659|NCT03593226|589909853|FG002|Overall Study|Adverse Event|0|||
163327660|NCT03593226|589909854|FG003|Overall Study|Adverse Event|0|||
163327661|NCT03593226|589909851|FG000|Overall Study|Withdrawal by Subject|0|||
163327662|NCT03593226|589909852|FG001|Overall Study|Withdrawal by Subject|4|||
163327663|NCT03593226|589909853|FG002|Overall Study|Withdrawal by Subject|1|||
163327664|NCT03593226|589909854|FG003|Overall Study|Withdrawal by Subject|0|||
163327665|NCT03593226|589909851|FG000|Overall Study|Physician Decision|0|||
163327666|NCT03593226|589909852|FG001|Overall Study|Physician Decision|1|||
163327667|NCT03593226|589909853|FG002|Overall Study|Physician Decision|0|||
163327668|NCT03593226|589909854|FG003|Overall Study|Physician Decision|0|||
163327669|NCT03593226|589909851|FG000|Overall Study|Clinical disease progression|0|||
163327670|NCT03593226|589909852|FG001|Overall Study|Clinical disease progression|0|||
163327671|NCT03593226|589909853|FG002|Overall Study|Clinical disease progression|1|||
163327672|NCT03593226|589909854|FG003|Overall Study|Clinical disease progression|0|||
163327673|NCT02500576|589909855|FG000|Overall Study|Adverse Event|0|||
163327674|NCT02500576|589909856|FG001|Overall Study|Adverse Event|1|||
163327675|NCT02500576|589909855|FG000|Overall Study|Death|2|||
163327676|NCT02500576|589909856|FG001|Overall Study|Death|1|||
163327677|NCT02500576|589909855|FG000|Overall Study|Lack of Efficacy|5|||
163327678|NCT02500576|589909856|FG001|Overall Study|Lack of Efficacy|5|||
163327679|NCT02500576|589909855|FG000|Overall Study|Withdrawal by Subject|1|||
163327680|NCT02500576|589909856|FG001|Overall Study|Withdrawal by Subject|1|||
162924756|NCT00096200|588426108|FG000|Overall Study|Withdrawal by Subject|1|||
162924757|NCT00096200|588426109|FG001|Overall Study|Withdrawal by Subject|2|||
162924758|NCT00096200|588426110|FG002|Overall Study|Withdrawal by Subject|0|||
162924759|NCT00096200|588426108|FG000|Overall Study|Ineligible pathology|0|||
162924760|NCT00096200|588426109|FG001|Overall Study|Ineligible pathology|1|||
162924761|NCT00096200|588426110|FG002|Overall Study|Ineligible pathology|0|||
162924762|NCT03014570|588426118|FG000|Overall Study|COVID-19 Restrictions|38|||
162924763|NCT03014570|588426119|FG001|Overall Study|COVID-19 Restrictions|24|||
162924764|NCT03014570|588426118|FG000|Overall Study|Death|70|||
162924765|NCT03014570|588426119|FG001|Overall Study|Death|79|||
162924766|NCT03014570|588426118|FG000|Overall Study|Transfer from facility|11|||
162924767|NCT03014570|588426119|FG001|Overall Study|Transfer from facility|14|||
162924768|NCT03014570|588426118|FG000|Overall Study|Hospitalized|5|||
163214127|NCT00227305|589497680|FG000|Overall Study|MOVED OUT OF AREA|3|||
163214128|NCT00227305|589497680|FG000|Overall Study|Lack of Efficacy|7|||
163214129|NCT00227305|589497680|FG000|Overall Study|Physician Decision|3|||
163214130|NCT00227305|589497680|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
163214131|NCT00227305|589497680|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
163214132|NCT00227305|589497680|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
163214133|NCT00857220|589497684|FG000|Overall Study|Adverse Event|35|||
163214134|NCT00857220|589497684|FG000|Overall Study|Death|1|||
163214135|NCT00857220|589497684|FG000|Overall Study|Lack of Efficacy|11|||
163214136|NCT00857220|589497684|FG000|Overall Study|Lost to Follow-up|30|||
163214137|NCT00857220|589497684|FG000|Overall Study|Physician Decision|4|||
163214138|NCT00857220|589497684|FG000|Overall Study|Protocol Violation|16|||
163214139|NCT00857220|589497684|FG000|Overall Study|Withdrawal by Subject|67|||
163214140|NCT00857220|589497684|FG000|Overall Study|Clinical Hold|6|||
163214141|NCT00857220|589497684|FG000|Overall Study|Site Closed|5|||
163214142|NCT00857220|589497684|FG000|Overall Study|Miscellaneous|8|||
163214143|NCT00137423|589497685|FG000|Overall Study|Adverse Event|7|||
163214144|NCT00137423|589497686|FG001|Overall Study|Adverse Event|9|||
163214145|NCT00137423|589497685|FG000|Overall Study|consent withdrawn|1|||
163214146|NCT00137423|589497686|FG001|Overall Study|consent withdrawn|1|||
163214147|NCT00137423|589497685|FG000|Overall Study|Lack of Efficacy|31|||
163214148|NCT00137423|589497686|FG001|Overall Study|Lack of Efficacy|33|||
163214149|NCT00137423|589497685|FG000|Overall Study|Death|0|||
163214150|NCT00137423|589497686|FG001|Overall Study|Death|1|||
163214151|NCT03187262|589497688|FG000|Induction|Lack of Efficacy|2|||
163214152|NCT03187262|589497688|FG000|Induction|Progressive Disease|4|||
163214153|NCT03187262|589497688|FG000|Consolidation|Progressive Disease|5|||
163214154|NCT00278109|589497689|FG000|Overall Study|Adverse Event|3|||
163214155|NCT00278109|589497689|FG000|Overall Study|social circumstances|1|||
163214156|NCT02580357|589497690|FG000|Overall Study|Lost to Follow-up|2|||
163214157|NCT02580357|589497691|FG001|Overall Study|Lost to Follow-up|0|||
163214158|NCT02580357|589497692|FG002|Overall Study|Lost to Follow-up|0|||
163214159|NCT02580357|589497690|FG000|Overall Study|Protocol Violation|1|||
163214160|NCT02580357|589497691|FG001|Overall Study|Protocol Violation|0|||
163214161|NCT02580357|589497692|FG002|Overall Study|Protocol Violation|0|||
163214162|NCT04339296|589497696|FG000|Overall Study|Refuse to participate after allocation|1|||
163214163|NCT04339296|589497697|FG001|Overall Study|Refuse to participate after allocation|1|||
163214164|NCT04339296|589497696|FG000|Overall Study|Withdrew after completion of baseline|2|||
163009621|NCT00370552|588737989|FG000|Overall Study|High risk of allergic reaction|0|||
163009622|NCT00370552|588737990|FG001|Overall Study|High risk of allergic reaction|1|||
163009623|NCT00370552|588737991|FG002|Overall Study|High risk of allergic reaction|0|||
163009624|NCT00370552|588737989|FG000|Overall Study|Planned radiation for palliation|0|||
163009625|NCT00370552|588737990|FG001|Overall Study|Planned radiation for palliation|1|||
163009626|NCT00370552|588737991|FG002|Overall Study|Planned radiation for palliation|0|||
163009627|NCT03499067|588737992|FG000|First Intervention|Physician Decision|2|||
163009628|NCT03499067|588737993|FG001|First Intervention|Physician Decision|1|||
163009629|NCT03499067|588737992|FG000|First Intervention|Withdrawal by Subject|3|||
163009630|NCT03499067|588737993|FG001|First Intervention|Withdrawal by Subject|6|||
163009631|NCT03776357|588737996|FG000|Overall Study|Lost to Follow-up|3|||
163009632|NCT02211209|588737998|FG000|Overall Study|Investigator judgment|0|||
163009633|NCT02211209|588737999|FG001|Overall Study|Investigator judgment|1|||
163009634|NCT02211209|588737998|FG000|Overall Study|Voluntary withdrawal|1|||
163009635|NCT02211209|588737999|FG001|Overall Study|Voluntary withdrawal|4|||
163009636|NCT02211209|588737998|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
163009637|NCT02211209|588737999|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
163009638|NCT02211209|588737998|FG000|Overall Study|Reason Not Specified|1|||
163009639|NCT02211209|588737999|FG001|Overall Study|Reason Not Specified|0|||
163214165|NCT04339296|589497697|FG001|Overall Study|Withdrew after completion of baseline|1|||
163327681|NCT03691493|589909857|FG000|Overall Study|Withdrawal by Subject|1|||
163384890|NCT00427895|590119257|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
163384891|NCT00427895|590119250|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
163384892|NCT00427895|590119251|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
163384893|NCT00427895|590119252|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
163384894|NCT00427895|590119253|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
163384895|NCT00427895|590119254|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
163384896|NCT00427895|590119255|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
163009640|NCT03889418|588738003|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
163009641|NCT03889418|588738004|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009642|NCT03889418|588738005|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009643|NCT03889418|588738006|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163214166|NCT04339296|589497696|FG000|Overall Study|Lost to Follow-up|0|||
163214167|NCT04339296|589497697|FG001|Overall Study|Lost to Follow-up|4|||
163214168|NCT04339296|589497696|FG000|Overall Study|Discontinued intervention|5|||
163214169|NCT04339296|589497697|FG001|Overall Study|Discontinued intervention|3|||
163214170|NCT03424265|589497698|FG000|Overall Study|screening failure|1|||
163214171|NCT03424265|589497699|FG001|Overall Study|screening failure|0|||
163214172|NCT03424265|589497698|FG000|Overall Study|Withdrawal by Subject|0|||
163214173|NCT03424265|589497699|FG001|Overall Study|Withdrawal by Subject|2|||
163214174|NCT00453544|589497700|FG000|Overall Study|Withdrawal by Subject|1|||
163214175|NCT00453544|589497701|FG001|Overall Study|Withdrawal by Subject|0|||
163214176|NCT00453544|589497702|FG002|Overall Study|Withdrawal by Subject|0|||
163214177|NCT00453544|589497703|FG003|Overall Study|Withdrawal by Subject|0|||
163214178|NCT00453544|589497700|FG000|Overall Study|Primary outcome measure not completed|1|||
163214179|NCT00453544|589497701|FG001|Overall Study|Primary outcome measure not completed|1|||
163214180|NCT00453544|589497702|FG002|Overall Study|Primary outcome measure not completed|0|||
163214181|NCT00453544|589497703|FG003|Overall Study|Primary outcome measure not completed|1|||
163214182|NCT01558752|589497704|FG000|Overall Study|Physician Decision|2|||
163214183|NCT01558752|589497705|FG001|Overall Study|Physician Decision|0|||
163214184|NCT01829230|589497706|FG000|Overall Study|Protocol Violation|0|||
163214185|NCT01829230|589497707|FG001|Overall Study|Protocol Violation|2|||
163214186|NCT01829230|589497706|FG000|Overall Study|Withdrawal by Subject|0|||
163214187|NCT01829230|589497707|FG001|Overall Study|Withdrawal by Subject|1|||
163214188|NCT01829230|589497706|FG000|Overall Study|Lost to Follow-up|1|||
163214189|NCT01829230|589497707|FG001|Overall Study|Lost to Follow-up|1|||
163214190|NCT00969150|589497708|FG000|Overall Study|Adverse Event|4|||
163214191|NCT00969150|589497709|FG001|Overall Study|Adverse Event|14|||
163214192|NCT00969150|589497708|FG000|Overall Study|Lack of Efficacy|1|||
163214193|NCT00969150|589497709|FG001|Overall Study|Lack of Efficacy|1|||
163214194|NCT00969150|589497708|FG000|Overall Study|Protocol Violation|9|||
163214195|NCT00969150|589497709|FG001|Overall Study|Protocol Violation|12|||
163214196|NCT00969150|589497708|FG000|Overall Study|Withdrawal by Subject|13|||
163214197|NCT00969150|589497709|FG001|Overall Study|Withdrawal by Subject|9|||
163214198|NCT00969150|589497708|FG000|Overall Study|Lost to Follow-up|5|||
163214199|NCT00969150|589497709|FG001|Overall Study|Lost to Follow-up|4|||
163214200|NCT00969150|589497708|FG000|Overall Study|Other reasons|1|||
163214201|NCT00969150|589497709|FG001|Overall Study|Other reasons|0|||
163214202|NCT00461682|589497710|FG000|Overall Study|Protocol Violation|1|||
163214203|NCT01367158|589497711|FG000|Overall Study|Withdrew consent|0|||
163214204|NCT01367158|589497712|FG001|Overall Study|Withdrew consent|2|||
163214205|NCT01367158|589497713|FG002|Overall Study|Withdrew consent|1|||
163214206|NCT01367158|589497714|FG003|Overall Study|Withdrew consent|0|||
163009644|NCT03889418|588738007|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009645|NCT03889418|588738008|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009646|NCT03889418|588738009|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009647|NCT03889418|588738010|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009648|NCT03889418|588738011|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009649|NCT03889418|588738012|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009650|NCT03889418|588738003|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009651|NCT03889418|588738004|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
163009652|NCT03889418|588738005|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
163327682|NCT03459196|589911450|FG000|Overall Study|Subject didn't receive study catheter|2|||
163327683|NCT03367156|589911451|FG000|Overall Study|Lack of interest|3|||
163327684|NCT03367156|589911452|FG001|Overall Study|Lack of interest|1|||
163327685|NCT03367156|589911451|FG000|Overall Study|Death|2|||
163327686|NCT03367156|589911452|FG001|Overall Study|Death|0|||
163327687|NCT03367156|589911451|FG000|Overall Study|Lost to Follow-up|2|||
163327688|NCT03367156|589911452|FG001|Overall Study|Lost to Follow-up|1|||
163327689|NCT03367156|589911451|FG000|Overall Study|Became ineligible|1|||
163327690|NCT03367156|589911452|FG001|Overall Study|Became ineligible|2|||
163327691|NCT03367156|589911451|FG000|Overall Study|Hospitalization|1|||
163327692|NCT03367156|589911452|FG001|Overall Study|Hospitalization|0|||
163327693|NCT03367156|589911451|FG000|Overall Study|Concerned about Treatment|11|||
163327694|NCT03367156|589911452|FG001|Overall Study|Concerned about Treatment|3|||
163327695|NCT03367156|589911451|FG000|Overall Study|Started new treatment|4|||
163327696|NCT03367156|589911452|FG001|Overall Study|Started new treatment|1|||
163327697|NCT03762850|589911453|FG000|Overall Study|Death|0|||
163327698|NCT03762850|589911454|FG001|Overall Study|Death|1|||
163327699|NCT03762850|589911453|FG000|Overall Study|Lost to Follow-up|0|||
163327700|NCT03762850|589911454|FG001|Overall Study|Lost to Follow-up|1|||
163327701|NCT03762850|589911453|FG000|Overall Study|Physician Decision|0|||
163327702|NCT03762850|589911454|FG001|Overall Study|Physician Decision|1|||
163327703|NCT03762850|589911453|FG000|Overall Study|Withdrawal by Subject|4|||
163327704|NCT03762850|589911454|FG001|Overall Study|Withdrawal by Subject|9|||
163327705|NCT00092534|589911457|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
163327706|NCT00092534|589911458|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
163327707|NCT00092534|589911459|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
163327708|NCT00092534|589911460|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
163327709|NCT00092534|589911461|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
163327710|NCT00092534|589911457|FG000|Base Study Vaccination Period|Adverse Event|3|||
163404523|NCT01500278|590191955|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
163009653|NCT03889418|588738006|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009654|NCT03889418|588738007|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009655|NCT03889418|588738008|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009656|NCT03889418|588738009|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009657|NCT03889418|588738010|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009658|NCT03889418|588738011|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009659|NCT03889418|588738012|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009660|NCT03889418|588738003|FG000|October-December 2019 (Month 7-9)|Death|0|||
163009661|NCT03889418|588738004|FG001|October-December 2019 (Month 7-9)|Death|0|||
163009662|NCT03889418|588738005|FG002|October-December 2019 (Month 7-9)|Death|0|||
163009663|NCT03889418|588738006|FG003|October-December 2019 (Month 7-9)|Death|0|||
163009664|NCT03889418|588738007|FG004|October-December 2019 (Month 7-9)|Death|0|||
163009665|NCT03889418|588738008|FG005|October-December 2019 (Month 7-9)|Death|0|||
163009666|NCT03889418|588738009|FG006|October-December 2019 (Month 7-9)|Death|0|||
163009667|NCT03889418|588738010|FG007|October-December 2019 (Month 7-9)|Death|0|||
163009668|NCT03889418|588738011|FG008|October-December 2019 (Month 7-9)|Death|1|||
163009669|NCT03889418|588738012|FG009|October-December 2019 (Month 7-9)|Death|0|||
163009670|NCT03889418|588738003|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009671|NCT03889418|588738004|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009672|NCT03889418|588738005|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009673|NCT03889418|588738006|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
163009674|NCT03889418|588738007|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009675|NCT03889418|588738008|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009676|NCT03889418|588738009|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009677|NCT03889418|588738010|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
163009678|NCT03889418|588738011|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009679|NCT03889418|588738012|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009680|NCT03889418|588738003|FG000|April - June 2020 (Month 13-15)|Death|0|||
163327711|NCT00092534|589911458|FG001|Base Study Vaccination Period|Adverse Event|1|||
163327712|NCT00092534|589911459|FG002|Base Study Vaccination Period|Adverse Event|0|||
163327713|NCT00092534|589911460|FG003|Base Study Vaccination Period|Adverse Event|0|||
163327714|NCT00092534|589911461|FG004|Base Study Vaccination Period|Adverse Event|0|||
163327715|NCT00092534|589911457|FG000|Base Study Vaccination Period|Death|5|||
163009681|NCT03889418|588738004|FG001|April - June 2020 (Month 13-15)|Death|1|||
163009682|NCT03889418|588738005|FG002|April - June 2020 (Month 13-15)|Death|0|||
163009683|NCT03889418|588738006|FG003|April - June 2020 (Month 13-15)|Death|0|||
163009684|NCT03889418|588738007|FG004|April - June 2020 (Month 13-15)|Death|0|||
163009685|NCT03889418|588738008|FG005|April - June 2020 (Month 13-15)|Death|0|||
163009686|NCT03889418|588738009|FG006|April - June 2020 (Month 13-15)|Death|0|||
163009687|NCT03889418|588738010|FG007|April - June 2020 (Month 13-15)|Death|0|||
163009688|NCT03889418|588738011|FG008|April - June 2020 (Month 13-15)|Death|0|||
163009689|NCT03889418|588738012|FG009|April - June 2020 (Month 13-15)|Death|0|||
163009690|NCT03889418|588738003|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009691|NCT03889418|588738004|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009692|NCT03889418|588738005|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009693|NCT03889418|588738006|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
163009694|NCT03889418|588738007|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009695|NCT03889418|588738008|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009696|NCT03889418|588738009|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009697|NCT03889418|588738010|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009698|NCT03889418|588738011|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009699|NCT03889418|588738012|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009700|NCT03889418|588738003|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
163009701|NCT03889418|588738004|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
163009702|NCT03889418|588738005|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
163009703|NCT03889418|588738006|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
163009704|NCT03889418|588738007|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
163009705|NCT03889418|588738008|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
163009706|NCT03889418|588738009|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
163009707|NCT03889418|588738010|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
163009708|NCT03889418|588738011|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
163009709|NCT03889418|588738012|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
163009710|NCT03889418|588738003|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
163009711|NCT03889418|588738004|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
163009712|NCT03889418|588738005|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
163009713|NCT03889418|588738006|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
163009714|NCT03889418|588738007|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
163009715|NCT03889418|588738008|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
163009716|NCT03889418|588738009|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
163009717|NCT03889418|588738010|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
163009718|NCT03889418|588738011|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
163009719|NCT03889418|588738012|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
163327716|NCT00092534|589911458|FG001|Base Study Vaccination Period|Death|4|||
163327717|NCT00092534|589911459|FG002|Base Study Vaccination Period|Death|0|||
163327718|NCT00092534|589911460|FG003|Base Study Vaccination Period|Death|0|||
163327719|NCT00092534|589911461|FG004|Base Study Vaccination Period|Death|0|||
163327720|NCT00092534|589911457|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
163327721|NCT00092534|589911458|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
163327722|NCT00092534|589911459|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
163327723|NCT00092534|589911460|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
163327724|NCT00092534|589911461|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
163327725|NCT00092534|589911457|FG000|Base Study Vaccination Period|Physician Decision|1|||
163327726|NCT00092534|589911458|FG001|Base Study Vaccination Period|Physician Decision|0|||
163327727|NCT00092534|589911459|FG002|Base Study Vaccination Period|Physician Decision|0|||
163327728|NCT00092534|589911460|FG003|Base Study Vaccination Period|Physician Decision|0|||
163327729|NCT00092534|589911461|FG004|Base Study Vaccination Period|Physician Decision|0|||
163327730|NCT00092534|589911457|FG000|Base Study Vaccination Period|Pregnancy|9|||
163327731|NCT00092534|589911458|FG001|Base Study Vaccination Period|Pregnancy|7|||
163327732|NCT00092534|589911459|FG002|Base Study Vaccination Period|Pregnancy|0|||
163327733|NCT00092534|589911460|FG003|Base Study Vaccination Period|Pregnancy|0|||
163327734|NCT00092534|589911461|FG004|Base Study Vaccination Period|Pregnancy|0|||
163009720|NCT00837148|588738016|FG000|Overall Study|Adverse Event|1|||
163009721|NCT00837148|588738016|FG000|Overall Study|Death|1|||
163009722|NCT01827111|588738017|FG000|Overall Study|Disease Progression|1|||
163009723|NCT03181633|588738018|FG000|Overall Study|Withdrawal by Subject|1|||
163009724|NCT03181633|588738018|FG000|Overall Study|Missing follow-up visit|1|||
163009725|NCT04383327|588738025|FG000|Overall Study|Lost to Follow-up|112|||
163327735|NCT00092534|589911457|FG000|Base Study Vaccination Period|Protocol Violation|2|||
163327736|NCT00092534|589911458|FG001|Base Study Vaccination Period|Protocol Violation|1|||
163327737|NCT00092534|589911459|FG002|Base Study Vaccination Period|Protocol Violation|0|||
163327738|NCT00092534|589911460|FG003|Base Study Vaccination Period|Protocol Violation|0|||
163009726|NCT04383327|588738026|FG001|Overall Study|Lost to Follow-up|14|||
163009727|NCT04383327|588738027|FG002|Overall Study|Lost to Follow-up|78|||
163009728|NCT04383327|588738028|FG003|Overall Study|Lost to Follow-up|13|||
163061694|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
163214207|NCT01367158|589497715|FG004|Overall Study|Withdrew consent|2|||
162924769|NCT03014570|588426119|FG001|Overall Study|Hospitalized|3|||
162924770|NCT03014570|588426118|FG000|Overall Study|Transfer within facility|1|||
162924771|NCT03014570|588426119|FG001|Overall Study|Transfer within facility|0|||
162924772|NCT03014570|588426118|FG000|Overall Study|Site refusal|0|||
162924773|NCT03014570|588426119|FG001|Overall Study|Site refusal|11|||
162924774|NCT01154673|588426120|FG000|Overall Study|Lost to Follow-up|1|||
162924775|NCT01154673|588426121|FG001|Overall Study|Lost to Follow-up|0|||
162924776|NCT01154673|588426120|FG000|Overall Study|moved out of province|1|||
162924777|NCT01154673|588426121|FG001|Overall Study|moved out of province|0|||
162924778|NCT01216319|588426125|FG000|Overall Study|Lost to Follow-up|2|||
162924779|NCT01216319|588426125|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
162924780|NCT02666768|588426128|FG000|Overall Study|Withdrawal by Subject|4|||
162924781|NCT03728257|588426129|FG000|Overall Study|Death|3|||
162924782|NCT03728257|588426130|FG001|Overall Study|Death|0|||
162924783|NCT00621309|588426131|FG000|Overall Study|Withdrawal by Subject|2|||
162924784|NCT00621309|588426132|FG001|Overall Study|Withdrawal by Subject|0|||
162924785|NCT00621309|588426133|FG002|Overall Study|Withdrawal by Subject|1|||
162924786|NCT00621309|588426134|FG003|Overall Study|Withdrawal by Subject|1|||
162924787|NCT00621309|588426135|FG004|Overall Study|Withdrawal by Subject|1|||
162924788|NCT00621309|588426136|FG005|Overall Study|Withdrawal by Subject|1|||
162924789|NCT04993339|588426137|FG000|Overall Study|Lost to Follow-up|0|||
162924790|NCT04993339|588426138|FG001|Overall Study|Lost to Follow-up|1|||
162924791|NCT04993339|588426137|FG000|Overall Study|no MRI scan|3|||
162924792|NCT04993339|588426138|FG001|Overall Study|no MRI scan|1|||
162924793|NCT00797316|588426139|FG000|Overall Study|Administrative problems|1|||
162924794|NCT00797316|588426140|FG001|Overall Study|Administrative problems|0|||
162924795|NCT00797316|588426139|FG000|Overall Study|Adverse Event|5|||
162924796|NCT00797316|588426140|FG001|Overall Study|Adverse Event|3|||
162924797|NCT00797316|588426139|FG000|Overall Study|Lost to Follow-up|4|||
162924798|NCT00797316|588426140|FG001|Overall Study|Lost to Follow-up|8|||
162924799|NCT00797316|588426139|FG000|Overall Study|Protocol Deviation|1|||
162924800|NCT00797316|588426140|FG001|Overall Study|Protocol Deviation|2|||
162924801|NCT00797316|588426139|FG000|Overall Study|Patient withdrew consent|12|||
162924802|NCT00797316|588426140|FG001|Overall Study|Patient withdrew consent|6|||
162924803|NCT00797316|588426139|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162924804|NCT00797316|588426140|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
162924805|NCT00402779|588426143|FG000|Overall Study|Screen Failure|77|||
162924806|NCT00402779|588426144|FG001|Overall Study|Screen Failure|76|||
162924807|NCT03075215|588426145|FG000|12-Month Primary Endpoint|Death|152|||
162924808|NCT03075215|588426145|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
162924809|NCT03075215|588426145|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
162924810|NCT03075215|588426145|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
162924811|NCT00690573|588426154|FG000|Overall Study|Lack of Efficacy|8|||
162924812|NCT00690573|588426154|FG000|Overall Study|Withdrawal by Subject|1|||
162924813|NCT00777920|588426155|FG000|Overall Study|Adverse Event|39|||
162924814|NCT00777920|588426155|FG000|Overall Study|Withdrawal of Consent|4|||
162924815|NCT00777920|588426155|FG000|Overall Study|Lost to Follow-up|1|||
162924816|NCT00777920|588426155|FG000|Overall Study|Investigator's discretion|1|||
162924817|NCT00777920|588426155|FG000|Overall Study|Clinical status did not improve|1|||
162924818|NCT00777920|588426155|FG000|Overall Study|Other, not specified|4|||
162924819|NCT02146365|588426156|FG000|Overall Study|Lost to Follow-up|2|||
162924820|NCT02146365|588426157|FG001|Overall Study|Lost to Follow-up|1|||
162924821|NCT02146365|588426158|FG002|Overall Study|Lost to Follow-up|3|||
163214208|NCT01367158|589497716|FG005|Overall Study|Withdrew consent|0|||
163214209|NCT01367158|589497717|FG006|Overall Study|Withdrew consent|0|||
163214210|NCT01367158|589497718|FG007|Overall Study|Withdrew consent|1|||
163214211|NCT01367158|589497719|FG008|Overall Study|Withdrew consent|0|||
163214212|NCT01367158|589497720|FG009|Overall Study|Withdrew consent|0|||
163214213|NCT01367158|589497721|FG010|Overall Study|Withdrew consent|0|||
163214214|NCT01367158|589497711|FG000|Overall Study|Lost to Follow-up|0|||
163214215|NCT01367158|589497712|FG001|Overall Study|Lost to Follow-up|0|||
163214216|NCT01367158|589497713|FG002|Overall Study|Lost to Follow-up|0|||
163214217|NCT01367158|589497714|FG003|Overall Study|Lost to Follow-up|1|||
163214218|NCT01367158|589497715|FG004|Overall Study|Lost to Follow-up|0|||
163214219|NCT01367158|589497716|FG005|Overall Study|Lost to Follow-up|2|||
163214220|NCT01367158|589497717|FG006|Overall Study|Lost to Follow-up|0|||
163214221|NCT01367158|589497718|FG007|Overall Study|Lost to Follow-up|1|||
163214222|NCT01367158|589497719|FG008|Overall Study|Lost to Follow-up|0|||
163214223|NCT01367158|589497720|FG009|Overall Study|Lost to Follow-up|0|||
163214224|NCT01367158|589497721|FG010|Overall Study|Lost to Follow-up|1|||
163214225|NCT01367158|589497711|FG000|Overall Study|Protocol Violation|0|||
163214226|NCT01367158|589497712|FG001|Overall Study|Protocol Violation|1|||
163214227|NCT01367158|589497713|FG002|Overall Study|Protocol Violation|0|||
163214228|NCT01367158|589497714|FG003|Overall Study|Protocol Violation|0|||
163214229|NCT01367158|589497715|FG004|Overall Study|Protocol Violation|0|||
163214230|NCT01367158|589497716|FG005|Overall Study|Protocol Violation|0|||
163327739|NCT00092534|589911461|FG004|Base Study Vaccination Period|Protocol Violation|0|||
163327740|NCT00092534|589911457|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
163327741|NCT00092534|589911458|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
163327742|NCT00092534|589911459|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
163327743|NCT00092534|589911460|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
163327744|NCT00092534|589911461|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
163327745|NCT00092534|589911457|FG000|Base Study Vaccination Period|Moved|14|||
163327746|NCT00092534|589911458|FG001|Base Study Vaccination Period|Moved|12|||
163009729|NCT04383327|588738029|FG004|Overall Study|Lost to Follow-up|110|||
163009730|NCT04383327|588738030|FG005|Overall Study|Lost to Follow-up|13|||
163009731|NCT04383327|588738031|FG006|Overall Study|Lost to Follow-up|74|||
163009732|NCT04383327|588738032|FG007|Overall Study|Lost to Follow-up|13|||
163009733|NCT04383327|588738033|FG008|Overall Study|Lost to Follow-up|78|||
163009734|NCT04383327|588738034|FG009|Overall Study|Lost to Follow-up|10|||
163009735|NCT04383327|588738035|FG010|Overall Study|Lost to Follow-up|160|||
163009736|NCT04383327|588738036|FG011|Overall Study|Lost to Follow-up|13|||
163009737|NCT04837196|588738037|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
163009738|NCT04837196|588738038|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
163009739|NCT04837196|588738039|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
163009740|NCT04837196|588738040|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
163009741|NCT04837196|588738041|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
163009742|NCT04837196|588738037|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
163009743|NCT04837196|588738038|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
163009744|NCT04837196|588738039|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
163009745|NCT04837196|588738040|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
163009746|NCT04837196|588738041|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
163009747|NCT04837196|588738037|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
163009748|NCT04837196|588738038|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
163009749|NCT04837196|588738039|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
163009750|NCT04837196|588738040|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
163009751|NCT04837196|588738041|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
163009752|NCT04837196|588738037|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
163009753|NCT04837196|588738038|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
163009754|NCT04837196|588738039|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
163009755|NCT04837196|588738040|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
163009756|NCT04837196|588738041|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
163009757|NCT04837196|588738037|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
163009758|NCT04837196|588738038|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
163009759|NCT04837196|588738039|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
163009760|NCT04837196|588738040|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
163009761|NCT04837196|588738041|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
163009762|NCT00991887|588738042|FG000|Overall Study|Lost to Follow-up|2|||
163009763|NCT00991887|588738043|FG001|Overall Study|Lost to Follow-up|1|||
163009764|NCT01306305|588738044|FG000|Overall Study|Lost to Follow-up|1|||
163009765|NCT01306305|588738045|FG001|Overall Study|Lost to Follow-up|0|||
163009766|NCT01306305|588738044|FG000|Overall Study|Withdrew consent|1|||
163009767|NCT01306305|588738045|FG001|Overall Study|Withdrew consent|0|||
163009768|NCT01964976|588738046|FG000|Overall Study|Protocol Violation|31|||
163009769|NCT01256879|588738047|FG000|Overall Study|Withdrawal by Subject|1|||
163009770|NCT02964247|588738049|FG000|Overall Study|Lost to Follow-up|2|||
163009771|NCT02964247|588738050|FG001|Overall Study|Lost to Follow-up|0|||
163009772|NCT02964247|588738049|FG000|Overall Study|Withdrawal by Subject|1|||
163009773|NCT02964247|588738050|FG001|Overall Study|Withdrawal by Subject|2|||
163009774|NCT00725920|588738051|FG000|Overall Study|Lack of Efficacy|3|||
163009775|NCT00725920|588738052|FG001|Overall Study|Lack of Efficacy|6|||
163009776|NCT00359424|588738053|FG000|Overall Study|Death|99|||
163009777|NCT00359424|588738054|FG001|Overall Study|Death|58|||
163009778|NCT00359424|588738053|FG000|Overall Study|Lost to Follow-up|19|||
163009779|NCT00359424|588738054|FG001|Overall Study|Lost to Follow-up|7|||
163214231|NCT01367158|589497717|FG006|Overall Study|Protocol Violation|0|||
163214232|NCT01367158|589497718|FG007|Overall Study|Protocol Violation|0|||
163214233|NCT01367158|589497719|FG008|Overall Study|Protocol Violation|0|||
163214234|NCT01367158|589497720|FG009|Overall Study|Protocol Violation|0|||
163214235|NCT01367158|589497721|FG010|Overall Study|Protocol Violation|0|||
163214236|NCT01765153|589497722|FG000|Training Phase 1|Format of intervention differed|1|||
163214237|NCT01765153|589497723|FG001|Training Phase 1|Format of intervention differed|0|||
163214238|NCT01765153|589497722|FG000|Training Phase 1|Poor participation in intervention|0|||
163214239|NCT01765153|589497723|FG001|Training Phase 1|Poor participation in intervention|1|||
163214240|NCT01765153|589497722|FG000|Rest Phase 1|Withdrawal by Subject|0|||
163214241|NCT01765153|589497723|FG001|Rest Phase 1|Withdrawal by Subject|1|||
163214242|NCT01765153|589497722|FG000|Training Phase 2|Withdrawal by Subject|0|||
163327747|NCT00092534|589911459|FG002|Base Study Vaccination Period|Moved|0|||
163327748|NCT00092534|589911460|FG003|Base Study Vaccination Period|Moved|0|||
163327749|NCT00092534|589911461|FG004|Base Study Vaccination Period|Moved|0|||
163327750|NCT00092534|589911457|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
163327751|NCT00092534|589911458|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
163327752|NCT00092534|589911459|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
163327753|NCT00092534|589911460|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
163327754|NCT00092534|589911461|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
163327755|NCT00092534|589911457|FG000|Base Study Vaccination Period|Travel|1|||
163327756|NCT00092534|589911458|FG001|Base Study Vaccination Period|Travel|0|||
163327757|NCT00092534|589911459|FG002|Base Study Vaccination Period|Travel|0|||
163327758|NCT00092534|589911460|FG003|Base Study Vaccination Period|Travel|0|||
163327759|NCT00092534|589911461|FG004|Base Study Vaccination Period|Travel|0|||
163327760|NCT00092534|589911457|FG000|Base Study Vaccination Period|Site Closed|0|||
163327761|NCT00092534|589911458|FG001|Base Study Vaccination Period|Site Closed|1|||
163327762|NCT00092534|589911459|FG002|Base Study Vaccination Period|Site Closed|0|||
163327763|NCT00092534|589911460|FG003|Base Study Vaccination Period|Site Closed|0|||
163327764|NCT00092534|589911461|FG004|Base Study Vaccination Period|Site Closed|0|||
163327765|NCT00092534|589911457|FG000|Base Study Follow-Up Period|Adverse Event|2|||
163327766|NCT00092534|589911458|FG001|Base Study Follow-Up Period|Adverse Event|4|||
163327767|NCT00092534|589911459|FG002|Base Study Follow-Up Period|Adverse Event|0|||
163327768|NCT00092534|589911460|FG003|Base Study Follow-Up Period|Adverse Event|0|||
163327769|NCT00092534|589911461|FG004|Base Study Follow-Up Period|Adverse Event|0|||
163327770|NCT00092534|589911457|FG000|Base Study Follow-Up Period|Death|2|||
163327771|NCT00092534|589911458|FG001|Base Study Follow-Up Period|Death|1|||
163327772|NCT00092534|589911459|FG002|Base Study Follow-Up Period|Death|0|||
163327773|NCT00092534|589911460|FG003|Base Study Follow-Up Period|Death|0|||
163327774|NCT00092534|589911461|FG004|Base Study Follow-Up Period|Death|0|||
163327775|NCT00092534|589911457|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
163327776|NCT00092534|589911458|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
163327777|NCT00092534|589911459|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
163327778|NCT00092534|589911460|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
163327779|NCT00092534|589911461|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
162924822|NCT02146365|588426159|FG003|Overall Study|Lost to Follow-up|3|||
162924823|NCT02146365|588426160|FG004|Overall Study|Lost to Follow-up|1|||
162924824|NCT02146365|588426161|FG005|Overall Study|Lost to Follow-up|1|||
162924825|NCT02146365|588426162|FG006|Overall Study|Lost to Follow-up|0|||
162924826|NCT02146365|588426163|FG007|Overall Study|Lost to Follow-up|1|||
162924827|NCT02146365|588426156|FG000|Overall Study|Withdrawal by Subject|1|||
162924828|NCT02146365|588426157|FG001|Overall Study|Withdrawal by Subject|2|||
162924829|NCT02146365|588426158|FG002|Overall Study|Withdrawal by Subject|1|||
162924830|NCT02146365|588426159|FG003|Overall Study|Withdrawal by Subject|5|||
162924831|NCT02146365|588426160|FG004|Overall Study|Withdrawal by Subject|1|||
162924832|NCT02146365|588426161|FG005|Overall Study|Withdrawal by Subject|0|||
162924833|NCT02146365|588426162|FG006|Overall Study|Withdrawal by Subject|0|||
162924834|NCT02146365|588426163|FG007|Overall Study|Withdrawal by Subject|0|||
162924835|NCT02146365|588426156|FG000|Overall Study|Unable to Comply with Protocol|0|||
162924836|NCT02146365|588426157|FG001|Overall Study|Unable to Comply with Protocol|1|||
162924837|NCT02146365|588426158|FG002|Overall Study|Unable to Comply with Protocol|1|||
162924838|NCT02146365|588426159|FG003|Overall Study|Unable to Comply with Protocol|0|||
162924839|NCT02146365|588426160|FG004|Overall Study|Unable to Comply with Protocol|0|||
162924840|NCT02146365|588426161|FG005|Overall Study|Unable to Comply with Protocol|0|||
162924841|NCT02146365|588426162|FG006|Overall Study|Unable to Comply with Protocol|0|||
162924842|NCT02146365|588426163|FG007|Overall Study|Unable to Comply with Protocol|0|||
162924843|NCT02146365|588426156|FG000|Overall Study|Other|1|||
162924844|NCT02146365|588426157|FG001|Overall Study|Other|0|||
162924845|NCT02146365|588426158|FG002|Overall Study|Other|2|||
162924846|NCT02146365|588426159|FG003|Overall Study|Other|1|||
162924847|NCT02146365|588426160|FG004|Overall Study|Other|0|||
162924848|NCT02146365|588426161|FG005|Overall Study|Other|0|||
162924849|NCT02146365|588426162|FG006|Overall Study|Other|0|||
162924850|NCT02146365|588426163|FG007|Overall Study|Other|0|||
162924851|NCT02332655|588426164|FG000|Overall Study|Lack of Efficacy|1|||
162924852|NCT01977482|588426165|FG000|Overall Study|Adverse Event|0|||
162924853|NCT01977482|588426166|FG001|Overall Study|Adverse Event|1|||
162924854|NCT01977482|588426167|FG002|Overall Study|Adverse Event|1|||
162924855|NCT01977482|588426168|FG003|Overall Study|Adverse Event|0|||
162924856|NCT01977482|588426169|FG004|Overall Study|Adverse Event|2|||
162924857|NCT01977482|588426170|FG005|Overall Study|Adverse Event|0|||
162924858|NCT01977482|588426165|FG000|Overall Study|Lost to Follow-up|1|||
162924859|NCT01977482|588426166|FG001|Overall Study|Lost to Follow-up|0|||
162924860|NCT01977482|588426167|FG002|Overall Study|Lost to Follow-up|0|||
163327780|NCT00092534|589911457|FG000|Base Study Follow-Up Period|Pregnancy|6|||
163327781|NCT00092534|589911458|FG001|Base Study Follow-Up Period|Pregnancy|10|||
163327782|NCT00092534|589911459|FG002|Base Study Follow-Up Period|Pregnancy|0|||
162924861|NCT01977482|588426168|FG003|Overall Study|Lost to Follow-up|0|||
163327783|NCT00092534|589911460|FG003|Base Study Follow-Up Period|Pregnancy|0|||
163327784|NCT00092534|589911461|FG004|Base Study Follow-Up Period|Pregnancy|0|||
163327785|NCT00092534|589911457|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
163327786|NCT00092534|589911458|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
163327787|NCT00092534|589911459|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
163327788|NCT00092534|589911460|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
163327789|NCT00092534|589911461|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
163327790|NCT00092534|589911457|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
163327791|NCT00092534|589911458|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
163327792|NCT00092534|589911459|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
163327793|NCT00092534|589911460|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
163327794|NCT00092534|589911461|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
163327795|NCT00092534|589911457|FG000|Base Study Follow-Up Period|Moved|62|||
163327796|NCT00092534|589911458|FG001|Base Study Follow-Up Period|Moved|58|||
163327797|NCT00092534|589911459|FG002|Base Study Follow-Up Period|Moved|0|||
163327798|NCT00092534|589911460|FG003|Base Study Follow-Up Period|Moved|0|||
163327799|NCT00092534|589911461|FG004|Base Study Follow-Up Period|Moved|0|||
163327800|NCT00092534|589911457|FG000|Base Study Follow-Up Period|Travel|10|||
163327801|NCT00092534|589911458|FG001|Base Study Follow-Up Period|Travel|7|||
163327802|NCT00092534|589911459|FG002|Base Study Follow-Up Period|Travel|0|||
163327803|NCT00092534|589911460|FG003|Base Study Follow-Up Period|Travel|0|||
163327804|NCT00092534|589911461|FG004|Base Study Follow-Up Period|Travel|0|||
163327805|NCT00092534|589911457|FG000|Base Study Follow-Up Period|Site Closed|0|||
163327806|NCT00092534|589911458|FG001|Base Study Follow-Up Period|Site Closed|2|||
163327807|NCT00092534|589911459|FG002|Base Study Follow-Up Period|Site Closed|0|||
163327808|NCT00092534|589911460|FG003|Base Study Follow-Up Period|Site Closed|0|||
163327809|NCT00092534|589911461|FG004|Base Study Follow-Up Period|Site Closed|0|||
163327810|NCT00092534|589911457|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
163327811|NCT00092534|589911458|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
163327812|NCT00092534|589911459|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
163327813|NCT00092534|589911460|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
163327814|NCT00092534|589911461|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
163327815|NCT00092534|589911457|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
163327816|NCT00092534|589911458|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
163327817|NCT00092534|589911459|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
163327818|NCT00092534|589911460|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
163327819|NCT00092534|589911461|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
163327820|NCT00092534|589911457|FG000|Base Study EXT|Lost to Follow-up|0|||
163327821|NCT00092534|589911458|FG001|Base Study EXT|Lost to Follow-up|0|||
163327822|NCT00092534|589911459|FG002|Base Study EXT|Lost to Follow-up|41|||
163327823|NCT00092534|589911460|FG003|Base Study EXT|Lost to Follow-up|0|||
163327824|NCT00092534|589911461|FG004|Base Study EXT|Lost to Follow-up|0|||
163327825|NCT00092534|589911457|FG000|Base Study EXT|Physician Decision|0|||
163327826|NCT00092534|589911458|FG001|Base Study EXT|Physician Decision|0|||
163327827|NCT00092534|589911459|FG002|Base Study EXT|Physician Decision|1|||
163327828|NCT00092534|589911460|FG003|Base Study EXT|Physician Decision|0|||
163327829|NCT00092534|589911461|FG004|Base Study EXT|Physician Decision|0|||
163327830|NCT00092534|589911457|FG000|Base Study EXT|Pregnancy|0|||
163327831|NCT00092534|589911458|FG001|Base Study EXT|Pregnancy|0|||
163327832|NCT00092534|589911459|FG002|Base Study EXT|Pregnancy|12|||
163327833|NCT00092534|589911460|FG003|Base Study EXT|Pregnancy|0|||
163327834|NCT00092534|589911461|FG004|Base Study EXT|Pregnancy|0|||
163327835|NCT00092534|589911457|FG000|Base Study EXT|Withdrawal by Subject|0|||
163327836|NCT00092534|589911458|FG001|Base Study EXT|Withdrawal by Subject|0|||
163327837|NCT00092534|589911459|FG002|Base Study EXT|Withdrawal by Subject|18|||
163009780|NCT00359424|588738053|FG000|Overall Study|Withdrawal by Subject|10|||
163009781|NCT00359424|588738054|FG001|Overall Study|Withdrawal by Subject|2|||
163009782|NCT00359424|588738053|FG000|Overall Study|follow up not conducted|2|||
163009783|NCT00359424|588738054|FG001|Overall Study|follow up not conducted|0|||
163009784|NCT06018129|588738055|FG000|Overall Study|Death|1|||
163327838|NCT00092534|589911460|FG003|Base Study EXT|Withdrawal by Subject|0|||
163327839|NCT00092534|589911461|FG004|Base Study EXT|Withdrawal by Subject|0|||
163327840|NCT00092534|589911457|FG000|Base Study EXT|Participant moved|0|||
163327841|NCT00092534|589911458|FG001|Base Study EXT|Participant moved|0|||
163327842|NCT00092534|589911459|FG002|Base Study EXT|Participant moved|6|||
163009785|NCT06018129|588738056|FG001|Overall Study|Death|1|||
163009786|NCT06018129|588738057|FG002|Overall Study|Death|2|||
163009787|NCT06018129|588738055|FG000|Overall Study|Sponsor Decision|2|||
163009788|NCT06018129|588738056|FG001|Overall Study|Sponsor Decision|2|||
163009789|NCT06018129|588738057|FG002|Overall Study|Sponsor Decision|1|||
163327843|NCT00092534|589911460|FG003|Base Study EXT|Participant moved|0|||
163327844|NCT00092534|589911461|FG004|Base Study EXT|Participant moved|0|||
163327845|NCT00092534|589911457|FG000|Base Study EXT|Travel|0|||
163327846|NCT00092534|589911458|FG001|Base Study EXT|Travel|0|||
163327847|NCT00092534|589911459|FG002|Base Study EXT|Travel|2|||
163327848|NCT00092534|589911460|FG003|Base Study EXT|Travel|0|||
163327849|NCT00092534|589911461|FG004|Base Study EXT|Travel|0|||
163009790|NCT03832686|588738058|FG000|Overall Study|Lost to Follow-up|6|||
163009791|NCT03832686|588738059|FG001|Overall Study|Lost to Follow-up|9|||
163009792|NCT03832686|588738058|FG000|Overall Study|Discontinued Intervention|5|||
163009793|NCT03832686|588738059|FG001|Overall Study|Discontinued Intervention|4|||
163009794|NCT02235454|588738062|FG000|Overall Study|Withdrawal by Subject|2|||
163009795|NCT03323398|588738063|FG000|Overall Study|Other than Specified|0|||
163009796|NCT03323398|588738064|FG001|Overall Study|Other than Specified|1|||
163009797|NCT03323398|588738065|FG002|Overall Study|Other than Specified|2|||
163009798|NCT03323398|588738066|FG003|Overall Study|Other than Specified|0|||
163009799|NCT03323398|588738067|FG004|Overall Study|Other than Specified|0|||
163009800|NCT03323398|588738068|FG005|Overall Study|Other than Specified|0|||
163009801|NCT03323398|588738069|FG006|Overall Study|Other than Specified|1|||
163009802|NCT03323398|588738070|FG007|Overall Study|Other than Specified|0|||
163009803|NCT03323398|588738071|FG008|Overall Study|Other than Specified|2|||
163009804|NCT03323398|588738063|FG000|Overall Study|Lost to Follow-up|1|||
163009805|NCT03323398|588738064|FG001|Overall Study|Lost to Follow-up|2|||
163009806|NCT03323398|588738065|FG002|Overall Study|Lost to Follow-up|1|||
163009807|NCT03323398|588738066|FG003|Overall Study|Lost to Follow-up|0|||
163009808|NCT03323398|588738067|FG004|Overall Study|Lost to Follow-up|0|||
163009809|NCT03323398|588738068|FG005|Overall Study|Lost to Follow-up|0|||
163009810|NCT03323398|588738069|FG006|Overall Study|Lost to Follow-up|0|||
163009811|NCT03323398|588738070|FG007|Overall Study|Lost to Follow-up|0|||
163009812|NCT03323398|588738071|FG008|Overall Study|Lost to Follow-up|0|||
163009813|NCT03323398|588738063|FG000|Overall Study|Death|4|||
163009814|NCT03323398|588738064|FG001|Overall Study|Death|6|||
163009815|NCT03323398|588738065|FG002|Overall Study|Death|2|||
163009816|NCT03323398|588738066|FG003|Overall Study|Death|2|||
163009817|NCT03323398|588738067|FG004|Overall Study|Death|1|||
163009818|NCT03323398|588738068|FG005|Overall Study|Death|2|||
163061695|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
163061696|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
163061697|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
163061698|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
163061699|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
163061700|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
163061701|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
163061702|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
163061703|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
163061704|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
163061705|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
163061706|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
163061707|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
163061708|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Depression|0|||
163061709|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Depression|1|||
163061710|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Depression|0|||
163061711|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
163061712|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
163061713|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
163061714|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Jailed|0|||
163061715|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Jailed|1|||
163061716|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Jailed|0|||
163061717|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Other|0|||
163327850|NCT00092534|589911457|FG000|Base Study EXT|Site closed|0|||
163327851|NCT00092534|589911458|FG001|Base Study EXT|Site closed|0|||
163327852|NCT00092534|589911459|FG002|Base Study EXT|Site closed|21|||
163327853|NCT00092534|589911460|FG003|Base Study EXT|Site closed|0|||
163327854|NCT00092534|589911461|FG004|Base Study EXT|Site closed|0|||
163327855|NCT00092534|589911457|FG000|Base Study EXT|Study ended|0|||
163327856|NCT00092534|589911458|FG001|Base Study EXT|Study ended|0|||
163327857|NCT00092534|589911459|FG002|Base Study EXT|Study ended|29|||
163327858|NCT00092534|589911460|FG003|Base Study EXT|Study ended|0|||
163327859|NCT00092534|589911461|FG004|Base Study EXT|Study ended|0|||
163327860|NCT00092534|589911457|FG000|Base Study EXT|Protocol Violation|0|||
163327861|NCT00092534|589911458|FG001|Base Study EXT|Protocol Violation|0|||
163327862|NCT00092534|589911459|FG002|Base Study EXT|Protocol Violation|15|||
163327863|NCT00092534|589911460|FG003|Base Study EXT|Protocol Violation|0|||
163327864|NCT00092534|589911461|FG004|Base Study EXT|Protocol Violation|0|||
163327865|NCT00092534|589911457|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
163327866|NCT00092534|589911458|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
163327867|NCT00092534|589911459|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
163327868|NCT00092534|589911460|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
163327869|NCT00092534|589911461|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
163009819|NCT03323398|588738069|FG006|Overall Study|Death|0|||
163009820|NCT03323398|588738070|FG007|Overall Study|Death|0|||
163009821|NCT03323398|588738071|FG008|Overall Study|Death|6|||
163327870|NCT03083366|589911462|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
163327871|NCT03083366|589911463|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
163327872|NCT03083366|589911462|FG000|Enrollment Period|Lack of Efficacy|1|||
163327873|NCT03083366|589911463|FG001|Enrollment Period|Lack of Efficacy|0|||
163327874|NCT05250115|589911464|FG000|Overall Study|Premature study end|40|||
163327875|NCT05250115|589911464|FG000|Overall Study|Adverse Event|8|||
163327876|NCT05250115|589911464|FG000|Overall Study|Lost to Follow-up|7|||
163327877|NCT05250115|589911464|FG000|Overall Study|Withdrawal by Subject|6|||
163327878|NCT05250115|589911464|FG000|Overall Study|Withdrawal of informed consent|1|||
163327879|NCT05250115|589911464|FG000|Overall Study|Other|7|||
163327880|NCT03244800|589911466|FG000|Overall Study|Adverse Event|0|||
163327881|NCT03244800|589911467|FG001|Overall Study|Adverse Event|1|||
162924862|NCT01977482|588426169|FG004|Overall Study|Lost to Follow-up|0|||
162924863|NCT01977482|588426170|FG005|Overall Study|Lost to Follow-up|0|||
162924864|NCT01977482|588426165|FG000|Overall Study|Physician Decision|0|||
162924865|NCT01977482|588426166|FG001|Overall Study|Physician Decision|1|||
162924866|NCT01977482|588426167|FG002|Overall Study|Physician Decision|0|||
162924867|NCT01977482|588426168|FG003|Overall Study|Physician Decision|0|||
162924868|NCT01977482|588426169|FG004|Overall Study|Physician Decision|0|||
162924869|NCT01977482|588426170|FG005|Overall Study|Physician Decision|0|||
162924870|NCT01977482|588426165|FG000|Overall Study|Protocol Violation|0|||
162924871|NCT01977482|588426166|FG001|Overall Study|Protocol Violation|0|||
162924872|NCT01977482|588426167|FG002|Overall Study|Protocol Violation|1|||
162924873|NCT01977482|588426168|FG003|Overall Study|Protocol Violation|0|||
162924874|NCT01977482|588426169|FG004|Overall Study|Protocol Violation|0|||
162924875|NCT01977482|588426170|FG005|Overall Study|Protocol Violation|0|||
162924876|NCT01977482|588426165|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
162924877|NCT01977482|588426166|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
162924878|NCT01977482|588426167|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
162924879|NCT01977482|588426168|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
162924880|NCT01977482|588426169|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
162924881|NCT01977482|588426170|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
162924882|NCT01977482|588426165|FG000|Overall Study|Withdrawal by Subject|2|||
162924883|NCT01977482|588426166|FG001|Overall Study|Withdrawal by Subject|4|||
162924884|NCT01977482|588426167|FG002|Overall Study|Withdrawal by Subject|1|||
162924885|NCT01977482|588426168|FG003|Overall Study|Withdrawal by Subject|3|||
162924886|NCT01977482|588426169|FG004|Overall Study|Withdrawal by Subject|1|||
162924887|NCT01977482|588426170|FG005|Overall Study|Withdrawal by Subject|5|||
162924888|NCT01964898|588427299|FG000|Overall Study|ineligible post-randomization|1|||
162924889|NCT01964898|588427300|FG001|Overall Study|ineligible post-randomization|1|||
162924890|NCT01964898|588427299|FG000|Overall Study|did not receive the allocated interventi|2|||
162924891|NCT01964898|588427300|FG001|Overall Study|did not receive the allocated interventi|1|||
162924892|NCT01964898|588427299|FG000|Overall Study|Lost to Follow-up|3|||
162924893|NCT01964898|588427300|FG001|Overall Study|Lost to Follow-up|5|||
162924894|NCT01964898|588427299|FG000|Overall Study|Withdrawal by Subject|1|||
162924895|NCT01964898|588427300|FG001|Overall Study|Withdrawal by Subject|0|||
162924896|NCT02428231|588427303|FG000|Overall Study|Other|10|||
162924897|NCT02428231|588427304|FG001|Overall Study|Other|16|||
162924898|NCT02428231|588427303|FG000|Overall Study|Required Symptomatic Therapy|0|||
162924899|NCT02428231|588427304|FG001|Overall Study|Required Symptomatic Therapy|1|||
162924900|NCT02428231|588427303|FG000|Overall Study|Adverse Event|3|||
162924901|NCT02428231|588427304|FG001|Overall Study|Adverse Event|0|||
162924902|NCT02957682|588427307|FG000|Overall Study|Adverse Event|64|||
162924903|NCT02957682|588427308|FG001|Overall Study|Adverse Event|67|||
162924904|NCT02957682|588427307|FG000|Overall Study|Poor Compliance to Protocol|30|||
162924905|NCT02957682|588427308|FG001|Overall Study|Poor Compliance to Protocol|26|||
162924906|NCT02957682|588427307|FG000|Overall Study|Physician Decision|4|||
162924907|NCT02957682|588427308|FG001|Overall Study|Physician Decision|4|||
162924908|NCT02957682|588427307|FG000|Overall Study|Study Terminated by Sponsor|4|||
162924909|NCT02957682|588427308|FG001|Overall Study|Study Terminated by Sponsor|3|||
162924910|NCT02957682|588427307|FG000|Overall Study|Subject Moved|10|||
162924911|NCT02957682|588427308|FG001|Overall Study|Subject Moved|16|||
162924912|NCT02957682|588427307|FG000|Overall Study|Withdrawal by Subject|64|||
162924913|NCT02957682|588427308|FG001|Overall Study|Withdrawal by Subject|33|||
162924914|NCT02957682|588427307|FG000|Overall Study|Related to IMP Administration|3|||
162924915|NCT02957682|588427308|FG001|Overall Study|Related to IMP Administration|6|||
162924916|NCT02957682|588427307|FG000|Overall Study|Non-disclosed|16|||
162924917|NCT02957682|588427308|FG001|Overall Study|Non-disclosed|12|||
162924918|NCT02957682|588427307|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
162924919|NCT02957682|588427308|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
162924920|NCT02953262|588427309|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
162924921|NCT02953262|588427310|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
162924922|NCT02953262|588427311|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
163009822|NCT03323398|588738063|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
163009823|NCT03323398|588738064|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
163009824|NCT03323398|588738065|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
163009825|NCT03323398|588738066|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
163009826|NCT03323398|588738067|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
163009827|NCT03323398|588738068|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
163009828|NCT03323398|588738069|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
163009829|NCT03323398|588738070|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
163009830|NCT03323398|588738071|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
163009831|NCT03323398|588738063|FG000|Overall Study|Withdrawal by Subject|2|||
163009832|NCT03323398|588738064|FG001|Overall Study|Withdrawal by Subject|1|||
163009833|NCT03323398|588738065|FG002|Overall Study|Withdrawal by Subject|3|||
163009834|NCT03323398|588738066|FG003|Overall Study|Withdrawal by Subject|0|||
163009835|NCT03323398|588738067|FG004|Overall Study|Withdrawal by Subject|0|||
163009836|NCT03323398|588738068|FG005|Overall Study|Withdrawal by Subject|1|||
163009837|NCT03323398|588738069|FG006|Overall Study|Withdrawal by Subject|0|||
163009838|NCT03323398|588738070|FG007|Overall Study|Withdrawal by Subject|0|||
163009839|NCT03323398|588738071|FG008|Overall Study|Withdrawal by Subject|0|||
163009840|NCT03323398|588738063|FG000|Overall Study|Participant was Put on Hospice|0|||
163009841|NCT03323398|588738064|FG001|Overall Study|Participant was Put on Hospice|0|||
163009842|NCT03323398|588738065|FG002|Overall Study|Participant was Put on Hospice|0|||
163009843|NCT03323398|588738066|FG003|Overall Study|Participant was Put on Hospice|0|||
163009844|NCT03323398|588738067|FG004|Overall Study|Participant was Put on Hospice|0|||
163009845|NCT03323398|588738068|FG005|Overall Study|Participant was Put on Hospice|0|||
163009846|NCT03323398|588738069|FG006|Overall Study|Participant was Put on Hospice|1|||
163009847|NCT03323398|588738070|FG007|Overall Study|Participant was Put on Hospice|0|||
163009848|NCT03323398|588738071|FG008|Overall Study|Participant was Put on Hospice|0|||
163009849|NCT03323398|588738063|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
163009850|NCT03323398|588738064|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
163061718|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Other|1|||
163061719|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Other|0|||
163009851|NCT03323398|588738065|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
163009852|NCT03323398|588738066|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
163009853|NCT03323398|588738067|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
163214243|NCT01765153|589497723|FG001|Training Phase 2|Withdrawal by Subject|1|||
163214244|NCT01765153|589497722|FG000|Rest Phase 2|Lost to Follow-up|2|||
163061720|NCT00947544|588934989|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
163061721|NCT00947544|588934990|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
163009854|NCT03323398|588738068|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
163009855|NCT03323398|588738069|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
163009856|NCT03323398|588738070|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
163009857|NCT03323398|588738071|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
163009858|NCT03641469|588738072|FG000|Overall Study|Ineligible|2|||
163214245|NCT01765153|589497723|FG001|Rest Phase 2|Lost to Follow-up|1|||
163214246|NCT02663674|589497724|FG000|Overall Study|Lost to Follow-up|5|||
163214247|NCT02663674|589497725|FG001|Overall Study|Lost to Follow-up|4|||
163214248|NCT02663674|589497724|FG000|Overall Study|Withdrawal by Subject|1|||
163214249|NCT02663674|589497725|FG001|Overall Study|Withdrawal by Subject|4|||
163214250|NCT02663674|589497724|FG000|Overall Study|Physician Decision|1|||
163214251|NCT02663674|589497725|FG001|Overall Study|Physician Decision|1|||
163214252|NCT02663674|589497724|FG000|Overall Study|Other Event (Health Related)|0|||
163214253|NCT02663674|589497725|FG001|Overall Study|Other Event (Health Related)|1|||
163214254|NCT01386554|589497728|FG000|Overall Study|Lost to Follow-up|0|||
163214255|NCT01386554|589497729|FG001|Overall Study|Lost to Follow-up|0|||
163214256|NCT01386554|589497730|FG002|Overall Study|Lost to Follow-up|1|||
163214257|NCT01386554|589497728|FG000|Overall Study|Adverse Event|2|||
163214258|NCT01386554|589497729|FG001|Overall Study|Adverse Event|5|||
163214259|NCT01386554|589497730|FG002|Overall Study|Adverse Event|2|||
163214260|NCT01386554|589497728|FG000|Overall Study|Progressive disease|1|||
163214261|NCT01386554|589497729|FG001|Overall Study|Progressive disease|2|||
163214262|NCT01386554|589497730|FG002|Overall Study|Progressive disease|2|||
163214263|NCT01386554|589497728|FG000|Overall Study|Administration of live vaccines|0|||
163214264|NCT01386554|589497729|FG001|Overall Study|Administration of live vaccines|1|||
163214265|NCT01386554|589497730|FG002|Overall Study|Administration of live vaccines|0|||
163214266|NCT01386554|589497728|FG000|Overall Study|Investigator discretion|0|||
163214267|NCT01386554|589497729|FG001|Overall Study|Investigator discretion|0|||
163214268|NCT01386554|589497730|FG002|Overall Study|Investigator discretion|1|||
163214269|NCT01386554|589497728|FG000|Overall Study|Reason not collected|0|||
163214270|NCT01386554|589497729|FG001|Overall Study|Reason not collected|1|||
163214271|NCT01386554|589497730|FG002|Overall Study|Reason not collected|0|||
163214272|NCT00353262|589497731|FG000|Overall Study|Adverse Event|8|||
163009859|NCT03641469|588738072|FG000|Overall Study|Withdrawal by Subject|5|||
163009860|NCT03641469|588738072|FG000|Overall Study|Physician Decision|1|||
163009861|NCT03641469|588738072|FG000|Overall Study|Protocol Violation|1|||
163009862|NCT03641469|588738072|FG000|Overall Study|Lost to Follow-up|2|||
163009863|NCT05479435|588738073|FG000|Overall Study|Withdrawal by Subject|1|||
163009864|NCT05479435|588738074|FG001|Overall Study|Withdrawal by Subject|0|||
163009865|NCT05479435|588738075|FG002|Overall Study|Withdrawal by Subject|0|||
163009866|NCT05479435|588738073|FG000|Overall Study|Covid 19|0|||
163009867|NCT05479435|588738074|FG001|Overall Study|Covid 19|0|||
163009868|NCT05479435|588738075|FG002|Overall Study|Covid 19|2|||
163009869|NCT00955617|588738076|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
163009870|NCT00955617|588738077|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
163009871|NCT00955617|588738076|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
163009872|NCT00955617|588738077|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
163009873|NCT00955617|588738076|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
163009874|NCT00955617|588738077|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
163009875|NCT00955617|588738076|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
163009876|NCT00955617|588738077|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
163009877|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Adverse Event|7|||
163009878|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
163009879|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Non-compliance|3|||
163009880|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Other|17|||
163009881|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Physician Decision|2|||
163009882|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Pregnancy|1|||
163009883|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
163009884|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
163009885|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
163009886|NCT05207865|588740077|FG000|Follow-up Phase|Lost to Follow-up|1|||
163009887|NCT05207865|588740077|FG000|Follow-up Phase|Non-compliance|1|||
163009888|NCT05207865|588740077|FG000|Follow-up Phase|Not reported|2|||
163009889|NCT05207865|588740077|FG000|Follow-up Phase|Not collected|11|||
163009890|NCT00739882|588740078|FG000|Double-blind Period|Adverse Event|1|||
163009891|NCT00739882|588740079|FG001|Double-blind Period|Adverse Event|2|||
163009892|NCT00739882|588740078|FG000|Double-blind Period|Protocol Violation|1|||
163009893|NCT00739882|588740079|FG001|Double-blind Period|Protocol Violation|0|||
163009894|NCT00739882|588740078|FG000|Double-blind Period|Lack of Efficacy|1|||
163009895|NCT00739882|588740079|FG001|Double-blind Period|Lack of Efficacy|1|||
163009896|NCT00739882|588740078|FG000|Double-blind Period|Other|16|||
163009897|NCT00739882|588740079|FG001|Double-blind Period|Other|8|||
163009898|NCT00739882|588740078|FG000|Open-label Period|Adverse Event|1|||
163009899|NCT00739882|588740079|FG001|Open-label Period|Adverse Event|0|||
163009900|NCT00739882|588740078|FG000|Open-label Period|Other|9|||
163009901|NCT00739882|588740079|FG001|Open-label Period|Other|5|||
163009902|NCT03055338|588740082|FG000|Overall Study|Lost to Follow-up|9|||
163009903|NCT03055338|588740083|FG001|Overall Study|Lost to Follow-up|2|||
163009904|NCT03055338|588740084|FG002|Overall Study|Lost to Follow-up|3|||
163009905|NCT03055338|588740082|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
163009906|NCT03055338|588740083|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
163009907|NCT03055338|588740084|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
163009908|NCT03055338|588740082|FG000|Overall Study|Physician Decision|0|||
163061722|NCT02566005|588934992|FG000|Overall Study|vaginal bleeding|0|||
163061723|NCT02566005|588934993|FG001|Overall Study|vaginal bleeding|1|||
163061724|NCT02566005|588934992|FG000|Overall Study|received foley|8|||
163061725|NCT02566005|588934993|FG001|Overall Study|received foley|0|||
163061726|NCT02566005|588934992|FG000|Overall Study|did not receive foley|0|||
163061727|NCT02566005|588934993|FG001|Overall Study|did not receive foley|1|||
163061728|NCT02566005|588934992|FG000|Overall Study|labor after randomization|0|||
163061729|NCT02566005|588934993|FG001|Overall Study|labor after randomization|4|||
163061730|NCT01134042|588934996|FG000|Overall Study|Adverse Event|3|||
163214273|NCT00353262|589497731|FG000|Overall Study|Withdrawal by Subject|2|||
163214274|NCT00353262|589497731|FG000|Overall Study|Insufficient Therapeutic Response|13|||
163214275|NCT00353262|589497731|FG000|Overall Study|Progression|1|||
163404524|NCT01500278|590191956|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
163061731|NCT01134042|588934997|FG001|Overall Study|Adverse Event|7|||
163214276|NCT00353262|589497731|FG000|Overall Study|Surgery|4|||
163061732|NCT01134042|588934998|FG002|Overall Study|Adverse Event|2|||
163009909|NCT03055338|588740083|FG001|Overall Study|Physician Decision|0|||
163009910|NCT03055338|588740084|FG002|Overall Study|Physician Decision|2|||
163009911|NCT03055338|588740082|FG000|Overall Study|Withdrawal by Subject|9|||
163009912|NCT03055338|588740083|FG001|Overall Study|Withdrawal by Subject|8|||
163009913|NCT03055338|588740084|FG002|Overall Study|Withdrawal by Subject|7|||
163009914|NCT00975611|588740085|FG000|Overall Study|Screen Fail|16|||
163009915|NCT00975611|588740085|FG000|Overall Study|Physician Decision|1|||
163009916|NCT03058705|588740086|FG000|Overall Study|Withdrawal by Subject|2|||
163214277|NCT00353262|589497731|FG000|Overall Study|Break from Chemotherapy|1|||
163214278|NCT04166513|589497732|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
163404525|NCT01500278|590191955|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
163009917|NCT03058705|588740086|FG000|Overall Study|Physician Decision|2|||
163009918|NCT01880554|588740087|FG000|Overall Study|Protocol Violation|14|||
163009919|NCT01880554|588740087|FG000|Overall Study|Simon's design requirements|2|||
163009920|NCT01415518|588740088|FG000|Overall Study|Withdrawal by Subject|2|||
163009921|NCT01415518|588740089|FG001|Overall Study|Withdrawal by Subject|12|||
163009922|NCT01415518|588740088|FG000|Overall Study|Protocol Violation|6|||
163009923|NCT01415518|588740089|FG001|Overall Study|Protocol Violation|8|||
163009924|NCT01415518|588740088|FG000|Overall Study|Lost to Follow-up|3|||
163009925|NCT01415518|588740089|FG001|Overall Study|Lost to Follow-up|5|||
163009926|NCT01415518|588740088|FG000|Overall Study|Adverse Event|3|||
163009927|NCT01415518|588740089|FG001|Overall Study|Adverse Event|4|||
163009928|NCT01415518|588740088|FG000|Overall Study|Death|1|||
163009929|NCT01415518|588740089|FG001|Overall Study|Death|1|||
163009930|NCT01415518|588740088|FG000|Overall Study|Condition under Investigation Worsened|1|||
163009931|NCT01415518|588740089|FG001|Overall Study|Condition under Investigation Worsened|1|||
163009932|NCT03752970|588740097|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
163009933|NCT03752970|588740098|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
163009934|NCT03752970|588740099|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
163009935|NCT03752970|588740097|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
163009936|NCT03752970|588740098|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
163009937|NCT03752970|588740099|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
163009938|NCT03752970|588740097|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
163009939|NCT03752970|588740098|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
163009940|NCT03752970|588740099|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
163009941|NCT03752970|588740097|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
163009942|NCT03752970|588740098|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
163009943|NCT03752970|588740099|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
163009944|NCT03752970|588740097|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
163009945|NCT03752970|588740098|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
163009946|NCT03752970|588740099|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
163009947|NCT03976362|588740100|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
163009948|NCT03976362|588740101|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
163009949|NCT03976362|588740102|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
163009950|NCT03976362|588740100|FG000|Induction Phase|Death|62|||
163009951|NCT03976362|588740101|FG001|Induction Phase|Death|0|||
163009952|NCT03976362|588740102|FG002|Induction Phase|Death|0|||
163009953|NCT03976362|588740100|FG000|Maintenance Phase|Participants Ongoing|0|||
163009954|NCT03976362|588740101|FG001|Maintenance Phase|Participants Ongoing|106|||
163009955|NCT03976362|588740102|FG002|Maintenance Phase|Participants Ongoing|103|||
163009956|NCT03976362|588740100|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163009957|NCT03976362|588740101|FG001|Maintenance Phase|Withdrawal by Subject|4|||
163009958|NCT03976362|588740102|FG002|Maintenance Phase|Withdrawal by Subject|4|||
163009959|NCT03976362|588740100|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
163009960|NCT03976362|588740101|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
163009961|NCT03976362|588740102|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
163009962|NCT03976362|588740100|FG000|Maintenance Phase|Death|0|||
163009963|NCT03976362|588740101|FG001|Maintenance Phase|Death|186|||
163009964|NCT03976362|588740102|FG002|Maintenance Phase|Death|187|||
163009965|NCT04767282|588740103|FG000|Overall Study|Refused or did not begin surveys|6|||
163009966|NCT04767282|588740104|FG001|Overall Study|Refused or did not begin surveys|2|||
163009967|NCT04767282|588740105|FG002|Overall Study|Refused or did not begin surveys|2|||
163009968|NCT04767282|588740103|FG000|Overall Study|Duplicate household previously enrolled|2|||
163009969|NCT04767282|588740104|FG001|Overall Study|Duplicate household previously enrolled|0|||
163009970|NCT04767282|588740105|FG002|Overall Study|Duplicate household previously enrolled|8|||
163009971|NCT04767282|588740103|FG000|Overall Study|Unable to confirm legal guardian|0|||
163009972|NCT04767282|588740104|FG001|Overall Study|Unable to confirm legal guardian|2|||
163009973|NCT04767282|588740105|FG002|Overall Study|Unable to confirm legal guardian|8|||
163009974|NCT04767282|588740103|FG000|Overall Study|Withdrawal by Subject|0|||
163009975|NCT04767282|588740104|FG001|Overall Study|Withdrawal by Subject|0|||
163404526|NCT01500278|590191956|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
163009976|NCT04767282|588740105|FG002|Overall Study|Withdrawal by Subject|6|||
163009977|NCT04767282|588740103|FG000|Overall Study|Survey comprehension challenges|4|||
163009978|NCT04767282|588740104|FG001|Overall Study|Survey comprehension challenges|0|||
163009979|NCT04767282|588740105|FG002|Overall Study|Survey comprehension challenges|0|||
163009980|NCT01467713|588740107|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
163009981|NCT01467713|588740108|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
163009982|NCT01467713|588740109|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
163009983|NCT01467713|588740110|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
163061733|NCT01134042|588934996|FG000|Overall Study|Lack of Efficacy|21|||
163404527|NCT01500278|590191955|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
163009984|NCT01467713|588740107|FG000|Overall Study|Major Protocol Deviation|2|||
163009985|NCT01467713|588740108|FG001|Overall Study|Major Protocol Deviation|4|||
163009986|NCT01467713|588740109|FG002|Overall Study|Major Protocol Deviation|4|||
163009987|NCT01467713|588740110|FG003|Overall Study|Major Protocol Deviation|1|||
163009988|NCT01467713|588740107|FG000|Overall Study|Lost to Follow-up|9|||
163009989|NCT01467713|588740108|FG001|Overall Study|Lost to Follow-up|12|||
163009990|NCT01467713|588740109|FG002|Overall Study|Lost to Follow-up|6|||
163061734|NCT01134042|588934997|FG001|Overall Study|Lack of Efficacy|6|||
163061735|NCT01134042|588934998|FG002|Overall Study|Lack of Efficacy|18|||
163061736|NCT01134042|588934996|FG000|Overall Study|Protocol Violation|5|||
163061737|NCT01134042|588934997|FG001|Overall Study|Protocol Violation|3|||
163061738|NCT01134042|588934998|FG002|Overall Study|Protocol Violation|5|||
163061739|NCT01134042|588934996|FG000|Overall Study|Lost to Follow-up|2|||
163061740|NCT01134042|588934997|FG001|Overall Study|Lost to Follow-up|0|||
163061741|NCT01134042|588934998|FG002|Overall Study|Lost to Follow-up|1|||
163061742|NCT01134042|588934996|FG000|Overall Study|Physician Decision|4|||
163061743|NCT01134042|588934997|FG001|Overall Study|Physician Decision|8|||
163061744|NCT01134042|588934998|FG002|Overall Study|Physician Decision|1|||
163061745|NCT01134042|588934996|FG000|Overall Study|Withdrawal by Subject|13|||
163061746|NCT01134042|588934997|FG001|Overall Study|Withdrawal by Subject|4|||
163061747|NCT01134042|588934998|FG002|Overall Study|Withdrawal by Subject|7|||
163061748|NCT03345004|588934999|FG000|Overall Study|Physician Decision|1|||
163061749|NCT03345004|588935000|FG001|Overall Study|Physician Decision|0|||
163061750|NCT03345004|588934999|FG000|Overall Study|Withdrawal by Subject|0|||
163061751|NCT03345004|588935000|FG001|Overall Study|Withdrawal by Subject|1|||
163061752|NCT01091259|588935005|FG000|Overall Study|Adverse Event|3|||
163061753|NCT01091259|588935005|FG000|Overall Study|Lack of Efficacy|2|||
163061754|NCT00984867|588935006|FG000|Overall Study|Adverse Event|3|||
163061755|NCT00984867|588935007|FG001|Overall Study|Adverse Event|7|||
163061756|NCT00984867|588935006|FG000|Overall Study|Death|1|||
163061757|NCT00984867|588935007|FG001|Overall Study|Death|0|||
163061758|NCT00984867|588935006|FG000|Overall Study|Withdrawal by Subject|13|||
163061759|NCT00984867|588935007|FG001|Overall Study|Withdrawal by Subject|4|||
163061760|NCT00984867|588935006|FG000|Overall Study|Lost to Follow-up|3|||
163061761|NCT00984867|588935007|FG001|Overall Study|Lost to Follow-up|4|||
163061762|NCT00984867|588935006|FG000|Overall Study|Poor/non-compliance|0|||
163061763|NCT00984867|588935007|FG001|Overall Study|Poor/non-compliance|1|||
163061764|NCT00984867|588935006|FG000|Overall Study|Subject no longer meets study criteria|1|||
163061765|NCT00984867|588935007|FG001|Overall Study|Subject no longer meets study criteria|1|||
163061766|NCT00984867|588935006|FG000|Overall Study|site closing|1|||
163061767|NCT00984867|588935007|FG001|Overall Study|site closing|0|||
163061768|NCT00984867|588935006|FG000|Overall Study|lack of efficacy and subject compliance|1|||
163061769|NCT00984867|588935007|FG001|Overall Study|lack of efficacy and subject compliance|0|||
163061770|NCT00671060|588935008|FG000|Overall Study|Protocol Violation|1|||
163061771|NCT00671060|588935009|FG001|Overall Study|Protocol Violation|0|||
163061772|NCT00671060|588935008|FG000|Overall Study|Physician Decision|0|||
163061773|NCT00671060|588935009|FG001|Overall Study|Physician Decision|1|||
163061774|NCT01541748|588935010|FG000|Overall Study|Lost to Follow-up|17|||
163009991|NCT01467713|588740110|FG003|Overall Study|Lost to Follow-up|9|||
163061775|NCT01541748|588935010|FG000|Overall Study|Moved out of state|1|||
163061776|NCT01541748|588935010|FG000|Overall Study|Withdrawal by Subject|7|||
163061777|NCT01541748|588935010|FG000|Overall Study|Screen failure|5|||
163061778|NCT01541748|588935010|FG000|Overall Study|Did not receive study device|1|||
163061779|NCT00626639|588935018|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
163061780|NCT00626639|588935019|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
163061781|NCT01155141|588935020|FG000|Overall Study|Withdrawal by Subject|1|||
163061782|NCT01155141|588935020|FG000|Overall Study|Screen Failure|1|||
163061783|NCT03473197|588935021|FG000|Overall Study|Adverse Event|4|||
163061784|NCT03473197|588935021|FG000|Overall Study|Lost to Follow-up|1|||
163061785|NCT03473197|588935021|FG000|Overall Study|Withdrawal by Subject|5|||
163061786|NCT00785629|588935022|FG000|Overall Study|Adverse Event|2|||
163061787|NCT00785629|588935023|FG001|Overall Study|Adverse Event|1|||
163061788|NCT00785629|588935024|FG002|Overall Study|Adverse Event|1|||
163061789|NCT00785629|588935025|FG003|Overall Study|Adverse Event|5|||
163061790|NCT00785629|588935022|FG000|Overall Study|Protocol Violation|1|||
163061791|NCT00785629|588935023|FG001|Overall Study|Protocol Violation|2|||
163214279|NCT04166513|589497733|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
163009992|NCT01467713|588740107|FG000|Overall Study|Voluntary Withdrawal|18|||
163061792|NCT00785629|588935024|FG002|Overall Study|Protocol Violation|4|||
163061793|NCT00785629|588935025|FG003|Overall Study|Protocol Violation|5|||
163061794|NCT00785629|588935022|FG000|Overall Study|administrative decision|5|||
163061795|NCT00785629|588935023|FG001|Overall Study|administrative decision|1|||
163061796|NCT00785629|588935024|FG002|Overall Study|administrative decision|3|||
163061797|NCT00785629|588935025|FG003|Overall Study|administrative decision|4|||
163061798|NCT00785629|588935022|FG000|Overall Study|Withdrawal by Subject|0|||
163061799|NCT00785629|588935023|FG001|Overall Study|Withdrawal by Subject|1|||
163061800|NCT00785629|588935024|FG002|Overall Study|Withdrawal by Subject|2|||
163214280|NCT04166513|589497734|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
163214281|NCT04166513|589497735|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
163214282|NCT04166513|589497732|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
163214283|NCT04166513|589497733|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
163214284|NCT04166513|589497734|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
163214285|NCT04166513|589497735|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
163214286|NCT04166513|589497732|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
163214287|NCT04166513|589497733|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
163214288|NCT04166513|589497734|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
163214289|NCT04166513|589497735|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
163214290|NCT04166513|589497732|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
163214291|NCT04166513|589497733|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
163214292|NCT04166513|589497734|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
163214293|NCT04166513|589497735|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
163214294|NCT04166513|589497732|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
163214295|NCT04166513|589497733|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
163009993|NCT01467713|588740108|FG001|Overall Study|Voluntary Withdrawal|14|||
163009994|NCT01467713|588740109|FG002|Overall Study|Voluntary Withdrawal|21|||
163009995|NCT01467713|588740110|FG003|Overall Study|Voluntary Withdrawal|20|||
163009996|NCT01467713|588740107|FG000|Overall Study|Study Termination|23|||
163009997|NCT01467713|588740108|FG001|Overall Study|Study Termination|33|||
163009998|NCT01467713|588740109|FG002|Overall Study|Study Termination|28|||
163009999|NCT01467713|588740110|FG003|Overall Study|Study Termination|29|||
163010000|NCT01467713|588740107|FG000|Overall Study|Pregnancy|0|||
163010001|NCT01467713|588740108|FG001|Overall Study|Pregnancy|1|||
163010002|NCT01467713|588740109|FG002|Overall Study|Pregnancy|1|||
163010003|NCT01467713|588740110|FG003|Overall Study|Pregnancy|3|||
163010004|NCT01467713|588740107|FG000|Overall Study|Relapse|35|||
163010005|NCT01467713|588740108|FG001|Overall Study|Relapse|25|||
163010006|NCT01467713|588740109|FG002|Overall Study|Relapse|28|||
163010007|NCT01467713|588740110|FG003|Overall Study|Relapse|35|||
163010008|NCT01467713|588740107|FG000|Overall Study|Reason not Specified|6|||
163010009|NCT01467713|588740108|FG001|Overall Study|Reason not Specified|11|||
163010010|NCT01467713|588740109|FG002|Overall Study|Reason not Specified|8|||
163010011|NCT01467713|588740110|FG003|Overall Study|Reason not Specified|7|||
163010012|NCT04846569|588740111|FG000|Overall Study|Withdrawal by Subject|3|||
163010013|NCT04846569|588740112|FG001|Overall Study|Withdrawal by Subject|1|||
163010014|NCT02525783|588740113|FG000|Overall Study|Lost to Follow-up|10|||
163010015|NCT02512302|588740114|FG000|Period 1|Adverse Event|0|||
163010016|NCT02512302|588740115|FG001|Period 1|Adverse Event|1|||
163010017|NCT02512302|588740116|FG002|Period 1|Adverse Event|0|||
163010018|NCT02512302|588740117|FG003|Period 1|Adverse Event|0|||
163010019|NCT02512302|588740118|FG004|Period 1|Adverse Event|0|||
163010020|NCT02512302|588740119|FG005|Period 1|Adverse Event|0|||
163010021|NCT02512302|588740120|FG006|Period 1|Adverse Event|0|||
163010022|NCT02512302|588740121|FG007|Period 1|Adverse Event|0|||
163010023|NCT02512302|588740122|FG008|Period 1|Adverse Event|0|||
163010024|NCT02512302|588740123|FG009|Period 1|Adverse Event|0|||
163010025|NCT02512302|588740114|FG000|Period 2|Adverse Event|0|||
163010026|NCT02512302|588740115|FG001|Period 2|Adverse Event|0|||
163010027|NCT02512302|588740116|FG002|Period 2|Adverse Event|0|||
163010028|NCT02512302|588740117|FG003|Period 2|Adverse Event|0|||
163010029|NCT02512302|588740118|FG004|Period 2|Adverse Event|0|||
163010030|NCT02512302|588740119|FG005|Period 2|Adverse Event|0|||
163010031|NCT02512302|588740120|FG006|Period 2|Adverse Event|0|||
163010032|NCT02512302|588740121|FG007|Period 2|Adverse Event|0|||
163010033|NCT02512302|588740122|FG008|Period 2|Adverse Event|0|||
163010034|NCT02512302|588740123|FG009|Period 2|Adverse Event|1|||
163010035|NCT02512302|588740114|FG000|Period 3|Lost to Follow-up|0|||
163010036|NCT02512302|588740115|FG001|Period 3|Lost to Follow-up|0|||
163010037|NCT02512302|588740116|FG002|Period 3|Lost to Follow-up|1|||
163010038|NCT02512302|588740117|FG003|Period 3|Lost to Follow-up|0|||
163010039|NCT02512302|588740118|FG004|Period 3|Lost to Follow-up|0|||
163010040|NCT02512302|588740119|FG005|Period 3|Lost to Follow-up|0|||
163010041|NCT02512302|588740120|FG006|Period 3|Lost to Follow-up|0|||
163010042|NCT02512302|588740121|FG007|Period 3|Lost to Follow-up|0|||
163010043|NCT02512302|588740122|FG008|Period 3|Lost to Follow-up|0|||
163010044|NCT02512302|588740123|FG009|Period 3|Lost to Follow-up|0|||
163010045|NCT02512302|588740114|FG000|Period 4|Adverse Event|0|||
163010046|NCT02512302|588740115|FG001|Period 4|Adverse Event|0|||
163010047|NCT02512302|588740116|FG002|Period 4|Adverse Event|0|||
163214296|NCT04166513|589497734|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
163214297|NCT04166513|589497735|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
163214298|NCT05286307|589497736|FG000|Overall Study|Incomplete outcome assessments|2|||
163010048|NCT02512302|588740117|FG003|Period 4|Adverse Event|0|||
163010049|NCT02512302|588740118|FG004|Period 4|Adverse Event|0|||
163010050|NCT02512302|588740119|FG005|Period 4|Adverse Event|0|||
163010051|NCT02512302|588740120|FG006|Period 4|Adverse Event|1|||
163010052|NCT02512302|588740121|FG007|Period 4|Adverse Event|0|||
163010053|NCT02512302|588740122|FG008|Period 4|Adverse Event|0|||
163010054|NCT02512302|588740123|FG009|Period 4|Adverse Event|0|||
163010055|NCT01735916|588740134|FG000|Overall Study|Subject not eligible to be randomized|11|||
163327882|NCT03244800|589911468|FG002|Overall Study|Adverse Event|0|||
163327883|NCT03244800|589911469|FG003|Overall Study|Adverse Event|1|||
163327884|NCT03244800|589911466|FG000|Overall Study|Withdrew treatment|0|||
163327885|NCT03244800|589911467|FG001|Overall Study|Withdrew treatment|0|||
163327886|NCT03244800|589911468|FG002|Overall Study|Withdrew treatment|0|||
163327887|NCT03244800|589911469|FG003|Overall Study|Withdrew treatment|1|||
163327888|NCT00890591|589911478|FG000|Overall Study|Lack of Efficacy|20|||
163327889|NCT02275611|589911483|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
163327890|NCT02275611|589911484|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
163327891|NCT02275611|589911485|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
163327892|NCT02275611|589911486|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
163327893|NCT01437319|589911492|FG000|Phase I|Lost to Follow-up|2|||
163327894|NCT01437319|589911493|FG001|Phase I|Lost to Follow-up|0|||
163327895|NCT01437319|589911494|FG002|Phase I|Lost to Follow-up|0|||
163327896|NCT01437319|589911492|FG000|Phase I|Protocol Violation|1|||
163327897|NCT01437319|589911493|FG001|Phase I|Protocol Violation|0|||
163327898|NCT01437319|589911494|FG002|Phase I|Protocol Violation|0|||
163327899|NCT01437319|589911492|FG000|Phase I|Study related symptoms/complaints|27|||
163327900|NCT01437319|589911493|FG001|Phase I|Study related symptoms/complaints|0|||
163327901|NCT01437319|589911494|FG002|Phase I|Study related symptoms/complaints|0|||
163327902|NCT01437319|589911492|FG000|Phase I|Withdrawal by Subject|25|||
163327903|NCT01437319|589911493|FG001|Phase I|Withdrawal by Subject|0|||
163327904|NCT01437319|589911494|FG002|Phase I|Withdrawal by Subject|0|||
163327905|NCT01437319|589911492|FG000|Phase II|Withdrawal by Subject|0|||
163327906|NCT01437319|589911493|FG001|Phase II|Withdrawal by Subject|8|||
163327907|NCT01437319|589911494|FG002|Phase II|Withdrawal by Subject|16|||
163327908|NCT01437319|589911492|FG000|Phase II|Lost to Follow-up|0|||
163327909|NCT01437319|589911493|FG001|Phase II|Lost to Follow-up|7|||
163327910|NCT01437319|589911494|FG002|Phase II|Lost to Follow-up|2|||
163327911|NCT01437319|589911492|FG000|Phase II|Study related symptoms/complaints|0|||
163327912|NCT01437319|589911493|FG001|Phase II|Study related symptoms/complaints|28|||
163327913|NCT01437319|589911494|FG002|Phase II|Study related symptoms/complaints|19|||
163327914|NCT01437319|589911492|FG000|Phase II|Protocol Violation|0|||
163327915|NCT01437319|589911493|FG001|Phase II|Protocol Violation|1|||
163327916|NCT01437319|589911494|FG002|Phase II|Protocol Violation|0|||
163327917|NCT00983294|589911495|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
163327918|NCT00983294|589911495|FG000|Colchicine With Azithromycin|Adverse Event|1|||
163327919|NCT00622700|589911496|FG000|Core Treatment Period|Randomized but Not Treated|0|||
163327920|NCT00622700|589911497|FG001|Core Treatment Period|Randomized but Not Treated|2|||
163327921|NCT00622700|589911498|FG002|Core Treatment Period|Randomized but Not Treated|2|||
163327922|NCT00622700|589911499|FG003|Core Treatment Period|Randomized but Not Treated|0|||
163327923|NCT00622700|589911500|FG004|Core Treatment Period|Randomized but Not Treated|0|||
163327924|NCT00622700|589911501|FG005|Core Treatment Period|Randomized but Not Treated|0|||
163327925|NCT00622700|589911502|FG006|Core Treatment Period|Randomized but Not Treated|0|||
163327926|NCT00622700|589911496|FG000|Core Treatment Period|Adverse Event|18|||
163327927|NCT00622700|589911497|FG001|Core Treatment Period|Adverse Event|25|||
163327928|NCT00622700|589911498|FG002|Core Treatment Period|Adverse Event|18|||
163327929|NCT00622700|589911499|FG003|Core Treatment Period|Adverse Event|0|||
163327930|NCT00622700|589911500|FG004|Core Treatment Period|Adverse Event|0|||
163327931|NCT00622700|589911501|FG005|Core Treatment Period|Adverse Event|0|||
163327932|NCT00622700|589911502|FG006|Core Treatment Period|Adverse Event|0|||
163327933|NCT00622700|589911496|FG000|Core Treatment Period|Lack of Efficacy|19|||
163327934|NCT00622700|589911497|FG001|Core Treatment Period|Lack of Efficacy|6|||
163327935|NCT00622700|589911498|FG002|Core Treatment Period|Lack of Efficacy|12|||
163327936|NCT00622700|589911499|FG003|Core Treatment Period|Lack of Efficacy|0|||
163327937|NCT00622700|589911500|FG004|Core Treatment Period|Lack of Efficacy|0|||
162924923|NCT02953262|588427312|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
162924924|NCT03284424|588427313|FG000|Overall Study|Death|70|||
162924925|NCT03284424|588427314|FG001|Overall Study|Death|24|||
162924926|NCT03284424|588427313|FG000|Overall Study|Lost to Follow-up|3|||
162924927|NCT03284424|588427314|FG001|Overall Study|Lost to Follow-up|1|||
162924928|NCT03284424|588427313|FG000|Overall Study|Physician Decision|1|||
162924929|NCT03284424|588427314|FG001|Overall Study|Physician Decision|2|||
162924930|NCT03284424|588427313|FG000|Overall Study|Withdrawal by Subject|4|||
162924931|NCT03284424|588427314|FG001|Overall Study|Withdrawal by Subject|5|||
162924932|NCT03284424|588427313|FG000|Overall Study|Sponsor's decision|27|||
162924933|NCT03284424|588427314|FG001|Overall Study|Sponsor's decision|22|||
162924934|NCT00765999|588427315|FG000|Overall Study|Adverse Event|203|||
162924935|NCT00765999|588427315|FG000|Overall Study|Insufficient Therapeutic Response|100|||
162924936|NCT00765999|588427315|FG000|Overall Study|Protocol Violation|95|||
162924937|NCT00765999|588427315|FG000|Overall Study|Consent Withdrawn|202|||
162924938|NCT00765999|588427315|FG000|Overall Study|Lost to Follow-up|131|||
162924939|NCT00765999|588427315|FG000|Overall Study|Study Terminated by Sponsor|2|||
162924940|NCT00765999|588427315|FG000|Overall Study|Other Miscellaneous Reasons|51|||
162924941|NCT00203892|588427319|FG000|Overall Study|Physician Decision|1|||
162924942|NCT00203892|588427320|FG001|Overall Study|Physician Decision|2|||
163327938|NCT00622700|589911501|FG005|Core Treatment Period|Lack of Efficacy|0|||
163010056|NCT01735916|588740135|FG001|Overall Study|Subject not eligible to be randomized|0|||
163010057|NCT01735916|588740136|FG002|Overall Study|Subject not eligible to be randomized|0|||
163010058|NCT01735916|588740134|FG000|Overall Study|Early termination of study by sponsor|4|||
163010059|NCT01735916|588740135|FG001|Overall Study|Early termination of study by sponsor|19|||
163010060|NCT01735916|588740136|FG002|Overall Study|Early termination of study by sponsor|7|||
163010061|NCT01735916|588740134|FG000|Overall Study|Withdrawal by Subject|3|||
163010062|NCT01735916|588740135|FG001|Overall Study|Withdrawal by Subject|0|||
163010063|NCT01735916|588740136|FG002|Overall Study|Withdrawal by Subject|0|||
163010064|NCT05177484|588740142|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
163010065|NCT05177484|588740143|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
163010066|NCT05177484|588740142|FG000|Overall Study|Inadvertently withdrawn|3|||
163010067|NCT05177484|588740143|FG001|Overall Study|Inadvertently withdrawn|1|||
163010068|NCT05177484|588740142|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
163010069|NCT05177484|588740143|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
163010070|NCT01379768|588740144|FG000|Overall Study|Adverse Event|1|||
163010071|NCT01379768|588740145|FG001|Overall Study|Adverse Event|1|||
163010072|NCT01379768|588740146|FG002|Overall Study|Adverse Event|0|||
163010073|NCT01379768|588740144|FG000|Overall Study|Lost to Follow-up|2|||
163010074|NCT01379768|588740145|FG001|Overall Study|Lost to Follow-up|0|||
163010075|NCT01379768|588740146|FG002|Overall Study|Lost to Follow-up|0|||
163010076|NCT03334435|588740151|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
163010077|NCT03334435|588740152|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
163010078|NCT03334435|588740153|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
163010079|NCT03334435|588740154|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
163010080|NCT03334435|588740155|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
163010081|NCT03334435|588740156|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010082|NCT03334435|588740157|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010083|NCT03334435|588740158|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010084|NCT03334435|588740159|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010085|NCT03334435|588740160|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010086|NCT03334435|588740161|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010087|NCT03334435|588740162|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010088|NCT03334435|588740163|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010089|NCT03334435|588740164|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163061801|NCT00785629|588935025|FG003|Overall Study|Withdrawal by Subject|2|||
163327939|NCT00622700|589911502|FG006|Core Treatment Period|Lack of Efficacy|0|||
163327940|NCT00622700|589911496|FG000|Core Treatment Period|Lost to Follow-up|1|||
163327941|NCT00622700|589911497|FG001|Core Treatment Period|Lost to Follow-up|1|||
163327942|NCT00622700|589911498|FG002|Core Treatment Period|Lost to Follow-up|1|||
163327943|NCT00622700|589911499|FG003|Core Treatment Period|Lost to Follow-up|0|||
163327944|NCT00622700|589911500|FG004|Core Treatment Period|Lost to Follow-up|0|||
163327945|NCT00622700|589911501|FG005|Core Treatment Period|Lost to Follow-up|0|||
163327946|NCT00622700|589911502|FG006|Core Treatment Period|Lost to Follow-up|0|||
163327947|NCT00622700|589911496|FG000|Core Treatment Period|Death|1|||
163327948|NCT00622700|589911497|FG001|Core Treatment Period|Death|0|||
163327949|NCT00622700|589911498|FG002|Core Treatment Period|Death|0|||
163327950|NCT00622700|589911499|FG003|Core Treatment Period|Death|0|||
163327951|NCT00622700|589911500|FG004|Core Treatment Period|Death|0|||
163327952|NCT00622700|589911501|FG005|Core Treatment Period|Death|0|||
163327953|NCT00622700|589911502|FG006|Core Treatment Period|Death|0|||
163327954|NCT00622700|589911496|FG000|Core Treatment Period|Progressive Disease|3|||
163327955|NCT00622700|589911497|FG001|Core Treatment Period|Progressive Disease|1|||
163327956|NCT00622700|589911498|FG002|Core Treatment Period|Progressive Disease|0|||
163327957|NCT00622700|589911499|FG003|Core Treatment Period|Progressive Disease|0|||
163327958|NCT00622700|589911500|FG004|Core Treatment Period|Progressive Disease|0|||
163327959|NCT00622700|589911501|FG005|Core Treatment Period|Progressive Disease|0|||
163327960|NCT00622700|589911502|FG006|Core Treatment Period|Progressive Disease|0|||
163327961|NCT00622700|589911496|FG000|Core Treatment Period|Withdrawal by Subject|12|||
163327962|NCT00622700|589911497|FG001|Core Treatment Period|Withdrawal by Subject|18|||
163327963|NCT00622700|589911498|FG002|Core Treatment Period|Withdrawal by Subject|15|||
163404528|NCT01500278|590191956|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
163404529|NCT01500278|590191955|FG000|Week 13 - Week 104|Non/bad compliance|7|||
163327964|NCT00622700|589911499|FG003|Core Treatment Period|Withdrawal by Subject|0|||
163327965|NCT00622700|589911500|FG004|Core Treatment Period|Withdrawal by Subject|0|||
163327966|NCT00622700|589911501|FG005|Core Treatment Period|Withdrawal by Subject|0|||
163327967|NCT00622700|589911502|FG006|Core Treatment Period|Withdrawal by Subject|0|||
163327968|NCT00622700|589911496|FG000|Core Treatment Period|Other than specified above|2|||
163327969|NCT00622700|589911497|FG001|Core Treatment Period|Other than specified above|2|||
163327970|NCT00622700|589911498|FG002|Core Treatment Period|Other than specified above|5|||
163327971|NCT00622700|589911499|FG003|Core Treatment Period|Other than specified above|0|||
163327972|NCT00622700|589911500|FG004|Core Treatment Period|Other than specified above|0|||
163327973|NCT00622700|589911501|FG005|Core Treatment Period|Other than specified above|0|||
163327974|NCT00622700|589911502|FG006|Core Treatment Period|Other than specified above|0|||
163327975|NCT00622700|589911496|FG000|Extension Treatment Period|Adverse Event|0|||
163327976|NCT00622700|589911497|FG001|Extension Treatment Period|Adverse Event|0|||
163327977|NCT00622700|589911498|FG002|Extension Treatment Period|Adverse Event|0|||
163327978|NCT00622700|589911499|FG003|Extension Treatment Period|Adverse Event|5|||
163327979|NCT00622700|589911500|FG004|Extension Treatment Period|Adverse Event|9|||
163327980|NCT00622700|589911501|FG005|Extension Treatment Period|Adverse Event|6|||
163327981|NCT00622700|589911502|FG006|Extension Treatment Period|Adverse Event|8|||
163327982|NCT00622700|589911496|FG000|Extension Treatment Period|Lack of Efficacy|0|||
163327983|NCT00622700|589911497|FG001|Extension Treatment Period|Lack of Efficacy|0|||
163327984|NCT00622700|589911498|FG002|Extension Treatment Period|Lack of Efficacy|0|||
163327985|NCT00622700|589911499|FG003|Extension Treatment Period|Lack of Efficacy|2|||
163327986|NCT00622700|589911500|FG004|Extension Treatment Period|Lack of Efficacy|8|||
163327987|NCT00622700|589911501|FG005|Extension Treatment Period|Lack of Efficacy|1|||
163327988|NCT00622700|589911502|FG006|Extension Treatment Period|Lack of Efficacy|9|||
163327989|NCT00622700|589911496|FG000|Extension Treatment Period|Protocol Violation|0|||
163327990|NCT00622700|589911497|FG001|Extension Treatment Period|Protocol Violation|0|||
163327991|NCT00622700|589911498|FG002|Extension Treatment Period|Protocol Violation|0|||
163327992|NCT00622700|589911499|FG003|Extension Treatment Period|Protocol Violation|0|||
163327993|NCT00622700|589911500|FG004|Extension Treatment Period|Protocol Violation|0|||
163010090|NCT03334435|588740165|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010091|NCT03334435|588740151|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
163010092|NCT03334435|588740152|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
163010093|NCT03334435|588740153|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
163010094|NCT03334435|588740154|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
163010095|NCT03334435|588740155|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
163010096|NCT03334435|588740156|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010097|NCT03334435|588740157|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010098|NCT03334435|588740158|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010099|NCT03334435|588740159|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010100|NCT03334435|588740160|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010101|NCT03334435|588740161|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010102|NCT03334435|588740162|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010103|NCT03334435|588740163|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010104|NCT03334435|588740164|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010105|NCT03334435|588740165|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010106|NCT03334435|588740151|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
163010107|NCT03334435|588740152|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
163010108|NCT03334435|588740153|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
163010109|NCT03334435|588740154|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
163061802|NCT02020941|588935028|FG000|Overall Study|Adverse Event|1|||
163327994|NCT00622700|589911501|FG005|Extension Treatment Period|Protocol Violation|2|||
163327995|NCT00622700|589911502|FG006|Extension Treatment Period|Protocol Violation|0|||
163327996|NCT00622700|589911496|FG000|Extension Treatment Period|Lost to Follow-up|0|||
163327997|NCT00622700|589911497|FG001|Extension Treatment Period|Lost to Follow-up|0|||
163327998|NCT00622700|589911498|FG002|Extension Treatment Period|Lost to Follow-up|0|||
163327999|NCT00622700|589911499|FG003|Extension Treatment Period|Lost to Follow-up|0|||
163328000|NCT00622700|589911500|FG004|Extension Treatment Period|Lost to Follow-up|1|||
163328001|NCT00622700|589911501|FG005|Extension Treatment Period|Lost to Follow-up|0|||
163328002|NCT00622700|589911502|FG006|Extension Treatment Period|Lost to Follow-up|0|||
163328003|NCT00622700|589911496|FG000|Extension Treatment Period|Progressive Disease|0|||
163328004|NCT00622700|589911497|FG001|Extension Treatment Period|Progressive Disease|0|||
163328005|NCT00622700|589911498|FG002|Extension Treatment Period|Progressive Disease|0|||
163328006|NCT00622700|589911499|FG003|Extension Treatment Period|Progressive Disease|1|||
163328007|NCT00622700|589911500|FG004|Extension Treatment Period|Progressive Disease|2|||
163328008|NCT00622700|589911501|FG005|Extension Treatment Period|Progressive Disease|0|||
163328009|NCT00622700|589911502|FG006|Extension Treatment Period|Progressive Disease|2|||
163328010|NCT00622700|589911496|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
163328011|NCT00622700|589911497|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
163328012|NCT00622700|589911498|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
163328013|NCT00622700|589911499|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
163328014|NCT00622700|589911500|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
163328015|NCT00622700|589911501|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
163328016|NCT00622700|589911502|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
162924943|NCT00203892|588427321|FG002|Overall Study|Physician Decision|0|||
162924944|NCT00203892|588427319|FG000|Overall Study|Death|1|||
162924945|NCT00203892|588427320|FG001|Overall Study|Death|0|||
162924946|NCT00203892|588427321|FG002|Overall Study|Death|0|||
162924947|NCT03829462|588427325|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
162924948|NCT03829462|588427326|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
162924949|NCT03829462|588427325|FG000|Overall Study|No treatment due to progression disease|0|||
162924950|NCT03829462|588427326|FG001|Overall Study|No treatment due to progression disease|1|||
162924951|NCT02341482|588427327|FG000|Overall Study|Adverse Event|1|||
162924952|NCT03000075|588427331|FG000|Part A|Adverse Event|4|||
162924953|NCT03000075|588427332|FG001|Part A|Adverse Event|0|||
162924954|NCT03000075|588427333|FG002|Part A|Adverse Event|0|||
162924955|NCT03000075|588427334|FG003|Part A|Adverse Event|0|||
162924956|NCT03000075|588427335|FG004|Part A|Adverse Event|0|||
162924957|NCT03000075|588427336|FG005|Part A|Adverse Event|0|||
162924958|NCT03000075|588427337|FG006|Part A|Adverse Event|0|||
162924959|NCT03000075|588427331|FG000|Part B|Not dosed due to AE|0|||
162924960|NCT03000075|588427332|FG001|Part B|Not dosed due to AE|0|||
162924961|NCT03000075|588427333|FG002|Part B|Not dosed due to AE|0|||
162924962|NCT03000075|588427334|FG003|Part B|Not dosed due to AE|0|||
162924963|NCT03000075|588427335|FG004|Part B|Not dosed due to AE|0|||
162924964|NCT03000075|588427336|FG005|Part B|Not dosed due to AE|2|||
162924965|NCT03000075|588427337|FG006|Part B|Not dosed due to AE|1|||
162924966|NCT03000075|588427331|FG000|Part B|Adverse Event|0|||
162924967|NCT03000075|588427332|FG001|Part B|Adverse Event|0|||
162924968|NCT03000075|588427333|FG002|Part B|Adverse Event|0|||
162924969|NCT03000075|588427334|FG003|Part B|Adverse Event|0|||
162924970|NCT03000075|588427335|FG004|Part B|Adverse Event|1|||
162924971|NCT03000075|588427336|FG005|Part B|Adverse Event|0|||
162924972|NCT03000075|588427337|FG006|Part B|Adverse Event|0|||
162924973|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
162924974|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
162924975|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Death|5|||
162924976|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Death|2|||
162924977|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
162924978|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
162924979|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
162924980|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
162924981|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
162924982|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
162924983|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Relapse|1|||
162924984|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Relapse|0|||
162924985|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
162924986|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
162924987|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
162924988|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
162924989|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
162924990|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
162924991|NCT00111007|588427338|FG000|Active Follow-up|Adverse Event|1|||
162924992|NCT00111007|588427339|FG001|Active Follow-up|Adverse Event|0|||
162924993|NCT00111007|588427338|FG000|Active Follow-up|Death|2|||
162924994|NCT00111007|588427339|FG001|Active Follow-up|Death|0|||
162924995|NCT00111007|588427338|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
162924996|NCT00111007|588427339|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
162924997|NCT00111007|588427338|FG000|Long Term Follow-up|Death|34|||
162924998|NCT00111007|588427339|FG001|Long Term Follow-up|Death|39|||
162924999|NCT00111007|588427338|FG000|Long Term Follow-up|Lost to Follow-up|1|||
162925000|NCT00111007|588427339|FG001|Long Term Follow-up|Lost to Follow-up|1|||
162925001|NCT00111007|588427338|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
162925002|NCT00111007|588427339|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
162925003|NCT00111007|588427338|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
162925004|NCT00111007|588427339|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
162925005|NCT00111007|588427338|FG000|Long Term Follow-up|Missing|10|||
162925006|NCT00111007|588427339|FG001|Long Term Follow-up|Missing|3|||
162925007|NCT01495793|588427340|FG000|Overall Study|Lost to Follow-up|1|||
162925008|NCT01495793|588427340|FG000|Overall Study|Violation of inclusion criteria|1|||
162925009|NCT03332212|588427341|FG000|Overall Study|Not treated|0|||
163061803|NCT02020941|588935028|FG000|Overall Study|Physician Decision|2|||
162925010|NCT03332212|588427342|FG001|Overall Study|Not treated|1|||
163010110|NCT03334435|588740155|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
163010111|NCT03334435|588740156|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010112|NCT03334435|588740157|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010113|NCT03334435|588740158|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010114|NCT03334435|588740159|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010115|NCT03334435|588740160|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010116|NCT03334435|588740161|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010117|NCT03334435|588740162|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010118|NCT03334435|588740163|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010119|NCT03334435|588740164|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010120|NCT03334435|588740165|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010121|NCT03334435|588740151|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
163010122|NCT03334435|588740152|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
163010123|NCT03334435|588740153|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
163010124|NCT03334435|588740154|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
163010125|NCT03334435|588740155|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
163010126|NCT03334435|588740156|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010127|NCT03334435|588740157|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010128|NCT03334435|588740158|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010129|NCT03334435|588740159|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010130|NCT03334435|588740160|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010131|NCT03334435|588740161|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010132|NCT03334435|588740162|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010133|NCT03334435|588740163|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010134|NCT03334435|588740164|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010135|NCT03334435|588740165|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010136|NCT03334435|588740151|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
163010137|NCT03334435|588740152|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010138|NCT03334435|588740153|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
163010139|NCT03334435|588740154|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
163010140|NCT03334435|588740155|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
163010141|NCT03334435|588740156|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010142|NCT03334435|588740157|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010143|NCT03334435|588740158|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010144|NCT03334435|588740159|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010145|NCT03334435|588740160|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010146|NCT03334435|588740161|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010147|NCT03334435|588740162|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010148|NCT03334435|588740163|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010149|NCT03334435|588740164|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010150|NCT03334435|588740165|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010151|NCT03334435|588740151|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010152|NCT03334435|588740152|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010153|NCT03334435|588740153|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010154|NCT03334435|588740154|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
163010155|NCT03334435|588740155|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010156|NCT03334435|588740156|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010157|NCT03334435|588740157|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010158|NCT03334435|588740158|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010159|NCT03334435|588740159|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010160|NCT03334435|588740160|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010161|NCT03334435|588740161|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010162|NCT03334435|588740162|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
163214299|NCT05286307|589497737|FG001|Overall Study|Incomplete outcome assessments|1|||
163214300|NCT05286307|589497736|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
163214301|NCT05286307|589497737|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
163214302|NCT05286307|589497736|FG000|Overall Study|Lost to follow up at 6 months|25|||
163010163|NCT03334435|588740163|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010164|NCT03334435|588740164|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010165|NCT03334435|588740165|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010166|NCT03334435|588740151|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010167|NCT03334435|588740152|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
163010168|NCT03334435|588740153|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
163010169|NCT03334435|588740154|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
163010170|NCT03334435|588740155|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
163214303|NCT05286307|589497737|FG001|Overall Study|Lost to follow up at 6 months|35|||
163010171|NCT03334435|588740156|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010172|NCT03334435|588740157|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010173|NCT03334435|588740158|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010174|NCT03334435|588740159|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010175|NCT03334435|588740160|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010176|NCT03334435|588740161|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010177|NCT03334435|588740162|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010178|NCT03334435|588740163|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010179|NCT03334435|588740164|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010180|NCT03334435|588740165|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010181|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
163010182|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
163010183|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
163010184|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
163010185|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
163010186|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
163010187|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
163010188|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
163010189|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
163010190|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
163010191|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
163010192|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
163010193|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
163010194|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
163010195|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
163010196|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
163010197|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
163010198|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
163010199|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
163010200|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
163010201|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
163010202|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
163010203|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
163010204|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
163010205|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
163010206|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
163010207|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
163010208|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
163010209|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
163010210|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
163010211|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
163010212|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
163010213|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
163010214|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
163010215|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
163010216|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
163010217|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
163010218|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
163010219|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
163010220|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
163010221|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
163010222|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
163010223|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
163328017|NCT00622700|589911496|FG000|Extension Treatment Period|Missing|0|||
163328018|NCT00622700|589911497|FG001|Extension Treatment Period|Missing|0|||
163328019|NCT00622700|589911498|FG002|Extension Treatment Period|Missing|0|||
163328020|NCT00622700|589911499|FG003|Extension Treatment Period|Missing|2|||
163328021|NCT00622700|589911500|FG004|Extension Treatment Period|Missing|3|||
163010224|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
163010225|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
163010226|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
163010227|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
163328022|NCT00622700|589911501|FG005|Extension Treatment Period|Missing|1|||
163328023|NCT00622700|589911502|FG006|Extension Treatment Period|Missing|0|||
163010228|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
163010229|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
163010230|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
163010231|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
163010232|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
163010233|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
163010234|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
163010235|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
163010236|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
163010237|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
163010238|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
163010239|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
163010240|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
163010241|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
163010242|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
163010243|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
163010244|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
163010245|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
163010246|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
163010247|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
163010248|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
163010249|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
163010250|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
163010251|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
163010252|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
163010253|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
163010254|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
163010255|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
163010256|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010257|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010258|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010259|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010260|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010261|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010262|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010263|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010264|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010265|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010266|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010267|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
163010268|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010269|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
163010270|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010271|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010272|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010273|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
163328024|NCT00622700|589911496|FG000|Extension Treatment Period|Other than specified above|0|||
163010274|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010275|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010276|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
163010277|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010278|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
163328025|NCT00622700|589911497|FG001|Extension Treatment Period|Other than specified above|0|||
163328026|NCT00622700|589911498|FG002|Extension Treatment Period|Other than specified above|0|||
163328027|NCT00622700|589911499|FG003|Extension Treatment Period|Other than specified above|0|||
163328028|NCT00622700|589911500|FG004|Extension Treatment Period|Other than specified above|0|||
163010279|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010280|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
163328029|NCT00622700|589911501|FG005|Extension Treatment Period|Other than specified above|1|||
163328030|NCT00622700|589911502|FG006|Extension Treatment Period|Other than specified above|1|||
163010281|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
163061804|NCT02020941|588935028|FG000|Overall Study|Withdrawal by Subject|1|||
163061805|NCT02020941|588935028|FG000|Overall Study|Disease Progression|4|||
163061806|NCT02107898|588935031|FG000|Overall Study|Adverse Event|4|||
163010282|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010283|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010284|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010285|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
163010286|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010287|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010288|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010289|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010290|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010291|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
163010292|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
163010293|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
163010294|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
163010295|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
163010296|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
163010297|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
163010298|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010299|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010300|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010301|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010302|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010303|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010304|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010305|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010306|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
163010307|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
163010308|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010309|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010310|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010311|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010312|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
163010313|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
163010314|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
163010315|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
163010316|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010317|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010318|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010319|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010320|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010321|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
163010322|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010323|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010324|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010325|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010326|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
163010327|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010328|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010329|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010330|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
163010331|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010332|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010333|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010334|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010335|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010336|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010337|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010338|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
163010339|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
163061807|NCT02107898|588935032|FG001|Overall Study|Adverse Event|7|||
163328031|NCT03611556|589911503|FG000|Overall Study|Death|7|||
163328032|NCT03611556|589911504|FG001|Overall Study|Death|7|||
163328033|NCT03611556|589911505|FG002|Overall Study|Death|3|||
163328034|NCT03611556|589911506|FG003|Overall Study|Death|8|||
163328035|NCT03611556|589911507|FG004|Overall Study|Death|47|||
163214304|NCT05286307|589497736|FG000|Overall Study|Study medication not available|1|||
162925011|NCT03332212|588427343|FG002|Overall Study|Not treated|0|||
162925012|NCT03332212|588427344|FG003|Overall Study|Not treated|0|||
162925013|NCT03332212|588427341|FG000|Overall Study|Adverse Event|0|||
162925014|NCT03332212|588427342|FG001|Overall Study|Adverse Event|0|||
162925015|NCT03332212|588427343|FG002|Overall Study|Adverse Event|0|||
162925016|NCT03332212|588427344|FG003|Overall Study|Adverse Event|1|||
162925017|NCT03332212|588427341|FG000|Overall Study|worsening of disease under study|1|||
162925018|NCT03332212|588427342|FG001|Overall Study|worsening of disease under study|1|||
162925019|NCT03332212|588427343|FG002|Overall Study|worsening of disease under study|0|||
162925020|NCT03332212|588427344|FG003|Overall Study|worsening of disease under study|0|||
162925021|NCT02362646|588427345|FG000|Overall Study|Death|15|||
162925022|NCT02362646|588427346|FG001|Overall Study|Death|8|||
162925023|NCT02362646|588427345|FG000|Overall Study|Withdrawal by Subject|2|||
162925024|NCT02362646|588427346|FG001|Overall Study|Withdrawal by Subject|2|||
162925025|NCT02362646|588427345|FG000|Overall Study|received transplant|21|||
162925026|NCT02362646|588427346|FG001|Overall Study|received transplant|14|||
162925027|NCT00929864|588427350|FG000|Overall Study|Death|1|||
162925028|NCT00929864|588427351|FG001|Overall Study|Death|1|||
162925029|NCT00929864|588427350|FG000|Overall Study|Adverse Event|11|||
162925030|NCT00929864|588427351|FG001|Overall Study|Adverse Event|30|||
162925031|NCT00929864|588427350|FG000|Overall Study|Lack of Efficacy|19|||
162925032|NCT00929864|588427351|FG001|Overall Study|Lack of Efficacy|16|||
162925033|NCT00929864|588427350|FG000|Overall Study|Lost to Follow-up|7|||
162925034|NCT00929864|588427351|FG001|Overall Study|Lost to Follow-up|12|||
162925035|NCT00929864|588427350|FG000|Overall Study|Withdrawal by Subject|20|||
162925036|NCT00929864|588427351|FG001|Overall Study|Withdrawal by Subject|9|||
162925037|NCT00929864|588427350|FG000|Overall Study|No longer met criteria|2|||
162925038|NCT00929864|588427351|FG001|Overall Study|No longer met criteria|1|||
162925039|NCT00929864|588427350|FG000|Overall Study|Poor or non-compliance|3|||
162925040|NCT00929864|588427351|FG001|Overall Study|Poor or non-compliance|3|||
162925041|NCT00929864|588427350|FG000|Overall Study|Pregnancy|0|||
162925042|NCT00929864|588427351|FG001|Overall Study|Pregnancy|3|||
162925043|NCT00929864|588427350|FG000|Overall Study|Administrative reason by Sponsor|1|||
162925044|NCT00929864|588427351|FG001|Overall Study|Administrative reason by Sponsor|1|||
162925045|NCT00929864|588427350|FG000|Overall Study|Non-specified|2|||
162925046|NCT00929864|588427351|FG001|Overall Study|Non-specified|7|||
162925047|NCT03940742|588427352|FG000|Overall Study|Lost to Follow-up|0|||
162925048|NCT03940742|588427353|FG001|Overall Study|Lost to Follow-up|0|||
162925049|NCT03940742|588427354|FG002|Overall Study|Lost to Follow-up|0|||
162925050|NCT03940742|588427355|FG003|Overall Study|Lost to Follow-up|1|||
162925051|NCT03428217|588427357|FG000|Overall Study|Death|89|||
162925052|NCT03428217|588427358|FG001|Overall Study|Death|93|||
162925053|NCT03428217|588427357|FG000|Overall Study|Withdrawal by Subject|8|||
162925054|NCT03428217|588427358|FG001|Overall Study|Withdrawal by Subject|7|||
162925055|NCT03428217|588427357|FG000|Overall Study|Lost to Follow-up|1|||
162925056|NCT03428217|588427358|FG001|Overall Study|Lost to Follow-up|3|||
162925057|NCT03428217|588427357|FG000|Overall Study|Study terminated by sponsor|124|||
162925058|NCT03428217|588427358|FG001|Overall Study|Study terminated by sponsor|118|||
162925059|NCT03428217|588427357|FG000|Overall Study|Other, Not Specified|1|||
162925060|NCT03428217|588427358|FG001|Overall Study|Other, Not Specified|0|||
162925061|NCT00905437|588427359|FG000|Overall Study|Adverse Event|3|||
162925062|NCT00905437|588427360|FG001|Overall Study|Adverse Event|2|||
162925063|NCT00905437|588427359|FG000|Overall Study|Lost to Follow-up|0|||
162925064|NCT00905437|588427360|FG001|Overall Study|Lost to Follow-up|1|||
162925065|NCT00905437|588427359|FG000|Overall Study|Withdrawal by Subject|0|||
162925066|NCT00905437|588427360|FG001|Overall Study|Withdrawal by Subject|1|||
162925067|NCT00905437|588427359|FG000|Overall Study|Other|5|||
162925068|NCT00905437|588427360|FG001|Overall Study|Other|6|||
162925069|NCT05246111|588427361|FG000|Period 01|NOT ELIGIBLE IC5|1|||
162925070|NCT05246111|588427362|FG001|Period 01|NOT ELIGIBLE IC5|0|||
162925071|NCT01306968|588427365|FG000|Overall Study|Lost to Follow-up|1|||
162925072|NCT01306968|588427366|FG001|Overall Study|Lost to Follow-up|1|||
162925073|NCT01306968|588427367|FG002|Overall Study|Lost to Follow-up|0|||
162925074|NCT01306968|588427368|FG003|Overall Study|Lost to Follow-up|0|||
162925075|NCT01306968|588427365|FG000|Overall Study|Physician Decision|0|||
162925076|NCT01306968|588427366|FG001|Overall Study|Physician Decision|1|||
162925077|NCT01306968|588427367|FG002|Overall Study|Physician Decision|0|||
162925078|NCT01306968|588427368|FG003|Overall Study|Physician Decision|0|||
162925079|NCT01306968|588427365|FG000|Overall Study|Relocated and left active duty|0|||
162925080|NCT01306968|588427366|FG001|Overall Study|Relocated and left active duty|1|||
162925081|NCT01306968|588427367|FG002|Overall Study|Relocated and left active duty|1|||
162925082|NCT01306968|588427368|FG003|Overall Study|Relocated and left active duty|1|||
162925083|NCT01306968|588427365|FG000|Overall Study|Withdrew - time commitment|0|||
162925084|NCT01306968|588427366|FG001|Overall Study|Withdrew - time commitment|0|||
162925085|NCT01306968|588427367|FG002|Overall Study|Withdrew - time commitment|0|||
162925086|NCT01306968|588427368|FG003|Overall Study|Withdrew - time commitment|2|||
162925087|NCT01306968|588427365|FG000|Overall Study|Withdrew over privacy concerns|0|||
163328036|NCT03611556|589911508|FG005|Overall Study|Death|32|||
163010340|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010341|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
163010342|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
163010343|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
163010344|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010345|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010346|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010347|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010348|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010349|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010350|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010351|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010352|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010353|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010354|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010355|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010356|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010357|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
163010358|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010359|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
163010360|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
163010361|NCT03922321|588740166|FG000|Overall Study|Participant Moved|1|||
163010362|NCT03922321|588740166|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
163010363|NCT02342678|588740170|FG000|Overall Study|Lost to Follow-up|0|||
163010364|NCT02342678|588740171|FG001|Overall Study|Lost to Follow-up|1|||
163010365|NCT02342678|588740170|FG000|Overall Study|Too busy to complete study|0|||
163010366|NCT02342678|588740171|FG001|Overall Study|Too busy to complete study|2|||
163010367|NCT02342678|588740170|FG000|Overall Study|Family illness/emergency|0|||
163010368|NCT02342678|588740171|FG001|Overall Study|Family illness/emergency|1|||
163010369|NCT02342678|588740170|FG000|Overall Study|Illness/medical reason|1|||
163061808|NCT02107898|588935031|FG000|Overall Study|Poor compliance to protocol|0|||
163061809|NCT02107898|588935032|FG001|Overall Study|Poor compliance to protocol|1|||
163061810|NCT02107898|588935031|FG000|Overall Study|Participant moved|0|||
163061811|NCT02107898|588935032|FG001|Overall Study|Participant moved|2|||
163061812|NCT02107898|588935031|FG000|Overall Study|Consent withdrawn by participant|2|||
163061813|NCT02107898|588935032|FG001|Overall Study|Consent withdrawn by participant|1|||
163061814|NCT02107898|588935031|FG000|Overall Study|Randomized but not treated|0|||
163061815|NCT02107898|588935032|FG001|Overall Study|Randomized but not treated|1|||
163061816|NCT03329989|588935033|FG000|Overall Study|Withdrawal by Subject|9|||
163061817|NCT03329989|588935033|FG000|Overall Study|Lost to Follow-up|8|||
163061818|NCT03329989|588935033|FG000|Overall Study|Adverse Event|5|||
163061819|NCT03329989|588935033|FG000|Overall Study|Protocol Violation|1|||
163061820|NCT01283386|588935034|FG000|Overall Study|Death|2|||
163061821|NCT01283386|588935035|FG001|Overall Study|Death|0|||
163061822|NCT01283386|588935034|FG000|Overall Study|Withdrawal by Subject|2|||
163061823|NCT01283386|588935035|FG001|Overall Study|Withdrawal by Subject|1|||
163061824|NCT01283386|588935034|FG000|Overall Study|Relapse of underlying disease|1|||
163061825|NCT01283386|588935035|FG001|Overall Study|Relapse of underlying disease|3|||
163061826|NCT01283386|588935034|FG000|Overall Study|Progression of underlying disease|2|||
163061827|NCT01283386|588935035|FG001|Overall Study|Progression of underlying disease|7|||
163061828|NCT01283386|588935034|FG000|Overall Study|Reason not specified|1|||
163061829|NCT01283386|588935035|FG001|Overall Study|Reason not specified|0|||
163061830|NCT01283386|588935034|FG000|Overall Study|Protocol Violation|0|||
163061831|NCT01283386|588935035|FG001|Overall Study|Protocol Violation|1|||
163061832|NCT02469857|588935036|FG000|Overall Study|Death|24|||
163061833|NCT02469857|588935037|FG001|Overall Study|Death|29|||
163061834|NCT02469857|588935036|FG000|Overall Study|Discontinuation|1|||
163061835|NCT02469857|588935037|FG001|Overall Study|Discontinuation|3|||
163061836|NCT01137786|588935038|FG000|Overall Study|Lost to Follow-up|0|||
163061837|NCT01137786|588935039|FG001|Overall Study|Lost to Follow-up|2|||
163061838|NCT01137786|588935038|FG000|Overall Study|Withdrawal by Subject|1|||
163214305|NCT05286307|589497737|FG001|Overall Study|Study medication not available|1|||
163214306|NCT04568590|589499018|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
163010370|NCT02342678|588740171|FG001|Overall Study|Illness/medical reason|1|||
163010371|NCT00460603|588740172|FG000|Phase 1|Death|1|||
163010372|NCT00460603|588740173|FG001|Phase 1|Death|0|||
163061839|NCT01137786|588935039|FG001|Overall Study|Withdrawal by Subject|1|||
163061840|NCT01531153|588935040|FG000|Overall Study|Withdrawal by Subject|10|||
163061841|NCT01531153|588935041|FG001|Overall Study|Withdrawal by Subject|9|||
163061842|NCT01531153|588935042|FG002|Overall Study|Withdrawal by Subject|15|||
163061843|NCT03416179|588935043|FG000|Overall Study|Death|90|||
163214307|NCT02489344|589499019|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
163214308|NCT02489344|589499019|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
163061844|NCT03416179|588935044|FG001|Overall Study|Death|87|||
163328037|NCT03611556|589911509|FG006|Overall Study|Death|53|||
163061845|NCT03416179|588935045|FG002|Overall Study|Death|117|||
163061846|NCT03416179|588935046|FG003|Overall Study|Death|113|||
163061847|NCT03416179|588935043|FG000|Overall Study|Withdrawal by Subject|15|||
163061848|NCT03416179|588935044|FG001|Overall Study|Withdrawal by Subject|20|||
163061849|NCT03416179|588935045|FG002|Overall Study|Withdrawal by Subject|6|||
163061850|NCT03416179|588935046|FG003|Overall Study|Withdrawal by Subject|9|||
163061851|NCT03416179|588935043|FG000|Overall Study|Lost to Follow-up|1|||
163061852|NCT03416179|588935044|FG001|Overall Study|Lost to Follow-up|1|||
163061853|NCT03416179|588935045|FG002|Overall Study|Lost to Follow-up|0|||
163061854|NCT03416179|588935046|FG003|Overall Study|Lost to Follow-up|3|||
163061855|NCT03416179|588935043|FG000|Overall Study|Study participation terminated by Sponsor|93|||
163061856|NCT03416179|588935044|FG001|Overall Study|Study participation terminated by Sponsor|91|||
163061857|NCT03416179|588935045|FG002|Overall Study|Study participation terminated by Sponsor|26|||
163061858|NCT03416179|588935046|FG003|Overall Study|Study participation terminated by Sponsor|31|||
163061859|NCT03416179|588935043|FG000|Overall Study|Other|2|||
163061860|NCT03416179|588935044|FG001|Overall Study|Other|3|||
163061861|NCT03416179|588935045|FG002|Overall Study|Other|1|||
163061862|NCT03416179|588935046|FG003|Overall Study|Other|0|||
163061863|NCT00879658|588935047|FG000|Overall Study|Abnormal laboratory value(s)|3|||
163061864|NCT00879658|588935048|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163061865|NCT00879658|588935049|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163061866|NCT00879658|588935050|FG003|Overall Study|Abnormal laboratory value(s)|1|||
163061867|NCT00879658|588935051|FG004|Overall Study|Abnormal laboratory value(s)|0|||
163061868|NCT00879658|588935052|FG005|Overall Study|Abnormal laboratory value(s)|0|||
163061869|NCT00879658|588935053|FG006|Overall Study|Abnormal laboratory value(s)|0|||
163061870|NCT00879658|588935047|FG000|Overall Study|Administrative problems|2|||
163061871|NCT00879658|588935048|FG001|Overall Study|Administrative problems|1|||
163061872|NCT00879658|588935049|FG002|Overall Study|Administrative problems|0|||
163061873|NCT00879658|588935050|FG003|Overall Study|Administrative problems|1|||
163061874|NCT00879658|588935051|FG004|Overall Study|Administrative problems|0|||
163061875|NCT00879658|588935052|FG005|Overall Study|Administrative problems|0|||
163061876|NCT00879658|588935053|FG006|Overall Study|Administrative problems|0|||
163061877|NCT00879658|588935047|FG000|Overall Study|Adverse Event|6|||
163061878|NCT00879658|588935048|FG001|Overall Study|Adverse Event|4|||
163061879|NCT00879658|588935049|FG002|Overall Study|Adverse Event|3|||
163061880|NCT00879658|588935050|FG003|Overall Study|Adverse Event|1|||
163061881|NCT00879658|588935051|FG004|Overall Study|Adverse Event|2|||
163061882|NCT00879658|588935052|FG005|Overall Study|Adverse Event|0|||
163061883|NCT00879658|588935053|FG006|Overall Study|Adverse Event|0|||
163061884|NCT00879658|588935047|FG000|Overall Study|Protocol Violation|1|||
163061885|NCT00879658|588935048|FG001|Overall Study|Protocol Violation|0|||
163061886|NCT00879658|588935049|FG002|Overall Study|Protocol Violation|0|||
163061887|NCT00879658|588935050|FG003|Overall Study|Protocol Violation|0|||
163061888|NCT00879658|588935051|FG004|Overall Study|Protocol Violation|0|||
163061889|NCT00879658|588935052|FG005|Overall Study|Protocol Violation|0|||
163061890|NCT00879658|588935053|FG006|Overall Study|Protocol Violation|0|||
163061891|NCT00879658|588935047|FG000|Overall Study|Withdrawal by Subject|3|||
163061892|NCT00879658|588935048|FG001|Overall Study|Withdrawal by Subject|0|||
163061893|NCT00879658|588935049|FG002|Overall Study|Withdrawal by Subject|2|||
163061894|NCT00879658|588935050|FG003|Overall Study|Withdrawal by Subject|0|||
163061895|NCT00879658|588935051|FG004|Overall Study|Withdrawal by Subject|0|||
163061896|NCT00879658|588935052|FG005|Overall Study|Withdrawal by Subject|1|||
163061897|NCT00879658|588935053|FG006|Overall Study|Withdrawal by Subject|0|||
163061898|NCT00879658|588935047|FG000|Overall Study|Lack of Efficacy|0|||
163061899|NCT00879658|588935048|FG001|Overall Study|Lack of Efficacy|0|||
163061900|NCT00879658|588935049|FG002|Overall Study|Lack of Efficacy|2|||
163061901|NCT00879658|588935050|FG003|Overall Study|Lack of Efficacy|0|||
163061902|NCT00879658|588935051|FG004|Overall Study|Lack of Efficacy|0|||
163061903|NCT00879658|588935052|FG005|Overall Study|Lack of Efficacy|0|||
163061904|NCT00879658|588935053|FG006|Overall Study|Lack of Efficacy|0|||
163328038|NCT03611556|589911503|FG000|Overall Study|Withdrawal by Subject|0|||
163328039|NCT03611556|589911504|FG001|Overall Study|Withdrawal by Subject|0|||
163061905|NCT00879658|588935047|FG000|Overall Study|misrandomized (never received study med)|0|||
163061906|NCT00879658|588935048|FG001|Overall Study|misrandomized (never received study med)|0|||
163061907|NCT00879658|588935049|FG002|Overall Study|misrandomized (never received study med)|0|||
163061908|NCT00879658|588935050|FG003|Overall Study|misrandomized (never received study med)|1|||
163061909|NCT00879658|588935051|FG004|Overall Study|misrandomized (never received study med)|0|||
163061910|NCT00879658|588935052|FG005|Overall Study|misrandomized (never received study med)|0|||
163061911|NCT00879658|588935053|FG006|Overall Study|misrandomized (never received study med)|0|||
163061912|NCT00157755|588935055|FG000|Overall Study|Death|2|||
163061913|NCT00157755|588935056|FG001|Overall Study|Death|3|||
163061914|NCT00157755|588935057|FG002|Overall Study|Death|3|||
163061915|NCT00157755|588935058|FG003|Overall Study|Death|2|||
163061916|NCT00157755|588935059|FG004|Overall Study|Death|0|||
163061917|NCT00157755|588935060|FG005|Overall Study|Death|0|||
163061918|NCT00157755|588935055|FG000|Overall Study|Lost to Follow-up|0|||
163328040|NCT03611556|589911505|FG002|Overall Study|Withdrawal by Subject|0|||
163061919|NCT00157755|588935056|FG001|Overall Study|Lost to Follow-up|0|||
163061920|NCT00157755|588935057|FG002|Overall Study|Lost to Follow-up|1|||
163328041|NCT03611556|589911506|FG003|Overall Study|Withdrawal by Subject|0|||
163328042|NCT03611556|589911507|FG004|Overall Study|Withdrawal by Subject|4|||
163328043|NCT03611556|589911508|FG005|Overall Study|Withdrawal by Subject|2|||
163328044|NCT03611556|589911509|FG006|Overall Study|Withdrawal by Subject|4|||
163328045|NCT03611556|589911503|FG000|Overall Study|Sponsor decision|0|||
163328046|NCT03611556|589911504|FG001|Overall Study|Sponsor decision|0|||
163328047|NCT03611556|589911505|FG002|Overall Study|Sponsor decision|0|||
163328048|NCT03611556|589911506|FG003|Overall Study|Sponsor decision|0|||
163328049|NCT03611556|589911507|FG004|Overall Study|Sponsor decision|9|||
163328050|NCT03611556|589911508|FG005|Overall Study|Sponsor decision|4|||
163328051|NCT03611556|589911509|FG006|Overall Study|Sponsor decision|12|||
163328052|NCT03611556|589911503|FG000|Overall Study|Reasons|0|||
163328053|NCT03611556|589911504|FG001|Overall Study|Reasons|0|||
163328054|NCT03611556|589911505|FG002|Overall Study|Reasons|0|||
163328055|NCT03611556|589911506|FG003|Overall Study|Reasons|0|||
163404530|NCT01500278|590191956|FG001|Week 13 - Week 104|Non/bad compliance|5|||
163404531|NCT01500278|590191955|FG000|Week 13 - Week 104|Recurrent infections|1|||
162925088|NCT01306968|588427366|FG001|Overall Study|Withdrew over privacy concerns|0|||
162925089|NCT01306968|588427367|FG002|Overall Study|Withdrew over privacy concerns|0|||
162925090|NCT01306968|588427368|FG003|Overall Study|Withdrew over privacy concerns|1|||
162925091|NCT02736695|588427369|FG000|Overall Study|Ineligible|6|||
162925092|NCT02736695|588427370|FG001|Overall Study|Ineligible|0|||
162925093|NCT01329562|588427373|FG000|Overall Study|Protocol Violation|5|||
162925094|NCT01329562|588427374|FG001|Overall Study|Protocol Violation|3|||
162925095|NCT01329562|588427373|FG000|Overall Study|Lost to Follow-up|1|||
162925096|NCT01329562|588427374|FG001|Overall Study|Lost to Follow-up|1|||
162925097|NCT01329562|588427373|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
162925098|NCT01329562|588427374|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
162925099|NCT01329562|588427373|FG000|Overall Study|Physician Decision|0|||
162925100|NCT01329562|588427374|FG001|Overall Study|Physician Decision|1|||
162925101|NCT03252015|588427375|FG000|Overall Study|Withdrawal by Subject|0|||
162925102|NCT03252015|588427376|FG001|Overall Study|Withdrawal by Subject|1|||
162925103|NCT03252015|588427377|FG002|Overall Study|Withdrawal by Subject|1|||
162925104|NCT03252015|588427378|FG003|Overall Study|Withdrawal by Subject|0|||
162925105|NCT03252015|588427375|FG000|Overall Study|Adverse Event|1|||
162925106|NCT03252015|588427376|FG001|Overall Study|Adverse Event|0|||
162925107|NCT03252015|588427377|FG002|Overall Study|Adverse Event|0|||
162925108|NCT03252015|588427378|FG003|Overall Study|Adverse Event|1|||
162925109|NCT00061568|588427379|FG000|Overall Study|Lost to Follow-up|12|||
162925110|NCT00061568|588427380|FG001|Overall Study|Lost to Follow-up|0|||
162925111|NCT00061568|588427379|FG000|Overall Study|Death|6|||
162925112|NCT00061568|588427380|FG001|Overall Study|Death|0|||
162925113|NCT00061568|588427379|FG000|Overall Study|Withdrawal by Subject|1|||
162925114|NCT00061568|588427380|FG001|Overall Study|Withdrawal by Subject|0|||
162925115|NCT01381068|588427381|FG000|Overall Study|Death|1|||
162925116|NCT01381068|588427382|FG001|Overall Study|Death|0|||
162925117|NCT01907516|588427387|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
162925118|NCT01907516|588427388|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
162925119|NCT01907516|588427387|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
162925120|NCT01907516|588427388|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
162925121|NCT01907516|588427387|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
162925122|NCT01907516|588427388|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
162925123|NCT01907516|588427387|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
162925124|NCT01907516|588427388|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
162925125|NCT00975000|588427392|FG000|Overall Study|Other|1|||
162925126|NCT00975000|588427393|FG001|Overall Study|Other|0|||
162925127|NCT00975000|588427392|FG000|Overall Study|Adverse Event|1|||
162925128|NCT00975000|588427393|FG001|Overall Study|Adverse Event|1|||
162925129|NCT00975000|588427392|FG000|Overall Study|Withdrawal by Subject|2|||
162925130|NCT00975000|588427393|FG001|Overall Study|Withdrawal by Subject|2|||
162925131|NCT00975000|588427392|FG000|Overall Study|Lost to Follow-up|0|||
162925132|NCT00975000|588427393|FG001|Overall Study|Lost to Follow-up|1|||
162925133|NCT00975000|588427392|FG000|Overall Study|Protocol-specified Criteria|1|||
162925134|NCT00975000|588427393|FG001|Overall Study|Protocol-specified Criteria|0|||
162925135|NCT00975000|588427392|FG000|Overall Study|Non-compliance|0|||
162925136|NCT00975000|588427393|FG001|Overall Study|Non-compliance|1|||
162925137|NCT01126359|588427396|FG000|First Intervention (20-minutes)|Physician Decision|0|||
163328056|NCT03611556|589911507|FG004|Overall Study|Reasons|2|||
162925138|NCT01126359|588427397|FG001|First Intervention (20-minutes)|Physician Decision|1|||
162925139|NCT00902486|588427398|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
162925140|NCT00902486|588427399|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
162925141|NCT00902486|588427400|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
162925142|NCT00902486|588427401|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
162925143|NCT00902486|588427402|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
163214309|NCT02489344|589499019|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
163214310|NCT02489344|589499019|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
163214311|NCT01132482|589499020|FG000|Overall Study|Adverse Event|1|||
163214312|NCT01132482|589499021|FG001|Overall Study|Adverse Event|0|||
163214313|NCT04499781|589499022|FG000|Overall Study|Lost to Follow-up|2|||
163214314|NCT04499781|589499023|FG001|Overall Study|Lost to Follow-up|3|||
163214315|NCT04499781|589499022|FG000|Overall Study|Withdrawal by Subject|2|||
163214316|NCT04499781|589499023|FG001|Overall Study|Withdrawal by Subject|0|||
163214317|NCT04105998|589499031|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
163214318|NCT04105998|589499032|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
163214319|NCT00613015|589499036|FG000|Overall Study|Lost to Follow-up|0|||
163214320|NCT00613015|589499037|FG001|Overall Study|Lost to Follow-up|1|||
163010373|NCT00460603|588740174|FG002|Phase 1|Death|0|||
163010374|NCT00460603|588740175|FG003|Phase 1|Death|2|||
163010375|NCT00460603|588740176|FG004|Phase 1|Death|0|||
163010376|NCT00460603|588740177|FG005|Phase 1|Death|0|||
163010377|NCT00460603|588740178|FG006|Phase 1|Death|0|||
163010378|NCT00460603|588740179|FG007|Phase 1|Death|0|||
163214321|NCT00613015|589499038|FG002|Overall Study|Lost to Follow-up|3|||
163214322|NCT00613015|589499039|FG003|Overall Study|Lost to Follow-up|3|||
163214323|NCT00613015|589499040|FG004|Overall Study|Lost to Follow-up|2|||
163214324|NCT00613015|589499041|FG005|Overall Study|Lost to Follow-up|3|||
163214325|NCT00071760|589499044|FG000|Overall Study|Adverse Event|2|||
163214326|NCT00071760|589499045|FG001|Overall Study|Adverse Event|1|||
163214327|NCT00071760|589499044|FG000|Overall Study|Lost to Follow-up|0|||
163214328|NCT00071760|589499045|FG001|Overall Study|Lost to Follow-up|3|||
163214329|NCT00071760|589499044|FG000|Overall Study|Protocol Violation|1|||
163214330|NCT00071760|589499045|FG001|Overall Study|Protocol Violation|0|||
163214331|NCT00071760|589499044|FG000|Overall Study|Withdrawal by Subject|0|||
163214332|NCT00071760|589499045|FG001|Overall Study|Withdrawal by Subject|1|||
163214333|NCT00071760|589499044|FG000|Overall Study|Insufficient Viral Load Response|1|||
163214334|NCT00071760|589499045|FG001|Overall Study|Insufficient Viral Load Response|1|||
163214335|NCT00071760|589499044|FG000|Overall Study|Lack of availability of RTV|1|||
163214336|NCT00071760|589499045|FG001|Overall Study|Lack of availability of RTV|0|||
163214337|NCT00071760|589499044|FG000|Overall Study|Physician Decision|2|||
163214338|NCT00071760|589499045|FG001|Overall Study|Physician Decision|1|||
163214339|NCT00071760|589499044|FG000|Overall Study|Relocation|0|||
163214340|NCT00071760|589499045|FG001|Overall Study|Relocation|1|||
163214341|NCT02073279|589499046|FG000|Double-blind Period|Adverse Event|1|||
163214342|NCT02073279|589499047|FG001|Double-blind Period|Adverse Event|1|||
163328057|NCT03611556|589911508|FG005|Overall Study|Reasons|0|||
163328058|NCT03611556|589911509|FG006|Overall Study|Reasons|1|||
163328059|NCT02844439|589911531|FG000|Overall Study|Withdrawal by Subject|1|||
163328060|NCT02844439|589911531|FG000|Overall Study|Lost to Follow-up|2|||
163010379|NCT00460603|588740180|FG008|Phase 1|Death|1|||
163010380|NCT00460603|588740181|FG009|Phase 1|Death|0|||
163010381|NCT00460603|588740182|FG010|Phase 1|Death|0|||
163010382|NCT00460603|588740183|FG011|Phase 1|Death|0|||
163010383|NCT00460603|588740172|FG000|Phase 1|Adverse Event|3|||
163010384|NCT00460603|588740173|FG001|Phase 1|Adverse Event|1|||
163010385|NCT00460603|588740174|FG002|Phase 1|Adverse Event|1|||
163010386|NCT00460603|588740175|FG003|Phase 1|Adverse Event|2|||
163010387|NCT00460603|588740176|FG004|Phase 1|Adverse Event|0|||
163010388|NCT00460603|588740177|FG005|Phase 1|Adverse Event|0|||
163010389|NCT00460603|588740178|FG006|Phase 1|Adverse Event|3|||
163010390|NCT00460603|588740179|FG007|Phase 1|Adverse Event|0|||
163010391|NCT00460603|588740180|FG008|Phase 1|Adverse Event|4|||
163010392|NCT00460603|588740181|FG009|Phase 1|Adverse Event|0|||
163010393|NCT00460603|588740182|FG010|Phase 1|Adverse Event|0|||
163010394|NCT00460603|588740183|FG011|Phase 1|Adverse Event|0|||
163061921|NCT00157755|588935058|FG003|Overall Study|Lost to Follow-up|0|||
163214343|NCT02073279|589499046|FG000|Double-blind Period|Switched to another treatment|1|||
163328061|NCT02844439|589911531|FG000|Overall Study|Termination by Sponsor|4|||
163010395|NCT00460603|588740172|FG000|Phase 1|Lack of Efficacy|1|||
163061922|NCT00157755|588935059|FG004|Overall Study|Lost to Follow-up|0|||
163214344|NCT02073279|589499047|FG001|Double-blind Period|Switched to another treatment|2|||
163328062|NCT02844439|589911531|FG000|Overall Study|Death|28|||
163328063|NCT02844439|589911531|FG000|Overall Study|Other|5|||
163328064|NCT00390884|589911534|FG000|Overall Study|Withdrawal by Subject|2|||
163010396|NCT00460603|588740173|FG001|Phase 1|Lack of Efficacy|0|||
163010397|NCT00460603|588740174|FG002|Phase 1|Lack of Efficacy|1|||
163010398|NCT00460603|588740175|FG003|Phase 1|Lack of Efficacy|2|||
163010399|NCT00460603|588740176|FG004|Phase 1|Lack of Efficacy|2|||
163010400|NCT00460603|588740177|FG005|Phase 1|Lack of Efficacy|2|||
163010401|NCT00460603|588740178|FG006|Phase 1|Lack of Efficacy|2|||
163214345|NCT02073279|589499046|FG000|Double-blind Period|Protocol Violation|0|||
163214346|NCT02073279|589499047|FG001|Double-blind Period|Protocol Violation|1|||
163214347|NCT02073279|589499046|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
163214348|NCT02073279|589499047|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
163214349|NCT02073279|589499046|FG000|Double-blind Period|Withdrawal by Subject|2|||
163214350|NCT02073279|589499047|FG001|Double-blind Period|Withdrawal by Subject|2|||
163328065|NCT00390884|589911535|FG001|Overall Study|Withdrawal by Subject|2|||
163328066|NCT00756574|589911536|FG000|Overall Study|Withdrawal by Subject|9|||
163328067|NCT00756574|589911537|FG001|Overall Study|Withdrawal by Subject|7|||
163328068|NCT00756574|589911536|FG000|Overall Study|Lost to Follow-up|4|||
163328069|NCT00756574|589911537|FG001|Overall Study|Lost to Follow-up|4|||
163328070|NCT04035447|589911538|FG000|Treatment Period|Lost to Follow-up|6|||
163328071|NCT04035447|589911539|FG001|Treatment Period|Lost to Follow-up|5|||
163328072|NCT04035447|589911538|FG000|Treatment Period|Physician Decision|0|||
163328073|NCT04035447|589911539|FG001|Treatment Period|Physician Decision|2|||
163328074|NCT04622332|589911540|FG000|Overall Study|Withdrawal by Subject|4|||
163328075|NCT04622332|589911541|FG001|Overall Study|Withdrawal by Subject|2|||
163328076|NCT04622332|589911540|FG000|Overall Study|Physician Decision|1|||
163328077|NCT04622332|589911541|FG001|Overall Study|Physician Decision|1|||
163328078|NCT04622332|589911540|FG000|Overall Study|Adverse Event|0|||
163328079|NCT04622332|589911541|FG001|Overall Study|Adverse Event|2|||
163328080|NCT04622332|589911540|FG000|Overall Study|Protocol Violation|0|||
163328081|NCT04622332|589911541|FG001|Overall Study|Protocol Violation|1|||
163328082|NCT05966155|589911542|FG000|Overall Study|Death|1|||
163328083|NCT05966155|589911543|FG001|Overall Study|Death|2|||
163328084|NCT05966155|589911542|FG000|Overall Study|Lost to Follow-up|63|||
163328085|NCT05966155|589911543|FG001|Overall Study|Lost to Follow-up|67|||
163328086|NCT05966155|589911542|FG000|Overall Study|Protocol Violation|1|||
163328087|NCT05966155|589911543|FG001|Overall Study|Protocol Violation|0|||
163328088|NCT05966155|589911542|FG000|Overall Study|Withdrawal by Subject|8|||
163328089|NCT05966155|589911543|FG001|Overall Study|Withdrawal by Subject|9|||
163328090|NCT05966155|589911542|FG000|Overall Study|Enrolled Erroneously|0|||
163328091|NCT05966155|589911543|FG001|Overall Study|Enrolled Erroneously|1|||
163328092|NCT05966155|589911542|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
163328093|NCT05966155|589911543|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
163328094|NCT03304587|589911547|FG000|Overall Study|Headache after intervention|0|||
163328095|NCT03304587|589911548|FG001|Overall Study|Headache after intervention|1|||
163328096|NCT03304587|589911547|FG000|Overall Study|Withdrawal by Subject|1|||
163328097|NCT03304587|589911548|FG001|Overall Study|Withdrawal by Subject|0|||
163328098|NCT05036278|589911553|FG000|Overall Study|Withdrawal by Subject|1|||
163328099|NCT05036278|589911553|FG000|Overall Study|Adverse Event|1|||
163328100|NCT01458366|589911555|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
163328101|NCT01458366|589911556|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
163328102|NCT01458366|589911557|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
163328103|NCT01458366|589911558|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
163328104|NCT01458366|589911559|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
163328105|NCT01458366|589911555|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
163328106|NCT01458366|589911556|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
163328107|NCT01458366|589911557|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
163328108|NCT01458366|589911558|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
163328109|NCT01458366|589911559|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
163328110|NCT04647487|589911562|FG000|Overall Study|Protocol Deviation|0|||
163328111|NCT04647487|589911563|FG001|Overall Study|Protocol Deviation|0|||
163328112|NCT04647487|589911564|FG002|Overall Study|Protocol Deviation|1|||
163328113|NCT04647487|589911562|FG000|Overall Study|Withdrawal by Subject|1|||
163328114|NCT04647487|589911563|FG001|Overall Study|Withdrawal by Subject|0|||
163328115|NCT04647487|589911564|FG002|Overall Study|Withdrawal by Subject|2|||
163328116|NCT02787005|589911565|FG000|Overall Study|Adverse Event|24|||
163328117|NCT02787005|589911566|FG001|Overall Study|Adverse Event|9|||
163328118|NCT02787005|589911567|FG002|Overall Study|Adverse Event|9|||
163328119|NCT02787005|589911568|FG003|Overall Study|Adverse Event|7|||
163328120|NCT02787005|589911569|FG004|Overall Study|Adverse Event|2|||
163328121|NCT02787005|589911565|FG000|Overall Study|Death|100|||
163328122|NCT02787005|589911566|FG001|Overall Study|Death|53|||
163328123|NCT02787005|589911567|FG002|Overall Study|Death|48|||
163328124|NCT02787005|589911568|FG003|Overall Study|Death|69|||
163328125|NCT02787005|589911569|FG004|Overall Study|Death|38|||
163328126|NCT02787005|589911565|FG000|Overall Study|Sponsor Decision|7|||
163328127|NCT02787005|589911566|FG001|Overall Study|Sponsor Decision|4|||
163328128|NCT02787005|589911567|FG002|Overall Study|Sponsor Decision|0|||
163328129|NCT02787005|589911568|FG003|Overall Study|Sponsor Decision|4|||
163328130|NCT02787005|589911569|FG004|Overall Study|Sponsor Decision|5|||
163328131|NCT02787005|589911565|FG000|Overall Study|Withdrawal by Subject|2|||
163328132|NCT02787005|589911566|FG001|Overall Study|Withdrawal by Subject|1|||
163328133|NCT02787005|589911567|FG002|Overall Study|Withdrawal by Subject|1|||
163328134|NCT02787005|589911568|FG003|Overall Study|Withdrawal by Subject|0|||
163328135|NCT02787005|589911569|FG004|Overall Study|Withdrawal by Subject|1|||
163328136|NCT02787005|589911565|FG000|Overall Study|Screen Failure|0|||
163328137|NCT02787005|589911566|FG001|Overall Study|Screen Failure|2|||
163328138|NCT02787005|589911567|FG002|Overall Study|Screen Failure|0|||
163328139|NCT02787005|589911568|FG003|Overall Study|Screen Failure|0|||
163328140|NCT02787005|589911569|FG004|Overall Study|Screen Failure|1|||
163328141|NCT02787005|589911565|FG000|Overall Study|Lost to Follow-up|0|||
163328142|NCT02787005|589911566|FG001|Overall Study|Lost to Follow-up|0|||
163328143|NCT02787005|589911567|FG002|Overall Study|Lost to Follow-up|0|||
163328144|NCT02787005|589911568|FG003|Overall Study|Lost to Follow-up|1|||
163328145|NCT02787005|589911569|FG004|Overall Study|Lost to Follow-up|0|||
163328146|NCT01753999|589911575|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
163328147|NCT01753999|589911576|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
163328148|NCT01753999|589911575|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
163328149|NCT01753999|589911576|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
163061923|NCT00157755|588935060|FG005|Overall Study|Lost to Follow-up|0|||
163061924|NCT00157755|588935055|FG000|Overall Study|Withdrawal by Subject|0|||
163061925|NCT00157755|588935056|FG001|Overall Study|Withdrawal by Subject|0|||
163061926|NCT00157755|588935057|FG002|Overall Study|Withdrawal by Subject|1|||
163061927|NCT00157755|588935058|FG003|Overall Study|Withdrawal by Subject|1|||
163061928|NCT00157755|588935059|FG004|Overall Study|Withdrawal by Subject|1|||
163061929|NCT00157755|588935060|FG005|Overall Study|Withdrawal by Subject|2|||
163061930|NCT00157755|588935055|FG000|Overall Study|Explant due to infection|0|||
163061931|NCT00157755|588935056|FG001|Overall Study|Explant due to infection|0|||
163328150|NCT01753999|589911575|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
163328151|NCT01753999|589911576|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
163328152|NCT01753999|589911575|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
163328153|NCT01753999|589911576|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
163328154|NCT01753999|589911575|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
163328155|NCT01753999|589911576|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
163328156|NCT01753999|589911575|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
163328157|NCT01753999|589911576|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
163328158|NCT03890289|589911577|FG000|Overall Study|Adverse Event|1|||
163328159|NCT03890289|589911577|FG000|Overall Study|Physician Decision|1|||
163328160|NCT03890289|589911577|FG000|Overall Study|Lack of Efficacy|2|||
163328161|NCT00174252|589911584|FG000|Overall Study|Protocol Violation|2|||
163328162|NCT02744066|589911585|FG000|Overall Study|Withdrawal by parent|0|||
163328163|NCT02744066|589911586|FG001|Overall Study|Withdrawal by parent|1|||
163328164|NCT02744066|589911585|FG000|Overall Study|Discharged from NICU prior to completion|0|||
163328165|NCT02744066|589911586|FG001|Overall Study|Discharged from NICU prior to completion|4|||
163328166|NCT05509816|589911587|FG000|Overall Study|Lost to Follow-up|1|||
163328167|NCT02107261|589911594|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
163328168|NCT02107261|589911595|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
163328169|NCT02107261|589911594|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
163328170|NCT02107261|589911595|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
163328171|NCT04337931|589911598|FG000|Overall Study|Death|4|||
163328172|NCT04337931|589911599|FG001|Overall Study|Death|1|||
163328173|NCT04337931|589911600|FG002|Overall Study|Death|7|||
163328174|NCT04337931|589911598|FG000|Overall Study|Withdrawal by Subject|0|||
163328175|NCT04337931|589911599|FG001|Overall Study|Withdrawal by Subject|1|||
163328176|NCT04337931|589911600|FG002|Overall Study|Withdrawal by Subject|0|||
163328177|NCT04337931|589911598|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
162925144|NCT00902486|588427403|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
162925145|NCT00902486|588427398|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
162925146|NCT00902486|588427399|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
162925147|NCT00902486|588427400|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
162925148|NCT00902486|588427401|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
162925149|NCT00902486|588427402|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
162925150|NCT00902486|588427403|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
162925151|NCT00902486|588427398|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
162925152|NCT00902486|588427399|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
162925153|NCT00902486|588427400|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
162925154|NCT00902486|588427401|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
162925155|NCT00902486|588427402|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
162925156|NCT00902486|588427403|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
162925157|NCT00902486|588427398|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
162925158|NCT00902486|588427399|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
162925159|NCT00902486|588427400|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
162925160|NCT00902486|588427401|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
162925161|NCT00902486|588427402|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
162925162|NCT00902486|588427403|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
162925163|NCT00902486|588427398|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
162925164|NCT00902486|588427399|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
162925165|NCT00902486|588427400|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
162925166|NCT00902486|588427401|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
163061932|NCT00157755|588935057|FG002|Overall Study|Explant due to infection|1|||
163010402|NCT00460603|588740179|FG007|Phase 1|Lack of Efficacy|2|||
163010403|NCT00460603|588740180|FG008|Phase 1|Lack of Efficacy|11|||
163010404|NCT00460603|588740181|FG009|Phase 1|Lack of Efficacy|0|||
163010405|NCT00460603|588740182|FG010|Phase 1|Lack of Efficacy|0|||
163010406|NCT00460603|588740183|FG011|Phase 1|Lack of Efficacy|0|||
163010407|NCT00460603|588740172|FG000|Phase 1|Withdrawal by Subject|1|||
163010408|NCT00460603|588740173|FG001|Phase 1|Withdrawal by Subject|2|||
163010409|NCT00460603|588740174|FG002|Phase 1|Withdrawal by Subject|1|||
163010410|NCT00460603|588740175|FG003|Phase 1|Withdrawal by Subject|1|||
163010411|NCT00460603|588740176|FG004|Phase 1|Withdrawal by Subject|3|||
163010412|NCT00460603|588740177|FG005|Phase 1|Withdrawal by Subject|0|||
163010413|NCT00460603|588740178|FG006|Phase 1|Withdrawal by Subject|1|||
163010414|NCT00460603|588740179|FG007|Phase 1|Withdrawal by Subject|0|||
163010415|NCT00460603|588740180|FG008|Phase 1|Withdrawal by Subject|2|||
163010416|NCT00460603|588740181|FG009|Phase 1|Withdrawal by Subject|0|||
163010417|NCT00460603|588740182|FG010|Phase 1|Withdrawal by Subject|0|||
163010418|NCT00460603|588740183|FG011|Phase 1|Withdrawal by Subject|0|||
163010419|NCT00460603|588740172|FG000|Phase 1|Other|0|||
163010420|NCT00460603|588740173|FG001|Phase 1|Other|3|||
163010421|NCT00460603|588740174|FG002|Phase 1|Other|1|||
163010422|NCT00460603|588740175|FG003|Phase 1|Other|1|||
163010423|NCT00460603|588740176|FG004|Phase 1|Other|1|||
163010424|NCT00460603|588740177|FG005|Phase 1|Other|2|||
163010425|NCT00460603|588740178|FG006|Phase 1|Other|0|||
163010426|NCT00460603|588740179|FG007|Phase 1|Other|1|||
163010427|NCT00460603|588740180|FG008|Phase 1|Other|0|||
163010428|NCT00460603|588740181|FG009|Phase 1|Other|0|||
163010429|NCT00460603|588740182|FG010|Phase 1|Other|0|||
163010430|NCT00460603|588740183|FG011|Phase 1|Other|0|||
163010431|NCT00460603|588740172|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010432|NCT00460603|588740173|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010433|NCT00460603|588740174|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163061933|NCT00157755|588935058|FG003|Overall Study|Explant due to infection|0|||
163061934|NCT00157755|588935059|FG004|Overall Study|Explant due to infection|0|||
163061935|NCT00157755|588935060|FG005|Overall Study|Explant due to infection|0|||
163061936|NCT00157755|588935055|FG000|Overall Study|Medical reason|0|||
163061937|NCT00157755|588935056|FG001|Overall Study|Medical reason|0|||
163061938|NCT00157755|588935057|FG002|Overall Study|Medical reason|1|||
163061939|NCT00157755|588935058|FG003|Overall Study|Medical reason|1|||
163061940|NCT00157755|588935059|FG004|Overall Study|Medical reason|0|||
163061941|NCT00157755|588935060|FG005|Overall Study|Medical reason|0|||
163061942|NCT00157755|588935055|FG000|Overall Study|Study site closure|0|||
163061943|NCT00157755|588935056|FG001|Overall Study|Study site closure|1|||
163061944|NCT00157755|588935057|FG002|Overall Study|Study site closure|0|||
163061945|NCT00157755|588935058|FG003|Overall Study|Study site closure|0|||
163061946|NCT00157755|588935059|FG004|Overall Study|Study site closure|0|||
163061947|NCT00157755|588935060|FG005|Overall Study|Study site closure|0|||
163061948|NCT00157755|588935055|FG000|Overall Study|Subject non-compliance|0|||
163061949|NCT00157755|588935056|FG001|Overall Study|Subject non-compliance|0|||
163061950|NCT00157755|588935057|FG002|Overall Study|Subject non-compliance|0|||
163061951|NCT00157755|588935058|FG003|Overall Study|Subject non-compliance|0|||
163061952|NCT00157755|588935059|FG004|Overall Study|Subject non-compliance|0|||
163061953|NCT00157755|588935060|FG005|Overall Study|Subject non-compliance|1|||
163061954|NCT00157755|588935055|FG000|Overall Study|Study completion|0|||
163061955|NCT00157755|588935056|FG001|Overall Study|Study completion|0|||
163061956|NCT00157755|588935057|FG002|Overall Study|Study completion|0|||
163061957|NCT00157755|588935058|FG003|Overall Study|Study completion|0|||
163061958|NCT00157755|588935059|FG004|Overall Study|Study completion|1|||
163061959|NCT00157755|588935060|FG005|Overall Study|Study completion|2|||
163061960|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
163328178|NCT04337931|589911599|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
163328179|NCT04337931|589911600|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
163328180|NCT04337931|589911598|FG000|Overall Study|Study terminated by sponsor|3|||
163328181|NCT04337931|589911599|FG001|Overall Study|Study terminated by sponsor|6|||
163328182|NCT04337931|589911600|FG002|Overall Study|Study terminated by sponsor|2|||
163328183|NCT04337931|589911598|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
163328184|NCT04337931|589911599|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
163328185|NCT04337931|589911600|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
163328186|NCT04337931|589911598|FG000|Overall Study|Colorectal cancer treatment|1|||
163061961|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
163061962|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
163061963|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
163061964|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Death|38|||
163010434|NCT00460603|588740175|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010435|NCT00460603|588740176|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010436|NCT00460603|588740177|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010437|NCT00460603|588740178|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010438|NCT00460603|588740179|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163061965|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Death|10|||
163061966|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
163061967|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
163061968|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
163061969|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
163328187|NCT04337931|589911599|FG001|Overall Study|Colorectal cancer treatment|0|||
163328188|NCT04337931|589911600|FG002|Overall Study|Colorectal cancer treatment|0|||
163328189|NCT04337931|589911598|FG000|Overall Study|Participant decision|0|||
163328190|NCT04337931|589911599|FG001|Overall Study|Participant decision|1|||
163328191|NCT04337931|589911600|FG002|Overall Study|Participant decision|0|||
163328192|NCT01738438|589911601|FG000|Overall Study|Disease Progression|32|||
163328193|NCT01738438|589911601|FG000|Overall Study|Adverse Event|3|||
163328194|NCT02130557|589911603|FG000|Overall Study|Withdrawal by Subject|12|||
163328195|NCT02130557|589911604|FG001|Overall Study|Withdrawal by Subject|12|||
163328196|NCT02130557|589911603|FG000|Overall Study|Investigator Request|0|||
163328197|NCT02130557|589911604|FG001|Overall Study|Investigator Request|2|||
163328198|NCT02130557|589911603|FG000|Overall Study|Deceased|14|||
163328199|NCT02130557|589911604|FG001|Overall Study|Deceased|14|||
163328200|NCT02130557|589911603|FG000|Overall Study|Lost to Follow-up|6|||
163328201|NCT02130557|589911604|FG001|Overall Study|Lost to Follow-up|7|||
163328202|NCT02130557|589911603|FG000|Overall Study|Other|2|||
163328203|NCT02130557|589911604|FG001|Overall Study|Other|1|||
163328204|NCT02130557|589911603|FG000|Overall Study|Missing|2|||
163328205|NCT02130557|589911604|FG001|Overall Study|Missing|1|||
163328206|NCT02928172|589911605|FG000|Overall Study|Device did not record data|1|||
163328207|NCT01532999|589911606|FG000|Overall Study|Lost to Follow-up|14|||
163328208|NCT01532999|589911607|FG001|Overall Study|Lost to Follow-up|8|||
163404532|NCT01500278|590191956|FG001|Week 13 - Week 104|Recurrent infections|0|||
163404533|NCT01500278|590191955|FG000|Week 13 - Week 104|False positive test|1|||
163404534|NCT01500278|590191956|FG001|Week 13 - Week 104|False positive test|2|||
163328209|NCT01532999|589911606|FG000|Overall Study|Physician Decision|1|||
163328210|NCT01532999|589911607|FG001|Overall Study|Physician Decision|2|||
163328211|NCT01532999|589911606|FG000|Overall Study|Withdrawal by Subject|5|||
163328212|NCT01532999|589911607|FG001|Overall Study|Withdrawal by Subject|0|||
163328213|NCT01532999|589911606|FG000|Overall Study|Relocated|2|||
163328214|NCT01532999|589911607|FG001|Overall Study|Relocated|0|||
163328215|NCT01532999|589911606|FG000|Overall Study|should not have been randomized|1|||
162925167|NCT00902486|588427402|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
162925168|NCT00902486|588427403|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
162925169|NCT00902486|588427398|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
162925170|NCT00902486|588427399|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
162925171|NCT00902486|588427400|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
162925172|NCT00902486|588427401|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
162925173|NCT00902486|588427402|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
162925174|NCT00902486|588427403|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
162925175|NCT00902486|588427398|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
162925176|NCT00902486|588427399|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
162925177|NCT00902486|588427400|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
162925178|NCT00902486|588427401|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
162925179|NCT00902486|588427402|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
162925180|NCT00902486|588427403|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
162925181|NCT00902486|588427398|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
162925182|NCT00902486|588427399|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
162925183|NCT00902486|588427400|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
162925184|NCT00902486|588427401|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
162925185|NCT00902486|588427402|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
162925186|NCT00902486|588427403|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
162925187|NCT00902486|588427398|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
162925188|NCT00902486|588427399|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
162925189|NCT00902486|588427400|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
162925190|NCT00902486|588427401|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
162925191|NCT00902486|588427402|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
162925192|NCT00902486|588427403|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
162925193|NCT00902486|588427398|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
162925194|NCT00902486|588427399|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
162925195|NCT00902486|588427400|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
162925196|NCT00902486|588427401|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
162925197|NCT00902486|588427402|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
162925198|NCT00902486|588427403|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
162925199|NCT00902486|588427398|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
163404535|NCT01500278|590191955|FG000|Week 13 - Week 104|Sponsor request|4|||
163328216|NCT01532999|589911607|FG001|Overall Study|should not have been randomized|0|||
163328217|NCT01532999|589911606|FG000|Overall Study|substantial noncompliance|2|||
163328218|NCT01532999|589911607|FG001|Overall Study|substantial noncompliance|0|||
163328219|NCT01532999|589911606|FG000|Overall Study|no show for week 9 assessments|6|||
163328220|NCT01532999|589911607|FG001|Overall Study|no show for week 9 assessments|4|||
163328221|NCT01532999|589911606|FG000|Overall Study|Adverse Event|0|||
163328222|NCT01532999|589911607|FG001|Overall Study|Adverse Event|1|||
163328223|NCT01532999|589911606|FG000|Overall Study|incarcerated|0|||
163328224|NCT01532999|589911607|FG001|Overall Study|incarcerated|1|||
163328225|NCT01532999|589911606|FG000|Overall Study|New job|0|||
163328226|NCT01532999|589911607|FG001|Overall Study|New job|2|||
163328227|NCT02408887|589911608|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
163328228|NCT02408887|589911609|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
163328229|NCT02408887|589911608|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
163328230|NCT02408887|589911609|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
163328231|NCT00589875|589911610|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
163328232|NCT00589875|589911610|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
163328233|NCT03598907|589911611|FG000|Overall Study|Physician Decision|14|||
163328234|NCT03598907|589911612|FG001|Overall Study|Physician Decision|19|||
163328235|NCT02678689|589911613|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
163328236|NCT02678689|589911614|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
163328237|NCT05071430|589911618|FG000|Overall Study|Adverse Event|1|||
163328238|NCT05071430|589911619|FG001|Overall Study|Adverse Event|2|||
163328239|NCT05071430|589911618|FG000|Overall Study|Lost to Follow-up|4|||
163328240|NCT05071430|589911619|FG001|Overall Study|Lost to Follow-up|4|||
163328241|NCT05071430|589911618|FG000|Overall Study|Protocol Violation|1|||
163328242|NCT05071430|589911619|FG001|Overall Study|Protocol Violation|0|||
163328243|NCT05071430|589911618|FG000|Overall Study|Withdrawal by Subject|3|||
163328244|NCT05071430|589911619|FG001|Overall Study|Withdrawal by Subject|2|||
163328245|NCT05071430|589911618|FG000|Overall Study|Other|1|||
163328246|NCT05071430|589911619|FG001|Overall Study|Other|1|||
163328247|NCT01958021|589911620|FG000|Treatment|Progressive disease|206|||
163328248|NCT01958021|589911621|FG001|Treatment|Progressive disease|265|||
163328249|NCT01958021|589911620|FG000|Treatment|Adverse Event|38|||
163328250|NCT01958021|589911621|FG001|Treatment|Adverse Event|10|||
163328251|NCT01958021|589911620|FG000|Treatment|Subject/guardian decision|29|||
163328252|NCT01958021|589911621|FG001|Treatment|Subject/guardian decision|25|||
163328253|NCT01958021|589911620|FG000|Treatment|Physician Decision|28|||
163328254|NCT01958021|589911621|FG001|Treatment|Physician Decision|21|||
163328255|NCT01958021|589911620|FG000|Treatment|Death|6|||
163328256|NCT01958021|589911621|FG001|Treatment|Death|1|||
163328257|NCT01958021|589911620|FG000|Treatment|Protocol deviation|3|||
163328258|NCT01958021|589911621|FG001|Treatment|Protocol deviation|1|||
163328259|NCT01958021|589911620|FG000|Treatment|Sponsor decision|24|||
163328260|NCT01958021|589911621|FG001|Treatment|Sponsor decision|11|||
163328261|NCT01958021|589911620|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
163328262|NCT01958021|589911621|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
163328263|NCT01958021|589911620|FG000|Post-treatment Efficacy Follow-up|Death|1|||
163328264|NCT01958021|589911621|FG001|Post-treatment Efficacy Follow-up|Death|0|||
163328265|NCT01958021|589911620|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
163328266|NCT01958021|589911621|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
163328267|NCT01958021|589911620|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
163328268|NCT01958021|589911621|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
163328269|NCT01958021|589911620|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
163328270|NCT01958021|589911621|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
163328271|NCT01958021|589911620|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
163328272|NCT01958021|589911621|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
163328273|NCT01958021|589911620|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
163328274|NCT01958021|589911621|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
163328275|NCT00490139|589911622|FG000|Overall Study|Lost to Follow-up|249|||
163328276|NCT00490139|589911623|FG001|Overall Study|Lost to Follow-up|216|||
163404536|NCT01500278|590191956|FG001|Week 13 - Week 104|Sponsor request|0|||
163404537|NCT01500278|590191955|FG000|Week 13 - Week 104|Withdrawn in error|1|||
163404538|NCT01500278|590191956|FG001|Week 13 - Week 104|Withdrawn in error|0|||
163328277|NCT00490139|589911624|FG002|Overall Study|Lost to Follow-up|205|||
163328278|NCT00490139|589911625|FG003|Overall Study|Lost to Follow-up|229|||
163328279|NCT00490139|589911622|FG000|Overall Study|Withdrawal by Subject|333|||
163328280|NCT00490139|589911623|FG001|Overall Study|Withdrawal by Subject|322|||
163328281|NCT00490139|589911624|FG002|Overall Study|Withdrawal by Subject|396|||
163404539|NCT01500278|590191955|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
163010439|NCT00460603|588740180|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010440|NCT00460603|588740181|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
163010441|NCT00460603|588740182|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010442|NCT00460603|588740183|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010443|NCT00460603|588740172|FG000|Phase 2|Adverse Event|0|||
163010444|NCT00460603|588740173|FG001|Phase 2|Adverse Event|0|||
163010445|NCT00460603|588740174|FG002|Phase 2|Adverse Event|0|||
163010446|NCT00460603|588740175|FG003|Phase 2|Adverse Event|0|||
163010447|NCT00460603|588740176|FG004|Phase 2|Adverse Event|0|||
163010448|NCT00460603|588740177|FG005|Phase 2|Adverse Event|0|||
163010449|NCT00460603|588740178|FG006|Phase 2|Adverse Event|0|||
163010450|NCT00460603|588740179|FG007|Phase 2|Adverse Event|0|||
163010451|NCT00460603|588740180|FG008|Phase 2|Adverse Event|0|||
163010452|NCT00460603|588740181|FG009|Phase 2|Adverse Event|12|||
163010453|NCT00460603|588740182|FG010|Phase 2|Adverse Event|9|||
163010454|NCT00460603|588740183|FG011|Phase 2|Adverse Event|10|||
163010455|NCT00460603|588740172|FG000|Phase 2|Death|0|||
163010456|NCT00460603|588740173|FG001|Phase 2|Death|0|||
163010457|NCT00460603|588740174|FG002|Phase 2|Death|0|||
163010458|NCT00460603|588740175|FG003|Phase 2|Death|0|||
163328282|NCT00490139|589911625|FG003|Overall Study|Withdrawal by Subject|295|||
163010459|NCT00460603|588740176|FG004|Phase 2|Death|0|||
163010460|NCT00460603|588740177|FG005|Phase 2|Death|0|||
163010461|NCT00460603|588740178|FG006|Phase 2|Death|0|||
163010462|NCT00460603|588740179|FG007|Phase 2|Death|0|||
163010463|NCT00460603|588740180|FG008|Phase 2|Death|0|||
163010464|NCT00460603|588740181|FG009|Phase 2|Death|4|||
163010465|NCT00460603|588740182|FG010|Phase 2|Death|2|||
163010466|NCT00460603|588740183|FG011|Phase 2|Death|2|||
163010467|NCT00460603|588740172|FG000|Phase 2|Protocol Violation|0|||
163010468|NCT00460603|588740173|FG001|Phase 2|Protocol Violation|0|||
163010469|NCT00460603|588740174|FG002|Phase 2|Protocol Violation|0|||
163010470|NCT00460603|588740175|FG003|Phase 2|Protocol Violation|0|||
163010471|NCT00460603|588740176|FG004|Phase 2|Protocol Violation|0|||
163010472|NCT00460603|588740177|FG005|Phase 2|Protocol Violation|0|||
163010473|NCT00460603|588740178|FG006|Phase 2|Protocol Violation|0|||
163010474|NCT00460603|588740179|FG007|Phase 2|Protocol Violation|0|||
163010475|NCT00460603|588740180|FG008|Phase 2|Protocol Violation|0|||
163010476|NCT00460603|588740181|FG009|Phase 2|Protocol Violation|1|||
163010477|NCT00460603|588740182|FG010|Phase 2|Protocol Violation|1|||
163010478|NCT00460603|588740183|FG011|Phase 2|Protocol Violation|0|||
163010479|NCT00460603|588740172|FG000|Phase 2|Lost to Follow-up|0|||
163010480|NCT00460603|588740173|FG001|Phase 2|Lost to Follow-up|0|||
163010481|NCT00460603|588740174|FG002|Phase 2|Lost to Follow-up|0|||
163010482|NCT00460603|588740175|FG003|Phase 2|Lost to Follow-up|0|||
163010483|NCT00460603|588740176|FG004|Phase 2|Lost to Follow-up|0|||
163010484|NCT00460603|588740177|FG005|Phase 2|Lost to Follow-up|0|||
163010485|NCT00460603|588740178|FG006|Phase 2|Lost to Follow-up|0|||
163010486|NCT00460603|588740179|FG007|Phase 2|Lost to Follow-up|0|||
163010487|NCT00460603|588740180|FG008|Phase 2|Lost to Follow-up|0|||
163010488|NCT00460603|588740181|FG009|Phase 2|Lost to Follow-up|1|||
163010489|NCT00460603|588740182|FG010|Phase 2|Lost to Follow-up|0|||
163010490|NCT00460603|588740183|FG011|Phase 2|Lost to Follow-up|0|||
163010491|NCT00460603|588740172|FG000|Phase 2|Other|0|||
163010492|NCT00460603|588740173|FG001|Phase 2|Other|0|||
163010493|NCT00460603|588740174|FG002|Phase 2|Other|0|||
163010494|NCT00460603|588740175|FG003|Phase 2|Other|0|||
163010495|NCT00460603|588740176|FG004|Phase 2|Other|0|||
163010496|NCT00460603|588740177|FG005|Phase 2|Other|0|||
163010497|NCT00460603|588740178|FG006|Phase 2|Other|0|||
163010498|NCT00460603|588740179|FG007|Phase 2|Other|0|||
163010499|NCT00460603|588740180|FG008|Phase 2|Other|0|||
163010500|NCT00460603|588740181|FG009|Phase 2|Other|6|||
163010501|NCT00460603|588740182|FG010|Phase 2|Other|16|||
163010502|NCT00460603|588740183|FG011|Phase 2|Other|7|||
163010503|NCT00460603|588740172|FG000|Phase 2|Objective Progression or Relapse|0|||
163010504|NCT00460603|588740173|FG001|Phase 2|Objective Progression or Relapse|0|||
163010505|NCT00460603|588740174|FG002|Phase 2|Objective Progression or Relapse|0|||
163010506|NCT00460603|588740175|FG003|Phase 2|Objective Progression or Relapse|0|||
163010507|NCT00460603|588740176|FG004|Phase 2|Objective Progression or Relapse|0|||
163010508|NCT00460603|588740177|FG005|Phase 2|Objective Progression or Relapse|0|||
163328283|NCT00490139|589911622|FG000|Overall Study|Patient did not sign ICF 12|169|||
163010509|NCT00460603|588740178|FG006|Phase 2|Objective Progression or Relapse|0|||
163010510|NCT00460603|588740179|FG007|Phase 2|Objective Progression or Relapse|0|||
163010511|NCT00460603|588740180|FG008|Phase 2|Objective Progression or Relapse|0|||
163010512|NCT00460603|588740181|FG009|Phase 2|Objective Progression or Relapse|9|||
163010513|NCT00460603|588740182|FG010|Phase 2|Objective Progression or Relapse|10|||
163010514|NCT00460603|588740183|FG011|Phase 2|Objective Progression or Relapse|17|||
163010515|NCT00460603|588740172|FG000|Phase 2|Global Deterioration of Health Status|0|||
163010516|NCT00460603|588740173|FG001|Phase 2|Global Deterioration of Health Status|0|||
163010517|NCT00460603|588740174|FG002|Phase 2|Global Deterioration of Health Status|0|||
163010518|NCT00460603|588740175|FG003|Phase 2|Global Deterioration of Health Status|0|||
163010519|NCT00460603|588740176|FG004|Phase 2|Global Deterioration of Health Status|0|||
163010520|NCT00460603|588740177|FG005|Phase 2|Global Deterioration of Health Status|0|||
163010521|NCT00460603|588740178|FG006|Phase 2|Global Deterioration of Health Status|0|||
163010522|NCT00460603|588740179|FG007|Phase 2|Global Deterioration of Health Status|0|||
163010523|NCT00460603|588740180|FG008|Phase 2|Global Deterioration of Health Status|0|||
163010524|NCT00460603|588740181|FG009|Phase 2|Global Deterioration of Health Status|0|||
163010525|NCT00460603|588740182|FG010|Phase 2|Global Deterioration of Health Status|1|||
163010526|NCT00460603|588740183|FG011|Phase 2|Global Deterioration of Health Status|0|||
163061970|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
163061971|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
163061972|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
163061973|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
163061974|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
163061975|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
163061976|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
163061977|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
163061978|NCT02421939|588935066|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
163328284|NCT00490139|589911623|FG001|Overall Study|Patient did not sign ICF 12|176|||
163328285|NCT00490139|589911624|FG002|Overall Study|Patient did not sign ICF 12|139|||
163328286|NCT00490139|589911625|FG003|Overall Study|Patient did not sign ICF 12|167|||
163328287|NCT00490139|589911622|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
163328288|NCT00490139|589911623|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
163328289|NCT00490139|589911624|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
163328290|NCT00490139|589911625|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
163328291|NCT00490139|589911622|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
163328292|NCT00490139|589911623|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
163328293|NCT00490139|589911624|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
163061979|NCT02421939|588935067|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
163328294|NCT00490139|589911625|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
163328295|NCT00490139|589911622|FG000|Overall Study|Other reasons as defined per protocol|98|||
163010527|NCT00460603|588740172|FG000|Phase 2|Withdrawal by Subject|0|||
163010528|NCT00460603|588740173|FG001|Phase 2|Withdrawal by Subject|0|||
163010529|NCT00460603|588740174|FG002|Phase 2|Withdrawal by Subject|0|||
163010530|NCT00460603|588740175|FG003|Phase 2|Withdrawal by Subject|0|||
163010531|NCT00460603|588740176|FG004|Phase 2|Withdrawal by Subject|0|||
163010532|NCT00460603|588740177|FG005|Phase 2|Withdrawal by Subject|0|||
163010533|NCT00460603|588740178|FG006|Phase 2|Withdrawal by Subject|0|||
163010534|NCT00460603|588740179|FG007|Phase 2|Withdrawal by Subject|0|||
163010535|NCT00460603|588740180|FG008|Phase 2|Withdrawal by Subject|0|||
163010536|NCT00460603|588740181|FG009|Phase 2|Withdrawal by Subject|5|||
163010537|NCT00460603|588740182|FG010|Phase 2|Withdrawal by Subject|4|||
163010538|NCT00460603|588740183|FG011|Phase 2|Withdrawal by Subject|5|||
163010539|NCT00460603|588740172|FG000|Phase 2|Randomized, but not treated|0|||
163010540|NCT00460603|588740173|FG001|Phase 2|Randomized, but not treated|0|||
163010541|NCT00460603|588740174|FG002|Phase 2|Randomized, but not treated|0|||
163010542|NCT00460603|588740175|FG003|Phase 2|Randomized, but not treated|0|||
163010543|NCT00460603|588740176|FG004|Phase 2|Randomized, but not treated|0|||
163010544|NCT00460603|588740177|FG005|Phase 2|Randomized, but not treated|0|||
163010545|NCT00460603|588740178|FG006|Phase 2|Randomized, but not treated|0|||
163010546|NCT00460603|588740179|FG007|Phase 2|Randomized, but not treated|0|||
163010547|NCT00460603|588740180|FG008|Phase 2|Randomized, but not treated|0|||
163010548|NCT00460603|588740181|FG009|Phase 2|Randomized, but not treated|3|||
163010549|NCT00460603|588740182|FG010|Phase 2|Randomized, but not treated|0|||
163010550|NCT00460603|588740183|FG011|Phase 2|Randomized, but not treated|0|||
163010551|NCT01651117|588740187|FG000|Overall Study|Death|2|||
163010552|NCT01651117|588740188|FG001|Overall Study|Death|3|||
163010553|NCT01651117|588740189|FG002|Overall Study|Death|2|||
163010554|NCT01651117|588740190|FG003|Overall Study|Death|2|||
163010555|NCT02075203|588740192|FG000|Overall Study|Withdrawal by Subject|1|||
163010556|NCT02075203|588740193|FG001|Overall Study|Withdrawal by Subject|0|||
163010557|NCT02075203|588740194|FG002|Overall Study|Withdrawal by Subject|1|||
163010558|NCT02075203|588740192|FG000|Overall Study|Adverse Event|1|||
163010559|NCT02075203|588740193|FG001|Overall Study|Adverse Event|0|||
163010560|NCT02075203|588740194|FG002|Overall Study|Adverse Event|0|||
163010561|NCT02075203|588740192|FG000|Overall Study|participant refused to use contraception|1|||
163010562|NCT02075203|588740193|FG001|Overall Study|participant refused to use contraception|0|||
163010563|NCT02075203|588740194|FG002|Overall Study|participant refused to use contraception|0|||
163328296|NCT00490139|589911623|FG001|Overall Study|Other reasons as defined per protocol|84|||
163328297|NCT00490139|589911624|FG002|Overall Study|Other reasons as defined per protocol|82|||
163010564|NCT00350207|588740195|FG000|Overall Study|Adverse Event|5|||
163010565|NCT00350207|588740196|FG001|Overall Study|Adverse Event|2|||
163010566|NCT00350207|588740197|FG002|Overall Study|Adverse Event|2|||
163010567|NCT00350207|588740195|FG000|Overall Study|Lack of Efficacy|1|||
163010568|NCT00350207|588740196|FG001|Overall Study|Lack of Efficacy|0|||
163010569|NCT00350207|588740197|FG002|Overall Study|Lack of Efficacy|2|||
163010570|NCT00350207|588740195|FG000|Overall Study|Lost to Follow-up|1|||
163010571|NCT00350207|588740196|FG001|Overall Study|Lost to Follow-up|0|||
163010572|NCT00350207|588740197|FG002|Overall Study|Lost to Follow-up|1|||
163010573|NCT00350207|588740195|FG000|Overall Study|Withdrawal by Subject|0|||
163010574|NCT00350207|588740196|FG001|Overall Study|Withdrawal by Subject|1|||
163214351|NCT02073279|589499046|FG000|Open-label Extension Period|Adverse Event|1|||
163214352|NCT02073279|589499047|FG001|Open-label Extension Period|Adverse Event|0|||
163214353|NCT02073279|589499046|FG000|Open-label Extension Period|Lack of Efficacy|1|||
163214354|NCT02073279|589499047|FG001|Open-label Extension Period|Lack of Efficacy|0|||
163214355|NCT02073279|589499046|FG000|Open-label Extension Period|Lost to Follow-up|0|||
163214356|NCT02073279|589499047|FG001|Open-label Extension Period|Lost to Follow-up|4|||
163214357|NCT02073279|589499046|FG000|Open-label Extension Period|Switched to another treatment|1|||
163214358|NCT02073279|589499047|FG001|Open-label Extension Period|Switched to another treatment|4|||
163214359|NCT02073279|589499046|FG000|Open-label Extension Period|Protocol Violation|0|||
163214360|NCT02073279|589499047|FG001|Open-label Extension Period|Protocol Violation|1|||
163214361|NCT02073279|589499046|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
163214362|NCT02073279|589499047|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
163214363|NCT02073279|589499046|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
163214364|NCT02073279|589499047|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
163214365|NCT01994629|589499048|FG000|Overall Study|Withdrawal by Subject|1|||
163214366|NCT01994629|589499049|FG001|Overall Study|Withdrawal by Subject|0|||
163214367|NCT01994629|589499048|FG000|Overall Study|Lost to Follow-up|0|||
163214368|NCT01994629|589499049|FG001|Overall Study|Lost to Follow-up|3|||
163214369|NCT03338062|589499052|FG000|Overall Study|Alternative Therapy|1|||
163214370|NCT03338062|589499053|FG001|Overall Study|Alternative Therapy|0|||
163214371|NCT04340362|589499055|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
163214372|NCT02375113|589499059|FG000|Overall Study|Undisclosed Reason(s).|1|||
163214373|NCT02375113|589499060|FG001|Overall Study|Undisclosed Reason(s).|1|||
163214374|NCT02375113|589499059|FG000|Overall Study|Poor adherence (<70%).|1|||
163214375|NCT02375113|589499060|FG001|Overall Study|Poor adherence (<70%).|0|||
163214376|NCT02375113|589499059|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
163214377|NCT02375113|589499060|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
163214378|NCT01214629|589499061|FG000|Overall Study|Progressive Disease|1|||
163214379|NCT01214629|589499062|FG001|Overall Study|Progressive Disease|1|||
163214380|NCT01214629|589499063|FG002|Overall Study|Progressive Disease|0|||
163214381|NCT01214629|589499064|FG003|Overall Study|Progressive Disease|1|||
163214382|NCT01214629|589499065|FG004|Overall Study|Progressive Disease|2|||
163214383|NCT01214629|589499066|FG005|Overall Study|Progressive Disease|3|||
163214384|NCT01214629|589499067|FG006|Overall Study|Progressive Disease|1|||
163214385|NCT01214629|589499068|FG007|Overall Study|Progressive Disease|1|||
163214386|NCT01214629|589499069|FG008|Overall Study|Progressive Disease|1|||
163214387|NCT01214629|589499070|FG009|Overall Study|Progressive Disease|5|||
163214388|NCT01214629|589499071|FG010|Overall Study|Progressive Disease|1|||
163214389|NCT01214629|589499061|FG000|Overall Study|Adverse Event|0|||
163214390|NCT01214629|589499062|FG001|Overall Study|Adverse Event|0|||
163214391|NCT01214629|589499063|FG002|Overall Study|Adverse Event|0|||
163214392|NCT01214629|589499064|FG003|Overall Study|Adverse Event|1|||
163214393|NCT01214629|589499065|FG004|Overall Study|Adverse Event|0|||
163214394|NCT01214629|589499066|FG005|Overall Study|Adverse Event|1|||
163214395|NCT01214629|589499067|FG006|Overall Study|Adverse Event|0|||
163214396|NCT01214629|589499068|FG007|Overall Study|Adverse Event|0|||
163214397|NCT01214629|589499069|FG008|Overall Study|Adverse Event|0|||
163214398|NCT01214629|589499070|FG009|Overall Study|Adverse Event|1|||
163214399|NCT01214629|589499071|FG010|Overall Study|Adverse Event|0|||
163214400|NCT01214629|589499061|FG000|Overall Study|Physician Decision|0|||
163214401|NCT01214629|589499062|FG001|Overall Study|Physician Decision|0|||
163214402|NCT01214629|589499063|FG002|Overall Study|Physician Decision|0|||
163214403|NCT01214629|589499064|FG003|Overall Study|Physician Decision|0|||
163214404|NCT01214629|589499065|FG004|Overall Study|Physician Decision|0|||
163214405|NCT01214629|589499066|FG005|Overall Study|Physician Decision|0|||
163328298|NCT00490139|589911625|FG003|Overall Study|Other reasons as defined per protocol|105|||
163328299|NCT00754325|589913197|FG000|Initial Treatment|Continuing Active Treatment|4|||
163328300|NCT00754325|589913198|FG001|Initial Treatment|Continuing Active Treatment|5|||
163328301|NCT00754325|589913197|FG000|Initial Treatment|Adverse Event|7|||
163214406|NCT01214629|589499067|FG006|Overall Study|Physician Decision|0|||
163214407|NCT01214629|589499068|FG007|Overall Study|Physician Decision|0|||
163214408|NCT01214629|589499069|FG008|Overall Study|Physician Decision|0|||
163214409|NCT01214629|589499070|FG009|Overall Study|Physician Decision|0|||
163214410|NCT01214629|589499071|FG010|Overall Study|Physician Decision|1|||
163214411|NCT01214629|589499061|FG000|Overall Study|Withdrawal by Subject|0|||
163214412|NCT01214629|589499062|FG001|Overall Study|Withdrawal by Subject|0|||
163214413|NCT01214629|589499063|FG002|Overall Study|Withdrawal by Subject|0|||
163214414|NCT01214629|589499064|FG003|Overall Study|Withdrawal by Subject|0|||
163214415|NCT01214629|589499065|FG004|Overall Study|Withdrawal by Subject|0|||
163214416|NCT01214629|589499066|FG005|Overall Study|Withdrawal by Subject|0|||
163214417|NCT01214629|589499067|FG006|Overall Study|Withdrawal by Subject|0|||
163328302|NCT00754325|589913198|FG001|Initial Treatment|Adverse Event|6|||
163328303|NCT00754325|589913197|FG000|Initial Treatment|Withdrawal by Subject|2|||
163328304|NCT00754325|589913198|FG001|Initial Treatment|Withdrawal by Subject|2|||
163214418|NCT01214629|589499068|FG007|Overall Study|Withdrawal by Subject|0|||
163328305|NCT00754325|589913197|FG000|Initial Treatment|Physician Decision|2|||
163061980|NCT02421939|588935066|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
163061981|NCT02421939|588935067|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
163061982|NCT02421939|588935066|FG000|Long Term Follow up: up to 3 Years|Death|118|||
163061983|NCT02421939|588935067|FG001|Long Term Follow up: up to 3 Years|Death|65|||
163061984|NCT02421939|588935066|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
163061985|NCT02421939|588935067|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
163061986|NCT01035138|588935071|FG000|Overall Study|Adverse Event|4|||
163061987|NCT01035138|588935072|FG001|Overall Study|Adverse Event|0|||
163061988|NCT01035138|588935073|FG002|Overall Study|Adverse Event|2|||
163061989|NCT01035138|588935071|FG000|Overall Study|Caregiver Decision|2|||
163061990|NCT01035138|588935072|FG001|Overall Study|Caregiver Decision|0|||
163061991|NCT01035138|588935073|FG002|Overall Study|Caregiver Decision|1|||
163061992|NCT01035138|588935071|FG000|Overall Study|Withdrawal by Subject|1|||
163061993|NCT01035138|588935072|FG001|Overall Study|Withdrawal by Subject|0|||
163061994|NCT01035138|588935073|FG002|Overall Study|Withdrawal by Subject|0|||
163061995|NCT01035138|588935071|FG000|Overall Study|Physician Decision|0|||
163061996|NCT01035138|588935072|FG001|Overall Study|Physician Decision|0|||
163061997|NCT01035138|588935073|FG002|Overall Study|Physician Decision|1|||
163061998|NCT01035138|588935071|FG000|Overall Study|Sponsor Decision|66|||
163061999|NCT01035138|588935072|FG001|Overall Study|Sponsor Decision|60|||
163062000|NCT01035138|588935073|FG002|Overall Study|Sponsor Decision|42|||
163062001|NCT01035138|588935071|FG000|Overall Study|Lost to Follow-up|0|||
163062002|NCT01035138|588935072|FG001|Overall Study|Lost to Follow-up|0|||
163062003|NCT01035138|588935073|FG002|Overall Study|Lost to Follow-up|1|||
163062004|NCT02966834|588935074|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
163062005|NCT02966834|588935075|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
163062006|NCT02966834|588935076|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
163062007|NCT02966834|588935077|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
163062008|NCT02966834|588935078|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
163062009|NCT02966834|588935079|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
163062010|NCT02966834|588935074|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
163062011|NCT02966834|588935075|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163062012|NCT02966834|588935076|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163062013|NCT02966834|588935077|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163062014|NCT02966834|588935078|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163062015|NCT02966834|588935079|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163062016|NCT02966834|588935074|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
163062017|NCT02966834|588935075|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
163062018|NCT02966834|588935076|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
163062019|NCT02966834|588935077|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
163062020|NCT02966834|588935078|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
163062021|NCT02966834|588935079|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
163010575|NCT00350207|588740197|FG002|Overall Study|Withdrawal by Subject|1|||
163010576|NCT00350207|588740195|FG000|Overall Study|Other|1|||
163010577|NCT00350207|588740196|FG001|Overall Study|Other|3|||
163010578|NCT00350207|588740197|FG002|Overall Study|Other|1|||
163010579|NCT03802825|588740198|FG000|Overall Study|Lost to follow-up for intervention|12|||
163010580|NCT03802825|588740199|FG001|Overall Study|Lost to follow-up for intervention|3|||
163010581|NCT03802825|588740198|FG000|Overall Study|Received only 1 component of intervention|0|||
163010582|NCT03802825|588740199|FG001|Overall Study|Received only 1 component of intervention|13|||
163010583|NCT00568451|588740203|FG000|Overall Study|Disease Progression|0|||
163010584|NCT00568451|588740204|FG001|Overall Study|Disease Progression|0|||
163010585|NCT00568451|588740205|FG002|Overall Study|Disease Progression|2|||
163010586|NCT00568451|588740206|FG003|Overall Study|Disease Progression|7|||
163010587|NCT00777296|588740207|FG000|Overall Study|Adverse Event|0|||
163010588|NCT00777296|588740208|FG001|Overall Study|Adverse Event|1|||
163010589|NCT00777296|588740209|FG002|Overall Study|Adverse Event|0|||
163010590|NCT00777296|588740210|FG003|Overall Study|Adverse Event|1|||
163010591|NCT00777296|588740207|FG000|Overall Study|Withdrawal by Subject|1|||
163010592|NCT00777296|588740208|FG001|Overall Study|Withdrawal by Subject|0|||
163010593|NCT00777296|588740209|FG002|Overall Study|Withdrawal by Subject|0|||
163010594|NCT00777296|588740210|FG003|Overall Study|Withdrawal by Subject|0|||
163010595|NCT00777296|588740207|FG000|Overall Study|CRF form not completed|0|||
163010596|NCT00777296|588740208|FG001|Overall Study|CRF form not completed|0|||
163010597|NCT00777296|588740209|FG002|Overall Study|CRF form not completed|2|||
163010598|NCT00777296|588740210|FG003|Overall Study|CRF form not completed|0|||
163010599|NCT00658723|588740211|FG000|Overall Study|Lost to Follow-up|0|||
163010600|NCT00658723|588740212|FG001|Overall Study|Lost to Follow-up|2|||
163010601|NCT00658723|588740213|FG002|Overall Study|Lost to Follow-up|2|||
163062022|NCT02966834|588935074|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
163062023|NCT02966834|588935075|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
163062024|NCT02966834|588935076|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
163062025|NCT02966834|588935077|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
163062026|NCT02966834|588935078|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
163062027|NCT02966834|588935079|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
163062028|NCT02966834|588935074|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
163062029|NCT02966834|588935075|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
163062030|NCT02966834|588935076|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
163062031|NCT02966834|588935077|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
163062032|NCT02966834|588935078|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
163062033|NCT02966834|588935079|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
163062034|NCT02966834|588935074|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
163062035|NCT02966834|588935075|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
163062036|NCT02966834|588935076|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
163062037|NCT02966834|588935077|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
163062038|NCT02966834|588935078|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
163062039|NCT02966834|588935079|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
163062040|NCT01925417|588935092|FG000|Overall Study|Withdrawal by Subject|2|||
163062041|NCT01925417|588935092|FG000|Overall Study|Death|1|||
163062042|NCT00655889|588935093|FG000|Overall Study|Inadequate cell growth|1|||
163062043|NCT00655889|588935093|FG000|Overall Study|Protocol Violation|1|||
163062044|NCT04739800|588935095|FG000|Overall Study|Adverse Event|2|||
163062045|NCT04739800|588935096|FG001|Overall Study|Adverse Event|1|||
163062046|NCT04739800|588935097|FG002|Overall Study|Adverse Event|4|||
163062047|NCT04739800|588935098|FG003|Overall Study|Adverse Event|5|||
163062048|NCT04739800|588935095|FG000|Overall Study|Never Treated|2|||
163062049|NCT04739800|588935096|FG001|Overall Study|Never Treated|0|||
163062050|NCT04739800|588935097|FG002|Overall Study|Never Treated|1|||
163062051|NCT04739800|588935098|FG003|Overall Study|Never Treated|1|||
163062052|NCT04739800|588935095|FG000|Overall Study|On Treatment|5|||
163062053|NCT04739800|588935096|FG001|Overall Study|On Treatment|9|||
163062054|NCT04739800|588935097|FG002|Overall Study|On Treatment|9|||
163062055|NCT04739800|588935098|FG003|Overall Study|On Treatment|9|||
163062056|NCT04739800|588935095|FG000|Overall Study|Symptomatic Deterioration|1|||
163062057|NCT04739800|588935096|FG001|Overall Study|Symptomatic Deterioration|1|||
163062058|NCT04739800|588935097|FG002|Overall Study|Symptomatic Deterioration|3|||
163062059|NCT04739800|588935098|FG003|Overall Study|Symptomatic Deterioration|0|||
163062060|NCT04739800|588935095|FG000|Overall Study|Withdrawal by Subject|1|||
163062061|NCT04739800|588935096|FG001|Overall Study|Withdrawal by Subject|2|||
163062062|NCT04739800|588935097|FG002|Overall Study|Withdrawal by Subject|1|||
163062063|NCT04739800|588935098|FG003|Overall Study|Withdrawal by Subject|3|||
163062064|NCT04739800|588935095|FG000|Overall Study|Other Reason|1|||
163062065|NCT04739800|588935096|FG001|Overall Study|Other Reason|3|||
163062066|NCT04739800|588935097|FG002|Overall Study|Other Reason|5|||
163062067|NCT04739800|588935098|FG003|Overall Study|Other Reason|4|||
163062068|NCT03573297|588935101|FG000|Open Label Treatment Period|Adverse Event|67|||
163062069|NCT03573297|588935102|FG001|Open Label Treatment Period|Adverse Event|0|||
163062070|NCT03573297|588935103|FG002|Open Label Treatment Period|Adverse Event|0|||
163062071|NCT03573297|588935104|FG003|Open Label Treatment Period|Adverse Event|0|||
163062072|NCT03573297|588935101|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
163062073|NCT03573297|588935102|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
163062074|NCT03573297|588935103|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
163062075|NCT03573297|588935104|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
163328306|NCT00754325|589913198|FG001|Initial Treatment|Physician Decision|0|||
163328307|NCT00754325|589913197|FG000|Initial Treatment|Sponsor Request|0|||
163328308|NCT00754325|589913198|FG001|Initial Treatment|Sponsor Request|1|||
163328309|NCT00754325|589913197|FG000|Initial Treatment|Disease Progression|35|||
163328310|NCT00754325|589913198|FG001|Initial Treatment|Disease Progression|35|||
163062076|NCT03573297|588935101|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
163062077|NCT03573297|588935102|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
163062078|NCT03573297|588935103|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
163328311|NCT03738228|589913199|FG000|Overall Study|Never received study treatment|2|||
163328312|NCT03738228|589913200|FG001|Overall Study|Never received study treatment|2|||
163328313|NCT03801148|589913201|FG000|Period 1 (2 Days)|Adverse Event|1|||
163328314|NCT03801148|589913202|FG001|Period 1 (2 Days)|Adverse Event|1|||
163062079|NCT03573297|588935104|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
163062080|NCT03573297|588935101|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
163328315|NCT03801148|589913203|FG002|Period 1 (2 Days)|Adverse Event|0|||
163328316|NCT03801148|589913204|FG003|Period 1 (2 Days)|Adverse Event|0|||
163062081|NCT03573297|588935102|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
163062082|NCT03573297|588935103|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
163062083|NCT03573297|588935104|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
163062084|NCT03573297|588935101|FG000|Open Label Treatment Period|Pregnancy|1|||
163062085|NCT03573297|588935102|FG001|Open Label Treatment Period|Pregnancy|0|||
163062086|NCT03573297|588935103|FG002|Open Label Treatment Period|Pregnancy|0|||
163062087|NCT03573297|588935104|FG003|Open Label Treatment Period|Pregnancy|0|||
163062088|NCT03573297|588935101|FG000|Open Label Treatment Period|Protocol Violation|17|||
163062089|NCT03573297|588935102|FG001|Open Label Treatment Period|Protocol Violation|0|||
163062090|NCT03573297|588935103|FG002|Open Label Treatment Period|Protocol Violation|0|||
163062091|NCT03573297|588935104|FG003|Open Label Treatment Period|Protocol Violation|0|||
163062092|NCT03573297|588935101|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
163062093|NCT03573297|588935102|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
163062094|NCT03573297|588935103|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
163062095|NCT03573297|588935104|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
163010602|NCT00658723|588740211|FG000|Overall Study|Death|2|||
163010603|NCT00658723|588740212|FG001|Overall Study|Death|1|||
163010604|NCT00658723|588740213|FG002|Overall Study|Death|4|||
163010605|NCT00658723|588740211|FG000|Overall Study|Scheduling Issue|1|||
163010606|NCT00658723|588740212|FG001|Overall Study|Scheduling Issue|1|||
163010607|NCT00658723|588740213|FG002|Overall Study|Scheduling Issue|0|||
163010608|NCT00658723|588740211|FG000|Overall Study|Withdrawal by Subject|1|||
163010609|NCT00658723|588740212|FG001|Overall Study|Withdrawal by Subject|0|||
163062096|NCT03573297|588935101|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
163062097|NCT03573297|588935102|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
163062098|NCT03573297|588935103|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
163062099|NCT03573297|588935104|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
163062100|NCT03573297|588935101|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
163062101|NCT03573297|588935102|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
163062102|NCT03573297|588935103|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
163062103|NCT03573297|588935104|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
163062104|NCT03573297|588935101|FG000|Open Label Treatment Period|Other, Not Specified|7|||
163062105|NCT03573297|588935102|FG001|Open Label Treatment Period|Other, Not Specified|0|||
163062106|NCT03573297|588935103|FG002|Open Label Treatment Period|Other, Not Specified|0|||
163062107|NCT03573297|588935104|FG003|Open Label Treatment Period|Other, Not Specified|0|||
163062108|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
163062109|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
163062110|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
163062111|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
163062112|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Adverse Event|0|||
163062113|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Adverse Event|1|||
163062114|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Adverse Event|5|||
163062115|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Adverse Event|1|||
163062116|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
163062117|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
163062118|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
163062119|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
163062120|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163062121|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
163062122|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
163062123|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
163062124|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163062125|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
163062126|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
163062127|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
163062128|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
163062129|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
163062130|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
163062131|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
163062132|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
163062133|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
163062134|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
163062135|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
163062136|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
163062137|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
163062138|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
163062139|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
163062140|NCT02696798|588935107|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
163062141|NCT02696798|588935108|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
163062142|NCT02696798|588935109|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
163062143|NCT02696798|588935107|FG000|Blinded Treatment Dosing Period|Death|0|||
163062144|NCT02696798|588935108|FG001|Blinded Treatment Dosing Period|Death|0|||
163062145|NCT02696798|588935109|FG002|Blinded Treatment Dosing Period|Death|1|||
163328317|NCT03801148|589913201|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
163010610|NCT00658723|588740213|FG002|Overall Study|Withdrawal by Subject|1|||
163010611|NCT03876743|588740214|FG000|Overall Study|Lost to Follow-up|6|||
163010612|NCT03876743|588740215|FG001|Overall Study|Lost to Follow-up|4|||
163010613|NCT03876743|588740216|FG002|Overall Study|Lost to Follow-up|4|||
163010614|NCT03876743|588740217|FG003|Overall Study|Lost to Follow-up|7|||
163010615|NCT00092118|588740219|FG000|Overall Study|Adverse Event|35|||
163010616|NCT00092118|588740220|FG001|Overall Study|Adverse Event|32|||
163010617|NCT00092118|588740219|FG000|Overall Study|Lack of Efficacy|12|||
163010618|NCT00092118|588740220|FG001|Overall Study|Lack of Efficacy|14|||
163010619|NCT00092118|588740219|FG000|Overall Study|Lost to Follow-up|4|||
163010620|NCT00092118|588740220|FG001|Overall Study|Lost to Follow-up|3|||
163010621|NCT00092118|588740219|FG000|Overall Study|Protocol Violation|23|||
163062146|NCT02696798|588935107|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
163062147|NCT02696798|588935108|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
163062148|NCT02696798|588935109|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
163062149|NCT02696798|588935107|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
163062150|NCT02696798|588935108|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
163062151|NCT02696798|588935109|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
163062152|NCT02696798|588935107|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
163062153|NCT02696798|588935108|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
163062154|NCT02696798|588935109|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
163062155|NCT02696798|588935107|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
163062156|NCT02696798|588935108|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
163062157|NCT02696798|588935109|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
163062158|NCT02696798|588935107|FG000|Extended Treatment Period|Adverse Event|1|||
163062159|NCT02696798|588935108|FG001|Extended Treatment Period|Adverse Event|4|||
163062160|NCT02696798|588935109|FG002|Extended Treatment Period|Adverse Event|5|||
163062161|NCT02696798|588935107|FG000|Extended Treatment Period|Lack of Efficacy|7|||
163062162|NCT02696798|588935108|FG001|Extended Treatment Period|Lack of Efficacy|2|||
163062163|NCT02696798|588935109|FG002|Extended Treatment Period|Lack of Efficacy|2|||
163062164|NCT02696798|588935107|FG000|Extended Treatment Period|Lost to Follow-up|1|||
163062165|NCT02696798|588935108|FG001|Extended Treatment Period|Lost to Follow-up|0|||
163062166|NCT02696798|588935109|FG002|Extended Treatment Period|Lost to Follow-up|0|||
163062167|NCT02696798|588935107|FG000|Extended Treatment Period|Physician Decision|0|||
163062168|NCT02696798|588935108|FG001|Extended Treatment Period|Physician Decision|1|||
163062169|NCT02696798|588935109|FG002|Extended Treatment Period|Physician Decision|0|||
163062170|NCT02696798|588935107|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
163062171|NCT02696798|588935108|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
163062172|NCT02696798|588935109|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
163062173|NCT02696798|588935107|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
163062174|NCT02696798|588935108|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
163062175|NCT02696798|588935109|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
163062176|NCT02696798|588935107|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
163062177|NCT02696798|588935108|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
163062178|NCT02696798|588935109|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
163062179|NCT02696798|588935107|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
163062180|NCT02696798|588935108|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
163062181|NCT02696798|588935109|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
163062182|NCT02696798|588935107|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
163062183|NCT02696798|588935108|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
163214419|NCT01214629|589499069|FG008|Overall Study|Withdrawal by Subject|0|||
163214420|NCT01214629|589499070|FG009|Overall Study|Withdrawal by Subject|1|||
163214421|NCT01214629|589499071|FG010|Overall Study|Withdrawal by Subject|0|||
162925200|NCT00902486|588427399|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
162925201|NCT00902486|588427400|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
162925202|NCT00902486|588427401|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
162925203|NCT00902486|588427402|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
162925204|NCT00902486|588427403|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
162925205|NCT01843660|588427404|FG000|Overall Study|Other|30|||
162925206|NCT00209560|588427405|FG000|Overall Study|Lack of Efficacy|1|||
162925207|NCT00209560|588427406|FG001|Overall Study|Lack of Efficacy|0|||
162925208|NCT04439110|588427407|FG000|Overall Study|Ineligible|2|||
162925209|NCT04439110|588427407|FG000|Overall Study|Adverse Event|4|||
162925210|NCT04439110|588427407|FG000|Overall Study|Death|2|||
162925211|NCT04439110|588427407|FG000|Overall Study|Disease proression|25|||
162925212|NCT04439110|588427407|FG000|Overall Study|Withdrawal by Subject|1|||
162925213|NCT04439110|588427407|FG000|Overall Study|Alternative therapy|1|||
162925214|NCT04439110|588427407|FG000|Overall Study|Other complicating disease|1|||
162925215|NCT04439110|588427407|FG000|Overall Study|Personal reasons|1|||
162925216|NCT04439110|588427407|FG000|Overall Study|Still on treatment|1|||
163010622|NCT00092118|588740220|FG001|Overall Study|Protocol Violation|25|||
163010623|NCT00092118|588740219|FG000|Overall Study|Withdrawal by Subject|4|||
163010624|NCT00092118|588740220|FG001|Overall Study|Withdrawal by Subject|10|||
163010625|NCT00092118|588740219|FG000|Overall Study|Other|6|||
163010626|NCT00092118|588740220|FG001|Overall Study|Other|5|||
163214422|NCT00877383|589499074|FG000|Overall Study|Adverse Event|13|||
162925217|NCT00526227|588427414|FG000|Overall Study|Device not implanted|1|||
162925218|NCT00526227|588427414|FG000|Overall Study|Death|1|||
162925219|NCT01525407|588427415|FG000|Overall Study|Change in recipient treatment plan|2|||
162925220|NCT01525407|588427416|FG001|Overall Study|Change in recipient treatment plan|2|||
162925221|NCT01525407|588427415|FG000|Overall Study|Withdrawal by Subject|0|||
162925222|NCT01525407|588427416|FG001|Overall Study|Withdrawal by Subject|1|||
162925223|NCT01525407|588427415|FG000|Overall Study|Transplant was delayed|0|||
162925224|NCT01525407|588427416|FG001|Overall Study|Transplant was delayed|1|||
162925225|NCT01525407|588427415|FG000|Overall Study|Delay in Transplant|1|||
162925226|NCT01525407|588427416|FG001|Overall Study|Delay in Transplant|0|||
162925227|NCT05257109|588427417|FG000|Overall Study|Withdrawal by Subject|1|||
162925228|NCT05257109|588427418|FG001|Overall Study|Withdrawal by Subject|0|||
162925229|NCT05257109|588427419|FG002|Overall Study|Withdrawal by Subject|0|||
162925230|NCT05257109|588427420|FG003|Overall Study|Withdrawal by Subject|0|||
162925231|NCT00858234|588428885|FG000|Overall Study|Adverse Event|6|||
162925232|NCT00858234|588428885|FG000|Overall Study|Progressive disease|2|||
162925233|NCT00858234|588428885|FG000|Overall Study|Status unknown|1|||
162925234|NCT01678924|588428886|FG000|Overall Study|Adverse Event|1|||
162925235|NCT01678924|588428887|FG001|Overall Study|Adverse Event|1|||
162925236|NCT01678924|588428888|FG002|Overall Study|Adverse Event|0|||
162925237|NCT01678924|588428889|FG003|Overall Study|Adverse Event|1|||
162925238|NCT01678924|588428886|FG000|Overall Study|Lack of Efficacy|7|||
163062184|NCT02696798|588935109|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
163062185|NCT02696798|588935107|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
163062186|NCT02696798|588935108|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
163062187|NCT02696798|588935109|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
163062188|NCT02696798|588935107|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
163062189|NCT02696798|588935108|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
163062190|NCT02696798|588935109|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
163062191|NCT04880850|588935110|FG000|Overall Study|Death|2|||
163062192|NCT04880850|588935111|FG001|Overall Study|Death|1|||
163062193|NCT04880850|588935110|FG000|Overall Study|Lost to Follow-up|3|||
163062194|NCT04880850|588935111|FG001|Overall Study|Lost to Follow-up|6|||
163062195|NCT04880850|588935110|FG000|Overall Study|Physician Decision|2|||
163062196|NCT04880850|588935111|FG001|Overall Study|Physician Decision|1|||
163062197|NCT04880850|588935110|FG000|Overall Study|Withdrawal by Subject|9|||
163062198|NCT04880850|588935111|FG001|Overall Study|Withdrawal by Subject|10|||
163062199|NCT04091451|588935112|FG000|Overall Study|Adverse Event|15|||
163062200|NCT04091451|588935113|FG001|Overall Study|Adverse Event|10|||
163062201|NCT04091451|588935112|FG000|Overall Study|Lost to Follow-up|8|||
163062202|NCT04091451|588935113|FG001|Overall Study|Lost to Follow-up|8|||
163062203|NCT04091451|588935112|FG000|Overall Study|Protocol Violation|5|||
163062204|NCT04091451|588935113|FG001|Overall Study|Protocol Violation|4|||
163062205|NCT04091451|588935112|FG000|Overall Study|Withdrawal by Subject|21|||
163062206|NCT04091451|588935113|FG001|Overall Study|Withdrawal by Subject|27|||
163062207|NCT04091451|588935112|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
163062208|NCT04091451|588935113|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
162925239|NCT01678924|588428887|FG001|Overall Study|Lack of Efficacy|2|||
162925240|NCT01678924|588428888|FG002|Overall Study|Lack of Efficacy|0|||
162925241|NCT01678924|588428889|FG003|Overall Study|Lack of Efficacy|5|||
162925242|NCT01678924|588428886|FG000|Overall Study|Lost to Follow-up|0|||
162925243|NCT01678924|588428887|FG001|Overall Study|Lost to Follow-up|4|||
162925244|NCT01678924|588428888|FG002|Overall Study|Lost to Follow-up|0|||
162925245|NCT01678924|588428889|FG003|Overall Study|Lost to Follow-up|2|||
162925246|NCT01678924|588428886|FG000|Overall Study|Personal Reasons|2|||
162925247|NCT01678924|588428887|FG001|Overall Study|Personal Reasons|2|||
162925248|NCT01678924|588428888|FG002|Overall Study|Personal Reasons|2|||
162925249|NCT01678924|588428889|FG003|Overall Study|Personal Reasons|7|||
162925250|NCT01678924|588428886|FG000|Overall Study|Withdrawal by Subject|0|||
162925251|NCT01678924|588428887|FG001|Overall Study|Withdrawal by Subject|3|||
162925252|NCT01678924|588428888|FG002|Overall Study|Withdrawal by Subject|0|||
162925253|NCT01678924|588428889|FG003|Overall Study|Withdrawal by Subject|2|||
162925254|NCT01678924|588428886|FG000|Overall Study|Unable to attend scheduled visits|0|||
162925255|NCT01678924|588428887|FG001|Overall Study|Unable to attend scheduled visits|0|||
162925256|NCT01678924|588428888|FG002|Overall Study|Unable to attend scheduled visits|0|||
162925257|NCT01678924|588428889|FG003|Overall Study|Unable to attend scheduled visits|1|||
162925258|NCT02253654|588428890|FG000|Overall Study|Withdrawal by Subject|12|||
162925259|NCT02253654|588428891|FG001|Overall Study|Withdrawal by Subject|4|||
162925260|NCT02253654|588428890|FG000|Overall Study|Decision by Sponsor|1|||
162925261|NCT02253654|588428891|FG001|Overall Study|Decision by Sponsor|1|||
162925262|NCT02253654|588428890|FG000|Overall Study|Lost to Follow-up|2|||
162925263|NCT02253654|588428891|FG001|Overall Study|Lost to Follow-up|5|||
162925264|NCT02253654|588428890|FG000|Overall Study|Death|4|||
162925265|NCT02253654|588428891|FG001|Overall Study|Death|7|||
162925266|NCT02253654|588428890|FG000|Overall Study|Did Not Receive Study Treatment|4|||
163010627|NCT01139125|588740221|FG000|Overall Study|Withdrawal by Subject|1|||
163010628|NCT00931411|588740224|FG000|First Intervention - 42 Days|Adverse Event|2|||
163010629|NCT00931411|588740225|FG001|First Intervention - 42 Days|Adverse Event|3|||
163010630|NCT00931411|588740224|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
163010631|NCT00931411|588740225|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
163010632|NCT00931411|588740224|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
163010633|NCT00931411|588740225|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
163010634|NCT04030299|588740228|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
163010635|NCT04030299|588740228|FG000|Overall Study|Withdrawal by Subject|3|||
163010636|NCT00699998|588740229|FG000|Overall Study|Withdrawal by Subject|194|||
163010637|NCT00699998|588740230|FG001|Overall Study|Withdrawal by Subject|83|||
163010638|NCT00699998|588740231|FG002|Overall Study|Withdrawal by Subject|202|||
163010639|NCT00699998|588740232|FG003|Overall Study|Withdrawal by Subject|80|||
163010640|NCT00699998|588740229|FG000|Overall Study|Physician Decision|3|||
163010641|NCT00699998|588740230|FG001|Overall Study|Physician Decision|2|||
163010642|NCT00699998|588740231|FG002|Overall Study|Physician Decision|1|||
163010643|NCT00699998|588740232|FG003|Overall Study|Physician Decision|1|||
163010644|NCT00699998|588740229|FG000|Overall Study|Lost to Follow-up|2|||
163010645|NCT00699998|588740230|FG001|Overall Study|Lost to Follow-up|1|||
163010646|NCT00699998|588740231|FG002|Overall Study|Lost to Follow-up|3|||
163010647|NCT00699998|588740232|FG003|Overall Study|Lost to Follow-up|1|||
163010648|NCT04616612|588740239|FG000|Overall Study|Lost to Follow-up|6|||
163010649|NCT04616612|588740240|FG001|Overall Study|Lost to Follow-up|3|||
163010650|NCT04740918|588740242|FG000|Overall Study|Study Terminated by Sponsor|41|||
163010651|NCT04740918|588740243|FG001|Overall Study|Study Terminated by Sponsor|32|||
163010652|NCT04740918|588740242|FG000|Overall Study|Death|3|||
163010653|NCT04740918|588740243|FG001|Overall Study|Death|6|||
163010654|NCT04740918|588740242|FG000|Overall Study|Withdrawal by Subject|5|||
163010655|NCT04740918|588740243|FG001|Overall Study|Withdrawal by Subject|4|||
163010656|NCT04740918|588740242|FG000|Overall Study|Lost to Follow-up|1|||
163010657|NCT04740918|588740243|FG001|Overall Study|Lost to Follow-up|3|||
163010658|NCT04740918|588740242|FG000|Overall Study|Progressive disease|0|||
163010659|NCT04740918|588740243|FG001|Overall Study|Progressive disease|1|||
163010660|NCT02208362|588740246|FG000|Overall Study|Participant did not complete treatment|0|||
163010661|NCT02208362|588740247|FG001|Overall Study|Participant did not complete treatment|1|||
163010662|NCT02208362|588740248|FG002|Overall Study|Participant did not complete treatment|0|||
163010663|NCT02208362|588740249|FG003|Overall Study|Participant did not complete treatment|0|||
163010664|NCT02208362|588740250|FG004|Overall Study|Participant did not complete treatment|0|||
163010665|NCT02208362|588740251|FG005|Overall Study|Participant did not complete treatment|0|||
163010666|NCT02208362|588740252|FG006|Overall Study|Participant did not complete treatment|1|||
163010667|NCT02208362|588740253|FG007|Overall Study|Participant did not complete treatment|1|||
163010668|NCT02208362|588740254|FG008|Overall Study|Participant did not complete treatment|2|||
163010669|NCT02208362|588740255|FG009|Overall Study|Participant did not complete treatment|0|||
163010670|NCT02208362|588740256|FG010|Overall Study|Participant did not complete treatment|1|||
163010671|NCT02208362|588740257|FG011|Overall Study|Participant did not complete treatment|0|||
163010672|NCT02208362|588740246|FG000|Overall Study|Participant received disallowed treatment|0|||
163010673|NCT02208362|588740247|FG001|Overall Study|Participant received disallowed treatment|0|||
163010674|NCT02208362|588740248|FG002|Overall Study|Participant received disallowed treatment|0|||
163010675|NCT02208362|588740249|FG003|Overall Study|Participant received disallowed treatment|0|||
163010676|NCT02208362|588740250|FG004|Overall Study|Participant received disallowed treatment|0|||
163010677|NCT02208362|588740251|FG005|Overall Study|Participant received disallowed treatment|0|||
163010678|NCT02208362|588740252|FG006|Overall Study|Participant received disallowed treatment|0|||
163010679|NCT02208362|588740253|FG007|Overall Study|Participant received disallowed treatment|0|||
163010680|NCT02208362|588740254|FG008|Overall Study|Participant received disallowed treatment|1|||
163010681|NCT02208362|588740255|FG009|Overall Study|Participant received disallowed treatment|0|||
163010682|NCT02208362|588740256|FG010|Overall Study|Participant received disallowed treatment|0|||
163010683|NCT02208362|588740257|FG011|Overall Study|Participant received disallowed treatment|0|||
163010684|NCT01609790|588740262|FG000|Overall Study|Protocol Violation|1|||
163010685|NCT01609790|588740263|FG001|Overall Study|Protocol Violation|7|||
163010686|NCT01609790|588740264|FG002|Overall Study|Protocol Violation|8|||
163010687|NCT00858273|588740265|FG000|Overall Study|Protocol Violation|3|||
163010688|NCT00858273|588740266|FG001|Overall Study|Protocol Violation|5|||
163010689|NCT00982657|588740267|FG000|Overall Study|Death|1|||
163010690|NCT00982657|588740268|FG001|Overall Study|Death|0|||
163010691|NCT00982657|588740269|FG002|Overall Study|Death|1|||
163010692|NCT00982657|588740270|FG003|Overall Study|Death|1|||
163010693|NCT00982657|588740267|FG000|Overall Study|Withdrawal by Subject|0|||
163010694|NCT00982657|588740268|FG001|Overall Study|Withdrawal by Subject|0|||
163010695|NCT00982657|588740269|FG002|Overall Study|Withdrawal by Subject|1|||
163010696|NCT00982657|588740270|FG003|Overall Study|Withdrawal by Subject|3|||
163010697|NCT00982657|588740267|FG000|Overall Study|Other|0|||
163010698|NCT00982657|588740268|FG001|Overall Study|Other|0|||
163010699|NCT00982657|588740269|FG002|Overall Study|Other|0|||
163010700|NCT00982657|588740270|FG003|Overall Study|Other|4|||
163214423|NCT00877383|589499075|FG001|Overall Study|Adverse Event|14|||
163214424|NCT00877383|589499074|FG000|Overall Study|Lost to Follow-up|5|||
163214425|NCT00877383|589499075|FG001|Overall Study|Lost to Follow-up|3|||
163214426|NCT00877383|589499074|FG000|Overall Study|Subject withdrew consent|3|||
163214427|NCT00877383|589499075|FG001|Overall Study|Subject withdrew consent|12|||
163214428|NCT00877383|589499074|FG000|Overall Study|Subject no longer requires study drug|2|||
163214429|NCT00877383|589499075|FG001|Overall Study|Subject no longer requires study drug|0|||
163214430|NCT00877383|589499074|FG000|Overall Study|Administrative problems|2|||
163214431|NCT00877383|589499075|FG001|Overall Study|Administrative problems|0|||
163214432|NCT00877383|589499074|FG000|Overall Study|Protocol deviation|2|||
163214433|NCT00877383|589499075|FG001|Overall Study|Protocol deviation|6|||
163214434|NCT00877383|589499074|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163214435|NCT00877383|589499075|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163214436|NCT00877383|589499074|FG000|Overall Study|Death|1|||
163214437|NCT00877383|589499075|FG001|Overall Study|Death|2|||
163214438|NCT00459108|589499077|FG000|Overall Study|Withdrawal by Subject|5|||
163214439|NCT00459108|589499077|FG000|Overall Study|Adverse Event|3|||
163214440|NCT00459108|589499077|FG000|Overall Study|Death|2|||
163214441|NCT00459108|589499077|FG000|Overall Study|Progression|1|||
163214442|NCT04387435|589499084|FG000|Overall Study|Physician Decision|1|||
163214443|NCT00391274|589499087|FG000|Overall Study|Death Due to Study Disease|55|||
163214444|NCT00391274|589499088|FG001|Overall Study|Death Due to Study Disease|45|||
163214445|NCT00391274|589499087|FG000|Overall Study|Lost to Follow-up|0|||
163214446|NCT00391274|589499088|FG001|Overall Study|Lost to Follow-up|3|||
163214447|NCT00391274|589499087|FG000|Overall Study|Physician Decision|4|||
163214448|NCT00391274|589499088|FG001|Overall Study|Physician Decision|2|||
163214449|NCT00391274|589499087|FG000|Overall Study|Withdrawal by Subject|0|||
163214450|NCT00391274|589499088|FG001|Overall Study|Withdrawal by Subject|3|||
163214451|NCT00391274|589499087|FG000|Overall Study|Death Due to Adverse Event|1|||
163214452|NCT00391274|589499088|FG001|Overall Study|Death Due to Adverse Event|3|||
163214453|NCT00391274|589499087|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
163214454|NCT00391274|589499088|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
163214455|NCT00391274|589499087|FG000|Overall Study|Death Not Study Related|0|||
163214456|NCT00391274|589499088|FG001|Overall Study|Death Not Study Related|1|||
163214457|NCT04501666|589499091|FG000|Overall Study|Physician Decision|0|||
163214458|NCT04501666|589499092|FG001|Overall Study|Physician Decision|1|||
163214459|NCT04501666|589499091|FG000|Overall Study|Adverse Event|12|||
163214460|NCT04501666|589499092|FG001|Overall Study|Adverse Event|4|||
163214461|NCT04501666|589499091|FG000|Overall Study|Subject's request|10|||
163214462|NCT04501666|589499092|FG001|Overall Study|Subject's request|6|||
163214463|NCT04501666|589499091|FG000|Overall Study|Protocol Deviation|2|||
163214464|NCT04501666|589499092|FG001|Overall Study|Protocol Deviation|1|||
163214465|NCT04501666|589499091|FG000|Overall Study|Other-- site permanently closing|0|||
163214466|NCT04501666|589499092|FG001|Overall Study|Other-- site permanently closing|1|||
163214467|NCT00642941|589499093|FG000|Overall Study|Physician Decision|3|||
163214468|NCT00642941|589499094|FG001|Overall Study|Physician Decision|1|||
163214469|NCT00642941|589499095|FG002|Overall Study|Physician Decision|0|||
163214470|NCT00642941|589499096|FG003|Overall Study|Physician Decision|0|||
163214471|NCT00642941|589499097|FG004|Overall Study|Physician Decision|0|||
163214472|NCT00642941|589499098|FG005|Overall Study|Physician Decision|0|||
163214473|NCT00642941|589499099|FG006|Overall Study|Physician Decision|1|||
163214474|NCT00642941|589499100|FG007|Overall Study|Physician Decision|0|||
163214475|NCT00642941|589499101|FG008|Overall Study|Physician Decision|0|||
163214476|NCT00642941|589499102|FG009|Overall Study|Physician Decision|1|||
163214477|NCT00642941|589499103|FG010|Overall Study|Physician Decision|0|||
163214478|NCT00642941|589499104|FG011|Overall Study|Physician Decision|1|||
163214479|NCT00642941|589499093|FG000|Overall Study|Death|4|||
163214480|NCT00642941|589499094|FG001|Overall Study|Death|0|||
163214481|NCT00642941|589499095|FG002|Overall Study|Death|1|||
163214482|NCT00642941|589499096|FG003|Overall Study|Death|1|||
163214483|NCT00642941|589499097|FG004|Overall Study|Death|2|||
163214484|NCT00642941|589499098|FG005|Overall Study|Death|1|||
163214485|NCT00642941|589499099|FG006|Overall Study|Death|0|||
163214486|NCT00642941|589499100|FG007|Overall Study|Death|0|||
163214487|NCT00642941|589499101|FG008|Overall Study|Death|0|||
163214488|NCT00642941|589499102|FG009|Overall Study|Death|0|||
163214489|NCT00642941|589499103|FG010|Overall Study|Death|0|||
163214490|NCT00642941|589499104|FG011|Overall Study|Death|1|||
163214491|NCT00642941|589499093|FG000|Overall Study|Study closed by Sponsor|0|||
163214492|NCT00642941|589499094|FG001|Overall Study|Study closed by Sponsor|1|||
163214493|NCT00642941|589499095|FG002|Overall Study|Study closed by Sponsor|0|||
163214494|NCT00642941|589499096|FG003|Overall Study|Study closed by Sponsor|0|||
163214495|NCT00642941|589499097|FG004|Overall Study|Study closed by Sponsor|0|||
163214496|NCT00642941|589499098|FG005|Overall Study|Study closed by Sponsor|0|||
163214497|NCT00642941|589499099|FG006|Overall Study|Study closed by Sponsor|0|||
163328318|NCT03801148|589913202|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
163328319|NCT03801148|589913203|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
163328320|NCT03801148|589913204|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
163010701|NCT00982657|588740267|FG000|Overall Study|On going at date of cut-off|0|||
163010702|NCT00982657|588740268|FG001|Overall Study|On going at date of cut-off|0|||
163010703|NCT00982657|588740269|FG002|Overall Study|On going at date of cut-off|0|||
163010704|NCT00982657|588740270|FG003|Overall Study|On going at date of cut-off|1|||
163010705|NCT03760744|588741532|FG000|Overall Study|Lost to Follow-up|3|||
163010706|NCT03760744|588741533|FG001|Overall Study|Lost to Follow-up|0|||
163010707|NCT01102257|588741538|FG000|Overall Study|Adverse Event|1|||
163010708|NCT01102257|588741539|FG001|Overall Study|Adverse Event|0|||
163010709|NCT01102257|588741538|FG000|Overall Study|Adverse Event|1|||
163010710|NCT01102257|588741539|FG001|Overall Study|Adverse Event|0|||
163010711|NCT05364931|588741540|FG000|Overall Study|Adverse Event|0|||
163010712|NCT05364931|588741541|FG001|Overall Study|Adverse Event|2|||
163010713|NCT05364931|588741542|FG002|Overall Study|Adverse Event|1|||
163010714|NCT05364931|588741543|FG003|Overall Study|Adverse Event|0|||
163010715|NCT05364931|588741540|FG000|Overall Study|Lost to Follow-up|1|||
163010716|NCT05364931|588741541|FG001|Overall Study|Lost to Follow-up|0|||
163010717|NCT05364931|588741542|FG002|Overall Study|Lost to Follow-up|0|||
163010718|NCT05364931|588741543|FG003|Overall Study|Lost to Follow-up|0|||
163010719|NCT05364931|588741540|FG000|Overall Study|Withdrawal by Subject|1|||
163010720|NCT05364931|588741541|FG001|Overall Study|Withdrawal by Subject|1|||
163010721|NCT05364931|588741542|FG002|Overall Study|Withdrawal by Subject|3|||
163010722|NCT05364931|588741543|FG003|Overall Study|Withdrawal by Subject|2|||
163010723|NCT05364931|588741540|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
163010724|NCT05364931|588741541|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
163010725|NCT05364931|588741542|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
163010726|NCT05364931|588741543|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
163010727|NCT05364931|588741540|FG000|Overall Study|Discontinued|1|||
163010728|NCT05364931|588741541|FG001|Overall Study|Discontinued|0|||
163010729|NCT05364931|588741542|FG002|Overall Study|Discontinued|0|||
163010730|NCT05364931|588741543|FG003|Overall Study|Discontinued|0|||
163010731|NCT05266053|588741546|FG000|Overall Study|Withdrawal by Subject|8|||
163010732|NCT05266053|588741547|FG001|Overall Study|Withdrawal by Subject|4|||
163010733|NCT05344560|588741548|FG000|Period 1|Subject out of visit window|1|||
163010734|NCT05344560|588741549|FG001|Period 1|Subject out of visit window|1|||
163010735|NCT05344560|588741548|FG000|Period 2|Covid-19 Related|1|||
163010736|NCT05344560|588741549|FG001|Period 2|Covid-19 Related|0|||
163010737|NCT05344560|588741548|FG000|Period 2|Adverse Event|1|||
163010738|NCT05344560|588741549|FG001|Period 2|Adverse Event|0|||
163010739|NCT05344560|588741548|FG000|Period 2|Subject out of visit window|1|||
163010740|NCT05344560|588741549|FG001|Period 2|Subject out of visit window|1|||
163010741|NCT05344560|588741548|FG000|Period 3|Subject out of visit window|1|||
163010742|NCT05344560|588741549|FG001|Period 3|Subject out of visit window|0|||
163010743|NCT01051960|588741554|FG000|Overall Study|Adverse Event|1|||
163010744|NCT02996968|588741555|FG000|Overall Study|Withdrawal by Subject|1|||
163010745|NCT02996968|588741556|FG001|Overall Study|Withdrawal by Subject|0|||
163010746|NCT01293695|588741560|FG000|Overall Study|Withdrawal by Subject|7|||
163010747|NCT01293695|588741561|FG001|Overall Study|Withdrawal by Subject|1|||
163010748|NCT01293695|588741560|FG000|Overall Study|Lost to Follow-up|8|||
163010749|NCT01293695|588741561|FG001|Overall Study|Lost to Follow-up|6|||
163010750|NCT00791778|588741565|FG000|Double-blind Treatment|Adverse Event|49|||
163010751|NCT00791778|588741566|FG001|Double-blind Treatment|Adverse Event|9|||
163010752|NCT00791778|588741565|FG000|Double-blind Treatment|Physician Decision|6|||
163010753|NCT00791778|588741566|FG001|Double-blind Treatment|Physician Decision|26|||
163010754|NCT00791778|588741565|FG000|Double-blind Treatment|Protocol Violation|0|||
163010755|NCT00791778|588741566|FG001|Double-blind Treatment|Protocol Violation|4|||
163010756|NCT00791778|588741565|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
163062209|NCT04091451|588935112|FG000|Overall Study|Migrated/moved from the study area|3|||
163062210|NCT04091451|588935113|FG001|Overall Study|Migrated/moved from the study area|5|||
163062211|NCT04091451|588935112|FG000|Overall Study|Suspected HZ episode|1|||
163010757|NCT00791778|588741566|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
163010758|NCT00791778|588741565|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
163010759|NCT00791778|588741566|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
163010760|NCT00791778|588741565|FG000|Follow-up|Withdrawal by Subject|3|||
163010761|NCT00791778|588741566|FG001|Follow-up|Withdrawal by Subject|0|||
163010762|NCT00791778|588741565|FG000|Follow-up|Lost to Follow-up|2|||
163010763|NCT00791778|588741566|FG001|Follow-up|Lost to Follow-up|1|||
163010764|NCT01082328|588741567|FG000|Overall Study|Adverse Event|1|||
163010765|NCT00031590|588741568|FG000|Overall Study|Adverse Event|1|||
163062212|NCT04091451|588935113|FG001|Overall Study|Suspected HZ episode|0|||
163010766|NCT00031590|588741568|FG000|Overall Study|Withdrawal by parents|2|||
163010767|NCT05506046|588741571|FG000|Overall Study|Lost to Follow-up|89|||
163010768|NCT05506046|588741572|FG001|Overall Study|Lost to Follow-up|101|||
163010769|NCT05506046|588741573|FG002|Overall Study|Lost to Follow-up|102|||
163010770|NCT05506046|588741574|FG003|Overall Study|Lost to Follow-up|99|||
163010771|NCT03313180|588741578|FG000|Overall Study|Adverse Event|120|||
163010772|NCT03313180|588741578|FG000|Overall Study|Lost to Follow-up|3|||
163010773|NCT03313180|588741578|FG000|Overall Study|Withdrawal by Subject|39|||
163010774|NCT03313180|588741578|FG000|Overall Study|Other than listed above|15|||
163010775|NCT03313180|588741578|FG000|Overall Study|Covid-19 related|2|||
163010776|NCT01058642|588741580|FG000|Treatment Period 1|Adverse Event|0|||
163010777|NCT01058642|588741581|FG001|Treatment Period 1|Adverse Event|1|||
163010778|NCT01058642|588741582|FG002|Treatment Period 1|Adverse Event|1|||
163010779|NCT01058642|588741583|FG003|Treatment Period 1|Adverse Event|0|||
163010780|NCT01058642|588741580|FG000|Treatment Period 1|Physician Decision|0|||
163010781|NCT01058642|588741581|FG001|Treatment Period 1|Physician Decision|0|||
163010782|NCT01058642|588741582|FG002|Treatment Period 1|Physician Decision|1|||
163010783|NCT01058642|588741583|FG003|Treatment Period 1|Physician Decision|0|||
163010784|NCT01058642|588741580|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163010785|NCT01058642|588741581|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163010786|NCT01058642|588741582|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163010787|NCT01058642|588741583|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163010788|NCT01058642|588741580|FG000|Treatment Period 1|Lack of Efficacy|0|||
163010789|NCT01058642|588741581|FG001|Treatment Period 1|Lack of Efficacy|0|||
163010790|NCT01058642|588741582|FG002|Treatment Period 1|Lack of Efficacy|0|||
163010791|NCT01058642|588741583|FG003|Treatment Period 1|Lack of Efficacy|1|||
163010792|NCT01058642|588741580|FG000|Treatment Period 1|Protocol Violation|0|||
163010793|NCT01058642|588741581|FG001|Treatment Period 1|Protocol Violation|0|||
163010794|NCT01058642|588741582|FG002|Treatment Period 1|Protocol Violation|0|||
163010795|NCT01058642|588741583|FG003|Treatment Period 1|Protocol Violation|1|||
163010796|NCT01058642|588741580|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
163010797|NCT01058642|588741581|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
163010798|NCT01058642|588741582|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
163010799|NCT01058642|588741583|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
163010800|NCT04177095|588741594|FG000|Overall Study|Withdrawal by Subject|3|||
163010801|NCT04177095|588741594|FG000|Overall Study|Screen Failure|3|||
163010802|NCT04177095|588741594|FG000|Overall Study|Problems with the Trugraf assay|1|||
163010803|NCT03810092|588741595|FG000|Overall Study|no ground support|17|||
163010804|NCT03810092|588741595|FG000|Overall Study|ADL not done at J0|16|||
163010805|NCT03810092|588741595|FG000|Overall Study|No hemoglobin measure at J5|27|||
163010806|NCT00235755|588741597|FG000|4-Week Titration Phase|Adverse Event|6|||
163010807|NCT00235755|588741598|FG001|4-Week Titration Phase|Adverse Event|14|||
163010808|NCT00235755|588741599|FG002|4-Week Titration Phase|Adverse Event|20|||
163010809|NCT00235755|588741597|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
163010810|NCT00235755|588741598|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
163010811|NCT00235755|588741599|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
163010812|NCT00235755|588741597|FG000|4-Week Titration Phase|Protocol Violation|2|||
163010813|NCT00235755|588741598|FG001|4-Week Titration Phase|Protocol Violation|2|||
163010814|NCT00235755|588741599|FG002|4-Week Titration Phase|Protocol Violation|1|||
163010815|NCT00235755|588741597|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
163010816|NCT00235755|588741598|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
163010817|NCT00235755|588741599|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
163010818|NCT00235755|588741597|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
163010819|NCT00235755|588741598|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
163010820|NCT00235755|588741599|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
163010821|NCT00235755|588741597|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
163010822|NCT00235755|588741598|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
163010823|NCT00235755|588741599|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
163010824|NCT00235755|588741597|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
163010825|NCT00235755|588741598|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
163010826|NCT00235755|588741599|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
163010827|NCT00235755|588741597|FG000|12-Week Maintenance Phase|Adverse Event|8|||
163010828|NCT00235755|588741598|FG001|12-Week Maintenance Phase|Adverse Event|12|||
163010829|NCT00235755|588741599|FG002|12-Week Maintenance Phase|Adverse Event|26|||
163010830|NCT00235755|588741597|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
163062213|NCT03074500|588935114|FG000|Overall Study|Lost to Follow-up|1|||
163062214|NCT03074500|588935115|FG001|Overall Study|Lost to Follow-up|0|||
163062215|NCT03074500|588935116|FG002|Overall Study|Lost to Follow-up|0|||
163062216|NCT03074500|588935114|FG000|Overall Study|Lack of Efficacy|0|||
163062217|NCT03074500|588935115|FG001|Overall Study|Lack of Efficacy|1|||
163062218|NCT03074500|588935116|FG002|Overall Study|Lack of Efficacy|0|||
163010831|NCT00235755|588741598|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
163010832|NCT00235755|588741599|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
163010833|NCT00235755|588741597|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
163010834|NCT00235755|588741598|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
163010835|NCT00235755|588741599|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
163010836|NCT00235755|588741597|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
163010837|NCT00235755|588741598|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
163010838|NCT00235755|588741599|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
163214498|NCT00642941|589499100|FG007|Overall Study|Study closed by Sponsor|0|||
163214499|NCT00642941|589499101|FG008|Overall Study|Study closed by Sponsor|0|||
163214500|NCT00642941|589499102|FG009|Overall Study|Study closed by Sponsor|0|||
163010839|NCT00235755|588741597|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
163010840|NCT00235755|588741598|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
163010841|NCT00235755|588741599|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
163010842|NCT00235755|588741597|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
163010843|NCT00235755|588741598|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
163214501|NCT00642941|589499103|FG010|Overall Study|Study closed by Sponsor|0|||
163214502|NCT00642941|589499104|FG011|Overall Study|Study closed by Sponsor|0|||
163214503|NCT00642941|589499093|FG000|Overall Study|Withdrawal by Subject|1|||
163214504|NCT00642941|589499094|FG001|Overall Study|Withdrawal by Subject|0|||
163214505|NCT00642941|589499095|FG002|Overall Study|Withdrawal by Subject|0|||
163214506|NCT00642941|589499096|FG003|Overall Study|Withdrawal by Subject|2|||
163214507|NCT00642941|589499097|FG004|Overall Study|Withdrawal by Subject|0|||
163214508|NCT00642941|589499098|FG005|Overall Study|Withdrawal by Subject|0|||
163214509|NCT00642941|589499099|FG006|Overall Study|Withdrawal by Subject|2|||
163214510|NCT00642941|589499100|FG007|Overall Study|Withdrawal by Subject|0|||
163214511|NCT00642941|589499101|FG008|Overall Study|Withdrawal by Subject|1|||
163214512|NCT00642941|589499102|FG009|Overall Study|Withdrawal by Subject|0|||
163214513|NCT00642941|589499103|FG010|Overall Study|Withdrawal by Subject|0|||
163214514|NCT00642941|589499104|FG011|Overall Study|Withdrawal by Subject|1|||
163214515|NCT00642941|589499093|FG000|Overall Study|Protocol Violation|0|||
163214516|NCT00642941|589499094|FG001|Overall Study|Protocol Violation|0|||
163214517|NCT00642941|589499095|FG002|Overall Study|Protocol Violation|0|||
163214518|NCT00642941|589499096|FG003|Overall Study|Protocol Violation|0|||
163214519|NCT00642941|589499097|FG004|Overall Study|Protocol Violation|0|||
163214520|NCT00642941|589499098|FG005|Overall Study|Protocol Violation|0|||
163214521|NCT00642941|589499099|FG006|Overall Study|Protocol Violation|1|||
163214522|NCT00642941|589499100|FG007|Overall Study|Protocol Violation|0|||
163214523|NCT00642941|589499101|FG008|Overall Study|Protocol Violation|0|||
163214524|NCT00642941|589499102|FG009|Overall Study|Protocol Violation|0|||
163214525|NCT00642941|589499103|FG010|Overall Study|Protocol Violation|0|||
163214526|NCT00642941|589499104|FG011|Overall Study|Protocol Violation|0|||
163214527|NCT00642941|589499093|FG000|Overall Study|Adverse Event|1|||
163214528|NCT00642941|589499094|FG001|Overall Study|Adverse Event|1|||
163214529|NCT00642941|589499095|FG002|Overall Study|Adverse Event|0|||
163214530|NCT00642941|589499096|FG003|Overall Study|Adverse Event|0|||
163214531|NCT00642941|589499097|FG004|Overall Study|Adverse Event|0|||
163214532|NCT00642941|589499098|FG005|Overall Study|Adverse Event|0|||
163214533|NCT00642941|589499099|FG006|Overall Study|Adverse Event|1|||
163214534|NCT00642941|589499100|FG007|Overall Study|Adverse Event|1|||
163214535|NCT00642941|589499101|FG008|Overall Study|Adverse Event|0|||
163214536|NCT00642941|589499102|FG009|Overall Study|Adverse Event|1|||
163214537|NCT00642941|589499103|FG010|Overall Study|Adverse Event|0|||
163214538|NCT00642941|589499104|FG011|Overall Study|Adverse Event|0|||
163214539|NCT00642941|589499093|FG000|Overall Study|Other|1|||
163214540|NCT00642941|589499094|FG001|Overall Study|Other|1|||
163214541|NCT00642941|589499095|FG002|Overall Study|Other|1|||
163214542|NCT00642941|589499096|FG003|Overall Study|Other|1|||
163214543|NCT00642941|589499097|FG004|Overall Study|Other|0|||
163214544|NCT00642941|589499098|FG005|Overall Study|Other|1|||
163214545|NCT00642941|589499099|FG006|Overall Study|Other|0|||
163214546|NCT00642941|589499100|FG007|Overall Study|Other|1|||
163214547|NCT00642941|589499101|FG008|Overall Study|Other|0|||
163214548|NCT00642941|589499102|FG009|Overall Study|Other|0|||
163214549|NCT00642941|589499103|FG010|Overall Study|Other|0|||
163214550|NCT00642941|589499104|FG011|Overall Study|Other|1|||
163214551|NCT00642941|589499093|FG000|Overall Study|Disease progression|60|||
163214552|NCT00642941|589499094|FG001|Overall Study|Disease progression|50|||
163214553|NCT00642941|589499095|FG002|Overall Study|Disease progression|5|||
163214554|NCT00642941|589499096|FG003|Overall Study|Disease progression|36|||
163010844|NCT00235755|588741599|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
163214555|NCT00642941|589499097|FG004|Overall Study|Disease progression|23|||
163214556|NCT00642941|589499098|FG005|Overall Study|Disease progression|39|||
163214557|NCT00642941|589499099|FG006|Overall Study|Disease progression|18|||
163214558|NCT00642941|589499100|FG007|Overall Study|Disease progression|12|||
163214559|NCT00642941|589499101|FG008|Overall Study|Disease progression|10|||
163214560|NCT00642941|589499102|FG009|Overall Study|Disease progression|7|||
163214561|NCT00642941|589499103|FG010|Overall Study|Disease progression|12|||
163214562|NCT00642941|589499104|FG011|Overall Study|Disease progression|7|||
163010845|NCT00806403|588741604|FG000|Overall Study|Death|4|||
163062219|NCT03074500|588935114|FG000|Overall Study|Adverse Event|0|||
163214563|NCT03051607|589499106|FG000|Overall Study|Adverse Event|66|||
163214564|NCT00894322|589499107|FG000|Overall Study|Withdrawal by Subject|1|||
163010846|NCT00806403|588741605|FG001|Overall Study|Death|3|||
163214565|NCT00894322|589499108|FG001|Overall Study|Withdrawal by Subject|0|||
163214566|NCT00894322|589499109|FG002|Overall Study|Withdrawal by Subject|0|||
163214567|NCT03338855|589499110|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
163010847|NCT01320293|588741606|FG000|Overall Study|Lack of Efficacy|1|||
163010848|NCT01320293|588741606|FG000|Overall Study|Adverse Event|1|||
163404540|NCT01500278|590191956|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
163404541|NCT01500278|590191955|FG000|Week 13 - Week 104|Protocol deviation|1|||
163404542|NCT01500278|590191956|FG001|Week 13 - Week 104|Protocol deviation|0|||
163010849|NCT01532934|588741609|FG000|Overall Study|Lost to Follow-up|11|||
163010850|NCT01532934|588741610|FG001|Overall Study|Lost to Follow-up|11|||
163010851|NCT01532934|588741609|FG000|Overall Study|In controlled environment|3|||
163010852|NCT01532934|588741610|FG001|Overall Study|In controlled environment|2|||
163010853|NCT00468819|588741612|FG000|Overall Study|Withdrawal by Subject|4|||
163062220|NCT03074500|588935115|FG001|Overall Study|Adverse Event|0|||
163062221|NCT03074500|588935116|FG002|Overall Study|Adverse Event|1|||
163062222|NCT00634504|588936830|FG000|Overall Study|Protocol Violation|1|||
163062223|NCT00634504|588936831|FG001|Overall Study|Protocol Violation|0|||
163062224|NCT00937950|588936832|FG000|Overall Study|Withdrawal by Subject|23|||
163062225|NCT00937950|588936832|FG000|Overall Study|Migrated/moved from study area|27|||
163404543|NCT01500278|590191955|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
163062226|NCT00937950|588936832|FG000|Overall Study|Lost to Follow-up|144|||
163404544|NCT01500278|590191956|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
163010854|NCT00468819|588741613|FG001|Overall Study|Withdrawal by Subject|0|||
163010855|NCT00468819|588741614|FG002|Overall Study|Withdrawal by Subject|1|||
163010856|NCT00468819|588741612|FG000|Overall Study|Lost to Follow-up|0|||
163010857|NCT00468819|588741613|FG001|Overall Study|Lost to Follow-up|0|||
163010858|NCT00468819|588741614|FG002|Overall Study|Lost to Follow-up|1|||
163062227|NCT00937950|588936832|FG000|Overall Study|Missing confirmed|4|||
163062228|NCT00937950|588936832|FG000|Overall Study|Other|18|||
163062229|NCT03483103|588936837|FG000|Pre-Treatment Phase|Other reasons|1|||
163062230|NCT03483103|588936837|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
163062231|NCT03483103|588936837|FG000|Pre-Treatment Phase|Disease-related complications|1|||
163062232|NCT03483103|588936837|FG000|Pre-Treatment Phase|Death|5|||
163062233|NCT03483103|588936837|FG000|Treatment Phase|Withdrawal by Subject|7|||
163062234|NCT03483103|588936837|FG000|Treatment Phase|Other reasons|1|||
163062235|NCT03483103|588936837|FG000|Treatment Phase|Death|23|||
163062236|NCT03483103|588936837|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
163062237|NCT03483103|588936837|FG000|Treatment Phase|Received nonconforming product|1|||
163062238|NCT02475213|588936838|FG000|Overall Study|Adverse Event|2|||
163062239|NCT02475213|588936839|FG001|Overall Study|Adverse Event|0|||
163062240|NCT02475213|588936840|FG002|Overall Study|Adverse Event|0|||
163062241|NCT02475213|588936841|FG003|Overall Study|Adverse Event|1|||
163062242|NCT02475213|588936842|FG004|Overall Study|Adverse Event|1|||
163062243|NCT02475213|588936843|FG005|Overall Study|Adverse Event|4|||
163062244|NCT02475213|588936844|FG006|Overall Study|Adverse Event|6|||
163062245|NCT02475213|588936845|FG007|Overall Study|Adverse Event|2|||
163062246|NCT02475213|588936838|FG000|Overall Study|Physician Decision|1|||
163062247|NCT02475213|588936839|FG001|Overall Study|Physician Decision|1|||
163062248|NCT02475213|588936840|FG002|Overall Study|Physician Decision|1|||
163062249|NCT02475213|588936841|FG003|Overall Study|Physician Decision|0|||
163062250|NCT02475213|588936842|FG004|Overall Study|Physician Decision|0|||
163062251|NCT02475213|588936843|FG005|Overall Study|Physician Decision|1|||
163062252|NCT02475213|588936844|FG006|Overall Study|Physician Decision|4|||
163062253|NCT02475213|588936845|FG007|Overall Study|Physician Decision|0|||
163062254|NCT02475213|588936838|FG000|Overall Study|Progressive Disease|3|||
163062255|NCT02475213|588936839|FG001|Overall Study|Progressive Disease|2|||
163062256|NCT02475213|588936840|FG002|Overall Study|Progressive Disease|2|||
163062257|NCT02475213|588936841|FG003|Overall Study|Progressive Disease|13|||
163062258|NCT02475213|588936842|FG004|Overall Study|Progressive Disease|15|||
163062259|NCT02475213|588936843|FG005|Overall Study|Progressive Disease|25|||
163062260|NCT02475213|588936844|FG006|Overall Study|Progressive Disease|30|||
163214568|NCT03338855|589499111|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
163214569|NCT03605303|589499119|FG000|Period 1|Study Terminated|2|||
163214570|NCT03605303|589499120|FG001|Period 1|Study Terminated|1|||
163214571|NCT00399360|589499121|FG000|Overall Study|Lost to Follow-up|2|||
163214572|NCT00399360|589499122|FG001|Overall Study|Lost to Follow-up|1|||
163214573|NCT00399360|589499123|FG002|Overall Study|Lost to Follow-up|2|||
163214574|NCT00399360|589499124|FG003|Overall Study|Lost to Follow-up|4|||
163214575|NCT00399360|589499121|FG000|Overall Study|Adverse Event|0|||
163214576|NCT00399360|589499122|FG001|Overall Study|Adverse Event|0|||
163214577|NCT00399360|589499123|FG002|Overall Study|Adverse Event|1|||
163214578|NCT00399360|589499124|FG003|Overall Study|Adverse Event|0|||
163214579|NCT00399360|589499121|FG000|Overall Study|Withdrawal by Subject|0|||
163214580|NCT00399360|589499122|FG001|Overall Study|Withdrawal by Subject|2|||
163214581|NCT00399360|589499123|FG002|Overall Study|Withdrawal by Subject|0|||
163214582|NCT00399360|589499124|FG003|Overall Study|Withdrawal by Subject|2|||
163214583|NCT02626520|589499126|FG000|Overall Study|Physician Decision|1|||
163214584|NCT02626520|589499127|FG001|Overall Study|Physician Decision|1|||
163214585|NCT02626520|589499126|FG000|Overall Study|Adverse Event|0|||
163214586|NCT02626520|589499127|FG001|Overall Study|Adverse Event|4|||
163404545|NCT01500278|590191955|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
163010859|NCT00468819|588741612|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
163010860|NCT00468819|588741613|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
163010861|NCT00468819|588741614|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
163010862|NCT03759392|588741617|FG000|Overall Study|Adverse Event|12|||
163010863|NCT03759392|588741618|FG001|Overall Study|Adverse Event|4|||
163010864|NCT03759392|588741617|FG000|Overall Study|Death|2|||
163010865|NCT03759392|588741618|FG001|Overall Study|Death|1|||
163010866|NCT03759392|588741617|FG000|Overall Study|Withdrawal by Subject|2|||
163010867|NCT03759392|588741618|FG001|Overall Study|Withdrawal by Subject|0|||
163010868|NCT03759392|588741617|FG000|Overall Study|Protocol Violation|2|||
163010869|NCT03759392|588741618|FG001|Overall Study|Protocol Violation|0|||
163010870|NCT03759392|588741617|FG000|Overall Study|Physician Decision|0|||
163010871|NCT03759392|588741618|FG001|Overall Study|Physician Decision|1|||
163010872|NCT03759392|588741617|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
163010873|NCT03759392|588741618|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
163010874|NCT03759392|588741617|FG000|Overall Study|No longer able to take medicines|1|||
163010875|NCT03759392|588741618|FG001|Overall Study|No longer able to take medicines|0|||
163010876|NCT03759392|588741617|FG000|Overall Study|Stopped taking study drug|1|||
163010877|NCT03759392|588741618|FG001|Overall Study|Stopped taking study drug|0|||
163010878|NCT01288079|588741619|FG000|Overall Study|Withdrawal by Subject|2|||
163010879|NCT01288079|588741620|FG001|Overall Study|Withdrawal by Subject|4|||
163010880|NCT01288079|588741621|FG002|Overall Study|Withdrawal by Subject|1|||
163010881|NCT01288079|588741622|FG003|Overall Study|Withdrawal by Subject|0|||
163010882|NCT01288079|588741619|FG000|Overall Study|Adverse Event|2|||
163010883|NCT01288079|588741620|FG001|Overall Study|Adverse Event|1|||
163010884|NCT01288079|588741621|FG002|Overall Study|Adverse Event|2|||
163010885|NCT01288079|588741622|FG003|Overall Study|Adverse Event|3|||
163010886|NCT01288079|588741619|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
163010887|NCT01288079|588741620|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
163010888|NCT01288079|588741621|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
163010889|NCT01288079|588741622|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
163010890|NCT01288079|588741619|FG000|Overall Study|Condition under Investigation Worsened|0|||
163010891|NCT01288079|588741620|FG001|Overall Study|Condition under Investigation Worsened|0|||
163010892|NCT01288079|588741621|FG002|Overall Study|Condition under Investigation Worsened|0|||
163010893|NCT01288079|588741622|FG003|Overall Study|Condition under Investigation Worsened|1|||
163010894|NCT01288079|588741619|FG000|Overall Study|Lack of Efficacy|2|||
163010895|NCT01288079|588741620|FG001|Overall Study|Lack of Efficacy|2|||
163010896|NCT01288079|588741621|FG002|Overall Study|Lack of Efficacy|0|||
163010897|NCT01288079|588741622|FG003|Overall Study|Lack of Efficacy|2|||
163010898|NCT01288079|588741619|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
163010899|NCT01288079|588741620|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
163010900|NCT01288079|588741621|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
163010901|NCT01288079|588741622|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
163010902|NCT01288079|588741619|FG000|Overall Study|Lost to Follow-up|1|||
163010903|NCT01288079|588741620|FG001|Overall Study|Lost to Follow-up|1|||
163010904|NCT01288079|588741621|FG002|Overall Study|Lost to Follow-up|1|||
163010905|NCT01288079|588741622|FG003|Overall Study|Lost to Follow-up|0|||
163010906|NCT01288079|588741619|FG000|Overall Study|Other or Study Termination|11|||
163010907|NCT01288079|588741620|FG001|Overall Study|Other or Study Termination|15|||
163010908|NCT01288079|588741621|FG002|Overall Study|Other or Study Termination|14|||
163010909|NCT01288079|588741622|FG003|Overall Study|Other or Study Termination|8|||
163010910|NCT03170544|588741623|FG000|Part 1|Lost to Follow-up|1|||
163010911|NCT03170544|588741624|FG001|Part 1|Lost to Follow-up|0|||
163010912|NCT03170544|588741625|FG002|Part 1|Lost to Follow-up|0|||
163010913|NCT03170544|588741626|FG003|Part 1|Lost to Follow-up|0|||
163010914|NCT03170544|588741627|FG004|Part 1|Lost to Follow-up|0|||
163010915|NCT03170544|588741628|FG005|Part 1|Lost to Follow-up|0|||
163010916|NCT03170544|588741629|FG006|Part 1|Lost to Follow-up|0|||
163062261|NCT02475213|588936845|FG007|Overall Study|Progressive Disease|10|||
163010917|NCT03170544|588741630|FG007|Part 1|Lost to Follow-up|0|||
163062262|NCT02475213|588936838|FG000|Overall Study|Death|0|||
163062263|NCT02475213|588936839|FG001|Overall Study|Death|0|||
163062264|NCT02475213|588936840|FG002|Overall Study|Death|0|||
163010918|NCT03170544|588741631|FG008|Part 1|Lost to Follow-up|0|||
163010919|NCT03170544|588741632|FG009|Part 1|Lost to Follow-up|0|||
163010920|NCT03170544|588741633|FG010|Part 1|Lost to Follow-up|0|||
163010921|NCT03170544|588741634|FG011|Part 1|Lost to Follow-up|0|||
163010922|NCT03170544|588741623|FG000|Part 1|Not treated|0|||
163010923|NCT03170544|588741624|FG001|Part 1|Not treated|0|||
163010924|NCT03170544|588741625|FG002|Part 1|Not treated|0|||
163010925|NCT03170544|588741626|FG003|Part 1|Not treated|1|||
163010926|NCT03170544|588741627|FG004|Part 1|Not treated|0|||
163010927|NCT03170544|588741628|FG005|Part 1|Not treated|0|||
163010928|NCT03170544|588741629|FG006|Part 1|Not treated|0|||
163062265|NCT02475213|588936841|FG003|Overall Study|Death|0|||
163010929|NCT03170544|588741630|FG007|Part 1|Not treated|0|||
163010930|NCT03170544|588741631|FG008|Part 1|Not treated|0|||
163010931|NCT03170544|588741632|FG009|Part 1|Not treated|0|||
163010932|NCT03170544|588741633|FG010|Part 1|Not treated|0|||
163010933|NCT03170544|588741634|FG011|Part 1|Not treated|0|||
163010934|NCT02387840|588741635|FG000|Overall Study|Death|0|||
163010935|NCT02387840|588741636|FG001|Overall Study|Death|0|||
163010936|NCT02387840|588741637|FG002|Overall Study|Death|0|||
163010937|NCT02387840|588741638|FG003|Overall Study|Death|0|||
163010938|NCT02387840|588741639|FG004|Overall Study|Death|0|||
163214587|NCT02626520|589499126|FG000|Overall Study|Lack of Efficacy|0|||
163214588|NCT02626520|589499127|FG001|Overall Study|Lack of Efficacy|2|||
163214589|NCT02626520|589499126|FG000|Overall Study|Did not start protocol therapy|0|||
163214590|NCT02626520|589499127|FG001|Overall Study|Did not start protocol therapy|2|||
163214591|NCT02626520|589499126|FG000|Overall Study|Study terminated|0|||
163214592|NCT02626520|589499127|FG001|Overall Study|Study terminated|1|||
163214593|NCT02472795|589499130|FG000|Overall Study|Adverse Event|0|||
163214594|NCT02472795|589499131|FG001|Overall Study|Adverse Event|1|||
163214595|NCT02472795|589499132|FG002|Overall Study|Adverse Event|0|||
163214596|NCT02472795|589499133|FG003|Overall Study|Adverse Event|0|||
163214597|NCT02472795|589499134|FG004|Overall Study|Adverse Event|2|||
163214598|NCT02472795|589499130|FG000|Overall Study|Withdrawal by Subject|0|||
163214599|NCT02472795|589499131|FG001|Overall Study|Withdrawal by Subject|0|||
163214600|NCT02472795|589499132|FG002|Overall Study|Withdrawal by Subject|0|||
163214601|NCT02472795|589499133|FG003|Overall Study|Withdrawal by Subject|0|||
163214602|NCT02472795|589499134|FG004|Overall Study|Withdrawal by Subject|1|||
163214603|NCT04318080|589501009|FG000|Overall Study|Study closed by sponsor|10|||
163214604|NCT04318080|589501010|FG001|Overall Study|Study closed by sponsor|22|||
163214605|NCT04318080|589501009|FG000|Overall Study|Death|3|||
163214606|NCT04318080|589501010|FG001|Overall Study|Death|9|||
163214607|NCT04318080|589501009|FG000|Overall Study|Withdrawal by Subject|1|||
163214608|NCT04318080|589501010|FG001|Overall Study|Withdrawal by Subject|0|||
163214609|NCT04318080|589501009|FG000|Overall Study|Protocol Deviation|1|||
163214610|NCT04318080|589501010|FG001|Overall Study|Protocol Deviation|0|||
163214611|NCT06308822|589501011|FG000|Overall Study|Mutation Status Not Confirmed|17|||
163214612|NCT06308822|589501011|FG000|Overall Study|Adverse Event|1|||
163214613|NCT06308822|589501011|FG000|Overall Study|Death|5|||
163214614|NCT06308822|589501011|FG000|Overall Study|Disease progression|8|||
163214615|NCT06308822|589501011|FG000|Overall Study|Withdrawal by Subject|1|||
163214616|NCT06308822|589501011|FG000|Overall Study|Physician Decision|3|||
163214617|NCT01536379|589501012|FG000|Overall Study|Adverse Event|1|||
163214618|NCT01536379|589501013|FG001|Overall Study|Adverse Event|2|||
163214619|NCT01536379|589501012|FG000|Overall Study|Withdrawal by Subject|1|||
163214620|NCT01536379|589501013|FG001|Overall Study|Withdrawal by Subject|1|||
163214621|NCT04734652|589501022|FG000|Overall Study|Withdrawal by Subject|2|||
163214622|NCT04734652|589501023|FG001|Overall Study|Withdrawal by Subject|0|||
163214623|NCT04734652|589501022|FG000|Overall Study|Death|0|||
163214624|NCT04734652|589501023|FG001|Overall Study|Death|1|||
163214625|NCT04729127|589501025|FG000|Overall Study|Suspended/Terminated EI Services|4|||
163214626|NCT04729127|589501026|FG001|Overall Study|Suspended/Terminated EI Services|0|||
163214627|NCT04729127|589501027|FG002|Overall Study|Suspended/Terminated EI Services|4|||
163214628|NCT04729127|589501028|FG003|Overall Study|Suspended/Terminated EI Services|6|||
163214629|NCT04729127|589501029|FG004|Overall Study|Suspended/Terminated EI Services|0|||
163214630|NCT04729127|589501030|FG005|Overall Study|Suspended/Terminated EI Services|6|||
163214631|NCT04729127|589501031|FG006|Overall Study|Suspended/Terminated EI Services|2|||
163214632|NCT04729127|589501032|FG007|Overall Study|Suspended/Terminated EI Services|0|||
163404546|NCT01500278|590191956|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
163010939|NCT02387840|588741640|FG005|Overall Study|Death|1|||
163010940|NCT01213966|588741641|FG000|Overall Study|Protocol Violation|1|||
163010941|NCT01213966|588741642|FG001|Overall Study|Protocol Violation|0|||
163010942|NCT01213966|588741643|FG002|Overall Study|Protocol Violation|3|||
163010943|NCT01213966|588741644|FG003|Overall Study|Protocol Violation|1|||
163010944|NCT00420420|588741659|FG000|Overall Study|Adverse Event|5|||
163010945|NCT00420420|588741660|FG001|Overall Study|Adverse Event|3|||
163010946|NCT00420420|588741659|FG000|Overall Study|Protocol Violation|1|||
163010947|NCT00420420|588741660|FG001|Overall Study|Protocol Violation|1|||
163010948|NCT00420420|588741659|FG000|Overall Study|Withdrawal by Subject|1|||
163010949|NCT00420420|588741660|FG001|Overall Study|Withdrawal by Subject|0|||
163010950|NCT00420420|588741659|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
163010951|NCT00420420|588741660|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
163214633|NCT04729127|589501033|FG008|Overall Study|Suspended/Terminated EI Services|2|||
163404547|NCT01500278|590191955|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
163010952|NCT00273182|588741661|FG000|Overall Study|Death|450|||
163010953|NCT00273182|588741661|FG000|Overall Study|Lost to Follow-up|88|||
163010954|NCT00273182|588741661|FG000|Overall Study|Withdrawal by Subject|257|||
163010955|NCT00273182|588741661|FG000|Overall Study|Device/System Explant|154|||
163062266|NCT02475213|588936842|FG004|Overall Study|Death|0|||
163214634|NCT04729127|589501025|FG000|Overall Study|Withdrawal by Subject|1|||
163214635|NCT04729127|589501026|FG001|Overall Study|Withdrawal by Subject|0|||
163214636|NCT04729127|589501027|FG002|Overall Study|Withdrawal by Subject|1|||
163404548|NCT01500278|590191956|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
163010956|NCT00273182|588741661|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
163010957|NCT04762160|588741662|FG000|Overall Study|Study terminated early due to business reasons|5|||
163010958|NCT00536939|588743696|FG000|Overall Study|Withdrawal by Subject|1|||
163010959|NCT00536939|588743697|FG001|Overall Study|Withdrawal by Subject|0|||
163010960|NCT00536939|588743696|FG000|Overall Study|Other Complicating Disease|1|||
163010961|NCT00536939|588743697|FG001|Overall Study|Other Complicating Disease|0|||
163010962|NCT01100086|588743698|FG000|Period 1|Withdrawal by Subject|1|||
163010963|NCT01100086|588743699|FG001|Period 1|Withdrawal by Subject|0|||
163010964|NCT01611935|588743702|FG000|Overall Study|Family Declined Participation|1|||
163010965|NCT01611935|588743703|FG001|Overall Study|Family Declined Participation|0|||
163010966|NCT04227197|588743704|FG000|Randomization|Protocol Violation|1|||
163010967|NCT04227197|588743705|FG001|Randomization|Protocol Violation|0|||
163010968|NCT04227197|588743704|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
163010969|NCT04227197|588743705|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
163010970|NCT04227197|588743704|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
163010971|NCT04227197|588743705|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
163010972|NCT04227197|588743704|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
163010973|NCT04227197|588743705|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
163010974|NCT04227197|588743704|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
163010975|NCT04227197|588743705|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
163010976|NCT04227197|588743704|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
163010977|NCT04227197|588743705|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
163010978|NCT04227197|588743704|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
163010979|NCT04227197|588743705|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
163010980|NCT02549859|588743710|FG000|Long-term 60 Hz DBS|Study Closed|1|||
163010981|NCT01209949|588743718|FG000|Overall Study|Lost to Follow-up|3|||
163010982|NCT00729612|588743719|FG000|Overall Study|Non evaluable for response|10|||
163010983|NCT00708552|588743720|FG000|Overall Study|Adverse Event|10|||
163010984|NCT00708552|588743721|FG001|Overall Study|Adverse Event|3|||
163062267|NCT02475213|588936843|FG005|Overall Study|Death|4|||
163062268|NCT02475213|588936844|FG006|Overall Study|Death|1|||
163062269|NCT02475213|588936845|FG007|Overall Study|Death|0|||
163062270|NCT02475213|588936838|FG000|Overall Study|Protocol Violation|0|||
163062271|NCT02475213|588936839|FG001|Overall Study|Protocol Violation|0|||
163062272|NCT02475213|588936840|FG002|Overall Study|Protocol Violation|0|||
163062273|NCT02475213|588936841|FG003|Overall Study|Protocol Violation|0|||
163062274|NCT02475213|588936842|FG004|Overall Study|Protocol Violation|1|||
163062275|NCT02475213|588936843|FG005|Overall Study|Protocol Violation|0|||
163062276|NCT02475213|588936844|FG006|Overall Study|Protocol Violation|0|||
163062277|NCT02475213|588936845|FG007|Overall Study|Protocol Violation|0|||
163062278|NCT02475213|588936838|FG000|Overall Study|Withdrawal by Subject|0|||
163062279|NCT02475213|588936839|FG001|Overall Study|Withdrawal by Subject|0|||
163062280|NCT02475213|588936840|FG002|Overall Study|Withdrawal by Subject|0|||
163062281|NCT02475213|588936841|FG003|Overall Study|Withdrawal by Subject|1|||
163062282|NCT02475213|588936842|FG004|Overall Study|Withdrawal by Subject|0|||
163062283|NCT02475213|588936843|FG005|Overall Study|Withdrawal by Subject|2|||
163062284|NCT02475213|588936844|FG006|Overall Study|Withdrawal by Subject|2|||
163062285|NCT02475213|588936845|FG007|Overall Study|Withdrawal by Subject|0|||
163062286|NCT02475213|588936838|FG000|Overall Study|Other|0|||
163062287|NCT02475213|588936839|FG001|Overall Study|Other|0|||
163062288|NCT02475213|588936840|FG002|Overall Study|Other|0|||
163062289|NCT02475213|588936841|FG003|Overall Study|Other|1|||
163062290|NCT02475213|588936842|FG004|Overall Study|Other|3|||
163062291|NCT02475213|588936843|FG005|Overall Study|Other|1|||
163062292|NCT02475213|588936844|FG006|Overall Study|Other|0|||
163062293|NCT02475213|588936845|FG007|Overall Study|Other|0|||
163062294|NCT00505921|588936846|FG000|Overall Study|Ineligible|1|||
163062295|NCT00505921|588936846|FG000|Overall Study|Failed to Mobilize|8|||
163214637|NCT04729127|589501028|FG003|Overall Study|Withdrawal by Subject|0|||
163214638|NCT04729127|589501029|FG004|Overall Study|Withdrawal by Subject|0|||
163062296|NCT00630292|588936847|FG000|Overall Study|Withdrawal by Subject|1|||
163062297|NCT00717886|588936849|FG000|Overall Study|Withdrawal by Subject|3|||
163214639|NCT04729127|589501030|FG005|Overall Study|Withdrawal by Subject|0|||
163010985|NCT00708552|588743722|FG002|Overall Study|Adverse Event|4|||
163010986|NCT00708552|588743723|FG003|Overall Study|Adverse Event|6|||
163214640|NCT04729127|589501031|FG006|Overall Study|Withdrawal by Subject|0|||
163010987|NCT00708552|588743720|FG000|Overall Study|Lack of Efficacy|0|||
163010988|NCT00708552|588743721|FG001|Overall Study|Lack of Efficacy|4|||
163010989|NCT00708552|588743722|FG002|Overall Study|Lack of Efficacy|1|||
163010990|NCT00708552|588743723|FG003|Overall Study|Lack of Efficacy|0|||
163010991|NCT00708552|588743720|FG000|Overall Study|Protocol Violation|0|||
163062298|NCT00717886|588936849|FG000|Overall Study|Treatment Failure|1|||
163062299|NCT01553851|588936850|FG000|Overall Study|Adverse Event|2|||
163062300|NCT01553851|588936850|FG000|Overall Study|constipation|1|||
163062301|NCT00797563|588936851|FG000|Overall Study|Adverse Event|1|||
163214641|NCT04729127|589501032|FG007|Overall Study|Withdrawal by Subject|0|||
163214642|NCT04729127|589501033|FG008|Overall Study|Withdrawal by Subject|0|||
163214643|NCT04729127|589501025|FG000|Overall Study|Switched Agency/Setting|1|||
163214644|NCT04729127|589501026|FG001|Overall Study|Switched Agency/Setting|0|||
163214645|NCT04729127|589501027|FG002|Overall Study|Switched Agency/Setting|1|||
163214646|NCT04729127|589501028|FG003|Overall Study|Switched Agency/Setting|1|||
163214647|NCT04729127|589501029|FG004|Overall Study|Switched Agency/Setting|0|||
163214648|NCT04729127|589501030|FG005|Overall Study|Switched Agency/Setting|1|||
163214649|NCT04729127|589501031|FG006|Overall Study|Switched Agency/Setting|1|||
163214650|NCT04729127|589501032|FG007|Overall Study|Switched Agency/Setting|0|||
163214651|NCT04729127|589501033|FG008|Overall Study|Switched Agency/Setting|1|||
163214652|NCT03662542|589501036|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
163214653|NCT03662542|589501037|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
163214654|NCT03662542|589501038|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
163214655|NCT03662542|589501039|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
163214656|NCT03662542|589501040|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
163214657|NCT03662542|589501041|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
163214658|NCT03662542|589501042|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
163214659|NCT03662542|589501043|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
163214660|NCT03662542|589501044|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
163214661|NCT03662542|589501036|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
163214662|NCT03662542|589501037|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
163214663|NCT03662542|589501038|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
163214664|NCT03662542|589501039|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
163214665|NCT03662542|589501040|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
163214666|NCT03662542|589501041|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
163214667|NCT03662542|589501042|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
163214668|NCT03662542|589501043|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
163214669|NCT03662542|589501044|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
163214670|NCT03662542|589501036|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
163214671|NCT03662542|589501037|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
163214672|NCT03662542|589501038|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
163214673|NCT03662542|589501039|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
163214674|NCT03662542|589501040|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
163214675|NCT03662542|589501041|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
163214676|NCT03662542|589501042|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
163214677|NCT03662542|589501043|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
163214678|NCT03662542|589501044|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
163214679|NCT03662542|589501036|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
163214680|NCT03662542|589501037|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
163214681|NCT03662542|589501038|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
163214682|NCT03662542|589501039|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
163214683|NCT03662542|589501040|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
163214684|NCT03662542|589501041|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
163214685|NCT03662542|589501042|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
163214686|NCT03662542|589501043|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
163214687|NCT03662542|589501044|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
163214688|NCT03662542|589501036|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
163214689|NCT03662542|589501037|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
163214690|NCT03662542|589501038|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
163214691|NCT03662542|589501039|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
163214692|NCT03662542|589501040|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
163214693|NCT03662542|589501041|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
163214694|NCT03662542|589501042|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
163214695|NCT03662542|589501043|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
163214696|NCT03662542|589501044|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
163214697|NCT03662542|589501036|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
163328321|NCT03801148|589913201|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
163328322|NCT03801148|589913202|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
163214698|NCT03662542|589501037|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
163214699|NCT03662542|589501038|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
163328323|NCT03801148|589913203|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
163328324|NCT03801148|589913204|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
163328325|NCT03801148|589913201|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
163328326|NCT03801148|589913202|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
163328327|NCT03801148|589913203|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
163328328|NCT03801148|589913204|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
163328329|NCT06212752|589913205|FG000|Overall Study|Death|5|||
163328330|NCT06212752|589913206|FG001|Overall Study|Death|3|||
163328331|NCT06212752|589913205|FG000|Overall Study|Participants ongoing|23|||
163328332|NCT06212752|589913206|FG001|Overall Study|Participants ongoing|8|||
163214700|NCT03662542|589501039|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
163214701|NCT03662542|589501040|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
163214702|NCT03662542|589501041|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
163214703|NCT03662542|589501042|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
163214704|NCT03662542|589501043|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
163214705|NCT03662542|589501044|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
163214706|NCT03662542|589501036|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
163214707|NCT03662542|589501037|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
163214708|NCT03662542|589501038|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
163214709|NCT03662542|589501039|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
163214710|NCT03662542|589501040|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
163214711|NCT03662542|589501041|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
163214712|NCT03662542|589501042|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
163214713|NCT03662542|589501043|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
163214714|NCT03662542|589501044|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
163214715|NCT03662542|589501036|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
163214716|NCT03662542|589501037|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
163214717|NCT03662542|589501038|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
163214718|NCT03662542|589501039|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
163214719|NCT03662542|589501040|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
163214720|NCT03662542|589501041|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
163214721|NCT03662542|589501042|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
163214722|NCT03662542|589501043|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
163214723|NCT03662542|589501044|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
163214724|NCT03662542|589501036|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
163214725|NCT03662542|589501037|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
163214726|NCT03662542|589501038|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
163214727|NCT03662542|589501039|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
163214728|NCT03662542|589501040|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
163214729|NCT03662542|589501041|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
163214730|NCT03662542|589501042|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
163214731|NCT03662542|589501043|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
163214732|NCT03662542|589501044|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
163214733|NCT03662542|589501036|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
163214734|NCT03662542|589501037|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
163214735|NCT03662542|589501038|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
163214736|NCT03662542|589501039|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
163214737|NCT03662542|589501040|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
163214738|NCT03662542|589501041|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
163214739|NCT03662542|589501042|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
163214740|NCT03662542|589501043|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
163214741|NCT03662542|589501044|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
163214742|NCT03662542|589501036|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
163214743|NCT03662542|589501037|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
163214744|NCT03662542|589501038|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
163214745|NCT03662542|589501039|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
163214746|NCT03662542|589501040|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
163214747|NCT03662542|589501041|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
163214748|NCT03662542|589501042|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
163214749|NCT03662542|589501043|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
163214750|NCT03662542|589501044|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
163214751|NCT03662542|589501036|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
163214752|NCT03662542|589501037|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
163214753|NCT03662542|589501038|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
163214754|NCT03662542|589501039|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
163214755|NCT03662542|589501040|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
163214756|NCT03662542|589501041|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
163214757|NCT03662542|589501042|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
163214758|NCT03662542|589501043|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
163214759|NCT03662542|589501044|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
163214760|NCT03662542|589501036|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
163214761|NCT03662542|589501037|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
163214762|NCT03662542|589501038|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
163214763|NCT03662542|589501039|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
163214764|NCT03662542|589501040|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
163214765|NCT03662542|589501041|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
163328333|NCT04162210|589913207|FG000|Overall Study|Lost to Follow-up|4|||
163010992|NCT00708552|588743721|FG001|Overall Study|Protocol Violation|0|||
163010993|NCT00708552|588743722|FG002|Overall Study|Protocol Violation|2|||
163010994|NCT00708552|588743723|FG003|Overall Study|Protocol Violation|4|||
163010995|NCT00708552|588743720|FG000|Overall Study|Lost to Follow-up|4|||
163010996|NCT00708552|588743721|FG001|Overall Study|Lost to Follow-up|2|||
163010997|NCT00708552|588743722|FG002|Overall Study|Lost to Follow-up|0|||
163010998|NCT00708552|588743723|FG003|Overall Study|Lost to Follow-up|1|||
163010999|NCT00708552|588743720|FG000|Overall Study|Physician Decision|1|||
163011000|NCT00708552|588743721|FG001|Overall Study|Physician Decision|2|||
163011001|NCT00708552|588743722|FG002|Overall Study|Physician Decision|0|||
163011002|NCT00708552|588743723|FG003|Overall Study|Physician Decision|0|||
163011003|NCT00708552|588743720|FG000|Overall Study|Withdrawal by Subject|12|||
163011004|NCT00708552|588743721|FG001|Overall Study|Withdrawal by Subject|7|||
163011005|NCT00708552|588743722|FG002|Overall Study|Withdrawal by Subject|8|||
163011006|NCT00708552|588743723|FG003|Overall Study|Withdrawal by Subject|10|||
163011007|NCT02309411|588743724|FG000|Overall Study|Physician Decision|1|||
163011008|NCT02309411|588743725|FG001|Overall Study|Physician Decision|0|||
163011009|NCT02309411|588743726|FG002|Overall Study|Physician Decision|0|||
163062302|NCT03822416|588936857|FG000|Overall Study|Lost to Follow-up|1|||
163062303|NCT03822416|588936858|FG001|Overall Study|Lost to Follow-up|0|||
163062304|NCT03822416|588936857|FG000|Overall Study|Withdrawal by Subject|0|||
163062305|NCT03822416|588936858|FG001|Overall Study|Withdrawal by Subject|1|||
163062306|NCT04666298|588936859|FG000|Overall Study|Subject decision|1|||
163062307|NCT04666298|588936860|FG001|Overall Study|Subject decision|0|||
163062308|NCT04666298|588936861|FG002|Overall Study|Subject decision|0|||
163062309|NCT04666298|588936862|FG003|Overall Study|Subject decision|2|||
163062310|NCT04666298|588936859|FG000|Overall Study|Death|1|||
163062311|NCT04666298|588936860|FG001|Overall Study|Death|0|||
163062312|NCT04666298|588936861|FG002|Overall Study|Death|0|||
163062313|NCT04666298|588936862|FG003|Overall Study|Death|0|||
163062314|NCT04666298|588936859|FG000|Overall Study|Lost to Follow-up|0|||
163062315|NCT04666298|588936860|FG001|Overall Study|Lost to Follow-up|0|||
163062316|NCT04666298|588936861|FG002|Overall Study|Lost to Follow-up|0|||
163062317|NCT04666298|588936862|FG003|Overall Study|Lost to Follow-up|1|||
163062318|NCT04666298|588936859|FG000|Overall Study|Physician Decision|0|||
163062319|NCT04666298|588936860|FG001|Overall Study|Physician Decision|0|||
163062320|NCT04666298|588936861|FG002|Overall Study|Physician Decision|0|||
163062321|NCT04666298|588936862|FG003|Overall Study|Physician Decision|1|||
163062322|NCT04666298|588936859|FG000|Overall Study|Protocol deviation|0|||
163062323|NCT04666298|588936860|FG001|Overall Study|Protocol deviation|0|||
163062324|NCT04666298|588936861|FG002|Overall Study|Protocol deviation|1|||
163062325|NCT04666298|588936862|FG003|Overall Study|Protocol deviation|0|||
163062326|NCT00844519|588936863|FG000|Overall Study|Withdrawal by Subject|1|||
163062327|NCT00844519|588936864|FG001|Overall Study|Withdrawal by Subject|1|||
163062328|NCT00844519|588936863|FG000|Overall Study|Adverse Event|1|||
163062329|NCT00844519|588936864|FG001|Overall Study|Adverse Event|0|||
163062330|NCT01303419|588936865|FG000|Overall Study|Discontinuation of study|60|||
163062331|NCT01303419|588936865|FG000|Overall Study|Did not complete both imaging methods|5|||
163062332|NCT01303419|588936865|FG000|Overall Study|Did not meet all I/E after screening|31|||
163062333|NCT06438601|588936866|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
163062334|NCT06438601|588936867|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
163062335|NCT06438601|588936866|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
163062336|NCT06438601|588936867|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
163062337|NCT03329001|588936868|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
163062338|NCT03329001|588936869|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
163062339|NCT03329001|588936870|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
163062340|NCT03329001|588936871|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
163062341|NCT03329001|588936872|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
163062342|NCT03329001|588936873|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
163062343|NCT03329001|588936874|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
163062344|NCT03329001|588936875|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
163011010|NCT02309411|588743724|FG000|Overall Study|Withdrawal by Subject|1|||
163011011|NCT02309411|588743725|FG001|Overall Study|Withdrawal by Subject|1|||
163062345|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
163062346|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
163062347|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
163062348|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
163062349|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
163062350|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
163011012|NCT02309411|588743726|FG002|Overall Study|Withdrawal by Subject|0|||
163011013|NCT04878432|588743728|FG000|Overall Study|Adverse Event|1|||
163011014|NCT04878432|588743728|FG000|Overall Study|Death|2|||
163062351|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
163062352|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
163062353|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
163328334|NCT04162210|589913208|FG001|Overall Study|Lost to Follow-up|1|||
163404549|NCT01500278|590191955|FG000|Week 13 - Week 104|Relocation|0|||
163404550|NCT01500278|590191956|FG001|Week 13 - Week 104|Relocation|1|||
163011015|NCT04878432|588743728|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
163011016|NCT04878432|588743728|FG000|Overall Study|Withdrawal by Subject|6|||
163011017|NCT04878432|588743728|FG000|Overall Study|Progressive Disease|7|||
163011018|NCT04878432|588743728|FG000|Overall Study|New Therapy for Study Indication|7|||
163011019|NCT04878432|588743728|FG000|Overall Study|Physician Decision|11|||
163011020|NCT03971071|588743729|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
163011021|NCT03971071|588743730|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
163011022|NCT03971071|588743731|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
163011023|NCT03971071|588743732|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
163011024|NCT03971071|588743733|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
163011025|NCT03971071|588743729|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
163062354|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
163062355|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
163062356|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
163062357|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
163062358|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
163062359|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
163062360|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
163062361|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
163062362|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
163062363|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
163062364|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
163062365|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
163062366|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
163062367|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
163062368|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
163062369|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
163062370|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
163011026|NCT03971071|588743730|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
163011027|NCT03971071|588743731|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
163011028|NCT03971071|588743732|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
163062371|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
163062372|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
163062373|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
163062374|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
163062375|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
163062376|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
163062377|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
163062378|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
163404551|NCT01500278|590191955|FG000|Week 13 - Week 104|Sponsor decision|0|||
163404552|NCT01500278|590191956|FG001|Week 13 - Week 104|Sponsor decision|2|||
163404553|NCT01500278|590191955|FG000|Week 13 - Week 104|Medical monitor decision|0|||
163404554|NCT01500278|590191956|FG001|Week 13 - Week 104|Medical monitor decision|2|||
163404555|NCT01500278|590191955|FG000|Week 13 - Week 104|Personal reason|0|||
163404556|NCT01500278|590191956|FG001|Week 13 - Week 104|Personal reason|1|||
163404557|NCT01500278|590191955|FG000|Week 13 - Week 104|Not completed|0|||
163404558|NCT01500278|590191956|FG001|Week 13 - Week 104|Not completed|1|||
163404559|NCT01500278|590191955|FG000|Week 13 - Week 104|Death|2|||
163404560|NCT01500278|590191956|FG001|Week 13 - Week 104|Death|4|||
163404561|NCT01500278|590191955|FG000|Week 13 - Week 104|Adverse Event|54|||
163404562|NCT01500278|590191956|FG001|Week 13 - Week 104|Adverse Event|54|||
163404563|NCT00414453|590191957|FG000|Overall Study|Abnormal lab work|16|||
163404564|NCT01157364|590191958|FG000|Overall Study|Other Reasons|1|||
163404565|NCT01157364|590191959|FG001|Overall Study|Other Reasons|1|||
163404566|NCT01157364|590191960|FG002|Overall Study|Other Reasons|2|||
163404567|NCT01157364|590191961|FG003|Overall Study|Other Reasons|1|||
163404568|NCT01157364|590191962|FG004|Overall Study|Other Reasons|0|||
163404569|NCT01157364|590191963|FG005|Overall Study|Other Reasons|0|||
163404570|NCT01157364|590191958|FG000|Overall Study|Personal Reasons|0|||
163404571|NCT01157364|590191959|FG001|Overall Study|Personal Reasons|2|||
163404572|NCT01157364|590191960|FG002|Overall Study|Personal Reasons|0|||
163404573|NCT01157364|590191961|FG003|Overall Study|Personal Reasons|0|||
163404574|NCT01157364|590191962|FG004|Overall Study|Personal Reasons|1|||
163011029|NCT03971071|588743733|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
163011030|NCT03971071|588743729|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
163011031|NCT03971071|588743730|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
163011032|NCT03971071|588743731|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
163011033|NCT03971071|588743732|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
163011034|NCT03971071|588743733|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
163011035|NCT03971071|588743729|FG000|Open-label Treatment Period|Sponsor decision|0|||
163011036|NCT03971071|588743730|FG001|Open-label Treatment Period|Sponsor decision|0|||
163011037|NCT03971071|588743731|FG002|Open-label Treatment Period|Sponsor decision|0|||
163011038|NCT03971071|588743732|FG003|Open-label Treatment Period|Sponsor decision|0|||
163011039|NCT03971071|588743733|FG004|Open-label Treatment Period|Sponsor decision|1|||
163011040|NCT03971071|588743729|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
163011041|NCT03971071|588743730|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
163011042|NCT03971071|588743731|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
163011043|NCT03971071|588743732|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
163011044|NCT03971071|588743733|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
163011045|NCT03971071|588743729|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
163011046|NCT03971071|588743730|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
163011047|NCT03971071|588743731|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
163011048|NCT03971071|588743732|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
163011049|NCT03971071|588743733|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
163011050|NCT00495391|588743734|FG000|Overall Study|Lack of Efficacy|34|||
163011051|NCT00495391|588743735|FG001|Overall Study|Lack of Efficacy|18|||
163011052|NCT00495391|588743734|FG000|Overall Study|Withdrawal by Subject|2|||
163011053|NCT00495391|588743735|FG001|Overall Study|Withdrawal by Subject|3|||
163011054|NCT03214224|588743736|FG000|Overall Study|Protocol Violation|1|||
163011055|NCT03214224|588743736|FG000|Overall Study|Withdrawal by Subject|2|||
163011056|NCT03214224|588743736|FG000|Overall Study|Practice controls or therapists|6|||
163011057|NCT02712320|588743745|FG000|Overall Study|Lost to Follow-up|1|||
163011058|NCT02712320|588743745|FG000|Overall Study|Withdrawal by Subject|1|||
163011059|NCT02712320|588743745|FG000|Overall Study|Transferred to another facility|1|||
163011060|NCT02712320|588743745|FG000|Overall Study|Treating with the prohibited medications|2|||
163011061|NCT00360282|588743746|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
163011062|NCT00360282|588743747|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
163011063|NCT00360282|588743748|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
163011064|NCT00360282|588743749|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
163011065|NCT00360282|588743746|FG000|Second Intervention|Adverse Event|0|||
163011066|NCT00360282|588743747|FG001|Second Intervention|Adverse Event|1|||
163011067|NCT00360282|588743748|FG002|Second Intervention|Adverse Event|0|||
163011068|NCT00360282|588743749|FG003|Second Intervention|Adverse Event|0|||
163011069|NCT04537078|588743750|FG000|Overall Study|Protocol Violation|3|||
163011070|NCT04537078|588743751|FG001|Overall Study|Protocol Violation|2|||
163011071|NCT04537078|588743750|FG000|Overall Study|Lost to Follow-up|1|||
163011072|NCT04537078|588743751|FG001|Overall Study|Lost to Follow-up|0|||
163011073|NCT04537078|588743750|FG000|Overall Study|Withdrawal by Subject|0|||
163011074|NCT04537078|588743751|FG001|Overall Study|Withdrawal by Subject|1|||
163011075|NCT03207815|588743752|FG000|Overall Study|Protocol Violation|3|||
163011076|NCT03207815|588743753|FG001|Overall Study|Protocol Violation|1|||
163011077|NCT03207815|588743752|FG000|Overall Study|Adverse Event|1|||
163011078|NCT03207815|588743753|FG001|Overall Study|Adverse Event|2|||
163011079|NCT03207815|588743752|FG000|Overall Study|Lost to Follow-up|1|||
163011080|NCT03207815|588743753|FG001|Overall Study|Lost to Follow-up|2|||
163011081|NCT03207815|588743752|FG000|Overall Study|Investigator's Discretion|1|||
163011082|NCT03207815|588743753|FG001|Overall Study|Investigator's Discretion|1|||
163011083|NCT03207815|588743752|FG000|Overall Study|Lack of Efficacy|0|||
163011084|NCT03207815|588743753|FG001|Overall Study|Lack of Efficacy|1|||
163011085|NCT03207815|588743752|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
163011086|NCT03207815|588743753|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
163011087|NCT03207815|588743752|FG000|Overall Study|Withdrew Consent|1|||
163011088|NCT03207815|588743753|FG001|Overall Study|Withdrew Consent|0|||
163011089|NCT00391768|588743754|FG000|Overall Study|Withdrawal by Subject|0|||
163011090|NCT00391768|588743755|FG001|Overall Study|Withdrawal by Subject|0|||
163011091|NCT00391768|588743756|FG002|Overall Study|Withdrawal by Subject|1|||
163011092|NCT00391768|588743757|FG003|Overall Study|Withdrawal by Subject|0|||
163011093|NCT00391768|588743758|FG004|Overall Study|Withdrawal by Subject|0|||
163011094|NCT00391768|588743759|FG005|Overall Study|Withdrawal by Subject|1|||
163011095|NCT00391768|588743760|FG006|Overall Study|Withdrawal by Subject|1|||
163011096|NCT00391768|588743754|FG000|Overall Study|Lost to Follow-up|0|||
163011097|NCT00391768|588743755|FG001|Overall Study|Lost to Follow-up|0|||
163154698|NCT01213472|589281382|FG000|Overall Study|Recurrence/Progressive disease|25|||
163328335|NCT04162210|589913207|FG000|Overall Study|Withdrawal by Subject|17|||
163011098|NCT00391768|588743756|FG002|Overall Study|Lost to Follow-up|0|||
163011099|NCT00391768|588743757|FG003|Overall Study|Lost to Follow-up|1|||
163011100|NCT00391768|588743758|FG004|Overall Study|Lost to Follow-up|2|||
163011101|NCT00391768|588743759|FG005|Overall Study|Lost to Follow-up|2|||
163328336|NCT04162210|589913208|FG001|Overall Study|Withdrawal by Subject|9|||
163328337|NCT04162210|589913207|FG000|Overall Study|Ongoing|113|||
163011102|NCT00391768|588743760|FG006|Overall Study|Lost to Follow-up|3|||
163011103|NCT01620138|588743761|FG000|Overall Study|Withdrawal by Subject|3|||
163011104|NCT01620138|588743762|FG001|Overall Study|Withdrawal by Subject|0|||
163011105|NCT01620138|588743761|FG000|Overall Study|Lack of Efficacy|1|||
163011106|NCT01620138|588743762|FG001|Overall Study|Lack of Efficacy|0|||
163011107|NCT01620138|588743761|FG000|Overall Study|Adverse Event|2|||
163011108|NCT01620138|588743762|FG001|Overall Study|Adverse Event|0|||
163011109|NCT00444535|588743765|FG000|Overall Study|Withdrawal by Subject|5|||
163011110|NCT00444535|588743765|FG000|Overall Study|Physician Decision|5|||
163011111|NCT00444535|588743765|FG000|Overall Study|progressive disease|1|||
163011112|NCT00444535|588743765|FG000|Overall Study|Adverse Event|2|||
163011113|NCT01568892|588743766|FG000|Open-label Phase|Adverse Event|2|||
163011114|NCT01568892|588743767|FG001|Open-label Phase|Adverse Event|0|||
163011115|NCT01568892|588743766|FG000|Open-label Phase|Lack of Efficacy|4|||
163011116|NCT01568892|588743767|FG001|Open-label Phase|Lack of Efficacy|2|||
163011117|NCT01568892|588743766|FG000|Open-label Phase|Lost to Follow-up|0|||
163011118|NCT01568892|588743767|FG001|Open-label Phase|Lost to Follow-up|1|||
163011119|NCT01697748|588743777|FG000|Overall Study|ineligible skin incision|1|||
163011120|NCT01697748|588743778|FG001|Overall Study|ineligible skin incision|2|||
163011121|NCT01697748|588743777|FG000|Overall Study|ineligible uterine incision|4|||
163011122|NCT01697748|588743778|FG001|Overall Study|ineligible uterine incision|1|||
163011123|NCT01697748|588743777|FG000|Overall Study|Lost to Follow-up|53|||
163011124|NCT01697748|588743778|FG001|Overall Study|Lost to Follow-up|65|||
163011125|NCT01704495|588743779|FG000|Subjects Randomized|Other Reason|3|||
163011126|NCT01704495|588743780|FG001|Subjects Randomized|Other Reason|2|||
163011127|NCT01704495|588743781|FG002|Subjects Randomized|Other Reason|3|||
163011128|NCT01704495|588743782|FG003|Subjects Randomized|Other Reason|2|||
163011129|NCT01704495|588743779|FG000|Subjects Randomized|Discontinuation criteria met|4|||
163011130|NCT01704495|588743780|FG001|Subjects Randomized|Discontinuation criteria met|2|||
163011131|NCT01704495|588743781|FG002|Subjects Randomized|Discontinuation criteria met|2|||
163011132|NCT01704495|588743782|FG003|Subjects Randomized|Discontinuation criteria met|0|||
163011133|NCT01704495|588743779|FG000|Subjects Randomized|Adverse Event|8|||
163011134|NCT01704495|588743780|FG001|Subjects Randomized|Adverse Event|2|||
163011135|NCT01704495|588743781|FG002|Subjects Randomized|Adverse Event|0|||
163011136|NCT01704495|588743782|FG003|Subjects Randomized|Adverse Event|7|||
163011137|NCT01704495|588743779|FG000|Subjects Randomized|Withdrawal by Subject|5|||
163011138|NCT01704495|588743780|FG001|Subjects Randomized|Withdrawal by Subject|5|||
163328338|NCT04162210|589913208|FG001|Overall Study|Ongoing|59|||
163328339|NCT02941549|589913209|FG000|Overall Study|Adverse Event|1|||
163328340|NCT02941549|589913210|FG001|Overall Study|Adverse Event|0|||
163328341|NCT02941549|589913211|FG002|Overall Study|Adverse Event|0|||
163011139|NCT01704495|588743781|FG002|Subjects Randomized|Withdrawal by Subject|5|||
163011140|NCT01704495|588743782|FG003|Subjects Randomized|Withdrawal by Subject|5|||
163011141|NCT01704495|588743779|FG000|Subjects Randomized|Protocol Violation|1|||
163011142|NCT01704495|588743780|FG001|Subjects Randomized|Protocol Violation|1|||
163011143|NCT01704495|588743781|FG002|Subjects Randomized|Protocol Violation|2|||
163011144|NCT01704495|588743782|FG003|Subjects Randomized|Protocol Violation|0|||
163011145|NCT01704495|588743779|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
163011146|NCT01704495|588743780|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
163011147|NCT01704495|588743781|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
163011148|NCT01704495|588743782|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
163011149|NCT01704495|588743779|FG000|Optional Safety Extension|Adverse Event|0|||
163011150|NCT01704495|588743780|FG001|Optional Safety Extension|Adverse Event|4|||
163011151|NCT01704495|588743781|FG002|Optional Safety Extension|Adverse Event|0|||
163011152|NCT01704495|588743782|FG003|Optional Safety Extension|Adverse Event|1|||
163011153|NCT01704495|588743779|FG000|Optional Safety Extension|Other reason|27|||
163011154|NCT01704495|588743780|FG001|Optional Safety Extension|Other reason|29|||
163011155|NCT01704495|588743781|FG002|Optional Safety Extension|Other reason|30|||
163011156|NCT01704495|588743782|FG003|Optional Safety Extension|Other reason|28|||
163011157|NCT01704495|588743779|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
163011158|NCT01704495|588743780|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
163011159|NCT01704495|588743781|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
163011160|NCT01704495|588743782|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
163011161|NCT01256450|588743783|FG000|Open-label Titration|Adverse Event|39|||
163011162|NCT01256450|588743784|FG001|Open-label Titration|Adverse Event|0|||
163011163|NCT01256450|588743785|FG002|Open-label Titration|Adverse Event|0|||
163011164|NCT01256450|588743783|FG000|Open-label Titration|Lost to Follow-up|7|||
163328342|NCT02941549|589913209|FG000|Overall Study|Withdrawal by Subject|2|||
163011165|NCT01256450|588743784|FG001|Open-label Titration|Lost to Follow-up|0|||
163011166|NCT01256450|588743785|FG002|Open-label Titration|Lost to Follow-up|0|||
163011167|NCT01256450|588743783|FG000|Open-label Titration|Lack of analgesic effect|30|||
163011168|NCT01256450|588743784|FG001|Open-label Titration|Lack of analgesic effect|0|||
163011169|NCT01256450|588743785|FG002|Open-label Titration|Lack of analgesic effect|0|||
163011170|NCT01256450|588743783|FG000|Open-label Titration|Non-compliance|9|||
163011171|NCT01256450|588743784|FG001|Open-label Titration|Non-compliance|0|||
163011172|NCT01256450|588743785|FG002|Open-label Titration|Non-compliance|0|||
163011173|NCT01256450|588743783|FG000|Open-label Titration|Screen failure|1|||
163011174|NCT01256450|588743784|FG001|Open-label Titration|Screen failure|0|||
163011175|NCT01256450|588743785|FG002|Open-label Titration|Screen failure|0|||
163011176|NCT01256450|588743783|FG000|Open-label Titration|Other|13|||
163011177|NCT01256450|588743784|FG001|Open-label Titration|Other|0|||
163011178|NCT01256450|588743785|FG002|Open-label Titration|Other|0|||
163011179|NCT01256450|588743783|FG000|Double-blind Treatment|Adverse Event|0|||
163011180|NCT01256450|588743784|FG001|Double-blind Treatment|Adverse Event|8|||
163011181|NCT01256450|588743785|FG002|Double-blind Treatment|Adverse Event|6|||
163011182|NCT01256450|588743783|FG000|Double-blind Treatment|Lost to Follow-up|0|||
163011183|NCT01256450|588743784|FG001|Double-blind Treatment|Lost to Follow-up|1|||
163011184|NCT01256450|588743785|FG002|Double-blind Treatment|Lost to Follow-up|7|||
163011185|NCT01256450|588743783|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
163011186|NCT01256450|588743784|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
163011187|NCT01256450|588743785|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
163011188|NCT01256450|588743783|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
163011189|NCT01256450|588743784|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
163011190|NCT01256450|588743785|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
163011191|NCT01256450|588743783|FG000|Double-blind Treatment|Non-compliance|0|||
163011192|NCT01256450|588743784|FG001|Double-blind Treatment|Non-compliance|5|||
163011193|NCT01256450|588743785|FG002|Double-blind Treatment|Non-compliance|4|||
163011194|NCT01256450|588743783|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
163011195|NCT01256450|588743784|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
163011196|NCT01256450|588743785|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
163011197|NCT01256450|588743783|FG000|Double-blind Treatment|Other|0|||
163011198|NCT01256450|588743784|FG001|Double-blind Treatment|Other|9|||
163011199|NCT01256450|588743785|FG002|Double-blind Treatment|Other|12|||
163011200|NCT02375971|588743787|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
163011201|NCT02375971|588743788|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
163062379|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
163062380|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
163062381|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
163062382|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
163062383|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
163062384|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
163062385|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
163062386|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
163062387|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
163062388|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
163062389|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
163062390|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
163062391|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
163062392|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
163062393|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
163062394|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
163062395|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
163214766|NCT03662542|589501042|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
163214767|NCT03662542|589501043|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
163214768|NCT03662542|589501044|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
163214769|NCT01217060|589501046|FG000|Overall Study|Withdrawal by Subject|1|||
163214770|NCT03388138|589501047|FG000|Overall Study|Protocol Violation|1|||
163214771|NCT03388138|589501048|FG001|Overall Study|Protocol Violation|0|||
163214772|NCT01528072|589501049|FG000|Overall Study|Withdrawal by Subject|5|||
163214773|NCT01528072|589501049|FG000|Overall Study|Physician Decision|1|||
163214774|NCT01528072|589501049|FG000|Overall Study|Determined not eligible by AEAC|1|||
163214775|NCT01528072|589501049|FG000|Overall Study|Missed Visit|2|||
163214776|NCT01528072|589501049|FG000|Overall Study|Lost to Follow-up|5|||
163214777|NCT01528072|589501049|FG000|Overall Study|Explanted|2|||
163214778|NCT01528072|589501049|FG000|Overall Study|Site Closure|4|||
163011202|NCT02375971|588743789|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
163011203|NCT02375971|588743787|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
163011204|NCT02375971|588743788|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
163011205|NCT02375971|588743789|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
163011206|NCT02375971|588743787|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
163214779|NCT01528072|589501049|FG000|Overall Study|Death|2|||
163214780|NCT01528072|589501049|FG000|Overall Study|Early Termination of Study|52|||
163214781|NCT02436759|589501056|FG000|Overall Study|Adverse Event|3|||
163214782|NCT02436759|589501057|FG001|Overall Study|Adverse Event|0|||
163214783|NCT02436759|589501056|FG000|Overall Study|Protocol Violation|1|||
163214784|NCT02436759|589501057|FG001|Overall Study|Protocol Violation|0|||
163214785|NCT02436759|589501056|FG000|Overall Study|Withdrawal by Subject|0|||
163214786|NCT02436759|589501057|FG001|Overall Study|Withdrawal by Subject|1|||
163214787|NCT04014075|589501058|FG000|Overall Study|Progressive Disease|53|||
163214788|NCT04014075|589501058|FG000|Overall Study|Adverse Event|15|||
163214789|NCT04014075|589501058|FG000|Overall Study|Clinical Progression|4|||
163214790|NCT04014075|589501058|FG000|Overall Study|Death|2|||
163214791|NCT04014075|589501058|FG000|Overall Study|Withdrawal by Subject|2|||
163328343|NCT02941549|589913210|FG001|Overall Study|Withdrawal by Subject|1|||
163328344|NCT02941549|589913211|FG002|Overall Study|Withdrawal by Subject|2|||
163011207|NCT02375971|588743788|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
163011208|NCT02375971|588743789|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
163011209|NCT02375971|588743787|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
163011210|NCT02375971|588743788|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
163011211|NCT02375971|588743789|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
163011212|NCT02375971|588743787|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
163011213|NCT02375971|588743788|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
163011214|NCT02375971|588743789|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
163011215|NCT02375971|588743787|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
163011216|NCT02375971|588743788|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
163011217|NCT02375971|588743789|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
163011218|NCT02375971|588743787|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
163011219|NCT02375971|588743788|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
163011220|NCT02375971|588743789|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
163011221|NCT02375971|588743787|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
163011222|NCT02375971|588743788|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
163011223|NCT02375971|588743789|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
163011224|NCT00891020|588743790|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
163011225|NCT00891020|588743791|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
163011226|NCT00891020|588743792|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
163011227|NCT00891020|588743790|FG000|24 Week Treatment Period|Death|0|||
163011228|NCT00891020|588743791|FG001|24 Week Treatment Period|Death|2|||
163011229|NCT00891020|588743792|FG002|24 Week Treatment Period|Death|0|||
163011230|NCT00891020|588743790|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
163011231|NCT00891020|588743791|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
163011232|NCT00891020|588743792|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
163011233|NCT00891020|588743790|FG000|24 Week Treatment Period|Failure to return|4|||
163011234|NCT00891020|588743791|FG001|24 Week Treatment Period|Failure to return|5|||
163011235|NCT00891020|588743792|FG002|24 Week Treatment Period|Failure to return|5|||
163011236|NCT00891020|588743790|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
163011237|NCT00891020|588743791|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
163011238|NCT00891020|588743792|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
163011239|NCT00891020|588743790|FG000|24 Week Treatment Period|Other protocol violation|1|||
163011240|NCT00891020|588743791|FG001|24 Week Treatment Period|Other protocol violation|1|||
163011241|NCT00891020|588743792|FG002|24 Week Treatment Period|Other protocol violation|2|||
163011242|NCT00891020|588743790|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
163011243|NCT00891020|588743791|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
163011244|NCT00891020|588743792|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
163011245|NCT00891020|588743790|FG000|24 Week Treatment Period|Withdrew consent|6|||
163011246|NCT00891020|588743791|FG001|24 Week Treatment Period|Withdrew consent|3|||
163011247|NCT00891020|588743792|FG002|24 Week Treatment Period|Withdrew consent|15|||
163011248|NCT00891020|588743790|FG000|24 Week Treatment Period|Administrative/Other|5|||
163328345|NCT00776009|589913212|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
163328346|NCT00776009|589913213|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
163328347|NCT00776009|589913214|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
163328348|NCT00776009|589913215|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
163011249|NCT00891020|588743791|FG001|24 Week Treatment Period|Administrative/Other|6|||
163011250|NCT00891020|588743792|FG002|24 Week Treatment Period|Administrative/Other|1|||
163011251|NCT00891020|588743790|FG000|Long-term Extension Period|Adverse Event|1|||
163011252|NCT00891020|588743791|FG001|Long-term Extension Period|Adverse Event|11|||
163011253|NCT00891020|588743792|FG002|Long-term Extension Period|Adverse Event|10|||
163214792|NCT04014075|589501058|FG000|Overall Study|Miscellaneous|2|||
163214793|NCT04014075|589501058|FG000|Overall Study|Physician Decision|1|||
163214794|NCT01912287|589501059|FG000|Overall Study|Ineligible|1|||
163214795|NCT01912287|589501060|FG001|Overall Study|Ineligible|0|||
163214796|NCT01912287|589501061|FG002|Overall Study|Ineligible|1|||
163214797|NCT01912287|589501059|FG000|Overall Study|No-show|0|||
163011254|NCT00891020|588743790|FG000|Long-term Extension Period|Death|0|||
163011255|NCT00891020|588743791|FG001|Long-term Extension Period|Death|0|||
163011256|NCT00891020|588743792|FG002|Long-term Extension Period|Death|1|||
163011257|NCT00891020|588743790|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
163011258|NCT00891020|588743791|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
163011259|NCT00891020|588743792|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
163011260|NCT00891020|588743790|FG000|Long-term Extension Period|Protocol Violation|0|||
163011261|NCT00891020|588743791|FG001|Long-term Extension Period|Protocol Violation|1|||
163011262|NCT00891020|588743792|FG002|Long-term Extension Period|Protocol Violation|1|||
163011263|NCT00891020|588743790|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
163011264|NCT00891020|588743791|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
163011265|NCT00891020|588743792|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
163011266|NCT00891020|588743790|FG000|Long-term Extension Period|Failure to return|0|||
163011267|NCT00891020|588743791|FG001|Long-term Extension Period|Failure to return|2|||
163011268|NCT00891020|588743792|FG002|Long-term Extension Period|Failure to return|3|||
163011269|NCT00891020|588743790|FG000|Long-term Extension Period|Administrative|1|||
163011270|NCT00891020|588743791|FG001|Long-term Extension Period|Administrative|2|||
163011271|NCT00891020|588743792|FG002|Long-term Extension Period|Administrative|2|||
163011272|NCT02275819|588743793|FG000|Overall Study|Adverse Event|0|||
163011273|NCT02275819|588743794|FG001|Overall Study|Adverse Event|1|||
163011274|NCT01346059|588743795|FG000|Overall Study|Withdrawal by Subject|1|||
163011275|NCT01346059|588743796|FG001|Overall Study|Withdrawal by Subject|0|||
163011276|NCT02556775|588743797|FG000|Overall Study|Withdrawal by Subject|1|||
163011277|NCT02556775|588743798|FG001|Overall Study|Withdrawal by Subject|0|||
163011278|NCT02556775|588743799|FG002|Overall Study|Withdrawal by Subject|1|||
163011279|NCT02556775|588743800|FG003|Overall Study|Withdrawal by Subject|0|||
163011280|NCT02556775|588743797|FG000|Overall Study|Lost to Follow-up|1|||
163011281|NCT02556775|588743798|FG001|Overall Study|Lost to Follow-up|0|||
163011282|NCT02556775|588743799|FG002|Overall Study|Lost to Follow-up|0|||
163011283|NCT02556775|588743800|FG003|Overall Study|Lost to Follow-up|0|||
163011284|NCT01592786|588743801|FG000|Overall Study|Adverse Event|60|||
163011285|NCT01592786|588743801|FG000|Overall Study|Lack of Efficacy|19|||
163011286|NCT01592786|588743801|FG000|Overall Study|Protocol Violation|14|||
163011287|NCT01592786|588743801|FG000|Overall Study|Withdrawal by Subject|23|||
163011288|NCT01592786|588743801|FG000|Overall Study|Lost to Follow-up|19|||
163011289|NCT01592786|588743801|FG000|Overall Study|Other|3|||
163011290|NCT02025725|588743802|FG000|Overall Study|Adverse Event|5|||
163011291|NCT02025725|588743803|FG001|Overall Study|Adverse Event|0|||
163011292|NCT02025725|588743802|FG000|Overall Study|Lost to Follow-up|2|||
163011293|NCT02025725|588743803|FG001|Overall Study|Lost to Follow-up|0|||
163011294|NCT02025725|588743802|FG000|Overall Study|Protocol Violation|1|||
163011295|NCT02025725|588743803|FG001|Overall Study|Protocol Violation|1|||
163011296|NCT02025725|588743802|FG000|Overall Study|Withdrawal by Subject|3|||
163011297|NCT02025725|588743803|FG001|Overall Study|Withdrawal by Subject|2|||
163011298|NCT02025725|588743802|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
163011299|NCT02025725|588743803|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
163011300|NCT02172664|588743809|FG000|Overall Study|Lost to Follow-up|4|||
163011301|NCT02172664|588743810|FG001|Overall Study|Lost to Follow-up|4|||
163011302|NCT02172664|588743809|FG000|Overall Study|Death|1|||
163011303|NCT02172664|588743810|FG001|Overall Study|Death|1|||
163011304|NCT02172664|588743809|FG000|Overall Study|Moved out of area|1|||
163011305|NCT02172664|588743810|FG001|Overall Study|Moved out of area|1|||
163011306|NCT01909934|588743811|FG000|Overall Study|Withdrawal by Subject|3|||
163011307|NCT01909934|588743811|FG000|Overall Study|Lost to Follow-up|1|||
163011308|NCT01909934|588743811|FG000|Overall Study|Death|25|||
163011309|NCT01909934|588743811|FG000|Overall Study|Withdrawal of Informed Consent|1|||
163011310|NCT01909934|588743811|FG000|Overall Study|Reason Not Specified|1|||
163011311|NCT01787292|588743814|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
163011312|NCT01787292|588743815|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
163011313|NCT01787292|588743814|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
163011314|NCT01787292|588743815|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
163011315|NCT01147068|588743816|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
163011316|NCT01147068|588743817|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
163011317|NCT01147068|588743818|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
163214798|NCT01912287|589501060|FG001|Overall Study|No-show|0|||
163011318|NCT01147068|588743819|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
163011319|NCT01147068|588743820|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
163011320|NCT01147068|588743821|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
163011321|NCT01147068|588743822|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
163011322|NCT01147068|588743816|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
163011323|NCT01147068|588743817|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
163011324|NCT01147068|588743818|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
163011325|NCT01147068|588743819|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
163214799|NCT01912287|589501061|FG002|Overall Study|No-show|1|||
163062396|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
163062397|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
163062398|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
163062399|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
163062400|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
163062401|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
163062402|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
163062403|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
163062404|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
163062405|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
163062406|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
163062407|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
163062408|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
163062409|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
163062410|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
163062411|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
163062412|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
163062413|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
163062414|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
163062415|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
163062416|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
163062417|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
163062418|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
163062419|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
163062420|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
163062421|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
163062422|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
163062423|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
163062424|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
163062425|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
163062426|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
163062427|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
163062428|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
163062429|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
163062430|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
163062431|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
163062432|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
163062433|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
163062434|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
163062435|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
163062436|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
163062437|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
163062438|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
163062439|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
163062440|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
163062441|NCT03329001|588936868|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
163062442|NCT03329001|588936869|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
163062443|NCT03329001|588936870|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
163062444|NCT03329001|588936871|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
163062445|NCT03329001|588936872|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
163062446|NCT03329001|588936873|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
163062447|NCT03329001|588936874|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
163062448|NCT03329001|588936875|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
163062449|NCT03329001|588936868|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
163062450|NCT03329001|588936869|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
163062451|NCT03329001|588936870|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
163062452|NCT03329001|588936871|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
163062453|NCT03329001|588936872|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
163062454|NCT03329001|588936873|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
163062455|NCT03329001|588936874|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
163062456|NCT03329001|588936875|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
163011326|NCT01147068|588743820|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
163011327|NCT01147068|588743821|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
163011328|NCT01147068|588743822|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
163011329|NCT01147068|588743816|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
163011330|NCT01147068|588743817|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
163011331|NCT01147068|588743818|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
163011332|NCT01147068|588743819|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
163011333|NCT01147068|588743820|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
163011334|NCT01147068|588743821|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
163011335|NCT01147068|588743822|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
163011336|NCT01147068|588743816|FG000|Subjects That Received 2nd Dose|Other|0|||
163011337|NCT01147068|588743817|FG001|Subjects That Received 2nd Dose|Other|3|||
163011338|NCT01147068|588743818|FG002|Subjects That Received 2nd Dose|Other|3|||
163011339|NCT01147068|588743819|FG003|Subjects That Received 2nd Dose|Other|0|||
163011340|NCT01147068|588743820|FG004|Subjects That Received 2nd Dose|Other|1|||
163011341|NCT01147068|588743821|FG005|Subjects That Received 2nd Dose|Other|0|||
163011342|NCT01147068|588743822|FG006|Subjects That Received 2nd Dose|Other|0|||
163011343|NCT01147068|588743816|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
163011344|NCT01147068|588743817|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
163011345|NCT01147068|588743818|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
163011346|NCT01147068|588743819|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
163011347|NCT01147068|588743820|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
163011348|NCT01147068|588743821|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
163011349|NCT01147068|588743822|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
163011350|NCT01147068|588743816|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
163011351|NCT01147068|588743817|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
163011352|NCT01147068|588743818|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
163011353|NCT01147068|588743819|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
163011354|NCT01147068|588743820|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
163011355|NCT01147068|588743821|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
163011356|NCT01147068|588743822|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
163011357|NCT01147068|588743816|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
163011358|NCT01147068|588743817|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
163011359|NCT01147068|588743818|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
163011360|NCT01147068|588743819|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
163011361|NCT01147068|588743820|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
163011362|NCT01147068|588743821|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
163011363|NCT01147068|588743822|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
163328349|NCT00776009|589913216|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
163011364|NCT02962648|588743823|FG000|Overall Study|Withdrawal by Subject|3|||
163011365|NCT02962648|588743823|FG000|Overall Study|Lost to Follow-up|3|||
163011366|NCT02962648|588743823|FG000|Overall Study|Physician Decision|1|||
163011367|NCT02962648|588743823|FG000|Overall Study|Subject had problems with transportation|2|||
163011368|NCT01597778|588743825|FG000|Overall Study|Death|7|||
163011369|NCT01597778|588743826|FG001|Overall Study|Death|10|||
163011370|NCT01597778|588743825|FG000|Overall Study|Withdrawal by Subject|3|||
163011371|NCT01597778|588743826|FG001|Overall Study|Withdrawal by Subject|4|||
163011372|NCT01597778|588743825|FG000|Overall Study|Adverse Event|1|||
163011373|NCT01597778|588743826|FG001|Overall Study|Adverse Event|1|||
163011374|NCT01597778|588743825|FG000|Overall Study|Protocol Violation|1|||
163011375|NCT01597778|588743826|FG001|Overall Study|Protocol Violation|11|||
163011376|NCT01597778|588743825|FG000|Overall Study|Transplanted off protocol|2|||
163011377|NCT01597778|588743826|FG001|Overall Study|Transplanted off protocol|3|||
163011378|NCT03267212|588743827|FG000|First Intervention|Lost to Follow-up|0|||
163011379|NCT03267212|588743828|FG001|First Intervention|Lost to Follow-up|2|||
163011380|NCT03267212|588743827|FG000|First Intervention|Withdrawal by Subject|1|||
163011381|NCT03267212|588743828|FG001|First Intervention|Withdrawal by Subject|1|||
163011382|NCT03267212|588743827|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
163062457|NCT03329001|588936868|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
163062458|NCT03329001|588936869|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
163062459|NCT03329001|588936870|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
163154699|NCT01213472|589281382|FG000|Overall Study|Withdrawal by Subject|1|||
163328350|NCT00776009|589913217|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
163011383|NCT03267212|588743828|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
163011384|NCT05691712|588743829|FG000|Overall Study|Adverse Event|0|||
163011385|NCT05691712|588743830|FG001|Overall Study|Adverse Event|1|||
163011386|NCT05691712|588743831|FG002|Overall Study|Adverse Event|2|||
163011387|NCT05691712|588743832|FG003|Overall Study|Adverse Event|1|||
163214800|NCT01912287|589501059|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
163214801|NCT01912287|589501060|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
163214802|NCT01912287|589501061|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
163214803|NCT01912287|589501059|FG000|Overall Study|Felt treatment no longer needed|0|||
163214804|NCT01912287|589501060|FG001|Overall Study|Felt treatment no longer needed|1|||
163214805|NCT01912287|589501061|FG002|Overall Study|Felt treatment no longer needed|0|||
163214806|NCT01912287|589501059|FG000|Overall Study|Life circumstances|4|||
163214807|NCT01912287|589501060|FG001|Overall Study|Life circumstances|2|||
163214808|NCT01912287|589501061|FG002|Overall Study|Life circumstances|0|||
163214809|NCT01912287|589501059|FG000|Overall Study|Lost Interest|1|||
163214810|NCT01912287|589501060|FG001|Overall Study|Lost Interest|0|||
163214811|NCT01912287|589501061|FG002|Overall Study|Lost Interest|0|||
163214812|NCT01912287|589501059|FG000|Overall Study|Uknown reason - subject drop out|5|||
163214813|NCT01912287|589501060|FG001|Overall Study|Uknown reason - subject drop out|7|||
163214814|NCT01912287|589501061|FG002|Overall Study|Uknown reason - subject drop out|3|||
163214815|NCT01912287|589501059|FG000|Overall Study|Missed Assesment|1|||
163214816|NCT01912287|589501060|FG001|Overall Study|Missed Assesment|1|||
163214817|NCT01912287|589501061|FG002|Overall Study|Missed Assesment|1|||
163214818|NCT01912287|589501059|FG000|Overall Study|Scheduling/change in availability|17|||
163214819|NCT01912287|589501060|FG001|Overall Study|Scheduling/change in availability|10|||
163214820|NCT01912287|589501061|FG002|Overall Study|Scheduling/change in availability|8|||
163011388|NCT05691712|588743829|FG000|Overall Study|Withdrawal by Subject|2|||
163214821|NCT02631850|589501062|FG000|Treatment Period|Lost to Follow-up|0|||
163214822|NCT02631850|589501063|FG001|Treatment Period|Lost to Follow-up|1|||
163214823|NCT02631850|589501064|FG002|Treatment Period|Lost to Follow-up|0|||
163214824|NCT02631850|589501065|FG003|Treatment Period|Lost to Follow-up|0|||
163214825|NCT02631850|589501062|FG000|Treatment Period|Protocol Violation|1|||
163214826|NCT02631850|589501063|FG001|Treatment Period|Protocol Violation|0|||
163011389|NCT05691712|588743830|FG001|Overall Study|Withdrawal by Subject|3|||
163011390|NCT05691712|588743831|FG002|Overall Study|Withdrawal by Subject|3|||
163011391|NCT05691712|588743832|FG003|Overall Study|Withdrawal by Subject|1|||
163011392|NCT05691712|588743829|FG000|Overall Study|Death|1|||
163011393|NCT05691712|588743830|FG001|Overall Study|Death|0|||
163011394|NCT05691712|588743831|FG002|Overall Study|Death|0|||
163011395|NCT05691712|588743832|FG003|Overall Study|Death|0|||
163011396|NCT05691712|588743829|FG000|Overall Study|Pregnancy|0|||
163011397|NCT05691712|588743830|FG001|Overall Study|Pregnancy|1|||
163011398|NCT05691712|588743831|FG002|Overall Study|Pregnancy|0|||
163011399|NCT05691712|588743832|FG003|Overall Study|Pregnancy|0|||
163011400|NCT05691712|588743829|FG000|Overall Study|Assigned Treatment by Mistake|1|||
163011401|NCT05691712|588743830|FG001|Overall Study|Assigned Treatment by Mistake|0|||
163011402|NCT05691712|588743831|FG002|Overall Study|Assigned Treatment by Mistake|0|||
163011403|NCT05691712|588743832|FG003|Overall Study|Assigned Treatment by Mistake|1|||
163011404|NCT05303194|588743833|FG000|Overall Study|Lost to Follow-up|1|||
163011405|NCT05303194|588743834|FG001|Overall Study|Lost to Follow-up|1|||
163011406|NCT05303194|588743833|FG000|Overall Study|Withdrawal by Subject|0|||
163011407|NCT05303194|588743834|FG001|Overall Study|Withdrawal by Subject|1|||
163011408|NCT01289678|588743844|FG000|Overall Study|Physician Decision|6|||
163011409|NCT00226499|588743845|FG000|Overall Study|Adverse Event|10|||
163011410|NCT00226499|588743846|FG001|Overall Study|Adverse Event|6|||
163011411|NCT00226499|588743847|FG002|Overall Study|Adverse Event|3|||
163011412|NCT00226499|588743845|FG000|Overall Study|Others|1064|||
163011413|NCT00226499|588743846|FG001|Overall Study|Others|1066|||
163011414|NCT00226499|588743847|FG002|Overall Study|Others|356|||
163011415|NCT02723344|588743848|FG000|Overall Study|Lost to Follow-up|0|||
163011416|NCT02723344|588743849|FG001|Overall Study|Lost to Follow-up|4|||
163011417|NCT02524847|588743851|FG000|Overall Study|Adverse Event|4|||
163011418|NCT02524847|588743851|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
163011419|NCT02524847|588743851|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
163011420|NCT02524847|588743851|FG000|Overall Study|Death|1|||
163011421|NCT02524847|588743851|FG000|Overall Study|Reason not Specified|1|||
163011422|NCT04352101|588743852|FG000|Overall Study|Physician Decision|2|||
163011423|NCT04352101|588743853|FG001|Overall Study|Physician Decision|1|||
163011424|NCT03539302|588743862|FG000|Overall Study|Spontaneous cardio version|0|||
163011425|NCT03539302|588743863|FG001|Overall Study|Spontaneous cardio version|0|||
163011426|NCT03539302|588743864|FG002|Overall Study|Spontaneous cardio version|0|||
163011427|NCT03539302|588743865|FG003|Overall Study|Spontaneous cardio version|0|||
163011428|NCT03539302|588743866|FG004|Overall Study|Spontaneous cardio version|0|||
163011429|NCT03539302|588743867|FG005|Overall Study|Spontaneous cardio version|1|||
163011430|NCT03539302|588743868|FG006|Overall Study|Spontaneous cardio version|1|||
163011431|NCT04564092|588743870|FG000|Overall Study|Withdrawal by Subject|1|||
163011432|NCT02362360|588743876|FG000|Period 1|Lack of Efficacy|1|||
163011433|NCT02362360|588743877|FG001|Period 1|Lack of Efficacy|0|||
163214827|NCT02631850|589501064|FG002|Treatment Period|Protocol Violation|0|||
163214828|NCT02631850|589501065|FG003|Treatment Period|Protocol Violation|0|||
163214829|NCT02631850|589501062|FG000|Treatment Period|Withdrawal by Subject|0|||
163214830|NCT02631850|589501063|FG001|Treatment Period|Withdrawal by Subject|5|||
163011434|NCT02362360|588743876|FG000|Period 1|Withdrawal by Subject|2|||
163011435|NCT02362360|588743877|FG001|Period 1|Withdrawal by Subject|1|||
163011436|NCT03817190|588743878|FG000|Overall Study|Early Termination|13|||
163011437|NCT03817190|588743879|FG001|Overall Study|Early Termination|20|||
163011438|NCT03817190|588743878|FG000|Overall Study|Adverse Event|10|||
163011439|NCT03817190|588743879|FG001|Overall Study|Adverse Event|17|||
163011440|NCT03817190|588743878|FG000|Overall Study|Withdrawal by Subject|12|||
163011441|NCT03817190|588743879|FG001|Overall Study|Withdrawal by Subject|8|||
163011442|NCT03817190|588743878|FG000|Overall Study|Lost to Follow-up|11|||
163011443|NCT03817190|588743879|FG001|Overall Study|Lost to Follow-up|7|||
163011444|NCT03817190|588743878|FG000|Overall Study|Lack of Efficacy|7|||
163011445|NCT03817190|588743879|FG001|Overall Study|Lack of Efficacy|5|||
163011446|NCT03817190|588743878|FG000|Overall Study|Investigator Decision|5|||
163011447|NCT03817190|588743879|FG001|Overall Study|Investigator Decision|1|||
163011448|NCT03817190|588743878|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
163011449|NCT03817190|588743879|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
163011450|NCT03817190|588743878|FG000|Overall Study|Lack of Contact|1|||
163214831|NCT02631850|589501064|FG002|Treatment Period|Withdrawal by Subject|2|||
163214832|NCT02631850|589501065|FG003|Treatment Period|Withdrawal by Subject|2|||
163011451|NCT03817190|588743879|FG001|Overall Study|Lack of Contact|0|||
163011452|NCT03817190|588743878|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
163011453|NCT03817190|588743879|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
163011454|NCT04146012|588743880|FG000|Overall Study|Study Terminated|30|||
163011455|NCT04146012|588743881|FG001|Overall Study|Study Terminated|15|||
163011456|NCT01546025|588743882|FG000|Overall Study|Lost to Follow-up|0|||
163011457|NCT01546025|588743883|FG001|Overall Study|Lost to Follow-up|1|||
163011458|NCT00868530|588743884|FG000|Overall Study|Adverse Event|3|||
163011459|NCT00868530|588743884|FG000|Overall Study|Lost to Follow-up|1|||
163011460|NCT05795153|588745687|FG000|Overall Study|Adverse Event|2|||
163011461|NCT05795153|588745687|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163011462|NCT05795153|588745687|FG000|Overall Study|Lost to Follow-up|1|||
163011463|NCT05795153|588745687|FG000|Overall Study|Subject decision|2|||
163011464|NCT03668119|588745688|FG000|Pre-treatment|Disease Progression|1|||
163011465|NCT03668119|588745689|FG001|Pre-treatment|Disease Progression|0|||
163011466|NCT03668119|588745688|FG000|Treatment|Disease Progression|76|||
163011467|NCT03668119|588745689|FG001|Treatment|Disease Progression|57|||
163011468|NCT03668119|588745688|FG000|Treatment|Study drug toxicity|19|||
163011469|NCT03668119|588745689|FG001|Treatment|Study drug toxicity|1|||
163011470|NCT03668119|588745688|FG000|Treatment|Death|3|||
163011471|NCT03668119|588745689|FG001|Treatment|Death|0|||
163011472|NCT03668119|588745688|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
163011473|NCT03668119|588745689|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
163011474|NCT03668119|588745688|FG000|Treatment|Withdrawal by Subject|1|||
163011475|NCT03668119|588745689|FG001|Treatment|Withdrawal by Subject|1|||
163011476|NCT03668119|588745688|FG000|Treatment|Participant request to discontinue study treatment|3|||
163011477|NCT03668119|588745689|FG001|Treatment|Participant request to discontinue study treatment|1|||
163011478|NCT03668119|588745688|FG000|Treatment|Maximum Clinical Benefit|0|||
163011479|NCT03668119|588745689|FG001|Treatment|Maximum Clinical Benefit|1|||
163011480|NCT03668119|588745688|FG000|Treatment|Participants completed treatment|27|||
163011481|NCT03668119|588745689|FG001|Treatment|Participants completed treatment|11|||
163011482|NCT03668119|588745688|FG000|Treatment|Other reasons|2|||
163011483|NCT03668119|588745689|FG001|Treatment|Other reasons|1|||
163011484|NCT03769168|588745690|FG000|Overall Study|Adverse Event|0|||
163011485|NCT03769168|588745691|FG001|Overall Study|Adverse Event|1|||
163011486|NCT03769168|588745690|FG000|Overall Study|Lack of Efficacy|2|||
163011487|NCT03769168|588745691|FG001|Overall Study|Lack of Efficacy|4|||
163011488|NCT03769168|588745690|FG000|Overall Study|Post study access to treatment|3|||
163011489|NCT03769168|588745691|FG001|Overall Study|Post study access to treatment|11|||
163011490|NCT03769168|588745690|FG000|Overall Study|Physician Decision|1|||
163011491|NCT03769168|588745691|FG001|Overall Study|Physician Decision|4|||
163011492|NCT03769168|588745690|FG000|Overall Study|Subject Decision|2|||
163011493|NCT03769168|588745691|FG001|Overall Study|Subject Decision|4|||
163011494|NCT03769168|588745690|FG000|Overall Study|Guardian decision|1|||
163011495|NCT03769168|588745691|FG001|Overall Study|Guardian decision|0|||
163011496|NCT05142722|588745692|FG000|Overall Study|Lost to Follow-up|16|||
163011497|NCT05142722|588745693|FG001|Overall Study|Lost to Follow-up|38|||
163011498|NCT05142722|588745692|FG000|Overall Study|Withdrawal by Subject|20|||
163011499|NCT05142722|588745693|FG001|Overall Study|Withdrawal by Subject|27|||
163011500|NCT05142722|588745692|FG000|Overall Study|Death|11|||
163011501|NCT05142722|588745693|FG001|Overall Study|Death|17|||
163011502|NCT05142722|588745692|FG000|Overall Study|Physician Decision|0|||
163011503|NCT05142722|588745693|FG001|Overall Study|Physician Decision|1|||
163011504|NCT05142722|588745692|FG000|Overall Study|Participant Moved Away|0|||
163011505|NCT05142722|588745693|FG001|Overall Study|Participant Moved Away|2|||
163011506|NCT05142722|588745692|FG000|Overall Study|Adverse Event|2|||
163214833|NCT02631850|589501062|FG000|Treatment Period|Adverse Event|1|||
163214834|NCT02631850|589501063|FG001|Treatment Period|Adverse Event|0|||
163011507|NCT05142722|588745693|FG001|Overall Study|Adverse Event|1|||
163011508|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
163011509|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
163011510|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
163011511|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
163011512|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
163011513|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
163011514|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
163011515|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
163011516|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
163011517|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
163011518|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
163011519|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
163011520|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
163011521|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
163011522|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
163011523|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
163011524|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
163011525|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
163011526|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
163011527|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
163011528|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
163011529|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
163011530|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
163011531|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
163011532|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
163011533|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
163011534|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
163011535|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
163011536|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
163011537|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
163011538|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
163011539|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
163011540|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011541|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011542|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
163011543|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011544|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011545|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011546|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
163011547|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011548|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
163011549|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
163011550|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
163011551|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
163011552|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
163011553|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
163011554|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
163011555|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
163011556|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
163011557|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
163011558|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
163011559|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
163011560|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
163011561|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
163328351|NCT00776009|589913212|FG000|Period 1: First Intervention|Protocol Violation|0|||
163328352|NCT00776009|589913213|FG001|Period 1: First Intervention|Protocol Violation|1|||
163328353|NCT00776009|589913214|FG002|Period 1: First Intervention|Protocol Violation|0|||
163328354|NCT00776009|589913215|FG003|Period 1: First Intervention|Protocol Violation|0|||
163328355|NCT00776009|589913216|FG004|Period 1: First Intervention|Protocol Violation|1|||
163404575|NCT01157364|590191963|FG005|Overall Study|Personal Reasons|1|||
163062460|NCT03329001|588936871|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
163062461|NCT03329001|588936872|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
163062462|NCT03329001|588936873|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
163062463|NCT03329001|588936874|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
163062464|NCT03329001|588936875|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
163011562|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
163011563|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
163062465|NCT03329001|588936868|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
163062466|NCT03329001|588936869|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
163062467|NCT03329001|588936870|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
163062468|NCT03329001|588936871|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
163062469|NCT03329001|588936872|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
163062470|NCT03329001|588936873|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
163011564|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
163011565|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
163011566|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
163011567|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
163011568|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
163011569|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
163011570|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
163011571|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
163011572|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
163011573|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
163011574|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
163011575|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
163011576|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
163011577|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
163011578|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
163011579|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
163011580|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011581|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011582|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011583|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011584|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011585|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
163011586|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011587|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011588|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
163011589|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
163011590|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
163011591|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
163011592|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
163011593|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
163011594|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
163011595|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
163011596|NCT05400655|588745704|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
163011597|NCT05400655|588745705|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
163011598|NCT05400655|588745706|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
163011599|NCT05400655|588745707|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
163011600|NCT05400655|588745708|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
163011601|NCT05400655|588745709|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
163062471|NCT03329001|588936874|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
163062472|NCT03329001|588936875|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
163062473|NCT03329001|588936868|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
163062474|NCT03329001|588936869|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
163154700|NCT01213472|589281382|FG000|Overall Study|Physician Decision|1|||
163154701|NCT02435992|589281385|FG000|Overall Study|non compliance with protocol|2|||
163154702|NCT02435992|589281386|FG001|Overall Study|non compliance with protocol|0|||
163154703|NCT02435992|589281387|FG002|Overall Study|non compliance with protocol|1|||
163154704|NCT02435992|589281388|FG003|Overall Study|non compliance with protocol|0|||
163011602|NCT05400655|588745710|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
163011603|NCT05400655|588745711|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
163011604|NCT05400655|588745712|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
163011605|NCT05400655|588745713|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
163011606|NCT05400655|588745714|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
163011607|NCT05400655|588745715|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
163011608|NCT05400655|588745716|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
163011609|NCT05400655|588745717|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
163011610|NCT05400655|588745718|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
163011611|NCT05400655|588745719|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
163011612|NCT05400655|588745720|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
163011613|NCT05400655|588745721|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
163011614|NCT05400655|588745722|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
163011615|NCT05400655|588745723|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
163011616|NCT05400655|588745724|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
163011617|NCT05400655|588745725|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
163011618|NCT05400655|588745704|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011619|NCT05400655|588745705|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011620|NCT05400655|588745706|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011621|NCT05400655|588745707|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011622|NCT05400655|588745708|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011623|NCT05400655|588745709|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011624|NCT05400655|588745710|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011625|NCT05400655|588745711|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011626|NCT05400655|588745712|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011627|NCT05400655|588745713|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011628|NCT05400655|588745714|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011629|NCT05400655|588745715|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011630|NCT05400655|588745716|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
163011631|NCT05400655|588745717|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011632|NCT05400655|588745718|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011633|NCT05400655|588745719|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011634|NCT05400655|588745720|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
163011635|NCT05400655|588745721|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011636|NCT05400655|588745722|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
163011637|NCT05400655|588745723|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
163011638|NCT05400655|588745724|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011639|NCT05400655|588745725|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011640|NCT05400655|588745704|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011641|NCT05400655|588745705|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011642|NCT05400655|588745706|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011643|NCT05400655|588745707|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011644|NCT05400655|588745708|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011645|NCT05400655|588745709|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011646|NCT05400655|588745710|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011647|NCT05400655|588745711|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011648|NCT05400655|588745712|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011649|NCT05400655|588745713|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011650|NCT05400655|588745714|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011651|NCT05400655|588745715|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011652|NCT05400655|588745716|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011653|NCT05400655|588745717|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
163011654|NCT05400655|588745718|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011655|NCT05400655|588745719|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011656|NCT05400655|588745720|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
163011657|NCT05400655|588745721|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011658|NCT05400655|588745722|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
163011659|NCT05400655|588745723|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011660|NCT05400655|588745724|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011661|NCT05400655|588745725|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011662|NCT05400655|588745704|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011663|NCT05400655|588745705|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011664|NCT05400655|588745706|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011665|NCT05400655|588745707|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011666|NCT05400655|588745708|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011667|NCT05400655|588745709|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011668|NCT05400655|588745710|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011669|NCT05400655|588745711|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011670|NCT05400655|588745712|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163214835|NCT02631850|589501064|FG002|Treatment Period|Adverse Event|2|||
163011671|NCT05400655|588745713|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011672|NCT05400655|588745714|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011673|NCT05400655|588745715|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163214836|NCT02631850|589501065|FG003|Treatment Period|Adverse Event|3|||
163214837|NCT02631850|589501062|FG000|Treatment Period|Family medical issue|1|||
163214838|NCT02631850|589501063|FG001|Treatment Period|Family medical issue|0|||
163214839|NCT02631850|589501064|FG002|Treatment Period|Family medical issue|0|||
163214840|NCT02631850|589501065|FG003|Treatment Period|Family medical issue|0|||
163214841|NCT02631850|589501062|FG000|6 Month Follow up|Lost to Follow-up|5|||
163214842|NCT02631850|589501063|FG001|6 Month Follow up|Lost to Follow-up|8|||
163214843|NCT02631850|589501064|FG002|6 Month Follow up|Lost to Follow-up|3|||
163214844|NCT02631850|589501065|FG003|6 Month Follow up|Lost to Follow-up|5|||
163214845|NCT02631850|589501062|FG000|6 Month Follow up|Withdrawal by Subject|1|||
163214846|NCT02631850|589501063|FG001|6 Month Follow up|Withdrawal by Subject|0|||
163214847|NCT02631850|589501064|FG002|6 Month Follow up|Withdrawal by Subject|0|||
163214848|NCT02631850|589501065|FG003|6 Month Follow up|Withdrawal by Subject|2|||
163214849|NCT02631850|589501062|FG000|6 Month Follow up|Adverse Event|1|||
163214850|NCT02631850|589501063|FG001|6 Month Follow up|Adverse Event|4|||
163214851|NCT02631850|589501064|FG002|6 Month Follow up|Adverse Event|1|||
163214852|NCT02631850|589501065|FG003|6 Month Follow up|Adverse Event|3|||
163214853|NCT02631850|589501062|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
163214854|NCT02631850|589501063|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
163011674|NCT05400655|588745716|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011675|NCT05400655|588745717|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011676|NCT05400655|588745718|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011677|NCT05400655|588745719|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011678|NCT05400655|588745720|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
163011679|NCT05400655|588745721|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
163011680|NCT05400655|588745722|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
163011681|NCT05400655|588745723|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011682|NCT05400655|588745724|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
163011683|NCT05400655|588745725|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
163011684|NCT05400655|588745704|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011685|NCT05400655|588745705|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011686|NCT05400655|588745706|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011687|NCT05400655|588745707|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011688|NCT05400655|588745708|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011689|NCT05400655|588745709|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011690|NCT05400655|588745710|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011691|NCT05400655|588745711|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011692|NCT05400655|588745712|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011693|NCT05400655|588745713|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011694|NCT05400655|588745714|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011695|NCT05400655|588745715|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011696|NCT05400655|588745716|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011697|NCT05400655|588745717|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011698|NCT05400655|588745718|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011699|NCT05400655|588745719|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011700|NCT05400655|588745720|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011701|NCT05400655|588745721|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
163011702|NCT05400655|588745722|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
163011703|NCT05400655|588745723|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011704|NCT05400655|588745724|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011705|NCT05400655|588745725|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011706|NCT05400655|588745704|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011707|NCT05400655|588745705|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011708|NCT05400655|588745706|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011709|NCT05400655|588745707|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011710|NCT05400655|588745708|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011711|NCT05400655|588745709|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011712|NCT05400655|588745710|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011713|NCT05400655|588745711|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011714|NCT05400655|588745712|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011715|NCT05400655|588745713|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011716|NCT05400655|588745714|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011717|NCT05400655|588745715|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011718|NCT05400655|588745716|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011719|NCT05400655|588745717|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011720|NCT05400655|588745718|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011721|NCT05400655|588745719|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163214855|NCT02631850|589501064|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
163214856|NCT02631850|589501065|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
163062475|NCT03329001|588936870|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
163062476|NCT03329001|588936871|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
163404576|NCT01157364|590191958|FG000|Overall Study|Lost to Follow-up|1|||
162925267|NCT02253654|588428891|FG001|Overall Study|Did Not Receive Study Treatment|1|||
162925268|NCT01614925|588428892|FG000|Overall Study|Withdrawal by Subject|1|||
162925269|NCT01614925|588428893|FG001|Overall Study|Withdrawal by Subject|0|||
162925270|NCT01614925|588428892|FG000|Overall Study|Protocol Violation|3|||
162925271|NCT01614925|588428893|FG001|Overall Study|Protocol Violation|2|||
162925272|NCT01652573|588428904|FG000|Overall Study|Adverse Event|0|||
162925273|NCT01652573|588428905|FG001|Overall Study|Adverse Event|1|||
162925274|NCT00934622|588428906|FG000|Overall Study|Lost to Follow-up|7|||
162925275|NCT00934622|588428906|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
162925276|NCT00468312|588428909|FG000|Overall Study|Adverse Event|2|||
162925277|NCT00468312|588428910|FG001|Overall Study|Adverse Event|1|||
162925278|NCT00468312|588428909|FG000|Overall Study|Lack of Efficacy|0|||
162925279|NCT00468312|588428910|FG001|Overall Study|Lack of Efficacy|1|||
162925280|NCT00468312|588428909|FG000|Overall Study|Withdrawal by Subject|0|||
162925281|NCT00468312|588428910|FG001|Overall Study|Withdrawal by Subject|1|||
162925282|NCT00468312|588428909|FG000|Overall Study|Protocol Violation|2|||
162925283|NCT00468312|588428910|FG001|Overall Study|Protocol Violation|1|||
162925284|NCT00468312|588428909|FG000|Overall Study|Did not meet protocol eligibility|0|||
162925285|NCT00468312|588428910|FG001|Overall Study|Did not meet protocol eligibility|1|||
162925286|NCT01052038|588428911|FG000|Overall Study|Lost to Follow-up|2|||
162925287|NCT01052038|588428912|FG001|Overall Study|Lost to Follow-up|3|||
162925288|NCT01052038|588428913|FG002|Overall Study|Lost to Follow-up|1|||
162925289|NCT01052038|588428911|FG000|Overall Study|Protocol Violation|2|||
162925290|NCT01052038|588428912|FG001|Overall Study|Protocol Violation|3|||
162925291|NCT01052038|588428913|FG002|Overall Study|Protocol Violation|3|||
162925292|NCT03349437|588428914|FG000|Screening|Screen Fail|4|||
162925293|NCT03349437|588428915|FG001|Screening|Screen Fail|0|||
162925294|NCT03349437|588428916|FG002|Screening|Screen Fail|0|||
162925295|NCT03349437|588428914|FG000|Screening|Withdrawn|1|||
162925296|NCT03349437|588428915|FG001|Screening|Withdrawn|0|||
162925297|NCT03349437|588428916|FG002|Screening|Withdrawn|0|||
162925298|NCT03343054|588428919|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
162925299|NCT03343054|588428920|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
162925300|NCT03343054|588428921|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
162925301|NCT03343054|588428919|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
162925302|NCT03343054|588428920|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
162925303|NCT03343054|588428921|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
162925304|NCT03343054|588428919|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
162925305|NCT03343054|588428920|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
162925306|NCT03343054|588428921|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
162925307|NCT03343054|588428919|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
162925308|NCT03343054|588428920|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
162925309|NCT03343054|588428921|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
162925310|NCT05723835|588428927|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
162925311|NCT05723835|588428928|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
162925312|NCT05723835|588428929|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
163011722|NCT05400655|588745720|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
163011723|NCT05400655|588745721|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011724|NCT05400655|588745722|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
163011725|NCT05400655|588745723|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
163011726|NCT05400655|588745724|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
163011727|NCT05400655|588745725|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
163011728|NCT01068678|588745734|FG000|Overall Study|Lack of Efficacy|3|||
163011729|NCT01068678|588745735|FG001|Overall Study|Lack of Efficacy|2|||
163011730|NCT01068678|588745734|FG000|Overall Study|Protocol Violation|5|||
163011731|NCT01068678|588745735|FG001|Overall Study|Protocol Violation|1|||
163011732|NCT01068678|588745734|FG000|Overall Study|Withdrawal criteria|12|||
163011733|NCT01068678|588745735|FG001|Overall Study|Withdrawal criteria|6|||
163011734|NCT01068678|588745734|FG000|Overall Study|Unclassified|18|||
163011735|NCT01068678|588745735|FG001|Overall Study|Unclassified|15|||
163011736|NCT05161481|588745736|FG000|Overall Study|Withdrawal of consent|0|||
163011737|NCT05161481|588745737|FG001|Overall Study|Withdrawal of consent|1|||
163011738|NCT05161481|588745738|FG002|Overall Study|Withdrawal of consent|1|||
163011739|NCT05161481|588745736|FG000|Overall Study|Study terminated by sponsor|3|||
163011740|NCT05161481|588745737|FG001|Overall Study|Study terminated by sponsor|3|||
163011741|NCT05161481|588745738|FG002|Overall Study|Study terminated by sponsor|2|||
163011742|NCT05161481|588745736|FG000|Overall Study|Adverse Event|3|||
163011743|NCT05161481|588745737|FG001|Overall Study|Adverse Event|0|||
163011744|NCT05161481|588745738|FG002|Overall Study|Adverse Event|6|||
163011745|NCT05161481|588745736|FG000|Overall Study|Randomised in error and was not treated|1|||
163011746|NCT05161481|588745737|FG001|Overall Study|Randomised in error and was not treated|0|||
163011747|NCT05161481|588745738|FG002|Overall Study|Randomised in error and was not treated|0|||
163011748|NCT05161481|588745736|FG000|Overall Study|Subject decision|0|||
163011749|NCT05161481|588745737|FG001|Overall Study|Subject decision|0|||
163011750|NCT05161481|588745738|FG002|Overall Study|Subject decision|1|||
163011751|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
163011752|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
163011753|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
163011754|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
163011755|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
163011756|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
163011757|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
163011758|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
163011759|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
163011760|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
163011761|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
163011762|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
163011763|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
163011764|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
163011765|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
163011766|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
163011767|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
163011768|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
163011769|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
163011770|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
163011771|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
163011772|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
163011773|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
163011774|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
163011775|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
163011776|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
163011777|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
163011778|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
163011779|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
163011780|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
163011781|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
163011782|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
163011783|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
163011784|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
163011785|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
163011786|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
163011787|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
163011788|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
163011789|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
163011790|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
163011791|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
163011792|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
163011793|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
163011794|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
163011795|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
163011796|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
163011797|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
163011798|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
163011799|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
163011800|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
163011801|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
163011802|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
163011803|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Site closed|0|||
163011804|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Site closed|0|||
163011805|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Site closed|1|||
163011806|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Site closed|0|||
163011807|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
163011808|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
163011809|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
163154705|NCT02435992|589281389|FG004|Overall Study|non compliance with protocol|0|||
163328356|NCT00776009|589913217|FG005|Period 1: First Intervention|Protocol Violation|0|||
163011810|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
163011811|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
163011812|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
163011813|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
163011814|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
163011815|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
163011816|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
163011817|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
163011818|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
163011819|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
163011820|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
163011821|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
163011822|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
163011823|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
163011824|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
163011825|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
163011826|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
163011827|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
163011828|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
163011829|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
163328357|NCT00776009|589913212|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
163328358|NCT00776009|589913213|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
163404577|NCT01157364|590191959|FG001|Overall Study|Lost to Follow-up|0|||
163011830|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
163011831|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
163011832|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
163011833|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
163011834|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
163011835|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
163011836|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
163011837|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
163011838|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
163011839|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
163011840|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
163011841|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
163011842|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
163011843|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
163011844|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
163011845|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
163011846|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
163011847|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
163011848|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
163011849|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
163011850|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
163011851|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
163011852|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
163011853|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
163011854|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
163011855|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
163011856|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
163011857|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
163011858|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
163011859|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Missing|1|||
163011860|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Missing|2|||
163011861|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Missing|1|||
163011862|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Missing|1|||
163011863|NCT04225715|588745743|FG000|Overall Study|Reason not Specified|1|||
163011864|NCT04225715|588745744|FG001|Overall Study|Reason not Specified|0|||
163011865|NCT04225715|588745745|FG002|Overall Study|Reason not Specified|0|||
163011866|NCT04225715|588745746|FG003|Overall Study|Reason not Specified|0|||
163011867|NCT04225715|588745747|FG004|Overall Study|Reason not Specified|0|||
163011868|NCT04225715|588745748|FG005|Overall Study|Reason not Specified|0|||
163011869|NCT04225715|588745749|FG006|Overall Study|Reason not Specified|0|||
163011870|NCT04225715|588745750|FG007|Overall Study|Reason not Specified|0|||
163011871|NCT04225715|588745751|FG008|Overall Study|Reason not Specified|0|||
163011872|NCT04225715|588745743|FG000|Overall Study|Protocol Violation|1|||
163011873|NCT04225715|588745744|FG001|Overall Study|Protocol Violation|0|||
163011874|NCT04225715|588745745|FG002|Overall Study|Protocol Violation|0|||
163214857|NCT01505868|589501089|FG000|Overall Study|Withdrawal by Subject|1|||
163214858|NCT01505868|589501090|FG001|Overall Study|Withdrawal by Subject|0|||
163214859|NCT01505868|589501091|FG002|Overall Study|Withdrawal by Subject|0|||
163214860|NCT01505868|589501092|FG003|Overall Study|Withdrawal by Subject|0|||
163214861|NCT01505868|589501093|FG004|Overall Study|Withdrawal by Subject|0|||
163214862|NCT00553150|589501094|FG000|Overall Study|Withdrawal by Subject|0|||
163214863|NCT00553150|589501095|FG001|Overall Study|Withdrawal by Subject|0|||
163214864|NCT00553150|589501096|FG002|Overall Study|Withdrawal by Subject|0|||
163214865|NCT00553150|589501097|FG003|Overall Study|Withdrawal by Subject|2|||
163214866|NCT00553150|589501094|FG000|Overall Study|Protocol Violation|0|||
163214867|NCT00553150|589501095|FG001|Overall Study|Protocol Violation|0|||
163214868|NCT00553150|589501096|FG002|Overall Study|Protocol Violation|0|||
163214869|NCT00553150|589501097|FG003|Overall Study|Protocol Violation|1|||
163214870|NCT00553150|589501094|FG000|Overall Study|Ineligible|0|||
163214871|NCT00553150|589501095|FG001|Overall Study|Ineligible|0|||
163214872|NCT00553150|589501096|FG002|Overall Study|Ineligible|0|||
163214873|NCT00553150|589501097|FG003|Overall Study|Ineligible|1|||
163214874|NCT00975481|589501099|FG000|Second Intervention Period|Adverse Event|2|||
163214875|NCT00975481|589501100|FG001|Second Intervention Period|Adverse Event|1|||
163214876|NCT00975481|589501101|FG002|Second Intervention Period|Adverse Event|0|||
163214877|NCT00975481|589501102|FG003|Second Intervention Period|Adverse Event|0|||
163214878|NCT00975481|589501103|FG004|Second Intervention Period|Adverse Event|0|||
163214879|NCT00975481|589501104|FG005|Second Intervention Period|Adverse Event|0|||
163214880|NCT00975481|589501099|FG000|Second Intervention Period|Withdrawal by Subject|0|||
163214881|NCT00975481|589501100|FG001|Second Intervention Period|Withdrawal by Subject|0|||
163214882|NCT00975481|589501101|FG002|Second Intervention Period|Withdrawal by Subject|1|||
163214883|NCT00975481|589501102|FG003|Second Intervention Period|Withdrawal by Subject|0|||
163214884|NCT00975481|589501103|FG004|Second Intervention Period|Withdrawal by Subject|0|||
163214885|NCT00975481|589501104|FG005|Second Intervention Period|Withdrawal by Subject|0|||
163214886|NCT00975481|589501099|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
163214887|NCT00975481|589501100|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
163214888|NCT00975481|589501101|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
163214889|NCT00975481|589501102|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
163214890|NCT00975481|589501103|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
163214891|NCT00975481|589501104|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
163214892|NCT00975481|589501099|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
163214893|NCT00975481|589501100|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
163214894|NCT00975481|589501101|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
163214895|NCT00975481|589501102|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
163214896|NCT00975481|589501103|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
163214897|NCT00975481|589501104|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
163214898|NCT03559257|589501107|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
163214899|NCT03559257|589501108|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
163214900|NCT03559257|589501107|FG000|Double Blind Treatment Period|Protocol Violation|1|||
163214901|NCT03559257|589501108|FG001|Double Blind Treatment Period|Protocol Violation|4|||
163214902|NCT03559257|589501107|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
163214903|NCT03559257|589501108|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
163214904|NCT03559257|589501107|FG000|Double Blind Treatment Period|Adverse Event|0|||
163214905|NCT03559257|589501108|FG001|Double Blind Treatment Period|Adverse Event|1|||
163214906|NCT03559257|589501107|FG000|Double Blind Treatment Period|Screen Failure|0|||
163214907|NCT03559257|589501108|FG001|Double Blind Treatment Period|Screen Failure|1|||
163214908|NCT03559257|589501107|FG000|Open-label Treatment Period|Adverse Event|1|||
163214909|NCT03559257|589501108|FG001|Open-label Treatment Period|Adverse Event|4|||
163214910|NCT03559257|589501107|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
163214911|NCT03559257|589501108|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
163214912|NCT03559257|589501107|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
163214913|NCT03559257|589501108|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
163214914|NCT03559257|589501107|FG000|Open-label Treatment Period|Protocol Violation|2|||
163214915|NCT03559257|589501108|FG001|Open-label Treatment Period|Protocol Violation|0|||
163214916|NCT03559257|589501107|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
163214917|NCT03559257|589501108|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
163214918|NCT03559257|589501107|FG000|Open-label Treatment Period|Physician Decision|0|||
163214919|NCT03559257|589501108|FG001|Open-label Treatment Period|Physician Decision|1|||
163214920|NCT03630120|589501110|FG000|Overall Study|Disease progression|0|||
163214921|NCT03630120|589501111|FG001|Overall Study|Disease progression|1|||
163214922|NCT03630120|589501112|FG002|Overall Study|Disease progression|1|||
163214923|NCT03630120|589501113|FG003|Overall Study|Disease progression|1|||
163214924|NCT03251079|589501114|FG000|Overall Study|Withdrawal by Subject|1|||
163214925|NCT01387347|589501115|FG000|Overall Study|Lost to Follow-up|2|||
163214926|NCT01387347|589501116|FG001|Overall Study|Lost to Follow-up|1|||
163214927|NCT01519960|589501117|FG000|Overall Study|Withdrawal from the study|26|||
163214928|NCT01519960|589501118|FG001|Overall Study|Withdrawal from the study|22|||
163214929|NCT01519960|589501119|FG002|Overall Study|Withdrawal from the study|5|||
163214930|NCT02953314|589501133|FG000|Overall Study|Adverse Event|0|||
163011875|NCT04225715|588745746|FG003|Overall Study|Protocol Violation|0|||
163011876|NCT04225715|588745747|FG004|Overall Study|Protocol Violation|0|||
163011877|NCT04225715|588745748|FG005|Overall Study|Protocol Violation|9|||
163011878|NCT04225715|588745749|FG006|Overall Study|Protocol Violation|0|||
163011879|NCT04225715|588745750|FG007|Overall Study|Protocol Violation|0|||
163011880|NCT04225715|588745751|FG008|Overall Study|Protocol Violation|0|||
163011881|NCT04225715|588745743|FG000|Overall Study|Withdrawal by Subject|4|||
163011882|NCT04225715|588745744|FG001|Overall Study|Withdrawal by Subject|1|||
163011883|NCT04225715|588745745|FG002|Overall Study|Withdrawal by Subject|1|||
163011884|NCT04225715|588745746|FG003|Overall Study|Withdrawal by Subject|0|||
163011885|NCT04225715|588745747|FG004|Overall Study|Withdrawal by Subject|3|||
163011886|NCT04225715|588745748|FG005|Overall Study|Withdrawal by Subject|1|||
163011887|NCT04225715|588745749|FG006|Overall Study|Withdrawal by Subject|1|||
163011888|NCT04225715|588745750|FG007|Overall Study|Withdrawal by Subject|1|||
163011889|NCT04225715|588745751|FG008|Overall Study|Withdrawal by Subject|0|||
163011890|NCT04225715|588745743|FG000|Overall Study|Adverse Event|0|||
163011891|NCT04225715|588745744|FG001|Overall Study|Adverse Event|0|||
163011892|NCT04225715|588745745|FG002|Overall Study|Adverse Event|0|||
163011893|NCT04225715|588745746|FG003|Overall Study|Adverse Event|0|||
163011894|NCT04225715|588745747|FG004|Overall Study|Adverse Event|0|||
163011895|NCT04225715|588745748|FG005|Overall Study|Adverse Event|0|||
163011896|NCT04225715|588745749|FG006|Overall Study|Adverse Event|0|||
163011897|NCT04225715|588745750|FG007|Overall Study|Adverse Event|0|||
163011898|NCT04225715|588745751|FG008|Overall Study|Adverse Event|1|||
163011899|NCT04225715|588745743|FG000|Overall Study|Arm Terminated By Sponsor|0|||
163011900|NCT04225715|588745744|FG001|Overall Study|Arm Terminated By Sponsor|0|||
163011901|NCT04225715|588745745|FG002|Overall Study|Arm Terminated By Sponsor|0|||
163011902|NCT04225715|588745746|FG003|Overall Study|Arm Terminated By Sponsor|0|||
163011903|NCT04225715|588745747|FG004|Overall Study|Arm Terminated By Sponsor|0|||
163011904|NCT04225715|588745748|FG005|Overall Study|Arm Terminated By Sponsor|0|||
163062477|NCT03329001|588936872|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
163062478|NCT03329001|588936873|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
163062479|NCT03329001|588936874|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
163062480|NCT03329001|588936875|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
163062481|NCT03329001|588936868|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
163062482|NCT03329001|588936869|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
163062483|NCT03329001|588936870|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
163062484|NCT03329001|588936871|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
163062485|NCT03329001|588936872|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
163062486|NCT03329001|588936873|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
163062487|NCT03329001|588936874|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
163062488|NCT03329001|588936875|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
163062489|NCT03329001|588936868|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
163062490|NCT03329001|588936869|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
163062491|NCT03329001|588936870|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
163062492|NCT03329001|588936871|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
163062493|NCT03329001|588936872|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
163062494|NCT03329001|588936873|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
163062495|NCT03329001|588936874|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
163062496|NCT03329001|588936875|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
163062497|NCT03329001|588936868|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
163062498|NCT03329001|588936869|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
163062499|NCT03329001|588936870|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
163062500|NCT03329001|588936871|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
163062501|NCT03329001|588936872|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
163062502|NCT03329001|588936873|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
163062503|NCT03329001|588936874|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
163062504|NCT03329001|588936875|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
163062505|NCT03329001|588936868|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
163062506|NCT03329001|588936869|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
163062507|NCT03329001|588936870|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
163062508|NCT03329001|588936871|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
163062509|NCT03329001|588936872|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
163062510|NCT03329001|588936873|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
163062511|NCT03329001|588936874|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
163404578|NCT01157364|590191960|FG002|Overall Study|Lost to Follow-up|1|||
163062512|NCT03329001|588936875|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
163011905|NCT04225715|588745749|FG006|Overall Study|Arm Terminated By Sponsor|0|||
163214931|NCT02953314|589501134|FG001|Overall Study|Adverse Event|1|||
163214932|NCT02953314|589501133|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
163214933|NCT02953314|589501134|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
163214934|NCT00535223|589501135|FG000|Overall Study|Withdrawal by Subject|4|||
163214935|NCT00535223|589501136|FG001|Overall Study|Withdrawal by Subject|1|||
163214936|NCT00492115|589501137|FG000|Overall Study|Withdrawal by Subject|3|||
163214937|NCT00492115|589501138|FG001|Overall Study|Withdrawal by Subject|4|||
163214938|NCT01288287|589501139|FG000|Overall Study|Lost to Follow-up|8|||
163214939|NCT01288287|589501139|FG000|Overall Study|Withdrawal by Subject|4|||
163214940|NCT01288287|589501139|FG000|Overall Study|Lack of Efficacy|13|||
163214941|NCT01288287|589501139|FG000|Overall Study|Other Reason|13|||
163214942|NCT01288287|589501139|FG000|Overall Study|Unknown Reason|1|||
163214943|NCT01288287|589501139|FG000|Overall Study|Unknown Status|7|||
163214944|NCT02515045|589501150|FG000|Overall Study|Adverse Event|0|||
163214945|NCT02515045|589501151|FG001|Overall Study|Adverse Event|3|||
163214946|NCT02515045|589501152|FG002|Overall Study|Adverse Event|3|||
163214947|NCT02515045|589501150|FG000|Overall Study|Lost to Follow-up|0|||
163214948|NCT02515045|589501151|FG001|Overall Study|Lost to Follow-up|1|||
163214949|NCT02515045|589501152|FG002|Overall Study|Lost to Follow-up|1|||
163214950|NCT00238121|589501153|FG000|Overall Study|Withdrawal by Subject|1|||
163214951|NCT00238121|589501154|FG001|Overall Study|Withdrawal by Subject|1|||
163214952|NCT00238121|589501153|FG000|Overall Study|Adverse Event|2|||
163214953|NCT00238121|589501154|FG001|Overall Study|Adverse Event|1|||
163214954|NCT03255382|589501155|FG000|Overall Study|Adverse Event|3|||
163214955|NCT03255382|589501156|FG001|Overall Study|Adverse Event|0|||
163214956|NCT03255382|589501155|FG000|Overall Study|Lost to Follow-up|2|||
163214957|NCT03255382|589501156|FG001|Overall Study|Lost to Follow-up|0|||
163062513|NCT03329001|588936868|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
163062514|NCT03329001|588936869|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
163062515|NCT03329001|588936870|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
163062516|NCT03329001|588936871|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
163062517|NCT03329001|588936872|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
163062518|NCT03329001|588936873|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
163062519|NCT03329001|588936874|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
163062520|NCT03329001|588936875|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
163062521|NCT03329001|588936868|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
163062522|NCT03329001|588936869|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
163214958|NCT03255382|589501155|FG000|Overall Study|Withdrawal by Subject|2|||
163214959|NCT03255382|589501156|FG001|Overall Study|Withdrawal by Subject|0|||
163214960|NCT03255382|589501155|FG000|Overall Study|Other|6|||
163214961|NCT03255382|589501156|FG001|Overall Study|Other|0|||
163214962|NCT02221284|589501157|FG000|Overall Study|Case Report Forms Uncollected|56|||
163214963|NCT02221284|589501157|FG000|Overall Study|Protocol Deviation|5|||
163214964|NCT00101907|589501161|FG000|Overall Study|Adverse Event|1|||
163214965|NCT00101907|589501162|FG001|Overall Study|Adverse Event|0|||
163214966|NCT00101907|589501163|FG002|Overall Study|Adverse Event|0|||
163214967|NCT00101907|589501164|FG003|Overall Study|Adverse Event|0|||
163214968|NCT00101907|589501165|FG004|Overall Study|Adverse Event|0|||
163214969|NCT00101907|589501166|FG005|Overall Study|Adverse Event|0|||
163214970|NCT00101907|589501161|FG000|Overall Study|Death|0|||
163214971|NCT00101907|589501162|FG001|Overall Study|Death|1|||
163214972|NCT00101907|589501163|FG002|Overall Study|Death|0|||
163214973|NCT00101907|589501164|FG003|Overall Study|Death|0|||
163214974|NCT00101907|589501165|FG004|Overall Study|Death|3|||
163328359|NCT00776009|589913214|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
163328360|NCT00776009|589913215|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
163328361|NCT00776009|589913216|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
163328362|NCT00776009|589913217|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
163328363|NCT00776009|589913212|FG000|Period 2: Second Intervention|Protocol Violation|1|||
163328364|NCT00776009|589913213|FG001|Period 2: Second Intervention|Protocol Violation|0|||
163328365|NCT00776009|589913214|FG002|Period 2: Second Intervention|Protocol Violation|1|||
163328366|NCT00776009|589913215|FG003|Period 2: Second Intervention|Protocol Violation|0|||
163328367|NCT00776009|589913216|FG004|Period 2: Second Intervention|Protocol Violation|0|||
163404579|NCT01157364|590191961|FG003|Overall Study|Lost to Follow-up|0|||
163404580|NCT01157364|590191962|FG004|Overall Study|Lost to Follow-up|0|||
163214975|NCT00101907|589501166|FG005|Overall Study|Death|0|||
163214976|NCT00101907|589501161|FG000|Overall Study|Physician Decision|0|||
163214977|NCT00101907|589501162|FG001|Overall Study|Physician Decision|0|||
163214978|NCT00101907|589501163|FG002|Overall Study|Physician Decision|0|||
163214979|NCT00101907|589501164|FG003|Overall Study|Physician Decision|1|||
163214980|NCT00101907|589501165|FG004|Overall Study|Physician Decision|1|||
163214981|NCT00101907|589501166|FG005|Overall Study|Physician Decision|0|||
163214982|NCT00101907|589501161|FG000|Overall Study|Withdrawal by Subject|1|||
163214983|NCT00101907|589501162|FG001|Overall Study|Withdrawal by Subject|0|||
163214984|NCT00101907|589501163|FG002|Overall Study|Withdrawal by Subject|1|||
163214985|NCT00101907|589501164|FG003|Overall Study|Withdrawal by Subject|0|||
163214986|NCT00101907|589501165|FG004|Overall Study|Withdrawal by Subject|1|||
163214987|NCT00101907|589501166|FG005|Overall Study|Withdrawal by Subject|0|||
163214988|NCT00624052|589501167|FG000|Overall Study|Adverse Event|7|||
163214989|NCT00624052|589501168|FG001|Overall Study|Adverse Event|6|||
163214990|NCT00624052|589501169|FG002|Overall Study|Adverse Event|0|||
163214991|NCT00624052|589501170|FG003|Overall Study|Adverse Event|3|||
163214992|NCT00624052|589501167|FG000|Overall Study|Lack of Efficacy|1|||
163214993|NCT00624052|589501168|FG001|Overall Study|Lack of Efficacy|1|||
163214994|NCT00624052|589501169|FG002|Overall Study|Lack of Efficacy|0|||
163214995|NCT00624052|589501170|FG003|Overall Study|Lack of Efficacy|0|||
163214996|NCT00624052|589501167|FG000|Overall Study|Lost to Follow-up|2|||
163214997|NCT00624052|589501168|FG001|Overall Study|Lost to Follow-up|3|||
163214998|NCT00624052|589501169|FG002|Overall Study|Lost to Follow-up|1|||
163214999|NCT00624052|589501170|FG003|Overall Study|Lost to Follow-up|0|||
163215000|NCT00624052|589501167|FG000|Overall Study|Non compliant with the protocol|2|||
163215001|NCT00624052|589501168|FG001|Overall Study|Non compliant with the protocol|1|||
163215002|NCT00624052|589501169|FG002|Overall Study|Non compliant with the protocol|1|||
163215003|NCT00624052|589501170|FG003|Overall Study|Non compliant with the protocol|1|||
163215004|NCT00624052|589501167|FG000|Overall Study|Consent withdrawn|3|||
163215005|NCT00624052|589501168|FG001|Overall Study|Consent withdrawn|1|||
163215006|NCT00624052|589501169|FG002|Overall Study|Consent withdrawn|1|||
163215007|NCT00624052|589501170|FG003|Overall Study|Consent withdrawn|0|||
163215008|NCT00624052|589501167|FG000|Overall Study|Changed job/ran out if meds|0|||
163215009|NCT00624052|589501168|FG001|Overall Study|Changed job/ran out if meds|2|||
163328368|NCT00776009|589913217|FG005|Period 2: Second Intervention|Protocol Violation|0|||
163328369|NCT00776009|589913212|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
163328370|NCT00776009|589913213|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
163328371|NCT00776009|589913214|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
163328372|NCT00776009|589913215|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
163328373|NCT00776009|589913216|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
163328374|NCT00776009|589913217|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
163328375|NCT01536093|589913223|FG000|Overall Study|Death|1|||
163215010|NCT00624052|589501169|FG002|Overall Study|Changed job/ran out if meds|0|||
163215011|NCT00624052|589501170|FG003|Overall Study|Changed job/ran out if meds|0|||
163215012|NCT01474876|589501175|FG000|Overall Study|Adverse Event|11|||
163215013|NCT01474876|589501176|FG001|Overall Study|Adverse Event|5|||
163215014|NCT01474876|589501177|FG002|Overall Study|Adverse Event|0|||
163215015|NCT01474876|589501175|FG000|Overall Study|Serious Adverse Event|2|||
163215016|NCT01474876|589501176|FG001|Overall Study|Serious Adverse Event|3|||
163215017|NCT01474876|589501177|FG002|Overall Study|Serious Adverse Event|0|||
163215018|NCT01474876|589501175|FG000|Overall Study|Lost to Follow-up|5|||
163215019|NCT01474876|589501176|FG001|Overall Study|Lost to Follow-up|4|||
163215020|NCT01474876|589501177|FG002|Overall Study|Lost to Follow-up|0|||
163215021|NCT01474876|589501175|FG000|Overall Study|Investigator's decision|28|||
163215022|NCT01474876|589501176|FG001|Overall Study|Investigator's decision|6|||
163215023|NCT01474876|589501177|FG002|Overall Study|Investigator's decision|0|||
163215024|NCT01474876|589501175|FG000|Overall Study|Patient's request|19|||
163215025|NCT01474876|589501176|FG001|Overall Study|Patient's request|5|||
163215026|NCT01474876|589501177|FG002|Overall Study|Patient's request|0|||
163215027|NCT01474876|589501175|FG000|Overall Study|Investigator's decision and pt request|1|||
163215028|NCT01474876|589501176|FG001|Overall Study|Investigator's decision and pt request|0|||
163215029|NCT01474876|589501177|FG002|Overall Study|Investigator's decision and pt request|0|||
163215030|NCT02291055|589501178|FG000|Overall Study|Death|2|||
163215031|NCT02291055|589501179|FG001|Overall Study|Death|2|||
163215032|NCT02291055|589501180|FG002|Overall Study|Death|5|||
163215033|NCT02291055|589501181|FG003|Overall Study|Death|8|||
163215034|NCT02291055|589501182|FG004|Overall Study|Death|12|||
163215035|NCT02291055|589501178|FG000|Overall Study|Lost to Follow-up|0|||
163215036|NCT02291055|589501179|FG001|Overall Study|Lost to Follow-up|0|||
163328376|NCT01536093|589913224|FG001|Overall Study|Death|2|||
163328377|NCT01536093|589913223|FG000|Overall Study|absence of maternal colostrum|2|||
163404581|NCT01157364|590191963|FG005|Overall Study|Lost to Follow-up|0|||
163404582|NCT01157364|590191958|FG000|Overall Study|Lack of Efficacy|0|||
163404583|NCT01157364|590191959|FG001|Overall Study|Lack of Efficacy|0|||
163404584|NCT01157364|590191960|FG002|Overall Study|Lack of Efficacy|0|||
163404585|NCT01157364|590191961|FG003|Overall Study|Lack of Efficacy|1|||
163062523|NCT03329001|588936870|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
163215037|NCT02291055|589501180|FG002|Overall Study|Lost to Follow-up|0|||
163215038|NCT02291055|589501181|FG003|Overall Study|Lost to Follow-up|1|||
163215039|NCT02291055|589501182|FG004|Overall Study|Lost to Follow-up|2|||
163215040|NCT02291055|589501178|FG000|Overall Study|Withdrawal by Subject|3|||
163215041|NCT02291055|589501179|FG001|Overall Study|Withdrawal by Subject|1|||
163215042|NCT02291055|589501180|FG002|Overall Study|Withdrawal by Subject|1|||
163215043|NCT02291055|589501181|FG003|Overall Study|Withdrawal by Subject|5|||
163215044|NCT02291055|589501182|FG004|Overall Study|Withdrawal by Subject|10|||
163215045|NCT02291055|589501178|FG000|Overall Study|Progressive Disease|0|||
163215046|NCT02291055|589501179|FG001|Overall Study|Progressive Disease|0|||
163215047|NCT02291055|589501180|FG002|Overall Study|Progressive Disease|1|||
163215048|NCT02291055|589501181|FG003|Overall Study|Progressive Disease|4|||
163215049|NCT02291055|589501182|FG004|Overall Study|Progressive Disease|2|||
163215050|NCT02291055|589501178|FG000|Overall Study|Study Terminated by Sponsor|0|||
163215051|NCT02291055|589501179|FG001|Overall Study|Study Terminated by Sponsor|0|||
163215052|NCT02291055|589501180|FG002|Overall Study|Study Terminated by Sponsor|0|||
163215053|NCT02291055|589501181|FG003|Overall Study|Study Terminated by Sponsor|5|||
163215054|NCT02291055|589501182|FG004|Overall Study|Study Terminated by Sponsor|1|||
163215055|NCT02291055|589501178|FG000|Overall Study|Other|0|||
163215056|NCT02291055|589501179|FG001|Overall Study|Other|2|||
163215057|NCT02291055|589501180|FG002|Overall Study|Other|1|||
163215058|NCT02291055|589501181|FG003|Overall Study|Other|4|||
163215059|NCT02291055|589501182|FG004|Overall Study|Other|0|||
163215060|NCT01523886|589501184|FG000|Overall Study|surgery cancelled|0|||
163215061|NCT01523886|589501185|FG001|Overall Study|surgery cancelled|1|||
163215062|NCT03839212|589501189|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
163215063|NCT00679263|589501190|FG000|Visit 2/Dose 1|Adverse Event|1|||
163215064|NCT00679263|589501191|FG001|Visit 2/Dose 1|Adverse Event|0|||
163215065|NCT00679263|589501192|FG002|Visit 2/Dose 1|Adverse Event|0|||
163215066|NCT00679263|589501190|FG000|Visit 2/Dose 1|subject not compliance|1|||
163215067|NCT00679263|589501191|FG001|Visit 2/Dose 1|subject not compliance|1|||
163215068|NCT00679263|589501192|FG002|Visit 2/Dose 1|subject not compliance|0|||
163215069|NCT00733746|589501198|FG000|Overall Study|Ineligible|5|||
163215070|NCT02113956|589501199|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
163215071|NCT02113956|589501200|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
163215072|NCT02113956|589501199|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
163215073|NCT02113956|589501200|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
163215074|NCT02113956|589501199|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
163215075|NCT02113956|589501200|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
163215076|NCT01499563|589501203|FG000|Overall Study|Withdrawal by Subject|10|||
163215077|NCT01499563|589501204|FG001|Overall Study|Withdrawal by Subject|11|||
163215078|NCT01499563|589501205|FG002|Overall Study|Withdrawal by Subject|7|||
163215079|NCT01499563|589501206|FG003|Overall Study|Withdrawal by Subject|8|||
163215080|NCT01499563|589501203|FG000|Overall Study|Physician Decision|2|||
163215081|NCT01499563|589501204|FG001|Overall Study|Physician Decision|1|||
163215082|NCT01499563|589501205|FG002|Overall Study|Physician Decision|3|||
163215083|NCT01499563|589501206|FG003|Overall Study|Physician Decision|0|||
163215084|NCT01499563|589501203|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
163215085|NCT01499563|589501204|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
163215086|NCT01499563|589501205|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
163215087|NCT01499563|589501206|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
163215088|NCT01499563|589501203|FG000|Overall Study|Adverse Event|2|||
163215089|NCT01499563|589501204|FG001|Overall Study|Adverse Event|0|||
163215090|NCT01499563|589501205|FG002|Overall Study|Adverse Event|1|||
163215091|NCT01499563|589501206|FG003|Overall Study|Adverse Event|3|||
163215092|NCT01499563|589501203|FG000|Overall Study|Lack of Efficacy|0|||
163215093|NCT01499563|589501204|FG001|Overall Study|Lack of Efficacy|1|||
163328378|NCT01536093|589913224|FG001|Overall Study|absence of maternal colostrum|0|||
163328379|NCT01536093|589913223|FG000|Overall Study|Withdrawal by Subject|0|||
163328380|NCT01536093|589913224|FG001|Overall Study|Withdrawal by Subject|1|||
163328381|NCT03631407|589913227|FG000|Overall Study|Withdrawal by Subject|3|||
163328382|NCT03631407|589913228|FG001|Overall Study|Withdrawal by Subject|2|||
163328383|NCT03631407|589913227|FG000|Overall Study|Sponsor Decision|0|||
163328384|NCT03631407|589913228|FG001|Overall Study|Sponsor Decision|2|||
163328385|NCT03631407|589913227|FG000|Overall Study|Death|16|||
163328386|NCT03631407|589913228|FG001|Overall Study|Death|16|||
163328387|NCT03631407|589913227|FG000|Overall Study|Randomized by mistake without study treatment|1|||
163328388|NCT03631407|589913228|FG001|Overall Study|Randomized by mistake without study treatment|0|||
163328389|NCT00811941|589913230|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
163328390|NCT00811941|589913231|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
163011906|NCT04225715|588745750|FG007|Overall Study|Arm Terminated By Sponsor|17|||
163215094|NCT01499563|589501205|FG002|Overall Study|Lack of Efficacy|6|||
163215095|NCT01499563|589501206|FG003|Overall Study|Lack of Efficacy|3|||
163011907|NCT04225715|588745751|FG008|Overall Study|Arm Terminated By Sponsor|18|||
163215096|NCT01499563|589501203|FG000|Overall Study|Other|8|||
163215097|NCT01499563|589501204|FG001|Overall Study|Other|6|||
163215098|NCT01499563|589501205|FG002|Overall Study|Other|6|||
163011908|NCT01894841|588745752|FG000|Overall Study|Withdrawal by Subject|9|||
163215099|NCT01499563|589501206|FG003|Overall Study|Other|4|||
163215100|NCT03658538|589501207|FG000|Overall Study|Death|2|||
163328391|NCT00811941|589913230|FG000|All Treated Patients|Adverse Event|2|||
163011909|NCT01894841|588745753|FG001|Overall Study|Withdrawal by Subject|4|||
163215101|NCT03658538|589501208|FG001|Overall Study|Death|1|||
163215102|NCT03658538|589501207|FG000|Overall Study|Cancer diagnosis|1|||
163215103|NCT03658538|589501208|FG001|Overall Study|Cancer diagnosis|0|||
163215104|NCT03658538|589501207|FG000|Overall Study|Change residence|1|||
163011910|NCT01894841|588745752|FG000|Overall Study|Withdrawn by investigator|2|||
163011911|NCT01894841|588745753|FG001|Overall Study|Withdrawn by investigator|2|||
163011912|NCT01894841|588745752|FG000|Overall Study|Lost to Follow-up|7|||
163011913|NCT01894841|588745753|FG001|Overall Study|Lost to Follow-up|3|||
163011914|NCT04168112|588745754|FG000|Overall Study|Lost to Follow-up|1|||
163011915|NCT04168112|588745755|FG001|Overall Study|Lost to Follow-up|0|||
163011916|NCT04168112|588745754|FG000|Overall Study|Withdrawal by Subject|1|||
163011917|NCT04168112|588745755|FG001|Overall Study|Withdrawal by Subject|0|||
163011918|NCT02275546|588745758|FG000|Treatment Period 2|Withdrawal by Subject|2|||
163011919|NCT02275546|588745759|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163011920|NCT02275546|588745758|FG000|Treatment Period 2|Protocol Violation|0|||
163011921|NCT02275546|588745759|FG001|Treatment Period 2|Protocol Violation|1|||
163011922|NCT00570141|588745769|FG000|Overall Study|Adverse Event|1|||
163011923|NCT00570141|588745769|FG000|Overall Study|Missed visits|1|||
163011924|NCT00570141|588745769|FG000|Overall Study|Lost to Follow-up|1|||
163011925|NCT00925704|588745770|FG000|First Intervention|Withdrew consent|0|||
163011926|NCT00925704|588745771|FG001|First Intervention|Withdrew consent|0|||
163011927|NCT00925704|588745772|FG002|First Intervention|Withdrew consent|0|||
163011928|NCT00925704|588745773|FG003|First Intervention|Withdrew consent|1|||
163011929|NCT00925704|588745774|FG004|First Intervention|Withdrew consent|1|||
163011930|NCT00925704|588745775|FG005|First Intervention|Withdrew consent|0|||
163011931|NCT00925704|588745770|FG000|Second Intervention|Withdrawal by Subject|1|||
163011932|NCT00925704|588745771|FG001|Second Intervention|Withdrawal by Subject|0|||
163011933|NCT00925704|588745772|FG002|Second Intervention|Withdrawal by Subject|0|||
163011934|NCT00925704|588745773|FG003|Second Intervention|Withdrawal by Subject|0|||
163011935|NCT00925704|588745774|FG004|Second Intervention|Withdrawal by Subject|1|||
163011936|NCT00925704|588745775|FG005|Second Intervention|Withdrawal by Subject|0|||
163011937|NCT00925704|588745770|FG000|Third Intervention|Withdrew consent|0|||
163011938|NCT00925704|588745771|FG001|Third Intervention|Withdrew consent|0|||
163011939|NCT00925704|588745772|FG002|Third Intervention|Withdrew consent|0|||
163011940|NCT00925704|588745773|FG003|Third Intervention|Withdrew consent|0|||
163011941|NCT00925704|588745774|FG004|Third Intervention|Withdrew consent|0|||
163011942|NCT00925704|588745775|FG005|Third Intervention|Withdrew consent|1|||
163011943|NCT03817853|588745778|FG000|Induction Phase|Adverse Event|5|||
163011944|NCT03817853|588745779|FG001|Induction Phase|Adverse Event|0|||
163011945|NCT03817853|588745780|FG002|Induction Phase|Adverse Event|0|||
163011946|NCT03817853|588745778|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
163011947|NCT03817853|588745779|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
163011948|NCT03817853|588745780|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
163011949|NCT03817853|588745778|FG000|Induction Phase|Physician Decision|2|||
163011950|NCT03817853|588745779|FG001|Induction Phase|Physician Decision|0|||
163011951|NCT03817853|588745780|FG002|Induction Phase|Physician Decision|0|||
163011952|NCT03817853|588745778|FG000|Induction Phase|Progressive Disease|6|||
163011953|NCT03817853|588745779|FG001|Induction Phase|Progressive Disease|0|||
163011954|NCT03817853|588745780|FG002|Induction Phase|Progressive Disease|0|||
163011955|NCT03817853|588745778|FG000|Induction Phase|Withdrawal by Subject|4|||
163011956|NCT03817853|588745779|FG001|Induction Phase|Withdrawal by Subject|0|||
163011957|NCT03817853|588745780|FG002|Induction Phase|Withdrawal by Subject|0|||
163011958|NCT03817853|588745778|FG000|Maintenance Phase|Adverse Event|0|||
163011959|NCT03817853|588745779|FG001|Maintenance Phase|Adverse Event|8|||
163011960|NCT03817853|588745780|FG002|Maintenance Phase|Adverse Event|0|||
163011961|NCT03817853|588745778|FG000|Maintenance Phase|Death|0|||
163011962|NCT03817853|588745779|FG001|Maintenance Phase|Death|5|||
163011963|NCT03817853|588745780|FG002|Maintenance Phase|Death|0|||
163011964|NCT03817853|588745778|FG000|Maintenance Phase|Progressive Disease|0|||
163011965|NCT03817853|588745779|FG001|Maintenance Phase|Progressive Disease|7|||
163011966|NCT03817853|588745780|FG002|Maintenance Phase|Progressive Disease|0|||
163011967|NCT03817853|588745778|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163011968|NCT03817853|588745779|FG001|Maintenance Phase|Withdrawal by Subject|2|||
163011969|NCT03817853|588745780|FG002|Maintenance Phase|Withdrawal by Subject|0|||
163011970|NCT03817853|588745778|FG000|Maintenance Phase|Physician Decision|0|||
163011971|NCT03817853|588745779|FG001|Maintenance Phase|Physician Decision|1|||
163011972|NCT03817853|588745780|FG002|Maintenance Phase|Physician Decision|0|||
163011973|NCT03817853|588745778|FG000|Maintenance Phase|Various reasons|0|||
163011974|NCT03817853|588745779|FG001|Maintenance Phase|Various reasons|4|||
163011975|NCT03817853|588745780|FG002|Maintenance Phase|Various reasons|0|||
163011976|NCT03817853|588745778|FG000|Maintenance Phase|Protocol Deviation|0|||
163011977|NCT03817853|588745779|FG001|Maintenance Phase|Protocol Deviation|1|||
163011978|NCT03817853|588745780|FG002|Maintenance Phase|Protocol Deviation|0|||
163011979|NCT03817853|588745778|FG000|Follow-up Phase|Adverse Event|0|||
163011980|NCT03817853|588745779|FG001|Follow-up Phase|Adverse Event|0|||
163011981|NCT03817853|588745780|FG002|Follow-up Phase|Adverse Event|2|||
163011982|NCT03817853|588745778|FG000|Follow-up Phase|Death|0|||
163011983|NCT03817853|588745779|FG001|Follow-up Phase|Death|0|||
163011984|NCT03817853|588745780|FG002|Follow-up Phase|Death|1|||
163062524|NCT03329001|588936871|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
163062525|NCT03329001|588936872|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
163062526|NCT03329001|588936873|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
163062527|NCT03329001|588936874|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
163062528|NCT03329001|588936875|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
163062529|NCT03329001|588936868|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
163062530|NCT03329001|588936869|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
163062531|NCT03329001|588936870|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
163062532|NCT03329001|588936871|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
163062533|NCT03329001|588936872|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
163062534|NCT03329001|588936873|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
163062535|NCT03329001|588936874|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
163062536|NCT03329001|588936875|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
163011985|NCT03817853|588745778|FG000|Follow-up Phase|Progressive Disease|0|||
163011986|NCT03817853|588745779|FG001|Follow-up Phase|Progressive Disease|0|||
163011987|NCT03817853|588745780|FG002|Follow-up Phase|Progressive Disease|3|||
163011988|NCT03817853|588745778|FG000|Follow-up Phase|Withdrawal by Subject|0|||
163011989|NCT03817853|588745779|FG001|Follow-up Phase|Withdrawal by Subject|0|||
163011990|NCT03817853|588745780|FG002|Follow-up Phase|Withdrawal by Subject|1|||
163011991|NCT05005507|588745781|FG000|Overall Study|Premature termination of study|1|||
163011992|NCT03866512|588745783|FG000|Overall Study|Lost to Follow-up|1|||
163011993|NCT03866512|588745784|FG001|Overall Study|Lost to Follow-up|2|||
163011994|NCT03866512|588745785|FG002|Overall Study|Lost to Follow-up|1|||
163011995|NCT03866512|588745783|FG000|Overall Study|Cannulation issues|0|||
163011996|NCT03866512|588745784|FG001|Overall Study|Cannulation issues|1|||
163011997|NCT03866512|588745785|FG002|Overall Study|Cannulation issues|2|||
163011998|NCT00320710|588745786|FG000|Overall Study|Disease progression|24|||
163062537|NCT03329001|588936868|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
163062538|NCT03329001|588936869|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
163062539|NCT03329001|588936870|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
163062540|NCT03329001|588936871|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
163062541|NCT03329001|588936872|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
163062542|NCT03329001|588936873|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
163062543|NCT03329001|588936874|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
163062544|NCT03329001|588936875|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
163062545|NCT03329001|588936868|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
163062546|NCT03329001|588936869|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
163062547|NCT03329001|588936870|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
163062548|NCT03329001|588936871|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
163062549|NCT03329001|588936872|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
163062550|NCT03329001|588936873|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
163062551|NCT03329001|588936874|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
163062552|NCT03329001|588936875|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
163062553|NCT03329001|588936868|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
163062554|NCT03329001|588936869|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
163062555|NCT03329001|588936870|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
163062556|NCT03329001|588936871|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
163062557|NCT03329001|588936872|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
163062558|NCT03329001|588936873|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
163062559|NCT03329001|588936874|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
163062560|NCT03329001|588936875|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
163062561|NCT03329001|588936868|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
163062562|NCT03329001|588936869|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
163062563|NCT03329001|588936870|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
163062564|NCT03329001|588936871|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
163328392|NCT00811941|589913231|FG001|All Treated Patients|Adverse Event|43|||
163328393|NCT00811941|589913230|FG000|All Treated Patients|Lack of Efficacy|2|||
163328394|NCT00811941|589913231|FG001|All Treated Patients|Lack of Efficacy|3|||
163328395|NCT00811941|589913230|FG000|All Treated Patients|Non-compliance|1|||
163328396|NCT00811941|589913231|FG001|All Treated Patients|Non-compliance|8|||
163011999|NCT00320710|588745787|FG001|Overall Study|Disease progression|19|||
163012000|NCT00320710|588745788|FG002|Overall Study|Disease progression|2|||
163012001|NCT00320710|588745786|FG000|Overall Study|Death|10|||
163012002|NCT00320710|588745787|FG001|Overall Study|Death|7|||
163012003|NCT00320710|588745788|FG002|Overall Study|Death|1|||
163012004|NCT00320710|588745786|FG000|Overall Study|Administrative problems|1|||
163012005|NCT00320710|588745787|FG001|Overall Study|Administrative problems|2|||
163012006|NCT00320710|588745788|FG002|Overall Study|Administrative problems|0|||
163012007|NCT00320710|588745786|FG000|Overall Study|Withdrawal by Subject|20|||
163012008|NCT00320710|588745787|FG001|Overall Study|Withdrawal by Subject|26|||
163012009|NCT00320710|588745788|FG002|Overall Study|Withdrawal by Subject|1|||
163012010|NCT00320710|588745786|FG000|Overall Study|Protocol Violation|6|||
163012011|NCT00320710|588745787|FG001|Overall Study|Protocol Violation|5|||
163012012|NCT00320710|588745788|FG002|Overall Study|Protocol Violation|0|||
163012013|NCT00320710|588745786|FG000|Overall Study|Abnormal test procedure result(s)|2|||
163012014|NCT00320710|588745787|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163012015|NCT00320710|588745788|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163012016|NCT00320710|588745786|FG000|Overall Study|Abnormal laboratory value(s)|12|||
163012017|NCT00320710|588745787|FG001|Overall Study|Abnormal laboratory value(s)|3|||
163012018|NCT00320710|588745788|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163012019|NCT00320710|588745786|FG000|Overall Study|Adverse Event|18|||
163012020|NCT00320710|588745787|FG001|Overall Study|Adverse Event|14|||
163012021|NCT00320710|588745788|FG002|Overall Study|Adverse Event|1|||
163012022|NCT00320710|588745786|FG000|Overall Study|Lost to Follow-up|1|||
163012023|NCT00320710|588745787|FG001|Overall Study|Lost to Follow-up|0|||
163012024|NCT00320710|588745788|FG002|Overall Study|Lost to Follow-up|0|||
163012025|NCT00997373|588745794|FG000|Overall Study|Withdrawal by Subject|5|||
163012026|NCT00997373|588745795|FG001|Overall Study|Withdrawal by Subject|0|||
163012027|NCT00997373|588745794|FG000|Overall Study|wrong tumor type|4|||
163012028|NCT00997373|588745795|FG001|Overall Study|wrong tumor type|0|||
163012029|NCT00997373|588745794|FG000|Overall Study|could not have hysterectomy|6|||
163012030|NCT00997373|588745795|FG001|Overall Study|could not have hysterectomy|0|||
163012031|NCT04578457|588745796|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
163012032|NCT04578457|588745796|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
163012033|NCT04578457|588745796|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
163012034|NCT04578457|588745796|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
163012035|NCT00832455|588745797|FG000|Overall Study|Adverse Event|13|||
163012036|NCT00832455|588745797|FG000|Overall Study|Lost to Follow-up|26|||
163012037|NCT00832455|588745797|FG000|Overall Study|Protocol Violation|4|||
163012038|NCT00832455|588745797|FG000|Overall Study|Withdrawal by Subject|17|||
163012039|NCT00832455|588745797|FG000|Overall Study|Screening Failure|2|||
163012040|NCT00832455|588745797|FG000|Overall Study|Stopped Medication|4|||
163012041|NCT00832455|588745797|FG000|Overall Study|Parent misunderstood study|1|||
163012042|NCT00832455|588745797|FG000|Overall Study|Parent dissatisfied|1|||
163012043|NCT00832455|588745797|FG000|Overall Study|No improvement|3|||
163012044|NCT00832455|588745797|FG000|Overall Study|Patient moved|1|||
163012045|NCT02841995|588745805|FG000|Overall Study|Disease progression|5|||
163012046|NCT02841995|588745806|FG001|Overall Study|Disease progression|11|||
163012047|NCT02841995|588745807|FG002|Overall Study|Disease progression|8|||
163012048|NCT02841995|588745805|FG000|Overall Study|Withdrawal by Subject|2|||
163012049|NCT02841995|588745806|FG001|Overall Study|Withdrawal by Subject|4|||
163012050|NCT02841995|588745807|FG002|Overall Study|Withdrawal by Subject|4|||
163012051|NCT02841995|588745805|FG000|Overall Study|Adverse Event|2|||
163012052|NCT02841995|588745806|FG001|Overall Study|Adverse Event|0|||
163012053|NCT02841995|588745807|FG002|Overall Study|Adverse Event|1|||
163012054|NCT02841995|588745805|FG000|Overall Study|Investigator decision|2|||
163012055|NCT02841995|588745806|FG001|Overall Study|Investigator decision|0|||
163012056|NCT02841995|588745807|FG002|Overall Study|Investigator decision|1|||
163012057|NCT02841995|588745805|FG000|Overall Study|Death|0|||
163012058|NCT02841995|588745806|FG001|Overall Study|Death|0|||
163012059|NCT02841995|588745807|FG002|Overall Study|Death|2|||
163012060|NCT02841995|588745805|FG000|Overall Study|Noncompliance to protocol|1|||
163012061|NCT02841995|588745806|FG001|Overall Study|Noncompliance to protocol|0|||
163012062|NCT02841995|588745807|FG002|Overall Study|Noncompliance to protocol|0|||
163012063|NCT02841995|588745805|FG000|Overall Study|Sponsor decision|1|||
163012064|NCT02841995|588745806|FG001|Overall Study|Sponsor decision|0|||
163012065|NCT02841995|588745807|FG002|Overall Study|Sponsor decision|0|||
163012066|NCT02841995|588745805|FG000|Overall Study|Other|4|||
163012067|NCT02841995|588745806|FG001|Overall Study|Other|1|||
163012068|NCT02841995|588745807|FG002|Overall Study|Other|5|||
163012069|NCT02755103|588745809|FG000|Overall Study|Lost to Follow-up|17|||
163012070|NCT02755103|588745810|FG001|Overall Study|Lost to Follow-up|15|||
163012071|NCT02755103|588745809|FG000|Overall Study|Death|0|||
163012072|NCT02755103|588745810|FG001|Overall Study|Death|1|||
163012073|NCT02755103|588745809|FG000|Overall Study|Physician Decision|0|||
163012074|NCT02755103|588745810|FG001|Overall Study|Physician Decision|1|||
163012075|NCT02755103|588745809|FG000|Overall Study|Pregnancy|0|||
163012076|NCT02755103|588745810|FG001|Overall Study|Pregnancy|1|||
163012077|NCT02755103|588745809|FG000|Overall Study|Withdrawal by Subject|3|||
163012078|NCT02755103|588745810|FG001|Overall Study|Withdrawal by Subject|0|||
163012079|NCT00739661|588745818|FG000|Overall Study|Adverse Event|2|||
163012080|NCT00739661|588745819|FG001|Overall Study|Adverse Event|0|||
163012081|NCT00739661|588745818|FG000|Overall Study|Physician decision to withdraw patient|1|||
163215105|NCT03658538|589501208|FG001|Overall Study|Change residence|2|||
163215106|NCT03658538|589501207|FG000|Overall Study|Lost to Follow-up|3|||
163215107|NCT03658538|589501208|FG001|Overall Study|Lost to Follow-up|3|||
163215108|NCT03658538|589501207|FG000|Overall Study|Unblinded|2|||
163215109|NCT03658538|589501208|FG001|Overall Study|Unblinded|3|||
163215110|NCT03658538|589501207|FG000|Overall Study|Physician Decision|0|||
163215111|NCT03658538|589501208|FG001|Overall Study|Physician Decision|1|||
163215112|NCT03658538|589501207|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
163215113|NCT03658538|589501208|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
163215114|NCT03658538|589501207|FG000|Overall Study|Evicted from home|1|||
163215115|NCT03658538|589501208|FG001|Overall Study|Evicted from home|0|||
163215116|NCT00597012|589501211|FG000|Overall Study|Death|1|||
163215117|NCT00597012|589501212|FG001|Overall Study|Death|1|||
163215118|NCT00597012|589501211|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
163215119|NCT00597012|589501212|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
163215120|NCT00597012|589501211|FG000|Overall Study|Withdrawal by Subject|7|||
163215121|NCT00597012|589501212|FG001|Overall Study|Withdrawal by Subject|4|||
163215122|NCT00597012|589501211|FG000|Overall Study|Ineligible|2|||
163215123|NCT00597012|589501212|FG001|Overall Study|Ineligible|0|||
163215124|NCT00597012|589501211|FG000|Overall Study|Lost to Follow-up|0|||
163215125|NCT00597012|589501212|FG001|Overall Study|Lost to Follow-up|2|||
163215126|NCT02926924|589503772|FG000|Overall Study|withdrawal - reason unknown|0|||
163215127|NCT02926924|589503773|FG001|Overall Study|withdrawal - reason unknown|1|||
163215128|NCT04146545|589503779|FG000|Overall Study|deemed ineligible after randomization|1|||
163215129|NCT04146545|589503780|FG001|Overall Study|deemed ineligible after randomization|0|||
163215130|NCT01139450|589503783|FG000|Overall Study|Withdrawal by Subject|7|||
163215131|NCT01139450|589503784|FG001|Overall Study|Withdrawal by Subject|10|||
163215132|NCT01139450|589503785|FG002|Overall Study|Withdrawal by Subject|13|||
163215133|NCT01139450|589503783|FG000|Overall Study|Lack of Efficacy|3|||
163215134|NCT01139450|589503784|FG001|Overall Study|Lack of Efficacy|1|||
163215135|NCT01139450|589503785|FG002|Overall Study|Lack of Efficacy|8|||
163215136|NCT01139450|589503783|FG000|Overall Study|Protocol Violation|6|||
163215137|NCT01139450|589503784|FG001|Overall Study|Protocol Violation|5|||
163215138|NCT01139450|589503785|FG002|Overall Study|Protocol Violation|2|||
163012082|NCT00739661|588745819|FG001|Overall Study|Physician decision to withdraw patient|0|||
163012083|NCT00739661|588745818|FG000|Overall Study|Patient decision to withdraw|9|||
163012084|NCT00739661|588745819|FG001|Overall Study|Patient decision to withdraw|4|||
163215139|NCT01139450|589503783|FG000|Overall Study|Lost to Follow-up|9|||
163215140|NCT01139450|589503784|FG001|Overall Study|Lost to Follow-up|7|||
163215141|NCT01139450|589503785|FG002|Overall Study|Lost to Follow-up|11|||
163215142|NCT01139450|589503783|FG000|Overall Study|Administrative|0|||
163215143|NCT01139450|589503784|FG001|Overall Study|Administrative|0|||
163215144|NCT01139450|589503785|FG002|Overall Study|Administrative|1|||
163215145|NCT01139450|589503783|FG000|Overall Study|Adverse Event|2|||
163215146|NCT01139450|589503784|FG001|Overall Study|Adverse Event|2|||
163215147|NCT01139450|589503785|FG002|Overall Study|Adverse Event|3|||
163215148|NCT01277523|589503786|FG000|Overall Study|Adverse Event|1|||
163215149|NCT01277523|589503787|FG001|Overall Study|Adverse Event|0|||
163215150|NCT01277523|589503788|FG002|Overall Study|Adverse Event|0|||
163215151|NCT01277523|589503786|FG000|Overall Study|Protocol Violation|2|||
163215152|NCT01277523|589503787|FG001|Overall Study|Protocol Violation|0|||
163215153|NCT01277523|589503788|FG002|Overall Study|Protocol Violation|0|||
163215154|NCT01277523|589503786|FG000|Overall Study|Other Reason not Defined|0|||
163215155|NCT01277523|589503787|FG001|Overall Study|Other Reason not Defined|1|||
163215156|NCT01277523|589503788|FG002|Overall Study|Other Reason not Defined|0|||
163215157|NCT04762680|589503798|FG000|Phase 2|Adverse Event|0|||
163215158|NCT04762680|589503799|FG001|Phase 2|Adverse Event|1|||
163215159|NCT04762680|589503800|FG002|Phase 2|Adverse Event|0|||
163328397|NCT00811941|589913230|FG000|All Treated Patients|Protocol Violation|5|||
163328398|NCT00811941|589913231|FG001|All Treated Patients|Protocol Violation|17|||
163012085|NCT00739661|588745818|FG000|Overall Study|Disease progression, radiographic|33|||
163012086|NCT00739661|588745819|FG001|Overall Study|Disease progression, radiographic|37|||
163012087|NCT00739661|588745818|FG000|Overall Study|Reason for discontinuation not available|1|||
163215160|NCT04762680|589503801|FG003|Phase 2|Adverse Event|0|||
163215161|NCT04762680|589503802|FG004|Phase 2|Adverse Event|0|||
163012088|NCT00739661|588745819|FG001|Overall Study|Reason for discontinuation not available|1|||
163215162|NCT04762680|589503803|FG005|Phase 2|Adverse Event|0|||
163215163|NCT04762680|589503804|FG006|Phase 2|Adverse Event|0|||
163215164|NCT04762680|589503805|FG007|Phase 2|Adverse Event|0|||
163328399|NCT00811941|589913230|FG000|All Treated Patients|Withdrawal by Subject|35|||
163404586|NCT01157364|590191962|FG004|Overall Study|Lack of Efficacy|0|||
163012089|NCT02883062|588745822|FG000|Overall Study|Withdrawal by Subject|6|||
163215165|NCT04762680|589503806|FG008|Phase 2|Adverse Event|0|||
163215166|NCT04762680|589503807|FG009|Phase 2|Adverse Event|0|||
163215167|NCT04762680|589503808|FG010|Phase 2|Adverse Event|0|||
163215168|NCT04762680|589503809|FG011|Phase 2|Adverse Event|0|||
163215169|NCT04762680|589503810|FG012|Phase 2|Adverse Event|0|||
163215170|NCT04762680|589503811|FG013|Phase 2|Adverse Event|0|||
163215171|NCT04762680|589503812|FG014|Phase 2|Adverse Event|0|||
163012090|NCT02883062|588745823|FG001|Overall Study|Withdrawal by Subject|0|||
163012091|NCT04578535|588745824|FG000|Overall Study|Lost to Follow-up|1|||
163012092|NCT04578535|588745825|FG001|Overall Study|Lost to Follow-up|0|||
163012093|NCT04578535|588745826|FG002|Overall Study|Lost to Follow-up|0|||
163012094|NCT04578535|588745827|FG003|Overall Study|Lost to Follow-up|1|||
163012095|NCT04578535|588745828|FG004|Overall Study|Lost to Follow-up|0|||
163012096|NCT04578535|588745829|FG005|Overall Study|Lost to Follow-up|2|||
163012097|NCT04578535|588745824|FG000|Overall Study|Pregnancy|1|||
163012098|NCT04578535|588745825|FG001|Overall Study|Pregnancy|0|||
163012099|NCT04578535|588745826|FG002|Overall Study|Pregnancy|0|||
163012100|NCT04578535|588745827|FG003|Overall Study|Pregnancy|0|||
163012101|NCT04578535|588745828|FG004|Overall Study|Pregnancy|0|||
163012102|NCT04578535|588745829|FG005|Overall Study|Pregnancy|0|||
163012103|NCT04578535|588745824|FG000|Overall Study|Withdrawal by Subject|0|||
163012104|NCT04578535|588745825|FG001|Overall Study|Withdrawal by Subject|0|||
163012105|NCT04578535|588745826|FG002|Overall Study|Withdrawal by Subject|0|||
163012106|NCT04578535|588745827|FG003|Overall Study|Withdrawal by Subject|1|||
163012107|NCT04578535|588745828|FG004|Overall Study|Withdrawal by Subject|1|||
163012108|NCT04578535|588745829|FG005|Overall Study|Withdrawal by Subject|5|||
163012109|NCT04578535|588745824|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
163012110|NCT04578535|588745825|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
163012111|NCT04578535|588745826|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
163012112|NCT04578535|588745827|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
163012113|NCT04578535|588745828|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
163012114|NCT04578535|588745829|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
163012115|NCT03839628|588745830|FG000|Overall Study|Withdrawal by Subject|1|||
163012116|NCT00380874|588745831|FG000|Overall Study|Adverse Event|7|||
163012117|NCT00380874|588745832|FG001|Overall Study|Adverse Event|7|||
163012118|NCT00380874|588745831|FG000|Overall Study|Death|1|||
163012119|NCT00380874|588745832|FG001|Overall Study|Death|0|||
163012120|NCT00380874|588745831|FG000|Overall Study|Withdrawal by Subject|2|||
163012121|NCT00380874|588745832|FG001|Overall Study|Withdrawal by Subject|1|||
163012122|NCT00380874|588745831|FG000|Overall Study|Not related to study drug|3|||
163012123|NCT00380874|588745832|FG001|Overall Study|Not related to study drug|2|||
163012124|NCT03380429|588745833|FG000|Overall Study|Physician Decision|0|||
163012125|NCT03380429|588745834|FG001|Overall Study|Physician Decision|1|||
163012126|NCT03380429|588745835|FG002|Overall Study|Physician Decision|0|||
163012127|NCT03380429|588745836|FG003|Overall Study|Physician Decision|1|||
163012128|NCT03380429|588745837|FG004|Overall Study|Physician Decision|1|||
163012129|NCT03380429|588745833|FG000|Overall Study|Withdrawal by Subject|3|||
163012130|NCT03380429|588745834|FG001|Overall Study|Withdrawal by Subject|3|||
163012131|NCT03380429|588745835|FG002|Overall Study|Withdrawal by Subject|5|||
163012132|NCT03380429|588745836|FG003|Overall Study|Withdrawal by Subject|2|||
163012133|NCT03380429|588745837|FG004|Overall Study|Withdrawal by Subject|1|||
163012134|NCT03380429|588745833|FG000|Overall Study|Lost to Follow-up|0|||
163012135|NCT03380429|588745834|FG001|Overall Study|Lost to Follow-up|2|||
163012136|NCT03380429|588745835|FG002|Overall Study|Lost to Follow-up|4|||
163012137|NCT03380429|588745836|FG003|Overall Study|Lost to Follow-up|3|||
163012138|NCT03380429|588745837|FG004|Overall Study|Lost to Follow-up|1|||
163012139|NCT03380429|588745833|FG000|Overall Study|Protocol Violation|1|||
163012140|NCT03380429|588745834|FG001|Overall Study|Protocol Violation|0|||
163012141|NCT03380429|588745835|FG002|Overall Study|Protocol Violation|1|||
163012142|NCT03380429|588745836|FG003|Overall Study|Protocol Violation|0|||
163012143|NCT03380429|588745837|FG004|Overall Study|Protocol Violation|1|||
163215172|NCT04762680|589503813|FG015|Phase 2|Adverse Event|0|||
163215173|NCT04762680|589503814|FG016|Phase 2|Adverse Event|0|||
163012144|NCT03380429|588745833|FG000|Overall Study|Lack of Efficacy|0|||
163012145|NCT03380429|588745834|FG001|Overall Study|Lack of Efficacy|0|||
163012146|NCT03380429|588745835|FG002|Overall Study|Lack of Efficacy|0|||
163012147|NCT03380429|588745836|FG003|Overall Study|Lack of Efficacy|2|||
163012148|NCT03380429|588745837|FG004|Overall Study|Lack of Efficacy|1|||
163012149|NCT03380429|588745833|FG000|Overall Study|Adverse Event|1|||
163012150|NCT03380429|588745834|FG001|Overall Study|Adverse Event|1|||
163012151|NCT03380429|588745835|FG002|Overall Study|Adverse Event|1|||
163012152|NCT03380429|588745836|FG003|Overall Study|Adverse Event|2|||
163012153|NCT03380429|588745837|FG004|Overall Study|Adverse Event|0|||
163012154|NCT01707290|588745842|FG000|Overall Study|Adverse event (AE)|1|||
163012155|NCT01707290|588745843|FG001|Overall Study|Adverse event (AE)|0|||
163012156|NCT01707290|588745842|FG000|Overall Study|Physician Decision|1|||
163012157|NCT01707290|588745843|FG001|Overall Study|Physician Decision|0|||
163012158|NCT01707290|588745842|FG000|Overall Study|Lost to Follow-up|3|||
163012159|NCT01707290|588745843|FG001|Overall Study|Lost to Follow-up|0|||
163012160|NCT01707290|588745842|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
163012161|NCT01707290|588745843|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
163012162|NCT01707290|588745842|FG000|Overall Study|Commercial drug available|60|||
163012163|NCT01707290|588745843|FG001|Overall Study|Commercial drug available|1|||
163012164|NCT01707290|588745842|FG000|Overall Study|Other unspecified|17|||
163012165|NCT01707290|588745843|FG001|Overall Study|Other unspecified|0|||
163215174|NCT04762680|589503815|FG017|Phase 2|Adverse Event|0|||
163215175|NCT04762680|589503816|FG018|Phase 2|Adverse Event|0|||
163215176|NCT04762680|589503817|FG019|Phase 2|Adverse Event|0|||
163215177|NCT04762680|589503818|FG020|Phase 2|Adverse Event|0|||
163215178|NCT04762680|589503819|FG021|Phase 2|Adverse Event|0|||
163215179|NCT04762680|589503798|FG000|Phase 2|Protocol Violation|5|||
163215180|NCT04762680|589503799|FG001|Phase 2|Protocol Violation|5|||
163215181|NCT04762680|589503800|FG002|Phase 2|Protocol Violation|1|||
163012166|NCT02314026|588745844|FG000|Overall Study|Protocol Violation|28|||
163012167|NCT01139775|588745845|FG000|Overall Study|Adverse Event|0|||
163012168|NCT01139775|588745846|FG001|Overall Study|Adverse Event|6|||
163012169|NCT01139775|588745847|FG002|Overall Study|Adverse Event|2|||
163215182|NCT04762680|589503801|FG003|Phase 2|Protocol Violation|0|||
163215183|NCT04762680|589503802|FG004|Phase 2|Protocol Violation|0|||
163215184|NCT04762680|589503803|FG005|Phase 2|Protocol Violation|0|||
163215185|NCT04762680|589503804|FG006|Phase 2|Protocol Violation|0|||
163215186|NCT04762680|589503805|FG007|Phase 2|Protocol Violation|0|||
163215187|NCT04762680|589503806|FG008|Phase 2|Protocol Violation|0|||
163215188|NCT04762680|589503807|FG009|Phase 2|Protocol Violation|0|||
163215189|NCT04762680|589503808|FG010|Phase 2|Protocol Violation|0|||
163215190|NCT04762680|589503809|FG011|Phase 2|Protocol Violation|0|||
163215191|NCT04762680|589503810|FG012|Phase 2|Protocol Violation|0|||
163215192|NCT04762680|589503811|FG013|Phase 2|Protocol Violation|0|||
163215193|NCT04762680|589503812|FG014|Phase 2|Protocol Violation|0|||
163215194|NCT04762680|589503813|FG015|Phase 2|Protocol Violation|0|||
163215195|NCT04762680|589503814|FG016|Phase 2|Protocol Violation|0|||
163215196|NCT04762680|589503815|FG017|Phase 2|Protocol Violation|0|||
163215197|NCT04762680|589503816|FG018|Phase 2|Protocol Violation|0|||
163215198|NCT04762680|589503817|FG019|Phase 2|Protocol Violation|0|||
163215199|NCT04762680|589503818|FG020|Phase 2|Protocol Violation|0|||
163215200|NCT04762680|589503819|FG021|Phase 2|Protocol Violation|0|||
163215201|NCT04762680|589503798|FG000|Phase 2|Withdrawal by Subject|23|||
163215202|NCT04762680|589503799|FG001|Phase 2|Withdrawal by Subject|21|||
163215203|NCT04762680|589503800|FG002|Phase 2|Withdrawal by Subject|28|||
163215204|NCT04762680|589503801|FG003|Phase 2|Withdrawal by Subject|0|||
163215205|NCT04762680|589503802|FG004|Phase 2|Withdrawal by Subject|0|||
163215206|NCT04762680|589503803|FG005|Phase 2|Withdrawal by Subject|0|||
163215207|NCT04762680|589503804|FG006|Phase 2|Withdrawal by Subject|0|||
163215208|NCT04762680|589503805|FG007|Phase 2|Withdrawal by Subject|0|||
163215209|NCT04762680|589503806|FG008|Phase 2|Withdrawal by Subject|0|||
163215210|NCT04762680|589503807|FG009|Phase 2|Withdrawal by Subject|0|||
163215211|NCT04762680|589503808|FG010|Phase 2|Withdrawal by Subject|0|||
163215212|NCT04762680|589503809|FG011|Phase 2|Withdrawal by Subject|0|||
163215213|NCT04762680|589503810|FG012|Phase 2|Withdrawal by Subject|0|||
163215214|NCT04762680|589503811|FG013|Phase 2|Withdrawal by Subject|0|||
163215215|NCT04762680|589503812|FG014|Phase 2|Withdrawal by Subject|0|||
163215216|NCT04762680|589503813|FG015|Phase 2|Withdrawal by Subject|0|||
163215217|NCT04762680|589503814|FG016|Phase 2|Withdrawal by Subject|0|||
163215218|NCT04762680|589503815|FG017|Phase 2|Withdrawal by Subject|0|||
163215219|NCT04762680|589503816|FG018|Phase 2|Withdrawal by Subject|0|||
163215220|NCT04762680|589503817|FG019|Phase 2|Withdrawal by Subject|0|||
163215221|NCT04762680|589503818|FG020|Phase 2|Withdrawal by Subject|0|||
163215222|NCT04762680|589503819|FG021|Phase 2|Withdrawal by Subject|0|||
163215223|NCT04762680|589503798|FG000|Phase 2|Lost to Follow-up|14|||
163215224|NCT04762680|589503799|FG001|Phase 2|Lost to Follow-up|8|||
163215225|NCT04762680|589503800|FG002|Phase 2|Lost to Follow-up|9|||
163215226|NCT04762680|589503801|FG003|Phase 2|Lost to Follow-up|0|||
163012170|NCT01139775|588745845|FG000|Overall Study|Protocol Violation|0|||
163012171|NCT01139775|588745846|FG001|Overall Study|Protocol Violation|5|||
163012172|NCT01139775|588745847|FG002|Overall Study|Protocol Violation|0|||
163012173|NCT01139775|588745845|FG000|Overall Study|Withdrawal by Subject|1|||
163012174|NCT01139775|588745846|FG001|Overall Study|Withdrawal by Subject|0|||
163012175|NCT01139775|588745847|FG002|Overall Study|Withdrawal by Subject|2|||
163012176|NCT01139775|588745845|FG000|Overall Study|Physician Decision|0|||
163012177|NCT01139775|588745846|FG001|Overall Study|Physician Decision|2|||
163012178|NCT01139775|588745847|FG002|Overall Study|Physician Decision|2|||
163012179|NCT01882985|588745850|FG000|Overall Study|Lost to Follow-up|1|||
163215227|NCT04762680|589503802|FG004|Phase 2|Lost to Follow-up|0|||
163215228|NCT04762680|589503803|FG005|Phase 2|Lost to Follow-up|0|||
163215229|NCT04762680|589503804|FG006|Phase 2|Lost to Follow-up|0|||
163215230|NCT04762680|589503805|FG007|Phase 2|Lost to Follow-up|0|||
163215231|NCT04762680|589503806|FG008|Phase 2|Lost to Follow-up|0|||
163215232|NCT04762680|589503807|FG009|Phase 2|Lost to Follow-up|0|||
163215233|NCT04762680|589503808|FG010|Phase 2|Lost to Follow-up|0|||
163215234|NCT04762680|589503809|FG011|Phase 2|Lost to Follow-up|0|||
163215235|NCT04762680|589503810|FG012|Phase 2|Lost to Follow-up|0|||
163215236|NCT04762680|589503811|FG013|Phase 2|Lost to Follow-up|0|||
163215237|NCT04762680|589503812|FG014|Phase 2|Lost to Follow-up|0|||
163215238|NCT04762680|589503813|FG015|Phase 2|Lost to Follow-up|0|||
163215239|NCT04762680|589503814|FG016|Phase 2|Lost to Follow-up|0|||
163215240|NCT04762680|589503815|FG017|Phase 2|Lost to Follow-up|0|||
163215241|NCT04762680|589503816|FG018|Phase 2|Lost to Follow-up|0|||
163215242|NCT04762680|589503817|FG019|Phase 2|Lost to Follow-up|0|||
163215243|NCT04762680|589503818|FG020|Phase 2|Lost to Follow-up|0|||
163012180|NCT01882985|588745850|FG000|Overall Study|Withdrawal by Subject|1|||
163012181|NCT03193853|588745857|FG000|Overall Study|Death|6|||
163012182|NCT04129125|588745858|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
163012183|NCT04129125|588745858|FG000|Overall Study|Study device was not used|3|||
163012184|NCT00740636|588745866|FG000|Overall Study|Adverse Event|0|||
163012185|NCT00740636|588745867|FG001|Overall Study|Adverse Event|2|||
163012186|NCT00740636|588745866|FG000|Overall Study|Patient Ineligible|0|||
163012187|NCT00740636|588745867|FG001|Overall Study|Patient Ineligible|1|||
163012188|NCT00740636|588745866|FG000|Overall Study|Patient Not Treated|0|||
163012189|NCT00740636|588745867|FG001|Overall Study|Patient Not Treated|1|||
163012190|NCT00740636|588745866|FG000|Overall Study|Progressive Disease|1|||
163012191|NCT00740636|588745867|FG001|Overall Study|Progressive Disease|0|||
163012192|NCT00740636|588745866|FG000|Overall Study|Death|1|||
163012193|NCT00740636|588745867|FG001|Overall Study|Death|0|||
163012194|NCT02174627|588745870|FG000|Overall Study|Missing|0|||
163012195|NCT02174627|588745871|FG001|Overall Study|Missing|1|||
163012196|NCT02174627|588745870|FG000|Overall Study|Incorrect enrolment before randomization|0|||
163012197|NCT02174627|588745871|FG001|Overall Study|Incorrect enrolment before randomization|1|||
163012198|NCT02174627|588745870|FG000|Overall Study|Participant decision|84|||
163012199|NCT02174627|588745871|FG001|Overall Study|Participant decision|128|||
163012200|NCT02166333|588745872|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
163012201|NCT02166333|588745873|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
163012202|NCT02166333|588745874|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
163012203|NCT02166333|588745875|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
163012204|NCT02166333|588745876|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
163012205|NCT02166333|588745877|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
163012206|NCT02166333|588745872|FG000|Stage 1|Death|4|||
163012207|NCT02166333|588745873|FG001|Stage 1|Death|0|||
163012208|NCT02166333|588745874|FG002|Stage 1|Death|2|||
163012209|NCT02166333|588745875|FG003|Stage 1|Death|0|||
163012210|NCT02166333|588745876|FG004|Stage 1|Death|3|||
163012211|NCT02166333|588745877|FG005|Stage 1|Death|2|||
163012212|NCT02166333|588745872|FG000|Stage 1|Lost to Follow-up|12|||
163012213|NCT02166333|588745873|FG001|Stage 1|Lost to Follow-up|0|||
163012214|NCT02166333|588745874|FG002|Stage 1|Lost to Follow-up|6|||
163012215|NCT02166333|588745875|FG003|Stage 1|Lost to Follow-up|0|||
163012216|NCT02166333|588745876|FG004|Stage 1|Lost to Follow-up|3|||
163012217|NCT02166333|588745877|FG005|Stage 1|Lost to Follow-up|3|||
163012218|NCT02166333|588745872|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
163012219|NCT02166333|588745873|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
163012220|NCT02166333|588745874|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
163012221|NCT02166333|588745875|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
163012222|NCT02166333|588745876|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
163012223|NCT02166333|588745877|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
163012224|NCT02166333|588745872|FG000|Stage 2|Death|4|||
163012225|NCT02166333|588745873|FG001|Stage 2|Death|2|||
163012226|NCT02166333|588745874|FG002|Stage 2|Death|1|||
163012227|NCT02166333|588745875|FG003|Stage 2|Death|0|||
163012228|NCT02166333|588745876|FG004|Stage 2|Death|0|||
163012229|NCT02166333|588745877|FG005|Stage 2|Death|1|||
163012230|NCT02166333|588745872|FG000|Stage 2|Lost to Follow-up|23|||
163012231|NCT02166333|588745873|FG001|Stage 2|Lost to Follow-up|4|||
163012232|NCT02166333|588745874|FG002|Stage 2|Lost to Follow-up|11|||
163012233|NCT02166333|588745875|FG003|Stage 2|Lost to Follow-up|9|||
163012234|NCT02166333|588745876|FG004|Stage 2|Lost to Follow-up|3|||
163012235|NCT02166333|588745877|FG005|Stage 2|Lost to Follow-up|6|||
163012236|NCT00503698|588745878|FG000|Overall Study|Protocol Violation|5|||
163012237|NCT00503698|588745879|FG001|Overall Study|Protocol Violation|6|||
163012238|NCT00503698|588745878|FG000|Overall Study|Adverse Event|52|||
163012239|NCT00503698|588745879|FG001|Overall Study|Adverse Event|41|||
163012240|NCT00503698|588745878|FG000|Overall Study|Death|1|||
163012241|NCT00503698|588745879|FG001|Overall Study|Death|0|||
163012242|NCT00503698|588745878|FG000|Overall Study|Lack of Efficacy|3|||
163062565|NCT03329001|588936872|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
163062566|NCT03329001|588936873|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
163012243|NCT00503698|588745879|FG001|Overall Study|Lack of Efficacy|4|||
163062567|NCT03329001|588936874|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
163062568|NCT03329001|588936875|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
163012244|NCT00503698|588745878|FG000|Overall Study|Trial terminated|216|||
163012245|NCT00503698|588745879|FG001|Overall Study|Trial terminated|253|||
163012246|NCT00503698|588745878|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
163012247|NCT00503698|588745879|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
163012248|NCT00503698|588745878|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
163012249|NCT00503698|588745879|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
163012250|NCT00503698|588745878|FG000|Overall Study|Any condition in exclusion criteria|4|||
163012251|NCT00503698|588745879|FG001|Overall Study|Any condition in exclusion criteria|6|||
163012252|NCT00503698|588745878|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
163012253|NCT00503698|588745879|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
163012254|NCT00503698|588745878|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
163012255|NCT00503698|588745879|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
163012256|NCT00503698|588745878|FG000|Overall Study|Critically ill|2|||
163215244|NCT04762680|589503819|FG021|Phase 2|Lost to Follow-up|0|||
163215245|NCT04762680|589503798|FG000|Phase 3|Adverse Event|0|||
163215246|NCT04762680|589503799|FG001|Phase 3|Adverse Event|0|||
163215247|NCT04762680|589503800|FG002|Phase 3|Adverse Event|0|||
163215248|NCT04762680|589503801|FG003|Phase 3|Adverse Event|1|||
163215249|NCT04762680|589503802|FG004|Phase 3|Adverse Event|0|||
163215250|NCT04762680|589503803|FG005|Phase 3|Adverse Event|0|||
163215251|NCT04762680|589503804|FG006|Phase 3|Adverse Event|0|||
163215252|NCT04762680|589503805|FG007|Phase 3|Adverse Event|0|||
163215253|NCT04762680|589503806|FG008|Phase 3|Adverse Event|0|||
163215254|NCT04762680|589503807|FG009|Phase 3|Adverse Event|0|||
163215255|NCT04762680|589503808|FG010|Phase 3|Adverse Event|0|||
163215256|NCT04762680|589503809|FG011|Phase 3|Adverse Event|0|||
163215257|NCT04762680|589503810|FG012|Phase 3|Adverse Event|0|||
163215258|NCT04762680|589503811|FG013|Phase 3|Adverse Event|0|||
163215259|NCT04762680|589503812|FG014|Phase 3|Adverse Event|0|||
163215260|NCT04762680|589503813|FG015|Phase 3|Adverse Event|0|||
163215261|NCT04762680|589503814|FG016|Phase 3|Adverse Event|0|||
163215262|NCT04762680|589503815|FG017|Phase 3|Adverse Event|3|||
163215263|NCT04762680|589503816|FG018|Phase 3|Adverse Event|0|||
163215264|NCT04762680|589503817|FG019|Phase 3|Adverse Event|0|||
163215265|NCT04762680|589503818|FG020|Phase 3|Adverse Event|0|||
163215266|NCT04762680|589503819|FG021|Phase 3|Adverse Event|0|||
163215267|NCT04762680|589503798|FG000|Phase 3|Protocol Violation|0|||
163215268|NCT04762680|589503799|FG001|Phase 3|Protocol Violation|0|||
163215269|NCT04762680|589503800|FG002|Phase 3|Protocol Violation|0|||
163215270|NCT04762680|589503801|FG003|Phase 3|Protocol Violation|4|||
163215271|NCT04762680|589503802|FG004|Phase 3|Protocol Violation|1|||
163215272|NCT04762680|589503803|FG005|Phase 3|Protocol Violation|5|||
163215273|NCT04762680|589503804|FG006|Phase 3|Protocol Violation|1|||
163215274|NCT04762680|589503805|FG007|Phase 3|Protocol Violation|0|||
163215275|NCT04762680|589503806|FG008|Phase 3|Protocol Violation|0|||
163215276|NCT04762680|589503807|FG009|Phase 3|Protocol Violation|0|||
163215277|NCT04762680|589503808|FG010|Phase 3|Protocol Violation|0|||
163215278|NCT04762680|589503809|FG011|Phase 3|Protocol Violation|2|||
163215279|NCT04762680|589503810|FG012|Phase 3|Protocol Violation|3|||
163215280|NCT04762680|589503811|FG013|Phase 3|Protocol Violation|0|||
163215281|NCT04762680|589503812|FG014|Phase 3|Protocol Violation|0|||
163215282|NCT04762680|589503813|FG015|Phase 3|Protocol Violation|1|||
163215283|NCT04762680|589503814|FG016|Phase 3|Protocol Violation|0|||
163215284|NCT04762680|589503815|FG017|Phase 3|Protocol Violation|10|||
163215285|NCT04762680|589503816|FG018|Phase 3|Protocol Violation|0|||
163215286|NCT04762680|589503817|FG019|Phase 3|Protocol Violation|0|||
163215287|NCT04762680|589503818|FG020|Phase 3|Protocol Violation|0|||
163215288|NCT04762680|589503819|FG021|Phase 3|Protocol Violation|0|||
163215289|NCT04762680|589503798|FG000|Phase 3|Withdrawal by Subject|0|||
163215290|NCT04762680|589503799|FG001|Phase 3|Withdrawal by Subject|0|||
163215291|NCT04762680|589503800|FG002|Phase 3|Withdrawal by Subject|0|||
163215292|NCT04762680|589503801|FG003|Phase 3|Withdrawal by Subject|13|||
163215293|NCT04762680|589503802|FG004|Phase 3|Withdrawal by Subject|17|||
163215294|NCT04762680|589503803|FG005|Phase 3|Withdrawal by Subject|12|||
163215295|NCT04762680|589503804|FG006|Phase 3|Withdrawal by Subject|8|||
163215296|NCT04762680|589503805|FG007|Phase 3|Withdrawal by Subject|3|||
163404587|NCT01157364|590191963|FG005|Overall Study|Lack of Efficacy|0|||
163012257|NCT00503698|588745879|FG001|Overall Study|Critically ill|0|||
163012258|NCT00503698|588745878|FG000|Overall Study|Unclassified|48|||
163012259|NCT00503698|588745879|FG001|Overall Study|Unclassified|32|||
163215297|NCT04762680|589503806|FG008|Phase 3|Withdrawal by Subject|2|||
163215298|NCT04762680|589503807|FG009|Phase 3|Withdrawal by Subject|4|||
163215299|NCT04762680|589503808|FG010|Phase 3|Withdrawal by Subject|3|||
163215300|NCT04762680|589503809|FG011|Phase 3|Withdrawal by Subject|1|||
163215301|NCT04762680|589503810|FG012|Phase 3|Withdrawal by Subject|3|||
163215302|NCT04762680|589503811|FG013|Phase 3|Withdrawal by Subject|2|||
163215303|NCT04762680|589503812|FG014|Phase 3|Withdrawal by Subject|1|||
163215304|NCT04762680|589503813|FG015|Phase 3|Withdrawal by Subject|4|||
163215305|NCT04762680|589503814|FG016|Phase 3|Withdrawal by Subject|6|||
163215306|NCT04762680|589503815|FG017|Phase 3|Withdrawal by Subject|32|||
163215307|NCT04762680|589503816|FG018|Phase 3|Withdrawal by Subject|0|||
163215308|NCT04762680|589503817|FG019|Phase 3|Withdrawal by Subject|0|||
163215309|NCT04762680|589503818|FG020|Phase 3|Withdrawal by Subject|0|||
163215310|NCT04762680|589503819|FG021|Phase 3|Withdrawal by Subject|0|||
163215311|NCT04762680|589503798|FG000|Phase 3|Lost to Follow-up|0|||
163215312|NCT04762680|589503799|FG001|Phase 3|Lost to Follow-up|0|||
163215313|NCT04762680|589503800|FG002|Phase 3|Lost to Follow-up|0|||
163215314|NCT04762680|589503801|FG003|Phase 3|Lost to Follow-up|9|||
163062569|NCT02178956|588936878|FG000|Overall Study|Lost to Follow-up|4|||
163062570|NCT02178956|588936879|FG001|Overall Study|Lost to Follow-up|4|||
163062571|NCT02178956|588936878|FG000|Overall Study|Sponsor terminated study|49|||
163062572|NCT02178956|588936879|FG001|Overall Study|Sponsor terminated study|58|||
163062573|NCT02178956|588936878|FG000|Overall Study|Withdrawal by Subject|15|||
163062574|NCT02178956|588936879|FG001|Overall Study|Withdrawal by Subject|11|||
163062575|NCT02178956|588936878|FG000|Overall Study|Various Reasons|3|||
163062576|NCT02178956|588936879|FG001|Overall Study|Various Reasons|5|||
163062577|NCT02709369|588936881|FG000|Overall Study|Lost to Follow-up|15|||
163062578|NCT02709369|588936881|FG000|Overall Study|Withdrawal by Subject|10|||
163062579|NCT02709369|588936881|FG000|Overall Study|Did not received intervention|2|||
163062580|NCT01341470|588936882|FG000|Overall Study|Sponsor decision|0|||
163062581|NCT01341470|588936883|FG001|Overall Study|Sponsor decision|0|||
163062582|NCT01341470|588936884|FG002|Overall Study|Sponsor decision|1|||
163062583|NCT01341470|588936885|FG003|Overall Study|Sponsor decision|1|||
163062584|NCT01341470|588936886|FG004|Overall Study|Sponsor decision|0|||
163062585|NCT01341470|588936887|FG005|Overall Study|Sponsor decision|1|||
163062586|NCT03282097|588936888|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
163062587|NCT03282097|588936889|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
163062588|NCT03282097|588936888|FG000|Intervention Visit Complete|Patient Death|13|||
163062589|NCT03282097|588936889|FG001|Intervention Visit Complete|Patient Death|15|||
163062590|NCT03282097|588936888|FG000|Intervention Visit Complete|Caregiver Death|0|||
163062591|NCT03282097|588936889|FG001|Intervention Visit Complete|Caregiver Death|3|||
163062592|NCT03282097|588936888|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
163062593|NCT03282097|588936889|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
163062594|NCT03282097|588936888|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
163062595|NCT03282097|588936889|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
163215315|NCT04762680|589503802|FG004|Phase 3|Lost to Follow-up|22|||
163215316|NCT04762680|589503803|FG005|Phase 3|Lost to Follow-up|24|||
163215317|NCT04762680|589503804|FG006|Phase 3|Lost to Follow-up|2|||
163062596|NCT03282097|588936888|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
163062597|NCT03282097|588936889|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
163062598|NCT03282097|588936888|FG000|Primary Outcome Data Collection Complete|Missing|2|||
163062599|NCT03282097|588936889|FG001|Primary Outcome Data Collection Complete|Missing|3|||
163062600|NCT03282097|588936888|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
163062601|NCT03282097|588936889|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
163062602|NCT03282097|588936888|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
163062603|NCT03282097|588936889|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
163062604|NCT03282097|588936888|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
163062605|NCT03282097|588936889|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
163062606|NCT02755090|588936891|FG000|Overall Study|equipment malfunction|1|||
163215318|NCT04762680|589503805|FG007|Phase 3|Lost to Follow-up|4|||
163215319|NCT04762680|589503806|FG008|Phase 3|Lost to Follow-up|6|||
163215320|NCT04762680|589503807|FG009|Phase 3|Lost to Follow-up|4|||
163215321|NCT04762680|589503808|FG010|Phase 3|Lost to Follow-up|3|||
163215322|NCT04762680|589503809|FG011|Phase 3|Lost to Follow-up|0|||
163215323|NCT04762680|589503810|FG012|Phase 3|Lost to Follow-up|5|||
163215324|NCT04762680|589503811|FG013|Phase 3|Lost to Follow-up|4|||
163215325|NCT04762680|589503812|FG014|Phase 3|Lost to Follow-up|6|||
163215326|NCT04762680|589503813|FG015|Phase 3|Lost to Follow-up|1|||
163215327|NCT04762680|589503814|FG016|Phase 3|Lost to Follow-up|1|||
163215328|NCT04762680|589503815|FG017|Phase 3|Lost to Follow-up|66|||
163215329|NCT04762680|589503816|FG018|Phase 3|Lost to Follow-up|0|||
163215330|NCT04762680|589503817|FG019|Phase 3|Lost to Follow-up|0|||
163215331|NCT04762680|589503818|FG020|Phase 3|Lost to Follow-up|0|||
163062607|NCT02755090|588936892|FG001|Overall Study|equipment malfunction|0|||
163062608|NCT03034967|588936895|FG000|Overall Study|Withdrawal by Subject|9|||
163062609|NCT03034967|588936896|FG001|Overall Study|Withdrawal by Subject|2|||
163062610|NCT03034967|588936897|FG002|Overall Study|Withdrawal by Subject|6|||
163062611|NCT03034967|588936898|FG003|Overall Study|Withdrawal by Subject|6|||
163062612|NCT03034967|588936899|FG004|Overall Study|Withdrawal by Subject|9|||
163062613|NCT03034967|588936900|FG005|Overall Study|Withdrawal by Subject|2|||
163062614|NCT03034967|588936895|FG000|Overall Study|Physician Decision|1|||
163062615|NCT03034967|588936896|FG001|Overall Study|Physician Decision|0|||
163062616|NCT03034967|588936897|FG002|Overall Study|Physician Decision|1|||
163215332|NCT04762680|589503819|FG021|Phase 3|Lost to Follow-up|0|||
163215333|NCT04762680|589503798|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215334|NCT04762680|589503799|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215335|NCT04762680|589503800|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215336|NCT04762680|589503801|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215337|NCT04762680|589503802|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215338|NCT04762680|589503803|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215339|NCT04762680|589503804|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215340|NCT04762680|589503805|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215341|NCT04762680|589503806|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215342|NCT04762680|589503807|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163328400|NCT00811941|589913231|FG001|All Treated Patients|Withdrawal by Subject|94|||
163328401|NCT00811941|589913230|FG000|All Treated Patients|Lost to Follow-up|3|||
163328402|NCT00811941|589913231|FG001|All Treated Patients|Lost to Follow-up|12|||
163328403|NCT00811941|589913230|FG000|All Treated Patients|Other Reason|4|||
163328404|NCT00811941|589913231|FG001|All Treated Patients|Other Reason|14|||
163012260|NCT00503698|588745878|FG000|Overall Study|Not exposed to trial drug|11|||
163012261|NCT00503698|588745879|FG001|Overall Study|Not exposed to trial drug|6|||
163012262|NCT02269098|588745880|FG000|Overall Study|Lost to Follow-up|14|||
163012263|NCT02269098|588745881|FG001|Overall Study|Lost to Follow-up|9|||
163012264|NCT00682786|588745886|FG000|Overall Study|Withdrawal by Subject|2|||
163012265|NCT00682786|588745887|FG001|Overall Study|Withdrawal by Subject|2|||
163012266|NCT00682786|588745886|FG000|Overall Study|Did not receive irinotecan|0|||
163012267|NCT00682786|588745887|FG001|Overall Study|Did not receive irinotecan|1|||
163012268|NCT03644342|588745888|FG000|Overall Study|Adverse Event|2|||
163012269|NCT03644342|588745889|FG001|Overall Study|Adverse Event|0|||
163012270|NCT03644342|588745888|FG000|Overall Study|Protocol Violation|0|||
163012271|NCT03644342|588745889|FG001|Overall Study|Protocol Violation|1|||
163012272|NCT02462603|588745892|FG000|Overall Study|Investigator Decision|1|||
163012273|NCT02462603|588745892|FG000|Overall Study|Non-Compliance|1|||
163012274|NCT02462603|588745892|FG000|Overall Study|Withdrawal by Subject|2|||
163012275|NCT01831635|588745893|FG000|Overall Study|Withdrawal by Subject|0|||
163012276|NCT01831635|588745894|FG001|Overall Study|Withdrawal by Subject|2|||
163328405|NCT03802994|589913234|FG000|Overall Study|Lost to Follow-up|0|||
163328406|NCT03802994|589913235|FG001|Overall Study|Lost to Follow-up|2|||
163328407|NCT03802994|589913236|FG002|Overall Study|Lost to Follow-up|3|||
163012277|NCT01831635|588745895|FG002|Overall Study|Withdrawal by Subject|0|||
163012278|NCT01991743|588745898|FG000|Overall Study|external cephalic version not performed|0|||
163012279|NCT01991743|588745899|FG001|Overall Study|external cephalic version not performed|0|||
163012280|NCT01991743|588745900|FG002|Overall Study|external cephalic version not performed|1|||
163012281|NCT01991743|588745901|FG003|Overall Study|external cephalic version not performed|0|||
163062617|NCT03034967|588936898|FG003|Overall Study|Physician Decision|1|||
163062618|NCT03034967|588936899|FG004|Overall Study|Physician Decision|1|||
163062619|NCT03034967|588936900|FG005|Overall Study|Physician Decision|0|||
163062620|NCT03034967|588936895|FG000|Overall Study|Lost to Follow-up|0|||
163062621|NCT03034967|588936896|FG001|Overall Study|Lost to Follow-up|0|||
163062622|NCT03034967|588936897|FG002|Overall Study|Lost to Follow-up|0|||
163062623|NCT03034967|588936898|FG003|Overall Study|Lost to Follow-up|1|||
163062624|NCT03034967|588936899|FG004|Overall Study|Lost to Follow-up|0|||
163062625|NCT03034967|588936900|FG005|Overall Study|Lost to Follow-up|2|||
163062626|NCT03034967|588936895|FG000|Overall Study|Liver function test abnormality|0|||
163062627|NCT03034967|588936896|FG001|Overall Study|Liver function test abnormality|0|||
163062628|NCT03034967|588936897|FG002|Overall Study|Liver function test abnormality|1|||
163062629|NCT03034967|588936898|FG003|Overall Study|Liver function test abnormality|0|||
163062630|NCT03034967|588936899|FG004|Overall Study|Liver function test abnormality|0|||
163062631|NCT03034967|588936900|FG005|Overall Study|Liver function test abnormality|0|||
163062632|NCT03034967|588936895|FG000|Overall Study|Protocol Violation|1|||
163062633|NCT03034967|588936896|FG001|Overall Study|Protocol Violation|0|||
163062634|NCT03034967|588936897|FG002|Overall Study|Protocol Violation|0|||
163062635|NCT03034967|588936898|FG003|Overall Study|Protocol Violation|0|||
163062636|NCT03034967|588936899|FG004|Overall Study|Protocol Violation|0|||
163062637|NCT03034967|588936900|FG005|Overall Study|Protocol Violation|2|||
163062638|NCT03034967|588936895|FG000|Overall Study|Lack of Efficacy|0|||
163062639|NCT03034967|588936896|FG001|Overall Study|Lack of Efficacy|1|||
163062640|NCT03034967|588936897|FG002|Overall Study|Lack of Efficacy|2|||
163062641|NCT03034967|588936898|FG003|Overall Study|Lack of Efficacy|1|||
163062642|NCT03034967|588936899|FG004|Overall Study|Lack of Efficacy|1|||
163062643|NCT03034967|588936900|FG005|Overall Study|Lack of Efficacy|0|||
163062644|NCT03034967|588936895|FG000|Overall Study|Adverse Event, non-fatal|3|||
163062645|NCT03034967|588936896|FG001|Overall Study|Adverse Event, non-fatal|1|||
163062646|NCT03034967|588936897|FG002|Overall Study|Adverse Event, non-fatal|2|||
163062647|NCT03034967|588936898|FG003|Overall Study|Adverse Event, non-fatal|0|||
163062648|NCT03034967|588936899|FG004|Overall Study|Adverse Event, non-fatal|2|||
163062649|NCT03034967|588936900|FG005|Overall Study|Adverse Event, non-fatal|8|||
163062650|NCT03034967|588936895|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
163062651|NCT03034967|588936896|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
163062652|NCT03034967|588936897|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
163328408|NCT03802994|589913237|FG003|Overall Study|Lost to Follow-up|2|||
163062653|NCT03034967|588936898|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
163062654|NCT03034967|588936899|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
163062655|NCT03034967|588936900|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
163062656|NCT05291689|588936907|FG000|Overall Study|Adverse Event|3|||
163062657|NCT05291689|588936907|FG000|Overall Study|Lack of Efficacy|10|||
163062658|NCT05291689|588936907|FG000|Overall Study|Withdrawal by Subject|4|||
163328409|NCT03802994|589913238|FG004|Overall Study|Lost to Follow-up|2|||
163062659|NCT01931098|588936908|FG000|Overall Study|Withdrawal by Subject|0|||
163062660|NCT01931098|588936909|FG001|Overall Study|Withdrawal by Subject|1|||
163012282|NCT04955691|588747982|FG000|Period 2|Discontinued intervention|1|||
163012283|NCT04955691|588747983|FG001|Period 2|Discontinued intervention|2|||
163012284|NCT05336227|588747984|FG000|Overall Study|Adverse Event|1|||
163012285|NCT05336227|588747985|FG001|Overall Study|Adverse Event|0|||
163012286|NCT05336227|588747984|FG000|Overall Study|Lost to Follow-up|2|||
163012287|NCT05336227|588747985|FG001|Overall Study|Lost to Follow-up|0|||
163012288|NCT05336227|588747984|FG000|Overall Study|Withdrawal by Subject|1|||
163012289|NCT05336227|588747985|FG001|Overall Study|Withdrawal by Subject|0|||
163012290|NCT05086744|588747986|FG000|Part A|Adverse Event|0|||
163012291|NCT05086744|588747987|FG001|Part A|Adverse Event|1|||
163012292|NCT05086744|588747986|FG000|Part A|Lack of Efficacy|3|||
163012293|NCT05086744|588747987|FG001|Part A|Lack of Efficacy|0|||
163012294|NCT05086744|588747986|FG000|Part A|Protocol deviation|1|||
163012295|NCT05086744|588747987|FG001|Part A|Protocol deviation|0|||
163012296|NCT05086744|588747986|FG000|Part A|Subject decision|1|||
163012297|NCT05086744|588747987|FG001|Part A|Subject decision|0|||
163012298|NCT05086744|588747986|FG000|Part B|Adverse Event|0|||
163012299|NCT05086744|588747987|FG001|Part B|Adverse Event|1|||
163012300|NCT05086744|588747986|FG000|Part B|Lack of Efficacy|0|||
163012301|NCT05086744|588747987|FG001|Part B|Lack of Efficacy|1|||
163012302|NCT05086744|588747986|FG000|Part B|Study terminated by sponsor|1|||
163012303|NCT05086744|588747987|FG001|Part B|Study terminated by sponsor|6|||
163012304|NCT04050462|588747988|FG000|Overall Study|Withdrawal by Subject|1|||
163012305|NCT04050462|588747989|FG001|Overall Study|Withdrawal by Subject|0|||
163012306|NCT04050462|588747990|FG002|Overall Study|Withdrawal by Subject|0|||
163012307|NCT05151744|588747993|FG000|Overall Study|Adverse Event|6|||
163012308|NCT05151744|588747994|FG001|Overall Study|Adverse Event|2|||
163012309|NCT05151744|588747993|FG000|Overall Study|Death|1|||
163012310|NCT05151744|588747994|FG001|Overall Study|Death|2|||
163012311|NCT05151744|588747993|FG000|Overall Study|Lack of Efficacy|1|||
163012312|NCT05151744|588747994|FG001|Overall Study|Lack of Efficacy|1|||
163012313|NCT05151744|588747993|FG000|Overall Study|Lost to Follow-up|2|||
163012314|NCT05151744|588747994|FG001|Overall Study|Lost to Follow-up|2|||
163012315|NCT05151744|588747993|FG000|Overall Study|Need for Rescue Treatment|0|||
163012316|NCT05151744|588747994|FG001|Overall Study|Need for Rescue Treatment|1|||
163012317|NCT05151744|588747993|FG000|Overall Study|Non-compliance with Study Drug|0|||
163012318|NCT05151744|588747994|FG001|Overall Study|Non-compliance with Study Drug|1|||
163012319|NCT05151744|588747993|FG000|Overall Study|Reason not Specified|10|||
163012320|NCT05151744|588747994|FG001|Overall Study|Reason not Specified|0|||
163012321|NCT05151744|588747993|FG000|Overall Study|Physician Decision|2|||
163012322|NCT05151744|588747994|FG001|Overall Study|Physician Decision|1|||
163012323|NCT05151744|588747993|FG000|Overall Study|Protocol Violation|1|||
163012324|NCT05151744|588747994|FG001|Overall Study|Protocol Violation|0|||
163012325|NCT05151744|588747993|FG000|Overall Study|Withdrawal by Subject|6|||
163012326|NCT05151744|588747994|FG001|Overall Study|Withdrawal by Subject|3|||
163012327|NCT04053868|588747995|FG000|Overall Study|Withdrawal by Subject|1|||
163012328|NCT04053868|588747996|FG001|Overall Study|Withdrawal by Subject|0|||
163012329|NCT05731700|588747997|FG000|Overall Study|Death|1|||
163012330|NCT01682226|588748000|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
163012331|NCT01682226|588748000|FG000|Overall Study|Participants did not receive treatment|2|||
163012332|NCT01682226|588748000|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
163012333|NCT03771898|588748009|FG000|Overall Study|Adverse Event|1|||
163012334|NCT03771898|588748010|FG001|Overall Study|Adverse Event|0|||
163012335|NCT03771898|588748011|FG002|Overall Study|Adverse Event|0|||
163012336|NCT03771898|588748012|FG003|Overall Study|Adverse Event|0|||
163012337|NCT03771898|588748013|FG004|Overall Study|Adverse Event|0|||
163012338|NCT03771898|588748009|FG000|Overall Study|Lost to Follow-up|1|||
163012339|NCT03771898|588748010|FG001|Overall Study|Lost to Follow-up|1|||
163012340|NCT03771898|588748011|FG002|Overall Study|Lost to Follow-up|1|||
163012341|NCT03771898|588748012|FG003|Overall Study|Lost to Follow-up|0|||
163012342|NCT03771898|588748013|FG004|Overall Study|Lost to Follow-up|0|||
163012343|NCT03771898|588748009|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163012344|NCT03771898|588748010|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163012345|NCT03771898|588748011|FG002|Overall Study|Withdrawal by parent/guardian|0|||
163012346|NCT03771898|588748012|FG003|Overall Study|Withdrawal by parent/guardian|0|||
163012347|NCT03771898|588748013|FG004|Overall Study|Withdrawal by parent/guardian|0|||
163012348|NCT03771898|588748009|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
163012349|NCT03771898|588748010|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
163012350|NCT03771898|588748011|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
163012351|NCT03771898|588748012|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
163012352|NCT03771898|588748013|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
163012353|NCT03123120|588748014|FG000|Overall Study|Lost to Follow-up|0|||
163012354|NCT03123120|588748015|FG001|Overall Study|Lost to Follow-up|1|||
163012355|NCT03123120|588748014|FG000|Overall Study|Withdrawal by Subject|0|||
163012356|NCT03123120|588748015|FG001|Overall Study|Withdrawal by Subject|1|||
163012357|NCT03135548|588748019|FG000|Overall Study|Lost to Follow-up|3|||
163012358|NCT03135548|588748020|FG001|Overall Study|Lost to Follow-up|0|||
163012359|NCT03135548|588748021|FG002|Overall Study|Lost to Follow-up|0|||
163012360|NCT03135548|588748019|FG000|Overall Study|Withdrawal by Subject|2|||
163012361|NCT03135548|588748020|FG001|Overall Study|Withdrawal by Subject|2|||
163012362|NCT03135548|588748021|FG002|Overall Study|Withdrawal by Subject|1|||
163012363|NCT03135548|588748019|FG000|Overall Study|Other than listed|0|||
163012364|NCT03135548|588748020|FG001|Overall Study|Other than listed|2|||
163012365|NCT03135548|588748021|FG002|Overall Study|Other than listed|2|||
163012366|NCT02632175|588748022|FG000|Overall Study|Withdrawal by Subject|6|||
163012367|NCT02632175|588748022|FG000|Overall Study|Lost to Follow-up|1|||
163012368|NCT02632175|588748022|FG000|Overall Study|Lack of Efficacy|18|||
163012369|NCT02632175|588748022|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
163012370|NCT02632175|588748022|FG000|Overall Study|Subject noncompliance|3|||
163012371|NCT02632175|588748022|FG000|Overall Study|other|2|||
163012372|NCT02088554|588748023|FG000|Overall Study|Exited before procedure|130|||
163012373|NCT02088554|588748023|FG000|Overall Study|Attempted but not implanted|31|||
163012374|NCT02088554|588748023|FG000|Overall Study|Implant not attempted|19|||
163012375|NCT02088554|588748023|FG000|Overall Study|Pending next visit|532|||
163012376|NCT02088554|588748023|FG000|Overall Study|Death|170|||
163012377|NCT02088554|588748023|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
163012378|NCT02088554|588748023|FG000|Overall Study|Lost to Follow-up|23|||
163012379|NCT02088554|588748023|FG000|Overall Study|Explanted|32|||
163012380|NCT02088554|588748023|FG000|Overall Study|Any other reason not covered by previous categories|11|||
163012381|NCT04623216|588748024|FG000|Overall Study|Death|5|||
163012382|NCT04623216|588748025|FG001|Overall Study|Death|2|||
163012383|NCT04623216|588748026|FG002|Overall Study|Death|0|||
163012384|NCT04623216|588748027|FG003|Overall Study|Death|0|||
163012385|NCT04623216|588748024|FG000|Overall Study|Terminated by Sponsor|3|||
163012386|NCT04623216|588748025|FG001|Overall Study|Terminated by Sponsor|2|||
163012387|NCT04623216|588748026|FG002|Overall Study|Terminated by Sponsor|2|||
163012388|NCT04623216|588748027|FG003|Overall Study|Terminated by Sponsor|0|||
163012389|NCT04623216|588748024|FG000|Overall Study|Physician Decision|1|||
163012390|NCT04623216|588748025|FG001|Overall Study|Physician Decision|0|||
163012391|NCT04623216|588748026|FG002|Overall Study|Physician Decision|0|||
163012392|NCT04623216|588748027|FG003|Overall Study|Physician Decision|0|||
163012393|NCT03521154|588748030|FG000|Overall Study|Ongoing study at data cut-off|111|||
163012394|NCT03521154|588748031|FG001|Overall Study|Ongoing study at data cut-off|52|||
163012395|NCT05468164|588748032|FG000|Treatment Period 4|Adverse Event|0|||
163012396|NCT05468164|588748033|FG001|Treatment Period 4|Adverse Event|0|||
163012397|NCT05468164|588748034|FG002|Treatment Period 4|Adverse Event|0|||
163012398|NCT05468164|588748035|FG003|Treatment Period 4|Adverse Event|1|||
163012399|NCT04632927|588748036|FG000|Overall Study|Adverse Event|0|||
163012400|NCT04632927|588748037|FG001|Overall Study|Adverse Event|1|||
163012401|NCT04632927|588748036|FG000|Overall Study|Lack of Efficacy|0|||
162925313|NCT05723835|588428930|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
162925314|NCT05723835|588428931|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
162925315|NCT05723835|588428932|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
162925316|NCT05723835|588428933|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
162925317|NCT05723835|588428934|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
162925318|NCT05226286|588428935|FG000|Overall Study|Screen failures prior to implant|62|||
162925319|NCT05226286|588428935|FG000|Overall Study|Withdrawal by Subject|13|||
162925320|NCT05226286|588428935|FG000|Overall Study|Lost to Follow-up|3|||
162925321|NCT05226286|588428935|FG000|Overall Study|Physician Decision|1|||
162925322|NCT05226286|588428935|FG000|Overall Study|Adverse Event|1|||
162925323|NCT05226286|588428935|FG000|Overall Study|Death|1|||
162925324|NCT05226286|588428935|FG000|Overall Study|Device explant with no planned replacement|1|||
162925325|NCT05226286|588428935|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
162925326|NCT05226286|588428935|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
162925327|NCT00602641|588428936|FG000|Overall Study|Never started protocol therapy|6|||
162925328|NCT00602641|588428937|FG001|Overall Study|Never started protocol therapy|2|||
162925329|NCT00602641|588428936|FG000|Overall Study|Still on treatment at time of analysis|8|||
162925330|NCT00602641|588428937|FG001|Overall Study|Still on treatment at time of analysis|15|||
162925331|NCT00602641|588428936|FG000|Overall Study|Adverse Event|62|||
162925332|NCT00602641|588428937|FG001|Overall Study|Adverse Event|53|||
163012402|NCT04632927|588748037|FG001|Overall Study|Lack of Efficacy|4|||
163012403|NCT04632927|588748036|FG000|Overall Study|Loss of efficacy|0|||
163012404|NCT04632927|588748037|FG001|Overall Study|Loss of efficacy|1|||
163012405|NCT04632927|588748036|FG000|Overall Study|Non-compliance with study drug|0|||
163012406|NCT04632927|588748037|FG001|Overall Study|Non-compliance with study drug|1|||
163012407|NCT04632927|588748036|FG000|Overall Study|Physician Decision|0|||
163012408|NCT04632927|588748037|FG001|Overall Study|Physician Decision|1|||
163012409|NCT04632927|588748036|FG000|Overall Study|Subject decision|0|||
163012410|NCT04632927|588748037|FG001|Overall Study|Subject decision|1|||
162925333|NCT00602641|588428936|FG000|Overall Study|Disease progression|38|||
162925334|NCT00602641|588428937|FG001|Overall Study|Disease progression|55|||
162925335|NCT00602641|588428936|FG000|Overall Study|Death|6|||
162925336|NCT00602641|588428937|FG001|Overall Study|Death|5|||
162925337|NCT00602641|588428936|FG000|Overall Study|Withdrawal by Subject|15|||
162925338|NCT00602641|588428937|FG001|Overall Study|Withdrawal by Subject|12|||
162925339|NCT00602641|588428936|FG000|Overall Study|Alternative therapy|5|||
162925340|NCT00602641|588428937|FG001|Overall Study|Alternative therapy|2|||
163012411|NCT04632927|588748036|FG000|Overall Study|Withdrawal by Subject|0|||
163012412|NCT04632927|588748037|FG001|Overall Study|Withdrawal by Subject|1|||
163012413|NCT03827291|588748038|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
163012414|NCT03827291|588748039|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
163012415|NCT04795466|588748040|FG000|Overall Study|Adverse Event|3|||
163012416|NCT04795466|588748041|FG001|Overall Study|Adverse Event|1|||
163012417|NCT04795466|588748040|FG000|Overall Study|Physician Decision|1|||
163012418|NCT04795466|588748041|FG001|Overall Study|Physician Decision|0|||
163012419|NCT04795466|588748040|FG000|Overall Study|Withdrawal by Subject|2|||
163012420|NCT04795466|588748041|FG001|Overall Study|Withdrawal by Subject|1|||
163012421|NCT02955355|588748049|FG000|Overall Study|Adverse Event|4|||
163012422|NCT02955355|588748049|FG000|Overall Study|Death|1|||
163012423|NCT02955355|588748049|FG000|Overall Study|Physician Decision|21|||
163012424|NCT02955355|588748049|FG000|Overall Study|Site Terminated by Sponsor|35|||
163012425|NCT02955355|588748049|FG000|Overall Study|Withdrawal by Subject|19|||
163012426|NCT02955355|588748049|FG000|Overall Study|Reason Not Specified|5|||
163012427|NCT02612623|588748050|FG000|Overall Study|Withdrawal by Subject|0|||
163012428|NCT02612623|588748051|FG001|Overall Study|Withdrawal by Subject|1|||
163012429|NCT02612623|588748052|FG002|Overall Study|Withdrawal by Subject|0|||
163012430|NCT02612623|588748053|FG003|Overall Study|Withdrawal by Subject|0|||
163012431|NCT02612623|588748050|FG000|Overall Study|Adverse Event|1|||
163012432|NCT02612623|588748051|FG001|Overall Study|Adverse Event|0|||
163012433|NCT02612623|588748052|FG002|Overall Study|Adverse Event|1|||
163012434|NCT02612623|588748053|FG003|Overall Study|Adverse Event|0|||
163012435|NCT03168711|588748055|FG000|Overall Study|Adverse Event|2|||
163012436|NCT03168711|588748056|FG001|Overall Study|Adverse Event|0|||
163012437|NCT03168711|588748055|FG000|Overall Study|Withdrawal by Subject|0|||
163012438|NCT03168711|588748056|FG001|Overall Study|Withdrawal by Subject|1|||
163012439|NCT03168711|588748055|FG000|Overall Study|Death|0|||
163012440|NCT03168711|588748056|FG001|Overall Study|Death|1|||
163012441|NCT01671007|588748061|FG000|Overall Study|Other reasons than listed|166|||
163012442|NCT01671007|588748062|FG001|Overall Study|Other reasons than listed|373|||
163012443|NCT01671007|588748063|FG002|Overall Study|Other reasons than listed|197|||
163012444|NCT01671007|588748064|FG003|Overall Study|Other reasons than listed|228|||
163012445|NCT01671007|588748065|FG004|Overall Study|Other reasons than listed|14|||
163012446|NCT01671007|588748066|FG005|Overall Study|Other reasons than listed|71|||
163012447|NCT01671007|588748067|FG006|Overall Study|Other reasons than listed|17|||
163012448|NCT01671007|588748068|FG007|Overall Study|Other reasons than listed|66|||
163012449|NCT01671007|588748069|FG008|Overall Study|Other reasons than listed|0|||
163012450|NCT01671007|588748061|FG000|Overall Study|Withdrawal by Subject|36|||
163012451|NCT01671007|588748062|FG001|Overall Study|Withdrawal by Subject|59|||
163012452|NCT01671007|588748063|FG002|Overall Study|Withdrawal by Subject|53|||
163012453|NCT01671007|588748064|FG003|Overall Study|Withdrawal by Subject|58|||
163012454|NCT01671007|588748065|FG004|Overall Study|Withdrawal by Subject|4|||
163012455|NCT01671007|588748066|FG005|Overall Study|Withdrawal by Subject|15|||
163012456|NCT01671007|588748067|FG006|Overall Study|Withdrawal by Subject|1|||
163012457|NCT01671007|588748068|FG007|Overall Study|Withdrawal by Subject|19|||
163012458|NCT01671007|588748069|FG008|Overall Study|Withdrawal by Subject|0|||
163012459|NCT01671007|588748061|FG000|Overall Study|Lost to Follow-up|93|||
163012460|NCT01671007|588748062|FG001|Overall Study|Lost to Follow-up|142|||
163012461|NCT01671007|588748063|FG002|Overall Study|Lost to Follow-up|91|||
163012462|NCT01671007|588748064|FG003|Overall Study|Lost to Follow-up|63|||
163012463|NCT01671007|588748065|FG004|Overall Study|Lost to Follow-up|7|||
163012464|NCT01671007|588748066|FG005|Overall Study|Lost to Follow-up|20|||
163012465|NCT01671007|588748067|FG006|Overall Study|Lost to Follow-up|2|||
163012466|NCT01671007|588748068|FG007|Overall Study|Lost to Follow-up|28|||
163012467|NCT01671007|588748069|FG008|Overall Study|Lost to Follow-up|0|||
162925341|NCT00602641|588428936|FG000|Overall Study|Other Complicating Disease|5|||
163012468|NCT01671007|588748061|FG000|Overall Study|No end of study case report form|3|||
163012469|NCT01671007|588748062|FG001|Overall Study|No end of study case report form|1|||
163012470|NCT01671007|588748063|FG002|Overall Study|No end of study case report form|0|||
163012471|NCT01671007|588748064|FG003|Overall Study|No end of study case report form|2|||
163012472|NCT01671007|588748065|FG004|Overall Study|No end of study case report form|0|||
163012473|NCT01671007|588748066|FG005|Overall Study|No end of study case report form|0|||
163012474|NCT01671007|588748067|FG006|Overall Study|No end of study case report form|0|||
163012475|NCT01671007|588748068|FG007|Overall Study|No end of study case report form|0|||
163012476|NCT01671007|588748069|FG008|Overall Study|No end of study case report form|0|||
163012477|NCT01671007|588748061|FG000|Overall Study|Not eligible|23|||
163012478|NCT01671007|588748062|FG001|Overall Study|Not eligible|76|||
163012479|NCT01671007|588748063|FG002|Overall Study|Not eligible|25|||
163012480|NCT01671007|588748064|FG003|Overall Study|Not eligible|17|||
163012481|NCT01671007|588748065|FG004|Overall Study|Not eligible|0|||
163012482|NCT01671007|588748066|FG005|Overall Study|Not eligible|6|||
163012483|NCT01671007|588748067|FG006|Overall Study|Not eligible|1|||
163012484|NCT01671007|588748068|FG007|Overall Study|Not eligible|19|||
163012485|NCT01671007|588748069|FG008|Overall Study|Not eligible|0|||
163012486|NCT03877068|588748070|FG000|Overall Study|Physician Decision|9|||
163012487|NCT03877068|588748071|FG001|Overall Study|Physician Decision|3|||
163012488|NCT00449865|588748072|FG000|Overall Study|Withdrawal by Subject|110|||
163012489|NCT00449865|588748073|FG001|Overall Study|Withdrawal by Subject|110|||
163012490|NCT00449865|588748072|FG000|Overall Study|Lost to Follow-up|36|||
163012491|NCT00449865|588748073|FG001|Overall Study|Lost to Follow-up|37|||
163012492|NCT00449865|588748072|FG000|Overall Study|Physician Decision|13|||
163012493|NCT00449865|588748073|FG001|Overall Study|Physician Decision|12|||
163012494|NCT00449865|588748072|FG000|Overall Study|Death|31|||
163012495|NCT00449865|588748073|FG001|Overall Study|Death|40|||
163012496|NCT00449865|588748072|FG000|Overall Study|Protocol Violation|8|||
163012497|NCT00449865|588748073|FG001|Overall Study|Protocol Violation|7|||
163012498|NCT00449865|588748072|FG000|Overall Study|Study was stopped|324|||
163012499|NCT00449865|588748073|FG001|Overall Study|Study was stopped|328|||
163012500|NCT00406367|588748074|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
163012501|NCT00406367|588748075|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
163012502|NCT00406367|588748074|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
163012503|NCT00406367|588748075|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
163012504|NCT00406367|588748074|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
163012505|NCT00406367|588748075|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
163012506|NCT00406367|588748074|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
163012507|NCT00406367|588748075|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
163012508|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
163012509|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
163012510|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
163012511|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
163012512|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
163012513|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
163012514|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
163012515|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
163012516|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
163012517|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
163012518|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
163012519|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
163012520|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
163012521|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
163012522|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
163012523|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
163012524|NCT03252535|588748076|FG000|Overall Study|Withdrawal by Subject|1|||
163012525|NCT03252535|588748077|FG001|Overall Study|Withdrawal by Subject|0|||
163012526|NCT03252535|588748078|FG002|Overall Study|Withdrawal by Subject|0|||
163012527|NCT03252535|588748076|FG000|Overall Study|Physician Decision|0|||
163062661|NCT01931098|588936908|FG000|Overall Study|Enrolled in different protocol|0|||
163062662|NCT01931098|588936909|FG001|Overall Study|Enrolled in different protocol|1|||
163062663|NCT01931098|588936908|FG000|Overall Study|Unable to begin trmt:active infection|0|||
163012528|NCT03252535|588748077|FG001|Overall Study|Physician Decision|1|||
163012529|NCT03252535|588748078|FG002|Overall Study|Physician Decision|0|||
163012530|NCT03252535|588748076|FG000|Overall Study|Met discontinuation criteria|0|||
163012531|NCT03252535|588748077|FG001|Overall Study|Met discontinuation criteria|1|||
163012532|NCT03252535|588748078|FG002|Overall Study|Met discontinuation criteria|0|||
163012533|NCT03922308|588748079|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
163012534|NCT03922308|588748080|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
163012535|NCT03922308|588748081|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
163012536|NCT03922308|588748079|FG000|Overall Study|Lost to Follow-up|1|||
163012537|NCT03922308|588748080|FG001|Overall Study|Lost to Follow-up|0|||
163012538|NCT03922308|588748081|FG002|Overall Study|Lost to Follow-up|0|||
163012539|NCT03922308|588748079|FG000|Overall Study|Reason not Specified|0|||
163012540|NCT03922308|588748080|FG001|Overall Study|Reason not Specified|2|||
163012541|NCT03922308|588748081|FG002|Overall Study|Reason not Specified|1|||
163012542|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
163012543|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
163012544|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
163062664|NCT01931098|588936909|FG001|Overall Study|Unable to begin trmt:active infection|1|||
163012545|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
163012546|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
163012547|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
163012548|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
163012549|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
163012550|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
163012551|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
163012552|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
163012553|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
163012554|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
163012555|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
163012556|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
163012557|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
163012558|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
163012559|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
163012560|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
163012561|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
163012562|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
163012563|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
163012564|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
163012565|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
163012566|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
163012567|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
163012568|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
163012569|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
163012570|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
163012571|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
163012572|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
163012573|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
163012574|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
163012575|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
163012576|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
163012577|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
163012578|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
163012579|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
163012580|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
163012581|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
163012582|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
163012583|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
163012584|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
163012585|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
163012586|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
163328410|NCT00942266|589913244|FG000|Overall Study|Withdrawal by Subject|1|||
163328411|NCT00942266|589913245|FG001|Overall Study|Withdrawal by Subject|0|||
163012587|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
163012588|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
163012589|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
163012590|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
163012591|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
163012592|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
163012593|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
163012594|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
163012595|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
163012596|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
163012597|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
163012598|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
163012599|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
163012600|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
163012601|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
163012602|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
163328412|NCT00942266|589913244|FG000|Overall Study|Adverse Event|2|||
163328413|NCT00942266|589913245|FG001|Overall Study|Adverse Event|1|||
163012603|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
163012604|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
163012605|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
163012606|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
163012607|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
163012608|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
163012609|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
163012610|NCT00506415|588748082|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
163012611|NCT00506415|588748083|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
163012612|NCT00506415|588748084|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
163012613|NCT00506415|588748085|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
163012614|NCT00506415|588748082|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
163012615|NCT00506415|588748083|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
163012616|NCT00506415|588748084|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
163012617|NCT00506415|588748085|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
163012618|NCT00506415|588748082|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
163012619|NCT00506415|588748083|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
163012620|NCT00506415|588748084|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
163012621|NCT00506415|588748085|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
163012622|NCT00506415|588748082|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
163012623|NCT00506415|588748083|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
163012624|NCT00506415|588748084|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
163012625|NCT00506415|588748085|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
163012626|NCT00506415|588748082|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
163012627|NCT00506415|588748083|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
163012628|NCT00506415|588748084|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
163012629|NCT00506415|588748085|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
163012630|NCT00506415|588748082|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
163012631|NCT00506415|588748083|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
163012632|NCT00506415|588748084|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
163012633|NCT00506415|588748085|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
163012634|NCT00506415|588748082|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
163012635|NCT00506415|588748083|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
163012636|NCT00506415|588748084|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
163012637|NCT00506415|588748085|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
163012638|NCT02198664|588748086|FG000|Overall Study|Adverse Event|2|||
163012639|NCT02198664|588748087|FG001|Overall Study|Adverse Event|0|||
163012640|NCT02198664|588748086|FG000|Overall Study|Withdrawal by Subject|11|||
163012641|NCT02198664|588748087|FG001|Overall Study|Withdrawal by Subject|8|||
163012642|NCT02198664|588748086|FG000|Overall Study|Failure to tolerate|2|||
163012643|NCT02198664|588748087|FG001|Overall Study|Failure to tolerate|0|||
163012644|NCT02198664|588748086|FG000|Overall Study|Not stated|1|||
163012645|NCT02198664|588748087|FG001|Overall Study|Not stated|0|||
163012646|NCT02632409|588748088|FG000|Randomized|AE unrelated to study Drug|0|||
163012647|NCT02632409|588748089|FG001|Randomized|AE unrelated to study Drug|1|||
163012648|NCT02632409|588748088|FG000|Randomized|Participant withdrew consent|2|||
163012649|NCT02632409|588748089|FG001|Randomized|Participant withdrew consent|1|||
163012650|NCT02632409|588748088|FG000|Randomized|No Longer meets study criteria|5|||
163012651|NCT02632409|588748089|FG001|Randomized|No Longer meets study criteria|0|||
163012652|NCT02632409|588748088|FG000|Randomized|other reasons|1|||
163012653|NCT02632409|588748089|FG001|Randomized|other reasons|0|||
163012654|NCT02632409|588748088|FG000|Treatment Period|Ongoing Treatment|20|||
163012655|NCT02632409|588748089|FG001|Treatment Period|Ongoing Treatment|21|||
163012656|NCT02632409|588748088|FG000|Treatment Period|Disease Recurrence|147|||
163012657|NCT02632409|588748089|FG001|Treatment Period|Disease Recurrence|90|||
163012658|NCT02632409|588748088|FG000|Treatment Period|Study Drug Toxicity|8|||
163012659|NCT02632409|588748089|FG001|Treatment Period|Study Drug Toxicity|49|||
163012660|NCT02632409|588748088|FG000|Treatment Period|Death|1|||
163012661|NCT02632409|588748089|FG001|Treatment Period|Death|0|||
163012662|NCT02632409|588748088|FG000|Treatment Period|AE unrelated to study drug|15|||
163012663|NCT02632409|588748089|FG001|Treatment Period|AE unrelated to study drug|16|||
163012664|NCT02632409|588748088|FG000|Treatment Period|Request to discontinue treatment|4|||
163012665|NCT02632409|588748089|FG001|Treatment Period|Request to discontinue treatment|19|||
163012666|NCT02632409|588748088|FG000|Treatment Period|Participant withdrew consent|7|||
163012667|NCT02632409|588748089|FG001|Treatment Period|Participant withdrew consent|5|||
163062665|NCT01931098|588936908|FG000|Overall Study|Refused further treatment|0|||
163062666|NCT01931098|588936909|FG001|Overall Study|Refused further treatment|1|||
163062667|NCT02612155|588936910|FG000|Overall Study|Death|1|||
163012668|NCT02632409|588748088|FG000|Treatment Period|Lost to Follow-up|0|||
163012669|NCT02632409|588748089|FG001|Treatment Period|Lost to Follow-up|1|||
163012670|NCT02632409|588748088|FG000|Treatment Period|Maximum clinical benefit|1|||
163012671|NCT02632409|588748089|FG001|Treatment Period|Maximum clinical benefit|0|||
163062668|NCT02612155|588936911|FG001|Overall Study|Death|1|||
163062669|NCT02612155|588936910|FG000|Overall Study|Lost to Follow-up|2|||
163062670|NCT02612155|588936911|FG001|Overall Study|Lost to Follow-up|2|||
163062671|NCT04235374|588936912|FG000|Overall Study|Death|91|||
163062672|NCT04235374|588936913|FG001|Overall Study|Death|91|||
163062673|NCT04235374|588936912|FG000|Overall Study|Refused|2|||
163062674|NCT04235374|588936913|FG001|Overall Study|Refused|2|||
163062675|NCT04235374|588936912|FG000|Overall Study|Unavailable|12|||
163062676|NCT04235374|588936913|FG001|Overall Study|Unavailable|3|||
163062677|NCT04235374|588936912|FG000|Overall Study|Withdrawal by Subject|0|||
163062678|NCT04235374|588936913|FG001|Overall Study|Withdrawal by Subject|1|||
163062679|NCT04235374|588936912|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
163215343|NCT04762680|589503808|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163012672|NCT02632409|588748088|FG000|Treatment Period|No longer meets study criteria|3|||
163012673|NCT02632409|588748089|FG001|Treatment Period|No longer meets study criteria|0|||
163012674|NCT02632409|588748088|FG000|Treatment Period|Administrative Reason by sponsor|0|||
163012675|NCT02632409|588748089|FG001|Treatment Period|Administrative Reason by sponsor|1|||
163012676|NCT02632409|588748088|FG000|Treatment Period|Other Reasons|10|||
163012677|NCT02632409|588748089|FG001|Treatment Period|Other Reasons|6|||
163012678|NCT04426006|588748090|FG000|Inclusion|Protocol Violation|1|||
163012679|NCT04426006|588748090|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
163012680|NCT04426006|588748090|FG000|Inclusion|Blood sample at inclusion not done|1|||
163012681|NCT04426006|588748090|FG000|3 Months|Lost to Follow-up|17|||
163012682|NCT04426006|588748090|FG000|12 Months|Lost to Follow-up|38|||
163012683|NCT01262872|588748093|FG000|Step 2|Death|0|||
163012684|NCT01262872|588748094|FG001|Step 2|Death|0|||
163012685|NCT01262872|588748095|FG002|Step 2|Death|0|||
163012686|NCT01262872|588748096|FG003|Step 2|Death|1|||
163012687|NCT01262872|588748097|FG004|Step 2|Death|0|||
163012688|NCT01262872|588748098|FG005|Step 2|Death|2|||
163012689|NCT01262872|588748099|FG006|Step 2|Death|2|||
163012690|NCT01262872|588748100|FG007|Step 2|Death|1|||
163012691|NCT01262872|588748093|FG000|Step 2|Protocol Violation|0|||
163012692|NCT01262872|588748094|FG001|Step 2|Protocol Violation|0|||
163012693|NCT01262872|588748095|FG002|Step 2|Protocol Violation|1|||
163012694|NCT01262872|588748096|FG003|Step 2|Protocol Violation|0|||
163012695|NCT01262872|588748097|FG004|Step 2|Protocol Violation|0|||
163012696|NCT01262872|588748098|FG005|Step 2|Protocol Violation|0|||
163012697|NCT01262872|588748099|FG006|Step 2|Protocol Violation|3|||
163012698|NCT01262872|588748100|FG007|Step 2|Protocol Violation|1|||
163012699|NCT01262872|588748093|FG000|Step 2|Withdrawal by Subject|0|||
163062680|NCT04235374|588936913|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
163062681|NCT01551173|588936914|FG000|Overall Study|Withdrawal by Subject|11|||
163062682|NCT01551173|588936915|FG001|Overall Study|Withdrawal by Subject|16|||
163062683|NCT01551173|588936914|FG000|Overall Study|Adverse Event|7|||
163062684|NCT01551173|588936915|FG001|Overall Study|Adverse Event|6|||
163215344|NCT04762680|589503809|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215345|NCT04762680|589503810|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215346|NCT04762680|589503811|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215347|NCT04762680|589503812|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215348|NCT04762680|589503813|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215349|NCT04762680|589503814|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215350|NCT04762680|589503815|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215351|NCT04762680|589503816|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215352|NCT04762680|589503817|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215353|NCT04762680|589503818|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163215354|NCT04762680|589503819|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
163215355|NCT04762680|589503798|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
163328414|NCT00942266|589913244|FG000|Overall Study|Disease Progression|38|||
163328415|NCT00942266|589913245|FG001|Overall Study|Disease Progression|11|||
163328416|NCT00942266|589913244|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
163328417|NCT00942266|589913245|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
163062685|NCT01551173|588936914|FG000|Overall Study|Lost to Follow-up|5|||
163062686|NCT01551173|588936915|FG001|Overall Study|Lost to Follow-up|7|||
163062687|NCT01551173|588936914|FG000|Overall Study|Other|5|||
163062688|NCT01551173|588936915|FG001|Overall Study|Other|3|||
163328418|NCT00942266|589913244|FG000|Overall Study|Intercurrent illness|0|||
163328419|NCT00942266|589913245|FG001|Overall Study|Intercurrent illness|1|||
163062689|NCT01394276|588936916|FG000|Overall Study|Related Adverse event (AEs)|15|||
163328420|NCT00942266|589913244|FG000|Overall Study|Physician Decision|2|||
163012700|NCT01262872|588748094|FG001|Step 2|Withdrawal by Subject|0|||
163012701|NCT01262872|588748095|FG002|Step 2|Withdrawal by Subject|4|||
163012702|NCT01262872|588748096|FG003|Step 2|Withdrawal by Subject|6|||
163012703|NCT01262872|588748097|FG004|Step 2|Withdrawal by Subject|3|||
163012704|NCT01262872|588748098|FG005|Step 2|Withdrawal by Subject|1|||
163012705|NCT01262872|588748099|FG006|Step 2|Withdrawal by Subject|2|||
163012706|NCT01262872|588748100|FG007|Step 2|Withdrawal by Subject|1|||
163012707|NCT01262872|588748093|FG000|Step 2|Migrated/moved from study area|0|||
163012708|NCT01262872|588748094|FG001|Step 2|Migrated/moved from study area|0|||
163062690|NCT01394276|588936916|FG000|Overall Study|Not related AEs|9|||
163012709|NCT01262872|588748095|FG002|Step 2|Migrated/moved from study area|4|||
163012710|NCT01262872|588748096|FG003|Step 2|Migrated/moved from study area|3|||
163012711|NCT01262872|588748097|FG004|Step 2|Migrated/moved from study area|2|||
163012712|NCT01262872|588748098|FG005|Step 2|Migrated/moved from study area|6|||
163012713|NCT01262872|588748099|FG006|Step 2|Migrated/moved from study area|2|||
163012714|NCT01262872|588748100|FG007|Step 2|Migrated/moved from study area|3|||
163012715|NCT01000155|588748103|FG000|Overall Study|Withdrawal by Subject|1|||
163012716|NCT01000155|588748103|FG000|Overall Study|Adverse Event|1|||
163012717|NCT01198470|588748106|FG000|Overall Study|Adverse Event|2|||
163012718|NCT00720213|588748107|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
163012719|NCT00720213|588748108|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
163012720|NCT00720213|588748109|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
163012721|NCT01924689|588748113|FG000|Overall Study|Death|0|||
163012722|NCT01924689|588748114|FG001|Overall Study|Death|1|||
163012723|NCT01924689|588748115|FG002|Overall Study|Death|0|||
163012724|NCT01924689|588748116|FG003|Overall Study|Death|1|||
163012725|NCT01924689|588748117|FG004|Overall Study|Death|0|||
163012726|NCT01924689|588748118|FG005|Overall Study|Death|0|||
163012727|NCT01924689|588748113|FG000|Overall Study|Disease progression|0|||
163012728|NCT01924689|588748114|FG001|Overall Study|Disease progression|0|||
163012729|NCT01924689|588748115|FG002|Overall Study|Disease progression|2|||
163012730|NCT01924689|588748116|FG003|Overall Study|Disease progression|0|||
163012731|NCT01924689|588748117|FG004|Overall Study|Disease progression|3|||
163012732|NCT01924689|588748118|FG005|Overall Study|Disease progression|2|||
163012733|NCT01924689|588748113|FG000|Overall Study|New therapy or study|3|||
163012734|NCT01924689|588748114|FG001|Overall Study|New therapy or study|2|||
163012735|NCT01924689|588748115|FG002|Overall Study|New therapy or study|1|||
163012736|NCT01924689|588748116|FG003|Overall Study|New therapy or study|4|||
163012737|NCT01924689|588748117|FG004|Overall Study|New therapy or study|2|||
163012738|NCT01924689|588748118|FG005|Overall Study|New therapy or study|0|||
163012739|NCT01924689|588748113|FG000|Overall Study|Withdrawal of consent|0|||
163215356|NCT04762680|589503799|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
163215357|NCT04762680|589503800|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
163215358|NCT04762680|589503801|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
163215359|NCT04762680|589503802|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
163215360|NCT04762680|589503803|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
163215361|NCT04762680|589503804|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
163215362|NCT04762680|589503805|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
163215363|NCT04762680|589503806|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
163215364|NCT04762680|589503807|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
163215365|NCT04762680|589503808|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
163012740|NCT01924689|588748114|FG001|Overall Study|Withdrawal of consent|0|||
163012741|NCT01924689|588748115|FG002|Overall Study|Withdrawal of consent|1|||
163012742|NCT01924689|588748116|FG003|Overall Study|Withdrawal of consent|1|||
163012743|NCT01924689|588748117|FG004|Overall Study|Withdrawal of consent|0|||
163012744|NCT01924689|588748118|FG005|Overall Study|Withdrawal of consent|0|||
163012745|NCT01924689|588748113|FG000|Overall Study|Other|0|||
163012746|NCT01924689|588748114|FG001|Overall Study|Other|0|||
163012747|NCT01924689|588748115|FG002|Overall Study|Other|0|||
163012748|NCT01924689|588748116|FG003|Overall Study|Other|0|||
163012749|NCT01924689|588748117|FG004|Overall Study|Other|1|||
163012750|NCT01924689|588748118|FG005|Overall Study|Other|0|||
163012751|NCT05271175|588748120|FG000|One Week Follow up|Lost to Follow-up|10|||
163012752|NCT05271175|588748121|FG001|One Week Follow up|Lost to Follow-up|7|||
163012753|NCT05271175|588748122|FG002|One Week Follow up|Lost to Follow-up|5|||
163012754|NCT05271175|588748120|FG000|One Month Follow up|Lost to Follow-up|12|||
163012755|NCT05271175|588748121|FG001|One Month Follow up|Lost to Follow-up|7|||
163012756|NCT05271175|588748122|FG002|One Month Follow up|Lost to Follow-up|9|||
163012757|NCT05271175|588748120|FG000|Six Months Follow up|Lost to Follow-up|8|||
163012758|NCT05271175|588748121|FG001|Six Months Follow up|Lost to Follow-up|2|||
163012759|NCT05271175|588748122|FG002|Six Months Follow up|Lost to Follow-up|2|||
163012760|NCT02492867|588748123|FG000|Overall Study|Alternate therapy|1|||
163012761|NCT02492867|588748123|FG000|Overall Study|Withdrawal by Subject|2|||
163012762|NCT02492867|588748123|FG000|Overall Study|Disease progression after treatment started|1|||
163012763|NCT02492867|588748123|FG000|Overall Study|Death|1|||
163012764|NCT03296527|588748124|FG000|Overall Study|Adverse Event|15|||
163012765|NCT03296527|588748125|FG001|Overall Study|Adverse Event|33|||
163012766|NCT03296527|588748124|FG000|Overall Study|Protocol Deviation|4|||
163012767|NCT03296527|588748125|FG001|Overall Study|Protocol Deviation|0|||
163012768|NCT03296527|588748124|FG000|Overall Study|Participant withdrew consent|3|||
163012769|NCT03296527|588748125|FG001|Overall Study|Participant withdrew consent|1|||
163012770|NCT03296527|588748124|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
163012771|NCT03296527|588748125|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
163012772|NCT03296527|588748124|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
163012773|NCT03296527|588748125|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
163215366|NCT04762680|589503809|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
163328421|NCT00942266|589913245|FG001|Overall Study|Physician Decision|0|||
163012774|NCT03296527|588748124|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
163012775|NCT03296527|588748125|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
163012776|NCT03296527|588748124|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
163012777|NCT03296527|588748125|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
163012778|NCT03296527|588748124|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
163012779|NCT03296527|588748125|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
163012780|NCT01597973|588748126|FG000|Overall Study|Found ineligible before study medication started|4|||
163012781|NCT01597973|588748127|FG001|Overall Study|Found ineligible before study medication started|2|||
163012782|NCT01597973|588748126|FG000|Overall Study|Eligible pathogen not confirmed|14|||
163012783|NCT01597973|588748127|FG001|Overall Study|Eligible pathogen not confirmed|15|||
163012784|NCT01597973|588748126|FG000|Overall Study|LAR not authorized to consent|0|||
163012785|NCT01597973|588748127|FG001|Overall Study|LAR not authorized to consent|1|||
163012786|NCT01597973|588748126|FG000|Overall Study|Ineligible due to early seizures|1|||
163012787|NCT01597973|588748127|FG001|Overall Study|Ineligible due to early seizures|0|||
163012788|NCT01597973|588748126|FG000|Overall Study|Ineligible due to non-target infection|1|||
163012789|NCT01597973|588748127|FG001|Overall Study|Ineligible due to non-target infection|1|||
163012790|NCT01326845|588748128|FG000|Overall Study|Administrative Problems|5|||
163012791|NCT01326845|588748129|FG001|Overall Study|Administrative Problems|2|||
163012792|NCT01326845|588748128|FG000|Overall Study|Adverse Event|1|||
163012793|NCT01326845|588748129|FG001|Overall Study|Adverse Event|0|||
163012794|NCT01326845|588748128|FG000|Overall Study|Misisng|1|||
163012795|NCT01326845|588748129|FG001|Overall Study|Misisng|3|||
163012796|NCT01662492|588748134|FG000|Overall Study|Other miscellaneous reasons.|1|||
163012797|NCT01662492|588748135|FG001|Overall Study|Other miscellaneous reasons.|0|||
163012798|NCT01662492|588748136|FG002|Overall Study|Other miscellaneous reasons.|1|||
163012799|NCT01662492|588748134|FG000|Overall Study|Withdrawal by Subject|0|||
163012800|NCT01662492|588748135|FG001|Overall Study|Withdrawal by Subject|0|||
163012801|NCT01662492|588748136|FG002|Overall Study|Withdrawal by Subject|1|||
163012802|NCT01662492|588748134|FG000|Overall Study|Protocol Violation|1|||
163012803|NCT01662492|588748135|FG001|Overall Study|Protocol Violation|0|||
163012804|NCT01662492|588748136|FG002|Overall Study|Protocol Violation|0|||
163012805|NCT01662492|588748134|FG000|Overall Study|Lost to Follow-up|0|||
163012806|NCT01662492|588748135|FG001|Overall Study|Lost to Follow-up|0|||
163012807|NCT01662492|588748136|FG002|Overall Study|Lost to Follow-up|2|||
163012808|NCT01662492|588748134|FG000|Overall Study|Lack of Efficacy|1|||
163012809|NCT01662492|588748135|FG001|Overall Study|Lack of Efficacy|1|||
163012810|NCT01662492|588748136|FG002|Overall Study|Lack of Efficacy|2|||
163012811|NCT01591096|588748137|FG000|Overall Study|Adverse Event|1|||
163012812|NCT03655405|588748138|FG000|Overall Study|Death after initial data collection|4|||
163012813|NCT03655405|588748139|FG001|Overall Study|Death after initial data collection|2|||
163012814|NCT03655405|588748138|FG000|Overall Study|Died before initial data collection|1|||
163012815|NCT03655405|588748139|FG001|Overall Study|Died before initial data collection|2|||
163012816|NCT03655405|588748138|FG000|Overall Study|Protocol Violation|0|||
163012817|NCT03655405|588748139|FG001|Overall Study|Protocol Violation|1|||
163012818|NCT05271370|588749844|FG000|Overall Study|Study early termination|8|||
163012819|NCT05271370|588749845|FG001|Overall Study|Study early termination|16|||
163012820|NCT05271370|588749846|FG002|Overall Study|Study early termination|29|||
163012821|NCT04066244|588749860|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
163012822|NCT04066244|588749861|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
163012823|NCT04066244|588749862|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
163012824|NCT04066244|588749863|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
163012825|NCT04066244|588749864|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
163012826|NCT04066244|588749865|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
163012827|NCT04066244|588749860|FG000|Part 2 (Cohort 5)|Death|0|||
163012828|NCT04066244|588749861|FG001|Part 2 (Cohort 5)|Death|0|||
163012829|NCT04066244|588749862|FG002|Part 2 (Cohort 5)|Death|0|||
163012830|NCT04066244|588749863|FG003|Part 2 (Cohort 5)|Death|0|||
163012831|NCT04066244|588749864|FG004|Part 2 (Cohort 5)|Death|0|||
163012832|NCT04066244|588749865|FG005|Part 2 (Cohort 5)|Death|2|||
163012833|NCT04066244|588749860|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
163012834|NCT04066244|588749861|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
163012835|NCT04066244|588749862|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
163012836|NCT04066244|588749863|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
163012837|NCT04066244|588749864|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
163012838|NCT04066244|588749865|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
163012839|NCT04066244|588749860|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
163012840|NCT04066244|588749861|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
163012841|NCT04066244|588749862|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
163154706|NCT02435992|589281385|FG000|Overall Study|Adverse Event|11|||
163154707|NCT02435992|589281386|FG001|Overall Study|Adverse Event|6|||
163154708|NCT02435992|589281387|FG002|Overall Study|Adverse Event|12|||
163154709|NCT02435992|589281388|FG003|Overall Study|Adverse Event|0|||
163154710|NCT02435992|589281389|FG004|Overall Study|Adverse Event|0|||
163012842|NCT04066244|588749863|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
163012843|NCT04066244|588749864|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
163012844|NCT04066244|588749865|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
163012845|NCT00866281|588749866|FG000|Overall Study|Adverse Event|1|||
163012846|NCT00866281|588749867|FG001|Overall Study|Adverse Event|0|||
163012847|NCT00866281|588749866|FG000|Overall Study|Withdrawal by participants|3|||
163012848|NCT00866281|588749867|FG001|Overall Study|Withdrawal by participants|0|||
163012849|NCT00866281|588749866|FG000|Overall Study|Disease progression|3|||
163012850|NCT00866281|588749867|FG001|Overall Study|Disease progression|11|||
163012851|NCT00866281|588749866|FG000|Overall Study|New cancer therapy|0|||
163012852|NCT00866281|588749867|FG001|Overall Study|New cancer therapy|4|||
163012853|NCT00529087|588749870|FG000|Overall Study|Adverse Event|10|||
163012854|NCT00529087|588749871|FG001|Overall Study|Adverse Event|13|||
163012855|NCT00529087|588749872|FG002|Overall Study|Adverse Event|4|||
163012856|NCT00529087|588749870|FG000|Overall Study|Lost to Follow-up|6|||
163012857|NCT00529087|588749871|FG001|Overall Study|Lost to Follow-up|4|||
163012858|NCT00529087|588749872|FG002|Overall Study|Lost to Follow-up|1|||
163012859|NCT00529087|588749870|FG000|Overall Study|Protocol Violation|8|||
163012860|NCT00529087|588749871|FG001|Overall Study|Protocol Violation|7|||
163012861|NCT00529087|588749872|FG002|Overall Study|Protocol Violation|6|||
163012862|NCT00529087|588749870|FG000|Overall Study|Withdrawal by Subject|3|||
163012863|NCT00529087|588749871|FG001|Overall Study|Withdrawal by Subject|3|||
163012864|NCT00529087|588749872|FG002|Overall Study|Withdrawal by Subject|3|||
163012865|NCT00529087|588749870|FG000|Overall Study|Protocol deviation|1|||
163012866|NCT00529087|588749871|FG001|Overall Study|Protocol deviation|1|||
163012867|NCT00529087|588749872|FG002|Overall Study|Protocol deviation|2|||
163012868|NCT02283268|588749875|FG000|Overall Study|Withdrawal by Subject|1|||
163012869|NCT00333983|588749876|FG000|Overall Study|Lost to Follow-up|2|||
163012870|NCT00333983|588749877|FG001|Overall Study|Lost to Follow-up|1|||
163012871|NCT00333983|588749878|FG002|Overall Study|Lost to Follow-up|0|||
163012872|NCT00333983|588749876|FG000|Overall Study|Adverse Event|1|||
163012873|NCT00333983|588749877|FG001|Overall Study|Adverse Event|1|||
163012874|NCT00333983|588749878|FG002|Overall Study|Adverse Event|1|||
163012875|NCT00333983|588749876|FG000|Overall Study|Withdrawal by Subject|0|||
163012876|NCT00333983|588749877|FG001|Overall Study|Withdrawal by Subject|3|||
163012877|NCT00333983|588749878|FG002|Overall Study|Withdrawal by Subject|1|||
163012878|NCT03656068|588749879|FG000|Overall Study|Withdrawal by Subject|4|||
163012879|NCT03656068|588749879|FG000|Overall Study|Adverse Event|1|||
163012880|NCT01436370|588749880|FG000|Overall Study|Lost to Follow-up|0|||
163012881|NCT01436370|588749881|FG001|Overall Study|Lost to Follow-up|0|||
163012882|NCT01436370|588749882|FG002|Overall Study|Lost to Follow-up|0|||
163012883|NCT01436370|588749883|FG003|Overall Study|Lost to Follow-up|0|||
163215367|NCT04762680|589503810|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
163215368|NCT04762680|589503811|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
163012884|NCT01436370|588749884|FG004|Overall Study|Lost to Follow-up|1|||
163012885|NCT01436370|588749885|FG005|Overall Study|Lost to Follow-up|0|||
163012886|NCT01436370|588749886|FG006|Overall Study|Lost to Follow-up|0|||
163012887|NCT01436370|588749887|FG007|Overall Study|Lost to Follow-up|0|||
163012888|NCT02770170|588749888|FG000|Overall Study|Withdrawal by Subject|0|||
163012889|NCT02770170|588749889|FG001|Overall Study|Withdrawal by Subject|0|||
163012890|NCT02770170|588749890|FG002|Overall Study|Withdrawal by Subject|0|||
163012891|NCT02770170|588749891|FG003|Overall Study|Withdrawal by Subject|2|||
163012892|NCT02770170|588749888|FG000|Overall Study|due to pregnancy|1|||
163012893|NCT02770170|588749889|FG001|Overall Study|due to pregnancy|0|||
163012894|NCT02770170|588749890|FG002|Overall Study|due to pregnancy|0|||
163012895|NCT02770170|588749891|FG003|Overall Study|due to pregnancy|0|||
163012896|NCT02770170|588749888|FG000|Overall Study|Lack of Efficacy|2|||
163012897|NCT02770170|588749889|FG001|Overall Study|Lack of Efficacy|0|||
163012898|NCT02770170|588749890|FG002|Overall Study|Lack of Efficacy|0|||
163012899|NCT02770170|588749891|FG003|Overall Study|Lack of Efficacy|1|||
163012900|NCT02770170|588749888|FG000|Overall Study|Adverse Event|4|||
163012901|NCT02770170|588749889|FG001|Overall Study|Adverse Event|3|||
163012902|NCT02770170|588749890|FG002|Overall Study|Adverse Event|5|||
163012903|NCT02770170|588749891|FG003|Overall Study|Adverse Event|3|||
163012904|NCT02770170|588749888|FG000|Overall Study|due to disease worsening|0|||
163012905|NCT02770170|588749889|FG001|Overall Study|due to disease worsening|0|||
163012906|NCT02770170|588749890|FG002|Overall Study|due to disease worsening|0|||
163012907|NCT02770170|588749891|FG003|Overall Study|due to disease worsening|1|||
163012908|NCT03270657|588749892|FG000|Overall Study|Withdrawal by Subject|1|||
163012909|NCT00162981|588749893|FG000|Overall Study|Adverse Event|2|||
163012910|NCT00162981|588749894|FG001|Overall Study|Adverse Event|5|||
163012911|NCT00162981|588749893|FG000|Overall Study|Withdrawal by Subject|1|||
163012912|NCT00162981|588749894|FG001|Overall Study|Withdrawal by Subject|1|||
163012913|NCT00162981|588749893|FG000|Overall Study|Physician Decision|1|||
163012914|NCT00162981|588749894|FG001|Overall Study|Physician Decision|0|||
163012915|NCT03187301|588749897|FG000|Titration Period|Adverse Event|0|||
163012916|NCT03187301|588749898|FG001|Titration Period|Adverse Event|0|||
163012917|NCT03187301|588749899|FG002|Titration Period|Adverse Event|0|||
163012918|NCT03187301|588749900|FG003|Titration Period|Adverse Event|0|||
163012919|NCT03187301|588749901|FG004|Titration Period|Adverse Event|0|||
163012920|NCT03187301|588749902|FG005|Titration Period|Adverse Event|0|||
163012921|NCT03187301|588749903|FG006|Titration Period|Adverse Event|5|||
163012922|NCT03187301|588749897|FG000|Titration Period|Withdrawal by Subject|0|||
163012923|NCT03187301|588749898|FG001|Titration Period|Withdrawal by Subject|0|||
163012924|NCT03187301|588749899|FG002|Titration Period|Withdrawal by Subject|0|||
163012925|NCT03187301|588749900|FG003|Titration Period|Withdrawal by Subject|0|||
163012926|NCT03187301|588749901|FG004|Titration Period|Withdrawal by Subject|0|||
163012927|NCT03187301|588749902|FG005|Titration Period|Withdrawal by Subject|0|||
163012928|NCT03187301|588749903|FG006|Titration Period|Withdrawal by Subject|1|||
163012929|NCT03187301|588749897|FG000|Titration Period|Exclusion Criteria Met|0|||
163012930|NCT03187301|588749898|FG001|Titration Period|Exclusion Criteria Met|0|||
163012931|NCT03187301|588749899|FG002|Titration Period|Exclusion Criteria Met|0|||
163012932|NCT03187301|588749900|FG003|Titration Period|Exclusion Criteria Met|0|||
163012933|NCT03187301|588749901|FG004|Titration Period|Exclusion Criteria Met|0|||
163012934|NCT03187301|588749902|FG005|Titration Period|Exclusion Criteria Met|0|||
163012935|NCT03187301|588749903|FG006|Titration Period|Exclusion Criteria Met|1|||
163012936|NCT03187301|588749897|FG000|Pre-Intervention|Withdrawal by Subject|1|||
163012937|NCT03187301|588749898|FG001|Pre-Intervention|Withdrawal by Subject|0|||
163012938|NCT03187301|588749899|FG002|Pre-Intervention|Withdrawal by Subject|0|||
163012939|NCT03187301|588749900|FG003|Pre-Intervention|Withdrawal by Subject|0|||
163012940|NCT03187301|588749901|FG004|Pre-Intervention|Withdrawal by Subject|0|||
163012941|NCT03187301|588749902|FG005|Pre-Intervention|Withdrawal by Subject|0|||
163012942|NCT03187301|588749903|FG006|Pre-Intervention|Withdrawal by Subject|0|||
163012943|NCT01966120|588749909|FG000|Overall Study|Withdrawal by Subject|0|||
163012944|NCT01966120|588749910|FG001|Overall Study|Withdrawal by Subject|5|||
163012945|NCT01966120|588749909|FG000|Overall Study|Lost to Follow-up|1|||
163012946|NCT01966120|588749910|FG001|Overall Study|Lost to Follow-up|1|||
163012947|NCT00461630|588749911|FG000|Overall Study|Death|798|||
163012948|NCT00461630|588749912|FG001|Overall Study|Death|732|||
163012949|NCT00461630|588749911|FG000|Overall Study|Lost to Follow-up|108|||
163012950|NCT00461630|588749912|FG001|Overall Study|Lost to Follow-up|95|||
163012951|NCT02588612|588749916|FG000|Overall Study|Physician Decision|1|||
163012952|NCT02588612|588749916|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
163012953|NCT02588612|588749916|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
163012954|NCT02588612|588749916|FG000|Overall Study|Death prior to T-cell infusion|1|||
163012955|NCT03809663|588749917|FG000|Overall Study|Decision by sponsor|24|||
163012956|NCT03809663|588749918|FG001|Overall Study|Decision by sponsor|18|||
163012957|NCT03809663|588749919|FG002|Overall Study|Decision by sponsor|20|||
163012958|NCT03809663|588749920|FG003|Overall Study|Decision by sponsor|20|||
163012959|NCT03809663|588749921|FG004|Overall Study|Decision by sponsor|0|||
163012960|NCT03809663|588749922|FG005|Overall Study|Decision by sponsor|0|||
163012961|NCT03809663|588749917|FG000|Overall Study|Withdrawal by Subject|26|||
163012962|NCT03809663|588749918|FG001|Overall Study|Withdrawal by Subject|22|||
163012963|NCT03809663|588749919|FG002|Overall Study|Withdrawal by Subject|27|||
163012964|NCT03809663|588749920|FG003|Overall Study|Withdrawal by Subject|26|||
163012965|NCT03809663|588749921|FG004|Overall Study|Withdrawal by Subject|0|||
163012966|NCT03809663|588749922|FG005|Overall Study|Withdrawal by Subject|0|||
163012967|NCT03809663|588749917|FG000|Overall Study|Lost to Follow-up|1|||
163012968|NCT03809663|588749918|FG001|Overall Study|Lost to Follow-up|4|||
163012969|NCT03809663|588749919|FG002|Overall Study|Lost to Follow-up|1|||
163012970|NCT03809663|588749920|FG003|Overall Study|Lost to Follow-up|1|||
163012971|NCT03809663|588749921|FG004|Overall Study|Lost to Follow-up|0|||
163012972|NCT03809663|588749922|FG005|Overall Study|Lost to Follow-up|0|||
163012973|NCT03376789|588749923|FG000|Overall Study|Withdrawal by Subject|3|||
163012974|NCT03376789|588749924|FG001|Overall Study|Withdrawal by Subject|5|||
163012975|NCT03376789|588749923|FG000|Overall Study|Protocol Violation|0|||
163012976|NCT03376789|588749924|FG001|Overall Study|Protocol Violation|1|||
163012977|NCT03376789|588749923|FG000|Overall Study|Adverse Event|0|||
163012978|NCT03376789|588749924|FG001|Overall Study|Adverse Event|1|||
163012979|NCT03376789|588749923|FG000|Overall Study|Lost to Follow-up|1|||
163012980|NCT03376789|588749924|FG001|Overall Study|Lost to Follow-up|1|||
163012981|NCT03376789|588749923|FG000|Overall Study|Per sponsor due to noncompliance|1|||
163012982|NCT03376789|588749924|FG001|Overall Study|Per sponsor due to noncompliance|0|||
163012983|NCT03376789|588749923|FG000|Overall Study|Subject off study medication|0|||
163012984|NCT03376789|588749924|FG001|Overall Study|Subject off study medication|1|||
163012985|NCT01703260|588749925|FG000|Overall Study|Adverse Event|1|||
163012986|NCT01703260|588749926|FG001|Overall Study|Adverse Event|2|||
163012987|NCT01703260|588749927|FG002|Overall Study|Adverse Event|2|||
163012988|NCT01703260|588749925|FG000|Overall Study|Lost to Follow-up|1|||
163012989|NCT01703260|588749926|FG001|Overall Study|Lost to Follow-up|0|||
163012990|NCT01703260|588749927|FG002|Overall Study|Lost to Follow-up|0|||
163012991|NCT01703260|588749925|FG000|Overall Study|Withdrawal by Subject|0|||
163012992|NCT01703260|588749926|FG001|Overall Study|Withdrawal by Subject|0|||
163012993|NCT01703260|588749927|FG002|Overall Study|Withdrawal by Subject|1|||
163012994|NCT01703260|588749925|FG000|Overall Study|Study Termination|1|||
163012995|NCT01703260|588749926|FG001|Overall Study|Study Termination|2|||
163012996|NCT01703260|588749927|FG002|Overall Study|Study Termination|0|||
163012997|NCT02042014|588749928|FG000|Overall Study|Adverse Event|1|||
163012998|NCT02042014|588749928|FG000|Overall Study|Physician Decision|7|||
163012999|NCT02792062|588749932|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
163013000|NCT02792062|588749933|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
163013001|NCT02792062|588749934|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
163013002|NCT02792062|588749935|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
163013003|NCT02792062|588749936|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
163013004|NCT02792062|588749937|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
163013005|NCT03309943|588749940|FG000|Overall Study|Withdrawal by Subject|0|||
163013006|NCT03309943|588749941|FG001|Overall Study|Withdrawal by Subject|1|||
163013007|NCT03309943|588749940|FG000|Overall Study|Inappropriate behavior towards staff|0|||
163013008|NCT03309943|588749941|FG001|Overall Study|Inappropriate behavior towards staff|1|||
163013009|NCT03123393|588749942|FG000|Overall Study|Study Terminated by Sponsor|6|||
163013010|NCT03123393|588749943|FG001|Overall Study|Study Terminated by Sponsor|9|||
163013011|NCT03123393|588749942|FG000|Overall Study|Withdrawal by Subject|2|||
163013012|NCT03123393|588749943|FG001|Overall Study|Withdrawal by Subject|1|||
163013013|NCT03123393|588749942|FG000|Overall Study|Reason not Specified|13|||
163013014|NCT03123393|588749943|FG001|Overall Study|Reason not Specified|13|||
163013015|NCT02230904|588749945|FG000|Overall Study|Safety follow up could not take place|0|||
163013016|NCT02230904|588749946|FG001|Overall Study|Safety follow up could not take place|1|||
163013017|NCT01464424|588749947|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
163013018|NCT01464424|588749948|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
163013019|NCT05047211|588749952|FG000|Overall Study|Lost to Follow-up|8|||
163013020|NCT05047211|588749953|FG001|Overall Study|Lost to Follow-up|5|||
163013021|NCT00561392|588749954|FG000|Overall Study|Adverse Event|38|||
163013022|NCT00561392|588749954|FG000|Overall Study|Lack of Efficacy|2|||
163013023|NCT00561392|588749954|FG000|Overall Study|Protocol Violation|1|||
163013024|NCT00561392|588749954|FG000|Overall Study|Withdrawal by Subject|8|||
163013025|NCT00561392|588749954|FG000|Overall Study|Administrative problems|4|||
163013026|NCT03822468|588749955|FG000|Treatment Period|Progressive disease|98|||
163013027|NCT03822468|588749956|FG001|Treatment Period|Progressive disease|94|||
163013028|NCT03822468|588749955|FG000|Treatment Period|Adverse Event|21|||
163013029|NCT03822468|588749956|FG001|Treatment Period|Adverse Event|24|||
163013030|NCT03822468|588749955|FG000|Treatment Period|Withdrawal by Subject|9|||
163013031|NCT03822468|588749956|FG001|Treatment Period|Withdrawal by Subject|5|||
163013032|NCT03822468|588749955|FG000|Treatment Period|Physician Decision|9|||
163013033|NCT03822468|588749956|FG001|Treatment Period|Physician Decision|7|||
163013034|NCT03822468|588749955|FG000|Treatment Period|Protocol Violation|2|||
163013035|NCT03822468|588749956|FG001|Treatment Period|Protocol Violation|1|||
163013036|NCT03822468|588749955|FG000|Treatment Period|Death|2|||
163013037|NCT03822468|588749956|FG001|Treatment Period|Death|3|||
163013038|NCT03822468|588749955|FG000|Treatment Period|Lost to Follow-up|1|||
163013039|NCT03822468|588749956|FG001|Treatment Period|Lost to Follow-up|1|||
163013040|NCT03822468|588749955|FG000|Treatment Period|Sponsor decision|46|||
163013041|NCT03822468|588749956|FG001|Treatment Period|Sponsor decision|53|||
163013042|NCT03822468|588749955|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
163013043|NCT03822468|588749956|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
163013044|NCT03822468|588749955|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
163013045|NCT03822468|588749956|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
163013046|NCT03822468|588749955|FG000|Post-treatment Efficacy Follow-up|Death|1|||
163013047|NCT03822468|588749956|FG001|Post-treatment Efficacy Follow-up|Death|0|||
163013048|NCT03822468|588749955|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
163013049|NCT03822468|588749956|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
163013050|NCT03822468|588749955|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
163013051|NCT03822468|588749956|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
163013052|NCT03822468|588749955|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
163013053|NCT03822468|588749956|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
163013054|NCT03822468|588749955|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
163328422|NCT00942266|589913244|FG000|Overall Study|medical deterioration (pneumonia)|0|||
163328423|NCT00942266|589913245|FG001|Overall Study|medical deterioration (pneumonia)|1|||
163328424|NCT04795167|589913248|FG000|Overall Study|Death|1|||
163013055|NCT03822468|588749956|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
163013056|NCT01808066|588749957|FG000|Overall Study|Withdrawal by Subject|15|||
163013057|NCT02949973|588749962|FG000|Overall Study|Physician Decision|1|||
163328425|NCT04795167|589913249|FG001|Overall Study|Death|18|||
163013058|NCT01420068|588749963|FG000|Overall Study|Administrative problems|1|||
163013059|NCT01420068|588749964|FG001|Overall Study|Administrative problems|3|||
163013060|NCT01420068|588749963|FG000|Overall Study|Withdrawal by Subject|1|||
163013061|NCT01420068|588749964|FG001|Overall Study|Withdrawal by Subject|2|||
163013062|NCT01252095|588749965|FG000|Overall Study|Disease progression|1|||
163013063|NCT01252095|588749966|FG001|Overall Study|Disease progression|0|||
163154711|NCT02435992|589281385|FG000|Overall Study|Lack of Efficacy|4|||
163328426|NCT04795167|589913250|FG002|Overall Study|Death|1|||
163013064|NCT00365794|588749967|FG000|Overall Study|Withdrawal by Subject|2|||
163013065|NCT00586703|588749968|FG000|Overall Study|Death|12|||
163013066|NCT04760626|588749969|FG000|Overall Study|Withdrawal by Subject|24|||
163013067|NCT04760626|588749970|FG001|Overall Study|Withdrawal by Subject|20|||
163013068|NCT04760626|588749969|FG000|Overall Study|Lost to Follow-up|14|||
163013069|NCT04760626|588749970|FG001|Overall Study|Lost to Follow-up|19|||
163013070|NCT04760626|588749969|FG000|Overall Study|Physician Decision|3|||
163013071|NCT04760626|588749970|FG001|Overall Study|Physician Decision|5|||
163013072|NCT04760626|588749969|FG000|Overall Study|Death|3|||
163013073|NCT04760626|588749970|FG001|Overall Study|Death|6|||
163013074|NCT04760626|588749969|FG000|Overall Study|Site closure|1|||
163013075|NCT04760626|588749970|FG001|Overall Study|Site closure|0|||
163013076|NCT02554682|588749973|FG000|Overall Study|Lost to Follow-up|11|||
163013077|NCT02554682|588749974|FG001|Overall Study|Lost to Follow-up|9|||
163013078|NCT02554682|588749975|FG002|Overall Study|Lost to Follow-up|4|||
163013079|NCT02554682|588749976|FG003|Overall Study|Lost to Follow-up|3|||
163013080|NCT02554682|588749977|FG004|Overall Study|Lost to Follow-up|2|||
163013081|NCT02554682|588749978|FG005|Overall Study|Lost to Follow-up|1|||
163013082|NCT02554682|588749979|FG006|Overall Study|Lost to Follow-up|6|||
163013083|NCT02554682|588749980|FG007|Overall Study|Lost to Follow-up|6|||
163013084|NCT02554682|588749981|FG008|Overall Study|Lost to Follow-up|2|||
163013085|NCT02554682|588749982|FG009|Overall Study|Lost to Follow-up|2|||
163013086|NCT02554682|588749973|FG000|Overall Study|Withdrawal by Subject|2|||
163013087|NCT02554682|588749974|FG001|Overall Study|Withdrawal by Subject|1|||
163013088|NCT02554682|588749975|FG002|Overall Study|Withdrawal by Subject|0|||
163013089|NCT02554682|588749976|FG003|Overall Study|Withdrawal by Subject|0|||
163013090|NCT02554682|588749977|FG004|Overall Study|Withdrawal by Subject|0|||
163013091|NCT02554682|588749978|FG005|Overall Study|Withdrawal by Subject|0|||
163013092|NCT02554682|588749979|FG006|Overall Study|Withdrawal by Subject|0|||
163013093|NCT02554682|588749980|FG007|Overall Study|Withdrawal by Subject|0|||
163013094|NCT02554682|588749981|FG008|Overall Study|Withdrawal by Subject|0|||
163013095|NCT02554682|588749982|FG009|Overall Study|Withdrawal by Subject|0|||
163013096|NCT02554682|588749973|FG000|Overall Study|Physician Decision|2|||
163013097|NCT02554682|588749974|FG001|Overall Study|Physician Decision|2|||
163013098|NCT02554682|588749975|FG002|Overall Study|Physician Decision|0|||
163013099|NCT02554682|588749976|FG003|Overall Study|Physician Decision|0|||
163013100|NCT02554682|588749977|FG004|Overall Study|Physician Decision|0|||
163013101|NCT02554682|588749978|FG005|Overall Study|Physician Decision|0|||
163013102|NCT02554682|588749979|FG006|Overall Study|Physician Decision|0|||
163013103|NCT02554682|588749980|FG007|Overall Study|Physician Decision|0|||
163013104|NCT02554682|588749981|FG008|Overall Study|Physician Decision|0|||
163013105|NCT02554682|588749982|FG009|Overall Study|Physician Decision|0|||
163013106|NCT00884117|588749985|FG000|Overall Study|Adverse Event|2|||
163013107|NCT00884117|588749985|FG000|Overall Study|Withdrawal by Subject|89|||
163013108|NCT00884117|588749985|FG000|Overall Study|Death|3|||
163013109|NCT00884117|588749985|FG000|Overall Study|Lost to Follow-up|143|||
163013110|NCT00884117|588749985|FG000|Overall Study|Other|12|||
163013111|NCT02946463|588749986|FG000|Primary Evaluation Period|Physician Decision|0|||
163013112|NCT02946463|588749987|FG001|Primary Evaluation Period|Physician Decision|1|||
163013113|NCT02946463|588749988|FG002|Primary Evaluation Period|Physician Decision|0|||
163013114|NCT02946463|588749989|FG003|Primary Evaluation Period|Physician Decision|0|||
163013115|NCT02946463|588749986|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
163062691|NCT01394276|588936916|FG000|Overall Study|Remission of disease|2|||
163062692|NCT01394276|588936916|FG000|Overall Study|Insufficient therapeutic effect|17|||
163062693|NCT01394276|588936916|FG000|Overall Study|Insufficient compliance|9|||
163062694|NCT01394276|588936916|FG000|Overall Study|Lost to Follow-up|5|||
163062695|NCT01394276|588936916|FG000|Overall Study|Participant moved to another site|1|||
163062696|NCT01394276|588936916|FG000|Overall Study|Pregnancy|1|||
163062697|NCT01394276|588936916|FG000|Overall Study|unavailability of drug at the Hospital|2|||
163062698|NCT01394276|588936916|FG000|Overall Study|Symptoms of concurrent diseases|1|||
163062699|NCT04530344|588936917|FG000|Overall Study|Lost to Follow-up|3|||
163215369|NCT04762680|589503812|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
163013116|NCT02946463|588749987|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
163062700|NCT04530344|588936918|FG001|Overall Study|Lost to Follow-up|3|||
163013117|NCT02946463|588749988|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
163062701|NCT04530344|588936919|FG002|Overall Study|Lost to Follow-up|3|||
163215370|NCT04762680|589503813|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
163013118|NCT02946463|588749989|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
163013119|NCT02946463|588749986|FG000|Extension Period|Death|4|||
163062702|NCT04530344|588936920|FG003|Overall Study|Lost to Follow-up|10|||
163215371|NCT04762680|589503814|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
163013120|NCT02946463|588749987|FG001|Extension Period|Death|4|||
163013121|NCT02946463|588749988|FG002|Extension Period|Death|0|||
163013122|NCT02946463|588749989|FG003|Extension Period|Death|0|||
163013123|NCT02946463|588749986|FG000|Extension Period|Withdrawal by Subject|4|||
163013124|NCT02946463|588749987|FG001|Extension Period|Withdrawal by Subject|3|||
163013125|NCT02946463|588749988|FG002|Extension Period|Withdrawal by Subject|0|||
163062703|NCT04530344|588936917|FG000|Overall Study|Withdrawal by Subject|14|||
163013126|NCT02946463|588749989|FG003|Extension Period|Withdrawal by Subject|0|||
163013127|NCT02946463|588749986|FG000|Extension Period|Other than specified|2|||
163013128|NCT02946463|588749987|FG001|Extension Period|Other than specified|3|||
163013129|NCT02946463|588749988|FG002|Extension Period|Other than specified|2|||
163013130|NCT02946463|588749989|FG003|Extension Period|Other than specified|0|||
163013131|NCT02946463|588749986|FG000|Extension Period|Physician Decision|1|||
163013132|NCT02946463|588749987|FG001|Extension Period|Physician Decision|4|||
163013133|NCT02946463|588749988|FG002|Extension Period|Physician Decision|0|||
163013134|NCT02946463|588749989|FG003|Extension Period|Physician Decision|0|||
163013135|NCT02946463|588749986|FG000|Extension Period|Pregnancy|3|||
163013136|NCT02946463|588749987|FG001|Extension Period|Pregnancy|1|||
163013137|NCT02946463|588749988|FG002|Extension Period|Pregnancy|0|||
163013138|NCT02946463|588749989|FG003|Extension Period|Pregnancy|0|||
163013139|NCT02946463|588749986|FG000|Extension Period|Adverse Event|1|||
163013140|NCT02946463|588749987|FG001|Extension Period|Adverse Event|2|||
163013141|NCT02946463|588749988|FG002|Extension Period|Adverse Event|0|||
163013142|NCT02946463|588749989|FG003|Extension Period|Adverse Event|0|||
163013143|NCT02946463|588749986|FG000|Extension Period|Lost to Follow-up|1|||
163013144|NCT02946463|588749987|FG001|Extension Period|Lost to Follow-up|0|||
163013145|NCT02946463|588749988|FG002|Extension Period|Lost to Follow-up|0|||
163013146|NCT02946463|588749989|FG003|Extension Period|Lost to Follow-up|0|||
163013147|NCT02022202|588749990|FG000|Overall Study|Withdrawal by Subject|2|||
163013148|NCT02022202|588749990|FG000|Overall Study|Disease Progression|3|||
163013149|NCT02022202|588749990|FG000|Overall Study|Desire go to immediately to surgery|3|||
163013150|NCT00122382|588749992|FG000|Double-Blind Study|Adverse Event|9|||
163013151|NCT00122382|588749993|FG001|Double-Blind Study|Adverse Event|11|||
163013152|NCT00122382|588749994|FG002|Double-Blind Study|Adverse Event|0|||
163013153|NCT00122382|588749992|FG000|Double-Blind Study|Death|2|||
163013154|NCT00122382|588749993|FG001|Double-Blind Study|Death|2|||
163013155|NCT00122382|588749994|FG002|Double-Blind Study|Death|0|||
163013156|NCT00122382|588749992|FG000|Double-Blind Study|Lack of Efficacy|0|||
163013157|NCT00122382|588749993|FG001|Double-Blind Study|Lack of Efficacy|8|||
163013158|NCT00122382|588749994|FG002|Double-Blind Study|Lack of Efficacy|0|||
163013159|NCT00122382|588749992|FG000|Double-Blind Study|Lost to Follow-up|2|||
163013160|NCT00122382|588749993|FG001|Double-Blind Study|Lost to Follow-up|1|||
163062704|NCT04530344|588936918|FG001|Overall Study|Withdrawal by Subject|5|||
163062705|NCT04530344|588936919|FG002|Overall Study|Withdrawal by Subject|18|||
163013161|NCT00122382|588749994|FG002|Double-Blind Study|Lost to Follow-up|0|||
163013162|NCT00122382|588749992|FG000|Double-Blind Study|Pregnancy|2|||
163013163|NCT00122382|588749993|FG001|Double-Blind Study|Pregnancy|0|||
163013164|NCT00122382|588749994|FG002|Double-Blind Study|Pregnancy|0|||
163013165|NCT00122382|588749992|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
163013166|NCT00122382|588749993|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
163013167|NCT00122382|588749994|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
163013168|NCT00122382|588749992|FG000|Double-Blind Study|Withdrawal of Consent|7|||
163013169|NCT00122382|588749993|FG001|Double-Blind Study|Withdrawal of Consent|3|||
163013170|NCT00122382|588749994|FG002|Double-Blind Study|Withdrawal of Consent|0|||
163013171|NCT00122382|588749992|FG000|Double-Blind Study|Protocol Violation|1|||
163013172|NCT00122382|588749993|FG001|Double-Blind Study|Protocol Violation|0|||
163013173|NCT00122382|588749994|FG002|Double-Blind Study|Protocol Violation|0|||
163013174|NCT00122382|588749992|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
163013175|NCT00122382|588749993|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
163062706|NCT04530344|588936920|FG003|Overall Study|Withdrawal by Subject|33|||
163062707|NCT04530344|588936917|FG000|Overall Study|Adverse Event|0|||
163062708|NCT04530344|588936918|FG001|Overall Study|Adverse Event|0|||
163062709|NCT04530344|588936919|FG002|Overall Study|Adverse Event|0|||
163062710|NCT04530344|588936920|FG003|Overall Study|Adverse Event|1|||
163062711|NCT04530344|588936917|FG000|Overall Study|Lack of Efficacy|0|||
163062712|NCT04530344|588936918|FG001|Overall Study|Lack of Efficacy|0|||
163062713|NCT04530344|588936919|FG002|Overall Study|Lack of Efficacy|0|||
163062714|NCT04530344|588936920|FG003|Overall Study|Lack of Efficacy|1|||
163062715|NCT04530344|588936917|FG000|Overall Study|Physician Decision|0|||
163062716|NCT04530344|588936918|FG001|Overall Study|Physician Decision|0|||
163062717|NCT04530344|588936919|FG002|Overall Study|Physician Decision|1|||
163013176|NCT00122382|588749994|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
163013177|NCT00122382|588749992|FG000|Double-Blind Study|Randomized but not treated|0|||
163013178|NCT00122382|588749993|FG001|Double-Blind Study|Randomized but not treated|2|||
163013179|NCT00122382|588749994|FG002|Double-Blind Study|Randomized but not treated|0|||
163013180|NCT00122382|588749992|FG000|Open-Label Study|Adverse Event|0|||
163013181|NCT00122382|588749993|FG001|Open-Label Study|Adverse Event|0|||
163062718|NCT04530344|588936920|FG003|Overall Study|Physician Decision|1|||
163013182|NCT00122382|588749994|FG002|Open-Label Study|Adverse Event|11|||
163013183|NCT00122382|588749992|FG000|Open-Label Study|Death|0|||
163013184|NCT00122382|588749993|FG001|Open-Label Study|Death|0|||
163013185|NCT00122382|588749994|FG002|Open-Label Study|Death|2|||
163013186|NCT00122382|588749992|FG000|Open-Label Study|Lack of Efficacy|0|||
163013187|NCT00122382|588749993|FG001|Open-Label Study|Lack of Efficacy|0|||
163062719|NCT04530344|588936917|FG000|Overall Study|Pregnancy|0|||
163013188|NCT00122382|588749994|FG002|Open-Label Study|Lack of Efficacy|3|||
163013189|NCT00122382|588749992|FG000|Open-Label Study|Lost to Follow-up|0|||
163013190|NCT00122382|588749993|FG001|Open-Label Study|Lost to Follow-up|0|||
163013191|NCT00122382|588749994|FG002|Open-Label Study|Lost to Follow-up|3|||
163013192|NCT00122382|588749992|FG000|Open-Label Study|Pregnancy|0|||
163215372|NCT04762680|589503815|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
163013193|NCT00122382|588749993|FG001|Open-Label Study|Pregnancy|0|||
163013194|NCT00122382|588749994|FG002|Open-Label Study|Pregnancy|2|||
163013195|NCT00122382|588749992|FG000|Open-Label Study|Poor/Non-Compliance|0|||
163013196|NCT00122382|588749993|FG001|Open-Label Study|Poor/Non-Compliance|0|||
163013197|NCT00122382|588749994|FG002|Open-Label Study|Poor/Non-Compliance|1|||
163013198|NCT00122382|588749992|FG000|Open-Label Study|Withdrawal of Consent|0|||
163013199|NCT00122382|588749993|FG001|Open-Label Study|Withdrawal of Consent|0|||
163013200|NCT00122382|588749994|FG002|Open-Label Study|Withdrawal of Consent|4|||
163013201|NCT02040805|588749995|FG000|Overall Study|Lost to Follow-up|14|||
163013202|NCT02040805|588749996|FG001|Overall Study|Lost to Follow-up|9|||
163013203|NCT02040805|588749995|FG000|Overall Study|Withdrawal by Subject|28|||
163013204|NCT02040805|588749996|FG001|Overall Study|Withdrawal by Subject|41|||
163013205|NCT00908544|588749997|FG000|Overall Study|Withdrawal by Subject|2|||
163013206|NCT00908544|588749998|FG001|Overall Study|Withdrawal by Subject|4|||
163013207|NCT00908544|588749997|FG000|Overall Study|Lack of Efficacy|0|||
163013208|NCT00908544|588749998|FG001|Overall Study|Lack of Efficacy|1|||
163013209|NCT00908544|588749997|FG000|Overall Study|Pregnancy|1|||
163013210|NCT00908544|588749998|FG001|Overall Study|Pregnancy|0|||
163013211|NCT00908544|588749997|FG000|Overall Study|Relocation abroad|1|||
163013212|NCT00908544|588749998|FG001|Overall Study|Relocation abroad|1|||
163013213|NCT00908544|588749997|FG000|Overall Study|Unable to visit sutdy center|1|||
163013214|NCT00908544|588749998|FG001|Overall Study|Unable to visit sutdy center|0|||
163013215|NCT02859337|588750004|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
163013216|NCT02859337|588750005|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
163013217|NCT02859337|588750006|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
163013218|NCT02859337|588750004|FG000|Overall Study|Withdrawal by Subject|3|||
163013219|NCT02859337|588750005|FG001|Overall Study|Withdrawal by Subject|1|||
163013220|NCT02859337|588750006|FG002|Overall Study|Withdrawal by Subject|0|||
163013221|NCT02859337|588750004|FG000|Overall Study|Lost to Follow-up|1|||
163013222|NCT02859337|588750005|FG001|Overall Study|Lost to Follow-up|0|||
163215373|NCT04762680|589503816|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
163215374|NCT04762680|589503817|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
163215375|NCT04762680|589503818|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
163215376|NCT04762680|589503819|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
163013223|NCT02859337|588750006|FG002|Overall Study|Lost to Follow-up|0|||
163013224|NCT00848718|588750007|FG000|Overall Study|Adverse Event|2|||
163013225|NCT00848718|588750008|FG001|Overall Study|Adverse Event|2|||
163013226|NCT00848718|588750009|FG002|Overall Study|Adverse Event|1|||
163013227|NCT00848718|588750010|FG003|Overall Study|Adverse Event|1|||
163013228|NCT00848718|588750011|FG004|Overall Study|Adverse Event|1|||
163013229|NCT00848718|588750012|FG005|Overall Study|Adverse Event|0|||
163013230|NCT00848718|588750013|FG006|Overall Study|Adverse Event|0|||
163013231|NCT00848718|588750014|FG007|Overall Study|Adverse Event|1|||
163013232|NCT00848718|588750015|FG008|Overall Study|Adverse Event|1|||
163013233|NCT00848718|588750016|FG009|Overall Study|Adverse Event|0|||
163013234|NCT00848718|588750017|FG010|Overall Study|Adverse Event|0|||
163013235|NCT00848718|588750018|FG011|Overall Study|Adverse Event|0|||
163013236|NCT00848718|588750019|FG012|Overall Study|Adverse Event|2|||
163013237|NCT00848718|588750007|FG000|Overall Study|Lack of Efficacy|0|||
163013238|NCT00848718|588750008|FG001|Overall Study|Lack of Efficacy|0|||
163013239|NCT00848718|588750009|FG002|Overall Study|Lack of Efficacy|1|||
163013240|NCT00848718|588750010|FG003|Overall Study|Lack of Efficacy|0|||
163013241|NCT00848718|588750011|FG004|Overall Study|Lack of Efficacy|0|||
163013242|NCT00848718|588750012|FG005|Overall Study|Lack of Efficacy|0|||
163013243|NCT00848718|588750013|FG006|Overall Study|Lack of Efficacy|1|||
163013244|NCT00848718|588750014|FG007|Overall Study|Lack of Efficacy|0|||
163013245|NCT00848718|588750015|FG008|Overall Study|Lack of Efficacy|0|||
163013246|NCT00848718|588750016|FG009|Overall Study|Lack of Efficacy|0|||
163013247|NCT00848718|588750017|FG010|Overall Study|Lack of Efficacy|0|||
163215377|NCT02584504|589503822|FG000|Double-blind Treatment|Participant withdrew consent|0|||
163215378|NCT02584504|589503823|FG001|Double-blind Treatment|Participant withdrew consent|0|||
163013248|NCT00848718|588750018|FG011|Overall Study|Lack of Efficacy|0|||
163013249|NCT00848718|588750019|FG012|Overall Study|Lack of Efficacy|0|||
163013250|NCT00848718|588750007|FG000|Overall Study|Physician Decision|0|||
163013251|NCT00848718|588750008|FG001|Overall Study|Physician Decision|1|||
163013252|NCT00848718|588750009|FG002|Overall Study|Physician Decision|0|||
163013253|NCT00848718|588750010|FG003|Overall Study|Physician Decision|0|||
163013254|NCT00848718|588750011|FG004|Overall Study|Physician Decision|1|||
163013255|NCT00848718|588750012|FG005|Overall Study|Physician Decision|1|||
163013256|NCT00848718|588750013|FG006|Overall Study|Physician Decision|0|||
163013257|NCT00848718|588750014|FG007|Overall Study|Physician Decision|0|||
163013258|NCT00848718|588750015|FG008|Overall Study|Physician Decision|1|||
163062720|NCT04530344|588936918|FG001|Overall Study|Pregnancy|0|||
163062721|NCT04530344|588936919|FG002|Overall Study|Pregnancy|2|||
163062722|NCT04530344|588936920|FG003|Overall Study|Pregnancy|1|||
163062723|NCT04530344|588936917|FG000|Overall Study|Protocol Violation|0|||
163062724|NCT04530344|588936918|FG001|Overall Study|Protocol Violation|0|||
163062725|NCT04530344|588936919|FG002|Overall Study|Protocol Violation|0|||
163062726|NCT04530344|588936920|FG003|Overall Study|Protocol Violation|1|||
163062727|NCT04530344|588936917|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
163062728|NCT04530344|588936918|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
163013259|NCT00848718|588750016|FG009|Overall Study|Physician Decision|2|||
163013260|NCT00848718|588750017|FG010|Overall Study|Physician Decision|0|||
163013261|NCT00848718|588750018|FG011|Overall Study|Physician Decision|0|||
163013262|NCT00848718|588750019|FG012|Overall Study|Physician Decision|1|||
163013263|NCT00848718|588750007|FG000|Overall Study|Progressive disease before treatment|1|||
163013264|NCT00848718|588750008|FG001|Overall Study|Progressive disease before treatment|5|||
163013265|NCT00848718|588750009|FG002|Overall Study|Progressive disease before treatment|1|||
163013266|NCT00848718|588750010|FG003|Overall Study|Progressive disease before treatment|3|||
163013267|NCT00848718|588750011|FG004|Overall Study|Progressive disease before treatment|4|||
163013268|NCT00848718|588750012|FG005|Overall Study|Progressive disease before treatment|4|||
163013269|NCT00848718|588750013|FG006|Overall Study|Progressive disease before treatment|2|||
163013270|NCT00848718|588750014|FG007|Overall Study|Progressive disease before treatment|1|||
163013271|NCT00848718|588750015|FG008|Overall Study|Progressive disease before treatment|2|||
163013272|NCT00848718|588750016|FG009|Overall Study|Progressive disease before treatment|7|||
163013273|NCT00848718|588750017|FG010|Overall Study|Progressive disease before treatment|3|||
163013274|NCT00848718|588750018|FG011|Overall Study|Progressive disease before treatment|6|||
163013275|NCT00848718|588750019|FG012|Overall Study|Progressive disease before treatment|2|||
163013276|NCT00848718|588750007|FG000|Overall Study|Protocol Violation|0|||
163013277|NCT00848718|588750008|FG001|Overall Study|Protocol Violation|1|||
163013278|NCT00848718|588750009|FG002|Overall Study|Protocol Violation|0|||
163013279|NCT00848718|588750010|FG003|Overall Study|Protocol Violation|0|||
163013280|NCT00848718|588750011|FG004|Overall Study|Protocol Violation|0|||
163013281|NCT00848718|588750012|FG005|Overall Study|Protocol Violation|0|||
163013282|NCT00848718|588750013|FG006|Overall Study|Protocol Violation|0|||
163013283|NCT00848718|588750014|FG007|Overall Study|Protocol Violation|1|||
163013284|NCT00848718|588750015|FG008|Overall Study|Protocol Violation|0|||
163013285|NCT00848718|588750016|FG009|Overall Study|Protocol Violation|0|||
163013286|NCT00848718|588750017|FG010|Overall Study|Protocol Violation|0|||
163013287|NCT00848718|588750018|FG011|Overall Study|Protocol Violation|0|||
163013288|NCT00848718|588750019|FG012|Overall Study|Protocol Violation|1|||
163013289|NCT00848718|588750007|FG000|Overall Study|Withdrawal by Subject|1|||
163013290|NCT00848718|588750008|FG001|Overall Study|Withdrawal by Subject|0|||
163013291|NCT00848718|588750009|FG002|Overall Study|Withdrawal by Subject|0|||
163013292|NCT00848718|588750010|FG003|Overall Study|Withdrawal by Subject|1|||
163013293|NCT00848718|588750011|FG004|Overall Study|Withdrawal by Subject|0|||
163013294|NCT00848718|588750012|FG005|Overall Study|Withdrawal by Subject|0|||
163013295|NCT00848718|588750013|FG006|Overall Study|Withdrawal by Subject|0|||
163013296|NCT00848718|588750014|FG007|Overall Study|Withdrawal by Subject|0|||
163013297|NCT00848718|588750015|FG008|Overall Study|Withdrawal by Subject|0|||
163013298|NCT00848718|588750016|FG009|Overall Study|Withdrawal by Subject|0|||
163328427|NCT04795167|589913248|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
163328428|NCT04795167|589913249|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
163328429|NCT04795167|589913250|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
163328430|NCT02029235|589913251|FG000|Overall Study|Non-compliance with study meds or diary|4|||
163328431|NCT02029235|589913252|FG001|Overall Study|Non-compliance with study meds or diary|1|||
163328432|NCT01400958|589913254|FG000|Overall Study|Physician Decision|0|||
163328433|NCT01400958|589913255|FG001|Overall Study|Physician Decision|1|||
163328434|NCT01400958|589913254|FG000|Overall Study|Withdrawal by Subject|0|||
163328435|NCT01400958|589913255|FG001|Overall Study|Withdrawal by Subject|1|||
163013299|NCT00848718|588750017|FG010|Overall Study|Withdrawal by Subject|1|||
163062729|NCT04530344|588936919|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
163062730|NCT04530344|588936920|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
163062731|NCT04530344|588936917|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
163328436|NCT01400958|589913254|FG000|Overall Study|Adverse Event|1|||
163328437|NCT01400958|589913255|FG001|Overall Study|Adverse Event|0|||
163013300|NCT00848718|588750018|FG011|Overall Study|Withdrawal by Subject|0|||
163013301|NCT00848718|588750019|FG012|Overall Study|Withdrawal by Subject|0|||
163013302|NCT00848718|588750007|FG000|Overall Study|Progressive disease during treatment|3|||
163013303|NCT00848718|588750008|FG001|Overall Study|Progressive disease during treatment|0|||
163013304|NCT00848718|588750009|FG002|Overall Study|Progressive disease during treatment|3|||
163013305|NCT00848718|588750010|FG003|Overall Study|Progressive disease during treatment|0|||
163013306|NCT00848718|588750011|FG004|Overall Study|Progressive disease during treatment|0|||
163013307|NCT00848718|588750012|FG005|Overall Study|Progressive disease during treatment|0|||
163062732|NCT04530344|588936918|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
163328438|NCT04436289|589913256|FG000|Overall Study|Death prior to hospital discharge|8|||
163328439|NCT04436289|589913257|FG001|Overall Study|Death prior to hospital discharge|5|||
163328440|NCT04436289|589913258|FG002|Overall Study|Death prior to hospital discharge|0|||
163328441|NCT04436289|589913259|FG003|Overall Study|Death prior to hospital discharge|1|||
163328442|NCT04436289|589913256|FG000|Overall Study|Withdrawal by Subject|0|||
163328443|NCT04436289|589913257|FG001|Overall Study|Withdrawal by Subject|1|||
163328444|NCT04436289|589913258|FG002|Overall Study|Withdrawal by Subject|4|||
163328445|NCT04436289|589913259|FG003|Overall Study|Withdrawal by Subject|0|||
163328446|NCT04436289|589913256|FG000|Overall Study|Extended hospital stay|0|||
163013308|NCT00848718|588750013|FG006|Overall Study|Progressive disease during treatment|0|||
163013309|NCT00848718|588750014|FG007|Overall Study|Progressive disease during treatment|2|||
163013310|NCT00848718|588750015|FG008|Overall Study|Progressive disease during treatment|0|||
163013311|NCT00848718|588750016|FG009|Overall Study|Progressive disease during treatment|0|||
163013312|NCT00848718|588750017|FG010|Overall Study|Progressive disease during treatment|0|||
163013313|NCT00848718|588750018|FG011|Overall Study|Progressive disease during treatment|0|||
163013314|NCT00848718|588750019|FG012|Overall Study|Progressive disease during treatment|2|||
163013315|NCT02389829|588750020|FG000|Overall Study|Lost to Follow-up|0|||
163013316|NCT02389829|588750021|FG001|Overall Study|Lost to Follow-up|1|||
163013317|NCT00833105|588751446|FG000|Overall Study|Withdrawal by Subject|1|||
163013318|NCT00833105|588751446|FG000|Overall Study|Adverse Event|2|||
163013319|NCT02898597|588751447|FG000|Overall Study|Protocol Violation|4|||
163013320|NCT02898597|588751448|FG001|Overall Study|Protocol Violation|2|||
163013321|NCT02898597|588751447|FG000|Overall Study|Lost to Follow-up|0|||
163013322|NCT02898597|588751448|FG001|Overall Study|Lost to Follow-up|9|||
163013323|NCT02898597|588751447|FG000|Overall Study|Death|0|||
163013324|NCT02898597|588751448|FG001|Overall Study|Death|1|||
163013325|NCT00171210|588751452|FG000|Overall Study|Adverse Event|16|||
163013326|NCT00171210|588751453|FG001|Overall Study|Adverse Event|27|||
163013327|NCT00171210|588751452|FG000|Overall Study|Abnormal laboratory value(s)|6|||
163013328|NCT00171210|588751453|FG001|Overall Study|Abnormal laboratory value(s)|3|||
163013329|NCT00171210|588751452|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163013330|NCT00171210|588751453|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163013331|NCT00171210|588751452|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
163013332|NCT00171210|588751453|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
163013333|NCT00171210|588751452|FG000|Overall Study|Protocol Violation|0|||
163013334|NCT00171210|588751453|FG001|Overall Study|Protocol Violation|2|||
163013335|NCT00171210|588751452|FG000|Overall Study|Withdrawal by Subject|32|||
163013336|NCT00171210|588751453|FG001|Overall Study|Withdrawal by Subject|30|||
163013337|NCT00171210|588751452|FG000|Overall Study|Lost to Follow-up|1|||
163013338|NCT00171210|588751453|FG001|Overall Study|Lost to Follow-up|0|||
163013339|NCT00171210|588751452|FG000|Overall Study|Administrative problems|1|||
163013340|NCT00171210|588751453|FG001|Overall Study|Administrative problems|1|||
163013341|NCT00171210|588751452|FG000|Overall Study|Death|2|||
163013342|NCT00171210|588751453|FG001|Overall Study|Death|3|||
163013343|NCT00171210|588751452|FG000|Overall Study|Stopped at end of core|0|||
163013344|NCT00171210|588751453|FG001|Overall Study|Stopped at end of core|32|||
163013345|NCT00171210|588751452|FG000|Overall Study|Stopped at end of extension 1|0|||
163013346|NCT00171210|588751453|FG001|Overall Study|Stopped at end of extension 1|1|||
163013347|NCT01609296|588751454|FG000|Overall Study|Death|253|||
163013348|NCT01609296|588751454|FG000|Overall Study|Withdrawal by Subject|151|||
163013349|NCT01609296|588751454|FG000|Overall Study|Lost to Follow-up|21|||
163013350|NCT01609296|588751454|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
163013351|NCT01609296|588751454|FG000|Overall Study|missed visit but known to be alive|28|||
163013352|NCT01681212|588751457|FG000|Overall Study|No longer met study criteria|5|||
163013353|NCT01681212|588751457|FG000|Overall Study|Administrative reason by sponsor|1|||
163013354|NCT01464333|588751458|FG000|Overall Study|Adverse Event|34|||
163013355|NCT01464333|588751458|FG000|Overall Study|Lack of Efficacy|72|||
163013356|NCT01464333|588751458|FG000|Overall Study|Withdrawal by Subject|11|||
163013357|NCT01464333|588751458|FG000|Overall Study|Other|4|||
163013358|NCT01464333|588751458|FG000|Overall Study|No Hospital Visit|42|||
163013359|NCT03321968|588751462|FG000|Overall Study|Withdrawal by Subject|1|||
163013360|NCT03321968|588751463|FG001|Overall Study|Withdrawal by Subject|2|||
163013361|NCT03321968|588751464|FG002|Overall Study|Withdrawal by Subject|1|||
163013362|NCT03321968|588751462|FG000|Overall Study|Lost to Follow-up|2|||
163013363|NCT03321968|588751463|FG001|Overall Study|Lost to Follow-up|0|||
163062733|NCT04530344|588936919|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
163328447|NCT04436289|589913257|FG001|Overall Study|Extended hospital stay|1|||
163062734|NCT04530344|588936920|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
163062735|NCT04530344|588936917|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
163328448|NCT04436289|589913258|FG002|Overall Study|Extended hospital stay|0|||
163328449|NCT04436289|589913259|FG003|Overall Study|Extended hospital stay|0|||
163013364|NCT03321968|588751464|FG002|Overall Study|Lost to Follow-up|1|||
163013365|NCT03321968|588751462|FG000|Overall Study|Other than specified|0|||
163013366|NCT03321968|588751463|FG001|Overall Study|Other than specified|0|||
163013367|NCT03321968|588751464|FG002|Overall Study|Other than specified|1|||
163013368|NCT02282813|588751467|FG000|Overall Study|Withdrawal by Subject|4|||
163013369|NCT02282813|588751468|FG001|Overall Study|Withdrawal by Subject|5|||
163013370|NCT02282813|588751469|FG002|Overall Study|Withdrawal by Subject|0|||
163013371|NCT02282813|588751467|FG000|Overall Study|Adverse Event|3|||
163013372|NCT02282813|588751468|FG001|Overall Study|Adverse Event|10|||
163013373|NCT02282813|588751469|FG002|Overall Study|Adverse Event|1|||
163013374|NCT02282813|588751467|FG000|Overall Study|Subject non-compliance|1|||
163013375|NCT02282813|588751468|FG001|Overall Study|Subject non-compliance|4|||
163013376|NCT02282813|588751469|FG002|Overall Study|Subject non-compliance|0|||
163013377|NCT02282813|588751467|FG000|Overall Study|Physician Decision|0|||
163013378|NCT02282813|588751468|FG001|Overall Study|Physician Decision|3|||
163013379|NCT02282813|588751469|FG002|Overall Study|Physician Decision|1|||
163013380|NCT02282813|588751467|FG000|Overall Study|Lost to Follow-up|2|||
163013381|NCT02282813|588751468|FG001|Overall Study|Lost to Follow-up|0|||
163013382|NCT02282813|588751469|FG002|Overall Study|Lost to Follow-up|1|||
163013383|NCT02282813|588751467|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
163013384|NCT02282813|588751468|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
163013385|NCT02282813|588751469|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
163013386|NCT02282813|588751467|FG000|Overall Study|Lack of Efficacy|1|||
163013387|NCT02282813|588751468|FG001|Overall Study|Lack of Efficacy|0|||
163013388|NCT02282813|588751469|FG002|Overall Study|Lack of Efficacy|0|||
163013389|NCT02282813|588751467|FG000|Overall Study|Administrative reasons|0|||
163013390|NCT02282813|588751468|FG001|Overall Study|Administrative reasons|1|||
163013391|NCT02282813|588751469|FG002|Overall Study|Administrative reasons|0|||
163013392|NCT00529308|588751470|FG000|Overall Study|Withdrawal by Subject|1|||
163013393|NCT00529308|588751471|FG001|Overall Study|Withdrawal by Subject|1|||
163013394|NCT06509438|588751472|FG000|Overall Study|Adverse Event|1|||
163013395|NCT06509438|588751472|FG000|Overall Study|Lost to Follow-up|3|||
163013396|NCT03331796|588751473|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
163013397|NCT03331796|588751474|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
163013398|NCT03331796|588751475|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
163013399|NCT03331796|588751473|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
163013400|NCT03331796|588751474|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
163013401|NCT03331796|588751475|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
163013402|NCT03331796|588751473|FG000|Extended Follow-up|Adverse Event|1|||
163013403|NCT03331796|588751474|FG001|Extended Follow-up|Adverse Event|0|||
163013404|NCT03331796|588751475|FG002|Extended Follow-up|Adverse Event|1|||
163013405|NCT03331796|588751473|FG000|Extended Follow-up|Lost to Follow-up|0|||
163013406|NCT03331796|588751474|FG001|Extended Follow-up|Lost to Follow-up|0|||
163013407|NCT03331796|588751475|FG002|Extended Follow-up|Lost to Follow-up|1|||
163013408|NCT03331796|588751473|FG000|Extended Follow-up|Withdrawal by Subject|1|||
163013409|NCT03331796|588751474|FG001|Extended Follow-up|Withdrawal by Subject|0|||
163013410|NCT03331796|588751475|FG002|Extended Follow-up|Withdrawal by Subject|0|||
163013411|NCT03331796|588751473|FG000|Extended Follow-up|Termination of Funding|0|||
163013412|NCT03331796|588751474|FG001|Extended Follow-up|Termination of Funding|1|||
163013413|NCT03331796|588751475|FG002|Extended Follow-up|Termination of Funding|0|||
163013414|NCT00745901|588751478|FG000|Overall Study|Adverse Event|3|||
163013415|NCT00745901|588751479|FG001|Overall Study|Adverse Event|4|||
163013416|NCT00745901|588751478|FG000|Overall Study|Protocol Violation|0|||
163013417|NCT00745901|588751479|FG001|Overall Study|Protocol Violation|1|||
163013418|NCT00745901|588751478|FG000|Overall Study|Withdrawal by Subject|1|||
163013419|NCT00745901|588751479|FG001|Overall Study|Withdrawal by Subject|0|||
163013420|NCT00745901|588751478|FG000|Overall Study|Lost to Follow-up|7|||
163013421|NCT00745901|588751479|FG001|Overall Study|Lost to Follow-up|4|||
163013422|NCT00745901|588751478|FG000|Overall Study|Pregnancy|2|||
163013423|NCT00745901|588751479|FG001|Overall Study|Pregnancy|4|||
163013424|NCT00745901|588751478|FG000|Overall Study|Lack of compliance|2|||
163013425|NCT00745901|588751479|FG001|Overall Study|Lack of compliance|2|||
163013426|NCT00745901|588751478|FG000|Overall Study|Patient's next menses did not start with|1|||
163013427|NCT00745901|588751479|FG001|Overall Study|Patient's next menses did not start with|0|||
163013428|NCT00745901|588751478|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
163013429|NCT00745901|588751479|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
163013430|NCT00745901|588751478|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
163013431|NCT00745901|588751479|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
163215379|NCT02584504|589503824|FG002|Double-blind Treatment|Participant withdrew consent|1|||
163215380|NCT02584504|589503822|FG000|Double-blind Treatment|Adverse Event|0|||
163215381|NCT02584504|589503823|FG001|Double-blind Treatment|Adverse Event|1|||
163013432|NCT00745901|588751478|FG000|Overall Study|Patient didn't take any study medication|7|||
163013433|NCT00745901|588751479|FG001|Overall Study|Patient didn't take any study medication|3|||
163013434|NCT01753310|588751481|FG000|Overall Study|Entered into open label extension study|25|||
163013435|NCT01753310|588751482|FG001|Overall Study|Entered into open label extension study|22|||
163013436|NCT01753310|588751481|FG000|Overall Study|Adverse Event|1|||
163013437|NCT01753310|588751482|FG001|Overall Study|Adverse Event|0|||
163013438|NCT01753310|588751481|FG000|Overall Study|Lost to Follow-up|2|||
163215382|NCT02584504|589503824|FG002|Double-blind Treatment|Adverse Event|0|||
163013439|NCT01753310|588751482|FG001|Overall Study|Lost to Follow-up|0|||
163013440|NCT01753310|588751481|FG000|Overall Study|Subject decision|2|||
163013441|NCT01753310|588751482|FG001|Overall Study|Subject decision|2|||
163013442|NCT01753310|588751481|FG000|Overall Study|Sponsor decision|1|||
163013443|NCT01753310|588751482|FG001|Overall Study|Sponsor decision|0|||
163013444|NCT01753310|588751481|FG000|Overall Study|Withdrawal by Subject|1|||
163013445|NCT01753310|588751482|FG001|Overall Study|Withdrawal by Subject|0|||
163013446|NCT05581641|588751483|FG000|Overall Study|Withdrawal by Subject|0|||
163013447|NCT05581641|588751484|FG001|Overall Study|Withdrawal by Subject|1|||
163013448|NCT05581641|588751485|FG002|Overall Study|Withdrawal by Subject|3|||
163013449|NCT05581641|588751486|FG003|Overall Study|Withdrawal by Subject|1|||
163013450|NCT05581641|588751483|FG000|Overall Study|Lost to Follow-up|0|||
163013451|NCT05581641|588751484|FG001|Overall Study|Lost to Follow-up|1|||
163013452|NCT05581641|588751485|FG002|Overall Study|Lost to Follow-up|0|||
163013453|NCT05581641|588751486|FG003|Overall Study|Lost to Follow-up|1|||
163013454|NCT05581641|588751483|FG000|Overall Study|Protocol Violation|1|||
163013455|NCT05581641|588751484|FG001|Overall Study|Protocol Violation|0|||
163013456|NCT05581641|588751485|FG002|Overall Study|Protocol Violation|0|||
163013457|NCT05581641|588751486|FG003|Overall Study|Protocol Violation|0|||
163013458|NCT05581641|588751483|FG000|Overall Study|Other|1|||
163013459|NCT05581641|588751484|FG001|Overall Study|Other|0|||
163013460|NCT05581641|588751485|FG002|Overall Study|Other|2|||
163013461|NCT05581641|588751486|FG003|Overall Study|Other|1|||
163013462|NCT04390763|588751487|FG000|Safety run-in Part|Adverse Event|4|||
163013463|NCT04390763|588751488|FG001|Safety run-in Part|Adverse Event|0|||
163013464|NCT04390763|588751489|FG002|Safety run-in Part|Adverse Event|0|||
163013465|NCT04390763|588751490|FG003|Safety run-in Part|Adverse Event|0|||
163013466|NCT04390763|588751487|FG000|Safety run-in Part|Physician Decision|1|||
163013467|NCT04390763|588751488|FG001|Safety run-in Part|Physician Decision|0|||
163013468|NCT04390763|588751489|FG002|Safety run-in Part|Physician Decision|0|||
163013469|NCT04390763|588751490|FG003|Safety run-in Part|Physician Decision|0|||
163013470|NCT04390763|588751487|FG000|Safety run-in Part|Progressive Disease|6|||
163013471|NCT04390763|588751488|FG001|Safety run-in Part|Progressive Disease|0|||
163013472|NCT04390763|588751489|FG002|Safety run-in Part|Progressive Disease|0|||
163013473|NCT04390763|588751490|FG003|Safety run-in Part|Progressive Disease|0|||
163013474|NCT04390763|588751487|FG000|Randomized Part|Adverse Event|0|||
163013475|NCT04390763|588751488|FG001|Randomized Part|Adverse Event|11|||
163013476|NCT04390763|588751489|FG002|Randomized Part|Adverse Event|5|||
163013477|NCT04390763|588751490|FG003|Randomized Part|Adverse Event|5|||
163013478|NCT04390763|588751487|FG000|Randomized Part|Death|0|||
163013479|NCT04390763|588751488|FG001|Randomized Part|Death|3|||
163013480|NCT04390763|588751489|FG002|Randomized Part|Death|4|||
163013481|NCT04390763|588751490|FG003|Randomized Part|Death|2|||
163013482|NCT04390763|588751487|FG000|Randomized Part|Physician Decision|0|||
163013483|NCT04390763|588751488|FG001|Randomized Part|Physician Decision|2|||
163013484|NCT04390763|588751489|FG002|Randomized Part|Physician Decision|2|||
163013485|NCT04390763|588751490|FG003|Randomized Part|Physician Decision|9|||
163013486|NCT04390763|588751487|FG000|Randomized Part|Progressive Disease|0|||
163013487|NCT04390763|588751488|FG001|Randomized Part|Progressive Disease|24|||
163013488|NCT04390763|588751489|FG002|Randomized Part|Progressive Disease|31|||
163013489|NCT04390763|588751490|FG003|Randomized Part|Progressive Disease|23|||
163013490|NCT04390763|588751487|FG000|Randomized Part|Study terminated by sponsor|0|||
163013491|NCT04390763|588751488|FG001|Randomized Part|Study terminated by sponsor|1|||
163013492|NCT04390763|588751489|FG002|Randomized Part|Study terminated by sponsor|0|||
163013493|NCT04390763|588751490|FG003|Randomized Part|Study terminated by sponsor|0|||
163013494|NCT04390763|588751487|FG000|Randomized Part|Participant Decision|0|||
163013495|NCT04390763|588751488|FG001|Randomized Part|Participant Decision|5|||
163013496|NCT04390763|588751489|FG002|Randomized Part|Participant Decision|7|||
163013497|NCT04390763|588751490|FG003|Randomized Part|Participant Decision|6|||
163013498|NCT04390763|588751487|FG000|Randomized Part|Not treated|0|||
163013499|NCT04390763|588751488|FG001|Randomized Part|Not treated|4|||
163013500|NCT04390763|588751489|FG002|Randomized Part|Not treated|2|||
163013501|NCT04390763|588751490|FG003|Randomized Part|Not treated|7|||
163013502|NCT01786993|588751491|FG000|Overall Study|Death|6|||
163013503|NCT01786993|588751492|FG001|Overall Study|Death|7|||
163013504|NCT01786993|588751491|FG000|Overall Study|Withdrawal by Subject|3|||
163013505|NCT01786993|588751492|FG001|Overall Study|Withdrawal by Subject|2|||
163013506|NCT01786993|588751491|FG000|Overall Study|Lost to Follow-up|0|||
163013507|NCT01786993|588751492|FG001|Overall Study|Lost to Follow-up|1|||
163013508|NCT01786993|588751491|FG000|Overall Study|Subject Non-Compliance|1|||
163013509|NCT01786993|588751492|FG001|Overall Study|Subject Non-Compliance|0|||
163013510|NCT01786993|588751491|FG000|Overall Study|System Explant|1|||
163013511|NCT01786993|588751492|FG001|Overall Study|System Explant|0|||
163013512|NCT01786993|588751491|FG000|Overall Study|Hospice Admission|1|||
163013513|NCT01786993|588751492|FG001|Overall Study|Hospice Admission|0|||
163013514|NCT00450437|588751493|FG000|Overall Study|Withdrawal by Subject|10|||
163013515|NCT00450437|588751494|FG001|Overall Study|Withdrawal by Subject|2|||
163013516|NCT00450437|588751495|FG002|Overall Study|Withdrawal by Subject|0|||
163013517|NCT00450437|588751496|FG003|Overall Study|Withdrawal by Subject|1|||
163013518|NCT00450437|588751493|FG000|Overall Study|Lost to Follow-up|31|||
163013519|NCT00450437|588751494|FG001|Overall Study|Lost to Follow-up|12|||
163013520|NCT00450437|588751495|FG002|Overall Study|Lost to Follow-up|19|||
163013521|NCT00450437|588751496|FG003|Overall Study|Lost to Follow-up|9|||
163013522|NCT00450437|588751493|FG000|Overall Study|Protocol Violation|0|||
163013523|NCT00450437|588751494|FG001|Overall Study|Protocol Violation|1|||
163013524|NCT00450437|588751495|FG002|Overall Study|Protocol Violation|0|||
163013525|NCT00450437|588751496|FG003|Overall Study|Protocol Violation|1|||
163013526|NCT00450437|588751493|FG000|Overall Study|Inappropriate enrollment|4|||
163013527|NCT00450437|588751494|FG001|Overall Study|Inappropriate enrollment|1|||
163013528|NCT00450437|588751495|FG002|Overall Study|Inappropriate enrollment|3|||
163013529|NCT00450437|588751496|FG003|Overall Study|Inappropriate enrollment|0|||
163013530|NCT00450437|588751493|FG000|Overall Study|Administrative reason|0|||
163013531|NCT00450437|588751494|FG001|Overall Study|Administrative reason|0|||
163013532|NCT00450437|588751495|FG002|Overall Study|Administrative reason|1|||
163013533|NCT00450437|588751496|FG003|Overall Study|Administrative reason|0|||
163013534|NCT00450437|588751493|FG000|Overall Study|Unable to Classify|1|||
163013535|NCT00450437|588751494|FG001|Overall Study|Unable to Classify|0|||
163013536|NCT00450437|588751495|FG002|Overall Study|Unable to Classify|1|||
163013537|NCT00450437|588751496|FG003|Overall Study|Unable to Classify|0|||
163013538|NCT01890122|588751497|FG000|Overall Study|Adverse Event|1|||
163013539|NCT01890122|588751498|FG001|Overall Study|Adverse Event|1|||
163013540|NCT01890122|588751499|FG002|Overall Study|Adverse Event|1|||
163013541|NCT01890122|588751500|FG003|Overall Study|Adverse Event|2|||
163013542|NCT01890122|588751497|FG000|Overall Study|Major Protocol Deviation|3|||
163013543|NCT01890122|588751498|FG001|Overall Study|Major Protocol Deviation|1|||
163404588|NCT01157364|590191958|FG000|Overall Study|Adverse Event|0|||
163404589|NCT01157364|590191959|FG001|Overall Study|Adverse Event|1|||
163404590|NCT01157364|590191960|FG002|Overall Study|Adverse Event|1|||
163404591|NCT01157364|590191961|FG003|Overall Study|Adverse Event|0|||
163404592|NCT01157364|590191962|FG004|Overall Study|Adverse Event|1|||
163404593|NCT01157364|590191963|FG005|Overall Study|Adverse Event|0|||
163404594|NCT00183274|590191966|FG000|Phase 1: Open-Label|Adverse Event|31|||
163404595|NCT00183274|590191967|FG001|Phase 1: Open-Label|Adverse Event|0|||
163404596|NCT00183274|590191968|FG002|Phase 1: Open-Label|Adverse Event|0|||
163404597|NCT00183274|590191969|FG003|Phase 1: Open-Label|Adverse Event|0|||
163404598|NCT00183274|590191970|FG004|Phase 1: Open-Label|Adverse Event|0|||
163404599|NCT00183274|590191971|FG005|Phase 1: Open-Label|Adverse Event|0|||
163404600|NCT00183274|590191966|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
163404601|NCT00183274|590191967|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
163404602|NCT00183274|590191968|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
163404603|NCT00183274|590191969|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
163404604|NCT00183274|590191970|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
163404605|NCT00183274|590191971|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
163404606|NCT00183274|590191966|FG000|Phase 1: Open-Label|Protocol Violation|11|||
163404607|NCT00183274|590191967|FG001|Phase 1: Open-Label|Protocol Violation|0|||
163404608|NCT00183274|590191968|FG002|Phase 1: Open-Label|Protocol Violation|0|||
163404609|NCT00183274|590191969|FG003|Phase 1: Open-Label|Protocol Violation|0|||
163404610|NCT00183274|590191970|FG004|Phase 1: Open-Label|Protocol Violation|0|||
163404611|NCT00183274|590191971|FG005|Phase 1: Open-Label|Protocol Violation|0|||
163404612|NCT00183274|590191966|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
163404613|NCT00183274|590191967|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
163404614|NCT00183274|590191968|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
163404615|NCT00183274|590191969|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
163404616|NCT00183274|590191970|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
163404617|NCT00183274|590191971|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
163404618|NCT00183274|590191966|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
163404619|NCT00183274|590191967|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
163404620|NCT00183274|590191968|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
163404621|NCT00183274|590191969|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
163404622|NCT00183274|590191970|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
163404623|NCT00183274|590191971|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
163404624|NCT00183274|590191966|FG000|Phase 1: Open-Label|Other|9|||
163404625|NCT00183274|590191967|FG001|Phase 1: Open-Label|Other|0|||
163013544|NCT01890122|588751499|FG002|Overall Study|Major Protocol Deviation|0|||
163013545|NCT01890122|588751500|FG003|Overall Study|Major Protocol Deviation|1|||
163013546|NCT01890122|588751497|FG000|Overall Study|Lost to Follow-up|0|||
163404626|NCT00183274|590191968|FG002|Phase 1: Open-Label|Other|0|||
163404627|NCT00183274|590191969|FG003|Phase 1: Open-Label|Other|0|||
163404628|NCT00183274|590191970|FG004|Phase 1: Open-Label|Other|0|||
163404629|NCT00183274|590191971|FG005|Phase 1: Open-Label|Other|0|||
163404630|NCT00183274|590191966|FG000|Phase 2: Double-Blind|Relapsed|0|||
163404631|NCT00183274|590191967|FG001|Phase 2: Double-Blind|Relapsed|8|||
163404632|NCT00183274|590191968|FG002|Phase 2: Double-Blind|Relapsed|29|||
163404633|NCT00183274|590191969|FG003|Phase 2: Double-Blind|Relapsed|0|||
163404634|NCT00183274|590191970|FG004|Phase 2: Double-Blind|Relapsed|0|||
163404635|NCT00183274|590191971|FG005|Phase 2: Double-Blind|Relapsed|0|||
163404636|NCT00183274|590191966|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
163013547|NCT01890122|588751498|FG001|Overall Study|Lost to Follow-up|1|||
163013548|NCT01890122|588751499|FG002|Overall Study|Lost to Follow-up|2|||
163013549|NCT01890122|588751500|FG003|Overall Study|Lost to Follow-up|2|||
163013550|NCT01890122|588751497|FG000|Overall Study|Voluntary Withdrawal|8|||
163013551|NCT01890122|588751498|FG001|Overall Study|Voluntary Withdrawal|8|||
163013552|NCT01890122|588751499|FG002|Overall Study|Voluntary Withdrawal|2|||
163013553|NCT01890122|588751500|FG003|Overall Study|Voluntary Withdrawal|11|||
163013554|NCT01890122|588751497|FG000|Overall Study|Lack of Efficacy|14|||
163013555|NCT01890122|588751498|FG001|Overall Study|Lack of Efficacy|24|||
163013556|NCT01890122|588751499|FG002|Overall Study|Lack of Efficacy|7|||
163013557|NCT01890122|588751500|FG003|Overall Study|Lack of Efficacy|41|||
163013558|NCT01890122|588751497|FG000|Overall Study|Reason not Specified|0|||
163013559|NCT01890122|588751498|FG001|Overall Study|Reason not Specified|1|||
163013560|NCT01890122|588751499|FG002|Overall Study|Reason not Specified|1|||
163013561|NCT01890122|588751500|FG003|Overall Study|Reason not Specified|2|||
163013562|NCT01890122|588751497|FG000|Overall Study|Randomized but not Treated|1|||
163013563|NCT01890122|588751498|FG001|Overall Study|Randomized but not Treated|1|||
163013564|NCT01890122|588751499|FG002|Overall Study|Randomized but not Treated|0|||
163013565|NCT01890122|588751500|FG003|Overall Study|Randomized but not Treated|0|||
163013566|NCT04025879|588751501|FG000|Randomization|Participant withdrew consent|0|||
163013567|NCT04025879|588751502|FG001|Randomization|Participant withdrew consent|1|||
163013568|NCT04025879|588751501|FG000|Randomization|Participant no longer met study criteria|1|||
163013569|NCT04025879|588751502|FG001|Randomization|Participant no longer met study criteria|1|||
163013570|NCT04025879|588751501|FG000|Treatment|Ongoing treatment|10|||
163013571|NCT04025879|588751502|FG001|Treatment|Ongoing treatment|8|||
163013572|NCT04025879|588751501|FG000|Treatment|Disease progression/recurrence|36|||
163013573|NCT04025879|588751502|FG001|Treatment|Disease progression/recurrence|72|||
163013574|NCT04025879|588751501|FG000|Treatment|Study drug toxicity|36|||
163062736|NCT04530344|588936918|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
163062737|NCT04530344|588936919|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
163062738|NCT04530344|588936920|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
163062739|NCT04530344|588936917|FG000|Overall Study|Personal Reasons|0|||
163062740|NCT04530344|588936918|FG001|Overall Study|Personal Reasons|0|||
163062741|NCT04530344|588936919|FG002|Overall Study|Personal Reasons|0|||
163062742|NCT04530344|588936920|FG003|Overall Study|Personal Reasons|1|||
163062743|NCT04530344|588936917|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
163062744|NCT04530344|588936918|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
163062745|NCT04530344|588936919|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
163013575|NCT04025879|588751502|FG001|Treatment|Study drug toxicity|13|||
163013576|NCT04025879|588751501|FG000|Treatment|Death|2|||
163062746|NCT04530344|588936920|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
163062747|NCT01402700|588936921|FG000|Overall Study|Death|3|||
163062748|NCT01402700|588936921|FG000|Overall Study|Withdrawal by Subject|3|||
163062749|NCT01402700|588936921|FG000|Overall Study|Missed Visit|1|||
163062750|NCT01933594|588936922|FG000|Overall Study|Lost to Follow-up|1|||
163062751|NCT01933594|588936923|FG001|Overall Study|Lost to Follow-up|0|||
163062752|NCT01933594|588936924|FG002|Overall Study|Lost to Follow-up|0|||
163062753|NCT01933594|588936925|FG003|Overall Study|Lost to Follow-up|0|||
163062754|NCT01933594|588936926|FG004|Overall Study|Lost to Follow-up|1|||
163062755|NCT01933594|588936927|FG005|Overall Study|Lost to Follow-up|0|||
163062756|NCT01933594|588936922|FG000|Overall Study|Ineligible for subsequent study step|0|||
163062757|NCT01933594|588936923|FG001|Overall Study|Ineligible for subsequent study step|0|||
163062758|NCT01933594|588936924|FG002|Overall Study|Ineligible for subsequent study step|0|||
163062759|NCT01933594|588936925|FG003|Overall Study|Ineligible for subsequent study step|0|||
163062760|NCT01933594|588936926|FG004|Overall Study|Ineligible for subsequent study step|1|||
163062761|NCT01933594|588936927|FG005|Overall Study|Ineligible for subsequent study step|0|||
163062762|NCT05352399|588936941|FG000|Overall Study|Discontinued intervention|6|||
163215383|NCT02584504|589503822|FG000|Double-blind Treatment|Family Matter|0|||
163013577|NCT04025879|588751502|FG001|Treatment|Death|0|||
163013578|NCT04025879|588751501|FG000|Treatment|Adverse event unrelated to study drug|21|||
163013579|NCT04025879|588751502|FG001|Treatment|Adverse event unrelated to study drug|14|||
163013580|NCT04025879|588751501|FG000|Treatment|Participant request to discontinue study treatment|16|||
163013581|NCT04025879|588751502|FG001|Treatment|Participant request to discontinue study treatment|8|||
163013582|NCT04025879|588751501|FG000|Treatment|Participant withdrew consent|1|||
163013583|NCT04025879|588751502|FG001|Treatment|Participant withdrew consent|3|||
163013584|NCT04025879|588751501|FG000|Treatment|Participant no longer meets study criteria|3|||
163013585|NCT04025879|588751502|FG001|Treatment|Participant no longer meets study criteria|2|||
163013586|NCT04025879|588751501|FG000|Treatment|Lost to Follow-up|1|||
163013587|NCT04025879|588751502|FG001|Treatment|Lost to Follow-up|0|||
163013588|NCT04025879|588751501|FG000|Treatment|Other reasons|15|||
163013589|NCT04025879|588751502|FG001|Treatment|Other reasons|17|||
163013590|NCT04025879|588751501|FG000|Treatment|Administrative reason by sponsor|0|||
163013591|NCT04025879|588751502|FG001|Treatment|Administrative reason by sponsor|1|||
163013592|NCT04025879|588751501|FG000|Treatment|Not reported|2|||
163328450|NCT04436289|589913256|FG000|Overall Study|Lost to Follow-up|0|||
163013593|NCT04025879|588751502|FG001|Treatment|Not reported|0|||
163013594|NCT01565889|588751507|FG000|Part A|Withdrawal by Subject|1|||
163013595|NCT01565889|588751508|FG001|Part A|Withdrawal by Subject|0|||
163013596|NCT01565889|588751509|FG002|Part A|Withdrawal by Subject|0|||
163013597|NCT01565889|588751510|FG003|Part A|Withdrawal by Subject|0|||
163013598|NCT01565889|588751511|FG004|Part A|Withdrawal by Subject|0|||
163013599|NCT01565889|588751512|FG005|Part A|Withdrawal by Subject|0|||
163013600|NCT01565889|588751507|FG000|Part B|Withdrawal by Subject|0|||
163013601|NCT01565889|588751508|FG001|Part B|Withdrawal by Subject|0|||
163013602|NCT01565889|588751509|FG002|Part B|Withdrawal by Subject|0|||
163013603|NCT01565889|588751510|FG003|Part B|Withdrawal by Subject|0|||
163013604|NCT01565889|588751511|FG004|Part B|Withdrawal by Subject|0|||
163013605|NCT01565889|588751512|FG005|Part B|Withdrawal by Subject|1|||
163013606|NCT01565889|588751507|FG000|Part B|Lack of Efficacy|0|||
163013607|NCT01565889|588751508|FG001|Part B|Lack of Efficacy|0|||
163013608|NCT01565889|588751509|FG002|Part B|Lack of Efficacy|0|||
163013609|NCT01565889|588751510|FG003|Part B|Lack of Efficacy|0|||
163013610|NCT01565889|588751511|FG004|Part B|Lack of Efficacy|0|||
163013611|NCT01565889|588751512|FG005|Part B|Lack of Efficacy|2|||
163013612|NCT01565889|588751507|FG000|Part B|Lost to Follow-up|0|||
163013613|NCT01565889|588751508|FG001|Part B|Lost to Follow-up|0|||
163013614|NCT01565889|588751509|FG002|Part B|Lost to Follow-up|0|||
163013615|NCT01565889|588751510|FG003|Part B|Lost to Follow-up|0|||
163013616|NCT01565889|588751511|FG004|Part B|Lost to Follow-up|0|||
163013617|NCT01565889|588751512|FG005|Part B|Lost to Follow-up|1|||
163013618|NCT00071110|588751513|FG000|Overall Study|Protocol Violation|0|||
163013619|NCT00071110|588751514|FG001|Overall Study|Protocol Violation|4|||
163013620|NCT02259010|588751519|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
163013621|NCT03194542|588751520|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
163013622|NCT03194542|588751521|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
163013623|NCT03194542|588751522|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
163013624|NCT03194542|588751523|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
163013625|NCT03194542|588751520|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
163013626|NCT03194542|588751521|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
163013627|NCT03194542|588751522|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
163013628|NCT03194542|588751523|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
163013629|NCT03194542|588751520|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
163013630|NCT03194542|588751521|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
163013631|NCT03194542|588751522|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
163013632|NCT03194542|588751523|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
163013633|NCT03194542|588751520|FG000|Overall Study|Loss of Response|4|||
163013634|NCT03194542|588751521|FG001|Overall Study|Loss of Response|2|||
163013635|NCT03194542|588751522|FG002|Overall Study|Loss of Response|3|||
163013636|NCT03194542|588751523|FG003|Overall Study|Loss of Response|4|||
163013637|NCT03194542|588751520|FG000|Overall Study|Physician Decision|0|||
163013638|NCT03194542|588751521|FG001|Overall Study|Physician Decision|1|||
163013639|NCT03194542|588751522|FG002|Overall Study|Physician Decision|0|||
163013640|NCT03194542|588751523|FG003|Overall Study|Physician Decision|0|||
163013641|NCT03194542|588751520|FG000|Overall Study|Lack of Efficacy|2|||
163013642|NCT03194542|588751521|FG001|Overall Study|Lack of Efficacy|2|||
163013643|NCT03194542|588751522|FG002|Overall Study|Lack of Efficacy|2|||
163013644|NCT03194542|588751523|FG003|Overall Study|Lack of Efficacy|6|||
163013645|NCT03194542|588751520|FG000|Overall Study|Withdrawal by Subject|2|||
163013646|NCT03194542|588751521|FG001|Overall Study|Withdrawal by Subject|1|||
163013647|NCT03194542|588751522|FG002|Overall Study|Withdrawal by Subject|5|||
163013648|NCT03194542|588751523|FG003|Overall Study|Withdrawal by Subject|4|||
163013649|NCT03194542|588751520|FG000|Overall Study|Progressive Disease|1|||
163013650|NCT03194542|588751521|FG001|Overall Study|Progressive Disease|0|||
163013651|NCT03194542|588751522|FG002|Overall Study|Progressive Disease|1|||
163013652|NCT03194542|588751523|FG003|Overall Study|Progressive Disease|1|||
163013653|NCT03194542|588751520|FG000|Overall Study|Adverse Event|1|||
163013654|NCT03194542|588751521|FG001|Overall Study|Adverse Event|2|||
163013655|NCT03194542|588751522|FG002|Overall Study|Adverse Event|0|||
163013656|NCT03194542|588751523|FG003|Overall Study|Adverse Event|5|||
163013657|NCT03194542|588751520|FG000|Overall Study|Death|1|||
163013658|NCT03194542|588751521|FG001|Overall Study|Death|2|||
163013659|NCT03194542|588751522|FG002|Overall Study|Death|0|||
163013660|NCT03194542|588751523|FG003|Overall Study|Death|5|||
163013661|NCT03194542|588751520|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
163013662|NCT03194542|588751521|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
163013663|NCT03194542|588751522|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
163013664|NCT03194542|588751523|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
163013665|NCT02640664|588751527|FG000|Epoch 1|Withdrawal of informed consent|1|||
163013666|NCT02640664|588751528|FG001|Epoch 1|Withdrawal of informed consent|0|||
163013667|NCT02640664|588751529|FG002|Epoch 1|Withdrawal of informed consent|0|||
163013668|NCT02640664|588751527|FG000|Epoch 1|Death|0|||
163013669|NCT02640664|588751528|FG001|Epoch 1|Death|0|||
163013670|NCT02640664|588751529|FG002|Epoch 1|Death|1|||
163013671|NCT02640664|588751527|FG000|Epoch 2|Withdrawal of informed consent|3|||
163013672|NCT02640664|588751528|FG001|Epoch 2|Withdrawal of informed consent|4|||
163013673|NCT02640664|588751529|FG002|Epoch 2|Withdrawal of informed consent|2|||
163013674|NCT02640664|588751527|FG000|Epoch 2|Subject/guardian decision|0|||
163013675|NCT02640664|588751528|FG001|Epoch 2|Subject/guardian decision|2|||
163013676|NCT02640664|588751529|FG002|Epoch 2|Subject/guardian decision|2|||
163013677|NCT02640664|588751527|FG000|Epoch 2|Lost to Follow-up|3|||
163013678|NCT02640664|588751528|FG001|Epoch 2|Lost to Follow-up|4|||
163013679|NCT02640664|588751529|FG002|Epoch 2|Lost to Follow-up|1|||
163013680|NCT02640664|588751527|FG000|Epoch 2|Death|0|||
163013681|NCT02640664|588751528|FG001|Epoch 2|Death|0|||
163013682|NCT02640664|588751529|FG002|Epoch 2|Death|1|||
163013683|NCT00722137|588751532|FG000|Overall Study|Overt Disease Progression|5|||
163013684|NCT00722137|588751533|FG001|Overall Study|Overt Disease Progression|4|||
163013685|NCT00722137|588751532|FG000|Overall Study|Adverse Event|17|||
163013686|NCT00722137|588751533|FG001|Overall Study|Adverse Event|21|||
163013687|NCT00722137|588751532|FG000|Overall Study|Death|12|||
163013688|NCT00722137|588751533|FG001|Overall Study|Death|7|||
163013689|NCT00722137|588751532|FG000|Overall Study|Withdrawal by Subject|6|||
163013690|NCT00722137|588751533|FG001|Overall Study|Withdrawal by Subject|9|||
163013691|NCT00722137|588751532|FG000|Overall Study|Other Reason Unknown|3|||
163013692|NCT00722137|588751533|FG001|Overall Study|Other Reason Unknown|4|||
163013693|NCT00722137|588751532|FG000|Overall Study|Randomized But Not Treated|2|||
163013694|NCT00722137|588751533|FG001|Overall Study|Randomized But Not Treated|3|||
163013695|NCT05514873|588751536|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
163013696|NCT05514873|588751536|FG000|Main Treatment Period|Adverse Event|2|||
163013697|NCT05514873|588751536|FG000|Extension Treatment Period|Lost to Follow-up|3|||
163013698|NCT02729025|588751537|FG000|Overall Study|Sponsor Decision|0|||
163013699|NCT02729025|588751538|FG001|Overall Study|Sponsor Decision|1|||
163013700|NCT03525678|588751542|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
163013701|NCT03525678|588751543|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
163013702|NCT03525678|588751544|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
163013703|NCT03525678|588751545|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
163013704|NCT03525678|588751546|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
163013705|NCT03525678|588751542|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
163013706|NCT03525678|588751543|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
163013707|NCT03525678|588751544|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
163013708|NCT03525678|588751545|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
163013709|NCT03525678|588751546|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
163013710|NCT03525678|588751542|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
163013711|NCT03525678|588751543|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
163013712|NCT03525678|588751544|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
163013713|NCT03525678|588751545|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
163013714|NCT03525678|588751546|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
163013715|NCT03525678|588751542|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
163013716|NCT03525678|588751543|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
163013717|NCT03525678|588751544|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
163013718|NCT03525678|588751545|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
163013719|NCT03525678|588751546|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
163013720|NCT03525678|588751542|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
163013721|NCT03525678|588751543|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
163013722|NCT03525678|588751544|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
163013723|NCT03525678|588751545|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
163013724|NCT03525678|588751546|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
163013725|NCT03525678|588751542|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
163013726|NCT03525678|588751543|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
163013727|NCT03525678|588751544|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
163013728|NCT03525678|588751545|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
163013729|NCT03525678|588751546|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
163013730|NCT05343000|588753050|FG000|Overall Study|Physician Decision|2|||
163013731|NCT04432831|588753051|FG000|Overall Study|Withdrawal by Subject|24|||
163013732|NCT04432831|588753052|FG001|Overall Study|Withdrawal by Subject|28|||
163013733|NCT04432831|588753053|FG002|Overall Study|Withdrawal by Subject|21|||
163328451|NCT04436289|589913257|FG001|Overall Study|Lost to Follow-up|4|||
163013734|NCT04432831|588753051|FG000|Overall Study|Death|23|||
163013735|NCT04432831|588753052|FG001|Overall Study|Death|23|||
163013736|NCT04432831|588753053|FG002|Overall Study|Death|17|||
163013737|NCT04432831|588753051|FG000|Overall Study|Lost to Follow-up|15|||
163013738|NCT04432831|588753052|FG001|Overall Study|Lost to Follow-up|15|||
163013739|NCT04432831|588753053|FG002|Overall Study|Lost to Follow-up|12|||
163013740|NCT04432831|588753051|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
163328452|NCT04436289|589913258|FG002|Overall Study|Lost to Follow-up|1|||
163013741|NCT04432831|588753052|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
163013742|NCT04432831|588753053|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
163215384|NCT02584504|589503823|FG001|Double-blind Treatment|Family Matter|1|||
163013743|NCT04432831|588753051|FG000|Overall Study|Reason Not Specified|7|||
163013744|NCT04432831|588753052|FG001|Overall Study|Reason Not Specified|11|||
163013745|NCT04432831|588753053|FG002|Overall Study|Reason Not Specified|9|||
163013746|NCT04432831|588753051|FG000|Overall Study|Adverse Event|7|||
163013747|NCT04432831|588753052|FG001|Overall Study|Adverse Event|7|||
163013748|NCT04432831|588753053|FG002|Overall Study|Adverse Event|7|||
163013749|NCT04432831|588753051|FG000|Overall Study|Physician Decision|1|||
163013750|NCT04432831|588753052|FG001|Overall Study|Physician Decision|3|||
163013751|NCT04432831|588753053|FG002|Overall Study|Physician Decision|6|||
163013752|NCT04432831|588753051|FG000|Overall Study|Protocol Violation|1|||
163013753|NCT04432831|588753052|FG001|Overall Study|Protocol Violation|0|||
163013754|NCT04432831|588753053|FG002|Overall Study|Protocol Violation|2|||
163013755|NCT04432831|588753051|FG000|Overall Study|Pregnancy|0|||
163013756|NCT04432831|588753052|FG001|Overall Study|Pregnancy|1|||
163013757|NCT04432831|588753053|FG002|Overall Study|Pregnancy|0|||
163013758|NCT04432831|588753051|FG000|Overall Study|Lack of Efficacy|0|||
163013759|NCT04432831|588753052|FG001|Overall Study|Lack of Efficacy|0|||
163013760|NCT04432831|588753053|FG002|Overall Study|Lack of Efficacy|2|||
163013761|NCT03782792|588753054|FG000|Overall Study|Patient left the country|0|||
163013762|NCT03782792|588753055|FG001|Overall Study|Patient left the country|1|||
163013763|NCT03782792|588753054|FG000|Overall Study|Withdrawal by Subject|1|||
163013764|NCT03782792|588753055|FG001|Overall Study|Withdrawal by Subject|2|||
163013765|NCT00617890|588753056|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
163013766|NCT00617890|588753057|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
163013767|NCT00617890|588753058|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
163013768|NCT00617890|588753059|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
163013769|NCT00617890|588753056|FG000|Overall Study|Lack of Efficacy|23|||
163013770|NCT00617890|588753057|FG001|Overall Study|Lack of Efficacy|26|||
163013771|NCT00617890|588753058|FG002|Overall Study|Lack of Efficacy|30|||
163013772|NCT00617890|588753059|FG003|Overall Study|Lack of Efficacy|97|||
163013773|NCT00617890|588753056|FG000|Overall Study|Lost to Follow-up|0|||
163013774|NCT00617890|588753057|FG001|Overall Study|Lost to Follow-up|0|||
163013775|NCT00617890|588753058|FG002|Overall Study|Lost to Follow-up|1|||
163013776|NCT00617890|588753059|FG003|Overall Study|Lost to Follow-up|2|||
163013777|NCT00617890|588753056|FG000|Overall Study|Withdrawal by Subject|4|||
163013778|NCT00617890|588753057|FG001|Overall Study|Withdrawal by Subject|1|||
163013779|NCT00617890|588753058|FG002|Overall Study|Withdrawal by Subject|0|||
163013780|NCT00617890|588753059|FG003|Overall Study|Withdrawal by Subject|2|||
163013781|NCT00617890|588753056|FG000|Overall Study|Protocol Violation|2|||
163215385|NCT02584504|589503824|FG002|Double-blind Treatment|Family Matter|0|||
163215386|NCT02584504|589503822|FG000|Open-label Treatment|Participant withdrew consent|0|||
163215387|NCT02584504|589503823|FG001|Open-label Treatment|Participant withdrew consent|0|||
163215388|NCT02584504|589503824|FG002|Open-label Treatment|Participant withdrew consent|4|||
163215389|NCT02584504|589503822|FG000|Open-label Treatment|Adverse Event|2|||
163013782|NCT00617890|588753057|FG001|Overall Study|Protocol Violation|1|||
163013783|NCT00617890|588753058|FG002|Overall Study|Protocol Violation|0|||
163215390|NCT02584504|589503823|FG001|Open-label Treatment|Adverse Event|2|||
163013784|NCT00617890|588753059|FG003|Overall Study|Protocol Violation|0|||
163013785|NCT00617890|588753056|FG000|Overall Study|Adverse Event|1|||
163013786|NCT00617890|588753057|FG001|Overall Study|Adverse Event|0|||
163013787|NCT00617890|588753058|FG002|Overall Study|Adverse Event|3|||
163013788|NCT00617890|588753059|FG003|Overall Study|Adverse Event|8|||
163013789|NCT00617890|588753056|FG000|Overall Study|Not treated|1|||
163013790|NCT00617890|588753057|FG001|Overall Study|Not treated|0|||
163013791|NCT00617890|588753058|FG002|Overall Study|Not treated|1|||
163013792|NCT00617890|588753059|FG003|Overall Study|Not treated|1|||
163013793|NCT00154284|588753063|FG000|Overall Study|Adverse Event|6|||
163215391|NCT02584504|589503824|FG002|Open-label Treatment|Adverse Event|3|||
163013794|NCT00154284|588753064|FG001|Overall Study|Adverse Event|9|||
163013795|NCT00154284|588753063|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163328453|NCT04436289|589913259|FG003|Overall Study|Lost to Follow-up|3|||
163328454|NCT03357952|589913264|FG000|Overall Study|Withdrawal by Subject|0|||
163328455|NCT03357952|589913265|FG001|Overall Study|Withdrawal by Subject|1|||
163328456|NCT03357952|589913264|FG000|Overall Study|Sponsor Decision|9|||
163328457|NCT03357952|589913265|FG001|Overall Study|Sponsor Decision|0|||
163013796|NCT00154284|588753064|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163013797|NCT00154284|588753063|FG000|Overall Study|Lack of Efficacy|1|||
163013798|NCT00154284|588753064|FG001|Overall Study|Lack of Efficacy|2|||
163013799|NCT00154284|588753063|FG000|Overall Study|Protocol Violation|0|||
163013800|NCT00154284|588753064|FG001|Overall Study|Protocol Violation|1|||
163013801|NCT01295671|588753075|FG000|Overall Study|Lost to Follow-up|4|||
163013802|NCT01295671|588753076|FG001|Overall Study|Lost to Follow-up|6|||
163013803|NCT01295671|588753077|FG002|Overall Study|Lost to Follow-up|3|||
163215392|NCT02584504|589503822|FG000|Open-label Treatment|Physician Decision|0|||
163215393|NCT02584504|589503823|FG001|Open-label Treatment|Physician Decision|1|||
163215394|NCT02584504|589503824|FG002|Open-label Treatment|Physician Decision|0|||
163013804|NCT01295671|588753075|FG000|Overall Study|Withdrawal by Subject|3|||
163013805|NCT01295671|588753076|FG001|Overall Study|Withdrawal by Subject|1|||
163013806|NCT01295671|588753077|FG002|Overall Study|Withdrawal by Subject|0|||
163013807|NCT02395848|588753078|FG000|Overall Study|Lost to Follow-up|2|||
163013808|NCT02276560|588753079|FG000|Overall Study|Adverse Event|1|||
163013809|NCT02276560|588753080|FG001|Overall Study|Adverse Event|0|||
163013810|NCT02276560|588753081|FG002|Overall Study|Adverse Event|0|||
163013811|NCT01609010|588753085|FG000|Overall Study|Stable disease (SD)|22|||
163013812|NCT01609010|588753086|FG001|Overall Study|Stable disease (SD)|16|||
163013813|NCT01609010|588753085|FG000|Overall Study|Progressive disease (PD)|8|||
163013814|NCT01609010|588753086|FG001|Overall Study|Progressive disease (PD)|10|||
163013815|NCT01609010|588753085|FG000|Overall Study|Adverse Event|3|||
163013816|NCT01609010|588753086|FG001|Overall Study|Adverse Event|6|||
163013817|NCT01609010|588753085|FG000|Overall Study|Withdrawal by Subject|2|||
163013818|NCT01609010|588753086|FG001|Overall Study|Withdrawal by Subject|2|||
163013819|NCT01609010|588753085|FG000|Overall Study|Other|2|||
163013820|NCT01609010|588753086|FG001|Overall Study|Other|0|||
163013821|NCT01609010|588753085|FG000|Overall Study|Other malignancy|1|||
163013822|NCT01609010|588753086|FG001|Overall Study|Other malignancy|0|||
163013823|NCT01609010|588753085|FG000|Overall Study|Pathology review|2|||
163013824|NCT01609010|588753086|FG001|Overall Study|Pathology review|1|||
163013825|NCT01609010|588753085|FG000|Overall Study|Protocol Violation|1|||
163013826|NCT01609010|588753086|FG001|Overall Study|Protocol Violation|1|||
163013827|NCT01609010|588753085|FG000|Overall Study|New cancer|1|||
163013828|NCT01609010|588753086|FG001|Overall Study|New cancer|0|||
163013829|NCT01609010|588753085|FG000|Overall Study|Lost to Follow-up|1|||
163013830|NCT01609010|588753086|FG001|Overall Study|Lost to Follow-up|1|||
163013831|NCT01134107|588753088|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
163013832|NCT01134107|588753089|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
163013833|NCT01134107|588753088|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
163013834|NCT01134107|588753089|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
163013835|NCT01134107|588753088|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
163013836|NCT01134107|588753089|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
163013837|NCT01134107|588753088|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
163013838|NCT01134107|588753089|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
163013839|NCT01134107|588753088|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
163013840|NCT01134107|588753089|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
163013841|NCT01134107|588753088|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
163013842|NCT01134107|588753089|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
163013843|NCT01134107|588753088|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
163013844|NCT01134107|588753089|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
163013845|NCT04541589|588753095|FG000|Treatment Period|Adverse Event|8|||
163013846|NCT04541589|588753096|FG001|Treatment Period|Adverse Event|2|||
163013847|NCT04541589|588753095|FG000|Treatment Period|Physician Decision|3|||
163013848|NCT04541589|588753096|FG001|Treatment Period|Physician Decision|1|||
163013849|NCT04541589|588753095|FG000|Treatment Period|Subject decision|7|||
163013850|NCT04541589|588753096|FG001|Treatment Period|Subject decision|4|||
163013851|NCT04541589|588753095|FG000|Treatment Period|Withdrawal by Subject|1|||
163013852|NCT04541589|588753096|FG001|Treatment Period|Withdrawal by Subject|0|||
163013853|NCT04541589|588753095|FG000|Safety Follow-up Period|Adverse Event|2|||
163013854|NCT04541589|588753096|FG001|Safety Follow-up Period|Adverse Event|1|||
163013855|NCT04541589|588753095|FG000|Safety Follow-up Period|Physician Decision|1|||
163013856|NCT04541589|588753096|FG001|Safety Follow-up Period|Physician Decision|0|||
163013857|NCT04541589|588753095|FG000|Safety Follow-up Period|Subject decision|5|||
163013858|NCT04541589|588753096|FG001|Safety Follow-up Period|Subject decision|3|||
163013859|NCT04541589|588753095|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
163013860|NCT04541589|588753096|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
163013861|NCT03581123|588753099|FG000|2-month Follow-up|Withdrawal by Subject|5|||
163013862|NCT03581123|588753100|FG001|2-month Follow-up|Withdrawal by Subject|4|||
163013863|NCT03581123|588753101|FG002|2-month Follow-up|Withdrawal by Subject|6|||
163013864|NCT03581123|588753102|FG003|2-month Follow-up|Withdrawal by Subject|4|||
163013865|NCT03581123|588753099|FG000|2-month Follow-up|Lost to Follow-up|8|||
163013866|NCT03581123|588753100|FG001|2-month Follow-up|Lost to Follow-up|1|||
163013867|NCT03581123|588753101|FG002|2-month Follow-up|Lost to Follow-up|2|||
163013868|NCT03581123|588753102|FG003|2-month Follow-up|Lost to Follow-up|2|||
163013869|NCT03581123|588753099|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
163013870|NCT03581123|588753100|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
163013871|NCT03581123|588753101|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
163013872|NCT03581123|588753102|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
163013873|NCT03581123|588753099|FG000|6-Month Follow-up|Lost to Follow-up|3|||
163013874|NCT03581123|588753100|FG001|6-Month Follow-up|Lost to Follow-up|3|||
163013875|NCT03581123|588753101|FG002|6-Month Follow-up|Lost to Follow-up|1|||
163013876|NCT03581123|588753102|FG003|6-Month Follow-up|Lost to Follow-up|1|||
163013877|NCT03581123|588753099|FG000|12-Month Follow-up|Lost to Follow-up|4|||
163013878|NCT03581123|588753100|FG001|12-Month Follow-up|Lost to Follow-up|3|||
163013879|NCT03581123|588753101|FG002|12-Month Follow-up|Lost to Follow-up|4|||
163013880|NCT03581123|588753102|FG003|12-Month Follow-up|Lost to Follow-up|5|||
163013881|NCT04195685|588753103|FG000|Overall Study|Withdrawal by Subject|6|||
163013882|NCT04195685|588753104|FG001|Overall Study|Withdrawal by Subject|2|||
163013883|NCT04195685|588753103|FG000|Overall Study|Lost to Follow-up|1|||
163013884|NCT04195685|588753104|FG001|Overall Study|Lost to Follow-up|4|||
163013885|NCT03448419|588753108|FG000|Overall Study|Adverse Event|10|||
163013886|NCT03448419|588753109|FG001|Overall Study|Adverse Event|9|||
163013887|NCT03448419|588753108|FG000|Overall Study|Lost to Follow-up|0|||
163013888|NCT03448419|588753109|FG001|Overall Study|Lost to Follow-up|2|||
163013889|NCT03448419|588753108|FG000|Overall Study|Withdrawal by Subject|3|||
163013890|NCT03448419|588753109|FG001|Overall Study|Withdrawal by Subject|1|||
163013891|NCT03448419|588753108|FG000|Overall Study|Not treated|0|||
163013892|NCT03448419|588753109|FG001|Overall Study|Not treated|1|||
163013893|NCT03448419|588753108|FG000|Overall Study|Patient did not attend all visits|0|||
163013894|NCT03448419|588753109|FG001|Overall Study|Patient did not attend all visits|2|||
163013895|NCT03448419|588753108|FG000|Overall Study|Withdrawn by Sponsor|0|||
163013896|NCT03448419|588753109|FG001|Overall Study|Withdrawn by Sponsor|1|||
163013897|NCT04548193|588753120|FG000|Overall Study|Lost to Follow-up|0|||
163013898|NCT04548193|588753121|FG001|Overall Study|Lost to Follow-up|1|||
163013899|NCT04548193|588753120|FG000|Overall Study|Death|0|||
163013900|NCT04548193|588753121|FG001|Overall Study|Death|1|||
163013901|NCT04548193|588753120|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
163013902|NCT04548193|588753121|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
163013903|NCT04548193|588753120|FG000|Overall Study|Withdrawal by Subject|2|||
163013904|NCT04548193|588753121|FG001|Overall Study|Withdrawal by Subject|2|||
163013905|NCT00630825|588753122|FG000|Overall Study|Adverse Event|4|||
163013906|NCT00630825|588753123|FG001|Overall Study|Adverse Event|4|||
163013907|NCT00630825|588753124|FG002|Overall Study|Adverse Event|3|||
163013908|NCT00630825|588753125|FG003|Overall Study|Adverse Event|1|||
163013909|NCT00630825|588753122|FG000|Overall Study|Entry Criteria Not Met|1|||
163013910|NCT00630825|588753123|FG001|Overall Study|Entry Criteria Not Met|0|||
163013911|NCT00630825|588753124|FG002|Overall Study|Entry Criteria Not Met|2|||
163013912|NCT00630825|588753125|FG003|Overall Study|Entry Criteria Not Met|1|||
163013913|NCT00630825|588753122|FG000|Overall Study|Lost to Follow-up|1|||
163013914|NCT00630825|588753123|FG001|Overall Study|Lost to Follow-up|1|||
163013915|NCT00630825|588753124|FG002|Overall Study|Lost to Follow-up|1|||
163013916|NCT00630825|588753125|FG003|Overall Study|Lost to Follow-up|1|||
163404637|NCT00183274|590191967|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
163404638|NCT00183274|590191968|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
163404639|NCT00183274|590191969|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
163404640|NCT00183274|590191970|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
163404641|NCT00183274|590191971|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
163404642|NCT00183274|590191966|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
163404643|NCT00183274|590191967|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
163404644|NCT00183274|590191968|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
163404645|NCT00183274|590191969|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
163404646|NCT00183274|590191970|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
163404647|NCT00183274|590191971|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
163404648|NCT00183274|590191966|FG000|Phase 3: Double-Blind|Relapsed|0|||
163404649|NCT00183274|590191967|FG001|Phase 3: Double-Blind|Relapsed|0|||
163404650|NCT00183274|590191968|FG002|Phase 3: Double-Blind|Relapsed|0|||
163404651|NCT00183274|590191969|FG003|Phase 3: Double-Blind|Relapsed|1|||
163404652|NCT00183274|590191970|FG004|Phase 3: Double-Blind|Relapsed|11|||
163404653|NCT00183274|590191971|FG005|Phase 3: Double-Blind|Relapsed|2|||
163404654|NCT00586495|590191976|FG000|Treatment Period|Adverse Event|11|||
163404655|NCT00586495|590191976|FG000|Treatment Period|Death|1|||
163404656|NCT00586495|590191976|FG000|Treatment Period|Protocol Violation|1|||
163404657|NCT00586495|590191976|FG000|Treatment Period|Withdrawal by Subject|1|||
163404658|NCT00586495|590191976|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
163404659|NCT00586495|590191976|FG000|Treatment Period|Switch to commercial drug|10|||
163404660|NCT00586495|590191976|FG000|Follow-up|Death|40|||
163404661|NCT00586495|590191976|FG000|Follow-up|Lost to Follow-up|1|||
163404662|NCT00586495|590191976|FG000|Follow-up|Withdrawal by Subject|4|||
163404663|NCT00586495|590191976|FG000|Follow-up|Protocol driven decision point|37|||
163404664|NCT00586495|590191976|FG000|Follow-up|Switch to commercial drug|10|||
163404665|NCT01046877|590191981|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
163404666|NCT01046877|590191981|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
163013917|NCT00630825|588753122|FG000|Overall Study|Physician Decision|1|||
163404667|NCT01081249|590191982|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
163404668|NCT01081249|590191983|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
163404669|NCT02813694|590191988|FG000|Overall Study|Physician Decision|0|||
163404670|NCT02813694|590191989|FG001|Overall Study|Physician Decision|1|||
163404671|NCT02813694|590191988|FG000|Overall Study|Withdrawal by Subject|10|||
163404672|NCT02813694|590191989|FG001|Overall Study|Withdrawal by Subject|9|||
163013918|NCT00630825|588753123|FG001|Overall Study|Physician Decision|0|||
163013919|NCT00630825|588753124|FG002|Overall Study|Physician Decision|0|||
163013920|NCT00630825|588753125|FG003|Overall Study|Physician Decision|0|||
163013921|NCT00630825|588753122|FG000|Overall Study|Withdrawal by Subject|2|||
163013922|NCT00630825|588753123|FG001|Overall Study|Withdrawal by Subject|2|||
163013923|NCT00630825|588753124|FG002|Overall Study|Withdrawal by Subject|2|||
163013924|NCT00630825|588753125|FG003|Overall Study|Withdrawal by Subject|3|||
163013925|NCT01081769|588753128|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
163013926|NCT01081769|588753129|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
163013927|NCT01081769|588753128|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
163013928|NCT01081769|588753129|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
163013929|NCT01081769|588753128|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
163013930|NCT01081769|588753129|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
163013931|NCT01081769|588753128|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
163013932|NCT01081769|588753129|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
163013933|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Adverse Event|14|||
163013934|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Adverse Event|11|||
163013935|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Death|1|||
163013936|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Death|1|||
163013937|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
163013938|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
163013939|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
163013940|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
163013941|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Pregnancy|1|||
163013942|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Pregnancy|0|||
163013943|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
163013944|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
163013945|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
163013946|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
163013947|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Other|0|||
163013948|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Other|1|||
163013949|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Ineligibility|3|||
163013950|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Ineligibility|4|||
163013951|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
163013952|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
163013953|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Patient Moved|2|||
163013954|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Patient Moved|2|||
163013955|NCT00558701|588753133|FG000|Overall Study|Protocol Deviations|1|||
163013956|NCT00558701|588753134|FG001|Overall Study|Protocol Deviations|4|||
163013957|NCT00427648|588753135|FG000|Overall Study|Protocol Violation|1|||
163013958|NCT00427648|588753136|FG001|Overall Study|Protocol Violation|2|||
163013959|NCT00427648|588753135|FG000|Overall Study|Adverse Event|0|||
163013960|NCT00427648|588753136|FG001|Overall Study|Adverse Event|1|||
163013961|NCT02187198|588753137|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
163013962|NCT02187198|588753138|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
163013963|NCT02187198|588753137|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
163013964|NCT02187198|588753138|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
163013965|NCT00546377|588753139|FG000|Overall Study|Deemed ineligible|1|||
163013966|NCT00546377|588753139|FG000|Overall Study|Adverse Event|6|||
163013967|NCT01532518|588753140|FG000|Overall Study|Withdrawal by Subject|0|||
163013968|NCT01532518|588753141|FG001|Overall Study|Withdrawal by Subject|0|||
163013969|NCT01532518|588753142|FG002|Overall Study|Withdrawal by Subject|1|||
163013970|NCT01575834|588753143|FG000|Overall Study|Withdrawal by Subject|352|||
163013971|NCT01575834|588753144|FG001|Overall Study|Withdrawal by Subject|390|||
163013972|NCT01575834|588753143|FG000|Overall Study|Death|81|||
163013973|NCT01575834|588753144|FG001|Overall Study|Death|74|||
163013974|NCT01575834|588753143|FG000|Overall Study|Other|70|||
163013975|NCT01575834|588753144|FG001|Overall Study|Other|70|||
163013976|NCT01575834|588753143|FG000|Overall Study|Adverse Event|63|||
163013977|NCT01575834|588753144|FG001|Overall Study|Adverse Event|61|||
163013978|NCT01575834|588753143|FG000|Overall Study|Lost to Follow-up|55|||
163013979|NCT01575834|588753144|FG001|Overall Study|Lost to Follow-up|68|||
163013980|NCT01575834|588753143|FG000|Overall Study|Noncompliance|52|||
163013981|NCT01575834|588753144|FG001|Overall Study|Noncompliance|27|||
163013982|NCT01575834|588753143|FG000|Overall Study|Administrative decision|15|||
163013983|NCT01575834|588753144|FG001|Overall Study|Administrative decision|33|||
163013984|NCT01575834|588753143|FG000|Overall Study|Ineligibility Determined|5|||
163013985|NCT01575834|588753144|FG001|Overall Study|Ineligibility Determined|8|||
163013986|NCT01575834|588753143|FG000|Overall Study|Protocol Deviation|4|||
163013987|NCT01575834|588753144|FG001|Overall Study|Protocol Deviation|3|||
163013988|NCT01575834|588753143|FG000|Overall Study|Requirement for Alternative Therapy|2|||
163013989|NCT01575834|588753144|FG001|Overall Study|Requirement for Alternative Therapy|4|||
163328458|NCT01675492|589913268|FG000|Overall Study|study completed early - product approval|42|||
163013990|NCT00488644|588753145|FG000|Overall Study|Not Eligible|1|||
163013991|NCT00488644|588753145|FG000|Overall Study|Not Evaluable|1|||
163013992|NCT01956773|588753150|FG000|Overall Study|Lost to Follow-up|628|||
163013993|NCT01956773|588753151|FG001|Overall Study|Lost to Follow-up|1|||
163013994|NCT01383174|588753154|FG000|3 Month Assessment|Death|0|||
163013995|NCT01383174|588753155|FG001|3 Month Assessment|Death|1|||
163013996|NCT01383174|588753154|FG000|3 Month Assessment|Lost to Follow-up|2|||
163013997|NCT01383174|588753155|FG001|3 Month Assessment|Lost to Follow-up|0|||
163013998|NCT01383174|588753154|FG000|3 Month Assessment|Refused to complete|4|||
163013999|NCT01383174|588753155|FG001|3 Month Assessment|Refused to complete|0|||
163014000|NCT01383174|588753154|FG000|6 Month Assessment|Lost to Follow-up|1|||
163014001|NCT01383174|588753155|FG001|6 Month Assessment|Lost to Follow-up|1|||
163014002|NCT01383174|588753154|FG000|6 Month Assessment|Refused to complete|4|||
163014003|NCT01383174|588753155|FG001|6 Month Assessment|Refused to complete|0|||
163014004|NCT01153815|588753156|FG000|Overall Study|Adverse Event|3|||
163014005|NCT01153815|588753157|FG001|Overall Study|Adverse Event|1|||
163014006|NCT01153815|588753156|FG000|Overall Study|Withdrawal by Subject|6|||
163014007|NCT01153815|588753157|FG001|Overall Study|Withdrawal by Subject|4|||
163014008|NCT02169271|588753160|FG000|Overall Study|Protocol Violation|1|||
163014009|NCT02169271|588753161|FG001|Overall Study|Protocol Violation|2|||
163014010|NCT03591874|588753166|FG000|Overall Study|Adverse Event|4|||
163014011|NCT03591874|588753167|FG001|Overall Study|Adverse Event|0|||
163014012|NCT03591874|588753166|FG000|Overall Study|Withdrawal by Subject|2|||
163014013|NCT03591874|588753167|FG001|Overall Study|Withdrawal by Subject|1|||
163014014|NCT03591874|588753166|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
163014015|NCT03591874|588753167|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
163014016|NCT03591874|588753166|FG000|Overall Study|On Study at Time of Study Termination|12|||
163014017|NCT03591874|588753167|FG001|Overall Study|On Study at Time of Study Termination|6|||
163014018|NCT03859427|588753168|FG000|Overall Study|Withdrawal by Subject|4|||
163014019|NCT03859427|588753169|FG001|Overall Study|Withdrawal by Subject|7|||
163014020|NCT03859427|588753168|FG000|Overall Study|Decision by sponsor|0|||
163014021|NCT03859427|588753169|FG001|Overall Study|Decision by sponsor|3|||
163014022|NCT03859427|588753168|FG000|Overall Study|Lost to Follow-up|3|||
163014023|NCT03859427|588753169|FG001|Overall Study|Lost to Follow-up|2|||
163014024|NCT03859427|588753168|FG000|Overall Study|Death|22|||
163014025|NCT03859427|588753169|FG001|Overall Study|Death|25|||
163014026|NCT04031846|588753170|FG000|Overall Study|Lost to Follow-up|4|||
163014027|NCT04031846|588753171|FG001|Overall Study|Lost to Follow-up|4|||
163014028|NCT04031846|588753170|FG000|Overall Study|Physician Decision|0|||
163014029|NCT04031846|588753171|FG001|Overall Study|Physician Decision|1|||
163014030|NCT04031846|588753170|FG000|Overall Study|Protocol Violation|1|||
163014031|NCT04031846|588753171|FG001|Overall Study|Protocol Violation|1|||
163014032|NCT04031846|588753170|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
163014033|NCT04031846|588753171|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
163014034|NCT02431676|588753172|FG000|Overall Study|no lab obtained|0|||
163014035|NCT02431676|588753173|FG001|Overall Study|no lab obtained|1|||
163014036|NCT02431676|588753174|FG002|Overall Study|no lab obtained|2|||
163014037|NCT00571727|588753175|FG000|Overall Study|Did not enter in this study|1|||
163014038|NCT00571727|588753175|FG000|Overall Study|Non-compliance|4|||
163014039|NCT00571727|588753175|FG000|Overall Study|Lost to Follow-up|30|||
163014040|NCT00571727|588753175|FG000|Overall Study|Poor growth|1|||
163014041|NCT00571727|588753175|FG000|Overall Study|Parent/patient decision|2|||
163014042|NCT00571727|588753175|FG000|Overall Study|Participant transferred to commercial drug|14|||
163014043|NCT00571727|588753175|FG000|Overall Study|Unable to provide study drug|6|||
163014044|NCT00571727|588753175|FG000|Overall Study|On-treatment at end of study|8|||
163014045|NCT01622673|588753176|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163014046|NCT01622673|588753177|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163014047|NCT01622673|588753178|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163014048|NCT01622673|588753179|FG003|Treatment Period 1|Withdrawal by Subject|1|||
163014049|NCT01622673|588753180|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163014050|NCT01622673|588753181|FG005|Treatment Period 1|Withdrawal by Subject|0|||
163014051|NCT01622673|588753176|FG000|Treatment Period 1|Protocol Violation|0|||
163328459|NCT04517435|589913285|FG000|Overall Study|Withdrawal by Subject|0|||
163328460|NCT04517435|589913286|FG001|Overall Study|Withdrawal by Subject|0|||
163014052|NCT01622673|588753177|FG001|Treatment Period 1|Protocol Violation|1|||
163014053|NCT01622673|588753178|FG002|Treatment Period 1|Protocol Violation|0|||
163014054|NCT01622673|588753179|FG003|Treatment Period 1|Protocol Violation|0|||
163014055|NCT01622673|588753180|FG004|Treatment Period 1|Protocol Violation|0|||
163014056|NCT01622673|588753181|FG005|Treatment Period 1|Protocol Violation|0|||
163014057|NCT01622673|588753176|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163328461|NCT04517435|589913287|FG002|Overall Study|Withdrawal by Subject|1|||
163014058|NCT01622673|588753177|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163014059|NCT01622673|588753178|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163014060|NCT01622673|588753179|FG003|Treatment Period 2|Withdrawal by Subject|1|||
163014061|NCT01622673|588753180|FG004|Treatment Period 2|Withdrawal by Subject|0|||
163014062|NCT01622673|588753181|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163014063|NCT01622673|588753176|FG000|Treatment Period 3|Protocol Violation|0|||
163014064|NCT01622673|588753177|FG001|Treatment Period 3|Protocol Violation|1|||
163014065|NCT01622673|588753178|FG002|Treatment Period 3|Protocol Violation|0|||
163014066|NCT01622673|588753179|FG003|Treatment Period 3|Protocol Violation|0|||
163014067|NCT01622673|588753180|FG004|Treatment Period 3|Protocol Violation|0|||
163014068|NCT01622673|588753181|FG005|Treatment Period 3|Protocol Violation|0|||
163014069|NCT02058537|588755000|FG000|Overall Study|Withdrawal by Subject|1|||
163014070|NCT02126579|588755001|FG000|Overall Study|disease progression|0|||
163014071|NCT02126579|588755002|FG001|Overall Study|disease progression|0|||
163014072|NCT02126579|588755003|FG002|Overall Study|disease progression|0|||
163014073|NCT02126579|588755004|FG003|Overall Study|disease progression|1|||
163014074|NCT02126579|588755005|FG004|Overall Study|disease progression|0|||
163014075|NCT02126579|588755006|FG005|Overall Study|disease progression|0|||
163014076|NCT02126579|588755007|FG006|Overall Study|disease progression|1|||
163014077|NCT01780038|588755010|FG000|Overall Study|Lost to Follow-up|4|||
163014078|NCT01780038|588755011|FG001|Overall Study|Lost to Follow-up|1|||
163014079|NCT02366637|588755012|FG000|First Intervention Period|Adverse Event|0|||
163014080|NCT02366637|588755013|FG001|First Intervention Period|Adverse Event|1|||
163014081|NCT02366637|588755012|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
163014082|NCT02366637|588755013|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
163014083|NCT02366637|588755012|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
163014084|NCT02366637|588755013|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
163014085|NCT00455403|588755024|FG000|Overall Study|Lost to Follow-up|2|||
163014086|NCT00455403|588755025|FG001|Overall Study|Lost to Follow-up|1|||
163014087|NCT00455403|588755024|FG000|Overall Study|Withdrawal by Subject|1|||
163014088|NCT00455403|588755025|FG001|Overall Study|Withdrawal by Subject|3|||
163014089|NCT00455403|588755024|FG000|Overall Study|Protocol Violation|0|||
163014090|NCT00455403|588755025|FG001|Overall Study|Protocol Violation|2|||
163014091|NCT04509076|588755026|FG000|Overall Study|Withdrawal by Subject|1|||
163014092|NCT04509076|588755027|FG001|Overall Study|Withdrawal by Subject|2|||
163014093|NCT04509076|588755026|FG000|Overall Study|Lost to Follow-up|1|||
163014094|NCT04509076|588755027|FG001|Overall Study|Lost to Follow-up|2|||
163014095|NCT03351608|588755028|FG000|Overall Study|Lost to Follow-up|0|||
163014096|NCT03351608|588755029|FG001|Overall Study|Lost to Follow-up|1|||
163014097|NCT03351608|588755030|FG002|Overall Study|Lost to Follow-up|1|||
163014098|NCT03351608|588755031|FG003|Overall Study|Lost to Follow-up|1|||
163014099|NCT03351608|588755032|FG004|Overall Study|Lost to Follow-up|1|||
163014100|NCT03351608|588755028|FG000|Overall Study|Physician Decision|1|||
163014101|NCT03351608|588755029|FG001|Overall Study|Physician Decision|0|||
163014102|NCT03351608|588755030|FG002|Overall Study|Physician Decision|0|||
163014103|NCT03351608|588755031|FG003|Overall Study|Physician Decision|2|||
163014104|NCT03351608|588755032|FG004|Overall Study|Physician Decision|1|||
163014105|NCT03351608|588755028|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
163014106|NCT03351608|588755029|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
163014107|NCT03351608|588755030|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
163014108|NCT03351608|588755031|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
163014109|NCT03351608|588755032|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
163014110|NCT03351608|588755028|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163014111|NCT03351608|588755029|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163014112|NCT03351608|588755030|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163014113|NCT03351608|588755031|FG003|Overall Study|Withdrawal by parent/guardian|1|||
163014114|NCT03351608|588755032|FG004|Overall Study|Withdrawal by parent/guardian|0|||
163062763|NCT04478266|588936942|FG000|Overall Study|Adverse Event|20|||
163062764|NCT04478266|588936943|FG001|Overall Study|Adverse Event|21|||
163062765|NCT04478266|588936942|FG000|Overall Study|Progressive disease|146|||
163062766|NCT04478266|588936943|FG001|Overall Study|Progressive disease|168|||
163062767|NCT04478266|588936942|FG000|Overall Study|Poor compliance to protocol|1|||
163062768|NCT04478266|588936943|FG001|Overall Study|Poor compliance to protocol|0|||
163215395|NCT02584504|589503822|FG000|Open-label Treatment|Entered but not treated|0|||
163215396|NCT02584504|589503823|FG001|Open-label Treatment|Entered but not treated|1|||
163215397|NCT02584504|589503824|FG002|Open-label Treatment|Entered but not treated|1|||
163404673|NCT02813694|590191988|FG000|Overall Study|Lost to Follow-up|1|||
163014115|NCT03351608|588755028|FG000|Overall Study|Other|0|||
163014116|NCT03351608|588755029|FG001|Overall Study|Other|1|||
163014117|NCT03351608|588755030|FG002|Overall Study|Other|1|||
163014118|NCT03351608|588755031|FG003|Overall Study|Other|3|||
163014119|NCT03351608|588755032|FG004|Overall Study|Other|0|||
163014120|NCT02877004|588755033|FG000|Overall Study|Pregnancy|0|||
163014121|NCT02877004|588755034|FG001|Overall Study|Pregnancy|0|||
163014122|NCT02877004|588755035|FG002|Overall Study|Pregnancy|1|||
163014123|NCT02727478|588755036|FG000|Overall Study|Withdrawal by Subject|8|||
163014124|NCT02727478|588755037|FG001|Overall Study|Withdrawal by Subject|10|||
163014125|NCT00502242|588755040|FG000|Overall Study|Lack of Efficacy|1|||
163014126|NCT00502242|588755041|FG001|Overall Study|Lack of Efficacy|11|||
163062769|NCT04478266|588936942|FG000|Overall Study|Withdrawal by Subject|19|||
163062770|NCT04478266|588936943|FG001|Overall Study|Withdrawal by Subject|16|||
163014127|NCT00502242|588755040|FG000|Overall Study|Adverse Event|31|||
163215398|NCT02432846|589503825|FG000|Overall Study (4 Arms/Strata)|Death|3|||
163014128|NCT00502242|588755041|FG001|Overall Study|Adverse Event|20|||
163014129|NCT00502242|588755040|FG000|Overall Study|Physician Decision|2|||
163014130|NCT00502242|588755041|FG001|Overall Study|Physician Decision|3|||
163014131|NCT00502242|588755040|FG000|Overall Study|Other - Unspecified|8|||
163014132|NCT00502242|588755041|FG001|Overall Study|Other - Unspecified|14|||
163014133|NCT00502242|588755040|FG000|Overall Study|Protocol Violation|3|||
163014134|NCT00502242|588755041|FG001|Overall Study|Protocol Violation|1|||
163014135|NCT00502242|588755040|FG000|Overall Study|Withdrawal by Subject|6|||
163014136|NCT00502242|588755041|FG001|Overall Study|Withdrawal by Subject|7|||
163014137|NCT00778817|588755042|FG000|Overall Study|Adverse Event|2|||
163014138|NCT00778817|588755042|FG000|Overall Study|Withdrawal by Subject|2|||
163014139|NCT02509507|588755043|FG000|Overall Study|Death|21|||
163014140|NCT02509507|588755044|FG001|Overall Study|Death|3|||
163014141|NCT02509507|588755045|FG002|Overall Study|Death|22|||
163014142|NCT02509507|588755046|FG003|Overall Study|Death|14|||
163014143|NCT02509507|588755047|FG004|Overall Study|Death|8|||
163014144|NCT02509507|588755048|FG005|Overall Study|Death|12|||
163014145|NCT02509507|588755049|FG006|Overall Study|Death|5|||
163014146|NCT02509507|588755050|FG007|Overall Study|Death|4|||
163014147|NCT02509507|588755051|FG008|Overall Study|Death|8|||
163014148|NCT02509507|588755043|FG000|Overall Study|Lost to Follow-up|0|||
163014149|NCT02509507|588755044|FG001|Overall Study|Lost to Follow-up|1|||
163014150|NCT02509507|588755045|FG002|Overall Study|Lost to Follow-up|0|||
163014151|NCT02509507|588755046|FG003|Overall Study|Lost to Follow-up|0|||
163014152|NCT02509507|588755047|FG004|Overall Study|Lost to Follow-up|0|||
163014153|NCT02509507|588755048|FG005|Overall Study|Lost to Follow-up|2|||
163014154|NCT02509507|588755049|FG006|Overall Study|Lost to Follow-up|0|||
163014155|NCT02509507|588755050|FG007|Overall Study|Lost to Follow-up|0|||
163014156|NCT02509507|588755051|FG008|Overall Study|Lost to Follow-up|0|||
163014157|NCT02509507|588755043|FG000|Overall Study|Withdrawal by Subject|2|||
163014158|NCT02509507|588755044|FG001|Overall Study|Withdrawal by Subject|0|||
163014159|NCT02509507|588755045|FG002|Overall Study|Withdrawal by Subject|1|||
163014160|NCT02509507|588755046|FG003|Overall Study|Withdrawal by Subject|4|||
163014161|NCT02509507|588755047|FG004|Overall Study|Withdrawal by Subject|1|||
163014162|NCT02509507|588755048|FG005|Overall Study|Withdrawal by Subject|3|||
163014163|NCT02509507|588755049|FG006|Overall Study|Withdrawal by Subject|4|||
163014164|NCT02509507|588755050|FG007|Overall Study|Withdrawal by Subject|0|||
163014165|NCT02509507|588755051|FG008|Overall Study|Withdrawal by Subject|1|||
163014166|NCT02356588|588755052|FG000|Overall Study|Lack of Efficacy|4|||
163014167|NCT02356588|588755053|FG001|Overall Study|Lack of Efficacy|10|||
163014168|NCT02356588|588755052|FG000|Overall Study|Adverse Event|0|||
163014169|NCT02356588|588755053|FG001|Overall Study|Adverse Event|2|||
163014170|NCT02356588|588755052|FG000|Overall Study|Withdrawal by Subject|1|||
163014171|NCT02356588|588755053|FG001|Overall Study|Withdrawal by Subject|0|||
163014172|NCT02356588|588755052|FG000|Overall Study|Protocol Violation|0|||
163014173|NCT02356588|588755053|FG001|Overall Study|Protocol Violation|1|||
163014174|NCT01418378|588755054|FG000|Overall Study|Death|1|||
163014175|NCT01418378|588755055|FG001|Overall Study|Death|2|||
163014176|NCT01418378|588755054|FG000|Overall Study|Physician Decision|0|||
163014177|NCT01418378|588755055|FG001|Overall Study|Physician Decision|1|||
163014178|NCT01418378|588755054|FG000|Overall Study|ligament imbalance|0|||
163014179|NCT01418378|588755055|FG001|Overall Study|ligament imbalance|1|||
163014180|NCT01418378|588755054|FG000|Overall Study|developed chronic myopathy|0|||
163014181|NCT01418378|588755055|FG001|Overall Study|developed chronic myopathy|1|||
163014182|NCT01812109|588755058|FG000|Overall Study|research personnel delay|16|||
163328462|NCT04517435|589913285|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
163014183|NCT01812109|588755058|FG000|Overall Study|NIRS Unattainable|17|||
163014184|NCT04630002|588755059|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
163014185|NCT04630002|588755060|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
163014186|NCT04630002|588755061|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
163014187|NCT04630002|588755059|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
163014188|NCT04630002|588755060|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
163014189|NCT04630002|588755061|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
163328463|NCT04517435|589913286|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
163328464|NCT04517435|589913287|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
163328465|NCT03656718|589913288|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
163014190|NCT04630002|588755059|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
163014191|NCT04630002|588755060|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
163328466|NCT03656718|589913289|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
163014192|NCT04630002|588755061|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
163014193|NCT04630002|588755059|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
163014194|NCT04630002|588755060|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
163014195|NCT04630002|588755061|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
163014196|NCT04630002|588755059|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
163014197|NCT04630002|588755060|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
163014198|NCT04630002|588755061|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
163014199|NCT04630002|588755059|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
163014200|NCT04630002|588755060|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
163014201|NCT04630002|588755061|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
163014202|NCT04630002|588755059|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
163014203|NCT04630002|588755060|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
163014204|NCT04630002|588755061|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
163014205|NCT04630002|588755059|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
163014206|NCT04630002|588755060|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
163014207|NCT04630002|588755061|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
163014208|NCT00442897|588755063|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
163014209|NCT00442897|588755064|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
163014210|NCT00442897|588755063|FG000|Base Study (12 Week Follow-up)|Death|0|||
163014211|NCT00442897|588755064|FG001|Base Study (12 Week Follow-up)|Death|1|||
163014212|NCT00442897|588755063|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
163014213|NCT00442897|588755064|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
163014214|NCT00442897|588755063|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
163014215|NCT00442897|588755064|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
163014216|NCT00442897|588755063|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
163014217|NCT00442897|588755064|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
163014218|NCT00442897|588755063|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
163014219|NCT00442897|588755064|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
163014220|NCT00442897|588755063|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
163014221|NCT00442897|588755064|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
163014222|NCT00442897|588755063|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
163014223|NCT00442897|588755064|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
163014224|NCT04498182|588755065|FG000|Overall Study|Adverse Event|2|||
163014225|NCT04498182|588755066|FG001|Overall Study|Adverse Event|3|||
163014226|NCT04498182|588755067|FG002|Overall Study|Adverse Event|2|||
163014227|NCT04498182|588755065|FG000|Overall Study|Withdrawal of Consent|3|||
163014228|NCT04498182|588755066|FG001|Overall Study|Withdrawal of Consent|4|||
163014229|NCT04498182|588755067|FG002|Overall Study|Withdrawal of Consent|3|||
163014230|NCT04498182|588755065|FG000|Overall Study|Non-Compliant|1|||
163014231|NCT04498182|588755066|FG001|Overall Study|Non-Compliant|0|||
163014232|NCT04498182|588755067|FG002|Overall Study|Non-Compliant|1|||
163014233|NCT04498182|588755065|FG000|Overall Study|Lost to Follow-up|0|||
163014234|NCT04498182|588755066|FG001|Overall Study|Lost to Follow-up|0|||
163014235|NCT04498182|588755067|FG002|Overall Study|Lost to Follow-up|1|||
163014236|NCT04498182|588755065|FG000|Overall Study|Investigator Decision|0|||
163014237|NCT04498182|588755066|FG001|Overall Study|Investigator Decision|0|||
163014238|NCT04498182|588755067|FG002|Overall Study|Investigator Decision|1|||
163014239|NCT04498182|588755065|FG000|Overall Study|Protocol Violation|1|||
163014240|NCT04498182|588755066|FG001|Overall Study|Protocol Violation|0|||
163014241|NCT04498182|588755067|FG002|Overall Study|Protocol Violation|2|||
163014242|NCT01372618|588755077|FG000|Overall Study|PI Died. Study Terminated|9|||
163014243|NCT04610346|588755078|FG000|Overall Study|Withdrawal by Subject|1|||
163014244|NCT04610346|588755079|FG001|Overall Study|Withdrawal by Subject|1|||
163014245|NCT04610346|588755078|FG000|Overall Study|did not complete shelter onboarding|2|||
163014246|NCT04610346|588755079|FG001|Overall Study|did not complete shelter onboarding|1|||
163014247|NCT00558467|588755080|FG000|Overall Study|Adverse Event|1|||
163014248|NCT00558467|588755081|FG001|Overall Study|Adverse Event|2|||
163014249|NCT00558467|588755080|FG000|Overall Study|Lack of Efficacy|0|||
163014250|NCT00558467|588755081|FG001|Overall Study|Lack of Efficacy|1|||
163014251|NCT00558467|588755080|FG000|Overall Study|Patient moving out of state|0|||
163014252|NCT00558467|588755081|FG001|Overall Study|Patient moving out of state|1|||
163014253|NCT00931255|588755082|FG000|Overall Study|Follow up biopsy not done|2|||
163014254|NCT00931255|588755083|FG001|Overall Study|Follow up biopsy not done|3|||
163014255|NCT02019264|588755084|FG000|Overall Study|Not treated|6|||
163014256|NCT02019264|588755085|FG001|Overall Study|Not treated|4|||
163014257|NCT02019264|588755084|FG000|Overall Study|Lost to Follow-up|50|||
163062771|NCT04478266|588936942|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
163062772|NCT04478266|588936943|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
163404674|NCT02813694|590191989|FG001|Overall Study|Lost to Follow-up|1|||
163014258|NCT02019264|588755085|FG001|Overall Study|Lost to Follow-up|47|||
163014259|NCT02019264|588755084|FG000|Overall Study|Withdrawal by Subject|142|||
163014260|NCT02019264|588755085|FG001|Overall Study|Withdrawal by Subject|117|||
163014261|NCT02019264|588755084|FG000|Overall Study|Administrative reason|36|||
163014262|NCT02019264|588755085|FG001|Overall Study|Administrative reason|28|||
163014263|NCT02019264|588755084|FG000|Overall Study|Missing|14|||
163014264|NCT02019264|588755085|FG001|Overall Study|Missing|11|||
163014265|NCT02220764|588755095|FG000|Overall Study|Lost to Follow-up|3|||
163014266|NCT02220764|588755096|FG001|Overall Study|Lost to Follow-up|1|||
163014267|NCT02220764|588755095|FG000|Overall Study|Death|1|||
163014268|NCT02220764|588755096|FG001|Overall Study|Death|0|||
163014269|NCT04526288|588755100|FG000|Overall Study|Disease Progression|1|||
163014270|NCT04526288|588755101|FG001|Overall Study|Disease Progression|0|||
163014271|NCT00952068|588755103|FG000|Overall Study|Adverse Event|3|||
163014272|NCT00952068|588755103|FG000|Overall Study|Withdrawal by Subject|4|||
163014273|NCT04926831|588755104|FG000|Overall Study|Withdrawal by Subject|2|||
163014274|NCT04926831|588755104|FG000|Overall Study|Adverse Event|2|||
163014275|NCT00564850|588755105|FG000|Overall Study|Protocol Violation|2|||
163014276|NCT01804946|588755106|FG000|Overall Study|Protocol Violation|1|||
163014277|NCT01804946|588755107|FG001|Overall Study|Protocol Violation|0|||
163014278|NCT01804946|588755106|FG000|Overall Study|Adverse Event|0|||
163014279|NCT01804946|588755107|FG001|Overall Study|Adverse Event|1|||
163014280|NCT01804946|588755106|FG000|Overall Study|Insufficient data available|0|||
163014281|NCT01804946|588755107|FG001|Overall Study|Insufficient data available|1|||
163014282|NCT01804946|588755106|FG000|Overall Study|Do not meet inclusion criteria|1|||
163014283|NCT01804946|588755107|FG001|Overall Study|Do not meet inclusion criteria|2|||
163014284|NCT01129557|588755109|FG000|Overall Study|Adverse Event|1|||
163014285|NCT01129557|588755110|FG001|Overall Study|Adverse Event|2|||
163014286|NCT01129557|588755111|FG002|Overall Study|Adverse Event|2|||
163014287|NCT01129557|588755109|FG000|Overall Study|Novartis terminated study early|3|||
163014288|NCT01129557|588755110|FG001|Overall Study|Novartis terminated study early|3|||
163014289|NCT01129557|588755111|FG002|Overall Study|Novartis terminated study early|2|||
163014290|NCT01486446|588755112|FG000|Overall Study|Adverse Event|1|||
163014291|NCT01486446|588755113|FG001|Overall Study|Adverse Event|0|||
163014292|NCT00669669|588755114|FG000|Overall Study|To late to start treatment|1|||
163014293|NCT04390113|588755115|FG000|Overall Study|Not Treated|0|||
163014294|NCT04390113|588755116|FG001|Overall Study|Not Treated|1|||
163014295|NCT04390113|588755115|FG000|Overall Study|Adverse Event|1|||
163014296|NCT04390113|588755116|FG001|Overall Study|Adverse Event|0|||
163014297|NCT04390113|588755115|FG000|Overall Study|Death|2|||
163014298|NCT04390113|588755116|FG001|Overall Study|Death|1|||
163014299|NCT04390113|588755115|FG000|Overall Study|Physician Decision|1|||
163014300|NCT04390113|588755116|FG001|Overall Study|Physician Decision|3|||
163014301|NCT04390113|588755115|FG000|Overall Study|Study Terminated by Sponsor|5|||
163014302|NCT04390113|588755116|FG001|Overall Study|Study Terminated by Sponsor|3|||
163014303|NCT04390113|588755115|FG000|Overall Study|Withdrawal by Subject|10|||
163014304|NCT04390113|588755116|FG001|Overall Study|Withdrawal by Subject|5|||
163014305|NCT04390113|588755115|FG000|Overall Study|Other|1|||
163014306|NCT04390113|588755116|FG001|Overall Study|Other|0|||
163014307|NCT04390113|588755115|FG000|Overall Study|Missing|0|||
163014308|NCT04390113|588755116|FG001|Overall Study|Missing|1|||
163014309|NCT01611883|588755117|FG000|Overall Study|Adverse Event|1|||
163014310|NCT01611883|588755118|FG001|Overall Study|Adverse Event|1|||
163014311|NCT03379727|588755120|FG000|Overall Study|Lack of Efficacy|73|||
163014312|NCT03379727|588755120|FG000|Overall Study|Adverse Event|32|||
163014313|NCT03379727|588755120|FG000|Overall Study|Death|18|||
163014314|NCT03379727|588755120|FG000|Overall Study|Patient/guardian decision|17|||
163014315|NCT03379727|588755120|FG000|Overall Study|Physician Decision|104|||
163014316|NCT03379727|588755120|FG000|Overall Study|Protocol Violation|4|||
163014317|NCT03379727|588755120|FG000|Overall Study|Lost to Follow-up|1|||
163014318|NCT00030901|588755124|FG000|Initial Registration|Ineligible|167|||
163014319|NCT00030901|588755125|FG001|Initial Registration|Ineligible|0|||
163014320|NCT00030901|588755126|FG002|Initial Registration|Ineligible|0|||
163014321|NCT00030901|588755124|FG000|Randomization|Adverse Event|0|||
163014322|NCT00030901|588755125|FG001|Randomization|Adverse Event|11|||
163014323|NCT00030901|588755126|FG002|Randomization|Adverse Event|7|||
163014324|NCT00030901|588755124|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
163014325|NCT00030901|588755125|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
163014326|NCT00030901|588755126|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
163014327|NCT00030901|588755124|FG000|Randomization|Progression/Relapse|0|||
163014328|NCT00030901|588755125|FG001|Randomization|Progression/Relapse|22|||
163404675|NCT02813694|590191988|FG000|Overall Study|Death|3|||
163014329|NCT00030901|588755126|FG002|Randomization|Progression/Relapse|21|||
163014330|NCT00030901|588755124|FG000|Randomization|Death|0|||
163014331|NCT00030901|588755125|FG001|Randomization|Death|1|||
163014332|NCT00030901|588755126|FG002|Randomization|Death|3|||
163014333|NCT00030901|588755124|FG000|Randomization|Other|0|||
163014334|NCT00030901|588755125|FG001|Randomization|Other|36|||
163014335|NCT00030901|588755126|FG002|Randomization|Other|33|||
163014336|NCT00030901|588755124|FG000|Randomization|Ineligible|0|||
163014337|NCT00030901|588755125|FG001|Randomization|Ineligible|15|||
163014338|NCT00030901|588755126|FG002|Randomization|Ineligible|14|||
163014339|NCT02576847|588755129|FG000|Overall Study|Adverse Event|27|||
163014340|NCT02576847|588755129|FG000|Overall Study|Lost to Follow-up|22|||
163014341|NCT02576847|588755129|FG000|Overall Study|Physician Decision|1|||
163014342|NCT02576847|588755129|FG000|Overall Study|Pregnancy|1|||
163014343|NCT02576847|588755129|FG000|Overall Study|Protocol Violation|3|||
163014344|NCT02576847|588755129|FG000|Overall Study|Withdrawal by Subject|78|||
163014345|NCT02576847|588755129|FG000|Overall Study|Other|5|||
163014346|NCT01806051|588755130|FG000|Overall Study|Withdrawal by Subject|6|||
163014347|NCT02418182|588755133|FG000|Overall Study|Unable to re-consent|18|||
163014348|NCT02418182|588755134|FG001|Overall Study|Unable to re-consent|15|||
163014349|NCT02418182|588755133|FG000|Overall Study|Lost to Follow-up|0|||
163014350|NCT02418182|588755134|FG001|Overall Study|Lost to Follow-up|2|||
163014351|NCT01205776|588755135|FG000|Overall Study|Lost to Follow-up|53|||
163014352|NCT01205776|588755136|FG001|Overall Study|Lost to Follow-up|61|||
163014353|NCT01205776|588755135|FG000|Overall Study|Withdrawal by Subject|11|||
163014354|NCT01205776|588755136|FG001|Overall Study|Withdrawal by Subject|34|||
163014355|NCT01540487|588757117|FG000|Overall Study|Protocol Violation|1|||
163014356|NCT01540487|588757118|FG001|Overall Study|Protocol Violation|0|||
163014357|NCT03503370|588757119|FG000|Overall Study|Death|3|||
163014358|NCT03503370|588757120|FG001|Overall Study|Death|1|||
163014359|NCT03483961|588757121|FG000|Overall Study|Lost to Follow-up|7|||
163014360|NCT03483961|588757122|FG001|Overall Study|Lost to Follow-up|6|||
163014361|NCT03483961|588757123|FG002|Overall Study|Lost to Follow-up|6|||
163014362|NCT03483961|588757124|FG003|Overall Study|Lost to Follow-up|6|||
163014363|NCT03483961|588757125|FG004|Overall Study|Lost to Follow-up|6|||
163014364|NCT03483961|588757126|FG005|Overall Study|Lost to Follow-up|4|||
163014365|NCT03483961|588757127|FG006|Overall Study|Lost to Follow-up|4|||
163014366|NCT03483961|588757128|FG007|Overall Study|Lost to Follow-up|11|||
163014367|NCT03483961|588757129|FG008|Overall Study|Lost to Follow-up|1|||
163014368|NCT03483961|588757130|FG009|Overall Study|Lost to Follow-up|0|||
163014369|NCT03483961|588757121|FG000|Overall Study|Withdrawal by Subject|3|||
163014370|NCT03483961|588757122|FG001|Overall Study|Withdrawal by Subject|4|||
163014371|NCT03483961|588757123|FG002|Overall Study|Withdrawal by Subject|5|||
163014372|NCT03483961|588757124|FG003|Overall Study|Withdrawal by Subject|3|||
163014373|NCT03483961|588757125|FG004|Overall Study|Withdrawal by Subject|4|||
163014374|NCT03483961|588757126|FG005|Overall Study|Withdrawal by Subject|2|||
163014375|NCT03483961|588757127|FG006|Overall Study|Withdrawal by Subject|1|||
163014376|NCT03483961|588757128|FG007|Overall Study|Withdrawal by Subject|2|||
163014377|NCT03483961|588757129|FG008|Overall Study|Withdrawal by Subject|1|||
163014378|NCT03483961|588757130|FG009|Overall Study|Withdrawal by Subject|0|||
163014379|NCT03483961|588757121|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
163014380|NCT03483961|588757122|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014381|NCT03483961|588757123|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014382|NCT03483961|588757124|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014383|NCT03483961|588757125|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014384|NCT03483961|588757126|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014385|NCT03483961|588757127|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014386|NCT03483961|588757128|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014387|NCT03483961|588757129|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014388|NCT03483961|588757130|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014389|NCT03483961|588757121|FG000|Overall Study|Adverse Event|0|||
163014390|NCT03483961|588757122|FG001|Overall Study|Adverse Event|0|||
163014391|NCT03483961|588757123|FG002|Overall Study|Adverse Event|1|||
163014392|NCT03483961|588757124|FG003|Overall Study|Adverse Event|0|||
163014393|NCT03483961|588757125|FG004|Overall Study|Adverse Event|0|||
163014394|NCT03483961|588757126|FG005|Overall Study|Adverse Event|0|||
163014395|NCT03483961|588757127|FG006|Overall Study|Adverse Event|0|||
163014396|NCT03483961|588757128|FG007|Overall Study|Adverse Event|0|||
163014397|NCT03483961|588757129|FG008|Overall Study|Adverse Event|0|||
163014398|NCT03483961|588757130|FG009|Overall Study|Adverse Event|0|||
163014399|NCT00298272|588757131|FG000|Double-blind Phase|Adverse Event|2|||
163014400|NCT00298272|588757132|FG001|Double-blind Phase|Adverse Event|0|||
163014401|NCT00298272|588757131|FG000|Double-blind Phase|Failure to Return|2|||
163014402|NCT00298272|588757132|FG001|Double-blind Phase|Failure to Return|0|||
163014403|NCT00298272|588757131|FG000|Double-blind Phase|Protocol Violation|2|||
163014404|NCT00298272|588757132|FG001|Double-blind Phase|Protocol Violation|0|||
163014405|NCT00298272|588757131|FG000|Double-blind Phase|Withdrawal by Subject|2|||
163014406|NCT00298272|588757132|FG001|Double-blind Phase|Withdrawal by Subject|0|||
163014407|NCT00298272|588757131|FG000|Open Label Retreatment Phase|Adverse Event|1|||
163014408|NCT00298272|588757132|FG001|Open Label Retreatment Phase|Adverse Event|2|||
163014409|NCT00298272|588757131|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
163014410|NCT00298272|588757132|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
163014411|NCT00298272|588757131|FG000|Open Label Retreatment Phase|Failure to Return|1|||
163014412|NCT00298272|588757132|FG001|Open Label Retreatment Phase|Failure to Return|0|||
163014413|NCT00298272|588757131|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
163014414|NCT00298272|588757132|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
163014415|NCT00298272|588757131|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
163014416|NCT00298272|588757132|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
163154712|NCT02435992|589281386|FG001|Overall Study|Lack of Efficacy|10|||
163014417|NCT00298272|588757131|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
163014418|NCT00298272|588757132|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
163014419|NCT00298272|588757131|FG000|Safety Follow-up Phase|Failure to Return|1|||
163014420|NCT00298272|588757132|FG001|Safety Follow-up Phase|Failure to Return|1|||
163014421|NCT00298272|588757131|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
163014422|NCT00298272|588757132|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
163014423|NCT00298272|588757131|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
163014424|NCT00298272|588757132|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
163014425|NCT00326716|588757133|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
163014426|NCT00326716|588757134|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
163014427|NCT00326716|588757135|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
163014428|NCT00326716|588757136|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
163014429|NCT00684411|588757137|FG000|Overall Study|New Primary Cancer|1|||
163014430|NCT00684411|588757137|FG000|Overall Study|Disease Progression|10|||
163014431|NCT00684411|588757137|FG000|Overall Study|Adverse Event|1|||
163014432|NCT00734162|588757138|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
163014433|NCT00734162|588757139|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
163014434|NCT00734162|588757140|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
163014435|NCT00734162|588757141|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
163014436|NCT00734162|588757138|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
163014437|NCT00734162|588757139|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
163014438|NCT00734162|588757140|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
163014439|NCT00734162|588757141|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
163014440|NCT00734162|588757138|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
163014441|NCT00734162|588757139|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
163014442|NCT00734162|588757140|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
163014443|NCT00734162|588757141|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
163014444|NCT00734162|588757138|FG000|Open-Label Phase|Withdrew Consent|1|||
163014445|NCT00734162|588757139|FG001|Open-Label Phase|Withdrew Consent|0|||
163014446|NCT00734162|588757140|FG002|Open-Label Phase|Withdrew Consent|1|||
163014447|NCT00734162|588757141|FG003|Open-Label Phase|Withdrew Consent|1|||
163014448|NCT00734162|588757138|FG000|Open-Label Phase|Lost to Follow-up|1|||
163014449|NCT00734162|588757139|FG001|Open-Label Phase|Lost to Follow-up|2|||
163014450|NCT00734162|588757140|FG002|Open-Label Phase|Lost to Follow-up|0|||
163014451|NCT00734162|588757141|FG003|Open-Label Phase|Lost to Follow-up|1|||
163014452|NCT00734162|588757138|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
163014453|NCT00734162|588757139|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
163014454|NCT00734162|588757140|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
163014455|NCT00734162|588757141|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
163014456|NCT05253573|588757142|FG000|Overall Study|Death|1|||
163014457|NCT05253573|588757143|FG001|Overall Study|Death|0|||
163014458|NCT01344824|588757144|FG000|Overall Study|Adverse Event|15|||
163014459|NCT01344824|588757144|FG000|Overall Study|Withdrawal by Subject|6|||
163014460|NCT01344824|588757144|FG000|Overall Study|Other complicating disease|1|||
163014461|NCT01344824|588757144|FG000|Overall Study|Progression|15|||
163014462|NCT00566020|588757145|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
163014463|NCT00566020|588757146|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
163014464|NCT00566020|588757145|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
163014465|NCT00566020|588757146|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
163014466|NCT00566020|588757145|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
163062773|NCT04478266|588936942|FG000|Overall Study|Study terminated by sponsor|33|||
163062774|NCT04478266|588936943|FG001|Overall Study|Study terminated by sponsor|35|||
163062775|NCT04478266|588936942|FG000|Overall Study|Other: unspecified|5|||
163062776|NCT04478266|588936943|FG001|Overall Study|Other: unspecified|7|||
163062777|NCT04478266|588936942|FG000|Overall Study|Randomized but not treated|1|||
163062778|NCT04478266|588936943|FG001|Overall Study|Randomized but not treated|1|||
163014467|NCT00566020|588757146|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
163014468|NCT00566020|588757145|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
163014469|NCT00566020|588757146|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
163014470|NCT00566020|588757145|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
163014471|NCT00566020|588757146|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
163014472|NCT00566020|588757145|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
163062779|NCT04058717|588936944|FG000|Randomization Period|Lost to Follow-up|2|||
163154713|NCT02435992|589281387|FG002|Overall Study|Lack of Efficacy|9|||
163154714|NCT02435992|589281388|FG003|Overall Study|Lack of Efficacy|0|||
163154715|NCT02435992|589281389|FG004|Overall Study|Lack of Efficacy|0|||
163154716|NCT02435992|589281385|FG000|Overall Study|Withdrawal by Subject|10|||
163154717|NCT02435992|589281386|FG001|Overall Study|Withdrawal by Subject|8|||
163154718|NCT02435992|589281387|FG002|Overall Study|Withdrawal by Subject|20|||
163154719|NCT02435992|589281388|FG003|Overall Study|Withdrawal by Subject|0|||
163154720|NCT02435992|589281389|FG004|Overall Study|Withdrawal by Subject|0|||
163328467|NCT03656718|589913290|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
163014473|NCT00566020|588757146|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
163014474|NCT01754129|588757147|FG000|Overall Study|Death|13|||
163014475|NCT01754129|588757147|FG000|Overall Study|Duodopa discontinuation|9|||
163014476|NCT01754129|588757147|FG000|Overall Study|Lost to Follow-up|7|||
163014477|NCT01754129|588757147|FG000|Overall Study|Withdrew consent|1|||
163014478|NCT01754129|588757147|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
163014479|NCT01085630|588757148|FG000|Overall Study|Insufficient data|1|||
163014480|NCT01085630|588757149|FG001|Overall Study|Insufficient data|0|||
163014481|NCT01085630|588757148|FG000|Overall Study|Ineligible|3|||
163014482|NCT01085630|588757149|FG001|Overall Study|Ineligible|0|||
163014483|NCT02609607|588757160|FG000|Overall Study|Lost to Follow-up|0|||
163014484|NCT02609607|588757161|FG001|Overall Study|Lost to Follow-up|1|||
163014485|NCT03691207|588757162|FG000|Overall Study|Death|41|||
163014486|NCT03691207|588757163|FG001|Overall Study|Death|26|||
163014487|NCT03691207|588757162|FG000|Overall Study|Lost to Follow-up|1|||
163014488|NCT03691207|588757163|FG001|Overall Study|Lost to Follow-up|1|||
163014489|NCT03691207|588757162|FG000|Overall Study|Withdrawal by Subject|2|||
163014490|NCT03691207|588757163|FG001|Overall Study|Withdrawal by Subject|8|||
163014491|NCT03691207|588757162|FG000|Overall Study|Sponsor decision|1|||
163014492|NCT03691207|588757163|FG001|Overall Study|Sponsor decision|7|||
163014493|NCT00651261|588757164|FG000|Overall Study|Adverse Event|32|||
163014494|NCT00651261|588757165|FG001|Overall Study|Adverse Event|22|||
163014495|NCT00651261|588757164|FG000|Overall Study|Death|18|||
163014496|NCT00651261|588757165|FG001|Overall Study|Death|18|||
163014497|NCT00651261|588757164|FG000|Overall Study|Withdrawal by Subject|22|||
163014498|NCT00651261|588757165|FG001|Overall Study|Withdrawal by Subject|40|||
163014499|NCT00651261|588757164|FG000|Overall Study|Induction failure|24|||
163014500|NCT00651261|588757165|FG001|Overall Study|Induction failure|35|||
163014501|NCT00651261|588757164|FG000|Overall Study|Disease progression|58|||
163014502|NCT00651261|588757165|FG001|Overall Study|Disease progression|58|||
163014503|NCT00651261|588757164|FG000|Overall Study|Alternative therapy|109|||
163014504|NCT00651261|588757165|FG001|Overall Study|Alternative therapy|107|||
163014505|NCT00651261|588757164|FG000|Overall Study|Other disease or participant decisions|23|||
163014506|NCT00651261|588757165|FG001|Overall Study|Other disease or participant decisions|23|||
163014507|NCT00651261|588757164|FG000|Overall Study|Never treated|5|||
163014508|NCT00651261|588757165|FG001|Overall Study|Never treated|3|||
163014509|NCT02027545|588757166|FG000|Overall Study|Failed to sign HIPAA|0|||
163014510|NCT02027545|588757167|FG001|Overall Study|Failed to sign HIPAA|2|||
163014511|NCT02027545|588757166|FG000|Overall Study|Failed to attend study visit|2|||
163014512|NCT02027545|588757167|FG001|Overall Study|Failed to attend study visit|0|||
163014513|NCT02027545|588757166|FG000|Overall Study|Protocol Violation|1|||
163014514|NCT02027545|588757167|FG001|Overall Study|Protocol Violation|0|||
163014515|NCT02633293|588757168|FG000|Overall Study|Death|56|||
163014516|NCT02633293|588757168|FG000|Overall Study|Progressive Disease|12|||
163014517|NCT02633293|588757168|FG000|Overall Study|Adverse Event|29|||
163014518|NCT02633293|588757168|FG000|Overall Study|Withdrawal by Subject|41|||
163014519|NCT02633293|588757168|FG000|Overall Study|Protocol Violation|1|||
163014520|NCT02633293|588757168|FG000|Overall Study|Lost to Follow-up|1|||
163014521|NCT02633293|588757168|FG000|Overall Study|Study Terminated by Sponsor|24|||
163014522|NCT02633293|588757168|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
163014523|NCT02633293|588757168|FG000|Overall Study|Lung Transplant|5|||
163014524|NCT02633293|588757168|FG000|Overall Study|Lack of Efficacy|2|||
163014525|NCT02633293|588757168|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
163014526|NCT01343043|588757169|FG000|Overall Study|Disease progression before treatment|1|||
163014527|NCT01343043|588757170|FG001|Overall Study|Disease progression before treatment|0|||
163014528|NCT01343043|588757171|FG002|Overall Study|Disease progression before treatment|0|||
163014529|NCT01343043|588757172|FG003|Overall Study|Disease progression before treatment|0|||
163014530|NCT01343043|588757169|FG000|Overall Study|Withdrawal by Subject|1|||
163014531|NCT01343043|588757170|FG001|Overall Study|Withdrawal by Subject|0|||
163014532|NCT01343043|588757171|FG002|Overall Study|Withdrawal by Subject|0|||
163014533|NCT01343043|588757172|FG003|Overall Study|Withdrawal by Subject|0|||
163014534|NCT01343043|588757169|FG000|Overall Study|Death|1|||
163014535|NCT01343043|588757170|FG001|Overall Study|Death|1|||
163328468|NCT03656718|589913291|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
163014536|NCT01343043|588757171|FG002|Overall Study|Death|0|||
163014537|NCT01343043|588757172|FG003|Overall Study|Death|1|||
163014538|NCT01017874|588757173|FG000|Overall Study|Withdrawal by Subject|23|||
163014539|NCT01017874|588757174|FG001|Overall Study|Withdrawal by Subject|20|||
163014540|NCT01017874|588757173|FG000|Overall Study|Sponsor decision|3|||
163014541|NCT01017874|588757174|FG001|Overall Study|Sponsor decision|1|||
163014542|NCT01017874|588757173|FG000|Overall Study|Lost to Follow-up|3|||
163014543|NCT01017874|588757174|FG001|Overall Study|Lost to Follow-up|2|||
163014544|NCT01017874|588757173|FG000|Overall Study|Physician Decision|1|||
163014545|NCT01017874|588757174|FG001|Overall Study|Physician Decision|3|||
163014546|NCT01790984|588757179|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
163154721|NCT02435992|589281385|FG000|Overall Study|Other Reason|1|||
163014547|NCT01790984|588757180|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
163014548|NCT01790984|588757181|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
163014549|NCT01790984|588757182|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
163014550|NCT01346696|588757185|FG000|Overall Study|Death|1|||
163014551|NCT02182843|588757186|FG000|Overall Study|Withdrawal by Subject|7|||
163014552|NCT02182843|588757186|FG000|Overall Study|Lost to Follow-up|2|||
163014553|NCT02182843|588757186|FG000|Overall Study|Adverse Event|1|||
163014554|NCT01051791|588757190|FG000|Overall Study|Failed screening|3|||
163014555|NCT01051791|588757190|FG000|Overall Study|Withdrawal by Subject|1|||
163014556|NCT00288626|588757197|FG000|Overall Study|Death|3|||
163014557|NCT00288626|588757197|FG000|Overall Study|Withdrawal by Subject|4|||
163014558|NCT01684423|588757198|FG000|Overall Study|Withdrawal by Subject|0|||
163014559|NCT01684423|588757199|FG001|Overall Study|Withdrawal by Subject|0|||
163014560|NCT01684423|588757200|FG002|Overall Study|Withdrawal by Subject|1|||
163014561|NCT01684423|588757201|FG003|Overall Study|Withdrawal by Subject|0|||
163014562|NCT01684423|588757202|FG004|Overall Study|Withdrawal by Subject|0|||
163014563|NCT02155283|588757203|FG000|Overall Study|Lost to Follow-up|3|||
163014564|NCT02155283|588757203|FG000|Overall Study|Withdrawal by Subject|1|||
163014565|NCT02155283|588757203|FG000|Overall Study|Protocol Violation|3|||
163014566|NCT01741688|588757207|FG000|Overall Study|Lack of insurance coverage|2|||
163014567|NCT01741688|588757207|FG000|Overall Study|Withdrawal by Subject|1|||
163014568|NCT03850496|588757212|FG000|Overall Study|Withdrawal by Subject|1|||
163014569|NCT03850496|588757213|FG001|Overall Study|Withdrawal by Subject|0|||
163014570|NCT03850496|588757214|FG002|Overall Study|Withdrawal by Subject|0|||
163014571|NCT03850496|588757212|FG000|Overall Study|Lost to Follow-up|0|||
163014572|NCT03850496|588757213|FG001|Overall Study|Lost to Follow-up|1|||
163014573|NCT03850496|588757214|FG002|Overall Study|Lost to Follow-up|4|||
163014574|NCT00869999|588757219|FG000|Overall Study|Withdrawal by Subject|1|||
163014575|NCT00869999|588757219|FG000|Overall Study|removed prior to starting therapy|1|||
163014576|NCT03674112|588757221|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
163014577|NCT03674112|588757222|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
163014578|NCT03674112|588757221|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
163014579|NCT03674112|588757222|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
163014580|NCT03674112|588757221|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
163014581|NCT03674112|588757222|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
163014582|NCT03674112|588757221|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
163014583|NCT03674112|588757222|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
163014584|NCT03674112|588757221|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
163014585|NCT03674112|588757222|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
163014586|NCT03674112|588757221|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
163014587|NCT03674112|588757222|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
163014588|NCT03674112|588757221|FG000|Follow-Up Period (≥3 Years)|Death|2|||
163014589|NCT03674112|588757222|FG001|Follow-Up Period (≥3 Years)|Death|0|||
163014590|NCT03674112|588757221|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
163014591|NCT03674112|588757222|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
163014592|NCT04157348|588757223|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
163014593|NCT04157348|588757224|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
163404676|NCT02813694|590191989|FG001|Overall Study|Death|3|||
163014594|NCT04157348|588757223|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
163014595|NCT04157348|588757224|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
163014596|NCT04157348|588757223|FG000|Double-blind Treatment Period|Adverse Event|0|||
163014597|NCT04157348|588757224|FG001|Double-blind Treatment Period|Adverse Event|1|||
163014598|NCT04157348|588757223|FG000|Open-label Extension Period|Adverse Event|1|||
163014599|NCT04157348|588757224|FG001|Open-label Extension Period|Adverse Event|1|||
163014600|NCT04157348|588757223|FG000|Open-label Extension Period|Death|0|||
163014601|NCT04157348|588757224|FG001|Open-label Extension Period|Death|1|||
163014602|NCT04157348|588757223|FG000|Open-label Extension Period|Lack of Efficacy|2|||
163014603|NCT04157348|588757224|FG001|Open-label Extension Period|Lack of Efficacy|2|||
163014604|NCT04157348|588757223|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
163014605|NCT04157348|588757224|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
163014606|NCT04157348|588757223|FG000|Open-label Extension Period|Ongoing|60|||
163014607|NCT04157348|588757224|FG001|Open-label Extension Period|Ongoing|57|||
163014608|NCT04157348|588757223|FG000|Open-label Extension Period|other reasons|1|||
163014609|NCT04157348|588757224|FG001|Open-label Extension Period|other reasons|1|||
163404677|NCT02813694|590191988|FG000|Overall Study|Randomized- did not receive study drug|2|||
163404678|NCT02813694|590191989|FG001|Overall Study|Randomized- did not receive study drug|0|||
163014610|NCT03020992|588757227|FG000|Overall Study|Adverse Event|5|||
163014611|NCT03020992|588757227|FG000|Overall Study|Withdrawal by Subject|1|||
163014612|NCT05000164|588757228|FG000|Overall Study|Adverse Event|1|||
163014613|NCT05000164|588757228|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
163014614|NCT05000164|588757228|FG000|Overall Study|Lens Discomfort|3|||
163014615|NCT05000164|588757228|FG000|Overall Study|Withdrew Consent during Study|2|||
163014616|NCT05000164|588757228|FG000|Overall Study|Subject Withdrawn by PI|2|||
163014617|NCT05000164|588757228|FG000|Overall Study|Other Fractured Test Article|1|||
163014618|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
163014619|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
163014620|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
163014621|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
163014622|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Pregnancy|0|||
163014623|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Pregnancy|1|||
163014624|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
163014625|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
163014626|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
163014627|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
163014628|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
163014629|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
163014630|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Other|3|||
163014631|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Other|0|||
163014632|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Adverse Event|0|||
163014633|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Adverse Event|4|||
163014634|NCT01006122|588757229|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
163014635|NCT01006122|588757230|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
163014636|NCT01006122|588757229|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
163014637|NCT01006122|588757230|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
163014638|NCT01006122|588757229|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
163014639|NCT01006122|588757230|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
163014640|NCT01006122|588757229|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
163014641|NCT01006122|588757230|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
163014642|NCT01006122|588757229|FG000|Second Double-blind Intervention Period|Death|0|||
163014643|NCT01006122|588757230|FG001|Second Double-blind Intervention Period|Death|1|||
163014644|NCT03493854|588757231|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
163014645|NCT03493854|588757232|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
163014646|NCT03493854|588757231|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
163014647|NCT03493854|588757232|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
163014648|NCT03493854|588757231|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
163014649|NCT03493854|588757232|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
163014650|NCT03493854|588757231|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
163014651|NCT03493854|588757232|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
163014652|NCT03493854|588757231|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
163014653|NCT03493854|588757232|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
163014654|NCT03493854|588757231|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
163014655|NCT03493854|588757232|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
163014656|NCT03493854|588757231|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
163014657|NCT03493854|588757232|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
163014658|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
163014659|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
163014660|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
163014661|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
163014662|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
163014663|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
163014664|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
163014665|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
163014666|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
163014667|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
163014668|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
163014669|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
163014670|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
163014671|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
163014672|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
163014673|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
163014674|NCT03493854|588757231|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
163014675|NCT03493854|588757232|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
163014676|NCT03493854|588757231|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
163014677|NCT03493854|588757232|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
163404679|NCT02813694|590191988|FG000|Overall Study|Patient hospitalized|1|||
163404680|NCT02813694|590191989|FG001|Overall Study|Patient hospitalized|0|||
163404681|NCT02980224|590191991|FG000|Overall Study|Adverse Event|4|||
163404682|NCT02980224|590191992|FG001|Overall Study|Adverse Event|1|||
163014678|NCT03493854|588757231|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
163014679|NCT03493854|588757232|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
163014680|NCT00410813|588757235|FG000|Overall Study|Adverse Event|6|||
163014681|NCT00410813|588757236|FG001|Overall Study|Adverse Event|11|||
163014682|NCT00410813|588757235|FG000|Overall Study|Progression|32|||
163014683|NCT00410813|588757236|FG001|Overall Study|Progression|21|||
163014684|NCT00410813|588757235|FG000|Overall Study|Not protocol specified|3|||
163014685|NCT00410813|588757236|FG001|Overall Study|Not protocol specified|4|||
163014686|NCT00410813|588757235|FG000|Overall Study|Ineligible|2|||
163014687|NCT00410813|588757236|FG001|Overall Study|Ineligible|4|||
163014688|NCT00410813|588757235|FG000|Overall Study|Death|0|||
163014689|NCT00410813|588757236|FG001|Overall Study|Death|2|||
163014690|NCT02712554|588757240|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
163014691|NCT02712554|588757241|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
163014692|NCT02712554|588757240|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
163014693|NCT02712554|588757241|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
163014694|NCT02712554|588757240|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
163014695|NCT02712554|588757241|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
163014696|NCT02712554|588757240|FG000|Part B: Qualification Phase|Adverse Event|0|||
163014697|NCT02712554|588757241|FG001|Part B: Qualification Phase|Adverse Event|1|||
163014698|NCT02712554|588757240|FG000|Part B: Treatment Phase|Adverse Event|0|||
163014699|NCT02712554|588757241|FG001|Part B: Treatment Phase|Adverse Event|1|||
163014700|NCT02712554|588757240|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
163014701|NCT02712554|588757241|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
163014702|NCT02712554|588757240|FG000|Part B: Treatment Phase|Other|0|||
163014703|NCT02712554|588757241|FG001|Part B: Treatment Phase|Other|1|||
163014704|NCT02503540|588757242|FG000|Overall Study|Death|2|||
163014705|NCT02503540|588757242|FG000|Overall Study|Withdrawal by Subject|1|||
163014706|NCT00979654|588757243|FG000|Overall Study|Lost to Follow-up|1|||
163014707|NCT00979654|588757243|FG000|Overall Study|Withdrawal by Subject|22|||
163014708|NCT00979654|588757243|FG000|Overall Study|Death|1|||
163014709|NCT00979654|588757243|FG000|Overall Study|Lack of Efficacy|6|||
163014710|NCT00979654|588757243|FG000|Overall Study|Adverse Event|1|||
163014711|NCT00979654|588757243|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
163014712|NCT00979654|588757243|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
163014713|NCT00979654|588757243|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
163014714|NCT00979654|588757243|FG000|Overall Study|Serious Adverse Event|1|||
163014715|NCT00979654|588757243|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
163014716|NCT03830333|588757247|FG000|Overall Study|Death|0|||
163014717|NCT03830333|588757248|FG001|Overall Study|Death|1|||
163014718|NCT03830333|588757247|FG000|Overall Study|Withdrawal by Subject|5|||
163014719|NCT03830333|588757248|FG001|Overall Study|Withdrawal by Subject|1|||
163014720|NCT03830333|588757247|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
163014721|NCT03830333|588757248|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
163014722|NCT01445730|588757249|FG000|Overall Study|Adverse Event|1|||
163014723|NCT01445730|588757249|FG000|Overall Study|For the advice of a dentist|1|||
163014724|NCT01445730|588757249|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
163014725|NCT01367886|588757250|FG000|Overall Study|Lost to Follow-up|4|||
163014726|NCT01367886|588757250|FG000|Overall Study|Lack of Efficacy|2|||
163014727|NCT01367886|588757250|FG000|Overall Study|Death|1|||
163014728|NCT00985504|588757255|FG000|Acute Treatment Period|Adverse Event|3|||
163014729|NCT00985504|588757256|FG001|Acute Treatment Period|Adverse Event|4|||
163014730|NCT00985504|588757255|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
163014731|NCT00985504|588757256|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
163014732|NCT00985504|588757255|FG000|Acute Treatment Period|Protocol Violation|2|||
163014733|NCT00985504|588757256|FG001|Acute Treatment Period|Protocol Violation|0|||
163014734|NCT00985504|588757255|FG000|Acute Treatment Period|Sponsor Decision|0|||
163014735|NCT00985504|588757256|FG001|Acute Treatment Period|Sponsor Decision|1|||
163062780|NCT04058717|588936945|FG001|Randomization Period|Lost to Follow-up|3|||
163062781|NCT04058717|588936946|FG002|Randomization Period|Lost to Follow-up|4|||
163062782|NCT04058717|588936947|FG003|Randomization Period|Lost to Follow-up|4|||
163062783|NCT04058717|588936944|FG000|Randomization Period|Withdrawal by Subject|1|||
163062784|NCT04058717|588936945|FG001|Randomization Period|Withdrawal by Subject|3|||
163062785|NCT04058717|588936946|FG002|Randomization Period|Withdrawal by Subject|3|||
163328469|NCT03656718|589913292|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
163328470|NCT03656718|589913293|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
163328471|NCT03656718|589913294|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
163328472|NCT03656718|589913288|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
163014736|NCT00985504|588757255|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
163014737|NCT00985504|588757256|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
163014738|NCT00985504|588757255|FG000|Optimization Period|Adverse Event|7|||
163014739|NCT00985504|588757256|FG001|Optimization Period|Adverse Event|9|||
163014740|NCT00985504|588757255|FG000|Optimization Period|Death|0|||
163014741|NCT00985504|588757256|FG001|Optimization Period|Death|1|||
163014742|NCT00985504|588757255|FG000|Optimization Period|Lack of Efficacy|5|||
163014743|NCT00985504|588757256|FG001|Optimization Period|Lack of Efficacy|3|||
163014744|NCT00985504|588757255|FG000|Optimization Period|Lost to Follow-up|0|||
163014745|NCT00985504|588757256|FG001|Optimization Period|Lost to Follow-up|1|||
163014746|NCT00985504|588757255|FG000|Optimization Period|Physician Decision|1|||
163014747|NCT00985504|588757256|FG001|Optimization Period|Physician Decision|0|||
163014748|NCT00985504|588757255|FG000|Optimization Period|Protocol Violation|3|||
163014749|NCT00985504|588757256|FG001|Optimization Period|Protocol Violation|1|||
163014750|NCT00985504|588757255|FG000|Optimization Period|Withdrawal by Subject|10|||
163014751|NCT00985504|588757256|FG001|Optimization Period|Withdrawal by Subject|8|||
163014752|NCT01167140|588757257|FG000|Overall Study|Withdrawal by Subject|1|||
163014753|NCT03805412|588757268|FG000|Overall Study|Lost to Follow-up|0|||
163014754|NCT03805412|588757269|FG001|Overall Study|Lost to Follow-up|1|||
163014755|NCT03711786|588757270|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
163014756|NCT03711786|588757271|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
163014757|NCT03711786|588757270|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
163014758|NCT03711786|588757271|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
163014759|NCT03711786|588757270|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
163014760|NCT03711786|588757271|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
163014761|NCT03711786|588757270|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
163014762|NCT03711786|588757271|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
163014763|NCT03711786|588757270|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
163014764|NCT03711786|588757271|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
163014765|NCT03711786|588757270|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
163014766|NCT03711786|588757271|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
163014767|NCT00734994|588757276|FG000|Overall Study|Withdrawal by Subject|1|||
163014768|NCT02747108|588757278|FG000|Overall Study|Death|2|||
163014769|NCT02747108|588757279|FG001|Overall Study|Death|2|||
163014770|NCT02747108|588757278|FG000|Overall Study|Withdrawal by Subject|1|||
163014771|NCT02747108|588757279|FG001|Overall Study|Withdrawal by Subject|0|||
163215399|NCT02432846|589503826|FG001|Overall Study (4 Arms/Strata)|Death|2|||
163215400|NCT02432846|589503827|FG002|Overall Study (4 Arms/Strata)|Death|4|||
163215401|NCT02432846|589503828|FG003|Overall Study (4 Arms/Strata)|Death|3|||
163014772|NCT02747108|588757278|FG000|Overall Study|Protocol Violation|2|||
163014773|NCT02747108|588757279|FG001|Overall Study|Protocol Violation|0|||
163014774|NCT03103152|588757280|FG000|Overall Study|Physician Decision|5|||
163014775|NCT03103152|588757281|FG001|Overall Study|Physician Decision|2|||
163014776|NCT03103152|588757282|FG002|Overall Study|Physician Decision|6|||
163014777|NCT03103152|588757283|FG003|Overall Study|Physician Decision|3|||
163014778|NCT03103152|588757284|FG004|Overall Study|Physician Decision|3|||
163014779|NCT03103152|588757285|FG005|Overall Study|Physician Decision|1|||
163014780|NCT03103152|588757280|FG000|Overall Study|Protocol Violation|2|||
163014781|NCT03103152|588757281|FG001|Overall Study|Protocol Violation|2|||
163014782|NCT03103152|588757282|FG002|Overall Study|Protocol Violation|1|||
163014783|NCT03103152|588757283|FG003|Overall Study|Protocol Violation|2|||
163014784|NCT03103152|588757284|FG004|Overall Study|Protocol Violation|1|||
163014785|NCT03103152|588757285|FG005|Overall Study|Protocol Violation|1|||
163014786|NCT03103152|588757280|FG000|Overall Study|Inter-current illness|0|||
163014787|NCT03103152|588757281|FG001|Overall Study|Inter-current illness|0|||
163014788|NCT03103152|588757282|FG002|Overall Study|Inter-current illness|1|||
163014789|NCT03103152|588757283|FG003|Overall Study|Inter-current illness|0|||
163215402|NCT02432846|589503829|FG004|Overall Study (4 Arms/Strata)|Death|0|||
163014790|NCT03103152|588757284|FG004|Overall Study|Inter-current illness|0|||
163014791|NCT03103152|588757285|FG005|Overall Study|Inter-current illness|0|||
163014792|NCT03103152|588757280|FG000|Overall Study|Death|0|||
163014793|NCT03103152|588757281|FG001|Overall Study|Death|1|||
163014794|NCT03103152|588757282|FG002|Overall Study|Death|0|||
163014795|NCT03103152|588757283|FG003|Overall Study|Death|0|||
163014796|NCT03103152|588757284|FG004|Overall Study|Death|0|||
163215403|NCT02432846|589503830|FG005|Overall Study (4 Arms/Strata)|Death|0|||
163014797|NCT03103152|588757285|FG005|Overall Study|Death|0|||
163014798|NCT03103152|588757280|FG000|Overall Study|Adverse Event|0|||
163014799|NCT03103152|588757281|FG001|Overall Study|Adverse Event|0|||
163014800|NCT03103152|588757282|FG002|Overall Study|Adverse Event|1|||
163014801|NCT03103152|588757283|FG003|Overall Study|Adverse Event|0|||
163215404|NCT02432846|589503825|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
163215405|NCT02432846|589503826|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
163014802|NCT03103152|588757284|FG004|Overall Study|Adverse Event|0|||
163014803|NCT03103152|588757285|FG005|Overall Study|Adverse Event|1|||
163014804|NCT03103152|588757280|FG000|Overall Study|Withdrawal by Subject|1|||
163014805|NCT03103152|588757281|FG001|Overall Study|Withdrawal by Subject|0|||
163014806|NCT03103152|588757282|FG002|Overall Study|Withdrawal by Subject|1|||
163014807|NCT03103152|588757283|FG003|Overall Study|Withdrawal by Subject|1|||
163014808|NCT03103152|588757284|FG004|Overall Study|Withdrawal by Subject|1|||
163014809|NCT03103152|588757285|FG005|Overall Study|Withdrawal by Subject|1|||
163014810|NCT03103152|588757280|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
163014811|NCT03103152|588757281|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
163014812|NCT03103152|588757282|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
163014813|NCT03103152|588757283|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
163014814|NCT03103152|588757284|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
163014815|NCT03103152|588757285|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
163014816|NCT03103152|588757280|FG000|Overall Study|Unacceptable side effects|0|||
163014817|NCT03103152|588757281|FG001|Overall Study|Unacceptable side effects|0|||
163014818|NCT03103152|588757282|FG002|Overall Study|Unacceptable side effects|0|||
163014819|NCT03103152|588757283|FG003|Overall Study|Unacceptable side effects|0|||
163014820|NCT03103152|588757284|FG004|Overall Study|Unacceptable side effects|0|||
163014821|NCT03103152|588757285|FG005|Overall Study|Unacceptable side effects|1|||
163014822|NCT03103152|588757280|FG000|Overall Study|Lost to Follow-up|0|||
163014823|NCT03103152|588757281|FG001|Overall Study|Lost to Follow-up|1|||
163014824|NCT03103152|588757282|FG002|Overall Study|Lost to Follow-up|0|||
163014825|NCT03103152|588757283|FG003|Overall Study|Lost to Follow-up|1|||
163014826|NCT03103152|588757284|FG004|Overall Study|Lost to Follow-up|0|||
163014827|NCT03103152|588757285|FG005|Overall Study|Lost to Follow-up|1|||
163014828|NCT03103152|588757280|FG000|Overall Study|Testicular pain|0|||
163014829|NCT03103152|588757281|FG001|Overall Study|Testicular pain|0|||
163014830|NCT03103152|588757282|FG002|Overall Study|Testicular pain|0|||
163014831|NCT03103152|588757283|FG003|Overall Study|Testicular pain|1|||
163014832|NCT03103152|588757284|FG004|Overall Study|Testicular pain|0|||
163014833|NCT03103152|588757285|FG005|Overall Study|Testicular pain|0|||
163014834|NCT05966584|588757286|FG000|Overall Study|Lost to Follow-up|1|||
163014835|NCT03100903|588758902|FG000|Overall Study|Withdrawal by Subject|0|||
163014836|NCT03100903|588758903|FG001|Overall Study|Withdrawal by Subject|0|||
163014837|NCT03100903|588758904|FG002|Overall Study|Withdrawal by Subject|1|||
163014838|NCT04659993|588758905|FG000|Overall Study|Withdrawal by Subject|2|||
163014839|NCT04659993|588758905|FG000|Overall Study|Lost to Follow-up|2|||
163014840|NCT06360588|588758908|FG000|Overall Study|Adverse Event|3|||
163014841|NCT06360588|588758908|FG000|Overall Study|Death|2|||
163014842|NCT06360588|588758908|FG000|Overall Study|Disease Progression|14|||
163014843|NCT06360588|588758908|FG000|Overall Study|Withdrawal by Subject|1|||
163014844|NCT06360588|588758908|FG000|Overall Study|Lack of Efficacy|1|||
163014845|NCT06360588|588758908|FG000|Overall Study|Ineligible|1|||
163014846|NCT04010240|588758909|FG000|Overall Study|IHC not performed|2299|||
163014847|NCT01481766|588758910|FG000|4 months|Lost to Follow-up|3|||
163014848|NCT01481766|588758911|FG001|4 months|Lost to Follow-up|2|||
163014849|NCT01481766|588758912|FG002|4 months|Lost to Follow-up|1|||
163014850|NCT01481766|588758913|FG003|4 months|Lost to Follow-up|5|||
163014851|NCT01481766|588758910|FG000|12 months|Lost to Follow-up|7|||
163014852|NCT01481766|588758911|FG001|12 months|Lost to Follow-up|8|||
163014853|NCT01481766|588758912|FG002|12 months|Lost to Follow-up|5|||
163328473|NCT03656718|589913289|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
163328474|NCT03656718|589913290|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
163328475|NCT03656718|589913291|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
163328476|NCT03656718|589913292|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
163328477|NCT03656718|589913293|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
163328478|NCT03656718|589913294|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
163328479|NCT03656718|589913288|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
163328480|NCT03656718|589913289|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
163014854|NCT01481766|588758913|FG003|12 months|Lost to Follow-up|3|||
163014855|NCT00347958|588758914|FG000|Overall Study|Adverse Event|1|||
163014856|NCT00347958|588758914|FG000|Overall Study|Protocol Violation|2|||
163014857|NCT00347958|588758914|FG000|Overall Study|Withdrawal by Subject|1|||
163014858|NCT00754234|588758915|FG000|Overall Study|Withdrawal by Subject|3|||
163014859|NCT00570687|588758916|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014860|NCT00570687|588758917|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014861|NCT00570687|588758918|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163328481|NCT03656718|589913290|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
163328482|NCT03656718|589913291|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
163404683|NCT02980224|590191991|FG000|Overall Study|Withdrawal by Subject|0|||
163404684|NCT02980224|590191992|FG001|Overall Study|Withdrawal by Subject|2|||
163014862|NCT00570687|588758919|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014863|NCT00570687|588758920|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
163014864|NCT00570687|588758921|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
163014865|NCT00570687|588758922|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
163014866|NCT00570687|588758923|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
163014867|NCT00570687|588758924|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
163014868|NCT00570687|588758925|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
163014869|NCT00570687|588758916|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014870|NCT00570687|588758917|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163328483|NCT03656718|589913292|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
163328484|NCT03656718|589913293|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
163328485|NCT03656718|589913294|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
163328486|NCT03656718|589913288|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
163328487|NCT03656718|589913289|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
163328488|NCT03656718|589913290|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
163328489|NCT03656718|589913291|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
163328490|NCT03656718|589913292|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
163328491|NCT03656718|589913293|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
163328492|NCT03656718|589913294|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
163328493|NCT03656718|589913288|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
163328494|NCT03656718|589913289|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
163328495|NCT03656718|589913290|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
163328496|NCT03656718|589913291|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
163014871|NCT00570687|588758918|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014872|NCT00570687|588758919|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014873|NCT00570687|588758920|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014874|NCT00570687|588758921|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014875|NCT00570687|588758922|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014876|NCT00570687|588758923|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014877|NCT00570687|588758924|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
163014878|NCT00570687|588758925|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014879|NCT00570687|588758916|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014880|NCT00570687|588758917|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014881|NCT00570687|588758918|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014882|NCT00570687|588758919|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014883|NCT00570687|588758920|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014884|NCT00570687|588758921|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014885|NCT00570687|588758922|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
163014886|NCT00570687|588758923|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014887|NCT00570687|588758924|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014888|NCT00570687|588758925|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014889|NCT03263936|588758926|FG000|Overall Study|Adverse Event|0|||
163014890|NCT03263936|588758927|FG001|Overall Study|Adverse Event|1|||
163014891|NCT03263936|588758928|FG002|Overall Study|Adverse Event|0|||
163014892|NCT03263936|588758926|FG000|Overall Study|Death|0|||
163014893|NCT03263936|588758927|FG001|Overall Study|Death|1|||
163014894|NCT03263936|588758928|FG002|Overall Study|Death|0|||
163014895|NCT00457002|588758930|FG000|Overall Study|Death|40|||
163014896|NCT00457002|588758931|FG001|Overall Study|Death|47|||
163014897|NCT00457002|588758930|FG000|Overall Study|Adverse Event|284|||
163014898|NCT00457002|588758931|FG001|Overall Study|Adverse Event|260|||
163014899|NCT00457002|588758930|FG000|Overall Study|Withdrawal by Subject|299|||
163014900|NCT00457002|588758931|FG001|Overall Study|Withdrawal by Subject|271|||
163014901|NCT00457002|588758930|FG000|Overall Study|Lost to Follow-up|72|||
163014902|NCT00457002|588758931|FG001|Overall Study|Lost to Follow-up|71|||
163014903|NCT00457002|588758930|FG000|Overall Study|Poor/Non-compliance|46|||
163014904|NCT00457002|588758931|FG001|Overall Study|Poor/Non-compliance|33|||
163014905|NCT00457002|588758930|FG000|Overall Study|No longer met criteria|41|||
163014906|NCT00457002|588758931|FG001|Overall Study|No longer met criteria|37|||
163014907|NCT00457002|588758930|FG000|Overall Study|Administrative reason by Sponsor|1|||
163014908|NCT00457002|588758931|FG001|Overall Study|Administrative reason by Sponsor|0|||
163062786|NCT04058717|588936947|FG003|Randomization Period|Withdrawal by Subject|3|||
163062787|NCT04058717|588936944|FG000|Randomization Period|PI decision|0|||
163062788|NCT04058717|588936945|FG001|Randomization Period|PI decision|1|||
163062789|NCT04058717|588936946|FG002|Randomization Period|PI decision|0|||
163062790|NCT04058717|588936947|FG003|Randomization Period|PI decision|0|||
163014909|NCT00457002|588758930|FG000|Overall Study|non-specified|29|||
163062791|NCT02799602|588936949|FG000|Overall Study|Protocol Violation|1|||
163014910|NCT00457002|588758931|FG001|Overall Study|non-specified|38|||
163062792|NCT02799602|588936950|FG001|Overall Study|Protocol Violation|0|||
163062793|NCT02799602|588936949|FG000|Overall Study|Physician Decision|5|||
163062794|NCT02799602|588936950|FG001|Overall Study|Physician Decision|6|||
163062795|NCT02799602|588936949|FG000|Overall Study|Lost to Follow-up|4|||
163062796|NCT02799602|588936950|FG001|Overall Study|Lost to Follow-up|2|||
163014911|NCT00457002|588758930|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
163014912|NCT00457002|588758931|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
163014913|NCT01623310|588758932|FG000|Overall Study|Adverse Event|21|||
163154722|NCT02435992|589281386|FG001|Overall Study|Other Reason|0|||
163014914|NCT01623310|588758932|FG000|Overall Study|Lost to Follow-up|18|||
163014915|NCT01623310|588758932|FG000|Overall Study|Lack of Efficacy|6|||
163014916|NCT01623310|588758932|FG000|Overall Study|Protocol Violation|6|||
163014917|NCT01623310|588758932|FG000|Overall Study|Withdrawal by Subject|25|||
163014918|NCT01623310|588758932|FG000|Overall Study|Became potentially child-bearing|1|||
163014919|NCT01623310|588758932|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
163014920|NCT01623310|588758932|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
163014921|NCT00454246|588758933|FG000|Overall Study|Adverse Event|2|||
163014922|NCT00454246|588758934|FG001|Overall Study|Adverse Event|2|||
163014923|NCT00454246|588758935|FG002|Overall Study|Adverse Event|0|||
163014924|NCT00454246|588758933|FG000|Overall Study|Violation of selection criteria at entry|6|||
163014925|NCT00454246|588758934|FG001|Overall Study|Violation of selection criteria at entry|0|||
163014926|NCT00454246|588758935|FG002|Overall Study|Violation of selection criteria at entry|0|||
163014927|NCT00454246|588758933|FG000|Overall Study|Protocol Violation|1|||
163014928|NCT00454246|588758934|FG001|Overall Study|Protocol Violation|0|||
163014929|NCT00454246|588758935|FG002|Overall Study|Protocol Violation|0|||
163014930|NCT00454246|588758933|FG000|Overall Study|Refused Treatment|1|||
163014931|NCT00454246|588758934|FG001|Overall Study|Refused Treatment|1|||
163014932|NCT00454246|588758935|FG002|Overall Study|Refused Treatment|0|||
163014933|NCT00454246|588758933|FG000|Overall Study|Failure to return|1|||
163014934|NCT00454246|588758934|FG001|Overall Study|Failure to return|0|||
163014935|NCT00454246|588758935|FG002|Overall Study|Failure to return|0|||
163014936|NCT00454246|588758933|FG000|Overall Study|Early termination of study|62|||
163014937|NCT00454246|588758934|FG001|Overall Study|Early termination of study|26|||
163014938|NCT00454246|588758935|FG002|Overall Study|Early termination of study|9|||
163014939|NCT00356603|588758936|FG000|Overall Study|Other|6|||
163014940|NCT00356603|588758937|FG001|Overall Study|Other|3|||
163014941|NCT05326529|588758938|FG000|Overall Study|Lack of Efficacy|0|||
163014942|NCT05326529|588758939|FG001|Overall Study|Lack of Efficacy|1|||
163014943|NCT05326529|588758940|FG002|Overall Study|Lack of Efficacy|0|||
163014944|NCT05326529|588758938|FG000|Overall Study|Physician Decision|0|||
163014945|NCT05326529|588758939|FG001|Overall Study|Physician Decision|0|||
163014946|NCT05326529|588758940|FG002|Overall Study|Physician Decision|2|||
163014947|NCT01262287|588758942|FG000|Overall Study|Lost to Follow-up|2|||
163014948|NCT01262287|588758943|FG001|Overall Study|Lost to Follow-up|1|||
163014949|NCT00932373|588758944|FG000|Overall Study|Progressive disease|3|||
163014950|NCT00932373|588758945|FG001|Overall Study|Progressive disease|1|||
163014951|NCT00932373|588758946|FG002|Overall Study|Progressive disease|0|||
163014952|NCT00932373|588758947|FG003|Overall Study|Progressive disease|0|||
163014953|NCT00932373|588758948|FG004|Overall Study|Progressive disease|10|||
163062797|NCT02799602|588936949|FG000|Overall Study|Additional primary malignancy|11|||
163328497|NCT03656718|589913292|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
163328498|NCT03656718|589913293|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
163328499|NCT03656718|589913294|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
163328500|NCT03656718|589913288|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
163328501|NCT03656718|589913289|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
163328502|NCT03656718|589913290|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
163328503|NCT03656718|589913291|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
163328504|NCT03656718|589913292|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
163328505|NCT03656718|589913293|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
163328506|NCT03656718|589913294|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
163328507|NCT03656718|589913288|FG000|Treatment Period Part C|Disease progression|0|||
163404685|NCT00879645|590191993|FG000|Overall Study|Adverse Event|1|||
163404686|NCT00879645|590191994|FG001|Overall Study|Adverse Event|0|||
163404687|NCT00879645|590191995|FG002|Overall Study|Adverse Event|0|||
163014954|NCT00932373|588758949|FG005|Overall Study|Progressive disease|1|||
163014955|NCT00932373|588758950|FG006|Overall Study|Progressive disease|0|||
163014956|NCT00932373|588758951|FG007|Overall Study|Progressive disease|2|||
163014957|NCT00932373|588758952|FG008|Overall Study|Progressive disease|1|||
163014958|NCT00932373|588758953|FG009|Overall Study|Progressive disease|9|||
163014959|NCT00932373|588758954|FG010|Overall Study|Progressive disease|2|||
163014960|NCT00932373|588758944|FG000|Overall Study|Adverse Event|0|||
163014961|NCT00932373|588758945|FG001|Overall Study|Adverse Event|0|||
163014962|NCT00932373|588758946|FG002|Overall Study|Adverse Event|0|||
163014963|NCT00932373|588758947|FG003|Overall Study|Adverse Event|0|||
163014964|NCT00932373|588758948|FG004|Overall Study|Adverse Event|2|||
163014965|NCT00932373|588758949|FG005|Overall Study|Adverse Event|1|||
163014966|NCT00932373|588758950|FG006|Overall Study|Adverse Event|0|||
163014967|NCT00932373|588758951|FG007|Overall Study|Adverse Event|1|||
163014968|NCT00932373|588758952|FG008|Overall Study|Adverse Event|0|||
163014969|NCT00932373|588758953|FG009|Overall Study|Adverse Event|2|||
163014970|NCT00932373|588758954|FG010|Overall Study|Adverse Event|1|||
163014971|NCT00932373|588758944|FG000|Overall Study|Physician Decision|0|||
163014972|NCT00932373|588758945|FG001|Overall Study|Physician Decision|0|||
163014973|NCT00932373|588758946|FG002|Overall Study|Physician Decision|1|||
163014974|NCT00932373|588758947|FG003|Overall Study|Physician Decision|0|||
163014975|NCT00932373|588758948|FG004|Overall Study|Physician Decision|2|||
163014976|NCT00932373|588758949|FG005|Overall Study|Physician Decision|0|||
163014977|NCT00932373|588758950|FG006|Overall Study|Physician Decision|0|||
163014978|NCT00932373|588758951|FG007|Overall Study|Physician Decision|0|||
163014979|NCT00932373|588758952|FG008|Overall Study|Physician Decision|0|||
163014980|NCT00932373|588758953|FG009|Overall Study|Physician Decision|1|||
163014981|NCT00932373|588758954|FG010|Overall Study|Physician Decision|0|||
163014982|NCT00932373|588758944|FG000|Overall Study|Dose limiting toxicity|0|||
163014983|NCT00932373|588758945|FG001|Overall Study|Dose limiting toxicity|0|||
163014984|NCT00932373|588758946|FG002|Overall Study|Dose limiting toxicity|0|||
163014985|NCT00932373|588758947|FG003|Overall Study|Dose limiting toxicity|0|||
163014986|NCT00932373|588758948|FG004|Overall Study|Dose limiting toxicity|0|||
163014987|NCT00932373|588758949|FG005|Overall Study|Dose limiting toxicity|1|||
163014988|NCT00932373|588758950|FG006|Overall Study|Dose limiting toxicity|0|||
163014989|NCT00932373|588758951|FG007|Overall Study|Dose limiting toxicity|0|||
163014990|NCT00932373|588758952|FG008|Overall Study|Dose limiting toxicity|0|||
163014991|NCT00932373|588758953|FG009|Overall Study|Dose limiting toxicity|0|||
163014992|NCT00932373|588758954|FG010|Overall Study|Dose limiting toxicity|0|||
163014993|NCT00932373|588758944|FG000|Overall Study|Withdrawal by Subject|0|||
163014994|NCT00932373|588758945|FG001|Overall Study|Withdrawal by Subject|0|||
163014995|NCT00932373|588758946|FG002|Overall Study|Withdrawal by Subject|0|||
163014996|NCT00932373|588758947|FG003|Overall Study|Withdrawal by Subject|0|||
163014997|NCT00932373|588758948|FG004|Overall Study|Withdrawal by Subject|0|||
163014998|NCT00932373|588758949|FG005|Overall Study|Withdrawal by Subject|0|||
163014999|NCT00932373|588758950|FG006|Overall Study|Withdrawal by Subject|0|||
163015000|NCT00932373|588758951|FG007|Overall Study|Withdrawal by Subject|0|||
163015001|NCT00932373|588758952|FG008|Overall Study|Withdrawal by Subject|1|||
163015002|NCT00932373|588758953|FG009|Overall Study|Withdrawal by Subject|0|||
163015003|NCT00932373|588758954|FG010|Overall Study|Withdrawal by Subject|0|||
163015004|NCT00932373|588758944|FG000|Overall Study|Clinical progression|0|||
163015005|NCT00932373|588758945|FG001|Overall Study|Clinical progression|0|||
163015006|NCT00932373|588758946|FG002|Overall Study|Clinical progression|0|||
163015007|NCT00932373|588758947|FG003|Overall Study|Clinical progression|0|||
163015008|NCT00932373|588758948|FG004|Overall Study|Clinical progression|0|||
163015009|NCT00932373|588758949|FG005|Overall Study|Clinical progression|0|||
163015010|NCT00932373|588758950|FG006|Overall Study|Clinical progression|1|||
163015011|NCT00932373|588758951|FG007|Overall Study|Clinical progression|0|||
163015012|NCT00932373|588758952|FG008|Overall Study|Clinical progression|0|||
163015013|NCT00932373|588758953|FG009|Overall Study|Clinical progression|0|||
163015014|NCT00932373|588758954|FG010|Overall Study|Clinical progression|0|||
163015015|NCT00932373|588758944|FG000|Overall Study|Lack of Efficacy|0|||
163015016|NCT00932373|588758945|FG001|Overall Study|Lack of Efficacy|0|||
163015017|NCT00932373|588758946|FG002|Overall Study|Lack of Efficacy|0|||
163015018|NCT00932373|588758947|FG003|Overall Study|Lack of Efficacy|0|||
163015019|NCT00932373|588758948|FG004|Overall Study|Lack of Efficacy|0|||
163015020|NCT00932373|588758949|FG005|Overall Study|Lack of Efficacy|0|||
163015021|NCT00932373|588758950|FG006|Overall Study|Lack of Efficacy|0|||
163015022|NCT00932373|588758951|FG007|Overall Study|Lack of Efficacy|0|||
163015023|NCT00932373|588758952|FG008|Overall Study|Lack of Efficacy|0|||
163015024|NCT00932373|588758953|FG009|Overall Study|Lack of Efficacy|1|||
163015025|NCT00932373|588758954|FG010|Overall Study|Lack of Efficacy|0|||
163015026|NCT04134767|588758957|FG000|Overall Study|Death|0|||
163015027|NCT04134767|588758958|FG001|Overall Study|Death|1|||
163015028|NCT04134767|588758957|FG000|Overall Study|Removed for harassing staff|0|||
163015029|NCT04134767|588758958|FG001|Overall Study|Removed for harassing staff|1|||
163015030|NCT04134767|588758957|FG000|Overall Study|Lost to Follow-up|44|||
163328508|NCT03656718|589913289|FG001|Treatment Period Part C|Disease progression|0|||
163328509|NCT03656718|589913290|FG002|Treatment Period Part C|Disease progression|0|||
163328510|NCT03656718|589913291|FG003|Treatment Period Part C|Disease progression|0|||
163328511|NCT03656718|589913292|FG004|Treatment Period Part C|Disease progression|12|||
163015031|NCT04134767|588758958|FG001|Overall Study|Lost to Follow-up|40|||
163015032|NCT01163851|588758966|FG000|Overall Study|Site Closure|0|||
163015033|NCT01163851|588758967|FG001|Overall Study|Site Closure|1|||
163015034|NCT01163851|588758966|FG000|Overall Study|Enrolled but not treated|1|||
163328512|NCT03656718|589913293|FG005|Treatment Period Part C|Disease progression|0|||
163015035|NCT01163851|588758967|FG001|Overall Study|Enrolled but not treated|0|||
163015036|NCT00789373|588758971|FG000|Induction|Adverse Event|64|||
163015037|NCT00789373|588758972|FG001|Induction|Adverse Event|0|||
163015038|NCT00789373|588758973|FG002|Induction|Adverse Event|0|||
163015039|NCT00789373|588758971|FG000|Induction|Death Due to study disease|24|||
163015040|NCT00789373|588758972|FG001|Induction|Death Due to study disease|0|||
163015041|NCT00789373|588758973|FG002|Induction|Death Due to study disease|0|||
163015042|NCT00789373|588758971|FG000|Induction|Death due to adverse event|19|||
163015043|NCT00789373|588758972|FG001|Induction|Death due to adverse event|0|||
163015044|NCT00789373|588758973|FG002|Induction|Death due to adverse event|0|||
163015045|NCT00789373|588758971|FG000|Induction|Death due to toxicity|11|||
163328513|NCT03656718|589913294|FG006|Treatment Period Part C|Disease progression|0|||
163215406|NCT02432846|589503827|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
163215407|NCT02432846|589503828|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
163215408|NCT02432846|589503829|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
163215409|NCT02432846|589503830|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
163215410|NCT02432846|589503825|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
163215411|NCT02432846|589503826|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
163215412|NCT02432846|589503827|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
163215413|NCT02432846|589503828|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
163215414|NCT02432846|589503829|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
163215415|NCT02432846|589503830|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
163215416|NCT02432846|589503825|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
163215417|NCT02432846|589503826|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
163215418|NCT02432846|589503827|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
163215419|NCT02432846|589503828|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
163215420|NCT02432846|589503829|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
163215421|NCT02432846|589503830|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
163215422|NCT02432846|589503825|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
163328514|NCT03656718|589913288|FG000|Treatment Period Part C|Death|0|||
163015046|NCT00789373|588758972|FG001|Induction|Death due to toxicity|0|||
163015047|NCT00789373|588758973|FG002|Induction|Death due to toxicity|0|||
163015048|NCT00789373|588758971|FG000|Induction|Death due to procedure|1|||
163015049|NCT00789373|588758972|FG001|Induction|Death due to procedure|0|||
163015050|NCT00789373|588758973|FG002|Induction|Death due to procedure|0|||
163015051|NCT00789373|588758971|FG000|Induction|Investigator decision|7|||
163015052|NCT00789373|588758972|FG001|Induction|Investigator decision|0|||
163015053|NCT00789373|588758973|FG002|Induction|Investigator decision|0|||
163015054|NCT00789373|588758971|FG000|Induction|Protocol entry criteria not met|9|||
163015055|NCT00789373|588758972|FG001|Induction|Protocol entry criteria not met|0|||
163015056|NCT00789373|588758973|FG002|Induction|Protocol entry criteria not met|0|||
163015057|NCT00789373|588758971|FG000|Induction|Lost to Follow-up|6|||
163015058|NCT00789373|588758972|FG001|Induction|Lost to Follow-up|0|||
163015059|NCT00789373|588758973|FG002|Induction|Lost to Follow-up|0|||
163015060|NCT00789373|588758971|FG000|Induction|Protocol Violation|1|||
163015061|NCT00789373|588758972|FG001|Induction|Protocol Violation|0|||
163015062|NCT00789373|588758973|FG002|Induction|Protocol Violation|0|||
163015063|NCT00789373|588758971|FG000|Induction|Progressive Disease|220|||
163015064|NCT00789373|588758972|FG001|Induction|Progressive Disease|0|||
163015065|NCT00789373|588758973|FG002|Induction|Progressive Disease|0|||
163015066|NCT00789373|588758971|FG000|Induction|Withdrawal by Subject|37|||
163015067|NCT00789373|588758972|FG001|Induction|Withdrawal by Subject|0|||
163015068|NCT00789373|588758973|FG002|Induction|Withdrawal by Subject|0|||
163015069|NCT00789373|588758971|FG000|Maintenance|Adverse Event|0|||
163015070|NCT00789373|588758972|FG001|Maintenance|Adverse Event|65|||
163015071|NCT00789373|588758973|FG002|Maintenance|Adverse Event|12|||
163015072|NCT00789373|588758971|FG000|Maintenance|Death due to study disease|0|||
163015073|NCT00789373|588758972|FG001|Maintenance|Death due to study disease|3|||
163015074|NCT00789373|588758973|FG002|Maintenance|Death due to study disease|1|||
163015075|NCT00789373|588758971|FG000|Maintenance|Death due to adverse event|0|||
163015076|NCT00789373|588758972|FG001|Maintenance|Death due to adverse event|4|||
163015077|NCT00789373|588758973|FG002|Maintenance|Death due to adverse event|1|||
163015078|NCT00789373|588758971|FG000|Maintenance|Death due to toxicity|0|||
163015079|NCT00789373|588758972|FG001|Maintenance|Death due to toxicity|1|||
163015080|NCT00789373|588758973|FG002|Maintenance|Death due to toxicity|2|||
163015081|NCT00789373|588758971|FG000|Maintenance|Investigator Decision|0|||
163062798|NCT02799602|588936950|FG001|Overall Study|Additional primary malignancy|6|||
163215423|NCT02432846|589503826|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
163215424|NCT02432846|589503827|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
163215425|NCT02432846|589503828|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
163215426|NCT02432846|589503829|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
163328515|NCT03656718|589913289|FG001|Treatment Period Part C|Death|0|||
163328516|NCT03656718|589913290|FG002|Treatment Period Part C|Death|0|||
163328517|NCT03656718|589913291|FG003|Treatment Period Part C|Death|0|||
163015082|NCT00789373|588758972|FG001|Maintenance|Investigator Decision|4|||
163015083|NCT00789373|588758973|FG002|Maintenance|Investigator Decision|2|||
163015084|NCT00789373|588758971|FG000|Maintenance|Protocol entry criteria not met|0|||
163015085|NCT00789373|588758972|FG001|Maintenance|Protocol entry criteria not met|2|||
163015086|NCT00789373|588758973|FG002|Maintenance|Protocol entry criteria not met|0|||
163015087|NCT00789373|588758971|FG000|Maintenance|Lost to Follow-up|0|||
163015088|NCT00789373|588758972|FG001|Maintenance|Lost to Follow-up|2|||
163015089|NCT00789373|588758973|FG002|Maintenance|Lost to Follow-up|0|||
163015090|NCT00789373|588758971|FG000|Maintenance|Progressive Disease|0|||
163015091|NCT00789373|588758972|FG001|Maintenance|Progressive Disease|253|||
163215427|NCT02432846|589503830|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
163215428|NCT02432846|589503825|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
163328518|NCT03656718|589913292|FG004|Treatment Period Part C|Death|1|||
163015092|NCT00789373|588758973|FG002|Maintenance|Progressive Disease|152|||
163015093|NCT00789373|588758971|FG000|Maintenance|Withdrawal by Subject|0|||
163015094|NCT00789373|588758972|FG001|Maintenance|Withdrawal by Subject|21|||
163015095|NCT00789373|588758973|FG002|Maintenance|Withdrawal by Subject|8|||
163015096|NCT00789373|588758971|FG000|Maintenance|Sponsor Decision|0|||
163015097|NCT00789373|588758972|FG001|Maintenance|Sponsor Decision|0|||
163015098|NCT00789373|588758973|FG002|Maintenance|Sponsor Decision|2|||
163015099|NCT00789373|588758971|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
163015100|NCT00789373|588758972|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
163015101|NCT00789373|588758973|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
163015102|NCT02268916|588758996|FG000|Overall Study|Lost to Follow-up|1|||
163015103|NCT02268916|588758997|FG001|Overall Study|Lost to Follow-up|1|||
163015104|NCT02268916|588758996|FG000|Overall Study|Withdrawal by Subject|6|||
163015105|NCT02268916|588758997|FG001|Overall Study|Withdrawal by Subject|5|||
163015106|NCT02268916|588758996|FG000|Overall Study|Participant did not have diabetes|1|||
163015107|NCT02268916|588758997|FG001|Overall Study|Participant did not have diabetes|0|||
163015108|NCT02268916|588758996|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
163015109|NCT02268916|588758997|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
163015110|NCT00594165|588759002|FG000|Overall Study|Major protocol violation|1|||
163015111|NCT00594165|588759002|FG000|Overall Study|Lack of Efficacy|12|||
163015112|NCT00594165|588759002|FG000|Overall Study|Adverse Event|52|||
163015113|NCT00594165|588759002|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
163015114|NCT00594165|588759002|FG000|Overall Study|Subject withdrew consent|27|||
163015115|NCT00594165|588759002|FG000|Overall Study|Study ended per sponsor|102|||
163015116|NCT00594165|588759002|FG000|Overall Study|Lost to Follow-up|4|||
163015117|NCT00594165|588759002|FG000|Overall Study|Other: PI discretion|5|||
163015118|NCT00594165|588759002|FG000|Overall Study|Other: Subject moving|3|||
163015119|NCT00594165|588759002|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
163015120|NCT00594165|588759002|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
163015121|NCT00594165|588759002|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
163015122|NCT00594165|588759002|FG000|Overall Study|Other: Site terminated participation|2|||
163015123|NCT04830969|588759003|FG000|Overall Study|Withdrawal by Subject|6|||
163015124|NCT04830969|588759004|FG001|Overall Study|Withdrawal by Subject|2|||
163015125|NCT04830969|588759003|FG000|Overall Study|Protocol Violation|3|||
163015126|NCT04830969|588759004|FG001|Overall Study|Protocol Violation|9|||
163015127|NCT04830969|588759003|FG000|Overall Study|Lost to Follow-up|4|||
163015128|NCT04830969|588759004|FG001|Overall Study|Lost to Follow-up|4|||
163015129|NCT02097745|588759007|FG000|Overall Study|Adverse Event|25|||
163015130|NCT02097745|588759007|FG000|Overall Study|Death|16|||
163015131|NCT02097745|588759007|FG000|Overall Study|Failure to Return|14|||
163015132|NCT02097745|588759007|FG000|Overall Study|Administrative/Other|27|||
163015133|NCT02097745|588759007|FG000|Overall Study|Reason Not Specified|96|||
163015134|NCT02748356|588759008|FG000|Overall Study|Withdrawal by Subject|1|||
163015135|NCT00425750|588759009|FG000|Overall Study|Death|1|||
163015136|NCT00425750|588759009|FG000|Overall Study|Withdrawal by Subject|3|||
163015137|NCT00425750|588759009|FG000|Overall Study|Adverse Event|3|||
163015138|NCT00425750|588759009|FG000|Overall Study|Progression of disease|18|||
163015139|NCT00996125|588759010|FG000|Overall Study|Adverse Event|0|||
163015140|NCT00996125|588759011|FG001|Overall Study|Adverse Event|2|||
163015141|NCT00996125|588759010|FG000|Overall Study|Lost to Follow-up|1|||
163015142|NCT00996125|588759011|FG001|Overall Study|Lost to Follow-up|6|||
163328519|NCT03656718|589913293|FG005|Treatment Period Part C|Death|0|||
163328520|NCT03656718|589913294|FG006|Treatment Period Part C|Death|0|||
163328521|NCT03656718|589913288|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
163328522|NCT03656718|589913289|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
163328523|NCT03656718|589913290|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
163328524|NCT03656718|589913291|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
163328525|NCT03656718|589913292|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
163015143|NCT00996125|588759010|FG000|Overall Study|Withdrawal by Subject|4|||
163015144|NCT00996125|588759011|FG001|Overall Study|Withdrawal by Subject|3|||
163015145|NCT04331067|588759012|FG000|Overall Study|Adverse Event|1|||
163062799|NCT02799602|588936949|FG000|Overall Study|Non-compliance with study drug|14|||
163062800|NCT02799602|588936950|FG001|Overall Study|Non-compliance with study drug|12|||
163328526|NCT03656718|589913293|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
163015146|NCT04331067|588759013|FG001|Overall Study|Adverse Event|3|||
163015147|NCT04331067|588759014|FG002|Overall Study|Adverse Event|1|||
163015148|NCT04331067|588759012|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
163015149|NCT04331067|588759013|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
163015150|NCT04331067|588759014|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
163015151|NCT05236764|588759015|FG000|Overall Study|In follow up (ongoing)|1|||
163015152|NCT05236764|588759015|FG000|Overall Study|Taken off study - secondary graft failure|1|||
163015153|NCT05236764|588759015|FG000|Overall Study|Death|1|||
163215429|NCT02432846|589503826|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
163215430|NCT02432846|589503827|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
163215431|NCT02432846|589503828|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
163215432|NCT02432846|589503829|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
163015154|NCT02062450|588759021|FG000|Overall Study|No follow-up visit|124|||
163015155|NCT01796392|588759022|FG000|Overall Study|Withdrawal by Subject|2|||
163015156|NCT01796392|588759023|FG001|Overall Study|Withdrawal by Subject|0|||
163015157|NCT01796392|588759022|FG000|Overall Study|Death|5|||
163015158|NCT01796392|588759023|FG001|Overall Study|Death|1|||
163015159|NCT01796392|588759022|FG000|Overall Study|Excluded for medical reasons|1|||
163015160|NCT01796392|588759023|FG001|Overall Study|Excluded for medical reasons|2|||
163015161|NCT01796392|588759022|FG000|Overall Study|Lost to Follow-up|1|||
163015162|NCT01796392|588759023|FG001|Overall Study|Lost to Follow-up|0|||
163015163|NCT03482635|588759024|FG000|Overall Study|Lack of Efficacy|0|||
163015164|NCT03482635|588759025|FG001|Overall Study|Lack of Efficacy|0|||
163015165|NCT03482635|588759026|FG002|Overall Study|Lack of Efficacy|1|||
163015166|NCT03482635|588759027|FG003|Overall Study|Lack of Efficacy|3|||
163015167|NCT03482635|588759024|FG000|Overall Study|Adverse Event|2|||
163015168|NCT03482635|588759025|FG001|Overall Study|Adverse Event|2|||
163015169|NCT03482635|588759026|FG002|Overall Study|Adverse Event|0|||
163015170|NCT03482635|588759027|FG003|Overall Study|Adverse Event|3|||
163015171|NCT03482635|588759024|FG000|Overall Study|Withdrawal by Subject|2|||
163015172|NCT03482635|588759025|FG001|Overall Study|Withdrawal by Subject|1|||
163015173|NCT03482635|588759026|FG002|Overall Study|Withdrawal by Subject|0|||
163015174|NCT03482635|588759027|FG003|Overall Study|Withdrawal by Subject|1|||
163015175|NCT03482635|588759024|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
163015176|NCT03482635|588759025|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
163015177|NCT03482635|588759026|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
163015178|NCT03482635|588759027|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
163015179|NCT03482635|588759024|FG000|Overall Study|Not treated|0|||
163015180|NCT03482635|588759025|FG001|Overall Study|Not treated|0|||
163015181|NCT03482635|588759026|FG002|Overall Study|Not treated|0|||
163015182|NCT03482635|588759027|FG003|Overall Study|Not treated|1|||
163154723|NCT02435992|589281387|FG002|Overall Study|Other Reason|0|||
163154724|NCT02435992|589281388|FG003|Overall Study|Other Reason|0|||
163154725|NCT02435992|589281389|FG004|Overall Study|Other Reason|0|||
163154726|NCT02435992|589281385|FG000|Overall Study|Physician Decision|0|||
163154727|NCT02435992|589281386|FG001|Overall Study|Physician Decision|0|||
163154728|NCT02435992|589281387|FG002|Overall Study|Physician Decision|1|||
163154729|NCT02435992|589281388|FG003|Overall Study|Physician Decision|0|||
163154730|NCT02435992|589281389|FG004|Overall Study|Physician Decision|0|||
163154731|NCT01210313|589281406|FG000|Overall Study|Withdrawal by Subject|3|||
163154732|NCT01210313|589281406|FG000|Overall Study|Adverse Event|2|||
163154733|NCT01210313|589281406|FG000|Overall Study|Distant recurrence|4|||
163154734|NCT01210313|589281406|FG000|Overall Study|Non-compliance|7|||
163154735|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
163154736|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
163154737|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
163154738|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
163154739|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
163154740|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
163154741|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
163154742|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
163154743|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
163154744|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
163154745|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
163154746|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
163154747|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
163154748|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
163154749|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
163154750|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
163154751|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
163154752|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
163154753|NCT03773978|589281411|FG000|DBW Period|Adverse Event|2|||
163154754|NCT03773978|589281412|FG001|DBW Period|Adverse Event|2|||
163154755|NCT03773978|589281411|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
163154756|NCT03773978|589281412|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
163154757|NCT03773978|589281411|FG000|DBW Period|Withdrawal by Subject|2|||
163154758|NCT03773978|589281412|FG001|DBW Period|Withdrawal by Subject|1|||
163154759|NCT03773978|589281411|FG000|DBW Period|Due to epidemic or pandemic|5|||
163154760|NCT03773978|589281412|FG001|DBW Period|Due to epidemic or pandemic|6|||
163154761|NCT03773978|589281411|FG000|DBW Period|Study team decision|1|||
163154762|NCT03773978|589281412|FG001|DBW Period|Study team decision|0|||
163215433|NCT02432846|589503830|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
163215434|NCT02432846|589503825|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
163215435|NCT02432846|589503826|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
163215436|NCT02432846|589503827|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
163215437|NCT02432846|589503828|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
163015183|NCT04639219|588759028|FG000|Overall Study|Withdrawal by Subject|8|||
163015184|NCT04639219|588759028|FG000|Overall Study|Lost to Follow-up|6|||
163015185|NCT04639219|588759028|FG000|Overall Study|Death|55|||
163015186|NCT04681066|588759029|FG000|Overall Study|Lost to Follow-up|3|||
163015187|NCT04681066|588759030|FG001|Overall Study|Lost to Follow-up|1|||
163015188|NCT04681066|588759031|FG002|Overall Study|Lost to Follow-up|2|||
163015189|NCT04681066|588759032|FG003|Overall Study|Lost to Follow-up|1|||
163015190|NCT04681066|588759029|FG000|Overall Study|Withdrawal by Subject|2|||
163015191|NCT04681066|588759030|FG001|Overall Study|Withdrawal by Subject|1|||
163015192|NCT04681066|588759031|FG002|Overall Study|Withdrawal by Subject|0|||
163015193|NCT04681066|588759032|FG003|Overall Study|Withdrawal by Subject|3|||
163015194|NCT04681066|588759029|FG000|Overall Study|Death|0|||
163015195|NCT04681066|588759030|FG001|Overall Study|Death|1|||
163015196|NCT04681066|588759031|FG002|Overall Study|Death|0|||
163015197|NCT04681066|588759032|FG003|Overall Study|Death|0|||
163015198|NCT04495829|588759033|FG000|Overall Study|Lost to Follow-up|2|||
163015199|NCT04495829|588759033|FG000|Overall Study|Inclusion criterion not met|3|||
163015200|NCT01205269|588759042|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
163015201|NCT01205269|588759043|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
163015202|NCT01205269|588759044|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
163215438|NCT02432846|589503829|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
163215439|NCT02432846|589503830|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
163328527|NCT03656718|589913294|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
163328528|NCT03656718|589913288|FG000|Treatment Period Part C|Other reasons|0|||
163328529|NCT03656718|589913289|FG001|Treatment Period Part C|Other reasons|0|||
163328530|NCT03656718|589913290|FG002|Treatment Period Part C|Other reasons|0|||
163328531|NCT03656718|589913291|FG003|Treatment Period Part C|Other reasons|0|||
163328532|NCT03656718|589913292|FG004|Treatment Period Part C|Other reasons|1|||
163328533|NCT03656718|589913293|FG005|Treatment Period Part C|Other reasons|0|||
163328534|NCT03656718|589913294|FG006|Treatment Period Part C|Other reasons|0|||
163328535|NCT03656718|589913288|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
163328536|NCT03656718|589913289|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
163328537|NCT03656718|589913290|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
163328538|NCT03656718|589913291|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
163328539|NCT03656718|589913292|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
163328540|NCT03656718|589913293|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
163328541|NCT03656718|589913294|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
163328542|NCT06191679|589913295|FG000|Baseline|Lost to Follow-up|1|||
163328543|NCT06191679|589913296|FG001|Baseline|Lost to Follow-up|0|||
163328544|NCT06191679|589913297|FG002|Baseline|Lost to Follow-up|1|||
163328545|NCT06191679|589913298|FG003|Baseline|Lost to Follow-up|0|||
163328546|NCT06191679|589913295|FG000|Allocation to Group|Withdrawal by Subject|0|||
163328547|NCT06191679|589913296|FG001|Allocation to Group|Withdrawal by Subject|1|||
163328548|NCT06191679|589913297|FG002|Allocation to Group|Withdrawal by Subject|2|||
163328549|NCT06191679|589913298|FG003|Allocation to Group|Withdrawal by Subject|0|||
163328550|NCT06191679|589913295|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
163328551|NCT06191679|589913296|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
163328552|NCT06191679|589913297|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
163328553|NCT06191679|589913298|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
163328554|NCT06191679|589913295|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
163328555|NCT06191679|589913296|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
163328556|NCT06191679|589913297|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
163328557|NCT06191679|589913298|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
163328558|NCT06191679|589913295|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
163328559|NCT06191679|589913296|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
163328560|NCT06191679|589913297|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
163015203|NCT01205269|588759045|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
163215440|NCT02432846|589503825|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
163215441|NCT02432846|589503826|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
163328561|NCT06191679|589913298|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
163015204|NCT01205269|588759046|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
163015205|NCT01205269|588759047|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
163015206|NCT00987337|588759048|FG000|Overall Study|Adverse Event|10|||
163015207|NCT00987337|588759049|FG001|Overall Study|Adverse Event|9|||
163015208|NCT00987337|588759050|FG002|Overall Study|Adverse Event|8|||
163015209|NCT00987337|588759048|FG000|Overall Study|Insufficient Virologic Response|10|||
163015210|NCT00987337|588759049|FG001|Overall Study|Insufficient Virologic Response|7|||
163015211|NCT00987337|588759050|FG002|Overall Study|Insufficient Virologic Response|12|||
163015212|NCT00987337|588759048|FG000|Overall Study|Virologic Breakthrough|2|||
163015213|NCT00987337|588759049|FG001|Overall Study|Virologic Breakthrough|2|||
163015214|NCT00987337|588759050|FG002|Overall Study|Virologic Breakthrough|8|||
163015215|NCT00987337|588759048|FG000|Overall Study|Lost to Follow-up|10|||
163015216|NCT00987337|588759049|FG001|Overall Study|Lost to Follow-up|6|||
163015217|NCT00987337|588759050|FG002|Overall Study|Lost to Follow-up|2|||
163015218|NCT00987337|588759048|FG000|Overall Study|Withdrawal by Subject|6|||
163015219|NCT00987337|588759049|FG001|Overall Study|Withdrawal by Subject|9|||
163015220|NCT00987337|588759050|FG002|Overall Study|Withdrawal by Subject|9|||
163015221|NCT00987337|588759048|FG000|Overall Study|Other|0|||
163015222|NCT00987337|588759049|FG001|Overall Study|Other|2|||
163015223|NCT00987337|588759050|FG002|Overall Study|Other|5|||
163015224|NCT00987337|588759048|FG000|Overall Study|Protocol Violation|1|||
163015225|NCT00987337|588759049|FG001|Overall Study|Protocol Violation|0|||
163015226|NCT00987337|588759050|FG002|Overall Study|Protocol Violation|2|||
163015227|NCT00987337|588759048|FG000|Overall Study|Participant Relapsed|18|||
163015228|NCT00987337|588759049|FG001|Overall Study|Participant Relapsed|20|||
163015229|NCT00987337|588759050|FG002|Overall Study|Participant Relapsed|5|||
163015230|NCT03868930|588760746|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
163015231|NCT03868930|588760747|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
163015232|NCT03868930|588760746|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
163015233|NCT03868930|588760747|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
163015234|NCT03868930|588760746|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
163015235|NCT03868930|588760747|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
163015236|NCT03868930|588760746|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
163062801|NCT02799602|588936949|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
163062802|NCT02799602|588936950|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
163062803|NCT02799602|588936949|FG000|Overall Study|Withdrawal by Subject|26|||
163062804|NCT02799602|588936950|FG001|Overall Study|Withdrawal by Subject|40|||
163062805|NCT02799602|588936949|FG000|Overall Study|Progressive disease - clinical progression|131|||
163062806|NCT02799602|588936950|FG001|Overall Study|Progressive disease - clinical progression|276|||
163062807|NCT02799602|588936949|FG000|Overall Study|Progressive disease - radiological progression|90|||
163062808|NCT02799602|588936950|FG001|Overall Study|Progressive disease - radiological progression|133|||
163062809|NCT02799602|588936949|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
163062810|NCT02799602|588936950|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
163062811|NCT02799602|588936949|FG000|Overall Study|Death|9|||
163062812|NCT02799602|588936950|FG001|Overall Study|Death|5|||
163062813|NCT02799602|588936949|FG000|Overall Study|Other|287|||
163062814|NCT02799602|588936950|FG001|Overall Study|Other|118|||
163062815|NCT02799602|588936949|FG000|Overall Study|Study drug never administered|0|||
163062816|NCT02799602|588936950|FG001|Overall Study|Study drug never administered|3|||
163062817|NCT01101178|588936955|FG000|Period 1|Withdrawal by Subject|1|||
163062818|NCT01101178|588936956|FG001|Period 1|Withdrawal by Subject|2|||
163062819|NCT01101178|588936955|FG000|Period 1|Positive drug screen|1|||
163062820|NCT01101178|588936956|FG001|Period 1|Positive drug screen|1|||
163062821|NCT01101178|588936955|FG000|Period 1|Adverse Event|2|||
163062822|NCT01101178|588936956|FG001|Period 1|Adverse Event|1|||
163062823|NCT01101178|588936955|FG000|Period 2|Withdrawal by Subject|0|||
163062824|NCT01101178|588936956|FG001|Period 2|Withdrawal by Subject|1|||
163062825|NCT01850641|588936957|FG000|Overall Study|Physician Decision|1|||
163062826|NCT01850641|588936957|FG000|Overall Study|Decrease in serum phosphorus|1|||
163062827|NCT01850641|588936957|FG000|Overall Study|Decrease in serum calcium|2|||
163062828|NCT01850641|588936957|FG000|Overall Study|Increase in serum ferritin|1|||
163062829|NCT00141817|588936958|FG000|Overall Study|Protocol Violation|0|||
163062830|NCT00141817|588936959|FG001|Overall Study|Protocol Violation|0|||
163062831|NCT00141817|588936960|FG002|Overall Study|Protocol Violation|1|||
163215442|NCT02432846|589503827|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
163215443|NCT02432846|589503828|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
163015237|NCT03868930|588760747|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
163404688|NCT00879645|590191996|FG003|Overall Study|Adverse Event|0|||
163015238|NCT03868930|588760746|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
163015239|NCT03868930|588760747|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
163015240|NCT02151851|588760750|FG000|Overall Study|Lack of Efficacy|67|||
163015241|NCT02151851|588760751|FG001|Overall Study|Lack of Efficacy|94|||
163015242|NCT02151851|588760750|FG000|Overall Study|Protocol Violation|0|||
163015243|NCT02151851|588760751|FG001|Overall Study|Protocol Violation|1|||
163062832|NCT00141817|588936961|FG003|Overall Study|Protocol Violation|0|||
163062833|NCT00141817|588936958|FG000|Overall Study|Parent request|1|||
163062834|NCT00141817|588936959|FG001|Overall Study|Parent request|0|||
163062835|NCT00141817|588936960|FG002|Overall Study|Parent request|0|||
163215444|NCT02432846|589503829|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
163215445|NCT02432846|589503830|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
163015244|NCT02151851|588760750|FG000|Overall Study|Withdrawal by Subject|2|||
163015245|NCT02151851|588760751|FG001|Overall Study|Withdrawal by Subject|5|||
163015246|NCT02151851|588760750|FG000|Overall Study|Medical impairment|1|||
163015247|NCT02151851|588760751|FG001|Overall Study|Medical impairment|0|||
163015248|NCT02151851|588760750|FG000|Overall Study|Low compliance to study visits|0|||
163015249|NCT02151851|588760751|FG001|Overall Study|Low compliance to study visits|1|||
163015250|NCT02151851|588760750|FG000|Overall Study|Subject entered into study in error|0|||
163015251|NCT02151851|588760751|FG001|Overall Study|Subject entered into study in error|1|||
163015252|NCT02151851|588760750|FG000|Overall Study|Adverse Event|6|||
163015253|NCT02151851|588760751|FG001|Overall Study|Adverse Event|28|||
163015254|NCT02159053|588760752|FG000|Overall Study|Death|2|||
163015255|NCT02159053|588760753|FG001|Overall Study|Death|0|||
163015256|NCT02159053|588760754|FG002|Overall Study|Death|1|||
163015257|NCT02159053|588760752|FG000|Overall Study|Physician Decision|0|||
163015258|NCT02159053|588760753|FG001|Overall Study|Physician Decision|1|||
163015259|NCT02159053|588760754|FG002|Overall Study|Physician Decision|1|||
163015260|NCT02159053|588760752|FG000|Overall Study|Lack of Efficacy|3|||
163015261|NCT02159053|588760753|FG001|Overall Study|Lack of Efficacy|4|||
163015262|NCT02159053|588760754|FG002|Overall Study|Lack of Efficacy|7|||
163015263|NCT02159053|588760752|FG000|Overall Study|Adverse Event|7|||
163015264|NCT02159053|588760753|FG001|Overall Study|Adverse Event|6|||
163015265|NCT02159053|588760754|FG002|Overall Study|Adverse Event|5|||
163015266|NCT02159053|588760752|FG000|Overall Study|Participants/guardian decision|8|||
163015267|NCT02159053|588760753|FG001|Overall Study|Participants/guardian decision|10|||
163015268|NCT02159053|588760754|FG002|Overall Study|Participants/guardian decision|6|||
163015269|NCT02640950|588760755|FG000|Overall Study|Adverse Event|1|||
163015270|NCT02640950|588760755|FG000|Overall Study|Withdrawal by Subject|1|||
163015271|NCT04545489|588760756|FG000|Overall Study|Withdrawal by Subject|12|||
163015272|NCT04545489|588760757|FG001|Overall Study|Withdrawal by Subject|4|||
163015273|NCT04545489|588760756|FG000|Overall Study|Lost to Follow-up|17|||
163015274|NCT04545489|588760757|FG001|Overall Study|Lost to Follow-up|18|||
163015275|NCT04545489|588760756|FG000|Overall Study|12month BP not collected|4|||
163015276|NCT04545489|588760757|FG001|Overall Study|12month BP not collected|4|||
163015277|NCT00652626|588760758|FG000|Initial Treatment Phase|Adverse Event|0|||
163015278|NCT00652626|588760759|FG001|Initial Treatment Phase|Adverse Event|0|||
163015279|NCT00652626|588760760|FG002|Initial Treatment Phase|Adverse Event|0|||
163015280|NCT00652626|588760761|FG003|Initial Treatment Phase|Adverse Event|0|||
163015281|NCT00652626|588760762|FG004|Initial Treatment Phase|Adverse Event|1|||
163015282|NCT00652626|588760763|FG005|Initial Treatment Phase|Adverse Event|0|||
163015283|NCT00652626|588760764|FG006|Initial Treatment Phase|Adverse Event|0|||
163015284|NCT00652626|588760758|FG000|Initial Treatment Phase|Protocol Violation|0|||
163015285|NCT00652626|588760759|FG001|Initial Treatment Phase|Protocol Violation|0|||
163015286|NCT00652626|588760760|FG002|Initial Treatment Phase|Protocol Violation|0|||
163015287|NCT00652626|588760761|FG003|Initial Treatment Phase|Protocol Violation|1|||
163015288|NCT00652626|588760762|FG004|Initial Treatment Phase|Protocol Violation|0|||
163015289|NCT00652626|588760763|FG005|Initial Treatment Phase|Protocol Violation|0|||
163015290|NCT00652626|588760764|FG006|Initial Treatment Phase|Protocol Violation|0|||
163015291|NCT00652626|588760758|FG000|Initial Treatment Phase|Physician Decision|0|||
163015292|NCT00652626|588760759|FG001|Initial Treatment Phase|Physician Decision|0|||
163015293|NCT00652626|588760760|FG002|Initial Treatment Phase|Physician Decision|0|||
163015294|NCT00652626|588760761|FG003|Initial Treatment Phase|Physician Decision|0|||
163015295|NCT00652626|588760762|FG004|Initial Treatment Phase|Physician Decision|1|||
163015296|NCT00652626|588760763|FG005|Initial Treatment Phase|Physician Decision|0|||
163015297|NCT00652626|588760764|FG006|Initial Treatment Phase|Physician Decision|0|||
163015298|NCT00652626|588760758|FG000|Initial Treatment Phase|Sponsor Request|0|||
163015299|NCT00652626|588760759|FG001|Initial Treatment Phase|Sponsor Request|0|||
163015300|NCT00652626|588760760|FG002|Initial Treatment Phase|Sponsor Request|1|||
163015301|NCT00652626|588760761|FG003|Initial Treatment Phase|Sponsor Request|0|||
163015302|NCT00652626|588760762|FG004|Initial Treatment Phase|Sponsor Request|0|||
163015303|NCT00652626|588760763|FG005|Initial Treatment Phase|Sponsor Request|0|||
163015304|NCT00652626|588760764|FG006|Initial Treatment Phase|Sponsor Request|0|||
163015305|NCT00652626|588760758|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
163015306|NCT00652626|588760759|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
163215446|NCT02432846|589503825|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
163215447|NCT02432846|589503826|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
163015307|NCT00652626|588760760|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
163015308|NCT00652626|588760761|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
163015309|NCT00652626|588760762|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
163015310|NCT00652626|588760763|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
163015311|NCT00652626|588760764|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
163404689|NCT00996944|590191997|FG000|Double-blind Treatment Period|Adverse Event|2|||
163015312|NCT00652626|588760758|FG000|Extension Phase|Withdrawal by Subject|0|||
163015313|NCT00652626|588760759|FG001|Extension Phase|Withdrawal by Subject|0|||
163015314|NCT00652626|588760760|FG002|Extension Phase|Withdrawal by Subject|0|||
163015315|NCT00652626|588760761|FG003|Extension Phase|Withdrawal by Subject|0|||
163215448|NCT02432846|589503827|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
163215449|NCT02432846|589503828|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
163215450|NCT02432846|589503829|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
163215451|NCT02432846|589503830|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
163215452|NCT02432846|589503825|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
163215453|NCT02432846|589503826|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
163015316|NCT00652626|588760762|FG004|Extension Phase|Withdrawal by Subject|0|||
163015317|NCT00652626|588760763|FG005|Extension Phase|Withdrawal by Subject|2|||
163015318|NCT00652626|588760764|FG006|Extension Phase|Withdrawal by Subject|0|||
163015319|NCT00652626|588760758|FG000|Extension Phase|Adverse Event|0|||
163015320|NCT00652626|588760759|FG001|Extension Phase|Adverse Event|0|||
163015321|NCT00652626|588760760|FG002|Extension Phase|Adverse Event|0|||
163015322|NCT00652626|588760761|FG003|Extension Phase|Adverse Event|0|||
163015323|NCT00652626|588760762|FG004|Extension Phase|Adverse Event|0|||
163015324|NCT00652626|588760763|FG005|Extension Phase|Adverse Event|2|||
163015325|NCT00652626|588760764|FG006|Extension Phase|Adverse Event|1|||
163015326|NCT00652626|588760758|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
163015327|NCT00652626|588760759|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
163015328|NCT00652626|588760760|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
163015329|NCT00652626|588760761|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
163015330|NCT00652626|588760762|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
163015331|NCT00652626|588760763|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
163015332|NCT00652626|588760764|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
163015333|NCT00652626|588760758|FG000|Extension Phase|Physician Decision|0|||
163015334|NCT00652626|588760759|FG001|Extension Phase|Physician Decision|0|||
163015335|NCT00652626|588760760|FG002|Extension Phase|Physician Decision|0|||
163015336|NCT00652626|588760761|FG003|Extension Phase|Physician Decision|0|||
163015337|NCT00652626|588760762|FG004|Extension Phase|Physician Decision|0|||
163015338|NCT00652626|588760763|FG005|Extension Phase|Physician Decision|1|||
163015339|NCT00652626|588760764|FG006|Extension Phase|Physician Decision|1|||
163015340|NCT00652626|588760758|FG000|Extension Phase|Death|0|||
163015341|NCT00652626|588760759|FG001|Extension Phase|Death|0|||
163015342|NCT00652626|588760760|FG002|Extension Phase|Death|0|||
163015343|NCT00652626|588760761|FG003|Extension Phase|Death|0|||
163015344|NCT00652626|588760762|FG004|Extension Phase|Death|0|||
163015345|NCT00652626|588760763|FG005|Extension Phase|Death|1|||
163015346|NCT00652626|588760764|FG006|Extension Phase|Death|1|||
163015347|NCT04003636|588760765|FG000|Overall Study|Death|409|||
163015348|NCT04003636|588760766|FG001|Overall Study|Death|443|||
163015349|NCT04003636|588760765|FG000|Overall Study|Lost to Follow-up|0|||
163015350|NCT04003636|588760766|FG001|Overall Study|Lost to Follow-up|1|||
163015351|NCT04003636|588760765|FG000|Overall Study|Withdrawal by Subject|5|||
163015352|NCT04003636|588760766|FG001|Overall Study|Withdrawal by Subject|2|||
163015353|NCT04003636|588760765|FG000|Overall Study|Participant On-going|119|||
163015354|NCT04003636|588760766|FG001|Overall Study|Participant On-going|90|||
163015355|NCT03048747|588760767|FG000|Overall Study|Adverse Event|2|||
163015356|NCT03048747|588760767|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
163015357|NCT03048747|588760767|FG000|Overall Study|Physician Decision|1|||
163015358|NCT00915018|588760770|FG000|Overall Study|Death|75|||
163015359|NCT00915018|588760771|FG001|Overall Study|Death|70|||
163015360|NCT00915018|588760770|FG000|Overall Study|Lost to Follow-up|10|||
163015361|NCT00915018|588760771|FG001|Overall Study|Lost to Follow-up|5|||
163015362|NCT00915018|588760770|FG000|Overall Study|Withdrawal by Subject|38|||
163015363|NCT00915018|588760771|FG001|Overall Study|Withdrawal by Subject|27|||
163015364|NCT00915018|588760770|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
163015365|NCT00915018|588760771|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
163015366|NCT00300885|588760772|FG000|Treatment|Adverse Event|134|||
163015367|NCT00300885|588760773|FG001|Treatment|Adverse Event|82|||
163015368|NCT00300885|588760772|FG000|Treatment|Death|20|||
163015369|NCT00300885|588760773|FG001|Treatment|Death|7|||
163015370|NCT00300885|588760772|FG000|Treatment|Lack of Efficacy|1|||
163015371|NCT00300885|588760773|FG001|Treatment|Lack of Efficacy|1|||
163015372|NCT00300885|588760772|FG000|Treatment|Lost to Follow-up|3|||
163015373|NCT00300885|588760773|FG001|Treatment|Lost to Follow-up|2|||
163015374|NCT00300885|588760772|FG000|Treatment|Physician Decision|4|||
163015375|NCT00300885|588760773|FG001|Treatment|Physician Decision|5|||
163015376|NCT00300885|588760772|FG000|Treatment|Protocol Violation|11|||
163015377|NCT00300885|588760773|FG001|Treatment|Protocol Violation|11|||
163015378|NCT00300885|588760772|FG000|Treatment|Withdrawal by Subject|26|||
163015379|NCT00300885|588760773|FG001|Treatment|Withdrawal by Subject|23|||
163062836|NCT00141817|588936961|FG003|Overall Study|Parent request|0|||
163328562|NCT03211247|589913299|FG000|Overall Study|Adverse Event|8|||
163015380|NCT00300885|588760772|FG000|Treatment|Disease progression|171|||
163015381|NCT00300885|588760773|FG001|Treatment|Disease progression|238|||
163015382|NCT00300885|588760772|FG000|Treatment|Random code broken (subject died)|0|||
163015383|NCT00300885|588760773|FG001|Treatment|Random code broken (subject died)|1|||
163015384|NCT00300885|588760772|FG000|Treatment|Non-compliant with study medication|3|||
163015385|NCT00300885|588760773|FG001|Treatment|Non-compliant with study medication|4|||
163015386|NCT00300885|588760772|FG000|Follow-up|Death|141|||
163015387|NCT00300885|588760773|FG001|Follow-up|Death|163|||
163015388|NCT00300885|588760772|FG000|Follow-up|Lost to Follow-up|11|||
163015389|NCT00300885|588760773|FG001|Follow-up|Lost to Follow-up|7|||
163015390|NCT00300885|588760772|FG000|Follow-up|Withdrawal by Subject|26|||
163015391|NCT00300885|588760773|FG001|Follow-up|Withdrawal by Subject|25|||
163015392|NCT02582242|588760774|FG000|Overall Study|Adverse Event|4|||
163015393|NCT02582242|588760775|FG001|Overall Study|Adverse Event|3|||
163015394|NCT02582242|588760774|FG000|Overall Study|Protocol Violation|3|||
163015395|NCT02582242|588760775|FG001|Overall Study|Protocol Violation|1|||
163015396|NCT02582242|588760774|FG000|Overall Study|Lost to Follow-up|0|||
163015397|NCT02582242|588760775|FG001|Overall Study|Lost to Follow-up|1|||
163015398|NCT02582242|588760774|FG000|Overall Study|Withdrawal by Subject|11|||
163015399|NCT02582242|588760775|FG001|Overall Study|Withdrawal by Subject|11|||
163015400|NCT02582242|588760774|FG000|Overall Study|Unclassified|2|||
163015401|NCT02582242|588760775|FG001|Overall Study|Unclassified|1|||
163015402|NCT02492984|588760776|FG000|Overall Study|Adverse Event|1|||
163015403|NCT02492984|588760777|FG001|Overall Study|Adverse Event|0|||
163015404|NCT02492984|588760776|FG000|Overall Study|Protocol Violation|1|||
163015405|NCT02492984|588760777|FG001|Overall Study|Protocol Violation|0|||
163015406|NCT02492984|588760776|FG000|Overall Study|Withdrawal by Subject|1|||
163015407|NCT02492984|588760777|FG001|Overall Study|Withdrawal by Subject|0|||
163015408|NCT02101736|588760781|FG000|Overall Study|Protocol Violation|3|||
163015409|NCT02101736|588760782|FG001|Overall Study|Protocol Violation|0|||
163015410|NCT02101736|588760781|FG000|Overall Study|Withdrawal by Subject|1|||
163015411|NCT02101736|588760782|FG001|Overall Study|Withdrawal by Subject|1|||
163015412|NCT02282631|588760783|FG000|Overall Study|Lost to Follow-up|2|||
163015413|NCT02282631|588760784|FG001|Overall Study|Lost to Follow-up|0|||
163015414|NCT02453334|588760785|FG000|Overall Study|Death|15|||
163015415|NCT02453334|588760786|FG001|Overall Study|Death|13|||
163015416|NCT02453334|588760785|FG000|Overall Study|Adverse Event|2|||
163015417|NCT02453334|588760786|FG001|Overall Study|Adverse Event|1|||
163015418|NCT02453334|588760785|FG000|Overall Study|Lost to Follow-up|5|||
163015419|NCT02453334|588760786|FG001|Overall Study|Lost to Follow-up|9|||
163015420|NCT02453334|588760785|FG000|Overall Study|Physician Decision|1|||
163015421|NCT02453334|588760786|FG001|Overall Study|Physician Decision|0|||
163015422|NCT02453334|588760785|FG000|Overall Study|Withdrawal by Subject|17|||
163015423|NCT02453334|588760786|FG001|Overall Study|Withdrawal by Subject|13|||
163015424|NCT02453334|588760785|FG000|Overall Study|Other reason|1|||
163015425|NCT02453334|588760786|FG001|Overall Study|Other reason|4|||
163015426|NCT01841762|588760787|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
163015427|NCT01841762|588760787|FG000|Treatment Period|Adverse Event|16|||
163015428|NCT01841762|588760787|FG000|Treatment Period|Death|1|||
163015429|NCT01841762|588760787|FG000|Treatment Period|Withdrawal by Subject|7|||
163015430|NCT01841762|588760787|FG000|Treatment Period|Lost to Follow-up|1|||
163015431|NCT01841762|588760787|FG000|Treatment Period|Physician Decision|2|||
163015432|NCT01841762|588760787|FG000|Treatment Period|Other, including non-compliance|5|||
163015433|NCT01841762|588760787|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
163015434|NCT01841762|588760787|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
163015435|NCT01841762|588760787|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
163015436|NCT01841762|588760787|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
163015437|NCT05483686|588760793|FG000|Overall Study|Lost to Follow-up|5|||
163015438|NCT05483686|588760794|FG001|Overall Study|Lost to Follow-up|7|||
163015439|NCT03981900|588760795|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
163015440|NCT03981900|588760795|FG000|Overall Study|Adverse Event|5|||
163015441|NCT03981900|588760795|FG000|Overall Study|Protocol Violation|1|||
163015442|NCT03981900|588760795|FG000|Overall Study|Withdrawal by Subject|7|||
163015443|NCT03981900|588760795|FG000|Overall Study|Lost to Follow-up|46|||
163015444|NCT03981900|588760795|FG000|Overall Study|Decision of the researcher|3|||
163015445|NCT03981900|588760795|FG000|Overall Study|Death|3|||
163015446|NCT03981900|588760795|FG000|Overall Study|Other|5|||
163015447|NCT02693106|588760796|FG000|Overall Study|No time|3|||
163015448|NCT06152224|588760806|FG000|Overall Study|Withdrawal by Subject|1|||
163015449|NCT06152224|588760807|FG001|Overall Study|Withdrawal by Subject|0|||
163328563|NCT03211247|589913300|FG001|Overall Study|Adverse Event|0|||
163015450|NCT06152224|588760806|FG000|Overall Study|Lost to Follow-up|0|||
163015451|NCT06152224|588760807|FG001|Overall Study|Lost to Follow-up|1|||
163015452|NCT06152224|588760806|FG000|Overall Study|On Follow Up|18|||
163015453|NCT06152224|588760807|FG001|Overall Study|On Follow Up|18|||
163015454|NCT05780983|588760808|FG000|Overall Study|Withdrawal by Subject|1|||
163015455|NCT06028438|588760812|FG000|Overall Study|Adverse Event|3|||
163015456|NCT06028438|588760813|FG001|Overall Study|Adverse Event|9|||
163015457|NCT06028438|588760812|FG000|Overall Study|Lack of Efficacy|1|||
163015458|NCT06028438|588760813|FG001|Overall Study|Lack of Efficacy|1|||
163015459|NCT06028438|588760812|FG000|Overall Study|Lost to Follow-up|1|||
163015460|NCT06028438|588760813|FG001|Overall Study|Lost to Follow-up|0|||
163015461|NCT06028438|588760812|FG000|Overall Study|Withdrawal by Subject|1|||
163062837|NCT00127803|588936964|FG000|Overall Study|Adverse Event|2|||
163015462|NCT06028438|588760813|FG001|Overall Study|Withdrawal by Subject|0|||
163015463|NCT06028438|588760812|FG000|Overall Study|Other|3|||
163015464|NCT06028438|588760813|FG001|Overall Study|Other|3|||
163015465|NCT05625802|588760814|FG000|Overall Study|Lost to Follow-up|1|||
163015466|NCT05625802|588760815|FG001|Overall Study|Lost to Follow-up|0|||
163015467|NCT00808210|588760817|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
163015468|NCT00808210|588760818|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
163015469|NCT00808210|588760817|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
163015470|NCT00808210|588760818|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
163015471|NCT00808210|588760817|FG000|Double-Blind TX Period|Adverse Event|0|||
163015472|NCT00808210|588760818|FG001|Double-Blind TX Period|Adverse Event|1|||
163015473|NCT00808210|588760817|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
163015474|NCT00808210|588760818|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
163015475|NCT00808210|588760817|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
163015476|NCT00808210|588760818|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
163015477|NCT00808210|588760817|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
163015478|NCT00808210|588760818|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
163015479|NCT02044302|588760819|FG000|Overall Study|study terminated|2|||
163015480|NCT02044302|588760820|FG001|Overall Study|study terminated|0|||
163015481|NCT03150719|588760821|FG000|Overall Study|Adverse Event|0|||
163015482|NCT03150719|588760822|FG001|Overall Study|Adverse Event|1|||
163015483|NCT03150719|588760821|FG000|Overall Study|Death|0|||
163015484|NCT03150719|588760822|FG001|Overall Study|Death|1|||
163015485|NCT03150719|588760821|FG000|Overall Study|Other|1|||
163015486|NCT03150719|588760822|FG001|Overall Study|Other|0|||
163015487|NCT01954056|588760824|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
163015488|NCT01954056|588760825|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
163015489|NCT04938180|588760829|FG000|Overall Study|Adverse Event|1|||
163015490|NCT01964222|588760832|FG000|Overall Study|Lost to Follow-up|7|||
163015491|NCT01964222|588760833|FG001|Overall Study|Lost to Follow-up|5|||
163015492|NCT01964222|588760832|FG000|Overall Study|Withdrawal by Subject|6|||
163015493|NCT01964222|588760833|FG001|Overall Study|Withdrawal by Subject|6|||
163015494|NCT01964222|588760832|FG000|Overall Study|Screening Failure|2|||
163015495|NCT01964222|588760833|FG001|Overall Study|Screening Failure|0|||
163015496|NCT01019694|588760836|FG000|Overall Study|Adverse Event|12|||
163015497|NCT01019694|588760837|FG001|Overall Study|Adverse Event|16|||
163015498|NCT01019694|588760838|FG002|Overall Study|Adverse Event|19|||
163015499|NCT01019694|588760836|FG000|Overall Study|Protocol Violation|2|||
163015500|NCT01019694|588760837|FG001|Overall Study|Protocol Violation|6|||
163015501|NCT01019694|588760838|FG002|Overall Study|Protocol Violation|4|||
163015502|NCT01019694|588760836|FG000|Overall Study|Lost to Follow-up|5|||
163015503|NCT01019694|588760837|FG001|Overall Study|Lost to Follow-up|3|||
163015504|NCT01019694|588760838|FG002|Overall Study|Lost to Follow-up|3|||
163015505|NCT01019694|588760836|FG000|Overall Study|Withdrawal by Subject|4|||
163015506|NCT01019694|588760837|FG001|Overall Study|Withdrawal by Subject|6|||
163015507|NCT01019694|588760838|FG002|Overall Study|Withdrawal by Subject|12|||
163015508|NCT01019694|588760836|FG000|Overall Study|Not treated|0|||
163015509|NCT01019694|588760837|FG001|Overall Study|Not treated|2|||
163015510|NCT01019694|588760838|FG002|Overall Study|Not treated|3|||
163015511|NCT01019694|588760836|FG000|Overall Study|Other reason (not specified)|1|||
163015512|NCT01019694|588760837|FG001|Overall Study|Other reason (not specified)|5|||
163015513|NCT01019694|588760838|FG002|Overall Study|Other reason (not specified)|6|||
163015514|NCT00441129|588760841|FG000|Overall Study|Withdrawal by Subject|6|||
163015515|NCT00441129|588760842|FG001|Overall Study|Withdrawal by Subject|14|||
163015516|NCT00463047|588760843|FG000|Titration Period 1|Adverse Event|10|||
163015517|NCT00463047|588760844|FG001|Titration Period 1|Adverse Event|8|||
163015518|NCT00463047|588760843|FG000|Titration Period 1|Lack of Efficacy|10|||
163015519|NCT00463047|588760844|FG001|Titration Period 1|Lack of Efficacy|4|||
163015520|NCT00463047|588760843|FG000|Titration Period 1|Lost to Follow-up|2|||
163015521|NCT00463047|588760844|FG001|Titration Period 1|Lost to Follow-up|0|||
163015522|NCT00463047|588760843|FG000|Titration Period 1|Non-compliance with study medication|3|||
163015523|NCT00463047|588760844|FG001|Titration Period 1|Non-compliance with study medication|5|||
163015524|NCT00463047|588760843|FG000|Titration Period 1|Protocol Violation|5|||
163062838|NCT00127803|588936965|FG001|Overall Study|Adverse Event|0|||
163062839|NCT00127803|588936966|FG002|Overall Study|Adverse Event|0|||
163015525|NCT00463047|588760844|FG001|Titration Period 1|Protocol Violation|5|||
163015526|NCT00463047|588760843|FG000|Titration Period 1|Withdrawal by Subject|3|||
163015527|NCT00463047|588760844|FG001|Titration Period 1|Withdrawal by Subject|5|||
163015528|NCT00463047|588760843|FG000|Titration Period 1|Non-compliance procedures|4|||
163015529|NCT00463047|588760844|FG001|Titration Period 1|Non-compliance procedures|10|||
163062840|NCT00127803|588936967|FG003|Overall Study|Adverse Event|0|||
163015530|NCT00463047|588760843|FG000|Titration Period 1|Other|0|||
163015531|NCT00463047|588760844|FG001|Titration Period 1|Other|2|||
163015532|NCT00463047|588760843|FG000|Titration Period 2|Adverse Event|9|||
163062841|NCT00127803|588936964|FG000|Overall Study|Withdrawal by Subject|1|||
163015533|NCT00463047|588760844|FG001|Titration Period 2|Adverse Event|9|||
163015534|NCT00463047|588760843|FG000|Titration Period 2|Lack of Efficacy|6|||
163015535|NCT00463047|588760844|FG001|Titration Period 2|Lack of Efficacy|4|||
163015536|NCT00463047|588760843|FG000|Titration Period 2|Withdrawal by Subject|1|||
163015537|NCT00463047|588760844|FG001|Titration Period 2|Withdrawal by Subject|0|||
163015538|NCT00463047|588760843|FG000|Titration Period 2|Protocol Violation|2|||
163015539|NCT00463047|588760844|FG001|Titration Period 2|Protocol Violation|3|||
163015540|NCT00463047|588760843|FG000|Titration Period 2|Lost to Follow-up|1|||
163015541|NCT00463047|588760844|FG001|Titration Period 2|Lost to Follow-up|2|||
163015542|NCT00463047|588760843|FG000|Titration Period 2|Non-compliance study medication|4|||
163015543|NCT00463047|588760844|FG001|Titration Period 2|Non-compliance study medication|2|||
163015544|NCT00463047|588760843|FG000|Titration Period 2|Non-compliance procedures|4|||
163015545|NCT00463047|588760844|FG001|Titration Period 2|Non-compliance procedures|1|||
163015546|NCT00463047|588760843|FG000|Titration Period 2|Other|3|||
163015547|NCT00463047|588760844|FG001|Titration Period 2|Other|2|||
163015548|NCT00463047|588760843|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
163015549|NCT00463047|588760844|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
163015550|NCT00463047|588760843|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
163015551|NCT00463047|588760844|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
163015552|NCT00463047|588760843|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
163015553|NCT00463047|588760844|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
163015554|NCT00463047|588760843|FG000|Double-Blind Treatment Period 1|Other|1|||
163015555|NCT00463047|588760844|FG001|Double-Blind Treatment Period 1|Other|0|||
163015556|NCT00463047|588760843|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
163015557|NCT00463047|588760844|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
163015558|NCT00463047|588760843|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
163015559|NCT00463047|588760844|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
163015560|NCT00463047|588760843|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
163015561|NCT00463047|588760844|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
163015562|NCT04278417|588760857|FG000|Overall Study|Withdrawal by Subject|20|||
163015563|NCT04278417|588760858|FG001|Overall Study|Withdrawal by Subject|20|||
163015564|NCT04278417|588760857|FG000|Overall Study|Progressive disease|0|||
163015565|NCT04278417|588760858|FG001|Overall Study|Progressive disease|2|||
163015566|NCT04278417|588760857|FG000|Overall Study|Physician Decision|4|||
163015567|NCT04278417|588760858|FG001|Overall Study|Physician Decision|6|||
163015568|NCT04278417|588760857|FG000|Overall Study|Lost to Follow-up|11|||
163015569|NCT04278417|588760858|FG001|Overall Study|Lost to Follow-up|13|||
163015570|NCT04278417|588760857|FG000|Overall Study|Death|8|||
163015571|NCT04278417|588760858|FG001|Overall Study|Death|9|||
163015572|NCT04278417|588760857|FG000|Overall Study|Adverse Event|3|||
163015573|NCT04278417|588760858|FG001|Overall Study|Adverse Event|5|||
163015574|NCT01732458|588760860|FG000|Overall Study|Lost to Follow-up|0|||
163015575|NCT01732458|588760861|FG001|Overall Study|Lost to Follow-up|2|||
163015576|NCT01732458|588760862|FG002|Overall Study|Lost to Follow-up|0|||
163015577|NCT01732458|588760863|FG003|Overall Study|Lost to Follow-up|0|||
163015578|NCT01732458|588760860|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163015579|NCT01732458|588760861|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163015580|NCT01732458|588760862|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163015581|NCT01732458|588760863|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163015582|NCT01732458|588760860|FG000|Overall Study|Physician Decision|1|||
163015583|NCT01732458|588760861|FG001|Overall Study|Physician Decision|2|||
163015584|NCT01732458|588760862|FG002|Overall Study|Physician Decision|2|||
163015585|NCT01732458|588760863|FG003|Overall Study|Physician Decision|0|||
163015586|NCT01732458|588760860|FG000|Overall Study|Protocol Violation|2|||
163015587|NCT01732458|588760861|FG001|Overall Study|Protocol Violation|0|||
163015588|NCT01732458|588760862|FG002|Overall Study|Protocol Violation|0|||
163015589|NCT01732458|588760863|FG003|Overall Study|Protocol Violation|2|||
163015590|NCT01732458|588760860|FG000|Overall Study|Screen Failure|0|||
163015591|NCT01732458|588760861|FG001|Overall Study|Screen Failure|1|||
163015592|NCT01732458|588760862|FG002|Overall Study|Screen Failure|0|||
163015593|NCT01732458|588760863|FG003|Overall Study|Screen Failure|0|||
163015594|NCT05870371|588760864|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
163015595|NCT05870371|588760865|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
163015596|NCT02203721|588760866|FG000|Overall Study|Lost to Follow-up|1|||
163015597|NCT02203721|588760867|FG001|Overall Study|Lost to Follow-up|0|||
163015598|NCT02203721|588760866|FG000|Overall Study|Death|0|||
163015599|NCT02203721|588760867|FG001|Overall Study|Death|2|||
163015600|NCT02203721|588760866|FG000|Overall Study|Illness|0|||
163015601|NCT02203721|588760867|FG001|Overall Study|Illness|1|||
163015602|NCT00703157|588760868|FG000|Overall Study|Lost to Follow-up|0|||
163015603|NCT00703157|588760869|FG001|Overall Study|Lost to Follow-up|1|||
163015604|NCT00703157|588760868|FG000|Overall Study|source data permanently lost/ other|4|||
163015605|NCT00703157|588760869|FG001|Overall Study|source data permanently lost/ other|1|||
163015606|NCT00347009|588760870|FG000|Overall Study|Death|1|||
163015607|NCT00347009|588760870|FG000|Overall Study|Adverse Event|6|||
163015608|NCT00347009|588760870|FG000|Overall Study|Withdrawal by Subject|3|||
163015609|NCT00347009|588760870|FG000|Overall Study|Physician Decision|5|||
163015610|NCT00347009|588760870|FG000|Overall Study|Lost to Follow-up|4|||
163015611|NCT00347009|588760870|FG000|Overall Study|Protocol Violation|2|||
163015612|NCT00347009|588760870|FG000|Overall Study|Adverse Laboratory Experience|1|||
163015613|NCT00347009|588760870|FG000|Overall Study|Insufficient Viral Suppression|3|||
163015614|NCT00347009|588760870|FG000|Overall Study|Increased ALT/HBV DNA|1|||
163015615|NCT00347009|588760870|FG000|Overall Study|Serious Adverse Event|1|||
163015616|NCT02522884|588760873|FG000|Overall Study|Withdrawal by Subject|6|||
163015617|NCT02522884|588760873|FG000|Overall Study|Death|3|||
163015618|NCT02522884|588760873|FG000|Overall Study|Missed 12-month Follow-up|9|||
163015619|NCT04495751|588760874|FG000|Overall Study|Withdrawal by Subject|1|||
163015620|NCT04495751|588760875|FG001|Overall Study|Withdrawal by Subject|0|||
163015621|NCT04495751|588760874|FG000|Overall Study|Lost to Follow-up|1|||
163015622|NCT04495751|588760875|FG001|Overall Study|Lost to Follow-up|0|||
163015623|NCT00708461|588760876|FG000|Overall Study|Lost to Follow-up|18|||
163015624|NCT00708461|588760877|FG001|Overall Study|Lost to Follow-up|11|||
163015625|NCT00708461|588760876|FG000|Overall Study|Withdrawal by Subject|8|||
163015626|NCT00708461|588760877|FG001|Overall Study|Withdrawal by Subject|9|||
163015627|NCT00708461|588760876|FG000|Overall Study|left workforce|115|||
163015628|NCT00708461|588760877|FG001|Overall Study|left workforce|180|||
163015629|NCT02907177|588760878|FG000|Overall Study|Death|0|||
163015630|NCT02907177|588760879|FG001|Overall Study|Death|1|||
163015631|NCT02907177|588760878|FG000|Overall Study|Physician Decision|3|||
163015632|NCT02907177|588760879|FG001|Overall Study|Physician Decision|3|||
163015633|NCT02907177|588760878|FG000|Overall Study|Withdrawal by Subject|15|||
163015634|NCT02907177|588760879|FG001|Overall Study|Withdrawal by Subject|7|||
163015635|NCT02907177|588760878|FG000|Overall Study|Sponsor's Decision|50|||
163015636|NCT02907177|588760879|FG001|Overall Study|Sponsor's Decision|57|||
163015637|NCT02968173|588760880|FG000|Overall Study|Withdrawal by Subject|1|||
163015638|NCT00314327|588760884|FG000|Overall Study|Withdrawal by Subject|1|||
163015639|NCT01207687|588760885|FG000|Overall Study|Adverse Event|1|||
163015640|NCT01207687|588760885|FG000|Overall Study|Withdrawal by Subject|1|||
163015641|NCT03474965|588760886|FG000|Overall Study|Pregnancy|1|||
163015642|NCT03474965|588760887|FG001|Overall Study|Pregnancy|0|||
163015643|NCT03474965|588760888|FG002|Overall Study|Pregnancy|0|||
163015644|NCT03474965|588760889|FG003|Overall Study|Pregnancy|0|||
163015645|NCT03474965|588760886|FG000|Overall Study|Lost to Follow-up|0|||
163015646|NCT03474965|588760887|FG001|Overall Study|Lost to Follow-up|0|||
163015647|NCT03474965|588760888|FG002|Overall Study|Lost to Follow-up|1|||
163015648|NCT03474965|588760889|FG003|Overall Study|Lost to Follow-up|0|||
163015649|NCT03474965|588760886|FG000|Overall Study|Death|1|||
163015650|NCT03474965|588760887|FG001|Overall Study|Death|0|||
163015651|NCT03474965|588760888|FG002|Overall Study|Death|0|||
163015652|NCT03474965|588760889|FG003|Overall Study|Death|0|||
163015653|NCT03474965|588760886|FG000|Overall Study|Adverse Event|1|||
163015654|NCT03474965|588760887|FG001|Overall Study|Adverse Event|0|||
163015655|NCT03474965|588760888|FG002|Overall Study|Adverse Event|0|||
163015656|NCT03474965|588760889|FG003|Overall Study|Adverse Event|1|||
163015657|NCT03474965|588760886|FG000|Overall Study|Physician Decision|3|||
163015658|NCT03474965|588760887|FG001|Overall Study|Physician Decision|1|||
163015659|NCT03474965|588760888|FG002|Overall Study|Physician Decision|2|||
163015660|NCT03474965|588760889|FG003|Overall Study|Physician Decision|0|||
163015661|NCT03474965|588760886|FG000|Overall Study|Participant Decision|7|||
163015662|NCT03474965|588760887|FG001|Overall Study|Participant Decision|0|||
163015663|NCT03474965|588760888|FG002|Overall Study|Participant Decision|1|||
163015664|NCT03474965|588760889|FG003|Overall Study|Participant Decision|0|||
163015665|NCT03474965|588760886|FG000|Overall Study|Guardian Decision|4|||
163015666|NCT03474965|588760887|FG001|Overall Study|Guardian Decision|2|||
163015667|NCT03474965|588760888|FG002|Overall Study|Guardian Decision|7|||
163015668|NCT03474965|588760889|FG003|Overall Study|Guardian Decision|2|||
163015669|NCT01637922|588762415|FG000|Overall Study|Adverse Event|0|||
163015670|NCT01637922|588762416|FG001|Overall Study|Adverse Event|1|||
163015671|NCT01637922|588762415|FG000|Overall Study|Protocol Violation|0|||
163015672|NCT01637922|588762416|FG001|Overall Study|Protocol Violation|1|||
163015673|NCT01637922|588762415|FG000|Overall Study|Withdrawal by Subject|0|||
163015674|NCT01637922|588762416|FG001|Overall Study|Withdrawal by Subject|3|||
163015675|NCT01637922|588762415|FG000|Overall Study|Lost to Follow-up|2|||
163015676|NCT01637922|588762416|FG001|Overall Study|Lost to Follow-up|0|||
163015677|NCT00638404|588762417|FG000|Overall Study|Physician Decision|8|||
163015678|NCT00638404|588762418|FG001|Overall Study|Physician Decision|0|||
163015679|NCT00459290|588762419|FG000|Overall Study|Adverse Event|3|||
163015680|NCT00459290|588762419|FG000|Overall Study|Ineligible|2|||
163015681|NCT00687271|588762420|FG000|Overall Study|Adverse Event|1|||
163015682|NCT00687271|588762421|FG001|Overall Study|Adverse Event|3|||
163015683|NCT00687271|588762422|FG002|Overall Study|Adverse Event|1|||
163015684|NCT00687271|588762423|FG003|Overall Study|Adverse Event|0|||
163015685|NCT00687271|588762420|FG000|Overall Study|Lost to Follow-up|0|||
163015686|NCT00687271|588762421|FG001|Overall Study|Lost to Follow-up|1|||
163015687|NCT00687271|588762422|FG002|Overall Study|Lost to Follow-up|0|||
163015688|NCT00687271|588762423|FG003|Overall Study|Lost to Follow-up|0|||
163015689|NCT00687271|588762420|FG000|Overall Study|Protocol Violation|2|||
163015690|NCT00687271|588762421|FG001|Overall Study|Protocol Violation|1|||
163015691|NCT00687271|588762422|FG002|Overall Study|Protocol Violation|1|||
163015692|NCT00687271|588762423|FG003|Overall Study|Protocol Violation|0|||
163015693|NCT00687271|588762420|FG000|Overall Study|Withdrawal by Subject|0|||
163015694|NCT00687271|588762421|FG001|Overall Study|Withdrawal by Subject|1|||
163015695|NCT00687271|588762422|FG002|Overall Study|Withdrawal by Subject|3|||
163015696|NCT00687271|588762423|FG003|Overall Study|Withdrawal by Subject|0|||
163015697|NCT04090060|588762430|FG000|Overall Study|Lost to Follow-up|76|||
163015698|NCT04090060|588762431|FG001|Overall Study|Lost to Follow-up|77|||
163015699|NCT03337113|588762438|FG000|Overall Study|Adverse Event|1|||
163015700|NCT03337113|588762439|FG001|Overall Study|Adverse Event|1|||
163015701|NCT03337113|588762440|FG002|Overall Study|Adverse Event|0|||
163015702|NCT03337113|588762441|FG003|Overall Study|Adverse Event|1|||
163015703|NCT03337113|588762438|FG000|Overall Study|Physician Decision|0|||
163015704|NCT03337113|588762439|FG001|Overall Study|Physician Decision|2|||
163015705|NCT03337113|588762440|FG002|Overall Study|Physician Decision|0|||
163015706|NCT03337113|588762441|FG003|Overall Study|Physician Decision|1|||
163015707|NCT03337113|588762438|FG000|Overall Study|Withdrawal by Subject|0|||
163015708|NCT03337113|588762439|FG001|Overall Study|Withdrawal by Subject|0|||
163015709|NCT03337113|588762440|FG002|Overall Study|Withdrawal by Subject|1|||
163015710|NCT03337113|588762441|FG003|Overall Study|Withdrawal by Subject|0|||
163015711|NCT01164579|588762442|FG000|Overall Study|Lack of Efficacy|0|||
163015712|NCT01164579|588762443|FG001|Overall Study|Lack of Efficacy|0|||
163015713|NCT01164579|588762444|FG002|Overall Study|Lack of Efficacy|6|||
163015714|NCT01164579|588762442|FG000|Overall Study|Lost to Follow-up|1|||
163015715|NCT01164579|588762443|FG001|Overall Study|Lost to Follow-up|1|||
163015716|NCT01164579|588762444|FG002|Overall Study|Lost to Follow-up|0|||
163015717|NCT01164579|588762442|FG000|Overall Study|Withdrawal by Subject|2|||
163015718|NCT01164579|588762443|FG001|Overall Study|Withdrawal by Subject|5|||
163015719|NCT01164579|588762444|FG002|Overall Study|Withdrawal by Subject|3|||
163015720|NCT01164579|588762442|FG000|Overall Study|Protocol Violation|0|||
163015721|NCT01164579|588762443|FG001|Overall Study|Protocol Violation|1|||
163015722|NCT01164579|588762444|FG002|Overall Study|Protocol Violation|2|||
163015723|NCT01164579|588762442|FG000|Overall Study|Adverse Event|4|||
163015724|NCT01164579|588762443|FG001|Overall Study|Adverse Event|2|||
163015725|NCT01164579|588762444|FG002|Overall Study|Adverse Event|5|||
163015726|NCT01164579|588762442|FG000|Overall Study|Reason not specified|1|||
163015727|NCT01164579|588762443|FG001|Overall Study|Reason not specified|0|||
163015728|NCT01164579|588762444|FG002|Overall Study|Reason not specified|0|||
163015729|NCT02176655|588762453|FG000|Overall Study|Subjects did not treat|6|||
163015730|NCT00507455|588762454|FG000|Overall Study|Adverse Event|3|||
163015731|NCT00507455|588762455|FG001|Overall Study|Adverse Event|3|||
163015732|NCT00507455|588762456|FG002|Overall Study|Adverse Event|6|||
163015733|NCT00507455|588762454|FG000|Overall Study|Withdrawal by Subject|2|||
163015734|NCT00507455|588762455|FG001|Overall Study|Withdrawal by Subject|1|||
163015735|NCT00507455|588762456|FG002|Overall Study|Withdrawal by Subject|2|||
163015736|NCT00507455|588762454|FG000|Overall Study|Protocol Violation|4|||
163015737|NCT00507455|588762455|FG001|Overall Study|Protocol Violation|1|||
163015738|NCT00507455|588762456|FG002|Overall Study|Protocol Violation|1|||
163015739|NCT00507455|588762454|FG000|Overall Study|Lost to Follow-up|2|||
163015740|NCT00507455|588762455|FG001|Overall Study|Lost to Follow-up|0|||
163015741|NCT00507455|588762456|FG002|Overall Study|Lost to Follow-up|2|||
163015742|NCT00507455|588762454|FG000|Overall Study|Lack of Efficacy|0|||
163015743|NCT00507455|588762455|FG001|Overall Study|Lack of Efficacy|1|||
163015744|NCT00507455|588762456|FG002|Overall Study|Lack of Efficacy|0|||
163015745|NCT00507455|588762454|FG000|Overall Study|Other - miscellaneous reason|1|||
163015746|NCT00507455|588762455|FG001|Overall Study|Other - miscellaneous reason|0|||
163015747|NCT00507455|588762456|FG002|Overall Study|Other - miscellaneous reason|1|||
163015748|NCT01372995|588762457|FG000|Overall Study|Spouse withdrew participant from study|0|||
163015749|NCT01372995|588762458|FG001|Overall Study|Spouse withdrew participant from study|1|||
163015750|NCT01372995|588762459|FG002|Overall Study|Spouse withdrew participant from study|0|||
163015751|NCT01372995|588762457|FG000|Overall Study|Physician Decision|0|||
163015752|NCT01372995|588762458|FG001|Overall Study|Physician Decision|0|||
163015753|NCT01372995|588762459|FG002|Overall Study|Physician Decision|1|||
163015754|NCT06110494|588762465|FG000|Overall Study|Protocol Violation|2|||
163015755|NCT06110494|588762466|FG001|Overall Study|Protocol Violation|0|||
163015756|NCT06110494|588762467|FG002|Overall Study|Protocol Violation|1|||
163015757|NCT06110494|588762465|FG000|Overall Study|Dixon's test for outlier analysis|1|||
163015758|NCT06110494|588762466|FG001|Overall Study|Dixon's test for outlier analysis|1|||
163015759|NCT06110494|588762467|FG002|Overall Study|Dixon's test for outlier analysis|0|||
163015760|NCT00105079|588762468|FG000|Overall Study|Adverse Event|5|||
163015761|NCT00105079|588762469|FG001|Overall Study|Adverse Event|12|||
163015762|NCT00105079|588762468|FG000|Overall Study|Death|3|||
163015763|NCT00105079|588762469|FG001|Overall Study|Death|1|||
163015764|NCT00105079|588762468|FG000|Overall Study|Lost to Follow-up|12|||
163015765|NCT00105079|588762469|FG001|Overall Study|Lost to Follow-up|12|||
163015766|NCT00105079|588762468|FG000|Overall Study|Lack of Efficacy|9|||
163062842|NCT00127803|588936965|FG001|Overall Study|Withdrawal by Subject|0|||
163062843|NCT00127803|588936966|FG002|Overall Study|Withdrawal by Subject|0|||
163062844|NCT00127803|588936967|FG003|Overall Study|Withdrawal by Subject|0|||
163062845|NCT00127803|588936964|FG000|Overall Study|Lost to Follow-up|0|||
163015767|NCT00105079|588762469|FG001|Overall Study|Lack of Efficacy|3|||
163015768|NCT00105079|588762468|FG000|Overall Study|Refused treatment|6|||
163015769|NCT00105079|588762469|FG001|Overall Study|Refused treatment|4|||
163015770|NCT00105079|588762468|FG000|Overall Study|Violation of selection criteria at entry|0|||
163015771|NCT00105079|588762469|FG001|Overall Study|Violation of selection criteria at entry|2|||
163015772|NCT00105079|588762468|FG000|Overall Study|Protocol Violation|1|||
163015773|NCT00105079|588762469|FG001|Overall Study|Protocol Violation|0|||
163015774|NCT00105079|588762468|FG000|Overall Study|Other|3|||
163015775|NCT00105079|588762469|FG001|Overall Study|Other|1|||
163015776|NCT01464593|588762470|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
163015777|NCT01297517|588762477|FG000|Overall Study|Adverse Event|21|||
163015778|NCT01297517|588762478|FG001|Overall Study|Adverse Event|7|||
163015779|NCT01297517|588762479|FG002|Overall Study|Adverse Event|16|||
163015780|NCT01297517|588762477|FG000|Overall Study|Lost to Follow-up|1|||
163015781|NCT01297517|588762478|FG001|Overall Study|Lost to Follow-up|0|||
163015782|NCT01297517|588762479|FG002|Overall Study|Lost to Follow-up|1|||
163015783|NCT01297517|588762477|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
163015784|NCT01297517|588762478|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
163015785|NCT01297517|588762479|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
163015786|NCT01297517|588762477|FG000|Overall Study|Noncompliance|1|||
163015787|NCT01297517|588762478|FG001|Overall Study|Noncompliance|0|||
163015788|NCT01297517|588762479|FG002|Overall Study|Noncompliance|0|||
163015789|NCT01297517|588762477|FG000|Overall Study|Protocol Violation|1|||
163015790|NCT01297517|588762478|FG001|Overall Study|Protocol Violation|1|||
163015791|NCT01297517|588762479|FG002|Overall Study|Protocol Violation|1|||
163015792|NCT01297517|588762477|FG000|Overall Study|Inadequate Control of IOP|1|||
163015793|NCT01297517|588762478|FG001|Overall Study|Inadequate Control of IOP|1|||
163015794|NCT01297517|588762479|FG002|Overall Study|Inadequate Control of IOP|2|||
163015795|NCT02914613|588762480|FG000|Overall Study|Withdrawal by Subject|1|||
163015796|NCT02914613|588762481|FG001|Overall Study|Withdrawal by Subject|2|||
163015797|NCT02914613|588762480|FG000|Overall Study|Adverse Event|1|||
163015798|NCT02914613|588762481|FG001|Overall Study|Adverse Event|0|||
163015799|NCT01737710|588762484|FG000|Overall Study|Lost to Follow-up|0|||
163015800|NCT01737710|588762485|FG001|Overall Study|Lost to Follow-up|2|||
163015801|NCT01737710|588762486|FG002|Overall Study|Lost to Follow-up|2|||
163015802|NCT01737710|588762487|FG003|Overall Study|Lost to Follow-up|0|||
163015803|NCT01737710|588762488|FG004|Overall Study|Lost to Follow-up|0|||
163015804|NCT01737710|588762484|FG000|Overall Study|Withdrawal by Subject|1|||
163015805|NCT01737710|588762485|FG001|Overall Study|Withdrawal by Subject|1|||
163015806|NCT01737710|588762486|FG002|Overall Study|Withdrawal by Subject|1|||
163015807|NCT01737710|588762487|FG003|Overall Study|Withdrawal by Subject|0|||
163015808|NCT01737710|588762488|FG004|Overall Study|Withdrawal by Subject|0|||
163015809|NCT01737710|588762484|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
163015810|NCT01737710|588762485|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
163015811|NCT01737710|588762486|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
163062846|NCT00127803|588936965|FG001|Overall Study|Lost to Follow-up|0|||
163215454|NCT02432846|589503827|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
163015812|NCT01737710|588762487|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
163015813|NCT01737710|588762488|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
163015814|NCT00921557|588762494|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
163015815|NCT00921557|588762495|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
163015816|NCT00921557|588762496|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
163015817|NCT00921557|588762494|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
163015818|NCT00921557|588762495|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
163015819|NCT00921557|588762496|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
163015820|NCT00921557|588762494|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
163015821|NCT00921557|588762495|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
163015822|NCT00921557|588762496|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
163015823|NCT00921557|588762494|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
163015824|NCT00921557|588762495|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
163215455|NCT02432846|589503828|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
163015825|NCT00921557|588762496|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
163015826|NCT00921557|588762494|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
163015827|NCT00921557|588762495|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
163015828|NCT00921557|588762496|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
163015829|NCT02993250|588762500|FG000|Overall Study|Lost to Follow-up|0|||
163015830|NCT02993250|588762501|FG001|Overall Study|Lost to Follow-up|1|||
163015831|NCT02527434|588762503|FG000|Overall Study|Lost to Follow-up|2|||
163015832|NCT02527434|588762504|FG001|Overall Study|Lost to Follow-up|2|||
163062847|NCT00127803|588936966|FG002|Overall Study|Lost to Follow-up|0|||
163015833|NCT02527434|588762505|FG002|Overall Study|Lost to Follow-up|0|||
163015834|NCT02527434|588762503|FG000|Overall Study|Death|19|||
163015835|NCT02527434|588762504|FG001|Overall Study|Death|6|||
163015836|NCT02527434|588762505|FG002|Overall Study|Death|17|||
163015837|NCT02527434|588762503|FG000|Overall Study|Withdrawal by Subject|5|||
163015838|NCT02527434|588762504|FG001|Overall Study|Withdrawal by Subject|3|||
163015839|NCT02527434|588762505|FG002|Overall Study|Withdrawal by Subject|3|||
163015840|NCT02527434|588762503|FG000|Overall Study|Reason Not Specified|1|||
163015841|NCT02527434|588762504|FG001|Overall Study|Reason Not Specified|0|||
163015842|NCT02527434|588762505|FG002|Overall Study|Reason Not Specified|0|||
163015843|NCT02527434|588762503|FG000|Overall Study|Site closure|1|||
163015844|NCT02527434|588762504|FG001|Overall Study|Site closure|0|||
163015845|NCT02527434|588762505|FG002|Overall Study|Site closure|0|||
163015846|NCT02861807|588762506|FG000|Overall Study|Lost to Follow-up|7|||
163015847|NCT02861807|588762507|FG001|Overall Study|Lost to Follow-up|6|||
163015848|NCT02861807|588762506|FG000|Overall Study|Withdrawal by Subject|5|||
163015849|NCT02861807|588762507|FG001|Overall Study|Withdrawal by Subject|8|||
163015850|NCT00568061|588762512|FG000|Overall Study|Inclusion / exclusion criteria|5|||
163015851|NCT00568061|588762513|FG001|Overall Study|Inclusion / exclusion criteria|1|||
163015852|NCT00568061|588762512|FG000|Overall Study|Adverse Event|0|||
163015853|NCT00568061|588762513|FG001|Overall Study|Adverse Event|1|||
163015854|NCT00356148|588762514|FG000|Overall Study|Reoperation within 30 days|2|||
163015855|NCT00356148|588762515|FG001|Overall Study|Reoperation within 30 days|1|||
163015856|NCT02693002|588762516|FG000|Overall Study|Withdrawal by Subject|1|||
163015857|NCT02693002|588762517|FG001|Overall Study|Withdrawal by Subject|0|||
163015858|NCT04666259|588762519|FG000|Treatment Phase|Physician Decision|9|||
163015859|NCT04666259|588762520|FG001|Treatment Phase|Physician Decision|3|||
163015860|NCT04666259|588762521|FG002|Treatment Phase|Physician Decision|3|||
163015861|NCT04666259|588762519|FG000|Treatment Phase|Adverse Event|3|||
163015862|NCT04666259|588762520|FG001|Treatment Phase|Adverse Event|1|||
163015863|NCT04666259|588762521|FG002|Treatment Phase|Adverse Event|0|||
163015864|NCT04666259|588762519|FG000|Treatment Phase|Subject decision|1|||
163015865|NCT04666259|588762520|FG001|Treatment Phase|Subject decision|2|||
163015866|NCT04666259|588762521|FG002|Treatment Phase|Subject decision|0|||
163015867|NCT04666259|588762519|FG000|Treatment Phase|Progressive disease|0|||
163015868|NCT04666259|588762520|FG001|Treatment Phase|Progressive disease|1|||
163015869|NCT04666259|588762521|FG002|Treatment Phase|Progressive disease|0|||
163015870|NCT04666259|588762519|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
163015871|NCT04666259|588762520|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
163015872|NCT04666259|588762521|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
163015873|NCT04666259|588762519|FG000|Safety Follow-up Phase|Physician Decision|2|||
163015874|NCT04666259|588762520|FG001|Safety Follow-up Phase|Physician Decision|0|||
163015875|NCT04666259|588762521|FG002|Safety Follow-up Phase|Physician Decision|0|||
163015876|NCT04666259|588762519|FG000|Safety Follow-up Phase|Subject decision|1|||
163015877|NCT04666259|588762520|FG001|Safety Follow-up Phase|Subject decision|0|||
163015878|NCT04666259|588762521|FG002|Safety Follow-up Phase|Subject decision|0|||
163015879|NCT04666259|588762519|FG000|Safety Follow-up Phase|Death|0|||
163015880|NCT04666259|588762520|FG001|Safety Follow-up Phase|Death|1|||
163015881|NCT04666259|588762521|FG002|Safety Follow-up Phase|Death|0|||
163015882|NCT01791894|588762526|FG000|Overall Study|Adverse Event|1|||
163015883|NCT01422889|588762527|FG000|Overall Study|No Data Entered for Study Stent|9|||
163015884|NCT03289754|588762538|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
163015885|NCT04873934|588762539|FG000|Overall Study|Adverse Event|0|||
163015886|NCT04873934|588762540|FG001|Overall Study|Adverse Event|1|||
163015887|NCT04873934|588762539|FG000|Overall Study|Death|0|||
163015888|NCT04873934|588762540|FG001|Overall Study|Death|2|||
163015889|NCT04873934|588762539|FG000|Overall Study|Lost to Follow-up|13|||
163015890|NCT04873934|588762540|FG001|Overall Study|Lost to Follow-up|9|||
163215456|NCT02432846|589503829|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
163215457|NCT02432846|589503830|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
163015891|NCT04873934|588762539|FG000|Overall Study|Physician Decision|1|||
163015892|NCT04873934|588762540|FG001|Overall Study|Physician Decision|1|||
163015893|NCT04873934|588762539|FG000|Overall Study|Protocol deviation|2|||
163015894|NCT04873934|588762540|FG001|Overall Study|Protocol deviation|1|||
163015895|NCT04873934|588762539|FG000|Overall Study|Subject decision|1|||
163015896|NCT04873934|588762540|FG001|Overall Study|Subject decision|8|||
163015897|NCT04873934|588762539|FG000|Overall Study|Withdrew consent|0|||
163015898|NCT04873934|588762540|FG001|Overall Study|Withdrew consent|4|||
163015899|NCT04873934|588762539|FG000|Overall Study|Missing|1|||
163215458|NCT02432846|589503825|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
163215459|NCT02432846|589503826|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
163215460|NCT02432846|589503827|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
163215461|NCT02432846|589503828|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
163215462|NCT02432846|589503829|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
163215463|NCT02432846|589503830|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
163015900|NCT04873934|588762540|FG001|Overall Study|Missing|0|||
163015901|NCT03584854|588762541|FG000|Overall Study|Primary outcome not measured|1|||
163015902|NCT03584854|588762542|FG001|Overall Study|Primary outcome not measured|2|||
163015903|NCT00153179|588762548|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
163015904|NCT00153179|588762549|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
163015905|NCT00153179|588762550|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
163015906|NCT00153179|588762551|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
163015907|NCT01801865|588762552|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
163015908|NCT01801865|588762552|FG000|Overall Study|Physician Decision|7|||
163015909|NCT01500382|588762555|FG000|Washout Period|Study site went out of business|0|||
163015910|NCT01500382|588762556|FG001|Washout Period|Study site went out of business|0|||
163015911|NCT01500382|588762557|FG002|Washout Period|Study site went out of business|1|||
163015912|NCT01500382|588762558|FG003|Washout Period|Study site went out of business|0|||
163015913|NCT02134015|588762559|FG000|Overall Study|Protocol Violation|0|||
163015914|NCT02134015|588762560|FG001|Overall Study|Protocol Violation|1|||
163015915|NCT02134015|588762559|FG000|Overall Study|Death|2|||
163015916|NCT02134015|588762560|FG001|Overall Study|Death|1|||
163015917|NCT02134015|588762559|FG000|Overall Study|Reason not provided|1|||
163015918|NCT02134015|588762560|FG001|Overall Study|Reason not provided|2|||
163015919|NCT02134015|588762559|FG000|Overall Study|Clinical progression|14|||
163015920|NCT02134015|588762560|FG001|Overall Study|Clinical progression|7|||
163015921|NCT02134015|588762559|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
163015922|NCT02134015|588762560|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
163015923|NCT02134015|588762559|FG000|Overall Study|Study terminated by sponsor|2|||
163015924|NCT02134015|588762560|FG001|Overall Study|Study terminated by sponsor|3|||
163015925|NCT02134015|588762559|FG000|Overall Study|Adverse Event|9|||
163015926|NCT02134015|588762560|FG001|Overall Study|Adverse Event|10|||
163015927|NCT02134015|588762559|FG000|Overall Study|Withdrawal by Subject|3|||
163015928|NCT02134015|588762560|FG001|Overall Study|Withdrawal by Subject|7|||
163015929|NCT02186873|588764112|FG000|Overall Study|Adverse Event|1|||
163015930|NCT02186873|588764113|FG001|Overall Study|Adverse Event|3|||
163015931|NCT02186873|588764112|FG000|Overall Study|Lack of Efficacy|0|||
163015932|NCT02186873|588764113|FG001|Overall Study|Lack of Efficacy|1|||
163015933|NCT02186873|588764112|FG000|Overall Study|Lost to Follow-up|1|||
163015934|NCT02186873|588764113|FG001|Overall Study|Lost to Follow-up|2|||
163015935|NCT02186873|588764112|FG000|Overall Study|Withdrawal by Subject|7|||
163015936|NCT02186873|588764113|FG001|Overall Study|Withdrawal by Subject|2|||
163015937|NCT03694002|588764114|FG000|Overall Study|Progression|4|||
163015938|NCT03694002|588764115|FG001|Overall Study|Progression|2|||
163015939|NCT03694002|588764114|FG000|Overall Study|Adverse Event|2|||
163015940|NCT03694002|588764115|FG001|Overall Study|Adverse Event|0|||
163015941|NCT03694002|588764114|FG000|Overall Study|Other not protocol specified|1|||
163015942|NCT03694002|588764115|FG001|Overall Study|Other not protocol specified|0|||
163015943|NCT03694002|588764114|FG000|Overall Study|Ineligible|0|||
163015944|NCT03694002|588764115|FG001|Overall Study|Ineligible|1|||
163015945|NCT03694002|588764114|FG000|Overall Study|Withdrew consent before starting treatment|0|||
163015946|NCT03694002|588764115|FG001|Overall Study|Withdrew consent before starting treatment|3|||
163015947|NCT01760655|588764116|FG000|Overall Study|Death|18|||
163015948|NCT01760655|588764116|FG000|Overall Study|Physician Decision|1|||
163015949|NCT00068393|588764121|FG000|Overall Study|Adverse Event|2|||
163015950|NCT00068393|588764121|FG000|Overall Study|Death|3|||
163015951|NCT00068393|588764121|FG000|Overall Study|Withdrawal by Subject|3|||
163015952|NCT00068393|588764121|FG000|Overall Study|Alternative treatment|1|||
163015953|NCT00068393|588764121|FG000|Overall Study|Quality of life worsening|1|||
163015954|NCT01399047|588764122|FG000|Overall Study|Withdrawal by Subject|0|||
163015955|NCT01399047|588764123|FG001|Overall Study|Withdrawal by Subject|1|||
163015956|NCT03300505|588764129|FG000|Overall Study|Death|0|||
163015957|NCT03300505|588764130|FG001|Overall Study|Death|1|||
163015958|NCT03300505|588764131|FG002|Overall Study|Death|0|||
163015959|NCT03300505|588764129|FG000|Overall Study|Withdrawal by Subject|0|||
163015960|NCT03300505|588764130|FG001|Overall Study|Withdrawal by Subject|1|||
163015961|NCT03300505|588764131|FG002|Overall Study|Withdrawal by Subject|1|||
163015962|NCT03300505|588764129|FG000|Overall Study|Sponsor Termination|0|||
163015963|NCT03300505|588764130|FG001|Overall Study|Sponsor Termination|1|||
163015964|NCT03300505|588764131|FG002|Overall Study|Sponsor Termination|0|||
163015965|NCT03300505|588764129|FG000|Overall Study|Adverse Event|0|||
163404690|NCT00996944|590191998|FG001|Double-blind Treatment Period|Adverse Event|1|||
163404691|NCT00996944|590191997|FG000|Double-blind Treatment Period|Protocol Violation|1|||
163015966|NCT03300505|588764130|FG001|Overall Study|Adverse Event|0|||
163015967|NCT03300505|588764131|FG002|Overall Study|Adverse Event|2|||
163015968|NCT01108341|588764134|FG000|Overall Study|Death|2|||
163015969|NCT01108341|588764134|FG000|Overall Study|Withdrawal by Subject|1|||
163015970|NCT01108341|588764134|FG000|Overall Study|Lost to Follow-up|1|||
163015971|NCT01108341|588764134|FG000|Overall Study|Other|1|||
163015972|NCT01515865|588764137|FG000|Part A (Open-label)|Other|3|||
163015973|NCT01515865|588764138|FG001|Part A (Open-label)|Other|0|||
163015974|NCT01515865|588764139|FG002|Part A (Open-label)|Other|0|||
163015975|NCT01515865|588764137|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
163015976|NCT01515865|588764138|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
163015977|NCT01515865|588764139|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
163015978|NCT01515865|588764137|FG000|Part B (Open-label)|Other|1|||
163015979|NCT01515865|588764138|FG001|Part B (Open-label)|Other|0|||
163015980|NCT01515865|588764139|FG002|Part B (Open-label)|Other|0|||
163015981|NCT02510664|588764144|FG000|Overall Study|Transferred Care|9|||
163015982|NCT02510664|588764145|FG001|Overall Study|Transferred Care|9|||
163015983|NCT02510664|588764146|FG002|Overall Study|Transferred Care|0|||
163015984|NCT02510664|588764144|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
163015985|NCT02510664|588764145|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
163015986|NCT02510664|588764146|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
163015987|NCT02510664|588764144|FG000|Overall Study|Time Constraints|1|||
163015988|NCT02510664|588764145|FG001|Overall Study|Time Constraints|1|||
163015989|NCT02510664|588764146|FG002|Overall Study|Time Constraints|0|||
163015990|NCT00386360|588764147|FG000|Overall Study|Adverse Event|4|||
163015991|NCT00386360|588764148|FG001|Overall Study|Adverse Event|2|||
163015992|NCT00386360|588764147|FG000|Overall Study|Physician Decision|2|||
163015993|NCT00386360|588764148|FG001|Overall Study|Physician Decision|2|||
163015994|NCT00386360|588764147|FG000|Overall Study|Lost to Follow-up|0|||
163015995|NCT00386360|588764148|FG001|Overall Study|Lost to Follow-up|2|||
163015996|NCT00386360|588764147|FG000|Overall Study|Protocol Violation|0|||
163015997|NCT00386360|588764148|FG001|Overall Study|Protocol Violation|3|||
163015998|NCT00386360|588764147|FG000|Overall Study|Withdrawal by Subject|3|||
163015999|NCT00386360|588764148|FG001|Overall Study|Withdrawal by Subject|6|||
163016000|NCT00386360|588764147|FG000|Overall Study|Did not take any study medication|0|||
163016001|NCT00386360|588764148|FG001|Overall Study|Did not take any study medication|2|||
163016002|NCT02490371|588764151|FG000|Overall Study|Lost to Follow-up|1|||
163016003|NCT02490371|588764152|FG001|Overall Study|Lost to Follow-up|1|||
163016004|NCT03018080|588764153|FG000|Overall Study|Death|12|||
163016005|NCT03018080|588764154|FG001|Overall Study|Death|19|||
163016006|NCT00026494|588764157|FG000|Overall Study|Withdrawal by Subject|1|||
163016007|NCT00026494|588764158|FG001|Overall Study|Withdrawal by Subject|0|||
163016008|NCT00026494|588764159|FG002|Overall Study|Withdrawal by Subject|1|||
163016009|NCT00026494|588764160|FG003|Overall Study|Withdrawal by Subject|0|||
163016010|NCT00026494|588764157|FG000|Overall Study|Patient non-compliance|1|||
163016011|NCT00026494|588764158|FG001|Overall Study|Patient non-compliance|0|||
163016012|NCT00026494|588764159|FG002|Overall Study|Patient non-compliance|0|||
163016013|NCT00026494|588764160|FG003|Overall Study|Patient non-compliance|0|||
163016014|NCT00026494|588764157|FG000|Overall Study|Patient not treated|0|||
163016015|NCT00026494|588764158|FG001|Overall Study|Patient not treated|0|||
163016016|NCT00026494|588764159|FG002|Overall Study|Patient not treated|2|||
163016017|NCT00026494|588764160|FG003|Overall Study|Patient not treated|0|||
163016018|NCT00026494|588764157|FG000|Overall Study|Clinical progression|0|||
163016019|NCT00026494|588764158|FG001|Overall Study|Clinical progression|0|||
163016020|NCT00026494|588764159|FG002|Overall Study|Clinical progression|3|||
163016021|NCT00026494|588764160|FG003|Overall Study|Clinical progression|0|||
163016022|NCT01455597|588764161|FG000|Overall Study|Adverse Event|7|||
163016023|NCT01455597|588764162|FG001|Overall Study|Adverse Event|0|||
163016024|NCT01455597|588764163|FG002|Overall Study|Adverse Event|5|||
163016025|NCT01455597|588764164|FG003|Overall Study|Adverse Event|1|||
163016026|NCT01455597|588764161|FG000|Overall Study|Lack of Efficacy|0|||
163016027|NCT01455597|588764162|FG001|Overall Study|Lack of Efficacy|1|||
163016028|NCT01455597|588764163|FG002|Overall Study|Lack of Efficacy|2|||
163016029|NCT01455597|588764164|FG003|Overall Study|Lack of Efficacy|0|||
163016030|NCT01455597|588764161|FG000|Overall Study|Lost to Follow-up|3|||
163016031|NCT01455597|588764162|FG001|Overall Study|Lost to Follow-up|0|||
163016032|NCT01455597|588764163|FG002|Overall Study|Lost to Follow-up|2|||
163016033|NCT01455597|588764164|FG003|Overall Study|Lost to Follow-up|1|||
163016034|NCT01455597|588764161|FG000|Overall Study|Withdrew Consent|6|||
163016035|NCT01455597|588764162|FG001|Overall Study|Withdrew Consent|5|||
163016036|NCT01455597|588764163|FG002|Overall Study|Withdrew Consent|8|||
163016037|NCT01455597|588764164|FG003|Overall Study|Withdrew Consent|5|||
163016038|NCT01455597|588764161|FG000|Overall Study|Reason not Specified|1|||
163016039|NCT01455597|588764162|FG001|Overall Study|Reason not Specified|2|||
163016040|NCT01455597|588764163|FG002|Overall Study|Reason not Specified|3|||
163404692|NCT00996944|590191998|FG001|Double-blind Treatment Period|Protocol Violation|0|||
163016041|NCT01455597|588764164|FG003|Overall Study|Reason not Specified|3|||
163016042|NCT03412734|588764168|FG000|Overall Study|Incorrect labeling of samples|2|||
163016043|NCT03412734|588764169|FG001|Overall Study|Incorrect labeling of samples|0|||
163016044|NCT03412734|588764168|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
163016045|NCT03412734|588764169|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
163016046|NCT00423332|588764170|FG000|Overall Study|Adverse Event|6|||
163016047|NCT00423332|588764171|FG001|Overall Study|Adverse Event|2|||
163016048|NCT00423332|588764170|FG000|Overall Study|Withdrawal by Subject|1|||
163016049|NCT00423332|588764171|FG001|Overall Study|Withdrawal by Subject|0|||
163016050|NCT00423332|588764170|FG000|Overall Study|Condition under investigation worsened|1|||
163016051|NCT00423332|588764171|FG001|Overall Study|Condition under investigation worsened|1|||
163016052|NCT00423332|588764170|FG000|Overall Study|Progressive at Week 6|0|||
163016053|NCT00423332|588764171|FG001|Overall Study|Progressive at Week 6|1|||
163016054|NCT00423332|588764170|FG000|Overall Study|Unblinded before 12 weeks|1|||
163016055|NCT00423332|588764171|FG001|Overall Study|Unblinded before 12 weeks|3|||
163016056|NCT03777436|588764172|FG000|Placebo-controlled Phase|Adverse Event|8|||
163016057|NCT03777436|588764173|FG001|Placebo-controlled Phase|Adverse Event|10|||
163016058|NCT03777436|588764174|FG002|Placebo-controlled Phase|Adverse Event|0|||
163016059|NCT03777436|588764172|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
163016060|NCT03777436|588764173|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
163016061|NCT03777436|588764174|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
163016062|NCT03777436|588764172|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
163016063|NCT03777436|588764173|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
163016064|NCT03777436|588764174|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
163016065|NCT03777436|588764172|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
163016066|NCT03777436|588764173|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
163016067|NCT03777436|588764174|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
163016068|NCT03777436|588764172|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
163016069|NCT03777436|588764173|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
163016070|NCT03777436|588764174|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
163016071|NCT03777436|588764172|FG000|Placebo-controlled Phase|Physician Decision|0|||
163016072|NCT03777436|588764173|FG001|Placebo-controlled Phase|Physician Decision|1|||
163016073|NCT03777436|588764174|FG002|Placebo-controlled Phase|Physician Decision|0|||
163016074|NCT03777436|588764172|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
163016075|NCT03777436|588764173|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
163016076|NCT03777436|588764174|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
163016077|NCT03777436|588764172|FG000|Apremilast Extension Phase|Adverse Event|0|||
163016078|NCT03777436|588764173|FG001|Apremilast Extension Phase|Adverse Event|0|||
163016079|NCT03777436|588764174|FG002|Apremilast Extension Phase|Adverse Event|6|||
163016080|NCT03777436|588764172|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
163016081|NCT03777436|588764173|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
163016082|NCT03777436|588764174|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
163016083|NCT03777436|588764172|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
163016084|NCT03777436|588764173|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
163016085|NCT03777436|588764174|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
163016086|NCT03777436|588764172|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
163016087|NCT03777436|588764173|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
163016088|NCT03777436|588764174|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
163016089|NCT03777436|588764172|FG000|Apremilast Extension Phase|Miscellaneous|0|||
163016090|NCT03777436|588764173|FG001|Apremilast Extension Phase|Miscellaneous|0|||
163016091|NCT03777436|588764174|FG002|Apremilast Extension Phase|Miscellaneous|1|||
163016092|NCT02035202|588764175|FG000|Overall Study|Lost to Follow-up|8|||
163016093|NCT02035202|588764176|FG001|Overall Study|Lost to Follow-up|16|||
163016094|NCT02035202|588764177|FG002|Overall Study|Lost to Follow-up|2|||
163016095|NCT00685399|588764178|FG000|Treatment Period 1|Withdrawal by Subject|2|||
163016096|NCT00685399|588764179|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163016097|NCT00685399|588764180|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163016098|NCT00685399|588764181|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163016099|NCT00685399|588764182|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163016100|NCT00685399|588764183|FG005|Treatment Period 1|Withdrawal by Subject|0|||
163016101|NCT00685399|588764184|FG006|Treatment Period 1|Withdrawal by Subject|0|||
163016102|NCT00685399|588764185|FG007|Treatment Period 1|Withdrawal by Subject|0|||
163016103|NCT00685399|588764178|FG000|Treatment Period 1|Protocol Violation|1|||
163016104|NCT00685399|588764179|FG001|Treatment Period 1|Protocol Violation|0|||
163016105|NCT00685399|588764180|FG002|Treatment Period 1|Protocol Violation|0|||
163016106|NCT00685399|588764181|FG003|Treatment Period 1|Protocol Violation|0|||
163016107|NCT00685399|588764182|FG004|Treatment Period 1|Protocol Violation|0|||
163016108|NCT00685399|588764183|FG005|Treatment Period 1|Protocol Violation|0|||
163062848|NCT00127803|588936967|FG003|Overall Study|Lost to Follow-up|1|||
163062849|NCT03907488|588936968|FG000|Overall Study|Adverse Event|20|||
163062850|NCT03907488|588936969|FG001|Overall Study|Adverse Event|20|||
163062851|NCT03907488|588936968|FG000|Overall Study|Withdrawal by Subject|9|||
163215464|NCT02432846|589503825|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
163016109|NCT00685399|588764184|FG006|Treatment Period 1|Protocol Violation|0|||
163016110|NCT00685399|588764185|FG007|Treatment Period 1|Protocol Violation|0|||
163404693|NCT00996944|590191997|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
163016111|NCT00685399|588764178|FG000|Treatment Period 1|Administrative|2|||
163016112|NCT00685399|588764179|FG001|Treatment Period 1|Administrative|0|||
163215465|NCT02432846|589503826|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
163016113|NCT00685399|588764180|FG002|Treatment Period 1|Administrative|0|||
163016114|NCT00685399|588764181|FG003|Treatment Period 1|Administrative|0|||
163016115|NCT00685399|588764182|FG004|Treatment Period 1|Administrative|0|||
163016116|NCT00685399|588764183|FG005|Treatment Period 1|Administrative|0|||
163016117|NCT00685399|588764184|FG006|Treatment Period 1|Administrative|0|||
163016118|NCT00685399|588764185|FG007|Treatment Period 1|Administrative|0|||
163016119|NCT00685399|588764178|FG000|Treatment Period 1|Lack of Efficacy|1|||
163016120|NCT00685399|588764179|FG001|Treatment Period 1|Lack of Efficacy|0|||
163016121|NCT00685399|588764180|FG002|Treatment Period 1|Lack of Efficacy|0|||
163016122|NCT00685399|588764181|FG003|Treatment Period 1|Lack of Efficacy|0|||
163016123|NCT00685399|588764182|FG004|Treatment Period 1|Lack of Efficacy|0|||
163016124|NCT00685399|588764183|FG005|Treatment Period 1|Lack of Efficacy|0|||
163016125|NCT00685399|588764184|FG006|Treatment Period 1|Lack of Efficacy|0|||
163016126|NCT00685399|588764185|FG007|Treatment Period 1|Lack of Efficacy|0|||
163016127|NCT00685399|588764178|FG000|Treatment Period 2|Administrative Problems|0|||
163016128|NCT00685399|588764179|FG001|Treatment Period 2|Administrative Problems|2|||
163016129|NCT00685399|588764180|FG002|Treatment Period 2|Administrative Problems|1|||
163016130|NCT00685399|588764181|FG003|Treatment Period 2|Administrative Problems|0|||
163016131|NCT00685399|588764182|FG004|Treatment Period 2|Administrative Problems|0|||
163016132|NCT00685399|588764183|FG005|Treatment Period 2|Administrative Problems|0|||
163016133|NCT00685399|588764184|FG006|Treatment Period 2|Administrative Problems|0|||
163016134|NCT00685399|588764185|FG007|Treatment Period 2|Administrative Problems|0|||
163016135|NCT00685399|588764178|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163016136|NCT00685399|588764179|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163016137|NCT00685399|588764180|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163016138|NCT00685399|588764181|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163016139|NCT00685399|588764182|FG004|Treatment Period 2|Withdrawal by Subject|0|||
163016140|NCT00685399|588764183|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163016141|NCT00685399|588764184|FG006|Treatment Period 2|Withdrawal by Subject|0|||
163016142|NCT00685399|588764185|FG007|Treatment Period 2|Withdrawal by Subject|2|||
163016143|NCT00685399|588764178|FG000|Treatment Period 2|Adverse Event|0|||
163016144|NCT00685399|588764179|FG001|Treatment Period 2|Adverse Event|0|||
163016145|NCT00685399|588764180|FG002|Treatment Period 2|Adverse Event|0|||
163016146|NCT00685399|588764181|FG003|Treatment Period 2|Adverse Event|0|||
163016147|NCT00685399|588764182|FG004|Treatment Period 2|Adverse Event|0|||
163062852|NCT03907488|588936969|FG001|Overall Study|Withdrawal by Subject|13|||
163062853|NCT03907488|588936968|FG000|Overall Study|Lack of Efficacy|0|||
163062854|NCT03907488|588936969|FG001|Overall Study|Lack of Efficacy|9|||
163062855|NCT03907488|588936968|FG000|Overall Study|Death|3|||
163062856|NCT03907488|588936969|FG001|Overall Study|Death|8|||
163062857|NCT03907488|588936968|FG000|Overall Study|not protocol specified|5|||
163062858|NCT03907488|588936969|FG001|Overall Study|not protocol specified|8|||
163062859|NCT03907488|588936968|FG000|Overall Study|Ineligible|9|||
163062860|NCT03907488|588936969|FG001|Overall Study|Ineligible|15|||
163062861|NCT03321721|588936971|FG000|Overall Study|Lost to Follow-up|4|||
163062862|NCT03321721|588936972|FG001|Overall Study|Lost to Follow-up|8|||
163062863|NCT03321721|588936973|FG002|Overall Study|Lost to Follow-up|11|||
163062864|NCT04809974|588938511|FG000|Lead-in Phase|Withdrawal by Subject|3|||
163062865|NCT04809974|588938512|FG001|Lead-in Phase|Withdrawal by Subject|0|||
163062866|NCT04809974|588938513|FG002|Lead-in Phase|Withdrawal by Subject|0|||
163062867|NCT04809974|588938511|FG000|Lead-in Phase|No longer eligible|11|||
163062868|NCT04809974|588938512|FG001|Lead-in Phase|No longer eligible|0|||
163062869|NCT04809974|588938513|FG002|Lead-in Phase|No longer eligible|0|||
163062870|NCT04809974|588938511|FG000|Randomized Phase|Lost to Follow-up|0|||
163062871|NCT04809974|588938512|FG001|Randomized Phase|Lost to Follow-up|1|||
163062872|NCT04809974|588938513|FG002|Randomized Phase|Lost to Follow-up|5|||
163062873|NCT04809974|588938511|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
163062874|NCT04809974|588938512|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
163062875|NCT04809974|588938513|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
163062876|NCT04809974|588938511|FG000|Randomized Phase|Adverse Event|0|||
163062877|NCT04809974|588938512|FG001|Randomized Phase|Adverse Event|1|||
163062878|NCT04809974|588938513|FG002|Randomized Phase|Adverse Event|4|||
163062879|NCT04809974|588938511|FG000|Randomized Phase|Withdrawal by Subject|0|||
163328564|NCT03211247|589913301|FG002|Overall Study|Adverse Event|1|||
163328565|NCT03211247|589913302|FG003|Overall Study|Adverse Event|0|||
163328566|NCT03211247|589913303|FG004|Overall Study|Adverse Event|0|||
163328567|NCT03211247|589913299|FG000|Overall Study|Lost to Follow-up|2|||
163062880|NCT04809974|588938512|FG001|Randomized Phase|Withdrawal by Subject|0|||
163016148|NCT00685399|588764183|FG005|Treatment Period 2|Adverse Event|1|||
163016149|NCT00685399|588764184|FG006|Treatment Period 2|Adverse Event|0|||
163062881|NCT04809974|588938513|FG002|Randomized Phase|Withdrawal by Subject|5|||
163062882|NCT04338581|588938514|FG000|Overall Study|Lack of Efficacy|1|||
163062883|NCT04338581|588938515|FG001|Overall Study|Lack of Efficacy|0|||
163062884|NCT04338581|588938514|FG000|Overall Study|Withdrawal by Subject|4|||
163328568|NCT03211247|589913300|FG001|Overall Study|Lost to Follow-up|1|||
163328569|NCT03211247|589913301|FG002|Overall Study|Lost to Follow-up|0|||
163016150|NCT00685399|588764185|FG007|Treatment Period 2|Adverse Event|0|||
163016151|NCT00685399|588764178|FG000|Treatment Period 2|Lack of Efficacy|0|||
163016152|NCT00685399|588764179|FG001|Treatment Period 2|Lack of Efficacy|10|||
163016153|NCT00685399|588764180|FG002|Treatment Period 2|Lack of Efficacy|2|||
163328570|NCT03211247|589913302|FG003|Overall Study|Lost to Follow-up|0|||
163016154|NCT00685399|588764181|FG003|Treatment Period 2|Lack of Efficacy|0|||
163016155|NCT00685399|588764182|FG004|Treatment Period 2|Lack of Efficacy|0|||
163016156|NCT00685399|588764183|FG005|Treatment Period 2|Lack of Efficacy|1|||
163016157|NCT00685399|588764184|FG006|Treatment Period 2|Lack of Efficacy|0|||
163016158|NCT00685399|588764185|FG007|Treatment Period 2|Lack of Efficacy|0|||
163016159|NCT00685399|588764178|FG000|Extension|Administrative Issues|0|||
163016160|NCT00685399|588764179|FG001|Extension|Administrative Issues|0|||
163016161|NCT00685399|588764180|FG002|Extension|Administrative Issues|0|||
163016162|NCT00685399|588764181|FG003|Extension|Administrative Issues|1|||
163016163|NCT00685399|588764182|FG004|Extension|Administrative Issues|0|||
163016164|NCT00685399|588764183|FG005|Extension|Administrative Issues|0|||
163016165|NCT00685399|588764184|FG006|Extension|Administrative Issues|0|||
163016166|NCT00685399|588764185|FG007|Extension|Administrative Issues|0|||
163016167|NCT00685399|588764178|FG000|Extension|Withdrawal by Subject|0|||
163016168|NCT00685399|588764179|FG001|Extension|Withdrawal by Subject|0|||
163016169|NCT00685399|588764180|FG002|Extension|Withdrawal by Subject|0|||
163016170|NCT00685399|588764181|FG003|Extension|Withdrawal by Subject|1|||
163016171|NCT00685399|588764182|FG004|Extension|Withdrawal by Subject|0|||
163016172|NCT00685399|588764183|FG005|Extension|Withdrawal by Subject|0|||
163016173|NCT00685399|588764184|FG006|Extension|Withdrawal by Subject|0|||
163016174|NCT00685399|588764185|FG007|Extension|Withdrawal by Subject|0|||
163016175|NCT00685399|588764178|FG000|Extension|Protocol Violation|0|||
163016176|NCT00685399|588764179|FG001|Extension|Protocol Violation|0|||
163016177|NCT00685399|588764180|FG002|Extension|Protocol Violation|0|||
163016178|NCT00685399|588764181|FG003|Extension|Protocol Violation|1|||
163016179|NCT00685399|588764182|FG004|Extension|Protocol Violation|0|||
163016180|NCT00685399|588764183|FG005|Extension|Protocol Violation|0|||
163016181|NCT00685399|588764184|FG006|Extension|Protocol Violation|0|||
163016182|NCT00685399|588764185|FG007|Extension|Protocol Violation|0|||
163016183|NCT00685399|588764178|FG000|Extension|Lack of Efficacy|0|||
163016184|NCT00685399|588764179|FG001|Extension|Lack of Efficacy|0|||
163016185|NCT00685399|588764180|FG002|Extension|Lack of Efficacy|0|||
163016186|NCT00685399|588764181|FG003|Extension|Lack of Efficacy|2|||
163016187|NCT00685399|588764182|FG004|Extension|Lack of Efficacy|0|||
163016188|NCT00685399|588764183|FG005|Extension|Lack of Efficacy|0|||
163016189|NCT00685399|588764184|FG006|Extension|Lack of Efficacy|0|||
163016190|NCT00685399|588764185|FG007|Extension|Lack of Efficacy|0|||
163016191|NCT00685399|588764178|FG000|Extension|Adverse Event|0|||
163016192|NCT00685399|588764179|FG001|Extension|Adverse Event|0|||
163016193|NCT00685399|588764180|FG002|Extension|Adverse Event|0|||
163016194|NCT00685399|588764181|FG003|Extension|Adverse Event|2|||
163016195|NCT00685399|588764182|FG004|Extension|Adverse Event|0|||
163016196|NCT00685399|588764183|FG005|Extension|Adverse Event|0|||
163016197|NCT00685399|588764184|FG006|Extension|Adverse Event|0|||
163016198|NCT00685399|588764185|FG007|Extension|Adverse Event|0|||
163016199|NCT00758485|588764187|FG000|Overall Study|Lost to Follow-up|0|||
163016200|NCT00758485|588764188|FG001|Overall Study|Lost to Follow-up|1|||
163016201|NCT00758485|588764187|FG000|Overall Study|Not Treated|1|||
163016202|NCT00758485|588764188|FG001|Overall Study|Not Treated|2|||
163016203|NCT00656292|588764189|FG000|Overall Study|Withdrawal by Subject|2|||
163016204|NCT00656292|588764190|FG001|Overall Study|Withdrawal by Subject|3|||
163016205|NCT00656292|588764189|FG000|Overall Study|Screen failure|1|||
163328571|NCT03211247|589913303|FG004|Overall Study|Lost to Follow-up|0|||
163016206|NCT00656292|588764190|FG001|Overall Study|Screen failure|2|||
163016207|NCT03259425|588764191|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
163016208|NCT03363776|588764196|FG000|Overall Study|Progressive disease|2|||
163016209|NCT03363776|588764197|FG001|Overall Study|Progressive disease|3|||
163016210|NCT03363776|588764198|FG002|Overall Study|Progressive disease|1|||
163016211|NCT03363776|588764196|FG000|Overall Study|Study drug toxicity|0|||
163016212|NCT03363776|588764197|FG001|Overall Study|Study drug toxicity|0|||
163016213|NCT03363776|588764198|FG002|Overall Study|Study drug toxicity|1|||
163016214|NCT03363776|588764196|FG000|Overall Study|Death|1|||
163328572|NCT03211247|589913299|FG000|Overall Study|Physician Decision|1|||
163016215|NCT03363776|588764197|FG001|Overall Study|Death|0|||
163016216|NCT03363776|588764198|FG002|Overall Study|Death|0|||
163016217|NCT01562782|588764199|FG000|Overall Study|Withdrawal by Subject|3|||
163016218|NCT01562782|588764200|FG001|Overall Study|Withdrawal by Subject|3|||
163016219|NCT01562782|588764199|FG000|Overall Study|screen failure|1|||
163016220|NCT01562782|588764200|FG001|Overall Study|screen failure|2|||
163062885|NCT04338581|588938515|FG001|Overall Study|Withdrawal by Subject|4|||
163016221|NCT02649439|588764205|FG000|Overall Study|Switched to alternative treatment|6|||
163016222|NCT02649439|588764206|FG001|Overall Study|Switched to alternative treatment|4|||
163328573|NCT03211247|589913300|FG001|Overall Study|Physician Decision|2|||
163016223|NCT02649439|588764205|FG000|Overall Study|Patient decision|1|||
163016224|NCT02649439|588764206|FG001|Overall Study|Patient decision|0|||
163016225|NCT02649439|588764205|FG000|Overall Study|Patient going out of country|1|||
163016226|NCT02649439|588764206|FG001|Overall Study|Patient going out of country|0|||
163016227|NCT02649439|588764205|FG000|Overall Study|To start finasteride|1|||
163016228|NCT02649439|588764206|FG001|Overall Study|To start finasteride|0|||
163016229|NCT02649439|588764205|FG000|Overall Study|Physician Decision|1|||
163016230|NCT02649439|588764206|FG001|Overall Study|Physician Decision|0|||
163016231|NCT02649439|588764205|FG000|Overall Study|Disease progression on study|12|||
163016232|NCT02649439|588764206|FG001|Overall Study|Disease progression on study|13|||
163016233|NCT02649439|588764205|FG000|Overall Study|Refused further treatment|1|||
163016234|NCT02649439|588764206|FG001|Overall Study|Refused further treatment|0|||
163016235|NCT02649439|588764205|FG000|Overall Study|Refused further follow up|2|||
163016236|NCT02649439|588764206|FG001|Overall Study|Refused further follow up|7|||
163016237|NCT02649439|588764205|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
163016238|NCT02649439|588764206|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
163016239|NCT02649439|588764205|FG000|Overall Study|No treatment, per protocol|1|||
163016240|NCT02649439|588764206|FG001|Overall Study|No treatment, per protocol|0|||
163016241|NCT02649439|588764205|FG000|Overall Study|PSA DT makes ineligible|0|||
163016242|NCT02649439|588764206|FG001|Overall Study|PSA DT makes ineligible|1|||
163016243|NCT02649439|588764205|FG000|Overall Study|Rising PSA No Mets|0|||
163016244|NCT02649439|588764206|FG001|Overall Study|Rising PSA No Mets|1|||
163016245|NCT02649439|588764205|FG000|Overall Study|Rising PSA|0|||
163016246|NCT02649439|588764206|FG001|Overall Study|Rising PSA|1|||
163016247|NCT02649439|588764205|FG000|Overall Study|Signed follow up protocol|0|||
163016248|NCT02649439|588764206|FG001|Overall Study|Signed follow up protocol|1|||
163016249|NCT02097238|588764207|FG000|Overall Study|Death|1|||
163016250|NCT02097238|588764207|FG000|Overall Study|Physician Decision|1|||
163016251|NCT02097238|588764207|FG000|Overall Study|Progressive Disease|17|||
163016252|NCT01282372|588764218|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
163016253|NCT01282372|588764218|FG000|Overall Study|Lost to Follow-up|23|||
163016254|NCT01282372|588764218|FG000|Overall Study|Withdrawal by Subject|11|||
163016255|NCT01282372|588764218|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
163016256|NCT01282372|588764218|FG000|Overall Study|Death|1|||
163016257|NCT01282372|588764218|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
163016258|NCT01282372|588764218|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
163016259|NCT01282372|588764218|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
163016260|NCT01282372|588764218|FG000|Overall Study|Adverse Event|12|||
163016261|NCT05027451|588764219|FG000|Overall Study|Lost to Follow-up|1|||
163016262|NCT05027451|588764220|FG001|Overall Study|Lost to Follow-up|1|||
163016263|NCT00812981|588764222|FG000|Overall Study|Other|0|||
163016264|NCT00812981|588764223|FG001|Overall Study|Other|1|||
163016265|NCT02737930|588764224|FG000|Overall Study|Withdrawal by Subject|0|||
163016266|NCT02737930|588764225|FG001|Overall Study|Withdrawal by Subject|1|||
163016267|NCT04178122|588764226|FG000|Overall Study|Withdrawal by Subject|1|||
163016268|NCT04178122|588764227|FG001|Overall Study|Withdrawal by Subject|1|||
163016269|NCT04178122|588764226|FG000|Overall Study|Death|2|||
163016270|NCT04178122|588764227|FG001|Overall Study|Death|0|||
163016271|NCT04178122|588764226|FG000|Overall Study|Did not complete testing|3|||
163016272|NCT04178122|588764227|FG001|Overall Study|Did not complete testing|13|||
163016273|NCT03124407|588764228|FG000|Overall Study|Lost to Follow-up|1|||
163016274|NCT03124407|588764229|FG001|Overall Study|Lost to Follow-up|0|||
163016275|NCT03124407|588764230|FG002|Overall Study|Lost to Follow-up|0|||
163016276|NCT03124407|588764231|FG003|Overall Study|Lost to Follow-up|0|||
163016277|NCT03124407|588764228|FG000|Overall Study|Adverse Event|0|||
163016278|NCT03124407|588764229|FG001|Overall Study|Adverse Event|0|||
163016279|NCT03124407|588764230|FG002|Overall Study|Adverse Event|1|||
163016280|NCT03124407|588764231|FG003|Overall Study|Adverse Event|0|||
163016281|NCT05343364|588764232|FG000|Overall Study|Miscellaneous|0|||
163016282|NCT05343364|588764233|FG001|Overall Study|Miscellaneous|1|||
163016283|NCT00984542|588764236|FG000|Overall Study|disease progression|19|||
163016284|NCT00984542|588764236|FG000|Overall Study|toxicity|7|||
163016285|NCT00984542|588764236|FG000|Overall Study|Death|7|||
163016286|NCT00984542|588764236|FG000|Overall Study|complicating disease|3|||
163016287|NCT00984542|588764236|FG000|Overall Study|Withdrawal by Subject|3|||
163062886|NCT04338581|588938514|FG000|Overall Study|Prohibited Medication|1|||
163062887|NCT04338581|588938515|FG001|Overall Study|Prohibited Medication|0|||
163062888|NCT00549055|588938516|FG000|Overall Study|Adverse Event|4|||
163062889|NCT00549055|588938516|FG000|Overall Study|Lack of Efficacy|18|||
163016288|NCT00984542|588764236|FG000|Overall Study|clinical deterioration|2|||
163016289|NCT01276756|588764238|FG000|Overall Study|Lost to Follow-up|2|||
163328574|NCT03211247|589913301|FG002|Overall Study|Physician Decision|0|||
163016290|NCT01276756|588764239|FG001|Overall Study|Lost to Follow-up|0|||
163016291|NCT01276756|588764238|FG000|Overall Study|Adverse Event|3|||
163328575|NCT03211247|589913302|FG003|Overall Study|Physician Decision|0|||
163016292|NCT01276756|588764239|FG001|Overall Study|Adverse Event|2|||
163016293|NCT02589639|588764240|FG000|Overall Study|Lost to Follow-up|1|||
163016294|NCT02589639|588764241|FG001|Overall Study|Lost to Follow-up|0|||
163016295|NCT02589639|588764242|FG002|Overall Study|Lost to Follow-up|0|||
163062890|NCT00549055|588938516|FG000|Overall Study|Stabilization|5|||
163062891|NCT00549055|588938516|FG000|Overall Study|Progression to fibrosis|2|||
163328576|NCT03211247|589913303|FG004|Overall Study|Physician Decision|0|||
163062892|NCT00549055|588938516|FG000|Overall Study|Decrease of size|1|||
163016296|NCT02589639|588764240|FG000|Overall Study|Protocol Violation|1|||
163016297|NCT02589639|588764241|FG001|Overall Study|Protocol Violation|0|||
163016298|NCT02589639|588764242|FG002|Overall Study|Protocol Violation|0|||
163016299|NCT02589639|588764240|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
163016300|NCT02589639|588764241|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
163016301|NCT02589639|588764242|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
163016302|NCT02589639|588764240|FG000|Overall Study|Adverse Event|4|||
163016303|NCT02589639|588764241|FG001|Overall Study|Adverse Event|5|||
163016304|NCT02589639|588764242|FG002|Overall Study|Adverse Event|3|||
163016305|NCT02589639|588764240|FG000|Overall Study|Other reason than specified above|1|||
163016306|NCT02589639|588764241|FG001|Overall Study|Other reason than specified above|2|||
163016307|NCT02589639|588764242|FG002|Overall Study|Other reason than specified above|1|||
163016308|NCT02589639|588764240|FG000|Overall Study|Not Treated|0|||
163016309|NCT02589639|588764241|FG001|Overall Study|Not Treated|3|||
163016310|NCT02589639|588764242|FG002|Overall Study|Not Treated|0|||
163016311|NCT05868577|588764243|FG000|Overall Study|Lost to Follow-up|5|||
163016312|NCT05868577|588764244|FG001|Overall Study|Lost to Follow-up|5|||
163016313|NCT02630251|588764246|FG000|Overall Study|Physician Decision|0|||
163016314|NCT02630251|588764247|FG001|Overall Study|Physician Decision|0|||
163016315|NCT02630251|588764248|FG002|Overall Study|Physician Decision|1|||
163016316|NCT02630251|588764249|FG003|Overall Study|Physician Decision|0|||
163016317|NCT02505217|588764250|FG000|Overall Study|Withdrawal by Subject|1|||
163016318|NCT02505217|588764251|FG001|Overall Study|Withdrawal by Subject|2|||
163016319|NCT03517540|588764252|FG000|Overall Study|Protocol Violation|2|||
163016320|NCT03517540|588764253|FG001|Overall Study|Protocol Violation|0|||
163016321|NCT03517540|588764254|FG002|Overall Study|Protocol Violation|0|||
163016322|NCT03517540|588764255|FG003|Overall Study|Protocol Violation|1|||
163016323|NCT03517540|588764252|FG000|Overall Study|Adverse Event|9|||
163016324|NCT03517540|588764253|FG001|Overall Study|Adverse Event|3|||
163016325|NCT03517540|588764254|FG002|Overall Study|Adverse Event|8|||
163016326|NCT03517540|588764255|FG003|Overall Study|Adverse Event|1|||
163016327|NCT03517540|588764252|FG000|Overall Study|Withdrawal by Subject|3|||
163016328|NCT03517540|588764253|FG001|Overall Study|Withdrawal by Subject|4|||
163016329|NCT03517540|588764254|FG002|Overall Study|Withdrawal by Subject|1|||
163016330|NCT03517540|588764255|FG003|Overall Study|Withdrawal by Subject|3|||
163016331|NCT00615550|588764260|FG000|Overall Study|Lost to Follow-up|6|||
163016332|NCT00615550|588764261|FG001|Overall Study|Lost to Follow-up|1|||
163016333|NCT01408303|588764262|FG000|Overall Study|Adverse Event|3|||
163016334|NCT01408303|588764263|FG001|Overall Study|Adverse Event|7|||
163016335|NCT01408303|588764264|FG002|Overall Study|Adverse Event|2|||
163016336|NCT01408303|588764262|FG000|Overall Study|Lost to Follow-up|0|||
163016337|NCT01408303|588764263|FG001|Overall Study|Lost to Follow-up|1|||
163016338|NCT01408303|588764264|FG002|Overall Study|Lost to Follow-up|2|||
163016339|NCT01408303|588764262|FG000|Overall Study|Withdrawal by Subject|2|||
163062893|NCT00549055|588938516|FG000|Overall Study|Active choroidal neovascula increased|1|||
163062894|NCT00549055|588938516|FG000|Overall Study|Vitreous hemorrhage|1|||
163062895|NCT00549055|588938516|FG000|Overall Study|Growth choroidal neovascularisation|1|||
163328577|NCT03211247|589913299|FG000|Overall Study|Non-compliance with study drug|2|||
163328578|NCT03211247|589913300|FG001|Overall Study|Non-compliance with study drug|0|||
163328579|NCT03211247|589913301|FG002|Overall Study|Non-compliance with study drug|0|||
163328580|NCT03211247|589913302|FG003|Overall Study|Non-compliance with study drug|0|||
163328581|NCT03211247|589913303|FG004|Overall Study|Non-compliance with study drug|0|||
163328582|NCT03211247|589913299|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
163328583|NCT03211247|589913300|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
163328584|NCT03211247|589913301|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
163328585|NCT03211247|589913302|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
163328586|NCT03211247|589913303|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
163328587|NCT03211247|589913299|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
163328588|NCT03211247|589913300|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
163328589|NCT03211247|589913301|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
163328590|NCT03211247|589913302|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
163328591|NCT03211247|589913303|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
163328592|NCT03211247|589913299|FG000|Overall Study|Protocol Violation|0|||
163328593|NCT03211247|589913300|FG001|Overall Study|Protocol Violation|1|||
163328594|NCT03211247|589913301|FG002|Overall Study|Protocol Violation|0|||
163328595|NCT03211247|589913302|FG003|Overall Study|Protocol Violation|0|||
163016340|NCT01408303|588764263|FG001|Overall Study|Withdrawal by Subject|3|||
163016341|NCT01408303|588764264|FG002|Overall Study|Withdrawal by Subject|1|||
163062896|NCT00549055|588938516|FG000|Overall Study|Choroidal neovascularization|1|||
163062897|NCT00549055|588938516|FG000|Overall Study|Very low visual acuity (VA)|1|||
163328596|NCT03211247|589913303|FG004|Overall Study|Protocol Violation|0|||
163016342|NCT01408303|588764262|FG000|Overall Study|Protocol Violation|0|||
163016343|NCT01408303|588764263|FG001|Overall Study|Protocol Violation|1|||
163016344|NCT01408303|588764264|FG002|Overall Study|Protocol Violation|0|||
163016345|NCT01408303|588764262|FG000|Overall Study|Noncompliance|1|||
163016346|NCT01408303|588764263|FG001|Overall Study|Noncompliance|0|||
163016347|NCT01408303|588764264|FG002|Overall Study|Noncompliance|1|||
163016348|NCT02644668|588764265|FG000|Overall Study|Adverse Event|2|||
163016349|NCT02644668|588764266|FG001|Overall Study|Adverse Event|0|||
163016350|NCT02644668|588764267|FG002|Overall Study|Adverse Event|1|||
163016351|NCT02644668|588764265|FG000|Overall Study|Protocol Violation|0|||
163016352|NCT02644668|588764266|FG001|Overall Study|Protocol Violation|0|||
163016353|NCT02644668|588764267|FG002|Overall Study|Protocol Violation|1|||
163016354|NCT02644668|588764265|FG000|Overall Study|Withdrawal by Subject|0|||
163016355|NCT02644668|588764266|FG001|Overall Study|Withdrawal by Subject|0|||
163062898|NCT00770809|588938517|FG000|Overall Study|Adverse Event|9|||
163016356|NCT02644668|588764267|FG002|Overall Study|Withdrawal by Subject|1|||
163016357|NCT05763875|588764272|FG000|Overall Study|Subject decision|5|||
163016358|NCT05763875|588764273|FG001|Overall Study|Subject decision|2|||
163016359|NCT05763875|588764274|FG002|Overall Study|Subject decision|1|||
163016360|NCT05763875|588764272|FG000|Overall Study|Lost to Follow-up|4|||
163016361|NCT05763875|588764273|FG001|Overall Study|Lost to Follow-up|1|||
163016362|NCT05763875|588764274|FG002|Overall Study|Lost to Follow-up|2|||
163016363|NCT05763875|588764272|FG000|Overall Study|Adverse Event|1|||
163016364|NCT05763875|588764273|FG001|Overall Study|Adverse Event|0|||
163016365|NCT05763875|588764274|FG002|Overall Study|Adverse Event|0|||
163016366|NCT01777282|588764275|FG000|Overall Study|Persistent Hyperglycemia|0|||
163016367|NCT01777282|588764276|FG001|Overall Study|Persistent Hyperglycemia|0|||
163016368|NCT01777282|588764277|FG002|Overall Study|Persistent Hyperglycemia|1|||
163016369|NCT01777282|588764278|FG003|Overall Study|Persistent Hyperglycemia|0|||
163016370|NCT01777282|588764279|FG004|Overall Study|Persistent Hyperglycemia|0|||
163016371|NCT01777282|588764275|FG000|Overall Study|New Antidiabetic Medication|0|||
163016372|NCT01777282|588764276|FG001|Overall Study|New Antidiabetic Medication|0|||
163016373|NCT01777282|588764277|FG002|Overall Study|New Antidiabetic Medication|1|||
163016374|NCT01777282|588764278|FG003|Overall Study|New Antidiabetic Medication|0|||
163016375|NCT01777282|588764279|FG004|Overall Study|New Antidiabetic Medication|0|||
163016376|NCT01777282|588764275|FG000|Overall Study|Adverse Event|4|||
163016377|NCT01777282|588764276|FG001|Overall Study|Adverse Event|4|||
163016378|NCT01777282|588764277|FG002|Overall Study|Adverse Event|2|||
163016379|NCT01777282|588764278|FG003|Overall Study|Adverse Event|1|||
163016380|NCT01777282|588764279|FG004|Overall Study|Adverse Event|3|||
163016381|NCT01777282|588764275|FG000|Overall Study|Withdrawal by Subject|4|||
163016382|NCT01777282|588764276|FG001|Overall Study|Withdrawal by Subject|0|||
163016383|NCT01777282|588764277|FG002|Overall Study|Withdrawal by Subject|0|||
163016384|NCT01777282|588764278|FG003|Overall Study|Withdrawal by Subject|1|||
163016385|NCT01777282|588764279|FG004|Overall Study|Withdrawal by Subject|2|||
163016386|NCT01777282|588764275|FG000|Overall Study|Protocol Violation|2|||
163016387|NCT01777282|588764276|FG001|Overall Study|Protocol Violation|0|||
163016388|NCT01777282|588764277|FG002|Overall Study|Protocol Violation|1|||
163016389|NCT01777282|588764278|FG003|Overall Study|Protocol Violation|0|||
163016390|NCT01777282|588764279|FG004|Overall Study|Protocol Violation|2|||
163016391|NCT01777282|588764275|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
163016392|NCT01777282|588764276|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
163215466|NCT02432846|589503827|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
163215467|NCT02432846|589503828|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
163215468|NCT02432846|589503829|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
163215469|NCT02432846|589503830|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
163215470|NCT02432846|589503825|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
163215471|NCT02432846|589503826|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
163215472|NCT02432846|589503827|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
163215473|NCT02432846|589503828|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
163215474|NCT02432846|589503829|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
163215475|NCT02432846|589503830|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
163215476|NCT02432846|589503825|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
163215477|NCT02432846|589503826|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
163215478|NCT02432846|589503827|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
163215479|NCT02432846|589503828|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
163215480|NCT02432846|589503829|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
163215481|NCT02432846|589503830|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
163215482|NCT00413192|589503831|FG000|Overall Study|Disease progression|26|||
163215483|NCT00413192|589503832|FG001|Overall Study|Disease progression|31|||
163215484|NCT00413192|589503833|FG002|Overall Study|Disease progression|16|||
163215485|NCT00413192|589503834|FG003|Overall Study|Disease progression|25|||
163215486|NCT00413192|589503831|FG000|Overall Study|Toxicity|3|||
163215487|NCT00413192|589503832|FG001|Overall Study|Toxicity|2|||
163215488|NCT00413192|589503833|FG002|Overall Study|Toxicity|2|||
163215489|NCT00413192|589503834|FG003|Overall Study|Toxicity|2|||
163215490|NCT00413192|589503831|FG000|Overall Study|Withdrawal by Subject|3|||
163215491|NCT00413192|589503832|FG001|Overall Study|Withdrawal by Subject|5|||
163016393|NCT01777282|588764277|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
163016394|NCT01777282|588764278|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
163016395|NCT01777282|588764279|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
163016396|NCT04015518|588764280|FG000|Overall Study|Adverse Event|6|||
163016397|NCT04015518|588764281|FG001|Overall Study|Adverse Event|1|||
163016398|NCT04015518|588764282|FG002|Overall Study|Adverse Event|1|||
163016399|NCT04015518|588764283|FG003|Overall Study|Adverse Event|3|||
163016400|NCT04015518|588764284|FG004|Overall Study|Adverse Event|3|||
163016401|NCT04015518|588764280|FG000|Overall Study|Lack of Efficacy|1|||
163016402|NCT04015518|588764281|FG001|Overall Study|Lack of Efficacy|0|||
163016403|NCT04015518|588764282|FG002|Overall Study|Lack of Efficacy|1|||
163215492|NCT00413192|589503833|FG002|Overall Study|Withdrawal by Subject|0|||
163215493|NCT00413192|589503834|FG003|Overall Study|Withdrawal by Subject|1|||
163215494|NCT00413192|589503831|FG000|Overall Study|Intercurrent illness|0|||
163215495|NCT00413192|589503832|FG001|Overall Study|Intercurrent illness|0|||
163215496|NCT00413192|589503833|FG002|Overall Study|Intercurrent illness|0|||
163215497|NCT00413192|589503834|FG003|Overall Study|Intercurrent illness|1|||
163215498|NCT00413192|589503831|FG000|Overall Study|Intercurrent death|0|||
163215499|NCT00413192|589503832|FG001|Overall Study|Intercurrent death|1|||
163215500|NCT00413192|589503833|FG002|Overall Study|Intercurrent death|0|||
163215501|NCT00413192|589503834|FG003|Overall Study|Intercurrent death|0|||
163215502|NCT00413192|589503831|FG000|Overall Study|Other|5|||
163215503|NCT00413192|589503832|FG001|Overall Study|Other|1|||
163215504|NCT00413192|589503833|FG002|Overall Study|Other|1|||
163215505|NCT00413192|589503834|FG003|Overall Study|Other|2|||
163215506|NCT00413192|589503831|FG000|Overall Study|Not treated|0|||
163215507|NCT00413192|589503832|FG001|Overall Study|Not treated|0|||
163215508|NCT00413192|589503833|FG002|Overall Study|Not treated|0|||
163215509|NCT00413192|589503834|FG003|Overall Study|Not treated|1|||
163215510|NCT01998633|589503835|FG000|Overall Study|Death|1|||
163215511|NCT03992781|589503836|FG000|Overall Study|Lost to Follow-up|5|||
163215512|NCT03992781|589503836|FG000|Overall Study|Adverse Event|1|||
163215513|NCT03992781|589503836|FG000|Overall Study|Lack of Efficacy|5|||
163215514|NCT01996826|589503837|FG000|Overall Study|Lost to Follow-up|6|||
163215515|NCT01996826|589503838|FG001|Overall Study|Lost to Follow-up|2|||
163215516|NCT01996826|589503837|FG000|Overall Study|Physician Decision|1|||
163215517|NCT01996826|589503838|FG001|Overall Study|Physician Decision|1|||
163215518|NCT00695396|589503839|FG000|Overall Study|Study Closed Prematurely|5|||
163215519|NCT00695396|589503840|FG001|Overall Study|Study Closed Prematurely|6|||
163215520|NCT00695396|589503841|FG002|Overall Study|Study Closed Prematurely|8|||
163215521|NCT00695396|589503839|FG000|Overall Study|Withdrawal by Subject|2|||
163215522|NCT00695396|589503840|FG001|Overall Study|Withdrawal by Subject|2|||
163215523|NCT00695396|589503841|FG002|Overall Study|Withdrawal by Subject|0|||
163215524|NCT00518323|589503843|FG000|Overall Study|Lack of Efficacy|14|||
163215525|NCT00518323|589503844|FG001|Overall Study|Lack of Efficacy|2|||
163215526|NCT00518323|589503845|FG002|Overall Study|Lack of Efficacy|4|||
163215527|NCT00518323|589503846|FG003|Overall Study|Lack of Efficacy|20|||
163215528|NCT00518323|589503843|FG000|Overall Study|Withdrawal by Subject|1|||
163215529|NCT00518323|589503844|FG001|Overall Study|Withdrawal by Subject|2|||
163215530|NCT00518323|589503845|FG002|Overall Study|Withdrawal by Subject|4|||
163215531|NCT00518323|589503846|FG003|Overall Study|Withdrawal by Subject|2|||
163215532|NCT00518323|589503843|FG000|Overall Study|Lost to Follow-up|0|||
163215533|NCT00518323|589503844|FG001|Overall Study|Lost to Follow-up|2|||
163215534|NCT00518323|589503845|FG002|Overall Study|Lost to Follow-up|1|||
163215535|NCT00518323|589503846|FG003|Overall Study|Lost to Follow-up|3|||
163215536|NCT00518323|589503843|FG000|Overall Study|Adverse Event|1|||
163215537|NCT00518323|589503844|FG001|Overall Study|Adverse Event|1|||
163328597|NCT02415127|589913304|FG000|Overall Study|Adverse Event|1|||
163328598|NCT02415127|589913305|FG001|Overall Study|Adverse Event|0|||
163016404|NCT04015518|588764283|FG003|Overall Study|Lack of Efficacy|0|||
163016405|NCT04015518|588764284|FG004|Overall Study|Lack of Efficacy|4|||
163016406|NCT04015518|588764280|FG000|Overall Study|Lost to Follow-up|0|||
163016407|NCT04015518|588764281|FG001|Overall Study|Lost to Follow-up|0|||
163016408|NCT04015518|588764282|FG002|Overall Study|Lost to Follow-up|0|||
163016409|NCT04015518|588764283|FG003|Overall Study|Lost to Follow-up|0|||
163016410|NCT04015518|588764284|FG004|Overall Study|Lost to Follow-up|1|||
163016411|NCT04015518|588764280|FG000|Overall Study|Withdrawal by Subject|0|||
163016412|NCT04015518|588764281|FG001|Overall Study|Withdrawal by Subject|1|||
163016413|NCT04015518|588764282|FG002|Overall Study|Withdrawal by Subject|0|||
163016414|NCT04015518|588764283|FG003|Overall Study|Withdrawal by Subject|1|||
163016415|NCT04015518|588764284|FG004|Overall Study|Withdrawal by Subject|1|||
163016416|NCT04015518|588764280|FG000|Overall Study|Patient did not come for consecutive visits|0|||
163016417|NCT04015518|588764281|FG001|Overall Study|Patient did not come for consecutive visits|1|||
163016418|NCT04015518|588764282|FG002|Overall Study|Patient did not come for consecutive visits|0|||
163016419|NCT04015518|588764283|FG003|Overall Study|Patient did not come for consecutive visits|0|||
163215538|NCT00518323|589503845|FG002|Overall Study|Adverse Event|1|||
163215539|NCT00518323|589503846|FG003|Overall Study|Adverse Event|0|||
163215540|NCT00518323|589503843|FG000|Overall Study|Prohibited medication and others|3|||
163016420|NCT04015518|588764284|FG004|Overall Study|Patient did not come for consecutive visits|0|||
163016421|NCT04015518|588764280|FG000|Overall Study|not willing to travel due to Covid-19|0|||
163016422|NCT04015518|588764281|FG001|Overall Study|not willing to travel due to Covid-19|0|||
163016423|NCT04015518|588764282|FG002|Overall Study|not willing to travel due to Covid-19|1|||
163016424|NCT04015518|588764283|FG003|Overall Study|not willing to travel due to Covid-19|0|||
163016425|NCT04015518|588764284|FG004|Overall Study|not willing to travel due to Covid-19|0|||
163016426|NCT04015518|588764280|FG000|Overall Study|Patient wants to discontinue treatment|0|||
163016427|NCT04015518|588764281|FG001|Overall Study|Patient wants to discontinue treatment|0|||
163016428|NCT04015518|588764282|FG002|Overall Study|Patient wants to discontinue treatment|0|||
163016429|NCT04015518|588764283|FG003|Overall Study|Patient wants to discontinue treatment|1|||
163016430|NCT04015518|588764284|FG004|Overall Study|Patient wants to discontinue treatment|0|||
163016431|NCT04015518|588764280|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
163016432|NCT04015518|588764281|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
163016433|NCT04015518|588764282|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
163016434|NCT04015518|588764283|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
163016435|NCT04015518|588764284|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
163016436|NCT04015518|588764280|FG000|Overall Study|Pregnancy|0|||
163016437|NCT04015518|588764281|FG001|Overall Study|Pregnancy|0|||
163016438|NCT04015518|588764282|FG002|Overall Study|Pregnancy|0|||
163016439|NCT04015518|588764283|FG003|Overall Study|Pregnancy|0|||
163016440|NCT04015518|588764284|FG004|Overall Study|Pregnancy|1|||
163016441|NCT04015518|588764280|FG000|Overall Study|Personal reasons|1|||
163016442|NCT04015518|588764281|FG001|Overall Study|Personal reasons|0|||
163016443|NCT04015518|588764282|FG002|Overall Study|Personal reasons|0|||
163016444|NCT04015518|588764283|FG003|Overall Study|Personal reasons|0|||
163016445|NCT04015518|588764284|FG004|Overall Study|Personal reasons|1|||
163016446|NCT04015518|588764280|FG000|Overall Study|Withdrew consent|1|||
163016447|NCT04015518|588764281|FG001|Overall Study|Withdrew consent|0|||
163016448|NCT04015518|588764282|FG002|Overall Study|Withdrew consent|0|||
163016449|NCT04015518|588764283|FG003|Overall Study|Withdrew consent|0|||
163016450|NCT04015518|588764284|FG004|Overall Study|Withdrew consent|0|||
163016451|NCT04015518|588764280|FG000|Overall Study|Prostate carcinoma|1|||
163016452|NCT04015518|588764281|FG001|Overall Study|Prostate carcinoma|0|||
163016453|NCT04015518|588764282|FG002|Overall Study|Prostate carcinoma|0|||
163016454|NCT04015518|588764283|FG003|Overall Study|Prostate carcinoma|0|||
163016455|NCT04015518|588764284|FG004|Overall Study|Prostate carcinoma|0|||
163016456|NCT04015518|588764280|FG000|Overall Study|Could not keep appointments due to work|1|||
163016457|NCT04015518|588764281|FG001|Overall Study|Could not keep appointments due to work|0|||
163016458|NCT04015518|588764282|FG002|Overall Study|Could not keep appointments due to work|0|||
163016459|NCT04015518|588764283|FG003|Overall Study|Could not keep appointments due to work|0|||
163016460|NCT04015518|588764284|FG004|Overall Study|Could not keep appointments due to work|0|||
163016461|NCT05119595|588766076|FG000|Overall Study|Death|1|||
163016462|NCT05119595|588766076|FG000|Overall Study|Lost to Follow-up|7|||
163016463|NCT01806961|588766077|FG000|Overall Study|sponsor decision|16|||
163016464|NCT03056638|588766084|FG000|Overall Study|Death|1|||
163016465|NCT03056638|588766085|FG001|Overall Study|Death|0|||
163016466|NCT02530125|588766086|FG000|Completed Treatment|Early termination of study|1|||
163016467|NCT02530125|588766086|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
163016468|NCT00468481|588766087|FG000|Overall Study|Adverse Event|13|||
163016469|NCT00468481|588766088|FG001|Overall Study|Adverse Event|3|||
163016470|NCT00468481|588766087|FG000|Overall Study|Lost to Follow-up|25|||
163016471|NCT00468481|588766088|FG001|Overall Study|Lost to Follow-up|8|||
163016472|NCT00468481|588766087|FG000|Overall Study|Pregnancy|2|||
163016473|NCT00468481|588766088|FG001|Overall Study|Pregnancy|0|||
163016474|NCT00468481|588766087|FG000|Overall Study|Protocol Violation|18|||
163016475|NCT00468481|588766088|FG001|Overall Study|Protocol Violation|8|||
163016476|NCT00468481|588766087|FG000|Overall Study|Withdrawal by Subject|12|||
163016477|NCT00468481|588766088|FG001|Overall Study|Withdrawal by Subject|3|||
163016478|NCT00468481|588766087|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
163016479|NCT00468481|588766088|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
163016480|NCT00468481|588766087|FG000|Overall Study|Prohibited Medication|1|||
163016481|NCT00468481|588766088|FG001|Overall Study|Prohibited Medication|1|||
163016482|NCT00468481|588766087|FG000|Overall Study|Egg Donor|1|||
163016483|NCT00468481|588766088|FG001|Overall Study|Egg Donor|0|||
163016484|NCT00468481|588766087|FG000|Overall Study|Moved out of area|4|||
163016485|NCT00468481|588766088|FG001|Overall Study|Moved out of area|1|||
163016486|NCT00468481|588766087|FG000|Overall Study|Non-Compliance|5|||
163016487|NCT00468481|588766088|FG001|Overall Study|Non-Compliance|0|||
163016488|NCT00468481|588766087|FG000|Overall Study|Other|6|||
163016489|NCT00468481|588766088|FG001|Overall Study|Other|0|||
163016490|NCT00728468|588766089|FG000|Overall Study|Enrolled but not treated|1|||
163016491|NCT00728468|588766089|FG000|Overall Study|Death|1|||
163016492|NCT00728468|588766089|FG000|Overall Study|Protocol Violation|4|||
163016493|NCT00728468|588766089|FG000|Overall Study|Objective progression or relapse|9|||
163215541|NCT00518323|589503844|FG001|Overall Study|Prohibited medication and others|1|||
163215542|NCT00518323|589503845|FG002|Overall Study|Prohibited medication and others|1|||
163215543|NCT00518323|589503846|FG003|Overall Study|Prohibited medication and others|0|||
163215544|NCT03164928|589503847|FG000|Overall Study|Lost to Follow-up|1|||
163215545|NCT03164928|589503848|FG001|Overall Study|Lost to Follow-up|0|||
163215546|NCT00326950|589503853|FG000|Overall Study|Progressive Disease|1|||
163016494|NCT00728468|588766089|FG000|Overall Study|Study terminated by sponsor|1|||
163016495|NCT01568034|588766090|FG000|Overall Study|Withdrawal by Subject|1|||
163016496|NCT01568034|588766091|FG001|Overall Study|Withdrawal by Subject|0|||
163016497|NCT01568034|588766092|FG002|Overall Study|Withdrawal by Subject|0|||
163016498|NCT01568034|588766093|FG003|Overall Study|Withdrawal by Subject|0|||
163016499|NCT00596687|588766094|FG000|Overall Study|< 24 hours of insulin treatment|8|||
163016500|NCT00596687|588766095|FG001|Overall Study|< 24 hours of insulin treatment|6|||
163016501|NCT00596687|588766094|FG000|Overall Study|continuous insulin infusion during TPN|2|||
163016502|NCT00596687|588766095|FG001|Overall Study|continuous insulin infusion during TPN|1|||
163016503|NCT00596687|588766094|FG000|Overall Study|Withdrawal by Subject|3|||
163016504|NCT00596687|588766095|FG001|Overall Study|Withdrawal by Subject|1|||
163016505|NCT00596687|588766094|FG000|Overall Study|cancelled surgery|1|||
163016506|NCT00596687|588766095|FG001|Overall Study|cancelled surgery|1|||
163016507|NCT03831113|588766096|FG000|Overall Study|Withdrawal by Subject|0|||
163016508|NCT03831113|588766097|FG001|Overall Study|Withdrawal by Subject|2|||
163016509|NCT03831113|588766096|FG000|Overall Study|Protocol Violation|0|||
163016510|NCT03831113|588766097|FG001|Overall Study|Protocol Violation|9|||
163016511|NCT03508726|588766098|FG000|Overall Study|Withdrawal by Subject|0|||
163016512|NCT03508726|588766099|FG001|Overall Study|Withdrawal by Subject|1|||
163016513|NCT01068730|588766100|FG000|Period 3|Personal reason|1|||
163016514|NCT01068730|588766101|FG001|Period 3|Personal reason|0|||
163016515|NCT01068730|588766102|FG002|Period 3|Personal reason|0|||
163016516|NCT01068730|588766103|FG003|Period 3|Personal reason|0|||
163016517|NCT01068730|588766100|FG000|Period 4|Family emergency|0|||
163016518|NCT01068730|588766101|FG001|Period 4|Family emergency|1|||
163016519|NCT01068730|588766102|FG002|Period 4|Family emergency|0|||
163016520|NCT01068730|588766103|FG003|Period 4|Family emergency|0|||
163016521|NCT02498444|588766107|FG000|Overall Study|Withdrawal by Subject|3|||
163016522|NCT02498444|588766108|FG001|Overall Study|Withdrawal by Subject|0|||
163016523|NCT02498444|588766107|FG000|Overall Study|Physician Decision|1|||
163016524|NCT02498444|588766108|FG001|Overall Study|Physician Decision|0|||
163016525|NCT01073605|588766122|FG000|Overall Study|Ongoing at Cutoff Date|1|||
163016526|NCT01073605|588766123|FG001|Overall Study|Ongoing at Cutoff Date|1|||
163016527|NCT01073605|588766124|FG002|Overall Study|Ongoing at Cutoff Date|0|||
163016528|NCT01073605|588766122|FG000|Overall Study|Adverse Event|2|||
163016529|NCT01073605|588766123|FG001|Overall Study|Adverse Event|1|||
163016530|NCT01073605|588766124|FG002|Overall Study|Adverse Event|0|||
163016531|NCT01073605|588766122|FG000|Overall Study|Lost to Follow-up|3|||
163016532|NCT01073605|588766123|FG001|Overall Study|Lost to Follow-up|4|||
163016533|NCT01073605|588766124|FG002|Overall Study|Lost to Follow-up|9|||
163016534|NCT01073605|588766122|FG000|Overall Study|Other|25|||
163016535|NCT01073605|588766123|FG001|Overall Study|Other|21|||
163016536|NCT01073605|588766124|FG002|Overall Study|Other|29|||
163016537|NCT01073605|588766122|FG000|Overall Study|Withdrawal by Subject|31|||
163016538|NCT01073605|588766123|FG001|Overall Study|Withdrawal by Subject|39|||
163016539|NCT01073605|588766124|FG002|Overall Study|Withdrawal by Subject|22|||
163016540|NCT01073605|588766122|FG000|Overall Study|Randomized But Not Treated|0|||
163016541|NCT01073605|588766123|FG001|Overall Study|Randomized But Not Treated|1|||
163016542|NCT01073605|588766124|FG002|Overall Study|Randomized But Not Treated|1|||
163016543|NCT03491462|588766125|FG000|Overall Study|Lost to Follow-up|2|||
163016544|NCT03491462|588766126|FG001|Overall Study|Lost to Follow-up|0|||
163016545|NCT03491462|588766125|FG000|Overall Study|Adverse Event|11|||
163016546|NCT03491462|588766126|FG001|Overall Study|Adverse Event|1|||
163016547|NCT03491462|588766125|FG000|Overall Study|Physician Decision|3|||
163016548|NCT03491462|588766126|FG001|Overall Study|Physician Decision|0|||
163215547|NCT01514760|589503854|FG000|Overall Study|Lost to Follow-up|2|||
163215548|NCT01275833|589503855|FG000|Overall Study|Study terminated|1|||
163016549|NCT03491462|588766125|FG000|Overall Study|Withdrawal by Subject|22|||
163016550|NCT03491462|588766126|FG001|Overall Study|Withdrawal by Subject|15|||
163062899|NCT00770809|588938518|FG001|Overall Study|Adverse Event|1|||
163215549|NCT01275833|589503856|FG001|Overall Study|Study terminated|1|||
163404694|NCT00996944|590191998|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
163016551|NCT00740792|588766127|FG000|Overall Study|Adverse Event|3|||
163016552|NCT00740792|588766128|FG001|Overall Study|Adverse Event|1|||
163016553|NCT00740792|588766129|FG002|Overall Study|Adverse Event|1|||
163016554|NCT00740792|588766130|FG003|Overall Study|Adverse Event|3|||
163016555|NCT00740792|588766127|FG000|Overall Study|Lack of Efficacy|1|||
163016556|NCT00740792|588766128|FG001|Overall Study|Lack of Efficacy|1|||
163016557|NCT00740792|588766129|FG002|Overall Study|Lack of Efficacy|0|||
163215550|NCT02118012|589503858|FG000|Overall Study|Adverse Event|0|||
163016558|NCT00740792|588766130|FG003|Overall Study|Lack of Efficacy|3|||
163016559|NCT00740792|588766127|FG000|Overall Study|Lost to Follow-up|2|||
163016560|NCT00740792|588766128|FG001|Overall Study|Lost to Follow-up|1|||
163016561|NCT00740792|588766129|FG002|Overall Study|Lost to Follow-up|0|||
163016562|NCT00740792|588766130|FG003|Overall Study|Lost to Follow-up|0|||
163016563|NCT00740792|588766127|FG000|Overall Study|Protocol Violation|0|||
163016564|NCT00740792|588766128|FG001|Overall Study|Protocol Violation|1|||
163016565|NCT00740792|588766129|FG002|Overall Study|Protocol Violation|0|||
163016566|NCT00740792|588766130|FG003|Overall Study|Protocol Violation|2|||
163016567|NCT00740792|588766127|FG000|Overall Study|Withdrawal by Subject|1|||
163016568|NCT00740792|588766128|FG001|Overall Study|Withdrawal by Subject|1|||
163016569|NCT00740792|588766129|FG002|Overall Study|Withdrawal by Subject|0|||
163016570|NCT00740792|588766130|FG003|Overall Study|Withdrawal by Subject|0|||
163016571|NCT00740792|588766127|FG000|Overall Study|administrative|3|||
163016572|NCT00740792|588766128|FG001|Overall Study|administrative|3|||
163016573|NCT00740792|588766129|FG002|Overall Study|administrative|8|||
163016574|NCT00740792|588766130|FG003|Overall Study|administrative|2|||
163016575|NCT00179660|588766139|FG000|Overall Study|Adverse Event|7|||
163062900|NCT00770809|588938519|FG002|Overall Study|Adverse Event|12|||
163062901|NCT00770809|588938517|FG000|Overall Study|Death|1|||
163062902|NCT00770809|588938518|FG001|Overall Study|Death|0|||
163062903|NCT00770809|588938519|FG002|Overall Study|Death|0|||
163016576|NCT00179660|588766139|FG000|Overall Study|Lack of therapeutic effect|28|||
163016577|NCT00179660|588766139|FG000|Overall Study|Withdrawal by Subject|2|||
163016578|NCT00179660|588766139|FG000|Overall Study|Lost to Follow-up|1|||
163016579|NCT00179660|588766139|FG000|Overall Study|Death|3|||
163016580|NCT00179660|588766139|FG000|Overall Study|Other - Unspecified|9|||
163016581|NCT04478695|588766140|FG000|Overall Study|Death|1|||
163016582|NCT04478695|588766141|FG001|Overall Study|Death|0|||
163016583|NCT00644917|588766142|FG000|Overall Study|Withdrawal by Subject|2|||
163016584|NCT01136356|588766143|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
163062904|NCT00770809|588938517|FG000|Overall Study|Withdrawal by Subject|3|||
163062905|NCT00770809|588938518|FG001|Overall Study|Withdrawal by Subject|3|||
163062906|NCT00770809|588938519|FG002|Overall Study|Withdrawal by Subject|7|||
163062907|NCT00770809|588938517|FG000|Overall Study|Progression|2|||
163062908|NCT00770809|588938518|FG001|Overall Study|Progression|2|||
163062909|NCT00770809|588938519|FG002|Overall Study|Progression|0|||
163062910|NCT00770809|588938517|FG000|Overall Study|Complicating illness|0|||
163062911|NCT00770809|588938518|FG001|Overall Study|Complicating illness|0|||
163062912|NCT00770809|588938519|FG002|Overall Study|Complicating illness|1|||
163062913|NCT00770809|588938517|FG000|Overall Study|Other Medical Reasons|2|||
163062914|NCT00770809|588938518|FG001|Overall Study|Other Medical Reasons|4|||
163062915|NCT00770809|588938519|FG002|Overall Study|Other Medical Reasons|3|||
163062916|NCT00770367|588938522|FG000|First Intervention|Withdrawal by Subject|0|||
163062917|NCT00770367|588938523|FG001|First Intervention|Withdrawal by Subject|2|||
163062918|NCT00770367|588938522|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
163062919|NCT00770367|588938523|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
163062920|NCT00770367|588938522|FG000|Second Intervention|Lost to Follow-up|2|||
163062921|NCT00770367|588938523|FG001|Second Intervention|Lost to Follow-up|0|||
163062922|NCT00435942|588938524|FG000|Overall Study|Death|17|||
163062923|NCT00435942|588938525|FG001|Overall Study|Death|10|||
163062924|NCT00435942|588938524|FG000|Overall Study|Withdrawal by Subject|2|||
163062925|NCT00435942|588938525|FG001|Overall Study|Withdrawal by Subject|0|||
163062926|NCT00435942|588938524|FG000|Overall Study|Lost to Follow-up|0|||
163062927|NCT00435942|588938525|FG001|Overall Study|Lost to Follow-up|16|||
163062928|NCT00435942|588938524|FG000|Overall Study|Conversion to Open Repair|1|||
163062929|NCT00435942|588938525|FG001|Overall Study|Conversion to Open Repair|0|||
163062930|NCT00435942|588938524|FG000|Overall Study|Technical Failure|3|||
163062931|NCT00435942|588938525|FG001|Overall Study|Technical Failure|0|||
163062932|NCT00435942|588938524|FG000|Overall Study|Other|0|||
163062933|NCT00435942|588938525|FG001|Overall Study|Other|1|||
163215551|NCT02118012|589503859|FG001|Overall Study|Adverse Event|1|||
163215552|NCT02118012|589503858|FG000|Overall Study|Physician Decision|0|||
163062934|NCT01898130|588938526|FG000|Treatment|Withdrawal by Subject|2|||
163062935|NCT01898130|588938526|FG000|Treatment|Progressive Disease|4|||
163062936|NCT01898130|588938526|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
163062937|NCT04115059|588938527|FG000|Overall Study|Withdrawal by Subject|1|||
163062938|NCT04115059|588938527|FG000|Overall Study|Lack of Efficacy|2|||
163215553|NCT02118012|589503859|FG001|Overall Study|Physician Decision|1|||
163215554|NCT00536107|589503860|FG000|Overall Study|Death|5|||
163215555|NCT00536107|589503861|FG001|Overall Study|Death|1|||
163215556|NCT00536107|589503860|FG000|Overall Study|Incorrect enrolment|1|||
163215557|NCT00536107|589503861|FG001|Overall Study|Incorrect enrolment|0|||
163215558|NCT00536107|589503860|FG000|Overall Study|Withdrawal by Subject|0|||
163215559|NCT00536107|589503861|FG001|Overall Study|Withdrawal by Subject|1|||
163215560|NCT00536107|589503860|FG000|Overall Study|Study Termination|2|||
163215561|NCT00536107|589503861|FG001|Overall Study|Study Termination|4|||
163215562|NCT03329690|589503862|FG000|Overall Study|Progressive disease per RECIST|85|||
163215563|NCT03329690|589503863|FG001|Overall Study|Progressive disease per RECIST|44|||
163215564|NCT03329690|589503864|FG002|Overall Study|Progressive disease per RECIST|6|||
163215565|NCT03329690|589503865|FG003|Overall Study|Progressive disease per RECIST|16|||
163016585|NCT01136356|588766144|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
163016586|NCT01136356|588766143|FG000|First 18-day Withdrawal|Physician Decision|1|||
163016587|NCT01136356|588766144|FG001|First 18-day Withdrawal|Physician Decision|0|||
163016588|NCT01136356|588766143|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
163016589|NCT01136356|588766144|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
163016590|NCT00402688|588766145|FG000|Overall Study|Adverse Event|12|||
163016591|NCT00402688|588766146|FG001|Overall Study|Adverse Event|9|||
163016592|NCT00402688|588766147|FG002|Overall Study|Adverse Event|3|||
163016593|NCT00402688|588766145|FG000|Overall Study|Withdrawal by Subject|3|||
163016594|NCT00402688|588766146|FG001|Overall Study|Withdrawal by Subject|1|||
163016595|NCT00402688|588766147|FG002|Overall Study|Withdrawal by Subject|1|||
163016596|NCT00402688|588766145|FG000|Overall Study|Physician Decision|0|||
163016597|NCT00402688|588766146|FG001|Overall Study|Physician Decision|0|||
163016598|NCT00402688|588766147|FG002|Overall Study|Physician Decision|1|||
163016599|NCT00402688|588766145|FG000|Overall Study|Lack of Efficacy|4|||
163016600|NCT00402688|588766146|FG001|Overall Study|Lack of Efficacy|4|||
163016601|NCT00402688|588766147|FG002|Overall Study|Lack of Efficacy|5|||
163016602|NCT00402688|588766145|FG000|Overall Study|Protocol Violation|1|||
163016603|NCT00402688|588766146|FG001|Overall Study|Protocol Violation|1|||
163016604|NCT00402688|588766147|FG002|Overall Study|Protocol Violation|1|||
163016605|NCT00402688|588766145|FG000|Overall Study|Lost to Follow-up|1|||
163016606|NCT00402688|588766146|FG001|Overall Study|Lost to Follow-up|0|||
163016607|NCT00402688|588766147|FG002|Overall Study|Lost to Follow-up|2|||
163016608|NCT00402688|588766145|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
163016609|NCT00402688|588766146|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
163016610|NCT00402688|588766147|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
163016611|NCT00402688|588766145|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
163016612|NCT00402688|588766146|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
163016613|NCT00402688|588766147|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
163016614|NCT00402688|588766145|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
163016615|NCT00402688|588766146|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
163016616|NCT00402688|588766147|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
163016617|NCT00178685|588766148|FG000|Overall Study|Death|3|||
163016618|NCT00178685|588766149|FG001|Overall Study|Death|3|||
163016619|NCT00178685|588766150|FG002|Overall Study|Death|6|||
163016620|NCT00178685|588766148|FG000|Overall Study|Lost to Follow-up|100|||
163016621|NCT00178685|588766149|FG001|Overall Study|Lost to Follow-up|187|||
163016622|NCT00178685|588766150|FG002|Overall Study|Lost to Follow-up|183|||
163016623|NCT00178685|588766148|FG000|Overall Study|Withdrawal by Subject|8|||
163016624|NCT00178685|588766149|FG001|Overall Study|Withdrawal by Subject|14|||
163016625|NCT00178685|588766150|FG002|Overall Study|Withdrawal by Subject|7|||
163016626|NCT00927862|588766151|FG000|Overall Study|Missing data needed for endpt analyses|27|||
163016627|NCT00927862|588766152|FG001|Overall Study|Missing data needed for endpt analyses|45|||
163016628|NCT00820248|588766153|FG000|Overall Study|No treated|4|||
163016629|NCT00820248|588766154|FG001|Overall Study|No treated|1|||
163016630|NCT04157296|588766164|FG000|Overall Study|Withdrawal by Subject|0|||
163016631|NCT04157296|588766165|FG001|Overall Study|Withdrawal by Subject|1|||
163016632|NCT04157296|588766164|FG000|Overall Study|Did not obtain second fMRI.|0|||
163016633|NCT04157296|588766165|FG001|Overall Study|Did not obtain second fMRI.|1|||
163016634|NCT04157296|588766164|FG000|Overall Study|MRI failed/no second fMRI|0|||
163016635|NCT04157296|588766165|FG001|Overall Study|MRI failed/no second fMRI|1|||
163016636|NCT02088905|588766170|FG000|Overall Study|Withdrawal by Subject|5|||
163016637|NCT02088905|588766171|FG001|Overall Study|Withdrawal by Subject|1|||
163016638|NCT05708976|588766186|FG000|Overall Study|Withdrawal by Subject|0|||
163016639|NCT05708976|588766187|FG001|Overall Study|Withdrawal by Subject|1|||
163016640|NCT02343939|588766198|FG000|Overall Study|Death|0|||
163016641|NCT02343939|588766199|FG001|Overall Study|Death|15|||
163016642|NCT02343939|588766200|FG002|Overall Study|Death|4|||
163016643|NCT02343939|588766201|FG003|Overall Study|Death|2|||
163016644|NCT02343939|588766202|FG004|Overall Study|Death|5|||
163016645|NCT02343939|588766203|FG005|Overall Study|Death|11|||
163016646|NCT02343939|588766204|FG006|Overall Study|Death|8|||
163016647|NCT02343939|588766205|FG007|Overall Study|Death|22|||
163016648|NCT02343939|588766206|FG008|Overall Study|Death|1|||
163016649|NCT02343939|588766198|FG000|Overall Study|Study terminated by sponsor|0|||
163016650|NCT02343939|588766199|FG001|Overall Study|Study terminated by sponsor|27|||
163016651|NCT02343939|588766200|FG002|Overall Study|Study terminated by sponsor|0|||
163016652|NCT02343939|588766201|FG003|Overall Study|Study terminated by sponsor|1|||
163016653|NCT02343939|588766202|FG004|Overall Study|Study terminated by sponsor|1|||
163016654|NCT02343939|588766203|FG005|Overall Study|Study terminated by sponsor|5|||
163016655|NCT02343939|588766204|FG006|Overall Study|Study terminated by sponsor|3|||
163016656|NCT02343939|588766205|FG007|Overall Study|Study terminated by sponsor|4|||
163016657|NCT02343939|588766206|FG008|Overall Study|Study terminated by sponsor|0|||
163016658|NCT02343939|588766198|FG000|Overall Study|Withdrew consent|3|||
163016659|NCT02343939|588766199|FG001|Overall Study|Withdrew consent|6|||
163016660|NCT02343939|588766200|FG002|Overall Study|Withdrew consent|1|||
163016661|NCT02343939|588766201|FG003|Overall Study|Withdrew consent|2|||
163016662|NCT02343939|588766202|FG004|Overall Study|Withdrew consent|2|||
163016663|NCT02343939|588766203|FG005|Overall Study|Withdrew consent|0|||
163016664|NCT02343939|588766204|FG006|Overall Study|Withdrew consent|0|||
163016665|NCT02343939|588766205|FG007|Overall Study|Withdrew consent|8|||
163016666|NCT02343939|588766206|FG008|Overall Study|Withdrew consent|6|||
163016667|NCT02343939|588766198|FG000|Overall Study|Treatment failure|0|||
163016668|NCT02343939|588766199|FG001|Overall Study|Treatment failure|0|||
163016669|NCT02343939|588766200|FG002|Overall Study|Treatment failure|0|||
163016670|NCT02343939|588766201|FG003|Overall Study|Treatment failure|0|||
163016671|NCT02343939|588766202|FG004|Overall Study|Treatment failure|0|||
163016672|NCT02343939|588766203|FG005|Overall Study|Treatment failure|0|||
163016673|NCT02343939|588766204|FG006|Overall Study|Treatment failure|2|||
163016674|NCT02343939|588766205|FG007|Overall Study|Treatment failure|1|||
163016675|NCT02343939|588766206|FG008|Overall Study|Treatment failure|0|||
163016676|NCT02343939|588766198|FG000|Overall Study|Investigator's discretion|0|||
163016677|NCT02343939|588766199|FG001|Overall Study|Investigator's discretion|0|||
163016678|NCT02343939|588766200|FG002|Overall Study|Investigator's discretion|0|||
163016679|NCT02343939|588766201|FG003|Overall Study|Investigator's discretion|1|||
163016680|NCT02343939|588766202|FG004|Overall Study|Investigator's discretion|0|||
163016681|NCT02343939|588766203|FG005|Overall Study|Investigator's discretion|0|||
163016682|NCT02343939|588766204|FG006|Overall Study|Investigator's discretion|1|||
163016683|NCT02343939|588766205|FG007|Overall Study|Investigator's discretion|0|||
163016684|NCT02343939|588766206|FG008|Overall Study|Investigator's discretion|0|||
163016685|NCT02343939|588766198|FG000|Overall Study|Adverse Event|0|||
163016686|NCT02343939|588766199|FG001|Overall Study|Adverse Event|0|||
163016687|NCT02343939|588766200|FG002|Overall Study|Adverse Event|0|||
163016688|NCT02343939|588766201|FG003|Overall Study|Adverse Event|0|||
163016689|NCT02343939|588766202|FG004|Overall Study|Adverse Event|0|||
163016690|NCT02343939|588766203|FG005|Overall Study|Adverse Event|1|||
163016691|NCT02343939|588766204|FG006|Overall Study|Adverse Event|0|||
163016692|NCT02343939|588766205|FG007|Overall Study|Adverse Event|0|||
163016693|NCT02343939|588766206|FG008|Overall Study|Adverse Event|0|||
163016694|NCT02343939|588766198|FG000|Overall Study|Never Treated With ENTO|0|||
163016695|NCT02343939|588766199|FG001|Overall Study|Never Treated With ENTO|0|||
163016696|NCT02343939|588766200|FG002|Overall Study|Never Treated With ENTO|0|||
163016697|NCT02343939|588766201|FG003|Overall Study|Never Treated With ENTO|0|||
163016698|NCT02343939|588766202|FG004|Overall Study|Never Treated With ENTO|0|||
163016699|NCT02343939|588766203|FG005|Overall Study|Never Treated With ENTO|0|||
163016700|NCT02343939|588766204|FG006|Overall Study|Never Treated With ENTO|1|||
163016701|NCT02343939|588766205|FG007|Overall Study|Never Treated With ENTO|2|||
163016702|NCT02343939|588766206|FG008|Overall Study|Never Treated With ENTO|0|||
163016703|NCT02684097|588766207|FG000|Overall Study|Lack of Efficacy|13|||
163016704|NCT02684097|588766208|FG001|Overall Study|Lack of Efficacy|6|||
163016705|NCT02064816|588766209|FG000|Overall Study|Adverse Event|3|||
163016706|NCT02064816|588766210|FG001|Overall Study|Adverse Event|2|||
163328599|NCT05827068|589913306|FG000|Overall Study|Lost to Follow-up|1|||
163016707|NCT02064816|588766209|FG000|Overall Study|Withdrawal by Subject|2|||
163016708|NCT02064816|588766210|FG001|Overall Study|Withdrawal by Subject|1|||
163016709|NCT02064816|588766209|FG000|Overall Study|Lost to Follow-up|2|||
163016710|NCT02064816|588766210|FG001|Overall Study|Lost to Follow-up|1|||
163016711|NCT02064816|588766209|FG000|Overall Study|Therapeutic failure|0|||
163016712|NCT02064816|588766210|FG001|Overall Study|Therapeutic failure|1|||
163016713|NCT02064816|588766209|FG000|Overall Study|Other|1|||
163016714|NCT02064816|588766210|FG001|Overall Study|Other|3|||
163016715|NCT01757184|588766211|FG000|Double-blind Period|Adverse Event|1|||
163016716|NCT01757184|588766212|FG001|Double-blind Period|Adverse Event|0|||
163016717|NCT01757184|588766213|FG002|Double-blind Period|Adverse Event|0|||
163016718|NCT01757184|588766214|FG003|Double-blind Period|Adverse Event|0|||
163016719|NCT01757184|588766211|FG000|Open-label Period|Lost to Follow-up|0|||
163016720|NCT01757184|588766212|FG001|Open-label Period|Lost to Follow-up|0|||
163016721|NCT01757184|588766213|FG002|Open-label Period|Lost to Follow-up|2|||
163016722|NCT01757184|588766214|FG003|Open-label Period|Lost to Follow-up|0|||
163016723|NCT01757184|588766211|FG000|Open-label Period|Withdrawal by Subject|0|||
163016724|NCT01757184|588766212|FG001|Open-label Period|Withdrawal by Subject|0|||
163016725|NCT01757184|588766213|FG002|Open-label Period|Withdrawal by Subject|1|||
163016726|NCT01757184|588766214|FG003|Open-label Period|Withdrawal by Subject|1|||
163016727|NCT01757184|588766211|FG000|Open-label Period|Discontinued by Sponsor|0|||
163016728|NCT01757184|588766212|FG001|Open-label Period|Discontinued by Sponsor|0|||
163016729|NCT01757184|588766213|FG002|Open-label Period|Discontinued by Sponsor|1|||
163016730|NCT01757184|588766214|FG003|Open-label Period|Discontinued by Sponsor|2|||
163016731|NCT04468347|588766217|FG000|Overall Study|Withdrawal by Subject|0|||
163016732|NCT04468347|588766218|FG001|Overall Study|Withdrawal by Subject|1|||
163016733|NCT04468347|588766219|FG002|Overall Study|Withdrawal by Subject|3|||
163016734|NCT04468347|588766220|FG003|Overall Study|Withdrawal by Subject|3|||
163016735|NCT04468347|588766217|FG000|Overall Study|Lost to Follow-up|0|||
163016736|NCT04468347|588766218|FG001|Overall Study|Lost to Follow-up|0|||
163016737|NCT04468347|588766219|FG002|Overall Study|Lost to Follow-up|1|||
163016738|NCT04468347|588766220|FG003|Overall Study|Lost to Follow-up|1|||
163016739|NCT04468347|588766217|FG000|Overall Study|Physician Decision|1|||
163016740|NCT04468347|588766218|FG001|Overall Study|Physician Decision|0|||
163016741|NCT04468347|588766219|FG002|Overall Study|Physician Decision|2|||
163016742|NCT04468347|588766220|FG003|Overall Study|Physician Decision|0|||
163016743|NCT04468347|588766217|FG000|Overall Study|Protocol Violation|1|||
163016744|NCT04468347|588766218|FG001|Overall Study|Protocol Violation|0|||
163016745|NCT04468347|588766219|FG002|Overall Study|Protocol Violation|0|||
163016746|NCT04468347|588766220|FG003|Overall Study|Protocol Violation|0|||
163016747|NCT00994461|588766221|FG000|Overall Study|Adverse Event|2|||
163016748|NCT00994461|588766222|FG001|Overall Study|Adverse Event|1|||
163016749|NCT00994461|588766223|FG002|Overall Study|Adverse Event|0|||
163016750|NCT04339062|588766224|FG000|Overall Study|Death|0|||
163016751|NCT04339062|588766225|FG001|Overall Study|Death|1|||
163016752|NCT04586244|588766226|FG000|Overall Study|Lost to Follow-up|1|||
163016753|NCT04586244|588766227|FG001|Overall Study|Lost to Follow-up|0|||
163016754|NCT04586244|588766228|FG002|Overall Study|Lost to Follow-up|0|||
163016755|NCT04586244|588766229|FG003|Overall Study|Lost to Follow-up|1|||
163016756|NCT04586244|588766230|FG004|Overall Study|Lost to Follow-up|0|||
163016757|NCT04586244|588766226|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
163016758|NCT04586244|588766227|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
163016759|NCT04586244|588766228|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
163016760|NCT04586244|588766229|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
163016761|NCT04586244|588766230|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
163016762|NCT03564119|588766231|FG000|Overall Study|Adverse Event|4|||
163016763|NCT03564119|588766232|FG001|Overall Study|Adverse Event|0|||
163016764|NCT03564119|588766231|FG000|Overall Study|Lost to Follow-up|1|||
163215566|NCT03329690|589503866|FG004|Overall Study|Progressive disease per RECIST|20|||
163215567|NCT03329690|589503862|FG000|Overall Study|Clinical progression|7|||
163215568|NCT03329690|589503863|FG001|Overall Study|Clinical progression|4|||
163016765|NCT03564119|588766232|FG001|Overall Study|Lost to Follow-up|4|||
163016766|NCT03564119|588766231|FG000|Overall Study|Protocol Violation|1|||
163016767|NCT03564119|588766232|FG001|Overall Study|Protocol Violation|0|||
163016768|NCT03564119|588766231|FG000|Overall Study|Withdrawal by Subject|9|||
163016769|NCT03564119|588766232|FG001|Overall Study|Withdrawal by Subject|4|||
163016770|NCT03564119|588766231|FG000|Overall Study|Other Than Specified|0|||
163016771|NCT03564119|588766232|FG001|Overall Study|Other Than Specified|1|||
163016772|NCT03896022|588766233|FG000|Overall Study|Withdrawal by Subject|1|||
163016773|NCT03896022|588766234|FG001|Overall Study|Withdrawal by Subject|0|||
163016774|NCT03896022|588766235|FG002|Overall Study|Withdrawal by Subject|0|||
163016775|NCT03896022|588766233|FG000|Overall Study|Did not have procedure|3|||
163016776|NCT03896022|588766234|FG001|Overall Study|Did not have procedure|0|||
163016777|NCT03896022|588766235|FG002|Overall Study|Did not have procedure|0|||
163016778|NCT02741076|588766236|FG000|Overall Study|Adverse Event|0|||
163016779|NCT02741076|588766237|FG001|Overall Study|Adverse Event|1|||
163016780|NCT02741076|588766238|FG002|Overall Study|Adverse Event|1|||
163016781|NCT02741076|588766239|FG003|Overall Study|Adverse Event|0|||
163016782|NCT02741076|588766236|FG000|Overall Study|Lack of Efficacy|1|||
163016783|NCT02741076|588766237|FG001|Overall Study|Lack of Efficacy|0|||
163016784|NCT02741076|588766238|FG002|Overall Study|Lack of Efficacy|0|||
163016785|NCT02741076|588766239|FG003|Overall Study|Lack of Efficacy|0|||
163016786|NCT02741076|588766236|FG000|Overall Study|Withdrawal by Subject|0|||
163016787|NCT02741076|588766237|FG001|Overall Study|Withdrawal by Subject|1|||
163016788|NCT02741076|588766238|FG002|Overall Study|Withdrawal by Subject|0|||
163215569|NCT03329690|589503864|FG002|Overall Study|Clinical progression|1|||
163215570|NCT03329690|589503865|FG003|Overall Study|Clinical progression|1|||
163215571|NCT03329690|589503866|FG004|Overall Study|Clinical progression|1|||
163016789|NCT02741076|588766239|FG003|Overall Study|Withdrawal by Subject|0|||
163016790|NCT02741076|588766236|FG000|Overall Study|Sponsor Request|2|||
163016791|NCT02741076|588766237|FG001|Overall Study|Sponsor Request|3|||
163016792|NCT02741076|588766238|FG002|Overall Study|Sponsor Request|0|||
163016793|NCT02741076|588766239|FG003|Overall Study|Sponsor Request|1|||
163016794|NCT02741076|588766236|FG000|Overall Study|No additional information available|0|||
163016795|NCT02741076|588766237|FG001|Overall Study|No additional information available|0|||
163016796|NCT02741076|588766238|FG002|Overall Study|No additional information available|1|||
163016797|NCT02741076|588766239|FG003|Overall Study|No additional information available|1|||
163016798|NCT01779440|588766240|FG000|Overall Study|Withdrawal by Subject|3|||
163016799|NCT01779440|588766241|FG001|Overall Study|Withdrawal by Subject|5|||
163016800|NCT00550745|588766242|FG000|Overall Study|Death|20|||
163016801|NCT00550745|588766243|FG001|Overall Study|Death|16|||
163016802|NCT00550745|588766242|FG000|Overall Study|Lost to Follow-up|45|||
163016803|NCT00550745|588766243|FG001|Overall Study|Lost to Follow-up|30|||
163016804|NCT00550745|588766242|FG000|Overall Study|Physician Decision|0|||
163016805|NCT00550745|588766243|FG001|Overall Study|Physician Decision|2|||
163016806|NCT00550745|588766242|FG000|Overall Study|Protocol Violation|4|||
163016807|NCT00550745|588766243|FG001|Overall Study|Protocol Violation|2|||
163016808|NCT00550745|588766242|FG000|Overall Study|Withdrawal by Subject|17|||
163215572|NCT03329690|589503862|FG000|Overall Study|Adverse Event|22|||
163215573|NCT03329690|589503863|FG001|Overall Study|Adverse Event|4|||
163215574|NCT03329690|589503864|FG002|Overall Study|Adverse Event|0|||
163215575|NCT03329690|589503865|FG003|Overall Study|Adverse Event|1|||
163215576|NCT03329690|589503866|FG004|Overall Study|Adverse Event|2|||
163215577|NCT03329690|589503862|FG000|Overall Study|Death|2|||
163215578|NCT03329690|589503863|FG001|Overall Study|Death|0|||
163215579|NCT03329690|589503864|FG002|Overall Study|Death|0|||
163016809|NCT00550745|588766243|FG001|Overall Study|Withdrawal by Subject|10|||
163016810|NCT00550745|588766242|FG000|Overall Study|Screen failure|1|||
163016811|NCT00550745|588766243|FG001|Overall Study|Screen failure|0|||
163016812|NCT01131455|588766244|FG000|Overall Study|Death of PI|6|||
163016813|NCT01131455|588766245|FG001|Overall Study|Death of PI|4|||
163016814|NCT01131455|588766246|FG002|Overall Study|Death of PI|0|||
163016815|NCT00764660|588766247|FG000|Overall Study|Adverse Event|6|||
163016816|NCT00764660|588766248|FG001|Overall Study|Adverse Event|3|||
163016817|NCT00764660|588766247|FG000|Overall Study|Lost to Follow-up|3|||
163016818|NCT00764660|588766248|FG001|Overall Study|Lost to Follow-up|4|||
163016819|NCT00764660|588766247|FG000|Overall Study|Withdrawal by Subject|7|||
163016820|NCT00764660|588766248|FG001|Overall Study|Withdrawal by Subject|3|||
163016821|NCT00764660|588766247|FG000|Overall Study|Noncompliance With Protocol|5|||
163016822|NCT00764660|588766248|FG001|Overall Study|Noncompliance With Protocol|1|||
163016823|NCT00764660|588766247|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
163016824|NCT00764660|588766248|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
163016825|NCT01190410|588767405|FG000|Overall Study|Adverse Event|0|||
163016826|NCT01190410|588767406|FG001|Overall Study|Adverse Event|3|||
163016827|NCT01190410|588767405|FG000|Overall Study|Lack of Efficacy|0|||
163016828|NCT01190410|588767406|FG001|Overall Study|Lack of Efficacy|2|||
163016829|NCT01190410|588767405|FG000|Overall Study|Withdrawal by Subject|0|||
163016830|NCT01190410|588767406|FG001|Overall Study|Withdrawal by Subject|2|||
163016831|NCT01190410|588767405|FG000|Overall Study|Administrative decision|1|||
163016832|NCT01190410|588767406|FG001|Overall Study|Administrative decision|0|||
163016833|NCT01190410|588767405|FG000|Overall Study|PI discretion|0|||
163016834|NCT01190410|588767406|FG001|Overall Study|PI discretion|2|||
163016835|NCT00769067|588767407|FG000|Overall Study|Death|89|||
163016836|NCT00769067|588767408|FG001|Overall Study|Death|86|||
163016837|NCT00769067|588767407|FG000|Overall Study|Lost to Follow-up|3|||
163016838|NCT00769067|588767408|FG001|Overall Study|Lost to Follow-up|1|||
163016839|NCT00769067|588767407|FG000|Overall Study|Study terminated by sponsor|1|||
163016840|NCT00769067|588767408|FG001|Overall Study|Study terminated by sponsor|3|||
163016841|NCT00769067|588767407|FG000|Overall Study|Other|1|||
163016842|NCT00769067|588767408|FG001|Overall Study|Other|3|||
163016843|NCT00769067|588767407|FG000|Overall Study|Withdrawal by Subject|0|||
163016844|NCT00769067|588767408|FG001|Overall Study|Withdrawal by Subject|1|||
163016845|NCT04981470|588767411|FG000|Overall Study|Device failure in all 4 patients|4|||
163016846|NCT04402138|588767412|FG000|Overall Study|Progressive Disease|2|||
163016847|NCT04402138|588767412|FG000|Overall Study|Adverse Event|1|||
163016848|NCT00784238|588767413|FG000|Overall Study|Adverse Event|14|||
163016849|NCT00784238|588767413|FG000|Overall Study|Death|2|||
163016850|NCT00784238|588767413|FG000|Overall Study|Lack of Efficacy|33|||
163016851|NCT00784238|588767413|FG000|Overall Study|Lost to Follow-up|29|||
163215580|NCT03329690|589503865|FG003|Overall Study|Death|1|||
163016852|NCT00784238|588767413|FG000|Overall Study|Pregnancy|1|||
163016853|NCT00784238|588767413|FG000|Overall Study|Withdrawal by Subject|26|||
163016854|NCT00784238|588767413|FG000|Overall Study|Other|14|||
163016855|NCT00078767|588767415|FG000|Overall Study|Withdrawal by Subject|1|||
163016856|NCT00078767|588767416|FG001|Overall Study|Withdrawal by Subject|1|||
163016857|NCT06098339|588767417|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
163016858|NCT06098339|588767418|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
163016859|NCT06098339|588767417|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
163016860|NCT06098339|588767418|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
163016861|NCT03656692|588767421|FG000|Overall Study|Worsening of disease activity|2|||
163016862|NCT03656692|588767421|FG000|Overall Study|Physician Decision|1|||
163016863|NCT00594100|588767422|FG000|Procedure|Technical Failure|9|||
163016864|NCT00594100|588767422|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
163016865|NCT00594100|588767422|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
163016866|NCT00594100|588767422|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
163016867|NCT02448537|588767423|FG000|Overall Study|Withdrawal by Subject|1|||
163016868|NCT02448537|588767424|FG001|Overall Study|Withdrawal by Subject|1|||
163016869|NCT02448537|588767425|FG002|Overall Study|Withdrawal by Subject|1|||
163016870|NCT03528369|588767426|FG000|Overall Study|Withdrawal by Subject|2|||
163016871|NCT03528369|588767427|FG001|Overall Study|Withdrawal by Subject|0|||
163215581|NCT03329690|589503866|FG004|Overall Study|Death|0|||
163215582|NCT03329690|589503862|FG000|Overall Study|Withdrawal by Subject|2|||
163215583|NCT03329690|589503863|FG001|Overall Study|Withdrawal by Subject|3|||
163016872|NCT03528369|588767428|FG002|Overall Study|Withdrawal by Subject|0|||
163016873|NCT03528369|588767426|FG000|Overall Study|Lost to Follow-up|1|||
163016874|NCT03528369|588767427|FG001|Overall Study|Lost to Follow-up|0|||
163016875|NCT03528369|588767428|FG002|Overall Study|Lost to Follow-up|0|||
163016876|NCT03528369|588767426|FG000|Overall Study|Adverse Event|0|||
163016877|NCT03528369|588767427|FG001|Overall Study|Adverse Event|1|||
163016878|NCT03528369|588767428|FG002|Overall Study|Adverse Event|0|||
163016879|NCT05656534|588767430|FG000|Overall Study|Withdrawal by Subject|1|||
163215584|NCT03329690|589503864|FG002|Overall Study|Withdrawal by Subject|0|||
163215585|NCT03329690|589503865|FG003|Overall Study|Withdrawal by Subject|1|||
163215586|NCT03329690|589503866|FG004|Overall Study|Withdrawal by Subject|0|||
163215587|NCT03329690|589503862|FG000|Overall Study|Physician Decision|1|||
163215588|NCT03329690|589503863|FG001|Overall Study|Physician Decision|0|||
163215589|NCT03329690|589503864|FG002|Overall Study|Physician Decision|0|||
163215590|NCT03329690|589503865|FG003|Overall Study|Physician Decision|0|||
163215591|NCT03329690|589503866|FG004|Overall Study|Physician Decision|1|||
163215592|NCT03329690|589503862|FG000|Overall Study|Miscellaneous|6|||
163215593|NCT03329690|589503863|FG001|Overall Study|Miscellaneous|0|||
163215594|NCT03329690|589503864|FG002|Overall Study|Miscellaneous|0|||
163215595|NCT03329690|589503865|FG003|Overall Study|Miscellaneous|0|||
163215596|NCT03329690|589503866|FG004|Overall Study|Miscellaneous|0|||
163215597|NCT03329690|589503862|FG000|Overall Study|Did not receive treatment|1|||
163215598|NCT03329690|589503863|FG001|Overall Study|Did not receive treatment|0|||
163215599|NCT03329690|589503864|FG002|Overall Study|Did not receive treatment|0|||
163215600|NCT03329690|589503865|FG003|Overall Study|Did not receive treatment|1|||
163215601|NCT03329690|589503866|FG004|Overall Study|Did not receive treatment|0|||
163016880|NCT05656534|588767431|FG001|Overall Study|Withdrawal by Subject|1|||
163016881|NCT05656534|588767432|FG002|Overall Study|Withdrawal by Subject|0|||
163215602|NCT00619801|589503874|FG000|Overall Study|Lack of Efficacy|0|||
163016882|NCT05656534|588767433|FG003|Overall Study|Withdrawal by Subject|0|||
163016883|NCT05656534|588767430|FG000|Overall Study|Physician Decision|1|||
163016884|NCT05656534|588767431|FG001|Overall Study|Physician Decision|1|||
163016885|NCT05656534|588767432|FG002|Overall Study|Physician Decision|0|||
163016886|NCT05656534|588767433|FG003|Overall Study|Physician Decision|0|||
163016887|NCT02801617|588767438|FG000|Overall Study|Protocol Violation|2|||
163016888|NCT02801617|588767439|FG001|Overall Study|Protocol Violation|6|||
163016889|NCT00302328|588767440|FG000|Overall Study|Physician Decision|0|||
163016890|NCT00302328|588767441|FG001|Overall Study|Physician Decision|1|||
163016891|NCT00302328|588767442|FG002|Overall Study|Physician Decision|0|||
163016892|NCT01718535|588767443|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
163016893|NCT01718535|588767444|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
163016894|NCT01718535|588767445|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
163016895|NCT01718535|588767446|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
163016896|NCT01718535|588767447|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
163016897|NCT01718535|588767448|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
163016898|NCT01718535|588767449|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
163016899|NCT01718535|588767450|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
163016900|NCT01718535|588767451|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
163016901|NCT01718535|588767452|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
163016902|NCT02476578|588767453|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
163016903|NCT02476578|588767454|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
163016904|NCT02476578|588767453|FG000|Overall Study|Lost to Follow-up|6|||
163016905|NCT02476578|588767454|FG001|Overall Study|Lost to Follow-up|13|||
163016906|NCT01057810|588767456|FG000|Overall Study|Disease progression|156|||
163016907|NCT01057810|588767457|FG001|Overall Study|Disease progression|197|||
163016908|NCT01057810|588767456|FG000|Overall Study|Study drug toxicity|5|||
163016909|NCT01057810|588767457|FG001|Overall Study|Study drug toxicity|114|||
163016910|NCT01057810|588767456|FG000|Overall Study|Adverse event unrelated to study drug|13|||
163016911|NCT01057810|588767457|FG001|Overall Study|Adverse event unrelated to study drug|29|||
163016912|NCT01057810|588767456|FG000|Overall Study|Withdrawal by Subject|10|||
163016913|NCT01057810|588767457|FG001|Overall Study|Withdrawal by Subject|25|||
163016914|NCT01057810|588767456|FG000|Overall Study|Death|2|||
163016915|NCT01057810|588767457|FG001|Overall Study|Death|12|||
163016916|NCT01057810|588767456|FG000|Overall Study|Maximum clinical benefit|5|||
163016917|NCT01057810|588767457|FG001|Overall Study|Maximum clinical benefit|5|||
163016918|NCT01057810|588767456|FG000|Overall Study|Poor/non-compliance|0|||
163016919|NCT01057810|588767457|FG001|Overall Study|Poor/non-compliance|1|||
163016920|NCT01057810|588767456|FG000|Overall Study|No longer met study criteria|0|||
163215603|NCT00619801|589503875|FG001|Overall Study|Lack of Efficacy|1|||
163215604|NCT00619801|589503874|FG000|Overall Study|Withdrawal by Subject|1|||
163215605|NCT00619801|589503875|FG001|Overall Study|Withdrawal by Subject|1|||
163215606|NCT00619801|589503874|FG000|Overall Study|Loss of efficacy|0|||
163215607|NCT00619801|589503875|FG001|Overall Study|Loss of efficacy|1|||
163016921|NCT01057810|588767457|FG001|Overall Study|No longer met study criteria|1|||
163016922|NCT01057810|588767456|FG000|Overall Study|Other|7|||
163016923|NCT01057810|588767457|FG001|Overall Study|Other|14|||
163016924|NCT00267969|588767458|FG000|Controlled Period|Adverse Event|6|||
163016925|NCT00267969|588767459|FG001|Controlled Period|Adverse Event|0|||
163016926|NCT00267969|588767460|FG002|Controlled Period|Adverse Event|2|||
163016927|NCT00267969|588767461|FG003|Controlled Period|Adverse Event|0|||
163016928|NCT00267969|588767462|FG004|Controlled Period|Adverse Event|0|||
163016929|NCT00267969|588767463|FG005|Controlled Period|Adverse Event|0|||
163016930|NCT00267969|588767464|FG006|Controlled Period|Adverse Event|0|||
163016931|NCT00267969|588767458|FG000|Controlled Period|Lack of Efficacy|3|||
163016932|NCT00267969|588767459|FG001|Controlled Period|Lack of Efficacy|0|||
163016933|NCT00267969|588767460|FG002|Controlled Period|Lack of Efficacy|1|||
163016934|NCT00267969|588767461|FG003|Controlled Period|Lack of Efficacy|0|||
163016935|NCT00267969|588767462|FG004|Controlled Period|Lack of Efficacy|0|||
163016936|NCT00267969|588767463|FG005|Controlled Period|Lack of Efficacy|0|||
163016937|NCT00267969|588767464|FG006|Controlled Period|Lack of Efficacy|0|||
163016938|NCT00267969|588767458|FG000|Controlled Period|Lost to Follow-up|1|||
163016939|NCT00267969|588767459|FG001|Controlled Period|Lost to Follow-up|0|||
163016940|NCT00267969|588767460|FG002|Controlled Period|Lost to Follow-up|1|||
163016941|NCT00267969|588767461|FG003|Controlled Period|Lost to Follow-up|0|||
163016942|NCT00267969|588767462|FG004|Controlled Period|Lost to Follow-up|0|||
163016943|NCT00267969|588767463|FG005|Controlled Period|Lost to Follow-up|0|||
163016944|NCT00267969|588767464|FG006|Controlled Period|Lost to Follow-up|0|||
163016945|NCT00267969|588767458|FG000|Controlled Period|Randomized but not treated|0|||
163016946|NCT00267969|588767459|FG001|Controlled Period|Randomized but not treated|0|||
163016947|NCT00267969|588767460|FG002|Controlled Period|Randomized but not treated|1|||
163016948|NCT00267969|588767461|FG003|Controlled Period|Randomized but not treated|0|||
163016949|NCT00267969|588767462|FG004|Controlled Period|Randomized but not treated|0|||
163016950|NCT00267969|588767463|FG005|Controlled Period|Randomized but not treated|0|||
163016951|NCT00267969|588767464|FG006|Controlled Period|Randomized but not treated|0|||
163016952|NCT00267969|588767458|FG000|Controlled Period|Other|2|||
163016953|NCT00267969|588767459|FG001|Controlled Period|Other|1|||
163016954|NCT00267969|588767460|FG002|Controlled Period|Other|6|||
163016955|NCT00267969|588767461|FG003|Controlled Period|Other|0|||
163016956|NCT00267969|588767462|FG004|Controlled Period|Other|0|||
163016957|NCT00267969|588767463|FG005|Controlled Period|Other|0|||
163016958|NCT00267969|588767464|FG006|Controlled Period|Other|0|||
163016959|NCT00267969|588767458|FG000|After Controlled Period|Adverse Event|0|||
163016960|NCT00267969|588767459|FG001|After Controlled Period|Adverse Event|0|||
163016961|NCT00267969|588767460|FG002|After Controlled Period|Adverse Event|0|||
163016962|NCT00267969|588767461|FG003|After Controlled Period|Adverse Event|7|||
163016963|NCT00267969|588767462|FG004|After Controlled Period|Adverse Event|8|||
163016964|NCT00267969|588767463|FG005|After Controlled Period|Adverse Event|23|||
163016965|NCT00267969|588767464|FG006|After Controlled Period|Adverse Event|21|||
163016966|NCT00267969|588767458|FG000|After Controlled Period|Death|0|||
163016967|NCT00267969|588767459|FG001|After Controlled Period|Death|0|||
163016968|NCT00267969|588767460|FG002|After Controlled Period|Death|0|||
163016969|NCT00267969|588767461|FG003|After Controlled Period|Death|1|||
163016970|NCT00267969|588767462|FG004|After Controlled Period|Death|2|||
163016971|NCT00267969|588767463|FG005|After Controlled Period|Death|0|||
163016972|NCT00267969|588767464|FG006|After Controlled Period|Death|1|||
163016973|NCT00267969|588767458|FG000|After Controlled Period|Lack of Efficacy|0|||
163016974|NCT00267969|588767459|FG001|After Controlled Period|Lack of Efficacy|0|||
163016975|NCT00267969|588767460|FG002|After Controlled Period|Lack of Efficacy|0|||
163016976|NCT00267969|588767461|FG003|After Controlled Period|Lack of Efficacy|10|||
163016977|NCT00267969|588767462|FG004|After Controlled Period|Lack of Efficacy|6|||
163016978|NCT00267969|588767463|FG005|After Controlled Period|Lack of Efficacy|28|||
163016979|NCT00267969|588767464|FG006|After Controlled Period|Lack of Efficacy|15|||
163016980|NCT00267969|588767458|FG000|After Controlled Period|Lost to Follow-up|0|||
163016981|NCT00267969|588767459|FG001|After Controlled Period|Lost to Follow-up|0|||
163016982|NCT00267969|588767460|FG002|After Controlled Period|Lost to Follow-up|0|||
163016983|NCT00267969|588767461|FG003|After Controlled Period|Lost to Follow-up|5|||
163016984|NCT00267969|588767462|FG004|After Controlled Period|Lost to Follow-up|8|||
163016985|NCT00267969|588767463|FG005|After Controlled Period|Lost to Follow-up|9|||
163016986|NCT00267969|588767464|FG006|After Controlled Period|Lost to Follow-up|10|||
163016987|NCT00267969|588767458|FG000|After Controlled Period|Other|0|||
163016988|NCT00267969|588767459|FG001|After Controlled Period|Other|0|||
163016989|NCT00267969|588767460|FG002|After Controlled Period|Other|0|||
163016990|NCT00267969|588767461|FG003|After Controlled Period|Other|13|||
163016991|NCT00267969|588767462|FG004|After Controlled Period|Other|11|||
163016992|NCT00267969|588767463|FG005|After Controlled Period|Other|22|||
163016993|NCT00267969|588767464|FG006|After Controlled Period|Other|25|||
163016994|NCT00862823|588767465|FG000|First Intervention|Withdrawal by Subject|1|||
163328600|NCT05827068|589913307|FG001|Overall Study|Lost to Follow-up|4|||
163328601|NCT05827068|589913308|FG002|Overall Study|Lost to Follow-up|1|||
163328602|NCT05827068|589913309|FG003|Overall Study|Lost to Follow-up|1|||
163016995|NCT00862823|588767466|FG001|First Intervention|Withdrawal by Subject|1|||
163016996|NCT00887315|588767467|FG000|Overall Study|Study termination|7|||
163016997|NCT00887315|588767468|FG001|Overall Study|Study termination|4|||
163016998|NCT00857896|588767475|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
163328603|NCT05827068|589913310|FG004|Overall Study|Lost to Follow-up|2|||
163016999|NCT02308540|588767476|FG000|Overall Study|Lost to Follow-up|0|||
163017000|NCT02308540|588767477|FG001|Overall Study|Lost to Follow-up|0|||
163017001|NCT02308540|588767478|FG002|Overall Study|Lost to Follow-up|0|||
163017002|NCT02308540|588767479|FG003|Overall Study|Lost to Follow-up|0|||
163017003|NCT02308540|588767480|FG004|Overall Study|Lost to Follow-up|0|||
163017004|NCT02308540|588767481|FG005|Overall Study|Lost to Follow-up|1|||
163017005|NCT01091662|588767482|FG000|Overall Study|Adverse Event|1|||
163017006|NCT01091662|588767483|FG001|Overall Study|Adverse Event|9|||
163017007|NCT01091662|588767482|FG000|Overall Study|Physician Decision|1|||
163017008|NCT01091662|588767483|FG001|Overall Study|Physician Decision|1|||
163017009|NCT01091662|588767482|FG000|Overall Study|Withdrawal by Subject|7|||
163017010|NCT01091662|588767483|FG001|Overall Study|Withdrawal by Subject|6|||
163017011|NCT01091662|588767482|FG000|Overall Study|met exit criteria|7|||
163017012|NCT01091662|588767483|FG001|Overall Study|met exit criteria|13|||
163017013|NCT01091662|588767482|FG000|Overall Study|met exclusion criteria|1|||
163017014|NCT01091662|588767483|FG001|Overall Study|met exclusion criteria|0|||
163017015|NCT01091662|588767482|FG000|Overall Study|Lost to Follow-up|0|||
163017016|NCT01091662|588767483|FG001|Overall Study|Lost to Follow-up|1|||
163017017|NCT01091662|588767482|FG000|Overall Study|Pregnancy|0|||
163017018|NCT01091662|588767483|FG001|Overall Study|Pregnancy|1|||
163017019|NCT01091662|588767482|FG000|Overall Study|Protocol Violation|0|||
163017020|NCT01091662|588767483|FG001|Overall Study|Protocol Violation|2|||
163017021|NCT01091662|588767482|FG000|Overall Study|unable to swallow capsule|0|||
163017022|NCT01091662|588767483|FG001|Overall Study|unable to swallow capsule|1|||
163017023|NCT04109391|588767484|FG000|Overall Study|Adverse Event|2|||
163017024|NCT04109391|588767485|FG001|Overall Study|Adverse Event|2|||
163017025|NCT04109391|588767486|FG002|Overall Study|Adverse Event|0|||
163017026|NCT04109391|588767484|FG000|Overall Study|Withdrawal by Subject|2|||
163017027|NCT04109391|588767485|FG001|Overall Study|Withdrawal by Subject|0|||
163017028|NCT04109391|588767486|FG002|Overall Study|Withdrawal by Subject|0|||
163017029|NCT04109391|588767484|FG000|Overall Study|Pregnancy|1|||
163017030|NCT04109391|588767485|FG001|Overall Study|Pregnancy|0|||
163017031|NCT04109391|588767486|FG002|Overall Study|Pregnancy|0|||
163017032|NCT04109391|588767484|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
163017033|NCT04109391|588767485|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
163017034|NCT04109391|588767486|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
163017035|NCT04109391|588767484|FG000|Overall Study|Lost to Follow-up|0|||
163017036|NCT04109391|588767485|FG001|Overall Study|Lost to Follow-up|0|||
163017037|NCT04109391|588767486|FG002|Overall Study|Lost to Follow-up|1|||
163017038|NCT04109391|588767484|FG000|Overall Study|Lack of Efficacy|2|||
163017039|NCT04109391|588767485|FG001|Overall Study|Lack of Efficacy|2|||
163017040|NCT04109391|588767486|FG002|Overall Study|Lack of Efficacy|3|||
163017041|NCT02285166|588767487|FG000|Overall Study|Case Report Forms Uncollected|564|||
163017042|NCT02285166|588767487|FG000|Overall Study|Protocol Deviation|402|||
163017043|NCT00443079|588767488|FG000|Overall Study|Lost to Follow-up|0|||
163017044|NCT00443079|588767489|FG001|Overall Study|Lost to Follow-up|1|||
163017045|NCT01421225|588767490|FG000|Overall Study|Withdrawal by Subject|0|||
163017046|NCT01421225|588767491|FG001|Overall Study|Withdrawal by Subject|1|||
163017047|NCT01106911|588767492|FG000|Overall Study|Physician Decision|2|||
163017048|NCT01106911|588767492|FG000|Overall Study|deemed ineligible after screening|3|||
163017049|NCT01814696|588767494|FG000|Overall Study|Withdrawal by Subject|1|||
163017050|NCT01814696|588767495|FG001|Overall Study|Withdrawal by Subject|0|||
163017051|NCT01814696|588767494|FG000|Overall Study|Randomized to wrong group|1|||
163017052|NCT01814696|588767495|FG001|Overall Study|Randomized to wrong group|0|||
163017053|NCT05310071|588767497|FG000|Overall Study|Death|0|||
163017054|NCT05310071|588767498|FG001|Overall Study|Death|3|||
163017055|NCT05310071|588767497|FG000|Overall Study|Adverse Event|4|||
163017056|NCT05310071|588767498|FG001|Overall Study|Adverse Event|31|||
163017057|NCT05310071|588767497|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
163017058|NCT05310071|588767498|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
163017059|NCT05310071|588767497|FG000|Overall Study|Protocol Deviation|2|||
163017060|NCT05310071|588767498|FG001|Overall Study|Protocol Deviation|0|||
163017061|NCT05310071|588767497|FG000|Overall Study|Randomized by Mistake|0|||
163017062|NCT05310071|588767498|FG001|Overall Study|Randomized by Mistake|1|||
163017063|NCT05310071|588767497|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
163017064|NCT05310071|588767498|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
163017065|NCT05310071|588767497|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
163017066|NCT05310071|588767498|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
163017067|NCT05310071|588767497|FG000|Overall Study|Site Terminated by Sponsor|0|||
163017068|NCT05310071|588767498|FG001|Overall Study|Site Terminated by Sponsor|2|||
163017069|NCT05310071|588767497|FG000|Overall Study|Study Terminated by Sponsor|282|||
163017070|NCT05310071|588767498|FG001|Overall Study|Study Terminated by Sponsor|559|||
163017071|NCT05310071|588767497|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
163017072|NCT05310071|588767498|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
163017073|NCT05310071|588767497|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
163017074|NCT05310071|588767498|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
163017075|NCT05310071|588767497|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
163017076|NCT05310071|588767498|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
163017077|NCT05310071|588767497|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
163017078|NCT05310071|588767498|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
163017079|NCT05310071|588767497|FG000|Overall Study|Withdrawal by Participant - Other|25|||
163017080|NCT05310071|588767498|FG001|Overall Study|Withdrawal by Participant - Other|30|||
163017081|NCT05310071|588767497|FG000|Overall Study|Lost to Follow-up|2|||
163017082|NCT05310071|588767498|FG001|Overall Study|Lost to Follow-up|4|||
163017083|NCT05310071|588767497|FG000|Overall Study|Reason Not Specified|1|||
163017084|NCT05310071|588767498|FG001|Overall Study|Reason Not Specified|3|||
163017085|NCT02105987|588767499|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
163017086|NCT02105987|588767500|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
163017087|NCT02105987|588767501|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
163017088|NCT02105987|588767502|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
163017089|NCT02105987|588767503|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
163017090|NCT02105987|588767504|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
163017091|NCT02105987|588767499|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
163017092|NCT02105987|588767500|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
163017093|NCT02105987|588767501|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
163017094|NCT02105987|588767502|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
163017095|NCT02105987|588767503|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
163017096|NCT02105987|588767504|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
163017097|NCT02105987|588767499|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
163017098|NCT02105987|588767500|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
163017099|NCT02105987|588767501|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017100|NCT02105987|588767502|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017101|NCT02105987|588767503|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017102|NCT02105987|588767504|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017103|NCT02105987|588767499|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
163017104|NCT02105987|588767500|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
163017105|NCT02105987|588767501|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163017106|NCT02105987|588767502|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163017107|NCT02105987|588767503|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163017108|NCT02105987|588767504|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163017109|NCT02105987|588767499|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
163017110|NCT02105987|588767500|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
163017111|NCT02105987|588767501|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
163017112|NCT02105987|588767502|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
163017113|NCT02105987|588767503|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
163017114|NCT02105987|588767504|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
163017115|NCT02105987|588767499|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
163017116|NCT02105987|588767500|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
163017117|NCT02105987|588767501|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
163017118|NCT02105987|588767502|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
163017119|NCT02105987|588767503|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
163017120|NCT02105987|588767504|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
163017121|NCT02105987|588767499|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
163017122|NCT02105987|588767500|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
163017123|NCT02105987|588767501|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
163017124|NCT02105987|588767502|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
163017125|NCT02105987|588767503|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
163017126|NCT02105987|588767504|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
163017127|NCT02105987|588767499|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
163017128|NCT02105987|588767500|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
163017129|NCT02105987|588767501|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
163017130|NCT02105987|588767502|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
163017131|NCT02105987|588767503|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
163017132|NCT02105987|588767504|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
163017133|NCT02105987|588767499|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017134|NCT02105987|588767500|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017135|NCT02105987|588767501|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
163017136|NCT02105987|588767502|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
163017137|NCT02105987|588767503|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017138|NCT02105987|588767504|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017139|NCT02105987|588767499|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163062939|NCT04491994|588938528|FG000|Overall Study|Withdrawal by Subject|10|||
163062940|NCT04491994|588938529|FG001|Overall Study|Withdrawal by Subject|5|||
163062941|NCT04491994|588938528|FG000|Overall Study|developed fever > 3 days|4|||
163062942|NCT04491994|588938529|FG001|Overall Study|developed fever > 3 days|1|||
163062943|NCT04491994|588938528|FG000|Overall Study|Protocol Violation|11|||
163062944|NCT04491994|588938529|FG001|Overall Study|Protocol Violation|2|||
163062945|NCT04491994|588938528|FG000|Overall Study|Lost to Follow-up|4|||
163062946|NCT04491994|588938529|FG001|Overall Study|Lost to Follow-up|3|||
163215608|NCT00450333|589503880|FG000|Overall Study|Study terminated|47|||
163215609|NCT00450333|589503881|FG001|Overall Study|Study terminated|54|||
163215610|NCT00450333|589503882|FG002|Overall Study|Study terminated|16|||
163017140|NCT02105987|588767500|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163017141|NCT02105987|588767501|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
163017142|NCT02105987|588767502|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
163017143|NCT02105987|588767503|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163017144|NCT02105987|588767504|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163017145|NCT02105987|588767499|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
163017146|NCT02105987|588767500|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
163017147|NCT02105987|588767501|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
163017148|NCT02105987|588767502|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
163017149|NCT02105987|588767503|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
163017150|NCT02105987|588767504|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
163017151|NCT02105987|588767499|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
163017152|NCT02105987|588767500|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
163017153|NCT02105987|588767501|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
163017154|NCT02105987|588767502|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
163017155|NCT02105987|588767503|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
163017156|NCT02105987|588767504|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
163017157|NCT02105987|588767499|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
163017158|NCT02105987|588767500|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
163017159|NCT02105987|588767501|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
163017160|NCT02105987|588767502|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
163017161|NCT02105987|588767503|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
163017162|NCT02105987|588767504|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
163017163|NCT02105987|588767499|FG000|Continuation Phase|Protocol Violation|0|||
163017164|NCT02105987|588767500|FG001|Continuation Phase|Protocol Violation|0|||
163017165|NCT02105987|588767501|FG002|Continuation Phase|Protocol Violation|0|||
163017166|NCT02105987|588767502|FG003|Continuation Phase|Protocol Violation|0|||
163017167|NCT02105987|588767503|FG004|Continuation Phase|Protocol Violation|1|||
163017168|NCT02105987|588767504|FG005|Continuation Phase|Protocol Violation|0|||
163017169|NCT02418949|588767505|FG000|Overall Study|Withdrawal by Subject|1|||
163017170|NCT02418949|588767506|FG001|Overall Study|Withdrawal by Subject|0|||
163017171|NCT02418949|588767507|FG002|Overall Study|Withdrawal by Subject|1|||
163017172|NCT02418949|588767508|FG003|Overall Study|Withdrawal by Subject|1|||
163017173|NCT02418949|588767505|FG000|Overall Study|Lost to Follow-up|1|||
163017174|NCT02418949|588767506|FG001|Overall Study|Lost to Follow-up|0|||
163017175|NCT02418949|588767507|FG002|Overall Study|Lost to Follow-up|1|||
163017176|NCT02418949|588767508|FG003|Overall Study|Lost to Follow-up|0|||
163017177|NCT02418949|588767505|FG000|Overall Study|Physician Decision|1|||
163017178|NCT02418949|588767506|FG001|Overall Study|Physician Decision|1|||
163017179|NCT02418949|588767507|FG002|Overall Study|Physician Decision|1|||
163017180|NCT02418949|588767508|FG003|Overall Study|Physician Decision|0|||
163017181|NCT00396656|588767510|FG000|First Treatment Period|Withdrawal by Subject|0|||
163017182|NCT00396656|588767511|FG001|First Treatment Period|Withdrawal by Subject|2|||
163017183|NCT00396656|588767510|FG000|Second Treatment Period|Adverse Event|0|||
163017184|NCT00396656|588767511|FG001|Second Treatment Period|Adverse Event|1|||
163017185|NCT01303172|588767512|FG000|Overall Study|Physician Decision|9|||
163017186|NCT01303172|588767513|FG001|Overall Study|Physician Decision|6|||
163017187|NCT01303172|588767512|FG000|Overall Study|Adverse Event|5|||
163017188|NCT01303172|588767513|FG001|Overall Study|Adverse Event|2|||
163017189|NCT01303172|588767512|FG000|Overall Study|Withdrawal by Subject|4|||
163017190|NCT01303172|588767513|FG001|Overall Study|Withdrawal by Subject|2|||
163017191|NCT01303172|588767512|FG000|Overall Study|Death|20|||
163017192|NCT01303172|588767513|FG001|Overall Study|Death|7|||
163017193|NCT01303172|588767512|FG000|Overall Study|Lack of Efficacy|25|||
163017194|NCT01303172|588767513|FG001|Overall Study|Lack of Efficacy|17|||
163017195|NCT00462709|588767514|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
163017196|NCT00462709|588767514|FG000|Overall Study|Lost to Follow-up|10|||
163017197|NCT00462709|588767514|FG000|Overall Study|Withdrawal by Subject|8|||
163017198|NCT00462709|588767514|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
163062947|NCT03575364|588938535|FG000|Overall Study|Death|45|||
163062948|NCT03575364|588938535|FG000|Overall Study|Lost to Follow-up|114|||
163062949|NCT03575364|588938535|FG000|Overall Study|Withdrawal by Subject|21|||
163404695|NCT00996944|590191997|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
163062950|NCT03575364|588938535|FG000|Overall Study|Physician Decision|11|||
163215611|NCT00450333|589503883|FG003|Overall Study|Study terminated|21|||
163017199|NCT00462709|588767514|FG000|Overall Study|Death|2|||
163017200|NCT00462709|588767514|FG000|Overall Study|Logistical reasons|2|||
163017201|NCT00462709|588767514|FG000|Overall Study|Physician Decision|1|||
163017202|NCT00462709|588767514|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
163017203|NCT02099110|588767519|FG000|Overall Study|Protocol Violation|2|||
163017204|NCT02099110|588767520|FG001|Overall Study|Protocol Violation|1|||
163017205|NCT02099110|588767521|FG002|Overall Study|Protocol Violation|0|||
163017206|NCT02099110|588767522|FG003|Overall Study|Protocol Violation|3|||
163017207|NCT02099110|588767523|FG004|Overall Study|Protocol Violation|1|||
163017208|NCT02099110|588767519|FG000|Overall Study|Participant moved|1|||
163017209|NCT02099110|588767520|FG001|Overall Study|Participant moved|1|||
163017210|NCT02099110|588767521|FG002|Overall Study|Participant moved|1|||
163017211|NCT02099110|588767522|FG003|Overall Study|Participant moved|0|||
163017212|NCT02099110|588767523|FG004|Overall Study|Participant moved|2|||
163017213|NCT02099110|588767519|FG000|Overall Study|Withdrawal by Subject|7|||
163017214|NCT02099110|588767520|FG001|Overall Study|Withdrawal by Subject|11|||
163017215|NCT02099110|588767521|FG002|Overall Study|Withdrawal by Subject|13|||
163017216|NCT02099110|588767522|FG003|Overall Study|Withdrawal by Subject|9|||
163017217|NCT02099110|588767523|FG004|Overall Study|Withdrawal by Subject|13|||
163017218|NCT02099110|588767519|FG000|Overall Study|Adverse Event|3|||
163017219|NCT02099110|588767520|FG001|Overall Study|Adverse Event|5|||
163017220|NCT02099110|588767521|FG002|Overall Study|Adverse Event|2|||
163017221|NCT02099110|588767522|FG003|Overall Study|Adverse Event|3|||
163017222|NCT02099110|588767523|FG004|Overall Study|Adverse Event|2|||
163062951|NCT03575364|588938535|FG000|Overall Study|Subject Refused Follow-up|13|||
163062952|NCT03575364|588938535|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
163062953|NCT03575364|588938535|FG000|Overall Study|Patient moved out of the state|1|||
163062954|NCT03575364|588938535|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
163062955|NCT03575364|588938535|FG000|Overall Study|Patient is lost to follow up|1|||
163062956|NCT03575364|588938535|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
163062957|NCT02567188|588938536|FG000|Overall Study|Death|10|||
163062958|NCT02567188|588938536|FG000|Overall Study|Terminated Mircera Treatment|9|||
163062959|NCT02567188|588938536|FG000|Overall Study|Lost to Follow-up|5|||
163062960|NCT02567188|588938536|FG000|Overall Study|Adverse Event|1|||
163062961|NCT02567188|588938536|FG000|Overall Study|Withdrawal by Subject|1|||
163062962|NCT02567188|588938536|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
163062963|NCT02567188|588938536|FG000|Overall Study|Moved and Changed Clinic|1|||
163062964|NCT02567188|588938536|FG000|Overall Study|Started Hemodialysis|2|||
163062965|NCT02567188|588938536|FG000|Overall Study|Protocol Violation|5|||
163062966|NCT01033136|588938537|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
163062967|NCT01033136|588938538|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
163062968|NCT05383209|588938539|FG000|Overall Study|Adverse Event: Non-ocular|0|||
163062969|NCT05383209|588938540|FG001|Overall Study|Adverse Event: Non-ocular|1|||
163062970|NCT05383209|588938541|FG002|Overall Study|Adverse Event: Non-ocular|0|||
163062971|NCT05383209|588938539|FG000|Overall Study|Lost to Follow-up|2|||
163062972|NCT05383209|588938540|FG001|Overall Study|Lost to Follow-up|1|||
163062973|NCT05383209|588938541|FG002|Overall Study|Lost to Follow-up|4|||
163062974|NCT05383209|588938539|FG000|Overall Study|Withdrawal by Subject|2|||
163062975|NCT05383209|588938540|FG001|Overall Study|Withdrawal by Subject|0|||
163062976|NCT05383209|588938541|FG002|Overall Study|Withdrawal by Subject|1|||
163062977|NCT05383209|588938539|FG000|Overall Study|Death|1|||
163062978|NCT05383209|588938540|FG001|Overall Study|Death|0|||
163062979|NCT05383209|588938541|FG002|Overall Study|Death|0|||
163062980|NCT05383209|588938539|FG000|Overall Study|Other|0|||
163215612|NCT00450333|589503880|FG000|Overall Study|Adverse Event|1|||
163215613|NCT00450333|589503881|FG001|Overall Study|Adverse Event|7|||
163215614|NCT00450333|589503882|FG002|Overall Study|Adverse Event|2|||
163017223|NCT02099110|588767519|FG000|Overall Study|Lost to Follow-up|6|||
163017224|NCT02099110|588767520|FG001|Overall Study|Lost to Follow-up|12|||
163017225|NCT02099110|588767521|FG002|Overall Study|Lost to Follow-up|11|||
163017226|NCT02099110|588767522|FG003|Overall Study|Lost to Follow-up|5|||
163062981|NCT05383209|588938540|FG001|Overall Study|Other|1|||
163062982|NCT05383209|588938541|FG002|Overall Study|Other|0|||
163062983|NCT01369433|588938542|FG000|Overall Study|Adverse Event|31|||
163062984|NCT01369433|588938543|FG001|Overall Study|Adverse Event|1|||
163062985|NCT01369433|588938542|FG000|Overall Study|Required significant surgical procedure|1|||
163062986|NCT01369433|588938543|FG001|Overall Study|Required significant surgical procedure|0|||
163215615|NCT00450333|589503883|FG003|Overall Study|Adverse Event|2|||
163017227|NCT02099110|588767523|FG004|Overall Study|Lost to Follow-up|6|||
163017228|NCT02099110|588767519|FG000|Overall Study|Death|0|||
163017229|NCT02099110|588767520|FG001|Overall Study|Death|1|||
163017230|NCT02099110|588767521|FG002|Overall Study|Death|0|||
163017231|NCT02099110|588767522|FG003|Overall Study|Death|0|||
163017232|NCT02099110|588767523|FG004|Overall Study|Death|0|||
163062987|NCT01369433|588938542|FG000|Overall Study|Non-compliance|1|||
163062988|NCT01369433|588938543|FG001|Overall Study|Non-compliance|0|||
163062989|NCT01369433|588938542|FG000|Overall Study|Withdrawal by Subject|5|||
163215616|NCT00450333|589503880|FG000|Overall Study|Protocol Violation|1|||
163062990|NCT01369433|588938543|FG001|Overall Study|Withdrawal by Subject|2|||
163017233|NCT02099110|588767519|FG000|Overall Study|Screen failure|0|||
163017234|NCT02099110|588767520|FG001|Overall Study|Screen failure|0|||
163017235|NCT02099110|588767521|FG002|Overall Study|Screen failure|0|||
163017236|NCT02099110|588767522|FG003|Overall Study|Screen failure|0|||
163017237|NCT02099110|588767523|FG004|Overall Study|Screen failure|1|||
163017238|NCT02099110|588767519|FG000|Overall Study|Non-compliance with study drug|2|||
163017239|NCT02099110|588767520|FG001|Overall Study|Non-compliance with study drug|0|||
163017240|NCT02099110|588767521|FG002|Overall Study|Non-compliance with study drug|0|||
163017241|NCT02099110|588767522|FG003|Overall Study|Non-compliance with study drug|0|||
163017242|NCT02099110|588767523|FG004|Overall Study|Non-compliance with study drug|1|||
163017243|NCT02099110|588767519|FG000|Overall Study|Physician Decision|3|||
163017244|NCT02099110|588767520|FG001|Overall Study|Physician Decision|0|||
163017245|NCT02099110|588767521|FG002|Overall Study|Physician Decision|1|||
163017246|NCT02099110|588767522|FG003|Overall Study|Physician Decision|2|||
163017247|NCT02099110|588767523|FG004|Overall Study|Physician Decision|1|||
163017248|NCT00237458|588767530|FG000|Overall Study|Lack of Efficacy|1|||
163017249|NCT00237458|588767530|FG000|Overall Study|Adverse Event|1|||
163017250|NCT00237458|588767530|FG000|Overall Study|Withdrawal by Subject|1|||
163017251|NCT05107492|588767531|FG000|Overall Study|Lost to Follow-up|1|||
163017252|NCT05107492|588767532|FG001|Overall Study|Lost to Follow-up|0|||
163017253|NCT03218826|588767533|FG000|Overall Study|Non-compliance with protocol|1|||
163017254|NCT03218826|588767534|FG001|Overall Study|Non-compliance with protocol|0|||
163017255|NCT03218826|588767535|FG002|Overall Study|Non-compliance with protocol|2|||
163017256|NCT03218826|588767536|FG003|Overall Study|Non-compliance with protocol|1|||
163017257|NCT03218826|588767537|FG004|Overall Study|Non-compliance with protocol|1|||
163017258|NCT02858583|588767540|FG000|Overall Study|Declined consent|1|||
163017259|NCT02858583|588767541|FG001|Overall Study|Declined consent|1|||
163017260|NCT00634036|588767548|FG000|Overall Study|Lost to Follow-up|1|||
163017261|NCT00634036|588767549|FG001|Overall Study|Lost to Follow-up|1|||
163017262|NCT00634036|588767548|FG000|Overall Study|Withdrawal by Subject|1|||
163017263|NCT00634036|588767549|FG001|Overall Study|Withdrawal by Subject|1|||
163017264|NCT00961350|588767550|FG000|Overall Study|Adverse Event|18|||
163017265|NCT00961350|588767551|FG001|Overall Study|Adverse Event|33|||
163062991|NCT01369433|588938542|FG000|Overall Study|Study terminated by Sponsor|67|||
163062992|NCT01369433|588938543|FG001|Overall Study|Study terminated by Sponsor|0|||
163062993|NCT01369433|588938542|FG000|Overall Study|Lost to Follow-up|1|||
163062994|NCT01369433|588938543|FG001|Overall Study|Lost to Follow-up|0|||
163062995|NCT01369433|588938542|FG000|Overall Study|Death|5|||
163062996|NCT01369433|588938543|FG001|Overall Study|Death|0|||
163062997|NCT01369433|588938542|FG000|Overall Study|Investigator discretion|6|||
163062998|NCT01369433|588938543|FG001|Overall Study|Investigator discretion|1|||
163062999|NCT01369433|588938542|FG000|Overall Study|Progressive Disease|92|||
163063000|NCT01369433|588938543|FG001|Overall Study|Progressive Disease|12|||
163063001|NCT02313155|588938544|FG000|Overall Study|Lost to Follow-up|0|||
163063002|NCT02313155|588938545|FG001|Overall Study|Lost to Follow-up|1|||
163063003|NCT00933933|588938551|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
163063004|NCT00933933|588938552|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
163063005|NCT00933933|588938553|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
163063006|NCT00933933|588938551|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
163063007|NCT00933933|588938552|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
163063008|NCT00933933|588938553|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
163063009|NCT01138046|588938556|FG000|Overall Study|Withdrawal due to death|6|||
163063010|NCT01104766|588938560|FG000|Overall Study|Did not meet inc/exc criteria|1|||
163063011|NCT01104766|588938561|FG001|Overall Study|Did not meet inc/exc criteria|0|||
163063012|NCT01104766|588938562|FG002|Overall Study|Did not meet inc/exc criteria|0|||
163063013|NCT01104766|588938563|FG003|Overall Study|Did not meet inc/exc criteria|0|||
163215617|NCT00450333|589503881|FG001|Overall Study|Protocol Violation|0|||
163215618|NCT00450333|589503882|FG002|Overall Study|Protocol Violation|1|||
163215619|NCT00450333|589503883|FG003|Overall Study|Protocol Violation|0|||
163215620|NCT00450333|589503880|FG000|Overall Study|Withdrawal by Subject|1|||
163215621|NCT00450333|589503881|FG001|Overall Study|Withdrawal by Subject|0|||
163215622|NCT00450333|589503882|FG002|Overall Study|Withdrawal by Subject|3|||
163063014|NCT01104766|588938560|FG000|Overall Study|Adverse Event|17|||
163063015|NCT01104766|588938561|FG001|Overall Study|Adverse Event|15|||
163063016|NCT01104766|588938562|FG002|Overall Study|Adverse Event|20|||
163215623|NCT00450333|589503883|FG003|Overall Study|Withdrawal by Subject|0|||
163215624|NCT00450333|589503880|FG000|Overall Study|Kidney transplant|1|||
163017266|NCT00961350|588767550|FG000|Overall Study|Withdrawal by Subject|10|||
163017267|NCT00961350|588767551|FG001|Overall Study|Withdrawal by Subject|10|||
163017268|NCT00961350|588767550|FG000|Overall Study|Lost to Follow-up|3|||
163017269|NCT00961350|588767551|FG001|Overall Study|Lost to Follow-up|3|||
163063017|NCT01104766|588938563|FG003|Overall Study|Adverse Event|14|||
163215625|NCT00450333|589503881|FG001|Overall Study|Kidney transplant|0|||
163017270|NCT00961350|588767550|FG000|Overall Study|Misc|16|||
163017271|NCT00961350|588767551|FG001|Overall Study|Misc|21|||
163017272|NCT03867201|588767552|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
163017273|NCT03867201|588767553|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
163017274|NCT03867201|588767552|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
163017275|NCT03867201|588767553|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
163017276|NCT03867201|588767552|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
163017277|NCT03867201|588767553|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
163017278|NCT03867201|588767552|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
163017279|NCT03867201|588767553|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
163017280|NCT03867201|588767552|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
163017281|NCT03867201|588767553|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
163017282|NCT03867201|588767552|FG000|Open-Label Period From Week 12|Adverse Event|5|||
163017283|NCT03867201|588767553|FG001|Open-Label Period From Week 12|Adverse Event|11|||
163017284|NCT03867201|588767552|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
163017285|NCT03867201|588767553|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
163017286|NCT03867201|588767552|FG000|Open-Label Period From Week 12|Physician Decision|6|||
163017287|NCT03867201|588767553|FG001|Open-Label Period From Week 12|Physician Decision|3|||
163017288|NCT03867201|588767552|FG000|Open-Label Period From Week 12|Pregnancy|2|||
163017289|NCT03867201|588767553|FG001|Open-Label Period From Week 12|Pregnancy|2|||
163017290|NCT03867201|588767552|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
163017291|NCT03867201|588767553|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
163017292|NCT03867201|588767552|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
163017293|NCT03867201|588767553|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
163017294|NCT03867201|588767552|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
163017295|NCT03867201|588767553|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
163017296|NCT03867201|588767552|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
163017297|NCT03867201|588767553|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
163017298|NCT01283334|588769029|FG000|Overall Study|Withdrawal by Subject|1|||
163017299|NCT01283334|588769029|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
163017300|NCT01283334|588769029|FG000|Overall Study|Adverse Event|4|||
163017301|NCT01283334|588769029|FG000|Overall Study|Physician Decision|1|||
163017302|NCT03467217|588769030|FG000|Overall Study|Trial stopped early|5|||
163017303|NCT03467217|588769031|FG001|Overall Study|Trial stopped early|2|||
163017304|NCT03467217|588769030|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
163017305|NCT03467217|588769031|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
163017306|NCT03467217|588769030|FG000|Overall Study|Lost to Follow-up|0|||
163017307|NCT03467217|588769031|FG001|Overall Study|Lost to Follow-up|2|||
163017308|NCT04390503|588769032|FG000|Overall Study|Physician Decision|2|||
163017309|NCT04390503|588769033|FG001|Overall Study|Physician Decision|1|||
163017310|NCT04390503|588769032|FG000|Overall Study|Adverse Event|1|||
163017311|NCT04390503|588769033|FG001|Overall Study|Adverse Event|0|||
163017312|NCT03233529|588769035|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
163017313|NCT03233529|588769035|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
163017314|NCT03260244|588769036|FG000|Overall Study|Death|19|||
163017315|NCT03260244|588769036|FG000|Overall Study|Lost to Follow-up|60|||
163017316|NCT03260244|588769036|FG000|Overall Study|Withdrawal by Subject|48|||
163017317|NCT03260244|588769036|FG000|Overall Study|Procedure Not Performed|21|||
163017318|NCT03260244|588769036|FG000|Overall Study|Enrollment Criteria Not Met|31|||
163017319|NCT03260244|588769036|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
163017320|NCT03260244|588769036|FG000|Overall Study|Subject Noncompliance|6|||
163017321|NCT03260244|588769036|FG000|Overall Study|No inducible Arrhythmia|2|||
163017322|NCT03260244|588769036|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
163017323|NCT03260244|588769036|FG000|Overall Study|Screen Failure|2|||
163017324|NCT03260244|588769036|FG000|Overall Study|Treated Off Label|69|||
163017325|NCT03260244|588769036|FG000|Overall Study|No Radiofrequency Ablation|14|||
163017326|NCT01177293|588769040|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
163017327|NCT01177293|588769041|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
163017328|NCT04725812|588769042|FG000|Overall Study|Withdrawal by Subject|1|||
163017329|NCT00839800|588769044|FG000|Overall Study|Adverse Event|8|||
163017330|NCT00839800|588769045|FG001|Overall Study|Adverse Event|12|||
163017331|NCT00839800|588769044|FG000|Overall Study|Lost to Follow-up|31|||
163017332|NCT00839800|588769045|FG001|Overall Study|Lost to Follow-up|26|||
163017333|NCT00839800|588769044|FG000|Overall Study|Withdrawal by Subject|28|||
163404696|NCT00996944|590191998|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
163017334|NCT00839800|588769045|FG001|Overall Study|Withdrawal by Subject|34|||
163017335|NCT00839800|588769044|FG000|Overall Study|Incorrect Enrolment|3|||
163063018|NCT01104766|588938560|FG000|Overall Study|Lack of Efficacy|20|||
163404697|NCT00996944|590191997|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
163404698|NCT00996944|590191998|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
163404699|NCT01378104|590192002|FG000|Overall Study|Adverse Event|8|||
163017336|NCT00839800|588769045|FG001|Overall Study|Incorrect Enrolment|3|||
163017337|NCT00839800|588769044|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
163017338|NCT00839800|588769045|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
163017339|NCT00839800|588769044|FG000|Overall Study|Safety Reasons|2|||
163017340|NCT00839800|588769045|FG001|Overall Study|Safety Reasons|1|||
163017341|NCT00839800|588769044|FG000|Overall Study|Other|8|||
163017342|NCT00839800|588769045|FG001|Overall Study|Other|14|||
163017343|NCT00839800|588769044|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
163017344|NCT00839800|588769045|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
163017345|NCT00912743|588769053|FG000|Overall Study|Adverse Event|3|||
163017346|NCT00912743|588769054|FG001|Overall Study|Adverse Event|1|||
163017347|NCT00912743|588769053|FG000|Overall Study|Lack of Efficacy|9|||
163017348|NCT00912743|588769054|FG001|Overall Study|Lack of Efficacy|18|||
163017349|NCT00912743|588769053|FG000|Overall Study|Toxicity|0|||
163404700|NCT01378104|590192003|FG001|Overall Study|Adverse Event|8|||
163404701|NCT01378104|590192002|FG000|Overall Study|Lack of Efficacy|7|||
163404702|NCT01378104|590192003|FG001|Overall Study|Lack of Efficacy|5|||
163404703|NCT01378104|590192002|FG000|Overall Study|Withdrawal by Subject|12|||
163404704|NCT01378104|590192003|FG001|Overall Study|Withdrawal by Subject|13|||
163404705|NCT02700997|590192004|FG000|Overall Study|Did not undergo CT imaging|1|||
163404706|NCT02700997|590192004|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
163404707|NCT04770389|590192005|FG000|Overall Study|Adverse Event|1|||
163404708|NCT04770389|590192006|FG001|Overall Study|Adverse Event|2|||
163404709|NCT04770389|590192007|FG002|Overall Study|Adverse Event|0|||
163017350|NCT00912743|588769054|FG001|Overall Study|Toxicity|1|||
163017351|NCT00912743|588769053|FG000|Overall Study|End of treatment form was not collected|1|||
163017352|NCT00912743|588769054|FG001|Overall Study|End of treatment form was not collected|0|||
163017353|NCT04747886|588769055|FG000|Overall Study|Withdrawal by Subject|1|||
163017354|NCT04747886|588769056|FG001|Overall Study|Withdrawal by Subject|4|||
163017355|NCT02237196|588769058|FG000|Overall Study|Adverse Event|0|||
163017356|NCT02237196|588769059|FG001|Overall Study|Adverse Event|1|||
163017357|NCT02237196|588769060|FG002|Overall Study|Adverse Event|1|||
163017358|NCT02237196|588769061|FG003|Overall Study|Adverse Event|0|||
163017359|NCT02237196|588769058|FG000|Overall Study|Lost to Follow-up|4|||
163017360|NCT02237196|588769059|FG001|Overall Study|Lost to Follow-up|2|||
163017361|NCT02237196|588769060|FG002|Overall Study|Lost to Follow-up|4|||
163017362|NCT02237196|588769061|FG003|Overall Study|Lost to Follow-up|6|||
163017363|NCT02237196|588769058|FG000|Overall Study|Physician Decision|2|||
163017364|NCT02237196|588769059|FG001|Overall Study|Physician Decision|0|||
163017365|NCT02237196|588769060|FG002|Overall Study|Physician Decision|0|||
163017366|NCT02237196|588769061|FG003|Overall Study|Physician Decision|1|||
163017367|NCT02237196|588769058|FG000|Overall Study|Pregnancy|0|||
163017368|NCT02237196|588769059|FG001|Overall Study|Pregnancy|0|||
163017369|NCT02237196|588769060|FG002|Overall Study|Pregnancy|1|||
163017370|NCT02237196|588769061|FG003|Overall Study|Pregnancy|1|||
163017371|NCT02237196|588769058|FG000|Overall Study|Withdrawal by Subject|1|||
163017372|NCT02237196|588769059|FG001|Overall Study|Withdrawal by Subject|1|||
163017373|NCT02237196|588769060|FG002|Overall Study|Withdrawal by Subject|4|||
163017374|NCT02237196|588769061|FG003|Overall Study|Withdrawal by Subject|1|||
163017375|NCT02237196|588769058|FG000|Overall Study|Site Error|1|||
163215626|NCT00450333|589503882|FG002|Overall Study|Kidney transplant|1|||
163215627|NCT00450333|589503883|FG003|Overall Study|Kidney transplant|3|||
163215628|NCT00450333|589503880|FG000|Overall Study|Death|3|||
163215629|NCT00450333|589503881|FG001|Overall Study|Death|2|||
163215630|NCT00450333|589503882|FG002|Overall Study|Death|2|||
163215631|NCT00450333|589503883|FG003|Overall Study|Death|2|||
163215632|NCT03855280|589503889|FG000|Treatment Phase|Adverse Event|1|||
163215633|NCT03855280|589503889|FG000|Treatment Phase|Withdrawal by Subject|1|||
163215634|NCT03855280|589503889|FG000|Continuation Phase|Protocol Violation|1|||
163215635|NCT03855280|589503889|FG000|Continuation Phase|Adverse Event|1|||
163215636|NCT03855280|589503889|FG000|Continuation Phase|Sponsor Concluded Study|1|||
163215637|NCT02738450|589503892|FG000|Overall Study|Withdrawal by Subject|0|||
163215638|NCT02738450|589503893|FG001|Overall Study|Withdrawal by Subject|2|||
163215639|NCT02738450|589503894|FG002|Overall Study|Withdrawal by Subject|0|||
163215640|NCT03204305|589503895|FG000|Overall Study|Lost to Follow-up|6|||
163215641|NCT03204305|589503896|FG001|Overall Study|Lost to Follow-up|4|||
163215642|NCT03204305|589503897|FG002|Overall Study|Lost to Follow-up|0|||
163215643|NCT03204305|589503898|FG003|Overall Study|Lost to Follow-up|0|||
163215644|NCT03204305|589503895|FG000|Overall Study|Physician Decision|1|||
163215645|NCT03204305|589503896|FG001|Overall Study|Physician Decision|0|||
163215646|NCT03204305|589503897|FG002|Overall Study|Physician Decision|0|||
163215647|NCT03204305|589503898|FG003|Overall Study|Physician Decision|0|||
163215648|NCT03204305|589503895|FG000|Overall Study|failure to place arterial line|2|||
163215649|NCT03204305|589503896|FG001|Overall Study|failure to place arterial line|1|||
163215650|NCT03204305|589503897|FG002|Overall Study|failure to place arterial line|0|||
163215651|NCT03204305|589503898|FG003|Overall Study|failure to place arterial line|0|||
163215652|NCT03204305|589503895|FG000|Overall Study|Withdrawal by Subject|2|||
163215653|NCT03204305|589503896|FG001|Overall Study|Withdrawal by Subject|0|||
163215654|NCT03204305|589503897|FG002|Overall Study|Withdrawal by Subject|0|||
163215655|NCT03204305|589503898|FG003|Overall Study|Withdrawal by Subject|0|||
163017376|NCT02237196|588769059|FG001|Overall Study|Site Error|2|||
163017377|NCT02237196|588769060|FG002|Overall Study|Site Error|0|||
163017378|NCT02237196|588769061|FG003|Overall Study|Site Error|2|||
163017379|NCT00619892|588769062|FG000|Overall Study|Adverse Event|3|||
163017380|NCT00619892|588769063|FG001|Overall Study|Adverse Event|0|||
163017381|NCT00619892|588769062|FG000|Overall Study|Lost to Follow-up|0|||
163017382|NCT00619892|588769063|FG001|Overall Study|Lost to Follow-up|1|||
163017383|NCT00619892|588769062|FG000|Overall Study|Intercurrent illness|0|||
163017384|NCT00619892|588769063|FG001|Overall Study|Intercurrent illness|1|||
163017385|NCT02049814|588769072|FG000|Overall Study|Reason not Specified|4|||
163017386|NCT02049814|588769073|FG001|Overall Study|Reason not Specified|3|||
163017387|NCT02049814|588769072|FG000|Overall Study|Pregnancy|1|||
163017388|NCT02049814|588769073|FG001|Overall Study|Pregnancy|0|||
163017389|NCT02049814|588769072|FG000|Overall Study|Lost to Follow-up|2|||
163017390|NCT02049814|588769073|FG001|Overall Study|Lost to Follow-up|3|||
163017391|NCT02049814|588769072|FG000|Overall Study|Serious Protocol Violation|5|||
163017392|NCT02049814|588769073|FG001|Overall Study|Serious Protocol Violation|7|||
163017393|NCT02049814|588769072|FG000|Overall Study|Study Termination|0|||
163017394|NCT02049814|588769073|FG001|Overall Study|Study Termination|1|||
163017395|NCT02049814|588769072|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
163017396|NCT02049814|588769073|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
163017397|NCT02049814|588769072|FG000|Overall Study|Voluntary withdrawal|9|||
163017398|NCT02049814|588769073|FG001|Overall Study|Voluntary withdrawal|8|||
163017399|NCT02714595|588769074|FG000|Overall Study|Lost to Follow-up|1|||
163017400|NCT02714595|588769075|FG001|Overall Study|Lost to Follow-up|0|||
163017401|NCT02714595|588769074|FG000|Overall Study|Withdrawal by Subject|1|||
163404710|NCT04770389|590192008|FG003|Overall Study|Adverse Event|1|||
163404711|NCT04770389|590192005|FG000|Overall Study|Withdrawal by Subject|0|||
163404712|NCT04770389|590192006|FG001|Overall Study|Withdrawal by Subject|2|||
163404713|NCT04770389|590192007|FG002|Overall Study|Withdrawal by Subject|1|||
163404714|NCT04770389|590192008|FG003|Overall Study|Withdrawal by Subject|0|||
163404715|NCT04770389|590192005|FG000|Overall Study|Failed attempt to draw blood|1|||
163404716|NCT04770389|590192006|FG001|Overall Study|Failed attempt to draw blood|0|||
163404717|NCT04770389|590192007|FG002|Overall Study|Failed attempt to draw blood|0|||
163404718|NCT04770389|590192008|FG003|Overall Study|Failed attempt to draw blood|0|||
163404719|NCT04770389|590192005|FG000|Overall Study|Left the country|0|||
163404720|NCT04770389|590192006|FG001|Overall Study|Left the country|0|||
163404721|NCT04770389|590192007|FG002|Overall Study|Left the country|1|||
163404722|NCT04770389|590192008|FG003|Overall Study|Left the country|2|||
163404723|NCT04770389|590192005|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
163404724|NCT04770389|590192006|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
163404725|NCT04770389|590192007|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
163404726|NCT04770389|590192008|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
163404727|NCT04770389|590192005|FG000|Overall Study|Lost to Follow-up|0|||
163404728|NCT04770389|590192006|FG001|Overall Study|Lost to Follow-up|0|||
163404729|NCT04770389|590192007|FG002|Overall Study|Lost to Follow-up|0|||
163404730|NCT04770389|590192008|FG003|Overall Study|Lost to Follow-up|1|||
163404731|NCT04770389|590192005|FG000|Overall Study|Moved away from study site|0|||
163404732|NCT04770389|590192006|FG001|Overall Study|Moved away from study site|1|||
163404733|NCT04770389|590192007|FG002|Overall Study|Moved away from study site|0|||
163404734|NCT04770389|590192008|FG003|Overall Study|Moved away from study site|0|||
163404735|NCT00794157|590192009|FG000|Overall Study|Adverse Event|4|||
163404736|NCT00794157|590192010|FG001|Overall Study|Adverse Event|1|||
163404737|NCT00794157|590192011|FG002|Overall Study|Adverse Event|8|||
163404738|NCT00794157|590192009|FG000|Overall Study|Subject withdrew consent|2|||
163404739|NCT00794157|590192010|FG001|Overall Study|Subject withdrew consent|0|||
163404740|NCT00794157|590192011|FG002|Overall Study|Subject withdrew consent|3|||
163404741|NCT00794157|590192009|FG000|Overall Study|Lost to Follow-up|2|||
163017402|NCT02714595|588769075|FG001|Overall Study|Withdrawal by Subject|2|||
163017403|NCT02714595|588769074|FG000|Overall Study|Lack of Efficacy|0|||
163017404|NCT02714595|588769075|FG001|Overall Study|Lack of Efficacy|1|||
163017405|NCT02714595|588769074|FG000|Overall Study|Death|30|||
163017406|NCT02714595|588769075|FG001|Overall Study|Death|9|||
163404742|NCT00794157|590192010|FG001|Overall Study|Lost to Follow-up|0|||
163404743|NCT00794157|590192011|FG002|Overall Study|Lost to Follow-up|1|||
163404744|NCT00794157|590192009|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163404745|NCT00794157|590192010|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163404746|NCT00794157|590192011|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
163404747|NCT00794157|590192009|FG000|Overall Study|Administrative problems|1|||
163404748|NCT00794157|590192010|FG001|Overall Study|Administrative problems|7|||
163404749|NCT00794157|590192011|FG002|Overall Study|Administrative problems|4|||
163017407|NCT02714595|588769074|FG000|Overall Study|Other-Miscellaneous|0|||
163017408|NCT02714595|588769075|FG001|Overall Study|Other-Miscellaneous|1|||
163017409|NCT00713258|588769076|FG000|Overall Study|Adverse Event|2|||
163017410|NCT00713258|588769077|FG001|Overall Study|Adverse Event|4|||
163017411|NCT00713258|588769076|FG000|Overall Study|Non-Compliance|2|||
163017412|NCT00713258|588769077|FG001|Overall Study|Non-Compliance|1|||
163017413|NCT00713258|588769076|FG000|Overall Study|Other|1|||
163017414|NCT00713258|588769077|FG001|Overall Study|Other|1|||
163017415|NCT01431716|588769078|FG000|Overall Study|Withdrawal of consent|1|||
163017416|NCT02199795|588769081|FG000|Overall Study|no longer met inclusion criteria|1|||
163017417|NCT02199795|588769082|FG001|Overall Study|no longer met inclusion criteria|0|||
163017418|NCT02199795|588769081|FG000|Overall Study|withdrew due to shoulder pain|1|||
163017419|NCT02199795|588769082|FG001|Overall Study|withdrew due to shoulder pain|0|||
163017420|NCT01339923|588769086|FG000|Overall Study|Adverse Event|1|||
163017421|NCT01339923|588769087|FG001|Overall Study|Adverse Event|1|||
163017422|NCT01339923|588769088|FG002|Overall Study|Adverse Event|1|||
163017423|NCT01339923|588769089|FG003|Overall Study|Adverse Event|0|||
163017424|NCT01339923|588769090|FG004|Overall Study|Adverse Event|0|||
163017425|NCT01339923|588769091|FG005|Overall Study|Adverse Event|0|||
163017426|NCT01339923|588769092|FG006|Overall Study|Adverse Event|1|||
163017427|NCT01339923|588769086|FG000|Overall Study|Inappropriate Enrollment|1|||
163017428|NCT01339923|588769087|FG001|Overall Study|Inappropriate Enrollment|0|||
163017429|NCT01339923|588769088|FG002|Overall Study|Inappropriate Enrollment|0|||
163017430|NCT01339923|588769089|FG003|Overall Study|Inappropriate Enrollment|0|||
163017431|NCT01339923|588769090|FG004|Overall Study|Inappropriate Enrollment|0|||
163017432|NCT01339923|588769091|FG005|Overall Study|Inappropriate Enrollment|1|||
163017433|NCT01339923|588769092|FG006|Overall Study|Inappropriate Enrollment|0|||
163017434|NCT01339923|588769086|FG000|Overall Study|Lost to Follow-up|4|||
163017435|NCT01339923|588769087|FG001|Overall Study|Lost to Follow-up|4|||
163017436|NCT01339923|588769088|FG002|Overall Study|Lost to Follow-up|0|||
163017437|NCT01339923|588769089|FG003|Overall Study|Lost to Follow-up|3|||
163017438|NCT01339923|588769090|FG004|Overall Study|Lost to Follow-up|1|||
163017439|NCT01339923|588769091|FG005|Overall Study|Lost to Follow-up|1|||
163017440|NCT01339923|588769092|FG006|Overall Study|Lost to Follow-up|5|||
163017441|NCT01339923|588769086|FG000|Overall Study|Protocol Violation|0|||
163017442|NCT01339923|588769087|FG001|Overall Study|Protocol Violation|0|||
163017443|NCT01339923|588769088|FG002|Overall Study|Protocol Violation|0|||
163017444|NCT01339923|588769089|FG003|Overall Study|Protocol Violation|0|||
163017445|NCT01339923|588769090|FG004|Overall Study|Protocol Violation|0|||
163017446|NCT01339923|588769091|FG005|Overall Study|Protocol Violation|3|||
163017447|NCT01339923|588769092|FG006|Overall Study|Protocol Violation|1|||
163017448|NCT01339923|588769086|FG000|Overall Study|Unable to Classify|1|||
163017449|NCT01339923|588769087|FG001|Overall Study|Unable to Classify|0|||
163017450|NCT01339923|588769088|FG002|Overall Study|Unable to Classify|1|||
163017451|NCT01339923|588769089|FG003|Overall Study|Unable to Classify|0|||
163017452|NCT01339923|588769090|FG004|Overall Study|Unable to Classify|0|||
163017453|NCT01339923|588769091|FG005|Overall Study|Unable to Classify|1|||
163017454|NCT01339923|588769092|FG006|Overall Study|Unable to Classify|5|||
163017455|NCT01339923|588769086|FG000|Overall Study|Withdrawal by Subject|7|||
163017456|NCT01339923|588769087|FG001|Overall Study|Withdrawal by Subject|11|||
163017457|NCT01339923|588769088|FG002|Overall Study|Withdrawal by Subject|6|||
163017458|NCT01339923|588769089|FG003|Overall Study|Withdrawal by Subject|1|||
163017459|NCT01339923|588769090|FG004|Overall Study|Withdrawal by Subject|4|||
163017460|NCT01339923|588769091|FG005|Overall Study|Withdrawal by Subject|3|||
163017461|NCT01339923|588769092|FG006|Overall Study|Withdrawal by Subject|2|||
163017462|NCT00828568|588769104|FG000|Randomized|Withdrawal by Subject|1|||
163017463|NCT00828568|588769105|FG001|Randomized|Withdrawal by Subject|0|||
163017464|NCT00828568|588769106|FG002|Randomized|Withdrawal by Subject|2|||
163017465|NCT00828568|588769104|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
163017466|NCT00828568|588769105|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
163017467|NCT00828568|588769106|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
163017468|NCT00828568|588769104|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
163017469|NCT00828568|588769105|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
163017470|NCT00828568|588769106|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
163017471|NCT00828568|588769104|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
163017472|NCT00828568|588769105|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
163017473|NCT00828568|588769106|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
163017474|NCT00828568|588769104|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
163017475|NCT00828568|588769105|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
163017476|NCT00828568|588769106|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
163017477|NCT00460811|588769108|FG000|Overall Study|Adverse Event|4|||
163017478|NCT00460811|588769109|FG001|Overall Study|Adverse Event|6|||
163017479|NCT00460811|588769110|FG002|Overall Study|Adverse Event|3|||
163404750|NCT00794157|590192009|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163017480|NCT00460811|588769111|FG003|Overall Study|Adverse Event|10|||
163017481|NCT00460811|588769112|FG004|Overall Study|Adverse Event|2|||
163017482|NCT00460811|588769108|FG000|Overall Study|Noncompliance|1|||
163017483|NCT00460811|588769109|FG001|Overall Study|Noncompliance|0|||
163017484|NCT00460811|588769110|FG002|Overall Study|Noncompliance|0|||
163017485|NCT00460811|588769111|FG003|Overall Study|Noncompliance|2|||
163017486|NCT00460811|588769112|FG004|Overall Study|Noncompliance|1|||
163017487|NCT00460811|588769108|FG000|Overall Study|Withdrawal by Subject|7|||
163017488|NCT00460811|588769109|FG001|Overall Study|Withdrawal by Subject|7|||
163017489|NCT00460811|588769110|FG002|Overall Study|Withdrawal by Subject|6|||
163017490|NCT00460811|588769111|FG003|Overall Study|Withdrawal by Subject|3|||
163017491|NCT00460811|588769112|FG004|Overall Study|Withdrawal by Subject|11|||
163017492|NCT00460811|588769108|FG000|Overall Study|Physician Decision|1|||
163017493|NCT00460811|588769109|FG001|Overall Study|Physician Decision|0|||
163017494|NCT00460811|588769110|FG002|Overall Study|Physician Decision|0|||
163017495|NCT00460811|588769111|FG003|Overall Study|Physician Decision|0|||
163017496|NCT00460811|588769112|FG004|Overall Study|Physician Decision|0|||
163017497|NCT00460811|588769108|FG000|Overall Study|Lost to Follow-up|3|||
163017498|NCT00460811|588769109|FG001|Overall Study|Lost to Follow-up|2|||
163017499|NCT00460811|588769110|FG002|Overall Study|Lost to Follow-up|5|||
163017500|NCT00460811|588769111|FG003|Overall Study|Lost to Follow-up|3|||
163017501|NCT00460811|588769112|FG004|Overall Study|Lost to Follow-up|6|||
163017502|NCT02821754|588769113|FG000|Overall Study|Procedure not required prior to amendment change|13|||
163017503|NCT02821754|588769114|FG001|Overall Study|Procedure not required prior to amendment change|11|||
163017504|NCT02821754|588769115|FG002|Overall Study|Procedure not required prior to amendment change|0|||
163017505|NCT02821754|588769113|FG000|Overall Study|Participant's Clinical status|2|||
163017506|NCT02821754|588769114|FG001|Overall Study|Participant's Clinical status|0|||
163017507|NCT02821754|588769115|FG002|Overall Study|Participant's Clinical status|0|||
163017508|NCT02821754|588769113|FG000|Overall Study|Participant removed for noncompliance|1|||
163017509|NCT02821754|588769114|FG001|Overall Study|Participant removed for noncompliance|0|||
163404751|NCT00794157|590192010|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163404752|NCT00794157|590192011|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163404753|NCT00794157|590192009|FG000|Overall Study|Protocol deviation|0|||
163404754|NCT00794157|590192010|FG001|Overall Study|Protocol deviation|1|||
163404755|NCT00794157|590192011|FG002|Overall Study|Protocol deviation|1|||
163404756|NCT03099187|590192023|FG000|Double-blind Treatment|Adverse Event|19|||
163404757|NCT03099187|590192024|FG001|Double-blind Treatment|Adverse Event|1|||
163404758|NCT03099187|590192025|FG002|Double-blind Treatment|Adverse Event|0|||
163404759|NCT03099187|590192026|FG003|Double-blind Treatment|Adverse Event|0|||
163404760|NCT03099187|590192023|FG000|Double-blind Treatment|Death|1|||
163404761|NCT03099187|590192024|FG001|Double-blind Treatment|Death|3|||
163404762|NCT03099187|590192025|FG002|Double-blind Treatment|Death|0|||
163404763|NCT03099187|590192026|FG003|Double-blind Treatment|Death|0|||
163404764|NCT03099187|590192023|FG000|Double-blind Treatment|Lack of Efficacy|1|||
163404765|NCT03099187|590192024|FG001|Double-blind Treatment|Lack of Efficacy|0|||
163404766|NCT03099187|590192025|FG002|Double-blind Treatment|Lack of Efficacy|0|||
163404767|NCT03099187|590192026|FG003|Double-blind Treatment|Lack of Efficacy|0|||
163404768|NCT03099187|590192023|FG000|Double-blind Treatment|Physician Decision|2|||
163404769|NCT03099187|590192024|FG001|Double-blind Treatment|Physician Decision|1|||
163404770|NCT03099187|590192025|FG002|Double-blind Treatment|Physician Decision|0|||
163404771|NCT03099187|590192026|FG003|Double-blind Treatment|Physician Decision|0|||
163404772|NCT03099187|590192023|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
163404773|NCT03099187|590192024|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
163404774|NCT03099187|590192025|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
163404775|NCT03099187|590192026|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
163404776|NCT03099187|590192023|FG000|Double-blind Treatment|Lung transplantation|0|||
163404777|NCT03099187|590192024|FG001|Double-blind Treatment|Lung transplantation|1|||
163404778|NCT03099187|590192025|FG002|Double-blind Treatment|Lung transplantation|0|||
163404779|NCT03099187|590192026|FG003|Double-blind Treatment|Lung transplantation|0|||
163404780|NCT03099187|590192023|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
163404781|NCT03099187|590192024|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
163404782|NCT03099187|590192025|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
163404783|NCT03099187|590192026|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
163404784|NCT03099187|590192023|FG000|Double-blind Treatment|Disease progression|0|||
163404785|NCT03099187|590192024|FG001|Double-blind Treatment|Disease progression|1|||
163404786|NCT03099187|590192025|FG002|Double-blind Treatment|Disease progression|0|||
163404787|NCT03099187|590192026|FG003|Double-blind Treatment|Disease progression|0|||
163404788|NCT03099187|590192023|FG000|Double-blind Treatment|Randomization error|0|||
163404789|NCT03099187|590192024|FG001|Double-blind Treatment|Randomization error|2|||
163404790|NCT03099187|590192025|FG002|Double-blind Treatment|Randomization error|0|||
163017510|NCT02821754|588769115|FG002|Overall Study|Participant removed for noncompliance|0|||
163063019|NCT01104766|588938561|FG001|Overall Study|Lack of Efficacy|15|||
163404791|NCT03099187|590192026|FG003|Double-blind Treatment|Randomization error|0|||
163404792|NCT03099187|590192023|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
163404793|NCT03099187|590192024|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
163017511|NCT02821754|588769113|FG000|Overall Study|Drug not available.|0|||
163017512|NCT02821754|588769114|FG001|Overall Study|Drug not available.|0|||
163017513|NCT02821754|588769115|FG002|Overall Study|Drug not available.|1|||
163063020|NCT01104766|588938562|FG002|Overall Study|Lack of Efficacy|14|||
163404794|NCT03099187|590192025|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
163404795|NCT03099187|590192026|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
163017514|NCT02821754|588769113|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
163017515|NCT02821754|588769114|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
163017516|NCT02821754|588769115|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
163017517|NCT03515811|588769117|FG000|Overall Study|Lost to Follow-up|2|||
163017518|NCT03515811|588769118|FG001|Overall Study|Lost to Follow-up|1|||
163017519|NCT03515811|588769117|FG000|Overall Study|Protocol Violation|1|||
163017520|NCT03515811|588769118|FG001|Overall Study|Protocol Violation|1|||
163017521|NCT03515811|588769117|FG000|Overall Study|Death|1|||
163017522|NCT03515811|588769118|FG001|Overall Study|Death|1|||
163017523|NCT03515811|588769117|FG000|Overall Study|Withdrawal by Subject|0|||
163017524|NCT03515811|588769118|FG001|Overall Study|Withdrawal by Subject|2|||
163017525|NCT03515811|588769117|FG000|Overall Study|Technical Problems|1|||
163017526|NCT03515811|588769118|FG001|Overall Study|Technical Problems|0|||
163017527|NCT03515811|588769117|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
163017528|NCT03515811|588769118|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
163017529|NCT03515811|588769117|FG000|Overall Study|COVID-19|0|||
163017530|NCT03515811|588769118|FG001|Overall Study|COVID-19|1|||
163017531|NCT01355575|588769119|FG000|Overall Study|Withdrawal by Subject|2|||
163017532|NCT01166438|588769120|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
163017533|NCT01166438|588769121|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
163017534|NCT01166438|588769120|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
163017535|NCT01166438|588769121|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
163017536|NCT01166438|588769120|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
163017537|NCT01166438|588769121|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
163017538|NCT01166438|588769120|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
163017539|NCT01166438|588769121|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
163017540|NCT01166438|588769120|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
163215656|NCT01165554|589503905|FG000|Overall Study|Withdrawal by Subject|23|||
163215657|NCT02951156|589503906|FG000|Overall Study|Death|3|||
163215658|NCT02951156|589503907|FG001|Overall Study|Death|8|||
163215659|NCT02951156|589503908|FG002|Overall Study|Death|5|||
163215660|NCT02951156|589503906|FG000|Overall Study|Progressive disease|1|||
163215661|NCT02951156|589503907|FG001|Overall Study|Progressive disease|0|||
163215662|NCT02951156|589503908|FG002|Overall Study|Progressive disease|1|||
163215663|NCT02951156|589503906|FG000|Overall Study|Withdrawal by Subject|0|||
163215664|NCT02951156|589503907|FG001|Overall Study|Withdrawal by Subject|0|||
163215665|NCT02951156|589503908|FG002|Overall Study|Withdrawal by Subject|1|||
163215666|NCT02951156|589503906|FG000|Overall Study|Study terminated by sponsor|0|||
163215667|NCT02951156|589503907|FG001|Overall Study|Study terminated by sponsor|0|||
163215668|NCT02951156|589503908|FG002|Overall Study|Study terminated by sponsor|1|||
163215669|NCT02951156|589503906|FG000|Overall Study|Other|5|||
163215670|NCT02951156|589503907|FG001|Overall Study|Other|1|||
163215671|NCT02951156|589503908|FG002|Overall Study|Other|2|||
163215672|NCT01603459|589503911|FG000|Overall Study|Adverse Event|5|||
163215673|NCT01603459|589503911|FG000|Overall Study|Withdrawal by Subject|5|||
163215674|NCT01603459|589503911|FG000|Overall Study|Lost to Follow-up|3|||
163215675|NCT01603459|589503911|FG000|Overall Study|Predefined discontinuation criteria|3|||
163215676|NCT01603459|589503911|FG000|Overall Study|Non-compliance|1|||
163215677|NCT01603459|589503911|FG000|Overall Study|Administrative reason|1|||
163215678|NCT01092182|589503912|FG000|Overall Study|Death|0|||
163215679|NCT01092182|589503913|FG001|Overall Study|Death|5|||
163215680|NCT01092182|589503914|FG002|Overall Study|Death|3|||
163215681|NCT01092182|589503912|FG000|Overall Study|participant safety|1|||
163215682|NCT01092182|589503913|FG001|Overall Study|participant safety|2|||
163215683|NCT01092182|589503914|FG002|Overall Study|participant safety|0|||
163215684|NCT01092182|589503912|FG000|Overall Study|Physician Decision|0|||
163215685|NCT01092182|589503913|FG001|Overall Study|Physician Decision|6|||
163215686|NCT01092182|589503914|FG002|Overall Study|Physician Decision|0|||
163215687|NCT01092182|589503912|FG000|Overall Study|Did not meet criteria|0|||
163215688|NCT01092182|589503913|FG001|Overall Study|Did not meet criteria|0|||
163215689|NCT01092182|589503914|FG002|Overall Study|Did not meet criteria|25|||
163215690|NCT01092182|589503912|FG000|Overall Study|Non-compliance|0|||
163215691|NCT01092182|589503913|FG001|Overall Study|Non-compliance|3|||
163215692|NCT01092182|589503914|FG002|Overall Study|Non-compliance|0|||
163215693|NCT01092182|589503912|FG000|Overall Study|Participant refused follow-up|0|||
163328604|NCT05827068|589913311|FG005|Overall Study|Lost to Follow-up|4|||
163215694|NCT01092182|589503913|FG001|Overall Study|Participant refused follow-up|2|||
163215695|NCT01092182|589503914|FG002|Overall Study|Participant refused follow-up|0|||
163215696|NCT01641692|589503915|FG000|Treatment Period 1|Adverse Event|1|||
163215697|NCT01641692|589503916|FG001|Treatment Period 1|Adverse Event|0|||
163215698|NCT01641692|589503917|FG002|Treatment Period 1|Adverse Event|0|||
163215699|NCT01641692|589503918|FG003|Treatment Period 1|Adverse Event|0|||
163215700|NCT01641692|589503919|FG004|Treatment Period 1|Adverse Event|0|||
163215701|NCT01641692|589503920|FG005|Treatment Period 1|Adverse Event|0|||
163215702|NCT01641692|589503921|FG006|Treatment Period 1|Adverse Event|0|||
163215703|NCT01641692|589503922|FG007|Treatment Period 1|Adverse Event|0|||
163017541|NCT01166438|588769121|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
163017542|NCT01166438|588769120|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
163017543|NCT01166438|588769121|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
163017544|NCT01197534|588769126|FG000|Overall Study|Not reported|16|||
163017545|NCT01197534|588769127|FG001|Overall Study|Not reported|10|||
163017546|NCT01197534|588769128|FG002|Overall Study|Not reported|16|||
163017547|NCT01197534|588769126|FG000|Overall Study|Enrolment in long term extension|57|||
163017548|NCT01197534|588769127|FG001|Overall Study|Enrolment in long term extension|66|||
163017549|NCT01197534|588769128|FG002|Overall Study|Enrolment in long term extension|119|||
163017550|NCT01197534|588769126|FG000|Overall Study|Severe non-compliance to protocol|3|||
163017551|NCT01197534|588769127|FG001|Overall Study|Severe non-compliance to protocol|4|||
163017552|NCT01197534|588769128|FG002|Overall Study|Severe non-compliance to protocol|1|||
163017553|NCT01197534|588769126|FG000|Overall Study|Lack of therapeutic response|9|||
163017554|NCT01197534|588769127|FG001|Overall Study|Lack of therapeutic response|4|||
163017555|NCT01197534|588769128|FG002|Overall Study|Lack of therapeutic response|9|||
163017556|NCT01197534|588769126|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
163017557|NCT01197534|588769127|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
163017558|NCT01197534|588769128|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
163017559|NCT01197534|588769126|FG000|Overall Study|Lost to Follow-up|1|||
163017560|NCT01197534|588769127|FG001|Overall Study|Lost to Follow-up|4|||
163017561|NCT01197534|588769128|FG002|Overall Study|Lost to Follow-up|2|||
163017562|NCT01197534|588769126|FG000|Overall Study|Adverse Event|35|||
163017563|NCT01197534|588769127|FG001|Overall Study|Adverse Event|36|||
163017564|NCT01197534|588769128|FG002|Overall Study|Adverse Event|24|||
163017565|NCT02593097|588769135|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
163017566|NCT02593097|588769136|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
163017567|NCT02593097|588769135|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
163017568|NCT02593097|588769136|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
163017569|NCT02593097|588769135|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
163017570|NCT02593097|588769136|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
163328605|NCT05827068|589913312|FG006|Overall Study|Lost to Follow-up|1|||
163328606|NCT05827068|589913306|FG000|Overall Study|Withdrawal by Subject|4|||
163017571|NCT02593097|588769135|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
163017572|NCT02593097|588769136|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
163017573|NCT02593097|588769135|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
163017574|NCT02593097|588769136|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
163017575|NCT03759587|588769137|FG000|Overall Study|Adverse Event|5|||
163017576|NCT03759587|588769137|FG000|Overall Study|Progressive Disease|10|||
163017577|NCT03759587|588769137|FG000|Overall Study|Site Terminated by Sponsor|3|||
163017578|NCT03759587|588769137|FG000|Overall Study|Withdrawal by Subject|1|||
163017579|NCT00591565|588769140|FG000|Overall Study|lost follow up, withdrawn|5|||
163017580|NCT00454363|588769141|FG000|Overall Study|Adverse Event|1|||
163017581|NCT00454363|588769142|FG001|Overall Study|Adverse Event|2|||
163017582|NCT00454363|588769141|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
163017583|NCT00454363|588769142|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
163017584|NCT01554527|588769144|FG000|Overall Study|Withdrawal by Subject|1|||
163017585|NCT01554527|588769145|FG001|Overall Study|Withdrawal by Subject|0|||
163017586|NCT01554527|588769146|FG002|Overall Study|Withdrawal by Subject|3|||
163017587|NCT01554527|588769144|FG000|Overall Study|Lost to Follow-up|0|||
163017588|NCT01554527|588769145|FG001|Overall Study|Lost to Follow-up|0|||
163215704|NCT01641692|589503915|FG000|Treatment Period 1|Lack of Efficacy|0|||
163328607|NCT05827068|589913307|FG001|Overall Study|Withdrawal by Subject|0|||
163328608|NCT05827068|589913308|FG002|Overall Study|Withdrawal by Subject|1|||
163328609|NCT05827068|589913309|FG003|Overall Study|Withdrawal by Subject|2|||
163328610|NCT05827068|589913310|FG004|Overall Study|Withdrawal by Subject|3|||
163328611|NCT05827068|589913311|FG005|Overall Study|Withdrawal by Subject|0|||
163328612|NCT05827068|589913312|FG006|Overall Study|Withdrawal by Subject|1|||
163328613|NCT05827068|589913306|FG000|Overall Study|Physician Decision|0|||
163328614|NCT05827068|589913307|FG001|Overall Study|Physician Decision|0|||
163017589|NCT01554527|588769146|FG002|Overall Study|Lost to Follow-up|4|||
163017590|NCT01554527|588769144|FG000|Overall Study|Physician Decision|0|||
163017591|NCT01554527|588769145|FG001|Overall Study|Physician Decision|0|||
163017592|NCT01554527|588769146|FG002|Overall Study|Physician Decision|1|||
163017593|NCT01863667|588769153|FG000|Overall Study|Adverse Event|1|||
163017594|NCT01863667|588769154|FG001|Overall Study|Adverse Event|0|||
163017595|NCT01863667|588769153|FG000|Overall Study|Study terminated by Sponsor|30|||
163215705|NCT01641692|589503916|FG001|Treatment Period 1|Lack of Efficacy|0|||
163215706|NCT01641692|589503917|FG002|Treatment Period 1|Lack of Efficacy|0|||
163215707|NCT01641692|589503918|FG003|Treatment Period 1|Lack of Efficacy|0|||
163215708|NCT01641692|589503919|FG004|Treatment Period 1|Lack of Efficacy|0|||
163215709|NCT01641692|589503920|FG005|Treatment Period 1|Lack of Efficacy|0|||
163215710|NCT01641692|589503921|FG006|Treatment Period 1|Lack of Efficacy|0|||
163215711|NCT01641692|589503922|FG007|Treatment Period 1|Lack of Efficacy|1|||
163215712|NCT01641692|589503915|FG000|Treatment Period 1|Protocol Violation|1|||
163404796|NCT03099187|590192023|FG000|12-month Safety Follow-up|Adverse Event|0|||
163404797|NCT03099187|590192024|FG001|12-month Safety Follow-up|Adverse Event|0|||
163404798|NCT03099187|590192025|FG002|12-month Safety Follow-up|Adverse Event|5|||
163404799|NCT03099187|590192026|FG003|12-month Safety Follow-up|Adverse Event|12|||
163404800|NCT03099187|590192023|FG000|12-month Safety Follow-up|Death|0|||
163404801|NCT03099187|590192024|FG001|12-month Safety Follow-up|Death|0|||
163404802|NCT03099187|590192025|FG002|12-month Safety Follow-up|Death|7|||
163404803|NCT03099187|590192026|FG003|12-month Safety Follow-up|Death|9|||
163404804|NCT03099187|590192023|FG000|12-month Safety Follow-up|Lung transplantation|0|||
163404805|NCT03099187|590192024|FG001|12-month Safety Follow-up|Lung transplantation|0|||
163404806|NCT03099187|590192025|FG002|12-month Safety Follow-up|Lung transplantation|2|||
163404807|NCT03099187|590192026|FG003|12-month Safety Follow-up|Lung transplantation|1|||
163404808|NCT03099187|590192023|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
163404809|NCT03099187|590192024|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
163063021|NCT01104766|588938563|FG003|Overall Study|Lack of Efficacy|8|||
163404810|NCT03099187|590192025|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
163404811|NCT03099187|590192026|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
163404812|NCT03099187|590192023|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
163404813|NCT03099187|590192024|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
163404814|NCT03099187|590192025|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
163404815|NCT03099187|590192026|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
163404816|NCT03099187|590192023|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
163404817|NCT03099187|590192024|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
163404818|NCT03099187|590192025|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
163404819|NCT03099187|590192026|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
163404820|NCT03099187|590192023|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
163404821|NCT03099187|590192024|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
163404822|NCT03099187|590192025|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
163404823|NCT03099187|590192026|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
163404824|NCT03885089|590192027|FG000|Overall Study|No informed consent for publication of study results|2|||
163404825|NCT03349099|590192028|FG000|Overall Study|Physician Decision|3|||
163404826|NCT03349099|590192029|FG001|Overall Study|Physician Decision|4|||
163404827|NCT03349099|590192028|FG000|Overall Study|Stone migrated from the kidney|1|||
163404828|NCT03349099|590192029|FG001|Overall Study|Stone migrated from the kidney|0|||
163404829|NCT04869345|590192033|FG000|Overall Study|Lost to Follow-up|8|||
163404830|NCT04869345|590192034|FG001|Overall Study|Lost to Follow-up|3|||
163404831|NCT00528021|590192037|FG000|Overall Study|Lack of Efficacy|17|||
163404832|NCT00528021|590192038|FG001|Overall Study|Lack of Efficacy|13|||
163404833|NCT00528021|590192039|FG002|Overall Study|Lack of Efficacy|7|||
163404834|NCT00528021|590192040|FG003|Overall Study|Lack of Efficacy|9|||
163404835|NCT05054114|590192047|FG000|Overall Study|Protocol Violation|13|||
163404836|NCT05054114|590192048|FG001|Overall Study|Protocol Violation|1|||
163017596|NCT01863667|588769154|FG001|Overall Study|Study terminated by Sponsor|30|||
163017597|NCT01863667|588769153|FG000|Overall Study|Withdrawal by Subject|2|||
163017598|NCT01863667|588769154|FG001|Overall Study|Withdrawal by Subject|2|||
163017599|NCT03627546|588769155|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
163017600|NCT03627546|588769156|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
163017601|NCT03627546|588769157|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
163017602|NCT03627546|588769155|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
163017603|NCT03627546|588769156|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
163063022|NCT01104766|588938560|FG000|Overall Study|Protocol Violation|2|||
163063023|NCT01104766|588938561|FG001|Overall Study|Protocol Violation|0|||
163063024|NCT01104766|588938562|FG002|Overall Study|Protocol Violation|0|||
163063025|NCT01104766|588938563|FG003|Overall Study|Protocol Violation|0|||
163063026|NCT01104766|588938560|FG000|Overall Study|Withdrawal by Subject|17|||
163063027|NCT01104766|588938561|FG001|Overall Study|Withdrawal by Subject|19|||
163063028|NCT01104766|588938562|FG002|Overall Study|Withdrawal by Subject|25|||
163063029|NCT01104766|588938563|FG003|Overall Study|Withdrawal by Subject|15|||
163063030|NCT01104766|588938560|FG000|Overall Study|Lost to Follow-up|1|||
163063031|NCT01104766|588938561|FG001|Overall Study|Lost to Follow-up|2|||
163215713|NCT01641692|589503916|FG001|Treatment Period 1|Protocol Violation|0|||
163215714|NCT01641692|589503917|FG002|Treatment Period 1|Protocol Violation|0|||
163215715|NCT01641692|589503918|FG003|Treatment Period 1|Protocol Violation|0|||
163215716|NCT01641692|589503919|FG004|Treatment Period 1|Protocol Violation|2|||
163404837|NCT05054114|590192047|FG000|Overall Study|Pregnancy|0|||
163404838|NCT05054114|590192048|FG001|Overall Study|Pregnancy|1|||
163404839|NCT03077685|590192053|FG000|Overall Study|Lost to Follow-up|0|||
163404840|NCT03077685|590192054|FG001|Overall Study|Lost to Follow-up|0|||
163404841|NCT03077685|590192055|FG002|Overall Study|Lost to Follow-up|0|||
163404842|NCT03077685|590192056|FG003|Overall Study|Lost to Follow-up|0|||
163404843|NCT03077685|590192057|FG004|Overall Study|Lost to Follow-up|1|||
163404844|NCT03077685|590192053|FG000|Overall Study|Death|0|||
163017604|NCT03627546|588769157|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
163063032|NCT01104766|588938562|FG002|Overall Study|Lost to Follow-up|1|||
163017605|NCT01537042|588769161|FG000|Overall Study|Adverse Event|0|||
163017606|NCT01537042|588769162|FG001|Overall Study|Adverse Event|2|||
163017607|NCT01537042|588769161|FG000|Overall Study|Lack of Efficacy|0|||
163017608|NCT01537042|588769162|FG001|Overall Study|Lack of Efficacy|1|||
163017609|NCT01537042|588769161|FG000|Overall Study|Protocol Violation|0|||
163017610|NCT01537042|588769162|FG001|Overall Study|Protocol Violation|1|||
163017611|NCT01537042|588769161|FG000|Overall Study|Other|0|||
163017612|NCT01537042|588769162|FG001|Overall Study|Other|1|||
163017613|NCT02837731|588769163|FG000|Allocation|Admitted to General Floor|3|||
163017614|NCT02837731|588769164|FG001|Allocation|Admitted to General Floor|4|||
163017615|NCT02837731|588769163|FG000|Allocation|Immediate surgery/withdrew|2|||
163017616|NCT02837731|588769164|FG001|Allocation|Immediate surgery/withdrew|0|||
163017617|NCT02837731|588769163|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
163017618|NCT02837731|588769164|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
163017619|NCT02837731|588769163|FG000|Allocation|Withdrawal by Subject|2|||
163017620|NCT02837731|588769164|FG001|Allocation|Withdrawal by Subject|0|||
163017621|NCT02837731|588769163|FG000|Allocation|Device not available|1|||
163017622|NCT02837731|588769164|FG001|Allocation|Device not available|0|||
163017623|NCT02837731|588769163|FG000|Allocation|Protocol not implemented|7|||
163017624|NCT02837731|588769164|FG001|Allocation|Protocol not implemented|0|||
163017625|NCT02837731|588769163|FG000|Allocation|Moribund/Do not resuscitate|2|||
163017626|NCT02837731|588769164|FG001|Allocation|Moribund/Do not resuscitate|0|||
163017627|NCT02837731|588769163|FG000|Allocation|Did not meet sepsis criteria|1|||
163017628|NCT02837731|588769164|FG001|Allocation|Did not meet sepsis criteria|2|||
163017629|NCT02837731|588769163|FG000|Allocation|Known aortic abnormalities|0|||
163017630|NCT02837731|588769164|FG001|Allocation|Known aortic abnormalities|1|||
163017631|NCT02965573|588769165|FG000|Overall Study|Lack of Efficacy|1|||
163017632|NCT02965573|588769166|FG001|Overall Study|Lack of Efficacy|0|||
163017633|NCT00315458|588769170|FG000|Overall Study|Administrative|0|||
163017634|NCT00315458|588769171|FG001|Overall Study|Administrative|3|||
163017635|NCT00315458|588769172|FG002|Overall Study|Administrative|8|||
163017636|NCT00315458|588769173|FG003|Overall Study|Administrative|21|||
163017637|NCT00315458|588769170|FG000|Overall Study|Adverse Event|2|||
163017638|NCT00315458|588769171|FG001|Overall Study|Adverse Event|4|||
163017639|NCT00315458|588769172|FG002|Overall Study|Adverse Event|23|||
163017640|NCT00315458|588769173|FG003|Overall Study|Adverse Event|3|||
163017641|NCT00315458|588769170|FG000|Overall Study|Lost to Follow-up|1|||
163017642|NCT00315458|588769171|FG001|Overall Study|Lost to Follow-up|2|||
163328615|NCT05827068|589913308|FG002|Overall Study|Physician Decision|0|||
163328616|NCT05827068|589913309|FG003|Overall Study|Physician Decision|0|||
163328617|NCT05827068|589913310|FG004|Overall Study|Physician Decision|1|||
163328618|NCT05827068|589913311|FG005|Overall Study|Physician Decision|0|||
163328619|NCT05827068|589913312|FG006|Overall Study|Physician Decision|1|||
163328620|NCT05827068|589913306|FG000|Overall Study|Other Than Specified|0|||
163328621|NCT05827068|589913307|FG001|Overall Study|Other Than Specified|1|||
163328622|NCT05827068|589913308|FG002|Overall Study|Other Than Specified|0|||
163328623|NCT05827068|589913309|FG003|Overall Study|Other Than Specified|0|||
163328624|NCT05827068|589913310|FG004|Overall Study|Other Than Specified|0|||
163328625|NCT05827068|589913311|FG005|Overall Study|Other Than Specified|0|||
163328626|NCT05827068|589913312|FG006|Overall Study|Other Than Specified|0|||
163328627|NCT05464732|589913315|FG000|Overall Study|Lost to Follow-up|0|||
163328628|NCT05464732|589913316|FG001|Overall Study|Lost to Follow-up|1|||
163328629|NCT05464732|589913315|FG000|Overall Study|Adverse Event|1|||
163328630|NCT05464732|589913316|FG001|Overall Study|Adverse Event|0|||
163328631|NCT04153890|589913317|FG000|Overall Study|Lost to Follow-up|9|||
163328632|NCT04153890|589913318|FG001|Overall Study|Lost to Follow-up|0|||
163328633|NCT04153890|589913319|FG002|Overall Study|Lost to Follow-up|9|||
163328634|NCT04153890|589913320|FG003|Overall Study|Lost to Follow-up|0|||
163328635|NCT04153890|589913317|FG000|Overall Study|Death|0|||
163328636|NCT04153890|589913318|FG001|Overall Study|Death|2|||
163328637|NCT04153890|589913319|FG002|Overall Study|Death|0|||
163328638|NCT04153890|589913320|FG003|Overall Study|Death|0|||
163328639|NCT04153890|589913317|FG000|Overall Study|Withdrawal by Subject|0|||
163328640|NCT04153890|589913318|FG001|Overall Study|Withdrawal by Subject|0|||
163328641|NCT04153890|589913319|FG002|Overall Study|Withdrawal by Subject|0|||
163328642|NCT04153890|589913320|FG003|Overall Study|Withdrawal by Subject|2|||
163328643|NCT03610581|589913321|FG000|Overall Study|Study terminated by sponsor|2|||
163328644|NCT03610581|589913322|FG001|Overall Study|Study terminated by sponsor|0|||
163328645|NCT03610581|589913321|FG000|Overall Study|Other|0|||
163328646|NCT03610581|589913322|FG001|Overall Study|Other|1|||
163328647|NCT03610581|589913321|FG000|Overall Study|Withdrawal by Subject|1|||
163328648|NCT03610581|589913322|FG001|Overall Study|Withdrawal by Subject|0|||
163328649|NCT05630833|589913327|FG000|Overall Study|Adverse Event|3|||
163328650|NCT05630833|589913328|FG001|Overall Study|Adverse Event|0|||
163328651|NCT05630833|589913327|FG000|Overall Study|Lack of Efficacy|0|||
163328652|NCT05630833|589913328|FG001|Overall Study|Lack of Efficacy|1|||
163328653|NCT05630833|589913327|FG000|Overall Study|Lost to Follow-up|1|||
163328654|NCT05630833|589913328|FG001|Overall Study|Lost to Follow-up|0|||
163328655|NCT05630833|589913327|FG000|Overall Study|Withdrawal by Subject|3|||
163017643|NCT00315458|588769172|FG002|Overall Study|Lost to Follow-up|0|||
163017644|NCT00315458|588769173|FG003|Overall Study|Lost to Follow-up|2|||
163017645|NCT00315458|588769170|FG000|Overall Study|Withdrawal by Subject|0|||
163017646|NCT00315458|588769171|FG001|Overall Study|Withdrawal by Subject|3|||
163017647|NCT00315458|588769172|FG002|Overall Study|Withdrawal by Subject|0|||
163017648|NCT00315458|588769173|FG003|Overall Study|Withdrawal by Subject|2|||
163017649|NCT00315458|588769170|FG000|Overall Study|Lack of Efficacy|0|||
163017650|NCT00315458|588769171|FG001|Overall Study|Lack of Efficacy|0|||
163017651|NCT00315458|588769172|FG002|Overall Study|Lack of Efficacy|20|||
163017652|NCT00315458|588769173|FG003|Overall Study|Lack of Efficacy|1|||
163017653|NCT00315458|588769170|FG000|Overall Study|Did not qualify|0|||
163017654|NCT00315458|588769171|FG001|Overall Study|Did not qualify|0|||
163017655|NCT00315458|588769172|FG002|Overall Study|Did not qualify|1|||
163017656|NCT00315458|588769173|FG003|Overall Study|Did not qualify|0|||
163017657|NCT06868654|588769175|FG000|Overall Study|Death|4|||
163017658|NCT06868654|588769176|FG001|Overall Study|Death|14|||
163017659|NCT06868654|588769175|FG000|Overall Study|Lost to Follow-up|0|||
163017660|NCT06868654|588769176|FG001|Overall Study|Lost to Follow-up|1|||
163017661|NCT06868654|588769175|FG000|Overall Study|Withdrawal by Subject|5|||
163017662|NCT06868654|588769176|FG001|Overall Study|Withdrawal by Subject|3|||
163017663|NCT06868654|588769175|FG000|Overall Study|Physician Decision|0|||
163017664|NCT06868654|588769176|FG001|Overall Study|Physician Decision|1|||
163017665|NCT06868654|588769175|FG000|Overall Study|Ongoing|23|||
163017666|NCT06868654|588769176|FG001|Overall Study|Ongoing|21|||
163017667|NCT03232931|588770668|FG000|Overall Study|Physician Decision|1|||
163215717|NCT01641692|589503920|FG005|Treatment Period 1|Protocol Violation|0|||
163215718|NCT01641692|589503921|FG006|Treatment Period 1|Protocol Violation|0|||
163215719|NCT01641692|589503922|FG007|Treatment Period 1|Protocol Violation|0|||
163215720|NCT01641692|589503915|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
163215721|NCT01641692|589503916|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
163215722|NCT01641692|589503917|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
163215723|NCT01641692|589503918|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
163215724|NCT01641692|589503919|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
163328656|NCT05630833|589913328|FG001|Overall Study|Withdrawal by Subject|1|||
163328657|NCT04306367|589913329|FG000|Overall Study|Progression of Disease|9|||
163328658|NCT04306367|589913329|FG000|Overall Study|Adverse Event|3|||
163328659|NCT04306367|589913329|FG000|Overall Study|Withdrawal by Subject|1|||
163328660|NCT02751528|589913336|FG000|Overall Study|Withdrawal by Subject|1|||
163328661|NCT02751528|589913336|FG000|Overall Study|Adverse Event|1|||
163328662|NCT05485805|589913337|FG000|Overall Study|Withdrawal by Subject|1|||
163328663|NCT05485805|589913338|FG001|Overall Study|Withdrawal by Subject|2|||
163328664|NCT05485805|589913339|FG002|Overall Study|Withdrawal by Subject|2|||
163328665|NCT05485805|589913340|FG003|Overall Study|Withdrawal by Subject|0|||
163328666|NCT05485805|589913341|FG004|Overall Study|Withdrawal by Subject|2|||
163328667|NCT05485805|589913337|FG000|Overall Study|Adverse Event|0|||
163328668|NCT05485805|589913338|FG001|Overall Study|Adverse Event|1|||
163328669|NCT05485805|589913339|FG002|Overall Study|Adverse Event|0|||
163328670|NCT05485805|589913340|FG003|Overall Study|Adverse Event|0|||
163328671|NCT05485805|589913341|FG004|Overall Study|Adverse Event|0|||
163017668|NCT03232931|588770669|FG001|Overall Study|Physician Decision|1|||
163017669|NCT03232931|588770668|FG000|Overall Study|Withdrawal by Subject|6|||
163017670|NCT03232931|588770669|FG001|Overall Study|Withdrawal by Subject|0|||
163017671|NCT03232931|588770668|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
163017672|NCT03232931|588770669|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
163017673|NCT03232931|588770668|FG000|Overall Study|Parent did not record voice|1|||
163017674|NCT03232931|588770669|FG001|Overall Study|Parent did not record voice|2|||
163017675|NCT03232931|588770668|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
163017676|NCT03232931|588770669|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
163017677|NCT04925557|588770670|FG000|Overall Study|Study closed|5|||
163017678|NCT04925557|588770671|FG001|Overall Study|Study closed|3|||
163017679|NCT01270464|588770675|FG000|Overall Study|Protocol Violation|4|||
163017680|NCT01270464|588770676|FG001|Overall Study|Protocol Violation|3|||
163017681|NCT01270464|588770677|FG002|Overall Study|Protocol Violation|2|||
163017682|NCT01270464|588770675|FG000|Overall Study|Lack of Efficacy|2|||
163017683|NCT01270464|588770676|FG001|Overall Study|Lack of Efficacy|3|||
163017684|NCT01270464|588770677|FG002|Overall Study|Lack of Efficacy|1|||
163017685|NCT01270464|588770675|FG000|Overall Study|Adverse Event|9|||
163017686|NCT01270464|588770676|FG001|Overall Study|Adverse Event|1|||
163017687|NCT01270464|588770677|FG002|Overall Study|Adverse Event|7|||
163017688|NCT01270464|588770675|FG000|Overall Study|Withdrawal by Subject|2|||
163017689|NCT01270464|588770676|FG001|Overall Study|Withdrawal by Subject|1|||
163017690|NCT01270464|588770677|FG002|Overall Study|Withdrawal by Subject|4|||
163017691|NCT01270464|588770675|FG000|Overall Study|Lost to Follow-up|2|||
163017692|NCT01270464|588770676|FG001|Overall Study|Lost to Follow-up|3|||
163017693|NCT01270464|588770677|FG002|Overall Study|Lost to Follow-up|1|||
163017694|NCT01270464|588770675|FG000|Overall Study|Other|1|||
163017695|NCT01270464|588770676|FG001|Overall Study|Other|1|||
163017696|NCT01270464|588770677|FG002|Overall Study|Other|3|||
163017697|NCT01750697|588770679|FG000|Overall Study|Transferred Back to Local Hospital|1|||
163017698|NCT01750697|588770679|FG000|Overall Study|Physician and Family Decision|1|||
163017699|NCT01750697|588770679|FG000|Overall Study|Transferred to Adult Services|5|||
163017700|NCT01750697|588770679|FG000|Overall Study|Physician Decision|1|||
163017701|NCT01750697|588770679|FG000|Overall Study|Withdrawal by Subject|1|||
163017702|NCT00384839|588770682|FG000|Overall Study|Adverse Event|4|||
163017703|NCT00384839|588770682|FG000|Overall Study|Investigator Request|1|||
163017704|NCT00384839|588770682|FG000|Overall Study|Patient Request|1|||
163017705|NCT00384839|588770682|FG000|Overall Study|Ineligible|2|||
163404845|NCT03077685|590192054|FG001|Overall Study|Death|0|||
163404846|NCT03077685|590192055|FG002|Overall Study|Death|1|||
163404847|NCT03077685|590192056|FG003|Overall Study|Death|1|||
163404848|NCT03077685|590192057|FG004|Overall Study|Death|3|||
163404849|NCT03077685|590192053|FG000|Overall Study|Withdrawal by Subject|0|||
163404850|NCT03077685|590192054|FG001|Overall Study|Withdrawal by Subject|0|||
163404851|NCT03077685|590192055|FG002|Overall Study|Withdrawal by Subject|0|||
163404852|NCT03077685|590192056|FG003|Overall Study|Withdrawal by Subject|2|||
163017706|NCT01322490|588770685|FG000|Treatment Period|Adverse Event|12|||
163017707|NCT01322490|588770686|FG001|Treatment Period|Adverse Event|18|||
163017708|NCT01322490|588770687|FG002|Treatment Period|Adverse Event|15|||
163017709|NCT01322490|588770685|FG000|Treatment Period|Death|5|||
163017710|NCT01322490|588770686|FG001|Treatment Period|Death|7|||
163017711|NCT01322490|588770687|FG002|Treatment Period|Death|3|||
163017712|NCT01322490|588770685|FG000|Treatment Period|Lack of Efficacy|89|||
163017713|NCT01322490|588770686|FG001|Treatment Period|Lack of Efficacy|100|||
163017714|NCT01322490|588770687|FG002|Treatment Period|Lack of Efficacy|112|||
163017715|NCT01322490|588770685|FG000|Treatment Period|Physician Decision|0|||
163017716|NCT01322490|588770686|FG001|Treatment Period|Physician Decision|2|||
163017717|NCT01322490|588770687|FG002|Treatment Period|Physician Decision|1|||
163017718|NCT01322490|588770685|FG000|Treatment Period|Protocol Violation|7|||
163017719|NCT01322490|588770686|FG001|Treatment Period|Protocol Violation|5|||
163017720|NCT01322490|588770687|FG002|Treatment Period|Protocol Violation|4|||
163017721|NCT01322490|588770685|FG000|Treatment Period|Withdrawal by Subject|14|||
163017722|NCT01322490|588770686|FG001|Treatment Period|Withdrawal by Subject|16|||
163017723|NCT01322490|588770687|FG002|Treatment Period|Withdrawal by Subject|11|||
163017724|NCT01322490|588770685|FG000|Treatment Period|Non-compliance with study drug|0|||
163017725|NCT01322490|588770686|FG001|Treatment Period|Non-compliance with study drug|0|||
163017726|NCT01322490|588770687|FG002|Treatment Period|Non-compliance with study drug|1|||
163017727|NCT01322490|588770685|FG000|Treatment Period|Other per report|2|||
163017728|NCT01322490|588770686|FG001|Treatment Period|Other per report|2|||
163017729|NCT01322490|588770687|FG002|Treatment Period|Other per report|1|||
163017730|NCT01322490|588770685|FG000|Treatment Period|Randomized but Not Treated|3|||
163017731|NCT01322490|588770686|FG001|Treatment Period|Randomized but Not Treated|3|||
163017732|NCT01322490|588770687|FG002|Treatment Period|Randomized but Not Treated|5|||
163017733|NCT01322490|588770685|FG000|Long Term Follow-up Period|Death|235|||
163017734|NCT01322490|588770686|FG001|Long Term Follow-up Period|Death|239|||
163017735|NCT01322490|588770687|FG002|Long Term Follow-up Period|Death|236|||
163017736|NCT01322490|588770685|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
163017737|NCT01322490|588770686|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
163017738|NCT01322490|588770687|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
163017739|NCT01322490|588770685|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
163017740|NCT01322490|588770686|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
163017741|NCT01322490|588770687|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
163017742|NCT01322490|588770685|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
163017743|NCT01322490|588770686|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
163017744|NCT01322490|588770687|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
163017745|NCT01322490|588770685|FG000|Long Term Follow-up Period|Other per report|3|||
163017746|NCT01322490|588770686|FG001|Long Term Follow-up Period|Other per report|2|||
163017747|NCT01322490|588770687|FG002|Long Term Follow-up Period|Other per report|2|||
163017748|NCT01322490|588770685|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
163017749|NCT01322490|588770686|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
163017750|NCT01322490|588770687|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
163017751|NCT02484456|588770688|FG000|Washout Period|Withdrawal by Subject|0|||
163017752|NCT02484456|588770689|FG001|Washout Period|Withdrawal by Subject|1|||
163404853|NCT03077685|590192057|FG004|Overall Study|Withdrawal by Subject|1|||
163404854|NCT03077685|590192053|FG000|Overall Study|Physician Decision|0|||
163017753|NCT02484456|588770688|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
163404855|NCT03077685|590192054|FG001|Overall Study|Physician Decision|0|||
163404856|NCT03077685|590192055|FG002|Overall Study|Physician Decision|1|||
163404857|NCT03077685|590192056|FG003|Overall Study|Physician Decision|0|||
163404858|NCT03077685|590192057|FG004|Overall Study|Physician Decision|3|||
163017754|NCT02484456|588770689|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
163017755|NCT02484456|588770688|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
163017756|NCT02484456|588770689|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
163063033|NCT01104766|588938563|FG003|Overall Study|Lost to Follow-up|1|||
163063034|NCT01136915|588938565|FG000|Overall Study|Lost to Follow-up|2|||
163063035|NCT01136915|588938566|FG001|Overall Study|Lost to Follow-up|0|||
163063036|NCT01136915|588938565|FG000|Overall Study|Exclusion criterion met|0|||
163063037|NCT01136915|588938566|FG001|Overall Study|Exclusion criterion met|1|||
163063038|NCT05452239|588938569|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
163017757|NCT02484456|588770688|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
163017758|NCT02484456|588770689|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
163017759|NCT00708214|588770690|FG000|Overall Study|Other Adverse Event|3|||
163017760|NCT00708214|588770691|FG001|Overall Study|Other Adverse Event|6|||
163017761|NCT00708214|588770692|FG002|Overall Study|Other Adverse Event|2|||
163017762|NCT00708214|588770690|FG000|Overall Study|Other|0|||
163017763|NCT00708214|588770691|FG001|Overall Study|Other|1|||
163017764|NCT00708214|588770692|FG002|Overall Study|Other|1|||
163017765|NCT00708214|588770690|FG000|Overall Study|Progressive Disease|4|||
163017766|NCT00708214|588770691|FG001|Overall Study|Progressive Disease|6|||
163017767|NCT00708214|588770692|FG002|Overall Study|Progressive Disease|5|||
163017768|NCT01908829|588770693|FG000|Overall Study|Adverse Event|13|||
163017769|NCT01908829|588770694|FG001|Overall Study|Adverse Event|11|||
163017770|NCT01908829|588770695|FG002|Overall Study|Adverse Event|13|||
163017771|NCT01908829|588770693|FG000|Overall Study|Lost to Follow-up|4|||
163017772|NCT01908829|588770694|FG001|Overall Study|Lost to Follow-up|2|||
163017773|NCT01908829|588770695|FG002|Overall Study|Lost to Follow-up|1|||
163017774|NCT01908829|588770693|FG000|Overall Study|Randomized no double-blind drug received|1|||
163017775|NCT01908829|588770694|FG001|Overall Study|Randomized no double-blind drug received|0|||
163063039|NCT05452239|588938570|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
163063040|NCT05452239|588938569|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
163063041|NCT05452239|588938570|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
163063042|NCT05452239|588938569|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
163063043|NCT05452239|588938570|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
163063044|NCT05452239|588938569|FG000|Placebo-controlled Period|Randomized but not treated|2|||
163063045|NCT05452239|588938570|FG001|Placebo-controlled Period|Randomized but not treated|2|||
163063046|NCT05452239|588938569|FG000|Placebo-controlled Period|Other than specified|1|||
163063047|NCT05452239|588938570|FG001|Placebo-controlled Period|Other than specified|1|||
163063048|NCT05452239|588938569|FG000|Open-label Period|Withdrawal by Subject|2|||
163063049|NCT05452239|588938570|FG001|Open-label Period|Withdrawal by Subject|1|||
163063050|NCT05452239|588938569|FG000|Open-label Period|Lost to Follow-up|3|||
163063051|NCT05452239|588938570|FG001|Open-label Period|Lost to Follow-up|0|||
163063052|NCT05452239|588938569|FG000|Open-label Period|Other than specified|1|||
163063053|NCT05452239|588938570|FG001|Open-label Period|Other than specified|2|||
163063054|NCT03965923|588938571|FG000|Overall Study|Withdrawal by Subject|1|||
163063055|NCT03965923|588938572|FG001|Overall Study|Withdrawal by Subject|2|||
163063056|NCT03965923|588938573|FG002|Overall Study|Withdrawal by Subject|3|||
163063057|NCT03965923|588938574|FG003|Overall Study|Withdrawal by Subject|1|||
163063058|NCT03965923|588938575|FG004|Overall Study|Withdrawal by Subject|2|||
163063059|NCT03965923|588938576|FG005|Overall Study|Withdrawal by Subject|0|||
163063060|NCT03965923|588938577|FG006|Overall Study|Withdrawal by Subject|4|||
163063061|NCT03965923|588938578|FG007|Overall Study|Withdrawal by Subject|3|||
163063062|NCT03965923|588938579|FG008|Overall Study|Withdrawal by Subject|4|||
163063063|NCT03965923|588938580|FG009|Overall Study|Withdrawal by Subject|0|||
163063064|NCT03965923|588938581|FG010|Overall Study|Withdrawal by Subject|2|||
163063065|NCT03965923|588938582|FG011|Overall Study|Withdrawal by Subject|0|||
163063066|NCT03965923|588938571|FG000|Overall Study|Lost to Follow-up|2|||
163063067|NCT03965923|588938572|FG001|Overall Study|Lost to Follow-up|1|||
163063068|NCT03965923|588938573|FG002|Overall Study|Lost to Follow-up|1|||
163063069|NCT03965923|588938574|FG003|Overall Study|Lost to Follow-up|0|||
163063070|NCT03965923|588938575|FG004|Overall Study|Lost to Follow-up|2|||
163063071|NCT03965923|588938576|FG005|Overall Study|Lost to Follow-up|1|||
163063072|NCT03965923|588938577|FG006|Overall Study|Lost to Follow-up|2|||
163063073|NCT03965923|588938578|FG007|Overall Study|Lost to Follow-up|1|||
163063074|NCT03965923|588938579|FG008|Overall Study|Lost to Follow-up|0|||
163063075|NCT03965923|588938580|FG009|Overall Study|Lost to Follow-up|2|||
163063076|NCT03965923|588938581|FG010|Overall Study|Lost to Follow-up|0|||
163063077|NCT03965923|588938582|FG011|Overall Study|Lost to Follow-up|0|||
163328672|NCT05485805|589913337|FG000|Overall Study|Lost to Follow-up|1|||
163328673|NCT05485805|589913338|FG001|Overall Study|Lost to Follow-up|1|||
163017776|NCT01908829|588770695|FG002|Overall Study|Randomized no double-blind drug received|1|||
163017777|NCT01908829|588770693|FG000|Overall Study|Discontinued (no EoT page)|2|||
163017778|NCT01908829|588770694|FG001|Overall Study|Discontinued (no EoT page)|0|||
163017779|NCT01908829|588770695|FG002|Overall Study|Discontinued (no EoT page)|0|||
163063078|NCT03965923|588938571|FG000|Overall Study|Death|0|||
163063079|NCT03965923|588938572|FG001|Overall Study|Death|0|||
163063080|NCT03965923|588938573|FG002|Overall Study|Death|0|||
163063081|NCT03965923|588938574|FG003|Overall Study|Death|0|||
163017780|NCT01908829|588770693|FG000|Overall Study|Miscellaneous|0|||
163017781|NCT01908829|588770694|FG001|Overall Study|Miscellaneous|2|||
163017782|NCT01908829|588770695|FG002|Overall Study|Miscellaneous|0|||
163017783|NCT01908829|588770693|FG000|Overall Study|Protocol Violation|2|||
163017784|NCT01908829|588770694|FG001|Overall Study|Protocol Violation|2|||
163017785|NCT01908829|588770695|FG002|Overall Study|Protocol Violation|0|||
163017786|NCT01908829|588770693|FG000|Overall Study|Lack of Efficacy|1|||
163017787|NCT01908829|588770694|FG001|Overall Study|Lack of Efficacy|3|||
163017788|NCT01908829|588770695|FG002|Overall Study|Lack of Efficacy|2|||
163017789|NCT01908829|588770693|FG000|Overall Study|Withdrawal by Subject|26|||
163404859|NCT03077685|590192053|FG000|Overall Study|Disease Progression|1|||
163404860|NCT03077685|590192054|FG001|Overall Study|Disease Progression|0|||
163404861|NCT03077685|590192055|FG002|Overall Study|Disease Progression|0|||
163404862|NCT03077685|590192056|FG003|Overall Study|Disease Progression|2|||
163017790|NCT01908829|588770694|FG001|Overall Study|Withdrawal by Subject|29|||
163017791|NCT01908829|588770695|FG002|Overall Study|Withdrawal by Subject|22|||
163017792|NCT02792192|588770696|FG000|Overall Study|Death|1|||
163017793|NCT02792192|588770697|FG001|Overall Study|Death|0|||
163017794|NCT02792192|588770698|FG002|Overall Study|Death|0|||
163017795|NCT02792192|588770699|FG003|Overall Study|Death|0|||
163017796|NCT02792192|588770696|FG000|Overall Study|Informed Consent Withdrawn|4|||
163017797|NCT02792192|588770697|FG001|Overall Study|Informed Consent Withdrawn|0|||
163017798|NCT02792192|588770698|FG002|Overall Study|Informed Consent Withdrawn|0|||
163017799|NCT02792192|588770699|FG003|Overall Study|Informed Consent Withdrawn|0|||
163063082|NCT03965923|588938575|FG004|Overall Study|Death|0|||
163215725|NCT01641692|589503920|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
163215726|NCT01641692|589503921|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
163215727|NCT01641692|589503922|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
163215728|NCT01641692|589503915|FG000|Treatment Period 1|Lost to Follow-up|0|||
163215729|NCT01641692|589503916|FG001|Treatment Period 1|Lost to Follow-up|0|||
163215730|NCT01641692|589503917|FG002|Treatment Period 1|Lost to Follow-up|1|||
163215731|NCT01641692|589503918|FG003|Treatment Period 1|Lost to Follow-up|0|||
163215732|NCT01641692|589503919|FG004|Treatment Period 1|Lost to Follow-up|0|||
163215733|NCT01641692|589503920|FG005|Treatment Period 1|Lost to Follow-up|0|||
163215734|NCT01641692|589503921|FG006|Treatment Period 1|Lost to Follow-up|0|||
163215735|NCT01641692|589503922|FG007|Treatment Period 1|Lost to Follow-up|0|||
163215736|NCT01641692|589503915|FG000|Treatment Period 1|Physician Decision|0|||
163215737|NCT01641692|589503916|FG001|Treatment Period 1|Physician Decision|0|||
163215738|NCT01641692|589503917|FG002|Treatment Period 1|Physician Decision|0|||
163215739|NCT01641692|589503918|FG003|Treatment Period 1|Physician Decision|0|||
163063083|NCT03965923|588938576|FG005|Overall Study|Death|0|||
163215740|NCT01641692|589503919|FG004|Treatment Period 1|Physician Decision|1|||
163215741|NCT01641692|589503920|FG005|Treatment Period 1|Physician Decision|0|||
163328674|NCT05485805|589913339|FG002|Overall Study|Lost to Follow-up|3|||
163328675|NCT05485805|589913340|FG003|Overall Study|Lost to Follow-up|1|||
163328676|NCT05485805|589913341|FG004|Overall Study|Lost to Follow-up|0|||
163328677|NCT04218357|589913342|FG000|1st Allocation|Withdrawal by Subject|1|||
163328678|NCT04218357|589913343|FG001|1st Allocation|Withdrawal by Subject|0|||
163328679|NCT05349838|589913344|FG000|Overall Study|Virological Failure|1|||
163328680|NCT05349838|589913345|FG001|Overall Study|Virological Failure|2|||
163328681|NCT05349838|589913344|FG000|Overall Study|Withdrawal by Subject|2|||
163328682|NCT05349838|589913345|FG001|Overall Study|Withdrawal by Subject|3|||
163328683|NCT05349838|589913344|FG000|Overall Study|Adverse Event|3|||
163328684|NCT05349838|589913345|FG001|Overall Study|Adverse Event|1|||
163328685|NCT05349838|589913344|FG000|Overall Study|Lost to Follow-up|1|||
163328686|NCT05349838|589913345|FG001|Overall Study|Lost to Follow-up|2|||
163328687|NCT05349838|589913344|FG000|Overall Study|Other reasons|5|||
163328688|NCT05349838|589913345|FG001|Overall Study|Other reasons|1|||
163328689|NCT05037513|589913350|FG000|Intervention Period|Lost to Follow-up|1|||
163328690|NCT05037513|589913351|FG001|Intervention Period|Lost to Follow-up|2|||
163328691|NCT05037513|589913350|FG000|Follow Up Period|Lost to Follow-up|16|||
163328692|NCT05037513|589913351|FG001|Follow Up Period|Lost to Follow-up|21|||
163328693|NCT05037513|589913350|FG000|Follow Up Period|Death|0|||
163017800|NCT02792192|588770696|FG000|Overall Study|Physician Decision|1|||
163017801|NCT02792192|588770697|FG001|Overall Study|Physician Decision|0|||
163215742|NCT01641692|589503921|FG006|Treatment Period 1|Physician Decision|0|||
163215743|NCT01641692|589503922|FG007|Treatment Period 1|Physician Decision|0|||
163215744|NCT01641692|589503915|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163328694|NCT05037513|589913351|FG001|Follow Up Period|Death|1|||
163328695|NCT05037513|589913350|FG000|Follow Up Period|Incarcerated|4|||
163328696|NCT05037513|589913351|FG001|Follow Up Period|Incarcerated|2|||
163328697|NCT03664804|589913353|FG000|Overall Study|Withdrawal by Subject|7|||
163328698|NCT05529992|589913354|FG000|Overall Study|Withdrawal by Subject|1|||
163328699|NCT06140290|589913355|FG000|Period 1|Adverse Event|1|||
163328700|NCT06140290|589913356|FG001|Period 1|Adverse Event|0|||
163017802|NCT02792192|588770698|FG002|Overall Study|Physician Decision|0|||
163063084|NCT03965923|588938577|FG006|Overall Study|Death|0|||
163063085|NCT03965923|588938578|FG007|Overall Study|Death|1|||
163328701|NCT06140290|589913355|FG000|Period 2|Assigned but not treated|0|||
163404863|NCT03077685|590192057|FG004|Overall Study|Disease Progression|1|||
163404864|NCT03077685|590192053|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
163404865|NCT03077685|590192054|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
163404866|NCT03077685|590192055|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
163404867|NCT03077685|590192056|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
163404868|NCT03077685|590192057|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
163404869|NCT03077685|590192053|FG000|Overall Study|Subject entered hospice care|0|||
163404870|NCT03077685|590192054|FG001|Overall Study|Subject entered hospice care|0|||
163404871|NCT03077685|590192055|FG002|Overall Study|Subject entered hospice care|0|||
163404872|NCT03077685|590192056|FG003|Overall Study|Subject entered hospice care|0|||
163404873|NCT03077685|590192057|FG004|Overall Study|Subject entered hospice care|1|||
163404874|NCT02116777|590192058|FG000|Overall Study|Adverse Event|0|||
163404875|NCT02116777|590192059|FG001|Overall Study|Adverse Event|0|||
163404876|NCT02116777|590192060|FG002|Overall Study|Adverse Event|0|||
163404877|NCT02116777|590192061|FG003|Overall Study|Adverse Event|0|||
163404878|NCT02116777|590192062|FG004|Overall Study|Adverse Event|2|||
163404879|NCT02116777|590192063|FG005|Overall Study|Adverse Event|2|||
163404880|NCT02116777|590192064|FG006|Overall Study|Adverse Event|0|||
163404881|NCT02116777|590192058|FG000|Overall Study|Death|0|||
163404882|NCT02116777|590192059|FG001|Overall Study|Death|0|||
163404883|NCT02116777|590192060|FG002|Overall Study|Death|0|||
163404884|NCT02116777|590192061|FG003|Overall Study|Death|1|||
163404885|NCT02116777|590192062|FG004|Overall Study|Death|0|||
163404886|NCT02116777|590192063|FG005|Overall Study|Death|0|||
163404887|NCT02116777|590192064|FG006|Overall Study|Death|0|||
163404888|NCT02116777|590192058|FG000|Overall Study|Lack of Efficacy|3|||
163404889|NCT02116777|590192059|FG001|Overall Study|Lack of Efficacy|3|||
163404890|NCT02116777|590192060|FG002|Overall Study|Lack of Efficacy|3|||
163404891|NCT02116777|590192061|FG003|Overall Study|Lack of Efficacy|8|||
163404892|NCT02116777|590192062|FG004|Overall Study|Lack of Efficacy|4|||
163404893|NCT02116777|590192063|FG005|Overall Study|Lack of Efficacy|1|||
163404894|NCT02116777|590192064|FG006|Overall Study|Lack of Efficacy|9|||
163404895|NCT02116777|590192058|FG000|Overall Study|Physician Decision|0|||
163404896|NCT02116777|590192059|FG001|Overall Study|Physician Decision|0|||
163404897|NCT02116777|590192060|FG002|Overall Study|Physician Decision|0|||
163404898|NCT02116777|590192061|FG003|Overall Study|Physician Decision|2|||
163404899|NCT02116777|590192062|FG004|Overall Study|Physician Decision|0|||
163404900|NCT02116777|590192063|FG005|Overall Study|Physician Decision|0|||
163404901|NCT02116777|590192064|FG006|Overall Study|Physician Decision|0|||
163404902|NCT02116777|590192058|FG000|Overall Study|Protocol Violation|0|||
163404903|NCT02116777|590192059|FG001|Overall Study|Protocol Violation|0|||
163404904|NCT02116777|590192060|FG002|Overall Study|Protocol Violation|0|||
163404905|NCT02116777|590192061|FG003|Overall Study|Protocol Violation|1|||
163404906|NCT02116777|590192062|FG004|Overall Study|Protocol Violation|0|||
163404907|NCT02116777|590192063|FG005|Overall Study|Protocol Violation|0|||
163404908|NCT02116777|590192064|FG006|Overall Study|Protocol Violation|0|||
163404909|NCT02116777|590192058|FG000|Overall Study|Withdrawal by Subject|0|||
163404910|NCT02116777|590192059|FG001|Overall Study|Withdrawal by Subject|0|||
163404911|NCT02116777|590192060|FG002|Overall Study|Withdrawal by Subject|0|||
163404912|NCT02116777|590192061|FG003|Overall Study|Withdrawal by Subject|1|||
163404913|NCT02116777|590192062|FG004|Overall Study|Withdrawal by Subject|0|||
163404914|NCT02116777|590192063|FG005|Overall Study|Withdrawal by Subject|0|||
163404915|NCT02116777|590192064|FG006|Overall Study|Withdrawal by Subject|0|||
163404916|NCT03770260|590193461|FG000|Overall Study|Disease progression|0|||
163404917|NCT03770260|590193462|FG001|Overall Study|Disease progression|1|||
163404918|NCT03770260|590193463|FG002|Overall Study|Disease progression|0|||
163404919|NCT03770260|590193464|FG003|Overall Study|Disease progression|0|||
163404920|NCT00477165|590193468|FG000|Overall Study|Adverse Event|7|||
163404921|NCT00477165|590193469|FG001|Overall Study|Adverse Event|2|||
163404922|NCT02135692|590193473|FG000|Overall Study|Adverse Event|3|||
163404923|NCT02135692|590193473|FG000|Overall Study|Lack of Efficacy|2|||
163404924|NCT02135692|590193473|FG000|Overall Study|Protocol Violation|2|||
163404925|NCT02135692|590193473|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
163404926|NCT02135692|590193473|FG000|Overall Study|Product commercially available|159|||
163404927|NCT02135692|590193473|FG000|Overall Study|Study closed/terminated|153|||
163404928|NCT02135692|590193473|FG000|Overall Study|Lost to Follow-up|4|||
163404929|NCT02135692|590193473|FG000|Overall Study|Withdrawal by Subject|15|||
163404930|NCT01097746|590193475|FG000|Overall Study|Adverse Event|4|||
163404931|NCT01097746|590193475|FG000|Overall Study|taken off study before any treatment given|1|||
163404932|NCT01514682|590193476|FG000|Overall Study|Withdrawal by Subject|2|||
163404933|NCT01514682|590193477|FG001|Overall Study|Withdrawal by Subject|3|||
163404934|NCT01514682|590193476|FG000|Overall Study|Physician Decision|4|||
163404935|NCT01514682|590193477|FG001|Overall Study|Physician Decision|3|||
163404936|NCT00769002|590193478|FG000|Overall Study|Study was not completed, no data|9|||
163404937|NCT00769002|590193479|FG001|Overall Study|Study was not completed, no data|9|||
163404938|NCT00960661|590193480|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
163404939|NCT00960661|590193481|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
163404940|NCT00960661|590193482|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
163017803|NCT02792192|588770699|FG003|Overall Study|Physician Decision|0|||
163017804|NCT02792192|588770696|FG000|Overall Study|Progressive Disease|0|||
163017805|NCT02792192|588770697|FG001|Overall Study|Progressive Disease|1|||
163017806|NCT02792192|588770698|FG002|Overall Study|Progressive Disease|0|||
163017807|NCT02792192|588770699|FG003|Overall Study|Progressive Disease|0|||
163017808|NCT02792192|588770696|FG000|Overall Study|Study Terminated By Sponsor|6|||
163017809|NCT02792192|588770697|FG001|Overall Study|Study Terminated By Sponsor|10|||
163017810|NCT02792192|588770698|FG002|Overall Study|Study Terminated By Sponsor|0|||
163017811|NCT02792192|588770699|FG003|Overall Study|Study Terminated By Sponsor|0|||
163017812|NCT01430403|588770700|FG000|Overall Study|Lost to Follow-up|5|||
163328702|NCT06140290|589913356|FG001|Period 2|Assigned but not treated|1|||
163328703|NCT06140290|589913355|FG000|Period 2|Withdrawal by Subject|0|||
163404941|NCT00960661|590193480|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
163404942|NCT00960661|590193481|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
163404943|NCT00960661|590193482|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
163404944|NCT00960661|590193480|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
163404945|NCT00960661|590193481|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
163404946|NCT00960661|590193482|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
163404947|NCT00960661|590193480|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
163404948|NCT00960661|590193481|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
163404949|NCT00960661|590193482|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
163404950|NCT00960661|590193480|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
163404951|NCT00960661|590193481|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
163404952|NCT00960661|590193482|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
163404953|NCT00960661|590193480|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
163404954|NCT00960661|590193481|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
163404955|NCT00960661|590193482|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
163404956|NCT00960661|590193480|FG000|Interventional Phase|Adverse Event|0|||
163404957|NCT00960661|590193481|FG001|Interventional Phase|Adverse Event|17|||
163404958|NCT00960661|590193482|FG002|Interventional Phase|Adverse Event|8|||
163404959|NCT00960661|590193480|FG000|Interventional Phase|Death|0|||
163404960|NCT00960661|590193481|FG001|Interventional Phase|Death|1|||
163404961|NCT00960661|590193482|FG002|Interventional Phase|Death|0|||
163404962|NCT00960661|590193480|FG000|Interventional Phase|Lost to Follow-up|0|||
163404963|NCT00960661|590193481|FG001|Interventional Phase|Lost to Follow-up|0|||
163404964|NCT00960661|590193482|FG002|Interventional Phase|Lost to Follow-up|2|||
163404965|NCT00960661|590193480|FG000|Interventional Phase|entry criteria not met|0|||
163404966|NCT00960661|590193481|FG001|Interventional Phase|entry criteria not met|3|||
163404967|NCT00960661|590193482|FG002|Interventional Phase|entry criteria not met|0|||
163404968|NCT00960661|590193480|FG000|Interventional Phase|Protocol Violation|0|||
163404969|NCT00960661|590193481|FG001|Interventional Phase|Protocol Violation|7|||
163404970|NCT00960661|590193482|FG002|Interventional Phase|Protocol Violation|2|||
163404971|NCT00960661|590193480|FG000|Interventional Phase|Withdrawal by Subject|0|||
163404972|NCT00960661|590193481|FG001|Interventional Phase|Withdrawal by Subject|18|||
163404973|NCT00960661|590193482|FG002|Interventional Phase|Withdrawal by Subject|29|||
163404974|NCT00960661|590193480|FG000|Interventional Phase|Physician Decision|0|||
163404975|NCT00960661|590193481|FG001|Interventional Phase|Physician Decision|3|||
163328704|NCT06140290|589913356|FG001|Period 2|Withdrawal by Subject|1|||
163328705|NCT02036970|589914838|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
163328706|NCT02036970|589914839|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
163328707|NCT02036970|589914840|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
163328708|NCT02036970|589914841|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
163328709|NCT02036970|589914842|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
163328710|NCT02036970|589914843|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
163328711|NCT02036970|589914844|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
163328712|NCT02036970|589914845|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
163328713|NCT02036970|589914846|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
163328714|NCT02036970|589914847|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
163404976|NCT00960661|590193482|FG002|Interventional Phase|Physician Decision|5|||
163404977|NCT00960661|590193480|FG000|Interventional Phase|sponsor decision|0|||
163404978|NCT00960661|590193481|FG001|Interventional Phase|sponsor decision|1|||
163017813|NCT01430403|588770701|FG001|Overall Study|Lost to Follow-up|5|||
163017814|NCT01430403|588770702|FG002|Overall Study|Lost to Follow-up|3|||
163017815|NCT01430403|588770700|FG000|Overall Study|Physician Decision|1|||
163017816|NCT01430403|588770701|FG001|Overall Study|Physician Decision|0|||
163017817|NCT01430403|588770702|FG002|Overall Study|Physician Decision|0|||
163017818|NCT01430403|588770700|FG000|Overall Study|Protocol Violation|2|||
163017819|NCT01430403|588770701|FG001|Overall Study|Protocol Violation|3|||
163328715|NCT02036970|589914838|FG000|Part 1: Day 1 Through Week 16|Death|0|||
163404979|NCT00960661|590193482|FG002|Interventional Phase|sponsor decision|0|||
163328716|NCT02036970|589914839|FG001|Part 1: Day 1 Through Week 16|Death|0|||
163328717|NCT02036970|589914840|FG002|Part 1: Day 1 Through Week 16|Death|0|||
163017820|NCT01430403|588770702|FG002|Overall Study|Protocol Violation|2|||
163215745|NCT01641692|589503916|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163215746|NCT01641692|589503917|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163215747|NCT01641692|589503918|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163215748|NCT01641692|589503919|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163215749|NCT01641692|589503920|FG005|Treatment Period 1|Withdrawal by Subject|2|||
163215750|NCT01641692|589503921|FG006|Treatment Period 1|Withdrawal by Subject|0|||
163215751|NCT01641692|589503922|FG007|Treatment Period 1|Withdrawal by Subject|1|||
163215752|NCT01641692|589503915|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
163215753|NCT01641692|589503916|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
163017821|NCT01430403|588770700|FG000|Overall Study|Withdrawal by Subject|9|||
163017822|NCT01430403|588770701|FG001|Overall Study|Withdrawal by Subject|1|||
163017823|NCT01430403|588770702|FG002|Overall Study|Withdrawal by Subject|3|||
163017824|NCT02677922|588770705|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
163017825|NCT02677922|588770706|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
163017826|NCT02677922|588770707|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
163017827|NCT02677922|588770708|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
163017828|NCT02677922|588770709|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
163017829|NCT02677922|588770710|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
163017830|NCT02677922|588770705|FG000|Treatment Period|Adverse Event|0|||
163017831|NCT02677922|588770706|FG001|Treatment Period|Adverse Event|0|||
163215754|NCT01641692|589503917|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
163215755|NCT01641692|589503918|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
163017832|NCT02677922|588770707|FG002|Treatment Period|Adverse Event|1|||
163017833|NCT02677922|588770708|FG003|Treatment Period|Adverse Event|3|||
163017834|NCT02677922|588770709|FG004|Treatment Period|Adverse Event|5|||
163017835|NCT02677922|588770710|FG005|Treatment Period|Adverse Event|2|||
163017836|NCT02677922|588770705|FG000|Treatment Period|Progressive Disease|1|||
163017837|NCT02677922|588770706|FG001|Treatment Period|Progressive Disease|1|||
163017838|NCT02677922|588770707|FG002|Treatment Period|Progressive Disease|0|||
163017839|NCT02677922|588770708|FG003|Treatment Period|Progressive Disease|0|||
163017840|NCT02677922|588770709|FG004|Treatment Period|Progressive Disease|8|||
163017841|NCT02677922|588770710|FG005|Treatment Period|Progressive Disease|7|||
163017842|NCT02677922|588770705|FG000|Treatment Period|Lack of Efficacy|0|||
163017843|NCT02677922|588770706|FG001|Treatment Period|Lack of Efficacy|0|||
163017844|NCT02677922|588770707|FG002|Treatment Period|Lack of Efficacy|0|||
163017845|NCT02677922|588770708|FG003|Treatment Period|Lack of Efficacy|1|||
163017846|NCT02677922|588770709|FG004|Treatment Period|Lack of Efficacy|1|||
163017847|NCT02677922|588770710|FG005|Treatment Period|Lack of Efficacy|6|||
163017848|NCT02677922|588770705|FG000|Treatment Period|Withdrawal by Subject|0|||
163215756|NCT01641692|589503919|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
163215757|NCT01641692|589503920|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
163215758|NCT01641692|589503921|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
163215759|NCT01641692|589503922|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
163215760|NCT01641692|589503915|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
163215761|NCT01641692|589503916|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
163215762|NCT01641692|589503917|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
163215763|NCT01641692|589503918|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
163215764|NCT01641692|589503919|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
163215765|NCT01641692|589503920|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
163215766|NCT01641692|589503921|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
163215767|NCT01641692|589503922|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
163215768|NCT01641692|589503915|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
163215769|NCT01641692|589503916|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
163215770|NCT01641692|589503917|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
163215771|NCT01641692|589503918|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
163215772|NCT01641692|589503919|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
163215773|NCT01641692|589503920|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
163215774|NCT01641692|589503921|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
163215775|NCT01641692|589503922|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
163215776|NCT01641692|589503915|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
163215777|NCT01641692|589503916|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
163215778|NCT01641692|589503917|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
163215779|NCT01641692|589503918|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
163215780|NCT01641692|589503919|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
163215781|NCT01641692|589503920|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
163215782|NCT01641692|589503921|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
163215783|NCT01641692|589503922|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
163215784|NCT01641692|589503915|FG000|Treatment Period 2|Lack of Efficacy|1|||
163017849|NCT02677922|588770706|FG001|Treatment Period|Withdrawal by Subject|0|||
163017850|NCT02677922|588770707|FG002|Treatment Period|Withdrawal by Subject|1|||
163215785|NCT01641692|589503916|FG001|Treatment Period 2|Lack of Efficacy|0|||
163017851|NCT02677922|588770708|FG003|Treatment Period|Withdrawal by Subject|3|||
163017852|NCT02677922|588770709|FG004|Treatment Period|Withdrawal by Subject|5|||
163017853|NCT02677922|588770710|FG005|Treatment Period|Withdrawal by Subject|5|||
163017854|NCT02677922|588770705|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
163017855|NCT02677922|588770706|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
163017856|NCT02677922|588770707|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
163017857|NCT02677922|588770708|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
163017858|NCT02677922|588770709|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
163017859|NCT02677922|588770710|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
163017860|NCT02677922|588770705|FG000|Treatment Period|Disease Relapse|0|||
163017861|NCT02677922|588770706|FG001|Treatment Period|Disease Relapse|0|||
163017862|NCT02677922|588770707|FG002|Treatment Period|Disease Relapse|0|||
163017863|NCT02677922|588770708|FG003|Treatment Period|Disease Relapse|3|||
163017864|NCT02677922|588770709|FG004|Treatment Period|Disease Relapse|6|||
163017865|NCT02677922|588770710|FG005|Treatment Period|Disease Relapse|1|||
163017866|NCT02677922|588770705|FG000|Treatment Period|Allogeneic HSCT|1|||
163017867|NCT02677922|588770706|FG001|Treatment Period|Allogeneic HSCT|0|||
163017868|NCT02677922|588770707|FG002|Treatment Period|Allogeneic HSCT|0|||
163017869|NCT02677922|588770708|FG003|Treatment Period|Allogeneic HSCT|1|||
163017870|NCT02677922|588770709|FG004|Treatment Period|Allogeneic HSCT|4|||
163017871|NCT02677922|588770710|FG005|Treatment Period|Allogeneic HSCT|1|||
163017872|NCT02677922|588770705|FG000|Treatment Period|Other Reasons|0|||
163017873|NCT02677922|588770706|FG001|Treatment Period|Other Reasons|0|||
163017874|NCT02677922|588770707|FG002|Treatment Period|Other Reasons|0|||
163017875|NCT02677922|588770708|FG003|Treatment Period|Other Reasons|1|||
163017876|NCT02677922|588770709|FG004|Treatment Period|Other Reasons|3|||
163017877|NCT02677922|588770710|FG005|Treatment Period|Other Reasons|5|||
163017878|NCT02677922|588770705|FG000|Treatment Period|Death|0|||
163017879|NCT02677922|588770706|FG001|Treatment Period|Death|0|||
163017880|NCT02677922|588770707|FG002|Treatment Period|Death|0|||
163017881|NCT02677922|588770708|FG003|Treatment Period|Death|0|||
163017882|NCT02677922|588770709|FG004|Treatment Period|Death|12|||
163017883|NCT02677922|588770710|FG005|Treatment Period|Death|1|||
163017884|NCT02677922|588770705|FG000|Treatment Period|Non-compliance with Study Drug|0|||
163017885|NCT02677922|588770706|FG001|Treatment Period|Non-compliance with Study Drug|0|||
163017886|NCT02677922|588770707|FG002|Treatment Period|Non-compliance with Study Drug|0|||
163017887|NCT02677922|588770708|FG003|Treatment Period|Non-compliance with Study Drug|0|||
163017888|NCT02677922|588770709|FG004|Treatment Period|Non-compliance with Study Drug|1|||
163017889|NCT02677922|588770710|FG005|Treatment Period|Non-compliance with Study Drug|0|||
163017890|NCT02677922|588770705|FG000|Treatment Period|Physician Decision|0|||
163017891|NCT02677922|588770706|FG001|Treatment Period|Physician Decision|0|||
163017892|NCT02677922|588770707|FG002|Treatment Period|Physician Decision|0|||
163017893|NCT02677922|588770708|FG003|Treatment Period|Physician Decision|0|||
163017894|NCT02677922|588770709|FG004|Treatment Period|Physician Decision|0|||
163017895|NCT02677922|588770710|FG005|Treatment Period|Physician Decision|1|||
163017896|NCT02677922|588770705|FG000|Treatment Period|Symptomatic Deterioration|0|||
163017897|NCT02677922|588770706|FG001|Treatment Period|Symptomatic Deterioration|0|||
163017898|NCT02677922|588770707|FG002|Treatment Period|Symptomatic Deterioration|0|||
163017899|NCT02677922|588770708|FG003|Treatment Period|Symptomatic Deterioration|0|||
163017900|NCT02677922|588770709|FG004|Treatment Period|Symptomatic Deterioration|1|||
163017901|NCT02677922|588770710|FG005|Treatment Period|Symptomatic Deterioration|0|||
163017902|NCT00637000|588770711|FG000|Overall Study|Withdrawal by Subject|4|||
163017903|NCT00637000|588770712|FG001|Overall Study|Withdrawal by Subject|3|||
163017904|NCT00183885|588770735|FG000|Overall Study|Adverse Event|11|||
163017905|NCT00183885|588770735|FG000|Overall Study|Death|1|||
163017906|NCT00183885|588770735|FG000|Overall Study|Lost to Follow-up|3|||
163017907|NCT00183885|588770735|FG000|Overall Study|Physician Decision|6|||
163017908|NCT00183885|588770735|FG000|Overall Study|Withdrawal by Subject|5|||
163017909|NCT00183885|588770735|FG000|Overall Study|Switched to alternative treatment|8|||
163017910|NCT00183885|588770735|FG000|Overall Study|Treatment delayed too long|4|||
163017911|NCT00183885|588770735|FG000|Overall Study|Developed second malignancy|1|||
163017912|NCT00014495|588770738|FG000|Overall Study|Death|0|||
163017913|NCT00014495|588770739|FG001|Overall Study|Death|0|||
163017914|NCT00014495|588770740|FG002|Overall Study|Death|1|||
163017915|NCT00014495|588770741|FG003|Overall Study|Death|0|||
163017916|NCT00014495|588770738|FG000|Overall Study|Clinical deterioration|0|||
163017917|NCT00014495|588770739|FG001|Overall Study|Clinical deterioration|0|||
163017918|NCT00014495|588770740|FG002|Overall Study|Clinical deterioration|0|||
163017919|NCT00014495|588770741|FG003|Overall Study|Clinical deterioration|1|||
163017920|NCT00403481|588770743|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
163017921|NCT00403481|588770743|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
163017922|NCT00403481|588770743|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
163017923|NCT00403481|588770743|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
163017924|NCT00403481|588770743|FG000|Olm 40 mg|Adverse Event|2|||
163017925|NCT00403481|588770743|FG000|Olm 40 mg|Protocol Violation|1|||
163017926|NCT00403481|588770743|FG000|Olm 40 mg|Withdrawal by Subject|1|||
163017927|NCT00403481|588770743|FG000|Olm 40 mg|Other|1|||
163017928|NCT00403481|588770743|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
163017929|NCT00403481|588770743|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
163017930|NCT00403481|588770743|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
163017931|NCT00403481|588770743|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
163017932|NCT00403481|588770743|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
163017933|NCT00403481|588770743|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
163017934|NCT02091089|588770744|FG000|Overall Study|Lost to Follow-up|2|||
163017935|NCT02929589|588770745|FG000|Overall Study|Withdrawal by Subject|1|||
163017936|NCT02929589|588770746|FG001|Overall Study|Withdrawal by Subject|0|||
163017937|NCT02929589|588770747|FG002|Overall Study|Withdrawal by Subject|0|||
163017938|NCT02929589|588770748|FG003|Overall Study|Withdrawal by Subject|0|||
163017939|NCT02929589|588770745|FG000|Overall Study|Physician Decision|2|||
163404980|NCT00960661|590193480|FG000|Interventional Phase|Lack of Efficacy|0|||
163017940|NCT02929589|588770746|FG001|Overall Study|Physician Decision|0|||
163017941|NCT02929589|588770747|FG002|Overall Study|Physician Decision|0|||
163063086|NCT03965923|588938579|FG008|Overall Study|Death|4|||
163215786|NCT01641692|589503917|FG002|Treatment Period 2|Lack of Efficacy|0|||
163215787|NCT01641692|589503918|FG003|Treatment Period 2|Lack of Efficacy|0|||
163017942|NCT02929589|588770748|FG003|Overall Study|Physician Decision|0|||
163017943|NCT00766636|588770759|FG000|Overall Study|Withdrawal by Subject|1|||
163063087|NCT03965923|588938580|FG009|Overall Study|Death|0|||
163063088|NCT03965923|588938581|FG010|Overall Study|Death|4|||
163215788|NCT01641692|589503919|FG004|Treatment Period 2|Lack of Efficacy|0|||
163215789|NCT01641692|589503920|FG005|Treatment Period 2|Lack of Efficacy|0|||
163215790|NCT01641692|589503921|FG006|Treatment Period 2|Lack of Efficacy|0|||
163215791|NCT01641692|589503922|FG007|Treatment Period 2|Lack of Efficacy|0|||
163215792|NCT01641692|589503915|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
163215793|NCT01641692|589503916|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
163215794|NCT01641692|589503917|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
163215795|NCT01641692|589503918|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
163215796|NCT01641692|589503919|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
163215797|NCT01641692|589503920|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
163215798|NCT01641692|589503921|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
163215799|NCT01641692|589503922|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
163215800|NCT01641692|589503915|FG000|Treatment Period 2|Lost to Follow-up|0|||
163215801|NCT01641692|589503916|FG001|Treatment Period 2|Lost to Follow-up|0|||
163215802|NCT01641692|589503917|FG002|Treatment Period 2|Lost to Follow-up|0|||
163215803|NCT01641692|589503918|FG003|Treatment Period 2|Lost to Follow-up|0|||
163215804|NCT01641692|589503919|FG004|Treatment Period 2|Lost to Follow-up|0|||
163215805|NCT01641692|589503920|FG005|Treatment Period 2|Lost to Follow-up|1|||
163215806|NCT01641692|589503921|FG006|Treatment Period 2|Lost to Follow-up|0|||
163215807|NCT01641692|589503922|FG007|Treatment Period 2|Lost to Follow-up|0|||
163215808|NCT01641692|589503915|FG000|Treatment Period 2|Withdrawal by Subject|1|||
163215809|NCT01641692|589503916|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163215810|NCT01641692|589503917|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163215811|NCT01641692|589503918|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163215812|NCT01641692|589503919|FG004|Treatment Period 2|Withdrawal by Subject|0|||
163215813|NCT01641692|589503920|FG005|Treatment Period 2|Withdrawal by Subject|1|||
163215814|NCT01641692|589503921|FG006|Treatment Period 2|Withdrawal by Subject|0|||
163215815|NCT01641692|589503922|FG007|Treatment Period 2|Withdrawal by Subject|1|||
163215816|NCT01641692|589503915|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
163215817|NCT01641692|589503916|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
163215818|NCT01641692|589503917|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
163215819|NCT01641692|589503918|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
163215820|NCT01641692|589503919|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
163215821|NCT01641692|589503920|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
163215822|NCT01641692|589503921|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
163215823|NCT01641692|589503922|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
163215824|NCT01641692|589503915|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
163215825|NCT01641692|589503916|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
163215826|NCT01641692|589503917|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
163215827|NCT01641692|589503918|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
163215828|NCT01641692|589503919|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
163215829|NCT01641692|589503920|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
163215830|NCT01641692|589503921|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
163215831|NCT01641692|589503922|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
163215832|NCT01641692|589503915|FG000|Treatment Period 3|Adverse Event|0|||
163215833|NCT01641692|589503916|FG001|Treatment Period 3|Adverse Event|0|||
163328718|NCT02036970|589914841|FG003|Part 1: Day 1 Through Week 16|Death|0|||
163404981|NCT00960661|590193481|FG001|Interventional Phase|Lack of Efficacy|2|||
163404982|NCT00960661|590193482|FG002|Interventional Phase|Lack of Efficacy|0|||
163404983|NCT02699892|590193483|FG000|Overall Study|Other|36|||
163404984|NCT00711100|590193484|FG000|Overall Study|Lack of Efficacy|5|||
163404985|NCT00711100|590193484|FG000|Overall Study|Withdrawal by Subject|8|||
163404986|NCT00001379|590193485|FG000|Initial Treatment|Disease progression|21|||
163404987|NCT00001379|590193486|FG001|Initial Treatment|Disease progression|3|||
163404988|NCT00001379|590193487|FG002|Initial Treatment|Disease progression|0|||
163404989|NCT00001379|590193488|FG003|Initial Treatment|Disease progression|0|||
163404990|NCT00001379|590193485|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
163404991|NCT00001379|590193486|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
163404992|NCT00001379|590193487|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
163404993|NCT00001379|590193488|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
163404994|NCT00001379|590193485|FG000|Initial Treatment|Received alternative treatment|2|||
163017944|NCT00766636|588770760|FG001|Overall Study|Withdrawal by Subject|1|||
163017945|NCT00766636|588770759|FG000|Overall Study|Incomplete Treatment|0|||
163017946|NCT00766636|588770760|FG001|Overall Study|Incomplete Treatment|1|||
163017947|NCT00766636|588770759|FG000|Overall Study|Adverse Event|1|||
163017948|NCT00766636|588770760|FG001|Overall Study|Adverse Event|0|||
163017949|NCT00766636|588770759|FG000|Overall Study|Disease Progression|1|||
163017950|NCT00766636|588770760|FG001|Overall Study|Disease Progression|0|||
163328719|NCT02036970|589914842|FG004|Part 1: Day 1 Through Week 16|Death|0|||
163328720|NCT02036970|589914843|FG005|Part 1: Day 1 Through Week 16|Death|0|||
163328721|NCT02036970|589914844|FG006|Part 1: Day 1 Through Week 16|Death|0|||
163328722|NCT02036970|589914845|FG007|Part 1: Day 1 Through Week 16|Death|0|||
163328723|NCT02036970|589914846|FG008|Part 1: Day 1 Through Week 16|Death|1|||
163328724|NCT02036970|589914847|FG009|Part 1: Day 1 Through Week 16|Death|0|||
163328725|NCT02036970|589914838|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
163328726|NCT02036970|589914839|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
163328727|NCT02036970|589914840|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
163328728|NCT02036970|589914841|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
163328729|NCT02036970|589914842|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
163328730|NCT02036970|589914843|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
163328731|NCT02036970|589914844|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
163328732|NCT02036970|589914845|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
163328733|NCT02036970|589914846|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
163328734|NCT02036970|589914847|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
163328735|NCT02036970|589914838|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
163328736|NCT02036970|589914839|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
163328737|NCT02036970|589914840|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
163404995|NCT00001379|590193486|FG001|Initial Treatment|Received alternative treatment|1|||
163017951|NCT02477332|588770763|FG000|Overall Study|Adverse Event|0|||
163017952|NCT02477332|588770764|FG001|Overall Study|Adverse Event|1|||
163017953|NCT02477332|588770765|FG002|Overall Study|Adverse Event|1|||
163017954|NCT02477332|588770766|FG003|Overall Study|Adverse Event|2|||
163017955|NCT02477332|588770767|FG004|Overall Study|Adverse Event|1|||
163017956|NCT02477332|588770768|FG005|Overall Study|Adverse Event|2|||
163017957|NCT02477332|588770763|FG000|Overall Study|Lack of Efficacy|1|||
163017958|NCT02477332|588770764|FG001|Overall Study|Lack of Efficacy|2|||
163017959|NCT02477332|588770765|FG002|Overall Study|Lack of Efficacy|1|||
163017960|NCT02477332|588770766|FG003|Overall Study|Lack of Efficacy|2|||
163017961|NCT02477332|588770767|FG004|Overall Study|Lack of Efficacy|1|||
163017962|NCT02477332|588770768|FG005|Overall Study|Lack of Efficacy|1|||
163017963|NCT02477332|588770763|FG000|Overall Study|Non-compliance with study treatment|0|||
163017964|NCT02477332|588770764|FG001|Overall Study|Non-compliance with study treatment|1|||
163017965|NCT02477332|588770765|FG002|Overall Study|Non-compliance with study treatment|2|||
163017966|NCT02477332|588770766|FG003|Overall Study|Non-compliance with study treatment|0|||
163017967|NCT02477332|588770767|FG004|Overall Study|Non-compliance with study treatment|0|||
163017968|NCT02477332|588770768|FG005|Overall Study|Non-compliance with study treatment|0|||
163017969|NCT02477332|588770763|FG000|Overall Study|Pregnancy|0|||
163017970|NCT02477332|588770764|FG001|Overall Study|Pregnancy|0|||
163017971|NCT02477332|588770765|FG002|Overall Study|Pregnancy|0|||
163017972|NCT02477332|588770766|FG003|Overall Study|Pregnancy|1|||
163017973|NCT02477332|588770767|FG004|Overall Study|Pregnancy|0|||
163017974|NCT02477332|588770768|FG005|Overall Study|Pregnancy|0|||
163017975|NCT02477332|588770763|FG000|Overall Study|Protocol Violation|2|||
163017976|NCT02477332|588770764|FG001|Overall Study|Protocol Violation|0|||
163328738|NCT02036970|589914841|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
163328739|NCT02036970|589914842|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
163017977|NCT02477332|588770765|FG002|Overall Study|Protocol Violation|3|||
163017978|NCT02477332|588770766|FG003|Overall Study|Protocol Violation|3|||
163017979|NCT02477332|588770767|FG004|Overall Study|Protocol Violation|1|||
163017980|NCT02477332|588770768|FG005|Overall Study|Protocol Violation|1|||
163017981|NCT02477332|588770763|FG000|Overall Study|Technical problems|0|||
163017982|NCT02477332|588770764|FG001|Overall Study|Technical problems|0|||
163017983|NCT02477332|588770765|FG002|Overall Study|Technical problems|1|||
163017984|NCT02477332|588770766|FG003|Overall Study|Technical problems|0|||
163017985|NCT02477332|588770767|FG004|Overall Study|Technical problems|0|||
163017986|NCT02477332|588770768|FG005|Overall Study|Technical problems|0|||
163328740|NCT02036970|589914843|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
163328741|NCT02036970|589914844|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
163328742|NCT02036970|589914845|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
163328743|NCT02036970|589914846|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
163328744|NCT02036970|589914847|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
163328745|NCT02036970|589914838|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
163328746|NCT02036970|589914839|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
163328747|NCT02036970|589914840|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
163328748|NCT02036970|589914841|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
163328749|NCT02036970|589914842|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
163328750|NCT02036970|589914843|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
163328751|NCT02036970|589914844|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
163328752|NCT02036970|589914845|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
163328753|NCT02036970|589914846|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
163328754|NCT02036970|589914847|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
163328755|NCT02036970|589914838|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
163328756|NCT02036970|589914839|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
163328757|NCT02036970|589914840|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
163328758|NCT02036970|589914841|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
163328759|NCT02036970|589914842|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
163328760|NCT02036970|589914843|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
163328761|NCT02036970|589914844|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
163328762|NCT02036970|589914845|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
163328763|NCT02036970|589914846|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
163328764|NCT02036970|589914847|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
163328765|NCT02036970|589914838|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
163328766|NCT02036970|589914839|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
163328767|NCT02036970|589914840|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
163328768|NCT02036970|589914841|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
163328769|NCT02036970|589914842|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
163328770|NCT02036970|589914843|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
163328771|NCT02036970|589914844|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
163328772|NCT02036970|589914845|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
163328773|NCT02036970|589914846|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
163328774|NCT02036970|589914847|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
163328775|NCT02036970|589914838|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
163328776|NCT02036970|589914839|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
163328777|NCT02036970|589914840|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
163328778|NCT02036970|589914841|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
163328779|NCT02036970|589914842|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
163328780|NCT02036970|589914843|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
163328781|NCT02036970|589914844|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
163328782|NCT02036970|589914845|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
163328783|NCT02036970|589914846|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
163328784|NCT02036970|589914847|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
163328785|NCT02036970|589914838|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
163328786|NCT02036970|589914839|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
163328787|NCT02036970|589914840|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
163328788|NCT02036970|589914841|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
163328789|NCT02036970|589914842|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
163328790|NCT02036970|589914843|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
163328791|NCT02036970|589914844|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
163328792|NCT02036970|589914845|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
163328793|NCT02036970|589914846|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
163328794|NCT02036970|589914847|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
163328795|NCT02386098|589914850|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
163328796|NCT02386098|589914851|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
163404996|NCT00001379|590193487|FG002|Initial Treatment|Received alternative treatment|0|||
163404997|NCT00001379|590193488|FG003|Initial Treatment|Received alternative treatment|0|||
163017987|NCT02477332|588770763|FG000|Overall Study|Lost to Follow-up|0|||
163017988|NCT02477332|588770764|FG001|Overall Study|Lost to Follow-up|0|||
163328797|NCT02386098|589914852|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
163328798|NCT02386098|589914853|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
163328799|NCT02386098|589914854|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
163328800|NCT02386098|589914850|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
163328801|NCT02386098|589914851|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
163017989|NCT02477332|588770765|FG002|Overall Study|Lost to Follow-up|2|||
163017990|NCT02477332|588770766|FG003|Overall Study|Lost to Follow-up|0|||
163017991|NCT02477332|588770767|FG004|Overall Study|Lost to Follow-up|0|||
163017992|NCT02477332|588770768|FG005|Overall Study|Lost to Follow-up|0|||
163017993|NCT02477332|588770763|FG000|Overall Study|Physician Decision|0|||
163017994|NCT02477332|588770764|FG001|Overall Study|Physician Decision|0|||
163017995|NCT02477332|588770765|FG002|Overall Study|Physician Decision|1|||
163017996|NCT02477332|588770766|FG003|Overall Study|Physician Decision|3|||
163017997|NCT02477332|588770767|FG004|Overall Study|Physician Decision|0|||
163017998|NCT02477332|588770768|FG005|Overall Study|Physician Decision|1|||
163017999|NCT02477332|588770763|FG000|Overall Study|Withdrawal by Subject|0|||
163018000|NCT02477332|588770764|FG001|Overall Study|Withdrawal by Subject|3|||
163018001|NCT02477332|588770765|FG002|Overall Study|Withdrawal by Subject|1|||
163018002|NCT02477332|588770766|FG003|Overall Study|Withdrawal by Subject|2|||
163018003|NCT02477332|588770767|FG004|Overall Study|Withdrawal by Subject|1|||
163018004|NCT02477332|588770768|FG005|Overall Study|Withdrawal by Subject|0|||
163018005|NCT04657198|588770769|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
163018006|NCT04657198|588770770|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
163018007|NCT04657198|588770771|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
163018008|NCT02977572|588770774|FG000|Overall Study|Exclusion criterion|2|||
163018009|NCT02977572|588770775|FG001|Overall Study|Exclusion criterion|2|||
163018010|NCT01075256|588770778|FG000|Overall Study|Withdrawal by Subject|1|||
163018011|NCT01075256|588770779|FG001|Overall Study|Withdrawal by Subject|0|||
163018012|NCT01075256|588770780|FG002|Overall Study|Withdrawal by Subject|0|||
163018013|NCT03502070|588770781|FG000|Overall Study|Withdrawal by Subject|1|||
163018014|NCT03502070|588770781|FG000|Overall Study|Screen Failure|1|||
163018015|NCT00523848|588770785|FG000|Overall Study|Adverse Event|11|||
163018016|NCT00523848|588770785|FG000|Overall Study|Withdrawal by Subject|2|||
163018017|NCT00523848|588770785|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
163018018|NCT00523848|588770785|FG000|Overall Study|Disease Progression|5|||
163018019|NCT00523848|588770785|FG000|Overall Study|Other, unspecified|4|||
163018020|NCT00086619|588770787|FG000|Overall Study|Withdrawal by Subject|6|||
163018021|NCT00086619|588770788|FG001|Overall Study|Withdrawal by Subject|6|||
163018022|NCT00086619|588770787|FG000|Overall Study|Adverse Event|8|||
163018023|NCT00086619|588770788|FG001|Overall Study|Adverse Event|10|||
163018024|NCT00086619|588770787|FG000|Overall Study|Protocol Violation|1|||
163018025|NCT00086619|588770788|FG001|Overall Study|Protocol Violation|1|||
163018026|NCT00489918|588770789|FG000|Overall Study|Withdrawal by Subject|2|||
163018027|NCT00489918|588770790|FG001|Overall Study|Withdrawal by Subject|1|||
163018028|NCT00489918|588770791|FG002|Overall Study|Withdrawal by Subject|1|||
163018029|NCT00489918|588770792|FG003|Overall Study|Withdrawal by Subject|0|||
163018030|NCT00489918|588770793|FG004|Overall Study|Withdrawal by Subject|1|||
163018031|NCT00489918|588770789|FG000|Overall Study|Adverse Event|0|||
163018032|NCT00489918|588770790|FG001|Overall Study|Adverse Event|1|||
163018033|NCT00489918|588770791|FG002|Overall Study|Adverse Event|1|||
163018034|NCT00489918|588770792|FG003|Overall Study|Adverse Event|0|||
163018035|NCT00489918|588770793|FG004|Overall Study|Adverse Event|0|||
163018036|NCT00489918|588770789|FG000|Overall Study|Lost to Follow-up|0|||
163215834|NCT01641692|589503917|FG002|Treatment Period 3|Adverse Event|0|||
163215835|NCT01641692|589503918|FG003|Treatment Period 3|Adverse Event|0|||
163215836|NCT01641692|589503919|FG004|Treatment Period 3|Adverse Event|0|||
163215837|NCT01641692|589503920|FG005|Treatment Period 3|Adverse Event|0|||
163215838|NCT01641692|589503921|FG006|Treatment Period 3|Adverse Event|1|||
163328802|NCT02386098|589914852|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
163328803|NCT02386098|589914853|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
163018037|NCT00489918|588770790|FG001|Overall Study|Lost to Follow-up|0|||
163018038|NCT00489918|588770791|FG002|Overall Study|Lost to Follow-up|1|||
163018039|NCT00489918|588770792|FG003|Overall Study|Lost to Follow-up|1|||
163018040|NCT00489918|588770793|FG004|Overall Study|Lost to Follow-up|0|||
163215839|NCT01641692|589503922|FG007|Treatment Period 3|Adverse Event|0|||
163215840|NCT01641692|589503915|FG000|Treatment Period 3|Protocol Violation|0|||
163215841|NCT01641692|589503916|FG001|Treatment Period 3|Protocol Violation|0|||
163215842|NCT01641692|589503917|FG002|Treatment Period 3|Protocol Violation|1|||
163215843|NCT01641692|589503918|FG003|Treatment Period 3|Protocol Violation|0|||
163215844|NCT01641692|589503919|FG004|Treatment Period 3|Protocol Violation|0|||
163215845|NCT01641692|589503920|FG005|Treatment Period 3|Protocol Violation|0|||
163215846|NCT01641692|589503921|FG006|Treatment Period 3|Protocol Violation|0|||
163215847|NCT01641692|589503922|FG007|Treatment Period 3|Protocol Violation|0|||
163215848|NCT01641692|589503915|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
163215849|NCT01641692|589503916|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
163215850|NCT01641692|589503917|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
163215851|NCT01641692|589503918|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
163215852|NCT01641692|589503919|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
163215853|NCT01641692|589503920|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
163215854|NCT01641692|589503921|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
163215855|NCT01641692|589503922|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
163018041|NCT00489918|588770789|FG000|Overall Study|Physician Decision|0|||
163018042|NCT00489918|588770790|FG001|Overall Study|Physician Decision|0|||
163018043|NCT00489918|588770791|FG002|Overall Study|Physician Decision|1|||
163018044|NCT00489918|588770792|FG003|Overall Study|Physician Decision|0|||
163018045|NCT00489918|588770793|FG004|Overall Study|Physician Decision|0|||
163018046|NCT02748213|588770794|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
163018047|NCT02748213|588770795|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
163018048|NCT02748213|588770794|FG000|Overall Study|Abnormal Laboratory Test|1|||
163018049|NCT02748213|588770795|FG001|Overall Study|Abnormal Laboratory Test|0|||
163018050|NCT02748213|588770794|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
163018051|NCT02748213|588770795|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
163018052|NCT02748213|588770794|FG000|Overall Study|Death|5|||
163018053|NCT02748213|588770795|FG001|Overall Study|Death|3|||
163018054|NCT02748213|588770794|FG000|Overall Study|Insufficient Therapeutic Response|56|||
163018055|NCT02748213|588770795|FG001|Overall Study|Insufficient Therapeutic Response|57|||
163018056|NCT02748213|588770794|FG000|Overall Study|Violation of Selection Criteria|2|||
163018057|NCT02748213|588770795|FG001|Overall Study|Violation of Selection Criteria|0|||
163018058|NCT02748213|588770794|FG000|Overall Study|Protocol Violation|6|||
163018059|NCT02748213|588770795|FG001|Overall Study|Protocol Violation|4|||
163018060|NCT02748213|588770794|FG000|Overall Study|Refused Treatment*|6|||
163018061|NCT02748213|588770795|FG001|Overall Study|Refused Treatment*|6|||
163018062|NCT02748213|588770794|FG000|Overall Study|Failure to Return|1|||
163018063|NCT02748213|588770795|FG001|Overall Study|Failure to Return|0|||
163018064|NCT02748213|588770794|FG000|Overall Study|Other|30|||
163018065|NCT02748213|588770795|FG001|Overall Study|Other|29|||
163018066|NCT01209520|588770799|FG000|Overall Study|Withdrawal by Subject|3|||
163018067|NCT03291431|588770800|FG000|Overall Study|Protocol Violation|2|||
163018068|NCT03291431|588770801|FG001|Overall Study|Protocol Violation|1|||
163018069|NCT03291431|588770800|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
163018070|NCT03291431|588770801|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
163018071|NCT03291431|588770800|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
163063089|NCT03965923|588938582|FG011|Overall Study|Death|0|||
163063090|NCT03965923|588938571|FG000|Overall Study|Other reason|0|||
163063091|NCT03965923|588938572|FG001|Overall Study|Other reason|0|||
163404998|NCT00001379|590193485|FG000|Initial Treatment|Refused further treatment|2|||
163404999|NCT00001379|590193486|FG001|Initial Treatment|Refused further treatment|0|||
163405000|NCT00001379|590193487|FG002|Initial Treatment|Refused further treatment|0|||
163405001|NCT00001379|590193488|FG003|Initial Treatment|Refused further treatment|0|||
163405002|NCT00001379|590193485|FG000|Initial Treatment|Did not receive protocol treatment|0|||
163405003|NCT00001379|590193486|FG001|Initial Treatment|Did not receive protocol treatment|0|||
163405004|NCT00001379|590193487|FG002|Initial Treatment|Did not receive protocol treatment|5|||
163405005|NCT00001379|590193488|FG003|Initial Treatment|Did not receive protocol treatment|0|||
163405006|NCT00001379|590193485|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
163405007|NCT00001379|590193486|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
163405008|NCT00001379|590193487|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
163405009|NCT00001379|590193488|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
163405010|NCT00001379|590193485|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
163405011|NCT00001379|590193486|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
163405012|NCT00001379|590193487|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
163405013|NCT00001379|590193488|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
163405014|NCT00001379|590193485|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
163405015|NCT00001379|590193486|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
163405016|NCT00001379|590193487|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
163405017|NCT00001379|590193488|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
163405018|NCT00001379|590193485|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
163405019|NCT00001379|590193486|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
163405020|NCT00001379|590193487|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
163405021|NCT00001379|590193488|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
163405022|NCT00001379|590193485|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
163405023|NCT00001379|590193486|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
163063092|NCT03965923|588938573|FG002|Overall Study|Other reason|0|||
163063093|NCT03965923|588938574|FG003|Overall Study|Other reason|1|||
163018072|NCT03291431|588770801|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
163018073|NCT03850483|588770802|FG000|Treatment for Stage 1|Adverse Event|1|||
163018074|NCT03850483|588770803|FG001|Treatment for Stage 1|Adverse Event|1|||
163063094|NCT03965923|588938575|FG004|Overall Study|Other reason|0|||
163063095|NCT03965923|588938576|FG005|Overall Study|Other reason|0|||
163063096|NCT03965923|588938577|FG006|Overall Study|Other reason|0|||
163063097|NCT03965923|588938578|FG007|Overall Study|Other reason|0|||
163063098|NCT03965923|588938579|FG008|Overall Study|Other reason|0|||
163063099|NCT03965923|588938580|FG009|Overall Study|Other reason|0|||
163063100|NCT03965923|588938581|FG010|Overall Study|Other reason|2|||
163063101|NCT03965923|588938582|FG011|Overall Study|Other reason|0|||
163063102|NCT00207740|588938583|FG000|Overall Study|Adverse Event|4|||
163063103|NCT00207740|588938584|FG001|Overall Study|Adverse Event|14|||
163063104|NCT00207740|588938585|FG002|Overall Study|Adverse Event|14|||
163063105|NCT00207740|588938586|FG003|Overall Study|Adverse Event|11|||
163063106|NCT00207740|588938583|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163063107|NCT00207740|588938584|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163063108|NCT00207740|588938585|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
163328804|NCT02386098|589914854|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
163328805|NCT02386098|589914850|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
163328806|NCT02386098|589914851|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
163328807|NCT02386098|589914852|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
163328808|NCT02386098|589914853|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
163328809|NCT02386098|589914854|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
163328810|NCT02386098|589914850|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
163328811|NCT02386098|589914851|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
163328812|NCT02386098|589914852|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
163328813|NCT02386098|589914853|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
163328814|NCT02386098|589914854|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
163328815|NCT02386098|589914850|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
163328816|NCT02386098|589914851|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
163328817|NCT02386098|589914852|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
163328818|NCT02386098|589914853|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
163328819|NCT02386098|589914854|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
163328820|NCT02386098|589914850|FG000|Stage 1 (96 Weeks)|Other|1|||
163328821|NCT02386098|589914851|FG001|Stage 1 (96 Weeks)|Other|0|||
163328822|NCT02386098|589914852|FG002|Stage 1 (96 Weeks)|Other|0|||
163328823|NCT02386098|589914853|FG003|Stage 1 (96 Weeks)|Other|0|||
163328824|NCT02386098|589914854|FG004|Stage 1 (96 Weeks)|Other|0|||
163328825|NCT02386098|589914850|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
163328826|NCT02386098|589914851|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
163328827|NCT02386098|589914852|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
163328828|NCT02386098|589914853|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
163328829|NCT02386098|589914854|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
163328830|NCT02702843|589914855|FG000|Overall Study|Insufficient data to analyze|15|||
163328831|NCT02702843|589914856|FG001|Overall Study|Insufficient data to analyze|23|||
163328832|NCT05029284|589914859|FG000|Overall Study|Lost to Follow-up|1|||
163328833|NCT03002194|589914861|FG000|Overall Study|Lost to Follow-up|6|||
163328834|NCT03002194|589914861|FG000|Overall Study|Adverse Event|1|||
163328835|NCT03002194|589914861|FG000|Overall Study|Lack of Efficacy|1|||
163328836|NCT03002194|589914861|FG000|Overall Study|Withdrawal by Subject|2|||
163328837|NCT02232737|589914862|FG000|Overall Study|Lost to Follow-up|18|||
163328838|NCT02232737|589914863|FG001|Overall Study|Lost to Follow-up|28|||
163328839|NCT02232737|589914864|FG002|Overall Study|Lost to Follow-up|33|||
163328840|NCT02232737|589914862|FG000|Overall Study|Personal reasons|7|||
163328841|NCT02232737|589914863|FG001|Overall Study|Personal reasons|8|||
163328842|NCT02232737|589914864|FG002|Overall Study|Personal reasons|14|||
163328843|NCT02232737|589914862|FG000|Overall Study|Adverse Event|6|||
163328844|NCT02232737|589914863|FG001|Overall Study|Adverse Event|3|||
163328845|NCT02232737|589914864|FG002|Overall Study|Adverse Event|8|||
163328846|NCT02232737|589914862|FG000|Overall Study|Incarcerated|2|||
163328847|NCT02232737|589914863|FG001|Overall Study|Incarcerated|1|||
163328848|NCT02232737|589914864|FG002|Overall Study|Incarcerated|2|||
163328849|NCT02232737|589914862|FG000|Overall Study|Withdrawal by Subject|0|||
163328850|NCT02232737|589914863|FG001|Overall Study|Withdrawal by Subject|1|||
163328851|NCT02232737|589914864|FG002|Overall Study|Withdrawal by Subject|2|||
163328852|NCT02232737|589914862|FG000|Overall Study|Death|0|||
163328853|NCT02232737|589914863|FG001|Overall Study|Death|1|||
163328854|NCT02232737|589914864|FG002|Overall Study|Death|1|||
163328855|NCT02232737|589914862|FG000|Overall Study|Physician Decision|1|||
163328856|NCT02232737|589914863|FG001|Overall Study|Physician Decision|3|||
163328857|NCT02232737|589914864|FG002|Overall Study|Physician Decision|1|||
163328858|NCT02232737|589914862|FG000|Overall Study|Protocol Violation|1|||
163328859|NCT02232737|589914863|FG001|Overall Study|Protocol Violation|0|||
163328860|NCT02232737|589914864|FG002|Overall Study|Protocol Violation|1|||
163328861|NCT02232737|589914862|FG000|Overall Study|Reason unknown|1|||
163063109|NCT00207740|588938586|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
163328862|NCT02232737|589914863|FG001|Overall Study|Reason unknown|0|||
163328863|NCT02232737|589914864|FG002|Overall Study|Reason unknown|0|||
163328864|NCT02200705|589914867|FG000|Overall Study|Excluded|12|||
163328865|NCT02200705|589914867|FG000|Overall Study|Death|21|||
163328866|NCT02200705|589914867|FG000|Overall Study|Withdrawal by Subject|22|||
163063110|NCT00207740|588938583|FG000|Overall Study|Lost to Follow-up|0|||
163063111|NCT00207740|588938584|FG001|Overall Study|Lost to Follow-up|2|||
163063112|NCT00207740|588938585|FG002|Overall Study|Lost to Follow-up|1|||
163063113|NCT00207740|588938586|FG003|Overall Study|Lost to Follow-up|1|||
163328867|NCT02200705|589914867|FG000|Overall Study|Lost to Follow-up|13|||
163328868|NCT02200705|589914867|FG000|Overall Study|Physician Decision|5|||
163328869|NCT02200705|589914867|FG000|Overall Study|Adverse Event|2|||
163328870|NCT03116464|589914872|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
163328871|NCT00065182|589914881|FG000|Overall Study|Adverse Event|24|||
163328872|NCT00065182|589914882|FG001|Overall Study|Adverse Event|17|||
163328873|NCT00065182|589914881|FG000|Overall Study|Lost to Follow-up|0|||
163328874|NCT00065182|589914882|FG001|Overall Study|Lost to Follow-up|4|||
163328875|NCT00065182|589914881|FG000|Overall Study|Protocol Violation|3|||
163328876|NCT00065182|589914882|FG001|Overall Study|Protocol Violation|4|||
163328877|NCT00065182|589914881|FG000|Overall Study|Serious adverse events (SAE)|1|||
163328878|NCT00065182|589914882|FG001|Overall Study|Serious adverse events (SAE)|0|||
163328879|NCT00065182|589914881|FG000|Overall Study|Sponsor Decision|11|||
163328880|NCT00065182|589914882|FG001|Overall Study|Sponsor Decision|7|||
163328881|NCT00065182|589914881|FG000|Overall Study|Withdrawal by Subject|8|||
163328882|NCT00065182|589914882|FG001|Overall Study|Withdrawal by Subject|3|||
163328883|NCT00065182|589914881|FG000|Overall Study|No clinical benefit|1|||
163328884|NCT00065182|589914882|FG001|Overall Study|No clinical benefit|0|||
163328885|NCT00065182|589914881|FG000|Overall Study|Death|0|||
163328886|NCT00065182|589914882|FG001|Overall Study|Death|1|||
163328887|NCT00065182|589914881|FG000|Overall Study|Decline in Status|0|||
163328888|NCT00065182|589914882|FG001|Overall Study|Decline in Status|1|||
163328889|NCT02633215|589914883|FG000|Overall Study|Lost to Follow-up|2|||
163328890|NCT02633215|589914884|FG001|Overall Study|Lost to Follow-up|3|||
163328891|NCT02568215|589914885|FG000|Overall Study|Death|1|||
163328892|NCT02568215|589914886|FG001|Overall Study|Death|2|||
163328893|NCT02568215|589914887|FG002|Overall Study|Death|0|||
163328894|NCT02568215|589914885|FG000|Overall Study|Physician Decision|2|||
163328895|NCT02568215|589914886|FG001|Overall Study|Physician Decision|2|||
163328896|NCT02568215|589914887|FG002|Overall Study|Physician Decision|2|||
163328897|NCT02568215|589914885|FG000|Overall Study|Lost to Follow-up|29|||
163328898|NCT02568215|589914886|FG001|Overall Study|Lost to Follow-up|32|||
163328899|NCT02568215|589914887|FG002|Overall Study|Lost to Follow-up|41|||
163328900|NCT02568215|589914885|FG000|Overall Study|Withdrawal by Subject|21|||
163328901|NCT02568215|589914886|FG001|Overall Study|Withdrawal by Subject|19|||
163328902|NCT02568215|589914887|FG002|Overall Study|Withdrawal by Subject|22|||
163328903|NCT02568215|589914885|FG000|Overall Study|Protocol Violation|1|||
163328904|NCT02568215|589914886|FG001|Overall Study|Protocol Violation|1|||
163328905|NCT02568215|589914887|FG002|Overall Study|Protocol Violation|0|||
163328906|NCT02568215|589914885|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
163328907|NCT02568215|589914886|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
163328908|NCT02568215|589914887|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
163328909|NCT02568215|589914885|FG000|Overall Study|Other|0|||
163328910|NCT02568215|589914886|FG001|Overall Study|Other|1|||
163328911|NCT02568215|589914887|FG002|Overall Study|Other|4|||
163328912|NCT01641900|589914888|FG000|Overall Study|Withdrawal by Subject|2|||
163328913|NCT01641900|589914889|FG001|Overall Study|Withdrawal by Subject|2|||
163328914|NCT00263757|589914890|FG000|Overall Study|Withdrawal by Subject|5|||
163328915|NCT00263757|589914891|FG001|Overall Study|Withdrawal by Subject|4|||
163328916|NCT00263757|589914890|FG000|Overall Study|Screen failure|0|||
163328917|NCT00263757|589914891|FG001|Overall Study|Screen failure|1|||
163328918|NCT00263757|589914890|FG000|Overall Study|Adverse Event|3|||
163328919|NCT00263757|589914891|FG001|Overall Study|Adverse Event|3|||
163328920|NCT00713596|589914892|FG000|Overall Study|Study was terminated|2|||
163328921|NCT00713596|589914893|FG001|Overall Study|Study was terminated|3|||
163328922|NCT00713596|589914894|FG002|Overall Study|Study was terminated|2|||
163328923|NCT03712371|589914895|FG000|Overall Study|Lack of Efficacy|0|||
163405024|NCT00001379|590193487|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
163405025|NCT00001379|590193488|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
163405026|NCT00264875|590193491|FG000|Overall Study|Adverse Event|6|||
163328924|NCT03712371|589914896|FG001|Overall Study|Lack of Efficacy|0|||
163328925|NCT03712371|589914897|FG002|Overall Study|Lack of Efficacy|0|||
163328926|NCT03712371|589914898|FG003|Overall Study|Lack of Efficacy|1|||
163328927|NCT01211184|589914903|FG000|Overall Study|Withdrawal by Subject|0|||
163328928|NCT01211184|589914904|FG001|Overall Study|Withdrawal by Subject|2|||
163328929|NCT01211184|589914905|FG002|Overall Study|Withdrawal by Subject|1|||
163328930|NCT01421667|589914906|FG000|Overall Study|Withdrawal by Subject|0|||
163328931|NCT01421667|589914907|FG001|Overall Study|Withdrawal by Subject|1|||
163328932|NCT01421667|589914908|FG002|Overall Study|Withdrawal by Subject|2|||
163328933|NCT01421667|589914909|FG003|Overall Study|Withdrawal by Subject|1|||
163328934|NCT01421667|589914906|FG000|Overall Study|Lost to Follow-up|0|||
163328935|NCT01421667|589914907|FG001|Overall Study|Lost to Follow-up|1|||
163328936|NCT01421667|589914908|FG002|Overall Study|Lost to Follow-up|0|||
163328937|NCT01421667|589914909|FG003|Overall Study|Lost to Follow-up|0|||
163405027|NCT00264875|590193491|FG000|Overall Study|Lost to Follow-up|6|||
163405028|NCT00264875|590193491|FG000|Overall Study|Protocol Violation|11|||
163405029|NCT00264875|590193491|FG000|Overall Study|Withdrawal by Subject|7|||
163405030|NCT00143312|590193494|FG000|Overall Study|Death|11|||
163405031|NCT00143312|590193494|FG000|Overall Study|Adverse Event|2|||
163405032|NCT00143312|590193494|FG000|Overall Study|Lost to Follow-up|1|||
163405033|NCT00143312|590193494|FG000|Overall Study|Other|1|||
163405034|NCT00143312|590193494|FG000|Overall Study|Withdrawal by Subject|1|||
163405035|NCT00607386|590193495|FG000|Overall Study|Physician Decision|1|||
163405036|NCT00446511|590193498|FG000|Overall Study|Adverse Event|7|||
163405037|NCT00446511|590193499|FG001|Overall Study|Adverse Event|2|||
163405038|NCT00446511|590193500|FG002|Overall Study|Adverse Event|3|||
163405039|NCT00446511|590193501|FG003|Overall Study|Adverse Event|1|||
163405040|NCT00446511|590193498|FG000|Overall Study|Protocol Violation|0|||
163405041|NCT00446511|590193499|FG001|Overall Study|Protocol Violation|0|||
163405042|NCT00446511|590193500|FG002|Overall Study|Protocol Violation|0|||
163405043|NCT00446511|590193501|FG003|Overall Study|Protocol Violation|1|||
163405044|NCT00446511|590193498|FG000|Overall Study|Withdrawal by Subject|0|||
163405045|NCT00446511|590193499|FG001|Overall Study|Withdrawal by Subject|0|||
163405046|NCT00446511|590193500|FG002|Overall Study|Withdrawal by Subject|0|||
163405047|NCT00446511|590193501|FG003|Overall Study|Withdrawal by Subject|3|||
163405048|NCT00446511|590193498|FG000|Overall Study|Administrative Problems|3|||
163405049|NCT00446511|590193499|FG001|Overall Study|Administrative Problems|0|||
163405050|NCT00446511|590193500|FG002|Overall Study|Administrative Problems|4|||
163405051|NCT00446511|590193501|FG003|Overall Study|Administrative Problems|1|||
163405052|NCT01073267|590193502|FG000|Overall Study|Disease Progression|3|||
163405053|NCT02970292|590193503|FG000|Overall Study|Physician Decision|1|||
163405054|NCT02970292|590193504|FG001|Overall Study|Physician Decision|1|||
163405055|NCT02970292|590193503|FG000|Overall Study|Withdrawal by Subject|11|||
163405056|NCT02970292|590193504|FG001|Overall Study|Withdrawal by Subject|5|||
163405057|NCT02970292|590193503|FG000|Overall Study|Noncompliance with study drug|2|||
163405058|NCT02970292|590193504|FG001|Overall Study|Noncompliance with study drug|2|||
163405059|NCT02970292|590193503|FG000|Overall Study|Adverse Event|5|||
163405060|NCT02970292|590193504|FG001|Overall Study|Adverse Event|0|||
163405061|NCT02970292|590193503|FG000|Overall Study|Lack of Efficacy|1|||
163405062|NCT02970292|590193504|FG001|Overall Study|Lack of Efficacy|0|||
163405063|NCT02970292|590193503|FG000|Overall Study|Lost to Follow-up|1|||
163405064|NCT02970292|590193504|FG001|Overall Study|Lost to Follow-up|0|||
163405065|NCT02970292|590193503|FG000|Overall Study|Protocol Violation|2|||
163405066|NCT02970292|590193504|FG001|Overall Study|Protocol Violation|0|||
163405067|NCT02970292|590193503|FG000|Overall Study|Other|1|||
163405068|NCT02970292|590193504|FG001|Overall Study|Other|0|||
163405069|NCT00814892|590193505|FG000|Overall Study|Disease Progression|1|||
163405070|NCT00814892|590193505|FG000|Overall Study|Study Termination|1|||
163405071|NCT00531752|590193509|FG000|First Double-blind Intervention Period|Adverse Event|2|||
163405072|NCT00531752|590193510|FG001|First Double-blind Intervention Period|Adverse Event|0|||
163405073|NCT00531752|590193511|FG002|First Double-blind Intervention Period|Adverse Event|1|||
163063114|NCT00207740|588938583|FG000|Overall Study|Death|0|||
163063115|NCT00207740|588938584|FG001|Overall Study|Death|0|||
163063116|NCT00207740|588938585|FG002|Overall Study|Death|0|||
163063117|NCT00207740|588938586|FG003|Overall Study|Death|1|||
163063118|NCT00207740|588938583|FG000|Overall Study|Sponsor Directive|22|||
163063119|NCT00207740|588938584|FG001|Overall Study|Sponsor Directive|15|||
163063120|NCT00207740|588938585|FG002|Overall Study|Sponsor Directive|16|||
163063121|NCT00207740|588938586|FG003|Overall Study|Sponsor Directive|21|||
163405074|NCT00531752|590193512|FG003|First Double-blind Intervention Period|Adverse Event|1|||
163018075|NCT03850483|588770804|FG002|Treatment for Stage 1|Adverse Event|3|||
163018076|NCT03850483|588770805|FG003|Treatment for Stage 1|Adverse Event|0|||
163018077|NCT03850483|588770806|FG004|Treatment for Stage 1|Adverse Event|2|||
163018078|NCT03850483|588770807|FG005|Treatment for Stage 1|Adverse Event|0|||
163405075|NCT00531752|590193509|FG000|First Double-blind Intervention Period|Other|1|||
163405076|NCT00531752|590193510|FG001|First Double-blind Intervention Period|Other|4|||
163405077|NCT00531752|590193511|FG002|First Double-blind Intervention Period|Other|4|||
163405078|NCT00531752|590193512|FG003|First Double-blind Intervention Period|Other|0|||
163405079|NCT00531752|590193509|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
163405080|NCT00531752|590193510|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
163405081|NCT00531752|590193511|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
163405082|NCT00531752|590193512|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
163018079|NCT03850483|588770808|FG006|Treatment for Stage 1|Adverse Event|2|||
163018080|NCT03850483|588770809|FG007|Treatment for Stage 1|Adverse Event|2|||
163018081|NCT03850483|588770810|FG008|Treatment for Stage 1|Adverse Event|0|||
163018082|NCT03850483|588770811|FG009|Treatment for Stage 1|Adverse Event|0|||
163018083|NCT03850483|588770802|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
163018084|NCT03850483|588770803|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
163018085|NCT03850483|588770804|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
163063122|NCT00207740|588938583|FG000|Overall Study|Other|2|||
163405083|NCT00531752|590193509|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
163405084|NCT00531752|590193510|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
163405085|NCT00531752|590193511|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
163018086|NCT03850483|588770805|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
163018087|NCT03850483|588770806|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
163018088|NCT03850483|588770807|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
163018089|NCT03850483|588770808|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
163018090|NCT03850483|588770809|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
163018091|NCT03850483|588770810|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
163018092|NCT03850483|588770811|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
163018093|NCT03850483|588770802|FG000|Treatment for Stage 1|Protocol Violation|1|||
163018094|NCT03850483|588770803|FG001|Treatment for Stage 1|Protocol Violation|0|||
163018095|NCT03850483|588770804|FG002|Treatment for Stage 1|Protocol Violation|0|||
163018096|NCT03850483|588770805|FG003|Treatment for Stage 1|Protocol Violation|0|||
163018097|NCT03850483|588770806|FG004|Treatment for Stage 1|Protocol Violation|0|||
163018098|NCT03850483|588770807|FG005|Treatment for Stage 1|Protocol Violation|0|||
163018099|NCT03850483|588770808|FG006|Treatment for Stage 1|Protocol Violation|1|||
163018100|NCT03850483|588770809|FG007|Treatment for Stage 1|Protocol Violation|0|||
163018101|NCT03850483|588770810|FG008|Treatment for Stage 1|Protocol Violation|0|||
163018102|NCT03850483|588770811|FG009|Treatment for Stage 1|Protocol Violation|0|||
163018103|NCT03850483|588770802|FG000|Treatment for Stage 1|Physician Decision|0|||
163018104|NCT03850483|588770803|FG001|Treatment for Stage 1|Physician Decision|0|||
163018105|NCT03850483|588770804|FG002|Treatment for Stage 1|Physician Decision|0|||
163018106|NCT03850483|588770805|FG003|Treatment for Stage 1|Physician Decision|0|||
163018107|NCT03850483|588770806|FG004|Treatment for Stage 1|Physician Decision|0|||
163405086|NCT00531752|590193512|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
163405087|NCT00531752|590193509|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
163405088|NCT00531752|590193510|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
163405089|NCT00531752|590193511|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
163405090|NCT00531752|590193512|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
163405091|NCT00531752|590193509|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
163405092|NCT00531752|590193510|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
163405093|NCT00531752|590193511|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
163405094|NCT00531752|590193512|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
163405095|NCT00531752|590193509|FG000|Second Double-blind Intervention Period|Other|1|||
163405096|NCT00531752|590193510|FG001|Second Double-blind Intervention Period|Other|1|||
163405097|NCT00531752|590193511|FG002|Second Double-blind Intervention Period|Other|0|||
163405098|NCT00531752|590193512|FG003|Second Double-blind Intervention Period|Other|0|||
163405099|NCT00531752|590193509|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
163405100|NCT00531752|590193510|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
163405101|NCT00531752|590193511|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
163405102|NCT00531752|590193512|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
163405103|NCT00531752|590193509|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
163405104|NCT00531752|590193510|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
163405105|NCT00531752|590193511|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
163405106|NCT00531752|590193512|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
163405107|NCT04486950|590193513|FG000|Overall Study|Lost to Follow-up|0|||
163405108|NCT04486950|590193514|FG001|Overall Study|Lost to Follow-up|0|||
163405109|NCT04486950|590193515|FG002|Overall Study|Lost to Follow-up|0|||
163405110|NCT04486950|590193516|FG003|Overall Study|Lost to Follow-up|0|||
163405111|NCT04486950|590193517|FG004|Overall Study|Lost to Follow-up|0|||
163405112|NCT04486950|590193518|FG005|Overall Study|Lost to Follow-up|1|||
163405113|NCT04486950|590193519|FG006|Overall Study|Lost to Follow-up|0|||
163405114|NCT02821715|590193520|FG000|Overall Study|Protocol Violation|1|||
163405115|NCT02821715|590193521|FG001|Overall Study|Protocol Violation|0|||
163405116|NCT02821715|590193522|FG002|Overall Study|Protocol Violation|0|||
163405117|NCT02821715|590193523|FG003|Overall Study|Protocol Violation|0|||
163405118|NCT02821715|590193524|FG004|Overall Study|Protocol Violation|0|||
163405119|NCT02821715|590193525|FG005|Overall Study|Protocol Violation|0|||
163405120|NCT00640328|590193526|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
163405121|NCT00640328|590193527|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
163405122|NCT00640328|590193528|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
163405123|NCT00640328|590193529|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
163405124|NCT00640328|590193530|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
163405125|NCT00640328|590193531|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
163018108|NCT03850483|588770807|FG005|Treatment for Stage 1|Physician Decision|1|||
163405126|NCT00640328|590193526|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
163018109|NCT03850483|588770808|FG006|Treatment for Stage 1|Physician Decision|0|||
163018110|NCT03850483|588770809|FG007|Treatment for Stage 1|Physician Decision|0|||
163018111|NCT03850483|588770810|FG008|Treatment for Stage 1|Physician Decision|0|||
163018112|NCT03850483|588770811|FG009|Treatment for Stage 1|Physician Decision|0|||
163018113|NCT03850483|588770802|FG000|Treatment for Stage 1|Other|0|||
163018114|NCT03850483|588770803|FG001|Treatment for Stage 1|Other|0|||
163018115|NCT03850483|588770804|FG002|Treatment for Stage 1|Other|0|||
163018116|NCT03850483|588770805|FG003|Treatment for Stage 1|Other|0|||
163215856|NCT01641692|589503915|FG000|Treatment Period 3|Lost to Follow-up|0|||
163215857|NCT01641692|589503916|FG001|Treatment Period 3|Lost to Follow-up|1|||
163215858|NCT01641692|589503917|FG002|Treatment Period 3|Lost to Follow-up|0|||
163215859|NCT01641692|589503918|FG003|Treatment Period 3|Lost to Follow-up|0|||
163215860|NCT01641692|589503919|FG004|Treatment Period 3|Lost to Follow-up|0|||
163215861|NCT01641692|589503920|FG005|Treatment Period 3|Lost to Follow-up|0|||
163215862|NCT01641692|589503921|FG006|Treatment Period 3|Lost to Follow-up|0|||
163215863|NCT01641692|589503922|FG007|Treatment Period 3|Lost to Follow-up|0|||
163215864|NCT01641692|589503915|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
163215865|NCT01641692|589503916|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
163215866|NCT01641692|589503917|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
163215867|NCT01641692|589503918|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
163215868|NCT01641692|589503919|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
163215869|NCT01641692|589503920|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
163215870|NCT01641692|589503921|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
163215871|NCT01641692|589503922|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
163215872|NCT01641692|589503915|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
163215873|NCT01641692|589503916|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
163215874|NCT01641692|589503917|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
163215875|NCT01641692|589503918|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
163215876|NCT01641692|589503919|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
163215877|NCT01641692|589503920|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
163215878|NCT01641692|589503921|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
163215879|NCT01641692|589503922|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
163215880|NCT01166178|589503923|FG000|Overall Study|Withdrawal by Subject|1|||
163215881|NCT01166178|589503924|FG001|Overall Study|Withdrawal by Subject|0|||
163215882|NCT01166178|589503923|FG000|Overall Study|Study was terminated|20|||
163215883|NCT01166178|589503924|FG001|Overall Study|Study was terminated|8|||
163328938|NCT00503906|589914910|FG000|Overall Study|Withdrawal by Subject|1|||
163328939|NCT05580003|589914911|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328940|NCT05580003|589914912|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328941|NCT05580003|589914913|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328942|NCT05580003|589914914|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328943|NCT05580003|589914915|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328944|NCT05580003|589914916|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328945|NCT05580003|589914917|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
163328946|NCT05580003|589914918|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328947|NCT05580003|589914919|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328948|NCT05580003|589914920|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328949|NCT05580003|589914921|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328950|NCT05580003|589914922|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328951|NCT05580003|589914923|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328952|NCT05580003|589914924|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328953|NCT05580003|589914925|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328954|NCT05580003|589914926|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328955|NCT05580003|589914927|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328956|NCT05580003|589914928|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328957|NCT05580003|589914929|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328958|NCT05580003|589914930|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328959|NCT05580003|589914931|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328960|NCT05580003|589914932|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328961|NCT05580003|589914933|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328962|NCT05580003|589914934|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328963|NCT05580003|589914935|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328964|NCT05580003|589914936|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163405127|NCT00640328|590193527|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
163018117|NCT03850483|588770806|FG004|Treatment for Stage 1|Other|2|||
163018118|NCT03850483|588770807|FG005|Treatment for Stage 1|Other|1|||
163018119|NCT03850483|588770808|FG006|Treatment for Stage 1|Other|0|||
163215884|NCT04948450|589503925|FG000|Overall Study|Return home|1|||
163018120|NCT03850483|588770809|FG007|Treatment for Stage 1|Other|0|||
163215885|NCT04948450|589503926|FG001|Overall Study|Return home|3|||
163215886|NCT01173718|589503937|FG000|Overall Study|Death|17|||
163215887|NCT01173718|589503937|FG000|Overall Study|Abandonment of study graft|27|||
163018121|NCT03850483|588770810|FG008|Treatment for Stage 1|Other|0|||
163018122|NCT03850483|588770811|FG009|Treatment for Stage 1|Other|0|||
163018123|NCT03850483|588770802|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163405128|NCT00640328|590193528|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
163405129|NCT00640328|590193529|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
163405130|NCT00640328|590193530|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
163405131|NCT00640328|590193531|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
163405132|NCT00640328|590193526|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
163405133|NCT00640328|590193527|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
163405134|NCT00640328|590193528|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
163405135|NCT00640328|590193529|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
163405136|NCT00640328|590193530|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
163405137|NCT00640328|590193531|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
163405138|NCT00640328|590193526|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
163405139|NCT00640328|590193527|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
163405140|NCT00640328|590193528|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
163405141|NCT00640328|590193529|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
163405142|NCT00640328|590193530|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
163405143|NCT00640328|590193531|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
163405144|NCT02374099|590193534|FG000|Overall Study|Adverse Event|1|||
163405145|NCT02374099|590193535|FG001|Overall Study|Adverse Event|0|||
163405146|NCT02374099|590193534|FG000|Overall Study|Progressive Disease|35|||
163405147|NCT02374099|590193535|FG001|Overall Study|Progressive Disease|40|||
163405148|NCT02374099|590193534|FG000|Overall Study|Withdrawal by Subject|5|||
163405149|NCT02374099|590193535|FG001|Overall Study|Withdrawal by Subject|1|||
163405150|NCT02374099|590193534|FG000|Overall Study|Miscellaneous|2|||
163405151|NCT02374099|590193535|FG001|Overall Study|Miscellaneous|3|||
163405152|NCT02374099|590193534|FG000|Overall Study|Randomized, but not treated|2|||
163405153|NCT02374099|590193535|FG001|Overall Study|Randomized, but not treated|1|||
163405154|NCT02374099|590193534|FG000|Overall Study|Study Terminated by Sponsor|3|||
163405155|NCT02374099|590193535|FG001|Overall Study|Study Terminated by Sponsor|4|||
163405156|NCT01033825|590193536|FG000|Overall Study|Withdrawal by Subject|2|||
163405157|NCT01033825|590193537|FG001|Overall Study|Withdrawal by Subject|3|||
163405158|NCT01033825|590193538|FG002|Overall Study|Withdrawal by Subject|2|||
163405159|NCT01033825|590193539|FG003|Overall Study|Withdrawal by Subject|1|||
163405160|NCT01033825|590193540|FG004|Overall Study|Withdrawal by Subject|1|||
163405161|NCT01033825|590193541|FG005|Overall Study|Withdrawal by Subject|0|||
163405162|NCT01033825|590193542|FG006|Overall Study|Withdrawal by Subject|0|||
163405163|NCT01033825|590193536|FG000|Overall Study|Adverse Event|0|||
163405164|NCT01033825|590193537|FG001|Overall Study|Adverse Event|0|||
163018124|NCT03850483|588770803|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018125|NCT03850483|588770804|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
163018126|NCT03850483|588770805|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018127|NCT03850483|588770806|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018128|NCT03850483|588770807|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018129|NCT03850483|588770808|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018130|NCT03850483|588770809|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018131|NCT03850483|588770810|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018132|NCT03850483|588770811|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018133|NCT03850483|588770802|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018134|NCT03850483|588770803|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018135|NCT03850483|588770804|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018136|NCT03850483|588770805|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018137|NCT03850483|588770806|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018138|NCT03850483|588770807|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
163018139|NCT03850483|588770808|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018140|NCT03850483|588770809|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018141|NCT03850483|588770810|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018142|NCT03850483|588770811|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018143|NCT03850483|588770802|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
163018144|NCT03850483|588770803|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
163018145|NCT03850483|588770804|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
163405165|NCT01033825|590193538|FG002|Overall Study|Adverse Event|0|||
163405166|NCT01033825|590193539|FG003|Overall Study|Adverse Event|1|||
163018146|NCT03850483|588770805|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
163018147|NCT03850483|588770806|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
163405167|NCT01033825|590193540|FG004|Overall Study|Adverse Event|0|||
163405168|NCT01033825|590193541|FG005|Overall Study|Adverse Event|0|||
163405169|NCT01033825|590193542|FG006|Overall Study|Adverse Event|0|||
163215888|NCT02738151|589503938|FG000|Overall Study|Randomized but not treated|4|||
163215889|NCT02738151|589503939|FG001|Overall Study|Randomized but not treated|1|||
163215890|NCT02738151|589503938|FG000|Overall Study|Adverse Event|4|||
163215891|NCT02738151|589503939|FG001|Overall Study|Adverse Event|5|||
163215892|NCT02738151|589503938|FG000|Overall Study|Hypoglycemia|0|||
163215893|NCT02738151|589503939|FG001|Overall Study|Hypoglycemia|1|||
163215894|NCT02738151|589503938|FG000|Overall Study|Poor Compliance to Protocol|4|||
163215895|NCT02738151|589503939|FG001|Overall Study|Poor Compliance to Protocol|3|||
163328965|NCT05580003|589914937|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328966|NCT05580003|589914938|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163328967|NCT05580003|589914911|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328968|NCT05580003|589914912|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163018148|NCT03850483|588770807|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
163018149|NCT03850483|588770808|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
163018150|NCT03850483|588770809|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
163018151|NCT03850483|588770810|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
163018152|NCT03850483|588770811|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
163018153|NCT03850483|588770802|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
163018154|NCT03850483|588770803|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
163018155|NCT03850483|588770804|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
163018156|NCT03850483|588770805|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
163018157|NCT03850483|588770806|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
163018158|NCT03850483|588770807|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
163018159|NCT03850483|588770808|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
163018160|NCT03850483|588770809|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
163018161|NCT03850483|588770810|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
163018162|NCT03850483|588770811|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
163018163|NCT03850483|588770802|FG000|Treatment for Stage 1|Death|0|||
163328969|NCT05580003|589914913|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328970|NCT05580003|589914914|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163018164|NCT03850483|588770803|FG001|Treatment for Stage 1|Death|0|||
163018165|NCT03850483|588770804|FG002|Treatment for Stage 1|Death|0|||
163018166|NCT03850483|588770805|FG003|Treatment for Stage 1|Death|0|||
163018167|NCT03850483|588770806|FG004|Treatment for Stage 1|Death|0|||
163018168|NCT03850483|588770807|FG005|Treatment for Stage 1|Death|1|||
163018169|NCT03850483|588770808|FG006|Treatment for Stage 1|Death|0|||
163018170|NCT03850483|588770809|FG007|Treatment for Stage 1|Death|0|||
163018171|NCT03850483|588770810|FG008|Treatment for Stage 1|Death|0|||
163018172|NCT03850483|588770811|FG009|Treatment for Stage 1|Death|0|||
163018173|NCT03850483|588770802|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
163018174|NCT03850483|588770803|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
163018175|NCT03850483|588770804|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
163018176|NCT03850483|588770805|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
163018177|NCT03850483|588770806|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
163018178|NCT03850483|588770807|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
163018179|NCT03850483|588770808|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
163018180|NCT03850483|588770809|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
163018181|NCT03850483|588770810|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
163018182|NCT03850483|588770811|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
163018183|NCT03850483|588770802|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
163018184|NCT03850483|588770803|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
163018185|NCT03850483|588770804|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
163018186|NCT03850483|588770805|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
163018187|NCT03850483|588770806|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
163018188|NCT03850483|588770807|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
163018189|NCT03850483|588770808|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
163018190|NCT03850483|588770809|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
163018191|NCT03850483|588770810|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
163018192|NCT03850483|588770811|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
163018193|NCT03850483|588770802|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
163018194|NCT03850483|588770803|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
163018195|NCT03850483|588770804|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
163215896|NCT02738151|589503938|FG000|Overall Study|Other than specified above|11|||
163018196|NCT03850483|588770805|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
163018197|NCT03850483|588770806|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
163018198|NCT03850483|588770807|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
163018199|NCT03850483|588770808|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
163063123|NCT00207740|588938584|FG001|Overall Study|Other|10|||
163215897|NCT02738151|589503939|FG001|Overall Study|Other than specified above|21|||
163215898|NCT03333044|589503940|FG000|Overall Study|Pregnancy|1|||
163328971|NCT05580003|589914915|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328972|NCT05580003|589914916|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
163328973|NCT05580003|589914917|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163018200|NCT03850483|588770809|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
163018201|NCT03850483|588770810|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
163018202|NCT03850483|588770811|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
163018203|NCT03850483|588770802|FG000|Follow-up for Stage 1|Physician Decision|0|||
163018204|NCT03850483|588770803|FG001|Follow-up for Stage 1|Physician Decision|0|||
163018205|NCT03850483|588770804|FG002|Follow-up for Stage 1|Physician Decision|0|||
163018206|NCT03850483|588770805|FG003|Follow-up for Stage 1|Physician Decision|0|||
163018207|NCT03850483|588770806|FG004|Follow-up for Stage 1|Physician Decision|1|||
163018208|NCT03850483|588770807|FG005|Follow-up for Stage 1|Physician Decision|0|||
163018209|NCT03850483|588770808|FG006|Follow-up for Stage 1|Physician Decision|1|||
163018210|NCT03850483|588770809|FG007|Follow-up for Stage 1|Physician Decision|0|||
163018211|NCT03850483|588770810|FG008|Follow-up for Stage 1|Physician Decision|0|||
163018212|NCT03850483|588770811|FG009|Follow-up for Stage 1|Physician Decision|0|||
163018213|NCT03850483|588770802|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
163018214|NCT03850483|588770803|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
163018215|NCT03850483|588770804|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
163018216|NCT03850483|588770805|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
163018217|NCT03850483|588770806|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
163018218|NCT03850483|588770807|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
163018219|NCT03850483|588770808|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
163018220|NCT03850483|588770809|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
163018221|NCT03850483|588770810|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
163018222|NCT03850483|588770811|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
163018223|NCT03850483|588770802|FG000|Follow-up for Stage 1|Adverse Event|0|||
163018224|NCT03850483|588770803|FG001|Follow-up for Stage 1|Adverse Event|0|||
163018225|NCT03850483|588770804|FG002|Follow-up for Stage 1|Adverse Event|1|||
163018226|NCT03850483|588770805|FG003|Follow-up for Stage 1|Adverse Event|0|||
163018227|NCT03850483|588770806|FG004|Follow-up for Stage 1|Adverse Event|0|||
163018228|NCT03850483|588770807|FG005|Follow-up for Stage 1|Adverse Event|1|||
163018229|NCT03850483|588770808|FG006|Follow-up for Stage 1|Adverse Event|0|||
163018230|NCT03850483|588770809|FG007|Follow-up for Stage 1|Adverse Event|0|||
163018231|NCT03850483|588770810|FG008|Follow-up for Stage 1|Adverse Event|0|||
163018232|NCT03850483|588770811|FG009|Follow-up for Stage 1|Adverse Event|0|||
163018233|NCT03850483|588770802|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
163018234|NCT03850483|588770803|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
163018235|NCT03850483|588770804|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
163018236|NCT03850483|588770805|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
163018237|NCT03850483|588770806|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
163018238|NCT03850483|588770807|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
163018239|NCT03850483|588770808|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
163018240|NCT03850483|588770809|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
163018241|NCT03850483|588770810|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
163018242|NCT03850483|588770811|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
163018243|NCT03850483|588770802|FG000|Follow-up for Stage 1|Other|0|||
163018244|NCT03850483|588770803|FG001|Follow-up for Stage 1|Other|2|||
163018245|NCT03850483|588770804|FG002|Follow-up for Stage 1|Other|0|||
163018246|NCT03850483|588770805|FG003|Follow-up for Stage 1|Other|2|||
163018247|NCT03850483|588770806|FG004|Follow-up for Stage 1|Other|0|||
163018248|NCT03850483|588770807|FG005|Follow-up for Stage 1|Other|1|||
163018249|NCT03850483|588770808|FG006|Follow-up for Stage 1|Other|0|||
163018250|NCT03850483|588770809|FG007|Follow-up for Stage 1|Other|0|||
163018251|NCT03850483|588770810|FG008|Follow-up for Stage 1|Other|0|||
163018252|NCT03850483|588770811|FG009|Follow-up for Stage 1|Other|0|||
163018253|NCT03850483|588770802|FG000|Treatment for Stage 2|Adverse Event|0|||
163018254|NCT03850483|588770803|FG001|Treatment for Stage 2|Adverse Event|0|||
163018255|NCT03850483|588770804|FG002|Treatment for Stage 2|Adverse Event|0|||
163018256|NCT03850483|588770805|FG003|Treatment for Stage 2|Adverse Event|0|||
163018257|NCT03850483|588770806|FG004|Treatment for Stage 2|Adverse Event|0|||
163018258|NCT03850483|588770807|FG005|Treatment for Stage 2|Adverse Event|0|||
163215899|NCT03333044|589503941|FG001|Overall Study|Pregnancy|0|||
163018259|NCT03850483|588770808|FG006|Treatment for Stage 2|Adverse Event|0|||
163018260|NCT03850483|588770809|FG007|Treatment for Stage 2|Adverse Event|0|||
163215900|NCT03333044|589503942|FG002|Overall Study|Pregnancy|0|||
163215901|NCT03333044|589503940|FG000|Overall Study|Lost to Follow-up|0|||
163215902|NCT03333044|589503941|FG001|Overall Study|Lost to Follow-up|14|||
163215903|NCT03333044|589503942|FG002|Overall Study|Lost to Follow-up|6|||
163215904|NCT04007094|589503950|FG000|Overall Study|Lost to Follow-up|1|||
163215905|NCT04007094|589503951|FG001|Overall Study|Lost to Follow-up|1|||
163215906|NCT02921776|589503952|FG000|Overall Study|patient deterioration, fatigue|2|||
163215907|NCT02921776|589503953|FG001|Overall Study|patient deterioration, fatigue|6|||
163215908|NCT02921776|589503954|FG002|Overall Study|patient deterioration, fatigue|0|||
163215909|NCT02921776|589503955|FG003|Overall Study|patient deterioration, fatigue|0|||
163215910|NCT02921776|589503956|FG004|Overall Study|patient deterioration, fatigue|0|||
163215911|NCT02921776|589503957|FG005|Overall Study|patient deterioration, fatigue|0|||
163018261|NCT03850483|588770810|FG008|Treatment for Stage 2|Adverse Event|0|||
163018262|NCT03850483|588770811|FG009|Treatment for Stage 2|Adverse Event|1|||
163018263|NCT03850483|588770802|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
163018264|NCT03850483|588770803|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
163018265|NCT03850483|588770804|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
163018266|NCT03850483|588770805|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
163018267|NCT03850483|588770806|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
163018268|NCT03850483|588770807|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
163018269|NCT03850483|588770808|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
163063124|NCT00207740|588938585|FG002|Overall Study|Other|7|||
163063125|NCT00207740|588938586|FG003|Overall Study|Other|5|||
163063126|NCT03916926|588938587|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
163063127|NCT03916926|588938588|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
163063128|NCT03916926|588938587|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
163063129|NCT03916926|588938588|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
163063130|NCT03916926|588938587|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
163063131|NCT03916926|588938588|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
163063132|NCT03916926|588938587|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
163063133|NCT03916926|588938588|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
163063134|NCT03806296|588938594|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
163063135|NCT03806296|588938595|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
163063136|NCT03806296|588938596|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
163063137|NCT03806296|588938594|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
163063138|NCT03806296|588938595|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
163063139|NCT03806296|588938596|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
163063140|NCT03806296|588938594|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
163063141|NCT03806296|588938595|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
163063142|NCT03806296|588938596|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
163063143|NCT02763566|588938605|FG000|Overall Study|Lost to Follow-up|1|||
163063144|NCT02763566|588938606|FG001|Overall Study|Lost to Follow-up|4|||
163063145|NCT02763566|588938607|FG002|Overall Study|Lost to Follow-up|0|||
163063146|NCT02763566|588938608|FG003|Overall Study|Lost to Follow-up|1|||
163063147|NCT02763566|588938605|FG000|Overall Study|On study treatment at study conclusion|114|||
163063148|NCT02763566|588938606|FG001|Overall Study|On study treatment at study conclusion|34|||
163063149|NCT02763566|588938607|FG002|Overall Study|On study treatment at study conclusion|54|||
163063150|NCT02763566|588938608|FG003|Overall Study|On study treatment at study conclusion|13|||
163063151|NCT02763566|588938605|FG000|Overall Study|Withdrawal by Subject|3|||
163063152|NCT02763566|588938606|FG001|Overall Study|Withdrawal by Subject|1|||
163063153|NCT02763566|588938607|FG002|Overall Study|Withdrawal by Subject|0|||
163063154|NCT02763566|588938608|FG003|Overall Study|Withdrawal by Subject|0|||
163063155|NCT04896385|588938609|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
163063156|NCT04896385|588938610|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
163063157|NCT04896385|588938611|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
163063158|NCT04896385|588938612|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
163063159|NCT04896385|588938609|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
163063160|NCT04896385|588938610|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
163063161|NCT04896385|588938611|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
163063162|NCT04896385|588938612|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
163063163|NCT04896385|588938609|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
163063164|NCT04896385|588938610|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
163063165|NCT04896385|588938611|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
163063166|NCT04896385|588938612|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
163063167|NCT04896385|588938609|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
163063168|NCT04896385|588938610|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
163063169|NCT04896385|588938611|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
163063170|NCT04896385|588938612|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
163063171|NCT04896385|588938609|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
163215912|NCT02921776|589503958|FG006|Overall Study|patient deterioration, fatigue|0|||
163215913|NCT02921776|589503959|FG007|Overall Study|patient deterioration, fatigue|0|||
163215914|NCT02921776|589503952|FG000|Overall Study|Withdrawal by Subject|0|||
163215915|NCT02921776|589503953|FG001|Overall Study|Withdrawal by Subject|2|||
163215916|NCT02921776|589503954|FG002|Overall Study|Withdrawal by Subject|0|||
163215917|NCT02921776|589503955|FG003|Overall Study|Withdrawal by Subject|1|||
163215918|NCT02921776|589503956|FG004|Overall Study|Withdrawal by Subject|1|||
163063172|NCT04896385|588938610|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
163215919|NCT02921776|589503957|FG005|Overall Study|Withdrawal by Subject|0|||
163215920|NCT02921776|589503958|FG006|Overall Study|Withdrawal by Subject|8|||
163018270|NCT03850483|588770809|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
163018271|NCT03850483|588770810|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
163018272|NCT03850483|588770811|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
163018273|NCT03850483|588770802|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
163018274|NCT03850483|588770803|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
163018275|NCT03850483|588770804|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
163018276|NCT03850483|588770805|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
163018277|NCT03850483|588770806|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
163018278|NCT03850483|588770807|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
163018279|NCT03850483|588770808|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
163018280|NCT03850483|588770809|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
163018281|NCT03850483|588770810|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
163018282|NCT03850483|588770811|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
163018283|NCT03850483|588770802|FG000|Treatment for Stage 2|Physician Decision|0|||
163018284|NCT03850483|588770803|FG001|Treatment for Stage 2|Physician Decision|0|||
163018285|NCT03850483|588770804|FG002|Treatment for Stage 2|Physician Decision|0|||
163018286|NCT03850483|588770805|FG003|Treatment for Stage 2|Physician Decision|0|||
163018287|NCT03850483|588770806|FG004|Treatment for Stage 2|Physician Decision|0|||
163018288|NCT03850483|588770807|FG005|Treatment for Stage 2|Physician Decision|0|||
163018289|NCT03850483|588770808|FG006|Treatment for Stage 2|Physician Decision|0|||
163018290|NCT03850483|588770809|FG007|Treatment for Stage 2|Physician Decision|0|||
163018291|NCT03850483|588770810|FG008|Treatment for Stage 2|Physician Decision|0|||
163018292|NCT03850483|588770811|FG009|Treatment for Stage 2|Physician Decision|1|||
163018293|NCT03850483|588770802|FG000|Treatment for Stage 2|Protocol Violation|0|||
163018294|NCT03850483|588770803|FG001|Treatment for Stage 2|Protocol Violation|0|||
163018295|NCT03850483|588770804|FG002|Treatment for Stage 2|Protocol Violation|0|||
163018296|NCT03850483|588770805|FG003|Treatment for Stage 2|Protocol Violation|0|||
163018297|NCT03850483|588770806|FG004|Treatment for Stage 2|Protocol Violation|0|||
163018298|NCT03850483|588770807|FG005|Treatment for Stage 2|Protocol Violation|0|||
163018299|NCT03850483|588770808|FG006|Treatment for Stage 2|Protocol Violation|0|||
163018300|NCT03850483|588770809|FG007|Treatment for Stage 2|Protocol Violation|0|||
163018301|NCT03850483|588770810|FG008|Treatment for Stage 2|Protocol Violation|1|||
163018302|NCT03850483|588770811|FG009|Treatment for Stage 2|Protocol Violation|0|||
163018303|NCT03850483|588770802|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
163018304|NCT03850483|588770803|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
163018305|NCT03850483|588770804|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
163018306|NCT03850483|588770805|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
163018307|NCT03850483|588770806|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
163018308|NCT03850483|588770807|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
163018309|NCT03850483|588770808|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
163018310|NCT03850483|588770809|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
163018311|NCT03850483|588770810|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
163018312|NCT03850483|588770811|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
163018313|NCT03850483|588770802|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018314|NCT03850483|588770803|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018315|NCT03850483|588770804|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018316|NCT03850483|588770805|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018317|NCT03850483|588770806|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018318|NCT03850483|588770807|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018319|NCT03850483|588770808|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018320|NCT03850483|588770809|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018321|NCT03850483|588770810|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018322|NCT03850483|588770811|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
163018323|NCT03850483|588770802|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
163018324|NCT03850483|588770803|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
163018325|NCT03850483|588770804|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
163018326|NCT03850483|588770805|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
163018327|NCT03850483|588770806|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
163018328|NCT03850483|588770807|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
163018329|NCT03850483|588770808|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
163018330|NCT03850483|588770809|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
163018331|NCT03850483|588770810|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
163018332|NCT03850483|588770811|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
163018333|NCT03850483|588770802|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
163018334|NCT03850483|588770803|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
163018335|NCT03850483|588770804|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
163018336|NCT03850483|588770805|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
163018337|NCT03850483|588770806|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
163018338|NCT03850483|588770807|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
163018339|NCT03850483|588770808|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
163018340|NCT03850483|588770809|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
163018341|NCT03850483|588770810|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
163018342|NCT03850483|588770811|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
163018343|NCT03850483|588770802|FG000|Follow-up For Stage 2|Other|0|||
163018344|NCT03850483|588770803|FG001|Follow-up For Stage 2|Other|0|||
163018345|NCT03850483|588770804|FG002|Follow-up For Stage 2|Other|0|||
163018346|NCT03850483|588770805|FG003|Follow-up For Stage 2|Other|0|||
163018347|NCT03850483|588770806|FG004|Follow-up For Stage 2|Other|0|||
163018348|NCT03850483|588770807|FG005|Follow-up For Stage 2|Other|0|||
163018349|NCT03850483|588770808|FG006|Follow-up For Stage 2|Other|0|||
163018350|NCT03850483|588770809|FG007|Follow-up For Stage 2|Other|0|||
163018351|NCT03850483|588770810|FG008|Follow-up For Stage 2|Other|0|||
163018352|NCT03850483|588770811|FG009|Follow-up For Stage 2|Other|1|||
163018353|NCT00076752|588772579|FG000|Overall Study|Death|2|||
163018354|NCT00076752|588772579|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
163018355|NCT01288937|588772580|FG000|Overall Study|Adverse Event|1|||
163018356|NCT01288937|588772581|FG001|Overall Study|Adverse Event|0|||
163018357|NCT02875613|588772585|FG000|Overall Study|Withdrawal by Subject|1|||
163018358|NCT02875613|588772585|FG000|Overall Study|Screen Failure|1|||
163018359|NCT00892151|588772586|FG000|Overall Study|Protocol Violation|1|||
163018360|NCT01222520|588772589|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
163018361|NCT01222520|588772590|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
163018362|NCT01222520|588772589|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
163018363|NCT01222520|588772590|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
163018364|NCT01222520|588772589|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
163018365|NCT01222520|588772590|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
163018366|NCT01222520|588772589|FG000|Double-blind Period|Adverse Event|0|||
163018367|NCT01222520|588772590|FG001|Double-blind Period|Adverse Event|1|||
163018368|NCT01222520|588772589|FG000|Double-blind Period|Lack of Efficacy|0|||
163018369|NCT01222520|588772590|FG001|Double-blind Period|Lack of Efficacy|1|||
163018370|NCT01222520|588772589|FG000|Double-blind Period|Study medication stolen|1|||
163018371|NCT01222520|588772590|FG001|Double-blind Period|Study medication stolen|0|||
163018372|NCT02257489|588772597|FG000|Overall Study|Withdrawal by Subject|0|||
163018373|NCT02257489|588772598|FG001|Overall Study|Withdrawal by Subject|0|||
163018374|NCT02257489|588772599|FG002|Overall Study|Withdrawal by Subject|0|||
163018375|NCT02257489|588772600|FG003|Overall Study|Withdrawal by Subject|1|||
163018376|NCT02257489|588772601|FG004|Overall Study|Withdrawal by Subject|0|||
163018377|NCT02257489|588772602|FG005|Overall Study|Withdrawal by Subject|0|||
163018378|NCT02257489|588772603|FG006|Overall Study|Withdrawal by Subject|0|||
163018379|NCT02257489|588772604|FG007|Overall Study|Withdrawal by Subject|0|||
163018380|NCT02257489|588772605|FG008|Overall Study|Withdrawal by Subject|0|||
163018381|NCT04606394|588772608|FG000|Overall Study|Withdrawal by Subject|3|||
163018382|NCT04606394|588772608|FG000|Overall Study|Exclusion criteria screen failure|12|||
163018383|NCT01896128|588772609|FG000|Overall Study|Withdrawal by Subject|3|||
163018384|NCT01896128|588772610|FG001|Overall Study|Withdrawal by Subject|3|||
163018385|NCT01996254|588772611|FG000|Overall Study|Change in Eligibility|0|||
163018386|NCT01996254|588772612|FG001|Overall Study|Change in Eligibility|2|||
163018387|NCT01996254|588772613|FG002|Overall Study|Change in Eligibility|0|||
163018388|NCT01996254|588772611|FG000|Overall Study|Withdrawal by Subject|0|||
163018389|NCT01996254|588772612|FG001|Overall Study|Withdrawal by Subject|3|||
163018390|NCT01996254|588772613|FG002|Overall Study|Withdrawal by Subject|4|||
163018391|NCT01996254|588772611|FG000|Overall Study|Lost to Follow-up|1|||
163018392|NCT01996254|588772612|FG001|Overall Study|Lost to Follow-up|0|||
163018393|NCT01996254|588772613|FG002|Overall Study|Lost to Follow-up|4|||
163018394|NCT01053663|588772614|FG000|Overall Study|Death|2|||
163018395|NCT01053663|588772614|FG000|Overall Study|Lost to Follow-up|1|||
163018396|NCT01053663|588772614|FG000|Overall Study|Poor IV Access|1|||
163018397|NCT01053663|588772614|FG000|Overall Study|Transferred to Another Hospital|1|||
163018398|NCT01053663|588772614|FG000|Overall Study|Negative Influenza Diagnosis|1|||
163063173|NCT04896385|588938611|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
163063174|NCT04896385|588938612|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
163215921|NCT02921776|589503959|FG007|Overall Study|Withdrawal by Subject|1|||
163215922|NCT02921776|589503952|FG000|Overall Study|Death|0|||
163215923|NCT02921776|589503953|FG001|Overall Study|Death|0|||
163018399|NCT02920008|588772615|FG000|Overall Study|Death|117|||
163018400|NCT02920008|588772616|FG001|Overall Study|Death|127|||
163018401|NCT02920008|588772615|FG000|Overall Study|Withdrawal by Subject|3|||
163063175|NCT04896385|588938609|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
163063176|NCT04896385|588938610|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
163018402|NCT02920008|588772616|FG001|Overall Study|Withdrawal by Subject|6|||
163018403|NCT02920008|588772615|FG000|Overall Study|Lost to Follow-up|0|||
163018404|NCT02920008|588772616|FG001|Overall Study|Lost to Follow-up|1|||
163018405|NCT03533114|588772619|FG000|Overall|Adverse Event|16|||
163215924|NCT02921776|589503954|FG002|Overall Study|Death|0|||
163018406|NCT03533114|588772620|FG001|Overall|Adverse Event|11|||
163018407|NCT03533114|588772619|FG000|Overall|Consent Withdrawal by Participant|7|||
163018408|NCT03533114|588772620|FG001|Overall|Consent Withdrawal by Participant|6|||
163018409|NCT03533114|588772619|FG000|Overall|Lack of Efficacy|5|||
163018410|NCT03533114|588772620|FG001|Overall|Lack of Efficacy|3|||
163018411|NCT03533114|588772619|FG000|Overall|Lost to Follow-up|1|||
163018412|NCT03533114|588772620|FG001|Overall|Lost to Follow-up|1|||
163063177|NCT04896385|588938611|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
163063178|NCT04896385|588938612|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
163063179|NCT05233761|588938613|FG000|Treatment Period A|Withdrawal by Subject|12|||
163063180|NCT05233761|588938614|FG001|Treatment Period A|Withdrawal by Subject|10|||
163063181|NCT05233761|588938613|FG000|Treatment Period A|Lost to Follow-up|6|||
163063182|NCT05233761|588938614|FG001|Treatment Period A|Lost to Follow-up|12|||
163063183|NCT05233761|588938613|FG000|Treatment Period A|Protocol Violation|8|||
163063184|NCT05233761|588938614|FG001|Treatment Period A|Protocol Violation|15|||
163063185|NCT03314935|588938617|FG000|Phase 1|Death|4|||
163063186|NCT03314935|588938618|FG001|Phase 1|Death|2|||
163063187|NCT03314935|588938619|FG002|Phase 1|Death|5|||
163063188|NCT03314935|588938620|FG003|Phase 1|Death|4|||
163063189|NCT03314935|588938621|FG004|Phase 1|Death|3|||
163063190|NCT03314935|588938622|FG005|Phase 1|Death|4|||
163063191|NCT03314935|588938623|FG006|Phase 1|Death|5|||
163063192|NCT03314935|588938624|FG007|Phase 1|Death|4|||
163063193|NCT03314935|588938625|FG008|Phase 1|Death|3|||
163063194|NCT03314935|588938626|FG009|Phase 1|Death|0|||
163063195|NCT03314935|588938627|FG010|Phase 1|Death|0|||
163063196|NCT03314935|588938628|FG011|Phase 1|Death|0|||
163063197|NCT03314935|588938629|FG012|Phase 1|Death|0|||
163063198|NCT03314935|588938630|FG013|Phase 1|Death|0|||
163063199|NCT03314935|588938631|FG014|Phase 1|Death|0|||
163063200|NCT03314935|588938617|FG000|Phase 1|Withdrawal by Subject|2|||
163063201|NCT03314935|588938618|FG001|Phase 1|Withdrawal by Subject|1|||
163063202|NCT03314935|588938619|FG002|Phase 1|Withdrawal by Subject|1|||
163063203|NCT03314935|588938620|FG003|Phase 1|Withdrawal by Subject|2|||
163063204|NCT03314935|588938621|FG004|Phase 1|Withdrawal by Subject|1|||
163063205|NCT03314935|588938622|FG005|Phase 1|Withdrawal by Subject|0|||
163063206|NCT03314935|588938623|FG006|Phase 1|Withdrawal by Subject|1|||
163063207|NCT03314935|588938624|FG007|Phase 1|Withdrawal by Subject|0|||
163063208|NCT03314935|588938625|FG008|Phase 1|Withdrawal by Subject|1|||
163063209|NCT03314935|588938626|FG009|Phase 1|Withdrawal by Subject|0|||
163063210|NCT03314935|588938627|FG010|Phase 1|Withdrawal by Subject|0|||
163063211|NCT03314935|588938628|FG011|Phase 1|Withdrawal by Subject|0|||
163063212|NCT03314935|588938629|FG012|Phase 1|Withdrawal by Subject|0|||
163215925|NCT02921776|589503955|FG003|Overall Study|Death|2|||
163215926|NCT02921776|589503956|FG004|Overall Study|Death|0|||
163215927|NCT02921776|589503957|FG005|Overall Study|Death|0|||
163215928|NCT02921776|589503958|FG006|Overall Study|Death|0|||
163215929|NCT02921776|589503959|FG007|Overall Study|Death|0|||
163215930|NCT02921776|589503952|FG000|Overall Study|extubation or early discharge|0|||
163215931|NCT02921776|589503953|FG001|Overall Study|extubation or early discharge|0|||
163215932|NCT02921776|589503954|FG002|Overall Study|extubation or early discharge|0|||
163215933|NCT02921776|589503955|FG003|Overall Study|extubation or early discharge|5|||
163215934|NCT02921776|589503956|FG004|Overall Study|extubation or early discharge|5|||
163018413|NCT03533114|588772619|FG000|Overall|Physician Decision|0|||
163018414|NCT03533114|588772620|FG001|Overall|Physician Decision|2|||
163018415|NCT03533114|588772619|FG000|Overall|Protocol deviation|1|||
163018416|NCT03533114|588772620|FG001|Overall|Protocol deviation|1|||
163018417|NCT03533114|588772619|FG000|Overall|Failure to meet randomization criteria|1|||
163018418|NCT03533114|588772620|FG001|Overall|Failure to meet randomization criteria|2|||
163018419|NCT03533114|588772619|FG000|Overall|Non-Compliance with study drug|0|||
163018420|NCT03533114|588772620|FG001|Overall|Non-Compliance with study drug|1|||
163018421|NCT03533114|588772619|FG000|Overall|Other|0|||
163063213|NCT03314935|588938630|FG013|Phase 1|Withdrawal by Subject|0|||
163063214|NCT03314935|588938631|FG014|Phase 1|Withdrawal by Subject|0|||
163063215|NCT03314935|588938617|FG000|Phase 1|Progressive Disease|2|||
163063216|NCT03314935|588938618|FG001|Phase 1|Progressive Disease|0|||
163063217|NCT03314935|588938619|FG002|Phase 1|Progressive Disease|0|||
163063218|NCT03314935|588938620|FG003|Phase 1|Progressive Disease|1|||
163063219|NCT03314935|588938621|FG004|Phase 1|Progressive Disease|0|||
163063220|NCT03314935|588938622|FG005|Phase 1|Progressive Disease|0|||
163215935|NCT02921776|589503957|FG005|Overall Study|extubation or early discharge|0|||
163215936|NCT02921776|589503958|FG006|Overall Study|extubation or early discharge|0|||
163215937|NCT02921776|589503959|FG007|Overall Study|extubation or early discharge|0|||
163215938|NCT02921776|589503952|FG000|Overall Study|Lost to Follow-up|0|||
163215939|NCT02921776|589503953|FG001|Overall Study|Lost to Follow-up|0|||
163215940|NCT02921776|589503954|FG002|Overall Study|Lost to Follow-up|0|||
163215941|NCT02921776|589503955|FG003|Overall Study|Lost to Follow-up|0|||
163215942|NCT02921776|589503956|FG004|Overall Study|Lost to Follow-up|0|||
163215943|NCT02921776|589503957|FG005|Overall Study|Lost to Follow-up|2|||
163018422|NCT03533114|588772620|FG001|Overall|Other|1|||
163018423|NCT03533114|588772619|FG000|Open Label Titration and Optimization|Adverse Event|11|||
163063221|NCT03314935|588938623|FG006|Phase 1|Progressive Disease|0|||
163063222|NCT03314935|588938624|FG007|Phase 1|Progressive Disease|0|||
163215944|NCT02921776|589503958|FG006|Overall Study|Lost to Follow-up|3|||
163018424|NCT03533114|588772620|FG001|Open Label Titration and Optimization|Adverse Event|8|||
163063223|NCT03314935|588938625|FG008|Phase 1|Progressive Disease|0|||
163063224|NCT03314935|588938626|FG009|Phase 1|Progressive Disease|0|||
163063225|NCT03314935|588938627|FG010|Phase 1|Progressive Disease|0|||
163018425|NCT03533114|588772619|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
163018426|NCT03533114|588772620|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
163018427|NCT03533114|588772619|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
163018428|NCT03533114|588772620|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
163018429|NCT03533114|588772619|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
163018430|NCT03533114|588772620|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
163018431|NCT03533114|588772619|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
163018432|NCT03533114|588772620|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
163018433|NCT03533114|588772619|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
163018434|NCT03533114|588772620|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
163018435|NCT03533114|588772619|FG000|Stable Dose|Adverse Event|0|||
163018436|NCT03533114|588772620|FG001|Stable Dose|Adverse Event|2|||
163018437|NCT03533114|588772619|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
163018438|NCT03533114|588772620|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
163018439|NCT03533114|588772619|FG000|Stable Dose|Lack of Efficacy|1|||
163018440|NCT03533114|588772620|FG001|Stable Dose|Lack of Efficacy|0|||
163018441|NCT03533114|588772619|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
163018442|NCT03533114|588772620|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
163018443|NCT03533114|588772619|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
163018444|NCT03533114|588772620|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
163018445|NCT03533114|588772619|FG000|Open-Label Safety Extension|Adverse Event|3|||
163018446|NCT03533114|588772620|FG001|Open-Label Safety Extension|Adverse Event|0|||
163018447|NCT03533114|588772619|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
163018448|NCT03533114|588772620|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
163018449|NCT03533114|588772619|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
163018450|NCT03533114|588772620|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
163018451|NCT03533114|588772619|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
163018452|NCT03533114|588772620|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
163018453|NCT03533114|588772619|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
163018454|NCT03533114|588772620|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
163018455|NCT01862250|588772621|FG000|Overall Study|Adverse Event|4|||
163018456|NCT03852264|588772622|FG000|Third Research Visit|Lost to Follow-up|1|||
163018457|NCT03852264|588772623|FG001|Third Research Visit|Lost to Follow-up|0|||
163018458|NCT02411396|588772627|FG000|Overall Study|Lost to Follow-up|31|||
163018459|NCT02411396|588772627|FG000|Overall Study|Death|10|||
163018464|NCT02016105|588772638|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
163018465|NCT02016105|588772639|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
163018466|NCT02016105|588772640|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
163018467|NCT02016105|588772641|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
163018468|NCT02016105|588772642|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
163018469|NCT02016105|588772643|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
163018470|NCT02016105|588772638|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
163018471|NCT02016105|588772639|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
163018472|NCT02016105|588772640|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
163018473|NCT02016105|588772641|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
163018474|NCT02016105|588772642|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
163018475|NCT02016105|588772643|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
163018476|NCT02016105|588772638|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
163018477|NCT02016105|588772639|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
163018478|NCT02016105|588772640|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
163018479|NCT02016105|588772641|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
163018480|NCT02016105|588772642|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
163018481|NCT02016105|588772643|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
163018482|NCT02016105|588772638|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
163018483|NCT02016105|588772639|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
163018484|NCT02016105|588772640|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
163018485|NCT02016105|588772641|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
163018486|NCT02016105|588772642|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
163018487|NCT02016105|588772643|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
163018488|NCT02016105|588772638|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
163018489|NCT02016105|588772639|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
163018490|NCT02016105|588772640|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
163018491|NCT02016105|588772641|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
163018492|NCT02016105|588772642|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
163018493|NCT02016105|588772643|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
163215945|NCT02921776|589503959|FG007|Overall Study|Lost to Follow-up|6|||
163018494|NCT02016105|588772638|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
163018495|NCT02016105|588772639|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
163018496|NCT02016105|588772640|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
163215946|NCT01239368|589506168|FG000|Overall Study|Principal investigator discretion|1|||
163215947|NCT01239368|589506169|FG001|Overall Study|Principal investigator discretion|0|||
163215948|NCT01239368|589506170|FG002|Overall Study|Principal investigator discretion|0|||
163215949|NCT01239368|589506171|FG003|Overall Study|Principal investigator discretion|0|||
163018497|NCT02016105|588772641|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
163018498|NCT02016105|588772642|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
163018499|NCT02016105|588772643|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
163018500|NCT02016105|588772638|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
163018501|NCT02016105|588772639|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
163018502|NCT02016105|588772640|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
163018503|NCT02016105|588772641|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
163018504|NCT02016105|588772642|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
163018505|NCT02016105|588772643|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
163018506|NCT02016105|588772638|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
163018507|NCT02016105|588772639|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
163018508|NCT02016105|588772640|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
163018509|NCT02016105|588772641|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
163018510|NCT02016105|588772642|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
163018511|NCT02016105|588772643|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
163018512|NCT02016105|588772638|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
163018513|NCT02016105|588772639|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
163018514|NCT02016105|588772640|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
163018515|NCT02016105|588772641|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
163018516|NCT02016105|588772642|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
163018517|NCT02016105|588772643|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
163018518|NCT02016105|588772638|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
163018519|NCT02016105|588772639|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
163018520|NCT02016105|588772640|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
163018521|NCT02016105|588772641|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
163018522|NCT02016105|588772642|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
163018523|NCT02016105|588772643|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
163018524|NCT02016105|588772638|FG000|TREATMENT PERIOD 2|Death|0|||
163018525|NCT02016105|588772639|FG001|TREATMENT PERIOD 2|Death|0|||
163018526|NCT02016105|588772640|FG002|TREATMENT PERIOD 2|Death|0|||
163018527|NCT02016105|588772641|FG003|TREATMENT PERIOD 2|Death|0|||
163018528|NCT02016105|588772642|FG004|TREATMENT PERIOD 2|Death|0|||
163018529|NCT02016105|588772643|FG005|TREATMENT PERIOD 2|Death|1|||
163018530|NCT02016105|588772638|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
163018531|NCT02016105|588772639|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
163018532|NCT02016105|588772640|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
163018533|NCT02016105|588772641|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
163018534|NCT02016105|588772642|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
163018535|NCT02016105|588772643|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
163018536|NCT02016105|588772638|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
163018537|NCT02016105|588772639|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
163018538|NCT02016105|588772640|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
163018539|NCT02016105|588772641|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
163018540|NCT02016105|588772642|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
163018541|NCT02016105|588772643|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
163018542|NCT02016105|588772638|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
163018543|NCT02016105|588772639|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
163018544|NCT02016105|588772640|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
163018545|NCT02016105|588772641|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
163018546|NCT02016105|588772642|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
163018547|NCT02016105|588772643|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
163018548|NCT02016105|588772638|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
163018549|NCT02016105|588772639|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
163018550|NCT02016105|588772640|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
163018551|NCT02016105|588772641|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
163018552|NCT02016105|588772642|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
163018553|NCT02016105|588772643|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
163018554|NCT02016105|588772638|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
163018555|NCT02016105|588772639|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
163018556|NCT02016105|588772640|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
163018557|NCT02016105|588772641|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
163018558|NCT02016105|588772642|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
163405170|NCT01033825|590193536|FG000|Overall Study|Protocol Violation|1|||
163405171|NCT01033825|590193537|FG001|Overall Study|Protocol Violation|0|||
163405172|NCT01033825|590193538|FG002|Overall Study|Protocol Violation|0|||
163018559|NCT02016105|588772643|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
163018560|NCT02016105|588772638|FG000|EXTENSION PERIOD|Adverse Event|0|||
163018561|NCT02016105|588772639|FG001|EXTENSION PERIOD|Adverse Event|0|||
163018562|NCT02016105|588772640|FG002|EXTENSION PERIOD|Adverse Event|2|||
163018563|NCT02016105|588772641|FG003|EXTENSION PERIOD|Adverse Event|0|||
163405173|NCT01033825|590193539|FG003|Overall Study|Protocol Violation|0|||
163018564|NCT02016105|588772642|FG004|EXTENSION PERIOD|Adverse Event|1|||
163018565|NCT02016105|588772643|FG005|EXTENSION PERIOD|Adverse Event|0|||
163018566|NCT02016105|588772638|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
163018567|NCT02016105|588772639|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
163018568|NCT02016105|588772640|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
163018569|NCT02016105|588772641|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
163018570|NCT02016105|588772642|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
163018571|NCT02016105|588772643|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
163018572|NCT02016105|588772638|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
163018573|NCT02016105|588772639|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
163018574|NCT02016105|588772640|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
163018575|NCT02016105|588772641|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
163018576|NCT02016105|588772642|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
163018577|NCT02016105|588772643|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
163018578|NCT02016105|588772638|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
163018579|NCT02016105|588772639|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
163018580|NCT02016105|588772640|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
163018581|NCT02016105|588772641|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
163018582|NCT02016105|588772642|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
163018583|NCT02016105|588772643|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
163018584|NCT00090493|588772644|FG000|Overall Study|Physician Decision|2|||
163018585|NCT02865499|588772647|FG000|Baseline|Adverse Event|1|||
163018586|NCT02865499|588772647|FG000|Baseline|Withdrawal by Subject|1|||
163018587|NCT02320058|588772648|FG000|Overall Study|Death|25|||
163018588|NCT02320058|588772649|FG001|Overall Study|Death|10|||
163018589|NCT02320058|588772648|FG000|Overall Study|Lost to Follow-up|4|||
163018590|NCT02320058|588772649|FG001|Overall Study|Lost to Follow-up|0|||
163018591|NCT02320058|588772648|FG000|Overall Study|Other reasons|4|||
163018592|NCT02320058|588772649|FG001|Overall Study|Other reasons|1|||
163018593|NCT02320058|588772648|FG000|Overall Study|Withdrawal by Subject|8|||
163018594|NCT02320058|588772649|FG001|Overall Study|Withdrawal by Subject|2|||
163018595|NCT02320058|588772648|FG000|Overall Study|Not reported|1|||
163018596|NCT02320058|588772649|FG001|Overall Study|Not reported|0|||
163018597|NCT00661609|588772650|FG000|Overall Study|Adverse Event|4|||
163018598|NCT00661609|588772650|FG000|Overall Study|Death|20|||
163018599|NCT00661609|588772650|FG000|Overall Study|Withdrawal by Subject|2|||
163018600|NCT00661609|588772650|FG000|Overall Study|PI Decision|1|||
163018601|NCT00661609|588772650|FG000|Overall Study|Survival follow up stage discontinued|11|||
163018602|NCT00661609|588772650|FG000|Overall Study|Disease progression|3|||
163018603|NCT03521115|588772651|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
163018604|NCT03521115|588772652|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
163018605|NCT03521115|588772651|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
163018606|NCT03521115|588772652|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
163018607|NCT01769508|588772656|FG000|Overall Study|Death|3|||
163018608|NCT01769508|588772656|FG000|Overall Study|Withdrawal by Subject|1|||
163018609|NCT01769508|588772656|FG000|Overall Study|Adverse Event|1|||
163018610|NCT01769508|588772656|FG000|Overall Study|Lost to Follow-up|1|||
163018611|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
163018612|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
163018613|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
163018614|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
163018615|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
163018616|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
163018617|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
163018618|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
163018619|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
163018620|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
163018621|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
163018622|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
163018623|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
163018624|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
163018625|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
163018626|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
163018627|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
163018628|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
163018629|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
163018630|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
163018631|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
163018632|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
163018633|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
163405174|NCT01033825|590193540|FG004|Overall Study|Protocol Violation|0|||
163018634|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
163018635|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
163018636|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
163018637|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
163018638|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
163018639|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
163018640|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
163018641|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
163018642|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
163018643|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
163018644|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
163018645|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
163018646|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
163018647|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
163018648|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
163018649|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
163018650|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
163018651|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
163018652|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
163018653|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
163018654|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
163018655|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
163018656|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
163018657|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
163018658|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
163018659|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
163018660|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
163018661|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
163018662|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
163018663|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
163018664|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
163018665|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
163018666|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
163018667|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
163018668|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
163018669|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
163018670|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
163018671|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
163018672|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
163018673|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
163018674|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
163018675|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
163018676|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
163018677|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
163018678|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
163018679|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
163018680|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
163018681|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
163018682|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
163018683|NCT02295020|588772666|FG000|Overall Study|Adverse Event|0|||
163018684|NCT02295020|588772667|FG001|Overall Study|Adverse Event|1|||
163018685|NCT02295020|588772666|FG000|Overall Study|Withdrawal by Subject|3|||
163018686|NCT02295020|588772667|FG001|Overall Study|Withdrawal by Subject|2|||
163018687|NCT02751450|588772668|FG000|Overall Study|Adverse Event|1|||
163018688|NCT02751450|588772669|FG001|Overall Study|Adverse Event|0|||
163018689|NCT00562302|588772670|FG000|Overall Study|Lost to Follow-up|3|||
163018690|NCT00562302|588772671|FG001|Overall Study|Lost to Follow-up|3|||
163018691|NCT00562302|588772670|FG000|Overall Study|Adverse Event|0|||
163018692|NCT00562302|588772671|FG001|Overall Study|Adverse Event|6|||
163018693|NCT00562302|588772670|FG000|Overall Study|Non-compliance|1|||
163018694|NCT00562302|588772671|FG001|Overall Study|Non-compliance|2|||
163018695|NCT00562302|588772670|FG000|Overall Study|Withdrawal by Subject|7|||
163018696|NCT00562302|588772671|FG001|Overall Study|Withdrawal by Subject|8|||
163018697|NCT00562302|588772670|FG000|Overall Study|Death|1|||
163018698|NCT00562302|588772671|FG001|Overall Study|Death|2|||
163063226|NCT03314935|588938628|FG011|Phase 1|Progressive Disease|0|||
163063227|NCT03314935|588938629|FG012|Phase 1|Progressive Disease|0|||
163063228|NCT03314935|588938630|FG013|Phase 1|Progressive Disease|0|||
163063229|NCT03314935|588938631|FG014|Phase 1|Progressive Disease|0|||
163063230|NCT03314935|588938617|FG000|Phase 1|Study Terminated by Sponsor|0|||
163405175|NCT01033825|590193541|FG005|Overall Study|Protocol Violation|0|||
163018699|NCT00562302|588772670|FG000|Overall Study|Lung resection prior to study completion|7|||
163018700|NCT00562302|588772671|FG001|Overall Study|Lung resection prior to study completion|7|||
163018701|NCT00562302|588772670|FG000|Overall Study|Not stated|1|||
163063231|NCT03314935|588938618|FG001|Phase 1|Study Terminated by Sponsor|1|||
163018702|NCT00562302|588772671|FG001|Overall Study|Not stated|4|||
163018703|NCT01855243|588772672|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
163018704|NCT01855243|588772673|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
163018705|NCT01855243|588772674|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
163018706|NCT03615144|588772675|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
163018707|NCT03615144|588772676|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
163018708|NCT02587598|588772679|FG000|Overall Study|Death|4|||
163018709|NCT02587598|588772680|FG001|Overall Study|Death|8|||
163018710|NCT02587598|588772681|FG002|Overall Study|Death|4|||
163018711|NCT02587598|588772682|FG003|Overall Study|Death|16|||
163018712|NCT02587598|588772683|FG004|Overall Study|Death|9|||
163018713|NCT02587598|588772684|FG005|Overall Study|Death|4|||
163018714|NCT02587598|588772685|FG006|Overall Study|Death|6|||
163018715|NCT02587598|588772686|FG007|Overall Study|Death|7|||
163018716|NCT02587598|588772687|FG008|Overall Study|Death|9|||
163018717|NCT02587598|588772688|FG009|Overall Study|Death|1|||
163018718|NCT02587598|588772689|FG010|Overall Study|Death|3|||
163018719|NCT02587598|588772679|FG000|Overall Study|Study Terminated by the Sponsor|0|||
163018720|NCT02587598|588772680|FG001|Overall Study|Study Terminated by the Sponsor|1|||
163018721|NCT02587598|588772681|FG002|Overall Study|Study Terminated by the Sponsor|0|||
163018722|NCT02587598|588772682|FG003|Overall Study|Study Terminated by the Sponsor|3|||
163018723|NCT02587598|588772683|FG004|Overall Study|Study Terminated by the Sponsor|0|||
163018724|NCT02587598|588772684|FG005|Overall Study|Study Terminated by the Sponsor|1|||
163018725|NCT02587598|588772685|FG006|Overall Study|Study Terminated by the Sponsor|0|||
163018726|NCT02587598|588772686|FG007|Overall Study|Study Terminated by the Sponsor|0|||
163018727|NCT02587598|588772687|FG008|Overall Study|Study Terminated by the Sponsor|0|||
163018728|NCT02587598|588772688|FG009|Overall Study|Study Terminated by the Sponsor|1|||
163018729|NCT02587598|588772689|FG010|Overall Study|Study Terminated by the Sponsor|6|||
163018730|NCT02587598|588772679|FG000|Overall Study|Reason for study withdrawal not specified|0|||
163018731|NCT02587598|588772680|FG001|Overall Study|Reason for study withdrawal not specified|1|||
163018732|NCT02587598|588772681|FG002|Overall Study|Reason for study withdrawal not specified|0|||
163018733|NCT02587598|588772682|FG003|Overall Study|Reason for study withdrawal not specified|0|||
163018734|NCT02587598|588772683|FG004|Overall Study|Reason for study withdrawal not specified|0|||
163018735|NCT02587598|588772684|FG005|Overall Study|Reason for study withdrawal not specified|0|||
163018736|NCT02587598|588772685|FG006|Overall Study|Reason for study withdrawal not specified|0|||
163018737|NCT02587598|588772686|FG007|Overall Study|Reason for study withdrawal not specified|0|||
163018738|NCT02587598|588772687|FG008|Overall Study|Reason for study withdrawal not specified|0|||
163018739|NCT02587598|588772688|FG009|Overall Study|Reason for study withdrawal not specified|0|||
163018740|NCT02587598|588772689|FG010|Overall Study|Reason for study withdrawal not specified|0|||
163018741|NCT02587598|588772679|FG000|Overall Study|Withdrawal by Subject|0|||
163018742|NCT02587598|588772680|FG001|Overall Study|Withdrawal by Subject|1|||
163018743|NCT02587598|588772681|FG002|Overall Study|Withdrawal by Subject|0|||
163018744|NCT02587598|588772682|FG003|Overall Study|Withdrawal by Subject|2|||
163018745|NCT02587598|588772683|FG004|Overall Study|Withdrawal by Subject|3|||
163018746|NCT02587598|588772684|FG005|Overall Study|Withdrawal by Subject|1|||
163018747|NCT02587598|588772685|FG006|Overall Study|Withdrawal by Subject|0|||
163018748|NCT02587598|588772686|FG007|Overall Study|Withdrawal by Subject|0|||
163018749|NCT02587598|588772687|FG008|Overall Study|Withdrawal by Subject|0|||
163018750|NCT02587598|588772688|FG009|Overall Study|Withdrawal by Subject|1|||
163018751|NCT02587598|588772689|FG010|Overall Study|Withdrawal by Subject|2|||
163018752|NCT02587598|588772679|FG000|Overall Study|Physician Decision|0|||
163018753|NCT02587598|588772680|FG001|Overall Study|Physician Decision|0|||
163018754|NCT02587598|588772681|FG002|Overall Study|Physician Decision|0|||
163018755|NCT02587598|588772682|FG003|Overall Study|Physician Decision|0|||
163018756|NCT02587598|588772683|FG004|Overall Study|Physician Decision|0|||
163018757|NCT02587598|588772684|FG005|Overall Study|Physician Decision|0|||
163018758|NCT02587598|588772685|FG006|Overall Study|Physician Decision|0|||
163018759|NCT02587598|588772686|FG007|Overall Study|Physician Decision|0|||
163018760|NCT02587598|588772687|FG008|Overall Study|Physician Decision|0|||
163018761|NCT02587598|588772688|FG009|Overall Study|Physician Decision|0|||
163018762|NCT02587598|588772689|FG010|Overall Study|Physician Decision|3|||
163018763|NCT01860040|588772690|FG000|Overall Study|Withdrawal by Subject|1|||
163018764|NCT01860040|588772691|FG001|Overall Study|Withdrawal by Subject|0|||
163018765|NCT00679289|588772692|FG000|Overall Study|Progressive disease|4|||
163018766|NCT00679289|588772693|FG001|Overall Study|Progressive disease|5|||
163018767|NCT00679289|588772694|FG002|Overall Study|Progressive disease|18|||
163063232|NCT03314935|588938619|FG002|Phase 1|Study Terminated by Sponsor|0|||
163063233|NCT03314935|588938620|FG003|Phase 1|Study Terminated by Sponsor|0|||
163018768|NCT00679289|588772692|FG000|Overall Study|Withdrawal by Subject|0|||
163018769|NCT00679289|588772693|FG001|Overall Study|Withdrawal by Subject|1|||
163018770|NCT00679289|588772694|FG002|Overall Study|Withdrawal by Subject|1|||
163063234|NCT03314935|588938621|FG004|Phase 1|Study Terminated by Sponsor|0|||
163018771|NCT00679289|588772692|FG000|Overall Study|Adverse Event|0|||
163018772|NCT00679289|588772693|FG001|Overall Study|Adverse Event|0|||
163018773|NCT00679289|588772694|FG002|Overall Study|Adverse Event|3|||
163018774|NCT00679289|588772692|FG000|Overall Study|Physician Decision|1|||
163018775|NCT00679289|588772693|FG001|Overall Study|Physician Decision|0|||
163018776|NCT00679289|588772694|FG002|Overall Study|Physician Decision|1|||
163018777|NCT00937040|588772695|FG000|Overall Study|Adverse Event|5|||
163018778|NCT00937040|588772696|FG001|Overall Study|Adverse Event|8|||
163018779|NCT00937040|588772695|FG000|Overall Study|Lost to Follow-up|12|||
163018780|NCT00937040|588772696|FG001|Overall Study|Lost to Follow-up|12|||
163018781|NCT00937040|588772695|FG000|Overall Study|Protocol Violation|3|||
163018782|NCT00937040|588772696|FG001|Overall Study|Protocol Violation|0|||
163018783|NCT00937040|588772695|FG000|Overall Study|Withdrawal by Subject|13|||
163018784|NCT00937040|588772696|FG001|Overall Study|Withdrawal by Subject|7|||
163018785|NCT00937040|588772695|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
163018786|NCT00937040|588772696|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
163018787|NCT00937040|588772695|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
163018788|NCT00937040|588772696|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
163018789|NCT02477826|588772697|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
163018790|NCT02477826|588772698|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
163018791|NCT02477826|588772699|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
163018792|NCT02477826|588772700|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
163018793|NCT02477826|588772701|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
163018794|NCT02477826|588772702|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
163018795|NCT02477826|588772703|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
163018796|NCT02477826|588772704|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
163018797|NCT02477826|588772705|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
163018798|NCT02477826|588772706|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
163018799|NCT02477826|588772697|FG000|Pre-Treatment|Other reasons|4|||
163018800|NCT02477826|588772698|FG001|Pre-Treatment|Other reasons|1|||
163018801|NCT02477826|588772699|FG002|Pre-Treatment|Other reasons|4|||
163018802|NCT02477826|588772700|FG003|Pre-Treatment|Other reasons|1|||
163018803|NCT02477826|588772701|FG004|Pre-Treatment|Other reasons|4|||
163018804|NCT02477826|588772702|FG005|Pre-Treatment|Other reasons|2|||
163018805|NCT02477826|588772703|FG006|Pre-Treatment|Other reasons|0|||
163018806|NCT02477826|588772704|FG007|Pre-Treatment|Other reasons|0|||
163018807|NCT02477826|588772705|FG008|Pre-Treatment|Other reasons|0|||
163018808|NCT02477826|588772706|FG009|Pre-Treatment|Other reasons|0|||
163018809|NCT02477826|588772697|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
163018810|NCT02477826|588772698|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
163018811|NCT02477826|588772699|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
163018812|NCT02477826|588772700|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
163018813|NCT02477826|588772701|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
163018814|NCT02477826|588772702|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
163018815|NCT02477826|588772703|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
163018816|NCT02477826|588772704|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
163018817|NCT02477826|588772705|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
163018818|NCT02477826|588772706|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
163018819|NCT02477826|588772697|FG000|Pre-Treatment|Subject withdrew consent|0|||
163018820|NCT02477826|588772698|FG001|Pre-Treatment|Subject withdrew consent|0|||
163018821|NCT02477826|588772699|FG002|Pre-Treatment|Subject withdrew consent|3|||
163018822|NCT02477826|588772700|FG003|Pre-Treatment|Subject withdrew consent|0|||
163018823|NCT02477826|588772701|FG004|Pre-Treatment|Subject withdrew consent|0|||
163018824|NCT02477826|588772702|FG005|Pre-Treatment|Subject withdrew consent|1|||
163018825|NCT02477826|588772703|FG006|Pre-Treatment|Subject withdrew consent|0|||
163018826|NCT02477826|588772704|FG007|Pre-Treatment|Subject withdrew consent|1|||
163018827|NCT02477826|588772705|FG008|Pre-Treatment|Subject withdrew consent|0|||
163018828|NCT02477826|588772706|FG009|Pre-Treatment|Subject withdrew consent|3|||
163018829|NCT02477826|588772697|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
163018830|NCT02477826|588772698|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
163018831|NCT02477826|588772699|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
163018832|NCT02477826|588772700|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
163018833|NCT02477826|588772701|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
163063235|NCT03314935|588938622|FG005|Phase 1|Study Terminated by Sponsor|0|||
163063236|NCT03314935|588938623|FG006|Phase 1|Study Terminated by Sponsor|0|||
163018834|NCT02477826|588772702|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
163018835|NCT02477826|588772703|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
163018836|NCT02477826|588772704|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
163018837|NCT02477826|588772705|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
163018838|NCT02477826|588772706|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
163018839|NCT02477826|588772697|FG000|Pre-Treatment|Death|0|||
163063237|NCT03314935|588938624|FG007|Phase 1|Study Terminated by Sponsor|0|||
163063238|NCT03314935|588938625|FG008|Phase 1|Study Terminated by Sponsor|1|||
163215950|NCT01239368|589506172|FG004|Overall Study|Principal investigator discretion|1|||
163018840|NCT02477826|588772698|FG001|Pre-Treatment|Death|0|||
163018841|NCT02477826|588772699|FG002|Pre-Treatment|Death|0|||
163018842|NCT02477826|588772700|FG003|Pre-Treatment|Death|0|||
163018843|NCT02477826|588772701|FG004|Pre-Treatment|Death|0|||
163018844|NCT02477826|588772702|FG005|Pre-Treatment|Death|0|||
163018845|NCT02477826|588772703|FG006|Pre-Treatment|Death|1|||
163018846|NCT02477826|588772704|FG007|Pre-Treatment|Death|0|||
163018847|NCT02477826|588772705|FG008|Pre-Treatment|Death|0|||
163018848|NCT02477826|588772706|FG009|Pre-Treatment|Death|0|||
163018849|NCT02477826|588772697|FG000|Treatment Period|Not reported|8|||
163018850|NCT02477826|588772698|FG001|Treatment Period|Not reported|6|||
163018851|NCT02477826|588772699|FG002|Treatment Period|Not reported|4|||
163018852|NCT02477826|588772700|FG003|Treatment Period|Not reported|4|||
163018853|NCT02477826|588772701|FG004|Treatment Period|Not reported|2|||
163018854|NCT02477826|588772702|FG005|Treatment Period|Not reported|1|||
163018855|NCT02477826|588772703|FG006|Treatment Period|Not reported|14|||
163018856|NCT02477826|588772704|FG007|Treatment Period|Not reported|8|||
163018857|NCT02477826|588772705|FG008|Treatment Period|Not reported|5|||
163018858|NCT02477826|588772706|FG009|Treatment Period|Not reported|2|||
163018859|NCT02477826|588772697|FG000|Treatment Period|Other reasons|5|||
163018860|NCT02477826|588772698|FG001|Treatment Period|Other reasons|6|||
163018861|NCT02477826|588772699|FG002|Treatment Period|Other reasons|12|||
163018862|NCT02477826|588772700|FG003|Treatment Period|Other reasons|7|||
163018863|NCT02477826|588772701|FG004|Treatment Period|Other reasons|5|||
163018864|NCT02477826|588772702|FG005|Treatment Period|Other reasons|1|||
163018865|NCT02477826|588772703|FG006|Treatment Period|Other reasons|8|||
163328974|NCT05580003|589914918|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163018866|NCT02477826|588772704|FG007|Treatment Period|Other reasons|8|||
163018867|NCT02477826|588772705|FG008|Treatment Period|Other reasons|21|||
163018868|NCT02477826|588772706|FG009|Treatment Period|Other reasons|1|||
163018869|NCT02477826|588772697|FG000|Treatment Period|Administrative reason by sponsor|0|||
163018870|NCT02477826|588772698|FG001|Treatment Period|Administrative reason by sponsor|3|||
163018871|NCT02477826|588772699|FG002|Treatment Period|Administrative reason by sponsor|0|||
163018872|NCT02477826|588772700|FG003|Treatment Period|Administrative reason by sponsor|0|||
163018873|NCT02477826|588772701|FG004|Treatment Period|Administrative reason by sponsor|0|||
163018874|NCT02477826|588772702|FG005|Treatment Period|Administrative reason by sponsor|0|||
163018875|NCT02477826|588772703|FG006|Treatment Period|Administrative reason by sponsor|0|||
163018876|NCT02477826|588772704|FG007|Treatment Period|Administrative reason by sponsor|0|||
163018877|NCT02477826|588772705|FG008|Treatment Period|Administrative reason by sponsor|0|||
163018878|NCT02477826|588772706|FG009|Treatment Period|Administrative reason by sponsor|0|||
163018879|NCT02477826|588772697|FG000|Treatment Period|Participant meet no longer study criteria|1|||
163018880|NCT02477826|588772698|FG001|Treatment Period|Participant meet no longer study criteria|1|||
163018881|NCT02477826|588772699|FG002|Treatment Period|Participant meet no longer study criteria|0|||
163018882|NCT02477826|588772700|FG003|Treatment Period|Participant meet no longer study criteria|0|||
163063239|NCT03314935|588938626|FG009|Phase 1|Study Terminated by Sponsor|0|||
163063240|NCT03314935|588938627|FG010|Phase 1|Study Terminated by Sponsor|0|||
163063241|NCT03314935|588938628|FG011|Phase 1|Study Terminated by Sponsor|0|||
163063242|NCT03314935|588938629|FG012|Phase 1|Study Terminated by Sponsor|0|||
163063243|NCT03314935|588938630|FG013|Phase 1|Study Terminated by Sponsor|0|||
163063244|NCT03314935|588938631|FG014|Phase 1|Study Terminated by Sponsor|0|||
163063245|NCT03314935|588938617|FG000|Phase 1|"Captured as Other in Database"|0|||
163063246|NCT03314935|588938618|FG001|Phase 1|"Captured as Other in Database"|2|||
163063247|NCT03314935|588938619|FG002|Phase 1|"Captured as Other in Database"|0|||
163328975|NCT05580003|589914919|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328976|NCT05580003|589914920|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163018883|NCT02477826|588772701|FG004|Treatment Period|Participant meet no longer study criteria|1|||
163018884|NCT02477826|588772702|FG005|Treatment Period|Participant meet no longer study criteria|1|||
163018885|NCT02477826|588772703|FG006|Treatment Period|Participant meet no longer study criteria|0|||
163018886|NCT02477826|588772704|FG007|Treatment Period|Participant meet no longer study criteria|1|||
163018887|NCT02477826|588772705|FG008|Treatment Period|Participant meet no longer study criteria|0|||
163018888|NCT02477826|588772706|FG009|Treatment Period|Participant meet no longer study criteria|0|||
163018889|NCT02477826|588772697|FG000|Treatment Period|Poor/Non Compliance|1|||
163018890|NCT02477826|588772698|FG001|Treatment Period|Poor/Non Compliance|0|||
163018891|NCT02477826|588772699|FG002|Treatment Period|Poor/Non Compliance|2|||
163018892|NCT02477826|588772700|FG003|Treatment Period|Poor/Non Compliance|0|||
163018893|NCT02477826|588772701|FG004|Treatment Period|Poor/Non Compliance|0|||
163018894|NCT02477826|588772702|FG005|Treatment Period|Poor/Non Compliance|1|||
163018895|NCT02477826|588772703|FG006|Treatment Period|Poor/Non Compliance|1|||
163018896|NCT02477826|588772704|FG007|Treatment Period|Poor/Non Compliance|0|||
163018897|NCT02477826|588772705|FG008|Treatment Period|Poor/Non Compliance|0|||
163018898|NCT02477826|588772706|FG009|Treatment Period|Poor/Non Compliance|1|||
163018899|NCT02477826|588772697|FG000|Treatment Period|Maximum Clinical Benefit|3|||
163063248|NCT03314935|588938620|FG003|Phase 1|"Captured as Other in Database"|0|||
163405176|NCT01033825|590193542|FG006|Overall Study|Protocol Violation|0|||
163018900|NCT02477826|588772698|FG001|Treatment Period|Maximum Clinical Benefit|3|||
163018901|NCT02477826|588772699|FG002|Treatment Period|Maximum Clinical Benefit|1|||
163018902|NCT02477826|588772700|FG003|Treatment Period|Maximum Clinical Benefit|1|||
163018903|NCT02477826|588772701|FG004|Treatment Period|Maximum Clinical Benefit|3|||
163018904|NCT02477826|588772702|FG005|Treatment Period|Maximum Clinical Benefit|0|||
163018905|NCT02477826|588772703|FG006|Treatment Period|Maximum Clinical Benefit|3|||
163018906|NCT02477826|588772704|FG007|Treatment Period|Maximum Clinical Benefit|2|||
163018907|NCT02477826|588772705|FG008|Treatment Period|Maximum Clinical Benefit|2|||
163018908|NCT02477826|588772706|FG009|Treatment Period|Maximum Clinical Benefit|2|||
163018909|NCT02477826|588772697|FG000|Treatment Period|Lost to Follow-up|0|||
163018910|NCT02477826|588772698|FG001|Treatment Period|Lost to Follow-up|0|||
163018911|NCT02477826|588772699|FG002|Treatment Period|Lost to Follow-up|1|||
163018912|NCT02477826|588772700|FG003|Treatment Period|Lost to Follow-up|1|||
163018913|NCT02477826|588772701|FG004|Treatment Period|Lost to Follow-up|0|||
163018914|NCT02477826|588772702|FG005|Treatment Period|Lost to Follow-up|0|||
163018915|NCT02477826|588772703|FG006|Treatment Period|Lost to Follow-up|2|||
163018916|NCT02477826|588772704|FG007|Treatment Period|Lost to Follow-up|2|||
163018917|NCT02477826|588772705|FG008|Treatment Period|Lost to Follow-up|0|||
163018918|NCT02477826|588772706|FG009|Treatment Period|Lost to Follow-up|0|||
163018919|NCT02477826|588772697|FG000|Treatment Period|Participant withdrew Consent|5|||
163018920|NCT02477826|588772698|FG001|Treatment Period|Participant withdrew Consent|5|||
163018921|NCT02477826|588772699|FG002|Treatment Period|Participant withdrew Consent|3|||
163018922|NCT02477826|588772700|FG003|Treatment Period|Participant withdrew Consent|3|||
163018923|NCT02477826|588772701|FG004|Treatment Period|Participant withdrew Consent|1|||
163018924|NCT02477826|588772702|FG005|Treatment Period|Participant withdrew Consent|3|||
163018925|NCT02477826|588772703|FG006|Treatment Period|Participant withdrew Consent|3|||
163018926|NCT02477826|588772704|FG007|Treatment Period|Participant withdrew Consent|3|||
163018927|NCT02477826|588772705|FG008|Treatment Period|Participant withdrew Consent|2|||
163018928|NCT02477826|588772706|FG009|Treatment Period|Participant withdrew Consent|3|||
163018929|NCT02477826|588772697|FG000|Treatment Period|Participant request to discontinue treatment|5|||
163018930|NCT02477826|588772698|FG001|Treatment Period|Participant request to discontinue treatment|3|||
163018931|NCT02477826|588772699|FG002|Treatment Period|Participant request to discontinue treatment|15|||
163018932|NCT02477826|588772700|FG003|Treatment Period|Participant request to discontinue treatment|5|||
163018933|NCT02477826|588772701|FG004|Treatment Period|Participant request to discontinue treatment|3|||
163018934|NCT02477826|588772702|FG005|Treatment Period|Participant request to discontinue treatment|6|||
163018935|NCT02477826|588772703|FG006|Treatment Period|Participant request to discontinue treatment|13|||
163018936|NCT02477826|588772704|FG007|Treatment Period|Participant request to discontinue treatment|15|||
163018937|NCT02477826|588772705|FG008|Treatment Period|Participant request to discontinue treatment|4|||
163018938|NCT02477826|588772706|FG009|Treatment Period|Participant request to discontinue treatment|18|||
163018939|NCT02477826|588772697|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
163018940|NCT02477826|588772698|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
163018941|NCT02477826|588772699|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
163018942|NCT02477826|588772700|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
163018943|NCT02477826|588772701|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
163018944|NCT02477826|588772702|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
163018945|NCT02477826|588772703|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
163018946|NCT02477826|588772704|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
163018947|NCT02477826|588772705|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
163018948|NCT02477826|588772706|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
163018949|NCT02477826|588772697|FG000|Treatment Period|Death|4|||
163018950|NCT02477826|588772698|FG001|Treatment Period|Death|7|||
163018951|NCT02477826|588772699|FG002|Treatment Period|Death|0|||
163018952|NCT02477826|588772700|FG003|Treatment Period|Death|0|||
163018953|NCT02477826|588772701|FG004|Treatment Period|Death|1|||
163018954|NCT02477826|588772702|FG005|Treatment Period|Death|2|||
163018955|NCT02477826|588772703|FG006|Treatment Period|Death|6|||
163063249|NCT03314935|588938621|FG004|Phase 1|"Captured as Other in Database"|0|||
163063250|NCT03314935|588938622|FG005|Phase 1|"Captured as Other in Database"|0|||
163063251|NCT03314935|588938623|FG006|Phase 1|"Captured as Other in Database"|1|||
163063252|NCT03314935|588938624|FG007|Phase 1|"Captured as Other in Database"|1|||
163063253|NCT03314935|588938625|FG008|Phase 1|"Captured as Other in Database"|1|||
163063254|NCT03314935|588938626|FG009|Phase 1|"Captured as Other in Database"|0|||
163063255|NCT03314935|588938627|FG010|Phase 1|"Captured as Other in Database"|0|||
163063256|NCT03314935|588938628|FG011|Phase 1|"Captured as Other in Database"|0|||
163018956|NCT02477826|588772704|FG007|Treatment Period|Death|5|||
163018957|NCT02477826|588772705|FG008|Treatment Period|Death|9|||
163018958|NCT02477826|588772706|FG009|Treatment Period|Death|0|||
163018959|NCT02477826|588772697|FG000|Treatment Period|Study Drug Toxicity|79|||
163018960|NCT02477826|588772698|FG001|Treatment Period|Study Drug Toxicity|51|||
163018961|NCT02477826|588772699|FG002|Treatment Period|Study Drug Toxicity|31|||
163018962|NCT02477826|588772700|FG003|Treatment Period|Study Drug Toxicity|39|||
163018963|NCT02477826|588772701|FG004|Treatment Period|Study Drug Toxicity|12|||
163063257|NCT03314935|588938629|FG012|Phase 1|"Captured as Other in Database"|0|||
163215951|NCT01239368|589506173|FG005|Overall Study|Principal investigator discretion|2|||
163215952|NCT01239368|589506174|FG006|Overall Study|Principal investigator discretion|0|||
163215953|NCT01239368|589506175|FG007|Overall Study|Principal investigator discretion|0|||
163215954|NCT01239368|589506176|FG008|Overall Study|Principal investigator discretion|0|||
163215955|NCT01239368|589506177|FG009|Overall Study|Principal investigator discretion|1|||
163215956|NCT01239368|589506168|FG000|Overall Study|Disease progression on study|1|||
163215957|NCT01239368|589506169|FG001|Overall Study|Disease progression on study|1|||
163215958|NCT01239368|589506170|FG002|Overall Study|Disease progression on study|1|||
163215959|NCT01239368|589506171|FG003|Overall Study|Disease progression on study|1|||
163215960|NCT01239368|589506172|FG004|Overall Study|Disease progression on study|4|||
163215961|NCT01239368|589506173|FG005|Overall Study|Disease progression on study|2|||
163215962|NCT01239368|589506174|FG006|Overall Study|Disease progression on study|5|||
163215963|NCT01239368|589506175|FG007|Overall Study|Disease progression on study|0|||
163215964|NCT01239368|589506176|FG008|Overall Study|Disease progression on study|0|||
163215965|NCT01239368|589506177|FG009|Overall Study|Disease progression on study|2|||
163215966|NCT01239368|589506168|FG000|Overall Study|Refused further treatment|0|||
163215967|NCT01239368|589506169|FG001|Overall Study|Refused further treatment|0|||
163215968|NCT01239368|589506170|FG002|Overall Study|Refused further treatment|0|||
163215969|NCT01239368|589506171|FG003|Overall Study|Refused further treatment|0|||
163215970|NCT01239368|589506172|FG004|Overall Study|Refused further treatment|0|||
163215971|NCT01239368|589506173|FG005|Overall Study|Refused further treatment|0|||
163215972|NCT01239368|589506174|FG006|Overall Study|Refused further treatment|0|||
163215973|NCT01239368|589506175|FG007|Overall Study|Refused further treatment|0|||
163215974|NCT01239368|589506176|FG008|Overall Study|Refused further treatment|0|||
163215975|NCT01239368|589506177|FG009|Overall Study|Refused further treatment|1|||
163215976|NCT01239368|589506168|FG000|Overall Study|Death|0|||
163215977|NCT01239368|589506169|FG001|Overall Study|Death|0|||
163215978|NCT01239368|589506170|FG002|Overall Study|Death|0|||
163215979|NCT01239368|589506171|FG003|Overall Study|Death|0|||
163215980|NCT01239368|589506172|FG004|Overall Study|Death|0|||
163215981|NCT01239368|589506173|FG005|Overall Study|Death|0|||
163215982|NCT01239368|589506174|FG006|Overall Study|Death|1|||
163215983|NCT01239368|589506175|FG007|Overall Study|Death|0|||
163215984|NCT01239368|589506176|FG008|Overall Study|Death|0|||
163215985|NCT01239368|589506177|FG009|Overall Study|Death|0|||
163215986|NCT03181399|589506179|FG000|6 Months on Treatment|Protocol non-compliance|7|||
163215987|NCT03181399|589506179|FG000|6 Months on Treatment|Adverse Event|4|||
163215988|NCT03181399|589506179|FG000|6 Months on Treatment|Tried alternative treatment|2|||
163215989|NCT03181399|589506179|FG000|6 Months on Treatment|Lost to Follow-up|2|||
163215990|NCT03181399|589506179|FG000|6 Months on Treatment|Personal reasons|1|||
163215991|NCT03181399|589506179|FG000|3 Months Off-treatment|Parent unable to travel|1|||
163215992|NCT00939809|589506181|FG000|Overall Study|Adverse Event|2|||
163215993|NCT00939809|589506181|FG000|Overall Study|Death|1|||
163215994|NCT01921179|589506182|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
163018964|NCT02477826|588772702|FG005|Treatment Period|Study Drug Toxicity|25|||
163018965|NCT02477826|588772703|FG006|Treatment Period|Study Drug Toxicity|52|||
163018966|NCT02477826|588772704|FG007|Treatment Period|Study Drug Toxicity|30|||
163018967|NCT02477826|588772705|FG008|Treatment Period|Study Drug Toxicity|20|||
163018968|NCT02477826|588772706|FG009|Treatment Period|Study Drug Toxicity|9|||
163018969|NCT02477826|588772697|FG000|Treatment Period|Disease progression|212|||
163018970|NCT02477826|588772698|FG001|Treatment Period|Disease progression|240|||
163018971|NCT02477826|588772699|FG002|Treatment Period|Disease progression|202|||
163018972|NCT02477826|588772700|FG003|Treatment Period|Disease progression|93|||
163018973|NCT02477826|588772701|FG004|Treatment Period|Disease progression|113|||
163018974|NCT02477826|588772702|FG005|Treatment Period|Disease progression|96|||
163018975|NCT02477826|588772703|FG006|Treatment Period|Disease progression|208|||
163018976|NCT02477826|588772704|FG007|Treatment Period|Disease progression|195|||
163018977|NCT02477826|588772705|FG008|Treatment Period|Disease progression|59|||
163018978|NCT02477826|588772706|FG009|Treatment Period|Disease progression|46|||
163018979|NCT02477826|588772697|FG000|Treatment Period|Pregnancy|0|||
163215995|NCT01921179|589506183|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
163215996|NCT01921179|589506182|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
163215997|NCT01921179|589506183|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
163215998|NCT00858442|589506185|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
163215999|NCT00858442|589506186|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
163216000|NCT02016625|589506187|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
163216001|NCT02016625|589506188|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
163216002|NCT02016625|589506187|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
163216003|NCT02016625|589506188|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
163216004|NCT02016625|589506187|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
163018980|NCT02477826|588772698|FG001|Treatment Period|Pregnancy|0|||
163018981|NCT02477826|588772699|FG002|Treatment Period|Pregnancy|0|||
163216005|NCT02016625|589506188|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
163216006|NCT02603809|589506191|FG000|Overall Study|Withdrawal by Subject|4|||
163018982|NCT02477826|588772700|FG003|Treatment Period|Pregnancy|0|||
163018983|NCT02477826|588772701|FG004|Treatment Period|Pregnancy|0|||
163018984|NCT02477826|588772702|FG005|Treatment Period|Pregnancy|0|||
163018985|NCT02477826|588772703|FG006|Treatment Period|Pregnancy|0|||
163018986|NCT02477826|588772704|FG007|Treatment Period|Pregnancy|0|||
163018987|NCT02477826|588772705|FG008|Treatment Period|Pregnancy|0|||
163018988|NCT02477826|588772706|FG009|Treatment Period|Pregnancy|1|||
163018989|NCT02477826|588772697|FG000|Treatment Period|Other|0|||
163018990|NCT02477826|588772698|FG001|Treatment Period|Other|0|||
163018991|NCT02477826|588772699|FG002|Treatment Period|Other|0|||
163018992|NCT02477826|588772700|FG003|Treatment Period|Other|0|||
163018993|NCT02477826|588772701|FG004|Treatment Period|Other|0|||
163018994|NCT02477826|588772702|FG005|Treatment Period|Other|0|||
163018995|NCT02477826|588772703|FG006|Treatment Period|Other|0|||
163018996|NCT02477826|588772704|FG007|Treatment Period|Other|0|||
163018997|NCT02477826|588772705|FG008|Treatment Period|Other|0|||
163018998|NCT02477826|588772706|FG009|Treatment Period|Other|1|||
163018999|NCT00364923|588772740|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
163019000|NCT00364923|588772740|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
163019001|NCT01218087|588772755|FG000|Overall Study|Death|2|||
163019002|NCT01218087|588772756|FG001|Overall Study|Death|1|||
163019003|NCT01218087|588772755|FG000|Overall Study|Withdrawal by Subject|5|||
163019004|NCT01218087|588772756|FG001|Overall Study|Withdrawal by Subject|0|||
163019005|NCT01218087|588772755|FG000|Overall Study|Transferred|8|||
163019006|NCT01218087|588772756|FG001|Overall Study|Transferred|5|||
163019007|NCT03170362|588772757|FG000|Overall Study|Death|2|||
163019008|NCT03170362|588772758|FG001|Overall Study|Death|2|||
163019009|NCT03170362|588772757|FG000|Overall Study|Withdrawal by Subject|23|||
163019010|NCT03170362|588772758|FG001|Overall Study|Withdrawal by Subject|22|||
163019011|NCT03170362|588772757|FG000|Overall Study|Lost to Follow-up|187|||
163019012|NCT03170362|588772758|FG001|Overall Study|Lost to Follow-up|167|||
163019013|NCT00552396|588772759|FG000|Overall Study|protocol withdrawal criteria|3|||
163019014|NCT00552396|588772760|FG001|Overall Study|protocol withdrawal criteria|3|||
163019015|NCT00552396|588772761|FG002|Overall Study|protocol withdrawal criteria|3|||
163019016|NCT00552396|588772762|FG003|Overall Study|protocol withdrawal criteria|6|||
163019017|NCT00552396|588772763|FG004|Overall Study|protocol withdrawal criteria|3|||
163019018|NCT00552396|588772764|FG005|Overall Study|protocol withdrawal criteria|3|||
163019019|NCT00552396|588772765|FG006|Overall Study|protocol withdrawal criteria|9|||
163019020|NCT03340454|588772766|FG000|Overall Study|Lost to Follow-up|0|||
163019021|NCT03340454|588772767|FG001|Overall Study|Lost to Follow-up|4|||
163019022|NCT01972438|588772768|FG000|Baseline-Month 3 Crossover Period|Death|1|||
163019023|NCT01972438|588772769|FG001|Baseline-Month 3 Crossover Period|Death|0|||
163019024|NCT01972438|588772768|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
163019025|NCT01972438|588772769|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
163019026|NCT01972438|588772768|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
163019027|NCT01972438|588772769|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
163019028|NCT01972438|588772768|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
163019029|NCT01972438|588772769|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
163019030|NCT01972438|588772768|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
163019031|NCT01972438|588772769|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
163019032|NCT01972438|588772768|FG000|Months 6-12 Study Period|Death|1|||
163019033|NCT01972438|588772769|FG001|Months 6-12 Study Period|Death|0|||
163019034|NCT01972438|588772768|FG000|Months 6-12 Study Period|Early Study Closure|2|||
163019035|NCT01972438|588772769|FG001|Months 6-12 Study Period|Early Study Closure|2|||
163019036|NCT01972438|588772768|FG000|Post Month 12 Study Period|Early Study Closure|3|||
163019037|NCT01972438|588772769|FG001|Post Month 12 Study Period|Early Study Closure|4|||
163019038|NCT00697463|588772775|FG000|Overall Study|Withdrawal by Subject|1|||
163019039|NCT02568189|588772776|FG000|Overall Study|Protocol Violation|0|||
163019040|NCT02568189|588772777|FG001|Overall Study|Protocol Violation|0|||
163019041|NCT02568189|588772778|FG002|Overall Study|Protocol Violation|19|||
163019042|NCT02568189|588772779|FG003|Overall Study|Protocol Violation|18|||
163019043|NCT00529373|588772780|FG000|Base Study|Adverse Event|525|||
163019044|NCT00529373|588772781|FG001|Base Study|Adverse Event|470|||
163019045|NCT00529373|588772780|FG000|Base Study|Lack of Efficacy|16|||
163019046|NCT00529373|588772781|FG001|Base Study|Lack of Efficacy|75|||
163019047|NCT00529373|588772780|FG000|Base Study|Lost to Follow-up|221|||
163019048|NCT00529373|588772781|FG001|Base Study|Lost to Follow-up|208|||
163019049|NCT00529373|588772780|FG000|Base Study|Other Protocol Specified Criteria|19|||
163019050|NCT00529373|588772781|FG001|Base Study|Other Protocol Specified Criteria|20|||
163019051|NCT00529373|588772780|FG000|Base Study|Physician Decision|60|||
163019052|NCT00529373|588772781|FG001|Base Study|Physician Decision|52|||
163019053|NCT00529373|588772780|FG000|Base Study|Protocol Violation|48|||
163019054|NCT00529373|588772781|FG001|Base Study|Protocol Violation|38|||
163405177|NCT01033825|590193536|FG000|Overall Study|Other|0|||
163019055|NCT00529373|588772780|FG000|Base Study|Withdrawal by Subject|1062|||
163019056|NCT00529373|588772781|FG001|Base Study|Withdrawal by Subject|967|||
163019057|NCT00529373|588772780|FG000|Base Study|Did not continue into Extension|1795|||
163019058|NCT00529373|588772781|FG001|Base Study|Did not continue into Extension|2238|||
163019059|NCT00529373|588772780|FG000|First Extension Study|Adverse Event|162|||
163019060|NCT00529373|588772781|FG001|First Extension Study|Adverse Event|142|||
163019061|NCT00529373|588772780|FG000|First Extension Study|Lack of Efficacy|65|||
163019062|NCT00529373|588772781|FG001|First Extension Study|Lack of Efficacy|427|||
163019063|NCT00529373|588772780|FG000|First Extension Study|Lost to Follow-up|41|||
163019064|NCT00529373|588772781|FG001|First Extension Study|Lost to Follow-up|37|||
163019065|NCT00529373|588772780|FG000|First Extension Study|Other|27|||
163019066|NCT00529373|588772781|FG001|First Extension Study|Other|47|||
163019067|NCT00529373|588772780|FG000|First Extension Study|Physician Decision|50|||
163019068|NCT00529373|588772781|FG001|First Extension Study|Physician Decision|45|||
163019069|NCT00529373|588772780|FG000|First Extension Study|Protocol Violation|16|||
163019070|NCT00529373|588772781|FG001|First Extension Study|Protocol Violation|13|||
163019071|NCT00529373|588772780|FG000|First Extension Study|Withdrawal by Subject|296|||
163019072|NCT00529373|588772781|FG001|First Extension Study|Withdrawal by Subject|287|||
163019073|NCT00529373|588772780|FG000|First Extension Study|Disposition record non-existing|0|||
163019074|NCT00529373|588772781|FG001|First Extension Study|Disposition record non-existing|1|||
163019075|NCT00529373|588772780|FG000|First Extension Study|Discontinued after 5 years completion|208|||
163019076|NCT00529373|588772781|FG001|First Extension Study|Discontinued after 5 years completion|346|||
163019077|NCT00529373|588772780|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
163019078|NCT00529373|588772781|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
163019079|NCT00529373|588772780|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
163019080|NCT00529373|588772781|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
163019081|NCT00529373|588772780|FG000|Second Extension Study|Adverse Event|101|||
163019082|NCT00529373|588772781|FG001|Second Extension Study|Adverse Event|51|||
163019083|NCT00529373|588772780|FG000|Second Extension Study|Lack of Efficacy|7|||
163019084|NCT00529373|588772781|FG001|Second Extension Study|Lack of Efficacy|15|||
163019085|NCT00529373|588772780|FG000|Second Extension Study|Lost to Follow-up|18|||
163019086|NCT00529373|588772781|FG001|Second Extension Study|Lost to Follow-up|12|||
163019087|NCT00529373|588772780|FG000|Second Extension Study|Other|7|||
163019088|NCT00529373|588772781|FG001|Second Extension Study|Other|12|||
163019089|NCT00529373|588772780|FG000|Second Extension Study|Physician Decision|63|||
163019090|NCT00529373|588772781|FG001|Second Extension Study|Physician Decision|26|||
163019091|NCT00529373|588772780|FG000|Second Extension Study|Protocol Violation|2|||
163019092|NCT00529373|588772781|FG001|Second Extension Study|Protocol Violation|1|||
163019093|NCT00529373|588772780|FG000|Second Extension Study|Withdrawal by Subject|97|||
163019094|NCT00529373|588772781|FG001|Second Extension Study|Withdrawal by Subject|75|||
163019095|NCT00529373|588772780|FG000|Second Extension Study|Status Missing|5|||
163019096|NCT00529373|588772781|FG001|Second Extension Study|Status Missing|5|||
163019097|NCT01074268|588772784|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
163019098|NCT01074268|588772785|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
163019099|NCT01074268|588772784|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
163019100|NCT01074268|588772785|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
163019101|NCT01074268|588772784|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
163019102|NCT01074268|588772785|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
163019103|NCT01074268|588772784|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
163019104|NCT01074268|588772785|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
163019105|NCT01074268|588772784|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
163019106|NCT01074268|588772785|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
163019107|NCT01074268|588772784|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
163019108|NCT01074268|588772785|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
163216007|NCT02603809|589506192|FG001|Overall Study|Withdrawal by Subject|1|||
163216008|NCT02603809|589506193|FG002|Overall Study|Withdrawal by Subject|2|||
163019109|NCT01074268|588772784|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
163019110|NCT01074268|588772785|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
163019111|NCT01074268|588772784|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
163019112|NCT01074268|588772785|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
163019113|NCT01074268|588772784|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
163019114|NCT01074268|588772785|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
163019115|NCT00603473|588772790|FG000|Overall Study|Adverse Event|4|||
163019116|NCT00603473|588772790|FG000|Overall Study|Lack of Efficacy|4|||
163019117|NCT00603473|588772790|FG000|Overall Study|Protocol Violation|1|||
163019118|NCT01134939|588772794|FG000|Overall Study|Adverse Event|9|||
163019119|NCT01134939|588772795|FG001|Overall Study|Adverse Event|3|||
163019120|NCT01134939|588772796|FG002|Overall Study|Adverse Event|4|||
163063258|NCT03314935|588938630|FG013|Phase 1|"Captured as Other in Database"|0|||
163063259|NCT03314935|588938631|FG014|Phase 1|"Captured as Other in Database"|0|||
163216009|NCT02603809|589506194|FG003|Overall Study|Withdrawal by Subject|3|||
163216010|NCT02603809|589506195|FG004|Overall Study|Withdrawal by Subject|3|||
163216011|NCT02603809|589506196|FG005|Overall Study|Withdrawal by Subject|4|||
163216012|NCT02603809|589506191|FG000|Overall Study|Lost to Follow-up|2|||
163216013|NCT02603809|589506192|FG001|Overall Study|Lost to Follow-up|3|||
163019121|NCT01134939|588772797|FG003|Overall Study|Adverse Event|5|||
163019122|NCT01134939|588772798|FG004|Overall Study|Adverse Event|5|||
163019123|NCT01134939|588772799|FG005|Overall Study|Adverse Event|5|||
163019124|NCT01134939|588772800|FG006|Overall Study|Adverse Event|1|||
163019125|NCT01134939|588772801|FG007|Overall Study|Adverse Event|0|||
163019126|NCT01134939|588772794|FG000|Overall Study|Lack of Efficacy|2|||
163019127|NCT01134939|588772795|FG001|Overall Study|Lack of Efficacy|5|||
163019128|NCT01134939|588772796|FG002|Overall Study|Lack of Efficacy|1|||
163019129|NCT01134939|588772797|FG003|Overall Study|Lack of Efficacy|0|||
163019130|NCT01134939|588772798|FG004|Overall Study|Lack of Efficacy|3|||
163019131|NCT01134939|588772799|FG005|Overall Study|Lack of Efficacy|0|||
163019132|NCT01134939|588772800|FG006|Overall Study|Lack of Efficacy|1|||
163019133|NCT01134939|588772801|FG007|Overall Study|Lack of Efficacy|0|||
163019134|NCT01134939|588772794|FG000|Overall Study|Lost to Follow-up|2|||
163019135|NCT01134939|588772795|FG001|Overall Study|Lost to Follow-up|3|||
163019136|NCT01134939|588772796|FG002|Overall Study|Lost to Follow-up|0|||
163019137|NCT01134939|588772797|FG003|Overall Study|Lost to Follow-up|1|||
163019138|NCT01134939|588772798|FG004|Overall Study|Lost to Follow-up|2|||
163019139|NCT01134939|588772799|FG005|Overall Study|Lost to Follow-up|1|||
163019140|NCT01134939|588772800|FG006|Overall Study|Lost to Follow-up|0|||
163019141|NCT01134939|588772801|FG007|Overall Study|Lost to Follow-up|0|||
163019142|NCT01134939|588772794|FG000|Overall Study|Death|0|||
163019143|NCT01134939|588772795|FG001|Overall Study|Death|1|||
163019144|NCT01134939|588772796|FG002|Overall Study|Death|0|||
163019145|NCT01134939|588772797|FG003|Overall Study|Death|0|||
163019146|NCT01134939|588772798|FG004|Overall Study|Death|0|||
163019147|NCT01134939|588772799|FG005|Overall Study|Death|0|||
163019148|NCT01134939|588772800|FG006|Overall Study|Death|0|||
163019149|NCT01134939|588772801|FG007|Overall Study|Death|0|||
163019150|NCT01134939|588772794|FG000|Overall Study|Termination page not available|4|||
163019151|NCT01134939|588772795|FG001|Overall Study|Termination page not available|6|||
163019152|NCT01134939|588772796|FG002|Overall Study|Termination page not available|5|||
163019153|NCT01134939|588772797|FG003|Overall Study|Termination page not available|8|||
163019154|NCT01134939|588772798|FG004|Overall Study|Termination page not available|0|||
163019155|NCT01134939|588772799|FG005|Overall Study|Termination page not available|3|||
163019156|NCT01134939|588772800|FG006|Overall Study|Termination page not available|7|||
163019157|NCT01134939|588772801|FG007|Overall Study|Termination page not available|0|||
163019158|NCT03225105|588772802|FG000|Overall Study|Withdrawal by Subject|1|||
163019159|NCT03225105|588772803|FG001|Overall Study|Withdrawal by Subject|0|||
163019160|NCT03225105|588772804|FG002|Overall Study|Withdrawal by Subject|0|||
163019161|NCT03225105|588772805|FG003|Overall Study|Withdrawal by Subject|0|||
163019162|NCT03225105|588772802|FG000|Overall Study|Death|0|||
163019163|NCT03225105|588772803|FG001|Overall Study|Death|4|||
163019164|NCT03225105|588772804|FG002|Overall Study|Death|2|||
163019165|NCT03225105|588772805|FG003|Overall Study|Death|0|||
163019166|NCT03225105|588772802|FG000|Overall Study|Study termination per Sponsor Decision|2|||
163019167|NCT03225105|588772803|FG001|Overall Study|Study termination per Sponsor Decision|0|||
163019168|NCT03225105|588772804|FG002|Overall Study|Study termination per Sponsor Decision|3|||
163019169|NCT03225105|588772805|FG003|Overall Study|Study termination per Sponsor Decision|3|||
163019170|NCT05488470|588774356|FG000|Overall Study|Physician Decision|2|||
163019171|NCT05488470|588774356|FG000|Overall Study|Withdrawal by Subject|1|||
163019172|NCT05488470|588774356|FG000|Overall Study|Death|1|||
163019173|NCT01736397|588774357|FG000|Overall Study|Lack of Efficacy|1|||
163019174|NCT01736397|588774358|FG001|Overall Study|Lack of Efficacy|11|||
163019175|NCT01736397|588774357|FG000|Overall Study|Withdrawal by Subject|6|||
163019176|NCT01736397|588774358|FG001|Overall Study|Withdrawal by Subject|5|||
163019177|NCT01736397|588774357|FG000|Overall Study|Lost to Follow-up|0|||
163019178|NCT01736397|588774358|FG001|Overall Study|Lost to Follow-up|1|||
163019179|NCT01736397|588774357|FG000|Overall Study|Adverse Event|6|||
163019180|NCT01736397|588774358|FG001|Overall Study|Adverse Event|3|||
163019181|NCT01736397|588774357|FG000|Overall Study|Not stated|1|||
163019182|NCT01736397|588774358|FG001|Overall Study|Not stated|4|||
163019183|NCT01868438|588774359|FG000|First Intervention|Withdrawal by Subject|5|||
163019184|NCT01868438|588774360|FG001|First Intervention|Withdrawal by Subject|1|||
163019185|NCT01868438|588774359|FG000|First Intervention|Lost to Follow-up|2|||
163019186|NCT01868438|588774360|FG001|First Intervention|Lost to Follow-up|3|||
163019187|NCT01868438|588774359|FG000|First Intervention|Meeting the non-redosing criteria|0|||
163019188|NCT01868438|588774360|FG001|First Intervention|Meeting the non-redosing criteria|1|||
163019189|NCT01868438|588774359|FG000|Second Intervention|Adverse Event|3|||
163019190|NCT01868438|588774360|FG001|Second Intervention|Adverse Event|3|||
163019191|NCT01284348|588774361|FG000|Overall Study|Death|1|||
163019192|NCT01284348|588774362|FG001|Overall Study|Death|1|||
163019193|NCT01284348|588774361|FG000|Overall Study|Withdrew consent|0|||
163019194|NCT01284348|588774362|FG001|Overall Study|Withdrew consent|1|||
163019195|NCT01284348|588774361|FG000|Overall Study|Status not recorded|9|||
163019196|NCT01284348|588774362|FG001|Overall Study|Status not recorded|10|||
163019197|NCT02347774|588774363|FG000|Study Participation|Lost to Follow-up|3|||
163019198|NCT02347774|588774364|FG001|Study Participation|Lost to Follow-up|6|||
163019199|NCT02347774|588774365|FG002|Study Participation|Lost to Follow-up|2|||
163019200|NCT02347774|588774363|FG000|Study Participation|Withdrawal by Subject|8|||
163019201|NCT02347774|588774364|FG001|Study Participation|Withdrawal by Subject|9|||
163019202|NCT02347774|588774365|FG002|Study Participation|Withdrawal by Subject|15|||
163019203|NCT02347774|588774363|FG000|Study Participation|Adverse Event|1|||
163019204|NCT02347774|588774364|FG001|Study Participation|Adverse Event|4|||
163019205|NCT02347774|588774365|FG002|Study Participation|Adverse Event|6|||
163019206|NCT02347774|588774363|FG000|Study Participation|withdrew consent|1|||
163019207|NCT02347774|588774364|FG001|Study Participation|withdrew consent|1|||
163019208|NCT02347774|588774365|FG002|Study Participation|withdrew consent|1|||
163019209|NCT02347774|588774363|FG000|Study Participation|Met Prolonged QT criteria|1|||
163019210|NCT02347774|588774364|FG001|Study Participation|Met Prolonged QT criteria|0|||
163019211|NCT02347774|588774365|FG002|Study Participation|Met Prolonged QT criteria|0|||
163019212|NCT02347774|588774363|FG000|Study Participation|non-compliance with study drug|0|||
163019213|NCT02347774|588774364|FG001|Study Participation|non-compliance with study drug|1|||
163019214|NCT02347774|588774365|FG002|Study Participation|non-compliance with study drug|0|||
163019215|NCT02347774|588774363|FG000|Study Participation|incarceration|1|||
163019216|NCT02347774|588774364|FG001|Study Participation|incarceration|0|||
163019217|NCT02347774|588774365|FG002|Study Participation|incarceration|0|||
163019218|NCT02347774|588774363|FG000|Study Participation|randomized in error|0|||
163019219|NCT02347774|588774364|FG001|Study Participation|randomized in error|0|||
163019220|NCT02347774|588774365|FG002|Study Participation|randomized in error|1|||
163019221|NCT02347774|588774363|FG000|On Study Treatment|Adverse Event|9|||
163019222|NCT02347774|588774364|FG001|On Study Treatment|Adverse Event|15|||
163019223|NCT02347774|588774365|FG002|On Study Treatment|Adverse Event|19|||
163019224|NCT02347774|588774363|FG000|On Study Treatment|Lack of Efficacy|3|||
163019225|NCT02347774|588774364|FG001|On Study Treatment|Lack of Efficacy|0|||
163019226|NCT02347774|588774365|FG002|On Study Treatment|Lack of Efficacy|2|||
163019227|NCT02347774|588774363|FG000|On Study Treatment|non-complicance with study medication|0|||
163019228|NCT02347774|588774364|FG001|On Study Treatment|non-complicance with study medication|2|||
163019229|NCT02347774|588774365|FG002|On Study Treatment|non-complicance with study medication|0|||
163019230|NCT02347774|588774363|FG000|On Study Treatment|Protocol Violation|0|||
163019231|NCT02347774|588774364|FG001|On Study Treatment|Protocol Violation|0|||
163019232|NCT02347774|588774365|FG002|On Study Treatment|Protocol Violation|1|||
163019233|NCT02347774|588774363|FG000|On Study Treatment|withdrew consent|9|||
163019234|NCT02347774|588774364|FG001|On Study Treatment|withdrew consent|8|||
163019235|NCT02347774|588774365|FG002|On Study Treatment|withdrew consent|12|||
163019236|NCT02347774|588774363|FG000|On Study Treatment|Lost to Follow-up|2|||
163019237|NCT02347774|588774364|FG001|On Study Treatment|Lost to Follow-up|6|||
163019238|NCT02347774|588774365|FG002|On Study Treatment|Lost to Follow-up|1|||
163019239|NCT02347774|588774363|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
163019240|NCT02347774|588774364|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
163019241|NCT02347774|588774365|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
163019242|NCT02347774|588774363|FG000|On Study Treatment|ranomized in error|0|||
163019243|NCT02347774|588774364|FG001|On Study Treatment|ranomized in error|0|||
163019244|NCT02347774|588774365|FG002|On Study Treatment|ranomized in error|1|||
163019245|NCT04075682|588774368|FG000|Overall Study|Lost to Follow-up|5|||
163019246|NCT04075682|588774369|FG001|Overall Study|Lost to Follow-up|5|||
163019247|NCT04075682|588774370|FG002|Overall Study|Lost to Follow-up|2|||
163019248|NCT04075682|588774371|FG003|Overall Study|Lost to Follow-up|2|||
163019249|NCT04075682|588774368|FG000|Overall Study|Withdrawal by Subject|1|||
163019250|NCT04075682|588774369|FG001|Overall Study|Withdrawal by Subject|0|||
163019251|NCT04075682|588774370|FG002|Overall Study|Withdrawal by Subject|1|||
163019252|NCT04075682|588774371|FG003|Overall Study|Withdrawal by Subject|0|||
163019253|NCT04075682|588774368|FG000|Overall Study|Protocol Violation|0|||
163019254|NCT04075682|588774369|FG001|Overall Study|Protocol Violation|1|||
163019255|NCT04075682|588774370|FG002|Overall Study|Protocol Violation|1|||
163019256|NCT04075682|588774371|FG003|Overall Study|Protocol Violation|0|||
163019257|NCT04075682|588774368|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
163019258|NCT04075682|588774369|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
163019259|NCT04075682|588774370|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
163019260|NCT04075682|588774371|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
163019261|NCT04075682|588774368|FG000|Overall Study|Lost study phone the first day of study participation|0|||
163019262|NCT04075682|588774369|FG001|Overall Study|Lost study phone the first day of study participation|1|||
163019263|NCT04075682|588774370|FG002|Overall Study|Lost study phone the first day of study participation|0|||
163063260|NCT03314935|588938617|FG000|Phase 1|Lost to Follow-up|0|||
163019264|NCT04075682|588774371|FG003|Overall Study|Lost study phone the first day of study participation|0|||
163063261|NCT03314935|588938618|FG001|Phase 1|Lost to Follow-up|0|||
163019265|NCT00954941|588774372|FG000|Overall Study|Received treatment at home|1|||
163019266|NCT00954941|588774373|FG001|Overall Study|Received treatment at home|0|||
163019267|NCT00954941|588774372|FG000|Overall Study|Withdrawal by Subject|1|||
163019268|NCT00954941|588774373|FG001|Overall Study|Withdrawal by Subject|0|||
163019269|NCT00954941|588774372|FG000|Overall Study|Insurance Denial|2|||
163019270|NCT00954941|588774373|FG001|Overall Study|Insurance Denial|2|||
163216014|NCT02603809|589506193|FG002|Overall Study|Lost to Follow-up|1|||
163216015|NCT02603809|589506194|FG003|Overall Study|Lost to Follow-up|4|||
163216016|NCT02603809|589506195|FG004|Overall Study|Lost to Follow-up|2|||
163216017|NCT02603809|589506196|FG005|Overall Study|Lost to Follow-up|2|||
163216018|NCT02603809|589506191|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
163019271|NCT00954941|588774372|FG000|Overall Study|Physician Decision|2|||
163019272|NCT00954941|588774373|FG001|Overall Study|Physician Decision|2|||
163019273|NCT00954941|588774372|FG000|Overall Study|Ineligible|2|||
163019274|NCT00954941|588774373|FG001|Overall Study|Ineligible|2|||
163019275|NCT00954941|588774372|FG000|Overall Study|Adverse Event|0|||
163019276|NCT00954941|588774373|FG001|Overall Study|Adverse Event|1|||
163019277|NCT00955955|588774374|FG000|Overall Study|Lost to Follow-up|2|||
163019278|NCT00955955|588774375|FG001|Overall Study|Lost to Follow-up|0|||
163019279|NCT00955955|588774376|FG002|Overall Study|Lost to Follow-up|0|||
163019280|NCT03423173|588774380|FG000|Overall Study|Randomized but not vaccinated|1|||
163019281|NCT03423173|588774381|FG001|Overall Study|Randomized but not vaccinated|0|||
163019282|NCT03423173|588774382|FG002|Overall Study|Randomized but not vaccinated|2|||
163019283|NCT03423173|588774383|FG003|Overall Study|Randomized but not vaccinated|1|||
163019284|NCT03423173|588774380|FG000|Overall Study|Adverse Event|1|||
163019285|NCT03423173|588774381|FG001|Overall Study|Adverse Event|1|||
163019286|NCT03423173|588774382|FG002|Overall Study|Adverse Event|1|||
163019287|NCT03423173|588774383|FG003|Overall Study|Adverse Event|1|||
163019288|NCT03423173|588774380|FG000|Overall Study|Lost to Follow-up|10|||
163019289|NCT03423173|588774381|FG001|Overall Study|Lost to Follow-up|19|||
163019290|NCT03423173|588774382|FG002|Overall Study|Lost to Follow-up|17|||
163019291|NCT03423173|588774383|FG003|Overall Study|Lost to Follow-up|22|||
163019292|NCT03423173|588774380|FG000|Overall Study|Withdrawal of consent|4|||
163019293|NCT03423173|588774381|FG001|Overall Study|Withdrawal of consent|10|||
163019294|NCT03423173|588774382|FG002|Overall Study|Withdrawal of consent|4|||
163019295|NCT03423173|588774383|FG003|Overall Study|Withdrawal of consent|5|||
163019296|NCT03423173|588774380|FG000|Overall Study|Death|1|||
163019297|NCT03423173|588774381|FG001|Overall Study|Death|0|||
163019298|NCT03423173|588774382|FG002|Overall Study|Death|0|||
163019299|NCT03423173|588774383|FG003|Overall Study|Death|0|||
163019300|NCT03423173|588774380|FG000|Overall Study|Reason not Specified|2|||
163019301|NCT03423173|588774381|FG001|Overall Study|Reason not Specified|5|||
163019302|NCT03423173|588774382|FG002|Overall Study|Reason not Specified|3|||
163019303|NCT03423173|588774383|FG003|Overall Study|Reason not Specified|1|||
163019304|NCT02071706|588774384|FG000|Overall Study|Adverse Event|1|||
163019305|NCT02071706|588774384|FG000|Overall Study|Withdrawal by Subject|2|||
163019306|NCT02247440|588774385|FG000|Overall Study|Withdrawal by Subject|1|||
163019307|NCT02247440|588774385|FG000|Overall Study|Lack of Efficacy|3|||
163019308|NCT00729157|588774386|FG000|Overall Study|Withdrawal by Subject|1|||
163019309|NCT01062113|588774387|FG000|Overall Study|Adverse Event|1|||
163019310|NCT01062113|588774388|FG001|Overall Study|Adverse Event|0|||
163019311|NCT01062113|588774389|FG002|Overall Study|Adverse Event|0|||
163019312|NCT01062113|588774387|FG000|Overall Study|Lack of Efficacy|38|||
163019313|NCT01062113|588774388|FG001|Overall Study|Lack of Efficacy|22|||
163019314|NCT01062113|588774389|FG002|Overall Study|Lack of Efficacy|31|||
163019315|NCT01062113|588774387|FG000|Overall Study|Withdrawal by Subject|1|||
163019316|NCT01062113|588774388|FG001|Overall Study|Withdrawal by Subject|0|||
163019317|NCT01062113|588774389|FG002|Overall Study|Withdrawal by Subject|0|||
163019318|NCT03499899|588774390|FG000|Overall Study|Adverse Event|2|||
163019319|NCT03499899|588774391|FG001|Overall Study|Adverse Event|3|||
163019320|NCT03499899|588774392|FG002|Overall Study|Adverse Event|3|||
163019321|NCT03499899|588774390|FG000|Overall Study|Death|0|||
163019322|NCT03499899|588774391|FG001|Overall Study|Death|0|||
163019323|NCT03499899|588774392|FG002|Overall Study|Death|1|||
163216019|NCT02603809|589506192|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
163216020|NCT02603809|589506193|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
163216021|NCT02603809|589506194|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
163019324|NCT03499899|588774390|FG000|Overall Study|Physician Decision|3|||
163019325|NCT03499899|588774391|FG001|Overall Study|Physician Decision|6|||
163216022|NCT02603809|589506195|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
163216023|NCT02603809|589506196|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
163216024|NCT02603809|589506191|FG000|Overall Study|Physician Decision|0|||
163328977|NCT05580003|589914921|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163019326|NCT03499899|588774392|FG002|Overall Study|Physician Decision|6|||
163019327|NCT03499899|588774390|FG000|Overall Study|Progressive disease|15|||
163019328|NCT03499899|588774391|FG001|Overall Study|Progressive disease|23|||
163019329|NCT03499899|588774392|FG002|Overall Study|Progressive disease|23|||
163019330|NCT03499899|588774390|FG000|Overall Study|Patient decision|0|||
163019331|NCT03499899|588774391|FG001|Overall Study|Patient decision|1|||
163019332|NCT03499899|588774392|FG002|Overall Study|Patient decision|1|||
163019333|NCT03499899|588774390|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
163019334|NCT03499899|588774391|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
163019335|NCT03499899|588774392|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
163019336|NCT03655470|588774393|FG000|Overall Study|Lost to Follow-up|6|||
163019337|NCT03655470|588774394|FG001|Overall Study|Lost to Follow-up|7|||
163019338|NCT03063086|588774395|FG000|Overall Study|technical problems|1|||
163019339|NCT03063086|588774396|FG001|Overall Study|technical problems|0|||
163019340|NCT03063086|588774397|FG002|Overall Study|technical problems|0|||
163019341|NCT03063086|588774398|FG003|Overall Study|technical problems|0|||
163019342|NCT03063086|588774399|FG004|Overall Study|technical problems|0|||
163019343|NCT03063086|588774400|FG005|Overall Study|technical problems|0|||
163019344|NCT03063086|588774395|FG000|Overall Study|Adverse Event|1|||
163019345|NCT03063086|588774396|FG001|Overall Study|Adverse Event|1|||
163019346|NCT03063086|588774397|FG002|Overall Study|Adverse Event|1|||
163019347|NCT03063086|588774398|FG003|Overall Study|Adverse Event|1|||
163019348|NCT03063086|588774399|FG004|Overall Study|Adverse Event|0|||
163019349|NCT03063086|588774400|FG005|Overall Study|Adverse Event|0|||
163019350|NCT03063086|588774395|FG000|Overall Study|subject/guardian decision|1|||
163019351|NCT03063086|588774396|FG001|Overall Study|subject/guardian decision|0|||
163019352|NCT03063086|588774397|FG002|Overall Study|subject/guardian decision|0|||
163019353|NCT03063086|588774398|FG003|Overall Study|subject/guardian decision|0|||
163019354|NCT03063086|588774399|FG004|Overall Study|subject/guardian decision|0|||
163019355|NCT03063086|588774400|FG005|Overall Study|subject/guardian decision|0|||
163019356|NCT03063086|588774395|FG000|Overall Study|Non-compliance with study treatment|0|||
163019357|NCT03063086|588774396|FG001|Overall Study|Non-compliance with study treatment|0|||
163019358|NCT03063086|588774397|FG002|Overall Study|Non-compliance with study treatment|0|||
163019359|NCT03063086|588774398|FG003|Overall Study|Non-compliance with study treatment|1|||
163019360|NCT03063086|588774399|FG004|Overall Study|Non-compliance with study treatment|0|||
163019361|NCT03063086|588774400|FG005|Overall Study|Non-compliance with study treatment|1|||
163019362|NCT03063086|588774395|FG000|Overall Study|Physician Decision|0|||
163019363|NCT03063086|588774396|FG001|Overall Study|Physician Decision|0|||
163019364|NCT03063086|588774397|FG002|Overall Study|Physician Decision|0|||
163019365|NCT03063086|588774398|FG003|Overall Study|Physician Decision|1|||
163019366|NCT03063086|588774399|FG004|Overall Study|Physician Decision|0|||
163019367|NCT03063086|588774400|FG005|Overall Study|Physician Decision|0|||
163019368|NCT02244463|588774405|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
163019369|NCT02244463|588774406|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
163019370|NCT02244463|588774407|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
163019371|NCT02244463|588774408|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
163019372|NCT02244463|588774409|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
163019373|NCT02244463|588774410|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
163019374|NCT02244463|588774405|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
163019375|NCT02244463|588774406|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
163019376|NCT02244463|588774407|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
163019377|NCT02244463|588774408|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
163019378|NCT02244463|588774409|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
163019379|NCT02244463|588774410|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
163019380|NCT02244463|588774405|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
163019381|NCT02244463|588774406|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
163019382|NCT02244463|588774407|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
163019383|NCT02244463|588774408|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
163019384|NCT02244463|588774409|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
163019385|NCT02244463|588774410|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
163019386|NCT02244463|588774405|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
163019387|NCT02244463|588774406|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
163019388|NCT02244463|588774407|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
163019389|NCT02244463|588774408|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
163019390|NCT02244463|588774409|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
163019391|NCT02244463|588774410|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
163019392|NCT02244463|588774405|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
163019393|NCT02244463|588774406|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
163019394|NCT02244463|588774407|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
163019395|NCT02244463|588774408|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
163019396|NCT02244463|588774409|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
163019397|NCT02244463|588774410|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
163019398|NCT02244463|588774405|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
163019399|NCT02244463|588774406|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
163019400|NCT02244463|588774407|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
163019401|NCT02244463|588774408|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
163019402|NCT02244463|588774409|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
163019403|NCT02244463|588774410|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
163019404|NCT02244463|588774405|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
163063262|NCT03314935|588938619|FG002|Phase 1|Lost to Follow-up|0|||
163063263|NCT03314935|588938620|FG003|Phase 1|Lost to Follow-up|0|||
163019405|NCT02244463|588774406|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
163019406|NCT02244463|588774407|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
163019407|NCT02244463|588774408|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
163019408|NCT02244463|588774409|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
163019409|NCT02244463|588774410|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
163019410|NCT02244463|588774405|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
163019411|NCT02244463|588774406|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
163019412|NCT02244463|588774407|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
163019413|NCT02244463|588774408|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
163019414|NCT02244463|588774409|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
163019415|NCT02244463|588774410|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
163019416|NCT02244463|588774405|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
163019417|NCT02244463|588774406|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
163019418|NCT02244463|588774407|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
163019419|NCT02244463|588774408|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
163019420|NCT02244463|588774409|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
163019421|NCT02244463|588774410|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
163019422|NCT02244463|588774405|FG000|Period 5: Phase II|Disease Progression|0|||
163019423|NCT02244463|588774406|FG001|Period 5: Phase II|Disease Progression|0|||
163019424|NCT02244463|588774407|FG002|Period 5: Phase II|Disease Progression|0|||
163019425|NCT02244463|588774408|FG003|Period 5: Phase II|Disease Progression|0|||
163019426|NCT02244463|588774409|FG004|Period 5: Phase II|Disease Progression|10|||
163019427|NCT02244463|588774410|FG005|Period 5: Phase II|Disease Progression|11|||
163019428|NCT02244463|588774405|FG000|Period 5: Phase II|Physician Decision|0|||
163019429|NCT02244463|588774406|FG001|Period 5: Phase II|Physician Decision|0|||
163063264|NCT03314935|588938621|FG004|Phase 1|Lost to Follow-up|0|||
163063265|NCT03314935|588938622|FG005|Phase 1|Lost to Follow-up|0|||
163063266|NCT03314935|588938623|FG006|Phase 1|Lost to Follow-up|0|||
163063267|NCT03314935|588938624|FG007|Phase 1|Lost to Follow-up|0|||
163063268|NCT03314935|588938625|FG008|Phase 1|Lost to Follow-up|1|||
163063269|NCT03314935|588938626|FG009|Phase 1|Lost to Follow-up|0|||
163063270|NCT03314935|588938627|FG010|Phase 1|Lost to Follow-up|0|||
163063271|NCT03314935|588938628|FG011|Phase 1|Lost to Follow-up|0|||
163063272|NCT03314935|588938629|FG012|Phase 1|Lost to Follow-up|0|||
163063273|NCT03314935|588938630|FG013|Phase 1|Lost to Follow-up|0|||
163063274|NCT03314935|588938631|FG014|Phase 1|Lost to Follow-up|0|||
163063275|NCT03314935|588938617|FG000|Phase 2|Death|0|||
163063276|NCT03314935|588938618|FG001|Phase 2|Death|0|||
163063277|NCT03314935|588938619|FG002|Phase 2|Death|0|||
163063278|NCT03314935|588938620|FG003|Phase 2|Death|0|||
163063279|NCT03314935|588938621|FG004|Phase 2|Death|0|||
163063280|NCT03314935|588938622|FG005|Phase 2|Death|0|||
163063281|NCT03314935|588938623|FG006|Phase 2|Death|0|||
163063282|NCT03314935|588938624|FG007|Phase 2|Death|0|||
163063283|NCT03314935|588938625|FG008|Phase 2|Death|0|||
163063284|NCT03314935|588938626|FG009|Phase 2|Death|5|||
163063285|NCT03314935|588938627|FG010|Phase 2|Death|20|||
163063286|NCT03314935|588938628|FG011|Phase 2|Death|6|||
163063287|NCT03314935|588938629|FG012|Phase 2|Death|7|||
163063288|NCT03314935|588938630|FG013|Phase 2|Death|6|||
163063289|NCT03314935|588938631|FG014|Phase 2|Death|17|||
163063290|NCT03314935|588938617|FG000|Phase 2|Withdrawal by Subject|0|||
163063291|NCT03314935|588938618|FG001|Phase 2|Withdrawal by Subject|0|||
163063292|NCT03314935|588938619|FG002|Phase 2|Withdrawal by Subject|0|||
163063293|NCT03314935|588938620|FG003|Phase 2|Withdrawal by Subject|0|||
163063294|NCT03314935|588938621|FG004|Phase 2|Withdrawal by Subject|0|||
163063295|NCT03314935|588938622|FG005|Phase 2|Withdrawal by Subject|0|||
163063296|NCT03314935|588938623|FG006|Phase 2|Withdrawal by Subject|0|||
163063297|NCT03314935|588938624|FG007|Phase 2|Withdrawal by Subject|0|||
163063298|NCT03314935|588938625|FG008|Phase 2|Withdrawal by Subject|0|||
163063299|NCT03314935|588938626|FG009|Phase 2|Withdrawal by Subject|1|||
163063300|NCT03314935|588938627|FG010|Phase 2|Withdrawal by Subject|4|||
163063301|NCT03314935|588938628|FG011|Phase 2|Withdrawal by Subject|0|||
163063302|NCT03314935|588938629|FG012|Phase 2|Withdrawal by Subject|1|||
163063303|NCT03314935|588938630|FG013|Phase 2|Withdrawal by Subject|0|||
163216025|NCT02603809|589506192|FG001|Overall Study|Physician Decision|0|||
163216026|NCT02603809|589506193|FG002|Overall Study|Physician Decision|0|||
163216027|NCT02603809|589506194|FG003|Overall Study|Physician Decision|1|||
163216028|NCT02603809|589506195|FG004|Overall Study|Physician Decision|2|||
163216029|NCT02603809|589506196|FG005|Overall Study|Physician Decision|1|||
163063304|NCT03314935|588938631|FG014|Phase 2|Withdrawal by Subject|1|||
163063305|NCT03314935|588938617|FG000|Phase 2|Progressive Disease|0|||
163063306|NCT03314935|588938618|FG001|Phase 2|Progressive Disease|0|||
163063307|NCT03314935|588938619|FG002|Phase 2|Progressive Disease|0|||
163063308|NCT03314935|588938620|FG003|Phase 2|Progressive Disease|0|||
163063309|NCT03314935|588938621|FG004|Phase 2|Progressive Disease|0|||
163063310|NCT03314935|588938622|FG005|Phase 2|Progressive Disease|0|||
163063311|NCT03314935|588938623|FG006|Phase 2|Progressive Disease|0|||
163216030|NCT02603809|589506191|FG000|Overall Study|Adverse Event|3|||
163216031|NCT02603809|589506192|FG001|Overall Study|Adverse Event|0|||
163063312|NCT03314935|588938624|FG007|Phase 2|Progressive Disease|0|||
163019430|NCT02244463|588774407|FG002|Period 5: Phase II|Physician Decision|0|||
163019431|NCT02244463|588774408|FG003|Period 5: Phase II|Physician Decision|0|||
163019432|NCT02244463|588774409|FG004|Period 5: Phase II|Physician Decision|3|||
163019433|NCT02244463|588774410|FG005|Period 5: Phase II|Physician Decision|2|||
163019434|NCT02244463|588774405|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
163019435|NCT02244463|588774406|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
163019436|NCT02244463|588774407|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
163019437|NCT02244463|588774408|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
163019438|NCT02244463|588774409|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
163019439|NCT02244463|588774410|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
163019440|NCT02244463|588774405|FG000|Period 5: Phase II|Intercurrent Illness|0|||
163019441|NCT02244463|588774406|FG001|Period 5: Phase II|Intercurrent Illness|0|||
163019442|NCT02244463|588774407|FG002|Period 5: Phase II|Intercurrent Illness|0|||
163019443|NCT02244463|588774408|FG003|Period 5: Phase II|Intercurrent Illness|0|||
163019444|NCT02244463|588774409|FG004|Period 5: Phase II|Intercurrent Illness|2|||
163019445|NCT02244463|588774410|FG005|Period 5: Phase II|Intercurrent Illness|0|||
163019446|NCT02244463|588774405|FG000|Period 5: Phase II|Adverse Event|0|||
163019447|NCT02244463|588774406|FG001|Period 5: Phase II|Adverse Event|0|||
163019448|NCT02244463|588774407|FG002|Period 5: Phase II|Adverse Event|0|||
163019449|NCT02244463|588774408|FG003|Period 5: Phase II|Adverse Event|0|||
163019450|NCT02244463|588774409|FG004|Period 5: Phase II|Adverse Event|0|||
163019451|NCT02244463|588774410|FG005|Period 5: Phase II|Adverse Event|2|||
163019452|NCT02244463|588774405|FG000|Period 5: Phase II|Still On treatment|0|||
163019453|NCT02244463|588774406|FG001|Period 5: Phase II|Still On treatment|0|||
163019454|NCT02244463|588774407|FG002|Period 5: Phase II|Still On treatment|0|||
163019455|NCT02244463|588774408|FG003|Period 5: Phase II|Still On treatment|0|||
163019456|NCT02244463|588774409|FG004|Period 5: Phase II|Still On treatment|0|||
163019457|NCT02244463|588774410|FG005|Period 5: Phase II|Still On treatment|3|||
163019458|NCT05481125|588774411|FG000|Overall Study|Adverse Event|1|||
163019459|NCT05481125|588774412|FG001|Overall Study|Adverse Event|0|||
163019460|NCT05481125|588774411|FG000|Overall Study|Lost to Follow-up|0|||
163019461|NCT05481125|588774412|FG001|Overall Study|Lost to Follow-up|1|||
163019462|NCT05481125|588774411|FG000|Overall Study|Withdrawal by Subject|0|||
163019463|NCT05481125|588774412|FG001|Overall Study|Withdrawal by Subject|1|||
163019464|NCT03702010|588774415|FG000|Follow-up (30days)|Lack of Efficacy|2|||
163019465|NCT03702010|588774416|FG001|Follow-up (30days)|Lack of Efficacy|2|||
163019466|NCT04791319|588774419|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
163019467|NCT04791319|588774420|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
163019468|NCT04791319|588774421|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
163019469|NCT04791319|588774422|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
163019470|NCT04791319|588774423|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
163019471|NCT04791319|588774424|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
163019472|NCT04791319|588774425|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
163019473|NCT04791319|588774426|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
163019474|NCT04791319|588774427|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
163019475|NCT04791319|588774428|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
163019476|NCT04791319|588774429|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
163019477|NCT04791319|588774419|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
163019478|NCT04791319|588774420|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019479|NCT04791319|588774421|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
163019480|NCT04791319|588774422|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
163019481|NCT04791319|588774423|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019482|NCT04791319|588774424|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019483|NCT04791319|588774425|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019484|NCT04791319|588774426|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019485|NCT04791319|588774427|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019486|NCT04791319|588774428|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019487|NCT04791319|588774429|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019488|NCT04791319|588774419|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
163019489|NCT04791319|588774420|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
163019490|NCT04791319|588774421|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
163019491|NCT04791319|588774422|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
163019492|NCT04791319|588774423|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
163063313|NCT03314935|588938625|FG008|Phase 2|Progressive Disease|0|||
163216032|NCT02603809|589506193|FG002|Overall Study|Adverse Event|2|||
163216033|NCT02603809|589506194|FG003|Overall Study|Adverse Event|2|||
163019493|NCT04791319|588774424|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
163216034|NCT02603809|589506195|FG004|Overall Study|Adverse Event|1|||
163216035|NCT02603809|589506196|FG005|Overall Study|Adverse Event|1|||
163019494|NCT04791319|588774425|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
163216036|NCT02603809|589506191|FG000|Overall Study|Lack of Efficacy|0|||
163019495|NCT04791319|588774426|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
163019496|NCT04791319|588774427|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
163019497|NCT04791319|588774428|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
163019498|NCT04791319|588774429|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
163019499|NCT04791319|588774419|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
163019500|NCT04791319|588774420|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
163019501|NCT04791319|588774421|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
163019502|NCT04791319|588774422|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
163019503|NCT04791319|588774423|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
163019504|NCT04791319|588774424|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
163019505|NCT04791319|588774425|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
163019506|NCT04791319|588774426|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
163019507|NCT04791319|588774427|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
163019508|NCT04791319|588774428|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
163019509|NCT04791319|588774429|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
163019510|NCT04791319|588774419|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019511|NCT04791319|588774420|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019512|NCT04791319|588774421|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019513|NCT04791319|588774422|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
163019514|NCT04791319|588774423|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019515|NCT04791319|588774424|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019516|NCT04791319|588774425|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019517|NCT04791319|588774426|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019518|NCT04791319|588774427|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019519|NCT04791319|588774428|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019520|NCT04791319|588774429|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019521|NCT04791319|588774419|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
163019522|NCT04791319|588774420|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
163019523|NCT04791319|588774421|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
163019524|NCT04791319|588774422|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
163019525|NCT04791319|588774423|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
163019526|NCT04791319|588774424|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
163019527|NCT04791319|588774425|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
163019528|NCT04791319|588774426|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
163019529|NCT04791319|588774427|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
163019530|NCT04791319|588774428|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
163019531|NCT04791319|588774429|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
163019532|NCT04791319|588774419|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019533|NCT04791319|588774420|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019534|NCT04791319|588774421|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019535|NCT04791319|588774422|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019536|NCT04791319|588774423|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019537|NCT04791319|588774424|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019538|NCT04791319|588774425|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019539|NCT04791319|588774426|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019540|NCT04791319|588774427|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019541|NCT04791319|588774428|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
163019542|NCT04791319|588774429|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019543|NCT04791319|588774419|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
163019544|NCT04791319|588774420|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
163019545|NCT04791319|588774421|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
163019546|NCT04791319|588774422|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
163019547|NCT04791319|588774423|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
163019548|NCT04791319|588774424|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
163019549|NCT04791319|588774425|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
163019550|NCT04791319|588774426|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
163063314|NCT03314935|588938626|FG009|Phase 2|Progressive Disease|1|||
163063315|NCT03314935|588938627|FG010|Phase 2|Progressive Disease|1|||
163216037|NCT02603809|589506192|FG001|Overall Study|Lack of Efficacy|1|||
163216038|NCT02603809|589506193|FG002|Overall Study|Lack of Efficacy|0|||
163216039|NCT02603809|589506194|FG003|Overall Study|Lack of Efficacy|0|||
163216040|NCT02603809|589506195|FG004|Overall Study|Lack of Efficacy|0|||
163019551|NCT04791319|588774427|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
163019552|NCT04791319|588774428|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
163019553|NCT04791319|588774429|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
163019554|NCT04791319|588774419|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
163019555|NCT04791319|588774420|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
163019556|NCT04791319|588774421|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
163019557|NCT04791319|588774422|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
163019558|NCT04791319|588774423|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
163019559|NCT04791319|588774424|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
163019560|NCT04791319|588774425|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
163019561|NCT04791319|588774426|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
163019562|NCT04791319|588774427|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
163019563|NCT04791319|588774428|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
163019564|NCT04791319|588774429|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
163019565|NCT01704651|588774434|FG000|Overall Study|Pre-op withdrawal by subject|1|||
163019566|NCT01704651|588774435|FG001|Overall Study|Pre-op withdrawal by subject|1|||
163019567|NCT01704651|588774434|FG000|Overall Study|Pre-op change in treatment plan|1|||
163019568|NCT01704651|588774435|FG001|Overall Study|Pre-op change in treatment plan|4|||
163019569|NCT01704651|588774434|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
163019570|NCT01704651|588774435|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
163019571|NCT01704651|588774434|FG000|Overall Study|Post-op did not have laparotomy|2|||
163019572|NCT01704651|588774435|FG001|Overall Study|Post-op did not have laparotomy|1|||
163019573|NCT01931995|588774436|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
163019574|NCT01931995|588774437|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
163019575|NCT01931995|588774436|FG000|First Intervention (1 Day)|Physician Decision|1|||
163019576|NCT01931995|588774437|FG001|First Intervention (1 Day)|Physician Decision|1|||
163019577|NCT01931995|588774436|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
163019578|NCT01931995|588774437|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
163019579|NCT00791661|588774438|FG000|7 Day Wash-out|Adverse Event|0|||
163019580|NCT00791661|588774439|FG001|7 Day Wash-out|Adverse Event|0|||
163019581|NCT00791661|588774440|FG002|7 Day Wash-out|Adverse Event|1|||
163019582|NCT00791661|588774438|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
163019583|NCT00791661|588774439|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
163019584|NCT00791661|588774440|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
163019585|NCT00427921|588774448|FG000|Overall Study|Adverse Event|26|||
163019586|NCT00427921|588774448|FG000|Overall Study|Withdrawal by Subject|4|||
163019587|NCT00427921|588774448|FG000|Overall Study|Lost to Follow-up|2|||
163019588|NCT00427921|588774448|FG000|Overall Study|Other reason not specified|10|||
163019589|NCT00427921|588774448|FG000|Overall Study|Adverse Event + Hospitalization|1|||
163019590|NCT00427921|588774448|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
163019591|NCT00427921|588774448|FG000|Overall Study|Adverse Event + No Response|1|||
163019592|NCT00427921|588774448|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
163019593|NCT00427921|588774448|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
163019594|NCT00427921|588774448|FG000|Overall Study|Adverse Event + Lost Response|1|||
163019595|NCT00427921|588774448|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
163019596|NCT00427921|588774448|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
163216041|NCT02603809|589506196|FG005|Overall Study|Lack of Efficacy|1|||
163216042|NCT00380978|589506198|FG000|Overall Study|Refused allocated intervention|0|||
163216043|NCT00380978|589506199|FG001|Overall Study|Refused allocated intervention|6|||
163216044|NCT00380978|589506198|FG000|Overall Study|Wrong study envelope|0|||
163216045|NCT00380978|589506199|FG001|Overall Study|Wrong study envelope|2|||
163216046|NCT00380978|589506198|FG000|Overall Study|Allocation prior to analgesia request|1|||
163216047|NCT00380978|589506199|FG001|Overall Study|Allocation prior to analgesia request|2|||
163216048|NCT00380978|589506198|FG000|Overall Study|Parous patient|1|||
163216049|NCT00380978|589506199|FG001|Overall Study|Parous patient|0|||
163216050|NCT01254227|589506200|FG000|Overall Study|Withdrawal by Subject|6|||
163019597|NCT00520533|588774451|FG000|Overall Study|Death|1|||
163019598|NCT00520533|588774451|FG000|Overall Study|Suspension of the study for safety reasons|1|||
163019599|NCT00520533|588774451|FG000|Overall Study|Withdrawal by Subject|1|||
163019600|NCT00520533|588774451|FG000|Overall Study|Physician Decision|1|||
163019601|NCT01464164|588774455|FG000|Overall Study|Screen failure|0|||
163019602|NCT01464164|588774456|FG001|Overall Study|Screen failure|1|||
163019603|NCT01464164|588774457|FG002|Overall Study|Screen failure|2|||
163019604|NCT01464164|588774458|FG003|Overall Study|Screen failure|0|||
163019605|NCT01464164|588774459|FG004|Overall Study|Screen failure|0|||
163063316|NCT03314935|588938628|FG011|Phase 2|Progressive Disease|1|||
163063317|NCT03314935|588938629|FG012|Phase 2|Progressive Disease|2|||
163019606|NCT01464164|588774460|FG005|Overall Study|Screen failure|0|||
163063318|NCT03314935|588938630|FG013|Phase 2|Progressive Disease|0|||
163019607|NCT01464164|588774461|FG006|Overall Study|Screen failure|0|||
163019608|NCT01464164|588774455|FG000|Overall Study|Physician Decision|0|||
163019609|NCT01464164|588774456|FG001|Overall Study|Physician Decision|1|||
163019610|NCT01464164|588774457|FG002|Overall Study|Physician Decision|0|||
163019611|NCT01464164|588774458|FG003|Overall Study|Physician Decision|0|||
163019612|NCT01464164|588774459|FG004|Overall Study|Physician Decision|0|||
163019613|NCT01464164|588774460|FG005|Overall Study|Physician Decision|0|||
163019614|NCT01464164|588774461|FG006|Overall Study|Physician Decision|2|||
163019615|NCT03307252|588774462|FG000|Part 2, Period 1|Treatment not received|0|||
163019616|NCT03307252|588774463|FG001|Part 2, Period 1|Treatment not received|0|||
163019617|NCT03307252|588774464|FG002|Part 2, Period 1|Treatment not received|0|||
163019618|NCT03307252|588774465|FG003|Part 2, Period 1|Treatment not received|0|||
163019619|NCT03307252|588774466|FG004|Part 2, Period 1|Treatment not received|0|||
163019620|NCT03307252|588774467|FG005|Part 2, Period 1|Treatment not received|1|||
163019621|NCT03307252|588774468|FG006|Part 2, Period 1|Treatment not received|0|||
163019622|NCT03307252|588774469|FG007|Part 2, Period 1|Treatment not received|0|||
163019623|NCT03307252|588774470|FG008|Part 2, Period 1|Treatment not received|0|||
163019624|NCT03307252|588774471|FG009|Part 2, Period 1|Treatment not received|0|||
163019625|NCT03307252|588774472|FG010|Part 2, Period 1|Treatment not received|0|||
163019626|NCT03307252|588774462|FG000|Part 2, Period 3|Other than listed|0|||
163019627|NCT03307252|588774463|FG001|Part 2, Period 3|Other than listed|0|||
163019628|NCT03307252|588774464|FG002|Part 2, Period 3|Other than listed|0|||
163019629|NCT03307252|588774465|FG003|Part 2, Period 3|Other than listed|0|||
163019630|NCT03307252|588774466|FG004|Part 2, Period 3|Other than listed|1|||
163019631|NCT03307252|588774467|FG005|Part 2, Period 3|Other than listed|0|||
163019632|NCT03307252|588774468|FG006|Part 2, Period 3|Other than listed|0|||
163019633|NCT03307252|588774469|FG007|Part 2, Period 3|Other than listed|0|||
163019634|NCT03307252|588774470|FG008|Part 2, Period 3|Other than listed|0|||
163019635|NCT03307252|588774471|FG009|Part 2, Period 3|Other than listed|0|||
163019636|NCT03307252|588774472|FG010|Part 2, Period 3|Other than listed|0|||
163019637|NCT03307252|588774462|FG000|Part 2, Period 4|Other than listed|0|||
163019638|NCT03307252|588774463|FG001|Part 2, Period 4|Other than listed|0|||
163019639|NCT03307252|588774464|FG002|Part 2, Period 4|Other than listed|0|||
163019640|NCT03307252|588774465|FG003|Part 2, Period 4|Other than listed|0|||
163019641|NCT03307252|588774466|FG004|Part 2, Period 4|Other than listed|0|||
163019642|NCT03307252|588774467|FG005|Part 2, Period 4|Other than listed|0|||
163019643|NCT03307252|588774468|FG006|Part 2, Period 4|Other than listed|1|||
163019644|NCT03307252|588774469|FG007|Part 2, Period 4|Other than listed|0|||
163019645|NCT03307252|588774470|FG008|Part 2, Period 4|Other than listed|0|||
163019646|NCT03307252|588774471|FG009|Part 2, Period 4|Other than listed|0|||
163019647|NCT03307252|588774472|FG010|Part 2, Period 4|Other than listed|0|||
163019648|NCT03307252|588774462|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019649|NCT03307252|588774463|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019650|NCT03307252|588774464|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019651|NCT03307252|588774465|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019652|NCT03307252|588774466|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019653|NCT03307252|588774467|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019654|NCT03307252|588774468|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019655|NCT03307252|588774469|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019656|NCT03307252|588774470|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019657|NCT03307252|588774471|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019658|NCT03307252|588774472|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
163019659|NCT01052480|588774473|FG000|Overall Study|Lost to Follow-up|3|||
163019660|NCT01052480|588774474|FG001|Overall Study|Lost to Follow-up|3|||
163019661|NCT01052480|588774473|FG000|Overall Study|Protocol Violation|1|||
163019662|NCT01052480|588774474|FG001|Overall Study|Protocol Violation|0|||
163019663|NCT01052480|588774473|FG000|Overall Study|Withdrawal by Subject|3|||
163019664|NCT01052480|588774474|FG001|Overall Study|Withdrawal by Subject|7|||
163019665|NCT01052480|588774473|FG000|Overall Study|Physician Decision|0|||
163019666|NCT01052480|588774474|FG001|Overall Study|Physician Decision|2|||
163019667|NCT01052480|588774473|FG000|Overall Study|Death|1|||
163019668|NCT01052480|588774474|FG001|Overall Study|Death|5|||
163019669|NCT01578239|588774475|FG000|Treatment Period|Progressive Disease|19|||
163019670|NCT01578239|588774476|FG001|Treatment Period|Progressive Disease|64|||
163405178|NCT01033825|590193537|FG001|Overall Study|Other|0|||
163019671|NCT01578239|588774475|FG000|Treatment Period|Physician Decision|17|||
163019672|NCT01578239|588774476|FG001|Treatment Period|Physician Decision|17|||
163019673|NCT01578239|588774475|FG000|Treatment Period|Adverse Event|13|||
163019674|NCT01578239|588774476|FG001|Treatment Period|Adverse Event|10|||
163019675|NCT01578239|588774475|FG000|Treatment Period|Non-compliance|2|||
163019676|NCT01578239|588774476|FG001|Treatment Period|Non-compliance|0|||
163019677|NCT01578239|588774475|FG000|Treatment Period|Withdrawal by Subject|10|||
163019678|NCT01578239|588774476|FG001|Treatment Period|Withdrawal by Subject|9|||
163019679|NCT01578239|588774475|FG000|Treatment Period|Other|6|||
163216051|NCT01254227|589506200|FG000|Overall Study|Lost to Follow-up|6|||
163216052|NCT01254227|589506200|FG000|Overall Study|Adverse Event|5|||
163216053|NCT01254227|589506200|FG000|Overall Study|Abnormal test procedure result|5|||
163216054|NCT01254227|589506200|FG000|Overall Study|Administrative problems|2|||
163216055|NCT01254227|589506200|FG000|Overall Study|Death|1|||
163216056|NCT01254227|589506200|FG000|Overall Study|Protocol deviation|1|||
163019680|NCT01578239|588774476|FG001|Treatment Period|Other|1|||
163019681|NCT01578239|588774475|FG000|Long-term Follow-Up Period|Death|69|||
163019682|NCT01578239|588774476|FG001|Long-term Follow-Up Period|Death|64|||
163019683|NCT01578239|588774475|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
163019684|NCT01578239|588774476|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
163019685|NCT01578239|588774475|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
163019686|NCT01578239|588774476|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
163019687|NCT01578239|588774475|FG000|Long-term Follow-Up Period|Other|2|||
163019688|NCT01578239|588774476|FG001|Long-term Follow-Up Period|Other|2|||
163019689|NCT02347813|588774479|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
163019690|NCT02347813|588774480|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
163019691|NCT02347813|588774479|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
163019692|NCT02347813|588774480|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
163019693|NCT01119859|588774481|FG000|Overall Study|Adverse Event|9|||
163019694|NCT01119859|588774482|FG001|Overall Study|Adverse Event|10|||
163019695|NCT01119859|588774481|FG000|Overall Study|Death|2|||
163019696|NCT01119859|588774482|FG001|Overall Study|Death|0|||
163019697|NCT01119859|588774481|FG000|Overall Study|Insufficient therapeutic response|7|||
163019698|NCT01119859|588774482|FG001|Overall Study|Insufficient therapeutic response|14|||
163019699|NCT01119859|588774481|FG000|Overall Study|Refused treatment|3|||
163019700|NCT01119859|588774482|FG001|Overall Study|Refused treatment|6|||
163019701|NCT01119859|588774481|FG000|Overall Study|Failure to return|3|||
163019702|NCT01119859|588774482|FG001|Overall Study|Failure to return|0|||
163019703|NCT00733421|588774483|FG000|Overall Study|Withdrawal by Subject|1|||
163019704|NCT00733421|588774484|FG001|Overall Study|Withdrawal by Subject|1|||
163019705|NCT04185220|588774488|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
163019706|NCT04185220|588774489|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
163019707|NCT04185220|588774488|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
163019708|NCT04185220|588774489|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
163019709|NCT01029782|588774490|FG000|Overall Study|Lost to Follow-up|2|||
163019710|NCT01029782|588774491|FG001|Overall Study|Lost to Follow-up|2|||
163063319|NCT03314935|588938631|FG014|Phase 2|Progressive Disease|1|||
163063320|NCT03314935|588938617|FG000|Phase 2|Study Terminated by Sponsor|0|||
163063321|NCT03314935|588938618|FG001|Phase 2|Study Terminated by Sponsor|0|||
163063322|NCT03314935|588938619|FG002|Phase 2|Study Terminated by Sponsor|0|||
163063323|NCT03314935|588938620|FG003|Phase 2|Study Terminated by Sponsor|0|||
163063324|NCT03314935|588938621|FG004|Phase 2|Study Terminated by Sponsor|0|||
163063325|NCT03314935|588938622|FG005|Phase 2|Study Terminated by Sponsor|0|||
163063326|NCT03314935|588938623|FG006|Phase 2|Study Terminated by Sponsor|0|||
163063327|NCT03314935|588938624|FG007|Phase 2|Study Terminated by Sponsor|0|||
163063328|NCT03314935|588938625|FG008|Phase 2|Study Terminated by Sponsor|0|||
163063329|NCT03314935|588938626|FG009|Phase 2|Study Terminated by Sponsor|0|||
163063330|NCT03314935|588938627|FG010|Phase 2|Study Terminated by Sponsor|7|||
163216057|NCT02750592|589506201|FG000|Overall Study|Adverse Event|3|||
163216058|NCT02750592|589506201|FG000|Overall Study|Lack of Efficacy|2|||
163216059|NCT02981342|589506202|FG000|Overall Study|Adverse Event|0|||
163216060|NCT02981342|589506203|FG001|Overall Study|Adverse Event|0|||
163216061|NCT02981342|589506204|FG002|Overall Study|Adverse Event|0|||
163216062|NCT02981342|589506205|FG003|Overall Study|Adverse Event|1|||
163216063|NCT02981342|589506202|FG000|Overall Study|Death|0|||
163216064|NCT02981342|589506203|FG001|Overall Study|Death|9|||
163216065|NCT02981342|589506204|FG002|Overall Study|Death|9|||
163216066|NCT02981342|589506205|FG003|Overall Study|Death|4|||
163216067|NCT02981342|589506202|FG000|Overall Study|Withdrawal by Subject|0|||
163216068|NCT02981342|589506203|FG001|Overall Study|Withdrawal by Subject|0|||
163216069|NCT02981342|589506204|FG002|Overall Study|Withdrawal by Subject|3|||
163216070|NCT02981342|589506205|FG003|Overall Study|Withdrawal by Subject|1|||
163216071|NCT02981342|589506202|FG000|Overall Study|Study closed by sponsor|0|||
163216072|NCT02981342|589506203|FG001|Overall Study|Study closed by sponsor|0|||
163019711|NCT01029782|588774490|FG000|Overall Study|Diagnosis changed|1|||
163019712|NCT01029782|588774491|FG001|Overall Study|Diagnosis changed|1|||
163019713|NCT01029782|588774490|FG000|Overall Study|Adverse Event|0|||
163019714|NCT01029782|588774491|FG001|Overall Study|Adverse Event|1|||
163019715|NCT01029782|588774490|FG000|Overall Study|Physician Decision|0|||
163063331|NCT03314935|588938628|FG011|Phase 2|Study Terminated by Sponsor|2|||
163216073|NCT02981342|589506204|FG002|Overall Study|Study closed by sponsor|1|||
163216074|NCT02981342|589506205|FG003|Overall Study|Study closed by sponsor|1|||
163216075|NCT02981342|589506202|FG000|Overall Study|Randomized, Never Treated|0|||
163019716|NCT01029782|588774491|FG001|Overall Study|Physician Decision|1|||
163019717|NCT01029782|588774490|FG000|Overall Study|Protocol Violation|0|||
163019718|NCT01029782|588774491|FG001|Overall Study|Protocol Violation|2|||
163019719|NCT01029782|588774490|FG000|Overall Study|Withdrawal by Subject|0|||
163019720|NCT01029782|588774491|FG001|Overall Study|Withdrawal by Subject|1|||
163019721|NCT02195869|588774495|FG000|Overall Study|cGVHD Progression|5|||
163019722|NCT02195869|588774495|FG000|Overall Study|Malignancy Progression/relapse|2|||
163019723|NCT02195869|588774495|FG000|Overall Study|Adverse Event|15|||
163019724|NCT02195869|588774495|FG000|Overall Study|Withdrawal by Subject|7|||
163019725|NCT02195869|588774495|FG000|Overall Study|Physician Decision|4|||
163019726|NCT02195869|588774495|FG000|Overall Study|Study Terminated by Sponsor|7|||
163019727|NCT02195869|588774495|FG000|Overall Study|Noncompliance with study drug|2|||
163019728|NCT02981082|588774499|FG000|Overall Study|Withdrawal by Subject|2|||
163019729|NCT02981082|588774500|FG001|Overall Study|Withdrawal by Subject|0|||
163019730|NCT02981082|588774499|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
163019731|NCT02981082|588774500|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
163019732|NCT02981082|588774499|FG000|Overall Study|Adverse Event|0|||
163019733|NCT02981082|588774500|FG001|Overall Study|Adverse Event|1|||
163019734|NCT03652636|588776258|FG000|Overall Study|Withdrawal by Subject|7|||
163019735|NCT00679029|588776261|FG000|Overall Study|Adverse Event|3|||
163019736|NCT00679029|588776261|FG000|Overall Study|Withdrawal by Subject|1|||
163019737|NCT00679029|588776261|FG000|Overall Study|Lost to Follow-up|1|||
163019738|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
163019739|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
163019740|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
163019741|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
163019742|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Death|0|||
163019743|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Death|0|||
163019744|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Death|1|||
163019745|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Death|0|||
163019746|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
163019747|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
163019748|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
163019749|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
163019750|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
163019751|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
163019752|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
163019753|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
163019754|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
163019755|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
163019756|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
163019757|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
163019758|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
163019759|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
163019760|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
163019761|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
163019762|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
163019763|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
163019764|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
163019765|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
163019766|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
163019767|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
163019768|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
163019769|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
163019770|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
163019771|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
163019772|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
163019773|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
163019774|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
163019775|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
163019776|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
163019777|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
163216076|NCT02981342|589506203|FG001|Overall Study|Randomized, Never Treated|1|||
163216077|NCT02981342|589506204|FG002|Overall Study|Randomized, Never Treated|0|||
163216078|NCT02981342|589506205|FG003|Overall Study|Randomized, Never Treated|7|||
163216079|NCT02981342|589506202|FG000|Overall Study|Lost to Follow-up|0|||
163216080|NCT02981342|589506203|FG001|Overall Study|Lost to Follow-up|1|||
163216081|NCT02981342|589506204|FG002|Overall Study|Lost to Follow-up|0|||
163216082|NCT02981342|589506205|FG003|Overall Study|Lost to Follow-up|0|||
163216083|NCT03970733|589506206|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
163216084|NCT03970733|589506207|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
163216085|NCT03970733|589506208|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
163216086|NCT03970733|589506209|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
163216087|NCT03970733|589506210|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
163216088|NCT03970733|589506206|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
163216089|NCT03970733|589506207|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
163216090|NCT03970733|589506208|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
163216091|NCT03970733|589506209|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
163216092|NCT03970733|589506210|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
163019778|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
163019779|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
163019780|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
163019781|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
163019782|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Other|8|||
163019783|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Other|14|||
163019784|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Other|8|||
163019785|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Other|23|||
163019786|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
163019787|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
163019788|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
163019789|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
163019790|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
163019791|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
163019792|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
163019793|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
163019794|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Death|0|||
163019795|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Death|0|||
163019796|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Death|0|||
163019797|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Death|1|||
163019798|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
163019799|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
163019800|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
163019801|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
163019802|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
163019803|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
163019804|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
163019805|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
163019806|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
163019807|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
163019808|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
163019809|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
163019810|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
163019811|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
163019812|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
163019813|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
163019814|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
163019815|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
163019816|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
163019817|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
163019818|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
163019819|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
163019820|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
163019821|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
163216093|NCT03970733|589506206|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
163216094|NCT03970733|589506207|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
163216095|NCT03970733|589506208|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
163216096|NCT03970733|589506209|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
163328978|NCT05580003|589914922|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328979|NCT05580003|589914923|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328980|NCT05580003|589914924|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328981|NCT05580003|589914925|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328982|NCT05580003|589914926|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328983|NCT05580003|589914927|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328984|NCT05580003|589914928|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163405179|NCT01033825|590193538|FG002|Overall Study|Other|0|||
163019822|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
163019823|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
163019824|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
163019825|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
163019826|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Other|6|||
163019827|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Other|5|||
163019828|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Other|8|||
163019829|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Other|5|||
163019830|NCT00972816|588776267|FG000|Overall Study|Adverse Event|0|||
163019831|NCT00972816|588776268|FG001|Overall Study|Adverse Event|0|||
163019832|NCT00972816|588776269|FG002|Overall Study|Adverse Event|1|||
163019833|NCT00972816|588776270|FG003|Overall Study|Adverse Event|0|||
163019834|NCT00972816|588776271|FG004|Overall Study|Adverse Event|0|||
163019835|NCT00972816|588776272|FG005|Overall Study|Adverse Event|0|||
163019836|NCT00972816|588776273|FG006|Overall Study|Adverse Event|0|||
163019837|NCT00972816|588776274|FG007|Overall Study|Adverse Event|0|||
163019838|NCT00972816|588776267|FG000|Overall Study|Withdrawal by Subject|4|||
163019839|NCT00972816|588776268|FG001|Overall Study|Withdrawal by Subject|2|||
163019840|NCT00972816|588776269|FG002|Overall Study|Withdrawal by Subject|1|||
163019841|NCT00972816|588776270|FG003|Overall Study|Withdrawal by Subject|3|||
163019842|NCT00972816|588776271|FG004|Overall Study|Withdrawal by Subject|0|||
163019843|NCT00972816|588776272|FG005|Overall Study|Withdrawal by Subject|1|||
163019844|NCT00972816|588776273|FG006|Overall Study|Withdrawal by Subject|1|||
163019845|NCT00972816|588776274|FG007|Overall Study|Withdrawal by Subject|2|||
163019846|NCT00972816|588776267|FG000|Overall Study|Lost to Follow-up|11|||
163019847|NCT00972816|588776268|FG001|Overall Study|Lost to Follow-up|9|||
163019848|NCT00972816|588776269|FG002|Overall Study|Lost to Follow-up|7|||
163216097|NCT03970733|589506210|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
163216098|NCT03970733|589506206|FG000|Main Study Phase (18 Months)|Other|1|||
163216099|NCT03970733|589506207|FG001|Main Study Phase (18 Months)|Other|1|||
163216100|NCT03970733|589506208|FG002|Main Study Phase (18 Months)|Other|0|||
163216101|NCT03970733|589506209|FG003|Main Study Phase (18 Months)|Other|0|||
163216102|NCT03970733|589506210|FG004|Main Study Phase (18 Months)|Other|0|||
163216103|NCT03970733|589506206|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
163216104|NCT03970733|589506207|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
163216105|NCT03970733|589506208|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
163216106|NCT03970733|589506209|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
163216107|NCT03970733|589506210|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
163216108|NCT02784821|589506214|FG000|Overall Study|Death|0|||
163216109|NCT02784821|589506215|FG001|Overall Study|Death|5|||
163216110|NCT02784821|589506216|FG002|Overall Study|Death|4|||
163216111|NCT02784821|589506217|FG003|Overall Study|Death|5|||
163216112|NCT02794103|589506218|FG000|Overall Study|Loss to follow up due to high sedation|3|||
163216113|NCT00112502|589506219|FG000|Overall Study|Withdrawal by Subject|0|||
163216114|NCT00112502|589506220|FG001|Overall Study|Withdrawal by Subject|1|||
163216115|NCT00112502|589506221|FG002|Overall Study|Withdrawal by Subject|1|||
163216116|NCT00112502|589506222|FG003|Overall Study|Withdrawal by Subject|4|||
163216117|NCT00112502|589506223|FG004|Overall Study|Withdrawal by Subject|2|||
163216118|NCT00112502|589506224|FG005|Overall Study|Withdrawal by Subject|5|||
163216119|NCT00112502|589506225|FG006|Overall Study|Withdrawal by Subject|3|||
163216120|NCT00112502|589506226|FG007|Overall Study|Withdrawal by Subject|7|||
163216121|NCT00265343|589506229|FG000|Overall Study|Adverse Event|10|||
163216122|NCT00265343|589506230|FG001|Overall Study|Adverse Event|7|||
163216123|NCT00265343|589506229|FG000|Overall Study|Withdrawal by Subject|3|||
163216124|NCT00265343|589506230|FG001|Overall Study|Withdrawal by Subject|9|||
163216125|NCT00265343|589506229|FG000|Overall Study|Other|8|||
163216126|NCT00265343|589506230|FG001|Overall Study|Other|3|||
163216127|NCT02608268|589506231|FG000|Overall Study|Adverse Event|0|||
163216128|NCT02608268|589506232|FG001|Overall Study|Adverse Event|0|||
163216129|NCT02608268|589506233|FG002|Overall Study|Adverse Event|1|||
163216130|NCT02608268|589506234|FG003|Overall Study|Adverse Event|0|||
163216131|NCT02608268|589506235|FG004|Overall Study|Adverse Event|0|||
163216132|NCT02608268|589506236|FG005|Overall Study|Adverse Event|0|||
163216133|NCT02608268|589506237|FG006|Overall Study|Adverse Event|0|||
163216134|NCT02608268|589506238|FG007|Overall Study|Adverse Event|0|||
163216135|NCT02608268|589506239|FG008|Overall Study|Adverse Event|0|||
163216136|NCT02608268|589506240|FG009|Overall Study|Adverse Event|0|||
163216137|NCT02608268|589506241|FG010|Overall Study|Adverse Event|0|||
163216138|NCT02608268|589506242|FG011|Overall Study|Adverse Event|0|||
163216139|NCT02608268|589506243|FG012|Overall Study|Adverse Event|2|||
163216140|NCT02608268|589506244|FG013|Overall Study|Adverse Event|0|||
163216141|NCT02608268|589506245|FG014|Overall Study|Adverse Event|0|||
163216142|NCT02608268|589506246|FG015|Overall Study|Adverse Event|0|||
163216143|NCT02608268|589506247|FG016|Overall Study|Adverse Event|0|||
163216144|NCT02608268|589506248|FG017|Overall Study|Adverse Event|0|||
163216145|NCT02608268|589506249|FG018|Overall Study|Adverse Event|0|||
163019849|NCT00972816|588776270|FG003|Overall Study|Lost to Follow-up|5|||
163019850|NCT00972816|588776271|FG004|Overall Study|Lost to Follow-up|11|||
163019851|NCT00972816|588776272|FG005|Overall Study|Lost to Follow-up|10|||
163019852|NCT00972816|588776273|FG006|Overall Study|Lost to Follow-up|7|||
163019853|NCT00972816|588776274|FG007|Overall Study|Lost to Follow-up|7|||
163019854|NCT00972816|588776267|FG000|Overall Study|Inappropriate enrolment|0|||
163019855|NCT00972816|588776268|FG001|Overall Study|Inappropriate enrolment|0|||
163019856|NCT00972816|588776269|FG002|Overall Study|Inappropriate enrolment|0|||
163328985|NCT05580003|589914929|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328986|NCT05580003|589914930|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328987|NCT05580003|589914931|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328988|NCT05580003|589914932|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328989|NCT05580003|589914933|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328990|NCT05580003|589914934|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328991|NCT05580003|589914935|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328992|NCT05580003|589914936|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328993|NCT05580003|589914937|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328994|NCT05580003|589914938|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163328995|NCT05580003|589914911|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163328996|NCT05580003|589914912|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163328997|NCT05580003|589914913|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163328998|NCT05580003|589914914|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
163328999|NCT05580003|589914915|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329000|NCT05580003|589914916|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329001|NCT05580003|589914917|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329002|NCT05580003|589914918|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329003|NCT05580003|589914919|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329004|NCT05580003|589914920|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329005|NCT05580003|589914921|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329006|NCT05580003|589914922|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329007|NCT05580003|589914923|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329008|NCT05580003|589914924|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329009|NCT05580003|589914925|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329010|NCT05580003|589914926|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329011|NCT05580003|589914927|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329012|NCT05580003|589914928|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329013|NCT05580003|589914929|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329014|NCT05580003|589914930|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329015|NCT05580003|589914931|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329016|NCT05580003|589914932|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329017|NCT05580003|589914933|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329018|NCT05580003|589914934|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329019|NCT05580003|589914935|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329020|NCT05580003|589914936|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329021|NCT05580003|589914937|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329022|NCT05580003|589914938|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163329023|NCT05580003|589914911|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329024|NCT05580003|589914912|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
163329025|NCT05580003|589914913|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329026|NCT05580003|589914914|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329027|NCT05580003|589914915|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329028|NCT05580003|589914916|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329029|NCT05580003|589914917|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329030|NCT05580003|589914918|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329031|NCT05580003|589914919|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329032|NCT05580003|589914920|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329033|NCT05580003|589914921|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329034|NCT05580003|589914922|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163405180|NCT01033825|590193539|FG003|Overall Study|Other|0|||
163405181|NCT01033825|590193540|FG004|Overall Study|Other|1|||
163019857|NCT00972816|588776270|FG003|Overall Study|Inappropriate enrolment|0|||
163019858|NCT00972816|588776271|FG004|Overall Study|Inappropriate enrolment|0|||
163019859|NCT00972816|588776272|FG005|Overall Study|Inappropriate enrolment|0|||
163019860|NCT00972816|588776273|FG006|Overall Study|Inappropriate enrolment|2|||
163019861|NCT00972816|588776274|FG007|Overall Study|Inappropriate enrolment|0|||
163019862|NCT00972816|588776267|FG000|Overall Study|Unable to classify|2|||
163019863|NCT00972816|588776268|FG001|Overall Study|Unable to classify|0|||
163019864|NCT00972816|588776269|FG002|Overall Study|Unable to classify|0|||
163019865|NCT00972816|588776270|FG003|Overall Study|Unable to classify|0|||
163019866|NCT00972816|588776271|FG004|Overall Study|Unable to classify|1|||
163019867|NCT00972816|588776272|FG005|Overall Study|Unable to classify|0|||
163329035|NCT05580003|589914923|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163405182|NCT01033825|590193541|FG005|Overall Study|Other|0|||
163019868|NCT00972816|588776273|FG006|Overall Study|Unable to classify|0|||
163019869|NCT00972816|588776274|FG007|Overall Study|Unable to classify|0|||
163019870|NCT03806933|588776275|FG000|Main Period|Physician Decision|0|||
163019871|NCT03806933|588776276|FG001|Main Period|Physician Decision|0|||
163019872|NCT03806933|588776277|FG002|Main Period|Physician Decision|0|||
163019873|NCT03806933|588776278|FG003|Main Period|Physician Decision|1|||
163019874|NCT03806933|588776275|FG000|Main Period|Pregnancy|0|||
163019875|NCT03806933|588776276|FG001|Main Period|Pregnancy|0|||
163019876|NCT03806933|588776277|FG002|Main Period|Pregnancy|1|||
163019877|NCT03806933|588776278|FG003|Main Period|Pregnancy|0|||
163019878|NCT03806933|588776275|FG000|Main Period|Withdrawal by Subject|2|||
163019879|NCT03806933|588776276|FG001|Main Period|Withdrawal by Subject|1|||
163216146|NCT02608268|589506250|FG019|Overall Study|Adverse Event|0|||
163216147|NCT02608268|589506251|FG020|Overall Study|Adverse Event|1|||
163216148|NCT02608268|589506252|FG021|Overall Study|Adverse Event|1|||
163216149|NCT02608268|589506253|FG022|Overall Study|Adverse Event|0|||
163216150|NCT02608268|589506254|FG023|Overall Study|Adverse Event|0|||
163216151|NCT02608268|589506255|FG024|Overall Study|Adverse Event|1|||
163216152|NCT02608268|589506256|FG025|Overall Study|Adverse Event|0|||
163216153|NCT02608268|589506257|FG026|Overall Study|Adverse Event|0|||
163216154|NCT02608268|589506258|FG027|Overall Study|Adverse Event|0|||
163216155|NCT02608268|589506259|FG028|Overall Study|Adverse Event|1|||
163216156|NCT02608268|589506260|FG029|Overall Study|Adverse Event|0|||
163216157|NCT02608268|589506231|FG000|Overall Study|Death|1|||
163216158|NCT02608268|589506232|FG001|Overall Study|Death|0|||
163216159|NCT02608268|589506233|FG002|Overall Study|Death|0|||
163216160|NCT02608268|589506234|FG003|Overall Study|Death|0|||
163216161|NCT02608268|589506235|FG004|Overall Study|Death|0|||
163216162|NCT02608268|589506236|FG005|Overall Study|Death|0|||
163216163|NCT02608268|589506237|FG006|Overall Study|Death|0|||
163216164|NCT02608268|589506238|FG007|Overall Study|Death|0|||
163216165|NCT02608268|589506239|FG008|Overall Study|Death|1|||
163216166|NCT02608268|589506240|FG009|Overall Study|Death|1|||
163216167|NCT02608268|589506241|FG010|Overall Study|Death|0|||
163216168|NCT02608268|589506242|FG011|Overall Study|Death|0|||
163216169|NCT02608268|589506243|FG012|Overall Study|Death|0|||
163216170|NCT02608268|589506244|FG013|Overall Study|Death|0|||
163216171|NCT02608268|589506245|FG014|Overall Study|Death|0|||
163216172|NCT02608268|589506246|FG015|Overall Study|Death|1|||
163216173|NCT02608268|589506247|FG016|Overall Study|Death|0|||
163216174|NCT02608268|589506248|FG017|Overall Study|Death|1|||
163216175|NCT02608268|589506249|FG018|Overall Study|Death|0|||
163216176|NCT02608268|589506250|FG019|Overall Study|Death|1|||
163216177|NCT02608268|589506251|FG020|Overall Study|Death|1|||
163216178|NCT02608268|589506252|FG021|Overall Study|Death|0|||
163216179|NCT02608268|589506253|FG022|Overall Study|Death|0|||
163216180|NCT02608268|589506254|FG023|Overall Study|Death|0|||
163216181|NCT02608268|589506255|FG024|Overall Study|Death|1|||
163216182|NCT02608268|589506256|FG025|Overall Study|Death|2|||
163216183|NCT02608268|589506257|FG026|Overall Study|Death|0|||
163216184|NCT02608268|589506258|FG027|Overall Study|Death|1|||
163216185|NCT02608268|589506259|FG028|Overall Study|Death|4|||
163216186|NCT02608268|589506260|FG029|Overall Study|Death|0|||
163216187|NCT02608268|589506231|FG000|Overall Study|Physician Decision|0|||
163216188|NCT02608268|589506232|FG001|Overall Study|Physician Decision|0|||
163216189|NCT02608268|589506233|FG002|Overall Study|Physician Decision|0|||
163216190|NCT02608268|589506234|FG003|Overall Study|Physician Decision|0|||
163216191|NCT02608268|589506235|FG004|Overall Study|Physician Decision|0|||
163216192|NCT02608268|589506236|FG005|Overall Study|Physician Decision|0|||
163216193|NCT02608268|589506237|FG006|Overall Study|Physician Decision|0|||
163216194|NCT02608268|589506238|FG007|Overall Study|Physician Decision|0|||
163216195|NCT02608268|589506239|FG008|Overall Study|Physician Decision|0|||
163216196|NCT02608268|589506240|FG009|Overall Study|Physician Decision|0|||
163216197|NCT02608268|589506241|FG010|Overall Study|Physician Decision|1|||
163216198|NCT02608268|589506242|FG011|Overall Study|Physician Decision|0|||
163216199|NCT02608268|589506243|FG012|Overall Study|Physician Decision|0|||
163216200|NCT02608268|589506244|FG013|Overall Study|Physician Decision|1|||
163216201|NCT02608268|589506245|FG014|Overall Study|Physician Decision|0|||
163216202|NCT02608268|589506246|FG015|Overall Study|Physician Decision|0|||
163216203|NCT02608268|589506247|FG016|Overall Study|Physician Decision|0|||
163216204|NCT02608268|589506248|FG017|Overall Study|Physician Decision|0|||
163216205|NCT02608268|589506249|FG018|Overall Study|Physician Decision|0|||
163216206|NCT02608268|589506250|FG019|Overall Study|Physician Decision|0|||
163216207|NCT02608268|589506251|FG020|Overall Study|Physician Decision|0|||
163216208|NCT02608268|589506252|FG021|Overall Study|Physician Decision|0|||
163216209|NCT02608268|589506253|FG022|Overall Study|Physician Decision|1|||
163216210|NCT02608268|589506254|FG023|Overall Study|Physician Decision|1|||
163216211|NCT02608268|589506255|FG024|Overall Study|Physician Decision|1|||
163216212|NCT02608268|589506256|FG025|Overall Study|Physician Decision|0|||
163216213|NCT02608268|589506257|FG026|Overall Study|Physician Decision|0|||
163216214|NCT02608268|589506258|FG027|Overall Study|Physician Decision|2|||
163216215|NCT02608268|589506259|FG028|Overall Study|Physician Decision|1|||
163216216|NCT02608268|589506260|FG029|Overall Study|Physician Decision|1|||
163216217|NCT02608268|589506231|FG000|Overall Study|Progressive disease|12|||
163019880|NCT03806933|588776277|FG002|Main Period|Withdrawal by Subject|1|||
163019881|NCT03806933|588776278|FG003|Main Period|Withdrawal by Subject|2|||
163019882|NCT03806933|588776275|FG000|Main Period|Lost to Follow-up|2|||
163019883|NCT03806933|588776276|FG001|Main Period|Lost to Follow-up|2|||
163019884|NCT03806933|588776277|FG002|Main Period|Lost to Follow-up|0|||
163019885|NCT03806933|588776278|FG003|Main Period|Lost to Follow-up|0|||
163019886|NCT03806933|588776275|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
163019887|NCT03806933|588776276|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
163019888|NCT03806933|588776277|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
163019889|NCT03806933|588776278|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
163019890|NCT05088603|588776279|FG000|Overall Study|Protocol Violation|6|||
163019891|NCT05088603|588776280|FG001|Overall Study|Protocol Violation|1|||
163019892|NCT00956592|588776285|FG000|Overall Study|Protocol Violation|1|||
163019893|NCT00956592|588776286|FG001|Overall Study|Protocol Violation|3|||
163019894|NCT02162719|588776287|FG000|Overall Study|Death|41|||
163019895|NCT02162719|588776288|FG001|Overall Study|Death|46|||
163019896|NCT02162719|588776287|FG000|Overall Study|Lost to Follow-up|1|||
163019897|NCT02162719|588776288|FG001|Overall Study|Lost to Follow-up|3|||
163019898|NCT02162719|588776287|FG000|Overall Study|Disease Progression|2|||
163019899|NCT02162719|588776288|FG001|Overall Study|Disease Progression|1|||
163019900|NCT02162719|588776287|FG000|Overall Study|Withdrawal by Subject|8|||
163019901|NCT02162719|588776288|FG001|Overall Study|Withdrawal by Subject|2|||
163019902|NCT02162719|588776287|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
163019903|NCT02162719|588776288|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
163019904|NCT03555565|588776290|FG000|Overall Study|Case Report Forms Uncollected|2|||
163019905|NCT03555565|588776290|FG000|Overall Study|Protocol Deviation|13|||
163019906|NCT03854370|588776295|FG000|Overall Study|samples not collected|1|||
163019907|NCT03854370|588776296|FG001|Overall Study|samples not collected|1|||
163019908|NCT03854370|588776297|FG002|Overall Study|samples not collected|1|||
163019909|NCT03854370|588776298|FG003|Overall Study|samples not collected|1|||
163019910|NCT02656290|588776299|FG000|Overall Study|Lost to Follow-up|1|||
163216218|NCT02608268|589506232|FG001|Overall Study|Progressive disease|8|||
163216219|NCT02608268|589506233|FG002|Overall Study|Progressive disease|13|||
163216220|NCT02608268|589506234|FG003|Overall Study|Progressive disease|5|||
163216221|NCT02608268|589506235|FG004|Overall Study|Progressive disease|2|||
163216222|NCT02608268|589506236|FG005|Overall Study|Progressive disease|4|||
163216223|NCT02608268|589506237|FG006|Overall Study|Progressive disease|6|||
163216224|NCT02608268|589506238|FG007|Overall Study|Progressive disease|2|||
163216225|NCT02608268|589506239|FG008|Overall Study|Progressive disease|5|||
163216226|NCT02608268|589506240|FG009|Overall Study|Progressive disease|6|||
163216227|NCT02608268|589506241|FG010|Overall Study|Progressive disease|5|||
163216228|NCT02608268|589506242|FG011|Overall Study|Progressive disease|5|||
163216229|NCT02608268|589506243|FG012|Overall Study|Progressive disease|4|||
163216230|NCT02608268|589506244|FG013|Overall Study|Progressive disease|11|||
163216231|NCT02608268|589506245|FG014|Overall Study|Progressive disease|6|||
163216232|NCT02608268|589506246|FG015|Overall Study|Progressive disease|3|||
163216233|NCT02608268|589506247|FG016|Overall Study|Progressive disease|5|||
163216234|NCT02608268|589506248|FG017|Overall Study|Progressive disease|5|||
163216235|NCT02608268|589506249|FG018|Overall Study|Progressive disease|5|||
163216236|NCT02608268|589506250|FG019|Overall Study|Progressive disease|2|||
163216237|NCT02608268|589506251|FG020|Overall Study|Progressive disease|10|||
163216238|NCT02608268|589506252|FG021|Overall Study|Progressive disease|4|||
163216239|NCT02608268|589506253|FG022|Overall Study|Progressive disease|5|||
163216240|NCT02608268|589506254|FG023|Overall Study|Progressive disease|5|||
163216241|NCT02608268|589506255|FG024|Overall Study|Progressive disease|3|||
163216242|NCT02608268|589506256|FG025|Overall Study|Progressive disease|11|||
163216243|NCT02608268|589506257|FG026|Overall Study|Progressive disease|16|||
163216244|NCT02608268|589506258|FG027|Overall Study|Progressive disease|11|||
163216245|NCT02608268|589506259|FG028|Overall Study|Progressive disease|10|||
163216246|NCT02608268|589506260|FG029|Overall Study|Progressive disease|15|||
163216247|NCT02608268|589506231|FG000|Overall Study|Subject/guardian decision|1|||
163216248|NCT02608268|589506232|FG001|Overall Study|Subject/guardian decision|1|||
163216249|NCT02608268|589506233|FG002|Overall Study|Subject/guardian decision|2|||
163216250|NCT02608268|589506234|FG003|Overall Study|Subject/guardian decision|0|||
163216251|NCT02608268|589506235|FG004|Overall Study|Subject/guardian decision|0|||
163216252|NCT02608268|589506236|FG005|Overall Study|Subject/guardian decision|0|||
163216253|NCT02608268|589506237|FG006|Overall Study|Subject/guardian decision|0|||
163216254|NCT02608268|589506238|FG007|Overall Study|Subject/guardian decision|0|||
163216255|NCT02608268|589506239|FG008|Overall Study|Subject/guardian decision|2|||
163216256|NCT02608268|589506240|FG009|Overall Study|Subject/guardian decision|2|||
163216257|NCT02608268|589506241|FG010|Overall Study|Subject/guardian decision|0|||
163216258|NCT02608268|589506242|FG011|Overall Study|Subject/guardian decision|1|||
163216259|NCT02608268|589506243|FG012|Overall Study|Subject/guardian decision|0|||
163216260|NCT02608268|589506244|FG013|Overall Study|Subject/guardian decision|1|||
163216261|NCT02608268|589506245|FG014|Overall Study|Subject/guardian decision|0|||
163216262|NCT02608268|589506246|FG015|Overall Study|Subject/guardian decision|1|||
163216263|NCT02608268|589506247|FG016|Overall Study|Subject/guardian decision|0|||
163329036|NCT05580003|589914924|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329037|NCT05580003|589914925|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329038|NCT05580003|589914926|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329039|NCT05580003|589914927|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329040|NCT05580003|589914928|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329041|NCT05580003|589914929|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163019911|NCT02656290|588776299|FG000|Overall Study|Reintervention|3|||
163019912|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
163019913|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
163019914|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
163019915|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
163019916|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
163019917|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
163019918|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
163019919|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
163019920|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Death|0|||
163019921|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Death|1|||
163019922|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
163019923|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
163019924|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
163019925|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
163019926|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
163019927|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
163019928|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
163019929|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
163019930|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
163019931|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
163019932|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Non compliance|0|||
163019933|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Non compliance|1|||
163019934|NCT00394836|588776300|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
163019935|NCT00394836|588776301|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
163019936|NCT00394836|588776300|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
163019937|NCT00394836|588776301|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
163019938|NCT00394836|588776300|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
163019939|NCT00394836|588776301|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
163019940|NCT00394836|588776300|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
163019941|NCT00394836|588776301|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
163019942|NCT03692325|588776302|FG000|Overall Study|Adverse Event|2|||
163019943|NCT03692325|588776302|FG000|Overall Study|Progression/Recurrence|2|||
163019944|NCT02817516|588776303|FG000|Overall Study|Other|0|||
163329042|NCT05580003|589914930|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329043|NCT05580003|589914931|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329044|NCT05580003|589914932|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329045|NCT05580003|589914933|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329046|NCT05580003|589914934|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329047|NCT05580003|589914935|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329048|NCT05580003|589914936|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329049|NCT05580003|589914937|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329050|NCT05580003|589914938|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163329051|NCT05580003|589914911|FG000|Part 2 (up to 10 Days)|Other|0|||
163329052|NCT05580003|589914912|FG001|Part 2 (up to 10 Days)|Other|0|||
163329053|NCT05580003|589914913|FG002|Part 2 (up to 10 Days)|Other|0|||
163329054|NCT05580003|589914914|FG003|Part 2 (up to 10 Days)|Other|0|||
163329055|NCT05580003|589914915|FG004|Part 2 (up to 10 Days)|Other|0|||
163329056|NCT05580003|589914916|FG005|Part 2 (up to 10 Days)|Other|0|||
163329057|NCT05580003|589914917|FG006|Part 2 (up to 10 Days)|Other|0|||
163329058|NCT05580003|589914918|FG007|Part 2 (up to 10 Days)|Other|0|||
163329059|NCT05580003|589914919|FG008|Part 2 (up to 10 Days)|Other|0|||
163329060|NCT05580003|589914920|FG009|Part 2 (up to 10 Days)|Other|1|||
163329061|NCT05580003|589914921|FG010|Part 2 (up to 10 Days)|Other|0|||
163019945|NCT02817516|588776304|FG001|Overall Study|Other|0|||
163329062|NCT05580003|589914922|FG011|Part 2 (up to 10 Days)|Other|0|||
163329063|NCT05580003|589914923|FG012|Part 2 (up to 10 Days)|Other|0|||
163329064|NCT05580003|589914924|FG013|Part 2 (up to 10 Days)|Other|0|||
163329065|NCT05580003|589914925|FG014|Part 2 (up to 10 Days)|Other|0|||
163329066|NCT05580003|589914926|FG015|Part 2 (up to 10 Days)|Other|0|||
163405183|NCT01033825|590193542|FG006|Overall Study|Other|0|||
163405184|NCT04294719|590193543|FG000|Overall Study|Withdrawal by Subject|1|||
163405185|NCT01714687|590193544|FG000|Overall Study|Withdrawal by Subject|1|||
163405186|NCT01714687|590193545|FG001|Overall Study|Withdrawal by Subject|0|||
163405187|NCT01714687|590193544|FG000|Overall Study|Lost to Follow-up|2|||
163329067|NCT05580003|589914927|FG016|Part 2 (up to 10 Days)|Other|0|||
163329068|NCT05580003|589914928|FG017|Part 2 (up to 10 Days)|Other|0|||
163329069|NCT05580003|589914929|FG018|Part 2 (up to 10 Days)|Other|0|||
163329070|NCT05580003|589914930|FG019|Part 2 (up to 10 Days)|Other|0|||
163329071|NCT05580003|589914931|FG020|Part 2 (up to 10 Days)|Other|0|||
163329072|NCT05580003|589914932|FG021|Part 2 (up to 10 Days)|Other|0|||
163329073|NCT05580003|589914933|FG022|Part 2 (up to 10 Days)|Other|0|||
163329074|NCT05580003|589914934|FG023|Part 2 (up to 10 Days)|Other|0|||
163329075|NCT05580003|589914935|FG024|Part 2 (up to 10 Days)|Other|0|||
163329076|NCT05580003|589914936|FG025|Part 2 (up to 10 Days)|Other|0|||
163329077|NCT05580003|589914937|FG026|Part 2 (up to 10 Days)|Other|0|||
163329078|NCT05580003|589914938|FG027|Part 2 (up to 10 Days)|Other|0|||
163329079|NCT05580003|589914911|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329080|NCT05580003|589914912|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329081|NCT05580003|589914913|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329082|NCT05580003|589914914|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329083|NCT05580003|589914915|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329084|NCT05580003|589914916|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329085|NCT05580003|589914917|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329086|NCT05580003|589914918|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329087|NCT05580003|589914919|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329088|NCT05580003|589914920|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329089|NCT05580003|589914921|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329090|NCT05580003|589914922|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329091|NCT05580003|589914923|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329092|NCT05580003|589914924|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329093|NCT05580003|589914925|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329094|NCT05580003|589914926|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329095|NCT05580003|589914927|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329096|NCT05580003|589914928|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329097|NCT05580003|589914929|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329098|NCT05580003|589914930|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
163329099|NCT05580003|589914931|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329100|NCT05580003|589914932|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329101|NCT05580003|589914933|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329102|NCT05580003|589914934|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329103|NCT05580003|589914935|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329104|NCT05580003|589914936|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329105|NCT05580003|589914937|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329106|NCT05580003|589914938|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163329107|NCT05580003|589914911|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329108|NCT05580003|589914912|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329109|NCT05580003|589914913|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329110|NCT05580003|589914914|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329111|NCT05580003|589914915|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329112|NCT05580003|589914916|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329113|NCT05580003|589914917|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329114|NCT05580003|589914918|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329115|NCT05580003|589914919|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329116|NCT05580003|589914920|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329117|NCT05580003|589914921|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329118|NCT05580003|589914922|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329119|NCT05580003|589914923|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329120|NCT05580003|589914924|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329121|NCT05580003|589914925|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163063332|NCT03314935|588938629|FG012|Phase 2|Study Terminated by Sponsor|1|||
163063333|NCT03314935|588938630|FG013|Phase 2|Study Terminated by Sponsor|4|||
163329122|NCT05580003|589914926|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329123|NCT05580003|589914927|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329124|NCT05580003|589914928|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329125|NCT05580003|589914929|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329126|NCT05580003|589914930|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329127|NCT05580003|589914931|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
163063334|NCT03314935|588938631|FG014|Phase 2|Study Terminated by Sponsor|4|||
163063335|NCT03314935|588938617|FG000|Phase 2|Lost to Follow-up|0|||
163329128|NCT05580003|589914932|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329129|NCT05580003|589914933|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329130|NCT05580003|589914934|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329131|NCT05580003|589914935|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329132|NCT05580003|589914936|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329133|NCT05580003|589914937|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163329134|NCT05580003|589914938|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163216264|NCT02608268|589506248|FG017|Overall Study|Subject/guardian decision|0|||
163216265|NCT02608268|589506249|FG018|Overall Study|Subject/guardian decision|1|||
163216266|NCT02608268|589506250|FG019|Overall Study|Subject/guardian decision|0|||
163216267|NCT02608268|589506251|FG020|Overall Study|Subject/guardian decision|0|||
163329135|NCT05580003|589914911|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329136|NCT05580003|589914912|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329137|NCT05580003|589914913|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329138|NCT05580003|589914914|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329139|NCT05580003|589914915|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329140|NCT05580003|589914916|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329141|NCT05580003|589914917|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329142|NCT05580003|589914918|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329143|NCT05580003|589914919|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329144|NCT05580003|589914920|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329145|NCT05580003|589914921|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329146|NCT05580003|589914922|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329147|NCT05580003|589914923|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329148|NCT05580003|589914924|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329149|NCT05580003|589914925|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329150|NCT05580003|589914926|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329151|NCT05580003|589914927|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329152|NCT05580003|589914928|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329153|NCT05580003|589914929|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329154|NCT05580003|589914930|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329155|NCT05580003|589914931|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329156|NCT05580003|589914932|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
163329157|NCT05580003|589914933|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329158|NCT05580003|589914934|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163216268|NCT02608268|589506252|FG021|Overall Study|Subject/guardian decision|0|||
163216269|NCT02608268|589506253|FG022|Overall Study|Subject/guardian decision|1|||
163216270|NCT02608268|589506254|FG023|Overall Study|Subject/guardian decision|0|||
163216271|NCT02608268|589506255|FG024|Overall Study|Subject/guardian decision|0|||
163216272|NCT02608268|589506256|FG025|Overall Study|Subject/guardian decision|1|||
163216273|NCT02608268|589506257|FG026|Overall Study|Subject/guardian decision|1|||
163216274|NCT02608268|589506258|FG027|Overall Study|Subject/guardian decision|1|||
163216275|NCT02608268|589506259|FG028|Overall Study|Subject/guardian decision|1|||
163216276|NCT02608268|589506260|FG029|Overall Study|Subject/guardian decision|0|||
163216277|NCT01859494|589506270|FG000|Overall Study|Adverse Event|1|||
163216278|NCT01290666|589506276|FG000|Overall Study|Lost to Follow-up|11|||
163216279|NCT01290666|589506276|FG000|Overall Study|Withdrawal by Subject|23|||
163216280|NCT01290666|589506276|FG000|Overall Study|Early Termination of Study|4|||
163216281|NCT00297037|589506279|FG000|Overall Study|Withdrawal by Subject|2|||
163329159|NCT05580003|589914935|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329160|NCT05580003|589914936|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329161|NCT05580003|589914937|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163216282|NCT00297037|589506280|FG001|Overall Study|Withdrawal by Subject|0|||
163216283|NCT03814746|589506283|FG000|Overall Study|Participant decision|9|||
163216284|NCT03814746|589506284|FG001|Overall Study|Participant decision|6|||
163216285|NCT03814746|589506285|FG002|Overall Study|Participant decision|15|||
163216286|NCT03814746|589506283|FG000|Overall Study|Physician Decision|2|||
163216287|NCT03814746|589506284|FG001|Overall Study|Physician Decision|2|||
163216288|NCT03814746|589506285|FG002|Overall Study|Physician Decision|4|||
163216289|NCT03814746|589506283|FG000|Overall Study|Death|2|||
163216290|NCT03814746|589506284|FG001|Overall Study|Death|2|||
163216291|NCT03814746|589506285|FG002|Overall Study|Death|2|||
163216292|NCT03814746|589506283|FG000|Overall Study|Adverse Event|2|||
163216293|NCT03814746|589506284|FG001|Overall Study|Adverse Event|2|||
163216294|NCT03814746|589506285|FG002|Overall Study|Adverse Event|1|||
163216295|NCT03814746|589506283|FG000|Overall Study|Lost to Follow-up|2|||
163216296|NCT03814746|589506284|FG001|Overall Study|Lost to Follow-up|1|||
163329162|NCT05580003|589914938|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163329163|NCT05580003|589914911|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163216297|NCT03814746|589506285|FG002|Overall Study|Lost to Follow-up|2|||
163405188|NCT01714687|590193545|FG001|Overall Study|Lost to Follow-up|4|||
163216298|NCT03814746|589506283|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163216299|NCT03814746|589506284|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163216300|NCT03814746|589506285|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
163216301|NCT03814746|589506283|FG000|Overall Study|Pregnancy|0|||
163216302|NCT03814746|589506284|FG001|Overall Study|Pregnancy|1|||
163216303|NCT03814746|589506285|FG002|Overall Study|Pregnancy|1|||
163216304|NCT03814746|589506283|FG000|Overall Study|Protocol Violation|1|||
163329164|NCT05580003|589914912|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329165|NCT05580003|589914913|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329166|NCT05580003|589914914|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163019946|NCT02817516|588776305|FG002|Overall Study|Other|1|||
163019947|NCT02817516|588776306|FG003|Overall Study|Other|0|||
163019948|NCT00610155|588776310|FG000|Period 1|Withdrawal by Subject|0|||
163019949|NCT00610155|588776311|FG001|Period 1|Withdrawal by Subject|0|||
163019950|NCT00610155|588776312|FG002|Period 1|Withdrawal by Subject|1|||
163019951|NCT00610155|588776313|FG003|Period 1|Withdrawal by Subject|0|||
163019952|NCT00610155|588776314|FG004|Period 1|Withdrawal by Subject|0|||
163019953|NCT00610155|588776315|FG005|Period 1|Withdrawal by Subject|0|||
163019954|NCT00610155|588776310|FG000|Period 3|Adverse Event|1|||
163019955|NCT00610155|588776311|FG001|Period 3|Adverse Event|0|||
163019956|NCT00610155|588776312|FG002|Period 3|Adverse Event|0|||
163019957|NCT00610155|588776313|FG003|Period 3|Adverse Event|0|||
163019958|NCT00610155|588776314|FG004|Period 3|Adverse Event|0|||
163019959|NCT00610155|588776315|FG005|Period 3|Adverse Event|0|||
163019960|NCT01560234|588776316|FG000|Overall Study|Lost to Follow-up|3|||
163019961|NCT01560234|588776317|FG001|Overall Study|Lost to Follow-up|0|||
163019962|NCT01560234|588776318|FG002|Overall Study|Lost to Follow-up|1|||
163019963|NCT01560234|588776319|FG003|Overall Study|Lost to Follow-up|0|||
163019964|NCT01560234|588776320|FG004|Overall Study|Lost to Follow-up|0|||
163019965|NCT01560234|588776321|FG005|Overall Study|Lost to Follow-up|2|||
163019966|NCT01560234|588776322|FG006|Overall Study|Lost to Follow-up|0|||
163019967|NCT01560234|588776323|FG007|Overall Study|Lost to Follow-up|2|||
163019968|NCT02028767|588776324|FG000|Treatment Period 2|Non compliant with protocol|1|||
163019969|NCT02028767|588776325|FG001|Treatment Period 2|Non compliant with protocol|0|||
163019970|NCT02028767|588776324|FG000|Treatment Period 2|Reason other than those specified above|1|||
163019971|NCT02028767|588776325|FG001|Treatment Period 2|Reason other than those specified above|0|||
163019972|NCT00083759|588776331|FG000|Overall Study|Adverse Event|5|||
163019973|NCT00083759|588776332|FG001|Overall Study|Adverse Event|3|||
163019974|NCT00083759|588776331|FG000|Overall Study|Lost to Follow-up|1|||
163019975|NCT00083759|588776332|FG001|Overall Study|Lost to Follow-up|0|||
163019976|NCT00083759|588776331|FG000|Overall Study|Death|1|||
163019977|NCT00083759|588776332|FG001|Overall Study|Death|1|||
163019978|NCT00083759|588776331|FG000|Overall Study|Inadequate Therapeutic Response|32|||
163019979|NCT00083759|588776332|FG001|Overall Study|Inadequate Therapeutic Response|35|||
163019980|NCT00083759|588776331|FG000|Overall Study|Subject Withdrew Consent|2|||
163019981|NCT00083759|588776332|FG001|Overall Study|Subject Withdrew Consent|2|||
163019982|NCT00083759|588776331|FG000|Overall Study|Non-Compliance|1|||
163019983|NCT00083759|588776332|FG001|Overall Study|Non-Compliance|0|||
163019984|NCT00083759|588776331|FG000|Overall Study|Sponsor's Discretion|28|||
163019985|NCT00083759|588776332|FG001|Overall Study|Sponsor's Discretion|29|||
163019986|NCT00083759|588776331|FG000|Overall Study|Other|14|||
163019987|NCT00083759|588776332|FG001|Overall Study|Other|13|||
163019988|NCT04112043|588776334|FG000|Overall Study|Withdrawal by Subject|1|||
163019989|NCT04112043|588776335|FG001|Overall Study|Withdrawal by Subject|1|||
163019990|NCT04112043|588776336|FG002|Overall Study|Withdrawal by Subject|1|||
163019991|NCT04112043|588776334|FG000|Overall Study|Taking NR supplement|1|||
163019992|NCT04112043|588776335|FG001|Overall Study|Taking NR supplement|0|||
163019993|NCT04112043|588776336|FG002|Overall Study|Taking NR supplement|0|||
163019994|NCT04112043|588776334|FG000|Overall Study|Adverse Event|0|||
163019995|NCT04112043|588776335|FG001|Overall Study|Adverse Event|1|||
163019996|NCT04112043|588776336|FG002|Overall Study|Adverse Event|0|||
163019997|NCT04292912|588776341|FG000|Overall Study|Physician Decision|1|||
163019998|NCT04292912|588776341|FG000|Overall Study|Protocol Violation|6|||
163019999|NCT03348930|588776342|FG000|Washout (1 Week)|Lost to Follow-up|1|||
163020000|NCT03348930|588776343|FG001|Washout (1 Week)|Lost to Follow-up|1|||
163020001|NCT05338502|588776344|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
163020002|NCT05338502|588776345|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
163020003|NCT05338502|588776346|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
163020004|NCT05338502|588776344|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
163020005|NCT05338502|588776345|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
163020006|NCT05338502|588776346|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
163329167|NCT05580003|589914915|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329168|NCT05580003|589914916|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329169|NCT05580003|589914917|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163020007|NCT01290679|588776354|FG000|Overall Study|Adverse Event|2|||
163020008|NCT01290679|588776355|FG001|Overall Study|Adverse Event|0|||
163020009|NCT01290679|588776354|FG000|Overall Study|Lost to Follow-up|8|||
163020010|NCT01290679|588776355|FG001|Overall Study|Lost to Follow-up|10|||
163020011|NCT01290679|588776354|FG000|Overall Study|Protocol Violation|0|||
163020012|NCT01290679|588776355|FG001|Overall Study|Protocol Violation|1|||
163020013|NCT01290679|588776354|FG000|Overall Study|Withdrawal by Subject|6|||
163020014|NCT01290679|588776355|FG001|Overall Study|Withdrawal by Subject|5|||
163020015|NCT01290679|588776354|FG000|Overall Study|Subject Entered Another Trial|0|||
163020016|NCT01290679|588776355|FG001|Overall Study|Subject Entered Another Trial|5|||
163329170|NCT05580003|589914918|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329171|NCT05580003|589914919|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329172|NCT05580003|589914920|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163063336|NCT03314935|588938618|FG001|Phase 2|Lost to Follow-up|0|||
163063337|NCT03314935|588938619|FG002|Phase 2|Lost to Follow-up|0|||
163063338|NCT03314935|588938620|FG003|Phase 2|Lost to Follow-up|0|||
163063339|NCT03314935|588938621|FG004|Phase 2|Lost to Follow-up|0|||
163063340|NCT03314935|588938622|FG005|Phase 2|Lost to Follow-up|0|||
163063341|NCT03314935|588938623|FG006|Phase 2|Lost to Follow-up|0|||
163063342|NCT03314935|588938624|FG007|Phase 2|Lost to Follow-up|0|||
163063343|NCT03314935|588938625|FG008|Phase 2|Lost to Follow-up|0|||
163063344|NCT03314935|588938626|FG009|Phase 2|Lost to Follow-up|1|||
163063345|NCT03314935|588938627|FG010|Phase 2|Lost to Follow-up|0|||
163063346|NCT03314935|588938628|FG011|Phase 2|Lost to Follow-up|0|||
163063347|NCT03314935|588938629|FG012|Phase 2|Lost to Follow-up|0|||
163063348|NCT03314935|588938630|FG013|Phase 2|Lost to Follow-up|0|||
163063349|NCT03314935|588938631|FG014|Phase 2|Lost to Follow-up|1|||
163063350|NCT03314935|588938617|FG000|Phase 2|Physician Decision|0|||
163063351|NCT03314935|588938618|FG001|Phase 2|Physician Decision|0|||
163063352|NCT03314935|588938619|FG002|Phase 2|Physician Decision|0|||
163063353|NCT03314935|588938620|FG003|Phase 2|Physician Decision|0|||
163063354|NCT03314935|588938621|FG004|Phase 2|Physician Decision|0|||
163063355|NCT03314935|588938622|FG005|Phase 2|Physician Decision|0|||
163063356|NCT03314935|588938623|FG006|Phase 2|Physician Decision|0|||
163063357|NCT03314935|588938624|FG007|Phase 2|Physician Decision|0|||
163063358|NCT03314935|588938625|FG008|Phase 2|Physician Decision|0|||
163063359|NCT03314935|588938626|FG009|Phase 2|Physician Decision|0|||
163063360|NCT03314935|588938627|FG010|Phase 2|Physician Decision|1|||
163063361|NCT03314935|588938628|FG011|Phase 2|Physician Decision|0|||
163063362|NCT03314935|588938629|FG012|Phase 2|Physician Decision|0|||
163063363|NCT03314935|588938630|FG013|Phase 2|Physician Decision|0|||
163063364|NCT03314935|588938631|FG014|Phase 2|Physician Decision|0|||
163063365|NCT05252702|588938632|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
163063366|NCT05252702|588938632|FG000|Overall Study|Death|16|||
163063367|NCT05252702|588938632|FG000|Overall Study|System explant|5|||
163063368|NCT05252702|588938632|FG000|Overall Study|Lost to Follow-up|1|||
163063369|NCT05252702|588938632|FG000|Overall Study|Withdrawn by investigator|1|||
163063370|NCT05252702|588938632|FG000|Overall Study|Visit not due|306|||
163063371|NCT05252702|588938632|FG000|Overall Study|Visit within window but not completed|92|||
163063372|NCT05252702|588938632|FG000|Overall Study|Unsuccessful implant|1|||
163063373|NCT02657551|588938633|FG000|Overall Study|Adverse Event|2|||
163063374|NCT02657551|588938633|FG000|Overall Study|Withdrawal by Subject|1|||
163063375|NCT02657551|588938633|FG000|Overall Study|Non-Compliance|1|||
163063376|NCT02657551|588938633|FG000|Overall Study|Progression / Relapse|4|||
163063377|NCT01192178|588938635|FG000|Overall Study|Withdrawal by Subject|6|||
163063378|NCT01192178|588938636|FG001|Overall Study|Withdrawal by Subject|10|||
163063379|NCT01192178|588938635|FG000|Overall Study|Protocol Violation|10|||
163063380|NCT01192178|588938636|FG001|Overall Study|Protocol Violation|3|||
163063381|NCT01192178|588938635|FG000|Overall Study|Physician Decision|2|||
163063382|NCT01192178|588938636|FG001|Overall Study|Physician Decision|4|||
163063383|NCT01192178|588938635|FG000|Overall Study|Lost to Follow-up|3|||
163063384|NCT01192178|588938636|FG001|Overall Study|Lost to Follow-up|3|||
163063385|NCT01192178|588938635|FG000|Overall Study|Adverse Event|2|||
163063386|NCT01192178|588938636|FG001|Overall Study|Adverse Event|1|||
163063387|NCT01192178|588938635|FG000|Overall Study|Lack of Efficacy|1|||
163063388|NCT01192178|588938636|FG001|Overall Study|Lack of Efficacy|2|||
163063389|NCT02164916|588938637|FG000|Overall Study|Adverse Event|3|||
163063390|NCT02164916|588938638|FG001|Overall Study|Adverse Event|8|||
163063391|NCT02164916|588938637|FG000|Overall Study|Death|1|||
163063392|NCT02164916|588938638|FG001|Overall Study|Death|1|||
163063393|NCT02164916|588938637|FG000|Overall Study|Refusal unrelated to adverse event|3|||
163063394|NCT02164916|588938638|FG001|Overall Study|Refusal unrelated to adverse event|7|||
163063395|NCT02164916|588938637|FG000|Overall Study|Progression|37|||
163063396|NCT02164916|588938638|FG001|Overall Study|Progression|26|||
163063397|NCT02164916|588938637|FG000|Overall Study|Not protocol specified|5|||
163063398|NCT02164916|588938638|FG001|Overall Study|Not protocol specified|1|||
163063399|NCT02164916|588938637|FG000|Overall Study|Reason under review|1|||
163063400|NCT02164916|588938638|FG001|Overall Study|Reason under review|6|||
163063401|NCT02164916|588938637|FG000|Overall Study|Not eligible|2|||
163063402|NCT02164916|588938638|FG001|Overall Study|Not eligible|5|||
163063403|NCT00296517|588938639|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
163063404|NCT00296517|588938640|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
163063405|NCT00296517|588938639|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
163063406|NCT00296517|588938640|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
163063407|NCT00296517|588938639|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
163063408|NCT00296517|588938640|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
163063409|NCT00296517|588938639|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
163063410|NCT00296517|588938640|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
163063411|NCT00296517|588938639|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
163063412|NCT00296517|588938640|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
163063413|NCT00296517|588938639|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
163063414|NCT00296517|588938640|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
163329173|NCT05580003|589914921|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329174|NCT05580003|589914922|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329175|NCT05580003|589914923|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329176|NCT05580003|589914924|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329177|NCT05580003|589914925|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329178|NCT05580003|589914926|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329179|NCT05580003|589914927|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329180|NCT05580003|589914928|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329181|NCT05580003|589914929|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329182|NCT05580003|589914930|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329183|NCT05580003|589914931|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329184|NCT05580003|589914932|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329185|NCT05580003|589914933|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329186|NCT05580003|589914934|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329187|NCT05580003|589914935|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329188|NCT05580003|589914936|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329189|NCT05580003|589914937|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163329190|NCT05580003|589914938|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
163329191|NCT05580003|589914911|FG000|Part 6 Period 2 (Day 1)|Other|0|||
163020017|NCT03474731|588776365|FG000|Overall Study|Withdrawal by Subject|36|||
163020018|NCT03474731|588776366|FG001|Overall Study|Withdrawal by Subject|29|||
163020019|NCT03474731|588776367|FG002|Overall Study|Withdrawal by Subject|11|||
163020020|NCT03474731|588776368|FG003|Overall Study|Withdrawal by Subject|27|||
163020021|NCT03474731|588776365|FG000|Overall Study|COVID|0|||
163020022|NCT03474731|588776366|FG001|Overall Study|COVID|23|||
163020023|NCT03474731|588776367|FG002|Overall Study|COVID|0|||
163329192|NCT05580003|589914912|FG001|Part 6 Period 2 (Day 1)|Other|0|||
163329193|NCT05580003|589914913|FG002|Part 6 Period 2 (Day 1)|Other|0|||
163329194|NCT05580003|589914914|FG003|Part 6 Period 2 (Day 1)|Other|0|||
163329195|NCT05580003|589914915|FG004|Part 6 Period 2 (Day 1)|Other|0|||
163329196|NCT05580003|589914916|FG005|Part 6 Period 2 (Day 1)|Other|0|||
163329197|NCT05580003|589914917|FG006|Part 6 Period 2 (Day 1)|Other|0|||
163329198|NCT05580003|589914918|FG007|Part 6 Period 2 (Day 1)|Other|0|||
163329199|NCT05580003|589914919|FG008|Part 6 Period 2 (Day 1)|Other|0|||
163329200|NCT05580003|589914920|FG009|Part 6 Period 2 (Day 1)|Other|0|||
163329201|NCT05580003|589914921|FG010|Part 6 Period 2 (Day 1)|Other|0|||
163329202|NCT05580003|589914922|FG011|Part 6 Period 2 (Day 1)|Other|0|||
163329203|NCT05580003|589914923|FG012|Part 6 Period 2 (Day 1)|Other|0|||
163329204|NCT05580003|589914924|FG013|Part 6 Period 2 (Day 1)|Other|0|||
163329205|NCT05580003|589914925|FG014|Part 6 Period 2 (Day 1)|Other|0|||
163329206|NCT05580003|589914926|FG015|Part 6 Period 2 (Day 1)|Other|0|||
163329207|NCT05580003|589914927|FG016|Part 6 Period 2 (Day 1)|Other|0|||
163329208|NCT05580003|589914928|FG017|Part 6 Period 2 (Day 1)|Other|0|||
163329209|NCT05580003|589914929|FG018|Part 6 Period 2 (Day 1)|Other|0|||
163329210|NCT05580003|589914930|FG019|Part 6 Period 2 (Day 1)|Other|0|||
163329211|NCT05580003|589914931|FG020|Part 6 Period 2 (Day 1)|Other|0|||
163329212|NCT05580003|589914932|FG021|Part 6 Period 2 (Day 1)|Other|0|||
163329213|NCT05580003|589914933|FG022|Part 6 Period 2 (Day 1)|Other|0|||
163329214|NCT05580003|589914934|FG023|Part 6 Period 2 (Day 1)|Other|0|||
163329215|NCT05580003|589914935|FG024|Part 6 Period 2 (Day 1)|Other|1|||
163329216|NCT05580003|589914936|FG025|Part 6 Period 2 (Day 1)|Other|0|||
163329217|NCT05580003|589914937|FG026|Part 6 Period 2 (Day 1)|Other|0|||
163329218|NCT05580003|589914938|FG027|Part 6 Period 2 (Day 1)|Other|0|||
163329219|NCT03516812|589914939|FG000|Overall Study|Adverse Event|4|||
163329220|NCT03516812|589914939|FG000|Overall Study|Lack of Efficacy|2|||
163329221|NCT03840902|589914940|FG000|Overall Study|Randomized but not treated|1|||
163329222|NCT03840902|589914941|FG001|Overall Study|Randomized but not treated|1|||
163020024|NCT03474731|588776368|FG003|Overall Study|COVID|0|||
163020025|NCT03474731|588776365|FG000|Overall Study|Participant moved from area|1|||
163020026|NCT03474731|588776366|FG001|Overall Study|Participant moved from area|0|||
163020027|NCT03474731|588776367|FG002|Overall Study|Participant moved from area|0|||
163020028|NCT03474731|588776368|FG003|Overall Study|Participant moved from area|0|||
163329223|NCT02392234|589914942|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
163329224|NCT02392234|589914943|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
163329225|NCT02392234|589914944|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
163329226|NCT02392234|589914945|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
163329227|NCT02392234|589914946|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
163329228|NCT02392234|589914947|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
163329229|NCT02392234|589914942|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
163020029|NCT03474731|588776365|FG000|Overall Study|Lost to Follow-up|11|||
163020030|NCT03474731|588776366|FG001|Overall Study|Lost to Follow-up|3|||
163063415|NCT00296517|588938639|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
163329230|NCT02392234|589914943|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
163329231|NCT02392234|589914944|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
163329232|NCT02392234|589914945|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
163020031|NCT03474731|588776367|FG002|Overall Study|Lost to Follow-up|18|||
163020032|NCT03474731|588776368|FG003|Overall Study|Lost to Follow-up|17|||
163020033|NCT03474731|588776365|FG000|Overall Study|Death|0|||
163020034|NCT03474731|588776366|FG001|Overall Study|Death|1|||
163020035|NCT03474731|588776367|FG002|Overall Study|Death|0|||
163020036|NCT03474731|588776368|FG003|Overall Study|Death|0|||
163020037|NCT03474731|588776365|FG000|Overall Study|Participant Removed|0|||
163020038|NCT03474731|588776366|FG001|Overall Study|Participant Removed|0|||
163020039|NCT03474731|588776367|FG002|Overall Study|Participant Removed|0|||
163020040|NCT03474731|588776368|FG003|Overall Study|Participant Removed|1|||
163020041|NCT00554515|588776369|FG000|Overall Study|Withdrawal by Subject|3|||
163020042|NCT00554515|588776369|FG000|Overall Study|Disease progression|52|||
163020043|NCT00554515|588776369|FG000|Overall Study|Physician Decision|18|||
163020044|NCT00554515|588776369|FG000|Overall Study|Withdrawal by Subject|11|||
163020045|NCT00554515|588776369|FG000|Overall Study|Adverse Event|9|||
163020046|NCT00554515|588776369|FG000|Overall Study|Death|2|||
163020047|NCT00554515|588776369|FG000|Overall Study|Achieved Stable Disease|7|||
163020048|NCT00554515|588776369|FG000|Overall Study|Other|1|||
163020049|NCT00554515|588776369|FG000|Overall Study|Misc|15|||
163020050|NCT03793842|588776377|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
163020051|NCT03793842|588776378|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
163020052|NCT03793842|588776377|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
163020053|NCT03793842|588776378|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
163020054|NCT02549287|588776379|FG000|Overall Study|Lost to Follow-up|65|||
163020055|NCT02549287|588776380|FG001|Overall Study|Lost to Follow-up|26|||
163020056|NCT02549287|588776379|FG000|Overall Study|Withdrawal by Subject|15|||
163020057|NCT02549287|588776380|FG001|Overall Study|Withdrawal by Subject|6|||
163020058|NCT04087720|588776381|FG000|Overall Study|Withdrawal by Subject|2|||
163020059|NCT04087720|588776381|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
163020060|NCT00900159|588776384|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
163020061|NCT00900159|588776385|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
163020062|NCT00765336|588776386|FG000|Overall Study|Protocol Violation|4|||
163020063|NCT00765336|588776387|FG001|Overall Study|Protocol Violation|2|||
163020064|NCT00765336|588776386|FG000|Overall Study|Withdrawal by Subject|6|||
163020065|NCT00765336|588776387|FG001|Overall Study|Withdrawal by Subject|4|||
163020066|NCT00765336|588776386|FG000|Overall Study|Lost to Follow-up|7|||
163020067|NCT00765336|588776387|FG001|Overall Study|Lost to Follow-up|9|||
163020068|NCT00765336|588776386|FG000|Overall Study|Adverse Event|2|||
163020069|NCT00765336|588776387|FG001|Overall Study|Adverse Event|1|||
163020070|NCT01377922|588776388|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
163020071|NCT01377922|588776389|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
163020072|NCT04615403|588776390|FG000|Overall Study|Death|1|||
163020073|NCT00665431|588776391|FG000|Overall Study|Adverse Event|16|||
163020074|NCT00665431|588776392|FG001|Overall Study|Adverse Event|22|||
163020075|NCT00665431|588776393|FG002|Overall Study|Adverse Event|6|||
163020076|NCT00665431|588776391|FG000|Overall Study|Withdrawal by Subject|17|||
163020077|NCT00665431|588776392|FG001|Overall Study|Withdrawal by Subject|25|||
163020078|NCT00665431|588776393|FG002|Overall Study|Withdrawal by Subject|15|||
163020079|NCT00665431|588776391|FG000|Overall Study|Lost to Follow-up|3|||
163020080|NCT00665431|588776392|FG001|Overall Study|Lost to Follow-up|3|||
163020081|NCT00665431|588776393|FG002|Overall Study|Lost to Follow-up|1|||
163020082|NCT00665431|588776391|FG000|Overall Study|Other|4|||
163020083|NCT00665431|588776392|FG001|Overall Study|Other|7|||
163020084|NCT00665431|588776393|FG002|Overall Study|Other|2|||
163020085|NCT02547220|588776394|FG000|Overall Study|Withdrawal by Subject|1|||
163020086|NCT02547220|588776395|FG001|Overall Study|Withdrawal by Subject|0|||
163020087|NCT02547220|588776394|FG000|Overall Study|Study terminated by sponsor|18|||
163020088|NCT02547220|588776395|FG001|Overall Study|Study terminated by sponsor|20|||
163020089|NCT03817229|588776396|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
163020090|NCT03817229|588776397|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
163020091|NCT03817229|588776398|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
163020092|NCT03817229|588776399|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
163020093|NCT03817229|588776396|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
163020094|NCT03817229|588776397|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
163020095|NCT03817229|588776398|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
163020096|NCT03817229|588776399|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
163020097|NCT03817229|588776396|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
163020098|NCT03817229|588776397|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
163020099|NCT03817229|588776398|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
163020100|NCT03817229|588776399|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
163020101|NCT03817229|588776396|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
163020102|NCT03817229|588776397|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
163020103|NCT03817229|588776398|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
163020104|NCT03817229|588776399|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
163020105|NCT03817229|588776396|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
163020106|NCT03817229|588776397|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
163405189|NCT00788372|590193546|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
163063416|NCT00296517|588938640|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
163063417|NCT00296517|588938639|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
163063418|NCT00296517|588938640|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
163063419|NCT00296517|588938639|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
163063420|NCT00296517|588938640|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
163063421|NCT00596635|588938645|FG000|Overall Study|Lost to Follow-up|0|||
163063422|NCT00596635|588938646|FG001|Overall Study|Lost to Follow-up|2|||
163063423|NCT00596635|588938647|FG002|Overall Study|Lost to Follow-up|0|||
163063424|NCT00596635|588938645|FG000|Overall Study|Treatment for symptomatic UTI|4|||
163063425|NCT00596635|588938646|FG001|Overall Study|Treatment for symptomatic UTI|6|||
163063426|NCT00596635|588938647|FG002|Overall Study|Treatment for symptomatic UTI|3|||
163063427|NCT00596635|588938645|FG000|Overall Study|Hip fracture|2|||
163063428|NCT00596635|588938646|FG001|Overall Study|Hip fracture|3|||
163063429|NCT00596635|588938647|FG002|Overall Study|Hip fracture|3|||
163063430|NCT00596635|588938645|FG000|Overall Study|Could not provide urine specimen|1|||
163063431|NCT00596635|588938646|FG001|Overall Study|Could not provide urine specimen|2|||
163063432|NCT00596635|588938647|FG002|Overall Study|Could not provide urine specimen|2|||
163063433|NCT01143324|588938650|FG000|Overall Study|Lost to Follow-up|11|||
163063434|NCT01143324|588938650|FG000|Overall Study|Withdrawal by Subject|4|||
163063435|NCT01143324|588938650|FG000|Overall Study|Explant of the device|4|||
163063436|NCT00858988|588938655|FG000|Analysis|Lactulose unable to be detected in urine|2|||
163063437|NCT00858988|588938656|FG001|Analysis|Lactulose unable to be detected in urine|1|||
163063438|NCT00846365|588938659|FG000|Overall Study|Adverse Event|20|||
163063439|NCT00846365|588938660|FG001|Overall Study|Adverse Event|30|||
163063440|NCT00846365|588938661|FG002|Overall Study|Adverse Event|11|||
163063441|NCT00846365|588938659|FG000|Overall Study|Protocol Violation|5|||
163063442|NCT00846365|588938660|FG001|Overall Study|Protocol Violation|4|||
163063443|NCT00846365|588938661|FG002|Overall Study|Protocol Violation|0|||
163063444|NCT00846365|588938659|FG000|Overall Study|Lost to Follow-up|8|||
163063445|NCT00846365|588938660|FG001|Overall Study|Lost to Follow-up|2|||
163063446|NCT00846365|588938661|FG002|Overall Study|Lost to Follow-up|5|||
163063447|NCT00846365|588938659|FG000|Overall Study|Withdrawal by Subject|11|||
163063448|NCT00846365|588938660|FG001|Overall Study|Withdrawal by Subject|11|||
163063449|NCT00846365|588938661|FG002|Overall Study|Withdrawal by Subject|9|||
163063450|NCT00846365|588938659|FG000|Overall Study|Pregnancy|1|||
163063451|NCT00846365|588938660|FG001|Overall Study|Pregnancy|0|||
163063452|NCT00846365|588938661|FG002|Overall Study|Pregnancy|0|||
163063453|NCT00846365|588938659|FG000|Overall Study|Lack of Efficacy|1|||
163063454|NCT00846365|588938660|FG001|Overall Study|Lack of Efficacy|1|||
163063455|NCT00846365|588938661|FG002|Overall Study|Lack of Efficacy|2|||
163063456|NCT00846365|588938659|FG000|Overall Study|Other|9|||
163063457|NCT00846365|588938660|FG001|Overall Study|Other|1|||
163063458|NCT00846365|588938661|FG002|Overall Study|Other|6|||
163063459|NCT01277861|588938669|FG000|Overall Study|Physician Decision|2|||
163063460|NCT01277861|588938670|FG001|Overall Study|Physician Decision|2|||
163063461|NCT05032196|588938671|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
163063462|NCT05032196|588938672|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
163063463|NCT05032196|588938673|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
163063464|NCT05032196|588938674|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
163063465|NCT05032196|588938675|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
163063466|NCT05032196|588938676|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
163063467|NCT05032196|588938671|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
163063468|NCT05032196|588938672|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
163063469|NCT05032196|588938673|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
163063470|NCT05032196|588938674|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
163063471|NCT05032196|588938675|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
163063472|NCT05032196|588938676|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
163063473|NCT05032196|588938671|FG000|Period 2 (Multidose)|Physician Decision|0|||
163063474|NCT05032196|588938672|FG001|Period 2 (Multidose)|Physician Decision|0|||
163216305|NCT03814746|589506284|FG001|Overall Study|Protocol Violation|0|||
163216306|NCT03814746|589506285|FG002|Overall Study|Protocol Violation|0|||
163216307|NCT05089682|589506286|FG000|Overall Study|Withdrawal by Subject|2|||
163216308|NCT00371254|589506292|FG000|Overall Study|Disease progression|13|||
163216309|NCT00371254|589506293|FG001|Overall Study|Disease progression|13|||
163216310|NCT00371254|589506292|FG000|Overall Study|Study drug toxicity|3|||
163216311|NCT00371254|589506293|FG001|Overall Study|Study drug toxicity|5|||
163216312|NCT00371254|589506292|FG000|Overall Study|Subject request|5|||
163216313|NCT00371254|589506293|FG001|Overall Study|Subject request|0|||
163216314|NCT00371254|589506292|FG000|Overall Study|Investigator Decision|2|||
163216315|NCT00371254|589506293|FG001|Overall Study|Investigator Decision|0|||
163216316|NCT00371254|589506292|FG000|Overall Study|Adverse event unrelated to study drug|0|||
163216317|NCT00371254|589506293|FG001|Overall Study|Adverse event unrelated to study drug|1|||
163216318|NCT00371254|589506292|FG000|Overall Study|Lost to Follow-up|0|||
163216319|NCT00371254|589506293|FG001|Overall Study|Lost to Follow-up|1|||
163216320|NCT00371254|589506292|FG000|Overall Study|Withdrawal by Subject|0|||
163020107|NCT03817229|588776398|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
163020108|NCT03817229|588776399|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
163020109|NCT03817229|588776396|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
163020110|NCT03817229|588776397|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
163020111|NCT03817229|588776398|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
163020112|NCT03817229|588776399|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
163020113|NCT03817229|588776396|FG000|Post-Intervention|Withdrawal by Subject|6|||
163020114|NCT03817229|588776397|FG001|Post-Intervention|Withdrawal by Subject|0|||
163063475|NCT05032196|588938673|FG002|Period 2 (Multidose)|Physician Decision|0|||
163063476|NCT05032196|588938674|FG003|Period 2 (Multidose)|Physician Decision|0|||
163063477|NCT05032196|588938675|FG004|Period 2 (Multidose)|Physician Decision|1|||
163063478|NCT05032196|588938676|FG005|Period 2 (Multidose)|Physician Decision|0|||
163063479|NCT00857389|588938677|FG000|Overall Study|Did not proceed to transplant|2|||
163329233|NCT02392234|589914946|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
163329234|NCT02392234|589914947|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
163329235|NCT02392234|589914942|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
163329236|NCT02392234|589914943|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
163329237|NCT02392234|589914944|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
163329238|NCT02392234|589914945|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
163329239|NCT02392234|589914946|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
163329240|NCT02392234|589914947|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
163329241|NCT02392234|589914942|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
163329242|NCT02392234|589914943|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
163329243|NCT02392234|589914944|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
163329244|NCT02392234|589914945|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
163329245|NCT02392234|589914946|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
163329246|NCT02392234|589914947|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
163329247|NCT02392234|589914942|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
163329248|NCT02392234|589914943|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
163329249|NCT02392234|589914944|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
163329250|NCT02392234|589914945|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
163329251|NCT02392234|589914946|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
163329252|NCT02392234|589914947|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
163329253|NCT02392234|589914942|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
163329254|NCT02392234|589914943|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
163329255|NCT02392234|589914944|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
163329256|NCT02392234|589914945|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
163329257|NCT02392234|589914946|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
163329258|NCT02392234|589914947|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
163329259|NCT02392234|589914942|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
163329260|NCT02392234|589914943|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
163329261|NCT02392234|589914944|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
163329262|NCT02392234|589914945|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
163329263|NCT02392234|589914946|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
163329264|NCT02392234|589914947|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
163329265|NCT02392234|589914942|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
163329266|NCT02392234|589914943|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
163329267|NCT02392234|589914944|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
163329268|NCT02392234|589914945|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
163329269|NCT02392234|589914946|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
163329270|NCT02392234|589914947|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
163329271|NCT02816398|589914952|FG000|Overall Study|Death|5|||
163329272|NCT02816398|589914952|FG000|Overall Study|Lack of Efficacy|8|||
163329273|NCT02816398|589914952|FG000|Overall Study|Lost to Follow-up|1|||
163329274|NCT01387516|589914953|FG000|Overall Study|Lost to Follow-up|4|||
163329275|NCT01387516|589914954|FG001|Overall Study|Lost to Follow-up|4|||
163329276|NCT01387516|589914955|FG002|Overall Study|Lost to Follow-up|2|||
163329277|NCT01387516|589914956|FG003|Overall Study|Lost to Follow-up|3|||
163329278|NCT01387516|589914953|FG000|Overall Study|Withdrawal by Subject|1|||
163329279|NCT01387516|589914954|FG001|Overall Study|Withdrawal by Subject|1|||
163329280|NCT01387516|589914955|FG002|Overall Study|Withdrawal by Subject|2|||
163020115|NCT03817229|588776398|FG002|Post-Intervention|Withdrawal by Subject|2|||
163063480|NCT00764517|588939884|FG000|Overall Study|Adverse Event|9|||
163063481|NCT00764517|588939885|FG001|Overall Study|Adverse Event|3|||
163329281|NCT01387516|589914956|FG003|Overall Study|Withdrawal by Subject|0|||
163329282|NCT01387516|589914953|FG000|Overall Study|Death|0|||
163329283|NCT01387516|589914954|FG001|Overall Study|Death|0|||
163329284|NCT01387516|589914955|FG002|Overall Study|Death|0|||
163329285|NCT01387516|589914956|FG003|Overall Study|Death|1|||
163329286|NCT03582475|589914957|FG000|Treatment Period|Withdrawal by Subject|0|||
163063482|NCT00764517|588939884|FG000|Overall Study|Death|3|||
163063483|NCT00764517|588939885|FG001|Overall Study|Death|11|||
163063484|NCT00764517|588939884|FG000|Overall Study|Physician Decision|3|||
163329287|NCT03582475|589914958|FG001|Treatment Period|Withdrawal by Subject|1|||
163329288|NCT03582475|589914957|FG000|Follow-up Period|Withdrawal by Subject|0|||
163329289|NCT03582475|589914958|FG001|Follow-up Period|Withdrawal by Subject|1|||
163329290|NCT03509909|589914964|FG000|Overall Study|Withdrawal by Subject|16|||
163329291|NCT03509909|589914965|FG001|Overall Study|Withdrawal by Subject|9|||
163063485|NCT00764517|588939885|FG001|Overall Study|Physician Decision|0|||
163063486|NCT00460798|588939886|FG000|Overall Study|Death|59|||
163063487|NCT00460798|588939886|FG000|Overall Study|Adverse Event|27|||
163063488|NCT00460798|588939886|FG000|Overall Study|Lost to Follow-up|19|||
163063489|NCT00460798|588939886|FG000|Overall Study|Progressive Disease|99|||
163063490|NCT00460798|588939886|FG000|Overall Study|Other|27|||
163063491|NCT00460798|588939886|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
163063492|NCT00460798|588939886|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
163063493|NCT03517137|588939892|FG000|Overall Study|Lack of Efficacy|1|||
163063494|NCT03517137|588939892|FG000|Overall Study|Adverse Event|2|||
163063495|NCT03517137|588939892|FG000|Overall Study|Withdrawal by Subject|2|||
163063496|NCT03517137|588939892|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
163063497|NCT01186770|588939893|FG000|Overall Study|Ineligibility|0|||
163063498|NCT01186770|588939894|FG001|Overall Study|Ineligibility|0|||
163063499|NCT01186770|588939895|FG002|Overall Study|Ineligibility|2|||
163063500|NCT01186770|588939896|FG003|Overall Study|Ineligibility|0|||
163063501|NCT01186770|588939893|FG000|Overall Study|Protocol Violation|7|||
163063502|NCT01186770|588939894|FG001|Overall Study|Protocol Violation|9|||
163063503|NCT01186770|588939895|FG002|Overall Study|Protocol Violation|12|||
163063504|NCT01186770|588939896|FG003|Overall Study|Protocol Violation|14|||
163063505|NCT01186770|588939893|FG000|Overall Study|Adverse Event|2|||
163063506|NCT01186770|588939894|FG001|Overall Study|Adverse Event|9|||
163063507|NCT01186770|588939895|FG002|Overall Study|Adverse Event|7|||
163063508|NCT01186770|588939896|FG003|Overall Study|Adverse Event|9|||
163063509|NCT01186770|588939893|FG000|Overall Study|Withdrawal by Subject|15|||
163063510|NCT01186770|588939894|FG001|Overall Study|Withdrawal by Subject|13|||
163063511|NCT01186770|588939895|FG002|Overall Study|Withdrawal by Subject|11|||
163063512|NCT01186770|588939896|FG003|Overall Study|Withdrawal by Subject|17|||
163063513|NCT01186770|588939893|FG000|Overall Study|Lost to Follow-up|10|||
163063514|NCT01186770|588939894|FG001|Overall Study|Lost to Follow-up|6|||
163063515|NCT01186770|588939895|FG002|Overall Study|Lost to Follow-up|14|||
163063516|NCT01186770|588939896|FG003|Overall Study|Lost to Follow-up|9|||
163063517|NCT01186770|588939893|FG000|Overall Study|Insufficient response to treatment|7|||
163063518|NCT01186770|588939894|FG001|Overall Study|Insufficient response to treatment|8|||
163063519|NCT01186770|588939895|FG002|Overall Study|Insufficient response to treatment|5|||
163063520|NCT01186770|588939896|FG003|Overall Study|Insufficient response to treatment|7|||
163063521|NCT01186770|588939893|FG000|Overall Study|Other than specified|0|||
163063522|NCT01186770|588939894|FG001|Overall Study|Other than specified|1|||
163063523|NCT01186770|588939895|FG002|Overall Study|Other than specified|1|||
163063524|NCT01186770|588939896|FG003|Overall Study|Other than specified|2|||
163063525|NCT02441283|588939897|FG000|Overall Study|Withdrew consent|15|||
163063526|NCT02441283|588939897|FG000|Overall Study|Lost to Follow-up|42|||
163063527|NCT02441283|588939897|FG000|Overall Study|Death|1|||
163063528|NCT02441283|588939897|FG000|Overall Study|Other, not specified|32|||
163063529|NCT02472353|588939899|FG000|Overall Study|Lost to Follow-up|1|||
163063530|NCT02472353|588939900|FG001|Overall Study|Lost to Follow-up|1|||
163329292|NCT03509909|589914964|FG000|Overall Study|Lost to Follow-up|3|||
163329293|NCT03509909|589914965|FG001|Overall Study|Lost to Follow-up|4|||
163329294|NCT03509909|589914964|FG000|Overall Study|Adverse Event|2|||
163329295|NCT03509909|589914965|FG001|Overall Study|Adverse Event|0|||
163329296|NCT03683576|589914967|FG000|Overall Study|Withdrawal by Subject|2|||
163405190|NCT00788372|590193546|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
163063531|NCT02472353|588939899|FG000|Overall Study|Withdrawal by Subject|2|||
163063532|NCT02472353|588939900|FG001|Overall Study|Withdrawal by Subject|1|||
163063533|NCT02472353|588939899|FG000|Overall Study|Study Termination|1|||
163063534|NCT02472353|588939900|FG001|Overall Study|Study Termination|4|||
163063535|NCT00688597|588939901|FG000|Overall Study|Adverse Event|2|||
163063536|NCT00688597|588939902|FG001|Overall Study|Adverse Event|0|||
163063537|NCT00688597|588939903|FG002|Overall Study|Adverse Event|0|||
163063538|NCT00688597|588939901|FG000|Overall Study|Physician Decision|1|||
163063539|NCT00688597|588939902|FG001|Overall Study|Physician Decision|0|||
163063540|NCT00688597|588939903|FG002|Overall Study|Physician Decision|0|||
163063541|NCT01995201|588939904|FG000|From Baseline Until Week 24|Adverse Event|4|||
163063542|NCT01995201|588939905|FG001|From Baseline Until Week 24|Adverse Event|15|||
163329297|NCT03683576|589914968|FG001|Overall Study|Withdrawal by Subject|0|||
163063543|NCT01995201|588939906|FG002|From Baseline Until Week 24|Adverse Event|0|||
163063544|NCT01995201|588939907|FG003|From Baseline Until Week 24|Adverse Event|0|||
163063545|NCT01995201|588939908|FG004|From Baseline Until Week 24|Adverse Event|0|||
163063546|NCT01995201|588939909|FG005|From Baseline Until Week 24|Adverse Event|0|||
163063547|NCT01995201|588939910|FG006|From Baseline Until Week 24|Adverse Event|0|||
163063548|NCT01995201|588939904|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
163063549|NCT01995201|588939905|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
163329298|NCT03683576|589914969|FG002|Overall Study|Withdrawal by Subject|8|||
163329299|NCT03683576|589914970|FG003|Overall Study|Withdrawal by Subject|3|||
163329300|NCT03683576|589914967|FG000|Overall Study|Adverse Event|3|||
163329301|NCT03683576|589914968|FG001|Overall Study|Adverse Event|0|||
163329302|NCT03683576|589914969|FG002|Overall Study|Adverse Event|0|||
163329303|NCT03683576|589914970|FG003|Overall Study|Adverse Event|4|||
163329304|NCT03683576|589914967|FG000|Overall Study|Lack of Efficacy|1|||
163329305|NCT03683576|589914968|FG001|Overall Study|Lack of Efficacy|0|||
163329306|NCT03683576|589914969|FG002|Overall Study|Lack of Efficacy|1|||
163329307|NCT03683576|589914970|FG003|Overall Study|Lack of Efficacy|1|||
163329308|NCT03683576|589914967|FG000|Overall Study|Lost to Follow-up|0|||
163329309|NCT03683576|589914968|FG001|Overall Study|Lost to Follow-up|1|||
163329310|NCT03683576|589914969|FG002|Overall Study|Lost to Follow-up|2|||
163329311|NCT03683576|589914970|FG003|Overall Study|Lost to Follow-up|0|||
163329312|NCT03683576|589914967|FG000|Overall Study|Other, Not Specified|0|||
163329313|NCT03683576|589914968|FG001|Overall Study|Other, Not Specified|2|||
163329314|NCT03683576|589914969|FG002|Overall Study|Other, Not Specified|0|||
163329315|NCT03683576|589914970|FG003|Overall Study|Other, Not Specified|0|||
163020116|NCT03817229|588776399|FG003|Post-Intervention|Withdrawal by Subject|2|||
163329316|NCT03683576|589914967|FG000|Overall Study|Protocol Violation|0|||
163329317|NCT03683576|589914968|FG001|Overall Study|Protocol Violation|1|||
163329318|NCT03683576|589914969|FG002|Overall Study|Protocol Violation|1|||
163329319|NCT03683576|589914970|FG003|Overall Study|Protocol Violation|0|||
163329320|NCT01588951|589914971|FG000|Overall Study|Ineligible in retrospect|0|||
163329321|NCT01588951|589914972|FG001|Overall Study|Ineligible in retrospect|0|||
163329322|NCT01588951|589914973|FG002|Overall Study|Ineligible in retrospect|1|||
163329323|NCT02454959|589914974|FG000|Overall Study|Protocol-Specified Criteria|3|||
163329324|NCT02454959|589914974|FG000|Overall Study|Physician Decision|1|||
163329325|NCT02454959|589914974|FG000|Overall Study|Withdrawal by Subject|3|||
163329326|NCT02454959|589914974|FG000|Overall Study|Adverse Event|2|||
163329327|NCT02350634|589914975|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
163329328|NCT02307682|589914992|FG000|Overall Study|Adverse Event|9|||
163329329|NCT02307682|589914993|FG001|Overall Study|Adverse Event|8|||
163329330|NCT02307682|589914994|FG002|Overall Study|Adverse Event|12|||
163329331|NCT02307682|589914992|FG000|Overall Study|Lack of Efficacy|1|||
163329332|NCT02307682|589914993|FG001|Overall Study|Lack of Efficacy|0|||
163329333|NCT02307682|589914994|FG002|Overall Study|Lack of Efficacy|1|||
163329334|NCT02307682|589914992|FG000|Overall Study|Physician Decision|2|||
163329335|NCT02307682|589914993|FG001|Overall Study|Physician Decision|2|||
163329336|NCT02307682|589914994|FG002|Overall Study|Physician Decision|8|||
163329337|NCT02307682|589914992|FG000|Overall Study|Progressive Disease|1|||
163329338|NCT02307682|589914993|FG001|Overall Study|Progressive Disease|0|||
163329339|NCT02307682|589914994|FG002|Overall Study|Progressive Disease|0|||
163329340|NCT02307682|589914992|FG000|Overall Study|Withdrawal by Subject|26|||
163329341|NCT02307682|589914993|FG001|Overall Study|Withdrawal by Subject|34|||
163329342|NCT02307682|589914994|FG002|Overall Study|Withdrawal by Subject|23|||
163329343|NCT02307682|589914992|FG000|Overall Study|Death|9|||
163329344|NCT02307682|589914993|FG001|Overall Study|Death|7|||
163329345|NCT02307682|589914994|FG002|Overall Study|Death|12|||
163329346|NCT02307682|589914992|FG000|Overall Study|Lost to Follow-up|1|||
163329347|NCT02307682|589914993|FG001|Overall Study|Lost to Follow-up|5|||
163329348|NCT02307682|589914994|FG002|Overall Study|Lost to Follow-up|6|||
163329349|NCT02307682|589914992|FG000|Overall Study|Protocol Deviation|0|||
163329350|NCT02307682|589914993|FG001|Overall Study|Protocol Deviation|0|||
163329351|NCT02307682|589914994|FG002|Overall Study|Protocol Deviation|2|||
163329352|NCT02307682|589914992|FG000|Overall Study|Other|1|||
163329353|NCT02307682|589914993|FG001|Overall Study|Other|1|||
163329354|NCT02307682|589914994|FG002|Overall Study|Other|0|||
163329355|NCT03997474|589914996|FG000|Overall Study|Death|6|||
163329356|NCT03997474|589914997|FG001|Overall Study|Death|2|||
163329357|NCT03997474|589914998|FG002|Overall Study|Death|1|||
163329358|NCT03997474|589914996|FG000|Overall Study|Physician Decision|2|||
163329359|NCT03997474|589914997|FG001|Overall Study|Physician Decision|0|||
163020117|NCT03817229|588776396|FG000|Post-Intervention|Withdrawal by Study Team|3|||
163329360|NCT03997474|589914998|FG002|Overall Study|Physician Decision|0|||
163329361|NCT03997474|589914996|FG000|Overall Study|study terminated by sponsor|1|||
163329362|NCT03997474|589914997|FG001|Overall Study|study terminated by sponsor|0|||
163329363|NCT03997474|589914998|FG002|Overall Study|study terminated by sponsor|1|||
163329364|NCT03277989|589915000|FG000|Overall Study|Lost to Follow-up|6|||
163329365|NCT03277989|589915000|FG000|Overall Study|Adverse Event|6|||
163329366|NCT03277989|589915000|FG000|Overall Study|Withdrawal by Subject|3|||
163329367|NCT03277989|589915000|FG000|Overall Study|Didn't Receive Study Device|7|||
163329368|NCT03277989|589915000|FG000|Overall Study|Site Closure|26|||
163329369|NCT03277989|589915000|FG000|Overall Study|Sponsor Closure|107|||
163329370|NCT00371345|589916566|FG000|Overall Study|Disease Progression|21|||
163329371|NCT00371345|589916567|FG001|Overall Study|Disease Progression|35|||
163329372|NCT00371345|589916566|FG000|Overall Study|Study Drug Toxicity|1|||
163329373|NCT00371345|589916567|FG001|Overall Study|Study Drug Toxicity|7|||
163329374|NCT00371345|589916566|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
163216321|NCT00371254|589506293|FG001|Overall Study|Withdrawal by Subject|1|||
163405191|NCT00788372|590193546|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
163020118|NCT03817229|588776397|FG001|Post-Intervention|Withdrawal by Study Team|1|||
163020119|NCT03817229|588776398|FG002|Post-Intervention|Withdrawal by Study Team|1|||
163020120|NCT03817229|588776399|FG003|Post-Intervention|Withdrawal by Study Team|4|||
163020121|NCT03817229|588776396|FG000|Post-Intervention|Weaned from medication|3|||
163020122|NCT03817229|588776397|FG001|Post-Intervention|Weaned from medication|0|||
163020123|NCT03817229|588776398|FG002|Post-Intervention|Weaned from medication|2|||
163020124|NCT03817229|588776399|FG003|Post-Intervention|Weaned from medication|1|||
163020125|NCT03817229|588776396|FG000|Post-Intervention|Transferred care to another institution|1|||
163020126|NCT03817229|588776397|FG001|Post-Intervention|Transferred care to another institution|0|||
163020127|NCT03817229|588776398|FG002|Post-Intervention|Transferred care to another institution|0|||
163405192|NCT00788372|590193546|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
163020128|NCT03817229|588776399|FG003|Post-Intervention|Transferred care to another institution|0|||
163020129|NCT03817229|588776396|FG000|Post-Intervention|Change in parental guardianship|0|||
163020130|NCT03817229|588776397|FG001|Post-Intervention|Change in parental guardianship|0|||
163020131|NCT03817229|588776398|FG002|Post-Intervention|Change in parental guardianship|1|||
163020132|NCT03817229|588776399|FG003|Post-Intervention|Change in parental guardianship|0|||
163020133|NCT03817229|588776396|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
163020134|NCT03817229|588776397|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
163020135|NCT03817229|588776398|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
163020136|NCT03817229|588776399|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
163020137|NCT03817229|588776396|FG000|Follow-up 1|Withdrawal by Subject|1|||
163020138|NCT03817229|588776397|FG001|Follow-up 1|Withdrawal by Subject|2|||
163020139|NCT03817229|588776398|FG002|Follow-up 1|Withdrawal by Subject|0|||
163020140|NCT03817229|588776399|FG003|Follow-up 1|Withdrawal by Subject|0|||
163020141|NCT03817229|588776396|FG000|Follow-up 1|Withdrawal by Study Team|3|||
163020142|NCT03817229|588776397|FG001|Follow-up 1|Withdrawal by Study Team|1|||
163020143|NCT03817229|588776398|FG002|Follow-up 1|Withdrawal by Study Team|0|||
163020144|NCT03817229|588776399|FG003|Follow-up 1|Withdrawal by Study Team|0|||
163020145|NCT03817229|588776396|FG000|Follow-up 1|Wean from medication|3|||
163020146|NCT03817229|588776397|FG001|Follow-up 1|Wean from medication|4|||
163020147|NCT03817229|588776398|FG002|Follow-up 1|Wean from medication|0|||
163020148|NCT03817229|588776399|FG003|Follow-up 1|Wean from medication|1|||
163020149|NCT03817229|588776396|FG000|Follow-up 1|Transferred care to another hospital|1|||
163020150|NCT03817229|588776397|FG001|Follow-up 1|Transferred care to another hospital|0|||
163020151|NCT03817229|588776398|FG002|Follow-up 1|Transferred care to another hospital|0|||
163216322|NCT01817725|589506294|FG000|Overall Study|Withdrawal by Subject|1|||
163216323|NCT00909779|589506295|FG000|Overall Study|Adverse Event|53|||
163216324|NCT00909779|589506296|FG001|Overall Study|Adverse Event|55|||
163216325|NCT00909779|589506295|FG000|Overall Study|Lack of Efficacy|7|||
163216326|NCT00909779|589506296|FG001|Overall Study|Lack of Efficacy|4|||
163216327|NCT00909779|589506295|FG000|Overall Study|Lost to Follow-up|19|||
163216328|NCT00909779|589506296|FG001|Overall Study|Lost to Follow-up|15|||
163216329|NCT00909779|589506295|FG000|Overall Study|Physician Decision|8|||
163216330|NCT00909779|589506296|FG001|Overall Study|Physician Decision|2|||
163216331|NCT00909779|589506295|FG000|Overall Study|Protocol Violation|2|||
163216332|NCT00909779|589506296|FG001|Overall Study|Protocol Violation|5|||
163216333|NCT00909779|589506295|FG000|Overall Study|Withdrawal by Subject|116|||
163216334|NCT00909779|589506296|FG001|Overall Study|Withdrawal by Subject|80|||
163216335|NCT00909779|589506295|FG000|Overall Study|Site Ceasing Operation|2|||
163216336|NCT00909779|589506296|FG001|Overall Study|Site Ceasing Operation|2|||
163216337|NCT00909779|589506295|FG000|Overall Study|Medical Monitor Decision|1|||
163216338|NCT00909779|589506296|FG001|Overall Study|Medical Monitor Decision|0|||
163216339|NCT00909779|589506295|FG000|Overall Study|Noncompliance|1|||
163216340|NCT00909779|589506296|FG001|Overall Study|Noncompliance|1|||
163216341|NCT00909779|589506295|FG000|Overall Study|Randomized in error|1|||
163216342|NCT00909779|589506296|FG001|Overall Study|Randomized in error|1|||
163216343|NCT02809677|589506297|FG000|Overall Study|Withdrawal by Subject|8|||
163216344|NCT05172544|589506300|FG000|Overall Study|Withdrawal by Subject|1|||
163216345|NCT05172544|589506301|FG001|Overall Study|Withdrawal by Subject|0|||
163216346|NCT05172544|589506302|FG002|Overall Study|Withdrawal by Subject|0|||
163216347|NCT05172544|589506300|FG000|Overall Study|Physician Decision|0|||
163216348|NCT05172544|589506301|FG001|Overall Study|Physician Decision|0|||
163216349|NCT05172544|589506302|FG002|Overall Study|Physician Decision|1|||
163216350|NCT00561080|589506307|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
163216351|NCT00561080|589506308|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
163216352|NCT00561080|589506309|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
163216353|NCT00561080|589506307|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
163216354|NCT00561080|589506308|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
163216355|NCT00561080|589506309|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
163216356|NCT00561080|589506307|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
163216357|NCT00561080|589506308|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
163020152|NCT03817229|588776399|FG003|Follow-up 1|Transferred care to another hospital|0|||
163020153|NCT03817229|588776396|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
163020154|NCT03817229|588776397|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
163020155|NCT03817229|588776398|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
163020156|NCT03817229|588776399|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
163020157|NCT03817229|588776396|FG000|Follow-up 2|Withdrawal by Subject|2|||
163020158|NCT03817229|588776397|FG001|Follow-up 2|Withdrawal by Subject|0|||
163020159|NCT03817229|588776398|FG002|Follow-up 2|Withdrawal by Subject|1|||
163020160|NCT03817229|588776399|FG003|Follow-up 2|Withdrawal by Subject|1|||
163020161|NCT03817229|588776396|FG000|Follow-up 2|Withdrawal by Study Team|2|||
163020162|NCT03817229|588776397|FG001|Follow-up 2|Withdrawal by Study Team|0|||
163020163|NCT03817229|588776398|FG002|Follow-up 2|Withdrawal by Study Team|1|||
163020164|NCT03817229|588776399|FG003|Follow-up 2|Withdrawal by Study Team|0|||
163020165|NCT03817229|588776396|FG000|Follow-up 2|Wean from medication|1|||
163020166|NCT03817229|588776397|FG001|Follow-up 2|Wean from medication|0|||
163020167|NCT03817229|588776398|FG002|Follow-up 2|Wean from medication|0|||
163020168|NCT03817229|588776399|FG003|Follow-up 2|Wean from medication|0|||
163216358|NCT00561080|589506309|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
163216359|NCT00561080|589506307|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
163216360|NCT00561080|589506308|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
163216361|NCT00561080|589506309|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
163216362|NCT00561080|589506307|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
163216363|NCT00561080|589506308|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
163216364|NCT00561080|589506309|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
163216365|NCT00561080|589506307|FG000|Vaccination Period (up to Month 4)|Other|0|||
163216366|NCT00561080|589506308|FG001|Vaccination Period (up to Month 4)|Other|2|||
163216367|NCT00561080|589506309|FG002|Vaccination Period (up to Month 4)|Other|1|||
163216368|NCT00561080|589506307|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
163216369|NCT00561080|589506308|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
163216370|NCT00561080|589506309|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
163216371|NCT00561080|589506307|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
163216372|NCT00561080|589506308|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
163216373|NCT00561080|589506309|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
163216374|NCT00561080|589506307|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
163216375|NCT00561080|589506308|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
163216376|NCT00561080|589506309|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
163216377|NCT00561080|589506307|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
163216378|NCT00561080|589506308|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
163216379|NCT00561080|589506309|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
163216380|NCT02295995|589506310|FG000|Overall Study|Lost to Follow-up|5|||
163216381|NCT02295995|589506311|FG001|Overall Study|Lost to Follow-up|1|||
163216382|NCT03158051|589506312|FG000|Overall Study|Lost to Follow-up|41|||
163216383|NCT03158051|589506313|FG001|Overall Study|Lost to Follow-up|47|||
163216384|NCT03158051|589506312|FG000|Overall Study|Physician Decision|6|||
163216385|NCT03158051|589506313|FG001|Overall Study|Physician Decision|7|||
163329375|NCT00371345|589916567|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
163329376|NCT00371345|589916566|FG000|Overall Study|Participant Request|1|||
163329377|NCT00371345|589916567|FG001|Overall Study|Participant Request|1|||
163329378|NCT00371345|589916566|FG000|Overall Study|Participant Withdrew Consent|0|||
163329379|NCT00371345|589916567|FG001|Overall Study|Participant Withdrew Consent|1|||
163329380|NCT00705406|589916568|FG000|Overall Study|Lost to Follow-up|3|||
163329381|NCT00705406|589916569|FG001|Overall Study|Lost to Follow-up|3|||
163329382|NCT00705406|589916568|FG000|Overall Study|Did not receive study drug|1|||
163329383|NCT00705406|589916569|FG001|Overall Study|Did not receive study drug|2|||
163329384|NCT00442104|589916570|FG000|Overall Study|Adverse Event|5|||
163329385|NCT00442104|589916570|FG000|Overall Study|Death|2|||
163329386|NCT00442104|589916570|FG000|Overall Study|Lost to Follow-up|3|||
163329387|NCT00442104|589916570|FG000|Overall Study|Withdrawal by Subject|5|||
163329388|NCT00442104|589916570|FG000|Overall Study|Insufficient Clinical Response|10|||
163329389|NCT00442104|589916570|FG000|Overall Study|Other|21|||
163329390|NCT00442104|589916570|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
163329391|NCT04545619|589916571|FG000|Overall Study|due to equipment challenges|1|||
163329392|NCT00975585|589916572|FG000|Overall Study|Adverse Event|0|||
163329393|NCT00975585|589916573|FG001|Overall Study|Adverse Event|4|||
163329394|NCT00975585|589916572|FG000|Overall Study|Lost to Follow-up|3|||
163329395|NCT00975585|589916573|FG001|Overall Study|Lost to Follow-up|5|||
163329396|NCT00975585|589916572|FG000|Overall Study|Withdrawal by Subject|2|||
163329397|NCT00975585|589916573|FG001|Overall Study|Withdrawal by Subject|1|||
163329398|NCT00975585|589916572|FG000|Overall Study|Lens issue|2|||
163329399|NCT00975585|589916573|FG001|Overall Study|Lens issue|2|||
163329400|NCT00683800|589916575|FG000|Overall Study|Adverse Event|195|||
163329401|NCT00683800|589916576|FG001|Overall Study|Adverse Event|102|||
163329402|NCT00683800|589916575|FG000|Overall Study|Death|0|||
163329403|NCT00683800|589916576|FG001|Overall Study|Death|1|||
163020169|NCT03817229|588776396|FG000|Follow-up 2|Transferred care|0|||
163020170|NCT03817229|588776397|FG001|Follow-up 2|Transferred care|0|||
163020171|NCT03817229|588776398|FG002|Follow-up 2|Transferred care|1|||
163020172|NCT03817229|588776399|FG003|Follow-up 2|Transferred care|0|||
163020173|NCT02887183|588776401|FG000|Overall Study|Adverse Event|44|||
163020174|NCT02887183|588776401|FG000|Overall Study|Death|30|||
163020175|NCT02887183|588776401|FG000|Overall Study|Pregnancy|1|||
163020176|NCT02887183|588776401|FG000|Overall Study|Protocol Violation|6|||
163020177|NCT02887183|588776401|FG000|Overall Study|Technical Problems|2|||
163020178|NCT02887183|588776401|FG000|Overall Study|Lost to Follow-up|13|||
163020179|NCT02887183|588776401|FG000|Overall Study|Physician Decision|10|||
163020180|NCT02887183|588776401|FG000|Overall Study|Withdrawal by Subject|35|||
163020181|NCT03634033|588777870|FG000|Overall Study|Did not have a post-assessment|384|||
163020182|NCT03634033|588777871|FG001|Overall Study|Did not have a post-assessment|291|||
163020183|NCT03634033|588777872|FG002|Overall Study|Did not have a post-assessment|114|||
163020184|NCT03634033|588777873|FG003|Overall Study|Did not have a post-assessment|161|||
163020185|NCT03634033|588777874|FG004|Overall Study|Did not have a post-assessment|5|||
163216386|NCT03158051|589506312|FG000|Overall Study|Withdrawal by Subject|24|||
163216387|NCT03158051|589506313|FG001|Overall Study|Withdrawal by Subject|15|||
163216388|NCT03158051|589506312|FG000|Overall Study|Death|0|||
163216389|NCT03158051|589506313|FG001|Overall Study|Death|1|||
163216390|NCT02005250|589506315|FG000|Overall Study|Lost to Follow-up|15|||
163216391|NCT02005250|589506316|FG001|Overall Study|Lost to Follow-up|5|||
163216392|NCT04350788|589506325|FG000|Overall Study|Lost to Follow-up|6|||
163216393|NCT04350788|589506326|FG001|Overall Study|Lost to Follow-up|2|||
163216394|NCT04350788|589506325|FG000|Overall Study|Withdrawal by Subject|2|||
163216395|NCT04350788|589506326|FG001|Overall Study|Withdrawal by Subject|4|||
163216396|NCT04350788|589506325|FG000|Overall Study|Protocol Violation|4|||
163216397|NCT04350788|589506326|FG001|Overall Study|Protocol Violation|0|||
163216398|NCT04537234|589506327|FG000|Overall Study|Withdrawal by Subject|2|||
163216399|NCT04537234|589506328|FG001|Overall Study|Withdrawal by Subject|0|||
163216400|NCT00378209|589506329|FG000|Overall Study|Progressive disease|11|||
163216401|NCT00378209|589506329|FG000|Overall Study|Adverse Event|3|||
163216402|NCT00378209|589506329|FG000|Overall Study|Initiation of non-protocol therapy|3|||
163216403|NCT00378209|589506329|FG000|Overall Study|Physician Decision|3|||
163216404|NCT00378209|589506329|FG000|Overall Study|Death|1|||
163216405|NCT00378209|589506329|FG000|Overall Study|Treatment delay|1|||
163216406|NCT02070744|589506330|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
163216407|NCT02070744|589506331|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
163216408|NCT02070744|589506332|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
163216409|NCT02070744|589506333|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
163216410|NCT02070744|589506334|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
163216411|NCT02070744|589506330|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
163216412|NCT02070744|589506331|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
163216413|NCT02070744|589506332|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
163216414|NCT02070744|589506333|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
163216415|NCT02070744|589506334|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
163216416|NCT02070744|589506330|FG000|OLE Phase (48 Weeks)|Other|0|||
163216417|NCT02070744|589506331|FG001|OLE Phase (48 Weeks)|Other|0|||
163216418|NCT02070744|589506332|FG002|OLE Phase (48 Weeks)|Other|0|||
163216419|NCT02070744|589506333|FG003|OLE Phase (48 Weeks)|Other|0|||
163216420|NCT02070744|589506334|FG004|OLE Phase (48 Weeks)|Other|1|||
163216421|NCT07114198|589506338|FG000|Overall Study|Protocol Violation|1|||
163216422|NCT07114198|589506339|FG001|Overall Study|Protocol Violation|1|||
163216423|NCT04709575|589507960|FG000|Overall Study|Withdrawal by Subject|6|||
163216424|NCT04709575|589507961|FG001|Overall Study|Withdrawal by Subject|2|||
163216425|NCT04709575|589507960|FG000|Overall Study|Lost to Follow-up|2|||
163216426|NCT04709575|589507961|FG001|Overall Study|Lost to Follow-up|2|||
163216427|NCT04709575|589507960|FG000|Overall Study|Adverse Event|1|||
163216428|NCT04709575|589507961|FG001|Overall Study|Adverse Event|0|||
163216429|NCT04709575|589507960|FG000|Overall Study|Protocol Violation|1|||
163216430|NCT04709575|589507961|FG001|Overall Study|Protocol Violation|1|||
163216431|NCT02967692|589507962|FG000|Overall Study|Progressive disease|3|||
163216432|NCT02967692|589507963|FG001|Overall Study|Progressive disease|15|||
163216433|NCT02967692|589507964|FG002|Overall Study|Progressive disease|114|||
163216434|NCT02967692|589507965|FG003|Overall Study|Progressive disease|151|||
163216435|NCT02967692|589507962|FG000|Overall Study|Subject/guardian decision|1|||
163216436|NCT02967692|589507963|FG001|Overall Study|Subject/guardian decision|1|||
163216437|NCT02967692|589507964|FG002|Overall Study|Subject/guardian decision|14|||
163216438|NCT02967692|589507965|FG003|Overall Study|Subject/guardian decision|22|||
163216439|NCT02967692|589507962|FG000|Overall Study|Death|0|||
163216440|NCT02967692|589507963|FG001|Overall Study|Death|1|||
163216441|NCT02967692|589507964|FG002|Overall Study|Death|13|||
163216442|NCT02967692|589507965|FG003|Overall Study|Death|13|||
163216443|NCT02967692|589507962|FG000|Overall Study|Protocol deviation|1|||
163216444|NCT02967692|589507963|FG001|Overall Study|Protocol deviation|0|||
163216445|NCT02967692|589507964|FG002|Overall Study|Protocol deviation|1|||
163216446|NCT02967692|589507965|FG003|Overall Study|Protocol deviation|1|||
163020186|NCT03634033|588777875|FG005|Overall Study|Did not have a post-assessment|0|||
163020187|NCT03634033|588777876|FG006|Overall Study|Did not have a post-assessment|0|||
163020188|NCT03634033|588777870|FG000|Overall Study|Death|0|||
163020189|NCT03634033|588777871|FG001|Overall Study|Death|0|||
163020190|NCT03634033|588777872|FG002|Overall Study|Death|0|||
163020191|NCT03634033|588777873|FG003|Overall Study|Death|0|||
163020192|NCT03634033|588777874|FG004|Overall Study|Death|0|||
163020193|NCT03634033|588777875|FG005|Overall Study|Death|7|||
163020194|NCT03634033|588777876|FG006|Overall Study|Death|7|||
163020195|NCT03634033|588777870|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
163020196|NCT03634033|588777871|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
163020197|NCT03634033|588777872|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
163020198|NCT03634033|588777873|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
163020199|NCT03634033|588777874|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
163020200|NCT03634033|588777875|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
163020201|NCT03634033|588777876|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
163020202|NCT03634033|588777870|FG000|Overall Study|Lost to Follow-up|0|||
163020203|NCT03634033|588777871|FG001|Overall Study|Lost to Follow-up|0|||
163020204|NCT03634033|588777872|FG002|Overall Study|Lost to Follow-up|0|||
163020205|NCT03634033|588777873|FG003|Overall Study|Lost to Follow-up|0|||
163020206|NCT03634033|588777874|FG004|Overall Study|Lost to Follow-up|0|||
163020207|NCT03634033|588777875|FG005|Overall Study|Lost to Follow-up|1|||
163020208|NCT03634033|588777876|FG006|Overall Study|Lost to Follow-up|2|||
163020209|NCT03634033|588777870|FG000|Overall Study|Withdrawal by Subject|0|||
163020210|NCT03634033|588777871|FG001|Overall Study|Withdrawal by Subject|0|||
163020211|NCT03634033|588777872|FG002|Overall Study|Withdrawal by Subject|0|||
163020212|NCT03634033|588777873|FG003|Overall Study|Withdrawal by Subject|0|||
163020213|NCT03634033|588777874|FG004|Overall Study|Withdrawal by Subject|0|||
163020214|NCT03634033|588777875|FG005|Overall Study|Withdrawal by Subject|0|||
163020215|NCT03634033|588777876|FG006|Overall Study|Withdrawal by Subject|1|||
163020216|NCT06366087|588777877|FG000|Overall Study|Withdrawal by Subject|0|||
163020217|NCT06366087|588777878|FG001|Overall Study|Withdrawal by Subject|1|||
163020218|NCT00199797|588777879|FG000|Overall Study|Progressive Disease|1|||
163020219|NCT00199797|588777879|FG000|Overall Study|Adverse Event|1|||
163020220|NCT00199797|588777879|FG000|Overall Study|Physician Decision|1|||
163020221|NCT00504725|588777887|FG000|Overall Study|Protocol Violation|1|||
163020222|NCT00504725|588777888|FG001|Overall Study|Protocol Violation|0|||
163020223|NCT01435018|588777889|FG000|Overall Study|Death|37|||
163020224|NCT01435018|588777890|FG001|Overall Study|Death|18|||
163020225|NCT01435018|588777891|FG002|Overall Study|Death|25|||
163020226|NCT01435018|588777889|FG000|Overall Study|Site is closing|4|||
163020227|NCT01435018|588777890|FG001|Overall Study|Site is closing|9|||
163020228|NCT01435018|588777891|FG002|Overall Study|Site is closing|7|||
163020229|NCT01435018|588777889|FG000|Overall Study|Withdrew consent|0|||
163020230|NCT01435018|588777890|FG001|Overall Study|Withdrew consent|3|||
163020231|NCT01435018|588777891|FG002|Overall Study|Withdrew consent|1|||
163020232|NCT01435018|588777889|FG000|Overall Study|Not willing to adhere to requirements|0|||
163020233|NCT01435018|588777890|FG001|Overall Study|Not willing to adhere to requirements|2|||
163020234|NCT01435018|588777891|FG002|Overall Study|Not willing to adhere to requirements|3|||
163020235|NCT01435018|588777889|FG000|Overall Study|Not able to get to clinic|2|||
163020236|NCT01435018|588777890|FG001|Overall Study|Not able to get to clinic|0|||
163020237|NCT01435018|588777891|FG002|Overall Study|Not able to get to clinic|2|||
163020238|NCT01435018|588777889|FG000|Overall Study|Severe debilitation, unable to continue|0|||
163020239|NCT01435018|588777890|FG001|Overall Study|Severe debilitation, unable to continue|0|||
163020240|NCT01435018|588777891|FG002|Overall Study|Severe debilitation, unable to continue|1|||
163020241|NCT01435018|588777889|FG000|Overall Study|Unable to contact participant/parent|1|||
163020242|NCT01435018|588777890|FG001|Overall Study|Unable to contact participant/parent|1|||
163020243|NCT01435018|588777891|FG002|Overall Study|Unable to contact participant/parent|1|||
163020244|NCT01435018|588777889|FG000|Overall Study|Enrollment Violation|0|||
163020245|NCT01435018|588777890|FG001|Overall Study|Enrollment Violation|1|||
163020246|NCT01435018|588777891|FG002|Overall Study|Enrollment Violation|0|||
163020247|NCT01435018|588777889|FG000|Overall Study|Never started chemotherapy|3|||
163020248|NCT01435018|588777890|FG001|Overall Study|Never started chemotherapy|0|||
163020249|NCT01435018|588777891|FG002|Overall Study|Never started chemotherapy|1|||
163020250|NCT03937908|588777892|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
163063550|NCT01995201|588939906|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
163063551|NCT01995201|588939907|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
163063552|NCT01995201|588939908|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
163063553|NCT01995201|588939909|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
163063554|NCT01995201|588939910|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
163063555|NCT01995201|588939904|FG000|From Baseline Until Week 24|Death|0|||
163216447|NCT02967692|589507962|FG000|Overall Study|Lost to Follow-up|0|||
163216448|NCT02967692|589507963|FG001|Overall Study|Lost to Follow-up|0|||
163216449|NCT02967692|589507964|FG002|Overall Study|Lost to Follow-up|1|||
163020251|NCT03937908|588777893|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
163020252|NCT03875092|588777894|FG000|Overall Study|Adverse Event|2|||
163020253|NCT03875092|588777895|FG001|Overall Study|Adverse Event|5|||
163020254|NCT03875092|588777894|FG000|Overall Study|Death|44|||
163020255|NCT03875092|588777895|FG001|Overall Study|Death|51|||
163020256|NCT03875092|588777894|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
163020257|NCT03875092|588777895|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
163020258|NCT03205761|588777896|FG000|Overall Study|Withdrawal by Subject|1|||
163020259|NCT03205761|588777896|FG000|Overall Study|Progressive Disease|10|||
163020260|NCT00636194|588777897|FG000|Overall Study|Study related symptoms and complaints|1|||
163020261|NCT00636194|588777898|FG001|Overall Study|Study related symptoms and complaints|0|||
163020262|NCT00636194|588777897|FG000|Overall Study|Protocol Violation|2|||
163020263|NCT00636194|588777898|FG001|Overall Study|Protocol Violation|0|||
163020264|NCT04114357|588777900|FG000|Baseline-Randomization|Adverse Event|2|||
163020265|NCT04114357|588777901|FG001|Baseline-Randomization|Adverse Event|1|||
163020266|NCT04114357|588777900|FG000|Baseline-Randomization|Lost to Follow-up|1|||
163020267|NCT04114357|588777901|FG001|Baseline-Randomization|Lost to Follow-up|1|||
163020268|NCT04114357|588777900|FG000|Cross-over|Adverse Event|0|||
163020269|NCT04114357|588777901|FG001|Cross-over|Adverse Event|1|||
163020270|NCT02163226|588777902|FG000|Overall Study|Death|2|||
163020271|NCT02163226|588777903|FG001|Overall Study|Death|1|||
163020272|NCT02163226|588777902|FG000|Overall Study|Withdrawal by Subject|5|||
163020273|NCT02163226|588777903|FG001|Overall Study|Withdrawal by Subject|2|||
163020274|NCT02163226|588777902|FG000|Overall Study|Returned home, local radiotherapy|3|||
163020275|NCT02163226|588777903|FG001|Overall Study|Returned home, local radiotherapy|0|||
163020276|NCT02163226|588777902|FG000|Overall Study|Repeat imaging showed no disease|2|||
163020277|NCT02163226|588777903|FG001|Overall Study|Repeat imaging showed no disease|0|||
163020278|NCT02163226|588777902|FG000|Overall Study|Incomplete radiotherapy|3|||
163020279|NCT02163226|588777903|FG001|Overall Study|Incomplete radiotherapy|0|||
163020280|NCT02163226|588777902|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
163020281|NCT02163226|588777903|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
163020282|NCT02163226|588777902|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
163020283|NCT02163226|588777903|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
163020284|NCT02163226|588777902|FG000|Overall Study|ineligible|0|||
163020285|NCT02163226|588777903|FG001|Overall Study|ineligible|3|||
163020286|NCT03625466|588777907|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
163020287|NCT03625466|588777908|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
163020288|NCT03625466|588777909|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
163020289|NCT03625466|588777907|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
163020290|NCT03625466|588777908|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
163020291|NCT03625466|588777909|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
163405193|NCT00788372|590193546|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
163020292|NCT03625466|588777907|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
163020293|NCT03625466|588777908|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
163020294|NCT03625466|588777909|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
163020295|NCT00809471|588777912|FG000|Overall Study|Protocol non-compliance|15|||
163020296|NCT00809471|588777913|FG001|Overall Study|Protocol non-compliance|15|||
163020297|NCT00809471|588777914|FG002|Overall Study|Protocol non-compliance|6|||
163020298|NCT00809471|588777912|FG000|Overall Study|Lost to Follow-up|4|||
163020299|NCT00809471|588777913|FG001|Overall Study|Lost to Follow-up|2|||
163020300|NCT00809471|588777914|FG002|Overall Study|Lost to Follow-up|9|||
163020301|NCT00809471|588777912|FG000|Overall Study|Adverse Event|0|||
163020302|NCT00809471|588777913|FG001|Overall Study|Adverse Event|2|||
163020303|NCT00809471|588777914|FG002|Overall Study|Adverse Event|2|||
163020304|NCT00809471|588777912|FG000|Overall Study|Requirement for restricted medication|1|||
163020305|NCT00809471|588777913|FG001|Overall Study|Requirement for restricted medication|1|||
163020306|NCT00809471|588777914|FG002|Overall Study|Requirement for restricted medication|0|||
163020307|NCT00831311|588777915|FG000|Overall Study|Definitive Contraindication|3|||
163020308|NCT00831311|588777916|FG001|Overall Study|Definitive Contraindication|3|||
163020309|NCT00831311|588777915|FG000|Overall Study|Lost to Follow-up|3|||
163020310|NCT00831311|588777916|FG001|Overall Study|Lost to Follow-up|0|||
163020311|NCT00831311|588777915|FG000|Overall Study|Physician Decision|0|||
163020312|NCT00831311|588777916|FG001|Overall Study|Physician Decision|1|||
163020313|NCT00831311|588777915|FG000|Overall Study|Withdrawal by Subject|6|||
163020314|NCT00831311|588777916|FG001|Overall Study|Withdrawal by Subject|4|||
163020315|NCT05318092|588777920|FG000|Overall Study|Lost to Follow-up|3|||
163020316|NCT05318092|588777920|FG000|Overall Study|Withdrawal by Subject|1|||
163020317|NCT00160706|588777922|FG000|Overall Study|Adverse Event|53|||
163020318|NCT00160706|588777922|FG000|Overall Study|Adverse Event and Other Reason|105|||
163020319|NCT00160706|588777922|FG000|Overall Study|Protocol Violation|3|||
163020320|NCT00160706|588777922|FG000|Overall Study|Withdrawal by Subject|41|||
163020321|NCT00160706|588777922|FG000|Overall Study|Withdrawal by Subject and Other|12|||
163216450|NCT02967692|589507965|FG003|Overall Study|Lost to Follow-up|0|||
163020322|NCT00160706|588777922|FG000|Overall Study|Physician Decision|10|||
163020323|NCT00160706|588777922|FG000|Overall Study|Physician Decision and Other|3|||
163020324|NCT00160706|588777922|FG000|Overall Study|Lost to Follow-up|4|||
163020325|NCT00160706|588777922|FG000|Overall Study|Lost to Follow-up and Other|1|||
163020326|NCT00160706|588777922|FG000|Overall Study|Lack of Efficacy|42|||
163020327|NCT00160706|588777922|FG000|Overall Study|Lack of Efficacy and Other|1|||
163020328|NCT00160706|588777922|FG000|Overall Study|Other Reason|11|||
163020329|NCT03214380|588777923|FG000|Lead-in|Adverse Event|3|||
163020330|NCT03214380|588777924|FG001|Lead-in|Adverse Event|0|||
163020331|NCT03214380|588777925|FG002|Lead-in|Adverse Event|0|||
163020332|NCT03214380|588777926|FG003|Lead-in|Adverse Event|1|||
163020333|NCT03214380|588777927|FG004|Lead-in|Adverse Event|0|||
163020334|NCT03214380|588777928|FG005|Lead-in|Adverse Event|0|||
163020335|NCT03214380|588777923|FG000|Lead-in|Lost to Follow-up|4|||
163020336|NCT03214380|588777924|FG001|Lead-in|Lost to Follow-up|0|||
163020337|NCT03214380|588777925|FG002|Lead-in|Lost to Follow-up|0|||
163020338|NCT03214380|588777926|FG003|Lead-in|Lost to Follow-up|1|||
163020339|NCT03214380|588777927|FG004|Lead-in|Lost to Follow-up|0|||
163020340|NCT03214380|588777928|FG005|Lead-in|Lost to Follow-up|0|||
163020341|NCT03214380|588777923|FG000|Lead-in|Eligibility Criteria|3|||
163020342|NCT03214380|588777924|FG001|Lead-in|Eligibility Criteria|0|||
163020343|NCT03214380|588777925|FG002|Lead-in|Eligibility Criteria|0|||
163020344|NCT03214380|588777926|FG003|Lead-in|Eligibility Criteria|0|||
163020345|NCT03214380|588777927|FG004|Lead-in|Eligibility Criteria|0|||
163020346|NCT03214380|588777928|FG005|Lead-in|Eligibility Criteria|0|||
163020347|NCT03214380|588777923|FG000|Lead-in|Physician Decision|6|||
163020348|NCT03214380|588777924|FG001|Lead-in|Physician Decision|0|||
163020349|NCT03214380|588777925|FG002|Lead-in|Physician Decision|0|||
163020350|NCT03214380|588777926|FG003|Lead-in|Physician Decision|0|||
163020351|NCT03214380|588777927|FG004|Lead-in|Physician Decision|0|||
163020352|NCT03214380|588777928|FG005|Lead-in|Physician Decision|0|||
163020353|NCT03214380|588777923|FG000|Lead-in|Protocol Deviation|7|||
163020354|NCT03214380|588777924|FG001|Lead-in|Protocol Deviation|0|||
163020355|NCT03214380|588777925|FG002|Lead-in|Protocol Deviation|0|||
163020356|NCT03214380|588777926|FG003|Lead-in|Protocol Deviation|3|||
163020357|NCT03214380|588777927|FG004|Lead-in|Protocol Deviation|0|||
163020358|NCT03214380|588777928|FG005|Lead-in|Protocol Deviation|0|||
163020359|NCT03214380|588777923|FG000|Lead-in|Withdrawal by Subject|41|||
163020360|NCT03214380|588777924|FG001|Lead-in|Withdrawal by Subject|0|||
163020361|NCT03214380|588777925|FG002|Lead-in|Withdrawal by Subject|0|||
163020362|NCT03214380|588777926|FG003|Lead-in|Withdrawal by Subject|14|||
163020363|NCT03214380|588777927|FG004|Lead-in|Withdrawal by Subject|0|||
163020364|NCT03214380|588777928|FG005|Lead-in|Withdrawal by Subject|0|||
163020365|NCT03214380|588777923|FG000|Lead-in|Family Emergency|1|||
163020366|NCT03214380|588777924|FG001|Lead-in|Family Emergency|0|||
163020367|NCT03214380|588777925|FG002|Lead-in|Family Emergency|0|||
163020368|NCT03214380|588777926|FG003|Lead-in|Family Emergency|0|||
163020369|NCT03214380|588777927|FG004|Lead-in|Family Emergency|0|||
163020370|NCT03214380|588777928|FG005|Lead-in|Family Emergency|0|||
163020371|NCT03214380|588777923|FG000|Lead-in|Natural Disaster|9|||
163020372|NCT03214380|588777924|FG001|Lead-in|Natural Disaster|0|||
163063556|NCT01995201|588939905|FG001|From Baseline Until Week 24|Death|1|||
163063557|NCT01995201|588939906|FG002|From Baseline Until Week 24|Death|0|||
163063558|NCT01995201|588939907|FG003|From Baseline Until Week 24|Death|0|||
163063559|NCT01995201|588939908|FG004|From Baseline Until Week 24|Death|0|||
163063560|NCT01995201|588939909|FG005|From Baseline Until Week 24|Death|0|||
163063561|NCT01995201|588939910|FG006|From Baseline Until Week 24|Death|0|||
163063562|NCT01995201|588939904|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
163063563|NCT01995201|588939905|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
163063564|NCT01995201|588939906|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
163063565|NCT01995201|588939907|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
163063566|NCT01995201|588939908|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
163063567|NCT01995201|588939909|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
163063568|NCT01995201|588939910|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
163063569|NCT01995201|588939904|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
163063570|NCT01995201|588939905|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
163063571|NCT01995201|588939906|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
163020373|NCT03214380|588777925|FG002|Lead-in|Natural Disaster|0|||
163020374|NCT03214380|588777926|FG003|Lead-in|Natural Disaster|0|||
163063572|NCT01995201|588939907|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
163063573|NCT01995201|588939908|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
163020375|NCT03214380|588777927|FG004|Lead-in|Natural Disaster|0|||
163020376|NCT03214380|588777928|FG005|Lead-in|Natural Disaster|0|||
163020377|NCT03214380|588777923|FG000|Lead-in|Non Compliance|1|||
163020378|NCT03214380|588777924|FG001|Lead-in|Non Compliance|0|||
163020379|NCT03214380|588777925|FG002|Lead-in|Non Compliance|0|||
163020380|NCT03214380|588777926|FG003|Lead-in|Non Compliance|0|||
163020381|NCT03214380|588777927|FG004|Lead-in|Non Compliance|0|||
163020382|NCT03214380|588777928|FG005|Lead-in|Non Compliance|0|||
163020383|NCT03214380|588777923|FG000|Lead-in|Participant Schedule|2|||
163063574|NCT01995201|588939909|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
163020384|NCT03214380|588777924|FG001|Lead-in|Participant Schedule|0|||
163020385|NCT03214380|588777925|FG002|Lead-in|Participant Schedule|0|||
163020386|NCT03214380|588777926|FG003|Lead-in|Participant Schedule|0|||
163020387|NCT03214380|588777927|FG004|Lead-in|Participant Schedule|0|||
163020388|NCT03214380|588777928|FG005|Lead-in|Participant Schedule|0|||
163020389|NCT03214380|588777923|FG000|Treatment Period|Adverse Event|0|||
163020390|NCT03214380|588777924|FG001|Treatment Period|Adverse Event|1|||
163063575|NCT01995201|588939910|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
163063576|NCT01995201|588939904|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
163063577|NCT01995201|588939905|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
163063578|NCT01995201|588939906|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
163063579|NCT01995201|588939907|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
163063580|NCT01995201|588939908|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
163020391|NCT03214380|588777925|FG002|Treatment Period|Adverse Event|1|||
163020392|NCT03214380|588777926|FG003|Treatment Period|Adverse Event|0|||
163063581|NCT01995201|588939909|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
163216451|NCT02967692|589507962|FG000|Overall Study|Physician Decision|0|||
163216452|NCT02967692|589507963|FG001|Overall Study|Physician Decision|0|||
163216453|NCT02967692|589507964|FG002|Overall Study|Physician Decision|22|||
163216454|NCT02967692|589507965|FG003|Overall Study|Physician Decision|13|||
163216455|NCT02967692|589507962|FG000|Overall Study|Adverse Event|2|||
163216456|NCT02967692|589507963|FG001|Overall Study|Adverse Event|9|||
163216457|NCT02967692|589507964|FG002|Overall Study|Adverse Event|60|||
163216458|NCT02967692|589507965|FG003|Overall Study|Adverse Event|28|||
163216459|NCT02967692|589507962|FG000|Overall Study|Study terminated by sponsor|2|||
163216460|NCT02967692|589507963|FG001|Overall Study|Study terminated by sponsor|1|||
163216461|NCT02967692|589507964|FG002|Overall Study|Study terminated by sponsor|42|||
163216462|NCT02967692|589507965|FG003|Overall Study|Study terminated by sponsor|37|||
163216463|NCT04447417|589507969|FG000|Overall Study|Withdrawal by Subject|1|||
163216464|NCT04447417|589507970|FG001|Overall Study|Withdrawal by Subject|0|||
163216465|NCT04447417|589507969|FG000|Overall Study|Failure to meet inclusion criteria|1|||
163216466|NCT04447417|589507970|FG001|Overall Study|Failure to meet inclusion criteria|0|||
163216467|NCT04447417|589507969|FG000|Overall Study|Lost to Follow-up|1|||
163216468|NCT04447417|589507970|FG001|Overall Study|Lost to Follow-up|0|||
163216469|NCT00066066|589507971|FG000|Overall Study|Lost to Follow-up|6|||
163216470|NCT00066066|589507972|FG001|Overall Study|Lost to Follow-up|4|||
163216471|NCT00066066|589507973|FG002|Overall Study|Lost to Follow-up|7|||
163216472|NCT00066066|589507974|FG003|Overall Study|Lost to Follow-up|4|||
163216473|NCT00066066|589507975|FG004|Overall Study|Lost to Follow-up|3|||
163216474|NCT00066066|589507976|FG005|Overall Study|Lost to Follow-up|5|||
163216475|NCT02155738|589507977|FG000|Overall Study|Missing critical information|1|||
163216476|NCT02155738|589507978|FG001|Overall Study|Missing critical information|0|||
163216477|NCT02155738|589507979|FG002|Overall Study|Missing critical information|0|||
163216478|NCT02155738|589507980|FG003|Overall Study|Missing critical information|1|||
163216479|NCT01466348|589507983|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
163216480|NCT01466348|589507984|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
163216481|NCT02189473|589507987|FG000|Overall Study|Death|22|||
163216482|NCT02189473|589507988|FG001|Overall Study|Death|23|||
163216483|NCT02189473|589507987|FG000|Overall Study|Lost to Follow-up|1|||
163216484|NCT02189473|589507988|FG001|Overall Study|Lost to Follow-up|2|||
163216485|NCT02385266|589507994|FG000|Overall Study|Withdrawal by Subject|1|||
163216486|NCT02385266|589507995|FG001|Overall Study|Withdrawal by Subject|3|||
163216487|NCT00914810|589507996|FG000|Overall Study|Withdrawal by Subject|1|||
163216488|NCT00914810|589507997|FG001|Overall Study|Withdrawal by Subject|0|||
163216489|NCT00914810|589507996|FG000|Overall Study|Relocated out of state|1|||
163216490|NCT00914810|589507997|FG001|Overall Study|Relocated out of state|0|||
163216491|NCT00914810|589507996|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
163216492|NCT00914810|589507997|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
163216493|NCT02082210|589507998|FG000|Overall Study|Death|0|||
163216494|NCT02082210|589507999|FG001|Overall Study|Death|0|||
163216495|NCT02082210|589508000|FG002|Overall Study|Death|1|||
163216496|NCT02082210|589508001|FG003|Overall Study|Death|1|||
163216497|NCT02082210|589508002|FG004|Overall Study|Death|1|||
163216498|NCT02082210|589508003|FG005|Overall Study|Death|0|||
163216499|NCT02082210|589507998|FG000|Overall Study|Withdrawal by Subject|0|||
163216500|NCT02082210|589507999|FG001|Overall Study|Withdrawal by Subject|0|||
163216501|NCT02082210|589508000|FG002|Overall Study|Withdrawal by Subject|0|||
163216502|NCT02082210|589508001|FG003|Overall Study|Withdrawal by Subject|1|||
163216503|NCT02082210|589508002|FG004|Overall Study|Withdrawal by Subject|2|||
163216504|NCT02082210|589508003|FG005|Overall Study|Withdrawal by Subject|2|||
163216505|NCT02082210|589507998|FG000|Overall Study|Clinical Progression|0|||
163216506|NCT02082210|589507999|FG001|Overall Study|Clinical Progression|0|||
163216507|NCT02082210|589508000|FG002|Overall Study|Clinical Progression|0|||
163216508|NCT02082210|589508001|FG003|Overall Study|Clinical Progression|1|||
163216509|NCT02082210|589508002|FG004|Overall Study|Clinical Progression|0|||
163329404|NCT00683800|589916575|FG000|Overall Study|Lost to Follow-up|57|||
163329405|NCT00683800|589916576|FG001|Overall Study|Lost to Follow-up|44|||
163329406|NCT00683800|589916575|FG000|Overall Study|Other|5|||
163329407|NCT00683800|589916576|FG001|Overall Study|Other|2|||
163329408|NCT00683800|589916575|FG000|Overall Study|Protocol Violation|13|||
163329409|NCT00683800|589916576|FG001|Overall Study|Protocol Violation|16|||
163329410|NCT00683800|589916575|FG000|Overall Study|Withdrawal by Subject|66|||
163329411|NCT00683800|589916576|FG001|Overall Study|Withdrawal by Subject|64|||
163329412|NCT00683800|589916575|FG000|Overall Study|Lack of Efficacy|61|||
163329413|NCT00683800|589916576|FG001|Overall Study|Lack of Efficacy|104|||
163329414|NCT00683800|589916575|FG000|Overall Study|Randomized, not treated|35|||
163329415|NCT00683800|589916576|FG001|Overall Study|Randomized, not treated|33|||
163329416|NCT00205179|589916579|FG000|Overall Study|Death|0|||
163329417|NCT00205179|589916580|FG001|Overall Study|Death|2|||
163329418|NCT00205179|589916579|FG000|Overall Study|Physician Decision|1|||
163329419|NCT00205179|589916580|FG001|Overall Study|Physician Decision|1|||
163329420|NCT00205179|589916579|FG000|Overall Study|Adverse Event|1|||
163329421|NCT00205179|589916580|FG001|Overall Study|Adverse Event|1|||
163329422|NCT01619059|589916587|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
163329423|NCT01619059|589916588|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
163329424|NCT01619059|589916587|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
163329425|NCT01619059|589916588|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
163329426|NCT01619059|589916587|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
163329427|NCT01619059|589916588|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
163020393|NCT03214380|588777927|FG004|Treatment Period|Adverse Event|1|||
163020394|NCT03214380|588777928|FG005|Treatment Period|Adverse Event|0|||
163020395|NCT03214380|588777923|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
163020396|NCT03214380|588777924|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
163020397|NCT03214380|588777925|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
163020398|NCT03214380|588777926|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
163020399|NCT03214380|588777927|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
163020400|NCT03214380|588777928|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
163020401|NCT03214380|588777923|FG000|Treatment Period|Withdrawal by Subject|0|||
163020402|NCT03214380|588777924|FG001|Treatment Period|Withdrawal by Subject|10|||
163020403|NCT03214380|588777925|FG002|Treatment Period|Withdrawal by Subject|8|||
163020404|NCT03214380|588777926|FG003|Treatment Period|Withdrawal by Subject|0|||
163329428|NCT01619059|589916587|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
163329429|NCT01619059|589916588|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
163329430|NCT01619059|589916587|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
163329431|NCT01619059|589916588|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
163329432|NCT01619059|589916587|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
163329433|NCT01619059|589916588|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
163405194|NCT00788372|590193546|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
163405195|NCT00788372|590193546|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
163020405|NCT03214380|588777927|FG004|Treatment Period|Withdrawal by Subject|7|||
163020406|NCT03214380|588777928|FG005|Treatment Period|Withdrawal by Subject|11|||
163020407|NCT03214380|588777923|FG000|Treatment Period|Death|0|||
163020408|NCT03214380|588777924|FG001|Treatment Period|Death|1|||
163020409|NCT03214380|588777925|FG002|Treatment Period|Death|2|||
163063582|NCT01995201|588939910|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
163063583|NCT01995201|588939904|FG000|From Baseline Until Week 24|Physician Decision|0|||
163063584|NCT01995201|588939905|FG001|From Baseline Until Week 24|Physician Decision|2|||
163063585|NCT01995201|588939906|FG002|From Baseline Until Week 24|Physician Decision|0|||
163063586|NCT01995201|588939907|FG003|From Baseline Until Week 24|Physician Decision|0|||
163063587|NCT01995201|588939908|FG004|From Baseline Until Week 24|Physician Decision|0|||
163063588|NCT01995201|588939909|FG005|From Baseline Until Week 24|Physician Decision|0|||
163063589|NCT01995201|588939910|FG006|From Baseline Until Week 24|Physician Decision|0|||
163063590|NCT01995201|588939904|FG000|From Baseline Until Week 24|Protocol Violation|0|||
163063591|NCT01995201|588939905|FG001|From Baseline Until Week 24|Protocol Violation|9|||
163063592|NCT01995201|588939906|FG002|From Baseline Until Week 24|Protocol Violation|0|||
163063593|NCT01995201|588939907|FG003|From Baseline Until Week 24|Protocol Violation|0|||
163063594|NCT01995201|588939908|FG004|From Baseline Until Week 24|Protocol Violation|0|||
163063595|NCT01995201|588939909|FG005|From Baseline Until Week 24|Protocol Violation|0|||
163329434|NCT01619059|589916587|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
163329435|NCT01619059|589916588|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
163329436|NCT01619059|589916587|FG000|Long-Term (LT) Treatment Period|Death|1|||
163329437|NCT01619059|589916588|FG001|Long-Term (LT) Treatment Period|Death|0|||
163329438|NCT01619059|589916587|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
163329439|NCT01619059|589916588|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
163063596|NCT01995201|588939910|FG006|From Baseline Until Week 24|Protocol Violation|0|||
163063597|NCT01995201|588939904|FG000|From Week 24 Until Week 48|Adverse Event|0|||
163329440|NCT01619059|589916587|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
163329441|NCT01619059|589916588|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
163020410|NCT03214380|588777926|FG003|Treatment Period|Death|0|||
163020411|NCT03214380|588777927|FG004|Treatment Period|Death|0|||
163020412|NCT03214380|588777928|FG005|Treatment Period|Death|0|||
163329442|NCT04949542|589916591|FG000|Overall Study|Lost to Follow-up|4|||
163329443|NCT04949542|589916592|FG001|Overall Study|Lost to Follow-up|1|||
163329444|NCT03021993|589916594|FG000|Overall Study|Withdrawal by Subject|4|||
163329445|NCT03021993|589916594|FG000|Overall Study|Physician Decision|1|||
163329446|NCT03021993|589916594|FG000|Overall Study|enrolled but were not treated|1|||
163329447|NCT03021993|589916594|FG000|Overall Study|Death|3|||
163329448|NCT02101775|589916596|FG000|Overall Study|Adverse Event|4|||
163329449|NCT02101775|589916597|FG001|Overall Study|Adverse Event|0|||
163329450|NCT02101775|589916598|FG002|Overall Study|Adverse Event|0|||
163329451|NCT02101775|589916596|FG000|Overall Study|Admission to Hospital|0|||
163329452|NCT02101775|589916597|FG001|Overall Study|Admission to Hospital|1|||
163329453|NCT02101775|589916598|FG002|Overall Study|Admission to Hospital|0|||
163329454|NCT03170648|589916606|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
163329455|NCT03170648|589916606|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
163329456|NCT02499328|589916612|FG000|Overall Study|Withdrawal by Subject|1|||
163329457|NCT02499328|589916613|FG001|Overall Study|Withdrawal by Subject|1|||
163329458|NCT02499328|589916614|FG002|Overall Study|Withdrawal by Subject|5|||
163329459|NCT02499328|589916615|FG003|Overall Study|Withdrawal by Subject|3|||
163329460|NCT02499328|589916616|FG004|Overall Study|Withdrawal by Subject|5|||
163329461|NCT02499328|589916617|FG005|Overall Study|Withdrawal by Subject|0|||
163329462|NCT02499328|589916618|FG006|Overall Study|Withdrawal by Subject|0|||
163329463|NCT02499328|589916619|FG007|Overall Study|Withdrawal by Subject|0|||
163329464|NCT02499328|589916620|FG008|Overall Study|Withdrawal by Subject|2|||
163329465|NCT02499328|589916621|FG009|Overall Study|Withdrawal by Subject|2|||
163329466|NCT02499328|589916622|FG010|Overall Study|Withdrawal by Subject|0|||
163329467|NCT02499328|589916623|FG011|Overall Study|Withdrawal by Subject|3|||
163329468|NCT02499328|589916624|FG012|Overall Study|Withdrawal by Subject|7|||
163329469|NCT02499328|589916625|FG013|Overall Study|Withdrawal by Subject|3|||
163329470|NCT02499328|589916626|FG014|Overall Study|Withdrawal by Subject|1|||
163329471|NCT02499328|589916627|FG015|Overall Study|Withdrawal by Subject|0|||
163329472|NCT02499328|589916628|FG016|Overall Study|Withdrawal by Subject|0|||
163329473|NCT02499328|589916629|FG017|Overall Study|Withdrawal by Subject|3|||
163329474|NCT02499328|589916630|FG018|Overall Study|Withdrawal by Subject|0|||
163329475|NCT02499328|589916612|FG000|Overall Study|Lost to Follow-up|0|||
163329476|NCT02499328|589916613|FG001|Overall Study|Lost to Follow-up|1|||
163329477|NCT02499328|589916614|FG002|Overall Study|Lost to Follow-up|1|||
163329478|NCT02499328|589916615|FG003|Overall Study|Lost to Follow-up|2|||
163329479|NCT02499328|589916616|FG004|Overall Study|Lost to Follow-up|0|||
163329480|NCT02499328|589916617|FG005|Overall Study|Lost to Follow-up|0|||
163329481|NCT02499328|589916618|FG006|Overall Study|Lost to Follow-up|0|||
163329482|NCT02499328|589916619|FG007|Overall Study|Lost to Follow-up|2|||
163329483|NCT02499328|589916620|FG008|Overall Study|Lost to Follow-up|3|||
163329484|NCT02499328|589916621|FG009|Overall Study|Lost to Follow-up|0|||
163329485|NCT02499328|589916622|FG010|Overall Study|Lost to Follow-up|0|||
163329486|NCT02499328|589916623|FG011|Overall Study|Lost to Follow-up|0|||
163329487|NCT02499328|589916624|FG012|Overall Study|Lost to Follow-up|0|||
163329488|NCT02499328|589916625|FG013|Overall Study|Lost to Follow-up|0|||
163329489|NCT02499328|589916626|FG014|Overall Study|Lost to Follow-up|0|||
163329490|NCT02499328|589916627|FG015|Overall Study|Lost to Follow-up|0|||
163329491|NCT02499328|589916628|FG016|Overall Study|Lost to Follow-up|0|||
163329492|NCT02499328|589916629|FG017|Overall Study|Lost to Follow-up|0|||
163329493|NCT02499328|589916630|FG018|Overall Study|Lost to Follow-up|1|||
163329494|NCT02499328|589916612|FG000|Overall Study|Death|0|||
163020413|NCT03214380|588777923|FG000|Treatment Period|Lost to Follow-up|0|||
163020414|NCT03214380|588777924|FG001|Treatment Period|Lost to Follow-up|6|||
163329495|NCT02499328|589916613|FG001|Overall Study|Death|3|||
163329496|NCT02499328|589916614|FG002|Overall Study|Death|3|||
163020415|NCT03214380|588777925|FG002|Treatment Period|Lost to Follow-up|3|||
163020416|NCT03214380|588777926|FG003|Treatment Period|Lost to Follow-up|0|||
163020417|NCT03214380|588777927|FG004|Treatment Period|Lost to Follow-up|0|||
163020418|NCT03214380|588777928|FG005|Treatment Period|Lost to Follow-up|0|||
163329497|NCT02499328|589916615|FG003|Overall Study|Death|2|||
163020419|NCT03214380|588777923|FG000|Treatment Period|Participant schedule|0|||
163329498|NCT02499328|589916616|FG004|Overall Study|Death|4|||
163329499|NCT02499328|589916617|FG005|Overall Study|Death|7|||
163329500|NCT02499328|589916618|FG006|Overall Study|Death|3|||
163329501|NCT02499328|589916619|FG007|Overall Study|Death|0|||
163329502|NCT02499328|589916620|FG008|Overall Study|Death|2|||
163329503|NCT02499328|589916621|FG009|Overall Study|Death|6|||
163329504|NCT02499328|589916622|FG010|Overall Study|Death|6|||
163329505|NCT02499328|589916623|FG011|Overall Study|Death|20|||
163329506|NCT02499328|589916624|FG012|Overall Study|Death|9|||
163329507|NCT02499328|589916625|FG013|Overall Study|Death|7|||
163020420|NCT03214380|588777924|FG001|Treatment Period|Participant schedule|0|||
163329508|NCT02499328|589916626|FG014|Overall Study|Death|3|||
163329509|NCT02499328|589916627|FG015|Overall Study|Death|1|||
163329510|NCT02499328|589916628|FG016|Overall Study|Death|1|||
163020421|NCT03214380|588777925|FG002|Treatment Period|Participant schedule|1|||
163020422|NCT03214380|588777926|FG003|Treatment Period|Participant schedule|0|||
163020423|NCT03214380|588777927|FG004|Treatment Period|Participant schedule|0|||
163020424|NCT03214380|588777928|FG005|Treatment Period|Participant schedule|0|||
163020425|NCT03214380|588777923|FG000|Treatment Period|Treatment Interruption|0|||
163020426|NCT03214380|588777924|FG001|Treatment Period|Treatment Interruption|0|||
163020427|NCT03214380|588777925|FG002|Treatment Period|Treatment Interruption|1|||
163020428|NCT03214380|588777926|FG003|Treatment Period|Treatment Interruption|0|||
163020429|NCT03214380|588777927|FG004|Treatment Period|Treatment Interruption|0|||
163020430|NCT03214380|588777928|FG005|Treatment Period|Treatment Interruption|0|||
163020431|NCT00614523|588777932|FG000|Overall Study|Adverse Event|4|||
163020432|NCT00614523|588777933|FG001|Overall Study|Adverse Event|20|||
163020433|NCT00614523|588777932|FG000|Overall Study|Death|5|||
163020434|NCT00614523|588777933|FG001|Overall Study|Death|8|||
163020435|NCT00614523|588777932|FG000|Overall Study|Lack of Efficacy|9|||
163020436|NCT00614523|588777933|FG001|Overall Study|Lack of Efficacy|11|||
163020437|NCT00614523|588777932|FG000|Overall Study|Lost to Follow-up|0|||
163020438|NCT00614523|588777933|FG001|Overall Study|Lost to Follow-up|1|||
163020439|NCT00614523|588777932|FG000|Overall Study|Protocol Violation|3|||
163020440|NCT00614523|588777933|FG001|Overall Study|Protocol Violation|2|||
163020441|NCT00614523|588777932|FG000|Overall Study|Withdrawal by Subject|12|||
163020442|NCT00614523|588777933|FG001|Overall Study|Withdrawal by Subject|22|||
163020443|NCT00614523|588777932|FG000|Overall Study|Other|6|||
163020444|NCT00614523|588777933|FG001|Overall Study|Other|11|||
163020445|NCT00614523|588777932|FG000|Overall Study|Ineligibility Determined|1|||
163020446|NCT00614523|588777933|FG001|Overall Study|Ineligibility Determined|2|||
163020447|NCT00614523|588777932|FG000|Overall Study|Disease Progression|0|||
163020448|NCT00614523|588777933|FG001|Overall Study|Disease Progression|8|||
163020449|NCT00614523|588777932|FG000|Overall Study|Administrative Decision|23|||
163020450|NCT00614523|588777933|FG001|Overall Study|Administrative Decision|46|||
163020451|NCT00723255|588777934|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
163020452|NCT00723255|588777934|FG000|Overall Study|Ineligible: Second primary|1|||
163020453|NCT00723255|588777934|FG000|Overall Study|Ineligible: Wrong Primary|2|||
163020454|NCT00452673|588777943|FG000|Dose Escalation Period|Disease Progression|6|||
163020455|NCT00452673|588777944|FG001|Dose Escalation Period|Disease Progression|6|||
163020456|NCT00452673|588777945|FG002|Dose Escalation Period|Disease Progression|2|||
163020457|NCT00452673|588777946|FG003|Dose Escalation Period|Disease Progression|6|||
163020458|NCT00452673|588777947|FG004|Dose Escalation Period|Disease Progression|0|||
163020459|NCT00452673|588777943|FG000|Dose Escalation Period|study drug toxicity|1|||
163020460|NCT00452673|588777944|FG001|Dose Escalation Period|study drug toxicity|3|||
163020461|NCT00452673|588777945|FG002|Dose Escalation Period|study drug toxicity|3|||
163020462|NCT00452673|588777946|FG003|Dose Escalation Period|study drug toxicity|1|||
163020463|NCT00452673|588777947|FG004|Dose Escalation Period|study drug toxicity|0|||
163020464|NCT00452673|588777943|FG000|Dose Escalation Period|Other|0|||
163020465|NCT00452673|588777944|FG001|Dose Escalation Period|Other|0|||
163020466|NCT00452673|588777945|FG002|Dose Escalation Period|Other|1|||
163020467|NCT00452673|588777946|FG003|Dose Escalation Period|Other|0|||
163020468|NCT00452673|588777947|FG004|Dose Escalation Period|Other|0|||
163020469|NCT00452673|588777943|FG000|Dose Escalation Period|Adverse Event|0|||
163020470|NCT00452673|588777944|FG001|Dose Escalation Period|Adverse Event|0|||
163020471|NCT00452673|588777945|FG002|Dose Escalation Period|Adverse Event|0|||
163020472|NCT00452673|588777946|FG003|Dose Escalation Period|Adverse Event|1|||
163020473|NCT00452673|588777947|FG004|Dose Escalation Period|Adverse Event|0|||
163020474|NCT00452673|588777943|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
163020475|NCT00452673|588777944|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
163020476|NCT00452673|588777945|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
163216510|NCT02082210|589508003|FG005|Overall Study|Clinical Progression|0|||
163216511|NCT02082210|589507998|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
163216512|NCT02082210|589507999|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
163216513|NCT02082210|589508000|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
163216514|NCT02082210|589508001|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
163216515|NCT02082210|589508002|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
163216516|NCT02082210|589508003|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
163216517|NCT02082210|589507998|FG000|Overall Study|Physician Decision|0|||
163216518|NCT02082210|589507999|FG001|Overall Study|Physician Decision|0|||
163216519|NCT02082210|589508000|FG002|Overall Study|Physician Decision|1|||
163216520|NCT02082210|589508001|FG003|Overall Study|Physician Decision|1|||
163216521|NCT02082210|589508002|FG004|Overall Study|Physician Decision|0|||
163216522|NCT02082210|589508003|FG005|Overall Study|Physician Decision|0|||
163216523|NCT00952341|589508010|FG000|Cycle 1|Adverse Event|4|||
163216524|NCT00952341|589508011|FG001|Cycle 1|Adverse Event|1|||
163020477|NCT00452673|588777946|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
163020478|NCT00452673|588777947|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
163020479|NCT00452673|588777943|FG000|Dose Expansion Period|Disease Progression|0|||
163020480|NCT00452673|588777944|FG001|Dose Expansion Period|Disease Progression|0|||
163216525|NCT00952341|589508010|FG000|Cycle 1|Withdrawal by Subject|3|||
163020481|NCT00452673|588777945|FG002|Dose Expansion Period|Disease Progression|0|||
163020482|NCT00452673|588777946|FG003|Dose Expansion Period|Disease Progression|0|||
163020483|NCT00452673|588777947|FG004|Dose Expansion Period|Disease Progression|19|||
163020484|NCT00452673|588777943|FG000|Dose Expansion Period|Other|0|||
163020485|NCT00452673|588777944|FG001|Dose Expansion Period|Other|0|||
163020486|NCT00452673|588777945|FG002|Dose Expansion Period|Other|0|||
163020487|NCT00452673|588777946|FG003|Dose Expansion Period|Other|0|||
163020488|NCT00452673|588777947|FG004|Dose Expansion Period|Other|2|||
163020489|NCT00748189|588777950|FG000|Overall Study|Death|99|||
163020490|NCT00748189|588777951|FG001|Overall Study|Death|84|||
163020491|NCT00748189|588777950|FG000|Overall Study|Withdrawal by Subject|23|||
163020492|NCT00748189|588777951|FG001|Overall Study|Withdrawal by Subject|29|||
163020493|NCT00748189|588777950|FG000|Overall Study|Physician Decision|16|||
163020494|NCT00748189|588777951|FG001|Overall Study|Physician Decision|5|||
163020495|NCT00748189|588777950|FG000|Overall Study|Lost to Follow-up|8|||
163020496|NCT00748189|588777951|FG001|Overall Study|Lost to Follow-up|15|||
163020497|NCT00748189|588777950|FG000|Overall Study|Study terminated by Sponsor|70|||
163020498|NCT00748189|588777951|FG001|Overall Study|Study terminated by Sponsor|79|||
163020499|NCT04481191|588777958|FG000|Overall Study|Withdrawn by parent/guardian|15|||
163020500|NCT04481191|588777959|FG001|Overall Study|Withdrawn by parent/guardian|10|||
163020501|NCT00546117|588777964|FG000|Overall Study|Withdrawal by Subject|3|||
163063598|NCT01995201|588939905|FG001|From Week 24 Until Week 48|Adverse Event|0|||
163063599|NCT01995201|588939906|FG002|From Week 24 Until Week 48|Adverse Event|2|||
163063600|NCT01995201|588939907|FG003|From Week 24 Until Week 48|Adverse Event|1|||
163063601|NCT01995201|588939908|FG004|From Week 24 Until Week 48|Adverse Event|1|||
163063602|NCT01995201|588939909|FG005|From Week 24 Until Week 48|Adverse Event|3|||
163063603|NCT01995201|588939910|FG006|From Week 24 Until Week 48|Adverse Event|1|||
163063604|NCT01995201|588939904|FG000|From Week 24 Until Week 48|Death|0|||
163063605|NCT01995201|588939905|FG001|From Week 24 Until Week 48|Death|0|||
163063606|NCT01995201|588939906|FG002|From Week 24 Until Week 48|Death|0|||
163063607|NCT01995201|588939907|FG003|From Week 24 Until Week 48|Death|0|||
163063608|NCT01995201|588939908|FG004|From Week 24 Until Week 48|Death|0|||
163063609|NCT01995201|588939909|FG005|From Week 24 Until Week 48|Death|2|||
163063610|NCT01995201|588939910|FG006|From Week 24 Until Week 48|Death|0|||
163063611|NCT01995201|588939904|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
163063612|NCT01995201|588939905|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
163063613|NCT01995201|588939906|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
163063614|NCT01995201|588939907|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
163063615|NCT01995201|588939908|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
163063616|NCT01995201|588939909|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
163063617|NCT01995201|588939910|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
163063618|NCT01995201|588939904|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
163063619|NCT01995201|588939905|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
163063620|NCT01995201|588939906|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
163063621|NCT01995201|588939907|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
163063622|NCT01995201|588939908|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
163063623|NCT01995201|588939909|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
163063624|NCT01995201|588939910|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
163063625|NCT01995201|588939904|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
163063626|NCT01995201|588939905|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
163063627|NCT01995201|588939906|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
163063628|NCT01995201|588939907|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
163063629|NCT01995201|588939908|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
163216526|NCT00952341|589508011|FG001|Cycle 1|Withdrawal by Subject|8|||
163216527|NCT00952341|589508010|FG000|Cycle 1|Protocol Violation|2|||
163216528|NCT00952341|589508011|FG001|Cycle 1|Protocol Violation|1|||
163216529|NCT00952341|589508010|FG000|Cycle 1|Lost to Follow-up|11|||
163216530|NCT00952341|589508011|FG001|Cycle 1|Lost to Follow-up|2|||
163020502|NCT00546117|588777965|FG001|Overall Study|Withdrawal by Subject|0|||
163063630|NCT01995201|588939909|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
163063631|NCT01995201|588939910|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
163216531|NCT00952341|589508010|FG000|Cycle 1|Physician Decision|0|||
163020503|NCT00546117|588777964|FG000|Overall Study|Inability to schedule follow-up visit|1|||
163063632|NCT01995201|588939904|FG000|From Week 24 Until Week 48|Physician Decision|0|||
163063633|NCT01995201|588939905|FG001|From Week 24 Until Week 48|Physician Decision|0|||
163063634|NCT01995201|588939906|FG002|From Week 24 Until Week 48|Physician Decision|0|||
163063635|NCT01995201|588939907|FG003|From Week 24 Until Week 48|Physician Decision|0|||
163063636|NCT01995201|588939908|FG004|From Week 24 Until Week 48|Physician Decision|1|||
163063637|NCT01995201|588939909|FG005|From Week 24 Until Week 48|Physician Decision|0|||
163063638|NCT01995201|588939910|FG006|From Week 24 Until Week 48|Physician Decision|0|||
163216532|NCT00952341|589508011|FG001|Cycle 1|Physician Decision|1|||
163020504|NCT00546117|588777965|FG001|Overall Study|Inability to schedule follow-up visit|0|||
163020505|NCT01598090|588777966|FG000|Treatment Period|Poor/non-compliance|0|||
163020506|NCT01598090|588777967|FG001|Treatment Period|Poor/non-compliance|2|||
163216533|NCT00952341|589508010|FG000|Cycle 2|Withdrawal by Subject|1|||
163020507|NCT01598090|588777968|FG002|Treatment Period|Poor/non-compliance|0|||
163020508|NCT01598090|588777966|FG000|Treatment Period|No longer meet study criteria|0|||
163020509|NCT01598090|588777967|FG001|Treatment Period|No longer meet study criteria|1|||
163020510|NCT01598090|588777968|FG002|Treatment Period|No longer meet study criteria|0|||
163020511|NCT01598090|588777966|FG000|Treatment Period|Lack of Efficacy|5|||
163020512|NCT01598090|588777967|FG001|Treatment Period|Lack of Efficacy|14|||
163020513|NCT01598090|588777968|FG002|Treatment Period|Lack of Efficacy|6|||
163020514|NCT01598090|588777966|FG000|Treatment Period|Adverse Event|2|||
163020515|NCT01598090|588777967|FG001|Treatment Period|Adverse Event|33|||
163020516|NCT01598090|588777968|FG002|Treatment Period|Adverse Event|17|||
163020517|NCT01598090|588777966|FG000|Treatment Period|Other reasons|0|||
163020518|NCT01598090|588777967|FG001|Treatment Period|Other reasons|4|||
163020519|NCT01598090|588777968|FG002|Treatment Period|Other reasons|1|||
163020520|NCT01598090|588777966|FG000|Treatment Period|Withdrawal by Subject|3|||
163020521|NCT01598090|588777967|FG001|Treatment Period|Withdrawal by Subject|13|||
163020522|NCT01598090|588777968|FG002|Treatment Period|Withdrawal by Subject|10|||
163020523|NCT01598090|588777966|FG000|Treatment Period|Lost to Follow-up|1|||
163020524|NCT01598090|588777967|FG001|Treatment Period|Lost to Follow-up|5|||
163020525|NCT01598090|588777968|FG002|Treatment Period|Lost to Follow-up|1|||
163020526|NCT01598090|588777966|FG000|Follow-up Period|Death|0|||
163020527|NCT01598090|588777967|FG001|Follow-up Period|Death|1|||
163020528|NCT01598090|588777968|FG002|Follow-up Period|Death|0|||
163020529|NCT01598090|588777966|FG000|Follow-up Period|No longer required per protocol|1|||
163020530|NCT01598090|588777967|FG001|Follow-up Period|No longer required per protocol|3|||
163020531|NCT01598090|588777968|FG002|Follow-up Period|No longer required per protocol|2|||
163063639|NCT01995201|588939904|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
163063640|NCT01995201|588939905|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
163329511|NCT02499328|589916629|FG017|Overall Study|Death|16|||
163329512|NCT02499328|589916630|FG018|Overall Study|Death|5|||
163063641|NCT01995201|588939906|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
163063642|NCT01995201|588939907|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
163063643|NCT01995201|588939908|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
163063644|NCT01995201|588939909|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
163063645|NCT01995201|588939910|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
163063646|NCT06001866|588939913|FG000|Overall Study|Withdrawal by Subject|0|||
163063647|NCT06001866|588939914|FG001|Overall Study|Withdrawal by Subject|2|||
163063648|NCT06001866|588939913|FG000|Overall Study|Protocol Violation|0|||
163063649|NCT06001866|588939914|FG001|Overall Study|Protocol Violation|2|||
163063650|NCT04703192|588939915|FG000|Overall Study|Withdrawal by Subject|2|||
163063651|NCT04703192|588939916|FG001|Overall Study|Withdrawal by Subject|0|||
163063652|NCT04703192|588939915|FG000|Overall Study|Death|3|||
163063653|NCT04703192|588939916|FG001|Overall Study|Death|1|||
163063654|NCT04703192|588939915|FG000|Overall Study|Adverse Event|13|||
163063655|NCT04703192|588939916|FG001|Overall Study|Adverse Event|2|||
163063656|NCT04703192|588939915|FG000|Overall Study|Progressive or Relapsed Disease|46|||
163063657|NCT04703192|588939916|FG001|Overall Study|Progressive or Relapsed Disease|7|||
163063658|NCT04703192|588939915|FG000|Overall Study|Clinical Progression|19|||
163063659|NCT04703192|588939916|FG001|Overall Study|Clinical Progression|8|||
163063660|NCT04703192|588939915|FG000|Overall Study|Lost to Follow-up|1|||
163329513|NCT02499328|589916612|FG000|Overall Study|"Other"|2|||
163329514|NCT02499328|589916613|FG001|Overall Study|"Other"|2|||
163329515|NCT02499328|589916614|FG002|Overall Study|"Other"|1|||
163063661|NCT04703192|588939916|FG001|Overall Study|Lost to Follow-up|0|||
163063662|NCT04703192|588939915|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
163063663|NCT04703192|588939916|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
163063664|NCT04703192|588939915|FG000|Overall Study|Other|5|||
163063665|NCT04703192|588939916|FG001|Overall Study|Other|1|||
163063666|NCT04797169|588939917|FG000|Overall Study|Lost to Follow-up|84|||
163063667|NCT04797169|588939918|FG001|Overall Study|Lost to Follow-up|67|||
163063668|NCT04797169|588939917|FG000|Overall Study|Pregnancy|1|||
163063669|NCT04797169|588939918|FG001|Overall Study|Pregnancy|3|||
163063670|NCT04797169|588939917|FG000|Overall Study|Withdrawal by Subject|27|||
163329516|NCT02499328|589916615|FG003|Overall Study|"Other"|3|||
163329517|NCT02499328|589916616|FG004|Overall Study|"Other"|6|||
163329518|NCT02499328|589916617|FG005|Overall Study|"Other"|2|||
163329519|NCT02499328|589916618|FG006|Overall Study|"Other"|3|||
163020532|NCT01598090|588777966|FG000|Follow-up Period|Not reported|0|||
163020533|NCT01598090|588777967|FG001|Follow-up Period|Not reported|10|||
163020534|NCT01598090|588777968|FG002|Follow-up Period|Not reported|4|||
163020535|NCT01598090|588777966|FG000|Follow-up Period|Withdrawal by Subject|0|||
163063671|NCT04797169|588939918|FG001|Overall Study|Withdrawal by Subject|35|||
163063672|NCT04725188|588939919|FG000|Overall Study|Death|72|||
163063673|NCT04725188|588939920|FG001|Overall Study|Death|69|||
163063674|NCT04725188|588939921|FG002|Overall Study|Death|76|||
163063675|NCT04725188|588939919|FG000|Overall Study|Lost to Follow-up|1|||
163063676|NCT04725188|588939920|FG001|Overall Study|Lost to Follow-up|0|||
163063677|NCT04725188|588939921|FG002|Overall Study|Lost to Follow-up|1|||
163329520|NCT02499328|589916619|FG007|Overall Study|"Other"|4|||
163329521|NCT02499328|589916620|FG008|Overall Study|"Other"|6|||
163020536|NCT01598090|588777967|FG001|Follow-up Period|Withdrawal by Subject|3|||
163020537|NCT01598090|588777968|FG002|Follow-up Period|Withdrawal by Subject|2|||
163020538|NCT01598090|588777966|FG000|Follow-up Period|Other reasons|2|||
163020539|NCT01598090|588777967|FG001|Follow-up Period|Other reasons|8|||
163020540|NCT01598090|588777968|FG002|Follow-up Period|Other reasons|8|||
163020541|NCT01598090|588777966|FG000|Follow-up Period|Lost to Follow-up|2|||
163020542|NCT01598090|588777967|FG001|Follow-up Period|Lost to Follow-up|10|||
163020543|NCT01598090|588777968|FG002|Follow-up Period|Lost to Follow-up|12|||
163020544|NCT00355147|588777971|FG000|Overall Study|Lost to Follow-up|10|||
163020545|NCT00355147|588777972|FG001|Overall Study|Lost to Follow-up|8|||
163020546|NCT00355147|588777971|FG000|Overall Study|Withdrawal by Subject|8|||
163020547|NCT00355147|588777972|FG001|Overall Study|Withdrawal by Subject|12|||
163020548|NCT03557931|588777977|FG000|Overall Study|Adverse Event|4|||
163020549|NCT03557931|588777978|FG001|Overall Study|Adverse Event|6|||
163020550|NCT03557931|588777979|FG002|Overall Study|Adverse Event|1|||
163020551|NCT03557931|588777977|FG000|Overall Study|Lost to Follow-up|4|||
163020552|NCT03557931|588777978|FG001|Overall Study|Lost to Follow-up|4|||
163020553|NCT03557931|588777979|FG002|Overall Study|Lost to Follow-up|1|||
163020554|NCT03557931|588777977|FG000|Overall Study|Protocol Violation|1|||
163020555|NCT03557931|588777978|FG001|Overall Study|Protocol Violation|4|||
163020556|NCT03557931|588777979|FG002|Overall Study|Protocol Violation|1|||
163020557|NCT03557931|588777977|FG000|Overall Study|Withdrawal by Subject|14|||
163020558|NCT03557931|588777978|FG001|Overall Study|Withdrawal by Subject|0|||
163020559|NCT03557931|588777979|FG002|Overall Study|Withdrawal by Subject|7|||
163020560|NCT03557931|588777977|FG000|Overall Study|Miscellaneous|8|||
163020561|NCT03557931|588777978|FG001|Overall Study|Miscellaneous|5|||
163020562|NCT03557931|588777979|FG002|Overall Study|Miscellaneous|3|||
163020563|NCT02394340|588777980|FG000|Overall Study|Failed drug screen test|1|||
163020564|NCT02394340|588777980|FG000|Overall Study|Adverse Event|1|||
163020565|NCT00886743|588777984|FG000|Overall Study|Adverse Event|3|||
163020566|NCT00886743|588777984|FG000|Overall Study|Other|1|||
163020567|NCT00478777|588777985|FG000|Overall Study|Adverse Event|29|||
163020568|NCT00478777|588777985|FG000|Overall Study|Lack of Efficacy|23|||
163020569|NCT00478777|588777985|FG000|Overall Study|Withdrawal by Subject|4|||
163020570|NCT00478777|588777985|FG000|Overall Study|Death|3|||
163020571|NCT00478777|588777985|FG000|Overall Study|Protocol Violation|3|||
163020572|NCT00478777|588777985|FG000|Overall Study|Lost to Follow-up|3|||
163020573|NCT00478777|588777985|FG000|Overall Study|Physician Decision|1|||
163020574|NCT00478777|588777985|FG000|Overall Study|Intolerance of therapy|1|||
163020575|NCT00478777|588777985|FG000|Overall Study|Lack of compliance|1|||
163020576|NCT00478777|588777985|FG000|Overall Study|Lymphocytes infusion|1|||
163020577|NCT00478777|588777985|FG000|Overall Study|End of therapy|2|||
163020578|NCT00478777|588777985|FG000|Overall Study|Not treated with lenalidomide|6|||
163020579|NCT01726270|588777988|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
163020580|NCT01726270|588777988|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
163020581|NCT01726270|588777988|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
163020582|NCT01726270|588777988|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
163020583|NCT01726270|588777988|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
163020584|NCT01726270|588777988|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
163020585|NCT01323387|588777989|FG000|Overall Study|Withdrawal by Subject|41|||
163020586|NCT01323387|588777989|FG000|Overall Study|Radiographic Data Unavailable|1|||
163020587|NCT01323387|588777989|FG000|Overall Study|Revision|14|||
163020588|NCT01323387|588777989|FG000|Overall Study|Protocol Violation|12|||
163020589|NCT01323387|588777989|FG000|Overall Study|Randomized but Never Treated|16|||
163020590|NCT02157376|588777992|FG000|Overall Study|Death|10|||
163020591|NCT02157376|588777993|FG001|Overall Study|Death|4|||
163020592|NCT02157376|588777992|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163020593|NCT02157376|588777993|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163329522|NCT02499328|589916621|FG009|Overall Study|"Other"|16|||
163329523|NCT02499328|589916622|FG010|Overall Study|"Other"|13|||
163329524|NCT02499328|589916623|FG011|Overall Study|"Other"|31|||
163329525|NCT02499328|589916624|FG012|Overall Study|"Other"|8|||
163329526|NCT02499328|589916625|FG013|Overall Study|"Other"|7|||
163329527|NCT02499328|589916626|FG014|Overall Study|"Other"|6|||
163020594|NCT02157376|588777992|FG000|Overall Study|Withdrawal by Subject|3|||
163020595|NCT02157376|588777993|FG001|Overall Study|Withdrawal by Subject|8|||
163020596|NCT02157376|588777992|FG000|Overall Study|Not treated|8|||
163020597|NCT02157376|588777993|FG001|Overall Study|Not treated|3|||
163020598|NCT02157376|588777992|FG000|Overall Study|Investigator's misjudgement|1|||
163020599|NCT02157376|588777993|FG001|Overall Study|Investigator's misjudgement|2|||
163020600|NCT04200651|588777994|FG000|Overall Study|Moved to another country during follow-up|2|||
163020601|NCT04200651|588777995|FG001|Overall Study|Moved to another country during follow-up|2|||
163020602|NCT04200651|588777994|FG000|Overall Study|Lost to Follow-up|1|||
163329528|NCT02499328|589916627|FG015|Overall Study|"Other"|0|||
163020603|NCT04200651|588777995|FG001|Overall Study|Lost to Follow-up|3|||
163020604|NCT03319732|588778005|FG000|Overall Study|Adverse Event|40|||
163020605|NCT03319732|588778005|FG000|Overall Study|Withdrawal by Subject|50|||
163329529|NCT02499328|589916628|FG016|Overall Study|"Other"|0|||
163020606|NCT03319732|588778005|FG000|Overall Study|MS relapse|10|||
163020607|NCT03319732|588778005|FG000|Overall Study|reason not specified|5|||
163020608|NCT00757042|588778006|FG000|Overall Study|Lost to Follow-up|0|||
163020609|NCT00757042|588778007|FG001|Overall Study|Lost to Follow-up|0|||
163020610|NCT00757042|588778008|FG002|Overall Study|Lost to Follow-up|0|||
163020611|NCT00757042|588778009|FG003|Overall Study|Lost to Follow-up|0|||
163020612|NCT00757042|588778010|FG004|Overall Study|Lost to Follow-up|0|||
163020613|NCT00757042|588778011|FG005|Overall Study|Lost to Follow-up|0|||
163020614|NCT00757042|588778012|FG006|Overall Study|Lost to Follow-up|0|||
163020615|NCT00757042|588778013|FG007|Overall Study|Lost to Follow-up|0|||
163020616|NCT00757042|588778014|FG008|Overall Study|Lost to Follow-up|1|||
163020617|NCT00757042|588778015|FG009|Overall Study|Lost to Follow-up|0|||
163020618|NCT00757042|588778016|FG010|Overall Study|Lost to Follow-up|0|||
163020619|NCT00757042|588778006|FG000|Overall Study|Ineligibility Determined|0|||
163020620|NCT00757042|588778007|FG001|Overall Study|Ineligibility Determined|0|||
163020621|NCT00757042|588778008|FG002|Overall Study|Ineligibility Determined|0|||
163020622|NCT00757042|588778009|FG003|Overall Study|Ineligibility Determined|0|||
163020623|NCT00757042|588778010|FG004|Overall Study|Ineligibility Determined|0|||
163020624|NCT00757042|588778011|FG005|Overall Study|Ineligibility Determined|0|||
163020625|NCT00757042|588778012|FG006|Overall Study|Ineligibility Determined|0|||
163020626|NCT00757042|588778013|FG007|Overall Study|Ineligibility Determined|0|||
163020627|NCT00757042|588778014|FG008|Overall Study|Ineligibility Determined|0|||
163020628|NCT00757042|588778015|FG009|Overall Study|Ineligibility Determined|0|||
163020629|NCT00757042|588778016|FG010|Overall Study|Ineligibility Determined|1|||
163020630|NCT00757042|588778006|FG000|Overall Study|Withdrawal by Subject|0|||
163020631|NCT00757042|588778007|FG001|Overall Study|Withdrawal by Subject|0|||
163020632|NCT00757042|588778008|FG002|Overall Study|Withdrawal by Subject|0|||
163020633|NCT00757042|588778009|FG003|Overall Study|Withdrawal by Subject|0|||
163020634|NCT00757042|588778010|FG004|Overall Study|Withdrawal by Subject|0|||
163020635|NCT00757042|588778011|FG005|Overall Study|Withdrawal by Subject|0|||
163020636|NCT00757042|588778012|FG006|Overall Study|Withdrawal by Subject|0|||
163020637|NCT00757042|588778013|FG007|Overall Study|Withdrawal by Subject|0|||
163020638|NCT00757042|588778014|FG008|Overall Study|Withdrawal by Subject|0|||
163020639|NCT00757042|588778015|FG009|Overall Study|Withdrawal by Subject|1|||
163020640|NCT00757042|588778016|FG010|Overall Study|Withdrawal by Subject|0|||
163020641|NCT02654977|588778018|FG000|Overall Study|Death|1|||
163020642|NCT02654977|588778018|FG000|Overall Study|Lost to Follow-up|1|||
163020643|NCT02654977|588778018|FG000|Overall Study|Adverse Event|1|||
163020644|NCT02654977|588778018|FG000|Overall Study|Withdrawal by Subject|1|||
163020645|NCT02654977|588778018|FG000|Overall Study|Lack of Efficacy|3|||
163020646|NCT01266291|588778019|FG000|Overall Study|Adverse Event|1|||
163020647|NCT02729051|588778022|FG000|Overall Study|Adverse Event|21|||
163020648|NCT02729051|588778023|FG001|Overall Study|Adverse Event|11|||
163020649|NCT02729051|588778022|FG000|Overall Study|Lack of Efficacy|1|||
163063678|NCT04725188|588939919|FG000|Overall Study|Withdrawal by Subject|2|||
163063679|NCT04725188|588939920|FG001|Overall Study|Withdrawal by Subject|2|||
163063680|NCT04725188|588939921|FG002|Overall Study|Withdrawal by Subject|1|||
163063681|NCT04725188|588939919|FG000|Overall Study|Sponsor Decision|12|||
163063682|NCT04725188|588939920|FG001|Overall Study|Sponsor Decision|12|||
163063683|NCT04725188|588939921|FG002|Overall Study|Sponsor Decision|7|||
163063684|NCT00390013|588939923|FG000|Phase 1|tired|0|||
163063685|NCT00390013|588939924|FG001|Phase 1|tired|0|||
163063686|NCT00390013|588939925|FG002|Phase 1|tired|0|||
163063687|NCT00390013|588939926|FG003|Phase 1|tired|1|||
163063688|NCT00390013|588939923|FG000|Phase 2 First Treatment|tired|1|||
163063689|NCT00390013|588939924|FG001|Phase 2 First Treatment|tired|0|||
163063690|NCT00390013|588939925|FG002|Phase 2 First Treatment|tired|0|||
163063691|NCT00390013|588939926|FG003|Phase 2 First Treatment|tired|0|||
163020650|NCT02729051|588778023|FG001|Overall Study|Lack of Efficacy|1|||
163020651|NCT02729051|588778022|FG000|Overall Study|Lost to Follow-up|1|||
163020652|NCT02729051|588778023|FG001|Overall Study|Lost to Follow-up|2|||
163020653|NCT02729051|588778022|FG000|Overall Study|Physician Decision|1|||
163020654|NCT02729051|588778023|FG001|Overall Study|Physician Decision|1|||
163020655|NCT02729051|588778022|FG000|Overall Study|Withdrawal by Subject|6|||
163020656|NCT02729051|588778023|FG001|Overall Study|Withdrawal by Subject|17|||
163020657|NCT02702388|588778024|FG000|Overall Study|Disease Progression|18|||
163020658|NCT02702388|588778025|FG001|Overall Study|Disease Progression|25|||
163020659|NCT02702388|588778024|FG000|Overall Study|Withdrawal by Subject|9|||
163020660|NCT02702388|588778025|FG001|Overall Study|Withdrawal by Subject|7|||
163063692|NCT00390013|588939923|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
163063693|NCT00390013|588939924|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
163063694|NCT00390013|588939925|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
163063695|NCT00390013|588939926|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
163020661|NCT02702388|588778024|FG000|Overall Study|Adverse Event|11|||
163020662|NCT02702388|588778025|FG001|Overall Study|Adverse Event|15|||
163020663|NCT02702388|588778024|FG000|Overall Study|Other|2|||
163020664|NCT02702388|588778025|FG001|Overall Study|Other|4|||
163020665|NCT00596817|588778026|FG000|Open-label Period|Adverse Event|0|||
163063696|NCT03839641|588939927|FG000|Overall Study|Withdrawal by Subject|1|||
163020666|NCT00596817|588778027|FG001|Open-label Period|Adverse Event|49|||
163020667|NCT00596817|588778026|FG000|Open-label Period|Lack of Efficacy|0|||
163020668|NCT00596817|588778027|FG001|Open-label Period|Lack of Efficacy|33|||
163020669|NCT00596817|588778026|FG000|Open-label Period|Other Reasons|0|||
163020670|NCT00596817|588778027|FG001|Open-label Period|Other Reasons|65|||
163020671|NCT00596817|588778026|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
163020672|NCT00596817|588778027|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
163020673|NCT00596817|588778026|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
163020674|NCT00596817|588778027|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
163020675|NCT00596817|588778026|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
163020676|NCT00596817|588778027|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
163020677|NCT00596817|588778026|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
163020678|NCT00596817|588778027|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
163020679|NCT00596817|588778026|FG000|Double-blind Period|Adverse Event|5|||
163020680|NCT00596817|588778027|FG001|Double-blind Period|Adverse Event|16|||
163020681|NCT00596817|588778026|FG000|Double-blind Period|Lack of Efficacy|52|||
163020682|NCT00596817|588778027|FG001|Double-blind Period|Lack of Efficacy|28|||
163020683|NCT00596817|588778026|FG000|Double-blind Period|Non-compliance With Study Product|3|||
163020684|NCT00596817|588778027|FG001|Double-blind Period|Non-compliance With Study Product|4|||
163020685|NCT00596817|588778026|FG000|Double-blind Period|Protocol Violation|11|||
163020686|NCT00596817|588778027|FG001|Double-blind Period|Protocol Violation|8|||
163020687|NCT00596817|588778026|FG000|Double-blind Period|Withdrawal of Consent|7|||
163020688|NCT00596817|588778027|FG001|Double-blind Period|Withdrawal of Consent|3|||
163020689|NCT00596817|588778026|FG000|Double-blind Period|Lost to Follow-up|0|||
163020690|NCT00596817|588778027|FG001|Double-blind Period|Lost to Follow-up|2|||
163020691|NCT00596817|588778026|FG000|Double-blind Period|Other Reasons|10|||
163020692|NCT00596817|588778027|FG001|Double-blind Period|Other Reasons|18|||
163020693|NCT01314872|588778036|FG000|Treatment Period 1|Protocol Violation|2|||
163020694|NCT01314872|588778037|FG001|Treatment Period 1|Protocol Violation|1|||
163020695|NCT01314872|588778038|FG002|Treatment Period 1|Protocol Violation|1|||
163020696|NCT01314872|588778039|FG003|Treatment Period 1|Protocol Violation|0|||
163020697|NCT01314872|588778040|FG004|Treatment Period 1|Protocol Violation|1|||
163020698|NCT01314872|588778041|FG005|Treatment Period 1|Protocol Violation|0|||
163020699|NCT01314872|588778042|FG006|Treatment Period 1|Protocol Violation|0|||
163020700|NCT01314872|588778043|FG007|Treatment Period 1|Protocol Violation|0|||
163020701|NCT01314872|588778044|FG008|Treatment Period 1|Protocol Violation|0|||
163020702|NCT01314872|588778045|FG009|Treatment Period 1|Protocol Violation|1|||
163020703|NCT01314872|588778046|FG010|Treatment Period 1|Protocol Violation|1|||
163063697|NCT03839641|588939928|FG001|Overall Study|Withdrawal by Subject|1|||
163063698|NCT03188822|588939936|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
163063699|NCT03188822|588939936|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
163020704|NCT01314872|588778047|FG011|Treatment Period 1|Protocol Violation|0|||
163020705|NCT01314872|588778048|FG012|Treatment Period 1|Protocol Violation|0|||
163020706|NCT01314872|588778049|FG013|Treatment Period 1|Protocol Violation|0|||
163063700|NCT04537299|588939937|FG000|Overall Study|Withdrawal by Subject|2|||
163063701|NCT04537299|588939938|FG001|Overall Study|Withdrawal by Subject|0|||
163063702|NCT04537299|588939937|FG000|Overall Study|Protocol Violation|1|||
163216534|NCT00952341|589508011|FG001|Cycle 2|Withdrawal by Subject|1|||
163020707|NCT01314872|588778050|FG014|Treatment Period 1|Protocol Violation|0|||
163216535|NCT00952341|589508010|FG000|Cycle 2|Protocol Violation|1|||
163020708|NCT01314872|588778036|FG000|Treatment Period 1|Physician Decision|0|||
163020709|NCT01314872|588778037|FG001|Treatment Period 1|Physician Decision|1|||
163020710|NCT01314872|588778038|FG002|Treatment Period 1|Physician Decision|0|||
163020711|NCT01314872|588778039|FG003|Treatment Period 1|Physician Decision|1|||
163020712|NCT01314872|588778040|FG004|Treatment Period 1|Physician Decision|0|||
163020713|NCT01314872|588778041|FG005|Treatment Period 1|Physician Decision|0|||
163216536|NCT00952341|589508011|FG001|Cycle 2|Protocol Violation|0|||
163216537|NCT00952341|589508010|FG000|Cycle 2|Lost to Follow-up|6|||
163216538|NCT00952341|589508011|FG001|Cycle 2|Lost to Follow-up|9|||
163216539|NCT00952341|589508010|FG000|Cycle 2|Physician Decision|1|||
163216540|NCT00952341|589508011|FG001|Cycle 2|Physician Decision|1|||
163216541|NCT00952341|589508010|FG000|Cycle 2|Progressive Disease|0|||
163216542|NCT00952341|589508011|FG001|Cycle 2|Progressive Disease|1|||
163216543|NCT02066467|589508016|FG000|Overall Study|Did not undergo implant procedure|24|||
163216544|NCT02066467|589508016|FG000|Overall Study|Attempted to implant withoput success|43|||
163216545|NCT02066467|589508016|FG000|Overall Study|Consent ineligible|1|||
163216546|NCT02066467|589508016|FG000|Overall Study|Death|54|||
163216547|NCT02066467|589508016|FG000|Overall Study|Lost to Follow-up|51|||
163216548|NCT02066467|589508016|FG000|Overall Study|Adverse Event|20|||
163216549|NCT02066467|589508016|FG000|Overall Study|Withdrawal by Subject|16|||
163216550|NCT02066467|589508016|FG000|Overall Study|Physician Decision|2|||
163216551|NCT02066467|589508016|FG000|Overall Study|Not defined|4|||
163216552|NCT00483379|589508024|FG000|Treatment Period|Adverse Event|1|||
163216553|NCT00483379|589508025|FG001|Treatment Period|Adverse Event|0|||
163329530|NCT02499328|589916629|FG017|Overall Study|"Other"|34|||
163020714|NCT01314872|588778042|FG006|Treatment Period 1|Physician Decision|0|||
163020715|NCT01314872|588778043|FG007|Treatment Period 1|Physician Decision|0|||
163020716|NCT01314872|588778044|FG008|Treatment Period 1|Physician Decision|0|||
163020717|NCT01314872|588778045|FG009|Treatment Period 1|Physician Decision|1|||
163020718|NCT01314872|588778046|FG010|Treatment Period 1|Physician Decision|0|||
163020719|NCT01314872|588778047|FG011|Treatment Period 1|Physician Decision|0|||
163020720|NCT01314872|588778048|FG012|Treatment Period 1|Physician Decision|0|||
163020721|NCT01314872|588778049|FG013|Treatment Period 1|Physician Decision|0|||
163020722|NCT01314872|588778050|FG014|Treatment Period 1|Physician Decision|0|||
163020723|NCT01314872|588778036|FG000|Treatment Period 1|Lack of Efficacy|1|||
163020724|NCT01314872|588778037|FG001|Treatment Period 1|Lack of Efficacy|0|||
163020725|NCT01314872|588778038|FG002|Treatment Period 1|Lack of Efficacy|0|||
163020726|NCT01314872|588778039|FG003|Treatment Period 1|Lack of Efficacy|0|||
163020727|NCT01314872|588778040|FG004|Treatment Period 1|Lack of Efficacy|0|||
163020728|NCT01314872|588778041|FG005|Treatment Period 1|Lack of Efficacy|1|||
163020729|NCT01314872|588778042|FG006|Treatment Period 1|Lack of Efficacy|0|||
163020730|NCT01314872|588778043|FG007|Treatment Period 1|Lack of Efficacy|2|||
163020731|NCT01314872|588778044|FG008|Treatment Period 1|Lack of Efficacy|0|||
163020732|NCT01314872|588778045|FG009|Treatment Period 1|Lack of Efficacy|0|||
163020733|NCT01314872|588778046|FG010|Treatment Period 1|Lack of Efficacy|0|||
163020734|NCT01314872|588778047|FG011|Treatment Period 1|Lack of Efficacy|0|||
163020735|NCT01314872|588778048|FG012|Treatment Period 1|Lack of Efficacy|0|||
163020736|NCT01314872|588778049|FG013|Treatment Period 1|Lack of Efficacy|0|||
163020737|NCT01314872|588778050|FG014|Treatment Period 1|Lack of Efficacy|0|||
163020738|NCT01314872|588778036|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
163020739|NCT01314872|588778037|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
163020740|NCT01314872|588778038|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
163020741|NCT01314872|588778039|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
163020742|NCT01314872|588778040|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
163020743|NCT01314872|588778041|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
163020744|NCT01314872|588778042|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
163020745|NCT01314872|588778043|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
163020746|NCT01314872|588778044|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
163020747|NCT01314872|588778045|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
163020748|NCT01314872|588778046|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
163020749|NCT01314872|588778047|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
163020750|NCT01314872|588778048|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
163020751|NCT01314872|588778049|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
163020752|NCT01314872|588778050|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
163020753|NCT01314872|588778036|FG000|Treatment Period 1|Withdrawal by Subject|3|||
163020754|NCT01314872|588778037|FG001|Treatment Period 1|Withdrawal by Subject|1|||
163020755|NCT01314872|588778038|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163020756|NCT01314872|588778039|FG003|Treatment Period 1|Withdrawal by Subject|2|||
163020757|NCT01314872|588778040|FG004|Treatment Period 1|Withdrawal by Subject|3|||
163020758|NCT01314872|588778041|FG005|Treatment Period 1|Withdrawal by Subject|1|||
163020759|NCT01314872|588778042|FG006|Treatment Period 1|Withdrawal by Subject|3|||
163020760|NCT01314872|588778043|FG007|Treatment Period 1|Withdrawal by Subject|2|||
163020761|NCT01314872|588778044|FG008|Treatment Period 1|Withdrawal by Subject|2|||
163020762|NCT01314872|588778045|FG009|Treatment Period 1|Withdrawal by Subject|2|||
163020763|NCT01314872|588778046|FG010|Treatment Period 1|Withdrawal by Subject|1|||
163020764|NCT01314872|588778047|FG011|Treatment Period 1|Withdrawal by Subject|0|||
163329531|NCT02499328|589916630|FG018|Overall Study|"Other"|43|||
163329532|NCT02499328|589916612|FG000|Overall Study|Disease Progression|0|||
163329533|NCT02499328|589916613|FG001|Overall Study|Disease Progression|0|||
163329534|NCT02499328|589916614|FG002|Overall Study|Disease Progression|0|||
163329535|NCT02499328|589916615|FG003|Overall Study|Disease Progression|0|||
163329536|NCT02499328|589916616|FG004|Overall Study|Disease Progression|0|||
163020765|NCT01314872|588778048|FG012|Treatment Period 1|Withdrawal by Subject|0|||
163020766|NCT01314872|588778049|FG013|Treatment Period 1|Withdrawal by Subject|0|||
163020767|NCT01314872|588778050|FG014|Treatment Period 1|Withdrawal by Subject|0|||
163020768|NCT01314872|588778036|FG000|Treatment Period 1|Lost to Follow-up|0|||
163020769|NCT01314872|588778037|FG001|Treatment Period 1|Lost to Follow-up|1|||
163020770|NCT01314872|588778038|FG002|Treatment Period 1|Lost to Follow-up|2|||
163020771|NCT01314872|588778039|FG003|Treatment Period 1|Lost to Follow-up|2|||
163020772|NCT01314872|588778040|FG004|Treatment Period 1|Lost to Follow-up|1|||
163020773|NCT01314872|588778041|FG005|Treatment Period 1|Lost to Follow-up|1|||
163020774|NCT01314872|588778042|FG006|Treatment Period 1|Lost to Follow-up|1|||
163329537|NCT02499328|589916617|FG005|Overall Study|Disease Progression|0|||
163329538|NCT02499328|589916618|FG006|Overall Study|Disease Progression|1|||
163329539|NCT02499328|589916619|FG007|Overall Study|Disease Progression|0|||
163329540|NCT02499328|589916620|FG008|Overall Study|Disease Progression|1|||
163020775|NCT01314872|588778043|FG007|Treatment Period 1|Lost to Follow-up|1|||
163020776|NCT01314872|588778044|FG008|Treatment Period 1|Lost to Follow-up|1|||
163020777|NCT01314872|588778045|FG009|Treatment Period 1|Lost to Follow-up|0|||
163063703|NCT04537299|588939938|FG001|Overall Study|Protocol Violation|1|||
163063704|NCT00876343|588939951|FG000|Overall Study|Adverse Event|7|||
163063705|NCT00876343|588939952|FG001|Overall Study|Adverse Event|8|||
163063706|NCT00876343|588939953|FG002|Overall Study|Adverse Event|2|||
163063707|NCT00876343|588939951|FG000|Overall Study|Withdrawal by Subject|4|||
163063708|NCT00876343|588939952|FG001|Overall Study|Withdrawal by Subject|4|||
163216554|NCT00483379|589508024|FG000|Treatment Period|Withdrawal by Subject|1|||
163216555|NCT00483379|589508025|FG001|Treatment Period|Withdrawal by Subject|0|||
163216556|NCT02418468|589508027|FG000|Overall Study|Adverse Event|1|||
163216557|NCT02418468|589508028|FG001|Overall Study|Adverse Event|0|||
163216558|NCT02418468|589508027|FG000|Overall Study|Withdrawal of informed consent|1|||
163216559|NCT02418468|589508028|FG001|Overall Study|Withdrawal of informed consent|1|||
163216560|NCT02914769|589508029|FG000|Overall Study|Protocol Violation|3|||
163216561|NCT02914769|589508030|FG001|Overall Study|Protocol Violation|2|||
163216562|NCT02914769|589508029|FG000|Overall Study|Withdrawal by Subject|0|||
163216563|NCT02914769|589508030|FG001|Overall Study|Withdrawal by Subject|1|||
163216564|NCT02337907|589508031|FG000|Overall Study|Other than listed|1|||
163216565|NCT02337907|589508032|FG001|Overall Study|Other than listed|0|||
163216566|NCT02337907|589508033|FG002|Overall Study|Other than listed|0|||
163216567|NCT02337907|589508034|FG003|Overall Study|Other than listed|1|||
163216568|NCT02337907|589508035|FG004|Overall Study|Other than listed|1|||
163216569|NCT02337907|589508036|FG005|Overall Study|Other than listed|0|||
163216570|NCT02337907|589508031|FG000|Overall Study|Withdrawal by Subject|2|||
163216571|NCT02337907|589508032|FG001|Overall Study|Withdrawal by Subject|3|||
163216572|NCT02337907|589508033|FG002|Overall Study|Withdrawal by Subject|0|||
163216573|NCT02337907|589508034|FG003|Overall Study|Withdrawal by Subject|2|||
163216574|NCT02337907|589508035|FG004|Overall Study|Withdrawal by Subject|5|||
163216575|NCT02337907|589508036|FG005|Overall Study|Withdrawal by Subject|0|||
163216576|NCT02337907|589508031|FG000|Overall Study|Lost to Follow-up|0|||
163216577|NCT02337907|589508032|FG001|Overall Study|Lost to Follow-up|0|||
163216578|NCT02337907|589508033|FG002|Overall Study|Lost to Follow-up|0|||
163216579|NCT02337907|589508034|FG003|Overall Study|Lost to Follow-up|0|||
163216580|NCT02337907|589508035|FG004|Overall Study|Lost to Follow-up|0|||
163216581|NCT02337907|589508036|FG005|Overall Study|Lost to Follow-up|1|||
163216582|NCT02337907|589508031|FG000|Overall Study|Adverse Event|1|||
163216583|NCT02337907|589508032|FG001|Overall Study|Adverse Event|1|||
163216584|NCT02337907|589508033|FG002|Overall Study|Adverse Event|1|||
163216585|NCT02337907|589508034|FG003|Overall Study|Adverse Event|1|||
163216586|NCT02337907|589508035|FG004|Overall Study|Adverse Event|4|||
163216587|NCT02337907|589508036|FG005|Overall Study|Adverse Event|0|||
163216588|NCT01592344|589508037|FG000|Overall Study|Adverse Event|1|||
163216589|NCT01592344|589508038|FG001|Overall Study|Adverse Event|1|||
163216590|NCT01592344|589508037|FG000|Overall Study|Lack of Efficacy|1|||
163216591|NCT01592344|589508038|FG001|Overall Study|Lack of Efficacy|0|||
163216592|NCT01592344|589508037|FG000|Overall Study|not available at primary outcome visit|2|||
163216593|NCT01592344|589508038|FG001|Overall Study|not available at primary outcome visit|4|||
163216594|NCT00099437|589508039|FG000|Overall Study|Lost to Follow-up|30|||
163216595|NCT00099437|589508040|FG001|Overall Study|Lost to Follow-up|33|||
163216596|NCT00099437|589508039|FG000|Overall Study|Death|293|||
163216597|NCT00099437|589508040|FG001|Overall Study|Death|261|||
163216598|NCT00099437|589508039|FG000|Overall Study|Withdrawal by Subject|6|||
163216599|NCT00099437|589508040|FG001|Overall Study|Withdrawal by Subject|10|||
163216600|NCT00099437|589508039|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
163216601|NCT00099437|589508040|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
163216602|NCT02738333|589508041|FG000|Overall Study|Death|1|||
163216603|NCT02738333|589508042|FG001|Overall Study|Death|0|||
163216604|NCT02738333|589508043|FG002|Overall Study|Death|0|||
163216605|NCT02738333|589508041|FG000|Overall Study|Lost to Follow-up|1|||
163216606|NCT02738333|589508042|FG001|Overall Study|Lost to Follow-up|0|||
163216607|NCT02738333|589508043|FG002|Overall Study|Lost to Follow-up|0|||
163216608|NCT00949325|589508044|FG000|Overall Study|Adverse Event|0|||
163216609|NCT00949325|589508045|FG001|Overall Study|Adverse Event|2|||
163216610|NCT00949325|589508046|FG002|Overall Study|Adverse Event|0|||
163216611|NCT03311659|589508051|FG000|Overall Study|Protocol Violation|1|||
163063709|NCT00876343|588939953|FG002|Overall Study|Withdrawal by Subject|3|||
163216612|NCT04327388|589508052|FG000|Overall Study|Adverse Event|17|||
163216613|NCT04327388|589508053|FG001|Overall Study|Adverse Event|18|||
163216614|NCT04327388|589508054|FG002|Overall Study|Adverse Event|9|||
163216615|NCT04327388|589508052|FG000|Overall Study|Other|1|||
163216616|NCT04327388|589508053|FG001|Overall Study|Other|2|||
163216617|NCT04327388|589508054|FG002|Overall Study|Other|0|||
163216618|NCT04327388|589508052|FG000|Overall Study|Randomized and not treated|2|||
163216619|NCT04327388|589508053|FG001|Overall Study|Randomized and not treated|0|||
163216620|NCT04327388|589508054|FG002|Overall Study|Randomized and not treated|2|||
163216621|NCT04829318|589508055|FG000|Overall Study|Adverse Event|6|||
163216622|NCT04829318|589508055|FG000|Overall Study|Death|1|||
163216623|NCT04829318|589508055|FG000|Overall Study|Lost to Follow-up|1|||
163216624|NCT04829318|589508055|FG000|Overall Study|Physician Decision|1|||
163216625|NCT04829318|589508055|FG000|Overall Study|Withdrawal by Subject|19|||
163329541|NCT02499328|589916621|FG009|Overall Study|Disease Progression|0|||
163329542|NCT02499328|589916622|FG010|Overall Study|Disease Progression|1|||
163329543|NCT02499328|589916623|FG011|Overall Study|Disease Progression|0|||
163329544|NCT02499328|589916624|FG012|Overall Study|Disease Progression|0|||
163329545|NCT02499328|589916625|FG013|Overall Study|Disease Progression|0|||
163329546|NCT02499328|589916626|FG014|Overall Study|Disease Progression|0|||
163329547|NCT02499328|589916627|FG015|Overall Study|Disease Progression|0|||
163329548|NCT02499328|589916628|FG016|Overall Study|Disease Progression|0|||
163329549|NCT02499328|589916629|FG017|Overall Study|Disease Progression|2|||
163329550|NCT02499328|589916630|FG018|Overall Study|Disease Progression|0|||
163329551|NCT02499328|589916612|FG000|Overall Study|Adverse Event|1|||
163329552|NCT02499328|589916613|FG001|Overall Study|Adverse Event|0|||
163063710|NCT00876343|588939951|FG000|Overall Study|Lack of Efficacy|0|||
163216626|NCT04829318|589508055|FG000|Overall Study|Site terminated by sponsor|1|||
163216627|NCT04829318|589508055|FG000|Overall Study|Sponsor decision|5|||
163216628|NCT04829318|589508055|FG000|Overall Study|Other|1|||
163216629|NCT00728130|589508056|FG000|Overall Study|Withdrawal by Subject|1|||
163216630|NCT00728130|589508056|FG000|Overall Study|Paperwork not completed in time|1|||
163216631|NCT00728130|589508056|FG000|Overall Study|Physician Decision|1|||
163216632|NCT04053023|589508057|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
163216633|NCT04053023|589508058|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
163216634|NCT03447990|589508059|FG000|Overall Study|Withdrawal by Subject|0|||
163216635|NCT03447990|589508060|FG001|Overall Study|Withdrawal by Subject|0|||
163216636|NCT03447990|589508061|FG002|Overall Study|Withdrawal by Subject|0|||
163216637|NCT03447990|589508062|FG003|Overall Study|Withdrawal by Subject|0|||
163216638|NCT03447990|589508063|FG004|Overall Study|Withdrawal by Subject|0|||
163216639|NCT03447990|589508064|FG005|Overall Study|Withdrawal by Subject|0|||
163216640|NCT03447990|589508065|FG006|Overall Study|Withdrawal by Subject|1|||
163216641|NCT00423150|589508067|FG000|Overall Study|Adverse Event|11|||
163216642|NCT00423150|589508067|FG000|Overall Study|Progression of disease being studied|69|||
163216643|NCT00423150|589508067|FG000|Overall Study|Withdrawal by Subject|1|||
163216644|NCT00423150|589508067|FG000|Overall Study|Non-compliance with protocol|1|||
163216645|NCT00423150|589508067|FG000|Overall Study|Administrative|4|||
163216646|NCT05104567|589508069|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
163216647|NCT05104567|589508070|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
163216648|NCT05104567|589508071|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
163216649|NCT05104567|589508072|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
163216650|NCT05104567|589508073|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
163216651|NCT05104567|589508074|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
163216652|NCT05104567|589508075|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
163216653|NCT05104567|589508069|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
163216654|NCT05104567|589508070|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
163216655|NCT05104567|589508071|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
163216656|NCT05104567|589508072|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
163216657|NCT05104567|589508073|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
163216658|NCT05104567|589508074|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
163216659|NCT05104567|589508075|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
163216660|NCT05104567|589508069|FG000|Overall Study|Progressive disease|3|||
163216661|NCT05104567|589508070|FG001|Overall Study|Progressive disease|13|||
163216662|NCT05104567|589508071|FG002|Overall Study|Progressive disease|13|||
163216663|NCT05104567|589508072|FG003|Overall Study|Progressive disease|17|||
163216664|NCT05104567|589508073|FG004|Overall Study|Progressive disease|17|||
163216665|NCT05104567|589508074|FG005|Overall Study|Progressive disease|28|||
163216666|NCT05104567|589508075|FG006|Overall Study|Progressive disease|24|||
163216667|NCT05104567|589508069|FG000|Overall Study|Withdrawal by Subject|1|||
163216668|NCT05104567|589508070|FG001|Overall Study|Withdrawal by Subject|1|||
163216669|NCT05104567|589508071|FG002|Overall Study|Withdrawal by Subject|2|||
163216670|NCT05104567|589508072|FG003|Overall Study|Withdrawal by Subject|0|||
163216671|NCT05104567|589508073|FG004|Overall Study|Withdrawal by Subject|0|||
163216672|NCT05104567|589508074|FG005|Overall Study|Withdrawal by Subject|0|||
163216673|NCT05104567|589508075|FG006|Overall Study|Withdrawal by Subject|0|||
163216674|NCT05104567|589508069|FG000|Overall Study|Other|1|||
163216675|NCT05104567|589508070|FG001|Overall Study|Other|1|||
163216676|NCT05104567|589508071|FG002|Overall Study|Other|1|||
163216677|NCT05104567|589508072|FG003|Overall Study|Other|0|||
163216678|NCT05104567|589508073|FG004|Overall Study|Other|0|||
163216679|NCT05104567|589508074|FG005|Overall Study|Other|0|||
163216680|NCT05104567|589508075|FG006|Overall Study|Other|0|||
163216681|NCT01464346|589508076|FG000|Overall Study|Withdrawal by Subject|0|||
163216682|NCT01464346|589508077|FG001|Overall Study|Withdrawal by Subject|0|||
163216683|NCT01464346|589508078|FG002|Overall Study|Withdrawal by Subject|1|||
163216684|NCT03999892|589508079|FG000|Overall Study|Lost to Follow-up|1|||
163063711|NCT00876343|588939952|FG001|Overall Study|Lack of Efficacy|0|||
163063712|NCT00876343|588939953|FG002|Overall Study|Lack of Efficacy|1|||
163063713|NCT00876343|588939951|FG000|Overall Study|Protocol Violation|4|||
163063714|NCT00876343|588939952|FG001|Overall Study|Protocol Violation|1|||
163063715|NCT00876343|588939953|FG002|Overall Study|Protocol Violation|1|||
163063716|NCT00876343|588939951|FG000|Overall Study|Physician Decision|0|||
163216685|NCT01848756|589508080|FG000|Overall Study|Adverse Event|1|||
163063717|NCT00876343|588939952|FG001|Overall Study|Physician Decision|1|||
163063718|NCT00876343|588939953|FG002|Overall Study|Physician Decision|1|||
163063719|NCT00876343|588939951|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
163216686|NCT01848756|589508080|FG000|Overall Study|Withdrawal by Subject|1|||
163216687|NCT01848756|589508080|FG000|Overall Study|Enrolled in Error|1|||
163216688|NCT01286012|589508081|FG000|Overall Study|Adverse Event|3|||
163216689|NCT01286012|589508082|FG001|Overall Study|Adverse Event|3|||
163216690|NCT01286012|589508081|FG000|Overall Study|Death|2|||
163216691|NCT01286012|589508082|FG001|Overall Study|Death|3|||
163216692|NCT01286012|589508081|FG000|Overall Study|Protocol Violation|1|||
163216693|NCT01286012|589508082|FG001|Overall Study|Protocol Violation|1|||
163216694|NCT01286012|589508081|FG000|Overall Study|Withdrawal by Subject|4|||
163216695|NCT01286012|589508082|FG001|Overall Study|Withdrawal by Subject|4|||
163216696|NCT01286012|589508081|FG000|Overall Study|Physician Decision|2|||
163216697|NCT01286012|589508082|FG001|Overall Study|Physician Decision|0|||
163216698|NCT01286012|589508081|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
163216699|NCT01286012|589508082|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
163216700|NCT04056195|589508085|FG000|Overall Study|Adverse Event|1|||
163216701|NCT04056195|589508086|FG001|Overall Study|Adverse Event|0|||
163216702|NCT04056195|589508087|FG002|Overall Study|Adverse Event|0|||
163216703|NCT04056195|589508085|FG000|Overall Study|Withdrawal by Subject|0|||
163216704|NCT04056195|589508086|FG001|Overall Study|Withdrawal by Subject|1|||
163216705|NCT04056195|589508087|FG002|Overall Study|Withdrawal by Subject|1|||
163216706|NCT04056195|589508085|FG000|Overall Study|Physician Decision|1|||
163216707|NCT04056195|589508086|FG001|Overall Study|Physician Decision|1|||
163216708|NCT04056195|589508087|FG002|Overall Study|Physician Decision|1|||
163216709|NCT01498458|589508088|FG000|Overall Study|Adverse Event|4|||
163216710|NCT01498458|589508088|FG000|Overall Study|Physician Decision|3|||
163216711|NCT02226003|589508089|FG000|Overall Study|Lost to Follow-up|2|||
163216712|NCT02226003|589508090|FG001|Overall Study|Lost to Follow-up|1|||
163216713|NCT02226003|589508091|FG002|Overall Study|Lost to Follow-up|3|||
163216714|NCT02226003|589508089|FG000|Overall Study|Withdrawal by Subject|0|||
163216715|NCT02226003|589508090|FG001|Overall Study|Withdrawal by Subject|0|||
163216716|NCT02226003|589508091|FG002|Overall Study|Withdrawal by Subject|3|||
163216717|NCT03279692|589508097|FG000|Overall Study|Withdrawal by Subject|1|||
163216718|NCT02446990|589508100|FG000|Overall Study|Death|485|||
163216719|NCT02446990|589508101|FG001|Overall Study|Death|458|||
163216720|NCT02446990|589508100|FG000|Overall Study|Lost to Follow-up|3|||
163216721|NCT02446990|589508101|FG001|Overall Study|Lost to Follow-up|1|||
163216722|NCT02446990|589508100|FG000|Overall Study|Physician Decision|1|||
163216723|NCT02446990|589508101|FG001|Overall Study|Physician Decision|0|||
163216724|NCT02446990|589508100|FG000|Overall Study|Withdrawal by Subject|231|||
163216725|NCT02446990|589508101|FG001|Overall Study|Withdrawal by Subject|199|||
163216726|NCT01064401|589508102|FG000|Overall Study|Adverse Event|47|||
163216727|NCT01064401|589508103|FG001|Overall Study|Adverse Event|56|||
163216728|NCT01064401|589508102|FG000|Overall Study|Lack of Efficacy|46|||
163216729|NCT01064401|589508103|FG001|Overall Study|Lack of Efficacy|23|||
163216730|NCT01064401|589508102|FG000|Overall Study|Lost to Follow-up|12|||
163216731|NCT01064401|589508103|FG001|Overall Study|Lost to Follow-up|9|||
163216732|NCT01064401|589508102|FG000|Overall Study|Consent Withdrawn|98|||
163216733|NCT01064401|589508103|FG001|Overall Study|Consent Withdrawn|80|||
163216734|NCT01064401|589508102|FG000|Overall Study|Investigator Decision|4|||
163216735|NCT01064401|589508103|FG001|Overall Study|Investigator Decision|6|||
163216736|NCT01064401|589508102|FG000|Overall Study|Death|4|||
163216737|NCT01064401|589508103|FG001|Overall Study|Death|0|||
163216738|NCT01064401|589508102|FG000|Overall Study|Pregnancy|4|||
163216739|NCT01064401|589508103|FG001|Overall Study|Pregnancy|7|||
163216740|NCT01064401|589508102|FG000|Overall Study|Noncompliance|7|||
163216741|NCT01064401|589508103|FG001|Overall Study|Noncompliance|8|||
163216742|NCT01064401|589508102|FG000|Overall Study|Site Closure|4|||
163216743|NCT01064401|589508103|FG001|Overall Study|Site Closure|5|||
163216744|NCT01064401|589508102|FG000|Overall Study|Other|2|||
163216745|NCT01064401|589508103|FG001|Overall Study|Other|1|||
163216746|NCT02588833|589508104|FG000|Part 1|Withdrawal by Subject|1|||
163216747|NCT02588833|589508105|FG001|Part 1|Withdrawal by Subject|0|||
163216748|NCT02588833|589508104|FG000|Part 2A|Physician Decision|0|||
163216749|NCT02588833|589508105|FG001|Part 2A|Physician Decision|1|||
163216750|NCT02588833|589508104|FG000|Part 2A|Withdrawal by Subject|0|||
163216751|NCT02588833|589508105|FG001|Part 2A|Withdrawal by Subject|1|||
163216752|NCT02588833|589508104|FG000|Part 2B|Adverse Event|0|||
163216753|NCT02588833|589508105|FG001|Part 2B|Adverse Event|1|||
163329553|NCT02499328|589916614|FG002|Overall Study|Adverse Event|0|||
163329554|NCT02499328|589916615|FG003|Overall Study|Adverse Event|1|||
163329555|NCT02499328|589916616|FG004|Overall Study|Adverse Event|0|||
163329556|NCT02499328|589916617|FG005|Overall Study|Adverse Event|0|||
163329557|NCT02499328|589916618|FG006|Overall Study|Adverse Event|0|||
163329558|NCT02499328|589916619|FG007|Overall Study|Adverse Event|0|||
163329559|NCT02499328|589916620|FG008|Overall Study|Adverse Event|0|||
163329560|NCT02499328|589916621|FG009|Overall Study|Adverse Event|0|||
163329561|NCT02499328|589916622|FG010|Overall Study|Adverse Event|0|||
163329562|NCT02499328|589916623|FG011|Overall Study|Adverse Event|0|||
163329563|NCT02499328|589916624|FG012|Overall Study|Adverse Event|1|||
163329564|NCT02499328|589916625|FG013|Overall Study|Adverse Event|0|||
163329565|NCT02499328|589916626|FG014|Overall Study|Adverse Event|0|||
163329566|NCT02499328|589916627|FG015|Overall Study|Adverse Event|0|||
163329567|NCT02499328|589916628|FG016|Overall Study|Adverse Event|0|||
163329568|NCT02499328|589916629|FG017|Overall Study|Adverse Event|0|||
163329569|NCT02499328|589916630|FG018|Overall Study|Adverse Event|0|||
163329570|NCT03611075|589916634|FG000|Overall Study|Physician Decision|0|||
163329571|NCT03611075|589916635|FG001|Overall Study|Physician Decision|1|||
163329572|NCT03611075|589916636|FG002|Overall Study|Physician Decision|1|||
163329573|NCT03611075|589916637|FG003|Overall Study|Physician Decision|0|||
163329574|NCT03611075|589916638|FG004|Overall Study|Physician Decision|0|||
163329575|NCT03611075|589916639|FG005|Overall Study|Physician Decision|0|||
163329576|NCT03611075|589916640|FG006|Overall Study|Physician Decision|0|||
163329577|NCT03611075|589916641|FG007|Overall Study|Physician Decision|0|||
163329578|NCT03611075|589916642|FG008|Overall Study|Physician Decision|0|||
163329579|NCT03611075|589916634|FG000|Overall Study|Lost to Follow-up|1|||
163020778|NCT01314872|588778046|FG010|Treatment Period 1|Lost to Follow-up|0|||
163020779|NCT01314872|588778047|FG011|Treatment Period 1|Lost to Follow-up|0|||
163020780|NCT01314872|588778048|FG012|Treatment Period 1|Lost to Follow-up|0|||
163020781|NCT01314872|588778049|FG013|Treatment Period 1|Lost to Follow-up|0|||
163020782|NCT01314872|588778050|FG014|Treatment Period 1|Lost to Follow-up|0|||
163020783|NCT01314872|588778036|FG000|Period 2|Protocol Violation|0|||
163020784|NCT01314872|588778037|FG001|Period 2|Protocol Violation|0|||
163020785|NCT01314872|588778038|FG002|Period 2|Protocol Violation|0|||
163020786|NCT01314872|588778039|FG003|Period 2|Protocol Violation|0|||
163020787|NCT01314872|588778040|FG004|Period 2|Protocol Violation|0|||
163020788|NCT01314872|588778041|FG005|Period 2|Protocol Violation|0|||
163020789|NCT01314872|588778042|FG006|Period 2|Protocol Violation|0|||
163020790|NCT01314872|588778043|FG007|Period 2|Protocol Violation|0|||
163020791|NCT01314872|588778044|FG008|Period 2|Protocol Violation|0|||
163020792|NCT01314872|588778045|FG009|Period 2|Protocol Violation|0|||
163020793|NCT01314872|588778046|FG010|Period 2|Protocol Violation|0|||
163020794|NCT01314872|588778047|FG011|Period 2|Protocol Violation|3|||
163020795|NCT01314872|588778048|FG012|Period 2|Protocol Violation|3|||
163020796|NCT01314872|588778049|FG013|Period 2|Protocol Violation|2|||
163020797|NCT01314872|588778050|FG014|Period 2|Protocol Violation|0|||
163020798|NCT01314872|588778036|FG000|Period 2|Non-compliance with study drug|0|||
163329580|NCT03611075|589916635|FG001|Overall Study|Lost to Follow-up|0|||
163329581|NCT03611075|589916636|FG002|Overall Study|Lost to Follow-up|0|||
163020799|NCT01314872|588778037|FG001|Period 2|Non-compliance with study drug|0|||
163020800|NCT01314872|588778038|FG002|Period 2|Non-compliance with study drug|0|||
163020801|NCT01314872|588778039|FG003|Period 2|Non-compliance with study drug|0|||
163020802|NCT01314872|588778040|FG004|Period 2|Non-compliance with study drug|0|||
163020803|NCT01314872|588778041|FG005|Period 2|Non-compliance with study drug|0|||
163020804|NCT01314872|588778042|FG006|Period 2|Non-compliance with study drug|0|||
163020805|NCT01314872|588778043|FG007|Period 2|Non-compliance with study drug|0|||
163020806|NCT01314872|588778044|FG008|Period 2|Non-compliance with study drug|0|||
163020807|NCT01314872|588778045|FG009|Period 2|Non-compliance with study drug|0|||
163020808|NCT01314872|588778046|FG010|Period 2|Non-compliance with study drug|0|||
163020809|NCT01314872|588778047|FG011|Period 2|Non-compliance with study drug|3|||
163020810|NCT01314872|588778048|FG012|Period 2|Non-compliance with study drug|3|||
163020811|NCT01314872|588778049|FG013|Period 2|Non-compliance with study drug|1|||
163020812|NCT01314872|588778050|FG014|Period 2|Non-compliance with study drug|2|||
163020813|NCT01314872|588778036|FG000|Period 2|Lack of Efficacy|0|||
163329582|NCT03611075|589916637|FG003|Overall Study|Lost to Follow-up|2|||
163329583|NCT03611075|589916638|FG004|Overall Study|Lost to Follow-up|0|||
163329584|NCT03611075|589916639|FG005|Overall Study|Lost to Follow-up|0|||
163020814|NCT01314872|588778037|FG001|Period 2|Lack of Efficacy|0|||
163020815|NCT01314872|588778038|FG002|Period 2|Lack of Efficacy|0|||
163020816|NCT01314872|588778039|FG003|Period 2|Lack of Efficacy|0|||
163020817|NCT01314872|588778040|FG004|Period 2|Lack of Efficacy|0|||
163329585|NCT03611075|589916640|FG006|Overall Study|Lost to Follow-up|0|||
163329586|NCT03611075|589916641|FG007|Overall Study|Lost to Follow-up|0|||
163329587|NCT03611075|589916642|FG008|Overall Study|Lost to Follow-up|0|||
163329588|NCT03611075|589916634|FG000|Overall Study|Withdrawal by Subject|0|||
163329589|NCT03611075|589916635|FG001|Overall Study|Withdrawal by Subject|1|||
163329590|NCT03611075|589916636|FG002|Overall Study|Withdrawal by Subject|1|||
163329591|NCT03611075|589916637|FG003|Overall Study|Withdrawal by Subject|1|||
163329592|NCT03611075|589916638|FG004|Overall Study|Withdrawal by Subject|0|||
163329593|NCT03611075|589916639|FG005|Overall Study|Withdrawal by Subject|0|||
163329594|NCT03611075|589916640|FG006|Overall Study|Withdrawal by Subject|1|||
163329595|NCT03611075|589916641|FG007|Overall Study|Withdrawal by Subject|0|||
163329596|NCT03611075|589916642|FG008|Overall Study|Withdrawal by Subject|0|||
163329597|NCT03611075|589916634|FG000|Overall Study|Reason unknown|0|||
163329598|NCT03611075|589916635|FG001|Overall Study|Reason unknown|0|||
163329599|NCT03611075|589916636|FG002|Overall Study|Reason unknown|0|||
163329600|NCT03611075|589916637|FG003|Overall Study|Reason unknown|1|||
163329601|NCT03611075|589916638|FG004|Overall Study|Reason unknown|0|||
163329602|NCT03611075|589916639|FG005|Overall Study|Reason unknown|0|||
163329603|NCT03611075|589916640|FG006|Overall Study|Reason unknown|1|||
163329604|NCT03611075|589916641|FG007|Overall Study|Reason unknown|0|||
163329605|NCT03611075|589916642|FG008|Overall Study|Reason unknown|0|||
163329606|NCT02972359|589916643|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
163329607|NCT02972359|589916643|FG000|Overall Study|Lack of Efficacy|1|||
163329608|NCT02972359|589916643|FG000|Overall Study|Adverse Event|4|||
163329609|NCT02972359|589916643|FG000|Overall Study|Death|1|||
163329610|NCT02972359|589916643|FG000|Overall Study|Withdrawal by Subject|30|||
163329611|NCT02972359|589916643|FG000|Overall Study|Protocol Violation|1|||
163329612|NCT02972359|589916643|FG000|Overall Study|Lost to Follow-up|26|||
163329613|NCT02972359|589916643|FG000|Overall Study|Other reasons|5|||
163329614|NCT02972359|589916643|FG000|Overall Study|Missing|1|||
163329615|NCT03488719|589916644|FG000|Overall Study|Adverse Event|0|||
163329616|NCT03488719|589916645|FG001|Overall Study|Adverse Event|4|||
163329617|NCT03488719|589916646|FG002|Overall Study|Adverse Event|2|||
163329618|NCT03488719|589916644|FG000|Overall Study|Other|0|||
163329619|NCT03488719|589916645|FG001|Overall Study|Other|0|||
163329620|NCT03488719|589916646|FG002|Overall Study|Other|5|||
163329621|NCT04801420|589916651|FG000|Overall Study|Other|1|||
163329622|NCT04801420|589916652|FG001|Overall Study|Other|2|||
163329623|NCT04801420|589916653|FG002|Overall Study|Other|1|||
163329624|NCT04801420|589916651|FG000|Overall Study|Lost to Follow-up|7|||
163329625|NCT04801420|589916652|FG001|Overall Study|Lost to Follow-up|9|||
163329626|NCT04801420|589916653|FG002|Overall Study|Lost to Follow-up|10|||
163329627|NCT04801420|589916651|FG000|Overall Study|Moved from study area|0|||
163329628|NCT04801420|589916652|FG001|Overall Study|Moved from study area|1|||
163329629|NCT04801420|589916653|FG002|Overall Study|Moved from study area|1|||
163329630|NCT04801420|589916651|FG000|Overall Study|Withdrawal by Subject|5|||
163329631|NCT04801420|589916652|FG001|Overall Study|Withdrawal by Subject|1|||
163329632|NCT04801420|589916653|FG002|Overall Study|Withdrawal by Subject|4|||
163329633|NCT04801420|589916651|FG000|Overall Study|Individual stopping criteria reached|0|||
163329634|NCT04801420|589916652|FG001|Overall Study|Individual stopping criteria reached|1|||
163329635|NCT04801420|589916653|FG002|Overall Study|Individual stopping criteria reached|0|||
163329636|NCT04801420|589916651|FG000|Overall Study|Ongoing in the study|195|||
163329637|NCT04801420|589916652|FG001|Overall Study|Ongoing in the study|195|||
163329638|NCT04801420|589916653|FG002|Overall Study|Ongoing in the study|192|||
163329639|NCT03414684|589916654|FG000|First-course Treatment|Complete response|0|||
163329640|NCT03414684|589916655|FG001|First-course Treatment|Complete response|1|||
163329641|NCT03414684|589916654|FG000|First-course Treatment|Intercurrent illness|1|||
163329642|NCT03414684|589916655|FG001|First-course Treatment|Intercurrent illness|0|||
163329643|NCT03414684|589916654|FG000|First-course Treatment|Progressive Disease|31|||
163329644|NCT03414684|589916655|FG001|First-course Treatment|Progressive Disease|32|||
163329645|NCT03414684|589916654|FG000|First-course Treatment|Adverse Event|1|||
163329646|NCT03414684|589916655|FG001|First-course Treatment|Adverse Event|2|||
163329647|NCT03414684|589916654|FG000|First-course Treatment|Physician Decision|0|||
163329648|NCT03414684|589916655|FG001|First-course Treatment|Physician Decision|1|||
163329649|NCT03414684|589916654|FG000|First-course Treatment|Withdrawal by Subject|0|||
163329650|NCT03414684|589916655|FG001|First-course Treatment|Withdrawal by Subject|1|||
163020818|NCT01314872|588778041|FG005|Period 2|Lack of Efficacy|0|||
163020819|NCT01314872|588778042|FG006|Period 2|Lack of Efficacy|0|||
163329651|NCT03414684|589916654|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
163329652|NCT03414684|589916655|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
163329653|NCT03414684|589916654|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
163329654|NCT03414684|589916655|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
163020820|NCT01314872|588778043|FG007|Period 2|Lack of Efficacy|0|||
163329655|NCT03414684|589916654|FG000|First-course Treatment|Still on treatment|3|||
163329656|NCT03414684|589916655|FG001|First-course Treatment|Still on treatment|0|||
163329657|NCT03414684|589916654|FG000|First-course Treatment|Never started protocol therapy|2|||
163329658|NCT03414684|589916655|FG001|First-course Treatment|Never started protocol therapy|1|||
163329659|NCT03414684|589916654|FG000|Crossover Treatment|Progressive disease|0|||
163329660|NCT03414684|589916655|FG001|Crossover Treatment|Progressive disease|12|||
163020821|NCT01314872|588778044|FG008|Period 2|Lack of Efficacy|0|||
163329661|NCT03414684|589916654|FG000|Crossover Treatment|Adverse Event|0|||
163329662|NCT03414684|589916655|FG001|Crossover Treatment|Adverse Event|3|||
163329663|NCT03414684|589916654|FG000|Crossover Treatment|Physician Decision|0|||
163020822|NCT01314872|588778045|FG009|Period 2|Lack of Efficacy|0|||
163020823|NCT01314872|588778046|FG010|Period 2|Lack of Efficacy|0|||
163020824|NCT01314872|588778047|FG011|Period 2|Lack of Efficacy|7|||
163020825|NCT01314872|588778048|FG012|Period 2|Lack of Efficacy|12|||
163020826|NCT01314872|588778049|FG013|Period 2|Lack of Efficacy|9|||
163020827|NCT01314872|588778050|FG014|Period 2|Lack of Efficacy|2|||
163020828|NCT01314872|588778036|FG000|Period 2|Pregnancy|0|||
163020829|NCT01314872|588778037|FG001|Period 2|Pregnancy|0|||
163020830|NCT01314872|588778038|FG002|Period 2|Pregnancy|0|||
163020831|NCT01314872|588778039|FG003|Period 2|Pregnancy|0|||
163020832|NCT01314872|588778040|FG004|Period 2|Pregnancy|0|||
163020833|NCT01314872|588778041|FG005|Period 2|Pregnancy|0|||
163020834|NCT01314872|588778042|FG006|Period 2|Pregnancy|0|||
163020835|NCT01314872|588778043|FG007|Period 2|Pregnancy|0|||
163020836|NCT01314872|588778044|FG008|Period 2|Pregnancy|0|||
163020837|NCT01314872|588778045|FG009|Period 2|Pregnancy|0|||
163020838|NCT01314872|588778046|FG010|Period 2|Pregnancy|0|||
163020839|NCT01314872|588778047|FG011|Period 2|Pregnancy|0|||
163020840|NCT01314872|588778048|FG012|Period 2|Pregnancy|0|||
163020841|NCT01314872|588778049|FG013|Period 2|Pregnancy|0|||
163020842|NCT01314872|588778050|FG014|Period 2|Pregnancy|1|||
163020843|NCT01314872|588778036|FG000|Period 2|Study terminated by Sponsor|0|||
163020844|NCT01314872|588778037|FG001|Period 2|Study terminated by Sponsor|0|||
163020845|NCT01314872|588778038|FG002|Period 2|Study terminated by Sponsor|0|||
163020846|NCT01314872|588778039|FG003|Period 2|Study terminated by Sponsor|0|||
163020847|NCT01314872|588778040|FG004|Period 2|Study terminated by Sponsor|0|||
163020848|NCT01314872|588778041|FG005|Period 2|Study terminated by Sponsor|0|||
163020849|NCT01314872|588778042|FG006|Period 2|Study terminated by Sponsor|0|||
163020850|NCT01314872|588778043|FG007|Period 2|Study terminated by Sponsor|0|||
163020851|NCT01314872|588778044|FG008|Period 2|Study terminated by Sponsor|0|||
163020852|NCT01314872|588778045|FG009|Period 2|Study terminated by Sponsor|0|||
163020853|NCT01314872|588778046|FG010|Period 2|Study terminated by Sponsor|0|||
163020854|NCT01314872|588778047|FG011|Period 2|Study terminated by Sponsor|2|||
163020855|NCT01314872|588778048|FG012|Period 2|Study terminated by Sponsor|2|||
163020856|NCT01314872|588778049|FG013|Period 2|Study terminated by Sponsor|3|||
163020857|NCT01314872|588778050|FG014|Period 2|Study terminated by Sponsor|0|||
163020858|NCT01314872|588778036|FG000|Period 2|Adverse event, non-fatal|0|||
163020859|NCT01314872|588778037|FG001|Period 2|Adverse event, non-fatal|0|||
163020860|NCT01314872|588778038|FG002|Period 2|Adverse event, non-fatal|0|||
163329664|NCT03414684|589916655|FG001|Crossover Treatment|Physician Decision|1|||
163329665|NCT03414684|589916654|FG000|Crossover Treatment|Still on treatment|0|||
163329666|NCT03414684|589916655|FG001|Crossover Treatment|Still on treatment|2|||
163329667|NCT04038580|589916656|FG000|Washout 1|Death|0|||
163329668|NCT04038580|589916657|FG001|Washout 1|Death|0|||
163329669|NCT04038580|589916658|FG002|Washout 1|Death|0|||
163329670|NCT04038580|589916659|FG003|Washout 1|Death|1|||
163329671|NCT04038580|589916660|FG004|Washout 1|Death|0|||
163329672|NCT04038580|589916661|FG005|Washout 1|Death|0|||
163329673|NCT04038580|589916656|FG000|Washout 1|Withdrawal by Subject|0|||
163329674|NCT04038580|589916657|FG001|Washout 1|Withdrawal by Subject|0|||
163329675|NCT04038580|589916658|FG002|Washout 1|Withdrawal by Subject|0|||
163329676|NCT04038580|589916659|FG003|Washout 1|Withdrawal by Subject|0|||
163329677|NCT04038580|589916660|FG004|Washout 1|Withdrawal by Subject|1|||
163020861|NCT01314872|588778039|FG003|Period 2|Adverse event, non-fatal|0|||
163020862|NCT01314872|588778040|FG004|Period 2|Adverse event, non-fatal|0|||
163020863|NCT01314872|588778041|FG005|Period 2|Adverse event, non-fatal|0|||
163063720|NCT00876343|588939952|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
163063721|NCT00876343|588939953|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
163063722|NCT00876343|588939951|FG000|Overall Study|Change of residence or other commitments|2|||
163063723|NCT00876343|588939952|FG001|Overall Study|Change of residence or other commitments|2|||
163063724|NCT00876343|588939953|FG002|Overall Study|Change of residence or other commitments|3|||
163329678|NCT04038580|589916661|FG005|Washout 1|Withdrawal by Subject|0|||
163329679|NCT04038580|589916656|FG000|Wash-out 2|Withdrawal by Subject|1|||
163329680|NCT04038580|589916657|FG001|Wash-out 2|Withdrawal by Subject|0|||
163329681|NCT04038580|589916658|FG002|Wash-out 2|Withdrawal by Subject|0|||
163405196|NCT01883635|590193548|FG000|Overall Study|Withdrawal by Subject|4|||
163020864|NCT01314872|588778042|FG006|Period 2|Adverse event, non-fatal|0|||
163329682|NCT04038580|589916659|FG003|Wash-out 2|Withdrawal by Subject|2|||
163020865|NCT01314872|588778043|FG007|Period 2|Adverse event, non-fatal|0|||
163020866|NCT01314872|588778044|FG008|Period 2|Adverse event, non-fatal|0|||
163020867|NCT01314872|588778045|FG009|Period 2|Adverse event, non-fatal|0|||
163020868|NCT01314872|588778046|FG010|Period 2|Adverse event, non-fatal|0|||
163020869|NCT01314872|588778047|FG011|Period 2|Adverse event, non-fatal|13|||
163020870|NCT01314872|588778048|FG012|Period 2|Adverse event, non-fatal|16|||
163063725|NCT00924898|588939957|FG000|Overall Study|Withdrawal by Subject|2|||
163329683|NCT04038580|589916660|FG004|Wash-out 2|Withdrawal by Subject|0|||
163329684|NCT04038580|589916661|FG005|Wash-out 2|Withdrawal by Subject|1|||
163329685|NCT04038580|589916656|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
163405197|NCT01883635|590193549|FG001|Overall Study|Withdrawal by Subject|0|||
163020871|NCT01314872|588778049|FG013|Period 2|Adverse event, non-fatal|24|||
163020872|NCT01314872|588778050|FG014|Period 2|Adverse event, non-fatal|9|||
163020873|NCT01314872|588778036|FG000|Period 2|Withdrawal by Subject|0|||
163020874|NCT01314872|588778037|FG001|Period 2|Withdrawal by Subject|0|||
163020875|NCT01314872|588778038|FG002|Period 2|Withdrawal by Subject|0|||
163020876|NCT01314872|588778039|FG003|Period 2|Withdrawal by Subject|0|||
163020877|NCT01314872|588778040|FG004|Period 2|Withdrawal by Subject|0|||
163020878|NCT01314872|588778041|FG005|Period 2|Withdrawal by Subject|0|||
163020879|NCT01314872|588778042|FG006|Period 2|Withdrawal by Subject|0|||
163020880|NCT01314872|588778043|FG007|Period 2|Withdrawal by Subject|0|||
163020881|NCT01314872|588778044|FG008|Period 2|Withdrawal by Subject|0|||
163020882|NCT01314872|588778045|FG009|Period 2|Withdrawal by Subject|0|||
163020883|NCT01314872|588778046|FG010|Period 2|Withdrawal by Subject|0|||
163020884|NCT01314872|588778047|FG011|Period 2|Withdrawal by Subject|14|||
163020885|NCT01314872|588778048|FG012|Period 2|Withdrawal by Subject|17|||
163020886|NCT01314872|588778049|FG013|Period 2|Withdrawal by Subject|12|||
163020887|NCT01314872|588778050|FG014|Period 2|Withdrawal by Subject|4|||
163020888|NCT01314872|588778036|FG000|Period 2|Lost to Follow-up|0|||
163020889|NCT01314872|588778037|FG001|Period 2|Lost to Follow-up|0|||
163020890|NCT01314872|588778038|FG002|Period 2|Lost to Follow-up|0|||
163020891|NCT01314872|588778039|FG003|Period 2|Lost to Follow-up|0|||
163020892|NCT01314872|588778040|FG004|Period 2|Lost to Follow-up|0|||
163020893|NCT01314872|588778041|FG005|Period 2|Lost to Follow-up|0|||
163020894|NCT01314872|588778042|FG006|Period 2|Lost to Follow-up|0|||
163020895|NCT01314872|588778043|FG007|Period 2|Lost to Follow-up|0|||
163020896|NCT01314872|588778044|FG008|Period 2|Lost to Follow-up|0|||
163020897|NCT01314872|588778045|FG009|Period 2|Lost to Follow-up|0|||
163020898|NCT01314872|588778046|FG010|Period 2|Lost to Follow-up|0|||
163020899|NCT01314872|588778047|FG011|Period 2|Lost to Follow-up|6|||
163020900|NCT01314872|588778048|FG012|Period 2|Lost to Follow-up|7|||
163020901|NCT01314872|588778049|FG013|Period 2|Lost to Follow-up|2|||
163020902|NCT01314872|588778050|FG014|Period 2|Lost to Follow-up|6|||
163020903|NCT01397786|588779529|FG000|Phase A|Lost to Follow-up|0|||
163020904|NCT01397786|588779530|FG001|Phase A|Lost to Follow-up|0|||
163020905|NCT01397786|588779531|FG002|Phase A|Lost to Follow-up|6|||
163020906|NCT01397786|588779529|FG000|Phase A|Adverse Event|0|||
163020907|NCT01397786|588779530|FG001|Phase A|Adverse Event|0|||
163020908|NCT01397786|588779531|FG002|Phase A|Adverse Event|8|||
163020909|NCT01397786|588779529|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
163020910|NCT01397786|588779530|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
163020911|NCT01397786|588779531|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
163020912|NCT01397786|588779529|FG000|Phase A|Physician Decision|0|||
163020913|NCT01397786|588779530|FG001|Phase A|Physician Decision|0|||
163020914|NCT01397786|588779531|FG002|Phase A|Physician Decision|1|||
163020915|NCT01397786|588779529|FG000|Phase A|Withdrawal by Subject|0|||
163020916|NCT01397786|588779530|FG001|Phase A|Withdrawal by Subject|0|||
163216754|NCT02588833|589508104|FG000|Part 2C|Adverse Event|0|||
163216755|NCT02588833|589508105|FG001|Part 2C|Adverse Event|1|||
163216756|NCT02588833|589508104|FG000|Part 2C|Withdrawal by Subject|0|||
163216757|NCT02588833|589508105|FG001|Part 2C|Withdrawal by Subject|1|||
163216758|NCT02588833|589508104|FG000|Part 3 (Safety Follow-up)|Other|0|||
163216759|NCT02588833|589508105|FG001|Part 3 (Safety Follow-up)|Other|2|||
163216760|NCT03649711|589508108|FG000|Overall Study|Adverse Event|0|||
163216761|NCT03649711|589508109|FG001|Overall Study|Adverse Event|1|||
163216762|NCT03649711|589508110|FG002|Overall Study|Adverse Event|0|||
163216763|NCT03649711|589508108|FG000|Overall Study|Kidney Transplant|1|||
163216764|NCT03649711|589508109|FG001|Overall Study|Kidney Transplant|0|||
163216765|NCT03649711|589508110|FG002|Overall Study|Kidney Transplant|0|||
163216766|NCT01581307|589508111|FG000|Overall Study|Withdrawal by Subject|1|||
163216767|NCT04439253|589510247|FG000|Overall Study|Adverse Event|1|||
163216768|NCT04439253|589510247|FG000|Overall Study|Disease progression|2|||
163216769|NCT04439253|589510247|FG000|Overall Study|Complicating disease|1|||
163216770|NCT00702403|589510248|FG000|From Consent to Engraftment|Progressive leukemia|6|||
163216771|NCT00702403|589510248|FG000|From Consent to Engraftment|Critically ill|2|||
163216772|NCT00702403|589510248|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
163216773|NCT00702403|589510248|FG000|From Consent to Engraftment|Myocardial infarction|1|||
163216774|NCT00702403|589510248|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
163216775|NCT00702403|589510248|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
163216776|NCT00702403|589510248|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
163216777|NCT00702403|589510248|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
163216778|NCT00702403|589510248|FG000|From Engraftment to Study Completion|Non-compliance|2|||
163216779|NCT00702403|589510248|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
163216780|NCT00702403|589510248|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
163216781|NCT00702403|589510248|FG000|From Engraftment to Study Completion|Suicide|1|||
163020917|NCT01397786|588779531|FG002|Phase A|Withdrawal by Subject|5|||
163020918|NCT01397786|588779529|FG000|Phase A|Lack of Efficacy|0|||
163020919|NCT01397786|588779530|FG001|Phase A|Lack of Efficacy|0|||
163020920|NCT01397786|588779531|FG002|Phase A|Lack of Efficacy|1|||
163020921|NCT01397786|588779529|FG000|Phase B|Lost to Follow-up|22|||
163020922|NCT01397786|588779530|FG001|Phase B|Lost to Follow-up|12|||
163020923|NCT01397786|588779531|FG002|Phase B|Lost to Follow-up|22|||
163020924|NCT01397786|588779529|FG000|Phase B|Adverse Event|109|||
163405198|NCT01464307|590193550|FG000|Main Period|Death|0|||
163405199|NCT01464307|590193551|FG001|Main Period|Death|1|||
163405200|NCT01464307|590193550|FG000|Main Period|Adverse Event|6|||
163405201|NCT01464307|590193551|FG001|Main Period|Adverse Event|1|||
163020925|NCT01397786|588779530|FG001|Phase B|Adverse Event|23|||
163020926|NCT01397786|588779531|FG002|Phase B|Adverse Event|27|||
163020927|NCT01397786|588779529|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
163020928|NCT01397786|588779530|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
163020929|NCT01397786|588779531|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
163020930|NCT01397786|588779529|FG000|Phase B|Physician Decision|9|||
163020931|NCT01397786|588779530|FG001|Phase B|Physician Decision|1|||
163020932|NCT01397786|588779531|FG002|Phase B|Physician Decision|3|||
163020933|NCT01397786|588779529|FG000|Phase B|Withdrawal by Subject|102|||
163020934|NCT01397786|588779530|FG001|Phase B|Withdrawal by Subject|45|||
163020935|NCT01397786|588779531|FG002|Phase B|Withdrawal by Subject|30|||
163020936|NCT01397786|588779529|FG000|Phase B|Protocol Deviation|1|||
163020937|NCT01397786|588779530|FG001|Phase B|Protocol Deviation|2|||
163020938|NCT01397786|588779531|FG002|Phase B|Protocol Deviation|4|||
163020939|NCT01397786|588779529|FG000|Phase B|Lack of Efficacy|22|||
163020940|NCT01397786|588779530|FG001|Phase B|Lack of Efficacy|7|||
163020941|NCT01397786|588779531|FG002|Phase B|Lack of Efficacy|14|||
163020942|NCT04250350|588779535|FG000|Overall Study|Withdrawal by Subject|13|||
163020943|NCT04250350|588779535|FG000|Overall Study|Lost to Follow-up|8|||
163020944|NCT04250350|588779535|FG000|Overall Study|Adverse Event|5|||
163020945|NCT04250350|588779535|FG000|Overall Study|Lack of Efficacy|4|||
163020946|NCT04250350|588779535|FG000|Overall Study|Physician Decision|1|||
163020947|NCT04250350|588779535|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
163020948|NCT00860249|588779536|FG000|Overall Study|trial was terminated prior to completion|21|||
163020949|NCT00860249|588779537|FG001|Overall Study|trial was terminated prior to completion|18|||
163020950|NCT00860249|588779538|FG002|Overall Study|trial was terminated prior to completion|21|||
163020951|NCT00743288|588779539|FG000|Overall Study|Adverse Event|1|||
163020952|NCT00743288|588779540|FG001|Overall Study|Adverse Event|1|||
163020953|NCT00743288|588779541|FG002|Overall Study|Adverse Event|2|||
163020954|NCT00743288|588779542|FG003|Overall Study|Adverse Event|2|||
163020955|NCT00743288|588779543|FG004|Overall Study|Adverse Event|1|||
163216782|NCT00702403|589510248|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
163020956|NCT00743288|588779544|FG005|Overall Study|Adverse Event|1|||
163216783|NCT00702403|589510248|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
163216784|NCT00702403|589510248|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
163216785|NCT00887354|589510254|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
163216786|NCT00887354|589510255|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
163216787|NCT00887354|589510254|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
163216788|NCT00887354|589510255|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
163216789|NCT00887354|589510254|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
163216790|NCT00887354|589510255|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
163216791|NCT00887354|589510254|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
163216792|NCT00887354|589510255|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
163216793|NCT00887354|589510254|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
163216794|NCT00887354|589510255|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
163216795|NCT00887354|589510254|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
163216796|NCT00887354|589510255|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
163216797|NCT00887354|589510254|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
163216798|NCT00887354|589510255|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
163216799|NCT00887354|589510254|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
163216800|NCT00887354|589510255|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
163216801|NCT00887354|589510254|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
163216802|NCT00887354|589510255|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
163216803|NCT00887354|589510254|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
163216804|NCT00887354|589510255|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
163216805|NCT00887354|589510254|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
163216806|NCT00887354|589510255|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
163216807|NCT00887354|589510254|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
163216808|NCT00887354|589510255|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
163216809|NCT00887354|589510254|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
163216810|NCT00887354|589510255|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
163216811|NCT00887354|589510254|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
163216812|NCT00887354|589510255|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
163216813|NCT00887354|589510254|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
163216814|NCT00887354|589510255|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
163216815|NCT00192504|589510258|FG000|Overall Study|Lost to Follow-up|1|||
163329686|NCT04038580|589916657|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
163329687|NCT04038580|589916658|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
163329688|NCT04038580|589916659|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
163329689|NCT04038580|589916660|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
163329690|NCT04038580|589916661|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
163329691|NCT04038580|589916656|FG000|Wash-out 3|Withdrawal by Subject|1|||
163329692|NCT04038580|589916657|FG001|Wash-out 3|Withdrawal by Subject|0|||
163329693|NCT04038580|589916658|FG002|Wash-out 3|Withdrawal by Subject|2|||
163329694|NCT04038580|589916659|FG003|Wash-out 3|Withdrawal by Subject|0|||
163329695|NCT04038580|589916660|FG004|Wash-out 3|Withdrawal by Subject|0|||
163329696|NCT04038580|589916661|FG005|Wash-out 3|Withdrawal by Subject|0|||
163329697|NCT03477175|589916662|FG000|Overall Study|Unable to travel due to COVID-19|0|||
163329698|NCT03477175|589916663|FG001|Overall Study|Unable to travel due to COVID-19|1|||
163329699|NCT03477175|589916662|FG000|Overall Study|Physician Decision|1|||
163329700|NCT03477175|589916663|FG001|Overall Study|Physician Decision|0|||
163329701|NCT03477175|589916662|FG000|Overall Study|Transitioned to commercial drug|6|||
163329702|NCT03477175|589916663|FG001|Overall Study|Transitioned to commercial drug|6|||
163329703|NCT03477175|589916662|FG000|Overall Study|Lost to Follow-up|1|||
163329704|NCT03477175|589916663|FG001|Overall Study|Lost to Follow-up|1|||
163329705|NCT03477175|589916662|FG000|Overall Study|Withdrawal by Subject|3|||
163329706|NCT03477175|589916663|FG001|Overall Study|Withdrawal by Subject|1|||
163329707|NCT03477175|589916662|FG000|Overall Study|Adverse Event|1|||
163329708|NCT03477175|589916663|FG001|Overall Study|Adverse Event|5|||
163329709|NCT03477175|589916662|FG000|Overall Study|Disease Progression|7|||
163329710|NCT03477175|589916663|FG001|Overall Study|Disease Progression|7|||
163329711|NCT02078648|589916664|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
163329712|NCT02078648|589916665|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
163329713|NCT02078648|589916664|FG000|Overall Study|Adverse Event|0|||
163216816|NCT00192504|589510259|FG001|Overall Study|Lost to Follow-up|0|||
163216817|NCT00192504|589510260|FG002|Overall Study|Lost to Follow-up|0|||
163216818|NCT00192504|589510261|FG003|Overall Study|Lost to Follow-up|0|||
163216819|NCT00192504|589510258|FG000|Overall Study|Dosing window missed|0|||
163216820|NCT00192504|589510259|FG001|Overall Study|Dosing window missed|0|||
163329714|NCT02078648|589916665|FG001|Overall Study|Adverse Event|1|||
163329715|NCT02078648|589916664|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
163329716|NCT02078648|589916665|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
163329717|NCT02078648|589916664|FG000|Overall Study|Withdrawal by Subject|3|||
163329718|NCT02078648|589916665|FG001|Overall Study|Withdrawal by Subject|1|||
163329719|NCT02078648|589916664|FG000|Overall Study|Investigator Decision|5|||
163329720|NCT02078648|589916665|FG001|Overall Study|Investigator Decision|7|||
163329721|NCT02078648|589916664|FG000|Overall Study|Death|1|||
163329722|NCT02078648|589916665|FG001|Overall Study|Death|1|||
163329723|NCT02078648|589916664|FG000|Overall Study|Undefined|0|||
163329724|NCT02078648|589916665|FG001|Overall Study|Undefined|1|||
163020957|NCT00743288|588779545|FG006|Overall Study|Adverse Event|2|||
163020958|NCT00743288|588779539|FG000|Overall Study|Withdrawal by Subject|0|||
163020959|NCT00743288|588779540|FG001|Overall Study|Withdrawal by Subject|0|||
163020960|NCT00743288|588779541|FG002|Overall Study|Withdrawal by Subject|1|||
163020961|NCT00743288|588779542|FG003|Overall Study|Withdrawal by Subject|0|||
163020962|NCT00743288|588779543|FG004|Overall Study|Withdrawal by Subject|0|||
163020963|NCT00743288|588779544|FG005|Overall Study|Withdrawal by Subject|1|||
163020964|NCT00743288|588779545|FG006|Overall Study|Withdrawal by Subject|1|||
163020965|NCT00743288|588779539|FG000|Overall Study|Progressive disease (PD)|2|||
163020966|NCT00743288|588779540|FG001|Overall Study|Progressive disease (PD)|0|||
163020967|NCT00743288|588779541|FG002|Overall Study|Progressive disease (PD)|1|||
163020968|NCT00743288|588779542|FG003|Overall Study|Progressive disease (PD)|4|||
163020969|NCT00743288|588779543|FG004|Overall Study|Progressive disease (PD)|5|||
163020970|NCT00743288|588779544|FG005|Overall Study|Progressive disease (PD)|3|||
163020971|NCT00743288|588779545|FG006|Overall Study|Progressive disease (PD)|6|||
163020972|NCT00743288|588779539|FG000|Overall Study|Worsening of condition (Not PD)|0|||
163216821|NCT00192504|589510260|FG002|Overall Study|Dosing window missed|1|||
163216822|NCT00192504|589510261|FG003|Overall Study|Dosing window missed|0|||
163216823|NCT00542919|589510264|FG000|Overall Study|Adverse Event|1|||
163216824|NCT00542919|589510265|FG001|Overall Study|Adverse Event|5|||
163216825|NCT00542919|589510266|FG002|Overall Study|Adverse Event|1|||
163216826|NCT00542919|589510264|FG000|Overall Study|Withdrawal by Subject|1|||
163216827|NCT00542919|589510265|FG001|Overall Study|Withdrawal by Subject|0|||
163216828|NCT00542919|589510266|FG002|Overall Study|Withdrawal by Subject|3|||
163216829|NCT00542919|589510264|FG000|Overall Study|Physician Decision|2|||
163216830|NCT00542919|589510265|FG001|Overall Study|Physician Decision|2|||
163216831|NCT00542919|589510266|FG002|Overall Study|Physician Decision|1|||
163216832|NCT00542919|589510264|FG000|Overall Study|Sponsor Decision|1|||
163216833|NCT00542919|589510265|FG001|Overall Study|Sponsor Decision|0|||
163216834|NCT00542919|589510266|FG002|Overall Study|Sponsor Decision|0|||
163216835|NCT00542919|589510264|FG000|Overall Study|Lost to Follow-up|2|||
163063726|NCT04153864|588939958|FG000|Overall Study|Withdrawal by Subject|21|||
163063727|NCT04153864|588939959|FG001|Overall Study|Withdrawal by Subject|7|||
163063728|NCT04153864|588939960|FG002|Overall Study|Withdrawal by Subject|23|||
163063729|NCT04153864|588939961|FG003|Overall Study|Withdrawal by Subject|2|||
163063730|NCT04153864|588939958|FG000|Overall Study|Lost to Follow-up|4|||
163063731|NCT04153864|588939959|FG001|Overall Study|Lost to Follow-up|0|||
163063732|NCT04153864|588939960|FG002|Overall Study|Lost to Follow-up|3|||
163063733|NCT04153864|588939961|FG003|Overall Study|Lost to Follow-up|0|||
163063734|NCT04153864|588939958|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
163063735|NCT04153864|588939959|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
163063736|NCT04153864|588939960|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
163063737|NCT04153864|588939961|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
163063738|NCT04717557|588939965|FG000|Overall Study|Withdrawal by Subject|2|||
163063739|NCT04717557|588939966|FG001|Overall Study|Withdrawal by Subject|0|||
163063740|NCT04717557|588939965|FG000|Overall Study|Death|1|||
163063741|NCT04717557|588939966|FG001|Overall Study|Death|0|||
163063742|NCT06354257|588939967|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163063743|NCT06354257|588939967|FG000|Treatment Period 2|Adverse Event|1|||
163063744|NCT01654276|588939968|FG000|Overall Study|Lack of Efficacy|1|||
163063745|NCT01654276|588939968|FG000|Overall Study|Lost to Follow-up|4|||
163063746|NCT01654276|588939968|FG000|Overall Study|Withdrawal by Subject|1|||
163063747|NCT02401230|588939969|FG000|Overall Study|Adverse Event|3|||
163063748|NCT02401230|588939970|FG001|Overall Study|Adverse Event|2|||
163063749|NCT02401230|588939971|FG002|Overall Study|Adverse Event|0|||
163063750|NCT02401230|588939969|FG000|Overall Study|Withdrawal by Subject|2|||
163063751|NCT02401230|588939970|FG001|Overall Study|Withdrawal by Subject|1|||
163063752|NCT02401230|588939971|FG002|Overall Study|Withdrawal by Subject|1|||
163063753|NCT02401230|588939969|FG000|Overall Study|Lost to Follow-up|1|||
163063754|NCT02401230|588939970|FG001|Overall Study|Lost to Follow-up|3|||
163063755|NCT02401230|588939971|FG002|Overall Study|Lost to Follow-up|3|||
163063756|NCT00964782|588939974|FG000|Overall Study|Lost to Follow-up|1|||
163063757|NCT00964782|588939975|FG001|Overall Study|Lost to Follow-up|0|||
163063758|NCT00720759|588939977|FG000|Overall Study|Lost to Follow-up|0|||
163063759|NCT00720759|588939978|FG001|Overall Study|Lost to Follow-up|1|||
163063760|NCT00720759|588939979|FG002|Overall Study|Lost to Follow-up|1|||
163063761|NCT00720759|588939980|FG003|Overall Study|Lost to Follow-up|0|||
163063762|NCT02318940|588939981|FG000|Overall Study|lost the record|1|||
163063763|NCT02318940|588939982|FG001|Overall Study|lost the record|0|||
163063764|NCT01047319|588939983|FG000|Overall Study|Teva requested participant withdrawal|3|||
163063765|NCT01047319|588939984|FG001|Overall Study|Teva requested participant withdrawal|0|||
163063766|NCT01047319|588939985|FG002|Overall Study|Teva requested participant withdrawal|1|||
163063767|NCT01047319|588939983|FG000|Overall Study|Protocol Violation|3|||
163216836|NCT00542919|589510265|FG001|Overall Study|Lost to Follow-up|0|||
163216837|NCT00542919|589510266|FG002|Overall Study|Lost to Follow-up|1|||
163063768|NCT01047319|588939984|FG001|Overall Study|Protocol Violation|2|||
163063769|NCT01047319|588939985|FG002|Overall Study|Protocol Violation|4|||
163063770|NCT01047319|588939983|FG000|Overall Study|Lack of Efficacy|4|||
163063771|NCT01047319|588939984|FG001|Overall Study|Lack of Efficacy|3|||
163063772|NCT01047319|588939985|FG002|Overall Study|Lack of Efficacy|3|||
163063773|NCT01047319|588939983|FG000|Overall Study|Death|5|||
163216838|NCT05123222|589510273|FG000|Overall Study|Lost to Follow-up|2|||
163063774|NCT01047319|588939984|FG001|Overall Study|Death|1|||
163063775|NCT01047319|588939985|FG002|Overall Study|Death|5|||
163063776|NCT01047319|588939983|FG000|Overall Study|Pregnancy|13|||
163063777|NCT01047319|588939984|FG001|Overall Study|Pregnancy|8|||
163063778|NCT01047319|588939985|FG002|Overall Study|Pregnancy|8|||
163216839|NCT05123222|589510274|FG001|Overall Study|Lost to Follow-up|0|||
163216840|NCT05123222|589510275|FG002|Overall Study|Lost to Follow-up|0|||
163216841|NCT05123222|589510276|FG003|Overall Study|Lost to Follow-up|0|||
163216842|NCT05123222|589510273|FG000|Overall Study|Protocol Violation|0|||
163216843|NCT05123222|589510274|FG001|Overall Study|Protocol Violation|0|||
163216844|NCT05123222|589510275|FG002|Overall Study|Protocol Violation|1|||
163216845|NCT05123222|589510276|FG003|Overall Study|Protocol Violation|0|||
163216846|NCT02535741|589510277|FG000|Overall Study|Adverse Event|3|||
163216847|NCT02535741|589510277|FG000|Overall Study|Withdrawal by Subject|9|||
163216848|NCT02535741|589510277|FG000|Overall Study|Lost to Follow-up|10|||
163216849|NCT02535741|589510277|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
163216850|NCT02535741|589510277|FG000|Overall Study|Missing data|6|||
163216851|NCT03020823|589510280|FG000|Overall Study|Physician Decision|4|||
163216852|NCT03020823|589510280|FG000|Overall Study|Lack of Efficacy|4|||
163216853|NCT03020823|589510280|FG000|Overall Study|Adverse Event|2|||
163216854|NCT03739112|589510281|FG000|Overall Study|Adverse Event|2|||
163216855|NCT03739112|589510282|FG001|Overall Study|Adverse Event|2|||
163216856|NCT03739112|589510281|FG000|Overall Study|Withdrawal by Subject|38|||
163216857|NCT03739112|589510282|FG001|Overall Study|Withdrawal by Subject|19|||
163216858|NCT03739112|589510281|FG000|Overall Study|Lost to Follow-up|31|||
163216859|NCT03739112|589510282|FG001|Overall Study|Lost to Follow-up|33|||
163329725|NCT04088227|589916666|FG000|Overall Study|Withdrawal by Subject|1|||
163329726|NCT04088227|589916667|FG001|Overall Study|Withdrawal by Subject|0|||
163329727|NCT04088227|589916666|FG000|Overall Study|Surgery postponed >5weeks|1|||
163329728|NCT04088227|589916667|FG001|Overall Study|Surgery postponed >5weeks|0|||
163329729|NCT04021862|589916668|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
163329730|NCT04021862|589916669|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
163329731|NCT04021862|589916670|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
163329732|NCT04021862|589916671|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
163329733|NCT04021862|589916672|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
163329734|NCT04021862|589916673|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
163329735|NCT04021862|589916668|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
163329736|NCT04021862|589916669|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
163329737|NCT04021862|589916670|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
163329738|NCT04021862|589916671|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
163329739|NCT04021862|589916672|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
163329740|NCT04021862|589916673|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
163329741|NCT04021862|589916668|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
163329742|NCT04021862|589916669|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
163329743|NCT04021862|589916670|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
163329744|NCT04021862|589916671|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
163329745|NCT04021862|589916672|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
163329746|NCT04021862|589916673|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
163329747|NCT04021862|589916668|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
163329748|NCT04021862|589916669|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
163329749|NCT04021862|589916670|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
163329750|NCT04021862|589916671|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
163329751|NCT04021862|589916672|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
163329752|NCT04021862|589916673|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
163329753|NCT04021862|589916668|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
163329754|NCT04021862|589916669|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
163329755|NCT04021862|589916670|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
163329756|NCT04021862|589916671|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
163329757|NCT04021862|589916672|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
163329758|NCT04021862|589916673|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
163329759|NCT01855750|589916674|FG000|Overall Study|Death|78|||
163329760|NCT01855750|589916675|FG001|Overall Study|Death|78|||
163329761|NCT01855750|589916674|FG000|Overall Study|Lost to Follow-up|9|||
163329762|NCT01855750|589916675|FG001|Overall Study|Lost to Follow-up|23|||
163329763|NCT01855750|589916674|FG000|Overall Study|Withdrawal by Subject|35|||
163329764|NCT01855750|589916675|FG001|Overall Study|Withdrawal by Subject|28|||
163329765|NCT01855750|589916674|FG000|Overall Study|Sponsor ends the study|297|||
163329766|NCT01855750|589916675|FG001|Overall Study|Sponsor ends the study|290|||
163329767|NCT05379270|589916676|FG000|Overall Study|Withdrawal by Subject|1|||
163329768|NCT05379270|589916677|FG001|Overall Study|Withdrawal by Subject|1|||
163329769|NCT05025384|589916678|FG000|Overall Study|Physician Decision|5|||
163329770|NCT05025384|589916679|FG001|Overall Study|Physician Decision|6|||
163329771|NCT03160885|589916680|FG000|Initial Treatment Period|Not dosed|2|||
163329772|NCT03160885|589916681|FG001|Initial Treatment Period|Not dosed|0|||
163329773|NCT03160885|589916682|FG002|Initial Treatment Period|Not dosed|0|||
163329774|NCT03160885|589916683|FG003|Initial Treatment Period|Not dosed|0|||
163329775|NCT03160885|589916684|FG004|Initial Treatment Period|Not dosed|0|||
163020973|NCT00743288|588779540|FG001|Overall Study|Worsening of condition (Not PD)|2|||
163020974|NCT00743288|588779541|FG002|Overall Study|Worsening of condition (Not PD)|1|||
163020975|NCT00743288|588779542|FG003|Overall Study|Worsening of condition (Not PD)|1|||
163020976|NCT00743288|588779543|FG004|Overall Study|Worsening of condition (Not PD)|0|||
163020977|NCT00743288|588779544|FG005|Overall Study|Worsening of condition (Not PD)|0|||
163020978|NCT00743288|588779545|FG006|Overall Study|Worsening of condition (Not PD)|0|||
163020979|NCT02836236|588779549|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
163020980|NCT02836236|588779550|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
163020981|NCT02836236|588779551|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
163020982|NCT02836236|588779552|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
163020983|NCT02836236|588779549|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
163020984|NCT02836236|588779550|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
163020985|NCT02836236|588779551|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
163063779|NCT01047319|588939983|FG000|Overall Study|Physician Decision|12|||
163063780|NCT01047319|588939984|FG001|Overall Study|Physician Decision|9|||
163329776|NCT03160885|589916685|FG005|Initial Treatment Period|Not dosed|0|||
163329777|NCT03160885|589916686|FG006|Initial Treatment Period|Not dosed|0|||
163329778|NCT03160885|589916680|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
163329779|NCT03160885|589916681|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
163329780|NCT03160885|589916682|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163329781|NCT03160885|589916683|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163329782|NCT03160885|589916684|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163329783|NCT03160885|589916685|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163329784|NCT03160885|589916686|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163329785|NCT03160885|589916680|FG000|Open-label Treatment|Not dosed|0|||
163329786|NCT03160885|589916681|FG001|Open-label Treatment|Not dosed|0|||
163329787|NCT03160885|589916682|FG002|Open-label Treatment|Not dosed|0|||
163329788|NCT03160885|589916683|FG003|Open-label Treatment|Not dosed|0|||
163329789|NCT03160885|589916684|FG004|Open-label Treatment|Not dosed|0|||
163329790|NCT03160885|589916685|FG005|Open-label Treatment|Not dosed|0|||
163329791|NCT03160885|589916686|FG006|Open-label Treatment|Not dosed|2|||
163329792|NCT03160885|589916680|FG000|Open-label Treatment|Discontinued IMP|0|||
163329793|NCT03160885|589916681|FG001|Open-label Treatment|Discontinued IMP|0|||
163329794|NCT03160885|589916682|FG002|Open-label Treatment|Discontinued IMP|0|||
163329795|NCT03160885|589916683|FG003|Open-label Treatment|Discontinued IMP|0|||
163329796|NCT03160885|589916684|FG004|Open-label Treatment|Discontinued IMP|0|||
163329797|NCT03160885|589916685|FG005|Open-label Treatment|Discontinued IMP|0|||
163329798|NCT03160885|589916686|FG006|Open-label Treatment|Discontinued IMP|131|||
163329799|NCT03160885|589916680|FG000|Open-label Treatment|Completed Week 50|0|||
163329800|NCT03160885|589916681|FG001|Open-label Treatment|Completed Week 50|0|||
163329801|NCT03160885|589916682|FG002|Open-label Treatment|Completed Week 50|0|||
163329802|NCT03160885|589916683|FG003|Open-label Treatment|Completed Week 50|0|||
163329803|NCT03160885|589916684|FG004|Open-label Treatment|Completed Week 50|0|||
163329804|NCT03160885|589916685|FG005|Open-label Treatment|Completed Week 50|0|||
163329805|NCT03160885|589916686|FG006|Open-label Treatment|Completed Week 50|4|||
163329806|NCT03160885|589916680|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
163329807|NCT03160885|589916681|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
163329808|NCT03160885|589916682|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
163329809|NCT03160885|589916683|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
163329810|NCT03160885|589916684|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
163329811|NCT03160885|589916685|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
163329812|NCT03160885|589916686|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
163329813|NCT03160885|589916680|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
163329814|NCT03160885|589916681|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
163329815|NCT03160885|589916682|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
163329816|NCT03160885|589916683|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
163329817|NCT03160885|589916684|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
163329818|NCT03160885|589916685|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
163329819|NCT03160885|589916686|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
163329820|NCT03160885|589916680|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
163329821|NCT03160885|589916681|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
163329822|NCT03160885|589916682|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
163329823|NCT03160885|589916683|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
163329824|NCT03160885|589916684|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
163329825|NCT03160885|589916685|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
163329826|NCT03160885|589916686|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
163329827|NCT03160885|589916680|FG000|Maintenance Treatment Period|Completed Week 50|0|||
163329828|NCT03160885|589916681|FG001|Maintenance Treatment Period|Completed Week 50|0|||
163329829|NCT03160885|589916682|FG002|Maintenance Treatment Period|Completed Week 50|1|||
163329830|NCT03160885|589916683|FG003|Maintenance Treatment Period|Completed Week 50|0|||
163329831|NCT03160885|589916684|FG004|Maintenance Treatment Period|Completed Week 50|0|||
163329832|NCT03160885|589916685|FG005|Maintenance Treatment Period|Completed Week 50|0|||
163329833|NCT03160885|589916686|FG006|Maintenance Treatment Period|Completed Week 50|0|||
163329834|NCT03425682|589916687|FG000|Overall Study|Lost to Follow-up|2|||
163329835|NCT03425682|589916688|FG001|Overall Study|Lost to Follow-up|4|||
163329836|NCT03425682|589916687|FG000|Overall Study|Withdrawal by Subject|0|||
163329837|NCT03425682|589916688|FG001|Overall Study|Withdrawal by Subject|3|||
163329838|NCT03425682|589916687|FG000|Overall Study|Subject did not meet I/E|4|||
163329839|NCT03425682|589916688|FG001|Overall Study|Subject did not meet I/E|10|||
163329840|NCT03835754|589916689|FG000|Overall Study|Death|4|||
163020986|NCT02836236|588779552|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
163020987|NCT02836236|588779549|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
163329841|NCT05810285|589916690|FG000|Overall Study|Death|4|||
163329842|NCT05810285|589916691|FG001|Overall Study|Death|21|||
163329843|NCT05810285|589916690|FG000|Overall Study|Adverse Event|18|||
163329844|NCT05810285|589916691|FG001|Overall Study|Adverse Event|16|||
163329845|NCT00345046|589917713|FG000|Overall Study|Protocol Violation|1|||
163063781|NCT01047319|588939985|FG002|Overall Study|Physician Decision|10|||
163329846|NCT00345046|589917714|FG001|Overall Study|Protocol Violation|1|||
163329847|NCT00345046|589917715|FG002|Overall Study|Protocol Violation|2|||
163329848|NCT04497415|589917722|FG000|Overall Study|Lost to Follow-up|43|||
163329849|NCT04497415|589917723|FG001|Overall Study|Lost to Follow-up|27|||
163329850|NCT02157116|589917724|FG000|Overall Study|Withdrawal by Subject|4|||
163329851|NCT02157116|589917724|FG000|Overall Study|Physician Decision|3|||
163329852|NCT02157116|589917724|FG000|Overall Study|Failed Screening|2|||
163329853|NCT02463448|589917725|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
163329854|NCT02463448|589917725|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
163329855|NCT02463448|589917725|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
163329856|NCT02463448|589917725|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
163329857|NCT01728324|589917726|FG000|Termination of DBV|Adverse Event|14|||
163329858|NCT01728324|589917727|FG001|Termination of DBV|Adverse Event|13|||
163329859|NCT01728324|589917728|FG002|Termination of DBV|Adverse Event|4|||
163329860|NCT01728324|589917726|FG000|Termination of DBV|Lack of Efficacy|14|||
163329861|NCT01728324|589917727|FG001|Termination of DBV|Lack of Efficacy|12|||
163329862|NCT01728324|589917728|FG002|Termination of DBV|Lack of Efficacy|8|||
163329863|NCT01728324|589917726|FG000|Termination of DBV|Withdrawal by Subject|9|||
163329864|NCT01728324|589917727|FG001|Termination of DBV|Withdrawal by Subject|6|||
163329865|NCT01728324|589917728|FG002|Termination of DBV|Withdrawal by Subject|2|||
163329866|NCT01728324|589917726|FG000|Termination of DBV|Other than stated|1|||
163329867|NCT01728324|589917727|FG001|Termination of DBV|Other than stated|3|||
163329868|NCT01728324|589917728|FG002|Termination of DBV|Other than stated|0|||
163329869|NCT01728324|589917726|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
163329870|NCT01728324|589917727|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
163329871|NCT01728324|589917728|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
163329872|NCT01728324|589917726|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
163020988|NCT02836236|588779550|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
163020989|NCT02836236|588779551|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
163020990|NCT02836236|588779552|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
163020991|NCT02836236|588779549|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
163020992|NCT02836236|588779550|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
163020993|NCT02836236|588779551|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
163020994|NCT02836236|588779552|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
163063782|NCT01047319|588939983|FG000|Overall Study|Lost to Follow-up|14|||
163329873|NCT01728324|589917727|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
163329874|NCT01728324|589917728|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
163329875|NCT01728324|589917726|FG000|Termination of FDV|Adverse Event|14|||
163329876|NCT01728324|589917727|FG001|Termination of FDV|Adverse Event|13|||
163329877|NCT01728324|589917728|FG002|Termination of FDV|Adverse Event|4|||
163329878|NCT01728324|589917726|FG000|Termination of FDV|Lack of Efficacy|14|||
163329879|NCT01728324|589917727|FG001|Termination of FDV|Lack of Efficacy|12|||
163329880|NCT01728324|589917728|FG002|Termination of FDV|Lack of Efficacy|8|||
163329881|NCT01728324|589917726|FG000|Termination of FDV|Withdrawal by Subject|9|||
163329882|NCT01728324|589917727|FG001|Termination of FDV|Withdrawal by Subject|6|||
163329883|NCT01728324|589917728|FG002|Termination of FDV|Withdrawal by Subject|2|||
163329884|NCT01728324|589917726|FG000|Termination of FDV|Other than stated|1|||
163329885|NCT01728324|589917727|FG001|Termination of FDV|Other than stated|3|||
163329886|NCT01728324|589917728|FG002|Termination of FDV|Other than stated|0|||
163329887|NCT01728324|589917726|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
163329888|NCT01728324|589917727|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
163329889|NCT01728324|589917728|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
163329890|NCT01728324|589917726|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
163329891|NCT01728324|589917727|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
163405202|NCT01464307|590193550|FG000|Main Period|Lack of Efficacy|2|||
163020995|NCT02836236|588779549|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
163020996|NCT02836236|588779550|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
163020997|NCT02836236|588779551|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
163020998|NCT02836236|588779552|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
163020999|NCT02836236|588779549|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
163021000|NCT02836236|588779550|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
163021001|NCT02836236|588779551|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
163063783|NCT01047319|588939984|FG001|Overall Study|Lost to Follow-up|10|||
163329892|NCT01728324|589917728|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
163329893|NCT01728324|589917726|FG000|Termination of RBV|Adverse Event|15|||
163329894|NCT01728324|589917727|FG001|Termination of RBV|Adverse Event|16|||
163329895|NCT01728324|589917728|FG002|Termination of RBV|Adverse Event|5|||
163329896|NCT01728324|589917726|FG000|Termination of RBV|Lack of Efficacy|14|||
163329897|NCT01728324|589917727|FG001|Termination of RBV|Lack of Efficacy|11|||
163329898|NCT01728324|589917728|FG002|Termination of RBV|Lack of Efficacy|7|||
163329899|NCT01728324|589917726|FG000|Termination of RBV|Withdrawal by Subject|9|||
163329900|NCT01728324|589917727|FG001|Termination of RBV|Withdrawal by Subject|5|||
163329901|NCT01728324|589917728|FG002|Termination of RBV|Withdrawal by Subject|2|||
163329902|NCT01728324|589917726|FG000|Termination of RBV|Other than stated|1|||
163329903|NCT01728324|589917727|FG001|Termination of RBV|Other than stated|3|||
163329904|NCT01728324|589917728|FG002|Termination of RBV|Other than stated|1|||
163329905|NCT01728324|589917726|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
163329906|NCT01728324|589917727|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
163329907|NCT01728324|589917728|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
163329908|NCT01728324|589917726|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
163329909|NCT01728324|589917727|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
163329910|NCT01728324|589917728|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
163329911|NCT01787032|589917731|FG000|Overall Study|Protocol Violation|0|||
163329912|NCT01787032|589917732|FG001|Overall Study|Protocol Violation|0|||
163329913|NCT01787032|589917733|FG002|Overall Study|Protocol Violation|0|||
163329914|NCT01787032|589917734|FG003|Overall Study|Protocol Violation|0|||
163329915|NCT01787032|589917735|FG004|Overall Study|Protocol Violation|1|||
163329916|NCT01787032|589917736|FG005|Overall Study|Protocol Violation|1|||
163329917|NCT00388726|589917737|FG000|Overall Study|Adverse Event|50|||
163329918|NCT00388726|589917738|FG001|Overall Study|Adverse Event|24|||
163329919|NCT00388726|589917737|FG000|Overall Study|Progressive Disease|336|||
163329920|NCT00388726|589917738|FG001|Overall Study|Progressive Disease|153|||
163063784|NCT01047319|588939985|FG002|Overall Study|Lost to Follow-up|10|||
163063785|NCT01047319|588939983|FG000|Overall Study|Adverse Event|16|||
163063786|NCT01047319|588939984|FG001|Overall Study|Adverse Event|27|||
163063787|NCT01047319|588939985|FG002|Overall Study|Adverse Event|21|||
163063788|NCT01047319|588939983|FG000|Overall Study|Withdrawal by Subject|77|||
163063789|NCT01047319|588939984|FG001|Overall Study|Withdrawal by Subject|75|||
163063790|NCT01047319|588939985|FG002|Overall Study|Withdrawal by Subject|87|||
163063791|NCT01047319|588939983|FG000|Overall Study|Study terminated by Sponsor|198|||
163063792|NCT01047319|588939984|FG001|Overall Study|Study terminated by Sponsor|215|||
163063793|NCT01047319|588939985|FG002|Overall Study|Study terminated by Sponsor|203|||
163063794|NCT05759338|588939991|FG000|Overall Study|Withdrawal by Subject|3|||
163329921|NCT00388726|589917737|FG000|Overall Study|Clinical Progression|61|||
163329922|NCT00388726|589917738|FG001|Overall Study|Clinical Progression|36|||
163329923|NCT00388726|589917737|FG000|Overall Study|Withdrawal by Subject|10|||
163329924|NCT00388726|589917738|FG001|Overall Study|Withdrawal by Subject|7|||
163329925|NCT00388726|589917737|FG000|Overall Study|Administrative|6|||
163329926|NCT00388726|589917738|FG001|Overall Study|Administrative|9|||
163329927|NCT00388726|589917737|FG000|Overall Study|Physician Decision|18|||
163329928|NCT00388726|589917738|FG001|Overall Study|Physician Decision|13|||
163329929|NCT00388726|589917737|FG000|Overall Study|Death|3|||
163329930|NCT00388726|589917738|FG001|Overall Study|Death|2|||
163329931|NCT02406092|589917739|FG000|Overall Study|Screen failure|10|||
163329932|NCT02406092|589917740|FG001|Overall Study|Screen failure|7|||
163329933|NCT02406092|589917739|FG000|Overall Study|Death|22|||
163329934|NCT02406092|589917740|FG001|Overall Study|Death|5|||
163329935|NCT02406092|589917739|FG000|Overall Study|Lost to Follow-up|4|||
163329936|NCT02406092|589917740|FG001|Overall Study|Lost to Follow-up|1|||
163329937|NCT02406092|589917739|FG000|Overall Study|Adverse Event|1|||
163329938|NCT02406092|589917740|FG001|Overall Study|Adverse Event|0|||
163329939|NCT02406092|589917739|FG000|Overall Study|Withdrawal by Subject|1|||
163329940|NCT02406092|589917740|FG001|Overall Study|Withdrawal by Subject|0|||
163329941|NCT03041233|589917741|FG000|Overall Study|Death|5|||
163063795|NCT04611126|588939992|FG000|Overall Study|TIL expansion unsuccessful|1|||
163063796|NCT04611126|588939993|FG001|Overall Study|TIL expansion unsuccessful|0|||
163063797|NCT05260008|588939994|FG000|Overall Study|Physician Decision|0|||
163329942|NCT03041233|589917741|FG000|Overall Study|Physician Decision|1|||
163329943|NCT03041233|589917741|FG000|Overall Study|Lost to Follow-up|16|||
163329944|NCT03041233|589917741|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
163329945|NCT03041233|589917741|FG000|Overall Study|Sponsor Request|1|||
163329946|NCT03041233|589917741|FG000|Overall Study|Duplicate subject|1|||
163329947|NCT03041233|589917741|FG000|Overall Study|Re-ablation|1|||
163329948|NCT00853593|589917745|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
163329949|NCT00853593|589917745|FG000|Overall Study|Model 4396 lead not attempted|29|||
163329950|NCT00853593|589917745|FG000|Overall Study|Implant not attempted|4|||
163329951|NCT00641537|589917748|FG000|96-week Period|Adverse Event|0|||
163405203|NCT01464307|590193551|FG001|Main Period|Lack of Efficacy|0|||
163405204|NCT01464307|590193550|FG000|Main Period|Withdrawal by Subject|5|||
163329952|NCT00641537|589917749|FG001|96-week Period|Adverse Event|1|||
163329953|NCT00641537|589917750|FG002|96-week Period|Adverse Event|3|||
163063798|NCT05260008|588939995|FG001|Overall Study|Physician Decision|1|||
163329954|NCT00641537|589917751|FG003|96-week Period|Adverse Event|0|||
163329955|NCT00641537|589917752|FG004|96-week Period|Adverse Event|2|||
163329956|NCT00641537|589917753|FG005|96-week Period|Adverse Event|0|||
163329957|NCT00641537|589917754|FG006|96-week Period|Adverse Event|0|||
163329958|NCT00641537|589917755|FG007|96-week Period|Adverse Event|0|||
163329959|NCT00641537|589917748|FG000|96-week Period|Lost to Follow-up|3|||
163329960|NCT00641537|589917749|FG001|96-week Period|Lost to Follow-up|1|||
163329961|NCT00641537|589917750|FG002|96-week Period|Lost to Follow-up|2|||
163063799|NCT05260008|588939996|FG002|Overall Study|Physician Decision|0|||
163063800|NCT05260008|588939997|FG003|Overall Study|Physician Decision|0|||
163063801|NCT01157845|588940000|FG000|Overall Study|Lost to Follow-up|5|||
163063802|NCT01157845|588940000|FG000|Overall Study|Withdrawal by Subject|12|||
163021002|NCT02836236|588779552|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
163021003|NCT02836236|588779549|FG000|Open-Label TAF Treatment Phase|Death|0|||
163021004|NCT02836236|588779550|FG001|Open-Label TAF Treatment Phase|Death|0|||
163021005|NCT02836236|588779551|FG002|Open-Label TAF Treatment Phase|Death|1|||
163021006|NCT02836236|588779552|FG003|Open-Label TAF Treatment Phase|Death|1|||
163021007|NCT02836236|588779549|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
163021008|NCT02836236|588779550|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
163021009|NCT02836236|588779551|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
163021010|NCT02836236|588779552|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
163021011|NCT00378508|588779553|FG000|Overall Study|Withdrawal by Subject|1|||
163021012|NCT00378508|588779554|FG001|Overall Study|Withdrawal by Subject|3|||
163021013|NCT00378508|588779553|FG000|Overall Study|Lost to Follow-up|1|||
163021014|NCT00378508|588779554|FG001|Overall Study|Lost to Follow-up|0|||
163021015|NCT00593684|588779555|FG000|Overall Study|Death|2|||
163021016|NCT00593684|588779556|FG001|Overall Study|Death|1|||
163021017|NCT04984278|588779561|FG000|Period 1|Withdrawal by Subject|1|||
163021018|NCT04984278|588779562|FG001|Period 1|Withdrawal by Subject|0|||
163021019|NCT04984278|588779561|FG000|Period 1|Other|0|||
163021020|NCT04984278|588779562|FG001|Period 1|Other|1|||
163021021|NCT04984278|588779561|FG000|Period 2|Adverse Event|1|||
163021022|NCT04984278|588779562|FG001|Period 2|Adverse Event|0|||
163021023|NCT04984278|588779561|FG000|Period 2|Other|0|||
163021024|NCT04984278|588779562|FG001|Period 2|Other|1|||
163021025|NCT04696055|588779563|FG000|Overall Study|Adverse Event|10|||
163021026|NCT04696055|588779564|FG001|Overall Study|Adverse Event|2|||
163021027|NCT04696055|588779563|FG000|Overall Study|Death|4|||
163021028|NCT04696055|588779564|FG001|Overall Study|Death|0|||
163021029|NCT04696055|588779563|FG000|Overall Study|Other|7|||
163021030|NCT04696055|588779564|FG001|Overall Study|Other|2|||
163021031|NCT04696055|588779563|FG000|Overall Study|Physician Decision|3|||
163021032|NCT04696055|588779564|FG001|Overall Study|Physician Decision|0|||
163021033|NCT04696055|588779563|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
163021034|NCT04696055|588779564|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
163021035|NCT04696055|588779563|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
163021036|NCT04696055|588779564|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
163021037|NCT04696055|588779563|FG000|Overall Study|Subject Decision|1|||
163021038|NCT04696055|588779564|FG001|Overall Study|Subject Decision|2|||
163021039|NCT03969901|588779565|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163021040|NCT03969901|588779566|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163021041|NCT03969901|588779567|FG002|Overall Study|Withdrawal by parent/guardian|0|||
163021042|NCT03969901|588779568|FG003|Overall Study|Withdrawal by parent/guardian|0|||
163021043|NCT03969901|588779569|FG004|Overall Study|Withdrawal by parent/guardian|1|||
163021044|NCT03969901|588779570|FG005|Overall Study|Withdrawal by parent/guardian|0|||
163021045|NCT03969901|588779571|FG006|Overall Study|Withdrawal by parent/guardian|0|||
163021046|NCT03969901|588779572|FG007|Overall Study|Withdrawal by parent/guardian|1|||
163021047|NCT03969901|588779573|FG008|Overall Study|Withdrawal by parent/guardian|1|||
163021048|NCT03969901|588779574|FG009|Overall Study|Withdrawal by parent/guardian|0|||
163021049|NCT00348595|588779575|FG000|Overall Study|Adverse Event|5|||
163021050|NCT00348595|588779576|FG001|Overall Study|Adverse Event|8|||
163021051|NCT01920958|588779577|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
163021052|NCT03192306|588779582|FG000|Overall Study|Did not treat cold sore during study|149|||
163021053|NCT03192306|588779583|FG001|Overall Study|Did not treat cold sore during study|143|||
163021054|NCT03192306|588779582|FG000|Overall Study|Withdrawal by Subject|1|||
163021055|NCT03192306|588779583|FG001|Overall Study|Withdrawal by Subject|1|||
163021056|NCT03192306|588779582|FG000|Overall Study|Lost to Follow-up|1|||
163021057|NCT03192306|588779583|FG001|Overall Study|Lost to Follow-up|0|||
163021058|NCT03192306|588779582|FG000|Overall Study|Protocol Violation|1|||
163021059|NCT03192306|588779583|FG001|Overall Study|Protocol Violation|1|||
163021060|NCT02589626|588779588|FG000|Overall Study|Other than the reason specified|1|||
163021061|NCT02589626|588779589|FG001|Overall Study|Other than the reason specified|0|||
163216860|NCT03739112|589510281|FG000|Overall Study|Protocol Deviation|12|||
163021062|NCT02589626|588779588|FG000|Overall Study|Withdrawal by Subject|1|||
163021063|NCT02589626|588779589|FG001|Overall Study|Withdrawal by Subject|1|||
163021064|NCT02589626|588779588|FG000|Overall Study|Adverse Event|1|||
163021065|NCT02589626|588779589|FG001|Overall Study|Adverse Event|1|||
163216861|NCT03739112|589510282|FG001|Overall Study|Protocol Deviation|9|||
163216862|NCT03739112|589510281|FG000|Overall Study|Physician Decision|1|||
163216863|NCT03739112|589510282|FG001|Overall Study|Physician Decision|0|||
163216864|NCT03739112|589510281|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
163216865|NCT03739112|589510282|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
163216866|NCT03739112|589510281|FG000|Overall Study|Site went on hold|65|||
163216867|NCT03739112|589510282|FG001|Overall Study|Site went on hold|67|||
163216868|NCT03739112|589510281|FG000|Overall Study|Other than specified|8|||
163216869|NCT03739112|589510282|FG001|Overall Study|Other than specified|5|||
163216870|NCT03739112|589510281|FG000|Overall Study|Randomized but not vaccinated|31|||
163021066|NCT00379080|588779590|FG000|Overall Study|Withdrawal by Subject|0|||
163021067|NCT00379080|588779591|FG001|Overall Study|Withdrawal by Subject|4|||
163021068|NCT00379080|588779592|FG002|Overall Study|Withdrawal by Subject|0|||
163021069|NCT01089608|588779593|FG000|Overall Study|Adverse Event|0|||
163021070|NCT01089608|588779594|FG001|Overall Study|Adverse Event|4|||
163021071|NCT01089608|588779593|FG000|Overall Study|Lost to Follow-up|0|||
163021072|NCT01089608|588779594|FG001|Overall Study|Lost to Follow-up|2|||
163021073|NCT00280397|588779595|FG000|Overall Study|Adverse Event|1|||
163021074|NCT01028014|588779601|FG000|Overall Study|Lost to Follow-up|1|||
163021075|NCT01028014|588779602|FG001|Overall Study|Lost to Follow-up|2|||
163021076|NCT01028014|588779603|FG002|Overall Study|Lost to Follow-up|0|||
163021077|NCT01028014|588779604|FG003|Overall Study|Lost to Follow-up|1|||
163021078|NCT01028014|588779605|FG004|Overall Study|Lost to Follow-up|1|||
163021079|NCT01028014|588779606|FG005|Overall Study|Lost to Follow-up|2|||
163021080|NCT01127451|588779607|FG000|Overall Study|Other|2|||
163021081|NCT01127451|588779608|FG001|Overall Study|Other|1|||
163021082|NCT01127451|588779607|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
163021083|NCT01127451|588779608|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
163021084|NCT01127451|588779607|FG000|Overall Study|Death|22|||
163021085|NCT01127451|588779608|FG001|Overall Study|Death|17|||
163021086|NCT01127451|588779607|FG000|Overall Study|Lost to Follow-up|3|||
163021087|NCT01127451|588779608|FG001|Overall Study|Lost to Follow-up|0|||
163021088|NCT01127451|588779607|FG000|Overall Study|Administrative Reason by Sponsor|2|||
163021089|NCT01127451|588779608|FG001|Overall Study|Administrative Reason by Sponsor|2|||
163021090|NCT00425061|588779609|FG000|Overall Study|Adverse Event|1|||
163021091|NCT00425061|588779610|FG001|Overall Study|Adverse Event|0|||
163021092|NCT00425061|588779611|FG002|Overall Study|Adverse Event|0|||
163021093|NCT00425061|588779612|FG003|Overall Study|Adverse Event|2|||
163021094|NCT00425061|588779613|FG004|Overall Study|Adverse Event|2|||
163021095|NCT00425061|588779614|FG005|Overall Study|Adverse Event|0|||
163021096|NCT00425061|588779615|FG006|Overall Study|Adverse Event|0|||
163021097|NCT00425061|588779609|FG000|Overall Study|Lost to Follow-up|0|||
163021098|NCT00425061|588779610|FG001|Overall Study|Lost to Follow-up|1|||
163021099|NCT00425061|588779611|FG002|Overall Study|Lost to Follow-up|0|||
163021100|NCT00425061|588779612|FG003|Overall Study|Lost to Follow-up|0|||
163021101|NCT00425061|588779613|FG004|Overall Study|Lost to Follow-up|0|||
163021102|NCT00425061|588779614|FG005|Overall Study|Lost to Follow-up|0|||
163021103|NCT00425061|588779615|FG006|Overall Study|Lost to Follow-up|0|||
163021104|NCT00425061|588779609|FG000|Overall Study|Protocol Violation|1|||
163021105|NCT00425061|588779610|FG001|Overall Study|Protocol Violation|0|||
163021106|NCT00425061|588779611|FG002|Overall Study|Protocol Violation|0|||
163021107|NCT00425061|588779612|FG003|Overall Study|Protocol Violation|0|||
163021108|NCT00425061|588779613|FG004|Overall Study|Protocol Violation|0|||
163021109|NCT00425061|588779614|FG005|Overall Study|Protocol Violation|0|||
163021110|NCT00425061|588779615|FG006|Overall Study|Protocol Violation|0|||
163021111|NCT00425061|588779609|FG000|Overall Study|Withdrawal by Subject|0|||
163021112|NCT00425061|588779610|FG001|Overall Study|Withdrawal by Subject|1|||
163021113|NCT00425061|588779611|FG002|Overall Study|Withdrawal by Subject|0|||
163021114|NCT00425061|588779612|FG003|Overall Study|Withdrawal by Subject|0|||
163021115|NCT00425061|588779613|FG004|Overall Study|Withdrawal by Subject|1|||
163021116|NCT00425061|588779614|FG005|Overall Study|Withdrawal by Subject|0|||
163021117|NCT00425061|588779615|FG006|Overall Study|Withdrawal by Subject|3|||
163021118|NCT00425061|588779609|FG000|Overall Study|Sponsor's request|0|||
163021119|NCT00425061|588779610|FG001|Overall Study|Sponsor's request|0|||
163021120|NCT00425061|588779611|FG002|Overall Study|Sponsor's request|0|||
163021121|NCT00425061|588779612|FG003|Overall Study|Sponsor's request|0|||
163021122|NCT00425061|588779613|FG004|Overall Study|Sponsor's request|19|||
163021123|NCT00425061|588779614|FG005|Overall Study|Sponsor's request|4|||
163021124|NCT00425061|588779615|FG006|Overall Study|Sponsor's request|15|||
163021125|NCT00425061|588779609|FG000|Overall Study|Physician Decision|0|||
163021126|NCT00425061|588779610|FG001|Overall Study|Physician Decision|0|||
163021127|NCT00425061|588779611|FG002|Overall Study|Physician Decision|0|||
163021128|NCT00425061|588779612|FG003|Overall Study|Physician Decision|0|||
163021129|NCT00425061|588779613|FG004|Overall Study|Physician Decision|1|||
163021130|NCT00425061|588779614|FG005|Overall Study|Physician Decision|0|||
163021131|NCT00425061|588779615|FG006|Overall Study|Physician Decision|0|||
163021132|NCT00425061|588779609|FG000|Overall Study|Other|0|||
163021133|NCT00425061|588779610|FG001|Overall Study|Other|0|||
163021134|NCT00425061|588779611|FG002|Overall Study|Other|0|||
163021135|NCT00425061|588779612|FG003|Overall Study|Other|0|||
163021136|NCT00425061|588779613|FG004|Overall Study|Other|3|||
163021137|NCT00425061|588779614|FG005|Overall Study|Other|0|||
163021138|NCT00425061|588779615|FG006|Overall Study|Other|1|||
163021139|NCT02111577|588779616|FG000|Overall Study|Protocol Violation|2|||
163021140|NCT02111577|588779617|FG001|Overall Study|Protocol Violation|0|||
163021141|NCT02111577|588779616|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
163021142|NCT02111577|588779617|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
163021143|NCT02111577|588779616|FG000|Overall Study|Failure to produce study treatment|6|||
163021144|NCT02111577|588779617|FG001|Overall Study|Failure to produce study treatment|0|||
163329962|NCT00641537|589917751|FG003|96-week Period|Lost to Follow-up|2|||
163329963|NCT00641537|589917752|FG004|96-week Period|Lost to Follow-up|4|||
163329964|NCT00641537|589917753|FG005|96-week Period|Lost to Follow-up|0|||
163329965|NCT00641537|589917754|FG006|96-week Period|Lost to Follow-up|1|||
163021145|NCT02111577|588779616|FG000|Overall Study|Death|518|||
163021146|NCT02111577|588779617|FG001|Overall Study|Death|254|||
163329966|NCT00641537|589917755|FG007|96-week Period|Lost to Follow-up|0|||
163021147|NCT02111577|588779616|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
163021148|NCT02111577|588779617|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
163021149|NCT02111577|588779616|FG000|Overall Study|Adverse Event|1|||
163021150|NCT02111577|588779617|FG001|Overall Study|Adverse Event|1|||
163021151|NCT02111577|588779616|FG000|Overall Study|Withdrawal by Subject|51|||
163021152|NCT02111577|588779617|FG001|Overall Study|Withdrawal by Subject|23|||
163021153|NCT02111577|588779616|FG000|Overall Study|Disease progression|0|||
163021154|NCT02111577|588779617|FG001|Overall Study|Disease progression|1|||
163021155|NCT02111577|588779616|FG000|Overall Study|Lost to Follow-up|19|||
163021156|NCT02111577|588779617|FG001|Overall Study|Lost to Follow-up|10|||
163021157|NCT02429778|588779619|FG000|Overall Study|Lost to Follow-up|2|||
163021158|NCT02429778|588779620|FG001|Overall Study|Lost to Follow-up|0|||
163021159|NCT02429778|588779619|FG000|Overall Study|Withdrawal by Subject|5|||
163021160|NCT02429778|588779620|FG001|Overall Study|Withdrawal by Subject|0|||
163021161|NCT04590586|588779627|FG000|Overall Study|Death|7|||
163021162|NCT04590586|588779628|FG001|Overall Study|Death|1|||
163021163|NCT04590586|588779629|FG002|Overall Study|Death|37|||
163021164|NCT04590586|588779630|FG003|Overall Study|Death|34|||
163021165|NCT04590586|588779631|FG004|Overall Study|Death|19|||
163021166|NCT04590586|588779632|FG005|Overall Study|Death|3|||
163021167|NCT04590586|588779627|FG000|Overall Study|Lost to Follow-up|3|||
163021168|NCT04590586|588779628|FG001|Overall Study|Lost to Follow-up|0|||
163021169|NCT04590586|588779629|FG002|Overall Study|Lost to Follow-up|11|||
163021170|NCT04590586|588779630|FG003|Overall Study|Lost to Follow-up|11|||
163021171|NCT04590586|588779631|FG004|Overall Study|Lost to Follow-up|6|||
163021172|NCT04590586|588779632|FG005|Overall Study|Lost to Follow-up|0|||
163021173|NCT04590586|588779627|FG000|Overall Study|Withdrawal by Subject|0|||
163021174|NCT04590586|588779628|FG001|Overall Study|Withdrawal by Subject|0|||
163021175|NCT04590586|588779629|FG002|Overall Study|Withdrawal by Subject|6|||
163021176|NCT04590586|588779630|FG003|Overall Study|Withdrawal by Subject|0|||
163021177|NCT04590586|588779631|FG004|Overall Study|Withdrawal by Subject|3|||
163021178|NCT04590586|588779632|FG005|Overall Study|Withdrawal by Subject|0|||
163021179|NCT04590586|588779627|FG000|Overall Study|Other|3|||
163021180|NCT04590586|588779628|FG001|Overall Study|Other|0|||
163021181|NCT04590586|588779629|FG002|Overall Study|Other|1|||
163021182|NCT04590586|588779630|FG003|Overall Study|Other|1|||
163021183|NCT04590586|588779631|FG004|Overall Study|Other|2|||
163021184|NCT04590586|588779632|FG005|Overall Study|Other|1|||
163021185|NCT01609543|588779633|FG000|Overall Study|Disease Progression|28|||
163021186|NCT01609543|588779633|FG000|Overall Study|Adverse Event|5|||
163021187|NCT01609543|588779633|FG000|Overall Study|Withdrawal by Subject|1|||
163021188|NCT01609543|588779633|FG000|Overall Study|Protocol Violation|1|||
163021189|NCT01609543|588779633|FG000|Overall Study|Death|7|||
163021190|NCT01893281|588779634|FG000|Overall Study|Adverse Event|1|||
163021191|NCT01893281|588779634|FG000|Overall Study|Protocol Violation|1|||
163021192|NCT01893281|588779634|FG000|Overall Study|Withdrawal by Subject|1|||
163021193|NCT03990571|588779640|FG000|Overall Study|Withdrawal by Subject|1|||
163021194|NCT03990571|588779640|FG000|Overall Study|Insurance Issues|3|||
163021195|NCT03990571|588779640|FG000|Overall Study|Covid Restrictions|2|||
163021196|NCT03605862|588779641|FG000|Overall Study|Withdrawal by Subject|12|||
163021197|NCT03605862|588779642|FG001|Overall Study|Withdrawal by Subject|9|||
163021198|NCT03605862|588779641|FG000|Overall Study|Adverse Event|2|||
163021199|NCT03605862|588779642|FG001|Overall Study|Adverse Event|1|||
163021200|NCT03605862|588779641|FG000|Overall Study|Physician Decision|3|||
163021201|NCT03605862|588779642|FG001|Overall Study|Physician Decision|1|||
163021202|NCT03605862|588779641|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
163329967|NCT00641537|589917748|FG000|96-week Period|Protocol Violation|0|||
163329968|NCT00641537|589917749|FG001|96-week Period|Protocol Violation|1|||
163329969|NCT00641537|589917750|FG002|96-week Period|Protocol Violation|0|||
163329970|NCT00641537|589917751|FG003|96-week Period|Protocol Violation|1|||
163329971|NCT00641537|589917752|FG004|96-week Period|Protocol Violation|0|||
163329972|NCT00641537|589917753|FG005|96-week Period|Protocol Violation|1|||
163021203|NCT03605862|588779642|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
163021204|NCT00675428|588779644|FG000|Overall Study|Disease Progression|2|||
163021205|NCT00675428|588779645|FG001|Overall Study|Disease Progression|2|||
163021206|NCT00675428|588779644|FG000|Overall Study|No Disease Response After Cycle 6|0|||
163021207|NCT00675428|588779645|FG001|Overall Study|No Disease Response After Cycle 6|1|||
163021208|NCT00675428|588779644|FG000|Overall Study|Physician Decision|1|||
163021209|NCT00675428|588779645|FG001|Overall Study|Physician Decision|0|||
163021210|NCT04105218|588779646|FG000|Overall Study|Withdrawal by Subject|3|||
163021211|NCT04105218|588779647|FG001|Overall Study|Withdrawal by Subject|2|||
163329973|NCT00641537|589917754|FG006|96-week Period|Protocol Violation|0|||
163021212|NCT04105218|588779646|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
163021213|NCT04105218|588779647|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
163021214|NCT04105218|588779646|FG000|Overall Study|Failed screening tests|2|||
163021215|NCT04105218|588779647|FG001|Overall Study|Failed screening tests|1|||
163329974|NCT00641537|589917755|FG007|96-week Period|Protocol Violation|0|||
163329975|NCT00641537|589917748|FG000|96-week Period|Death|2|||
163329976|NCT00641537|589917749|FG001|96-week Period|Death|0|||
163329977|NCT00641537|589917750|FG002|96-week Period|Death|1|||
163329978|NCT00641537|589917751|FG003|96-week Period|Death|0|||
163329979|NCT00641537|589917752|FG004|96-week Period|Death|0|||
163329980|NCT00641537|589917753|FG005|96-week Period|Death|0|||
163329981|NCT00641537|589917754|FG006|96-week Period|Death|0|||
163329982|NCT00641537|589917755|FG007|96-week Period|Death|0|||
163329983|NCT00641537|589917748|FG000|96-week Period|Other|4|||
163329984|NCT00641537|589917749|FG001|96-week Period|Other|7|||
163329985|NCT00641537|589917750|FG002|96-week Period|Other|14|||
163329986|NCT00641537|589917751|FG003|96-week Period|Other|9|||
163329987|NCT00641537|589917752|FG004|96-week Period|Other|11|||
163329988|NCT00641537|589917753|FG005|96-week Period|Other|6|||
163329989|NCT00641537|589917754|FG006|96-week Period|Other|4|||
163329990|NCT00641537|589917755|FG007|96-week Period|Other|6|||
163329991|NCT00641537|589917748|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
163329992|NCT00641537|589917749|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
163329993|NCT00641537|589917750|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
163329994|NCT00641537|589917751|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
163329995|NCT00641537|589917752|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
163329996|NCT00641537|589917753|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
163329997|NCT00641537|589917754|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
163329998|NCT00641537|589917755|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
163329999|NCT00641537|589917748|FG000|24-Week Supplemental Follow-up Period|Other|0|||
163330000|NCT00641537|589917749|FG001|24-Week Supplemental Follow-up Period|Other|2|||
163330001|NCT00641537|589917750|FG002|24-Week Supplemental Follow-up Period|Other|2|||
163330002|NCT00641537|589917751|FG003|24-Week Supplemental Follow-up Period|Other|1|||
163330003|NCT00641537|589917752|FG004|24-Week Supplemental Follow-up Period|Other|3|||
163330004|NCT00641537|589917753|FG005|24-Week Supplemental Follow-up Period|Other|0|||
163330005|NCT00641537|589917754|FG006|24-Week Supplemental Follow-up Period|Other|1|||
163330006|NCT00641537|589917755|FG007|24-Week Supplemental Follow-up Period|Other|1|||
163330007|NCT03229408|589917756|FG000|Overall Study|Withdrawal by Subject|4|||
163330008|NCT03229408|589917757|FG001|Overall Study|Withdrawal by Subject|1|||
163330009|NCT03229408|589917756|FG000|Overall Study|Adverse Event|2|||
163330010|NCT03229408|589917757|FG001|Overall Study|Adverse Event|0|||
163330011|NCT03229408|589917756|FG000|Overall Study|Pregnancy|0|||
163330012|NCT03229408|589917757|FG001|Overall Study|Pregnancy|1|||
163330013|NCT03229408|589917756|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
163330014|NCT03229408|589917757|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
163330015|NCT03745313|589917760|FG000|At 30 Days Follow-up|Death|2|||
163330016|NCT03745313|589917760|FG000|At 6 Months Follow-up|Death|1|||
163330017|NCT03745313|589917760|FG000|At 6 Months Follow-up|Missed Visit|1|||
163330018|NCT03745313|589917760|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
163330019|NCT03745313|589917760|FG000|At 1 Year Follow-up|Death|2|||
163330020|NCT03745313|589917760|FG000|At 1 Year Follow-up|Missed Visit|2|||
163330021|NCT03745313|589917760|FG000|At 2 Year Follow-up|Missed Visit|1|||
163330022|NCT02052440|589917764|FG000|Overall Study|Withdrawal by Subject|0|||
163330023|NCT02052440|589917765|FG001|Overall Study|Withdrawal by Subject|1|||
163330024|NCT01367236|589917766|FG000|Overall Study|Withdrawal by Subject|3|||
163330025|NCT01367236|589917767|FG001|Overall Study|Withdrawal by Subject|1|||
163330026|NCT02235298|589917768|FG000|Overall Study|Lost to Follow-up|6|||
163330027|NCT02235298|589917769|FG001|Overall Study|Lost to Follow-up|5|||
163330028|NCT02235298|589917768|FG000|Overall Study|Adverse Event|2|||
163330029|NCT02235298|589917769|FG001|Overall Study|Adverse Event|2|||
163330030|NCT02235298|589917768|FG000|Overall Study|Withdrawal by Subject|0|||
163330031|NCT02235298|589917769|FG001|Overall Study|Withdrawal by Subject|1|||
163330032|NCT02628626|589917774|FG000|Overall Study|Withdrawal by Subject|2|||
163330033|NCT02628626|589917775|FG001|Overall Study|Withdrawal by Subject|2|||
163330034|NCT01593020|589917776|FG000|Overall Study|Adverse Event|1|||
163330035|NCT01593020|589917777|FG001|Overall Study|Adverse Event|1|||
163330036|NCT01593020|589917776|FG000|Overall Study|Death|0|||
163330037|NCT01593020|589917777|FG001|Overall Study|Death|1|||
163330038|NCT01593020|589917776|FG000|Overall Study|Ineligible|1|||
163021216|NCT02553499|588779652|FG000|Overall Study|Adverse Event|0|||
163330039|NCT01593020|589917777|FG001|Overall Study|Ineligible|0|||
163330040|NCT05525572|589917780|FG000|Overall Study|Lost to Follow-up|2|||
163330041|NCT00489307|589917787|FG000|Overall Study|Death|1|||
163330042|NCT00489307|589917788|FG001|Overall Study|Death|1|||
163330043|NCT00489307|589917787|FG000|Overall Study|Lost to Follow-up|2|||
163405205|NCT01464307|590193551|FG001|Main Period|Withdrawal by Subject|2|||
163330044|NCT00489307|589917788|FG001|Overall Study|Lost to Follow-up|2|||
163330045|NCT00489307|589917787|FG000|Overall Study|Physician Decision|1|||
163330046|NCT00489307|589917788|FG001|Overall Study|Physician Decision|0|||
163330047|NCT00489307|589917787|FG000|Overall Study|Withdrawal by Subject|2|||
163330048|NCT00489307|589917788|FG001|Overall Study|Withdrawal by Subject|4|||
163330049|NCT00489307|589917787|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
163330050|NCT00489307|589917788|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
163330051|NCT00489307|589917787|FG000|Overall Study|Surgery after assignment|1|||
163330052|NCT00489307|589917788|FG001|Overall Study|Surgery after assignment|0|||
163330053|NCT00489307|589917787|FG000|Overall Study|Did not fill up the forms|2|||
163330054|NCT00489307|589917788|FG001|Overall Study|Did not fill up the forms|1|||
163330055|NCT00489307|589917787|FG000|Overall Study|Patient or family refusal|5|||
163330056|NCT00489307|589917788|FG001|Overall Study|Patient or family refusal|9|||
163330057|NCT03227861|589917791|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
163330058|NCT03227861|589917791|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
163330059|NCT03227861|589917791|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
163330060|NCT03227861|589917791|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
163330061|NCT03227861|589917791|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
163330062|NCT03227861|589917791|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
163330063|NCT03227861|589917791|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
163330064|NCT03227861|589917791|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
163330065|NCT03227861|589917791|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
163330066|NCT03227861|589917791|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
163330067|NCT05613907|589917792|FG000|Overall Study|Lost to Follow-up|5|||
163330068|NCT05613907|589917792|FG000|Overall Study|Death|3|||
163330069|NCT05613907|589917792|FG000|Overall Study|Withdrawal by Subject|2|||
163330070|NCT03789656|589917802|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
163330071|NCT03789656|589917803|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
163330072|NCT03789656|589917804|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
163330073|NCT03789656|589917805|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
163330074|NCT03789656|589917806|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
163330075|NCT03789656|589917802|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
163330076|NCT03789656|589917803|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
163330077|NCT03789656|589917804|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
163330078|NCT03789656|589917805|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
163330079|NCT03789656|589917806|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
163330080|NCT03789656|589917802|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
163330081|NCT03789656|589917803|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
163330082|NCT03789656|589917804|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
163330083|NCT03789656|589917805|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
163330084|NCT03789656|589917806|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
163330085|NCT03789656|589917802|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
163330086|NCT03789656|589917803|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
163330087|NCT03789656|589917804|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
163330088|NCT03789656|589917805|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
163330089|NCT03789656|589917806|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
163330090|NCT04484623|589917813|FG000|Overall Study|Lost to Follow-up|0|||
163330091|NCT04484623|589917814|FG001|Overall Study|Lost to Follow-up|1|||
163330092|NCT04484623|589917813|FG000|Overall Study|Protocol Deviation|1|||
163330093|NCT04484623|589917814|FG001|Overall Study|Protocol Deviation|0|||
163330094|NCT04484623|589917813|FG000|Overall Study|Physician Decision|1|||
163330095|NCT04484623|589917814|FG001|Overall Study|Physician Decision|0|||
163330096|NCT04484623|589917813|FG000|Overall Study|Withdrawal by Subject|11|||
163330097|NCT04484623|589917814|FG001|Overall Study|Withdrawal by Subject|8|||
163330098|NCT04484623|589917813|FG000|Overall Study|Ongoing|94|||
163330099|NCT04484623|589917814|FG001|Overall Study|Ongoing|84|||
163330100|NCT05886777|589917815|FG000|Overall Study|Lost to Follow-up|1|||
163330101|NCT05886777|589917816|FG001|Overall Study|Lost to Follow-up|0|||
163021217|NCT02553499|588779653|FG001|Overall Study|Adverse Event|0|||
163021218|NCT02553499|588779654|FG002|Overall Study|Adverse Event|0|||
163021219|NCT02553499|588779655|FG003|Overall Study|Adverse Event|0|||
163021220|NCT02553499|588779656|FG004|Overall Study|Adverse Event|0|||
163330102|NCT05886777|589917817|FG002|Overall Study|Lost to Follow-up|2|||
163330103|NCT05886777|589917818|FG003|Overall Study|Lost to Follow-up|1|||
163330104|NCT05886777|589917819|FG004|Overall Study|Lost to Follow-up|0|||
163330105|NCT05886777|589917820|FG005|Overall Study|Lost to Follow-up|2|||
163330106|NCT05886777|589917821|FG006|Overall Study|Lost to Follow-up|0|||
163330107|NCT05886777|589917815|FG000|Overall Study|Other|0|||
163330108|NCT05886777|589917816|FG001|Overall Study|Other|2|||
163330109|NCT05886777|589917817|FG002|Overall Study|Other|1|||
163330110|NCT05886777|589917818|FG003|Overall Study|Other|0|||
163330111|NCT05886777|589917819|FG004|Overall Study|Other|0|||
163330112|NCT05886777|589917820|FG005|Overall Study|Other|0|||
163330113|NCT05886777|589917821|FG006|Overall Study|Other|0|||
163021221|NCT02553499|588779657|FG005|Overall Study|Adverse Event|0|||
163021222|NCT02553499|588779658|FG006|Overall Study|Adverse Event|1|||
163021223|NCT02553499|588779659|FG007|Overall Study|Adverse Event|1|||
163021224|NCT02553499|588779660|FG008|Overall Study|Adverse Event|0|||
163021225|NCT02553499|588779661|FG009|Overall Study|Adverse Event|0|||
163021226|NCT02553499|588779662|FG010|Overall Study|Adverse Event|0|||
163021227|NCT02553499|588779663|FG011|Overall Study|Adverse Event|0|||
163021228|NCT02553499|588779664|FG012|Overall Study|Adverse Event|0|||
163021229|NCT02553499|588779665|FG013|Overall Study|Adverse Event|1|||
163021230|NCT02553499|588779652|FG000|Overall Study|Death|0|||
163021231|NCT02553499|588779653|FG001|Overall Study|Death|1|||
163021232|NCT02553499|588779654|FG002|Overall Study|Death|1|||
163021233|NCT02553499|588779655|FG003|Overall Study|Death|0|||
163021234|NCT02553499|588779656|FG004|Overall Study|Death|1|||
163021235|NCT02553499|588779657|FG005|Overall Study|Death|2|||
163021236|NCT02553499|588779658|FG006|Overall Study|Death|0|||
163021237|NCT02553499|588779659|FG007|Overall Study|Death|0|||
163021238|NCT02553499|588779660|FG008|Overall Study|Death|0|||
163021239|NCT02553499|588779661|FG009|Overall Study|Death|0|||
163021240|NCT02553499|588779662|FG010|Overall Study|Death|1|||
163021241|NCT02553499|588779663|FG011|Overall Study|Death|0|||
163021242|NCT02553499|588779664|FG012|Overall Study|Death|0|||
163021243|NCT02553499|588779665|FG013|Overall Study|Death|0|||
163021244|NCT02553499|588779652|FG000|Overall Study|Lost to Follow-up|0|||
163021245|NCT02553499|588779653|FG001|Overall Study|Lost to Follow-up|0|||
163021246|NCT02553499|588779654|FG002|Overall Study|Lost to Follow-up|0|||
163021247|NCT02553499|588779655|FG003|Overall Study|Lost to Follow-up|0|||
163021248|NCT02553499|588779656|FG004|Overall Study|Lost to Follow-up|0|||
163021249|NCT02553499|588779657|FG005|Overall Study|Lost to Follow-up|0|||
163021250|NCT02553499|588779658|FG006|Overall Study|Lost to Follow-up|1|||
163021251|NCT02553499|588779659|FG007|Overall Study|Lost to Follow-up|0|||
163021252|NCT02553499|588779660|FG008|Overall Study|Lost to Follow-up|0|||
163021253|NCT02553499|588779661|FG009|Overall Study|Lost to Follow-up|0|||
163021254|NCT02553499|588779662|FG010|Overall Study|Lost to Follow-up|0|||
163021255|NCT02553499|588779663|FG011|Overall Study|Lost to Follow-up|0|||
163021256|NCT02553499|588779664|FG012|Overall Study|Lost to Follow-up|0|||
163021257|NCT02553499|588779665|FG013|Overall Study|Lost to Follow-up|0|||
163021258|NCT02553499|588779652|FG000|Overall Study|Physician Decision|0|||
163021259|NCT02553499|588779653|FG001|Overall Study|Physician Decision|1|||
163021260|NCT02553499|588779654|FG002|Overall Study|Physician Decision|1|||
163021261|NCT02553499|588779655|FG003|Overall Study|Physician Decision|0|||
163021262|NCT02553499|588779656|FG004|Overall Study|Physician Decision|1|||
163021263|NCT02553499|588779657|FG005|Overall Study|Physician Decision|0|||
163021264|NCT02553499|588779658|FG006|Overall Study|Physician Decision|0|||
163216871|NCT03739112|589510282|FG001|Overall Study|Randomized but not vaccinated|25|||
163216872|NCT00588822|589510284|FG000|Overall Study|progression of disease|8|||
163021265|NCT02553499|588779659|FG007|Overall Study|Physician Decision|1|||
163216873|NCT01727141|589510288|FG000|Overall Study|Physician Decision|0|||
163021266|NCT02553499|588779660|FG008|Overall Study|Physician Decision|1|||
163021267|NCT02553499|588779661|FG009|Overall Study|Physician Decision|2|||
163021268|NCT02553499|588779662|FG010|Overall Study|Physician Decision|1|||
163021269|NCT02553499|588779663|FG011|Overall Study|Physician Decision|3|||
163021270|NCT02553499|588779664|FG012|Overall Study|Physician Decision|1|||
163021271|NCT02553499|588779665|FG013|Overall Study|Physician Decision|0|||
163021272|NCT02553499|588779652|FG000|Overall Study|Progressive Disease|0|||
163216874|NCT01727141|589510289|FG001|Overall Study|Physician Decision|1|||
163216875|NCT01727141|589510290|FG002|Overall Study|Physician Decision|0|||
163216876|NCT01727141|589510291|FG003|Overall Study|Physician Decision|2|||
163216877|NCT01727141|589510288|FG000|Overall Study|Lost to Follow-up|0|||
163216878|NCT01727141|589510289|FG001|Overall Study|Lost to Follow-up|2|||
163216879|NCT01727141|589510290|FG002|Overall Study|Lost to Follow-up|0|||
163216880|NCT01727141|589510291|FG003|Overall Study|Lost to Follow-up|0|||
163216881|NCT01727141|589510288|FG000|Overall Study|Death|0|||
163216882|NCT01727141|589510289|FG001|Overall Study|Death|1|||
163216883|NCT01727141|589510290|FG002|Overall Study|Death|1|||
163216884|NCT01727141|589510291|FG003|Overall Study|Death|1|||
163216885|NCT01727141|589510288|FG000|Overall Study|Protocol deviation|1|||
163216886|NCT01727141|589510289|FG001|Overall Study|Protocol deviation|1|||
163216887|NCT01727141|589510290|FG002|Overall Study|Protocol deviation|0|||
163216888|NCT01727141|589510291|FG003|Overall Study|Protocol deviation|1|||
163216889|NCT01727141|589510288|FG000|Overall Study|Withdrawal by Subject|4|||
163216890|NCT01727141|589510289|FG001|Overall Study|Withdrawal by Subject|4|||
163216891|NCT01727141|589510290|FG002|Overall Study|Withdrawal by Subject|2|||
163216892|NCT01727141|589510291|FG003|Overall Study|Withdrawal by Subject|11|||
163216893|NCT02529137|589510292|FG000|Overall Study|Discontinuation for different reasons|8|||
163216894|NCT02731729|589510295|FG000|Overall Study|Death|2|||
163216895|NCT02731729|589510296|FG001|Overall Study|Death|2|||
163216896|NCT02731729|589510295|FG000|Overall Study|Study terminated by Sponsor|6|||
163216897|NCT02731729|589510296|FG001|Overall Study|Study terminated by Sponsor|6|||
163216898|NCT02731729|589510295|FG000|Overall Study|Withdrawal by Subject|1|||
163216899|NCT02731729|589510296|FG001|Overall Study|Withdrawal by Subject|0|||
163021273|NCT02553499|588779653|FG001|Overall Study|Progressive Disease|0|||
163021274|NCT02553499|588779654|FG002|Overall Study|Progressive Disease|0|||
163021275|NCT02553499|588779655|FG003|Overall Study|Progressive Disease|2|||
163021276|NCT02553499|588779656|FG004|Overall Study|Progressive Disease|1|||
163021277|NCT02553499|588779657|FG005|Overall Study|Progressive Disease|1|||
163021278|NCT02553499|588779658|FG006|Overall Study|Progressive Disease|1|||
163021279|NCT02553499|588779659|FG007|Overall Study|Progressive Disease|0|||
163021280|NCT02553499|588779660|FG008|Overall Study|Progressive Disease|0|||
163021281|NCT02553499|588779661|FG009|Overall Study|Progressive Disease|1|||
163021282|NCT02553499|588779662|FG010|Overall Study|Progressive Disease|0|||
163021283|NCT02553499|588779663|FG011|Overall Study|Progressive Disease|0|||
163021284|NCT02553499|588779664|FG012|Overall Study|Progressive Disease|2|||
163021285|NCT02553499|588779665|FG013|Overall Study|Progressive Disease|1|||
163021286|NCT02553499|588779652|FG000|Overall Study|Study Terminated by Sponsor|0|||
163021287|NCT02553499|588779653|FG001|Overall Study|Study Terminated by Sponsor|0|||
163021288|NCT02553499|588779654|FG002|Overall Study|Study Terminated by Sponsor|0|||
163021289|NCT02553499|588779655|FG003|Overall Study|Study Terminated by Sponsor|0|||
163021290|NCT02553499|588779656|FG004|Overall Study|Study Terminated by Sponsor|0|||
163021291|NCT02553499|588779657|FG005|Overall Study|Study Terminated by Sponsor|0|||
163021292|NCT02553499|588779658|FG006|Overall Study|Study Terminated by Sponsor|0|||
163021293|NCT02553499|588779659|FG007|Overall Study|Study Terminated by Sponsor|0|||
163021294|NCT02553499|588779660|FG008|Overall Study|Study Terminated by Sponsor|1|||
163021295|NCT02553499|588779661|FG009|Overall Study|Study Terminated by Sponsor|0|||
163021296|NCT02553499|588779662|FG010|Overall Study|Study Terminated by Sponsor|0|||
163021297|NCT02553499|588779663|FG011|Overall Study|Study Terminated by Sponsor|0|||
163021298|NCT02553499|588779664|FG012|Overall Study|Study Terminated by Sponsor|0|||
163021299|NCT02553499|588779665|FG013|Overall Study|Study Terminated by Sponsor|0|||
163021300|NCT02553499|588779652|FG000|Overall Study|Withdrawal by Subject|2|||
163021301|NCT02553499|588779653|FG001|Overall Study|Withdrawal by Subject|0|||
163021302|NCT02553499|588779654|FG002|Overall Study|Withdrawal by Subject|0|||
163021303|NCT02553499|588779655|FG003|Overall Study|Withdrawal by Subject|0|||
163021304|NCT02553499|588779656|FG004|Overall Study|Withdrawal by Subject|0|||
163021305|NCT02553499|588779657|FG005|Overall Study|Withdrawal by Subject|0|||
163021306|NCT02553499|588779658|FG006|Overall Study|Withdrawal by Subject|0|||
163021307|NCT02553499|588779659|FG007|Overall Study|Withdrawal by Subject|1|||
163021308|NCT02553499|588779660|FG008|Overall Study|Withdrawal by Subject|1|||
163021309|NCT02553499|588779661|FG009|Overall Study|Withdrawal by Subject|0|||
163021310|NCT02553499|588779662|FG010|Overall Study|Withdrawal by Subject|1|||
163021311|NCT02553499|588779663|FG011|Overall Study|Withdrawal by Subject|0|||
163021312|NCT02553499|588779664|FG012|Overall Study|Withdrawal by Subject|0|||
163021313|NCT02553499|588779665|FG013|Overall Study|Withdrawal by Subject|0|||
163021314|NCT01582178|588779666|FG000|Overall Study|Physician Decision|6|||
163021315|NCT01582178|588779667|FG001|Overall Study|Physician Decision|5|||
163021316|NCT00570063|588779668|FG000|Overall Study|Adverse Event|4|||
163021317|NCT00570063|588779669|FG001|Overall Study|Adverse Event|1|||
163021318|NCT00570063|588779668|FG000|Overall Study|Lack of Efficacy|0|||
163021319|NCT00570063|588779669|FG001|Overall Study|Lack of Efficacy|1|||
163021320|NCT00570063|588779668|FG000|Overall Study|Withdrawal by Subject|4|||
163021321|NCT00570063|588779669|FG001|Overall Study|Withdrawal by Subject|3|||
163021322|NCT00570063|588779668|FG000|Overall Study|Sponsor's Decision|7|||
163021323|NCT00570063|588779669|FG001|Overall Study|Sponsor's Decision|3|||
163021324|NCT00550043|588779673|FG000|Overall Study|Adverse Event|0|||
163021325|NCT00550043|588779674|FG001|Overall Study|Adverse Event|0|||
163021326|NCT00550043|588779675|FG002|Overall Study|Adverse Event|0|||
163021327|NCT00550043|588779676|FG003|Overall Study|Adverse Event|1|||
163021328|NCT00550043|588779677|FG004|Overall Study|Adverse Event|1|||
163021329|NCT00550043|588779673|FG000|Overall Study|Subject Withdrew Consent|0|||
163021330|NCT00550043|588779674|FG001|Overall Study|Subject Withdrew Consent|2|||
163021331|NCT00550043|588779675|FG002|Overall Study|Subject Withdrew Consent|1|||
163021332|NCT00550043|588779676|FG003|Overall Study|Subject Withdrew Consent|0|||
163021333|NCT00550043|588779677|FG004|Overall Study|Subject Withdrew Consent|0|||
163021334|NCT00550043|588779673|FG000|Overall Study|Other Reasons- Unspecified|0|||
163021335|NCT00550043|588779674|FG001|Overall Study|Other Reasons- Unspecified|1|||
163021336|NCT00550043|588779675|FG002|Overall Study|Other Reasons- Unspecified|0|||
163021337|NCT00550043|588779676|FG003|Overall Study|Other Reasons- Unspecified|1|||
163021338|NCT00550043|588779677|FG004|Overall Study|Other Reasons- Unspecified|0|||
163021339|NCT01031680|588779681|FG000|Overall Study|Adverse Event|8|||
163021340|NCT01031680|588779682|FG001|Overall Study|Adverse Event|3|||
163021341|NCT01031680|588779681|FG000|Overall Study|Lost to Follow-up|2|||
163021342|NCT01031680|588779682|FG001|Overall Study|Lost to Follow-up|10|||
163021343|NCT01031680|588779681|FG000|Overall Study|Withdrawal by Subject|12|||
163021344|NCT01031680|588779682|FG001|Overall Study|Withdrawal by Subject|16|||
163021345|NCT01031680|588779681|FG000|Overall Study|Death|2|||
163021346|NCT01031680|588779682|FG001|Overall Study|Death|1|||
163021347|NCT01031680|588779681|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
163021348|NCT01031680|588779682|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
163021349|NCT01031680|588779681|FG000|Overall Study|Poor/Non-compliance|5|||
163021350|NCT01031680|588779682|FG001|Overall Study|Poor/Non-compliance|6|||
163021351|NCT01031680|588779681|FG000|Overall Study|Safety|1|||
163021352|NCT01031680|588779682|FG001|Overall Study|Safety|0|||
163021353|NCT01031680|588779681|FG000|Overall Study|Incorrect Enrolment|1|||
163021354|NCT01031680|588779682|FG001|Overall Study|Incorrect Enrolment|2|||
163021355|NCT01031680|588779681|FG000|Overall Study|Administrative Reason by Sponsor|0|||
163021356|NCT01031680|588779682|FG001|Overall Study|Administrative Reason by Sponsor|1|||
163021357|NCT01031680|588779681|FG000|Overall Study|Various|0|||
163021358|NCT01031680|588779682|FG001|Overall Study|Various|2|||
163021359|NCT01186692|588779683|FG000|Overall Study|Not Catheterized|11|||
163021360|NCT01186692|588779683|FG000|Overall Study|Futher testing contraindicated implant|19|||
163021361|NCT01186692|588779683|FG000|Overall Study|Adverse Event|2|||
163021362|NCT00789698|588779684|FG000|Overall Study|Lack of Efficacy|10|||
163021363|NCT00789698|588779685|FG001|Overall Study|Lack of Efficacy|4|||
163021364|NCT00789698|588779686|FG002|Overall Study|Lack of Efficacy|5|||
163021365|NCT00789698|588779687|FG003|Overall Study|Lack of Efficacy|18|||
163021366|NCT00789698|588779684|FG000|Overall Study|Adverse Event|5|||
163021367|NCT00789698|588779685|FG001|Overall Study|Adverse Event|5|||
163021368|NCT00789698|588779686|FG002|Overall Study|Adverse Event|3|||
163021369|NCT00789698|588779687|FG003|Overall Study|Adverse Event|4|||
163021370|NCT00789698|588779684|FG000|Overall Study|Lost to Follow-up|5|||
163021371|NCT00789698|588779685|FG001|Overall Study|Lost to Follow-up|5|||
163021372|NCT00789698|588779686|FG002|Overall Study|Lost to Follow-up|2|||
163021373|NCT00789698|588779687|FG003|Overall Study|Lost to Follow-up|9|||
163021374|NCT00789698|588779684|FG000|Overall Study|Protocol Violation|6|||
163021375|NCT00789698|588779685|FG001|Overall Study|Protocol Violation|1|||
163021376|NCT00789698|588779686|FG002|Overall Study|Protocol Violation|2|||
163021377|NCT00789698|588779687|FG003|Overall Study|Protocol Violation|1|||
163021378|NCT00789698|588779684|FG000|Overall Study|Withdrawal by Subject|14|||
163021379|NCT00789698|588779685|FG001|Overall Study|Withdrawal by Subject|15|||
163021380|NCT00789698|588779686|FG002|Overall Study|Withdrawal by Subject|12|||
163021381|NCT00789698|588779687|FG003|Overall Study|Withdrawal by Subject|19|||
163021382|NCT00789698|588779684|FG000|Overall Study|Administrative|0|||
163021383|NCT00789698|588779685|FG001|Overall Study|Administrative|3|||
163021384|NCT00789698|588779686|FG002|Overall Study|Administrative|3|||
163021385|NCT00789698|588779687|FG003|Overall Study|Administrative|1|||
163021386|NCT01921101|588779688|FG000|Overall Study|Death|16|||
163021387|NCT01921101|588779689|FG001|Overall Study|Death|6|||
163021388|NCT00519428|588782119|FG000|Overall Study|Adverse Event|5|||
163021389|NCT00519428|588782120|FG001|Overall Study|Adverse Event|2|||
163021390|NCT00519428|588782121|FG002|Overall Study|Adverse Event|10|||
163021391|NCT00519428|588782119|FG000|Overall Study|Lost to Follow-up|7|||
163021392|NCT00519428|588782120|FG001|Overall Study|Lost to Follow-up|7|||
163021393|NCT00519428|588782121|FG002|Overall Study|Lost to Follow-up|6|||
163021394|NCT00519428|588782119|FG000|Overall Study|Withdrawal by Subject|8|||
163021395|NCT00519428|588782120|FG001|Overall Study|Withdrawal by Subject|3|||
163021396|NCT00519428|588782121|FG002|Overall Study|Withdrawal by Subject|7|||
163021397|NCT00519428|588782119|FG000|Overall Study|unstated|1|||
163021398|NCT00519428|588782120|FG001|Overall Study|unstated|3|||
163021399|NCT00519428|588782121|FG002|Overall Study|unstated|2|||
163021400|NCT00688701|588782123|FG000|Overall Study|Adverse Event|1|||
163021401|NCT00688701|588782124|FG001|Overall Study|Adverse Event|0|||
163021402|NCT00688701|588782125|FG002|Overall Study|Adverse Event|5|||
163021403|NCT00688701|588782126|FG003|Overall Study|Adverse Event|3|||
163021404|NCT00688701|588782123|FG000|Overall Study|Lack of Efficacy|0|||
163021405|NCT00688701|588782124|FG001|Overall Study|Lack of Efficacy|1|||
163021406|NCT00688701|588782125|FG002|Overall Study|Lack of Efficacy|0|||
163021407|NCT00688701|588782126|FG003|Overall Study|Lack of Efficacy|0|||
163021408|NCT00688701|588782123|FG000|Overall Study|Withdrawal by Subject|3|||
163021409|NCT00688701|588782124|FG001|Overall Study|Withdrawal by Subject|3|||
163021410|NCT00688701|588782125|FG002|Overall Study|Withdrawal by Subject|4|||
163021411|NCT00688701|588782126|FG003|Overall Study|Withdrawal by Subject|8|||
163021412|NCT00688701|588782123|FG000|Overall Study|Poor compliance to protocol|0|||
163021413|NCT00688701|588782124|FG001|Overall Study|Poor compliance to protocol|1|||
163021414|NCT00688701|588782125|FG002|Overall Study|Poor compliance to protocol|1|||
163021415|NCT00688701|588782126|FG003|Overall Study|Poor compliance to protocol|0|||
163021416|NCT01275755|588782134|FG000|Double-blind Treatment Period|Adverse Event|0|||
163021417|NCT01275755|588782135|FG001|Double-blind Treatment Period|Adverse Event|2|||
163021418|NCT01275755|588782134|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
163021419|NCT01275755|588782135|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
163021420|NCT01275755|588782134|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
163021421|NCT01275755|588782135|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
163021422|NCT01275755|588782134|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
163021423|NCT01275755|588782135|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
163021424|NCT04420585|588782140|FG000|Overall Study|Adverse Event|1|||
163021425|NCT04420585|588782140|FG000|Overall Study|Never initiated medication|2|||
163021426|NCT03693612|588782143|FG000|Overall Study|Lost to Follow-up|0|||
163021427|NCT03693612|588782144|FG001|Overall Study|Lost to Follow-up|0|||
163021428|NCT03693612|588782145|FG002|Overall Study|Lost to Follow-up|0|||
163021429|NCT03693612|588782146|FG003|Overall Study|Lost to Follow-up|0|||
163021430|NCT03693612|588782147|FG004|Overall Study|Lost to Follow-up|1|||
163021431|NCT03693612|588782148|FG005|Overall Study|Lost to Follow-up|0|||
163021432|NCT03693612|588782149|FG006|Overall Study|Lost to Follow-up|0|||
163021433|NCT03693612|588782143|FG000|Overall Study|Withdrawal by Subject|0|||
163021434|NCT03693612|588782144|FG001|Overall Study|Withdrawal by Subject|0|||
163021435|NCT03693612|588782145|FG002|Overall Study|Withdrawal by Subject|1|||
163021436|NCT03693612|588782146|FG003|Overall Study|Withdrawal by Subject|0|||
163021437|NCT03693612|588782147|FG004|Overall Study|Withdrawal by Subject|2|||
163021438|NCT03693612|588782148|FG005|Overall Study|Withdrawal by Subject|0|||
163021439|NCT03693612|588782149|FG006|Overall Study|Withdrawal by Subject|0|||
163021440|NCT03693612|588782143|FG000|Overall Study|Study Terminated by Sponsor|0|||
163021441|NCT03693612|588782144|FG001|Overall Study|Study Terminated by Sponsor|1|||
163021442|NCT03693612|588782145|FG002|Overall Study|Study Terminated by Sponsor|0|||
163021443|NCT03693612|588782146|FG003|Overall Study|Study Terminated by Sponsor|0|||
163021444|NCT03693612|588782147|FG004|Overall Study|Study Terminated by Sponsor|3|||
163021445|NCT03693612|588782148|FG005|Overall Study|Study Terminated by Sponsor|0|||
163021446|NCT03693612|588782149|FG006|Overall Study|Study Terminated by Sponsor|0|||
163021447|NCT01669174|588782156|FG000|Overall Study|Subject withdrew consent|2|||
163021448|NCT01669174|588782157|FG001|Overall Study|Subject withdrew consent|2|||
163021449|NCT01669174|588782156|FG000|Overall Study|Lost to Follow-up|1|||
163021450|NCT01669174|588782157|FG001|Overall Study|Lost to Follow-up|0|||
163021451|NCT01669174|588782156|FG000|Overall Study|Adverse Event|2|||
163021452|NCT01669174|588782157|FG001|Overall Study|Adverse Event|2|||
163021453|NCT01669174|588782156|FG000|Overall Study|Administrative problems|1|||
163021454|NCT01669174|588782157|FG001|Overall Study|Administrative problems|2|||
163021455|NCT01953601|588782161|FG000|Part 1 (Base Study)|Adverse Event|24|||
163021456|NCT01953601|588782162|FG001|Part 1 (Base Study)|Adverse Event|37|||
163021457|NCT01953601|588782163|FG002|Part 1 (Base Study)|Adverse Event|15|||
163021458|NCT01953601|588782161|FG000|Part 1 (Base Study)|Death|2|||
163021459|NCT01953601|588782162|FG001|Part 1 (Base Study)|Death|0|||
163021460|NCT01953601|588782163|FG002|Part 1 (Base Study)|Death|3|||
163021461|NCT01953601|588782161|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
163021462|NCT01953601|588782162|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
163021463|NCT01953601|588782163|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
163021464|NCT01953601|588782161|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
163021465|NCT01953601|588782162|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
163405206|NCT01464307|590193550|FG000|Main Period|Predefined discontinuation criteria|2|||
163405207|NCT01464307|590193551|FG001|Main Period|Predefined discontinuation criteria|1|||
163021466|NCT01953601|588782163|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
163021467|NCT01953601|588782161|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
163021468|NCT01953601|588782162|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
163021469|NCT01953601|588782163|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
163021470|NCT01953601|588782161|FG000|Part 1 (Base Study)|Physician Decision|3|||
163021471|NCT01953601|588782162|FG001|Part 1 (Base Study)|Physician Decision|7|||
163021472|NCT01953601|588782163|FG002|Part 1 (Base Study)|Physician Decision|4|||
163021473|NCT01953601|588782161|FG000|Part 1 (Base Study)|Screen failure|1|||
163021474|NCT01953601|588782162|FG001|Part 1 (Base Study)|Screen failure|0|||
163021475|NCT01953601|588782163|FG002|Part 1 (Base Study)|Screen failure|1|||
163021476|NCT01953601|588782161|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
163021477|NCT01953601|588782162|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
163021478|NCT01953601|588782163|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
163021479|NCT01953601|588782161|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
163021480|NCT01953601|588782162|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
163021481|NCT01953601|588782163|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
163021482|NCT01953601|588782161|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
163021483|NCT01953601|588782162|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
163021484|NCT01953601|588782163|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
163021485|NCT01953601|588782161|FG000|Part 1 (Base Study)|Subject moved|2|||
163021486|NCT01953601|588782162|FG001|Part 1 (Base Study)|Subject moved|2|||
163021487|NCT01953601|588782163|FG002|Part 1 (Base Study)|Subject moved|1|||
163021488|NCT01953601|588782161|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
163021489|NCT01953601|588782162|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
163021490|NCT01953601|588782163|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
163405208|NCT01464307|590193550|FG000|Open-Label Extension Period|Adverse Event|15|||
163021491|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Adverse Event|1|||
163021492|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Adverse Event|1|||
163021493|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Adverse Event|10|||
163021494|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Death|0|||
163021495|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Death|3|||
163021496|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Death|0|||
163021497|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
163021498|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
163021499|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
163021500|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
163405209|NCT01464307|590193551|FG001|Open-Label Extension Period|Adverse Event|0|||
163021501|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
163021502|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
163021503|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Physician Decision|2|||
163021504|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Physician Decision|0|||
163021505|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Physician Decision|2|||
163021506|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
163021507|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
163021508|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
163021509|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
163021510|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
163021511|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
163021512|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
163021513|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
163021514|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
163021515|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Subject moved|0|||
163021516|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Subject moved|0|||
163021517|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Subject moved|1|||
163021518|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
163021519|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
163021520|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
163021521|NCT01905553|588782170|FG000|Period 2|Adverse Event|1|||
163021522|NCT01905553|588782171|FG001|Period 2|Adverse Event|0|||
163021523|NCT04310397|588782172|FG000|Overall Study|Lack of Efficacy|3|||
163021524|NCT04310397|588782172|FG000|Overall Study|Withdrawal by Subject|1|||
163021525|NCT03962790|588782175|FG000|Period 1|Adverse Event|0|||
163021526|NCT03962790|588782176|FG001|Period 1|Adverse Event|1|||
163021527|NCT03962790|588782175|FG000|Period 1|Failed to meet all eligibility criteria|1|||
163021528|NCT03962790|588782176|FG001|Period 1|Failed to meet all eligibility criteria|1|||
163021529|NCT03962790|588782175|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
163021530|NCT03962790|588782176|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
163021531|NCT03962790|588782175|FG000|Period 1|Withdrawal by Subject|1|||
163021532|NCT03962790|588782176|FG001|Period 1|Withdrawal by Subject|0|||
163021533|NCT01608087|588782184|FG000|Overall Study|Lost to Follow-up|0|||
163021534|NCT01608087|588782185|FG001|Overall Study|Lost to Follow-up|1|||
163021535|NCT01608087|588782186|FG002|Overall Study|Lost to Follow-up|0|||
163021536|NCT01608087|588782184|FG000|Overall Study|Other Reason|0|||
163021537|NCT01608087|588782185|FG001|Overall Study|Other Reason|1|||
163021538|NCT01608087|588782186|FG002|Overall Study|Other Reason|0|||
163021539|NCT00664859|588782196|FG000|Overall Study|Adverse Event|2|||
163021540|NCT00664859|588782197|FG001|Overall Study|Adverse Event|1|||
163021541|NCT00664859|588782198|FG002|Overall Study|Adverse Event|3|||
163021542|NCT00664859|588782196|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
163021543|NCT00664859|588782197|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
163021544|NCT00664859|588782198|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
163021545|NCT00664859|588782196|FG000|Overall Study|Noncompliance with protocol|1|||
163021546|NCT00664859|588782197|FG001|Overall Study|Noncompliance with protocol|0|||
163021547|NCT00664859|588782198|FG002|Overall Study|Noncompliance with protocol|4|||
163021548|NCT00664859|588782196|FG000|Overall Study|Laboratory abnormality|2|||
163021549|NCT00664859|588782197|FG001|Overall Study|Laboratory abnormality|1|||
163021550|NCT00664859|588782198|FG002|Overall Study|Laboratory abnormality|4|||
163021551|NCT00664859|588782196|FG000|Overall Study|Withdrawal by Subject|4|||
163021552|NCT00664859|588782197|FG001|Overall Study|Withdrawal by Subject|1|||
163021553|NCT00664859|588782198|FG002|Overall Study|Withdrawal by Subject|3|||
163021554|NCT00664859|588782196|FG000|Overall Study|Lost to Follow-up|2|||
163021555|NCT00664859|588782197|FG001|Overall Study|Lost to Follow-up|2|||
163021556|NCT00664859|588782198|FG002|Overall Study|Lost to Follow-up|1|||
163021557|NCT00664859|588782196|FG000|Overall Study|Other|0|||
163021558|NCT00664859|588782197|FG001|Overall Study|Other|1|||
163021559|NCT00664859|588782198|FG002|Overall Study|Other|2|||
163021560|NCT01943851|588782201|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021561|NCT01943851|588782202|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021562|NCT01943851|588782203|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163063803|NCT01157845|588940000|FG000|Overall Study|Physician Decision|3|||
163021563|NCT01943851|588782204|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
163021564|NCT01943851|588782205|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021565|NCT01943851|588782206|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021566|NCT01943851|588782207|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
163021567|NCT01943851|588782208|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
163021568|NCT01943851|588782209|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
163021569|NCT01943851|588782210|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021570|NCT01943851|588782211|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021571|NCT01943851|588782212|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163063804|NCT01157845|588940000|FG000|Overall Study|Protocol Violation|13|||
163063805|NCT01157845|588940000|FG000|Overall Study|Study was ended|1|||
163021572|NCT01943851|588782213|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163330114|NCT05886777|589917815|FG000|Overall Study|Withdrawal by Subject|1|||
163330115|NCT05886777|589917816|FG001|Overall Study|Withdrawal by Subject|0|||
163330116|NCT05886777|589917817|FG002|Overall Study|Withdrawal by Subject|1|||
163330117|NCT05886777|589917818|FG003|Overall Study|Withdrawal by Subject|4|||
163330118|NCT05886777|589917819|FG004|Overall Study|Withdrawal by Subject|3|||
163330119|NCT05886777|589917820|FG005|Overall Study|Withdrawal by Subject|1|||
163021573|NCT01943851|588782214|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021574|NCT01943851|588782215|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021575|NCT01943851|588782216|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021576|NCT01943851|588782217|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021577|NCT01943851|588782218|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021578|NCT01943851|588782201|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021579|NCT01943851|588782202|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021580|NCT01943851|588782203|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021581|NCT01943851|588782204|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021582|NCT01943851|588782205|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
163021583|NCT01943851|588782206|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021584|NCT01943851|588782207|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021585|NCT01943851|588782208|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
163021586|NCT01943851|588782209|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021587|NCT01943851|588782210|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021588|NCT01943851|588782211|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021589|NCT01943851|588782212|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021590|NCT01943851|588782213|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021591|NCT01943851|588782214|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021592|NCT01943851|588782215|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021593|NCT01943851|588782216|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021594|NCT01943851|588782217|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021595|NCT01943851|588782218|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021596|NCT01943851|588782201|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021597|NCT01943851|588782202|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021598|NCT01943851|588782203|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021599|NCT01943851|588782204|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021600|NCT01943851|588782205|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021601|NCT01943851|588782206|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021602|NCT01943851|588782207|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021603|NCT01943851|588782208|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021604|NCT01943851|588782209|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021605|NCT01943851|588782210|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021606|NCT01943851|588782211|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021607|NCT01943851|588782212|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021608|NCT01943851|588782213|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021609|NCT01943851|588782214|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
163021610|NCT01943851|588782215|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021611|NCT01943851|588782216|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021612|NCT01943851|588782217|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021613|NCT01943851|588782218|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021614|NCT01943851|588782201|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163330120|NCT05886777|589917821|FG006|Overall Study|Withdrawal by Subject|1|||
163330121|NCT05886777|589917815|FG000|Overall Study|Protocol Violation|0|||
163330122|NCT05886777|589917816|FG001|Overall Study|Protocol Violation|0|||
163330123|NCT05886777|589917817|FG002|Overall Study|Protocol Violation|1|||
163330124|NCT05886777|589917818|FG003|Overall Study|Protocol Violation|0|||
163021615|NCT01943851|588782202|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021616|NCT01943851|588782203|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021617|NCT01943851|588782204|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021618|NCT01943851|588782205|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021619|NCT01943851|588782206|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021620|NCT01943851|588782207|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021621|NCT01943851|588782208|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021622|NCT01943851|588782209|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021623|NCT01943851|588782210|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021624|NCT01943851|588782211|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021625|NCT01943851|588782212|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021626|NCT01943851|588782213|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021627|NCT01943851|588782214|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021628|NCT01943851|588782215|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163330125|NCT05886777|589917819|FG004|Overall Study|Protocol Violation|0|||
163330126|NCT05886777|589917820|FG005|Overall Study|Protocol Violation|0|||
163330127|NCT05886777|589917821|FG006|Overall Study|Protocol Violation|0|||
163021629|NCT01943851|588782216|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
163021630|NCT01943851|588782217|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021631|NCT01943851|588782218|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021632|NCT01943851|588782201|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021633|NCT01943851|588782202|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021634|NCT01943851|588782203|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021635|NCT01943851|588782204|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021636|NCT01943851|588782205|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021637|NCT01943851|588782206|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021638|NCT01943851|588782207|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021639|NCT01943851|588782208|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021640|NCT01943851|588782209|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021641|NCT01943851|588782210|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021642|NCT01943851|588782211|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021643|NCT01943851|588782212|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021644|NCT01943851|588782213|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021645|NCT01943851|588782214|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021646|NCT01943851|588782215|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021647|NCT01943851|588782216|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
163021648|NCT01943851|588782217|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
163021649|NCT01943851|588782218|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
163021650|NCT00401544|588782222|FG000|Overall Study|Adverse Event|5|||
163021651|NCT00401544|588782223|FG001|Overall Study|Adverse Event|1|||
163021652|NCT00401544|588782224|FG002|Overall Study|Adverse Event|1|||
163021653|NCT00401544|588782225|FG003|Overall Study|Adverse Event|1|||
163021654|NCT00401544|588782222|FG000|Overall Study|Death|3|||
163021655|NCT00401544|588782223|FG001|Overall Study|Death|6|||
163021656|NCT00401544|588782224|FG002|Overall Study|Death|2|||
163021657|NCT00401544|588782225|FG003|Overall Study|Death|5|||
163021658|NCT00401544|588782222|FG000|Overall Study|Lost to Follow-up|2|||
163021659|NCT00401544|588782223|FG001|Overall Study|Lost to Follow-up|0|||
163021660|NCT00401544|588782224|FG002|Overall Study|Lost to Follow-up|1|||
163021661|NCT00401544|588782225|FG003|Overall Study|Lost to Follow-up|1|||
163021662|NCT00401544|588782222|FG000|Overall Study|Withdrawal by Subject|7|||
163021663|NCT00401544|588782223|FG001|Overall Study|Withdrawal by Subject|6|||
163021664|NCT00401544|588782224|FG002|Overall Study|Withdrawal by Subject|6|||
163021665|NCT00401544|588782225|FG003|Overall Study|Withdrawal by Subject|5|||
163021666|NCT00401544|588782222|FG000|Overall Study|Physician Decision|1|||
163021667|NCT00401544|588782223|FG001|Overall Study|Physician Decision|3|||
163021668|NCT00401544|588782224|FG002|Overall Study|Physician Decision|0|||
163021669|NCT00401544|588782225|FG003|Overall Study|Physician Decision|0|||
163021670|NCT00401544|588782222|FG000|Overall Study|Ineligibility determined|0|||
163021671|NCT00401544|588782223|FG001|Overall Study|Ineligibility determined|1|||
163021672|NCT00401544|588782224|FG002|Overall Study|Ineligibility determined|0|||
163021673|NCT00401544|588782225|FG003|Overall Study|Ineligibility determined|2|||
163021674|NCT00401544|588782222|FG000|Overall Study|Disease progression|0|||
163021675|NCT00401544|588782223|FG001|Overall Study|Disease progression|1|||
163021676|NCT00401544|588782224|FG002|Overall Study|Disease progression|0|||
163021677|NCT00401544|588782225|FG003|Overall Study|Disease progression|0|||
163021678|NCT00401544|588782222|FG000|Overall Study|Other|0|||
163021679|NCT00401544|588782223|FG001|Overall Study|Other|0|||
163021680|NCT00401544|588782224|FG002|Overall Study|Other|2|||
163021681|NCT00401544|588782225|FG003|Overall Study|Other|2|||
163021682|NCT03645395|588782227|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
163021683|NCT03645395|588782228|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
163021684|NCT03645395|588782229|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
163021685|NCT03645395|588782230|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
163021686|NCT03645395|588782227|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
163063806|NCT01157845|588940000|FG000|Overall Study|Device malfunction|1|||
163063807|NCT04817410|588941483|FG000|Overall Study|Withdrawal by Subject|5|||
163063808|NCT04817410|588941483|FG000|Overall Study|Physician Decision|3|||
163063809|NCT03595748|588941484|FG000|Overall Study|Death|11|||
163063810|NCT03595748|588941485|FG001|Overall Study|Death|12|||
163063811|NCT03595748|588941484|FG000|Overall Study|Withdrawal by Subject|28|||
163021687|NCT03645395|588782228|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
163021688|NCT03645395|588782229|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
163021689|NCT03645395|588782230|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
163021690|NCT03645395|588782227|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
163021691|NCT03645395|588782228|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
163021692|NCT03645395|588782229|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
163021693|NCT03645395|588782230|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
163021694|NCT03645395|588782227|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
163021695|NCT03645395|588782228|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
163021696|NCT03645395|588782229|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
163063812|NCT03595748|588941485|FG001|Overall Study|Withdrawal by Subject|29|||
163021697|NCT03645395|588782230|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
163021698|NCT01289639|588782232|FG000|Overall Study|Lost to Follow-up|1|||
163021699|NCT01289639|588782233|FG001|Overall Study|Lost to Follow-up|0|||
163021700|NCT01289639|588782234|FG002|Overall Study|Lost to Follow-up|0|||
163021701|NCT02780713|588782235|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
163021702|NCT02780713|588782236|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
163021703|NCT02780713|588782237|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
163021704|NCT02780713|588782238|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
163021705|NCT02780713|588782239|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
163021706|NCT01931475|588782242|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
163021707|NCT01931475|588782243|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
163021708|NCT01931475|588782242|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
163021709|NCT01931475|588782243|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
163021710|NCT01931475|588782242|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
163021711|NCT01931475|588782243|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
163021712|NCT01931475|588782242|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
163021713|NCT01931475|588782243|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
163021714|NCT01931475|588782242|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
163021715|NCT01931475|588782243|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
163021716|NCT01931475|588782242|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
163021717|NCT01931475|588782243|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
163021718|NCT01931475|588782242|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
163021719|NCT01931475|588782243|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
163021720|NCT01931475|588782242|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
163021721|NCT01931475|588782243|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
163021722|NCT01931475|588782242|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
163021723|NCT01931475|588782243|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
163021724|NCT01931475|588782242|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
163021725|NCT01931475|588782243|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
163021726|NCT01931475|588782242|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
163021727|NCT01931475|588782243|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
163021728|NCT01250873|588782248|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
163021729|NCT01250873|588782248|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
163021730|NCT01254318|588782255|FG000|Overall Study|Lost to Follow-up|5|||
163021731|NCT01254318|588782255|FG000|Overall Study|Death|47|||
163021732|NCT01137110|588782262|FG000|Overall Study|Protocol Violation|1|||
163021733|NCT01137110|588782263|FG001|Overall Study|Protocol Violation|0|||
163021734|NCT02828124|588782266|FG000|Overall Study|Disease Progression|1|||
163021735|NCT02828124|588782267|FG001|Overall Study|Disease Progression|2|||
163021736|NCT02828124|588782268|FG002|Overall Study|Disease Progression|1|||
163021737|NCT02828124|588782269|FG003|Overall Study|Disease Progression|4|||
163021738|NCT02828124|588782266|FG000|Overall Study|AE Unrelated to Study Drug|0|||
163021739|NCT02828124|588782267|FG001|Overall Study|AE Unrelated to Study Drug|0|||
163021740|NCT02828124|588782268|FG002|Overall Study|AE Unrelated to Study Drug|0|||
163021741|NCT02828124|588782269|FG003|Overall Study|AE Unrelated to Study Drug|1|||
163021742|NCT02828124|588782266|FG000|Overall Study|Subject Withdrew Consent|0|||
163021743|NCT02828124|588782267|FG001|Overall Study|Subject Withdrew Consent|0|||
163021744|NCT02828124|588782268|FG002|Overall Study|Subject Withdrew Consent|0|||
163021745|NCT02828124|588782269|FG003|Overall Study|Subject Withdrew Consent|1|||
163021746|NCT06586788|588782270|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
163021747|NCT03514485|588782272|FG000|Overall Study|Lost to Follow-up|5|||
163021748|NCT03514485|588782273|FG001|Overall Study|Lost to Follow-up|3|||
163021749|NCT03514485|588782274|FG002|Overall Study|Lost to Follow-up|2|||
163021750|NCT03514485|588782275|FG003|Overall Study|Lost to Follow-up|0|||
163330128|NCT05886777|589917815|FG000|Overall Study|No longer met eligibility criteria|0|||
163330129|NCT05886777|589917816|FG001|Overall Study|No longer met eligibility criteria|1|||
163021751|NCT03514485|588782276|FG004|Overall Study|Lost to Follow-up|1|||
163021752|NCT03514485|588782277|FG005|Overall Study|Lost to Follow-up|4|||
163021753|NCT03514485|588782272|FG000|Overall Study|Withdrawal by Subject|0|||
163021754|NCT03514485|588782273|FG001|Overall Study|Withdrawal by Subject|1|||
163021755|NCT03514485|588782274|FG002|Overall Study|Withdrawal by Subject|3|||
163021756|NCT03514485|588782275|FG003|Overall Study|Withdrawal by Subject|1|||
163021757|NCT03514485|588782276|FG004|Overall Study|Withdrawal by Subject|2|||
163021758|NCT03514485|588782277|FG005|Overall Study|Withdrawal by Subject|1|||
163021759|NCT03075891|588782278|FG000|Overall Study|Withdrawal by Subject|3|||
163021760|NCT03075891|588782279|FG001|Overall Study|Withdrawal by Subject|6|||
163021761|NCT03075891|588782278|FG000|Overall Study|Lost to Follow-up|1|||
163021762|NCT03075891|588782279|FG001|Overall Study|Lost to Follow-up|0|||
163021763|NCT03075891|588782278|FG000|Overall Study|Pregnancy|3|||
163063813|NCT03595748|588941484|FG000|Overall Study|Protocol Violation|0|||
163063814|NCT03595748|588941485|FG001|Overall Study|Protocol Violation|1|||
163330130|NCT05886777|589917817|FG002|Overall Study|No longer met eligibility criteria|0|||
163021764|NCT03075891|588782279|FG001|Overall Study|Pregnancy|1|||
163021765|NCT03075891|588782278|FG000|Overall Study|visits not performed (no time)|1|||
163021766|NCT03075891|588782279|FG001|Overall Study|visits not performed (no time)|0|||
163021767|NCT03075891|588782278|FG000|Overall Study|Drug abuse relapse issue|0|||
163021768|NCT03075891|588782279|FG001|Overall Study|Drug abuse relapse issue|1|||
163021769|NCT03075891|588782278|FG000|Overall Study|Participant requiring study withdrawal|0|||
163021770|NCT03075891|588782279|FG001|Overall Study|Participant requiring study withdrawal|1|||
163021771|NCT03075891|588782278|FG000|Overall Study|Adverse event, non-fatal|1|||
163021772|NCT03075891|588782279|FG001|Overall Study|Adverse event, non-fatal|4|||
163021773|NCT00634803|588782281|FG000|Overall Study|Lost to Follow-up|6|||
163021774|NCT00634803|588782282|FG001|Overall Study|Lost to Follow-up|7|||
163021775|NCT00634803|588782283|FG002|Overall Study|Lost to Follow-up|7|||
163021776|NCT01300338|588783589|FG000|Overall Study|Lost to Follow-up|5|||
163021777|NCT01300338|588783590|FG001|Overall Study|Lost to Follow-up|0|||
163021778|NCT02461524|588783591|FG000|Overall Study|Death|16|||
163021779|NCT02461524|588783591|FG000|Overall Study|Withdrawal by Subject|4|||
163021780|NCT02461524|588783591|FG000|Overall Study|Device Explanted|5|||
163021781|NCT02461524|588783591|FG000|Overall Study|Missed Visit|6|||
163021782|NCT00381238|588783595|FG000|Overall Study|Adverse Event|3|||
163021783|NCT00381238|588783595|FG000|Overall Study|Protocol Violation|1|||
163021784|NCT00381238|588783595|FG000|Overall Study|Withdrawal by Subject|4|||
163021785|NCT00381238|588783595|FG000|Overall Study|Lack of Efficacy|2|||
163021786|NCT00381238|588783595|FG000|Overall Study|Withdrew by physician|1|||
163021787|NCT00381238|588783595|FG000|Overall Study|Disease progression|1|||
163021788|NCT00843037|588783598|FG000|Overall Study|Lost to Follow-up|1|||
163021789|NCT02564900|588783599|FG000|Dose Escalation|Progressive disease per RECIST|2|||
163021790|NCT02564900|588783600|FG001|Dose Escalation|Progressive disease per RECIST|3|||
163021791|NCT02564900|588783601|FG002|Dose Escalation|Progressive disease per RECIST|3|||
163021792|NCT02564900|588783602|FG003|Dose Escalation|Progressive disease per RECIST|3|||
163021793|NCT02564900|588783603|FG004|Dose Escalation|Progressive disease per RECIST|3|||
163021794|NCT02564900|588783604|FG005|Dose Escalation|Progressive disease per RECIST|1|||
163021795|NCT02564900|588783605|FG006|Dose Escalation|Progressive disease per RECIST|0|||
163021796|NCT02564900|588783606|FG007|Dose Escalation|Progressive disease per RECIST|0|||
163021797|NCT02564900|588783607|FG008|Dose Escalation|Progressive disease per RECIST|0|||
163021798|NCT02564900|588783608|FG009|Dose Escalation|Progressive disease per RECIST|0|||
163021799|NCT02564900|588783609|FG010|Dose Escalation|Progressive disease per RECIST|0|||
163021800|NCT02564900|588783610|FG011|Dose Escalation|Progressive disease per RECIST|0|||
163021801|NCT02564900|588783611|FG012|Dose Escalation|Progressive disease per RECIST|0|||
163021802|NCT02564900|588783612|FG013|Dose Escalation|Progressive disease per RECIST|0|||
163021803|NCT02564900|588783613|FG014|Dose Escalation|Progressive disease per RECIST|0|||
163021804|NCT02564900|588783599|FG000|Dose Escalation|Ongoing|1|||
163021805|NCT02564900|588783600|FG001|Dose Escalation|Ongoing|0|||
163021806|NCT02564900|588783601|FG002|Dose Escalation|Ongoing|0|||
163021807|NCT02564900|588783602|FG003|Dose Escalation|Ongoing|2|||
163021808|NCT02564900|588783603|FG004|Dose Escalation|Ongoing|2|||
163021809|NCT02564900|588783604|FG005|Dose Escalation|Ongoing|2|||
163021810|NCT02564900|588783605|FG006|Dose Escalation|Ongoing|0|||
163021811|NCT02564900|588783606|FG007|Dose Escalation|Ongoing|0|||
163021812|NCT02564900|588783607|FG008|Dose Escalation|Ongoing|0|||
163021813|NCT02564900|588783608|FG009|Dose Escalation|Ongoing|0|||
163021814|NCT02564900|588783609|FG010|Dose Escalation|Ongoing|0|||
163021815|NCT02564900|588783610|FG011|Dose Escalation|Ongoing|0|||
163021816|NCT02564900|588783611|FG012|Dose Escalation|Ongoing|0|||
163021817|NCT02564900|588783612|FG013|Dose Escalation|Ongoing|0|||
163021818|NCT02564900|588783613|FG014|Dose Escalation|Ongoing|0|||
163021819|NCT02564900|588783599|FG000|Dose Escalation|Adverse Event|0|||
163021820|NCT02564900|588783600|FG001|Dose Escalation|Adverse Event|0|||
163021821|NCT02564900|588783601|FG002|Dose Escalation|Adverse Event|0|||
163021822|NCT02564900|588783602|FG003|Dose Escalation|Adverse Event|1|||
163021823|NCT02564900|588783603|FG004|Dose Escalation|Adverse Event|1|||
163021824|NCT02564900|588783604|FG005|Dose Escalation|Adverse Event|3|||
163021825|NCT02564900|588783605|FG006|Dose Escalation|Adverse Event|0|||
163063815|NCT02328014|588941486|FG000|Overall Study|Adverse Event|1|||
163063816|NCT02328014|588941487|FG001|Overall Study|Adverse Event|0|||
163021826|NCT02564900|588783606|FG007|Dose Escalation|Adverse Event|0|||
163021827|NCT02564900|588783607|FG008|Dose Escalation|Adverse Event|0|||
163021828|NCT02564900|588783608|FG009|Dose Escalation|Adverse Event|0|||
163021829|NCT02564900|588783609|FG010|Dose Escalation|Adverse Event|0|||
163021830|NCT02564900|588783610|FG011|Dose Escalation|Adverse Event|0|||
163021831|NCT02564900|588783611|FG012|Dose Escalation|Adverse Event|0|||
163021832|NCT02564900|588783612|FG013|Dose Escalation|Adverse Event|0|||
163021833|NCT02564900|588783613|FG014|Dose Escalation|Adverse Event|0|||
163021834|NCT02564900|588783599|FG000|Dose Expansion|Progressive disease per RECIST|0|||
163021835|NCT02564900|588783600|FG001|Dose Expansion|Progressive disease per RECIST|0|||
163021836|NCT02564900|588783601|FG002|Dose Expansion|Progressive disease per RECIST|0|||
163021837|NCT02564900|588783602|FG003|Dose Expansion|Progressive disease per RECIST|0|||
163021838|NCT02564900|588783603|FG004|Dose Expansion|Progressive disease per RECIST|0|||
163021839|NCT02564900|588783604|FG005|Dose Expansion|Progressive disease per RECIST|0|||
163021840|NCT02564900|588783605|FG006|Dose Expansion|Progressive disease per RECIST|19|||
163021841|NCT02564900|588783606|FG007|Dose Expansion|Progressive disease per RECIST|17|||
163021842|NCT02564900|588783607|FG008|Dose Expansion|Progressive disease per RECIST|8|||
163021843|NCT02564900|588783608|FG009|Dose Expansion|Progressive disease per RECIST|16|||
163021844|NCT02564900|588783609|FG010|Dose Expansion|Progressive disease per RECIST|13|||
163021845|NCT02564900|588783610|FG011|Dose Expansion|Progressive disease per RECIST|19|||
163021846|NCT02564900|588783611|FG012|Dose Expansion|Progressive disease per RECIST|10|||
163021847|NCT02564900|588783612|FG013|Dose Expansion|Progressive disease per RECIST|13|||
163021848|NCT02564900|588783613|FG014|Dose Expansion|Progressive disease per RECIST|11|||
163021849|NCT02564900|588783599|FG000|Dose Expansion|Clinical progression|0|||
163021850|NCT02564900|588783600|FG001|Dose Expansion|Clinical progression|0|||
163021851|NCT02564900|588783601|FG002|Dose Expansion|Clinical progression|0|||
163021852|NCT02564900|588783602|FG003|Dose Expansion|Clinical progression|0|||
163021853|NCT02564900|588783603|FG004|Dose Expansion|Clinical progression|0|||
163021854|NCT02564900|588783604|FG005|Dose Expansion|Clinical progression|0|||
163021855|NCT02564900|588783605|FG006|Dose Expansion|Clinical progression|5|||
163021856|NCT02564900|588783606|FG007|Dose Expansion|Clinical progression|12|||
163021857|NCT02564900|588783607|FG008|Dose Expansion|Clinical progression|0|||
163021858|NCT02564900|588783608|FG009|Dose Expansion|Clinical progression|3|||
163021859|NCT02564900|588783609|FG010|Dose Expansion|Clinical progression|2|||
163021860|NCT02564900|588783610|FG011|Dose Expansion|Clinical progression|0|||
163021861|NCT02564900|588783611|FG012|Dose Expansion|Clinical progression|1|||
163021862|NCT02564900|588783612|FG013|Dose Expansion|Clinical progression|3|||
163021863|NCT02564900|588783613|FG014|Dose Expansion|Clinical progression|1|||
163021864|NCT02564900|588783599|FG000|Dose Expansion|Adverse Event|0|||
163021865|NCT02564900|588783600|FG001|Dose Expansion|Adverse Event|0|||
163021866|NCT02564900|588783601|FG002|Dose Expansion|Adverse Event|0|||
163021867|NCT02564900|588783602|FG003|Dose Expansion|Adverse Event|0|||
163021868|NCT02564900|588783603|FG004|Dose Expansion|Adverse Event|0|||
163021869|NCT02564900|588783604|FG005|Dose Expansion|Adverse Event|0|||
163021870|NCT02564900|588783605|FG006|Dose Expansion|Adverse Event|9|||
163021871|NCT02564900|588783606|FG007|Dose Expansion|Adverse Event|22|||
163021872|NCT02564900|588783607|FG008|Dose Expansion|Adverse Event|0|||
163021873|NCT02564900|588783608|FG009|Dose Expansion|Adverse Event|11|||
163021874|NCT02564900|588783609|FG010|Dose Expansion|Adverse Event|0|||
163021875|NCT02564900|588783610|FG011|Dose Expansion|Adverse Event|5|||
163021876|NCT02564900|588783611|FG012|Dose Expansion|Adverse Event|2|||
163021877|NCT02564900|588783612|FG013|Dose Expansion|Adverse Event|2|||
163021878|NCT02564900|588783613|FG014|Dose Expansion|Adverse Event|1|||
163021879|NCT02564900|588783599|FG000|Dose Expansion|Ongoing|0|||
163021880|NCT02564900|588783600|FG001|Dose Expansion|Ongoing|0|||
163021881|NCT02564900|588783601|FG002|Dose Expansion|Ongoing|0|||
163021882|NCT02564900|588783602|FG003|Dose Expansion|Ongoing|0|||
163021883|NCT02564900|588783603|FG004|Dose Expansion|Ongoing|0|||
163063817|NCT02328014|588941488|FG002|Overall Study|Adverse Event|0|||
163063818|NCT02328014|588941489|FG003|Overall Study|Adverse Event|1|||
163063819|NCT02328014|588941486|FG000|Overall Study|Death|0|||
163063820|NCT02328014|588941487|FG001|Overall Study|Death|0|||
163063821|NCT02328014|588941488|FG002|Overall Study|Death|0|||
163063822|NCT02328014|588941489|FG003|Overall Study|Death|4|||
163063823|NCT02328014|588941486|FG000|Overall Study|Physician Decision|0|||
163063824|NCT02328014|588941487|FG001|Overall Study|Physician Decision|0|||
163063825|NCT02328014|588941488|FG002|Overall Study|Physician Decision|0|||
163063826|NCT02328014|588941489|FG003|Overall Study|Physician Decision|1|||
163063827|NCT02328014|588941486|FG000|Overall Study|Disease Progression|1|||
163063828|NCT02328014|588941487|FG001|Overall Study|Disease Progression|0|||
163330131|NCT05886777|589917818|FG003|Overall Study|No longer met eligibility criteria|0|||
163330132|NCT05886777|589917819|FG004|Overall Study|No longer met eligibility criteria|0|||
163330133|NCT05886777|589917820|FG005|Overall Study|No longer met eligibility criteria|0|||
163330134|NCT05886777|589917821|FG006|Overall Study|No longer met eligibility criteria|0|||
163330135|NCT03773107|589917822|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
163021884|NCT02564900|588783604|FG005|Dose Expansion|Ongoing|0|||
163021885|NCT02564900|588783605|FG006|Dose Expansion|Ongoing|9|||
163021886|NCT02564900|588783606|FG007|Dose Expansion|Ongoing|10|||
163063829|NCT02328014|588941488|FG002|Overall Study|Disease Progression|1|||
163063830|NCT02328014|588941489|FG003|Overall Study|Disease Progression|3|||
163063831|NCT02328014|588941486|FG000|Overall Study|Study Terminated by Sponsor|4|||
163063832|NCT02328014|588941487|FG001|Overall Study|Study Terminated by Sponsor|1|||
163021887|NCT02564900|588783607|FG008|Dose Expansion|Ongoing|11|||
163021888|NCT02564900|588783608|FG009|Dose Expansion|Ongoing|3|||
163021889|NCT02564900|588783609|FG010|Dose Expansion|Ongoing|0|||
163021890|NCT02564900|588783610|FG011|Dose Expansion|Ongoing|0|||
163021891|NCT02564900|588783611|FG012|Dose Expansion|Ongoing|4|||
163063833|NCT02328014|588941488|FG002|Overall Study|Study Terminated by Sponsor|1|||
163063834|NCT02328014|588941489|FG003|Overall Study|Study Terminated by Sponsor|0|||
163021892|NCT02564900|588783612|FG013|Dose Expansion|Ongoing|0|||
163063835|NCT02328014|588941486|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
163021893|NCT02564900|588783613|FG014|Dose Expansion|Ongoing|6|||
163216900|NCT01344447|589510297|FG000|Overall Study|Adverse Event|1|||
163216901|NCT01344447|589510297|FG000|Overall Study|Protocol Violation|1|||
163021894|NCT02564900|588783599|FG000|Dose Expansion|Death|0|||
163021895|NCT02564900|588783600|FG001|Dose Expansion|Death|0|||
163021896|NCT02564900|588783601|FG002|Dose Expansion|Death|0|||
163021897|NCT02564900|588783602|FG003|Dose Expansion|Death|0|||
163021898|NCT02564900|588783603|FG004|Dose Expansion|Death|0|||
163021899|NCT02564900|588783604|FG005|Dose Expansion|Death|0|||
163021900|NCT02564900|588783605|FG006|Dose Expansion|Death|1|||
163021901|NCT02564900|588783606|FG007|Dose Expansion|Death|0|||
163021902|NCT02564900|588783607|FG008|Dose Expansion|Death|0|||
163021903|NCT02564900|588783608|FG009|Dose Expansion|Death|0|||
163021904|NCT02564900|588783609|FG010|Dose Expansion|Death|1|||
163021905|NCT02564900|588783610|FG011|Dose Expansion|Death|0|||
163021906|NCT02564900|588783611|FG012|Dose Expansion|Death|1|||
163021907|NCT02564900|588783612|FG013|Dose Expansion|Death|1|||
163021908|NCT02564900|588783613|FG014|Dose Expansion|Death|0|||
163021909|NCT02564900|588783599|FG000|Dose Expansion|Withdrawal by Subject|0|||
163021910|NCT02564900|588783600|FG001|Dose Expansion|Withdrawal by Subject|0|||
163021911|NCT02564900|588783601|FG002|Dose Expansion|Withdrawal by Subject|0|||
163021912|NCT02564900|588783602|FG003|Dose Expansion|Withdrawal by Subject|0|||
163021913|NCT02564900|588783603|FG004|Dose Expansion|Withdrawal by Subject|0|||
163021914|NCT02564900|588783604|FG005|Dose Expansion|Withdrawal by Subject|0|||
163021915|NCT02564900|588783605|FG006|Dose Expansion|Withdrawal by Subject|4|||
163021916|NCT02564900|588783606|FG007|Dose Expansion|Withdrawal by Subject|0|||
163021917|NCT02564900|588783607|FG008|Dose Expansion|Withdrawal by Subject|0|||
163021918|NCT02564900|588783608|FG009|Dose Expansion|Withdrawal by Subject|0|||
163021919|NCT02564900|588783609|FG010|Dose Expansion|Withdrawal by Subject|1|||
163021920|NCT02564900|588783610|FG011|Dose Expansion|Withdrawal by Subject|0|||
163021921|NCT02564900|588783611|FG012|Dose Expansion|Withdrawal by Subject|0|||
163021922|NCT02564900|588783612|FG013|Dose Expansion|Withdrawal by Subject|1|||
163021923|NCT02564900|588783613|FG014|Dose Expansion|Withdrawal by Subject|1|||
163021924|NCT02564900|588783599|FG000|Dose Expansion|Other|0|||
163021925|NCT02564900|588783600|FG001|Dose Expansion|Other|0|||
163021926|NCT02564900|588783601|FG002|Dose Expansion|Other|0|||
163021927|NCT02564900|588783602|FG003|Dose Expansion|Other|0|||
163021928|NCT02564900|588783603|FG004|Dose Expansion|Other|0|||
163021929|NCT02564900|588783604|FG005|Dose Expansion|Other|0|||
163021930|NCT02564900|588783605|FG006|Dose Expansion|Other|1|||
163021931|NCT02564900|588783606|FG007|Dose Expansion|Other|0|||
163021932|NCT02564900|588783607|FG008|Dose Expansion|Other|1|||
163021933|NCT02564900|588783608|FG009|Dose Expansion|Other|0|||
163021934|NCT02564900|588783609|FG010|Dose Expansion|Other|0|||
163021935|NCT02564900|588783610|FG011|Dose Expansion|Other|0|||
163021936|NCT02564900|588783611|FG012|Dose Expansion|Other|0|||
163216902|NCT01344447|589510297|FG000|Overall Study|Withdrawal by Subject|1|||
163216903|NCT01344447|589510297|FG000|Overall Study|The contrast was not seen|1|||
163216904|NCT01344447|589510297|FG000|Overall Study|Physician Decision|1|||
163330136|NCT03773107|589917823|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
163330137|NCT03773107|589917824|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
163330138|NCT03773107|589917825|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
163330139|NCT07204444|589917827|FG000|Overall Study|Medical/Hospitalization|6|||
163330140|NCT07204444|589917828|FG001|Overall Study|Medical/Hospitalization|9|||
163330141|NCT07204444|589917829|FG002|Overall Study|Medical/Hospitalization|6|||
163330142|NCT07204444|589917827|FG000|Overall Study|Treatment Provider Issue|1|||
163330143|NCT07204444|589917828|FG001|Overall Study|Treatment Provider Issue|3|||
163330144|NCT07204444|589917829|FG002|Overall Study|Treatment Provider Issue|0|||
163330145|NCT07204444|589917827|FG000|Overall Study|Withdrawal by Subject|11|||
163330146|NCT07204444|589917828|FG001|Overall Study|Withdrawal by Subject|5|||
163021937|NCT02564900|588783612|FG013|Dose Expansion|Other|0|||
163021938|NCT02564900|588783613|FG014|Dose Expansion|Other|1|||
163021939|NCT02564900|588783599|FG000|Dose Expansion|Did not receive treatment|0|||
163021940|NCT02564900|588783600|FG001|Dose Expansion|Did not receive treatment|0|||
163216905|NCT01344447|589510297|FG000|Overall Study|MRA unsuccessful|1|||
163216906|NCT01344447|589510297|FG000|Overall Study|Bolus tracking failed|1|||
163330147|NCT07204444|589917829|FG002|Overall Study|Withdrawal by Subject|5|||
163330148|NCT07204444|589917827|FG000|Overall Study|Death|3|||
163330149|NCT07204444|589917828|FG001|Overall Study|Death|6|||
163021941|NCT02564900|588783601|FG002|Dose Expansion|Did not receive treatment|0|||
163021942|NCT02564900|588783602|FG003|Dose Expansion|Did not receive treatment|0|||
163216907|NCT01344447|589510297|FG000|Overall Study|Error of power injector|1|||
163216908|NCT01660711|589510298|FG000|Overall Study|Adverse Event|7|||
163330150|NCT07204444|589917829|FG002|Overall Study|Death|1|||
163330151|NCT07204444|589917827|FG000|Overall Study|Unable To Reach|29|||
163021943|NCT02564900|588783603|FG004|Dose Expansion|Did not receive treatment|0|||
163021944|NCT02564900|588783604|FG005|Dose Expansion|Did not receive treatment|0|||
163021945|NCT02564900|588783605|FG006|Dose Expansion|Did not receive treatment|1|||
163021946|NCT02564900|588783606|FG007|Dose Expansion|Did not receive treatment|1|||
163330152|NCT07204444|589917828|FG001|Overall Study|Unable To Reach|26|||
163021947|NCT02564900|588783607|FG008|Dose Expansion|Did not receive treatment|0|||
163021948|NCT02564900|588783608|FG009|Dose Expansion|Did not receive treatment|0|||
163021949|NCT02564900|588783609|FG010|Dose Expansion|Did not receive treatment|0|||
163021950|NCT02564900|588783610|FG011|Dose Expansion|Did not receive treatment|0|||
163021951|NCT02564900|588783611|FG012|Dose Expansion|Did not receive treatment|0|||
163021952|NCT02564900|588783612|FG013|Dose Expansion|Did not receive treatment|0|||
163021953|NCT02564900|588783613|FG014|Dose Expansion|Did not receive treatment|1|||
163021954|NCT03991299|588783614|FG000|Overall Study|Study closed, sponsor decision|3|||
163021955|NCT03991299|588783614|FG000|Overall Study|Withdrawal by Subject|1|||
163021956|NCT02278939|588783619|FG000|Overall Study|lack of time|1|||
163021957|NCT02278939|588783620|FG001|Overall Study|lack of time|0|||
163021958|NCT02278939|588783619|FG000|Overall Study|Lost to Follow-up|1|||
163021959|NCT02278939|588783620|FG001|Overall Study|Lost to Follow-up|1|||
163021960|NCT02278939|588783619|FG000|Overall Study|death in family|1|||
163021961|NCT02278939|588783620|FG001|Overall Study|death in family|0|||
163021962|NCT02278939|588783619|FG000|Overall Study|family emergency unable to commit|2|||
163021963|NCT02278939|588783620|FG001|Overall Study|family emergency unable to commit|0|||
163021964|NCT02423343|588783626|FG000|Overall Study|Withdrawal by Subject|0|||
163021965|NCT02423343|588783627|FG001|Overall Study|Withdrawal by Subject|1|||
163021966|NCT02423343|588783628|FG002|Overall Study|Withdrawal by Subject|0|||
163021967|NCT02423343|588783629|FG003|Overall Study|Withdrawal by Subject|0|||
163021968|NCT02423343|588783630|FG004|Overall Study|Withdrawal by Subject|0|||
163021969|NCT02423343|588783631|FG005|Overall Study|Withdrawal by Subject|0|||
163021970|NCT02423343|588783626|FG000|Overall Study|Progressive Disease|0|||
163021971|NCT02423343|588783627|FG001|Overall Study|Progressive Disease|0|||
163021972|NCT02423343|588783628|FG002|Overall Study|Progressive Disease|0|||
163021973|NCT02423343|588783629|FG003|Overall Study|Progressive Disease|0|||
163021974|NCT02423343|588783630|FG004|Overall Study|Progressive Disease|2|||
163021975|NCT02423343|588783631|FG005|Overall Study|Progressive Disease|0|||
163021976|NCT02423343|588783626|FG000|Overall Study|Adverse Event|0|||
163021977|NCT02423343|588783627|FG001|Overall Study|Adverse Event|0|||
163021978|NCT02423343|588783628|FG002|Overall Study|Adverse Event|0|||
163021979|NCT02423343|588783629|FG003|Overall Study|Adverse Event|0|||
163021980|NCT02423343|588783630|FG004|Overall Study|Adverse Event|2|||
163021981|NCT02423343|588783631|FG005|Overall Study|Adverse Event|0|||
163021982|NCT02423343|588783626|FG000|Overall Study|Death|0|||
163021983|NCT02423343|588783627|FG001|Overall Study|Death|0|||
163021984|NCT02423343|588783628|FG002|Overall Study|Death|0|||
163021985|NCT02423343|588783629|FG003|Overall Study|Death|0|||
163021986|NCT02423343|588783630|FG004|Overall Study|Death|1|||
163021987|NCT02423343|588783631|FG005|Overall Study|Death|0|||
163021988|NCT04429555|588783635|FG000|Overall Study|Death|0|||
163021989|NCT04429555|588783636|FG001|Overall Study|Death|2|||
163330153|NCT07204444|589917829|FG002|Overall Study|Unable To Reach|17|||
163330154|NCT07204444|589917827|FG000|Overall Study|Protocol Deviation|3|||
163330155|NCT07204444|589917828|FG001|Overall Study|Protocol Deviation|2|||
163330156|NCT07204444|589917829|FG002|Overall Study|Protocol Deviation|0|||
163330157|NCT04172675|589918986|FG000|Overall Study|Withdrawal by Subject|7|||
163330158|NCT04172675|589918987|FG001|Overall Study|Withdrawal by Subject|5|||
163330159|NCT04172675|589918988|FG002|Overall Study|Withdrawal by Subject|1|||
163330160|NCT04172675|589918989|FG003|Overall Study|Withdrawal by Subject|4|||
163330161|NCT00378898|589918990|FG000|Overall Study|Withdrawal by Subject|10|||
163330162|NCT00378898|589918991|FG001|Overall Study|Withdrawal by Subject|5|||
163330163|NCT00378898|589918990|FG000|Overall Study|Protocol Violation|1|||
163330164|NCT00378898|589918991|FG001|Overall Study|Protocol Violation|1|||
163330165|NCT00551421|589918992|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
163330166|NCT02000752|589918995|FG000|Overall Study|Dystocic delivery|19|||
163021990|NCT04429555|588783635|FG000|Overall Study|Other|2|||
163021991|NCT04429555|588783636|FG001|Overall Study|Other|0|||
163021992|NCT00930774|588783638|FG000|Overall Study|Withdrawal by Subject|1|||
163021993|NCT00930774|588783639|FG001|Overall Study|Withdrawal by Subject|9|||
163021994|NCT00930774|588783640|FG002|Overall Study|Withdrawal by Subject|2|||
163021995|NCT00930774|588783641|FG003|Overall Study|Withdrawal by Subject|0|||
163021996|NCT02703272|588783642|FG000|Overall Study|Death|4|||
163021997|NCT02703272|588783643|FG001|Overall Study|Death|9|||
163021998|NCT02703272|588783644|FG002|Overall Study|Death|19|||
163021999|NCT02703272|588783645|FG003|Overall Study|Death|10|||
163022000|NCT02703272|588783642|FG000|Overall Study|Withdrawal by Subject|0|||
163022001|NCT02703272|588783643|FG001|Overall Study|Withdrawal by Subject|0|||
163330167|NCT02000752|589918996|FG001|Overall Study|Dystocic delivery|8|||
163022002|NCT02703272|588783644|FG002|Overall Study|Withdrawal by Subject|4|||
163022003|NCT02703272|588783645|FG003|Overall Study|Withdrawal by Subject|2|||
163022004|NCT02703272|588783642|FG000|Overall Study|Study Terminated by Sponsor|6|||
163022005|NCT02703272|588783643|FG001|Overall Study|Study Terminated by Sponsor|1|||
163022006|NCT02703272|588783644|FG002|Overall Study|Study Terminated by Sponsor|12|||
163022007|NCT02703272|588783645|FG003|Overall Study|Study Terminated by Sponsor|4|||
163330168|NCT02000752|589918995|FG000|Overall Study|Shift Changes|12|||
163330169|NCT02000752|589918996|FG001|Overall Study|Shift Changes|5|||
163330170|NCT00512252|589918998|FG000|Overall Study|Lost to Follow-up|0|||
163022008|NCT02703272|588783642|FG000|Overall Study|Other|1|||
163022009|NCT02703272|588783643|FG001|Overall Study|Other|0|||
163022010|NCT02703272|588783644|FG002|Overall Study|Other|0|||
163022011|NCT02703272|588783645|FG003|Overall Study|Other|0|||
163022012|NCT00712881|588783646|FG000|Overall Study|Adverse Event|3|||
163022013|NCT00712881|588783647|FG001|Overall Study|Adverse Event|3|||
163022014|NCT00712881|588783646|FG000|Overall Study|Withdrawal by Subject|1|||
163022015|NCT00712881|588783647|FG001|Overall Study|Withdrawal by Subject|1|||
163022016|NCT00712881|588783646|FG000|Overall Study|Disease Progression|2|||
163022017|NCT00712881|588783647|FG001|Overall Study|Disease Progression|1|||
163022018|NCT00712881|588783646|FG000|Overall Study|Lost to Follow-up|1|||
163022019|NCT00712881|588783647|FG001|Overall Study|Lost to Follow-up|1|||
163022020|NCT00712881|588783646|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
163022021|NCT00712881|588783647|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
163022022|NCT00712881|588783646|FG000|Overall Study|Protocol Violation|1|||
163022023|NCT00712881|588783647|FG001|Overall Study|Protocol Violation|1|||
163022024|NCT00712881|588783646|FG000|Overall Study|Randomized but not treated|1|||
163022025|NCT00712881|588783647|FG001|Overall Study|Randomized but not treated|0|||
163022026|NCT03200704|588783648|FG000|Overall Study|Withdrawal by Subject|1|||
163022027|NCT01680861|588783649|FG000|Early Post-transplant Period|Protocol Violation|1|||
163022028|NCT01680861|588783650|FG001|Early Post-transplant Period|Protocol Violation|1|||
163022029|NCT04967885|588783651|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
163022030|NCT04967885|588783652|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
163022031|NCT04967885|588783651|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
163022032|NCT04967885|588783652|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
163022033|NCT04967885|588783651|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
163022034|NCT04967885|588783652|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
163022035|NCT04967885|588783651|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
163022036|NCT04967885|588783652|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
163022037|NCT04967885|588783651|FG000|EMI-II Intervention|Lost to Follow-up|14|||
163022038|NCT04967885|588783652|FG001|EMI-II Intervention|Lost to Follow-up|10|||
163022039|NCT01011465|588783653|FG000|Overall Study|Withdrawal by Subject|2|||
163022040|NCT01011465|588783654|FG001|Overall Study|Withdrawal by Subject|1|||
163022041|NCT01011465|588783655|FG002|Overall Study|Withdrawal by Subject|0|||
163022042|NCT01011465|588783656|FG003|Overall Study|Withdrawal by Subject|0|||
163022043|NCT01011465|588783657|FG004|Overall Study|Withdrawal by Subject|1|||
163022044|NCT01011465|588783658|FG005|Overall Study|Withdrawal by Subject|0|||
163022045|NCT01011465|588783659|FG006|Overall Study|Withdrawal by Subject|1|||
163022046|NCT01011465|588783660|FG007|Overall Study|Withdrawal by Subject|0|||
163022047|NCT02042950|588783663|FG000|Overall Study|Progressive Disease|4|||
163022048|NCT01940887|588783667|FG000|Year 1|Protocol Violation|0|||
163022049|NCT01940887|588783668|FG001|Year 1|Protocol Violation|1|||
163022050|NCT01940887|588783667|FG000|Year 1|Physician Decision|7|||
163022051|NCT01940887|588783668|FG001|Year 1|Physician Decision|3|||
163022052|NCT01940887|588783667|FG000|Year 1|Death|5|||
163022053|NCT01940887|588783668|FG001|Year 1|Death|3|||
163022054|NCT01940887|588783667|FG000|Year 1|Adverse Event|7|||
163022055|NCT01940887|588783668|FG001|Year 1|Adverse Event|6|||
163022056|NCT01940887|588783667|FG000|Year 1|Withdrawal by Subject|18|||
163022057|NCT01940887|588783668|FG001|Year 1|Withdrawal by Subject|9|||
163022058|NCT01940887|588783667|FG000|Year 1|Lost to Follow-up|2|||
163022059|NCT01940887|588783668|FG001|Year 1|Lost to Follow-up|1|||
163022060|NCT01940887|588783667|FG000|Year 2|Physician Decision|8|||
163022061|NCT01940887|588783668|FG001|Year 2|Physician Decision|1|||
163022062|NCT01940887|588783667|FG000|Year 2|Death|0|||
163022063|NCT01940887|588783668|FG001|Year 2|Death|2|||
163022064|NCT01940887|588783667|FG000|Year 2|Sponsor Decision, early termination|192|||
163022065|NCT01940887|588783668|FG001|Year 2|Sponsor Decision, early termination|203|||
163022066|NCT01940887|588783667|FG000|Year 2|Adverse Event|8|||
163022067|NCT01940887|588783668|FG001|Year 2|Adverse Event|2|||
163022068|NCT01940887|588783667|FG000|Year 2|Withdrawal by Subject|8|||
163022069|NCT01940887|588783668|FG001|Year 2|Withdrawal by Subject|8|||
163022070|NCT01940887|588783667|FG000|Year 2|Lost to Follow-up|1|||
163022071|NCT01940887|588783668|FG001|Year 2|Lost to Follow-up|6|||
163022072|NCT00747474|588783669|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022073|NCT00747474|588783670|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022074|NCT00747474|588783671|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022075|NCT00747474|588783672|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022076|NCT00747474|588783673|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163330171|NCT00512252|589918999|FG001|Overall Study|Lost to Follow-up|0|||
163022077|NCT00747474|588783674|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022078|NCT00747474|588783675|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022079|NCT00747474|588783676|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
163022080|NCT00747474|588783677|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022081|NCT00747474|588783678|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022082|NCT00747474|588783679|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022083|NCT00747474|588783680|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022084|NCT00330343|588783682|FG000|Overall Study|Lost to Follow-up|5|||
163022085|NCT00256854|588783683|FG000|Overall Study|Withdrawal by Subject|2|||
163022086|NCT00256854|588783684|FG001|Overall Study|Withdrawal by Subject|3|||
163022087|NCT00256854|588783685|FG002|Overall Study|Withdrawal by Subject|0|||
163022088|NCT00256854|588783686|FG003|Overall Study|Withdrawal by Subject|0|||
163022089|NCT00256854|588783687|FG004|Overall Study|Withdrawal by Subject|0|||
163022090|NCT00256854|588783688|FG005|Overall Study|Withdrawal by Subject|0|||
163022091|NCT00256854|588783683|FG000|Overall Study|Lack of Efficacy|1|||
163022092|NCT00256854|588783684|FG001|Overall Study|Lack of Efficacy|0|||
163022093|NCT00256854|588783685|FG002|Overall Study|Lack of Efficacy|0|||
163022094|NCT00256854|588783686|FG003|Overall Study|Lack of Efficacy|0|||
163022095|NCT00256854|588783687|FG004|Overall Study|Lack of Efficacy|0|||
163022096|NCT00256854|588783688|FG005|Overall Study|Lack of Efficacy|0|||
163022097|NCT00256854|588783683|FG000|Overall Study|Protocol Violation|0|||
163022098|NCT00256854|588783684|FG001|Overall Study|Protocol Violation|1|||
163022099|NCT00256854|588783685|FG002|Overall Study|Protocol Violation|1|||
163022100|NCT00256854|588783686|FG003|Overall Study|Protocol Violation|1|||
163022101|NCT00256854|588783687|FG004|Overall Study|Protocol Violation|0|||
163022102|NCT00256854|588783688|FG005|Overall Study|Protocol Violation|0|||
163022103|NCT00256854|588783683|FG000|Overall Study|Adverse Event|0|||
163022104|NCT00256854|588783684|FG001|Overall Study|Adverse Event|0|||
163022105|NCT00256854|588783685|FG002|Overall Study|Adverse Event|2|||
163022106|NCT00256854|588783686|FG003|Overall Study|Adverse Event|2|||
163022107|NCT00256854|588783687|FG004|Overall Study|Adverse Event|0|||
163022108|NCT00256854|588783688|FG005|Overall Study|Adverse Event|1|||
163022109|NCT00256854|588783683|FG000|Overall Study|Not compliant with the study drug|0|||
163022110|NCT00256854|588783684|FG001|Overall Study|Not compliant with the study drug|0|||
163022111|NCT00256854|588783685|FG002|Overall Study|Not compliant with the study drug|0|||
163022112|NCT00256854|588783686|FG003|Overall Study|Not compliant with the study drug|0|||
163022113|NCT00256854|588783687|FG004|Overall Study|Not compliant with the study drug|1|||
163022114|NCT00256854|588783688|FG005|Overall Study|Not compliant with the study drug|0|||
163022115|NCT03047720|588783692|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
163022116|NCT03047720|588783693|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
163022117|NCT04603482|588783704|FG000|Overall Study|Lost to Follow-up|15|||
163022118|NCT04603482|588783705|FG001|Overall Study|Lost to Follow-up|15|||
163022119|NCT04603482|588783706|FG002|Overall Study|Lost to Follow-up|15|||
163022120|NCT00179673|588783707|FG000|Overall Study|Adverse Event|7|||
163022121|NCT00179673|588783707|FG000|Overall Study|Lack of Efficacy|15|||
163022122|NCT00179673|588783707|FG000|Overall Study|Withdrawal by Subject|3|||
163022123|NCT00179673|588783707|FG000|Overall Study|Death|4|||
163022124|NCT00179673|588783707|FG000|Overall Study|Other Observations and options|14|||
163022125|NCT00582608|588783724|FG000|Overall Study|Not Treated|7|||
163022126|NCT00582608|588783724|FG000|Overall Study|Patient Ineligible|1|||
163022127|NCT00582608|588783724|FG000|Overall Study|Lack of accrual|4|||
163022128|NCT03482453|588783725|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022129|NCT03482453|588783726|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022130|NCT03482453|588783727|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022131|NCT03482453|588783728|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022132|NCT03482453|588783729|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163063836|NCT02328014|588941487|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
163063837|NCT02328014|588941488|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
163216909|NCT01660711|589510298|FG000|Overall Study|Withdrawal by Subject|1|||
163216910|NCT01652664|589510299|FG000|Overall Study|Treatment Failure|5|||
163216911|NCT01652664|589510300|FG001|Overall Study|Treatment Failure|1|||
163216912|NCT01652664|589510299|FG000|Overall Study|Inadequate IOP control|1|||
163216913|NCT01652664|589510300|FG001|Overall Study|Inadequate IOP control|0|||
163216914|NCT00581776|589510304|FG000|Overall Study|Disease progression or no response|3|||
163216915|NCT02357901|589510305|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
163216916|NCT02357901|589510306|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
163216917|NCT02357901|589510307|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
163216918|NCT02357901|589510308|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
163216919|NCT02357901|589510305|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
163216920|NCT02357901|589510306|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
163216921|NCT02357901|589510307|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
163022133|NCT03482453|588783730|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022134|NCT03482453|588783731|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022135|NCT03482453|588783732|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022136|NCT03482453|588783733|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022137|NCT03482453|588783734|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022138|NCT03482453|588783735|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
163022139|NCT03482453|588783736|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022140|NCT03478644|588783737|FG000|Phase 2|Withdrawal by Subject|2|||
163022141|NCT03478644|588783738|FG001|Phase 2|Withdrawal by Subject|1|||
163022142|NCT03478644|588783737|FG000|Phase 2|Lost to Follow-up|1|||
163022143|NCT03478644|588783738|FG001|Phase 2|Lost to Follow-up|0|||
163022144|NCT01870973|588783739|FG000|Overall Study|Lost to Follow-up|10|||
163022145|NCT01870973|588783740|FG001|Overall Study|Lost to Follow-up|3|||
163022146|NCT02504827|588783743|FG000|Overall Study|Could not produce sputum|1|||
163022147|NCT00686829|588783744|FG000|Overall Study|Adverse Event|5|||
163022148|NCT00686829|588783744|FG000|Overall Study|Lack of Efficacy|6|||
163022149|NCT00686829|588783744|FG000|Overall Study|Lost to Follow-up|4|||
163022150|NCT00686829|588783744|FG000|Overall Study|Withdrawal by Subject|14|||
163022151|NCT00686829|588783744|FG000|Overall Study|Protocol Violation|3|||
163022152|NCT00686829|588783744|FG000|Overall Study|Sponsor discontinued VCV|47|||
163022153|NCT00712543|588783745|FG000|Day 8-14|Lost to Follow-up|0|||
163022154|NCT00712543|588783746|FG001|Day 8-14|Lost to Follow-up|2|||
163022155|NCT04740827|588783747|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
163022156|NCT04740827|588783748|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
163022157|NCT04740827|588783747|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
163022158|NCT04740827|588783748|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
163022159|NCT04740827|588783747|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
163022160|NCT04740827|588783748|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
163022161|NCT04740827|588783747|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
163022162|NCT04740827|588783748|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
163022163|NCT04740827|588783747|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
163022164|NCT04740827|588783748|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
163022165|NCT04740827|588783747|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
163022166|NCT04740827|588783748|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
163022167|NCT00940823|588783749|FG000|Overall Study|Death|8|||
163022168|NCT00940823|588783750|FG001|Overall Study|Death|12|||
163022169|NCT00940823|588783749|FG000|Overall Study|Lost to Follow-up|27|||
163022170|NCT00940823|588783750|FG001|Overall Study|Lost to Follow-up|20|||
163022171|NCT00784550|588786256|FG000|Overall Study|Adverse Event|12|||
163022172|NCT00784550|588786257|FG001|Overall Study|Adverse Event|10|||
163022173|NCT00784550|588786256|FG000|Overall Study|Lack of Efficacy|0|||
163022174|NCT00784550|588786257|FG001|Overall Study|Lack of Efficacy|1|||
163022175|NCT00784550|588786256|FG000|Overall Study|Protocol Violation|10|||
163022176|NCT00784550|588786257|FG001|Overall Study|Protocol Violation|10|||
163022177|NCT00784550|588786256|FG000|Overall Study|Lost to Follow-up|8|||
163022178|NCT00784550|588786257|FG001|Overall Study|Lost to Follow-up|5|||
163022179|NCT00784550|588786256|FG000|Overall Study|Physician Decision|2|||
163022180|NCT00784550|588786257|FG001|Overall Study|Physician Decision|3|||
163022181|NCT00784550|588786256|FG000|Overall Study|Withdrawal by Subject|4|||
163022182|NCT00784550|588786257|FG001|Overall Study|Withdrawal by Subject|13|||
163022183|NCT00477750|588786259|FG000|Overall Study|Currently Receiving Treatment|11|||
163022184|NCT03558152|588786260|FG000|Overall Study|Adverse Event|0|||
163022185|NCT03558152|588786261|FG001|Overall Study|Adverse Event|0|||
163022186|NCT03558152|588786262|FG002|Overall Study|Adverse Event|1|||
163022187|NCT03558152|588786263|FG003|Overall Study|Adverse Event|1|||
163022188|NCT03558152|588786264|FG004|Overall Study|Adverse Event|2|||
163022189|NCT03558152|588786265|FG005|Overall Study|Adverse Event|1|||
163022190|NCT03558152|588786266|FG006|Overall Study|Adverse Event|1|||
163022191|NCT03558152|588786267|FG007|Overall Study|Adverse Event|0|||
163022192|NCT03558152|588786260|FG000|Overall Study|Death|0|||
163022193|NCT03558152|588786261|FG001|Overall Study|Death|0|||
163022194|NCT03558152|588786262|FG002|Overall Study|Death|0|||
163022195|NCT03558152|588786263|FG003|Overall Study|Death|0|||
163022196|NCT03558152|588786264|FG004|Overall Study|Death|1|||
163022197|NCT03558152|588786265|FG005|Overall Study|Death|0|||
163022198|NCT03558152|588786266|FG006|Overall Study|Death|0|||
163022199|NCT03558152|588786267|FG007|Overall Study|Death|0|||
163022200|NCT03558152|588786260|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
163022201|NCT03558152|588786261|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
163022202|NCT03558152|588786262|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
163022203|NCT03558152|588786263|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
163022204|NCT03558152|588786264|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
163022205|NCT03558152|588786265|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
163022206|NCT03558152|588786266|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
163022207|NCT03558152|588786267|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
163022208|NCT03558152|588786260|FG000|Overall Study|Miscalculation in mmcs|0|||
163022209|NCT03558152|588786261|FG001|Overall Study|Miscalculation in mmcs|0|||
163022210|NCT03558152|588786262|FG002|Overall Study|Miscalculation in mmcs|0|||
163022211|NCT03558152|588786263|FG003|Overall Study|Miscalculation in mmcs|0|||
163022212|NCT03558152|588786264|FG004|Overall Study|Miscalculation in mmcs|0|||
163022213|NCT03558152|588786265|FG005|Overall Study|Miscalculation in mmcs|0|||
163022214|NCT03558152|588786266|FG006|Overall Study|Miscalculation in mmcs|1|||
163022215|NCT03558152|588786267|FG007|Overall Study|Miscalculation in mmcs|0|||
163022216|NCT03558152|588786260|FG000|Overall Study|Mistake in calculation|0|||
163022217|NCT03558152|588786261|FG001|Overall Study|Mistake in calculation|0|||
163022218|NCT03558152|588786262|FG002|Overall Study|Mistake in calculation|0|||
163022219|NCT03558152|588786263|FG003|Overall Study|Mistake in calculation|1|||
163022220|NCT03558152|588786264|FG004|Overall Study|Mistake in calculation|0|||
163022221|NCT03558152|588786265|FG005|Overall Study|Mistake in calculation|0|||
163022222|NCT03558152|588786266|FG006|Overall Study|Mistake in calculation|0|||
163022223|NCT03558152|588786267|FG007|Overall Study|Mistake in calculation|0|||
163022224|NCT03558152|588786260|FG000|Overall Study|Mistake in evaluation of disease status|0|||
163022225|NCT03558152|588786261|FG001|Overall Study|Mistake in evaluation of disease status|0|||
163022226|NCT03558152|588786262|FG002|Overall Study|Mistake in evaluation of disease status|0|||
163022227|NCT03558152|588786263|FG003|Overall Study|Mistake in evaluation of disease status|0|||
163022228|NCT03558152|588786264|FG004|Overall Study|Mistake in evaluation of disease status|0|||
163022229|NCT03558152|588786265|FG005|Overall Study|Mistake in evaluation of disease status|0|||
163022230|NCT03558152|588786266|FG006|Overall Study|Mistake in evaluation of disease status|0|||
163022231|NCT03558152|588786267|FG007|Overall Study|Mistake in evaluation of disease status|1|||
163022232|NCT03558152|588786260|FG000|Overall Study|Physician Decision|0|||
163022233|NCT03558152|588786261|FG001|Overall Study|Physician Decision|0|||
163022234|NCT03558152|588786262|FG002|Overall Study|Physician Decision|0|||
163022235|NCT03558152|588786263|FG003|Overall Study|Physician Decision|0|||
163022236|NCT03558152|588786264|FG004|Overall Study|Physician Decision|0|||
163022237|NCT03558152|588786265|FG005|Overall Study|Physician Decision|0|||
163022238|NCT03558152|588786266|FG006|Overall Study|Physician Decision|1|||
163022239|NCT03558152|588786267|FG007|Overall Study|Physician Decision|0|||
163022240|NCT03558152|588786260|FG000|Overall Study|Withdrawal by Subject|2|||
163022241|NCT03558152|588786261|FG001|Overall Study|Withdrawal by Subject|3|||
163022242|NCT03558152|588786262|FG002|Overall Study|Withdrawal by Subject|2|||
163022243|NCT03558152|588786263|FG003|Overall Study|Withdrawal by Subject|1|||
163022244|NCT03558152|588786264|FG004|Overall Study|Withdrawal by Subject|1|||
163022245|NCT03558152|588786265|FG005|Overall Study|Withdrawal by Subject|1|||
163022246|NCT03558152|588786266|FG006|Overall Study|Withdrawal by Subject|3|||
163022247|NCT03558152|588786267|FG007|Overall Study|Withdrawal by Subject|2|||
163022248|NCT03558152|588786260|FG000|Overall Study|Lack of Efficacy|11|||
163022249|NCT03558152|588786261|FG001|Overall Study|Lack of Efficacy|11|||
163022250|NCT03558152|588786262|FG002|Overall Study|Lack of Efficacy|10|||
163022251|NCT03558152|588786263|FG003|Overall Study|Lack of Efficacy|11|||
163022252|NCT03558152|588786264|FG004|Overall Study|Lack of Efficacy|14|||
163022253|NCT03558152|588786265|FG005|Overall Study|Lack of Efficacy|12|||
163022254|NCT03558152|588786266|FG006|Overall Study|Lack of Efficacy|14|||
163022255|NCT03558152|588786267|FG007|Overall Study|Lack of Efficacy|13|||
163022256|NCT03558152|588786260|FG000|Overall Study|Protocol Violation|1|||
163022257|NCT03558152|588786261|FG001|Overall Study|Protocol Violation|1|||
163022258|NCT03558152|588786262|FG002|Overall Study|Protocol Violation|0|||
163022259|NCT03558152|588786263|FG003|Overall Study|Protocol Violation|1|||
163022260|NCT03558152|588786264|FG004|Overall Study|Protocol Violation|1|||
163022261|NCT03558152|588786265|FG005|Overall Study|Protocol Violation|0|||
163022262|NCT03558152|588786266|FG006|Overall Study|Protocol Violation|2|||
163022263|NCT03558152|588786267|FG007|Overall Study|Protocol Violation|0|||
163022264|NCT04166591|588786268|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
163022265|NCT04166591|588786269|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
163022266|NCT04166591|588786270|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163022267|NCT04166591|588786271|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163022268|NCT04166591|588786268|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
163022269|NCT04166591|588786269|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
163022270|NCT04166591|588786270|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163022271|NCT04166591|588786271|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163022272|NCT03960021|588786272|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
163022273|NCT03535194|588786273|FG000|Induction Period|Adverse Event|2|||
163022274|NCT03535194|588786274|FG001|Induction Period|Adverse Event|2|||
163022275|NCT03535194|588786275|FG002|Induction Period|Adverse Event|1|||
163022276|NCT03535194|588786276|FG003|Induction Period|Adverse Event|3|||
163022277|NCT03535194|588786277|FG004|Induction Period|Adverse Event|0|||
163022278|NCT03535194|588786273|FG000|Induction Period|Death|0|||
163022279|NCT03535194|588786274|FG001|Induction Period|Death|1|||
163022280|NCT03535194|588786275|FG002|Induction Period|Death|0|||
163022281|NCT03535194|588786276|FG003|Induction Period|Death|0|||
163022282|NCT03535194|588786277|FG004|Induction Period|Death|0|||
163022283|NCT03535194|588786273|FG000|Induction Period|Lack of Efficacy|1|||
163022284|NCT03535194|588786274|FG001|Induction Period|Lack of Efficacy|3|||
163022285|NCT03535194|588786275|FG002|Induction Period|Lack of Efficacy|2|||
163022286|NCT03535194|588786276|FG003|Induction Period|Lack of Efficacy|2|||
163022287|NCT03535194|588786277|FG004|Induction Period|Lack of Efficacy|0|||
163022288|NCT03535194|588786273|FG000|Induction Period|Lost to Follow-up|3|||
163022289|NCT03535194|588786274|FG001|Induction Period|Lost to Follow-up|5|||
163022290|NCT03535194|588786275|FG002|Induction Period|Lost to Follow-up|2|||
163022291|NCT03535194|588786276|FG003|Induction Period|Lost to Follow-up|3|||
163022292|NCT03535194|588786277|FG004|Induction Period|Lost to Follow-up|0|||
163022293|NCT03535194|588786273|FG000|Induction Period|Physician Decision|1|||
163022294|NCT03535194|588786274|FG001|Induction Period|Physician Decision|1|||
163022295|NCT03535194|588786275|FG002|Induction Period|Physician Decision|0|||
163022296|NCT03535194|588786276|FG003|Induction Period|Physician Decision|0|||
163022297|NCT03535194|588786277|FG004|Induction Period|Physician Decision|0|||
163022298|NCT03535194|588786273|FG000|Induction Period|Protocol Violation|1|||
163022299|NCT03535194|588786274|FG001|Induction Period|Protocol Violation|0|||
163022300|NCT03535194|588786275|FG002|Induction Period|Protocol Violation|0|||
163022301|NCT03535194|588786276|FG003|Induction Period|Protocol Violation|1|||
163022302|NCT03535194|588786277|FG004|Induction Period|Protocol Violation|0|||
163022303|NCT03535194|588786273|FG000|Induction Period|Screen Failure|0|||
163022304|NCT03535194|588786274|FG001|Induction Period|Screen Failure|1|||
163022305|NCT03535194|588786275|FG002|Induction Period|Screen Failure|0|||
163022306|NCT03535194|588786276|FG003|Induction Period|Screen Failure|0|||
163022307|NCT03535194|588786277|FG004|Induction Period|Screen Failure|0|||
163022308|NCT03535194|588786273|FG000|Induction Period|Withdrawal by Subject|3|||
163022309|NCT03535194|588786274|FG001|Induction Period|Withdrawal by Subject|4|||
163022310|NCT03535194|588786275|FG002|Induction Period|Withdrawal by Subject|3|||
163022311|NCT03535194|588786276|FG003|Induction Period|Withdrawal by Subject|2|||
163022312|NCT03535194|588786277|FG004|Induction Period|Withdrawal by Subject|0|||
163022313|NCT03535194|588786273|FG000|Maintenance Period|Adverse Event|6|||
163022314|NCT03535194|588786274|FG001|Maintenance Period|Adverse Event|5|||
163022315|NCT03535194|588786275|FG002|Maintenance Period|Adverse Event|1|||
163022316|NCT03535194|588786276|FG003|Maintenance Period|Adverse Event|11|||
163022317|NCT03535194|588786277|FG004|Maintenance Period|Adverse Event|4|||
163022318|NCT03535194|588786273|FG000|Maintenance Period|Lack of Efficacy|3|||
163022319|NCT03535194|588786274|FG001|Maintenance Period|Lack of Efficacy|2|||
163022320|NCT03535194|588786275|FG002|Maintenance Period|Lack of Efficacy|5|||
163022321|NCT03535194|588786276|FG003|Maintenance Period|Lack of Efficacy|9|||
163022322|NCT03535194|588786277|FG004|Maintenance Period|Lack of Efficacy|0|||
163022323|NCT03535194|588786273|FG000|Maintenance Period|Lost to Follow-up|4|||
163022324|NCT03535194|588786274|FG001|Maintenance Period|Lost to Follow-up|2|||
163022325|NCT03535194|588786275|FG002|Maintenance Period|Lost to Follow-up|1|||
163405210|NCT01464307|590193550|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
163405211|NCT01464307|590193551|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
163405212|NCT01464307|590193550|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
163405213|NCT01464307|590193551|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
163405214|NCT01464307|590193550|FG000|Open-Label Extension Period|Death|1|||
163405215|NCT01464307|590193551|FG001|Open-Label Extension Period|Death|0|||
163405216|NCT01464307|590193550|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
163405217|NCT01464307|590193551|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
163405218|NCT01464307|590193550|FG000|Open-Label Extension Period|Non-compliance|9|||
163405219|NCT01464307|590193551|FG001|Open-Label Extension Period|Non-compliance|0|||
163405220|NCT01464307|590193550|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
163405221|NCT01464307|590193551|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
163405222|NCT00159861|590193554|FG000|Core Study - 16 Weeks|Death|3|||
163405223|NCT00159861|590193555|FG001|Core Study - 16 Weeks|Death|0|||
163405224|NCT00159861|590193554|FG000|Core Study - 16 Weeks|Adverse Event|12|||
163405225|NCT00159861|590193555|FG001|Core Study - 16 Weeks|Adverse Event|6|||
163405226|NCT00159861|590193554|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
163405227|NCT00159861|590193555|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
163405228|NCT00159861|590193554|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
163405229|NCT00159861|590193555|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
163405230|NCT00159861|590193554|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
163405231|NCT00159861|590193555|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
163405232|NCT00159861|590193554|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
163405233|NCT00159861|590193555|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
163405234|NCT00159861|590193554|FG000|Extension Study - up to 3 Years|Death|24|||
163405235|NCT00159861|590193555|FG001|Extension Study - up to 3 Years|Death|28|||
163405236|NCT00159861|590193554|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
163405237|NCT00159861|590193555|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
163405238|NCT00159861|590193554|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
163022326|NCT03535194|588786276|FG003|Maintenance Period|Lost to Follow-up|5|||
163022327|NCT03535194|588786277|FG004|Maintenance Period|Lost to Follow-up|2|||
163022328|NCT03535194|588786273|FG000|Maintenance Period|Other|1|||
163022329|NCT03535194|588786274|FG001|Maintenance Period|Other|2|||
163022330|NCT03535194|588786275|FG002|Maintenance Period|Other|0|||
163022331|NCT03535194|588786276|FG003|Maintenance Period|Other|0|||
163022332|NCT03535194|588786277|FG004|Maintenance Period|Other|0|||
163022333|NCT03535194|588786273|FG000|Maintenance Period|Physician Decision|1|||
163022334|NCT03535194|588786274|FG001|Maintenance Period|Physician Decision|2|||
163022335|NCT03535194|588786275|FG002|Maintenance Period|Physician Decision|0|||
163022336|NCT03535194|588786276|FG003|Maintenance Period|Physician Decision|2|||
163022337|NCT03535194|588786277|FG004|Maintenance Period|Physician Decision|0|||
163022338|NCT03535194|588786273|FG000|Maintenance Period|Pregnancy|0|||
163022339|NCT03535194|588786274|FG001|Maintenance Period|Pregnancy|0|||
163022340|NCT03535194|588786275|FG002|Maintenance Period|Pregnancy|0|||
163405239|NCT00159861|590193555|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
163405240|NCT00159861|590193554|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
163405241|NCT00159861|590193555|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
163405242|NCT00159861|590193554|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
163405243|NCT00159861|590193555|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
163405244|NCT01210690|590193558|FG000|Overall Study|Adverse Event|7|||
163405245|NCT01210690|590193558|FG000|Overall Study|Lack of Efficacy|12|||
163405246|NCT01210690|590193558|FG000|Overall Study|Lost to Follow-up|3|||
163405247|NCT01210690|590193558|FG000|Overall Study|Disease Remission|1|||
163405248|NCT01210690|590193558|FG000|Overall Study|Withdrawal by Subject|1|||
163405249|NCT01210690|590193558|FG000|Overall Study|Patient refused to swallow|1|||
163405250|NCT01210690|590193558|FG000|Overall Study|Patient could not take glucose|1|||
163405251|NCT00894556|590193559|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
163405252|NCT00894556|590193560|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
163405253|NCT00894556|590193561|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
163405254|NCT00894556|590193562|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
163405255|NCT00894556|590193559|FG000|Treatment Phase|Lost to Follow-up|2|||
163405256|NCT00894556|590193560|FG001|Treatment Phase|Lost to Follow-up|3|||
163405257|NCT00894556|590193561|FG002|Treatment Phase|Lost to Follow-up|1|||
163405258|NCT00894556|590193562|FG003|Treatment Phase|Lost to Follow-up|0|||
163405259|NCT00894556|590193559|FG000|Treatment Phase|Lack of Qualifying Event|2|||
163405260|NCT00894556|590193560|FG001|Treatment Phase|Lack of Qualifying Event|1|||
163405261|NCT00894556|590193561|FG002|Treatment Phase|Lack of Qualifying Event|0|||
163063838|NCT02328014|588941489|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
163063839|NCT02328014|588941486|FG000|Overall Study|Withdrawal by Subject|0|||
163063840|NCT02328014|588941487|FG001|Overall Study|Withdrawal by Subject|0|||
163063841|NCT02328014|588941488|FG002|Overall Study|Withdrawal by Subject|0|||
163063842|NCT02328014|588941489|FG003|Overall Study|Withdrawal by Subject|1|||
163063843|NCT05028569|588941506|FG000|Double-Blind Phase|Death|0|||
163063844|NCT05028569|588941507|FG001|Double-Blind Phase|Death|0|||
163063845|NCT05028569|588941508|FG002|Double-Blind Phase|Death|0|||
163063846|NCT05028569|588941509|FG003|Double-Blind Phase|Death|1|||
163063847|NCT05028569|588941510|FG004|Double-Blind Phase|Death|0|||
163063848|NCT05028569|588941511|FG005|Double-Blind Phase|Death|0|||
163063849|NCT05028569|588941512|FG006|Double-Blind Phase|Death|0|||
163063850|NCT05028569|588941506|FG000|Double-Blind Phase|Lost to Follow-up|0|||
163063851|NCT05028569|588941507|FG001|Double-Blind Phase|Lost to Follow-up|6|||
163063852|NCT05028569|588941508|FG002|Double-Blind Phase|Lost to Follow-up|3|||
163063853|NCT05028569|588941509|FG003|Double-Blind Phase|Lost to Follow-up|9|||
163063854|NCT05028569|588941510|FG004|Double-Blind Phase|Lost to Follow-up|0|||
163063855|NCT05028569|588941511|FG005|Double-Blind Phase|Lost to Follow-up|0|||
163063856|NCT05028569|588941512|FG006|Double-Blind Phase|Lost to Follow-up|0|||
163063857|NCT05028569|588941506|FG000|Double-Blind Phase|Protocol Deviation|0|||
163063858|NCT05028569|588941507|FG001|Double-Blind Phase|Protocol Deviation|2|||
163063859|NCT05028569|588941508|FG002|Double-Blind Phase|Protocol Deviation|0|||
163063860|NCT05028569|588941509|FG003|Double-Blind Phase|Protocol Deviation|0|||
163063861|NCT05028569|588941510|FG004|Double-Blind Phase|Protocol Deviation|0|||
163063862|NCT05028569|588941511|FG005|Double-Blind Phase|Protocol Deviation|0|||
163063863|NCT05028569|588941512|FG006|Double-Blind Phase|Protocol Deviation|0|||
163063864|NCT05028569|588941506|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
163063865|NCT05028569|588941507|FG001|Double-Blind Phase|Withdrawal by Subject|27|||
163063866|NCT05028569|588941508|FG002|Double-Blind Phase|Withdrawal by Subject|20|||
163063867|NCT05028569|588941509|FG003|Double-Blind Phase|Withdrawal by Subject|22|||
163063868|NCT05028569|588941510|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
163063869|NCT05028569|588941511|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
163063870|NCT05028569|588941512|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
163063871|NCT05028569|588941506|FG000|Double-Blind Phase|Other, not specified|0|||
163063872|NCT05028569|588941507|FG001|Double-Blind Phase|Other, not specified|5|||
163405262|NCT00894556|590193562|FG003|Treatment Phase|Lack of Qualifying Event|0|||
163405263|NCT01806779|590193569|FG000|Overall Study|Physician Decision|2|||
163405264|NCT01806779|590193570|FG001|Overall Study|Physician Decision|0|||
163405265|NCT01806779|590193571|FG002|Overall Study|Physician Decision|1|||
163063873|NCT05028569|588941508|FG002|Double-Blind Phase|Other, not specified|4|||
163063874|NCT05028569|588941509|FG003|Double-Blind Phase|Other, not specified|6|||
163063875|NCT05028569|588941510|FG004|Double-Blind Phase|Other, not specified|0|||
163063876|NCT05028569|588941511|FG005|Double-Blind Phase|Other, not specified|0|||
163063877|NCT05028569|588941512|FG006|Double-Blind Phase|Other, not specified|0|||
163405266|NCT01806779|590193569|FG000|Overall Study|Lack of Efficacy|1|||
163405267|NCT01806779|590193570|FG001|Overall Study|Lack of Efficacy|1|||
163405268|NCT01806779|590193571|FG002|Overall Study|Lack of Efficacy|0|||
163063878|NCT05028569|588941506|FG000|Open-Label Phase|Death|0|||
163063879|NCT05028569|588941507|FG001|Open-Label Phase|Death|0|||
163063880|NCT05028569|588941508|FG002|Open-Label Phase|Death|0|||
163063881|NCT05028569|588941509|FG003|Open-Label Phase|Death|0|||
163063882|NCT05028569|588941510|FG004|Open-Label Phase|Death|0|||
163063883|NCT05028569|588941511|FG005|Open-Label Phase|Death|0|||
163063884|NCT05028569|588941512|FG006|Open-Label Phase|Death|1|||
163216922|NCT02357901|589510308|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
163216923|NCT02357901|589510305|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
163216924|NCT02357901|589510306|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
163216925|NCT02357901|589510307|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
163216926|NCT02357901|589510308|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
163216927|NCT02357901|589510305|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
163216928|NCT02357901|589510306|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
163216929|NCT02357901|589510307|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
163216930|NCT02357901|589510308|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
163216931|NCT02357901|589510305|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
163216932|NCT02357901|589510306|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
163216933|NCT02357901|589510307|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
163216934|NCT02357901|589510308|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
163330172|NCT00512252|589919000|FG002|Overall Study|Lost to Follow-up|1|||
163330173|NCT00512252|589918998|FG000|Overall Study|Protocol Violation|0|||
163330174|NCT00512252|589918999|FG001|Overall Study|Protocol Violation|0|||
163330175|NCT00512252|589919000|FG002|Overall Study|Protocol Violation|1|||
163330176|NCT00512252|589918998|FG000|Overall Study|Death|0|||
163330177|NCT00512252|589918999|FG001|Overall Study|Death|0|||
163330178|NCT00512252|589919000|FG002|Overall Study|Death|1|||
163330179|NCT02357966|589919001|FG000|Overall Study|Death|0|||
163330180|NCT02357966|589919002|FG001|Overall Study|Death|0|||
163330181|NCT02357966|589919003|FG002|Overall Study|Death|1|||
163330182|NCT02357966|589919004|FG003|Overall Study|Death|0|||
163330183|NCT02357966|589919005|FG004|Overall Study|Death|2|||
163330184|NCT02357966|589919006|FG005|Overall Study|Death|0|||
163330185|NCT02357966|589919001|FG000|Overall Study|Physician Decision|1|||
163330186|NCT02357966|589919002|FG001|Overall Study|Physician Decision|0|||
163330187|NCT02357966|589919003|FG002|Overall Study|Physician Decision|0|||
163330188|NCT02357966|589919004|FG003|Overall Study|Physician Decision|0|||
163330189|NCT02357966|589919005|FG004|Overall Study|Physician Decision|1|||
163330190|NCT02357966|589919006|FG005|Overall Study|Physician Decision|0|||
163330191|NCT01779700|589919007|FG000|Overall Study|Adverse Event|4|||
163330192|NCT01779700|589919008|FG001|Overall Study|Adverse Event|3|||
163330193|NCT01779700|589919007|FG000|Overall Study|Withdrawal by Subject|0|||
163330194|NCT01779700|589919008|FG001|Overall Study|Withdrawal by Subject|2|||
163330195|NCT00019604|589919009|FG000|Overall Study|Death|1|||
163330196|NCT00019604|589919009|FG000|Overall Study|Progressive disease|23|||
163022341|NCT03535194|588786276|FG003|Maintenance Period|Pregnancy|2|||
163022342|NCT03535194|588786277|FG004|Maintenance Period|Pregnancy|0|||
163022343|NCT03535194|588786273|FG000|Maintenance Period|Protocol Violation|0|||
163022344|NCT03535194|588786274|FG001|Maintenance Period|Protocol Violation|1|||
163022345|NCT03535194|588786275|FG002|Maintenance Period|Protocol Violation|0|||
163022346|NCT03535194|588786276|FG003|Maintenance Period|Protocol Violation|0|||
163022347|NCT03535194|588786277|FG004|Maintenance Period|Protocol Violation|0|||
163022348|NCT03535194|588786273|FG000|Maintenance Period|Withdrawal by Subject|7|||
163022349|NCT03535194|588786274|FG001|Maintenance Period|Withdrawal by Subject|2|||
163022350|NCT03535194|588786275|FG002|Maintenance Period|Withdrawal by Subject|1|||
163022351|NCT03535194|588786276|FG003|Maintenance Period|Withdrawal by Subject|8|||
163022352|NCT03535194|588786277|FG004|Maintenance Period|Withdrawal by Subject|0|||
163022353|NCT03535194|588786273|FG000|Post-Treatment Followup Period|Adverse Event|4|||
163022354|NCT03535194|588786274|FG001|Post-Treatment Followup Period|Adverse Event|5|||
163022355|NCT03535194|588786275|FG002|Post-Treatment Followup Period|Adverse Event|1|||
163022356|NCT03535194|588786276|FG003|Post-Treatment Followup Period|Adverse Event|8|||
163022357|NCT03535194|588786277|FG004|Post-Treatment Followup Period|Adverse Event|0|||
163022358|NCT03535194|588786273|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
163022359|NCT03535194|588786274|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
163022360|NCT03535194|588786275|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
163022361|NCT03535194|588786276|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
163022362|NCT03535194|588786277|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
163022363|NCT03535194|588786273|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
163022364|NCT03535194|588786274|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
163022365|NCT03535194|588786275|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
163022366|NCT03535194|588786276|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
163022367|NCT03535194|588786277|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
163022368|NCT03535194|588786273|FG000|Post-Treatment Followup Period|Other|1|||
163022369|NCT03535194|588786274|FG001|Post-Treatment Followup Period|Other|0|||
163022370|NCT03535194|588786275|FG002|Post-Treatment Followup Period|Other|0|||
163022371|NCT03535194|588786276|FG003|Post-Treatment Followup Period|Other|5|||
163022372|NCT03535194|588786277|FG004|Post-Treatment Followup Period|Other|0|||
163022373|NCT03535194|588786273|FG000|Post-Treatment Followup Period|Physician Decision|0|||
163022374|NCT03535194|588786274|FG001|Post-Treatment Followup Period|Physician Decision|2|||
163022375|NCT03535194|588786275|FG002|Post-Treatment Followup Period|Physician Decision|1|||
163063885|NCT05028569|588941506|FG000|Open-Label Phase|Lost to Follow-up|0|||
163063886|NCT05028569|588941507|FG001|Open-Label Phase|Lost to Follow-up|0|||
163063887|NCT05028569|588941508|FG002|Open-Label Phase|Lost to Follow-up|0|||
163063888|NCT05028569|588941509|FG003|Open-Label Phase|Lost to Follow-up|0|||
163216935|NCT02357901|589510305|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
163216936|NCT02357901|589510306|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
163216937|NCT02357901|589510307|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
163216938|NCT02357901|589510308|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
163216939|NCT02357901|589510305|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
163216940|NCT02357901|589510306|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
163216941|NCT02357901|589510307|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
163216942|NCT02357901|589510308|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
163216943|NCT02357901|589510305|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
163216944|NCT02357901|589510306|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
163216945|NCT02357901|589510307|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
163216946|NCT02357901|589510308|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
163216947|NCT02357901|589510305|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
163216948|NCT02357901|589510306|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
163216949|NCT02357901|589510307|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
163216950|NCT02357901|589510308|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
163216951|NCT02357901|589510305|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
163216952|NCT02357901|589510306|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
163216953|NCT02357901|589510307|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
163216954|NCT02357901|589510308|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
163216955|NCT02357901|589510305|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
163216956|NCT02357901|589510306|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
163216957|NCT02357901|589510307|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
163216958|NCT02357901|589510308|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
163216959|NCT02759120|589510311|FG000|Overall Study|Death|34|||
163216960|NCT02759120|589510312|FG001|Overall Study|Death|36|||
163216961|NCT02759120|589510311|FG000|Overall Study|Lost to Follow-up|4|||
163216962|NCT02759120|589510312|FG001|Overall Study|Lost to Follow-up|7|||
163216963|NCT02759120|589510311|FG000|Overall Study|Physician Decision|3|||
163216964|NCT02759120|589510312|FG001|Overall Study|Physician Decision|0|||
163216965|NCT02759120|589510311|FG000|Overall Study|Withdrawal by Subject|28|||
163216966|NCT02759120|589510312|FG001|Overall Study|Withdrawal by Subject|15|||
163216967|NCT02759120|589510311|FG000|Overall Study|Moved out of area|3|||
163216968|NCT02759120|589510312|FG001|Overall Study|Moved out of area|4|||
163216969|NCT02759120|589510311|FG000|Overall Study|Lung transplant|3|||
163216970|NCT02759120|589510312|FG001|Overall Study|Lung transplant|5|||
163216971|NCT02759120|589510311|FG000|Overall Study|Other reason not completed|10|||
163216972|NCT02759120|589510312|FG001|Overall Study|Other reason not completed|12|||
163216973|NCT04461015|589510316|FG000|Overall Study|IV access lost during the study|0|||
163216974|NCT04461015|589510317|FG001|Overall Study|IV access lost during the study|1|||
163216975|NCT04461015|589510316|FG000|Overall Study|Withdrawal by Subject|0|||
163216976|NCT04461015|589510317|FG001|Overall Study|Withdrawal by Subject|1|||
163216977|NCT00491387|589510319|FG000|Overall Study|study terminated|20|||
163216978|NCT02063854|589510326|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
163216979|NCT02063854|589510327|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
163216980|NCT02063854|589510328|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
163216981|NCT02063854|589510329|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
163216982|NCT02063854|589510330|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
163216983|NCT02063854|589510331|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
163216984|NCT02063854|589510332|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
163216985|NCT02063854|589510326|FG000|Overall Study|Major Protocol Deviation|0|||
163216986|NCT02063854|589510327|FG001|Overall Study|Major Protocol Deviation|0|||
163216987|NCT02063854|589510328|FG002|Overall Study|Major Protocol Deviation|3|||
163216988|NCT02063854|589510329|FG003|Overall Study|Major Protocol Deviation|0|||
163216989|NCT02063854|589510330|FG004|Overall Study|Major Protocol Deviation|0|||
163216990|NCT02063854|589510331|FG005|Overall Study|Major Protocol Deviation|0|||
163216991|NCT02063854|589510332|FG006|Overall Study|Major Protocol Deviation|0|||
163216992|NCT02063854|589510326|FG000|Overall Study|Voluntary Withdrawal|2|||
163216993|NCT02063854|589510327|FG001|Overall Study|Voluntary Withdrawal|0|||
163216994|NCT02063854|589510328|FG002|Overall Study|Voluntary Withdrawal|8|||
163216995|NCT02063854|589510329|FG003|Overall Study|Voluntary Withdrawal|1|||
163216996|NCT02063854|589510330|FG004|Overall Study|Voluntary Withdrawal|3|||
163216997|NCT02063854|589510331|FG005|Overall Study|Voluntary Withdrawal|6|||
163405269|NCT01806779|590193569|FG000|Overall Study|Lost to Follow-up|19|||
163405270|NCT01806779|590193570|FG001|Overall Study|Lost to Follow-up|20|||
163405271|NCT01806779|590193571|FG002|Overall Study|Lost to Follow-up|0|||
163405272|NCT01806779|590193569|FG000|Overall Study|Withdrawal by Subject|20|||
163405273|NCT01806779|590193570|FG001|Overall Study|Withdrawal by Subject|23|||
163405274|NCT01806779|590193571|FG002|Overall Study|Withdrawal by Subject|22|||
163405275|NCT00805480|590193572|FG000|Overall Study|Withdrawal by Subject|13|||
163405276|NCT00805480|590193573|FG001|Overall Study|Withdrawal by Subject|5|||
163405277|NCT00805480|590193574|FG002|Overall Study|Withdrawal by Subject|11|||
163405278|NCT00805480|590193575|FG003|Overall Study|Withdrawal by Subject|5|||
163405279|NCT00805480|590193572|FG000|Overall Study|Lost to Follow-up|1|||
163405280|NCT00805480|590193573|FG001|Overall Study|Lost to Follow-up|2|||
163405281|NCT00805480|590193574|FG002|Overall Study|Lost to Follow-up|0|||
163405282|NCT00805480|590193575|FG003|Overall Study|Lost to Follow-up|0|||
163405283|NCT00805480|590193572|FG000|Overall Study|Adverse Event|0|||
163405284|NCT00805480|590193573|FG001|Overall Study|Adverse Event|0|||
163405285|NCT00805480|590193574|FG002|Overall Study|Adverse Event|1|||
163405286|NCT00805480|590193575|FG003|Overall Study|Adverse Event|0|||
163405287|NCT04294901|590193576|FG000|Overall Study|Death|86|||
163405288|NCT04294901|590193577|FG001|Overall Study|Death|110|||
163405289|NCT04294901|590193576|FG000|Overall Study|Provider did not have historical control patients|581|||
163405290|NCT04294901|590193577|FG001|Overall Study|Provider did not have historical control patients|0|||
163405291|NCT04294901|590193576|FG000|Overall Study|Provider did not have intervention patients|0|||
163405292|NCT04294901|590193577|FG001|Overall Study|Provider did not have intervention patients|98|||
163405293|NCT01934556|590193580|FG000|Overall Study|Withdrawal by Subject|0|||
163405294|NCT01934556|590193581|FG001|Overall Study|Withdrawal by Subject|1|||
163063889|NCT05028569|588941510|FG004|Open-Label Phase|Lost to Follow-up|5|||
163063890|NCT05028569|588941511|FG005|Open-Label Phase|Lost to Follow-up|5|||
163063891|NCT05028569|588941512|FG006|Open-Label Phase|Lost to Follow-up|4|||
163063892|NCT05028569|588941506|FG000|Open-Label Phase|Protocol Deviation|0|||
163063893|NCT05028569|588941507|FG001|Open-Label Phase|Protocol Deviation|0|||
163063894|NCT05028569|588941508|FG002|Open-Label Phase|Protocol Deviation|0|||
163063895|NCT05028569|588941509|FG003|Open-Label Phase|Protocol Deviation|0|||
163063896|NCT05028569|588941510|FG004|Open-Label Phase|Protocol Deviation|1|||
163063897|NCT05028569|588941511|FG005|Open-Label Phase|Protocol Deviation|0|||
163063898|NCT05028569|588941512|FG006|Open-Label Phase|Protocol Deviation|0|||
163063899|NCT05028569|588941506|FG000|Open-Label Phase|Pregnancy|0|||
163063900|NCT05028569|588941507|FG001|Open-Label Phase|Pregnancy|0|||
163063901|NCT05028569|588941508|FG002|Open-Label Phase|Pregnancy|0|||
163405295|NCT01934556|590193582|FG002|Overall Study|Withdrawal by Subject|1|||
163405296|NCT01934556|590193580|FG000|Overall Study|Lost to Follow-up|4|||
163405297|NCT01934556|590193581|FG001|Overall Study|Lost to Follow-up|10|||
163405298|NCT01934556|590193582|FG002|Overall Study|Lost to Follow-up|7|||
163405299|NCT01934556|590193580|FG000|Overall Study|Death|1|||
163405300|NCT01934556|590193581|FG001|Overall Study|Death|5|||
163405301|NCT01934556|590193582|FG002|Overall Study|Death|2|||
163405302|NCT00733954|590193585|FG000|Overall Study|Lost to Follow-up|5|||
163405303|NCT00733954|590193586|FG001|Overall Study|Lost to Follow-up|2|||
163405304|NCT00733954|590193585|FG000|Overall Study|Protocol Violation|1|||
163063902|NCT05028569|588941509|FG003|Open-Label Phase|Pregnancy|0|||
163063903|NCT05028569|588941510|FG004|Open-Label Phase|Pregnancy|0|||
163063904|NCT05028569|588941511|FG005|Open-Label Phase|Pregnancy|1|||
163063905|NCT05028569|588941512|FG006|Open-Label Phase|Pregnancy|0|||
163063906|NCT05028569|588941506|FG000|Open-Label Phase|Withdrawal by Subject|0|||
163063907|NCT05028569|588941507|FG001|Open-Label Phase|Withdrawal by Subject|0|||
163063908|NCT05028569|588941508|FG002|Open-Label Phase|Withdrawal by Subject|0|||
163063909|NCT05028569|588941509|FG003|Open-Label Phase|Withdrawal by Subject|0|||
163063910|NCT05028569|588941510|FG004|Open-Label Phase|Withdrawal by Subject|15|||
163216998|NCT02063854|589510332|FG006|Overall Study|Voluntary Withdrawal|1|||
163216999|NCT02063854|589510326|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
163217000|NCT02063854|589510327|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
163405305|NCT00733954|590193586|FG001|Overall Study|Protocol Violation|0|||
163405306|NCT00733954|590193585|FG000|Overall Study|Withdrawal by Subject|2|||
163063911|NCT05028569|588941511|FG005|Open-Label Phase|Withdrawal by Subject|8|||
163063912|NCT05028569|588941512|FG006|Open-Label Phase|Withdrawal by Subject|13|||
163063913|NCT05028569|588941506|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
163063914|NCT05028569|588941507|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
163063915|NCT05028569|588941508|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
163063916|NCT05028569|588941509|FG003|Open-Label Phase|Study Terminated by Sponsor|0|||
163405307|NCT00733954|590193586|FG001|Overall Study|Withdrawal by Subject|0|||
163405308|NCT02663453|590193587|FG000|Overall Study|Death|4|||
163405309|NCT02663453|590193588|FG001|Overall Study|Death|4|||
163405310|NCT02663453|590193587|FG000|Overall Study|Withdrawal by Subject|1|||
163405311|NCT02663453|590193588|FG001|Overall Study|Withdrawal by Subject|0|||
163405312|NCT02495844|590194836|FG000|Overall Study|Lack of Efficacy|1|||
163405313|NCT02495844|590194837|FG001|Overall Study|Lack of Efficacy|2|||
163405314|NCT02495844|590194836|FG000|Overall Study|AE, non-fatal|0|||
163405315|NCT02495844|590194837|FG001|Overall Study|AE, non-fatal|1|||
163405316|NCT02495844|590194836|FG000|Overall Study|Hepatitis Positivity|0|||
163405317|NCT02495844|590194837|FG001|Overall Study|Hepatitis Positivity|1|||
163405318|NCT00647556|590194839|FG000|Overall Study|Adverse Event|0|||
163405319|NCT00647556|590194840|FG001|Overall Study|Adverse Event|1|||
163405320|NCT00647556|590194839|FG000|Overall Study|Lost to Follow-up|1|||
163405321|NCT00647556|590194840|FG001|Overall Study|Lost to Follow-up|0|||
163405322|NCT00647556|590194839|FG000|Overall Study|Protocol Violation|0|||
163405323|NCT00647556|590194840|FG001|Overall Study|Protocol Violation|1|||
163405324|NCT00647556|590194839|FG000|Overall Study|Withdrawal by Subject|1|||
163405325|NCT00647556|590194840|FG001|Overall Study|Withdrawal by Subject|0|||
163405326|NCT00647556|590194839|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
163405327|NCT00647556|590194840|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
163405328|NCT00623480|590194841|FG000|Overall Study|Lost to Follow-up|0|||
163405329|NCT00623480|590194842|FG001|Overall Study|Lost to Follow-up|1|||
163405330|NCT00623480|590194841|FG000|Overall Study|Withdrawal by Subject|2|||
163405331|NCT00623480|590194842|FG001|Overall Study|Withdrawal by Subject|4|||
163405332|NCT00623480|590194841|FG000|Overall Study|Lack of Efficacy|1|||
163405333|NCT00623480|590194842|FG001|Overall Study|Lack of Efficacy|0|||
163405334|NCT00623480|590194841|FG000|Overall Study|Non-compliant with study medication|4|||
163405335|NCT00623480|590194842|FG001|Overall Study|Non-compliant with study medication|0|||
163405336|NCT00623480|590194841|FG000|Overall Study|Protocol Violation|0|||
163405337|NCT00623480|590194842|FG001|Overall Study|Protocol Violation|1|||
163405338|NCT00623480|590194841|FG000|Overall Study|Site closed by sponsor|0|||
163405339|NCT00623480|590194842|FG001|Overall Study|Site closed by sponsor|1|||
163405340|NCT01594853|590194843|FG000|Overall Study|Withdrawal by Subject|1|||
163405341|NCT01594853|590194844|FG001|Overall Study|Withdrawal by Subject|1|||
163405342|NCT01594853|590194843|FG000|Overall Study|Lost to Follow-up|1|||
163405343|NCT01594853|590194844|FG001|Overall Study|Lost to Follow-up|1|||
163405344|NCT01594853|590194843|FG000|Overall Study|noncompliance with exercise|0|||
163405345|NCT01594853|590194844|FG001|Overall Study|noncompliance with exercise|1|||
163405346|NCT04677712|590194851|FG000|Overall Study|Lost to Follow-up|0|||
163405347|NCT04677712|590194852|FG001|Overall Study|Lost to Follow-up|1|||
163405348|NCT04677712|590194853|FG002|Overall Study|Lost to Follow-up|0|||
163405349|NCT04677712|590194854|FG003|Overall Study|Lost to Follow-up|0|||
163405350|NCT04677712|590194855|FG004|Overall Study|Lost to Follow-up|0|||
163405351|NCT04677712|590194856|FG005|Overall Study|Lost to Follow-up|0|||
163405352|NCT00847912|590194857|FG000|Overall Study|Protocol Violation|6|||
163405353|NCT00847912|590194858|FG001|Overall Study|Protocol Violation|7|||
163405354|NCT00847912|590194857|FG000|Overall Study|Withdrawal by Subject|3|||
163405355|NCT00847912|590194858|FG001|Overall Study|Withdrawal by Subject|6|||
163405356|NCT02083380|590194860|FG000|Overall Study|Lack of Efficacy|68|||
163405357|NCT02083380|590194861|FG001|Overall Study|Lack of Efficacy|79|||
163405358|NCT02083380|590194862|FG002|Overall Study|Lack of Efficacy|64|||
163405359|NCT02083380|590194860|FG000|Overall Study|Withdrawal by Subject|9|||
163405360|NCT02083380|590194861|FG001|Overall Study|Withdrawal by Subject|3|||
163405361|NCT02083380|590194862|FG002|Overall Study|Withdrawal by Subject|7|||
163405362|NCT02083380|590194860|FG000|Overall Study|Physician Decision|1|||
163405363|NCT02083380|590194861|FG001|Overall Study|Physician Decision|6|||
163405364|NCT02083380|590194862|FG002|Overall Study|Physician Decision|3|||
163405365|NCT02083380|590194860|FG000|Overall Study|Adverse Event|0|||
163405366|NCT02083380|590194861|FG001|Overall Study|Adverse Event|0|||
163405367|NCT02083380|590194862|FG002|Overall Study|Adverse Event|1|||
163405368|NCT02083380|590194860|FG000|Overall Study|Lost to Follow-up|5|||
163405369|NCT02083380|590194861|FG001|Overall Study|Lost to Follow-up|3|||
163405370|NCT02083380|590194862|FG002|Overall Study|Lost to Follow-up|3|||
163405371|NCT02083380|590194860|FG000|Overall Study|Other|8|||
163405372|NCT02083380|590194861|FG001|Overall Study|Other|4|||
163405373|NCT02083380|590194862|FG002|Overall Study|Other|6|||
163405374|NCT01032915|590194866|FG000|Overall Study|Adverse Event|2|||
163405375|NCT01032915|590194867|FG001|Overall Study|Adverse Event|2|||
163405376|NCT01032915|590194868|FG002|Overall Study|Adverse Event|1|||
163063917|NCT05028569|588941510|FG004|Open-Label Phase|Study Terminated by Sponsor|4|||
163063918|NCT05028569|588941511|FG005|Open-Label Phase|Study Terminated by Sponsor|10|||
163405377|NCT01032915|590194869|FG003|Overall Study|Adverse Event|1|||
163405378|NCT01032915|590194866|FG000|Overall Study|Abnormal test procedure result|0|||
163405379|NCT01032915|590194867|FG001|Overall Study|Abnormal test procedure result|0|||
163405380|NCT01032915|590194868|FG002|Overall Study|Abnormal test procedure result|1|||
163405381|NCT01032915|590194869|FG003|Overall Study|Abnormal test procedure result|0|||
163405382|NCT01032915|590194866|FG000|Overall Study|Withdrawal by Subject|0|||
163405383|NCT01032915|590194867|FG001|Overall Study|Withdrawal by Subject|3|||
163405384|NCT01032915|590194868|FG002|Overall Study|Withdrawal by Subject|1|||
163405385|NCT01032915|590194869|FG003|Overall Study|Withdrawal by Subject|1|||
163405386|NCT01032915|590194866|FG000|Overall Study|Administrative reasons|5|||
163405387|NCT01032915|590194867|FG001|Overall Study|Administrative reasons|6|||
163405388|NCT01032915|590194868|FG002|Overall Study|Administrative reasons|4|||
163405389|NCT01032915|590194869|FG003|Overall Study|Administrative reasons|4|||
163405390|NCT01032915|590194866|FG000|Overall Study|Protocol Violation|1|||
163405391|NCT01032915|590194867|FG001|Overall Study|Protocol Violation|0|||
163063919|NCT05028569|588941512|FG006|Open-Label Phase|Study Terminated by Sponsor|5|||
163063920|NCT05028569|588941506|FG000|Open-Label Phase|Other, not specified|0|||
163063921|NCT05028569|588941507|FG001|Open-Label Phase|Other, not specified|0|||
163063922|NCT05028569|588941508|FG002|Open-Label Phase|Other, not specified|0|||
163063923|NCT05028569|588941509|FG003|Open-Label Phase|Other, not specified|0|||
163063924|NCT05028569|588941510|FG004|Open-Label Phase|Other, not specified|6|||
163063925|NCT05028569|588941511|FG005|Open-Label Phase|Other, not specified|5|||
163063926|NCT05028569|588941512|FG006|Open-Label Phase|Other, not specified|7|||
163330197|NCT00019604|589919009|FG000|Overall Study|Refused treatment|1|||
163330198|NCT00019604|589919009|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
163330199|NCT00019604|589919009|FG000|Overall Study|Going to have liver transplant|1|||
163330200|NCT00019604|589919009|FG000|Overall Study|Move to a different study|1|||
163330201|NCT00019604|589919009|FG000|Overall Study|Non compliant on systemic CH|1|||
163330202|NCT00019604|589919009|FG000|Overall Study|Non compliant|1|||
163330203|NCT00019604|589919009|FG000|Overall Study|Resectable disease|1|||
163330204|NCT00019604|589919009|FG000|Overall Study|Started new chemo regimen|1|||
163330205|NCT00019604|589919009|FG000|Overall Study|Pt going to immunotherapy study|1|||
163330206|NCT00019604|589919009|FG000|Overall Study|Too much disease|1|||
163330207|NCT00019604|589919009|FG000|Overall Study|Unable to evaluate|1|||
163330208|NCT00019604|589919009|FG000|Overall Study|Details for other not available|4|||
163330209|NCT04608409|589919013|FG000|Overall Study|Physician Decision|1|||
163330210|NCT04608409|589919014|FG001|Overall Study|Physician Decision|1|||
163330211|NCT04608409|589919015|FG002|Overall Study|Physician Decision|2|||
163330212|NCT00918333|589919017|FG000|Overall Study|Drug not taken per protocol|1|||
163330213|NCT00918333|589919018|FG001|Overall Study|Drug not taken per protocol|0|||
163330214|NCT00918333|589919017|FG000|Overall Study|Inadequate amount of drugs provided|1|||
163330215|NCT00918333|589919018|FG001|Overall Study|Inadequate amount of drugs provided|4|||
163330216|NCT00918333|589919017|FG000|Overall Study|Ineligible|1|||
163330217|NCT00918333|589919018|FG001|Overall Study|Ineligible|0|||
163330218|NCT00918333|589919017|FG000|Overall Study|Withdrawal by Subject|0|||
163330219|NCT00918333|589919018|FG001|Overall Study|Withdrawal by Subject|1|||
163330220|NCT03392194|589919019|FG000|Overall Study|Withdrawal by Subject|1|||
163330221|NCT03392194|589919020|FG001|Overall Study|Withdrawal by Subject|2|||
163330222|NCT03392194|589919019|FG000|Overall Study|Conflicts with personal schedule|1|||
163330223|NCT03392194|589919020|FG001|Overall Study|Conflicts with personal schedule|0|||
163330224|NCT00620854|589919023|FG000|Washout 1|Withdrawal by Subject|0|||
163330225|NCT00620854|589919024|FG001|Washout 1|Withdrawal by Subject|0|||
163330226|NCT00620854|589919025|FG002|Washout 1|Withdrawal by Subject|1|||
163330227|NCT00620854|589919026|FG003|Washout 1|Withdrawal by Subject|1|||
163330228|NCT00620854|589919027|FG004|Washout 1|Withdrawal by Subject|0|||
163330229|NCT00620854|589919028|FG005|Washout 1|Withdrawal by Subject|0|||
163330230|NCT00463229|589919042|FG000|Overall Study|Lost to Follow-up|5|||
163330231|NCT00463229|589919043|FG001|Overall Study|Lost to Follow-up|7|||
163330232|NCT00463229|589919042|FG000|Overall Study|Death|4|||
163330233|NCT00463229|589919043|FG001|Overall Study|Death|3|||
163330234|NCT01359150|589919050|FG000|Overall Study|Lack of Efficacy|1|||
163330235|NCT01359150|589919051|FG001|Overall Study|Lack of Efficacy|1|||
163330236|NCT01359150|589919050|FG000|Overall Study|Withdrawal by Subject|1|||
163330237|NCT01359150|589919051|FG001|Overall Study|Withdrawal by Subject|1|||
163330238|NCT01359150|589919050|FG000|Overall Study|Adverse Event|4|||
163330239|NCT01359150|589919051|FG001|Overall Study|Adverse Event|3|||
163330240|NCT01359150|589919050|FG000|Overall Study|Other|1|||
163330241|NCT01359150|589919051|FG001|Overall Study|Other|0|||
163330242|NCT01170208|589919052|FG000|Overall Study|Withdrawal by Subject|5|||
163330243|NCT01170208|589919053|FG001|Overall Study|Withdrawal by Subject|0|||
163330244|NCT01170208|589919054|FG002|Overall Study|Withdrawal by Subject|1|||
163330245|NCT01170208|589919052|FG000|Overall Study|Protocol Violation|1|||
163330246|NCT01170208|589919053|FG001|Overall Study|Protocol Violation|0|||
163330247|NCT01170208|589919054|FG002|Overall Study|Protocol Violation|1|||
163330248|NCT03113409|589919055|FG000|Overall Study|Withdrawal by Subject|5|||
163330249|NCT03113409|589919056|FG001|Overall Study|Withdrawal by Subject|0|||
163330250|NCT03113409|589919057|FG002|Overall Study|Withdrawal by Subject|0|||
163330251|NCT02040870|589919058|FG000|Overall Study|Completed treatment phase|6|||
163330252|NCT02040870|589919058|FG000|Overall Study|Adverse Event|7|||
163330253|NCT02040870|589919058|FG000|Overall Study|Progressive disease|58|||
163330254|NCT02040870|589919058|FG000|Overall Study|Physician Decision|6|||
163330255|NCT02040870|589919058|FG000|Overall Study|Subject/guardian decision|10|||
163330256|NCT02040870|589919058|FG000|Overall Study|Lost to Follow-up|3|||
163330257|NCT02040870|589919058|FG000|Overall Study|Death|13|||
163330258|NCT01706159|589919068|FG000|Overall Study|Withdrawal Criteria|2|||
163330259|NCT01706159|589919069|FG001|Overall Study|Withdrawal Criteria|1|||
163330260|NCT01706159|589919068|FG000|Overall Study|Unclassified|6|||
163330261|NCT01706159|589919069|FG001|Overall Study|Unclassified|1|||
163330262|NCT03371017|589919070|FG000|Overall Study|Physician Decision|0|||
163330263|NCT03371017|589919071|FG001|Overall Study|Physician Decision|1|||
163330264|NCT03371017|589919070|FG000|Overall Study|Reason not Specified|0|||
163330265|NCT03371017|589919071|FG001|Overall Study|Reason not Specified|1|||
163405392|NCT01032915|590194868|FG002|Overall Study|Protocol Violation|0|||
163405393|NCT01032915|590194869|FG003|Overall Study|Protocol Violation|1|||
163405394|NCT01577186|590194870|FG000|Overall Study|Adverse Event|23|||
163405395|NCT01577186|590194870|FG000|Overall Study|Death|1|||
163405396|NCT01577186|590194870|FG000|Overall Study|Lost to Follow-up|28|||
163405397|NCT01577186|590194870|FG000|Overall Study|Withdrawal by Subject|35|||
163405398|NCT01577186|590194870|FG000|Overall Study|Insufficient Response|18|||
163405399|NCT01577186|590194870|FG000|Overall Study|Ineligible to Continue|15|||
163405400|NCT01577186|590194870|FG000|Overall Study|Non-Compliant|8|||
163405401|NCT01577186|590194870|FG000|Overall Study|Other|2|||
163405402|NCT02915523|590194872|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
163405403|NCT02915523|590194873|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
163405404|NCT02915523|590194874|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
163405405|NCT02915523|590194875|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
163405406|NCT02915523|590194872|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
163405407|NCT02915523|590194873|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
163405408|NCT02915523|590194874|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
163405409|NCT02915523|590194875|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
163405410|NCT02915523|590194872|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
163405411|NCT02915523|590194873|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
163405412|NCT02915523|590194874|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
163405413|NCT02915523|590194875|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
163405414|NCT02915523|590194872|FG000|Expansion Phase (Phase 2)|Death|0|||
163405415|NCT02915523|590194873|FG001|Expansion Phase (Phase 2)|Death|0|||
163405416|NCT02915523|590194874|FG002|Expansion Phase (Phase 2)|Death|26|||
163405417|NCT02915523|590194875|FG003|Expansion Phase (Phase 2)|Death|53|||
163405418|NCT02915523|590194872|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
163405419|NCT02915523|590194873|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
163405420|NCT02915523|590194874|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
163405421|NCT02915523|590194875|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
163405422|NCT02915523|590194872|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
163405423|NCT02915523|590194873|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
163405424|NCT02915523|590194874|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
163405425|NCT02915523|590194875|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
163405426|NCT02915523|590194872|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
163405427|NCT02915523|590194873|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
163405428|NCT02915523|590194874|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
163405429|NCT02915523|590194875|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
163405430|NCT02797808|590194876|FG000|Overall Study|Withdrawal by Subject|1|||
163405431|NCT02797808|590194877|FG001|Overall Study|Withdrawal by Subject|1|||
163405432|NCT02797808|590194876|FG000|Overall Study|Physician Decision|6|||
163405433|NCT02797808|590194877|FG001|Overall Study|Physician Decision|2|||
163405434|NCT00535132|590194880|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
163405435|NCT00535132|590194881|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
163405436|NCT00535132|590194880|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
163405437|NCT00535132|590194881|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
163405438|NCT00708500|590194888|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
163405439|NCT00708500|590194889|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
163405440|NCT00708500|590194890|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
163405441|NCT00708500|590194888|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
163405442|NCT00708500|590194889|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
163330266|NCT03371017|589919070|FG000|Overall Study|Lost to Follow-up|13|||
163330267|NCT03371017|589919071|FG001|Overall Study|Lost to Follow-up|16|||
163330268|NCT03371017|589919070|FG000|Overall Study|Death|228|||
163330269|NCT03371017|589919071|FG001|Overall Study|Death|215|||
163330270|NCT03371017|589919070|FG000|Overall Study|Withdrawal by Subject|20|||
163330271|NCT03371017|589919071|FG001|Overall Study|Withdrawal by Subject|25|||
163330272|NCT03371017|589919070|FG000|Overall Study|Study Ended by Sponsor|37|||
163330273|NCT03371017|589919071|FG001|Overall Study|Study Ended by Sponsor|38|||
163330274|NCT03371017|589919070|FG000|Overall Study|Protocol Deviation|0|||
163330275|NCT03371017|589919071|FG001|Overall Study|Protocol Deviation|1|||
163330276|NCT04057131|589919072|FG000|Overall Study|Protocol Violation|24|||
163330277|NCT02830204|589919073|FG000|Overall Study|Death|9|||
163330278|NCT02830204|589919073|FG000|Overall Study|Withdrawal by Subject|1|||
163405443|NCT00708500|590194890|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
163405444|NCT00708500|590194888|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
163405445|NCT00708500|590194889|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
163405446|NCT00708500|590194890|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
163405447|NCT00708500|590194888|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
163330279|NCT02517268|589919076|FG000|Overall Study|Withdrawal by Subject|1|||
163330280|NCT02517268|589919077|FG001|Overall Study|Withdrawal by Subject|0|||
163330281|NCT04686266|589919080|FG000|Overall Study|Withdrawal by Subject|0|||
163063927|NCT05028569|588941506|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
163063928|NCT05028569|588941507|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
163063929|NCT05028569|588941508|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
163063930|NCT05028569|588941509|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
163063931|NCT05028569|588941510|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
163063932|NCT05028569|588941511|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|2|||
163063933|NCT05028569|588941512|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
163063934|NCT05028569|588941506|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
163063935|NCT05028569|588941507|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
163330282|NCT04686266|589919081|FG001|Overall Study|Withdrawal by Subject|1|||
163330283|NCT02401815|589919086|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163330284|NCT02401815|589919087|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163330285|NCT02401815|589919088|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163330286|NCT02401815|589919089|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
163330287|NCT02401815|589919090|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163330288|NCT02401815|589919091|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163330289|NCT02401815|589919092|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163330290|NCT02401815|589919093|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163330291|NCT02401815|589919094|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163330292|NCT02401815|589919095|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163330293|NCT02401815|589919086|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
163330294|NCT02401815|589919087|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
163330295|NCT02401815|589919088|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
163330296|NCT02401815|589919089|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
163330297|NCT02401815|589919090|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
163330298|NCT02401815|589919091|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
163330299|NCT02401815|589919092|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
163330300|NCT02401815|589919093|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
163330301|NCT02401815|589919094|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
163330302|NCT02401815|589919095|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
163330303|NCT02401815|589919086|FG000|Dose Escalation (up to 670 Days)|Death|1|||
163330304|NCT02401815|589919087|FG001|Dose Escalation (up to 670 Days)|Death|2|||
163330305|NCT02401815|589919088|FG002|Dose Escalation (up to 670 Days)|Death|3|||
163330306|NCT02401815|589919089|FG003|Dose Escalation (up to 670 Days)|Death|5|||
163330307|NCT02401815|589919090|FG004|Dose Escalation (up to 670 Days)|Death|4|||
163330308|NCT02401815|589919091|FG005|Dose Escalation (up to 670 Days)|Death|0|||
163330309|NCT02401815|589919092|FG006|Dose Escalation (up to 670 Days)|Death|0|||
163330310|NCT02401815|589919093|FG007|Dose Escalation (up to 670 Days)|Death|0|||
163330311|NCT02401815|589919094|FG008|Dose Escalation (up to 670 Days)|Death|0|||
163330312|NCT02401815|589919095|FG009|Dose Escalation (up to 670 Days)|Death|0|||
163330313|NCT02401815|589919086|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
163330314|NCT02401815|589919087|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
163330315|NCT02401815|589919088|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
163330316|NCT02401815|589919089|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
163330317|NCT02401815|589919090|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
163330318|NCT02401815|589919091|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
163330319|NCT02401815|589919092|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
163330320|NCT02401815|589919093|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
163330321|NCT02401815|589919094|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
163330322|NCT02401815|589919095|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
163330323|NCT02401815|589919086|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
163330324|NCT02401815|589919087|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163330325|NCT02401815|589919088|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163330326|NCT02401815|589919089|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163330327|NCT02401815|589919090|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
163330328|NCT02401815|589919091|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163330329|NCT02401815|589919092|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163330330|NCT02401815|589919093|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163330331|NCT02401815|589919094|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163330332|NCT02401815|589919095|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163330333|NCT02401815|589919086|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163330334|NCT02401815|589919087|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163330335|NCT02401815|589919088|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163330336|NCT02401815|589919089|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163330337|NCT02401815|589919090|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163405448|NCT00708500|590194889|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
163405449|NCT00708500|590194890|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
163405450|NCT00708500|590194888|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
163405451|NCT00708500|590194889|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
163405452|NCT00708500|590194890|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
163405453|NCT00708500|590194888|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
163405454|NCT00708500|590194889|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
163405455|NCT00708500|590194890|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
163405456|NCT00708500|590194888|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
163405457|NCT00708500|590194889|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
163405458|NCT00708500|590194890|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
163405459|NCT00708500|590194888|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
163405460|NCT00708500|590194889|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
163405461|NCT00708500|590194890|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
163405462|NCT00708500|590194888|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
163405463|NCT00708500|590194889|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
163405464|NCT00708500|590194890|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
163405465|NCT00708500|590194888|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
163405466|NCT00708500|590194889|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
163405467|NCT00708500|590194890|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
163405468|NCT00708500|590194888|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
163405469|NCT00708500|590194889|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
163405470|NCT00708500|590194890|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
163405471|NCT00708500|590194888|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
163405472|NCT00708500|590194889|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
163405473|NCT00708500|590194890|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
163405474|NCT00708500|590194888|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
163405475|NCT00708500|590194889|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
163405476|NCT00708500|590194890|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
163405477|NCT00708500|590194888|FG000|FOLLOWUP|Adverse Event|0|||
163405478|NCT00708500|590194889|FG001|FOLLOWUP|Adverse Event|1|||
163405479|NCT00708500|590194890|FG002|FOLLOWUP|Adverse Event|0|||
163405480|NCT00708500|590194888|FG000|FOLLOWUP|Lost to Follow-up|1|||
163405481|NCT00708500|590194889|FG001|FOLLOWUP|Lost to Follow-up|6|||
163405482|NCT00708500|590194890|FG002|FOLLOWUP|Lost to Follow-up|4|||
163405483|NCT00708500|590194888|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
163405484|NCT00708500|590194889|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
163405485|NCT00708500|590194890|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
163405486|NCT00708500|590194888|FG000|FOLLOWUP|Subject withdrew consent|31|||
163405487|NCT00708500|590194889|FG001|FOLLOWUP|Subject withdrew consent|4|||
163405488|NCT00708500|590194890|FG002|FOLLOWUP|Subject withdrew consent|5|||
163405489|NCT00708500|590194888|FG000|FOLLOWUP|Non-compliance with protocol|5|||
163405490|NCT00708500|590194889|FG001|FOLLOWUP|Non-compliance with protocol|0|||
163405491|NCT00708500|590194890|FG002|FOLLOWUP|Non-compliance with protocol|1|||
163063936|NCT05028569|588941508|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
163063937|NCT05028569|588941509|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
163063938|NCT05028569|588941510|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
163063939|NCT05028569|588941511|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
163063940|NCT05028569|588941512|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|1|||
163063941|NCT04609553|588941513|FG000|Overall Study|Lost to Follow-up|27|||
163063942|NCT04609553|588941514|FG001|Overall Study|Lost to Follow-up|31|||
163063943|NCT04609553|588941515|FG002|Overall Study|Lost to Follow-up|24|||
163063944|NCT04609553|588941513|FG000|Overall Study|Discontinued|12|||
163063945|NCT04609553|588941514|FG001|Overall Study|Discontinued|10|||
163063946|NCT04609553|588941515|FG002|Overall Study|Discontinued|9|||
163063947|NCT02362451|588941526|FG000|Overall Study|Withdrawal by Subject|0|||
163063948|NCT02362451|588941527|FG001|Overall Study|Withdrawal by Subject|1|||
163063949|NCT02362451|588941526|FG000|Overall Study|Lack of Efficacy|2|||
163063950|NCT02362451|588941527|FG001|Overall Study|Lack of Efficacy|0|||
163063951|NCT02362451|588941526|FG000|Overall Study|Progression|1|||
163063952|NCT02362451|588941527|FG001|Overall Study|Progression|0|||
163063953|NCT02362451|588941526|FG000|Overall Study|Participant chose other therapy.|1|||
163063954|NCT02362451|588941527|FG001|Overall Study|Participant chose other therapy.|0|||
163063955|NCT02101294|588941529|FG000|Overall Study|Withdrawal by Subject|5|||
163063956|NCT02101294|588941529|FG000|Overall Study|Lost to Follow-up|6|||
163063957|NCT00689936|588941530|FG000|Active Treatment Phase|Adverse Event|68|||
163063958|NCT00689936|588941531|FG001|Active Treatment Phase|Adverse Event|71|||
163063959|NCT00689936|588941532|FG002|Active Treatment Phase|Adverse Event|76|||
163405492|NCT00794677|590194901|FG000|First Intervention|Withdrawal by Subject|2|||
163405493|NCT00794677|590194902|FG001|First Intervention|Withdrawal by Subject|0|||
163217001|NCT02063854|589510328|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
163405494|NCT01029366|590194903|FG000|Overall Study|Withdrawal by Subject|1|||
163405495|NCT01029366|590194904|FG001|Overall Study|Withdrawal by Subject|0|||
163217002|NCT02063854|589510329|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
163405496|NCT01029366|590194903|FG000|Overall Study|Death|1|||
163405497|NCT01029366|590194904|FG001|Overall Study|Death|1|||
163405498|NCT01029366|590194903|FG000|Overall Study|disease progression|2|||
163405499|NCT01029366|590194904|FG001|Overall Study|disease progression|0|||
163405500|NCT01029366|590194903|FG000|Overall Study|manufacturing failure|0|||
163405501|NCT01029366|590194904|FG001|Overall Study|manufacturing failure|1|||
163405502|NCT03681119|590194909|FG000|Overall Study|No specific reason|4|||
163405503|NCT03681119|590194910|FG001|Overall Study|No specific reason|0|||
163405504|NCT03681119|590194909|FG000|Overall Study|Sickness|2|||
163405505|NCT03681119|590194910|FG001|Overall Study|Sickness|0|||
163405506|NCT02941627|590194919|FG000|Overall Study|Death|1|||
163405507|NCT02941627|590194919|FG000|Overall Study|Surgical failure|1|||
163405508|NCT02941627|590194919|FG000|Overall Study|cholesteatoma prevented implantation|1|||
163405509|NCT00563186|590194920|FG000|Overall Study|LOS<48 hours|97|||
163405510|NCT00563186|590194921|FG001|Overall Study|LOS<48 hours|74|||
163405511|NCT00563186|590194920|FG000|Overall Study|Incomplete data|1|||
163405512|NCT00563186|590194921|FG001|Overall Study|Incomplete data|1|||
163405513|NCT01136655|590194922|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
163405514|NCT01136655|590194922|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
163405515|NCT01136655|590194922|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
163405516|NCT01136655|590194922|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
163405517|NCT01265550|590194923|FG000|Pre Randomization|Withdrawal by Subject|0|||
163405518|NCT01265550|590194924|FG001|Pre Randomization|Withdrawal by Subject|0|||
163405519|NCT01265550|590194925|FG002|Pre Randomization|Withdrawal by Subject|0|||
163405520|NCT01265550|590194926|FG003|Pre Randomization|Withdrawal by Subject|70|||
163405521|NCT01265550|590194923|FG000|Pre Randomization|Technical Exclusions|0|||
163405522|NCT01265550|590194924|FG001|Pre Randomization|Technical Exclusions|0|||
163405523|NCT01265550|590194925|FG002|Pre Randomization|Technical Exclusions|0|||
163405524|NCT01265550|590194926|FG003|Pre Randomization|Technical Exclusions|54|||
163405525|NCT01265550|590194923|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
163405526|NCT01265550|590194924|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
163405527|NCT01265550|590194925|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
163405528|NCT01265550|590194926|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
163405529|NCT01265550|590194923|FG000|Pre Randomization|Non-GERD organic disorders|0|||
163405530|NCT01265550|590194924|FG001|Pre Randomization|Non-GERD organic disorders|0|||
163405531|NCT01265550|590194925|FG002|Pre Randomization|Non-GERD organic disorders|0|||
163405532|NCT01265550|590194926|FG003|Pre Randomization|Non-GERD organic disorders|23|||
163405533|NCT01265550|590194923|FG000|Pre Randomization|Functional heartburn|0|||
163405534|NCT01265550|590194924|FG001|Pre Randomization|Functional heartburn|0|||
163063960|NCT00689936|588941530|FG000|Active Treatment Phase|Disease Progression|273|||
163063961|NCT00689936|588941531|FG001|Active Treatment Phase|Disease Progression|362|||
163063962|NCT00689936|588941532|FG002|Active Treatment Phase|Disease Progression|339|||
163063963|NCT00689936|588941530|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
163063964|NCT00689936|588941531|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
163063965|NCT00689936|588941532|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
163063966|NCT00689936|588941530|FG000|Active Treatment Phase|Death|60|||
163063967|NCT00689936|588941531|FG001|Active Treatment Phase|Death|28|||
163063968|NCT00689936|588941532|FG002|Active Treatment Phase|Death|37|||
163063969|NCT00689936|588941530|FG000|Active Treatment Phase|Lost to Follow-up|0|||
163063970|NCT00689936|588941531|FG001|Active Treatment Phase|Lost to Follow-up|2|||
163063971|NCT00689936|588941532|FG002|Active Treatment Phase|Lost to Follow-up|2|||
163063972|NCT00689936|588941530|FG000|Active Treatment Phase|Protocol Violation|2|||
163063973|NCT00689936|588941531|FG001|Active Treatment Phase|Protocol Violation|2|||
163217003|NCT02063854|589510330|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
163217004|NCT02063854|589510331|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
163405535|NCT01265550|590194925|FG002|Pre Randomization|Functional heartburn|0|||
163405536|NCT01265550|590194926|FG003|Pre Randomization|Functional heartburn|99|||
163063974|NCT00689936|588941532|FG002|Active Treatment Phase|Protocol Violation|4|||
163063975|NCT00689936|588941530|FG000|Active Treatment Phase|Study Close Out|64|||
163217005|NCT02063854|589510332|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
163217006|NCT02063854|589510326|FG000|Overall Study|Reason Not Specified|1|||
163217007|NCT02063854|589510327|FG001|Overall Study|Reason Not Specified|0|||
163405537|NCT01929408|590194927|FG000|Overall Study|received HCT as initial treatment|8|||
163405538|NCT00652366|590194937|FG000|Overall Study|Adverse Event|8|||
163405539|NCT00652366|590194938|FG001|Overall Study|Adverse Event|4|||
163405540|NCT00652366|590194939|FG002|Overall Study|Adverse Event|7|||
163063976|NCT00689936|588941531|FG001|Active Treatment Phase|Study Close Out|26|||
163405541|NCT00652366|590194940|FG003|Overall Study|Adverse Event|17|||
163405542|NCT00652366|590194941|FG004|Overall Study|Adverse Event|13|||
163405543|NCT00652366|590194937|FG000|Overall Study|Death|5|||
163405544|NCT00652366|590194938|FG001|Overall Study|Death|4|||
163217008|NCT02063854|589510328|FG002|Overall Study|Reason Not Specified|0|||
163217009|NCT02063854|589510329|FG003|Overall Study|Reason Not Specified|0|||
163217010|NCT02063854|589510330|FG004|Overall Study|Reason Not Specified|0|||
163405545|NCT00652366|590194939|FG002|Overall Study|Death|1|||
163405546|NCT00652366|590194940|FG003|Overall Study|Death|8|||
163405547|NCT00652366|590194941|FG004|Overall Study|Death|5|||
163405548|NCT00652366|590194937|FG000|Overall Study|Lack of Efficacy|84|||
163405549|NCT00652366|590194938|FG001|Overall Study|Lack of Efficacy|58|||
163405550|NCT00652366|590194939|FG002|Overall Study|Lack of Efficacy|53|||
163405551|NCT00652366|590194940|FG003|Overall Study|Lack of Efficacy|133|||
163405552|NCT00652366|590194941|FG004|Overall Study|Lack of Efficacy|13|||
163405553|NCT00652366|590194937|FG000|Overall Study|Violation of Selection Criteria|0|||
163405554|NCT00652366|590194938|FG001|Overall Study|Violation of Selection Criteria|0|||
163405555|NCT00652366|590194939|FG002|Overall Study|Violation of Selection Criteria|1|||
163405556|NCT00652366|590194940|FG003|Overall Study|Violation of Selection Criteria|0|||
163405557|NCT00652366|590194941|FG004|Overall Study|Violation of Selection Criteria|0|||
163405558|NCT00652366|590194937|FG000|Overall Study|Protocol Violation|1|||
163405559|NCT00652366|590194938|FG001|Overall Study|Protocol Violation|0|||
163405560|NCT00652366|590194939|FG002|Overall Study|Protocol Violation|0|||
163405561|NCT00652366|590194940|FG003|Overall Study|Protocol Violation|0|||
163405562|NCT00652366|590194941|FG004|Overall Study|Protocol Violation|0|||
163405563|NCT00652366|590194937|FG000|Overall Study|Refused treatment|3|||
163405564|NCT00652366|590194938|FG001|Overall Study|Refused treatment|7|||
163405565|NCT00652366|590194939|FG002|Overall Study|Refused treatment|6|||
163405566|NCT00652366|590194940|FG003|Overall Study|Refused treatment|17|||
163405567|NCT00652366|590194941|FG004|Overall Study|Refused treatment|5|||
163405568|NCT00652366|590194937|FG000|Overall Study|Other|5|||
163405569|NCT00652366|590194938|FG001|Overall Study|Other|2|||
163405570|NCT00652366|590194939|FG002|Overall Study|Other|3|||
163405571|NCT00652366|590194940|FG003|Overall Study|Other|4|||
163405572|NCT00652366|590194941|FG004|Overall Study|Other|0|||
163405573|NCT03873714|590194942|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
163405574|NCT01970501|590194943|FG000|Overall Study|Discontinuation of study by sponsor|16|||
163405575|NCT01970501|590194944|FG001|Overall Study|Discontinuation of study by sponsor|14|||
163405576|NCT01970501|590194943|FG000|Overall Study|Withdrawal by Subject|6|||
163405577|NCT01970501|590194944|FG001|Overall Study|Withdrawal by Subject|7|||
163405578|NCT01970501|590194943|FG000|Overall Study|Adverse Event|2|||
163405579|NCT01970501|590194944|FG001|Overall Study|Adverse Event|4|||
163405580|NCT01970501|590194943|FG000|Overall Study|Death|1|||
163405581|NCT01970501|590194944|FG001|Overall Study|Death|3|||
163405582|NCT01970501|590194943|FG000|Overall Study|Physician Decision|2|||
163405583|NCT01970501|590194944|FG001|Overall Study|Physician Decision|0|||
163405584|NCT00708123|590194945|FG000|Period 1|Protocol Violation|0|||
163405585|NCT00708123|590194946|FG001|Period 1|Protocol Violation|1|||
163405586|NCT00708123|590194947|FG002|Period 1|Protocol Violation|0|||
163405587|NCT00708123|590194948|FG003|Period 1|Protocol Violation|1|||
163405588|NCT00708123|590194949|FG004|Period 1|Protocol Violation|0|||
163405589|NCT00708123|590194945|FG000|Period 1|Adverse Event|0|||
163405590|NCT00708123|590194946|FG001|Period 1|Adverse Event|0|||
163405591|NCT00708123|590194947|FG002|Period 1|Adverse Event|1|||
163405592|NCT00708123|590194948|FG003|Period 1|Adverse Event|0|||
163405593|NCT00708123|590194949|FG004|Period 1|Adverse Event|0|||
163405594|NCT00708123|590194945|FG000|Period 2|Protocol Violation|0|||
163405595|NCT00708123|590194946|FG001|Period 2|Protocol Violation|0|||
163405596|NCT00708123|590194947|FG002|Period 2|Protocol Violation|0|||
163405597|NCT00708123|590194948|FG003|Period 2|Protocol Violation|1|||
163405598|NCT00708123|590194949|FG004|Period 2|Protocol Violation|0|||
163405599|NCT00708123|590194945|FG000|Period 2|Other Reason|1|||
163405600|NCT00708123|590194946|FG001|Period 2|Other Reason|0|||
163405601|NCT00708123|590194947|FG002|Period 2|Other Reason|0|||
163405602|NCT00708123|590194948|FG003|Period 2|Other Reason|0|||
163405603|NCT00708123|590194949|FG004|Period 2|Other Reason|0|||
163405604|NCT00708123|590194945|FG000|Period 3|Lost to Follow-up|0|||
163405605|NCT00708123|590194946|FG001|Period 3|Lost to Follow-up|0|||
163405606|NCT00708123|590194947|FG002|Period 3|Lost to Follow-up|1|||
163405607|NCT00708123|590194948|FG003|Period 3|Lost to Follow-up|1|||
163405608|NCT00708123|590194949|FG004|Period 3|Lost to Follow-up|0|||
163217011|NCT02063854|589510331|FG005|Overall Study|Reason Not Specified|0|||
163405609|NCT00708123|590194945|FG000|Period 4|Protocol Violation|0|||
163405610|NCT00708123|590194946|FG001|Period 4|Protocol Violation|1|||
163405611|NCT00708123|590194947|FG002|Period 4|Protocol Violation|0|||
163405612|NCT00708123|590194948|FG003|Period 4|Protocol Violation|0|||
163405613|NCT00708123|590194949|FG004|Period 4|Protocol Violation|0|||
163405614|NCT00845650|590194950|FG000|Overall Study|Withdrawal by Subject|0|||
163405615|NCT00845650|590194951|FG001|Overall Study|Withdrawal by Subject|0|||
163405616|NCT00845650|590194952|FG002|Overall Study|Withdrawal by Subject|0|||
163217012|NCT02063854|589510332|FG006|Overall Study|Reason Not Specified|0|||
163405617|NCT00845650|590194953|FG003|Overall Study|Withdrawal by Subject|0|||
163405618|NCT00845650|590194954|FG004|Overall Study|Withdrawal by Subject|2|||
163405619|NCT00845650|590194955|FG005|Overall Study|Withdrawal by Subject|0|||
163405620|NCT00845650|590194950|FG000|Overall Study|Lost to Follow-up|0|||
163405621|NCT00845650|590194951|FG001|Overall Study|Lost to Follow-up|0|||
163405622|NCT00845650|590194952|FG002|Overall Study|Lost to Follow-up|3|||
163405623|NCT00845650|590194953|FG003|Overall Study|Lost to Follow-up|1|||
163405624|NCT00845650|590194954|FG004|Overall Study|Lost to Follow-up|0|||
163405625|NCT00845650|590194955|FG005|Overall Study|Lost to Follow-up|1|||
163405626|NCT00845650|590194950|FG000|Overall Study|Sponsor hold on dosing|0|||
163405627|NCT00845650|590194951|FG001|Overall Study|Sponsor hold on dosing|0|||
163405628|NCT00845650|590194952|FG002|Overall Study|Sponsor hold on dosing|0|||
163405629|NCT00845650|590194953|FG003|Overall Study|Sponsor hold on dosing|0|||
163405630|NCT00845650|590194954|FG004|Overall Study|Sponsor hold on dosing|1|||
163405631|NCT00845650|590194955|FG005|Overall Study|Sponsor hold on dosing|1|||
163405632|NCT00845650|590194950|FG000|Overall Study|Unable to access IV line|1|||
163405633|NCT00845650|590194951|FG001|Overall Study|Unable to access IV line|0|||
163405634|NCT00845650|590194952|FG002|Overall Study|Unable to access IV line|0|||
163405635|NCT00845650|590194953|FG003|Overall Study|Unable to access IV line|0|||
163405636|NCT00845650|590194954|FG004|Overall Study|Unable to access IV line|0|||
163405637|NCT00845650|590194955|FG005|Overall Study|Unable to access IV line|0|||
163405638|NCT00677014|590194957|FG000|Overall Study|Lost to Follow-up|20|||
163405639|NCT00677014|590194958|FG001|Overall Study|Lost to Follow-up|12|||
163405640|NCT00677014|590194959|FG002|Overall Study|Lost to Follow-up|24|||
163405641|NCT00677014|590194957|FG000|Overall Study|Death|6|||
163405642|NCT00677014|590194958|FG001|Overall Study|Death|15|||
163405643|NCT00677014|590194959|FG002|Overall Study|Death|7|||
163405644|NCT00677014|590194957|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
163405645|NCT00677014|590194958|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
163405646|NCT00677014|590194959|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
163405647|NCT01326546|590194962|FG000|Overall Study|Lost to Follow-up|8|||
163405648|NCT01326546|590194963|FG001|Overall Study|Lost to Follow-up|7|||
163405649|NCT01326546|590194962|FG000|Overall Study|Protocol Violation|3|||
163405650|NCT01326546|590194963|FG001|Overall Study|Protocol Violation|4|||
163405651|NCT01326546|590194962|FG000|Overall Study|Pregnancy|0|||
163405652|NCT01326546|590194963|FG001|Overall Study|Pregnancy|1|||
163405653|NCT01326546|590194962|FG000|Overall Study|Adverse Event|1|||
163405654|NCT01326546|590194963|FG001|Overall Study|Adverse Event|0|||
163405655|NCT01326546|590194962|FG000|Overall Study|Withdrawal by Subject|5|||
163405656|NCT01326546|590194963|FG001|Overall Study|Withdrawal by Subject|1|||
163405657|NCT00081159|590194967|FG000|Overall Study|Withdrawal by Subject|0|||
163405658|NCT00081159|590194968|FG001|Overall Study|Withdrawal by Subject|3|||
163405659|NCT00081159|590194967|FG000|Overall Study|Myelosuppression prior to treatment|0|||
163405660|NCT00081159|590194968|FG001|Overall Study|Myelosuppression prior to treatment|1|||
163405661|NCT00081159|590194967|FG000|Overall Study|Lost to Follow-up|2|||
163405662|NCT00081159|590194968|FG001|Overall Study|Lost to Follow-up|1|||
163405663|NCT00923130|590194971|FG000|Overall Study|Stopped treatment due to progression|17|||
163405664|NCT00923130|590194971|FG000|Overall Study|Death|1|||
163405665|NCT00923130|590194971|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
163405666|NCT00923130|590194971|FG000|Overall Study|Switched to alternative treatment|2|||
163405667|NCT00923130|590194971|FG000|Overall Study|Refused further treatment|2|||
163405668|NCT03693625|590194972|FG000|Overall Study|Adverse Event|2|||
163063977|NCT00689936|588941532|FG002|Active Treatment Phase|Study Close Out|21|||
163063978|NCT00689936|588941530|FG000|Active Treatment Phase|Miscellaneous|52|||
163063979|NCT00689936|588941531|FG001|Active Treatment Phase|Miscellaneous|34|||
163063980|NCT00689936|588941532|FG002|Active Treatment Phase|Miscellaneous|47|||
163063981|NCT00689936|588941530|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
163063982|NCT00689936|588941531|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
163063983|NCT00689936|588941532|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
163063984|NCT01925794|588941543|FG000|180 Days|Death|2|||
163405669|NCT03693625|590194973|FG001|Overall Study|Adverse Event|0|||
163405670|NCT03693625|590194972|FG000|Overall Study|Study Terminated By Sponsor|20|||
163405671|NCT03693625|590194973|FG001|Overall Study|Study Terminated By Sponsor|7|||
163405672|NCT03693625|590194972|FG000|Overall Study|Withdrawal by Subject|1|||
163063985|NCT01925794|588941543|FG000|180 Days|Withdrawal by Subject|2|||
163063986|NCT01925794|588941543|FG000|270 Days|Death|2|||
163063987|NCT01925794|588941543|FG000|270 Days|Protocol Violation|3|||
163063988|NCT01901562|588941544|FG000|Overall Study|Protocol Violation|5|||
163063989|NCT01901562|588941544|FG000|Overall Study|Excluded intraoperatively|4|||
163063990|NCT03126110|588941545|FG000|Phase 1|Death|2|||
163063991|NCT03126110|588941546|FG001|Phase 1|Death|2|||
163063992|NCT03126110|588941547|FG002|Phase 1|Death|4|||
163405673|NCT03693625|590194973|FG001|Overall Study|Withdrawal by Subject|1|||
163405674|NCT00761514|590194974|FG000|Overall Study|Adverse Event|1|||
163405675|NCT00761514|590194974|FG000|Overall Study|Withdrawal by Subject|2|||
163405676|NCT00761514|590194974|FG000|Overall Study|Lost to Follow-up|1|||
163405677|NCT00761514|590194974|FG000|Overall Study|Health insurance didn't cover study drug|1|||
163405678|NCT00761514|590194974|FG000|Overall Study|Problem complying with study visit|1|||
163063993|NCT03126110|588941548|FG003|Phase 1|Death|3|||
163063994|NCT03126110|588941549|FG004|Phase 1|Death|4|||
163063995|NCT03126110|588941550|FG005|Phase 1|Death|4|||
163405679|NCT00761514|590194974|FG000|Overall Study|Unable to pay for medications|1|||
163405680|NCT02457637|590194975|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
163405681|NCT01035905|590194976|FG000|Overall Study|Lack of Efficacy|1|||
163405682|NCT01035905|590194977|FG001|Overall Study|Lack of Efficacy|1|||
163405683|NCT01979536|590194978|FG000|Overall Study|Physician Decision|2|||
163405684|NCT01979536|590194979|FG001|Overall Study|Physician Decision|3|||
163405685|NCT01979536|590194978|FG000|Overall Study|Withdrawal by Subject|0|||
163063996|NCT03126110|588941551|FG006|Phase 1|Death|3|||
163063997|NCT03126110|588941552|FG007|Phase 1|Death|4|||
163063998|NCT03126110|588941553|FG008|Phase 1|Death|5|||
163063999|NCT03126110|588941554|FG009|Phase 1|Death|2|||
163064000|NCT03126110|588941555|FG010|Phase 1|Death|6|||
163064001|NCT03126110|588941556|FG011|Phase 1|Death|0|||
163064002|NCT03126110|588941557|FG012|Phase 1|Death|0|||
163064003|NCT03126110|588941558|FG013|Phase 1|Death|0|||
163064004|NCT03126110|588941559|FG014|Phase 1|Death|0|||
163064005|NCT03126110|588941560|FG015|Phase 1|Death|0|||
163064006|NCT03126110|588941561|FG016|Phase 1|Death|0|||
163405686|NCT01979536|590194979|FG001|Overall Study|Withdrawal by Subject|1|||
163405687|NCT01979536|590194978|FG000|Overall Study|Refusal|0|||
163405688|NCT01979536|590194979|FG001|Overall Study|Refusal|1|||
163064007|NCT03126110|588941545|FG000|Phase 1|Lost to Follow-up|0|||
163064008|NCT03126110|588941546|FG001|Phase 1|Lost to Follow-up|1|||
163064009|NCT03126110|588941547|FG002|Phase 1|Lost to Follow-up|0|||
163064010|NCT03126110|588941548|FG003|Phase 1|Lost to Follow-up|0|||
163064011|NCT03126110|588941549|FG004|Phase 1|Lost to Follow-up|0|||
163064012|NCT03126110|588941550|FG005|Phase 1|Lost to Follow-up|0|||
163064013|NCT03126110|588941551|FG006|Phase 1|Lost to Follow-up|0|||
163064014|NCT03126110|588941552|FG007|Phase 1|Lost to Follow-up|0|||
163064015|NCT03126110|588941553|FG008|Phase 1|Lost to Follow-up|1|||
163064016|NCT03126110|588941554|FG009|Phase 1|Lost to Follow-up|0|||
163064017|NCT03126110|588941555|FG010|Phase 1|Lost to Follow-up|0|||
163064018|NCT03126110|588941556|FG011|Phase 1|Lost to Follow-up|0|||
163064019|NCT03126110|588941557|FG012|Phase 1|Lost to Follow-up|0|||
163064020|NCT03126110|588941558|FG013|Phase 1|Lost to Follow-up|0|||
163064021|NCT03126110|588941559|FG014|Phase 1|Lost to Follow-up|0|||
163064022|NCT03126110|588941560|FG015|Phase 1|Lost to Follow-up|0|||
163064023|NCT03126110|588941561|FG016|Phase 1|Lost to Follow-up|0|||
163064024|NCT03126110|588941545|FG000|Phase 1|Withdrawal by Subject|1|||
163064025|NCT03126110|588941546|FG001|Phase 1|Withdrawal by Subject|0|||
163064026|NCT03126110|588941547|FG002|Phase 1|Withdrawal by Subject|0|||
163064027|NCT03126110|588941548|FG003|Phase 1|Withdrawal by Subject|1|||
163064028|NCT03126110|588941549|FG004|Phase 1|Withdrawal by Subject|1|||
163064029|NCT03126110|588941550|FG005|Phase 1|Withdrawal by Subject|0|||
163064030|NCT03126110|588941551|FG006|Phase 1|Withdrawal by Subject|0|||
163064031|NCT03126110|588941552|FG007|Phase 1|Withdrawal by Subject|0|||
163064032|NCT03126110|588941553|FG008|Phase 1|Withdrawal by Subject|2|||
163064033|NCT03126110|588941554|FG009|Phase 1|Withdrawal by Subject|1|||
163064034|NCT03126110|588941555|FG010|Phase 1|Withdrawal by Subject|0|||
163064035|NCT03126110|588941556|FG011|Phase 1|Withdrawal by Subject|0|||
163064036|NCT03126110|588941557|FG012|Phase 1|Withdrawal by Subject|0|||
163064037|NCT03126110|588941558|FG013|Phase 1|Withdrawal by Subject|0|||
163064038|NCT03126110|588941559|FG014|Phase 1|Withdrawal by Subject|0|||
163064039|NCT03126110|588941560|FG015|Phase 1|Withdrawal by Subject|0|||
163064040|NCT03126110|588941561|FG016|Phase 1|Withdrawal by Subject|0|||
163064041|NCT03126110|588941545|FG000|Phase 1|Safety follow-up no longer necessary|1|||
163064042|NCT03126110|588941546|FG001|Phase 1|Safety follow-up no longer necessary|0|||
163064043|NCT03126110|588941547|FG002|Phase 1|Safety follow-up no longer necessary|0|||
163064044|NCT03126110|588941548|FG003|Phase 1|Safety follow-up no longer necessary|0|||
163064045|NCT03126110|588941549|FG004|Phase 1|Safety follow-up no longer necessary|0|||
163064046|NCT03126110|588941550|FG005|Phase 1|Safety follow-up no longer necessary|0|||
163217013|NCT02063854|589510326|FG000|Overall Study|Did Not Receive Study Drug|0|||
163405689|NCT01979536|590194978|FG000|Overall Study|Relapse|0|||
163064047|NCT03126110|588941551|FG006|Phase 1|Safety follow-up no longer necessary|0|||
163405690|NCT01979536|590194979|FG001|Overall Study|Relapse|1|||
163064048|NCT03126110|588941552|FG007|Phase 1|Safety follow-up no longer necessary|0|||
163064049|NCT03126110|588941553|FG008|Phase 1|Safety follow-up no longer necessary|0|||
163064050|NCT03126110|588941554|FG009|Phase 1|Safety follow-up no longer necessary|0|||
163064051|NCT03126110|588941555|FG010|Phase 1|Safety follow-up no longer necessary|0|||
163405691|NCT01979536|590194978|FG000|Overall Study|Study terminated by Sponsor|0|||
163064052|NCT03126110|588941556|FG011|Phase 1|Safety follow-up no longer necessary|0|||
163064053|NCT03126110|588941557|FG012|Phase 1|Safety follow-up no longer necessary|0|||
163064054|NCT03126110|588941558|FG013|Phase 1|Safety follow-up no longer necessary|0|||
163064055|NCT03126110|588941559|FG014|Phase 1|Safety follow-up no longer necessary|0|||
163217014|NCT02063854|589510327|FG001|Overall Study|Did Not Receive Study Drug|0|||
163405692|NCT01979536|590194979|FG001|Overall Study|Study terminated by Sponsor|1|||
163064056|NCT03126110|588941560|FG015|Phase 1|Safety follow-up no longer necessary|0|||
163064057|NCT03126110|588941561|FG016|Phase 1|Safety follow-up no longer necessary|0|||
163064058|NCT03126110|588941545|FG000|Phase 1|Survival follow-up no longer necessary|0|||
163064059|NCT03126110|588941546|FG001|Phase 1|Survival follow-up no longer necessary|0|||
163405693|NCT01979536|590194978|FG000|Overall Study|Did not start treatment|0|||
163405694|NCT01979536|590194979|FG001|Overall Study|Did not start treatment|1|||
163405695|NCT05038020|590194981|FG000|Overall Study|Early Termination|3|||
163405696|NCT05038020|590194982|FG001|Overall Study|Early Termination|0|||
163405697|NCT03416153|590194984|FG000|Overall Study|Physician Decision|1|||
163405698|NCT03416153|590194985|FG001|Overall Study|Physician Decision|1|||
163405699|NCT03416153|590194984|FG000|Overall Study|Withdrawal by Subject|1|||
163405700|NCT03416153|590194985|FG001|Overall Study|Withdrawal by Subject|0|||
163405701|NCT03468855|590196551|FG000|Overall Study|Adverse Event|2|||
163405702|NCT03468855|590196551|FG000|Overall Study|Lost to Follow-up|5|||
163405703|NCT03468855|590196551|FG000|Overall Study|Withdrawal by Subject|3|||
163405704|NCT03468855|590196551|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
163405705|NCT01908101|590196552|FG000|Overall Study|Physician Decision|1|||
163405706|NCT01908101|590196552|FG000|Overall Study|Withdrawal by Subject|1|||
163405707|NCT01908101|590196552|FG000|Overall Study|Incorrect Diagnosis|2|||
163405708|NCT01908101|590196552|FG000|Overall Study|Incorrect Starting Dose|1|||
163405709|NCT01908101|590196552|FG000|Overall Study|Did not complete the first cycle|4|||
163405710|NCT01394939|590196553|FG000|Overall Study|Adverse Event|1|||
163405711|NCT01394939|590196554|FG001|Overall Study|Adverse Event|3|||
163405712|NCT01394939|590196555|FG002|Overall Study|Adverse Event|0|||
163405713|NCT01394939|590196556|FG003|Overall Study|Adverse Event|2|||
163405714|NCT01394939|590196553|FG000|Overall Study|Death|0|||
163405715|NCT01394939|590196554|FG001|Overall Study|Death|2|||
163405716|NCT01394939|590196555|FG002|Overall Study|Death|0|||
163405717|NCT01394939|590196556|FG003|Overall Study|Death|0|||
163405718|NCT01394939|590196553|FG000|Overall Study|Physician Decision|0|||
163405719|NCT01394939|590196554|FG001|Overall Study|Physician Decision|1|||
163405720|NCT01394939|590196555|FG002|Overall Study|Physician Decision|0|||
163405721|NCT01394939|590196556|FG003|Overall Study|Physician Decision|0|||
163405722|NCT01394939|590196553|FG000|Overall Study|Withdrawal by Subject|0|||
163405723|NCT01394939|590196554|FG001|Overall Study|Withdrawal by Subject|2|||
163405724|NCT01394939|590196555|FG002|Overall Study|Withdrawal by Subject|0|||
163405725|NCT01394939|590196556|FG003|Overall Study|Withdrawal by Subject|2|||
163405726|NCT01394939|590196553|FG000|Overall Study|Others|0|||
163405727|NCT01394939|590196554|FG001|Overall Study|Others|2|||
163405728|NCT01394939|590196555|FG002|Overall Study|Others|0|||
163405729|NCT01394939|590196556|FG003|Overall Study|Others|3|||
163405730|NCT02068547|590196559|FG000|Overall Study|Lost to Follow-up|3|||
163405731|NCT02068547|590196560|FG001|Overall Study|Lost to Follow-up|3|||
163405732|NCT02068547|590196559|FG000|Overall Study|Physician Decision|1|||
163405733|NCT02068547|590196560|FG001|Overall Study|Physician Decision|0|||
163405734|NCT03657043|590196561|FG000|Overall Study|Withdrawal by Subject|1|||
163405735|NCT03657043|590196562|FG001|Overall Study|Withdrawal by Subject|1|||
163405736|NCT03657043|590196563|FG002|Overall Study|Withdrawal by Subject|0|||
163405737|NCT03657043|590196564|FG003|Overall Study|Withdrawal by Subject|0|||
163405738|NCT03657043|590196565|FG004|Overall Study|Withdrawal by Subject|4|||
163405739|NCT03657043|590196561|FG000|Overall Study|Study closure by Sponsor|0|||
163405740|NCT03657043|590196562|FG001|Overall Study|Study closure by Sponsor|2|||
163405741|NCT03657043|590196563|FG002|Overall Study|Study closure by Sponsor|0|||
163405742|NCT03657043|590196564|FG003|Overall Study|Study closure by Sponsor|0|||
163405743|NCT03657043|590196565|FG004|Overall Study|Study closure by Sponsor|17|||
163405744|NCT03657043|590196561|FG000|Overall Study|Lost to Follow-up|0|||
163405745|NCT03657043|590196562|FG001|Overall Study|Lost to Follow-up|0|||
163405746|NCT03657043|590196563|FG002|Overall Study|Lost to Follow-up|0|||
163405747|NCT03657043|590196564|FG003|Overall Study|Lost to Follow-up|0|||
163405748|NCT03657043|590196565|FG004|Overall Study|Lost to Follow-up|4|||
163405749|NCT03657043|590196561|FG000|Overall Study|Death|6|||
163405750|NCT03657043|590196562|FG001|Overall Study|Death|5|||
163405751|NCT03657043|590196563|FG002|Overall Study|Death|0|||
163405752|NCT03657043|590196564|FG003|Overall Study|Death|0|||
163405753|NCT03657043|590196565|FG004|Overall Study|Death|53|||
163405754|NCT03657043|590196561|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
163405755|NCT03657043|590196562|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
163405756|NCT03657043|590196563|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
163217015|NCT02063854|589510328|FG002|Overall Study|Did Not Receive Study Drug|0|||
163405757|NCT03657043|590196564|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
163217016|NCT02063854|589510329|FG003|Overall Study|Did Not Receive Study Drug|0|||
163217017|NCT02063854|589510330|FG004|Overall Study|Did Not Receive Study Drug|0|||
163217018|NCT02063854|589510331|FG005|Overall Study|Did Not Receive Study Drug|1|||
163405758|NCT03657043|590196565|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
163405759|NCT03657043|590196561|FG000|Overall Study|Adverse Event|0|||
163405760|NCT03657043|590196562|FG001|Overall Study|Adverse Event|0|||
163405761|NCT03657043|590196563|FG002|Overall Study|Adverse Event|0|||
163405762|NCT03657043|590196564|FG003|Overall Study|Adverse Event|0|||
163405763|NCT03657043|590196565|FG004|Overall Study|Adverse Event|2|||
163217019|NCT02063854|589510332|FG006|Overall Study|Did Not Receive Study Drug|0|||
163405764|NCT03657043|590196561|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
163405765|NCT03657043|590196562|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
163405766|NCT03657043|590196563|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
163330338|NCT02401815|589919091|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
163330339|NCT02401815|589919092|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163330340|NCT02401815|589919093|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163330341|NCT02401815|589919094|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163330342|NCT02401815|589919095|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163330343|NCT02401815|589919086|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330344|NCT02401815|589919087|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330345|NCT02401815|589919088|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330346|NCT02401815|589919089|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330347|NCT02401815|589919090|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330348|NCT02401815|589919091|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330349|NCT02401815|589919092|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
163330350|NCT02401815|589919093|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330351|NCT02401815|589919094|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330352|NCT02401815|589919095|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330353|NCT02401815|589919086|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
163330354|NCT02401815|589919087|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
163330355|NCT02401815|589919088|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
163330356|NCT02401815|589919089|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
163330357|NCT02401815|589919090|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
163330358|NCT02401815|589919091|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
163330359|NCT02401815|589919092|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
163330360|NCT02401815|589919093|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
163330361|NCT02401815|589919094|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
163330362|NCT02401815|589919095|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
163330363|NCT02401815|589919086|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163330364|NCT02401815|589919087|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163330365|NCT02401815|589919088|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163330366|NCT02401815|589919089|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163330367|NCT02401815|589919090|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163330368|NCT02401815|589919091|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
163330369|NCT02401815|589919092|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163330370|NCT02401815|589919093|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163330371|NCT02401815|589919094|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163330372|NCT02401815|589919095|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163330373|NCT02401815|589919086|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
163330374|NCT02401815|589919087|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
163330375|NCT02401815|589919088|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
163330376|NCT02401815|589919089|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
163330377|NCT02401815|589919090|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
163330378|NCT02401815|589919091|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
163330379|NCT02401815|589919092|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
163330380|NCT02401815|589919093|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
163330381|NCT02401815|589919094|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
163330382|NCT02401815|589919095|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
163330383|NCT02401815|589919086|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330384|NCT02401815|589919087|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330385|NCT02401815|589919088|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330386|NCT02401815|589919089|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330387|NCT02401815|589919090|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330388|NCT02401815|589919091|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330389|NCT02401815|589919092|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330390|NCT02401815|589919093|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163330391|NCT02401815|589919094|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
163330392|NCT02401815|589919095|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
163330393|NCT02401815|589919086|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163330394|NCT02401815|589919087|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163330395|NCT02401815|589919088|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163330396|NCT02401815|589919089|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163330397|NCT02401815|589919090|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163330398|NCT02401815|589919091|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163330399|NCT02401815|589919092|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163405767|NCT03657043|590196564|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
163405768|NCT03657043|590196565|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
163405769|NCT03657043|590196561|FG000|Overall Study|Withdrawal - declined follow-up|0|||
163405770|NCT03657043|590196562|FG001|Overall Study|Withdrawal - declined follow-up|0|||
163405771|NCT03657043|590196563|FG002|Overall Study|Withdrawal - declined follow-up|0|||
163405772|NCT03657043|590196564|FG003|Overall Study|Withdrawal - declined follow-up|0|||
163405773|NCT03657043|590196565|FG004|Overall Study|Withdrawal - declined follow-up|1|||
163405774|NCT00880893|590196566|FG000|Overall Study|Protocol Violation|13|||
163405775|NCT00880893|590196567|FG001|Overall Study|Protocol Violation|1|||
163405776|NCT00880893|590196566|FG000|Overall Study|Withdrawal by Subject|15|||
163405777|NCT00880893|590196567|FG001|Overall Study|Withdrawal by Subject|11|||
163405778|NCT00880893|590196566|FG000|Overall Study|Lost to Follow-up|76|||
163405779|NCT00880893|590196567|FG001|Overall Study|Lost to Follow-up|33|||
163405780|NCT00880893|590196566|FG000|Overall Study|Serious adverse event|3|||
163405781|NCT00880893|590196567|FG001|Overall Study|Serious adverse event|0|||
163405782|NCT01736579|590196571|FG000|Overall Study|Termination of Study by Sponsor|2|||
163405783|NCT01736579|590196572|FG001|Overall Study|Termination of Study by Sponsor|2|||
163405784|NCT01995071|590196573|FG000|Overall Study|Adverse Event|0|||
163405785|NCT01995071|590196574|FG001|Overall Study|Adverse Event|0|||
163405786|NCT01995071|590196575|FG002|Overall Study|Adverse Event|0|||
163405787|NCT01995071|590196576|FG003|Overall Study|Adverse Event|0|||
163405788|NCT01995071|590196577|FG004|Overall Study|Adverse Event|0|||
163405789|NCT01995071|590196578|FG005|Overall Study|Adverse Event|0|||
163405790|NCT01995071|590196579|FG006|Overall Study|Adverse Event|1|||
163405791|NCT01995071|590196580|FG007|Overall Study|Adverse Event|0|||
163405792|NCT01995071|590196581|FG008|Overall Study|Adverse Event|0|||
163405793|NCT01995071|590196582|FG009|Overall Study|Adverse Event|0|||
163405794|NCT01995071|590196583|FG010|Overall Study|Adverse Event|0|||
163405795|NCT01995071|590196584|FG011|Overall Study|Adverse Event|0|||
163405796|NCT01995071|590196573|FG000|Overall Study|Moved|0|||
163405797|NCT01995071|590196574|FG001|Overall Study|Moved|0|||
163405798|NCT01995071|590196575|FG002|Overall Study|Moved|1|||
163405799|NCT01995071|590196576|FG003|Overall Study|Moved|0|||
163405800|NCT01995071|590196577|FG004|Overall Study|Moved|1|||
163405801|NCT01995071|590196578|FG005|Overall Study|Moved|0|||
163405802|NCT01995071|590196579|FG006|Overall Study|Moved|0|||
163405803|NCT01995071|590196580|FG007|Overall Study|Moved|0|||
163405804|NCT01995071|590196581|FG008|Overall Study|Moved|0|||
163405805|NCT01995071|590196582|FG009|Overall Study|Moved|0|||
163405806|NCT01995071|590196583|FG010|Overall Study|Moved|1|||
163405807|NCT01995071|590196584|FG011|Overall Study|Moved|0|||
163405808|NCT01995071|590196573|FG000|Overall Study|Lost to Follow-up|1|||
163405809|NCT01995071|590196574|FG001|Overall Study|Lost to Follow-up|0|||
163405810|NCT01995071|590196575|FG002|Overall Study|Lost to Follow-up|0|||
163405811|NCT01995071|590196576|FG003|Overall Study|Lost to Follow-up|0|||
163405812|NCT01995071|590196577|FG004|Overall Study|Lost to Follow-up|0|||
163405813|NCT01995071|590196578|FG005|Overall Study|Lost to Follow-up|0|||
163405814|NCT01995071|590196579|FG006|Overall Study|Lost to Follow-up|0|||
163405815|NCT01995071|590196580|FG007|Overall Study|Lost to Follow-up|1|||
163405816|NCT01995071|590196581|FG008|Overall Study|Lost to Follow-up|1|||
163405817|NCT01995071|590196582|FG009|Overall Study|Lost to Follow-up|0|||
163405818|NCT01995071|590196583|FG010|Overall Study|Lost to Follow-up|0|||
163405819|NCT01995071|590196584|FG011|Overall Study|Lost to Follow-up|0|||
163405820|NCT01995071|590196573|FG000|Overall Study|Incarcerated|0|||
163405821|NCT01995071|590196574|FG001|Overall Study|Incarcerated|0|||
163405822|NCT01995071|590196575|FG002|Overall Study|Incarcerated|0|||
163405823|NCT01995071|590196576|FG003|Overall Study|Incarcerated|0|||
163405824|NCT01995071|590196577|FG004|Overall Study|Incarcerated|0|||
163405825|NCT01995071|590196578|FG005|Overall Study|Incarcerated|0|||
163405826|NCT01995071|590196579|FG006|Overall Study|Incarcerated|0|||
163405827|NCT01995071|590196580|FG007|Overall Study|Incarcerated|1|||
163405828|NCT01995071|590196581|FG008|Overall Study|Incarcerated|0|||
163405829|NCT01995071|590196582|FG009|Overall Study|Incarcerated|0|||
163405830|NCT01995071|590196583|FG010|Overall Study|Incarcerated|0|||
163405831|NCT01995071|590196584|FG011|Overall Study|Incarcerated|0|||
163405832|NCT01979523|590196586|FG000|Overall Study|Withdrawal by Subject|1|||
163405833|NCT01979523|590196587|FG001|Overall Study|Withdrawal by Subject|0|||
163405834|NCT00772954|590196600|FG000|Overall Study|Adverse Event|0|||
163405835|NCT00772954|590196601|FG001|Overall Study|Adverse Event|0|||
163405836|NCT00772954|590196602|FG002|Overall Study|Adverse Event|1|||
163405837|NCT01661140|590196605|FG000|Open-Label Period|Adverse Event|44|||
163405838|NCT01661140|590196606|FG001|Open-Label Period|Adverse Event|0|||
163405839|NCT01661140|590196607|FG002|Open-Label Period|Adverse Event|0|||
163405840|NCT01661140|590196605|FG000|Open-Label Period|Protocol Violation|3|||
163405841|NCT01661140|590196606|FG001|Open-Label Period|Protocol Violation|0|||
163405842|NCT01661140|590196607|FG002|Open-Label Period|Protocol Violation|0|||
163405843|NCT01661140|590196605|FG000|Open-Label Period|Withdrawal by Subject|5|||
163405844|NCT01661140|590196606|FG001|Open-Label Period|Withdrawal by Subject|0|||
163405845|NCT01661140|590196607|FG002|Open-Label Period|Withdrawal by Subject|0|||
163405846|NCT01661140|590196605|FG000|Open-Label Period|Investigator Decision|3|||
163217020|NCT01413360|589510337|FG000|Overall Study|Lost to Follow-up|2|||
163217021|NCT01413360|589510337|FG000|Overall Study|Adverse Event|1|||
163217022|NCT02246673|589510339|FG000|Overall Study|Sponsor Decision|1|||
163217023|NCT02246673|589510340|FG001|Overall Study|Sponsor Decision|0|||
163217024|NCT02246673|589510341|FG002|Overall Study|Sponsor Decision|0|||
163217025|NCT02246673|589510342|FG003|Overall Study|Sponsor Decision|0|||
163217026|NCT02246673|589510343|FG004|Overall Study|Sponsor Decision|0|||
163217027|NCT02246673|589510339|FG000|Overall Study|Withdrawal by Subject|0|||
163217028|NCT02246673|589510340|FG001|Overall Study|Withdrawal by Subject|0|||
163217029|NCT02246673|589510341|FG002|Overall Study|Withdrawal by Subject|0|||
163217030|NCT02246673|589510342|FG003|Overall Study|Withdrawal by Subject|0|||
163217031|NCT02246673|589510343|FG004|Overall Study|Withdrawal by Subject|1|||
163217032|NCT02246673|589510339|FG000|Overall Study|Lost to Follow-up|0|||
163217033|NCT02246673|589510340|FG001|Overall Study|Lost to Follow-up|0|||
163217034|NCT02246673|589510341|FG002|Overall Study|Lost to Follow-up|0|||
163217035|NCT02246673|589510342|FG003|Overall Study|Lost to Follow-up|1|||
163217036|NCT02246673|589510343|FG004|Overall Study|Lost to Follow-up|0|||
163217037|NCT02246673|589510339|FG000|Overall Study|Protocol Violation|0|||
163217038|NCT02246673|589510340|FG001|Overall Study|Protocol Violation|0|||
163217039|NCT02246673|589510341|FG002|Overall Study|Protocol Violation|0|||
163217040|NCT02246673|589510342|FG003|Overall Study|Protocol Violation|1|||
163217041|NCT02246673|589510343|FG004|Overall Study|Protocol Violation|0|||
163217042|NCT05413369|589510344|FG000|Overall Study|Adverse Event|1|||
163217043|NCT05413369|589510345|FG001|Overall Study|Adverse Event|1|||
163217044|NCT05413369|589510344|FG000|Overall Study|Withdrawal by Subject|13|||
163217045|NCT05413369|589510345|FG001|Overall Study|Withdrawal by Subject|4|||
163217046|NCT05413369|589510344|FG000|Overall Study|Non-compliance with study schedule|2|||
163217047|NCT05413369|589510345|FG001|Overall Study|Non-compliance with study schedule|1|||
163217048|NCT05413369|589510344|FG000|Overall Study|Other|1|||
163217049|NCT05413369|589510345|FG001|Overall Study|Other|1|||
163217050|NCT01679002|589510350|FG000|Overall Study|Adverse Event|1|||
163217051|NCT01679002|589510351|FG001|Overall Study|Adverse Event|1|||
163217052|NCT01679002|589510352|FG002|Overall Study|Adverse Event|0|||
163217053|NCT00730912|589510355|FG000|Overall Study|Discontinued|0|||
163217054|NCT00730912|589510356|FG001|Overall Study|Discontinued|0|||
163217055|NCT00730912|589510357|FG002|Overall Study|Discontinued|1|||
163217056|NCT02205333|589510365|FG000|Overall Study|Death|5|||
163217057|NCT02205333|589510366|FG001|Overall Study|Death|6|||
163217058|NCT02205333|589510367|FG002|Overall Study|Death|2|||
163217059|NCT02205333|589510368|FG003|Overall Study|Death|6|||
163217060|NCT02205333|589510369|FG004|Overall Study|Death|5|||
163217061|NCT02205333|589510370|FG005|Overall Study|Death|3|||
163217062|NCT02205333|589510371|FG006|Overall Study|Death|3|||
163217063|NCT02205333|589510372|FG007|Overall Study|Death|2|||
163217064|NCT02205333|589510373|FG008|Overall Study|Death|0|||
163217065|NCT02205333|589510365|FG000|Overall Study|Withdrawal by Subject|1|||
163217066|NCT02205333|589510366|FG001|Overall Study|Withdrawal by Subject|0|||
163217067|NCT02205333|589510367|FG002|Overall Study|Withdrawal by Subject|0|||
163217068|NCT02205333|589510368|FG003|Overall Study|Withdrawal by Subject|1|||
163217069|NCT02205333|589510369|FG004|Overall Study|Withdrawal by Subject|0|||
163217070|NCT02205333|589510370|FG005|Overall Study|Withdrawal by Subject|0|||
163217071|NCT02205333|589510371|FG006|Overall Study|Withdrawal by Subject|2|||
163217072|NCT02205333|589510372|FG007|Overall Study|Withdrawal by Subject|0|||
163217073|NCT02205333|589510373|FG008|Overall Study|Withdrawal by Subject|0|||
163217074|NCT01176266|589510374|FG000|Overall Study|Death|6|||
163217075|NCT01176266|589510374|FG000|Overall Study|Withdrawal by Subject|3|||
163217076|NCT01179477|589510375|FG000|Overall Study|Death|542|||
163217077|NCT01179477|589510375|FG000|Overall Study|Unsuccessful implant|80|||
163217078|NCT01179477|589510375|FG000|Overall Study|Non-death withdrawal|438|||
163217079|NCT01179477|589510375|FG000|Overall Study|Did not complete final visit|27|||
163217080|NCT03755414|589510379|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
163217081|NCT03755414|589510380|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
163217082|NCT03755414|589510381|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
163217083|NCT03755414|589510379|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
163217084|NCT03755414|589510380|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
163217085|NCT03755414|589510381|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
163217086|NCT03755414|589510379|FG000|Overall Study|Non-compliance|0|||
163217087|NCT03755414|589510380|FG001|Overall Study|Non-compliance|1|||
163217088|NCT03755414|589510381|FG002|Overall Study|Non-compliance|0|||
163217089|NCT02153112|589510382|FG000|Overall Study|Adverse Event|0|||
163217090|NCT02153112|589510383|FG001|Overall Study|Adverse Event|0|||
163217091|NCT02153112|589510384|FG002|Overall Study|Adverse Event|1|||
163217092|NCT02153112|589510385|FG003|Overall Study|Adverse Event|0|||
163217093|NCT02153112|589510386|FG004|Overall Study|Adverse Event|0|||
163217094|NCT02153112|589510387|FG005|Overall Study|Adverse Event|0|||
163064060|NCT03126110|588941547|FG002|Phase 1|Survival follow-up no longer necessary|1|||
163217095|NCT02153112|589510388|FG006|Overall Study|Adverse Event|0|||
163217096|NCT02153112|589510389|FG007|Overall Study|Adverse Event|0|||
163217097|NCT02153112|589510390|FG008|Overall Study|Adverse Event|0|||
163217098|NCT02153112|589510391|FG009|Overall Study|Adverse Event|0|||
163217099|NCT02153112|589510382|FG000|Overall Study|Lost to Follow-up|1|||
163217100|NCT02153112|589510383|FG001|Overall Study|Lost to Follow-up|1|||
163217101|NCT02153112|589510384|FG002|Overall Study|Lost to Follow-up|0|||
163217102|NCT02153112|589510385|FG003|Overall Study|Lost to Follow-up|0|||
163217103|NCT02153112|589510386|FG004|Overall Study|Lost to Follow-up|2|||
163217104|NCT02153112|589510387|FG005|Overall Study|Lost to Follow-up|1|||
163217105|NCT02153112|589510388|FG006|Overall Study|Lost to Follow-up|1|||
163217106|NCT02153112|589510389|FG007|Overall Study|Lost to Follow-up|0|||
163217107|NCT02153112|589510390|FG008|Overall Study|Lost to Follow-up|1|||
163217108|NCT02153112|589510391|FG009|Overall Study|Lost to Follow-up|1|||
163217109|NCT02153112|589510382|FG000|Overall Study|Withdrawal by Subject|3|||
163217110|NCT02153112|589510383|FG001|Overall Study|Withdrawal by Subject|1|||
163217111|NCT02153112|589510384|FG002|Overall Study|Withdrawal by Subject|2|||
163217112|NCT02153112|589510385|FG003|Overall Study|Withdrawal by Subject|2|||
163217113|NCT02153112|589510386|FG004|Overall Study|Withdrawal by Subject|1|||
163217114|NCT02153112|589510387|FG005|Overall Study|Withdrawal by Subject|1|||
163217115|NCT02153112|589510388|FG006|Overall Study|Withdrawal by Subject|7|||
163217116|NCT02153112|589510389|FG007|Overall Study|Withdrawal by Subject|2|||
163217117|NCT02153112|589510390|FG008|Overall Study|Withdrawal by Subject|13|||
163217118|NCT02153112|589510391|FG009|Overall Study|Withdrawal by Subject|12|||
163217119|NCT02153112|589510382|FG000|Overall Study|Reason not Specified|0|||
163217120|NCT02153112|589510383|FG001|Overall Study|Reason not Specified|0|||
163217121|NCT02153112|589510384|FG002|Overall Study|Reason not Specified|0|||
163217122|NCT02153112|589510385|FG003|Overall Study|Reason not Specified|0|||
163217123|NCT02153112|589510386|FG004|Overall Study|Reason not Specified|0|||
163217124|NCT02153112|589510387|FG005|Overall Study|Reason not Specified|0|||
163217125|NCT02153112|589510388|FG006|Overall Study|Reason not Specified|0|||
163217126|NCT02153112|589510389|FG007|Overall Study|Reason not Specified|0|||
163217127|NCT02153112|589510390|FG008|Overall Study|Reason not Specified|1|||
163217128|NCT02153112|589510391|FG009|Overall Study|Reason not Specified|1|||
163217129|NCT00455429|589510392|FG000|Overall Study|Study Terminated by Sponsor|0|||
163217130|NCT00455429|589510393|FG001|Overall Study|Study Terminated by Sponsor|0|||
163217131|NCT00455429|589510394|FG002|Overall Study|Study Terminated by Sponsor|0|||
163217132|NCT00455429|589510395|FG003|Overall Study|Study Terminated by Sponsor|3|||
163217133|NCT00455429|589510392|FG000|Overall Study|Lost to Follow-up|1|||
163217134|NCT00455429|589510393|FG001|Overall Study|Lost to Follow-up|0|||
163217135|NCT00455429|589510394|FG002|Overall Study|Lost to Follow-up|0|||
163217136|NCT00455429|589510395|FG003|Overall Study|Lost to Follow-up|3|||
163217137|NCT00455429|589510392|FG000|Overall Study|Withdrawal by Subject|0|||
163217138|NCT00455429|589510393|FG001|Overall Study|Withdrawal by Subject|1|||
163217139|NCT00455429|589510394|FG002|Overall Study|Withdrawal by Subject|1|||
163217140|NCT00455429|589510395|FG003|Overall Study|Withdrawal by Subject|0|||
163217141|NCT00455429|589510392|FG000|Overall Study|Lack of Efficacy|0|||
163217142|NCT00455429|589510393|FG001|Overall Study|Lack of Efficacy|1|||
163217143|NCT00455429|589510394|FG002|Overall Study|Lack of Efficacy|0|||
163217144|NCT00455429|589510395|FG003|Overall Study|Lack of Efficacy|1|||
163217145|NCT00455429|589510392|FG000|Overall Study|Adverse Event|0|||
163217146|NCT00455429|589510393|FG001|Overall Study|Adverse Event|1|||
163217147|NCT00455429|589510394|FG002|Overall Study|Adverse Event|0|||
163217148|NCT00455429|589510395|FG003|Overall Study|Adverse Event|3|||
163217149|NCT00455429|589510392|FG000|Overall Study|Randomly assigned but not treated|0|||
163217150|NCT00455429|589510393|FG001|Overall Study|Randomly assigned but not treated|0|||
163217151|NCT00455429|589510394|FG002|Overall Study|Randomly assigned but not treated|0|||
163217152|NCT00455429|589510395|FG003|Overall Study|Randomly assigned but not treated|2|||
163217153|NCT00455429|589510392|FG000|Overall Study|Personal Reason|1|||
163217154|NCT00455429|589510393|FG001|Overall Study|Personal Reason|0|||
163217155|NCT00455429|589510394|FG002|Overall Study|Personal Reason|0|||
163217156|NCT00455429|589510395|FG003|Overall Study|Personal Reason|0|||
163217157|NCT00455429|589510392|FG000|Overall Study|Non-compliance|0|||
163217158|NCT00455429|589510393|FG001|Overall Study|Non-compliance|0|||
163217159|NCT00455429|589510394|FG002|Overall Study|Non-compliance|0|||
163217160|NCT00455429|589510395|FG003|Overall Study|Non-compliance|1|||
163217161|NCT00455429|589510392|FG000|Overall Study|Other|0|||
163217162|NCT00455429|589510393|FG001|Overall Study|Other|2|||
163217163|NCT00455429|589510394|FG002|Overall Study|Other|0|||
163217164|NCT00455429|589510395|FG003|Overall Study|Other|1|||
163217165|NCT04351087|589510396|FG000|Overall Study|Lost to Follow-up|7|||
163217166|NCT04351087|589510397|FG001|Overall Study|Lost to Follow-up|3|||
163217167|NCT04351087|589510396|FG000|Overall Study|Withdrawal by Subject|3|||
163217168|NCT04351087|589510397|FG001|Overall Study|Withdrawal by Subject|4|||
163217169|NCT04351087|589510396|FG000|Overall Study|Lack of Efficacy|3|||
163217170|NCT04351087|589510397|FG001|Overall Study|Lack of Efficacy|2|||
163405847|NCT01661140|590196606|FG001|Open-Label Period|Investigator Decision|0|||
163405848|NCT01661140|590196607|FG002|Open-Label Period|Investigator Decision|0|||
163405849|NCT01661140|590196605|FG000|Open-Label Period|Death|1|||
163405850|NCT01661140|590196606|FG001|Open-Label Period|Death|0|||
163405851|NCT01661140|590196607|FG002|Open-Label Period|Death|0|||
163405852|NCT01661140|590196605|FG000|Open-Label Period|Administrative/Other|1|||
163405853|NCT01661140|590196606|FG001|Open-Label Period|Administrative/Other|0|||
163405854|NCT01661140|590196607|FG002|Open-Label Period|Administrative/Other|0|||
163405855|NCT01661140|590196605|FG000|Open-Label Period|Sponsor termination|16|||
163405856|NCT01661140|590196606|FG001|Open-Label Period|Sponsor termination|0|||
163405857|NCT01661140|590196607|FG002|Open-Label Period|Sponsor termination|0|||
163405858|NCT01661140|590196605|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
163405859|NCT01661140|590196606|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
163405860|NCT01661140|590196607|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
163405861|NCT01661140|590196605|FG000|Open-Label Period|Lost to Follow-up|2|||
163405862|NCT01661140|590196606|FG001|Open-Label Period|Lost to Follow-up|0|||
163405863|NCT01661140|590196607|FG002|Open-Label Period|Lost to Follow-up|0|||
163405864|NCT01661140|590196605|FG000|Double-Blind Period|Refused Treatment|0|||
163405865|NCT01661140|590196606|FG001|Double-Blind Period|Refused Treatment|0|||
163405866|NCT01661140|590196607|FG002|Double-Blind Period|Refused Treatment|1|||
163405867|NCT01661140|590196605|FG000|Double-Blind Period|Adverse Event|0|||
163405868|NCT01661140|590196606|FG001|Double-Blind Period|Adverse Event|16|||
163405869|NCT01661140|590196607|FG002|Double-Blind Period|Adverse Event|18|||
163405870|NCT01661140|590196605|FG000|Double-Blind Period|Protocol Violation|0|||
163405871|NCT01661140|590196606|FG001|Double-Blind Period|Protocol Violation|2|||
163405872|NCT01661140|590196607|FG002|Double-Blind Period|Protocol Violation|3|||
163405873|NCT01661140|590196605|FG000|Double-Blind Period|Withdrawal by Subject|0|||
163405874|NCT01661140|590196606|FG001|Double-Blind Period|Withdrawal by Subject|1|||
163405875|NCT01661140|590196607|FG002|Double-Blind Period|Withdrawal by Subject|3|||
163405876|NCT01661140|590196605|FG000|Double-Blind Period|Investigator's Decision|0|||
163405877|NCT01661140|590196606|FG001|Double-Blind Period|Investigator's Decision|1|||
163405878|NCT01661140|590196607|FG002|Double-Blind Period|Investigator's Decision|2|||
163405879|NCT01661140|590196605|FG000|Double-Blind Period|Sponsor Termination|0|||
163405880|NCT01661140|590196606|FG001|Double-Blind Period|Sponsor Termination|14|||
163405881|NCT01661140|590196607|FG002|Double-Blind Period|Sponsor Termination|17|||
163405882|NCT01661140|590196605|FG000|Double-Blind Period|Administrative/Other|0|||
163405883|NCT01661140|590196606|FG001|Double-Blind Period|Administrative/Other|7|||
163405884|NCT01661140|590196607|FG002|Double-Blind Period|Administrative/Other|6|||
163405885|NCT02239939|590196608|FG000|Overall Study|Adverse Event|1|||
163405886|NCT02239939|590196609|FG001|Overall Study|Adverse Event|0|||
163405887|NCT02239939|590196608|FG000|Overall Study|Withdrawal by Subject|1|||
163405888|NCT02239939|590196609|FG001|Overall Study|Withdrawal by Subject|1|||
163405889|NCT02239939|590196608|FG000|Overall Study|Lost to Follow-up|0|||
163405890|NCT02239939|590196609|FG001|Overall Study|Lost to Follow-up|1|||
163405891|NCT01659320|590196612|FG000|Overall Study|Withdrawal by Subject|2|||
163405892|NCT01659320|590196612|FG000|Overall Study|Physician Decision|1|||
163405893|NCT00590590|590196613|FG000|Overall Study|Lack of Efficacy|1|||
163405894|NCT00590590|590196614|FG001|Overall Study|Lack of Efficacy|2|||
163405895|NCT00590590|590196615|FG002|Overall Study|Lack of Efficacy|0|||
163405896|NCT00590590|590196613|FG000|Overall Study|Adverse Event|1|||
163405897|NCT00590590|590196614|FG001|Overall Study|Adverse Event|0|||
163405898|NCT00590590|590196615|FG002|Overall Study|Adverse Event|0|||
163405899|NCT00590590|590196613|FG000|Overall Study|Protocol Violation|0|||
163405900|NCT00590590|590196614|FG001|Overall Study|Protocol Violation|0|||
163405901|NCT00590590|590196615|FG002|Overall Study|Protocol Violation|2|||
163405902|NCT00590590|590196613|FG000|Overall Study|Lost to Follow-up|4|||
163405903|NCT00590590|590196614|FG001|Overall Study|Lost to Follow-up|1|||
163405904|NCT00590590|590196615|FG002|Overall Study|Lost to Follow-up|2|||
163405905|NCT00590590|590196613|FG000|Overall Study|Withdrawal by Subject|0|||
163405906|NCT00590590|590196614|FG001|Overall Study|Withdrawal by Subject|1|||
163405907|NCT00590590|590196615|FG002|Overall Study|Withdrawal by Subject|1|||
163405908|NCT00590590|590196613|FG000|Overall Study|Did not complete due to study closure|1|||
163405909|NCT00590590|590196614|FG001|Overall Study|Did not complete due to study closure|1|||
163405910|NCT00590590|590196615|FG002|Overall Study|Did not complete due to study closure|1|||
163217171|NCT03519347|589510398|FG000|Interventional Crossover Period 1|Death|0|||
163405911|NCT00590590|590196613|FG000|Overall Study|Did not complete study|0|||
163405912|NCT00590590|590196614|FG001|Overall Study|Did not complete study|1|||
163405913|NCT00590590|590196615|FG002|Overall Study|Did not complete study|0|||
163405914|NCT00272038|590196618|FG000|Overall Study|withdrew before they received 2 cycles|7|||
163405915|NCT00493870|590196619|FG000|Overall Study|Lost to Follow-up|12|||
163405916|NCT00493870|590196620|FG001|Overall Study|Lost to Follow-up|15|||
163405917|NCT03605680|590196621|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
163405918|NCT03605680|590196622|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
163217172|NCT03519347|589510399|FG001|Interventional Crossover Period 1|Death|0|||
163217173|NCT03519347|589510400|FG002|Interventional Crossover Period 1|Death|0|||
163405919|NCT03605680|590196623|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
163405920|NCT03605680|590196624|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
163405921|NCT03605680|590196621|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
163405922|NCT03605680|590196622|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
163405923|NCT03605680|590196623|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
163405924|NCT03605680|590196624|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
163405925|NCT03605680|590196621|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
163405926|NCT03605680|590196622|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
163405927|NCT03605680|590196623|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
163405928|NCT03605680|590196624|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
163405929|NCT03605680|590196621|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
163405930|NCT03605680|590196622|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
163405931|NCT03605680|590196623|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
163405932|NCT03605680|590196624|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
163405933|NCT03605680|590196621|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
163405934|NCT03605680|590196622|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
163405935|NCT03605680|590196623|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
163405936|NCT03605680|590196624|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
163405937|NCT03605680|590196621|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
163405938|NCT03605680|590196622|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
163405939|NCT03605680|590196623|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
163405940|NCT03605680|590196624|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
163405941|NCT03605680|590196621|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
163405942|NCT03605680|590196622|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
163405943|NCT03605680|590196623|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
163405944|NCT03605680|590196624|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
163405945|NCT03605680|590196621|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
163405946|NCT03605680|590196622|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
163405947|NCT03605680|590196623|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
163405948|NCT03605680|590196624|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
163405949|NCT03605680|590196621|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
163405950|NCT03605680|590196622|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
163405951|NCT03605680|590196623|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
163405952|NCT03605680|590196624|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
163405953|NCT03605680|590196621|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
163405954|NCT03605680|590196622|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
163405955|NCT03605680|590196623|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
163405956|NCT03605680|590196624|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
163405957|NCT03605680|590196621|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
163405958|NCT03605680|590196622|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
163405959|NCT03605680|590196623|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
163405960|NCT03605680|590196624|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
163405961|NCT03605680|590196621|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
163405962|NCT03605680|590196622|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
163405963|NCT03605680|590196623|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
163405964|NCT03605680|590196624|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
163405965|NCT03605680|590196621|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
163405966|NCT03605680|590196622|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
163405967|NCT03605680|590196623|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
163405968|NCT03605680|590196624|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
163405969|NCT03605680|590196621|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
163405970|NCT03605680|590196622|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
163405971|NCT03605680|590196623|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
163405972|NCT03605680|590196624|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
163405973|NCT03605680|590196621|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
163405974|NCT03605680|590196622|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
163405975|NCT03605680|590196623|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
163405976|NCT03605680|590196624|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
163405977|NCT03605680|590196621|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
163405978|NCT03605680|590196622|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
163405979|NCT03605680|590196623|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
163405980|NCT03605680|590196624|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
163405981|NCT03605680|590196621|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
163405982|NCT03605680|590196622|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
163405983|NCT03605680|590196623|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
163405984|NCT03605680|590196624|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
163405985|NCT03605680|590196621|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
163405986|NCT03605680|590196622|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
163405987|NCT03605680|590196623|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
163405988|NCT03605680|590196624|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
163405989|NCT03605680|590196621|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
163405990|NCT03605680|590196622|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
163405991|NCT03605680|590196623|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
163405992|NCT03605680|590196624|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
163405993|NCT05594173|590196625|FG000|Overall Study|Adverse Event|1|||
163405994|NCT05594173|590196625|FG000|Overall Study|COVID-19 Pandemic|2|||
163405995|NCT03865706|590196628|FG000|Overall Study|Death|0|||
163405996|NCT03865706|590196629|FG001|Overall Study|Death|3|||
163405997|NCT03865706|590196630|FG002|Overall Study|Death|1|||
163405998|NCT02095535|590196631|FG000|Recruitment|Protocol Violation|2|||
163405999|NCT02646982|590196632|FG000|Overall Study|Adverse Event|1|||
163406000|NCT02646982|590196633|FG001|Overall Study|Adverse Event|1|||
163406001|NCT02646982|590196632|FG000|Overall Study|Withdrawal by Subject|2|||
163406002|NCT02646982|590196633|FG001|Overall Study|Withdrawal by Subject|1|||
163406003|NCT01877187|590196634|FG000|Overall Study|Death|2|||
163406004|NCT01877187|590196634|FG000|Overall Study|Withdrawal by Subject|4|||
163406005|NCT01877187|590196634|FG000|Overall Study|Lost to Follow-up|3|||
163406006|NCT01877187|590196634|FG000|Overall Study|Declining clinical status|11|||
163406007|NCT01877187|590196634|FG000|Overall Study|Liver transplant|2|||
163406008|NCT03221751|590196639|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
163406009|NCT03221751|590196640|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
163406010|NCT02590588|590196643|FG000|Overall Study|Adverse Event|1|||
163406011|NCT01098071|590196649|FG000|Overall Study|Surgery (adenoidectomy)|2|||
163406012|NCT01098071|590196649|FG000|Overall Study|Lost to Follow-up|13|||
163406013|NCT00382993|590196655|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
163406014|NCT00382993|590196656|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
163406015|NCT00382993|590196655|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
163406016|NCT00382993|590196656|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
163406017|NCT00382993|590196655|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
163406018|NCT00382993|590196656|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
163406019|NCT00382993|590196655|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
163406020|NCT00382993|590196656|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
163406021|NCT00382993|590196655|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
163406022|NCT00382993|590196656|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
163406023|NCT00382993|590196655|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
163406024|NCT00382993|590196656|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
163406025|NCT00382993|590196655|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
163406026|NCT00382993|590196656|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
163406027|NCT00382993|590196655|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
163406028|NCT00382993|590196656|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
163406029|NCT00382993|590196655|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
163406030|NCT00382993|590196656|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
163406031|NCT00382993|590196655|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
163406032|NCT00382993|590196656|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
163406033|NCT01965262|590196676|FG000|Second Intervention (7 Days)|Discontinued|0|||
163406034|NCT01965262|590196677|FG001|Second Intervention (7 Days)|Discontinued|1|||
163406035|NCT01965262|590196676|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
163406036|NCT01965262|590196677|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
163406037|NCT01965262|590196676|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
163406038|NCT01965262|590196677|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
163406039|NCT00906087|590196683|FG000|Initial Washout|Withdrawal by Subject|1|||
163406040|NCT00906087|590196683|FG000|Initial Washout|Physician Decision|1|||
163406041|NCT00440947|590196684|FG000|36-Week Induction Phase|Adverse Event|16|||
163406042|NCT00440947|590196685|FG001|36-Week Induction Phase|Adverse Event|0|||
163406043|NCT00440947|590196686|FG002|36-Week Induction Phase|Adverse Event|0|||
163406044|NCT00440947|590196687|FG003|36-Week Induction Phase|Adverse Event|0|||
163406045|NCT00440947|590196688|FG004|36-Week Induction Phase|Adverse Event|0|||
163406046|NCT00440947|590196684|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
163406047|NCT00440947|590196685|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
163406048|NCT00440947|590196686|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
163406049|NCT00440947|590196687|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
163406050|NCT00440947|590196688|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
163406051|NCT00440947|590196684|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
163406052|NCT00440947|590196685|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
163406053|NCT00440947|590196686|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
163406054|NCT00440947|590196687|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
163406055|NCT00440947|590196688|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
163406056|NCT00440947|590196684|FG000|36-Week Induction Phase|Non-compliance|10|||
163406057|NCT00440947|590196685|FG001|36-Week Induction Phase|Non-compliance|0|||
163406058|NCT00440947|590196686|FG002|36-Week Induction Phase|Non-compliance|0|||
163406059|NCT00440947|590196687|FG003|36-Week Induction Phase|Non-compliance|0|||
163406060|NCT00440947|590196688|FG004|36-Week Induction Phase|Non-compliance|0|||
163406061|NCT00440947|590196684|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
163406062|NCT00440947|590196685|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
163406063|NCT00440947|590196686|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
163406064|NCT00440947|590196687|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
163406065|NCT00440947|590196688|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
163406066|NCT00440947|590196684|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
163406067|NCT00440947|590196685|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
163406068|NCT00440947|590196686|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
163406069|NCT00440947|590196687|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
163406070|NCT00440947|590196688|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
163406071|NCT00440947|590196684|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
163406072|NCT00440947|590196685|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
163406073|NCT00440947|590196686|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
163406074|NCT00440947|590196687|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
163406075|NCT00440947|590196688|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
163406076|NCT00440947|590196684|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
163406077|NCT00440947|590196685|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
163406078|NCT00440947|590196686|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
163406079|NCT00440947|590196687|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
163406080|NCT00440947|590196688|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
163406081|NCT00440947|590196684|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
163406082|NCT00440947|590196685|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
163406083|NCT00440947|590196686|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
163406084|NCT00440947|590196687|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
163406085|NCT00440947|590196688|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
163406086|NCT00440947|590196684|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
163406087|NCT00440947|590196685|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
163406088|NCT00440947|590196686|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
163406089|NCT00440947|590196687|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
163406090|NCT00440947|590196688|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
163406091|NCT00440947|590196684|FG000|36-Week Induction Phase|Incarceration|3|||
163406092|NCT00440947|590196685|FG001|36-Week Induction Phase|Incarceration|0|||
163406093|NCT00440947|590196686|FG002|36-Week Induction Phase|Incarceration|0|||
163406094|NCT00440947|590196687|FG003|36-Week Induction Phase|Incarceration|0|||
163406095|NCT00440947|590196688|FG004|36-Week Induction Phase|Incarceration|0|||
163406096|NCT00440947|590196684|FG000|36-Week Induction Phase|Pregnancy|1|||
163406097|NCT00440947|590196685|FG001|36-Week Induction Phase|Pregnancy|0|||
163406098|NCT00440947|590196686|FG002|36-Week Induction Phase|Pregnancy|0|||
163406099|NCT00440947|590196687|FG003|36-Week Induction Phase|Pregnancy|0|||
163406100|NCT00440947|590196688|FG004|36-Week Induction Phase|Pregnancy|0|||
163406101|NCT00440947|590196684|FG000|48-Week Randomization Phase|Adverse Event|0|||
163406102|NCT00440947|590196685|FG001|48-Week Randomization Phase|Adverse Event|2|||
163406103|NCT00440947|590196686|FG002|48-Week Randomization Phase|Adverse Event|5|||
163406104|NCT00440947|590196687|FG003|48-Week Randomization Phase|Adverse Event|0|||
163406105|NCT00440947|590196688|FG004|48-Week Randomization Phase|Adverse Event|0|||
163406106|NCT00440947|590196684|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
163406107|NCT00440947|590196685|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
163406108|NCT00440947|590196686|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
163406109|NCT00440947|590196687|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
163406110|NCT00440947|590196688|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
163406111|NCT00440947|590196684|FG000|48-Week Randomization Phase|Non-compliance|0|||
163217174|NCT03519347|589510401|FG003|Interventional Crossover Period 1|Death|1|||
163217175|NCT01412021|589510402|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
163217176|NCT01412021|589510402|FG000|Overall Study|Treatment Prior to Approval|3|||
163217177|NCT01412021|589510402|FG000|Overall Study|Transferred to Other Hospital|9|||
163217178|NCT00484939|589510405|FG000|Overall Study|Death|9|||
163217179|NCT00484939|589510406|FG001|Overall Study|Death|13|||
163217180|NCT00484939|589510405|FG000|Overall Study|Adverse Event|22|||
163217181|NCT00484939|589510406|FG001|Overall Study|Adverse Event|12|||
163217182|NCT00484939|589510405|FG000|Overall Study|Patient Withdrew Consent|19|||
163217183|NCT00484939|589510406|FG001|Overall Study|Patient Withdrew Consent|10|||
163330400|NCT02401815|589919093|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163330401|NCT02401815|589919094|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163330402|NCT02401815|589919095|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
163217184|NCT00484939|589510405|FG000|Overall Study|Protocol Violation|3|||
163217185|NCT00484939|589510406|FG001|Overall Study|Protocol Violation|3|||
163217186|NCT00484939|589510405|FG000|Overall Study|Lost to Follow-up|0|||
163217187|NCT00484939|589510406|FG001|Overall Study|Lost to Follow-up|3|||
163217188|NCT00484939|589510405|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
163217189|NCT00484939|589510406|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
163217190|NCT00484939|589510405|FG000|Overall Study|Disease progression|67|||
163217191|NCT00484939|589510406|FG001|Overall Study|Disease progression|88|||
163217192|NCT00484939|589510405|FG000|Overall Study|Screen Failure|2|||
163217193|NCT00484939|589510406|FG001|Overall Study|Screen Failure|2|||
163217194|NCT00484939|589510405|FG000|Overall Study|Reason Not Specified|11|||
163217195|NCT00484939|589510406|FG001|Overall Study|Reason Not Specified|6|||
163217196|NCT01522365|589510409|FG000|Overall Study|Withdrawal by Subject|1|||
163217197|NCT01522365|589510410|FG001|Overall Study|Withdrawal by Subject|1|||
163217198|NCT01522365|589510409|FG000|Overall Study|Lost to Follow-up|1|||
163217199|NCT01522365|589510410|FG001|Overall Study|Lost to Follow-up|1|||
163217200|NCT02466555|589510413|FG000|Overall Study|Lost to Follow-up|2|||
163217201|NCT00529542|589510414|FG000|Overall Study|Withdrawal by Subject|1|||
163217202|NCT00529542|589510415|FG001|Overall Study|Withdrawal by Subject|0|||
163217203|NCT00529542|589510414|FG000|Overall Study|Lost to Follow-up|0|||
163217204|NCT00529542|589510415|FG001|Overall Study|Lost to Follow-up|1|||
163217205|NCT02865915|589510416|FG000|Overall Study|Pregnancy|1|||
163217206|NCT02865915|589510417|FG001|Overall Study|Pregnancy|0|||
163217207|NCT02865915|589510416|FG000|Overall Study|Withdrawal by Subject|1|||
163217208|NCT02865915|589510417|FG001|Overall Study|Withdrawal by Subject|1|||
163217209|NCT02865915|589510416|FG000|Overall Study|Adverse Event|0|||
163217210|NCT02865915|589510417|FG001|Overall Study|Adverse Event|4|||
163217211|NCT02865915|589510416|FG000|Overall Study|Lost to Follow-up|0|||
163217212|NCT02865915|589510417|FG001|Overall Study|Lost to Follow-up|1|||
163217213|NCT02865915|589510416|FG000|Overall Study|Protocol Violation|0|||
163217214|NCT02865915|589510417|FG001|Overall Study|Protocol Violation|1|||
163217215|NCT02865915|589510416|FG000|Overall Study|Study terminated by sponsor|23|||
163217216|NCT02865915|589510417|FG001|Overall Study|Study terminated by sponsor|18|||
163217217|NCT02865915|589510416|FG000|Overall Study|Dosing group discontinued|0|||
163217218|NCT02865915|589510417|FG001|Overall Study|Dosing group discontinued|5|||
163217219|NCT05760300|589510422|FG000|Overall Study|Adverse Event|0|||
163217220|NCT05760300|589510423|FG001|Overall Study|Adverse Event|0|||
163217221|NCT05760300|589510424|FG002|Overall Study|Adverse Event|1|||
163217222|NCT05760300|589510425|FG003|Overall Study|Adverse Event|0|||
163217223|NCT05760300|589510422|FG000|Overall Study|Participant Decision|1|||
163217224|NCT05760300|589510423|FG001|Overall Study|Participant Decision|0|||
163217225|NCT05760300|589510424|FG002|Overall Study|Participant Decision|0|||
163217226|NCT05760300|589510425|FG003|Overall Study|Participant Decision|0|||
163217227|NCT03989440|589512113|FG000|Overall Study|COVID-19 travel restrictions|0|||
163217228|NCT03989440|589512114|FG001|Overall Study|COVID-19 travel restrictions|0|||
163217229|NCT03989440|589512115|FG002|Overall Study|COVID-19 travel restrictions|1|||
163217230|NCT03989440|589512116|FG003|Overall Study|COVID-19 travel restrictions|0|||
163217231|NCT03989440|589512117|FG004|Overall Study|COVID-19 travel restrictions|0|||
163217232|NCT03989440|589512118|FG005|Overall Study|COVID-19 travel restrictions|0|||
163217233|NCT03989440|589512113|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
163217234|NCT03989440|589512114|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
163217235|NCT03989440|589512115|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
163217236|NCT03989440|589512116|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
163217237|NCT03989440|589512117|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
163217238|NCT03989440|589512118|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
163217239|NCT01955161|589512119|FG000|Overall Study|Withdrawal before treatment|2|||
163217240|NCT01955161|589512120|FG001|Overall Study|Withdrawal before treatment|0|||
163217241|NCT01955161|589512121|FG002|Overall Study|Withdrawal before treatment|1|||
163217242|NCT01955161|589512119|FG000|Overall Study|Adverse Event|10|||
163217243|NCT01955161|589512120|FG001|Overall Study|Adverse Event|14|||
163217244|NCT01955161|589512121|FG002|Overall Study|Adverse Event|15|||
163217245|NCT01955161|589512119|FG000|Overall Study|Death|1|||
163217246|NCT01955161|589512120|FG001|Overall Study|Death|1|||
163217247|NCT01955161|589512121|FG002|Overall Study|Death|3|||
163217248|NCT01955161|589512119|FG000|Overall Study|Withdrawal by Subject|9|||
163217249|NCT01955161|589512120|FG001|Overall Study|Withdrawal by Subject|8|||
163330403|NCT02401815|589919086|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163330404|NCT02401815|589919087|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163330405|NCT02401815|589919088|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163330406|NCT02401815|589919089|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163330407|NCT02401815|589919090|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163330408|NCT02401815|589919091|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163330409|NCT02401815|589919092|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163330410|NCT02401815|589919093|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163330411|NCT02401815|589919094|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
163330412|NCT02401815|589919095|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163330413|NCT02401815|589919086|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
163330414|NCT02401815|589919087|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
163330415|NCT02401815|589919088|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
163330416|NCT02401815|589919089|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
163330417|NCT02401815|589919090|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
163330418|NCT02401815|589919091|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
163330419|NCT02401815|589919092|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
163330420|NCT02401815|589919093|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
163330421|NCT02401815|589919094|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
163330422|NCT02401815|589919095|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
163330423|NCT00748709|589919096|FG000|Overall Study|Progressive disease|15|||
163330424|NCT00748709|589919096|FG000|Overall Study|Drug reducing Toxity|2|||
163330425|NCT00748709|589919096|FG000|Overall Study|Other Adverse Event|1|||
163330426|NCT00748709|589919096|FG000|Overall Study|Withdrawal by Subject|1|||
163330427|NCT00748709|589919096|FG000|Overall Study|Other Reasons|1|||
163330428|NCT05470114|589919098|FG000|Overall Study|Withdrawal by Subject|1|||
163330429|NCT05470114|589919099|FG001|Overall Study|Withdrawal by Subject|0|||
163330430|NCT05470114|589919098|FG000|Overall Study|Lost to Follow-up|1|||
163330431|NCT05470114|589919099|FG001|Overall Study|Lost to Follow-up|0|||
163330432|NCT05325294|589919104|FG000|Overall Study|Adverse Event|3|||
163330433|NCT05325294|589919105|FG001|Overall Study|Adverse Event|3|||
163330434|NCT05325294|589919104|FG000|Overall Study|Physician Decision|0|||
163330435|NCT05325294|589919105|FG001|Overall Study|Physician Decision|1|||
163330436|NCT05325294|589919104|FG000|Overall Study|Withdrawal by Subject|0|||
163330437|NCT05325294|589919105|FG001|Overall Study|Withdrawal by Subject|3|||
163330438|NCT05325294|589919104|FG000|Overall Study|Lost to Follow-up|1|||
163330439|NCT05325294|589919105|FG001|Overall Study|Lost to Follow-up|0|||
163330440|NCT05325294|589919104|FG000|Overall Study|Sponsor Request|0|||
163330441|NCT05325294|589919105|FG001|Overall Study|Sponsor Request|2|||
163330442|NCT04649047|589919106|FG000|Overall Study|Withdrawal by Subject|3|||
163330443|NCT02488408|589919107|FG000|Part A|Adverse Event|2|||
163330444|NCT02488408|589919108|FG001|Part A|Adverse Event|0|||
163330445|NCT02488408|589919109|FG002|Part A|Adverse Event|0|||
163330446|NCT02488408|589919110|FG003|Part A|Adverse Event|0|||
163330447|NCT02488408|589919111|FG004|Part A|Adverse Event|0|||
163330448|NCT02488408|589919112|FG005|Part A|Adverse Event|0|||
163330449|NCT02488408|589919113|FG006|Part A|Adverse Event|0|||
163330450|NCT02488408|589919114|FG007|Part A|Adverse Event|0|||
163330451|NCT02488408|589919115|FG008|Part A|Adverse Event|0|||
163330452|NCT02488408|589919116|FG009|Part A|Adverse Event|0|||
163330453|NCT02488408|589919107|FG000|Part A|Death|1|||
163330454|NCT02488408|589919108|FG001|Part A|Death|5|||
163330455|NCT02488408|589919109|FG002|Part A|Death|0|||
163330456|NCT02488408|589919110|FG003|Part A|Death|0|||
163330457|NCT02488408|589919111|FG004|Part A|Death|3|||
163330458|NCT02488408|589919112|FG005|Part A|Death|0|||
163330459|NCT02488408|589919113|FG006|Part A|Death|0|||
163330460|NCT02488408|589919114|FG007|Part A|Death|0|||
163330461|NCT02488408|589919115|FG008|Part A|Death|0|||
163330462|NCT02488408|589919116|FG009|Part A|Death|0|||
163330463|NCT02488408|589919107|FG000|Part A|Disease Progression|2|||
163330464|NCT02488408|589919108|FG001|Part A|Disease Progression|8|||
163330465|NCT02488408|589919109|FG002|Part A|Disease Progression|2|||
163330466|NCT02488408|589919110|FG003|Part A|Disease Progression|3|||
163330467|NCT02488408|589919111|FG004|Part A|Disease Progression|4|||
163330468|NCT02488408|589919112|FG005|Part A|Disease Progression|0|||
163330469|NCT02488408|589919113|FG006|Part A|Disease Progression|0|||
163330470|NCT02488408|589919114|FG007|Part A|Disease Progression|0|||
163330471|NCT02488408|589919115|FG008|Part A|Disease Progression|0|||
163330472|NCT02488408|589919116|FG009|Part A|Disease Progression|0|||
163330473|NCT02488408|589919107|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
163330474|NCT02488408|589919108|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
163330475|NCT02488408|589919109|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
163330476|NCT02488408|589919110|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
163330477|NCT02488408|589919111|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
163330478|NCT02488408|589919112|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
163406112|NCT00440947|590196685|FG001|48-Week Randomization Phase|Non-compliance|3|||
163406113|NCT00440947|590196686|FG002|48-Week Randomization Phase|Non-compliance|4|||
163406114|NCT00440947|590196687|FG003|48-Week Randomization Phase|Non-compliance|0|||
163406115|NCT00440947|590196688|FG004|48-Week Randomization Phase|Non-compliance|0|||
163406116|NCT00440947|590196684|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
163406117|NCT00440947|590196685|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
163406118|NCT00440947|590196686|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
163406119|NCT00440947|590196687|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
163406120|NCT00440947|590196688|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
163406121|NCT00440947|590196684|FG000|48-Week Randomization Phase|Protocol Violation|0|||
163406122|NCT00440947|590196685|FG001|48-Week Randomization Phase|Protocol Violation|0|||
163406123|NCT00440947|590196686|FG002|48-Week Randomization Phase|Protocol Violation|1|||
163406124|NCT00440947|590196687|FG003|48-Week Randomization Phase|Protocol Violation|0|||
163406125|NCT00440947|590196688|FG004|48-Week Randomization Phase|Protocol Violation|0|||
163406126|NCT00440947|590196684|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
163406127|NCT00440947|590196685|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
163406128|NCT00440947|590196686|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
163406129|NCT00440947|590196687|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
163406130|NCT00440947|590196688|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
163406131|NCT00440947|590196684|FG000|48-Week Randomization Phase|Pregnancy|0|||
163406132|NCT00440947|590196685|FG001|48-Week Randomization Phase|Pregnancy|0|||
163406133|NCT00440947|590196686|FG002|48-Week Randomization Phase|Pregnancy|1|||
163406134|NCT00440947|590196687|FG003|48-Week Randomization Phase|Pregnancy|0|||
163406135|NCT00440947|590196688|FG004|48-Week Randomization Phase|Pregnancy|0|||
163406136|NCT00440947|590196684|FG000|48-Week Randomization Phase|Incarceration|0|||
163406137|NCT00440947|590196685|FG001|48-Week Randomization Phase|Incarceration|3|||
163406138|NCT00440947|590196686|FG002|48-Week Randomization Phase|Incarceration|0|||
163406139|NCT00440947|590196687|FG003|48-Week Randomization Phase|Incarceration|0|||
163406140|NCT00440947|590196688|FG004|48-Week Randomization Phase|Incarceration|0|||
163406141|NCT00440947|590196684|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
163406142|NCT00440947|590196685|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
163406143|NCT00440947|590196686|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
163406144|NCT00440947|590196687|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
163406145|NCT00440947|590196688|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
163406146|NCT00440947|590196684|FG000|48-Week Randomization Phase|Physician Decision|0|||
163406147|NCT00440947|590196685|FG001|48-Week Randomization Phase|Physician Decision|2|||
163406148|NCT00440947|590196686|FG002|48-Week Randomization Phase|Physician Decision|0|||
163406149|NCT00440947|590196687|FG003|48-Week Randomization Phase|Physician Decision|0|||
163406150|NCT00440947|590196688|FG004|48-Week Randomization Phase|Physician Decision|0|||
163406151|NCT00440947|590196684|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
163406152|NCT00440947|590196685|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
163406153|NCT00440947|590196686|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
163406154|NCT00440947|590196687|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
163406155|NCT00440947|590196688|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
163406156|NCT00440947|590196684|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
163406157|NCT00440947|590196685|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
163406158|NCT00440947|590196686|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
163406159|NCT00440947|590196687|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
163406160|NCT00440947|590196688|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
163406161|NCT00440947|590196684|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
163406162|NCT00440947|590196685|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
163406163|NCT00440947|590196686|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
163406164|NCT00440947|590196687|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
163406165|NCT00440947|590196688|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
163406166|NCT00440947|590196684|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
163406167|NCT00440947|590196685|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
163406168|NCT00440947|590196686|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
163406169|NCT00440947|590196687|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
163406170|NCT00440947|590196688|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
163406171|NCT00440947|590196684|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
163064061|NCT03126110|588941548|FG003|Phase 1|Survival follow-up no longer necessary|0|||
163064062|NCT03126110|588941549|FG004|Phase 1|Survival follow-up no longer necessary|0|||
163064063|NCT03126110|588941550|FG005|Phase 1|Survival follow-up no longer necessary|0|||
163064064|NCT03126110|588941551|FG006|Phase 1|Survival follow-up no longer necessary|0|||
163064065|NCT03126110|588941552|FG007|Phase 1|Survival follow-up no longer necessary|0|||
163217250|NCT01955161|589512121|FG002|Overall Study|Withdrawal by Subject|12|||
163406172|NCT00440947|590196685|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
163406173|NCT00440947|590196686|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
163406174|NCT00440947|590196687|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
163406175|NCT00440947|590196688|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
163406176|NCT00440947|590196684|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
163406177|NCT00440947|590196685|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
163406178|NCT00440947|590196686|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
163406179|NCT00440947|590196687|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
163406180|NCT00440947|590196688|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
163406181|NCT00440947|590196684|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
163406182|NCT00440947|590196685|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
163406183|NCT00440947|590196686|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
163406184|NCT00440947|590196687|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
163406185|NCT00440947|590196688|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
163406186|NCT00440947|590196684|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
163406187|NCT00440947|590196685|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
163406188|NCT00440947|590196686|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
163406189|NCT00440947|590196687|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
163406190|NCT00440947|590196688|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
163406191|NCT00440947|590196684|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
163406192|NCT00440947|590196685|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
163406193|NCT00440947|590196686|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
163406194|NCT00440947|590196687|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
163406195|NCT00440947|590196688|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
163406196|NCT00440947|590196684|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
163406197|NCT00440947|590196685|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
163406198|NCT00440947|590196686|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
163406199|NCT00440947|590196687|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
163406200|NCT00440947|590196688|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
163406201|NCT00440947|590196684|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
163406202|NCT00440947|590196685|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
163406203|NCT00440947|590196686|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
163406204|NCT00440947|590196687|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
163406205|NCT00440947|590196688|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
163406206|NCT00440947|590196684|FG000|Optional 60-Week Extension Phase|Other|0|||
163406207|NCT00440947|590196685|FG001|Optional 60-Week Extension Phase|Other|0|||
163406208|NCT00440947|590196686|FG002|Optional 60-Week Extension Phase|Other|0|||
163406209|NCT00440947|590196687|FG003|Optional 60-Week Extension Phase|Other|1|||
163406210|NCT00440947|590196688|FG004|Optional 60-Week Extension Phase|Other|0|||
163406211|NCT00440947|590196684|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
163406212|NCT00440947|590196685|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
163406213|NCT00440947|590196686|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
163406214|NCT00440947|590196687|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
163406215|NCT00440947|590196688|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
163406216|NCT00440947|590196684|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
163406217|NCT00440947|590196685|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
163406218|NCT00440947|590196686|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
163406219|NCT00440947|590196687|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
163406220|NCT00440947|590196688|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
163406221|NCT02898259|590196689|FG000|Overall Study|Adverse Event|0|||
163406222|NCT02898259|590196690|FG001|Overall Study|Adverse Event|0|||
163406223|NCT02898259|590196691|FG002|Overall Study|Adverse Event|1|||
163406224|NCT02898259|590196692|FG003|Overall Study|Adverse Event|0|||
163406225|NCT02898259|590196693|FG004|Overall Study|Adverse Event|0|||
163406226|NCT02898259|590196689|FG000|Overall Study|Lack of Efficacy|1|||
163406227|NCT02898259|590196690|FG001|Overall Study|Lack of Efficacy|1|||
163406228|NCT02898259|590196691|FG002|Overall Study|Lack of Efficacy|3|||
163406229|NCT02898259|590196692|FG003|Overall Study|Lack of Efficacy|0|||
163406230|NCT02898259|590196693|FG004|Overall Study|Lack of Efficacy|0|||
163406231|NCT02898259|590196689|FG000|Overall Study|Lost to Follow-up|0|||
163406232|NCT02898259|590196690|FG001|Overall Study|Lost to Follow-up|0|||
163406233|NCT02898259|590196691|FG002|Overall Study|Lost to Follow-up|1|||
163406234|NCT02898259|590196692|FG003|Overall Study|Lost to Follow-up|0|||
163406235|NCT02898259|590196693|FG004|Overall Study|Lost to Follow-up|0|||
163406236|NCT02898259|590196689|FG000|Overall Study|Transformation before study began|0|||
163406237|NCT02898259|590196690|FG001|Overall Study|Transformation before study began|0|||
163406238|NCT02898259|590196691|FG002|Overall Study|Transformation before study began|0|||
163064066|NCT03126110|588941553|FG008|Phase 1|Survival follow-up no longer necessary|0|||
163064067|NCT03126110|588941554|FG009|Phase 1|Survival follow-up no longer necessary|0|||
163406239|NCT02898259|590196692|FG003|Overall Study|Transformation before study began|1|||
163406240|NCT02898259|590196693|FG004|Overall Study|Transformation before study began|0|||
163406241|NCT01834274|590196699|FG000|Overall Study|Study Termination|41|||
163406242|NCT01834274|590196700|FG001|Overall Study|Study Termination|38|||
163406243|NCT01834274|590196699|FG000|Overall Study|Withdrawal by Subject|1|||
163406244|NCT01834274|590196700|FG001|Overall Study|Withdrawal by Subject|1|||
163406245|NCT01834274|590196699|FG000|Overall Study|Lost to Follow-up|3|||
163406246|NCT01834274|590196700|FG001|Overall Study|Lost to Follow-up|1|||
163406247|NCT01834274|590196699|FG000|Overall Study|Other|2|||
163406248|NCT01834274|590196700|FG001|Overall Study|Other|1|||
163406249|NCT01827670|590196701|FG000|Overall Study|Withdrawal of Consent|3|||
163406250|NCT01827670|590196702|FG001|Overall Study|Withdrawal of Consent|2|||
163406251|NCT01827670|590196701|FG000|Overall Study|Lost to Follow-up|0|||
163406252|NCT01827670|590196702|FG001|Overall Study|Lost to Follow-up|1|||
163406253|NCT02595723|590196706|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
163406254|NCT02595723|590196707|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
163406255|NCT02595723|590196708|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
163406256|NCT02595723|590196706|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
163406257|NCT02595723|590196707|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
163406258|NCT02595723|590196708|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
163406259|NCT00769184|590196710|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
163406260|NCT00769184|590196711|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
163406261|NCT00769184|590196710|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
163406262|NCT00769184|590196711|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
163406263|NCT00769184|590196710|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
163406264|NCT00769184|590196711|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
163406265|NCT00517829|590196712|FG000|Overall Study|Adverse Event|22|||
163406266|NCT00517829|590196713|FG001|Overall Study|Adverse Event|34|||
163406267|NCT00517829|590196712|FG000|Overall Study|Disease Progression|39|||
163406268|NCT00517829|590196713|FG001|Overall Study|Disease Progression|32|||
163406269|NCT00517829|590196712|FG000|Overall Study|Patient Request|6|||
163406270|NCT00517829|590196713|FG001|Overall Study|Patient Request|5|||
163406271|NCT00517829|590196712|FG000|Overall Study|Investigator Request|5|||
163406272|NCT00517829|590196713|FG001|Overall Study|Investigator Request|3|||
163406273|NCT00517829|590196712|FG000|Overall Study|Other|3|||
163406274|NCT00517829|590196713|FG001|Overall Study|Other|1|||
163406275|NCT00385255|590196714|FG000|Overall Study|Serious Adverse Event|1|||
163406276|NCT00385255|590196715|FG001|Overall Study|Serious Adverse Event|2|||
163406277|NCT00385255|590196714|FG000|Overall Study|Protocol Violation|0|||
163406278|NCT00385255|590196715|FG001|Overall Study|Protocol Violation|4|||
163406279|NCT00385255|590196714|FG000|Overall Study|Withdrawal by Subject|0|||
163406280|NCT00385255|590196715|FG001|Overall Study|Withdrawal by Subject|8|||
163406281|NCT00385255|590196714|FG000|Overall Study|Migrated/moved from study area|0|||
163406282|NCT00385255|590196715|FG001|Overall Study|Migrated/moved from study area|1|||
163406283|NCT00385255|590196714|FG000|Overall Study|Lost to Follow-up|20|||
163406284|NCT00385255|590196715|FG001|Overall Study|Lost to Follow-up|58|||
163406285|NCT00835237|590196720|FG000|Overall Study|Lost to Follow-up|4|||
163406286|NCT00835237|590196721|FG001|Overall Study|Lost to Follow-up|0|||
163406287|NCT00835237|590196720|FG000|Overall Study|Withdrawal by Subject|2|||
163406288|NCT00835237|590196721|FG001|Overall Study|Withdrawal by Subject|0|||
163406289|NCT03436862|590196724|FG000|Overall Study|Adverse Event|4|||
163406290|NCT03436862|590196724|FG000|Overall Study|Progressive Disease|2|||
163406291|NCT00606086|590196725|FG000|Overall Study|Adverse Event|1|||
163406292|NCT00606086|590196726|FG001|Overall Study|Adverse Event|1|||
163406293|NCT00606086|590196725|FG000|Overall Study|Lost to Follow-up|4|||
163406294|NCT00606086|590196726|FG001|Overall Study|Lost to Follow-up|8|||
163406295|NCT00606086|590196725|FG000|Overall Study|Protocol Violation|1|||
163406296|NCT00606086|590196726|FG001|Overall Study|Protocol Violation|0|||
163406297|NCT00606086|590196725|FG000|Overall Study|Withdrawal by Subject|5|||
163406298|NCT00606086|590196726|FG001|Overall Study|Withdrawal by Subject|3|||
163406299|NCT00606086|590196725|FG000|Overall Study|Non-compliance|0|||
163406300|NCT00606086|590196726|FG001|Overall Study|Non-compliance|1|||
163406301|NCT00606086|590196725|FG000|Overall Study|Randomized, not treated|1|||
163406302|NCT00606086|590196726|FG001|Overall Study|Randomized, not treated|2|||
163406303|NCT00391222|590196729|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
163406304|NCT00391222|590196730|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
163406305|NCT00391222|590196731|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
163406306|NCT00391222|590196732|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
163406307|NCT00391222|590196729|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
163406308|NCT00391222|590196730|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
163406309|NCT00391222|590196731|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
163406310|NCT00391222|590196732|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
163406311|NCT00391222|590196729|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
163406312|NCT00391222|590196730|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
163406313|NCT00391222|590196731|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
163406314|NCT00391222|590196732|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
163406315|NCT00391222|590196729|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
163330479|NCT02488408|589919113|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
163330480|NCT02488408|589919114|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
163330481|NCT02488408|589919115|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
163330482|NCT02488408|589919116|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
163330483|NCT02488408|589919107|FG000|Part A|Investigator Decision|0|||
163330484|NCT02488408|589919108|FG001|Part A|Investigator Decision|1|||
163330485|NCT02488408|589919109|FG002|Part A|Investigator Decision|1|||
163330486|NCT02488408|589919110|FG003|Part A|Investigator Decision|0|||
163330487|NCT02488408|589919111|FG004|Part A|Investigator Decision|0|||
163330488|NCT02488408|589919112|FG005|Part A|Investigator Decision|0|||
163330489|NCT02488408|589919113|FG006|Part A|Investigator Decision|0|||
163330490|NCT02488408|589919114|FG007|Part A|Investigator Decision|0|||
163330491|NCT02488408|589919115|FG008|Part A|Investigator Decision|0|||
163330492|NCT02488408|589919116|FG009|Part A|Investigator Decision|0|||
163330493|NCT02488408|589919107|FG000|Part A|Withdrawal by Subject|0|||
163330494|NCT02488408|589919108|FG001|Part A|Withdrawal by Subject|0|||
163330495|NCT02488408|589919109|FG002|Part A|Withdrawal by Subject|2|||
163330496|NCT02488408|589919110|FG003|Part A|Withdrawal by Subject|0|||
163330497|NCT02488408|589919111|FG004|Part A|Withdrawal by Subject|0|||
163330498|NCT02488408|589919112|FG005|Part A|Withdrawal by Subject|0|||
163330499|NCT02488408|589919113|FG006|Part A|Withdrawal by Subject|0|||
163330500|NCT02488408|589919114|FG007|Part A|Withdrawal by Subject|0|||
163330501|NCT02488408|589919115|FG008|Part A|Withdrawal by Subject|0|||
163330502|NCT02488408|589919116|FG009|Part A|Withdrawal by Subject|0|||
163330503|NCT02488408|589919107|FG000|Part A|Other|1|||
163330504|NCT02488408|589919108|FG001|Part A|Other|0|||
163330505|NCT02488408|589919109|FG002|Part A|Other|0|||
163330506|NCT02488408|589919110|FG003|Part A|Other|0|||
163330507|NCT02488408|589919111|FG004|Part A|Other|0|||
163330508|NCT02488408|589919112|FG005|Part A|Other|0|||
163330509|NCT02488408|589919113|FG006|Part A|Other|0|||
163330510|NCT02488408|589919114|FG007|Part A|Other|0|||
163330511|NCT02488408|589919115|FG008|Part A|Other|0|||
163330512|NCT02488408|589919116|FG009|Part A|Other|0|||
163330513|NCT02488408|589919107|FG000|Part B|Adverse Event|0|||
163330514|NCT02488408|589919108|FG001|Part B|Adverse Event|0|||
163330515|NCT02488408|589919109|FG002|Part B|Adverse Event|0|||
163330516|NCT02488408|589919110|FG003|Part B|Adverse Event|0|||
163330517|NCT02488408|589919111|FG004|Part B|Adverse Event|0|||
163330518|NCT02488408|589919112|FG005|Part B|Adverse Event|2|||
163330519|NCT02488408|589919113|FG006|Part B|Adverse Event|2|||
163330520|NCT02488408|589919114|FG007|Part B|Adverse Event|7|||
163330521|NCT02488408|589919115|FG008|Part B|Adverse Event|2|||
163330522|NCT02488408|589919116|FG009|Part B|Adverse Event|2|||
163330523|NCT02488408|589919107|FG000|Part B|Death|0|||
163330524|NCT02488408|589919108|FG001|Part B|Death|0|||
163330525|NCT02488408|589919109|FG002|Part B|Death|0|||
163330526|NCT02488408|589919110|FG003|Part B|Death|0|||
163330527|NCT02488408|589919111|FG004|Part B|Death|0|||
163330528|NCT02488408|589919112|FG005|Part B|Death|3|||
163330529|NCT02488408|589919113|FG006|Part B|Death|1|||
163330530|NCT02488408|589919114|FG007|Part B|Death|2|||
163330531|NCT02488408|589919115|FG008|Part B|Death|2|||
163330532|NCT02488408|589919116|FG009|Part B|Death|2|||
163330533|NCT02488408|589919107|FG000|Part B|Death due to Disease Progression|0|||
163330534|NCT02488408|589919108|FG001|Part B|Death due to Disease Progression|0|||
163330535|NCT02488408|589919109|FG002|Part B|Death due to Disease Progression|0|||
163330536|NCT02488408|589919110|FG003|Part B|Death due to Disease Progression|0|||
163330537|NCT02488408|589919111|FG004|Part B|Death due to Disease Progression|0|||
163330538|NCT02488408|589919112|FG005|Part B|Death due to Disease Progression|2|||
163330539|NCT02488408|589919113|FG006|Part B|Death due to Disease Progression|2|||
163330540|NCT02488408|589919114|FG007|Part B|Death due to Disease Progression|1|||
163330541|NCT02488408|589919115|FG008|Part B|Death due to Disease Progression|1|||
163330542|NCT02488408|589919116|FG009|Part B|Death due to Disease Progression|1|||
163330543|NCT02488408|589919107|FG000|Part B|Disease Progression|0|||
163330544|NCT02488408|589919108|FG001|Part B|Disease Progression|0|||
163330545|NCT02488408|589919109|FG002|Part B|Disease Progression|0|||
163330546|NCT02488408|589919110|FG003|Part B|Disease Progression|0|||
163330547|NCT02488408|589919111|FG004|Part B|Disease Progression|0|||
163330548|NCT02488408|589919112|FG005|Part B|Disease Progression|6|||
163330549|NCT02488408|589919113|FG006|Part B|Disease Progression|9|||
163330550|NCT02488408|589919114|FG007|Part B|Disease Progression|7|||
163330551|NCT02488408|589919115|FG008|Part B|Disease Progression|9|||
163330552|NCT02488408|589919116|FG009|Part B|Disease Progression|11|||
163330553|NCT02488408|589919107|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
163330554|NCT02488408|589919108|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
163330555|NCT02488408|589919109|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
163330556|NCT02488408|589919110|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
163330557|NCT02488408|589919111|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
163330558|NCT02488408|589919112|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
163330559|NCT02488408|589919113|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
163330560|NCT02488408|589919114|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
163406316|NCT00391222|590196730|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
163406317|NCT00391222|590196731|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
163406318|NCT00391222|590196732|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
163406319|NCT00391222|590196729|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
163406320|NCT00391222|590196730|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
163406321|NCT00391222|590196731|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
163406322|NCT00391222|590196732|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
163406323|NCT00391222|590196729|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
163406324|NCT00391222|590196730|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
163406325|NCT00391222|590196731|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
163406326|NCT00391222|590196732|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
163406327|NCT00391222|590196729|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
163406328|NCT00391222|590196730|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
163406329|NCT00391222|590196731|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
163406330|NCT00391222|590196732|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
163406331|NCT00391222|590196729|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
163406332|NCT00391222|590196730|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
163406333|NCT00391222|590196731|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
163406334|NCT00391222|590196732|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
163406335|NCT00391222|590196729|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
163406336|NCT00391222|590196730|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
163406337|NCT00391222|590196731|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
163406338|NCT00391222|590196732|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
163406339|NCT00391222|590196729|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
163406340|NCT00391222|590196730|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
163406341|NCT00391222|590196731|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
163406342|NCT00391222|590196732|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
163064068|NCT03126110|588941555|FG010|Phase 1|Survival follow-up no longer necessary|0|||
163064069|NCT03126110|588941556|FG011|Phase 1|Survival follow-up no longer necessary|0|||
163064070|NCT03126110|588941557|FG012|Phase 1|Survival follow-up no longer necessary|0|||
163217251|NCT01955161|589512119|FG000|Overall Study|Protocol Violation|2|||
163217252|NCT01955161|589512120|FG001|Overall Study|Protocol Violation|0|||
163217253|NCT01955161|589512121|FG002|Overall Study|Protocol Violation|0|||
163064071|NCT03126110|588941558|FG013|Phase 1|Survival follow-up no longer necessary|0|||
163064072|NCT03126110|588941559|FG014|Phase 1|Survival follow-up no longer necessary|0|||
163064073|NCT03126110|588941560|FG015|Phase 1|Survival follow-up no longer necessary|0|||
163064074|NCT03126110|588941561|FG016|Phase 1|Survival follow-up no longer necessary|0|||
163064075|NCT03126110|588941545|FG000|Phase 2|Study terminated by the sponsor|0|||
163064076|NCT03126110|588941546|FG001|Phase 2|Study terminated by the sponsor|0|||
163064077|NCT03126110|588941547|FG002|Phase 2|Study terminated by the sponsor|0|||
163064078|NCT03126110|588941548|FG003|Phase 2|Study terminated by the sponsor|0|||
163064079|NCT03126110|588941549|FG004|Phase 2|Study terminated by the sponsor|0|||
163064080|NCT03126110|588941550|FG005|Phase 2|Study terminated by the sponsor|0|||
163217254|NCT01955161|589512119|FG000|Overall Study|Other reason: physician decision|0|||
163217255|NCT01955161|589512120|FG001|Overall Study|Other reason: physician decision|1|||
163217256|NCT01955161|589512121|FG002|Overall Study|Other reason: physician decision|1|||
163217257|NCT01955161|589512119|FG000|Overall Study|Other reason: disallowed medication|1|||
163217258|NCT01955161|589512120|FG001|Overall Study|Other reason: disallowed medication|0|||
163217259|NCT01955161|589512121|FG002|Overall Study|Other reason: disallowed medication|1|||
163330561|NCT02488408|589919115|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
163330562|NCT02488408|589919116|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
163330563|NCT02488408|589919107|FG000|Part B|Investigator Decision|0|||
163330564|NCT02488408|589919108|FG001|Part B|Investigator Decision|0|||
163330565|NCT02488408|589919109|FG002|Part B|Investigator Decision|0|||
163330566|NCT02488408|589919110|FG003|Part B|Investigator Decision|0|||
163330567|NCT02488408|589919111|FG004|Part B|Investigator Decision|0|||
163330568|NCT02488408|589919112|FG005|Part B|Investigator Decision|0|||
163330569|NCT02488408|589919113|FG006|Part B|Investigator Decision|1|||
163330570|NCT02488408|589919114|FG007|Part B|Investigator Decision|0|||
163330571|NCT02488408|589919115|FG008|Part B|Investigator Decision|2|||
163330572|NCT02488408|589919116|FG009|Part B|Investigator Decision|1|||
163330573|NCT00719888|589919117|FG000|Overall Study|Death|24|||
163330574|NCT00719888|589919118|FG001|Overall Study|Death|9|||
163330575|NCT00719888|589919117|FG000|Overall Study|Relapse|8|||
163330576|NCT00719888|589919118|FG001|Overall Study|Relapse|3|||
163217260|NCT01955161|589512119|FG000|Overall Study|Other reason: caregiver unavailable|1|||
163217261|NCT01955161|589512120|FG001|Overall Study|Other reason: caregiver unavailable|0|||
163217262|NCT01955161|589512121|FG002|Overall Study|Other reason: caregiver unavailable|0|||
163217263|NCT01955161|589512119|FG000|Overall Study|Other reason: moved to nursing home|0|||
163217264|NCT01955161|589512120|FG001|Overall Study|Other reason: moved to nursing home|1|||
163217265|NCT01955161|589512121|FG002|Overall Study|Other reason: moved to nursing home|0|||
163022376|NCT03535194|588786276|FG003|Post-Treatment Followup Period|Physician Decision|1|||
163022377|NCT03535194|588786277|FG004|Post-Treatment Followup Period|Physician Decision|0|||
163022378|NCT03535194|588786273|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
163022379|NCT03535194|588786274|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
163022380|NCT03535194|588786275|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
163022381|NCT03535194|588786276|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
163022382|NCT03535194|588786277|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163022383|NCT04411810|588786278|FG000|Overall Study|Screen failure|1|||
163022384|NCT04411810|588786278|FG000|Overall Study|Withdrawal by Subject|1|||
163022385|NCT04304235|588786282|FG000|Overall Study|incomplete triage data|0|||
163022386|NCT04304235|588786283|FG001|Overall Study|incomplete triage data|69|||
163022387|NCT04304235|588786284|FG002|Overall Study|incomplete triage data|0|||
163022388|NCT04304235|588786285|FG003|Overall Study|incomplete triage data|0|||
163022389|NCT04304235|588786286|FG004|Overall Study|incomplete triage data|289|||
163022390|NCT04304235|588786287|FG005|Overall Study|incomplete triage data|123|||
163022391|NCT04304235|588786288|FG006|Overall Study|incomplete triage data|65|||
163022392|NCT04470544|588786289|FG000|Overall Study|Withdrawal by Subject|4|||
163022393|NCT04470544|588786290|FG001|Overall Study|Withdrawal by Subject|6|||
163022394|NCT02217410|588786293|FG000|Overall Study|Graft Loss|0|||
163022395|NCT02217410|588786294|FG001|Overall Study|Graft Loss|0|||
163022396|NCT02217410|588786295|FG002|Overall Study|Graft Loss|2|||
163022397|NCT02217410|588786293|FG000|Overall Study|Withdrawal by Subject|0|||
163022398|NCT02217410|588786294|FG001|Overall Study|Withdrawal by Subject|0|||
163022399|NCT02217410|588786295|FG002|Overall Study|Withdrawal by Subject|2|||
163022400|NCT02217410|588786293|FG000|Overall Study|Lost to Follow-up|0|||
163022401|NCT02217410|588786294|FG001|Overall Study|Lost to Follow-up|0|||
163022402|NCT02217410|588786295|FG002|Overall Study|Lost to Follow-up|1|||
163022403|NCT02217410|588786293|FG000|Overall Study|Lack of Efficacy|0|||
163022404|NCT02217410|588786294|FG001|Overall Study|Lack of Efficacy|1|||
163022405|NCT02217410|588786295|FG002|Overall Study|Lack of Efficacy|0|||
163022406|NCT02217410|588786293|FG000|Overall Study|Physician Decision|1|||
163022407|NCT02217410|588786294|FG001|Overall Study|Physician Decision|3|||
163022408|NCT02217410|588786295|FG002|Overall Study|Physician Decision|0|||
163022409|NCT00626821|588786296|FG000|Overall Study|Adverse Event|44|||
163022410|NCT00626821|588786296|FG000|Overall Study|Protocol Violation|33|||
163022411|NCT00626821|588786296|FG000|Overall Study|Withdrawal by Subject|10|||
163022412|NCT00626821|588786296|FG000|Overall Study|Physician Decision|9|||
163022413|NCT00626821|588786296|FG000|Overall Study|Product dysfunction|21|||
163022414|NCT00626821|588786296|FG000|Overall Study|other/unknown reason|104|||
163022415|NCT01471340|588786300|FG000|Overall Study|Death|5|||
163022416|NCT01471340|588786301|FG001|Overall Study|Death|4|||
163022417|NCT01471340|588786300|FG000|Overall Study|Lost to Follow-up|0|||
163022418|NCT01471340|588786301|FG001|Overall Study|Lost to Follow-up|1|||
163022419|NCT01471340|588786300|FG000|Overall Study|Investigational site closure|0|||
163022420|NCT01471340|588786301|FG001|Overall Study|Investigational site closure|1|||
163022421|NCT01471340|588786300|FG000|Overall Study|Invalid informed consent|1|||
163022422|NCT01471340|588786301|FG001|Overall Study|Invalid informed consent|0|||
163022423|NCT02475265|588786302|FG000|Overall Study|Physician Decision|1|||
163022424|NCT02475265|588786302|FG000|Overall Study|Withdrawal by Subject|2|||
163022425|NCT02218736|588786306|FG000|Overall Study|Withdrawal by Subject|10|||
163022426|NCT02218736|588786307|FG001|Overall Study|Withdrawal by Subject|9|||
163022427|NCT02218736|588786306|FG000|Overall Study|Protocol Violation|2|||
163022428|NCT02218736|588786307|FG001|Overall Study|Protocol Violation|0|||
163022429|NCT03452488|588786308|FG000|Overall Study|Adverse Event|4|||
163022430|NCT03452488|588786309|FG001|Overall Study|Adverse Event|6|||
163022431|NCT03452488|588786310|FG002|Overall Study|Adverse Event|1|||
163022432|NCT03452488|588786308|FG000|Overall Study|Death|0|||
163022433|NCT03452488|588786309|FG001|Overall Study|Death|0|||
163022434|NCT03452488|588786310|FG002|Overall Study|Death|1|||
163022435|NCT03452488|588786308|FG000|Overall Study|Lost to Follow-up|1|||
163022436|NCT03452488|588786309|FG001|Overall Study|Lost to Follow-up|2|||
163022437|NCT03452488|588786310|FG002|Overall Study|Lost to Follow-up|0|||
163330577|NCT00719888|589919117|FG000|Overall Study|Physician Decision|1|||
163022438|NCT03452488|588786308|FG000|Overall Study|PI Decision|1|||
163022439|NCT03452488|588786309|FG001|Overall Study|PI Decision|0|||
163022440|NCT03452488|588786310|FG002|Overall Study|PI Decision|0|||
163022441|NCT03452488|588786308|FG000|Overall Study|Withdrew consent|4|||
163022442|NCT03452488|588786309|FG001|Overall Study|Withdrew consent|2|||
163022443|NCT03452488|588786310|FG002|Overall Study|Withdrew consent|2|||
163022444|NCT03452488|588786308|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
163022445|NCT03452488|588786309|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
163022446|NCT03452488|588786310|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
163022447|NCT03452488|588786308|FG000|Overall Study|Other|0|||
163022448|NCT03452488|588786309|FG001|Overall Study|Other|2|||
163022449|NCT03452488|588786310|FG002|Overall Study|Other|2|||
163022450|NCT00623935|588786313|FG000|Overall Study|Death|1|||
163022451|NCT00623935|588786313|FG000|Overall Study|Patient Declined Transplant|1|||
163022452|NCT03315286|588786314|FG000|Overall Study|Lost to Follow-up|0|||
163022453|NCT03315286|588786315|FG001|Overall Study|Lost to Follow-up|3|||
163022454|NCT03315286|588786314|FG000|Overall Study|Withdrawal by Subject|1|||
163022455|NCT03315286|588786315|FG001|Overall Study|Withdrawal by Subject|0|||
163022456|NCT03315286|588786314|FG000|Overall Study|Protocol Violation|0|||
163022457|NCT03315286|588786315|FG001|Overall Study|Protocol Violation|1|||
163022458|NCT02829723|588786316|FG000|Overall Study|Adverse Event|0|||
163022459|NCT02829723|588786317|FG001|Overall Study|Adverse Event|0|||
163022460|NCT02829723|588786318|FG002|Overall Study|Adverse Event|1|||
163022461|NCT02829723|588786319|FG003|Overall Study|Adverse Event|1|||
163022462|NCT02829723|588786320|FG004|Overall Study|Adverse Event|0|||
163022463|NCT02829723|588786321|FG005|Overall Study|Adverse Event|0|||
163022464|NCT02829723|588786322|FG006|Overall Study|Adverse Event|0|||
163022465|NCT02829723|588786323|FG007|Overall Study|Adverse Event|1|||
163022466|NCT02829723|588786324|FG008|Overall Study|Adverse Event|0|||
163022467|NCT02829723|588786325|FG009|Overall Study|Adverse Event|0|||
163022468|NCT02829723|588786326|FG010|Overall Study|Adverse Event|0|||
163022469|NCT02829723|588786327|FG011|Overall Study|Adverse Event|0|||
163022470|NCT02829723|588786328|FG012|Overall Study|Adverse Event|0|||
163022471|NCT02829723|588786329|FG013|Overall Study|Adverse Event|0|||
163022472|NCT02829723|588786330|FG014|Overall Study|Adverse Event|1|||
163022473|NCT02829723|588786331|FG015|Overall Study|Adverse Event|1|||
163022474|NCT02829723|588786332|FG016|Overall Study|Adverse Event|1|||
163022475|NCT02829723|588786333|FG017|Overall Study|Adverse Event|2|||
163022476|NCT02829723|588786334|FG018|Overall Study|Adverse Event|1|||
163022477|NCT02829723|588786335|FG019|Overall Study|Adverse Event|1|||
163022478|NCT02829723|588786336|FG020|Overall Study|Adverse Event|3|||
163022479|NCT02829723|588786337|FG021|Overall Study|Adverse Event|0|||
163022480|NCT02829723|588786338|FG022|Overall Study|Adverse Event|0|||
163022481|NCT02829723|588786339|FG023|Overall Study|Adverse Event|1|||
163022482|NCT02829723|588786340|FG024|Overall Study|Adverse Event|1|||
163022483|NCT02829723|588786341|FG025|Overall Study|Adverse Event|3|||
163022484|NCT02829723|588786342|FG026|Overall Study|Adverse Event|5|||
163022485|NCT02829723|588786316|FG000|Overall Study|Death|1|||
163022486|NCT02829723|588786317|FG001|Overall Study|Death|0|||
163022487|NCT02829723|588786318|FG002|Overall Study|Death|1|||
163022488|NCT02829723|588786319|FG003|Overall Study|Death|1|||
163022489|NCT02829723|588786320|FG004|Overall Study|Death|0|||
163022490|NCT02829723|588786321|FG005|Overall Study|Death|0|||
163022491|NCT02829723|588786322|FG006|Overall Study|Death|2|||
163022492|NCT02829723|588786323|FG007|Overall Study|Death|0|||
163022493|NCT02829723|588786324|FG008|Overall Study|Death|1|||
163022494|NCT02829723|588786325|FG009|Overall Study|Death|0|||
163022495|NCT02829723|588786326|FG010|Overall Study|Death|0|||
163022496|NCT02829723|588786327|FG011|Overall Study|Death|0|||
163022497|NCT02829723|588786328|FG012|Overall Study|Death|2|||
163022498|NCT02829723|588786329|FG013|Overall Study|Death|1|||
163022499|NCT02829723|588786330|FG014|Overall Study|Death|0|||
163022500|NCT02829723|588786331|FG015|Overall Study|Death|0|||
163022501|NCT02829723|588786332|FG016|Overall Study|Death|0|||
163022502|NCT02829723|588786333|FG017|Overall Study|Death|0|||
163022503|NCT02829723|588786334|FG018|Overall Study|Death|0|||
163022504|NCT02829723|588786335|FG019|Overall Study|Death|0|||
163022505|NCT02829723|588786336|FG020|Overall Study|Death|0|||
163022506|NCT02829723|588786337|FG021|Overall Study|Death|2|||
163022507|NCT02829723|588786338|FG022|Overall Study|Death|0|||
163022508|NCT02829723|588786339|FG023|Overall Study|Death|0|||
163217266|NCT01955161|589512119|FG000|Overall Study|Other reason: insufficient compliance|0|||
163217267|NCT01955161|589512120|FG001|Overall Study|Other reason: insufficient compliance|0|||
163217268|NCT01955161|589512121|FG002|Overall Study|Other reason: insufficient compliance|1|||
163217269|NCT01955161|589512119|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
163217270|NCT01955161|589512120|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
163217271|NCT01955161|589512121|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
163217272|NCT01955161|589512119|FG000|Overall Study|Other reason: patient's will|0|||
163022509|NCT02829723|588786340|FG024|Overall Study|Death|0|||
163022510|NCT02829723|588786341|FG025|Overall Study|Death|1|||
163022511|NCT02829723|588786342|FG026|Overall Study|Death|2|||
163022512|NCT02829723|588786316|FG000|Overall Study|Physician Decision|0|||
163022513|NCT02829723|588786317|FG001|Overall Study|Physician Decision|0|||
163022514|NCT02829723|588786318|FG002|Overall Study|Physician Decision|0|||
163022515|NCT02829723|588786319|FG003|Overall Study|Physician Decision|0|||
163022516|NCT02829723|588786320|FG004|Overall Study|Physician Decision|0|||
163022517|NCT02829723|588786321|FG005|Overall Study|Physician Decision|0|||
163022518|NCT02829723|588786322|FG006|Overall Study|Physician Decision|0|||
163330578|NCT00719888|589919118|FG001|Overall Study|Physician Decision|0|||
163022519|NCT02829723|588786323|FG007|Overall Study|Physician Decision|0|||
163022520|NCT02829723|588786324|FG008|Overall Study|Physician Decision|0|||
163022521|NCT02829723|588786325|FG009|Overall Study|Physician Decision|1|||
163022522|NCT02829723|588786326|FG010|Overall Study|Physician Decision|1|||
163022523|NCT02829723|588786327|FG011|Overall Study|Physician Decision|0|||
163022524|NCT02829723|588786328|FG012|Overall Study|Physician Decision|0|||
163022525|NCT02829723|588786329|FG013|Overall Study|Physician Decision|1|||
163022526|NCT02829723|588786330|FG014|Overall Study|Physician Decision|0|||
163022527|NCT02829723|588786331|FG015|Overall Study|Physician Decision|0|||
163022528|NCT02829723|588786332|FG016|Overall Study|Physician Decision|2|||
163022529|NCT02829723|588786333|FG017|Overall Study|Physician Decision|0|||
163022530|NCT02829723|588786334|FG018|Overall Study|Physician Decision|0|||
163022531|NCT02829723|588786335|FG019|Overall Study|Physician Decision|0|||
163022532|NCT02829723|588786336|FG020|Overall Study|Physician Decision|0|||
163022533|NCT02829723|588786337|FG021|Overall Study|Physician Decision|0|||
163022534|NCT02829723|588786338|FG022|Overall Study|Physician Decision|1|||
163022535|NCT02829723|588786339|FG023|Overall Study|Physician Decision|1|||
163022536|NCT02829723|588786340|FG024|Overall Study|Physician Decision|1|||
163022537|NCT02829723|588786341|FG025|Overall Study|Physician Decision|1|||
163022538|NCT02829723|588786342|FG026|Overall Study|Physician Decision|3|||
163022539|NCT02829723|588786316|FG000|Overall Study|Progressive disease|4|||
163022540|NCT02829723|588786317|FG001|Overall Study|Progressive disease|6|||
163022541|NCT02829723|588786318|FG002|Overall Study|Progressive disease|3|||
163022542|NCT02829723|588786319|FG003|Overall Study|Progressive disease|3|||
163022543|NCT02829723|588786320|FG004|Overall Study|Progressive disease|3|||
163022544|NCT02829723|588786321|FG005|Overall Study|Progressive disease|5|||
163022545|NCT02829723|588786322|FG006|Overall Study|Progressive disease|4|||
163022546|NCT02829723|588786323|FG007|Overall Study|Progressive disease|6|||
163022547|NCT02829723|588786324|FG008|Overall Study|Progressive disease|8|||
163022548|NCT02829723|588786325|FG009|Overall Study|Progressive disease|4|||
163022549|NCT02829723|588786326|FG010|Overall Study|Progressive disease|9|||
163022550|NCT02829723|588786327|FG011|Overall Study|Progressive disease|0|||
163022551|NCT02829723|588786328|FG012|Overall Study|Progressive disease|3|||
163022552|NCT02829723|588786329|FG013|Overall Study|Progressive disease|4|||
163022553|NCT02829723|588786330|FG014|Overall Study|Progressive disease|2|||
163022554|NCT02829723|588786331|FG015|Overall Study|Progressive disease|4|||
163022555|NCT02829723|588786332|FG016|Overall Study|Progressive disease|5|||
163022556|NCT02829723|588786333|FG017|Overall Study|Progressive disease|3|||
163022557|NCT02829723|588786334|FG018|Overall Study|Progressive disease|4|||
163022558|NCT02829723|588786335|FG019|Overall Study|Progressive disease|4|||
163022559|NCT02829723|588786336|FG020|Overall Study|Progressive disease|7|||
163022560|NCT02829723|588786337|FG021|Overall Study|Progressive disease|6|||
163022561|NCT02829723|588786338|FG022|Overall Study|Progressive disease|3|||
163022562|NCT02829723|588786339|FG023|Overall Study|Progressive disease|3|||
163022563|NCT02829723|588786340|FG024|Overall Study|Progressive disease|3|||
163022564|NCT02829723|588786341|FG025|Overall Study|Progressive disease|16|||
163022565|NCT02829723|588786342|FG026|Overall Study|Progressive disease|10|||
163022566|NCT02829723|588786316|FG000|Overall Study|Subject/guardian decision|0|||
163022567|NCT02829723|588786317|FG001|Overall Study|Subject/guardian decision|1|||
163022568|NCT02829723|588786318|FG002|Overall Study|Subject/guardian decision|0|||
163022569|NCT02829723|588786319|FG003|Overall Study|Subject/guardian decision|1|||
163022570|NCT02829723|588786320|FG004|Overall Study|Subject/guardian decision|0|||
163022571|NCT02829723|588786321|FG005|Overall Study|Subject/guardian decision|0|||
163022572|NCT02829723|588786322|FG006|Overall Study|Subject/guardian decision|0|||
163022573|NCT02829723|588786323|FG007|Overall Study|Subject/guardian decision|1|||
163022574|NCT02829723|588786324|FG008|Overall Study|Subject/guardian decision|0|||
163022575|NCT02829723|588786325|FG009|Overall Study|Subject/guardian decision|0|||
163022576|NCT02829723|588786326|FG010|Overall Study|Subject/guardian decision|0|||
163022577|NCT02829723|588786327|FG011|Overall Study|Subject/guardian decision|0|||
163022578|NCT02829723|588786328|FG012|Overall Study|Subject/guardian decision|0|||
163022579|NCT02829723|588786329|FG013|Overall Study|Subject/guardian decision|0|||
163022580|NCT02829723|588786330|FG014|Overall Study|Subject/guardian decision|1|||
163022581|NCT02829723|588786331|FG015|Overall Study|Subject/guardian decision|0|||
163022582|NCT02829723|588786332|FG016|Overall Study|Subject/guardian decision|1|||
163022583|NCT02829723|588786333|FG017|Overall Study|Subject/guardian decision|0|||
163022584|NCT02829723|588786334|FG018|Overall Study|Subject/guardian decision|1|||
163022585|NCT02829723|588786335|FG019|Overall Study|Subject/guardian decision|0|||
163022586|NCT02829723|588786336|FG020|Overall Study|Subject/guardian decision|1|||
163022587|NCT02829723|588786337|FG021|Overall Study|Subject/guardian decision|0|||
163022588|NCT02829723|588786338|FG022|Overall Study|Subject/guardian decision|0|||
163022589|NCT02829723|588786339|FG023|Overall Study|Subject/guardian decision|1|||
163064081|NCT03126110|588941551|FG006|Phase 2|Study terminated by the sponsor|0|||
163022590|NCT02829723|588786340|FG024|Overall Study|Subject/guardian decision|0|||
163022591|NCT02829723|588786341|FG025|Overall Study|Subject/guardian decision|1|||
163022592|NCT02829723|588786342|FG026|Overall Study|Subject/guardian decision|1|||
163022593|NCT02829723|588786316|FG000|Overall Study|Study terminated by sponsor|0|||
163217273|NCT01955161|589512120|FG001|Overall Study|Other reason: patient's will|0|||
163022594|NCT02829723|588786317|FG001|Overall Study|Study terminated by sponsor|0|||
163022595|NCT02829723|588786318|FG002|Overall Study|Study terminated by sponsor|0|||
163217274|NCT01955161|589512121|FG002|Overall Study|Other reason: patient's will|1|||
163022596|NCT02829723|588786319|FG003|Overall Study|Study terminated by sponsor|0|||
163022597|NCT02829723|588786320|FG004|Overall Study|Study terminated by sponsor|0|||
163217275|NCT04608500|589512122|FG000|Overall Study|Adverse Event|2|||
163217276|NCT04608500|589512123|FG001|Overall Study|Adverse Event|0|||
163217277|NCT04608500|589512122|FG000|Overall Study|Lost to Follow-up|15|||
163217278|NCT04608500|589512123|FG001|Overall Study|Lost to Follow-up|9|||
163406343|NCT00391222|590196729|FG000|Period III (Double-Blind Treatment)|Other|6|||
163406344|NCT00391222|590196730|FG001|Period III (Double-Blind Treatment)|Other|1|||
163022598|NCT02829723|588786321|FG005|Overall Study|Study terminated by sponsor|0|||
163022599|NCT02829723|588786322|FG006|Overall Study|Study terminated by sponsor|0|||
163022600|NCT02829723|588786323|FG007|Overall Study|Study terminated by sponsor|0|||
163022601|NCT02829723|588786324|FG008|Overall Study|Study terminated by sponsor|0|||
163022602|NCT02829723|588786325|FG009|Overall Study|Study terminated by sponsor|0|||
163022603|NCT02829723|588786326|FG010|Overall Study|Study terminated by sponsor|0|||
163022604|NCT02829723|588786327|FG011|Overall Study|Study terminated by sponsor|0|||
163022605|NCT02829723|588786328|FG012|Overall Study|Study terminated by sponsor|0|||
163022606|NCT02829723|588786329|FG013|Overall Study|Study terminated by sponsor|0|||
163022607|NCT02829723|588786330|FG014|Overall Study|Study terminated by sponsor|0|||
163022608|NCT02829723|588786331|FG015|Overall Study|Study terminated by sponsor|0|||
163022609|NCT02829723|588786332|FG016|Overall Study|Study terminated by sponsor|0|||
163022610|NCT02829723|588786333|FG017|Overall Study|Study terminated by sponsor|0|||
163022611|NCT02829723|588786334|FG018|Overall Study|Study terminated by sponsor|0|||
163022612|NCT02829723|588786335|FG019|Overall Study|Study terminated by sponsor|0|||
163022613|NCT02829723|588786336|FG020|Overall Study|Study terminated by sponsor|0|||
163022614|NCT02829723|588786337|FG021|Overall Study|Study terminated by sponsor|1|||
163022615|NCT02829723|588786338|FG022|Overall Study|Study terminated by sponsor|0|||
163022616|NCT02829723|588786339|FG023|Overall Study|Study terminated by sponsor|0|||
163022617|NCT02829723|588786340|FG024|Overall Study|Study terminated by sponsor|0|||
163022618|NCT02829723|588786341|FG025|Overall Study|Study terminated by sponsor|0|||
163022619|NCT02829723|588786342|FG026|Overall Study|Study terminated by sponsor|0|||
163022620|NCT02989649|588786343|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
163022621|NCT02989649|588786343|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
163022622|NCT02989649|588786343|FG000|Overall Study|Lost For Observation During Study|3|||
163022623|NCT02989649|588786343|FG000|Overall Study|Reason Not Specified|13|||
163022624|NCT00281632|588786344|FG000|Overall Study|Adverse Event|7|||
163022625|NCT00281632|588786344|FG000|Overall Study|Withdrawal by Subject|2|||
163022626|NCT00281632|588786344|FG000|Overall Study|Disease Progression|22|||
163022627|NCT00281632|588786344|FG000|Overall Study|Death|1|||
163022628|NCT00281632|588786344|FG000|Overall Study|Physician Decision|1|||
163022629|NCT00281632|588786344|FG000|Overall Study|Ongoing|3|||
163022630|NCT01878084|588786347|FG000|Overall Study|Physician Decision|2|||
163022631|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
163022632|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
163022633|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
163022634|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
163022635|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
163022636|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
163022637|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
163022638|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
163022639|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
163022640|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
163022641|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Death|1|||
163022642|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Death|0|||
163022643|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
163022644|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
163022645|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
163022646|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
163022647|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
163022648|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
163022649|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
163022650|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
163022651|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Adverse Event|2|||
163022652|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Adverse Event|6|||
163022653|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
163022654|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
163022655|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Progressive disease|4|||
163217279|NCT04608500|589512122|FG000|Overall Study|Participant request|11|||
163217280|NCT04608500|589512123|FG001|Overall Study|Participant request|7|||
163217281|NCT04608500|589512122|FG000|Overall Study|Protocol Violation|1|||
163217282|NCT04608500|589512123|FG001|Overall Study|Protocol Violation|0|||
163217283|NCT04608500|589512122|FG000|Overall Study|Other|6|||
163217284|NCT04608500|589512123|FG001|Overall Study|Other|2|||
163217285|NCT01030523|589512128|FG000|Initial Study (5 Years)|Death|1|||
163217286|NCT01030523|589512129|FG001|Initial Study (5 Years)|Death|0|||
163217287|NCT01030523|589512128|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
163217288|NCT01030523|589512129|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
163217289|NCT01030523|589512128|FG000|Initial Study (5 Years)|Implant failure|1|||
163022656|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Progressive disease|35|||
163022657|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
163022658|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
163022659|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
163022660|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
163022661|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Death|0|||
163022662|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Death|1|||
163022663|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Other than specified above|9|||
163022664|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Other than specified above|18|||
163022665|NCT01475851|588786350|FG000|Overall Study|Protocol defined stopping criteria|1|||
163022666|NCT01475851|588786351|FG001|Overall Study|Protocol defined stopping criteria|0|||
163022667|NCT00732758|588786352|FG000|Overall Study|Lost to Follow-up|8|||
163022668|NCT00732758|588786353|FG001|Overall Study|Lost to Follow-up|16|||
163022669|NCT00373958|588786354|FG000|Infant Series|Withdrawal by Subject|13|||
163022670|NCT00373958|588786355|FG001|Infant Series|Withdrawal by Subject|15|||
163022671|NCT00373958|588786354|FG000|Infant Series|Failed to return|8|||
163022672|NCT00373958|588786355|FG001|Infant Series|Failed to return|13|||
163022673|NCT00373958|588786354|FG000|Infant Series|Lost to Follow-up|6|||
163022674|NCT00373958|588786355|FG001|Infant Series|Lost to Follow-up|5|||
163022675|NCT00373958|588786354|FG000|Infant Series|Protocol Violation|3|||
163022676|NCT00373958|588786355|FG001|Infant Series|Protocol Violation|7|||
163022677|NCT00373958|588786354|FG000|Infant Series|Lost Kaiser coverage|4|||
163022678|NCT00373958|588786355|FG001|Infant Series|Lost Kaiser coverage|0|||
163022679|NCT00373958|588786354|FG000|Infant Series|Child relocated|1|||
163022680|NCT00373958|588786355|FG001|Infant Series|Child relocated|0|||
163022681|NCT00373958|588786354|FG000|Infant Series|Consent was not received|1|||
163022682|NCT00373958|588786355|FG001|Infant Series|Consent was not received|0|||
163022683|NCT00373958|588786354|FG000|Infant Series|Adverse Event|3|||
163022684|NCT00373958|588786355|FG001|Infant Series|Adverse Event|1|||
163022685|NCT00373958|588786354|FG000|Infant Series|Physician Decision|1|||
163022686|NCT00373958|588786355|FG001|Infant Series|Physician Decision|1|||
163022687|NCT00373958|588786354|FG000|Toddler Dose|Lost to Follow-up|5|||
163022688|NCT00373958|588786355|FG001|Toddler Dose|Lost to Follow-up|8|||
163022689|NCT00373958|588786354|FG000|Toddler Dose|Withdrawal by Subject|2|||
163022690|NCT00373958|588786355|FG001|Toddler Dose|Withdrawal by Subject|2|||
163022691|NCT00373958|588786354|FG000|Toddler Dose|Failed to return|1|||
163022692|NCT00373958|588786355|FG001|Toddler Dose|Failed to return|2|||
163022693|NCT00373958|588786354|FG000|Toddler Dose|Protocol Violation|0|||
163022694|NCT00373958|588786355|FG001|Toddler Dose|Protocol Violation|1|||
163022695|NCT00373958|588786354|FG000|Toddler Dose|Withdrawn after infant series|22|||
163022696|NCT00373958|588786355|FG001|Toddler Dose|Withdrawn after infant series|25|||
163022697|NCT01552915|588786356|FG000|Overall Study|Adverse Event|3|||
163022698|NCT01552915|588786357|FG001|Overall Study|Adverse Event|14|||
163022699|NCT01552915|588786358|FG002|Overall Study|Adverse Event|3|||
163022700|NCT01552915|588786356|FG000|Overall Study|Lost to Follow-up|4|||
163022701|NCT01552915|588786357|FG001|Overall Study|Lost to Follow-up|6|||
163022702|NCT01552915|588786358|FG002|Overall Study|Lost to Follow-up|5|||
163022703|NCT01552915|588786356|FG000|Overall Study|Withdrawal by Subject|6|||
163022704|NCT01552915|588786357|FG001|Overall Study|Withdrawal by Subject|4|||
163022705|NCT01552915|588786358|FG002|Overall Study|Withdrawal by Subject|5|||
163022706|NCT01552915|588786356|FG000|Overall Study|Protocol Violation|0|||
163022707|NCT01552915|588786357|FG001|Overall Study|Protocol Violation|4|||
163022708|NCT01552915|588786358|FG002|Overall Study|Protocol Violation|4|||
163022709|NCT01552915|588786356|FG000|Overall Study|Lack of Efficacy|8|||
163022710|NCT01552915|588786357|FG001|Overall Study|Lack of Efficacy|1|||
163022711|NCT01552915|588786358|FG002|Overall Study|Lack of Efficacy|4|||
163022712|NCT01552915|588786356|FG000|Overall Study|Other|2|||
163022713|NCT01552915|588786357|FG001|Overall Study|Other|0|||
163022714|NCT01552915|588786358|FG002|Overall Study|Other|6|||
163022715|NCT00492648|588786361|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
163022716|NCT00492648|588786362|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
163064082|NCT03126110|588941552|FG007|Phase 2|Study terminated by the sponsor|0|||
163217290|NCT01030523|589512129|FG001|Initial Study (5 Years)|Implant failure|0|||
163217291|NCT01030523|589512128|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
163217292|NCT01030523|589512129|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
163217293|NCT01030523|589512128|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
163022717|NCT00282113|588786363|FG000|Overall Study|Removed at parents request|1|||
163022718|NCT00282113|588786364|FG001|Overall Study|Removed at parents request|0|||
163217294|NCT01030523|589512129|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
163022719|NCT00282113|588786365|FG002|Overall Study|Removed at parents request|0|||
163022720|NCT03382834|588786366|FG000|Step 1|Lost to Follow-up|0|||
163022721|NCT03382834|588786367|FG001|Step 1|Lost to Follow-up|1|||
163022722|NCT03382834|588786366|FG000|Step 2|Death|1|||
163022723|NCT03382834|588786367|FG001|Step 2|Death|0|||
163022724|NCT03382834|588786366|FG000|Step 2|Lost to Follow-up|2|||
163022725|NCT03382834|588786367|FG001|Step 2|Lost to Follow-up|2|||
163022726|NCT03382834|588786366|FG000|Step 2|Site Terminated by Sponsor|1|||
163022727|NCT03382834|588786367|FG001|Step 2|Site Terminated by Sponsor|0|||
163022728|NCT02387957|588786368|FG000|Overall Study|The study was discontinued|21|||
163022729|NCT02387957|588786369|FG001|Overall Study|The study was discontinued|21|||
163022730|NCT02387957|588786370|FG002|Overall Study|The study was discontinued|20|||
163022731|NCT02887248|588786371|FG000|Overall Study|Withdrawal by Subject|1|||
163022732|NCT02887248|588786371|FG000|Overall Study|Adverse Event|1|||
163022733|NCT02887248|588786371|FG000|Overall Study|Progressive Disease|1|||
163022734|NCT02294396|588786372|FG000|Overall Study|Adverse Event|26|||
163022735|NCT02294396|588786373|FG001|Overall Study|Adverse Event|25|||
163022736|NCT02294396|588786374|FG002|Overall Study|Adverse Event|21|||
163022737|NCT02294396|588786375|FG003|Overall Study|Adverse Event|24|||
163022738|NCT02294396|588786372|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
163022739|NCT02294396|588786373|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
163022740|NCT02294396|588786374|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
163022741|NCT02294396|588786375|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
163022742|NCT02294396|588786372|FG000|Overall Study|Withdrawal by Subject|8|||
163022743|NCT02294396|588786373|FG001|Overall Study|Withdrawal by Subject|6|||
163022744|NCT02294396|588786374|FG002|Overall Study|Withdrawal by Subject|6|||
163022745|NCT02294396|588786375|FG003|Overall Study|Withdrawal by Subject|8|||
163022746|NCT02294396|588786372|FG000|Overall Study|Lost to Follow-up|0|||
163022747|NCT02294396|588786373|FG001|Overall Study|Lost to Follow-up|0|||
163022748|NCT02294396|588786374|FG002|Overall Study|Lost to Follow-up|1|||
163022749|NCT02294396|588786375|FG003|Overall Study|Lost to Follow-up|1|||
163022750|NCT02294396|588786372|FG000|Overall Study|Protocol Deviation|3|||
163022751|NCT02294396|588786373|FG001|Overall Study|Protocol Deviation|2|||
163022752|NCT02294396|588786374|FG002|Overall Study|Protocol Deviation|2|||
163022753|NCT02294396|588786375|FG003|Overall Study|Protocol Deviation|1|||
163022754|NCT02294396|588786372|FG000|Overall Study|Miscellaneous|2|||
163022755|NCT02294396|588786373|FG001|Overall Study|Miscellaneous|0|||
163022756|NCT02294396|588786374|FG002|Overall Study|Miscellaneous|5|||
163022757|NCT02294396|588786375|FG003|Overall Study|Miscellaneous|2|||
163022758|NCT02120833|588786376|FG000|Overall Study|Adverse Event|1|||
163022759|NCT02120833|588786377|FG001|Overall Study|Adverse Event|0|||
163022760|NCT02120833|588786376|FG000|Overall Study|Withdrawal by Subject|2|||
163022761|NCT02120833|588786377|FG001|Overall Study|Withdrawal by Subject|0|||
163022762|NCT02120833|588786376|FG000|Overall Study|Lost to Follow-up|1|||
163022763|NCT02120833|588786377|FG001|Overall Study|Lost to Follow-up|1|||
163022764|NCT02438826|588786380|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
163022765|NCT02438826|588786381|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
163022766|NCT02438826|588786382|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
163022767|NCT02438826|588786383|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
163022768|NCT02438826|588786380|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
163022769|NCT02438826|588786381|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
163022770|NCT02438826|588786382|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
163022771|NCT02438826|588786383|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
163022772|NCT02438826|588786380|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
163022773|NCT02438826|588786381|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
163022774|NCT02438826|588786382|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
163022775|NCT02438826|588786383|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
163022776|NCT02438826|588786380|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
163022777|NCT02438826|588786381|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
163064083|NCT03126110|588941553|FG008|Phase 2|Study terminated by the sponsor|0|||
163064084|NCT03126110|588941554|FG009|Phase 2|Study terminated by the sponsor|0|||
163064085|NCT03126110|588941555|FG010|Phase 2|Study terminated by the sponsor|0|||
163064086|NCT03126110|588941556|FG011|Phase 2|Study terminated by the sponsor|0|||
163064087|NCT03126110|588941557|FG012|Phase 2|Study terminated by the sponsor|0|||
163217295|NCT01030523|589512128|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
163217296|NCT01030523|589512129|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
163217297|NCT01063764|589512132|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
163217298|NCT01063764|589512132|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
163022778|NCT02438826|588786382|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
163022779|NCT02438826|588786383|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
163022780|NCT02438826|588786380|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
163022781|NCT02438826|588786381|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
163022782|NCT02438826|588786382|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
163022783|NCT02438826|588786383|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
163022784|NCT02438826|588786380|FG000|Open-Label Treatment Phase|Adverse Event|11|||
163022785|NCT02438826|588786381|FG001|Open-Label Treatment Phase|Adverse Event|6|||
163022786|NCT02438826|588786382|FG002|Open-Label Treatment Phase|Adverse Event|0|||
163022787|NCT02438826|588786383|FG003|Open-Label Treatment Phase|Adverse Event|0|||
163022788|NCT02438826|588786380|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
163022789|NCT02438826|588786381|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
163022790|NCT02438826|588786382|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
163064088|NCT03126110|588941558|FG013|Phase 2|Study terminated by the sponsor|4|||
163022791|NCT02438826|588786383|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
163022792|NCT02438826|588786380|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
163022793|NCT02438826|588786381|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
163022794|NCT02438826|588786382|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
163022795|NCT02438826|588786383|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
163022796|NCT02438826|588786380|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
163022797|NCT02438826|588786381|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
163022798|NCT02438826|588786382|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
163022799|NCT02438826|588786383|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
163022800|NCT02438826|588786380|FG000|Post-Treatment Phase|Adverse Event|3|||
163022801|NCT02438826|588786381|FG001|Post-Treatment Phase|Adverse Event|0|||
163022802|NCT02438826|588786382|FG002|Post-Treatment Phase|Adverse Event|0|||
163022803|NCT02438826|588786383|FG003|Post-Treatment Phase|Adverse Event|0|||
163022804|NCT02438826|588786380|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
163022805|NCT02438826|588786381|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
163022806|NCT02438826|588786382|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
163022807|NCT02438826|588786383|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
163022808|NCT02438826|588786380|FG000|Post-Treatment Phase|Physician Decision|1|||
163022809|NCT02438826|588786381|FG001|Post-Treatment Phase|Physician Decision|0|||
163022810|NCT02438826|588786382|FG002|Post-Treatment Phase|Physician Decision|0|||
163022811|NCT02438826|588786383|FG003|Post-Treatment Phase|Physician Decision|0|||
163022812|NCT02438826|588786380|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
163022813|NCT02438826|588786381|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
163022814|NCT02438826|588786382|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
163022815|NCT02438826|588786383|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
163022816|NCT03429244|588786385|FG000|Overall Study|Withdrawal by Subject|2|||
163022817|NCT03429244|588786386|FG001|Overall Study|Withdrawal by Subject|1|||
163022818|NCT03429244|588786387|FG002|Overall Study|Withdrawal by Subject|1|||
163022819|NCT01500187|588786388|FG000|Overall Study|Lost to Follow-up|6|||
163022820|NCT01500187|588786389|FG001|Overall Study|Lost to Follow-up|0|||
163022821|NCT00586820|588786395|FG000|Overall Study|Unsuccessful PCI|1|||
163022822|NCT00586820|588786396|FG001|Overall Study|Unsuccessful PCI|0|||
163022823|NCT02073929|588786397|FG000|Overall Study|Lost to Follow-up|2|||
163022824|NCT02073929|588786398|FG001|Overall Study|Lost to Follow-up|1|||
163022825|NCT02073929|588786397|FG000|Overall Study|Adverse Event|2|||
163022826|NCT02073929|588786398|FG001|Overall Study|Adverse Event|1|||
163022827|NCT02073929|588786397|FG000|Overall Study|Withdrawal by Subject|0|||
163022828|NCT02073929|588786398|FG001|Overall Study|Withdrawal by Subject|1|||
163217299|NCT01063764|589512132|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
163217300|NCT01063764|589512132|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
163217301|NCT01063764|589512132|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
163022829|NCT00430573|588786399|FG000|Overall Study|Withdrawal by Subject|5|||
163022830|NCT01483027|588786402|FG000|Overall Study|Administrative Reasons|2|||
163022831|NCT01483027|588786403|FG001|Overall Study|Administrative Reasons|1|||
163022832|NCT01483027|588786402|FG000|Overall Study|Withdrawal by Subject|21|||
163022833|NCT01483027|588786403|FG001|Overall Study|Withdrawal by Subject|32|||
163022834|NCT01483027|588786402|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
163022835|NCT01483027|588786403|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
163022836|NCT01483027|588786402|FG000|Overall Study|Lost to Follow-up|1|||
163022837|NCT01483027|588786403|FG001|Overall Study|Lost to Follow-up|1|||
163022838|NCT01483027|588786402|FG000|Overall Study|Adverse Event|0|||
163022839|NCT01483027|588786403|FG001|Overall Study|Adverse Event|1|||
163022840|NCT01483027|588786402|FG000|Overall Study|Withdrawal by Subject|0|||
163022841|NCT01483027|588786403|FG001|Overall Study|Withdrawal by Subject|1|||
163022842|NCT04463251|588786408|FG000|Overall Study|Death|1|||
163022843|NCT04463251|588786409|FG001|Overall Study|Death|0|||
163022844|NCT04463251|588786410|FG002|Overall Study|Death|1|||
163022845|NCT04463251|588786408|FG000|Overall Study|Adverse Event|0|||
163022846|NCT04463251|588786409|FG001|Overall Study|Adverse Event|1|||
163022847|NCT04463251|588786410|FG002|Overall Study|Adverse Event|0|||
163022848|NCT04463251|588786408|FG000|Overall Study|Lost to Follow-up|0|||
163022849|NCT04463251|588786409|FG001|Overall Study|Lost to Follow-up|1|||
163217302|NCT01063764|589512132|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
163217303|NCT01063764|589512132|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
163022850|NCT04463251|588786410|FG002|Overall Study|Lost to Follow-up|0|||
163022851|NCT04463251|588786408|FG000|Overall Study|Withdrawal by Subject|0|||
163022852|NCT04463251|588786409|FG001|Overall Study|Withdrawal by Subject|2|||
163022853|NCT04463251|588786410|FG002|Overall Study|Withdrawal by Subject|2|||
163217304|NCT00697515|589512133|FG000|Dose Optimization Period|Adverse Event|4|||
163406345|NCT00391222|590196731|FG002|Period III (Double-Blind Treatment)|Other|6|||
163022854|NCT05020665|588786411|FG000|Overall Study|Study terminated by Sponsor|5|||
163022855|NCT05020665|588786412|FG001|Overall Study|Study terminated by Sponsor|4|||
163022856|NCT05020665|588786411|FG000|Overall Study|Death|2|||
163022857|NCT05020665|588786412|FG001|Overall Study|Death|1|||
163022858|NCT05020665|588786411|FG000|Overall Study|Physician Decision|0|||
163022859|NCT05020665|588786412|FG001|Overall Study|Physician Decision|1|||
163022860|NCT05020665|588786411|FG000|Overall Study|Withdrawal by Subject|0|||
163022861|NCT05020665|588786412|FG001|Overall Study|Withdrawal by Subject|1|||
163022862|NCT05020665|588786411|FG000|Overall Study|Reason not specified|1|||
163022863|NCT05020665|588786412|FG001|Overall Study|Reason not specified|0|||
163022864|NCT01743560|588786417|FG000|Overall Study|Disease progression|26|||
163022865|NCT01743560|588786417|FG000|Overall Study|Adverse Event|8|||
163022866|NCT01743560|588786417|FG000|Overall Study|Death|3|||
163022867|NCT01743560|588786417|FG000|Overall Study|Withdrawal by Subject|2|||
163022868|NCT01743560|588786417|FG000|Overall Study|Protocol Violation|1|||
163022869|NCT01743560|588786417|FG000|Overall Study|>1 dose of study drug|3|||
163022870|NCT01732640|588786423|FG000|Overall Study|Adverse Event|0|||
163022871|NCT01732640|588786424|FG001|Overall Study|Adverse Event|1|||
163022872|NCT01732640|588786423|FG000|Overall Study|Death|0|||
163022873|NCT01732640|588786424|FG001|Overall Study|Death|1|||
163022874|NCT00877487|588786427|FG000|Open-label Treatment Phase|Adverse Event|1|||
163022875|NCT00877487|588786428|FG001|Open-label Treatment Phase|Adverse Event|0|||
163022876|NCT00877487|588786427|FG000|Open-label Treatment Phase|Protocol Violation|3|||
163022877|NCT00877487|588786428|FG001|Open-label Treatment Phase|Protocol Violation|0|||
163022878|NCT00877487|588786427|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
163022879|NCT00877487|588786428|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
163022880|NCT00877487|588786427|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
163022881|NCT00877487|588786428|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
163022882|NCT00877487|588786427|FG000|Open-label Treatment Phase|Out of country for business|1|||
163022883|NCT00877487|588786428|FG001|Open-label Treatment Phase|Out of country for business|0|||
163022884|NCT00877487|588786427|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
163022885|NCT00877487|588786428|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
163022886|NCT00877487|588786427|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
163022887|NCT00877487|588786428|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
163022888|NCT00877487|588786427|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
163022889|NCT00877487|588786428|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
163022890|NCT00877487|588786427|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
163022891|NCT00877487|588786428|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
163022892|NCT03070002|588786429|FG000|Follow up for 2 Years|Death|1|||
163022893|NCT03425396|588786441|FG000|Overall Study|Lost to Follow-up|2|||
163022894|NCT03425396|588786442|FG001|Overall Study|Lost to Follow-up|5|||
163022895|NCT03425396|588786443|FG002|Overall Study|Lost to Follow-up|2|||
163022896|NCT03425396|588786444|FG003|Overall Study|Lost to Follow-up|0|||
163022897|NCT03425396|588786445|FG004|Overall Study|Lost to Follow-up|0|||
163022898|NCT03425396|588786441|FG000|Overall Study|Withdrawal by Subject|0|||
163022899|NCT03425396|588786442|FG001|Overall Study|Withdrawal by Subject|1|||
163022900|NCT03425396|588786443|FG002|Overall Study|Withdrawal by Subject|0|||
163022901|NCT03425396|588786444|FG003|Overall Study|Withdrawal by Subject|1|||
163022902|NCT03425396|588786445|FG004|Overall Study|Withdrawal by Subject|0|||
163022903|NCT03425396|588786441|FG000|Overall Study|Other|0|||
163022904|NCT03425396|588786442|FG001|Overall Study|Other|1|||
163022905|NCT03425396|588786443|FG002|Overall Study|Other|1|||
163022906|NCT03425396|588786444|FG003|Overall Study|Other|0|||
163022907|NCT03425396|588786445|FG004|Overall Study|Other|1|||
163022908|NCT00601172|588788615|FG000|Overall Study|Adverse Event|43|||
163022909|NCT00601172|588788616|FG001|Overall Study|Adverse Event|32|||
163022910|NCT00601172|588788615|FG000|Overall Study|Lack of Efficacy|11|||
163022911|NCT00601172|588788616|FG001|Overall Study|Lack of Efficacy|12|||
163022912|NCT00601172|588788615|FG000|Overall Study|Protocol Violation|2|||
163022913|NCT00601172|588788616|FG001|Overall Study|Protocol Violation|5|||
163022914|NCT00601172|588788615|FG000|Overall Study|Lost to Follow-up|4|||
163022915|NCT00601172|588788616|FG001|Overall Study|Lost to Follow-up|3|||
163022916|NCT00601172|588788615|FG000|Overall Study|Physician Decision|27|||
163022917|NCT00601172|588788616|FG001|Overall Study|Physician Decision|28|||
163022918|NCT00601172|588788615|FG000|Overall Study|Withdrawal by Subject|35|||
163022919|NCT00601172|588788616|FG001|Overall Study|Withdrawal by Subject|27|||
163022920|NCT00601172|588788615|FG000|Overall Study|Did not meet continuation criteria|19|||
163022921|NCT00601172|588788616|FG001|Overall Study|Did not meet continuation criteria|20|||
163022922|NCT04434469|588788620|FG000|Overall Study|Death|2|||
163022923|NCT04434469|588788621|FG001|Overall Study|Death|3|||
163022924|NCT04434469|588788622|FG002|Overall Study|Death|2|||
163022925|NCT04434469|588788623|FG003|Overall Study|Death|2|||
163022926|NCT04434469|588788624|FG004|Overall Study|Death|2|||
163022927|NCT04434469|588788625|FG005|Overall Study|Death|0|||
163022928|NCT04434469|588788620|FG000|Overall Study|Lost to Follow-up|0|||
163022929|NCT04434469|588788621|FG001|Overall Study|Lost to Follow-up|0|||
163022930|NCT04434469|588788622|FG002|Overall Study|Lost to Follow-up|0|||
163022931|NCT04434469|588788623|FG003|Overall Study|Lost to Follow-up|1|||
163022932|NCT04434469|588788624|FG004|Overall Study|Lost to Follow-up|1|||
163022933|NCT04434469|588788625|FG005|Overall Study|Lost to Follow-up|0|||
163022934|NCT04434469|588788620|FG000|Overall Study|Study terminated by sponsor|1|||
163022935|NCT04434469|588788621|FG001|Overall Study|Study terminated by sponsor|1|||
163022936|NCT04434469|588788622|FG002|Overall Study|Study terminated by sponsor|1|||
163022937|NCT04434469|588788623|FG003|Overall Study|Study terminated by sponsor|2|||
163022938|NCT04434469|588788624|FG004|Overall Study|Study terminated by sponsor|3|||
163022939|NCT04434469|588788625|FG005|Overall Study|Study terminated by sponsor|3|||
163022940|NCT04434469|588788620|FG000|Overall Study|Withdrawal by Subject|0|||
163022941|NCT04434469|588788621|FG001|Overall Study|Withdrawal by Subject|0|||
163022942|NCT04434469|588788622|FG002|Overall Study|Withdrawal by Subject|1|||
163022943|NCT04434469|588788623|FG003|Overall Study|Withdrawal by Subject|0|||
163022944|NCT04434469|588788624|FG004|Overall Study|Withdrawal by Subject|0|||
163022945|NCT04434469|588788625|FG005|Overall Study|Withdrawal by Subject|0|||
163022946|NCT01936181|588788629|FG000|Randomised, Double-blind|Adverse Event|27|||
163022947|NCT01936181|588788630|FG001|Randomised, Double-blind|Adverse Event|21|||
163022948|NCT01936181|588788631|FG002|Randomised, Double-blind|Adverse Event|0|||
163022949|NCT01936181|588788632|FG003|Randomised, Double-blind|Adverse Event|0|||
163022950|NCT01936181|588788629|FG000|Randomised, Double-blind|Protocol Violation|1|||
163022951|NCT01936181|588788630|FG001|Randomised, Double-blind|Protocol Violation|5|||
163022952|NCT01936181|588788631|FG002|Randomised, Double-blind|Protocol Violation|0|||
163022953|NCT01936181|588788632|FG003|Randomised, Double-blind|Protocol Violation|0|||
163022954|NCT01936181|588788629|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
163022955|NCT01936181|588788630|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
163022956|NCT01936181|588788631|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
163022957|NCT01936181|588788632|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
163022958|NCT01936181|588788629|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
163022959|NCT01936181|588788630|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
163022960|NCT01936181|588788631|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
163022961|NCT01936181|588788632|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
163022962|NCT01936181|588788629|FG000|Randomised, Double-blind|Pregnancy|0|||
163022963|NCT01936181|588788630|FG001|Randomised, Double-blind|Pregnancy|1|||
163022964|NCT01936181|588788631|FG002|Randomised, Double-blind|Pregnancy|0|||
163022965|NCT01936181|588788632|FG003|Randomised, Double-blind|Pregnancy|0|||
163022966|NCT01936181|588788629|FG000|Randomised, Double-blind|Physician Decision|4|||
163022967|NCT01936181|588788630|FG001|Randomised, Double-blind|Physician Decision|4|||
163022968|NCT01936181|588788631|FG002|Randomised, Double-blind|Physician Decision|0|||
163022969|NCT01936181|588788632|FG003|Randomised, Double-blind|Physician Decision|0|||
163022970|NCT01936181|588788629|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
163022971|NCT01936181|588788630|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
163022972|NCT01936181|588788631|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
163022973|NCT01936181|588788632|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
163022974|NCT01936181|588788629|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
163022975|NCT01936181|588788630|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
163022976|NCT01936181|588788631|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
163022977|NCT01936181|588788632|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
163022978|NCT01936181|588788629|FG000|Transition-extension|Adverse Event|3|||
163022979|NCT01936181|588788630|FG001|Transition-extension|Adverse Event|0|||
163022980|NCT01936181|588788631|FG002|Transition-extension|Adverse Event|3|||
163022981|NCT01936181|588788632|FG003|Transition-extension|Adverse Event|1|||
163022982|NCT01936181|588788629|FG000|Transition-extension|Lost to Follow-up|3|||
163022983|NCT01936181|588788630|FG001|Transition-extension|Lost to Follow-up|0|||
163022984|NCT01936181|588788631|FG002|Transition-extension|Lost to Follow-up|1|||
163022985|NCT01936181|588788632|FG003|Transition-extension|Lost to Follow-up|2|||
163022986|NCT01936181|588788629|FG000|Transition-extension|Physician Decision|2|||
163022987|NCT01936181|588788630|FG001|Transition-extension|Physician Decision|0|||
163022988|NCT01936181|588788631|FG002|Transition-extension|Physician Decision|0|||
163022989|NCT01936181|588788632|FG003|Transition-extension|Physician Decision|1|||
163022990|NCT01936181|588788629|FG000|Transition-extension|Withdrawal by Subject|7|||
163022991|NCT01936181|588788630|FG001|Transition-extension|Withdrawal by Subject|0|||
163022992|NCT01936181|588788631|FG002|Transition-extension|Withdrawal by Subject|2|||
163022993|NCT01936181|588788632|FG003|Transition-extension|Withdrawal by Subject|1|||
163022994|NCT01346189|588788633|FG000|Overall Study|Withdrawal by Subject|7|||
163022995|NCT01346189|588788634|FG001|Overall Study|Withdrawal by Subject|5|||
163022996|NCT01346189|588788635|FG002|Overall Study|Withdrawal by Subject|3|||
163064089|NCT03126110|588941559|FG014|Phase 2|Study terminated by the sponsor|0|||
163064090|NCT03126110|588941560|FG015|Phase 2|Study terminated by the sponsor|0|||
163064091|NCT03126110|588941561|FG016|Phase 2|Study terminated by the sponsor|0|||
163064092|NCT03126110|588941545|FG000|Phase 2|Withdrawal by Subject|0|||
163022997|NCT01346189|588788636|FG003|Overall Study|Withdrawal by Subject|5|||
163022998|NCT01346189|588788633|FG000|Overall Study|Physician Decision|4|||
163022999|NCT01346189|588788634|FG001|Overall Study|Physician Decision|0|||
163023000|NCT01346189|588788635|FG002|Overall Study|Physician Decision|0|||
163023001|NCT01346189|588788636|FG003|Overall Study|Physician Decision|0|||
163217305|NCT00697515|589512134|FG001|Dose Optimization Period|Adverse Event|0|||
163217306|NCT00697515|589512133|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
163217307|NCT00697515|589512134|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
163064093|NCT03126110|588941546|FG001|Phase 2|Withdrawal by Subject|0|||
163064094|NCT03126110|588941547|FG002|Phase 2|Withdrawal by Subject|0|||
163064095|NCT03126110|588941548|FG003|Phase 2|Withdrawal by Subject|0|||
163064096|NCT03126110|588941549|FG004|Phase 2|Withdrawal by Subject|0|||
163064097|NCT03126110|588941550|FG005|Phase 2|Withdrawal by Subject|0|||
163023002|NCT01346189|588788633|FG000|Overall Study|Moved|3|||
163023003|NCT01346189|588788634|FG001|Overall Study|Moved|0|||
163023004|NCT01346189|588788635|FG002|Overall Study|Moved|4|||
163023005|NCT01346189|588788636|FG003|Overall Study|Moved|0|||
163023006|NCT01346189|588788633|FG000|Overall Study|Other|2|||
163023007|NCT01346189|588788634|FG001|Overall Study|Other|4|||
163023008|NCT01346189|588788635|FG002|Overall Study|Other|7|||
163023009|NCT01346189|588788636|FG003|Overall Study|Other|3|||
163023010|NCT01346189|588788633|FG000|Overall Study|Death|0|||
163023011|NCT01346189|588788634|FG001|Overall Study|Death|3|||
163023012|NCT01346189|588788635|FG002|Overall Study|Death|0|||
163023013|NCT01346189|588788636|FG003|Overall Study|Death|0|||
163023014|NCT01346189|588788633|FG000|Overall Study|Non-health system primary care physician|0|||
163023015|NCT01346189|588788634|FG001|Overall Study|Non-health system primary care physician|5|||
163023016|NCT01346189|588788635|FG002|Overall Study|Non-health system primary care physician|0|||
163023017|NCT01346189|588788636|FG003|Overall Study|Non-health system primary care physician|0|||
163023018|NCT01346189|588788633|FG000|Overall Study|Travel|0|||
163023019|NCT01346189|588788634|FG001|Overall Study|Travel|0|||
163023020|NCT01346189|588788635|FG002|Overall Study|Travel|0|||
163023021|NCT01346189|588788636|FG003|Overall Study|Travel|3|||
163023022|NCT00900757|588788637|FG000|Overall Study|screen failure|19|||
163023023|NCT02005692|588788642|FG000|Overall Study|Protocol Violation|1|||
163023024|NCT02005692|588788642|FG000|Overall Study|Withdrawal by Subject|1|||
163023025|NCT02005692|588788642|FG000|Overall Study|Discharged earlier than anticipated|5|||
163023026|NCT00654875|588788643|FG000|Overall Study|Adverse Event|5|||
163023027|NCT00654875|588788644|FG001|Overall Study|Adverse Event|5|||
163023028|NCT00654875|588788643|FG000|Overall Study|Withdrawal by Subject|4|||
163023029|NCT00654875|588788644|FG001|Overall Study|Withdrawal by Subject|4|||
163023030|NCT00654875|588788643|FG000|Overall Study|Protocol Violation|3|||
163023031|NCT00654875|588788644|FG001|Overall Study|Protocol Violation|3|||
163023032|NCT00654875|588788643|FG000|Overall Study|Lack of Efficacy|2|||
163023033|NCT00654875|588788644|FG001|Overall Study|Lack of Efficacy|2|||
163023034|NCT00654875|588788643|FG000|Overall Study|Lost to Follow-up|1|||
163023035|NCT00654875|588788644|FG001|Overall Study|Lost to Follow-up|3|||
163064098|NCT03126110|588941551|FG006|Phase 2|Withdrawal by Subject|0|||
163064099|NCT03126110|588941552|FG007|Phase 2|Withdrawal by Subject|0|||
163064100|NCT03126110|588941553|FG008|Phase 2|Withdrawal by Subject|0|||
163064101|NCT03126110|588941554|FG009|Phase 2|Withdrawal by Subject|0|||
163064102|NCT03126110|588941555|FG010|Phase 2|Withdrawal by Subject|0|||
163064103|NCT03126110|588941556|FG011|Phase 2|Withdrawal by Subject|1|||
163064104|NCT03126110|588941557|FG012|Phase 2|Withdrawal by Subject|3|||
163064105|NCT03126110|588941558|FG013|Phase 2|Withdrawal by Subject|3|||
163064106|NCT03126110|588941559|FG014|Phase 2|Withdrawal by Subject|2|||
163064107|NCT03126110|588941560|FG015|Phase 2|Withdrawal by Subject|1|||
163064108|NCT03126110|588941561|FG016|Phase 2|Withdrawal by Subject|0|||
163064109|NCT03126110|588941545|FG000|Phase 2|Lost to Follow-up|0|||
163064110|NCT03126110|588941546|FG001|Phase 2|Lost to Follow-up|0|||
163064111|NCT03126110|588941547|FG002|Phase 2|Lost to Follow-up|0|||
163064112|NCT03126110|588941548|FG003|Phase 2|Lost to Follow-up|0|||
163064113|NCT03126110|588941549|FG004|Phase 2|Lost to Follow-up|0|||
163064114|NCT03126110|588941550|FG005|Phase 2|Lost to Follow-up|0|||
163217308|NCT00697515|589512133|FG000|Dose Optimization Period|Lost to Follow-up|2|||
163023036|NCT00654875|588788643|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
163023037|NCT00654875|588788644|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
163023038|NCT00654875|588788643|FG000|Overall Study|Administrative Problems|1|||
163023039|NCT00654875|588788644|FG001|Overall Study|Administrative Problems|0|||
163064115|NCT03126110|588941551|FG006|Phase 2|Lost to Follow-up|0|||
163064116|NCT03126110|588941552|FG007|Phase 2|Lost to Follow-up|0|||
163023040|NCT00723008|588788645|FG000|Enrollment|Lost to Follow-up|1|||
163023041|NCT00723008|588788646|FG001|Enrollment|Lost to Follow-up|0|||
163064117|NCT03126110|588941553|FG008|Phase 2|Lost to Follow-up|0|||
163064118|NCT03126110|588941554|FG009|Phase 2|Lost to Follow-up|0|||
163064119|NCT03126110|588941555|FG010|Phase 2|Lost to Follow-up|0|||
163064120|NCT03126110|588941556|FG011|Phase 2|Lost to Follow-up|1|||
163023042|NCT00723008|588788645|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
163023043|NCT00723008|588788646|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
163064121|NCT03126110|588941557|FG012|Phase 2|Lost to Follow-up|1|||
163064122|NCT03126110|588941558|FG013|Phase 2|Lost to Follow-up|1|||
163217309|NCT00697515|589512134|FG001|Dose Optimization Period|Lost to Follow-up|0|||
163217310|NCT00697515|589512133|FG000|Dose Optimization Period|sponsor request|2|||
163217311|NCT00697515|589512134|FG001|Dose Optimization Period|sponsor request|0|||
163217312|NCT00697515|589512133|FG000|Dose Optimization Period|called to active duty|1|||
163217313|NCT00697515|589512134|FG001|Dose Optimization Period|called to active duty|0|||
163217314|NCT00697515|589512133|FG000|Dose Optimization Period|elevated QTc|1|||
163217315|NCT00697515|589512134|FG001|Dose Optimization Period|elevated QTc|0|||
163330579|NCT00719888|589919117|FG000|Overall Study|Withdrawal by Subject|1|||
163330580|NCT00719888|589919118|FG001|Overall Study|Withdrawal by Subject|0|||
163330581|NCT00491894|589919119|FG000|Overall Study|Adverse Event|14|||
163330582|NCT00491894|589919119|FG000|Overall Study|Withdrawal by Subject|5|||
163023044|NCT00723008|588788645|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
163023045|NCT00723008|588788646|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
163023046|NCT00723008|588788645|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
163023047|NCT00723008|588788646|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
163023048|NCT00723008|588788645|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
163023049|NCT00723008|588788646|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
163023050|NCT00723008|588788645|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
163023051|NCT00723008|588788646|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
163023052|NCT05896527|588788648|FG000|Overall Study|Withdrawal by Subject|11|||
163023053|NCT05896527|588788649|FG001|Overall Study|Withdrawal by Subject|10|||
163023054|NCT05896527|588788650|FG002|Overall Study|Withdrawal by Subject|4|||
163023055|NCT05896527|588788651|FG003|Overall Study|Withdrawal by Subject|3|||
163023056|NCT05896527|588788652|FG004|Overall Study|Withdrawal by Subject|2|||
163023057|NCT05896527|588788648|FG000|Overall Study|Lost to Follow-up|0|||
163023058|NCT05896527|588788649|FG001|Overall Study|Lost to Follow-up|2|||
163023059|NCT05896527|588788650|FG002|Overall Study|Lost to Follow-up|2|||
163023060|NCT05896527|588788651|FG003|Overall Study|Lost to Follow-up|2|||
163023061|NCT05896527|588788652|FG004|Overall Study|Lost to Follow-up|1|||
163023062|NCT05896527|588788648|FG000|Overall Study|Significant protocol noncompliance|0|||
163023063|NCT05896527|588788649|FG001|Overall Study|Significant protocol noncompliance|1|||
163023064|NCT05896527|588788650|FG002|Overall Study|Significant protocol noncompliance|0|||
163023065|NCT05896527|588788651|FG003|Overall Study|Significant protocol noncompliance|0|||
163023066|NCT05896527|588788652|FG004|Overall Study|Significant protocol noncompliance|0|||
163023067|NCT05896527|588788648|FG000|Overall Study|Eligibility criteria not met|1|||
163023068|NCT05896527|588788649|FG001|Overall Study|Eligibility criteria not met|0|||
163023069|NCT05896527|588788650|FG002|Overall Study|Eligibility criteria not met|0|||
163023070|NCT05896527|588788651|FG003|Overall Study|Eligibility criteria not met|0|||
163023071|NCT05896527|588788652|FG004|Overall Study|Eligibility criteria not met|0|||
163023072|NCT05896527|588788648|FG000|Overall Study|Sponsor's decision|0|||
163023073|NCT05896527|588788649|FG001|Overall Study|Sponsor's decision|0|||
163023074|NCT05896527|588788650|FG002|Overall Study|Sponsor's decision|0|||
163023075|NCT05896527|588788651|FG003|Overall Study|Sponsor's decision|1|||
163023076|NCT05896527|588788652|FG004|Overall Study|Sponsor's decision|0|||
163023077|NCT05896527|588788648|FG000|Overall Study|Investigator's decision|0|||
163023078|NCT05896527|588788649|FG001|Overall Study|Investigator's decision|1|||
163023079|NCT05896527|588788650|FG002|Overall Study|Investigator's decision|0|||
163023080|NCT05896527|588788651|FG003|Overall Study|Investigator's decision|0|||
163023081|NCT05896527|588788652|FG004|Overall Study|Investigator's decision|0|||
163023082|NCT05896527|588788648|FG000|Overall Study|Pregnancy of his partner|0|||
163023083|NCT05896527|588788649|FG001|Overall Study|Pregnancy of his partner|0|||
163023084|NCT05896527|588788650|FG002|Overall Study|Pregnancy of his partner|0|||
163023085|NCT05896527|588788651|FG003|Overall Study|Pregnancy of his partner|1|||
163023086|NCT05896527|588788652|FG004|Overall Study|Pregnancy of his partner|0|||
163023087|NCT01279070|588788653|FG000|Overall Study|Withdrawal by Subject|2|||
163023088|NCT01279070|588788654|FG001|Overall Study|Withdrawal by Subject|3|||
163023089|NCT01279070|588788653|FG000|Overall Study|Acute exacerbation|3|||
163023090|NCT01279070|588788654|FG001|Overall Study|Acute exacerbation|1|||
163023091|NCT01014988|588788656|FG000|Overall Study|Adverse Event|20|||
163023092|NCT01014988|588788657|FG001|Overall Study|Adverse Event|0|||
163023093|NCT01014988|588788658|FG002|Overall Study|Adverse Event|1|||
163023094|NCT01014988|588788659|FG003|Overall Study|Adverse Event|0|||
163023095|NCT01014988|588788660|FG004|Overall Study|Adverse Event|1|||
163023096|NCT01014988|588788661|FG005|Overall Study|Adverse Event|3|||
163023097|NCT01014988|588788656|FG000|Overall Study|Lost to Follow-up|1|||
163023098|NCT01014988|588788657|FG001|Overall Study|Lost to Follow-up|0|||
163023099|NCT01014988|588788658|FG002|Overall Study|Lost to Follow-up|1|||
163330583|NCT00491894|589919119|FG000|Overall Study|Death|3|||
163330584|NCT00491894|589919119|FG000|Overall Study|Lost to Follow-up|3|||
163330585|NCT00491894|589919119|FG000|Overall Study|Lack of Efficacy|2|||
163023100|NCT01014988|588788659|FG003|Overall Study|Lost to Follow-up|0|||
163023101|NCT01014988|588788660|FG004|Overall Study|Lost to Follow-up|0|||
163330586|NCT00491894|589919119|FG000|Overall Study|Other-Failed to meet any criteria|2|||
163330587|NCT00491894|589919119|FG000|Overall Study|Physician Decision|2|||
163023102|NCT01014988|588788661|FG005|Overall Study|Lost to Follow-up|0|||
163023103|NCT01014988|588788656|FG000|Overall Study|Physician Decision|1|||
163023104|NCT01014988|588788657|FG001|Overall Study|Physician Decision|0|||
163023105|NCT01014988|588788658|FG002|Overall Study|Physician Decision|0|||
163023106|NCT01014988|588788659|FG003|Overall Study|Physician Decision|0|||
163023107|NCT01014988|588788660|FG004|Overall Study|Physician Decision|0|||
163023108|NCT01014988|588788661|FG005|Overall Study|Physician Decision|0|||
163023109|NCT01014988|588788656|FG000|Overall Study|Withdrawal by Subject|1|||
163023110|NCT01014988|588788657|FG001|Overall Study|Withdrawal by Subject|0|||
163023111|NCT01014988|588788658|FG002|Overall Study|Withdrawal by Subject|0|||
163023112|NCT01014988|588788659|FG003|Overall Study|Withdrawal by Subject|0|||
163023113|NCT01014988|588788660|FG004|Overall Study|Withdrawal by Subject|0|||
163023114|NCT01014988|588788661|FG005|Overall Study|Withdrawal by Subject|0|||
163023115|NCT05835011|588788662|FG000|Overall Study|Study Terminated by the Sponsor|1|||
163217316|NCT00697515|589512133|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
163217317|NCT00697515|589512134|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
163217318|NCT00697515|589512133|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
163217319|NCT00697515|589512134|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
163217320|NCT00697515|589512133|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
163217321|NCT00697515|589512134|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
163217322|NCT00697515|589512133|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
163217323|NCT00697515|589512134|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
163217324|NCT05954052|589512135|FG000|Overall Study|Adverse Event|1|||
163217325|NCT01957462|589512136|FG000|Test Period 1|Withdrawal by Subject|1|||
163217326|NCT01957462|589512137|FG001|Test Period 1|Withdrawal by Subject|0|||
163217327|NCT01957462|589512136|FG000|Test Period 1|Adverse Event|1|||
163217328|NCT01957462|589512137|FG001|Test Period 1|Adverse Event|0|||
163217329|NCT03102918|589512138|FG000|Overall Study|Protocol Violation|1|||
163217330|NCT03102918|589512139|FG001|Overall Study|Protocol Violation|0|||
163217331|NCT04765358|589512140|FG000|Overall Study|Withdrawal by Subject|1|||
163217332|NCT02419742|589512141|FG000|Overall Study|Adverse Event|2|||
163217333|NCT02419742|589512142|FG001|Overall Study|Adverse Event|0|||
163217334|NCT02419742|589512141|FG000|Overall Study|Disease Progression|0|||
163217335|NCT02419742|589512142|FG001|Overall Study|Disease Progression|1|||
163217336|NCT02419742|589512141|FG000|Overall Study|Withdrew Consent|2|||
163217337|NCT02419742|589512142|FG001|Overall Study|Withdrew Consent|1|||
163217338|NCT02419742|589512141|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
163217339|NCT02419742|589512142|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
163217340|NCT04519645|589512145|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
163217341|NCT04519645|589512146|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
163217342|NCT04519645|589512147|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
163217343|NCT04519645|589512145|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
163217344|NCT04519645|589512146|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
163023116|NCT05835011|588788662|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
163023117|NCT01683266|588788665|FG000|Overall Study|Adverse Event|5|||
163023118|NCT01683266|588788666|FG001|Overall Study|Adverse Event|4|||
163023119|NCT01683266|588788665|FG000|Overall Study|Lack of Efficacy|5|||
163023120|NCT01683266|588788666|FG001|Overall Study|Lack of Efficacy|2|||
163023121|NCT01683266|588788665|FG000|Overall Study|Protocol Violation|13|||
163023122|NCT01683266|588788666|FG001|Overall Study|Protocol Violation|6|||
163023123|NCT01683266|588788665|FG000|Overall Study|Personal Reason|17|||
163023124|NCT01683266|588788666|FG001|Overall Study|Personal Reason|25|||
163023125|NCT01683266|588788665|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
163023126|NCT01683266|588788666|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
163023127|NCT01683266|588788665|FG000|Overall Study|Lost to Follow-up|5|||
163023128|NCT01683266|588788666|FG001|Overall Study|Lost to Follow-up|0|||
163023129|NCT01683266|588788665|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
163023130|NCT01683266|588788666|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
163023131|NCT01683266|588788665|FG000|Overall Study|Nonserious Hypoglycemia|0|||
163023132|NCT01683266|588788666|FG001|Overall Study|Nonserious Hypoglycemia|3|||
163023133|NCT01683266|588788665|FG000|Overall Study|Perceived Lack of Efficacy|1|||
163023134|NCT01683266|588788666|FG001|Overall Study|Perceived Lack of Efficacy|1|||
163023135|NCT01683266|588788665|FG000|Overall Study|Possibly Hypoglycemia|1|||
163023136|NCT01683266|588788666|FG001|Overall Study|Possibly Hypoglycemia|0|||
163023137|NCT01683266|588788665|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
163023138|NCT01683266|588788666|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
163023139|NCT02222545|588788667|FG000|Overall Study|Adverse Event|1|||
163023140|NCT02222545|588788668|FG001|Overall Study|Adverse Event|0|||
163023141|NCT02222545|588788669|FG002|Overall Study|Adverse Event|2|||
163023142|NCT02222545|588788667|FG000|Overall Study|Death|0|||
163023143|NCT02222545|588788668|FG001|Overall Study|Death|0|||
163023144|NCT02222545|588788669|FG002|Overall Study|Death|9|||
163023145|NCT02222545|588788667|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
163023146|NCT02222545|588788668|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
163023147|NCT02222545|588788669|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
163023148|NCT02222545|588788667|FG000|Overall Study|Withdrawal by Subject|0|||
163023149|NCT02222545|588788668|FG001|Overall Study|Withdrawal by Subject|0|||
163023150|NCT02222545|588788669|FG002|Overall Study|Withdrawal by Subject|3|||
163217345|NCT04519645|589512147|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
163217346|NCT04519645|589512145|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
163217347|NCT04519645|589512146|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
163330588|NCT00491894|589919119|FG000|Overall Study|Protocol Violation|2|||
163330589|NCT00491894|589919119|FG000|Overall Study|Other-Intake of prohibited medication|1|||
163330590|NCT05422339|589920598|FG000|Overall Study|Withdrawal by Subject|17|||
163330591|NCT05422339|589920599|FG001|Overall Study|Withdrawal by Subject|15|||
163330592|NCT01278030|589920606|FG000|Overall Study|Withdrawal by Subject|8|||
163023151|NCT02222545|588788667|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
163023152|NCT02222545|588788668|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
163023153|NCT02222545|588788669|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
163023154|NCT00090220|588788670|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
163023155|NCT00090220|588788671|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
163023156|NCT00090220|588788672|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
163023157|NCT00090220|588788673|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
163023158|NCT00090220|588788674|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
163023159|NCT00090220|588788675|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
163023160|NCT00090220|588788670|FG000|Base Study Vaccination Period|Adverse Event|6|||
163023161|NCT00090220|588788671|FG001|Base Study Vaccination Period|Adverse Event|1|||
163023162|NCT00090220|588788672|FG002|Base Study Vaccination Period|Adverse Event|0|||
163023163|NCT00090220|588788673|FG003|Base Study Vaccination Period|Adverse Event|0|||
163023164|NCT00090220|588788674|FG004|Base Study Vaccination Period|Adverse Event|0|||
163023165|NCT00090220|588788675|FG005|Base Study Vaccination Period|Adverse Event|0|||
163023166|NCT00090220|588788670|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
163023167|NCT00090220|588788671|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
163023168|NCT00090220|588788672|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
163023169|NCT00090220|588788673|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
163023170|NCT00090220|588788674|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
163023171|NCT00090220|588788675|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
163023172|NCT00090220|588788670|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
163023173|NCT00090220|588788671|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
163023174|NCT00090220|588788672|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
163023175|NCT00090220|588788673|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
163023176|NCT00090220|588788674|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
163023177|NCT00090220|588788675|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
163023178|NCT00090220|588788670|FG000|Base Study Vaccination Period|Patient Moved|6|||
163023179|NCT00090220|588788671|FG001|Base Study Vaccination Period|Patient Moved|2|||
163023180|NCT00090220|588788672|FG002|Base Study Vaccination Period|Patient Moved|0|||
163023181|NCT00090220|588788673|FG003|Base Study Vaccination Period|Patient Moved|0|||
163023182|NCT00090220|588788674|FG004|Base Study Vaccination Period|Patient Moved|0|||
163023183|NCT00090220|588788675|FG005|Base Study Vaccination Period|Patient Moved|0|||
163023184|NCT00090220|588788670|FG000|Base Study Vaccination Period|Other|4|||
163023185|NCT00090220|588788671|FG001|Base Study Vaccination Period|Other|4|||
163023186|NCT00090220|588788672|FG002|Base Study Vaccination Period|Other|0|||
163023187|NCT00090220|588788673|FG003|Base Study Vaccination Period|Other|0|||
163023188|NCT00090220|588788674|FG004|Base Study Vaccination Period|Other|0|||
163023189|NCT00090220|588788675|FG005|Base Study Vaccination Period|Other|0|||
163023190|NCT00090220|588788670|FG000|Base Study Follow-up Period|Adverse Event|6|||
163023191|NCT00090220|588788671|FG001|Base Study Follow-up Period|Adverse Event|1|||
163023192|NCT00090220|588788672|FG002|Base Study Follow-up Period|Adverse Event|0|||
163023193|NCT00090220|588788673|FG003|Base Study Follow-up Period|Adverse Event|0|||
163023194|NCT00090220|588788674|FG004|Base Study Follow-up Period|Adverse Event|0|||
163023195|NCT00090220|588788675|FG005|Base Study Follow-up Period|Adverse Event|0|||
163023196|NCT00090220|588788670|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
163023197|NCT00090220|588788671|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
163023198|NCT00090220|588788672|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
163023199|NCT00090220|588788673|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
163023200|NCT00090220|588788674|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
163023201|NCT00090220|588788675|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
163023202|NCT00090220|588788670|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
163023203|NCT00090220|588788671|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
163023204|NCT00090220|588788672|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
163023205|NCT00090220|588788673|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
163023206|NCT00090220|588788674|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
163023207|NCT00090220|588788675|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
163023208|NCT00090220|588788670|FG000|Base Study Follow-up Period|Patient Moved|20|||
163023209|NCT00090220|588788671|FG001|Base Study Follow-up Period|Patient Moved|28|||
163023210|NCT00090220|588788672|FG002|Base Study Follow-up Period|Patient Moved|0|||
163023211|NCT00090220|588788673|FG003|Base Study Follow-up Period|Patient Moved|0|||
163023212|NCT00090220|588788674|FG004|Base Study Follow-up Period|Patient Moved|0|||
163023213|NCT00090220|588788675|FG005|Base Study Follow-up Period|Patient Moved|0|||
163023214|NCT00090220|588788670|FG000|Base Study Follow-up Period|Other|19|||
163023215|NCT00090220|588788671|FG001|Base Study Follow-up Period|Other|21|||
163330593|NCT01278030|589920607|FG001|Overall Study|Withdrawal by Subject|4|||
163330594|NCT05815342|589920612|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
163023216|NCT00090220|588788672|FG002|Base Study Follow-up Period|Other|0|||
163023217|NCT00090220|588788673|FG003|Base Study Follow-up Period|Other|0|||
163023218|NCT00090220|588788674|FG004|Base Study Follow-up Period|Other|0|||
163023219|NCT00090220|588788675|FG005|Base Study Follow-up Period|Other|0|||
163023220|NCT00090220|588788670|FG000|Extension 1 (EXT1)|Adverse Event|0|||
163023221|NCT00090220|588788671|FG001|Extension 1 (EXT1)|Adverse Event|0|||
163023222|NCT00090220|588788672|FG002|Extension 1 (EXT1)|Adverse Event|4|||
163023223|NCT00090220|588788673|FG003|Extension 1 (EXT1)|Adverse Event|0|||
163023224|NCT00090220|588788674|FG004|Extension 1 (EXT1)|Adverse Event|0|||
163023225|NCT00090220|588788675|FG005|Extension 1 (EXT1)|Adverse Event|0|||
163023226|NCT00090220|588788670|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
163023227|NCT00090220|588788671|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
163023228|NCT00090220|588788672|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
163023229|NCT00090220|588788673|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
163023230|NCT00090220|588788674|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
163023231|NCT00090220|588788675|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
163023232|NCT00090220|588788670|FG000|Extension 1 (EXT1)|Moved|0|||
163023233|NCT00090220|588788671|FG001|Extension 1 (EXT1)|Moved|0|||
163023234|NCT00090220|588788672|FG002|Extension 1 (EXT1)|Moved|2|||
163023235|NCT00090220|588788673|FG003|Extension 1 (EXT1)|Moved|1|||
163023236|NCT00090220|588788674|FG004|Extension 1 (EXT1)|Moved|0|||
163023237|NCT00090220|588788675|FG005|Extension 1 (EXT1)|Moved|0|||
163023238|NCT00090220|588788670|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
163023239|NCT00090220|588788671|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
163023240|NCT00090220|588788672|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
163023241|NCT00090220|588788673|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
163023242|NCT00090220|588788674|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
163023243|NCT00090220|588788675|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
163023244|NCT00090220|588788670|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
163023245|NCT00090220|588788671|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
163023246|NCT00090220|588788672|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
163023247|NCT00090220|588788673|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
163023248|NCT00090220|588788674|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
163023249|NCT00090220|588788675|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
163023250|NCT00090220|588788670|FG000|Extension 1 (EXT1)|Other reason|0|||
163023251|NCT00090220|588788671|FG001|Extension 1 (EXT1)|Other reason|0|||
163023252|NCT00090220|588788672|FG002|Extension 1 (EXT1)|Other reason|2|||
163023253|NCT00090220|588788673|FG003|Extension 1 (EXT1)|Other reason|0|||
163023254|NCT00090220|588788674|FG004|Extension 1 (EXT1)|Other reason|0|||
163023255|NCT00090220|588788675|FG005|Extension 1 (EXT1)|Other reason|0|||
163023256|NCT00090220|588788670|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
163023257|NCT00090220|588788671|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
163023258|NCT00090220|588788672|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
163023259|NCT00090220|588788673|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
163023260|NCT00090220|588788674|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
163023261|NCT00090220|588788675|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
163023262|NCT00090220|588788670|FG000|Long-term Follow-up (EXT2)|Death|0|||
163023263|NCT00090220|588788671|FG001|Long-term Follow-up (EXT2)|Death|0|||
163023264|NCT00090220|588788672|FG002|Long-term Follow-up (EXT2)|Death|0|||
163023265|NCT00090220|588788673|FG003|Long-term Follow-up (EXT2)|Death|0|||
163023266|NCT00090220|588788674|FG004|Long-term Follow-up (EXT2)|Death|1|||
163023267|NCT00090220|588788675|FG005|Long-term Follow-up (EXT2)|Death|1|||
163023268|NCT00090220|588788670|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
163023269|NCT00090220|588788671|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
163023270|NCT00090220|588788672|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
163023271|NCT00090220|588788673|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
163023272|NCT00090220|588788674|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
163023273|NCT00090220|588788675|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
163023274|NCT00090220|588788670|FG000|Long-term Follow-up (EXT2)|Other|0|||
163023275|NCT00090220|588788671|FG001|Long-term Follow-up (EXT2)|Other|0|||
163023276|NCT00090220|588788672|FG002|Long-term Follow-up (EXT2)|Other|0|||
163023277|NCT00090220|588788673|FG003|Long-term Follow-up (EXT2)|Other|0|||
163023278|NCT00090220|588788674|FG004|Long-term Follow-up (EXT2)|Other|1|||
163330595|NCT05815342|589920612|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
163023279|NCT00090220|588788675|FG005|Long-term Follow-up (EXT2)|Other|0|||
163023280|NCT00941863|588788676|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
163023281|NCT00941863|588788677|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
163023282|NCT00941863|588788678|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
163023283|NCT00941863|588788679|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
163023284|NCT00941863|588788680|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
163023285|NCT00941863|588788676|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
163023286|NCT00941863|588788677|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
163023287|NCT00941863|588788678|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
163023288|NCT00941863|588788679|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
163023289|NCT00941863|588788680|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
163023290|NCT00941863|588788676|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
163023291|NCT00941863|588788677|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
163023292|NCT00941863|588788678|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
163023293|NCT00941863|588788679|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
163023294|NCT00941863|588788680|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
163023295|NCT00941863|588788676|FG000|Until Primary Completion Date (PCD)|Death|0|||
163023296|NCT00941863|588788677|FG001|Until Primary Completion Date (PCD)|Death|0|||
163023297|NCT00941863|588788678|FG002|Until Primary Completion Date (PCD)|Death|1|||
163023298|NCT00941863|588788679|FG003|Until Primary Completion Date (PCD)|Death|2|||
163023299|NCT00941863|588788680|FG004|Until Primary Completion Date (PCD)|Death|7|||
163023300|NCT00941863|588788676|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
163023301|NCT00941863|588788677|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
163023302|NCT00941863|588788678|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
163023303|NCT00941863|588788679|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
163023304|NCT00941863|588788680|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
163023305|NCT00941863|588788676|FG000|Continued After PCD|Withdrawal by Subject|0|||
163023306|NCT00941863|588788677|FG001|Continued After PCD|Withdrawal by Subject|0|||
163023307|NCT00941863|588788678|FG002|Continued After PCD|Withdrawal by Subject|0|||
163023308|NCT00941863|588788679|FG003|Continued After PCD|Withdrawal by Subject|0|||
163023309|NCT00941863|588788680|FG004|Continued After PCD|Withdrawal by Subject|1|||
163023310|NCT00941863|588788676|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
163023311|NCT00941863|588788677|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
163023312|NCT00941863|588788678|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
163023313|NCT00941863|588788679|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
163023314|NCT00941863|588788680|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
163023315|NCT02651155|588788683|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
163023316|NCT02651155|588788684|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
163023317|NCT02651155|588788683|FG000|Overall Study|Voluntary Withdrawal|5|||
163023318|NCT02651155|588788684|FG001|Overall Study|Voluntary Withdrawal|0|||
163023319|NCT01867710|588788685|FG000|Overall Study|Death|25|||
163023320|NCT01867710|588788686|FG001|Overall Study|Death|15|||
163023321|NCT01867710|588788687|FG002|Overall Study|Death|27|||
163023322|NCT01867710|588788688|FG003|Overall Study|Death|20|||
163023323|NCT01867710|588788685|FG000|Overall Study|Lost to Follow-up|3|||
163023324|NCT01867710|588788686|FG001|Overall Study|Lost to Follow-up|4|||
163023325|NCT01867710|588788687|FG002|Overall Study|Lost to Follow-up|3|||
163023326|NCT01867710|588788688|FG003|Overall Study|Lost to Follow-up|2|||
163023327|NCT01867710|588788685|FG000|Overall Study|Withdrawal of consent|2|||
163023328|NCT01867710|588788686|FG001|Overall Study|Withdrawal of consent|5|||
163023329|NCT01867710|588788687|FG002|Overall Study|Withdrawal of consent|1|||
163023330|NCT01867710|588788688|FG003|Overall Study|Withdrawal of consent|2|||
163023331|NCT01867710|588788685|FG000|Overall Study|Study Terminated by Sponsor|9|||
163023332|NCT01867710|588788686|FG001|Overall Study|Study Terminated by Sponsor|13|||
163023333|NCT01867710|588788687|FG002|Overall Study|Study Terminated by Sponsor|8|||
163023334|NCT01867710|588788688|FG003|Overall Study|Study Terminated by Sponsor|16|||
163023335|NCT01867710|588788685|FG000|Overall Study|Biochemical progression|0|||
163023336|NCT01867710|588788686|FG001|Overall Study|Biochemical progression|1|||
163023337|NCT01867710|588788687|FG002|Overall Study|Biochemical progression|0|||
163023338|NCT01867710|588788688|FG003|Overall Study|Biochemical progression|0|||
163023339|NCT01867710|588788685|FG000|Overall Study|Clinical progression|0|||
163023340|NCT01867710|588788686|FG001|Overall Study|Clinical progression|0|||
163023341|NCT01867710|588788687|FG002|Overall Study|Clinical progression|1|||
163023342|NCT01867710|588788688|FG003|Overall Study|Clinical progression|0|||
163023343|NCT01867710|588788685|FG000|Overall Study|Disease progression|1|||
163023344|NCT01867710|588788686|FG001|Overall Study|Disease progression|0|||
163023345|NCT01867710|588788687|FG002|Overall Study|Disease progression|0|||
163023346|NCT01867710|588788688|FG003|Overall Study|Disease progression|0|||
163023347|NCT01867710|588788685|FG000|Overall Study|Patient decision|0|||
163023348|NCT01867710|588788686|FG001|Overall Study|Patient decision|0|||
163217348|NCT04519645|589512147|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
163023349|NCT01867710|588788687|FG002|Overall Study|Patient decision|0|||
163023350|NCT01867710|588788688|FG003|Overall Study|Patient decision|1|||
163023351|NCT01867710|588788685|FG000|Overall Study|Patient to follow subsequent treatment|0|||
163023352|NCT01867710|588788686|FG001|Overall Study|Patient to follow subsequent treatment|1|||
163023353|NCT01867710|588788687|FG002|Overall Study|Patient to follow subsequent treatment|0|||
163023354|NCT01867710|588788688|FG003|Overall Study|Patient to follow subsequent treatment|0|||
163023355|NCT01867710|588788685|FG000|Overall Study|Progressive disease|1|||
163023356|NCT01867710|588788686|FG001|Overall Study|Progressive disease|0|||
163023357|NCT01867710|588788687|FG002|Overall Study|Progressive disease|0|||
163217349|NCT04519645|589512145|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
163217350|NCT04519645|589512146|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
163217351|NCT04519645|589512147|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
163217352|NCT05517382|589512156|FG000|Overall Study|Lost to Follow-up|0|||
163023358|NCT01867710|588788688|FG003|Overall Study|Progressive disease|0|||
163023359|NCT01867710|588788685|FG000|Overall Study|Protocol Violation|0|||
163023360|NCT01867710|588788686|FG001|Overall Study|Protocol Violation|0|||
163023361|NCT01867710|588788687|FG002|Overall Study|Protocol Violation|0|||
163023362|NCT01867710|588788688|FG003|Overall Study|Protocol Violation|1|||
163023363|NCT01867710|588788685|FG000|Overall Study|PSA-progression|0|||
163023364|NCT01867710|588788686|FG001|Overall Study|PSA-progression|1|||
163023365|NCT01867710|588788687|FG002|Overall Study|PSA-progression|0|||
163023366|NCT01867710|588788688|FG003|Overall Study|PSA-progression|0|||
163023367|NCT01867710|588788685|FG000|Overall Study|Study medication no longer effective|0|||
163023368|NCT01867710|588788686|FG001|Overall Study|Study medication no longer effective|1|||
163023369|NCT01867710|588788687|FG002|Overall Study|Study medication no longer effective|0|||
163023370|NCT01867710|588788688|FG003|Overall Study|Study medication no longer effective|0|||
163023371|NCT05113979|588788689|FG000|Overall Study|Death|2|||
163023372|NCT05113979|588788689|FG000|Overall Study|Lost to Follow-up|1|||
163023373|NCT00976820|588788690|FG000|Overall Study|Lost to Follow-up|5|||
163330596|NCT05815342|589920612|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
163330597|NCT05815342|589920612|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
163330598|NCT05815342|589920612|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
163023374|NCT00976820|588788691|FG001|Overall Study|Lost to Follow-up|16|||
163023375|NCT00976820|588788692|FG002|Overall Study|Lost to Follow-up|2|||
163023376|NCT00976820|588788693|FG003|Overall Study|Lost to Follow-up|3|||
163023377|NCT00976820|588788690|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
163023378|NCT00976820|588788691|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
163023379|NCT00976820|588788692|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
163023380|NCT00976820|588788693|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
163023381|NCT00976820|588788690|FG000|Overall Study|Withdrawal by Subject|2|||
163023382|NCT00976820|588788691|FG001|Overall Study|Withdrawal by Subject|4|||
163023383|NCT00976820|588788692|FG002|Overall Study|Withdrawal by Subject|1|||
163023384|NCT00976820|588788693|FG003|Overall Study|Withdrawal by Subject|4|||
163023385|NCT02048826|588788694|FG000|Overall Study|Withdrawal by Subject|1|||
163023386|NCT02048826|588788695|FG001|Overall Study|Withdrawal by Subject|0|||
163023387|NCT00526669|588788696|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
163023388|NCT00526669|588788697|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
163023389|NCT00526669|588788696|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
163023390|NCT00526669|588788697|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
163023391|NCT00526669|588788696|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
163023392|NCT00526669|588788697|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
163023393|NCT00526669|588788696|FG000|Combined Treatment Phase|Death|0|||
163023394|NCT00526669|588788697|FG001|Combined Treatment Phase|Death|2|||
163023395|NCT00968981|588788698|FG000|Overall Study|Adverse Event|2|||
163023396|NCT00968981|588788699|FG001|Overall Study|Adverse Event|0|||
163023397|NCT00968981|588788700|FG002|Overall Study|Adverse Event|0|||
163023398|NCT00968981|588788698|FG000|Overall Study|Disease Progression|14|||
163023399|NCT00968981|588788699|FG001|Overall Study|Disease Progression|16|||
163023400|NCT00968981|588788700|FG002|Overall Study|Disease Progression|13|||
163023401|NCT00968981|588788698|FG000|Overall Study|Lost to Follow-up|0|||
163023402|NCT00968981|588788699|FG001|Overall Study|Lost to Follow-up|0|||
163023403|NCT00968981|588788700|FG002|Overall Study|Lost to Follow-up|1|||
163064123|NCT03126110|588941559|FG014|Phase 2|Lost to Follow-up|2|||
163064124|NCT03126110|588941560|FG015|Phase 2|Lost to Follow-up|0|||
163064125|NCT03126110|588941561|FG016|Phase 2|Lost to Follow-up|0|||
163064126|NCT03126110|588941545|FG000|Phase 2|Death|0|||
163064127|NCT03126110|588941546|FG001|Phase 2|Death|0|||
163064128|NCT03126110|588941547|FG002|Phase 2|Death|0|||
163064129|NCT03126110|588941548|FG003|Phase 2|Death|0|||
163330599|NCT01555138|589920613|FG000|Overall Study|Death|0|||
163330600|NCT01555138|589920614|FG001|Overall Study|Death|1|||
163023404|NCT00968981|588788698|FG000|Overall Study|Physician Decision|5|||
163023405|NCT00968981|588788699|FG001|Overall Study|Physician Decision|3|||
163023406|NCT00968981|588788700|FG002|Overall Study|Physician Decision|5|||
163023407|NCT00968981|588788698|FG000|Overall Study|Withdrawal by Subject|1|||
163064130|NCT03126110|588941549|FG004|Phase 2|Death|0|||
163064131|NCT03126110|588941550|FG005|Phase 2|Death|0|||
163023408|NCT00968981|588788699|FG001|Overall Study|Withdrawal by Subject|3|||
163064132|NCT03126110|588941551|FG006|Phase 2|Death|0|||
163064133|NCT03126110|588941552|FG007|Phase 2|Death|0|||
163064134|NCT03126110|588941553|FG008|Phase 2|Death|0|||
163330601|NCT01555138|589920613|FG000|Overall Study|Lost to Follow-up|1|||
163023409|NCT00968981|588788700|FG002|Overall Study|Withdrawal by Subject|3|||
163064135|NCT03126110|588941554|FG009|Phase 2|Death|0|||
163330602|NCT01555138|589920614|FG001|Overall Study|Lost to Follow-up|0|||
163330603|NCT01555138|589920613|FG000|Overall Study|Abnormal Lab reults|1|||
163023410|NCT01489254|588788711|FG000|Double-blind Part|Adverse Event|7|||
163023411|NCT01489254|588788712|FG001|Double-blind Part|Adverse Event|2|||
163023412|NCT01489254|588788713|FG002|Double-blind Part|Adverse Event|2|||
163023413|NCT01489254|588788714|FG003|Double-blind Part|Adverse Event|0|||
163064136|NCT03126110|588941555|FG010|Phase 2|Death|0|||
163064137|NCT03126110|588941556|FG011|Phase 2|Death|6|||
163064138|NCT03126110|588941557|FG012|Phase 2|Death|12|||
163023414|NCT01489254|588788711|FG000|Double-blind Part|Pregnancy|1|||
163023415|NCT01489254|588788712|FG001|Double-blind Part|Pregnancy|3|||
163023416|NCT01489254|588788713|FG002|Double-blind Part|Pregnancy|0|||
163023417|NCT01489254|588788714|FG003|Double-blind Part|Pregnancy|0|||
163023418|NCT01489254|588788711|FG000|Double-blind Part|Withdrawal by Subject|12|||
163023419|NCT01489254|588788712|FG001|Double-blind Part|Withdrawal by Subject|20|||
163023420|NCT01489254|588788713|FG002|Double-blind Part|Withdrawal by Subject|1|||
163023421|NCT01489254|588788714|FG003|Double-blind Part|Withdrawal by Subject|0|||
163023422|NCT01489254|588788711|FG000|Double-blind Part|Lost to Follow-up|1|||
163023423|NCT01489254|588788712|FG001|Double-blind Part|Lost to Follow-up|2|||
163023424|NCT01489254|588788713|FG002|Double-blind Part|Lost to Follow-up|0|||
163023425|NCT01489254|588788714|FG003|Double-blind Part|Lost to Follow-up|0|||
163023426|NCT01489254|588788711|FG000|Double-blind Part|Other reasons for not completing study|4|||
163023427|NCT01489254|588788712|FG001|Double-blind Part|Other reasons for not completing study|6|||
163023428|NCT01489254|588788713|FG002|Double-blind Part|Other reasons for not completing study|0|||
163023429|NCT01489254|588788714|FG003|Double-blind Part|Other reasons for not completing study|0|||
163023430|NCT01489254|588788711|FG000|Open-label Extension Part|Adverse Event|0|||
163023431|NCT01489254|588788712|FG001|Open-label Extension Part|Adverse Event|0|||
163023432|NCT01489254|588788713|FG002|Open-label Extension Part|Adverse Event|0|||
163023433|NCT01489254|588788714|FG003|Open-label Extension Part|Adverse Event|10|||
163023434|NCT01489254|588788711|FG000|Open-label Extension Part|Pregnancy|0|||
163023435|NCT01489254|588788712|FG001|Open-label Extension Part|Pregnancy|0|||
163023436|NCT01489254|588788713|FG002|Open-label Extension Part|Pregnancy|0|||
163023437|NCT01489254|588788714|FG003|Open-label Extension Part|Pregnancy|3|||
163023438|NCT01489254|588788711|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
163023439|NCT01489254|588788712|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
163023440|NCT01489254|588788713|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
163023441|NCT01489254|588788714|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
163023442|NCT01489254|588788711|FG000|Open-label Extension Part|Protocol Violation|0|||
163023443|NCT01489254|588788712|FG001|Open-label Extension Part|Protocol Violation|0|||
163023444|NCT01489254|588788713|FG002|Open-label Extension Part|Protocol Violation|0|||
163023445|NCT01489254|588788714|FG003|Open-label Extension Part|Protocol Violation|1|||
163023446|NCT01489254|588788711|FG000|Open-label Extension Part|Lost to Follow-up|0|||
163023447|NCT01489254|588788712|FG001|Open-label Extension Part|Lost to Follow-up|0|||
163023448|NCT01489254|588788713|FG002|Open-label Extension Part|Lost to Follow-up|0|||
163023449|NCT01489254|588788714|FG003|Open-label Extension Part|Lost to Follow-up|9|||
163023450|NCT01489254|588788711|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
163023451|NCT01489254|588788712|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
163023452|NCT01489254|588788713|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
163023453|NCT01489254|588788714|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
163023454|NCT01981954|588788715|FG000|Titration Period|Protocol Deviation|1|||
163023455|NCT01981954|588788715|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
163023456|NCT04016779|588788717|FG000|Overall Study|Adverse Event|9|||
163023457|NCT04016779|588788718|FG001|Overall Study|Adverse Event|17|||
163023458|NCT04016779|588788717|FG000|Overall Study|Lack of Efficacy|4|||
163023459|NCT04016779|588788718|FG001|Overall Study|Lack of Efficacy|1|||
163023460|NCT04016779|588788717|FG000|Overall Study|Lost to Follow-up|5|||
163023461|NCT04016779|588788718|FG001|Overall Study|Lost to Follow-up|14|||
163023462|NCT04016779|588788717|FG000|Overall Study|Physician Decision|1|||
163023463|NCT04016779|588788718|FG001|Overall Study|Physician Decision|3|||
163023464|NCT04016779|588788717|FG000|Overall Study|Withdrawal by Subject|6|||
163023465|NCT04016779|588788718|FG001|Overall Study|Withdrawal by Subject|8|||
163023466|NCT04016779|588788717|FG000|Overall Study|Non-compliance with Study Drug|2|||
163023467|NCT04016779|588788718|FG001|Overall Study|Non-compliance with Study Drug|3|||
163023468|NCT04016779|588788717|FG000|Overall Study|Other, Multiple categories|17|||
163023469|NCT04016779|588788718|FG001|Overall Study|Other, Multiple categories|17|||
163023470|NCT02738879|588788731|FG000|Overall Study|Adverse Event|1|||
163023471|NCT02738879|588788732|FG001|Overall Study|Adverse Event|1|||
163023472|NCT02738879|588788731|FG000|Overall Study|Death|0|||
163023473|NCT02738879|588788732|FG001|Overall Study|Death|2|||
163330604|NCT01555138|589920614|FG001|Overall Study|Abnormal Lab reults|3|||
163023474|NCT02738879|588788731|FG000|Overall Study|Lost to Follow-up|1|||
163023475|NCT02738879|588788732|FG001|Overall Study|Lost to Follow-up|5|||
163023476|NCT02738879|588788731|FG000|Overall Study|Protocol Violation|1|||
163330605|NCT01555138|589920613|FG000|Overall Study|Lack of Efficacy|2|||
163023477|NCT02738879|588788732|FG001|Overall Study|Protocol Violation|3|||
163023478|NCT02738879|588788731|FG000|Overall Study|Physician Decision|3|||
163023479|NCT02738879|588788732|FG001|Overall Study|Physician Decision|4|||
163023480|NCT02738879|588788731|FG000|Overall Study|Pregnancy|0|||
163023481|NCT02738879|588788732|FG001|Overall Study|Pregnancy|1|||
163023482|NCT02738879|588788731|FG000|Overall Study|Screen Failure|1|||
163023483|NCT02738879|588788732|FG001|Overall Study|Screen Failure|2|||
163023484|NCT02738879|588788731|FG000|Overall Study|Site Discontinued Study Participation|1|||
163023485|NCT02738879|588788732|FG001|Overall Study|Site Discontinued Study Participation|0|||
163023486|NCT02738879|588788731|FG000|Overall Study|Withdrawal by Subject|5|||
163330606|NCT01555138|589920614|FG001|Overall Study|Lack of Efficacy|2|||
163330607|NCT01555138|589920613|FG000|Overall Study|Protocol Violation|5|||
163330608|NCT01555138|589920614|FG001|Overall Study|Protocol Violation|3|||
163330609|NCT01555138|589920613|FG000|Overall Study|Administrative problems|8|||
163023487|NCT02738879|588788732|FG001|Overall Study|Withdrawal by Subject|7|||
163023488|NCT00890084|588788733|FG000|Overall Study|Adverse Event|16|||
163023489|NCT00890084|588788733|FG000|Overall Study|Lost to Follow-up|126|||
163023490|NCT03089697|588788738|FG000|Overall Study|Adverse Event|1|||
163023491|NCT03089697|588788739|FG001|Overall Study|Adverse Event|2|||
163023492|NCT03089697|588788738|FG000|Overall Study|Withdrawal by Subject|1|||
163023493|NCT03089697|588788739|FG001|Overall Study|Withdrawal by Subject|0|||
163023494|NCT00638443|588788740|FG000|First Intervention|Adverse Event|2|||
163023495|NCT00638443|588788741|FG001|First Intervention|Adverse Event|1|||
163023496|NCT01044290|588788742|FG000|Follow-up 1|Death|3|||
163023497|NCT01044290|588788743|FG001|Follow-up 1|Death|3|||
163023498|NCT01044290|588788744|FG002|Follow-up 1|Death|1|||
163023499|NCT01044290|588788742|FG000|Follow-up 1|Withdrawal by Subject|2|||
163023500|NCT01044290|588788743|FG001|Follow-up 1|Withdrawal by Subject|2|||
163023501|NCT01044290|588788744|FG002|Follow-up 1|Withdrawal by Subject|0|||
163023502|NCT01044290|588788742|FG000|Follow-Up 2|Death|0|||
163023503|NCT01044290|588788743|FG001|Follow-Up 2|Death|1|||
163023504|NCT01044290|588788744|FG002|Follow-Up 2|Death|1|||
163023505|NCT01044290|588788742|FG000|Follow-Up 2|Withdrawal by Subject|0|||
163023506|NCT01044290|588788743|FG001|Follow-Up 2|Withdrawal by Subject|1|||
163023507|NCT01044290|588788744|FG002|Follow-Up 2|Withdrawal by Subject|1|||
163023508|NCT03613649|588788750|FG000|Second Treatment|Lost to Follow-up|0|||
163023509|NCT03613649|588788751|FG001|Second Treatment|Lost to Follow-up|0|||
163023510|NCT03613649|588788752|FG002|Second Treatment|Lost to Follow-up|1|||
163023511|NCT03613649|588788753|FG003|Second Treatment|Lost to Follow-up|0|||
163023512|NCT03613649|588788754|FG004|Second Treatment|Lost to Follow-up|0|||
163023513|NCT03613649|588788755|FG005|Second Treatment|Lost to Follow-up|0|||
163023514|NCT03613649|588788756|FG006|Second Treatment|Lost to Follow-up|0|||
163023515|NCT03613649|588788757|FG007|Second Treatment|Lost to Follow-up|0|||
163023516|NCT03613649|588788758|FG008|Second Treatment|Lost to Follow-up|0|||
163023517|NCT03613649|588788759|FG009|Second Treatment|Lost to Follow-up|0|||
163023518|NCT03613649|588788760|FG010|Second Treatment|Lost to Follow-up|0|||
163023519|NCT03613649|588788761|FG011|Second Treatment|Lost to Follow-up|0|||
163023520|NCT03613649|588788750|FG000|Second Treatment|Withdrawal by Subject|0|||
163023521|NCT03613649|588788751|FG001|Second Treatment|Withdrawal by Subject|0|||
163023522|NCT03613649|588788752|FG002|Second Treatment|Withdrawal by Subject|0|||
163023523|NCT03613649|588788753|FG003|Second Treatment|Withdrawal by Subject|0|||
163023524|NCT03613649|588788754|FG004|Second Treatment|Withdrawal by Subject|1|||
163023525|NCT03613649|588788755|FG005|Second Treatment|Withdrawal by Subject|0|||
163023526|NCT03613649|588788756|FG006|Second Treatment|Withdrawal by Subject|0|||
163023527|NCT03613649|588788757|FG007|Second Treatment|Withdrawal by Subject|0|||
163023528|NCT03613649|588788758|FG008|Second Treatment|Withdrawal by Subject|0|||
163023529|NCT03613649|588788759|FG009|Second Treatment|Withdrawal by Subject|0|||
163023530|NCT03613649|588788760|FG010|Second Treatment|Withdrawal by Subject|0|||
163023531|NCT03613649|588788761|FG011|Second Treatment|Withdrawal by Subject|0|||
163023532|NCT03613649|588788750|FG000|Third Treatment|Lost to Follow-up|0|||
163023533|NCT03613649|588788751|FG001|Third Treatment|Lost to Follow-up|0|||
163330610|NCT01555138|589920614|FG001|Overall Study|Administrative problems|0|||
163023534|NCT03613649|588788752|FG002|Third Treatment|Lost to Follow-up|0|||
163023535|NCT03613649|588788753|FG003|Third Treatment|Lost to Follow-up|0|||
163023536|NCT03613649|588788754|FG004|Third Treatment|Lost to Follow-up|1|||
163023537|NCT03613649|588788755|FG005|Third Treatment|Lost to Follow-up|0|||
163023538|NCT03613649|588788756|FG006|Third Treatment|Lost to Follow-up|0|||
163023539|NCT03613649|588788757|FG007|Third Treatment|Lost to Follow-up|0|||
163023540|NCT03613649|588788758|FG008|Third Treatment|Lost to Follow-up|0|||
163023541|NCT03613649|588788759|FG009|Third Treatment|Lost to Follow-up|0|||
163330611|NCT01555138|589920613|FG000|Overall Study|Withdrawal by Subject|16|||
163330612|NCT01555138|589920614|FG001|Overall Study|Withdrawal by Subject|15|||
163330613|NCT01555138|589920613|FG000|Overall Study|Adverse Event|14|||
163330614|NCT01555138|589920614|FG001|Overall Study|Adverse Event|14|||
163023542|NCT03613649|588788760|FG010|Third Treatment|Lost to Follow-up|0|||
163023543|NCT03613649|588788761|FG011|Third Treatment|Lost to Follow-up|1|||
163023544|NCT03613649|588788750|FG000|Third Treatment|Protocol Violation|0|||
163023545|NCT03613649|588788751|FG001|Third Treatment|Protocol Violation|0|||
163023546|NCT03613649|588788752|FG002|Third Treatment|Protocol Violation|0|||
163023547|NCT03613649|588788753|FG003|Third Treatment|Protocol Violation|0|||
163023548|NCT03613649|588788754|FG004|Third Treatment|Protocol Violation|0|||
163023549|NCT03613649|588788755|FG005|Third Treatment|Protocol Violation|0|||
163023550|NCT03613649|588788756|FG006|Third Treatment|Protocol Violation|1|||
163023551|NCT03613649|588788757|FG007|Third Treatment|Protocol Violation|0|||
163023552|NCT03613649|588788758|FG008|Third Treatment|Protocol Violation|0|||
163023553|NCT03613649|588788759|FG009|Third Treatment|Protocol Violation|0|||
163023554|NCT03613649|588788760|FG010|Third Treatment|Protocol Violation|0|||
163023555|NCT03613649|588788761|FG011|Third Treatment|Protocol Violation|1|||
163023556|NCT03613649|588788750|FG000|Fourth Treatment|Protocol Violation|1|||
163023557|NCT03613649|588788751|FG001|Fourth Treatment|Protocol Violation|0|||
163023558|NCT03613649|588788752|FG002|Fourth Treatment|Protocol Violation|0|||
163023559|NCT03613649|588788753|FG003|Fourth Treatment|Protocol Violation|0|||
163023560|NCT03613649|588788754|FG004|Fourth Treatment|Protocol Violation|1|||
163217353|NCT05517382|589512157|FG001|Overall Study|Lost to Follow-up|1|||
163217354|NCT03886220|589512158|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
163217355|NCT03886220|589512159|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
163217356|NCT03886220|589512158|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
163023561|NCT03613649|588788755|FG005|Fourth Treatment|Protocol Violation|0|||
163023562|NCT03613649|588788756|FG006|Fourth Treatment|Protocol Violation|0|||
163023563|NCT03613649|588788757|FG007|Fourth Treatment|Protocol Violation|0|||
163023564|NCT03613649|588788758|FG008|Fourth Treatment|Protocol Violation|0|||
163023565|NCT03613649|588788759|FG009|Fourth Treatment|Protocol Violation|0|||
163023566|NCT03613649|588788760|FG010|Fourth Treatment|Protocol Violation|0|||
163023567|NCT03613649|588788761|FG011|Fourth Treatment|Protocol Violation|0|||
163023568|NCT03613649|588788750|FG000|Fourth Treatment|Physician Decision|0|||
163023569|NCT03613649|588788751|FG001|Fourth Treatment|Physician Decision|0|||
163023570|NCT03613649|588788752|FG002|Fourth Treatment|Physician Decision|0|||
163023571|NCT03613649|588788753|FG003|Fourth Treatment|Physician Decision|0|||
163023572|NCT03613649|588788754|FG004|Fourth Treatment|Physician Decision|0|||
163023573|NCT03613649|588788755|FG005|Fourth Treatment|Physician Decision|0|||
163023574|NCT03613649|588788756|FG006|Fourth Treatment|Physician Decision|1|||
163023575|NCT03613649|588788757|FG007|Fourth Treatment|Physician Decision|0|||
163023576|NCT03613649|588788758|FG008|Fourth Treatment|Physician Decision|0|||
163023577|NCT03613649|588788759|FG009|Fourth Treatment|Physician Decision|0|||
163023578|NCT03613649|588788760|FG010|Fourth Treatment|Physician Decision|0|||
163023579|NCT03613649|588788761|FG011|Fourth Treatment|Physician Decision|0|||
163023580|NCT02783729|588788762|FG000|Overall Study|Lack of Efficacy|1|||
163023581|NCT02783729|588788763|FG001|Overall Study|Lack of Efficacy|0|||
163023582|NCT02783729|588788764|FG002|Overall Study|Lack of Efficacy|0|||
163023583|NCT02783729|588788765|FG003|Overall Study|Lack of Efficacy|0|||
163023584|NCT02783729|588788762|FG000|Overall Study|Adverse Event|2|||
163023585|NCT02783729|588788763|FG001|Overall Study|Adverse Event|6|||
163023586|NCT02783729|588788764|FG002|Overall Study|Adverse Event|2|||
163023587|NCT02783729|588788765|FG003|Overall Study|Adverse Event|3|||
163023588|NCT02783729|588788762|FG000|Overall Study|Other|1|||
163023589|NCT02783729|588788763|FG001|Overall Study|Other|6|||
163023590|NCT02783729|588788764|FG002|Overall Study|Other|2|||
163023591|NCT02783729|588788765|FG003|Overall Study|Other|3|||
163023592|NCT02783729|588788762|FG000|Overall Study|Withdrawal by Subject|2|||
163023593|NCT02783729|588788763|FG001|Overall Study|Withdrawal by Subject|3|||
163023594|NCT02783729|588788764|FG002|Overall Study|Withdrawal by Subject|1|||
163023595|NCT02783729|588788765|FG003|Overall Study|Withdrawal by Subject|2|||
163023596|NCT02783729|588788762|FG000|Overall Study|Participant's choice|2|||
163023597|NCT02783729|588788763|FG001|Overall Study|Participant's choice|1|||
163023598|NCT02783729|588788764|FG002|Overall Study|Participant's choice|2|||
163023599|NCT02783729|588788765|FG003|Overall Study|Participant's choice|1|||
163023600|NCT02783729|588788762|FG000|Overall Study|Lost to Follow-up|2|||
163023601|NCT02783729|588788763|FG001|Overall Study|Lost to Follow-up|1|||
163023602|NCT02783729|588788764|FG002|Overall Study|Lost to Follow-up|1|||
163023603|NCT02783729|588788765|FG003|Overall Study|Lost to Follow-up|0|||
163023604|NCT00319592|588788766|FG000|Overall Study|Protocol Violation|1|||
163023605|NCT00319592|588788767|FG001|Overall Study|Protocol Violation|0|||
163023606|NCT00319592|588788766|FG000|Overall Study|Physician Decision|0|||
163023607|NCT00319592|588788767|FG001|Overall Study|Physician Decision|1|||
163023608|NCT00750139|588788774|FG000|Overall Study|Adverse Event|1|||
163023609|NCT00750139|588788775|FG001|Overall Study|Adverse Event|2|||
163064139|NCT03126110|588941558|FG013|Phase 2|Death|25|||
163064140|NCT03126110|588941559|FG014|Phase 2|Death|11|||
163023610|NCT00750139|588788776|FG002|Overall Study|Adverse Event|0|||
163023611|NCT00750139|588788777|FG003|Overall Study|Adverse Event|1|||
163023612|NCT00750139|588788774|FG000|Overall Study|Lost to Follow-up|17|||
163023613|NCT00750139|588788775|FG001|Overall Study|Lost to Follow-up|12|||
163023614|NCT00750139|588788776|FG002|Overall Study|Lost to Follow-up|15|||
163064141|NCT03126110|588941560|FG015|Phase 2|Death|3|||
163023615|NCT00750139|588788777|FG003|Overall Study|Lost to Follow-up|6|||
163023616|NCT00750139|588788774|FG000|Overall Study|Withdrawal by Subject|3|||
163023617|NCT00750139|588788775|FG001|Overall Study|Withdrawal by Subject|2|||
163023618|NCT00750139|588788776|FG002|Overall Study|Withdrawal by Subject|6|||
163023619|NCT00750139|588788777|FG003|Overall Study|Withdrawal by Subject|2|||
163023620|NCT00750139|588788774|FG000|Overall Study|Physician Decision|1|||
163023621|NCT00750139|588788775|FG001|Overall Study|Physician Decision|1|||
163023622|NCT00750139|588788776|FG002|Overall Study|Physician Decision|0|||
163023623|NCT00750139|588788777|FG003|Overall Study|Physician Decision|0|||
163023624|NCT00750139|588788774|FG000|Overall Study|Non-compliance|1|||
163023625|NCT00750139|588788775|FG001|Overall Study|Non-compliance|0|||
163023626|NCT00750139|588788776|FG002|Overall Study|Non-compliance|1|||
163064142|NCT03126110|588941561|FG016|Phase 2|Death|2|||
163023627|NCT00750139|588788777|FG003|Overall Study|Non-compliance|3|||
163023628|NCT00750139|588788774|FG000|Overall Study|Termination by sponsor|4|||
163023629|NCT00750139|588788775|FG001|Overall Study|Termination by sponsor|0|||
163023630|NCT00750139|588788776|FG002|Overall Study|Termination by sponsor|0|||
163023631|NCT00750139|588788777|FG003|Overall Study|Termination by sponsor|1|||
163023632|NCT00750139|588788774|FG000|Overall Study|Non-specific|62|||
163023633|NCT00750139|588788775|FG001|Overall Study|Non-specific|42|||
163023634|NCT00750139|588788776|FG002|Overall Study|Non-specific|79|||
163023635|NCT00750139|588788777|FG003|Overall Study|Non-specific|33|||
163023636|NCT00658775|588788778|FG000|Overall Study|Adverse Event|4|||
163023637|NCT00658775|588788779|FG001|Overall Study|Adverse Event|6|||
163023638|NCT00658775|588788778|FG000|Overall Study|Lost to Follow-up|17|||
163023639|NCT00658775|588788779|FG001|Overall Study|Lost to Follow-up|18|||
163023640|NCT00658775|588788778|FG000|Overall Study|Withdrawal by Subject|6|||
163023641|NCT00658775|588788779|FG001|Overall Study|Withdrawal by Subject|4|||
163023642|NCT00658775|588788778|FG000|Overall Study|Withdrawal of consent|8|||
163023643|NCT00658775|588788779|FG001|Overall Study|Withdrawal of consent|7|||
163023644|NCT00658775|588788778|FG000|Overall Study|Other|7|||
163023645|NCT00658775|588788779|FG001|Overall Study|Other|8|||
163023646|NCT04152837|588788792|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
163217357|NCT03886220|589512159|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163023647|NCT04152837|588788792|FG000|Maintenance Period|Adverse Event|1|||
163023648|NCT04152837|588788792|FG000|Maintenance Period|Withdrawal by Subject|1|||
163023649|NCT04152837|588788792|FG000|Maintenance Period|Sponsor Termination of Study|2|||
163023650|NCT01082211|588788793|FG000|Overall Study|Protocol Violation|4|||
163023651|NCT01082211|588788793|FG000|Overall Study|No protocol treatment received|3|||
163023652|NCT04999163|588788794|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
163023653|NCT04999163|588788795|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
163023654|NCT04999163|588788794|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
163023655|NCT04999163|588788795|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
163023656|NCT04999163|588788794|FG000|Overall Study|Withdrawal by Subject|1|||
163023657|NCT04999163|588788795|FG001|Overall Study|Withdrawal by Subject|0|||
163023658|NCT05903924|588791021|FG000|Overall Study|Lost to Follow-up|1|||
163023659|NCT05903924|588791022|FG001|Overall Study|Lost to Follow-up|0|||
163023660|NCT05903924|588791023|FG002|Overall Study|Lost to Follow-up|0|||
163023661|NCT04338269|588791024|FG000|Overall Study|Death|86|||
163023662|NCT04338269|588791025|FG001|Overall Study|Death|89|||
163023663|NCT04338269|588791024|FG000|Overall Study|Lost to Follow-up|1|||
163023664|NCT04338269|588791025|FG001|Overall Study|Lost to Follow-up|2|||
163023665|NCT04338269|588791024|FG000|Overall Study|Physician Decision|1|||
163023666|NCT04338269|588791025|FG001|Overall Study|Physician Decision|0|||
163023667|NCT04338269|588791024|FG000|Overall Study|Withdrawal by Subject|14|||
163023668|NCT04338269|588791025|FG001|Overall Study|Withdrawal by Subject|11|||
163023669|NCT00174967|588791026|FG000|Overall Study|Adverse Event|1|||
163023670|NCT00174967|588791027|FG001|Overall Study|Adverse Event|2|||
163023671|NCT00174967|588791028|FG002|Overall Study|Adverse Event|2|||
163023672|NCT00174967|588791029|FG003|Overall Study|Adverse Event|1|||
163023673|NCT00174967|588791026|FG000|Overall Study|Gout Flare|0|||
163023674|NCT00174967|588791027|FG001|Overall Study|Gout Flare|0|||
163023675|NCT00174967|588791028|FG002|Overall Study|Gout Flare|0|||
163217358|NCT03886220|589512158|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
163217359|NCT03886220|589512159|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
163023676|NCT00174967|588791029|FG003|Overall Study|Gout Flare|1|||
163023677|NCT00174967|588791026|FG000|Overall Study|Other|0|||
163023678|NCT00174967|588791027|FG001|Overall Study|Other|1|||
163023679|NCT00174967|588791028|FG002|Overall Study|Other|0|||
163023680|NCT00174967|588791029|FG003|Overall Study|Other|0|||
163023681|NCT03030989|588791030|FG000|Overall Study|Fever|2|||
163023682|NCT03030989|588791031|FG001|Overall Study|Fever|2|||
163023683|NCT03030989|588791030|FG000|Overall Study|Rash|2|||
163023684|NCT03030989|588791031|FG001|Overall Study|Rash|1|||
163023685|NCT03030989|588791030|FG000|Overall Study|Fatigue/Overwhelmed|1|||
163023686|NCT03030989|588791031|FG001|Overall Study|Fatigue/Overwhelmed|5|||
163023687|NCT03030989|588791030|FG000|Overall Study|Positive Blood Cultures|2|||
163217360|NCT01675128|589512166|FG000|Overall Study|Disease progression on study|1|||
163217361|NCT01675128|589512167|FG001|Overall Study|Disease progression on study|1|||
163217362|NCT01675128|589512168|FG002|Overall Study|Disease progression on study|1|||
163217363|NCT01675128|589512166|FG000|Overall Study|Refused further treatment|1|||
163217364|NCT01675128|589512167|FG001|Overall Study|Refused further treatment|0|||
163217365|NCT01675128|589512168|FG002|Overall Study|Refused further treatment|0|||
163217366|NCT01675128|589512166|FG000|Overall Study|Pulmonary complication; off study|0|||
163217367|NCT01675128|589512167|FG001|Overall Study|Pulmonary complication; off study|1|||
163217368|NCT01675128|589512168|FG002|Overall Study|Pulmonary complication; off study|0|||
163217369|NCT03526458|589512174|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
163217370|NCT03526458|589512175|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
163217371|NCT03526458|589512174|FG000|Overall Study|Stone passed, surgery cancelled|2|||
163023688|NCT03030989|588791031|FG001|Overall Study|Positive Blood Cultures|1|||
163023689|NCT03030989|588791030|FG000|Overall Study|Line Removed|0|||
163023690|NCT03030989|588791031|FG001|Overall Study|Line Removed|2|||
163023691|NCT03030989|588791030|FG000|Overall Study|No longer interested|5|||
163023692|NCT03030989|588791031|FG001|Overall Study|No longer interested|3|||
163023693|NCT02730377|588791032|FG000|Overall Study|Other|5|||
163023694|NCT02730377|588791033|FG001|Overall Study|Other|4|||
163023695|NCT02730377|588791032|FG000|Overall Study|Death|1|||
163023696|NCT02730377|588791033|FG001|Overall Study|Death|8|||
163023697|NCT02730377|588791032|FG000|Overall Study|Inadequate glycaemic control|368|||
163023698|NCT02730377|588791033|FG001|Overall Study|Inadequate glycaemic control|473|||
163023699|NCT02730377|588791032|FG000|Overall Study|Adverse Event|79|||
163023700|NCT02730377|588791033|FG001|Overall Study|Adverse Event|41|||
163023701|NCT02730377|588791032|FG000|Overall Study|Protocol Violation|23|||
163023702|NCT02730377|588791033|FG001|Overall Study|Protocol Violation|30|||
163023703|NCT02730377|588791032|FG000|Overall Study|Lack of Efficacy|4|||
163023704|NCT02730377|588791033|FG001|Overall Study|Lack of Efficacy|13|||
163023705|NCT02730377|588791032|FG000|Overall Study|Pregnancy|0|||
163023706|NCT02730377|588791033|FG001|Overall Study|Pregnancy|1|||
163023707|NCT02730377|588791032|FG000|Overall Study|Withdrawal by Subject|45|||
163023708|NCT02730377|588791033|FG001|Overall Study|Withdrawal by Subject|42|||
163023709|NCT02730377|588791032|FG000|Overall Study|Lost to Follow-up|25|||
163023710|NCT02730377|588791033|FG001|Overall Study|Lost to Follow-up|21|||
163023711|NCT02706886|588791034|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
163023712|NCT02706886|588791035|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
163023713|NCT02706886|588791036|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
163023714|NCT02706886|588791037|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
163023715|NCT02706886|588791038|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
163023716|NCT02706886|588791039|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
163023717|NCT02706886|588791040|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
163023718|NCT02706886|588791041|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
163023719|NCT02706886|588791042|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
163023720|NCT03917472|588791043|FG000|Overall Study|Physician Decision|4|||
163023721|NCT03917472|588791044|FG001|Overall Study|Physician Decision|0|||
163023722|NCT03917472|588791043|FG000|Overall Study|Adverse Event|3|||
163023723|NCT03917472|588791044|FG001|Overall Study|Adverse Event|1|||
163023724|NCT03917472|588791043|FG000|Overall Study|Death|7|||
163023725|NCT03917472|588791044|FG001|Overall Study|Death|5|||
163023726|NCT03917472|588791043|FG000|Overall Study|Withdrawal by Subject|11|||
163023727|NCT03917472|588791044|FG001|Overall Study|Withdrawal by Subject|4|||
163023728|NCT03917472|588791043|FG000|Overall Study|Lost to Follow-up|10|||
163023729|NCT03917472|588791044|FG001|Overall Study|Lost to Follow-up|5|||
163023730|NCT01154296|588791045|FG000|Randomization and Intervention|Decided to decline|1|||
163023731|NCT01154296|588791046|FG001|Randomization and Intervention|Decided to decline|1|||
163023732|NCT01154296|588791045|FG000|Randomization and Intervention|Declined by staff|1|||
163023733|NCT01154296|588791046|FG001|Randomization and Intervention|Declined by staff|0|||
163023734|NCT01154296|588791045|FG000|Randomization and Intervention|Did not return|1|||
163023735|NCT01154296|588791046|FG001|Randomization and Intervention|Did not return|0|||
163023736|NCT01154296|588791045|FG000|Randomization and Intervention|Left before test|0|||
163023737|NCT01154296|588791046|FG001|Randomization and Intervention|Left before test|1|||
163023738|NCT01154296|588791045|FG000|Randomization and Intervention|Left clinic early|2|||
163023739|NCT01154296|588791046|FG001|Randomization and Intervention|Left clinic early|0|||
163023740|NCT01154296|588791045|FG000|6-month Follow-up|Lost contact|269|||
163023741|NCT01154296|588791046|FG001|6-month Follow-up|Lost contact|275|||
163023742|NCT01154296|588791045|FG000|6-month Follow-up|Incarcerated|37|||
163023743|NCT01154296|588791046|FG001|6-month Follow-up|Incarcerated|32|||
163023744|NCT01154296|588791045|FG000|6-month Follow-up|Withdrew consent|14|||
163023745|NCT01154296|588791046|FG001|6-month Follow-up|Withdrew consent|15|||
163023746|NCT01154296|588791045|FG000|6-month Follow-up|Death|3|||
163023747|NCT01154296|588791046|FG001|6-month Follow-up|Death|2|||
163023748|NCT01154296|588791045|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
163023749|NCT01154296|588791046|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
163023750|NCT02203851|588791047|FG000|Overall Study|Lost to Follow-up|4|||
163023751|NCT02203851|588791047|FG000|Overall Study|Withdrawal by Subject|6|||
163023752|NCT02203851|588791047|FG000|Overall Study|Other|1|||
163023753|NCT04934189|588791048|FG000|Overall Study|Lost to Follow-up|4|||
163023754|NCT04934189|588791048|FG000|Overall Study|Withdrawal by Subject|17|||
163023755|NCT01194999|588791049|FG000|Overall Study|Lost to Follow-up|17|||
163023756|NCT03781583|588791052|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
163023757|NCT03781583|588791053|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
163023758|NCT03781583|588791054|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
163023759|NCT03781583|588791055|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
163023760|NCT03781583|588791052|FG000|Overall Study|Technology did not work for that person in that environment|1|||
163023761|NCT03781583|588791053|FG001|Overall Study|Technology did not work for that person in that environment|0|||
163023762|NCT03781583|588791054|FG002|Overall Study|Technology did not work for that person in that environment|0|||
163217372|NCT03526458|589512175|FG001|Overall Study|Stone passed, surgery cancelled|1|||
163217373|NCT03526458|589512174|FG000|Overall Study|Withdrawal by Subject|1|||
163217374|NCT03526458|589512175|FG001|Overall Study|Withdrawal by Subject|0|||
163217375|NCT03526458|589512174|FG000|Overall Study|Physician Decision|2|||
163023763|NCT03781583|588791055|FG003|Overall Study|Technology did not work for that person in that environment|0|||
163023764|NCT03781583|588791052|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
163023765|NCT03781583|588791053|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
163023766|NCT03781583|588791054|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
163023767|NCT03781583|588791055|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
163023768|NCT03781583|588791052|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
163023769|NCT03781583|588791053|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
163023770|NCT03781583|588791054|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
163023771|NCT03781583|588791055|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
163023772|NCT01938430|588791056|FG000|Overall Study|Randomized but Not Treated|0|||
163023773|NCT01938430|588791057|FG001|Overall Study|Randomized but Not Treated|0|||
163023774|NCT01938430|588791058|FG002|Overall Study|Randomized but Not Treated|0|||
163023775|NCT01938430|588791059|FG003|Overall Study|Randomized but Not Treated|0|||
163023776|NCT01938430|588791060|FG004|Overall Study|Randomized but Not Treated|0|||
163023777|NCT01938430|588791061|FG005|Overall Study|Randomized but Not Treated|0|||
163023778|NCT01938430|588791062|FG006|Overall Study|Randomized but Not Treated|0|||
163023779|NCT01938430|588791063|FG007|Overall Study|Randomized but Not Treated|0|||
163023780|NCT01938430|588791064|FG008|Overall Study|Randomized but Not Treated|0|||
163023781|NCT01938430|588791065|FG009|Overall Study|Randomized but Not Treated|0|||
163023782|NCT01938430|588791066|FG010|Overall Study|Randomized but Not Treated|1|||
163023783|NCT01938430|588791067|FG011|Overall Study|Randomized but Not Treated|0|||
163023784|NCT01938430|588791068|FG012|Overall Study|Randomized but Not Treated|0|||
163023785|NCT01938430|588791069|FG013|Overall Study|Randomized but Not Treated|1|||
163023786|NCT01938430|588791056|FG000|Overall Study|Adverse Event|0|||
163023787|NCT01938430|588791057|FG001|Overall Study|Adverse Event|0|||
163023788|NCT01938430|588791058|FG002|Overall Study|Adverse Event|0|||
163023789|NCT01938430|588791059|FG003|Overall Study|Adverse Event|0|||
163023790|NCT01938430|588791060|FG004|Overall Study|Adverse Event|0|||
163023791|NCT01938430|588791061|FG005|Overall Study|Adverse Event|0|||
163023792|NCT01938430|588791062|FG006|Overall Study|Adverse Event|1|||
163023793|NCT01938430|588791063|FG007|Overall Study|Adverse Event|0|||
163023794|NCT01938430|588791064|FG008|Overall Study|Adverse Event|0|||
163023795|NCT01938430|588791065|FG009|Overall Study|Adverse Event|0|||
163023796|NCT01938430|588791066|FG010|Overall Study|Adverse Event|0|||
163023797|NCT01938430|588791067|FG011|Overall Study|Adverse Event|0|||
163023798|NCT01938430|588791068|FG012|Overall Study|Adverse Event|0|||
163217376|NCT03526458|589512175|FG001|Overall Study|Physician Decision|1|||
163023799|NCT01938430|588791069|FG013|Overall Study|Adverse Event|0|||
163023800|NCT01938430|588791056|FG000|Overall Study|Death|1|||
163023801|NCT01938430|588791057|FG001|Overall Study|Death|2|||
163023802|NCT01938430|588791058|FG002|Overall Study|Death|2|||
163023803|NCT01938430|588791059|FG003|Overall Study|Death|1|||
163023804|NCT01938430|588791060|FG004|Overall Study|Death|0|||
163023805|NCT01938430|588791061|FG005|Overall Study|Death|0|||
163023806|NCT01938430|588791062|FG006|Overall Study|Death|1|||
163023807|NCT01938430|588791063|FG007|Overall Study|Death|1|||
163023808|NCT01938430|588791064|FG008|Overall Study|Death|2|||
163023809|NCT01938430|588791065|FG009|Overall Study|Death|3|||
163023810|NCT01938430|588791066|FG010|Overall Study|Death|0|||
163023811|NCT01938430|588791067|FG011|Overall Study|Death|0|||
163023812|NCT01938430|588791068|FG012|Overall Study|Death|0|||
163023813|NCT01938430|588791069|FG013|Overall Study|Death|0|||
163023814|NCT01938430|588791056|FG000|Overall Study|Investigator's Discretion|0|||
163023815|NCT01938430|588791057|FG001|Overall Study|Investigator's Discretion|0|||
163023816|NCT01938430|588791058|FG002|Overall Study|Investigator's Discretion|1|||
163023817|NCT01938430|588791059|FG003|Overall Study|Investigator's Discretion|0|||
163217377|NCT03526458|589512174|FG000|Overall Study|Lack of equipment|1|||
163217378|NCT03526458|589512175|FG001|Overall Study|Lack of equipment|1|||
163217379|NCT00271947|589512176|FG000|Overall Study|Lost to Follow-up|1|||
163023818|NCT01938430|588791060|FG004|Overall Study|Investigator's Discretion|0|||
163023819|NCT01938430|588791061|FG005|Overall Study|Investigator's Discretion|0|||
163023820|NCT01938430|588791062|FG006|Overall Study|Investigator's Discretion|0|||
163023821|NCT01938430|588791063|FG007|Overall Study|Investigator's Discretion|0|||
163064143|NCT03126110|588941545|FG000|Phase 2|Progressive Disease|0|||
163217380|NCT00735878|589512177|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
163217381|NCT00735878|589512178|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
163023822|NCT01938430|588791064|FG008|Overall Study|Investigator's Discretion|0|||
163023823|NCT01938430|588791065|FG009|Overall Study|Investigator's Discretion|0|||
163023824|NCT01938430|588791066|FG010|Overall Study|Investigator's Discretion|0|||
163217382|NCT00735878|589512179|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
163023825|NCT01938430|588791067|FG011|Overall Study|Investigator's Discretion|0|||
163023826|NCT01938430|588791068|FG012|Overall Study|Investigator's Discretion|0|||
163023827|NCT01938430|588791069|FG013|Overall Study|Investigator's Discretion|0|||
163023828|NCT01938430|588791056|FG000|Overall Study|Lack of Efficacy|3|||
163023829|NCT01938430|588791057|FG001|Overall Study|Lack of Efficacy|1|||
163023830|NCT01938430|588791058|FG002|Overall Study|Lack of Efficacy|1|||
163023831|NCT01938430|588791059|FG003|Overall Study|Lack of Efficacy|1|||
163023832|NCT01938430|588791060|FG004|Overall Study|Lack of Efficacy|0|||
163023833|NCT01938430|588791061|FG005|Overall Study|Lack of Efficacy|0|||
163023834|NCT01938430|588791062|FG006|Overall Study|Lack of Efficacy|0|||
163023835|NCT01938430|588791063|FG007|Overall Study|Lack of Efficacy|0|||
163023836|NCT01938430|588791064|FG008|Overall Study|Lack of Efficacy|1|||
163023837|NCT01938430|588791065|FG009|Overall Study|Lack of Efficacy|0|||
163023838|NCT01938430|588791066|FG010|Overall Study|Lack of Efficacy|2|||
163023839|NCT01938430|588791067|FG011|Overall Study|Lack of Efficacy|1|||
163023840|NCT01938430|588791068|FG012|Overall Study|Lack of Efficacy|0|||
163023841|NCT01938430|588791069|FG013|Overall Study|Lack of Efficacy|0|||
163023842|NCT01938430|588791056|FG000|Overall Study|Lost to Follow-up|0|||
163023843|NCT01938430|588791057|FG001|Overall Study|Lost to Follow-up|0|||
163023844|NCT01938430|588791058|FG002|Overall Study|Lost to Follow-up|1|||
163023845|NCT01938430|588791059|FG003|Overall Study|Lost to Follow-up|0|||
163023846|NCT01938430|588791060|FG004|Overall Study|Lost to Follow-up|0|||
163023847|NCT01938430|588791061|FG005|Overall Study|Lost to Follow-up|1|||
163023848|NCT01938430|588791062|FG006|Overall Study|Lost to Follow-up|0|||
163023849|NCT01938430|588791063|FG007|Overall Study|Lost to Follow-up|0|||
163023850|NCT01938430|588791064|FG008|Overall Study|Lost to Follow-up|0|||
163023851|NCT01938430|588791065|FG009|Overall Study|Lost to Follow-up|0|||
163023852|NCT01938430|588791066|FG010|Overall Study|Lost to Follow-up|0|||
163023853|NCT01938430|588791067|FG011|Overall Study|Lost to Follow-up|0|||
163023854|NCT01938430|588791068|FG012|Overall Study|Lost to Follow-up|0|||
163023855|NCT01938430|588791069|FG013|Overall Study|Lost to Follow-up|0|||
163023856|NCT01938430|588791056|FG000|Overall Study|Withdrew Consent|0|||
163023857|NCT01938430|588791057|FG001|Overall Study|Withdrew Consent|0|||
163023858|NCT01938430|588791058|FG002|Overall Study|Withdrew Consent|0|||
163023859|NCT01938430|588791059|FG003|Overall Study|Withdrew Consent|0|||
163023860|NCT01938430|588791060|FG004|Overall Study|Withdrew Consent|0|||
163023861|NCT01938430|588791061|FG005|Overall Study|Withdrew Consent|0|||
163023862|NCT01938430|588791062|FG006|Overall Study|Withdrew Consent|0|||
163023863|NCT01938430|588791063|FG007|Overall Study|Withdrew Consent|0|||
163023864|NCT01938430|588791064|FG008|Overall Study|Withdrew Consent|1|||
163023865|NCT01938430|588791065|FG009|Overall Study|Withdrew Consent|0|||
163023866|NCT01938430|588791066|FG010|Overall Study|Withdrew Consent|0|||
163023867|NCT01938430|588791067|FG011|Overall Study|Withdrew Consent|0|||
163023868|NCT01938430|588791068|FG012|Overall Study|Withdrew Consent|0|||
163023869|NCT01938430|588791069|FG013|Overall Study|Withdrew Consent|0|||
163023870|NCT02980341|588791074|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
163023871|NCT02980341|588791075|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
163023872|NCT02980341|588791076|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
163023873|NCT02980341|588791077|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
163023874|NCT02980341|588791078|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
163023875|NCT02980341|588791079|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
163023876|NCT02980341|588791080|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
163023877|NCT02980341|588791081|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
163023878|NCT02980341|588791082|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
163064144|NCT03126110|588941546|FG001|Phase 2|Progressive Disease|0|||
163064145|NCT03126110|588941547|FG002|Phase 2|Progressive Disease|0|||
163064146|NCT03126110|588941548|FG003|Phase 2|Progressive Disease|0|||
163064147|NCT03126110|588941549|FG004|Phase 2|Progressive Disease|0|||
163064148|NCT03126110|588941550|FG005|Phase 2|Progressive Disease|0|||
163064149|NCT03126110|588941551|FG006|Phase 2|Progressive Disease|0|||
163064150|NCT03126110|588941552|FG007|Phase 2|Progressive Disease|0|||
163064151|NCT03126110|588941553|FG008|Phase 2|Progressive Disease|0|||
163064152|NCT03126110|588941554|FG009|Phase 2|Progressive Disease|0|||
163064153|NCT03126110|588941555|FG010|Phase 2|Progressive Disease|0|||
163064154|NCT03126110|588941556|FG011|Phase 2|Progressive Disease|0|||
163064155|NCT03126110|588941557|FG012|Phase 2|Progressive Disease|0|||
163023879|NCT02980341|588791083|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
163023880|NCT02980341|588791084|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
163023881|NCT02980341|588791074|FG000|Dose Escalation|Clinical progression|0|||
163064156|NCT03126110|588941558|FG013|Phase 2|Progressive Disease|1|||
163023882|NCT02980341|588791075|FG001|Dose Escalation|Clinical progression|0|||
163023883|NCT02980341|588791076|FG002|Dose Escalation|Clinical progression|2|||
163023884|NCT02980341|588791077|FG003|Dose Escalation|Clinical progression|1|||
163023885|NCT02980341|588791078|FG004|Dose Escalation|Clinical progression|0|||
163023886|NCT02980341|588791079|FG005|Dose Escalation|Clinical progression|0|||
163023887|NCT02980341|588791080|FG006|Dose Escalation|Clinical progression|0|||
163064157|NCT03126110|588941559|FG014|Phase 2|Progressive Disease|0|||
163064158|NCT03126110|588941560|FG015|Phase 2|Progressive Disease|0|||
163023888|NCT02980341|588791081|FG007|Dose Escalation|Clinical progression|0|||
163023889|NCT02980341|588791082|FG008|Dose Escalation|Clinical progression|0|||
163023890|NCT02980341|588791083|FG009|Dose Escalation|Clinical progression|0|||
163023891|NCT02980341|588791084|FG010|Dose Escalation|Clinical progression|0|||
163023892|NCT02980341|588791074|FG000|Dose Escalation|Adverse Event|0|||
163023893|NCT02980341|588791075|FG001|Dose Escalation|Adverse Event|0|||
163023894|NCT02980341|588791076|FG002|Dose Escalation|Adverse Event|1|||
163023895|NCT02980341|588791077|FG003|Dose Escalation|Adverse Event|2|||
163023896|NCT02980341|588791078|FG004|Dose Escalation|Adverse Event|2|||
163023897|NCT02980341|588791079|FG005|Dose Escalation|Adverse Event|0|||
163023898|NCT02980341|588791080|FG006|Dose Escalation|Adverse Event|0|||
163023899|NCT02980341|588791081|FG007|Dose Escalation|Adverse Event|0|||
163023900|NCT02980341|588791082|FG008|Dose Escalation|Adverse Event|0|||
163023901|NCT02980341|588791083|FG009|Dose Escalation|Adverse Event|0|||
163023902|NCT02980341|588791084|FG010|Dose Escalation|Adverse Event|0|||
163023903|NCT02980341|588791074|FG000|Dose Escalation|Withdrawal by Subject|0|||
163023904|NCT02980341|588791075|FG001|Dose Escalation|Withdrawal by Subject|0|||
163023905|NCT02980341|588791076|FG002|Dose Escalation|Withdrawal by Subject|1|||
163023906|NCT02980341|588791077|FG003|Dose Escalation|Withdrawal by Subject|0|||
163023907|NCT02980341|588791078|FG004|Dose Escalation|Withdrawal by Subject|0|||
163023908|NCT02980341|588791079|FG005|Dose Escalation|Withdrawal by Subject|0|||
163023909|NCT02980341|588791080|FG006|Dose Escalation|Withdrawal by Subject|0|||
163023910|NCT02980341|588791081|FG007|Dose Escalation|Withdrawal by Subject|0|||
163023911|NCT02980341|588791082|FG008|Dose Escalation|Withdrawal by Subject|0|||
163023912|NCT02980341|588791083|FG009|Dose Escalation|Withdrawal by Subject|0|||
163023913|NCT02980341|588791084|FG010|Dose Escalation|Withdrawal by Subject|0|||
163023914|NCT02980341|588791074|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023915|NCT02980341|588791075|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023916|NCT02980341|588791076|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023917|NCT02980341|588791077|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
163023918|NCT02980341|588791078|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023919|NCT02980341|588791079|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023920|NCT02980341|588791080|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023921|NCT02980341|588791081|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023922|NCT02980341|588791082|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023923|NCT02980341|588791083|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023924|NCT02980341|588791084|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023925|NCT02980341|588791074|FG000|Dose Escalation|Due to investigator's decision|0|||
163023926|NCT02980341|588791075|FG001|Dose Escalation|Due to investigator's decision|0|||
163023927|NCT02980341|588791076|FG002|Dose Escalation|Due to investigator's decision|0|||
163023928|NCT02980341|588791077|FG003|Dose Escalation|Due to investigator's decision|0|||
163023929|NCT02980341|588791078|FG004|Dose Escalation|Due to investigator's decision|1|||
163023930|NCT02980341|588791079|FG005|Dose Escalation|Due to investigator's decision|0|||
163023931|NCT02980341|588791080|FG006|Dose Escalation|Due to investigator's decision|0|||
163023932|NCT02980341|588791081|FG007|Dose Escalation|Due to investigator's decision|0|||
163023933|NCT02980341|588791082|FG008|Dose Escalation|Due to investigator's decision|0|||
163023934|NCT02980341|588791083|FG009|Dose Escalation|Due to investigator's decision|0|||
163023935|NCT02980341|588791084|FG010|Dose Escalation|Due to investigator's decision|0|||
163023936|NCT02980341|588791074|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023937|NCT02980341|588791075|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023938|NCT02980341|588791076|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023939|NCT02980341|588791077|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023940|NCT02980341|588791078|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023941|NCT02980341|588791079|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
163023942|NCT02980341|588791080|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
163023943|NCT02980341|588791081|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023944|NCT02980341|588791082|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023945|NCT02980341|588791083|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023946|NCT02980341|588791084|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023947|NCT02980341|588791074|FG000|Dose Finding|Adverse Event|0|||
163023948|NCT02980341|588791075|FG001|Dose Finding|Adverse Event|0|||
163023949|NCT02980341|588791076|FG002|Dose Finding|Adverse Event|0|||
163023950|NCT02980341|588791077|FG003|Dose Finding|Adverse Event|0|||
163064159|NCT03126110|588941561|FG016|Phase 2|Progressive Disease|0|||
163064160|NCT03126110|588941545|FG000|Phase 2|Started new treatment|0|||
163330615|NCT03220724|589920618|FG000|Overall Study|Lost to Follow-up|2|||
163023951|NCT02980341|588791078|FG004|Dose Finding|Adverse Event|0|||
163023952|NCT02980341|588791079|FG005|Dose Finding|Adverse Event|3|||
163023953|NCT02980341|588791080|FG006|Dose Finding|Adverse Event|0|||
163023954|NCT02980341|588791081|FG007|Dose Finding|Adverse Event|0|||
163023955|NCT02980341|588791082|FG008|Dose Finding|Adverse Event|0|||
163023956|NCT02980341|588791083|FG009|Dose Finding|Adverse Event|0|||
163023957|NCT02980341|588791084|FG010|Dose Finding|Adverse Event|0|||
163023958|NCT02980341|588791074|FG000|Dose Finding|Withdrawal by Subject|0|||
163023959|NCT02980341|588791075|FG001|Dose Finding|Withdrawal by Subject|0|||
163023960|NCT02980341|588791076|FG002|Dose Finding|Withdrawal by Subject|0|||
163023961|NCT02980341|588791077|FG003|Dose Finding|Withdrawal by Subject|0|||
163023962|NCT02980341|588791078|FG004|Dose Finding|Withdrawal by Subject|0|||
163023963|NCT02980341|588791079|FG005|Dose Finding|Withdrawal by Subject|1|||
163023964|NCT02980341|588791080|FG006|Dose Finding|Withdrawal by Subject|1|||
163023965|NCT02980341|588791081|FG007|Dose Finding|Withdrawal by Subject|0|||
163023966|NCT02980341|588791082|FG008|Dose Finding|Withdrawal by Subject|0|||
163023967|NCT02980341|588791083|FG009|Dose Finding|Withdrawal by Subject|0|||
163023968|NCT02980341|588791084|FG010|Dose Finding|Withdrawal by Subject|0|||
163023969|NCT02980341|588791074|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
163023970|NCT02980341|588791075|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
163023971|NCT02980341|588791076|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
163023972|NCT02980341|588791077|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
163023973|NCT02980341|588791078|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
163023974|NCT02980341|588791079|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
163023975|NCT02980341|588791080|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
163023976|NCT02980341|588791081|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
163023977|NCT02980341|588791082|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
163023978|NCT02980341|588791083|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
163023979|NCT02980341|588791084|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
163023980|NCT02980341|588791074|FG000|Dose Expansion|Clinical progression|0|||
163023981|NCT02980341|588791075|FG001|Dose Expansion|Clinical progression|0|||
163023982|NCT02980341|588791076|FG002|Dose Expansion|Clinical progression|0|||
163023983|NCT02980341|588791077|FG003|Dose Expansion|Clinical progression|0|||
163023984|NCT02980341|588791078|FG004|Dose Expansion|Clinical progression|0|||
163023985|NCT02980341|588791079|FG005|Dose Expansion|Clinical progression|0|||
163023986|NCT02980341|588791080|FG006|Dose Expansion|Clinical progression|0|||
163023987|NCT02980341|588791081|FG007|Dose Expansion|Clinical progression|4|||
163023988|NCT02980341|588791082|FG008|Dose Expansion|Clinical progression|3|||
163023989|NCT02980341|588791083|FG009|Dose Expansion|Clinical progression|1|||
163023990|NCT02980341|588791084|FG010|Dose Expansion|Clinical progression|4|||
163023991|NCT02980341|588791074|FG000|Dose Expansion|Adverse Event|0|||
163023992|NCT02980341|588791075|FG001|Dose Expansion|Adverse Event|0|||
163023993|NCT02980341|588791076|FG002|Dose Expansion|Adverse Event|0|||
163023994|NCT02980341|588791077|FG003|Dose Expansion|Adverse Event|0|||
163023995|NCT02980341|588791078|FG004|Dose Expansion|Adverse Event|0|||
163023996|NCT02980341|588791079|FG005|Dose Expansion|Adverse Event|0|||
163023997|NCT02980341|588791080|FG006|Dose Expansion|Adverse Event|0|||
163023998|NCT02980341|588791081|FG007|Dose Expansion|Adverse Event|3|||
163023999|NCT02980341|588791082|FG008|Dose Expansion|Adverse Event|0|||
163024000|NCT02980341|588791083|FG009|Dose Expansion|Adverse Event|1|||
163024001|NCT02980341|588791084|FG010|Dose Expansion|Adverse Event|3|||
163024002|NCT02980341|588791074|FG000|Dose Expansion|Death|0|||
163024003|NCT02980341|588791075|FG001|Dose Expansion|Death|0|||
163024004|NCT02980341|588791076|FG002|Dose Expansion|Death|0|||
163024005|NCT02980341|588791077|FG003|Dose Expansion|Death|0|||
163024006|NCT02980341|588791078|FG004|Dose Expansion|Death|0|||
163024007|NCT02980341|588791079|FG005|Dose Expansion|Death|0|||
163024008|NCT02980341|588791080|FG006|Dose Expansion|Death|0|||
163024009|NCT02980341|588791081|FG007|Dose Expansion|Death|0|||
163024010|NCT02980341|588791082|FG008|Dose Expansion|Death|2|||
163024011|NCT02980341|588791083|FG009|Dose Expansion|Death|1|||
163024012|NCT02980341|588791084|FG010|Dose Expansion|Death|0|||
163024013|NCT02980341|588791074|FG000|Dose Expansion|Withdrawal by Subject|0|||
163024014|NCT02980341|588791075|FG001|Dose Expansion|Withdrawal by Subject|0|||
163024015|NCT02980341|588791076|FG002|Dose Expansion|Withdrawal by Subject|0|||
163024016|NCT02980341|588791077|FG003|Dose Expansion|Withdrawal by Subject|0|||
163024017|NCT02980341|588791078|FG004|Dose Expansion|Withdrawal by Subject|0|||
163024018|NCT02980341|588791079|FG005|Dose Expansion|Withdrawal by Subject|0|||
163024019|NCT02980341|588791080|FG006|Dose Expansion|Withdrawal by Subject|0|||
163024020|NCT02980341|588791081|FG007|Dose Expansion|Withdrawal by Subject|2|||
163024021|NCT02980341|588791082|FG008|Dose Expansion|Withdrawal by Subject|0|||
163024022|NCT02980341|588791083|FG009|Dose Expansion|Withdrawal by Subject|1|||
163024023|NCT02980341|588791084|FG010|Dose Expansion|Withdrawal by Subject|0|||
163330616|NCT03220724|589920619|FG001|Overall Study|Lost to Follow-up|2|||
163024024|NCT02980341|588791074|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024025|NCT02980341|588791075|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024026|NCT02980341|588791076|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024027|NCT02980341|588791077|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024028|NCT02980341|588791078|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024029|NCT02980341|588791079|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163064161|NCT03126110|588941546|FG001|Phase 2|Started new treatment|0|||
163064162|NCT03126110|588941547|FG002|Phase 2|Started new treatment|0|||
163064163|NCT03126110|588941548|FG003|Phase 2|Started new treatment|0|||
163064164|NCT03126110|588941549|FG004|Phase 2|Started new treatment|0|||
163064165|NCT03126110|588941550|FG005|Phase 2|Started new treatment|0|||
163064166|NCT03126110|588941551|FG006|Phase 2|Started new treatment|0|||
163064167|NCT03126110|588941552|FG007|Phase 2|Started new treatment|0|||
163064168|NCT03126110|588941553|FG008|Phase 2|Started new treatment|0|||
163064169|NCT03126110|588941554|FG009|Phase 2|Started new treatment|0|||
163064170|NCT03126110|588941555|FG010|Phase 2|Started new treatment|0|||
163064171|NCT03126110|588941556|FG011|Phase 2|Started new treatment|0|||
163064172|NCT03126110|588941557|FG012|Phase 2|Started new treatment|0|||
163064173|NCT03126110|588941558|FG013|Phase 2|Started new treatment|0|||
163064174|NCT03126110|588941559|FG014|Phase 2|Started new treatment|1|||
163064175|NCT03126110|588941560|FG015|Phase 2|Started new treatment|0|||
163064176|NCT03126110|588941561|FG016|Phase 2|Started new treatment|0|||
163064177|NCT00314145|588941562|FG000|Overall Study|Withdrawal by Subject|8|||
163064178|NCT00314145|588941563|FG001|Overall Study|Withdrawal by Subject|10|||
163064179|NCT00314145|588941562|FG000|Overall Study|Lost to Follow-up|5|||
163064180|NCT00314145|588941563|FG001|Overall Study|Lost to Follow-up|12|||
163064181|NCT00314145|588941562|FG000|Overall Study|Physician Decision|3|||
163064182|NCT00314145|588941563|FG001|Overall Study|Physician Decision|4|||
163064183|NCT00314145|588941562|FG000|Overall Study|Adverse Event|0|||
163064184|NCT00314145|588941563|FG001|Overall Study|Adverse Event|3|||
163064185|NCT00314145|588941562|FG000|Overall Study|Protocol Violation|3|||
163064186|NCT00314145|588941563|FG001|Overall Study|Protocol Violation|0|||
163064187|NCT00314145|588941562|FG000|Overall Study|Sponsor Decision|2|||
163064188|NCT00314145|588941563|FG001|Overall Study|Sponsor Decision|0|||
163024030|NCT02980341|588791080|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024031|NCT02980341|588791081|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
163024032|NCT02980341|588791082|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024033|NCT02980341|588791083|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024034|NCT02980341|588791084|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024035|NCT02980341|588791074|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024036|NCT02980341|588791075|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024037|NCT02980341|588791076|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024038|NCT02980341|588791077|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024039|NCT02980341|588791078|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024040|NCT02980341|588791079|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024041|NCT02980341|588791080|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024042|NCT02980341|588791081|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024043|NCT02980341|588791082|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
163024044|NCT02980341|588791083|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024045|NCT02980341|588791084|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024046|NCT02980341|588791074|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024047|NCT02980341|588791075|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024048|NCT02980341|588791076|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024049|NCT02980341|588791077|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024050|NCT02980341|588791078|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024051|NCT02980341|588791079|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024052|NCT02980341|588791080|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024053|NCT02980341|588791081|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024054|NCT02980341|588791082|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
163024055|NCT02980341|588791083|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163064189|NCT00294658|588941564|FG000|Overall Study|Death|0|||
163064190|NCT00294658|588941565|FG001|Overall Study|Death|1|||
163064191|NCT00294658|588941564|FG000|Overall Study|Lost to Follow-up|4|||
163064192|NCT00294658|588941565|FG001|Overall Study|Lost to Follow-up|0|||
163064193|NCT00294658|588941564|FG000|Overall Study|Physician Decision|1|||
163064194|NCT00294658|588941565|FG001|Overall Study|Physician Decision|2|||
163064195|NCT00294658|588941564|FG000|Overall Study|Pregnancy|0|||
163064196|NCT00294658|588941565|FG001|Overall Study|Pregnancy|1|||
163064197|NCT00294658|588941564|FG000|Overall Study|Withdrawal by Subject|0|||
163064198|NCT00294658|588941565|FG001|Overall Study|Withdrawal by Subject|4|||
163064199|NCT00294658|588941564|FG000|Overall Study|Found to have invasive thymoma|1|||
163064200|NCT00294658|588941565|FG001|Overall Study|Found to have invasive thymoma|0|||
163064201|NCT00294658|588941564|FG000|Overall Study|Patient and family were not satisfied|0|||
163217383|NCT04404855|589512180|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
163217384|NCT04404855|589512181|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
163217385|NCT00651755|589512182|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
163217386|NCT00651755|589512183|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
163217387|NCT00651755|589512182|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
163217388|NCT00651755|589512183|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
163024056|NCT02980341|588791084|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024057|NCT02980341|588791074|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024058|NCT02980341|588791075|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024059|NCT02980341|588791076|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024060|NCT02980341|588791077|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024061|NCT02980341|588791078|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024062|NCT02980341|588791079|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024063|NCT02980341|588791080|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024064|NCT02980341|588791081|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024065|NCT02980341|588791082|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024066|NCT02980341|588791083|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024067|NCT02980341|588791084|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
163024068|NCT01647516|588791085|FG000|Induction Period (IP)|Physician Decision|2|||
163024069|NCT01647516|588791086|FG001|Induction Period (IP)|Physician Decision|0|||
163024070|NCT01647516|588791087|FG002|Induction Period (IP)|Physician Decision|0|||
163024071|NCT01647516|588791088|FG003|Induction Period (IP)|Physician Decision|0|||
163024072|NCT01647516|588791089|FG004|Induction Period (IP)|Physician Decision|0|||
163024073|NCT01647516|588791090|FG005|Induction Period (IP)|Physician Decision|0|||
163024074|NCT01647516|588791085|FG000|Induction Period (IP)|Adverse Event|1|||
163024075|NCT01647516|588791086|FG001|Induction Period (IP)|Adverse Event|2|||
163024076|NCT01647516|588791087|FG002|Induction Period (IP)|Adverse Event|0|||
163024077|NCT01647516|588791088|FG003|Induction Period (IP)|Adverse Event|0|||
163024078|NCT01647516|588791089|FG004|Induction Period (IP)|Adverse Event|0|||
163024079|NCT01647516|588791090|FG005|Induction Period (IP)|Adverse Event|0|||
163024080|NCT01647516|588791085|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
163024081|NCT01647516|588791086|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
163024082|NCT01647516|588791087|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
163024083|NCT01647516|588791088|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
163024084|NCT01647516|588791089|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
163024085|NCT01647516|588791090|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
163024086|NCT01647516|588791085|FG000|Induction Period (IP)|Participant Choice|0|||
163024087|NCT01647516|588791086|FG001|Induction Period (IP)|Participant Choice|0|||
163024088|NCT01647516|588791087|FG002|Induction Period (IP)|Participant Choice|1|||
163024089|NCT01647516|588791088|FG003|Induction Period (IP)|Participant Choice|0|||
163024090|NCT01647516|588791089|FG004|Induction Period (IP)|Participant Choice|0|||
163024091|NCT01647516|588791090|FG005|Induction Period (IP)|Participant Choice|0|||
163024092|NCT01647516|588791085|FG000|Induction Period (IP)|Lack of Efficacy|1|||
163024093|NCT01647516|588791086|FG001|Induction Period (IP)|Lack of Efficacy|0|||
163024094|NCT01647516|588791087|FG002|Induction Period (IP)|Lack of Efficacy|0|||
163024095|NCT01647516|588791088|FG003|Induction Period (IP)|Lack of Efficacy|0|||
163024096|NCT01647516|588791089|FG004|Induction Period (IP)|Lack of Efficacy|0|||
163024097|NCT01647516|588791090|FG005|Induction Period (IP)|Lack of Efficacy|0|||
163024098|NCT01647516|588791085|FG000|Induction Period (IP)|No study drug received|1|||
163024099|NCT01647516|588791086|FG001|Induction Period (IP)|No study drug received|1|||
163024100|NCT01647516|588791087|FG002|Induction Period (IP)|No study drug received|0|||
163024101|NCT01647516|588791088|FG003|Induction Period (IP)|No study drug received|0|||
163024102|NCT01647516|588791089|FG004|Induction Period (IP)|No study drug received|0|||
163024103|NCT01647516|588791090|FG005|Induction Period (IP)|No study drug received|0|||
163024104|NCT01647516|588791085|FG000|Maintenance Period (MP)|Adverse Event|2|||
163024105|NCT01647516|588791086|FG001|Maintenance Period (MP)|Adverse Event|1|||
163024106|NCT01647516|588791087|FG002|Maintenance Period (MP)|Adverse Event|0|||
163024107|NCT01647516|588791088|FG003|Maintenance Period (MP)|Adverse Event|0|||
163024108|NCT01647516|588791089|FG004|Maintenance Period (MP)|Adverse Event|0|||
163024109|NCT01647516|588791090|FG005|Maintenance Period (MP)|Adverse Event|0|||
163024110|NCT01647516|588791085|FG000|Maintenance Period (MP)|Non-compliance|1|||
163024111|NCT01647516|588791086|FG001|Maintenance Period (MP)|Non-compliance|0|||
163217389|NCT01120756|589512184|FG000|Overall Study|Withdrawal by Subject|1|||
163217390|NCT01120756|589512185|FG001|Overall Study|Withdrawal by Subject|1|||
163217391|NCT00698581|589512190|FG000|Overall Study|Lack of Efficacy|23|||
163217392|NCT00698581|589512191|FG001|Overall Study|Lack of Efficacy|11|||
163217393|NCT00698581|589512190|FG000|Overall Study|Withdrawal by Subject|6|||
163217394|NCT00698581|589512191|FG001|Overall Study|Withdrawal by Subject|0|||
163217395|NCT00698581|589512190|FG000|Overall Study|Other reason|9|||
163330617|NCT03220724|589920620|FG002|Overall Study|Lost to Follow-up|0|||
163330618|NCT03220724|589920621|FG003|Overall Study|Lost to Follow-up|3|||
163330619|NCT03220724|589920622|FG004|Overall Study|Lost to Follow-up|1|||
163024112|NCT01647516|588791087|FG002|Maintenance Period (MP)|Non-compliance|0|||
163024113|NCT01647516|588791088|FG003|Maintenance Period (MP)|Non-compliance|0|||
163024114|NCT01647516|588791089|FG004|Maintenance Period (MP)|Non-compliance|0|||
163024115|NCT01647516|588791090|FG005|Maintenance Period (MP)|Non-compliance|0|||
163024116|NCT01647516|588791085|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
163024117|NCT01647516|588791086|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
163024118|NCT01647516|588791087|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
163024119|NCT01647516|588791088|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
163024120|NCT01647516|588791089|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
163024121|NCT01647516|588791090|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
163024122|NCT01647516|588791085|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
163024123|NCT01647516|588791086|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
163024124|NCT01647516|588791087|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
163024125|NCT01647516|588791088|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
163024126|NCT01647516|588791089|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
163024127|NCT01647516|588791090|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
163024128|NCT01647516|588791085|FG000|Open-Label Period|Adverse Event|0|||
163024129|NCT01647516|588791086|FG001|Open-Label Period|Adverse Event|0|||
163024130|NCT01647516|588791087|FG002|Open-Label Period|Adverse Event|0|||
163024131|NCT01647516|588791088|FG003|Open-Label Period|Adverse Event|5|||
163024132|NCT01647516|588791089|FG004|Open-Label Period|Adverse Event|6|||
163024133|NCT01647516|588791090|FG005|Open-Label Period|Adverse Event|3|||
163024134|NCT01647516|588791085|FG000|Open-Label Period|Pregnancy|0|||
163024135|NCT01647516|588791086|FG001|Open-Label Period|Pregnancy|0|||
163024136|NCT01647516|588791087|FG002|Open-Label Period|Pregnancy|0|||
163024137|NCT01647516|588791088|FG003|Open-Label Period|Pregnancy|0|||
163024138|NCT01647516|588791089|FG004|Open-Label Period|Pregnancy|0|||
163024139|NCT01647516|588791090|FG005|Open-Label Period|Pregnancy|1|||
163024140|NCT01647516|588791085|FG000|Open-Label Period|Non-compliance|0|||
163024141|NCT01647516|588791086|FG001|Open-Label Period|Non-compliance|0|||
163024142|NCT01647516|588791087|FG002|Open-Label Period|Non-compliance|0|||
163024143|NCT01647516|588791088|FG003|Open-Label Period|Non-compliance|1|||
163024144|NCT01647516|588791089|FG004|Open-Label Period|Non-compliance|0|||
163024145|NCT01647516|588791090|FG005|Open-Label Period|Non-compliance|1|||
163024146|NCT01647516|588791085|FG000|Open-Label Period|Physician Decision|0|||
163024147|NCT01647516|588791086|FG001|Open-Label Period|Physician Decision|0|||
163024148|NCT01647516|588791087|FG002|Open-Label Period|Physician Decision|0|||
163024149|NCT01647516|588791088|FG003|Open-Label Period|Physician Decision|1|||
163024150|NCT01647516|588791089|FG004|Open-Label Period|Physician Decision|1|||
163024151|NCT01647516|588791090|FG005|Open-Label Period|Physician Decision|0|||
163024152|NCT01647516|588791085|FG000|Open-Label Period|Withdrawal by Subject|0|||
163024153|NCT01647516|588791086|FG001|Open-Label Period|Withdrawal by Subject|0|||
163024154|NCT01647516|588791087|FG002|Open-Label Period|Withdrawal by Subject|0|||
163024155|NCT01647516|588791088|FG003|Open-Label Period|Withdrawal by Subject|9|||
163024156|NCT01647516|588791089|FG004|Open-Label Period|Withdrawal by Subject|11|||
163024157|NCT01647516|588791090|FG005|Open-Label Period|Withdrawal by Subject|6|||
163024158|NCT01647516|588791085|FG000|Open-Label Period|Lost to Follow-up|0|||
163024159|NCT01647516|588791086|FG001|Open-Label Period|Lost to Follow-up|0|||
163024160|NCT01647516|588791087|FG002|Open-Label Period|Lost to Follow-up|0|||
163024161|NCT01647516|588791088|FG003|Open-Label Period|Lost to Follow-up|1|||
163024162|NCT01647516|588791089|FG004|Open-Label Period|Lost to Follow-up|0|||
163024163|NCT01647516|588791090|FG005|Open-Label Period|Lost to Follow-up|1|||
163024164|NCT01647516|588791085|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
163024165|NCT01647516|588791086|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
163024166|NCT01647516|588791087|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
163024167|NCT01647516|588791088|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
163024168|NCT01647516|588791089|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
163024169|NCT01647516|588791090|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
163024170|NCT01647516|588791085|FG000|Open-Label Period|Lack of Efficacy|0|||
163024171|NCT01647516|588791086|FG001|Open-Label Period|Lack of Efficacy|0|||
163024172|NCT01647516|588791087|FG002|Open-Label Period|Lack of Efficacy|0|||
163024173|NCT01647516|588791088|FG003|Open-Label Period|Lack of Efficacy|7|||
163024174|NCT01647516|588791089|FG004|Open-Label Period|Lack of Efficacy|9|||
163024175|NCT01647516|588791090|FG005|Open-Label Period|Lack of Efficacy|10|||
163024176|NCT01647516|588791085|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
163024177|NCT01647516|588791086|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
163024178|NCT01647516|588791087|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
163024179|NCT01647516|588791088|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
163024180|NCT01647516|588791089|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
163024181|NCT01647516|588791090|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
163024182|NCT01647516|588791085|FG000|Open-Label Period|No completion / discontinuation visit|0|||
163024183|NCT01647516|588791086|FG001|Open-Label Period|No completion / discontinuation visit|0|||
163024184|NCT01647516|588791087|FG002|Open-Label Period|No completion / discontinuation visit|0|||
163024185|NCT01647516|588791088|FG003|Open-Label Period|No completion / discontinuation visit|0|||
163024186|NCT01647516|588791089|FG004|Open-Label Period|No completion / discontinuation visit|2|||
163024187|NCT01647516|588791090|FG005|Open-Label Period|No completion / discontinuation visit|1|||
163024188|NCT04964544|588791093|FG000|Overall Study|Screen failure or other uncategorised|10|||
163024189|NCT04964544|588791093|FG000|Overall Study|Physician Decision|4|||
163024190|NCT04964544|588791093|FG000|Overall Study|Lost to Follow-up|9|||
163024191|NCT04964544|588791093|FG000|Overall Study|Withdrawal by Subject|18|||
163024192|NCT04964544|588791093|FG000|Overall Study|Death|1|||
163024193|NCT01613222|588791096|FG000|Overall Study|Physician Decision|1|||
163024194|NCT01613222|588791096|FG000|Overall Study|Unable to place arterial line|1|||
163024195|NCT01613222|588791096|FG000|Overall Study|Reused disposable sensors|10|||
163024196|NCT02691936|588791098|FG000|Overall Study|Withdrawal by Subject|2|||
163024197|NCT02691936|588791099|FG001|Overall Study|Withdrawal by Subject|5|||
163024198|NCT00749684|588791103|FG000|Overall Study|Death|1|||
163024199|NCT00749684|588791103|FG000|Overall Study|Adverse Event|27|||
163024200|NCT00749684|588791103|FG000|Overall Study|Participant's Wish|10|||
163024201|NCT00749684|588791103|FG000|Overall Study|Not Documented|1|||
163024202|NCT00749684|588791103|FG000|Overall Study|Progressive Desease|31|||
163024203|NCT00749684|588791103|FG000|Overall Study|Therapy according to protocol + AE|2|||
163024204|NCT00749684|588791103|FG000|Overall Study|AE+discontinuation on participants wish|1|||
163024205|NCT00749684|588791103|FG000|Overall Study|Missing|9|||
163024206|NCT01194531|588791104|FG000|Overall Study|Withdrawal by Subject|1|||
163024207|NCT01194531|588791105|FG001|Overall Study|Withdrawal by Subject|0|||
163024208|NCT01194531|588791104|FG000|Overall Study|Protocol Violation|4|||
163024209|NCT01194531|588791105|FG001|Overall Study|Protocol Violation|1|||
163024210|NCT01194531|588791104|FG000|Overall Study|Physician Decision|0|||
163024211|NCT01194531|588791105|FG001|Overall Study|Physician Decision|2|||
163024212|NCT04143594|588791108|FG000|Overall Study|Withdrew consent|3|||
163024213|NCT04143594|588791109|FG001|Overall Study|Withdrew consent|10|||
163024214|NCT04143594|588791110|FG002|Overall Study|Withdrew consent|3|||
163024215|NCT04143594|588791111|FG003|Overall Study|Withdrew consent|1|||
163024216|NCT04143594|588791108|FG000|Overall Study|Lost to Follow-up|3|||
163024217|NCT04143594|588791109|FG001|Overall Study|Lost to Follow-up|5|||
163024218|NCT04143594|588791110|FG002|Overall Study|Lost to Follow-up|11|||
163024219|NCT04143594|588791111|FG003|Overall Study|Lost to Follow-up|0|||
163024220|NCT04143594|588791108|FG000|Overall Study|Investigator's discretion|2|||
163024221|NCT04143594|588791109|FG001|Overall Study|Investigator's discretion|2|||
163024222|NCT04143594|588791110|FG002|Overall Study|Investigator's discretion|0|||
163024223|NCT04143594|588791111|FG003|Overall Study|Investigator's discretion|0|||
163024224|NCT04143594|588791108|FG000|Overall Study|Randomized but never treated|0|||
163024225|NCT04143594|588791109|FG001|Overall Study|Randomized but never treated|0|||
163024226|NCT04143594|588791110|FG002|Overall Study|Randomized but never treated|0|||
163024227|NCT04143594|588791111|FG003|Overall Study|Randomized but never treated|1|||
163024228|NCT04143594|588791108|FG000|Overall Study|Death|1|||
163024229|NCT04143594|588791109|FG001|Overall Study|Death|0|||
163024230|NCT04143594|588791110|FG002|Overall Study|Death|1|||
163024231|NCT04143594|588791111|FG003|Overall Study|Death|0|||
163024232|NCT04143594|588791108|FG000|Overall Study|Adverse Event|1|||
163024233|NCT04143594|588791109|FG001|Overall Study|Adverse Event|0|||
163024234|NCT04143594|588791110|FG002|Overall Study|Adverse Event|0|||
163024235|NCT04143594|588791111|FG003|Overall Study|Adverse Event|0|||
163024236|NCT04143594|588791108|FG000|Overall Study|Pregnancy|0|||
163024237|NCT04143594|588791109|FG001|Overall Study|Pregnancy|0|||
163024238|NCT04143594|588791110|FG002|Overall Study|Pregnancy|1|||
163024239|NCT04143594|588791111|FG003|Overall Study|Pregnancy|0|||
163024240|NCT04143594|588791108|FG000|Overall Study|Lack of Efficacy|1|||
163024241|NCT04143594|588791109|FG001|Overall Study|Lack of Efficacy|1|||
163024242|NCT04143594|588791110|FG002|Overall Study|Lack of Efficacy|0|||
163024243|NCT04143594|588791111|FG003|Overall Study|Lack of Efficacy|0|||
163024244|NCT01023256|588791114|FG000|Overall Study|Protocol Violation|2|||
163024245|NCT01023256|588791115|FG001|Overall Study|Protocol Violation|3|||
163024246|NCT01023256|588791116|FG002|Overall Study|Protocol Violation|0|||
163024247|NCT01023256|588791117|FG003|Overall Study|Protocol Violation|0|||
163024248|NCT01023256|588791114|FG000|Overall Study|Randomized but not treated|1|||
163024249|NCT01023256|588791115|FG001|Overall Study|Randomized but not treated|0|||
163024250|NCT01023256|588791116|FG002|Overall Study|Randomized but not treated|1|||
163024251|NCT01023256|588791117|FG003|Overall Study|Randomized but not treated|0|||
163024252|NCT01023256|588791114|FG000|Overall Study|Other|1|||
163024253|NCT01023256|588791115|FG001|Overall Study|Other|0|||
163024254|NCT01023256|588791116|FG002|Overall Study|Other|0|||
163024255|NCT01023256|588791117|FG003|Overall Study|Other|2|||
163024256|NCT01023256|588791114|FG000|Overall Study|Adverse Event|0|||
163024257|NCT01023256|588791115|FG001|Overall Study|Adverse Event|0|||
163024258|NCT01023256|588791116|FG002|Overall Study|Adverse Event|0|||
163024259|NCT01023256|588791117|FG003|Overall Study|Adverse Event|1|||
163024260|NCT01023256|588791114|FG000|Overall Study|Withdrawal by Subject|0|||
163024261|NCT01023256|588791115|FG001|Overall Study|Withdrawal by Subject|0|||
163024262|NCT01023256|588791116|FG002|Overall Study|Withdrawal by Subject|0|||
163064202|NCT00294658|588941565|FG001|Overall Study|Patient and family were not satisfied|1|||
163064203|NCT00976027|588941567|FG000|Overall Study|Serious Adverse Event|36|||
163064204|NCT00976027|588941568|FG001|Overall Study|Serious Adverse Event|17|||
163064205|NCT00976027|588941567|FG000|Overall Study|Adverse Event|0|||
163064206|NCT00976027|588941568|FG001|Overall Study|Adverse Event|2|||
163064207|NCT00976027|588941567|FG000|Overall Study|Protocol Violation|60|||
163064208|NCT00976027|588941568|FG001|Overall Study|Protocol Violation|27|||
163064209|NCT00976027|588941567|FG000|Overall Study|Lost to Follow-up|208|||
163064210|NCT00976027|588941568|FG001|Overall Study|Lost to Follow-up|103|||
163064211|NCT00976027|588941567|FG000|Overall Study|Withdrawal by Subject|107|||
163064212|NCT00976027|588941568|FG001|Overall Study|Withdrawal by Subject|66|||
163064213|NCT01771107|588941574|FG000|Overall Study|Adverse Event|1|||
163064214|NCT01771107|588941575|FG001|Overall Study|Adverse Event|3|||
163064215|NCT01771107|588941574|FG000|Overall Study|Withdrawal by Subject|0|||
163064216|NCT01771107|588941575|FG001|Overall Study|Withdrawal by Subject|2|||
163064217|NCT01771107|588941574|FG000|Overall Study|Lost to Follow-up|0|||
163064218|NCT01771107|588941575|FG001|Overall Study|Lost to Follow-up|1|||
163024263|NCT01023256|588791117|FG003|Overall Study|Withdrawal by Subject|2|||
163024264|NCT00308087|588791118|FG000|Overall Study|Progressive Disease|19|||
163024265|NCT00308087|588791119|FG001|Overall Study|Progressive Disease|21|||
163024266|NCT00308087|588791118|FG000|Overall Study|Study Closure|11|||
163024267|NCT00308087|588791119|FG001|Overall Study|Study Closure|12|||
163024268|NCT00308087|588791118|FG000|Overall Study|Withdrawal by Subject|2|||
163024269|NCT00308087|588791119|FG001|Overall Study|Withdrawal by Subject|1|||
163024270|NCT00308087|588791118|FG000|Overall Study|Other|4|||
163024271|NCT00308087|588791119|FG001|Overall Study|Other|3|||
163024272|NCT01967706|588791120|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
163024273|NCT01967706|588791121|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
163024274|NCT01967706|588791122|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
163024275|NCT01967706|588791123|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
163024276|NCT01154088|588791124|FG000|Overall Study|Lost to Follow-up|4|||
163024277|NCT01154088|588791125|FG001|Overall Study|Lost to Follow-up|6|||
163024278|NCT01154088|588791126|FG002|Overall Study|Lost to Follow-up|7|||
163024279|NCT05129137|588791127|FG000|Second Period|Adverse Event|1|||
163024280|NCT05129137|588791128|FG001|Second Period|Adverse Event|0|||
163024281|NCT05129137|588791129|FG002|Second Period|Adverse Event|0|||
163024282|NCT05129137|588791130|FG003|Second Period|Adverse Event|0|||
163024283|NCT05129137|588791127|FG000|Second Period|Protocol Violation|0|||
163024284|NCT05129137|588791128|FG001|Second Period|Protocol Violation|0|||
163024285|NCT05129137|588791129|FG002|Second Period|Protocol Violation|0|||
163024286|NCT05129137|588791130|FG003|Second Period|Protocol Violation|1|||
163024287|NCT05129137|588791127|FG000|Third Period|Protocol Violation|0|||
163024288|NCT05129137|588791128|FG001|Third Period|Protocol Violation|0|||
163024289|NCT05129137|588791129|FG002|Third Period|Protocol Violation|0|||
163024290|NCT05129137|588791130|FG003|Third Period|Protocol Violation|1|||
163024291|NCT05129137|588791127|FG000|Forth Period|Protocol Violation|0|||
163024292|NCT05129137|588791128|FG001|Forth Period|Protocol Violation|1|||
163024293|NCT05129137|588791129|FG002|Forth Period|Protocol Violation|0|||
163024294|NCT05129137|588791130|FG003|Forth Period|Protocol Violation|0|||
163024295|NCT05129137|588791127|FG000|Forth Period|Withdrawal by Subject|0|||
163024296|NCT05129137|588791128|FG001|Forth Period|Withdrawal by Subject|0|||
163024297|NCT05129137|588791129|FG002|Forth Period|Withdrawal by Subject|1|||
163024298|NCT05129137|588791130|FG003|Forth Period|Withdrawal by Subject|0|||
163024299|NCT02949843|588791132|FG000|Overall Study|Withdrawal by Subject|0|||
163024300|NCT02949843|588791133|FG001|Overall Study|Withdrawal by Subject|1|||
163024301|NCT02949843|588791134|FG002|Overall Study|Withdrawal by Subject|1|||
163024302|NCT02693171|588791137|FG000|Overall Study|Adverse Event|1|||
163024303|NCT02693171|588791137|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
163024304|NCT03085238|588791141|FG000|Overall Study|Adverse Event|2|||
163064219|NCT01771107|588941574|FG000|Overall Study|participant moved|0|||
163064220|NCT01771107|588941575|FG001|Overall Study|participant moved|1|||
163330620|NCT03220724|589920623|FG005|Overall Study|Lost to Follow-up|0|||
163024305|NCT03085238|588791141|FG000|Overall Study|Death|2|||
163024306|NCT01992653|588791142|FG000|Overall Study|Death|0|||
163024307|NCT01992653|588791143|FG001|Overall Study|Death|0|||
163330621|NCT03220724|589920624|FG006|Overall Study|Lost to Follow-up|2|||
163024308|NCT01992653|588791144|FG002|Overall Study|Death|1|||
163024309|NCT01992653|588791145|FG003|Overall Study|Death|0|||
163024310|NCT01992653|588791146|FG004|Overall Study|Death|1|||
163024311|NCT01992653|588791147|FG005|Overall Study|Death|0|||
163024312|NCT01992653|588791148|FG006|Overall Study|Death|4|||
163024313|NCT01992653|588791149|FG007|Overall Study|Death|2|||
163024314|NCT01992653|588791142|FG000|Overall Study|Lost to Follow-up|0|||
163024315|NCT01992653|588791143|FG001|Overall Study|Lost to Follow-up|0|||
163024316|NCT01992653|588791144|FG002|Overall Study|Lost to Follow-up|0|||
163064221|NCT01771107|588941574|FG000|Overall Study|Other|0|||
163064222|NCT01771107|588941575|FG001|Overall Study|Other|1|||
163064223|NCT03805841|588941576|FG000|Overall Study|Clinical Progression|2|||
163024317|NCT01992653|588791145|FG003|Overall Study|Lost to Follow-up|0|||
163024318|NCT01992653|588791146|FG004|Overall Study|Lost to Follow-up|0|||
163064224|NCT03805841|588941577|FG001|Overall Study|Clinical Progression|0|||
163064225|NCT03805841|588941578|FG002|Overall Study|Clinical Progression|0|||
163064226|NCT03805841|588941576|FG000|Overall Study|Death|0|||
163064227|NCT03805841|588941577|FG001|Overall Study|Death|3|||
163064228|NCT03805841|588941578|FG002|Overall Study|Death|1|||
163064229|NCT03805841|588941576|FG000|Overall Study|Lost to Follow-up|0|||
163064230|NCT03805841|588941577|FG001|Overall Study|Lost to Follow-up|0|||
163064231|NCT03805841|588941578|FG002|Overall Study|Lost to Follow-up|1|||
163064232|NCT03805841|588941576|FG000|Overall Study|Withdrawal by Subject|2|||
163064233|NCT03805841|588941577|FG001|Overall Study|Withdrawal by Subject|3|||
163064234|NCT03805841|588941578|FG002|Overall Study|Withdrawal by Subject|0|||
163064235|NCT03805841|588941576|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
163064236|NCT03805841|588941577|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
163064237|NCT03805841|588941578|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
163064238|NCT03621592|588941581|FG000|Overall Study|Lost to Follow-up|1|||
163064239|NCT03621592|588941582|FG001|Overall Study|Lost to Follow-up|0|||
163064240|NCT03621592|588941581|FG000|Overall Study|Lack of Improvement|1|||
163064241|NCT03621592|588941582|FG001|Overall Study|Lack of Improvement|0|||
163064242|NCT03621592|588941581|FG000|Overall Study|Preference to receive wound care closer to home|1|||
163064243|NCT03621592|588941582|FG001|Overall Study|Preference to receive wound care closer to home|0|||
163064244|NCT03621592|588941581|FG000|Overall Study|Lack of healing|0|||
163064245|NCT03621592|588941582|FG001|Overall Study|Lack of healing|2|||
163064246|NCT00831844|588941588|FG000|Overall Study|Adverse Event|2|||
163064247|NCT00831844|588941589|FG001|Overall Study|Adverse Event|0|||
163064248|NCT00831844|588941590|FG002|Overall Study|Adverse Event|0|||
163064249|NCT00831844|588941591|FG003|Overall Study|Adverse Event|0|||
163064250|NCT00831844|588941592|FG004|Overall Study|Adverse Event|1|||
163064251|NCT00831844|588941593|FG005|Overall Study|Adverse Event|1|||
163064252|NCT00831844|588941594|FG006|Overall Study|Adverse Event|2|||
163064253|NCT00831844|588941595|FG007|Overall Study|Adverse Event|0|||
163064254|NCT00831844|588941596|FG008|Overall Study|Adverse Event|0|||
163064255|NCT00831844|588941597|FG009|Overall Study|Adverse Event|0|||
163064256|NCT00831844|588941588|FG000|Overall Study|Death|0|||
163064257|NCT00831844|588941589|FG001|Overall Study|Death|0|||
163064258|NCT00831844|588941590|FG002|Overall Study|Death|0|||
163064259|NCT00831844|588941591|FG003|Overall Study|Death|1|||
163064260|NCT00831844|588941592|FG004|Overall Study|Death|0|||
163064261|NCT00831844|588941593|FG005|Overall Study|Death|0|||
163064262|NCT00831844|588941594|FG006|Overall Study|Death|0|||
163064263|NCT00831844|588941595|FG007|Overall Study|Death|0|||
163064264|NCT00831844|588941596|FG008|Overall Study|Death|0|||
163064265|NCT00831844|588941597|FG009|Overall Study|Death|0|||
163064266|NCT00831844|588941588|FG000|Overall Study|Lack of Efficacy|8|||
163064267|NCT00831844|588941589|FG001|Overall Study|Lack of Efficacy|10|||
163024319|NCT01992653|588791147|FG005|Overall Study|Lost to Follow-up|0|||
163024320|NCT01992653|588791148|FG006|Overall Study|Lost to Follow-up|0|||
163024321|NCT01992653|588791149|FG007|Overall Study|Lost to Follow-up|1|||
163024322|NCT01992653|588791142|FG000|Overall Study|Study Completed|0|||
163024323|NCT01992653|588791143|FG001|Overall Study|Study Completed|0|||
163024324|NCT01992653|588791144|FG002|Overall Study|Study Completed|0|||
163024325|NCT01992653|588791145|FG003|Overall Study|Study Completed|0|||
163024326|NCT01992653|588791146|FG004|Overall Study|Study Completed|0|||
163024327|NCT01992653|588791147|FG005|Overall Study|Study Completed|0|||
163024328|NCT01992653|588791148|FG006|Overall Study|Study Completed|0|||
163024329|NCT01992653|588791149|FG007|Overall Study|Study Completed|1|||
163024330|NCT01992653|588791142|FG000|Overall Study|Disease Progression|0|||
163024331|NCT01992653|588791143|FG001|Overall Study|Disease Progression|0|||
163024332|NCT01992653|588791144|FG002|Overall Study|Disease Progression|0|||
163024333|NCT01992653|588791145|FG003|Overall Study|Disease Progression|0|||
163024334|NCT01992653|588791146|FG004|Overall Study|Disease Progression|0|||
163024335|NCT01992653|588791147|FG005|Overall Study|Disease Progression|0|||
163024336|NCT01992653|588791148|FG006|Overall Study|Disease Progression|4|||
163024337|NCT01992653|588791149|FG007|Overall Study|Disease Progression|0|||
163024338|NCT01435460|588791150|FG000|Overall Study|Adverse Event|2|||
163024339|NCT01435460|588791151|FG001|Overall Study|Adverse Event|1|||
163024340|NCT01435460|588791150|FG000|Overall Study|Lost to Follow-up|6|||
163024341|NCT01435460|588791151|FG001|Overall Study|Lost to Follow-up|1|||
163024342|NCT01435460|588791150|FG000|Overall Study|Withdrawal by Subject|1|||
163064268|NCT00831844|588941590|FG002|Overall Study|Lack of Efficacy|15|||
163064269|NCT00831844|588941591|FG003|Overall Study|Lack of Efficacy|8|||
163064270|NCT00831844|588941592|FG004|Overall Study|Lack of Efficacy|11|||
163064271|NCT00831844|588941593|FG005|Overall Study|Lack of Efficacy|17|||
163064272|NCT00831844|588941594|FG006|Overall Study|Lack of Efficacy|8|||
163064273|NCT00831844|588941595|FG007|Overall Study|Lack of Efficacy|9|||
163064274|NCT00831844|588941596|FG008|Overall Study|Lack of Efficacy|7|||
163064275|NCT00831844|588941597|FG009|Overall Study|Lack of Efficacy|0|||
163064276|NCT00831844|588941588|FG000|Overall Study|Physician Decision|0|||
163024343|NCT01435460|588791151|FG001|Overall Study|Withdrawal by Subject|3|||
163024344|NCT01435460|588791150|FG000|Overall Study|Protocol Violation|0|||
163024345|NCT01435460|588791151|FG001|Overall Study|Protocol Violation|1|||
163024346|NCT01435460|588791150|FG000|Overall Study|Did not meet eligibility criteria|2|||
163024347|NCT01435460|588791151|FG001|Overall Study|Did not meet eligibility criteria|0|||
163024348|NCT01706939|588791152|FG000|Pre Randomization|Screen Failure|1|||
163024349|NCT01706939|588791153|FG001|Pre Randomization|Screen Failure|0|||
163024350|NCT01706939|588791154|FG002|Pre Randomization|Screen Failure|0|||
163024351|NCT01706939|588791152|FG000|Pre Randomization|Ineligible for Randomization|1|||
163024352|NCT01706939|588791153|FG001|Pre Randomization|Ineligible for Randomization|0|||
163024353|NCT01706939|588791154|FG002|Pre Randomization|Ineligible for Randomization|0|||
163024354|NCT01706939|588791152|FG000|Pre Randomization|Withdrawal by Subject|1|||
163024355|NCT01706939|588791153|FG001|Pre Randomization|Withdrawal by Subject|0|||
163024356|NCT01706939|588791154|FG002|Pre Randomization|Withdrawal by Subject|0|||
163024357|NCT01706939|588791152|FG000|Randomization|Insufficient QoL survey compliance|0|||
163024358|NCT01706939|588791153|FG001|Randomization|Insufficient QoL survey compliance|1|||
163024359|NCT01706939|588791154|FG002|Randomization|Insufficient QoL survey compliance|1|||
163024360|NCT01706939|588791152|FG000|Randomization|Progression of disease|0|||
163024361|NCT01706939|588791153|FG001|Randomization|Progression of disease|2|||
163024362|NCT01706939|588791154|FG002|Randomization|Progression of disease|1|||
163024363|NCT01046903|588791155|FG000|Overall Study|Lost to Follow-up|16|||
163024364|NCT01046903|588791155|FG000|Overall Study|Adverse Event|4|||
163024365|NCT01046903|588791155|FG000|Overall Study|Withdrawal by Subject|3|||
163024366|NCT01046903|588791155|FG000|Overall Study|Other|5|||
163024367|NCT00977314|588791156|FG000|Overall Study|Withdrawal by Subject|1|||
163024368|NCT00977314|588791157|FG001|Overall Study|Withdrawal by Subject|0|||
163024369|NCT00977314|588791156|FG000|Overall Study|Physician Decision|1|||
163024370|NCT00977314|588791157|FG001|Overall Study|Physician Decision|0|||
163024371|NCT01343277|588791158|FG000|Overall Study|Other|3|||
163024372|NCT01343277|588791159|FG001|Overall Study|Other|3|||
163024373|NCT01343277|588791158|FG000|Overall Study|Withdrawal by Subject|18|||
163024374|NCT01343277|588791159|FG001|Overall Study|Withdrawal by Subject|13|||
163024375|NCT01343277|588791158|FG000|Overall Study|Physician Decision|1|||
163024376|NCT01343277|588791159|FG001|Overall Study|Physician Decision|2|||
163024377|NCT01343277|588791158|FG000|Overall Study|Death|10|||
163024378|NCT01343277|588791159|FG001|Overall Study|Death|1|||
163024379|NCT01343277|588791158|FG000|Overall Study|Adverse Event|67|||
163024380|NCT01343277|588791159|FG001|Overall Study|Adverse Event|13|||
163024381|NCT01343277|588791158|FG000|Overall Study|Disease progression|270|||
163024382|NCT01343277|588791159|FG001|Overall Study|Disease progression|138|||
163024383|NCT01343277|588791158|FG000|Overall Study|Randomized not treated|6|||
163024384|NCT01343277|588791159|FG001|Overall Study|Randomized not treated|21|||
163024385|NCT01343277|588791158|FG000|Overall Study|Treatment ongoing|8|||
163024386|NCT01343277|588791159|FG001|Overall Study|Treatment ongoing|2|||
163024387|NCT01343277|588791158|FG000|Overall Study|Subsequent anticancer therapy|1|||
163024388|NCT01343277|588791159|FG001|Overall Study|Subsequent anticancer therapy|0|||
163024389|NCT01894100|588791162|FG000|Overall Study|Lost to Follow-up|0|||
163024390|NCT01894100|588791163|FG001|Overall Study|Lost to Follow-up|1|||
163024391|NCT01894100|588791162|FG000|Overall Study|Withdrawal by Subject|3|||
163024392|NCT01894100|588791163|FG001|Overall Study|Withdrawal by Subject|0|||
163024393|NCT00135512|588791166|FG000|Overall Study|Adverse Event|56|||
163024394|NCT00135512|588791166|FG000|Overall Study|Lack of Efficacy|25|||
163024395|NCT00135512|588791166|FG000|Overall Study|Other|42|||
163024396|NCT01094301|588791167|FG000|Trial Stage|Withdrawal by Subject|1|||
163024397|NCT01094301|588791167|FG000|Implant Stage|Adverse Event|1|||
163024398|NCT01094301|588791167|FG000|Implant Stage|Protocol Violation|1|||
163024399|NCT01094301|588791167|FG000|Implant Stage|Withdrawal by Subject|2|||
163024400|NCT01094301|588791167|FG000|Implant Stage|No return of pain|4|||
163024401|NCT00556933|588791171|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
163024402|NCT00556933|588791172|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
163024403|NCT00556933|588791173|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
163024404|NCT00556933|588791174|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
163024405|NCT00556933|588791171|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
163024406|NCT00556933|588791172|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
163024407|NCT00556933|588791173|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
163024408|NCT00556933|588791174|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
163024409|NCT00556933|588791171|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
163217396|NCT00698581|589512191|FG001|Overall Study|Other reason|1|||
163024410|NCT00556933|588791172|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
163024411|NCT00556933|588791173|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
163024412|NCT00556933|588791174|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
163024413|NCT00556933|588791171|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
163024414|NCT00556933|588791172|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
163024415|NCT00556933|588791173|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
163024416|NCT00556933|588791174|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
163217397|NCT00698581|589512190|FG000|Overall Study|SAE, non-fatal|1|||
163217398|NCT00698581|589512191|FG001|Overall Study|SAE, non-fatal|0|||
163064277|NCT00831844|588941589|FG001|Overall Study|Physician Decision|1|||
163064278|NCT00831844|588941590|FG002|Overall Study|Physician Decision|3|||
163064279|NCT00831844|588941591|FG003|Overall Study|Physician Decision|1|||
163064280|NCT00831844|588941592|FG004|Overall Study|Physician Decision|1|||
163217399|NCT00698581|589512190|FG000|Overall Study|AE, non-serious non-fatal|4|||
163217400|NCT00698581|589512191|FG001|Overall Study|AE, non-serious non-fatal|0|||
163217401|NCT00698581|589512190|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
163217402|NCT00698581|589512191|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
163217403|NCT00698581|589512190|FG000|Overall Study|AE of unknown type|1|||
163217404|NCT00698581|589512191|FG001|Overall Study|AE of unknown type|0|||
163217405|NCT03760146|589512192|FG000|Overall Study|Adverse Event|11|||
163217406|NCT03760146|589512193|FG001|Overall Study|Adverse Event|8|||
163217407|NCT03760146|589512194|FG002|Overall Study|Adverse Event|0|||
163217408|NCT03760146|589512195|FG003|Overall Study|Adverse Event|0|||
163217409|NCT03760146|589512196|FG004|Overall Study|Adverse Event|0|||
163217410|NCT03760146|589512197|FG005|Overall Study|Adverse Event|0|||
163217411|NCT03760146|589512192|FG000|Overall Study|Death|1|||
163217412|NCT03760146|589512193|FG001|Overall Study|Death|0|||
163217413|NCT03760146|589512194|FG002|Overall Study|Death|0|||
163217414|NCT03760146|589512195|FG003|Overall Study|Death|0|||
163217415|NCT03760146|589512196|FG004|Overall Study|Death|0|||
163217416|NCT03760146|589512197|FG005|Overall Study|Death|0|||
163217417|NCT03760146|589512192|FG000|Overall Study|Lost to Follow-up|41|||
163217418|NCT03760146|589512193|FG001|Overall Study|Lost to Follow-up|28|||
163217419|NCT03760146|589512194|FG002|Overall Study|Lost to Follow-up|9|||
163217420|NCT03760146|589512195|FG003|Overall Study|Lost to Follow-up|2|||
163217421|NCT03760146|589512196|FG004|Overall Study|Lost to Follow-up|14|||
163217422|NCT03760146|589512197|FG005|Overall Study|Lost to Follow-up|8|||
163217423|NCT03760146|589512192|FG000|Overall Study|No longer met eligibility criteria|3|||
163330622|NCT03220724|589920625|FG007|Overall Study|Lost to Follow-up|1|||
163330623|NCT03220724|589920626|FG008|Overall Study|Lost to Follow-up|0|||
163330624|NCT03220724|589920618|FG000|Overall Study|Withdrawal by Subject|1|||
163330625|NCT03220724|589920619|FG001|Overall Study|Withdrawal by Subject|0|||
163330626|NCT03220724|589920620|FG002|Overall Study|Withdrawal by Subject|1|||
163330627|NCT03220724|589920621|FG003|Overall Study|Withdrawal by Subject|0|||
163330628|NCT03220724|589920622|FG004|Overall Study|Withdrawal by Subject|0|||
163024417|NCT00556933|588791171|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
163024418|NCT00556933|588791172|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
163024419|NCT00556933|588791173|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
163024420|NCT00556933|588791174|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
163024421|NCT00556933|588791171|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
163024422|NCT00556933|588791172|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
163024423|NCT00556933|588791173|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
163024424|NCT00556933|588791174|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
163024425|NCT00556933|588791171|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
163024426|NCT00556933|588791172|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
163024427|NCT00556933|588791173|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
163024428|NCT00556933|588791174|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
163024429|NCT00556933|588791171|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
163024430|NCT00556933|588791172|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
163024431|NCT00556933|588791173|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
163024432|NCT00556933|588791174|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
163024433|NCT00556933|588791171|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
163024434|NCT00556933|588791172|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
163024435|NCT00556933|588791173|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
163024436|NCT00556933|588791174|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
163024437|NCT00556933|588791171|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
163024438|NCT00556933|588791172|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
163024439|NCT00556933|588791173|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
163024440|NCT00556933|588791174|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
163024441|NCT00556933|588791171|FG000|CNI Withdrawal vs. Minimization|Death|0|||
163024442|NCT00556933|588791172|FG001|CNI Withdrawal vs. Minimization|Death|0|||
163024443|NCT00556933|588791173|FG002|CNI Withdrawal vs. Minimization|Death|0|||
163024444|NCT00556933|588791174|FG003|CNI Withdrawal vs. Minimization|Death|1|||
163064281|NCT00831844|588941593|FG005|Overall Study|Physician Decision|1|||
163217424|NCT03760146|589512193|FG001|Overall Study|No longer met eligibility criteria|9|||
163217425|NCT03760146|589512194|FG002|Overall Study|No longer met eligibility criteria|0|||
163217426|NCT03760146|589512195|FG003|Overall Study|No longer met eligibility criteria|0|||
163330629|NCT03220724|589920623|FG005|Overall Study|Withdrawal by Subject|0|||
163217427|NCT03760146|589512196|FG004|Overall Study|No longer met eligibility criteria|1|||
163217428|NCT03760146|589512197|FG005|Overall Study|No longer met eligibility criteria|0|||
163217429|NCT03760146|589512192|FG000|Overall Study|Protocol Violation|21|||
163217430|NCT03760146|589512193|FG001|Overall Study|Protocol Violation|13|||
163330630|NCT03220724|589920624|FG006|Overall Study|Withdrawal by Subject|0|||
163330631|NCT03220724|589920625|FG007|Overall Study|Withdrawal by Subject|0|||
163330632|NCT03220724|589920626|FG008|Overall Study|Withdrawal by Subject|0|||
163330633|NCT01613417|589920627|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
163330634|NCT01613417|589920628|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
163330635|NCT00047385|589920629|FG000|Overall Study|Death before any screening|2|||
163024445|NCT00767455|588791175|FG000|Overall Study|Investigator error|19|||
163024446|NCT00746564|588791176|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
163024447|NCT01827267|588791177|FG000|Overall Study|Did not receive study drug|1|||
163024448|NCT01827267|588791178|FG001|Overall Study|Did not receive study drug|1|||
163024449|NCT01827267|588791177|FG000|Overall Study|Physician Decision|1|||
163024450|NCT01827267|588791178|FG001|Overall Study|Physician Decision|0|||
163024451|NCT01827267|588791177|FG000|Overall Study|Disease Progression|1|||
163024452|NCT01827267|588791178|FG001|Overall Study|Disease Progression|1|||
163024453|NCT01827267|588791177|FG000|Overall Study|Sponsor Discontinued Study|2|||
163024454|NCT01827267|588791178|FG001|Overall Study|Sponsor Discontinued Study|8|||
163024455|NCT01827267|588791177|FG000|Overall Study|Still on study|0|||
163024456|NCT01827267|588791178|FG001|Overall Study|Still on study|2|||
163024457|NCT02147158|588791185|FG000|Treatment Course 1|Adverse Event|1|||
163024458|NCT02147158|588791186|FG001|Treatment Course 1|Adverse Event|4|||
163024459|NCT02147158|588791187|FG002|Treatment Course 1|Adverse Event|3|||
163024460|NCT02147158|588791188|FG003|Treatment Course 1|Adverse Event|4|||
163024461|NCT02147158|588791189|FG004|Treatment Course 1|Adverse Event|1|||
163024462|NCT02147158|588791190|FG005|Treatment Course 1|Adverse Event|2|||
163024463|NCT02147158|588791185|FG000|Treatment Course 1|Lost to Follow-up|2|||
163024464|NCT02147158|588791186|FG001|Treatment Course 1|Lost to Follow-up|4|||
163024465|NCT02147158|588791187|FG002|Treatment Course 1|Lost to Follow-up|3|||
163024466|NCT02147158|588791188|FG003|Treatment Course 1|Lost to Follow-up|3|||
163024467|NCT02147158|588791189|FG004|Treatment Course 1|Lost to Follow-up|2|||
163024468|NCT02147158|588791190|FG005|Treatment Course 1|Lost to Follow-up|4|||
163024469|NCT02147158|588791185|FG000|Treatment Course 1|Protocol Violation|0|||
163024470|NCT02147158|588791186|FG001|Treatment Course 1|Protocol Violation|0|||
163024471|NCT02147158|588791187|FG002|Treatment Course 1|Protocol Violation|1|||
163024472|NCT02147158|588791188|FG003|Treatment Course 1|Protocol Violation|1|||
163024473|NCT02147158|588791189|FG004|Treatment Course 1|Protocol Violation|0|||
163024474|NCT02147158|588791190|FG005|Treatment Course 1|Protocol Violation|0|||
163024475|NCT02147158|588791185|FG000|Treatment Course 1|Withdrawal of Consent|1|||
163024476|NCT02147158|588791186|FG001|Treatment Course 1|Withdrawal of Consent|1|||
163024477|NCT02147158|588791187|FG002|Treatment Course 1|Withdrawal of Consent|1|||
163024478|NCT02147158|588791188|FG003|Treatment Course 1|Withdrawal of Consent|5|||
163024479|NCT02147158|588791189|FG004|Treatment Course 1|Withdrawal of Consent|3|||
163024480|NCT02147158|588791190|FG005|Treatment Course 1|Withdrawal of Consent|2|||
163024481|NCT02147158|588791185|FG000|Off-Treatment Interval 1|Adverse Event|1|||
163024482|NCT02147158|588791186|FG001|Off-Treatment Interval 1|Adverse Event|0|||
163024483|NCT02147158|588791187|FG002|Off-Treatment Interval 1|Adverse Event|0|||
163024484|NCT02147158|588791188|FG003|Off-Treatment Interval 1|Adverse Event|1|||
163024485|NCT02147158|588791189|FG004|Off-Treatment Interval 1|Adverse Event|0|||
163024486|NCT02147158|588791190|FG005|Off-Treatment Interval 1|Adverse Event|0|||
163024487|NCT02147158|588791185|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
163024488|NCT02147158|588791186|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
163024489|NCT02147158|588791187|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
163024490|NCT02147158|588791188|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
163024491|NCT02147158|588791189|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
163024492|NCT02147158|588791190|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
163024493|NCT02147158|588791185|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
163024494|NCT02147158|588791186|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
163024495|NCT02147158|588791187|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
163024496|NCT02147158|588791188|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
163024497|NCT02147158|588791189|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
163024498|NCT02147158|588791190|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
163024499|NCT02147158|588791185|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
163024500|NCT02147158|588791186|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
163024501|NCT02147158|588791187|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
163024502|NCT02147158|588791188|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
163024503|NCT02147158|588791189|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
163024504|NCT02147158|588791190|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
163024505|NCT02147158|588791185|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
163024506|NCT02147158|588791186|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
163064282|NCT00831844|588941594|FG006|Overall Study|Physician Decision|0|||
163024507|NCT02147158|588791187|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
163064283|NCT00831844|588941595|FG007|Overall Study|Physician Decision|0|||
163330636|NCT00047385|589920630|FG001|Overall Study|Death before any screening|5|||
163024508|NCT02147158|588791188|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
163024509|NCT02147158|588791189|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
163217431|NCT03760146|589512194|FG002|Overall Study|Protocol Violation|1|||
163217432|NCT03760146|589512195|FG003|Overall Study|Protocol Violation|0|||
163217433|NCT03760146|589512196|FG004|Overall Study|Protocol Violation|1|||
163217434|NCT03760146|589512197|FG005|Overall Study|Protocol Violation|0|||
163024510|NCT02147158|588791190|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
163024511|NCT02147158|588791185|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
163024512|NCT02147158|588791186|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
163024513|NCT02147158|588791187|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
163024514|NCT02147158|588791188|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
163024515|NCT02147158|588791189|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
163024516|NCT02147158|588791190|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
163024517|NCT02147158|588791185|FG000|Treatment Course 2|Adverse Event|0|||
163024518|NCT02147158|588791186|FG001|Treatment Course 2|Adverse Event|4|||
163024519|NCT02147158|588791187|FG002|Treatment Course 2|Adverse Event|2|||
163024520|NCT02147158|588791188|FG003|Treatment Course 2|Adverse Event|1|||
163024521|NCT02147158|588791189|FG004|Treatment Course 2|Adverse Event|0|||
163024522|NCT02147158|588791190|FG005|Treatment Course 2|Adverse Event|1|||
163024523|NCT02147158|588791185|FG000|Treatment Course 2|Withdrawal of Consent|0|||
163024524|NCT02147158|588791186|FG001|Treatment Course 2|Withdrawal of Consent|1|||
163024525|NCT02147158|588791187|FG002|Treatment Course 2|Withdrawal of Consent|2|||
163024526|NCT02147158|588791188|FG003|Treatment Course 2|Withdrawal of Consent|3|||
163024527|NCT02147158|588791189|FG004|Treatment Course 2|Withdrawal of Consent|0|||
163024528|NCT02147158|588791190|FG005|Treatment Course 2|Withdrawal of Consent|0|||
163024529|NCT02147158|588791185|FG000|Treatment Course 2|Lost to Follow-up|1|||
163024530|NCT02147158|588791186|FG001|Treatment Course 2|Lost to Follow-up|0|||
163024531|NCT02147158|588791187|FG002|Treatment Course 2|Lost to Follow-up|1|||
163024532|NCT02147158|588791188|FG003|Treatment Course 2|Lost to Follow-up|1|||
163024533|NCT02147158|588791189|FG004|Treatment Course 2|Lost to Follow-up|0|||
163024534|NCT02147158|588791190|FG005|Treatment Course 2|Lost to Follow-up|1|||
163024535|NCT02147158|588791185|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
163024536|NCT02147158|588791186|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
163024537|NCT02147158|588791187|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
163024538|NCT02147158|588791188|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
163024539|NCT02147158|588791189|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
163024540|NCT02147158|588791190|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
163024541|NCT02147158|588791185|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
163024542|NCT02147158|588791186|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
163024543|NCT02147158|588791187|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
163024544|NCT02147158|588791188|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
163024545|NCT02147158|588791189|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
163024546|NCT02147158|588791190|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
163024547|NCT02147158|588791185|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
163024548|NCT02147158|588791186|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
163024549|NCT02147158|588791187|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
163024550|NCT02147158|588791188|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
163024551|NCT02147158|588791189|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
163024552|NCT02147158|588791190|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
163024553|NCT02147158|588791185|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
163024554|NCT02147158|588791186|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
163024555|NCT02147158|588791187|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
163024556|NCT02147158|588791188|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
163024557|NCT02147158|588791189|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
163024558|NCT02147158|588791190|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
163024559|NCT02147158|588791185|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
163024560|NCT02147158|588791186|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
163024561|NCT02147158|588791187|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
163024562|NCT02147158|588791188|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
163024563|NCT02147158|588791189|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
163024564|NCT02147158|588791190|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
163024565|NCT04520997|588791191|FG000|Overall Study|Lost to Follow-up|1|||
163024566|NCT04520997|588791192|FG001|Overall Study|Lost to Follow-up|1|||
163024567|NCT04520997|588791191|FG000|Overall Study|Withdrawal by Subject|1|||
163217435|NCT03760146|589512192|FG000|Overall Study|Withdrawal by Subject|19|||
163024568|NCT04520997|588791192|FG001|Overall Study|Withdrawal by Subject|0|||
163024569|NCT04520997|588791191|FG000|Overall Study|Not Treated|0|||
163024570|NCT04520997|588791192|FG001|Overall Study|Not Treated|1|||
163024571|NCT03689374|588791193|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
163024572|NCT03689374|588791194|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
163024573|NCT03689374|588791195|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
163217436|NCT03760146|589512193|FG001|Overall Study|Withdrawal by Subject|20|||
163217437|NCT03760146|589512194|FG002|Overall Study|Withdrawal by Subject|1|||
163217438|NCT03760146|589512195|FG003|Overall Study|Withdrawal by Subject|0|||
163217439|NCT03760146|589512196|FG004|Overall Study|Withdrawal by Subject|1|||
163024574|NCT03689374|588791193|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
163024575|NCT03689374|588791194|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
163024576|NCT03689374|588791195|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
163024577|NCT03689374|588791193|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
163024578|NCT03689374|588791194|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
163024579|NCT03689374|588791195|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
163024580|NCT03689374|588791193|FG000|Treatment Period (Week 0 to 52)|Death|0|||
163024581|NCT03689374|588791194|FG001|Treatment Period (Week 0 to 52)|Death|11|||
163024582|NCT03689374|588791195|FG002|Treatment Period (Week 0 to 52)|Death|1|||
163024583|NCT05367973|588791196|FG000|Overall Study|Adverse Event|0|||
163024584|NCT05367973|588791197|FG001|Overall Study|Adverse Event|2|||
163024585|NCT00986921|588791198|FG000|Overall Study|Physician Decision|1|||
163024586|NCT00986921|588791199|FG001|Overall Study|Physician Decision|0|||
163024587|NCT01758731|588791200|FG000|Overall Study|Physician Decision|1|||
163024588|NCT04445714|588791201|FG000|Overall Study|Discontinuation of the study|14|||
163024589|NCT04445714|588791201|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
163024590|NCT04445714|588791201|FG000|Overall Study|Withdrawal of Informed Consent|8|||
163024591|NCT02396420|588791206|FG000|Overall Study|Death|1|||
163024592|NCT01273623|588791208|FG000|Overall Study|did not meet IVUS criteria|29|||
163024593|NCT02122887|588791216|FG000|Overall Study|Withdrawal by Subject|20|||
163024594|NCT02122887|588791217|FG001|Overall Study|Withdrawal by Subject|2|||
163024595|NCT03320850|588792671|FG000|Overall Study|Lost to Follow-up|0|||
163024596|NCT03320850|588792672|FG001|Overall Study|Lost to Follow-up|0|||
163024597|NCT03320850|588792673|FG002|Overall Study|Lost to Follow-up|0|||
163024598|NCT03320850|588792674|FG003|Overall Study|Lost to Follow-up|0|||
163024599|NCT03320850|588792675|FG004|Overall Study|Lost to Follow-up|1|||
163024600|NCT03320850|588792676|FG005|Overall Study|Lost to Follow-up|2|||
163024601|NCT03320850|588792677|FG006|Overall Study|Lost to Follow-up|2|||
163024602|NCT03320850|588792678|FG007|Overall Study|Lost to Follow-up|0|||
163024603|NCT03320850|588792679|FG008|Overall Study|Lost to Follow-up|6|||
163024604|NCT03320850|588792680|FG009|Overall Study|Lost to Follow-up|4|||
163024605|NCT03320850|588792671|FG000|Overall Study|Withdrawal by Subject|0|||
163024606|NCT03320850|588792672|FG001|Overall Study|Withdrawal by Subject|0|||
163024607|NCT03320850|588792673|FG002|Overall Study|Withdrawal by Subject|0|||
163024608|NCT03320850|588792674|FG003|Overall Study|Withdrawal by Subject|0|||
163024609|NCT03320850|588792675|FG004|Overall Study|Withdrawal by Subject|1|||
163024610|NCT03320850|588792676|FG005|Overall Study|Withdrawal by Subject|2|||
163024611|NCT03320850|588792677|FG006|Overall Study|Withdrawal by Subject|4|||
163217440|NCT03760146|589512197|FG005|Overall Study|Withdrawal by Subject|0|||
163217441|NCT00449644|589512198|FG000|Overall Study|Adverse Event|0|||
163217442|NCT00449644|589512199|FG001|Overall Study|Adverse Event|0|||
163217443|NCT00449644|589512200|FG002|Overall Study|Adverse Event|3|||
163217444|NCT00449644|589512201|FG003|Overall Study|Adverse Event|5|||
163217445|NCT00449644|589512198|FG000|Overall Study|Death|1|||
163217446|NCT00449644|589512199|FG001|Overall Study|Death|0|||
163217447|NCT00449644|589512200|FG002|Overall Study|Death|6|||
163217448|NCT00449644|589512201|FG003|Overall Study|Death|1|||
163217449|NCT00449644|589512198|FG000|Overall Study|Lost to Follow-up|1|||
163217450|NCT00449644|589512199|FG001|Overall Study|Lost to Follow-up|1|||
163217451|NCT00449644|589512200|FG002|Overall Study|Lost to Follow-up|5|||
163217452|NCT00449644|589512201|FG003|Overall Study|Lost to Follow-up|3|||
163217453|NCT00449644|589512198|FG000|Overall Study|Pregnancy|0|||
163217454|NCT00449644|589512199|FG001|Overall Study|Pregnancy|0|||
163217455|NCT00449644|589512200|FG002|Overall Study|Pregnancy|3|||
163217456|NCT00449644|589512201|FG003|Overall Study|Pregnancy|2|||
163217457|NCT00449644|589512198|FG000|Overall Study|Protocol Violation|4|||
163217458|NCT00449644|589512199|FG001|Overall Study|Protocol Violation|4|||
163217459|NCT00449644|589512200|FG002|Overall Study|Protocol Violation|3|||
163217460|NCT00449644|589512201|FG003|Overall Study|Protocol Violation|7|||
163217461|NCT00449644|589512198|FG000|Overall Study|Withdrawal by Subject|3|||
163217462|NCT00449644|589512199|FG001|Overall Study|Withdrawal by Subject|4|||
163217463|NCT00449644|589512200|FG002|Overall Study|Withdrawal by Subject|6|||
163217464|NCT00449644|589512201|FG003|Overall Study|Withdrawal by Subject|7|||
163217465|NCT00449644|589512198|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
163217466|NCT00449644|589512199|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
163217467|NCT00449644|589512200|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
163217468|NCT00449644|589512201|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
163024612|NCT03320850|588792678|FG007|Overall Study|Withdrawal by Subject|5|||
163217469|NCT00449644|589512198|FG000|Overall Study|Other|1|||
163217470|NCT00449644|589512199|FG001|Overall Study|Other|4|||
163217471|NCT00449644|589512200|FG002|Overall Study|Other|1|||
163217472|NCT00449644|589512201|FG003|Overall Study|Other|0|||
163217473|NCT00449644|589512198|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
163217474|NCT00449644|589512199|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
163217475|NCT00449644|589512200|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
163217476|NCT00449644|589512201|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
163024613|NCT03320850|588792679|FG008|Overall Study|Withdrawal by Subject|2|||
163024614|NCT03320850|588792680|FG009|Overall Study|Withdrawal by Subject|1|||
163024615|NCT03320850|588792671|FG000|Overall Study|Lack of Efficacy|0|||
163024616|NCT03320850|588792672|FG001|Overall Study|Lack of Efficacy|0|||
163024617|NCT03320850|588792673|FG002|Overall Study|Lack of Efficacy|0|||
163024618|NCT03320850|588792674|FG003|Overall Study|Lack of Efficacy|1|||
163024619|NCT03320850|588792675|FG004|Overall Study|Lack of Efficacy|0|||
163024620|NCT03320850|588792676|FG005|Overall Study|Lack of Efficacy|1|||
163024621|NCT03320850|588792677|FG006|Overall Study|Lack of Efficacy|0|||
163024622|NCT03320850|588792678|FG007|Overall Study|Lack of Efficacy|2|||
163024623|NCT03320850|588792679|FG008|Overall Study|Lack of Efficacy|0|||
163024624|NCT03320850|588792680|FG009|Overall Study|Lack of Efficacy|3|||
163024625|NCT03320850|588792671|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
163024626|NCT03320850|588792672|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
163024627|NCT03320850|588792673|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
163024628|NCT03320850|588792674|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
163024629|NCT03320850|588792675|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
163024630|NCT03320850|588792676|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
163024631|NCT03320850|588792677|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
163024632|NCT03320850|588792678|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
163024633|NCT03320850|588792679|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
163024634|NCT03320850|588792680|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
163024635|NCT03320850|588792671|FG000|Overall Study|Adverse Event|0|||
163024636|NCT03320850|588792672|FG001|Overall Study|Adverse Event|0|||
163024637|NCT03320850|588792673|FG002|Overall Study|Adverse Event|0|||
163024638|NCT03320850|588792674|FG003|Overall Study|Adverse Event|0|||
163024639|NCT03320850|588792675|FG004|Overall Study|Adverse Event|0|||
163024640|NCT03320850|588792676|FG005|Overall Study|Adverse Event|2|||
163024641|NCT03320850|588792677|FG006|Overall Study|Adverse Event|1|||
163024642|NCT03320850|588792678|FG007|Overall Study|Adverse Event|0|||
163024643|NCT03320850|588792679|FG008|Overall Study|Adverse Event|2|||
163024644|NCT03320850|588792680|FG009|Overall Study|Adverse Event|0|||
163024645|NCT03320850|588792671|FG000|Overall Study|Reason Not Specified|0|||
163024646|NCT03320850|588792672|FG001|Overall Study|Reason Not Specified|0|||
163024647|NCT03320850|588792673|FG002|Overall Study|Reason Not Specified|0|||
163024648|NCT03320850|588792674|FG003|Overall Study|Reason Not Specified|0|||
163024649|NCT03320850|588792675|FG004|Overall Study|Reason Not Specified|0|||
163024650|NCT03320850|588792676|FG005|Overall Study|Reason Not Specified|1|||
163024651|NCT03320850|588792677|FG006|Overall Study|Reason Not Specified|0|||
163024652|NCT03320850|588792678|FG007|Overall Study|Reason Not Specified|0|||
163024653|NCT03320850|588792679|FG008|Overall Study|Reason Not Specified|0|||
163024654|NCT03320850|588792680|FG009|Overall Study|Reason Not Specified|1|||
163024655|NCT02002533|588792683|FG000|Overall Study|Withdrawal by Subject|6|||
163024656|NCT02002533|588792684|FG001|Overall Study|Withdrawal by Subject|13|||
163024657|NCT02002533|588792683|FG000|Overall Study|Protocol Violation|0|||
163024658|NCT02002533|588792684|FG001|Overall Study|Protocol Violation|1|||
163024659|NCT02002533|588792683|FG000|Overall Study|Adverse Event|0|||
163024660|NCT02002533|588792684|FG001|Overall Study|Adverse Event|3|||
163024661|NCT02002533|588792683|FG000|Overall Study|Lost to Follow-up|0|||
163024662|NCT02002533|588792684|FG001|Overall Study|Lost to Follow-up|1|||
163024663|NCT02086448|588792690|FG000|Overall Study|Withdrawal by Subject|1|||
163024664|NCT02086448|588792691|FG001|Overall Study|Withdrawal by Subject|0|||
163024665|NCT02086448|588792692|FG002|Overall Study|Withdrawal by Subject|0|||
163024666|NCT02086448|588792693|FG003|Overall Study|Withdrawal by Subject|2|||
163024667|NCT02031640|588792702|FG000|Screening Period|Adverse Event|1|||
163024668|NCT02031640|588792703|FG001|Screening Period|Adverse Event|0|||
163024669|NCT02031640|588792704|FG002|Screening Period|Adverse Event|0|||
163024670|NCT02031640|588792705|FG003|Screening Period|Adverse Event|0|||
163024671|NCT02031640|588792706|FG004|Screening Period|Adverse Event|0|||
163024672|NCT02031640|588792707|FG005|Screening Period|Adverse Event|0|||
163024673|NCT02031640|588792702|FG000|Screening Period|Withdrawal by Subject|29|||
163024674|NCT02031640|588792703|FG001|Screening Period|Withdrawal by Subject|0|||
163330637|NCT00047385|589920629|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
163330638|NCT00047385|589920630|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
163024675|NCT02031640|588792704|FG002|Screening Period|Withdrawal by Subject|0|||
163024676|NCT02031640|588792705|FG003|Screening Period|Withdrawal by Subject|0|||
163024677|NCT02031640|588792706|FG004|Screening Period|Withdrawal by Subject|0|||
163024678|NCT02031640|588792707|FG005|Screening Period|Withdrawal by Subject|0|||
163024679|NCT02031640|588792702|FG000|Screening Period|Inclusion criteria not met|312|||
163024680|NCT02031640|588792703|FG001|Screening Period|Inclusion criteria not met|0|||
163024681|NCT02031640|588792704|FG002|Screening Period|Inclusion criteria not met|0|||
163330639|NCT00047385|589920629|FG000|Overall Study|Eligible for screening but had no screen|260|||
163024682|NCT02031640|588792705|FG003|Screening Period|Inclusion criteria not met|0|||
163024683|NCT02031640|588792706|FG004|Screening Period|Inclusion criteria not met|0|||
163024684|NCT02031640|588792707|FG005|Screening Period|Inclusion criteria not met|0|||
163064284|NCT00831844|588941596|FG008|Overall Study|Physician Decision|1|||
163064285|NCT00831844|588941597|FG009|Overall Study|Physician Decision|0|||
163064286|NCT00831844|588941588|FG000|Overall Study|Withdrawal by Subject|0|||
163064287|NCT00831844|588941589|FG001|Overall Study|Withdrawal by Subject|0|||
163064288|NCT00831844|588941590|FG002|Overall Study|Withdrawal by Subject|1|||
163064289|NCT00831844|588941591|FG003|Overall Study|Withdrawal by Subject|0|||
163064290|NCT00831844|588941592|FG004|Overall Study|Withdrawal by Subject|0|||
163064291|NCT00831844|588941593|FG005|Overall Study|Withdrawal by Subject|0|||
163064292|NCT00831844|588941594|FG006|Overall Study|Withdrawal by Subject|0|||
163064293|NCT00831844|588941595|FG007|Overall Study|Withdrawal by Subject|1|||
163064294|NCT00831844|588941596|FG008|Overall Study|Withdrawal by Subject|1|||
163064295|NCT00831844|588941597|FG009|Overall Study|Withdrawal by Subject|0|||
163064296|NCT00831844|588941588|FG000|Overall Study|Ineligible|0|||
163064297|NCT00831844|588941589|FG001|Overall Study|Ineligible|1|||
163064298|NCT00831844|588941590|FG002|Overall Study|Ineligible|1|||
163064299|NCT00831844|588941591|FG003|Overall Study|Ineligible|0|||
163064300|NCT00831844|588941592|FG004|Overall Study|Ineligible|1|||
163064301|NCT00831844|588941593|FG005|Overall Study|Ineligible|0|||
163064302|NCT00831844|588941594|FG006|Overall Study|Ineligible|0|||
163064303|NCT00831844|588941595|FG007|Overall Study|Ineligible|0|||
163064304|NCT00831844|588941596|FG008|Overall Study|Ineligible|0|||
163064305|NCT00831844|588941597|FG009|Overall Study|Ineligible|0|||
163064306|NCT03980223|588941600|FG000|Overall Study|Lost to Follow-up|3|||
163064307|NCT03980223|588941601|FG001|Overall Study|Lost to Follow-up|7|||
163064308|NCT03980223|588941602|FG002|Overall Study|Lost to Follow-up|10|||
163064309|NCT03980223|588941603|FG003|Overall Study|Lost to Follow-up|8|||
163064310|NCT03980223|588941600|FG000|Overall Study|Withdrawal by Subject|0|||
163064311|NCT03980223|588941601|FG001|Overall Study|Withdrawal by Subject|0|||
163064312|NCT03980223|588941602|FG002|Overall Study|Withdrawal by Subject|1|||
163064313|NCT03980223|588941603|FG003|Overall Study|Withdrawal by Subject|2|||
163064314|NCT03980223|588941600|FG000|Overall Study|Physician Decision|0|||
163064315|NCT03980223|588941601|FG001|Overall Study|Physician Decision|0|||
163064316|NCT03980223|588941602|FG002|Overall Study|Physician Decision|1|||
163064317|NCT03980223|588941603|FG003|Overall Study|Physician Decision|0|||
163064318|NCT03980223|588941600|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
163064319|NCT03980223|588941601|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
163064320|NCT03980223|588941602|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
163064321|NCT03980223|588941603|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
163064322|NCT02460289|588941607|FG000|Overall Study|Adverse Event|1|||
163064323|NCT02460289|588941607|FG000|Overall Study|Withdrawal by Subject|8|||
163064324|NCT02460289|588941607|FG000|Overall Study|Lost to Follow-up|1|||
163064325|NCT02916927|588941608|FG000|Overall Study|Discharged prior to study drug receipt|0|||
163064326|NCT02916927|588941609|FG001|Overall Study|Discharged prior to study drug receipt|2|||
163064327|NCT02916927|588941608|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
163064328|NCT02916927|588941609|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
163064329|NCT02916927|588941608|FG000|Overall Study|Withdrawal before first time point|1|||
163064330|NCT02916927|588941609|FG001|Overall Study|Withdrawal before first time point|0|||
163064331|NCT01020123|588941610|FG000|Main Period|Withdrawal by Subject|6|||
163064332|NCT01020123|588941611|FG001|Main Period|Withdrawal by Subject|5|||
163064333|NCT01020123|588941612|FG002|Main Period|Withdrawal by Subject|3|||
163064334|NCT01020123|588941613|FG003|Main Period|Withdrawal by Subject|1|||
163064335|NCT01020123|588941614|FG004|Main Period|Withdrawal by Subject|6|||
163064336|NCT01020123|588941615|FG005|Main Period|Withdrawal by Subject|3|||
163064337|NCT01020123|588941616|FG006|Main Period|Withdrawal by Subject|2|||
163064338|NCT01020123|588941610|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
163064339|NCT01020123|588941611|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
163064340|NCT01020123|588941612|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
163064341|NCT01020123|588941613|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
163064342|NCT01020123|588941614|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
163064343|NCT01020123|588941615|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
163064344|NCT01020123|588941616|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
163064345|NCT01020123|588941610|FG000|Main Period|Adverse Event|5|||
163064346|NCT01020123|588941611|FG001|Main Period|Adverse Event|2|||
163064347|NCT01020123|588941612|FG002|Main Period|Adverse Event|2|||
163064348|NCT01020123|588941613|FG003|Main Period|Adverse Event|1|||
163064349|NCT01020123|588941614|FG004|Main Period|Adverse Event|1|||
163064350|NCT01020123|588941615|FG005|Main Period|Adverse Event|2|||
163064351|NCT01020123|588941616|FG006|Main Period|Adverse Event|1|||
163064352|NCT01020123|588941610|FG000|Main Period|Protocol Violation|4|||
163064353|NCT01020123|588941611|FG001|Main Period|Protocol Violation|4|||
163064354|NCT01020123|588941612|FG002|Main Period|Protocol Violation|2|||
163064355|NCT01020123|588941613|FG003|Main Period|Protocol Violation|5|||
163064356|NCT01020123|588941614|FG004|Main Period|Protocol Violation|2|||
163064357|NCT01020123|588941615|FG005|Main Period|Protocol Violation|3|||
163064358|NCT01020123|588941616|FG006|Main Period|Protocol Violation|2|||
163064359|NCT01020123|588941610|FG000|Main Period|Lost to Follow-up|0|||
163024685|NCT02031640|588792702|FG000|Screening Period|Exclusion criteria met|30|||
163024686|NCT02031640|588792703|FG001|Screening Period|Exclusion criteria met|0|||
163024687|NCT02031640|588792704|FG002|Screening Period|Exclusion criteria met|0|||
163024688|NCT02031640|588792705|FG003|Screening Period|Exclusion criteria met|0|||
163024689|NCT02031640|588792706|FG004|Screening Period|Exclusion criteria met|0|||
163024690|NCT02031640|588792707|FG005|Screening Period|Exclusion criteria met|0|||
163024691|NCT02031640|588792702|FG000|Screening Period|Lost to Follow-up|14|||
163024692|NCT02031640|588792703|FG001|Screening Period|Lost to Follow-up|0|||
163024693|NCT02031640|588792704|FG002|Screening Period|Lost to Follow-up|0|||
163024694|NCT02031640|588792705|FG003|Screening Period|Lost to Follow-up|0|||
163024695|NCT02031640|588792706|FG004|Screening Period|Lost to Follow-up|0|||
163024696|NCT02031640|588792707|FG005|Screening Period|Lost to Follow-up|0|||
163024697|NCT02031640|588792702|FG000|Screening Period|Enrollment closed|26|||
163024698|NCT02031640|588792703|FG001|Screening Period|Enrollment closed|0|||
163024699|NCT02031640|588792704|FG002|Screening Period|Enrollment closed|0|||
163024700|NCT02031640|588792705|FG003|Screening Period|Enrollment closed|0|||
163024701|NCT02031640|588792706|FG004|Screening Period|Enrollment closed|0|||
163024702|NCT02031640|588792707|FG005|Screening Period|Enrollment closed|0|||
163024703|NCT02031640|588792702|FG000|Run-In Period|Adverse Event|4|||
163024704|NCT02031640|588792703|FG001|Run-In Period|Adverse Event|0|||
163024705|NCT02031640|588792704|FG002|Run-In Period|Adverse Event|0|||
163024706|NCT02031640|588792705|FG003|Run-In Period|Adverse Event|0|||
163024707|NCT02031640|588792706|FG004|Run-In Period|Adverse Event|0|||
163024708|NCT02031640|588792707|FG005|Run-In Period|Adverse Event|0|||
163024709|NCT02031640|588792702|FG000|Run-In Period|Withdrawal by Subject|17|||
163024710|NCT02031640|588792703|FG001|Run-In Period|Withdrawal by Subject|0|||
163024711|NCT02031640|588792704|FG002|Run-In Period|Withdrawal by Subject|0|||
163024712|NCT02031640|588792705|FG003|Run-In Period|Withdrawal by Subject|0|||
163024713|NCT02031640|588792706|FG004|Run-In Period|Withdrawal by Subject|0|||
163024714|NCT02031640|588792707|FG005|Run-In Period|Withdrawal by Subject|0|||
163024715|NCT02031640|588792702|FG000|Run-In Period|Inclusion criteria not met|38|||
163024716|NCT02031640|588792703|FG001|Run-In Period|Inclusion criteria not met|0|||
163024717|NCT02031640|588792704|FG002|Run-In Period|Inclusion criteria not met|0|||
163024718|NCT02031640|588792705|FG003|Run-In Period|Inclusion criteria not met|0|||
163024719|NCT02031640|588792706|FG004|Run-In Period|Inclusion criteria not met|0|||
163024720|NCT02031640|588792707|FG005|Run-In Period|Inclusion criteria not met|0|||
163024721|NCT02031640|588792702|FG000|Run-In Period|Exclusion criteria met|8|||
163024722|NCT02031640|588792703|FG001|Run-In Period|Exclusion criteria met|0|||
163024723|NCT02031640|588792704|FG002|Run-In Period|Exclusion criteria met|0|||
163024724|NCT02031640|588792705|FG003|Run-In Period|Exclusion criteria met|0|||
163024725|NCT02031640|588792706|FG004|Run-In Period|Exclusion criteria met|0|||
163024726|NCT02031640|588792707|FG005|Run-In Period|Exclusion criteria met|0|||
163024727|NCT02031640|588792702|FG000|Run-In Period|Randomization criteria not met|85|||
163024728|NCT02031640|588792703|FG001|Run-In Period|Randomization criteria not met|0|||
163024729|NCT02031640|588792704|FG002|Run-In Period|Randomization criteria not met|0|||
163024730|NCT02031640|588792705|FG003|Run-In Period|Randomization criteria not met|0|||
163024731|NCT02031640|588792706|FG004|Run-In Period|Randomization criteria not met|0|||
163024732|NCT02031640|588792707|FG005|Run-In Period|Randomization criteria not met|0|||
163024733|NCT02031640|588792702|FG000|Run-In Period|Various administrative reasons|17|||
163024734|NCT02031640|588792703|FG001|Run-In Period|Various administrative reasons|0|||
163024735|NCT02031640|588792704|FG002|Run-In Period|Various administrative reasons|0|||
163024736|NCT02031640|588792705|FG003|Run-In Period|Various administrative reasons|0|||
163024737|NCT02031640|588792706|FG004|Run-In Period|Various administrative reasons|0|||
163024738|NCT02031640|588792707|FG005|Run-In Period|Various administrative reasons|0|||
163024739|NCT02031640|588792702|FG000|Double-blind Treatment Period|Protocol deviation|0|||
163024740|NCT02031640|588792703|FG001|Double-blind Treatment Period|Protocol deviation|2|||
163024741|NCT02031640|588792704|FG002|Double-blind Treatment Period|Protocol deviation|0|||
163024742|NCT02031640|588792705|FG003|Double-blind Treatment Period|Protocol deviation|1|||
163024743|NCT02031640|588792706|FG004|Double-blind Treatment Period|Protocol deviation|3|||
163024744|NCT02031640|588792707|FG005|Double-blind Treatment Period|Protocol deviation|1|||
163330640|NCT00047385|589920630|FG001|Overall Study|Eligible for screening but had no screen|492|||
163330641|NCT03865732|589920631|FG000|Overall Study|Adverse Event|0|||
163330642|NCT03865732|589920632|FG001|Overall Study|Adverse Event|1|||
163024745|NCT02031640|588792702|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
163024746|NCT02031640|588792703|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
163024747|NCT02031640|588792704|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
163024748|NCT02031640|588792705|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
163024749|NCT02031640|588792706|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
163330643|NCT00454194|589920633|FG000|Overall Study|Adverse Event|7|||
163330644|NCT00454194|589920634|FG001|Overall Study|Adverse Event|2|||
163024750|NCT02031640|588792707|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
163024751|NCT02031640|588792702|FG000|Double-blind Treatment Period|Non-compliance|0|||
163024752|NCT02031640|588792703|FG001|Double-blind Treatment Period|Non-compliance|1|||
163064360|NCT01020123|588941611|FG001|Main Period|Lost to Follow-up|2|||
163064361|NCT01020123|588941612|FG002|Main Period|Lost to Follow-up|0|||
163064362|NCT01020123|588941613|FG003|Main Period|Lost to Follow-up|0|||
163064363|NCT01020123|588941614|FG004|Main Period|Lost to Follow-up|0|||
163064364|NCT01020123|588941615|FG005|Main Period|Lost to Follow-up|0|||
163064365|NCT01020123|588941616|FG006|Main Period|Lost to Follow-up|0|||
163064366|NCT01020123|588941610|FG000|Main Period|Unclasified|2|||
163064367|NCT01020123|588941611|FG001|Main Period|Unclasified|0|||
163064368|NCT01020123|588941612|FG002|Main Period|Unclasified|1|||
163064369|NCT01020123|588941613|FG003|Main Period|Unclasified|0|||
163064370|NCT01020123|588941614|FG004|Main Period|Unclasified|1|||
163064371|NCT01020123|588941615|FG005|Main Period|Unclasified|3|||
163064372|NCT01020123|588941616|FG006|Main Period|Unclasified|6|||
163064373|NCT01020123|588941610|FG000|Extention Period|Withdrawal by Subject|2|||
163064374|NCT01020123|588941611|FG001|Extention Period|Withdrawal by Subject|1|||
163064375|NCT01020123|588941612|FG002|Extention Period|Withdrawal by Subject|1|||
163064376|NCT01020123|588941613|FG003|Extention Period|Withdrawal by Subject|0|||
163064377|NCT01020123|588941614|FG004|Extention Period|Withdrawal by Subject|0|||
163064378|NCT01020123|588941615|FG005|Extention Period|Withdrawal by Subject|0|||
163064379|NCT01020123|588941616|FG006|Extention Period|Withdrawal by Subject|0|||
163064380|NCT01020123|588941610|FG000|Extention Period|Adverse Event|0|||
163064381|NCT01020123|588941611|FG001|Extention Period|Adverse Event|0|||
163064382|NCT01020123|588941612|FG002|Extention Period|Adverse Event|0|||
163064383|NCT01020123|588941613|FG003|Extention Period|Adverse Event|1|||
163064384|NCT01020123|588941614|FG004|Extention Period|Adverse Event|0|||
163064385|NCT01020123|588941615|FG005|Extention Period|Adverse Event|0|||
163064386|NCT01020123|588941616|FG006|Extention Period|Adverse Event|0|||
163064387|NCT01020123|588941610|FG000|Extention Period|Protocol Violation|1|||
163064388|NCT01020123|588941611|FG001|Extention Period|Protocol Violation|1|||
163064389|NCT01020123|588941612|FG002|Extention Period|Protocol Violation|1|||
163064390|NCT01020123|588941613|FG003|Extention Period|Protocol Violation|0|||
163064391|NCT01020123|588941614|FG004|Extention Period|Protocol Violation|0|||
163064392|NCT01020123|588941615|FG005|Extention Period|Protocol Violation|0|||
163064393|NCT01020123|588941616|FG006|Extention Period|Protocol Violation|1|||
163064394|NCT01020123|588941610|FG000|Extention Period|Lost to Follow-up|0|||
163064395|NCT01020123|588941611|FG001|Extention Period|Lost to Follow-up|0|||
163064396|NCT01020123|588941612|FG002|Extention Period|Lost to Follow-up|0|||
163064397|NCT01020123|588941613|FG003|Extention Period|Lost to Follow-up|0|||
163064398|NCT01020123|588941614|FG004|Extention Period|Lost to Follow-up|0|||
163064399|NCT01020123|588941615|FG005|Extention Period|Lost to Follow-up|2|||
163064400|NCT01020123|588941616|FG006|Extention Period|Lost to Follow-up|0|||
163064401|NCT01349595|588941617|FG000|Overall Study|Lack of funding|2|||
163064402|NCT01349595|588941618|FG001|Overall Study|Lack of funding|2|||
163064403|NCT03479905|588941621|FG000|Overall Study|Other airway method used|4|||
163064404|NCT03479905|588941622|FG001|Overall Study|Other airway method used|5|||
163064405|NCT03479905|588941623|FG002|Overall Study|Other airway method used|5|||
163064406|NCT01706328|588941628|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
163064407|NCT01706328|588941629|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163064408|NCT01706328|588941630|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163064409|NCT01706328|588941628|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
163064410|NCT01706328|588941629|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
163064411|NCT01706328|588941630|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
163064412|NCT01706328|588941628|FG000|2-week Run-in Period|Physician Decision|4|||
163064413|NCT01706328|588941629|FG001|2-week Run-in Period|Physician Decision|0|||
163064414|NCT01706328|588941630|FG002|2-week Run-in Period|Physician Decision|0|||
163064415|NCT01706328|588941628|FG000|2-week Run-in Period|Adverse Event|4|||
163064416|NCT01706328|588941629|FG001|2-week Run-in Period|Adverse Event|0|||
163064417|NCT01706328|588941630|FG002|2-week Run-in Period|Adverse Event|0|||
163064418|NCT01706328|588941628|FG000|2-week Run-in Period|Lost to Follow-up|2|||
163064419|NCT01706328|588941629|FG001|2-week Run-in Period|Lost to Follow-up|0|||
163064420|NCT01706328|588941630|FG002|2-week Run-in Period|Lost to Follow-up|0|||
163064421|NCT01706328|588941628|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
163064422|NCT01706328|588941629|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
163064423|NCT01706328|588941630|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
163064424|NCT01706328|588941628|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
163064425|NCT01706328|588941629|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
163064426|NCT01706328|588941630|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
163064427|NCT01706328|588941628|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
163064428|NCT01706328|588941629|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
163064429|NCT01706328|588941630|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
163064430|NCT01706328|588941628|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
163064431|NCT01706328|588941629|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
163064432|NCT01706328|588941630|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
163064433|NCT01706328|588941628|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
163064434|NCT01706328|588941629|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
163330645|NCT00454194|589920633|FG000|Overall Study|Withdrawal by Subject|12|||
163330646|NCT00454194|589920634|FG001|Overall Study|Withdrawal by Subject|8|||
163330647|NCT00454194|589920633|FG000|Overall Study|Other Medical Problems|1|||
163330648|NCT00454194|589920634|FG001|Overall Study|Other Medical Problems|2|||
163330649|NCT00454194|589920633|FG000|Overall Study|Other Unspecified Reason|2|||
163330650|NCT00454194|589920634|FG001|Overall Study|Other Unspecified Reason|2|||
163330651|NCT02095145|589920637|FG000|Overall Study|Withdrawal by Subject|1|||
163330652|NCT02095145|589920638|FG001|Overall Study|Withdrawal by Subject|0|||
163330653|NCT02085941|589920641|FG000|Overall Study|Lack of Efficacy|1|||
163330654|NCT02085941|589920642|FG001|Overall Study|Lack of Efficacy|0|||
163330655|NCT02085941|589920641|FG000|Overall Study|Death|6|||
163330656|NCT02085941|589920642|FG001|Overall Study|Death|1|||
163330657|NCT02085941|589920641|FG000|Overall Study|Lost to Follow-up|1|||
163024753|NCT02031640|588792704|FG002|Double-blind Treatment Period|Non-compliance|0|||
163024754|NCT02031640|588792705|FG003|Double-blind Treatment Period|Non-compliance|1|||
163024755|NCT02031640|588792706|FG004|Double-blind Treatment Period|Non-compliance|1|||
163024756|NCT02031640|588792707|FG005|Double-blind Treatment Period|Non-compliance|0|||
163024757|NCT02031640|588792702|FG000|Double-blind Treatment Period|Adverse Event|0|||
163024758|NCT02031640|588792703|FG001|Double-blind Treatment Period|Adverse Event|0|||
163024759|NCT02031640|588792704|FG002|Double-blind Treatment Period|Adverse Event|0|||
163024760|NCT02031640|588792705|FG003|Double-blind Treatment Period|Adverse Event|2|||
163024761|NCT02031640|588792706|FG004|Double-blind Treatment Period|Adverse Event|0|||
163024762|NCT02031640|588792707|FG005|Double-blind Treatment Period|Adverse Event|0|||
163024763|NCT02031640|588792702|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
163024764|NCT02031640|588792703|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
163024765|NCT02031640|588792704|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
163024766|NCT02031640|588792705|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
163024767|NCT02031640|588792706|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
163024768|NCT02031640|588792707|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
163024769|NCT02031640|588792702|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
163024770|NCT02031640|588792703|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
163024771|NCT02031640|588792704|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
163024772|NCT02031640|588792705|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
163024773|NCT02031640|588792706|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
163024774|NCT02031640|588792707|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
163024775|NCT01895270|588792712|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
163024776|NCT01895270|588792713|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
163024777|NCT01895270|588792712|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
163024778|NCT01895270|588792713|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
163024779|NCT01895270|588792712|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
163024780|NCT01895270|588792713|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
163024781|NCT01895270|588792712|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
163024782|NCT01895270|588792713|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
163024783|NCT01895270|588792712|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
163024784|NCT01895270|588792713|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
163024785|NCT01895270|588792712|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
163024786|NCT01895270|588792713|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
163024787|NCT01895270|588792712|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
163024788|NCT01895270|588792713|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
163024789|NCT02091375|588792716|FG000|Overall Study|Adverse Event|8|||
163024790|NCT02091375|588792717|FG001|Overall Study|Adverse Event|1|||
163024791|NCT02091375|588792716|FG000|Overall Study|Lost to Follow-up|0|||
163024792|NCT02091375|588792717|FG001|Overall Study|Lost to Follow-up|1|||
163024793|NCT02091375|588792716|FG000|Overall Study|Withdrawal by Subject|0|||
163024794|NCT02091375|588792717|FG001|Overall Study|Withdrawal by Subject|1|||
163024795|NCT02091375|588792716|FG000|Overall Study|Withdrawn by the investigator|1|||
163024796|NCT02091375|588792717|FG001|Overall Study|Withdrawn by the investigator|0|||
163024797|NCT04720911|588792719|FG000|Overall Study|Withdrawal by Subject|0|||
163024798|NCT04720911|588792720|FG001|Overall Study|Withdrawal by Subject|1|||
163024799|NCT04720911|588792721|FG002|Overall Study|Withdrawal by Subject|0|||
163024800|NCT00537316|588792723|FG000|Part 1|Adverse Event|7|||
163024801|NCT00537316|588792724|FG001|Part 1|Adverse Event|11|||
163024802|NCT00537316|588792725|FG002|Part 1|Adverse Event|8|||
163024803|NCT00537316|588792726|FG003|Part 1|Adverse Event|0|||
163024804|NCT00537316|588792727|FG004|Part 1|Adverse Event|0|||
163024805|NCT00537316|588792728|FG005|Part 1|Adverse Event|0|||
163024806|NCT00537316|588792729|FG006|Part 1|Adverse Event|0|||
163024807|NCT00537316|588792723|FG000|Part 1|Protocol defined clinical event|1|||
163024808|NCT00537316|588792724|FG001|Part 1|Protocol defined clinical event|0|||
163024809|NCT00537316|588792725|FG002|Part 1|Protocol defined clinical event|0|||
163024810|NCT00537316|588792726|FG003|Part 1|Protocol defined clinical event|0|||
163024811|NCT00537316|588792727|FG004|Part 1|Protocol defined clinical event|0|||
163064435|NCT01706328|588941630|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
163064436|NCT01706328|588941628|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
163064437|NCT01706328|588941629|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
163330658|NCT02085941|589920642|FG001|Overall Study|Lost to Follow-up|0|||
163330659|NCT02085941|589920641|FG000|Overall Study|Physician Decision|0|||
163330660|NCT02085941|589920642|FG001|Overall Study|Physician Decision|2|||
163330661|NCT00229658|589920651|FG000|Overall Study|Administrative|2|||
163064438|NCT01706328|588941630|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
163064439|NCT01706328|588941628|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
163064440|NCT01706328|588941629|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
163064441|NCT01706328|588941630|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
163064442|NCT06481579|588941632|FG000|Overall Study|Death|1|||
163064443|NCT06481579|588941633|FG001|Overall Study|Death|0|||
163064444|NCT06481579|588941632|FG000|Overall Study|Withdrawal by Subject|3|||
163064445|NCT06481579|588941633|FG001|Overall Study|Withdrawal by Subject|0|||
163064446|NCT06481579|588941632|FG000|Overall Study|Other|1|||
163064447|NCT06481579|588941633|FG001|Overall Study|Other|1|||
163064448|NCT04584788|588941634|FG000|Overall Study|Physician Decision|8|||
163064449|NCT04584788|588941634|FG000|Overall Study|Withdrawal by Subject|1|||
163064450|NCT04584788|588941634|FG000|Overall Study|Adverse Event|3|||
163064451|NCT03311555|588941635|FG000|Overall Study|Adverse Event|1|||
163064452|NCT04284774|588941637|FG000|Overall Study|Progressive disease|5|||
163064453|NCT01240746|588943494|FG000|Overall Study|Adverse Event|2|||
163064454|NCT01240746|588943495|FG001|Overall Study|Adverse Event|0|||
163064455|NCT01240746|588943496|FG002|Overall Study|Adverse Event|10|||
163064456|NCT01240746|588943494|FG000|Overall Study|Lost to Follow-up|23|||
163064457|NCT01240746|588943495|FG001|Overall Study|Lost to Follow-up|20|||
163064458|NCT01240746|588943496|FG002|Overall Study|Lost to Follow-up|102|||
163064459|NCT01240746|588943494|FG000|Overall Study|Protocol Violation|24|||
163064460|NCT01240746|588943495|FG001|Overall Study|Protocol Violation|15|||
163064461|NCT01240746|588943496|FG002|Overall Study|Protocol Violation|72|||
163064462|NCT01240746|588943494|FG000|Overall Study|Withdrawal by Subject|10|||
163064463|NCT01240746|588943495|FG001|Overall Study|Withdrawal by Subject|13|||
163064464|NCT01240746|588943496|FG002|Overall Study|Withdrawal by Subject|59|||
163064465|NCT01136954|588943497|FG000|Overall Study|Adverse Event|3|||
163064466|NCT01136954|588943498|FG001|Overall Study|Adverse Event|2|||
163064467|NCT01136954|588943497|FG000|Overall Study|Withdrawal by Subject|6|||
163064468|NCT01136954|588943498|FG001|Overall Study|Withdrawal by Subject|2|||
163064469|NCT01136954|588943497|FG000|Overall Study|Lack of Efficacy|14|||
163064470|NCT01136954|588943498|FG001|Overall Study|Lack of Efficacy|13|||
163064471|NCT01136954|588943497|FG000|Overall Study|Physician Decision|0|||
163064472|NCT01136954|588943498|FG001|Overall Study|Physician Decision|1|||
163064473|NCT01136954|588943497|FG000|Overall Study|Other|1|||
163064474|NCT01136954|588943498|FG001|Overall Study|Other|3|||
163064475|NCT04190225|588943516|FG000|Overall Study|Lost to Follow-up|2|||
163064476|NCT04190225|588943517|FG001|Overall Study|Lost to Follow-up|3|||
163064477|NCT04190225|588943516|FG000|Overall Study|Withdrawal by Subject|3|||
163064478|NCT04190225|588943517|FG001|Overall Study|Withdrawal by Subject|2|||
163064479|NCT04190225|588943516|FG000|Overall Study|Unrelated health condition|2|||
163064480|NCT04190225|588943517|FG001|Overall Study|Unrelated health condition|0|||
163064481|NCT01732783|588943520|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
163064482|NCT01732783|588943521|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
163064483|NCT01732783|588943522|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
163064484|NCT01732783|588943520|FG000|Overall Study|Death|13|||
163064485|NCT01732783|588943521|FG001|Overall Study|Death|4|||
163064486|NCT01732783|588943522|FG002|Overall Study|Death|1|||
163330662|NCT00229658|589920652|FG001|Overall Study|Administrative|1|||
163064487|NCT01732783|588943520|FG000|Overall Study|Lost to Follow-up|7|||
163064488|NCT01732783|588943521|FG001|Overall Study|Lost to Follow-up|1|||
163064489|NCT01732783|588943522|FG002|Overall Study|Lost to Follow-up|1|||
163064490|NCT01732783|588943520|FG000|Overall Study|Administrative Decision|8|||
163064491|NCT01732783|588943521|FG001|Overall Study|Administrative Decision|2|||
163064492|NCT01732783|588943522|FG002|Overall Study|Administrative Decision|1|||
163064493|NCT01732783|588943520|FG000|Overall Study|Withdrawal by Subject|1|||
163064494|NCT01732783|588943521|FG001|Overall Study|Withdrawal by Subject|0|||
163064495|NCT01732783|588943522|FG002|Overall Study|Withdrawal by Subject|0|||
163064496|NCT02239328|588943523|FG000|Overall Study|Benign disease noted at time of surgery|6|||
163064497|NCT02239328|588943523|FG000|Overall Study|Equipment or website malfunction|2|||
163064498|NCT04429971|588943525|FG000|Overall Study|Lost to Follow-up|7|||
163064499|NCT04429971|588943526|FG001|Overall Study|Lost to Follow-up|8|||
163064500|NCT03331562|588943527|FG000|Overall Study|Adverse Event|2|||
163330663|NCT00229658|589920651|FG000|Overall Study|Investigator decision|13|||
163064501|NCT03331562|588943528|FG001|Overall Study|Adverse Event|0|||
163064502|NCT03331562|588943527|FG000|Overall Study|Death|1|||
163064503|NCT03331562|588943528|FG001|Overall Study|Death|0|||
163064504|NCT03718000|588943536|FG000|Overall Study|Relocation|2|||
163330664|NCT00229658|589920652|FG001|Overall Study|Investigator decision|10|||
163064505|NCT03718000|588943537|FG001|Overall Study|Relocation|4|||
163217477|NCT00445965|589512208|FG000|Overall Study|Adverse Event|2|||
163024812|NCT00537316|588792728|FG005|Part 1|Protocol defined clinical event|0|||
163024813|NCT00537316|588792729|FG006|Part 1|Protocol defined clinical event|0|||
163024814|NCT00537316|588792723|FG000|Part 1|Lost to Follow-up|1|||
163024815|NCT00537316|588792724|FG001|Part 1|Lost to Follow-up|0|||
163024816|NCT00537316|588792725|FG002|Part 1|Lost to Follow-up|0|||
163024817|NCT00537316|588792726|FG003|Part 1|Lost to Follow-up|0|||
163024818|NCT00537316|588792727|FG004|Part 1|Lost to Follow-up|0|||
163024819|NCT00537316|588792728|FG005|Part 1|Lost to Follow-up|0|||
163024820|NCT00537316|588792729|FG006|Part 1|Lost to Follow-up|0|||
163024821|NCT00537316|588792723|FG000|Part 1|Withdrawal by Subject|3|||
163024822|NCT00537316|588792724|FG001|Part 1|Withdrawal by Subject|8|||
163024823|NCT00537316|588792725|FG002|Part 1|Withdrawal by Subject|4|||
163024824|NCT00537316|588792726|FG003|Part 1|Withdrawal by Subject|0|||
163024825|NCT00537316|588792727|FG004|Part 1|Withdrawal by Subject|0|||
163024826|NCT00537316|588792728|FG005|Part 1|Withdrawal by Subject|0|||
163024827|NCT00537316|588792729|FG006|Part 1|Withdrawal by Subject|0|||
163024828|NCT00537316|588792723|FG000|Part 1|Protocol Violation|1|||
163024829|NCT00537316|588792724|FG001|Part 1|Protocol Violation|5|||
163024830|NCT00537316|588792725|FG002|Part 1|Protocol Violation|1|||
163024831|NCT00537316|588792726|FG003|Part 1|Protocol Violation|0|||
163024832|NCT00537316|588792727|FG004|Part 1|Protocol Violation|0|||
163024833|NCT00537316|588792728|FG005|Part 1|Protocol Violation|0|||
163024834|NCT00537316|588792729|FG006|Part 1|Protocol Violation|0|||
163024835|NCT00537316|588792723|FG000|Part 1|Did not meet protocol eligibility|1|||
163024836|NCT00537316|588792724|FG001|Part 1|Did not meet protocol eligibility|3|||
163024837|NCT00537316|588792725|FG002|Part 1|Did not meet protocol eligibility|2|||
163024838|NCT00537316|588792726|FG003|Part 1|Did not meet protocol eligibility|0|||
163024839|NCT00537316|588792727|FG004|Part 1|Did not meet protocol eligibility|0|||
163024840|NCT00537316|588792728|FG005|Part 1|Did not meet protocol eligibility|0|||
163024841|NCT00537316|588792729|FG006|Part 1|Did not meet protocol eligibility|0|||
163024842|NCT00537316|588792723|FG000|Part 1|Administrative|0|||
163024843|NCT00537316|588792724|FG001|Part 1|Administrative|0|||
163024844|NCT00537316|588792725|FG002|Part 1|Administrative|2|||
163217478|NCT00445965|589512208|FG000|Overall Study|Physician Decision|1|||
163217479|NCT00445965|589512208|FG000|Overall Study|Enrolled but not treated|1|||
163217480|NCT00445965|589512208|FG000|Overall Study|Removed due to progressive disease|29|||
163024845|NCT00537316|588792726|FG003|Part 1|Administrative|0|||
163024846|NCT00537316|588792727|FG004|Part 1|Administrative|0|||
163024847|NCT00537316|588792728|FG005|Part 1|Administrative|0|||
163024848|NCT00537316|588792729|FG006|Part 1|Administrative|0|||
163024849|NCT00537316|588792723|FG000|Part 2|Never entered follow-up|0|||
163024850|NCT00537316|588792724|FG001|Part 2|Never entered follow-up|0|||
163024851|NCT00537316|588792725|FG002|Part 2|Never entered follow-up|0|||
163024852|NCT00537316|588792726|FG003|Part 2|Never entered follow-up|0|||
163024853|NCT00537316|588792727|FG004|Part 2|Never entered follow-up|0|||
163024854|NCT00537316|588792728|FG005|Part 2|Never entered follow-up|0|||
163024855|NCT00537316|588792729|FG006|Part 2|Never entered follow-up|1|||
163024856|NCT00537316|588792723|FG000|Part 2|Adverse Event|4|||
163024857|NCT00537316|588792724|FG001|Part 2|Adverse Event|0|||
163024858|NCT00537316|588792725|FG002|Part 2|Adverse Event|2|||
163024859|NCT00537316|588792726|FG003|Part 2|Adverse Event|0|||
163024860|NCT00537316|588792727|FG004|Part 2|Adverse Event|0|||
163024861|NCT00537316|588792728|FG005|Part 2|Adverse Event|0|||
163024862|NCT00537316|588792729|FG006|Part 2|Adverse Event|0|||
163024863|NCT00537316|588792723|FG000|Part 2|Lost to Follow-up|1|||
163064506|NCT03718000|588943536|FG000|Overall Study|Pregnancy|0|||
163024864|NCT00537316|588792724|FG001|Part 2|Lost to Follow-up|0|||
163024865|NCT00537316|588792725|FG002|Part 2|Lost to Follow-up|2|||
163024866|NCT00537316|588792726|FG003|Part 2|Lost to Follow-up|0|||
163024867|NCT00537316|588792727|FG004|Part 2|Lost to Follow-up|0|||
163024868|NCT00537316|588792728|FG005|Part 2|Lost to Follow-up|0|||
163024869|NCT00537316|588792729|FG006|Part 2|Lost to Follow-up|0|||
163024870|NCT00537316|588792723|FG000|Part 2|Withdrawal by Subject|5|||
163024871|NCT00537316|588792724|FG001|Part 2|Withdrawal by Subject|1|||
163217481|NCT05778786|589512213|FG000|Period 1|COVID-19 Related|3|||
163217482|NCT05778786|589512214|FG001|Period 1|COVID-19 Related|3|||
163217483|NCT05778786|589512213|FG000|Period 1|Withdrew Consent during Study|1|||
163217484|NCT05778786|589512214|FG001|Period 1|Withdrew Consent during Study|0|||
163217485|NCT05778786|589512213|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
163217486|NCT05778786|589512214|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
163217487|NCT05778786|589512213|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
163217488|NCT05778786|589512214|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
163217489|NCT02075658|589512215|FG000|Overall Study|Physician Decision|2|||
163217490|NCT02075658|589512216|FG001|Overall Study|Physician Decision|2|||
163217491|NCT02406651|589512218|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
163217492|NCT00718328|589512223|FG000|Overall Study|Lost to Follow-up|1|||
163217493|NCT00718328|589512224|FG001|Overall Study|Lost to Follow-up|0|||
163217494|NCT00663052|589512225|FG000|Overall Study|Adverse Event|6|||
163217495|NCT00663052|589512226|FG001|Overall Study|Adverse Event|3|||
163217496|NCT00663052|589512225|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
163217497|NCT00663052|589512226|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
163217498|NCT00663052|589512225|FG000|Overall Study|Protocol Violation|1|||
163024872|NCT00537316|588792725|FG002|Part 2|Withdrawal by Subject|4|||
163024873|NCT00537316|588792726|FG003|Part 2|Withdrawal by Subject|0|||
163024874|NCT00537316|588792727|FG004|Part 2|Withdrawal by Subject|0|||
163024875|NCT00537316|588792728|FG005|Part 2|Withdrawal by Subject|0|||
163024876|NCT00537316|588792729|FG006|Part 2|Withdrawal by Subject|0|||
163024877|NCT00537316|588792723|FG000|Part 2|Administrative|16|||
163024878|NCT00537316|588792724|FG001|Part 2|Administrative|8|||
163024879|NCT00537316|588792725|FG002|Part 2|Administrative|24|||
163024880|NCT00537316|588792726|FG003|Part 2|Administrative|3|||
163024881|NCT00537316|588792727|FG004|Part 2|Administrative|1|||
163024882|NCT00537316|588792728|FG005|Part 2|Administrative|4|||
163024883|NCT00537316|588792729|FG006|Part 2|Administrative|1|||
163024884|NCT04533412|588792731|FG000|Overall Study|Withdrawal by Subject|1|||
163024885|NCT04533412|588792732|FG001|Overall Study|Withdrawal by Subject|1|||
163024886|NCT04533412|588792731|FG000|Overall Study|Lost to Follow-up|1|||
163024887|NCT04533412|588792732|FG001|Overall Study|Lost to Follow-up|4|||
163024888|NCT03261674|588792733|FG000|Overall Study|Lost to Follow-up|6|||
163024889|NCT03261674|588792734|FG001|Overall Study|Lost to Follow-up|7|||
163024890|NCT03261674|588792733|FG000|Overall Study|Protocol Violation|1|||
163024891|NCT03261674|588792734|FG001|Overall Study|Protocol Violation|4|||
163024892|NCT03261674|588792733|FG000|Overall Study|Withdrawal by Subject|1|||
163024893|NCT03261674|588792734|FG001|Overall Study|Withdrawal by Subject|4|||
163024894|NCT03261674|588792733|FG000|Overall Study|Physician Decision|1|||
163024895|NCT03261674|588792734|FG001|Overall Study|Physician Decision|0|||
163024896|NCT00782184|588792735|FG000|Overall Study|Adverse Event|1|||
163024897|NCT00782184|588792736|FG001|Overall Study|Adverse Event|2|||
163024898|NCT00782184|588792735|FG000|Overall Study|Protocol Violation|0|||
163024899|NCT00782184|588792736|FG001|Overall Study|Protocol Violation|1|||
163024900|NCT00782184|588792735|FG000|Overall Study|Withdrawal by Subject|3|||
163024901|NCT00782184|588792736|FG001|Overall Study|Withdrawal by Subject|2|||
163024902|NCT01438294|588792737|FG000|Overall Study|Lost to Follow-up|3|||
163024903|NCT01438294|588792738|FG001|Overall Study|Lost to Follow-up|7|||
163024904|NCT01730534|588792743|FG000|Overall Study|Withdrawal by Subject|97|||
163024905|NCT01730534|588792744|FG001|Overall Study|Withdrawal by Subject|127|||
163024906|NCT01730534|588792743|FG000|Overall Study|Lost to Follow-up|12|||
163024907|NCT01730534|588792744|FG001|Overall Study|Lost to Follow-up|18|||
163024908|NCT01676896|588792745|FG000|Overall Study|Withdrawal by Subject|12|||
163024909|NCT01676896|588792746|FG001|Overall Study|Withdrawal by Subject|7|||
163024910|NCT01676896|588792747|FG002|Overall Study|Withdrawal by Subject|19|||
163024911|NCT03614078|588792748|FG000|Overall Study|Withdrawal by Subject|2|||
163024912|NCT03614078|588792749|FG001|Overall Study|Withdrawal by Subject|2|||
163024913|NCT03614078|588792750|FG002|Overall Study|Withdrawal by Subject|3|||
163024914|NCT03614078|588792748|FG000|Overall Study|Participant Did Not Return for Visit|0|||
163024915|NCT03614078|588792749|FG001|Overall Study|Participant Did Not Return for Visit|1|||
163024916|NCT03614078|588792750|FG002|Overall Study|Participant Did Not Return for Visit|0|||
163024917|NCT03614078|588792748|FG000|Overall Study|High Neutrophils|0|||
163024918|NCT03614078|588792749|FG001|Overall Study|High Neutrophils|0|||
163024919|NCT03614078|588792750|FG002|Overall Study|High Neutrophils|2|||
163024920|NCT03614078|588792748|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
163024921|NCT03614078|588792749|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
163024922|NCT03614078|588792750|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
163024923|NCT03614078|588792748|FG000|Overall Study|Exacerbation of Psoriasis|0|||
163024924|NCT03614078|588792749|FG001|Overall Study|Exacerbation of Psoriasis|1|||
163024925|NCT03614078|588792750|FG002|Overall Study|Exacerbation of Psoriasis|0|||
163024926|NCT03614078|588792748|FG000|Overall Study|Adverse Event|0|||
163024927|NCT03614078|588792749|FG001|Overall Study|Adverse Event|2|||
163024928|NCT03614078|588792750|FG002|Overall Study|Adverse Event|0|||
163024929|NCT03614078|588792748|FG000|Overall Study|Dizziness and Rash|0|||
163024930|NCT03614078|588792749|FG001|Overall Study|Dizziness and Rash|1|||
163024931|NCT03614078|588792750|FG002|Overall Study|Dizziness and Rash|0|||
163024932|NCT01895608|588792752|FG000|Overall Study|change in health status|0|||
163024933|NCT01895608|588792753|FG001|Overall Study|change in health status|1|||
163024934|NCT01895608|588792754|FG002|Overall Study|change in health status|1|||
163024935|NCT01895608|588792755|FG003|Overall Study|change in health status|0|||
163024936|NCT01895608|588792752|FG000|Overall Study|Withdrawal by Subject|0|||
163024937|NCT01895608|588792753|FG001|Overall Study|Withdrawal by Subject|0|||
163024938|NCT01895608|588792754|FG002|Overall Study|Withdrawal by Subject|2|||
163024939|NCT01895608|588792755|FG003|Overall Study|Withdrawal by Subject|0|||
163024940|NCT03696108|588792757|FG000|Overall Study|Physician Decision|1|||
163024941|NCT03696108|588792758|FG001|Overall Study|Physician Decision|0|||
163024942|NCT03696108|588792757|FG000|Overall Study|Withdrawal by Subject|3|||
163024943|NCT03696108|588792758|FG001|Overall Study|Withdrawal by Subject|6|||
163024944|NCT03505593|588792760|FG000|Overall Study|Withdrawal by Subject|1|||
163064507|NCT03718000|588943537|FG001|Overall Study|Pregnancy|1|||
163064508|NCT05522751|588943543|FG000|Overall Study|Adverse Event|1|||
163064509|NCT04044690|588943545|FG000|Period 1|Lack of Efficacy|1|||
163064510|NCT04044690|588943546|FG001|Period 1|Lack of Efficacy|1|||
163064511|NCT04044690|588943545|FG000|Period 1|Adverse Event|4|||
163064512|NCT04044690|588943546|FG001|Period 1|Adverse Event|2|||
163064513|NCT04044690|588943545|FG000|Period 1|Physician Decision|0|||
163064514|NCT04044690|588943546|FG001|Period 1|Physician Decision|1|||
163064515|NCT04044690|588943545|FG000|Period 1|Withdrawal by Subject|2|||
163064516|NCT04044690|588943546|FG001|Period 1|Withdrawal by Subject|5|||
163064517|NCT04044690|588943545|FG000|Period 1|Protocol Deviation|2|||
163064518|NCT04044690|588943546|FG001|Period 1|Protocol Deviation|0|||
163064519|NCT04044690|588943545|FG000|Period 1|Site Terminated by Sponsor|0|||
163064520|NCT04044690|588943546|FG001|Period 1|Site Terminated by Sponsor|1|||
163064521|NCT04044690|588943545|FG000|Period 1|Study Terminated by Sponsor|0|||
163064522|NCT04044690|588943546|FG001|Period 1|Study Terminated by Sponsor|1|||
163064523|NCT04044690|588943545|FG000|Period 1|Death|1|||
163064524|NCT04044690|588943546|FG001|Period 1|Death|1|||
163064525|NCT04044690|588943545|FG000|Period 1|Other: Unspecified|1|||
163064526|NCT04044690|588943546|FG001|Period 1|Other: Unspecified|0|||
163064527|NCT04044690|588943545|FG000|Period 2|Lack of Efficacy|0|||
163064528|NCT04044690|588943546|FG001|Period 2|Lack of Efficacy|1|||
163064529|NCT04044690|588943545|FG000|Period 2|Adverse Event|0|||
163064530|NCT04044690|588943546|FG001|Period 2|Adverse Event|1|||
163064531|NCT04044690|588943545|FG000|Period 2|Physician Decision|0|||
163064532|NCT04044690|588943546|FG001|Period 2|Physician Decision|2|||
163064533|NCT04044690|588943545|FG000|Period 2|Withdrawal by Subject|5|||
163064534|NCT04044690|588943546|FG001|Period 2|Withdrawal by Subject|5|||
163064535|NCT04044690|588943545|FG000|Period 2|Lost to Follow-up|0|||
163064536|NCT04044690|588943546|FG001|Period 2|Lost to Follow-up|1|||
163064537|NCT04044690|588943545|FG000|Period 2|Site Terminated by Sponsor|1|||
163064538|NCT04044690|588943546|FG001|Period 2|Site Terminated by Sponsor|3|||
163064539|NCT04044690|588943545|FG000|Period 2|Study Terminated by Sponsor|8|||
163064540|NCT04044690|588943546|FG001|Period 2|Study Terminated by Sponsor|3|||
163064541|NCT04044690|588943545|FG000|Period 2|Death|1|||
163064542|NCT04044690|588943546|FG001|Period 2|Death|0|||
163064543|NCT04044690|588943545|FG000|Period 2|Other: Unspecified|1|||
163024945|NCT03505593|588792760|FG000|Overall Study|Died before procedure|1|||
163024946|NCT03505593|588792760|FG000|Overall Study|Anatomical abnormality|1|||
163024947|NCT03505593|588792760|FG000|Overall Study|Unable to pass through esophagus|1|||
163024948|NCT03505593|588792760|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
163024949|NCT03891862|588792761|FG000|Open-label Period|Adverse Event|2|||
163024950|NCT03891862|588792762|FG001|Open-label Period|Adverse Event|0|||
163024951|NCT03891862|588792763|FG002|Open-label Period|Adverse Event|0|||
163024952|NCT03891862|588792761|FG000|Open-label Period|Protocol Violation|5|||
163024953|NCT03891862|588792762|FG001|Open-label Period|Protocol Violation|0|||
163024954|NCT03891862|588792763|FG002|Open-label Period|Protocol Violation|0|||
163024955|NCT03891862|588792761|FG000|Open-label Period|Withdrawal by Subject|6|||
163024956|NCT03891862|588792762|FG001|Open-label Period|Withdrawal by Subject|0|||
163024957|NCT03891862|588792763|FG002|Open-label Period|Withdrawal by Subject|0|||
163024958|NCT03891862|588792761|FG000|Open-label Period|Death|1|||
163024959|NCT03891862|588792762|FG001|Open-label Period|Death|0|||
163024960|NCT03891862|588792763|FG002|Open-label Period|Death|0|||
163064544|NCT04044690|588943546|FG001|Period 2|Other: Unspecified|1|||
163064545|NCT04044690|588943545|FG000|Period 3|Site Terminated by Sponsor|1|||
163064546|NCT04044690|588943546|FG001|Period 3|Site Terminated by Sponsor|2|||
163064547|NCT04044690|588943545|FG000|Period 3|Study Terminated by Sponsor|24|||
163064548|NCT04044690|588943546|FG001|Period 3|Study Terminated by Sponsor|18|||
163064549|NCT04044690|588943545|FG000|Period 3|Missing|0|||
163064550|NCT04044690|588943546|FG001|Period 3|Missing|2|||
163064551|NCT01582451|588943552|FG000|Overall Study|Adverse Event|1|||
163064552|NCT01582451|588943553|FG001|Overall Study|Adverse Event|3|||
163064553|NCT01582451|588943552|FG000|Overall Study|Death|3|||
163064554|NCT01582451|588943553|FG001|Overall Study|Death|3|||
163217499|NCT00663052|589512226|FG001|Overall Study|Protocol Violation|0|||
163064555|NCT01582451|588943552|FG000|Overall Study|Lost to Follow-up|0|||
163064556|NCT01582451|588943553|FG001|Overall Study|Lost to Follow-up|2|||
163064557|NCT01582451|588943552|FG000|Overall Study|Protocol Violation|11|||
163064558|NCT01582451|588943553|FG001|Overall Study|Protocol Violation|3|||
163064559|NCT01582451|588943552|FG000|Overall Study|Withdrawal by Subject|13|||
163064560|NCT01582451|588943553|FG001|Overall Study|Withdrawal by Subject|9|||
163024961|NCT03891862|588792761|FG000|Open-label Period|Lost to Follow-up|2|||
163064561|NCT01582451|588943552|FG000|Overall Study|Physician Decision|3|||
163064562|NCT01582451|588943553|FG001|Overall Study|Physician Decision|0|||
163064563|NCT01582451|588943552|FG000|Overall Study|Sponsor Decision|1|||
163217500|NCT00663052|589512225|FG000|Overall Study|Withdrawal by Subject|2|||
163217501|NCT00663052|589512226|FG001|Overall Study|Withdrawal by Subject|5|||
163217502|NCT00663052|589512225|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
163217503|NCT00663052|589512226|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
163217504|NCT00663052|589512225|FG000|Overall Study|Other|0|||
163217505|NCT00663052|589512226|FG001|Overall Study|Other|1|||
163064564|NCT01582451|588943553|FG001|Overall Study|Sponsor Decision|0|||
163064565|NCT00716417|588943556|FG000|Overall Study|Adverse Event|0|||
163064566|NCT00716417|588943557|FG001|Overall Study|Adverse Event|0|||
163064567|NCT00716417|588943558|FG002|Overall Study|Adverse Event|2|||
163064568|NCT00716417|588943559|FG003|Overall Study|Adverse Event|1|||
163064569|NCT00716417|588943560|FG004|Overall Study|Adverse Event|0|||
163064570|NCT00716417|588943561|FG005|Overall Study|Adverse Event|0|||
163064571|NCT00716417|588943562|FG006|Overall Study|Adverse Event|3|||
163064572|NCT00716417|588943563|FG007|Overall Study|Adverse Event|1|||
163064573|NCT00716417|588943564|FG008|Overall Study|Adverse Event|0|||
163064574|NCT00716417|588943565|FG009|Overall Study|Adverse Event|3|||
163064575|NCT00716417|588943556|FG000|Overall Study|Withdrawal by Subject|0|||
163064576|NCT00716417|588943557|FG001|Overall Study|Withdrawal by Subject|1|||
163064577|NCT00716417|588943558|FG002|Overall Study|Withdrawal by Subject|0|||
163064578|NCT00716417|588943559|FG003|Overall Study|Withdrawal by Subject|2|||
163064579|NCT00716417|588943560|FG004|Overall Study|Withdrawal by Subject|0|||
163064580|NCT00716417|588943561|FG005|Overall Study|Withdrawal by Subject|0|||
163064581|NCT00716417|588943562|FG006|Overall Study|Withdrawal by Subject|1|||
163064582|NCT00716417|588943563|FG007|Overall Study|Withdrawal by Subject|0|||
163064583|NCT00716417|588943564|FG008|Overall Study|Withdrawal by Subject|0|||
163064584|NCT00716417|588943565|FG009|Overall Study|Withdrawal by Subject|0|||
163064585|NCT00716417|588943556|FG000|Overall Study|Progressive disease|3|||
163064586|NCT00716417|588943557|FG001|Overall Study|Progressive disease|5|||
163064587|NCT00716417|588943558|FG002|Overall Study|Progressive disease|3|||
163064588|NCT00716417|588943559|FG003|Overall Study|Progressive disease|8|||
163064589|NCT00716417|588943560|FG004|Overall Study|Progressive disease|0|||
163064590|NCT00716417|588943561|FG005|Overall Study|Progressive disease|3|||
163064591|NCT00716417|588943562|FG006|Overall Study|Progressive disease|3|||
163064592|NCT00716417|588943563|FG007|Overall Study|Progressive disease|1|||
163064593|NCT00716417|588943564|FG008|Overall Study|Progressive disease|5|||
163064594|NCT00716417|588943565|FG009|Overall Study|Progressive disease|0|||
163064595|NCT00716417|588943556|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
163064596|NCT00716417|588943557|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
163064597|NCT00716417|588943558|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
163064598|NCT00716417|588943559|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
163064599|NCT00716417|588943560|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
163064600|NCT00716417|588943561|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
163064601|NCT00716417|588943562|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
163064602|NCT00716417|588943563|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
163064603|NCT00716417|588943564|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
163064604|NCT00716417|588943565|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
163064605|NCT00716417|588943556|FG000|Overall Study|On patient request due to toxicities|0|||
163064606|NCT00716417|588943557|FG001|Overall Study|On patient request due to toxicities|0|||
163064607|NCT00716417|588943558|FG002|Overall Study|On patient request due to toxicities|0|||
163064608|NCT00716417|588943559|FG003|Overall Study|On patient request due to toxicities|0|||
163064609|NCT00716417|588943560|FG004|Overall Study|On patient request due to toxicities|0|||
163064610|NCT00716417|588943561|FG005|Overall Study|On patient request due to toxicities|0|||
163064611|NCT00716417|588943562|FG006|Overall Study|On patient request due to toxicities|0|||
163064612|NCT00716417|588943563|FG007|Overall Study|On patient request due to toxicities|1|||
163064613|NCT00716417|588943564|FG008|Overall Study|On patient request due to toxicities|0|||
163064614|NCT00716417|588943565|FG009|Overall Study|On patient request due to toxicities|0|||
163064615|NCT00487188|588943566|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
163064616|NCT00487188|588943567|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
163064617|NCT00487188|588943568|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
163064618|NCT00487188|588943566|FG000|Induction Phase|Adverse Event|5|||
163064619|NCT00487188|588943567|FG001|Induction Phase|Adverse Event|0|||
163064620|NCT00487188|588943568|FG002|Induction Phase|Adverse Event|0|||
163330665|NCT00229658|589920651|FG000|Overall Study|Other|80|||
163330666|NCT00229658|589920652|FG001|Overall Study|Other|60|||
163330667|NCT00229658|589920651|FG000|Overall Study|Lost to Follow-up|82|||
163330668|NCT00229658|589920652|FG001|Overall Study|Lost to Follow-up|55|||
163064621|NCT00487188|588943566|FG000|Induction Phase|Lack of Efficacy|0|||
163064622|NCT00487188|588943567|FG001|Induction Phase|Lack of Efficacy|1|||
163064623|NCT00487188|588943568|FG002|Induction Phase|Lack of Efficacy|0|||
163064624|NCT00487188|588943566|FG000|Induction Phase|Protocol Violation|1|||
163064625|NCT00487188|588943567|FG001|Induction Phase|Protocol Violation|0|||
163064626|NCT00487188|588943568|FG002|Induction Phase|Protocol Violation|0|||
163064627|NCT00487188|588943566|FG000|Induction Phase|Refused Treatment|1|||
163064628|NCT00487188|588943567|FG001|Induction Phase|Refused Treatment|2|||
163064629|NCT00487188|588943568|FG002|Induction Phase|Refused Treatment|0|||
163064630|NCT00487188|588943566|FG000|Induction Phase|Lost to Follow-up|2|||
163064631|NCT00487188|588943567|FG001|Induction Phase|Lost to Follow-up|2|||
163064632|NCT00487188|588943568|FG002|Induction Phase|Lost to Follow-up|0|||
163064633|NCT00487188|588943566|FG000|Induction Phase|Administrative|0|||
163330669|NCT00229658|589920651|FG000|Overall Study|Serious Adverse Event|2|||
163330670|NCT00229658|589920652|FG001|Overall Study|Serious Adverse Event|2|||
163064634|NCT00487188|588943567|FG001|Induction Phase|Administrative|1|||
163064635|NCT00487188|588943568|FG002|Induction Phase|Administrative|0|||
163064636|NCT00487188|588943566|FG000|Maintenance Phase|Adverse Event|1|||
163064637|NCT00487188|588943567|FG001|Maintenance Phase|Adverse Event|0|||
163064638|NCT00487188|588943568|FG002|Maintenance Phase|Adverse Event|0|||
163064639|NCT00487188|588943566|FG000|Maintenance Phase|Death|1|||
163064640|NCT00487188|588943567|FG001|Maintenance Phase|Death|0|||
163064641|NCT00487188|588943568|FG002|Maintenance Phase|Death|0|||
163064642|NCT00487188|588943566|FG000|Maintenance Phase|Lost to Follow-up|1|||
163064643|NCT00487188|588943567|FG001|Maintenance Phase|Lost to Follow-up|0|||
163064644|NCT00487188|588943568|FG002|Maintenance Phase|Lost to Follow-up|0|||
163064645|NCT00487188|588943566|FG000|Maintenance Phase|Administrative|0|||
163064646|NCT00487188|588943567|FG001|Maintenance Phase|Administrative|0|||
163064647|NCT00487188|588943568|FG002|Maintenance Phase|Administrative|1|||
163064648|NCT01838876|588943569|FG000|Overall Study|Adverse Event|49|||
163064649|NCT01838876|588943569|FG000|Overall Study|Insufficient Therapeutic Response|10|||
163064650|NCT01838876|588943569|FG000|Overall Study|Protocol Violation|34|||
163064651|NCT01838876|588943569|FG000|Overall Study|Withdrawal of Consent|33|||
163064652|NCT01838876|588943569|FG000|Overall Study|Lost to Follow-up|21|||
163064653|NCT01838876|588943569|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
163064654|NCT01838876|588943569|FG000|Overall Study|Reason not Specified|7|||
163064655|NCT01838876|588943569|FG000|Overall Study|Did not meet eligibility criteria|78|||
163064656|NCT01682031|588943570|FG000|Overall Study|Withdrawal by Subject|0|||
163064657|NCT01682031|588943571|FG001|Overall Study|Withdrawal by Subject|1|||
163064658|NCT01682031|588943570|FG000|Overall Study|Adverse Event|0|||
163064659|NCT01682031|588943571|FG001|Overall Study|Adverse Event|2|||
163064660|NCT01682031|588943570|FG000|Overall Study|MRI results indicate increased nodul|0|||
163064661|NCT01682031|588943571|FG001|Overall Study|MRI results indicate increased nodul|1|||
163064662|NCT01682031|588943570|FG000|Overall Study|Patient could not swallow tablets|1|||
163064663|NCT01682031|588943571|FG001|Overall Study|Patient could not swallow tablets|0|||
163064664|NCT01682031|588943570|FG000|Overall Study|Patient stopped selenium on his own|0|||
163064665|NCT01682031|588943571|FG001|Overall Study|Patient stopped selenium on his own|1|||
163064666|NCT03881371|588943576|FG000|Overall Study|Adverse Event|8|||
163064667|NCT03881371|588943577|FG001|Overall Study|Adverse Event|9|||
163064668|NCT03881371|588943576|FG000|Overall Study|Death|1|||
163064669|NCT03881371|588943577|FG001|Overall Study|Death|0|||
163064670|NCT03881371|588943576|FG000|Overall Study|Lost to Follow-up|1|||
163064671|NCT03881371|588943577|FG001|Overall Study|Lost to Follow-up|0|||
163064672|NCT03881371|588943576|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163064673|NCT03881371|588943577|FG001|Overall Study|Non-Compliance with Study Drug|2|||
163064674|NCT03881371|588943576|FG000|Overall Study|Physician Decision|3|||
163064675|NCT03881371|588943577|FG001|Overall Study|Physician Decision|3|||
163064676|NCT03881371|588943576|FG000|Overall Study|Withdrawal by Subject|2|||
163064677|NCT03881371|588943577|FG001|Overall Study|Withdrawal by Subject|10|||
163064678|NCT03881371|588943576|FG000|Overall Study|Discontinuation from Study|1|||
163064679|NCT03881371|588943577|FG001|Overall Study|Discontinuation from Study|0|||
163064680|NCT05376358|588943583|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
163064681|NCT05376358|588943584|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
163064682|NCT05376358|588943583|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
163064683|NCT05376358|588943584|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
163064684|NCT05376358|588943583|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
163064685|NCT05376358|588943584|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
163064686|NCT05376358|588943583|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
163064687|NCT05376358|588943584|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
163217506|NCT02946047|589512228|FG000|Overall Study|Adverse Event|1|||
163217507|NCT02946047|589512229|FG001|Overall Study|Adverse Event|0|||
163217508|NCT02946047|589512230|FG002|Overall Study|Adverse Event|0|||
163217509|NCT02946047|589512231|FG003|Overall Study|Adverse Event|0|||
163217510|NCT03615105|589512232|FG000|Overall Study|Protocol Violation|1|||
163217511|NCT03615105|589512233|FG001|Overall Study|Protocol Violation|0|||
163217512|NCT03615105|589512234|FG002|Overall Study|Protocol Violation|0|||
163217513|NCT03615105|589512232|FG000|Overall Study|Death|0|||
163217514|NCT03615105|589512233|FG001|Overall Study|Death|2|||
163217515|NCT03615105|589512234|FG002|Overall Study|Death|0|||
163217516|NCT05041322|589512235|FG000|Baseline|Withdrawal by Subject|1|||
163217517|NCT05041322|589512236|FG001|Baseline|Withdrawal by Subject|0|||
163217518|NCT05041322|589512235|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
163217519|NCT05041322|589512236|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
163217520|NCT05041322|589512235|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
163217521|NCT05041322|589512236|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
163217522|NCT01252940|589512237|FG000|Main Study Phase|Randomized but not treated|4|||
163330671|NCT00229658|589920651|FG000|Overall Study|Withdrawal of consent|46|||
163330672|NCT00229658|589920652|FG001|Overall Study|Withdrawal of consent|39|||
163024962|NCT03891862|588792762|FG001|Open-label Period|Lost to Follow-up|0|||
163024963|NCT03891862|588792763|FG002|Open-label Period|Lost to Follow-up|0|||
163024964|NCT03891862|588792761|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
163024965|NCT03891862|588792762|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
163024966|NCT03891862|588792763|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
163024967|NCT03891862|588792761|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
163024968|NCT03891862|588792762|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
163024969|NCT03891862|588792763|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
163024970|NCT03891862|588792761|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
163024971|NCT03891862|588792762|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
163024972|NCT03891862|588792763|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
163024973|NCT03891862|588792761|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
163024974|NCT03891862|588792762|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
163024975|NCT03891862|588792763|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
163024976|NCT01053962|588792764|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
163024977|NCT01053962|588792765|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
163024978|NCT01053962|588792766|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
163024979|NCT01053962|588792767|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
163024980|NCT01053962|588792768|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
163024981|NCT01053962|588792764|FG000|Pretreatment Period|Venipuncture Failure|0|||
163024982|NCT01053962|588792765|FG001|Pretreatment Period|Venipuncture Failure|0|||
163024983|NCT01053962|588792766|FG002|Pretreatment Period|Venipuncture Failure|1|||
163024984|NCT01053962|588792767|FG003|Pretreatment Period|Venipuncture Failure|0|||
163024985|NCT01053962|588792768|FG004|Pretreatment Period|Venipuncture Failure|0|||
163024986|NCT01053962|588792764|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
163024987|NCT01053962|588792765|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
163024988|NCT01053962|588792766|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
163024989|NCT01053962|588792767|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
163024990|NCT01053962|588792768|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
163024991|NCT01053962|588792764|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
163024992|NCT01053962|588792765|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
163024993|NCT01053962|588792766|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
163024994|NCT01053962|588792767|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
163024995|NCT01053962|588792768|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
163024996|NCT01053962|588792764|FG000|Treatment Period|Lack of Efficacy|0|||
163024997|NCT01053962|588792765|FG001|Treatment Period|Lack of Efficacy|0|||
163024998|NCT01053962|588792766|FG002|Treatment Period|Lack of Efficacy|0|||
163024999|NCT01053962|588792767|FG003|Treatment Period|Lack of Efficacy|0|||
163025000|NCT01053962|588792768|FG004|Treatment Period|Lack of Efficacy|1|||
163025001|NCT01053962|588792764|FG000|Treatment Period|Adverse Event|0|||
163025002|NCT01053962|588792765|FG001|Treatment Period|Adverse Event|0|||
163025003|NCT01053962|588792766|FG002|Treatment Period|Adverse Event|0|||
163025004|NCT01053962|588792767|FG003|Treatment Period|Adverse Event|0|||
163025005|NCT01053962|588792768|FG004|Treatment Period|Adverse Event|1|||
163025006|NCT01053962|588792764|FG000|Treatment Period|Withdrawal by Subject|0|||
163025007|NCT01053962|588792765|FG001|Treatment Period|Withdrawal by Subject|0|||
163025008|NCT01053962|588792766|FG002|Treatment Period|Withdrawal by Subject|0|||
163025009|NCT01053962|588792767|FG003|Treatment Period|Withdrawal by Subject|0|||
163025010|NCT01053962|588792768|FG004|Treatment Period|Withdrawal by Subject|1|||
163025011|NCT01053962|588792764|FG000|Treatment Period|Noncompliance with protocol|1|||
163025012|NCT01053962|588792765|FG001|Treatment Period|Noncompliance with protocol|0|||
163025013|NCT01053962|588792766|FG002|Treatment Period|Noncompliance with protocol|0|||
163025014|NCT01053962|588792767|FG003|Treatment Period|Noncompliance with protocol|0|||
163025015|NCT01053962|588792768|FG004|Treatment Period|Noncompliance with protocol|0|||
163025016|NCT02833844|588792769|FG000|Double-Blind Period|Withdrawal by Subject|2|||
163025017|NCT02833844|588792770|FG001|Double-Blind Period|Withdrawal by Subject|3|||
163025018|NCT02833844|588792769|FG000|Double-Blind Period|Protocol Violation|0|||
163025019|NCT02833844|588792770|FG001|Double-Blind Period|Protocol Violation|4|||
163025020|NCT02833844|588792769|FG000|Open-Label Period|Death|0|||
163025021|NCT02833844|588792770|FG001|Open-Label Period|Death|2|||
163025022|NCT02833844|588792769|FG000|Open-Label Period|Lost to Follow-up|1|||
163025023|NCT02833844|588792770|FG001|Open-Label Period|Lost to Follow-up|0|||
163025024|NCT02833844|588792769|FG000|Open-Label Period|Withdrawal by Subject|1|||
163025025|NCT02833844|588792770|FG001|Open-Label Period|Withdrawal by Subject|0|||
163330673|NCT00093496|589920653|FG000|Overall Study|Protocol Violation|1|||
163025026|NCT01646021|588792772|FG000|Overall Study|Death|77|||
163025027|NCT01646021|588792773|FG001|Overall Study|Death|83|||
163025028|NCT01646021|588792772|FG000|Overall Study|Study Terminated by Sponsor|50|||
163025029|NCT01646021|588792773|FG001|Overall Study|Study Terminated by Sponsor|41|||
163025030|NCT01646021|588792772|FG000|Overall Study|Lost to Follow-up|2|||
163025031|NCT01646021|588792773|FG001|Overall Study|Lost to Follow-up|2|||
163217523|NCT01252940|589512238|FG001|Main Study Phase|Randomized but not treated|2|||
163217524|NCT01252940|589512237|FG000|Main Study Phase|Adverse Event|3|||
163064688|NCT05376358|588943583|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
163064689|NCT05376358|588943584|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
163064690|NCT05376358|588943583|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
163064691|NCT05376358|588943584|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
163064692|NCT04225832|588943585|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
163064693|NCT04225832|588943586|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
163064694|NCT04225832|588943585|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
163064695|NCT04225832|588943586|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
163064696|NCT00311168|588943587|FG000|First Intervention|Withdrawal by Subject|2|||
163064697|NCT00311168|588943588|FG001|First Intervention|Withdrawal by Subject|2|||
163064698|NCT00311168|588943587|FG000|First Intervention|Lost to Follow-up|1|||
163064699|NCT00311168|588943588|FG001|First Intervention|Lost to Follow-up|1|||
163064700|NCT00311168|588943587|FG000|First Intervention|Protocol Violation|1|||
163064701|NCT00311168|588943588|FG001|First Intervention|Protocol Violation|1|||
163064702|NCT00311168|588943587|FG000|First Intervention|Adverse Event|1|||
163064703|NCT00311168|588943588|FG001|First Intervention|Adverse Event|0|||
163064704|NCT00311168|588943587|FG000|First Intervention|Other|2|||
163064705|NCT00311168|588943588|FG001|First Intervention|Other|2|||
163064706|NCT00311168|588943587|FG000|Second Intervention|Lost to Follow-up|9|||
163064707|NCT00311168|588943588|FG001|Second Intervention|Lost to Follow-up|2|||
163064708|NCT00311168|588943587|FG000|Second Intervention|Withdrawal by Subject|0|||
163064709|NCT00311168|588943588|FG001|Second Intervention|Withdrawal by Subject|1|||
163064710|NCT00311168|588943587|FG000|Second Intervention|Other|1|||
163064711|NCT00311168|588943588|FG001|Second Intervention|Other|1|||
163064712|NCT05472142|588943589|FG000|Total Participants|Lost to Follow-up|312|||
163064713|NCT05472142|588943590|FG001|Total Participants|Lost to Follow-up|0|||
163064714|NCT05472142|588943589|FG000|Clinic Patients|Lost to Follow-up|312|||
163064715|NCT05472142|588943590|FG001|Clinic Patients|Lost to Follow-up|0|||
163064716|NCT02452190|588943591|FG000|Overall Study|Withdrawal by Sponsor|1|||
163064717|NCT02452190|588943592|FG001|Overall Study|Withdrawal by Sponsor|3|||
163064718|NCT02452190|588943591|FG000|Overall Study|Pregnancy|1|||
163064719|NCT02452190|588943592|FG001|Overall Study|Pregnancy|0|||
163064720|NCT02452190|588943591|FG000|Overall Study|Investigator's Decision|2|||
163064721|NCT02452190|588943592|FG001|Overall Study|Investigator's Decision|0|||
163064722|NCT02452190|588943591|FG000|Overall Study|Lack of Efficacy|3|||
163064723|NCT02452190|588943592|FG001|Overall Study|Lack of Efficacy|1|||
163064724|NCT02452190|588943591|FG000|Overall Study|Lost to Follow-up|4|||
163064725|NCT02452190|588943592|FG001|Overall Study|Lost to Follow-up|3|||
163064726|NCT02452190|588943591|FG000|Overall Study|Adverse Event|2|||
163064727|NCT02452190|588943592|FG001|Overall Study|Adverse Event|5|||
163064728|NCT02452190|588943591|FG000|Overall Study|Withdrawal by Subject|20|||
163064729|NCT02452190|588943592|FG001|Overall Study|Withdrawal by Subject|11|||
163064730|NCT02452190|588943591|FG000|Overall Study|Noncompliance with study drug|1|||
163064731|NCT02452190|588943592|FG001|Overall Study|Noncompliance with study drug|0|||
163064732|NCT02452190|588943591|FG000|Overall Study|Participant traveled abroad|1|||
163064733|NCT02452190|588943592|FG001|Overall Study|Participant traveled abroad|0|||
163064734|NCT02452190|588943591|FG000|Overall Study|Death|0|||
163064735|NCT02452190|588943592|FG001|Overall Study|Death|1|||
163064736|NCT06001021|588943593|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
163064737|NCT06001021|588943594|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
163064738|NCT06001021|588943595|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
163064739|NCT06001021|588943596|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
163064740|NCT06001021|588943597|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
163064741|NCT06001021|588943598|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
163064742|NCT06001021|588943599|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
163064743|NCT06001021|588943593|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
163064744|NCT06001021|588943594|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
163064745|NCT06001021|588943595|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
163217525|NCT01252940|589512238|FG001|Main Study Phase|Adverse Event|1|||
163064746|NCT06001021|588943596|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
163064747|NCT06001021|588943597|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
163064748|NCT06001021|588943598|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
163217526|NCT01252940|589512237|FG000|Main Study Phase|Lack of Efficacy|1|||
163217527|NCT01252940|589512238|FG001|Main Study Phase|Lack of Efficacy|0|||
163217528|NCT01252940|589512237|FG000|Main Study Phase|Lost to Follow-up|6|||
163217529|NCT01252940|589512238|FG001|Main Study Phase|Lost to Follow-up|1|||
163217530|NCT01252940|589512237|FG000|Main Study Phase|Physician Decision|1|||
163217531|NCT01252940|589512238|FG001|Main Study Phase|Physician Decision|0|||
163217532|NCT01252940|589512237|FG000|Main Study Phase|Protocol Violation|4|||
163217533|NCT01252940|589512238|FG001|Main Study Phase|Protocol Violation|2|||
163064749|NCT06001021|588943599|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
163064750|NCT03112603|588943602|FG000|End of Randomization Period|Lost to Follow-up|3|||
163064751|NCT03112603|588943603|FG001|End of Randomization Period|Lost to Follow-up|0|||
163064752|NCT03112603|588943604|FG002|End of Randomization Period|Lost to Follow-up|0|||
163064753|NCT03112603|588943602|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
163064754|NCT03112603|588943603|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
163064755|NCT03112603|588943604|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
163064756|NCT03112603|588943602|FG000|End of Randomization Period|Physician Decision|43|||
163064757|NCT03112603|588943603|FG001|End of Randomization Period|Physician Decision|18|||
163064758|NCT03112603|588943604|FG002|End of Randomization Period|Physician Decision|0|||
163064759|NCT03112603|588943602|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
163064760|NCT03112603|588943603|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
163064761|NCT03112603|588943604|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
163064762|NCT03112603|588943602|FG000|End of Randomization Period|Death|10|||
163064763|NCT03112603|588943603|FG001|End of Randomization Period|Death|7|||
163064764|NCT03112603|588943604|FG002|End of Randomization Period|Death|0|||
163064765|NCT03112603|588943602|FG000|End of Randomization Period|Disease Relapse|12|||
163064766|NCT03112603|588943603|FG001|End of Randomization Period|Disease Relapse|7|||
163064767|NCT03112603|588943604|FG002|End of Randomization Period|Disease Relapse|0|||
163064768|NCT03112603|588943602|FG000|End of Randomization Period|Lack of Efficacy|25|||
163064769|NCT03112603|588943603|FG001|End of Randomization Period|Lack of Efficacy|77|||
163064770|NCT03112603|588943604|FG002|End of Randomization Period|Lack of Efficacy|0|||
163064771|NCT03112603|588943602|FG000|End of Randomization Period|Adverse Event|32|||
163064772|NCT03112603|588943603|FG001|End of Randomization Period|Adverse Event|12|||
163064773|NCT03112603|588943604|FG002|End of Randomization Period|Adverse Event|0|||
163064774|NCT03112603|588943602|FG000|End of Cross Over Period|Death|0|||
163064775|NCT03112603|588943603|FG001|End of Cross Over Period|Death|0|||
163064776|NCT03112603|588943604|FG002|End of Cross Over Period|Death|2|||
163064777|NCT03112603|588943602|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
163064778|NCT03112603|588943603|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
163064779|NCT03112603|588943604|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
163064780|NCT03112603|588943602|FG000|End of Cross Over Period|Physician Decision|0|||
163064781|NCT03112603|588943603|FG001|End of Cross Over Period|Physician Decision|0|||
163064782|NCT03112603|588943604|FG002|End of Cross Over Period|Physician Decision|29|||
163064783|NCT03112603|588943602|FG000|End of Cross Over Period|Lack of Efficacy|0|||
163217534|NCT01252940|589512237|FG000|Main Study Phase|Withdrawal by Subject|6|||
163217535|NCT01252940|589512238|FG001|Main Study Phase|Withdrawal by Subject|5|||
163217536|NCT01252940|589512237|FG000|Main Study Phase|Subject Non-compliance|1|||
163064784|NCT03112603|588943603|FG001|End of Cross Over Period|Lack of Efficacy|0|||
163064785|NCT03112603|588943604|FG002|End of Cross Over Period|Lack of Efficacy|8|||
163064786|NCT03112603|588943602|FG000|End of Cross Over Period|Adverse Event|0|||
163064787|NCT03112603|588943603|FG001|End of Cross Over Period|Adverse Event|0|||
163064788|NCT03112603|588943604|FG002|End of Cross Over Period|Adverse Event|6|||
163064789|NCT03112603|588943602|FG000|End of Cross Over Period|Disease Relapse|0|||
163064790|NCT03112603|588943603|FG001|End of Cross Over Period|Disease Relapse|0|||
163064791|NCT03112603|588943604|FG002|End of Cross Over Period|Disease Relapse|2|||
163064792|NCT02278354|588943605|FG000|Overall Study|Lost to Follow-up|2|||
163064793|NCT02278354|588943606|FG001|Overall Study|Lost to Follow-up|2|||
163064794|NCT02278354|588943605|FG000|Overall Study|Withdrawal by Subject|0|||
163064795|NCT02278354|588943606|FG001|Overall Study|Withdrawal by Subject|1|||
163064796|NCT02278354|588943605|FG000|Overall Study|<10 professional fights|2|||
163064797|NCT02278354|588943606|FG001|Overall Study|<10 professional fights|0|||
163064798|NCT01564407|588943614|FG000|Overall Study|Lost to Follow-up|0|||
163064799|NCT01564407|588943615|FG001|Overall Study|Lost to Follow-up|1|||
163064800|NCT01564407|588943616|FG002|Overall Study|Lost to Follow-up|0|||
163064801|NCT01564407|588943617|FG003|Overall Study|Lost to Follow-up|0|||
163064802|NCT01564407|588943618|FG004|Overall Study|Lost to Follow-up|0|||
163064803|NCT01564407|588943614|FG000|Overall Study|Withdrawal by Subject|0|||
163064804|NCT01564407|588943615|FG001|Overall Study|Withdrawal by Subject|1|||
163064805|NCT01564407|588943616|FG002|Overall Study|Withdrawal by Subject|0|||
163217537|NCT01252940|589512238|FG001|Main Study Phase|Subject Non-compliance|1|||
163064806|NCT01564407|588943617|FG003|Overall Study|Withdrawal by Subject|0|||
163064807|NCT01564407|588943618|FG004|Overall Study|Withdrawal by Subject|0|||
163064808|NCT01564407|588943614|FG000|Overall Study|funding lost, study ended|0|||
163064809|NCT01564407|588943615|FG001|Overall Study|funding lost, study ended|0|||
163064810|NCT01564407|588943616|FG002|Overall Study|funding lost, study ended|0|||
163064811|NCT01564407|588943617|FG003|Overall Study|funding lost, study ended|1|||
163064812|NCT01564407|588943618|FG004|Overall Study|funding lost, study ended|0|||
163217538|NCT01252940|589512237|FG000|Extension Phase|Adverse Event|2|||
163217539|NCT01252940|589512238|FG001|Extension Phase|Adverse Event|1|||
163217540|NCT01252940|589512237|FG000|Extension Phase|Lack of Efficacy|1|||
163217541|NCT01252940|589512238|FG001|Extension Phase|Lack of Efficacy|0|||
163217542|NCT01252940|589512237|FG000|Extension Phase|Lost to Follow-up|5|||
163025032|NCT01646021|588792772|FG000|Overall Study|Withdrawal by Subject|10|||
163025033|NCT01646021|588792773|FG001|Overall Study|Withdrawal by Subject|15|||
163025034|NCT02347891|588792774|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
163025035|NCT02347891|588792775|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
163025036|NCT02347891|588792774|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
163025037|NCT02347891|588792775|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
163025038|NCT00614120|588792779|FG000|Overall Study|Adverse Event|9|||
163025039|NCT00614120|588792780|FG001|Overall Study|Adverse Event|22|||
163025040|NCT00614120|588792781|FG002|Overall Study|Adverse Event|30|||
163025041|NCT00614120|588792782|FG003|Overall Study|Adverse Event|3|||
163025042|NCT00614120|588792779|FG000|Overall Study|Lack of Efficacy|3|||
163025043|NCT00614120|588792780|FG001|Overall Study|Lack of Efficacy|3|||
163025044|NCT00614120|588792781|FG002|Overall Study|Lack of Efficacy|2|||
163025045|NCT00614120|588792782|FG003|Overall Study|Lack of Efficacy|2|||
163025046|NCT00614120|588792779|FG000|Overall Study|Protocol Violation|2|||
163025047|NCT00614120|588792780|FG001|Overall Study|Protocol Violation|5|||
163025048|NCT00614120|588792781|FG002|Overall Study|Protocol Violation|3|||
163025049|NCT00614120|588792782|FG003|Overall Study|Protocol Violation|1|||
163025050|NCT00614120|588792779|FG000|Overall Study|Withdrawal criteria|1|||
163025051|NCT00614120|588792780|FG001|Overall Study|Withdrawal criteria|0|||
163025052|NCT00614120|588792781|FG002|Overall Study|Withdrawal criteria|0|||
163025053|NCT00614120|588792782|FG003|Overall Study|Withdrawal criteria|0|||
163025054|NCT00614120|588792779|FG000|Overall Study|Withdrawal by Subject|9|||
163025055|NCT00614120|588792780|FG001|Overall Study|Withdrawal by Subject|10|||
163025056|NCT00614120|588792781|FG002|Overall Study|Withdrawal by Subject|16|||
163025057|NCT00614120|588792782|FG003|Overall Study|Withdrawal by Subject|3|||
163025058|NCT00614120|588792779|FG000|Overall Study|Did not meet trial criteria|0|||
163025059|NCT00614120|588792780|FG001|Overall Study|Did not meet trial criteria|1|||
163025060|NCT00614120|588792781|FG002|Overall Study|Did not meet trial criteria|1|||
163025061|NCT00614120|588792782|FG003|Overall Study|Did not meet trial criteria|1|||
163025062|NCT00614120|588792779|FG000|Overall Study|hCG positive (not pregnant)|0|||
163025063|NCT00614120|588792780|FG001|Overall Study|hCG positive (not pregnant)|0|||
163025064|NCT00614120|588792781|FG002|Overall Study|hCG positive (not pregnant)|1|||
163025065|NCT00614120|588792782|FG003|Overall Study|hCG positive (not pregnant)|0|||
163025066|NCT00614120|588792779|FG000|Overall Study|Hypoglycaemia|0|||
163025067|NCT00614120|588792780|FG001|Overall Study|Hypoglycaemia|0|||
163025068|NCT00614120|588792781|FG002|Overall Study|Hypoglycaemia|0|||
163025069|NCT00614120|588792782|FG003|Overall Study|Hypoglycaemia|1|||
163025070|NCT00614120|588792779|FG000|Overall Study|Lack of trial product|3|||
163025071|NCT00614120|588792780|FG001|Overall Study|Lack of trial product|3|||
163025072|NCT00614120|588792781|FG002|Overall Study|Lack of trial product|2|||
163025073|NCT00614120|588792782|FG003|Overall Study|Lack of trial product|0|||
163025074|NCT00614120|588792779|FG000|Overall Study|Late syphilis, latent|1|||
163025075|NCT00614120|588792780|FG001|Overall Study|Late syphilis, latent|0|||
163025076|NCT00614120|588792781|FG002|Overall Study|Late syphilis, latent|0|||
163025077|NCT00614120|588792782|FG003|Overall Study|Late syphilis, latent|0|||
163025078|NCT00614120|588792779|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
163025079|NCT00614120|588792780|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
163025080|NCT00614120|588792781|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
163025081|NCT00614120|588792782|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
163025082|NCT00614120|588792779|FG000|Overall Study|Lost to Follow-up|1|||
163025083|NCT00614120|588792780|FG001|Overall Study|Lost to Follow-up|2|||
163025084|NCT00614120|588792781|FG002|Overall Study|Lost to Follow-up|3|||
163025085|NCT00614120|588792782|FG003|Overall Study|Lost to Follow-up|4|||
163025086|NCT00727844|588792783|FG000|Initial Randomization|Physician Decision|2|||
163025087|NCT00727844|588792784|FG001|Initial Randomization|Physician Decision|0|||
163025088|NCT00727844|588792785|FG002|Initial Randomization|Physician Decision|0|||
163025089|NCT00727844|588792786|FG003|Initial Randomization|Physician Decision|0|||
163025090|NCT04439214|588792787|FG000|Overall Study|Adverse Event|13|||
163025091|NCT04439214|588792787|FG000|Overall Study|Disease progression|16|||
163025092|NCT04439214|588792787|FG000|Overall Study|Death|1|||
163025093|NCT04439214|588792787|FG000|Overall Study|Withdrawal by Subject|2|||
163025094|NCT04439214|588792787|FG000|Overall Study|Declining health|1|||
163217543|NCT01252940|589512238|FG001|Extension Phase|Lost to Follow-up|0|||
163025095|NCT04439214|588792787|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
163025096|NCT04439214|588792787|FG000|Overall Study|Ineligible|5|||
163025097|NCT02964208|588792788|FG000|Overall Study|Death|103|||
163025098|NCT02964208|588792788|FG000|Overall Study|Withdrawal by Subject|6|||
163217544|NCT01252940|589512237|FG000|Extension Phase|Physician Decision|0|||
163217545|NCT01252940|589512238|FG001|Extension Phase|Physician Decision|1|||
163025099|NCT02964208|588792788|FG000|Overall Study|Lost to Follow-up|6|||
163025100|NCT02964208|588792788|FG000|Overall Study|Unsuccessful Procedure|5|||
163025101|NCT02964208|588792788|FG000|Overall Study|Device Explant|1|||
163025102|NCT02964208|588792788|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
163025103|NCT04013672|588792793|FG000|Overall Study|Withdrawal by Subject|3|||
163025104|NCT04013672|588792794|FG001|Overall Study|Withdrawal by Subject|0|||
163064813|NCT05845619|588943619|FG000|Overall Study|duplicate enrollment|2|||
163064814|NCT05845619|588943620|FG001|Overall Study|duplicate enrollment|2|||
163064815|NCT05845619|588943621|FG002|Overall Study|duplicate enrollment|1|||
163064816|NCT04967222|588943624|FG000|Randomized|Lost to Follow-up|0|||
163064817|NCT04967222|588943625|FG001|Randomized|Lost to Follow-up|1|||
163064818|NCT04967222|588943626|FG002|Randomized|Lost to Follow-up|1|||
163064819|NCT04967222|588943624|FG000|Randomized|Physician Decision|0|||
163064820|NCT04967222|588943625|FG001|Randomized|Physician Decision|0|||
163064821|NCT04967222|588943626|FG002|Randomized|Physician Decision|1|||
163064822|NCT04967222|588943624|FG000|Randomized|Withdrawal by Subject|0|||
163064823|NCT04967222|588943625|FG001|Randomized|Withdrawal by Subject|0|||
163064824|NCT04967222|588943626|FG002|Randomized|Withdrawal by Subject|2|||
163064825|NCT04967222|588943624|FG000|Randomized|abnormal finding in MRI|0|||
163064826|NCT04967222|588943625|FG001|Randomized|abnormal finding in MRI|2|||
163064827|NCT04967222|588943626|FG002|Randomized|abnormal finding in MRI|0|||
163064828|NCT02629159|588943627|FG000|Overall Study|Adverse Event|17|||
163064829|NCT02629159|588943628|FG001|Overall Study|Adverse Event|20|||
163064830|NCT02629159|588943629|FG002|Overall Study|Adverse Event|22|||
163064831|NCT02629159|588943627|FG000|Overall Study|Withdrawal by Subject|22|||
163064832|NCT02629159|588943628|FG001|Overall Study|Withdrawal by Subject|11|||
163064833|NCT02629159|588943629|FG002|Overall Study|Withdrawal by Subject|15|||
163064834|NCT02629159|588943627|FG000|Overall Study|Lost to Follow-up|7|||
163064835|NCT02629159|588943628|FG001|Overall Study|Lost to Follow-up|4|||
163064836|NCT02629159|588943629|FG002|Overall Study|Lost to Follow-up|5|||
163064837|NCT02629159|588943627|FG000|Overall Study|Lack of Efficacy|4|||
163064838|NCT02629159|588943628|FG001|Overall Study|Lack of Efficacy|0|||
163064839|NCT02629159|588943629|FG002|Overall Study|Lack of Efficacy|1|||
163064840|NCT02629159|588943627|FG000|Overall Study|Other|6|||
163064841|NCT02629159|588943628|FG001|Overall Study|Other|4|||
163064842|NCT02629159|588943629|FG002|Overall Study|Other|8|||
163064843|NCT05722015|588943630|FG000|Overall Study|Death|57|||
163064844|NCT05722015|588943631|FG001|Overall Study|Death|37|||
163064845|NCT05722015|588943630|FG000|Overall Study|Lost to Follow-up|1|||
163064846|NCT05722015|588943631|FG001|Overall Study|Lost to Follow-up|0|||
163064847|NCT05722015|588943630|FG000|Overall Study|Withdrawal by Subject|5|||
163064848|NCT05722015|588943631|FG001|Overall Study|Withdrawal by Subject|1|||
163064849|NCT05722015|588943630|FG000|Overall Study|Participants Ongoing|188|||
163064850|NCT05722015|588943631|FG001|Overall Study|Participants Ongoing|88|||
163064851|NCT02685735|588943632|FG000|Overall Study|Surgery Cancelled|4|||
163064852|NCT02685735|588943633|FG001|Overall Study|Surgery Cancelled|9|||
163064853|NCT02685735|588943632|FG000|Overall Study|Adverse Event|10|||
163064854|NCT02685735|588943633|FG001|Overall Study|Adverse Event|3|||
163064855|NCT02685735|588943632|FG000|Overall Study|Preop testing found to be incomplete|2|||
163064856|NCT02685735|588943633|FG001|Overall Study|Preop testing found to be incomplete|2|||
163064857|NCT02685735|588943632|FG000|Overall Study|Withdrawal by Subject|1|||
163064858|NCT02685735|588943633|FG001|Overall Study|Withdrawal by Subject|2|||
163064859|NCT02685735|588943632|FG000|Overall Study|Death|1|||
163064860|NCT02685735|588943633|FG001|Overall Study|Death|0|||
163064861|NCT04133909|588943634|FG000|Overall Study|Death|11|||
163064862|NCT04133909|588943635|FG001|Overall Study|Death|11|||
163064863|NCT04133909|588943634|FG000|Overall Study|Adverse Event|4|||
163064864|NCT04133909|588943635|FG001|Overall Study|Adverse Event|5|||
163064865|NCT04133909|588943634|FG000|Overall Study|Lost to Follow-up|3|||
163064866|NCT04133909|588943635|FG001|Overall Study|Lost to Follow-up|5|||
163064867|NCT04133909|588943634|FG000|Overall Study|Physician Decision|4|||
163064868|NCT04133909|588943635|FG001|Overall Study|Physician Decision|7|||
163064869|NCT04133909|588943634|FG000|Overall Study|Withdrawal by Subject|40|||
163064870|NCT04133909|588943635|FG001|Overall Study|Withdrawal by Subject|35|||
163064871|NCT04133909|588943634|FG000|Overall Study|Lack of Efficacy|2|||
163064872|NCT04133909|588943635|FG001|Overall Study|Lack of Efficacy|7|||
163064873|NCT04133909|588943634|FG000|Overall Study|Randomized in error|1|||
163064874|NCT04133909|588943635|FG001|Overall Study|Randomized in error|1|||
163064875|NCT05020743|588943636|FG000|Overall Study|Enrollment in Interventional Study|2|||
163330674|NCT00093496|589920654|FG001|Overall Study|Protocol Violation|3|||
163330675|NCT01953224|589920655|FG000|Overall Study|Lost to Follow-up|1|||
163064876|NCT05020743|588943637|FG001|Overall Study|Enrollment in Interventional Study|9|||
163064877|NCT05020743|588943638|FG002|Overall Study|Enrollment in Interventional Study|0|||
163064878|NCT05020743|588943636|FG000|Overall Study|Withdrawal by Subject|0|||
163064879|NCT05020743|588943637|FG001|Overall Study|Withdrawal by Subject|3|||
163064880|NCT05020743|588943638|FG002|Overall Study|Withdrawal by Subject|1|||
163064881|NCT05020743|588943636|FG000|Overall Study|Lost to Follow-up|1|||
163064882|NCT05020743|588943637|FG001|Overall Study|Lost to Follow-up|0|||
163064883|NCT05020743|588943638|FG002|Overall Study|Lost to Follow-up|0|||
163064884|NCT05020743|588943636|FG000|Overall Study|Study Termination by Sponsor|10|||
163064885|NCT05020743|588943637|FG001|Overall Study|Study Termination by Sponsor|11|||
163064886|NCT05020743|588943638|FG002|Overall Study|Study Termination by Sponsor|10|||
163064887|NCT02003924|588943639|FG000|Double-blind Phase|Lost to Follow-up|2|||
163330676|NCT01953224|589920656|FG001|Overall Study|Lost to Follow-up|1|||
163330677|NCT01953224|589920655|FG000|Overall Study|Withdrawal by Subject|1|||
163064888|NCT02003924|588943640|FG001|Double-blind Phase|Lost to Follow-up|1|||
163064889|NCT02003924|588943641|FG002|Double-blind Phase|Lost to Follow-up|0|||
163064890|NCT02003924|588943639|FG000|Double-blind Phase|Protocol Violation|1|||
163064891|NCT02003924|588943640|FG001|Double-blind Phase|Protocol Violation|2|||
163064892|NCT02003924|588943641|FG002|Double-blind Phase|Protocol Violation|0|||
163064893|NCT02003924|588943639|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
163064894|NCT02003924|588943640|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
163064895|NCT02003924|588943641|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
163064896|NCT02003924|588943639|FG000|Double-blind Phase|Disease Progression|229|||
163064897|NCT02003924|588943640|FG001|Double-blind Phase|Disease Progression|247|||
163064898|NCT02003924|588943641|FG002|Double-blind Phase|Disease Progression|0|||
163064899|NCT02003924|588943639|FG000|Double-blind Phase|Adverse Event|120|||
163064900|NCT02003924|588943640|FG001|Double-blind Phase|Adverse Event|31|||
163064901|NCT02003924|588943641|FG002|Double-blind Phase|Adverse Event|0|||
163064902|NCT02003924|588943639|FG000|Double-blind Phase|Randomized But not Treated|3|||
163064903|NCT02003924|588943640|FG001|Double-blind Phase|Randomized But not Treated|3|||
163064904|NCT02003924|588943641|FG002|Double-blind Phase|Randomized But not Treated|0|||
163064905|NCT02003924|588943639|FG000|Double-blind Phase|Other|29|||
163064906|NCT02003924|588943640|FG001|Double-blind Phase|Other|50|||
163064907|NCT02003924|588943641|FG002|Double-blind Phase|Other|0|||
163064908|NCT02003924|588943639|FG000|Open-label Phase|Lost to Follow-up|0|||
163064909|NCT02003924|588943640|FG001|Open-label Phase|Lost to Follow-up|0|||
163064910|NCT02003924|588943641|FG002|Open-label Phase|Lost to Follow-up|1|||
163064911|NCT02003924|588943639|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
163064912|NCT02003924|588943640|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
163064913|NCT02003924|588943641|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
163064914|NCT02003924|588943639|FG000|Open-label Phase|Disease Progression|59|||
163064915|NCT02003924|588943640|FG001|Open-label Phase|Disease Progression|0|||
163064916|NCT02003924|588943641|FG002|Open-label Phase|Disease Progression|5|||
163064917|NCT02003924|588943639|FG000|Open-label Phase|Adverse Event|25|||
163064918|NCT02003924|588943640|FG001|Open-label Phase|Adverse Event|0|||
163064919|NCT02003924|588943641|FG002|Open-label Phase|Adverse Event|10|||
163064920|NCT02003924|588943639|FG000|Open-label Phase|Other|7|||
163064921|NCT02003924|588943640|FG001|Open-label Phase|Other|0|||
163064922|NCT02003924|588943641|FG002|Open-label Phase|Other|0|||
163064923|NCT02003924|588943639|FG000|Long-term Follow-up Phase|Death|288|||
163064924|NCT02003924|588943640|FG001|Long-term Follow-up Phase|Death|174|||
163064925|NCT02003924|588943641|FG002|Long-term Follow-up Phase|Death|4|||
163064926|NCT02003924|588943639|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
163064927|NCT02003924|588943640|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
163064928|NCT02003924|588943641|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
163064929|NCT02003924|588943639|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
163064930|NCT02003924|588943640|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
163064931|NCT02003924|588943641|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
163064932|NCT02003924|588943639|FG000|Long-term Follow-up Phase|Other|5|||
163064933|NCT02003924|588943640|FG001|Long-term Follow-up Phase|Other|2|||
163064934|NCT02003924|588943641|FG002|Long-term Follow-up Phase|Other|1|||
163064935|NCT02340949|588943642|FG000|Overall Study|Adverse Event|4|||
163064936|NCT02340949|588943643|FG001|Overall Study|Adverse Event|2|||
163064937|NCT02340949|588943642|FG000|Overall Study|Withdrawal by Subject|2|||
163064938|NCT02340949|588943643|FG001|Overall Study|Withdrawal by Subject|0|||
163064939|NCT02340949|588943642|FG000|Overall Study|Progression disease|6|||
163064940|NCT02340949|588943643|FG001|Overall Study|Progression disease|2|||
163064941|NCT02340949|588943642|FG000|Overall Study|Death|3|||
163064942|NCT02340949|588943643|FG001|Overall Study|Death|0|||
163064943|NCT02340949|588943642|FG000|Overall Study|Physician Decision|1|||
163064944|NCT02340949|588943643|FG001|Overall Study|Physician Decision|0|||
163064945|NCT01155570|588943644|FG000|Overall Study|Adverse Event|39|||
163064946|NCT01155570|588943644|FG000|Overall Study|Lack of Efficacy|46|||
163064947|NCT01155570|588943644|FG000|Overall Study|Participant's Economic Reasons|17|||
163064948|NCT01155570|588943644|FG000|Overall Study|No Hospital Visits|7|||
163064949|NCT01155570|588943644|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
163064950|NCT01155570|588943644|FG000|Overall Study|Adverse Event + Other Reasons|7|||
163064951|NCT01155570|588943644|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
163064952|NCT01155570|588943644|FG000|Overall Study|Other Reasons|23|||
163064953|NCT01922934|588943645|FG000|Eligible Patients|Death|0|||
163064954|NCT01922934|588943646|FG001|Eligible Patients|Death|7|||
163064955|NCT01922934|588943645|FG000|Eligible Patients|Physician Decision|17|||
163064956|NCT01922934|588943646|FG001|Eligible Patients|Physician Decision|0|||
163064957|NCT01922934|588943645|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
163064958|NCT01922934|588943646|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
163064959|NCT01922934|588943645|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
163064960|NCT01922934|588943646|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
163064961|NCT01922934|588943645|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
163064962|NCT01922934|588943646|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
163217546|NCT01252940|589512237|FG000|Extension Phase|Subject Non-compliance|1|||
163217547|NCT01252940|589512238|FG001|Extension Phase|Subject Non-compliance|0|||
163217548|NCT01252940|589512237|FG000|Extension Phase|Withdrawal by Subject|1|||
163217549|NCT01252940|589512238|FG001|Extension Phase|Withdrawal by Subject|1|||
163025105|NCT04013672|588792793|FG000|Overall Study|Death|1|||
163025106|NCT04013672|588792794|FG001|Overall Study|Death|0|||
163025107|NCT04013672|588792793|FG000|Overall Study|Physician Decision|5|||
163025108|NCT04013672|588792794|FG001|Overall Study|Physician Decision|0|||
163025109|NCT02847494|588792799|FG000|Overall Study|Lost to Follow-up|8|||
163025110|NCT02847494|588792800|FG001|Overall Study|Lost to Follow-up|5|||
163025111|NCT03887442|588792804|FG000|Overall Study|Adverse Event|1|||
163025112|NCT03887442|588792805|FG001|Overall Study|Adverse Event|0|||
163025113|NCT01628198|588792808|FG000|Overall Study|Lost to Follow-up|7|||
163025114|NCT01628198|588792808|FG000|Overall Study|Withdrawal by Subject|10|||
163025115|NCT01628198|588792808|FG000|Overall Study|Screen failure|1|||
163025116|NCT00022698|588792809|FG000|Overall Study|Adverse Event|5|||
163025117|NCT00022698|588792810|FG001|Overall Study|Adverse Event|9|||
163025118|NCT00022698|588792809|FG000|Overall Study|Death|0|||
163025119|NCT00022698|588792810|FG001|Overall Study|Death|2|||
163025120|NCT00022698|588792809|FG000|Overall Study|Failure to return|0|||
163025121|NCT00022698|588792810|FG001|Overall Study|Failure to return|1|||
163025122|NCT00022698|588792809|FG000|Overall Study|Refused treatment|0|||
163025123|NCT00022698|588792810|FG001|Overall Study|Refused treatment|2|||
163025124|NCT00022698|588792809|FG000|Overall Study|Insufficient therapeutic response|2|||
163025125|NCT00022698|588792810|FG001|Overall Study|Insufficient therapeutic response|14|||
163025126|NCT00022698|588792809|FG000|Overall Study|Administrative /other|1|||
163025127|NCT00022698|588792810|FG001|Overall Study|Administrative /other|7|||
163025128|NCT03386994|588792811|FG000|Overall Study|Lung transplant|1|||
163025129|NCT03386994|588792811|FG000|Overall Study|Adverse Event|14|||
163025130|NCT03386994|588792811|FG000|Overall Study|Lost to Follow-up|4|||
163025131|NCT03386994|588792811|FG000|Overall Study|Withdrawal by Subject|3|||
163025132|NCT03386994|588792811|FG000|Overall Study|Death|16|||
163025133|NCT04553471|588792813|FG000|Overall Study|Did not start treatment on protocol|3|||
163025134|NCT04553471|588792813|FG000|Overall Study|Death|1|||
163025135|NCT01441765|588792814|FG000|Overall Study|Death|1|||
163025136|NCT01441765|588792815|FG001|Overall Study|Death|0|||
163025137|NCT00813813|588792818|FG000|Overall Study|Withdrawal by Subject|1|||
163025138|NCT00813813|588792819|FG001|Overall Study|Withdrawal by Subject|1|||
163025139|NCT00813813|588792818|FG000|Overall Study|Lost to Follow-up|2|||
163025140|NCT00813813|588792819|FG001|Overall Study|Lost to Follow-up|7|||
163025141|NCT00813813|588792818|FG000|Overall Study|Other|0|||
163025142|NCT00813813|588792819|FG001|Overall Study|Other|1|||
163025143|NCT01684943|588792822|FG000|Overall Study|Inadequate Venous Access|3|||
163025144|NCT01684943|588792823|FG001|Overall Study|Inadequate Venous Access|0|||
163025145|NCT01684943|588792824|FG002|Overall Study|Inadequate Venous Access|0|||
163025146|NCT01684943|588792822|FG000|Overall Study|Principal Investigator Determination|1|||
163025147|NCT01684943|588792823|FG001|Overall Study|Principal Investigator Determination|0|||
163025148|NCT01684943|588792824|FG002|Overall Study|Principal Investigator Determination|0|||
163025149|NCT01684943|588792822|FG000|Overall Study|Excluded from Analysis|1|||
163025150|NCT01684943|588792823|FG001|Overall Study|Excluded from Analysis|1|||
163025151|NCT01684943|588792824|FG002|Overall Study|Excluded from Analysis|1|||
163025152|NCT01684943|588792822|FG000|Overall Study|Lost to Follow-up|3|||
163025153|NCT01684943|588792823|FG001|Overall Study|Lost to Follow-up|0|||
163025154|NCT01684943|588792824|FG002|Overall Study|Lost to Follow-up|0|||
163025155|NCT01684943|588792822|FG000|Overall Study|Planning Pregnancy|1|||
163025156|NCT01684943|588792823|FG001|Overall Study|Planning Pregnancy|0|||
163025157|NCT01684943|588792824|FG002|Overall Study|Planning Pregnancy|0|||
163025158|NCT01493284|588792825|FG000|Overall Study|Death|29|||
163025159|NCT01493284|588792825|FG000|Overall Study|Withdrawal by Subject|32|||
163025160|NCT03395184|588792826|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
163025161|NCT03395184|588792827|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
163025162|NCT03395184|588792828|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
163025163|NCT03395184|588792829|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
163217550|NCT01502423|589512239|FG000|Overall Study|Withdrawal by Subject|0|||
163217551|NCT01502423|589512240|FG001|Overall Study|Withdrawal by Subject|1|||
163217552|NCT04199117|589512241|FG000|Overall Study|Withdrawal by Subject|3|||
163217553|NCT04199117|589512242|FG001|Overall Study|Withdrawal by Subject|0|||
163025164|NCT03395184|588792830|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
163025165|NCT03395184|588792831|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
163025166|NCT03395184|588792832|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
163025167|NCT03395184|588792826|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
163025168|NCT03395184|588792827|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
163217554|NCT04199117|589512243|FG002|Overall Study|Withdrawal by Subject|0|||
163025169|NCT03395184|588792828|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
163025170|NCT03395184|588792829|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
163025171|NCT03395184|588792830|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
163064963|NCT01922934|588943645|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
163064964|NCT01922934|588943646|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
163064965|NCT02774889|588943649|FG000|Overall Study|Lost to Follow-up|2|||
163064966|NCT02774889|588943650|FG001|Overall Study|Lost to Follow-up|1|||
163064967|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
163064968|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
163064969|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
163064970|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
163064971|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
163064972|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
163064973|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
163064974|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
163064975|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
163064976|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
163064977|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
163064978|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
163064979|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
163064980|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
163064981|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
163064982|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
163064983|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
163064984|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
163064985|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Removal|1|||
163064986|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Removal|0|||
163064987|NCT00724945|588943653|FG000|Period 1|non-compliance|1|||
163064988|NCT00724945|588943654|FG001|Period 1|non-compliance|0|||
163064989|NCT00724945|588943653|FG000|Period 1|Adverse Event|1|||
163064990|NCT00724945|588943654|FG001|Period 1|Adverse Event|1|||
163064991|NCT00724945|588943653|FG000|Period 1|Lost to Follow-up|1|||
163064992|NCT00724945|588943654|FG001|Period 1|Lost to Follow-up|0|||
163064993|NCT00724945|588943653|FG000|Period 2|lens comfort issue|3|||
163064994|NCT00724945|588943654|FG001|Period 2|lens comfort issue|0|||
163064995|NCT00724945|588943653|FG000|Period 2|lens physiology issue|1|||
163064996|NCT00724945|588943654|FG001|Period 2|lens physiology issue|0|||
163064997|NCT05166876|588943655|FG000|Overall Study|Withdrawal by Subject|1|||
163064998|NCT05166876|588943656|FG001|Overall Study|Withdrawal by Subject|0|||
163064999|NCT05166876|588943657|FG002|Overall Study|Withdrawal by Subject|0|||
163065000|NCT00658528|588943658|FG000|Overall Study|Adverse Event|5|||
163065001|NCT00658528|588943659|FG001|Overall Study|Adverse Event|7|||
163065002|NCT00658528|588943658|FG000|Overall Study|Lost to Follow-up|14|||
163065003|NCT00658528|588943659|FG001|Overall Study|Lost to Follow-up|22|||
163065004|NCT00658528|588943658|FG000|Overall Study|Withdrawal by Subject|8|||
163065005|NCT00658528|588943659|FG001|Overall Study|Withdrawal by Subject|6|||
163065006|NCT00658528|588943658|FG000|Overall Study|Withdrawal of consent|5|||
163065007|NCT00658528|588943659|FG001|Overall Study|Withdrawal of consent|6|||
163065008|NCT00658528|588943658|FG000|Overall Study|Other|8|||
163065009|NCT00658528|588943659|FG001|Overall Study|Other|4|||
163065010|NCT01147458|588943666|FG000|First Intervention|Study terminated by sponsor|8|||
163065011|NCT01147458|588943667|FG001|First Intervention|Study terminated by sponsor|8|||
163065012|NCT01147458|588943668|FG002|First Intervention|Study terminated by sponsor|7|||
163065013|NCT01147458|588943669|FG003|First Intervention|Study terminated by sponsor|8|||
163065014|NCT01147458|588943666|FG000|First Intervention|Protocol Violation|2|||
163065015|NCT01147458|588943667|FG001|First Intervention|Protocol Violation|3|||
163065016|NCT01147458|588943668|FG002|First Intervention|Protocol Violation|2|||
163065017|NCT01147458|588943669|FG003|First Intervention|Protocol Violation|3|||
163065018|NCT01147458|588943666|FG000|First Intervention|Withdrawal by Subject|3|||
163065019|NCT01147458|588943667|FG001|First Intervention|Withdrawal by Subject|0|||
163065020|NCT01147458|588943668|FG002|First Intervention|Withdrawal by Subject|1|||
163065021|NCT01147458|588943669|FG003|First Intervention|Withdrawal by Subject|0|||
163065022|NCT01147458|588943666|FG000|First Intervention|Adverse Event|0|||
163065023|NCT01147458|588943667|FG001|First Intervention|Adverse Event|3|||
163065024|NCT01147458|588943668|FG002|First Intervention|Adverse Event|2|||
163065025|NCT01147458|588943669|FG003|First Intervention|Adverse Event|3|||
163065026|NCT01147458|588943666|FG000|First Intervention|Other|1|||
163065027|NCT01147458|588943667|FG001|First Intervention|Other|2|||
163065028|NCT01147458|588943668|FG002|First Intervention|Other|0|||
163065029|NCT01147458|588943669|FG003|First Intervention|Other|0|||
163065030|NCT01147458|588943666|FG000|Second Intervention|Study terminated by sponsor|7|||
163330678|NCT01953224|589920656|FG001|Overall Study|Withdrawal by Subject|2|||
163330679|NCT00586313|589920657|FG000|Overall Study|Lack of Efficacy|2|||
163330680|NCT03205566|589920662|FG000|Phase 1|Protocol Violation|1|||
163330681|NCT03205566|589920663|FG001|Phase 1|Protocol Violation|1|||
163330682|NCT03184987|589920664|FG000|Overall Study|Withdrawal by Subject|0|||
163065031|NCT01147458|588943667|FG001|Second Intervention|Study terminated by sponsor|5|||
163065032|NCT01147458|588943668|FG002|Second Intervention|Study terminated by sponsor|5|||
163065033|NCT01147458|588943669|FG003|Second Intervention|Study terminated by sponsor|3|||
163065034|NCT01147458|588943666|FG000|Second Intervention|Protocol Violation|0|||
163065035|NCT01147458|588943667|FG001|Second Intervention|Protocol Violation|1|||
163065036|NCT01147458|588943668|FG002|Second Intervention|Protocol Violation|1|||
163065037|NCT01147458|588943669|FG003|Second Intervention|Protocol Violation|0|||
163065038|NCT01147458|588943666|FG000|Second Intervention|Withdrawal by Subject|0|||
163065039|NCT01147458|588943667|FG001|Second Intervention|Withdrawal by Subject|1|||
163065040|NCT01147458|588943668|FG002|Second Intervention|Withdrawal by Subject|0|||
163065041|NCT01147458|588943669|FG003|Second Intervention|Withdrawal by Subject|0|||
163065042|NCT01147458|588943666|FG000|Second Intervention|Adverse Event|2|||
163065043|NCT01147458|588943667|FG001|Second Intervention|Adverse Event|0|||
163065044|NCT01147458|588943668|FG002|Second Intervention|Adverse Event|1|||
163065045|NCT01147458|588943669|FG003|Second Intervention|Adverse Event|1|||
163065046|NCT01147458|588943666|FG000|Second Intervention|Other|0|||
163065047|NCT01147458|588943667|FG001|Second Intervention|Other|0|||
163065048|NCT01147458|588943668|FG002|Second Intervention|Other|1|||
163065049|NCT01147458|588943669|FG003|Second Intervention|Other|0|||
163065050|NCT02811159|588943681|FG000|Treatment Course 1|Lost to Follow-up|1|||
163065051|NCT04603066|588943682|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
163065052|NCT04603066|588943683|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
163065053|NCT04409002|588943684|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
163065054|NCT00963235|588945669|FG000|Overall Study|Withdrawal by Subject|22|||
163065055|NCT00963235|588945669|FG000|Overall Study|Lost to Follow-up|14|||
163065056|NCT00963235|588945669|FG000|Overall Study|Failed to return|9|||
163065057|NCT00963235|588945669|FG000|Overall Study|Protocol Violation|7|||
163065058|NCT00963235|588945669|FG000|Overall Study|Adverse Event|5|||
163065059|NCT00963235|588945669|FG000|Overall Study|Physician Decision|2|||
163065060|NCT00963235|588945669|FG000|Overall Study|Other|1|||
163065061|NCT01756235|588945670|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
163065062|NCT02327078|588945677|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
163065063|NCT02327078|588945678|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
163065064|NCT02327078|588945679|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
163065065|NCT02327078|588945680|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
163065066|NCT02327078|588945681|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
163065067|NCT02327078|588945682|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
163065068|NCT02327078|588945683|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
163065069|NCT02327078|588945684|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
163065070|NCT02327078|588945685|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
163065071|NCT02327078|588945677|FG000|Overall Study|Death|2|||
163065072|NCT02327078|588945678|FG001|Overall Study|Death|4|||
163065073|NCT02327078|588945679|FG002|Overall Study|Death|10|||
163065074|NCT02327078|588945680|FG003|Overall Study|Death|6|||
163065075|NCT02327078|588945681|FG004|Overall Study|Death|4|||
163065076|NCT02327078|588945682|FG005|Overall Study|Death|3|||
163065077|NCT02327078|588945683|FG006|Overall Study|Death|2|||
163065078|NCT02327078|588945684|FG007|Overall Study|Death|51|||
163065079|NCT02327078|588945685|FG008|Overall Study|Death|97|||
163065080|NCT02327078|588945677|FG000|Overall Study|Lost to Follow-up|0|||
163065081|NCT02327078|588945678|FG001|Overall Study|Lost to Follow-up|1|||
163065082|NCT02327078|588945679|FG002|Overall Study|Lost to Follow-up|1|||
163065083|NCT02327078|588945680|FG003|Overall Study|Lost to Follow-up|0|||
163065084|NCT02327078|588945681|FG004|Overall Study|Lost to Follow-up|0|||
163065085|NCT02327078|588945682|FG005|Overall Study|Lost to Follow-up|0|||
163065086|NCT02327078|588945683|FG006|Overall Study|Lost to Follow-up|0|||
163065087|NCT02327078|588945684|FG007|Overall Study|Lost to Follow-up|2|||
163065088|NCT02327078|588945685|FG008|Overall Study|Lost to Follow-up|5|||
163065089|NCT02327078|588945677|FG000|Overall Study|Site Terminated by Sponsor|1|||
163065090|NCT02327078|588945678|FG001|Overall Study|Site Terminated by Sponsor|0|||
163065091|NCT02327078|588945679|FG002|Overall Study|Site Terminated by Sponsor|1|||
163065092|NCT02327078|588945680|FG003|Overall Study|Site Terminated by Sponsor|4|||
163065093|NCT02327078|588945681|FG004|Overall Study|Site Terminated by Sponsor|0|||
163330683|NCT03184987|589920665|FG001|Overall Study|Withdrawal by Subject|1|||
163065094|NCT02327078|588945682|FG005|Overall Study|Site Terminated by Sponsor|0|||
163065095|NCT02327078|588945683|FG006|Overall Study|Site Terminated by Sponsor|0|||
163065096|NCT02327078|588945684|FG007|Overall Study|Site Terminated by Sponsor|11|||
163065097|NCT02327078|588945685|FG008|Overall Study|Site Terminated by Sponsor|25|||
163065098|NCT02327078|588945677|FG000|Overall Study|Physician Decision|0|||
163330684|NCT03184987|589920666|FG002|Overall Study|Withdrawal by Subject|2|||
163065099|NCT02327078|588945678|FG001|Overall Study|Physician Decision|0|||
163065100|NCT02327078|588945679|FG002|Overall Study|Physician Decision|0|||
163065101|NCT02327078|588945680|FG003|Overall Study|Physician Decision|1|||
163065102|NCT02327078|588945681|FG004|Overall Study|Physician Decision|0|||
163065103|NCT02327078|588945682|FG005|Overall Study|Physician Decision|0|||
163330685|NCT03184987|589920664|FG000|Overall Study|Physician Decision|0|||
163330686|NCT03184987|589920665|FG001|Overall Study|Physician Decision|0|||
163330687|NCT03184987|589920666|FG002|Overall Study|Physician Decision|1|||
163330688|NCT03184987|589920664|FG000|Overall Study|Adverse Event|1|||
163330689|NCT03184987|589920665|FG001|Overall Study|Adverse Event|0|||
163330690|NCT03184987|589920666|FG002|Overall Study|Adverse Event|1|||
163330691|NCT01767467|589920667|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
163330692|NCT01767467|589920668|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
163330693|NCT01767467|589920667|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
163330694|NCT01767467|589920668|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
163330695|NCT01767467|589920667|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
163330696|NCT01767467|589920668|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
163330697|NCT01767467|589920667|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
163330698|NCT01767467|589920668|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
163330699|NCT01767467|589920667|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
163330700|NCT01767467|589920668|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
163330701|NCT01767467|589920667|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
163330702|NCT01767467|589920668|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
163025172|NCT03395184|588792831|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
163025173|NCT03395184|588792832|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
163025174|NCT03395184|588792826|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
163025175|NCT03395184|588792827|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
163025176|NCT03395184|588792828|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
163025177|NCT03395184|588792829|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
163025178|NCT03395184|588792830|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
163025179|NCT03395184|588792831|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
163025180|NCT03395184|588792832|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
163025181|NCT03395184|588792826|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
163025182|NCT03395184|588792827|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
163025183|NCT03395184|588792828|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
163025184|NCT03395184|588792829|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
163025185|NCT03395184|588792830|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
163025186|NCT03395184|588792831|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
163025187|NCT03395184|588792832|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
163025188|NCT03395184|588792826|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
163025189|NCT03395184|588792827|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163025190|NCT03395184|588792828|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
163025191|NCT03395184|588792829|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163025192|NCT03395184|588792830|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163025193|NCT03395184|588792831|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163025194|NCT03395184|588792832|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163025195|NCT03395184|588792826|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
163025196|NCT03395184|588792827|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
163025197|NCT03395184|588792828|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
163025198|NCT03395184|588792829|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
163025199|NCT03395184|588792830|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
163025200|NCT03395184|588792831|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
163025201|NCT03395184|588792832|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
163025202|NCT03395184|588792826|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
163025203|NCT03395184|588792827|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
163025204|NCT03395184|588792828|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
163025205|NCT03395184|588792829|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
163025206|NCT03395184|588792830|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
163025207|NCT03395184|588792831|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
163025208|NCT03395184|588792832|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
163025209|NCT03395184|588792826|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
163025210|NCT03395184|588792827|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
163025211|NCT03395184|588792828|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
163025212|NCT03395184|588792829|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
163025213|NCT03395184|588792830|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
163025214|NCT03395184|588792831|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
163025215|NCT03395184|588792832|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
163025216|NCT03395184|588792826|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
163025217|NCT03395184|588792827|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
163065104|NCT02327078|588945683|FG006|Overall Study|Physician Decision|0|||
163025218|NCT03395184|588792828|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
163065105|NCT02327078|588945684|FG007|Overall Study|Physician Decision|0|||
163065106|NCT02327078|588945685|FG008|Overall Study|Physician Decision|1|||
163330703|NCT01767467|589920667|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
163330704|NCT01767467|589920668|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
163406346|NCT00391222|590196732|FG003|Period III (Double-Blind Treatment)|Other|0|||
163406347|NCT01181011|590196734|FG000|Overall Study|Adverse Event|2|||
163025219|NCT03395184|588792829|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
163025220|NCT03395184|588792830|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
163025221|NCT03395184|588792831|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
163025222|NCT03395184|588792832|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
163025223|NCT03395184|588792826|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
163025224|NCT03395184|588792827|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
163025225|NCT03395184|588792828|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
163025226|NCT03395184|588792829|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
163025227|NCT03395184|588792830|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
163025228|NCT03395184|588792831|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
163025229|NCT03395184|588792832|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
163025230|NCT03395184|588792826|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
163025231|NCT03395184|588792827|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
163025232|NCT03395184|588792828|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
163025233|NCT03395184|588792829|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
163025234|NCT03395184|588792830|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
163025235|NCT03395184|588792831|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
163025236|NCT03395184|588792832|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
163025237|NCT03395184|588792826|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
163025238|NCT03395184|588792827|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
163025239|NCT03395184|588792828|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
163025240|NCT03395184|588792829|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
163025241|NCT03395184|588792830|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
163025242|NCT03395184|588792831|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
163025243|NCT03395184|588792832|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
163025244|NCT05033262|588792838|FG000|Overall Study|Lost to Follow-up|1|||
163025245|NCT05033262|588792839|FG001|Overall Study|Lost to Follow-up|0|||
163025246|NCT05033262|588792840|FG002|Overall Study|Lost to Follow-up|0|||
163025247|NCT05033262|588792841|FG003|Overall Study|Lost to Follow-up|1|||
163025248|NCT03197467|588794527|FG000|Overall Study|Withdrawal by Subject|1|||
163025249|NCT03666533|588794528|FG000|Overall Study|Lost to Follow-up|2|||
163025250|NCT03666533|588794529|FG001|Overall Study|Lost to Follow-up|2|||
163025251|NCT02017717|588794530|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025252|NCT02017717|588794531|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025253|NCT02017717|588794532|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025254|NCT02017717|588794533|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025255|NCT02017717|588794534|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025256|NCT02017717|588794535|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025257|NCT02017717|588794536|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025258|NCT02017717|588794537|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
163025259|NCT02017717|588794538|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025260|NCT02017717|588794530|FG000|Before Treatment Period|Participant request to stop therapy|0|||
163025261|NCT02017717|588794531|FG001|Before Treatment Period|Participant request to stop therapy|0|||
163025262|NCT02017717|588794532|FG002|Before Treatment Period|Participant request to stop therapy|0|||
163025263|NCT02017717|588794533|FG003|Before Treatment Period|Participant request to stop therapy|0|||
163025264|NCT02017717|588794534|FG004|Before Treatment Period|Participant request to stop therapy|0|||
163025265|NCT02017717|588794535|FG005|Before Treatment Period|Participant request to stop therapy|0|||
163025266|NCT02017717|588794536|FG006|Before Treatment Period|Participant request to stop therapy|0|||
163025267|NCT02017717|588794537|FG007|Before Treatment Period|Participant request to stop therapy|0|||
163025268|NCT02017717|588794538|FG008|Before Treatment Period|Participant request to stop therapy|5|||
163025269|NCT02017717|588794530|FG000|Before Treatment Period|Participant withdrew consent|0|||
163025270|NCT02017717|588794531|FG001|Before Treatment Period|Participant withdrew consent|0|||
163025271|NCT02017717|588794532|FG002|Before Treatment Period|Participant withdrew consent|0|||
163025272|NCT02017717|588794533|FG003|Before Treatment Period|Participant withdrew consent|0|||
163025273|NCT02017717|588794534|FG004|Before Treatment Period|Participant withdrew consent|0|||
163025274|NCT02017717|588794535|FG005|Before Treatment Period|Participant withdrew consent|0|||
163025275|NCT02017717|588794536|FG006|Before Treatment Period|Participant withdrew consent|2|||
163025276|NCT02017717|588794537|FG007|Before Treatment Period|Participant withdrew consent|0|||
163025277|NCT02017717|588794538|FG008|Before Treatment Period|Participant withdrew consent|11|||
163025278|NCT02017717|588794530|FG000|Before Treatment Period|Lost to Follow-up|0|||
163025279|NCT02017717|588794531|FG001|Before Treatment Period|Lost to Follow-up|0|||
163025280|NCT02017717|588794532|FG002|Before Treatment Period|Lost to Follow-up|0|||
163025281|NCT02017717|588794533|FG003|Before Treatment Period|Lost to Follow-up|0|||
163025282|NCT02017717|588794534|FG004|Before Treatment Period|Lost to Follow-up|0|||
163406348|NCT01181011|590196734|FG000|Overall Study|Lost to Follow-up|1|||
163406349|NCT00401375|590196735|FG000|Overall Study|Protocol Violation|2|||
163025283|NCT02017717|588794535|FG005|Before Treatment Period|Lost to Follow-up|0|||
163025284|NCT02017717|588794536|FG006|Before Treatment Period|Lost to Follow-up|0|||
163025285|NCT02017717|588794537|FG007|Before Treatment Period|Lost to Follow-up|0|||
163025286|NCT02017717|588794538|FG008|Before Treatment Period|Lost to Follow-up|1|||
163025287|NCT02017717|588794530|FG000|Before Treatment Period|Participant no longer met criteria|0|||
163025288|NCT02017717|588794531|FG001|Before Treatment Period|Participant no longer met criteria|0|||
163025289|NCT02017717|588794532|FG002|Before Treatment Period|Participant no longer met criteria|0|||
163025290|NCT02017717|588794533|FG003|Before Treatment Period|Participant no longer met criteria|0|||
163025291|NCT02017717|588794534|FG004|Before Treatment Period|Participant no longer met criteria|0|||
163025292|NCT02017717|588794535|FG005|Before Treatment Period|Participant no longer met criteria|1|||
163025293|NCT02017717|588794536|FG006|Before Treatment Period|Participant no longer met criteria|0|||
163025294|NCT02017717|588794537|FG007|Before Treatment Period|Participant no longer met criteria|1|||
163025295|NCT02017717|588794538|FG008|Before Treatment Period|Participant no longer met criteria|2|||
163025296|NCT02017717|588794530|FG000|Before Treatment Period|other reason|0|||
163025297|NCT02017717|588794531|FG001|Before Treatment Period|other reason|0|||
163025298|NCT02017717|588794532|FG002|Before Treatment Period|other reason|0|||
163025299|NCT02017717|588794533|FG003|Before Treatment Period|other reason|0|||
163025300|NCT02017717|588794534|FG004|Before Treatment Period|other reason|0|||
163025301|NCT02017717|588794535|FG005|Before Treatment Period|other reason|0|||
163025302|NCT02017717|588794536|FG006|Before Treatment Period|other reason|0|||
163025303|NCT02017717|588794537|FG007|Before Treatment Period|other reason|0|||
163025304|NCT02017717|588794538|FG008|Before Treatment Period|other reason|1|||
163025305|NCT02017717|588794530|FG000|Treatment Period|Disease progression|7|||
163025306|NCT02017717|588794531|FG001|Treatment Period|Disease progression|9|||
163025307|NCT02017717|588794532|FG002|Treatment Period|Disease progression|12|||
163025308|NCT02017717|588794533|FG003|Treatment Period|Disease progression|20|||
163025309|NCT02017717|588794534|FG004|Treatment Period|Disease progression|26|||
163025310|NCT02017717|588794535|FG005|Treatment Period|Disease progression|16|||
163025311|NCT02017717|588794536|FG006|Treatment Period|Disease progression|22|||
163025312|NCT02017717|588794537|FG007|Treatment Period|Disease progression|165|||
163025313|NCT02017717|588794538|FG008|Treatment Period|Disease progression|135|||
163025314|NCT02017717|588794530|FG000|Treatment Period|Study drug toxicity|3|||
163025315|NCT02017717|588794531|FG001|Treatment Period|Study drug toxicity|0|||
163025316|NCT02017717|588794532|FG002|Treatment Period|Study drug toxicity|1|||
163025317|NCT02017717|588794533|FG003|Treatment Period|Study drug toxicity|4|||
163025318|NCT02017717|588794534|FG004|Treatment Period|Study drug toxicity|4|||
163025319|NCT02017717|588794535|FG005|Treatment Period|Study drug toxicity|5|||
163025320|NCT02017717|588794536|FG006|Treatment Period|Study drug toxicity|3|||
163025321|NCT02017717|588794537|FG007|Treatment Period|Study drug toxicity|7|||
163025322|NCT02017717|588794538|FG008|Treatment Period|Study drug toxicity|11|||
163025323|NCT02017717|588794530|FG000|Treatment Period|Death|0|||
163025324|NCT02017717|588794531|FG001|Treatment Period|Death|0|||
163025325|NCT02017717|588794532|FG002|Treatment Period|Death|1|||
163025326|NCT02017717|588794533|FG003|Treatment Period|Death|0|||
163025327|NCT02017717|588794534|FG004|Treatment Period|Death|0|||
163025328|NCT02017717|588794535|FG005|Treatment Period|Death|2|||
163025329|NCT02017717|588794536|FG006|Treatment Period|Death|0|||
163025330|NCT02017717|588794537|FG007|Treatment Period|Death|0|||
163025331|NCT02017717|588794538|FG008|Treatment Period|Death|0|||
163025332|NCT02017717|588794530|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
163025333|NCT02017717|588794531|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
163025334|NCT02017717|588794532|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
163025335|NCT02017717|588794533|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
163025336|NCT02017717|588794534|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
163025337|NCT02017717|588794535|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
163025338|NCT02017717|588794536|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
163025339|NCT02017717|588794537|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
163025340|NCT02017717|588794538|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
163025341|NCT02017717|588794530|FG000|Treatment Period|Participant request to stop therapy|0|||
163025342|NCT02017717|588794531|FG001|Treatment Period|Participant request to stop therapy|0|||
163025343|NCT02017717|588794532|FG002|Treatment Period|Participant request to stop therapy|3|||
163025344|NCT02017717|588794533|FG003|Treatment Period|Participant request to stop therapy|6|||
163025345|NCT02017717|588794534|FG004|Treatment Period|Participant request to stop therapy|0|||
163025346|NCT02017717|588794535|FG005|Treatment Period|Participant request to stop therapy|2|||
163065107|NCT02327078|588945677|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
163217555|NCT04199117|589512244|FG003|Overall Study|Withdrawal by Subject|1|||
163217556|NCT04199117|589512245|FG004|Overall Study|Withdrawal by Subject|1|||
163217557|NCT04199117|589512246|FG005|Overall Study|Withdrawal by Subject|0|||
163217558|NCT04199117|589512247|FG006|Overall Study|Withdrawal by Subject|0|||
163217559|NCT04199117|589512248|FG007|Overall Study|Withdrawal by Subject|2|||
163217560|NCT04199117|589512249|FG008|Overall Study|Withdrawal by Subject|0|||
163217561|NCT04199117|589512250|FG009|Overall Study|Withdrawal by Subject|0|||
163330705|NCT01767467|589920667|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
163330706|NCT01767467|589920668|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
163330707|NCT01767467|589920667|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
163330708|NCT01767467|589920668|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
163330709|NCT01767467|589920667|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
163330710|NCT01767467|589920668|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
163330711|NCT01767467|589920667|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
163330712|NCT01767467|589920668|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
163330713|NCT01767467|589920667|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
163330714|NCT01767467|589920668|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
163330715|NCT01767467|589920667|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
163330716|NCT01767467|589920668|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
163330717|NCT01767467|589920667|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
163330718|NCT01767467|589920668|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
163330719|NCT00853580|589920669|FG000|Overall Study|Lost to Follow-up|3|||
163330720|NCT00853580|589920670|FG001|Overall Study|Lost to Follow-up|5|||
163330721|NCT00853580|589920669|FG000|Overall Study|Protocol Violation|2|||
163330722|NCT00853580|589920670|FG001|Overall Study|Protocol Violation|1|||
163025347|NCT02017717|588794536|FG006|Treatment Period|Participant request to stop therapy|1|||
163025348|NCT02017717|588794537|FG007|Treatment Period|Participant request to stop therapy|4|||
163025349|NCT02017717|588794538|FG008|Treatment Period|Participant request to stop therapy|7|||
163025350|NCT02017717|588794530|FG000|Treatment Period|Participant withdrew consent|0|||
163025351|NCT02017717|588794531|FG001|Treatment Period|Participant withdrew consent|0|||
163025352|NCT02017717|588794532|FG002|Treatment Period|Participant withdrew consent|1|||
163025353|NCT02017717|588794533|FG003|Treatment Period|Participant withdrew consent|0|||
163025354|NCT02017717|588794534|FG004|Treatment Period|Participant withdrew consent|0|||
163025355|NCT02017717|588794535|FG005|Treatment Period|Participant withdrew consent|2|||
163025356|NCT02017717|588794536|FG006|Treatment Period|Participant withdrew consent|0|||
163025357|NCT02017717|588794537|FG007|Treatment Period|Participant withdrew consent|1|||
163025358|NCT02017717|588794538|FG008|Treatment Period|Participant withdrew consent|4|||
163025359|NCT02017717|588794530|FG000|Treatment Period|Participant no longer met criteria|0|||
163025360|NCT02017717|588794531|FG001|Treatment Period|Participant no longer met criteria|0|||
163025361|NCT02017717|588794532|FG002|Treatment Period|Participant no longer met criteria|0|||
163025362|NCT02017717|588794533|FG003|Treatment Period|Participant no longer met criteria|0|||
163025363|NCT02017717|588794534|FG004|Treatment Period|Participant no longer met criteria|0|||
163025364|NCT02017717|588794535|FG005|Treatment Period|Participant no longer met criteria|0|||
163025365|NCT02017717|588794536|FG006|Treatment Period|Participant no longer met criteria|0|||
163025366|NCT02017717|588794537|FG007|Treatment Period|Participant no longer met criteria|0|||
163025367|NCT02017717|588794538|FG008|Treatment Period|Participant no longer met criteria|1|||
163025368|NCT02017717|588794530|FG000|Treatment Period|Other reasons|0|||
163025369|NCT02017717|588794531|FG001|Treatment Period|Other reasons|0|||
163025370|NCT02017717|588794532|FG002|Treatment Period|Other reasons|0|||
163025371|NCT02017717|588794533|FG003|Treatment Period|Other reasons|1|||
163025372|NCT02017717|588794534|FG004|Treatment Period|Other reasons|0|||
163025373|NCT02017717|588794535|FG005|Treatment Period|Other reasons|1|||
163025374|NCT02017717|588794536|FG006|Treatment Period|Other reasons|1|||
163025375|NCT02017717|588794537|FG007|Treatment Period|Other reasons|1|||
163025376|NCT02017717|588794538|FG008|Treatment Period|Other reasons|1|||
163025377|NCT02017717|588794530|FG000|Treatment Period|Maximum clinical benefit|0|||
163025378|NCT02017717|588794531|FG001|Treatment Period|Maximum clinical benefit|0|||
163025379|NCT02017717|588794532|FG002|Treatment Period|Maximum clinical benefit|0|||
163025380|NCT02017717|588794533|FG003|Treatment Period|Maximum clinical benefit|0|||
163025381|NCT02017717|588794534|FG004|Treatment Period|Maximum clinical benefit|0|||
163025382|NCT02017717|588794535|FG005|Treatment Period|Maximum clinical benefit|0|||
163025383|NCT02017717|588794536|FG006|Treatment Period|Maximum clinical benefit|0|||
163025384|NCT02017717|588794537|FG007|Treatment Period|Maximum clinical benefit|0|||
163025385|NCT02017717|588794538|FG008|Treatment Period|Maximum clinical benefit|1|||
163025386|NCT02017717|588794530|FG000|Treatment Period|Not reported|0|||
163025387|NCT02017717|588794531|FG001|Treatment Period|Not reported|1|||
163025388|NCT02017717|588794532|FG002|Treatment Period|Not reported|0|||
163025389|NCT02017717|588794533|FG003|Treatment Period|Not reported|0|||
163025390|NCT02017717|588794534|FG004|Treatment Period|Not reported|0|||
163025391|NCT02017717|588794535|FG005|Treatment Period|Not reported|0|||
163025392|NCT02017717|588794536|FG006|Treatment Period|Not reported|0|||
163330723|NCT00853580|589920669|FG000|Overall Study|Withdrawal by Subject|2|||
163025393|NCT02017717|588794537|FG007|Treatment Period|Not reported|0|||
163025394|NCT02017717|588794538|FG008|Treatment Period|Not reported|0|||
163025395|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
163025396|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
163025397|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
163330724|NCT00853580|589920670|FG001|Overall Study|Withdrawal by Subject|8|||
163065108|NCT02327078|588945678|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
163065109|NCT02327078|588945679|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
163065110|NCT02327078|588945680|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
163065111|NCT02327078|588945681|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
163065112|NCT02327078|588945682|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
163217562|NCT04199117|589512251|FG010|Overall Study|Withdrawal by Subject|1|||
163217563|NCT04199117|589512252|FG011|Overall Study|Withdrawal by Subject|1|||
163217564|NCT04199117|589512253|FG012|Overall Study|Withdrawal by Subject|2|||
163217565|NCT04199117|589512254|FG013|Overall Study|Withdrawal by Subject|1|||
163217566|NCT04199117|589512255|FG014|Overall Study|Withdrawal by Subject|1|||
163217567|NCT04199117|589512256|FG015|Overall Study|Withdrawal by Subject|1|||
163217568|NCT04199117|589512241|FG000|Overall Study|Death|1|||
163217569|NCT04199117|589512242|FG001|Overall Study|Death|1|||
163217570|NCT04199117|589512243|FG002|Overall Study|Death|0|||
163217571|NCT04199117|589512244|FG003|Overall Study|Death|0|||
163217572|NCT04199117|589512245|FG004|Overall Study|Death|0|||
163217573|NCT04199117|589512246|FG005|Overall Study|Death|0|||
163217574|NCT04199117|589512247|FG006|Overall Study|Death|0|||
163217575|NCT04199117|589512248|FG007|Overall Study|Death|0|||
163217576|NCT04199117|589512249|FG008|Overall Study|Death|0|||
163217577|NCT04199117|589512250|FG009|Overall Study|Death|0|||
163217578|NCT04199117|589512251|FG010|Overall Study|Death|0|||
163217579|NCT04199117|589512252|FG011|Overall Study|Death|1|||
163217580|NCT04199117|589512253|FG012|Overall Study|Death|0|||
163217581|NCT04199117|589512254|FG013|Overall Study|Death|1|||
163217582|NCT04199117|589512255|FG014|Overall Study|Death|0|||
163217583|NCT04199117|589512256|FG015|Overall Study|Death|0|||
163217584|NCT04199117|589512241|FG000|Overall Study|Withdrawal by PI|0|||
163217585|NCT04199117|589512242|FG001|Overall Study|Withdrawal by PI|0|||
163217586|NCT04199117|589512243|FG002|Overall Study|Withdrawal by PI|0|||
163217587|NCT04199117|589512244|FG003|Overall Study|Withdrawal by PI|0|||
163217588|NCT04199117|589512245|FG004|Overall Study|Withdrawal by PI|0|||
163217589|NCT04199117|589512246|FG005|Overall Study|Withdrawal by PI|0|||
163217590|NCT04199117|589512247|FG006|Overall Study|Withdrawal by PI|0|||
163330725|NCT00853580|589920669|FG000|Overall Study|Commenced contraindicated therapy|0|||
163330726|NCT00853580|589920670|FG001|Overall Study|Commenced contraindicated therapy|2|||
163330727|NCT01700205|589920671|FG000|Overall Study|Withdrawal by Subject|13|||
163330728|NCT01700205|589920672|FG001|Overall Study|Withdrawal by Subject|13|||
163330729|NCT01700205|589920671|FG000|Overall Study|Protocol Violation|2|||
163330730|NCT01700205|589920672|FG001|Overall Study|Protocol Violation|2|||
163065113|NCT02327078|588945683|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
163065114|NCT02327078|588945684|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
163065115|NCT02327078|588945685|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
163065116|NCT02327078|588945677|FG000|Overall Study|Reason not Specified|0|||
163065117|NCT02327078|588945678|FG001|Overall Study|Reason not Specified|0|||
163065118|NCT02327078|588945679|FG002|Overall Study|Reason not Specified|0|||
163065119|NCT02327078|588945680|FG003|Overall Study|Reason not Specified|0|||
163065120|NCT02327078|588945681|FG004|Overall Study|Reason not Specified|0|||
163065121|NCT02327078|588945682|FG005|Overall Study|Reason not Specified|0|||
163065122|NCT02327078|588945683|FG006|Overall Study|Reason not Specified|0|||
163065123|NCT02327078|588945684|FG007|Overall Study|Reason not Specified|5|||
163217591|NCT04199117|589512248|FG007|Overall Study|Withdrawal by PI|0|||
163217592|NCT04199117|589512249|FG008|Overall Study|Withdrawal by PI|0|||
163330731|NCT03335488|589920675|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
163330732|NCT03335488|589920676|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
163025398|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
163025399|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
163025400|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
163025401|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
163025402|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
163025403|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
163025404|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
163025405|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
163025406|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
163025407|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
163065124|NCT02327078|588945685|FG008|Overall Study|Reason not Specified|12|||
163065125|NCT04092777|588945687|FG000|Overall Study|Lost to Follow-up|28|||
163217593|NCT04199117|589512250|FG009|Overall Study|Withdrawal by PI|0|||
163217594|NCT04199117|589512251|FG010|Overall Study|Withdrawal by PI|0|||
163217595|NCT04199117|589512252|FG011|Overall Study|Withdrawal by PI|0|||
163217596|NCT04199117|589512253|FG012|Overall Study|Withdrawal by PI|1|||
163217597|NCT04199117|589512254|FG013|Overall Study|Withdrawal by PI|0|||
163217598|NCT04199117|589512255|FG014|Overall Study|Withdrawal by PI|0|||
163217599|NCT04199117|589512256|FG015|Overall Study|Withdrawal by PI|0|||
163217600|NCT04383743|589512257|FG000|Overall Study|Withdrawal by Subject|1|||
163217601|NCT04383743|589512257|FG000|Overall Study|Adverse Event|1|||
163217602|NCT04814433|589512260|FG000|Overall Study|Survey not returned|4|||
163217603|NCT04814433|589512261|FG001|Overall Study|Survey not returned|8|||
163217604|NCT04814433|589512262|FG002|Overall Study|Survey not returned|4|||
163217605|NCT04814433|589512263|FG003|Overall Study|Survey not returned|5|||
163217606|NCT03482791|589512268|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
163217607|NCT03482791|589512269|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
163406350|NCT00401375|590196736|FG001|Overall Study|Protocol Violation|2|||
163025408|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
163025409|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
163025410|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
163025411|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
163025412|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
163025413|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
163025414|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
163025415|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
163025416|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
163025417|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
163025418|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
163025419|NCT04488419|588794540|FG000|Primary Analysis Population|Adverse Event|6|||
163025420|NCT04488419|588794541|FG001|Primary Analysis Population|Adverse Event|9|||
163025421|NCT04488419|588794542|FG002|Primary Analysis Population|Adverse Event|0|||
163025422|NCT04488419|588794540|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
163025423|NCT04488419|588794541|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
163025424|NCT04488419|588794542|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
163025425|NCT04488419|588794540|FG000|Primary Analysis Population|Protocol Violation|1|||
163025426|NCT04488419|588794541|FG001|Primary Analysis Population|Protocol Violation|1|||
163025427|NCT04488419|588794542|FG002|Primary Analysis Population|Protocol Violation|0|||
163025428|NCT04488419|588794540|FG000|Primary Analysis Population|Undetermined|7|||
163025429|NCT04488419|588794541|FG001|Primary Analysis Population|Undetermined|3|||
163025430|NCT04488419|588794542|FG002|Primary Analysis Population|Undetermined|0|||
163025431|NCT04488419|588794540|FG000|Primary Analysis Population|>1 Reason|2|||
163025432|NCT04488419|588794541|FG001|Primary Analysis Population|>1 Reason|4|||
163025433|NCT04488419|588794542|FG002|Primary Analysis Population|>1 Reason|0|||
163025434|NCT00970632|588794548|FG000|Overall Study|Adverse Event|2|||
163025435|NCT00970632|588794549|FG001|Overall Study|Adverse Event|2|||
163025436|NCT00970632|588794550|FG002|Overall Study|Adverse Event|1|||
163025437|NCT00970632|588794548|FG000|Overall Study|Lack of Efficacy|3|||
163025438|NCT00970632|588794549|FG001|Overall Study|Lack of Efficacy|0|||
163025439|NCT00970632|588794550|FG002|Overall Study|Lack of Efficacy|0|||
163025440|NCT00970632|588794548|FG000|Overall Study|Lost to Follow-up|3|||
163025441|NCT00970632|588794549|FG001|Overall Study|Lost to Follow-up|0|||
163025442|NCT00970632|588794550|FG002|Overall Study|Lost to Follow-up|2|||
163025443|NCT00970632|588794548|FG000|Overall Study|Protocol Violation|8|||
163025444|NCT00970632|588794549|FG001|Overall Study|Protocol Violation|5|||
163025445|NCT00970632|588794550|FG002|Overall Study|Protocol Violation|8|||
163025446|NCT00970632|588794548|FG000|Overall Study|Withdrawal by Subject|7|||
163025447|NCT00970632|588794549|FG001|Overall Study|Withdrawal by Subject|6|||
163025448|NCT00970632|588794550|FG002|Overall Study|Withdrawal by Subject|4|||
163025449|NCT00970632|588794548|FG000|Overall Study|Entry criteria not met|0|||
163025450|NCT00970632|588794549|FG001|Overall Study|Entry criteria not met|2|||
163025451|NCT00970632|588794550|FG002|Overall Study|Entry criteria not met|2|||
163025452|NCT00970632|588794548|FG000|Overall Study|Sponsor decision|1|||
163025453|NCT00970632|588794549|FG001|Overall Study|Sponsor decision|0|||
163025454|NCT00970632|588794550|FG002|Overall Study|Sponsor decision|1|||
163025455|NCT01286168|588794557|FG000|Overall Study|Withdrawal by Subject|1|||
163025456|NCT01286168|588794557|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
163025457|NCT02487771|588794558|FG000|Overall Study|Lost to Follow-up|2|||
163025458|NCT02487771|588794559|FG001|Overall Study|Lost to Follow-up|3|||
163025459|NCT02487771|588794558|FG000|Overall Study|Moved out of area|5|||
163025460|NCT02487771|588794559|FG001|Overall Study|Moved out of area|6|||
163025461|NCT02487771|588794558|FG000|Overall Study|Withdrawal by Subject|3|||
163025462|NCT02487771|588794559|FG001|Overall Study|Withdrawal by Subject|5|||
163025463|NCT01871402|588794566|FG000|Overall Study|Lost to Follow-up|1|||
163025464|NCT01871402|588794567|FG001|Overall Study|Lost to Follow-up|0|||
163025465|NCT01871402|588794566|FG000|Overall Study|Withdrawal by Subject|0|||
163025466|NCT01871402|588794567|FG001|Overall Study|Withdrawal by Subject|2|||
163025467|NCT01871402|588794566|FG000|Overall Study|Non-compliance|0|||
163065126|NCT04092777|588945688|FG001|Overall Study|Lost to Follow-up|46|||
163065127|NCT04092777|588945687|FG000|Overall Study|Withdrawal by Subject|8|||
163217608|NCT01721330|589512271|FG000|Overall Study|Withdrawal by Subject|0|||
163025468|NCT01871402|588794567|FG001|Overall Study|Non-compliance|1|||
163025469|NCT04594941|588794568|FG000|Overall Study|Other|0|||
163025470|NCT04594941|588794569|FG001|Overall Study|Other|3|||
163217609|NCT01721330|589512272|FG001|Overall Study|Withdrawal by Subject|1|||
163065128|NCT04092777|588945688|FG001|Overall Study|Withdrawal by Subject|5|||
163065129|NCT03330197|588945691|FG000|Overall Study|Adverse Event|0|||
163065130|NCT03330197|588945692|FG001|Overall Study|Adverse Event|1|||
163065131|NCT03330197|588945691|FG000|Overall Study|Withdrawal by Subject|0|||
163065132|NCT03330197|588945692|FG001|Overall Study|Withdrawal by Subject|1|||
163065133|NCT03765073|588945693|FG000|Stage 1|Lost to Follow-up|1|||
163065134|NCT03765073|588945694|FG001|Stage 1|Lost to Follow-up|0|||
163065135|NCT03765073|588945695|FG002|Stage 1|Lost to Follow-up|0|||
163065136|NCT03765073|588945696|FG003|Stage 1|Lost to Follow-up|0|||
163065137|NCT03765073|588945697|FG004|Stage 1|Lost to Follow-up|0|||
163065138|NCT03765073|588945698|FG005|Stage 1|Lost to Follow-up|0|||
163065139|NCT03765073|588945699|FG006|Stage 1|Lost to Follow-up|0|||
163065140|NCT03765073|588945700|FG007|Stage 1|Lost to Follow-up|0|||
163065141|NCT03765073|588945701|FG008|Stage 1|Lost to Follow-up|0|||
163065142|NCT03765073|588945702|FG009|Stage 1|Lost to Follow-up|0|||
163065143|NCT03765073|588945703|FG010|Stage 1|Lost to Follow-up|0|||
163065144|NCT03765073|588945704|FG011|Stage 1|Lost to Follow-up|0|||
163065145|NCT03765073|588945705|FG012|Stage 1|Lost to Follow-up|0|||
163065146|NCT03765073|588945706|FG013|Stage 1|Lost to Follow-up|0|||
163065147|NCT03765073|588945707|FG014|Stage 1|Lost to Follow-up|0|||
163065148|NCT03765073|588945708|FG015|Stage 1|Lost to Follow-up|0|||
163065149|NCT03765073|588945709|FG016|Stage 1|Lost to Follow-up|0|||
163065150|NCT03765073|588945710|FG017|Stage 1|Lost to Follow-up|0|||
163065151|NCT03765073|588945711|FG018|Stage 1|Lost to Follow-up|0|||
163065152|NCT03765073|588945712|FG019|Stage 1|Lost to Follow-up|0|||
163065153|NCT03765073|588945713|FG020|Stage 1|Lost to Follow-up|0|||
163065154|NCT03765073|588945693|FG000|Stage 1|Withdrawal by participant|0|||
163065155|NCT03765073|588945694|FG001|Stage 1|Withdrawal by participant|1|||
163065156|NCT03765073|588945695|FG002|Stage 1|Withdrawal by participant|0|||
163065157|NCT03765073|588945696|FG003|Stage 1|Withdrawal by participant|0|||
163065158|NCT03765073|588945697|FG004|Stage 1|Withdrawal by participant|0|||
163065159|NCT03765073|588945698|FG005|Stage 1|Withdrawal by participant|0|||
163065160|NCT03765073|588945699|FG006|Stage 1|Withdrawal by participant|0|||
163065161|NCT03765073|588945700|FG007|Stage 1|Withdrawal by participant|0|||
163065162|NCT03765073|588945701|FG008|Stage 1|Withdrawal by participant|0|||
163065163|NCT03765073|588945702|FG009|Stage 1|Withdrawal by participant|0|||
163065164|NCT03765073|588945703|FG010|Stage 1|Withdrawal by participant|0|||
163065165|NCT03765073|588945704|FG011|Stage 1|Withdrawal by participant|0|||
163065166|NCT03765073|588945705|FG012|Stage 1|Withdrawal by participant|0|||
163065167|NCT03765073|588945706|FG013|Stage 1|Withdrawal by participant|0|||
163065168|NCT03765073|588945707|FG014|Stage 1|Withdrawal by participant|0|||
163065169|NCT03765073|588945708|FG015|Stage 1|Withdrawal by participant|0|||
163065170|NCT03765073|588945709|FG016|Stage 1|Withdrawal by participant|0|||
163065171|NCT03765073|588945710|FG017|Stage 1|Withdrawal by participant|0|||
163065172|NCT03765073|588945711|FG018|Stage 1|Withdrawal by participant|0|||
163065173|NCT03765073|588945712|FG019|Stage 1|Withdrawal by participant|0|||
163065174|NCT03765073|588945713|FG020|Stage 1|Withdrawal by participant|0|||
163065175|NCT03765073|588945693|FG000|Stage 2|Death|0|||
163065176|NCT03765073|588945694|FG001|Stage 2|Death|0|||
163065177|NCT03765073|588945695|FG002|Stage 2|Death|0|||
163065178|NCT03765073|588945696|FG003|Stage 2|Death|0|||
163065179|NCT03765073|588945697|FG004|Stage 2|Death|0|||
163065180|NCT03765073|588945698|FG005|Stage 2|Death|0|||
163065181|NCT03765073|588945699|FG006|Stage 2|Death|0|||
163065182|NCT03765073|588945700|FG007|Stage 2|Death|0|||
163065183|NCT03765073|588945701|FG008|Stage 2|Death|0|||
163065184|NCT03765073|588945702|FG009|Stage 2|Death|1|||
163065185|NCT03765073|588945703|FG010|Stage 2|Death|0|||
163065186|NCT03765073|588945704|FG011|Stage 2|Death|1|||
163065187|NCT03765073|588945705|FG012|Stage 2|Death|0|||
163065188|NCT03765073|588945706|FG013|Stage 2|Death|0|||
163065189|NCT03765073|588945707|FG014|Stage 2|Death|0|||
163065190|NCT03765073|588945708|FG015|Stage 2|Death|0|||
163065191|NCT03765073|588945709|FG016|Stage 2|Death|2|||
163065192|NCT03765073|588945710|FG017|Stage 2|Death|0|||
163065193|NCT03765073|588945711|FG018|Stage 2|Death|0|||
163217610|NCT00296374|589512273|FG000|Overall Study|Adverse Event|14|||
163406351|NCT00401375|590196737|FG002|Overall Study|Protocol Violation|1|||
163065194|NCT03765073|588945712|FG019|Stage 2|Death|0|||
163217611|NCT00296374|589512274|FG001|Overall Study|Adverse Event|10|||
163406352|NCT00401375|590196735|FG000|Overall Study|Adverse Event|6|||
163217612|NCT00296374|589512275|FG002|Overall Study|Adverse Event|7|||
163217613|NCT00296374|589512273|FG000|Overall Study|Withdrawal by Subject|3|||
163065195|NCT03765073|588945713|FG020|Stage 2|Death|0|||
163065196|NCT03765073|588945693|FG000|Stage 2|Lost to Follow-up|0|||
163065197|NCT03765073|588945694|FG001|Stage 2|Lost to Follow-up|0|||
163065198|NCT03765073|588945695|FG002|Stage 2|Lost to Follow-up|0|||
163065199|NCT03765073|588945696|FG003|Stage 2|Lost to Follow-up|5|||
163065200|NCT03765073|588945697|FG004|Stage 2|Lost to Follow-up|1|||
163065201|NCT03765073|588945698|FG005|Stage 2|Lost to Follow-up|0|||
163065202|NCT03765073|588945699|FG006|Stage 2|Lost to Follow-up|3|||
163065203|NCT03765073|588945700|FG007|Stage 2|Lost to Follow-up|3|||
163065204|NCT03765073|588945701|FG008|Stage 2|Lost to Follow-up|1|||
163065205|NCT03765073|588945702|FG009|Stage 2|Lost to Follow-up|6|||
163065206|NCT03765073|588945703|FG010|Stage 2|Lost to Follow-up|5|||
163065207|NCT03765073|588945704|FG011|Stage 2|Lost to Follow-up|1|||
163217614|NCT00296374|589512274|FG001|Overall Study|Withdrawal by Subject|5|||
163406353|NCT00401375|590196736|FG001|Overall Study|Adverse Event|11|||
163406354|NCT00401375|590196737|FG002|Overall Study|Adverse Event|10|||
163025471|NCT04594941|588794570|FG002|Overall Study|Other|1|||
163025472|NCT04594941|588794571|FG003|Overall Study|Other|0|||
163025473|NCT03408444|588794572|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
163025474|NCT03408444|588794573|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
163025475|NCT03408444|588794574|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
163025476|NCT03408444|588794575|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
163025477|NCT03408444|588794572|FG000|Overall Study|Lens Discomfort|0|||
163025478|NCT03408444|588794573|FG001|Overall Study|Lens Discomfort|1|||
163025479|NCT03408444|588794574|FG002|Overall Study|Lens Discomfort|0|||
163025480|NCT03408444|588794575|FG003|Overall Study|Lens Discomfort|0|||
163025481|NCT03408444|588794572|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
163025482|NCT03408444|588794573|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
163025483|NCT03408444|588794574|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
163025484|NCT03408444|588794575|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
163025485|NCT03408444|588794572|FG000|Overall Study|Withdrawal by Subject|0|||
163025486|NCT03408444|588794573|FG001|Overall Study|Withdrawal by Subject|2|||
163025487|NCT03408444|588794574|FG002|Overall Study|Withdrawal by Subject|3|||
163025488|NCT03408444|588794575|FG003|Overall Study|Withdrawal by Subject|0|||
163025489|NCT03408444|588794572|FG000|Overall Study|Lost to Follow-up|0|||
163025490|NCT03408444|588794573|FG001|Overall Study|Lost to Follow-up|0|||
163025491|NCT03408444|588794574|FG002|Overall Study|Lost to Follow-up|1|||
163025492|NCT03408444|588794575|FG003|Overall Study|Lost to Follow-up|0|||
163025493|NCT03408444|588794572|FG000|Overall Study|Adverse Event|0|||
163025494|NCT03408444|588794573|FG001|Overall Study|Adverse Event|0|||
163025495|NCT03408444|588794574|FG002|Overall Study|Adverse Event|0|||
163025496|NCT03408444|588794575|FG003|Overall Study|Adverse Event|1|||
163025497|NCT03408444|588794572|FG000|Overall Study|Lens Handling Difficulties|0|||
163025498|NCT03408444|588794573|FG001|Overall Study|Lens Handling Difficulties|0|||
163025499|NCT03408444|588794574|FG002|Overall Study|Lens Handling Difficulties|1|||
163025500|NCT03408444|588794575|FG003|Overall Study|Lens Handling Difficulties|0|||
163025501|NCT03408444|588794572|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
163025502|NCT03408444|588794573|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
163025503|NCT03408444|588794574|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
163025504|NCT03408444|588794575|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
163025505|NCT01482065|588794576|FG000|Overall Study|Withdrawal by Subject|0|||
163025506|NCT01482065|588794577|FG001|Overall Study|Withdrawal by Subject|1|||
163025507|NCT03728426|588794578|FG000|Overall Study|Death|3|||
163025508|NCT00231114|588794579|FG000|Randomized|Withdrawal by Subject|6|||
163025509|NCT00231114|588794580|FG001|Randomized|Withdrawal by Subject|3|||
163025510|NCT00231114|588794579|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
163025511|NCT00231114|588794580|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
163025512|NCT00231114|588794579|FG000|Post-Treatment Period|Lost to Follow-up|6|||
163025513|NCT00231114|588794580|FG001|Post-Treatment Period|Lost to Follow-up|1|||
163025514|NCT00231114|588794579|FG000|Post-Treatment Period|Physician Decision|1|||
163025515|NCT00231114|588794580|FG001|Post-Treatment Period|Physician Decision|0|||
163025516|NCT00231114|588794579|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
163025517|NCT00231114|588794580|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
163025518|NCT02682823|588794582|FG000|Overall Study|Withdrawal by Subject|0|||
163025519|NCT02682823|588794583|FG001|Overall Study|Withdrawal by Subject|0|||
163025520|NCT02682823|588794584|FG002|Overall Study|Withdrawal by Subject|1|||
163025521|NCT02682823|588794585|FG003|Overall Study|Withdrawal by Subject|0|||
163025522|NCT02682823|588794586|FG004|Overall Study|Withdrawal by Subject|1|||
163025523|NCT02682823|588794582|FG000|Overall Study|Protocol Deviation|0|||
163025524|NCT02682823|588794583|FG001|Overall Study|Protocol Deviation|1|||
163025525|NCT02682823|588794584|FG002|Overall Study|Protocol Deviation|0|||
163025526|NCT02682823|588794585|FG003|Overall Study|Protocol Deviation|0|||
163025527|NCT02682823|588794586|FG004|Overall Study|Protocol Deviation|0|||
163025528|NCT02682823|588794582|FG000|Overall Study|Adverse Event|0|||
163025529|NCT02682823|588794583|FG001|Overall Study|Adverse Event|0|||
163025530|NCT02682823|588794584|FG002|Overall Study|Adverse Event|0|||
163025531|NCT02682823|588794585|FG003|Overall Study|Adverse Event|1|||
163025532|NCT02682823|588794586|FG004|Overall Study|Adverse Event|0|||
163025533|NCT01995175|588794587|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
163025534|NCT01995175|588794587|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
163025535|NCT01995175|588794587|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
163025536|NCT01995175|588794587|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
163025537|NCT01995175|588794587|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
163025538|NCT01995175|588794587|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
163025539|NCT01995175|588794587|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
163025540|NCT01995175|588794587|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
163025541|NCT01995175|588794587|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
163025542|NCT01741792|588794588|FG000|Overall Study|Death|6|||
163025543|NCT01741792|588794589|FG001|Overall Study|Death|1|||
163025544|NCT01741792|588794590|FG002|Overall Study|Death|12|||
163025545|NCT02045862|588794591|FG000|Overall Study|Death|0|||
163025546|NCT02045862|588794592|FG001|Overall Study|Death|0|||
163025547|NCT02045862|588794593|FG002|Overall Study|Death|1|||
163025548|NCT02045862|588794591|FG000|Overall Study|Miscellaneous|5|||
163025549|NCT02045862|588794592|FG001|Overall Study|Miscellaneous|0|||
163025550|NCT02045862|588794593|FG002|Overall Study|Miscellaneous|8|||
163025551|NCT02045862|588794591|FG000|Overall Study|Withdrawal by Patient|18|||
163025552|NCT02045862|588794592|FG001|Overall Study|Withdrawal by Patient|27|||
163025553|NCT02045862|588794593|FG002|Overall Study|Withdrawal by Patient|57|||
163025554|NCT02045862|588794591|FG000|Overall Study|Protocol Violation|0|||
163025555|NCT02045862|588794592|FG001|Overall Study|Protocol Violation|0|||
163025556|NCT02045862|588794593|FG002|Overall Study|Protocol Violation|6|||
163025557|NCT02045862|588794591|FG000|Overall Study|Lack of Efficacy|8|||
163025558|NCT02045862|588794592|FG001|Overall Study|Lack of Efficacy|4|||
163025559|NCT02045862|588794593|FG002|Overall Study|Lack of Efficacy|13|||
163025560|NCT02045862|588794591|FG000|Overall Study|Randomized but not Received Study Drug|0|||
163025561|NCT02045862|588794592|FG001|Overall Study|Randomized but not Received Study Drug|2|||
163025562|NCT02045862|588794593|FG002|Overall Study|Randomized but not Received Study Drug|8|||
163025563|NCT02045862|588794591|FG000|Overall Study|Adverse Event|7|||
163025564|NCT02045862|588794592|FG001|Overall Study|Adverse Event|5|||
163025565|NCT02045862|588794593|FG002|Overall Study|Adverse Event|27|||
163025566|NCT02045862|588794591|FG000|Overall Study|Lost to Follow-up|1|||
163025567|NCT02045862|588794592|FG001|Overall Study|Lost to Follow-up|2|||
163025568|NCT02045862|588794593|FG002|Overall Study|Lost to Follow-up|6|||
163025569|NCT02353442|588794598|FG000|Overall Study|Withdrawal by Subject|3|||
163025570|NCT02353442|588794599|FG001|Overall Study|Withdrawal by Subject|4|||
163025571|NCT01075646|588794602|FG000|Overall Study|Lost to Follow-up|4|||
163025572|NCT01075646|588794603|FG001|Overall Study|Lost to Follow-up|3|||
163025573|NCT01075646|588794604|FG002|Overall Study|Lost to Follow-up|1|||
163025574|NCT01075646|588794605|FG003|Overall Study|Lost to Follow-up|2|||
163025575|NCT02004886|588794609|FG000|Overall Study|Adverse Event|0|||
163025576|NCT02004886|588794610|FG001|Overall Study|Adverse Event|1|||
163025577|NCT02004886|588794611|FG002|Overall Study|Adverse Event|0|||
163025578|NCT02004886|588794612|FG003|Overall Study|Adverse Event|0|||
163025579|NCT02004886|588794609|FG000|Overall Study|Unable to attend future visits|1|||
163025580|NCT02004886|588794610|FG001|Overall Study|Unable to attend future visits|0|||
163025581|NCT02004886|588794611|FG002|Overall Study|Unable to attend future visits|0|||
163025582|NCT02004886|588794612|FG003|Overall Study|Unable to attend future visits|0|||
163025583|NCT02822573|588794613|FG000|Overall Study|Lost to Follow-up|5|||
163025584|NCT02822573|588794614|FG001|Overall Study|Lost to Follow-up|3|||
163025585|NCT02822573|588794613|FG000|Overall Study|Physician Decision|1|||
163025586|NCT02822573|588794614|FG001|Overall Study|Physician Decision|1|||
163025587|NCT02822573|588794613|FG000|Overall Study|Withdrawal by Subject|9|||
163025588|NCT02822573|588794614|FG001|Overall Study|Withdrawal by Subject|5|||
163025589|NCT02822573|588794613|FG000|Overall Study|Protocol Violation|6|||
163025590|NCT02822573|588794614|FG001|Overall Study|Protocol Violation|4|||
163025591|NCT02822573|588794613|FG000|Overall Study|Too sick or ill|2|||
163025592|NCT02822573|588794614|FG001|Overall Study|Too sick or ill|1|||
163025593|NCT02822573|588794613|FG000|Overall Study|Disease Progression|1|||
163025594|NCT02822573|588794614|FG001|Overall Study|Disease Progression|1|||
163025595|NCT02822573|588794613|FG000|Overall Study|No reason given|6|||
163025596|NCT02822573|588794614|FG001|Overall Study|No reason given|4|||
163025597|NCT02892422|588794616|FG000|Overall Study|Enrolled not treated|4|||
163025598|NCT02892422|588794616|FG000|Overall Study|Adverse Event|38|||
163025599|NCT02892422|588794616|FG000|Overall Study|Lack of Efficacy|32|||
163025600|NCT02892422|588794616|FG000|Overall Study|Non-compliance with study drug|11|||
163025601|NCT02892422|588794616|FG000|Overall Study|Protocol Violation|4|||
163025602|NCT02892422|588794616|FG000|Overall Study|Withdrawal by Subject|56|||
163025603|NCT02892422|588794616|FG000|Overall Study|Lost to Follow-up|5|||
163025604|NCT02892422|588794616|FG000|Overall Study|sponsor information 16159A results|21|||
163025605|NCT02892422|588794616|FG000|Overall Study|withdrawal of consent|13|||
163025606|NCT02892422|588794616|FG000|Overall Study|exclusion criteria met|3|||
163025607|NCT02892422|588794616|FG000|Overall Study|moving elsewhere|4|||
163025608|NCT02892422|588794616|FG000|Overall Study|non-compliance|10|||
163025609|NCT02892422|588794616|FG000|Overall Study|patient legally incapable|1|||
163025610|NCT02892422|588794616|FG000|Overall Study|patient decision|7|||
163025611|NCT02892422|588794616|FG000|Overall Study|Investigator decision|1|||
163025612|NCT04323306|588794617|FG000|Overall Study|Physician Decision|1|||
163025613|NCT04323306|588794618|FG001|Overall Study|Physician Decision|0|||
163025614|NCT04323306|588794619|FG002|Overall Study|Physician Decision|0|||
163025615|NCT04323306|588794620|FG003|Overall Study|Physician Decision|0|||
163065208|NCT03765073|588945705|FG012|Stage 2|Lost to Follow-up|1|||
163025616|NCT04323306|588794621|FG004|Overall Study|Physician Decision|0|||
163025617|NCT04323306|588794622|FG005|Overall Study|Physician Decision|0|||
163025618|NCT04323306|588794623|FG006|Overall Study|Physician Decision|0|||
163025619|NCT04323306|588794624|FG007|Overall Study|Physician Decision|0|||
163330733|NCT03335488|589920675|FG000|Safety Extension Period|Adverse Event|1|||
163330734|NCT03335488|589920676|FG001|Safety Extension Period|Adverse Event|0|||
163330735|NCT03335488|589920675|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
163330736|NCT03335488|589920676|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
163330737|NCT04971733|589920677|FG000|Overall Study|Adverse Event|1|||
163330738|NCT04971733|589920678|FG001|Overall Study|Adverse Event|1|||
163330739|NCT04971733|589920677|FG000|Overall Study|Subject choice|2|||
163406355|NCT00401375|590196735|FG000|Overall Study|Withdrawal by Subject|9|||
163025620|NCT04323306|588794625|FG008|Overall Study|Physician Decision|0|||
163025621|NCT04323306|588794617|FG000|Overall Study|Withdrawal by Subject|0|||
163025622|NCT04323306|588794618|FG001|Overall Study|Withdrawal by Subject|0|||
163025623|NCT04323306|588794619|FG002|Overall Study|Withdrawal by Subject|0|||
163025624|NCT04323306|588794620|FG003|Overall Study|Withdrawal by Subject|0|||
163025625|NCT04323306|588794621|FG004|Overall Study|Withdrawal by Subject|0|||
163025626|NCT04323306|588794622|FG005|Overall Study|Withdrawal by Subject|1|||
163025627|NCT04323306|588794623|FG006|Overall Study|Withdrawal by Subject|3|||
163025628|NCT04323306|588794624|FG007|Overall Study|Withdrawal by Subject|0|||
163025629|NCT04323306|588794625|FG008|Overall Study|Withdrawal by Subject|1|||
163025630|NCT00759785|588794626|FG000|Overall Study|Participant sample not evaluable|11|||
163025631|NCT00759785|588794627|FG001|Overall Study|Participant sample not evaluable|2|||
163025632|NCT00759785|588794626|FG000|Overall Study|Participant sample lost|0|||
163025633|NCT00759785|588794627|FG001|Overall Study|Participant sample lost|1|||
163025634|NCT00759785|588794626|FG000|Overall Study|Protocol Violation|1|||
163025635|NCT00759785|588794627|FG001|Overall Study|Protocol Violation|0|||
163025636|NCT00759785|588794626|FG000|Overall Study|Physician Decision|0|||
163025637|NCT00759785|588794627|FG001|Overall Study|Physician Decision|1|||
163025638|NCT00759785|588794626|FG000|Overall Study|Withdrawal by Subject|0|||
163025639|NCT00759785|588794627|FG001|Overall Study|Withdrawal by Subject|1|||
163025640|NCT00089778|588794628|FG000|Overall Study|Protocol Violation|0|||
163025641|NCT00089778|588794629|FG001|Overall Study|Protocol Violation|0|||
163025642|NCT00089778|588794630|FG002|Overall Study|Protocol Violation|1|||
163025643|NCT04712019|588794631|FG000|Overall Study|Withdrawal by Subject|2|||
163025644|NCT04712019|588794632|FG001|Overall Study|Withdrawal by Subject|2|||
163025645|NCT04712019|588794631|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
163025646|NCT04712019|588794632|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
163025647|NCT00725608|588794640|FG000|Overall Study|Lost to Follow-up|60|||
163025648|NCT00725608|588794640|FG000|Overall Study|Adverse Event|14|||
163025649|NCT00725608|588794640|FG000|Overall Study|Individual reasons|86|||
163025650|NCT00725608|588794640|FG000|Overall Study|Other|7|||
163025651|NCT01084668|588794641|FG000|Overall Study|Lack of Efficacy|5|||
163025652|NCT01084668|588794641|FG000|Overall Study|Withdrawal by Subject|2|||
163025653|NCT01084668|588794641|FG000|Overall Study|Pregnancy|1|||
163025654|NCT01084668|588794641|FG000|Overall Study|Non-compliance|1|||
163025655|NCT03729570|588794644|FG000|Overall Study|Lost to Follow-up|16|||
163025656|NCT03729570|588794645|FG001|Overall Study|Lost to Follow-up|20|||
163025657|NCT03729570|588794644|FG000|Overall Study|Seroconversion|5|||
163025658|NCT03729570|588794645|FG001|Overall Study|Seroconversion|0|||
163025659|NCT03729570|588794644|FG000|Overall Study|Moved out of the city|1|||
163025660|NCT03729570|588794645|FG001|Overall Study|Moved out of the city|0|||
163025661|NCT03729570|588794644|FG000|Overall Study|Time Conflict|1|||
163025662|NCT03729570|588794645|FG001|Overall Study|Time Conflict|0|||
163025663|NCT03729570|588794644|FG000|Overall Study|Time Commitment|2|||
163025664|NCT03729570|588794645|FG001|Overall Study|Time Commitment|0|||
163025665|NCT03729570|588794644|FG000|Overall Study|Bad Experience|0|||
163025666|NCT03729570|588794645|FG001|Overall Study|Bad Experience|1|||
163025667|NCT03729570|588794644|FG000|Overall Study|No reason provided|2|||
163025668|NCT03729570|588794645|FG001|Overall Study|No reason provided|1|||
163025669|NCT03729570|588794644|FG000|Overall Study|Family Conflict|0|||
163025670|NCT03729570|588794645|FG001|Overall Study|Family Conflict|1|||
163025671|NCT03729570|588794644|FG000|Overall Study|Did not want to continue taking medications|0|||
163025672|NCT03729570|588794645|FG001|Overall Study|Did not want to continue taking medications|1|||
163025673|NCT03729570|588794644|FG000|Overall Study|Found another PrEP provider|1|||
163025674|NCT03729570|588794645|FG001|Overall Study|Found another PrEP provider|0|||
163025675|NCT03729570|588794644|FG000|Overall Study|Did not enjoy being in the control group|0|||
163025676|NCT03729570|588794645|FG001|Overall Study|Did not enjoy being in the control group|1|||
163025677|NCT02447497|588794646|FG000|Overall Study|Did not meet treatment day baseline.|6|||
163406356|NCT00401375|590196736|FG001|Overall Study|Withdrawal by Subject|7|||
163025678|NCT02447497|588794647|FG001|Overall Study|Did not meet treatment day baseline.|5|||
163025679|NCT02447497|588794648|FG002|Overall Study|Did not meet treatment day baseline.|2|||
163406357|NCT00401375|590196737|FG002|Overall Study|Withdrawal by Subject|7|||
163025680|NCT02447497|588794649|FG003|Overall Study|Did not meet treatment day baseline.|2|||
163025681|NCT02447497|588794646|FG000|Overall Study|Dressing was compromised|0|||
163406358|NCT00401375|590196735|FG000|Overall Study|Lost to Follow-up|0|||
163025682|NCT02447497|588794647|FG001|Overall Study|Dressing was compromised|1|||
163025683|NCT02447497|588794648|FG002|Overall Study|Dressing was compromised|0|||
163330740|NCT04971733|589920678|FG001|Overall Study|Subject choice|0|||
163025684|NCT02447497|588794649|FG003|Overall Study|Dressing was compromised|0|||
163025685|NCT02017912|588794650|FG000|Overall Study|Withdrawal by Subject|2|||
163406359|NCT00401375|590196736|FG001|Overall Study|Lost to Follow-up|1|||
163025686|NCT02017912|588794651|FG001|Overall Study|Withdrawal by Subject|1|||
163025687|NCT02017912|588794650|FG000|Overall Study|miscellaneous|1|||
163025688|NCT02017912|588794651|FG001|Overall Study|miscellaneous|1|||
163025689|NCT04569968|588794652|FG000|Overall Study|Lost to Follow-up|2|||
163025690|NCT04569968|588794653|FG001|Overall Study|Lost to Follow-up|5|||
163025691|NCT04569968|588794652|FG000|Overall Study|Story of head and/or neck surgery|2|||
163025692|NCT04569968|588794653|FG001|Overall Study|Story of head and/or neck surgery|2|||
163025693|NCT04569968|588794652|FG000|Overall Study|Time of stroke onset|8|||
163025694|NCT04569968|588794653|FG001|Overall Study|Time of stroke onset|7|||
163025695|NCT04569968|588794652|FG000|Overall Study|Type of strokr|12|||
163025696|NCT04569968|588794653|FG001|Overall Study|Type of strokr|8|||
163025697|NCT04569968|588794652|FG000|Overall Study|Cooperation|8|||
163025698|NCT04569968|588794653|FG001|Overall Study|Cooperation|8|||
163025699|NCT04569968|588794652|FG000|Overall Study|Age interval|17|||
163025700|NCT04569968|588794653|FG001|Overall Study|Age interval|6|||
163025701|NCT04569968|588794652|FG000|Overall Study|Denial of participation to the study|0|||
163025702|NCT04569968|588794653|FG001|Overall Study|Denial of participation to the study|3|||
163025703|NCT04569968|588794652|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
163025704|NCT04569968|588794653|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
163025705|NCT04569968|588794652|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
163025706|NCT04569968|588794653|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
163025707|NCT04569968|588794652|FG000|Overall Study|Quarantine|1|||
163025708|NCT04569968|588794653|FG001|Overall Study|Quarantine|0|||
163025709|NCT04569968|588794652|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
163025710|NCT04569968|588794653|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
163025711|NCT04569968|588794652|FG000|Overall Study|Repetitive stroke|8|||
163025712|NCT04569968|588794653|FG001|Overall Study|Repetitive stroke|0|||
163025713|NCT04569968|588794652|FG000|Overall Study|Insufficient mastication|1|||
163025714|NCT04569968|588794653|FG001|Overall Study|Insufficient mastication|0|||
163025715|NCT04569968|588794652|FG000|Overall Study|Infection|1|||
163025716|NCT04569968|588794653|FG001|Overall Study|Infection|0|||
163025717|NCT00985959|588794658|FG000|Overall Study|Adverse Event|0|||
163025718|NCT00985959|588794659|FG001|Overall Study|Adverse Event|0|||
163025719|NCT00985959|588794660|FG002|Overall Study|Adverse Event|19|||
163025720|NCT00985959|588794658|FG000|Overall Study|Withdrawal by Subject|0|||
163025721|NCT00985959|588794659|FG001|Overall Study|Withdrawal by Subject|0|||
163025722|NCT00985959|588794660|FG002|Overall Study|Withdrawal by Subject|8|||
163025723|NCT00985959|588794658|FG000|Overall Study|Progressive disease|1|||
163025724|NCT00985959|588794659|FG001|Overall Study|Progressive disease|2|||
163025725|NCT00985959|588794660|FG002|Overall Study|Progressive disease|8|||
163025726|NCT00985959|588794658|FG000|Overall Study|Unrecovered toxicity|0|||
163025727|NCT00985959|588794659|FG001|Overall Study|Unrecovered toxicity|0|||
163025728|NCT00985959|588794660|FG002|Overall Study|Unrecovered toxicity|7|||
163025729|NCT00985959|588794658|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
163025730|NCT00985959|588794659|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
163025731|NCT00985959|588794660|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
163025732|NCT00985959|588794658|FG000|Overall Study|Complete response observed over 2 cycles|0|||
163025733|NCT00985959|588794659|FG001|Overall Study|Complete response observed over 2 cycles|1|||
163025734|NCT00985959|588794660|FG002|Overall Study|Complete response observed over 2 cycles|4|||
163025735|NCT00985959|588794658|FG000|Overall Study|Other|0|||
163025736|NCT00985959|588794659|FG001|Overall Study|Other|0|||
163025737|NCT00985959|588794660|FG002|Overall Study|Other|11|||
163025738|NCT00979420|588794661|FG000|Overall Study|Adverse Event|1|||
163025739|NCT00979420|588794662|FG001|Overall Study|Adverse Event|0|||
163025740|NCT00979420|588794663|FG002|Overall Study|Adverse Event|0|||
163025741|NCT00979420|588794664|FG003|Overall Study|Adverse Event|0|||
163025742|NCT00979420|588794661|FG000|Overall Study|Lack of Efficacy|3|||
163025743|NCT00979420|588794662|FG001|Overall Study|Lack of Efficacy|0|||
163025744|NCT00979420|588794663|FG002|Overall Study|Lack of Efficacy|1|||
163025745|NCT00979420|588794664|FG003|Overall Study|Lack of Efficacy|1|||
163025746|NCT00979420|588794661|FG000|Overall Study|Other reasons not related to Viramune|3|||
163025747|NCT00979420|588794662|FG001|Overall Study|Other reasons not related to Viramune|0|||
163025748|NCT00979420|588794663|FG002|Overall Study|Other reasons not related to Viramune|0|||
163025749|NCT00979420|588794664|FG003|Overall Study|Other reasons not related to Viramune|1|||
163025750|NCT02107859|588794666|FG000|Overall Study|Withdrawal by Subject|14|||
163025751|NCT02107859|588794666|FG000|Overall Study|Adverse Event|3|||
163025752|NCT02107859|588794666|FG000|Overall Study|Study closure|41|||
163025753|NCT02107859|588794666|FG000|Overall Study|Other than specified|3|||
163025754|NCT02235077|588794667|FG000|Overall Study|Death|5|||
163025755|NCT02235077|588794668|FG001|Overall Study|Death|7|||
163025756|NCT02235077|588794667|FG000|Overall Study|Lost to Follow-up|5|||
163025757|NCT02235077|588794668|FG001|Overall Study|Lost to Follow-up|6|||
163406360|NCT00401375|590196737|FG002|Overall Study|Lost to Follow-up|1|||
163065209|NCT03765073|588945706|FG013|Stage 2|Lost to Follow-up|3|||
163065210|NCT03765073|588945707|FG014|Stage 2|Lost to Follow-up|3|||
163065211|NCT03765073|588945708|FG015|Stage 2|Lost to Follow-up|1|||
163065212|NCT03765073|588945709|FG016|Stage 2|Lost to Follow-up|6|||
163065213|NCT03765073|588945710|FG017|Stage 2|Lost to Follow-up|0|||
163065214|NCT03765073|588945711|FG018|Stage 2|Lost to Follow-up|0|||
163065215|NCT03765073|588945712|FG019|Stage 2|Lost to Follow-up|0|||
163065216|NCT03765073|588945713|FG020|Stage 2|Lost to Follow-up|0|||
163065217|NCT03765073|588945693|FG000|Stage 2|Other|0|||
163065218|NCT03765073|588945694|FG001|Stage 2|Other|0|||
163065219|NCT03765073|588945695|FG002|Stage 2|Other|0|||
163065220|NCT03765073|588945696|FG003|Stage 2|Other|0|||
163065221|NCT03765073|588945697|FG004|Stage 2|Other|0|||
163065222|NCT03765073|588945698|FG005|Stage 2|Other|0|||
163065223|NCT03765073|588945699|FG006|Stage 2|Other|0|||
163065224|NCT03765073|588945700|FG007|Stage 2|Other|1|||
163065225|NCT03765073|588945701|FG008|Stage 2|Other|1|||
163065226|NCT03765073|588945702|FG009|Stage 2|Other|3|||
163065227|NCT03765073|588945703|FG010|Stage 2|Other|0|||
163065228|NCT03765073|588945704|FG011|Stage 2|Other|0|||
163065229|NCT03765073|588945705|FG012|Stage 2|Other|0|||
163065230|NCT03765073|588945706|FG013|Stage 2|Other|0|||
163065231|NCT03765073|588945707|FG014|Stage 2|Other|0|||
163065232|NCT03765073|588945708|FG015|Stage 2|Other|1|||
163065233|NCT03765073|588945709|FG016|Stage 2|Other|2|||
163065234|NCT03765073|588945710|FG017|Stage 2|Other|0|||
163065235|NCT03765073|588945711|FG018|Stage 2|Other|0|||
163065236|NCT03765073|588945712|FG019|Stage 2|Other|0|||
163065237|NCT03765073|588945713|FG020|Stage 2|Other|0|||
163065238|NCT03765073|588945693|FG000|Stage 2|Withdrawal by parent/guardian|0|||
163065239|NCT03765073|588945694|FG001|Stage 2|Withdrawal by parent/guardian|0|||
163065240|NCT03765073|588945695|FG002|Stage 2|Withdrawal by parent/guardian|0|||
163065241|NCT03765073|588945696|FG003|Stage 2|Withdrawal by parent/guardian|0|||
163065242|NCT03765073|588945697|FG004|Stage 2|Withdrawal by parent/guardian|0|||
163065243|NCT03765073|588945698|FG005|Stage 2|Withdrawal by parent/guardian|0|||
163065244|NCT03765073|588945699|FG006|Stage 2|Withdrawal by parent/guardian|0|||
163065245|NCT03765073|588945700|FG007|Stage 2|Withdrawal by parent/guardian|0|||
163065246|NCT03765073|588945701|FG008|Stage 2|Withdrawal by parent/guardian|0|||
163065247|NCT03765073|588945702|FG009|Stage 2|Withdrawal by parent/guardian|0|||
163065248|NCT03765073|588945703|FG010|Stage 2|Withdrawal by parent/guardian|3|||
163065249|NCT03765073|588945704|FG011|Stage 2|Withdrawal by parent/guardian|3|||
163065250|NCT03765073|588945705|FG012|Stage 2|Withdrawal by parent/guardian|3|||
163065251|NCT03765073|588945706|FG013|Stage 2|Withdrawal by parent/guardian|1|||
163065252|NCT03765073|588945707|FG014|Stage 2|Withdrawal by parent/guardian|1|||
163065253|NCT03765073|588945708|FG015|Stage 2|Withdrawal by parent/guardian|0|||
163065254|NCT03765073|588945709|FG016|Stage 2|Withdrawal by parent/guardian|3|||
163065255|NCT03765073|588945710|FG017|Stage 2|Withdrawal by parent/guardian|0|||
163065256|NCT03765073|588945711|FG018|Stage 2|Withdrawal by parent/guardian|0|||
163065257|NCT03765073|588945712|FG019|Stage 2|Withdrawal by parent/guardian|0|||
163065258|NCT03765073|588945713|FG020|Stage 2|Withdrawal by parent/guardian|0|||
163065259|NCT03765073|588945693|FG000|Stage 2|Withdrawal by Subject|0|||
163065260|NCT03765073|588945694|FG001|Stage 2|Withdrawal by Subject|0|||
163065261|NCT03765073|588945695|FG002|Stage 2|Withdrawal by Subject|0|||
163065262|NCT03765073|588945696|FG003|Stage 2|Withdrawal by Subject|3|||
163065263|NCT03765073|588945697|FG004|Stage 2|Withdrawal by Subject|3|||
163065264|NCT03765073|588945698|FG005|Stage 2|Withdrawal by Subject|3|||
163065265|NCT03765073|588945699|FG006|Stage 2|Withdrawal by Subject|0|||
163065266|NCT03765073|588945700|FG007|Stage 2|Withdrawal by Subject|1|||
163065267|NCT03765073|588945701|FG008|Stage 2|Withdrawal by Subject|0|||
163065268|NCT03765073|588945702|FG009|Stage 2|Withdrawal by Subject|5|||
163065269|NCT03765073|588945703|FG010|Stage 2|Withdrawal by Subject|0|||
163065270|NCT03765073|588945704|FG011|Stage 2|Withdrawal by Subject|0|||
163065271|NCT03765073|588945705|FG012|Stage 2|Withdrawal by Subject|0|||
163065272|NCT03765073|588945706|FG013|Stage 2|Withdrawal by Subject|0|||
163065273|NCT03765073|588945707|FG014|Stage 2|Withdrawal by Subject|0|||
163065274|NCT03765073|588945708|FG015|Stage 2|Withdrawal by Subject|0|||
163065275|NCT03765073|588945709|FG016|Stage 2|Withdrawal by Subject|0|||
163065276|NCT03765073|588945710|FG017|Stage 2|Withdrawal by Subject|0|||
163065277|NCT03765073|588945711|FG018|Stage 2|Withdrawal by Subject|0|||
163065278|NCT03765073|588945712|FG019|Stage 2|Withdrawal by Subject|0|||
163065279|NCT03765073|588945713|FG020|Stage 2|Withdrawal by Subject|0|||
163065280|NCT03765073|588945693|FG000|Stage 3|Adverse Event|0|||
163065281|NCT03765073|588945694|FG001|Stage 3|Adverse Event|0|||
163065282|NCT03765073|588945695|FG002|Stage 3|Adverse Event|0|||
163065283|NCT03765073|588945696|FG003|Stage 3|Adverse Event|0|||
163065284|NCT03765073|588945697|FG004|Stage 3|Adverse Event|0|||
163065285|NCT03765073|588945698|FG005|Stage 3|Adverse Event|0|||
163065286|NCT03765073|588945699|FG006|Stage 3|Adverse Event|0|||
163065287|NCT03765073|588945700|FG007|Stage 3|Adverse Event|0|||
163065288|NCT03765073|588945701|FG008|Stage 3|Adverse Event|0|||
163065289|NCT03765073|588945702|FG009|Stage 3|Adverse Event|0|||
163065290|NCT03765073|588945703|FG010|Stage 3|Adverse Event|0|||
163065291|NCT03765073|588945704|FG011|Stage 3|Adverse Event|0|||
163065292|NCT03765073|588945705|FG012|Stage 3|Adverse Event|0|||
163065293|NCT03765073|588945706|FG013|Stage 3|Adverse Event|0|||
163065294|NCT03765073|588945707|FG014|Stage 3|Adverse Event|0|||
163065295|NCT03765073|588945708|FG015|Stage 3|Adverse Event|0|||
163065296|NCT03765073|588945709|FG016|Stage 3|Adverse Event|0|||
163065297|NCT03765073|588945710|FG017|Stage 3|Adverse Event|0|||
163065298|NCT03765073|588945711|FG018|Stage 3|Adverse Event|1|||
163065299|NCT03765073|588945712|FG019|Stage 3|Adverse Event|0|||
163065300|NCT03765073|588945713|FG020|Stage 3|Adverse Event|0|||
163065301|NCT03765073|588945693|FG000|Stage 3|Death|0|||
163065302|NCT03765073|588945694|FG001|Stage 3|Death|0|||
163065303|NCT03765073|588945695|FG002|Stage 3|Death|0|||
163065304|NCT03765073|588945696|FG003|Stage 3|Death|0|||
163065305|NCT03765073|588945697|FG004|Stage 3|Death|0|||
163065306|NCT03765073|588945698|FG005|Stage 3|Death|0|||
163065307|NCT03765073|588945699|FG006|Stage 3|Death|0|||
163065308|NCT03765073|588945700|FG007|Stage 3|Death|0|||
163065309|NCT03765073|588945701|FG008|Stage 3|Death|0|||
163065310|NCT03765073|588945702|FG009|Stage 3|Death|0|||
163065311|NCT03765073|588945703|FG010|Stage 3|Death|0|||
163065312|NCT03765073|588945704|FG011|Stage 3|Death|0|||
163065313|NCT03765073|588945705|FG012|Stage 3|Death|0|||
163065314|NCT03765073|588945706|FG013|Stage 3|Death|0|||
163065315|NCT03765073|588945707|FG014|Stage 3|Death|0|||
163065316|NCT03765073|588945708|FG015|Stage 3|Death|0|||
163065317|NCT03765073|588945709|FG016|Stage 3|Death|0|||
163065318|NCT03765073|588945710|FG017|Stage 3|Death|0|||
163065319|NCT03765073|588945711|FG018|Stage 3|Death|0|||
163065320|NCT03765073|588945712|FG019|Stage 3|Death|3|||
163065321|NCT03765073|588945713|FG020|Stage 3|Death|2|||
163065322|NCT03765073|588945693|FG000|Stage 3|Lost to Follow-up|0|||
163065323|NCT03765073|588945694|FG001|Stage 3|Lost to Follow-up|0|||
163065324|NCT03765073|588945695|FG002|Stage 3|Lost to Follow-up|0|||
163065325|NCT03765073|588945696|FG003|Stage 3|Lost to Follow-up|0|||
163065326|NCT03765073|588945697|FG004|Stage 3|Lost to Follow-up|0|||
163065327|NCT03765073|588945698|FG005|Stage 3|Lost to Follow-up|0|||
163065328|NCT03765073|588945699|FG006|Stage 3|Lost to Follow-up|0|||
163065329|NCT03765073|588945700|FG007|Stage 3|Lost to Follow-up|0|||
163065330|NCT03765073|588945701|FG008|Stage 3|Lost to Follow-up|0|||
163065331|NCT03765073|588945702|FG009|Stage 3|Lost to Follow-up|0|||
163065332|NCT03765073|588945703|FG010|Stage 3|Lost to Follow-up|0|||
163065333|NCT03765073|588945704|FG011|Stage 3|Lost to Follow-up|0|||
163065334|NCT03765073|588945705|FG012|Stage 3|Lost to Follow-up|0|||
163065335|NCT03765073|588945706|FG013|Stage 3|Lost to Follow-up|0|||
163065336|NCT03765073|588945707|FG014|Stage 3|Lost to Follow-up|0|||
163065337|NCT03765073|588945708|FG015|Stage 3|Lost to Follow-up|0|||
163065338|NCT03765073|588945709|FG016|Stage 3|Lost to Follow-up|0|||
163065339|NCT03765073|588945710|FG017|Stage 3|Lost to Follow-up|8|||
163065340|NCT03765073|588945711|FG018|Stage 3|Lost to Follow-up|5|||
163065341|NCT03765073|588945712|FG019|Stage 3|Lost to Follow-up|7|||
163065342|NCT03765073|588945713|FG020|Stage 3|Lost to Follow-up|4|||
163065343|NCT03765073|588945693|FG000|Stage 3|No longer meets eligibility criteria|0|||
163065344|NCT03765073|588945694|FG001|Stage 3|No longer meets eligibility criteria|0|||
163065345|NCT03765073|588945695|FG002|Stage 3|No longer meets eligibility criteria|0|||
163065346|NCT03765073|588945696|FG003|Stage 3|No longer meets eligibility criteria|0|||
163065347|NCT03765073|588945697|FG004|Stage 3|No longer meets eligibility criteria|0|||
163065348|NCT03765073|588945698|FG005|Stage 3|No longer meets eligibility criteria|0|||
163065349|NCT03765073|588945699|FG006|Stage 3|No longer meets eligibility criteria|0|||
163065350|NCT03765073|588945700|FG007|Stage 3|No longer meets eligibility criteria|0|||
163065351|NCT03765073|588945701|FG008|Stage 3|No longer meets eligibility criteria|0|||
163065352|NCT03765073|588945702|FG009|Stage 3|No longer meets eligibility criteria|0|||
163065353|NCT03765073|588945703|FG010|Stage 3|No longer meets eligibility criteria|0|||
163065354|NCT03765073|588945704|FG011|Stage 3|No longer meets eligibility criteria|0|||
163065355|NCT03765073|588945705|FG012|Stage 3|No longer meets eligibility criteria|0|||
163065356|NCT03765073|588945706|FG013|Stage 3|No longer meets eligibility criteria|0|||
163065357|NCT03765073|588945707|FG014|Stage 3|No longer meets eligibility criteria|0|||
163065358|NCT03765073|588945708|FG015|Stage 3|No longer meets eligibility criteria|0|||
163065359|NCT03765073|588945709|FG016|Stage 3|No longer meets eligibility criteria|0|||
163065360|NCT03765073|588945710|FG017|Stage 3|No longer meets eligibility criteria|0|||
163065361|NCT03765073|588945711|FG018|Stage 3|No longer meets eligibility criteria|1|||
163065362|NCT03765073|588945712|FG019|Stage 3|No longer meets eligibility criteria|0|||
163065363|NCT03765073|588945713|FG020|Stage 3|No longer meets eligibility criteria|1|||
163065364|NCT03765073|588945693|FG000|Stage 3|Other|0|||
163065365|NCT03765073|588945694|FG001|Stage 3|Other|0|||
163065366|NCT03765073|588945695|FG002|Stage 3|Other|0|||
163065367|NCT03765073|588945696|FG003|Stage 3|Other|0|||
163065368|NCT03765073|588945697|FG004|Stage 3|Other|0|||
163065369|NCT03765073|588945698|FG005|Stage 3|Other|0|||
163065370|NCT03765073|588945699|FG006|Stage 3|Other|0|||
163065371|NCT03765073|588945700|FG007|Stage 3|Other|0|||
163065372|NCT03765073|588945701|FG008|Stage 3|Other|0|||
163065373|NCT03765073|588945702|FG009|Stage 3|Other|0|||
163065374|NCT03765073|588945703|FG010|Stage 3|Other|0|||
163065375|NCT03765073|588945704|FG011|Stage 3|Other|0|||
163065376|NCT03765073|588945705|FG012|Stage 3|Other|0|||
163065377|NCT03765073|588945706|FG013|Stage 3|Other|0|||
163065378|NCT03765073|588945707|FG014|Stage 3|Other|0|||
163065379|NCT03765073|588945708|FG015|Stage 3|Other|0|||
163065380|NCT03765073|588945709|FG016|Stage 3|Other|0|||
163065381|NCT03765073|588945710|FG017|Stage 3|Other|1|||
163065382|NCT03765073|588945711|FG018|Stage 3|Other|2|||
163065383|NCT03765073|588945712|FG019|Stage 3|Other|2|||
163065384|NCT03765073|588945713|FG020|Stage 3|Other|2|||
163065385|NCT03765073|588945693|FG000|Stage 3|Withdrawal by parent/guardian|0|||
163065386|NCT03765073|588945694|FG001|Stage 3|Withdrawal by parent/guardian|0|||
163065387|NCT03765073|588945695|FG002|Stage 3|Withdrawal by parent/guardian|0|||
163065388|NCT03765073|588945696|FG003|Stage 3|Withdrawal by parent/guardian|0|||
163065389|NCT03765073|588945697|FG004|Stage 3|Withdrawal by parent/guardian|0|||
163065390|NCT03765073|588945698|FG005|Stage 3|Withdrawal by parent/guardian|0|||
163065391|NCT03765073|588945699|FG006|Stage 3|Withdrawal by parent/guardian|0|||
163065392|NCT03765073|588945700|FG007|Stage 3|Withdrawal by parent/guardian|0|||
163065393|NCT03765073|588945701|FG008|Stage 3|Withdrawal by parent/guardian|0|||
163065394|NCT03765073|588945702|FG009|Stage 3|Withdrawal by parent/guardian|0|||
163065395|NCT03765073|588945703|FG010|Stage 3|Withdrawal by parent/guardian|0|||
163065396|NCT03765073|588945704|FG011|Stage 3|Withdrawal by parent/guardian|0|||
163065397|NCT03765073|588945705|FG012|Stage 3|Withdrawal by parent/guardian|0|||
163065398|NCT03765073|588945706|FG013|Stage 3|Withdrawal by parent/guardian|0|||
163065399|NCT03765073|588945707|FG014|Stage 3|Withdrawal by parent/guardian|0|||
163065400|NCT03765073|588945708|FG015|Stage 3|Withdrawal by parent/guardian|0|||
163065401|NCT03765073|588945709|FG016|Stage 3|Withdrawal by parent/guardian|0|||
163065402|NCT03765073|588945710|FG017|Stage 3|Withdrawal by parent/guardian|0|||
163065403|NCT03765073|588945711|FG018|Stage 3|Withdrawal by parent/guardian|0|||
163065404|NCT03765073|588945712|FG019|Stage 3|Withdrawal by parent/guardian|6|||
163065405|NCT03765073|588945713|FG020|Stage 3|Withdrawal by parent/guardian|9|||
163065406|NCT03765073|588945693|FG000|Stage 3|Withdrawal by Subject|0|||
163065407|NCT03765073|588945694|FG001|Stage 3|Withdrawal by Subject|0|||
163065408|NCT03765073|588945695|FG002|Stage 3|Withdrawal by Subject|0|||
163065409|NCT03765073|588945696|FG003|Stage 3|Withdrawal by Subject|0|||
163065410|NCT03765073|588945697|FG004|Stage 3|Withdrawal by Subject|0|||
163065411|NCT03765073|588945698|FG005|Stage 3|Withdrawal by Subject|0|||
163065412|NCT03765073|588945699|FG006|Stage 3|Withdrawal by Subject|0|||
163065413|NCT03765073|588945700|FG007|Stage 3|Withdrawal by Subject|0|||
163065414|NCT03765073|588945701|FG008|Stage 3|Withdrawal by Subject|0|||
163065415|NCT03765073|588945702|FG009|Stage 3|Withdrawal by Subject|0|||
163065416|NCT03765073|588945703|FG010|Stage 3|Withdrawal by Subject|0|||
163065417|NCT03765073|588945704|FG011|Stage 3|Withdrawal by Subject|0|||
163065418|NCT03765073|588945705|FG012|Stage 3|Withdrawal by Subject|0|||
163065419|NCT03765073|588945706|FG013|Stage 3|Withdrawal by Subject|0|||
163065420|NCT03765073|588945707|FG014|Stage 3|Withdrawal by Subject|0|||
163065421|NCT03765073|588945708|FG015|Stage 3|Withdrawal by Subject|0|||
163065422|NCT03765073|588945709|FG016|Stage 3|Withdrawal by Subject|0|||
163065423|NCT03765073|588945710|FG017|Stage 3|Withdrawal by Subject|8|||
163065424|NCT03765073|588945711|FG018|Stage 3|Withdrawal by Subject|11|||
163217615|NCT00296374|589512275|FG002|Overall Study|Withdrawal by Subject|11|||
163217616|NCT00296374|589512273|FG000|Overall Study|Incorrect enrollment|3|||
163217617|NCT00296374|589512274|FG001|Overall Study|Incorrect enrollment|3|||
163217618|NCT00296374|589512275|FG002|Overall Study|Incorrect enrollment|4|||
163217619|NCT00296374|589512273|FG000|Overall Study|Protocol Violation|1|||
163065425|NCT03765073|588945712|FG019|Stage 3|Withdrawal by Subject|0|||
163065426|NCT03765073|588945713|FG020|Stage 3|Withdrawal by Subject|0|||
163065427|NCT02802228|588945717|FG000|Overall Study|Withdrawal by Subject|2|||
163065428|NCT02802228|588945718|FG001|Overall Study|Withdrawal by Subject|0|||
163065429|NCT02802228|588945717|FG000|Overall Study|Lost to Follow-up|1|||
163065430|NCT02802228|588945718|FG001|Overall Study|Lost to Follow-up|0|||
163065431|NCT02802228|588945717|FG000|Overall Study|Adverse Event|1|||
163065432|NCT02802228|588945718|FG001|Overall Study|Adverse Event|0|||
163065433|NCT02802228|588945717|FG000|Overall Study|Physician Decision|1|||
163065434|NCT02802228|588945718|FG001|Overall Study|Physician Decision|0|||
163065435|NCT00695019|588945721|FG000|Overall Study|Withdrawal by Subject|8|||
163065436|NCT00695019|588945722|FG001|Overall Study|Withdrawal by Subject|6|||
163065437|NCT00695019|588945723|FG002|Overall Study|Withdrawal by Subject|4|||
163065438|NCT00695019|588945721|FG000|Overall Study|Protocol Violation|1|||
163065439|NCT00695019|588945722|FG001|Overall Study|Protocol Violation|3|||
163065440|NCT00695019|588945723|FG002|Overall Study|Protocol Violation|1|||
163065441|NCT00695019|588945721|FG000|Overall Study|Lack of Efficacy|0|||
163065442|NCT00695019|588945722|FG001|Overall Study|Lack of Efficacy|0|||
163065443|NCT00695019|588945723|FG002|Overall Study|Lack of Efficacy|1|||
163065444|NCT00695019|588945721|FG000|Overall Study|Various|4|||
163065445|NCT00695019|588945722|FG001|Overall Study|Various|5|||
163065446|NCT00695019|588945723|FG002|Overall Study|Various|4|||
163065447|NCT00580840|588945730|FG000|Run-in|Adverse Event|17|||
163065448|NCT00580840|588945731|FG001|Run-in|Adverse Event|0|||
163065449|NCT00580840|588945732|FG002|Run-in|Adverse Event|0|||
163065450|NCT00580840|588945733|FG003|Run-in|Adverse Event|0|||
163217620|NCT00296374|589512274|FG001|Overall Study|Protocol Violation|2|||
163217621|NCT00296374|589512275|FG002|Overall Study|Protocol Violation|3|||
163217622|NCT00296374|589512273|FG000|Overall Study|Lost to Follow-up|3|||
163217623|NCT00296374|589512274|FG001|Overall Study|Lost to Follow-up|1|||
163065451|NCT00580840|588945730|FG000|Run-in|Lack of Efficacy|93|||
163065452|NCT00580840|588945731|FG001|Run-in|Lack of Efficacy|0|||
163065453|NCT00580840|588945732|FG002|Run-in|Lack of Efficacy|0|||
163065454|NCT00580840|588945733|FG003|Run-in|Lack of Efficacy|0|||
163065455|NCT00580840|588945730|FG000|Run-in|Loss of Efficacy|1|||
163065456|NCT00580840|588945731|FG001|Run-in|Loss of Efficacy|0|||
163065457|NCT00580840|588945732|FG002|Run-in|Loss of Efficacy|0|||
163065458|NCT00580840|588945733|FG003|Run-in|Loss of Efficacy|0|||
163065459|NCT00580840|588945730|FG000|Run-in|Lost to Follow-up|4|||
163065460|NCT00580840|588945731|FG001|Run-in|Lost to Follow-up|0|||
163065461|NCT00580840|588945732|FG002|Run-in|Lost to Follow-up|0|||
163065462|NCT00580840|588945733|FG003|Run-in|Lost to Follow-up|0|||
163065463|NCT00580840|588945730|FG000|Run-in|Withdrawal by Subject|5|||
163065464|NCT00580840|588945731|FG001|Run-in|Withdrawal by Subject|0|||
163065465|NCT00580840|588945732|FG002|Run-in|Withdrawal by Subject|0|||
163065466|NCT00580840|588945733|FG003|Run-in|Withdrawal by Subject|0|||
163065467|NCT00580840|588945730|FG000|Run-in|Other: Per Sponsor Request|2|||
163065468|NCT00580840|588945731|FG001|Run-in|Other: Per Sponsor Request|0|||
163065469|NCT00580840|588945732|FG002|Run-in|Other: Per Sponsor Request|0|||
163065470|NCT00580840|588945733|FG003|Run-in|Other: Per Sponsor Request|0|||
163065471|NCT00580840|588945730|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
163065472|NCT00580840|588945731|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
163065473|NCT00580840|588945732|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
163065474|NCT00580840|588945733|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
163065475|NCT00580840|588945730|FG000|Run-in|Other: Exclusionary Lab Value|1|||
163065476|NCT00580840|588945731|FG001|Run-in|Other: Exclusionary Lab Value|0|||
163065477|NCT00580840|588945732|FG002|Run-in|Other: Exclusionary Lab Value|0|||
163065478|NCT00580840|588945733|FG003|Run-in|Other: Exclusionary Lab Value|0|||
163065479|NCT00580840|588945730|FG000|Double-Blind|Adverse Event|0|||
163065480|NCT00580840|588945731|FG001|Double-Blind|Adverse Event|3|||
163065481|NCT00580840|588945732|FG002|Double-Blind|Adverse Event|4|||
163065482|NCT00580840|588945733|FG003|Double-Blind|Adverse Event|1|||
163065483|NCT00580840|588945730|FG000|Double-Blind|Loss of Efficacy|0|||
163065484|NCT00580840|588945731|FG001|Double-Blind|Loss of Efficacy|1|||
163065485|NCT00580840|588945732|FG002|Double-Blind|Loss of Efficacy|2|||
163065486|NCT00580840|588945733|FG003|Double-Blind|Loss of Efficacy|10|||
163065487|NCT00580840|588945730|FG000|Double-Blind|Lost to Follow-up|0|||
163065488|NCT00580840|588945731|FG001|Double-Blind|Lost to Follow-up|1|||
163065489|NCT00580840|588945732|FG002|Double-Blind|Lost to Follow-up|0|||
163065490|NCT00580840|588945733|FG003|Double-Blind|Lost to Follow-up|2|||
163065491|NCT00580840|588945730|FG000|Double-Blind|Withdrawal by Subject|0|||
163065492|NCT00580840|588945731|FG001|Double-Blind|Withdrawal by Subject|1|||
163065493|NCT00580840|588945732|FG002|Double-Blind|Withdrawal by Subject|2|||
163065494|NCT00580840|588945733|FG003|Double-Blind|Withdrawal by Subject|2|||
163065495|NCT00580840|588945730|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
163065496|NCT00580840|588945731|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
163065497|NCT00580840|588945732|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
163065498|NCT00580840|588945733|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
163065499|NCT00580840|588945730|FG000|Double-Blind|Other: Forbidden Medication|0|||
163065500|NCT00580840|588945731|FG001|Double-Blind|Other: Forbidden Medication|0|||
163065501|NCT00580840|588945732|FG002|Double-Blind|Other: Forbidden Medication|1|||
163065502|NCT00580840|588945733|FG003|Double-Blind|Other: Forbidden Medication|0|||
163065503|NCT01160614|588945736|FG000|Overall Study|Withdrawal by Subject|0|||
163065504|NCT01160614|588945737|FG001|Overall Study|Withdrawal by Subject|2|||
163065505|NCT00984399|588945738|FG000|Overall Study|Adverse Event|0|||
163065506|NCT00984399|588945739|FG001|Overall Study|Adverse Event|1|||
163065507|NCT00984399|588945738|FG000|Overall Study|Physician Decision|1|||
163065508|NCT00984399|588945739|FG001|Overall Study|Physician Decision|0|||
163065509|NCT00984399|588945738|FG000|Overall Study|Withdrawal by Subject|1|||
163065510|NCT00984399|588945739|FG001|Overall Study|Withdrawal by Subject|1|||
163065511|NCT00984399|588945738|FG000|Overall Study|Protocol Violation|0|||
163065512|NCT00984399|588945739|FG001|Overall Study|Protocol Violation|1|||
163065513|NCT00984399|588945738|FG000|Overall Study|Pts did not start treatment|2|||
163217624|NCT00296374|589512275|FG002|Overall Study|Lost to Follow-up|1|||
163217625|NCT00296374|589512273|FG000|Overall Study|Relocated to another state|1|||
163217626|NCT00296374|589512274|FG001|Overall Study|Relocated to another state|0|||
163065514|NCT00984399|588945739|FG001|Overall Study|Pts did not start treatment|2|||
163065515|NCT05049122|588945740|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
163065516|NCT05049122|588945740|FG000|Overall Study|Participant moved|1|||
163217627|NCT00296374|589512275|FG002|Overall Study|Relocated to another state|0|||
163065517|NCT05049122|588945740|FG000|Overall Study|At the direction of the doctor|1|||
163065518|NCT01723774|588945742|FG000|Neoadjuvant|Ki67 > 10%|4|||
163065519|NCT01723774|588945743|FG001|Neoadjuvant|Ki67 > 10%|0|||
163065520|NCT01723774|588945744|FG002|Neoadjuvant|Ki67 > 10%|10|||
163065521|NCT01723774|588945745|FG003|Neoadjuvant|Ki67 > 10%|0|||
163065522|NCT01723774|588945742|FG000|Neoadjuvant|Withdrawal by Subject|3|||
163065523|NCT01723774|588945743|FG001|Neoadjuvant|Withdrawal by Subject|1|||
163065524|NCT01723774|588945744|FG002|Neoadjuvant|Withdrawal by Subject|0|||
163217628|NCT00296374|589512273|FG000|Overall Study|Stopped drug before end of study visit|0|||
163065525|NCT01723774|588945745|FG003|Neoadjuvant|Withdrawal by Subject|0|||
163065526|NCT01723774|588945742|FG000|Neoadjuvant|Disease progression|0|||
163065527|NCT01723774|588945743|FG001|Neoadjuvant|Disease progression|1|||
163065528|NCT01723774|588945744|FG002|Neoadjuvant|Disease progression|1|||
163065529|NCT01723774|588945745|FG003|Neoadjuvant|Disease progression|0|||
163065530|NCT01723774|588945742|FG000|Neoadjuvant|Adverse Event|0|||
163065531|NCT01723774|588945743|FG001|Neoadjuvant|Adverse Event|1|||
163065532|NCT01723774|588945744|FG002|Neoadjuvant|Adverse Event|2|||
163065533|NCT01723774|588945745|FG003|Neoadjuvant|Adverse Event|0|||
163065534|NCT01723774|588945742|FG000|Neoadjuvant|High estradiol|0|||
163065535|NCT01723774|588945743|FG001|Neoadjuvant|High estradiol|1|||
163065536|NCT01723774|588945744|FG002|Neoadjuvant|High estradiol|0|||
163065537|NCT01723774|588945745|FG003|Neoadjuvant|High estradiol|0|||
163065538|NCT01910441|588945746|FG000|Overall Study|Sponsor decision|0|||
163065539|NCT01910441|588945747|FG001|Overall Study|Sponsor decision|2|||
163065540|NCT01910441|588945746|FG000|Overall Study|Lost to Follow-up|6|||
163065541|NCT01910441|588945747|FG001|Overall Study|Lost to Follow-up|5|||
163065542|NCT01910441|588945746|FG000|Overall Study|Withdrawal by Subject|0|||
163065543|NCT01910441|588945747|FG001|Overall Study|Withdrawal by Subject|1|||
163065544|NCT01910441|588945746|FG000|Overall Study|Non-compliance|0|||
163065545|NCT01910441|588945747|FG001|Overall Study|Non-compliance|1|||
163065546|NCT01910441|588945746|FG000|Overall Study|Adverse Event|1|||
163065547|NCT01910441|588945747|FG001|Overall Study|Adverse Event|0|||
163065548|NCT01910441|588945746|FG000|Overall Study|Physician Decision|0|||
163065549|NCT01910441|588945747|FG001|Overall Study|Physician Decision|1|||
163065550|NCT02964182|588945748|FG000|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
163065551|NCT02964182|588945749|FG001|Phase 2 (Weeks 2-4)|Lost to Follow-up|7|||
163065552|NCT02964182|588945750|FG002|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
163065553|NCT02964182|588945751|FG003|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
163065554|NCT02964182|588945752|FG004|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
163065555|NCT02964182|588945753|FG005|Phase 2 (Weeks 2-4)|Lost to Follow-up|2|||
163065556|NCT02964182|588945754|FG006|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
163065557|NCT02964182|588945755|FG007|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
163065558|NCT02964182|588945748|FG000|Phase 2 (Weeks 2-4)|Physician Decision|0|||
163065559|NCT02964182|588945749|FG001|Phase 2 (Weeks 2-4)|Physician Decision|0|||
163065560|NCT02964182|588945750|FG002|Phase 2 (Weeks 2-4)|Physician Decision|0|||
163065561|NCT02964182|588945751|FG003|Phase 2 (Weeks 2-4)|Physician Decision|0|||
163065562|NCT02964182|588945752|FG004|Phase 2 (Weeks 2-4)|Physician Decision|0|||
163065563|NCT02964182|588945753|FG005|Phase 2 (Weeks 2-4)|Physician Decision|12|||
163065564|NCT02964182|588945754|FG006|Phase 2 (Weeks 2-4)|Physician Decision|0|||
163065565|NCT02964182|588945755|FG007|Phase 2 (Weeks 2-4)|Physician Decision|0|||
163065566|NCT02964182|588945748|FG000|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
163065567|NCT02964182|588945749|FG001|Phase 2 (Weeks 2-4)|Withdrawal by Subject|11|||
163065568|NCT02964182|588945750|FG002|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
163065569|NCT02964182|588945751|FG003|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
163065570|NCT02964182|588945752|FG004|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
163065571|NCT02964182|588945753|FG005|Phase 2 (Weeks 2-4)|Withdrawal by Subject|1|||
163065572|NCT02964182|588945754|FG006|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
163065573|NCT02964182|588945755|FG007|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
163065574|NCT02964182|588945748|FG000|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
163065575|NCT02964182|588945749|FG001|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
163065576|NCT02964182|588945750|FG002|Phase 3 (Weeks 5-7)|Lost to Follow-up|3|||
163065577|NCT02964182|588945751|FG003|Phase 3 (Weeks 5-7)|Lost to Follow-up|2|||
163065578|NCT02964182|588945752|FG004|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
163065579|NCT02964182|588945753|FG005|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
163065580|NCT02964182|588945754|FG006|Phase 3 (Weeks 5-7)|Lost to Follow-up|1|||
163065581|NCT02964182|588945755|FG007|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
163065582|NCT02964182|588945748|FG000|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
163065583|NCT02964182|588945749|FG001|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
163065584|NCT02964182|588945750|FG002|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
163065585|NCT02964182|588945751|FG003|Phase 3 (Weeks 5-7)|Withdrawal by Subject|5|||
163065586|NCT02964182|588945752|FG004|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
163065587|NCT02964182|588945753|FG005|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
163065588|NCT02964182|588945754|FG006|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
163065589|NCT02964182|588945755|FG007|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
163330741|NCT04971733|589920677|FG000|Overall Study|Withdrawal by Subject|1|||
163065590|NCT02964182|588945748|FG000|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
163065591|NCT02964182|588945749|FG001|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
163065592|NCT02964182|588945750|FG002|Phase 4 (Weeks 8-10)|Lost to Follow-up|1|||
163065593|NCT02964182|588945751|FG003|Phase 4 (Weeks 8-10)|Lost to Follow-up|2|||
163065594|NCT02964182|588945752|FG004|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
163065595|NCT02964182|588945753|FG005|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
163065596|NCT02964182|588945754|FG006|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
163065597|NCT02964182|588945755|FG007|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
163065598|NCT02964182|588945748|FG000|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
163065599|NCT02964182|588945749|FG001|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
163065600|NCT02964182|588945750|FG002|Phase 4 (Weeks 8-10)|Withdrawal by Subject|3|||
163065601|NCT02964182|588945751|FG003|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
163065602|NCT02964182|588945752|FG004|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
163065603|NCT02964182|588945753|FG005|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
163065604|NCT02964182|588945754|FG006|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
163065605|NCT02964182|588945755|FG007|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
163065606|NCT03636477|588945756|FG000|Overall Study|Adverse Event|0|||
163065607|NCT03636477|588945757|FG001|Overall Study|Adverse Event|0|||
163065608|NCT03636477|588945758|FG002|Overall Study|Adverse Event|1|||
163065609|NCT02382380|588945760|FG000|Overall Study|Withdrawal by Subject|2|||
163065610|NCT02382380|588945761|FG001|Overall Study|Withdrawal by Subject|2|||
163065611|NCT02382380|588945760|FG000|Overall Study|Lost to Follow-up|0|||
163065612|NCT02382380|588945761|FG001|Overall Study|Lost to Follow-up|1|||
163065613|NCT01295944|588945762|FG000|Overall Study|Switched to alternative treatment|1|||
163065614|NCT01295944|588945762|FG000|Overall Study|Ineligible|9|||
163065615|NCT01295944|588945762|FG000|Overall Study|Withdrawal by Subject|1|||
163065616|NCT01295944|588945762|FG000|Overall Study|Participant chose to be treated in Peru|1|||
163065617|NCT01295944|588945762|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
163065618|NCT01295944|588945762|FG000|Overall Study|Physician Decision|1|||
163065619|NCT01295944|588945762|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
163065620|NCT01295944|588945762|FG000|Overall Study|Disease progression|4|||
163065621|NCT01295944|588945762|FG000|Overall Study|Transferred care before starting new treatment|1|||
163065622|NCT03785366|588945763|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
163065623|NCT03785366|588945764|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
163065624|NCT03785366|588945763|FG000|Overall Study|Lost to Follow-up|1|||
163065625|NCT03785366|588945764|FG001|Overall Study|Lost to Follow-up|0|||
163065626|NCT03785366|588945763|FG000|Overall Study|Partial IUD Expulsion|0|||
163065627|NCT03785366|588945764|FG001|Overall Study|Partial IUD Expulsion|2|||
163065628|NCT03785366|588945763|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
163065629|NCT03785366|588945764|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
163065630|NCT05168800|588945765|FG000|Time 1 Survey|Did not start T1 survey|182|||
163065631|NCT05168800|588945766|FG001|Time 1 Survey|Did not start T1 survey|150|||
163065632|NCT05168800|588945767|FG002|Time 1 Survey|Did not start T1 survey|140|||
163065633|NCT05168800|588945765|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
163065634|NCT05168800|588945766|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
163065635|NCT05168800|588945767|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
163065636|NCT05168800|588945765|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
163065637|NCT05168800|588945766|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
163065638|NCT05168800|588945767|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
163065639|NCT05168800|588945765|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
163065640|NCT05168800|588945766|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
163065641|NCT05168800|588945767|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
163065642|NCT05168800|588945765|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
163065643|NCT05168800|588945766|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
163065644|NCT05168800|588945767|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
163065645|NCT05168800|588945765|FG000|Time 1 Survey|Withdrawal by Subject|6|||
163065646|NCT05168800|588945766|FG001|Time 1 Survey|Withdrawal by Subject|3|||
163065647|NCT05168800|588945767|FG002|Time 1 Survey|Withdrawal by Subject|2|||
163065648|NCT05168800|588945765|FG000|Time 2 Survey|Already excluded at Time 1|228|||
163065649|NCT05168800|588945766|FG001|Time 2 Survey|Already excluded at Time 1|202|||
163065650|NCT05168800|588945767|FG002|Time 2 Survey|Already excluded at Time 1|173|||
163065651|NCT05168800|588945765|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
163065652|NCT05168800|588945766|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
163065653|NCT05168800|588945767|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
163065654|NCT05168800|588945765|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
163065655|NCT05168800|588945766|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
163065656|NCT05168800|588945767|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
163065657|NCT05168800|588945765|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
163065658|NCT05168800|588945766|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
163065659|NCT05168800|588945767|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
163330742|NCT04971733|589920678|FG001|Overall Study|Withdrawal by Subject|0|||
163330743|NCT04971733|589920677|FG000|Overall Study|Other|1|||
163330744|NCT04971733|589920678|FG001|Overall Study|Other|0|||
163330745|NCT01160354|589920679|FG000|Overall Study|Death|0|||
163065660|NCT05168800|588945765|FG000|Time 2 Survey|Withdrawal by Subject|1|||
163330746|NCT01160354|589920680|FG001|Overall Study|Death|1|||
163065661|NCT05168800|588945766|FG001|Time 2 Survey|Withdrawal by Subject|0|||
163330747|NCT01160354|589920681|FG002|Overall Study|Death|1|||
163065662|NCT05168800|588945767|FG002|Time 2 Survey|Withdrawal by Subject|1|||
163065663|NCT05168800|588945765|FG000|Time 3 Survey|Already excluded at Time 1|228|||
163330748|NCT00600353|589920685|FG000|Overall Study|history of malignancy within 5 years|1|||
163330749|NCT00600353|589920686|FG001|Overall Study|history of malignancy within 5 years|0|||
163330750|NCT00600353|589920685|FG000|Overall Study|History of prepartive regimen|0|||
163065664|NCT05168800|588945766|FG001|Time 3 Survey|Already excluded at Time 1|200|||
163065665|NCT05168800|588945767|FG002|Time 3 Survey|Already excluded at Time 1|173|||
163330751|NCT00600353|589920686|FG001|Overall Study|History of prepartive regimen|1|||
163330752|NCT04941482|589920687|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
163065666|NCT05168800|588945765|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
163065667|NCT05168800|588945766|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
163065668|NCT05168800|588945767|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
163065669|NCT05168800|588945765|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
163065670|NCT05168800|588945766|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
163065671|NCT05168800|588945767|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
163065672|NCT05168800|588945765|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
163065673|NCT05168800|588945766|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
163065674|NCT05168800|588945767|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
163065675|NCT03240874|588945768|FG000|Overall Study|Lost to Follow-up|0|||
163065676|NCT03240874|588945769|FG001|Overall Study|Lost to Follow-up|2|||
163065677|NCT03240874|588945770|FG002|Overall Study|Lost to Follow-up|4|||
163065678|NCT03240874|588945771|FG003|Overall Study|Lost to Follow-up|1|||
163065679|NCT04958707|588945772|FG000|Post Intervention|Withdrawal by Subject|1|||
163065680|NCT04958707|588945773|FG001|Post Intervention|Withdrawal by Subject|0|||
163065681|NCT04958707|588945774|FG002|Post Intervention|Withdrawal by Subject|0|||
163065682|NCT04958707|588945772|FG000|3 Months Follow- up|Lost to Follow-up|0|||
163065683|NCT04958707|588945773|FG001|3 Months Follow- up|Lost to Follow-up|3|||
163065684|NCT04958707|588945774|FG002|3 Months Follow- up|Lost to Follow-up|0|||
163065685|NCT04958707|588945772|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
163065686|NCT04958707|588945773|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
163065687|NCT04958707|588945774|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
163065688|NCT04279522|588945777|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
163065689|NCT04279522|588945778|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
163065690|NCT04279522|588945777|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
163065691|NCT04279522|588945778|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
163065692|NCT04279522|588945777|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
163065693|NCT04279522|588945778|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
163065694|NCT04279522|588945777|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
163065695|NCT04279522|588945778|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
163065696|NCT04279522|588945777|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
163065697|NCT04279522|588945778|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
163065698|NCT04279522|588945777|FG000|Period 2: Open Label Phase|Physician Decision|0|||
163065699|NCT04279522|588945778|FG001|Period 2: Open Label Phase|Physician Decision|3|||
163065700|NCT04279522|588945777|FG000|Period 2: Open Label Phase|Adverse Event|0|||
163065701|NCT04279522|588945778|FG001|Period 2: Open Label Phase|Adverse Event|1|||
163065702|NCT04279522|588945777|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
163065703|NCT04279522|588945778|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
163065704|NCT02783274|588945784|FG000|Overall Study|Withdrawal by Subject|16|||
163065705|NCT02783274|588945784|FG000|Overall Study|Physician Decision|6|||
163065706|NCT02783274|588945784|FG000|Overall Study|Death|9|||
163065707|NCT02783274|588945784|FG000|Overall Study|Lost to Follow-up|22|||
163065708|NCT02783274|588945784|FG000|Overall Study|Other|22|||
163065709|NCT05567172|588945787|FG000|Overall Study|Death|3|||
163065710|NCT02246777|588945790|FG000|Overall Study|Adverse Event|2|||
163065711|NCT02246777|588945790|FG000|Overall Study|Change of residence|1|||
163065712|NCT00927472|588945791|FG000|Overall Study|Withdrawal by Subject|10|||
163065713|NCT00927472|588945792|FG001|Overall Study|Withdrawal by Subject|11|||
163065714|NCT00927472|588945791|FG000|Overall Study|Lost to Follow-up|1|||
163065715|NCT00927472|588945792|FG001|Overall Study|Lost to Follow-up|6|||
163065716|NCT00927472|588945791|FG000|Overall Study|Protocol Violation|0|||
163065717|NCT00927472|588945792|FG001|Overall Study|Protocol Violation|1|||
163065718|NCT00927472|588945791|FG000|Overall Study|Post treatment Assessment out of window|0|||
163065719|NCT00927472|588945792|FG001|Overall Study|Post treatment Assessment out of window|4|||
163330753|NCT04941482|589920688|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
163330754|NCT02743819|589920689|FG000|Overall Study|Lack of Efficacy|5|||
163330755|NCT02743819|589920689|FG000|Overall Study|Death|2|||
163330756|NCT02743819|589920689|FG000|Overall Study|Adverse Event|1|||
163330757|NCT04200664|589920690|FG000|Overall Study|Withdrawal by Subject|1|||
163065720|NCT04707469|588945793|FG000|Overall Study|Site closure|0|||
163065721|NCT04707469|588945794|FG001|Overall Study|Site closure|2|||
163065722|NCT04707469|588945795|FG002|Overall Study|Site closure|0|||
163065723|NCT04707469|588945793|FG000|Overall Study|Physician Decision|2|||
163065724|NCT04707469|588945794|FG001|Overall Study|Physician Decision|2|||
163065725|NCT04707469|588945795|FG002|Overall Study|Physician Decision|2|||
163065726|NCT04707469|588945793|FG000|Overall Study|Death|1|||
163330758|NCT04200664|589920691|FG001|Overall Study|Withdrawal by Subject|0|||
163065727|NCT04707469|588945794|FG001|Overall Study|Death|6|||
163065728|NCT04707469|588945795|FG002|Overall Study|Death|2|||
163330759|NCT04200664|589920692|FG002|Overall Study|Withdrawal by Subject|0|||
163065729|NCT04707469|588945793|FG000|Overall Study|Lost to Follow-up|9|||
163065730|NCT04707469|588945794|FG001|Overall Study|Lost to Follow-up|19|||
163065731|NCT04707469|588945795|FG002|Overall Study|Lost to Follow-up|14|||
163065732|NCT04707469|588945793|FG000|Overall Study|Withdrawal by Subject|17|||
163065733|NCT04707469|588945794|FG001|Overall Study|Withdrawal by Subject|16|||
163065734|NCT04707469|588945795|FG002|Overall Study|Withdrawal by Subject|12|||
163065735|NCT04635423|588945808|FG000|Overall Study|Ongoing|493|||
163065736|NCT04635423|588945809|FG001|Overall Study|Ongoing|501|||
163065737|NCT04635423|588945808|FG000|Overall Study|Withdrawal by Subject|36|||
163065738|NCT04635423|588945809|FG001|Overall Study|Withdrawal by Subject|29|||
163065739|NCT05556057|588945810|FG000|Overall Study|Lost to Follow-up|5|||
163065740|NCT05556057|588945811|FG001|Overall Study|Lost to Follow-up|4|||
163065741|NCT05556057|588945810|FG000|Overall Study|Withdrawal by Subject|0|||
163065742|NCT05556057|588945811|FG001|Overall Study|Withdrawal by Subject|2|||
163065743|NCT03488524|588945822|FG000|Overall Study|Withdrawal by Subject|51|||
163217629|NCT00296374|589512274|FG001|Overall Study|Stopped drug before end of study visit|1|||
163217630|NCT00296374|589512275|FG002|Overall Study|Stopped drug before end of study visit|0|||
163217631|NCT00296374|589512273|FG000|Overall Study|Nephrologist introduced ACE|0|||
163217632|NCT00296374|589512274|FG001|Overall Study|Nephrologist introduced ACE|1|||
163217633|NCT00296374|589512275|FG002|Overall Study|Nephrologist introduced ACE|0|||
163217634|NCT00296374|589512273|FG000|Overall Study|Pregnancy|0|||
163217635|NCT00296374|589512274|FG001|Overall Study|Pregnancy|0|||
163217636|NCT00296374|589512275|FG002|Overall Study|Pregnancy|2|||
163217637|NCT00296374|589512273|FG000|Overall Study|Other|0|||
163217638|NCT00296374|589512274|FG001|Overall Study|Other|0|||
163217639|NCT00296374|589512275|FG002|Overall Study|Other|1|||
163217640|NCT01816893|589512276|FG000|Washout Period|Withdrawal by Subject|2|||
163217641|NCT01816893|589512277|FG001|Washout Period|Withdrawal by Subject|0|||
163217642|NCT00699972|589513758|FG000|Overall Study|Adverse Event|7|||
163217643|NCT00699972|589513759|FG001|Overall Study|Adverse Event|9|||
163217644|NCT00699972|589513760|FG002|Overall Study|Adverse Event|24|||
163217645|NCT00699972|589513758|FG000|Overall Study|Lost to Follow-up|0|||
163217646|NCT00699972|589513759|FG001|Overall Study|Lost to Follow-up|2|||
163217647|NCT00699972|589513760|FG002|Overall Study|Lost to Follow-up|0|||
163217648|NCT00699972|589513758|FG000|Overall Study|Withdrawal by Subject|3|||
163217649|NCT00699972|589513759|FG001|Overall Study|Withdrawal by Subject|7|||
163217650|NCT00699972|589513760|FG002|Overall Study|Withdrawal by Subject|4|||
163217651|NCT00699972|589513758|FG000|Overall Study|Lack of Efficacy|2|||
163217652|NCT00699972|589513759|FG001|Overall Study|Lack of Efficacy|0|||
163217653|NCT00699972|589513760|FG002|Overall Study|Lack of Efficacy|2|||
163217654|NCT00699972|589513758|FG000|Overall Study|Administrative/Other|3|||
163217655|NCT00699972|589513759|FG001|Overall Study|Administrative/Other|1|||
163217656|NCT00699972|589513760|FG002|Overall Study|Administrative/Other|4|||
163217657|NCT00699972|589513758|FG000|Overall Study|Randomized, Not Treated|1|||
163217658|NCT00699972|589513759|FG001|Overall Study|Randomized, Not Treated|0|||
163217659|NCT00699972|589513760|FG002|Overall Study|Randomized, Not Treated|1|||
163217660|NCT01545817|589513761|FG000|Pazopanib|Disease progression|51|||
163217661|NCT01545817|589513762|FG001|Pazopanib|Disease progression|0|||
163217662|NCT01545817|589513761|FG000|Pazopanib|Adverse Event|19|||
163217663|NCT01545817|589513762|FG001|Pazopanib|Adverse Event|0|||
163217664|NCT01545817|589513761|FG000|Pazopanib|Other reason|4|||
163217665|NCT01545817|589513762|FG001|Pazopanib|Other reason|0|||
163217666|NCT01545817|589513761|FG000|Everolimus|Other reason|0|||
163217667|NCT01545817|589513762|FG001|Everolimus|Other reason|7|||
163217668|NCT01545817|589513761|FG000|Everolimus|Disease progression|0|||
163217669|NCT01545817|589513762|FG001|Everolimus|Disease progression|25|||
163217670|NCT01545817|589513761|FG000|Everolimus|Adverse Event|0|||
163217671|NCT01545817|589513762|FG001|Everolimus|Adverse Event|6|||
163217672|NCT00706641|589513763|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
163406361|NCT00401375|590196735|FG000|Overall Study|Other than specified|2|||
163406362|NCT00401375|590196736|FG001|Overall Study|Other than specified|1|||
163217673|NCT00706641|589513763|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
163217674|NCT00706641|589513763|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
163217675|NCT04782856|589513764|FG000|Overall Study|Withdrawal by Subject|0|||
163065744|NCT03488524|588945822|FG000|Overall Study|Death|19|||
163065745|NCT03488524|588945822|FG000|Overall Study|Study Sponsor|11|||
163065746|NCT03488524|588945822|FG000|Overall Study|Physician Decision|4|||
163065747|NCT03488524|588945822|FG000|Overall Study|Lost to Follow-up|3|||
163065748|NCT00830765|588945823|FG000|Overall Study|Protocol Violation|3|||
163065749|NCT00830765|588945824|FG001|Overall Study|Protocol Violation|2|||
163065750|NCT00315445|588945825|FG000|Overall Study|Adverse Event|7|||
163065751|NCT00315445|588945826|FG001|Overall Study|Adverse Event|12|||
163217676|NCT04782856|589513765|FG001|Overall Study|Withdrawal by Subject|1|||
163217677|NCT00798369|589513766|FG000|Overall Study|Subject withdrew consent|0|||
163217678|NCT00798369|589513767|FG001|Overall Study|Subject withdrew consent|0|||
163217679|NCT00798369|589513768|FG002|Overall Study|Subject withdrew consent|1|||
163217680|NCT00798369|589513769|FG003|Overall Study|Subject withdrew consent|1|||
163217681|NCT00798369|589513770|FG004|Overall Study|Subject withdrew consent|0|||
163217682|NCT00798369|589513771|FG005|Overall Study|Subject withdrew consent|2|||
163065752|NCT00315445|588945827|FG002|Overall Study|Adverse Event|15|||
163065753|NCT00315445|588945825|FG000|Overall Study|Lack of Efficacy|16|||
163065754|NCT00315445|588945826|FG001|Overall Study|Lack of Efficacy|1|||
163065755|NCT00315445|588945827|FG002|Overall Study|Lack of Efficacy|7|||
163065756|NCT00315445|588945825|FG000|Overall Study|Lost to Follow-up|1|||
163065757|NCT00315445|588945826|FG001|Overall Study|Lost to Follow-up|0|||
163065758|NCT00315445|588945827|FG002|Overall Study|Lost to Follow-up|1|||
163065759|NCT00315445|588945825|FG000|Overall Study|Protocol Violation|2|||
163065760|NCT00315445|588945826|FG001|Overall Study|Protocol Violation|0|||
163065761|NCT00315445|588945827|FG002|Overall Study|Protocol Violation|1|||
163065762|NCT00315445|588945825|FG000|Overall Study|Other|1|||
163065763|NCT00315445|588945826|FG001|Overall Study|Other|3|||
163065764|NCT00315445|588945827|FG002|Overall Study|Other|0|||
163065765|NCT02390284|588945828|FG000|Overall Study|Physician Decision|0|||
163065766|NCT02390284|588945829|FG001|Overall Study|Physician Decision|0|||
163065767|NCT02390284|588945830|FG002|Overall Study|Physician Decision|9|||
163065768|NCT01299909|588945831|FG000|Overall Study|Lost to Follow-up|22|||
163065769|NCT01299909|588945832|FG001|Overall Study|Lost to Follow-up|18|||
163065770|NCT01299909|588945833|FG002|Overall Study|Lost to Follow-up|17|||
163065771|NCT01811238|588945834|FG000|Overall Study|Withdrawal by Subject|42|||
163065772|NCT01811238|588945834|FG000|Overall Study|Adverse Event|25|||
163065773|NCT01811238|588945834|FG000|Overall Study|Protocol Violation|4|||
163065774|NCT01811238|588945834|FG000|Overall Study|Lack of Efficacy|4|||
163065775|NCT01811238|588945834|FG000|Overall Study|subject refused study medication|6|||
163065776|NCT01977846|588945835|FG000|Total Study - Prospective|Death|0|||
163065777|NCT01977846|588945836|FG001|Total Study - Prospective|Death|1|||
163065778|NCT01977846|588945835|FG000|Total Study - Prospective|Lost to Follow-up|0|||
163065779|NCT01977846|588945836|FG001|Total Study - Prospective|Lost to Follow-up|8|||
163065780|NCT01977846|588945835|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
163065781|NCT01977846|588945836|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
163065782|NCT01977846|588945835|FG000|Total Study - Prospective|Not available at time of visit|0|||
163065783|NCT01977846|588945836|FG001|Total Study - Prospective|Not available at time of visit|5|||
163065784|NCT01977846|588945835|FG000|Total Study - Prospective|No show|0|||
163065785|NCT01977846|588945836|FG001|Total Study - Prospective|No show|1|||
163065786|NCT01977846|588945835|FG000|Total Study - Prospective|Protocol Violation|0|||
163065787|NCT01977846|588945836|FG001|Total Study - Prospective|Protocol Violation|1|||
163065788|NCT00143507|588947348|FG000|Overall Study|Death|572|||
163065789|NCT00143507|588947349|FG001|Overall Study|Death|547|||
163065790|NCT00143507|588947348|FG000|Overall Study|Withdrawal by Subject|114|||
163065791|NCT00143507|588947349|FG001|Overall Study|Withdrawal by Subject|102|||
163065792|NCT00143507|588947348|FG000|Overall Study|Lost to Follow-up|1|||
163065793|NCT00143507|588947349|FG001|Overall Study|Lost to Follow-up|0|||
163065794|NCT00143507|588947348|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
163065795|NCT00143507|588947349|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
163065796|NCT00177671|588947350|FG000|Overall Study|Withdrawal by Subject|5|||
163065797|NCT00177671|588947351|FG001|Overall Study|Withdrawal by Subject|6|||
163065798|NCT00177671|588947350|FG000|Overall Study|medical complications|2|||
163065799|NCT00177671|588947351|FG001|Overall Study|medical complications|0|||
163065800|NCT00177671|588947350|FG000|Overall Study|Adverse Event|6|||
163065801|NCT00177671|588947351|FG001|Overall Study|Adverse Event|0|||
163065802|NCT00177671|588947350|FG000|Overall Study|Physician Decision|12|||
163065803|NCT00177671|588947351|FG001|Overall Study|Physician Decision|8|||
163065804|NCT00690898|588947352|FG000|SCREENING|Screen failure|18|||
163065805|NCT00690898|588947352|FG000|TREATMENT|Adverse Event|3|||
163065806|NCT00690898|588947352|FG000|TREATMENT|Lack of Efficacy|18|||
163065807|NCT00690898|588947352|FG000|TREATMENT|Withdrawal by Subject|4|||
163065808|NCT00690898|588947352|FG000|TREATMENT|Other (not otherwise specified)|1|||
163065809|NCT01121926|588947353|FG000|First Intervention Period|Adverse Event|1|||
163065810|NCT01121926|588947354|FG001|First Intervention Period|Adverse Event|0|||
163065811|NCT01121926|588947353|FG000|Washout Period|Adverse Event|0|||
163065812|NCT01121926|588947354|FG001|Washout Period|Adverse Event|1|||
163330760|NCT03362190|589920695|FG000|Overall Study|Adverse Event|0|||
163065813|NCT01121926|588947353|FG000|Washout Period|Positive pregnancy test|0|||
163065814|NCT01121926|588947354|FG001|Washout Period|Positive pregnancy test|1|||
163065815|NCT00356590|588947355|FG000|Overall Study|Adverse Event|54|||
163065816|NCT00356590|588947355|FG000|Overall Study|Death|10|||
163065817|NCT00356590|588947355|FG000|Overall Study|Lost to Follow-up|35|||
163065818|NCT00356590|588947355|FG000|Overall Study|Physician Decision|46|||
163065819|NCT00356590|588947355|FG000|Overall Study|Withdrawal by Subject|41|||
163330761|NCT03362190|589920696|FG001|Overall Study|Adverse Event|0|||
163330762|NCT03362190|589920697|FG002|Overall Study|Adverse Event|0|||
163065820|NCT00356590|588947355|FG000|Overall Study|Completed month 12 only|2|||
163065821|NCT00356590|588947355|FG000|Overall Study|Protocol issues|6|||
163065822|NCT00356590|588947355|FG000|Overall Study|Response status|28|||
163065823|NCT00356590|588947355|FG000|Overall Study|Other|52|||
163065824|NCT01496456|588947357|FG000|Overall Study|Protocol Violation|1|||
163065825|NCT01496456|588947357|FG000|Overall Study|Lost to Follow-up|7|||
163065826|NCT04919161|588947358|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
163065827|NCT04919161|588947359|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
163065828|NCT04919161|588947358|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
163065829|NCT04919161|588947359|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
163065830|NCT04919161|588947358|FG000|Overall Study|Acute ankle sprain after session 1|0|||
163065831|NCT04919161|588947359|FG001|Overall Study|Acute ankle sprain after session 1|1|||
163065832|NCT02175758|588947360|FG000|Treatment Phase|Lost to Follow-up|0|||
163065833|NCT02175758|588947361|FG001|Treatment Phase|Lost to Follow-up|1|||
163065834|NCT02175758|588947362|FG002|Treatment Phase|Lost to Follow-up|0|||
163065835|NCT02175758|588947363|FG003|Treatment Phase|Lost to Follow-up|0|||
163065836|NCT02175758|588947364|FG004|Treatment Phase|Lost to Follow-up|0|||
163065837|NCT02175758|588947365|FG005|Treatment Phase|Lost to Follow-up|0|||
163065838|NCT02175758|588947360|FG000|Treatment Phase|Adverse Event|0|||
163065839|NCT02175758|588947361|FG001|Treatment Phase|Adverse Event|0|||
163065840|NCT02175758|588947362|FG002|Treatment Phase|Adverse Event|0|||
163065841|NCT02175758|588947363|FG003|Treatment Phase|Adverse Event|0|||
163065842|NCT02175758|588947364|FG004|Treatment Phase|Adverse Event|1|||
163065843|NCT02175758|588947365|FG005|Treatment Phase|Adverse Event|0|||
163065844|NCT02489773|588947366|FG000|Overall Study|Lost to Follow-up|4|||
163065845|NCT02489773|588947367|FG001|Overall Study|Lost to Follow-up|1|||
163065846|NCT02489773|588947366|FG000|Overall Study|Physician Decision|1|||
163065847|NCT02489773|588947367|FG001|Overall Study|Physician Decision|0|||
163065848|NCT02489773|588947366|FG000|Overall Study|Withdrawal by Subject|1|||
163065849|NCT02489773|588947367|FG001|Overall Study|Withdrawal by Subject|0|||
163065850|NCT02489773|588947366|FG000|Overall Study|Leave the country or the state|1|||
163065851|NCT02489773|588947367|FG001|Overall Study|Leave the country or the state|1|||
163065852|NCT00712920|588947368|FG000|Overall Study|Adverse Event|3|||
163065853|NCT00712920|588947369|FG001|Overall Study|Adverse Event|4|||
163065854|NCT00712920|588947370|FG002|Overall Study|Adverse Event|7|||
163065855|NCT00712920|588947368|FG000|Overall Study|Withdrawal by Subject|4|||
163065856|NCT00712920|588947369|FG001|Overall Study|Withdrawal by Subject|2|||
163065857|NCT00712920|588947370|FG002|Overall Study|Withdrawal by Subject|1|||
163065858|NCT00712920|588947368|FG000|Overall Study|Lost to Follow-up|1|||
163065859|NCT00712920|588947369|FG001|Overall Study|Lost to Follow-up|4|||
163065860|NCT00712920|588947370|FG002|Overall Study|Lost to Follow-up|0|||
163065861|NCT00712920|588947368|FG000|Overall Study|Lack of Efficacy|1|||
163065862|NCT00712920|588947369|FG001|Overall Study|Lack of Efficacy|0|||
163065863|NCT00712920|588947370|FG002|Overall Study|Lack of Efficacy|1|||
163065864|NCT00712920|588947368|FG000|Overall Study|Other|5|||
163065865|NCT00712920|588947369|FG001|Overall Study|Other|7|||
163065866|NCT00712920|588947370|FG002|Overall Study|Other|3|||
163065867|NCT00712920|588947368|FG000|Overall Study|Non-compliance|3|||
163065868|NCT00712920|588947369|FG001|Overall Study|Non-compliance|0|||
163065869|NCT00712920|588947370|FG002|Overall Study|Non-compliance|0|||
163065870|NCT00620542|588947372|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
163065871|NCT00620542|588947373|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
163065872|NCT00620542|588947374|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
163065873|NCT00620542|588947375|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
163065874|NCT00620542|588947372|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
163065875|NCT00620542|588947373|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
163065876|NCT00620542|588947374|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
163065877|NCT00620542|588947375|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
163065878|NCT00620542|588947372|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
163065879|NCT00620542|588947373|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
163065880|NCT00620542|588947374|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
163065881|NCT00620542|588947375|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
163065882|NCT00620542|588947372|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
163065883|NCT00620542|588947373|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
163065884|NCT00620542|588947374|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
163065885|NCT00620542|588947375|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
163065886|NCT00620542|588947372|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
163065887|NCT00620542|588947373|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
163065888|NCT00620542|588947374|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
163065889|NCT00620542|588947375|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
163065890|NCT00620542|588947372|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
163065891|NCT00620542|588947373|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
163065892|NCT00620542|588947374|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
163065893|NCT00620542|588947375|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
163065894|NCT00620542|588947372|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
163065895|NCT00620542|588947373|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
163065896|NCT00620542|588947374|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
163065897|NCT00620542|588947375|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
163065898|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
163065899|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
163065900|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
163330763|NCT03362190|589920698|FG003|Overall Study|Adverse Event|1|||
163330764|NCT03362190|589920695|FG000|Overall Study|Withdrawal by Subject|0|||
163330765|NCT03362190|589920696|FG001|Overall Study|Withdrawal by Subject|0|||
163330766|NCT03362190|589920697|FG002|Overall Study|Withdrawal by Subject|0|||
163330767|NCT03362190|589920698|FG003|Overall Study|Withdrawal by Subject|1|||
163330768|NCT00687219|589920699|FG000|Overall Study|Adverse Event|8|||
163330769|NCT00687219|589920699|FG000|Overall Study|Discontinuance criteria met|7|||
163330770|NCT00687219|589920699|FG000|Overall Study|HCV-RNA positive conversion|34|||
163330771|NCT00687219|589920699|FG000|Overall Study|Withdrawal by Subject|1|||
163065901|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
163065902|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
163065903|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
163065904|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
163065905|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
163065906|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
163065907|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
163065908|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
163065909|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
163065910|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
163065911|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
163065912|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
163065913|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
163065914|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
163065915|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
163065916|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
163065917|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
163065918|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
163065919|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
163065920|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
163065921|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
163065922|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
163065923|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
163065924|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
163065925|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
163065926|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
163065927|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
163065928|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
163065929|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
163065930|NCT02550795|588947382|FG000|Overall Study|Physician Decision|0|||
163065931|NCT02550795|588947383|FG001|Overall Study|Physician Decision|1|||
163065932|NCT02550795|588947384|FG002|Overall Study|Physician Decision|0|||
163065933|NCT02225587|588947385|FG000|Overall Study|Adverse Event|5|||
163065934|NCT02225587|588947386|FG001|Overall Study|Adverse Event|5|||
163065935|NCT02225587|588947385|FG000|Overall Study|Lost to Follow-up|5|||
163065936|NCT02225587|588947386|FG001|Overall Study|Lost to Follow-up|5|||
163065937|NCT02225587|588947385|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163065938|NCT02225587|588947386|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163065939|NCT02225587|588947385|FG000|Overall Study|Physician Decision|2|||
163065940|NCT02225587|588947386|FG001|Overall Study|Physician Decision|0|||
163065941|NCT02225587|588947385|FG000|Overall Study|Protocol Violation|1|||
163065942|NCT02225587|588947386|FG001|Overall Study|Protocol Violation|0|||
163065943|NCT02225587|588947385|FG000|Overall Study|Participant Moved|1|||
163065944|NCT02225587|588947386|FG001|Overall Study|Participant Moved|0|||
163065945|NCT02225587|588947385|FG000|Overall Study|Withdrawal by Subject|13|||
163065946|NCT02225587|588947386|FG001|Overall Study|Withdrawal by Subject|28|||
163065947|NCT03483584|588947389|FG000|Overall Study|Lost to Follow-up|40|||
163065948|NCT03483584|588947390|FG001|Overall Study|Lost to Follow-up|7|||
163065949|NCT03483584|588947389|FG000|Overall Study|Withdrawal by Subject|4|||
163065950|NCT03483584|588947390|FG001|Overall Study|Withdrawal by Subject|1|||
163065951|NCT02879695|588947391|FG000|Overall Study|Did not start study treatment|2|||
163065952|NCT02879695|588947392|FG001|Overall Study|Did not start study treatment|0|||
163065953|NCT02879695|588947393|FG002|Overall Study|Did not start study treatment|3|||
163065954|NCT02879695|588947394|FG003|Overall Study|Did not start study treatment|0|||
163065955|NCT04063163|588947395|FG000|Overall Study|Death|281|||
163065956|NCT04063163|588947396|FG001|Overall Study|Death|166|||
163065957|NCT04063163|588947395|FG000|Overall Study|Lost to Follow-up|12|||
163065958|NCT04063163|588947396|FG001|Overall Study|Lost to Follow-up|8|||
163065959|NCT04063163|588947395|FG000|Overall Study|Withdrawal by Subject|19|||
163065960|NCT04063163|588947396|FG001|Overall Study|Withdrawal by Subject|10|||
163065961|NCT02572167|588947397|FG000|Overall Study|Withdrawal by Subject|0|||
163065962|NCT02572167|588947398|FG001|Overall Study|Withdrawal by Subject|3|||
163065963|NCT02572167|588947399|FG002|Overall Study|Withdrawal by Subject|0|||
163330772|NCT00687219|589920699|FG000|Overall Study|Lack of Efficacy|1|||
163065964|NCT02572167|588947397|FG000|Overall Study|Lost to Follow-up|2|||
163065965|NCT02572167|588947398|FG001|Overall Study|Lost to Follow-up|5|||
163065966|NCT02572167|588947399|FG002|Overall Study|Lost to Follow-up|3|||
163065967|NCT02572167|588947397|FG000|Overall Study|Death|0|||
163065968|NCT02572167|588947398|FG001|Overall Study|Death|8|||
163065969|NCT02572167|588947399|FG002|Overall Study|Death|3|||
163065970|NCT02572167|588947397|FG000|Overall Study|Did not meet inclusion criteria|0|||
163065971|NCT02572167|588947398|FG001|Overall Study|Did not meet inclusion criteria|0|||
163065972|NCT02572167|588947399|FG002|Overall Study|Did not meet inclusion criteria|1|||
163065973|NCT02572167|588947397|FG000|Overall Study|Study closure by Sponsor|4|||
163065974|NCT02572167|588947398|FG001|Overall Study|Study closure by Sponsor|40|||
163065975|NCT02572167|588947399|FG002|Overall Study|Study closure by Sponsor|24|||
163065976|NCT00005047|588947400|FG000|Overall Study|Withdrawal by Subject|12|||
163065977|NCT00005047|588947401|FG001|Overall Study|Withdrawal by Subject|0|||
163065978|NCT00005047|588947402|FG002|Overall Study|Withdrawal by Subject|0|||
163065979|NCT00005047|588947403|FG003|Overall Study|Withdrawal by Subject|0|||
163065980|NCT00005047|588947400|FG000|Overall Study|Adverse Event|5|||
163065981|NCT00005047|588947401|FG001|Overall Study|Adverse Event|0|||
163065982|NCT00005047|588947402|FG002|Overall Study|Adverse Event|0|||
163065983|NCT00005047|588947403|FG003|Overall Study|Adverse Event|0|||
163065984|NCT00005047|588947400|FG000|Overall Study|Lost to Follow-up|1|||
163065985|NCT00005047|588947401|FG001|Overall Study|Lost to Follow-up|0|||
163065986|NCT00005047|588947402|FG002|Overall Study|Lost to Follow-up|0|||
163065987|NCT00005047|588947403|FG003|Overall Study|Lost to Follow-up|0|||
163330776|NCT03102034|589920709|FG000|Overall Study|Withdrawal by Subject|1|||
163330777|NCT03102034|589920710|FG001|Overall Study|Withdrawal by Subject|0|||
163065988|NCT00005047|588947400|FG000|Overall Study|Lack of Efficacy|1|||
163065989|NCT00005047|588947401|FG001|Overall Study|Lack of Efficacy|0|||
163065990|NCT00005047|588947402|FG002|Overall Study|Lack of Efficacy|0|||
163065991|NCT00005047|588947403|FG003|Overall Study|Lack of Efficacy|0|||
163065992|NCT04435626|588947404|FG000|Overall Study|Lost to Follow-up|1|||
163065993|NCT04435626|588947405|FG001|Overall Study|Lost to Follow-up|5|||
163065994|NCT04435626|588947404|FG000|Overall Study|Withdrawal by Subject|6|||
163065995|NCT04435626|588947405|FG001|Overall Study|Withdrawal by Subject|7|||
163065996|NCT04435626|588947404|FG000|Overall Study|major GCP violations|8|||
163065997|NCT04435626|588947405|FG001|Overall Study|major GCP violations|7|||
163065998|NCT05248386|588947413|FG000|Overall Study|Technical problems|0|||
163065999|NCT05248386|588947414|FG001|Overall Study|Technical problems|1|||
163066000|NCT05248386|588947413|FG000|Overall Study|Withdrawal by Subject|15|||
163066001|NCT05248386|588947414|FG001|Overall Study|Withdrawal by Subject|10|||
163066002|NCT05248386|588947413|FG000|Overall Study|Physician Decision|0|||
163066003|NCT05248386|588947414|FG001|Overall Study|Physician Decision|1|||
163066004|NCT05248386|588947413|FG000|Overall Study|Adverse Event|2|||
163066005|NCT05248386|588947414|FG001|Overall Study|Adverse Event|4|||
163066006|NCT05248386|588947413|FG000|Overall Study|Other|1|||
163066007|NCT05248386|588947414|FG001|Overall Study|Other|0|||
163066008|NCT05248386|588947413|FG000|Overall Study|Lack of Efficacy|14|||
163066009|NCT05248386|588947414|FG001|Overall Study|Lack of Efficacy|12|||
163066010|NCT03036254|588947425|FG000|Overall Study|Adverse Event|6|||
163066011|NCT03036254|588947426|FG001|Overall Study|Adverse Event|4|||
163066012|NCT03036254|588947425|FG000|Overall Study|Death|3|||
163066013|NCT03036254|588947426|FG001|Overall Study|Death|1|||
163066014|NCT03036254|588947425|FG000|Overall Study|Lack of Efficacy|5|||
163066015|NCT03036254|588947426|FG001|Overall Study|Lack of Efficacy|1|||
163066016|NCT03036254|588947425|FG000|Overall Study|Withdrawal by Subject|3|||
163066017|NCT03036254|588947426|FG001|Overall Study|Withdrawal by Subject|5|||
163066018|NCT01802281|588947438|FG000|Overall Study|Death|1|||
163330778|NCT00676091|589920712|FG000|Infant Series|Parent or legal guardian request|10|||
163066019|NCT01802281|588947439|FG001|Overall Study|Death|2|||
163066020|NCT01802281|588947438|FG000|Overall Study|Withdrawal by Subject|2|||
163066021|NCT01802281|588947439|FG001|Overall Study|Withdrawal by Subject|1|||
163330779|NCT00676091|589920713|FG001|Infant Series|Parent or legal guardian request|8|||
163330780|NCT00676091|589920712|FG000|Infant Series|Protocol Violation|6|||
163330781|NCT00676091|589920713|FG001|Infant Series|Protocol Violation|3|||
163330782|NCT00676091|589920712|FG000|Infant Series|Adverse Event|2|||
163066022|NCT01802281|588947438|FG000|Overall Study|Ineligible|5|||
163066023|NCT01802281|588947439|FG001|Overall Study|Ineligible|3|||
163066024|NCT05523297|588947440|FG000|Overall Study|Death|7|||
163066025|NCT05523297|588947441|FG001|Overall Study|Death|8|||
163066026|NCT05523297|588947440|FG000|Overall Study|Lost to Follow-up|2|||
163066027|NCT05523297|588947441|FG001|Overall Study|Lost to Follow-up|1|||
163066028|NCT03168672|588947444|FG000|Overall Study|Withdrawal by Subject|13|||
163066029|NCT03168672|588947444|FG000|Overall Study|Death|3|||
163066030|NCT03168672|588947444|FG000|Overall Study|Investigator's Decision|137|||
163066031|NCT03168672|588947444|FG000|Overall Study|Adverse Event|1|||
163066032|NCT03168672|588947444|FG000|Overall Study|Other|2|||
163066033|NCT03168672|588947444|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
163066034|NCT00433537|588947445|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
163066035|NCT00433537|588947446|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
163066036|NCT00433537|588947447|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
163066037|NCT00433537|588947445|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
163066038|NCT00433537|588947446|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
163066039|NCT00433537|588947447|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
163066040|NCT00433537|588947445|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
163066041|NCT00433537|588947446|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
163066042|NCT00433537|588947447|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
163066043|NCT00433537|588947445|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
163066044|NCT00433537|588947446|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
163066045|NCT00433537|588947447|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
163066046|NCT00433537|588947445|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
163066047|NCT00433537|588947446|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
163066048|NCT00433537|588947447|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
163066049|NCT00433537|588947445|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
163066050|NCT00433537|588947446|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
163066051|NCT00433537|588947447|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
163066052|NCT00433537|588947445|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
163066053|NCT00433537|588947446|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
163066054|NCT00433537|588947447|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
163066055|NCT00433537|588947445|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
163066056|NCT00433537|588947446|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
163066057|NCT00433537|588947447|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
163066058|NCT00433537|588947445|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
163066059|NCT00433537|588947446|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
163066060|NCT00433537|588947447|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
163066061|NCT04556097|588947448|FG000|Overall Study|Death|0|||
163066062|NCT04556097|588947449|FG001|Overall Study|Death|5|||
163066063|NCT04556097|588947450|FG002|Overall Study|Death|0|||
163066064|NCT04556097|588947451|FG003|Overall Study|Death|0|||
163066065|NCT04556097|588947448|FG000|Overall Study|No caregiver|43|||
163066066|NCT04556097|588947449|FG001|Overall Study|No caregiver|53|||
163066067|NCT04556097|588947450|FG002|Overall Study|No caregiver|0|||
163066068|NCT04556097|588947451|FG003|Overall Study|No caregiver|0|||
163066069|NCT04556097|588947448|FG000|Overall Study|Ineligible, SNF|2|||
163066070|NCT04556097|588947449|FG001|Overall Study|Ineligible, SNF|2|||
163066071|NCT04556097|588947450|FG002|Overall Study|Ineligible, SNF|0|||
163066072|NCT04556097|588947451|FG003|Overall Study|Ineligible, SNF|0|||
163066073|NCT04556097|588947448|FG000|Overall Study|Ineligible, health|3|||
163330783|NCT00676091|589920713|FG001|Infant Series|Adverse Event|3|||
163330784|NCT00676091|589920712|FG000|Infant Series|Failed to return|1|||
163330785|NCT00676091|589920713|FG001|Infant Series|Failed to return|3|||
163330786|NCT00676091|589920712|FG000|Infant Series|Lost to Follow-up|1|||
163330787|NCT00676091|589920713|FG001|Infant Series|Lost to Follow-up|0|||
163330788|NCT00676091|589920712|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
163330789|NCT00676091|589920713|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
163330790|NCT00676091|589920712|FG000|After Infant Series|Adverse Event|0|||
163406363|NCT00401375|590196737|FG002|Overall Study|Other than specified|3|||
163066074|NCT04556097|588947449|FG001|Overall Study|Ineligible, health|4|||
163066075|NCT04556097|588947450|FG002|Overall Study|Ineligible, health|0|||
163066076|NCT04556097|588947451|FG003|Overall Study|Ineligible, health|0|||
163066077|NCT04556097|588947448|FG000|Overall Study|Ineligible, language|0|||
163066078|NCT04556097|588947449|FG001|Overall Study|Ineligible, language|1|||
163066079|NCT04556097|588947450|FG002|Overall Study|Ineligible, language|0|||
163066080|NCT04556097|588947451|FG003|Overall Study|Ineligible, language|0|||
163406364|NCT00401375|590196735|FG000|Overall Study|Randomized but not treated|3|||
163066081|NCT04556097|588947448|FG000|Overall Study|Ineligible, no longer in care management|0|||
163066082|NCT04556097|588947449|FG001|Overall Study|Ineligible, no longer in care management|2|||
163066083|NCT04556097|588947450|FG002|Overall Study|Ineligible, no longer in care management|1|||
163066084|NCT04556097|588947451|FG003|Overall Study|Ineligible, no longer in care management|0|||
163066085|NCT04556097|588947448|FG000|Overall Study|No dementia|13|||
163066086|NCT04556097|588947449|FG001|Overall Study|No dementia|3|||
163066087|NCT04556097|588947450|FG002|Overall Study|No dementia|0|||
163330791|NCT00676091|589920713|FG001|After Infant Series|Adverse Event|1|||
163330792|NCT00676091|589920712|FG000|After Infant Series|Protocol Violation|0|||
163066088|NCT04556097|588947451|FG003|Overall Study|No dementia|0|||
163066089|NCT04556097|588947448|FG000|Overall Study|Missing identifier|2|||
163066090|NCT04556097|588947449|FG001|Overall Study|Missing identifier|4|||
163066091|NCT04556097|588947450|FG002|Overall Study|Missing identifier|0|||
163066092|NCT04556097|588947451|FG003|Overall Study|Missing identifier|0|||
163066093|NCT04556097|588947448|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
163066094|NCT04556097|588947449|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
163066095|NCT04556097|588947450|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
163066096|NCT04556097|588947451|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
163066097|NCT05436613|588947452|FG000|Overall Study|Lost to Follow-up|9|||
163066098|NCT05436613|588947452|FG000|Overall Study|Withdrawal by Subject|3|||
163066099|NCT05317546|588947455|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
163066100|NCT05317546|588947456|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
163066101|NCT02555878|588947470|FG000|Overall Study|Lost to Follow-up|2|||
163066102|NCT02555878|588947471|FG001|Overall Study|Lost to Follow-up|3|||
163066103|NCT02555878|588947470|FG000|Overall Study|Withdrawal by Subject|48|||
163066104|NCT02555878|588947471|FG001|Overall Study|Withdrawal by Subject|48|||
163066105|NCT02555878|588947470|FG000|Overall Study|Adverse Event|12|||
163066106|NCT02555878|588947471|FG001|Overall Study|Adverse Event|8|||
163066107|NCT02555878|588947470|FG000|Overall Study|Death|74|||
163066108|NCT02555878|588947471|FG001|Overall Study|Death|59|||
163066109|NCT02555878|588947470|FG000|Overall Study|Protocol Violation|1|||
163066110|NCT02555878|588947471|FG001|Overall Study|Protocol Violation|2|||
163066111|NCT02555878|588947470|FG000|Overall Study|Physician Decision|12|||
163066112|NCT02555878|588947471|FG001|Overall Study|Physician Decision|13|||
163066113|NCT02555878|588947470|FG000|Overall Study|Other|17|||
163066114|NCT02555878|588947471|FG001|Overall Study|Other|17|||
163066115|NCT00765076|588947472|FG000|Overall Study|Adverse Event|1|||
163066116|NCT00765076|588947473|FG001|Overall Study|Adverse Event|0|||
163066117|NCT00765076|588947474|FG002|Overall Study|Adverse Event|0|||
163066118|NCT00765076|588947472|FG000|Overall Study|Withdrawal by Subject|0|||
163066119|NCT00765076|588947473|FG001|Overall Study|Withdrawal by Subject|0|||
163066120|NCT00765076|588947474|FG002|Overall Study|Withdrawal by Subject|1|||
163066121|NCT01164475|588947475|FG000|Overall Study|Lack of Efficacy|1|||
163066122|NCT01164475|588947476|FG001|Overall Study|Lack of Efficacy|0|||
163066123|NCT01164475|588947475|FG000|Overall Study|Other|0|||
163066124|NCT01164475|588947476|FG001|Overall Study|Other|1|||
163066125|NCT01164475|588947475|FG000|Overall Study|Progressive disease|0|||
163066126|NCT01164475|588947476|FG001|Overall Study|Progressive disease|1|||
163066127|NCT01164475|588947475|FG000|Overall Study|Protocol Violation|1|||
163066128|NCT01164475|588947476|FG001|Overall Study|Protocol Violation|0|||
163066129|NCT02335944|588947477|FG000|Treatment Phase|Progressive Disease|2|||
163066130|NCT02335944|588947478|FG001|Treatment Phase|Progressive Disease|5|||
163066131|NCT02335944|588947479|FG002|Treatment Phase|Progressive Disease|2|||
163066132|NCT02335944|588947480|FG003|Treatment Phase|Progressive Disease|11|||
163066133|NCT02335944|588947481|FG004|Treatment Phase|Progressive Disease|4|||
163066134|NCT02335944|588947482|FG005|Treatment Phase|Progressive Disease|25|||
163066135|NCT02335944|588947483|FG006|Treatment Phase|Progressive Disease|2|||
163066136|NCT02335944|588947484|FG007|Treatment Phase|Progressive Disease|30|||
163066137|NCT02335944|588947485|FG008|Treatment Phase|Progressive Disease|27|||
163066138|NCT02335944|588947486|FG009|Treatment Phase|Progressive Disease|0|||
163066139|NCT02335944|588947477|FG000|Treatment Phase|Adverse Event|2|||
163066140|NCT02335944|588947478|FG001|Treatment Phase|Adverse Event|0|||
163066141|NCT02335944|588947479|FG002|Treatment Phase|Adverse Event|0|||
163066142|NCT02335944|588947480|FG003|Treatment Phase|Adverse Event|2|||
163066143|NCT02335944|588947481|FG004|Treatment Phase|Adverse Event|1|||
163066144|NCT02335944|588947482|FG005|Treatment Phase|Adverse Event|15|||
163066145|NCT02335944|588947483|FG006|Treatment Phase|Adverse Event|0|||
163066146|NCT02335944|588947484|FG007|Treatment Phase|Adverse Event|5|||
163066147|NCT02335944|588947485|FG008|Treatment Phase|Adverse Event|7|||
163066148|NCT02335944|588947486|FG009|Treatment Phase|Adverse Event|0|||
163066149|NCT02335944|588947477|FG000|Treatment Phase|Physician Decision|0|||
163066150|NCT02335944|588947478|FG001|Treatment Phase|Physician Decision|0|||
163066151|NCT02335944|588947479|FG002|Treatment Phase|Physician Decision|0|||
163066152|NCT02335944|588947480|FG003|Treatment Phase|Physician Decision|1|||
163066153|NCT02335944|588947481|FG004|Treatment Phase|Physician Decision|0|||
163066154|NCT02335944|588947482|FG005|Treatment Phase|Physician Decision|6|||
163066155|NCT02335944|588947483|FG006|Treatment Phase|Physician Decision|1|||
163066156|NCT02335944|588947484|FG007|Treatment Phase|Physician Decision|2|||
163066157|NCT02335944|588947485|FG008|Treatment Phase|Physician Decision|1|||
163066158|NCT02335944|588947486|FG009|Treatment Phase|Physician Decision|0|||
163066159|NCT02335944|588947477|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
163330793|NCT00676091|589920713|FG001|After Infant Series|Protocol Violation|1|||
163330794|NCT00676091|589920712|FG000|After Infant Series|Failed to return|1|||
163066160|NCT02335944|588947478|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
163330795|NCT00676091|589920713|FG001|After Infant Series|Failed to return|1|||
163066161|NCT02335944|588947479|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
163066162|NCT02335944|588947480|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
163330796|NCT00676091|589920712|FG000|Toddler Dose|Failed to return|2|||
163066163|NCT02335944|588947481|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
163066164|NCT02335944|588947482|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
163066165|NCT02335944|588947483|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
163066166|NCT02335944|588947484|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
163066167|NCT02335944|588947485|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
163066168|NCT02335944|588947486|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
163066169|NCT02335944|588947477|FG000|Treatment Phase|Subject/Guardian Decision|0|||
163066170|NCT02335944|588947478|FG001|Treatment Phase|Subject/Guardian Decision|0|||
163066171|NCT02335944|588947479|FG002|Treatment Phase|Subject/Guardian Decision|1|||
163066172|NCT02335944|588947480|FG003|Treatment Phase|Subject/Guardian Decision|0|||
163066173|NCT02335944|588947481|FG004|Treatment Phase|Subject/Guardian Decision|0|||
163066174|NCT02335944|588947482|FG005|Treatment Phase|Subject/Guardian Decision|1|||
163066175|NCT02335944|588947483|FG006|Treatment Phase|Subject/Guardian Decision|0|||
163066176|NCT02335944|588947484|FG007|Treatment Phase|Subject/Guardian Decision|4|||
163066177|NCT02335944|588947485|FG008|Treatment Phase|Subject/Guardian Decision|0|||
163066178|NCT02335944|588947486|FG009|Treatment Phase|Subject/Guardian Decision|0|||
163066179|NCT02335944|588947477|FG000|Post-treatment Follow-up|Progressive Disease|0|||
163066180|NCT02335944|588947478|FG001|Post-treatment Follow-up|Progressive Disease|0|||
163066181|NCT02335944|588947479|FG002|Post-treatment Follow-up|Progressive Disease|0|||
163066182|NCT02335944|588947480|FG003|Post-treatment Follow-up|Progressive Disease|1|||
163066183|NCT02335944|588947481|FG004|Post-treatment Follow-up|Progressive Disease|0|||
163066184|NCT02335944|588947482|FG005|Post-treatment Follow-up|Progressive Disease|9|||
163066185|NCT02335944|588947483|FG006|Post-treatment Follow-up|Progressive Disease|0|||
163066186|NCT02335944|588947484|FG007|Post-treatment Follow-up|Progressive Disease|2|||
163066187|NCT02335944|588947485|FG008|Post-treatment Follow-up|Progressive Disease|3|||
163066188|NCT02335944|588947486|FG009|Post-treatment Follow-up|Progressive Disease|0|||
163066189|NCT02335944|588947477|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066190|NCT02335944|588947478|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066191|NCT02335944|588947479|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066192|NCT02335944|588947480|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066193|NCT02335944|588947481|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066194|NCT02335944|588947482|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
163066195|NCT02335944|588947483|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066196|NCT02335944|588947484|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066197|NCT02335944|588947485|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066198|NCT02335944|588947486|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066199|NCT02335944|588947477|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066200|NCT02335944|588947478|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066201|NCT02335944|588947479|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066202|NCT02335944|588947480|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066203|NCT02335944|588947481|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066204|NCT02335944|588947482|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066205|NCT02335944|588947483|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066206|NCT02335944|588947484|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
163066207|NCT02335944|588947485|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066208|NCT02335944|588947486|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066209|NCT02335944|588947477|FG000|Post-treatment Follow-up|Adverse Event|0|||
163066210|NCT02335944|588947478|FG001|Post-treatment Follow-up|Adverse Event|0|||
163066211|NCT02335944|588947479|FG002|Post-treatment Follow-up|Adverse Event|0|||
163066212|NCT02335944|588947480|FG003|Post-treatment Follow-up|Adverse Event|0|||
163066213|NCT02335944|588947481|FG004|Post-treatment Follow-up|Adverse Event|0|||
163066214|NCT02335944|588947482|FG005|Post-treatment Follow-up|Adverse Event|1|||
163066215|NCT02335944|588947483|FG006|Post-treatment Follow-up|Adverse Event|0|||
163066216|NCT02335944|588947484|FG007|Post-treatment Follow-up|Adverse Event|0|||
163066217|NCT02335944|588947485|FG008|Post-treatment Follow-up|Adverse Event|0|||
163066218|NCT02335944|588947486|FG009|Post-treatment Follow-up|Adverse Event|0|||
163066219|NCT02335944|588947477|FG000|Post-treatment Follow-up|Death|0|||
163066220|NCT02335944|588947478|FG001|Post-treatment Follow-up|Death|0|||
163066221|NCT02335944|588947479|FG002|Post-treatment Follow-up|Death|0|||
163066222|NCT02335944|588947480|FG003|Post-treatment Follow-up|Death|1|||
163066223|NCT02335944|588947481|FG004|Post-treatment Follow-up|Death|0|||
163066224|NCT02335944|588947482|FG005|Post-treatment Follow-up|Death|1|||
163066225|NCT02335944|588947483|FG006|Post-treatment Follow-up|Death|0|||
163066226|NCT02335944|588947484|FG007|Post-treatment Follow-up|Death|0|||
163066227|NCT02335944|588947485|FG008|Post-treatment Follow-up|Death|0|||
163066228|NCT02335944|588947486|FG009|Post-treatment Follow-up|Death|0|||
163066229|NCT02335944|588947477|FG000|Post-treatment Follow-up|Physician Decision|1|||
163066230|NCT02335944|588947478|FG001|Post-treatment Follow-up|Physician Decision|0|||
163066231|NCT02335944|588947479|FG002|Post-treatment Follow-up|Physician Decision|0|||
163066232|NCT02335944|588947480|FG003|Post-treatment Follow-up|Physician Decision|0|||
163066233|NCT02335944|588947481|FG004|Post-treatment Follow-up|Physician Decision|0|||
163066234|NCT02335944|588947482|FG005|Post-treatment Follow-up|Physician Decision|0|||
163066235|NCT02335944|588947483|FG006|Post-treatment Follow-up|Physician Decision|0|||
163066236|NCT02335944|588947484|FG007|Post-treatment Follow-up|Physician Decision|1|||
163066237|NCT02335944|588947485|FG008|Post-treatment Follow-up|Physician Decision|0|||
163217683|NCT00798369|589513766|FG000|Overall Study|Lost to Follow-up|1|||
163217684|NCT00798369|589513767|FG001|Overall Study|Lost to Follow-up|1|||
163217685|NCT00798369|589513768|FG002|Overall Study|Lost to Follow-up|1|||
163066238|NCT02335944|588947486|FG009|Post-treatment Follow-up|Physician Decision|0|||
163066239|NCT00832975|588947487|FG000|Overall Study|Lost to Follow-up|7|||
163066240|NCT00832975|588947487|FG000|Overall Study|Protocol Violation|6|||
163066241|NCT00832975|588947487|FG000|Overall Study|Death|5|||
163066242|NCT00832975|588947487|FG000|Overall Study|Physician Decision|4|||
163066243|NCT00832975|588947487|FG000|Overall Study|Withdrawal by Subject|3|||
163066244|NCT00832975|588947487|FG000|Overall Study|Other reasons|14|||
163066245|NCT06081829|588947490|FG000|Overall Study|Participants still on-study|8|||
163066246|NCT06081829|588947490|FG000|Overall Study|Death|4|||
163066247|NCT04835441|588947491|FG000|Overall Study|Physician Decision|4|||
163066248|NCT04835441|588947492|FG001|Overall Study|Physician Decision|4|||
163066249|NCT04835441|588947491|FG000|Overall Study|Other|1|||
163066250|NCT04835441|588947492|FG001|Overall Study|Other|1|||
163066251|NCT04835441|588947491|FG000|Overall Study|Lost to Follow-up|0|||
163066252|NCT04835441|588947492|FG001|Overall Study|Lost to Follow-up|1|||
163066253|NCT02293499|588948412|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
163066254|NCT02293499|588948413|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
163066255|NCT02293499|588948414|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
163066256|NCT02293499|588948412|FG000|Intervention - Camp|Withdrawal by Subject|3|||
163066257|NCT02293499|588948413|FG001|Intervention - Camp|Withdrawal by Subject|6|||
163066258|NCT02293499|588948414|FG002|Intervention - Camp|Withdrawal by Subject|2|||
163066259|NCT02293499|588948412|FG000|Intervention - Camp|these are those not showing up at camp|24|||
163066260|NCT02293499|588948413|FG001|Intervention - Camp|these are those not showing up at camp|28|||
163066261|NCT02293499|588948414|FG002|Intervention - Camp|these are those not showing up at camp|4|||
163066262|NCT02293499|588948412|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
163066263|NCT02293499|588948413|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
163066264|NCT02293499|588948414|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
163066265|NCT02293499|588948412|FG000|3 Month Follow Up|Lost to Follow-up|14|||
163066266|NCT02293499|588948413|FG001|3 Month Follow Up|Lost to Follow-up|15|||
163066267|NCT02293499|588948414|FG002|3 Month Follow Up|Lost to Follow-up|6|||
163066268|NCT02293499|588948412|FG000|6 Month Follow Up|Lost to Follow-up|17|||
163066269|NCT02293499|588948413|FG001|6 Month Follow Up|Lost to Follow-up|27|||
163066270|NCT02293499|588948414|FG002|6 Month Follow Up|Lost to Follow-up|6|||
163066271|NCT02293499|588948412|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
163066272|NCT02293499|588948413|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
163066273|NCT02293499|588948414|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
163066274|NCT02293499|588948412|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
163066275|NCT02293499|588948413|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
163066276|NCT02293499|588948414|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
163066277|NCT02293499|588948412|FG000|9 Month Follow Up|Lost to Follow-up|24|||
163066278|NCT02293499|588948413|FG001|9 Month Follow Up|Lost to Follow-up|28|||
163066279|NCT02293499|588948414|FG002|9 Month Follow Up|Lost to Follow-up|4|||
163066280|NCT02293499|588948412|FG000|12 Month Follow Up|Lost to Follow-up|26|||
163066281|NCT02293499|588948413|FG001|12 Month Follow Up|Lost to Follow-up|25|||
163066282|NCT02293499|588948414|FG002|12 Month Follow Up|Lost to Follow-up|6|||
163066283|NCT02293499|588948412|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
163066284|NCT02293499|588948413|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
163066285|NCT02293499|588948414|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
163066286|NCT02293499|588948412|FG000|15 Month Follow Up|Lost to Follow-up|22|||
163066287|NCT02293499|588948413|FG001|15 Month Follow Up|Lost to Follow-up|22|||
163066288|NCT02293499|588948414|FG002|15 Month Follow Up|Lost to Follow-up|7|||
163066289|NCT03915067|588948415|FG000|Overall Study|Adverse Event|0|||
163066290|NCT03915067|588948416|FG001|Overall Study|Adverse Event|0|||
163066291|NCT03915067|588948417|FG002|Overall Study|Adverse Event|1|||
163066292|NCT03915067|588948415|FG000|Overall Study|Withdrawal by Subject|4|||
163066293|NCT03915067|588948416|FG001|Overall Study|Withdrawal by Subject|3|||
163066294|NCT03915067|588948417|FG002|Overall Study|Withdrawal by Subject|0|||
163066295|NCT03915067|588948415|FG000|Overall Study|Lost to Follow-up|3|||
163066296|NCT03915067|588948416|FG001|Overall Study|Lost to Follow-up|2|||
163066297|NCT03915067|588948417|FG002|Overall Study|Lost to Follow-up|0|||
163066298|NCT03915067|588948415|FG000|Overall Study|Protocol Deviation|0|||
163066299|NCT03915067|588948416|FG001|Overall Study|Protocol Deviation|0|||
163330797|NCT00676091|589920713|FG001|Toddler Dose|Failed to return|0|||
163066300|NCT03915067|588948417|FG002|Overall Study|Protocol Deviation|1|||
163066301|NCT03915067|588948415|FG000|Overall Study|Covid-19 Related Issues|2|||
163330798|NCT00676091|589920712|FG000|Toddler Dose|Parent or legal guardian request|1|||
163330799|NCT00676091|589920713|FG001|Toddler Dose|Parent or legal guardian request|0|||
163330800|NCT00989196|589920719|FG000|Treatment Period|Lost to Follow-up|1|||
163066302|NCT03915067|588948416|FG001|Overall Study|Covid-19 Related Issues|4|||
163066303|NCT03915067|588948417|FG002|Overall Study|Covid-19 Related Issues|4|||
163066304|NCT03915067|588948415|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
163066305|NCT03915067|588948416|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
163066306|NCT03915067|588948417|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
163066307|NCT03317496|588948418|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
163330801|NCT00989196|589920720|FG001|Treatment Period|Lost to Follow-up|0|||
163066308|NCT03317496|588948419|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
163066309|NCT03317496|588948420|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
163066310|NCT03317496|588948421|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
163066311|NCT03317496|588948422|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
163066312|NCT03317496|588948418|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
163066313|NCT03317496|588948419|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
163066314|NCT03317496|588948420|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
163066315|NCT03317496|588948421|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
163066316|NCT03317496|588948422|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
163066317|NCT03317496|588948418|FG000|Phase 1b Lead-in: Treatment|Death|0|||
163066318|NCT03317496|588948419|FG001|Phase 1b Lead-in: Treatment|Death|0|||
163066319|NCT03317496|588948420|FG002|Phase 1b Lead-in: Treatment|Death|1|||
163066320|NCT03317496|588948421|FG003|Phase 1b Lead-in: Treatment|Death|0|||
163066321|NCT03317496|588948422|FG004|Phase 1b Lead-in: Treatment|Death|0|||
163066322|NCT03317496|588948418|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
163066323|NCT03317496|588948419|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
163066324|NCT03317496|588948420|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
163066325|NCT03317496|588948421|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
163066326|NCT03317496|588948422|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
163066327|NCT03317496|588948418|FG000|Phase 1b Lead-in: Treatment|Other|2|||
163066328|NCT03317496|588948419|FG001|Phase 1b Lead-in: Treatment|Other|1|||
163066329|NCT03317496|588948420|FG002|Phase 1b Lead-in: Treatment|Other|0|||
163066330|NCT03317496|588948421|FG003|Phase 1b Lead-in: Treatment|Other|0|||
163066331|NCT03317496|588948422|FG004|Phase 1b Lead-in: Treatment|Other|0|||
163066332|NCT03317496|588948418|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
163066333|NCT03317496|588948419|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
163066334|NCT03317496|588948420|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
163066335|NCT03317496|588948421|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
163066336|NCT03317496|588948422|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
163066337|NCT03317496|588948418|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
163066338|NCT03317496|588948419|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
163066339|NCT03317496|588948420|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
163066340|NCT03317496|588948421|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
163066341|NCT03317496|588948422|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
163066342|NCT03317496|588948418|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
163066343|NCT03317496|588948419|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
163066344|NCT03317496|588948420|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
163066345|NCT03317496|588948421|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
163066346|NCT03317496|588948422|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
163066347|NCT03317496|588948418|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
163066348|NCT03317496|588948419|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
163066349|NCT03317496|588948420|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
163066350|NCT03317496|588948421|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
163066351|NCT03317496|588948422|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
163066352|NCT03317496|588948418|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
163066353|NCT03317496|588948419|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
163066354|NCT03317496|588948420|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
163066355|NCT03317496|588948421|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
163066356|NCT03317496|588948422|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
163066357|NCT03317496|588948418|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
163066358|NCT03317496|588948419|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
163066359|NCT03317496|588948420|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
163066360|NCT03317496|588948421|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
163066361|NCT03317496|588948422|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
163066362|NCT03317496|588948418|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
163066363|NCT03317496|588948419|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
163066364|NCT03317496|588948420|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
163066365|NCT03317496|588948421|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
163066366|NCT03317496|588948422|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
163066367|NCT03317496|588948418|FG000|Phase 2: Treatment|Adverse Event|0|||
163330802|NCT04300023|589920723|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
163330803|NCT04300023|589920724|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
163066368|NCT03317496|588948419|FG001|Phase 2: Treatment|Adverse Event|0|||
163066369|NCT03317496|588948420|FG002|Phase 2: Treatment|Adverse Event|0|||
163066370|NCT03317496|588948421|FG003|Phase 2: Treatment|Adverse Event|0|||
163066371|NCT03317496|588948422|FG004|Phase 2: Treatment|Adverse Event|6|||
163066372|NCT03317496|588948418|FG000|Phase 2: Treatment|Progressive disease|0|||
163066373|NCT03317496|588948419|FG001|Phase 2: Treatment|Progressive disease|0|||
163066374|NCT03317496|588948420|FG002|Phase 2: Treatment|Progressive disease|0|||
163330804|NCT05251363|589920725|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
163330805|NCT05251363|589920725|FG000|Overall Study After Implant Period|Death|9|||
163066375|NCT03317496|588948421|FG003|Phase 2: Treatment|Progressive disease|0|||
163066376|NCT03317496|588948422|FG004|Phase 2: Treatment|Progressive disease|22|||
163066377|NCT03317496|588948418|FG000|Phase 2: Treatment|Other|0|||
163066378|NCT03317496|588948419|FG001|Phase 2: Treatment|Other|0|||
163066379|NCT03317496|588948420|FG002|Phase 2: Treatment|Other|0|||
163066380|NCT03317496|588948421|FG003|Phase 2: Treatment|Other|0|||
163066381|NCT03317496|588948422|FG004|Phase 2: Treatment|Other|4|||
163066382|NCT03317496|588948418|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
163066383|NCT03317496|588948419|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
163066384|NCT03317496|588948420|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
163066385|NCT03317496|588948421|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
163066386|NCT03317496|588948422|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
163066387|NCT03317496|588948418|FG000|Phase 2: Treatment|Physician Decision|0|||
163066388|NCT03317496|588948419|FG001|Phase 2: Treatment|Physician Decision|0|||
163066389|NCT03317496|588948420|FG002|Phase 2: Treatment|Physician Decision|0|||
163066390|NCT03317496|588948421|FG003|Phase 2: Treatment|Physician Decision|0|||
163066391|NCT03317496|588948422|FG004|Phase 2: Treatment|Physician Decision|1|||
163066392|NCT03317496|588948418|FG000|Phase 2: Treatment|Death|0|||
163066393|NCT03317496|588948419|FG001|Phase 2: Treatment|Death|0|||
163066394|NCT03317496|588948420|FG002|Phase 2: Treatment|Death|0|||
163066395|NCT03317496|588948421|FG003|Phase 2: Treatment|Death|0|||
163066396|NCT03317496|588948422|FG004|Phase 2: Treatment|Death|1|||
163066397|NCT03317496|588948418|FG000|Phase 2: Follow-up|Death|0|||
163066398|NCT03317496|588948419|FG001|Phase 2: Follow-up|Death|0|||
163066399|NCT03317496|588948420|FG002|Phase 2: Follow-up|Death|0|||
163066400|NCT03317496|588948421|FG003|Phase 2: Follow-up|Death|0|||
163066401|NCT03317496|588948422|FG004|Phase 2: Follow-up|Death|24|||
163066402|NCT03317496|588948418|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
163066403|NCT03317496|588948419|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
163066404|NCT03317496|588948420|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
163066405|NCT03317496|588948421|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
163066406|NCT03317496|588948422|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
163066407|NCT03317496|588948418|FG000|Phase 2: Follow-up|Other|0|||
163066408|NCT03317496|588948419|FG001|Phase 2: Follow-up|Other|0|||
163066409|NCT03317496|588948420|FG002|Phase 2: Follow-up|Other|0|||
163066410|NCT03317496|588948421|FG003|Phase 2: Follow-up|Other|0|||
163066411|NCT03317496|588948422|FG004|Phase 2: Follow-up|Other|1|||
163066412|NCT03317496|588948418|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
163066413|NCT03317496|588948419|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
163066414|NCT03317496|588948420|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
163066415|NCT03317496|588948421|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
163066416|NCT03317496|588948422|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
163066417|NCT02693418|588948423|FG000|Overall Study|Lost to Follow-up|1|||
163066418|NCT02693418|588948424|FG001|Overall Study|Lost to Follow-up|2|||
163066419|NCT02693418|588948425|FG002|Overall Study|Lost to Follow-up|0|||
163066420|NCT02693418|588948426|FG003|Overall Study|Lost to Follow-up|0|||
163066421|NCT02693418|588948427|FG004|Overall Study|Lost to Follow-up|0|||
163066422|NCT02693418|588948423|FG000|Overall Study|Menses during study period|0|||
163066423|NCT02693418|588948424|FG001|Overall Study|Menses during study period|0|||
163066424|NCT02693418|588948425|FG002|Overall Study|Menses during study period|2|||
163066425|NCT02693418|588948426|FG003|Overall Study|Menses during study period|0|||
163066426|NCT02693418|588948427|FG004|Overall Study|Menses during study period|0|||
163066427|NCT01750346|588948428|FG000|Overall Study|Adverse Event|1|||
163066428|NCT01750346|588948429|FG001|Overall Study|Adverse Event|0|||
163066429|NCT01750346|588948430|FG002|Overall Study|Adverse Event|0|||
163066430|NCT01001104|588948433|FG000|Overall Study|Adverse Event|2|||
163066431|NCT01001104|588948434|FG001|Overall Study|Adverse Event|1|||
163066432|NCT01001104|588948435|FG002|Overall Study|Adverse Event|0|||
163066433|NCT01001104|588948436|FG003|Overall Study|Adverse Event|0|||
163066434|NCT01001104|588948433|FG000|Overall Study|Lost to Follow-up|0|||
163066435|NCT01001104|588948434|FG001|Overall Study|Lost to Follow-up|0|||
163066436|NCT01001104|588948435|FG002|Overall Study|Lost to Follow-up|1|||
163066437|NCT01001104|588948436|FG003|Overall Study|Lost to Follow-up|0|||
163066438|NCT01001104|588948433|FG000|Overall Study|Entry Criteria Not Met|0|||
163066439|NCT01001104|588948434|FG001|Overall Study|Entry Criteria Not Met|0|||
163066440|NCT01001104|588948435|FG002|Overall Study|Entry Criteria Not Met|0|||
163066441|NCT01001104|588948436|FG003|Overall Study|Entry Criteria Not Met|1|||
163217686|NCT00798369|589513769|FG003|Overall Study|Lost to Follow-up|0|||
163217687|NCT00798369|589513770|FG004|Overall Study|Lost to Follow-up|1|||
163066442|NCT01001104|588948433|FG000|Overall Study|Withdrawal by Subject|0|||
163066443|NCT01001104|588948434|FG001|Overall Study|Withdrawal by Subject|0|||
163066444|NCT01001104|588948435|FG002|Overall Study|Withdrawal by Subject|0|||
163217688|NCT00798369|589513771|FG005|Overall Study|Lost to Follow-up|0|||
163066445|NCT01001104|588948436|FG003|Overall Study|Withdrawal by Subject|2|||
163066446|NCT02034591|588948437|FG000|Overall Study|Withdrawal by Subject|0|||
163066447|NCT02034591|588948438|FG001|Overall Study|Withdrawal by Subject|0|||
163217689|NCT00798369|589513766|FG000|Overall Study|Adminstrative problems|0|||
163217690|NCT00798369|589513767|FG001|Overall Study|Adminstrative problems|0|||
163217691|NCT00798369|589513768|FG002|Overall Study|Adminstrative problems|0|||
163330806|NCT05251363|589920725|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
163330807|NCT05251363|589920725|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
163025758|NCT02235077|588794667|FG000|Overall Study|Withdrawal by Subject|8|||
163025759|NCT02235077|588794668|FG001|Overall Study|Withdrawal by Subject|5|||
163025760|NCT02235077|588794667|FG000|Overall Study|Physician Decision|0|||
163025761|NCT02235077|588794668|FG001|Overall Study|Physician Decision|1|||
163025762|NCT03852628|588794669|FG000|Overall Study|Lost to Follow-up|7|||
163025763|NCT03852628|588794670|FG001|Overall Study|Lost to Follow-up|6|||
163025764|NCT03852628|588794669|FG000|Overall Study|Lack of Efficacy|6|||
163025765|NCT03852628|588794670|FG001|Overall Study|Lack of Efficacy|6|||
163025766|NCT00325156|588794676|FG000|Overall Study|Protocol Violation|8|||
163025767|NCT00325156|588794676|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
163025768|NCT00325156|588794676|FG000|Overall Study|Migrated/moved from study area|12|||
163025769|NCT00325156|588794676|FG000|Overall Study|Adverse event, non-fatal|3|||
163025770|NCT00325156|588794676|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
163025771|NCT00325156|588794676|FG000|Overall Study|Other|1|||
163025772|NCT00325156|588794676|FG000|Overall Study|Withdrawal by Subject|31|||
163025773|NCT04064411|588794677|FG000|Overall Study|Adverse Event|29|||
163025774|NCT04064411|588794678|FG001|Overall Study|Adverse Event|19|||
163025775|NCT04064411|588794677|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
163025776|NCT04064411|588794678|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
163025777|NCT04064411|588794677|FG000|Overall Study|Protocol Deviation|0|||
163025778|NCT04064411|588794678|FG001|Overall Study|Protocol Deviation|2|||
163025779|NCT04064411|588794677|FG000|Overall Study|Withdrawal by Subject|25|||
163025780|NCT04064411|588794678|FG001|Overall Study|Withdrawal by Subject|29|||
163025781|NCT04064411|588794677|FG000|Overall Study|Lost to Follow-up|5|||
163025782|NCT04064411|588794678|FG001|Overall Study|Lost to Follow-up|2|||
163025783|NCT04064411|588794677|FG000|Overall Study|Other than Specified|4|||
163025784|NCT04064411|588794678|FG001|Overall Study|Other than Specified|1|||
163025785|NCT04064411|588794677|FG000|Overall Study|Death|1|||
163025786|NCT04064411|588794678|FG001|Overall Study|Death|0|||
163025787|NCT03512210|588794680|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
163025788|NCT03512210|588794680|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
163025789|NCT03512210|588794680|FG000|Step 2:Post-MINMON|Death|2|||
163025790|NCT03512210|588794680|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
163025791|NCT03512210|588794680|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
163025792|NCT01672710|588794681|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
163025793|NCT01672710|588794682|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
163025794|NCT01672710|588794681|FG000|3 Month Follow up|Lost to Follow-up|2|||
163025795|NCT01672710|588794682|FG001|3 Month Follow up|Lost to Follow-up|3|||
163025796|NCT01672710|588794681|FG000|3 Month Follow up|follow up due after termination date|4|||
163025797|NCT01672710|588794682|FG001|3 Month Follow up|follow up due after termination date|1|||
163025798|NCT03725761|588794683|FG000|Overall Study|still on study|1|||
163025799|NCT05239494|588797113|FG000|Overall Study|Lost to Follow-up|1|||
163025800|NCT02855359|588797114|FG000|Overall Study|Death|2|||
163025801|NCT02855359|588797115|FG001|Overall Study|Death|2|||
163025802|NCT02855359|588797116|FG002|Overall Study|Death|0|||
163025803|NCT02855359|588797117|FG003|Overall Study|Death|0|||
163025804|NCT02855359|588797114|FG000|Overall Study|Study Termination by Sponsor|9|||
163025805|NCT02855359|588797115|FG001|Overall Study|Study Termination by Sponsor|11|||
163025806|NCT02855359|588797116|FG002|Overall Study|Study Termination by Sponsor|0|||
163025807|NCT02855359|588797117|FG003|Overall Study|Study Termination by Sponsor|0|||
163025808|NCT03155178|588797118|FG000|Overall Study|Did not meet treatment day baseline|7|||
163025809|NCT03155178|588797119|FG001|Overall Study|Did not meet treatment day baseline|7|||
163025810|NCT03155178|588797120|FG002|Overall Study|Did not meet treatment day baseline|7|||
163025811|NCT03155178|588797121|FG003|Overall Study|Did not meet treatment day baseline|7|||
163025812|NCT02677038|588797126|FG000|Overall Study|Physician Decision|1|||
163025813|NCT02677038|588797126|FG000|Overall Study|Withdrawal by Subject|1|||
163025814|NCT02777970|588797131|FG000|Overall Study|Lost to Follow-up|0|||
163025815|NCT02777970|588797132|FG001|Overall Study|Lost to Follow-up|1|||
163025816|NCT02777970|588797133|FG002|Overall Study|Lost to Follow-up|0|||
163330808|NCT05251363|589920725|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
163330809|NCT05251363|589920725|FG000|Overall Study After Implant Period|Physician Decision|1|||
163330810|NCT05251363|589920725|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
163330811|NCT03070392|589922432|FG000|Overall Study|Not Treated|7|||
163025817|NCT02777970|588797131|FG000|Overall Study|Protocol Violation|1|||
163025818|NCT02777970|588797132|FG001|Overall Study|Protocol Violation|0|||
163025819|NCT02777970|588797133|FG002|Overall Study|Protocol Violation|0|||
163066448|NCT02034591|588948439|FG002|Overall Study|Withdrawal by Subject|0|||
163330812|NCT03070392|589922433|FG001|Overall Study|Not Treated|0|||
163025820|NCT02541669|588797141|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
163025821|NCT02541669|588797142|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
163025822|NCT02541669|588797143|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
163330813|NCT03070392|589922434|FG002|Overall Study|Not Treated|3|||
163066449|NCT02034591|588948440|FG003|Overall Study|Withdrawal by Subject|0|||
163066450|NCT02034591|588948441|FG004|Overall Study|Withdrawal by Subject|1|||
163066451|NCT02034591|588948442|FG005|Overall Study|Withdrawal by Subject|0|||
163066452|NCT00599313|588948443|FG000|Overall Study|Adverse Event|19|||
163066453|NCT00599313|588948443|FG000|Overall Study|Disease Progression|12|||
163066454|NCT00599313|588948443|FG000|Overall Study|Patient Request|4|||
163066455|NCT00599313|588948443|FG000|Overall Study|Ineligible|1|||
163066456|NCT02782468|588948446|FG000|Overall Study|Progressive Disease|2|||
163066457|NCT02782468|588948447|FG001|Overall Study|Progressive Disease|5|||
163066458|NCT02782468|588948448|FG002|Overall Study|Progressive Disease|0|||
163066459|NCT02782468|588948449|FG003|Overall Study|Progressive Disease|4|||
163066460|NCT02782468|588948446|FG000|Overall Study|Adverse Event|0|||
163066461|NCT02782468|588948447|FG001|Overall Study|Adverse Event|2|||
163066462|NCT02782468|588948448|FG002|Overall Study|Adverse Event|2|||
163066463|NCT02782468|588948449|FG003|Overall Study|Adverse Event|3|||
163066464|NCT02782468|588948446|FG000|Overall Study|Other|0|||
163066465|NCT02782468|588948447|FG001|Overall Study|Other|0|||
163066466|NCT02782468|588948448|FG002|Overall Study|Other|1|||
163066467|NCT02782468|588948449|FG003|Overall Study|Other|1|||
163066468|NCT02782468|588948446|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
163066469|NCT02782468|588948447|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
163066470|NCT02782468|588948448|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
163066471|NCT02782468|588948449|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
163066472|NCT02782468|588948446|FG000|Overall Study|Symptomatic Deterioration|0|||
163066473|NCT02782468|588948447|FG001|Overall Study|Symptomatic Deterioration|0|||
163066474|NCT02782468|588948448|FG002|Overall Study|Symptomatic Deterioration|0|||
163066475|NCT02782468|588948449|FG003|Overall Study|Symptomatic Deterioration|1|||
163066476|NCT02782468|588948446|FG000|Overall Study|Withdrawal by Subject|1|||
163066477|NCT02782468|588948447|FG001|Overall Study|Withdrawal by Subject|0|||
163066478|NCT02782468|588948448|FG002|Overall Study|Withdrawal by Subject|0|||
163066479|NCT02782468|588948449|FG003|Overall Study|Withdrawal by Subject|0|||
163066480|NCT05350202|588948452|FG000|Visit 1 - Baseline|Not-treated|18|||
163066481|NCT05350202|588948453|FG001|Visit 1 - Baseline|Not-treated|0|||
163066482|NCT05350202|588948452|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
163066483|NCT05350202|588948453|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
163066484|NCT05350202|588948452|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
163066485|NCT05350202|588948453|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
163066486|NCT05350202|588948452|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
163066487|NCT05350202|588948453|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
163066488|NCT05350202|588948452|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
163066489|NCT05350202|588948453|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
163066490|NCT05350202|588948452|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
163066491|NCT05350202|588948453|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
163066492|NCT05350202|588948452|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
163066493|NCT05350202|588948453|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
163066494|NCT04364646|588948454|FG000|Overall Study|Lost to Follow-up|1|||
163066495|NCT04364646|588948455|FG001|Overall Study|Lost to Follow-up|0|||
163066496|NCT04364646|588948454|FG000|Overall Study|Withdrawal by Subject|7|||
163066497|NCT04364646|588948455|FG001|Overall Study|Withdrawal by Subject|14|||
163066498|NCT04364646|588948454|FG000|Overall Study|Protocol Violation|4|||
163066499|NCT04364646|588948455|FG001|Overall Study|Protocol Violation|5|||
163066500|NCT01525589|588948460|FG000|Overall Study|Non-treatment-related AE|1|||
163066501|NCT01525589|588948461|FG001|Overall Study|Non-treatment-related AE|0|||
163066502|NCT01525589|588948462|FG002|Overall Study|Non-treatment-related AE|0|||
163066503|NCT01525589|588948460|FG000|Overall Study|Progressive disease|48|||
163066504|NCT01525589|588948461|FG001|Overall Study|Progressive disease|15|||
163066505|NCT01525589|588948462|FG002|Overall Study|Progressive disease|29|||
163066506|NCT01525589|588948460|FG000|Overall Study|Never treated|2|||
163066507|NCT01525589|588948461|FG001|Overall Study|Never treated|0|||
163066508|NCT01525589|588948462|FG002|Overall Study|Never treated|0|||
163066509|NCT01525589|588948460|FG000|Overall Study|Physician Decision|4|||
163066510|NCT01525589|588948461|FG001|Overall Study|Physician Decision|2|||
163066511|NCT01525589|588948462|FG002|Overall Study|Physician Decision|2|||
163066512|NCT01525589|588948460|FG000|Overall Study|Death|0|||
163066513|NCT01525589|588948461|FG001|Overall Study|Death|0|||
163066514|NCT01525589|588948462|FG002|Overall Study|Death|2|||
163066515|NCT01525589|588948460|FG000|Overall Study|Treatment-related AE|1|||
163066516|NCT01525589|588948461|FG001|Overall Study|Treatment-related AE|1|||
163066517|NCT01525589|588948462|FG002|Overall Study|Treatment-related AE|2|||
163066518|NCT01525589|588948460|FG000|Overall Study|Other reasons|0|||
163066519|NCT01525589|588948461|FG001|Overall Study|Other reasons|1|||
163066520|NCT01525589|588948462|FG002|Overall Study|Other reasons|0|||
163066521|NCT01525589|588948460|FG000|Overall Study|Withdrawal by Subject|0|||
163066522|NCT01525589|588948461|FG001|Overall Study|Withdrawal by Subject|1|||
163066523|NCT01525589|588948462|FG002|Overall Study|Withdrawal by Subject|0|||
163330814|NCT03070392|589922435|FG003|Overall Study|Not Treated|12|||
163066524|NCT02924376|588948463|FG000|Overall Study|Progressive Disease|4|||
163066525|NCT02924376|588948464|FG001|Overall Study|Progressive Disease|0|||
163066526|NCT02924376|588948465|FG002|Overall Study|Progressive Disease|1|||
163066527|NCT02924376|588948466|FG003|Overall Study|Progressive Disease|0|||
163066528|NCT02924376|588948463|FG000|Overall Study|Death|73|||
163066529|NCT02924376|588948464|FG001|Overall Study|Death|18|||
163066530|NCT02924376|588948465|FG002|Overall Study|Death|15|||
163066531|NCT02924376|588948466|FG003|Overall Study|Death|2|||
163066532|NCT02924376|588948463|FG000|Overall Study|Lost to Follow-up|3|||
163066533|NCT02924376|588948464|FG001|Overall Study|Lost to Follow-up|0|||
163066534|NCT02924376|588948465|FG002|Overall Study|Lost to Follow-up|0|||
163066535|NCT02924376|588948466|FG003|Overall Study|Lost to Follow-up|0|||
163066536|NCT02924376|588948463|FG000|Overall Study|Study Terminated by Sponsor|19|||
163066537|NCT02924376|588948464|FG001|Overall Study|Study Terminated by Sponsor|0|||
163066538|NCT02924376|588948465|FG002|Overall Study|Study Terminated by Sponsor|0|||
163066539|NCT02924376|588948466|FG003|Overall Study|Study Terminated by Sponsor|0|||
163066540|NCT02924376|588948463|FG000|Overall Study|Physician Decision|1|||
163066541|NCT02924376|588948464|FG001|Overall Study|Physician Decision|0|||
163066542|NCT02924376|588948465|FG002|Overall Study|Physician Decision|0|||
163066543|NCT02924376|588948466|FG003|Overall Study|Physician Decision|0|||
163066544|NCT02924376|588948463|FG000|Overall Study|Withdrawal by Subject|7|||
163066545|NCT02924376|588948464|FG001|Overall Study|Withdrawal by Subject|2|||
163066546|NCT02924376|588948465|FG002|Overall Study|Withdrawal by Subject|1|||
163066547|NCT02924376|588948466|FG003|Overall Study|Withdrawal by Subject|0|||
163066548|NCT02924376|588948463|FG000|Overall Study|Rolled Over to Another Study|1|||
163066549|NCT02924376|588948464|FG001|Overall Study|Rolled Over to Another Study|0|||
163066550|NCT02924376|588948465|FG002|Overall Study|Rolled Over to Another Study|0|||
163066551|NCT02924376|588948466|FG003|Overall Study|Rolled Over to Another Study|0|||
163066552|NCT03608033|588948467|FG000|Treatment Period|Death|0|||
163066553|NCT03608033|588948468|FG001|Treatment Period|Death|1|||
163066554|NCT03608033|588948467|FG000|Treatment Period|Adverse Event|1|||
163066555|NCT03608033|588948468|FG001|Treatment Period|Adverse Event|5|||
163066556|NCT03608033|588948467|FG000|Treatment Period|Lack of Efficacy|4|||
163066557|NCT03608033|588948468|FG001|Treatment Period|Lack of Efficacy|3|||
163066558|NCT03608033|588948467|FG000|Treatment Period|Lost to Follow-up|2|||
163066559|NCT03608033|588948468|FG001|Treatment Period|Lost to Follow-up|6|||
163066560|NCT03608033|588948467|FG000|Treatment Period|Physician Decision|6|||
163066561|NCT03608033|588948468|FG001|Treatment Period|Physician Decision|10|||
163066562|NCT03608033|588948467|FG000|Treatment Period|Pregnancy|1|||
163066563|NCT03608033|588948468|FG001|Treatment Period|Pregnancy|0|||
163066564|NCT03608033|588948467|FG000|Treatment Period|Protocol Violation|1|||
163066565|NCT03608033|588948468|FG001|Treatment Period|Protocol Violation|2|||
163066566|NCT03608033|588948467|FG000|Treatment Period|Withdrawal by Subject|46|||
163066567|NCT03608033|588948468|FG001|Treatment Period|Withdrawal by Subject|45|||
163066568|NCT03608033|588948467|FG000|Treatment Period|Study terminated by sponsor|82|||
163066569|NCT03608033|588948468|FG001|Treatment Period|Study terminated by sponsor|68|||
163066570|NCT03608033|588948467|FG000|Treatment Period|Site Terminated by Sponsor|1|||
163066571|NCT03608033|588948468|FG001|Treatment Period|Site Terminated by Sponsor|0|||
163066572|NCT03608033|588948467|FG000|Open-Label Period: OMS721|Adverse Event|1|||
163066573|NCT03608033|588948468|FG001|Open-Label Period: OMS721|Adverse Event|0|||
163066574|NCT03608033|588948467|FG000|Open-Label Period: OMS721|Lack of Efficacy|1|||
163066575|NCT03608033|588948468|FG001|Open-Label Period: OMS721|Lack of Efficacy|0|||
163066576|NCT03608033|588948467|FG000|Open-Label Period: OMS721|Lost to Follow-up|1|||
163066577|NCT03608033|588948468|FG001|Open-Label Period: OMS721|Lost to Follow-up|0|||
163066578|NCT03608033|588948467|FG000|Open-Label Period: OMS721|Study Terminated By Sponsor|11|||
163066579|NCT03608033|588948468|FG001|Open-Label Period: OMS721|Study Terminated By Sponsor|0|||
163066580|NCT03608033|588948467|FG000|Open-Label Period: OMS721|Withdrawal by Subject|5|||
163066581|NCT03608033|588948468|FG001|Open-Label Period: OMS721|Withdrawal by Subject|0|||
163066582|NCT05253807|588948470|FG000|Overall Study|Death|1|||
163066583|NCT05253807|588948471|FG001|Overall Study|Death|4|||
163066584|NCT05253807|588948470|FG000|Overall Study|Withdrawal by Subject|1|||
163066585|NCT05253807|588948471|FG001|Overall Study|Withdrawal by Subject|0|||
163330815|NCT03070392|589922432|FG000|Overall Study|Death|3|||
163330816|NCT03070392|589922433|FG001|Overall Study|Death|0|||
163066586|NCT05253807|588948470|FG000|Overall Study|Study Terminated by Sponsor|1|||
163066587|NCT05253807|588948471|FG001|Overall Study|Study Terminated by Sponsor|1|||
163066588|NCT02360579|588948473|FG000|Initial|Death|16|||
163066589|NCT02360579|588948474|FG001|Initial|Death|49|||
163066590|NCT02360579|588948475|FG002|Initial|Death|0|||
163066591|NCT02360579|588948476|FG003|Initial|Death|71|||
163066592|NCT02360579|588948473|FG000|Initial|Lost to Follow-up|0|||
163066593|NCT02360579|588948474|FG001|Initial|Lost to Follow-up|4|||
163066594|NCT02360579|588948475|FG002|Initial|Lost to Follow-up|0|||
163066595|NCT02360579|588948476|FG003|Initial|Lost to Follow-up|1|||
163066596|NCT02360579|588948473|FG000|Initial|Withdrawal by Subject|0|||
163066597|NCT02360579|588948474|FG001|Initial|Withdrawal by Subject|0|||
163066598|NCT02360579|588948475|FG002|Initial|Withdrawal by Subject|0|||
163066599|NCT02360579|588948476|FG003|Initial|Withdrawal by Subject|3|||
163330817|NCT03070392|589922434|FG002|Overall Study|Death|0|||
163066600|NCT02360579|588948473|FG000|Initial|Other|7|||
163066601|NCT02360579|588948474|FG001|Initial|Other|0|||
163066602|NCT02360579|588948475|FG002|Initial|Other|0|||
163066603|NCT02360579|588948476|FG003|Initial|Other|0|||
163066604|NCT02360579|588948473|FG000|Initial|Did not receive TIL|8|||
163066605|NCT02360579|588948474|FG001|Initial|Did not receive TIL|11|||
163066606|NCT02360579|588948475|FG002|Initial|Did not receive TIL|0|||
163066607|NCT02360579|588948476|FG003|Initial|Did not receive TIL|22|||
163066608|NCT02360579|588948473|FG000|Retreatment|Death|0|||
163066609|NCT02360579|588948474|FG001|Retreatment|Death|0|||
163066610|NCT02360579|588948475|FG002|Retreatment|Death|11|||
163066611|NCT02360579|588948476|FG003|Retreatment|Death|0|||
163066612|NCT06455111|588948479|FG000|Overall Study|Withdrawal by Subject|11|||
163066613|NCT06455111|588948480|FG001|Overall Study|Withdrawal by Subject|4|||
163066614|NCT03682848|588948481|FG000|Overall Study|Withdrawal by Subject|3|||
163066615|NCT03682848|588948481|FG000|Overall Study|Site closed|5|||
163066616|NCT03682848|588948481|FG000|Overall Study|Protocol Deviation|1|||
163066617|NCT03682848|588948481|FG000|Overall Study|Adverse Event|2|||
163066618|NCT03682848|588948481|FG000|Overall Study|Lack of Efficacy|1|||
163066619|NCT02145390|588948485|FG000|Overall Study|Withdrawal by Subject|1|||
163066620|NCT01991314|588949520|FG000|Overall Study|Adverse Event|5|||
163066621|NCT01991314|588949521|FG001|Overall Study|Adverse Event|1|||
163066622|NCT01991314|588949520|FG000|Overall Study|Lost to Follow-up|6|||
163066623|NCT01991314|588949521|FG001|Overall Study|Lost to Follow-up|10|||
163066624|NCT00970944|588949523|FG000|Overall Study|Death|1|||
163066625|NCT00970944|588949524|FG001|Overall Study|Death|0|||
163066626|NCT00970944|588949523|FG000|Overall Study|Physician Decision|0|||
163066627|NCT00970944|588949524|FG001|Overall Study|Physician Decision|2|||
163066628|NCT02008370|588949525|FG000|Overall Study|Lost to Follow-up|7|||
163066629|NCT00662259|588949526|FG000|Overall Study|Adverse Event|2|||
163066630|NCT00662259|588949527|FG001|Overall Study|Adverse Event|0|||
163066631|NCT00972738|588949528|FG000|Overall Study|Adverse Event|7|||
163066632|NCT00972738|588949529|FG001|Overall Study|Adverse Event|1|||
163066633|NCT00972738|588949530|FG002|Overall Study|Adverse Event|8|||
163066634|NCT00972738|588949528|FG000|Overall Study|Protocol Violation|2|||
163066635|NCT00972738|588949529|FG001|Overall Study|Protocol Violation|1|||
163066636|NCT00972738|588949530|FG002|Overall Study|Protocol Violation|3|||
163066637|NCT00972738|588949528|FG000|Overall Study|Lost to Follow-up|1|||
163066638|NCT00972738|588949529|FG001|Overall Study|Lost to Follow-up|0|||
163066639|NCT00972738|588949530|FG002|Overall Study|Lost to Follow-up|1|||
163066640|NCT00972738|588949528|FG000|Overall Study|Lack of Efficacy|5|||
163066641|NCT00972738|588949529|FG001|Overall Study|Lack of Efficacy|1|||
163066642|NCT00972738|588949530|FG002|Overall Study|Lack of Efficacy|11|||
163066643|NCT00972738|588949528|FG000|Overall Study|Withdrawal by Subject|5|||
163066644|NCT00972738|588949529|FG001|Overall Study|Withdrawal by Subject|1|||
163066645|NCT00972738|588949530|FG002|Overall Study|Withdrawal by Subject|4|||
163066646|NCT00972738|588949528|FG000|Overall Study|Moved|0|||
163066647|NCT00972738|588949529|FG001|Overall Study|Moved|0|||
163066648|NCT00972738|588949530|FG002|Overall Study|Moved|1|||
163066649|NCT00972738|588949528|FG000|Overall Study|Other|1|||
163066650|NCT00972738|588949529|FG001|Overall Study|Other|2|||
163066651|NCT00972738|588949530|FG002|Overall Study|Other|1|||
163066652|NCT02636283|588949535|FG000|Overall Study|Adverse Event|2|||
163066653|NCT02636283|588949536|FG001|Overall Study|Adverse Event|0|||
163066654|NCT02636283|588949535|FG000|Overall Study|Trial Terminated Prematurely|0|||
163066655|NCT02636283|588949536|FG001|Overall Study|Trial Terminated Prematurely|3|||
163066656|NCT01879852|588949537|FG000|Overall Study|Withdrawal by Subject|2|||
163066657|NCT01879852|588949538|FG001|Overall Study|Withdrawal by Subject|0|||
163066658|NCT02696616|588949540|FG000|Overall Study|Adverse Event|0|||
163066659|NCT02696616|588949541|FG001|Overall Study|Adverse Event|1|||
163066660|NCT02696616|588949542|FG002|Overall Study|Adverse Event|0|||
163066661|NCT02696616|588949543|FG003|Overall Study|Adverse Event|0|||
163066662|NCT02696616|588949544|FG004|Overall Study|Adverse Event|0|||
163066663|NCT02696616|588949545|FG005|Overall Study|Adverse Event|0|||
163066664|NCT02696616|588949546|FG006|Overall Study|Adverse Event|0|||
163066665|NCT03086343|588949547|FG000|Period 1|Adverse Event|7|||
163066666|NCT03086343|588949548|FG001|Period 1|Adverse Event|7|||
163066667|NCT03086343|588949549|FG002|Period 1|Adverse Event|0|||
163066668|NCT03086343|588949550|FG003|Period 1|Adverse Event|1|||
163066669|NCT03086343|588949547|FG000|Period 1|Withdrawal by Subject|6|||
163066670|NCT03086343|588949548|FG001|Period 1|Withdrawal by Subject|10|||
163066671|NCT03086343|588949549|FG002|Period 1|Withdrawal by Subject|0|||
163066672|NCT03086343|588949550|FG003|Period 1|Withdrawal by Subject|0|||
163066673|NCT03086343|588949547|FG000|Period 1|Lost to Follow-up|1|||
163066674|NCT03086343|588949548|FG001|Period 1|Lost to Follow-up|3|||
163066675|NCT03086343|588949549|FG002|Period 1|Lost to Follow-up|1|||
163066676|NCT03086343|588949550|FG003|Period 1|Lost to Follow-up|0|||
163066677|NCT03086343|588949547|FG000|Period 1|Other, Not Specified|10|||
163066678|NCT03086343|588949548|FG001|Period 1|Other, Not Specified|12|||
163066679|NCT03086343|588949549|FG002|Period 1|Other, Not Specified|2|||
163066680|NCT03086343|588949550|FG003|Period 1|Other, Not Specified|1|||
163066681|NCT03086343|588949547|FG000|Period 1|Missing|1|||
163066682|NCT03086343|588949548|FG001|Period 1|Missing|0|||
163330818|NCT03070392|589922435|FG003|Overall Study|Death|1|||
163330819|NCT03070392|589922432|FG000|Overall Study|Withdrawal by Subject|7|||
163330820|NCT03070392|589922433|FG001|Overall Study|Withdrawal by Subject|0|||
163066683|NCT03086343|588949549|FG002|Period 1|Missing|0|||
163066684|NCT03086343|588949550|FG003|Period 1|Missing|0|||
163066685|NCT03086343|588949547|FG000|Period 2|Adverse Event|20|||
163066686|NCT03086343|588949548|FG001|Period 2|Adverse Event|11|||
163066687|NCT03086343|588949549|FG002|Period 2|Adverse Event|1|||
163066688|NCT03086343|588949550|FG003|Period 2|Adverse Event|2|||
163066689|NCT03086343|588949547|FG000|Period 2|Withdrawal by Subject|15|||
163066690|NCT03086343|588949548|FG001|Period 2|Withdrawal by Subject|25|||
163066691|NCT03086343|588949549|FG002|Period 2|Withdrawal by Subject|2|||
163066692|NCT03086343|588949550|FG003|Period 2|Withdrawal by Subject|2|||
163066693|NCT03086343|588949547|FG000|Period 2|Lost to Follow-up|6|||
163066694|NCT03086343|588949548|FG001|Period 2|Lost to Follow-up|11|||
163066695|NCT03086343|588949549|FG002|Period 2|Lost to Follow-up|1|||
163066696|NCT03086343|588949550|FG003|Period 2|Lost to Follow-up|0|||
163066697|NCT03086343|588949547|FG000|Period 2|COVID-19 Infection|5|||
163066698|NCT03086343|588949548|FG001|Period 2|COVID-19 Infection|0|||
163066699|NCT03086343|588949549|FG002|Period 2|COVID-19 Infection|0|||
163066700|NCT03086343|588949550|FG003|Period 2|COVID-19 Infection|0|||
163066701|NCT03086343|588949547|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
163066702|NCT03086343|588949548|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
163066703|NCT03086343|588949549|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
163066704|NCT03086343|588949550|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
163066705|NCT03086343|588949547|FG000|Period 2|Other, Not Specified|23|||
163066706|NCT03086343|588949548|FG001|Period 2|Other, Not Specified|22|||
163066707|NCT03086343|588949549|FG002|Period 2|Other, Not Specified|2|||
163066708|NCT03086343|588949550|FG003|Period 2|Other, Not Specified|4|||
163066709|NCT04900272|588949551|FG000|Overall Study|Lost to Follow-up|2|||
163066710|NCT04900272|588949551|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
163066711|NCT04900272|588949551|FG000|Overall Study|Withdrawal by Subject|1|||
163066712|NCT01625182|588949553|FG000|Overall Study|Administrative problems|1|||
163066713|NCT01625182|588949554|FG001|Overall Study|Administrative problems|0|||
163066714|NCT01625182|588949553|FG000|Overall Study|Protocol deviation|0|||
163066715|NCT01625182|588949554|FG001|Overall Study|Protocol deviation|2|||
163066716|NCT01625182|588949553|FG000|Overall Study|Adverse Event|2|||
163066717|NCT01625182|588949554|FG001|Overall Study|Adverse Event|0|||
163066718|NCT01625182|588949553|FG000|Overall Study|Withdrawal by Subject|5|||
163066719|NCT01625182|588949554|FG001|Overall Study|Withdrawal by Subject|1|||
163066720|NCT01625182|588949553|FG000|Overall Study|Lack of Efficacy|12|||
163066721|NCT01625182|588949554|FG001|Overall Study|Lack of Efficacy|8|||
163066722|NCT01500083|588949555|FG000|Overall Study|Adverse Event|4|||
163066723|NCT01500083|588949556|FG001|Overall Study|Adverse Event|17|||
163066724|NCT01500083|588949555|FG000|Overall Study|Death|0|||
163066725|NCT01500083|588949556|FG001|Overall Study|Death|2|||
163066726|NCT01500083|588949555|FG000|Overall Study|Lost to Follow-up|1|||
163066727|NCT01500083|588949556|FG001|Overall Study|Lost to Follow-up|0|||
163066728|NCT01500083|588949555|FG000|Overall Study|Withdrawal of Consent|0|||
163066729|NCT01500083|588949556|FG001|Overall Study|Withdrawal of Consent|1|||
163066730|NCT01500083|588949555|FG000|Overall Study|Disease Progression|2|||
163066731|NCT01500083|588949556|FG001|Overall Study|Disease Progression|10|||
163066732|NCT01500083|588949555|FG000|Overall Study|Investigator Discretion|3|||
163066733|NCT01500083|588949556|FG001|Overall Study|Investigator Discretion|8|||
163066734|NCT01500083|588949555|FG000|Overall Study|Other Reasons|2|||
163066735|NCT01500083|588949556|FG001|Overall Study|Other Reasons|5|||
163066736|NCT00741611|588949557|FG000|Overall Study|Death|0|||
163066737|NCT00741611|588949558|FG001|Overall Study|Death|0|||
163066738|NCT00741611|588949559|FG002|Overall Study|Death|1|||
163066739|NCT00741611|588949557|FG000|Overall Study|Withdrawal by Subject|0|||
163066740|NCT00741611|588949558|FG001|Overall Study|Withdrawal by Subject|2|||
163066741|NCT00741611|588949559|FG002|Overall Study|Withdrawal by Subject|2|||
163066742|NCT01970371|588949560|FG000|Overall Study|Death|8|||
163066743|NCT01970371|588949561|FG001|Overall Study|Death|13|||
163066744|NCT01970371|588949562|FG002|Overall Study|Death|12|||
163066745|NCT01970371|588949560|FG000|Overall Study|Lost to Follow-up|0|||
163066746|NCT01970371|588949561|FG001|Overall Study|Lost to Follow-up|0|||
163066747|NCT01970371|588949562|FG002|Overall Study|Lost to Follow-up|1|||
163066748|NCT01481779|588949563|FG000|Overall Study|Adverse Event|23|||
163066749|NCT01481779|588949564|FG001|Overall Study|Adverse Event|5|||
163330821|NCT03070392|589922434|FG002|Overall Study|Withdrawal by Subject|0|||
163330822|NCT03070392|589922435|FG003|Overall Study|Withdrawal by Subject|3|||
163066750|NCT01481779|588949563|FG000|Overall Study|Lost to Follow-up|3|||
163066751|NCT01481779|588949564|FG001|Overall Study|Lost to Follow-up|2|||
163066752|NCT01481779|588949563|FG000|Overall Study|Protocol Violation|2|||
163066753|NCT01481779|588949564|FG001|Overall Study|Protocol Violation|3|||
163066754|NCT01481779|588949563|FG000|Overall Study|Withdrawal by Subject|26|||
163066755|NCT01481779|588949564|FG001|Overall Study|Withdrawal by Subject|13|||
163066756|NCT01481779|588949563|FG000|Overall Study|Physician Decision|13|||
163066757|NCT01481779|588949564|FG001|Overall Study|Physician Decision|4|||
163066758|NCT01481779|588949563|FG000|Overall Study|Sponsor Decision|3|||
163066759|NCT01481779|588949564|FG001|Overall Study|Sponsor Decision|1|||
163066760|NCT01555931|588949567|FG000|Overall Study|Lost to Follow-up|2|||
163066761|NCT01555931|588949568|FG001|Overall Study|Lost to Follow-up|5|||
163066762|NCT01922011|588949569|FG000|Overall Study|Protocol Violation|0|||
163066763|NCT01922011|588949570|FG001|Overall Study|Protocol Violation|1|||
163066764|NCT01922011|588949569|FG000|Overall Study|Physician Decision|0|||
163066765|NCT01922011|588949570|FG001|Overall Study|Physician Decision|1|||
163066766|NCT01922011|588949569|FG000|Overall Study|Parent/Guardian Decision|3|||
163066767|NCT01922011|588949570|FG001|Overall Study|Parent/Guardian Decision|0|||
163066768|NCT01922011|588949569|FG000|Overall Study|Lost to Follow-up|0|||
163066769|NCT01922011|588949570|FG001|Overall Study|Lost to Follow-up|1|||
163066770|NCT01922011|588949569|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
163066771|NCT01922011|588949570|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
163066772|NCT01922011|588949569|FG000|Overall Study|Not Treated|1|||
163066773|NCT01922011|588949570|FG001|Overall Study|Not Treated|0|||
163066774|NCT01922011|588949569|FG000|Overall Study|Lack of willing home health agency|1|||
163066775|NCT01922011|588949570|FG001|Overall Study|Lack of willing home health agency|0|||
163066776|NCT01922011|588949569|FG000|Overall Study|Randomized in error|1|||
163066777|NCT01922011|588949570|FG001|Overall Study|Randomized in error|0|||
163066778|NCT01510756|588949571|FG000|Overall Study|Death|1|||
163330823|NCT03070392|589922432|FG000|Overall Study|Physician Decision|1|||
163025823|NCT02541669|588797144|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
163025824|NCT02541669|588797145|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
163025825|NCT00834639|588797146|FG000|Second Intervention|Physician Decision|0|||
163025826|NCT00834639|588797147|FG001|Second Intervention|Physician Decision|2|||
163025827|NCT04739722|588797151|FG000|Overall Study|Lost to Follow-up|5301|||
163025828|NCT04739722|588797151|FG000|Overall Study|Withdrawal by Subject|42|||
163025829|NCT04739722|588797151|FG000|Overall Study|Non Average-risk|1157|||
163025830|NCT01968707|588797154|FG000|Overall Study|Did not meet treatment day baseline|49|||
163025831|NCT01968707|588797155|FG001|Overall Study|Did not meet treatment day baseline|12|||
163025832|NCT01968707|588797156|FG002|Overall Study|Did not meet treatment day baseline|41|||
163025833|NCT01968707|588797157|FG003|Overall Study|Did not meet treatment day baseline|44|||
163025834|NCT01968707|588797158|FG004|Overall Study|Did not meet treatment day baseline|36|||
163025835|NCT01968707|588797159|FG005|Overall Study|Did not meet treatment day baseline|11|||
163025836|NCT01968707|588797160|FG006|Overall Study|Did not meet treatment day baseline|34|||
163025837|NCT01968707|588797161|FG007|Overall Study|Did not meet treatment day baseline|35|||
163025838|NCT00631410|588797167|FG000|Overall Study|Adverse Event|1|||
163025839|NCT00631410|588797168|FG001|Overall Study|Adverse Event|3|||
163025840|NCT00631410|588797167|FG000|Overall Study|Objective Progression or Relapse|4|||
163025841|NCT00631410|588797168|FG001|Overall Study|Objective Progression or Relapse|3|||
163025842|NCT00631410|588797167|FG000|Overall Study|Surgery|1|||
163025843|NCT00631410|588797168|FG001|Overall Study|Surgery|0|||
163025844|NCT02083185|588797170|FG000|Overall Study|Lost to Follow-up|0|||
163025845|NCT02083185|588797171|FG001|Overall Study|Lost to Follow-up|3|||
163025846|NCT02083185|588797172|FG002|Overall Study|Lost to Follow-up|0|||
163025847|NCT02083185|588797170|FG000|Overall Study|Withdrawal by Subject|9|||
163025848|NCT02083185|588797171|FG001|Overall Study|Withdrawal by Subject|15|||
163025849|NCT02083185|588797172|FG002|Overall Study|Withdrawal by Subject|1|||
163025850|NCT02083185|588797170|FG000|Overall Study|Death|2|||
163025851|NCT02083185|588797171|FG001|Overall Study|Death|2|||
163025852|NCT02083185|588797172|FG002|Overall Study|Death|1|||
163025853|NCT02083185|588797170|FG000|Overall Study|Reason not Specified|9|||
163025854|NCT02083185|588797171|FG001|Overall Study|Reason not Specified|6|||
163025855|NCT02083185|588797172|FG002|Overall Study|Reason not Specified|5|||
163025856|NCT02083185|588797170|FG000|Overall Study|Study Terminated by Sponsor|0|||
163025857|NCT02083185|588797171|FG001|Overall Study|Study Terminated by Sponsor|1|||
163025858|NCT02083185|588797172|FG002|Overall Study|Study Terminated by Sponsor|0|||
163025859|NCT02083185|588797170|FG000|Overall Study|Did not Receive Study Drug|0|||
163025860|NCT02083185|588797171|FG001|Overall Study|Did not Receive Study Drug|2|||
163066779|NCT01510756|588949571|FG000|Overall Study|Lack of Efficacy|2|||
163066780|NCT01510756|588949571|FG000|Overall Study|Physician Decision|1|||
163066781|NCT04398134|588949578|FG000|Overall Study|Adverse Event|0|||
163066782|NCT04398134|588949579|FG001|Overall Study|Adverse Event|0|||
163066783|NCT04398134|588949580|FG002|Overall Study|Adverse Event|1|||
163066784|NCT04398134|588949581|FG003|Overall Study|Adverse Event|0|||
163066785|NCT04398134|588949578|FG000|Overall Study|Withdrawal by Subject|2|||
163330824|NCT03070392|589922433|FG001|Overall Study|Physician Decision|0|||
163330825|NCT03070392|589922434|FG002|Overall Study|Physician Decision|0|||
163025861|NCT02083185|588797172|FG002|Overall Study|Did not Receive Study Drug|0|||
163025862|NCT03419598|588797173|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
163025863|NCT02474589|588797174|FG000|Overall Study|Adverse Event|6|||
163025864|NCT02474589|588797175|FG001|Overall Study|Adverse Event|2|||
163025865|NCT02474589|588797174|FG000|Overall Study|Lost to Follow-up|6|||
163066786|NCT04398134|588949579|FG001|Overall Study|Withdrawal by Subject|0|||
163066787|NCT04398134|588949580|FG002|Overall Study|Withdrawal by Subject|0|||
163330826|NCT03070392|589922435|FG003|Overall Study|Physician Decision|2|||
163066788|NCT04398134|588949581|FG003|Overall Study|Withdrawal by Subject|1|||
163066789|NCT04398134|588949578|FG000|Overall Study|Study Terminated by Sponsor|30|||
163066790|NCT04398134|588949579|FG001|Overall Study|Study Terminated by Sponsor|11|||
163066791|NCT04398134|588949580|FG002|Overall Study|Study Terminated by Sponsor|32|||
163066792|NCT04398134|588949581|FG003|Overall Study|Study Terminated by Sponsor|11|||
163066793|NCT04225039|588949586|FG000|Overall Study|Withdrawal by Subject|1|||
163066794|NCT04225039|588949587|FG001|Overall Study|Withdrawal by Subject|0|||
163066795|NCT04225039|588949588|FG002|Overall Study|Withdrawal by Subject|0|||
163066796|NCT04225039|588949589|FG003|Overall Study|Withdrawal by Subject|1|||
163066797|NCT04225039|588949586|FG000|Overall Study|Currently active on study treatment|0|||
163066798|NCT04225039|588949587|FG001|Overall Study|Currently active on study treatment|1|||
163066799|NCT04225039|588949588|FG002|Overall Study|Currently active on study treatment|0|||
163066800|NCT04225039|588949589|FG003|Overall Study|Currently active on study treatment|0|||
163066801|NCT04225039|588949586|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
163066802|NCT04225039|588949587|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
163066803|NCT04225039|588949588|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
163066804|NCT04225039|588949589|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
163066805|NCT04225039|588949586|FG000|Overall Study|Ineligible for treatment|0|||
163066806|NCT04225039|588949587|FG001|Overall Study|Ineligible for treatment|0|||
163066807|NCT04225039|588949588|FG002|Overall Study|Ineligible for treatment|0|||
163066808|NCT04225039|588949589|FG003|Overall Study|Ineligible for treatment|4|||
163066809|NCT00975923|588949590|FG000|Overall Study|Withdrawal by Subject|0|||
163066810|NCT00975923|588949591|FG001|Overall Study|Withdrawal by Subject|1|||
163066811|NCT01964404|588949592|FG000|Pre-Randomization - Scan 1|Screen Fail|49|||
163066812|NCT01964404|588949593|FG001|Pre-Randomization - Scan 1|Screen Fail|36|||
163066813|NCT01964404|588949594|FG002|Pre-Randomization - Scan 1|Screen Fail|12|||
163066814|NCT01964404|588949595|FG003|Pre-Randomization - Scan 1|Screen Fail|9|||
163066815|NCT01964404|588949596|FG004|Pre-Randomization - Scan 1|Screen Fail|0|||
163066816|NCT01964404|588949597|FG005|Pre-Randomization - Scan 1|Screen Fail|0|||
163066817|NCT01964404|588949598|FG006|Pre-Randomization - Scan 1|Screen Fail|0|||
163066818|NCT01964404|588949599|FG007|Pre-Randomization - Scan 1|Screen Fail|0|||
163066819|NCT01964404|588949600|FG008|Pre-Randomization - Scan 1|Screen Fail|0|||
163066820|NCT01964404|588949601|FG009|Pre-Randomization - Scan 1|Screen Fail|0|||
163066821|NCT01964404|588949592|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
163066822|NCT01964404|588949593|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
163066823|NCT01964404|588949594|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
163066824|NCT01964404|588949595|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
163066825|NCT01964404|588949596|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066826|NCT01964404|588949597|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066827|NCT01964404|588949598|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066828|NCT01964404|588949599|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066829|NCT01964404|588949600|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066830|NCT01964404|588949601|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066831|NCT01964404|588949592|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
163066832|NCT01964404|588949593|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
163066833|NCT01964404|588949594|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066834|NCT01964404|588949595|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
163066835|NCT01964404|588949596|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066836|NCT01964404|588949597|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066837|NCT01964404|588949598|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066838|NCT01964404|588949599|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066839|NCT01964404|588949600|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066840|NCT01964404|588949601|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066841|NCT00325416|588949604|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
163066842|NCT00325416|588949605|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
163066843|NCT00325416|588949604|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
163066844|NCT00325416|588949605|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
163066845|NCT00325416|588949604|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
163066846|NCT00325416|588949605|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
163066847|NCT00325416|588949604|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
163066848|NCT00325416|588949605|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
163066849|NCT00325416|588949604|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
163066850|NCT00325416|588949605|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
163066851|NCT00325416|588949604|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
163330827|NCT03070392|589922432|FG000|Overall Study|Progressive Disease|154|||
163066852|NCT00325416|588949605|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
163066853|NCT06239610|588949606|FG000|Overall Study|no usable migration data for minimum of one day|11|||
163066854|NCT02830087|588949609|FG000|Overall Study|No study staff to follow-up patients|4|||
163066855|NCT02830087|588949610|FG001|Overall Study|No study staff to follow-up patients|4|||
163066856|NCT02830087|588949611|FG002|Overall Study|No study staff to follow-up patients|4|||
163066857|NCT02830087|588949612|FG003|Overall Study|No study staff to follow-up patients|3|||
163066858|NCT02830087|588949613|FG004|Overall Study|No study staff to follow-up patients|3|||
163066859|NCT02830087|588949614|FG005|Overall Study|No study staff to follow-up patients|3|||
163066860|NCT02916771|588949615|FG000|Overall Study|Withdrawal by Subject|9|||
163066861|NCT02916771|588949615|FG000|Overall Study|Physician Decision|1|||
163066862|NCT02916771|588949615|FG000|Overall Study|Began treatment for another active malignancy|1|||
163066863|NCT02337686|588949616|FG000|Overall Study|Adverse Event|1|||
163066864|NCT00479232|588950803|FG000|Overall Study|Adverse Event|0|||
163066865|NCT00479232|588950804|FG001|Overall Study|Adverse Event|0|||
163066866|NCT00479232|588950805|FG002|Overall Study|Adverse Event|5|||
163066867|NCT00479232|588950806|FG003|Overall Study|Adverse Event|0|||
163066868|NCT00479232|588950807|FG004|Overall Study|Adverse Event|0|||
163066869|NCT00479232|588950808|FG005|Overall Study|Adverse Event|10|||
163066870|NCT00479232|588950803|FG000|Overall Study|Deviation from Protocol|0|||
163066871|NCT00479232|588950804|FG001|Overall Study|Deviation from Protocol|0|||
163066872|NCT00479232|588950805|FG002|Overall Study|Deviation from Protocol|1|||
163066873|NCT00479232|588950806|FG003|Overall Study|Deviation from Protocol|0|||
163066874|NCT00479232|588950807|FG004|Overall Study|Deviation from Protocol|0|||
163066875|NCT00479232|588950808|FG005|Overall Study|Deviation from Protocol|0|||
163066876|NCT00479232|588950803|FG000|Overall Study|Lack of Efficacy|0|||
163066877|NCT00479232|588950804|FG001|Overall Study|Lack of Efficacy|0|||
163066878|NCT00479232|588950805|FG002|Overall Study|Lack of Efficacy|2|||
163066879|NCT00479232|588950806|FG003|Overall Study|Lack of Efficacy|0|||
163066880|NCT00479232|588950807|FG004|Overall Study|Lack of Efficacy|0|||
163066881|NCT00479232|588950808|FG005|Overall Study|Lack of Efficacy|4|||
163066882|NCT00479232|588950803|FG000|Overall Study|Physician Decision|0|||
163066883|NCT00479232|588950804|FG001|Overall Study|Physician Decision|0|||
163066884|NCT00479232|588950805|FG002|Overall Study|Physician Decision|2|||
163066885|NCT00479232|588950806|FG003|Overall Study|Physician Decision|0|||
163066886|NCT00479232|588950807|FG004|Overall Study|Physician Decision|0|||
163066887|NCT00479232|588950808|FG005|Overall Study|Physician Decision|1|||
163066888|NCT00479232|588950803|FG000|Overall Study|Progressive Disease|3|||
163066889|NCT00479232|588950804|FG001|Overall Study|Progressive Disease|1|||
163066890|NCT00479232|588950805|FG002|Overall Study|Progressive Disease|12|||
163066891|NCT00479232|588950806|FG003|Overall Study|Progressive Disease|3|||
163066892|NCT00479232|588950807|FG004|Overall Study|Progressive Disease|3|||
163066893|NCT00479232|588950808|FG005|Overall Study|Progressive Disease|12|||
163066894|NCT00479232|588950803|FG000|Overall Study|Withdrew Consent|0|||
163066895|NCT00479232|588950804|FG001|Overall Study|Withdrew Consent|2|||
163066896|NCT00479232|588950805|FG002|Overall Study|Withdrew Consent|6|||
163066897|NCT00479232|588950806|FG003|Overall Study|Withdrew Consent|0|||
163066898|NCT00479232|588950807|FG004|Overall Study|Withdrew Consent|1|||
163066899|NCT00479232|588950808|FG005|Overall Study|Withdrew Consent|3|||
163066900|NCT05977868|588950809|FG000|Overall Study|Withdrawal by Subject|1|||
163066901|NCT05977868|588950810|FG001|Overall Study|Withdrawal by Subject|2|||
163066902|NCT05977868|588950809|FG000|Overall Study|Transitioned to comfort care|1|||
163066903|NCT05977868|588950810|FG001|Overall Study|Transitioned to comfort care|0|||
163025866|NCT02474589|588797175|FG001|Overall Study|Lost to Follow-up|1|||
163025867|NCT02474589|588797174|FG000|Overall Study|Protocol Violation|4|||
163025868|NCT02474589|588797175|FG001|Overall Study|Protocol Violation|1|||
163025869|NCT02474589|588797174|FG000|Overall Study|Withdrawal by Subject|4|||
163025870|NCT02474589|588797175|FG001|Overall Study|Withdrawal by Subject|0|||
163025871|NCT02474589|588797174|FG000|Overall Study|Inability to complete study procedures|5|||
163025872|NCT02474589|588797175|FG001|Overall Study|Inability to complete study procedures|1|||
163025873|NCT00380081|588797178|FG000|Overall Study|Withdrawal by Subject|0|||
163025874|NCT00380081|588797179|FG001|Overall Study|Withdrawal by Subject|0|||
163025875|NCT00380081|588797180|FG002|Overall Study|Withdrawal by Subject|0|||
163025876|NCT00380081|588797181|FG003|Overall Study|Withdrawal by Subject|0|||
163025877|NCT00380081|588797182|FG004|Overall Study|Withdrawal by Subject|1|||
163025878|NCT00380081|588797183|FG005|Overall Study|Withdrawal by Subject|0|||
163025879|NCT00380081|588797178|FG000|Overall Study|Family Emergency|0|||
163025880|NCT00380081|588797179|FG001|Overall Study|Family Emergency|0|||
163025881|NCT00380081|588797180|FG002|Overall Study|Family Emergency|0|||
163025882|NCT00380081|588797181|FG003|Overall Study|Family Emergency|0|||
163025883|NCT00380081|588797182|FG004|Overall Study|Family Emergency|0|||
163025884|NCT00380081|588797183|FG005|Overall Study|Family Emergency|1|||
163025885|NCT02231879|588797184|FG000|Overall Study|Adverse Event|2|||
163025886|NCT02231879|588797185|FG001|Overall Study|Adverse Event|1|||
163066904|NCT00876395|588950811|FG000|Overall Study|Untreated|8|||
163066905|NCT00876395|588950812|FG001|Overall Study|Untreated|1|||
163066906|NCT00876395|588950811|FG000|Overall Study|Adverse Event|63|||
163066907|NCT00876395|588950812|FG001|Overall Study|Adverse Event|11|||
163066908|NCT00876395|588950811|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163066909|NCT00876395|588950812|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163066910|NCT00876395|588950811|FG000|Overall Study|Disease progression|259|||
163066911|NCT00876395|588950812|FG001|Overall Study|Disease progression|162|||
163066912|NCT00876395|588950811|FG000|Overall Study|New cancer therapy|25|||
163066913|NCT00876395|588950812|FG001|Overall Study|New cancer therapy|7|||
163066914|NCT00876395|588950811|FG000|Overall Study|Protocol Violation|5|||
163066915|NCT00876395|588950812|FG001|Overall Study|Protocol Violation|2|||
163066916|NCT00876395|588950811|FG000|Overall Study|Withdrawal by Subject|66|||
163066917|NCT00876395|588950812|FG001|Overall Study|Withdrawal by Subject|33|||
163066918|NCT00876395|588950811|FG000|Overall Study|Lost to Follow-up|2|||
163066919|NCT00876395|588950812|FG001|Overall Study|Lost to Follow-up|0|||
163066920|NCT00876395|588950811|FG000|Overall Study|Administrative problems|39|||
163066921|NCT00876395|588950812|FG001|Overall Study|Administrative problems|23|||
163066922|NCT00876395|588950811|FG000|Overall Study|Death|12|||
163066923|NCT00876395|588950812|FG001|Overall Study|Death|0|||
163066924|NCT01787838|588950817|FG000|Overall Study|refused|1413|||
163066925|NCT02260986|588950822|FG000|Overall Study|Adverse Event|24|||
163066926|NCT02260986|588950823|FG001|Overall Study|Adverse Event|0|||
163066927|NCT02260986|588950824|FG002|Overall Study|Adverse Event|11|||
163066928|NCT02260986|588950822|FG000|Overall Study|Lack of Efficacy|27|||
163066929|NCT02260986|588950823|FG001|Overall Study|Lack of Efficacy|3|||
163066930|NCT02260986|588950824|FG002|Overall Study|Lack of Efficacy|0|||
163066931|NCT02260986|588950822|FG000|Overall Study|Protocol Violation|14|||
163066932|NCT02260986|588950823|FG001|Overall Study|Protocol Violation|5|||
163066933|NCT02260986|588950824|FG002|Overall Study|Protocol Violation|16|||
163066934|NCT02260986|588950822|FG000|Overall Study|Car accident|0|||
163066935|NCT02260986|588950823|FG001|Overall Study|Car accident|0|||
163066936|NCT02260986|588950824|FG002|Overall Study|Car accident|1|||
163066937|NCT02260986|588950822|FG000|Overall Study|Withdrawal by Subject|17|||
163066938|NCT02260986|588950823|FG001|Overall Study|Withdrawal by Subject|4|||
163066939|NCT02260986|588950824|FG002|Overall Study|Withdrawal by Subject|9|||
163066940|NCT02260986|588950822|FG000|Overall Study|Incorrect randomization|0|||
163066941|NCT02260986|588950823|FG001|Overall Study|Incorrect randomization|1|||
163066942|NCT02260986|588950824|FG002|Overall Study|Incorrect randomization|0|||
163066943|NCT02260986|588950822|FG000|Overall Study|Lack of investigation product supply|2|||
163066944|NCT02260986|588950823|FG001|Overall Study|Lack of investigation product supply|0|||
163066945|NCT02260986|588950824|FG002|Overall Study|Lack of investigation product supply|1|||
163066946|NCT02260986|588950822|FG000|Overall Study|Lost to Follow-up|4|||
163066947|NCT02260986|588950823|FG001|Overall Study|Lost to Follow-up|0|||
163066948|NCT02260986|588950824|FG002|Overall Study|Lost to Follow-up|3|||
163066949|NCT02260986|588950822|FG000|Overall Study|Pregnancy|2|||
163066950|NCT02260986|588950823|FG001|Overall Study|Pregnancy|0|||
163066951|NCT02260986|588950824|FG002|Overall Study|Pregnancy|0|||
163066952|NCT01793935|588950825|FG000|Overall Study|Pregnancy|1|||
163066953|NCT01793935|588950826|FG001|Overall Study|Pregnancy|0|||
163066954|NCT01793935|588950825|FG000|Overall Study|Protocol Violation|2|||
163066955|NCT01793935|588950826|FG001|Overall Study|Protocol Violation|1|||
163066956|NCT01793935|588950825|FG000|Overall Study|Adverse Event|2|||
163066957|NCT01793935|588950826|FG001|Overall Study|Adverse Event|0|||
163066958|NCT01793935|588950825|FG000|Overall Study|Patient did not take study medication|1|||
163066959|NCT01793935|588950826|FG001|Overall Study|Patient did not take study medication|1|||
163066960|NCT01793935|588950825|FG000|Overall Study|Lost to Follow-up|0|||
163066961|NCT01793935|588950826|FG001|Overall Study|Lost to Follow-up|1|||
163066962|NCT02536794|588950828|FG000|Reached 1st Response Assessment|Adverse Event|2|||
163066963|NCT02536794|588950828|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
163066964|NCT02536794|588950828|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
163066965|NCT02536794|588950828|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
163066966|NCT02536794|588950828|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
163066967|NCT02536794|588950828|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
163066968|NCT00313170|588950829|FG000|Overall Study|Death|2|||
163066969|NCT00313170|588950830|FG001|Overall Study|Death|4|||
163066970|NCT00313170|588950831|FG002|Overall Study|Death|2|||
163066971|NCT00313170|588950829|FG000|Overall Study|Adverse Event|1|||
163066972|NCT00313170|588950830|FG001|Overall Study|Adverse Event|2|||
163066973|NCT00313170|588950831|FG002|Overall Study|Adverse Event|0|||
163066974|NCT00313170|588950829|FG000|Overall Study|Disease progression|31|||
163066975|NCT00313170|588950830|FG001|Overall Study|Disease progression|26|||
163066976|NCT00313170|588950831|FG002|Overall Study|Disease progression|27|||
163217692|NCT00798369|589513769|FG003|Overall Study|Adminstrative problems|0|||
163066977|NCT00313170|588950829|FG000|Overall Study|Withdrawal by Subject|1|||
163066978|NCT00313170|588950830|FG001|Overall Study|Withdrawal by Subject|0|||
163066979|NCT00313170|588950831|FG002|Overall Study|Withdrawal by Subject|1|||
163217693|NCT00798369|589513770|FG004|Overall Study|Adminstrative problems|0|||
163066980|NCT00313170|588950829|FG000|Overall Study|Incorrect enrollment|0|||
163066981|NCT00313170|588950830|FG001|Overall Study|Incorrect enrollment|2|||
163066982|NCT00313170|588950831|FG002|Overall Study|Incorrect enrollment|1|||
163066983|NCT00313170|588950829|FG000|Overall Study|Lost to Follow-up|0|||
163066984|NCT00313170|588950830|FG001|Overall Study|Lost to Follow-up|0|||
163066985|NCT00313170|588950831|FG002|Overall Study|Lost to Follow-up|1|||
163066986|NCT00313170|588950829|FG000|Overall Study|Progression (investigators opinion)|1|||
163066987|NCT00313170|588950830|FG001|Overall Study|Progression (investigators opinion)|0|||
163217694|NCT00798369|589513771|FG005|Overall Study|Adminstrative problems|1|||
163217695|NCT04475588|589513772|FG000|Overall Study|Adverse Event|2|||
163066988|NCT00313170|588950831|FG002|Overall Study|Progression (investigators opinion)|0|||
163066989|NCT00817063|588950837|FG000|Overall Study|Adverse Event|32|||
163066990|NCT00817063|588950838|FG001|Overall Study|Adverse Event|13|||
163066991|NCT00817063|588950837|FG000|Overall Study|Death|1|||
163066992|NCT00817063|588950838|FG001|Overall Study|Death|1|||
163066993|NCT00817063|588950837|FG000|Overall Study|Lack of Efficacy|33|||
163066994|NCT00817063|588950838|FG001|Overall Study|Lack of Efficacy|86|||
163066995|NCT00817063|588950837|FG000|Overall Study|Failure to Return|13|||
163066996|NCT00817063|588950838|FG001|Overall Study|Failure to Return|12|||
163066997|NCT00817063|588950837|FG000|Overall Study|Violation of Selection at Entry|7|||
163066998|NCT00817063|588950838|FG001|Overall Study|Violation of Selection at Entry|4|||
163066999|NCT00817063|588950837|FG000|Overall Study|Protocol Violation|3|||
163067000|NCT00817063|588950838|FG001|Overall Study|Protocol Violation|8|||
163067001|NCT00817063|588950837|FG000|Overall Study|Withdrawal by Subject|17|||
163067002|NCT00817063|588950838|FG001|Overall Study|Withdrawal by Subject|37|||
163067003|NCT00817063|588950837|FG000|Overall Study|Early Improvement|19|||
163067004|NCT00817063|588950838|FG001|Overall Study|Early Improvement|4|||
163067005|NCT00817063|588950837|FG000|Overall Study|Administrative|10|||
163067006|NCT00817063|588950838|FG001|Overall Study|Administrative|4|||
163067007|NCT00817063|588950837|FG000|Overall Study|Abnormality of Laboratory Test|2|||
163067008|NCT00817063|588950838|FG001|Overall Study|Abnormality of Laboratory Test|1|||
163067009|NCT00529035|588950839|FG000|Overall Study|Withdrawal by Subject|1|||
163067010|NCT03439514|588950840|FG000|Double-Blind Treatment Period|Other|4|||
163067011|NCT03439514|588950841|FG001|Double-Blind Treatment Period|Other|1|||
163067012|NCT03439514|588950840|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
163067013|NCT03439514|588950841|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
163067014|NCT03439514|588950840|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
163067015|NCT03439514|588950841|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
163067016|NCT03439514|588950840|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
163067017|NCT03439514|588950841|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
163067018|NCT03439514|588950840|FG000|Double-Blind Treatment Period|Death|1|||
163067019|NCT03439514|588950841|FG001|Double-Blind Treatment Period|Death|2|||
163067020|NCT01521364|588950842|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
163067021|NCT01521364|588950842|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
163067022|NCT03418675|588950843|FG000|Overall Study|Lost to Follow-up|13|||
163067023|NCT03418675|588950844|FG001|Overall Study|Lost to Follow-up|10|||
163067024|NCT03418675|588950843|FG000|Overall Study|Adverse Event|2|||
163067025|NCT03418675|588950844|FG001|Overall Study|Adverse Event|0|||
163067026|NCT02447029|588950848|FG000|Overall Study|Withdrawal by Subject|3|||
163067027|NCT02447029|588950849|FG001|Overall Study|Withdrawal by Subject|2|||
163067028|NCT06420232|588950851|FG000|Overall Study|Withdrawal by Subject|3|||
163067029|NCT01697579|588950852|FG000|Base Study-Cycle 1|Adverse Event|1|||
163067030|NCT01697579|588950853|FG001|Base Study-Cycle 1|Adverse Event|0|||
163067031|NCT01697579|588950854|FG002|Base Study-Cycle 1|Adverse Event|0|||
163067032|NCT01697579|588950855|FG003|Base Study-Cycle 1|Adverse Event|0|||
163067033|NCT01697579|588950856|FG004|Base Study-Cycle 1|Adverse Event|0|||
163067034|NCT01697579|588950857|FG005|Base Study-Cycle 1|Adverse Event|0|||
163067035|NCT01697579|588950858|FG006|Base Study-Cycle 1|Adverse Event|0|||
163067036|NCT01697579|588950852|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
163067037|NCT01697579|588950853|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
163067038|NCT01697579|588950854|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
163067039|NCT01697579|588950855|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
163067040|NCT01697579|588950856|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
163067041|NCT01697579|588950857|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
163067042|NCT01697579|588950858|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
163067043|NCT01697579|588950852|FG000|Base Study-Cycle 1|Protocol Violation|0|||
163067044|NCT01697579|588950853|FG001|Base Study-Cycle 1|Protocol Violation|0|||
163067045|NCT01697579|588950854|FG002|Base Study-Cycle 1|Protocol Violation|0|||
163067046|NCT01697579|588950855|FG003|Base Study-Cycle 1|Protocol Violation|0|||
163067047|NCT01697579|588950856|FG004|Base Study-Cycle 1|Protocol Violation|3|||
163067048|NCT01697579|588950857|FG005|Base Study-Cycle 1|Protocol Violation|0|||
163067049|NCT01697579|588950858|FG006|Base Study-Cycle 1|Protocol Violation|0|||
163067050|NCT01697579|588950852|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
163067051|NCT01697579|588950853|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
163067052|NCT01697579|588950854|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
163067053|NCT01697579|588950855|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
163067054|NCT01697579|588950856|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
163067055|NCT01697579|588950857|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
163067056|NCT01697579|588950858|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
163067057|NCT01697579|588950852|FG000|Base Study-Cycle 1|Technical Problems|0|||
163067058|NCT01697579|588950853|FG001|Base Study-Cycle 1|Technical Problems|0|||
163067059|NCT01697579|588950854|FG002|Base Study-Cycle 1|Technical Problems|1|||
163067060|NCT01697579|588950855|FG003|Base Study-Cycle 1|Technical Problems|1|||
163067061|NCT01697579|588950856|FG004|Base Study-Cycle 1|Technical Problems|0|||
163067062|NCT01697579|588950857|FG005|Base Study-Cycle 1|Technical Problems|0|||
163067063|NCT01697579|588950858|FG006|Base Study-Cycle 1|Technical Problems|0|||
163067064|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Death|0|||
163067065|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Death|0|||
163067066|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Death|0|||
163067067|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Death|0|||
163067068|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Death|0|||
163067069|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Death|0|||
163067070|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Death|2|||
163067071|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
163067072|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
163067073|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
163067074|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
163067075|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
163067076|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
163067077|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
163067078|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
163067079|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
163067080|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
163067081|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
163067082|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
163067083|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
163067084|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
163067085|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
163067086|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
163067087|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
163067088|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
163067089|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
163067090|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
163067091|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
163067092|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
163067093|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
163067094|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
163067095|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
163067096|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
163067097|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
163067098|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
163067099|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
163067100|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
163067101|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
163067102|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
163067103|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
163067104|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
163067105|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
163067106|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
163067107|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
163067108|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
163067109|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
163067110|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
163067111|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
163067112|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
163067113|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
163067114|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
163067115|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
163067116|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
163067117|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
163067118|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
163067119|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
163067120|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
163067121|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
163067122|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
163067123|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
163067124|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
163067125|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
163067126|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
163330828|NCT03070392|589922433|FG001|Overall Study|Progressive Disease|6|||
163330829|NCT03070392|589922434|FG002|Overall Study|Progressive Disease|2|||
163330830|NCT03070392|589922435|FG003|Overall Study|Progressive Disease|70|||
163330831|NCT03070392|589922432|FG000|Overall Study|Adverse Event|6|||
163025887|NCT02231879|588797184|FG000|Overall Study|Lack of Efficacy|0|||
163025888|NCT02231879|588797185|FG001|Overall Study|Lack of Efficacy|1|||
163025889|NCT00189306|588797186|FG000|Treatment Period|Withdrawal by Subject|2|||
163025890|NCT00189306|588797186|FG000|Treatment Period|Adverse Event|2|||
163025891|NCT00189306|588797186|FG000|Treatment Period|Protocol Violation|1|||
163025892|NCT00189306|588797186|FG000|Posttreatment Period|Death|1|||
163025893|NCT00189306|588797186|FG000|Posttreatment Period|Withdrawal by Subject|2|||
163025894|NCT00189306|588797186|FG000|Posttreatment Period|Noncompliance|1|||
163025895|NCT00189306|588797186|FG000|Posttreatment Period|Target lesion excised|1|||
163025896|NCT00189306|588797186|FG000|Posttreatment Period|Protocol Violation|1|||
163025897|NCT00189306|588797186|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
163025898|NCT00189306|588797186|FG000|Posttreatment Period|Local skin reaction/sign|1|||
163025899|NCT00189306|588797186|FG000|Long-Term Follow-up|Adverse Event|2|||
163025900|NCT00189306|588797186|FG000|Long-Term Follow-up|Death|4|||
163025901|NCT00189306|588797186|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
163025902|NCT00189306|588797186|FG000|Long-Term Follow-up|Intercurrent disease|2|||
163025903|NCT00189306|588797186|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
163025904|NCT00189306|588797186|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
163025905|NCT00459706|588797187|FG000|Overall Study|Adverse Event|19|||
163025906|NCT00459706|588797188|FG001|Overall Study|Adverse Event|13|||
163025907|NCT00459706|588797187|FG000|Overall Study|Withdrawal by Subject|1|||
163025908|NCT00459706|588797188|FG001|Overall Study|Withdrawal by Subject|6|||
163025909|NCT00459706|588797187|FG000|Overall Study|Physician Decision|2|||
163025910|NCT00459706|588797188|FG001|Overall Study|Physician Decision|0|||
163025911|NCT00459706|588797187|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
163025912|NCT00459706|588797188|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
163025913|NCT00459706|588797187|FG000|Overall Study|Protocol Violation|2|||
163025914|NCT00459706|588797188|FG001|Overall Study|Protocol Violation|1|||
163025915|NCT00459706|588797187|FG000|Overall Study|Failed to Return|1|||
163025916|NCT00459706|588797188|FG001|Overall Study|Failed to Return|0|||
163025917|NCT00459706|588797187|FG000|Overall Study|Other|0|||
163025918|NCT00459706|588797188|FG001|Overall Study|Other|1|||
163025919|NCT03640481|588797189|FG000|Overall Study|Death|14|||
163025920|NCT03640481|588797190|FG001|Overall Study|Death|14|||
163025921|NCT03640481|588797191|FG002|Overall Study|Death|0|||
163025922|NCT03640481|588797192|FG003|Overall Study|Death|0|||
163025923|NCT03640481|588797189|FG000|Overall Study|Lost to Follow-up|2|||
163025924|NCT03640481|588797190|FG001|Overall Study|Lost to Follow-up|0|||
163025925|NCT03640481|588797191|FG002|Overall Study|Lost to Follow-up|0|||
163025926|NCT03640481|588797192|FG003|Overall Study|Lost to Follow-up|0|||
163025927|NCT03640481|588797189|FG000|Overall Study|Site terminated by sponsor|1|||
163025928|NCT03640481|588797190|FG001|Overall Study|Site terminated by sponsor|3|||
163025929|NCT03640481|588797191|FG002|Overall Study|Site terminated by sponsor|0|||
163025930|NCT03640481|588797192|FG003|Overall Study|Site terminated by sponsor|0|||
163025931|NCT03640481|588797189|FG000|Overall Study|Study terminated by sponsor|29|||
163025932|NCT03640481|588797190|FG001|Overall Study|Study terminated by sponsor|42|||
163025933|NCT03640481|588797191|FG002|Overall Study|Study terminated by sponsor|1|||
163025934|NCT03640481|588797192|FG003|Overall Study|Study terminated by sponsor|0|||
163025935|NCT03640481|588797189|FG000|Overall Study|Withdrawal by Subject|5|||
163025936|NCT03640481|588797190|FG001|Overall Study|Withdrawal by Subject|4|||
163025937|NCT03640481|588797191|FG002|Overall Study|Withdrawal by Subject|0|||
163025938|NCT03640481|588797192|FG003|Overall Study|Withdrawal by Subject|1|||
163025939|NCT03640481|588797189|FG000|Overall Study|Other|26|||
163025940|NCT03640481|588797190|FG001|Overall Study|Other|12|||
163025941|NCT03640481|588797191|FG002|Overall Study|Other|1|||
163025942|NCT03640481|588797192|FG003|Overall Study|Other|0|||
163025943|NCT03640481|588797189|FG000|Overall Study|Randomized, but not treated|1|||
163025944|NCT03640481|588797190|FG001|Overall Study|Randomized, but not treated|3|||
163025945|NCT03640481|588797191|FG002|Overall Study|Randomized, but not treated|0|||
163025946|NCT03640481|588797192|FG003|Overall Study|Randomized, but not treated|0|||
163025947|NCT01322035|588797193|FG000|Overall Study|Lost to Follow-up|8|||
163025948|NCT01322035|588797194|FG001|Overall Study|Lost to Follow-up|3|||
163025949|NCT00535847|588797195|FG000|Overall Study|Adverse Event|5|||
163025950|NCT00535847|588797196|FG001|Overall Study|Adverse Event|3|||
163025951|NCT00535847|588797197|FG002|Overall Study|Adverse Event|2|||
163025952|NCT00535847|588797195|FG000|Overall Study|Non compliance|1|||
163025953|NCT00535847|588797196|FG001|Overall Study|Non compliance|1|||
163025954|NCT00535847|588797197|FG002|Overall Study|Non compliance|0|||
163025955|NCT00535847|588797195|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
163025956|NCT00535847|588797196|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
163025957|NCT00535847|588797197|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
163330832|NCT03070392|589922433|FG001|Overall Study|Adverse Event|1|||
163330833|NCT03070392|589922434|FG002|Overall Study|Adverse Event|1|||
163330834|NCT03070392|589922435|FG003|Overall Study|Adverse Event|3|||
163330835|NCT03070392|589922432|FG000|Overall Study|Alternate anticancer treatment|1|||
163330836|NCT03070392|589922433|FG001|Overall Study|Alternate anticancer treatment|0|||
163025958|NCT01546168|588797200|FG000|Overall Study|Lost to Follow-up|1|||
163025959|NCT01546168|588797201|FG001|Overall Study|Lost to Follow-up|0|||
163025960|NCT01546168|588797200|FG000|Overall Study|Withdrawal by Subject|1|||
163025961|NCT01546168|588797201|FG001|Overall Study|Withdrawal by Subject|0|||
163025962|NCT01546168|588797200|FG000|Overall Study|ineligible after signing consent|2|||
163025963|NCT01546168|588797201|FG001|Overall Study|ineligible after signing consent|0|||
163025964|NCT02850016|588797204|FG000|Overall Study|Withdrawal by Subject|1|||
163025965|NCT02850016|588797205|FG001|Overall Study|Withdrawal by Subject|2|||
163025966|NCT00070018|588797208|FG000|Overall Study|Adverse Event|2|||
163025967|NCT00070018|588797208|FG000|Overall Study|Lack of Efficacy|1|||
163025968|NCT00070018|588797208|FG000|Overall Study|Withdrawal by Subject|1|||
163025969|NCT02939716|588797209|FG000|Overall Study|scanner failure|0|||
163025970|NCT02939716|588797210|FG001|Overall Study|scanner failure|0|||
163025971|NCT02939716|588797211|FG002|Overall Study|scanner failure|0|||
163025972|NCT02939716|588797212|FG003|Overall Study|scanner failure|1|||
163025973|NCT02939716|588797213|FG004|Overall Study|scanner failure|1|||
163025974|NCT02939716|588797214|FG005|Overall Study|scanner failure|1|||
163025975|NCT01054196|588797220|FG000|Overall Study|Physician Decision|0|||
163025976|NCT01054196|588797221|FG001|Overall Study|Physician Decision|0|||
163025977|NCT01054196|588797222|FG002|Overall Study|Physician Decision|0|||
163025978|NCT01054196|588797223|FG003|Overall Study|Physician Decision|1|||
163025979|NCT01054196|588797224|FG004|Overall Study|Physician Decision|0|||
163025980|NCT01054196|588797225|FG005|Overall Study|Physician Decision|0|||
163025981|NCT01054196|588797226|FG006|Overall Study|Physician Decision|1|||
163025982|NCT01820572|588797231|FG000|Randomization|Not Treated|2|||
163025983|NCT01820572|588797232|FG001|Randomization|Not Treated|1|||
163025984|NCT01820572|588797231|FG000|Treatment Period|Adverse Event|12|||
163025985|NCT01820572|588797232|FG001|Treatment Period|Adverse Event|7|||
163025986|NCT01820572|588797231|FG000|Treatment Period|Death|3|||
163025987|NCT01820572|588797232|FG001|Treatment Period|Death|3|||
163025988|NCT01820572|588797231|FG000|Treatment Period|Lack of Efficacy|1|||
163025989|NCT01820572|588797232|FG001|Treatment Period|Lack of Efficacy|0|||
163025990|NCT01820572|588797231|FG000|Treatment Period|poor/non compliance|0|||
163025991|NCT01820572|588797232|FG001|Treatment Period|poor/non compliance|3|||
163025992|NCT01820572|588797231|FG000|Treatment Period|request to discontinue|6|||
163025993|NCT01820572|588797232|FG001|Treatment Period|request to discontinue|11|||
163025994|NCT01820572|588797231|FG000|Treatment Period|No longer meets study criteria|3|||
163025995|NCT01820572|588797232|FG001|Treatment Period|No longer meets study criteria|10|||
163025996|NCT01820572|588797231|FG000|Treatment Period|withdrew consent|1|||
163025997|NCT01820572|588797232|FG001|Treatment Period|withdrew consent|2|||
163025998|NCT00595517|588797233|FG000|Overall Study|Adverse Event|6|||
163025999|NCT00595517|588797233|FG000|Overall Study|Withdrawal by Subject|4|||
163026000|NCT00595517|588797233|FG000|Overall Study|Protocol Violation|2|||
163026001|NCT00595517|588797233|FG000|Overall Study|Recurrence of ulcer|5|||
163026002|NCT00595517|588797233|FG000|Overall Study|usage of prohibited treatment|1|||
163026003|NCT00595517|588797233|FG000|Overall Study|No intention to attend regularly|1|||
163026004|NCT00387010|588797236|FG000|Dose Titration Period|Adverse Event|12|||
163026005|NCT00387010|588797236|FG000|Dose Titration Period|Lack of Efficacy|5|||
163026006|NCT00387010|588797236|FG000|Dose Titration Period|Withdrawal by Subject|3|||
163026007|NCT00387010|588797236|FG000|Dose Titration Period|Protocol Violation|1|||
163026008|NCT00387010|588797236|FG000|Dose Titration Period|Lost to Follow-up|2|||
163026009|NCT00387010|588797236|FG000|Dose Titration Period|Noncompliance with study medication|8|||
163026010|NCT00387010|588797236|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
163026011|NCT00387010|588797236|FG000|Treatment Period|Adverse Event|4|||
163026012|NCT00387010|588797236|FG000|Treatment Period|Withdrawal by Subject|1|||
163026013|NCT00387010|588797236|FG000|Treatment Period|Noncompliance with study medication|2|||
163026014|NCT00387010|588797236|FG000|Treatment Period|Noncompliance with study procedures|3|||
163026015|NCT00387010|588797236|FG000|Treatment Period|Participant reported study drug stolen|1|||
163067127|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
163330837|NCT03070392|589922434|FG002|Overall Study|Alternate anticancer treatment|0|||
163330838|NCT03070392|589922435|FG003|Overall Study|Alternate anticancer treatment|1|||
163330839|NCT03070392|589922432|FG000|Overall Study|Ongoing|73|||
163026016|NCT01167881|588797241|FG000|Overall Study|Adverse Event|47|||
163026017|NCT01167881|588797242|FG001|Overall Study|Adverse Event|51|||
163026018|NCT01167881|588797241|FG000|Overall Study|Lack of Efficacy|4|||
163026019|NCT01167881|588797242|FG001|Overall Study|Lack of Efficacy|7|||
163026020|NCT01167881|588797241|FG000|Overall Study|Non compliant with protocol|9|||
163026021|NCT01167881|588797242|FG001|Overall Study|Non compliant with protocol|18|||
163330840|NCT03070392|589922433|FG001|Overall Study|Ongoing|0|||
163330841|NCT03070392|589922434|FG002|Overall Study|Ongoing|0|||
163330842|NCT03070392|589922435|FG003|Overall Study|Ongoing|11|||
163026022|NCT01167881|588797241|FG000|Overall Study|Lost to Follow-up|19|||
163026023|NCT01167881|588797242|FG001|Overall Study|Lost to Follow-up|20|||
163026024|NCT01167881|588797241|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
163026025|NCT01167881|588797242|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
163026026|NCT01167881|588797241|FG000|Overall Study|Not treated|4|||
163026027|NCT01167881|588797242|FG001|Overall Study|Not treated|0|||
163026028|NCT01167881|588797241|FG000|Overall Study|Other not defined above|31|||
163026029|NCT01167881|588797242|FG001|Overall Study|Other not defined above|55|||
163026030|NCT01931956|588797243|FG000|Overall Study|Death|42|||
163026031|NCT01931956|588797244|FG001|Overall Study|Death|7|||
163026032|NCT01931956|588797245|FG002|Overall Study|Death|379|||
163026033|NCT01931956|588797246|FG003|Overall Study|Death|96|||
163026034|NCT01931956|588797243|FG000|Overall Study|Withdrawal by Subject|5|||
163026035|NCT01931956|588797244|FG001|Overall Study|Withdrawal by Subject|0|||
163026036|NCT01931956|588797245|FG002|Overall Study|Withdrawal by Subject|70|||
163026037|NCT01931956|588797246|FG003|Overall Study|Withdrawal by Subject|30|||
163026038|NCT01931956|588797243|FG000|Overall Study|Lost to Follow-up|2|||
163026039|NCT01931956|588797244|FG001|Overall Study|Lost to Follow-up|0|||
163026040|NCT01931956|588797245|FG002|Overall Study|Lost to Follow-up|11|||
163026041|NCT01931956|588797246|FG003|Overall Study|Lost to Follow-up|7|||
163026042|NCT01931956|588797243|FG000|Overall Study|Expected|2|||
163026043|NCT01931956|588797244|FG001|Overall Study|Expected|0|||
163026044|NCT01931956|588797245|FG002|Overall Study|Expected|6|||
163026045|NCT01931956|588797246|FG003|Overall Study|Expected|0|||
163026046|NCT01931956|588797243|FG000|Overall Study|Not due|0|||
163026047|NCT01931956|588797244|FG001|Overall Study|Not due|0|||
163026048|NCT01931956|588797245|FG002|Overall Study|Not due|21|||
163026049|NCT01931956|588797246|FG003|Overall Study|Not due|0|||
163026050|NCT02294175|588797247|FG000|Overall Study|Withdrawal by Subject|1|||
163026051|NCT02294175|588797248|FG001|Overall Study|Withdrawal by Subject|2|||
163026052|NCT02294175|588797247|FG000|Overall Study|pt taking excluded medication|3|||
163026053|NCT02294175|588797248|FG001|Overall Study|pt taking excluded medication|1|||
163026054|NCT02294175|588797247|FG000|Overall Study|Protocol Violation|1|||
163026055|NCT02294175|588797248|FG001|Overall Study|Protocol Violation|0|||
163026056|NCT02294175|588797247|FG000|Overall Study|Lost to Follow-up|0|||
163026057|NCT02294175|588797248|FG001|Overall Study|Lost to Follow-up|1|||
163026058|NCT02294175|588797247|FG000|Overall Study|wound healed|0|||
163026059|NCT02294175|588797248|FG001|Overall Study|wound healed|2|||
163026060|NCT02548351|588797249|FG000|Overall Study|Withdrawal by Subject|149|||
163026061|NCT02548351|588797250|FG001|Overall Study|Withdrawal by Subject|154|||
163026062|NCT02548351|588797251|FG002|Overall Study|Withdrawal by Subject|152|||
163026063|NCT02548351|588797249|FG000|Overall Study|Death|11|||
163026064|NCT02548351|588797250|FG001|Overall Study|Death|15|||
163026065|NCT02548351|588797251|FG002|Overall Study|Death|12|||
163026066|NCT02548351|588797249|FG000|Overall Study|Adverse Event|22|||
163026067|NCT02548351|588797250|FG001|Overall Study|Adverse Event|56|||
163026068|NCT02548351|588797251|FG002|Overall Study|Adverse Event|36|||
163026069|NCT02548351|588797249|FG000|Overall Study|Study Terminated by Sponsor|549|||
163026070|NCT02548351|588797250|FG001|Overall Study|Study Terminated by Sponsor|509|||
163026071|NCT02548351|588797251|FG002|Overall Study|Study Terminated by Sponsor|528|||
163026072|NCT02548351|588797249|FG000|Overall Study|Site Closure|14|||
163026073|NCT02548351|588797250|FG001|Overall Study|Site Closure|5|||
163026074|NCT02548351|588797251|FG002|Overall Study|Site Closure|7|||
163026075|NCT02548351|588797249|FG000|Overall Study|Non-compliance with Study Drug|4|||
163026076|NCT02548351|588797250|FG001|Overall Study|Non-compliance with Study Drug|2|||
163026077|NCT02548351|588797251|FG002|Overall Study|Non-compliance with Study Drug|0|||
163026078|NCT02548351|588797249|FG000|Overall Study|Protocol Violation|2|||
163026079|NCT02548351|588797250|FG001|Overall Study|Protocol Violation|1|||
163026080|NCT02548351|588797251|FG002|Overall Study|Protocol Violation|2|||
163026081|NCT02548351|588797249|FG000|Overall Study|Physician Decision|11|||
163026082|NCT02548351|588797250|FG001|Overall Study|Physician Decision|18|||
163026083|NCT02548351|588797251|FG002|Overall Study|Physician Decision|11|||
163026084|NCT02548351|588797249|FG000|Overall Study|Lost to Follow-up|43|||
163026085|NCT02548351|588797250|FG001|Overall Study|Lost to Follow-up|50|||
163026086|NCT02548351|588797251|FG002|Overall Study|Lost to Follow-up|57|||
163026087|NCT02548351|588797249|FG000|Overall Study|Other|19|||
163026088|NCT02548351|588797250|FG001|Overall Study|Other|16|||
163026089|NCT02548351|588797251|FG002|Overall Study|Other|20|||
163026090|NCT02548351|588797249|FG000|Overall Study|Missing|1|||
163026091|NCT02548351|588797250|FG001|Overall Study|Missing|1|||
163026092|NCT02548351|588797251|FG002|Overall Study|Missing|0|||
163026093|NCT01901653|588797252|FG000|Overall Study|Death|2|||
163026094|NCT01901653|588797253|FG001|Overall Study|Death|1|||
163026095|NCT01901653|588797254|FG002|Overall Study|Death|8|||
163026096|NCT01901653|588797255|FG003|Overall Study|Death|3|||
163026097|NCT01901653|588797256|FG004|Overall Study|Death|2|||
163026098|NCT01901653|588797257|FG005|Overall Study|Death|2|||
163026099|NCT01901653|588797258|FG006|Overall Study|Death|6|||
163026100|NCT01901653|588797259|FG007|Overall Study|Death|9|||
163026101|NCT01901653|588797260|FG008|Overall Study|Death|1|||
163026102|NCT01901653|588797261|FG009|Overall Study|Death|16|||
163026103|NCT01901653|588797262|FG010|Overall Study|Death|2|||
163026104|NCT01901653|588797263|FG011|Overall Study|Death|15|||
163067128|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
163067129|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
163067130|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
163067131|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
163067132|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
163067133|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
163067134|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
163067135|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
163067136|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
163067137|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
163067138|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
163067139|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
163067140|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
163067141|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
163067142|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
163067143|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
163067144|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
163067145|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
163067146|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
163067147|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
163067148|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
163067149|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
163067150|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
163067151|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
163067152|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
163067153|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
163067154|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
163067155|NCT01044498|588950859|FG000|Overall Study|Withdrew consent|1|||
163067156|NCT01044498|588950860|FG001|Overall Study|Withdrew consent|1|||
163067157|NCT01044498|588950859|FG000|Overall Study|Adverse Event|1|||
163067158|NCT01044498|588950860|FG001|Overall Study|Adverse Event|1|||
163067159|NCT01044498|588950859|FG000|Overall Study|Other|1|||
163067160|NCT01044498|588950860|FG001|Overall Study|Other|0|||
163067161|NCT02903914|588950865|FG000|Overall Study|Adverse Event|0|||
163067162|NCT02903914|588950866|FG001|Overall Study|Adverse Event|0|||
163067163|NCT02903914|588950867|FG002|Overall Study|Adverse Event|1|||
163067164|NCT02903914|588950868|FG003|Overall Study|Adverse Event|0|||
163067165|NCT02903914|588950869|FG004|Overall Study|Adverse Event|0|||
163067166|NCT02903914|588950870|FG005|Overall Study|Adverse Event|0|||
163067167|NCT02903914|588950871|FG006|Overall Study|Adverse Event|2|||
163067168|NCT02903914|588950872|FG007|Overall Study|Adverse Event|0|||
163067169|NCT02903914|588950865|FG000|Overall Study|Withdrawal by Subject|3|||
163067170|NCT02903914|588950866|FG001|Overall Study|Withdrawal by Subject|1|||
163067171|NCT02903914|588950867|FG002|Overall Study|Withdrawal by Subject|28|||
163067172|NCT02903914|588950868|FG003|Overall Study|Withdrawal by Subject|0|||
163067173|NCT02903914|588950869|FG004|Overall Study|Withdrawal by Subject|1|||
163067174|NCT02903914|588950870|FG005|Overall Study|Withdrawal by Subject|2|||
163067175|NCT02903914|588950871|FG006|Overall Study|Withdrawal by Subject|12|||
163067176|NCT02903914|588950872|FG007|Overall Study|Withdrawal by Subject|0|||
163067177|NCT02903914|588950865|FG000|Overall Study|Progressive Disease|1|||
163067178|NCT02903914|588950866|FG001|Overall Study|Progressive Disease|0|||
163067179|NCT02903914|588950867|FG002|Overall Study|Progressive Disease|4|||
163067180|NCT02903914|588950868|FG003|Overall Study|Progressive Disease|0|||
163067181|NCT02903914|588950869|FG004|Overall Study|Progressive Disease|0|||
163067182|NCT02903914|588950870|FG005|Overall Study|Progressive Disease|0|||
163067183|NCT02903914|588950871|FG006|Overall Study|Progressive Disease|2|||
163067184|NCT02903914|588950872|FG007|Overall Study|Progressive Disease|0|||
163067185|NCT02903914|588950865|FG000|Overall Study|Death|0|||
163067186|NCT02903914|588950866|FG001|Overall Study|Death|0|||
163330843|NCT02972034|589922436|FG000|Overall Study|Death|11|||
163067187|NCT02903914|588950867|FG002|Overall Study|Death|9|||
163067188|NCT02903914|588950868|FG003|Overall Study|Death|0|||
163067189|NCT02903914|588950869|FG004|Overall Study|Death|1|||
163067190|NCT02903914|588950870|FG005|Overall Study|Death|3|||
163067191|NCT02903914|588950871|FG006|Overall Study|Death|24|||
163067192|NCT02903914|588950872|FG007|Overall Study|Death|2|||
163067193|NCT02903914|588950865|FG000|Overall Study|Lost to Follow-up|0|||
163067194|NCT02903914|588950866|FG001|Overall Study|Lost to Follow-up|1|||
163067195|NCT02903914|588950867|FG002|Overall Study|Lost to Follow-up|0|||
163067196|NCT02903914|588950868|FG003|Overall Study|Lost to Follow-up|0|||
163067197|NCT02903914|588950869|FG004|Overall Study|Lost to Follow-up|2|||
163067198|NCT02903914|588950870|FG005|Overall Study|Lost to Follow-up|0|||
163067199|NCT02903914|588950871|FG006|Overall Study|Lost to Follow-up|1|||
163067200|NCT02903914|588950872|FG007|Overall Study|Lost to Follow-up|0|||
163067201|NCT02903914|588950865|FG000|Overall Study|Physician Decision|0|||
163067202|NCT02903914|588950866|FG001|Overall Study|Physician Decision|0|||
163067203|NCT02903914|588950867|FG002|Overall Study|Physician Decision|1|||
163067204|NCT02903914|588950868|FG003|Overall Study|Physician Decision|0|||
163067205|NCT02903914|588950869|FG004|Overall Study|Physician Decision|0|||
163067206|NCT02903914|588950870|FG005|Overall Study|Physician Decision|0|||
163067207|NCT02903914|588950871|FG006|Overall Study|Physician Decision|1|||
163067208|NCT02903914|588950872|FG007|Overall Study|Physician Decision|0|||
163067209|NCT02903914|588950865|FG000|Overall Study|Symptomatic Deterioration|0|||
163067210|NCT02903914|588950866|FG001|Overall Study|Symptomatic Deterioration|0|||
163067211|NCT02903914|588950867|FG002|Overall Study|Symptomatic Deterioration|1|||
163067212|NCT02903914|588950868|FG003|Overall Study|Symptomatic Deterioration|0|||
163067213|NCT02903914|588950869|FG004|Overall Study|Symptomatic Deterioration|0|||
163067214|NCT02903914|588950870|FG005|Overall Study|Symptomatic Deterioration|0|||
163067215|NCT02903914|588950871|FG006|Overall Study|Symptomatic Deterioration|0|||
163067216|NCT02903914|588950872|FG007|Overall Study|Symptomatic Deterioration|0|||
163067217|NCT02903914|588950865|FG000|Overall Study|New Cancer Therapy|2|||
163067218|NCT02903914|588950866|FG001|Overall Study|New Cancer Therapy|2|||
163067219|NCT02903914|588950867|FG002|Overall Study|New Cancer Therapy|21|||
163067220|NCT02903914|588950868|FG003|Overall Study|New Cancer Therapy|4|||
163067221|NCT02903914|588950869|FG004|Overall Study|New Cancer Therapy|3|||
163067222|NCT02903914|588950870|FG005|Overall Study|New Cancer Therapy|6|||
163067223|NCT02903914|588950871|FG006|Overall Study|New Cancer Therapy|56|||
163067224|NCT02903914|588950872|FG007|Overall Study|New Cancer Therapy|3|||
163067225|NCT02903914|588950865|FG000|Overall Study|Didn't Return to Site|1|||
163067226|NCT02903914|588950866|FG001|Overall Study|Didn't Return to Site|0|||
163067227|NCT02903914|588950867|FG002|Overall Study|Didn't Return to Site|1|||
163067228|NCT02903914|588950868|FG003|Overall Study|Didn't Return to Site|1|||
163067229|NCT02903914|588950869|FG004|Overall Study|Didn't Return to Site|0|||
163067230|NCT02903914|588950870|FG005|Overall Study|Didn't Return to Site|0|||
163067231|NCT02903914|588950871|FG006|Overall Study|Didn't Return to Site|2|||
163067232|NCT02903914|588950872|FG007|Overall Study|Didn't Return to Site|0|||
163067233|NCT02903914|588950865|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
163067234|NCT02903914|588950866|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
163067235|NCT02903914|588950867|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
163067236|NCT02903914|588950868|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
163067237|NCT02903914|588950869|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
163067238|NCT02903914|588950870|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
163067239|NCT02903914|588950871|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
163067240|NCT02903914|588950872|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
163067241|NCT02903914|588950865|FG000|Overall Study|Follow-up Did Not Occur|0|||
163067242|NCT02903914|588950866|FG001|Overall Study|Follow-up Did Not Occur|1|||
163067243|NCT02903914|588950867|FG002|Overall Study|Follow-up Did Not Occur|1|||
163067244|NCT02903914|588950868|FG003|Overall Study|Follow-up Did Not Occur|0|||
163067245|NCT02903914|588950869|FG004|Overall Study|Follow-up Did Not Occur|2|||
163067246|NCT02903914|588950870|FG005|Overall Study|Follow-up Did Not Occur|0|||
163067247|NCT02903914|588950871|FG006|Overall Study|Follow-up Did Not Occur|8|||
163067248|NCT02903914|588950872|FG007|Overall Study|Follow-up Did Not Occur|0|||
163067249|NCT02903914|588950865|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
163067250|NCT02903914|588950866|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
163067251|NCT02903914|588950867|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
163067252|NCT02903914|588950868|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
163067253|NCT02903914|588950869|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
163067254|NCT02903914|588950870|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
163067255|NCT02903914|588950871|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
163067256|NCT02903914|588950872|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
163067257|NCT02903914|588950865|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
163067258|NCT02903914|588950866|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
163067259|NCT02903914|588950867|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
163067260|NCT02903914|588950868|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
163067261|NCT02903914|588950869|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
163067262|NCT02903914|588950870|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
163067263|NCT02903914|588950871|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
163067264|NCT02903914|588950872|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
163067265|NCT02903914|588950865|FG000|Overall Study|Clinical Disease Progression|0|||
163067266|NCT02903914|588950866|FG001|Overall Study|Clinical Disease Progression|0|||
163067267|NCT02903914|588950867|FG002|Overall Study|Clinical Disease Progression|2|||
163067268|NCT02903914|588950868|FG003|Overall Study|Clinical Disease Progression|0|||
163067269|NCT02903914|588950869|FG004|Overall Study|Clinical Disease Progression|0|||
163067270|NCT02903914|588950870|FG005|Overall Study|Clinical Disease Progression|0|||
163067271|NCT02903914|588950871|FG006|Overall Study|Clinical Disease Progression|0|||
163067272|NCT02903914|588950872|FG007|Overall Study|Clinical Disease Progression|0|||
163067273|NCT02903914|588950865|FG000|Overall Study|Completed Follow-up Period|0|||
163067274|NCT02903914|588950866|FG001|Overall Study|Completed Follow-up Period|0|||
163067275|NCT02903914|588950867|FG002|Overall Study|Completed Follow-up Period|6|||
163067276|NCT02903914|588950868|FG003|Overall Study|Completed Follow-up Period|2|||
163067277|NCT02903914|588950869|FG004|Overall Study|Completed Follow-up Period|1|||
163067278|NCT02903914|588950870|FG005|Overall Study|Completed Follow-up Period|0|||
163067279|NCT02903914|588950871|FG006|Overall Study|Completed Follow-up Period|9|||
163067280|NCT02903914|588950872|FG007|Overall Study|Completed Follow-up Period|1|||
163067281|NCT02903914|588950865|FG000|Overall Study|Taken off Treatment per Protocol|0|||
163067282|NCT02903914|588950866|FG001|Overall Study|Taken off Treatment per Protocol|0|||
163067283|NCT02903914|588950867|FG002|Overall Study|Taken off Treatment per Protocol|0|||
163067284|NCT02903914|588950868|FG003|Overall Study|Taken off Treatment per Protocol|0|||
163067285|NCT02903914|588950869|FG004|Overall Study|Taken off Treatment per Protocol|0|||
163067286|NCT02903914|588950870|FG005|Overall Study|Taken off Treatment per Protocol|1|||
163067287|NCT02903914|588950871|FG006|Overall Study|Taken off Treatment per Protocol|0|||
163067288|NCT02903914|588950872|FG007|Overall Study|Taken off Treatment per Protocol|0|||
163067289|NCT02903914|588950865|FG000|Overall Study|Refused Further Treatment/Contact|0|||
163067290|NCT02903914|588950866|FG001|Overall Study|Refused Further Treatment/Contact|0|||
163067291|NCT02903914|588950867|FG002|Overall Study|Refused Further Treatment/Contact|0|||
163067292|NCT02903914|588950868|FG003|Overall Study|Refused Further Treatment/Contact|0|||
163067293|NCT02903914|588950869|FG004|Overall Study|Refused Further Treatment/Contact|0|||
163067294|NCT02903914|588950870|FG005|Overall Study|Refused Further Treatment/Contact|0|||
163067295|NCT02903914|588950871|FG006|Overall Study|Refused Further Treatment/Contact|1|||
163067296|NCT02903914|588950872|FG007|Overall Study|Refused Further Treatment/Contact|0|||
163067297|NCT02903914|588950865|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
163067298|NCT02903914|588950866|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
163067299|NCT02903914|588950867|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
163067300|NCT02903914|588950868|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
163067301|NCT02903914|588950869|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
163067302|NCT02903914|588950870|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
163067303|NCT02903914|588950871|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
163067304|NCT02903914|588950872|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
163067305|NCT03487445|588950875|FG000|Randomization|Not treated for administrative reasons|1|||
163067306|NCT03487445|588950876|FG001|Randomization|Not treated for administrative reasons|0|||
163067307|NCT04132050|588950881|FG000|Period I (Double-blind Period)|Adverse Event|3|||
163067308|NCT04132050|588950882|FG001|Period I (Double-blind Period)|Adverse Event|0|||
163067309|NCT04132050|588950881|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
163067310|NCT04132050|588950882|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
163067311|NCT04132050|588950881|FG000|R788 Treatment Period|Adverse Event|5|||
163067312|NCT04132050|588950882|FG001|R788 Treatment Period|Adverse Event|0|||
163067313|NCT04132050|588950881|FG000|R788 Treatment Period|Lack of Efficacy|5|||
163067314|NCT04132050|588950882|FG001|R788 Treatment Period|Lack of Efficacy|0|||
163067315|NCT04132050|588950881|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
163067316|NCT04132050|588950882|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
163067317|NCT02406612|588950892|FG000|Overall Study|Screening Failure|3|||
163067318|NCT02406612|588950893|FG001|Overall Study|Screening Failure|0|||
163067319|NCT02406612|588950892|FG000|Overall Study|Intra-procedural Exclusion|1|||
163067320|NCT02406612|588950893|FG001|Overall Study|Intra-procedural Exclusion|3|||
163067321|NCT02406612|588950892|FG000|Overall Study|Guidewire Failure|0|||
163067322|NCT02406612|588950893|FG001|Overall Study|Guidewire Failure|1|||
163067323|NCT03483012|588950897|FG000|Overall Study|Lack of Efficacy|6|||
163067324|NCT02900976|588950898|FG000|Overall Study|Adverse Event|0|||
163067325|NCT02900976|588950899|FG001|Overall Study|Adverse Event|1|||
163067326|NCT02900976|588950898|FG000|Overall Study|Physician Decision|0|||
163067327|NCT02900976|588950899|FG001|Overall Study|Physician Decision|2|||
163067328|NCT02900976|588950898|FG000|Overall Study|Progressive disease|0|||
163067329|NCT02900976|588950899|FG001|Overall Study|Progressive disease|6|||
163067330|NCT03611946|588950906|FG000|Overall Study|Withdrawal by Subject|0|||
163067331|NCT03611946|588950907|FG001|Overall Study|Withdrawal by Subject|0|||
163067332|NCT03611946|588950908|FG002|Overall Study|Withdrawal by Subject|1|||
163067333|NCT03611946|588950909|FG003|Overall Study|Withdrawal by Subject|0|||
163067334|NCT02872714|588950913|FG000|Overall Study|Progressive Disease|1|||
163330844|NCT02972034|589922437|FG001|Overall Study|Death|1|||
163330845|NCT02972034|589922438|FG002|Overall Study|Death|3|||
163067335|NCT02872714|588950914|FG001|Overall Study|Progressive Disease|2|||
163067336|NCT02872714|588950915|FG002|Overall Study|Progressive Disease|0|||
163067337|NCT02872714|588950916|FG003|Overall Study|Progressive Disease|0|||
163067338|NCT02872714|588950917|FG004|Overall Study|Progressive Disease|0|||
163330846|NCT02972034|589922439|FG003|Overall Study|Death|3|||
163330847|NCT02972034|589922440|FG004|Overall Study|Death|2|||
163067339|NCT02872714|588950913|FG000|Overall Study|Death|87|||
163067340|NCT02872714|588950914|FG001|Overall Study|Death|36|||
163067341|NCT02872714|588950915|FG002|Overall Study|Death|8|||
163067342|NCT02872714|588950916|FG003|Overall Study|Death|81|||
163067343|NCT02872714|588950917|FG004|Overall Study|Death|2|||
163330848|NCT02972034|589922441|FG005|Overall Study|Death|2|||
163067344|NCT02872714|588950913|FG000|Overall Study|Lost to Follow-up|2|||
163067345|NCT02872714|588950914|FG001|Overall Study|Lost to Follow-up|1|||
163067346|NCT02872714|588950915|FG002|Overall Study|Lost to Follow-up|0|||
163330849|NCT02972034|589922442|FG006|Overall Study|Death|3|||
163330850|NCT02972034|589922443|FG007|Overall Study|Death|4|||
163067347|NCT02872714|588950916|FG003|Overall Study|Lost to Follow-up|3|||
163067348|NCT02872714|588950917|FG004|Overall Study|Lost to Follow-up|0|||
163067349|NCT02872714|588950913|FG000|Overall Study|Physician Decision|0|||
163067350|NCT02872714|588950914|FG001|Overall Study|Physician Decision|0|||
163067351|NCT02872714|588950915|FG002|Overall Study|Physician Decision|0|||
163067352|NCT02872714|588950916|FG003|Overall Study|Physician Decision|1|||
163067353|NCT02872714|588950917|FG004|Overall Study|Physician Decision|0|||
163067354|NCT02872714|588950913|FG000|Overall Study|Withdrawal by Subject|1|||
163067355|NCT02872714|588950914|FG001|Overall Study|Withdrawal by Subject|3|||
163067356|NCT02872714|588950915|FG002|Overall Study|Withdrawal by Subject|0|||
163067357|NCT02872714|588950916|FG003|Overall Study|Withdrawal by Subject|2|||
163067358|NCT02872714|588950917|FG004|Overall Study|Withdrawal by Subject|0|||
163067359|NCT02872714|588950913|FG000|Overall Study|Captured as Other|2|||
163067360|NCT02872714|588950914|FG001|Overall Study|Captured as Other|0|||
163067361|NCT02872714|588950915|FG002|Overall Study|Captured as Other|0|||
163067362|NCT02872714|588950916|FG003|Overall Study|Captured as Other|1|||
163067363|NCT02872714|588950917|FG004|Overall Study|Captured as Other|0|||
163067364|NCT06717399|588950918|FG000|Overall Study|Death|1|||
163067365|NCT03043573|588950919|FG000|Overall Study|Lost to Follow-up|3|||
163067366|NCT03043573|588950920|FG001|Overall Study|Lost to Follow-up|3|||
163067367|NCT03043573|588950919|FG000|Overall Study|Physician Decision|0|||
163067368|NCT03043573|588950920|FG001|Overall Study|Physician Decision|5|||
163067369|NCT03043573|588950919|FG000|Overall Study|Withdrawal by Subject|0|||
163067370|NCT03043573|588950920|FG001|Overall Study|Withdrawal by Subject|4|||
163067371|NCT03580928|588950921|FG000|Overall Study|Death|0|||
163067372|NCT03580928|588950922|FG001|Overall Study|Death|3|||
163067373|NCT03580928|588950921|FG000|Overall Study|Withdrawal by Subject|2|||
163067374|NCT03580928|588950922|FG001|Overall Study|Withdrawal by Subject|1|||
163067375|NCT03580928|588950921|FG000|Overall Study|Lost to Follow-up|2|||
163067376|NCT03580928|588950922|FG001|Overall Study|Lost to Follow-up|0|||
163067377|NCT03580928|588950921|FG000|Overall Study|Progressive Disease|0|||
163067378|NCT03580928|588950922|FG001|Overall Study|Progressive Disease|1|||
163067379|NCT00484159|588952512|FG000|Overall Study|Lost to Follow-up|1|||
163067380|NCT00484159|588952513|FG001|Overall Study|Lost to Follow-up|1|||
163067381|NCT00484159|588952514|FG002|Overall Study|Lost to Follow-up|0|||
163067382|NCT01239680|588952517|FG000|Overall Study|Withdrawal by Subject|2|||
163067383|NCT01239680|588952518|FG001|Overall Study|Withdrawal by Subject|0|||
163067384|NCT00639379|588952519|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
163067385|NCT00639379|588952520|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
163067386|NCT00639379|588952519|FG000|Period 1 - 2 Weeks|lens issue|3|||
163067387|NCT00639379|588952520|FG001|Period 1 - 2 Weeks|lens issue|0|||
163067388|NCT01797185|588952521|FG000|Overall Study|Adverse Event|5|||
163067389|NCT01797185|588952522|FG001|Overall Study|Adverse Event|15|||
163067390|NCT01797185|588952523|FG002|Overall Study|Adverse Event|6|||
163067391|NCT01797185|588952521|FG000|Overall Study|Withdrawal by Subject|6|||
163067392|NCT01797185|588952522|FG001|Overall Study|Withdrawal by Subject|9|||
163067393|NCT01797185|588952523|FG002|Overall Study|Withdrawal by Subject|5|||
163067394|NCT01797185|588952521|FG000|Overall Study|Site terminated|8|||
163067395|NCT01797185|588952522|FG001|Overall Study|Site terminated|4|||
163067396|NCT01797185|588952523|FG002|Overall Study|Site terminated|0|||
163330851|NCT02972034|589922444|FG008|Overall Study|Death|8|||
163330852|NCT02972034|589922445|FG009|Overall Study|Death|11|||
163330853|NCT02972034|589922446|FG010|Overall Study|Death|3|||
163330854|NCT02972034|589922447|FG011|Overall Study|Death|2|||
163330855|NCT02972034|589922448|FG012|Overall Study|Death|11|||
163067397|NCT01797185|588952521|FG000|Overall Study|Lost to Follow-up|2|||
163067398|NCT01797185|588952522|FG001|Overall Study|Lost to Follow-up|6|||
163330856|NCT02972034|589922449|FG013|Overall Study|Death|10|||
163330857|NCT02972034|589922450|FG014|Overall Study|Death|9|||
163067399|NCT01797185|588952523|FG002|Overall Study|Lost to Follow-up|1|||
163067400|NCT01797185|588952521|FG000|Overall Study|Withdrawn per sponsor|5|||
163067401|NCT01797185|588952522|FG001|Overall Study|Withdrawn per sponsor|0|||
163067402|NCT01797185|588952523|FG002|Overall Study|Withdrawn per sponsor|0|||
163067403|NCT01797185|588952521|FG000|Overall Study|Physician Decision|1|||
163067404|NCT01797185|588952522|FG001|Overall Study|Physician Decision|3|||
163067405|NCT01797185|588952523|FG002|Overall Study|Physician Decision|0|||
163067406|NCT01797185|588952521|FG000|Overall Study|Protocol Violation|1|||
163067407|NCT01797185|588952522|FG001|Overall Study|Protocol Violation|1|||
163067408|NCT01797185|588952523|FG002|Overall Study|Protocol Violation|0|||
163067409|NCT01033942|588952524|FG000|Overall Study|Withdrawal by Subject|1|||
163067410|NCT01033942|588952525|FG001|Overall Study|Withdrawal by Subject|1|||
163067411|NCT01033942|588952526|FG002|Overall Study|Withdrawal by Subject|1|||
163067412|NCT01033942|588952524|FG000|Overall Study|Lost to Follow-up|1|||
163067413|NCT01033942|588952525|FG001|Overall Study|Lost to Follow-up|0|||
163330858|NCT02972034|589922436|FG000|Overall Study|Lost to Follow-up|0|||
163067414|NCT01033942|588952526|FG002|Overall Study|Lost to Follow-up|0|||
163067415|NCT01033942|588952524|FG000|Overall Study|Enrolled in Extension Study|0|||
163067416|NCT01033942|588952525|FG001|Overall Study|Enrolled in Extension Study|3|||
163067417|NCT01033942|588952526|FG002|Overall Study|Enrolled in Extension Study|0|||
163067418|NCT02115386|588952533|FG000|Overall Study|Protocol Violation|1|||
163067419|NCT02115386|588952533|FG000|Overall Study|Administrative - trial was terminated|6|||
163067420|NCT02493855|588952534|FG000|Overall Study|Non-compliance|1|||
163067421|NCT02493855|588952535|FG001|Overall Study|Non-compliance|0|||
163067422|NCT02493855|588952536|FG002|Overall Study|Non-compliance|0|||
163067423|NCT02493855|588952534|FG000|Overall Study|Adverse Event|0|||
163067424|NCT02493855|588952535|FG001|Overall Study|Adverse Event|1|||
163067425|NCT02493855|588952536|FG002|Overall Study|Adverse Event|0|||
163067426|NCT02493855|588952534|FG000|Overall Study|Withdrawal by Subject|1|||
163067427|NCT02493855|588952535|FG001|Overall Study|Withdrawal by Subject|0|||
163067428|NCT02493855|588952536|FG002|Overall Study|Withdrawal by Subject|0|||
163067429|NCT02299167|588952537|FG000|Overall Study|patients were excluded from the study|11|||
163067430|NCT03600428|588952538|FG000|Overall Study|Not eligible|0|||
163067431|NCT03600428|588952539|FG001|Overall Study|Not eligible|1|||
163067432|NCT03600428|588952538|FG000|Overall Study|Lost to Follow-up|5|||
163067433|NCT03600428|588952539|FG001|Overall Study|Lost to Follow-up|4|||
163067434|NCT00549328|588952540|FG000|Overall Study|Adverse Event|2|||
163067435|NCT00549328|588952540|FG000|Overall Study|Disease Progression|10|||
163067436|NCT00549328|588952540|FG000|Overall Study|Death|1|||
163067437|NCT00549328|588952540|FG000|Overall Study|Use of Prohibited Medication|1|||
163067438|NCT04868682|588952546|FG000|Post-treatment|Lost to Follow-up|1|||
163067439|NCT04868682|588952547|FG001|Post-treatment|Lost to Follow-up|1|||
163067440|NCT04868682|588952546|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
163067441|NCT04868682|588952547|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
163067442|NCT04868682|588952546|FG000|Six-month Assessment|Lost to Follow-up|1|||
163067443|NCT04868682|588952547|FG001|Six-month Assessment|Lost to Follow-up|0|||
163330859|NCT02972034|589922437|FG001|Overall Study|Lost to Follow-up|0|||
163330860|NCT02972034|589922438|FG002|Overall Study|Lost to Follow-up|0|||
163330861|NCT02972034|589922439|FG003|Overall Study|Lost to Follow-up|0|||
163067444|NCT04868682|588952546|FG000|Six-month Assessment|Death|1|||
163067445|NCT04868682|588952547|FG001|Six-month Assessment|Death|0|||
163067446|NCT04868682|588952546|FG000|Six-month Assessment|Refused|0|||
163067447|NCT04868682|588952547|FG001|Six-month Assessment|Refused|1|||
163067448|NCT04868682|588952546|FG000|12-month Assessment|Lost to Follow-up|2|||
163067449|NCT04868682|588952547|FG001|12-month Assessment|Lost to Follow-up|1|||
163067450|NCT04868682|588952546|FG000|12-month Assessment|Death|0|||
163067451|NCT04868682|588952547|FG001|12-month Assessment|Death|1|||
163067452|NCT03880565|588952551|FG000|Overall Study|Withdrawal by Subject|1|||
163217696|NCT04475588|589513773|FG001|Overall Study|Adverse Event|0|||
163217697|NCT01327300|589513774|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
163217698|NCT01327300|589513775|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
163217699|NCT05620576|589513776|FG000|Overall Study|Adverse Event|1|||
163217700|NCT05620576|589513777|FG001|Overall Study|Adverse Event|1|||
163217701|NCT05620576|589513776|FG000|Overall Study|Lost to Follow-up|3|||
163330862|NCT02972034|589922440|FG004|Overall Study|Lost to Follow-up|1|||
163330863|NCT02972034|589922441|FG005|Overall Study|Lost to Follow-up|0|||
163217702|NCT05620576|589513777|FG001|Overall Study|Lost to Follow-up|1|||
163217703|NCT05620576|589513776|FG000|Overall Study|Physician Decision|0|||
163330864|NCT02972034|589922442|FG006|Overall Study|Lost to Follow-up|0|||
163330865|NCT02972034|589922443|FG007|Overall Study|Lost to Follow-up|1|||
163330866|NCT02972034|589922444|FG008|Overall Study|Lost to Follow-up|0|||
163330867|NCT02972034|589922445|FG009|Overall Study|Lost to Follow-up|0|||
163330868|NCT02972034|589922446|FG010|Overall Study|Lost to Follow-up|0|||
163330869|NCT02972034|589922447|FG011|Overall Study|Lost to Follow-up|0|||
163330870|NCT02972034|589922448|FG012|Overall Study|Lost to Follow-up|0|||
163330871|NCT02972034|589922449|FG013|Overall Study|Lost to Follow-up|0|||
163330872|NCT02972034|589922450|FG014|Overall Study|Lost to Follow-up|1|||
163330873|NCT02972034|589922436|FG000|Overall Study|Physician Decision|0|||
163330874|NCT02972034|589922437|FG001|Overall Study|Physician Decision|0|||
163330875|NCT02972034|589922438|FG002|Overall Study|Physician Decision|0|||
163330876|NCT02972034|589922439|FG003|Overall Study|Physician Decision|0|||
163330877|NCT02972034|589922440|FG004|Overall Study|Physician Decision|0|||
163330878|NCT02972034|589922441|FG005|Overall Study|Physician Decision|0|||
163067453|NCT03880565|588952552|FG001|Overall Study|Withdrawal by Subject|0|||
163067454|NCT02202616|588952553|FG000|Overall Study|Screen failed|24|||
163067455|NCT02202616|588952553|FG000|Overall Study|Adverse Event|32|||
163067456|NCT02202616|588952553|FG000|Overall Study|Protocol deviation|18|||
163067457|NCT02202616|588952553|FG000|Overall Study|Patient withdrew consent|12|||
163217704|NCT05620576|589513777|FG001|Overall Study|Physician Decision|1|||
163067458|NCT02202616|588952553|FG000|Overall Study|Lost to Follow-up|6|||
163067459|NCT02202616|588952553|FG000|Overall Study|Administrative problems|6|||
163217705|NCT05620576|589513776|FG000|Overall Study|Protocol Deviation|1|||
163217706|NCT05620576|589513777|FG001|Overall Study|Protocol Deviation|1|||
163217707|NCT05620576|589513776|FG000|Overall Study|Withdrawal by Subject|2|||
163330879|NCT02972034|589922442|FG006|Overall Study|Physician Decision|0|||
163330880|NCT02972034|589922443|FG007|Overall Study|Physician Decision|1|||
163330881|NCT02972034|589922444|FG008|Overall Study|Physician Decision|0|||
163330882|NCT02972034|589922445|FG009|Overall Study|Physician Decision|0|||
163330883|NCT02972034|589922446|FG010|Overall Study|Physician Decision|1|||
163330884|NCT02972034|589922447|FG011|Overall Study|Physician Decision|0|||
163330885|NCT02972034|589922448|FG012|Overall Study|Physician Decision|0|||
163026105|NCT01901653|588797264|FG012|Overall Study|Death|4|||
163026106|NCT01901653|588797252|FG000|Overall Study|Lost to Follow-up|1|||
163026107|NCT01901653|588797253|FG001|Overall Study|Lost to Follow-up|0|||
163026108|NCT01901653|588797254|FG002|Overall Study|Lost to Follow-up|2|||
163026109|NCT01901653|588797255|FG003|Overall Study|Lost to Follow-up|0|||
163026110|NCT01901653|588797256|FG004|Overall Study|Lost to Follow-up|0|||
163026111|NCT01901653|588797257|FG005|Overall Study|Lost to Follow-up|1|||
163026112|NCT01901653|588797258|FG006|Overall Study|Lost to Follow-up|0|||
163026113|NCT01901653|588797259|FG007|Overall Study|Lost to Follow-up|1|||
163026114|NCT01901653|588797260|FG008|Overall Study|Lost to Follow-up|0|||
163026115|NCT01901653|588797261|FG009|Overall Study|Lost to Follow-up|0|||
163026116|NCT01901653|588797262|FG010|Overall Study|Lost to Follow-up|0|||
163026117|NCT01901653|588797263|FG011|Overall Study|Lost to Follow-up|0|||
163026118|NCT01901653|588797264|FG012|Overall Study|Lost to Follow-up|0|||
163026119|NCT01901653|588797252|FG000|Overall Study|Withdrawal by Subject|0|||
163026120|NCT01901653|588797253|FG001|Overall Study|Withdrawal by Subject|0|||
163026121|NCT01901653|588797254|FG002|Overall Study|Withdrawal by Subject|0|||
163026122|NCT01901653|588797255|FG003|Overall Study|Withdrawal by Subject|0|||
163026123|NCT01901653|588797256|FG004|Overall Study|Withdrawal by Subject|0|||
163026124|NCT01901653|588797257|FG005|Overall Study|Withdrawal by Subject|0|||
163026125|NCT01901653|588797258|FG006|Overall Study|Withdrawal by Subject|1|||
163026126|NCT01901653|588797259|FG007|Overall Study|Withdrawal by Subject|0|||
163026127|NCT01901653|588797260|FG008|Overall Study|Withdrawal by Subject|0|||
163026128|NCT01901653|588797261|FG009|Overall Study|Withdrawal by Subject|0|||
163026129|NCT01901653|588797262|FG010|Overall Study|Withdrawal by Subject|0|||
163026130|NCT01901653|588797263|FG011|Overall Study|Withdrawal by Subject|0|||
163026131|NCT01901653|588797264|FG012|Overall Study|Withdrawal by Subject|0|||
163026132|NCT01901653|588797252|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
163026133|NCT01901653|588797253|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
163026134|NCT01901653|588797254|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
163026135|NCT01901653|588797255|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
163026136|NCT01901653|588797256|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
163026137|NCT01901653|588797257|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
163026138|NCT01901653|588797258|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
163026139|NCT01901653|588797259|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
163026140|NCT01901653|588797260|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
163026141|NCT01901653|588797261|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
163026142|NCT01901653|588797262|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
163026143|NCT01901653|588797263|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
163026144|NCT01901653|588797264|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
163026145|NCT01295827|588797269|FG000|Overall Study|Adverse Event|1|||
163026146|NCT01295827|588797270|FG001|Overall Study|Adverse Event|2|||
163026147|NCT01295827|588797271|FG002|Overall Study|Adverse Event|2|||
163026148|NCT01295827|588797272|FG003|Overall Study|Adverse Event|1|||
163026149|NCT01295827|588797273|FG004|Overall Study|Adverse Event|1|||
163026150|NCT01295827|588797274|FG005|Overall Study|Adverse Event|4|||
163026151|NCT01295827|588797275|FG006|Overall Study|Adverse Event|15|||
163026152|NCT01295827|588797276|FG007|Overall Study|Adverse Event|49|||
163026153|NCT01295827|588797277|FG008|Overall Study|Adverse Event|22|||
163026154|NCT01295827|588797278|FG009|Overall Study|Adverse Event|7|||
163026155|NCT01295827|588797279|FG010|Overall Study|Adverse Event|50|||
163026156|NCT01295827|588797280|FG011|Overall Study|Adverse Event|21|||
163067460|NCT02202616|588952553|FG000|Overall Study|Abnormal test procedure result|1|||
163026157|NCT01295827|588797281|FG012|Overall Study|Adverse Event|0|||
163026158|NCT01295827|588797282|FG013|Overall Study|Adverse Event|0|||
163026159|NCT01295827|588797283|FG014|Overall Study|Adverse Event|0|||
163026160|NCT01295827|588797269|FG000|Overall Study|Lost to Follow-up|0|||
163026161|NCT01295827|588797270|FG001|Overall Study|Lost to Follow-up|0|||
163067461|NCT02202616|588952553|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163026162|NCT01295827|588797271|FG002|Overall Study|Lost to Follow-up|3|||
163026163|NCT01295827|588797272|FG003|Overall Study|Lost to Follow-up|0|||
163026164|NCT01295827|588797273|FG004|Overall Study|Lost to Follow-up|1|||
163026165|NCT01295827|588797274|FG005|Overall Study|Lost to Follow-up|0|||
163026166|NCT01295827|588797275|FG006|Overall Study|Lost to Follow-up|4|||
163026167|NCT01295827|588797276|FG007|Overall Study|Lost to Follow-up|8|||
163026168|NCT01295827|588797277|FG008|Overall Study|Lost to Follow-up|7|||
163026169|NCT01295827|588797278|FG009|Overall Study|Lost to Follow-up|4|||
163330886|NCT02972034|589922449|FG013|Overall Study|Physician Decision|0|||
163330887|NCT02972034|589922450|FG014|Overall Study|Physician Decision|0|||
163330888|NCT02972034|589922436|FG000|Overall Study|Sponsor Decision|0|||
163067462|NCT04327271|588952557|FG000|Overall Study|Death|1|||
163067463|NCT04327271|588952558|FG001|Overall Study|Death|0|||
163067464|NCT04327271|588952557|FG000|Overall Study|Withdrawal by Subject|1|||
163067465|NCT04327271|588952558|FG001|Overall Study|Withdrawal by Subject|0|||
163067466|NCT04327271|588952557|FG000|Overall Study|randomization error (data capture)|4|||
163067467|NCT04327271|588952558|FG001|Overall Study|randomization error (data capture)|3|||
163067468|NCT01695746|588952562|FG000|Overall Study|Adverse Event|1|||
163067469|NCT01695746|588952562|FG000|Overall Study|Non-compliance by the participant|3|||
163067470|NCT01695746|588952562|FG000|Overall Study|Protocol Violation|5|||
163067471|NCT01695746|588952562|FG000|Overall Study|Participant not willing to participate|3|||
163067472|NCT03506477|588952568|FG000|Overall Study|Withdrawal by Subject|1|||
163067473|NCT03506477|588952569|FG001|Overall Study|Withdrawal by Subject|0|||
163067474|NCT03462680|588952570|FG000|Overall Study|Withdrawal by Subject|3|||
163067475|NCT03462680|588952571|FG001|Overall Study|Withdrawal by Subject|5|||
163067476|NCT02516241|588952572|FG000|Overall Study|Death|255|||
163067477|NCT02516241|588952573|FG001|Overall Study|Death|262|||
163067478|NCT02516241|588952574|FG002|Overall Study|Death|270|||
163067479|NCT02516241|588952572|FG000|Overall Study|Lost to Follow-up|1|||
163067480|NCT02516241|588952573|FG001|Overall Study|Lost to Follow-up|1|||
163067481|NCT02516241|588952574|FG002|Overall Study|Lost to Follow-up|3|||
163067482|NCT02516241|588952572|FG000|Overall Study|Withdrawal by Subject|2|||
163067483|NCT02516241|588952573|FG001|Overall Study|Withdrawal by Subject|7|||
163067484|NCT02516241|588952574|FG002|Overall Study|Withdrawal by Subject|12|||
163067485|NCT02516241|588952572|FG000|Overall Study|participants ongoing at data cut-off|84|||
163067486|NCT02516241|588952573|FG001|Overall Study|participants ongoing at data cut-off|76|||
163067487|NCT02516241|588952574|FG002|Overall Study|participants ongoing at data cut-off|59|||
163067488|NCT00462462|588952576|FG000|Overall Study|Physician Decision|0|||
163067489|NCT00462462|588952577|FG001|Overall Study|Physician Decision|1|||
163217708|NCT05620576|589513777|FG001|Overall Study|Withdrawal by Subject|3|||
163217709|NCT02603432|589513778|FG000|Overall Study|Adverse Event|1|||
163217710|NCT02603432|589513779|FG001|Overall Study|Adverse Event|0|||
163217711|NCT02603432|589513778|FG000|Overall Study|Death|221|||
163217712|NCT02603432|589513779|FG001|Overall Study|Death|242|||
163217713|NCT02603432|589513778|FG000|Overall Study|Lost to Follow-up|3|||
163217714|NCT02603432|589513779|FG001|Overall Study|Lost to Follow-up|9|||
163217715|NCT02603432|589513778|FG000|Overall Study|Progressive Disease|7|||
163217716|NCT02603432|589513779|FG001|Overall Study|Progressive Disease|5|||
163217717|NCT02603432|589513778|FG000|Overall Study|Withdrawal by Subject|12|||
163217718|NCT02603432|589513779|FG001|Overall Study|Withdrawal by Subject|18|||
163217719|NCT02603432|589513778|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
163217720|NCT02603432|589513779|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
163217721|NCT02603432|589513778|FG000|Overall Study|Study terminated by sponsor|74|||
163217722|NCT02603432|589513779|FG001|Overall Study|Study terminated by sponsor|75|||
163217723|NCT02603432|589513778|FG000|Overall Study|Other|13|||
163217724|NCT02603432|589513779|FG001|Overall Study|Other|0|||
163217725|NCT00666757|589513783|FG000|Overall Study|Lost to Follow-up|39|||
163217726|NCT00666757|589513784|FG001|Overall Study|Lost to Follow-up|35|||
163217727|NCT00666757|589513783|FG000|Overall Study|Protocol Violation|23|||
163217728|NCT00666757|589513784|FG001|Overall Study|Protocol Violation|24|||
163217729|NCT00666757|589513783|FG000|Overall Study|Adverse Event|22|||
163217730|NCT00666757|589513784|FG001|Overall Study|Adverse Event|12|||
163217731|NCT00666757|589513783|FG000|Overall Study|Withdrawal by Subject|13|||
163217732|NCT00666757|589513784|FG001|Overall Study|Withdrawal by Subject|17|||
163217733|NCT00666757|589513783|FG000|Overall Study|Lack of Efficacy|3|||
163217734|NCT00666757|589513784|FG001|Overall Study|Lack of Efficacy|6|||
163217735|NCT00666757|589513783|FG000|Overall Study|Physician Decision|0|||
163217736|NCT00666757|589513784|FG001|Overall Study|Physician Decision|2|||
163217737|NCT00666757|589513783|FG000|Overall Study|Sponsor decision|0|||
163217738|NCT00666757|589513784|FG001|Overall Study|Sponsor decision|1|||
163217739|NCT01231581|589513785|FG000|Overall Study|Lost to Follow-up|2|||
163330889|NCT02972034|589922437|FG001|Overall Study|Sponsor Decision|0|||
163330890|NCT02972034|589922438|FG002|Overall Study|Sponsor Decision|0|||
163067490|NCT01163617|588952578|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
163067491|NCT01163617|588952579|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
163067492|NCT01163617|588952580|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
163067493|NCT01163617|588952581|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
163067494|NCT01163617|588952582|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
163067495|NCT01163617|588952583|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
163217740|NCT01231581|589513786|FG001|Overall Study|Lost to Follow-up|2|||
163217741|NCT01231581|589513785|FG000|Overall Study|Withdrawal by Subject|6|||
163217742|NCT01231581|589513786|FG001|Overall Study|Withdrawal by Subject|9|||
163217743|NCT01231581|589513785|FG000|Overall Study|Study Closed/Terminated|6|||
163217744|NCT01231581|589513786|FG001|Overall Study|Study Closed/Terminated|5|||
163217745|NCT01231581|589513785|FG000|Overall Study|Death|65|||
163217746|NCT01231581|589513786|FG001|Overall Study|Death|64|||
163217747|NCT01231581|589513785|FG000|Overall Study|Ongoing|1|||
163217748|NCT01231581|589513786|FG001|Overall Study|Ongoing|0|||
163026170|NCT01295827|588797279|FG010|Overall Study|Lost to Follow-up|7|||
163026171|NCT01295827|588797280|FG011|Overall Study|Lost to Follow-up|3|||
163026172|NCT01295827|588797281|FG012|Overall Study|Lost to Follow-up|0|||
163026173|NCT01295827|588797282|FG013|Overall Study|Lost to Follow-up|0|||
163026174|NCT01295827|588797283|FG014|Overall Study|Lost to Follow-up|0|||
163026175|NCT01295827|588797269|FG000|Overall Study|Not Reported|0|||
163067496|NCT01163617|588952584|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
163067497|NCT01163617|588952585|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
163067498|NCT01163617|588952578|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
163067499|NCT01163617|588952579|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
163067500|NCT01163617|588952580|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
163067501|NCT01163617|588952581|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
163067502|NCT01163617|588952582|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
163067503|NCT01163617|588952583|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
163067504|NCT01163617|588952584|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
163067505|NCT01163617|588952585|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
163067506|NCT01163617|588952578|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
163067507|NCT01163617|588952579|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
163067508|NCT01163617|588952580|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
163067509|NCT01163617|588952581|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
163067510|NCT01163617|588952582|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
163067511|NCT01163617|588952583|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
163067512|NCT01163617|588952584|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
163067513|NCT01163617|588952585|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
163067514|NCT02394756|588952586|FG000|Period 1|Lens Discomfort|0|||
163067515|NCT02394756|588952587|FG001|Period 1|Lens Discomfort|0|||
163067516|NCT02394756|588952588|FG002|Period 1|Lens Discomfort|0|||
163067517|NCT02394756|588952589|FG003|Period 1|Lens Discomfort|0|||
163067518|NCT02394756|588952590|FG004|Period 1|Lens Discomfort|0|||
163067519|NCT02394756|588952591|FG005|Period 1|Lens Discomfort|1|||
163067520|NCT02394756|588952586|FG000|Period 1|Withdrawal by Subject|0|||
163067521|NCT02394756|588952587|FG001|Period 1|Withdrawal by Subject|1|||
163067522|NCT02394756|588952588|FG002|Period 1|Withdrawal by Subject|1|||
163067523|NCT02394756|588952589|FG003|Period 1|Withdrawal by Subject|1|||
163067524|NCT02394756|588952590|FG004|Period 1|Withdrawal by Subject|0|||
163067525|NCT02394756|588952591|FG005|Period 1|Withdrawal by Subject|0|||
163067526|NCT02394756|588952586|FG000|Period 2|Unsatisfactory Visual Response|0|||
163067527|NCT02394756|588952587|FG001|Period 2|Unsatisfactory Visual Response|0|||
163067528|NCT02394756|588952588|FG002|Period 2|Unsatisfactory Visual Response|0|||
163067529|NCT02394756|588952589|FG003|Period 2|Unsatisfactory Visual Response|0|||
163067530|NCT02394756|588952590|FG004|Period 2|Unsatisfactory Visual Response|1|||
163067531|NCT02394756|588952591|FG005|Period 2|Unsatisfactory Visual Response|0|||
163067532|NCT00191100|588952594|FG000|Overall Study|Adverse Event|18|||
163067533|NCT00191100|588952595|FG001|Overall Study|Adverse Event|1|||
163067534|NCT00191100|588952594|FG000|Overall Study|Lost to Follow-up|2|||
163067535|NCT00191100|588952595|FG001|Overall Study|Lost to Follow-up|0|||
163067536|NCT00191100|588952594|FG000|Overall Study|Patient Moved|0|||
163067537|NCT00191100|588952595|FG001|Overall Study|Patient Moved|1|||
163067538|NCT00191100|588952594|FG000|Overall Study|Withdrawal by Subject|9|||
163067539|NCT00191100|588952595|FG001|Overall Study|Withdrawal by Subject|3|||
163067540|NCT00191100|588952594|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
163067541|NCT00191100|588952595|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
163026176|NCT01295827|588797270|FG001|Overall Study|Not Reported|0|||
163026177|NCT01295827|588797271|FG002|Overall Study|Not Reported|0|||
163026178|NCT01295827|588797272|FG003|Overall Study|Not Reported|1|||
163026179|NCT01295827|588797273|FG004|Overall Study|Not Reported|0|||
163026180|NCT01295827|588797274|FG005|Overall Study|Not Reported|0|||
163026181|NCT01295827|588797275|FG006|Overall Study|Not Reported|24|||
163067542|NCT00191100|588952594|FG000|Overall Study|Clinical Relapse|2|||
163067543|NCT00191100|588952595|FG001|Overall Study|Clinical Relapse|1|||
163067544|NCT00191100|588952594|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
163067545|NCT00191100|588952595|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
163067546|NCT00191100|588952594|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
163067547|NCT00191100|588952595|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
163067548|NCT00191100|588952594|FG000|Overall Study|Physician Decision|3|||
163067549|NCT00191100|588952595|FG001|Overall Study|Physician Decision|1|||
163026182|NCT01295827|588797276|FG007|Overall Study|Not Reported|58|||
163026183|NCT01295827|588797277|FG008|Overall Study|Not Reported|41|||
163026184|NCT01295827|588797278|FG009|Overall Study|Not Reported|2|||
163026185|NCT01295827|588797279|FG010|Overall Study|Not Reported|23|||
163067550|NCT00191100|588952594|FG000|Overall Study|Death from Study Drug Toxicity|2|||
163026186|NCT01295827|588797280|FG011|Overall Study|Not Reported|13|||
163330891|NCT02972034|589922439|FG003|Overall Study|Sponsor Decision|1|||
163330892|NCT02972034|589922440|FG004|Overall Study|Sponsor Decision|0|||
163330893|NCT02972034|589922441|FG005|Overall Study|Sponsor Decision|0|||
163330894|NCT02972034|589922442|FG006|Overall Study|Sponsor Decision|1|||
163330895|NCT02972034|589922443|FG007|Overall Study|Sponsor Decision|1|||
163330896|NCT02972034|589922444|FG008|Overall Study|Sponsor Decision|1|||
163330897|NCT02972034|589922445|FG009|Overall Study|Sponsor Decision|2|||
163330898|NCT02972034|589922446|FG010|Overall Study|Sponsor Decision|2|||
163330899|NCT02972034|589922447|FG011|Overall Study|Sponsor Decision|0|||
163330900|NCT02972034|589922448|FG012|Overall Study|Sponsor Decision|1|||
163026187|NCT01295827|588797281|FG012|Overall Study|Not Reported|0|||
163026188|NCT01295827|588797282|FG013|Overall Study|Not Reported|0|||
163026189|NCT01295827|588797283|FG014|Overall Study|Not Reported|0|||
163026190|NCT01295827|588797269|FG000|Overall Study|Progressive Disease|2|||
163026191|NCT01295827|588797270|FG001|Overall Study|Progressive Disease|1|||
163026192|NCT01295827|588797271|FG002|Overall Study|Progressive Disease|5|||
163026193|NCT01295827|588797272|FG003|Overall Study|Progressive Disease|2|||
163026194|NCT01295827|588797273|FG004|Overall Study|Progressive Disease|0|||
163026195|NCT01295827|588797274|FG005|Overall Study|Progressive Disease|1|||
163026196|NCT01295827|588797275|FG006|Overall Study|Progressive Disease|87|||
163026197|NCT01295827|588797276|FG007|Overall Study|Progressive Disease|144|||
163026198|NCT01295827|588797277|FG008|Overall Study|Progressive Disease|85|||
163026199|NCT01295827|588797278|FG009|Overall Study|Progressive Disease|40|||
163026200|NCT01295827|588797279|FG010|Overall Study|Progressive Disease|175|||
163026201|NCT01295827|588797280|FG011|Overall Study|Progressive Disease|136|||
163026202|NCT01295827|588797281|FG012|Overall Study|Progressive Disease|0|||
163026203|NCT01295827|588797282|FG013|Overall Study|Progressive Disease|0|||
163026204|NCT01295827|588797283|FG014|Overall Study|Progressive Disease|0|||
163026205|NCT01295827|588797269|FG000|Overall Study|Screen Failure|0|||
163026206|NCT01295827|588797270|FG001|Overall Study|Screen Failure|0|||
163026207|NCT01295827|588797271|FG002|Overall Study|Screen Failure|0|||
163026208|NCT01295827|588797272|FG003|Overall Study|Screen Failure|0|||
163026209|NCT01295827|588797273|FG004|Overall Study|Screen Failure|0|||
163026210|NCT01295827|588797274|FG005|Overall Study|Screen Failure|0|||
163026211|NCT01295827|588797275|FG006|Overall Study|Screen Failure|2|||
163026212|NCT01295827|588797276|FG007|Overall Study|Screen Failure|2|||
163026213|NCT01295827|588797277|FG008|Overall Study|Screen Failure|2|||
163026214|NCT01295827|588797278|FG009|Overall Study|Screen Failure|0|||
163026215|NCT01295827|588797279|FG010|Overall Study|Screen Failure|1|||
163026216|NCT01295827|588797280|FG011|Overall Study|Screen Failure|0|||
163026217|NCT01295827|588797281|FG012|Overall Study|Screen Failure|0|||
163026218|NCT01295827|588797282|FG013|Overall Study|Screen Failure|0|||
163026219|NCT01295827|588797283|FG014|Overall Study|Screen Failure|0|||
163026220|NCT01295827|588797269|FG000|Overall Study|Withdrawal by Subject|1|||
163026221|NCT01295827|588797270|FG001|Overall Study|Withdrawal by Subject|0|||
163026222|NCT01295827|588797271|FG002|Overall Study|Withdrawal by Subject|2|||
163026223|NCT01295827|588797272|FG003|Overall Study|Withdrawal by Subject|0|||
163026224|NCT01295827|588797273|FG004|Overall Study|Withdrawal by Subject|0|||
163026225|NCT01295827|588797274|FG005|Overall Study|Withdrawal by Subject|1|||
163026226|NCT01295827|588797275|FG006|Overall Study|Withdrawal by Subject|13|||
163026227|NCT01295827|588797276|FG007|Overall Study|Withdrawal by Subject|35|||
163026228|NCT01295827|588797277|FG008|Overall Study|Withdrawal by Subject|11|||
163026229|NCT01295827|588797278|FG009|Overall Study|Withdrawal by Subject|2|||
163026230|NCT01295827|588797279|FG010|Overall Study|Withdrawal by Subject|18|||
163026231|NCT01295827|588797280|FG011|Overall Study|Withdrawal by Subject|13|||
163026232|NCT01295827|588797281|FG012|Overall Study|Withdrawal by Subject|0|||
163026233|NCT01295827|588797282|FG013|Overall Study|Withdrawal by Subject|0|||
163026234|NCT01295827|588797283|FG014|Overall Study|Withdrawal by Subject|0|||
163026235|NCT01295827|588797269|FG000|Overall Study|Other|0|||
163026236|NCT01295827|588797270|FG001|Overall Study|Other|0|||
163026237|NCT01295827|588797271|FG002|Overall Study|Other|0|||
163026238|NCT01295827|588797272|FG003|Overall Study|Other|0|||
163026239|NCT01295827|588797273|FG004|Overall Study|Other|0|||
163026240|NCT01295827|588797274|FG005|Overall Study|Other|0|||
163026241|NCT01295827|588797275|FG006|Overall Study|Other|1|||
163026242|NCT01295827|588797276|FG007|Overall Study|Other|1|||
163026243|NCT01295827|588797277|FG008|Overall Study|Other|1|||
163026244|NCT01295827|588797278|FG009|Overall Study|Other|0|||
163026245|NCT01295827|588797279|FG010|Overall Study|Other|2|||
163026246|NCT01295827|588797280|FG011|Overall Study|Other|0|||
163026247|NCT01295827|588797281|FG012|Overall Study|Other|0|||
163026248|NCT01295827|588797282|FG013|Overall Study|Other|0|||
163026249|NCT01295827|588797283|FG014|Overall Study|Other|0|||
163026250|NCT01668173|588797284|FG000|Overall Study|Adverse Event|3|||
163026251|NCT01668173|588797284|FG000|Overall Study|Trial suspension|4|||
163026252|NCT00101166|588797285|FG000|Overall Study|progressive disease|10|||
163026253|NCT01868022|588797286|FG000|Overall Study|Withdrawal by Subject|0|||
163330901|NCT02972034|589922449|FG013|Overall Study|Sponsor Decision|0|||
163026254|NCT01868022|588797287|FG001|Overall Study|Withdrawal by Subject|0|||
163026255|NCT01868022|588797288|FG002|Overall Study|Withdrawal by Subject|1|||
163026256|NCT01868022|588797289|FG003|Overall Study|Withdrawal by Subject|1|||
163067551|NCT00191100|588952595|FG001|Overall Study|Death from Study Drug Toxicity|0|||
163067552|NCT00191100|588952594|FG000|Overall Study|Protocol Violation|1|||
163067553|NCT00191100|588952595|FG001|Overall Study|Protocol Violation|1|||
163067554|NCT00191100|588952594|FG000|Overall Study|Death from Other Cause|1|||
163067555|NCT00191100|588952595|FG001|Overall Study|Death from Other Cause|0|||
163067556|NCT00191100|588952594|FG000|Overall Study|Reason Not Specified|0|||
163067557|NCT00191100|588952595|FG001|Overall Study|Reason Not Specified|1|||
163067558|NCT04766333|588953764|FG000|Overall Study|Lost to Follow-up|40|||
163067559|NCT04766333|588953765|FG001|Overall Study|Lost to Follow-up|826|||
163067560|NCT03234881|588953766|FG000|Overall Study|Lost to Follow-up|9|||
163067561|NCT03234881|588953767|FG001|Overall Study|Lost to Follow-up|3|||
163067562|NCT03807843|588953768|FG000|Overall Study|Lost to Follow-up|1|||
163067563|NCT03807843|588953769|FG001|Overall Study|Lost to Follow-up|0|||
163067564|NCT05177094|588953774|FG000|Overall Study|Adverse Event|5|||
163067565|NCT05177094|588953775|FG001|Overall Study|Adverse Event|5|||
163067566|NCT05177094|588953774|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
163067567|NCT05177094|588953775|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
163067568|NCT05177094|588953774|FG000|Overall Study|Protocol Deviation|3|||
163067569|NCT05177094|588953775|FG001|Overall Study|Protocol Deviation|0|||
163067570|NCT05177094|588953774|FG000|Overall Study|Withdrawal by Subject|6|||
163067571|NCT05177094|588953775|FG001|Overall Study|Withdrawal by Subject|3|||
163067572|NCT05177094|588953774|FG000|Overall Study|Participant could not tolerate long study visits|1|||
163067573|NCT05177094|588953775|FG001|Overall Study|Participant could not tolerate long study visits|0|||
163067574|NCT02737618|588953776|FG000|Overall Study|Withdrawal by Subject|9|||
163067575|NCT05276804|588953780|FG000|Overall Study|screen failure|23|||
163067576|NCT05276804|588953781|FG001|Overall Study|screen failure|0|||
163067577|NCT02827708|588953782|FG000|Overall Study|Lost to Follow-up|3|||
163067578|NCT02827708|588953783|FG001|Overall Study|Lost to Follow-up|1|||
163067579|NCT02827708|588953782|FG000|Overall Study|Withdrawal by Subject|1|||
163067580|NCT02827708|588953783|FG001|Overall Study|Withdrawal by Subject|2|||
163067581|NCT02827708|588953782|FG000|Overall Study|Death|1|||
163067582|NCT02827708|588953783|FG001|Overall Study|Death|2|||
163067583|NCT00407511|588953785|FG000|Overall Study|Adverse Event|9|||
163067584|NCT00407511|588953785|FG000|Overall Study|Lost to Follow-up|4|||
163067585|NCT00407511|588953785|FG000|Overall Study|Other|5|||
163067586|NCT00407511|588953785|FG000|Overall Study|Withdrawal by Subject|4|||
163067587|NCT05059080|588953786|FG000|Overall Study|Withdrawal by Subject|3|||
163067588|NCT05059080|588953786|FG000|Overall Study|Study Terminated by Sponsor|64|||
163067589|NCT01047501|588953787|FG000|Overall Study|Adverse Event|7|||
163067590|NCT01047501|588953788|FG001|Overall Study|Adverse Event|8|||
163067591|NCT01047501|588953789|FG002|Overall Study|Adverse Event|5|||
163067592|NCT01047501|588953787|FG000|Overall Study|Withdrew Consent|6|||
163067593|NCT01047501|588953788|FG001|Overall Study|Withdrew Consent|2|||
163067594|NCT01047501|588953789|FG002|Overall Study|Withdrew Consent|4|||
163067595|NCT01047501|588953787|FG000|Overall Study|Lost to Follow-up|0|||
163067596|NCT01047501|588953788|FG001|Overall Study|Lost to Follow-up|1|||
163067597|NCT01047501|588953789|FG002|Overall Study|Lost to Follow-up|1|||
163067598|NCT01047501|588953787|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
163067599|NCT01047501|588953788|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
163067600|NCT01047501|588953789|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
163067601|NCT01047501|588953787|FG000|Overall Study|Death|1|||
163067602|NCT01047501|588953788|FG001|Overall Study|Death|0|||
163067603|NCT01047501|588953789|FG002|Overall Study|Death|0|||
163217749|NCT01649375|589513789|FG000|Up to Week 16|Adverse Event|2|||
163067604|NCT01047501|588953787|FG000|Overall Study|Other discontinuation|1|||
163067605|NCT01047501|588953788|FG001|Overall Study|Other discontinuation|0|||
163067606|NCT01047501|588953789|FG002|Overall Study|Other discontinuation|1|||
163067607|NCT01047501|588953787|FG000|Overall Study|Investigator judgement|0|||
163067608|NCT01047501|588953788|FG001|Overall Study|Investigator judgement|0|||
163067609|NCT01047501|588953789|FG002|Overall Study|Investigator judgement|1|||
163067610|NCT00770484|588953792|FG000|Overall Study|Withdrawal by Subject|1|||
163067611|NCT00770484|588953793|FG001|Overall Study|Withdrawal by Subject|0|||
163067612|NCT05696847|588953795|FG000|Overall Study|Withdrawal by Subject|1|||
163067613|NCT05696847|588953796|FG001|Overall Study|Withdrawal by Subject|0|||
163217750|NCT01649375|589513790|FG001|Up to Week 16|Adverse Event|5|||
163217751|NCT01649375|589513791|FG002|Up to Week 16|Adverse Event|4|||
163217752|NCT01649375|589513792|FG003|Up to Week 16|Adverse Event|0|||
163217753|NCT01649375|589513793|FG004|Up to Week 16|Adverse Event|0|||
163217754|NCT01649375|589513789|FG000|Up to Week 16|Lack of Efficacy|0|||
163217755|NCT01649375|589513790|FG001|Up to Week 16|Lack of Efficacy|0|||
163217756|NCT01649375|589513791|FG002|Up to Week 16|Lack of Efficacy|1|||
163217757|NCT01649375|589513792|FG003|Up to Week 16|Lack of Efficacy|0|||
163217758|NCT01649375|589513793|FG004|Up to Week 16|Lack of Efficacy|0|||
163217759|NCT01649375|589513789|FG000|Up to Week 16|Physician Decision|0|||
163217760|NCT01649375|589513790|FG001|Up to Week 16|Physician Decision|0|||
163217761|NCT01649375|589513791|FG002|Up to Week 16|Physician Decision|1|||
163217762|NCT01649375|589513792|FG003|Up to Week 16|Physician Decision|0|||
163217763|NCT01649375|589513793|FG004|Up to Week 16|Physician Decision|0|||
163067614|NCT05696847|588953797|FG002|Overall Study|Withdrawal by Subject|0|||
163067615|NCT05696847|588953798|FG003|Overall Study|Withdrawal by Subject|0|||
163067616|NCT05696847|588953799|FG004|Overall Study|Withdrawal by Subject|0|||
163067617|NCT05696847|588953800|FG005|Overall Study|Withdrawal by Subject|0|||
163067618|NCT05696847|588953795|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163067619|NCT05696847|588953796|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163067620|NCT05696847|588953797|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163067621|NCT05696847|588953798|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163067622|NCT05696847|588953799|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
163067623|NCT05696847|588953800|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
163067624|NCT05696847|588953795|FG000|Overall Study|Adverse Event|0|||
163067625|NCT05696847|588953796|FG001|Overall Study|Adverse Event|0|||
163067626|NCT05696847|588953797|FG002|Overall Study|Adverse Event|0|||
163067627|NCT05696847|588953798|FG003|Overall Study|Adverse Event|0|||
163067628|NCT05696847|588953799|FG004|Overall Study|Adverse Event|0|||
163067629|NCT05696847|588953800|FG005|Overall Study|Adverse Event|1|||
163067630|NCT05696847|588953795|FG000|Overall Study|Sponsor Decision|0|||
163067631|NCT05696847|588953796|FG001|Overall Study|Sponsor Decision|0|||
163067632|NCT05696847|588953797|FG002|Overall Study|Sponsor Decision|0|||
163067633|NCT05696847|588953798|FG003|Overall Study|Sponsor Decision|1|||
163067634|NCT05696847|588953799|FG004|Overall Study|Sponsor Decision|0|||
163067635|NCT05696847|588953800|FG005|Overall Study|Sponsor Decision|0|||
163067636|NCT05513950|588953801|FG000|Overall Study|Not treated due to technical reasons|0|||
163067637|NCT05513950|588953802|FG001|Overall Study|Not treated due to technical reasons|0|||
163067638|NCT05513950|588953803|FG002|Overall Study|Not treated due to technical reasons|1|||
163067639|NCT05513950|588953804|FG003|Overall Study|Not treated due to technical reasons|0|||
163067640|NCT05561140|588953805|FG000|Randomized Treatment Period|Adverse Event|1|||
163067641|NCT05561140|588953806|FG001|Randomized Treatment Period|Adverse Event|0|||
163067642|NCT05561140|588953805|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
163067643|NCT05561140|588953806|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
163067644|NCT05561140|588953805|FG000|Open Label Treatment Period|Adverse Event|6|||
163067645|NCT05561140|588953806|FG001|Open Label Treatment Period|Adverse Event|4|||
163067646|NCT05561140|588953805|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
163067647|NCT05561140|588953806|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
163067648|NCT05561140|588953805|FG000|Open Label Treatment Period|Physician Decision|0|||
163067649|NCT05561140|588953806|FG001|Open Label Treatment Period|Physician Decision|1|||
163067650|NCT05561140|588953805|FG000|Open Label Treatment Period|Pregnancy|1|||
163067651|NCT05561140|588953806|FG001|Open Label Treatment Period|Pregnancy|0|||
163067652|NCT05561140|588953805|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
163067653|NCT05561140|588953806|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
163067654|NCT05561140|588953805|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
163067655|NCT05561140|588953806|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
163067656|NCT05561140|588953805|FG000|Open Label Treatment Period|Other|1|||
163067657|NCT05561140|588953806|FG001|Open Label Treatment Period|Other|0|||
163067658|NCT00221104|588953807|FG000|Overall Study|Adverse Event|1|||
163067659|NCT00221104|588953808|FG001|Overall Study|Adverse Event|0|||
163067660|NCT00221104|588953807|FG000|Overall Study|Physician Decision|1|||
163067661|NCT00221104|588953808|FG001|Overall Study|Physician Decision|0|||
163067662|NCT00221104|588953807|FG000|Overall Study|Protocol Violation|2|||
163067663|NCT00221104|588953808|FG001|Overall Study|Protocol Violation|0|||
163067664|NCT00221104|588953807|FG000|Overall Study|Withdrawal by Subject|42|||
163067665|NCT00221104|588953808|FG001|Overall Study|Withdrawal by Subject|29|||
163067666|NCT00221104|588953807|FG000|Overall Study|Others|37|||
163067667|NCT00221104|588953808|FG001|Overall Study|Others|47|||
163067668|NCT02989389|588953809|FG000|Period 1|Lost to Follow-up|0|||
163067669|NCT02989389|588953810|FG001|Period 1|Lost to Follow-up|1|||
163067670|NCT02989389|588953811|FG002|Period 1|Lost to Follow-up|0|||
163067671|NCT02989389|588953812|FG003|Period 1|Lost to Follow-up|0|||
163067672|NCT02989389|588953813|FG004|Period 1|Lost to Follow-up|0|||
163067673|NCT02989389|588953814|FG005|Period 1|Lost to Follow-up|0|||
163067674|NCT02989389|588953815|FG006|Period 1|Lost to Follow-up|0|||
163217764|NCT01649375|589513789|FG000|Up to Week 16|Withdrawal by Subject|2|||
163217765|NCT01649375|589513790|FG001|Up to Week 16|Withdrawal by Subject|1|||
163217766|NCT01649375|589513791|FG002|Up to Week 16|Withdrawal by Subject|2|||
163067675|NCT02989389|588953816|FG007|Period 1|Lost to Follow-up|0|||
163067676|NCT02989389|588953817|FG008|Period 1|Lost to Follow-up|0|||
163067677|NCT02989389|588953818|FG009|Period 1|Lost to Follow-up|0|||
163067678|NCT02989389|588953809|FG000|Period 1|Physician Decision|0|||
163067679|NCT02989389|588953810|FG001|Period 1|Physician Decision|0|||
163067680|NCT02989389|588953811|FG002|Period 1|Physician Decision|0|||
163067681|NCT02989389|588953812|FG003|Period 1|Physician Decision|0|||
163067682|NCT02989389|588953813|FG004|Period 1|Physician Decision|0|||
163067683|NCT02989389|588953814|FG005|Period 1|Physician Decision|0|||
163067684|NCT02989389|588953815|FG006|Period 1|Physician Decision|0|||
163067685|NCT02989389|588953816|FG007|Period 1|Physician Decision|0|||
163067686|NCT02989389|588953817|FG008|Period 1|Physician Decision|1|||
163330902|NCT02972034|589922450|FG014|Overall Study|Sponsor Decision|1|||
163330903|NCT02972034|589922436|FG000|Overall Study|Withdrawal by Subject|3|||
163330904|NCT02972034|589922437|FG001|Overall Study|Withdrawal by Subject|0|||
163330905|NCT02972034|589922438|FG002|Overall Study|Withdrawal by Subject|0|||
163330906|NCT02972034|589922439|FG003|Overall Study|Withdrawal by Subject|0|||
163026257|NCT01868022|588797290|FG004|Overall Study|Withdrawal by Subject|0|||
163026258|NCT01868022|588797291|FG005|Overall Study|Withdrawal by Subject|0|||
163026259|NCT01868022|588797292|FG006|Overall Study|Withdrawal by Subject|0|||
163026260|NCT01868022|588797293|FG007|Overall Study|Withdrawal by Subject|1|||
163026261|NCT01868022|588797294|FG008|Overall Study|Withdrawal by Subject|0|||
163026262|NCT01868022|588797286|FG000|Overall Study|Adverse Event|0|||
163026263|NCT01868022|588797287|FG001|Overall Study|Adverse Event|0|||
163026264|NCT01868022|588797288|FG002|Overall Study|Adverse Event|0|||
163026265|NCT01868022|588797289|FG003|Overall Study|Adverse Event|0|||
163026266|NCT01868022|588797290|FG004|Overall Study|Adverse Event|2|||
163026267|NCT01868022|588797291|FG005|Overall Study|Adverse Event|0|||
163026268|NCT01868022|588797292|FG006|Overall Study|Adverse Event|0|||
163026269|NCT01868022|588797293|FG007|Overall Study|Adverse Event|2|||
163026270|NCT01868022|588797294|FG008|Overall Study|Adverse Event|2|||
163026271|NCT01868022|588797286|FG000|Overall Study|Physician Decision|0|||
163026272|NCT01868022|588797287|FG001|Overall Study|Physician Decision|0|||
163026273|NCT01868022|588797288|FG002|Overall Study|Physician Decision|0|||
163026274|NCT01868022|588797289|FG003|Overall Study|Physician Decision|0|||
163026275|NCT01868022|588797290|FG004|Overall Study|Physician Decision|0|||
163026276|NCT01868022|588797291|FG005|Overall Study|Physician Decision|1|||
163026277|NCT01868022|588797292|FG006|Overall Study|Physician Decision|0|||
163026278|NCT01868022|588797293|FG007|Overall Study|Physician Decision|2|||
163026279|NCT01868022|588797294|FG008|Overall Study|Physician Decision|0|||
163026280|NCT01868022|588797286|FG000|Overall Study|Study closed/terminated|0|||
163026281|NCT01868022|588797287|FG001|Overall Study|Study closed/terminated|0|||
163026282|NCT01868022|588797288|FG002|Overall Study|Study closed/terminated|0|||
163026283|NCT01868022|588797289|FG003|Overall Study|Study closed/terminated|0|||
163026284|NCT01868022|588797290|FG004|Overall Study|Study closed/terminated|0|||
163026285|NCT01868022|588797291|FG005|Overall Study|Study closed/terminated|0|||
163026286|NCT01868022|588797292|FG006|Overall Study|Study closed/terminated|0|||
163026287|NCT01868022|588797293|FG007|Overall Study|Study closed/terminated|1|||
163026288|NCT01868022|588797294|FG008|Overall Study|Study closed/terminated|0|||
163026289|NCT01868022|588797286|FG000|Overall Study|Ongoing|0|||
163026290|NCT01868022|588797287|FG001|Overall Study|Ongoing|0|||
163026291|NCT01868022|588797288|FG002|Overall Study|Ongoing|0|||
163026292|NCT01868022|588797289|FG003|Overall Study|Ongoing|0|||
163026293|NCT01868022|588797290|FG004|Overall Study|Ongoing|0|||
163026294|NCT01868022|588797291|FG005|Overall Study|Ongoing|0|||
163026295|NCT01868022|588797292|FG006|Overall Study|Ongoing|0|||
163026296|NCT01868022|588797293|FG007|Overall Study|Ongoing|3|||
163026297|NCT01868022|588797294|FG008|Overall Study|Ongoing|0|||
163026298|NCT03226769|588797297|FG000|Overall Study|Withdrawal by Subject|0|||
163026299|NCT03226769|588797298|FG001|Overall Study|Withdrawal by Subject|1|||
163026300|NCT01516008|588797299|FG000|Overall Study|Adverse Event|0|||
163026301|NCT01516008|588797300|FG001|Overall Study|Adverse Event|2|||
163026302|NCT01516008|588797301|FG002|Overall Study|Adverse Event|7|||
163026303|NCT01516008|588797299|FG000|Overall Study|Lack of Efficacy|44|||
163026304|NCT01516008|588797300|FG001|Overall Study|Lack of Efficacy|14|||
163026305|NCT01516008|588797301|FG002|Overall Study|Lack of Efficacy|10|||
163026306|NCT01516008|588797299|FG000|Overall Study|Protocol Violation|1|||
163026307|NCT01516008|588797300|FG001|Overall Study|Protocol Violation|0|||
163026308|NCT01516008|588797301|FG002|Overall Study|Protocol Violation|0|||
163026309|NCT01516008|588797299|FG000|Overall Study|Reason not specified|0|||
163026310|NCT01516008|588797300|FG001|Overall Study|Reason not specified|0|||
163026311|NCT01516008|588797301|FG002|Overall Study|Reason not specified|1|||
163026312|NCT01217476|588797302|FG000|Overall Study|Adverse Event|6|||
163026313|NCT01217476|588797303|FG001|Overall Study|Adverse Event|1|||
163026314|NCT01217476|588797302|FG000|Overall Study|Physician Decision|0|||
163026315|NCT01217476|588797303|FG001|Overall Study|Physician Decision|1|||
163026316|NCT01217476|588797302|FG000|Overall Study|Withdrawal by Subject|3|||
163026317|NCT01217476|588797303|FG001|Overall Study|Withdrawal by Subject|3|||
163026318|NCT01217476|588797302|FG000|Overall Study|Surgery on the Target Limb|0|||
163026319|NCT01217476|588797303|FG001|Overall Study|Surgery on the Target Limb|2|||
163026320|NCT01217476|588797302|FG000|Overall Study|Protocol Deviation|1|||
163026321|NCT01217476|588797303|FG001|Overall Study|Protocol Deviation|0|||
163026322|NCT01217476|588797302|FG000|Overall Study|Other|2|||
163026323|NCT01217476|588797303|FG001|Overall Study|Other|0|||
163026324|NCT03033602|588797304|FG000|Overall Study|Withdrawal by Subject|11|||
163330907|NCT02972034|589922440|FG004|Overall Study|Withdrawal by Subject|1|||
163026325|NCT03033602|588797305|FG001|Overall Study|Withdrawal by Subject|21|||
163330908|NCT02972034|589922441|FG005|Overall Study|Withdrawal by Subject|1|||
163330909|NCT02972034|589922442|FG006|Overall Study|Withdrawal by Subject|0|||
163026326|NCT03033602|588797304|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
163330910|NCT02972034|589922443|FG007|Overall Study|Withdrawal by Subject|0|||
163067687|NCT02989389|588953818|FG009|Period 1|Physician Decision|0|||
163067688|NCT01666652|588953819|FG000|Overall Study|Serious Adverse Event|0|||
163067689|NCT01666652|588953820|FG001|Overall Study|Serious Adverse Event|0|||
163067690|NCT01666652|588953821|FG002|Overall Study|Serious Adverse Event|0|||
163067691|NCT01666652|588953822|FG003|Overall Study|Serious Adverse Event|1|||
163067692|NCT01666652|588953823|FG004|Overall Study|Serious Adverse Event|0|||
163067693|NCT01666652|588953819|FG000|Overall Study|Withdrawal by Subject|0|||
163067694|NCT01666652|588953820|FG001|Overall Study|Withdrawal by Subject|0|||
163067695|NCT01666652|588953821|FG002|Overall Study|Withdrawal by Subject|0|||
163067696|NCT01666652|588953822|FG003|Overall Study|Withdrawal by Subject|0|||
163067697|NCT01666652|588953823|FG004|Overall Study|Withdrawal by Subject|1|||
163067698|NCT01666652|588953819|FG000|Overall Study|Moved from study area|1|||
163067699|NCT01666652|588953820|FG001|Overall Study|Moved from study area|0|||
163067700|NCT01666652|588953821|FG002|Overall Study|Moved from study area|0|||
163067701|NCT01666652|588953822|FG003|Overall Study|Moved from study area|2|||
163067702|NCT01666652|588953823|FG004|Overall Study|Moved from study area|0|||
163067703|NCT01666652|588953819|FG000|Overall Study|Lost to Follow-up|1|||
163067704|NCT01666652|588953820|FG001|Overall Study|Lost to Follow-up|1|||
163067705|NCT01666652|588953821|FG002|Overall Study|Lost to Follow-up|1|||
163067706|NCT01666652|588953822|FG003|Overall Study|Lost to Follow-up|1|||
163067707|NCT01666652|588953823|FG004|Overall Study|Lost to Follow-up|0|||
163067708|NCT00088153|588953824|FG000|Overall Study|Physician Decision|3|||
163067709|NCT00088153|588953825|FG001|Overall Study|Physician Decision|3|||
163067710|NCT00088153|588953824|FG000|Overall Study|Withdrawal by Subject|10|||
163067711|NCT00088153|588953825|FG001|Overall Study|Withdrawal by Subject|10|||
163067712|NCT00088153|588953824|FG000|Overall Study|Lost to Follow-up|11|||
163067713|NCT00088153|588953825|FG001|Overall Study|Lost to Follow-up|12|||
163067714|NCT01132755|588953826|FG000|Overall Study|Procedure not done due to medical reason|23|||
163067715|NCT01132755|588953826|FG000|Overall Study|Protocol Violation|15|||
163067716|NCT01132755|588953826|FG000|Overall Study|Withdrawal by Subject|4|||
163067717|NCT01757847|588953827|FG000|Overall Study|Withdrawal by Subject|3|||
163067718|NCT01757847|588953828|FG001|Overall Study|Withdrawal by Subject|4|||
163067719|NCT04057365|588953829|FG000|Overall Study|Withdrawal by Subject|2|||
163067720|NCT04057365|588953830|FG001|Overall Study|Withdrawal by Subject|0|||
163067721|NCT01063114|588953831|FG000|Overall Study|Lost to Follow-up|1|||
163067722|NCT04598828|588953834|FG000|Overall Study|Physician Decision|1|||
163067723|NCT04598828|588953835|FG001|Overall Study|Physician Decision|0|||
163067724|NCT04598828|588953834|FG000|Overall Study|Withdrawal by Subject|0|||
163067725|NCT04598828|588953835|FG001|Overall Study|Withdrawal by Subject|1|||
163067726|NCT04598828|588953834|FG000|Overall Study|Withdrawal by Subject|0|||
163067727|NCT04598828|588953835|FG001|Overall Study|Withdrawal by Subject|1|||
163067728|NCT02676973|588953836|FG000|Overall Study|Withdrawal by Subject|9|||
163067729|NCT02676973|588953837|FG001|Overall Study|Withdrawal by Subject|8|||
163067730|NCT02676973|588953838|FG002|Overall Study|Withdrawal by Subject|11|||
163067731|NCT02676973|588953836|FG000|Overall Study|Lost to Follow-up|8|||
163067732|NCT02676973|588953837|FG001|Overall Study|Lost to Follow-up|12|||
163067733|NCT02676973|588953838|FG002|Overall Study|Lost to Follow-up|8|||
163067734|NCT02676973|588953836|FG000|Overall Study|Death|2|||
163067735|NCT02676973|588953837|FG001|Overall Study|Death|1|||
163067736|NCT02676973|588953838|FG002|Overall Study|Death|5|||
163067737|NCT01078662|588953840|FG000|Overall Study|Death|41|||
163067738|NCT01078662|588953841|FG001|Overall Study|Death|103|||
163067739|NCT01078662|588953842|FG002|Overall Study|Death|18|||
163067740|NCT01078662|588953843|FG003|Overall Study|Death|5|||
163067741|NCT01078662|588953844|FG004|Overall Study|Death|8|||
163067742|NCT01078662|588953840|FG000|Overall Study|Patients reached data cut-off|12|||
163067743|NCT01078662|588953841|FG001|Overall Study|Patients reached data cut-off|53|||
163067744|NCT01078662|588953842|FG002|Overall Study|Patients reached data cut-off|2|||
163067745|NCT01078662|588953843|FG003|Overall Study|Patients reached data cut-off|2|||
163067746|NCT01078662|588953844|FG004|Overall Study|Patients reached data cut-off|3|||
163067747|NCT01078662|588953840|FG000|Overall Study|Withdrawal by Subject|4|||
163067748|NCT01078662|588953841|FG001|Overall Study|Withdrawal by Subject|11|||
163067749|NCT01078662|588953842|FG002|Overall Study|Withdrawal by Subject|1|||
163067750|NCT01078662|588953843|FG003|Overall Study|Withdrawal by Subject|0|||
163067751|NCT01078662|588953844|FG004|Overall Study|Withdrawal by Subject|0|||
163067752|NCT01078662|588953840|FG000|Overall Study|Protocol Violation|0|||
163067753|NCT01078662|588953841|FG001|Overall Study|Protocol Violation|1|||
163067754|NCT01078662|588953842|FG002|Overall Study|Protocol Violation|0|||
163067755|NCT01078662|588953843|FG003|Overall Study|Protocol Violation|0|||
163067756|NCT01078662|588953844|FG004|Overall Study|Protocol Violation|0|||
163067757|NCT01078662|588953840|FG000|Overall Study|Lost to Follow-up|1|||
163067758|NCT01078662|588953841|FG001|Overall Study|Lost to Follow-up|0|||
163067759|NCT01078662|588953842|FG002|Overall Study|Lost to Follow-up|0|||
163067760|NCT01078662|588953843|FG003|Overall Study|Lost to Follow-up|0|||
163067761|NCT01078662|588953844|FG004|Overall Study|Lost to Follow-up|0|||
163067762|NCT02875080|588953849|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
163067763|NCT02875080|588953850|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
163067764|NCT02875080|588953851|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
163067765|NCT03018938|588953852|FG000|Overall Study|Death|0|||
163067766|NCT03018938|588953853|FG001|Overall Study|Death|1|||
163067767|NCT03018938|588953852|FG000|Overall Study|Lost to Follow-up|21|||
163067768|NCT03018938|588953853|FG001|Overall Study|Lost to Follow-up|32|||
163067769|NCT03018938|588953852|FG000|Overall Study|Withdrawal by Subject|38|||
163067770|NCT03018938|588953853|FG001|Overall Study|Withdrawal by Subject|45|||
163067771|NCT03018938|588953852|FG000|Overall Study|Physician Decision|3|||
163067772|NCT03018938|588953853|FG001|Overall Study|Physician Decision|2|||
163067773|NCT03018938|588953852|FG000|Overall Study|Sponsor Decision|0|||
163067774|NCT03018938|588953853|FG001|Overall Study|Sponsor Decision|1|||
163067775|NCT03018938|588953852|FG000|Overall Study|Screen failure-After randomization|4|||
163067776|NCT03018938|588953853|FG001|Overall Study|Screen failure-After randomization|2|||
163067777|NCT03018938|588953852|FG000|Overall Study|Not recorded|0|||
163067778|NCT03018938|588953853|FG001|Overall Study|Not recorded|2|||
163067779|NCT03069989|588953866|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
163067780|NCT03069989|588953867|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
163067781|NCT01127061|588955069|FG000|Overall Study|Lost to Follow-up|7|||
163067782|NCT01127061|588955070|FG001|Overall Study|Lost to Follow-up|10|||
163067783|NCT01127061|588955069|FG000|Overall Study|Physician Decision|3|||
163067784|NCT01127061|588955070|FG001|Overall Study|Physician Decision|3|||
163067785|NCT03921541|588955073|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
163067786|NCT03921541|588955074|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
163067787|NCT00003456|588955075|FG000|Overall Study|Not evaluable|8|||
163067788|NCT00420407|588955077|FG000|Overall Study|Lost to Follow-up|0|||
163067789|NCT00420407|588955078|FG001|Overall Study|Lost to Follow-up|3|||
163067790|NCT00420407|588955077|FG000|Overall Study|Physician Decision|2|||
163067791|NCT00420407|588955078|FG001|Overall Study|Physician Decision|1|||
163067792|NCT00420407|588955077|FG000|Overall Study|subject identified as detainee|1|||
163067793|NCT00420407|588955078|FG001|Overall Study|subject identified as detainee|0|||
163067794|NCT00420407|588955077|FG000|Overall Study|subject identified as Jehovah's witness|1|||
163067795|NCT00420407|588955078|FG001|Overall Study|subject identified as Jehovah's witness|0|||
163067796|NCT00420407|588955077|FG000|Overall Study|Withdrawal by Subject|0|||
163067797|NCT00420407|588955078|FG001|Overall Study|Withdrawal by Subject|2|||
163067798|NCT04633447|588955081|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
163067799|NCT04633447|588955082|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
163067800|NCT04633447|588955081|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
163067801|NCT04633447|588955082|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
163067802|NCT04633447|588955081|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
163067803|NCT04633447|588955082|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
163067804|NCT04633447|588955081|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
163067805|NCT04633447|588955082|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
163067806|NCT04633447|588955081|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
163067807|NCT04633447|588955082|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
163067808|NCT04633447|588955081|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
163067809|NCT04633447|588955082|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
163067810|NCT04333498|588955083|FG000|Overall Study|Lost to Follow-up|1|||
163067811|NCT04333498|588955084|FG001|Overall Study|Lost to Follow-up|0|||
163067812|NCT04333498|588955083|FG000|Overall Study|Lost to Follow-up|0|||
163067813|NCT04333498|588955084|FG001|Overall Study|Lost to Follow-up|1|||
163067814|NCT01565694|588955085|FG000|Dose-Titration Period|Adverse Event|4|||
163067815|NCT01565694|588955085|FG000|Dose-Titration Period|Protocol Violation|10|||
163067816|NCT01565694|588955085|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
163067817|NCT05399771|588955087|FG000|Overall Study|Physician Decision|3|||
163067818|NCT05399771|588955087|FG000|Overall Study|Adverse Event|1|||
163067819|NCT00541229|588955090|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
163067820|NCT00541229|588955091|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
163067821|NCT00541229|588955092|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
163067822|NCT00541229|588955093|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
163067823|NCT00541229|588955094|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
163067824|NCT00541229|588955095|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
163067825|NCT00541229|588955090|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
163067826|NCT00541229|588955091|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
163067827|NCT00541229|588955092|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
163067828|NCT00541229|588955093|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
163067829|NCT00541229|588955094|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
163067830|NCT00541229|588955095|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
163067831|NCT00541229|588955090|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
163067832|NCT00541229|588955091|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
163067833|NCT00541229|588955092|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
163330911|NCT02972034|589922444|FG008|Overall Study|Withdrawal by Subject|1|||
163330912|NCT02972034|589922445|FG009|Overall Study|Withdrawal by Subject|1|||
163330913|NCT02972034|589922446|FG010|Overall Study|Withdrawal by Subject|2|||
163330914|NCT02972034|589922447|FG011|Overall Study|Withdrawal by Subject|1|||
163330915|NCT02972034|589922448|FG012|Overall Study|Withdrawal by Subject|1|||
163330916|NCT02972034|589922449|FG013|Overall Study|Withdrawal by Subject|1|||
163330917|NCT02972034|589922450|FG014|Overall Study|Withdrawal by Subject|0|||
163330918|NCT02972034|589922436|FG000|Overall Study|Screen Failure|0|||
163330919|NCT02972034|589922437|FG001|Overall Study|Screen Failure|0|||
163330920|NCT02972034|589922438|FG002|Overall Study|Screen Failure|0|||
163067834|NCT00541229|588955093|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
163067835|NCT00541229|588955094|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
163067836|NCT00541229|588955095|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
163067837|NCT00541229|588955090|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
163067838|NCT00541229|588955091|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
163067839|NCT00541229|588955092|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
163067840|NCT00541229|588955093|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
163067841|NCT00541229|588955094|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
163067842|NCT00541229|588955095|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
163067843|NCT00541229|588955090|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
163067844|NCT00541229|588955091|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
163067845|NCT00541229|588955092|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
163067846|NCT00541229|588955093|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
163067847|NCT00541229|588955094|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
163067848|NCT00541229|588955095|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
163067849|NCT00541229|588955090|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
163067850|NCT00541229|588955091|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
163067851|NCT00541229|588955092|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
163067852|NCT00541229|588955093|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
163067853|NCT00541229|588955094|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
163067854|NCT00541229|588955095|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
163067855|NCT00541229|588955090|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
163067856|NCT00541229|588955091|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
163067857|NCT00541229|588955092|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
163067858|NCT00541229|588955093|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
163067859|NCT00541229|588955094|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
163067860|NCT00541229|588955095|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
163067861|NCT00541229|588955090|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
163067862|NCT00541229|588955091|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
163067863|NCT00541229|588955092|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
163067864|NCT00541229|588955093|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
163067865|NCT00541229|588955094|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
163067866|NCT00541229|588955095|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
163067867|NCT00541229|588955090|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
163067868|NCT00541229|588955091|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
163067869|NCT00541229|588955092|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
163067870|NCT00541229|588955093|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
163067871|NCT00541229|588955094|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
163067872|NCT00541229|588955095|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
163067873|NCT00541229|588955090|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
163067874|NCT00541229|588955091|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
163067875|NCT00541229|588955092|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
163067876|NCT00541229|588955093|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
163067877|NCT00541229|588955094|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
163067878|NCT00541229|588955095|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
163067879|NCT00541229|588955090|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
163067880|NCT00541229|588955091|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
163067881|NCT00541229|588955092|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
163067882|NCT00541229|588955093|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
163067883|NCT00541229|588955094|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
163330921|NCT02972034|589922439|FG003|Overall Study|Screen Failure|0|||
163330922|NCT02972034|589922440|FG004|Overall Study|Screen Failure|0|||
163330923|NCT02972034|589922441|FG005|Overall Study|Screen Failure|0|||
163330924|NCT02972034|589922442|FG006|Overall Study|Screen Failure|0|||
163330925|NCT02972034|589922443|FG007|Overall Study|Screen Failure|0|||
163330926|NCT02972034|589922444|FG008|Overall Study|Screen Failure|0|||
163067884|NCT00541229|588955095|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
163330927|NCT02972034|589922445|FG009|Overall Study|Screen Failure|0|||
163067885|NCT00541229|588955090|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
163067886|NCT00541229|588955091|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
163330928|NCT02972034|589922446|FG010|Overall Study|Screen Failure|0|||
163330929|NCT02972034|589922447|FG011|Overall Study|Screen Failure|0|||
163330930|NCT02972034|589922448|FG012|Overall Study|Screen Failure|1|||
163067887|NCT00541229|588955092|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
163067888|NCT00541229|588955093|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
163067889|NCT00541229|588955094|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
163067890|NCT00541229|588955095|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
163067891|NCT00541229|588955090|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
163067892|NCT00541229|588955091|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
163067893|NCT00541229|588955092|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
163067894|NCT00541229|588955093|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
163067895|NCT00541229|588955094|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
163067896|NCT00541229|588955095|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
163067897|NCT00541229|588955090|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
163067898|NCT00541229|588955091|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
163067899|NCT00541229|588955092|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
163067900|NCT00541229|588955093|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
163067901|NCT00541229|588955094|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
163067902|NCT00541229|588955095|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
163067903|NCT00541229|588955090|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
163067904|NCT00541229|588955091|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
163067905|NCT00541229|588955092|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
163067906|NCT00541229|588955093|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
163067907|NCT00541229|588955094|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
163067908|NCT00541229|588955095|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
163067909|NCT00541229|588955090|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
163067910|NCT00541229|588955091|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
163067911|NCT00541229|588955092|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
163067912|NCT00541229|588955093|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
163067913|NCT00541229|588955094|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
163067914|NCT00541229|588955095|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
163067915|NCT01312129|588955096|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
163067916|NCT01312129|588955097|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
163067917|NCT02397837|588955101|FG000|Overall Study|Withdrawal by Subject|6|||
163067918|NCT02397837|588955102|FG001|Overall Study|Withdrawal by Subject|5|||
163067919|NCT02397837|588955101|FG000|Overall Study|Physician Decision|1|||
163067920|NCT02397837|588955102|FG001|Overall Study|Physician Decision|1|||
163067921|NCT00263562|588955109|FG000|Overall Study|Protocol Violation|3|||
163067922|NCT00263562|588955110|FG001|Overall Study|Protocol Violation|0|||
163067923|NCT04602000|588955111|FG000|Overall Study|Withdrawal by Subject|3|||
163067924|NCT04602000|588955112|FG001|Overall Study|Withdrawal by Subject|6|||
163067925|NCT04602000|588955113|FG002|Overall Study|Withdrawal by Subject|3|||
163067926|NCT04602000|588955114|FG003|Overall Study|Withdrawal by Subject|27|||
163067927|NCT04602000|588955115|FG004|Overall Study|Withdrawal by Subject|39|||
163067928|NCT04602000|588955111|FG000|Overall Study|Physician Decision|1|||
163067929|NCT04602000|588955112|FG001|Overall Study|Physician Decision|0|||
163067930|NCT04602000|588955113|FG002|Overall Study|Physician Decision|0|||
163067931|NCT04602000|588955114|FG003|Overall Study|Physician Decision|2|||
163067932|NCT04602000|588955115|FG004|Overall Study|Physician Decision|2|||
163067933|NCT04602000|588955111|FG000|Overall Study|Death|0|||
163067934|NCT04602000|588955112|FG001|Overall Study|Death|1|||
163067935|NCT04602000|588955113|FG002|Overall Study|Death|0|||
163067936|NCT04602000|588955114|FG003|Overall Study|Death|1|||
163067937|NCT04602000|588955115|FG004|Overall Study|Death|2|||
163067938|NCT04602000|588955111|FG000|Overall Study|Lost to Follow-up|0|||
163067939|NCT04602000|588955112|FG001|Overall Study|Lost to Follow-up|0|||
163067940|NCT04602000|588955113|FG002|Overall Study|Lost to Follow-up|0|||
163067941|NCT04602000|588955114|FG003|Overall Study|Lost to Follow-up|3|||
163067942|NCT04602000|588955115|FG004|Overall Study|Lost to Follow-up|4|||
163067943|NCT04602000|588955111|FG000|Overall Study|Other|4|||
163067944|NCT04602000|588955112|FG001|Overall Study|Other|1|||
163330931|NCT02972034|589922449|FG013|Overall Study|Screen Failure|0|||
163330932|NCT02972034|589922450|FG014|Overall Study|Screen Failure|0|||
163330933|NCT03861052|589922451|FG000|Overall Study|Adverse Event|1|||
163330934|NCT03861052|589922452|FG001|Overall Study|Adverse Event|1|||
163330935|NCT03861052|589922453|FG002|Overall Study|Adverse Event|2|||
163330936|NCT03861052|589922454|FG003|Overall Study|Adverse Event|4|||
163330937|NCT03861052|589922451|FG000|Overall Study|Lost to Follow-up|0|||
163330938|NCT03861052|589922452|FG001|Overall Study|Lost to Follow-up|0|||
163330939|NCT03861052|589922453|FG002|Overall Study|Lost to Follow-up|0|||
163067945|NCT04602000|588955113|FG002|Overall Study|Other|2|||
163067946|NCT04602000|588955114|FG003|Overall Study|Other|5|||
163067947|NCT04602000|588955115|FG004|Overall Study|Other|4|||
163067948|NCT04602000|588955111|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
163067949|NCT04602000|588955112|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
163330940|NCT03861052|589922454|FG003|Overall Study|Lost to Follow-up|1|||
163330941|NCT03861052|589922451|FG000|Overall Study|Physician Decision|0|||
163330942|NCT03861052|589922452|FG001|Overall Study|Physician Decision|1|||
163330943|NCT03861052|589922453|FG002|Overall Study|Physician Decision|0|||
163330944|NCT03861052|589922454|FG003|Overall Study|Physician Decision|0|||
163330945|NCT03861052|589922451|FG000|Overall Study|Withdrawal by Subject|2|||
163330946|NCT03861052|589922452|FG001|Overall Study|Withdrawal by Subject|5|||
163330947|NCT03861052|589922453|FG002|Overall Study|Withdrawal by Subject|3|||
163330948|NCT03861052|589922454|FG003|Overall Study|Withdrawal by Subject|0|||
163330949|NCT03861052|589922451|FG000|Overall Study|Relocation to other city|1|||
163330950|NCT03861052|589922452|FG001|Overall Study|Relocation to other city|0|||
163330951|NCT03861052|589922453|FG002|Overall Study|Relocation to other city|0|||
163330952|NCT03861052|589922454|FG003|Overall Study|Relocation to other city|0|||
163330953|NCT03009344|589922455|FG000|Overall Study|Lack of Efficacy|5|||
163330954|NCT03009344|589922455|FG000|Overall Study|Withdrawal by Subject|1|||
163330955|NCT03009344|589922455|FG000|Overall Study|Adverse Event|1|||
163330956|NCT03678688|589922456|FG000|Overall Study|Reason not Specified|0|||
163330957|NCT03678688|589922457|FG001|Overall Study|Reason not Specified|0|||
163330958|NCT03678688|589922458|FG002|Overall Study|Reason not Specified|3|||
163026327|NCT03033602|588797305|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
163026328|NCT02805660|588797307|FG000|Overall Study|Death|5|||
163026329|NCT02805660|588797308|FG001|Overall Study|Death|2|||
163026330|NCT02805660|588797309|FG002|Overall Study|Death|9|||
163026331|NCT02805660|588797310|FG003|Overall Study|Death|5|||
163026332|NCT02805660|588797311|FG004|Overall Study|Death|0|||
163026333|NCT02805660|588797312|FG005|Overall Study|Death|14|||
163026334|NCT02805660|588797313|FG006|Overall Study|Death|12|||
163026335|NCT02805660|588797307|FG000|Overall Study|Lost to Follow-up|0|||
163026336|NCT02805660|588797308|FG001|Overall Study|Lost to Follow-up|1|||
163026337|NCT02805660|588797309|FG002|Overall Study|Lost to Follow-up|1|||
163026338|NCT02805660|588797310|FG003|Overall Study|Lost to Follow-up|2|||
163026339|NCT02805660|588797311|FG004|Overall Study|Lost to Follow-up|0|||
163026340|NCT02805660|588797312|FG005|Overall Study|Lost to Follow-up|0|||
163026341|NCT02805660|588797313|FG006|Overall Study|Lost to Follow-up|0|||
163026342|NCT02805660|588797307|FG000|Overall Study|Withdrawal by Subject|0|||
163026343|NCT02805660|588797308|FG001|Overall Study|Withdrawal by Subject|0|||
163026344|NCT02805660|588797309|FG002|Overall Study|Withdrawal by Subject|0|||
163026345|NCT02805660|588797310|FG003|Overall Study|Withdrawal by Subject|3|||
163026346|NCT02805660|588797311|FG004|Overall Study|Withdrawal by Subject|1|||
163026347|NCT02805660|588797312|FG005|Overall Study|Withdrawal by Subject|0|||
163026348|NCT02805660|588797313|FG006|Overall Study|Withdrawal by Subject|2|||
163026349|NCT02805660|588797307|FG000|Overall Study|Study terminated by Sponsor|0|||
163026350|NCT02805660|588797308|FG001|Overall Study|Study terminated by Sponsor|0|||
163026351|NCT02805660|588797309|FG002|Overall Study|Study terminated by Sponsor|1|||
163026352|NCT02805660|588797310|FG003|Overall Study|Study terminated by Sponsor|4|||
163026353|NCT02805660|588797311|FG004|Overall Study|Study terminated by Sponsor|2|||
163026354|NCT02805660|588797312|FG005|Overall Study|Study terminated by Sponsor|3|||
163026355|NCT02805660|588797313|FG006|Overall Study|Study terminated by Sponsor|1|||
163026356|NCT02805660|588797307|FG000|Overall Study|Miscellaneous|0|||
163026357|NCT02805660|588797308|FG001|Overall Study|Miscellaneous|1|||
163026358|NCT02805660|588797309|FG002|Overall Study|Miscellaneous|0|||
163026359|NCT02805660|588797310|FG003|Overall Study|Miscellaneous|4|||
163026360|NCT02805660|588797311|FG004|Overall Study|Miscellaneous|0|||
163026361|NCT02805660|588797312|FG005|Overall Study|Miscellaneous|6|||
163026362|NCT02805660|588797313|FG006|Overall Study|Miscellaneous|4|||
163026363|NCT02572076|588797314|FG000|Overall Study|Protocol Violation|1|||
163026364|NCT02778074|588797315|FG000|Overall Study|Lost to Follow-up|7|||
163026365|NCT02778074|588797316|FG001|Overall Study|Lost to Follow-up|10|||
163026366|NCT03489707|588797317|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
163026367|NCT03489707|588797318|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
163026368|NCT03489707|588797317|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
163026369|NCT03489707|588797318|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
163026370|NCT03963232|588797319|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
163026371|NCT03963232|588797320|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
163026372|NCT03963232|588797319|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
163026373|NCT03963232|588797320|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
163026374|NCT03963232|588797319|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
163026375|NCT03963232|588797320|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
163330959|NCT03678688|589922459|FG003|Overall Study|Reason not Specified|0|||
163330960|NCT03678688|589922460|FG004|Overall Study|Reason not Specified|1|||
163330961|NCT03678688|589922461|FG005|Overall Study|Reason not Specified|0|||
163330962|NCT03678688|589922462|FG006|Overall Study|Reason not Specified|0|||
163026376|NCT03963232|588797319|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
163026377|NCT03963232|588797320|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
163026378|NCT03963232|588797319|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
163217767|NCT01649375|589513792|FG003|Up to Week 16|Withdrawal by Subject|0|||
163026379|NCT03963232|588797320|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
163026380|NCT03963232|588797319|FG000|Open-Label Treatment Phase|Adverse Event|1|||
163026381|NCT03963232|588797320|FG001|Open-Label Treatment Phase|Adverse Event|2|||
163026382|NCT03963232|588797319|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
163026383|NCT03963232|588797320|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
163026384|NCT03963232|588797319|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
163026385|NCT03963232|588797320|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
163026386|NCT03963232|588797319|FG000|Open-Label Treatment Phase|Pregnancy|1|||
163026387|NCT03963232|588797320|FG001|Open-Label Treatment Phase|Pregnancy|0|||
163026388|NCT03963232|588797319|FG000|Follow-up Phase|Withdrawal by Subject|7|||
163026389|NCT03963232|588797320|FG001|Follow-up Phase|Withdrawal by Subject|5|||
163026390|NCT03963232|588797319|FG000|Follow-up Phase|Protocol Violation|0|||
163026391|NCT03963232|588797320|FG001|Follow-up Phase|Protocol Violation|2|||
163026392|NCT03963232|588797319|FG000|Follow-up Phase|Adverse Event|0|||
163026393|NCT03963232|588797320|FG001|Follow-up Phase|Adverse Event|1|||
163026394|NCT03963232|588797319|FG000|Follow-up Phase|Lost to Follow-up|0|||
163026395|NCT03963232|588797320|FG001|Follow-up Phase|Lost to Follow-up|1|||
163026396|NCT00356135|588797321|FG000|Overall Study|Protocol Violation|1|||
163026397|NCT00356135|588797322|FG001|Overall Study|Protocol Violation|0|||
163026398|NCT00356135|588797323|FG002|Overall Study|Protocol Violation|0|||
163026399|NCT00356135|588797321|FG000|Overall Study|Adverse Event|1|||
163026400|NCT00356135|588797322|FG001|Overall Study|Adverse Event|0|||
163026401|NCT00356135|588797323|FG002|Overall Study|Adverse Event|0|||
163026402|NCT00356135|588797321|FG000|Overall Study|Lost to Follow-up|0|||
163026403|NCT00356135|588797322|FG001|Overall Study|Lost to Follow-up|0|||
163026404|NCT00356135|588797323|FG002|Overall Study|Lost to Follow-up|1|||
163026405|NCT00356135|588797321|FG000|Overall Study|Physician Decision|1|||
163026406|NCT00356135|588797322|FG001|Overall Study|Physician Decision|1|||
163026407|NCT00356135|588797323|FG002|Overall Study|Physician Decision|1|||
163026408|NCT00356135|588797321|FG000|Overall Study|Subject non-compliance|1|||
163026409|NCT00356135|588797322|FG001|Overall Study|Subject non-compliance|1|||
163026410|NCT00356135|588797323|FG002|Overall Study|Subject non-compliance|3|||
163026411|NCT03617770|588797324|FG000|Overall Study|Lost to Follow-up|1|||
163026412|NCT03617770|588797325|FG001|Overall Study|Lost to Follow-up|0|||
163026413|NCT05270395|588797331|FG000|Overall Study|Lost to Follow-up|2|||
163026414|NCT05270395|588797332|FG001|Overall Study|Lost to Follow-up|2|||
163026415|NCT05270395|588797331|FG000|Overall Study|Death|1|||
163026416|NCT05270395|588797332|FG001|Overall Study|Death|2|||
163026417|NCT05270395|588797331|FG000|Overall Study|Study Team Withdrew|1|||
163026418|NCT05270395|588797332|FG001|Overall Study|Study Team Withdrew|0|||
163026419|NCT03055494|588799154|FG000|Overall Study|Lost to Follow-up|6|||
163026420|NCT03055494|588799155|FG001|Overall Study|Lost to Follow-up|0|||
163026421|NCT03055494|588799154|FG000|Overall Study|Physician Decision|2|||
163026422|NCT03055494|588799155|FG001|Overall Study|Physician Decision|0|||
163026423|NCT03055494|588799154|FG000|Overall Study|Withdrawal by Subject|1|||
163026424|NCT03055494|588799155|FG001|Overall Study|Withdrawal by Subject|0|||
163026425|NCT03055494|588799154|FG000|Overall Study|Adverse Event|0|||
163026426|NCT03055494|588799155|FG001|Overall Study|Adverse Event|1|||
163026427|NCT03055494|588799154|FG000|Overall Study|Non-compliance with study treatment|1|||
163026428|NCT03055494|588799155|FG001|Overall Study|Non-compliance with study treatment|0|||
163026429|NCT04743804|588799158|FG000|Overall Study|Other|1|||
163026430|NCT04743804|588799159|FG001|Overall Study|Other|0|||
163026431|NCT04743804|588799158|FG000|Overall Study|Withdrawal by Subject|0|||
163026432|NCT04743804|588799159|FG001|Overall Study|Withdrawal by Subject|1|||
163026433|NCT04743804|588799158|FG000|Overall Study|Study Terminated by Sponsor|1|||
163026434|NCT04743804|588799159|FG001|Overall Study|Study Terminated by Sponsor|4|||
163026435|NCT04743804|588799158|FG000|Overall Study|Physician Decision|0|||
163026436|NCT04743804|588799159|FG001|Overall Study|Physician Decision|1|||
163026437|NCT04743804|588799158|FG000|Overall Study|Death|3|||
163026438|NCT04743804|588799159|FG001|Overall Study|Death|0|||
163026439|NCT04598451|588799160|FG000|Overall Study|Adverse Event|3|||
163026440|NCT04598451|588799161|FG001|Overall Study|Adverse Event|2|||
163026441|NCT04598451|588799160|FG000|Overall Study|Withdrawal by Subject|3|||
163026442|NCT04598451|588799161|FG001|Overall Study|Withdrawal by Subject|7|||
163026443|NCT04598451|588799160|FG000|Overall Study|Lost to Follow-up|2|||
163026444|NCT04598451|588799161|FG001|Overall Study|Lost to Follow-up|0|||
163217768|NCT01649375|589513793|FG004|Up to Week 16|Withdrawal by Subject|0|||
163026445|NCT04598451|588799160|FG000|Overall Study|Physician Decision|4|||
163026446|NCT04598451|588799161|FG001|Overall Study|Physician Decision|1|||
163026447|NCT04598451|588799160|FG000|Overall Study|Requires Prohibited Medication|1|||
163026448|NCT04598451|588799161|FG001|Overall Study|Requires Prohibited Medication|0|||
163026449|NCT04598451|588799160|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
163026450|NCT04598451|588799161|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
163026451|NCT01632150|588799162|FG000|Overall Study|Disease progression|27|||
163026452|NCT01632150|588799162|FG000|Overall Study|Study drug toxicity|1|||
163217769|NCT01649375|589513789|FG000|Up to Week 16|Death|1|||
163026453|NCT01632150|588799162|FG000|Overall Study|Unrelated adverse event|7|||
163026454|NCT01632150|588799162|FG000|Overall Study|Withdrawal by Subject|2|||
163026455|NCT01632150|588799162|FG000|Overall Study|Patient underwent autologous transplant|1|||
163026456|NCT01632150|588799162|FG000|Overall Study|Moved to compassionate program|2|||
163026457|NCT02879994|588799165|FG000|Overall Study|off treatment early|7|||
163026458|NCT02879994|588799165|FG000|Overall Study|Adverse Event|2|||
163026459|NCT02879994|588799165|FG000|Overall Study|Death|2|||
163026460|NCT02143791|588799166|FG000|Enrolled|Withdrawal by Subject|4|||
163026461|NCT02143791|588799166|FG000|Trial Stimulation|Lack of Efficacy|21|||
163026462|NCT02143791|588799166|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
163026463|NCT02143791|588799166|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
163026464|NCT02143791|588799166|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
163026465|NCT02143791|588799166|FG000|Any Programming (3-6 Months)|Missing Data|1|||
163026466|NCT02143791|588799166|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
163026467|NCT04984681|588799171|FG000|Overall Study|Lost to Follow-up|3|||
163026468|NCT04984681|588799172|FG001|Overall Study|Lost to Follow-up|1|||
163026469|NCT04327661|588799173|FG000|Overall Study|Withdrawal by Subject|1|||
163026470|NCT04327661|588799174|FG001|Overall Study|Withdrawal by Subject|0|||
163026471|NCT04327661|588799175|FG002|Overall Study|Withdrawal by Subject|0|||
163026472|NCT02091960|588799176|FG000|Overall Study|Death|7|||
163026473|NCT02091960|588799176|FG000|Overall Study|Withdrawal by Subject|1|||
163026474|NCT02091960|588799176|FG000|Overall Study|Miscellaneous Reasons|37|||
163026475|NCT01942486|588799187|FG000|Overall Study|Lost to Follow-up|27|||
163026476|NCT02424630|588799190|FG000|Overall Study|No rotator cuff tear|1|||
163026477|NCT02424630|588799191|FG001|Overall Study|No rotator cuff tear|2|||
163026478|NCT02424630|588799190|FG000|Overall Study|Open procedure|0|||
163026479|NCT02424630|588799191|FG001|Overall Study|Open procedure|1|||
163026480|NCT02637895|588799192|FG000|Overall Study|Lost to Follow-up|4|||
163026481|NCT02637895|588799193|FG001|Overall Study|Lost to Follow-up|0|||
163026482|NCT02637895|588799192|FG000|Overall Study|Protocol Violation|0|||
163026483|NCT02637895|588799193|FG001|Overall Study|Protocol Violation|1|||
163026484|NCT02637895|588799192|FG000|Overall Study|Lack of Efficacy|1|||
163026485|NCT02637895|588799193|FG001|Overall Study|Lack of Efficacy|0|||
163026486|NCT02637895|588799192|FG000|Overall Study|Withdrawal by Subject|1|||
163026487|NCT02637895|588799193|FG001|Overall Study|Withdrawal by Subject|1|||
163026488|NCT02637895|588799192|FG000|Overall Study|Abnormal baseline lab|0|||
163026489|NCT02637895|588799193|FG001|Overall Study|Abnormal baseline lab|1|||
163026490|NCT00984061|588799196|FG000|Clarithromycin Alone|Protocol Violation|1|||
163026491|NCT05139303|588799197|FG000|Overall Study|Lost to Follow-up|3|||
163026492|NCT05139303|588799198|FG001|Overall Study|Lost to Follow-up|0|||
163026493|NCT05139303|588799197|FG000|Overall Study|Adverse Event|1|||
163026494|NCT05139303|588799198|FG001|Overall Study|Adverse Event|0|||
163026495|NCT04507256|588799202|FG000|Overall Study|Withdrawal by Subject|1|||
163026496|NCT04507256|588799203|FG001|Overall Study|Withdrawal by Subject|0|||
163026497|NCT04507256|588799204|FG002|Overall Study|Withdrawal by Subject|0|||
163026498|NCT04507256|588799205|FG003|Overall Study|Withdrawal by Subject|1|||
163026499|NCT04507256|588799206|FG004|Overall Study|Withdrawal by Subject|0|||
163026500|NCT04507256|588799207|FG005|Overall Study|Withdrawal by Subject|0|||
163026501|NCT04240457|588799208|FG000|Overall Study|Lost to Follow-up|5|||
163026502|NCT04240457|588799209|FG001|Overall Study|Lost to Follow-up|1|||
163026503|NCT02858180|588799214|FG000|Overall Study|Lost to Follow-up|0|||
163026504|NCT02858180|588799215|FG001|Overall Study|Lost to Follow-up|2|||
163026505|NCT00844480|588799216|FG000|Overall Study|Withdrawal by Subject|2|||
163026506|NCT00844480|588799217|FG001|Overall Study|Withdrawal by Subject|3|||
163026507|NCT00574249|588799222|FG000|Overall Study|Adverse Event|6|||
163026508|NCT00574249|588799223|FG001|Overall Study|Adverse Event|18|||
163026509|NCT00574249|588799222|FG000|Overall Study|Lack of Efficacy|5|||
163026510|NCT00574249|588799223|FG001|Overall Study|Lack of Efficacy|3|||
163026511|NCT00574249|588799222|FG000|Overall Study|Lost to Follow-up|4|||
163026512|NCT00574249|588799223|FG001|Overall Study|Lost to Follow-up|3|||
163026513|NCT00574249|588799222|FG000|Overall Study|Protocol Violation|5|||
163026514|NCT00574249|588799223|FG001|Overall Study|Protocol Violation|2|||
163026515|NCT00574249|588799222|FG000|Overall Study|History of carcinoma|1|||
163026516|NCT00574249|588799223|FG001|Overall Study|History of carcinoma|0|||
163026517|NCT00574249|588799222|FG000|Overall Study|Withdrawal by Subject|3|||
163026518|NCT00574249|588799223|FG001|Overall Study|Withdrawal by Subject|0|||
163406365|NCT00401375|590196736|FG001|Overall Study|Randomized but not treated|3|||
163026519|NCT00574249|588799222|FG000|Overall Study|Physician Decision|1|||
163026520|NCT00574249|588799223|FG001|Overall Study|Physician Decision|0|||
163026521|NCT00574249|588799222|FG000|Overall Study|Pregnancy|1|||
163026522|NCT00574249|588799223|FG001|Overall Study|Pregnancy|0|||
163026523|NCT00574249|588799222|FG000|Overall Study|Excluded by company|0|||
163026524|NCT00574249|588799223|FG001|Overall Study|Excluded by company|1|||
163026525|NCT00574249|588799222|FG000|Overall Study|PPD test taken twice|0|||
163026526|NCT00574249|588799223|FG001|Overall Study|PPD test taken twice|1|||
163026527|NCT03197870|588799224|FG000|Overall Study|Adverse Event|9|||
163026528|NCT03197870|588799225|FG001|Overall Study|Adverse Event|4|||
163026529|NCT03197870|588799226|FG002|Overall Study|Adverse Event|6|||
163067950|NCT04602000|588955113|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
163067951|NCT04602000|588955114|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
163067952|NCT04602000|588955115|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
163067953|NCT01257542|588955119|FG000|Overall Study|Protocol Violation|3|||
163067954|NCT01257542|588955120|FG001|Overall Study|Protocol Violation|5|||
163067955|NCT01257542|588955119|FG000|Overall Study|Withdrawal by Subject|0|||
163067956|NCT01257542|588955120|FG001|Overall Study|Withdrawal by Subject|2|||
163067957|NCT03097315|588955125|FG000|Overall Study|Withdrawal by Subject|1|||
163067958|NCT00195429|588955126|FG000|Overall Study|Adverse Event|2|||
163067959|NCT00195429|588955127|FG001|Overall Study|Adverse Event|4|||
163067960|NCT00195429|588955126|FG000|Overall Study|Lack of Efficacy|2|||
163067961|NCT00195429|588955127|FG001|Overall Study|Lack of Efficacy|1|||
163067962|NCT00195429|588955126|FG000|Overall Study|Lost to Follow-up|1|||
163067963|NCT00195429|588955127|FG001|Overall Study|Lost to Follow-up|0|||
163026530|NCT03197870|588799224|FG000|Overall Study|Withdrawal by Subject|2|||
163026531|NCT03197870|588799225|FG001|Overall Study|Withdrawal by Subject|3|||
163026532|NCT03197870|588799226|FG002|Overall Study|Withdrawal by Subject|0|||
163026533|NCT03197870|588799224|FG000|Overall Study|Lost to Follow-up|2|||
163026534|NCT03197870|588799225|FG001|Overall Study|Lost to Follow-up|2|||
163026535|NCT03197870|588799226|FG002|Overall Study|Lost to Follow-up|0|||
163026536|NCT03197870|588799224|FG000|Overall Study|data not available|1|||
163026537|NCT03197870|588799225|FG001|Overall Study|data not available|1|||
163026538|NCT03197870|588799226|FG002|Overall Study|data not available|0|||
163026539|NCT01618019|588799228|FG000|Overall Study|Withdrawal by Subject|14|||
163026540|NCT01618019|588799229|FG001|Overall Study|Withdrawal by Subject|14|||
163026541|NCT01542034|588799230|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
163026542|NCT01542034|588799231|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
163026543|NCT01542034|588799230|FG000|Overall Study|Administrative decision|0|||
163026544|NCT01542034|588799231|FG001|Overall Study|Administrative decision|3|||
163026545|NCT01542034|588799230|FG000|Overall Study|Subject Noncompliance|1|||
163026546|NCT01542034|588799231|FG001|Overall Study|Subject Noncompliance|0|||
163026547|NCT01542034|588799230|FG000|Overall Study|Adverse Event|2|||
163026548|NCT01542034|588799231|FG001|Overall Study|Adverse Event|2|||
163026549|NCT01542034|588799230|FG000|Overall Study|Lost to Follow-up|7|||
163026550|NCT01542034|588799231|FG001|Overall Study|Lost to Follow-up|6|||
163026551|NCT02612610|588799232|FG000|Overall Study|Withdrawal by Subject|1|||
163026552|NCT02612610|588799233|FG001|Overall Study|Withdrawal by Subject|1|||
163026553|NCT02612610|588799234|FG002|Overall Study|Withdrawal by Subject|0|||
163026554|NCT02612610|588799235|FG003|Overall Study|Withdrawal by Subject|2|||
163026555|NCT02612610|588799232|FG000|Overall Study|Adverse Event|2|||
163026556|NCT02612610|588799233|FG001|Overall Study|Adverse Event|2|||
163026557|NCT02612610|588799234|FG002|Overall Study|Adverse Event|3|||
163026558|NCT02612610|588799235|FG003|Overall Study|Adverse Event|10|||
163026559|NCT02612610|588799232|FG000|Overall Study|Lost to Follow-up|0|||
163026560|NCT02612610|588799233|FG001|Overall Study|Lost to Follow-up|1|||
163026561|NCT02612610|588799234|FG002|Overall Study|Lost to Follow-up|0|||
163026562|NCT02612610|588799235|FG003|Overall Study|Lost to Follow-up|0|||
163026563|NCT02612610|588799232|FG000|Overall Study|Protocol Violation|0|||
163026564|NCT02612610|588799233|FG001|Overall Study|Protocol Violation|1|||
163026565|NCT02612610|588799234|FG002|Overall Study|Protocol Violation|1|||
163026566|NCT02612610|588799235|FG003|Overall Study|Protocol Violation|0|||
163026567|NCT02612610|588799232|FG000|Overall Study|Lack of Efficacy|1|||
163026568|NCT02612610|588799233|FG001|Overall Study|Lack of Efficacy|2|||
163026569|NCT02612610|588799234|FG002|Overall Study|Lack of Efficacy|0|||
163026570|NCT02612610|588799235|FG003|Overall Study|Lack of Efficacy|1|||
163026571|NCT02612610|588799232|FG000|Overall Study|Physician Decision|0|||
163026572|NCT02612610|588799233|FG001|Overall Study|Physician Decision|1|||
163026573|NCT02612610|588799234|FG002|Overall Study|Physician Decision|0|||
163026574|NCT02612610|588799235|FG003|Overall Study|Physician Decision|0|||
163026575|NCT02612610|588799232|FG000|Overall Study|Noncompliance|1|||
163026576|NCT02612610|588799233|FG001|Overall Study|Noncompliance|0|||
163026577|NCT02612610|588799234|FG002|Overall Study|Noncompliance|0|||
163026578|NCT02612610|588799235|FG003|Overall Study|Noncompliance|0|||
163026579|NCT02612610|588799232|FG000|Overall Study|Cough Improvement|0|||
163026580|NCT02612610|588799233|FG001|Overall Study|Cough Improvement|0|||
163026581|NCT02612610|588799234|FG002|Overall Study|Cough Improvement|1|||
163067964|NCT00367458|588955128|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
163067965|NCT00367458|588955129|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
163026582|NCT02612610|588799235|FG003|Overall Study|Cough Improvement|0|||
163026583|NCT01546571|588799238|FG000|Overall Study|Adverse Event|1|||
163026584|NCT01546571|588799239|FG001|Overall Study|Adverse Event|0|||
163026585|NCT01546571|588799240|FG002|Overall Study|Adverse Event|0|||
163026586|NCT01546571|588799241|FG003|Overall Study|Adverse Event|1|||
163026587|NCT01546571|588799242|FG004|Overall Study|Adverse Event|0|||
163026588|NCT01546571|588799238|FG000|Overall Study|assigned placebo in Part A|0|||
163026589|NCT01546571|588799239|FG001|Overall Study|assigned placebo in Part A|0|||
163026590|NCT01546571|588799240|FG002|Overall Study|assigned placebo in Part A|22|||
163067966|NCT02948400|588955132|FG000|Overall Study|Withdrawal by Subject|17|||
163067967|NCT02948400|588955133|FG001|Overall Study|Withdrawal by Subject|10|||
163067968|NCT02948400|588955132|FG000|Overall Study|failed to attend appointments|47|||
163067969|NCT02948400|588955133|FG001|Overall Study|failed to attend appointments|34|||
163067970|NCT02948400|588955132|FG000|Overall Study|COVID-related closure|6|||
163067971|NCT02948400|588955133|FG001|Overall Study|COVID-related closure|2|||
163067972|NCT02948400|588955132|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
163067973|NCT02948400|588955133|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
163067974|NCT02948400|588955132|FG000|Overall Study|motion sickness in virtual reality|2|||
163067975|NCT02948400|588955133|FG001|Overall Study|motion sickness in virtual reality|0|||
163067976|NCT01716156|588955134|FG000|Overall Study|Protocol Violation|1|||
163067977|NCT01716156|588955135|FG001|Overall Study|Protocol Violation|0|||
163067978|NCT01716156|588955136|FG002|Overall Study|Protocol Violation|0|||
163067979|NCT01716156|588955134|FG000|Overall Study|Withdrawal by Subject|0|||
163067980|NCT01716156|588955135|FG001|Overall Study|Withdrawal by Subject|1|||
163067981|NCT01716156|588955136|FG002|Overall Study|Withdrawal by Subject|2|||
163067982|NCT01716156|588955134|FG000|Overall Study|Lost to Follow-up|1|||
163067983|NCT01716156|588955135|FG001|Overall Study|Lost to Follow-up|0|||
163067984|NCT01716156|588955136|FG002|Overall Study|Lost to Follow-up|0|||
163067985|NCT05221866|588955139|FG000|Overall Study|Withdrawal by Subject|5|||
163067986|NCT05221866|588955140|FG001|Overall Study|Withdrawal by Subject|7|||
163330963|NCT03678688|589922463|FG007|Overall Study|Reason not Specified|0|||
163330964|NCT03678688|589922464|FG008|Overall Study|Reason not Specified|0|||
163330965|NCT03678688|589922456|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
163330966|NCT03678688|589922457|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
163330967|NCT03678688|589922458|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
163026591|NCT01546571|588799241|FG003|Overall Study|assigned placebo in Part A|0|||
163026592|NCT01546571|588799242|FG004|Overall Study|assigned placebo in Part A|0|||
163026593|NCT01546571|588799238|FG000|Overall Study|Death|0|||
163026594|NCT01546571|588799239|FG001|Overall Study|Death|1|||
163026595|NCT01546571|588799240|FG002|Overall Study|Death|0|||
163026596|NCT01546571|588799241|FG003|Overall Study|Death|0|||
163026597|NCT01546571|588799242|FG004|Overall Study|Death|0|||
163026598|NCT01546571|588799238|FG000|Overall Study|Lost to Follow-up|0|||
163026599|NCT01546571|588799239|FG001|Overall Study|Lost to Follow-up|0|||
163026600|NCT01546571|588799240|FG002|Overall Study|Lost to Follow-up|2|||
163026601|NCT01546571|588799241|FG003|Overall Study|Lost to Follow-up|2|||
163026602|NCT01546571|588799242|FG004|Overall Study|Lost to Follow-up|3|||
163026603|NCT01546571|588799238|FG000|Overall Study|Pregnancy|0|||
163026604|NCT01546571|588799239|FG001|Overall Study|Pregnancy|0|||
163026605|NCT01546571|588799240|FG002|Overall Study|Pregnancy|0|||
163026606|NCT01546571|588799241|FG003|Overall Study|Pregnancy|1|||
163026607|NCT01546571|588799242|FG004|Overall Study|Pregnancy|0|||
163026608|NCT01546571|588799238|FG000|Overall Study|Disease Progression|20|||
163026609|NCT01546571|588799239|FG001|Overall Study|Disease Progression|18|||
163026610|NCT01546571|588799240|FG002|Overall Study|Disease Progression|15|||
163026611|NCT01546571|588799241|FG003|Overall Study|Disease Progression|73|||
163026612|NCT01546571|588799242|FG004|Overall Study|Disease Progression|37|||
163026613|NCT01546571|588799238|FG000|Overall Study|Withdrawal by Subject|1|||
163026614|NCT01546571|588799239|FG001|Overall Study|Withdrawal by Subject|2|||
163026615|NCT01546571|588799240|FG002|Overall Study|Withdrawal by Subject|4|||
163026616|NCT01546571|588799241|FG003|Overall Study|Withdrawal by Subject|9|||
163026617|NCT01546571|588799242|FG004|Overall Study|Withdrawal by Subject|2|||
163026618|NCT01546571|588799238|FG000|Overall Study|Intercurrent Illness|1|||
163026619|NCT01546571|588799239|FG001|Overall Study|Intercurrent Illness|2|||
163026620|NCT01546571|588799240|FG002|Overall Study|Intercurrent Illness|0|||
163026621|NCT01546571|588799241|FG003|Overall Study|Intercurrent Illness|0|||
163026622|NCT01546571|588799242|FG004|Overall Study|Intercurrent Illness|0|||
163026623|NCT01546571|588799238|FG000|Overall Study|Other Cancers|0|||
163026624|NCT01546571|588799239|FG001|Overall Study|Other Cancers|0|||
163026625|NCT01546571|588799240|FG002|Overall Study|Other Cancers|0|||
163026626|NCT01546571|588799241|FG003|Overall Study|Other Cancers|3|||
163026627|NCT01546571|588799242|FG004|Overall Study|Other Cancers|1|||
163026628|NCT01546571|588799238|FG000|Overall Study|Other|0|||
163026629|NCT01546571|588799239|FG001|Overall Study|Other|0|||
163026630|NCT01546571|588799240|FG002|Overall Study|Other|3|||
163026631|NCT01546571|588799241|FG003|Overall Study|Other|0|||
163067987|NCT05221866|588955141|FG002|Overall Study|Withdrawal by Subject|6|||
163067988|NCT05221866|588955142|FG003|Overall Study|Withdrawal by Subject|4|||
163067989|NCT05221866|588955139|FG000|Overall Study|Physician Decision|3|||
163067990|NCT05221866|588955140|FG001|Overall Study|Physician Decision|2|||
163330968|NCT03678688|589922459|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
163026632|NCT01546571|588799242|FG004|Overall Study|Other|0|||
163026633|NCT00478699|588799248|FG000|Overall Study|Inclusion Error|1|||
163026634|NCT00478699|588799249|FG001|Overall Study|Inclusion Error|7|||
163026635|NCT00478699|588799248|FG000|Overall Study|Not receive study treatment|6|||
163026636|NCT00478699|588799249|FG001|Overall Study|Not receive study treatment|30|||
163026637|NCT01508130|588799250|FG000|Overall Study|Adverse Event|81|||
163067991|NCT05221866|588955141|FG002|Overall Study|Physician Decision|1|||
163067992|NCT05221866|588955142|FG003|Overall Study|Physician Decision|4|||
163067993|NCT05221866|588955139|FG000|Overall Study|Lost to Follow-up|12|||
163067994|NCT05221866|588955140|FG001|Overall Study|Lost to Follow-up|17|||
163067995|NCT05221866|588955141|FG002|Overall Study|Lost to Follow-up|14|||
163067996|NCT05221866|588955142|FG003|Overall Study|Lost to Follow-up|14|||
163067997|NCT05221866|588955139|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
163067998|NCT05221866|588955140|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
163067999|NCT05221866|588955141|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
163068000|NCT05221866|588955142|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
163068001|NCT05774977|588955145|FG000|Overall Study|Withdrawal by Subject|2|||
163068002|NCT04470427|588955147|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
163068003|NCT04470427|588955148|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
163068004|NCT04470427|588955149|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
163068005|NCT04470427|588955150|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
163068006|NCT04470427|588955151|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
163068007|NCT04470427|588955152|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
163068008|NCT04470427|588955147|FG000|Part B :Open-label|Other than specified|0|||
163068009|NCT04470427|588955148|FG001|Part B :Open-label|Other than specified|0|||
163068010|NCT04470427|588955149|FG002|Part B :Open-label|Other than specified|788|||
163068011|NCT04470427|588955150|FG003|Part B :Open-label|Other than specified|0|||
163068012|NCT04470427|588955151|FG004|Part B :Open-label|Other than specified|523|||
163068013|NCT04470427|588955152|FG005|Part B :Open-label|Other than specified|0|||
163068014|NCT04470427|588955147|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
163068015|NCT04470427|588955148|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
163068016|NCT04470427|588955149|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
163068017|NCT04470427|588955150|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
163068018|NCT04470427|588955151|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
163068019|NCT04470427|588955152|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
163068020|NCT04470427|588955147|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
163068021|NCT04470427|588955148|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
163068022|NCT04470427|588955149|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
163068023|NCT04470427|588955150|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
163068024|NCT04470427|588955151|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
163068025|NCT04470427|588955152|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
163068026|NCT01018979|588955153|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
163068027|NCT01018979|588955154|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
163068028|NCT01018979|588955153|FG000|Overall Study|Not received at least one dose|0|||
163068029|NCT01018979|588955154|FG001|Overall Study|Not received at least one dose|1|||
163068030|NCT02324153|588955157|FG000|Overall Study|Withdrawal by Subject|4|||
163068031|NCT02324153|588955158|FG001|Overall Study|Withdrawal by Subject|1|||
163068032|NCT02324153|588955157|FG000|Overall Study|Surgery postponed after randomization|3|||
163068033|NCT02324153|588955158|FG001|Overall Study|Surgery postponed after randomization|0|||
163068034|NCT02324153|588955157|FG000|Overall Study|Developed delirium preoperatively|1|||
163068035|NCT02324153|588955158|FG001|Overall Study|Developed delirium preoperatively|0|||
163068036|NCT01937299|588955159|FG000|Overall Study|Adverse Event|13|||
163068037|NCT01937299|588955160|FG001|Overall Study|Adverse Event|0|||
163068038|NCT01937299|588955159|FG000|Overall Study|Lack of Efficacy|0|||
163068039|NCT01937299|588955160|FG001|Overall Study|Lack of Efficacy|4|||
163068040|NCT01937299|588955159|FG000|Overall Study|Withdrawal by Subject|1|||
163068041|NCT01937299|588955160|FG001|Overall Study|Withdrawal by Subject|0|||
163068042|NCT01913353|588955161|FG000|Overall Study|Adverse Event|2|||
163068043|NCT01913353|588955162|FG001|Overall Study|Adverse Event|0|||
163068044|NCT01913353|588955161|FG000|Overall Study|Physician Decision|0|||
163068045|NCT01913353|588955162|FG001|Overall Study|Physician Decision|2|||
163068046|NCT01913353|588955161|FG000|Overall Study|Withdrawal by Subject|20|||
163068047|NCT01913353|588955162|FG001|Overall Study|Withdrawal by Subject|6|||
163068048|NCT01913353|588955161|FG000|Overall Study|multiple reasons|10|||
163068049|NCT01913353|588955162|FG001|Overall Study|multiple reasons|7|||
163068050|NCT00385840|588955163|FG000|Overall Study|Adverse Event|1|||
163068051|NCT00385840|588955164|FG001|Overall Study|Adverse Event|1|||
163068052|NCT00385840|588955163|FG000|Overall Study|Lost to Follow-up|3|||
163068053|NCT00385840|588955164|FG001|Overall Study|Lost to Follow-up|13|||
163068054|NCT04017962|588955165|FG000|Overall Study|Death|2|||
163068055|NCT04017962|588955166|FG001|Overall Study|Death|0|||
163068056|NCT04017962|588955165|FG000|Overall Study|Lost to Follow-up|2|||
163068057|NCT04017962|588955166|FG001|Overall Study|Lost to Follow-up|0|||
163068058|NCT04017962|588955165|FG000|Overall Study|Physician Decision|1|||
163068059|NCT04017962|588955166|FG001|Overall Study|Physician Decision|0|||
163068060|NCT04017962|588955165|FG000|Overall Study|Discontinued LTV|5|||
163068061|NCT04017962|588955166|FG001|Overall Study|Discontinued LTV|0|||
163068062|NCT00700635|588955167|FG000|Overall Study|Adverse Event|1|||
163068063|NCT00700635|588955168|FG001|Overall Study|Adverse Event|0|||
163068064|NCT00700635|588955169|FG002|Overall Study|Adverse Event|0|||
163068065|NCT00700635|588955167|FG000|Overall Study|Lost to Follow-up|1|||
163068066|NCT00700635|588955168|FG001|Overall Study|Lost to Follow-up|3|||
163068067|NCT00700635|588955169|FG002|Overall Study|Lost to Follow-up|0|||
163068068|NCT00700635|588955167|FG000|Overall Study|Protocol Violation|2|||
163068069|NCT00700635|588955168|FG001|Overall Study|Protocol Violation|2|||
163068070|NCT00700635|588955169|FG002|Overall Study|Protocol Violation|0|||
163068071|NCT00700635|588955167|FG000|Overall Study|Withdrawal by Subject|7|||
163068072|NCT00700635|588955168|FG001|Overall Study|Withdrawal by Subject|3|||
163068073|NCT00700635|588955169|FG002|Overall Study|Withdrawal by Subject|1|||
163068074|NCT05172570|588955170|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
163068075|NCT05172570|588955171|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
163068076|NCT05172570|588955172|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
163068077|NCT05172570|588955170|FG000|Overall Study|PI Decision due to equipment shortages|0|||
163068078|NCT05172570|588955171|FG001|Overall Study|PI Decision due to equipment shortages|0|||
163068079|NCT05172570|588955172|FG002|Overall Study|PI Decision due to equipment shortages|1|||
163068080|NCT01260948|588955173|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
163068081|NCT01260948|588955174|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
163068082|NCT01260948|588955173|FG000|Second Intervention|Emesis|0|||
163068083|NCT01260948|588955174|FG001|Second Intervention|Emesis|1|||
163068084|NCT00768053|588955175|FG000|Overall Study|Adverse Event|10|||
163068085|NCT00768053|588955175|FG000|Overall Study|Lost to Follow-up|1|||
163068086|NCT01202591|588955176|FG000|Overall Study|Adverse Event|2|||
163068087|NCT01202591|588955177|FG001|Overall Study|Adverse Event|1|||
163068088|NCT01202591|588955178|FG002|Overall Study|Adverse Event|4|||
163068089|NCT01202591|588955179|FG003|Overall Study|Adverse Event|4|||
163068090|NCT01202591|588955180|FG004|Overall Study|Adverse Event|0|||
163068091|NCT01202591|588955181|FG005|Overall Study|Adverse Event|0|||
163068092|NCT01202591|588955176|FG000|Overall Study|Other reason as per investigator|3|||
163068093|NCT01202591|588955177|FG001|Overall Study|Other reason as per investigator|4|||
163068094|NCT01202591|588955178|FG002|Overall Study|Other reason as per investigator|7|||
163068095|NCT01202591|588955179|FG003|Overall Study|Other reason as per investigator|3|||
163068096|NCT01202591|588955180|FG004|Overall Study|Other reason as per investigator|1|||
163068097|NCT01202591|588955181|FG005|Overall Study|Other reason as per investigator|3|||
163068098|NCT01202591|588955176|FG000|Overall Study|Withdrawal by Subject|0|||
163068099|NCT01202591|588955177|FG001|Overall Study|Withdrawal by Subject|0|||
163068100|NCT01202591|588955178|FG002|Overall Study|Withdrawal by Subject|0|||
163068101|NCT01202591|588955179|FG003|Overall Study|Withdrawal by Subject|0|||
163068102|NCT01202591|588955180|FG004|Overall Study|Withdrawal by Subject|2|||
163068103|NCT01202591|588955181|FG005|Overall Study|Withdrawal by Subject|1|||
163068104|NCT01202591|588955176|FG000|Overall Study|Objective Disease Progression|0|||
163068105|NCT01202591|588955177|FG001|Overall Study|Objective Disease Progression|0|||
163068106|NCT01202591|588955178|FG002|Overall Study|Objective Disease Progression|0|||
163068107|NCT01202591|588955179|FG003|Overall Study|Objective Disease Progression|0|||
163068108|NCT01202591|588955180|FG004|Overall Study|Objective Disease Progression|2|||
163068109|NCT01202591|588955181|FG005|Overall Study|Objective Disease Progression|0|||
163068110|NCT00182637|588955804|FG000|Overall Study|Adverse Event|2|||
163068111|NCT00182637|588955804|FG000|Overall Study|Disease Progression|1|||
163330969|NCT03678688|589922460|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
163330970|NCT03678688|589922461|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
163330971|NCT03678688|589922462|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
163330972|NCT03678688|589922463|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
163330973|NCT03678688|589922464|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
163026638|NCT01508130|588799251|FG001|Overall Study|Adverse Event|28|||
163026639|NCT01508130|588799250|FG000|Overall Study|Death|3|||
163026640|NCT01508130|588799251|FG001|Overall Study|Death|1|||
163026641|NCT01508130|588799250|FG000|Overall Study|Protocol Violation|2|||
163026642|NCT01508130|588799251|FG001|Overall Study|Protocol Violation|0|||
163026643|NCT01508130|588799250|FG000|Overall Study|Lost to Follow-up|25|||
163026644|NCT01508130|588799251|FG001|Overall Study|Lost to Follow-up|2|||
163026645|NCT01508130|588799250|FG000|Overall Study|Withdrawal by Subject|3|||
163026646|NCT01508130|588799251|FG001|Overall Study|Withdrawal by Subject|3|||
163026647|NCT01508130|588799250|FG000|Overall Study|Subject's substantial non-compliance|25|||
163026648|NCT01508130|588799251|FG001|Overall Study|Subject's substantial non-compliance|9|||
163068112|NCT02068794|588955805|FG000|Overall Study|Withdrawal by Subject|0|||
163068113|NCT02068794|588955806|FG001|Overall Study|Withdrawal by Subject|1|||
163068114|NCT02068794|588955807|FG002|Overall Study|Withdrawal by Subject|2|||
163068115|NCT02068794|588955805|FG000|Overall Study|Early Progression|1|||
163068116|NCT02068794|588955806|FG001|Overall Study|Early Progression|0|||
163068117|NCT02068794|588955807|FG002|Overall Study|Early Progression|1|||
163068118|NCT02068794|588955805|FG000|Overall Study|Ineligible|0|||
163330974|NCT03678688|589922456|FG000|Overall Study|Covid Related Adverse Event|0|||
163068119|NCT02068794|588955806|FG001|Overall Study|Ineligible|0|||
163068120|NCT02068794|588955807|FG002|Overall Study|Ineligible|1|||
163068121|NCT00898807|588955808|FG000|Overall Study|Withdrawal by Subject|5|||
163068122|NCT00898807|588955809|FG001|Overall Study|Withdrawal by Subject|3|||
163068123|NCT00898807|588955808|FG000|Overall Study|Family pressure to discontinue|2|||
163068124|NCT00898807|588955809|FG001|Overall Study|Family pressure to discontinue|2|||
163068125|NCT00898807|588955808|FG000|Overall Study|Lost to Follow-up|1|||
163068126|NCT00898807|588955809|FG001|Overall Study|Lost to Follow-up|3|||
163068127|NCT00898807|588955808|FG000|Overall Study|Death|0|||
163068128|NCT00898807|588955809|FG001|Overall Study|Death|1|||
163068129|NCT01482221|588955812|FG000|Overall Study|Lack of Efficacy|1|||
163068130|NCT01482221|588955813|FG001|Overall Study|Lack of Efficacy|0|||
163068131|NCT01482221|588955814|FG002|Overall Study|Lack of Efficacy|1|||
163068132|NCT01482221|588955812|FG000|Overall Study|Lost to Follow-up|3|||
163068133|NCT01482221|588955813|FG001|Overall Study|Lost to Follow-up|2|||
163068134|NCT01482221|588955814|FG002|Overall Study|Lost to Follow-up|1|||
163068135|NCT01482221|588955812|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
163068136|NCT01482221|588955813|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
163068137|NCT01482221|588955814|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
163068138|NCT01482221|588955812|FG000|Overall Study|Condition under Investigation Worsened|3|||
163068139|NCT01482221|588955813|FG001|Overall Study|Condition under Investigation Worsened|2|||
163068140|NCT01482221|588955814|FG002|Overall Study|Condition under Investigation Worsened|4|||
163068141|NCT01482221|588955812|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
163068142|NCT01482221|588955813|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
163068143|NCT01482221|588955814|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
163068144|NCT01482221|588955812|FG000|Overall Study|Adverse Event|1|||
163068145|NCT01482221|588955813|FG001|Overall Study|Adverse Event|7|||
163068146|NCT01482221|588955814|FG002|Overall Study|Adverse Event|3|||
163068147|NCT01482221|588955812|FG000|Overall Study|Withdrawal by Subject|10|||
163068148|NCT01482221|588955813|FG001|Overall Study|Withdrawal by Subject|7|||
163068149|NCT01482221|588955814|FG002|Overall Study|Withdrawal by Subject|12|||
163068150|NCT01482221|588955812|FG000|Overall Study|Incorrect randomization|0|||
163068151|NCT01482221|588955813|FG001|Overall Study|Incorrect randomization|1|||
163068152|NCT01482221|588955814|FG002|Overall Study|Incorrect randomization|0|||
163068153|NCT01482221|588955812|FG000|Overall Study|Physician Decision|0|||
163068154|NCT01482221|588955813|FG001|Overall Study|Physician Decision|1|||
163068155|NCT01482221|588955814|FG002|Overall Study|Physician Decision|0|||
163068156|NCT05607043|588955815|FG000|Overall Study|Lost to Follow-up|2|||
163068157|NCT05427916|588955819|FG000|Overall Study|Adverse Event|3|||
163068158|NCT05427916|588955820|FG001|Overall Study|Adverse Event|0|||
163068159|NCT05427916|588955819|FG000|Overall Study|Lack of Efficacy|6|||
163068160|NCT05427916|588955820|FG001|Overall Study|Lack of Efficacy|0|||
163068161|NCT05427916|588955819|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
163068162|NCT05427916|588955820|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
163068163|NCT00081458|588955823|FG000|Overall Study|Adverse Event|1|||
163068164|NCT00081458|588955824|FG001|Overall Study|Adverse Event|5|||
163068165|NCT00081458|588955825|FG002|Overall Study|Adverse Event|2|||
163068166|NCT00081458|588955823|FG000|Overall Study|Withdrawal by Subject|0|||
163068167|NCT00081458|588955824|FG001|Overall Study|Withdrawal by Subject|3|||
163068168|NCT00081458|588955825|FG002|Overall Study|Withdrawal by Subject|1|||
163068169|NCT00081458|588955823|FG000|Overall Study|Randomized but not dosed|0|||
163068170|NCT00081458|588955824|FG001|Overall Study|Randomized but not dosed|0|||
163068171|NCT00081458|588955825|FG002|Overall Study|Randomized but not dosed|1|||
163068172|NCT03384966|588955826|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
163068173|NCT03384966|588955827|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
163068174|NCT03384966|588955828|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
163068175|NCT03384966|588955826|FG000|Follow-up Period|Adverse Event|1|||
163068176|NCT03384966|588955827|FG001|Follow-up Period|Adverse Event|0|||
163068177|NCT03384966|588955828|FG002|Follow-up Period|Adverse Event|0|||
163068178|NCT04790201|588955829|FG000|Overall Study|Lost to Follow-up|0|||
163068179|NCT04790201|588955830|FG001|Overall Study|Lost to Follow-up|0|||
163330975|NCT03678688|589922457|FG001|Overall Study|Covid Related Adverse Event|0|||
163330976|NCT03678688|589922458|FG002|Overall Study|Covid Related Adverse Event|0|||
163330977|NCT03678688|589922459|FG003|Overall Study|Covid Related Adverse Event|0|||
163330978|NCT03678688|589922460|FG004|Overall Study|Covid Related Adverse Event|0|||
163330979|NCT03678688|589922461|FG005|Overall Study|Covid Related Adverse Event|3|||
163068180|NCT04790201|588955831|FG002|Overall Study|Lost to Follow-up|2|||
163068181|NCT04790201|588955829|FG000|Overall Study|Death|0|||
163068182|NCT04790201|588955830|FG001|Overall Study|Death|1|||
163068183|NCT04790201|588955831|FG002|Overall Study|Death|0|||
163068184|NCT04790201|588955829|FG000|Overall Study|Protocol Violation|1|||
163068185|NCT04790201|588955830|FG001|Overall Study|Protocol Violation|0|||
163068186|NCT04790201|588955831|FG002|Overall Study|Protocol Violation|1|||
163068187|NCT01334515|588955832|FG000|Overall Study|Adverse Event|1|||
163068188|NCT01334515|588955833|FG001|Overall Study|Adverse Event|6|||
163068189|NCT01334515|588955832|FG000|Overall Study|Death|1|||
163068190|NCT01334515|588955833|FG001|Overall Study|Death|0|||
163068191|NCT01334515|588955832|FG000|Overall Study|Lack of Efficacy|8|||
163068192|NCT01334515|588955833|FG001|Overall Study|Lack of Efficacy|21|||
163068193|NCT01334515|588955832|FG000|Overall Study|Physician Decision|1|||
163068194|NCT01334515|588955833|FG001|Overall Study|Physician Decision|1|||
163068195|NCT01334515|588955832|FG000|Overall Study|Withdrawal by Subject|1|||
163068196|NCT01334515|588955833|FG001|Overall Study|Withdrawal by Subject|1|||
163068197|NCT03637374|588955834|FG000|Overall Study|Death|2|||
163068198|NCT03637374|588955835|FG001|Overall Study|Death|0|||
163068199|NCT00776997|588955837|FG000|Overall Study|Adverse Event|2|||
163068200|NCT00933166|588955838|FG000|Overall Study|Lost to Follow-up|4|||
163068201|NCT00933166|588955838|FG000|Overall Study|Lack of Efficacy|9|||
163026649|NCT01508130|588799250|FG000|Overall Study|Insufficient therapeutic response|74|||
163026650|NCT01508130|588799251|FG001|Overall Study|Insufficient therapeutic response|23|||
163026651|NCT01508130|588799250|FG000|Overall Study|Administrative|14|||
163026652|NCT01508130|588799251|FG001|Overall Study|Administrative|3|||
163026653|NCT01880086|588799253|FG000|Overall Study|Lost to Follow-up|1|||
163068202|NCT00933166|588955838|FG000|Overall Study|Unavailable|4|||
163068203|NCT00933166|588955838|FG000|Overall Study|Withdrawal by Subject|1|||
163068204|NCT03925220|588955840|FG000|Overall Study|Withdrawal by Subject|4|||
163068205|NCT03925220|588955841|FG001|Overall Study|Withdrawal by Subject|4|||
163068206|NCT03925220|588955842|FG002|Overall Study|Withdrawal by Subject|4|||
163026654|NCT01880086|588799254|FG001|Overall Study|Lost to Follow-up|1|||
163026655|NCT02288091|588799257|FG000|Overall Study|Lost to Follow-up|1|||
163026656|NCT02288091|588799257|FG000|Overall Study|Screen fail|7|||
163026657|NCT03843632|588799264|FG000|Overall Study|Withdrawal by Subject|1|||
163026658|NCT03843632|588799265|FG001|Overall Study|Withdrawal by Subject|0|||
163026659|NCT03843632|588799266|FG002|Overall Study|Withdrawal by Subject|0|||
163026660|NCT03843632|588799267|FG003|Overall Study|Withdrawal by Subject|0|||
163026661|NCT03403751|588799269|FG000|Overall Study|Death|5|||
163026662|NCT03403751|588799270|FG001|Overall Study|Death|6|||
163026663|NCT03403751|588799269|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
163026664|NCT03403751|588799270|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
163026665|NCT00520481|588799277|FG000|Overall Study|Adverse Event|4|||
163026666|NCT00520481|588799278|FG001|Overall Study|Adverse Event|1|||
163026667|NCT00520481|588799277|FG000|Overall Study|Withdrawal by Subject|3|||
163026668|NCT00520481|588799278|FG001|Overall Study|Withdrawal by Subject|0|||
163026669|NCT04442269|588799281|FG000|Overall Study|Adverse Event|1|||
163026670|NCT04442269|588799282|FG001|Overall Study|Adverse Event|0|||
163026671|NCT04442269|588799281|FG000|Overall Study|Death|0|||
163026672|NCT04442269|588799282|FG001|Overall Study|Death|1|||
163026673|NCT04442269|588799281|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
163026674|NCT04442269|588799282|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
163026675|NCT04442269|588799281|FG000|Overall Study|Lost to Follow-up|1|||
163026676|NCT04442269|588799282|FG001|Overall Study|Lost to Follow-up|0|||
163026677|NCT04442269|588799281|FG000|Overall Study|Withdrawal by Subject|3|||
163026678|NCT04442269|588799282|FG001|Overall Study|Withdrawal by Subject|2|||
163026679|NCT04442269|588799281|FG000|Overall Study|Protocol Deviation|0|||
163026680|NCT04442269|588799282|FG001|Overall Study|Protocol Deviation|1|||
163026681|NCT04442269|588799281|FG000|Overall Study|Travel Limitations|1|||
163026682|NCT04442269|588799282|FG001|Overall Study|Travel Limitations|1|||
163026683|NCT03802565|588799286|FG000|Overall Study|Adverse Event|0|||
163026684|NCT03802565|588799287|FG001|Overall Study|Adverse Event|1|||
163026685|NCT03802565|588799288|FG002|Overall Study|Adverse Event|2|||
163026686|NCT03802565|588799289|FG003|Overall Study|Adverse Event|1|||
163026687|NCT03802565|588799290|FG004|Overall Study|Adverse Event|1|||
163026688|NCT03802565|588799286|FG000|Overall Study|Withdrawal by Subject|2|||
163026689|NCT03802565|588799287|FG001|Overall Study|Withdrawal by Subject|2|||
163026690|NCT03802565|588799288|FG002|Overall Study|Withdrawal by Subject|2|||
163026691|NCT03802565|588799289|FG003|Overall Study|Withdrawal by Subject|0|||
163026692|NCT03802565|588799290|FG004|Overall Study|Withdrawal by Subject|1|||
163026693|NCT03802565|588799286|FG000|Overall Study|Protocol Violation|2|||
163068207|NCT03925220|588955843|FG003|Overall Study|Withdrawal by Subject|4|||
163330980|NCT03678688|589922462|FG006|Overall Study|Covid Related Adverse Event|1|||
163026694|NCT03802565|588799287|FG001|Overall Study|Protocol Violation|1|||
163068208|NCT03925220|588955840|FG000|Overall Study|Lost to Follow-up|40|||
163068209|NCT03925220|588955841|FG001|Overall Study|Lost to Follow-up|46|||
163068210|NCT03925220|588955842|FG002|Overall Study|Lost to Follow-up|37|||
163068211|NCT03925220|588955843|FG003|Overall Study|Lost to Follow-up|38|||
163330981|NCT03678688|589922463|FG007|Overall Study|Covid Related Adverse Event|1|||
163026695|NCT03802565|588799288|FG002|Overall Study|Protocol Violation|4|||
163026696|NCT03802565|588799289|FG003|Overall Study|Protocol Violation|5|||
163026697|NCT03802565|588799290|FG004|Overall Study|Protocol Violation|1|||
163026698|NCT03802565|588799286|FG000|Overall Study|Lost to Follow-up|0|||
163026699|NCT03802565|588799287|FG001|Overall Study|Lost to Follow-up|0|||
163026700|NCT03802565|588799288|FG002|Overall Study|Lost to Follow-up|1|||
163068212|NCT00374868|588955844|FG000|Overall Study|Adverse Event|12|||
163068213|NCT00374868|588955844|FG000|Overall Study|Progressive Disease|7|||
163068214|NCT00374868|588955844|FG000|Overall Study|Physician Decision|13|||
163330982|NCT03678688|589922464|FG008|Overall Study|Covid Related Adverse Event|0|||
163068215|NCT00374868|588955844|FG000|Overall Study|Lost to Follow-up|1|||
163068216|NCT00374868|588955844|FG000|Overall Study|Death|2|||
163068217|NCT00374868|588955844|FG000|Overall Study|Other - Not Specified|1|||
163068218|NCT03188185|588955845|FG000|Stage 1|Adverse Event|4|||
163068219|NCT03188185|588955846|FG001|Stage 1|Adverse Event|12|||
163068220|NCT03188185|588955847|FG002|Stage 1|Adverse Event|0|||
163068221|NCT03188185|588955848|FG003|Stage 1|Adverse Event|0|||
163068222|NCT03188185|588955845|FG000|Stage 1|Lack of Efficacy|0|||
163068223|NCT03188185|588955846|FG001|Stage 1|Lack of Efficacy|2|||
163068224|NCT03188185|588955847|FG002|Stage 1|Lack of Efficacy|0|||
163068225|NCT03188185|588955848|FG003|Stage 1|Lack of Efficacy|0|||
163068226|NCT03188185|588955845|FG000|Stage 1|Lost to Follow-up|6|||
163068227|NCT03188185|588955846|FG001|Stage 1|Lost to Follow-up|1|||
163068228|NCT03188185|588955847|FG002|Stage 1|Lost to Follow-up|0|||
163068229|NCT03188185|588955848|FG003|Stage 1|Lost to Follow-up|0|||
163068230|NCT03188185|588955845|FG000|Stage 1|Withdrawal by Subject|9|||
163068231|NCT03188185|588955846|FG001|Stage 1|Withdrawal by Subject|0|||
163068232|NCT03188185|588955847|FG002|Stage 1|Withdrawal by Subject|0|||
163068233|NCT03188185|588955848|FG003|Stage 1|Withdrawal by Subject|0|||
163068234|NCT03188185|588955845|FG000|Stage 1|Identified as a professional patient|0|||
163068235|NCT03188185|588955846|FG001|Stage 1|Identified as a professional patient|1|||
163068236|NCT03188185|588955847|FG002|Stage 1|Identified as a professional patient|0|||
163068237|NCT03188185|588955848|FG003|Stage 1|Identified as a professional patient|0|||
163068238|NCT03188185|588955845|FG000|Stage 2|Adverse Event|0|||
163068239|NCT03188185|588955846|FG001|Stage 2|Adverse Event|0|||
163068240|NCT03188185|588955847|FG002|Stage 2|Adverse Event|2|||
163068241|NCT03188185|588955848|FG003|Stage 2|Adverse Event|4|||
163068242|NCT03188185|588955845|FG000|Stage 2|Lack of Efficacy|0|||
163068243|NCT03188185|588955846|FG001|Stage 2|Lack of Efficacy|0|||
163068244|NCT03188185|588955847|FG002|Stage 2|Lack of Efficacy|3|||
163068245|NCT03188185|588955848|FG003|Stage 2|Lack of Efficacy|0|||
163068246|NCT03188185|588955845|FG000|Stage 2|Lost to Follow-up|0|||
163068247|NCT03188185|588955846|FG001|Stage 2|Lost to Follow-up|0|||
163068248|NCT03188185|588955847|FG002|Stage 2|Lost to Follow-up|1|||
163068249|NCT03188185|588955848|FG003|Stage 2|Lost to Follow-up|0|||
163068250|NCT03188185|588955845|FG000|Stage 2|Physician Decision|0|||
163068251|NCT03188185|588955846|FG001|Stage 2|Physician Decision|0|||
163068252|NCT03188185|588955847|FG002|Stage 2|Physician Decision|0|||
163068253|NCT03188185|588955848|FG003|Stage 2|Physician Decision|1|||
163068254|NCT03188185|588955845|FG000|Stage 2|Withdrawal by Subject|0|||
163068255|NCT03188185|588955846|FG001|Stage 2|Withdrawal by Subject|0|||
163068256|NCT03188185|588955847|FG002|Stage 2|Withdrawal by Subject|3|||
163068257|NCT03188185|588955848|FG003|Stage 2|Withdrawal by Subject|1|||
163068258|NCT03301714|588955849|FG000|Overall Study|Lost to Follow-up|10|||
163068259|NCT03301714|588955850|FG001|Overall Study|Lost to Follow-up|4|||
163068260|NCT03301714|588955851|FG002|Overall Study|Lost to Follow-up|4|||
163068261|NCT03301714|588955849|FG000|Overall Study|Did not receive allocated intervention|0|||
163068262|NCT03301714|588955850|FG001|Overall Study|Did not receive allocated intervention|2|||
163068263|NCT03301714|588955851|FG002|Overall Study|Did not receive allocated intervention|3|||
163068264|NCT04465955|588955852|FG000|Overall Study|Withdrew consent|6|||
163068265|NCT04465955|588955853|FG001|Overall Study|Withdrew consent|10|||
163068266|NCT04465955|588955854|FG002|Overall Study|Withdrew consent|7|||
163068267|NCT04465955|588955852|FG000|Overall Study|Adverse Event|6|||
163068268|NCT04465955|588955853|FG001|Overall Study|Adverse Event|5|||
163068269|NCT04465955|588955854|FG002|Overall Study|Adverse Event|1|||
163068270|NCT04465955|588955852|FG000|Overall Study|Lost to Follow-up|2|||
163068271|NCT04465955|588955853|FG001|Overall Study|Lost to Follow-up|0|||
163068272|NCT04465955|588955854|FG002|Overall Study|Lost to Follow-up|3|||
163068273|NCT04465955|588955852|FG000|Overall Study|Other|1|||
163068274|NCT04465955|588955853|FG001|Overall Study|Other|1|||
163068275|NCT04465955|588955854|FG002|Overall Study|Other|3|||
163068276|NCT04738487|588955855|FG000|Overall Study|Participant Ongoing in Study|298|||
163068277|NCT04738487|588955856|FG001|Overall Study|Participant Ongoing in Study|297|||
163068278|NCT04738487|588955855|FG000|Overall Study|Withdrawal by Subject|7|||
163068279|NCT04738487|588955856|FG001|Overall Study|Withdrawal by Subject|9|||
163068280|NCT04738487|588955855|FG000|Overall Study|Lost to Follow-up|2|||
163068281|NCT04738487|588955856|FG001|Overall Study|Lost to Follow-up|0|||
163068282|NCT04738487|588955855|FG000|Overall Study|Death|287|||
163068283|NCT04738487|588955856|FG001|Overall Study|Death|306|||
163068284|NCT00632359|588955857|FG000|Overall Study|Withdrawal by Subject|2|||
163068285|NCT03599713|588955860|FG000|Overall Study|Death|38|||
163068286|NCT03599713|588955861|FG001|Overall Study|Death|3|||
163068287|NCT03599713|588955860|FG000|Overall Study|Withdrawal by Subject|17|||
163068288|NCT03599713|588955861|FG001|Overall Study|Withdrawal by Subject|0|||
163068289|NCT03599713|588955860|FG000|Overall Study|Lost to Follow-up|4|||
163068290|NCT03599713|588955861|FG001|Overall Study|Lost to Follow-up|0|||
163068291|NCT03599713|588955860|FG000|Overall Study|Discontinued Due to End of Study|42|||
163068292|NCT03599713|588955861|FG001|Overall Study|Discontinued Due to End of Study|3|||
163068293|NCT05578872|588955862|FG000|Overall Study|Withdrawal by Subject|2|||
163068294|NCT05578872|588955863|FG001|Overall Study|Withdrawal by Subject|1|||
163068295|NCT05578872|588955862|FG000|Overall Study|Adverse Event|1|||
163068296|NCT05578872|588955863|FG001|Overall Study|Adverse Event|1|||
163068297|NCT05578872|588955862|FG000|Overall Study|Physician Decision|1|||
163068298|NCT05578872|588955863|FG001|Overall Study|Physician Decision|2|||
163068299|NCT05578872|588955862|FG000|Overall Study|Progressive disease|10|||
163068300|NCT05578872|588955863|FG001|Overall Study|Progressive disease|9|||
163068301|NCT05578872|588955862|FG000|Overall Study|Sponsor decision|0|||
163068302|NCT05578872|588955863|FG001|Overall Study|Sponsor decision|1|||
163068303|NCT05578872|588955862|FG000|Overall Study|Toxicity and Patient's decision|0|||
163068304|NCT05578872|588955863|FG001|Overall Study|Toxicity and Patient's decision|1|||
163068305|NCT04941898|588957225|FG000|Overall Study|Protocol Violation|1|||
163068306|NCT03641924|588957226|FG000|Overall Study|Withdrawal by Subject|26|||
163068307|NCT03641924|588957226|FG000|Overall Study|Lost to Follow-up|16|||
163068308|NCT03641924|588957226|FG000|Overall Study|Protocol Violation|10|||
163068309|NCT01022580|588957227|FG000|Overall Study|Death|18|||
163068310|NCT01022580|588957228|FG001|Overall Study|Death|22|||
163068311|NCT03439839|588957229|FG000|Overall Study|Death|3|||
163068312|NCT03439839|588957230|FG001|Overall Study|Death|0|||
163068313|NCT03720847|588957231|FG000|Washout|Physician Decision|1|||
163068314|NCT03720847|588957232|FG001|Washout|Physician Decision|2|||
163068315|NCT01500096|588957233|FG000|Overall Study|Lost to Follow-up|1|||
163068316|NCT01500096|588957234|FG001|Overall Study|Lost to Follow-up|0|||
163068317|NCT01500096|588957235|FG002|Overall Study|Lost to Follow-up|0|||
163068318|NCT01500096|588957236|FG003|Overall Study|Lost to Follow-up|2|||
163068319|NCT03033901|588957240|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
163068320|NCT03033901|588957240|FG000|Overall Study|Refused PSG|23|||
163068321|NCT03033901|588957240|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
163068322|NCT03033901|588957240|FG000|Overall Study|Missing Oximetry Data|3|||
163068323|NCT00924651|588957243|FG000|Overall Study|Chemo started too soon|2|||
163068324|NCT00924651|588957244|FG001|Overall Study|Chemo started too soon|3|||
163068325|NCT00924651|588957243|FG000|Overall Study|No Reason|3|||
163068326|NCT00924651|588957244|FG001|Overall Study|No Reason|7|||
163068327|NCT00924651|588957243|FG000|Overall Study|Overwhelmed|6|||
163068328|NCT00924651|588957244|FG001|Overall Study|Overwhelmed|6|||
163068329|NCT00924651|588957243|FG000|Overall Study|Noncompliant|1|||
163068330|NCT00924651|588957244|FG001|Overall Study|Noncompliant|4|||
163068331|NCT00924651|588957243|FG000|Overall Study|Medical|1|||
163068332|NCT00924651|588957244|FG001|Overall Study|Medical|3|||
163068333|NCT00924651|588957243|FG000|Overall Study|Changed Mind|10|||
163068334|NCT00924651|588957244|FG001|Overall Study|Changed Mind|1|||
163068335|NCT00924651|588957243|FG000|Overall Study|Incomplete Form|2|||
163068336|NCT00924651|588957244|FG001|Overall Study|Incomplete Form|1|||
163068337|NCT00723944|588957245|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
163068338|NCT00723944|588957246|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
163068339|NCT00723944|588957245|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
163068340|NCT00723944|588957246|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
163068341|NCT00723944|588957245|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
163068342|NCT00723944|588957246|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
163068343|NCT00835978|588957247|FG000|Overall Study|Death|33|||
163068344|NCT00835978|588957248|FG001|Overall Study|Death|40|||
163068345|NCT00835978|588957249|FG002|Overall Study|Death|49|||
163068346|NCT00835978|588957250|FG003|Overall Study|Death|4|||
163068347|NCT00835978|588957247|FG000|Overall Study|Lost to Follow-up|3|||
163068348|NCT00835978|588957248|FG001|Overall Study|Lost to Follow-up|4|||
163068349|NCT00835978|588957249|FG002|Overall Study|Lost to Follow-up|2|||
163068350|NCT00835978|588957250|FG003|Overall Study|Lost to Follow-up|1|||
163068351|NCT00835978|588957247|FG000|Overall Study|Other|5|||
163217770|NCT01649375|589513790|FG001|Up to Week 16|Death|0|||
163217771|NCT01649375|589513791|FG002|Up to Week 16|Death|0|||
163217772|NCT01649375|589513792|FG003|Up to Week 16|Death|0|||
163217773|NCT01649375|589513793|FG004|Up to Week 16|Death|0|||
163217774|NCT01649375|589513789|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
163217775|NCT01649375|589513790|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
163217776|NCT01649375|589513791|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
163217777|NCT01649375|589513792|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
163068352|NCT00835978|588957248|FG001|Overall Study|Other|1|||
163068353|NCT00835978|588957249|FG002|Overall Study|Other|8|||
163068354|NCT00835978|588957250|FG003|Overall Study|Other|0|||
163068355|NCT00835978|588957247|FG000|Overall Study|Objective progression or relapse|2|||
163068356|NCT00835978|588957248|FG001|Overall Study|Objective progression or relapse|0|||
163068357|NCT00835978|588957249|FG002|Overall Study|Objective progression or relapse|1|||
163068358|NCT00835978|588957250|FG003|Overall Study|Objective progression or relapse|0|||
163068359|NCT00835978|588957247|FG000|Overall Study|Adverse Event|1|||
163068360|NCT00835978|588957248|FG001|Overall Study|Adverse Event|0|||
163068361|NCT00835978|588957249|FG002|Overall Study|Adverse Event|1|||
163068362|NCT00835978|588957250|FG003|Overall Study|Adverse Event|0|||
163068363|NCT00835978|588957247|FG000|Overall Study|Withdrawal by Subject|0|||
163068364|NCT00835978|588957248|FG001|Overall Study|Withdrawal by Subject|3|||
163217778|NCT01649375|589513793|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
163217779|NCT01649375|589513789|FG000|Week 16 up to Week 260|Non-compliance|0|||
163217780|NCT01649375|589513790|FG001|Week 16 up to Week 260|Non-compliance|1|||
163068365|NCT00835978|588957249|FG002|Overall Study|Withdrawal by Subject|0|||
163068366|NCT00835978|588957250|FG003|Overall Study|Withdrawal by Subject|5|||
163068367|NCT00835978|588957247|FG000|Overall Study|Study terminated by sponsor|12|||
163068368|NCT00835978|588957248|FG001|Overall Study|Study terminated by sponsor|8|||
163068369|NCT00835978|588957249|FG002|Overall Study|Study terminated by sponsor|30|||
163068370|NCT00835978|588957250|FG003|Overall Study|Study terminated by sponsor|0|||
163068371|NCT02506036|588957251|FG000|First Intervention (4-6 Weeks)|Death|1|||
163068372|NCT02506036|588957252|FG001|First Intervention (4-6 Weeks)|Death|0|||
163068373|NCT02506036|588957251|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
163068374|NCT02506036|588957252|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
163068375|NCT02506036|588957251|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
163068376|NCT02506036|588957252|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
163068377|NCT01410604|588957254|FG000|Overall Study|Adverse Event|2|||
163068378|NCT01410604|588957255|FG001|Overall Study|Adverse Event|1|||
163068379|NCT01410604|588957254|FG000|Overall Study|Lost to Follow-up|1|||
163068380|NCT01410604|588957255|FG001|Overall Study|Lost to Follow-up|0|||
163068381|NCT01410604|588957254|FG000|Overall Study|Physician Decision|0|||
163068382|NCT01410604|588957255|FG001|Overall Study|Physician Decision|1|||
163068383|NCT02383173|588957260|FG000|Overall Study|Palliative Care Team withdrew|0|||
163068384|NCT02383173|588957261|FG001|Overall Study|Palliative Care Team withdrew|2|||
163068385|NCT00800540|588957262|FG000|Period One: 6 Weeks|Noncompliance|1|||
163068386|NCT00800540|588957263|FG001|Period One: 6 Weeks|Noncompliance|0|||
163068387|NCT00800540|588957262|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
163068388|NCT00800540|588957263|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
163068389|NCT00800540|588957262|FG000|Period 2: 6 Weeks|Adverse Event|0|||
163068390|NCT00800540|588957263|FG001|Period 2: 6 Weeks|Adverse Event|1|||
163068391|NCT00429299|588957264|FG000|Overall Study|Disease Progression|1|||
163068392|NCT00429299|588957265|FG001|Overall Study|Disease Progression|1|||
163068393|NCT00429299|588957266|FG002|Overall Study|Disease Progression|0|||
163068394|NCT00429299|588957264|FG000|Overall Study|Adverse Event|2|||
163068395|NCT00429299|588957265|FG001|Overall Study|Adverse Event|5|||
163068396|NCT00429299|588957266|FG002|Overall Study|Adverse Event|1|||
163068397|NCT00429299|588957264|FG000|Overall Study|Protocol Violation|1|||
163068398|NCT00429299|588957265|FG001|Overall Study|Protocol Violation|0|||
163068399|NCT00429299|588957266|FG002|Overall Study|Protocol Violation|0|||
163068400|NCT00429299|588957264|FG000|Overall Study|Withdrawal by Subject|0|||
163026701|NCT03802565|588799289|FG003|Overall Study|Lost to Follow-up|0|||
163026702|NCT03802565|588799290|FG004|Overall Study|Lost to Follow-up|0|||
163026703|NCT03802565|588799286|FG000|Overall Study|Subjects Related to Each Other|1|||
163026704|NCT03802565|588799287|FG001|Overall Study|Subjects Related to Each Other|0|||
163026705|NCT03802565|588799288|FG002|Overall Study|Subjects Related to Each Other|0|||
163026706|NCT03802565|588799289|FG003|Overall Study|Subjects Related to Each Other|2|||
163026707|NCT03802565|588799290|FG004|Overall Study|Subjects Related to Each Other|1|||
163026708|NCT03802565|588799286|FG000|Overall Study|Elevated Enzymes|0|||
163026709|NCT03802565|588799287|FG001|Overall Study|Elevated Enzymes|0|||
163026710|NCT03802565|588799288|FG002|Overall Study|Elevated Enzymes|0|||
163026711|NCT03802565|588799289|FG003|Overall Study|Elevated Enzymes|0|||
163026712|NCT03802565|588799290|FG004|Overall Study|Elevated Enzymes|2|||
163026713|NCT00430352|588799291|FG000|Overall Study|Disease progression|58|||
163026714|NCT00430352|588799291|FG000|Overall Study|Withdrawal by Subject|11|||
163026715|NCT00430352|588799291|FG000|Overall Study|Adverse Event|16|||
163026716|NCT00430352|588799291|FG000|Overall Study|Death|5|||
163026717|NCT00430352|588799291|FG000|Overall Study|Other|48|||
163026718|NCT03099694|588799292|FG000|Overall Study|Withdrawal by Subject|11|||
163026719|NCT03099694|588799293|FG001|Overall Study|Withdrawal by Subject|13|||
163026720|NCT03099694|588799292|FG000|Overall Study|Lost to Follow-up|9|||
163026721|NCT03099694|588799293|FG001|Overall Study|Lost to Follow-up|5|||
163026722|NCT04326439|588799294|FG000|Overall Study|Withdrawal by Subject|1|||
163026723|NCT04326439|588799295|FG001|Overall Study|Withdrawal by Subject|0|||
163026724|NCT04326439|588799294|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
163026725|NCT04326439|588799295|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
163026726|NCT04326439|588799294|FG000|Overall Study|Relapse after Induction 2|0|||
163026727|NCT04326439|588799295|FG001|Overall Study|Relapse after Induction 2|1|||
163026728|NCT04326439|588799294|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
163026729|NCT04326439|588799295|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
163068401|NCT00429299|588957265|FG001|Overall Study|Withdrawal by Subject|1|||
163026730|NCT00471718|588799297|FG000|Overall Study|Adverse Event|3|||
163026731|NCT00471718|588799297|FG000|Overall Study|other complicating disease|1|||
163026732|NCT00471718|588799297|FG000|Overall Study|disease progression|22|||
163068402|NCT00429299|588957266|FG002|Overall Study|Withdrawal by Subject|3|||
163068403|NCT04871113|588957267|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068404|NCT04871113|588957268|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068405|NCT04871113|588957269|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068406|NCT04871113|588957270|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068407|NCT04871113|588957271|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068408|NCT04871113|588957272|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
163068409|NCT04871113|588957273|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068410|NCT04871113|588957274|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068411|NCT04871113|588957275|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068412|NCT04871113|588957276|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068413|NCT04871113|588957267|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068414|NCT04871113|588957268|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068415|NCT04871113|588957269|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068416|NCT04871113|588957270|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068417|NCT04871113|588957271|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068418|NCT04871113|588957272|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068419|NCT04871113|588957273|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
163068420|NCT04871113|588957274|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
163068421|NCT04871113|588957275|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068422|NCT04871113|588957276|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068423|NCT02143778|588957277|FG000|Overall Study|Withdrawal by Subject|2|||
163068424|NCT02143778|588957277|FG000|Overall Study|Device malfunction|1|||
163068425|NCT05630755|588957278|FG000|Overall Study|Lost to Follow-up|7|||
163068426|NCT05630755|588957279|FG001|Overall Study|Lost to Follow-up|0|||
163068427|NCT05630755|588957278|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
163068428|NCT05630755|588957279|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
163068429|NCT05630755|588957278|FG000|Overall Study|Withdrawal by Subject|9|||
163068430|NCT05630755|588957279|FG001|Overall Study|Withdrawal by Subject|3|||
163068431|NCT05630755|588957278|FG000|Overall Study|Participant moved away from trial site|0|||
163068432|NCT05630755|588957279|FG001|Overall Study|Participant moved away from trial site|1|||
163068433|NCT05630755|588957278|FG000|Overall Study|Status not Recorded|316|||
163068434|NCT05630755|588957279|FG001|Overall Study|Status not Recorded|161|||
163068435|NCT02836769|588957285|FG000|Overall Study|Lost to Follow-up|10|||
163068436|NCT02836769|588957285|FG000|Overall Study|Medical withdrawal|2|||
163068437|NCT02836769|588957285|FG000|Overall Study|Withdrawal by Subject|3|||
163068438|NCT04339972|588957286|FG000|Overall Study|Scheduling Issues|3|||
163068439|NCT04339972|588957287|FG001|Overall Study|Scheduling Issues|3|||
163068440|NCT04339972|588957286|FG000|Overall Study|dropout|1|||
163068441|NCT04339972|588957287|FG001|Overall Study|dropout|1|||
163068442|NCT04339972|588957286|FG000|Overall Study|Technical issues|1|||
163068443|NCT04339972|588957287|FG001|Overall Study|Technical issues|0|||
163068444|NCT04339972|588957286|FG000|Overall Study|Claustraphobia|0|||
163068445|NCT04339972|588957287|FG001|Overall Study|Claustraphobia|1|||
163068446|NCT02403271|588957291|FG000|Period 1|Other varied reasons|1|||
163068447|NCT02403271|588957292|FG001|Period 1|Other varied reasons|0|||
163068448|NCT02403271|588957291|FG000|Period 2|Withdrawal by Subject|0|||
163068449|NCT02403271|588957292|FG001|Period 2|Withdrawal by Subject|14|||
163068450|NCT02403271|588957291|FG000|Period 2|Death|0|||
163068451|NCT02403271|588957292|FG001|Period 2|Death|84|||
163068452|NCT02403271|588957291|FG000|Period 2|Lost to Follow-up|0|||
163068453|NCT02403271|588957292|FG001|Period 2|Lost to Follow-up|2|||
163068454|NCT02403271|588957291|FG000|Period 2|Study Terminated by Sponsor|0|||
163068455|NCT02403271|588957292|FG001|Period 2|Study Terminated by Sponsor|14|||
163068456|NCT02403271|588957291|FG000|Period 2|Other varied reasons|0|||
163068457|NCT02403271|588957292|FG001|Period 2|Other varied reasons|10|||
163068458|NCT02112552|588957295|FG000|Overall Study|Withdrawal by Subject|1|||
163068459|NCT02112552|588957295|FG000|Overall Study|Adverse Event|1|||
163068460|NCT00774748|588957296|FG000|Overall Study|Lost to Follow-up|3|||
163068461|NCT03349515|588957298|FG000|Overall Study|Lack of Efficacy|2|||
163068462|NCT03349515|588957299|FG001|Overall Study|Lack of Efficacy|0|||
163068463|NCT03349515|588957298|FG000|Overall Study|Physician Decision|3|||
163068464|NCT03349515|588957299|FG001|Overall Study|Physician Decision|1|||
163068465|NCT02965456|588957306|FG000|Overall Study|Lost to Follow-up|40|||
163068466|NCT02965456|588957307|FG001|Overall Study|Lost to Follow-up|18|||
163068467|NCT02965456|588957306|FG000|Overall Study|Subject Request|22|||
163068468|NCT02965456|588957307|FG001|Overall Study|Subject Request|13|||
163068469|NCT02965456|588957306|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
163068470|NCT02965456|588957307|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
163068471|NCT02965456|588957306|FG000|Overall Study|Adverse Event|3|||
163068472|NCT02965456|588957307|FG001|Overall Study|Adverse Event|0|||
163068473|NCT02965456|588957306|FG000|Overall Study|Noncompliance with Study Drug|1|||
163068474|NCT02965456|588957307|FG001|Overall Study|Noncompliance with Study Drug|1|||
163068475|NCT02965456|588957306|FG000|Overall Study|Worsening Condition|0|||
163068476|NCT02965456|588957307|FG001|Overall Study|Worsening Condition|2|||
163068477|NCT02965456|588957306|FG000|Overall Study|Lack of Efficacy|1|||
163068478|NCT02965456|588957307|FG001|Overall Study|Lack of Efficacy|0|||
163068479|NCT02965456|588957306|FG000|Overall Study|Physician Decision|0|||
163068480|NCT02965456|588957307|FG001|Overall Study|Physician Decision|1|||
163068481|NCT02965456|588957306|FG000|Overall Study|Pregnancy|1|||
163068482|NCT02965456|588957307|FG001|Overall Study|Pregnancy|0|||
163068483|NCT02965456|588957306|FG000|Overall Study|Protocol Violation|0|||
163068484|NCT02965456|588957307|FG001|Overall Study|Protocol Violation|1|||
163068485|NCT02965456|588957306|FG000|Overall Study|Participant ran out of study drug|0|||
163068486|NCT02965456|588957307|FG001|Overall Study|Participant ran out of study drug|1|||
163068487|NCT05073315|588957308|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
163068488|NCT05073315|588957309|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
163068489|NCT05073315|588957310|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
163068490|NCT05073315|588957308|FG000|Period 1 (Lead-in Period)|Death|1|||
163068491|NCT05073315|588957309|FG001|Period 1 (Lead-in Period)|Death|0|||
163068492|NCT05073315|588957310|FG002|Period 1 (Lead-in Period)|Death|0|||
163068493|NCT05073315|588957308|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
163068494|NCT05073315|588957309|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
163068495|NCT05073315|588957310|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
163068496|NCT05073315|588957308|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
163068497|NCT05073315|588957309|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
163068498|NCT05073315|588957310|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
163068499|NCT05073315|588957308|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
163068500|NCT05073315|588957309|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
163068501|NCT05073315|588957310|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
163068502|NCT05073315|588957308|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
163068503|NCT05073315|588957309|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
163068504|NCT05073315|588957310|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
163068505|NCT05073315|588957308|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
163068506|NCT05073315|588957309|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
163068507|NCT05073315|588957310|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
163068508|NCT05073315|588957308|FG000|Period 2|Adverse Event|0|||
163068509|NCT05073315|588957309|FG001|Period 2|Adverse Event|3|||
163068510|NCT05073315|588957310|FG002|Period 2|Adverse Event|6|||
163068511|NCT05073315|588957308|FG000|Period 2|Lost to Follow-up|0|||
163068512|NCT05073315|588957309|FG001|Period 2|Lost to Follow-up|5|||
163068513|NCT05073315|588957310|FG002|Period 2|Lost to Follow-up|5|||
163068514|NCT05073315|588957308|FG000|Period 2|Withdrawal by Subject|0|||
163068515|NCT05073315|588957309|FG001|Period 2|Withdrawal by Subject|4|||
163068516|NCT05073315|588957310|FG002|Period 2|Withdrawal by Subject|9|||
163068517|NCT05073315|588957308|FG000|Period 2|Protocol Violation|0|||
163068518|NCT05073315|588957309|FG001|Period 2|Protocol Violation|0|||
163068519|NCT05073315|588957310|FG002|Period 2|Protocol Violation|1|||
163068520|NCT01529268|588957311|FG000|Overall Study|Lost to Follow-up|9|||
163068521|NCT01529268|588957312|FG001|Overall Study|Lost to Follow-up|3|||
163068522|NCT01529268|588957311|FG000|Overall Study|Moved|3|||
163068523|NCT01529268|588957312|FG001|Overall Study|Moved|0|||
163068524|NCT00303953|588957313|FG000|Overall Study|Ineligible|1|||
163068525|NCT00303953|588957313|FG000|Overall Study|Death|1|||
163068526|NCT00303953|588957313|FG000|Overall Study|Adverse Event|4|||
163068527|NCT00303953|588957313|FG000|Overall Study|Lack of Efficacy|12|||
163068528|NCT00303953|588957313|FG000|Overall Study|Physician Decision|1|||
163068529|NCT00021255|588957314|FG000|Overall Study|Death|1|||
163068530|NCT00021255|588957315|FG001|Overall Study|Death|0|||
163068531|NCT00021255|588957316|FG002|Overall Study|Death|2|||
163068532|NCT00021255|588957314|FG000|Overall Study|Breast cancer relapse|5|||
163068533|NCT00021255|588957315|FG001|Overall Study|Breast cancer relapse|18|||
163068534|NCT00021255|588957316|FG002|Overall Study|Breast cancer relapse|11|||
163068535|NCT00021255|588957314|FG000|Overall Study|Second primary malignancy|0|||
163068536|NCT00021255|588957315|FG001|Overall Study|Second primary malignancy|4|||
163068537|NCT00021255|588957316|FG002|Overall Study|Second primary malignancy|1|||
163068538|NCT00021255|588957314|FG000|Overall Study|Withdrawal by Subject|41|||
163068539|NCT00021255|588957315|FG001|Overall Study|Withdrawal by Subject|64|||
163068540|NCT00021255|588957316|FG002|Overall Study|Withdrawal by Subject|26|||
163068541|NCT00021255|588957314|FG000|Overall Study|Lost to Follow-up|0|||
163217781|NCT01649375|589513791|FG002|Week 16 up to Week 260|Non-compliance|0|||
163217782|NCT01649375|589513792|FG003|Week 16 up to Week 260|Non-compliance|1|||
163217783|NCT01649375|589513793|FG004|Week 16 up to Week 260|Non-compliance|0|||
163217784|NCT01649375|589513789|FG000|Week 16 up to Week 260|Physician Decision|0|||
163217785|NCT01649375|589513790|FG001|Week 16 up to Week 260|Physician Decision|2|||
163217786|NCT01649375|589513791|FG002|Week 16 up to Week 260|Physician Decision|0|||
163068542|NCT00021255|588957315|FG001|Overall Study|Lost to Follow-up|2|||
163068543|NCT00021255|588957316|FG002|Overall Study|Lost to Follow-up|3|||
163068544|NCT00021255|588957314|FG000|Overall Study|Cardiac toxicity|0|||
163068545|NCT00021255|588957315|FG001|Overall Study|Cardiac toxicity|61|||
163068546|NCT00021255|588957316|FG002|Overall Study|Cardiac toxicity|32|||
163068547|NCT00021255|588957314|FG000|Overall Study|Herceptin toxicity|0|||
163068548|NCT00021255|588957315|FG001|Overall Study|Herceptin toxicity|22|||
163068549|NCT00021255|588957316|FG002|Overall Study|Herceptin toxicity|6|||
163068550|NCT00021255|588957314|FG000|Overall Study|Adverse Event|46|||
163068551|NCT00021255|588957315|FG001|Overall Study|Adverse Event|30|||
163068552|NCT00021255|588957316|FG002|Overall Study|Adverse Event|18|||
163068553|NCT00021255|588957314|FG000|Overall Study|Protocol Violation|0|||
163217787|NCT01649375|589513792|FG003|Week 16 up to Week 260|Physician Decision|0|||
163068554|NCT00021255|588957315|FG001|Overall Study|Protocol Violation|2|||
163068555|NCT00021255|588957316|FG002|Overall Study|Protocol Violation|0|||
163068556|NCT00021255|588957314|FG000|Overall Study|Other than specified above|0|||
163068557|NCT00021255|588957315|FG001|Overall Study|Other than specified above|38|||
163068558|NCT00021255|588957316|FG002|Overall Study|Other than specified above|19|||
163068559|NCT00021255|588957314|FG000|Overall Study|Missing|0|||
163068560|NCT00021255|588957315|FG001|Overall Study|Missing|27|||
163068561|NCT00021255|588957316|FG002|Overall Study|Missing|13|||
163068562|NCT00021255|588957314|FG000|Overall Study|Randomized but not treated|28|||
163068563|NCT00021255|588957315|FG001|Overall Study|Randomized but not treated|2|||
163068564|NCT00021255|588957316|FG002|Overall Study|Randomized but not treated|18|||
163068565|NCT02232698|588957317|FG000|Overall Study|Pregnancy|1|||
163068566|NCT02232698|588957318|FG001|Overall Study|Pregnancy|1|||
163068567|NCT02232698|588957317|FG000|Overall Study|Met exclusion criteria|1|||
163068568|NCT02232698|588957318|FG001|Overall Study|Met exclusion criteria|1|||
163068569|NCT02232698|588957317|FG000|Overall Study|Had device-associated symptoms|7|||
163068570|NCT02232698|588957318|FG001|Overall Study|Had device-associated symptoms|0|||
163068571|NCT02232698|588957317|FG000|Overall Study|Non-compliance with study device|1|||
163068572|NCT02232698|588957318|FG001|Overall Study|Non-compliance with study device|4|||
163068573|NCT02232698|588957317|FG000|Overall Study|Allocated to control group|0|||
163068574|NCT02232698|588957318|FG001|Overall Study|Allocated to control group|3|||
163068575|NCT02232698|588957317|FG000|Overall Study|Withdrawal by Subject|0|||
163068576|NCT02232698|588957318|FG001|Overall Study|Withdrawal by Subject|11|||
163068577|NCT02393755|588957319|FG000|Overall Study|Withdrawal by Subject|0|||
163068578|NCT02393755|588957320|FG001|Overall Study|Withdrawal by Subject|3|||
163068579|NCT02393755|588957319|FG000|Overall Study|Adverse Event|0|||
163068580|NCT02393755|588957320|FG001|Overall Study|Adverse Event|2|||
163068581|NCT02393755|588957319|FG000|Overall Study|Physician Decision|0|||
163068582|NCT02393755|588957320|FG001|Overall Study|Physician Decision|2|||
163068583|NCT05324371|588957321|FG000|Overall Study|Withdrawal by Subject|1|||
163068584|NCT05324371|588957321|FG000|Overall Study|Death|1|||
163068585|NCT04069520|588957324|FG000|Overall Study|Lost to Follow-up|0|||
163068586|NCT04069520|588957325|FG001|Overall Study|Lost to Follow-up|2|||
163068587|NCT04069520|588957324|FG000|Overall Study|Withdrawal by Subject|0|||
163068588|NCT04069520|588957325|FG001|Overall Study|Withdrawal by Subject|1|||
163068589|NCT04069520|588957324|FG000|Overall Study|Prior Injury|1|||
163068590|NCT04069520|588957325|FG001|Overall Study|Prior Injury|0|||
163068591|NCT04069520|588957324|FG000|Overall Study|Orthodontia|1|||
163068592|NCT04069520|588957325|FG001|Overall Study|Orthodontia|0|||
163068593|NCT04069520|588957324|FG000|Overall Study|Cut from team|0|||
163068594|NCT04069520|588957325|FG001|Overall Study|Cut from team|2|||
163068595|NCT01068912|588957326|FG000|Overall Study|Adverse Event|2|||
163068596|NCT01068912|588957327|FG001|Overall Study|Adverse Event|3|||
163068597|NCT01068912|588957328|FG002|Overall Study|Adverse Event|2|||
163068598|NCT01068912|588957326|FG000|Overall Study|Withdrawal by Subject|5|||
163068599|NCT01068912|588957327|FG001|Overall Study|Withdrawal by Subject|6|||
163068600|NCT01068912|588957328|FG002|Overall Study|Withdrawal by Subject|6|||
163068601|NCT01068912|588957326|FG000|Overall Study|Lost to Follow-up|3|||
163068602|NCT01068912|588957327|FG001|Overall Study|Lost to Follow-up|7|||
163068603|NCT01068912|588957328|FG002|Overall Study|Lost to Follow-up|3|||
163068604|NCT01068912|588957326|FG000|Overall Study|Protocol Violation|0|||
163068605|NCT01068912|588957327|FG001|Overall Study|Protocol Violation|2|||
163068606|NCT01068912|588957328|FG002|Overall Study|Protocol Violation|0|||
163068607|NCT01068912|588957326|FG000|Overall Study|aggravation influenza|1|||
163068608|NCT01068912|588957327|FG001|Overall Study|aggravation influenza|1|||
163068609|NCT01068912|588957328|FG002|Overall Study|aggravation influenza|1|||
163068610|NCT01068912|588957326|FG000|Overall Study|other underlying illness|0|||
163068611|NCT01068912|588957327|FG001|Overall Study|other underlying illness|3|||
163217788|NCT01649375|589513793|FG004|Week 16 up to Week 260|Physician Decision|0|||
163330983|NCT03678688|589922456|FG000|Overall Study|Physician Decision|0|||
163068612|NCT01068912|588957328|FG002|Overall Study|other underlying illness|3|||
163068613|NCT04822194|588957329|FG000|Overall Study|Withdrawal by Subject|5|||
163068614|NCT04822194|588957330|FG001|Overall Study|Withdrawal by Subject|4|||
163068615|NCT04822194|588957329|FG000|Overall Study|Technical issues with MR scanner|1|||
163068616|NCT04822194|588957330|FG001|Overall Study|Technical issues with MR scanner|0|||
163068617|NCT04822194|588957329|FG000|Overall Study|Lost to Follow-up|5|||
163068618|NCT04822194|588957330|FG001|Overall Study|Lost to Follow-up|7|||
163068619|NCT05182125|588957331|FG000|Overall Study|Withdrawal by Subject|0|||
163068620|NCT05182125|588957332|FG001|Overall Study|Withdrawal by Subject|0|||
163068621|NCT05182125|588957333|FG002|Overall Study|Withdrawal by Subject|0|||
163068622|NCT05182125|588957334|FG003|Overall Study|Withdrawal by Subject|0|||
163068623|NCT05182125|588957335|FG004|Overall Study|Withdrawal by Subject|2|||
163068624|NCT05182125|588957336|FG005|Overall Study|Withdrawal by Subject|0|||
163217789|NCT01649375|589513789|FG000|Week 16 up to Week 260|Technical issues|0|||
163217790|NCT01649375|589513790|FG001|Week 16 up to Week 260|Technical issues|1|||
163217791|NCT01649375|589513791|FG002|Week 16 up to Week 260|Technical issues|0|||
163217792|NCT01649375|589513792|FG003|Week 16 up to Week 260|Technical issues|1|||
163217793|NCT01649375|589513793|FG004|Week 16 up to Week 260|Technical issues|0|||
163068625|NCT05182125|588957331|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
163068626|NCT05182125|588957332|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
163068627|NCT05182125|588957333|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
163068628|NCT05182125|588957334|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
163068629|NCT05182125|588957335|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
163068630|NCT05182125|588957336|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
163068631|NCT05182125|588957331|FG000|Overall Study|Death|0|||
163068632|NCT05182125|588957332|FG001|Overall Study|Death|0|||
163068633|NCT05182125|588957333|FG002|Overall Study|Death|0|||
163068634|NCT05182125|588957334|FG003|Overall Study|Death|0|||
163068635|NCT05182125|588957335|FG004|Overall Study|Death|1|||
163068636|NCT05182125|588957336|FG005|Overall Study|Death|0|||
163068637|NCT02965833|588957341|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
163068638|NCT02965833|588957342|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
163068639|NCT02965833|588957341|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
163068640|NCT02965833|588957342|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
163068641|NCT02965833|588957341|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
163068642|NCT02965833|588957342|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
163068643|NCT02965833|588957341|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
163068644|NCT02965833|588957342|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
163068645|NCT02965833|588957341|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
163068646|NCT02965833|588957342|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
163068647|NCT03370302|588957343|FG000|Dose Escalation Phase|Other|0|||
163068648|NCT03370302|588957344|FG001|Dose Escalation Phase|Other|1|||
163068649|NCT03370302|588957345|FG002|Dose Escalation Phase|Other|1|||
163068650|NCT03370302|588957346|FG003|Dose Escalation Phase|Other|0|||
163068651|NCT03370302|588957347|FG004|Dose Escalation Phase|Other|0|||
163068652|NCT03370302|588957348|FG005|Dose Escalation Phase|Other|0|||
163068653|NCT03370302|588957343|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
163068654|NCT03370302|588957344|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
163068655|NCT03370302|588957345|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
163068656|NCT03370302|588957346|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
163068657|NCT03370302|588957347|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
163068658|NCT03370302|588957348|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
163068659|NCT03370302|588957343|FG000|Dose Escalation Phase|Adverse Event|1|||
163068660|NCT03370302|588957344|FG001|Dose Escalation Phase|Adverse Event|0|||
163068661|NCT03370302|588957345|FG002|Dose Escalation Phase|Adverse Event|2|||
163068662|NCT03370302|588957346|FG003|Dose Escalation Phase|Adverse Event|0|||
163068663|NCT03370302|588957347|FG004|Dose Escalation Phase|Adverse Event|0|||
163068664|NCT03370302|588957348|FG005|Dose Escalation Phase|Adverse Event|0|||
163068665|NCT03370302|588957343|FG000|Dose Escalation Phase|Progressive Disease|2|||
163068666|NCT03370302|588957344|FG001|Dose Escalation Phase|Progressive Disease|4|||
163068667|NCT03370302|588957345|FG002|Dose Escalation Phase|Progressive Disease|2|||
163068668|NCT03370302|588957346|FG003|Dose Escalation Phase|Progressive Disease|0|||
163068669|NCT03370302|588957347|FG004|Dose Escalation Phase|Progressive Disease|3|||
163068670|NCT03370302|588957348|FG005|Dose Escalation Phase|Progressive Disease|1|||
163068671|NCT03370302|588957343|FG000|Dose Expansion Phase|Progressive Disease|0|||
163068672|NCT03370302|588957344|FG001|Dose Expansion Phase|Progressive Disease|0|||
163068673|NCT03370302|588957345|FG002|Dose Expansion Phase|Progressive Disease|0|||
163068674|NCT03370302|588957346|FG003|Dose Expansion Phase|Progressive Disease|6|||
163068675|NCT03370302|588957347|FG004|Dose Expansion Phase|Progressive Disease|0|||
163068676|NCT03370302|588957348|FG005|Dose Expansion Phase|Progressive Disease|0|||
163068677|NCT00118287|588957349|FG000|Overall Study|Intracranial haemorrhage|1|||
163068678|NCT00118287|588957349|FG000|Overall Study|Muscle pain|1|||
163068679|NCT03976375|588957350|FG000|Overall Study|Death|158|||
163068680|NCT03976375|588957351|FG001|Overall Study|Death|160|||
163068681|NCT03976375|588957352|FG002|Overall Study|Death|42|||
163068682|NCT03976375|588957350|FG000|Overall Study|Lost to Follow-up|2|||
163068683|NCT03976375|588957351|FG001|Overall Study|Lost to Follow-up|1|||
163068684|NCT03976375|588957352|FG002|Overall Study|Lost to Follow-up|1|||
163068685|NCT03976375|588957350|FG000|Overall Study|Withdrawal by Subject|5|||
163068686|NCT03976375|588957351|FG001|Overall Study|Withdrawal by Subject|9|||
163068687|NCT03976375|588957352|FG002|Overall Study|Withdrawal by Subject|4|||
163068688|NCT03976375|588957350|FG000|Overall Study|Sponsor decision|20|||
163068689|NCT03976375|588957351|FG001|Overall Study|Sponsor decision|19|||
163068690|NCT03976375|588957352|FG002|Overall Study|Sponsor decision|1|||
163068691|NCT04818112|588957353|FG000|Overall Study|Withdrawal by Subject|54|||
163406366|NCT00401375|590196737|FG002|Overall Study|Randomized but not treated|3|||
163068692|NCT04818112|588957354|FG001|Overall Study|Withdrawal by Subject|12|||
163068693|NCT04818112|588957353|FG000|Overall Study|Lost to Follow-up|38|||
163068694|NCT04818112|588957354|FG001|Overall Study|Lost to Follow-up|10|||
163068695|NCT03091439|588957355|FG000|Overall Study|Study Terminated by the Sponsor|1|||
163068696|NCT03091439|588957356|FG001|Overall Study|Study Terminated by the Sponsor|0|||
163068697|NCT03122106|588957357|FG000|Overall Study|Not enough tissue|1|||
163068698|NCT03122106|588957357|FG000|Overall Study|Disease progression during screening|2|||
163068699|NCT03122106|588957357|FG000|Overall Study|Poor RNA quality for vaccine|1|||
163068700|NCT00640289|588957358|FG000|Overall Study|Death|3|||
163068701|NCT00640289|588957358|FG000|Overall Study|Withdrawal by Subject|1|||
163068702|NCT00640289|588957358|FG000|Overall Study|Lost to Follow-up|1|||
163068703|NCT00640289|588957358|FG000|Overall Study|Data collected under different amendment|2|||
163068704|NCT00640289|588957358|FG000|Overall Study|Transferred to another center|1|||
163068705|NCT00640289|588957358|FG000|Overall Study|Missing status|5|||
163068706|NCT03550209|588957360|FG000|Overall Study|Lost to Follow-up|1|||
163068707|NCT03550209|588957361|FG001|Overall Study|Lost to Follow-up|0|||
163068708|NCT03550209|588957362|FG002|Overall Study|Lost to Follow-up|1|||
163068709|NCT03550209|588957363|FG003|Overall Study|Lost to Follow-up|0|||
163068710|NCT03550209|588957360|FG000|Overall Study|Withdrawal by Subject|0|||
163068711|NCT03550209|588957361|FG001|Overall Study|Withdrawal by Subject|3|||
163068712|NCT03550209|588957362|FG002|Overall Study|Withdrawal by Subject|1|||
163068713|NCT03550209|588957363|FG003|Overall Study|Withdrawal by Subject|2|||
163068714|NCT03550209|588957360|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
163068715|NCT03550209|588957361|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
163068716|NCT03550209|588957362|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
163068717|NCT03550209|588957363|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
163068718|NCT06170827|588957366|FG000|Overall Study|Withdrawal by Subject|1|||
163068719|NCT06170827|588957367|FG001|Overall Study|Withdrawal by Subject|1|||
163068720|NCT05643794|588958923|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
163068721|NCT05643794|588958924|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
163068722|NCT05643794|588958925|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
163068723|NCT05643794|588958923|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
163068724|NCT05643794|588958924|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163068725|NCT05643794|588958925|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163068726|NCT05643794|588958923|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
163068727|NCT05643794|588958924|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
163068728|NCT05643794|588958925|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
163068729|NCT05643794|588958923|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
163068730|NCT05643794|588958924|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
163026733|NCT00471718|588799297|FG000|Overall Study|Withdrawal by Subject|1|||
163026734|NCT01446237|588799298|FG000|Overall Study|Adverse Event|1|||
163026735|NCT01446237|588799298|FG000|Overall Study|Lost to Follow-up|2|||
163026736|NCT01446237|588799298|FG000|Overall Study|Withdrawal by Subject|7|||
163026737|NCT02640677|588799310|FG000|Overall Study|Lost to Follow-up|1|||
163026738|NCT02640677|588799310|FG000|Overall Study|Withdrawal by Subject|1|||
163026739|NCT01817582|588799329|FG000|Overall Study|Withdrawal by Subject|0|||
163026740|NCT01817582|588799330|FG001|Overall Study|Withdrawal by Subject|1|||
163026741|NCT01817582|588799331|FG002|Overall Study|Withdrawal by Subject|0|||
163026742|NCT01817582|588799329|FG000|Overall Study|Participant revealed masked treatment|1|||
163026743|NCT01817582|588799330|FG001|Overall Study|Participant revealed masked treatment|0|||
163026744|NCT01817582|588799331|FG002|Overall Study|Participant revealed masked treatment|0|||
163026745|NCT01817582|588799329|FG000|Overall Study|Randomized but exclusion criteria met|1|||
163026746|NCT01817582|588799330|FG001|Overall Study|Randomized but exclusion criteria met|0|||
163026747|NCT01817582|588799331|FG002|Overall Study|Randomized but exclusion criteria met|0|||
163068731|NCT05643794|588958925|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
163068732|NCT05643794|588958923|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
163217794|NCT01649375|589513789|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
163217795|NCT01649375|589513790|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
163217796|NCT01649375|589513791|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
163217797|NCT01649375|589513792|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
163217798|NCT01649375|589513793|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
163217799|NCT01649375|589513789|FG000|Week 16 up to Week 260|Death|1|||
163217800|NCT01649375|589513790|FG001|Week 16 up to Week 260|Death|1|||
163217801|NCT01649375|589513791|FG002|Week 16 up to Week 260|Death|0|||
163217802|NCT01649375|589513792|FG003|Week 16 up to Week 260|Death|0|||
163217803|NCT01649375|589513793|FG004|Week 16 up to Week 260|Death|0|||
163217804|NCT01649375|589513789|FG000|Week 16 up to Week 260|Adverse Event|5|||
163217805|NCT01649375|589513790|FG001|Week 16 up to Week 260|Adverse Event|2|||
163217806|NCT01649375|589513791|FG002|Week 16 up to Week 260|Adverse Event|0|||
163217807|NCT01649375|589513792|FG003|Week 16 up to Week 260|Adverse Event|3|||
163217808|NCT01649375|589513793|FG004|Week 16 up to Week 260|Adverse Event|2|||
163217809|NCT01856790|589513794|FG000|Closed Loop Control|Withdrawal by Subject|2|||
163217810|NCT01856790|589513794|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
163217811|NCT04091646|589513797|FG000|Overall Study|Adverse Event|2|||
163217812|NCT04091646|589513798|FG001|Overall Study|Adverse Event|1|||
163217813|NCT04091646|589513797|FG000|Overall Study|Lost to Follow-up|6|||
163217814|NCT04091646|589513798|FG001|Overall Study|Lost to Follow-up|2|||
163217815|NCT04091646|589513797|FG000|Overall Study|Protocol Violation|0|||
163026748|NCT03053063|588799332|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
163026749|NCT03053063|588799333|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
163026750|NCT03053063|588799334|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
163026751|NCT03053063|588799335|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
163026752|NCT03053063|588799332|FG000|Randomized Phase|Withdrew consent|8|||
163026753|NCT03053063|588799333|FG001|Randomized Phase|Withdrew consent|11|||
163026754|NCT03053063|588799334|FG002|Randomized Phase|Withdrew consent|5|||
163026755|NCT03053063|588799335|FG003|Randomized Phase|Withdrew consent|0|||
163026756|NCT03053063|588799332|FG000|Randomized Phase|Investigator's Discretion|8|||
163026757|NCT03053063|588799333|FG001|Randomized Phase|Investigator's Discretion|6|||
163026758|NCT03053063|588799334|FG002|Randomized Phase|Investigator's Discretion|2|||
163026759|NCT03053063|588799335|FG003|Randomized Phase|Investigator's Discretion|0|||
163026760|NCT03053063|588799332|FG000|Randomized Phase|Lost to Follow-up|3|||
163026761|NCT03053063|588799333|FG001|Randomized Phase|Lost to Follow-up|5|||
163026762|NCT03053063|588799334|FG002|Randomized Phase|Lost to Follow-up|1|||
163026763|NCT03053063|588799335|FG003|Randomized Phase|Lost to Follow-up|0|||
163026764|NCT03053063|588799332|FG000|Randomized Phase|Adverse Event|0|||
163026765|NCT03053063|588799333|FG001|Randomized Phase|Adverse Event|1|||
163026766|NCT03053063|588799334|FG002|Randomized Phase|Adverse Event|0|||
163026767|NCT03053063|588799335|FG003|Randomized Phase|Adverse Event|0|||
163026768|NCT03053063|588799332|FG000|Randomized Phase|Randomized but Never Treated|1|||
163026769|NCT03053063|588799333|FG001|Randomized Phase|Randomized but Never Treated|3|||
163026770|NCT03053063|588799334|FG002|Randomized Phase|Randomized but Never Treated|2|||
163026771|NCT03053063|588799335|FG003|Randomized Phase|Randomized but Never Treated|0|||
163026772|NCT03053063|588799332|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
163026773|NCT03053063|588799333|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
163026774|NCT03053063|588799334|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
163026775|NCT03053063|588799335|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
163026776|NCT03053063|588799332|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
163026777|NCT03053063|588799333|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
163026778|NCT03053063|588799334|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
163026779|NCT03053063|588799335|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
163026780|NCT03053063|588799332|FG000|Open-Label Phase|Death|0|||
163026781|NCT03053063|588799333|FG001|Open-Label Phase|Death|0|||
163026782|NCT03053063|588799334|FG002|Open-Label Phase|Death|0|||
163026783|NCT03053063|588799335|FG003|Open-Label Phase|Death|2|||
163026784|NCT03053063|588799332|FG000|Open-Label Phase|Investigator's discretion|0|||
163026785|NCT03053063|588799333|FG001|Open-Label Phase|Investigator's discretion|0|||
163026786|NCT03053063|588799334|FG002|Open-Label Phase|Investigator's discretion|0|||
163026787|NCT03053063|588799335|FG003|Open-Label Phase|Investigator's discretion|2|||
163026788|NCT02600845|588799336|FG000|Overall Study|Reason Not Specified|3|||
163026789|NCT02600845|588799336|FG000|Overall Study|Non-compliance with Study Procedures|10|||
163026790|NCT02600845|588799336|FG000|Overall Study|Consent Withdrawal|5|||
163026791|NCT00197002|588801288|FG000|Overall Study|Adverse Event|0|||
163026792|NCT00197002|588801289|FG001|Overall Study|Adverse Event|1|||
163026793|NCT00197002|588801290|FG002|Overall Study|Adverse Event|0|||
163026794|NCT00197002|588801288|FG000|Overall Study|Protocol Violation|1|||
163026795|NCT00197002|588801289|FG001|Overall Study|Protocol Violation|0|||
163026796|NCT00197002|588801290|FG002|Overall Study|Protocol Violation|2|||
163026797|NCT00197002|588801288|FG000|Overall Study|Withdrawal by Subject|9|||
163026798|NCT00197002|588801289|FG001|Overall Study|Withdrawal by Subject|5|||
163026799|NCT00197002|588801290|FG002|Overall Study|Withdrawal by Subject|7|||
163026800|NCT00197002|588801288|FG000|Overall Study|Migrated/moved from study area|3|||
163026801|NCT00197002|588801289|FG001|Overall Study|Migrated/moved from study area|5|||
163026802|NCT00197002|588801290|FG002|Overall Study|Migrated/moved from study area|1|||
163026803|NCT00197002|588801288|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
163026804|NCT00197002|588801289|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
163026805|NCT00197002|588801290|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
163026806|NCT00197002|588801288|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
163026807|NCT00197002|588801289|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
163026808|NCT00197002|588801290|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
163026809|NCT00197002|588801288|FG000|Overall Study|Others|3|||
163026810|NCT00197002|588801289|FG001|Overall Study|Others|1|||
163026811|NCT00197002|588801290|FG002|Overall Study|Others|1|||
163026812|NCT03569293|588801293|FG000|Overall Study|Adverse Event|4|||
163026813|NCT03569293|588801294|FG001|Overall Study|Adverse Event|1|||
163026814|NCT03569293|588801295|FG002|Overall Study|Adverse Event|5|||
163026815|NCT03569293|588801296|FG003|Overall Study|Adverse Event|1|||
163026816|NCT03569293|588801297|FG004|Overall Study|Adverse Event|0|||
163026817|NCT03569293|588801298|FG005|Overall Study|Adverse Event|0|||
163026818|NCT03569293|588801293|FG000|Overall Study|Withdrawal by Subject|16|||
163026819|NCT03569293|588801294|FG001|Overall Study|Withdrawal by Subject|2|||
163026820|NCT03569293|588801295|FG002|Overall Study|Withdrawal by Subject|4|||
163026821|NCT03569293|588801296|FG003|Overall Study|Withdrawal by Subject|1|||
163026822|NCT03569293|588801297|FG004|Overall Study|Withdrawal by Subject|0|||
163068733|NCT05643794|588958924|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
163068734|NCT05643794|588958925|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
163068735|NCT05643794|588958923|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
163068736|NCT05643794|588958924|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
163068737|NCT05643794|588958925|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
163068738|NCT00587457|588958926|FG000|Overall Study|Adverse Event|1|||
163068739|NCT00587457|588958927|FG001|Overall Study|Adverse Event|2|||
163068740|NCT00587457|588958928|FG002|Overall Study|Adverse Event|1|||
163068741|NCT00587457|588958926|FG000|Overall Study|Disease progression|2|||
163068742|NCT00587457|588958927|FG001|Overall Study|Disease progression|0|||
163068743|NCT00587457|588958928|FG002|Overall Study|Disease progression|2|||
163068744|NCT00587457|588958926|FG000|Overall Study|Initiation of alternative therapy|0|||
163068745|NCT00587457|588958927|FG001|Overall Study|Initiation of alternative therapy|1|||
163068746|NCT00587457|588958928|FG002|Overall Study|Initiation of alternative therapy|0|||
163068747|NCT00587457|588958926|FG000|Overall Study|Undefined|0|||
163068748|NCT00587457|588958927|FG001|Overall Study|Undefined|0|||
163068749|NCT00587457|588958928|FG002|Overall Study|Undefined|1|||
163068750|NCT00587457|588958926|FG000|Overall Study|Development of neutralizing Abs|0|||
163068751|NCT00587457|588958927|FG001|Overall Study|Development of neutralizing Abs|0|||
163068752|NCT00587457|588958928|FG002|Overall Study|Development of neutralizing Abs|1|||
163068753|NCT02927145|588958929|FG000|Initial Recruitment|Withdrawal by Subject|0|||
163068754|NCT02927145|588958930|FG001|Initial Recruitment|Withdrawal by Subject|1|||
163068755|NCT02927145|588958931|FG002|Initial Recruitment|Withdrawal by Subject|1|||
163068756|NCT02927145|588958932|FG003|Initial Recruitment|Withdrawal by Subject|4|||
163068757|NCT02927145|588958933|FG004|Initial Recruitment|Withdrawal by Subject|1|||
163068758|NCT02927145|588958934|FG005|Initial Recruitment|Withdrawal by Subject|1|||
163068759|NCT02927145|588958935|FG006|Initial Recruitment|Withdrawal by Subject|0|||
163068760|NCT02927145|588958936|FG007|Initial Recruitment|Withdrawal by Subject|0|||
163068761|NCT02927145|588958937|FG008|Initial Recruitment|Withdrawal by Subject|2|||
163068762|NCT02927145|588958929|FG000|Initial Recruitment|Adverse Event|0|||
163068763|NCT02927145|588958930|FG001|Initial Recruitment|Adverse Event|0|||
163068764|NCT02927145|588958931|FG002|Initial Recruitment|Adverse Event|0|||
163068765|NCT02927145|588958932|FG003|Initial Recruitment|Adverse Event|0|||
163068766|NCT02927145|588958933|FG004|Initial Recruitment|Adverse Event|2|||
163068767|NCT02927145|588958934|FG005|Initial Recruitment|Adverse Event|0|||
163068768|NCT02927145|588958935|FG006|Initial Recruitment|Adverse Event|0|||
163068769|NCT02927145|588958936|FG007|Initial Recruitment|Adverse Event|0|||
163068770|NCT02927145|588958937|FG008|Initial Recruitment|Adverse Event|0|||
163068771|NCT02927145|588958929|FG000|Invitation for Additional Challenge|Pregnancy|0|||
163068772|NCT02927145|588958930|FG001|Invitation for Additional Challenge|Pregnancy|0|||
163068773|NCT02927145|588958931|FG002|Invitation for Additional Challenge|Pregnancy|0|||
163068774|NCT02927145|588958932|FG003|Invitation for Additional Challenge|Pregnancy|0|||
163068775|NCT02927145|588958933|FG004|Invitation for Additional Challenge|Pregnancy|0|||
163068776|NCT02927145|588958934|FG005|Invitation for Additional Challenge|Pregnancy|0|||
163068777|NCT02927145|588958935|FG006|Invitation for Additional Challenge|Pregnancy|1|||
163068778|NCT02927145|588958936|FG007|Invitation for Additional Challenge|Pregnancy|0|||
163068779|NCT02927145|588958937|FG008|Invitation for Additional Challenge|Pregnancy|0|||
163068780|NCT03298061|588958938|FG000|Overall Study|Adverse Event|3|||
163068781|NCT03298061|588958938|FG000|Overall Study|Lack of Efficacy|6|||
163068782|NCT03298061|588958938|FG000|Overall Study|Protocol Violation|1|||
163068783|NCT03298061|588958938|FG000|Overall Study|Physician Decision|7|||
163068784|NCT03298061|588958938|FG000|Overall Study|Withdrawal by Subject|10|||
163068785|NCT01239745|588958945|FG000|Overall Study|Study terminated by sponsor|45|||
163068786|NCT01239745|588958945|FG000|Overall Study|Adverse Event|1|||
163068787|NCT01946802|588958950|FG000|Overall Study|Death|1|||
163068788|NCT01946802|588958950|FG000|Overall Study|Withdrawal by Subject|2|||
163068789|NCT01946802|588958950|FG000|Overall Study|Combined septic shock|1|||
163068790|NCT01946802|588958950|FG000|Overall Study|Protocol Violation|1|||
163068791|NCT00153920|588958951|FG000|Overall Study|Adverse Event|9|||
163330984|NCT03678688|589922457|FG001|Overall Study|Physician Decision|0|||
163330985|NCT03678688|589922458|FG002|Overall Study|Physician Decision|0|||
163330986|NCT03678688|589922459|FG003|Overall Study|Physician Decision|0|||
163330987|NCT03678688|589922460|FG004|Overall Study|Physician Decision|0|||
163330988|NCT03678688|589922461|FG005|Overall Study|Physician Decision|1|||
163330989|NCT03678688|589922462|FG006|Overall Study|Physician Decision|0|||
163330990|NCT03678688|589922463|FG007|Overall Study|Physician Decision|0|||
163068792|NCT00153920|588958951|FG000|Overall Study|Progressive Disease|9|||
163068793|NCT00153920|588958951|FG000|Overall Study|Physician Decision|3|||
163068794|NCT00153920|588958951|FG000|Overall Study|Lack of Response|3|||
163330991|NCT03678688|589922464|FG008|Overall Study|Physician Decision|0|||
163068795|NCT00153920|588958951|FG000|Overall Study|Death|2|||
163330992|NCT03678688|589922456|FG000|Overall Study|Withdrawal by Subject|0|||
163330993|NCT03678688|589922457|FG001|Overall Study|Withdrawal by Subject|0|||
163068796|NCT00153920|588958951|FG000|Overall Study|Withdrawal by Subject|1|||
163068797|NCT00153920|588958951|FG000|Overall Study|Non-Protocol Therapy|1|||
163068798|NCT00153920|588958951|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
163068799|NCT00153920|588958951|FG000|Overall Study|Progressive Disease before Trt|1|||
163068800|NCT02541903|588958952|FG000|Overall Study|Death|1|||
163068801|NCT02969018|588958953|FG000|Overall Study|Adverse Event|2|||
163068802|NCT02969018|588958954|FG001|Overall Study|Adverse Event|4|||
163068803|NCT02969018|588958955|FG002|Overall Study|Adverse Event|1|||
163068804|NCT02969018|588958956|FG003|Overall Study|Adverse Event|2|||
163068805|NCT02969018|588958957|FG004|Overall Study|Adverse Event|0|||
163068806|NCT02969018|588958958|FG005|Overall Study|Adverse Event|1|||
163068807|NCT02969018|588958959|FG006|Overall Study|Adverse Event|2|||
163068808|NCT02969018|588958960|FG007|Overall Study|Adverse Event|0|||
163068809|NCT02969018|588958953|FG000|Overall Study|Lack of Efficacy|0|||
163068810|NCT02969018|588958954|FG001|Overall Study|Lack of Efficacy|1|||
163068811|NCT02969018|588958955|FG002|Overall Study|Lack of Efficacy|0|||
163068812|NCT02969018|588958956|FG003|Overall Study|Lack of Efficacy|0|||
163068813|NCT02969018|588958957|FG004|Overall Study|Lack of Efficacy|1|||
163068814|NCT02969018|588958958|FG005|Overall Study|Lack of Efficacy|1|||
163068815|NCT02969018|588958959|FG006|Overall Study|Lack of Efficacy|1|||
163068816|NCT02969018|588958960|FG007|Overall Study|Lack of Efficacy|1|||
163068817|NCT02969018|588958953|FG000|Overall Study|Lost to Follow-up|1|||
163217816|NCT04091646|589513798|FG001|Overall Study|Protocol Violation|1|||
163217817|NCT04091646|589513797|FG000|Overall Study|Withdrawal by Subject|4|||
163217818|NCT04091646|589513798|FG001|Overall Study|Withdrawal by Subject|1|||
163217819|NCT04091646|589513797|FG000|Overall Study|Participant Incarcerated|1|||
163068818|NCT02969018|588958954|FG001|Overall Study|Lost to Follow-up|2|||
163068819|NCT02969018|588958955|FG002|Overall Study|Lost to Follow-up|2|||
163068820|NCT02969018|588958956|FG003|Overall Study|Lost to Follow-up|0|||
163068821|NCT02969018|588958957|FG004|Overall Study|Lost to Follow-up|1|||
163068822|NCT02969018|588958958|FG005|Overall Study|Lost to Follow-up|1|||
163217820|NCT04091646|589513798|FG001|Overall Study|Participant Incarcerated|0|||
163217821|NCT01921829|589513799|FG000|Overall Study|Withdrawal by Subject|0|||
163217822|NCT01921829|589513800|FG001|Overall Study|Withdrawal by Subject|1|||
163217823|NCT01316276|589513805|FG000|Overall Study|Death|1|||
163217824|NCT01316276|589513805|FG000|Overall Study|Adverse Event|19|||
163217825|NCT01316276|589513805|FG000|Overall Study|Withdrawal of consent|24|||
163217826|NCT01316276|589513805|FG000|Overall Study|Lost to Follow-up|1|||
163217827|NCT01316276|589513805|FG000|Overall Study|Other|22|||
163217828|NCT00605475|589513806|FG000|Overall Study|Abnormal Laboratory Values|0|||
163217829|NCT00605475|589513807|FG001|Overall Study|Abnormal Laboratory Values|0|||
163217830|NCT00605475|589513808|FG002|Overall Study|Abnormal Laboratory Values|0|||
163217831|NCT00605475|589513809|FG003|Overall Study|Abnormal Laboratory Values|0|||
163217832|NCT00605475|589513810|FG004|Overall Study|Abnormal Laboratory Values|0|||
163217833|NCT00605475|589513811|FG005|Overall Study|Abnormal Laboratory Values|0|||
163217834|NCT00605475|589513812|FG006|Overall Study|Abnormal Laboratory Values|0|||
163217835|NCT00605475|589513813|FG007|Overall Study|Abnormal Laboratory Values|0|||
163217836|NCT00605475|589513814|FG008|Overall Study|Abnormal Laboratory Values|1|||
163217837|NCT00605475|589513815|FG009|Overall Study|Abnormal Laboratory Values|0|||
163217838|NCT00605475|589513806|FG000|Overall Study|Administrative problems|0|||
163217839|NCT00605475|589513807|FG001|Overall Study|Administrative problems|0|||
163217840|NCT00605475|589513808|FG002|Overall Study|Administrative problems|0|||
163217841|NCT00605475|589513809|FG003|Overall Study|Administrative problems|0|||
163217842|NCT00605475|589513810|FG004|Overall Study|Administrative problems|0|||
163217843|NCT00605475|589513811|FG005|Overall Study|Administrative problems|0|||
163217844|NCT00605475|589513812|FG006|Overall Study|Administrative problems|1|||
163217845|NCT00605475|589513813|FG007|Overall Study|Administrative problems|0|||
163217846|NCT00605475|589513814|FG008|Overall Study|Administrative problems|0|||
163217847|NCT00605475|589513815|FG009|Overall Study|Administrative problems|0|||
163217848|NCT00605475|589513806|FG000|Overall Study|Lost to Follow-up|0|||
163217849|NCT00605475|589513807|FG001|Overall Study|Lost to Follow-up|0|||
163217850|NCT00605475|589513808|FG002|Overall Study|Lost to Follow-up|0|||
163217851|NCT00605475|589513809|FG003|Overall Study|Lost to Follow-up|0|||
163217852|NCT00605475|589513810|FG004|Overall Study|Lost to Follow-up|0|||
163217853|NCT00605475|589513811|FG005|Overall Study|Lost to Follow-up|0|||
163217854|NCT00605475|589513812|FG006|Overall Study|Lost to Follow-up|0|||
163217855|NCT00605475|589513813|FG007|Overall Study|Lost to Follow-up|0|||
163217856|NCT00605475|589513814|FG008|Overall Study|Lost to Follow-up|1|||
163068823|NCT02969018|588958959|FG006|Overall Study|Lost to Follow-up|0|||
163068824|NCT02969018|588958960|FG007|Overall Study|Lost to Follow-up|1|||
163068825|NCT02969018|588958953|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
163068826|NCT02969018|588958954|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
163068827|NCT02969018|588958955|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
163068828|NCT02969018|588958956|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
163217857|NCT00605475|589513815|FG009|Overall Study|Lost to Follow-up|1|||
163217858|NCT00605475|589513806|FG000|Overall Study|Protocol Violation|0|||
163217859|NCT00605475|589513807|FG001|Overall Study|Protocol Violation|0|||
163217860|NCT00605475|589513808|FG002|Overall Study|Protocol Violation|0|||
163217861|NCT00605475|589513809|FG003|Overall Study|Protocol Violation|0|||
163217862|NCT00605475|589513810|FG004|Overall Study|Protocol Violation|1|||
163217863|NCT00605475|589513811|FG005|Overall Study|Protocol Violation|0|||
163068829|NCT02969018|588958957|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
163068830|NCT02969018|588958958|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
163068831|NCT02969018|588958959|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
163068832|NCT02969018|588958960|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
163068833|NCT02969018|588958953|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163068834|NCT02969018|588958954|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163068835|NCT02969018|588958955|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163068836|NCT02969018|588958956|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163068837|NCT02969018|588958957|FG004|Overall Study|Non-Compliance With Study Drug|0|||
163068838|NCT02969018|588958958|FG005|Overall Study|Non-Compliance With Study Drug|0|||
163068839|NCT02969018|588958959|FG006|Overall Study|Non-Compliance With Study Drug|0|||
163068840|NCT02969018|588958960|FG007|Overall Study|Non-Compliance With Study Drug|0|||
163068841|NCT02969018|588958953|FG000|Overall Study|Other|0|||
163068842|NCT02969018|588958954|FG001|Overall Study|Other|0|||
163068843|NCT02969018|588958955|FG002|Overall Study|Other|0|||
163068844|NCT02969018|588958956|FG003|Overall Study|Other|1|||
163068845|NCT02969018|588958957|FG004|Overall Study|Other|0|||
163068846|NCT02969018|588958958|FG005|Overall Study|Other|0|||
163068847|NCT02969018|588958959|FG006|Overall Study|Other|0|||
163068848|NCT02969018|588958960|FG007|Overall Study|Other|2|||
163068849|NCT02969018|588958953|FG000|Overall Study|Pregnancy|0|||
163068850|NCT02969018|588958954|FG001|Overall Study|Pregnancy|0|||
163068851|NCT02969018|588958955|FG002|Overall Study|Pregnancy|0|||
163068852|NCT02969018|588958956|FG003|Overall Study|Pregnancy|0|||
163068853|NCT02969018|588958957|FG004|Overall Study|Pregnancy|0|||
163068854|NCT02969018|588958958|FG005|Overall Study|Pregnancy|1|||
163068855|NCT02969018|588958959|FG006|Overall Study|Pregnancy|0|||
163068856|NCT02969018|588958960|FG007|Overall Study|Pregnancy|0|||
163068857|NCT02969018|588958953|FG000|Overall Study|Protocol Violation|0|||
163068858|NCT02969018|588958954|FG001|Overall Study|Protocol Violation|0|||
163068859|NCT02969018|588958955|FG002|Overall Study|Protocol Violation|1|||
163068860|NCT02969018|588958956|FG003|Overall Study|Protocol Violation|1|||
163068861|NCT02969018|588958957|FG004|Overall Study|Protocol Violation|0|||
163068862|NCT02969018|588958958|FG005|Overall Study|Protocol Violation|0|||
163068863|NCT02969018|588958959|FG006|Overall Study|Protocol Violation|0|||
163068864|NCT02969018|588958960|FG007|Overall Study|Protocol Violation|0|||
163068865|NCT02969018|588958953|FG000|Overall Study|Withdrawal by Subject|0|||
163068866|NCT02969018|588958954|FG001|Overall Study|Withdrawal by Subject|1|||
163068867|NCT02969018|588958955|FG002|Overall Study|Withdrawal by Subject|2|||
163068868|NCT02969018|588958956|FG003|Overall Study|Withdrawal by Subject|1|||
163068869|NCT02969018|588958957|FG004|Overall Study|Withdrawal by Subject|0|||
163068870|NCT02969018|588958958|FG005|Overall Study|Withdrawal by Subject|4|||
163068871|NCT02969018|588958959|FG006|Overall Study|Withdrawal by Subject|4|||
163068872|NCT02969018|588958960|FG007|Overall Study|Withdrawal by Subject|3|||
163068873|NCT00827242|588958961|FG000|Overall Study|Withdrawal by Subject|2|||
163068874|NCT00827242|588958962|FG001|Overall Study|Withdrawal by Subject|4|||
163068875|NCT00827242|588958961|FG000|Overall Study|Protocol Violation|1|||
163068876|NCT00827242|588958962|FG001|Overall Study|Protocol Violation|3|||
163068877|NCT00827242|588958961|FG000|Overall Study|Lost to Follow-up|0|||
163068878|NCT00827242|588958962|FG001|Overall Study|Lost to Follow-up|3|||
163068879|NCT00827242|588958961|FG000|Overall Study|Adverse Event Excluding Death|2|||
163068880|NCT00827242|588958962|FG001|Overall Study|Adverse Event Excluding Death|1|||
163068881|NCT00827242|588958961|FG000|Overall Study|Entry Criteria Not Met|4|||
163068882|NCT00827242|588958962|FG001|Overall Study|Entry Criteria Not Met|1|||
163068883|NCT00827242|588958961|FG000|Overall Study|Physician Decision|2|||
163068884|NCT00827242|588958962|FG001|Overall Study|Physician Decision|0|||
163068885|NCT00827242|588958961|FG000|Overall Study|Death|1|||
163068886|NCT00827242|588958962|FG001|Overall Study|Death|0|||
163068887|NCT00827242|588958961|FG000|Overall Study|Lack of Efficacy|1|||
163068888|NCT00827242|588958962|FG001|Overall Study|Lack of Efficacy|0|||
163068889|NCT05762679|588958963|FG000|Overall Study|Withdrawal by Subject|1|||
163068890|NCT05762679|588958963|FG000|Overall Study|No analyzable imaging data|1|||
163068891|NCT04795323|588958968|FG000|Overall Study|Did not interact with TARA|1|||
163068892|NCT04795323|588958969|FG001|Overall Study|Did not interact with TARA|0|||
163068893|NCT01479530|588958970|FG000|Overall Study|Adverse Event|5|||
163068894|NCT01479530|588958971|FG001|Overall Study|Adverse Event|6|||
163068895|NCT01479530|588958970|FG000|Overall Study|Lack of Efficacy|0|||
163068896|NCT01479530|588958971|FG001|Overall Study|Lack of Efficacy|1|||
163068897|NCT01479530|588958970|FG000|Overall Study|Protocol Violation|2|||
163068898|NCT01479530|588958971|FG001|Overall Study|Protocol Violation|3|||
163068899|NCT01479530|588958970|FG000|Overall Study|Withdrawal of Consent|3|||
163068900|NCT01479530|588958971|FG001|Overall Study|Withdrawal of Consent|2|||
163068901|NCT00376506|588958979|FG000|Overall Study|Death|0|||
163068902|NCT00376506|588958980|FG001|Overall Study|Death|2|||
163068903|NCT01944774|588958981|FG000|Overall Study|Withdrawal by Subject|2|||
163068904|NCT01944774|588958982|FG001|Overall Study|Withdrawal by Subject|3|||
163068905|NCT01944774|588958983|FG002|Overall Study|Withdrawal by Subject|3|||
163068906|NCT01944774|588958981|FG000|Overall Study|Adverse Event|3|||
163068907|NCT01944774|588958982|FG001|Overall Study|Adverse Event|2|||
163068908|NCT01944774|588958983|FG002|Overall Study|Adverse Event|3|||
163068909|NCT01944774|588958981|FG000|Overall Study|Lack of Efficacy|1|||
163068910|NCT01944774|588958982|FG001|Overall Study|Lack of Efficacy|2|||
163068911|NCT01944774|588958983|FG002|Overall Study|Lack of Efficacy|2|||
163068912|NCT01944774|588958981|FG000|Overall Study|Lost to Follow-up|0|||
163068913|NCT01944774|588958982|FG001|Overall Study|Lost to Follow-up|1|||
163068914|NCT01944774|588958983|FG002|Overall Study|Lost to Follow-up|0|||
163068915|NCT00812097|588958984|FG000|Overall Study|Death|3|||
163068916|NCT00812097|588958985|FG001|Overall Study|Death|10|||
163068917|NCT00812097|588958986|FG002|Overall Study|Death|3|||
163068918|NCT00812097|588958987|FG003|Overall Study|Death|3|||
163068919|NCT00812097|588958984|FG000|Overall Study|Withdrawal by Subject|14|||
163068920|NCT00812097|588958985|FG001|Overall Study|Withdrawal by Subject|12|||
163068921|NCT00812097|588958986|FG002|Overall Study|Withdrawal by Subject|8|||
163068922|NCT00812097|588958987|FG003|Overall Study|Withdrawal by Subject|2|||
163068923|NCT00812097|588958984|FG000|Overall Study|Lost to Follow-up|90|||
163068924|NCT00812097|588958985|FG001|Overall Study|Lost to Follow-up|14|||
163068925|NCT00812097|588958986|FG002|Overall Study|Lost to Follow-up|17|||
163068926|NCT00812097|588958987|FG003|Overall Study|Lost to Follow-up|5|||
163068927|NCT00812097|588958984|FG000|Overall Study|Explantation of study device(s)|27|||
163068928|NCT00812097|588958985|FG001|Overall Study|Explantation of study device(s)|29|||
163068929|NCT00812097|588958986|FG002|Overall Study|Explantation of study device(s)|14|||
163068930|NCT00812097|588958987|FG003|Overall Study|Explantation of study device(s)|20|||
163068931|NCT00812097|588958984|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
163068932|NCT00812097|588958985|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
163068933|NCT00812097|588958986|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
163068934|NCT00812097|588958987|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
163068935|NCT00927082|588958988|FG000|Overall Study|Lost to Follow-up|9|||
163068936|NCT00927082|588958989|FG001|Overall Study|Lost to Follow-up|8|||
163068937|NCT00927082|588958990|FG002|Overall Study|Lost to Follow-up|12|||
163068938|NCT00927082|588958991|FG003|Overall Study|Lost to Follow-up|16|||
163068939|NCT00927082|588958988|FG000|Overall Study|Withdrawal by Subject|3|||
163068940|NCT00927082|588958989|FG001|Overall Study|Withdrawal by Subject|2|||
163068941|NCT00927082|588958990|FG002|Overall Study|Withdrawal by Subject|7|||
163068942|NCT00927082|588958991|FG003|Overall Study|Withdrawal by Subject|2|||
163068943|NCT00927082|588958988|FG000|Overall Study|Death|0|||
163068944|NCT00927082|588958989|FG001|Overall Study|Death|0|||
163068945|NCT00927082|588958990|FG002|Overall Study|Death|1|||
163068946|NCT00927082|588958991|FG003|Overall Study|Death|0|||
163068947|NCT00927082|588958988|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
163068948|NCT00927082|588958989|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
163068949|NCT00927082|588958990|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
163068950|NCT00927082|588958991|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
163068951|NCT01786109|588958993|FG000|Overall Study|fail manometry barostat tube placement|1|||
163068952|NCT01786109|588958994|FG001|Overall Study|fail manometry barostat tube placement|0|||
163068953|NCT01786109|588958995|FG002|Overall Study|fail manometry barostat tube placement|0|||
163068954|NCT01786109|588958993|FG000|Overall Study|unrelated illness|0|||
163068955|NCT01786109|588958994|FG001|Overall Study|unrelated illness|0|||
163068956|NCT01786109|588958995|FG002|Overall Study|unrelated illness|1|||
163068957|NCT01786109|588958993|FG000|Overall Study|adverse effects colon preparation|0|||
163068958|NCT01786109|588958994|FG001|Overall Study|adverse effects colon preparation|0|||
163068959|NCT01786109|588958995|FG002|Overall Study|adverse effects colon preparation|1|||
163068960|NCT02513563|588958996|FG000|Overall Study|Death|4|||
163068961|NCT02513563|588958996|FG000|Overall Study|Withdrawal by Subject|4|||
163068962|NCT02513563|588958996|FG000|Overall Study|Physician Decision|1|||
163068963|NCT00317369|588958997|FG000|Overall Study|Adverse Event|2|||
163068964|NCT00317369|588958998|FG001|Overall Study|Adverse Event|1|||
163068965|NCT00317369|588958999|FG002|Overall Study|Adverse Event|0|||
163068966|NCT00317369|588958997|FG000|Overall Study|Lack of Efficacy|0|||
163068967|NCT00317369|588958998|FG001|Overall Study|Lack of Efficacy|1|||
163068968|NCT00317369|588958999|FG002|Overall Study|Lack of Efficacy|1|||
163068969|NCT00317369|588958997|FG000|Overall Study|Withdrawal by Subject|0|||
163068970|NCT00317369|588958998|FG001|Overall Study|Withdrawal by Subject|0|||
163068971|NCT00317369|588958999|FG002|Overall Study|Withdrawal by Subject|1|||
163068972|NCT00825175|588959004|FG000|Overall Study|Withdrawal by Subject|0|||
163068973|NCT00825175|588959005|FG001|Overall Study|Withdrawal by Subject|5|||
163068974|NCT03998462|588959009|FG000|Overall Study|Withdrawal by Subject|10|||
163068975|NCT03998462|588959010|FG001|Overall Study|Withdrawal by Subject|4|||
163068976|NCT03998462|588959009|FG000|Overall Study|Lost to Follow-up|1|||
163068977|NCT03998462|588959010|FG001|Overall Study|Lost to Follow-up|0|||
163068978|NCT03998462|588959009|FG000|Overall Study|Technical Difficulties|1|||
163068979|NCT03998462|588959010|FG001|Overall Study|Technical Difficulties|2|||
163068980|NCT05710224|588959011|FG000|Overall Study|Death|1|||
163068981|NCT05710224|588959012|FG001|Overall Study|Death|0|||
163068982|NCT05710224|588959011|FG000|Overall Study|Lost to Follow-up|16|||
163068983|NCT05710224|588959012|FG001|Overall Study|Lost to Follow-up|7|||
163026823|NCT03569293|588801298|FG005|Overall Study|Withdrawal by Subject|0|||
163026824|NCT03569293|588801293|FG000|Overall Study|Lost to Follow-up|1|||
163026825|NCT03569293|588801294|FG001|Overall Study|Lost to Follow-up|3|||
163026826|NCT03569293|588801295|FG002|Overall Study|Lost to Follow-up|1|||
163026827|NCT03569293|588801296|FG003|Overall Study|Lost to Follow-up|1|||
163026828|NCT03569293|588801297|FG004|Overall Study|Lost to Follow-up|0|||
163026829|NCT03569293|588801298|FG005|Overall Study|Lost to Follow-up|0|||
163026830|NCT03569293|588801293|FG000|Overall Study|Other|8|||
163026831|NCT03569293|588801294|FG001|Overall Study|Other|2|||
163026832|NCT03569293|588801295|FG002|Overall Study|Other|1|||
163026833|NCT03569293|588801296|FG003|Overall Study|Other|1|||
163026834|NCT03569293|588801297|FG004|Overall Study|Other|0|||
163026835|NCT03569293|588801298|FG005|Overall Study|Other|0|||
163026836|NCT03569293|588801293|FG000|Overall Study|Ongoing at Time of Analysis|8|||
163026837|NCT03569293|588801294|FG001|Overall Study|Ongoing at Time of Analysis|1|||
163026838|NCT03569293|588801295|FG002|Overall Study|Ongoing at Time of Analysis|3|||
163026839|NCT03569293|588801296|FG003|Overall Study|Ongoing at Time of Analysis|0|||
163026840|NCT03569293|588801297|FG004|Overall Study|Ongoing at Time of Analysis|0|||
163026841|NCT03569293|588801298|FG005|Overall Study|Ongoing at Time of Analysis|0|||
163026842|NCT05072106|588801309|FG000|Overall Study|Progressive disease|3|||
163026843|NCT05072106|588801310|FG001|Overall Study|Progressive disease|3|||
163026844|NCT05072106|588801309|FG000|Overall Study|Compassionate use|3|||
163026845|NCT05072106|588801310|FG001|Overall Study|Compassionate use|1|||
163026846|NCT05072106|588801309|FG000|Overall Study|Withdrawal by Subject|1|||
163026847|NCT05072106|588801310|FG001|Overall Study|Withdrawal by Subject|0|||
163026848|NCT03839459|588801311|FG000|Overall Study|Withdrawal by Subject|2|||
163026849|NCT03839459|588801311|FG000|Overall Study|progression of disease|3|||
163026850|NCT05376241|588801312|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
163026851|NCT05376241|588801312|FG000|Overall Study|103 did not complete the survey|103|||
163026852|NCT05376241|588801312|FG000|Overall Study|17 failed 2 attention check questions|17|||
163026853|NCT04240886|588801313|FG000|Treatment Phase|Death|4|||
163026854|NCT04240886|588801313|FG000|Treatment Phase|Discontinuation by Subject|1|||
163026855|NCT04240886|588801313|FG000|Treatment Phase|Adverse Event|5|||
163026856|NCT04240886|588801313|FG000|Follow-up Phase|Withdrawal by Subject|1|||
163026857|NCT04240886|588801313|FG000|Follow-up Phase|Discontinuation by Subject|1|||
163026858|NCT04240886|588801313|FG000|Follow-up Phase|Death|2|||
163026859|NCT02276053|588801314|FG000|Overall Study|Death|2|||
163026860|NCT02276053|588801314|FG000|Overall Study|Adverse Event|5|||
163026861|NCT02276053|588801314|FG000|Overall Study|Lack of Efficacy|2|||
163026862|NCT02276053|588801314|FG000|Overall Study|Withdrawal by Subject|1|||
163026863|NCT02276053|588801314|FG000|Overall Study|Patient does not meet selection criteria|3|||
163026864|NCT02276053|588801314|FG000|Overall Study|Patient needs to increase baseline AED|1|||
163026865|NCT02059434|588801315|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
163026866|NCT02059434|588801316|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
163026867|NCT02059434|588801317|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
163026868|NCT02059434|588801318|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
163026869|NCT02059434|588801319|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
163026870|NCT02059434|588801320|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
163026871|NCT02059434|588801321|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
163026872|NCT02059434|588801322|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
163026873|NCT02059434|588801323|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
163026874|NCT02059434|588801315|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
163026875|NCT02059434|588801316|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
163026876|NCT02059434|588801317|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
163026877|NCT02059434|588801318|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
163026878|NCT02059434|588801319|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
163026879|NCT02059434|588801320|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
163026880|NCT02059434|588801321|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
163026881|NCT02059434|588801322|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
163026882|NCT02059434|588801323|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
163026883|NCT02059434|588801315|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
163026884|NCT02059434|588801316|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
163026885|NCT02059434|588801317|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
163026886|NCT02059434|588801318|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
163026887|NCT02059434|588801319|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
163026888|NCT02059434|588801320|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
163026889|NCT02059434|588801321|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
163026890|NCT02059434|588801322|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
163026891|NCT02059434|588801323|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
163026892|NCT02059434|588801315|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
163026893|NCT02059434|588801316|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
163068984|NCT05710224|588959011|FG000|Overall Study|Withdrawal by Subject|4|||
163068985|NCT05710224|588959012|FG001|Overall Study|Withdrawal by Subject|6|||
163330994|NCT03678688|589922458|FG002|Overall Study|Withdrawal by Subject|0|||
163068986|NCT05710224|588959011|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
163068987|NCT05710224|588959012|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
163068988|NCT05710224|588959011|FG000|Overall Study|Participants Left The City|0|||
163068989|NCT05710224|588959012|FG001|Overall Study|Participants Left The City|2|||
163068990|NCT03369223|588959015|FG000|Overall Study|Lost to Follow-up|0|||
163068991|NCT03369223|588959016|FG001|Overall Study|Lost to Follow-up|0|||
163068992|NCT03369223|588959017|FG002|Overall Study|Lost to Follow-up|0|||
163068993|NCT03369223|588959018|FG003|Overall Study|Lost to Follow-up|0|||
163068994|NCT03369223|588959019|FG004|Overall Study|Lost to Follow-up|0|||
163068995|NCT03369223|588959020|FG005|Overall Study|Lost to Follow-up|0|||
163068996|NCT03369223|588959021|FG006|Overall Study|Lost to Follow-up|0|||
163068997|NCT03369223|588959022|FG007|Overall Study|Lost to Follow-up|0|||
163068998|NCT03369223|588959023|FG008|Overall Study|Lost to Follow-up|0|||
163068999|NCT03369223|588959024|FG009|Overall Study|Lost to Follow-up|0|||
163069000|NCT03369223|588959025|FG010|Overall Study|Lost to Follow-up|0|||
163069001|NCT03369223|588959026|FG011|Overall Study|Lost to Follow-up|0|||
163330995|NCT03678688|589922459|FG003|Overall Study|Withdrawal by Subject|0|||
163330996|NCT03678688|589922460|FG004|Overall Study|Withdrawal by Subject|0|||
163330997|NCT03678688|589922461|FG005|Overall Study|Withdrawal by Subject|0|||
163330998|NCT03678688|589922462|FG006|Overall Study|Withdrawal by Subject|2|||
163330999|NCT03678688|589922463|FG007|Overall Study|Withdrawal by Subject|1|||
163331000|NCT03678688|589922464|FG008|Overall Study|Withdrawal by Subject|0|||
163331001|NCT02534233|589922467|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
163331002|NCT03136159|589922472|FG000|Overall Study|chorioamnionitis|2|||
163331003|NCT03136159|589922473|FG001|Overall Study|chorioamnionitis|0|||
163331004|NCT03136159|589922472|FG000|Overall Study|vertical skin incision|1|||
163331005|NCT03136159|589922473|FG001|Overall Study|vertical skin incision|0|||
163331006|NCT03136159|589922472|FG000|Overall Study|additional dressing|1|||
163331007|NCT03136159|589922473|FG001|Overall Study|additional dressing|0|||
163331008|NCT03136159|589922472|FG000|Overall Study|never got dressing placed|1|||
163331009|NCT03136159|589922473|FG001|Overall Study|never got dressing placed|0|||
163331010|NCT03823703|589922474|FG000|Overall Study|Sponsor request|0|||
163331011|NCT03823703|589922475|FG001|Overall Study|Sponsor request|3|||
163331012|NCT03823703|589922476|FG002|Overall Study|Sponsor request|4|||
163331013|NCT03823703|589922474|FG000|Overall Study|Adverse Event|3|||
163026894|NCT02059434|588801317|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
163026895|NCT02059434|588801318|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
163026896|NCT02059434|588801319|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
163026897|NCT02059434|588801320|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
163026898|NCT02059434|588801321|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
163026899|NCT02059434|588801322|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
163026900|NCT02059434|588801323|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
163026901|NCT02059434|588801315|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026902|NCT02059434|588801316|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026903|NCT02059434|588801317|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026904|NCT02059434|588801318|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026905|NCT02059434|588801319|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026906|NCT02059434|588801320|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026907|NCT02059434|588801321|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026908|NCT02059434|588801322|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026909|NCT02059434|588801323|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
163026910|NCT02928770|588801328|FG000|Overall Study|Withdrawal by Subject|2|||
163026911|NCT03201874|588801329|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
163026912|NCT03201874|588801330|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
163026913|NCT03201874|588801329|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
163026914|NCT03201874|588801330|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
163026915|NCT02759055|588801336|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
163026916|NCT02759055|588801337|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
163026917|NCT02515994|588801338|FG000|Overall Study|Protocol Violation|3|||
163026918|NCT02515994|588801339|FG001|Overall Study|Protocol Violation|5|||
163026919|NCT02515994|588801338|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
163026920|NCT02515994|588801339|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
163026921|NCT02515994|588801338|FG000|Overall Study|Adverse Event|3|||
163026922|NCT02515994|588801339|FG001|Overall Study|Adverse Event|1|||
163026923|NCT02515994|588801338|FG000|Overall Study|Withdrawal by Subject|2|||
163026924|NCT02515994|588801339|FG001|Overall Study|Withdrawal by Subject|0|||
163069002|NCT03369223|588959027|FG012|Overall Study|Lost to Follow-up|0|||
163069003|NCT03369223|588959028|FG013|Overall Study|Lost to Follow-up|0|||
163331014|NCT03823703|589922475|FG001|Overall Study|Adverse Event|1|||
163331015|NCT03823703|589922476|FG002|Overall Study|Adverse Event|0|||
163331016|NCT03823703|589922474|FG000|Overall Study|Withdrawal by Subject|0|||
163069004|NCT03369223|588959029|FG014|Overall Study|Lost to Follow-up|0|||
163069005|NCT03369223|588959030|FG015|Overall Study|Lost to Follow-up|0|||
163069006|NCT03369223|588959031|FG016|Overall Study|Lost to Follow-up|0|||
163069007|NCT03369223|588959032|FG017|Overall Study|Lost to Follow-up|0|||
163069008|NCT03369223|588959033|FG018|Overall Study|Lost to Follow-up|2|||
163069009|NCT03369223|588959034|FG019|Overall Study|Lost to Follow-up|1|||
163069010|NCT03369223|588959015|FG000|Overall Study|Participant no longer meets study criteria|0|||
163069011|NCT03369223|588959016|FG001|Overall Study|Participant no longer meets study criteria|0|||
163069012|NCT03369223|588959017|FG002|Overall Study|Participant no longer meets study criteria|0|||
163069013|NCT03369223|588959018|FG003|Overall Study|Participant no longer meets study criteria|0|||
163069014|NCT03369223|588959019|FG004|Overall Study|Participant no longer meets study criteria|0|||
163069015|NCT03369223|588959020|FG005|Overall Study|Participant no longer meets study criteria|0|||
163069016|NCT03369223|588959021|FG006|Overall Study|Participant no longer meets study criteria|0|||
163069017|NCT03369223|588959022|FG007|Overall Study|Participant no longer meets study criteria|0|||
163069018|NCT03369223|588959023|FG008|Overall Study|Participant no longer meets study criteria|0|||
163069019|NCT03369223|588959024|FG009|Overall Study|Participant no longer meets study criteria|0|||
163069020|NCT03369223|588959025|FG010|Overall Study|Participant no longer meets study criteria|0|||
163069021|NCT03369223|588959026|FG011|Overall Study|Participant no longer meets study criteria|0|||
163069022|NCT03369223|588959027|FG012|Overall Study|Participant no longer meets study criteria|0|||
163069023|NCT03369223|588959028|FG013|Overall Study|Participant no longer meets study criteria|0|||
163069024|NCT03369223|588959029|FG014|Overall Study|Participant no longer meets study criteria|2|||
163069025|NCT03369223|588959030|FG015|Overall Study|Participant no longer meets study criteria|0|||
163069026|NCT03369223|588959031|FG016|Overall Study|Participant no longer meets study criteria|2|||
163069027|NCT03369223|588959032|FG017|Overall Study|Participant no longer meets study criteria|0|||
163069028|NCT03369223|588959033|FG018|Overall Study|Participant no longer meets study criteria|0|||
163069029|NCT03369223|588959034|FG019|Overall Study|Participant no longer meets study criteria|0|||
163069030|NCT03369223|588959015|FG000|Overall Study|Other reasons|0|||
163069031|NCT03369223|588959016|FG001|Overall Study|Other reasons|0|||
163069032|NCT03369223|588959017|FG002|Overall Study|Other reasons|0|||
163069033|NCT03369223|588959018|FG003|Overall Study|Other reasons|0|||
163069034|NCT03369223|588959019|FG004|Overall Study|Other reasons|0|||
163069035|NCT03369223|588959020|FG005|Overall Study|Other reasons|0|||
163069036|NCT03369223|588959021|FG006|Overall Study|Other reasons|0|||
163069037|NCT03369223|588959022|FG007|Overall Study|Other reasons|0|||
163069038|NCT03369223|588959023|FG008|Overall Study|Other reasons|0|||
163069039|NCT03369223|588959024|FG009|Overall Study|Other reasons|0|||
163069040|NCT03369223|588959025|FG010|Overall Study|Other reasons|0|||
163069041|NCT03369223|588959026|FG011|Overall Study|Other reasons|0|||
163069042|NCT03369223|588959027|FG012|Overall Study|Other reasons|0|||
163069043|NCT03369223|588959028|FG013|Overall Study|Other reasons|1|||
163069044|NCT03369223|588959029|FG014|Overall Study|Other reasons|2|||
163069045|NCT03369223|588959030|FG015|Overall Study|Other reasons|0|||
163069046|NCT03369223|588959031|FG016|Overall Study|Other reasons|1|||
163069047|NCT03369223|588959032|FG017|Overall Study|Other reasons|0|||
163069048|NCT03369223|588959033|FG018|Overall Study|Other reasons|0|||
163069049|NCT03369223|588959034|FG019|Overall Study|Other reasons|2|||
163069050|NCT03369223|588959015|FG000|Overall Study|Death|0|||
163069051|NCT03369223|588959016|FG001|Overall Study|Death|0|||
163069052|NCT03369223|588959017|FG002|Overall Study|Death|0|||
163069053|NCT03369223|588959018|FG003|Overall Study|Death|0|||
163069054|NCT03369223|588959019|FG004|Overall Study|Death|0|||
163069055|NCT03369223|588959020|FG005|Overall Study|Death|0|||
163069056|NCT03369223|588959021|FG006|Overall Study|Death|0|||
163069057|NCT03369223|588959022|FG007|Overall Study|Death|0|||
163069058|NCT03369223|588959023|FG008|Overall Study|Death|0|||
163069059|NCT03369223|588959024|FG009|Overall Study|Death|0|||
163069060|NCT03369223|588959025|FG010|Overall Study|Death|0|||
163069061|NCT03369223|588959026|FG011|Overall Study|Death|0|||
163069062|NCT03369223|588959027|FG012|Overall Study|Death|0|||
163069063|NCT03369223|588959028|FG013|Overall Study|Death|1|||
163069064|NCT03369223|588959029|FG014|Overall Study|Death|0|||
163069065|NCT03369223|588959030|FG015|Overall Study|Death|0|||
163069066|NCT03369223|588959031|FG016|Overall Study|Death|0|||
163069067|NCT03369223|588959032|FG017|Overall Study|Death|0|||
163069068|NCT03369223|588959033|FG018|Overall Study|Death|1|||
163069069|NCT03369223|588959034|FG019|Overall Study|Death|0|||
163069070|NCT03369223|588959015|FG000|Overall Study|Adverse event unrelated to study drug|0|||
163069071|NCT03369223|588959016|FG001|Overall Study|Adverse event unrelated to study drug|0|||
163069072|NCT03369223|588959017|FG002|Overall Study|Adverse event unrelated to study drug|0|||
163069073|NCT03369223|588959018|FG003|Overall Study|Adverse event unrelated to study drug|0|||
163069074|NCT03369223|588959019|FG004|Overall Study|Adverse event unrelated to study drug|0|||
163069075|NCT03369223|588959020|FG005|Overall Study|Adverse event unrelated to study drug|0|||
163069076|NCT03369223|588959021|FG006|Overall Study|Adverse event unrelated to study drug|1|||
163069077|NCT03369223|588959022|FG007|Overall Study|Adverse event unrelated to study drug|0|||
163069078|NCT03369223|588959023|FG008|Overall Study|Adverse event unrelated to study drug|0|||
163069079|NCT03369223|588959024|FG009|Overall Study|Adverse event unrelated to study drug|1|||
163069080|NCT03369223|588959025|FG010|Overall Study|Adverse event unrelated to study drug|0|||
163069081|NCT03369223|588959026|FG011|Overall Study|Adverse event unrelated to study drug|0|||
163069082|NCT03369223|588959027|FG012|Overall Study|Adverse event unrelated to study drug|0|||
163069083|NCT03369223|588959028|FG013|Overall Study|Adverse event unrelated to study drug|4|||
163069084|NCT03369223|588959029|FG014|Overall Study|Adverse event unrelated to study drug|2|||
163069085|NCT03369223|588959030|FG015|Overall Study|Adverse event unrelated to study drug|0|||
163069086|NCT03369223|588959031|FG016|Overall Study|Adverse event unrelated to study drug|2|||
163069087|NCT03369223|588959032|FG017|Overall Study|Adverse event unrelated to study drug|1|||
163069088|NCT03369223|588959033|FG018|Overall Study|Adverse event unrelated to study drug|3|||
163069089|NCT03369223|588959034|FG019|Overall Study|Adverse event unrelated to study drug|2|||
163069090|NCT03369223|588959015|FG000|Overall Study|Disease progression|6|||
163069091|NCT03369223|588959016|FG001|Overall Study|Disease progression|8|||
163069092|NCT03369223|588959017|FG002|Overall Study|Disease progression|5|||
163217864|NCT00605475|589513812|FG006|Overall Study|Protocol Violation|0|||
163217865|NCT00605475|589513813|FG007|Overall Study|Protocol Violation|0|||
163217866|NCT00605475|589513814|FG008|Overall Study|Protocol Violation|0|||
163217867|NCT00605475|589513815|FG009|Overall Study|Protocol Violation|0|||
163217868|NCT00605475|589513806|FG000|Overall Study|Withdrawal by Subject|0|||
163069093|NCT03369223|588959018|FG003|Overall Study|Disease progression|1|||
163069094|NCT03369223|588959019|FG004|Overall Study|Disease progression|9|||
163069095|NCT03369223|588959020|FG005|Overall Study|Disease progression|9|||
163069096|NCT03369223|588959021|FG006|Overall Study|Disease progression|4|||
163217869|NCT00605475|589513807|FG001|Overall Study|Withdrawal by Subject|0|||
163217870|NCT00605475|589513808|FG002|Overall Study|Withdrawal by Subject|0|||
163217871|NCT00605475|589513809|FG003|Overall Study|Withdrawal by Subject|0|||
163217872|NCT00605475|589513810|FG004|Overall Study|Withdrawal by Subject|0|||
163217873|NCT00605475|589513811|FG005|Overall Study|Withdrawal by Subject|2|||
163217874|NCT00605475|589513812|FG006|Overall Study|Withdrawal by Subject|0|||
163217875|NCT00605475|589513813|FG007|Overall Study|Withdrawal by Subject|0|||
163217876|NCT00605475|589513814|FG008|Overall Study|Withdrawal by Subject|0|||
163217877|NCT00605475|589513815|FG009|Overall Study|Withdrawal by Subject|1|||
163217878|NCT03538158|589513821|FG000|Overall Study|Lost to Follow-up|13|||
163217879|NCT03538158|589513822|FG001|Overall Study|Lost to Follow-up|7|||
163217880|NCT03538158|589513821|FG000|Overall Study|Withdrawal by Subject|2|||
163217881|NCT03538158|589513822|FG001|Overall Study|Withdrawal by Subject|1|||
163217882|NCT04356963|589513832|FG000|First Session|Withdrawal by Subject|1|||
163217883|NCT04356963|589513832|FG000|Second Session|Withdrawal by Subject|3|||
163217884|NCT04356963|589513832|FG000|Second Session|Lost to Follow-up|1|||
163217885|NCT04356963|589513832|FG000|Third Session|Lost to Follow-up|6|||
163217886|NCT04356963|589513832|FG000|Third Session|Withdrawal by Subject|1|||
163217887|NCT02410954|589513835|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
163217888|NCT02410954|589513836|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
163217889|NCT02410954|589513835|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
163217890|NCT02410954|589513836|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
163217891|NCT00791518|589513838|FG000|Overall Study|Protocol Violation|93|||
163217892|NCT02488681|589513839|FG000|Overall Study|Implant unsuccessful|7|||
163217893|NCT00720057|589513840|FG000|Overall Study|Lost to Follow-up|0|||
163217894|NCT00720057|589513841|FG001|Overall Study|Lost to Follow-up|2|||
163217895|NCT00720057|589513840|FG000|Overall Study|Protocol Violation|1|||
163069097|NCT03369223|588959022|FG007|Overall Study|Disease progression|6|||
163069098|NCT03369223|588959023|FG008|Overall Study|Disease progression|10|||
163069099|NCT03369223|588959024|FG009|Overall Study|Disease progression|7|||
163069100|NCT03369223|588959025|FG010|Overall Study|Disease progression|4|||
163217896|NCT00720057|589513841|FG001|Overall Study|Protocol Violation|0|||
163217897|NCT00720057|589513840|FG000|Overall Study|Withdrawal by Subject|0|||
163217898|NCT00720057|589513841|FG001|Overall Study|Withdrawal by Subject|1|||
163331017|NCT03823703|589922475|FG001|Overall Study|Withdrawal by Subject|1|||
163026925|NCT01424514|588801341|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
163026926|NCT01424514|588801342|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
163026927|NCT01424514|588801341|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
163026928|NCT01424514|588801342|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
163026929|NCT02653170|588801343|FG000|Overall Study|Withdrawal by Subject|3|||
163026930|NCT02653170|588801344|FG001|Overall Study|Withdrawal by Subject|8|||
163026931|NCT02653170|588801345|FG002|Overall Study|Withdrawal by Subject|3|||
163026932|NCT02653170|588801343|FG000|Overall Study|withdrawn by study team|2|||
163026933|NCT02653170|588801344|FG001|Overall Study|withdrawn by study team|4|||
163026934|NCT02653170|588801345|FG002|Overall Study|withdrawn by study team|5|||
163026935|NCT02653170|588801343|FG000|Overall Study|Lost to Follow-up|12|||
163069101|NCT03369223|588959026|FG011|Overall Study|Disease progression|1|||
163069102|NCT03369223|588959027|FG012|Overall Study|Disease progression|1|||
163069103|NCT03369223|588959028|FG013|Overall Study|Disease progression|25|||
163217899|NCT00271609|589513853|FG000|Overall Study|Adverse Event|11|||
163217900|NCT00271609|589513854|FG001|Overall Study|Adverse Event|3|||
163217901|NCT00271609|589513853|FG000|Overall Study|Withdrawal by Subject|2|||
163069104|NCT03369223|588959029|FG014|Overall Study|Disease progression|22|||
163069105|NCT03369223|588959030|FG015|Overall Study|Disease progression|2|||
163069106|NCT03369223|588959031|FG016|Overall Study|Disease progression|10|||
163069107|NCT03369223|588959032|FG017|Overall Study|Disease progression|1|||
163069108|NCT03369223|588959033|FG018|Overall Study|Disease progression|18|||
163069109|NCT03369223|588959034|FG019|Overall Study|Disease progression|28|||
163069110|NCT03369223|588959015|FG000|Overall Study|Study drug toxicity|0|||
163069111|NCT03369223|588959016|FG001|Overall Study|Study drug toxicity|1|||
163069112|NCT03369223|588959017|FG002|Overall Study|Study drug toxicity|4|||
163069113|NCT03369223|588959018|FG003|Overall Study|Study drug toxicity|0|||
163069114|NCT03369223|588959019|FG004|Overall Study|Study drug toxicity|1|||
163069115|NCT03369223|588959020|FG005|Overall Study|Study drug toxicity|2|||
163069116|NCT03369223|588959021|FG006|Overall Study|Study drug toxicity|4|||
163069117|NCT03369223|588959022|FG007|Overall Study|Study drug toxicity|2|||
163069118|NCT03369223|588959023|FG008|Overall Study|Study drug toxicity|2|||
163069119|NCT03369223|588959024|FG009|Overall Study|Study drug toxicity|0|||
163069120|NCT03369223|588959025|FG010|Overall Study|Study drug toxicity|6|||
163069121|NCT03369223|588959026|FG011|Overall Study|Study drug toxicity|1|||
163069122|NCT03369223|588959027|FG012|Overall Study|Study drug toxicity|2|||
163069123|NCT03369223|588959028|FG013|Overall Study|Study drug toxicity|19|||
163069124|NCT03369223|588959029|FG014|Overall Study|Study drug toxicity|19|||
163069125|NCT03369223|588959030|FG015|Overall Study|Study drug toxicity|0|||
163069126|NCT03369223|588959031|FG016|Overall Study|Study drug toxicity|18|||
163069127|NCT03369223|588959032|FG017|Overall Study|Study drug toxicity|3|||
163069128|NCT03369223|588959033|FG018|Overall Study|Study drug toxicity|11|||
163069129|NCT03369223|588959034|FG019|Overall Study|Study drug toxicity|7|||
163069130|NCT03369223|588959015|FG000|Overall Study|Participant request to discontinue study treatment|0|||
163069131|NCT03369223|588959016|FG001|Overall Study|Participant request to discontinue study treatment|1|||
163069132|NCT03369223|588959017|FG002|Overall Study|Participant request to discontinue study treatment|0|||
163069133|NCT03369223|588959018|FG003|Overall Study|Participant request to discontinue study treatment|0|||
163069134|NCT03369223|588959019|FG004|Overall Study|Participant request to discontinue study treatment|1|||
163069135|NCT03369223|588959020|FG005|Overall Study|Participant request to discontinue study treatment|1|||
163069136|NCT03369223|588959021|FG006|Overall Study|Participant request to discontinue study treatment|1|||
163069137|NCT03369223|588959022|FG007|Overall Study|Participant request to discontinue study treatment|0|||
163069138|NCT03369223|588959023|FG008|Overall Study|Participant request to discontinue study treatment|0|||
163069139|NCT03369223|588959024|FG009|Overall Study|Participant request to discontinue study treatment|0|||
163069140|NCT03369223|588959025|FG010|Overall Study|Participant request to discontinue study treatment|0|||
163069141|NCT03369223|588959026|FG011|Overall Study|Participant request to discontinue study treatment|0|||
163069142|NCT03369223|588959027|FG012|Overall Study|Participant request to discontinue study treatment|0|||
163069143|NCT03369223|588959028|FG013|Overall Study|Participant request to discontinue study treatment|1|||
163069144|NCT03369223|588959029|FG014|Overall Study|Participant request to discontinue study treatment|1|||
163069145|NCT03369223|588959030|FG015|Overall Study|Participant request to discontinue study treatment|0|||
163069146|NCT03369223|588959031|FG016|Overall Study|Participant request to discontinue study treatment|0|||
163069147|NCT03369223|588959032|FG017|Overall Study|Participant request to discontinue study treatment|0|||
163069148|NCT03369223|588959033|FG018|Overall Study|Participant request to discontinue study treatment|1|||
163069149|NCT03369223|588959034|FG019|Overall Study|Participant request to discontinue study treatment|0|||
163069150|NCT03369223|588959015|FG000|Overall Study|Participant withdrew consent|0|||
163069151|NCT03369223|588959016|FG001|Overall Study|Participant withdrew consent|1|||
163069152|NCT03369223|588959017|FG002|Overall Study|Participant withdrew consent|1|||
163069153|NCT03369223|588959018|FG003|Overall Study|Participant withdrew consent|0|||
163069154|NCT03369223|588959019|FG004|Overall Study|Participant withdrew consent|0|||
163069155|NCT03369223|588959020|FG005|Overall Study|Participant withdrew consent|0|||
163069156|NCT03369223|588959021|FG006|Overall Study|Participant withdrew consent|1|||
163069157|NCT03369223|588959022|FG007|Overall Study|Participant withdrew consent|1|||
163069158|NCT03369223|588959023|FG008|Overall Study|Participant withdrew consent|1|||
163069159|NCT03369223|588959024|FG009|Overall Study|Participant withdrew consent|0|||
163069160|NCT03369223|588959025|FG010|Overall Study|Participant withdrew consent|0|||
163069161|NCT03369223|588959026|FG011|Overall Study|Participant withdrew consent|1|||
163069162|NCT03369223|588959027|FG012|Overall Study|Participant withdrew consent|0|||
163069163|NCT03369223|588959028|FG013|Overall Study|Participant withdrew consent|0|||
163069164|NCT03369223|588959029|FG014|Overall Study|Participant withdrew consent|3|||
163069165|NCT03369223|588959030|FG015|Overall Study|Participant withdrew consent|0|||
163069166|NCT03369223|588959031|FG016|Overall Study|Participant withdrew consent|1|||
163069167|NCT03369223|588959032|FG017|Overall Study|Participant withdrew consent|0|||
163331018|NCT03823703|589922476|FG002|Overall Study|Withdrawal by Subject|0|||
163331019|NCT00799409|589922477|FG000|Overall Study|Withdrawal by Subject|1|||
163331020|NCT00799409|589922478|FG001|Overall Study|Withdrawal by Subject|0|||
163331021|NCT00799409|589922479|FG002|Overall Study|Withdrawal by Subject|0|||
163069168|NCT03369223|588959033|FG018|Overall Study|Participant withdrew consent|4|||
163331022|NCT00799409|589922477|FG000|Overall Study|Lost to Follow-up|1|||
163331023|NCT00799409|589922478|FG001|Overall Study|Lost to Follow-up|0|||
163069169|NCT03369223|588959034|FG019|Overall Study|Participant withdrew consent|2|||
163069170|NCT03369223|588959015|FG000|Overall Study|Randomized but not treated|0|||
163069171|NCT03369223|588959016|FG001|Overall Study|Randomized but not treated|0|||
163069172|NCT03369223|588959017|FG002|Overall Study|Randomized but not treated|0|||
163069173|NCT03369223|588959018|FG003|Overall Study|Randomized but not treated|0|||
163069174|NCT03369223|588959019|FG004|Overall Study|Randomized but not treated|0|||
163069175|NCT03369223|588959020|FG005|Overall Study|Randomized but not treated|0|||
163069176|NCT03369223|588959021|FG006|Overall Study|Randomized but not treated|0|||
163069177|NCT03369223|588959022|FG007|Overall Study|Randomized but not treated|0|||
163069178|NCT03369223|588959023|FG008|Overall Study|Randomized but not treated|0|||
163069179|NCT03369223|588959024|FG009|Overall Study|Randomized but not treated|0|||
163069180|NCT03369223|588959025|FG010|Overall Study|Randomized but not treated|0|||
163069181|NCT03369223|588959026|FG011|Overall Study|Randomized but not treated|0|||
163069182|NCT03369223|588959027|FG012|Overall Study|Randomized but not treated|0|||
163069183|NCT03369223|588959028|FG013|Overall Study|Randomized but not treated|1|||
163069184|NCT03369223|588959029|FG014|Overall Study|Randomized but not treated|1|||
163069185|NCT03369223|588959030|FG015|Overall Study|Randomized but not treated|0|||
163069186|NCT03369223|588959031|FG016|Overall Study|Randomized but not treated|0|||
163069187|NCT03369223|588959032|FG017|Overall Study|Randomized but not treated|0|||
163069188|NCT03369223|588959033|FG018|Overall Study|Randomized but not treated|0|||
163069189|NCT03369223|588959034|FG019|Overall Study|Randomized but not treated|0|||
163069190|NCT04615507|588959035|FG000|Period 1|Covid-19 exposure|2|||
163069191|NCT04615507|588959036|FG001|Period 1|Covid-19 exposure|1|||
163069192|NCT04615507|588959035|FG000|Period 2|Covid-19 exposure|0|||
163069193|NCT04615507|588959036|FG001|Period 2|Covid-19 exposure|1|||
163069194|NCT04615507|588959035|FG000|Period 2|Protocol Violation|1|||
163069195|NCT04615507|588959036|FG001|Period 2|Protocol Violation|0|||
163069196|NCT04615507|588959035|FG000|Period 2|Withdrawal by Subject|1|||
163069197|NCT04615507|588959036|FG001|Period 2|Withdrawal by Subject|0|||
163069198|NCT04615507|588959035|FG000|Period 2|Adverse Event|0|||
163069199|NCT04615507|588959036|FG001|Period 2|Adverse Event|1|||
163069200|NCT04615507|588959035|FG000|Period 3|Covid-19 exposure|0|||
163069201|NCT04615507|588959036|FG001|Period 3|Covid-19 exposure|1|||
163069202|NCT03407482|588959037|FG000|Overall Study|Adverse Event|12|||
163069203|NCT03407482|588959037|FG000|Overall Study|Disease Relapse|1|||
163069204|NCT03407482|588959037|FG000|Overall Study|Lost to Follow-up|1|||
163069205|NCT03407482|588959037|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163069206|NCT03407482|588959037|FG000|Overall Study|Pregnancy|2|||
163069207|NCT03407482|588959037|FG000|Overall Study|Protocol Violation|1|||
163069208|NCT03407482|588959037|FG000|Overall Study|Study Terminated By Sponsor|106|||
163069209|NCT03407482|588959037|FG000|Overall Study|Withdrawal by Subject|6|||
163069210|NCT03407482|588959037|FG000|Overall Study|Data Entry Error|1|||
163069211|NCT05887401|588959041|FG000|Overall Study|Withdrawal by Subject|0|||
163069212|NCT05887401|588959042|FG001|Overall Study|Withdrawal by Subject|0|||
163069213|NCT05887401|588959043|FG002|Overall Study|Withdrawal by Subject|0|||
163069214|NCT05887401|588959044|FG003|Overall Study|Withdrawal by Subject|0|||
163069215|NCT05887401|588959045|FG004|Overall Study|Withdrawal by Subject|0|||
163069216|NCT05887401|588959046|FG005|Overall Study|Withdrawal by Subject|0|||
163069217|NCT05887401|588959047|FG006|Overall Study|Withdrawal by Subject|0|||
163069218|NCT05887401|588959048|FG007|Overall Study|Withdrawal by Subject|0|||
163069219|NCT05887401|588959049|FG008|Overall Study|Withdrawal by Subject|0|||
163069220|NCT05887401|588959050|FG009|Overall Study|Withdrawal by Subject|1|||
163069221|NCT05887401|588959051|FG010|Overall Study|Withdrawal by Subject|0|||
163069222|NCT05887401|588959052|FG011|Overall Study|Withdrawal by Subject|0|||
163331024|NCT00799409|589922479|FG002|Overall Study|Lost to Follow-up|0|||
163331025|NCT00799409|589922477|FG000|Overall Study|Optimal Dose Not Achieved|2|||
163331026|NCT00799409|589922478|FG001|Overall Study|Optimal Dose Not Achieved|0|||
163069223|NCT05887401|588959053|FG012|Overall Study|Withdrawal by Subject|0|||
163069224|NCT05887401|588959054|FG013|Overall Study|Withdrawal by Subject|0|||
163069225|NCT05887401|588959055|FG014|Overall Study|Withdrawal by Subject|0|||
163069226|NCT05887401|588959056|FG015|Overall Study|Withdrawal by Subject|1|||
163069227|NCT05887401|588959041|FG000|Overall Study|Lost to Follow-up|0|||
163069228|NCT05887401|588959042|FG001|Overall Study|Lost to Follow-up|1|||
163331027|NCT00799409|589922479|FG002|Overall Study|Optimal Dose Not Achieved|0|||
163069229|NCT05887401|588959043|FG002|Overall Study|Lost to Follow-up|1|||
163331028|NCT00799409|589922477|FG000|Overall Study|Failure to follow study protocol)|1|||
163069230|NCT05887401|588959044|FG003|Overall Study|Lost to Follow-up|2|||
163069231|NCT05887401|588959045|FG004|Overall Study|Lost to Follow-up|0|||
163069232|NCT05887401|588959046|FG005|Overall Study|Lost to Follow-up|0|||
163069233|NCT05887401|588959047|FG006|Overall Study|Lost to Follow-up|0|||
163069234|NCT05887401|588959048|FG007|Overall Study|Lost to Follow-up|0|||
163069235|NCT05887401|588959049|FG008|Overall Study|Lost to Follow-up|1|||
163069236|NCT05887401|588959050|FG009|Overall Study|Lost to Follow-up|1|||
163069237|NCT05887401|588959051|FG010|Overall Study|Lost to Follow-up|2|||
163069238|NCT05887401|588959052|FG011|Overall Study|Lost to Follow-up|1|||
163069239|NCT05887401|588959053|FG012|Overall Study|Lost to Follow-up|0|||
163069240|NCT05887401|588959054|FG013|Overall Study|Lost to Follow-up|0|||
163069241|NCT05887401|588959055|FG014|Overall Study|Lost to Follow-up|0|||
163069242|NCT05887401|588959056|FG015|Overall Study|Lost to Follow-up|0|||
163069243|NCT02369458|588959060|FG000|Overall Study|Determined to be not eligible|1|||
163069244|NCT02369458|588959061|FG001|Overall Study|Determined to be not eligible|0|||
163069245|NCT03853798|588959062|FG000|Overall Study|Death|0|||
163069246|NCT03853798|588959063|FG001|Overall Study|Death|0|||
163069247|NCT03853798|588959064|FG002|Overall Study|Death|0|||
163069248|NCT03853798|588959065|FG003|Overall Study|Death|0|||
163069249|NCT03853798|588959066|FG004|Overall Study|Death|0|||
163069250|NCT03853798|588959067|FG005|Overall Study|Death|1|||
163069251|NCT03853798|588959068|FG006|Overall Study|Death|0|||
163069252|NCT03853798|588959069|FG007|Overall Study|Death|0|||
163069253|NCT03853798|588959070|FG008|Overall Study|Death|0|||
163069254|NCT03853798|588959062|FG000|Overall Study|Adverse Event|0|||
163331029|NCT00799409|589922478|FG001|Overall Study|Failure to follow study protocol)|0|||
163331030|NCT00799409|589922479|FG002|Overall Study|Failure to follow study protocol)|0|||
163331031|NCT00799409|589922477|FG000|Overall Study|Did not attend lab school day 1|1|||
163331032|NCT00799409|589922478|FG001|Overall Study|Did not attend lab school day 1|0|||
163331033|NCT00799409|589922479|FG002|Overall Study|Did not attend lab school day 1|0|||
163331034|NCT00799409|589922477|FG000|Overall Study|medication compliance|1|||
163331035|NCT00799409|589922478|FG001|Overall Study|medication compliance|0|||
163331036|NCT00799409|589922479|FG002|Overall Study|medication compliance|0|||
163331037|NCT04323800|589922480|FG000|Overall Study|Withdrawal by Subject|4|||
163331038|NCT04323800|589922481|FG001|Overall Study|Withdrawal by Subject|4|||
163331039|NCT04323800|589922480|FG000|Overall Study|Incomplete transfusion|1|||
163331040|NCT04323800|589922481|FG001|Overall Study|Incomplete transfusion|0|||
163331041|NCT04323800|589922480|FG000|Overall Study|Other|0|||
163331042|NCT04323800|589922481|FG001|Overall Study|Other|1|||
163331043|NCT04323800|589922480|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
163331044|NCT04323800|589922481|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
163069255|NCT03853798|588959063|FG001|Overall Study|Adverse Event|0|||
163069256|NCT03853798|588959064|FG002|Overall Study|Adverse Event|2|||
163069257|NCT03853798|588959065|FG003|Overall Study|Adverse Event|0|||
163069258|NCT03853798|588959066|FG004|Overall Study|Adverse Event|0|||
163069259|NCT03853798|588959067|FG005|Overall Study|Adverse Event|0|||
163069260|NCT03853798|588959068|FG006|Overall Study|Adverse Event|0|||
163069261|NCT03853798|588959069|FG007|Overall Study|Adverse Event|0|||
163069262|NCT03853798|588959070|FG008|Overall Study|Adverse Event|0|||
163069263|NCT03853798|588959062|FG000|Overall Study|Withdrawal by Subject|0|||
163069264|NCT03853798|588959063|FG001|Overall Study|Withdrawal by Subject|1|||
163069265|NCT03853798|588959064|FG002|Overall Study|Withdrawal by Subject|4|||
163069266|NCT03853798|588959065|FG003|Overall Study|Withdrawal by Subject|0|||
163069267|NCT03853798|588959066|FG004|Overall Study|Withdrawal by Subject|0|||
163069268|NCT03853798|588959067|FG005|Overall Study|Withdrawal by Subject|5|||
163069269|NCT03853798|588959068|FG006|Overall Study|Withdrawal by Subject|0|||
163069270|NCT03853798|588959069|FG007|Overall Study|Withdrawal by Subject|0|||
163069271|NCT03853798|588959070|FG008|Overall Study|Withdrawal by Subject|4|||
163069272|NCT03853798|588959062|FG000|Overall Study|Physician Decision|1|||
163069273|NCT03853798|588959063|FG001|Overall Study|Physician Decision|0|||
163069274|NCT03853798|588959064|FG002|Overall Study|Physician Decision|0|||
163069275|NCT03853798|588959065|FG003|Overall Study|Physician Decision|0|||
163069276|NCT03853798|588959066|FG004|Overall Study|Physician Decision|0|||
163069277|NCT03853798|588959067|FG005|Overall Study|Physician Decision|0|||
163069278|NCT03853798|588959068|FG006|Overall Study|Physician Decision|0|||
163331045|NCT00489554|589922482|FG000|Overall Study|Adverse Event|2|||
163331046|NCT00489554|589922482|FG000|Overall Study|Withdrawal by Subject|1|||
163331047|NCT00489554|589922482|FG000|Overall Study|Lost to Follow-up|1|||
163331048|NCT01732757|589922483|FG000|Overall Study|Lost to Follow-up|1|||
163331049|NCT01732757|589922484|FG001|Overall Study|Lost to Follow-up|0|||
163331050|NCT01732757|589922485|FG002|Overall Study|Lost to Follow-up|0|||
163331051|NCT00925548|589922486|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
163069279|NCT03853798|588959069|FG007|Overall Study|Physician Decision|0|||
163069280|NCT03853798|588959070|FG008|Overall Study|Physician Decision|1|||
163069281|NCT03853798|588959062|FG000|Overall Study|Lack of Efficacy|0|||
163069282|NCT03853798|588959063|FG001|Overall Study|Lack of Efficacy|0|||
163331052|NCT00925548|589922487|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
163331053|NCT00731692|589922489|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
163331054|NCT00731692|589922490|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
163069283|NCT03853798|588959064|FG002|Overall Study|Lack of Efficacy|2|||
163069284|NCT03853798|588959065|FG003|Overall Study|Lack of Efficacy|0|||
163069285|NCT03853798|588959066|FG004|Overall Study|Lack of Efficacy|0|||
163069286|NCT03853798|588959067|FG005|Overall Study|Lack of Efficacy|0|||
163069287|NCT03853798|588959068|FG006|Overall Study|Lack of Efficacy|0|||
163069288|NCT03853798|588959069|FG007|Overall Study|Lack of Efficacy|0|||
163069289|NCT03853798|588959070|FG008|Overall Study|Lack of Efficacy|1|||
163069290|NCT03853798|588959062|FG000|Overall Study|Approved Drug Available for Indication|0|||
163069291|NCT03853798|588959063|FG001|Overall Study|Approved Drug Available for Indication|0|||
163331055|NCT00731692|589922491|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
163069292|NCT03853798|588959064|FG002|Overall Study|Approved Drug Available for Indication|1|||
163069293|NCT03853798|588959065|FG003|Overall Study|Approved Drug Available for Indication|0|||
163069294|NCT03853798|588959066|FG004|Overall Study|Approved Drug Available for Indication|0|||
163069295|NCT03853798|588959067|FG005|Overall Study|Approved Drug Available for Indication|1|||
163069296|NCT03853798|588959068|FG006|Overall Study|Approved Drug Available for Indication|0|||
163069297|NCT03853798|588959069|FG007|Overall Study|Approved Drug Available for Indication|0|||
163069298|NCT03853798|588959070|FG008|Overall Study|Approved Drug Available for Indication|0|||
163069299|NCT03853798|588959062|FG000|Overall Study|Other un-specified|0|||
163069300|NCT03853798|588959063|FG001|Overall Study|Other un-specified|0|||
163069301|NCT03853798|588959064|FG002|Overall Study|Other un-specified|2|||
163069302|NCT03853798|588959065|FG003|Overall Study|Other un-specified|0|||
163069303|NCT03853798|588959066|FG004|Overall Study|Other un-specified|0|||
163069304|NCT03853798|588959067|FG005|Overall Study|Other un-specified|1|||
163069305|NCT03853798|588959068|FG006|Overall Study|Other un-specified|0|||
163069306|NCT03853798|588959069|FG007|Overall Study|Other un-specified|0|||
163069307|NCT03853798|588959070|FG008|Overall Study|Other un-specified|0|||
163069308|NCT02743494|588959071|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
163069309|NCT02743494|588959072|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
163069310|NCT02743494|588959071|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
163069311|NCT02743494|588959072|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
163069312|NCT02743494|588959071|FG000|Treatment Period|Disease recurrence|152|||
163069313|NCT02743494|588959072|FG001|Treatment Period|Disease recurrence|115|||
163069314|NCT02743494|588959071|FG000|Treatment Period|Study drug toxicity|56|||
163069315|NCT02743494|588959072|FG001|Treatment Period|Study drug toxicity|8|||
163069316|NCT02743494|588959071|FG000|Treatment Period|Death|1|||
163069317|NCT02743494|588959072|FG001|Treatment Period|Death|1|||
163069318|NCT02743494|588959071|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
163069319|NCT02743494|588959072|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
163069320|NCT02743494|588959071|FG000|Treatment Period|Participant request to discontinue treatment|31|||
163069321|NCT02743494|588959072|FG001|Treatment Period|Participant request to discontinue treatment|5|||
163069322|NCT02743494|588959071|FG000|Treatment Period|Participant withdrew consent|11|||
163069323|NCT02743494|588959072|FG001|Treatment Period|Participant withdrew consent|4|||
163069324|NCT02743494|588959071|FG000|Treatment Period|Lost to Follow-up|0|||
163069325|NCT02743494|588959072|FG001|Treatment Period|Lost to Follow-up|1|||
163069326|NCT02743494|588959071|FG000|Treatment Period|Poor/Non-compliance|2|||
163069327|NCT02743494|588959072|FG001|Treatment Period|Poor/Non-compliance|0|||
163069328|NCT02743494|588959071|FG000|Treatment Period|Other reasons|4|||
163069329|NCT02743494|588959072|FG001|Treatment Period|Other reasons|1|||
163069330|NCT02207608|588959073|FG000|Overall Study|Adverse Event|1|||
163069331|NCT02207608|588959074|FG001|Overall Study|Adverse Event|0|||
163069332|NCT02850406|588959081|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
163069333|NCT02850406|588959082|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
163069334|NCT02850406|588959083|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
163069335|NCT02850406|588959084|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
163069336|NCT02850406|588959085|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
163069337|NCT02850406|588959086|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
163069338|NCT02850406|588959087|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
163069339|NCT02850406|588959088|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
163069340|NCT02850406|588959081|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
163069341|NCT02850406|588959082|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
163069342|NCT02850406|588959083|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
163069343|NCT02850406|588959084|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
163069344|NCT02850406|588959085|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
163069345|NCT02850406|588959086|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
163069346|NCT02850406|588959087|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
163069347|NCT02850406|588959088|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
163069348|NCT02850406|588959081|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
163069349|NCT02850406|588959082|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
163069350|NCT02850406|588959083|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
163069351|NCT02850406|588959084|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
163069352|NCT02850406|588959085|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
163069353|NCT02850406|588959086|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
163069354|NCT02850406|588959087|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
163069355|NCT02850406|588959088|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
163069356|NCT02850406|588959081|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
163069357|NCT02850406|588959082|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
163069358|NCT02850406|588959083|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
163069359|NCT02850406|588959084|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
163069360|NCT02850406|588959085|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
163069361|NCT02850406|588959086|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
163069362|NCT02850406|588959087|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
163069363|NCT02850406|588959088|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
163069364|NCT02850406|588959081|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
163069365|NCT02850406|588959082|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
163069366|NCT02850406|588959083|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
163069367|NCT02850406|588959084|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
163069368|NCT02850406|588959085|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
163069369|NCT02850406|588959086|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
163331056|NCT00731692|589922489|FG000|Core Study (36 Months)|Physician Decision|1|||
163331057|NCT00731692|589922490|FG001|Core Study (36 Months)|Physician Decision|0|||
163331058|NCT00731692|589922491|FG002|Core Study (36 Months)|Physician Decision|2|||
163331059|NCT00731692|589922489|FG000|Core Study (36 Months)|Death|2|||
163331060|NCT00731692|589922490|FG001|Core Study (36 Months)|Death|1|||
163331061|NCT00731692|589922491|FG002|Core Study (36 Months)|Death|2|||
163331062|NCT00731692|589922489|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
163069370|NCT02850406|588959087|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
163069371|NCT02850406|588959088|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
163069372|NCT02850406|588959081|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
163331063|NCT00731692|589922490|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
163069373|NCT02850406|588959082|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069374|NCT02850406|588959083|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069375|NCT02850406|588959084|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069376|NCT02850406|588959085|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
163069377|NCT02850406|588959086|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
163069378|NCT02850406|588959087|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069379|NCT02850406|588959088|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069380|NCT02850406|588959081|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
163069381|NCT02850406|588959082|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
163069382|NCT02850406|588959083|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
163069383|NCT02850406|588959084|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
163069384|NCT02850406|588959085|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
163069385|NCT02850406|588959086|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
163069386|NCT02850406|588959087|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
163069387|NCT02850406|588959088|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
163069388|NCT02850406|588959081|FG000|Part C (Up to 52 Weeks)|Other|0|||
163331064|NCT00731692|589922491|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
163331065|NCT00731692|589922489|FG000|Core Study (36 Months)|Administrative|2|||
163331066|NCT00731692|589922490|FG001|Core Study (36 Months)|Administrative|2|||
163331067|NCT00731692|589922491|FG002|Core Study (36 Months)|Administrative|6|||
163331068|NCT00731692|589922489|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
163331069|NCT00731692|589922490|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
163331070|NCT00731692|589922491|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
163406367|NCT00950664|590196738|FG000|First Intervention|Lost to Follow-up|1|||
163406368|NCT00950664|590196739|FG001|First Intervention|Lost to Follow-up|3|||
163406369|NCT00950664|590196738|FG000|First Intervention|Withdrawal by Subject|2|||
163406370|NCT00950664|590196739|FG001|First Intervention|Withdrawal by Subject|2|||
163406371|NCT03152019|590196740|FG000|Overall Study|Adverse Event|0|||
163026936|NCT02653170|588801344|FG001|Overall Study|Lost to Follow-up|4|||
163026937|NCT02653170|588801345|FG002|Overall Study|Lost to Follow-up|10|||
163026938|NCT01473394|588801346|FG000|Overall Study|Adverse Event|13|||
163026939|NCT01473394|588801347|FG001|Overall Study|Adverse Event|16|||
163026940|NCT01473394|588801346|FG000|Overall Study|Insufficient Therapeutic Response|4|||
163026941|NCT01473394|588801347|FG001|Overall Study|Insufficient Therapeutic Response|1|||
163026942|NCT01473394|588801346|FG000|Overall Study|Protocol Violation|7|||
163026943|NCT01473394|588801347|FG001|Overall Study|Protocol Violation|5|||
163026944|NCT01473394|588801346|FG000|Overall Study|Withdrew Consent|12|||
163026945|NCT01473394|588801347|FG001|Overall Study|Withdrew Consent|10|||
163026946|NCT01473394|588801346|FG000|Overall Study|Lost to Follow-up|9|||
163026947|NCT01473394|588801347|FG001|Overall Study|Lost to Follow-up|11|||
163026948|NCT03391232|588801348|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
163026949|NCT03391232|588801349|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
163026950|NCT03391232|588801348|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
163026951|NCT03391232|588801349|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
163026952|NCT00761280|588801350|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
163026953|NCT00761280|588801351|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
163069389|NCT02850406|588959082|FG001|Part C (Up to 52 Weeks)|Other|0|||
163069390|NCT02850406|588959083|FG002|Part C (Up to 52 Weeks)|Other|0|||
163406372|NCT03152019|590196741|FG001|Overall Study|Adverse Event|1|||
163026954|NCT00761280|588801350|FG000|Randomization to First Dose|Sponsor decision|1|||
163026955|NCT00761280|588801351|FG001|Randomization to First Dose|Sponsor decision|0|||
163026956|NCT00761280|588801350|FG000|Randomization to First Dose|Other|1|||
163026957|NCT00761280|588801351|FG001|Randomization to First Dose|Other|0|||
163026958|NCT00761280|588801350|FG000|First Dose to End of Study|End of trial|5|||
163026959|NCT00761280|588801351|FG001|First Dose to End of Study|End of trial|5|||
163026960|NCT00761280|588801350|FG000|First Dose to End of Study|Progressive disease|5|||
163069391|NCT02850406|588959084|FG003|Part C (Up to 52 Weeks)|Other|0|||
163069392|NCT02850406|588959085|FG004|Part C (Up to 52 Weeks)|Other|1|||
163069393|NCT02850406|588959086|FG005|Part C (Up to 52 Weeks)|Other|3|||
163069394|NCT02850406|588959087|FG006|Part C (Up to 52 Weeks)|Other|0|||
163069395|NCT02850406|588959088|FG007|Part C (Up to 52 Weeks)|Other|0|||
163069396|NCT02850406|588959081|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
163069397|NCT02850406|588959082|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
163069398|NCT02850406|588959083|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
163069399|NCT02850406|588959084|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
163069400|NCT02850406|588959085|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
163069401|NCT02850406|588959086|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
163069402|NCT02850406|588959087|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
163069403|NCT02850406|588959088|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
163069404|NCT02850406|588959081|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069405|NCT02850406|588959082|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069406|NCT02850406|588959083|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069407|NCT02850406|588959084|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069408|NCT02850406|588959085|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069409|NCT02850406|588959086|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069410|NCT02850406|588959087|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069411|NCT02850406|588959088|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
163069412|NCT02850406|588959081|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
163069413|NCT02850406|588959082|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
163069414|NCT02850406|588959083|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
163069415|NCT02850406|588959084|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
163069416|NCT02850406|588959085|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
163069417|NCT02850406|588959086|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
163069418|NCT02850406|588959087|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
163069419|NCT02850406|588959088|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
163069420|NCT02850406|588959081|FG000|Part D (Up to 52 Weeks)|Other|0|||
163069421|NCT02850406|588959082|FG001|Part D (Up to 52 Weeks)|Other|0|||
163069422|NCT02850406|588959083|FG002|Part D (Up to 52 Weeks)|Other|0|||
163069423|NCT02850406|588959084|FG003|Part D (Up to 52 Weeks)|Other|0|||
163069424|NCT02850406|588959085|FG004|Part D (Up to 52 Weeks)|Other|0|||
163069425|NCT02850406|588959086|FG005|Part D (Up to 52 Weeks)|Other|0|||
163069426|NCT02850406|588959087|FG006|Part D (Up to 52 Weeks)|Other|0|||
163069427|NCT02850406|588959088|FG007|Part D (Up to 52 Weeks)|Other|1|||
163154763|NCT03113487|589281413|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
163154764|NCT03777982|589281414|FG000|Overall Study|Physician Decision|0|||
163154765|NCT03777982|589281415|FG001|Overall Study|Physician Decision|1|||
163154766|NCT01502293|589281416|FG000|Overall Study|Progressive Disease|20|||
163154767|NCT01502293|589281417|FG001|Overall Study|Progressive Disease|12|||
163154768|NCT01502293|589281418|FG002|Overall Study|Progressive Disease|2|||
163154769|NCT01502293|589281416|FG000|Overall Study|Withdrawal by Subject|3|||
163154770|NCT01502293|589281417|FG001|Overall Study|Withdrawal by Subject|3|||
163154771|NCT01502293|589281418|FG002|Overall Study|Withdrawal by Subject|1|||
163154772|NCT01502293|589281416|FG000|Overall Study|Adverse Event|0|||
163154773|NCT01502293|589281417|FG001|Overall Study|Adverse Event|2|||
163154774|NCT01502293|589281418|FG002|Overall Study|Adverse Event|0|||
163154775|NCT01502293|589281416|FG000|Overall Study|Reason Not Specified|2|||
163154776|NCT01502293|589281417|FG001|Overall Study|Reason Not Specified|0|||
163154777|NCT01502293|589281418|FG002|Overall Study|Reason Not Specified|0|||
163154778|NCT01502293|589281416|FG000|Overall Study|Physician Decision|0|||
163154779|NCT01502293|589281417|FG001|Overall Study|Physician Decision|0|||
163154780|NCT01502293|589281418|FG002|Overall Study|Physician Decision|1|||
163154781|NCT03944577|589281423|FG000|Overall Study|Adverse Event|3|||
163154782|NCT00391586|589281425|FG000|Overall Study|Progressive disease|13|||
163154783|NCT00391586|589281425|FG000|Overall Study|Adverse Event|5|||
163154784|NCT00391586|589281425|FG000|Overall Study|Physician Decision|2|||
163154785|NCT00391586|589281425|FG000|Overall Study|Death|4|||
163331071|NCT00731692|589922489|FG000|Core Study (36 Months)|Protocol Violation|4|||
163331072|NCT00731692|589922490|FG001|Core Study (36 Months)|Protocol Violation|5|||
163331073|NCT00731692|589922491|FG002|Core Study (36 Months)|Protocol Violation|8|||
163331074|NCT00731692|589922489|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
163331075|NCT00731692|589922490|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
163331076|NCT00731692|589922491|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
163331077|NCT00731692|589922489|FG000|Core Study (36 Months)|Adverse Event|25|||
163331078|NCT00731692|589922490|FG001|Core Study (36 Months)|Adverse Event|28|||
163154786|NCT00198822|589281426|FG000|Overall Study|Lost to Follow-up|14|||
163154787|NCT00198822|589281427|FG001|Overall Study|Lost to Follow-up|20|||
163154788|NCT00198822|589281428|FG002|Overall Study|Lost to Follow-up|21|||
163154789|NCT03011099|589281429|FG000|Overall Study|Withdrawal by Subject|0|||
163154790|NCT03011099|589281430|FG001|Overall Study|Withdrawal by Subject|2|||
163154791|NCT03058146|589281434|FG000|Overall Study|Withdrawal by Subject|4|||
163154792|NCT03058146|589281435|FG001|Overall Study|Withdrawal by Subject|1|||
163154793|NCT03058146|589281434|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
163154794|NCT03058146|589281435|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
163069428|NCT01653262|588960383|FG000|Overall Study|Lack of Efficacy|1|||
163069429|NCT01653262|588960383|FG000|Overall Study|SAE, non-fatal|1|||
163069430|NCT01653262|588960383|FG000|Overall Study|AE, non-serious non-fatal|1|||
163069431|NCT01112267|588960385|FG000|Overall Study|Adverse Event|24|||
163069432|NCT01112267|588960386|FG001|Overall Study|Adverse Event|6|||
163069433|NCT01112267|588960385|FG000|Overall Study|Withdrawal by Subject|3|||
163069434|NCT01112267|588960386|FG001|Overall Study|Withdrawal by Subject|5|||
163069435|NCT01112267|588960385|FG000|Overall Study|Protocol Violation|5|||
163069436|NCT01112267|588960386|FG001|Overall Study|Protocol Violation|3|||
163069437|NCT01112267|588960385|FG000|Overall Study|Participants not compliant|1|||
163069438|NCT01112267|588960386|FG001|Overall Study|Participants not compliant|2|||
163069439|NCT01112267|588960385|FG000|Overall Study|Participants not receive any study drug|1|||
163069440|NCT01112267|588960386|FG001|Overall Study|Participants not receive any study drug|2|||
163069441|NCT02014103|588960387|FG000|Overall Study|Protocol Violation|7|||
163069442|NCT02014103|588960388|FG001|Overall Study|Protocol Violation|7|||
163069443|NCT02014103|588960387|FG000|Overall Study|Adverse Event|1|||
163069444|NCT02014103|588960388|FG001|Overall Study|Adverse Event|0|||
163069445|NCT02014103|588960387|FG000|Overall Study|Lost venous access|1|||
163069446|NCT02014103|588960388|FG001|Overall Study|Lost venous access|0|||
163069447|NCT02014103|588960387|FG000|Overall Study|Withdrawal by Subject|0|||
163069448|NCT02014103|588960388|FG001|Overall Study|Withdrawal by Subject|2|||
163069449|NCT05638737|588960389|FG000|Overall Study|Withdrawal by Subject|4|||
163069450|NCT05638737|588960390|FG001|Overall Study|Withdrawal by Subject|7|||
163069451|NCT01373229|588960393|FG000|Overall Study|Death|3|||
163069452|NCT01373229|588960393|FG000|Overall Study|Physician Decision|3|||
163069453|NCT04439175|588960394|FG000|Overall Study|Never started treatment|4|||
163069454|NCT04439175|588960394|FG000|Overall Study|Ineligible|5|||
163069455|NCT04439175|588960394|FG000|Overall Study|Adverse Event|6|||
163069456|NCT04439175|588960394|FG000|Overall Study|Death|4|||
163069457|NCT04439175|588960394|FG000|Overall Study|Disease progression|44|||
163069458|NCT04439175|588960394|FG000|Overall Study|Withdrawal by Subject|4|||
163069459|NCT04439175|588960394|FG000|Overall Study|Alternative Therapy|1|||
163069460|NCT04439175|588960394|FG000|Overall Study|Other|2|||
163069461|NCT05417113|588960397|FG000|Overall Study|Lost to Follow-up|2|||
163069462|NCT05417113|588960398|FG001|Overall Study|Lost to Follow-up|2|||
163069463|NCT01847209|588960399|FG000|Overall Study|Withdrawal by Subject|1|||
163069464|NCT01847209|588960399|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
163069465|NCT00729586|588960400|FG000|Overall Study|Ineligible|0|||
163069466|NCT00729586|588960401|FG001|Overall Study|Ineligible|1|||
163069467|NCT00729586|588960400|FG000|Overall Study|never treated|1|||
163069468|NCT00729586|588960401|FG001|Overall Study|never treated|0|||
163069469|NCT02513199|588960404|FG000|Treatment|Death|1|||
163069470|NCT02513199|588960404|FG000|Treatment|Lost to Follow-up|1|||
163069471|NCT02513199|588960404|FG000|Follow-Up|Death|11|||
163069472|NCT04307394|588960410|FG000|Overall Study|Lost to Follow-up|3|||
163069473|NCT04307394|588960410|FG000|Overall Study|Withdrawal by Subject|2|||
163069474|NCT00530075|588960411|FG000|Overall Study|Adverse Event|1|||
163069475|NCT00530075|588960411|FG000|Overall Study|Death|1|||
163069476|NCT00530075|588960411|FG000|Overall Study|Lack of Efficacy|3|||
163069477|NCT00530075|588960411|FG000|Overall Study|Protocol Violation|1|||
163069478|NCT00530075|588960411|FG000|Overall Study|Withdrawal by Subject|1|||
163069479|NCT01166945|588960412|FG000|Randomized|diagnosed with Group A strep|4|||
163069480|NCT01166945|588960413|FG001|Randomized|diagnosed with Group A strep|4|||
163217902|NCT00271609|589513854|FG001|Overall Study|Withdrawal by Subject|0|||
163217903|NCT03341533|589513855|FG000|Overall Study|Withdrawal by Subject|1|||
163217904|NCT03341533|589513856|FG001|Overall Study|Withdrawal by Subject|1|||
163217905|NCT03341533|589513855|FG000|Overall Study|Not eligible after randomization|2|||
163217906|NCT03341533|589513856|FG001|Overall Study|Not eligible after randomization|1|||
163217907|NCT00643682|589513857|FG000|Overall Study|did not keep appointment|522|||
163217908|NCT00643682|589513858|FG001|Overall Study|did not keep appointment|509|||
163217909|NCT01782664|589513860|FG000|Overall Study|Adverse Event|2|||
163217910|NCT01782664|589513861|FG001|Overall Study|Adverse Event|2|||
163217911|NCT01782664|589513862|FG002|Overall Study|Adverse Event|2|||
163217912|NCT01782664|589513863|FG003|Overall Study|Adverse Event|2|||
163331079|NCT00731692|589922491|FG002|Core Study (36 Months)|Adverse Event|29|||
163217913|NCT01782664|589513864|FG004|Overall Study|Adverse Event|0|||
163069481|NCT01166945|588960412|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
163069482|NCT01166945|588960413|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
163069483|NCT01166945|588960412|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
163069484|NCT01166945|588960413|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
163069485|NCT01166945|588960412|FG000|Day 30|Lost to Follow-up|4|||
163069486|NCT01166945|588960413|FG001|Day 30|Lost to Follow-up|3|||
163069487|NCT02453048|588960416|FG000|Overall Study|Only part of initial 6 mo. study|0|||
163069488|NCT02453048|588960417|FG001|Overall Study|Only part of initial 6 mo. study|0|||
163069489|NCT02453048|588960418|FG002|Overall Study|Only part of initial 6 mo. study|0|||
163069490|NCT02453048|588960419|FG003|Overall Study|Only part of initial 6 mo. study|0|||
163069491|NCT02453048|588960420|FG004|Overall Study|Only part of initial 6 mo. study|6|||
163069492|NCT02453048|588960416|FG000|Overall Study|Lost to Follow-up|0|||
163069493|NCT02453048|588960417|FG001|Overall Study|Lost to Follow-up|1|||
163069494|NCT02453048|588960418|FG002|Overall Study|Lost to Follow-up|2|||
163069495|NCT02453048|588960419|FG003|Overall Study|Lost to Follow-up|0|||
163069496|NCT02453048|588960420|FG004|Overall Study|Lost to Follow-up|0|||
163069497|NCT00447278|588960424|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
163069498|NCT00447278|588960425|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
163069499|NCT00447278|588960424|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
163069500|NCT00447278|588960425|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
163069501|NCT00447278|588960424|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
163069502|NCT00447278|588960425|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
163069503|NCT00447278|588960424|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
163069504|NCT00447278|588960425|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
163069505|NCT00447278|588960424|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
163069506|NCT00447278|588960425|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
163069507|NCT00447278|588960424|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
163069508|NCT00447278|588960425|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
163069509|NCT00447278|588960424|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
163069510|NCT00447278|588960425|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
163069511|NCT00447278|588960424|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
163331080|NCT00731692|589922489|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
163331081|NCT00731692|589922490|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
163331082|NCT00731692|589922491|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
163026961|NCT00761280|588801351|FG001|First Dose to End of Study|Progressive disease|3|||
163026962|NCT00761280|588801350|FG000|First Dose to End of Study|Sponsor decision|1|||
163026963|NCT00761280|588801351|FG001|First Dose to End of Study|Sponsor decision|2|||
163026964|NCT00761280|588801350|FG000|First Dose to End of Study|Death|1|||
163026965|NCT00761280|588801351|FG001|First Dose to End of Study|Death|0|||
163026966|NCT00761280|588801350|FG000|First Dose to End of Study|Lost to Follow-up|0|||
163026967|NCT00761280|588801351|FG001|First Dose to End of Study|Lost to Follow-up|1|||
163026968|NCT03875482|588801352|FG000|Overall Study|Adverse Event|0|||
163026969|NCT03875482|588801353|FG001|Overall Study|Adverse Event|1|||
163026970|NCT03875482|588801352|FG000|Overall Study|Withdrew consent|5|||
163026971|NCT03875482|588801353|FG001|Overall Study|Withdrew consent|6|||
163026972|NCT03875482|588801352|FG000|Overall Study|Lost to Follow-up|8|||
163026973|NCT03875482|588801353|FG001|Overall Study|Lost to Follow-up|2|||
163026974|NCT03875482|588801352|FG000|Overall Study|Lack of Efficacy|0|||
163026975|NCT03875482|588801353|FG001|Overall Study|Lack of Efficacy|11|||
163026976|NCT04777201|588801354|FG000|Main Study|Withdrawal by Subject|19|||
163026977|NCT04777201|588801355|FG001|Main Study|Withdrawal by Subject|27|||
163026978|NCT04777201|588801356|FG002|Main Study|Withdrawal by Subject|0|||
163026979|NCT04777201|588801354|FG000|Main Study|Death|13|||
163026980|NCT04777201|588801355|FG001|Main Study|Death|27|||
163026981|NCT04777201|588801356|FG002|Main Study|Death|0|||
163026982|NCT04777201|588801354|FG000|Main Study|Subject missed the safety follow-up visit|9|||
163026983|NCT04777201|588801355|FG001|Main Study|Subject missed the safety follow-up visit|10|||
163026984|NCT04777201|588801356|FG002|Main Study|Subject missed the safety follow-up visit|0|||
163026985|NCT04777201|588801354|FG000|Main Study|Physician Decision|8|||
163026986|NCT04777201|588801355|FG001|Main Study|Physician Decision|10|||
163026987|NCT04777201|588801356|FG002|Main Study|Physician Decision|0|||
163026988|NCT04777201|588801354|FG000|Main Study|Adverse Event|8|||
163026989|NCT04777201|588801355|FG001|Main Study|Adverse Event|8|||
163026990|NCT04777201|588801356|FG002|Main Study|Adverse Event|0|||
163026991|NCT04777201|588801354|FG000|Main Study|Lost to Follow-up|9|||
163026992|NCT04777201|588801355|FG001|Main Study|Lost to Follow-up|4|||
163026993|NCT04777201|588801356|FG002|Main Study|Lost to Follow-up|0|||
163026994|NCT04777201|588801354|FG000|Main Study|Reason not specified|3|||
163026995|NCT04777201|588801355|FG001|Main Study|Reason not specified|3|||
163026996|NCT04777201|588801356|FG002|Main Study|Reason not specified|0|||
163026997|NCT04777201|588801354|FG000|Main Study|Lack of Efficacy|1|||
163026998|NCT04777201|588801355|FG001|Main Study|Lack of Efficacy|1|||
163026999|NCT04777201|588801356|FG002|Main Study|Lack of Efficacy|0|||
163027000|NCT04777201|588801354|FG000|Main Study|Protocol Violation|1|||
163027001|NCT04777201|588801355|FG001|Main Study|Protocol Violation|0|||
163027002|NCT04777201|588801356|FG002|Main Study|Protocol Violation|0|||
163027003|NCT04777201|588801354|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
163027004|NCT04777201|588801355|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
163027005|NCT04777201|588801356|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
163027006|NCT04777201|588801354|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
163027007|NCT04777201|588801355|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
163027008|NCT04777201|588801356|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
163027009|NCT04777201|588801354|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
163027010|NCT04777201|588801355|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
163027011|NCT04777201|588801356|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
163154795|NCT03041181|589281436|FG000|Overall Study|Disease Progression|1|||
163069512|NCT00447278|588960425|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
163069513|NCT00447278|588960424|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
163069514|NCT00447278|588960425|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
163069515|NCT00447278|588960424|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
163069516|NCT00447278|588960425|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
163069517|NCT00447278|588960424|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
163069518|NCT00447278|588960425|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
163069519|NCT00447278|588960424|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
163069520|NCT00447278|588960425|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
163069521|NCT00447278|588960424|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
163069522|NCT00447278|588960425|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
163069523|NCT00447278|588960424|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
163069524|NCT00447278|588960425|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
163069525|NCT03677401|588960426|FG000|Overall Study|Adverse Event|4|||
163069526|NCT03677401|588960427|FG001|Overall Study|Adverse Event|14|||
163069527|NCT03677401|588960426|FG000|Overall Study|Lack of Efficacy|3|||
163069528|NCT03677401|588960427|FG001|Overall Study|Lack of Efficacy|1|||
163069529|NCT03677401|588960426|FG000|Overall Study|Withdrawal by Subject|2|||
163069530|NCT03677401|588960427|FG001|Overall Study|Withdrawal by Subject|2|||
163069531|NCT03677401|588960426|FG000|Overall Study|Sponsor decision|0|||
163069532|NCT03677401|588960427|FG001|Overall Study|Sponsor decision|1|||
163069533|NCT03677401|588960426|FG000|Overall Study|Reason Unspecified|1|||
163069534|NCT03677401|588960427|FG001|Overall Study|Reason Unspecified|0|||
163069535|NCT00726557|588960428|FG000|Overall Study|Screening failure|4|||
163069536|NCT00726557|588960428|FG000|Overall Study|No end of treatment documentation|37|||
163069537|NCT00726557|588960428|FG000|Overall Study|No follow-up documentation available|55|||
163027012|NCT04777201|588801354|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
163027013|NCT04777201|588801355|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
163027014|NCT04777201|588801356|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
163027015|NCT04777201|588801354|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
163027016|NCT04777201|588801355|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
163027017|NCT04777201|588801356|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
163027018|NCT04777201|588801354|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
163027019|NCT04777201|588801355|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
163027020|NCT04777201|588801356|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
163027021|NCT00507819|588801359|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
163027022|NCT00507819|588801360|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
163027023|NCT02691013|588801363|FG000|Overall Study|Withdrawal by Subject|3|||
163027024|NCT02691013|588801364|FG001|Overall Study|Withdrawal by Subject|0|||
163027025|NCT02111785|588801367|FG000|Overall Study|Death|0|||
163027026|NCT02111785|588801368|FG001|Overall Study|Death|1|||
163027027|NCT02111785|588801369|FG002|Overall Study|Death|0|||
163027028|NCT02111785|588801370|FG003|Overall Study|Death|0|||
163027029|NCT02256982|588801372|FG000|Overall Study|Disease Progression|0|||
163027030|NCT02256982|588801373|FG001|Overall Study|Disease Progression|1|||
163027031|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Adverse Event|6|||
163027032|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Adverse Event|14|||
163027033|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Death|3|||
163027034|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Death|1|||
163027035|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
163027036|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
163027037|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
163027038|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
163027039|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
163027040|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
163027041|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
163027042|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
163027043|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
163027044|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
163027045|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Physician Decision|2|||
163027046|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Physician Decision|4|||
163069538|NCT00726557|588960428|FG000|Overall Study|Treatment less than 3 months|17|||
163069539|NCT00726557|588960428|FG000|Overall Study|Inclusion criteria not met|15|||
163027047|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Pregnancy|2|||
163027048|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Pregnancy|1|||
163027049|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
163027050|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
163027051|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
163027052|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
163027053|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
163069540|NCT06262607|588960431|FG000|Overall Study|Physician Decision|0|||
163069541|NCT06262607|588960432|FG001|Overall Study|Physician Decision|1|||
163069542|NCT06262607|588960431|FG000|Overall Study|Withdrawal by Subject|2|||
163217914|NCT01782664|589513865|FG005|Overall Study|Adverse Event|0|||
163217915|NCT01782664|589513860|FG000|Overall Study|Lack of Efficacy|2|||
163217916|NCT01782664|589513861|FG001|Overall Study|Lack of Efficacy|0|||
163217917|NCT01782664|589513862|FG002|Overall Study|Lack of Efficacy|2|||
163217918|NCT01782664|589513863|FG003|Overall Study|Lack of Efficacy|2|||
163069543|NCT06262607|588960432|FG001|Overall Study|Withdrawal by Subject|0|||
163069544|NCT00574951|588960433|FG000|Overall Study|Ineligible - improper prior treatment|1|||
163069545|NCT05161936|588960434|FG000|Overall Study|Study terminated by Sponsor|1|||
163069546|NCT05161936|588960435|FG001|Overall Study|Study terminated by Sponsor|0|||
163069547|NCT05161936|588960436|FG002|Overall Study|Study terminated by Sponsor|0|||
163069548|NCT05161936|588960434|FG000|Overall Study|Withdrawal by Subject|0|||
163069549|NCT05161936|588960435|FG001|Overall Study|Withdrawal by Subject|0|||
163069550|NCT05161936|588960436|FG002|Overall Study|Withdrawal by Subject|1|||
163069551|NCT04925934|588960442|FG000|Overall Study|Adverse Event|1|||
163069552|NCT04925934|588960443|FG001|Overall Study|Adverse Event|0|||
163069553|NCT04925934|588960444|FG002|Overall Study|Adverse Event|0|||
163069554|NCT04925934|588960442|FG000|Overall Study|Lost to Follow-up|2|||
163069555|NCT04925934|588960443|FG001|Overall Study|Lost to Follow-up|0|||
163069556|NCT04925934|588960444|FG002|Overall Study|Lost to Follow-up|1|||
163069557|NCT04925934|588960442|FG000|Overall Study|Death|0|||
163069558|NCT04925934|588960443|FG001|Overall Study|Death|1|||
163069559|NCT04925934|588960444|FG002|Overall Study|Death|0|||
163069560|NCT04925934|588960442|FG000|Overall Study|Withdrawal by Subject|8|||
163069561|NCT04925934|588960443|FG001|Overall Study|Withdrawal by Subject|5|||
163069562|NCT04925934|588960444|FG002|Overall Study|Withdrawal by Subject|9|||
163069563|NCT04925934|588960442|FG000|Overall Study|Other|2|||
163069564|NCT04925934|588960443|FG001|Overall Study|Other|2|||
163069565|NCT04925934|588960444|FG002|Overall Study|Other|2|||
163069566|NCT04925934|588960442|FG000|Overall Study|Eastern European Conflict|7|||
163069567|NCT04925934|588960443|FG001|Overall Study|Eastern European Conflict|3|||
163069568|NCT04925934|588960444|FG002|Overall Study|Eastern European Conflict|2|||
163069569|NCT04425018|588960446|FG000|Overall Study|Withdrawal by Subject|1|||
163069570|NCT04425018|588960447|FG001|Overall Study|Withdrawal by Subject|2|||
163069571|NCT02503865|588960448|FG000|Overall Study|Moved out of area|1|||
163069572|NCT02503865|588960449|FG001|Overall Study|Moved out of area|8|||
163069573|NCT02503865|588960450|FG002|Overall Study|Moved out of area|0|||
163069574|NCT02503865|588960448|FG000|Overall Study|Refused treatment|4|||
163069575|NCT02503865|588960449|FG001|Overall Study|Refused treatment|39|||
163069576|NCT02503865|588960450|FG002|Overall Study|Refused treatment|2|||
163069577|NCT01327703|588960451|FG000|Second Treatment Period|Adverse Event|1|||
163069578|NCT01327703|588960452|FG001|Second Treatment Period|Adverse Event|1|||
163069579|NCT01327703|588960451|FG000|Second Treatment Period|Protocol Violation|0|||
163069580|NCT01327703|588960452|FG001|Second Treatment Period|Protocol Violation|1|||
163069581|NCT00849472|588960459|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
163069582|NCT00849472|588960459|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
163069583|NCT00849472|588960459|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
163069584|NCT00849472|588960459|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
163069585|NCT00849472|588960459|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
163069586|NCT00849472|588960459|FG000|Weekly Paclitaxel|Disease Progression|1|||
163069587|NCT00849472|588960459|FG000|Weekly Paclitaxel|Adverse Event|11|||
163069588|NCT00849472|588960459|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
163069589|NCT00849472|588960459|FG000|Weekly Paclitaxel|Physician Decision|3|||
163069590|NCT00849472|588960459|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
163069591|NCT00849472|588960459|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
163069592|NCT00849472|588960459|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
163069593|NCT00849472|588960459|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
163069594|NCT00849472|588960459|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
163069595|NCT00849472|588960459|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
163069596|NCT00849472|588960459|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
163069597|NCT00849472|588960459|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
163217919|NCT01782664|589513864|FG004|Overall Study|Lack of Efficacy|0|||
163217920|NCT01782664|589513865|FG005|Overall Study|Lack of Efficacy|0|||
163217921|NCT01782664|589513860|FG000|Overall Study|Protocol Violation|0|||
163217922|NCT01782664|589513861|FG001|Overall Study|Protocol Violation|1|||
163069598|NCT05128942|588960460|FG000|Overall Study|Withdrawal by Subject|1|||
163069599|NCT05128942|588960461|FG001|Overall Study|Withdrawal by Subject|0|||
163069600|NCT05128942|588960462|FG002|Overall Study|Withdrawal by Subject|1|||
163069601|NCT05128942|588960463|FG003|Overall Study|Withdrawal by Subject|0|||
163069602|NCT05128942|588960464|FG004|Overall Study|Withdrawal by Subject|0|||
163069603|NCT05128942|588960465|FG005|Overall Study|Withdrawal by Subject|0|||
163069604|NCT05128942|588960466|FG006|Overall Study|Withdrawal by Subject|0|||
163069605|NCT05128942|588960467|FG007|Overall Study|Withdrawal by Subject|0|||
163069606|NCT05128942|588960468|FG008|Overall Study|Withdrawal by Subject|0|||
163069607|NCT05128942|588960460|FG000|Overall Study|Other|2|||
163069608|NCT05128942|588960461|FG001|Overall Study|Other|0|||
163069609|NCT05128942|588960462|FG002|Overall Study|Other|2|||
163069610|NCT05128942|588960463|FG003|Overall Study|Other|0|||
163069611|NCT05128942|588960464|FG004|Overall Study|Other|0|||
163069612|NCT05128942|588960465|FG005|Overall Study|Other|0|||
163069613|NCT05128942|588960466|FG006|Overall Study|Other|0|||
163069614|NCT05128942|588960467|FG007|Overall Study|Other|0|||
163069615|NCT05128942|588960468|FG008|Overall Study|Other|0|||
163069616|NCT05128942|588960460|FG000|Overall Study|Termination by Sponsor|2|||
163069617|NCT05128942|588960461|FG001|Overall Study|Termination by Sponsor|6|||
163069618|NCT05128942|588960462|FG002|Overall Study|Termination by Sponsor|14|||
163069619|NCT05128942|588960463|FG003|Overall Study|Termination by Sponsor|2|||
163069620|NCT05128942|588960464|FG004|Overall Study|Termination by Sponsor|4|||
163069621|NCT05128942|588960465|FG005|Overall Study|Termination by Sponsor|8|||
163069622|NCT05128942|588960466|FG006|Overall Study|Termination by Sponsor|11|||
163069623|NCT05128942|588960467|FG007|Overall Study|Termination by Sponsor|6|||
163069624|NCT05128942|588960468|FG008|Overall Study|Termination by Sponsor|0|||
163069625|NCT05128942|588960460|FG000|Overall Study|Adverse Event|0|||
163069626|NCT05128942|588960461|FG001|Overall Study|Adverse Event|0|||
163069627|NCT05128942|588960462|FG002|Overall Study|Adverse Event|0|||
163069628|NCT05128942|588960463|FG003|Overall Study|Adverse Event|0|||
163069629|NCT05128942|588960464|FG004|Overall Study|Adverse Event|0|||
163069630|NCT05128942|588960465|FG005|Overall Study|Adverse Event|0|||
163069631|NCT05128942|588960466|FG006|Overall Study|Adverse Event|1|||
163069632|NCT05128942|588960467|FG007|Overall Study|Adverse Event|1|||
163069633|NCT05128942|588960468|FG008|Overall Study|Adverse Event|0|||
163069634|NCT05128942|588960460|FG000|Overall Study|Lost to Follow-up|0|||
163069635|NCT05128942|588960461|FG001|Overall Study|Lost to Follow-up|0|||
163069636|NCT05128942|588960462|FG002|Overall Study|Lost to Follow-up|0|||
163069637|NCT05128942|588960463|FG003|Overall Study|Lost to Follow-up|0|||
163069638|NCT05128942|588960464|FG004|Overall Study|Lost to Follow-up|1|||
163069639|NCT05128942|588960465|FG005|Overall Study|Lost to Follow-up|0|||
163069640|NCT05128942|588960466|FG006|Overall Study|Lost to Follow-up|0|||
163069641|NCT05128942|588960467|FG007|Overall Study|Lost to Follow-up|0|||
163069642|NCT05128942|588960468|FG008|Overall Study|Lost to Follow-up|0|||
163069643|NCT05942040|588960469|FG000|Overall Study|No longer employed at study site.|0|||
163069644|NCT05942040|588960470|FG001|Overall Study|No longer employed at study site.|0|||
163069645|NCT05942040|588960471|FG002|Overall Study|No longer employed at study site.|3|||
163069646|NCT03442569|588960472|FG000|Overall Study|Subject was ineligible after enrollment|1|||
163069647|NCT06461455|588960473|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
163069648|NCT06461455|588960474|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
163069649|NCT06461455|588960473|FG000|First Wear Period (Approx 30 Days)|Screen failure|1|||
163069650|NCT06461455|588960474|FG001|First Wear Period (Approx 30 Days)|Screen failure|0|||
163069651|NCT06461455|588960473|FG000|Washout Period (Approx 2-4 Days)|Adverse Event|0|||
163069652|NCT06461455|588960474|FG001|Washout Period (Approx 2-4 Days)|Adverse Event|1|||
163069653|NCT06142383|588960475|FG000|Overall Study|Mis-randomized|0|||
163069654|NCT06142383|588960476|FG001|Overall Study|Mis-randomized|0|||
163069655|NCT06142383|588960477|FG002|Overall Study|Mis-randomized|1|||
163069656|NCT06142383|588960478|FG003|Overall Study|Mis-randomized|0|||
163069657|NCT06142383|588960479|FG004|Overall Study|Mis-randomized|0|||
163069658|NCT06142383|588960475|FG000|Overall Study|Adverse Event|0|||
163069659|NCT06142383|588960476|FG001|Overall Study|Adverse Event|1|||
163069660|NCT06142383|588960477|FG002|Overall Study|Adverse Event|1|||
163069661|NCT06142383|588960478|FG003|Overall Study|Adverse Event|0|||
163331083|NCT00731692|589922489|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
163331084|NCT00731692|589922490|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
163069662|NCT06142383|588960479|FG004|Overall Study|Adverse Event|0|||
163069663|NCT06142383|588960475|FG000|Overall Study|Death|0|||
163069664|NCT06142383|588960476|FG001|Overall Study|Death|1|||
163069665|NCT06142383|588960477|FG002|Overall Study|Death|3|||
163069666|NCT06142383|588960478|FG003|Overall Study|Death|0|||
163069667|NCT06142383|588960479|FG004|Overall Study|Death|1|||
163069668|NCT06142383|588960475|FG000|Overall Study|Study Terminated by Sponsor|20|||
163331085|NCT00731692|589922491|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
163069669|NCT06142383|588960476|FG001|Overall Study|Study Terminated by Sponsor|17|||
163069670|NCT06142383|588960477|FG002|Overall Study|Study Terminated by Sponsor|33|||
163069671|NCT06142383|588960478|FG003|Overall Study|Study Terminated by Sponsor|0|||
163069672|NCT06142383|588960479|FG004|Overall Study|Study Terminated by Sponsor|21|||
163069673|NCT06142383|588960475|FG000|Overall Study|Subject Decision|0|||
163069674|NCT06142383|588960476|FG001|Overall Study|Subject Decision|1|||
163069675|NCT06142383|588960477|FG002|Overall Study|Subject Decision|2|||
163069676|NCT06142383|588960478|FG003|Overall Study|Subject Decision|0|||
163069677|NCT06142383|588960479|FG004|Overall Study|Subject Decision|0|||
163069678|NCT03010501|588960482|FG000|Study Week 1|Withdrawal by Subject|2|||
163069679|NCT03010501|588960483|FG001|Study Week 1|Withdrawal by Subject|1|||
163069680|NCT03010501|588960484|FG002|Study Week 1|Withdrawal by Subject|0|||
163069681|NCT03010501|588960485|FG003|Study Week 1|Withdrawal by Subject|2|||
163069682|NCT03010501|588960486|FG004|Study Week 1|Withdrawal by Subject|0|||
163069683|NCT03010501|588960487|FG005|Study Week 1|Withdrawal by Subject|0|||
163069684|NCT03010501|588960482|FG000|Study Week 3|Withdrawal by Subject|0|||
163069685|NCT03010501|588960483|FG001|Study Week 3|Withdrawal by Subject|0|||
163069686|NCT03010501|588960484|FG002|Study Week 3|Withdrawal by Subject|0|||
163069687|NCT03010501|588960485|FG003|Study Week 3|Withdrawal by Subject|1|||
163069688|NCT03010501|588960486|FG004|Study Week 3|Withdrawal by Subject|0|||
163069689|NCT03010501|588960487|FG005|Study Week 3|Withdrawal by Subject|0|||
163069690|NCT02347787|588960490|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
163069691|NCT02347787|588960491|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
163069692|NCT02347787|588960490|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
163069693|NCT02347787|588960491|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
163069694|NCT02347787|588960490|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
163069695|NCT02347787|588960491|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
163069696|NCT02347787|588960490|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
163069697|NCT02347787|588960491|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
163069698|NCT00544882|588960495|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
163069699|NCT00544882|588960496|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
163069700|NCT00544882|588960497|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
163069701|NCT00544882|588960495|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
163069702|NCT00544882|588960496|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
163069703|NCT00544882|588960497|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
163069704|NCT00544882|588960495|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
163069705|NCT00544882|588960496|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
163069706|NCT00544882|588960497|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
163069707|NCT00544882|588960495|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
163069708|NCT00544882|588960496|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
163069709|NCT00544882|588960497|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
163069710|NCT00544882|588960495|FG000|Cycle 3: Follow-up|Noncompliance|0|||
163069711|NCT00544882|588960496|FG001|Cycle 3: Follow-up|Noncompliance|1|||
163069712|NCT00544882|588960497|FG002|Cycle 3: Follow-up|Noncompliance|0|||
163069713|NCT00544882|588960495|FG000|Cycle 3: Follow-up|Pregnancy|0|||
163069714|NCT00544882|588960496|FG001|Cycle 3: Follow-up|Pregnancy|1|||
163069715|NCT00544882|588960497|FG002|Cycle 3: Follow-up|Pregnancy|0|||
163069716|NCT00308685|588960498|FG000|Overall Study|Lost to Follow-up|1|||
163069717|NCT00308685|588960499|FG001|Overall Study|Lost to Follow-up|0|||
163069718|NCT00308685|588960498|FG000|Overall Study|Need to administer prohibited medication|1|||
163069719|NCT00308685|588960499|FG001|Overall Study|Need to administer prohibited medication|2|||
163069720|NCT00308685|588960498|FG000|Overall Study|Other than specified|1|||
163069721|NCT00308685|588960499|FG001|Overall Study|Other than specified|3|||
163069722|NCT01121575|588960500|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
163069723|NCT01121575|588960501|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
163069724|NCT01121575|588960502|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
163069725|NCT01121575|588960503|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
163069726|NCT01121575|588960504|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
163069727|NCT01121575|588960505|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
163069728|NCT01121575|588960500|FG000|Overall Study|Unspecified Reasons|8|||
163069729|NCT01121575|588960501|FG001|Overall Study|Unspecified Reasons|6|||
163069730|NCT01121575|588960502|FG002|Overall Study|Unspecified Reasons|7|||
163069731|NCT01121575|588960503|FG003|Overall Study|Unspecified Reasons|5|||
163069732|NCT01121575|588960504|FG004|Overall Study|Unspecified Reasons|13|||
163069733|NCT01121575|588960505|FG005|Overall Study|Unspecified Reasons|10|||
163069734|NCT01121575|588960500|FG000|Overall Study|Death|6|||
163069735|NCT01121575|588960501|FG001|Overall Study|Death|0|||
163069736|NCT01121575|588960502|FG002|Overall Study|Death|0|||
163069737|NCT01121575|588960503|FG003|Overall Study|Death|1|||
163069738|NCT01121575|588960504|FG004|Overall Study|Death|7|||
163069739|NCT01121575|588960505|FG005|Overall Study|Death|1|||
163069740|NCT02583269|588960506|FG000|Overall Study|Patient hospitalized prior to start|1|||
163069741|NCT02583269|588960507|FG001|Overall Study|Patient hospitalized prior to start|0|||
163069742|NCT02583269|588960508|FG002|Overall Study|Patient hospitalized prior to start|0|||
163217923|NCT01782664|589513862|FG002|Overall Study|Protocol Violation|0|||
163217924|NCT01782664|589513863|FG003|Overall Study|Protocol Violation|1|||
163217925|NCT01782664|589513864|FG004|Overall Study|Protocol Violation|0|||
163217926|NCT01782664|589513865|FG005|Overall Study|Protocol Violation|0|||
163069743|NCT02583269|588960509|FG003|Overall Study|Patient hospitalized prior to start|0|||
163069744|NCT02583269|588960510|FG004|Overall Study|Patient hospitalized prior to start|0|||
163069745|NCT03244189|588960512|FG000|Overall Study|Death|0|||
163069746|NCT03244189|588960513|FG001|Overall Study|Death|2|||
163069747|NCT03244189|588960512|FG000|Overall Study|Lost to Follow-up|92|||
163069748|NCT03244189|588960513|FG001|Overall Study|Lost to Follow-up|107|||
163069749|NCT03244189|588960512|FG000|Overall Study|Physician Decision|4|||
163069750|NCT03244189|588960513|FG001|Overall Study|Physician Decision|2|||
163069751|NCT03244189|588960512|FG000|Overall Study|Pregnancy|7|||
163069752|NCT03244189|588960513|FG001|Overall Study|Pregnancy|5|||
163069753|NCT03244189|588960512|FG000|Overall Study|Protocol Violation|0|||
163069754|NCT03244189|588960513|FG001|Overall Study|Protocol Violation|2|||
163069755|NCT03244189|588960512|FG000|Overall Study|Withdrawal by Subject|45|||
163069756|NCT03244189|588960513|FG001|Overall Study|Withdrawal by Subject|23|||
163069757|NCT03244189|588960512|FG000|Overall Study|Technical Problems|2|||
163069758|NCT03244189|588960513|FG001|Overall Study|Technical Problems|0|||
163069759|NCT03860584|588960521|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
163069760|NCT03860584|588960522|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
163069761|NCT03860584|588960521|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
163069762|NCT03860584|588960522|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
163069763|NCT03860584|588960521|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
163069764|NCT03860584|588960522|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
163069765|NCT03860584|588960521|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
163069766|NCT03860584|588960522|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
163069767|NCT05800145|588960523|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
163069768|NCT05800145|588960524|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
163069769|NCT05800145|588960525|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
163069770|NCT05800145|588960526|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
163069771|NCT05800145|588960527|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
163069772|NCT05800145|588960528|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
163069773|NCT05800145|588960523|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
163069774|NCT05800145|588960524|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
163069775|NCT05800145|588960525|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
163069776|NCT05800145|588960526|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
163069777|NCT05800145|588960527|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
163069778|NCT05800145|588960528|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
163069779|NCT05800145|588960523|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
163069780|NCT05800145|588960524|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
163069781|NCT05800145|588960525|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
163069782|NCT05800145|588960526|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
163069783|NCT05800145|588960527|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
163069784|NCT05800145|588960528|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
163069785|NCT04167670|588962268|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
163069786|NCT04167670|588962269|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
163069787|NCT04167670|588962270|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
163069788|NCT04167670|588962268|FG000|Overall Study|Significant protocol deviation|3|||
163069789|NCT04167670|588962269|FG001|Overall Study|Significant protocol deviation|1|||
163069790|NCT04167670|588962270|FG002|Overall Study|Significant protocol deviation|0|||
163069791|NCT04167670|588962268|FG000|Overall Study|Lost to Follow-up|0|||
163069792|NCT04167670|588962269|FG001|Overall Study|Lost to Follow-up|3|||
163069793|NCT04167670|588962270|FG002|Overall Study|Lost to Follow-up|3|||
163069794|NCT04167670|588962268|FG000|Overall Study|Voluntary Withdrawal|0|||
163069795|NCT04167670|588962269|FG001|Overall Study|Voluntary Withdrawal|1|||
163069796|NCT04167670|588962270|FG002|Overall Study|Voluntary Withdrawal|1|||
163069797|NCT04167670|588962268|FG000|Overall Study|Withdrawal of Consent|4|||
163069798|NCT04167670|588962269|FG001|Overall Study|Withdrawal of Consent|1|||
163069799|NCT04167670|588962270|FG002|Overall Study|Withdrawal of Consent|3|||
163069800|NCT04167670|588962268|FG000|Overall Study|Miscellaneous|7|||
163069801|NCT04167670|588962269|FG001|Overall Study|Miscellaneous|5|||
163069802|NCT04167670|588962270|FG002|Overall Study|Miscellaneous|3|||
163069803|NCT04827446|588962271|FG000|Overall Study|Lost to Follow-up|1|||
163069804|NCT04827446|588962272|FG001|Overall Study|Lost to Follow-up|1|||
163069805|NCT04827446|588962271|FG000|Overall Study|Death|2|||
163069806|NCT04827446|588962272|FG001|Overall Study|Death|0|||
163069807|NCT04827446|588962271|FG000|Overall Study|Withdrawal by Subject|2|||
163069808|NCT04827446|588962272|FG001|Overall Study|Withdrawal by Subject|2|||
163069809|NCT05399485|588962273|FG000|DBT Phase|Other|6|||
163069810|NCT05399485|588962274|FG001|DBT Phase|Other|5|||
163069811|NCT05399485|588962273|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
163069812|NCT05399485|588962274|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
163069813|NCT05399485|588962273|FG000|DBT Phase|Withdrawal by Subject|3|||
163069814|NCT05399485|588962274|FG001|DBT Phase|Withdrawal by Subject|2|||
163069815|NCT05399485|588962273|FG000|DBT Phase|Protocol Violation|2|||
163069816|NCT05399485|588962274|FG001|DBT Phase|Protocol Violation|1|||
163069817|NCT05399485|588962273|FG000|DBT Phase|Physician Decision|0|||
163069818|NCT05399485|588962274|FG001|DBT Phase|Physician Decision|1|||
163406373|NCT04703075|590196742|FG000|Overall Study|Adverse Event|11|||
163069819|NCT05399485|588962273|FG000|DBT Phase|Adverse Event|2|||
163069820|NCT05399485|588962274|FG001|DBT Phase|Adverse Event|1|||
163069821|NCT05399485|588962273|FG000|OLE Phase|Protocol deviation|1|||
163069822|NCT05399485|588962274|FG001|OLE Phase|Protocol deviation|0|||
163069823|NCT05399485|588962273|FG000|OLE Phase|Other|5|||
163069824|NCT05399485|588962274|FG001|OLE Phase|Other|5|||
163069825|NCT05399485|588962273|FG000|OLE Phase|Withdrawal by Subject|12|||
163069826|NCT05399485|588962274|FG001|OLE Phase|Withdrawal by Subject|7|||
163069827|NCT05399485|588962273|FG000|OLE Phase|Pregnancy|0|||
163069828|NCT05399485|588962274|FG001|OLE Phase|Pregnancy|2|||
163069829|NCT05399485|588962273|FG000|OLE Phase|Physician Decision|3|||
163069830|NCT05399485|588962274|FG001|OLE Phase|Physician Decision|0|||
163069831|NCT05399485|588962273|FG000|OLE Phase|Adverse Event|2|||
163069832|NCT05399485|588962274|FG001|OLE Phase|Adverse Event|2|||
163069833|NCT03554473|588962277|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
163069834|NCT03554473|588962278|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
163069835|NCT03554473|588962279|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
163069836|NCT03554473|588962277|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
163069837|NCT03554473|588962278|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
163069838|NCT03554473|588962279|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
163069839|NCT03554473|588962277|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
163069840|NCT03554473|588962278|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
163069841|NCT03554473|588962279|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
163069842|NCT01363076|588962280|FG000|Overall Study|Withdrawal by Subject|0|||
163069843|NCT01363076|588962281|FG001|Overall Study|Withdrawal by Subject|1|||
163069844|NCT04706403|588962282|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
163069845|NCT04706403|588962283|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
163069846|NCT04706403|588962284|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
163069847|NCT04706403|588962285|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
163069848|NCT04706403|588962286|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
163069849|NCT02642679|588962287|FG000|Overall Study|Withdrawal by Subject|1|||
163069850|NCT02642679|588962287|FG000|Overall Study|Physician Decision|1|||
163069851|NCT02642679|588962287|FG000|Overall Study|Physician Decision|1|||
163069852|NCT05206604|588962288|FG000|Overall Study|Non-compliance with study drug|0|||
163069853|NCT05206604|588962289|FG001|Overall Study|Non-compliance with study drug|0|||
163069854|NCT05206604|588962290|FG002|Overall Study|Non-compliance with study drug|0|||
163069855|NCT05206604|588962291|FG003|Overall Study|Non-compliance with study drug|0|||
163069856|NCT05206604|588962292|FG004|Overall Study|Non-compliance with study drug|0|||
163069857|NCT05206604|588962293|FG005|Overall Study|Non-compliance with study drug|1|||
163069858|NCT05206604|588962294|FG006|Overall Study|Non-compliance with study drug|0|||
163069859|NCT05206604|588962295|FG007|Overall Study|Non-compliance with study drug|0|||
163069860|NCT03735498|588962296|FG000|Overall Study|Withdrawal by Subject|3|||
163069861|NCT03735498|588962296|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
163069862|NCT00160615|588962297|FG000|Overall Study|Adverse Event|5|||
163069863|NCT00160615|588962298|FG001|Overall Study|Adverse Event|12|||
163069864|NCT00160615|588962297|FG000|Overall Study|Withdrawal by Subject|0|||
163069865|NCT00160615|588962298|FG001|Overall Study|Withdrawal by Subject|2|||
163069866|NCT00160615|588962297|FG000|Overall Study|Lack of Efficacy|11|||
163069867|NCT00160615|588962298|FG001|Overall Study|Lack of Efficacy|23|||
163069868|NCT00160615|588962297|FG000|Overall Study|Patient decision|1|||
163069869|NCT00160615|588962298|FG001|Overall Study|Patient decision|2|||
163069870|NCT00160615|588962297|FG000|Overall Study|Investigator decision|1|||
163069871|NCT00160615|588962298|FG001|Overall Study|Investigator decision|1|||
163069872|NCT00160615|588962297|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
163069873|NCT00160615|588962298|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
163069874|NCT00160615|588962297|FG000|Overall Study|Switch to surgical treatment|0|||
163069875|NCT00160615|588962298|FG001|Overall Study|Switch to surgical treatment|2|||
163069876|NCT00160615|588962297|FG000|Overall Study|Non-compliance was suspected|0|||
163069877|NCT00160615|588962298|FG001|Overall Study|Non-compliance was suspected|1|||
163069878|NCT00160615|588962297|FG000|Overall Study|Poor compliance|0|||
163069879|NCT00160615|588962298|FG001|Overall Study|Poor compliance|1|||
163069880|NCT03928704|588962303|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
163069881|NCT03928704|588962304|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
163069882|NCT03928704|588962305|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
163069883|NCT03928704|588962306|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
163069884|NCT03928704|588962307|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
163069885|NCT03928704|588962308|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
163069886|NCT03928704|588962303|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
163069887|NCT03928704|588962304|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
163217927|NCT01782664|589513860|FG000|Overall Study|Withdrawal by Subject|2|||
163069888|NCT03928704|588962305|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
163217928|NCT01782664|589513861|FG001|Overall Study|Withdrawal by Subject|2|||
163217929|NCT01782664|589513862|FG002|Overall Study|Withdrawal by Subject|0|||
163217930|NCT01782664|589513863|FG003|Overall Study|Withdrawal by Subject|0|||
163069889|NCT03928704|588962306|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
163069890|NCT03928704|588962307|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
163069891|NCT03928704|588962308|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
163069892|NCT03928704|588962303|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
163069893|NCT03928704|588962304|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
163069894|NCT03928704|588962305|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
163069895|NCT03928704|588962306|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
163069896|NCT03928704|588962307|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
163069897|NCT03928704|588962308|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
163069898|NCT03928704|588962303|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
163069899|NCT03928704|588962304|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
163069900|NCT03928704|588962305|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
163069901|NCT03928704|588962306|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
163069902|NCT03928704|588962307|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
163069903|NCT03928704|588962308|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
163069904|NCT03928704|588962303|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
163069905|NCT03928704|588962304|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
163069906|NCT03928704|588962305|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
163069907|NCT03928704|588962306|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
163069908|NCT03928704|588962307|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
163069909|NCT03928704|588962308|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
163069910|NCT03928704|588962303|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
163069911|NCT03928704|588962304|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
163069912|NCT03928704|588962305|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
163069913|NCT03928704|588962306|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
163069914|NCT03928704|588962307|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
163069915|NCT03928704|588962308|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
163069916|NCT03928704|588962303|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
163069917|NCT03928704|588962304|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
163069918|NCT03928704|588962305|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
163069919|NCT03928704|588962306|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
163069920|NCT03928704|588962307|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
163069921|NCT03928704|588962308|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
163069922|NCT03928704|588962303|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
163069923|NCT03928704|588962304|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
163069924|NCT03928704|588962305|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
163069925|NCT03928704|588962306|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
163069926|NCT03928704|588962307|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
163069927|NCT03928704|588962308|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
163069928|NCT03928704|588962303|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
163069929|NCT03928704|588962304|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
163069930|NCT03928704|588962305|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
163069931|NCT03928704|588962306|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
163069932|NCT03928704|588962307|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
163069933|NCT03928704|588962308|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
163069934|NCT03928704|588962303|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
163069935|NCT03928704|588962304|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
163069936|NCT03928704|588962305|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
163069937|NCT03928704|588962306|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
163069938|NCT03928704|588962307|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
163069939|NCT03928704|588962308|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
163069940|NCT01631188|588962309|FG000|Overall Study|Physician Decision|75|||
163069941|NCT04575324|588962313|FG000|Overall Study|Lost to Follow-up|29|||
163069942|NCT04575324|588962314|FG001|Overall Study|Lost to Follow-up|25|||
163069943|NCT04575324|588962313|FG000|Overall Study|Death|1|||
163069944|NCT04575324|588962314|FG001|Overall Study|Death|2|||
163069945|NCT04575324|588962313|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
163069946|NCT04575324|588962314|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
163069947|NCT01105130|588962315|FG000|Overall Study|Withdrawal by Subject|4|||
163069948|NCT01105130|588962316|FG001|Overall Study|Withdrawal by Subject|6|||
163217931|NCT01782664|589513864|FG004|Overall Study|Withdrawal by Subject|0|||
163217932|NCT01782664|589513865|FG005|Overall Study|Withdrawal by Subject|0|||
163217933|NCT04170348|589513866|FG000|Overall Study|Lost to Follow-up|2|||
163217934|NCT04170348|589513867|FG001|Overall Study|Lost to Follow-up|2|||
163069949|NCT01105130|588962317|FG002|Overall Study|Withdrawal by Subject|2|||
163069950|NCT01105130|588962315|FG000|Overall Study|Never Started|2|||
163069951|NCT01105130|588962316|FG001|Overall Study|Never Started|2|||
163069952|NCT01105130|588962317|FG002|Overall Study|Never Started|4|||
163069953|NCT01105130|588962315|FG000|Overall Study|Toxicity|1|||
163069954|NCT01105130|588962316|FG001|Overall Study|Toxicity|3|||
163069955|NCT01105130|588962317|FG002|Overall Study|Toxicity|2|||
163069956|NCT01105130|588962315|FG000|Overall Study|Multiple Reasons|3|||
163069957|NCT01105130|588962316|FG001|Overall Study|Multiple Reasons|0|||
163069958|NCT01105130|588962317|FG002|Overall Study|Multiple Reasons|2|||
163069959|NCT02582632|588962319|FG000|Overall Study|Other|1|||
163069960|NCT00266812|588962322|FG000|Overall Study|Disease Progression|9|||
163069961|NCT00266812|588962323|FG001|Overall Study|Disease Progression|3|||
163069962|NCT00266812|588962322|FG000|Overall Study|Death|5|||
163069963|NCT00266812|588962323|FG001|Overall Study|Death|4|||
163069964|NCT00266812|588962322|FG000|Overall Study|Adverse Event|3|||
163069965|NCT00266812|588962323|FG001|Overall Study|Adverse Event|1|||
163069966|NCT00266812|588962322|FG000|Overall Study|Protocol Violation|0|||
163069967|NCT00266812|588962323|FG001|Overall Study|Protocol Violation|1|||
163069968|NCT00266812|588962322|FG000|Overall Study|Withdrawal by Subject|0|||
163069969|NCT00266812|588962323|FG001|Overall Study|Withdrawal by Subject|2|||
163069970|NCT00266812|588962322|FG000|Overall Study|Discontinued before starting study drug|4|||
163069971|NCT00266812|588962323|FG001|Overall Study|Discontinued before starting study drug|0|||
163069972|NCT02323334|588962324|FG000|Period 3|Lost to Follow-up|0|||
163069973|NCT02323334|588962325|FG001|Period 3|Lost to Follow-up|0|||
163069974|NCT02323334|588962326|FG002|Period 3|Lost to Follow-up|1|||
163069975|NCT02323334|588962327|FG003|Period 3|Lost to Follow-up|0|||
163069976|NCT02323334|588962328|FG004|Period 3|Lost to Follow-up|0|||
163069977|NCT02323334|588962329|FG005|Period 3|Lost to Follow-up|0|||
163069978|NCT02323334|588962330|FG006|Period 3|Lost to Follow-up|0|||
163069979|NCT02323334|588962331|FG007|Period 3|Lost to Follow-up|0|||
163069980|NCT02323334|588962332|FG008|Period 3|Lost to Follow-up|0|||
163069981|NCT02323334|588962333|FG009|Period 3|Lost to Follow-up|0|||
163069982|NCT02323334|588962334|FG010|Period 3|Lost to Follow-up|0|||
163069983|NCT02323334|588962335|FG011|Period 3|Lost to Follow-up|0|||
163069984|NCT02323334|588962336|FG012|Period 3|Lost to Follow-up|0|||
163069985|NCT02323334|588962337|FG013|Period 3|Lost to Follow-up|0|||
163069986|NCT02323334|588962338|FG014|Period 3|Lost to Follow-up|0|||
163069987|NCT02323334|588962339|FG015|Period 3|Lost to Follow-up|0|||
163069988|NCT02323334|588962340|FG016|Period 3|Lost to Follow-up|0|||
163069989|NCT02323334|588962324|FG000|Period 3|Withdrawal by Subject|1|||
163069990|NCT02323334|588962325|FG001|Period 3|Withdrawal by Subject|0|||
163069991|NCT02323334|588962326|FG002|Period 3|Withdrawal by Subject|0|||
163069992|NCT02323334|588962327|FG003|Period 3|Withdrawal by Subject|0|||
163069993|NCT02323334|588962328|FG004|Period 3|Withdrawal by Subject|0|||
163069994|NCT02323334|588962329|FG005|Period 3|Withdrawal by Subject|0|||
163069995|NCT02323334|588962330|FG006|Period 3|Withdrawal by Subject|0|||
163069996|NCT02323334|588962331|FG007|Period 3|Withdrawal by Subject|0|||
163069997|NCT02323334|588962332|FG008|Period 3|Withdrawal by Subject|0|||
163069998|NCT02323334|588962333|FG009|Period 3|Withdrawal by Subject|0|||
163069999|NCT02323334|588962334|FG010|Period 3|Withdrawal by Subject|0|||
163070000|NCT02323334|588962335|FG011|Period 3|Withdrawal by Subject|0|||
163070001|NCT02323334|588962336|FG012|Period 3|Withdrawal by Subject|0|||
163070002|NCT02323334|588962337|FG013|Period 3|Withdrawal by Subject|0|||
163070003|NCT02323334|588962338|FG014|Period 3|Withdrawal by Subject|0|||
163070004|NCT02323334|588962339|FG015|Period 3|Withdrawal by Subject|0|||
163070005|NCT02323334|588962340|FG016|Period 3|Withdrawal by Subject|0|||
163070006|NCT01617967|588962342|FG000|Overall Study|Protocol Violation|0|||
163070007|NCT01617967|588962343|FG001|Overall Study|Protocol Violation|0|||
163070008|NCT01617967|588962344|FG002|Overall Study|Protocol Violation|0|||
163070009|NCT01617967|588962345|FG003|Overall Study|Protocol Violation|1|||
163070010|NCT01617967|588962346|FG004|Overall Study|Protocol Violation|0|||
163070011|NCT01617967|588962347|FG005|Overall Study|Protocol Violation|0|||
163070012|NCT01617967|588962342|FG000|Overall Study|Withdrawal by Subject|0|||
163070013|NCT01617967|588962343|FG001|Overall Study|Withdrawal by Subject|0|||
163070014|NCT01617967|588962344|FG002|Overall Study|Withdrawal by Subject|0|||
163070015|NCT01617967|588962345|FG003|Overall Study|Withdrawal by Subject|0|||
163070016|NCT01617967|588962346|FG004|Overall Study|Withdrawal by Subject|0|||
163070017|NCT01617967|588962347|FG005|Overall Study|Withdrawal by Subject|1|||
163070018|NCT01617967|588962342|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
163070019|NCT01617967|588962343|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
163070020|NCT01617967|588962344|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
163070021|NCT01617967|588962345|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
163070022|NCT01617967|588962346|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
163070023|NCT01617967|588962347|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
163070024|NCT00416949|588962350|FG000|Overall Study|Patients refused to participate|5|||
163070025|NCT03520569|588962353|FG000|Overall Study|Withdrawal by Subject|1|||
163070026|NCT01178411|588962354|FG000|Overall Study|Adverse Event|5|||
163070027|NCT01178411|588962354|FG000|Overall Study|Withdrawal by Subject|4|||
163070028|NCT01178411|588962354|FG000|Overall Study|Protocol Violation|1|||
163070029|NCT01178411|588962354|FG000|Overall Study|Progressive disease per RECIST|32|||
163070030|NCT01178411|588962354|FG000|Overall Study|Progressive disease per clinician|9|||
163070031|NCT01178411|588962354|FG000|Overall Study|Physician Decision|6|||
163070032|NCT01178411|588962354|FG000|Overall Study|Death|1|||
163070033|NCT01178411|588962354|FG000|Overall Study|No reason provided|1|||
163070034|NCT01178411|588962354|FG000|Overall Study|Drug manufacturing ended|1|||
163070035|NCT00784927|588962355|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
163070036|NCT00784927|588962355|FG000|Overall Study|Protocol Violation|1|||
163070037|NCT00784927|588962355|FG000|Overall Study|Ineligible|1|||
163070038|NCT01137812|588962358|FG000|Overall Study|Adverse Event|21|||
163070039|NCT01137812|588962359|FG001|Overall Study|Adverse Event|14|||
163070040|NCT01137812|588962358|FG000|Overall Study|Lost to Follow-up|6|||
163070041|NCT01137812|588962359|FG001|Overall Study|Lost to Follow-up|8|||
163070042|NCT01137812|588962358|FG000|Overall Study|Physician Decision|25|||
163070043|NCT01137812|588962359|FG001|Overall Study|Physician Decision|17|||
163070044|NCT01137812|588962358|FG000|Overall Study|Protocol Violation|5|||
163070045|NCT01137812|588962359|FG001|Overall Study|Protocol Violation|4|||
163070046|NCT01137812|588962358|FG000|Overall Study|Withdrawal by Subject|5|||
163070047|NCT01137812|588962359|FG001|Overall Study|Withdrawal by Subject|13|||
163070048|NCT01137812|588962358|FG000|Overall Study|Death|2|||
163070049|NCT01137812|588962359|FG001|Overall Study|Death|0|||
163070050|NCT01137812|588962358|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
163070051|NCT01137812|588962359|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
163070052|NCT01137812|588962358|FG000|Overall Study|Other|19|||
163070053|NCT01137812|588962359|FG001|Overall Study|Other|27|||
163070054|NCT02265744|588962362|FG000|Overall Study|Poor/Non-compliance|1|||
163070055|NCT02265744|588962363|FG001|Overall Study|Poor/Non-compliance|1|||
163070056|NCT02265744|588962364|FG002|Overall Study|Poor/Non-compliance|0|||
163070057|NCT02265744|588962365|FG003|Overall Study|Poor/Non-compliance|0|||
163070058|NCT02265744|588962366|FG004|Overall Study|Poor/Non-compliance|2|||
163070059|NCT02265744|588962362|FG000|Overall Study|Lost to Follow-up|0|||
163070060|NCT02265744|588962363|FG001|Overall Study|Lost to Follow-up|0|||
163070061|NCT02265744|588962364|FG002|Overall Study|Lost to Follow-up|0|||
163070062|NCT02265744|588962365|FG003|Overall Study|Lost to Follow-up|1|||
163070063|NCT02265744|588962366|FG004|Overall Study|Lost to Follow-up|0|||
163070064|NCT02265744|588962362|FG000|Overall Study|Death|0|||
163070065|NCT02265744|588962363|FG001|Overall Study|Death|0|||
163070066|NCT02265744|588962364|FG002|Overall Study|Death|0|||
163070067|NCT02265744|588962365|FG003|Overall Study|Death|2|||
163070068|NCT02265744|588962366|FG004|Overall Study|Death|0|||
163070069|NCT02265744|588962362|FG000|Overall Study|Withdrawal by Subject|2|||
163070070|NCT02265744|588962363|FG001|Overall Study|Withdrawal by Subject|0|||
163070071|NCT02265744|588962364|FG002|Overall Study|Withdrawal by Subject|0|||
163070072|NCT02265744|588962365|FG003|Overall Study|Withdrawal by Subject|2|||
163070073|NCT02265744|588962366|FG004|Overall Study|Withdrawal by Subject|0|||
163070074|NCT02265744|588962362|FG000|Overall Study|Participant request to discontinue|2|||
163070075|NCT02265744|588962363|FG001|Overall Study|Participant request to discontinue|2|||
163070076|NCT02265744|588962364|FG002|Overall Study|Participant request to discontinue|2|||
163070077|NCT02265744|588962365|FG003|Overall Study|Participant request to discontinue|0|||
163070078|NCT02265744|588962366|FG004|Overall Study|Participant request to discontinue|0|||
163070079|NCT02265744|588962362|FG000|Overall Study|Adverse Event|8|||
163070080|NCT02265744|588962363|FG001|Overall Study|Adverse Event|4|||
163070081|NCT02265744|588962364|FG002|Overall Study|Adverse Event|9|||
163070082|NCT02265744|588962365|FG003|Overall Study|Adverse Event|8|||
163070083|NCT02265744|588962366|FG004|Overall Study|Adverse Event|2|||
163070084|NCT02265744|588962362|FG000|Overall Study|Lack of Efficacy|2|||
163070085|NCT02265744|588962363|FG001|Overall Study|Lack of Efficacy|4|||
163070086|NCT02265744|588962364|FG002|Overall Study|Lack of Efficacy|3|||
163070087|NCT02265744|588962365|FG003|Overall Study|Lack of Efficacy|4|||
163070088|NCT02265744|588962366|FG004|Overall Study|Lack of Efficacy|5|||
163070089|NCT02265744|588962362|FG000|Overall Study|Reason not provided by Investigator|1|||
163070090|NCT02265744|588962363|FG001|Overall Study|Reason not provided by Investigator|0|||
163070091|NCT02265744|588962364|FG002|Overall Study|Reason not provided by Investigator|0|||
163070092|NCT02265744|588962365|FG003|Overall Study|Reason not provided by Investigator|2|||
163070093|NCT02265744|588962366|FG004|Overall Study|Reason not provided by Investigator|0|||
163331086|NCT00731692|589922489|FG000|Extension Phase|Abnormal test procedure|0|||
163070094|NCT02265744|588962362|FG000|Overall Study|Administrative reason by sponsor|3|||
163070095|NCT02265744|588962363|FG001|Overall Study|Administrative reason by sponsor|2|||
163070096|NCT02265744|588962364|FG002|Overall Study|Administrative reason by sponsor|2|||
163070097|NCT02265744|588962365|FG003|Overall Study|Administrative reason by sponsor|3|||
163070098|NCT02265744|588962366|FG004|Overall Study|Administrative reason by sponsor|3|||
163070099|NCT02265744|588962362|FG000|Overall Study|Subject no longer meets study criteria|0|||
163070100|NCT02265744|588962363|FG001|Overall Study|Subject no longer meets study criteria|0|||
163070101|NCT02265744|588962364|FG002|Overall Study|Subject no longer meets study criteria|0|||
163070102|NCT02265744|588962365|FG003|Overall Study|Subject no longer meets study criteria|0|||
163070103|NCT02265744|588962366|FG004|Overall Study|Subject no longer meets study criteria|1|||
163070104|NCT02265744|588962362|FG000|Overall Study|Pregnancy|1|||
163070105|NCT02265744|588962363|FG001|Overall Study|Pregnancy|2|||
163070106|NCT02265744|588962364|FG002|Overall Study|Pregnancy|1|||
163070107|NCT02265744|588962365|FG003|Overall Study|Pregnancy|1|||
163070108|NCT02265744|588962366|FG004|Overall Study|Pregnancy|0|||
163070109|NCT00923702|588962367|FG000|Overall Study|Ongoing enrollment|0|||
163070110|NCT00923702|588962368|FG001|Overall Study|Ongoing enrollment|0|||
163070111|NCT00923702|588962369|FG002|Overall Study|Ongoing enrollment|0|||
163070112|NCT00923702|588962370|FG003|Overall Study|Ongoing enrollment|0|||
163070113|NCT00923702|588962371|FG004|Overall Study|Ongoing enrollment|354|||
163070114|NCT05950906|588962375|FG000|Overall Study|Adverse Event|0|||
163070115|NCT05950906|588962376|FG001|Overall Study|Adverse Event|0|||
163070116|NCT05950906|588962377|FG002|Overall Study|Adverse Event|0|||
163070117|NCT05950906|588962378|FG003|Overall Study|Adverse Event|0|||
163070118|NCT05950906|588962379|FG004|Overall Study|Adverse Event|0|||
163070119|NCT05950906|588962380|FG005|Overall Study|Adverse Event|0|||
163070120|NCT05950906|588962381|FG006|Overall Study|Adverse Event|0|||
163070121|NCT05950906|588962382|FG007|Overall Study|Adverse Event|0|||
163070122|NCT05950906|588962383|FG008|Overall Study|Adverse Event|0|||
163070123|NCT05950906|588962384|FG009|Overall Study|Adverse Event|0|||
163070124|NCT05950906|588962385|FG010|Overall Study|Adverse Event|0|||
163070125|NCT05950906|588962386|FG011|Overall Study|Adverse Event|0|||
163070126|NCT05950906|588962387|FG012|Overall Study|Adverse Event|1|||
163070127|NCT05950906|588962388|FG013|Overall Study|Adverse Event|0|||
163070128|NCT05950906|588962375|FG000|Overall Study|Physician Decision|0|||
163070129|NCT05950906|588962376|FG001|Overall Study|Physician Decision|0|||
163070130|NCT05950906|588962377|FG002|Overall Study|Physician Decision|0|||
163070131|NCT05950906|588962378|FG003|Overall Study|Physician Decision|0|||
163070132|NCT05950906|588962379|FG004|Overall Study|Physician Decision|0|||
163070133|NCT05950906|588962380|FG005|Overall Study|Physician Decision|0|||
163070134|NCT05950906|588962381|FG006|Overall Study|Physician Decision|0|||
163070135|NCT05950906|588962382|FG007|Overall Study|Physician Decision|0|||
163070136|NCT05950906|588962383|FG008|Overall Study|Physician Decision|0|||
163070137|NCT05950906|588962384|FG009|Overall Study|Physician Decision|0|||
163070138|NCT05950906|588962385|FG010|Overall Study|Physician Decision|0|||
163070139|NCT05950906|588962386|FG011|Overall Study|Physician Decision|0|||
163070140|NCT05950906|588962387|FG012|Overall Study|Physician Decision|1|||
163070141|NCT05950906|588962388|FG013|Overall Study|Physician Decision|0|||
163070142|NCT02448043|588962389|FG000|Overall Study|Withdrawal by Subject|2|||
163070143|NCT02448043|588962390|FG001|Overall Study|Withdrawal by Subject|2|||
163070144|NCT02448043|588962389|FG000|Overall Study|Protocol Violation|1|||
163070145|NCT02448043|588962390|FG001|Overall Study|Protocol Violation|2|||
163070146|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
163070147|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
163070148|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
163070149|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
163070150|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
163070151|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
163070152|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
163070153|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
163070154|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
163070155|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
163070156|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
163070157|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
163070158|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
163070159|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
163070160|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
163070161|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
163070162|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
163070163|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
163070164|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
163070165|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
163070166|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
163070167|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
163217935|NCT04170348|589513866|FG000|Overall Study|Withdrawal by Subject|1|||
163217936|NCT04170348|589513867|FG001|Overall Study|Withdrawal by Subject|5|||
163217937|NCT04170348|589513866|FG000|Overall Study|Non-adherence|1|||
163217938|NCT04170348|589513867|FG001|Overall Study|Non-adherence|1|||
163217939|NCT04170348|589513866|FG000|Overall Study|Adverse Event|1|||
163217940|NCT04170348|589513867|FG001|Overall Study|Adverse Event|0|||
163217941|NCT03642717|589513869|FG000|Overall Study|Lost to Follow-up|2|||
163217942|NCT03642717|589513869|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
163070168|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
163070169|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
163217943|NCT03642717|589513869|FG000|Overall Study|Taken study drug prior to contract date|3|||
163217944|NCT02587065|589513870|FG000|Overall Study|Adverse Event|14|||
163070170|NCT02337946|588962399|FG000|In-between Period|Without Informed Consent|1|||
163070171|NCT02337946|588962400|FG001|In-between Period|Without Informed Consent|0|||
163070172|NCT02337946|588962401|FG002|In-between Period|Without Informed Consent|0|||
163070173|NCT02337946|588962399|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
163070174|NCT02337946|588962400|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
163070175|NCT02337946|588962401|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
163070176|NCT02337946|588962399|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
163070177|NCT02337946|588962400|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
163070178|NCT02337946|588962401|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
163070179|NCT02337946|588962399|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
163070180|NCT02337946|588962400|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
163070181|NCT02337946|588962401|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
163070182|NCT02337946|588962399|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
163070183|NCT02337946|588962400|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
163070184|NCT02337946|588962401|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
163070185|NCT02337946|588962399|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
163070186|NCT02337946|588962400|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
163070187|NCT02337946|588962401|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
163070188|NCT02337946|588962399|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
163070189|NCT02337946|588962400|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
163070190|NCT02337946|588962401|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
163070191|NCT01131585|588962402|FG000|Overall Study|Adverse Event|0|||
163070192|NCT01131585|588962403|FG001|Overall Study|Adverse Event|2|||
163070193|NCT01131585|588962402|FG000|Overall Study|Abnormal laboratory value|1|||
163070194|NCT01131585|588962403|FG001|Overall Study|Abnormal laboratory value|0|||
163070195|NCT01131585|588962402|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163070196|NCT01131585|588962403|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
163070197|NCT01131585|588962402|FG000|Overall Study|Protocol Violation|2|||
163070198|NCT01131585|588962403|FG001|Overall Study|Protocol Violation|1|||
163070199|NCT01131585|588962402|FG000|Overall Study|Withdrawal by Subject|3|||
163070200|NCT01131585|588962403|FG001|Overall Study|Withdrawal by Subject|3|||
163070201|NCT01131585|588962402|FG000|Overall Study|Lost to Follow-up|0|||
163070202|NCT01131585|588962403|FG001|Overall Study|Lost to Follow-up|1|||
163070203|NCT01131585|588962402|FG000|Overall Study|Administrative problems|1|||
163070204|NCT01131585|588962403|FG001|Overall Study|Administrative problems|1|||
163070205|NCT01131585|588962402|FG000|Overall Study|Study termination|78|||
163070206|NCT01131585|588962403|FG001|Overall Study|Study termination|32|||
163070207|NCT02949934|588962404|FG000|Natural Drinking Period|Adverse Event|1|||
163070208|NCT02949934|588962405|FG001|Natural Drinking Period|Adverse Event|0|||
163070209|NCT02949934|588962406|FG002|Natural Drinking Period|Adverse Event|0|||
163070210|NCT02949934|588962407|FG003|Natural Drinking Period|Adverse Event|1|||
163070211|NCT02949934|588962408|FG004|Natural Drinking Period|Adverse Event|0|||
163070212|NCT02949934|588962409|FG005|Natural Drinking Period|Adverse Event|0|||
163070213|NCT02949934|588962404|FG000|Natural Drinking Period|Lost to Follow-up|0|||
163070214|NCT02949934|588962405|FG001|Natural Drinking Period|Lost to Follow-up|0|||
163070215|NCT02949934|588962406|FG002|Natural Drinking Period|Lost to Follow-up|0|||
163070216|NCT02949934|588962407|FG003|Natural Drinking Period|Lost to Follow-up|0|||
163070217|NCT02949934|588962408|FG004|Natural Drinking Period|Lost to Follow-up|1|||
163070218|NCT02949934|588962409|FG005|Natural Drinking Period|Lost to Follow-up|0|||
163070219|NCT02949934|588962404|FG000|Neuroimaging|Protocol Violation|2|||
163070220|NCT02949934|588962405|FG001|Neuroimaging|Protocol Violation|0|||
163070221|NCT02949934|588962406|FG002|Neuroimaging|Protocol Violation|0|||
163070222|NCT02949934|588962407|FG003|Neuroimaging|Protocol Violation|0|||
163070223|NCT02949934|588962408|FG004|Neuroimaging|Protocol Violation|1|||
163070224|NCT02949934|588962409|FG005|Neuroimaging|Protocol Violation|0|||
163070225|NCT02949934|588962404|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
163070226|NCT02949934|588962405|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
163070227|NCT02949934|588962406|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
163070228|NCT02949934|588962407|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
163070229|NCT02949934|588962408|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
163070230|NCT02949934|588962409|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
163070231|NCT02949934|588962404|FG000|Neuroimaging|Not scanned|0|||
163070232|NCT02949934|588962405|FG001|Neuroimaging|Not scanned|0|||
163070233|NCT02949934|588962406|FG002|Neuroimaging|Not scanned|1|||
163070234|NCT02949934|588962407|FG003|Neuroimaging|Not scanned|0|||
163070235|NCT02949934|588962408|FG004|Neuroimaging|Not scanned|0|||
163406374|NCT04703075|590196743|FG001|Overall Study|Adverse Event|7|||
163406375|NCT04703075|590196742|FG000|Overall Study|Lost to Follow-up|6|||
163406376|NCT04703075|590196743|FG001|Overall Study|Lost to Follow-up|12|||
163406377|NCT04703075|590196742|FG000|Overall Study|Physician Decision|3|||
163406378|NCT04703075|590196743|FG001|Overall Study|Physician Decision|0|||
163070236|NCT02949934|588962409|FG005|Neuroimaging|Not scanned|2|||
163070237|NCT02949934|588962404|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
163070238|NCT02949934|588962405|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
163070239|NCT02949934|588962406|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
163070240|NCT02949934|588962407|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
163406379|NCT04703075|590196742|FG000|Overall Study|Moved|0|||
163406380|NCT04703075|590196743|FG001|Overall Study|Moved|2|||
163406381|NCT04703075|590196742|FG000|Overall Study|Index INH Resistant|0|||
163406382|NCT04703075|590196743|FG001|Overall Study|Index INH Resistant|1|||
163070241|NCT02949934|588962408|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
163070242|NCT02949934|588962409|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
163070243|NCT02949934|588962404|FG000|Bar Laboratory|Adverse Event|1|||
163070244|NCT02949934|588962405|FG001|Bar Laboratory|Adverse Event|0|||
163070245|NCT02949934|588962406|FG002|Bar Laboratory|Adverse Event|2|||
163070246|NCT02949934|588962407|FG003|Bar Laboratory|Adverse Event|0|||
163070247|NCT02949934|588962408|FG004|Bar Laboratory|Adverse Event|1|||
163070248|NCT02949934|588962409|FG005|Bar Laboratory|Adverse Event|0|||
163070249|NCT02949934|588962404|FG000|Bar Laboratory|Protocol Violation|0|||
163070250|NCT02949934|588962405|FG001|Bar Laboratory|Protocol Violation|0|||
163070251|NCT02949934|588962406|FG002|Bar Laboratory|Protocol Violation|0|||
163070252|NCT02949934|588962407|FG003|Bar Laboratory|Protocol Violation|1|||
163070253|NCT02949934|588962408|FG004|Bar Laboratory|Protocol Violation|0|||
163070254|NCT02949934|588962409|FG005|Bar Laboratory|Protocol Violation|0|||
163070255|NCT04530526|588962413|FG000|Overall Study|Withdrawal by Subject|6|||
163070256|NCT03770455|588962414|FG000|Overall Study|Screen failures|3|||
163070257|NCT03971422|588963686|FG000|Overall Study|Lost to Follow-up|0|||
163070258|NCT03971422|588963687|FG001|Overall Study|Lost to Follow-up|1|||
163070259|NCT03971422|588963688|FG002|Overall Study|Lost to Follow-up|0|||
163070260|NCT03971422|588963686|FG000|Overall Study|Lack of Efficacy|5|||
163070261|NCT03971422|588963687|FG001|Overall Study|Lack of Efficacy|1|||
163070262|NCT03971422|588963688|FG002|Overall Study|Lack of Efficacy|1|||
163070263|NCT03971422|588963686|FG000|Overall Study|Adverse event, not fatal|2|||
163070264|NCT03971422|588963687|FG001|Overall Study|Adverse event, not fatal|2|||
163070265|NCT03971422|588963688|FG002|Overall Study|Adverse event, not fatal|5|||
163070266|NCT03971422|588963686|FG000|Overall Study|Worsening of MG Symptoms|1|||
163070267|NCT03971422|588963687|FG001|Overall Study|Worsening of MG Symptoms|4|||
163070268|NCT03971422|588963688|FG002|Overall Study|Worsening of MG Symptoms|2|||
163070269|NCT03971422|588963686|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
163070270|NCT03971422|588963687|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
163070271|NCT03971422|588963688|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
163070272|NCT03971422|588963686|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
163070273|NCT03971422|588963687|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
163070274|NCT03971422|588963688|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
163070275|NCT03971422|588963686|FG000|Overall Study|Due to COVID-19 pandemic|0|||
163070276|NCT03971422|588963687|FG001|Overall Study|Due to COVID-19 pandemic|1|||
163070277|NCT03971422|588963688|FG002|Overall Study|Due to COVID-19 pandemic|1|||
163070278|NCT01658878|588963689|FG000|Treatment Period|Disease Progression|1|||
163070279|NCT01658878|588963690|FG001|Treatment Period|Disease Progression|3|||
163070280|NCT01658878|588963691|FG002|Treatment Period|Disease Progression|2|||
163070281|NCT01658878|588963692|FG003|Treatment Period|Disease Progression|1|||
163217945|NCT02587065|589513870|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
163070282|NCT01658878|588963693|FG004|Treatment Period|Disease Progression|13|||
163070283|NCT01658878|588963694|FG005|Treatment Period|Disease Progression|3|||
163070284|NCT01658878|588963695|FG006|Treatment Period|Disease Progression|4|||
163070285|NCT01658878|588963696|FG007|Treatment Period|Disease Progression|3|||
163070286|NCT01658878|588963697|FG008|Treatment Period|Disease Progression|5|||
163070287|NCT01658878|588963698|FG009|Treatment Period|Disease Progression|3|||
163070288|NCT01658878|588963699|FG010|Treatment Period|Disease Progression|3|||
163070289|NCT01658878|588963700|FG011|Treatment Period|Disease Progression|4|||
163070290|NCT01658878|588963701|FG012|Treatment Period|Disease Progression|43|||
163070291|NCT01658878|588963702|FG013|Treatment Period|Disease Progression|48|||
163070292|NCT01658878|588963703|FG014|Treatment Period|Disease Progression|33|||
163217946|NCT02587065|589513870|FG000|Overall Study|Non-adherence to the Protocol|3|||
163070293|NCT01658878|588963704|FG015|Treatment Period|Disease Progression|46|||
163070294|NCT01658878|588963705|FG016|Treatment Period|Disease Progression|41|||
163070295|NCT01658878|588963706|FG017|Treatment Period|Disease Progression|42|||
163070296|NCT01658878|588963707|FG018|Treatment Period|Disease Progression|28|||
163070297|NCT01658878|588963708|FG019|Treatment Period|Disease Progression|37|||
163217947|NCT02587065|589513870|FG000|Overall Study|Discontinuation of Study Medication|2|||
163217948|NCT02587065|589513870|FG000|Overall Study|Reason not Specified|3|||
163217949|NCT01559012|589513871|FG000|Overall Study|Withdrawal by Subject|0|||
163217950|NCT01559012|589513872|FG001|Overall Study|Withdrawal by Subject|1|||
163217951|NCT00946712|589513873|FG000|Overall Study|Adverse Event|118|||
163217952|NCT00946712|589513874|FG001|Overall Study|Adverse Event|124|||
163217953|NCT00946712|589513873|FG000|Overall Study|Disease progression|308|||
163217954|NCT00946712|589513874|FG001|Overall Study|Disease progression|404|||
163217955|NCT00946712|589513873|FG000|Overall Study|Death|21|||
163217956|NCT00946712|589513874|FG001|Overall Study|Death|22|||
163217957|NCT00946712|589513873|FG000|Overall Study|No treatment given|25|||
163217958|NCT00946712|589513874|FG001|Overall Study|No treatment given|29|||
163217959|NCT00946712|589513873|FG000|Overall Study|Other reasons|61|||
163217960|NCT00946712|589513874|FG001|Overall Study|Other reasons|73|||
163217961|NCT00946712|589513873|FG000|Overall Study|On Treatment|0|||
163070298|NCT01658878|588963709|FG020|Treatment Period|Disease Progression|37|||
163070299|NCT01658878|588963710|FG021|Treatment Period|Disease Progression|39|||
163070300|NCT01658878|588963711|FG022|Treatment Period|Disease Progression|27|||
163070301|NCT01658878|588963712|FG023|Treatment Period|Disease Progression|19|||
163070302|NCT01658878|588963689|FG000|Treatment Period|Study Drug Toxicity|0|||
163070303|NCT01658878|588963690|FG001|Treatment Period|Study Drug Toxicity|0|||
163070304|NCT01658878|588963691|FG002|Treatment Period|Study Drug Toxicity|0|||
163070305|NCT01658878|588963692|FG003|Treatment Period|Study Drug Toxicity|1|||
163070306|NCT01658878|588963693|FG004|Treatment Period|Study Drug Toxicity|0|||
163070307|NCT01658878|588963694|FG005|Treatment Period|Study Drug Toxicity|0|||
163070308|NCT01658878|588963695|FG006|Treatment Period|Study Drug Toxicity|0|||
163070309|NCT01658878|588963696|FG007|Treatment Period|Study Drug Toxicity|0|||
163070310|NCT01658878|588963697|FG008|Treatment Period|Study Drug Toxicity|0|||
163070311|NCT01658878|588963698|FG009|Treatment Period|Study Drug Toxicity|0|||
163070312|NCT01658878|588963699|FG010|Treatment Period|Study Drug Toxicity|0|||
163070313|NCT01658878|588963700|FG011|Treatment Period|Study Drug Toxicity|0|||
163070314|NCT01658878|588963701|FG012|Treatment Period|Study Drug Toxicity|7|||
163070315|NCT01658878|588963702|FG013|Treatment Period|Study Drug Toxicity|1|||
163070316|NCT01658878|588963703|FG014|Treatment Period|Study Drug Toxicity|5|||
163070317|NCT01658878|588963704|FG015|Treatment Period|Study Drug Toxicity|0|||
163070318|NCT01658878|588963705|FG016|Treatment Period|Study Drug Toxicity|5|||
163070319|NCT01658878|588963706|FG017|Treatment Period|Study Drug Toxicity|10|||
163070320|NCT01658878|588963707|FG018|Treatment Period|Study Drug Toxicity|12|||
163070321|NCT01658878|588963708|FG019|Treatment Period|Study Drug Toxicity|4|||
163070322|NCT01658878|588963709|FG020|Treatment Period|Study Drug Toxicity|2|||
163070323|NCT01658878|588963710|FG021|Treatment Period|Study Drug Toxicity|3|||
163070324|NCT01658878|588963711|FG022|Treatment Period|Study Drug Toxicity|2|||
163070325|NCT01658878|588963712|FG023|Treatment Period|Study Drug Toxicity|6|||
163070326|NCT01658878|588963689|FG000|Treatment Period|Maximum Clinical Benefit|0|||
163070327|NCT01658878|588963690|FG001|Treatment Period|Maximum Clinical Benefit|0|||
163070328|NCT01658878|588963691|FG002|Treatment Period|Maximum Clinical Benefit|1|||
163070329|NCT01658878|588963692|FG003|Treatment Period|Maximum Clinical Benefit|0|||
163070330|NCT01658878|588963693|FG004|Treatment Period|Maximum Clinical Benefit|0|||
163070331|NCT01658878|588963694|FG005|Treatment Period|Maximum Clinical Benefit|0|||
163070332|NCT01658878|588963695|FG006|Treatment Period|Maximum Clinical Benefit|0|||
163070333|NCT01658878|588963696|FG007|Treatment Period|Maximum Clinical Benefit|0|||
163070334|NCT01658878|588963697|FG008|Treatment Period|Maximum Clinical Benefit|0|||
163070335|NCT01658878|588963698|FG009|Treatment Period|Maximum Clinical Benefit|0|||
163070336|NCT01658878|588963699|FG010|Treatment Period|Maximum Clinical Benefit|0|||
163070337|NCT01658878|588963700|FG011|Treatment Period|Maximum Clinical Benefit|0|||
163070338|NCT01658878|588963701|FG012|Treatment Period|Maximum Clinical Benefit|0|||
163070339|NCT01658878|588963702|FG013|Treatment Period|Maximum Clinical Benefit|0|||
163070340|NCT01658878|588963703|FG014|Treatment Period|Maximum Clinical Benefit|0|||
163070341|NCT01658878|588963704|FG015|Treatment Period|Maximum Clinical Benefit|0|||
163070342|NCT01658878|588963705|FG016|Treatment Period|Maximum Clinical Benefit|0|||
163070343|NCT01658878|588963706|FG017|Treatment Period|Maximum Clinical Benefit|0|||
163070344|NCT01658878|588963707|FG018|Treatment Period|Maximum Clinical Benefit|1|||
163070345|NCT01658878|588963708|FG019|Treatment Period|Maximum Clinical Benefit|1|||
163070346|NCT01658878|588963709|FG020|Treatment Period|Maximum Clinical Benefit|0|||
163070347|NCT01658878|588963710|FG021|Treatment Period|Maximum Clinical Benefit|0|||
163070348|NCT01658878|588963711|FG022|Treatment Period|Maximum Clinical Benefit|0|||
163070349|NCT01658878|588963712|FG023|Treatment Period|Maximum Clinical Benefit|0|||
163070350|NCT01658878|588963689|FG000|Treatment Period|Other Reasons|0|||
163070351|NCT01658878|588963690|FG001|Treatment Period|Other Reasons|0|||
163070352|NCT01658878|588963691|FG002|Treatment Period|Other Reasons|0|||
163070353|NCT01658878|588963692|FG003|Treatment Period|Other Reasons|1|||
163070354|NCT01658878|588963693|FG004|Treatment Period|Other Reasons|0|||
163070355|NCT01658878|588963694|FG005|Treatment Period|Other Reasons|0|||
163070356|NCT01658878|588963695|FG006|Treatment Period|Other Reasons|0|||
163070357|NCT01658878|588963696|FG007|Treatment Period|Other Reasons|0|||
163070358|NCT01658878|588963697|FG008|Treatment Period|Other Reasons|0|||
163070359|NCT01658878|588963698|FG009|Treatment Period|Other Reasons|0|||
163070360|NCT01658878|588963699|FG010|Treatment Period|Other Reasons|0|||
163070361|NCT01658878|588963700|FG011|Treatment Period|Other Reasons|0|||
163070362|NCT01658878|588963701|FG012|Treatment Period|Other Reasons|2|||
163070363|NCT01658878|588963702|FG013|Treatment Period|Other Reasons|0|||
163070364|NCT01658878|588963703|FG014|Treatment Period|Other Reasons|0|||
163070365|NCT01658878|588963704|FG015|Treatment Period|Other Reasons|2|||
163070366|NCT01658878|588963705|FG016|Treatment Period|Other Reasons|1|||
163070367|NCT01658878|588963706|FG017|Treatment Period|Other Reasons|1|||
163070368|NCT01658878|588963707|FG018|Treatment Period|Other Reasons|3|||
163070369|NCT01658878|588963708|FG019|Treatment Period|Other Reasons|1|||
163070370|NCT01658878|588963709|FG020|Treatment Period|Other Reasons|4|||
163070371|NCT01658878|588963710|FG021|Treatment Period|Other Reasons|0|||
163070372|NCT01658878|588963711|FG022|Treatment Period|Other Reasons|0|||
163070373|NCT01658878|588963712|FG023|Treatment Period|Other Reasons|4|||
163070374|NCT01658878|588963689|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070375|NCT01658878|588963690|FG001|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070376|NCT01658878|588963691|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070377|NCT01658878|588963692|FG003|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070378|NCT01658878|588963693|FG004|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070379|NCT01658878|588963694|FG005|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070380|NCT01658878|588963695|FG006|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070381|NCT01658878|588963696|FG007|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070382|NCT01658878|588963697|FG008|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070383|NCT01658878|588963698|FG009|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070384|NCT01658878|588963699|FG010|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070385|NCT01658878|588963700|FG011|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070386|NCT01658878|588963701|FG012|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070387|NCT01658878|588963702|FG013|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070388|NCT01658878|588963703|FG014|Treatment Period|Participant No Longer Meets Study Criteria|1|||
163070389|NCT01658878|588963704|FG015|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070390|NCT01658878|588963705|FG016|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070391|NCT01658878|588963706|FG017|Treatment Period|Participant No Longer Meets Study Criteria|1|||
163070392|NCT01658878|588963707|FG018|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070393|NCT01658878|588963708|FG019|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070394|NCT01658878|588963709|FG020|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070395|NCT01658878|588963710|FG021|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070396|NCT01658878|588963711|FG022|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070397|NCT01658878|588963712|FG023|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070398|NCT01658878|588963689|FG000|Treatment Period|Poor/Non-compliance|0|||
163070399|NCT01658878|588963690|FG001|Treatment Period|Poor/Non-compliance|0|||
163070400|NCT01658878|588963691|FG002|Treatment Period|Poor/Non-compliance|0|||
163070401|NCT01658878|588963692|FG003|Treatment Period|Poor/Non-compliance|0|||
163070402|NCT01658878|588963693|FG004|Treatment Period|Poor/Non-compliance|0|||
163070403|NCT01658878|588963694|FG005|Treatment Period|Poor/Non-compliance|0|||
163070404|NCT01658878|588963695|FG006|Treatment Period|Poor/Non-compliance|0|||
163070405|NCT01658878|588963696|FG007|Treatment Period|Poor/Non-compliance|0|||
163070406|NCT01658878|588963697|FG008|Treatment Period|Poor/Non-compliance|0|||
163070407|NCT01658878|588963698|FG009|Treatment Period|Poor/Non-compliance|0|||
163070408|NCT01658878|588963699|FG010|Treatment Period|Poor/Non-compliance|0|||
163070409|NCT01658878|588963700|FG011|Treatment Period|Poor/Non-compliance|0|||
163070410|NCT01658878|588963701|FG012|Treatment Period|Poor/Non-compliance|0|||
163070411|NCT01658878|588963702|FG013|Treatment Period|Poor/Non-compliance|0|||
163070412|NCT01658878|588963703|FG014|Treatment Period|Poor/Non-compliance|0|||
163070413|NCT01658878|588963704|FG015|Treatment Period|Poor/Non-compliance|1|||
163070414|NCT01658878|588963705|FG016|Treatment Period|Poor/Non-compliance|0|||
163070415|NCT01658878|588963706|FG017|Treatment Period|Poor/Non-compliance|0|||
163070416|NCT01658878|588963707|FG018|Treatment Period|Poor/Non-compliance|0|||
163070417|NCT01658878|588963708|FG019|Treatment Period|Poor/Non-compliance|0|||
163070418|NCT01658878|588963709|FG020|Treatment Period|Poor/Non-compliance|0|||
163070419|NCT01658878|588963710|FG021|Treatment Period|Poor/Non-compliance|0|||
163070420|NCT01658878|588963711|FG022|Treatment Period|Poor/Non-compliance|0|||
163070421|NCT01658878|588963712|FG023|Treatment Period|Poor/Non-compliance|0|||
163070422|NCT01658878|588963689|FG000|Treatment Period|Participant Withdrew Consent|0|||
163070423|NCT01658878|588963690|FG001|Treatment Period|Participant Withdrew Consent|0|||
163070424|NCT01658878|588963691|FG002|Treatment Period|Participant Withdrew Consent|0|||
163070425|NCT01658878|588963692|FG003|Treatment Period|Participant Withdrew Consent|0|||
163070426|NCT01658878|588963693|FG004|Treatment Period|Participant Withdrew Consent|0|||
163070427|NCT01658878|588963694|FG005|Treatment Period|Participant Withdrew Consent|0|||
163070428|NCT01658878|588963695|FG006|Treatment Period|Participant Withdrew Consent|0|||
163070429|NCT01658878|588963696|FG007|Treatment Period|Participant Withdrew Consent|0|||
163070430|NCT01658878|588963697|FG008|Treatment Period|Participant Withdrew Consent|0|||
163070431|NCT01658878|588963698|FG009|Treatment Period|Participant Withdrew Consent|0|||
163070432|NCT01658878|588963699|FG010|Treatment Period|Participant Withdrew Consent|0|||
163070433|NCT01658878|588963700|FG011|Treatment Period|Participant Withdrew Consent|0|||
163070434|NCT01658878|588963701|FG012|Treatment Period|Participant Withdrew Consent|1|||
163070435|NCT01658878|588963702|FG013|Treatment Period|Participant Withdrew Consent|0|||
163070436|NCT01658878|588963703|FG014|Treatment Period|Participant Withdrew Consent|2|||
163070437|NCT01658878|588963704|FG015|Treatment Period|Participant Withdrew Consent|0|||
163070438|NCT01658878|588963705|FG016|Treatment Period|Participant Withdrew Consent|0|||
163070439|NCT01658878|588963706|FG017|Treatment Period|Participant Withdrew Consent|2|||
163070440|NCT01658878|588963707|FG018|Treatment Period|Participant Withdrew Consent|1|||
163406383|NCT04703075|590196742|FG000|Overall Study|Lack of Efficacy|6|||
163406384|NCT04703075|590196743|FG001|Overall Study|Lack of Efficacy|18|||
163406385|NCT01187953|590196744|FG000|Overall Study|Death|11|||
163070441|NCT01658878|588963708|FG019|Treatment Period|Participant Withdrew Consent|2|||
163070442|NCT01658878|588963709|FG020|Treatment Period|Participant Withdrew Consent|1|||
163070443|NCT01658878|588963710|FG021|Treatment Period|Participant Withdrew Consent|0|||
163070444|NCT01658878|588963711|FG022|Treatment Period|Participant Withdrew Consent|2|||
163070445|NCT01658878|588963712|FG023|Treatment Period|Participant Withdrew Consent|2|||
163070446|NCT01658878|588963689|FG000|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070447|NCT01658878|588963690|FG001|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070448|NCT01658878|588963691|FG002|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070449|NCT01658878|588963692|FG003|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070450|NCT01658878|588963693|FG004|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070451|NCT01658878|588963694|FG005|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070452|NCT01658878|588963695|FG006|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070453|NCT01658878|588963696|FG007|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070454|NCT01658878|588963697|FG008|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070455|NCT01658878|588963698|FG009|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070456|NCT01658878|588963699|FG010|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070457|NCT01658878|588963700|FG011|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070458|NCT01658878|588963701|FG012|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
163070459|NCT01658878|588963702|FG013|Treatment Period|Participant Request to Discontinue Study Treatment|4|||
163070460|NCT01658878|588963703|FG014|Treatment Period|Participant Request to Discontinue Study Treatment|3|||
163070461|NCT01658878|588963704|FG015|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
163070462|NCT01658878|588963705|FG016|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
163070463|NCT01658878|588963706|FG017|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
163070464|NCT01658878|588963707|FG018|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070465|NCT01658878|588963708|FG019|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
163070466|NCT01658878|588963709|FG020|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
163070467|NCT01658878|588963710|FG021|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
163070468|NCT01658878|588963711|FG022|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070469|NCT01658878|588963712|FG023|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
163070470|NCT01658878|588963689|FG000|Treatment Period|Adverse Event Related to Study Drug|0|||
163070471|NCT01658878|588963690|FG001|Treatment Period|Adverse Event Related to Study Drug|0|||
163070472|NCT01658878|588963691|FG002|Treatment Period|Adverse Event Related to Study Drug|0|||
163070473|NCT01658878|588963692|FG003|Treatment Period|Adverse Event Related to Study Drug|0|||
163070474|NCT01658878|588963693|FG004|Treatment Period|Adverse Event Related to Study Drug|0|||
163070475|NCT01658878|588963694|FG005|Treatment Period|Adverse Event Related to Study Drug|0|||
163070476|NCT01658878|588963695|FG006|Treatment Period|Adverse Event Related to Study Drug|0|||
163070477|NCT01658878|588963696|FG007|Treatment Period|Adverse Event Related to Study Drug|0|||
163070478|NCT01658878|588963697|FG008|Treatment Period|Adverse Event Related to Study Drug|0|||
163070479|NCT01658878|588963698|FG009|Treatment Period|Adverse Event Related to Study Drug|0|||
163070480|NCT01658878|588963699|FG010|Treatment Period|Adverse Event Related to Study Drug|0|||
163070481|NCT01658878|588963700|FG011|Treatment Period|Adverse Event Related to Study Drug|0|||
163070482|NCT01658878|588963701|FG012|Treatment Period|Adverse Event Related to Study Drug|0|||
163070483|NCT01658878|588963702|FG013|Treatment Period|Adverse Event Related to Study Drug|4|||
163070484|NCT01658878|588963703|FG014|Treatment Period|Adverse Event Related to Study Drug|6|||
163070485|NCT01658878|588963704|FG015|Treatment Period|Adverse Event Related to Study Drug|0|||
163070486|NCT01658878|588963705|FG016|Treatment Period|Adverse Event Related to Study Drug|0|||
163070487|NCT01658878|588963706|FG017|Treatment Period|Adverse Event Related to Study Drug|0|||
163070488|NCT01658878|588963707|FG018|Treatment Period|Adverse Event Related to Study Drug|0|||
163070489|NCT01658878|588963708|FG019|Treatment Period|Adverse Event Related to Study Drug|0|||
163070490|NCT01658878|588963709|FG020|Treatment Period|Adverse Event Related to Study Drug|0|||
163070491|NCT01658878|588963710|FG021|Treatment Period|Adverse Event Related to Study Drug|0|||
163070492|NCT01658878|588963711|FG022|Treatment Period|Adverse Event Related to Study Drug|0|||
163070493|NCT01658878|588963712|FG023|Treatment Period|Adverse Event Related to Study Drug|0|||
163070494|NCT01658878|588963689|FG000|Treatment Period|Death|0|||
163070495|NCT01658878|588963690|FG001|Treatment Period|Death|0|||
163070496|NCT01658878|588963691|FG002|Treatment Period|Death|0|||
163070497|NCT01658878|588963692|FG003|Treatment Period|Death|0|||
163070498|NCT01658878|588963693|FG004|Treatment Period|Death|0|||
163070499|NCT01658878|588963694|FG005|Treatment Period|Death|0|||
163070500|NCT01658878|588963695|FG006|Treatment Period|Death|0|||
163070501|NCT01658878|588963696|FG007|Treatment Period|Death|0|||
163070502|NCT01658878|588963697|FG008|Treatment Period|Death|0|||
163070503|NCT01658878|588963698|FG009|Treatment Period|Death|0|||
163070504|NCT01658878|588963699|FG010|Treatment Period|Death|0|||
163070505|NCT01658878|588963700|FG011|Treatment Period|Death|0|||
163331087|NCT00731692|589922490|FG001|Extension Phase|Abnormal test procedure|0|||
163070506|NCT01658878|588963701|FG012|Treatment Period|Death|1|||
163070507|NCT01658878|588963702|FG013|Treatment Period|Death|0|||
163070508|NCT01658878|588963703|FG014|Treatment Period|Death|0|||
163070509|NCT01658878|588963704|FG015|Treatment Period|Death|0|||
163070510|NCT01658878|588963705|FG016|Treatment Period|Death|1|||
163070511|NCT01658878|588963706|FG017|Treatment Period|Death|1|||
163070512|NCT01658878|588963707|FG018|Treatment Period|Death|0|||
163070513|NCT01658878|588963708|FG019|Treatment Period|Death|0|||
163070514|NCT01658878|588963709|FG020|Treatment Period|Death|0|||
163070515|NCT01658878|588963710|FG021|Treatment Period|Death|2|||
163070516|NCT01658878|588963711|FG022|Treatment Period|Death|0|||
163070517|NCT01658878|588963712|FG023|Treatment Period|Death|0|||
163070518|NCT01658878|588963689|FG000|Treatment Period|Adverse Event|0|||
163070519|NCT01658878|588963690|FG001|Treatment Period|Adverse Event|0|||
163070520|NCT01658878|588963691|FG002|Treatment Period|Adverse Event|0|||
163070521|NCT01658878|588963692|FG003|Treatment Period|Adverse Event|0|||
163070522|NCT01658878|588963693|FG004|Treatment Period|Adverse Event|0|||
163070523|NCT01658878|588963694|FG005|Treatment Period|Adverse Event|0|||
163070524|NCT01658878|588963695|FG006|Treatment Period|Adverse Event|0|||
163070525|NCT01658878|588963696|FG007|Treatment Period|Adverse Event|0|||
163070526|NCT01658878|588963697|FG008|Treatment Period|Adverse Event|0|||
163070527|NCT01658878|588963698|FG009|Treatment Period|Adverse Event|0|||
163070528|NCT01658878|588963699|FG010|Treatment Period|Adverse Event|0|||
163070529|NCT01658878|588963700|FG011|Treatment Period|Adverse Event|0|||
163070530|NCT01658878|588963701|FG012|Treatment Period|Adverse Event|0|||
163070531|NCT01658878|588963702|FG013|Treatment Period|Adverse Event|0|||
163070532|NCT01658878|588963703|FG014|Treatment Period|Adverse Event|0|||
163070533|NCT01658878|588963704|FG015|Treatment Period|Adverse Event|0|||
163070534|NCT01658878|588963705|FG016|Treatment Period|Adverse Event|10|||
163070535|NCT01658878|588963706|FG017|Treatment Period|Adverse Event|3|||
163070536|NCT01658878|588963707|FG018|Treatment Period|Adverse Event|3|||
163070537|NCT01658878|588963708|FG019|Treatment Period|Adverse Event|2|||
163070538|NCT01658878|588963709|FG020|Treatment Period|Adverse Event|3|||
163070539|NCT01658878|588963710|FG021|Treatment Period|Adverse Event|3|||
163070540|NCT01658878|588963711|FG022|Treatment Period|Adverse Event|4|||
163070541|NCT01658878|588963712|FG023|Treatment Period|Adverse Event|3|||
163070542|NCT01658878|588963689|FG000|Treatment Period|Lost to Follow-up|0|||
163070543|NCT01658878|588963690|FG001|Treatment Period|Lost to Follow-up|0|||
163070544|NCT01658878|588963691|FG002|Treatment Period|Lost to Follow-up|0|||
163070545|NCT01658878|588963692|FG003|Treatment Period|Lost to Follow-up|0|||
163070546|NCT01658878|588963693|FG004|Treatment Period|Lost to Follow-up|0|||
163070547|NCT01658878|588963694|FG005|Treatment Period|Lost to Follow-up|0|||
163070548|NCT01658878|588963695|FG006|Treatment Period|Lost to Follow-up|0|||
163070549|NCT01658878|588963696|FG007|Treatment Period|Lost to Follow-up|0|||
163070550|NCT01658878|588963697|FG008|Treatment Period|Lost to Follow-up|0|||
163070551|NCT01658878|588963698|FG009|Treatment Period|Lost to Follow-up|0|||
163070552|NCT01658878|588963699|FG010|Treatment Period|Lost to Follow-up|0|||
163070553|NCT01658878|588963700|FG011|Treatment Period|Lost to Follow-up|0|||
163070554|NCT01658878|588963701|FG012|Treatment Period|Lost to Follow-up|0|||
163070555|NCT01658878|588963702|FG013|Treatment Period|Lost to Follow-up|0|||
163070556|NCT01658878|588963703|FG014|Treatment Period|Lost to Follow-up|0|||
163070557|NCT01658878|588963704|FG015|Treatment Period|Lost to Follow-up|0|||
163070558|NCT01658878|588963705|FG016|Treatment Period|Lost to Follow-up|1|||
163070559|NCT01658878|588963706|FG017|Treatment Period|Lost to Follow-up|0|||
163070560|NCT01658878|588963707|FG018|Treatment Period|Lost to Follow-up|1|||
163070561|NCT01658878|588963708|FG019|Treatment Period|Lost to Follow-up|1|||
163070562|NCT01658878|588963709|FG020|Treatment Period|Lost to Follow-up|0|||
163070563|NCT01658878|588963710|FG021|Treatment Period|Lost to Follow-up|0|||
163070564|NCT01658878|588963711|FG022|Treatment Period|Lost to Follow-up|1|||
163070565|NCT01658878|588963712|FG023|Treatment Period|Lost to Follow-up|0|||
163070566|NCT00327171|588963715|FG000|Overall Study|Did not receive study medication|3|||
163070567|NCT00327171|588963716|FG001|Overall Study|Did not receive study medication|0|||
163070568|NCT00327171|588963715|FG000|Overall Study|Adverse Event|23|||
163070569|NCT00327171|588963716|FG001|Overall Study|Adverse Event|23|||
163070570|NCT00327171|588963715|FG000|Overall Study|Disease progression/lack of efficacy|68|||
163070571|NCT00327171|588963716|FG001|Overall Study|Disease progression/lack of efficacy|69|||
163070572|NCT00327171|588963715|FG000|Overall Study|Investigator/participant request|1|||
163070573|NCT00327171|588963716|FG001|Overall Study|Investigator/participant request|8|||
163070574|NCT00327171|588963715|FG000|Overall Study|Clinical progression|12|||
163070575|NCT00327171|588963716|FG001|Overall Study|Clinical progression|8|||
163070576|NCT00327171|588963715|FG000|Overall Study|Undisclosed history of ischemia|0|||
163070577|NCT00327171|588963716|FG001|Overall Study|Undisclosed history of ischemia|1|||
163070578|NCT00327171|588963715|FG000|Overall Study|Other|1|||
163070579|NCT00327171|588963716|FG001|Overall Study|Other|0|||
163070580|NCT01363440|588963717|FG000|Overall Study|Adverse Event|5|||
163070581|NCT01363440|588963718|FG001|Overall Study|Adverse Event|4|||
163070582|NCT01363440|588963719|FG002|Overall Study|Adverse Event|4|||
163070583|NCT01363440|588963717|FG000|Overall Study|Death|3|||
163070584|NCT01363440|588963718|FG001|Overall Study|Death|7|||
163070585|NCT01363440|588963719|FG002|Overall Study|Death|5|||
163070586|NCT01363440|588963717|FG000|Overall Study|Withdrawal by Subject|9|||
163070587|NCT01363440|588963718|FG001|Overall Study|Withdrawal by Subject|11|||
163070588|NCT01363440|588963719|FG002|Overall Study|Withdrawal by Subject|11|||
163070589|NCT01363440|588963717|FG000|Overall Study|Lost to Follow-up|2|||
163070590|NCT01363440|588963718|FG001|Overall Study|Lost to Follow-up|4|||
163070591|NCT01363440|588963719|FG002|Overall Study|Lost to Follow-up|5|||
163070592|NCT01363440|588963717|FG000|Overall Study|Other|4|||
163070593|NCT01363440|588963718|FG001|Overall Study|Other|5|||
163070594|NCT01363440|588963719|FG002|Overall Study|Other|2|||
163070595|NCT00992836|588963720|FG000|Overall Study|Lost to Follow-up|1|||
163070596|NCT00992836|588963720|FG000|Overall Study|Withdrawal by Subject|2|||
163070597|NCT00992836|588963720|FG000|Overall Study|Protocol Violation|2|||
163070598|NCT03695094|588963721|FG000|Overall Study|Adverse Event|1|||
163070599|NCT03695094|588963722|FG001|Overall Study|Adverse Event|1|||
163070600|NCT03695094|588963721|FG000|Overall Study|Withdrawal by Subject|1|||
163070601|NCT03695094|588963722|FG001|Overall Study|Withdrawal by Subject|0|||
163070602|NCT01471574|588963723|FG000|Treatment Period|Lack of Efficacy|12|||
163070603|NCT01471574|588963724|FG001|Treatment Period|Lack of Efficacy|4|||
163070604|NCT01471574|588963725|FG002|Treatment Period|Lack of Efficacy|14|||
163070605|NCT01471574|588963726|FG003|Treatment Period|Lack of Efficacy|1|||
163070606|NCT01471574|588963723|FG000|Treatment Period|Adverse Event|7|||
163070607|NCT01471574|588963724|FG001|Treatment Period|Adverse Event|3|||
163070608|NCT01471574|588963725|FG002|Treatment Period|Adverse Event|6|||
163070609|NCT01471574|588963726|FG003|Treatment Period|Adverse Event|1|||
163070610|NCT01471574|588963723|FG000|Treatment Period|Withdrawal by Subject|5|||
163070611|NCT01471574|588963724|FG001|Treatment Period|Withdrawal by Subject|1|||
163070612|NCT01471574|588963725|FG002|Treatment Period|Withdrawal by Subject|1|||
163070613|NCT01471574|588963726|FG003|Treatment Period|Withdrawal by Subject|0|||
163070614|NCT01471574|588963723|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
163070615|NCT01471574|588963724|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
163070616|NCT01471574|588963725|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
163070617|NCT01471574|588963726|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
163070618|NCT01471574|588963723|FG000|Treatment Period|Lost to Follow-up|1|||
163070619|NCT01471574|588963724|FG001|Treatment Period|Lost to Follow-up|2|||
163070620|NCT01471574|588963725|FG002|Treatment Period|Lost to Follow-up|2|||
163070621|NCT01471574|588963726|FG003|Treatment Period|Lost to Follow-up|0|||
163070622|NCT01471574|588963723|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
163070623|NCT01471574|588963724|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
163070624|NCT01471574|588963725|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
163070625|NCT01471574|588963726|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
163070626|NCT01471574|588963723|FG000|Treatment Period|Other|1|||
163070627|NCT01471574|588963724|FG001|Treatment Period|Other|0|||
163070628|NCT01471574|588963725|FG002|Treatment Period|Other|0|||
163070629|NCT01471574|588963726|FG003|Treatment Period|Other|0|||
163070630|NCT01471574|588963723|FG000|Follow-up Period|Withdrawal by Subject|3|||
163070631|NCT01471574|588963724|FG001|Follow-up Period|Withdrawal by Subject|0|||
163070632|NCT01471574|588963725|FG002|Follow-up Period|Withdrawal by Subject|3|||
163070633|NCT01471574|588963726|FG003|Follow-up Period|Withdrawal by Subject|1|||
163070634|NCT01471574|588963723|FG000|Follow-up Period|Lost to Follow-up|4|||
163217962|NCT00946712|589513874|FG001|Overall Study|On Treatment|4|||
163070635|NCT01471574|588963724|FG001|Follow-up Period|Lost to Follow-up|1|||
163070636|NCT01471574|588963725|FG002|Follow-up Period|Lost to Follow-up|3|||
163070637|NCT01471574|588963726|FG003|Follow-up Period|Lost to Follow-up|2|||
163070638|NCT01471574|588963723|FG000|Follow-up Period|Death|0|||
163070639|NCT01471574|588963724|FG001|Follow-up Period|Death|0|||
163070640|NCT01471574|588963725|FG002|Follow-up Period|Death|1|||
163070641|NCT01471574|588963726|FG003|Follow-up Period|Death|0|||
163070642|NCT01471574|588963723|FG000|Follow-up Period|Follow-up no longer required|0|||
163070643|NCT01471574|588963724|FG001|Follow-up Period|Follow-up no longer required|1|||
163070644|NCT01471574|588963725|FG002|Follow-up Period|Follow-up no longer required|0|||
163070645|NCT01471574|588963726|FG003|Follow-up Period|Follow-up no longer required|0|||
163070646|NCT01795937|588963727|FG000|Overall Study|Withdrawal by Subject|1|||
163070647|NCT01795937|588963728|FG001|Overall Study|Withdrawal by Subject|0|||
163070648|NCT01795937|588963729|FG002|Overall Study|Withdrawal by Subject|0|||
163070649|NCT01795937|588963727|FG000|Overall Study|Physician Decision|0|||
163070650|NCT01795937|588963728|FG001|Overall Study|Physician Decision|1|||
163070651|NCT01795937|588963729|FG002|Overall Study|Physician Decision|0|||
163217963|NCT00946712|589513873|FG000|Overall Study|Ineligible|14|||
163217964|NCT00946712|589513874|FG001|Overall Study|Ineligible|6|||
163070652|NCT03927157|588963731|FG000|Overall Study|Adverse Event|1|||
163070653|NCT03927157|588963732|FG001|Overall Study|Adverse Event|3|||
163070654|NCT03927157|588963731|FG000|Overall Study|Protocol Violation|1|||
163070655|NCT03927157|588963732|FG001|Overall Study|Protocol Violation|2|||
163070656|NCT03927157|588963731|FG000|Overall Study|Withdrawal by Subject|8|||
163070657|NCT03927157|588963732|FG001|Overall Study|Withdrawal by Subject|21|||
163217965|NCT00302458|589513875|FG000|Overall Study|Lost to Follow-up|1|||
163217966|NCT00302458|589513875|FG000|Overall Study|Ineligible after screening|1|||
163070658|NCT03927157|588963731|FG000|Overall Study|Due to COVID-19 pandemic|5|||
163070659|NCT03927157|588963732|FG001|Overall Study|Due to COVID-19 pandemic|2|||
163070660|NCT03927157|588963731|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
163070661|NCT03927157|588963732|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
163070662|NCT03927157|588963731|FG000|Overall Study|Other than above|0|||
163070663|NCT03927157|588963732|FG001|Overall Study|Other than above|1|||
163070664|NCT02965716|588963733|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
163070665|NCT02965716|588963734|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
163070666|NCT02965716|588963733|FG000|Overall Study|Progression/Relapse|8|||
163070667|NCT02965716|588963734|FG001|Overall Study|Progression/Relapse|16|||
163070668|NCT02965716|588963733|FG000|Overall Study|Death|1|||
163070669|NCT02965716|588963734|FG001|Overall Study|Death|0|||
163070670|NCT02965716|588963733|FG000|Overall Study|Not Protocol Specified|1|||
163070671|NCT02965716|588963734|FG001|Overall Study|Not Protocol Specified|3|||
163070672|NCT02691663|588963739|FG000|Overall Study|Screen failure after baseline|2|||
163070673|NCT02691663|588963740|FG001|Overall Study|Screen failure after baseline|2|||
163070674|NCT02691663|588963739|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
163070675|NCT02691663|588963740|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
163070676|NCT02691663|588963739|FG000|Overall Study|Withdrawn after Follow up 2|1|||
163070677|NCT02691663|588963740|FG001|Overall Study|Withdrawn after Follow up 2|1|||
163070678|NCT02691663|588963739|FG000|Overall Study|Lost to Follow-up|3|||
163070679|NCT02691663|588963740|FG001|Overall Study|Lost to Follow-up|2|||
163070680|NCT00303628|588963741|FG000|Overall Study|Disease progression|0|||
163070681|NCT00303628|588963742|FG001|Overall Study|Disease progression|1|||
163070682|NCT00303628|588963741|FG000|Overall Study|Adverse Event|26|||
163070683|NCT00303628|588963742|FG001|Overall Study|Adverse Event|36|||
163070684|NCT00303628|588963741|FG000|Overall Study|Death|0|||
163070685|NCT00303628|588963742|FG001|Overall Study|Death|1|||
163070686|NCT00303628|588963741|FG000|Overall Study|Withdrawal by Subject|11|||
163070687|NCT00303628|588963742|FG001|Overall Study|Withdrawal by Subject|20|||
163070688|NCT00303628|588963741|FG000|Overall Study|Alternative therapy|2|||
163070689|NCT00303628|588963742|FG001|Overall Study|Alternative therapy|0|||
163070690|NCT00303628|588963741|FG000|Overall Study|Other complicating disease|0|||
163070691|NCT00303628|588963742|FG001|Overall Study|Other complicating disease|1|||
163070692|NCT00303628|588963741|FG000|Overall Study|Not start protocol therapy|3|||
163070693|NCT00303628|588963742|FG001|Overall Study|Not start protocol therapy|5|||
163070694|NCT00303628|588963741|FG000|Overall Study|Other|8|||
163070695|NCT00303628|588963742|FG001|Overall Study|Other|9|||
163070696|NCT03158688|588963743|FG000|Overall Study|Withdrawal by Subject|14|||
163070697|NCT03158688|588963744|FG001|Overall Study|Withdrawal by Subject|28|||
163070698|NCT03158688|588963743|FG000|Overall Study|Decision by sponsor|13|||
163070699|NCT03158688|588963744|FG001|Overall Study|Decision by sponsor|37|||
163070700|NCT03158688|588963743|FG000|Overall Study|Lost to Follow-up|4|||
163070701|NCT03158688|588963744|FG001|Overall Study|Lost to Follow-up|3|||
163070702|NCT03158688|588963743|FG000|Overall Study|Death|74|||
163070703|NCT03158688|588963744|FG001|Overall Study|Death|142|||
163070704|NCT02942407|588963745|FG000|Overall Study|Lost to Follow-up|3|||
163070705|NCT02942407|588963746|FG001|Overall Study|Lost to Follow-up|2|||
163070706|NCT02942407|588963745|FG000|Overall Study|Withdrawal by Subject|7|||
163070707|NCT02942407|588963746|FG001|Overall Study|Withdrawal by Subject|9|||
163070708|NCT02942407|588963745|FG000|Overall Study|Death|16|||
163070709|NCT02942407|588963746|FG001|Overall Study|Death|13|||
163070710|NCT05887908|588963747|FG000|Overall Study|Adverse Event|6|||
163070711|NCT05887908|588963748|FG001|Overall Study|Adverse Event|1|||
163070712|NCT05887908|588963749|FG002|Overall Study|Adverse Event|1|||
163070713|NCT05887908|588963747|FG000|Overall Study|Physician Decision|4|||
163070714|NCT05887908|588963748|FG001|Overall Study|Physician Decision|1|||
163070715|NCT05887908|588963749|FG002|Overall Study|Physician Decision|0|||
163070716|NCT05887908|588963747|FG000|Overall Study|Withdrawal by Subject|3|||
163070717|NCT05887908|588963748|FG001|Overall Study|Withdrawal by Subject|2|||
163070718|NCT05887908|588963749|FG002|Overall Study|Withdrawal by Subject|3|||
163070719|NCT05887908|588963747|FG000|Overall Study|Ineligibility after the start of the study|4|||
163070720|NCT05887908|588963748|FG001|Overall Study|Ineligibility after the start of the study|1|||
163070721|NCT05887908|588963749|FG002|Overall Study|Ineligibility after the start of the study|0|||
163070722|NCT05887908|588963747|FG000|Overall Study|Subject non-compliance|4|||
163070723|NCT05887908|588963748|FG001|Overall Study|Subject non-compliance|0|||
163070724|NCT05887908|588963749|FG002|Overall Study|Subject non-compliance|4|||
163070725|NCT05887908|588963747|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
163070726|NCT05887908|588963748|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
163070727|NCT05887908|588963749|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
163070728|NCT05887908|588963747|FG000|Overall Study|Pregnancy|0|||
163070729|NCT05887908|588963748|FG001|Overall Study|Pregnancy|1|||
163070730|NCT05887908|588963749|FG002|Overall Study|Pregnancy|0|||
163070731|NCT05887908|588963747|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
163070732|NCT05887908|588963748|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
163070733|NCT05887908|588963749|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
163070734|NCT05887908|588963747|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
163070735|NCT05887908|588963748|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
163070736|NCT05887908|588963749|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
163070737|NCT05887908|588963747|FG000|Overall Study|Other Reason|3|||
163070738|NCT05887908|588963748|FG001|Overall Study|Other Reason|3|||
163070739|NCT05887908|588963749|FG002|Overall Study|Other Reason|3|||
163070740|NCT03928743|588963750|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
163070741|NCT03928743|588963751|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
163070742|NCT03928743|588963752|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
163070743|NCT03928743|588963750|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
163070744|NCT03928743|588963751|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
163070745|NCT03928743|588963752|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
163070746|NCT03928743|588963750|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
163070747|NCT03928743|588963751|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
163070748|NCT03928743|588963752|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
163070749|NCT03928743|588963750|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
163070750|NCT03928743|588963751|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
163070751|NCT03928743|588963752|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
163070752|NCT03928743|588963750|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
163070753|NCT03928743|588963751|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
163070754|NCT03928743|588963752|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
163070755|NCT03928743|588963750|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
163070756|NCT03928743|588963751|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
163070757|NCT03928743|588963752|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
163070758|NCT03928743|588963750|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
163070759|NCT03928743|588963751|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
163070760|NCT03928743|588963752|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
163070761|NCT03928743|588963750|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
163070762|NCT03928743|588963751|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
163070763|NCT03928743|588963752|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
163070764|NCT03928743|588963750|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
163070765|NCT03928743|588963751|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
163070766|NCT03928743|588963752|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
163070767|NCT03928743|588963750|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
163070768|NCT03928743|588963751|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
163070769|NCT03928743|588963752|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
163070770|NCT03928743|588963750|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
163070771|NCT03928743|588963751|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
163070772|NCT03928743|588963752|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
163070773|NCT03325439|588963755|FG000|Overall Study|Ineligibility|3|||
163070774|NCT02315625|588963756|FG000|First Intervention|Disease Progression|1|||
163070775|NCT02315625|588963757|FG001|First Intervention|Disease Progression|0|||
163070776|NCT02315625|588963756|FG000|Second Intervention|Physician Decision|2|||
163070777|NCT02315625|588963757|FG001|Second Intervention|Physician Decision|1|||
163070778|NCT02315625|588963756|FG000|Second Intervention|Study closure|1|||
163070779|NCT02315625|588963757|FG001|Second Intervention|Study closure|0|||
163331088|NCT00731692|589922491|FG002|Extension Phase|Abnormal test procedure|1|||
163070780|NCT02315625|588963756|FG000|Second Intervention|Disease Progression|1|||
163070781|NCT02315625|588963757|FG001|Second Intervention|Disease Progression|0|||
163070782|NCT06132386|588963758|FG000|Overall Study|ineligble laboratory|1|||
163070783|NCT06132386|588963759|FG001|Overall Study|ineligble laboratory|0|||
163070784|NCT06132386|588963760|FG002|Overall Study|ineligble laboratory|0|||
163070785|NCT06132386|588963761|FG003|Overall Study|ineligble laboratory|0|||
163070786|NCT06132386|588963762|FG004|Overall Study|ineligble laboratory|1|||
163070787|NCT06132386|588963763|FG005|Overall Study|ineligble laboratory|0|||
163070788|NCT06132386|588963758|FG000|Overall Study|ineligible vital signs|0|||
163070789|NCT06132386|588963759|FG001|Overall Study|ineligible vital signs|1|||
163070790|NCT06132386|588963760|FG002|Overall Study|ineligible vital signs|0|||
163070791|NCT06132386|588963761|FG003|Overall Study|ineligible vital signs|0|||
163070792|NCT06132386|588963762|FG004|Overall Study|ineligible vital signs|0|||
163070793|NCT06132386|588963763|FG005|Overall Study|ineligible vital signs|0|||
163070794|NCT02762604|588963764|FG000|Overall Study|Lost to Follow-up|2|||
163070795|NCT02762604|588963765|FG001|Overall Study|Lost to Follow-up|7|||
163070796|NCT02762604|588963764|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
163070797|NCT02762604|588963765|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
163070798|NCT06061952|588963766|FG000|Overall Study|Withdrawal by Subject|1|||
163070799|NCT06061952|588963767|FG001|Overall Study|Withdrawal by Subject|2|||
163331089|NCT00731692|589922489|FG000|Extension Phase|Abnormal lab values|0|||
163331090|NCT00731692|589922490|FG001|Extension Phase|Abnormal lab values|0|||
163331091|NCT00731692|589922491|FG002|Extension Phase|Abnormal lab values|1|||
163331092|NCT00731692|589922489|FG000|Extension Phase|Lost to Follow-up|0|||
163331093|NCT00731692|589922490|FG001|Extension Phase|Lost to Follow-up|1|||
163331094|NCT00731692|589922491|FG002|Extension Phase|Lost to Follow-up|4|||
163331095|NCT00731692|589922489|FG000|Extension Phase|Withdrawal by Subject|4|||
163331096|NCT00731692|589922490|FG001|Extension Phase|Withdrawal by Subject|5|||
163331097|NCT00731692|589922491|FG002|Extension Phase|Withdrawal by Subject|3|||
163331098|NCT00731692|589922489|FG000|Extension Phase|Adverse Event|1|||
163331099|NCT00731692|589922490|FG001|Extension Phase|Adverse Event|1|||
163331100|NCT00731692|589922491|FG002|Extension Phase|Adverse Event|15|||
163331101|NCT00458783|589922492|FG000|Overall Study|Protocol Violation|1228|||
163331102|NCT00458783|589922493|FG001|Overall Study|Protocol Violation|1220|||
163027054|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
163027055|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
163027056|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
163027057|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
163027058|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
163027059|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
163027060|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
163027061|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
163027062|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
163027063|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
163027064|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
163027065|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
163027066|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
163027067|NCT02275780|588801374|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
163027068|NCT02275780|588801375|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
163027069|NCT02275780|588801374|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
163027070|NCT02275780|588801375|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
163027071|NCT02275780|588801374|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
163027072|NCT02275780|588801375|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
163027073|NCT02275780|588801374|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
163027074|NCT02275780|588801375|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
163027075|NCT02275780|588801374|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
163027076|NCT02275780|588801375|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
163027077|NCT02275780|588801374|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
163027078|NCT02275780|588801375|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
163027079|NCT02275780|588801374|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
163027080|NCT02275780|588801375|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
163027081|NCT02275780|588801374|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
163027082|NCT02275780|588801375|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
163027083|NCT02275780|588801374|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
163027084|NCT02275780|588801375|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
163027085|NCT02275780|588801374|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
163027086|NCT02275780|588801375|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
163027087|NCT02275780|588801374|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
163027088|NCT02275780|588801375|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
163027089|NCT02275780|588801374|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
163027090|NCT02275780|588801375|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
163027091|NCT02275780|588801374|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
163027092|NCT02275780|588801375|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
163027093|NCT01054300|588801380|FG000|Period 1|Adverse Event|1|||
163027094|NCT01054300|588801381|FG001|Period 1|Adverse Event|0|||
163027095|NCT01054300|588801382|FG002|Period 1|Adverse Event|0|||
163027096|NCT01054300|588801383|FG003|Period 1|Adverse Event|0|||
163027097|NCT01054300|588801380|FG000|Period 2|Withdrawal by Subject|0|||
163027098|NCT01054300|588801381|FG001|Period 2|Withdrawal by Subject|0|||
163027099|NCT01054300|588801382|FG002|Period 2|Withdrawal by Subject|1|||
163027100|NCT01054300|588801383|FG003|Period 2|Withdrawal by Subject|0|||
163027101|NCT01899742|588801388|FG000|Overall Study|Adverse Event|5|||
163027102|NCT01899742|588801389|FG001|Overall Study|Adverse Event|4|||
163027103|NCT01899742|588801388|FG000|Overall Study|Lack of Efficacy|1|||
163027104|NCT01899742|588801389|FG001|Overall Study|Lack of Efficacy|5|||
163027105|NCT01899742|588801388|FG000|Overall Study|Protocol Violation|2|||
163027106|NCT01899742|588801389|FG001|Overall Study|Protocol Violation|2|||
163027107|NCT01899742|588801388|FG000|Overall Study|Withdrawal by Subject|9|||
163331103|NCT01737398|589922494|FG000|Overall Study|Adverse event or SAE|16|||
163331104|NCT01737398|589922495|FG001|Overall Study|Adverse event or SAE|1|||
163070800|NCT06061952|588963766|FG000|Overall Study|Lost to Follow-up|2|||
163070801|NCT06061952|588963767|FG001|Overall Study|Lost to Follow-up|2|||
163070802|NCT01405911|588963768|FG000|Overall Study|Pre-treatment lab AE|0|||
163070803|NCT01405911|588963769|FG001|Overall Study|Pre-treatment lab AE|1|||
163070804|NCT01405911|588963770|FG002|Overall Study|Pre-treatment lab AE|0|||
163070805|NCT01405911|588963768|FG000|Overall Study|Lost to Follow-up|0|||
163070806|NCT01405911|588963769|FG001|Overall Study|Lost to Follow-up|1|||
163070807|NCT01405911|588963770|FG002|Overall Study|Lost to Follow-up|0|||
163070808|NCT01405911|588963768|FG000|Overall Study|Protocol Violation|1|||
163070809|NCT01405911|588963769|FG001|Overall Study|Protocol Violation|0|||
163070810|NCT01405911|588963770|FG002|Overall Study|Protocol Violation|0|||
163070811|NCT01405911|588963768|FG000|Overall Study|Withdrawal by Subject|3|||
163070812|NCT01405911|588963769|FG001|Overall Study|Withdrawal by Subject|1|||
163070813|NCT01405911|588963770|FG002|Overall Study|Withdrawal by Subject|1|||
163070814|NCT04937387|588963779|FG000|Overall Study|Adverse Event|1|||
163070815|NCT04937387|588963780|FG001|Overall Study|Adverse Event|0|||
163070816|NCT04937387|588963781|FG002|Overall Study|Adverse Event|2|||
163070817|NCT04937387|588963782|FG003|Overall Study|Adverse Event|0|||
163070818|NCT04937387|588963779|FG000|Overall Study|Lack of Efficacy|1|||
163070819|NCT04937387|588963780|FG001|Overall Study|Lack of Efficacy|0|||
163070820|NCT04937387|588963781|FG002|Overall Study|Lack of Efficacy|0|||
163070821|NCT04937387|588963782|FG003|Overall Study|Lack of Efficacy|1|||
163070822|NCT04937387|588963779|FG000|Overall Study|Withdrawal by Subject|1|||
163070823|NCT04937387|588963780|FG001|Overall Study|Withdrawal by Subject|0|||
163070824|NCT04937387|588963781|FG002|Overall Study|Withdrawal by Subject|1|||
163070825|NCT04937387|588963782|FG003|Overall Study|Withdrawal by Subject|1|||
163070826|NCT04937387|588963779|FG000|Overall Study|Randomized in error|0|||
163070827|NCT04937387|588963780|FG001|Overall Study|Randomized in error|0|||
163070828|NCT04937387|588963781|FG002|Overall Study|Randomized in error|0|||
163070829|NCT04937387|588963782|FG003|Overall Study|Randomized in error|1|||
163070830|NCT01039675|588963783|FG000|Overall Study|Adverse Event|0|||
163070831|NCT01039675|588963784|FG001|Overall Study|Adverse Event|2|||
163070832|NCT01039675|588963783|FG000|Overall Study|Lack of Efficacy|0|||
163070833|NCT01039675|588963784|FG001|Overall Study|Lack of Efficacy|2|||
163070834|NCT01039675|588963783|FG000|Overall Study|Withdrawal by Subject|0|||
163070835|NCT01039675|588963784|FG001|Overall Study|Withdrawal by Subject|1|||
163070836|NCT01039675|588963783|FG000|Overall Study|Lost to Follow-up|0|||
163070837|NCT01039675|588963784|FG001|Overall Study|Lost to Follow-up|1|||
163070838|NCT01039675|588963783|FG000|Overall Study|Physician Decision|0|||
163070839|NCT01039675|588963784|FG001|Overall Study|Physician Decision|1|||
163070840|NCT03514017|588963789|FG000|Overall Study|Death|1|||
163070841|NCT03514017|588963789|FG000|Overall Study|Adverse Event|1|||
163070842|NCT01807520|588964702|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
163070843|NCT01807520|588964703|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
163070844|NCT01807520|588964704|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
163070845|NCT01807520|588964705|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
163070846|NCT01807520|588964706|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
163070847|NCT01807520|588964707|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
163070848|NCT01807520|588964708|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
163070849|NCT01807520|588964702|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
163070850|NCT01807520|588964703|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
163070851|NCT01807520|588964704|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
163070852|NCT01807520|588964705|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
163070853|NCT01807520|588964706|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
163070854|NCT01807520|588964707|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
163070855|NCT01807520|588964708|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
163070856|NCT01807520|588964702|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
163070857|NCT01807520|588964703|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
163070858|NCT01807520|588964704|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
163070859|NCT01807520|588964705|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
163070860|NCT01807520|588964706|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
163070861|NCT01807520|588964707|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
163070862|NCT01807520|588964708|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
163070863|NCT01807520|588964702|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
163070864|NCT01807520|588964703|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
163070865|NCT01807520|588964704|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
163070866|NCT01807520|588964705|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
163070867|NCT01807520|588964706|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
163070868|NCT01807520|588964707|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
163070869|NCT01807520|588964708|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
163070870|NCT01807520|588964702|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
163070871|NCT01807520|588964703|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
163070872|NCT01807520|588964704|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
163070873|NCT01807520|588964705|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
163070874|NCT01807520|588964706|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
163070875|NCT01807520|588964707|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
163070876|NCT01807520|588964708|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
163070877|NCT01807520|588964702|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
163070878|NCT01807520|588964703|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
163070879|NCT01807520|588964704|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
163070880|NCT01807520|588964705|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
163070881|NCT01807520|588964706|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
163070882|NCT01807520|588964707|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
163070883|NCT01807520|588964708|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
163070884|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
163070885|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
163070886|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
163070887|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
163070888|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
163070889|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
163070890|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
163070891|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
163070892|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
163070893|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
163070894|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
163070895|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
163070896|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
163070897|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
163070898|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
163070899|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
163070900|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
163070901|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
163070902|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
163070903|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
163070904|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
163070905|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
163070906|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
163070907|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
163070908|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
163070909|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
163070910|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
163070911|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
163070912|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
163070913|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
163070914|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
163070915|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
163070916|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
163070917|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
163070918|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
163070919|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
163070920|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
163070921|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
163070922|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
163070923|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
163070924|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
163070925|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
163070926|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
163070927|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
163070928|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
163070929|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
163070930|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
163070931|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
163070932|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
163070933|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
163070934|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
163070935|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
163070936|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
163070937|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
163217967|NCT00302458|589513875|FG000|Overall Study|Withdrawal by Subject|1|||
163217968|NCT00853723|589513878|FG000|Overall Study|Adverse Event|3|||
163217969|NCT00853723|589513879|FG001|Overall Study|Adverse Event|4|||
163070938|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
163070939|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
163070940|NCT01807520|588964702|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
163070941|NCT01807520|588964703|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
163070942|NCT01807520|588964704|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
163070943|NCT01807520|588964705|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
163070944|NCT01807520|588964706|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
163070945|NCT01807520|588964707|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
163070946|NCT01807520|588964708|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
163070947|NCT01807520|588964702|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
163070948|NCT01807520|588964703|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
163070949|NCT01807520|588964704|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
163070950|NCT01807520|588964705|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
163070951|NCT01807520|588964706|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
163070952|NCT01807520|588964707|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
163070953|NCT01807520|588964708|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
163070954|NCT01807520|588964702|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
163070955|NCT01807520|588964703|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
163070956|NCT01807520|588964704|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
163070957|NCT01807520|588964705|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
163070958|NCT01807520|588964706|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
163070959|NCT01807520|588964707|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
163070960|NCT01807520|588964708|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
163070961|NCT03600350|588964712|FG000|Overall Study|Death|1|||
163070962|NCT03600350|588964712|FG000|Overall Study|On Follow Up|18|||
163070963|NCT02400736|588964713|FG000|Overall Study|Lost to Follow-up|6|||
163070964|NCT02400736|588964714|FG001|Overall Study|Lost to Follow-up|6|||
163070965|NCT02400736|588964713|FG000|Overall Study|Withdrawal by Subject|2|||
163070966|NCT02400736|588964714|FG001|Overall Study|Withdrawal by Subject|1|||
163070967|NCT02400736|588964713|FG000|Overall Study|Moved from the area|3|||
163070968|NCT02400736|588964714|FG001|Overall Study|Moved from the area|1|||
163070969|NCT01771913|588964715|FG000|Overall Study|Withdrawal by Subject|1|||
163070970|NCT01771913|588964716|FG001|Overall Study|Withdrawal by Subject|0|||
163070971|NCT00552058|588964717|FG000|Overall Study|Adverse Event|8|||
163070972|NCT00552058|588964718|FG001|Overall Study|Adverse Event|7|||
163070973|NCT00552058|588964717|FG000|Overall Study|Lack of Efficacy|1|||
163070974|NCT00552058|588964718|FG001|Overall Study|Lack of Efficacy|5|||
163070975|NCT00552058|588964717|FG000|Overall Study|Lost to Follow-up|1|||
163070976|NCT00552058|588964718|FG001|Overall Study|Lost to Follow-up|0|||
163070977|NCT00552058|588964717|FG000|Overall Study|Withdrawal by Subject|4|||
163070978|NCT00552058|588964718|FG001|Overall Study|Withdrawal by Subject|4|||
163070979|NCT00552058|588964717|FG000|Overall Study|Other: Protocol Violation|0|||
163070980|NCT00552058|588964718|FG001|Overall Study|Other: Protocol Violation|1|||
163070981|NCT00552058|588964717|FG000|Overall Study|Other: Non Compliance|1|||
163070982|NCT00552058|588964718|FG001|Overall Study|Other: Non Compliance|2|||
163070983|NCT00552058|588964717|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
163070984|NCT00552058|588964718|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
163070985|NCT00552058|588964717|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
163070986|NCT00552058|588964718|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
163070987|NCT00552058|588964717|FG000|Overall Study|Other: Positive Stool Result|0|||
163070988|NCT00552058|588964718|FG001|Overall Study|Other: Positive Stool Result|1|||
163070989|NCT00552058|588964717|FG000|Overall Study|Other: Randomized in error|0|||
163070990|NCT00552058|588964718|FG001|Overall Study|Other: Randomized in error|1|||
163070991|NCT00552058|588964717|FG000|Overall Study|Other: Sponsors Decision|0|||
163070992|NCT00552058|588964718|FG001|Overall Study|Other: Sponsors Decision|1|||
163070993|NCT00552058|588964717|FG000|Overall Study|Other: Early Roll Over|1|||
163070994|NCT00552058|588964718|FG001|Overall Study|Other: Early Roll Over|0|||
163070995|NCT01028053|588964725|FG000|Overall Study|Screen Failure|113|||
163070996|NCT01028053|588964725|FG000|Overall Study|Patient Request|11|||
163070997|NCT01028053|588964725|FG000|Overall Study|Protocol Violation|1|||
163070998|NCT01028053|588964725|FG000|Overall Study|Physician Decision|2|||
163070999|NCT01028053|588964725|FG000|Overall Study|Technical Problem|1|||
163071000|NCT01028053|588964725|FG000|Overall Study|Terminated by Sponsor|1|||
163071001|NCT01028053|588964725|FG000|Overall Study|Various reasons|4|||
163217970|NCT00853723|589513880|FG002|Overall Study|Adverse Event|1|||
163217971|NCT00853723|589513878|FG000|Overall Study|Withdrawal by Subject|2|||
163217972|NCT00853723|589513879|FG001|Overall Study|Withdrawal by Subject|1|||
163071002|NCT01177410|588964726|FG000|Overall Study|Adverse Event|0|||
163071003|NCT01177410|588964727|FG001|Overall Study|Adverse Event|2|||
163071004|NCT01177410|588964728|FG002|Overall Study|Adverse Event|2|||
163071005|NCT01177410|588964726|FG000|Overall Study|Withdrawal by Subject|1|||
163071006|NCT01177410|588964727|FG001|Overall Study|Withdrawal by Subject|4|||
163071007|NCT01177410|588964728|FG002|Overall Study|Withdrawal by Subject|3|||
163217973|NCT00853723|589513880|FG002|Overall Study|Withdrawal by Subject|0|||
163071008|NCT01177410|588964726|FG000|Overall Study|Lost to Follow-up|0|||
163071009|NCT01177410|588964727|FG001|Overall Study|Lost to Follow-up|1|||
163071010|NCT01177410|588964728|FG002|Overall Study|Lost to Follow-up|0|||
163071011|NCT00471354|588964729|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
163217974|NCT00853723|589513878|FG000|Overall Study|Protocol Violation|1|||
163217975|NCT00853723|589513879|FG001|Overall Study|Protocol Violation|2|||
163217976|NCT00853723|589513880|FG002|Overall Study|Protocol Violation|1|||
163217977|NCT04248933|589513881|FG000|Overall Study|Lost to Follow-up|9|||
163217978|NCT04248933|589513881|FG000|Overall Study|Withdrawal by Subject|2|||
163071012|NCT00471354|588964729|FG000|Overall Study|Adverse Event|13|||
163071013|NCT00471354|588964729|FG000|Overall Study|Protocol Violation|12|||
163071014|NCT00471354|588964729|FG000|Overall Study|Withdrawal by Subject|1|||
163071015|NCT00471354|588964729|FG000|Overall Study|Physician Decision|4|||
163071016|NCT00471354|588964729|FG000|Overall Study|Sponsor Decision|1|||
163071017|NCT00471354|588964729|FG000|Overall Study|Lost to Follow-up|3|||
163071018|NCT00471354|588964729|FG000|Overall Study|Lack of Efficacy|5|||
163071019|NCT00471354|588964729|FG000|Overall Study|Patient/Caregiver Decision|12|||
163071020|NCT05558410|588964730|FG000|Overall Study|Adverse Event|1|||
163071021|NCT05558410|588964731|FG001|Overall Study|Adverse Event|2|||
163071022|NCT05558410|588964732|FG002|Overall Study|Adverse Event|0|||
163071023|NCT05558410|588964730|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
163071024|NCT05558410|588964731|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
163071025|NCT05558410|588964732|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
163071026|NCT05558410|588964730|FG000|Overall Study|Lost to Follow-up|10|||
163071027|NCT05558410|588964731|FG001|Overall Study|Lost to Follow-up|17|||
163071028|NCT05558410|588964732|FG002|Overall Study|Lost to Follow-up|19|||
163071029|NCT05558410|588964730|FG000|Overall Study|Death|1|||
163071030|NCT05558410|588964731|FG001|Overall Study|Death|0|||
163071031|NCT05558410|588964732|FG002|Overall Study|Death|0|||
163071032|NCT05558410|588964730|FG000|Overall Study|Other non-compliance|0|||
163071033|NCT05558410|588964731|FG001|Overall Study|Other non-compliance|1|||
163071034|NCT05558410|588964732|FG002|Overall Study|Other non-compliance|2|||
163071035|NCT05558410|588964730|FG000|Overall Study|Sponsor Decision|1|||
163071036|NCT05558410|588964731|FG001|Overall Study|Sponsor Decision|0|||
163071037|NCT05558410|588964732|FG002|Overall Study|Sponsor Decision|0|||
163071038|NCT05558410|588964730|FG000|Overall Study|Other|1|||
163071039|NCT05558410|588964731|FG001|Overall Study|Other|0|||
163071040|NCT05558410|588964732|FG002|Overall Study|Other|1|||
163071041|NCT01336972|588964736|FG000|Overall Study|Adverse Event|1|||
163071042|NCT01336972|588964737|FG001|Overall Study|Adverse Event|1|||
163071043|NCT01336972|588964738|FG002|Overall Study|Adverse Event|0|||
163071044|NCT03446573|588964739|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
163071045|NCT03446573|588964740|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
163071046|NCT03446573|588964739|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
163071047|NCT03446573|588964740|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
163071048|NCT03446573|588964739|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
163071049|NCT03446573|588964740|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
163071050|NCT03446573|588964739|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
163071051|NCT03446573|588964740|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
163071052|NCT03446573|588964739|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
163071053|NCT03446573|588964740|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
163071054|NCT03446573|588964739|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
163071055|NCT03446573|588964740|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
163071056|NCT03446573|588964739|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
163071057|NCT03446573|588964740|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
163071058|NCT03446573|588964739|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
163071059|NCT03446573|588964740|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
163071060|NCT03446573|588964739|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
163071061|NCT03446573|588964740|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
163071062|NCT03446573|588964739|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
163071063|NCT03446573|588964740|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
163217979|NCT02642432|589513884|FG000|Overall Study|Adverse Event|2|||
163071064|NCT03446573|588964739|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
163071065|NCT03446573|588964740|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
163071066|NCT03446573|588964739|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
163071067|NCT03446573|588964740|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
163071068|NCT03446573|588964739|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
163071069|NCT03446573|588964740|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
163071070|NCT02639559|588964741|FG000|Overall Study|Mobilization failure|0|||
163071071|NCT02639559|588964742|FG001|Overall Study|Mobilization failure|3|||
163071072|NCT02639559|588964741|FG000|Overall Study|Issues with vascular acess|1|||
163217980|NCT02642432|589513884|FG000|Overall Study|Withdrew Consent|1|||
163217981|NCT02642432|589513884|FG000|Overall Study|Lost to Follow-up|2|||
163071073|NCT02639559|588964742|FG001|Overall Study|Issues with vascular acess|0|||
163071074|NCT03142750|588964745|FG000|Overall Study|Lost to Follow-up|4|||
163071075|NCT03142750|588964746|FG001|Overall Study|Lost to Follow-up|1|||
163071076|NCT00471107|588964751|FG000|Overall Study|Technical problems/data loss|3|||
163071077|NCT00471107|588964752|FG001|Overall Study|Technical problems/data loss|1|||
163071078|NCT00471107|588964753|FG002|Overall Study|Technical problems/data loss|3|||
163071079|NCT04828486|588964759|FG000|Overall Study|Adverse Event|2|||
163071080|NCT04828486|588964759|FG000|Overall Study|Death|1|||
163071081|NCT04828486|588964759|FG000|Overall Study|Disease Progression|8|||
163071082|NCT04828486|588964759|FG000|Overall Study|Other Complicating Disease|1|||
163071083|NCT04828486|588964759|FG000|Overall Study|Withdrawal by Subject|1|||
163071084|NCT06204887|588964760|FG000|Overall Study|Lost to Follow-up|3|||
163071085|NCT06204887|588964761|FG001|Overall Study|Lost to Follow-up|4|||
163071086|NCT06204887|588964762|FG002|Overall Study|Lost to Follow-up|1|||
163071087|NCT06204887|588964763|FG003|Overall Study|Lost to Follow-up|6|||
163071088|NCT03833167|588964767|FG000|Overall Study|Withdrawal by Subject|4|||
163071089|NCT03833167|588964768|FG001|Overall Study|Withdrawal by Subject|6|||
163071090|NCT03833167|588964767|FG000|Overall Study|Ongoing|186|||
163071091|NCT03833167|588964768|FG001|Overall Study|Ongoing|194|||
163071092|NCT03833167|588964767|FG000|Overall Study|Lost to Follow-up|1|||
163071093|NCT03833167|588964768|FG001|Overall Study|Lost to Follow-up|1|||
163071094|NCT03833167|588964767|FG000|Overall Study|Physician Decision|0|||
163071095|NCT03833167|588964768|FG001|Overall Study|Physician Decision|2|||
163071096|NCT03833167|588964767|FG000|Overall Study|Death|34|||
163071097|NCT03833167|588964768|FG001|Overall Study|Death|22|||
163071098|NCT02227199|588964770|FG000|Overall Study|Physician Decision|0|||
163071099|NCT02227199|588964771|FG001|Overall Study|Physician Decision|0|||
163071100|NCT02227199|588964772|FG002|Overall Study|Physician Decision|1|||
163071101|NCT02227199|588964770|FG000|Overall Study|Adverse Event|0|||
163071102|NCT02227199|588964771|FG001|Overall Study|Adverse Event|0|||
163071103|NCT02227199|588964772|FG002|Overall Study|Adverse Event|3|||
163071104|NCT01428128|588964773|FG000|Overall Study|Withdrawal by Subject|4|||
163071105|NCT01428128|588964773|FG000|Overall Study|Screen failure by p53|10|||
163071106|NCT01428128|588964773|FG000|Overall Study|Received Neulasta in one cycle|2|||
163071107|NCT01428128|588964773|FG000|Overall Study|Adverse Event|1|||
163071108|NCT03003962|588964774|FG000|Overall Study|Withdrawal by Subject|5|||
163071109|NCT03003962|588964775|FG001|Overall Study|Withdrawal by Subject|17|||
163071110|NCT03003962|588964774|FG000|Overall Study|Death|274|||
163071111|NCT03003962|588964775|FG001|Overall Study|Death|277|||
163071112|NCT03003962|588964774|FG000|Overall Study|Participants ongoing at DCO|55|||
163071113|NCT03003962|588964775|FG001|Overall Study|Participants ongoing at DCO|40|||
163071114|NCT05179603|588964776|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
163071115|NCT05179603|588964776|FG000|Overall Study|Withdrawal by Subject|1|||
163071116|NCT05179603|588964776|FG000|Overall Study|Progressive disease|4|||
163071117|NCT05179603|588964776|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
163071118|NCT05937373|588964777|FG000|Overall Study|Out of Window|2|||
163071119|NCT05937373|588964778|FG001|Overall Study|Out of Window|0|||
163071120|NCT05937373|588964777|FG000|Overall Study|Device fell off prior to date of surgery|0|||
163071121|NCT05937373|588964778|FG001|Overall Study|Device fell off prior to date of surgery|2|||
163071122|NCT04337021|588964780|FG000|Overall Study|Lost to Follow-up|54|||
163071123|NCT04337021|588964781|FG001|Overall Study|Lost to Follow-up|66|||
163071124|NCT06375655|588964782|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
163071125|NCT06375655|588964783|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
163071126|NCT01685437|588964784|FG000|Overall Study|Withdrawal by Subject|22|||
163071127|NCT01685437|588964784|FG000|Overall Study|Lost to Follow-up|3|||
163071128|NCT01685437|588964784|FG000|Overall Study|Adverse Event|1|||
163071129|NCT01685437|588964784|FG000|Overall Study|Protocol Violation|4|||
163071130|NCT01685437|588964784|FG000|Overall Study|Unable to make visits due to work|1|||
163071131|NCT00567580|588966035|FG000|Overall Study|Protocol Violation|28|||
163071132|NCT00567580|588966036|FG001|Overall Study|Protocol Violation|24|||
163071133|NCT00567580|588966037|FG002|Overall Study|Protocol Violation|24|||
163071134|NCT00134719|588966038|FG000|Primary Vaccination Phase|Adverse Event|4|||
163071135|NCT00134719|588966039|FG001|Primary Vaccination Phase|Adverse Event|0|||
163071136|NCT00134719|588966040|FG002|Primary Vaccination Phase|Adverse Event|0|||
163071137|NCT00134719|588966038|FG000|Primary Vaccination Phase|Protocol Violation|1|||
163071138|NCT00134719|588966039|FG001|Primary Vaccination Phase|Protocol Violation|0|||
163071139|NCT00134719|588966040|FG002|Primary Vaccination Phase|Protocol Violation|0|||
163217982|NCT02642432|589513884|FG000|Overall Study|Other|3|||
163071140|NCT00134719|588966038|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
163071141|NCT00134719|588966039|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
163071142|NCT00134719|588966040|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
163071143|NCT00134719|588966038|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
163217983|NCT02447081|589513885|FG000|Overall Study|Death|161|||
163217984|NCT02447081|589513885|FG000|Overall Study|Lost to Follow-up|36|||
163217985|NCT02447081|589513885|FG000|Overall Study|Visit not completed|17|||
163217986|NCT02447081|589513885|FG000|Overall Study|unsuccessful implant procedure|10|||
163217987|NCT02867709|589513888|FG000|Treatment Period|Adverse Event|1|||
163071144|NCT00134719|588966039|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
163071145|NCT00134719|588966040|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
163071146|NCT00134719|588966038|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
163071147|NCT00134719|588966039|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
163071148|NCT00134719|588966040|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
163071149|NCT00134719|588966038|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
163071150|NCT00134719|588966039|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
163071151|NCT00134719|588966040|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
163071152|NCT00620035|588966041|FG000|Overall Study|Adverse Event|106|||
163071153|NCT00620035|588966041|FG000|Overall Study|Withdrawal of Informed Consent|1|||
163071154|NCT00620035|588966041|FG000|Overall Study|Other Reason|38|||
163071155|NCT01002105|588966042|FG000|Overall Study|Lost to Follow-up|10|||
163071156|NCT01002105|588966043|FG001|Overall Study|Lost to Follow-up|16|||
163071157|NCT01002105|588966042|FG000|Overall Study|non compliance|5|||
163071158|NCT01002105|588966043|FG001|Overall Study|non compliance|3|||
163071159|NCT01002105|588966042|FG000|Overall Study|condition worsened|4|||
163071160|NCT01002105|588966043|FG001|Overall Study|condition worsened|2|||
163071161|NCT00845182|588966044|FG000|Overall Study|Lost to Follow-up|3|||
163071162|NCT00845182|588966045|FG001|Overall Study|Lost to Follow-up|3|||
163071163|NCT00845182|588966046|FG002|Overall Study|Lost to Follow-up|4|||
163071164|NCT00845182|588966044|FG000|Overall Study|Adverse Event|0|||
163071165|NCT00845182|588966045|FG001|Overall Study|Adverse Event|1|||
163071166|NCT00845182|588966046|FG002|Overall Study|Adverse Event|1|||
163071167|NCT00845182|588966044|FG000|Overall Study|Physician Decision|0|||
163071168|NCT00845182|588966045|FG001|Overall Study|Physician Decision|0|||
163071169|NCT00845182|588966046|FG002|Overall Study|Physician Decision|1|||
163071170|NCT04621760|588966047|FG000|Overall Study|Lost to Follow-up|2|||
163217988|NCT02867709|589513889|FG001|Treatment Period|Adverse Event|1|||
163217989|NCT02867709|589513890|FG002|Treatment Period|Adverse Event|2|||
163217990|NCT02867709|589513888|FG000|Treatment Period|Withdrawal of Consent|7|||
163217991|NCT02867709|589513889|FG001|Treatment Period|Withdrawal of Consent|9|||
163217992|NCT02867709|589513890|FG002|Treatment Period|Withdrawal of Consent|8|||
163027108|NCT01899742|588801389|FG001|Overall Study|Withdrawal by Subject|5|||
163027109|NCT00738881|588801393|FG000|Overall Study|Withdrawal by Subject|0|||
163027110|NCT00738881|588801394|FG001|Overall Study|Withdrawal by Subject|2|||
163027111|NCT02662764|588801395|FG000|Overall Study|Adverse Event|6|||
163027112|NCT02662764|588801395|FG000|Overall Study|Lack of Efficacy|8|||
163027113|NCT02662764|588801395|FG000|Overall Study|Protocol Violation|1|||
163027114|NCT02662764|588801395|FG000|Overall Study|Withdrawal by Subject|5|||
163027115|NCT02662764|588801395|FG000|Overall Study|Device failure|4|||
163027116|NCT02662764|588801395|FG000|Overall Study|Patient changed treatment|1|||
163027117|NCT02662764|588801395|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
163027118|NCT00177307|588801397|FG000|Overall Study|Withdrawal by Subject|1|||
163027119|NCT01282164|588801400|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
163027120|NCT01282164|588801401|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
163027121|NCT04521621|588801402|FG000|Overall Study|Death|17|||
163027122|NCT04521621|588801403|FG001|Overall Study|Death|8|||
163027123|NCT04521621|588801404|FG002|Overall Study|Death|8|||
163027124|NCT04521621|588801405|FG003|Overall Study|Death|5|||
163027125|NCT04521621|588801406|FG004|Overall Study|Death|2|||
163027126|NCT04521621|588801407|FG005|Overall Study|Death|7|||
163027127|NCT04521621|588801408|FG006|Overall Study|Death|0|||
163027128|NCT04521621|588801409|FG007|Overall Study|Death|0|||
163071171|NCT04621760|588966048|FG001|Overall Study|Lost to Follow-up|4|||
163071172|NCT04621760|588966047|FG000|Overall Study|Withdrawal by Subject|1|||
163071173|NCT04621760|588966048|FG001|Overall Study|Withdrawal by Subject|0|||
163071174|NCT05141357|588966049|FG000|Overall Study|Adverse Event|3|||
163071175|NCT05141357|588966049|FG000|Overall Study|Lack of Efficacy|2|||
163071176|NCT01028560|588966050|FG000|Overall Study|Lack of Efficacy|3|||
163071177|NCT01028560|588966051|FG001|Overall Study|Lack of Efficacy|6|||
163071178|NCT01028560|588966050|FG000|Overall Study|Withdrawal by Subject|7|||
163071179|NCT01028560|588966051|FG001|Overall Study|Withdrawal by Subject|12|||
163071180|NCT01960842|588966054|FG000|Overall Study|Adverse Event|1|||
163071181|NCT01960842|588966054|FG000|Overall Study|Withdrawal by Subject|2|||
163071182|NCT02029443|588966056|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
163071183|NCT02029443|588966057|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
163071184|NCT02029443|588966058|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
163071185|NCT02029443|588966059|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
163071186|NCT02029443|588966060|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
163071187|NCT02029443|588966056|FG000|Overall Study|Death|13|||
163027129|NCT04521621|588801402|FG000|Overall Study|Study Terminated by Sponsor|4|||
163027130|NCT04521621|588801403|FG001|Overall Study|Study Terminated by Sponsor|6|||
163027131|NCT04521621|588801404|FG002|Overall Study|Study Terminated by Sponsor|8|||
163027132|NCT04521621|588801405|FG003|Overall Study|Study Terminated by Sponsor|0|||
163217993|NCT02867709|589513888|FG000|Treatment Period|Lost to Follow-up|17|||
163217994|NCT02867709|589513889|FG001|Treatment Period|Lost to Follow-up|20|||
163217995|NCT02867709|589513890|FG002|Treatment Period|Lost to Follow-up|20|||
163071188|NCT02029443|588966057|FG001|Overall Study|Death|2|||
163071189|NCT02029443|588966058|FG002|Overall Study|Death|2|||
163071190|NCT02029443|588966059|FG003|Overall Study|Death|11|||
163071191|NCT02029443|588966060|FG004|Overall Study|Death|2|||
163071192|NCT02029443|588966056|FG000|Overall Study|Lost to Follow-up|1|||
163071193|NCT02029443|588966057|FG001|Overall Study|Lost to Follow-up|0|||
163071194|NCT02029443|588966058|FG002|Overall Study|Lost to Follow-up|1|||
163071195|NCT02029443|588966059|FG003|Overall Study|Lost to Follow-up|1|||
163071196|NCT02029443|588966060|FG004|Overall Study|Lost to Follow-up|0|||
163071197|NCT02029443|588966056|FG000|Overall Study|Started other anti-cancer therapy|17|||
163071198|NCT02029443|588966057|FG001|Overall Study|Started other anti-cancer therapy|4|||
163071199|NCT02029443|588966058|FG002|Overall Study|Started other anti-cancer therapy|7|||
163071200|NCT02029443|588966059|FG003|Overall Study|Started other anti-cancer therapy|9|||
163071201|NCT02029443|588966060|FG004|Overall Study|Started other anti-cancer therapy|3|||
163071202|NCT02029443|588966056|FG000|Overall Study|Withdrawal by Subject|3|||
163071203|NCT02029443|588966057|FG001|Overall Study|Withdrawal by Subject|1|||
163071204|NCT02029443|588966058|FG002|Overall Study|Withdrawal by Subject|1|||
163071205|NCT02029443|588966059|FG003|Overall Study|Withdrawal by Subject|1|||
163071206|NCT02029443|588966060|FG004|Overall Study|Withdrawal by Subject|0|||
163071207|NCT02029443|588966056|FG000|Overall Study|Other|6|||
163071208|NCT02029443|588966057|FG001|Overall Study|Other|6|||
163071209|NCT02029443|588966058|FG002|Overall Study|Other|4|||
163071210|NCT02029443|588966059|FG003|Overall Study|Other|2|||
163071211|NCT02029443|588966060|FG004|Overall Study|Other|0|||
163071212|NCT03123588|588966061|FG000|Overall Study|Study Terminated by Sponsor|2|||
163071213|NCT03123588|588966062|FG001|Overall Study|Study Terminated by Sponsor|5|||
163071214|NCT03123588|588966061|FG000|Overall Study|Withdrawal by Subject|1|||
163071215|NCT03123588|588966062|FG001|Overall Study|Withdrawal by Subject|0|||
163071216|NCT03123588|588966061|FG000|Overall Study|Adverse Event|1|||
163071217|NCT03123588|588966062|FG001|Overall Study|Adverse Event|0|||
163071218|NCT03123588|588966061|FG000|Overall Study|Physician Decision|2|||
163071219|NCT03123588|588966062|FG001|Overall Study|Physician Decision|1|||
163071220|NCT04740567|588966063|FG000|Overall Study|Death|31|||
163071221|NCT04740567|588966064|FG001|Overall Study|Death|43|||
163071222|NCT04740567|588966063|FG000|Overall Study|Lost to Follow-up|2|||
163071223|NCT04740567|588966064|FG001|Overall Study|Lost to Follow-up|11|||
163071224|NCT04740567|588966063|FG000|Overall Study|Patient declined to participate|13|||
163071225|NCT04740567|588966064|FG001|Overall Study|Patient declined to participate|26|||
163071226|NCT04740567|588966063|FG000|Overall Study|Patient was physically incapable|1|||
163071227|NCT04740567|588966064|FG001|Overall Study|Patient was physically incapable|3|||
163071228|NCT04740567|588966063|FG000|Overall Study|Patient's spouse was had prolongued ICU stay|0|||
163071229|NCT04740567|588966064|FG001|Overall Study|Patient's spouse was had prolongued ICU stay|1|||
163071230|NCT02063724|588966065|FG000|Overall Study|Disease progression|1|||
163071231|NCT00896233|588966066|FG000|Overall Study|Claustrophobia during MRI|1|||
163071232|NCT02697422|588966067|FG000|Overall Study|Declined exit survey|9|||
163071233|NCT02697422|588966068|FG001|Overall Study|Declined exit survey|2|||
163071234|NCT02697422|588966067|FG000|Overall Study|Lost to Follow-up|13|||
163071235|NCT02697422|588966068|FG001|Overall Study|Lost to Follow-up|8|||
163071236|NCT02697422|588966067|FG000|Overall Study|Death|2|||
163071237|NCT02697422|588966068|FG001|Overall Study|Death|1|||
163071238|NCT02697422|588966067|FG000|Overall Study|Withdrawal by Subject|0|||
163071239|NCT02697422|588966068|FG001|Overall Study|Withdrawal by Subject|1|||
163071240|NCT02697422|588966067|FG000|Overall Study|Physician Decision|1|||
163071241|NCT02697422|588966068|FG001|Overall Study|Physician Decision|1|||
163071242|NCT02697422|588966067|FG000|Overall Study|Exit survey data lost|1|||
163071243|NCT02697422|588966068|FG001|Overall Study|Exit survey data lost|0|||
163071244|NCT02068599|588966070|FG000|Overall Study|Adverse Event|4|||
163071245|NCT02068599|588966071|FG001|Overall Study|Adverse Event|1|||
163071246|NCT02068599|588966072|FG002|Overall Study|Adverse Event|1|||
163071247|NCT02068599|588966070|FG000|Overall Study|Withdrawal by Subject|2|||
163071248|NCT02068599|588966071|FG001|Overall Study|Withdrawal by Subject|7|||
163071249|NCT02068599|588966072|FG002|Overall Study|Withdrawal by Subject|5|||
163071250|NCT02068599|588966070|FG000|Overall Study|Protocol Violation|4|||
163071251|NCT02068599|588966071|FG001|Overall Study|Protocol Violation|2|||
163071252|NCT02068599|588966072|FG002|Overall Study|Protocol Violation|3|||
163071253|NCT02068599|588966070|FG000|Overall Study|Lost to Follow-up|1|||
163071254|NCT02068599|588966071|FG001|Overall Study|Lost to Follow-up|0|||
163071255|NCT02068599|588966072|FG002|Overall Study|Lost to Follow-up|0|||
163071256|NCT02068599|588966070|FG000|Overall Study|Lack of Efficacy|0|||
163071257|NCT02068599|588966071|FG001|Overall Study|Lack of Efficacy|0|||
163071258|NCT02068599|588966072|FG002|Overall Study|Lack of Efficacy|3|||
163071259|NCT02068599|588966070|FG000|Overall Study|Noncompliance|0|||
163071260|NCT02068599|588966071|FG001|Overall Study|Noncompliance|0|||
163071261|NCT02068599|588966072|FG002|Overall Study|Noncompliance|1|||
163071262|NCT01263028|588966073|FG000|Overall Study|Withdrawal by Subject|1|||
163071263|NCT01263028|588966073|FG000|Overall Study|Adverse Event|1|||
163071264|NCT01263028|588966073|FG000|Overall Study|Study terminated due to low enrollment.|4|||
163071265|NCT03019588|588966074|FG000|Overall Study|Death|44|||
163071266|NCT03019588|588966075|FG001|Overall Study|Death|46|||
163071267|NCT03019588|588966074|FG000|Overall Study|Study terminated by Sponsor|3|||
163071268|NCT03019588|588966075|FG001|Overall Study|Study terminated by Sponsor|1|||
163071269|NCT00366535|588966076|FG000|First Phase: 12 Weeks|Adverse Event|1|||
163071270|NCT00366535|588966077|FG001|First Phase: 12 Weeks|Adverse Event|3|||
163071271|NCT00366535|588966076|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
163071272|NCT00366535|588966077|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
163071273|NCT00366535|588966076|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
163071274|NCT00366535|588966077|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
163071275|NCT00366535|588966076|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
163071276|NCT00366535|588966077|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
163071277|NCT02958527|588966082|FG000|Overall Study|Not collected CRFs|12|||
163071278|NCT06042855|588966085|FG000|Overall Study|No Receipt of Study Drug|48|||
163071279|NCT06042855|588966086|FG001|Overall Study|No Receipt of Study Drug|57|||
163071280|NCT06042855|588966085|FG000|Overall Study|Administratively Withdrawn|59|||
163071281|NCT06042855|588966086|FG001|Overall Study|Administratively Withdrawn|59|||
163071282|NCT02939781|588966092|FG000|Overall Study|Protocol Violation|8|||
163071283|NCT02939781|588966092|FG000|Overall Study|Withdrawal by Subject|1|||
163071284|NCT06100250|588966093|FG000|Overall Study|Lost to Follow-up|5|||
163071285|NCT05259033|588966096|FG000|Overall Study|Withdrawal by Subject|10|||
163071286|NCT05259033|588966097|FG001|Overall Study|Withdrawal by Subject|5|||
163071287|NCT05259033|588966096|FG000|Overall Study|Lost to Follow-up|1|||
163071288|NCT05259033|588966097|FG001|Overall Study|Lost to Follow-up|0|||
163071289|NCT05259033|588966096|FG000|Overall Study|Death|2|||
163071290|NCT05259033|588966097|FG001|Overall Study|Death|0|||
163071291|NCT05537571|588966098|FG000|Overall Study|Withdrawal by Subject|1|||
163071292|NCT05537571|588966099|FG001|Overall Study|Withdrawal by Subject|1|||
163071293|NCT05537571|588966100|FG002|Overall Study|Withdrawal by Subject|0|||
163071294|NCT05537571|588966101|FG003|Overall Study|Withdrawal by Subject|0|||
163071295|NCT05537571|588966102|FG004|Overall Study|Withdrawal by Subject|0|||
163071296|NCT05537571|588966098|FG000|Overall Study|Adverse Event|2|||
163071297|NCT05537571|588966099|FG001|Overall Study|Adverse Event|0|||
163071298|NCT05537571|588966100|FG002|Overall Study|Adverse Event|0|||
163071299|NCT05537571|588966101|FG003|Overall Study|Adverse Event|0|||
163071300|NCT05537571|588966102|FG004|Overall Study|Adverse Event|0|||
163071301|NCT05537571|588966098|FG000|Overall Study|Hepatitis A screening result|2|||
163071302|NCT05537571|588966099|FG001|Overall Study|Hepatitis A screening result|0|||
163071303|NCT05537571|588966100|FG002|Overall Study|Hepatitis A screening result|0|||
163071304|NCT05537571|588966101|FG003|Overall Study|Hepatitis A screening result|0|||
163071305|NCT05537571|588966102|FG004|Overall Study|Hepatitis A screening result|0|||
163071306|NCT05537571|588966098|FG000|Overall Study|Lost to Follow-up|0|||
163071307|NCT05537571|588966099|FG001|Overall Study|Lost to Follow-up|0|||
163071308|NCT05537571|588966100|FG002|Overall Study|Lost to Follow-up|1|||
163071309|NCT05537571|588966101|FG003|Overall Study|Lost to Follow-up|0|||
163071310|NCT05537571|588966102|FG004|Overall Study|Lost to Follow-up|1|||
163071311|NCT00424008|588966103|FG000|Overall Study|Adverse Event|8|||
163071312|NCT00424008|588966104|FG001|Overall Study|Adverse Event|6|||
163071313|NCT00424008|588966103|FG000|Overall Study|Lack of Efficacy|40|||
163071314|NCT00424008|588966104|FG001|Overall Study|Lack of Efficacy|34|||
163071315|NCT00424008|588966103|FG000|Overall Study|Lost to Follow-up|1|||
163071316|NCT00424008|588966104|FG001|Overall Study|Lost to Follow-up|2|||
163071317|NCT00424008|588966103|FG000|Overall Study|Withdrawal by Subject|5|||
163071318|NCT00424008|588966104|FG001|Overall Study|Withdrawal by Subject|8|||
163071319|NCT00424008|588966103|FG000|Overall Study|Noncompliance with protocol|13|||
163071320|NCT00424008|588966104|FG001|Overall Study|Noncompliance with protocol|7|||
163071321|NCT00424008|588966103|FG000|Overall Study|Did not meet protocol eligibility|16|||
163071322|NCT00424008|588966104|FG001|Overall Study|Did not meet protocol eligibility|21|||
163071323|NCT00424008|588966103|FG000|Overall Study|Administrative|266|||
163071324|NCT00424008|588966104|FG001|Overall Study|Administrative|257|||
163071325|NCT02530242|588966108|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
163071326|NCT02530242|588966109|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
163217996|NCT02867709|589513888|FG000|Treatment Period|Lack of Qualifying Event|42|||
163071327|NCT00283959|588966110|FG000|Extension Period|Low Compliance|1|||
163071328|NCT02665455|588966113|FG000|Overall Study|Withdrawal by Subject|6|||
163217997|NCT02867709|589513889|FG001|Treatment Period|Lack of Qualifying Event|55|||
163217998|NCT02867709|589513890|FG002|Treatment Period|Lack of Qualifying Event|42|||
163071329|NCT02665455|588966113|FG000|Overall Study|Lost to Follow-up|1|||
163071330|NCT02665455|588966113|FG000|Overall Study|Adverse Event|1|||
163071331|NCT02665455|588966113|FG000|Overall Study|Protocol Violation|1|||
163071332|NCT05865886|588966114|FG000|Overall Study|Serious adverse event|0|||
163071333|NCT05865886|588966115|FG001|Overall Study|Serious adverse event|1|||
163071334|NCT06394323|588966116|FG000|Overall Study|Death|0|||
163071335|NCT06394323|588966117|FG001|Overall Study|Death|1|||
163071336|NCT06394323|588966118|FG002|Overall Study|Death|0|||
163071337|NCT06394323|588966119|FG003|Overall Study|Death|0|||
163071338|NCT06394323|588966116|FG000|Overall Study|Physician Decision|0|||
163071339|NCT06394323|588966117|FG001|Overall Study|Physician Decision|2|||
163071340|NCT06394323|588966118|FG002|Overall Study|Physician Decision|0|||
163071341|NCT06394323|588966119|FG003|Overall Study|Physician Decision|0|||
163071342|NCT06394323|588966116|FG000|Overall Study|Withdrawal by Subject|4|||
163071343|NCT06394323|588966117|FG001|Overall Study|Withdrawal by Subject|4|||
163071344|NCT06394323|588966118|FG002|Overall Study|Withdrawal by Subject|0|||
163071345|NCT06394323|588966119|FG003|Overall Study|Withdrawal by Subject|0|||
163071346|NCT03787212|588967110|FG000|Period 1|Study Termination|2|||
163071347|NCT03787212|588967111|FG001|Period 1|Study Termination|2|||
163071348|NCT01778985|588967116|FG000|Overall Study|Lost to Follow-up|1|||
163071349|NCT01778985|588967117|FG001|Overall Study|Lost to Follow-up|0|||
163071350|NCT01778985|588967116|FG000|Overall Study|Physician Decision|2|||
163071351|NCT01778985|588967117|FG001|Overall Study|Physician Decision|2|||
163071352|NCT01778985|588967116|FG000|Overall Study|Protocol Violation|4|||
163071353|NCT01778985|588967117|FG001|Overall Study|Protocol Violation|1|||
163071354|NCT05788328|588967119|FG000|Treatment Period 4 (5 Days)|Other|1|||
163071355|NCT05788328|588967119|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
163071356|NCT00145327|588967120|FG000|Overall Study|Withdrawal by Subject|77|||
163071357|NCT00145327|588967121|FG001|Overall Study|Withdrawal by Subject|72|||
163071358|NCT00145327|588967122|FG002|Overall Study|Withdrawal by Subject|164|||
163071359|NCT00145327|588967120|FG000|Overall Study|Death|26|||
163071360|NCT00145327|588967121|FG001|Overall Study|Death|18|||
163071361|NCT00145327|588967122|FG002|Overall Study|Death|30|||
163071362|NCT00145327|588967120|FG000|Overall Study|Adverse Event|14|||
163071363|NCT00145327|588967121|FG001|Overall Study|Adverse Event|11|||
163071364|NCT00145327|588967122|FG002|Overall Study|Adverse Event|22|||
163071365|NCT00145327|588967120|FG000|Overall Study|Lost to Follow-up|9|||
163071366|NCT00145327|588967121|FG001|Overall Study|Lost to Follow-up|14|||
163071367|NCT00145327|588967122|FG002|Overall Study|Lost to Follow-up|14|||
163071368|NCT00145327|588967120|FG000|Overall Study|Administrative problems|12|||
163071369|NCT00145327|588967121|FG001|Overall Study|Administrative problems|9|||
163071370|NCT00145327|588967122|FG002|Overall Study|Administrative problems|13|||
163071371|NCT00145327|588967120|FG000|Overall Study|Protocol Violation|2|||
163071372|NCT00145327|588967121|FG001|Overall Study|Protocol Violation|0|||
163071373|NCT00145327|588967122|FG002|Overall Study|Protocol Violation|2|||
163071374|NCT00145327|588967120|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163071375|NCT00145327|588967121|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163071376|NCT00145327|588967122|FG002|Overall Study|Abnormal laboratory value(s)|2|||
163071377|NCT00145327|588967120|FG000|Overall Study|Missing - not stated|1|||
163071378|NCT00145327|588967121|FG001|Overall Study|Missing - not stated|0|||
163071379|NCT00145327|588967122|FG002|Overall Study|Missing - not stated|1|||
163071380|NCT01875237|588967127|FG000|Overall Study|GVDH before DLI|1|||
163071381|NCT01875237|588967128|FG001|Overall Study|GVDH before DLI|0|||
163071382|NCT01875237|588967127|FG000|Overall Study|DLI cells could not be produced|1|||
163071383|NCT01875237|588967128|FG001|Overall Study|DLI cells could not be produced|0|||
163071384|NCT02441114|588967129|FG000|Washout2|Withdrawal by Subject|4|||
163071385|NCT05278065|588967130|FG000|Overall Study|Withdrawal by Subject|1|||
163071386|NCT05278065|588967131|FG001|Overall Study|Withdrawal by Subject|0|||
163071387|NCT02070991|588967137|FG000|Overall Study|Death|2|||
163071388|NCT02070991|588967138|FG001|Overall Study|Death|0|||
163071389|NCT02070991|588967137|FG000|Overall Study|Withdrawal by Subject|1|||
163331105|NCT01737398|589922494|FG000|Overall Study|Stopping rule met|2|||
163331106|NCT01737398|589922495|FG001|Overall Study|Stopping rule met|1|||
163027133|NCT04521621|588801406|FG004|Overall Study|Study Terminated by Sponsor|1|||
163027134|NCT04521621|588801407|FG005|Overall Study|Study Terminated by Sponsor|7|||
163027135|NCT04521621|588801408|FG006|Overall Study|Study Terminated by Sponsor|0|||
163027136|NCT04521621|588801409|FG007|Overall Study|Study Terminated by Sponsor|0|||
163027137|NCT04521621|588801402|FG000|Overall Study|Withdrawal by Subject|0|||
163027138|NCT04521621|588801403|FG001|Overall Study|Withdrawal by Subject|0|||
163027139|NCT04521621|588801404|FG002|Overall Study|Withdrawal by Subject|1|||
163027140|NCT04521621|588801405|FG003|Overall Study|Withdrawal by Subject|1|||
163027141|NCT04521621|588801406|FG004|Overall Study|Withdrawal by Subject|0|||
163027142|NCT04521621|588801407|FG005|Overall Study|Withdrawal by Subject|0|||
163071390|NCT02070991|588967138|FG001|Overall Study|Withdrawal by Subject|0|||
163071391|NCT04999020|588967139|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
163071392|NCT04999020|588967140|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
163071393|NCT04999020|588967141|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
163071394|NCT04999020|588967142|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
163027143|NCT04521621|588801408|FG006|Overall Study|Withdrawal by Subject|0|||
163027144|NCT04521621|588801409|FG007|Overall Study|Withdrawal by Subject|0|||
163071395|NCT04999020|588967139|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
163071396|NCT04999020|588967140|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
163071397|NCT04999020|588967141|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
163071398|NCT04999020|588967142|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
163071399|NCT04999020|588967139|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
163154796|NCT03041181|589281437|FG001|Overall Study|Disease Progression|2|||
163154797|NCT02667119|589281438|FG000|Overall Study|Lost to Follow-up|3|||
163331107|NCT01737398|589922494|FG000|Overall Study|Voluntary withdrawal|2|||
163331108|NCT01737398|589922495|FG001|Overall Study|Voluntary withdrawal|3|||
163331109|NCT01737398|589922494|FG000|Overall Study|Ineligibility|1|||
163331110|NCT01737398|589922495|FG001|Overall Study|Ineligibility|0|||
163331111|NCT01737398|589922494|FG000|Overall Study|Liver transplant|1|||
163331112|NCT01737398|589922495|FG001|Overall Study|Liver transplant|0|||
163331113|NCT01737398|589922494|FG000|Overall Study|Disease progression|2|||
163331114|NCT01737398|589922495|FG001|Overall Study|Disease progression|3|||
163331115|NCT01737398|589922494|FG000|Overall Study|Sponsor's decision|2|||
163331116|NCT01737398|589922495|FG001|Overall Study|Sponsor's decision|0|||
163331117|NCT02372799|589922496|FG000|Treatment Period|Adverse Event|3|||
163331118|NCT02372799|589922497|FG001|Treatment Period|Adverse Event|10|||
163331119|NCT02372799|589922498|FG002|Treatment Period|Adverse Event|6|||
163331120|NCT02372799|589922496|FG000|Treatment Period|Insufficient therapeutic response|2|||
163331121|NCT02372799|589922497|FG001|Treatment Period|Insufficient therapeutic response|2|||
163331122|NCT02372799|589922498|FG002|Treatment Period|Insufficient therapeutic response|0|||
163071400|NCT04999020|588967140|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
163071401|NCT04999020|588967141|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
163071402|NCT04999020|588967142|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
163071403|NCT04999020|588967139|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163071404|NCT04999020|588967140|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163071405|NCT04999020|588967141|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
163071406|NCT04999020|588967142|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
163071407|NCT04999020|588967139|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
163071408|NCT04999020|588967140|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
163071409|NCT04999020|588967141|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
163071410|NCT04999020|588967142|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
163071411|NCT04999020|588967139|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
163071412|NCT04999020|588967140|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
163071413|NCT04999020|588967141|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
163071414|NCT04999020|588967142|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
163071415|NCT04999020|588967139|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163071416|NCT04999020|588967140|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163071417|NCT04999020|588967141|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
163071418|NCT04999020|588967142|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163071419|NCT04999020|588967139|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
163071420|NCT04999020|588967140|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
163071421|NCT04999020|588967141|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
163071422|NCT04999020|588967142|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
163071423|NCT00866320|588967148|FG000|Overall Study|Withdrawal by Subject|4|||
163071424|NCT00866320|588967148|FG000|Overall Study|Death|2|||
163071425|NCT06038643|588967156|FG000|Overall Study|Withdrawal by Subject|9|||
163071426|NCT06038643|588967157|FG001|Overall Study|Withdrawal by Subject|4|||
163071427|NCT06038643|588967156|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
163071428|NCT06038643|588967157|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
163071429|NCT03573882|588967158|FG000|Overall Study|Study Terminated by Sponsor|22|||
163071430|NCT03573882|588967159|FG001|Overall Study|Study Terminated by Sponsor|17|||
163071431|NCT03573882|588967160|FG002|Overall Study|Study Terminated by Sponsor|18|||
163071432|NCT03573882|588967158|FG000|Overall Study|Withdrawal by Subject|6|||
163071433|NCT03573882|588967159|FG001|Overall Study|Withdrawal by Subject|11|||
163071434|NCT03573882|588967160|FG002|Overall Study|Withdrawal by Subject|7|||
163071435|NCT03573882|588967158|FG000|Overall Study|Adverse Event|7|||
163071436|NCT03573882|588967159|FG001|Overall Study|Adverse Event|5|||
163071437|NCT03573882|588967160|FG002|Overall Study|Adverse Event|6|||
163071438|NCT03573882|588967158|FG000|Overall Study|Lost to Follow-up|2|||
163071439|NCT03573882|588967159|FG001|Overall Study|Lost to Follow-up|5|||
163071440|NCT03573882|588967160|FG002|Overall Study|Lost to Follow-up|3|||
163071441|NCT03573882|588967158|FG000|Overall Study|Physician Decision|4|||
163071442|NCT03573882|588967159|FG001|Overall Study|Physician Decision|3|||
163071443|NCT03573882|588967160|FG002|Overall Study|Physician Decision|2|||
163331123|NCT02372799|589922496|FG000|Treatment Period|Withdrawal by Subject|10|||
163331124|NCT02372799|589922497|FG001|Treatment Period|Withdrawal by Subject|10|||
163331125|NCT02372799|589922498|FG002|Treatment Period|Withdrawal by Subject|2|||
163331126|NCT02372799|589922496|FG000|Treatment Period|Lost to Follow-up|11|||
163331127|NCT02372799|589922497|FG001|Treatment Period|Lost to Follow-up|5|||
163331128|NCT02372799|589922498|FG002|Treatment Period|Lost to Follow-up|3|||
163071444|NCT03573882|588967158|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
163071445|NCT03573882|588967159|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
163071446|NCT03573882|588967160|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
163071447|NCT03573882|588967158|FG000|Overall Study|Pregnancy|1|||
163071448|NCT03573882|588967159|FG001|Overall Study|Pregnancy|2|||
163071449|NCT03573882|588967160|FG002|Overall Study|Pregnancy|0|||
163331129|NCT02372799|589922496|FG000|Treatment Period|Protocol Violation|3|||
163071450|NCT03573882|588967158|FG000|Overall Study|Other|4|||
163071451|NCT03573882|588967159|FG001|Overall Study|Other|2|||
163071452|NCT03573882|588967160|FG002|Overall Study|Other|2|||
163071453|NCT02691572|588967161|FG000|Overall Study|Withdrawal by Subject|1|||
163071454|NCT02691572|588967162|FG001|Overall Study|Withdrawal by Subject|0|||
163071455|NCT02691572|588967161|FG000|Overall Study|Protocol Violation|0|||
163071456|NCT02691572|588967162|FG001|Overall Study|Protocol Violation|1|||
163071457|NCT00699751|588967163|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
163071458|NCT00699751|588967164|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
163071459|NCT00699751|588967163|FG000|Period 1: Without/Before Drug Switch|Death|28|||
163071460|NCT00699751|588967164|FG001|Period 1: Without/Before Drug Switch|Death|29|||
163071461|NCT00699751|588967163|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
163071462|NCT00699751|588967164|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
163071463|NCT00699751|588967163|FG000|Period 1: Without/Before Drug Switch|Other|30|||
163071464|NCT00699751|588967164|FG001|Period 1: Without/Before Drug Switch|Other|20|||
163071465|NCT00699751|588967163|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
163071466|NCT00699751|588967164|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
163071467|NCT00699751|588967163|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
163071468|NCT00699751|588967164|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
163071469|NCT00699751|588967163|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
163071470|NCT00699751|588967164|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
163071471|NCT00699751|588967163|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
163071472|NCT00699751|588967164|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
163071473|NCT01947933|588967165|FG000|Overall Study|Withdrawal by Subject|0|||
163071474|NCT01947933|588967166|FG001|Overall Study|Withdrawal by Subject|0|||
163071475|NCT01947933|588967167|FG002|Overall Study|Withdrawal by Subject|1|||
163071476|NCT01947933|588967168|FG003|Overall Study|Withdrawal by Subject|0|||
163071477|NCT01947933|588967169|FG004|Overall Study|Withdrawal by Subject|0|||
163071478|NCT01947933|588967170|FG005|Overall Study|Withdrawal by Subject|0|||
163071479|NCT01947933|588967171|FG006|Overall Study|Withdrawal by Subject|0|||
163071480|NCT01947933|588967172|FG007|Overall Study|Withdrawal by Subject|0|||
163071481|NCT01947933|588967173|FG008|Overall Study|Withdrawal by Subject|0|||
163071482|NCT01947933|588967165|FG000|Overall Study|Lost to Follow-up|0|||
163071483|NCT01947933|588967166|FG001|Overall Study|Lost to Follow-up|0|||
163071484|NCT01947933|588967167|FG002|Overall Study|Lost to Follow-up|0|||
163071485|NCT01947933|588967168|FG003|Overall Study|Lost to Follow-up|0|||
163071486|NCT01947933|588967169|FG004|Overall Study|Lost to Follow-up|0|||
163071487|NCT01947933|588967170|FG005|Overall Study|Lost to Follow-up|0|||
163071488|NCT01947933|588967171|FG006|Overall Study|Lost to Follow-up|0|||
163071489|NCT01947933|588967172|FG007|Overall Study|Lost to Follow-up|0|||
163071490|NCT01947933|588967173|FG008|Overall Study|Lost to Follow-up|1|||
163071491|NCT00294398|588967174|FG000|Overall Study|Lost to Follow-up|21|||
163071492|NCT00294398|588967175|FG001|Overall Study|Lost to Follow-up|26|||
163071493|NCT00250718|588967178|FG000|Overall Study|Death|1|||
163071494|NCT00250718|588967178|FG000|Overall Study|Adverse Event|1|||
163071495|NCT00250718|588967178|FG000|Overall Study|Withdrawal by Subject|1|||
163071496|NCT04439123|588967181|FG000|Overall Study|Adverse Event|11|||
163071497|NCT04439123|588967181|FG000|Overall Study|Death|1|||
163071498|NCT04439123|588967181|FG000|Overall Study|Disease progression|19|||
163071499|NCT04439123|588967181|FG000|Overall Study|Withdrawal by Subject|2|||
163071500|NCT04439123|588967181|FG000|Overall Study|Still on treatment|2|||
163071501|NCT02593864|588967183|FG000|Overall Study|Withdrawal by Subject|3|||
163071502|NCT02593864|588967183|FG000|Overall Study|Lost to Follow-up|3|||
163071503|NCT02114684|588967189|FG000|Overall Study|Death|6|||
163071504|NCT02114684|588967190|FG001|Overall Study|Death|4|||
163071505|NCT02114684|588967189|FG000|Overall Study|Lost to Follow-up|1|||
163071506|NCT02114684|588967190|FG001|Overall Study|Lost to Follow-up|2|||
163071507|NCT02114684|588967189|FG000|Overall Study|Withdrawal by Subject|1|||
163071508|NCT02114684|588967190|FG001|Overall Study|Withdrawal by Subject|2|||
163071509|NCT02114684|588967189|FG000|Overall Study|Relocation|3|||
163071510|NCT02114684|588967190|FG001|Overall Study|Relocation|1|||
163071511|NCT02114684|588967189|FG000|Overall Study|Rifampicin resistant on culture|0|||
163071512|NCT02114684|588967190|FG001|Overall Study|Rifampicin resistant on culture|1|||
163331130|NCT02372799|589922497|FG001|Treatment Period|Protocol Violation|0|||
163071513|NCT02114684|588967189|FG000|Overall Study|Patient Incarcerated|1|||
163071514|NCT02114684|588967190|FG001|Overall Study|Patient Incarcerated|0|||
163071515|NCT03828383|588967193|FG000|Overall Study|Lost to Follow-up|3|||
163071516|NCT03828383|588967194|FG001|Overall Study|Lost to Follow-up|2|||
163071517|NCT03828383|588967193|FG000|Overall Study|Withdrawal by Subject|4|||
163071518|NCT03828383|588967194|FG001|Overall Study|Withdrawal by Subject|5|||
163071519|NCT03345095|588967195|FG000|Overall Study|Lack of Efficacy|184|||
163071520|NCT03345095|588967196|FG001|Overall Study|Lack of Efficacy|156|||
163071521|NCT03345095|588967195|FG000|Overall Study|Adverse Event|36|||
163071522|NCT03345095|588967196|FG001|Overall Study|Adverse Event|118|||
163071523|NCT03345095|588967195|FG000|Overall Study|Withdrawal by Subject|22|||
163331131|NCT02372799|589922498|FG002|Treatment Period|Protocol Violation|0|||
163071524|NCT03345095|588967196|FG001|Overall Study|Withdrawal by Subject|59|||
163071525|NCT03345095|588967195|FG000|Overall Study|Physician Decision|3|||
163071526|NCT03345095|588967196|FG001|Overall Study|Physician Decision|18|||
163071527|NCT03345095|588967195|FG000|Overall Study|Death|2|||
163071528|NCT03345095|588967196|FG001|Overall Study|Death|4|||
163071529|NCT03345095|588967195|FG000|Overall Study|Other reasons|2|||
163071530|NCT03345095|588967196|FG001|Overall Study|Other reasons|11|||
163071531|NCT03345095|588967195|FG000|Overall Study|Protocol Violation|0|||
163071532|NCT03345095|588967196|FG001|Overall Study|Protocol Violation|1|||
163071533|NCT06991803|588967199|FG000|Overall Study|Lost to Follow-up|0|||
163071534|NCT06991803|588967200|FG001|Overall Study|Lost to Follow-up|4|||
163071535|NCT06991803|588967201|FG002|Overall Study|Lost to Follow-up|0|||
163071536|NCT06991803|588967202|FG003|Overall Study|Lost to Follow-up|3|||
163071537|NCT06991803|588967203|FG004|Overall Study|Lost to Follow-up|2|||
163071538|NCT06991803|588967204|FG005|Overall Study|Lost to Follow-up|5|||
163071539|NCT01671059|588967205|FG000|Overall Study|Adverse Event|4|||
163071540|NCT01671059|588967205|FG000|Overall Study|Lack of Efficacy|1|||
163071541|NCT02564978|588967211|FG000|Overall Study|Adverse Event|8|||
163071542|NCT02564978|588967211|FG000|Overall Study|Death|1|||
163071543|NCT02564978|588967211|FG000|Overall Study|Lost to Follow-up|1|||
163071544|NCT02564978|588967211|FG000|Overall Study|Withdrawal by Subject|15|||
163071545|NCT02564978|588967211|FG000|Overall Study|Early Study Closure|2|||
163071546|NCT02564978|588967211|FG000|Overall Study|Other Reason|5|||
163071547|NCT03166631|588969579|FG000|Overall Study|Progressive disease|2|||
163071548|NCT03166631|588969580|FG001|Overall Study|Progressive disease|1|||
163071549|NCT03166631|588969581|FG002|Overall Study|Progressive disease|3|||
163071550|NCT03166631|588969582|FG003|Overall Study|Progressive disease|4|||
163071551|NCT03166631|588969583|FG004|Overall Study|Progressive disease|2|||
163071552|NCT03166631|588969584|FG005|Overall Study|Progressive disease|2|||
163071553|NCT03166631|588969585|FG006|Overall Study|Progressive disease|5|||
163071554|NCT03166631|588969586|FG007|Overall Study|Progressive disease|6|||
163071555|NCT03166631|588969587|FG008|Overall Study|Progressive disease|11|||
163071556|NCT03166631|588969588|FG009|Overall Study|Progressive disease|5|||
163071557|NCT03166631|588969589|FG010|Overall Study|Progressive disease|7|||
163071558|NCT03166631|588969579|FG000|Overall Study|Physician Decision|0|||
163071559|NCT03166631|588969580|FG001|Overall Study|Physician Decision|0|||
163071560|NCT03166631|588969581|FG002|Overall Study|Physician Decision|0|||
163071561|NCT03166631|588969582|FG003|Overall Study|Physician Decision|0|||
163071562|NCT03166631|588969583|FG004|Overall Study|Physician Decision|0|||
163071563|NCT03166631|588969584|FG005|Overall Study|Physician Decision|0|||
163071564|NCT03166631|588969585|FG006|Overall Study|Physician Decision|1|||
163071565|NCT03166631|588969586|FG007|Overall Study|Physician Decision|0|||
163071566|NCT03166631|588969587|FG008|Overall Study|Physician Decision|1|||
163071567|NCT03166631|588969588|FG009|Overall Study|Physician Decision|0|||
163071568|NCT03166631|588969589|FG010|Overall Study|Physician Decision|1|||
163071569|NCT03166631|588969579|FG000|Overall Study|Death|0|||
163071570|NCT03166631|588969580|FG001|Overall Study|Death|0|||
163071571|NCT03166631|588969581|FG002|Overall Study|Death|0|||
163071572|NCT03166631|588969582|FG003|Overall Study|Death|0|||
163071573|NCT03166631|588969583|FG004|Overall Study|Death|1|||
163071574|NCT03166631|588969584|FG005|Overall Study|Death|0|||
163071575|NCT03166631|588969585|FG006|Overall Study|Death|1|||
163071576|NCT03166631|588969586|FG007|Overall Study|Death|0|||
163071577|NCT03166631|588969587|FG008|Overall Study|Death|0|||
163071578|NCT03166631|588969588|FG009|Overall Study|Death|0|||
163071579|NCT03166631|588969589|FG010|Overall Study|Death|0|||
163071580|NCT03166631|588969579|FG000|Overall Study|Adverse Event|1|||
163071581|NCT03166631|588969580|FG001|Overall Study|Adverse Event|0|||
163071582|NCT03166631|588969581|FG002|Overall Study|Adverse Event|0|||
163071583|NCT03166631|588969582|FG003|Overall Study|Adverse Event|0|||
163071584|NCT03166631|588969583|FG004|Overall Study|Adverse Event|0|||
163071585|NCT03166631|588969584|FG005|Overall Study|Adverse Event|1|||
163071586|NCT03166631|588969585|FG006|Overall Study|Adverse Event|1|||
163071587|NCT03166631|588969586|FG007|Overall Study|Adverse Event|0|||
163071588|NCT03166631|588969587|FG008|Overall Study|Adverse Event|1|||
163071589|NCT03166631|588969588|FG009|Overall Study|Adverse Event|2|||
163071590|NCT03166631|588969589|FG010|Overall Study|Adverse Event|1|||
163071591|NCT03166631|588969579|FG000|Overall Study|Withdrawal by Subject|0|||
163071592|NCT03166631|588969580|FG001|Overall Study|Withdrawal by Subject|0|||
163071593|NCT03166631|588969581|FG002|Overall Study|Withdrawal by Subject|0|||
163071594|NCT03166631|588969582|FG003|Overall Study|Withdrawal by Subject|0|||
163071595|NCT03166631|588969583|FG004|Overall Study|Withdrawal by Subject|0|||
163071596|NCT03166631|588969584|FG005|Overall Study|Withdrawal by Subject|0|||
163071597|NCT03166631|588969585|FG006|Overall Study|Withdrawal by Subject|0|||
163071598|NCT03166631|588969586|FG007|Overall Study|Withdrawal by Subject|0|||
163071599|NCT03166631|588969587|FG008|Overall Study|Withdrawal by Subject|1|||
163331132|NCT02372799|589922496|FG000|Treatment Period|Non-compliance with study drug|4|||
163071600|NCT03166631|588969588|FG009|Overall Study|Withdrawal by Subject|1|||
163071601|NCT03166631|588969589|FG010|Overall Study|Withdrawal by Subject|0|||
163071602|NCT03022630|588969590|FG000|Overall Study|Death|9|||
163071603|NCT03022630|588969591|FG001|Overall Study|Death|7|||
163071604|NCT03022630|588969590|FG000|Overall Study|Withdrawal by Subject|0|||
163071605|NCT03022630|588969591|FG001|Overall Study|Withdrawal by Subject|5|||
163071606|NCT00382070|588969592|FG000|Overall Study|No follow up data mapped to Other|17|||
163071607|NCT00382070|588969593|FG001|Overall Study|No follow up data mapped to Other|19|||
163071608|NCT00382070|588969592|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
163071609|NCT00382070|588969593|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
163071610|NCT00382070|588969592|FG000|Overall Study|No clinical assessment|9|||
163071611|NCT00382070|588969593|FG001|Overall Study|No clinical assessment|11|||
163071612|NCT00504231|588969594|FG000|Overall Study|Discrepant chart documentation re route|0|||
163071613|NCT00504231|588969595|FG001|Overall Study|Discrepant chart documentation re route|0|||
163071614|NCT00504231|588969596|FG002|Overall Study|Discrepant chart documentation re route|1|||
163071615|NCT00504231|588969597|FG003|Overall Study|Discrepant chart documentation re route|0|||
163071616|NCT01629563|588969598|FG000|Overall Study|Adverse Event|16|||
163071617|NCT01629563|588969599|FG001|Overall Study|Adverse Event|16|||
163071618|NCT01629563|588969598|FG000|Overall Study|Death|2|||
163071619|NCT01629563|588969599|FG001|Overall Study|Death|0|||
163071620|NCT01629563|588969598|FG000|Overall Study|Lack of Efficacy|2|||
163071621|NCT01629563|588969599|FG001|Overall Study|Lack of Efficacy|3|||
163071622|NCT01629563|588969598|FG000|Overall Study|Lost to Follow-up|1|||
163071623|NCT01629563|588969599|FG001|Overall Study|Lost to Follow-up|0|||
163071624|NCT01629563|588969598|FG000|Overall Study|Pregnancy|1|||
163071625|NCT01629563|588969599|FG001|Overall Study|Pregnancy|2|||
163071626|NCT01629563|588969598|FG000|Overall Study|Protocol Violation|0|||
163071627|NCT01629563|588969599|FG001|Overall Study|Protocol Violation|1|||
163071628|NCT01629563|588969598|FG000|Overall Study|Withdrawal by Subject|27|||
163071629|NCT01629563|588969599|FG001|Overall Study|Withdrawal by Subject|20|||
163071630|NCT01629563|588969598|FG000|Overall Study|surgery|0|||
163071631|NCT01629563|588969599|FG001|Overall Study|surgery|3|||
163071632|NCT01629563|588969598|FG000|Overall Study|Lack of return of menses|12|||
163071633|NCT01629563|588969599|FG001|Overall Study|Lack of return of menses|7|||
163071634|NCT01629563|588969598|FG000|Overall Study|Protocol Violation|0|||
163071635|NCT01629563|588969599|FG001|Overall Study|Protocol Violation|1|||
163071636|NCT00088881|588969601|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
163071637|NCT00088881|588969601|FG000|Step 1 - R-CHOP|Adverse Event|1|||
163071638|NCT00088881|588969601|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
163071639|NCT00088881|588969601|FG000|Step 1 - R-CHOP|Physician Decision|1|||
163071640|NCT00088881|588969601|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
163071641|NCT00088881|588969601|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
163071642|NCT00088881|588969601|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
163071643|NCT02370394|588969609|FG000|Overall Study|Lost to Follow-up|2|||
163071644|NCT02370394|588969610|FG001|Overall Study|Lost to Follow-up|1|||
163071645|NCT02370394|588969609|FG000|Overall Study|Withdrawal by Subject|0|||
163071646|NCT02370394|588969610|FG001|Overall Study|Withdrawal by Subject|1|||
163071647|NCT00456612|588969612|FG000|Overall Study|Withdrawal by Subject|3|||
163071648|NCT02316613|588969613|FG000|Overall Study|Death|63|||
163071649|NCT02316613|588969613|FG000|Overall Study|Lost to Follow-up|9|||
163071650|NCT02316613|588969613|FG000|Overall Study|Lymphoma transformation|2|||
163071651|NCT02316613|588969613|FG000|Overall Study|Participant moved/changed medical team|11|||
163071652|NCT02316613|588969613|FG000|Overall Study|No data and duplicate cases|5|||
163071653|NCT02316613|588969613|FG000|Overall Study|Did not met selection criteria|14|||
163071654|NCT02545127|588969620|FG000|Overall Study|Lost to Follow-up|1|||
163071655|NCT02545127|588969621|FG001|Overall Study|Lost to Follow-up|0|||
163071656|NCT03309605|588969626|FG000|Overall Study|Adverse Event|0|||
163071657|NCT03309605|588969627|FG001|Overall Study|Adverse Event|0|||
163071658|NCT03309605|588969628|FG002|Overall Study|Adverse Event|0|||
163071659|NCT03309605|588969629|FG003|Overall Study|Adverse Event|1|||
163071660|NCT03309605|588969630|FG004|Overall Study|Adverse Event|0|||
163071661|NCT03309605|588969631|FG005|Overall Study|Adverse Event|0|||
163071662|NCT03309605|588969632|FG006|Overall Study|Adverse Event|2|||
163071663|NCT03309605|588969633|FG007|Overall Study|Adverse Event|1|||
163071664|NCT03309605|588969626|FG000|Overall Study|Withdrawal by Subject|0|||
163071665|NCT03309605|588969627|FG001|Overall Study|Withdrawal by Subject|0|||
163071666|NCT03309605|588969628|FG002|Overall Study|Withdrawal by Subject|0|||
163071667|NCT03309605|588969629|FG003|Overall Study|Withdrawal by Subject|0|||
163071668|NCT03309605|588969630|FG004|Overall Study|Withdrawal by Subject|1|||
163071669|NCT03309605|588969631|FG005|Overall Study|Withdrawal by Subject|0|||
163071670|NCT03309605|588969632|FG006|Overall Study|Withdrawal by Subject|1|||
163071671|NCT03309605|588969633|FG007|Overall Study|Withdrawal by Subject|1|||
163071672|NCT01129284|588969634|FG000|Overall Study|Adverse Event|2|||
163217999|NCT02867709|589513888|FG000|Treatment Period|Protocol Violation|3|||
163071673|NCT01129284|588969635|FG001|Overall Study|Adverse Event|0|||
163071674|NCT01129284|588969636|FG002|Overall Study|Adverse Event|1|||
163071675|NCT02082483|588969637|FG000|Overall Study|Lost to Follow-up|1|||
163071676|NCT02082483|588969638|FG001|Overall Study|Lost to Follow-up|1|||
163071677|NCT02082483|588969637|FG000|Overall Study|Withdrawal by Subject|2|||
163218000|NCT02867709|589513889|FG001|Treatment Period|Protocol Violation|2|||
163071678|NCT02082483|588969638|FG001|Overall Study|Withdrawal by Subject|1|||
163071679|NCT02082483|588969637|FG000|Overall Study|Physician Decision|1|||
163071680|NCT02082483|588969638|FG001|Overall Study|Physician Decision|1|||
163071681|NCT02082483|588969637|FG000|Overall Study|Death|2|||
163071682|NCT02082483|588969638|FG001|Overall Study|Death|3|||
163071683|NCT00422461|588969639|FG000|Overall Study|Adverse Event|1|||
163071684|NCT00422461|588969640|FG001|Overall Study|Adverse Event|2|||
163071685|NCT00422461|588969641|FG002|Overall Study|Adverse Event|1|||
163071686|NCT00422461|588969642|FG003|Overall Study|Adverse Event|1|||
163071687|NCT00422461|588969639|FG000|Overall Study|Other|0|||
163071688|NCT00422461|588969640|FG001|Overall Study|Other|0|||
163071689|NCT00422461|588969641|FG002|Overall Study|Other|0|||
163071690|NCT00422461|588969642|FG003|Overall Study|Other|2|||
163071691|NCT00422461|588969639|FG000|Overall Study|Participants no longer willing to participate in study|1|||
163071692|NCT00422461|588969640|FG001|Overall Study|Participants no longer willing to participate in study|0|||
163071693|NCT00422461|588969641|FG002|Overall Study|Participants no longer willing to participate in study|0|||
163071694|NCT00422461|588969642|FG003|Overall Study|Participants no longer willing to participate in study|0|||
163071695|NCT00422461|588969639|FG000|Overall Study|Randomized but not treated|1|||
163071696|NCT00422461|588969640|FG001|Overall Study|Randomized but not treated|1|||
163071697|NCT00422461|588969641|FG002|Overall Study|Randomized but not treated|0|||
163071698|NCT00422461|588969642|FG003|Overall Study|Randomized but not treated|0|||
163071699|NCT02181621|588969643|FG000|Overall Study|Adverse Event|1|||
163071700|NCT02181621|588969644|FG001|Overall Study|Adverse Event|0|||
163071701|NCT02181621|588969643|FG000|Overall Study|Previously Enrolled|0|||
163071702|NCT02181621|588969644|FG001|Overall Study|Previously Enrolled|1|||
163071703|NCT02181621|588969643|FG000|Overall Study|Enrollment Hold|1|||
163071704|NCT02181621|588969644|FG001|Overall Study|Enrollment Hold|1|||
163071705|NCT00960856|588969645|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
163071706|NCT00960856|588969646|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
163071707|NCT00960856|588969647|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
163071708|NCT00960856|588969648|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
163071709|NCT00960856|588969645|FG000|Washout Period of 7 Days|Adverse Event|0|||
163071710|NCT00960856|588969646|FG001|Washout Period of 7 Days|Adverse Event|0|||
163071711|NCT00960856|588969647|FG002|Washout Period of 7 Days|Adverse Event|1|||
163071712|NCT00960856|588969648|FG003|Washout Period of 7 Days|Adverse Event|0|||
163071713|NCT04027946|588969650|FG000|Overall Study|Screen failures|3|||
163071714|NCT05938010|588969651|FG000|Overall Study|Lost to Follow-up|2|||
163071715|NCT00985192|588969652|FG000|Overall Study|Withdrawal by Subject|1|||
163071716|NCT00985192|588969652|FG000|Overall Study|Disease Progression|1|||
163071717|NCT00985192|588969652|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
163071718|NCT01454063|588969653|FG000|Randomized|Adverse Event|1|||
163071719|NCT01454063|588969654|FG001|Randomized|Adverse Event|1|||
163071720|NCT01454063|588969653|FG000|Randomized|Protocol Violation|0|||
163071721|NCT01454063|588969654|FG001|Randomized|Protocol Violation|1|||
163071722|NCT01562444|588969657|FG000|Overall Study|Did not meet entry criteria|2|||
163071723|NCT01562444|588969658|FG001|Overall Study|Did not meet entry criteria|0|||
163071724|NCT01562444|588969659|FG002|Overall Study|Did not meet entry criteria|3|||
163071725|NCT01562444|588969657|FG000|Overall Study|Did not comply with blood draw schedule|1|||
163071726|NCT01562444|588969658|FG001|Overall Study|Did not comply with blood draw schedule|0|||
163071727|NCT01562444|588969659|FG002|Overall Study|Did not comply with blood draw schedule|1|||
163331133|NCT02372799|589922497|FG001|Treatment Period|Non-compliance with study drug|4|||
163331134|NCT02372799|589922498|FG002|Treatment Period|Non-compliance with study drug|4|||
163331135|NCT02372799|589922496|FG000|Treatment Period|Miscellaneous Reasons|1|||
163331136|NCT02372799|589922497|FG001|Treatment Period|Miscellaneous Reasons|1|||
163331137|NCT02372799|589922498|FG002|Treatment Period|Miscellaneous Reasons|0|||
163331138|NCT02372799|589922496|FG000|Down-taper Period|Lost to Follow-up|1|||
163331139|NCT02372799|589922497|FG001|Down-taper Period|Lost to Follow-up|2|||
163331140|NCT02372799|589922498|FG002|Down-taper Period|Lost to Follow-up|2|||
163071728|NCT01562444|588969657|FG000|Overall Study|Unavailable serological results|0|||
163071729|NCT01562444|588969658|FG001|Overall Study|Unavailable serological results|2|||
163071730|NCT01562444|588969659|FG002|Overall Study|Unavailable serological results|2|||
163071731|NCT01562444|588969657|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
163071732|NCT01562444|588969658|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
163071733|NCT01562444|588969659|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
163071734|NCT01562444|588969657|FG000|Overall Study|Protocol forbidden medication|1|||
163071735|NCT01562444|588969658|FG001|Overall Study|Protocol forbidden medication|0|||
163071736|NCT01562444|588969659|FG002|Overall Study|Protocol forbidden medication|0|||
163071737|NCT03055195|588969662|FG000|Overall Study|Lack of Efficacy|1|||
163331141|NCT00089609|589922499|FG000|Overall Study|Withdrawal by Subject|3|||
163071738|NCT03055195|588969663|FG001|Overall Study|Lack of Efficacy|0|||
163071739|NCT03055195|588969662|FG000|Overall Study|Withdrawal by Subject|6|||
163071740|NCT03055195|588969663|FG001|Overall Study|Withdrawal by Subject|7|||
163071741|NCT03055195|588969662|FG000|Overall Study|Study Terminated by Sponsor|2|||
163071742|NCT03055195|588969663|FG001|Overall Study|Study Terminated by Sponsor|6|||
163331142|NCT00089609|589922500|FG001|Overall Study|Withdrawal by Subject|1|||
163071743|NCT03055195|588969662|FG000|Overall Study|Protocol Violation|2|||
163071744|NCT03055195|588969663|FG001|Overall Study|Protocol Violation|1|||
163071745|NCT03055195|588969662|FG000|Overall Study|Physician Decision|1|||
163071746|NCT03055195|588969663|FG001|Overall Study|Physician Decision|0|||
163071747|NCT00421733|588969667|FG000|Overall Study|Adverse Event|4|||
163071748|NCT00421733|588969668|FG001|Overall Study|Adverse Event|9|||
163071749|NCT00421733|588969669|FG002|Overall Study|Adverse Event|2|||
163071750|NCT00421733|588969667|FG000|Overall Study|Lost to Follow-up|1|||
163071751|NCT00421733|588969668|FG001|Overall Study|Lost to Follow-up|2|||
163071752|NCT00421733|588969669|FG002|Overall Study|Lost to Follow-up|4|||
163071753|NCT00421733|588969667|FG000|Overall Study|Withdrawal by Subject|1|||
163071754|NCT00421733|588969668|FG001|Overall Study|Withdrawal by Subject|2|||
163071755|NCT00421733|588969669|FG002|Overall Study|Withdrawal by Subject|7|||
163071756|NCT00421733|588969667|FG000|Overall Study|Death|0|||
163071757|NCT00421733|588969668|FG001|Overall Study|Death|3|||
163071758|NCT00421733|588969669|FG002|Overall Study|Death|0|||
163071759|NCT00421733|588969667|FG000|Overall Study|Required dialysis|1|||
163071760|NCT00421733|588969668|FG001|Overall Study|Required dialysis|0|||
163071761|NCT00421733|588969669|FG002|Overall Study|Required dialysis|0|||
163071762|NCT00421733|588969667|FG000|Overall Study|Administrative|2|||
163071763|NCT00421733|588969668|FG001|Overall Study|Administrative|0|||
163071764|NCT00421733|588969669|FG002|Overall Study|Administrative|0|||
163071765|NCT00421733|588969667|FG000|Overall Study|Did not satisfy entry criteria|1|||
163071766|NCT00421733|588969668|FG001|Overall Study|Did not satisfy entry criteria|3|||
163071767|NCT00421733|588969669|FG002|Overall Study|Did not satisfy entry criteria|2|||
163071768|NCT00421733|588969667|FG000|Overall Study|Sponsor request|1|||
163071769|NCT00421733|588969668|FG001|Overall Study|Sponsor request|0|||
163071770|NCT00421733|588969669|FG002|Overall Study|Sponsor request|3|||
163071771|NCT00421733|588969667|FG000|Overall Study|Protocol deviation|4|||
163071772|NCT00421733|588969668|FG001|Overall Study|Protocol deviation|7|||
163071773|NCT00421733|588969669|FG002|Overall Study|Protocol deviation|2|||
163071774|NCT00790933|588969670|FG000|Overall Study|Adverse Event|94|||
163071775|NCT00790933|588969671|FG001|Overall Study|Adverse Event|119|||
163071776|NCT00790933|588969672|FG002|Overall Study|Adverse Event|65|||
163071777|NCT00790933|588969673|FG003|Overall Study|Adverse Event|5|||
163071778|NCT00790933|588969674|FG004|Overall Study|Adverse Event|69|||
163071779|NCT00790933|588969670|FG000|Overall Study|Protocol Violation(s)|8|||
163071780|NCT00790933|588969671|FG001|Overall Study|Protocol Violation(s)|18|||
163071781|NCT00790933|588969672|FG002|Overall Study|Protocol Violation(s)|7|||
163071782|NCT00790933|588969673|FG003|Overall Study|Protocol Violation(s)|0|||
163071783|NCT00790933|588969674|FG004|Overall Study|Protocol Violation(s)|12|||
163071784|NCT00790933|588969670|FG000|Overall Study|Lack of Efficacy|192|||
163071785|NCT00790933|588969671|FG001|Overall Study|Lack of Efficacy|176|||
163071786|NCT00790933|588969672|FG002|Overall Study|Lack of Efficacy|130|||
163071787|NCT00790933|588969673|FG003|Overall Study|Lack of Efficacy|1|||
163071788|NCT00790933|588969674|FG004|Overall Study|Lack of Efficacy|121|||
163071789|NCT00790933|588969670|FG000|Overall Study|Study Terminated by Sponsor|0|||
163071790|NCT00790933|588969671|FG001|Overall Study|Study Terminated by Sponsor|0|||
163071791|NCT00790933|588969672|FG002|Overall Study|Study Terminated by Sponsor|1|||
163071792|NCT00790933|588969673|FG003|Overall Study|Study Terminated by Sponsor|0|||
163071793|NCT00790933|588969674|FG004|Overall Study|Study Terminated by Sponsor|0|||
163071794|NCT00790933|588969670|FG000|Overall Study|Withdrawal by Subject|123|||
163218001|NCT02867709|589513890|FG002|Treatment Period|Protocol Violation|3|||
163071795|NCT00790933|588969671|FG001|Overall Study|Withdrawal by Subject|120|||
163071796|NCT00790933|588969672|FG002|Overall Study|Withdrawal by Subject|52|||
163071797|NCT00790933|588969673|FG003|Overall Study|Withdrawal by Subject|6|||
163071798|NCT00790933|588969674|FG004|Overall Study|Withdrawal by Subject|50|||
163071799|NCT00790933|588969670|FG000|Overall Study|Lost to Follow-up|13|||
163071800|NCT00790933|588969671|FG001|Overall Study|Lost to Follow-up|31|||
163071801|NCT00790933|588969672|FG002|Overall Study|Lost to Follow-up|10|||
163071802|NCT00790933|588969673|FG003|Overall Study|Lost to Follow-up|1|||
163071803|NCT00790933|588969674|FG004|Overall Study|Lost to Follow-up|15|||
163071804|NCT00790933|588969670|FG000|Overall Study|Reason Not Specified|8|||
163218002|NCT02867709|589513888|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
163218003|NCT02867709|589513889|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
163218004|NCT02867709|589513890|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
163218005|NCT02867709|589513888|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
163218006|NCT02867709|589513889|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
163218007|NCT02867709|589513890|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
163218008|NCT02867709|589513888|FG000|Safety Follow-up Period|Pregnancy|0|||
163218009|NCT02867709|589513889|FG001|Safety Follow-up Period|Pregnancy|1|||
163218010|NCT02867709|589513890|FG002|Safety Follow-up Period|Pregnancy|0|||
163218011|NCT02867709|589513888|FG000|Safety Follow-up Period|Protocol Violation|0|||
163218012|NCT02867709|589513889|FG001|Safety Follow-up Period|Protocol Violation|1|||
163218013|NCT02867709|589513890|FG002|Safety Follow-up Period|Protocol Violation|1|||
163218014|NCT03188094|589513893|FG000|Overall Study|Screen failure|1|||
163218015|NCT03188094|589513894|FG001|Overall Study|Screen failure|0|||
163218016|NCT03188094|589513895|FG002|Overall Study|Screen failure|0|||
163071805|NCT00790933|588969671|FG001|Overall Study|Reason Not Specified|16|||
163071806|NCT00790933|588969672|FG002|Overall Study|Reason Not Specified|4|||
163071807|NCT00790933|588969673|FG003|Overall Study|Reason Not Specified|1|||
163071808|NCT00790933|588969674|FG004|Overall Study|Reason Not Specified|9|||
163071809|NCT00720083|588969677|FG000|Overall Study|Ineligible|1|||
163071810|NCT00720083|588969678|FG001|Overall Study|Ineligible|2|||
163071811|NCT00894647|588969679|FG000|Overall Study|Adverse Event|5|||
163071812|NCT00894647|588969680|FG001|Overall Study|Adverse Event|4|||
163071813|NCT00894647|588969679|FG000|Overall Study|Withdrawal by Subject|4|||
163071814|NCT00894647|588969680|FG001|Overall Study|Withdrawal by Subject|4|||
163071815|NCT00894647|588969679|FG000|Overall Study|Lost to Follow-up|0|||
163071816|NCT00894647|588969680|FG001|Overall Study|Lost to Follow-up|2|||
163071817|NCT00894647|588969679|FG000|Overall Study|Non-compliance with study procedures|0|||
163071818|NCT00894647|588969680|FG001|Overall Study|Non-compliance with study procedures|2|||
163071819|NCT00894647|588969679|FG000|Overall Study|Other, not due to AE|1|||
163071820|NCT00894647|588969680|FG001|Overall Study|Other, not due to AE|2|||
163071821|NCT01913470|588969687|FG000|Overall Study|Lost to Follow-up|0|||
163071822|NCT01913470|588969688|FG001|Overall Study|Lost to Follow-up|1|||
163071823|NCT01913470|588969687|FG000|Overall Study|Physician Decision|0|||
163071824|NCT01913470|588969688|FG001|Overall Study|Physician Decision|1|||
163071825|NCT01913470|588969687|FG000|Overall Study|Withdrawal by Subject|0|||
163071826|NCT01913470|588969688|FG001|Overall Study|Withdrawal by Subject|1|||
163071827|NCT00245570|588969689|FG000|Washout Between Periods III and IV|Adverse Event|0|||
163071828|NCT00245570|588969690|FG001|Washout Between Periods III and IV|Adverse Event|1|||
163071829|NCT00245570|588969691|FG002|Washout Between Periods III and IV|Adverse Event|0|||
163071830|NCT00245570|588969692|FG003|Washout Between Periods III and IV|Adverse Event|0|||
163071831|NCT00245570|588969693|FG004|Washout Between Periods III and IV|Adverse Event|0|||
163071832|NCT00245570|588969694|FG005|Washout Between Periods III and IV|Adverse Event|0|||
163071833|NCT01524705|588969695|FG000|Overall Study|Adverse Event|2|||
163071834|NCT01524705|588969696|FG001|Overall Study|Adverse Event|0|||
163071835|NCT01524705|588969695|FG000|Overall Study|Death|1|||
163071836|NCT01524705|588969696|FG001|Overall Study|Death|0|||
163071837|NCT01524705|588969695|FG000|Overall Study|Lost to Follow-up|0|||
163071838|NCT01524705|588969696|FG001|Overall Study|Lost to Follow-up|1|||
163071839|NCT01524705|588969695|FG000|Overall Study|Withdrawal by Subject|0|||
163071840|NCT01524705|588969696|FG001|Overall Study|Withdrawal by Subject|1|||
163071841|NCT01524705|588969695|FG000|Overall Study|Pancreatic Cancer|0|||
163071842|NCT01524705|588969696|FG001|Overall Study|Pancreatic Cancer|1|||
163071843|NCT02573467|588969706|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
163071844|NCT02573467|588969707|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
163071845|NCT02573467|588969708|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
163071846|NCT02573467|588969709|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
163071847|NCT02573467|588969706|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
163071848|NCT02573467|588969707|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
163071849|NCT02573467|588969708|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
163071850|NCT02573467|588969709|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
163071851|NCT02573467|588969706|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
163071852|NCT02573467|588969707|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
163071853|NCT02573467|588969708|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
163071854|NCT02573467|588969709|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
163071855|NCT02573467|588969706|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
163071856|NCT02573467|588969707|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
163071857|NCT02573467|588969708|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
163071858|NCT02573467|588969709|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
163071859|NCT02573467|588969706|FG000|Post-treatment Follow up Epoch|Death|1|||
163071860|NCT02573467|588969707|FG001|Post-treatment Follow up Epoch|Death|1|||
163071861|NCT02573467|588969708|FG002|Post-treatment Follow up Epoch|Death|0|||
163071862|NCT02573467|588969709|FG003|Post-treatment Follow up Epoch|Death|1|||
163071863|NCT02573467|588969706|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
163071864|NCT02573467|588969707|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
163071865|NCT02573467|588969708|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
163071866|NCT02573467|588969709|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
163071867|NCT02573467|588969706|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
163071868|NCT02573467|588969707|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
163071869|NCT02573467|588969708|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
163071870|NCT02573467|588969709|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
163071871|NCT01829165|588969710|FG000|Overall Study|Did not complete intervention|2|||
163071872|NCT01829165|588969711|FG001|Overall Study|Did not complete intervention|0|||
163071873|NCT00103506|588969712|FG000|Overall Study|Study closed by sponsor|34|||
163071874|NCT00103506|588969713|FG001|Overall Study|Study closed by sponsor|37|||
163071875|NCT00103506|588969712|FG000|Overall Study|Death|257|||
163071876|NCT00103506|588969713|FG001|Overall Study|Death|253|||
163071877|NCT00103506|588969712|FG000|Overall Study|Lost to Follow-up|13|||
163071878|NCT00103506|588969713|FG001|Overall Study|Lost to Follow-up|13|||
163071879|NCT00103506|588969712|FG000|Overall Study|Withdrawal by Subject|18|||
163071880|NCT00103506|588969713|FG001|Overall Study|Withdrawal by Subject|21|||
163071881|NCT00710970|588969716|FG000|Overall Study|Never took drug|3|||
163071882|NCT02153827|588969717|FG000|Overall Study|Lost to Follow-up|3|||
163071883|NCT02153827|588969718|FG001|Overall Study|Lost to Follow-up|9|||
163071884|NCT00625378|588969725|FG000|Overall Study|Adverse Event|22|||
163071885|NCT00625378|588969726|FG001|Overall Study|Adverse Event|0|||
163071886|NCT00625378|588969725|FG000|Overall Study|Withdrawal by Subject|16|||
163071887|NCT00625378|588969726|FG001|Overall Study|Withdrawal by Subject|0|||
163071888|NCT00625378|588969725|FG000|Overall Study|Death|38|||
163071889|NCT00625378|588969726|FG001|Overall Study|Death|0|||
163071890|NCT00625378|588969725|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
163071891|NCT00625378|588969726|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
163071892|NCT00625378|588969725|FG000|Overall Study|Lost to Follow-up|17|||
163071893|NCT00625378|588969726|FG001|Overall Study|Lost to Follow-up|0|||
163071894|NCT00625378|588969725|FG000|Overall Study|Non-compliant with study medication|3|||
163071895|NCT00625378|588969726|FG001|Overall Study|Non-compliant with study medication|0|||
163071896|NCT00625378|588969725|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
163071897|NCT00625378|588969726|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
163071898|NCT00625378|588969725|FG000|Overall Study|Medical decision|1|||
163071899|NCT00625378|588969726|FG001|Overall Study|Medical decision|0|||
163071900|NCT00625378|588969725|FG000|Overall Study|Multiple toxicities|1|||
163071901|NCT00625378|588969726|FG001|Overall Study|Multiple toxicities|0|||
163071902|NCT00625378|588969725|FG000|Overall Study|New cancer|1|||
163071903|NCT00625378|588969726|FG001|Overall Study|New cancer|0|||
163071904|NCT00625378|588969725|FG000|Overall Study|PTA program|2|||
163071905|NCT00625378|588969726|FG001|Overall Study|PTA program|0|||
163071906|NCT00625378|588969725|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
163071907|NCT00625378|588969726|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
163071908|NCT00625378|588969725|FG000|Overall Study|Sponsor decision|1|||
163071909|NCT00625378|588969726|FG001|Overall Study|Sponsor decision|0|||
163071910|NCT00625378|588969725|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
163071911|NCT00625378|588969726|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
163071912|NCT00625378|588969725|FG000|Overall Study|Switch to commercial drug|6|||
163071913|NCT00625378|588969726|FG001|Overall Study|Switch to commercial drug|1|||
163071914|NCT00625378|588969725|FG000|Overall Study|Missing|2|||
163071915|NCT00625378|588969726|FG001|Overall Study|Missing|0|||
163071916|NCT00625378|588969725|FG000|Overall Study|End of treatment not available|2|||
163071917|NCT00625378|588969726|FG001|Overall Study|End of treatment not available|0|||
163071918|NCT00625378|588969725|FG000|Overall Study|Never treated|2|||
163071919|NCT00625378|588969726|FG001|Overall Study|Never treated|0|||
163071920|NCT02609633|588969729|FG000|Overall Study|Consent Withdrawn|0|||
163071921|NCT02609633|588969730|FG001|Overall Study|Consent Withdrawn|1|||
163071922|NCT02609633|588969729|FG000|Overall Study|Protocol Deviation|1|||
163071923|NCT02609633|588969730|FG001|Overall Study|Protocol Deviation|0|||
163071924|NCT02609633|588969729|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
163071925|NCT02609633|588969730|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
163071926|NCT02609633|588969729|FG000|Overall Study|Reason not Specified|2|||
163071927|NCT02609633|588969730|FG001|Overall Study|Reason not Specified|1|||
163071928|NCT01769443|588969733|FG000|Overall Study|Study closure|1|||
163071929|NCT01769443|588969734|FG001|Overall Study|Study closure|0|||
163071930|NCT02583477|588969735|FG000|Overall Study|Adverse Event|0|||
163071931|NCT02583477|588969736|FG001|Overall Study|Adverse Event|2|||
163071932|NCT02583477|588969735|FG000|Overall Study|Death|1|||
163071933|NCT02583477|588969736|FG001|Overall Study|Death|16|||
163071934|NCT02583477|588969735|FG000|Overall Study|Study terminated|2|||
163071935|NCT02583477|588969736|FG001|Overall Study|Study terminated|2|||
163071936|NCT05507450|588969737|FG000|Overall Study|Death|0|||
163071937|NCT05507450|588969738|FG001|Overall Study|Death|0|||
163071938|NCT05507450|588969739|FG002|Overall Study|Death|1|||
163071939|NCT05507450|588969740|FG003|Overall Study|Death|0|||
163071940|NCT05507450|588969737|FG000|Overall Study|Lost to Follow-up|22|||
163071941|NCT05507450|588969738|FG001|Overall Study|Lost to Follow-up|20|||
163071942|NCT05507450|588969739|FG002|Overall Study|Lost to Follow-up|20|||
163071943|NCT05507450|588969740|FG003|Overall Study|Lost to Follow-up|7|||
163331143|NCT00747006|589922501|FG000|Overall Study|Adverse Event|1|||
163071944|NCT05507450|588969737|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163071945|NCT05507450|588969738|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
163071946|NCT05507450|588969739|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
163071947|NCT05507450|588969740|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163071948|NCT05507450|588969737|FG000|Overall Study|Withdrawal by Subject|4|||
163071949|NCT05507450|588969738|FG001|Overall Study|Withdrawal by Subject|11|||
163071950|NCT05507450|588969739|FG002|Overall Study|Withdrawal by Subject|7|||
163071951|NCT05507450|588969740|FG003|Overall Study|Withdrawal by Subject|3|||
163071952|NCT05507450|588969737|FG000|Overall Study|Participant left the country|0|||
163071953|NCT05507450|588969738|FG001|Overall Study|Participant left the country|0|||
163331144|NCT00747006|589922502|FG001|Overall Study|Adverse Event|0|||
163071954|NCT05507450|588969739|FG002|Overall Study|Participant left the country|1|||
163071955|NCT05507450|588969740|FG003|Overall Study|Participant left the country|0|||
163071956|NCT05436288|588969741|FG000|Overall Study|Lost to Follow-up|1|||
163071957|NCT05436288|588969741|FG000|Overall Study|Adverse Event|1|||
163071958|NCT03767894|588969744|FG000|Overall Study|Withdrawal by Subject|1|||
163071959|NCT00387127|588969745|FG000|Overall Study|Lost to Follow-up|0|||
163071960|NCT00387127|588969746|FG001|Overall Study|Lost to Follow-up|4|||
163071961|NCT00387127|588969745|FG000|Overall Study|Death|16|||
163071962|NCT00387127|588969746|FG001|Overall Study|Death|16|||
163071963|NCT00387127|588969745|FG000|Overall Study|Physician Decision|0|||
163027145|NCT04521621|588801402|FG000|Overall Study|Allocated in error without study intervention|1|||
163027146|NCT04521621|588801403|FG001|Overall Study|Allocated in error without study intervention|0|||
163027147|NCT04521621|588801404|FG002|Overall Study|Allocated in error without study intervention|0|||
163027148|NCT04521621|588801405|FG003|Overall Study|Allocated in error without study intervention|0|||
163027149|NCT04521621|588801406|FG004|Overall Study|Allocated in error without study intervention|0|||
163027150|NCT04521621|588801407|FG005|Overall Study|Allocated in error without study intervention|0|||
163027151|NCT04521621|588801408|FG006|Overall Study|Allocated in error without study intervention|0|||
163027152|NCT04521621|588801409|FG007|Overall Study|Allocated in error without study intervention|0|||
163027153|NCT03671564|588801410|FG000|Overall Study|Progressive Disease|3|||
163027154|NCT03671564|588801411|FG001|Overall Study|Progressive Disease|5|||
163027155|NCT03671564|588801412|FG002|Overall Study|Progressive Disease|3|||
163027156|NCT03671564|588801410|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
163027157|NCT03671564|588801411|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
163027158|NCT03671564|588801412|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
163027159|NCT03671564|588801410|FG000|Overall Study|Withdrawal by Subject|1|||
163027160|NCT03671564|588801411|FG001|Overall Study|Withdrawal by Subject|1|||
163027161|NCT03671564|588801412|FG002|Overall Study|Withdrawal by Subject|0|||
163027162|NCT05845567|588801417|FG000|Overall Study|Withdrawal by Subject|1|||
163027163|NCT01104246|588801422|FG000|Overall Study|Withdrawal by Subject|1|||
163027164|NCT01104246|588801422|FG000|Overall Study|did not meet inclusion criteria|4|||
163027165|NCT05178641|588801423|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
163027166|NCT05178641|588801424|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
163027167|NCT05178641|588801423|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
163027168|NCT05178641|588801424|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
163027169|NCT01869699|588801427|FG000|Overall Study|Withdrawal by Subject|1|||
163027170|NCT01869699|588801428|FG001|Overall Study|Withdrawal by Subject|0|||
163027171|NCT01083186|588801430|FG000|Overall Study|Lost to Follow-up|48|||
163027172|NCT01083186|588801430|FG000|Overall Study|Consent Withdrawal|7|||
163027173|NCT01083186|588801430|FG000|Overall Study|Death|3|||
163027174|NCT01083186|588801430|FG000|Overall Study|Adverse Event|3|||
163027175|NCT01083186|588801430|FG000|Overall Study|Lack of Efficacy|2|||
163027176|NCT01083186|588801430|FG000|Overall Study|Hemodialysis Initiation|28|||
163027177|NCT01083186|588801430|FG000|Overall Study|Administrative Reasons|2|||
163027178|NCT01083186|588801430|FG000|Overall Study|Non-compliance to Study Treatment|1|||
163027179|NCT01867294|588801438|FG000|Overall Study|Withdrawal by Subject|1|||
163027180|NCT01867294|588801439|FG001|Overall Study|Withdrawal by Subject|1|||
163027181|NCT01867294|588801440|FG002|Overall Study|Withdrawal by Subject|0|||
163027182|NCT01867294|588801441|FG003|Overall Study|Withdrawal by Subject|0|||
163027183|NCT02035748|588801442|FG000|Overall Study|Adverse Event|5|||
163027184|NCT02035748|588801442|FG000|Overall Study|Death|3|||
163027185|NCT02035748|588801442|FG000|Overall Study|Lost to Follow-up|2|||
163027186|NCT02035748|588801442|FG000|Overall Study|Physician Decision|3|||
163027187|NCT02035748|588801442|FG000|Overall Study|Withdrawal by Subject|6|||
163027188|NCT02035748|588801442|FG000|Overall Study|Progressive Disease|1|||
163027189|NCT01740128|588801443|FG000|Overall Study|Pregnancy|0|||
163027190|NCT01740128|588801444|FG001|Overall Study|Pregnancy|1|||
163027191|NCT01740128|588801443|FG000|Overall Study|Protocol Violation|1|||
163027192|NCT01740128|588801444|FG001|Overall Study|Protocol Violation|2|||
163027193|NCT01740128|588801443|FG000|Overall Study|Lost to Follow-up|2|||
163027194|NCT01740128|588801444|FG001|Overall Study|Lost to Follow-up|2|||
163027195|NCT01740128|588801443|FG000|Overall Study|Withdrawal by Subject|1|||
163027196|NCT01740128|588801444|FG001|Overall Study|Withdrawal by Subject|0|||
163027197|NCT01740128|588801443|FG000|Overall Study|Insufficient protocol compliance|2|||
163027198|NCT01740128|588801444|FG001|Overall Study|Insufficient protocol compliance|2|||
163027199|NCT01041976|588801445|FG000|Overall Study|Withdrawal by Subject|3|||
163027200|NCT01041976|588801446|FG001|Overall Study|Withdrawal by Subject|0|||
163027201|NCT01041976|588801445|FG000|Overall Study|Incarceration|2|||
163071964|NCT00387127|588969746|FG001|Overall Study|Physician Decision|1|||
163027202|NCT01041976|588801446|FG001|Overall Study|Incarceration|0|||
163027203|NCT01041976|588801445|FG000|Overall Study|Death|0|||
163027204|NCT01041976|588801446|FG001|Overall Study|Death|4|||
163027205|NCT02658734|588801447|FG000|Overall Study|Adverse Event|2|||
163027206|NCT02658734|588801447|FG000|Overall Study|Death|4|||
163027207|NCT02658734|588801447|FG000|Overall Study|Lost to Follow-up|7|||
163027208|NCT02658734|588801447|FG000|Overall Study|Withdrawal of Consent|16|||
163071965|NCT00387127|588969745|FG000|Overall Study|Withdrawal by Subject|3|||
163071966|NCT00387127|588969746|FG001|Overall Study|Withdrawal by Subject|2|||
163071967|NCT00387127|588969745|FG000|Overall Study|Required by Protocol Amendment #4|12|||
163071968|NCT00387127|588969746|FG001|Overall Study|Required by Protocol Amendment #4|10|||
163071969|NCT00387127|588969745|FG000|Overall Study|Serious Adverse Event|1|||
163071970|NCT00387127|588969746|FG001|Overall Study|Serious Adverse Event|1|||
163071971|NCT00387127|588969745|FG000|Overall Study|Sponsor Unblinded|1|||
163071972|NCT00387127|588969746|FG001|Overall Study|Sponsor Unblinded|0|||
163071973|NCT04149353|588969747|FG000|Overall Study|Study terminated|1|||
163071974|NCT01871727|588969748|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
163071975|NCT01871727|588969749|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
163071976|NCT01871727|588969750|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
163071977|NCT01871727|588969751|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
163071978|NCT01871727|588969752|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
163071979|NCT01871727|588969748|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
163071980|NCT01871727|588969749|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
163071981|NCT01871727|588969750|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
163071982|NCT01871727|588969751|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
163071983|NCT01871727|588969752|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
163071984|NCT01871727|588969748|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
163071985|NCT01871727|588969749|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
163071986|NCT01871727|588969750|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
163071987|NCT01871727|588969751|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
163071988|NCT01871727|588969752|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
163071989|NCT01871727|588969748|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
163071990|NCT01871727|588969749|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
163071991|NCT01871727|588969750|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
163071992|NCT01871727|588969751|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
163071993|NCT01871727|588969752|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
163071994|NCT01871727|588969748|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
163071995|NCT01871727|588969749|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
163071996|NCT01871727|588969750|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
163071997|NCT01871727|588969751|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
163071998|NCT01871727|588969752|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
163071999|NCT01871727|588969748|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
163072000|NCT01871727|588969749|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
163072001|NCT01871727|588969750|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
163072002|NCT01871727|588969751|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
163072003|NCT01871727|588969752|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
163072004|NCT01871727|588969748|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
163072005|NCT01871727|588969749|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
163072006|NCT01871727|588969750|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
163072007|NCT01871727|588969751|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
163072008|NCT01871727|588969752|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
163072009|NCT00002874|588969753|FG000|Overall Study|Withdrawal by Subject|1|||
163072010|NCT00002874|588969754|FG001|Overall Study|Withdrawal by Subject|1|||
163072011|NCT00002874|588969753|FG000|Overall Study|Protocol Violation|44|||
163072012|NCT00002874|588969754|FG001|Overall Study|Protocol Violation|34|||
163218017|NCT03188094|589513893|FG000|Overall Study|Pregnancy|3|||
163218018|NCT03188094|589513894|FG001|Overall Study|Pregnancy|0|||
163218019|NCT03188094|589513895|FG002|Overall Study|Pregnancy|0|||
163218020|NCT03188094|589513893|FG000|Overall Study|Ineligible|1|||
163218021|NCT03188094|589513894|FG001|Overall Study|Ineligible|0|||
163218022|NCT03188094|589513895|FG002|Overall Study|Ineligible|0|||
163218023|NCT03188094|589513893|FG000|Overall Study|Lost to Follow-up|0|||
163218024|NCT03188094|589513894|FG001|Overall Study|Lost to Follow-up|0|||
163218025|NCT03188094|589513895|FG002|Overall Study|Lost to Follow-up|17|||
163218026|NCT01894581|589513896|FG000|Overall Study|Withdrawal by Subject|2|||
163218027|NCT01894581|589513897|FG001|Overall Study|Withdrawal by Subject|3|||
163072013|NCT04971837|588971350|FG000|Overall Study|Long Term Illness|1|||
163072014|NCT04971837|588971350|FG000|Overall Study|BMI too low|9|||
163072015|NCT04971837|588971350|FG000|Overall Study|geographic location|1|||
163072016|NCT04971837|588971350|FG000|Overall Study|Discontinued scheduling conflict|1|||
163218028|NCT01894581|589513896|FG000|Overall Study|Screen Failure|3|||
163072017|NCT04289298|588971351|FG000|Overall Study|Lost to Follow-up|5|||
163072018|NCT04289298|588971352|FG001|Overall Study|Lost to Follow-up|0|||
163072019|NCT04289298|588971351|FG000|Overall Study|Withdrawal by Subject|2|||
163072020|NCT04289298|588971352|FG001|Overall Study|Withdrawal by Subject|0|||
163072021|NCT01734928|588971353|FG000|Randomization|Physician Decision|0|||
163072022|NCT01734928|588971354|FG001|Randomization|Physician Decision|1|||
163218029|NCT01894581|589513897|FG001|Overall Study|Screen Failure|4|||
163218030|NCT03313804|589513898|FG000|Treatment|Death|5|||
163218031|NCT03313804|589513898|FG000|Treatment|still on treatment|2|||
163072023|NCT01734928|588971353|FG000|Randomization|clinical progression|0|||
163072024|NCT01734928|588971354|FG001|Randomization|clinical progression|1|||
163072025|NCT01734928|588971353|FG000|Randomization|progressive disease|0|||
163072026|NCT01734928|588971354|FG001|Randomization|progressive disease|2|||
163072027|NCT01734928|588971353|FG000|Randomization|Withdrew informed consent|0|||
163072028|NCT01734928|588971354|FG001|Randomization|Withdrew informed consent|4|||
163072029|NCT01734928|588971353|FG000|Randomization|Death|1|||
163072030|NCT01734928|588971354|FG001|Randomization|Death|0|||
163072031|NCT01734928|588971353|FG000|Randomization|Randomization error|1|||
163072032|NCT01734928|588971354|FG001|Randomization|Randomization error|0|||
163072033|NCT01734928|588971353|FG000|Randomization|Lost to Follow-up|1|||
163072034|NCT01734928|588971354|FG001|Randomization|Lost to Follow-up|0|||
163072035|NCT01734928|588971353|FG000|Treatment Period|Lost to Follow-up|0|||
163072036|NCT01734928|588971354|FG001|Treatment Period|Lost to Follow-up|2|||
163072037|NCT01734928|588971353|FG000|Treatment Period|Progressive Disease|167|||
163072038|NCT01734928|588971354|FG001|Treatment Period|Progressive Disease|165|||
163072039|NCT01734928|588971353|FG000|Treatment Period|Adverse Event|39|||
163072040|NCT01734928|588971354|FG001|Treatment Period|Adverse Event|52|||
163072041|NCT01734928|588971353|FG000|Treatment Period|Withdrawal of Consent|25|||
163072042|NCT01734928|588971354|FG001|Treatment Period|Withdrawal of Consent|22|||
163072043|NCT01734928|588971353|FG000|Treatment Period|Death|20|||
163072044|NCT01734928|588971354|FG001|Treatment Period|Death|9|||
163072045|NCT01734928|588971353|FG000|Treatment Period|Other Reasons|27|||
163072046|NCT01734928|588971354|FG001|Treatment Period|Other Reasons|19|||
163072047|NCT01734928|588971353|FG000|Treatment Period|Pregnancy|0|||
163072048|NCT01734928|588971354|FG001|Treatment Period|Pregnancy|1|||
163072049|NCT01108796|588971357|FG000|Overall Study|Adverse Event|0|||
163072050|NCT01108796|588971358|FG001|Overall Study|Adverse Event|1|||
163072051|NCT01108796|588971357|FG000|Overall Study|Lost to Follow-up|7|||
163072052|NCT01108796|588971358|FG001|Overall Study|Lost to Follow-up|6|||
163072053|NCT00397930|588971365|FG000|Overall Study|Personal reasons|14|||
163072054|NCT00397930|588971366|FG001|Overall Study|Personal reasons|8|||
163072055|NCT00397930|588971365|FG000|Overall Study|Other medical|9|||
163072056|NCT00397930|588971366|FG001|Overall Study|Other medical|4|||
163072057|NCT00397930|588971365|FG000|Overall Study|Unknown reasons|9|||
163072058|NCT00397930|588971366|FG001|Overall Study|Unknown reasons|14|||
163072059|NCT00397930|588971365|FG000|Overall Study|Noncompliant|3|||
163072060|NCT00397930|588971366|FG001|Overall Study|Noncompliant|2|||
163072061|NCT00397930|588971365|FG000|Overall Study|Too time-consuming|2|||
163072062|NCT00397930|588971366|FG001|Overall Study|Too time-consuming|9|||
163072063|NCT00397930|588971365|FG000|Overall Study|Started own yoga program|1|||
163072064|NCT00397930|588971366|FG001|Overall Study|Started own yoga program|1|||
163072065|NCT00397930|588971365|FG000|Overall Study|Did not want to be in control group|0|||
163072066|NCT00397930|588971366|FG001|Overall Study|Did not want to be in control group|1|||
163072067|NCT00397930|588971365|FG000|Overall Study|Withdrawal by Subject|0|||
163072068|NCT00397930|588971366|FG001|Overall Study|Withdrawal by Subject|8|||
163072069|NCT00397930|588971365|FG000|Overall Study|Missing data|0|||
163072070|NCT00397930|588971366|FG001|Overall Study|Missing data|4|||
163072071|NCT01158404|588971367|FG000|Overall Study|Withdrawal by Subject|0|||
163072072|NCT01158404|588971368|FG001|Overall Study|Withdrawal by Subject|1|||
163072073|NCT01158404|588971369|FG002|Overall Study|Withdrawal by Subject|0|||
163072074|NCT01158404|588971370|FG003|Overall Study|Withdrawal by Subject|0|||
163072075|NCT01158404|588971371|FG004|Overall Study|Withdrawal by Subject|3|||
163072076|NCT01158404|588971372|FG005|Overall Study|Withdrawal by Subject|1|||
163072077|NCT01158404|588971373|FG006|Overall Study|Withdrawal by Subject|0|||
163072078|NCT01158404|588971374|FG007|Overall Study|Withdrawal by Subject|1|||
163072079|NCT01158404|588971367|FG000|Overall Study|Physician Decision|0|||
163072080|NCT01158404|588971368|FG001|Overall Study|Physician Decision|0|||
163072081|NCT01158404|588971369|FG002|Overall Study|Physician Decision|0|||
163072082|NCT01158404|588971370|FG003|Overall Study|Physician Decision|0|||
163072083|NCT01158404|588971371|FG004|Overall Study|Physician Decision|0|||
163072084|NCT01158404|588971372|FG005|Overall Study|Physician Decision|0|||
163072085|NCT01158404|588971373|FG006|Overall Study|Physician Decision|0|||
163072086|NCT01158404|588971374|FG007|Overall Study|Physician Decision|1|||
163072087|NCT01158404|588971367|FG000|Overall Study|Progressive Disease|0|||
163331145|NCT00747006|589922503|FG002|Overall Study|Adverse Event|0|||
163331146|NCT00747006|589922501|FG000|Overall Study|Lost to Follow-up|0|||
163072088|NCT01158404|588971368|FG001|Overall Study|Progressive Disease|0|||
163072089|NCT01158404|588971369|FG002|Overall Study|Progressive Disease|0|||
163072090|NCT01158404|588971370|FG003|Overall Study|Progressive Disease|0|||
163072091|NCT01158404|588971371|FG004|Overall Study|Progressive Disease|0|||
163072092|NCT01158404|588971372|FG005|Overall Study|Progressive Disease|0|||
163072093|NCT01158404|588971373|FG006|Overall Study|Progressive Disease|1|||
163072094|NCT01158404|588971374|FG007|Overall Study|Progressive Disease|0|||
163072095|NCT02056288|588971375|FG000|In-Hospital Data|Surgery cancelled|1|||
163072096|NCT02056288|588971376|FG001|In-Hospital Data|Surgery cancelled|0|||
163072097|NCT02056288|588971375|FG000|In-Hospital Data|Protocol Violation|3|||
163072098|NCT02056288|588971376|FG001|In-Hospital Data|Protocol Violation|0|||
163072099|NCT02056288|588971375|FG000|In-Hospital Data|Physician Decision|1|||
163072100|NCT02056288|588971376|FG001|In-Hospital Data|Physician Decision|0|||
163072101|NCT02056288|588971375|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
163072102|NCT02056288|588971376|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
163072103|NCT02400580|588971379|FG000|Overall Study|Withdrawal by Subject|1|||
163072104|NCT02400580|588971380|FG001|Overall Study|Withdrawal by Subject|1|||
163072105|NCT02400580|588971379|FG000|Overall Study|Adverse Event|1|||
163072106|NCT02400580|588971380|FG001|Overall Study|Adverse Event|0|||
163072107|NCT00965094|588971381|FG000|Overall Study|Adverse Event|5|||
163072108|NCT00965094|588971382|FG001|Overall Study|Adverse Event|0|||
163072109|NCT00965094|588971381|FG000|Overall Study|Lost to Follow-up|0|||
163072110|NCT00965094|588971382|FG001|Overall Study|Lost to Follow-up|1|||
163072111|NCT01060111|588971383|FG000|Overall Study|Adverse Event|9|||
163072112|NCT01060111|588971384|FG001|Overall Study|Adverse Event|5|||
163072113|NCT01060111|588971385|FG002|Overall Study|Adverse Event|18|||
163072114|NCT01060111|588971383|FG000|Overall Study|Lack of Efficacy|2|||
163072115|NCT01060111|588971384|FG001|Overall Study|Lack of Efficacy|1|||
163072116|NCT01060111|588971385|FG002|Overall Study|Lack of Efficacy|0|||
163072117|NCT01060111|588971383|FG000|Overall Study|Inappropriate participant|5|||
163072118|NCT01060111|588971384|FG001|Overall Study|Inappropriate participant|4|||
163072119|NCT01060111|588971385|FG002|Overall Study|Inappropriate participant|5|||
163072120|NCT01060111|588971383|FG000|Overall Study|Participants' evasion for hospital visit|0|||
163072121|NCT01060111|588971384|FG001|Overall Study|Participants' evasion for hospital visit|3|||
163072122|NCT01060111|588971385|FG002|Overall Study|Participants' evasion for hospital visit|2|||
163072123|NCT01060111|588971383|FG000|Overall Study|Participants' non-cooperation|8|||
163072124|NCT01060111|588971384|FG001|Overall Study|Participants' non-cooperation|6|||
163072125|NCT01060111|588971385|FG002|Overall Study|Participants' non-cooperation|6|||
163072126|NCT01060111|588971383|FG000|Overall Study|Adverse event and insufficient effect|0|||
163072127|NCT01060111|588971384|FG001|Overall Study|Adverse event and insufficient effect|1|||
163072128|NCT01060111|588971385|FG002|Overall Study|Adverse event and insufficient effect|0|||
163072129|NCT01060111|588971383|FG000|Overall Study|Participants' non-cooperation|1|||
163072130|NCT01060111|588971384|FG001|Overall Study|Participants' non-cooperation|0|||
163072131|NCT01060111|588971385|FG002|Overall Study|Participants' non-cooperation|0|||
163072132|NCT01060111|588971383|FG000|Overall Study|Other|2|||
163072133|NCT01060111|588971384|FG001|Overall Study|Other|3|||
163072134|NCT01060111|588971385|FG002|Overall Study|Other|4|||
163072135|NCT01433978|588971386|FG000|Core Study|Adverse Event, Non-Fatal|0|||
163072136|NCT01433978|588971387|FG001|Core Study|Adverse Event, Non-Fatal|1|||
163072137|NCT01433978|588971388|FG002|Core Study|Adverse Event, Non-Fatal|0|||
163072138|NCT01433978|588971386|FG000|Core Study|Lack of Efficacy|5|||
163072139|NCT01433978|588971387|FG001|Core Study|Lack of Efficacy|1|||
163072140|NCT01433978|588971388|FG002|Core Study|Lack of Efficacy|0|||
163072141|NCT01433978|588971386|FG000|Core Study|Study Terminated by Sponsor|6|||
163072142|NCT01433978|588971387|FG001|Core Study|Study Terminated by Sponsor|9|||
163072143|NCT01433978|588971388|FG002|Core Study|Study Terminated by Sponsor|0|||
163072144|NCT01433978|588971386|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
163072145|NCT01433978|588971387|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
163072146|NCT01433978|588971388|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
163072147|NCT01433978|588971386|FG000|Extension Phase|Lack of Efficacy|0|||
163072148|NCT01433978|588971387|FG001|Extension Phase|Lack of Efficacy|0|||
163072149|NCT01433978|588971388|FG002|Extension Phase|Lack of Efficacy|1|||
163072150|NCT01433978|588971386|FG000|Extension Phase|Study Terminated by Sponsor|0|||
163072151|NCT01433978|588971387|FG001|Extension Phase|Study Terminated by Sponsor|0|||
163072152|NCT01433978|588971388|FG002|Extension Phase|Study Terminated by Sponsor|4|||
163072153|NCT01773889|588971390|FG000|Overall Study|lack of funding|2|||
163072154|NCT04233580|588971391|FG000|Overall Study|Adverse Event|3|||
163072155|NCT04233580|588971392|FG001|Overall Study|Adverse Event|3|||
163072156|NCT04233580|588971391|FG000|Overall Study|Withdrawal by Subject|2|||
163072157|NCT04233580|588971392|FG001|Overall Study|Withdrawal by Subject|1|||
163072158|NCT03954938|588971393|FG000|Overall Study|Withdrawal by Subject|2|||
163072159|NCT03954938|588971393|FG000|Overall Study|Adverse Event|1|||
163072160|NCT01371565|588971394|FG000|Overall Study|Withdrawal by Subject|1|||
163072161|NCT01371565|588971394|FG000|Overall Study|Death|1|||
163072162|NCT01371565|588971394|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
163072163|NCT02565186|588971395|FG000|Overall Study|Adverse Event|113|||
163072164|NCT02565186|588971396|FG001|Overall Study|Adverse Event|148|||
163072165|NCT02565186|588971395|FG000|Overall Study|Lost to Follow-up|102|||
163218032|NCT03313804|589513898|FG000|Follow Up|still on follow up|3|||
163072166|NCT02565186|588971396|FG001|Overall Study|Lost to Follow-up|93|||
163072167|NCT02565186|588971395|FG000|Overall Study|Non-Compliance|57|||
163072168|NCT02565186|588971396|FG001|Overall Study|Non-Compliance|55|||
163072169|NCT02565186|588971395|FG000|Overall Study|Withdrawal by Subject|229|||
163072170|NCT02565186|588971396|FG001|Overall Study|Withdrawal by Subject|214|||
163072171|NCT02565186|588971395|FG000|Overall Study|Physician Decision|18|||
163072172|NCT02565186|588971396|FG001|Overall Study|Physician Decision|16|||
163072173|NCT02565186|588971395|FG000|Overall Study|Sponsor Request|5|||
163072174|NCT02565186|588971396|FG001|Overall Study|Sponsor Request|9|||
163218033|NCT03795298|589513899|FG000|Overall Study|Death|34|||
163027209|NCT02658734|588801447|FG000|Overall Study|Disease Progression|28|||
163027210|NCT00976209|588801450|FG000|Treatment Period 1|Protocol Violation|1|||
163027211|NCT00976209|588801451|FG001|Treatment Period 1|Protocol Violation|0|||
163027212|NCT00976209|588801450|FG000|Treatment Period 1|Lost to Follow-up|2|||
163027213|NCT00976209|588801451|FG001|Treatment Period 1|Lost to Follow-up|0|||
163027214|NCT00976209|588801450|FG000|Treatment Period 1|Other|0|||
163027215|NCT00976209|588801451|FG001|Treatment Period 1|Other|1|||
163027216|NCT00976209|588801450|FG000|Wash-out Period|Adverse Event|1|||
163027217|NCT00976209|588801451|FG001|Wash-out Period|Adverse Event|2|||
163027218|NCT00976209|588801450|FG000|Wash-out Period|Lost to Follow-up|1|||
163027219|NCT00976209|588801451|FG001|Wash-out Period|Lost to Follow-up|0|||
163027220|NCT00976209|588801450|FG000|Wash-out Period|Protocol Violation|1|||
163027221|NCT00976209|588801451|FG001|Wash-out Period|Protocol Violation|0|||
163027222|NCT00976209|588801450|FG000|Wash-out Period|Other|1|||
163027223|NCT00976209|588801451|FG001|Wash-out Period|Other|0|||
163027224|NCT00976209|588801450|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163027225|NCT00976209|588801451|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163027226|NCT00976209|588801450|FG000|Treatment Period 2|Lost to Follow-up|0|||
163027227|NCT00976209|588801451|FG001|Treatment Period 2|Lost to Follow-up|1|||
163027228|NCT01252563|588801452|FG000|Overall Study|Contract Deviation|41|||
163027229|NCT01252563|588801452|FG000|Overall Study|Centralized Registration Deviation|30|||
163027230|NCT01252563|588801452|FG000|Overall Study|Lost to Follow-up|161|||
163027231|NCT01252563|588801452|FG000|Overall Study|No visit after first day of treatment|194|||
163027232|NCT01252563|588801452|FG000|Overall Study|No drug administration|6|||
163027233|NCT01866657|588801453|FG000|Overall Study|Surgery canceled|2|||
163027234|NCT01866657|588801454|FG001|Overall Study|Surgery canceled|0|||
163027235|NCT00978250|588801460|FG000|Overall Study|Late determination of ineligibility|0|||
163027236|NCT00978250|588801461|FG001|Overall Study|Late determination of ineligibility|1|||
163027237|NCT00978250|588801462|FG002|Overall Study|Late determination of ineligibility|0|||
163027238|NCT00978250|588801463|FG003|Overall Study|Late determination of ineligibility|1|||
163027239|NCT03036098|588803989|FG000|Pre-Treatment|Other Reasons|1|||
163027240|NCT03036098|588803990|FG001|Pre-Treatment|Other Reasons|2|||
163027241|NCT03036098|588803991|FG002|Pre-Treatment|Other Reasons|0|||
163027242|NCT03036098|588803992|FG003|Pre-Treatment|Other Reasons|5|||
163027243|NCT03036098|588803989|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
163027244|NCT03036098|588803990|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
163027245|NCT03036098|588803991|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
163027246|NCT03036098|588803992|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
163027247|NCT03036098|588803989|FG000|Pre-Treatment|Withdrawal by Subject|1|||
163027248|NCT03036098|588803990|FG001|Pre-Treatment|Withdrawal by Subject|14|||
163027249|NCT03036098|588803991|FG002|Pre-Treatment|Withdrawal by Subject|0|||
163027250|NCT03036098|588803992|FG003|Pre-Treatment|Withdrawal by Subject|5|||
163027251|NCT03036098|588803989|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
163027252|NCT03036098|588803990|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
163027253|NCT03036098|588803991|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
163027254|NCT03036098|588803992|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
163027255|NCT03036098|588803989|FG000|Treatment|Disease Progression|130|||
163027256|NCT03036098|588803990|FG001|Treatment|Disease Progression|77|||
163027257|NCT03036098|588803991|FG002|Treatment|Disease Progression|168|||
163027258|NCT03036098|588803992|FG003|Treatment|Disease Progression|50|||
163027259|NCT03036098|588803989|FG000|Treatment|Study Drug Toxicity|95|||
163027260|NCT03036098|588803990|FG001|Treatment|Study Drug Toxicity|45|||
163027261|NCT03036098|588803991|FG002|Treatment|Study Drug Toxicity|26|||
163027262|NCT03036098|588803992|FG003|Treatment|Study Drug Toxicity|22|||
163027263|NCT03036098|588803989|FG000|Treatment|Death|9|||
163027264|NCT03036098|588803990|FG001|Treatment|Death|3|||
163027265|NCT03036098|588803991|FG002|Treatment|Death|1|||
163027266|NCT03036098|588803992|FG003|Treatment|Death|2|||
163027267|NCT03036098|588803989|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
163027268|NCT03036098|588803990|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
163027269|NCT03036098|588803991|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
163331147|NCT00747006|589922502|FG001|Overall Study|Lost to Follow-up|1|||
163331148|NCT00747006|589922503|FG002|Overall Study|Lost to Follow-up|0|||
163331149|NCT00747006|589922501|FG000|Overall Study|Physician Decision|2|||
163027270|NCT03036098|588803992|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
163027271|NCT03036098|588803989|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
163027272|NCT03036098|588803990|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
163027273|NCT03036098|588803991|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
163027274|NCT03036098|588803992|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
163027275|NCT03036098|588803989|FG000|Treatment|Withdrawal by Subject|2|||
163027276|NCT03036098|588803990|FG001|Treatment|Withdrawal by Subject|9|||
163027277|NCT03036098|588803991|FG002|Treatment|Withdrawal by Subject|2|||
163027278|NCT03036098|588803992|FG003|Treatment|Withdrawal by Subject|4|||
163027279|NCT03036098|588803989|FG000|Treatment|Maximum Clinical Benefit|6|||
163027280|NCT03036098|588803990|FG001|Treatment|Maximum Clinical Benefit|1|||
163331150|NCT00747006|589922502|FG001|Overall Study|Physician Decision|0|||
163072175|NCT02565186|588971395|FG000|Overall Study|Missing|1|||
163072176|NCT02565186|588971396|FG001|Overall Study|Missing|0|||
163072177|NCT02565186|588971395|FG000|Overall Study|Did Not Receive Study Drug|55|||
163072178|NCT02565186|588971396|FG001|Overall Study|Did Not Receive Study Drug|86|||
163072179|NCT00617903|588971397|FG000|Overall Study|Withdrawal by Subject|2|||
163072180|NCT00617903|588971398|FG001|Overall Study|Withdrawal by Subject|3|||
163072181|NCT00617903|588971397|FG000|Overall Study|Lost to Follow-up|1|||
163072182|NCT00617903|588971398|FG001|Overall Study|Lost to Follow-up|1|||
163072183|NCT00617903|588971397|FG000|Overall Study|Lack of Efficacy|0|||
163072184|NCT00617903|588971398|FG001|Overall Study|Lack of Efficacy|1|||
163072185|NCT00617903|588971397|FG000|Overall Study|Adverse Event|0|||
163072186|NCT00617903|588971398|FG001|Overall Study|Adverse Event|1|||
163072187|NCT00617903|588971397|FG000|Overall Study|noncompliance|0|||
163072188|NCT00617903|588971398|FG001|Overall Study|noncompliance|1|||
163072189|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
163072190|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
163072191|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
163072192|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
163072193|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
163072194|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
163072195|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
163072196|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
163072197|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
163072198|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
163072199|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
163072200|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
163072201|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
163072202|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
163072203|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
163072204|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
163072205|NCT00976391|588971399|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
163072206|NCT00976391|588971400|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
163072207|NCT00976391|588971399|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
163072208|NCT00976391|588971400|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
163072209|NCT00976391|588971399|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
163072210|NCT00976391|588971400|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
163072211|NCT00976391|588971399|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
163072212|NCT00976391|588971400|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
163072213|NCT00976391|588971399|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
163072214|NCT00976391|588971400|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
163072215|NCT00976391|588971399|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
163072216|NCT00976391|588971400|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
163072217|NCT04676646|588971401|FG000|Open-label Run-in Phase|Adverse Event|3|||
163072218|NCT04676646|588971402|FG001|Open-label Run-in Phase|Adverse Event|0|||
163072219|NCT04676646|588971403|FG002|Open-label Run-in Phase|Adverse Event|0|||
163072220|NCT04676646|588971401|FG000|Open-label Run-in Phase|Death|3|||
163072221|NCT04676646|588971402|FG001|Open-label Run-in Phase|Death|0|||
163072222|NCT04676646|588971403|FG002|Open-label Run-in Phase|Death|0|||
163072223|NCT04676646|588971401|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
163072224|NCT04676646|588971402|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
163072225|NCT04676646|588971403|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
163072226|NCT04676646|588971401|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
163072227|NCT04676646|588971402|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
163072228|NCT04676646|588971403|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
163072229|NCT04676646|588971401|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
163072230|NCT04676646|588971402|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
163218034|NCT03795298|589513900|FG001|Overall Study|Death|29|||
163218035|NCT03795298|589513899|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
163218036|NCT03795298|589513900|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
163218037|NCT03795298|589513899|FG000|Overall Study|Lost to Follow-up|28|||
163218038|NCT03795298|589513900|FG001|Overall Study|Lost to Follow-up|17|||
163218039|NCT03795298|589513899|FG000|Overall Study|Physician Decision|5|||
163218040|NCT03795298|589513900|FG001|Overall Study|Physician Decision|4|||
163218041|NCT03795298|589513899|FG000|Overall Study|Withdrawal by Subject|43|||
163218042|NCT03795298|589513900|FG001|Overall Study|Withdrawal by Subject|28|||
163218043|NCT03795298|589513899|FG000|Overall Study|Reason not reported|7|||
163072231|NCT04676646|588971403|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
163072232|NCT04676646|588971401|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
163072233|NCT04676646|588971402|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
163072234|NCT04676646|588971403|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
163072235|NCT04676646|588971401|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
163218044|NCT03795298|589513900|FG001|Overall Study|Reason not reported|9|||
163072236|NCT04676646|588971402|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
163072237|NCT04676646|588971403|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
163072238|NCT04676646|588971401|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
163072239|NCT04676646|588971402|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
163072240|NCT04676646|588971403|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
163072241|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
163072242|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
163072243|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
163072244|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Death|0|||
163072245|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Death|1|||
163072246|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Death|2|||
163072247|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
163072248|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
163072249|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
163072250|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
163072251|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
163072252|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
163072253|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
163072254|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
163072255|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
163072256|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
163072257|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
163072258|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
163072259|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
163072260|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
163072261|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
163072262|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
163072263|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
163072264|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
163072265|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
163072266|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
163072267|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
163072268|NCT04270760|588971404|FG000|Overall Study|Withdrawal by Subject|0|||
163072269|NCT04270760|588971405|FG001|Overall Study|Withdrawal by Subject|1|||
163072270|NCT04270760|588971406|FG002|Overall Study|Withdrawal by Subject|3|||
163072271|NCT04270760|588971407|FG003|Overall Study|Withdrawal by Subject|0|||
163072272|NCT04270760|588971408|FG004|Overall Study|Withdrawal by Subject|0|||
163072273|NCT04270760|588971404|FG000|Overall Study|Lost to Follow-up|1|||
163072274|NCT04270760|588971405|FG001|Overall Study|Lost to Follow-up|2|||
163072275|NCT04270760|588971406|FG002|Overall Study|Lost to Follow-up|1|||
163072276|NCT04270760|588971407|FG003|Overall Study|Lost to Follow-up|0|||
163072277|NCT04270760|588971408|FG004|Overall Study|Lost to Follow-up|0|||
163072278|NCT04270760|588971404|FG000|Overall Study|Death|0|||
163072279|NCT04270760|588971405|FG001|Overall Study|Death|0|||
163072280|NCT04270760|588971406|FG002|Overall Study|Death|0|||
163072281|NCT04270760|588971407|FG003|Overall Study|Death|0|||
163072282|NCT04270760|588971408|FG004|Overall Study|Death|1|||
163072283|NCT05156125|588971409|FG000|Overall Study|Lack of Efficacy|1|||
163072284|NCT05156125|588971410|FG001|Overall Study|Lack of Efficacy|1|||
163072285|NCT05156125|588971411|FG002|Overall Study|Lack of Efficacy|1|||
163072286|NCT05156125|588971409|FG000|Overall Study|Physician Decision|0|||
163072287|NCT05156125|588971410|FG001|Overall Study|Physician Decision|0|||
163072288|NCT05156125|588971411|FG002|Overall Study|Physician Decision|1|||
163072289|NCT05156125|588971409|FG000|Overall Study|Non-compliance|0|||
163072290|NCT05156125|588971410|FG001|Overall Study|Non-compliance|1|||
163072291|NCT05156125|588971411|FG002|Overall Study|Non-compliance|1|||
163072292|NCT05156125|588971409|FG000|Overall Study|Withdrawal by Subject|0|||
163072293|NCT05156125|588971410|FG001|Overall Study|Withdrawal by Subject|0|||
163072294|NCT05156125|588971411|FG002|Overall Study|Withdrawal by Subject|1|||
163072295|NCT05156125|588971409|FG000|Overall Study|Adverse Event|2|||
163072296|NCT05156125|588971410|FG001|Overall Study|Adverse Event|1|||
163331151|NCT00747006|589922503|FG002|Overall Study|Physician Decision|1|||
163331152|NCT00357994|589922504|FG000|Overall Study|Adverse Event|1|||
163331153|NCT00357994|589922505|FG001|Overall Study|Adverse Event|2|||
163331154|NCT00357994|589922504|FG000|Overall Study|Lack of Efficacy|0|||
163331155|NCT00357994|589922505|FG001|Overall Study|Lack of Efficacy|1|||
163331156|NCT00357994|589922504|FG000|Overall Study|Protocol Violation|1|||
163331157|NCT00357994|589922505|FG001|Overall Study|Protocol Violation|0|||
163331158|NCT02132949|589922510|FG000|Overall Study|Death|7|||
163331159|NCT02132949|589922511|FG001|Overall Study|Death|13|||
163331160|NCT02132949|589922510|FG000|Overall Study|Lost to Follow-up|14|||
163331161|NCT02132949|589922511|FG001|Overall Study|Lost to Follow-up|4|||
163331162|NCT02132949|589922510|FG000|Overall Study|Withdrawal by Subject|6|||
163331163|NCT02132949|589922511|FG001|Overall Study|Withdrawal by Subject|5|||
163072297|NCT05156125|588971411|FG002|Overall Study|Adverse Event|0|||
163072298|NCT03670628|588971412|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
163072299|NCT03670628|588971413|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
163072300|NCT03670628|588971412|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
163072301|NCT03670628|588971413|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
163072302|NCT00997126|588971417|FG000|Overall Study|Physician Decision|7|||
163072303|NCT00997126|588971418|FG001|Overall Study|Physician Decision|11|||
163072304|NCT01755637|588971419|FG000|Period 1|Adverse Event|0|||
163072305|NCT01755637|588971420|FG001|Period 1|Adverse Event|1|||
163072306|NCT00899847|588971421|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
163072307|NCT02287025|588971422|FG000|Overall Study|Not treated|2|||
163072308|NCT02287025|588971423|FG001|Overall Study|Not treated|0|||
163072309|NCT02287025|588971422|FG000|Overall Study|Progression of disease|3|||
163072310|NCT02287025|588971423|FG001|Overall Study|Progression of disease|2|||
163072311|NCT02287025|588971422|FG000|Overall Study|Adverse Event|2|||
163072312|NCT02287025|588971423|FG001|Overall Study|Adverse Event|4|||
163072313|NCT02287025|588971422|FG000|Overall Study|Withdrawal by Subject|2|||
163072314|NCT02287025|588971423|FG001|Overall Study|Withdrawal by Subject|2|||
163072315|NCT02287025|588971422|FG000|Overall Study|Screening failed|1|||
163072316|NCT02287025|588971423|FG001|Overall Study|Screening failed|1|||
163072317|NCT03338023|588971424|FG000|Overall Study|Withdrawal by Subject|3|||
163072318|NCT03338023|588971425|FG001|Overall Study|Withdrawal by Subject|4|||
163072319|NCT03338023|588971424|FG000|Overall Study|Protocol Violation|3|||
163072320|NCT03338023|588971425|FG001|Overall Study|Protocol Violation|3|||
163072321|NCT03338023|588971424|FG000|Overall Study|Lost to Follow-up|2|||
163072322|NCT03338023|588971425|FG001|Overall Study|Lost to Follow-up|1|||
163072323|NCT03338023|588971424|FG000|Overall Study|Physician Decision|1|||
163072324|NCT03338023|588971425|FG001|Overall Study|Physician Decision|2|||
163072325|NCT04996264|588971426|FG000|Overall Study|Lost to Follow-up|0|||
163072326|NCT04996264|588971427|FG001|Overall Study|Lost to Follow-up|1|||
163072327|NCT04996264|588971426|FG000|Overall Study|Withdrawal by Subject|4|||
163072328|NCT04996264|588971427|FG001|Overall Study|Withdrawal by Subject|3|||
163072329|NCT04996264|588971426|FG000|Overall Study|1 left AMA|0|||
163072330|NCT04996264|588971427|FG001|Overall Study|1 left AMA|1|||
163072331|NCT04996264|588971426|FG000|Overall Study|Subject changed hospitals|0|||
163072332|NCT04996264|588971427|FG001|Overall Study|Subject changed hospitals|1|||
163072333|NCT04996264|588971426|FG000|Overall Study|unable to complete due to work|0|||
163072334|NCT04996264|588971427|FG001|Overall Study|unable to complete due to work|1|||
163072335|NCT00685698|588971428|FG000|Overall Study|Withdrawal by Subject|1|||
163072336|NCT00685698|588971428|FG000|Overall Study|Protocol Violation|6|||
163072337|NCT00685698|588971428|FG000|Overall Study|Adverse Event|3|||
163072338|NCT00685698|588971428|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
163072339|NCT00685698|588971428|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
163072340|NCT00685698|588971428|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
163072341|NCT02030418|588971429|FG000|Overall Study|Death|78|||
163331164|NCT02132949|589922510|FG000|Overall Study|Noncompliance|5|||
163072342|NCT02030418|588971429|FG000|Overall Study|Missed 12-Month Visit|9|||
163072343|NCT02030418|588971429|FG000|Overall Study|Withdrawn|57|||
163072344|NCT03412890|588971430|FG000|Overall Study|Adverse Event|5|||
163072345|NCT03412890|588971431|FG001|Overall Study|Adverse Event|5|||
163072346|NCT03412890|588971432|FG002|Overall Study|Adverse Event|9|||
163072347|NCT03412890|588971430|FG000|Overall Study|Protocol deviation|2|||
163072348|NCT03412890|588971431|FG001|Overall Study|Protocol deviation|1|||
163072349|NCT03412890|588971432|FG002|Overall Study|Protocol deviation|2|||
163072350|NCT03412890|588971430|FG000|Overall Study|Lost to Follow-up|7|||
163072351|NCT03412890|588971431|FG001|Overall Study|Lost to Follow-up|10|||
163331165|NCT02132949|589922511|FG001|Overall Study|Noncompliance|1|||
163072352|NCT03412890|588971432|FG002|Overall Study|Lost to Follow-up|10|||
163072353|NCT03412890|588971430|FG000|Overall Study|Withdrawal by Subject|9|||
163072354|NCT03412890|588971431|FG001|Overall Study|Withdrawal by Subject|12|||
163072355|NCT03412890|588971432|FG002|Overall Study|Withdrawal by Subject|11|||
163072356|NCT03412890|588971430|FG000|Overall Study|Lack of Efficacy|2|||
163072357|NCT03412890|588971431|FG001|Overall Study|Lack of Efficacy|7|||
163331166|NCT02132949|589922510|FG000|Overall Study|Physician Decision|3|||
163331167|NCT02132949|589922511|FG001|Overall Study|Physician Decision|1|||
163072358|NCT03412890|588971432|FG002|Overall Study|Lack of Efficacy|5|||
163072359|NCT03412890|588971430|FG000|Overall Study|Other|5|||
163072360|NCT03412890|588971431|FG001|Overall Study|Other|6|||
163072361|NCT03412890|588971432|FG002|Overall Study|Other|5|||
163072362|NCT03412890|588971430|FG000|Overall Study|Participants who did not receive any study drug|0|||
163072363|NCT03412890|588971431|FG001|Overall Study|Participants who did not receive any study drug|1|||
163072364|NCT03412890|588971432|FG002|Overall Study|Participants who did not receive any study drug|0|||
163072365|NCT00887588|588971436|FG000|Core Period|Death|1|||
163072366|NCT00887588|588971437|FG001|Core Period|Death|1|||
163072367|NCT00887588|588971436|FG000|Core Period|Lost to Follow-up|3|||
163072368|NCT00887588|588971437|FG001|Core Period|Lost to Follow-up|1|||
163072369|NCT00887588|588971436|FG000|Core Period|Withdrawal by Subject|6|||
163072370|NCT00887588|588971437|FG001|Core Period|Withdrawal by Subject|8|||
163072371|NCT00887588|588971436|FG000|Core Period|Adverse Event|9|||
163072372|NCT00887588|588971437|FG001|Core Period|Adverse Event|11|||
163072373|NCT00887588|588971436|FG000|Extension Period|Adverse Event|4|||
163072374|NCT00887588|588971437|FG001|Extension Period|Adverse Event|4|||
163072375|NCT00887588|588971436|FG000|Extension Period|Death|0|||
163072376|NCT00887588|588971437|FG001|Extension Period|Death|1|||
163072377|NCT00887588|588971436|FG000|Extension Period|Protocol deviation|1|||
163072378|NCT00887588|588971437|FG001|Extension Period|Protocol deviation|0|||
163072379|NCT00887588|588971436|FG000|Extension Period|Lost to Follow-up|1|||
163072380|NCT00887588|588971437|FG001|Extension Period|Lost to Follow-up|0|||
163072381|NCT00567112|588971438|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
163072382|NCT00567112|588971439|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
163072383|NCT00567112|588971440|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
163072384|NCT00567112|588971438|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
163072385|NCT00567112|588971439|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
163072386|NCT00567112|588971440|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
163072387|NCT00567112|588971438|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
163072388|NCT00567112|588971439|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
163072389|NCT00567112|588971440|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
163072390|NCT03753542|588971444|FG000|Overall Study|Lost to Follow-up|9|||
163072391|NCT03753542|588971445|FG001|Overall Study|Lost to Follow-up|14|||
163072392|NCT04180696|588971448|FG000|Overall Study|Death|5|||
163072393|NCT04180696|588971449|FG001|Overall Study|Death|6|||
163072394|NCT04180696|588971448|FG000|Overall Study|Lost to Follow-up|1|||
163072395|NCT04180696|588971449|FG001|Overall Study|Lost to Follow-up|0|||
163072396|NCT04180696|588971448|FG000|Overall Study|Withdrawal by Subject|0|||
163072397|NCT04180696|588971449|FG001|Overall Study|Withdrawal by Subject|1|||
163072398|NCT04210375|588971452|FG000|Overall Study|Death|0|||
163072399|NCT04210375|588971453|FG001|Overall Study|Death|1|||
163072400|NCT04210375|588971454|FG002|Overall Study|Death|0|||
163072401|NCT04210375|588971455|FG003|Overall Study|Death|0|||
163072402|NCT05752487|588971458|FG000|Overall Study|Enrolled, not treated|9|||
163072403|NCT05752487|588971458|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
163072404|NCT05752487|588971458|FG000|Overall Study|Withdrawal by Subject|2|||
163072405|NCT04124965|588971460|FG000|Overall Study|Adverse event, non-fatal|3|||
163072406|NCT04124965|588971461|FG001|Overall Study|Adverse event, non-fatal|1|||
163072407|NCT04124965|588971460|FG000|Overall Study|Withdrawal by Subject|1|||
163072408|NCT04124965|588971461|FG001|Overall Study|Withdrawal by Subject|1|||
163072409|NCT04124965|588971460|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
163072410|NCT04124965|588971461|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
163072411|NCT04124965|588971460|FG000|Overall Study|Pregnancy|1|||
163072412|NCT04124965|588971461|FG001|Overall Study|Pregnancy|0|||
163072413|NCT04124965|588971460|FG000|Overall Study|Sponsor and participant decision|0|||
163072414|NCT04124965|588971461|FG001|Overall Study|Sponsor and participant decision|1|||
163218045|NCT03971695|589515728|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
163218046|NCT03971695|589515729|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
163218047|NCT03971695|589515730|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
163218048|NCT03971695|589515731|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
163218049|NCT03971695|589515732|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
163218050|NCT03971695|589515733|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
163218051|NCT03971695|589515734|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
163072415|NCT04124965|588971460|FG000|Overall Study|Personal surgery|0|||
163072416|NCT04124965|588971461|FG001|Overall Study|Personal surgery|1|||
163072417|NCT04124965|588971460|FG000|Overall Study|Physician Decision|0|||
163072418|NCT04124965|588971461|FG001|Overall Study|Physician Decision|1|||
163072419|NCT01214720|588971464|FG000|Overall Study|Alive and still on treatment|34|||
163072420|NCT01214720|588971465|FG001|Overall Study|Alive and still on treatment|18|||
163072421|NCT01214720|588971464|FG000|Overall Study|Alive and in follow-up|45|||
163072422|NCT01214720|588971465|FG001|Overall Study|Alive and in follow-up|48|||
163072423|NCT01214720|588971464|FG000|Overall Study|Lost to Follow-up|6|||
163072424|NCT01214720|588971465|FG001|Overall Study|Lost to Follow-up|2|||
163072425|NCT04625972|588971466|FG000|Overall Study|Death|3|||
163072426|NCT04625972|588971467|FG001|Overall Study|Death|2|||
163072427|NCT04625972|588971466|FG000|Overall Study|Lost to Follow-up|82|||
163072428|NCT04625972|588971467|FG001|Overall Study|Lost to Follow-up|38|||
163331168|NCT02132949|589922510|FG000|Overall Study|Disease Progression|3|||
163331169|NCT02132949|589922511|FG001|Overall Study|Disease Progression|0|||
163331170|NCT02132949|589922510|FG000|Overall Study|Adverse Event|2|||
163331171|NCT02132949|589922511|FG001|Overall Study|Adverse Event|1|||
163331172|NCT02132949|589922510|FG000|Overall Study|Withdrew Prior to Treatment|1|||
163331173|NCT02132949|589922511|FG001|Overall Study|Withdrew Prior to Treatment|2|||
163331174|NCT02132949|589922510|FG000|Overall Study|Reason Unspecified|0|||
163331175|NCT02132949|589922511|FG001|Overall Study|Reason Unspecified|1|||
163027281|NCT03036098|588803991|FG002|Treatment|Maximum Clinical Benefit|6|||
163027282|NCT03036098|588803992|FG003|Treatment|Maximum Clinical Benefit|10|||
163027283|NCT03036098|588803989|FG000|Treatment|Poor/Non Compliance|1|||
163027284|NCT03036098|588803990|FG001|Treatment|Poor/Non Compliance|2|||
163027285|NCT03036098|588803991|FG002|Treatment|Poor/Non Compliance|0|||
163027286|NCT03036098|588803992|FG003|Treatment|Poor/Non Compliance|1|||
163027287|NCT03036098|588803989|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
163027288|NCT03036098|588803990|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
163027289|NCT03036098|588803991|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
163027290|NCT03036098|588803992|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
163027291|NCT03036098|588803989|FG000|Treatment|Administrative Reason by Sponsor|1|||
163027292|NCT03036098|588803990|FG001|Treatment|Administrative Reason by Sponsor|0|||
163027293|NCT03036098|588803991|FG002|Treatment|Administrative Reason by Sponsor|2|||
163027294|NCT03036098|588803992|FG003|Treatment|Administrative Reason by Sponsor|1|||
163027295|NCT03036098|588803989|FG000|Treatment|Other Reasons|31|||
163027296|NCT03036098|588803990|FG001|Treatment|Other Reasons|5|||
163027297|NCT03036098|588803991|FG002|Treatment|Other Reasons|21|||
163027298|NCT03036098|588803992|FG003|Treatment|Other Reasons|8|||
163027299|NCT03036098|588803989|FG000|Treatment|Ongoing Treatment|0|||
163027300|NCT03036098|588803990|FG001|Treatment|Ongoing Treatment|0|||
163027301|NCT03036098|588803991|FG002|Treatment|Ongoing Treatment|23|||
163027302|NCT03036098|588803992|FG003|Treatment|Ongoing Treatment|0|||
163027303|NCT01632904|588803997|FG000|Overall Study|Adverse Event|4|||
163027304|NCT01632904|588803998|FG001|Overall Study|Adverse Event|1|||
163027305|NCT01632904|588803997|FG000|Overall Study|Physician Decision|0|||
163027306|NCT01632904|588803998|FG001|Overall Study|Physician Decision|1|||
163027307|NCT01632904|588803997|FG000|Overall Study|Subject decision|3|||
163027308|NCT01632904|588803998|FG001|Overall Study|Subject decision|2|||
163027309|NCT01632904|588803997|FG000|Overall Study|Disease Progression|0|||
163027310|NCT01632904|588803998|FG001|Overall Study|Disease Progression|1|||
163027311|NCT01632904|588803997|FG000|Overall Study|Reason for discontinuation not available|0|||
163027312|NCT01632904|588803998|FG001|Overall Study|Reason for discontinuation not available|1|||
163027313|NCT01004406|588803999|FG000|Overall Study|Withdrawal by Subject|2|||
163027314|NCT01004406|588804000|FG001|Overall Study|Withdrawal by Subject|0|||
163027315|NCT01004406|588803999|FG000|Overall Study|Lost to Follow-up|1|||
163027316|NCT01004406|588804000|FG001|Overall Study|Lost to Follow-up|0|||
163027317|NCT04542499|588804005|FG000|Overall Study|Adverse Event|23|||
163027318|NCT04542499|588804006|FG001|Overall Study|Adverse Event|43|||
163027319|NCT04542499|588804005|FG000|Overall Study|Lack of Efficacy|5|||
163027320|NCT04542499|588804006|FG001|Overall Study|Lack of Efficacy|2|||
163027321|NCT04542499|588804005|FG000|Overall Study|Lost to Follow-up|3|||
163027322|NCT04542499|588804006|FG001|Overall Study|Lost to Follow-up|4|||
163027323|NCT04542499|588804005|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
163027324|NCT04542499|588804006|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
163027325|NCT04542499|588804005|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
163027326|NCT04542499|588804006|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
163027327|NCT04542499|588804005|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163027328|NCT04542499|588804006|FG001|Overall Study|Non-Compliance with Study Drug|2|||
163027329|NCT04542499|588804005|FG000|Overall Study|Physician Decision|0|||
163027330|NCT04542499|588804006|FG001|Overall Study|Physician Decision|1|||
163027331|NCT04542499|588804005|FG000|Overall Study|Site Terminated by Sponsor|3|||
163027332|NCT04542499|588804006|FG001|Overall Study|Site Terminated by Sponsor|5|||
163027333|NCT04542499|588804005|FG000|Overall Study|Withdrawal by Subject|12|||
163027334|NCT04542499|588804006|FG001|Overall Study|Withdrawal by Subject|33|||
163331176|NCT00745875|589922518|FG000|Overall Study|Continuing study treatment|4|||
163331177|NCT00745875|589922519|FG001|Overall Study|Continuing study treatment|4|||
163027335|NCT04542499|588804005|FG000|Overall Study|Other|2|||
163027336|NCT04542499|588804006|FG001|Overall Study|Other|2|||
163027337|NCT05906836|588804010|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
163027338|NCT05906836|588804010|FG000|Overall Study|Lost to Follow-up|1|||
163027339|NCT04035434|588804013|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027340|NCT04035434|588804014|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
163027341|NCT04035434|588804015|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027342|NCT04035434|588804016|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
163331178|NCT01833455|589922522|FG000|Overall Study|Withdrawal by Subject|1|||
163331179|NCT01833455|589922523|FG001|Overall Study|Withdrawal by Subject|0|||
163027343|NCT04035434|588804017|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
163218052|NCT03971695|589515735|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
163218053|NCT03971695|589515736|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
163218054|NCT03971695|589515737|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
163218055|NCT03971695|589515738|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
163027344|NCT04035434|588804018|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027345|NCT04035434|588804019|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027346|NCT04035434|588804020|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027347|NCT04035434|588804021|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027348|NCT04035434|588804022|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027349|NCT04035434|588804023|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
163027350|NCT04035434|588804024|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
163027351|NCT04035434|588804025|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027352|NCT04035434|588804013|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
163027353|NCT04035434|588804014|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
163027354|NCT04035434|588804015|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
163027355|NCT04035434|588804016|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
163027356|NCT04035434|588804017|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
163027357|NCT04035434|588804018|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
163027358|NCT04035434|588804019|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
163027359|NCT04035434|588804020|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
163027360|NCT04035434|588804021|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
163027361|NCT04035434|588804022|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
163027362|NCT04035434|588804023|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
163027363|NCT04035434|588804024|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
163027364|NCT04035434|588804025|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
163027365|NCT04035434|588804013|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027366|NCT04035434|588804014|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
163027367|NCT04035434|588804015|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
163027368|NCT04035434|588804016|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027369|NCT04035434|588804017|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
163027370|NCT04035434|588804018|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
163027371|NCT04035434|588804019|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027372|NCT04035434|588804020|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027373|NCT04035434|588804021|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
163027374|NCT04035434|588804022|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
163027375|NCT04035434|588804023|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027376|NCT04035434|588804024|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
163027377|NCT04035434|588804025|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
163027378|NCT04035434|588804013|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027379|NCT04035434|588804014|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027380|NCT04035434|588804015|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027381|NCT04035434|588804016|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
163027382|NCT04035434|588804017|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027383|NCT04035434|588804018|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027384|NCT04035434|588804019|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027385|NCT04035434|588804020|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027386|NCT04035434|588804021|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027387|NCT04035434|588804022|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027388|NCT04035434|588804023|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027389|NCT04035434|588804024|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027390|NCT04035434|588804025|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027391|NCT04035434|588804013|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027392|NCT04035434|588804014|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027393|NCT04035434|588804015|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027394|NCT04035434|588804016|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027395|NCT04035434|588804017|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027396|NCT04035434|588804018|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
163027397|NCT04035434|588804019|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
163027398|NCT04035434|588804020|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027399|NCT04035434|588804021|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027400|NCT04035434|588804022|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027401|NCT04035434|588804023|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027402|NCT04035434|588804024|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027403|NCT04035434|588804025|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163072429|NCT04625972|588971466|FG000|Overall Study|Physician Decision|2|||
163072430|NCT04625972|588971467|FG001|Overall Study|Physician Decision|0|||
163072431|NCT04625972|588971466|FG000|Overall Study|Protocol Violation|0|||
163072432|NCT04625972|588971467|FG001|Overall Study|Protocol Violation|1|||
163072433|NCT04625972|588971466|FG000|Overall Study|Withdrawal by Subject|37|||
163072434|NCT04625972|588971467|FG001|Overall Study|Withdrawal by Subject|24|||
163072435|NCT04625972|588971466|FG000|Overall Study|Not specified elsewhere|8|||
163072436|NCT04625972|588971467|FG001|Overall Study|Not specified elsewhere|6|||
163072437|NCT05591755|588971468|FG000|Overall Study|Screen Failure|1|||
163072438|NCT05591755|588971469|FG001|Overall Study|Screen Failure|0|||
163072439|NCT05591755|588971470|FG002|Overall Study|Screen Failure|0|||
163072440|NCT05591755|588971471|FG003|Overall Study|Screen Failure|0|||
163072441|NCT05591755|588971468|FG000|Overall Study|Protocol Violation|0|||
163072442|NCT05591755|588971469|FG001|Overall Study|Protocol Violation|0|||
163072443|NCT05591755|588971470|FG002|Overall Study|Protocol Violation|2|||
163072444|NCT05591755|588971471|FG003|Overall Study|Protocol Violation|0|||
163072445|NCT05591755|588971468|FG000|Overall Study|Withdrawal by Subject|0|||
163072446|NCT05591755|588971469|FG001|Overall Study|Withdrawal by Subject|1|||
163072447|NCT05591755|588971470|FG002|Overall Study|Withdrawal by Subject|0|||
163072448|NCT05591755|588971471|FG003|Overall Study|Withdrawal by Subject|0|||
163072449|NCT00433290|588971472|FG000|Overall Study|Adverse Event|24|||
163072450|NCT00433290|588971473|FG001|Overall Study|Adverse Event|7|||
163072451|NCT00433290|588971472|FG000|Overall Study|Lack of Efficacy|1|||
163072452|NCT00433290|588971473|FG001|Overall Study|Lack of Efficacy|5|||
163072453|NCT00433290|588971472|FG000|Overall Study|Withdrawal by Subject|4|||
163072454|NCT00433290|588971473|FG001|Overall Study|Withdrawal by Subject|2|||
163072455|NCT00433290|588971472|FG000|Overall Study|Protocol Violation|3|||
163072456|NCT00433290|588971473|FG001|Overall Study|Protocol Violation|2|||
163072457|NCT00433290|588971472|FG000|Overall Study|Physician Decision|2|||
163072458|NCT00433290|588971473|FG001|Overall Study|Physician Decision|0|||
163072459|NCT00433290|588971472|FG000|Overall Study|Entry Criteria Not Met|0|||
163072460|NCT00433290|588971473|FG001|Overall Study|Entry Criteria Not Met|1|||
163072461|NCT00433290|588971472|FG000|Overall Study|Lost to Follow-up|1|||
163072462|NCT00433290|588971473|FG001|Overall Study|Lost to Follow-up|0|||
163072463|NCT01397747|588971475|FG000|Overall Study|Multitarget DNA test excluded|689|||
163072464|NCT01397747|588971475|FG000|Overall Study|Colonoscopy excluded|304|||
163072465|NCT01397747|588971475|FG000|Overall Study|FIT excluded|34|||
163072466|NCT00504309|588971476|FG000|Overall Study|Death|0|||
163072467|NCT00504309|588971477|FG001|Overall Study|Death|0|||
163072468|NCT00504309|588971478|FG002|Overall Study|Death|0|||
163072469|NCT00504309|588971479|FG003|Overall Study|Death|0|||
163072470|NCT00504309|588971480|FG004|Overall Study|Death|1|||
163072471|NCT00504309|588971481|FG005|Overall Study|Death|0|||
163072472|NCT00504309|588971476|FG000|Overall Study|Withdrawal by Subject|0|||
163072473|NCT00504309|588971477|FG001|Overall Study|Withdrawal by Subject|0|||
163072474|NCT00504309|588971478|FG002|Overall Study|Withdrawal by Subject|1|||
163072475|NCT00504309|588971479|FG003|Overall Study|Withdrawal by Subject|0|||
163072476|NCT00504309|588971480|FG004|Overall Study|Withdrawal by Subject|0|||
163072477|NCT00504309|588971481|FG005|Overall Study|Withdrawal by Subject|0|||
163072478|NCT00983957|588971491|FG000|Overall Study|Adverse Event|1|||
163072479|NCT00983957|588971491|FG000|Overall Study|Personal Reasons|1|||
163072480|NCT01560416|588971492|FG000|Randomized Phase|Crossover Participants|7|||
163072481|NCT01560416|588971493|FG001|Randomized Phase|Crossover Participants|0|||
163072482|NCT00884949|588972944|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
163072483|NCT00884949|588972944|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
163072484|NCT03684057|588972949|FG000|Overall Study|Withdrawal by Subject|4|||
163072485|NCT03684057|588972950|FG001|Overall Study|Withdrawal by Subject|5|||
163072486|NCT00758043|588972951|FG000|Overall Study|Adverse Event|1|||
163072487|NCT00758043|588972952|FG001|Overall Study|Adverse Event|20|||
163072488|NCT00758043|588972953|FG002|Overall Study|Adverse Event|12|||
163072489|NCT00758043|588972954|FG003|Overall Study|Adverse Event|62|||
163072490|NCT00758043|588972951|FG000|Overall Study|Lack of Efficacy|0|||
163072491|NCT00758043|588972952|FG001|Overall Study|Lack of Efficacy|6|||
163072492|NCT00758043|588972953|FG002|Overall Study|Lack of Efficacy|18|||
163072493|NCT00758043|588972954|FG003|Overall Study|Lack of Efficacy|12|||
163072494|NCT00758043|588972951|FG000|Overall Study|Refused Further Treatment|0|||
163072495|NCT00758043|588972952|FG001|Overall Study|Refused Further Treatment|11|||
163072496|NCT00758043|588972953|FG002|Overall Study|Refused Further Treatment|5|||
163072497|NCT00758043|588972954|FG003|Overall Study|Refused Further Treatment|8|||
163072498|NCT00758043|588972951|FG000|Overall Study|Lost to Follow-up|0|||
163072499|NCT00758043|588972952|FG001|Overall Study|Lost to Follow-up|2|||
163072500|NCT00758043|588972953|FG002|Overall Study|Lost to Follow-up|2|||
163072501|NCT00758043|588972954|FG003|Overall Study|Lost to Follow-up|5|||
163072502|NCT00758043|588972951|FG000|Overall Study|Withdrawal by Subject|0|||
163072503|NCT00758043|588972952|FG001|Overall Study|Withdrawal by Subject|1|||
163072504|NCT00758043|588972953|FG002|Overall Study|Withdrawal by Subject|1|||
163072505|NCT00758043|588972954|FG003|Overall Study|Withdrawal by Subject|4|||
163072506|NCT00758043|588972951|FG000|Overall Study|Required Prohibited Medication|0|||
163154798|NCT02667119|589281439|FG001|Overall Study|Lost to Follow-up|0|||
163072507|NCT00758043|588972952|FG001|Overall Study|Required Prohibited Medication|0|||
163072508|NCT00758043|588972953|FG002|Overall Study|Required Prohibited Medication|1|||
163072509|NCT00758043|588972954|FG003|Overall Study|Required Prohibited Medication|3|||
163072510|NCT00758043|588972951|FG000|Overall Study|Non-Compliant With study Drug|0|||
163072511|NCT00758043|588972952|FG001|Overall Study|Non-Compliant With study Drug|0|||
163072512|NCT00758043|588972953|FG002|Overall Study|Non-Compliant With study Drug|0|||
163072513|NCT00758043|588972954|FG003|Overall Study|Non-Compliant With study Drug|1|||
163072514|NCT00758043|588972951|FG000|Overall Study|Other Reasons|0|||
163072515|NCT00758043|588972952|FG001|Overall Study|Other Reasons|1|||
163072516|NCT00758043|588972953|FG002|Overall Study|Other Reasons|0|||
163072517|NCT00758043|588972954|FG003|Overall Study|Other Reasons|5|||
163072518|NCT03422718|588972955|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
163072519|NCT03422718|588972956|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
163072520|NCT03422718|588972957|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
163072521|NCT03422718|588972958|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
163072522|NCT03422718|588972959|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
163072523|NCT03422718|588972960|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
163072524|NCT03422718|588972961|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
163072525|NCT03422718|588972962|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
163072526|NCT03422718|588972955|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
163072527|NCT03422718|588972956|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
163072528|NCT03422718|588972957|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
163072529|NCT03422718|588972958|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
163072530|NCT03422718|588972959|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
163072531|NCT03422718|588972960|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
163072532|NCT03422718|588972961|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
163072533|NCT03422718|588972962|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
163072534|NCT03422718|588972955|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
163072535|NCT03422718|588972956|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
163072536|NCT03422718|588972957|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
163072537|NCT03422718|588972958|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
163072538|NCT03422718|588972959|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
163072539|NCT03422718|588972960|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
163072540|NCT03422718|588972961|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
163072541|NCT03422718|588972962|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
163072542|NCT03422718|588972955|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
163072543|NCT03422718|588972956|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
163072544|NCT03422718|588972957|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
163072545|NCT03422718|588972958|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
163072546|NCT03422718|588972959|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
163072547|NCT03422718|588972960|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
163072548|NCT03422718|588972961|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
163072549|NCT03422718|588972962|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
163072550|NCT03422718|588972955|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
163072551|NCT03422718|588972956|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
163072552|NCT03422718|588972957|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
163072553|NCT03422718|588972958|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
163072554|NCT03422718|588972959|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
163072555|NCT03422718|588972960|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
163072556|NCT03422718|588972961|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
163072557|NCT03422718|588972962|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
163072558|NCT03422718|588972955|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
163072559|NCT03422718|588972956|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
163072560|NCT03422718|588972957|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
163072561|NCT03422718|588972958|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
163072562|NCT03422718|588972959|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
163072563|NCT03422718|588972960|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
163072564|NCT03422718|588972961|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
163072565|NCT03422718|588972962|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
163072566|NCT03197935|588972968|FG000|Overall Study|Death due to any cause|26|||
163072567|NCT03197935|588972969|FG001|Overall Study|Death due to any cause|15|||
163072568|NCT03197935|588972968|FG000|Overall Study|Lost to Follow-up|3|||
163072569|NCT03197935|588972969|FG001|Overall Study|Lost to Follow-up|5|||
163072570|NCT03197935|588972968|FG000|Overall Study|Physician Decision|2|||
163072571|NCT03197935|588972969|FG001|Overall Study|Physician Decision|1|||
163072572|NCT03197935|588972968|FG000|Overall Study|Withdrawal by Subject|16|||
163072573|NCT03197935|588972969|FG001|Overall Study|Withdrawal by Subject|8|||
163331180|NCT03689946|589922526|FG000|Overall Study|Withdrawal by Subject|3|||
163027404|NCT04035434|588804013|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027405|NCT04035434|588804014|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027406|NCT04035434|588804015|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027407|NCT04035434|588804016|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027408|NCT04035434|588804017|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027409|NCT04035434|588804018|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
163027410|NCT04035434|588804019|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
163027411|NCT04035434|588804020|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027412|NCT04035434|588804021|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027413|NCT04035434|588804022|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027414|NCT04035434|588804023|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027415|NCT04035434|588804024|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027416|NCT04035434|588804025|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027417|NCT04035434|588804013|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027418|NCT04035434|588804014|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027419|NCT04035434|588804015|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027420|NCT04035434|588804016|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027421|NCT04035434|588804017|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027422|NCT04035434|588804018|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
163027423|NCT04035434|588804019|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
163027424|NCT04035434|588804020|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027425|NCT04035434|588804021|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027426|NCT04035434|588804022|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027427|NCT04035434|588804023|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027428|NCT04035434|588804024|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027429|NCT04035434|588804025|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027430|NCT04488497|588804026|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
163027431|NCT04488497|588804027|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
163027432|NCT04488497|588804026|FG000|Intervention|Physician Decision|2|||
163027433|NCT04488497|588804027|FG001|Intervention|Physician Decision|1|||
163027434|NCT04488497|588804026|FG000|Intervention|Withdrawal by Subject|5|||
163027435|NCT04488497|588804027|FG001|Intervention|Withdrawal by Subject|6|||
163027436|NCT04488497|588804026|FG000|Intervention|Lost to Follow-up|2|||
163027437|NCT04488497|588804027|FG001|Intervention|Lost to Follow-up|0|||
163027438|NCT04488497|588804026|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
163027439|NCT04488497|588804027|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
163027440|NCT04488497|588804026|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
163027441|NCT04488497|588804027|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
163027442|NCT04322539|588804028|FG000|Overall Study|Adverse Event|2|||
163027443|NCT04322539|588804029|FG001|Overall Study|Adverse Event|0|||
163027444|NCT04322539|588804028|FG000|Overall Study|Death|411|||
163027445|NCT04322539|588804029|FG001|Overall Study|Death|203|||
163027446|NCT04322539|588804028|FG000|Overall Study|Lost to Follow-up|3|||
163027447|NCT04322539|588804029|FG001|Overall Study|Lost to Follow-up|1|||
163027448|NCT04322539|588804028|FG000|Overall Study|Withdrawal of consent|14|||
163027449|NCT04322539|588804029|FG001|Overall Study|Withdrawal of consent|8|||
163027450|NCT04322539|588804028|FG000|Overall Study|Radiological Disease Progression|6|||
163027451|NCT04322539|588804029|FG001|Overall Study|Radiological Disease Progression|0|||
163027452|NCT04322539|588804028|FG000|Overall Study|Sponsor Decision|19|||
163027453|NCT04322539|588804029|FG001|Overall Study|Sponsor Decision|14|||
163027454|NCT04322539|588804028|FG000|Overall Study|Other|6|||
163027455|NCT04322539|588804029|FG001|Overall Study|Other|4|||
163027456|NCT04161079|588804032|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
163027457|NCT01702532|588804033|FG000|Overall Study|Adverse Event|0|||
163027458|NCT01702532|588804034|FG001|Overall Study|Adverse Event|1|||
163027459|NCT03617861|588804035|FG000|Second Intervention (1 Day)|Adverse Event|0|||
163027460|NCT03617861|588804036|FG001|Second Intervention (1 Day)|Adverse Event|0|||
163027461|NCT03617861|588804037|FG002|Second Intervention (1 Day)|Adverse Event|1|||
163027462|NCT03617861|588804038|FG003|Second Intervention (1 Day)|Adverse Event|0|||
163027463|NCT00623597|588804039|FG000|Overall Study|Failed to return|1|||
163072574|NCT03315689|588972974|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
163331181|NCT03689946|589922526|FG000|Overall Study|Lost to Follow-up|3|||
163331182|NCT03689946|589922526|FG000|Overall Study|Data corruption|2|||
163331183|NCT02203799|589922531|FG000|Overall Study|Withdrawal by Subject|3|||
163027464|NCT00623597|588804040|FG001|Overall Study|Failed to return|0|||
163027465|NCT01451164|588804041|FG000|Overall Study|Adverse Event|19|||
163027466|NCT01451164|588804042|FG001|Overall Study|Adverse Event|12|||
163331184|NCT02384382|589922534|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
163331185|NCT02384382|589922534|FG000|Overall Study|Death|1|||
163331186|NCT02384382|589922534|FG000|Overall Study|Adverse Event|1|||
163331187|NCT02384382|589922534|FG000|Overall Study|Disease progression|16|||
163331188|NCT01953692|589922535|FG000|Overall Study|Adverse Event|5|||
163331189|NCT01953692|589922536|FG001|Overall Study|Adverse Event|2|||
163331190|NCT01953692|589922537|FG002|Overall Study|Adverse Event|4|||
163331191|NCT01953692|589922538|FG003|Overall Study|Adverse Event|2|||
163331192|NCT01953692|589922539|FG004|Overall Study|Adverse Event|1|||
163331193|NCT01953692|589922540|FG005|Overall Study|Adverse Event|2|||
163331194|NCT01953692|589922541|FG006|Overall Study|Adverse Event|0|||
163027467|NCT01451164|588804043|FG002|Overall Study|Adverse Event|18|||
163027468|NCT01451164|588804044|FG003|Overall Study|Adverse Event|21|||
163027469|NCT01451164|588804041|FG000|Overall Study|Withdrawal Criteria|1|||
163027470|NCT01451164|588804042|FG001|Overall Study|Withdrawal Criteria|1|||
163027471|NCT01451164|588804043|FG002|Overall Study|Withdrawal Criteria|1|||
163027472|NCT01451164|588804044|FG003|Overall Study|Withdrawal Criteria|1|||
163027473|NCT01451164|588804041|FG000|Overall Study|Physician Decision|2|||
163027474|NCT01451164|588804042|FG001|Overall Study|Physician Decision|0|||
163027475|NCT01451164|588804043|FG002|Overall Study|Physician Decision|1|||
163027476|NCT01451164|588804044|FG003|Overall Study|Physician Decision|0|||
163027477|NCT01451164|588804041|FG000|Overall Study|Withdrawal by Subject|14|||
163027478|NCT01451164|588804042|FG001|Overall Study|Withdrawal by Subject|11|||
163027479|NCT01451164|588804043|FG002|Overall Study|Withdrawal by Subject|16|||
163027480|NCT01451164|588804044|FG003|Overall Study|Withdrawal by Subject|17|||
163027481|NCT01451164|588804041|FG000|Overall Study|Protocol Violation|0|||
163027482|NCT01451164|588804042|FG001|Overall Study|Protocol Violation|1|||
163027483|NCT01451164|588804043|FG002|Overall Study|Protocol Violation|0|||
163027484|NCT01451164|588804044|FG003|Overall Study|Protocol Violation|0|||
163027485|NCT01451164|588804041|FG000|Overall Study|Lack of Efficacy|7|||
163027486|NCT01451164|588804042|FG001|Overall Study|Lack of Efficacy|9|||
163027487|NCT01451164|588804043|FG002|Overall Study|Lack of Efficacy|9|||
163027488|NCT01451164|588804044|FG003|Overall Study|Lack of Efficacy|7|||
163027489|NCT04045132|588804049|FG000|Overall Study|Lost to Follow-up|3|||
163027490|NCT04045132|588804050|FG001|Overall Study|Lost to Follow-up|6|||
163027491|NCT02963558|588804051|FG000|Overall Study|Withdrawn by investigator|1|||
163027492|NCT02963558|588804052|FG001|Overall Study|Withdrawn by investigator|0|||
163027493|NCT02963558|588804051|FG000|Overall Study|Withdrawal by Subject|0|||
163027494|NCT02963558|588804052|FG001|Overall Study|Withdrawal by Subject|1|||
163027495|NCT04063657|588804056|FG000|Overall Study|Lost to Follow-up|1|||
163027496|NCT04063657|588804057|FG001|Overall Study|Lost to Follow-up|0|||
163027497|NCT01214252|588804058|FG000|Overall Study|Not eligible per protocol|82|||
163027498|NCT01371877|588804060|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
163027499|NCT01371877|588804061|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
163027500|NCT05932225|588804062|FG000|Overall Study|Lost to Follow-up|0|||
163027501|NCT05932225|588804063|FG001|Overall Study|Lost to Follow-up|1|||
163027502|NCT05932225|588804064|FG002|Overall Study|Lost to Follow-up|0|||
163027503|NCT05932225|588804062|FG000|Overall Study|Withdrawal by Subject|1|||
163027504|NCT05932225|588804063|FG001|Overall Study|Withdrawal by Subject|0|||
163027505|NCT05932225|588804064|FG002|Overall Study|Withdrawal by Subject|0|||
163027506|NCT05932225|588804062|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
163027507|NCT05932225|588804063|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
163027508|NCT05932225|588804064|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
163027509|NCT00552032|588804065|FG000|Overall Study|Withdrawal by Subject|2|||
163027510|NCT00552032|588804066|FG001|Overall Study|Withdrawal by Subject|2|||
163027511|NCT00552032|588804065|FG000|Overall Study|Protocol Violation|7|||
163027512|NCT00552032|588804066|FG001|Overall Study|Protocol Violation|12|||
163027513|NCT00552032|588804065|FG000|Overall Study|Lost to Follow-up|8|||
163027514|NCT00552032|588804066|FG001|Overall Study|Lost to Follow-up|5|||
163027515|NCT00345878|588804067|FG000|Overall Study|Adverse Event|1|||
163027516|NCT00345878|588804068|FG001|Overall Study|Adverse Event|0|||
163027517|NCT00345878|588804067|FG000|Overall Study|Lost to Follow-up|2|||
163331195|NCT01953692|589922542|FG007|Overall Study|Adverse Event|0|||
163027518|NCT00345878|588804068|FG001|Overall Study|Lost to Follow-up|1|||
163027519|NCT00345878|588804067|FG000|Overall Study|Other|1|||
163027520|NCT00345878|588804068|FG001|Overall Study|Other|0|||
163027521|NCT02045732|588804069|FG000|Overall Study|At the discretion of the investigator|1|||
163027522|NCT02045732|588804070|FG001|Overall Study|At the discretion of the investigator|1|||
163027523|NCT01877551|588804074|FG000|Overall Study|Physician Decision|0|||
163027524|NCT01877551|588804075|FG001|Overall Study|Physician Decision|1|||
163027525|NCT02659514|588804078|FG000|Overall Study|Adverse Event|3|||
163027526|NCT02659514|588804079|FG001|Overall Study|Adverse Event|12|||
163027527|NCT02659514|588804078|FG000|Overall Study|Disease Progression|23|||
163027528|NCT02659514|588804079|FG001|Overall Study|Disease Progression|13|||
163027529|NCT02659514|588804078|FG000|Overall Study|Withdrawal by Subject|0|||
163072575|NCT03315689|588972975|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
163331196|NCT01953692|589922543|FG008|Overall Study|Adverse Event|0|||
163027530|NCT02659514|588804079|FG001|Overall Study|Withdrawal by Subject|4|||
163331197|NCT01953692|589922535|FG000|Overall Study|Clinical Progression|0|||
163331198|NCT01953692|589922536|FG001|Overall Study|Clinical Progression|15|||
163331199|NCT01953692|589922537|FG002|Overall Study|Clinical Progression|7|||
163331200|NCT01953692|589922538|FG003|Overall Study|Clinical Progression|5|||
163331201|NCT01953692|589922539|FG004|Overall Study|Clinical Progression|0|||
163331202|NCT01953692|589922540|FG005|Overall Study|Clinical Progression|7|||
163331203|NCT01953692|589922541|FG006|Overall Study|Clinical Progression|20|||
163331204|NCT01953692|589922542|FG007|Overall Study|Clinical Progression|3|||
163331205|NCT01953692|589922543|FG008|Overall Study|Clinical Progression|3|||
163331206|NCT01953692|589922535|FG000|Overall Study|Death|5|||
163331207|NCT01953692|589922536|FG001|Overall Study|Death|0|||
163331208|NCT01953692|589922537|FG002|Overall Study|Death|2|||
163331209|NCT01953692|589922538|FG003|Overall Study|Death|2|||
163331210|NCT01953692|589922539|FG004|Overall Study|Death|1|||
163331211|NCT01953692|589922540|FG005|Overall Study|Death|3|||
163331212|NCT01953692|589922541|FG006|Overall Study|Death|6|||
163331213|NCT01953692|589922542|FG007|Overall Study|Death|2|||
163331214|NCT01953692|589922543|FG008|Overall Study|Death|1|||
163072576|NCT03315689|588972974|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
163072577|NCT03315689|588972975|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
163072578|NCT03315689|588972974|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
163072579|NCT03315689|588972975|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
163072580|NCT00864513|588972976|FG000|Overall Study|Withdrawal by Subject|3|||
163331215|NCT01953692|589922535|FG000|Overall Study|Excluded Medication|1|||
163331216|NCT01953692|589922536|FG001|Overall Study|Excluded Medication|0|||
163027531|NCT02659514|588804078|FG000|Overall Study|Lost to Follow-up|0|||
163027532|NCT02659514|588804079|FG001|Overall Study|Lost to Follow-up|1|||
163027533|NCT02659514|588804078|FG000|Overall Study|Death|6|||
163027534|NCT02659514|588804079|FG001|Overall Study|Death|1|||
163027535|NCT02659514|588804078|FG000|Overall Study|Reason Unspecified|0|||
163027536|NCT02659514|588804079|FG001|Overall Study|Reason Unspecified|3|||
163027537|NCT03409107|588804080|FG000|Overall Study|Withdrawal by Subject|4|||
163027538|NCT03409107|588804081|FG001|Overall Study|Withdrawal by Subject|2|||
163027539|NCT03409107|588804080|FG000|Overall Study|Physician Decision|1|||
163027540|NCT03409107|588804081|FG001|Overall Study|Physician Decision|0|||
163027541|NCT03409107|588804080|FG000|Overall Study|Lost to Follow-up|7|||
163027542|NCT03409107|588804081|FG001|Overall Study|Lost to Follow-up|2|||
163027543|NCT03409107|588804080|FG000|Overall Study|Adverse Event|5|||
163027544|NCT03409107|588804081|FG001|Overall Study|Adverse Event|3|||
163027545|NCT02062944|588804088|FG000|Overall Study|Lost to Follow-up|1|||
163027546|NCT02062944|588804088|FG000|Overall Study|New hemotological disorder identified|1|||
163027547|NCT02062944|588804088|FG000|Overall Study|Uncontrolled Hypertension|1|||
163027548|NCT02062944|588804088|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
163027549|NCT00278148|588804089|FG000|Phase II - Expansion Phase|Disease progression|0|||
163027550|NCT00278148|588804090|FG001|Phase II - Expansion Phase|Disease progression|0|||
163027551|NCT00278148|588804091|FG002|Phase II - Expansion Phase|Disease progression|4|||
163027552|NCT00278148|588804089|FG000|Phase II - Expansion Phase|Adverse Event|0|||
163027553|NCT00278148|588804090|FG001|Phase II - Expansion Phase|Adverse Event|0|||
163027554|NCT00278148|588804091|FG002|Phase II - Expansion Phase|Adverse Event|2|||
163027555|NCT01459718|588804094|FG000|Overall Study|Physician Decision|1|||
163027556|NCT01459718|588804094|FG000|Overall Study|Lost to Follow-up|1|||
163027557|NCT01459718|588804094|FG000|Overall Study|Adverse Event|1|||
163027558|NCT05174949|588804100|FG000|Overall Study|Physician Decision|1|||
163027559|NCT05174949|588804101|FG001|Overall Study|Physician Decision|2|||
163027560|NCT05174949|588804102|FG002|Overall Study|Physician Decision|0|||
163027561|NCT05174949|588804103|FG003|Overall Study|Physician Decision|1|||
163027562|NCT05174949|588804104|FG004|Overall Study|Physician Decision|0|||
163027563|NCT05174949|588804105|FG005|Overall Study|Physician Decision|0|||
163027564|NCT05174949|588804100|FG000|Overall Study|Withdrawal by Subject|0|||
163027565|NCT05174949|588804101|FG001|Overall Study|Withdrawal by Subject|1|||
163027566|NCT05174949|588804102|FG002|Overall Study|Withdrawal by Subject|0|||
163027567|NCT05174949|588804103|FG003|Overall Study|Withdrawal by Subject|0|||
163027568|NCT05174949|588804104|FG004|Overall Study|Withdrawal by Subject|0|||
163027569|NCT05174949|588804105|FG005|Overall Study|Withdrawal by Subject|0|||
163027570|NCT05174949|588804100|FG000|Overall Study|Lost to Follow-up|0|||
163027571|NCT05174949|588804101|FG001|Overall Study|Lost to Follow-up|0|||
163027572|NCT05174949|588804102|FG002|Overall Study|Lost to Follow-up|0|||
163027573|NCT05174949|588804103|FG003|Overall Study|Lost to Follow-up|1|||
163027574|NCT05174949|588804104|FG004|Overall Study|Lost to Follow-up|0|||
163027575|NCT05174949|588804105|FG005|Overall Study|Lost to Follow-up|0|||
163027576|NCT02951533|588804106|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
163027577|NCT02951533|588804107|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
163027578|NCT02951533|588804108|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
163072581|NCT00762788|588972977|FG000|Overall Study|Lost to Follow-up|26|||
163072582|NCT00762788|588972978|FG001|Overall Study|Lost to Follow-up|37|||
163331217|NCT01953692|589922537|FG002|Overall Study|Excluded Medication|0|||
163331218|NCT01953692|589922538|FG003|Overall Study|Excluded Medication|0|||
163331219|NCT01953692|589922539|FG004|Overall Study|Excluded Medication|0|||
163331220|NCT01953692|589922540|FG005|Overall Study|Excluded Medication|0|||
163072583|NCT00762788|588972979|FG002|Overall Study|Lost to Follow-up|21|||
163072584|NCT00762788|588972980|FG003|Overall Study|Lost to Follow-up|26|||
163072585|NCT00762788|588972981|FG004|Overall Study|Lost to Follow-up|13|||
163072586|NCT00762788|588972982|FG005|Overall Study|Lost to Follow-up|21|||
163072587|NCT03073109|588972983|FG000|Overall Study|Adverse Event|0|||
163072588|NCT03073109|588972984|FG001|Overall Study|Adverse Event|1|||
163072589|NCT03073109|588972983|FG000|Overall Study|Other|2|||
163072590|NCT03073109|588972984|FG001|Overall Study|Other|0|||
163072591|NCT03073109|588972983|FG000|Overall Study|Lost to Follow-up|8|||
163072592|NCT03073109|588972984|FG001|Overall Study|Lost to Follow-up|1|||
163072593|NCT00669331|588972987|FG000|Randomisation to First Dose|Adverse Event|1|||
163072594|NCT00669331|588972988|FG001|Randomisation to First Dose|Adverse Event|0|||
163072595|NCT00669331|588972987|FG000|Randomisation to First Dose|Protocol Violation|1|||
163072596|NCT00669331|588972988|FG001|Randomisation to First Dose|Protocol Violation|0|||
163072597|NCT00669331|588972987|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
163072598|NCT00669331|588972988|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
163072599|NCT00669331|588972987|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
163072600|NCT00669331|588972988|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
163072601|NCT00669331|588972987|FG000|Randomisation to First Dose|Death|1|||
163072602|NCT00669331|588972988|FG001|Randomisation to First Dose|Death|0|||
163072603|NCT00669331|588972987|FG000|Randomisation to First Dose|Sponsor decision|0|||
163072604|NCT00669331|588972988|FG001|Randomisation to First Dose|Sponsor decision|1|||
163072605|NCT00669331|588972987|FG000|Randomisation to First Dose|Randomised in error|3|||
163218056|NCT03971695|589515739|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
163218057|NCT03971695|589515740|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
163218058|NCT00156533|589515741|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
163218059|NCT00156533|589515742|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
163218060|NCT00156533|589515743|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
163406386|NCT01187953|590196745|FG001|Overall Study|Death|13|||
163406387|NCT01187953|590196744|FG000|Overall Study|Adverse Event|1|||
163027579|NCT02951533|588804106|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
163027580|NCT02951533|588804107|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
163027581|NCT02951533|588804108|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
163027582|NCT02951533|588804106|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
163027583|NCT02951533|588804107|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
163027584|NCT02951533|588804108|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
163027585|NCT02951533|588804106|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
163027586|NCT02951533|588804107|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
163027587|NCT02951533|588804108|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
163027588|NCT02951533|588804106|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
163027589|NCT02951533|588804107|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
163027590|NCT02951533|588804108|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
163027591|NCT02951533|588804106|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
163027592|NCT02951533|588804107|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
163027593|NCT02951533|588804108|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
163027594|NCT02951533|588804106|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
163027595|NCT02951533|588804107|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
163027596|NCT02951533|588804108|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
163027597|NCT02951533|588804106|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
163027598|NCT02951533|588804107|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
163027599|NCT02951533|588804108|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
163027600|NCT02951533|588804106|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
163027601|NCT02951533|588804107|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
163027602|NCT02951533|588804108|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
163027603|NCT02951533|588804106|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
163027604|NCT02951533|588804107|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
163027605|NCT02951533|588804108|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
163027606|NCT02951533|588804106|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
163027607|NCT02951533|588804107|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
163027608|NCT02951533|588804108|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
163027609|NCT02029989|588804109|FG000|Overall Study|Withdrawal by Subject|1|||
163027610|NCT02029989|588804110|FG001|Overall Study|Withdrawal by Subject|0|||
163027611|NCT02029989|588804109|FG000|Overall Study|Withdrawal: Fear of needles|1|||
163027612|NCT02029989|588804110|FG001|Overall Study|Withdrawal: Fear of needles|0|||
163072606|NCT00669331|588972988|FG001|Randomisation to First Dose|Randomised in error|10|||
163072607|NCT00669331|588972987|FG000|Blinded Treatment Period|Adverse Event|16|||
163072608|NCT00669331|588972988|FG001|Blinded Treatment Period|Adverse Event|10|||
163072609|NCT00669331|588972987|FG000|Blinded Treatment Period|Protocol Violation|1|||
163072610|NCT00669331|588972988|FG001|Blinded Treatment Period|Protocol Violation|1|||
163406388|NCT01187953|590196745|FG001|Overall Study|Adverse Event|2|||
163072611|NCT00669331|588972987|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
163072612|NCT00669331|588972988|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
163072613|NCT00669331|588972987|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
163072614|NCT00669331|588972988|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
163072615|NCT00669331|588972987|FG000|Blinded Treatment Period|Death|0|||
163072616|NCT00669331|588972988|FG001|Blinded Treatment Period|Death|2|||
163331221|NCT01953692|589922541|FG006|Overall Study|Excluded Medication|0|||
163331222|NCT01953692|589922542|FG007|Overall Study|Excluded Medication|0|||
163331223|NCT01953692|589922543|FG008|Overall Study|Excluded Medication|0|||
163331224|NCT01953692|589922535|FG000|Overall Study|Lost to Follow-up|1|||
163072617|NCT00669331|588972987|FG000|Blinded Treatment Period|Physician Decision|3|||
163072618|NCT00669331|588972988|FG001|Blinded Treatment Period|Physician Decision|3|||
163072619|NCT00669331|588972987|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
163072620|NCT00669331|588972988|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
163072621|NCT03387046|588972989|FG000|Overall Study|Adverse Event|1|||
163072622|NCT03387046|588972990|FG001|Overall Study|Adverse Event|1|||
163072623|NCT00509600|588972991|FG000|Overall Study|Adverse Event|1|||
163072624|NCT00986232|588972992|FG000|Overall Study|Adverse Event|1|||
163072625|NCT00986232|588972993|FG001|Overall Study|Adverse Event|2|||
163072626|NCT00986232|588972994|FG002|Overall Study|Adverse Event|3|||
163072627|NCT00986232|588972995|FG003|Overall Study|Adverse Event|0|||
163072628|NCT00986232|588972992|FG000|Overall Study|Lost to Follow-up|19|||
163072629|NCT00986232|588972993|FG001|Overall Study|Lost to Follow-up|12|||
163072630|NCT00986232|588972994|FG002|Overall Study|Lost to Follow-up|12|||
163072631|NCT00986232|588972995|FG003|Overall Study|Lost to Follow-up|7|||
163072632|NCT00986232|588972992|FG000|Overall Study|Protocol Violation|2|||
163072633|NCT00986232|588972993|FG001|Overall Study|Protocol Violation|3|||
163072634|NCT00986232|588972994|FG002|Overall Study|Protocol Violation|0|||
163072635|NCT00986232|588972995|FG003|Overall Study|Protocol Violation|1|||
163072636|NCT00986232|588972992|FG000|Overall Study|Withdrawal by Subject|13|||
163072637|NCT00986232|588972993|FG001|Overall Study|Withdrawal by Subject|16|||
163072638|NCT00986232|588972994|FG002|Overall Study|Withdrawal by Subject|12|||
163072639|NCT00986232|588972995|FG003|Overall Study|Withdrawal by Subject|3|||
163072640|NCT00986232|588972992|FG000|Overall Study|Missed one or more bleeds|13|||
163072641|NCT00986232|588972993|FG001|Overall Study|Missed one or more bleeds|10|||
163072642|NCT00986232|588972994|FG002|Overall Study|Missed one or more bleeds|6|||
163072643|NCT00986232|588972995|FG003|Overall Study|Missed one or more bleeds|7|||
163072644|NCT00986232|588972992|FG000|Overall Study|Incomplete safety follow-up|3|||
163072645|NCT00986232|588972993|FG001|Overall Study|Incomplete safety follow-up|7|||
163072646|NCT00986232|588972994|FG002|Overall Study|Incomplete safety follow-up|2|||
163072647|NCT00986232|588972995|FG003|Overall Study|Incomplete safety follow-up|2|||
163072648|NCT02568423|588972996|FG000|Overall Study|Lost to Follow-up|0|||
163072649|NCT02568423|588972997|FG001|Overall Study|Lost to Follow-up|2|||
163072650|NCT02568423|588972998|FG002|Overall Study|Lost to Follow-up|0|||
163072651|NCT02568423|588972999|FG003|Overall Study|Lost to Follow-up|0|||
163072652|NCT02568423|588973000|FG004|Overall Study|Lost to Follow-up|0|||
163072653|NCT02568423|588973001|FG005|Overall Study|Lost to Follow-up|0|||
163072654|NCT02568423|588973002|FG006|Overall Study|Lost to Follow-up|0|||
163072655|NCT02568423|588973003|FG007|Overall Study|Lost to Follow-up|0|||
163072656|NCT02568423|588972996|FG000|Overall Study|Physician Decision|0|||
163072657|NCT02568423|588972997|FG001|Overall Study|Physician Decision|0|||
163072658|NCT02568423|588972998|FG002|Overall Study|Physician Decision|0|||
163072659|NCT02568423|588972999|FG003|Overall Study|Physician Decision|0|||
163072660|NCT02568423|588973000|FG004|Overall Study|Physician Decision|0|||
163331225|NCT01953692|589922536|FG001|Overall Study|Lost to Follow-up|0|||
163331226|NCT01953692|589922537|FG002|Overall Study|Lost to Follow-up|3|||
163072661|NCT02568423|588973001|FG005|Overall Study|Physician Decision|1|||
163072662|NCT02568423|588973002|FG006|Overall Study|Physician Decision|0|||
163072663|NCT02568423|588973003|FG007|Overall Study|Physician Decision|0|||
163331227|NCT01953692|589922538|FG003|Overall Study|Lost to Follow-up|1|||
163331228|NCT01953692|589922539|FG004|Overall Study|Lost to Follow-up|0|||
163331229|NCT01953692|589922540|FG005|Overall Study|Lost to Follow-up|1|||
163072664|NCT03794544|588973004|FG000|Overall Study|Withdrawal by Subject|1|||
163072665|NCT03794544|588973005|FG001|Overall Study|Withdrawal by Subject|1|||
163072666|NCT03794544|588973006|FG002|Overall Study|Withdrawal by Subject|0|||
163072667|NCT03794544|588973007|FG003|Overall Study|Withdrawal by Subject|0|||
163072668|NCT03794544|588973004|FG000|Overall Study|Death|0|||
163072669|NCT03794544|588973005|FG001|Overall Study|Death|0|||
163072670|NCT03794544|588973006|FG002|Overall Study|Death|0|||
163072671|NCT03794544|588973007|FG003|Overall Study|Death|1|||
163072672|NCT03794544|588973004|FG000|Overall Study|Lost to Follow-up|0|||
163072673|NCT03794544|588973005|FG001|Overall Study|Lost to Follow-up|1|||
163072674|NCT03794544|588973006|FG002|Overall Study|Lost to Follow-up|1|||
163072675|NCT03794544|588973007|FG003|Overall Study|Lost to Follow-up|0|||
163072676|NCT03794544|588973004|FG000|Overall Study|Other|0|||
163072677|NCT03794544|588973005|FG001|Overall Study|Other|1|||
163331230|NCT01953692|589922541|FG006|Overall Study|Lost to Follow-up|0|||
163331231|NCT01953692|589922542|FG007|Overall Study|Lost to Follow-up|0|||
163331232|NCT01953692|589922543|FG008|Overall Study|Lost to Follow-up|0|||
163331233|NCT01953692|589922535|FG000|Overall Study|Physician Decision|11|||
163331234|NCT01953692|589922536|FG001|Overall Study|Physician Decision|4|||
163331235|NCT01953692|589922537|FG002|Overall Study|Physician Decision|2|||
163331236|NCT01953692|589922538|FG003|Overall Study|Physician Decision|2|||
163331237|NCT01953692|589922539|FG004|Overall Study|Physician Decision|1|||
163331238|NCT01953692|589922540|FG005|Overall Study|Physician Decision|2|||
163331239|NCT01953692|589922541|FG006|Overall Study|Physician Decision|4|||
163331240|NCT01953692|589922542|FG007|Overall Study|Physician Decision|1|||
163331241|NCT01953692|589922543|FG008|Overall Study|Physician Decision|0|||
163331242|NCT01953692|589922535|FG000|Overall Study|Protocol Violation|0|||
163331243|NCT01953692|589922536|FG001|Overall Study|Protocol Violation|2|||
163331244|NCT01953692|589922537|FG002|Overall Study|Protocol Violation|1|||
163331245|NCT01953692|589922538|FG003|Overall Study|Protocol Violation|0|||
163331246|NCT01953692|589922539|FG004|Overall Study|Protocol Violation|0|||
163331247|NCT01953692|589922540|FG005|Overall Study|Protocol Violation|0|||
163331248|NCT01953692|589922541|FG006|Overall Study|Protocol Violation|0|||
163331249|NCT01953692|589922542|FG007|Overall Study|Protocol Violation|1|||
163331250|NCT01953692|589922543|FG008|Overall Study|Protocol Violation|0|||
163331251|NCT01953692|589922535|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
163331252|NCT01953692|589922536|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
163331253|NCT01953692|589922537|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
163331254|NCT01953692|589922538|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
163331255|NCT01953692|589922539|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
163331256|NCT01953692|589922540|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
163331257|NCT01953692|589922541|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
163331258|NCT01953692|589922542|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
163331259|NCT01953692|589922543|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
163331260|NCT01953692|589922535|FG000|Overall Study|Withdrawal by Subject|4|||
163331261|NCT01953692|589922536|FG001|Overall Study|Withdrawal by Subject|2|||
163331262|NCT01953692|589922537|FG002|Overall Study|Withdrawal by Subject|1|||
163331263|NCT01953692|589922538|FG003|Overall Study|Withdrawal by Subject|2|||
163331264|NCT01953692|589922539|FG004|Overall Study|Withdrawal by Subject|0|||
163331265|NCT01953692|589922540|FG005|Overall Study|Withdrawal by Subject|3|||
163027613|NCT02029989|588804109|FG000|Overall Study|Change of location|2|||
163027614|NCT02029989|588804110|FG001|Overall Study|Change of location|3|||
163027615|NCT02029989|588804109|FG000|Overall Study|Physician Decision|2|||
163027616|NCT02029989|588804110|FG001|Overall Study|Physician Decision|0|||
163027617|NCT02029989|588804109|FG000|Overall Study|Lost to Follow-up|9|||
163027618|NCT02029989|588804110|FG001|Overall Study|Lost to Follow-up|7|||
163027619|NCT02029989|588804109|FG000|Overall Study|Death|0|||
163027620|NCT02029989|588804110|FG001|Overall Study|Death|1|||
163027621|NCT02029989|588804109|FG000|Overall Study|Protocol Violation|1|||
163027622|NCT02029989|588804110|FG001|Overall Study|Protocol Violation|0|||
163027623|NCT04351373|588804111|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
163027624|NCT01123941|588804117|FG000|Overall Study|Lost to Follow-up|2|||
163027625|NCT01123941|588804118|FG001|Overall Study|Lost to Follow-up|1|||
163027626|NCT05036668|588804119|FG000|Overall Study|lost to follow Up|0|||
163027627|NCT05036668|588804120|FG001|Overall Study|lost to follow Up|0|||
163027628|NCT05036668|588804121|FG002|Overall Study|lost to follow Up|1|||
163027629|NCT01537068|588804122|FG000|Overall Study|Lost to Follow-up|2|||
163027630|NCT01537068|588804123|FG001|Overall Study|Lost to Follow-up|1|||
163027631|NCT01537068|588804122|FG000|Overall Study|Adverse Event|0|||
163027632|NCT01537068|588804123|FG001|Overall Study|Adverse Event|1|||
163027633|NCT01537068|588804122|FG000|Overall Study|Withdrawal by Subject|1|||
163027634|NCT01537068|588804123|FG001|Overall Study|Withdrawal by Subject|1|||
163027635|NCT01537068|588804122|FG000|Overall Study|Lack of Efficacy|1|||
163027636|NCT01537068|588804123|FG001|Overall Study|Lack of Efficacy|0|||
163027637|NCT06011161|588804124|FG000|Overall Study|Withdrawal by Subject|2|||
163027638|NCT06011161|588804124|FG000|Overall Study|Lost to Follow-up|5|||
163027639|NCT02291601|588804125|FG000|Abdomen|Did not qualify|333|||
163027640|NCT02291601|588804126|FG001|Abdomen|Did not qualify|54|||
163027641|NCT02291601|588804127|FG002|Abdomen|Did not qualify|339|||
163027642|NCT02291601|588804125|FG000|Groin|Did not qualify|183|||
163027643|NCT02291601|588804126|FG001|Groin|Did not qualify|30|||
163027644|NCT02291601|588804127|FG002|Groin|Did not qualify|177|||
163027645|NCT04017832|588804130|FG000|Overall Study|Withdrawal by Subject|13|||
163027646|NCT04017832|588804131|FG001|Overall Study|Withdrawal by Subject|12|||
163027647|NCT04017832|588804132|FG002|Overall Study|Withdrawal by Subject|21|||
163331266|NCT01953692|589922541|FG006|Overall Study|Withdrawal by Subject|2|||
163331267|NCT01953692|589922542|FG007|Overall Study|Withdrawal by Subject|1|||
163331268|NCT01953692|589922543|FG008|Overall Study|Withdrawal by Subject|1|||
163027648|NCT04017832|588804133|FG003|Overall Study|Withdrawal by Subject|7|||
163027649|NCT04017832|588804130|FG000|Overall Study|Lost to Follow-up|0|||
163027650|NCT04017832|588804131|FG001|Overall Study|Lost to Follow-up|3|||
163027651|NCT04017832|588804132|FG002|Overall Study|Lost to Follow-up|3|||
163331269|NCT01822756|589922550|FG000|Overall Study|Adverse Event|0|||
163331270|NCT01822756|589922551|FG001|Overall Study|Adverse Event|0|||
163331271|NCT01822756|589922552|FG002|Overall Study|Adverse Event|0|||
163072678|NCT03794544|588973006|FG002|Overall Study|Other|0|||
163072679|NCT03794544|588973007|FG003|Overall Study|Other|0|||
163072680|NCT02502383|588973009|FG000|Overall Study|Lost to Follow-up|130|||
163072681|NCT02502383|588973010|FG001|Overall Study|Lost to Follow-up|131|||
163072682|NCT02502383|588973009|FG000|Overall Study|Withdrawal by Subject|31|||
163072683|NCT02502383|588973010|FG001|Overall Study|Withdrawal by Subject|24|||
163072684|NCT01428713|588973011|FG000|Overall Study|Non-compliance|2|||
163072685|NCT01428713|588973012|FG001|Overall Study|Non-compliance|2|||
163072686|NCT01428713|588973011|FG000|Overall Study|Withdrawal by Subject|1|||
163072687|NCT01428713|588973012|FG001|Overall Study|Withdrawal by Subject|1|||
163072688|NCT01428713|588973011|FG000|Overall Study|Adverse Event|0|||
163072689|NCT01428713|588973012|FG001|Overall Study|Adverse Event|2|||
163072690|NCT00875667|588973015|FG000|Overall Study|Adverse Event|29|||
163072691|NCT00875667|588973016|FG001|Overall Study|Adverse Event|10|||
163072692|NCT00875667|588973015|FG000|Overall Study|Withdrawal by Subject|17|||
163072693|NCT00875667|588973016|FG001|Overall Study|Withdrawal by Subject|5|||
163072694|NCT00875667|588973015|FG000|Overall Study|Death|7|||
163072695|NCT00875667|588973016|FG001|Overall Study|Death|2|||
163072696|NCT00875667|588973015|FG000|Overall Study|Protocol Violation|2|||
163072697|NCT00875667|588973016|FG001|Overall Study|Protocol Violation|0|||
163072698|NCT00875667|588973015|FG000|Overall Study|Disease Progression|100|||
163072699|NCT00875667|588973016|FG001|Overall Study|Disease Progression|49|||
163072700|NCT00875667|588973015|FG000|Overall Study|Miscellaneous|12|||
163072701|NCT00875667|588973016|FG001|Overall Study|Miscellaneous|6|||
163072702|NCT00875667|588973015|FG000|Overall Study|Randomized but no Study Drug Given|3|||
163072703|NCT00875667|588973016|FG001|Overall Study|Randomized but no Study Drug Given|1|||
163072704|NCT00120250|588973017|FG000|Overall Study|Lost to Follow-up|1|||
163072705|NCT00120250|588973018|FG001|Overall Study|Lost to Follow-up|1|||
163072706|NCT00120250|588973017|FG000|Overall Study|Protocol Violation|0|||
163072707|NCT00120250|588973018|FG001|Overall Study|Protocol Violation|1|||
163072708|NCT01967277|588973019|FG000|Overall Study|Lost to Follow-up|1|||
163072709|NCT01967277|588973020|FG001|Overall Study|Lost to Follow-up|2|||
163072710|NCT01967277|588973019|FG000|Overall Study|Unrelated illness|0|||
163072711|NCT01967277|588973020|FG001|Overall Study|Unrelated illness|1|||
163072712|NCT02384460|588973029|FG000|Overall Study|Protocol Violation|0|||
163072713|NCT02384460|588973030|FG001|Overall Study|Protocol Violation|1|||
163072714|NCT02384460|588973029|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
163072715|NCT02384460|588973030|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
163072716|NCT02384460|588973029|FG000|Overall Study|Adverse Event|5|||
163072717|NCT02384460|588973030|FG001|Overall Study|Adverse Event|2|||
163072718|NCT02384460|588973029|FG000|Overall Study|Withdrawal by Subject|0|||
163072719|NCT02384460|588973030|FG001|Overall Study|Withdrawal by Subject|3|||
163072720|NCT02384460|588973029|FG000|Overall Study|Elective medical treatment|1|||
163072721|NCT02384460|588973030|FG001|Overall Study|Elective medical treatment|0|||
163072722|NCT02384460|588973029|FG000|Overall Study|Non-compliance|1|||
163072723|NCT02384460|588973030|FG001|Overall Study|Non-compliance|0|||
163072724|NCT02301429|588973034|FG000|Overall Study|not acceptable vascular anatomy|3|||
163072725|NCT01279200|588973040|FG000|Overall Study|Withdrawal by Subject|1|||
163072726|NCT01279200|588973041|FG001|Overall Study|Withdrawal by Subject|3|||
163072727|NCT01279200|588973040|FG000|Overall Study|Patient withdrawal due to high cost|0|||
163072728|NCT01279200|588973041|FG001|Overall Study|Patient withdrawal due to high cost|1|||
163072729|NCT01279200|588973040|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
163072730|NCT01279200|588973041|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
163072731|NCT01279200|588973040|FG000|Overall Study|ultrasound screening failure|0|||
163072732|NCT01279200|588973041|FG001|Overall Study|ultrasound screening failure|1|||
163218061|NCT00156533|589515744|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
163218062|NCT00156533|589515741|FG000|Overall Study|Withdrawal by Subject|1|||
163218063|NCT00156533|589515742|FG001|Overall Study|Withdrawal by Subject|0|||
163072733|NCT01279200|588973040|FG000|Overall Study|Lost to Follow-up|0|||
163218064|NCT00156533|589515743|FG002|Overall Study|Withdrawal by Subject|0|||
163072734|NCT01279200|588973041|FG001|Overall Study|Lost to Follow-up|1|||
163072735|NCT01279200|588973040|FG000|Overall Study|Adverse Event|1|||
163072736|NCT01279200|588973041|FG001|Overall Study|Adverse Event|0|||
163072737|NCT01399099|588973042|FG000|Overall Study|Lost to Follow-up|14|||
163072738|NCT01399099|588973042|FG000|Overall Study|Physician Decision|1|||
163072739|NCT01399099|588973042|FG000|Overall Study|Protocol Violation|1|||
163218065|NCT00156533|589515744|FG003|Overall Study|Withdrawal by Subject|1|||
163218066|NCT00156533|589515741|FG000|Overall Study|Failed Screening|1|||
163218067|NCT00156533|589515742|FG001|Overall Study|Failed Screening|0|||
163218068|NCT00156533|589515743|FG002|Overall Study|Failed Screening|1|||
163218069|NCT00156533|589515744|FG003|Overall Study|Failed Screening|1|||
163218070|NCT01881230|589515745|FG000|Overall Study|Death|2|||
163218071|NCT01881230|589515746|FG001|Overall Study|Death|0|||
163218072|NCT01881230|589515747|FG002|Overall Study|Death|1|||
163218073|NCT01881230|589515745|FG000|Overall Study|Adverse Event|9|||
163218074|NCT01881230|589515746|FG001|Overall Study|Adverse Event|13|||
163218075|NCT01881230|589515747|FG002|Overall Study|Adverse Event|12|||
163218076|NCT01881230|589515745|FG000|Overall Study|Progressive Disease|31|||
163072740|NCT01399099|588973042|FG000|Overall Study|Skin Irritation|13|||
163072741|NCT01399099|588973042|FG000|Overall Study|Infection|1|||
163072742|NCT01399099|588973042|FG000|Overall Study|Miscellaneous|4|||
163072743|NCT01179516|588973043|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
163072744|NCT01179516|588973044|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
163072745|NCT01179516|588973045|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
163072746|NCT01179516|588973043|FG000|Overall Study|Lack of Efficacy|4|||
163072747|NCT01179516|588973044|FG001|Overall Study|Lack of Efficacy|2|||
163072748|NCT01179516|588973045|FG002|Overall Study|Lack of Efficacy|0|||
163072749|NCT01179516|588973043|FG000|Overall Study|Noncompliance with Study Drug|2|||
163072750|NCT01179516|588973044|FG001|Overall Study|Noncompliance with Study Drug|0|||
163072751|NCT01179516|588973045|FG002|Overall Study|Noncompliance with Study Drug|1|||
163072752|NCT01179516|588973043|FG000|Overall Study|Protocol Deviations|4|||
163072753|NCT01179516|588973044|FG001|Overall Study|Protocol Deviations|3|||
163072754|NCT01179516|588973045|FG002|Overall Study|Protocol Deviations|3|||
163072755|NCT01179516|588973043|FG000|Overall Study|Withdrawal of Consent|2|||
163072756|NCT01179516|588973044|FG001|Overall Study|Withdrawal of Consent|6|||
163072757|NCT01179516|588973045|FG002|Overall Study|Withdrawal of Consent|10|||
163072758|NCT01179516|588973043|FG000|Overall Study|Lost to Follow-up|7|||
163072759|NCT01179516|588973044|FG001|Overall Study|Lost to Follow-up|7|||
163072760|NCT01179516|588973045|FG002|Overall Study|Lost to Follow-up|3|||
163072761|NCT01179516|588973043|FG000|Overall Study|Other|2|||
163072762|NCT01179516|588973044|FG001|Overall Study|Other|0|||
163072763|NCT01179516|588973045|FG002|Overall Study|Other|2|||
163072764|NCT01668537|588973046|FG000|Overall Study|Request to Discontinue Prematurely|1|||
163072765|NCT01668537|588973047|FG001|Overall Study|Request to Discontinue Prematurely|1|||
163072766|NCT01668537|588973046|FG000|Overall Study|Subject unwilling/unable to comply|5|||
163072767|NCT01668537|588973047|FG001|Overall Study|Subject unwilling/unable to comply|0|||
163072768|NCT01668537|588973046|FG000|Overall Study|Reason Precludes Participation|1|||
163072769|NCT01668537|588973047|FG001|Overall Study|Reason Precludes Participation|0|||
163072770|NCT01668537|588973046|FG000|Overall Study|Lost to Follow-up|13|||
163072771|NCT01668537|588973047|FG001|Overall Study|Lost to Follow-up|6|||
163072772|NCT01668537|588973046|FG000|Overall Study|Other|2|||
163072773|NCT01668537|588973047|FG001|Overall Study|Other|3|||
163072774|NCT01149538|588973048|FG000|Overall Study|Lost to Follow-up|0|||
163072775|NCT01149538|588973049|FG001|Overall Study|Lost to Follow-up|1|||
163072776|NCT01149538|588973048|FG000|Overall Study|Withdrawal by Subject|5|||
163072777|NCT01149538|588973049|FG001|Overall Study|Withdrawal by Subject|3|||
163072778|NCT02336503|588973054|FG000|Overall Study|Lost to Follow-up|0|||
163072779|NCT02336503|588973055|FG001|Overall Study|Lost to Follow-up|3|||
163072780|NCT02336503|588973056|FG002|Overall Study|Lost to Follow-up|0|||
163072781|NCT02336503|588973057|FG003|Overall Study|Lost to Follow-up|2|||
163072782|NCT02336503|588973054|FG000|Overall Study|Withdrawal by Subject|2|||
163072783|NCT02336503|588973055|FG001|Overall Study|Withdrawal by Subject|0|||
163072784|NCT02336503|588973056|FG002|Overall Study|Withdrawal by Subject|0|||
163072785|NCT02336503|588973057|FG003|Overall Study|Withdrawal by Subject|4|||
163072786|NCT02336503|588973054|FG000|Overall Study|Adverse Event|0|||
163072787|NCT02336503|588973055|FG001|Overall Study|Adverse Event|0|||
163072788|NCT02336503|588973056|FG002|Overall Study|Adverse Event|1|||
163072789|NCT02336503|588973057|FG003|Overall Study|Adverse Event|0|||
163072790|NCT01436500|588973059|FG000|Overall Study|Death|1|||
163072791|NCT01436500|588973060|FG001|Overall Study|Death|0|||
163072792|NCT01436500|588973061|FG002|Overall Study|Death|0|||
163072793|NCT01436500|588973062|FG003|Overall Study|Death|0|||
163072794|NCT01436500|588973063|FG004|Overall Study|Death|0|||
163072795|NCT01436500|588973059|FG000|Overall Study|Adverse Event|0|||
163072796|NCT01436500|588973060|FG001|Overall Study|Adverse Event|2|||
163072797|NCT01436500|588973061|FG002|Overall Study|Adverse Event|2|||
163072798|NCT01436500|588973062|FG003|Overall Study|Adverse Event|0|||
163072799|NCT01436500|588973063|FG004|Overall Study|Adverse Event|1|||
163072800|NCT01436500|588973059|FG000|Overall Study|Withdrawal by Subject|0|||
163072801|NCT01436500|588973060|FG001|Overall Study|Withdrawal by Subject|0|||
163072802|NCT01436500|588973061|FG002|Overall Study|Withdrawal by Subject|2|||
163072803|NCT01436500|588973062|FG003|Overall Study|Withdrawal by Subject|0|||
163072804|NCT01436500|588973063|FG004|Overall Study|Withdrawal by Subject|2|||
163072805|NCT01436500|588973059|FG000|Overall Study|Physician Decision|0|||
163072806|NCT01436500|588973060|FG001|Overall Study|Physician Decision|0|||
163072807|NCT01436500|588973061|FG002|Overall Study|Physician Decision|1|||
163072808|NCT01436500|588973062|FG003|Overall Study|Physician Decision|0|||
163072809|NCT01436500|588973063|FG004|Overall Study|Physician Decision|0|||
163072810|NCT01436500|588973059|FG000|Overall Study|liver transplant|1|||
163072811|NCT01436500|588973060|FG001|Overall Study|liver transplant|0|||
163072812|NCT01436500|588973061|FG002|Overall Study|liver transplant|0|||
163072813|NCT01436500|588973062|FG003|Overall Study|liver transplant|0|||
163072814|NCT01436500|588973063|FG004|Overall Study|liver transplant|0|||
163072815|NCT01436500|588973059|FG000|Overall Study|initiation of dialysis|0|||
163072816|NCT01436500|588973060|FG001|Overall Study|initiation of dialysis|0|||
163072817|NCT01436500|588973061|FG002|Overall Study|initiation of dialysis|0|||
163072818|NCT01436500|588973062|FG003|Overall Study|initiation of dialysis|0|||
163072819|NCT01436500|588973063|FG004|Overall Study|initiation of dialysis|1|||
163072820|NCT01436500|588973059|FG000|Overall Study|discontinued study drug|1|||
163072821|NCT01436500|588973060|FG001|Overall Study|discontinued study drug|0|||
163072822|NCT01436500|588973061|FG002|Overall Study|discontinued study drug|0|||
163072823|NCT01436500|588973062|FG003|Overall Study|discontinued study drug|0|||
163072824|NCT01436500|588973063|FG004|Overall Study|discontinued study drug|0|||
163072825|NCT01436500|588973059|FG000|Overall Study|Other|0|||
163072826|NCT01436500|588973060|FG001|Overall Study|Other|1|||
163072827|NCT01436500|588973061|FG002|Overall Study|Other|0|||
163072828|NCT01436500|588973062|FG003|Overall Study|Other|1|||
163072829|NCT01436500|588973063|FG004|Overall Study|Other|0|||
163072830|NCT02184156|588973069|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
163072831|NCT02184156|588973070|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
163072832|NCT02184156|588973069|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
163072833|NCT02184156|588973070|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
163072834|NCT02405962|588973072|FG000|Overall Study|Lost to Follow-up|1|||
163072835|NCT02405962|588973073|FG001|Overall Study|Lost to Follow-up|4|||
163072836|NCT02405962|588973072|FG000|Overall Study|A participant has moved to another place|0|||
163072837|NCT02405962|588973073|FG001|Overall Study|A participant has moved to another place|1|||
163072838|NCT01980888|588973074|FG000|Overall Study|Study Terminated by Sponsor|116|||
163072839|NCT01980888|588973075|FG001|Overall Study|Study Terminated by Sponsor|122|||
163072840|NCT01980888|588973074|FG000|Overall Study|Withdrew Consent|17|||
163072841|NCT01980888|588973075|FG001|Overall Study|Withdrew Consent|6|||
163072842|NCT01980888|588973074|FG000|Overall Study|Investigator's Discretion|8|||
163072843|NCT01980888|588973075|FG001|Overall Study|Investigator's Discretion|3|||
163072844|NCT01980888|588973074|FG000|Overall Study|Non-Compliance with Study Drug|3|||
163072845|NCT01980888|588973075|FG001|Overall Study|Non-Compliance with Study Drug|2|||
163072846|NCT00086307|588973080|FG000|Overall Study|Lack of Efficacy|1|||
163072847|NCT00086307|588973081|FG001|Overall Study|Lack of Efficacy|1|||
163072848|NCT00086307|588973082|FG002|Overall Study|Lack of Efficacy|2|||
163072849|NCT00086307|588973080|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
163072850|NCT00086307|588973081|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
163072851|NCT00086307|588973082|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
163072852|NCT00086307|588973080|FG000|Overall Study|Nausea and headaches|0|||
163072853|NCT00086307|588973081|FG001|Overall Study|Nausea and headaches|0|||
163072854|NCT00086307|588973082|FG002|Overall Study|Nausea and headaches|1|||
163072855|NCT00086307|588973080|FG000|Overall Study|Constipation and sleepiness|0|||
163072856|NCT00086307|588973081|FG001|Overall Study|Constipation and sleepiness|0|||
163072857|NCT00086307|588973082|FG002|Overall Study|Constipation and sleepiness|1|||
163072858|NCT00086307|588973080|FG000|Overall Study|Suicidal ideation|0|||
163072859|NCT00086307|588973081|FG001|Overall Study|Suicidal ideation|0|||
163072860|NCT00086307|588973082|FG002|Overall Study|Suicidal ideation|1|||
163072861|NCT00086307|588973080|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
163072862|NCT00086307|588973081|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
163072863|NCT00086307|588973082|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
163072864|NCT00086307|588973080|FG000|Overall Study|Withdrawal by Subject|0|||
163072865|NCT00086307|588973081|FG001|Overall Study|Withdrawal by Subject|0|||
163072866|NCT00086307|588973082|FG002|Overall Study|Withdrawal by Subject|2|||
163072867|NCT03158311|588973085|FG000|Overall Study|Subject/Guardian Decision|10|||
163072868|NCT03158311|588973086|FG001|Overall Study|Subject/Guardian Decision|6|||
163072869|NCT03158311|588973087|FG002|Overall Study|Subject/Guardian Decision|11|||
163072870|NCT03158311|588973085|FG000|Overall Study|Adverse Event|5|||
163072871|NCT03158311|588973086|FG001|Overall Study|Adverse Event|3|||
163072872|NCT03158311|588973087|FG002|Overall Study|Adverse Event|3|||
163072873|NCT03158311|588973085|FG000|Overall Study|Techinical Problems|3|||
163072874|NCT03158311|588973086|FG001|Overall Study|Techinical Problems|1|||
163072875|NCT03158311|588973087|FG002|Overall Study|Techinical Problems|5|||
163072876|NCT03158311|588973085|FG000|Overall Study|Physician Decision|2|||
163072877|NCT03158311|588973086|FG001|Overall Study|Physician Decision|3|||
163218077|NCT01881230|589515746|FG001|Overall Study|Progressive Disease|35|||
163072878|NCT03158311|588973087|FG002|Overall Study|Physician Decision|7|||
163072879|NCT03158311|588973085|FG000|Overall Study|Lost to Follow-up|1|||
163072880|NCT03158311|588973086|FG001|Overall Study|Lost to Follow-up|1|||
163218078|NCT01881230|589515747|FG002|Overall Study|Progressive Disease|36|||
163072881|NCT03158311|588973087|FG002|Overall Study|Lost to Follow-up|1|||
163072882|NCT03158311|588973085|FG000|Overall Study|Sponsor decision|1|||
163072883|NCT03158311|588973086|FG001|Overall Study|Sponsor decision|0|||
163072884|NCT03158311|588973087|FG002|Overall Study|Sponsor decision|0|||
163072885|NCT03158311|588973085|FG000|Overall Study|Pregnancy|0|||
163072886|NCT03158311|588973086|FG001|Overall Study|Pregnancy|2|||
163072887|NCT03158311|588973087|FG002|Overall Study|Pregnancy|0|||
163072888|NCT03158311|588973085|FG000|Overall Study|Randomized in error|0|||
163072889|NCT03158311|588973086|FG001|Overall Study|Randomized in error|0|||
163072890|NCT03158311|588973087|FG002|Overall Study|Randomized in error|1|||
163218079|NCT01881230|589515745|FG000|Overall Study|Symptomatic Deterioration|3|||
163218080|NCT01881230|589515746|FG001|Overall Study|Symptomatic Deterioration|3|||
163218081|NCT01881230|589515747|FG002|Overall Study|Symptomatic Deterioration|1|||
163072891|NCT01018953|588973088|FG000|Overall Study|Adverse Event|2|||
163072892|NCT01018953|588973088|FG000|Overall Study|Withdrawal by Subject|1|||
163072893|NCT01018953|588973088|FG000|Overall Study|Study termination by sponsor|5|||
163072894|NCT00724503|588973089|FG000|Overall Study|Lost to Follow-up|4|||
163072895|NCT00724503|588973090|FG001|Overall Study|Lost to Follow-up|8|||
163072896|NCT00724503|588973089|FG000|Overall Study|Withdrawal by Subject|11|||
163072897|NCT00724503|588973090|FG001|Overall Study|Withdrawal by Subject|23|||
163072898|NCT00724503|588973089|FG000|Overall Study|Death|190|||
163072899|NCT00724503|588973090|FG001|Overall Study|Death|182|||
163072900|NCT00724503|588973089|FG000|Overall Study|Adverse Event|1|||
163072901|NCT00724503|588973090|FG001|Overall Study|Adverse Event|0|||
163072902|NCT00724503|588973089|FG000|Overall Study|Not otherwise specified|4|||
163072903|NCT00724503|588973090|FG001|Overall Study|Not otherwise specified|7|||
163072904|NCT01184118|588973091|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
163072905|NCT01184118|588973091|FG000|Overall Study|No physiologic confirmation of asthma|8|||
163072906|NCT01184118|588973091|FG000|Overall Study|FEV1 <60% predicted|2|||
163072907|NCT01184118|588973091|FG000|Overall Study|Exclusionary medical condition|2|||
163072908|NCT01184118|588973091|FG000|Overall Study|Withdrawal by Subject|5|||
163072909|NCT01186419|588973092|FG000|Overall Study|Withdrawal by Subject|5|||
163072910|NCT01186419|588973093|FG001|Overall Study|Withdrawal by Subject|3|||
163072911|NCT01186419|588973092|FG000|Overall Study|Adverse Event|1|||
163072912|NCT01186419|588973093|FG001|Overall Study|Adverse Event|2|||
163072913|NCT01186419|588973092|FG000|Overall Study|Physician Decision|0|||
163072914|NCT01186419|588973093|FG001|Overall Study|Physician Decision|3|||
163218082|NCT01881230|589515745|FG000|Overall Study|Withdrawal by Subject|6|||
163218083|NCT01881230|589515746|FG001|Overall Study|Withdrawal by Subject|4|||
163218084|NCT01881230|589515747|FG002|Overall Study|Withdrawal by Subject|6|||
163072915|NCT01186419|588973092|FG000|Overall Study|Other|1|||
163072916|NCT01186419|588973093|FG001|Overall Study|Other|1|||
163072917|NCT01033071|588973099|FG000|Overall Study|Adverse Event|28|||
163072918|NCT01033071|588973100|FG001|Overall Study|Adverse Event|51|||
163072919|NCT01033071|588973101|FG002|Overall Study|Adverse Event|26|||
163072920|NCT01033071|588973099|FG000|Overall Study|Protocol Violation|0|||
163072921|NCT01033071|588973100|FG001|Overall Study|Protocol Violation|2|||
163218085|NCT01881230|589515745|FG000|Overall Study|Physician Decision|4|||
163218086|NCT01881230|589515746|FG001|Overall Study|Physician Decision|3|||
163072922|NCT01033071|588973101|FG002|Overall Study|Protocol Violation|1|||
163072923|NCT01033071|588973099|FG000|Overall Study|Lost to Follow-up|4|||
163072924|NCT01033071|588973100|FG001|Overall Study|Lost to Follow-up|5|||
163072925|NCT01033071|588973101|FG002|Overall Study|Lost to Follow-up|5|||
163072926|NCT01033071|588973099|FG000|Overall Study|Withdrawal by Subject|17|||
163072927|NCT01033071|588973100|FG001|Overall Study|Withdrawal by Subject|14|||
163072928|NCT01033071|588973101|FG002|Overall Study|Withdrawal by Subject|11|||
163072929|NCT01033071|588973099|FG000|Overall Study|Lack of Efficacy|0|||
163072930|NCT01033071|588973100|FG001|Overall Study|Lack of Efficacy|1|||
163072931|NCT01033071|588973101|FG002|Overall Study|Lack of Efficacy|1|||
163072932|NCT01033071|588973099|FG000|Overall Study|Other|6|||
163072933|NCT01033071|588973100|FG001|Overall Study|Other|4|||
163072934|NCT01033071|588973101|FG002|Overall Study|Other|3|||
163072935|NCT04073407|588973104|FG000|Part 1|Withdrawal by Subject|1|||
163072936|NCT04073407|588973105|FG001|Part 1|Withdrawal by Subject|0|||
163072937|NCT04073407|588973104|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
163072938|NCT04073407|588973105|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
163072939|NCT04073407|588973104|FG000|Part 2|Withdrawal by Subject|0|||
163072940|NCT04073407|588973105|FG001|Part 2|Withdrawal by Subject|1|||
163072941|NCT00585585|588974496|FG000|Overall Study|Adverse Event|1|||
163072942|NCT01964560|588974499|FG000|Overall Study|Adverse Event|23|||
163072943|NCT01964560|588974499|FG000|Overall Study|Lack of Efficacy|46|||
163072944|NCT01964560|588974499|FG000|Overall Study|Protocol deviation|2|||
163072945|NCT01964560|588974499|FG000|Overall Study|Lost to Follow-up|4|||
163072946|NCT01964560|588974499|FG000|Overall Study|Withdrawal by Subject|64|||
163072947|NCT01964560|588974499|FG000|Overall Study|Surgery-hemispherotomy|1|||
163072948|NCT01964560|588974499|FG000|Overall Study|Surgery|1|||
163218087|NCT01881230|589515747|FG002|Overall Study|Physician Decision|6|||
163218088|NCT01881230|589515745|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163218089|NCT01881230|589515746|FG001|Overall Study|Non-Compliance with Study Drug|2|||
163218090|NCT01881230|589515747|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163218091|NCT01881230|589515745|FG000|Overall Study|Given Commercially Available Drug|0|||
163218092|NCT01881230|589515746|FG001|Overall Study|Given Commercially Available Drug|0|||
163218093|NCT01881230|589515747|FG002|Overall Study|Given Commercially Available Drug|2|||
163218094|NCT01881230|589515745|FG000|Overall Study|Protocol Violation|1|||
163218095|NCT01881230|589515746|FG001|Overall Study|Protocol Violation|1|||
163218096|NCT01881230|589515747|FG002|Overall Study|Protocol Violation|0|||
163218097|NCT01881230|589515745|FG000|Overall Study|Miscellaneous|3|||
163218098|NCT01881230|589515746|FG001|Overall Study|Miscellaneous|3|||
163218099|NCT01881230|589515747|FG002|Overall Study|Miscellaneous|0|||
163218100|NCT01881230|589515745|FG000|Overall Study|Untreated: Other|0|||
163072949|NCT01964560|588974499|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
163072950|NCT01964560|588974499|FG000|Overall Study|Patient and Investigator choice|1|||
163072951|NCT01964560|588974499|FG000|Overall Study|Patient was prescribed CBD|1|||
163072952|NCT01964560|588974499|FG000|Overall Study|Participant moved to another country|1|||
163072953|NCT02217982|588974511|FG000|Overall Study|Trial discontinued|1|||
163072954|NCT02217982|588974512|FG001|Overall Study|Trial discontinued|0|||
163072955|NCT02217982|588974511|FG000|Overall Study|Adverse Event|0|||
163072956|NCT02217982|588974512|FG001|Overall Study|Adverse Event|1|||
163072957|NCT03791060|588974513|FG000|Overall Study|Withdrawal by Subject|1|||
163072958|NCT01011283|588974514|FG000|Overall Study|Adverse Event|4|||
163072959|NCT01011283|588974515|FG001|Overall Study|Adverse Event|2|||
163072960|NCT01011283|588974514|FG000|Overall Study|Progressive Disease|0|||
163072961|NCT01011283|588974515|FG001|Overall Study|Progressive Disease|2|||
163072962|NCT01011283|588974514|FG000|Overall Study|Terminated by Sponsor|5|||
163072963|NCT01011283|588974515|FG001|Overall Study|Terminated by Sponsor|5|||
163072964|NCT01011283|588974514|FG000|Overall Study|Other|2|||
163072965|NCT01011283|588974515|FG001|Overall Study|Other|2|||
163072966|NCT01717859|588974516|FG000|Overall Study|Adverse Event|5|||
163072967|NCT01717859|588974516|FG000|Overall Study|Moved out of state|1|||
163072968|NCT01717859|588974516|FG000|Overall Study|Patient concerned about mental health|1|||
163072969|NCT01717859|588974516|FG000|Overall Study|Lost to Follow-up|1|||
163218101|NCT01881230|589515746|FG001|Overall Study|Untreated: Other|0|||
163218102|NCT01881230|589515747|FG002|Overall Study|Untreated: Other|1|||
163218103|NCT01881230|589515745|FG000|Overall Study|Untreated: Death|0|||
163218104|NCT01881230|589515746|FG001|Overall Study|Untreated: Death|0|||
163218105|NCT01881230|589515747|FG002|Overall Study|Untreated: Death|1|||
163218106|NCT01881230|589515745|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
163218107|NCT01881230|589515746|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
163218108|NCT01881230|589515747|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
163218109|NCT02747420|589515748|FG000|Overall Study|Lost to Follow-up|4|||
163218110|NCT02747420|589515749|FG001|Overall Study|Lost to Follow-up|2|||
163218111|NCT02747420|589515748|FG000|Overall Study|Withdrawal by Subject|3|||
163218112|NCT02747420|589515749|FG001|Overall Study|Withdrawal by Subject|2|||
163218113|NCT05129488|589515750|FG000|Overall Study|Protocol Violation|3|||
163218114|NCT04307446|589515751|FG000|Overall Study|Lost to Follow-up|2|||
163218115|NCT04307446|589515752|FG001|Overall Study|Lost to Follow-up|0|||
163218116|NCT02515942|589515753|FG000|Overall Study|Adverse Event|5|||
163218117|NCT02515942|589515754|FG001|Overall Study|Adverse Event|0|||
163218118|NCT02515942|589515755|FG002|Overall Study|Adverse Event|0|||
163218119|NCT02515942|589515753|FG000|Overall Study|Death|0|||
163218120|NCT02515942|589515754|FG001|Overall Study|Death|0|||
163218121|NCT02515942|589515755|FG002|Overall Study|Death|1|||
163218122|NCT02515942|589515753|FG000|Overall Study|Lack of Efficacy|0|||
163218123|NCT02515942|589515754|FG001|Overall Study|Lack of Efficacy|0|||
163218124|NCT02515942|589515755|FG002|Overall Study|Lack of Efficacy|1|||
163218125|NCT02515942|589515753|FG000|Overall Study|Lost to Follow-up|2|||
163218126|NCT02515942|589515754|FG001|Overall Study|Lost to Follow-up|0|||
163218127|NCT02515942|589515755|FG002|Overall Study|Lost to Follow-up|0|||
163218128|NCT02515942|589515753|FG000|Overall Study|Withdrawal by Subject|0|||
163218129|NCT02515942|589515754|FG001|Overall Study|Withdrawal by Subject|3|||
163218130|NCT02515942|589515755|FG002|Overall Study|Withdrawal by Subject|2|||
163218131|NCT02622828|589515756|FG000|Overall Study|participant withdrew|3|||
163218132|NCT03616912|589515757|FG000|Overall Study|Adverse Event|17|||
163218133|NCT03616912|589515758|FG001|Overall Study|Adverse Event|21|||
163218134|NCT03616912|589515759|FG002|Overall Study|Adverse Event|9|||
163218135|NCT03616912|589515760|FG003|Overall Study|Adverse Event|0|||
163218136|NCT03616912|589515761|FG004|Overall Study|Adverse Event|0|||
163218137|NCT03616912|589515762|FG005|Overall Study|Adverse Event|0|||
163218138|NCT03616912|589515757|FG000|Overall Study|Death|1|||
163072970|NCT01717859|588974516|FG000|Overall Study|Withdrawal by Subject|2|||
163072971|NCT04389671|588974517|FG000|Overall Study|Death|7|||
163072972|NCT00724893|588974526|FG000|Overall Study|Adverse Event|76|||
163072973|NCT00724893|588974527|FG001|Overall Study|Adverse Event|142|||
163072974|NCT00724893|588974526|FG000|Overall Study|Withdrawal by Subject|0|||
163072975|NCT00724893|588974527|FG001|Overall Study|Withdrawal by Subject|1|||
163072976|NCT00724893|588974526|FG000|Overall Study|Lack of virologic response|94|||
163218139|NCT03616912|589515758|FG001|Overall Study|Death|1|||
163218140|NCT03616912|589515759|FG002|Overall Study|Death|0|||
163218141|NCT03616912|589515760|FG003|Overall Study|Death|0|||
163218142|NCT03616912|589515761|FG004|Overall Study|Death|0|||
163218143|NCT03616912|589515762|FG005|Overall Study|Death|0|||
163218144|NCT03616912|589515757|FG000|Overall Study|Lack of Efficacy|13|||
163218145|NCT03616912|589515758|FG001|Overall Study|Lack of Efficacy|6|||
163218146|NCT03616912|589515759|FG002|Overall Study|Lack of Efficacy|8|||
163218147|NCT03616912|589515760|FG003|Overall Study|Lack of Efficacy|4|||
163072977|NCT00724893|588974527|FG001|Overall Study|Lack of virologic response|202|||
163218148|NCT03616912|589515761|FG004|Overall Study|Lack of Efficacy|5|||
163218149|NCT03616912|589515762|FG005|Overall Study|Lack of Efficacy|1|||
163218150|NCT03616912|589515757|FG000|Overall Study|Lost to Follow-up|1|||
163072978|NCT00724893|588974526|FG000|Overall Study|Reason not specified|193|||
163072979|NCT00724893|588974527|FG001|Overall Study|Reason not specified|7|||
163072980|NCT00724893|588974526|FG000|Overall Study|Patient choice|0|||
163072981|NCT00724893|588974527|FG001|Overall Study|Patient choice|26|||
163072982|NCT00724893|588974526|FG000|Overall Study|Geographic reasons|0|||
163072983|NCT00724893|588974527|FG001|Overall Study|Geographic reasons|11|||
163072984|NCT00724893|588974526|FG000|Overall Study|Incarceration|0|||
163072985|NCT00724893|588974527|FG001|Overall Study|Incarceration|9|||
163072986|NCT00724893|588974526|FG000|Overall Study|Substance abuse|0|||
163072987|NCT00724893|588974527|FG001|Overall Study|Substance abuse|3|||
163072988|NCT00724893|588974526|FG000|Overall Study|Financial reasons|0|||
163072989|NCT00724893|588974527|FG001|Overall Study|Financial reasons|2|||
163072990|NCT00724893|588974526|FG000|Overall Study|Assigned shorter treatment|0|||
163072991|NCT00724893|588974527|FG001|Overall Study|Assigned shorter treatment|2|||
163072992|NCT00724893|588974526|FG000|Overall Study|Lost to Follow-up|0|||
163072993|NCT00724893|588974527|FG001|Overall Study|Lost to Follow-up|52|||
163072994|NCT00724893|588974526|FG000|Overall Study|Unknown, missing data|1|||
163072995|NCT00724893|588974527|FG001|Overall Study|Unknown, missing data|1|||
163072996|NCT01290731|588974528|FG000|Overall Study|Withdrawal by Subject|1|||
163072997|NCT02181738|588974536|FG000|Overall Study|Participant Withdrew Consent|2|||
163072998|NCT02181738|588974537|FG001|Overall Study|Participant Withdrew Consent|1|||
163072999|NCT02181738|588974538|FG002|Overall Study|Participant Withdrew Consent|1|||
163073000|NCT02181738|588974539|FG003|Overall Study|Participant Withdrew Consent|1|||
163073001|NCT02181738|588974536|FG000|Overall Study|Lost to Follow-up|1|||
163073002|NCT02181738|588974537|FG001|Overall Study|Lost to Follow-up|2|||
163073003|NCT02181738|588974538|FG002|Overall Study|Lost to Follow-up|1|||
163073004|NCT02181738|588974539|FG003|Overall Study|Lost to Follow-up|1|||
163073005|NCT02181738|588974536|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
163073006|NCT02181738|588974537|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
163073007|NCT02181738|588974538|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
163073008|NCT02181738|588974539|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
163073009|NCT02181738|588974536|FG000|Overall Study|Poor/Non-Compliance|1|||
163073010|NCT02181738|588974537|FG001|Overall Study|Poor/Non-Compliance|0|||
163073011|NCT02181738|588974538|FG002|Overall Study|Poor/Non-Compliance|2|||
163073012|NCT02181738|588974539|FG003|Overall Study|Poor/Non-Compliance|1|||
163073013|NCT02181738|588974536|FG000|Overall Study|Disease Progression|28|||
163073014|NCT02181738|588974537|FG001|Overall Study|Disease Progression|35|||
163073015|NCT02181738|588974538|FG002|Overall Study|Disease Progression|40|||
163073016|NCT02181738|588974539|FG003|Overall Study|Disease Progression|0|||
163073017|NCT02181738|588974536|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
163073018|NCT02181738|588974537|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
163073019|NCT02181738|588974538|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
163073020|NCT02181738|588974539|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
163073021|NCT02181738|588974536|FG000|Overall Study|Study Drug Toxicity|6|||
163073022|NCT02181738|588974537|FG001|Overall Study|Study Drug Toxicity|11|||
163073023|NCT02181738|588974538|FG002|Overall Study|Study Drug Toxicity|8|||
163073024|NCT02181738|588974539|FG003|Overall Study|Study Drug Toxicity|1|||
163073025|NCT02181738|588974536|FG000|Overall Study|Other Reasons|14|||
163073026|NCT02181738|588974537|FG001|Overall Study|Other Reasons|16|||
163073027|NCT02181738|588974538|FG002|Overall Study|Other Reasons|28|||
163073028|NCT02181738|588974539|FG003|Overall Study|Other Reasons|0|||
163073029|NCT02181738|588974536|FG000|Overall Study|Maximum Clinical Benefit|3|||
163073030|NCT02181738|588974537|FG001|Overall Study|Maximum Clinical Benefit|0|||
163073031|NCT02181738|588974538|FG002|Overall Study|Maximum Clinical Benefit|1|||
163073032|NCT02181738|588974539|FG003|Overall Study|Maximum Clinical Benefit|0|||
163073033|NCT02181738|588974536|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
163073034|NCT02181738|588974537|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
163073035|NCT02181738|588974538|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
163073036|NCT02181738|588974539|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163073037|NCT00888849|588974542|FG000|Overall Study|Death|4|||
163073038|NCT00888849|588974543|FG001|Overall Study|Death|7|||
163073039|NCT00888849|588974542|FG000|Overall Study|Lost to Follow-up|1|||
163073040|NCT00888849|588974543|FG001|Overall Study|Lost to Follow-up|2|||
163073041|NCT05064800|588974544|FG000|Period 3|Withdrawal by Subject|0|||
163073042|NCT05064800|588974545|FG001|Period 3|Withdrawal by Subject|0|||
163073043|NCT05064800|588974546|FG002|Period 3|Withdrawal by Subject|0|||
163073044|NCT05064800|588974547|FG003|Period 3|Withdrawal by Subject|0|||
163073045|NCT05064800|588974548|FG004|Period 3|Withdrawal by Subject|1|||
163073046|NCT05064800|588974549|FG005|Period 3|Withdrawal by Subject|0|||
163073047|NCT00629239|588974552|FG000|Overall Study|Adverse Event|7|||
163073048|NCT00629239|588974553|FG001|Overall Study|Adverse Event|4|||
163331272|NCT01822756|589922553|FG003|Overall Study|Adverse Event|2|||
163073049|NCT00629239|588974552|FG000|Overall Study|Physician Decision|1|||
163073050|NCT00629239|588974553|FG001|Overall Study|Physician Decision|0|||
163073051|NCT00183391|588974554|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
163073052|NCT00183391|588974555|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
163218151|NCT03616912|589515758|FG001|Overall Study|Lost to Follow-up|2|||
163218152|NCT03616912|589515759|FG002|Overall Study|Lost to Follow-up|3|||
163331273|NCT01822756|589922554|FG004|Overall Study|Adverse Event|0|||
163331274|NCT01822756|589922550|FG000|Overall Study|Disease progression|11|||
163331275|NCT01822756|589922551|FG001|Overall Study|Disease progression|1|||
163331276|NCT01822756|589922552|FG002|Overall Study|Disease progression|7|||
163331277|NCT01822756|589922553|FG003|Overall Study|Disease progression|2|||
163331278|NCT01822756|589922554|FG004|Overall Study|Disease progression|6|||
163218153|NCT03616912|589515760|FG003|Overall Study|Lost to Follow-up|0|||
163218154|NCT03616912|589515761|FG004|Overall Study|Lost to Follow-up|0|||
163218155|NCT03616912|589515762|FG005|Overall Study|Lost to Follow-up|0|||
163218156|NCT03616912|589515757|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
163218157|NCT03616912|589515758|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
163218158|NCT03616912|589515759|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
163218159|NCT03616912|589515760|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
163218160|NCT03616912|589515761|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
163218161|NCT03616912|589515762|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
163218162|NCT03616912|589515757|FG000|Overall Study|Withdrawal by Subject|12|||
163218163|NCT03616912|589515758|FG001|Overall Study|Withdrawal by Subject|12|||
163218164|NCT03616912|589515759|FG002|Overall Study|Withdrawal by Subject|15|||
163218165|NCT03616912|589515760|FG003|Overall Study|Withdrawal by Subject|2|||
163218166|NCT03616912|589515761|FG004|Overall Study|Withdrawal by Subject|0|||
163218167|NCT03616912|589515762|FG005|Overall Study|Withdrawal by Subject|2|||
163218168|NCT03616912|589515757|FG000|Overall Study|Study Terminated by Sponsor|0|||
163218169|NCT03616912|589515758|FG001|Overall Study|Study Terminated by Sponsor|0|||
163218170|NCT03616912|589515759|FG002|Overall Study|Study Terminated by Sponsor|0|||
163218171|NCT03616912|589515760|FG003|Overall Study|Study Terminated by Sponsor|10|||
163218172|NCT03616912|589515761|FG004|Overall Study|Study Terminated by Sponsor|9|||
163218173|NCT03616912|589515762|FG005|Overall Study|Study Terminated by Sponsor|11|||
163218174|NCT03616912|589515757|FG000|Overall Study|Protocol Deviation|1|||
163218175|NCT03616912|589515758|FG001|Overall Study|Protocol Deviation|1|||
163218176|NCT03616912|589515759|FG002|Overall Study|Protocol Deviation|0|||
163218177|NCT03616912|589515760|FG003|Overall Study|Protocol Deviation|0|||
163218178|NCT03616912|589515761|FG004|Overall Study|Protocol Deviation|0|||
163218179|NCT03616912|589515762|FG005|Overall Study|Protocol Deviation|0|||
163218180|NCT03616912|589515757|FG000|Overall Study|Pregnancy|1|||
163218181|NCT03616912|589515758|FG001|Overall Study|Pregnancy|0|||
163218182|NCT03616912|589515759|FG002|Overall Study|Pregnancy|4|||
163218183|NCT03616912|589515760|FG003|Overall Study|Pregnancy|0|||
163218184|NCT03616912|589515761|FG004|Overall Study|Pregnancy|0|||
163331279|NCT01822756|589922550|FG000|Overall Study|Death|2|||
163331280|NCT01822756|589922551|FG001|Overall Study|Death|2|||
163406389|NCT01187953|590196744|FG000|Overall Study|Lost to Follow-up|0|||
163406390|NCT01187953|590196745|FG001|Overall Study|Lost to Follow-up|3|||
163027652|NCT04017832|588804133|FG003|Overall Study|Lost to Follow-up|1|||
163027653|NCT04017832|588804130|FG000|Overall Study|Physician Decision|1|||
163027654|NCT04017832|588804131|FG001|Overall Study|Physician Decision|1|||
163027655|NCT04017832|588804132|FG002|Overall Study|Physician Decision|1|||
163027656|NCT04017832|588804133|FG003|Overall Study|Physician Decision|1|||
163027657|NCT04017832|588804130|FG000|Overall Study|Death|2|||
163027658|NCT04017832|588804131|FG001|Overall Study|Death|2|||
163027659|NCT04017832|588804132|FG002|Overall Study|Death|1|||
163027660|NCT04017832|588804133|FG003|Overall Study|Death|0|||
163027661|NCT01744184|588804137|FG000|Overall Study|Adverse Event|1|||
163027662|NCT01744184|588804138|FG001|Overall Study|Adverse Event|0|||
163027663|NCT01744184|588804137|FG000|Overall Study|Withdrawal by Subject|0|||
163027664|NCT01744184|588804138|FG001|Overall Study|Withdrawal by Subject|1|||
163027665|NCT00072280|588804139|FG000|Treatment|Found ineligible|1|||
163027666|NCT00072280|588804140|FG001|Treatment|Found ineligible|2|||
163027667|NCT00072280|588804139|FG000|Follow-up|Early termination of study|2|||
163027668|NCT00072280|588804140|FG001|Follow-up|Early termination of study|2|||
163027669|NCT02841280|588804141|FG000|Overall Study|Adverse Event|2|||
163027670|NCT02841280|588804142|FG001|Overall Study|Adverse Event|1|||
163027671|NCT02841280|588804141|FG000|Overall Study|Death|1|||
163027672|NCT02841280|588804142|FG001|Overall Study|Death|0|||
163027673|NCT02841280|588804141|FG000|Overall Study|Lost to Follow-up|2|||
163027674|NCT02841280|588804142|FG001|Overall Study|Lost to Follow-up|2|||
163027675|NCT02841280|588804141|FG000|Overall Study|Withdrawal by Subject|7|||
163027676|NCT02841280|588804142|FG001|Overall Study|Withdrawal by Subject|3|||
163027677|NCT02841280|588804141|FG000|Overall Study|Stop Point: BP above threshold|2|||
163027678|NCT02841280|588804142|FG001|Overall Study|Stop Point: BP above threshold|0|||
163027679|NCT00125242|588804143|FG000|Overall Study|did not qualify|7|||
163027680|NCT00125242|588804144|FG001|Overall Study|did not qualify|2|||
163027681|NCT01664949|588804145|FG000|Overall Study|Adverse Event|11|||
163027682|NCT01664949|588804146|FG001|Overall Study|Adverse Event|12|||
163027683|NCT01664949|588804145|FG000|Overall Study|Lack of Efficacy|1|||
163027684|NCT01664949|588804146|FG001|Overall Study|Lack of Efficacy|1|||
163027685|NCT01664949|588804145|FG000|Overall Study|Lost to Follow-up|1|||
163027686|NCT01664949|588804146|FG001|Overall Study|Lost to Follow-up|2|||
163073053|NCT00183391|588974554|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
163073054|NCT00183391|588974555|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
163073055|NCT00395512|588974556|FG000|Overall Study|Adverse Event|3|||
163073056|NCT00395512|588974557|FG001|Overall Study|Adverse Event|8|||
163073057|NCT00395512|588974558|FG002|Overall Study|Adverse Event|6|||
163073058|NCT00395512|588974559|FG003|Overall Study|Adverse Event|6|||
163073059|NCT00395512|588974556|FG000|Overall Study|Protocol Violation|2|||
163073060|NCT00395512|588974557|FG001|Overall Study|Protocol Violation|3|||
163073061|NCT00395512|588974558|FG002|Overall Study|Protocol Violation|6|||
163073062|NCT00395512|588974559|FG003|Overall Study|Protocol Violation|7|||
163073063|NCT00395512|588974556|FG000|Overall Study|Lost to Follow-up|2|||
163073064|NCT00395512|588974557|FG001|Overall Study|Lost to Follow-up|6|||
163073065|NCT00395512|588974558|FG002|Overall Study|Lost to Follow-up|5|||
163073066|NCT00395512|588974559|FG003|Overall Study|Lost to Follow-up|5|||
163073067|NCT00395512|588974556|FG000|Overall Study|Withdrawal by Subject|6|||
163073068|NCT00395512|588974557|FG001|Overall Study|Withdrawal by Subject|5|||
163073069|NCT00395512|588974558|FG002|Overall Study|Withdrawal by Subject|5|||
163073070|NCT00395512|588974559|FG003|Overall Study|Withdrawal by Subject|12|||
163073071|NCT00395512|588974556|FG000|Overall Study|Physician Decision|6|||
163073072|NCT00395512|588974557|FG001|Overall Study|Physician Decision|4|||
163073073|NCT00395512|588974558|FG002|Overall Study|Physician Decision|2|||
163073074|NCT00395512|588974559|FG003|Overall Study|Physician Decision|2|||
163073075|NCT00395512|588974556|FG000|Overall Study|Other|1|||
163073076|NCT00395512|588974557|FG001|Overall Study|Other|1|||
163073077|NCT00395512|588974558|FG002|Overall Study|Other|0|||
163073078|NCT00395512|588974559|FG003|Overall Study|Other|0|||
163073079|NCT00395512|588974556|FG000|Overall Study|Hyperglycemic Rescue|18|||
163073080|NCT00395512|588974557|FG001|Overall Study|Hyperglycemic Rescue|10|||
163073081|NCT00395512|588974558|FG002|Overall Study|Hyperglycemic Rescue|4|||
163073082|NCT00395512|588974559|FG003|Overall Study|Hyperglycemic Rescue|6|||
163073083|NCT04584554|588974560|FG000|Overall Study|Withdrawal by Subject|2|||
163073084|NCT04584554|588974561|FG001|Overall Study|Withdrawal by Subject|2|||
163073085|NCT03983109|588974564|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
163073086|NCT03983109|588974565|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
163073087|NCT02021318|588974566|FG000|Overall Study|Adverse Event|2|||
163073088|NCT02021318|588974567|FG001|Overall Study|Adverse Event|1|||
163073089|NCT02021318|588974566|FG000|Overall Study|Death|33|||
163073090|NCT02021318|588974567|FG001|Overall Study|Death|34|||
163073091|NCT02021318|588974566|FG000|Overall Study|Lost to Follow-up|3|||
163073092|NCT02021318|588974567|FG001|Overall Study|Lost to Follow-up|3|||
163073093|NCT02021318|588974566|FG000|Overall Study|Progressive Disease|0|||
163073094|NCT02021318|588974567|FG001|Overall Study|Progressive Disease|1|||
163073095|NCT02021318|588974566|FG000|Overall Study|Withdrawal by Subject|30|||
163073096|NCT02021318|588974567|FG001|Overall Study|Withdrawal by Subject|18|||
163073097|NCT02021318|588974566|FG000|Overall Study|Physician Decision|3|||
163073098|NCT02021318|588974567|FG001|Overall Study|Physician Decision|3|||
163073099|NCT02021318|588974566|FG000|Overall Study|Miscellaneous|2|||
163073100|NCT02021318|588974567|FG001|Overall Study|Miscellaneous|3|||
163073101|NCT01068249|588974568|FG000|Overall Study|Death|1|||
163073102|NCT01068249|588974568|FG000|Overall Study|Withdrawal by Subject|3|||
163073103|NCT01740427|588974569|FG000|Overall Study|Objective Progression or Relapse|286|||
163073104|NCT01740427|588974570|FG001|Overall Study|Objective Progression or Relapse|172|||
163073105|NCT01740427|588974569|FG000|Overall Study|Adverse Event|32|||
163073106|NCT01740427|588974570|FG001|Overall Study|Adverse Event|9|||
163073107|NCT01740427|588974569|FG000|Overall Study|Global Deterioration of Health Status|28|||
163073108|NCT01740427|588974570|FG001|Overall Study|Global Deterioration of Health Status|12|||
163073109|NCT01740427|588974569|FG000|Overall Study|Participant Refused Continued Treatment|27|||
163073110|NCT01740427|588974570|FG001|Overall Study|Participant Refused Continued Treatment|15|||
163073111|NCT01740427|588974569|FG000|Overall Study|Unspecified reasons|52|||
163073112|NCT01740427|588974570|FG001|Overall Study|Unspecified reasons|8|||
163073113|NCT01740427|588974569|FG000|Overall Study|Death|10|||
163073114|NCT01740427|588974570|FG001|Overall Study|Death|3|||
163073115|NCT01740427|588974569|FG000|Overall Study|Protocol Violation|5|||
163073116|NCT01740427|588974570|FG001|Overall Study|Protocol Violation|3|||
163073117|NCT01740427|588974569|FG000|Overall Study|Lost to Follow-up|3|||
163073118|NCT01740427|588974570|FG001|Overall Study|Lost to Follow-up|0|||
163073119|NCT01740427|588974569|FG000|Overall Study|Site Terminated by Sponsor|1|||
163073120|NCT01740427|588974570|FG001|Overall Study|Site Terminated by Sponsor|0|||
163073121|NCT00165698|588974573|FG000|Overall Study|Adverse Event|2|||
163073122|NCT00165698|588974574|FG001|Overall Study|Adverse Event|10|||
163073123|NCT00165698|588974573|FG000|Overall Study|Lost to Follow-up|2|||
163073124|NCT00165698|588974574|FG001|Overall Study|Lost to Follow-up|2|||
163073125|NCT00165698|588974573|FG000|Overall Study|Withdrawal by Subject|2|||
163073126|NCT00165698|588974574|FG001|Overall Study|Withdrawal by Subject|1|||
163073127|NCT00165698|588974573|FG000|Overall Study|Protocol Violation|1|||
163073128|NCT00165698|588974574|FG001|Overall Study|Protocol Violation|0|||
163073129|NCT00165698|588974573|FG000|Overall Study|Not Taken/Lost the medicine|1|||
163073130|NCT00165698|588974574|FG001|Overall Study|Not Taken/Lost the medicine|2|||
163073131|NCT01483651|588974575|FG000|Overall Study|Withdrawal by Subject|0|||
163073132|NCT01483651|588974576|FG001|Overall Study|Withdrawal by Subject|1|||
163073133|NCT01483651|588974577|FG002|Overall Study|Withdrawal by Subject|1|||
163073134|NCT01483651|588974578|FG003|Overall Study|Withdrawal by Subject|0|||
163073135|NCT01483651|588974579|FG004|Overall Study|Withdrawal by Subject|0|||
163073136|NCT01483651|588974580|FG005|Overall Study|Withdrawal by Subject|1|||
163073137|NCT02547935|588974587|FG000|Overall Study|Other|0|||
163073138|NCT02547935|588974588|FG001|Overall Study|Other|1|||
163073139|NCT02547935|588974589|FG002|Overall Study|Other|0|||
163073140|NCT02547935|588974587|FG000|Overall Study|Withdrawal by Subject|2|||
163073141|NCT02547935|588974588|FG001|Overall Study|Withdrawal by Subject|3|||
163073142|NCT02547935|588974589|FG002|Overall Study|Withdrawal by Subject|4|||
163073143|NCT02547935|588974587|FG000|Overall Study|Screen Failure|2|||
163073144|NCT02547935|588974588|FG001|Overall Study|Screen Failure|0|||
163073145|NCT02547935|588974589|FG002|Overall Study|Screen Failure|0|||
163073146|NCT02547935|588974587|FG000|Overall Study|Physician Decision|0|||
163073147|NCT02547935|588974588|FG001|Overall Study|Physician Decision|1|||
163073148|NCT02547935|588974589|FG002|Overall Study|Physician Decision|0|||
163073149|NCT02547935|588974587|FG000|Overall Study|Lost to Follow-up|0|||
163073150|NCT02547935|588974588|FG001|Overall Study|Lost to Follow-up|2|||
163073151|NCT02547935|588974589|FG002|Overall Study|Lost to Follow-up|1|||
163073152|NCT02547935|588974587|FG000|Overall Study|Death|1|||
163073153|NCT02547935|588974588|FG001|Overall Study|Death|1|||
163073154|NCT02547935|588974589|FG002|Overall Study|Death|0|||
163073155|NCT03020888|588974594|FG000|Overall Study|Physician Decision|4|||
163073156|NCT03020888|588974594|FG000|Overall Study|Withdrawal by Subject|6|||
163073157|NCT03020888|588974594|FG000|Overall Study|Insurance coverage|2|||
163073158|NCT03020888|588974594|FG000|Overall Study|Lost to Follow-up|1|||
163073159|NCT01928771|588974598|FG000|Overall Study|Adverse Event|6|||
163073160|NCT01928771|588974599|FG001|Overall Study|Adverse Event|5|||
163073161|NCT01928771|588974600|FG002|Overall Study|Adverse Event|1|||
163073162|NCT01928771|588974598|FG000|Overall Study|Death|2|||
163073163|NCT01928771|588974599|FG001|Overall Study|Death|2|||
163073164|NCT01928771|588974600|FG002|Overall Study|Death|2|||
163331281|NCT01822756|589922552|FG002|Overall Study|Death|1|||
163073165|NCT01928771|588974598|FG000|Overall Study|Lost to Follow-up|5|||
163073166|NCT01928771|588974599|FG001|Overall Study|Lost to Follow-up|6|||
163073167|NCT01928771|588974600|FG002|Overall Study|Lost to Follow-up|3|||
163073168|NCT01928771|588974598|FG000|Overall Study|Withdrawal by Subject|20|||
163073169|NCT01928771|588974599|FG001|Overall Study|Withdrawal by Subject|15|||
163073170|NCT01928771|588974600|FG002|Overall Study|Withdrawal by Subject|17|||
163073171|NCT01928771|588974598|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
163073172|NCT01928771|588974599|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
163073173|NCT01928771|588974600|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
163073174|NCT01928771|588974598|FG000|Overall Study|Other Reasons|9|||
163073175|NCT01928771|588974599|FG001|Overall Study|Other Reasons|9|||
163073176|NCT01928771|588974600|FG002|Overall Study|Other Reasons|14|||
163073177|NCT01928771|588974598|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
163073178|NCT01928771|588974599|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
163073179|NCT01928771|588974600|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
163073180|NCT01937117|588974601|FG000|Overall Study|Disease Progression|7|||
163073181|NCT01937117|588974601|FG000|Overall Study|Physician Decision|4|||
163073182|NCT01937117|588974601|FG000|Overall Study|Adverse Event|2|||
163073183|NCT01407367|588974604|FG000|Overall Study|Death|24|||
163073184|NCT01407367|588974605|FG001|Overall Study|Death|32|||
163073185|NCT01407367|588974604|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
163073186|NCT01407367|588974605|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
163073187|NCT01407367|588974604|FG000|Overall Study|Withdrawal by Subject|4|||
163073188|NCT01407367|588974605|FG001|Overall Study|Withdrawal by Subject|15|||
163073189|NCT01407367|588974604|FG000|Overall Study|Lost to Follow-up|0|||
163331282|NCT01822756|589922553|FG003|Overall Study|Death|0|||
163073190|NCT01407367|588974605|FG001|Overall Study|Lost to Follow-up|2|||
163073191|NCT01695772|588974611|FG000|Overall Study|Withdrawal by Subject|18|||
163073192|NCT01695772|588974611|FG000|Overall Study|Progressive Disease|8|||
163073193|NCT01695772|588974611|FG000|Overall Study|Investigator Decision|5|||
163073194|NCT01695772|588974611|FG000|Overall Study|Lost to Follow-up|4|||
163073195|NCT01695772|588974611|FG000|Overall Study|Protocol Violation|2|||
163073196|NCT01695772|588974611|FG000|Overall Study|Unspecified Reason|1|||
163073197|NCT00004859|588974612|FG000|Overall Study|Lack of Efficacy|43|||
163073198|NCT00004859|588974613|FG001|Overall Study|Lack of Efficacy|113|||
163073199|NCT00004859|588974612|FG000|Overall Study|Adverse Event|31|||
163073200|NCT00004859|588974613|FG001|Overall Study|Adverse Event|93|||
163073201|NCT00004859|588974612|FG000|Overall Study|Death|5|||
163073202|NCT00004859|588974613|FG001|Overall Study|Death|5|||
163073203|NCT00004859|588974612|FG000|Overall Study|Withdrawal by Subject|7|||
163073204|NCT00004859|588974613|FG001|Overall Study|Withdrawal by Subject|33|||
163073205|NCT00004859|588974612|FG000|Overall Study|Protocol Violation|2|||
163073206|NCT00004859|588974613|FG001|Overall Study|Protocol Violation|2|||
163073207|NCT00004859|588974612|FG000|Overall Study|other disease|0|||
163331283|NCT01822756|589922554|FG004|Overall Study|Death|0|||
163073208|NCT00004859|588974613|FG001|Overall Study|other disease|3|||
163073209|NCT00004859|588974612|FG000|Overall Study|error|3|||
163073210|NCT00004859|588974613|FG001|Overall Study|error|1|||
163073211|NCT00004859|588974612|FG000|Overall Study|missing data|14|||
163073212|NCT00004859|588974613|FG001|Overall Study|missing data|11|||
163073213|NCT00004859|588974612|FG000|Overall Study|Other|13|||
163331284|NCT01822756|589922550|FG000|Overall Study|Lost to Follow-up|1|||
163331285|NCT01822756|589922551|FG001|Overall Study|Lost to Follow-up|0|||
163331286|NCT01822756|589922552|FG002|Overall Study|Lost to Follow-up|1|||
163331287|NCT01822756|589922553|FG003|Overall Study|Lost to Follow-up|0|||
163331288|NCT01822756|589922554|FG004|Overall Study|Lost to Follow-up|1|||
163331289|NCT01822756|589922550|FG000|Overall Study|Physician Decision|0|||
163073214|NCT00004859|588974613|FG001|Overall Study|Other|21|||
163073215|NCT03882801|588976373|FG000|Period 1|Adverse Event|0|||
163073216|NCT03882801|588976374|FG001|Period 1|Adverse Event|1|||
163073217|NCT03882801|588976373|FG000|Period 1|Non-compliance with study drug|1|||
163073218|NCT03882801|588976374|FG001|Period 1|Non-compliance with study drug|1|||
163073219|NCT03882801|588976373|FG000|Period 1|Never treated with study drug|1|||
163073220|NCT03882801|588976374|FG001|Period 1|Never treated with study drug|0|||
163073221|NCT03882801|588976373|FG000|Washout Period|Physician Decision|0|||
163073222|NCT03882801|588976374|FG001|Washout Period|Physician Decision|1|||
163073223|NCT03882801|588976373|FG000|Period 2|Non-compliance with study drug|0|||
163073224|NCT03882801|588976374|FG001|Period 2|Non-compliance with study drug|1|||
163073225|NCT01567085|588976375|FG000|Overall Study|Death|6|||
163073226|NCT01567085|588976375|FG000|Overall Study|Adverse Event|6|||
163073227|NCT01567085|588976375|FG000|Overall Study|Lost to Follow-up|3|||
163073228|NCT01567085|588976375|FG000|Overall Study|Graft loss|2|||
163073229|NCT01567085|588976375|FG000|Overall Study|Renal transplantectomy|1|||
163073230|NCT01567085|588976375|FG000|Overall Study|Returned to chronic dialysis|1|||
163073231|NCT01567085|588976375|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
163073232|NCT04193176|588976376|FG000|Overall Study|Withdrawal by Subject|6|||
163218185|NCT03616912|589515762|FG005|Overall Study|Pregnancy|0|||
163218186|NCT03616912|589515757|FG000|Overall Study|Protocol Violation|1|||
163218187|NCT03616912|589515758|FG001|Overall Study|Protocol Violation|0|||
163218188|NCT03616912|589515759|FG002|Overall Study|Protocol Violation|2|||
163218189|NCT03616912|589515760|FG003|Overall Study|Protocol Violation|0|||
163218190|NCT03616912|589515761|FG004|Overall Study|Protocol Violation|0|||
163218191|NCT03616912|589515762|FG005|Overall Study|Protocol Violation|0|||
163218192|NCT03616912|589515757|FG000|Overall Study|Physician Decision|2|||
163218193|NCT03616912|589515758|FG001|Overall Study|Physician Decision|0|||
163218194|NCT03616912|589515759|FG002|Overall Study|Physician Decision|0|||
163218195|NCT03616912|589515760|FG003|Overall Study|Physician Decision|0|||
163218196|NCT03616912|589515761|FG004|Overall Study|Physician Decision|1|||
163218197|NCT03616912|589515762|FG005|Overall Study|Physician Decision|0|||
163218198|NCT03616912|589515757|FG000|Overall Study|Randomized But Never Treated|0|||
163218199|NCT03616912|589515758|FG001|Overall Study|Randomized But Never Treated|2|||
163218200|NCT03616912|589515759|FG002|Overall Study|Randomized But Never Treated|0|||
163218201|NCT03616912|589515760|FG003|Overall Study|Randomized But Never Treated|0|||
163218202|NCT03616912|589515761|FG004|Overall Study|Randomized But Never Treated|0|||
163218203|NCT03616912|589515762|FG005|Overall Study|Randomized But Never Treated|0|||
163331290|NCT01822756|589922551|FG001|Overall Study|Physician Decision|1|||
163331291|NCT01822756|589922552|FG002|Overall Study|Physician Decision|0|||
163331292|NCT01822756|589922553|FG003|Overall Study|Physician Decision|0|||
163027687|NCT01664949|588804145|FG000|Overall Study|Personal Reasons|3|||
163027688|NCT01664949|588804146|FG001|Overall Study|Personal Reasons|4|||
163027689|NCT01664949|588804145|FG000|Overall Study|Protocol Violation|5|||
163027690|NCT01664949|588804146|FG001|Overall Study|Protocol Violation|5|||
163027691|NCT01664949|588804145|FG000|Overall Study|Other Miscellaneous Reasons|3|||
163027692|NCT01664949|588804146|FG001|Overall Study|Other Miscellaneous Reasons|1|||
163027693|NCT02727777|588804153|FG000|Overall Study|Screen Failure|2|||
163027694|NCT02727777|588804154|FG001|Overall Study|Screen Failure|0|||
163027695|NCT02727777|588804155|FG002|Overall Study|Screen Failure|0|||
163027696|NCT02727777|588804153|FG000|Overall Study|Progressive disease|2|||
163027697|NCT02727777|588804154|FG001|Overall Study|Progressive disease|0|||
163027698|NCT02727777|588804155|FG002|Overall Study|Progressive disease|0|||
163027699|NCT03003494|588804156|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
163027700|NCT00957268|588804157|FG000|Overall Study|Voluntary Withdrawal|0|||
163027701|NCT00957268|588804158|FG001|Overall Study|Voluntary Withdrawal|0|||
163073233|NCT04193176|588976377|FG001|Overall Study|Withdrawal by Subject|10|||
163027702|NCT00957268|588804159|FG002|Overall Study|Voluntary Withdrawal|1|||
163073234|NCT00944645|588976382|FG000|Period 2|Adverse Event|1|||
163073235|NCT00944645|588976383|FG001|Period 2|Adverse Event|0|||
163073236|NCT00944645|588976382|FG000|Period 2|Lost to Follow-up|0|||
163073237|NCT00944645|588976383|FG001|Period 2|Lost to Follow-up|3|||
163073238|NCT00944645|588976382|FG000|Period 2|Withdrawal by Subject|7|||
163073239|NCT00944645|588976383|FG001|Period 2|Withdrawal by Subject|6|||
163218204|NCT01723163|589515763|FG000|Treatment Phase|Withdrawal by Subject|14|||
163218205|NCT01723163|589515764|FG001|Treatment Phase|Withdrawal by Subject|6|||
163218206|NCT01723163|589515763|FG000|Treatment Phase|Withdrawal by PI|5|||
163073240|NCT03537729|588976387|FG000|Overall Study|Death|2|||
163073241|NCT03537729|588976388|FG001|Overall Study|Death|2|||
163073242|NCT03537729|588976389|FG002|Overall Study|Death|7|||
163073243|NCT03537729|588976387|FG000|Overall Study|Withdrawal by Subject|3|||
163073244|NCT03537729|588976388|FG001|Overall Study|Withdrawal by Subject|3|||
163073245|NCT03537729|588976389|FG002|Overall Study|Withdrawal by Subject|0|||
163073246|NCT03537729|588976387|FG000|Overall Study|Subject Moved|8|||
163073247|NCT03537729|588976388|FG001|Overall Study|Subject Moved|5|||
163073248|NCT03537729|588976389|FG002|Overall Study|Subject Moved|4|||
163073249|NCT03537729|588976387|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
163073250|NCT03537729|588976388|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
163073251|NCT03537729|588976389|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
163073252|NCT03537729|588976387|FG000|Overall Study|COVID-19 Site Restrictions|11|||
163073253|NCT03537729|588976388|FG001|Overall Study|COVID-19 Site Restrictions|15|||
163073254|NCT03537729|588976389|FG002|Overall Study|COVID-19 Site Restrictions|18|||
163073255|NCT03537729|588976387|FG000|Overall Study|Decline in Health|5|||
163073256|NCT03537729|588976388|FG001|Overall Study|Decline in Health|9|||
163073257|NCT03537729|588976389|FG002|Overall Study|Decline in Health|4|||
163073258|NCT03537729|588976387|FG000|Overall Study|Determined Ineligible|0|||
163073259|NCT03537729|588976388|FG001|Overall Study|Determined Ineligible|0|||
163073260|NCT03537729|588976389|FG002|Overall Study|Determined Ineligible|1|||
163073261|NCT00284934|588976392|FG000|Overall Study|Adverse Event|1|||
163073262|NCT00284934|588976393|FG001|Overall Study|Adverse Event|2|||
163073263|NCT00284934|588976392|FG000|Overall Study|Other reasons|3|||
163073264|NCT00284934|588976393|FG001|Overall Study|Other reasons|1|||
163073265|NCT01783015|588976399|FG000|Blinded Treatment|Adverse Event|0|||
163073266|NCT01783015|588976400|FG001|Blinded Treatment|Adverse Event|1|||
163073267|NCT01783015|588976401|FG002|Blinded Treatment|Adverse Event|0|||
163073268|NCT01783015|588976399|FG000|Blinded Treatment|Protocol Violation|0|||
163073269|NCT01783015|588976400|FG001|Blinded Treatment|Protocol Violation|1|||
163073270|NCT01783015|588976401|FG002|Blinded Treatment|Protocol Violation|0|||
163073271|NCT01783015|588976399|FG000|Blinded Treatment|Withdrawal by Subject|0|||
163073272|NCT01783015|588976400|FG001|Blinded Treatment|Withdrawal by Subject|1|||
163073273|NCT01783015|588976401|FG002|Blinded Treatment|Withdrawal by Subject|0|||
163073274|NCT01783015|588976399|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
163073275|NCT01783015|588976400|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
163073276|NCT01783015|588976401|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
163073277|NCT01783015|588976399|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
163073278|NCT01783015|588976400|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
163073279|NCT01783015|588976401|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
163073280|NCT01297244|588976402|FG000|Overall Study|Progressive disease|22|||
163073281|NCT01297244|588976403|FG001|Overall Study|Progressive disease|3|||
163073282|NCT01297244|588976402|FG000|Overall Study|Adverse Event|9|||
163073283|NCT01297244|588976403|FG001|Overall Study|Adverse Event|1|||
163073284|NCT01297244|588976402|FG000|Overall Study|Death|1|||
163073285|NCT01297244|588976403|FG001|Overall Study|Death|1|||
163073286|NCT01297244|588976402|FG000|Overall Study|Clinical progression|1|||
163073287|NCT01297244|588976403|FG001|Overall Study|Clinical progression|1|||
163073288|NCT01297244|588976402|FG000|Overall Study|Withdrawal by Subject|2|||
163073289|NCT01297244|588976403|FG001|Overall Study|Withdrawal by Subject|0|||
163073290|NCT01348698|588976404|FG000|Overall Study|Does not meet lesion size criteria|1|||
163073291|NCT01348698|588976404|FG000|Overall Study|Death|3|||
163073292|NCT01348698|588976404|FG000|Overall Study|PI decision to close study|68|||
163073293|NCT02595749|588976405|FG000|Overall Study|Withdrawal by Subject|12|||
163073294|NCT02595749|588976406|FG001|Overall Study|Withdrawal by Subject|7|||
163073295|NCT00504556|588976412|FG000|Overall Study|Adverse Event|11|||
163073296|NCT00504556|588976413|FG001|Overall Study|Adverse Event|11|||
163073297|NCT00504556|588976414|FG002|Overall Study|Adverse Event|14|||
163073298|NCT00504556|588976415|FG003|Overall Study|Adverse Event|13|||
163073299|NCT00504556|588976416|FG004|Overall Study|Adverse Event|5|||
163073300|NCT00504556|588976412|FG000|Overall Study|Death|3|||
163073301|NCT00504556|588976413|FG001|Overall Study|Death|3|||
163073302|NCT00504556|588976414|FG002|Overall Study|Death|1|||
163073303|NCT00504556|588976415|FG003|Overall Study|Death|0|||
163073304|NCT00504556|588976416|FG004|Overall Study|Death|2|||
163073305|NCT00504556|588976412|FG000|Overall Study|Protocol Violation|1|||
163073306|NCT00504556|588976413|FG001|Overall Study|Protocol Violation|3|||
163073307|NCT00504556|588976414|FG002|Overall Study|Protocol Violation|2|||
163073308|NCT00504556|588976415|FG003|Overall Study|Protocol Violation|1|||
163073309|NCT00504556|588976416|FG004|Overall Study|Protocol Violation|2|||
163073310|NCT00504556|588976412|FG000|Overall Study|Lost to Follow-up|0|||
163073311|NCT00504556|588976413|FG001|Overall Study|Lost to Follow-up|0|||
163073312|NCT00504556|588976414|FG002|Overall Study|Lost to Follow-up|1|||
163073313|NCT00504556|588976415|FG003|Overall Study|Lost to Follow-up|1|||
163073314|NCT00504556|588976416|FG004|Overall Study|Lost to Follow-up|1|||
163073315|NCT00504556|588976412|FG000|Overall Study|Withdrawal by Subject|16|||
163073316|NCT00504556|588976413|FG001|Overall Study|Withdrawal by Subject|16|||
163073317|NCT00504556|588976414|FG002|Overall Study|Withdrawal by Subject|7|||
163073318|NCT00504556|588976415|FG003|Overall Study|Withdrawal by Subject|8|||
163073319|NCT00504556|588976416|FG004|Overall Study|Withdrawal by Subject|12|||
163218207|NCT01723163|589515764|FG001|Treatment Phase|Withdrawal by PI|1|||
163218208|NCT01723163|589515763|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
163218209|NCT01723163|589515764|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
163218210|NCT01723163|589515763|FG000|3-Month Follow-up|Unable to Contact|12|||
163218211|NCT01723163|589515764|FG001|3-Month Follow-up|Unable to Contact|19|||
163218212|NCT01723163|589515763|FG000|6-Month Follow-up|Death|1|||
163218213|NCT01723163|589515764|FG001|6-Month Follow-up|Death|0|||
163218214|NCT01723163|589515763|FG000|6-Month Follow-up|Unable to Contact|17|||
163218215|NCT01723163|589515764|FG001|6-Month Follow-up|Unable to Contact|15|||
163218216|NCT01723163|589515763|FG000|12-Month Follow-up|Death|1|||
163218217|NCT01723163|589515764|FG001|12-Month Follow-up|Death|0|||
163218218|NCT01723163|589515763|FG000|12-Month Follow-up|Unable to Contact|23|||
163218219|NCT01723163|589515764|FG001|12-Month Follow-up|Unable to Contact|28|||
163218220|NCT02510794|589515765|FG000|Overall Study|Adverse Event|0|||
163218221|NCT02510794|589515766|FG001|Overall Study|Adverse Event|1|||
163218222|NCT02510794|589515767|FG002|Overall Study|Adverse Event|0|||
163218223|NCT02510794|589515768|FG003|Overall Study|Adverse Event|0|||
163218224|NCT02510794|589515765|FG000|Overall Study|Death|1|||
163218225|NCT02510794|589515766|FG001|Overall Study|Death|2|||
163218226|NCT02510794|589515767|FG002|Overall Study|Death|1|||
163218227|NCT02510794|589515768|FG003|Overall Study|Death|1|||
163218228|NCT02510794|589515765|FG000|Overall Study|Lack of Efficacy|3|||
163218229|NCT02510794|589515766|FG001|Overall Study|Lack of Efficacy|1|||
163218230|NCT02510794|589515767|FG002|Overall Study|Lack of Efficacy|1|||
163218231|NCT02510794|589515768|FG003|Overall Study|Lack of Efficacy|0|||
163218232|NCT02510794|589515765|FG000|Overall Study|Participant moved out of the area|0|||
163218233|NCT02510794|589515766|FG001|Overall Study|Participant moved out of the area|0|||
163218234|NCT02510794|589515767|FG002|Overall Study|Participant moved out of the area|0|||
163218235|NCT02510794|589515768|FG003|Overall Study|Participant moved out of the area|1|||
163218236|NCT02510794|589515765|FG000|Overall Study|Physician Decision|3|||
163218237|NCT02510794|589515766|FG001|Overall Study|Physician Decision|0|||
163027703|NCT00957268|588804160|FG003|Overall Study|Voluntary Withdrawal|0|||
163027704|NCT00957268|588804161|FG004|Overall Study|Voluntary Withdrawal|0|||
163027705|NCT01738503|588804162|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
163027706|NCT01738503|588804163|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
163027707|NCT01738503|588804164|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
163027708|NCT01738503|588804165|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
163027709|NCT01738503|588804166|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
163027710|NCT01738503|588804167|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
163027711|NCT01738503|588804168|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
163027712|NCT01738503|588804162|FG000|Treatment Period|Adverse Event|0|||
163027713|NCT01738503|588804163|FG001|Treatment Period|Adverse Event|1|||
163027714|NCT01738503|588804164|FG002|Treatment Period|Adverse Event|0|||
163027715|NCT01738503|588804165|FG003|Treatment Period|Adverse Event|1|||
163027716|NCT01738503|588804166|FG004|Treatment Period|Adverse Event|2|||
163027717|NCT01738503|588804167|FG005|Treatment Period|Adverse Event|2|||
163027718|NCT01738503|588804168|FG006|Treatment Period|Adverse Event|2|||
163027719|NCT01738503|588804162|FG000|Treatment Period|Lost to Follow-up|0|||
163027720|NCT01738503|588804163|FG001|Treatment Period|Lost to Follow-up|0|||
163027721|NCT01738503|588804164|FG002|Treatment Period|Lost to Follow-up|3|||
163027722|NCT01738503|588804165|FG003|Treatment Period|Lost to Follow-up|4|||
163027723|NCT01738503|588804166|FG004|Treatment Period|Lost to Follow-up|1|||
163027724|NCT01738503|588804167|FG005|Treatment Period|Lost to Follow-up|1|||
163027725|NCT01738503|588804168|FG006|Treatment Period|Lost to Follow-up|5|||
163027726|NCT01738503|588804162|FG000|Treatment Period|Withdrawal by Subject|0|||
163027727|NCT01738503|588804163|FG001|Treatment Period|Withdrawal by Subject|1|||
163027728|NCT01738503|588804164|FG002|Treatment Period|Withdrawal by Subject|0|||
163027729|NCT01738503|588804165|FG003|Treatment Period|Withdrawal by Subject|1|||
163027730|NCT01738503|588804166|FG004|Treatment Period|Withdrawal by Subject|1|||
163027731|NCT01738503|588804167|FG005|Treatment Period|Withdrawal by Subject|1|||
163027732|NCT01738503|588804168|FG006|Treatment Period|Withdrawal by Subject|1|||
163027733|NCT01738503|588804162|FG000|Treatment Period|Protocol Violation|0|||
163218238|NCT02510794|589515767|FG002|Overall Study|Physician Decision|0|||
163027734|NCT01738503|588804163|FG001|Treatment Period|Protocol Violation|3|||
163027735|NCT01738503|588804164|FG002|Treatment Period|Protocol Violation|1|||
163027736|NCT01738503|588804165|FG003|Treatment Period|Protocol Violation|0|||
163027737|NCT01738503|588804166|FG004|Treatment Period|Protocol Violation|4|||
163027738|NCT01738503|588804167|FG005|Treatment Period|Protocol Violation|2|||
163073320|NCT00504556|588976412|FG000|Overall Study|administrative reasons|0|||
163218239|NCT02510794|589515768|FG003|Overall Study|Physician Decision|0|||
163218240|NCT02510794|589515765|FG000|Overall Study|Protocol Violation|0|||
163218241|NCT02510794|589515766|FG001|Overall Study|Protocol Violation|0|||
163218242|NCT02510794|589515767|FG002|Overall Study|Protocol Violation|1|||
163218243|NCT02510794|589515768|FG003|Overall Study|Protocol Violation|0|||
163073321|NCT00504556|588976413|FG001|Overall Study|administrative reasons|2|||
163073322|NCT00504556|588976414|FG002|Overall Study|administrative reasons|2|||
163073323|NCT00504556|588976415|FG003|Overall Study|administrative reasons|1|||
163073324|NCT00504556|588976416|FG004|Overall Study|administrative reasons|2|||
163073325|NCT00504556|588976412|FG000|Overall Study|did not meet entry criteria|2|||
163073326|NCT00504556|588976413|FG001|Overall Study|did not meet entry criteria|0|||
163073327|NCT00504556|588976414|FG002|Overall Study|did not meet entry criteria|1|||
163073328|NCT00504556|588976415|FG003|Overall Study|did not meet entry criteria|1|||
163073329|NCT00504556|588976416|FG004|Overall Study|did not meet entry criteria|0|||
163073330|NCT00504556|588976412|FG000|Overall Study|data monitor committee decision|0|||
163073331|NCT00504556|588976413|FG001|Overall Study|data monitor committee decision|0|||
163073332|NCT00504556|588976414|FG002|Overall Study|data monitor committee decision|0|||
163073333|NCT00504556|588976415|FG003|Overall Study|data monitor committee decision|100|||
163073334|NCT00504556|588976416|FG004|Overall Study|data monitor committee decision|0|||
163073335|NCT00504556|588976412|FG000|Overall Study|Other|2|||
163073336|NCT00504556|588976413|FG001|Overall Study|Other|2|||
163073337|NCT00504556|588976414|FG002|Overall Study|Other|2|||
163073338|NCT00504556|588976415|FG003|Overall Study|Other|3|||
163073339|NCT00504556|588976416|FG004|Overall Study|Other|0|||
163073340|NCT00504556|588976412|FG000|Overall Study|not in safety analysis set|0|||
163073341|NCT00504556|588976413|FG001|Overall Study|not in safety analysis set|1|||
163073342|NCT00504556|588976414|FG002|Overall Study|not in safety analysis set|1|||
163073343|NCT00504556|588976415|FG003|Overall Study|not in safety analysis set|0|||
163073344|NCT00504556|588976416|FG004|Overall Study|not in safety analysis set|1|||
163073345|NCT03558672|588976417|FG000|Overall Study|Study Early Termination|10|||
163073346|NCT03607695|588976418|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
163073347|NCT03607695|588976418|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
163073348|NCT01027416|588976419|FG000|Overall Study|Withdrawal by Subject|0|||
163073349|NCT01027416|588976420|FG001|Overall Study|Withdrawal by Subject|1|||
163073350|NCT01027416|588976419|FG000|Overall Study|Physician Decision|1|||
163073351|NCT01027416|588976420|FG001|Overall Study|Physician Decision|4|||
163073352|NCT01560988|588976440|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
163073353|NCT01560988|588976441|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
163073354|NCT01560988|588976440|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
163073355|NCT01560988|588976441|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
163073356|NCT01560988|588976440|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
163073357|NCT01560988|588976441|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
163073358|NCT01441414|588976444|FG000|Overall Study|Participant died|9|||
163073359|NCT01441414|588976444|FG000|Overall Study|Other reasons|3|||
163073360|NCT01441414|588976444|FG000|Overall Study|Study terminated by sponsor|2|||
163073361|NCT01441414|588976444|FG000|Overall Study|Subject refused further follow-up|1|||
163073362|NCT00500110|588976445|FG000|Overall Study|Withdrawal by Subject|3|||
163073363|NCT00605657|588976446|FG000|Overall Study|Adverse Event|1|||
163073364|NCT00605657|588976446|FG000|Overall Study|Protocol Violation|1|||
163073365|NCT02018887|588976451|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
163073366|NCT02018887|588976452|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073367|NCT02018887|588976453|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073368|NCT02018887|588976454|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073369|NCT02018887|588976455|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073370|NCT02018887|588976456|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073371|NCT02018887|588976457|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073372|NCT02018887|588976458|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073373|NCT02018887|588976459|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073374|NCT02018887|588976460|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073375|NCT02018887|588976461|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073376|NCT02018887|588976451|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073377|NCT02018887|588976452|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073378|NCT02018887|588976453|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073379|NCT02018887|588976454|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073380|NCT02018887|588976455|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
163073381|NCT02018887|588976456|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073382|NCT02018887|588976457|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
163073383|NCT02018887|588976458|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
163406391|NCT01187953|590196744|FG000|Overall Study|Withdrawal by Subject|3|||
163073384|NCT02018887|588976459|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073385|NCT02018887|588976460|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073386|NCT02018887|588976461|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073387|NCT02018887|588976451|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
163073388|NCT02018887|588976452|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
163073389|NCT02018887|588976453|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
163073390|NCT02018887|588976454|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
163073391|NCT02018887|588976455|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
163073392|NCT02018887|588976456|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
163406392|NCT01187953|590196745|FG001|Overall Study|Withdrawal by Subject|3|||
163331293|NCT01822756|589922554|FG004|Overall Study|Physician Decision|0|||
163331294|NCT01822756|589922550|FG000|Overall Study|disease progression & patient preference|2|||
163331295|NCT01822756|589922551|FG001|Overall Study|disease progression & patient preference|0|||
163331296|NCT01822756|589922552|FG002|Overall Study|disease progression & patient preference|1|||
163331297|NCT01822756|589922553|FG003|Overall Study|disease progression & patient preference|0|||
163073393|NCT02018887|588976457|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
163073394|NCT02018887|588976458|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
163073395|NCT02018887|588976459|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
163073396|NCT02018887|588976460|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
163073397|NCT02018887|588976461|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
163073398|NCT02018887|588976451|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
163073399|NCT02018887|588976452|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
163073400|NCT02018887|588976453|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
163073401|NCT02018887|588976454|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
163073402|NCT02018887|588976455|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
163073403|NCT02018887|588976456|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
163073404|NCT02018887|588976457|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
163073405|NCT02018887|588976458|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
163073406|NCT02018887|588976459|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
163073407|NCT02018887|588976460|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
163073408|NCT02018887|588976461|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
163073409|NCT01058005|588976462|FG000|Overall Study|Adverse Event|0|||
163073410|NCT01058005|588976463|FG001|Overall Study|Adverse Event|2|||
163073411|NCT01058005|588976464|FG002|Overall Study|Adverse Event|1|||
163073412|NCT01058005|588976462|FG000|Overall Study|Physician Decision|2|||
163073413|NCT01058005|588976463|FG001|Overall Study|Physician Decision|2|||
163073414|NCT01058005|588976464|FG002|Overall Study|Physician Decision|0|||
163073415|NCT01058005|588976462|FG000|Overall Study|Withdrawal by Subject|4|||
163073416|NCT01058005|588976463|FG001|Overall Study|Withdrawal by Subject|5|||
163073417|NCT01058005|588976464|FG002|Overall Study|Withdrawal by Subject|11|||
163073418|NCT01058005|588976462|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
163073419|NCT01058005|588976463|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
163073420|NCT01058005|588976464|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
163073421|NCT01058005|588976462|FG000|Overall Study|Reason Missing|5|||
163073422|NCT01058005|588976463|FG001|Overall Study|Reason Missing|3|||
163073423|NCT01058005|588976464|FG002|Overall Study|Reason Missing|1|||
163073424|NCT01623752|588976465|FG000|Phase 1 (78 Weeks)|No Data|249|||
163073425|NCT01623752|588976466|FG001|Phase 1 (78 Weeks)|No Data|66|||
163073426|NCT01623752|588976467|FG002|Phase 1 (78 Weeks)|No Data|2|||
163073427|NCT01623752|588976465|FG000|Phase 1 (78 Weeks)|Other|33|||
163073428|NCT01623752|588976466|FG001|Phase 1 (78 Weeks)|Other|20|||
163073429|NCT01623752|588976467|FG002|Phase 1 (78 Weeks)|Other|0|||
163073430|NCT01623752|588976465|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
163073431|NCT01623752|588976466|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
163073432|NCT01623752|588976467|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
163073433|NCT01623752|588976465|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
163073434|NCT01623752|588976466|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
163073435|NCT01623752|588976467|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
163073436|NCT01623752|588976465|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
163073437|NCT01623752|588976466|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
163073438|NCT01623752|588976467|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
163073439|NCT01623752|588976465|FG000|Phase 2 (78 Weeks)|Other|5|||
163073440|NCT01623752|588976466|FG001|Phase 2 (78 Weeks)|Other|1|||
163073441|NCT01623752|588976467|FG002|Phase 2 (78 Weeks)|Other|0|||
163073442|NCT01623752|588976465|FG000|Phase 2 (78 Weeks)|No Data|43|||
163073443|NCT01623752|588976466|FG001|Phase 2 (78 Weeks)|No Data|11|||
163073444|NCT01623752|588976467|FG002|Phase 2 (78 Weeks)|No Data|0|||
163073445|NCT01623752|588976465|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
163073446|NCT01623752|588976466|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
163073447|NCT01623752|588976467|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
163073448|NCT01814332|588976468|FG000|Overall Study|Adverse Event|8|||
163073449|NCT01814332|588976469|FG001|Overall Study|Adverse Event|3|||
163073450|NCT01814332|588976468|FG000|Overall Study|Withdrawal by Subject|3|||
163073451|NCT01814332|588976469|FG001|Overall Study|Withdrawal by Subject|8|||
163073452|NCT01814332|588976468|FG000|Overall Study|Protocol Violation|0|||
163331298|NCT01822756|589922554|FG004|Overall Study|disease progression & patient preference|0|||
163331299|NCT01065779|589922555|FG000|Overall Study|Duplicate Investigation|1|||
163073453|NCT01814332|588976469|FG001|Overall Study|Protocol Violation|4|||
163073454|NCT01814332|588976468|FG000|Overall Study|Lost to Follow-up|5|||
163073455|NCT01814332|588976469|FG001|Overall Study|Lost to Follow-up|1|||
163073456|NCT05987540|588976470|FG000|Overall Study|Withdrawal by Subject|2|||
163073457|NCT05987540|588976470|FG000|Overall Study|Death|1|||
163073458|NCT05987540|588976470|FG000|Overall Study|Study Termination|1|||
163073459|NCT05987540|588976470|FG000|Overall Study|Adverse Event|2|||
163073460|NCT04053452|588976471|FG000|Overall Study|Withdrawal by Subject|1|||
163073461|NCT04053452|588976472|FG001|Overall Study|Withdrawal by Subject|0|||
163154799|NCT00521079|589281440|FG000|Overall Study|Adverse Event|7|||
163073462|NCT04053452|588976471|FG000|Overall Study|Time restraint due to inpatient needs|1|||
163073463|NCT04053452|588976472|FG001|Overall Study|Time restraint due to inpatient needs|2|||
163073464|NCT01421134|588976473|FG000|Overall Study|Adverse Event|3|||
163073465|NCT01421134|588976474|FG001|Overall Study|Adverse Event|5|||
163073466|NCT01421134|588976473|FG000|Overall Study|Lack of Efficacy|2|||
163073467|NCT01421134|588976474|FG001|Overall Study|Lack of Efficacy|4|||
163073468|NCT01421134|588976473|FG000|Overall Study|Protocol Violation|0|||
163073469|NCT01421134|588976474|FG001|Overall Study|Protocol Violation|3|||
163073470|NCT01421134|588976473|FG000|Overall Study|Withdrawal by Subject|1|||
163073471|NCT01421134|588976474|FG001|Overall Study|Withdrawal by Subject|1|||
163073472|NCT01421134|588976473|FG000|Overall Study|Administrative|0|||
163073473|NCT01421134|588976474|FG001|Overall Study|Administrative|1|||
163073474|NCT01421134|588976473|FG000|Overall Study|Lost to Follow-up|1|||
163073475|NCT01421134|588976474|FG001|Overall Study|Lost to Follow-up|1|||
163073476|NCT02959892|588976475|FG000|Overall Study|PET tracer synthesis failure|1|||
163073477|NCT02959892|588976476|FG001|Overall Study|PET tracer synthesis failure|0|||
163073478|NCT02959892|588976475|FG000|Overall Study|Study termination|0|||
163073479|NCT02959892|588976476|FG001|Overall Study|Study termination|1|||
163073480|NCT00122187|588976477|FG000|Overall Study|Withdrew because of resource limitations|2|||
163073481|NCT00122187|588976478|FG001|Overall Study|Withdrew because of resource limitations|2|||
163073482|NCT02061592|588976482|FG000|Period 1|Withdrawal by Subject|1|||
163073483|NCT02061592|588976483|FG001|Period 1|Withdrawal by Subject|0|||
163073484|NCT02061592|588976482|FG000|Period 1|Protocol Violation|1|||
163073485|NCT02061592|588976483|FG001|Period 1|Protocol Violation|0|||
163073486|NCT02061592|588976482|FG000|Period 2|Lost to Follow-up|0|||
163073487|NCT02061592|588976483|FG001|Period 2|Lost to Follow-up|1|||
163073488|NCT04433975|588976484|FG000|1-month Follow Up|Withdrawal by Subject|1|||
163073489|NCT04433975|588976485|FG001|1-month Follow Up|Withdrawal by Subject|1|||
163073490|NCT04433975|588976484|FG000|1-month Follow Up|Lost to Follow-up|21|||
163073491|NCT04433975|588976485|FG001|1-month Follow Up|Lost to Follow-up|25|||
163073492|NCT04433975|588976484|FG000|3-month Follow Up|Lost to Follow-up|20|||
163073493|NCT04433975|588976485|FG001|3-month Follow Up|Lost to Follow-up|24|||
163073494|NCT04433975|588976484|FG000|3-month Follow Up|Death|1|||
163073495|NCT04433975|588976485|FG001|3-month Follow Up|Death|0|||
163073496|NCT04433975|588976484|FG000|3-month Follow Up|Withdrawal by Subject|2|||
163073497|NCT04433975|588976485|FG001|3-month Follow Up|Withdrawal by Subject|0|||
163073498|NCT04433975|588976484|FG000|6-month Follow Up|Lost to Follow-up|23|||
163073499|NCT04433975|588976485|FG001|6-month Follow Up|Lost to Follow-up|28|||
163073500|NCT04433975|588976484|FG000|6-month Follow Up|Withdrawal by Subject|1|||
163073501|NCT04433975|588976485|FG001|6-month Follow Up|Withdrawal by Subject|1|||
163073502|NCT04433975|588976484|FG000|9-month Follow Up|Lost to Follow-up|27|||
163073503|NCT04433975|588976485|FG001|9-month Follow Up|Lost to Follow-up|36|||
163073504|NCT04433975|588976484|FG000|9-month Follow Up|Death|0|||
163073505|NCT04433975|588976485|FG001|9-month Follow Up|Death|1|||
163073506|NCT04433975|588976484|FG000|12-month Follow Up|Lost to Follow-up|27|||
163073507|NCT04433975|588976485|FG001|12-month Follow Up|Lost to Follow-up|31|||
163073508|NCT04882215|588976486|FG000|Overall Study|Withdrawal by Subject|5|||
163073509|NCT04882215|588976487|FG001|Overall Study|Withdrawal by Subject|0|||
163073510|NCT06083493|588976488|FG000|Overall Study|Technical issues with the interventional device|2|||
163073511|NCT06083493|588976489|FG001|Overall Study|Technical issues with the interventional device|2|||
163073512|NCT06083493|588976488|FG000|Overall Study|Performed incorrect visual task|1|||
163073513|NCT06083493|588976489|FG001|Overall Study|Performed incorrect visual task|0|||
163073514|NCT06083493|588976488|FG000|Overall Study|Insufficient baseline performance|0|||
163073515|NCT06083493|588976489|FG001|Overall Study|Insufficient baseline performance|1|||
163073516|NCT04392635|588976492|FG000|Overall Study|Lost to Follow-up|0|||
163073517|NCT04392635|588976493|FG001|Overall Study|Lost to Follow-up|1|||
163073518|NCT01851369|588976498|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073519|NCT01851369|588976499|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073520|NCT01851369|588976500|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073521|NCT01851369|588976501|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073522|NCT01851369|588976502|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073523|NCT01851369|588976503|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
163073524|NCT01851369|588976504|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073525|NCT01851369|588976505|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073526|NCT01851369|588976506|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073527|NCT01851369|588976507|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073528|NCT01851369|588976508|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073529|NCT01851369|588976509|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073530|NCT01851369|588976510|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073531|NCT02460380|588976512|FG000|Overall Study|Withdrawal by Subject|10|||
163073532|NCT02460380|588976513|FG001|Overall Study|Withdrawal by Subject|5|||
163073533|NCT01936974|588976518|FG000|Overall Study|Physician Decision|2|||
163073534|NCT01936974|588976519|FG001|Overall Study|Physician Decision|5|||
163073535|NCT00063999|588976520|FG000|Overall Study|Withdrawal by Subject|1|||
163073536|NCT00063999|588976521|FG001|Overall Study|Withdrawal by Subject|0|||
163073537|NCT00063999|588976520|FG000|Overall Study|Ineligible|44|||
163073538|NCT00063999|588976521|FG001|Overall Study|Ineligible|24|||
163073539|NCT02497755|588976523|FG000|Overall Study|Protocol Violation|1|||
163073540|NCT02497755|588976524|FG001|Overall Study|Protocol Violation|0|||
163073541|NCT04560309|588976539|FG000|Overall Study|Meet drop out criteria|1|||
163073542|NCT04560309|588976540|FG001|Overall Study|Meet drop out criteria|1|||
163073543|NCT05085405|588976541|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
163073544|NCT05085405|588976542|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
163073545|NCT05085405|588976543|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
163073546|NCT05085405|588976544|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
163073547|NCT05085405|588976545|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
163073548|NCT05085405|588976546|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
163073549|NCT05085405|588976541|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
163073550|NCT05085405|588976542|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
163073551|NCT05085405|588976543|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
163073552|NCT05085405|588976544|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
163073553|NCT05085405|588976545|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
163073554|NCT05085405|588976546|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
163073555|NCT01860404|588976547|FG000|Overall Study|Lost to Follow-up|3|||
163073556|NCT01860404|588976548|FG001|Overall Study|Lost to Follow-up|4|||
163073557|NCT01860404|588976549|FG002|Overall Study|Lost to Follow-up|1|||
163073558|NCT01860404|588976550|FG003|Overall Study|Lost to Follow-up|6|||
163073559|NCT01860404|588976551|FG004|Overall Study|Lost to Follow-up|4|||
163073560|NCT01860404|588976547|FG000|Overall Study|Withdrawal by Subject|0|||
163073561|NCT01860404|588976548|FG001|Overall Study|Withdrawal by Subject|0|||
163073562|NCT01860404|588976549|FG002|Overall Study|Withdrawal by Subject|4|||
163073563|NCT01860404|588976550|FG003|Overall Study|Withdrawal by Subject|0|||
163073564|NCT01860404|588976551|FG004|Overall Study|Withdrawal by Subject|0|||
163073565|NCT00356421|588976553|FG000|Overall Study|Lack of Efficacy|3|||
163073566|NCT00356421|588976554|FG001|Overall Study|Lack of Efficacy|0|||
163073567|NCT00356421|588976553|FG000|Overall Study|Withdrawal by Subject|9|||
163073568|NCT00356421|588976554|FG001|Overall Study|Withdrawal by Subject|2|||
163073569|NCT00356421|588976553|FG000|Overall Study|Related to study drug|15|||
163073570|NCT00356421|588976554|FG001|Overall Study|Related to study drug|12|||
163073571|NCT00356421|588976553|FG000|Overall Study|Not related to study drug|5|||
163073572|NCT00356421|588976554|FG001|Overall Study|Not related to study drug|3|||
163331300|NCT01065779|589922555|FG000|Overall Study|Investigation Before Contract Date|37|||
163331301|NCT01065779|589922555|FG000|Overall Study|Non-enrollment Period Administration|10|||
163331302|NCT01065779|589922555|FG000|Overall Study|Not Administered With Study Drug|17|||
163331303|NCT01065779|589922555|FG000|Overall Study|Failed to Follow-up|10|||
163331304|NCT01065779|589922555|FG000|Overall Study|Inclusion Criteria Violation|7|||
163331305|NCT02157948|589922556|FG000|Overall Study|Withdrawal by Subject|4|||
163331306|NCT02157948|589922557|FG001|Overall Study|Withdrawal by Subject|5|||
163073573|NCT04689009|588976555|FG000|Overall Study|Adverse Event|1|||
163073574|NCT04689009|588976556|FG001|Overall Study|Adverse Event|0|||
163073575|NCT04689009|588976555|FG000|Overall Study|Lost to Follow-up|1|||
163073576|NCT04689009|588976556|FG001|Overall Study|Lost to Follow-up|2|||
163073577|NCT04689009|588976555|FG000|Overall Study|Withdrawal by Subject|4|||
163073578|NCT04689009|588976556|FG001|Overall Study|Withdrawal by Subject|3|||
163073579|NCT04689009|588976555|FG000|Overall Study|Protocol Violation|1|||
163073580|NCT04689009|588976556|FG001|Overall Study|Protocol Violation|0|||
163073581|NCT02187055|588976557|FG000|Overall Study|Lack of Efficacy|10|||
163073582|NCT02187055|588976558|FG001|Overall Study|Lack of Efficacy|3|||
163073583|NCT02187055|588976559|FG002|Overall Study|Lack of Efficacy|7|||
163073584|NCT02187055|588976557|FG000|Overall Study|Lost to Follow-up|2|||
163073585|NCT02187055|588976558|FG001|Overall Study|Lost to Follow-up|7|||
163073586|NCT02187055|588976559|FG002|Overall Study|Lost to Follow-up|3|||
163073587|NCT02187055|588976557|FG000|Overall Study|No longer meets eligibility criteria|0|||
163073588|NCT02187055|588976558|FG001|Overall Study|No longer meets eligibility criteria|2|||
163073589|NCT02187055|588976559|FG002|Overall Study|No longer meets eligibility criteria|0|||
163073590|NCT02187055|588976557|FG000|Overall Study|No longer willing to participate|6|||
163073591|NCT02187055|588976558|FG001|Overall Study|No longer willing to participate|8|||
163073592|NCT02187055|588976559|FG002|Overall Study|No longer willing to participate|10|||
163073593|NCT02187055|588976557|FG000|Overall Study|Other|5|||
163073594|NCT02187055|588976558|FG001|Overall Study|Other|6|||
163331307|NCT02157948|589922556|FG000|Overall Study|Lost to Follow-up|3|||
163331308|NCT02157948|589922557|FG001|Overall Study|Lost to Follow-up|2|||
163073595|NCT02187055|588976559|FG002|Overall Study|Other|3|||
163073596|NCT02187055|588976557|FG000|Overall Study|Protocol Violation|9|||
163073597|NCT02187055|588976558|FG001|Overall Study|Protocol Violation|9|||
163073598|NCT02187055|588976559|FG002|Overall Study|Protocol Violation|4|||
163073599|NCT02187055|588976557|FG000|Overall Study|Pregnancy|3|||
163073600|NCT02187055|588976558|FG001|Overall Study|Pregnancy|1|||
163073601|NCT02187055|588976559|FG002|Overall Study|Pregnancy|0|||
163073602|NCT02187055|588976557|FG000|Overall Study|Withdrawal by Subject|11|||
163073603|NCT02187055|588976558|FG001|Overall Study|Withdrawal by Subject|11|||
163073604|NCT02187055|588976559|FG002|Overall Study|Withdrawal by Subject|11|||
163073605|NCT02187055|588976557|FG000|Overall Study|Adverse Event|21|||
163073606|NCT02187055|588976558|FG001|Overall Study|Adverse Event|26|||
163073607|NCT02187055|588976559|FG002|Overall Study|Adverse Event|36|||
163073608|NCT02187055|588976557|FG000|Overall Study|Death|2|||
163073609|NCT02187055|588976558|FG001|Overall Study|Death|0|||
163073610|NCT02187055|588976559|FG002|Overall Study|Death|0|||
163073611|NCT00985790|588976562|FG000|Overall Study|Withdrawal by Subject|1|||
163073612|NCT00985790|588976563|FG001|Overall Study|Withdrawal by Subject|1|||
163073613|NCT00985790|588976562|FG000|Overall Study|Lost to Follow-up|6|||
163073614|NCT00985790|588976563|FG001|Overall Study|Lost to Follow-up|7|||
163073615|NCT01030900|588976564|FG000|Overall Study|Not treated due to congestive heart failure|1|||
163073616|NCT01030900|588976564|FG000|Overall Study|Not treated due to rapid disease|1|||
163073617|NCT00441896|588976565|FG000|Overall Study|Withdrawal by Subject|0|||
163073618|NCT00441896|588976566|FG001|Overall Study|Withdrawal by Subject|0|||
163073619|NCT00441896|588976567|FG002|Overall Study|Withdrawal by Subject|0|||
163073620|NCT00441896|588976568|FG003|Overall Study|Withdrawal by Subject|1|||
163073621|NCT00441896|588976569|FG004|Overall Study|Withdrawal by Subject|0|||
163073622|NCT00441896|588976570|FG005|Overall Study|Withdrawal by Subject|0|||
163073623|NCT00441896|588976571|FG006|Overall Study|Withdrawal by Subject|0|||
163073624|NCT00441896|588976572|FG007|Overall Study|Withdrawal by Subject|0|||
163073625|NCT00441896|588976573|FG008|Overall Study|Withdrawal by Subject|0|||
163073626|NCT00441896|588976574|FG009|Overall Study|Withdrawal by Subject|0|||
163073627|NCT00441896|588976565|FG000|Overall Study|Other|0|||
163073628|NCT00441896|588976566|FG001|Overall Study|Other|0|||
163218244|NCT02510794|589515765|FG000|Overall Study|Withdrawal by Subject|1|||
163218245|NCT02510794|589515766|FG001|Overall Study|Withdrawal by Subject|2|||
163218246|NCT02510794|589515767|FG002|Overall Study|Withdrawal by Subject|4|||
163073629|NCT00441896|588976567|FG002|Overall Study|Other|0|||
163073630|NCT00441896|588976568|FG003|Overall Study|Other|0|||
163073631|NCT00441896|588976569|FG004|Overall Study|Other|1|||
163073632|NCT00441896|588976570|FG005|Overall Study|Other|0|||
163218247|NCT02510794|589515768|FG003|Overall Study|Withdrawal by Subject|3|||
163218248|NCT01124604|589515769|FG000|Overall Study|Adverse Event|10|||
163218249|NCT01124604|589515770|FG001|Overall Study|Adverse Event|1|||
163073633|NCT00441896|588976571|FG006|Overall Study|Other|0|||
163073634|NCT00441896|588976572|FG007|Overall Study|Other|0|||
163073635|NCT00441896|588976573|FG008|Overall Study|Other|0|||
163073636|NCT00441896|588976574|FG009|Overall Study|Other|0|||
163218250|NCT01124604|589515769|FG000|Overall Study|Lack of Efficacy|1|||
163218251|NCT01124604|589515770|FG001|Overall Study|Lack of Efficacy|0|||
163218252|NCT01124604|589515769|FG000|Overall Study|Withdrawal by Subject|4|||
163218253|NCT01124604|589515770|FG001|Overall Study|Withdrawal by Subject|0|||
163218254|NCT01124604|589515769|FG000|Overall Study|Disease Progression|0|||
163218255|NCT01124604|589515770|FG001|Overall Study|Disease Progression|1|||
163218256|NCT01859507|589515771|FG000|Overall Study|left the country|4|||
163218257|NCT01762943|589515772|FG000|Overall Study|Physician Decision|1|||
163218258|NCT01762943|589515773|FG001|Overall Study|Physician Decision|1|||
163218259|NCT01762943|589515772|FG000|Overall Study|Protocol Violation|1|||
163218260|NCT01762943|589515773|FG001|Overall Study|Protocol Violation|0|||
163218261|NCT01762943|589515772|FG000|Overall Study|Withdrawal by Subject|2|||
163218262|NCT01762943|589515773|FG001|Overall Study|Withdrawal by Subject|1|||
163218263|NCT00539838|589515774|FG000|Overall Study|Fail to return|2|||
163218264|NCT00539838|589515775|FG001|Overall Study|Fail to return|0|||
163218265|NCT00539838|589515776|FG002|Overall Study|Fail to return|0|||
163218266|NCT00539838|589515774|FG000|Overall Study|Withdrawal by Subject|0|||
163218267|NCT00539838|589515775|FG001|Overall Study|Withdrawal by Subject|4|||
163218268|NCT00539838|589515776|FG002|Overall Study|Withdrawal by Subject|0|||
163218269|NCT00539838|589515774|FG000|Overall Study|Death|0|||
163218270|NCT00539838|589515775|FG001|Overall Study|Death|2|||
163218271|NCT00539838|589515776|FG002|Overall Study|Death|0|||
163218272|NCT00539838|589515774|FG000|Overall Study|Did not cooperate|1|||
163218273|NCT00539838|589515775|FG001|Overall Study|Did not cooperate|0|||
163218274|NCT00539838|589515776|FG002|Overall Study|Did not cooperate|1|||
163218275|NCT00539838|589515774|FG000|Overall Study|Administrative|4|||
163218276|NCT00539838|589515775|FG001|Overall Study|Administrative|0|||
163218277|NCT00539838|589515776|FG002|Overall Study|Administrative|8|||
163218278|NCT03090100|589515780|FG000|Overall Study|Adverse Event|9|||
163218279|NCT03090100|589515781|FG001|Overall Study|Adverse Event|11|||
163218280|NCT03090100|589515780|FG000|Overall Study|Pregnancy|1|||
163218281|NCT03090100|589515781|FG001|Overall Study|Pregnancy|1|||
163218282|NCT03090100|589515780|FG000|Overall Study|Lack of Efficacy|2|||
163073637|NCT01301092|588976575|FG000|Overall Study|Lost to Follow-up|0|||
163073638|NCT01301092|588976576|FG001|Overall Study|Lost to Follow-up|0|||
163073639|NCT01301092|588976577|FG002|Overall Study|Lost to Follow-up|1|||
163073640|NCT03334175|588976578|FG000|Overall Study|Lost to Follow-up|0|||
163073641|NCT03334175|588976579|FG001|Overall Study|Lost to Follow-up|1|||
163073642|NCT01793129|588978172|FG000|Overall Study|Lost to Follow-up|3|||
163073643|NCT01793129|588978173|FG001|Overall Study|Lost to Follow-up|7|||
163073644|NCT01793129|588978172|FG000|Overall Study|Withdrawal by Subject|0|||
163073645|NCT01793129|588978173|FG001|Overall Study|Withdrawal by Subject|2|||
163073646|NCT00454142|588978176|FG000|Overall Study|Withdrawal by Subject|1|||
163073647|NCT00520572|588978177|FG000|Overall Study|Adverse Event|9|||
163073648|NCT00520572|588978178|FG001|Overall Study|Adverse Event|3|||
163073649|NCT00520572|588978179|FG002|Overall Study|Adverse Event|6|||
163073650|NCT00520572|588978180|FG003|Overall Study|Adverse Event|9|||
163073651|NCT00520572|588978181|FG004|Overall Study|Adverse Event|7|||
163073652|NCT00520572|588978182|FG005|Overall Study|Adverse Event|2|||
163073653|NCT00520572|588978177|FG000|Overall Study|Withdrawal by Subject|0|||
163073654|NCT00520572|588978178|FG001|Overall Study|Withdrawal by Subject|9|||
163073655|NCT00520572|588978179|FG002|Overall Study|Withdrawal by Subject|5|||
163073656|NCT00520572|588978180|FG003|Overall Study|Withdrawal by Subject|2|||
163073657|NCT00520572|588978181|FG004|Overall Study|Withdrawal by Subject|2|||
163073658|NCT00520572|588978182|FG005|Overall Study|Withdrawal by Subject|0|||
163073659|NCT00520572|588978177|FG000|Overall Study|Protocol Violation|0|||
163073660|NCT00520572|588978178|FG001|Overall Study|Protocol Violation|0|||
163406393|NCT02404103|590198619|FG000|Overall Study|Adverse Event|1|||
163073661|NCT00520572|588978179|FG002|Overall Study|Protocol Violation|1|||
163073662|NCT00520572|588978180|FG003|Overall Study|Protocol Violation|0|||
163073663|NCT00520572|588978181|FG004|Overall Study|Protocol Violation|0|||
163073664|NCT00520572|588978182|FG005|Overall Study|Protocol Violation|0|||
163073665|NCT00520572|588978177|FG000|Overall Study|Lack of Efficacy|1|||
163073666|NCT00520572|588978178|FG001|Overall Study|Lack of Efficacy|1|||
163073667|NCT00520572|588978179|FG002|Overall Study|Lack of Efficacy|1|||
163073668|NCT00520572|588978180|FG003|Overall Study|Lack of Efficacy|2|||
163073669|NCT00520572|588978181|FG004|Overall Study|Lack of Efficacy|1|||
163073670|NCT00520572|588978182|FG005|Overall Study|Lack of Efficacy|0|||
163073671|NCT00520572|588978177|FG000|Overall Study|Lost to Follow-up|0|||
163073672|NCT00520572|588978178|FG001|Overall Study|Lost to Follow-up|0|||
163073673|NCT00520572|588978179|FG002|Overall Study|Lost to Follow-up|0|||
163073674|NCT00520572|588978180|FG003|Overall Study|Lost to Follow-up|0|||
163073675|NCT00520572|588978181|FG004|Overall Study|Lost to Follow-up|1|||
163073676|NCT00520572|588978182|FG005|Overall Study|Lost to Follow-up|0|||
163073677|NCT00520572|588978177|FG000|Overall Study|Incorrect enrollment|1|||
163073678|NCT00520572|588978178|FG001|Overall Study|Incorrect enrollment|0|||
163073679|NCT00520572|588978179|FG002|Overall Study|Incorrect enrollment|1|||
163073680|NCT00520572|588978180|FG003|Overall Study|Incorrect enrollment|0|||
163073681|NCT00520572|588978181|FG004|Overall Study|Incorrect enrollment|1|||
163073682|NCT00520572|588978182|FG005|Overall Study|Incorrect enrollment|0|||
163073683|NCT00520572|588978177|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
163073684|NCT00520572|588978178|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
163073685|NCT00520572|588978179|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
163073686|NCT00520572|588978180|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
163073687|NCT00520572|588978181|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
163073688|NCT00520572|588978182|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
163073689|NCT00520572|588978177|FG000|Overall Study|Long break in taking Medication|0|||
163073690|NCT00520572|588978178|FG001|Overall Study|Long break in taking Medication|0|||
163218283|NCT03090100|589515781|FG001|Overall Study|Lack of Efficacy|7|||
163218284|NCT03090100|589515780|FG000|Overall Study|Lost to Follow-up|2|||
163218285|NCT03090100|589515781|FG001|Overall Study|Lost to Follow-up|2|||
163073691|NCT00520572|588978179|FG002|Overall Study|Long break in taking Medication|0|||
163073692|NCT00520572|588978180|FG003|Overall Study|Long break in taking Medication|1|||
163073693|NCT00520572|588978181|FG004|Overall Study|Long break in taking Medication|0|||
163218286|NCT03090100|589515780|FG000|Overall Study|Withdrawal by Subject|7|||
163073694|NCT00520572|588978182|FG005|Overall Study|Long break in taking Medication|0|||
163073695|NCT00520572|588978177|FG000|Overall Study|Did not receive Treatment|1|||
163073696|NCT00520572|588978178|FG001|Overall Study|Did not receive Treatment|0|||
163073697|NCT00520572|588978179|FG002|Overall Study|Did not receive Treatment|1|||
163073698|NCT00520572|588978180|FG003|Overall Study|Did not receive Treatment|0|||
163218287|NCT03090100|589515781|FG001|Overall Study|Withdrawal by Subject|19|||
163218288|NCT03090100|589515780|FG000|Overall Study|Protocol Violation|2|||
163218289|NCT03090100|589515781|FG001|Overall Study|Protocol Violation|6|||
163218290|NCT03090100|589515780|FG000|Overall Study|Non-compliance|2|||
163218291|NCT03090100|589515781|FG001|Overall Study|Non-compliance|0|||
163218292|NCT03090100|589515780|FG000|Overall Study|Other|2|||
163218293|NCT03090100|589515781|FG001|Overall Study|Other|2|||
163218294|NCT03446040|589515782|FG000|Overall Study|Disease progression|3|||
163218295|NCT03446040|589515783|FG001|Overall Study|Disease progression|3|||
163218296|NCT03446040|589515784|FG002|Overall Study|Disease progression|3|||
163073699|NCT00520572|588978181|FG004|Overall Study|Did not receive Treatment|0|||
163073700|NCT00520572|588978182|FG005|Overall Study|Did not receive Treatment|0|||
163073701|NCT03548415|588978185|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
163073702|NCT03548415|588978186|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
163073703|NCT03548415|588978187|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
163073704|NCT03548415|588978188|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
163073705|NCT03548415|588978189|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
163073706|NCT04605588|588978190|FG000|Overall Study|Withdrawal by Subject|1|||
163073707|NCT04605588|588978191|FG001|Overall Study|Withdrawal by Subject|0|||
163073708|NCT01230814|588978192|FG000|Overall Study|Lost to Follow-up|11|||
163331309|NCT02157948|589922556|FG000|Overall Study|Protocol Specified Criteria|2|||
163073709|NCT01230814|588978193|FG001|Overall Study|Lost to Follow-up|3|||
163073710|NCT01230814|588978192|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
163073711|NCT01230814|588978193|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
163073712|NCT01803737|588978194|FG000|Overall Study|Lack of Time|1|||
163073713|NCT01803737|588978195|FG001|Overall Study|Lack of Time|0|||
163073714|NCT01803737|588978194|FG000|Overall Study|Medical Reason|0|||
163073715|NCT01803737|588978195|FG001|Overall Study|Medical Reason|1|||
163073716|NCT01803737|588978194|FG000|Overall Study|Lost to Follow-up|0|||
163073717|NCT01803737|588978195|FG001|Overall Study|Lost to Follow-up|2|||
163073718|NCT02741193|588978196|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
163073719|NCT02741193|588978196|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
163073720|NCT00676052|588978200|FG000|Overall Study|Adverse Event|0|||
163073721|NCT00676052|588978201|FG001|Overall Study|Adverse Event|1|||
163073722|NCT00676052|588978202|FG002|Overall Study|Adverse Event|1|||
163073723|NCT00676052|588978203|FG003|Overall Study|Adverse Event|2|||
163073724|NCT00676052|588978204|FG004|Overall Study|Adverse Event|2|||
163073725|NCT00676052|588978205|FG005|Overall Study|Adverse Event|2|||
163073726|NCT00676052|588978200|FG000|Overall Study|Lack of Efficacy|2|||
163073727|NCT00676052|588978201|FG001|Overall Study|Lack of Efficacy|2|||
163073728|NCT00676052|588978202|FG002|Overall Study|Lack of Efficacy|1|||
163073729|NCT00676052|588978203|FG003|Overall Study|Lack of Efficacy|1|||
163073730|NCT00676052|588978204|FG004|Overall Study|Lack of Efficacy|2|||
163073731|NCT00676052|588978205|FG005|Overall Study|Lack of Efficacy|1|||
163073732|NCT00676052|588978200|FG000|Overall Study|Protocol Violation|5|||
163073733|NCT00676052|588978201|FG001|Overall Study|Protocol Violation|3|||
163073734|NCT00676052|588978202|FG002|Overall Study|Protocol Violation|2|||
163073735|NCT00676052|588978203|FG003|Overall Study|Protocol Violation|2|||
163073736|NCT00676052|588978204|FG004|Overall Study|Protocol Violation|1|||
163073737|NCT00676052|588978205|FG005|Overall Study|Protocol Violation|2|||
163073738|NCT00676052|588978200|FG000|Overall Study|Lost to Follow-up|0|||
163073739|NCT00676052|588978201|FG001|Overall Study|Lost to Follow-up|0|||
163073740|NCT00676052|588978202|FG002|Overall Study|Lost to Follow-up|0|||
163073741|NCT00676052|588978203|FG003|Overall Study|Lost to Follow-up|0|||
163073742|NCT00676052|588978204|FG004|Overall Study|Lost to Follow-up|1|||
163073743|NCT00676052|588978205|FG005|Overall Study|Lost to Follow-up|0|||
163073744|NCT00676052|588978200|FG000|Overall Study|Physician Decision|1|||
163073745|NCT00676052|588978201|FG001|Overall Study|Physician Decision|1|||
163073746|NCT00676052|588978202|FG002|Overall Study|Physician Decision|1|||
163073747|NCT00676052|588978203|FG003|Overall Study|Physician Decision|0|||
163073748|NCT00676052|588978204|FG004|Overall Study|Physician Decision|0|||
163073749|NCT00676052|588978205|FG005|Overall Study|Physician Decision|1|||
163331310|NCT02157948|589922557|FG001|Overall Study|Protocol Specified Criteria|1|||
163331311|NCT02157948|589922556|FG000|Overall Study|Decision by Sponsor|0|||
163331312|NCT02157948|589922557|FG001|Overall Study|Decision by Sponsor|1|||
163331313|NCT01801007|589922558|FG000|Overall Study|Adverse Event|2|||
163331314|NCT01801007|589922558|FG000|Overall Study|Lost to Follow-up|4|||
163331315|NCT01801007|589922558|FG000|Overall Study|Withdrawal by Subject|5|||
163331316|NCT01683409|589922559|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
163331317|NCT01683409|589922560|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
163073750|NCT00676052|588978200|FG000|Overall Study|Withdrawal by Subject|1|||
163073751|NCT00676052|588978201|FG001|Overall Study|Withdrawal by Subject|0|||
163073752|NCT00676052|588978202|FG002|Overall Study|Withdrawal by Subject|1|||
163073753|NCT00676052|588978203|FG003|Overall Study|Withdrawal by Subject|0|||
163073754|NCT00676052|588978204|FG004|Overall Study|Withdrawal by Subject|0|||
163073755|NCT00676052|588978205|FG005|Overall Study|Withdrawal by Subject|0|||
163073756|NCT00903344|588978206|FG000|Overall Study|Pregnancy|2|||
163331318|NCT01683409|589922561|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
163073757|NCT00903344|588978207|FG001|Overall Study|Pregnancy|3|||
163073758|NCT00903344|588978206|FG000|Overall Study|Lost to Follow-up|3|||
163073759|NCT00903344|588978207|FG001|Overall Study|Lost to Follow-up|0|||
163073760|NCT00585169|588978208|FG000|Overall Study|Withdrawal by Subject|1|||
163073761|NCT03055221|588978209|FG000|Overall Study|Adverse Event|2|||
163073762|NCT03055221|588978209|FG000|Overall Study|Withdrawal by Subject|4|||
163073763|NCT03055221|588978209|FG000|Overall Study|Death|6|||
163073764|NCT03055221|588978209|FG000|Overall Study|Physician Decision|1|||
163406394|NCT02404103|590198620|FG001|Overall Study|Adverse Event|0|||
163331319|NCT01683409|589922562|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
163331320|NCT01683409|589922563|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
163331321|NCT01683409|589922559|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
163331322|NCT01683409|589922560|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
163331323|NCT01683409|589922561|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
163331324|NCT01683409|589922562|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
163331325|NCT01683409|589922563|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
163331326|NCT01683409|589922559|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
163331327|NCT01683409|589922560|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
163331328|NCT01683409|589922561|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
163331329|NCT01683409|589922562|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
163331330|NCT01683409|589922563|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
163331331|NCT01683409|589922559|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
163331332|NCT01683409|589922560|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
163331333|NCT01683409|589922561|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
163331334|NCT01683409|589922562|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
163331335|NCT01683409|589922563|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
163331336|NCT01683409|589922559|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
163073765|NCT03055221|588978209|FG000|Overall Study|Study terminated by Sponsor|3|||
163073766|NCT03055221|588978209|FG000|Overall Study|Lost to Follow-up|4|||
163073767|NCT01243424|588978210|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
163073768|NCT01243424|588978211|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
163073769|NCT01243424|588978210|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
163073770|NCT01243424|588978211|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
163073771|NCT01243424|588978210|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
163073772|NCT01243424|588978211|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
163073773|NCT01243424|588978210|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
163073774|NCT01243424|588978211|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
163073775|NCT01243424|588978210|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
163073776|NCT01243424|588978211|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
163073777|NCT01243424|588978210|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
163073778|NCT01243424|588978211|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
163073779|NCT01243424|588978210|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
163073780|NCT01243424|588978211|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
163073781|NCT01243424|588978210|FG000|Discontinuation From Treatment|Not treated|5|||
163073782|NCT01243424|588978211|FG001|Discontinuation From Treatment|Not treated|4|||
163073783|NCT01243424|588978210|FG000|Discontinuation From Treatment|Adverse Event|457|||
163073784|NCT01243424|588978211|FG001|Discontinuation From Treatment|Adverse Event|523|||
163073785|NCT01243424|588978210|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
163073786|NCT01243424|588978211|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
163073787|NCT01243424|588978210|FG000|Discontinuation From Treatment|Protocol Violation|46|||
163073788|NCT01243424|588978211|FG001|Discontinuation From Treatment|Protocol Violation|47|||
163073789|NCT01243424|588978210|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
163073790|NCT01243424|588978211|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
163073791|NCT01243424|588978210|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
163073792|NCT01243424|588978211|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
163073793|NCT01243424|588978210|FG000|Discontinuation From Treatment|Other than listed above|230|||
163073794|NCT01243424|588978211|FG001|Discontinuation From Treatment|Other than listed above|211|||
163331337|NCT01683409|589922560|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
163331338|NCT01683409|589922561|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
163331339|NCT01683409|589922562|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
163331340|NCT01683409|589922563|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
163331341|NCT01683409|589922559|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
163331342|NCT01683409|589922560|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
163331343|NCT01683409|589922561|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
163331344|NCT01683409|589922562|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
163073795|NCT00710554|588978212|FG000|Overall Study|Adverse Event|24|||
163073796|NCT00710554|588978213|FG001|Overall Study|Adverse Event|7|||
163073797|NCT00710554|588978212|FG000|Overall Study|Withdrawal by Subject|7|||
163073798|NCT00710554|588978213|FG001|Overall Study|Withdrawal by Subject|3|||
163073799|NCT00710554|588978212|FG000|Overall Study|Lost to Follow-up|7|||
163073800|NCT00710554|588978213|FG001|Overall Study|Lost to Follow-up|1|||
163073801|NCT00710554|588978212|FG000|Overall Study|Lack of Efficacy|11|||
163073802|NCT00710554|588978213|FG001|Overall Study|Lack of Efficacy|12|||
163331345|NCT01683409|589922563|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
163331346|NCT01683409|589922559|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
163331347|NCT01683409|589922560|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
163073803|NCT00710554|588978212|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
163073804|NCT00710554|588978213|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
163073805|NCT01093885|588978214|FG000|Overall Study|Adverse Event|4|||
163073806|NCT01093885|588978214|FG000|Overall Study|Lost to Follow-up|1|||
163073807|NCT00292370|588978219|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
163073808|NCT00292370|588978220|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
163073809|NCT00292370|588978221|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
163073810|NCT00292370|588978219|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
163073811|NCT00292370|588978220|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
163073812|NCT00292370|588978221|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
163073813|NCT00292370|588978219|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
163073814|NCT00292370|588978220|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
163073815|NCT00292370|588978221|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
163073816|NCT00292370|588978219|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
163073817|NCT00292370|588978220|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
163073818|NCT00292370|588978221|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
163073819|NCT00292370|588978219|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
163073820|NCT00292370|588978220|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
163073821|NCT00292370|588978221|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
163073822|NCT00292370|588978219|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
163073823|NCT00292370|588978220|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
163073824|NCT00292370|588978221|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
163073825|NCT01346709|588978222|FG000|Overall Study|Protocol Violation|35|||
163073826|NCT01346709|588978222|FG000|Overall Study|Lost to Follow-up|31|||
163073827|NCT01346709|588978222|FG000|Overall Study|Missing data in candidate risk factor|285|||
163073828|NCT02365064|588978223|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
163073829|NCT02365064|588978224|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
163073830|NCT02365064|588978223|FG000|Overall Study|Withdrawal by Subject|6|||
163073831|NCT02365064|588978224|FG001|Overall Study|Withdrawal by Subject|9|||
163073832|NCT02365064|588978223|FG000|Overall Study|Treatment intolerance|2|||
163073833|NCT02365064|588978224|FG001|Overall Study|Treatment intolerance|4|||
163073834|NCT00662038|588978233|FG000|Overall Study|Reason not specified|3|||
163073835|NCT00662038|588978233|FG000|Overall Study|Withdrawn consent|22|||
163073836|NCT00662038|588978233|FG000|Overall Study|Withdrawal by Subject|83|||
163073837|NCT00662038|588978233|FG000|Overall Study|Sponsor decision|1|||
163073838|NCT00662038|588978233|FG000|Overall Study|Physician Decision|19|||
163073839|NCT00662038|588978233|FG000|Overall Study|Lung transplantation|44|||
163073840|NCT00662038|588978233|FG000|Overall Study|Lost to Follow-up|1|||
163073841|NCT00662038|588978233|FG000|Overall Study|Death|95|||
163073842|NCT00662038|588978233|FG000|Overall Study|Adverse Event|358|||
163073843|NCT00662038|588978233|FG000|Overall Study|Continued treatment|5|||
163073844|NCT00397046|588978234|FG000|Overall Study|Disease Progression|3|||
163073845|NCT00397046|588978235|FG001|Overall Study|Disease Progression|3|||
163073846|NCT00397046|588978236|FG002|Overall Study|Disease Progression|10|||
163073847|NCT00397046|588978237|FG003|Overall Study|Disease Progression|5|||
163073848|NCT01975285|588978239|FG000|Overall Study|Failed Block and follow up|2|||
163218297|NCT03446040|589515785|FG003|Overall Study|Disease progression|4|||
163073849|NCT01975285|588978240|FG001|Overall Study|Failed Block and follow up|2|||
163073850|NCT04535362|588978241|FG000|Overall Study|Lost to Follow-up|3|||
163073851|NCT04535362|588978242|FG001|Overall Study|Lost to Follow-up|1|||
163218298|NCT03446040|589515786|FG004|Overall Study|Disease progression|4|||
163218299|NCT03446040|589515787|FG005|Overall Study|Disease progression|6|||
163218300|NCT03446040|589515788|FG006|Overall Study|Disease progression|3|||
163218301|NCT03446040|589515789|FG007|Overall Study|Disease progression|4|||
163218302|NCT03446040|589515790|FG008|Overall Study|Disease progression|2|||
163218303|NCT03446040|589515791|FG009|Overall Study|Disease progression|4|||
163218304|NCT03446040|589515792|FG010|Overall Study|Disease progression|9|||
163218305|NCT03446040|589515793|FG011|Overall Study|Disease progression|3|||
163218306|NCT03446040|589515794|FG012|Overall Study|Disease progression|7|||
163218307|NCT03446040|589515795|FG013|Overall Study|Disease progression|7|||
163218308|NCT03446040|589515782|FG000|Overall Study|Study drug toxicity|0|||
163218309|NCT03446040|589515783|FG001|Overall Study|Study drug toxicity|0|||
163218310|NCT03446040|589515784|FG002|Overall Study|Study drug toxicity|0|||
163218311|NCT03446040|589515785|FG003|Overall Study|Study drug toxicity|0|||
163218312|NCT03446040|589515786|FG004|Overall Study|Study drug toxicity|0|||
163218313|NCT03446040|589515787|FG005|Overall Study|Study drug toxicity|0|||
163218314|NCT03446040|589515788|FG006|Overall Study|Study drug toxicity|0|||
163218315|NCT03446040|589515789|FG007|Overall Study|Study drug toxicity|0|||
163218316|NCT03446040|589515790|FG008|Overall Study|Study drug toxicity|1|||
163218317|NCT03446040|589515791|FG009|Overall Study|Study drug toxicity|0|||
163218318|NCT03446040|589515792|FG010|Overall Study|Study drug toxicity|0|||
163218319|NCT03446040|589515793|FG011|Overall Study|Study drug toxicity|0|||
163218320|NCT03446040|589515794|FG012|Overall Study|Study drug toxicity|0|||
163073852|NCT02421510|588978246|FG000|Overall Study|Other|4|||
163073853|NCT02421510|588978247|FG001|Overall Study|Other|2|||
163073854|NCT02421510|588978248|FG002|Overall Study|Other|3|||
163073855|NCT02421510|588978246|FG000|Overall Study|Protocol Violation|1|||
163073856|NCT02421510|588978247|FG001|Overall Study|Protocol Violation|2|||
163073857|NCT02421510|588978248|FG002|Overall Study|Protocol Violation|0|||
163073858|NCT02421510|588978246|FG000|Overall Study|Death|1|||
163073859|NCT02421510|588978247|FG001|Overall Study|Death|0|||
163073860|NCT02421510|588978248|FG002|Overall Study|Death|0|||
163073861|NCT02421510|588978246|FG000|Overall Study|Noncompliance with study drug|1|||
163073862|NCT02421510|588978247|FG001|Overall Study|Noncompliance with study drug|0|||
163073863|NCT02421510|588978248|FG002|Overall Study|Noncompliance with study drug|0|||
163073864|NCT02421510|588978246|FG000|Overall Study|Physician Decision|1|||
163073865|NCT02421510|588978247|FG001|Overall Study|Physician Decision|1|||
163073866|NCT02421510|588978248|FG002|Overall Study|Physician Decision|3|||
163073867|NCT02421510|588978246|FG000|Overall Study|Adverse Event|9|||
163073868|NCT02421510|588978247|FG001|Overall Study|Adverse Event|10|||
163073869|NCT02421510|588978248|FG002|Overall Study|Adverse Event|18|||
163073870|NCT02421510|588978246|FG000|Overall Study|Pregnancy|1|||
163073871|NCT02421510|588978247|FG001|Overall Study|Pregnancy|1|||
163073872|NCT02421510|588978248|FG002|Overall Study|Pregnancy|0|||
163073873|NCT02421510|588978246|FG000|Overall Study|Withdrawal by Subject|14|||
163073874|NCT02421510|588978247|FG001|Overall Study|Withdrawal by Subject|18|||
163073875|NCT02421510|588978248|FG002|Overall Study|Withdrawal by Subject|12|||
163073876|NCT02421510|588978246|FG000|Overall Study|Lost to Follow-up|1|||
163073877|NCT02421510|588978247|FG001|Overall Study|Lost to Follow-up|1|||
163073878|NCT02421510|588978248|FG002|Overall Study|Lost to Follow-up|0|||
163073879|NCT04098302|588978258|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
163073880|NCT04098302|588978259|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
163073881|NCT04098302|588978260|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
163073882|NCT04098302|588978261|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
163073883|NCT04098302|588978258|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
163073884|NCT04098302|588978259|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
163073885|NCT04098302|588978260|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
163073886|NCT04098302|588978261|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
163073887|NCT04098302|588978258|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
163073888|NCT04098302|588978259|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
163073889|NCT04098302|588978260|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
163073890|NCT04098302|588978261|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
163073891|NCT04098302|588978258|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
163073892|NCT04098302|588978259|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
163073893|NCT04098302|588978260|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
163073894|NCT04098302|588978261|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
163073895|NCT04098302|588978258|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
163073896|NCT04098302|588978259|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
163073897|NCT04098302|588978260|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
163073898|NCT04098302|588978261|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
163073899|NCT04098302|588978258|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
163073900|NCT04098302|588978259|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
163073901|NCT04098302|588978260|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
163073902|NCT04098302|588978261|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
163073903|NCT04098302|588978258|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
163073904|NCT04098302|588978259|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
163218321|NCT03446040|589515795|FG013|Overall Study|Study drug toxicity|0|||
163218322|NCT03446040|589515782|FG000|Overall Study|Adverse Event|0|||
163218323|NCT03446040|589515783|FG001|Overall Study|Adverse Event|0|||
163218324|NCT03446040|589515784|FG002|Overall Study|Adverse Event|0|||
163218325|NCT03446040|589515785|FG003|Overall Study|Adverse Event|0|||
163331348|NCT01683409|589922561|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
163218326|NCT03446040|589515786|FG004|Overall Study|Adverse Event|0|||
163073905|NCT04098302|588978260|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
163218327|NCT03446040|589515787|FG005|Overall Study|Adverse Event|2|||
163218328|NCT03446040|589515788|FG006|Overall Study|Adverse Event|0|||
163331349|NCT01683409|589922562|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
163331350|NCT01683409|589922563|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
163073906|NCT04098302|588978261|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
163073907|NCT04098302|588978258|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
163073908|NCT04098302|588978259|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
163073909|NCT04098302|588978260|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
163073910|NCT04098302|588978261|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
163073911|NCT05061706|588978262|FG000|Overall Study|Adverse Event|29|||
163073912|NCT05061706|588978263|FG001|Overall Study|Adverse Event|1|||
163073913|NCT05061706|588978262|FG000|Overall Study|Lack of Efficacy|0|||
163406395|NCT02404103|590198619|FG000|Overall Study|Lost to Follow-up|3|||
163218329|NCT03446040|589515789|FG007|Overall Study|Adverse Event|0|||
163218330|NCT03446040|589515790|FG008|Overall Study|Adverse Event|1|||
163073914|NCT05061706|588978263|FG001|Overall Study|Lack of Efficacy|1|||
163073915|NCT05061706|588978262|FG000|Overall Study|Lost to Follow-up|2|||
163073916|NCT05061706|588978263|FG001|Overall Study|Lost to Follow-up|2|||
163073917|NCT05061706|588978262|FG000|Overall Study|Protocol Violation|3|||
163073918|NCT05061706|588978263|FG001|Overall Study|Protocol Violation|1|||
163073919|NCT05061706|588978262|FG000|Overall Study|Withdrawal by Subject|3|||
163073920|NCT05061706|588978263|FG001|Overall Study|Withdrawal by Subject|9|||
163073921|NCT00191152|588978264|FG000|Initial Treatment|Adverse Event|43|||
163073922|NCT00191152|588978265|FG001|Initial Treatment|Adverse Event|67|||
163073923|NCT00191152|588978264|FG000|Initial Treatment|Physician Decision|40|||
163073924|NCT00191152|588978265|FG001|Initial Treatment|Physician Decision|31|||
163073925|NCT00191152|588978264|FG000|Initial Treatment|Withdrawal by Subject|40|||
163073926|NCT00191152|588978265|FG001|Initial Treatment|Withdrawal by Subject|28|||
163073927|NCT00191152|588978264|FG000|Initial Treatment|Lost to Follow-up|0|||
163073928|NCT00191152|588978265|FG001|Initial Treatment|Lost to Follow-up|6|||
163073929|NCT00191152|588978264|FG000|Initial Treatment|Other|18|||
163073930|NCT00191152|588978265|FG001|Initial Treatment|Other|21|||
163073931|NCT00191152|588978264|FG000|Crossover Treatment|Adverse Event|8|||
163073932|NCT00191152|588978265|FG001|Crossover Treatment|Adverse Event|8|||
163073933|NCT00191152|588978264|FG000|Crossover Treatment|Physician Decision|7|||
163073934|NCT00191152|588978265|FG001|Crossover Treatment|Physician Decision|7|||
163073935|NCT00191152|588978264|FG000|Crossover Treatment|Withdrawal by Subject|6|||
163073936|NCT00191152|588978265|FG001|Crossover Treatment|Withdrawal by Subject|9|||
163073937|NCT00191152|588978264|FG000|Crossover Treatment|Lost to Follow-up|2|||
163073938|NCT00191152|588978265|FG001|Crossover Treatment|Lost to Follow-up|1|||
163073939|NCT00191152|588978264|FG000|Crossover Treatment|Other|4|||
163073940|NCT00191152|588978265|FG001|Crossover Treatment|Other|3|||
163073941|NCT00114777|588978266|FG000|Randomization to Month 36|Death|10|||
163073942|NCT00114777|588978267|FG001|Randomization to Month 36|Death|4|||
163073943|NCT00114777|588978268|FG002|Randomization to Month 36|Death|3|||
163073944|NCT00114777|588978266|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
163073945|NCT00114777|588978267|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
163073946|NCT00114777|588978268|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
163073947|NCT00114777|588978266|FG000|Randomization to Month 36|Lack of Efficacy|19|||
163073948|NCT00114777|588978267|FG001|Randomization to Month 36|Lack of Efficacy|15|||
163073949|NCT00114777|588978268|FG002|Randomization to Month 36|Lack of Efficacy|17|||
163073950|NCT00114777|588978266|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
163218331|NCT03446040|589515791|FG009|Overall Study|Adverse Event|0|||
163073951|NCT00114777|588978267|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
163073952|NCT00114777|588978268|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
163073953|NCT00114777|588978266|FG000|Randomization to Month 36|Adverse Event|34|||
163073954|NCT00114777|588978267|FG001|Randomization to Month 36|Adverse Event|35|||
163073955|NCT00114777|588978268|FG002|Randomization to Month 36|Adverse Event|44|||
163073956|NCT00114777|588978266|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
163073957|NCT00114777|588978267|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
163073958|NCT00114777|588978268|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
163218332|NCT03446040|589515792|FG010|Overall Study|Adverse Event|0|||
163218333|NCT03446040|589515793|FG011|Overall Study|Adverse Event|0|||
163218334|NCT03446040|589515794|FG012|Overall Study|Adverse Event|0|||
163218335|NCT03446040|589515795|FG013|Overall Study|Adverse Event|0|||
163218336|NCT03446040|589515782|FG000|Overall Study|Death|0|||
163218337|NCT03446040|589515783|FG001|Overall Study|Death|0|||
163218338|NCT03446040|589515784|FG002|Overall Study|Death|0|||
163218339|NCT03446040|589515785|FG003|Overall Study|Death|0|||
163218340|NCT03446040|589515786|FG004|Overall Study|Death|0|||
163218341|NCT03446040|589515787|FG005|Overall Study|Death|0|||
163218342|NCT03446040|589515788|FG006|Overall Study|Death|0|||
163218343|NCT03446040|589515789|FG007|Overall Study|Death|0|||
163218344|NCT03446040|589515790|FG008|Overall Study|Death|0|||
163218345|NCT03446040|589515791|FG009|Overall Study|Death|0|||
163218346|NCT03446040|589515792|FG010|Overall Study|Death|1|||
163218347|NCT03446040|589515793|FG011|Overall Study|Death|0|||
163218348|NCT03446040|589515794|FG012|Overall Study|Death|0|||
163218349|NCT03446040|589515795|FG013|Overall Study|Death|2|||
163218350|NCT03446040|589515782|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
163218351|NCT03446040|589515783|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
163218352|NCT03446040|589515784|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
163218353|NCT03446040|589515785|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
163218354|NCT03446040|589515786|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
163218355|NCT03446040|589515787|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
163218356|NCT03446040|589515788|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
163218357|NCT03446040|589515789|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
163331351|NCT01683409|589922559|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
163331352|NCT01683409|589922560|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
163331353|NCT01683409|589922561|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
163331354|NCT01683409|589922562|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
163331355|NCT01683409|589922563|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
163331356|NCT01683409|589922559|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
163331357|NCT01683409|589922560|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
163331358|NCT01683409|589922561|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
163331359|NCT01683409|589922562|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
163331360|NCT01683409|589922563|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
163331361|NCT01683409|589922559|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
163331362|NCT01683409|589922560|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
163331363|NCT01683409|589922561|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
163331364|NCT01683409|589922562|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
163331365|NCT01683409|589922563|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
163331366|NCT01683409|589922559|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
163331367|NCT01683409|589922560|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
163331368|NCT01683409|589922561|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
163331369|NCT01683409|589922562|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
163331370|NCT01683409|589922563|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
163331371|NCT00553332|589922569|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
163331372|NCT00145470|589922577|FG000|Overall Study|Adverse Event|19|||
163331373|NCT00145470|589922578|FG001|Overall Study|Adverse Event|25|||
163331374|NCT00145470|589922577|FG000|Overall Study|Lack of Efficacy|27|||
163331375|NCT00145470|589922578|FG001|Overall Study|Lack of Efficacy|13|||
163331376|NCT00145470|589922577|FG000|Overall Study|Withdrawal by Subject|36|||
163331377|NCT00145470|589922578|FG001|Overall Study|Withdrawal by Subject|34|||
163331378|NCT00145470|589922577|FG000|Overall Study|Lost to Follow-up|21|||
163331379|NCT00145470|589922578|FG001|Overall Study|Lost to Follow-up|17|||
163027739|NCT01738503|588804168|FG006|Treatment Period|Protocol Violation|0|||
163027740|NCT01738503|588804162|FG000|Treatment Period|Other|0|||
163027741|NCT01738503|588804163|FG001|Treatment Period|Other|0|||
163027742|NCT01738503|588804164|FG002|Treatment Period|Other|1|||
163027743|NCT01738503|588804165|FG003|Treatment Period|Other|0|||
163027744|NCT01738503|588804166|FG004|Treatment Period|Other|0|||
163027745|NCT01738503|588804167|FG005|Treatment Period|Other|0|||
163027746|NCT01738503|588804168|FG006|Treatment Period|Other|0|||
163027747|NCT01738503|588804162|FG000|PET Imaging Sub-study|Adverse Event|0|||
163027748|NCT01738503|588804163|FG001|PET Imaging Sub-study|Adverse Event|0|||
163027749|NCT01738503|588804164|FG002|PET Imaging Sub-study|Adverse Event|0|||
163027750|NCT01738503|588804165|FG003|PET Imaging Sub-study|Adverse Event|0|||
163027751|NCT01738503|588804166|FG004|PET Imaging Sub-study|Adverse Event|0|||
163027752|NCT01738503|588804167|FG005|PET Imaging Sub-study|Adverse Event|1|||
163027753|NCT01738503|588804168|FG006|PET Imaging Sub-study|Adverse Event|0|||
163027754|NCT01738503|588804162|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
163027755|NCT01738503|588804163|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
163027756|NCT01738503|588804164|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
163027757|NCT01738503|588804165|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
163027758|NCT01738503|588804166|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
163027759|NCT01738503|588804167|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
163027760|NCT01738503|588804168|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
163027761|NCT01340027|588804170|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
163027762|NCT01340027|588804171|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
163027763|NCT01340027|588804172|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
163027764|NCT01340027|588804173|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
163027765|NCT01340027|588804174|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
163027766|NCT01340027|588804175|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
163027767|NCT01340027|588804176|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
163027768|NCT01340027|588804177|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
163027769|NCT01340027|588804178|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
163027770|NCT01340027|588804179|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
163027771|NCT01340027|588804180|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
163027772|NCT01340027|588804181|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
163027773|NCT01340027|588804170|FG000|Overall Study|Adverse Event|0|||
163027774|NCT01340027|588804171|FG001|Overall Study|Adverse Event|1|||
163027775|NCT01340027|588804172|FG002|Overall Study|Adverse Event|2|||
163027776|NCT01340027|588804173|FG003|Overall Study|Adverse Event|0|||
163027777|NCT01340027|588804174|FG004|Overall Study|Adverse Event|1|||
163027778|NCT01340027|588804175|FG005|Overall Study|Adverse Event|2|||
163331380|NCT00145470|589922577|FG000|Overall Study|Reason Not Reported|9|||
163331381|NCT00145470|589922578|FG001|Overall Study|Reason Not Reported|9|||
163331382|NCT02063659|589922579|FG000|Double-Blind Treatment Period|Adverse Event|1|||
163331383|NCT02063659|589922580|FG001|Double-Blind Treatment Period|Adverse Event|2|||
163331384|NCT02063659|589922581|FG002|Double-Blind Treatment Period|Adverse Event|0|||
163331385|NCT02063659|589922582|FG003|Double-Blind Treatment Period|Adverse Event|0|||
163331386|NCT02063659|589922579|FG000|Double-Blind Treatment Period|Physician Decision|1|||
163331387|NCT02063659|589922580|FG001|Double-Blind Treatment Period|Physician Decision|0|||
163331388|NCT02063659|589922581|FG002|Double-Blind Treatment Period|Physician Decision|0|||
163331389|NCT02063659|589922582|FG003|Double-Blind Treatment Period|Physician Decision|0|||
163331390|NCT02063659|589922579|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
163331391|NCT02063659|589922580|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
163331392|NCT02063659|589922581|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
163331393|NCT02063659|589922582|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
163331394|NCT02063659|589922579|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
163331395|NCT02063659|589922580|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
163331396|NCT02063659|589922581|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
163331397|NCT02063659|589922582|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
163331398|NCT02063659|589922579|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
163027779|NCT01340027|588804176|FG006|Overall Study|Adverse Event|2|||
163027780|NCT01340027|588804177|FG007|Overall Study|Adverse Event|1|||
163027781|NCT01340027|588804178|FG008|Overall Study|Adverse Event|4|||
163027782|NCT01340027|588804179|FG009|Overall Study|Adverse Event|1|||
163027783|NCT01340027|588804180|FG010|Overall Study|Adverse Event|1|||
163027784|NCT01340027|588804181|FG011|Overall Study|Adverse Event|3|||
163027785|NCT01340027|588804170|FG000|Overall Study|Lack of Efficacy|0|||
163027786|NCT01340027|588804171|FG001|Overall Study|Lack of Efficacy|0|||
163027787|NCT01340027|588804172|FG002|Overall Study|Lack of Efficacy|0|||
163027788|NCT01340027|588804173|FG003|Overall Study|Lack of Efficacy|0|||
163027789|NCT01340027|588804174|FG004|Overall Study|Lack of Efficacy|0|||
163027790|NCT01340027|588804175|FG005|Overall Study|Lack of Efficacy|0|||
163027791|NCT01340027|588804176|FG006|Overall Study|Lack of Efficacy|1|||
163027792|NCT01340027|588804177|FG007|Overall Study|Lack of Efficacy|1|||
163027793|NCT01340027|588804178|FG008|Overall Study|Lack of Efficacy|1|||
163027794|NCT01340027|588804179|FG009|Overall Study|Lack of Efficacy|0|||
163027795|NCT01340027|588804180|FG010|Overall Study|Lack of Efficacy|0|||
163027796|NCT01340027|588804181|FG011|Overall Study|Lack of Efficacy|0|||
163027797|NCT01340027|588804170|FG000|Overall Study|Lost to Follow-up|0|||
163027798|NCT01340027|588804171|FG001|Overall Study|Lost to Follow-up|1|||
163027799|NCT01340027|588804172|FG002|Overall Study|Lost to Follow-up|0|||
163027800|NCT01340027|588804173|FG003|Overall Study|Lost to Follow-up|0|||
163027801|NCT01340027|588804174|FG004|Overall Study|Lost to Follow-up|0|||
163027802|NCT01340027|588804175|FG005|Overall Study|Lost to Follow-up|0|||
163027803|NCT01340027|588804176|FG006|Overall Study|Lost to Follow-up|1|||
163027804|NCT01340027|588804177|FG007|Overall Study|Lost to Follow-up|0|||
163027805|NCT01340027|588804178|FG008|Overall Study|Lost to Follow-up|0|||
163027806|NCT01340027|588804179|FG009|Overall Study|Lost to Follow-up|1|||
163027807|NCT01340027|588804180|FG010|Overall Study|Lost to Follow-up|0|||
163027808|NCT01340027|588804181|FG011|Overall Study|Lost to Follow-up|0|||
163027809|NCT01340027|588804170|FG000|Overall Study|Protocol Violation|1|||
163027810|NCT01340027|588804171|FG001|Overall Study|Protocol Violation|2|||
163027811|NCT01340027|588804172|FG002|Overall Study|Protocol Violation|0|||
163027812|NCT01340027|588804173|FG003|Overall Study|Protocol Violation|0|||
163027813|NCT01340027|588804174|FG004|Overall Study|Protocol Violation|6|||
163027814|NCT01340027|588804175|FG005|Overall Study|Protocol Violation|0|||
163027815|NCT01340027|588804176|FG006|Overall Study|Protocol Violation|0|||
163027816|NCT01340027|588804177|FG007|Overall Study|Protocol Violation|1|||
163027817|NCT01340027|588804178|FG008|Overall Study|Protocol Violation|2|||
163027818|NCT01340027|588804179|FG009|Overall Study|Protocol Violation|2|||
163027819|NCT01340027|588804180|FG010|Overall Study|Protocol Violation|0|||
163027820|NCT01340027|588804181|FG011|Overall Study|Protocol Violation|0|||
163027821|NCT01340027|588804170|FG000|Overall Study|Withdrawal by Subject|4|||
163027822|NCT01340027|588804171|FG001|Overall Study|Withdrawal by Subject|3|||
163027823|NCT01340027|588804172|FG002|Overall Study|Withdrawal by Subject|1|||
163027824|NCT01340027|588804173|FG003|Overall Study|Withdrawal by Subject|3|||
163027825|NCT01340027|588804174|FG004|Overall Study|Withdrawal by Subject|3|||
163027826|NCT01340027|588804175|FG005|Overall Study|Withdrawal by Subject|2|||
163027827|NCT01340027|588804176|FG006|Overall Study|Withdrawal by Subject|3|||
163027828|NCT01340027|588804177|FG007|Overall Study|Withdrawal by Subject|4|||
163027829|NCT01340027|588804178|FG008|Overall Study|Withdrawal by Subject|1|||
163027830|NCT01340027|588804179|FG009|Overall Study|Withdrawal by Subject|2|||
163027831|NCT01340027|588804180|FG010|Overall Study|Withdrawal by Subject|0|||
163027832|NCT01340027|588804181|FG011|Overall Study|Withdrawal by Subject|1|||
163027833|NCT01340027|588804170|FG000|Overall Study|Miscellaneous|0|||
163027834|NCT01340027|588804171|FG001|Overall Study|Miscellaneous|0|||
163027835|NCT01340027|588804172|FG002|Overall Study|Miscellaneous|0|||
163027836|NCT01340027|588804173|FG003|Overall Study|Miscellaneous|1|||
163027837|NCT01340027|588804174|FG004|Overall Study|Miscellaneous|0|||
163027838|NCT01340027|588804175|FG005|Overall Study|Miscellaneous|0|||
163027839|NCT01340027|588804176|FG006|Overall Study|Miscellaneous|0|||
163073959|NCT00114777|588978266|FG000|Randomization to Month 36|Other|9|||
163073960|NCT00114777|588978267|FG001|Randomization to Month 36|Other|3|||
163073961|NCT00114777|588978268|FG002|Randomization to Month 36|Other|12|||
163073962|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Death|8|||
163073963|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Death|13|||
163073964|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Death|7|||
163073965|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
163073966|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
163073967|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
163073968|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
163073969|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
163073970|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
163073971|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
163073972|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
163073973|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
163073974|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
163073975|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
163073976|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
163073977|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
163073978|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
163073979|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
163073980|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
163073981|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
163073982|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
163073983|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
163073984|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
163073985|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
163073986|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Other|2|||
163073987|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Other|0|||
163073988|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Other|2|||
163073989|NCT01181128|588978272|FG000|Overall Study|Withdrawal by Subject|2|||
163218358|NCT03446040|589515790|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
163406396|NCT02404103|590198620|FG001|Overall Study|Lost to Follow-up|3|||
163027840|NCT01340027|588804177|FG007|Overall Study|Miscellaneous|0|||
163027841|NCT01340027|588804178|FG008|Overall Study|Miscellaneous|0|||
163027842|NCT01340027|588804179|FG009|Overall Study|Miscellaneous|0|||
163027843|NCT01340027|588804180|FG010|Overall Study|Miscellaneous|1|||
163027844|NCT01340027|588804181|FG011|Overall Study|Miscellaneous|0|||
163027845|NCT03005327|588804182|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
163027846|NCT03005327|588804183|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
163027847|NCT03005327|588804184|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
163027848|NCT03005327|588804185|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
163027849|NCT03005327|588804182|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163027850|NCT03005327|588804183|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
163027851|NCT03005327|588804184|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163027852|NCT03005327|588804185|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163027853|NCT00833482|588804186|FG000|Days 11-20|Adverse Event|0|||
163027854|NCT00833482|588804187|FG001|Days 11-20|Adverse Event|2|||
163027855|NCT00833482|588804188|FG002|Days 11-20|Adverse Event|0|||
163027856|NCT00833482|588804189|FG003|Days 11-20|Adverse Event|0|||
163027857|NCT00833482|588804190|FG004|Days 11-20|Adverse Event|0|||
163027858|NCT00833482|588804191|FG005|Days 11-20|Adverse Event|0|||
163027859|NCT00833482|588804186|FG000|Days 11-20|Withdrawal by Subject|0|||
163027860|NCT00833482|588804187|FG001|Days 11-20|Withdrawal by Subject|1|||
163027861|NCT00833482|588804188|FG002|Days 11-20|Withdrawal by Subject|0|||
163027862|NCT00833482|588804189|FG003|Days 11-20|Withdrawal by Subject|0|||
163027863|NCT00833482|588804190|FG004|Days 11-20|Withdrawal by Subject|0|||
163027864|NCT00833482|588804191|FG005|Days 11-20|Withdrawal by Subject|0|||
163027865|NCT00833482|588804186|FG000|Days 21-30|Adverse Event|0|||
163027866|NCT00833482|588804187|FG001|Days 21-30|Adverse Event|0|||
163027867|NCT00833482|588804188|FG002|Days 21-30|Adverse Event|1|||
163027868|NCT00833482|588804189|FG003|Days 21-30|Adverse Event|0|||
163027869|NCT00833482|588804190|FG004|Days 21-30|Adverse Event|0|||
163027870|NCT00833482|588804191|FG005|Days 21-30|Adverse Event|0|||
163027871|NCT00833482|588804186|FG000|Days 21-30|Withdrawal by Subject|0|||
163027872|NCT00833482|588804187|FG001|Days 21-30|Withdrawal by Subject|0|||
163027873|NCT00833482|588804188|FG002|Days 21-30|Withdrawal by Subject|0|||
163027874|NCT00833482|588804189|FG003|Days 21-30|Withdrawal by Subject|0|||
163027875|NCT00833482|588804190|FG004|Days 21-30|Withdrawal by Subject|1|||
163027876|NCT00833482|588804191|FG005|Days 21-30|Withdrawal by Subject|0|||
163027877|NCT01794793|588804193|FG000|Treatment Period|Withdrawal by Subject|24|||
163027878|NCT01794793|588804193|FG000|Treatment Period|Lack of Efficacy|22|||
163027879|NCT01794793|588804193|FG000|Treatment Period|Adverse Event|17|||
163027880|NCT01794793|588804193|FG000|Treatment Period|Physician Decision|14|||
163073990|NCT01181128|588978273|FG001|Overall Study|Withdrawal by Subject|2|||
163073991|NCT01181128|588978274|FG002|Overall Study|Withdrawal by Subject|0|||
163073992|NCT01181128|588978272|FG000|Overall Study|Death|1|||
163073993|NCT01181128|588978273|FG001|Overall Study|Death|0|||
163073994|NCT01181128|588978274|FG002|Overall Study|Death|0|||
163073995|NCT01181128|588978272|FG000|Overall Study|Physician Decision|2|||
163073996|NCT01181128|588978273|FG001|Overall Study|Physician Decision|0|||
163073997|NCT01181128|588978274|FG002|Overall Study|Physician Decision|0|||
163073998|NCT01181128|588978272|FG000|Overall Study|Adverse Event|0|||
163073999|NCT01181128|588978273|FG001|Overall Study|Adverse Event|2|||
163074000|NCT01181128|588978274|FG002|Overall Study|Adverse Event|0|||
163074001|NCT01181128|588978272|FG000|Overall Study|Other|1|||
163074002|NCT01181128|588978273|FG001|Overall Study|Other|1|||
163074003|NCT01181128|588978274|FG002|Overall Study|Other|1|||
163074004|NCT04477486|588978277|FG000|Overall Study|Death|2|||
163074005|NCT04477486|588978277|FG000|Overall Study|Ongoing at Time of Analysis|11|||
163074006|NCT01543503|588978279|FG000|Overall Study|Lost to Follow-up|32|||
163074007|NCT01543503|588978280|FG001|Overall Study|Lost to Follow-up|36|||
163074008|NCT01543503|588978279|FG000|Overall Study|Adverse Event|9|||
163074009|NCT01543503|588978280|FG001|Overall Study|Adverse Event|13|||
163074010|NCT01543503|588978279|FG000|Overall Study|Lack of Efficacy|4|||
163074011|NCT01543503|588978280|FG001|Overall Study|Lack of Efficacy|16|||
163074012|NCT01543503|588978279|FG000|Overall Study|Participant withdrew informed consent|8|||
163074013|NCT01543503|588978280|FG001|Overall Study|Participant withdrew informed consent|10|||
163074014|NCT01543503|588978279|FG000|Overall Study|Change of jobs|0|||
163074015|NCT01543503|588978280|FG001|Overall Study|Change of jobs|1|||
163074016|NCT01543503|588978279|FG000|Overall Study|Intolerance to the biologic treatment|0|||
163074017|NCT01543503|588978280|FG001|Overall Study|Intolerance to the biologic treatment|1|||
163074018|NCT01543503|588978279|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
163074019|NCT01543503|588978280|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
163074020|NCT01543503|588978279|FG000|Overall Study|Participant did not complete last visit|0|||
163074021|NCT01543503|588978280|FG001|Overall Study|Participant did not complete last visit|2|||
163074022|NCT01543503|588978279|FG000|Overall Study|Refused to continue treatment|7|||
163074023|NCT01543503|588978280|FG001|Overall Study|Refused to continue treatment|0|||
163074024|NCT01543503|588978279|FG000|Overall Study|Incorrect medication received|1|||
163074025|NCT01543503|588978280|FG001|Overall Study|Incorrect medication received|0|||
163074026|NCT01543503|588978279|FG000|Overall Study|Participant moved to another city|2|||
163074027|NCT01543503|588978280|FG001|Overall Study|Participant moved to another city|0|||
163074028|NCT01543503|588978279|FG000|Overall Study|Participant will not return for visits|0|||
163074029|NCT01543503|588978280|FG001|Overall Study|Participant will not return for visits|2|||
163074030|NCT01543503|588978279|FG000|Overall Study|Participant transferred to another city|1|||
163074031|NCT01543503|588978280|FG001|Overall Study|Participant transferred to another city|0|||
163074032|NCT01543503|588978279|FG000|Overall Study|Participant moved to Scotland|1|||
163074033|NCT01543503|588978280|FG001|Overall Study|Participant moved to Scotland|0|||
163074034|NCT01543503|588978279|FG000|Overall Study|Participant decision to stop treatment|1|||
163074035|NCT01543503|588978280|FG001|Overall Study|Participant decision to stop treatment|0|||
163074036|NCT01543503|588978279|FG000|Overall Study|Investigator did not wish to participate|1|||
163074037|NCT01543503|588978280|FG001|Overall Study|Investigator did not wish to participate|1|||
163074038|NCT01543503|588978279|FG000|Overall Study|Participant recruited after closing date|0|||
163074039|NCT01543503|588978280|FG001|Overall Study|Participant recruited after closing date|1|||
163074040|NCT01543503|588978279|FG000|Overall Study|Site stopped participation|5|||
163074041|NCT01543503|588978280|FG001|Overall Study|Site stopped participation|1|||
163074042|NCT01543503|588978279|FG000|Overall Study|Participant did not attend a visit|1|||
163074043|NCT01543503|588978280|FG001|Overall Study|Participant did not attend a visit|0|||
163074044|NCT01543503|588978279|FG000|Overall Study|Moved to other rheumatologic site|0|||
163218359|NCT03446040|589515791|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
163218360|NCT03446040|589515792|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
163074045|NCT01543503|588978280|FG001|Overall Study|Moved to other rheumatologic site|1|||
163074046|NCT01543503|588978279|FG000|Overall Study|Participant consented to another study|0|||
163074047|NCT01543503|588978280|FG001|Overall Study|Participant consented to another study|2|||
163074048|NCT01543503|588978279|FG000|Overall Study|Participant went to United States|1|||
163074049|NCT01543503|588978280|FG001|Overall Study|Participant went to United States|0|||
163074050|NCT01543503|588978279|FG000|Overall Study|Screen failure|1|||
163074051|NCT01543503|588978280|FG001|Overall Study|Screen failure|0|||
163074052|NCT01986751|588978281|FG000|Overall Study|improperly consented|10|||
163074053|NCT01986751|588978282|FG001|Overall Study|improperly consented|2|||
163218361|NCT03446040|589515793|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
163218362|NCT03446040|589515794|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
163218363|NCT03446040|589515795|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
163218364|NCT03446040|589515782|FG000|Overall Study|Participant withdrew consent|0|||
163218365|NCT03446040|589515783|FG001|Overall Study|Participant withdrew consent|0|||
163218366|NCT03446040|589515784|FG002|Overall Study|Participant withdrew consent|0|||
163074054|NCT00052715|588978288|FG000|Overall Study|wrong histology|1|||
163074055|NCT01774370|588978295|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
163074056|NCT01774370|588978295|FG000|Overall Study|Administered prior to the contract date|4|||
163074057|NCT01774370|588978295|FG000|Overall Study|Subjects of contraindications|34|||
163074058|NCT01774370|588978295|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
163074059|NCT01774370|588978295|FG000|Overall Study|Follow-up failure|34|||
163074060|NCT00514917|588978296|FG000|Overall Study|Death|4|||
163074061|NCT00514917|588978297|FG001|Overall Study|Death|10|||
163074062|NCT00514917|588978296|FG000|Overall Study|Protocol Violation|1|||
163074063|NCT00514917|588978297|FG001|Overall Study|Protocol Violation|0|||
163074064|NCT00514917|588978296|FG000|Overall Study|Lost to Follow-up|4|||
163074065|NCT00514917|588978297|FG001|Overall Study|Lost to Follow-up|3|||
163074066|NCT00514917|588978296|FG000|Overall Study|Withdrawal by Subject|18|||
163074067|NCT00514917|588978297|FG001|Overall Study|Withdrawal by Subject|16|||
163074068|NCT00514917|588978296|FG000|Overall Study|Discontinued due to study closure|88|||
163074069|NCT00514917|588978297|FG001|Overall Study|Discontinued due to study closure|81|||
163074070|NCT00514917|588978296|FG000|Overall Study|Undefined|11|||
163074071|NCT00514917|588978297|FG001|Overall Study|Undefined|5|||
163074072|NCT04243837|588978298|FG000|Overall Study|Adverse Event|2|||
163074073|NCT04243837|588978299|FG001|Overall Study|Adverse Event|1|||
163074074|NCT04243837|588978298|FG000|Overall Study|Withdrawal by Subject|4|||
163074075|NCT04243837|588978299|FG001|Overall Study|Withdrawal by Subject|2|||
163074076|NCT04243837|588978298|FG000|Overall Study|Covid-19 lock down|1|||
163074077|NCT04243837|588978299|FG001|Overall Study|Covid-19 lock down|0|||
163074078|NCT04243837|588978298|FG000|Overall Study|Study Terminated by Sponsor|11|||
163074079|NCT04243837|588978299|FG001|Overall Study|Study Terminated by Sponsor|12|||
163074080|NCT02280499|588978300|FG000|Overall Study|Death|14|||
163074081|NCT02280499|588978300|FG000|Overall Study|Lost to Follow-up|42|||
163074082|NCT02280499|588978300|FG000|Overall Study|Adverse Event|5|||
163074083|NCT01666314|588978306|FG000|Overall Study|Adverse Event|3|||
163074084|NCT01666314|588978307|FG001|Overall Study|Adverse Event|13|||
163074085|NCT01666314|588978308|FG002|Overall Study|Adverse Event|7|||
163074086|NCT01666314|588978309|FG003|Overall Study|Adverse Event|7|||
163074087|NCT01666314|588978306|FG000|Overall Study|Progressive Disease|11|||
163074088|NCT01666314|588978307|FG001|Overall Study|Progressive Disease|9|||
163074089|NCT01666314|588978308|FG002|Overall Study|Progressive Disease|19|||
163074090|NCT01666314|588978309|FG003|Overall Study|Progressive Disease|20|||
163074091|NCT01666314|588978306|FG000|Overall Study|Symptomatic Deterioration|1|||
163074092|NCT01666314|588978307|FG001|Overall Study|Symptomatic Deterioration|0|||
163074093|NCT01666314|588978308|FG002|Overall Study|Symptomatic Deterioration|2|||
163074094|NCT01666314|588978309|FG003|Overall Study|Symptomatic Deterioration|0|||
163074095|NCT01666314|588978306|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
163074096|NCT01666314|588978307|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
163074097|NCT01666314|588978308|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
163074098|NCT01666314|588978309|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
163074099|NCT01666314|588978306|FG000|Overall Study|Withdrawal by Subject|1|||
163074100|NCT01666314|588978307|FG001|Overall Study|Withdrawal by Subject|1|||
163074101|NCT01666314|588978308|FG002|Overall Study|Withdrawal by Subject|2|||
163074102|NCT01666314|588978309|FG003|Overall Study|Withdrawal by Subject|3|||
163074103|NCT01666314|588978306|FG000|Overall Study|Reason not Specified|10|||
163074104|NCT01666314|588978307|FG001|Overall Study|Reason not Specified|7|||
163074105|NCT01666314|588978308|FG002|Overall Study|Reason not Specified|5|||
163074106|NCT01666314|588978309|FG003|Overall Study|Reason not Specified|5|||
163074107|NCT03462563|588978313|FG000|Overall Study|Death|1|||
163074108|NCT03462563|588978314|FG001|Overall Study|Death|1|||
163074109|NCT03462563|588978313|FG000|Overall Study|Termination of study|2|||
163074110|NCT03462563|588978314|FG001|Overall Study|Termination of study|1|||
163074111|NCT03462563|588978313|FG000|Overall Study|Adverse Event|1|||
163074112|NCT03462563|588978314|FG001|Overall Study|Adverse Event|3|||
163074113|NCT03462563|588978313|FG000|Overall Study|Unspecified reason|10|||
163074114|NCT03462563|588978314|FG001|Overall Study|Unspecified reason|12|||
163074115|NCT03462563|588978313|FG000|Overall Study|Physician Decision|1|||
163074116|NCT03462563|588978314|FG001|Overall Study|Physician Decision|0|||
163074117|NCT05089357|588978315|FG000|Overall Study|Withdrawal by Subject|23|||
163074118|NCT05089357|588978315|FG000|Overall Study|Lost to Follow-up|6|||
163074119|NCT05089357|588978315|FG000|Overall Study|Medical reason|1|||
163074120|NCT05089357|588978315|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
163074121|NCT05089357|588978315|FG000|Overall Study|Pregnancy|2|||
163074122|NCT00689052|588978316|FG000|Overall Study|Adverse Event|4|||
163074123|NCT00689052|588978317|FG001|Overall Study|Adverse Event|6|||
163074124|NCT00689052|588978316|FG000|Overall Study|Protocol Violation|1|||
163074125|NCT00689052|588978317|FG001|Overall Study|Protocol Violation|0|||
163074126|NCT00689052|588978316|FG000|Overall Study|Lost to Follow-up|2|||
163074127|NCT00689052|588978317|FG001|Overall Study|Lost to Follow-up|0|||
163154800|NCT00521079|589281441|FG001|Overall Study|Adverse Event|1|||
163154801|NCT00521079|589281440|FG000|Overall Study|Lost to Follow-up|2|||
163154802|NCT00521079|589281441|FG001|Overall Study|Lost to Follow-up|1|||
163074128|NCT00689052|588978316|FG000|Overall Study|Withdrawal by Subject|2|||
163074129|NCT00689052|588978317|FG001|Overall Study|Withdrawal by Subject|0|||
163074130|NCT00689052|588978316|FG000|Overall Study|Early termination of the trial|22|||
163074131|NCT00689052|588978317|FG001|Overall Study|Early termination of the trial|24|||
163074132|NCT04796207|588978318|FG000|Overall Study|Lost to Follow-up|7|||
163074133|NCT04796207|588978319|FG001|Overall Study|Lost to Follow-up|2|||
163074134|NCT01860989|588978322|FG000|Overall Study|Unsatisfactory therapeutic|5|||
163074135|NCT04739709|588978323|FG000|Overall Study|Physician Decision|1|||
163074136|NCT04739709|588978324|FG001|Overall Study|Physician Decision|0|||
163331399|NCT02063659|589922580|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
163331400|NCT02063659|589922581|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
163331401|NCT02063659|589922582|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
163331402|NCT02063659|589922579|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
163331403|NCT02063659|589922580|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
163074143|NCT00421993|588978330|FG000|Overall Study|Withdrawal by Subject|22|||
163074144|NCT00421993|588978331|FG001|Overall Study|Withdrawal by Subject|23|||
163027881|NCT01794793|588804193|FG000|Treatment Period|Lost to Follow-up|7|||
163027882|NCT01794793|588804193|FG000|Treatment Period|Death|6|||
163027883|NCT01794793|588804193|FG000|Treatment Period|Protocol Violation|5|||
163027884|NCT01794793|588804193|FG000|Treatment Period|administrative problem|3|||
163027885|NCT01794793|588804193|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
163027886|NCT01794793|588804193|FG000|Post-treatment Follow-up|Adverse Event|8|||
163027887|NCT01794793|588804193|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
163027888|NCT01794793|588804193|FG000|Post-treatment Follow-up|administrative problem|5|||
163027889|NCT01794793|588804193|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
163027890|NCT01794793|588804193|FG000|Post-treatment Follow-up|Protocol Violation|3|||
163027891|NCT02234596|588804194|FG000|Overall Study|Participant not treated|2|||
163027892|NCT04852679|588804195|FG000|Main Intervention Period|Withdrawal by Subject|3|||
163027893|NCT04852679|588804195|FG000|Main Intervention Period|Adverse Event|1|||
163027894|NCT04852679|588804195|FG000|Main Intervention Period|Progressive Disease|16|||
163027895|NCT04852679|588804195|FG000|Main Intervention Period|Refused study visit|1|||
163027896|NCT04852679|588804195|FG000|Independent Injection Period|Missed study visit|1|||
163027897|NCT02907593|588805310|FG000|Overall Study|Withdrawal by Subject|0|||
163027898|NCT02907593|588805311|FG001|Overall Study|Withdrawal by Subject|0|||
163027899|NCT02907593|588805312|FG002|Overall Study|Withdrawal by Subject|1|||
163027900|NCT02907593|588805313|FG003|Overall Study|Withdrawal by Subject|0|||
163027901|NCT01944670|588805314|FG000|Overall Study|Lost to Follow-up|2|||
163027902|NCT01752634|588805318|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
163027903|NCT01752634|588805319|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
163027904|NCT01752634|588805320|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
163027905|NCT01752634|588805321|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
163027906|NCT01752634|588805322|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
163027907|NCT01752634|588805323|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
163027908|NCT01752634|588805318|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
163027909|NCT01752634|588805319|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
163027910|NCT01752634|588805320|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
163027911|NCT01752634|588805321|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
163027912|NCT01752634|588805322|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
163027913|NCT01752634|588805323|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
163027914|NCT01752634|588805318|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
163027915|NCT01752634|588805319|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
163027916|NCT01752634|588805320|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
163027917|NCT01752634|588805321|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
163027918|NCT01752634|588805322|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
163027919|NCT01752634|588805323|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
163027920|NCT01752634|588805318|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
163027921|NCT01752634|588805319|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
163027922|NCT01752634|588805320|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
163027923|NCT01752634|588805321|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
163027924|NCT01752634|588805322|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
163027925|NCT01752634|588805323|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
163027926|NCT01752634|588805318|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
163027927|NCT01752634|588805319|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
163027928|NCT01752634|588805320|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
163027929|NCT01752634|588805321|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
163027930|NCT01752634|588805322|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
163027931|NCT01752634|588805323|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
163027932|NCT01752634|588805318|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
163027933|NCT01752634|588805319|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
163074145|NCT00421993|588978332|FG002|Overall Study|Withdrawal by Subject|23|||
163074146|NCT00421993|588978333|FG003|Overall Study|Withdrawal by Subject|24|||
163074147|NCT00421993|588978330|FG000|Overall Study|Lost to Follow-up|18|||
163074148|NCT00421993|588978331|FG001|Overall Study|Lost to Follow-up|19|||
163074149|NCT00421993|588978332|FG002|Overall Study|Lost to Follow-up|22|||
163074150|NCT00421993|588978333|FG003|Overall Study|Lost to Follow-up|20|||
163074151|NCT00421993|588978330|FG000|Overall Study|Adverse Event|11|||
163074152|NCT00421993|588978331|FG001|Overall Study|Adverse Event|1|||
163074153|NCT00421993|588978332|FG002|Overall Study|Adverse Event|6|||
163406397|NCT01783678|590198621|FG000|Overall Study|Randomized but Not Treated|0|||
163074154|NCT00421993|588978333|FG003|Overall Study|Adverse Event|4|||
163074155|NCT00421993|588978330|FG000|Overall Study|Protocol Violation|2|||
163074156|NCT00421993|588978331|FG001|Overall Study|Protocol Violation|2|||
163074157|NCT00421993|588978332|FG002|Overall Study|Protocol Violation|0|||
163074158|NCT00421993|588978333|FG003|Overall Study|Protocol Violation|1|||
163074159|NCT00421993|588978330|FG000|Overall Study|Lack of Efficacy|0|||
163074160|NCT00421993|588978331|FG001|Overall Study|Lack of Efficacy|3|||
163074161|NCT00421993|588978332|FG002|Overall Study|Lack of Efficacy|0|||
163074162|NCT00421993|588978333|FG003|Overall Study|Lack of Efficacy|5|||
163074163|NCT00421993|588978330|FG000|Overall Study|Pregnancy|0|||
163074164|NCT00421993|588978331|FG001|Overall Study|Pregnancy|1|||
163074165|NCT00421993|588978332|FG002|Overall Study|Pregnancy|1|||
163074166|NCT00421993|588978333|FG003|Overall Study|Pregnancy|2|||
163074167|NCT00421993|588978330|FG000|Overall Study|Subject transportation issues|0|||
163074168|NCT00421993|588978331|FG001|Overall Study|Subject transportation issues|0|||
163074169|NCT00421993|588978332|FG002|Overall Study|Subject transportation issues|0|||
163074170|NCT00421993|588978333|FG003|Overall Study|Subject transportation issues|1|||
163074171|NCT01751685|588978334|FG000|6-mo Followup|Missed study visit|1|||
163074172|NCT01751685|588978335|FG001|6-mo Followup|Missed study visit|0|||
163074173|NCT01751685|588978334|FG000|6-mo Followup|Withdrawal by Subject|2|||
163074174|NCT01751685|588978335|FG001|6-mo Followup|Withdrawal by Subject|2|||
163074175|NCT01751685|588978334|FG000|6-mo Followup|Lost to Follow-up|0|||
163074176|NCT01751685|588978335|FG001|6-mo Followup|Lost to Follow-up|1|||
163074177|NCT01751685|588978334|FG000|12-mo Followup|Lost to Follow-up|5|||
163074178|NCT01751685|588978335|FG001|12-mo Followup|Lost to Follow-up|0|||
163074179|NCT02724644|588980488|FG000|Overall Study|Adverse Event|7|||
163074180|NCT02724644|588980489|FG001|Overall Study|Adverse Event|1|||
163074181|NCT02724644|588980488|FG000|Overall Study|Lost to Follow-up|6|||
163074182|NCT02724644|588980489|FG001|Overall Study|Lost to Follow-up|2|||
163074183|NCT02724644|588980488|FG000|Overall Study|Withdrawal by Subject|7|||
163074184|NCT02724644|588980489|FG001|Overall Study|Withdrawal by Subject|1|||
163074185|NCT02724644|588980488|FG000|Overall Study|Administrative|1|||
163074186|NCT02724644|588980489|FG001|Overall Study|Administrative|0|||
163074187|NCT01882829|588980490|FG000|Overall Study|Adverse Event|4|||
163074188|NCT01882829|588980490|FG000|Overall Study|Protocol Violation|1|||
163074189|NCT01882829|588980490|FG000|Overall Study|Withdrawal by Subject|1|||
163074190|NCT03312114|588980491|FG000|Overall Study|All the five enrolled dropped out of the|5|||
163074191|NCT02469961|588980498|FG000|Overall Study|Physician Decision|4|||
163074192|NCT02469961|588980499|FG001|Overall Study|Physician Decision|1|||
163074193|NCT01245751|588980507|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
163074194|NCT01245751|588980508|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
163074195|NCT01245751|588980509|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
163074196|NCT01245751|588980510|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
163074197|NCT01245751|588980507|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
163074198|NCT01245751|588980508|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
163074199|NCT01245751|588980509|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
163074200|NCT01245751|588980510|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
163074201|NCT01245751|588980507|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
163074202|NCT01245751|588980508|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
163074203|NCT01245751|588980509|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
163074204|NCT01245751|588980510|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
163074205|NCT01748552|588980515|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
163074206|NCT01748552|588980516|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
163074207|NCT01748552|588980517|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
163074208|NCT01748552|588980518|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
163074209|NCT01748552|588980519|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
163074210|NCT01748552|588980520|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
163074211|NCT01748552|588980521|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
163074212|NCT01748552|588980522|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
163074213|NCT01748552|588980523|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
163074214|NCT01748552|588980524|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
163074215|NCT01748552|588980525|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
163074216|NCT01748552|588980526|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
163074217|NCT01748552|588980515|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074218|NCT01748552|588980516|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074219|NCT01748552|588980517|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074220|NCT01748552|588980518|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074221|NCT01748552|588980519|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074222|NCT01748552|588980520|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074223|NCT01748552|588980521|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
163074224|NCT01748552|588980522|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
163074225|NCT01748552|588980523|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
163074226|NCT01748552|588980524|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074227|NCT01748552|588980525|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074228|NCT01748552|588980526|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074229|NCT01386645|588980527|FG000|Overall Study|Physician Decision|0|||
163074230|NCT01386645|588980528|FG001|Overall Study|Physician Decision|0|||
163074231|NCT01386645|588980529|FG002|Overall Study|Physician Decision|1|||
163074232|NCT01386645|588980527|FG000|Overall Study|Withdrawal by Subject|0|||
163074233|NCT01386645|588980528|FG001|Overall Study|Withdrawal by Subject|1|||
163074234|NCT01386645|588980529|FG002|Overall Study|Withdrawal by Subject|1|||
163074235|NCT02930941|588980530|FG000|Overall Study|Lost to Follow-up|1|||
163074236|NCT02930941|588980531|FG001|Overall Study|Lost to Follow-up|2|||
163074237|NCT00289978|588980532|FG000|Overall Study|Withdrawal by Subject|31|||
163074238|NCT00289978|588980533|FG001|Overall Study|Withdrawal by Subject|17|||
163074239|NCT00289978|588980534|FG002|Overall Study|Withdrawal by Subject|28|||
163074240|NCT00289978|588980532|FG000|Overall Study|Adverse Event|22|||
163074241|NCT00289978|588980533|FG001|Overall Study|Adverse Event|13|||
163074242|NCT00289978|588980534|FG002|Overall Study|Adverse Event|18|||
163074243|NCT00289978|588980532|FG000|Overall Study|Lack of Efficacy|13|||
163074244|NCT00289978|588980533|FG001|Overall Study|Lack of Efficacy|6|||
163074245|NCT00289978|588980534|FG002|Overall Study|Lack of Efficacy|25|||
163074246|NCT00289978|588980532|FG000|Overall Study|Abnormal laboratory value(s)|20|||
163074247|NCT00289978|588980533|FG001|Overall Study|Abnormal laboratory value(s)|9|||
163074248|NCT00289978|588980534|FG002|Overall Study|Abnormal laboratory value(s)|1|||
163074249|NCT00289978|588980532|FG000|Overall Study|Lost to Follow-up|3|||
163074250|NCT00289978|588980533|FG001|Overall Study|Lost to Follow-up|5|||
163074251|NCT00289978|588980534|FG002|Overall Study|Lost to Follow-up|7|||
163074252|NCT00289978|588980532|FG000|Overall Study|Protocol Violation|5|||
163074253|NCT00289978|588980533|FG001|Overall Study|Protocol Violation|5|||
163074254|NCT00289978|588980534|FG002|Overall Study|Protocol Violation|4|||
163074255|NCT00289978|588980532|FG000|Overall Study|Abnormal test procedure result(s)|2|||
163074256|NCT00289978|588980533|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163074257|NCT00289978|588980534|FG002|Overall Study|Abnormal test procedure result(s)|1|||
163074258|NCT00289978|588980532|FG000|Overall Study|Death|1|||
163074259|NCT00289978|588980533|FG001|Overall Study|Death|0|||
163074260|NCT00289978|588980534|FG002|Overall Study|Death|2|||
163074261|NCT00527748|588980547|FG000|Overall Study|Other|3|||
163074262|NCT02391584|588980553|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
163074263|NCT02391584|588980554|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
163074264|NCT02391584|588980553|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
163074265|NCT02391584|588980554|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
163074266|NCT02391584|588980553|FG000|3 Month|Lost to Follow-up|1|||
163074267|NCT02391584|588980554|FG001|3 Month|Lost to Follow-up|0|||
163074268|NCT02391584|588980553|FG000|6 Month|Withdrawal by Subject|1|||
163074269|NCT02391584|588980554|FG001|6 Month|Withdrawal by Subject|0|||
163074270|NCT02391584|588980553|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
163074271|NCT02391584|588980554|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
163074272|NCT04621786|588980555|FG000|Overall Study|Lost to Follow-up|9|||
163074273|NCT04621786|588980555|FG000|Overall Study|Protocol Violation|3|||
163074274|NCT01301001|588980556|FG000|First Intervention|Lost to Follow-up|4|||
163074275|NCT01301001|588980557|FG001|First Intervention|Lost to Follow-up|4|||
163074276|NCT01301001|588980556|FG000|First Intervention|Withdrawal by Subject|1|||
163074277|NCT01301001|588980557|FG001|First Intervention|Withdrawal by Subject|4|||
163074278|NCT01301001|588980556|FG000|First Intervention|Adverse Event|5|||
163074279|NCT01301001|588980557|FG001|First Intervention|Adverse Event|0|||
163074280|NCT01301001|588980556|FG000|First Intervention|Protocol Violation|0|||
163074281|NCT01301001|588980557|FG001|First Intervention|Protocol Violation|1|||
163074282|NCT01301001|588980556|FG000|Second Intervention|Adverse Event|2|||
163218367|NCT03446040|589515785|FG003|Overall Study|Participant withdrew consent|0|||
163218368|NCT03446040|589515786|FG004|Overall Study|Participant withdrew consent|0|||
163074283|NCT01301001|588980557|FG001|Second Intervention|Adverse Event|0|||
163074284|NCT01301001|588980556|FG000|Second Intervention|Withdrawal by Subject|2|||
163074285|NCT01301001|588980557|FG001|Second Intervention|Withdrawal by Subject|0|||
163074286|NCT04821245|588980558|FG000|Overall Study|Withdrawal by Subject|3|||
163074287|NCT04821245|588980558|FG000|Overall Study|Physician Decision|1|||
163074288|NCT04821245|588980558|FG000|Overall Study|Protocol Violation|5|||
163074289|NCT01840163|588980559|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
163074290|NCT01840163|588980560|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
163074291|NCT01840163|588980559|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
163074292|NCT01840163|588980560|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
163074293|NCT01840163|588980559|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
163074294|NCT01840163|588980560|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
163074295|NCT03636269|588980564|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
163074296|NCT03636269|588980565|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
163074297|NCT03636269|588980566|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
163074298|NCT03636269|588980564|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
163074299|NCT03636269|588980565|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
163074300|NCT03636269|588980566|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
163074301|NCT03636269|588980564|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
163074302|NCT03636269|588980565|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
163074303|NCT03636269|588980566|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
163074304|NCT03636269|588980564|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
163074305|NCT03636269|588980565|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
163074306|NCT03636269|588980566|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
163074307|NCT03636269|588980564|FG000|Period 1: Double-blind Phase|Other|6|||
163074308|NCT03636269|588980565|FG001|Period 1: Double-blind Phase|Other|3|||
163074309|NCT03636269|588980566|FG002|Period 1: Double-blind Phase|Other|0|||
163074310|NCT03636269|588980564|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
163074311|NCT03636269|588980565|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
163074312|NCT03636269|588980566|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
163074313|NCT03636269|588980564|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
163074314|NCT03636269|588980565|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
163074315|NCT03636269|588980566|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
163074316|NCT03636269|588980564|FG000|Period 2: Open-label Phase|Adverse Event|0|||
163074317|NCT03636269|588980565|FG001|Period 2: Open-label Phase|Adverse Event|0|||
163074318|NCT03636269|588980566|FG002|Period 2: Open-label Phase|Adverse Event|21|||
163074319|NCT03636269|588980564|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
163074320|NCT03636269|588980565|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
163074321|NCT03636269|588980566|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
163074322|NCT03636269|588980564|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
163074323|NCT03636269|588980565|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
163074324|NCT03636269|588980566|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
163074325|NCT03636269|588980564|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
163074326|NCT03636269|588980565|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
163074327|NCT03636269|588980566|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
163074328|NCT03636269|588980564|FG000|Period 2: Open-label Phase|Administrative|0|||
163074329|NCT03636269|588980565|FG001|Period 2: Open-label Phase|Administrative|0|||
163074330|NCT03636269|588980566|FG002|Period 2: Open-label Phase|Administrative|36|||
163074331|NCT03636269|588980564|FG000|Period 2: Open-label Phase|Other|0|||
163074332|NCT03636269|588980565|FG001|Period 2: Open-label Phase|Other|0|||
163074333|NCT03636269|588980566|FG002|Period 2: Open-label Phase|Other|9|||
163074334|NCT03636269|588980564|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
163074335|NCT03636269|588980565|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
163074336|NCT03636269|588980566|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
163074337|NCT02852434|588980582|FG000|Overall Study|Withdrawal by Subject|0|||
163074338|NCT02852434|588980583|FG001|Overall Study|Withdrawal by Subject|1|||
163074339|NCT02852434|588980582|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
163074340|NCT02852434|588980583|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
163074341|NCT03774810|588980586|FG000|Phase 1|Lack of Efficacy|21|||
163074342|NCT03774810|588980587|FG001|Phase 1|Lack of Efficacy|0|||
163074343|NCT03774810|588980588|FG002|Phase 1|Lack of Efficacy|0|||
163074344|NCT03774810|588980589|FG003|Phase 1|Lack of Efficacy|0|||
163074345|NCT03774810|588980590|FG004|Phase 1|Lack of Efficacy|0|||
163074346|NCT03774810|588980586|FG000|Phase 1|Withdrawal by Subject|9|||
163074347|NCT03774810|588980587|FG001|Phase 1|Withdrawal by Subject|0|||
163074348|NCT03774810|588980588|FG002|Phase 1|Withdrawal by Subject|0|||
163074349|NCT03774810|588980589|FG003|Phase 1|Withdrawal by Subject|0|||
163074350|NCT03774810|588980590|FG004|Phase 1|Withdrawal by Subject|0|||
163074351|NCT03774810|588980586|FG000|Phase 1|Lost to Follow-up|2|||
163074352|NCT03774810|588980587|FG001|Phase 1|Lost to Follow-up|0|||
163074353|NCT03774810|588980588|FG002|Phase 1|Lost to Follow-up|0|||
163074354|NCT03774810|588980589|FG003|Phase 1|Lost to Follow-up|0|||
163218369|NCT03446040|589515787|FG005|Overall Study|Participant withdrew consent|1|||
163074355|NCT03774810|588980590|FG004|Phase 1|Lost to Follow-up|0|||
163074356|NCT03774810|588980586|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
163074357|NCT03774810|588980587|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
163218370|NCT03446040|589515788|FG006|Overall Study|Participant withdrew consent|0|||
163218371|NCT03446040|589515789|FG007|Overall Study|Participant withdrew consent|1|||
163218372|NCT03446040|589515790|FG008|Overall Study|Participant withdrew consent|0|||
163218373|NCT03446040|589515791|FG009|Overall Study|Participant withdrew consent|0|||
163218374|NCT03446040|589515792|FG010|Overall Study|Participant withdrew consent|0|||
163074358|NCT03774810|588980588|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
163074359|NCT03774810|588980589|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
163074360|NCT03774810|588980590|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
163074361|NCT03774810|588980586|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
163074362|NCT03774810|588980587|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
163074363|NCT03774810|588980588|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
163074364|NCT03774810|588980589|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
163074365|NCT03774810|588980590|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
163074366|NCT03774810|588980586|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
163074367|NCT03774810|588980587|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
163074368|NCT03774810|588980588|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
163074369|NCT03774810|588980589|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
163074370|NCT03774810|588980590|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
163074371|NCT03774810|588980586|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
163074372|NCT03774810|588980587|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
163074373|NCT03774810|588980588|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
163074374|NCT03774810|588980589|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
163074375|NCT03774810|588980590|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
163074376|NCT03774810|588980586|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
163074377|NCT03774810|588980587|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
163074378|NCT03774810|588980588|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
163074379|NCT03774810|588980589|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
163074380|NCT03774810|588980590|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
163074381|NCT03774810|588980586|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
163074382|NCT03774810|588980587|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
163074383|NCT03774810|588980588|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
163074384|NCT03774810|588980589|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
163074385|NCT03774810|588980590|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
163074386|NCT00927186|588980591|FG000|12 Months Primary Study|Adverse Event|5|||
163074387|NCT00927186|588980592|FG001|12 Months Primary Study|Adverse Event|2|||
163074388|NCT00927186|588980591|FG000|12 Months Primary Study|Lost to Follow-up|1|||
163074389|NCT00927186|588980592|FG001|12 Months Primary Study|Lost to Follow-up|0|||
163074390|NCT00927186|588980591|FG000|12 Months Primary Study|Protocol Violation|0|||
163074391|NCT00927186|588980592|FG001|12 Months Primary Study|Protocol Violation|1|||
163074392|NCT00927186|588980591|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
163074393|NCT00927186|588980592|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
163074394|NCT01145222|588980593|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
163074395|NCT01145222|588980594|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
163074396|NCT01145222|588980595|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
163074397|NCT01145222|588980596|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
163074398|NCT01145222|588980593|FG000|Overall Study|Poor bowel preparation|0|||
163074399|NCT01145222|588980594|FG001|Overall Study|Poor bowel preparation|0|||
163074400|NCT01145222|588980595|FG002|Overall Study|Poor bowel preparation|0|||
163074401|NCT01145222|588980596|FG003|Overall Study|Poor bowel preparation|1|||
163074402|NCT00604383|588980597|FG000|Overall Study|Withdrawal by Subject|33|||
163074403|NCT00604383|588980598|FG001|Overall Study|Withdrawal by Subject|31|||
163074404|NCT00604383|588980597|FG000|Overall Study|Lost to Follow-up|24|||
163074405|NCT00604383|588980598|FG001|Overall Study|Lost to Follow-up|19|||
163074406|NCT00604383|588980597|FG000|Overall Study|Death|14|||
163074407|NCT00604383|588980598|FG001|Overall Study|Death|22|||
163074408|NCT00604383|588980597|FG000|Overall Study|Adverse Event|16|||
163074409|NCT00604383|588980598|FG001|Overall Study|Adverse Event|9|||
163074410|NCT00604383|588980597|FG000|Overall Study|Physician Decision|0|||
163074411|NCT00604383|588980598|FG001|Overall Study|Physician Decision|3|||
163074412|NCT01698008|588980599|FG000|Overall Study|Withdrawal by Subject|1|||
163074413|NCT01698008|588980600|FG001|Overall Study|Withdrawal by Subject|2|||
163074414|NCT03994120|588980605|FG000|Overall Study|Lost to Follow-up|3|||
163074415|NCT03994120|588980606|FG001|Overall Study|Lost to Follow-up|1|||
163074416|NCT01429623|588980607|FG000|Overall Study|Death|1|||
163074417|NCT01429623|588980608|FG001|Overall Study|Death|0|||
163074418|NCT01429623|588980607|FG000|Overall Study|Adverse Event|7|||
163074419|NCT01429623|588980608|FG001|Overall Study|Adverse Event|14|||
163074420|NCT01429623|588980607|FG000|Overall Study|Withdrawal by Subject|19|||
163074421|NCT01429623|588980608|FG001|Overall Study|Withdrawal by Subject|13|||
163074422|NCT01429623|588980607|FG000|Overall Study|Physician Decision|2|||
163218375|NCT03446040|589515793|FG011|Overall Study|Participant withdrew consent|0|||
163218376|NCT03446040|589515794|FG012|Overall Study|Participant withdrew consent|0|||
163218377|NCT03446040|589515795|FG013|Overall Study|Participant withdrew consent|0|||
163218378|NCT03446040|589515782|FG000|Overall Study|Not reported|0|||
163074423|NCT01429623|588980608|FG001|Overall Study|Physician Decision|3|||
163074424|NCT01429623|588980607|FG000|Overall Study|Protocol Violation|3|||
163074425|NCT01429623|588980608|FG001|Overall Study|Protocol Violation|2|||
163074426|NCT01429623|588980607|FG000|Overall Study|Assorted|1|||
163074427|NCT01429623|588980608|FG001|Overall Study|Assorted|2|||
163074428|NCT01429623|588980607|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
163074429|NCT01429623|588980608|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
163074430|NCT01429623|588980607|FG000|Overall Study|No post baseline data|4|||
163074431|NCT01429623|588980608|FG001|Overall Study|No post baseline data|4|||
163074432|NCT00981175|588980609|FG000|Primary Dose Vaccination|Adverse Event|1|||
163074433|NCT00981175|588980610|FG001|Primary Dose Vaccination|Adverse Event|0|||
163074434|NCT00981175|588980609|FG000|Primary Dose Vaccination|Protocol Violation|0|||
163074435|NCT00981175|588980610|FG001|Primary Dose Vaccination|Protocol Violation|1|||
163074436|NCT00981175|588980609|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
163074437|NCT00981175|588980610|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
163074438|NCT00981175|588980609|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
163074439|NCT00981175|588980610|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
163074440|NCT02619812|588980611|FG000|Overall Study|Withdrawal by Subject|0|||
163074441|NCT02619812|588980612|FG001|Overall Study|Withdrawal by Subject|0|||
163074442|NCT02619812|588980613|FG002|Overall Study|Withdrawal by Subject|1|||
163074443|NCT02619812|588980614|FG003|Overall Study|Withdrawal by Subject|2|||
163074444|NCT00621322|588980626|FG000|Overall Study|Lost to Follow-up|0|||
163074445|NCT00621322|588980627|FG001|Overall Study|Lost to Follow-up|0|||
163074446|NCT00621322|588980628|FG002|Overall Study|Lost to Follow-up|0|||
163074447|NCT00621322|588980629|FG003|Overall Study|Lost to Follow-up|0|||
163074448|NCT00621322|588980630|FG004|Overall Study|Lost to Follow-up|1|||
163074449|NCT00621322|588980631|FG005|Overall Study|Lost to Follow-up|0|||
163074450|NCT00621322|588980626|FG000|Overall Study|Physician Decision|0|||
163074451|NCT00621322|588980627|FG001|Overall Study|Physician Decision|0|||
163074452|NCT00621322|588980628|FG002|Overall Study|Physician Decision|1|||
163074453|NCT00621322|588980629|FG003|Overall Study|Physician Decision|1|||
163074454|NCT00621322|588980630|FG004|Overall Study|Physician Decision|0|||
163074455|NCT00621322|588980631|FG005|Overall Study|Physician Decision|0|||
163074456|NCT00621322|588980626|FG000|Overall Study|Withdrawal by Subject|0|||
163074457|NCT00621322|588980627|FG001|Overall Study|Withdrawal by Subject|0|||
163074458|NCT00621322|588980628|FG002|Overall Study|Withdrawal by Subject|0|||
163074459|NCT00621322|588980629|FG003|Overall Study|Withdrawal by Subject|1|||
163074460|NCT00621322|588980630|FG004|Overall Study|Withdrawal by Subject|0|||
163074461|NCT00621322|588980631|FG005|Overall Study|Withdrawal by Subject|2|||
163074462|NCT00621322|588980626|FG000|Overall Study|Migrated/moved from study area|1|||
163074463|NCT00621322|588980627|FG001|Overall Study|Migrated/moved from study area|0|||
163074464|NCT00621322|588980628|FG002|Overall Study|Migrated/moved from study area|1|||
163074465|NCT00621322|588980629|FG003|Overall Study|Migrated/moved from study area|1|||
163074466|NCT00621322|588980630|FG004|Overall Study|Migrated/moved from study area|0|||
163074467|NCT00621322|588980631|FG005|Overall Study|Migrated/moved from study area|2|||
163074468|NCT04865978|588980635|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
163074469|NCT04865978|588980636|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
163074470|NCT05587998|588980637|FG000|Overall Study|Withdrawal by Subject|1|||
163074471|NCT05587998|588980638|FG001|Overall Study|Withdrawal by Subject|1|||
163218379|NCT03446040|589515783|FG001|Overall Study|Not reported|0|||
163218380|NCT03446040|589515784|FG002|Overall Study|Not reported|1|||
163218381|NCT03446040|589515785|FG003|Overall Study|Not reported|0|||
163218382|NCT03446040|589515786|FG004|Overall Study|Not reported|0|||
163218383|NCT03446040|589515787|FG005|Overall Study|Not reported|0|||
163218384|NCT03446040|589515788|FG006|Overall Study|Not reported|0|||
163218385|NCT03446040|589515789|FG007|Overall Study|Not reported|0|||
163218386|NCT03446040|589515790|FG008|Overall Study|Not reported|0|||
163218387|NCT03446040|589515791|FG009|Overall Study|Not reported|0|||
163027934|NCT01752634|588805320|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
163027935|NCT01752634|588805321|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
163027936|NCT01752634|588805322|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
163027937|NCT01752634|588805323|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
163027938|NCT01752634|588805318|FG000|Week 24 to Week 260|Physician Decision|1|||
163027939|NCT01752634|588805319|FG001|Week 24 to Week 260|Physician Decision|2|||
163027940|NCT01752634|588805320|FG002|Week 24 to Week 260|Physician Decision|4|||
163027941|NCT01752634|588805321|FG003|Week 24 to Week 260|Physician Decision|2|||
163027942|NCT01752634|588805322|FG004|Week 24 to Week 260|Physician Decision|1|||
163027943|NCT01752634|588805323|FG005|Week 24 to Week 260|Physician Decision|0|||
163027944|NCT01752634|588805318|FG000|Week 24 to Week 260|Death|0|||
163027945|NCT01752634|588805319|FG001|Week 24 to Week 260|Death|1|||
163027946|NCT01752634|588805320|FG002|Week 24 to Week 260|Death|0|||
163027947|NCT01752634|588805321|FG003|Week 24 to Week 260|Death|0|||
163027948|NCT01752634|588805322|FG004|Week 24 to Week 260|Death|0|||
163027949|NCT01752634|588805323|FG005|Week 24 to Week 260|Death|0|||
163027950|NCT01752634|588805318|FG000|Week 24 to Week 260|Pregnancy|0|||
163027951|NCT01752634|588805319|FG001|Week 24 to Week 260|Pregnancy|0|||
163027952|NCT01752634|588805320|FG002|Week 24 to Week 260|Pregnancy|1|||
163027953|NCT01752634|588805321|FG003|Week 24 to Week 260|Pregnancy|0|||
163027954|NCT01752634|588805322|FG004|Week 24 to Week 260|Pregnancy|0|||
163331404|NCT02063659|589922581|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
163331405|NCT02063659|589922582|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
163331406|NCT02063659|589922579|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
163331407|NCT02063659|589922580|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
163331408|NCT02063659|589922581|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
163331409|NCT02063659|589922582|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
163331410|NCT02063659|589922579|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
163331411|NCT02063659|589922580|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
163331412|NCT02063659|589922581|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
163331413|NCT02063659|589922582|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
163331414|NCT04762277|589922583|FG000|Overall Study|Withdrawal by Subject|0|||
163331415|NCT04762277|589922584|FG001|Overall Study|Withdrawal by Subject|2|||
163331416|NCT04762277|589922583|FG000|Overall Study|Protocol Violation|0|||
163331417|NCT04762277|589922584|FG001|Overall Study|Protocol Violation|1|||
163331418|NCT04762277|589922583|FG000|Overall Study|Adverse Event|1|||
163331419|NCT04762277|589922584|FG001|Overall Study|Adverse Event|0|||
163331420|NCT02556918|589923961|FG000|Overall Study|Protocol Violation|5|||
163331421|NCT02556918|589923962|FG001|Overall Study|Protocol Violation|6|||
163331422|NCT02556918|589923961|FG000|Overall Study|Withdrawal by Subject|4|||
163331423|NCT02556918|589923962|FG001|Overall Study|Withdrawal by Subject|4|||
163331424|NCT04511702|589923972|FG000|Overall Study|Lost to Follow-up|3|||
163331425|NCT04511702|589923973|FG001|Overall Study|Lost to Follow-up|0|||
163331426|NCT04511702|589923974|FG002|Overall Study|Lost to Follow-up|4|||
163331427|NCT04511702|589923972|FG000|Overall Study|Withdrawal by Subject|17|||
163331428|NCT04511702|589923973|FG001|Overall Study|Withdrawal by Subject|1|||
163331429|NCT04511702|589923974|FG002|Overall Study|Withdrawal by Subject|8|||
163331430|NCT05349721|589923975|FG000|Part A (24 Weeks)|Adverse Event|9|||
163331431|NCT05349721|589923976|FG001|Part A (24 Weeks)|Adverse Event|2|||
163331432|NCT05349721|589923975|FG000|Part A (24 Weeks)|Death|8|||
163331433|NCT05349721|589923976|FG001|Part A (24 Weeks)|Death|3|||
163331434|NCT05349721|589923975|FG000|Part A (24 Weeks)|Disease Progression|1|||
163331435|NCT05349721|589923976|FG001|Part A (24 Weeks)|Disease Progression|1|||
163331436|NCT05349721|589923975|FG000|Part A (24 Weeks)|Screen Failure|2|||
163331437|NCT05349721|589923976|FG001|Part A (24 Weeks)|Screen Failure|0|||
163331438|NCT05349721|589923975|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
163074472|NCT05587998|588980637|FG000|Overall Study|Not treated|3|||
163074473|NCT05587998|588980638|FG001|Overall Study|Not treated|1|||
163074474|NCT05587998|588980637|FG000|Overall Study|Non-compliance with study procedures|0|||
163074475|NCT05587998|588980638|FG001|Overall Study|Non-compliance with study procedures|1|||
163074476|NCT04263532|588980639|FG000|Overall Study|Withdrawal by Subject|2|||
163074477|NCT04263532|588980640|FG001|Overall Study|Withdrawal by Subject|0|||
163074478|NCT00601107|588980641|FG000|Overall Study|Adverse Event|0|||
163074479|NCT00601107|588980642|FG001|Overall Study|Adverse Event|1|||
163074480|NCT00601107|588980643|FG002|Overall Study|Adverse Event|3|||
163074481|NCT00601107|588980644|FG003|Overall Study|Adverse Event|0|||
163074482|NCT00601107|588980641|FG000|Overall Study|Withdrawal by Subject|5|||
163074483|NCT00601107|588980642|FG001|Overall Study|Withdrawal by Subject|4|||
163074484|NCT00601107|588980643|FG002|Overall Study|Withdrawal by Subject|7|||
163074485|NCT00601107|588980644|FG003|Overall Study|Withdrawal by Subject|4|||
163074486|NCT00601107|588980641|FG000|Overall Study|Lost to Follow-up|3|||
163074487|NCT00601107|588980642|FG001|Overall Study|Lost to Follow-up|3|||
163074488|NCT00601107|588980643|FG002|Overall Study|Lost to Follow-up|0|||
163074489|NCT00601107|588980644|FG003|Overall Study|Lost to Follow-up|3|||
163074490|NCT00601107|588980641|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
163074491|NCT00601107|588980642|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
163074492|NCT00601107|588980643|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
163074493|NCT00601107|588980644|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
163074494|NCT00601107|588980641|FG000|Overall Study|Worsening of Psoriasis|4|||
163074495|NCT00601107|588980642|FG001|Overall Study|Worsening of Psoriasis|1|||
163331439|NCT05349721|589923976|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
163331440|NCT05349721|589923975|FG000|Part A (24 Weeks)|Other Than Specified|5|||
163331441|NCT05349721|589923976|FG001|Part A (24 Weeks)|Other Than Specified|1|||
163331442|NCT05349721|589923975|FG000|Part B (28 Weeks)|Adverse Event|3|||
163331443|NCT05349721|589923976|FG001|Part B (28 Weeks)|Adverse Event|0|||
163331444|NCT05349721|589923975|FG000|Part B (28 Weeks)|Death|21|||
163331445|NCT05349721|589923976|FG001|Part B (28 Weeks)|Death|11|||
163027955|NCT01752634|588805323|FG005|Week 24 to Week 260|Pregnancy|0|||
163027956|NCT01752634|588805318|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
163027957|NCT01752634|588805319|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
163027958|NCT01752634|588805320|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
163027959|NCT01752634|588805321|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
163027960|NCT01752634|588805322|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
163027961|NCT01752634|588805323|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
163027962|NCT01752634|588805318|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
163331446|NCT05349721|589923975|FG000|Part B (28 Weeks)|Disease Progression|2|||
163218388|NCT03446040|589515792|FG010|Overall Study|Not reported|0|||
163218389|NCT03446040|589515793|FG011|Overall Study|Not reported|0|||
163027963|NCT01752634|588805319|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
163027964|NCT01752634|588805320|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
163027965|NCT01752634|588805321|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
163027966|NCT01752634|588805322|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
163027967|NCT01752634|588805323|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
163027968|NCT01752634|588805318|FG000|Week 24 to Week 260|Adverse Event|4|||
163027969|NCT01752634|588805319|FG001|Week 24 to Week 260|Adverse Event|8|||
163027970|NCT01752634|588805320|FG002|Week 24 to Week 260|Adverse Event|8|||
163027971|NCT01752634|588805321|FG003|Week 24 to Week 260|Adverse Event|4|||
163027972|NCT01752634|588805322|FG004|Week 24 to Week 260|Adverse Event|2|||
163027973|NCT01752634|588805323|FG005|Week 24 to Week 260|Adverse Event|0|||
163027974|NCT05128773|588805332|FG000|Overall Study|Sponsor decision to terminate study|3|||
163027975|NCT04250714|588805333|FG000|Overall Study|Treatment - withdrawal by subject|14|||
163027976|NCT04250714|588805333|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
163027977|NCT04250714|588805333|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
163027978|NCT04250714|588805333|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
163027979|NCT04250714|588805333|FG000|Overall Study|Treatment - Death|1|||
163027980|NCT04250714|588805333|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
163027981|NCT04250714|588805333|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
163027982|NCT04250714|588805333|FG000|Overall Study|Attempt|2|||
163027983|NCT04250714|588805333|FG000|Overall Study|Intent|7|||
163027984|NCT04697056|588805334|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
163027985|NCT04697056|588805335|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
163027986|NCT03339726|588805336|FG000|Overall Study|Withdrawal by Subject|1|||
163027987|NCT03339726|588805337|FG001|Overall Study|Withdrawal by Subject|0|||
163027988|NCT03339726|588805338|FG002|Overall Study|Withdrawal by Subject|0|||
163027989|NCT03339726|588805336|FG000|Overall Study|Lost to Follow-up|0|||
163027990|NCT03339726|588805337|FG001|Overall Study|Lost to Follow-up|1|||
163027991|NCT03339726|588805338|FG002|Overall Study|Lost to Follow-up|0|||
163027992|NCT00308750|588805344|FG000|Overall Study|Adverse Event|9|||
163027993|NCT00308750|588805345|FG001|Overall Study|Adverse Event|9|||
163027994|NCT00308750|588805346|FG002|Overall Study|Adverse Event|13|||
163027995|NCT00308750|588805344|FG000|Overall Study|Withdrawal by Subject|6|||
163027996|NCT00308750|588805345|FG001|Overall Study|Withdrawal by Subject|2|||
163027997|NCT00308750|588805346|FG002|Overall Study|Withdrawal by Subject|3|||
163027998|NCT00308750|588805344|FG000|Overall Study|Physician Decision|3|||
163027999|NCT00308750|588805345|FG001|Overall Study|Physician Decision|4|||
163028000|NCT00308750|588805346|FG002|Overall Study|Physician Decision|3|||
163028001|NCT00308750|588805344|FG000|Overall Study|Sponsor Decision|1|||
163028002|NCT00308750|588805345|FG001|Overall Study|Sponsor Decision|0|||
163028003|NCT00308750|588805346|FG002|Overall Study|Sponsor Decision|0|||
163028004|NCT00308750|588805344|FG000|Overall Study|Disease Progression|47|||
163028005|NCT00308750|588805345|FG001|Overall Study|Disease Progression|24|||
163028006|NCT00308750|588805346|FG002|Overall Study|Disease Progression|28|||
163028007|NCT00308750|588805344|FG000|Overall Study|Unrelated Complication|3|||
163028008|NCT00308750|588805345|FG001|Overall Study|Unrelated Complication|0|||
163028009|NCT00308750|588805346|FG002|Overall Study|Unrelated Complication|1|||
163028010|NCT00308750|588805344|FG000|Overall Study|Death|1|||
163028011|NCT00308750|588805345|FG001|Overall Study|Death|0|||
163028012|NCT00308750|588805346|FG002|Overall Study|Death|1|||
163028013|NCT00308750|588805344|FG000|Overall Study|Protocol Violation|1|||
163028014|NCT00308750|588805345|FG001|Overall Study|Protocol Violation|0|||
163028015|NCT00308750|588805346|FG002|Overall Study|Protocol Violation|0|||
163028016|NCT00308750|588805344|FG000|Overall Study|New Primary Disease Identified|1|||
163028017|NCT00308750|588805345|FG001|Overall Study|New Primary Disease Identified|1|||
163028018|NCT00308750|588805346|FG002|Overall Study|New Primary Disease Identified|0|||
163028019|NCT01088243|588805353|FG000|Overall Study|Adverse Event|1|||
163028020|NCT01088243|588805354|FG001|Overall Study|Adverse Event|0|||
163028021|NCT05007041|588805368|FG000|Overall Study|Missing Diary Entries|0|||
163028022|NCT05007041|588805369|FG001|Overall Study|Missing Diary Entries|1|||
163028023|NCT04495816|588805370|FG000|Overall Study|Lost to Follow-up|10|||
163028024|NCT04495816|588805371|FG001|Overall Study|Lost to Follow-up|4|||
163028025|NCT04495816|588805370|FG000|Overall Study|Withdrawal by Subject|3|||
163028026|NCT04495816|588805371|FG001|Overall Study|Withdrawal by Subject|5|||
163028027|NCT02370667|588805372|FG000|Overall Study|Lost to Follow-up|0|||
163028028|NCT02370667|588805373|FG001|Overall Study|Lost to Follow-up|1|||
163028029|NCT02370667|588805374|FG002|Overall Study|Lost to Follow-up|0|||
163028030|NCT03536949|588805375|FG000|Overall Study|Adverse Event|4|||
163028031|NCT03536949|588805376|FG001|Overall Study|Adverse Event|0|||
163028032|NCT03536949|588805375|FG000|Overall Study|Lost to Follow-up|2|||
163028033|NCT03536949|588805376|FG001|Overall Study|Lost to Follow-up|1|||
163028034|NCT03536949|588805375|FG000|Overall Study|Withdrawal by Subject|6|||
163028035|NCT03536949|588805376|FG001|Overall Study|Withdrawal by Subject|0|||
163028036|NCT03536949|588805375|FG000|Overall Study|Non-compliance|2|||
163218390|NCT03446040|589515794|FG012|Overall Study|Not reported|0|||
163074496|NCT00601107|588980643|FG002|Overall Study|Worsening of Psoriasis|1|||
163074497|NCT00601107|588980644|FG003|Overall Study|Worsening of Psoriasis|4|||
163074498|NCT00601107|588980641|FG000|Overall Study|Undefined|1|||
163074499|NCT00601107|588980642|FG001|Overall Study|Undefined|0|||
163074500|NCT00601107|588980643|FG002|Overall Study|Undefined|1|||
163074501|NCT00601107|588980644|FG003|Overall Study|Undefined|0|||
163074502|NCT01078545|588980651|FG000|Overall Study|Lost to Follow-up|13|||
163074503|NCT01078545|588980651|FG000|Overall Study|Physician Decision|6|||
163074504|NCT01078545|588980651|FG000|Overall Study|Withdrawal by Subject|3|||
163074505|NCT01078545|588980651|FG000|Overall Study|Death|3|||
163074506|NCT01078545|588980651|FG000|Overall Study|Participant moved to another physician|1|||
163074507|NCT03501277|588980659|FG000|Intervention Period 1 (4 Days)|Other|0|||
163074508|NCT03501277|588980660|FG001|Intervention Period 1 (4 Days)|Other|0|||
163074509|NCT03501277|588980661|FG002|Intervention Period 1 (4 Days)|Other|1|||
163074510|NCT03501277|588980662|FG003|Intervention Period 1 (4 Days)|Other|0|||
163074511|NCT03501277|588980659|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
163074512|NCT03501277|588980660|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
163074513|NCT03501277|588980661|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
163074514|NCT03501277|588980662|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
163074515|NCT03501277|588980659|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
163074516|NCT03501277|588980660|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
163074517|NCT03501277|588980661|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
163074518|NCT03501277|588980662|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
163074519|NCT03501277|588980659|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
163074520|NCT03501277|588980660|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
163074521|NCT03501277|588980661|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
163074522|NCT03501277|588980662|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
163074523|NCT01489358|588980664|FG000|Overall Study|Lost to Follow-up|0|||
163074524|NCT01489358|588980665|FG001|Overall Study|Lost to Follow-up|0|||
163074525|NCT01489358|588980666|FG002|Overall Study|Lost to Follow-up|2|||
163074526|NCT01873833|588980667|FG000|Overall Study|Withdrawal by Subject|1|||
163074527|NCT01968785|588980668|FG000|Overall Study|Withdrawal by Subject|1|||
163074528|NCT01968785|588980669|FG001|Overall Study|Withdrawal by Subject|0|||
163074529|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Adverse Event|14|||
163074530|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Adverse Event|27|||
163074531|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Adverse Event|60|||
163074532|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Adverse Event|0|||
163074533|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Adverse Event|0|||
163074534|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Pregnancy|0|||
163074535|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Pregnancy|7|||
163074536|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Pregnancy|9|||
163074537|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Pregnancy|0|||
163074538|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Pregnancy|0|||
163074539|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
163074540|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
163074541|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
163074542|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
163074543|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
163074544|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
163074545|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
163074546|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
163074547|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
163074548|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
163074549|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Death|1|||
163074550|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Death|2|||
163074551|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Death|2|||
163074552|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Death|0|||
163074553|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Death|0|||
163074554|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
163074555|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
163074556|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
163074557|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
163074558|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
163074559|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
163074560|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
163074561|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
163074562|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
163074563|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
163074564|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
163074565|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
163074566|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
163074567|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
163074568|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
163074569|NCT00098293|588980670|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
163331447|NCT05349721|589923976|FG001|Part B (28 Weeks)|Disease Progression|1|||
163331448|NCT05349721|589923975|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
163331449|NCT05349721|589923976|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
163331450|NCT05349721|589923975|FG000|Part B (28 Weeks)|Physician Decision|1|||
163331451|NCT05349721|589923976|FG001|Part B (28 Weeks)|Physician Decision|0|||
163331452|NCT05349721|589923975|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
163331453|NCT05349721|589923976|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
163331454|NCT05349721|589923975|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
163331455|NCT05349721|589923976|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
163331456|NCT05349721|589923975|FG000|Part B (28 Weeks)|Other Than Specified|4|||
163331457|NCT05349721|589923976|FG001|Part B (28 Weeks)|Other Than Specified|2|||
163331458|NCT05349721|589923975|FG000|Part C (108 Weeks)|Death|0|||
163331459|NCT05349721|589923976|FG001|Part C (108 Weeks)|Death|1|||
163331460|NCT05349721|589923975|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
163074570|NCT00098293|588980671|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
163074571|NCT00098293|588980672|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
163074572|NCT00098293|588980673|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
163074573|NCT00098293|588980674|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
163074574|NCT00098293|588980670|FG000|Open-label (OL) Phase|Adverse Event|0|||
163074575|NCT00098293|588980671|FG001|Open-label (OL) Phase|Adverse Event|3|||
163074576|NCT00098293|588980672|FG002|Open-label (OL) Phase|Adverse Event|7|||
163074577|NCT00098293|588980673|FG003|Open-label (OL) Phase|Adverse Event|6|||
163074578|NCT00098293|588980674|FG004|Open-label (OL) Phase|Adverse Event|0|||
163074579|NCT00098293|588980670|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
163074580|NCT00098293|588980671|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
163074581|NCT00098293|588980672|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
163074582|NCT00098293|588980673|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
163074583|NCT00098293|588980674|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
163074584|NCT00098293|588980670|FG000|Open-label (OL) Phase|Pregnancy|0|||
163074585|NCT00098293|588980671|FG001|Open-label (OL) Phase|Pregnancy|1|||
163074586|NCT00098293|588980672|FG002|Open-label (OL) Phase|Pregnancy|0|||
163074587|NCT00098293|588980673|FG003|Open-label (OL) Phase|Pregnancy|3|||
163074588|NCT00098293|588980674|FG004|Open-label (OL) Phase|Pregnancy|0|||
163074589|NCT00098293|588980670|FG000|Open-label (OL) Phase|Protocol Violation|0|||
163074590|NCT00098293|588980671|FG001|Open-label (OL) Phase|Protocol Violation|6|||
163074591|NCT00098293|588980672|FG002|Open-label (OL) Phase|Protocol Violation|13|||
163074592|NCT00098293|588980673|FG003|Open-label (OL) Phase|Protocol Violation|16|||
163074593|NCT00098293|588980674|FG004|Open-label (OL) Phase|Protocol Violation|0|||
163074594|NCT00098293|588980670|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
163074595|NCT00098293|588980671|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
163074596|NCT00098293|588980672|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
163074597|NCT00098293|588980673|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
163074598|NCT00098293|588980674|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
163074599|NCT00098293|588980670|FG000|Open-label (OL) Phase|Death|0|||
163074600|NCT00098293|588980671|FG001|Open-label (OL) Phase|Death|2|||
163074601|NCT00098293|588980672|FG002|Open-label (OL) Phase|Death|3|||
163074602|NCT00098293|588980673|FG003|Open-label (OL) Phase|Death|0|||
163074603|NCT00098293|588980674|FG004|Open-label (OL) Phase|Death|0|||
163074604|NCT00098293|588980670|FG000|Supplemental Phase (SP)|Death|0|||
163074605|NCT00098293|588980671|FG001|Supplemental Phase (SP)|Death|0|||
163074606|NCT00098293|588980672|FG002|Supplemental Phase (SP)|Death|0|||
163074607|NCT00098293|588980673|FG003|Supplemental Phase (SP)|Death|0|||
163074608|NCT00098293|588980674|FG004|Supplemental Phase (SP)|Death|1|||
163074609|NCT00098293|588980670|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
163074610|NCT00098293|588980671|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
163074611|NCT00098293|588980672|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
163074612|NCT00098293|588980673|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
163074613|NCT00098293|588980674|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
163074614|NCT00098293|588980670|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
163074615|NCT00098293|588980671|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
163074616|NCT00098293|588980672|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
163074617|NCT00098293|588980673|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
163074618|NCT00098293|588980674|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
163074619|NCT00098293|588980670|FG000|Supplemental Phase (SP)|Other|0|||
163074620|NCT00098293|588980671|FG001|Supplemental Phase (SP)|Other|0|||
163074621|NCT00098293|588980672|FG002|Supplemental Phase (SP)|Other|0|||
163074622|NCT00098293|588980673|FG003|Supplemental Phase (SP)|Other|0|||
163074623|NCT00098293|588980674|FG004|Supplemental Phase (SP)|Other|22|||
163406398|NCT01783678|590198622|FG001|Overall Study|Randomized but Not Treated|0|||
163074624|NCT01727154|588980678|FG000|Overall Study|Death|17|||
163074625|NCT01727154|588980678|FG000|Overall Study|Withdrawal by Subject|14|||
163074626|NCT01727154|588980678|FG000|Overall Study|Subject Withdrew Consent|18|||
163074627|NCT01727154|588980678|FG000|Overall Study|Study Terminated|6|||
163074628|NCT01727154|588980678|FG000|Overall Study|No Discontinuation Documentation|4|||
163331461|NCT05349721|589923976|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
163406399|NCT01783678|590198623|FG002|Overall Study|Randomized but Not Treated|0|||
163074629|NCT00003474|588980679|FG000|Overall Study|Not Evaluable|14|||
163074630|NCT01198548|588980683|FG000|Overall Study|Disease Progression|9|||
163074631|NCT01198548|588980683|FG000|Overall Study|Administrative Decision|1|||
163074632|NCT02186171|588980685|FG000|Overall Study|Withdrawal by Subject|1|||
163074633|NCT02186171|588980686|FG001|Overall Study|Withdrawal by Subject|9|||
163074634|NCT02186171|588980685|FG000|Overall Study|Lost to Follow-up|2|||
163074635|NCT02186171|588980686|FG001|Overall Study|Lost to Follow-up|2|||
163074636|NCT02186171|588980685|FG000|Overall Study|Death|1|||
163074637|NCT02186171|588980686|FG001|Overall Study|Death|2|||
163074638|NCT02186171|588980685|FG000|Overall Study|Protocol-specified Criteria|0|||
163074639|NCT02186171|588980686|FG001|Overall Study|Protocol-specified Criteria|2|||
163074640|NCT01245062|588980687|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
163074641|NCT01245062|588980688|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
163074642|NCT01245062|588980689|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
163074643|NCT01245062|588980687|FG000|Randomization and Crossover Phase|Physician Decision|2|||
163074644|NCT01245062|588980688|FG001|Randomization and Crossover Phase|Physician Decision|4|||
163074645|NCT01245062|588980689|FG002|Randomization and Crossover Phase|Physician Decision|0|||
163074646|NCT01245062|588980687|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
163074647|NCT01245062|588980688|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
163074648|NCT01245062|588980689|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
163074649|NCT01245062|588980687|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
163074650|NCT01245062|588980688|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
163074651|NCT01245062|588980689|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
163074652|NCT01245062|588980687|FG000|Cross-over Phase|Lost to Follow-up|0|||
163074653|NCT01245062|588980688|FG001|Cross-over Phase|Lost to Follow-up|0|||
163074654|NCT01245062|588980689|FG002|Cross-over Phase|Lost to Follow-up|1|||
163074655|NCT01245062|588980687|FG000|Cross-over Phase|Physician Decision|0|||
163074656|NCT01245062|588980688|FG001|Cross-over Phase|Physician Decision|0|||
163074657|NCT01245062|588980689|FG002|Cross-over Phase|Physician Decision|1|||
163074658|NCT01245062|588980687|FG000|Cross-over Phase|Withdrew Consent|0|||
163074659|NCT01245062|588980688|FG001|Cross-over Phase|Withdrew Consent|0|||
163074660|NCT01245062|588980689|FG002|Cross-over Phase|Withdrew Consent|4|||
163074661|NCT01245062|588980687|FG000|Cross-over Phase|Study closed/ terminated|0|||
163074662|NCT01245062|588980688|FG001|Cross-over Phase|Study closed/ terminated|0|||
163074663|NCT01245062|588980689|FG002|Cross-over Phase|Study closed/ terminated|11|||
163074664|NCT06025695|588980691|FG000|Overall Study|Adverse Event|5|||
163074665|NCT06025695|588980692|FG001|Overall Study|Adverse Event|6|||
163074666|NCT06025695|588980691|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
163074667|NCT06025695|588980692|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
163074668|NCT06025695|588980691|FG000|Overall Study|Other|23|||
163074669|NCT06025695|588980692|FG001|Overall Study|Other|19|||
163074670|NCT06025695|588980691|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
163218391|NCT03446040|589515795|FG013|Overall Study|Not reported|0|||
163218392|NCT00456521|589515796|FG000|Overall Study|Adverse Event|150|||
163218393|NCT00456521|589515797|FG001|Overall Study|Adverse Event|25|||
163218394|NCT00456521|589515796|FG000|Overall Study|Withdrawal by Subject|43|||
163218395|NCT00456521|589515797|FG001|Overall Study|Withdrawal by Subject|24|||
163218396|NCT00456521|589515796|FG000|Overall Study|Lost to Follow-up|22|||
163218397|NCT00456521|589515797|FG001|Overall Study|Lost to Follow-up|17|||
163218398|NCT00456521|589515796|FG000|Overall Study|Lack of Efficacy|3|||
163218399|NCT00456521|589515797|FG001|Overall Study|Lack of Efficacy|6|||
163218400|NCT00456521|589515796|FG000|Overall Study|Protocol Violation|4|||
163218401|NCT00456521|589515797|FG001|Overall Study|Protocol Violation|0|||
163218402|NCT00456521|589515796|FG000|Overall Study|Pregnancy|1|||
163218403|NCT00456521|589515797|FG001|Overall Study|Pregnancy|1|||
163218404|NCT00456521|589515796|FG000|Overall Study|Drug non-compliance, moved, other|26|||
163218405|NCT00456521|589515797|FG001|Overall Study|Drug non-compliance, moved, other|11|||
163218406|NCT02596854|589515798|FG000|Overall Study|Withdrawn|8|||
163028037|NCT03536949|588805376|FG001|Overall Study|Non-compliance|1|||
163028038|NCT00705718|588805377|FG000|Overall Study|Death|6|||
163028039|NCT00705718|588805378|FG001|Overall Study|Death|6|||
163028040|NCT00705718|588805377|FG000|Overall Study|Not due for Visit|0|||
163028041|NCT00705718|588805378|FG001|Overall Study|Not due for Visit|12|||
163028042|NCT00705718|588805377|FG000|Overall Study|Follow up not done|1|||
163028043|NCT00705718|588805378|FG001|Overall Study|Follow up not done|4|||
163028044|NCT01258075|588805383|FG000|Overall Study|Adverse Event|8|||
163028045|NCT01258075|588805384|FG001|Overall Study|Adverse Event|3|||
163028046|NCT01258075|588805383|FG000|Overall Study|Lost to Follow-up|11|||
163028047|NCT01258075|588805384|FG001|Overall Study|Lost to Follow-up|6|||
163028048|NCT01258075|588805383|FG000|Overall Study|Withdrawal by Subject|10|||
163028049|NCT01258075|588805384|FG001|Overall Study|Withdrawal by Subject|7|||
163028050|NCT01258075|588805383|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
163028051|NCT01258075|588805384|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
163028052|NCT01258075|588805383|FG000|Overall Study|Other|12|||
163028053|NCT01258075|588805384|FG001|Overall Study|Other|5|||
163074671|NCT06025695|588980692|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
163074672|NCT01452347|588980693|FG000|Overall Study|Adverse Event|2|||
163074673|NCT01452347|588980694|FG001|Overall Study|Adverse Event|1|||
163074674|NCT01452347|588980693|FG000|Overall Study|Non compliance protocol|2|||
163074675|NCT01452347|588980694|FG001|Overall Study|Non compliance protocol|0|||
163074676|NCT01452347|588980693|FG000|Overall Study|Lost to Follow-up|2|||
163074677|NCT01452347|588980694|FG001|Overall Study|Lost to Follow-up|0|||
163074678|NCT01452347|588980693|FG000|Overall Study|Withdrawal by Subject|3|||
163074679|NCT01452347|588980694|FG001|Overall Study|Withdrawal by Subject|3|||
163074680|NCT01452347|588980693|FG000|Overall Study|Not treated|6|||
163074681|NCT01452347|588980694|FG001|Overall Study|Not treated|3|||
163074682|NCT01452347|588980693|FG000|Overall Study|Other reason not defined above|2|||
163074683|NCT01452347|588980694|FG001|Overall Study|Other reason not defined above|0|||
163074684|NCT05762744|588980695|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
163074685|NCT05762744|588980696|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
163074686|NCT05762744|588980695|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
163074687|NCT05762744|588980696|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
163074688|NCT01350973|588980697|FG000|Overall Study|Adverse Event|4|||
163074689|NCT01350973|588980698|FG001|Overall Study|Adverse Event|7|||
163074690|NCT01350973|588980699|FG002|Overall Study|Adverse Event|7|||
163074691|NCT01350973|588980697|FG000|Overall Study|Voluntary Withdrawal|2|||
163074692|NCT01350973|588980698|FG001|Overall Study|Voluntary Withdrawal|1|||
163074693|NCT01350973|588980699|FG002|Overall Study|Voluntary Withdrawal|1|||
163074694|NCT01160744|588982283|FG000|Overall Study|Withdrawal by Subject|11|||
163074695|NCT01160744|588982284|FG001|Overall Study|Withdrawal by Subject|5|||
163074696|NCT01160744|588982285|FG002|Overall Study|Withdrawal by Subject|6|||
163074697|NCT01160744|588982286|FG003|Overall Study|Withdrawal by Subject|4|||
163074698|NCT01160744|588982283|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
163074699|NCT01160744|588982284|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
163074700|NCT01160744|588982285|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
163074701|NCT01160744|588982286|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
163074702|NCT01502072|588982288|FG000|Overall Study|Withdrawal by Subject|1|||
163074703|NCT01502072|588982289|FG001|Overall Study|Withdrawal by Subject|0|||
163074704|NCT01502072|588982290|FG002|Overall Study|Withdrawal by Subject|0|||
163074705|NCT01502072|588982288|FG000|Overall Study|Death|0|||
163074706|NCT01502072|588982289|FG001|Overall Study|Death|1|||
163074707|NCT01502072|588982290|FG002|Overall Study|Death|0|||
163074708|NCT02773537|588982298|FG000|Overall Study|Lost to Follow-up|0|||
163074709|NCT02773537|588982299|FG001|Overall Study|Lost to Follow-up|1|||
163074710|NCT02773537|588982300|FG002|Overall Study|Lost to Follow-up|4|||
163074711|NCT03188705|588982301|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
163074712|NCT03188705|588982301|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
163074713|NCT03156621|588982303|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
163074714|NCT03156621|588982304|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
163074715|NCT03156621|588982303|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163074716|NCT03156621|588982304|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
163074717|NCT04985682|588982305|FG000|Overall Study|Withdrawal by Subject|1|||
163074718|NCT03016403|588982308|FG000|Baseline|Death|5|||
163074719|NCT03016403|588982309|FG001|Baseline|Death|8|||
163074720|NCT03016403|588982310|FG002|Baseline|Death|1|||
163074721|NCT03016403|588982311|FG003|Baseline|Death|0|||
163074722|NCT03016403|588982308|FG000|Baseline|Withdrawal by Subject|2|||
163074723|NCT03016403|588982309|FG001|Baseline|Withdrawal by Subject|8|||
163074724|NCT03016403|588982310|FG002|Baseline|Withdrawal by Subject|4|||
163074725|NCT03016403|588982311|FG003|Baseline|Withdrawal by Subject|10|||
163074726|NCT03016403|588982308|FG000|Baseline|Lost to Follow-up|9|||
163074727|NCT03016403|588982309|FG001|Baseline|Lost to Follow-up|11|||
163074728|NCT03016403|588982310|FG002|Baseline|Lost to Follow-up|6|||
163074729|NCT03016403|588982311|FG003|Baseline|Lost to Follow-up|24|||
163074730|NCT03016403|588982308|FG000|6-week Follow-up|Death|1|||
163074731|NCT03016403|588982309|FG001|6-week Follow-up|Death|4|||
163074732|NCT03016403|588982310|FG002|6-week Follow-up|Death|0|||
163074733|NCT03016403|588982311|FG003|6-week Follow-up|Death|0|||
163074734|NCT03016403|588982308|FG000|6-week Follow-up|Lost to Follow-up|2|||
163074735|NCT03016403|588982309|FG001|6-week Follow-up|Lost to Follow-up|7|||
163074736|NCT03016403|588982310|FG002|6-week Follow-up|Lost to Follow-up|4|||
163074737|NCT03016403|588982311|FG003|6-week Follow-up|Lost to Follow-up|8|||
163074738|NCT03016403|588982308|FG000|6-week Follow-up|Withdrawal by Subject|0|||
163074739|NCT03016403|588982309|FG001|6-week Follow-up|Withdrawal by Subject|2|||
163074740|NCT03016403|588982310|FG002|6-week Follow-up|Withdrawal by Subject|0|||
163074741|NCT03016403|588982311|FG003|6-week Follow-up|Withdrawal by Subject|1|||
163074742|NCT03016403|588982308|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
163074743|NCT03016403|588982309|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
163074744|NCT03016403|588982310|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
163074745|NCT03016403|588982311|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
163074746|NCT03016403|588982308|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
163074747|NCT03016403|588982309|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
163074748|NCT03016403|588982310|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
163074749|NCT03016403|588982311|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
163074750|NCT03016403|588982308|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
163074751|NCT03016403|588982309|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
163074752|NCT03016403|588982310|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
163074753|NCT03016403|588982311|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
163074754|NCT00799864|588982312|FG000|Overall Study|Participant reached a virologic endpoint|9|||
163074755|NCT00799864|588982313|FG001|Overall Study|Participant reached a virologic endpoint|2|||
163074756|NCT00799864|588982314|FG002|Overall Study|Participant reached a virologic endpoint|2|||
163074757|NCT00799864|588982315|FG003|Overall Study|Participant reached a virologic endpoint|0|||
163074758|NCT00799864|588982316|FG004|Overall Study|Participant reached a virologic endpoint|0|||
163074759|NCT00799864|588982312|FG000|Overall Study|Other|2|||
163074760|NCT00799864|588982313|FG001|Overall Study|Other|1|||
163074761|NCT00799864|588982314|FG002|Overall Study|Other|0|||
163074762|NCT00799864|588982315|FG003|Overall Study|Other|0|||
163074763|NCT00799864|588982316|FG004|Overall Study|Other|0|||
163074764|NCT00225758|588982317|FG000|Overall Study|Adverse Event|4|||
163074765|NCT00576407|588982318|FG000|Overall Study|Death|7|||
163074766|NCT00576407|588982318|FG000|Overall Study|Physician Decision|1|||
163074767|NCT04641975|588982319|FG000|Overall Study|Protocol Violation|1|||
163074768|NCT04641975|588982320|FG001|Overall Study|Protocol Violation|2|||
163074769|NCT04641975|588982321|FG002|Overall Study|Protocol Violation|0|||
163074770|NCT04641975|588982322|FG003|Overall Study|Protocol Violation|0|||
163074771|NCT04641975|588982319|FG000|Overall Study|Adverse Event|0|||
163074772|NCT04641975|588982320|FG001|Overall Study|Adverse Event|0|||
163074773|NCT04641975|588982321|FG002|Overall Study|Adverse Event|1|||
163074774|NCT04641975|588982322|FG003|Overall Study|Adverse Event|1|||
163074775|NCT04641975|588982319|FG000|Overall Study|Withdrawal by Subject|1|||
163074776|NCT04641975|588982320|FG001|Overall Study|Withdrawal by Subject|0|||
163074777|NCT04641975|588982321|FG002|Overall Study|Withdrawal by Subject|0|||
163074778|NCT04641975|588982322|FG003|Overall Study|Withdrawal by Subject|0|||
163074779|NCT01259024|588982324|FG000|Overall Study|Physician Decision|1|||
163074780|NCT01657500|588982325|FG000|Overall Study|set impropperly matched|3|||
163074781|NCT01657500|588982326|FG001|Overall Study|set impropperly matched|3|||
163074782|NCT01657500|588982325|FG000|Overall Study|Lost to Follow-up|2|||
163074783|NCT01657500|588982326|FG001|Overall Study|Lost to Follow-up|2|||
163074784|NCT00756444|588982329|FG000|Overall Study|Adverse Event|1|||
163074785|NCT00756444|588982330|FG001|Overall Study|Adverse Event|1|||
163074786|NCT00756444|588982329|FG000|Overall Study|Withdrawal by Subject|6|||
163074787|NCT00756444|588982330|FG001|Overall Study|Withdrawal by Subject|8|||
163074788|NCT00756444|588982329|FG000|Overall Study|Lost to Follow-up|0|||
163074789|NCT00756444|588982330|FG001|Overall Study|Lost to Follow-up|1|||
163074790|NCT00756444|588982329|FG000|Overall Study|Death|5|||
163074791|NCT00756444|588982330|FG001|Overall Study|Death|4|||
163074792|NCT00756444|588982329|FG000|Overall Study|Disease Progression|2|||
163074793|NCT00756444|588982330|FG001|Overall Study|Disease Progression|7|||
163074794|NCT00756444|588982329|FG000|Overall Study|Ineligibility Determined|1|||
163074795|NCT00756444|588982330|FG001|Overall Study|Ineligibility Determined|0|||
163074796|NCT03528577|588982333|FG000|Sequence 1|Failed Spirometry|1|||
163074797|NCT03528577|588982333|FG000|Sequence 1|Restricted medication|1|||
163074798|NCT03528577|588982333|FG000|Sequence 2|Adverse Event|1|||
163074799|NCT03528577|588982333|FG000|Sequence 2|Withdrawal by Subject|1|||
163074800|NCT03528577|588982333|FG000|Sequence 2|Failed Spirometry|1|||
163074801|NCT03528577|588982333|FG000|Sequence 3|Failed Spirometry|1|||
163074802|NCT03528577|588982333|FG000|Sequence 4|Failed Spirometry|2|||
163074803|NCT03528577|588982333|FG000|Sequence 4|Adverse Event|1|||
163074804|NCT03892915|588982334|FG000|Overall Study|Lost to Follow-up|6|||
163074805|NCT03892915|588982335|FG001|Overall Study|Lost to Follow-up|12|||
163074806|NCT03892915|588982334|FG000|Overall Study|Death|0|||
163074807|NCT03892915|588982335|FG001|Overall Study|Death|2|||
163218407|NCT00464568|589515801|FG000|Overall Study|Adverse Event|2|||
163218408|NCT00405587|589515802|FG000|Overall Study|Death|0|||
163074808|NCT03892915|588982334|FG000|Overall Study|Withdrawal by Subject|1|||
163074809|NCT03892915|588982335|FG001|Overall Study|Withdrawal by Subject|1|||
163074810|NCT03892915|588982334|FG000|Overall Study|unsuccessful delivery|13|||
163074811|NCT03892915|588982335|FG001|Overall Study|unsuccessful delivery|18|||
163074812|NCT03364686|588982336|FG000|Overall Study|Physician Decision|2|||
163074813|NCT01520714|588982337|FG000|Overall Study|Protocol Violation|0|||
163074814|NCT01520714|588982338|FG001|Overall Study|Protocol Violation|3|||
163074815|NCT01520714|588982337|FG000|Overall Study|Adverse Event|0|||
163074816|NCT01520714|588982338|FG001|Overall Study|Adverse Event|2|||
163074817|NCT01520714|588982337|FG000|Overall Study|Lack of Efficacy|0|||
163074818|NCT01520714|588982338|FG001|Overall Study|Lack of Efficacy|1|||
163074819|NCT01478087|588982343|FG000|Overall Study|due to sponsor closing study|1|||
163074820|NCT03566550|588982344|FG000|Overall Study|Withdrawal by Subject|0|||
163218409|NCT00405587|589515803|FG001|Overall Study|Death|0|||
163218410|NCT00405587|589515804|FG002|Overall Study|Death|0|||
163074821|NCT03566550|588982345|FG001|Overall Study|Withdrawal by Subject|1|||
163074822|NCT03518203|588982349|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
163074823|NCT03518203|588982349|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
163074824|NCT02829957|588982350|FG000|Overall Study|Lost to Follow-up|2|||
163074825|NCT02829957|588982351|FG001|Overall Study|Lost to Follow-up|1|||
163074826|NCT03511066|588982353|FG000|Overall Study|Withdrawal by Subject|1|||
163074827|NCT03511066|588982354|FG001|Overall Study|Withdrawal by Subject|2|||
163074828|NCT03511066|588982355|FG002|Overall Study|Withdrawal by Subject|3|||
163074829|NCT03511066|588982353|FG000|Overall Study|Lost to Follow-up|2|||
163074830|NCT03511066|588982354|FG001|Overall Study|Lost to Follow-up|3|||
163074831|NCT03511066|588982355|FG002|Overall Study|Lost to Follow-up|0|||
163074832|NCT04146909|588982356|FG000|Overall Study|Withdrawal by Subject|3|||
163074833|NCT04146909|588982356|FG000|Overall Study|Did not qualify after consented|1|||
163074834|NCT00345592|588982357|FG000|Overall Study|Death|14|||
163074835|NCT00345592|588982358|FG001|Overall Study|Death|16|||
163074836|NCT00345592|588982357|FG000|Overall Study|Withdrawal by Subject|11|||
163074837|NCT00345592|588982358|FG001|Overall Study|Withdrawal by Subject|8|||
163074838|NCT03467945|588982363|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163074839|NCT03467945|588982364|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163074840|NCT03467945|588982365|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163074841|NCT03467945|588982366|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163074842|NCT03467945|588982363|FG000|Treatment Period 3|Withdrawal by Subject|1|||
163074843|NCT03467945|588982364|FG001|Treatment Period 3|Withdrawal by Subject|0|||
163074844|NCT03467945|588982365|FG002|Treatment Period 3|Withdrawal by Subject|2|||
163074845|NCT03467945|588982366|FG003|Treatment Period 3|Withdrawal by Subject|1|||
163074846|NCT03336866|588982381|FG000|Overall Study|Lost to Follow-up|2|||
163074847|NCT03336866|588982382|FG001|Overall Study|Lost to Follow-up|0|||
163074848|NCT03336866|588982383|FG002|Overall Study|Lost to Follow-up|3|||
163074849|NCT03336866|588982381|FG000|Overall Study|Withdrawal by Subject|1|||
163074850|NCT03336866|588982382|FG001|Overall Study|Withdrawal by Subject|1|||
163074851|NCT03336866|588982383|FG002|Overall Study|Withdrawal by Subject|0|||
163074852|NCT03336866|588982381|FG000|Overall Study|Noncompliance with clinic house rules|0|||
163074853|NCT03336866|588982382|FG001|Overall Study|Noncompliance with clinic house rules|0|||
163074854|NCT03336866|588982383|FG002|Overall Study|Noncompliance with clinic house rules|1|||
163074855|NCT00032487|588982384|FG000|Overall Study|Withdrawal by Subject|67|||
163074856|NCT00032487|588982385|FG001|Overall Study|Withdrawal by Subject|43|||
163074857|NCT00032487|588982384|FG000|Overall Study|Adverse Event|3|||
163074858|NCT00032487|588982385|FG001|Overall Study|Adverse Event|7|||
163074859|NCT00032487|588982384|FG000|Overall Study|Lost to Follow-up|57|||
163074860|NCT00032487|588982385|FG001|Overall Study|Lost to Follow-up|58|||
163074861|NCT00032487|588982384|FG000|Overall Study|Had other reason|12|||
163074862|NCT00032487|588982385|FG001|Overall Study|Had other reason|12|||
163074863|NCT02218268|588982386|FG000|24 Hour Washout|Physician Decision|11|||
163074864|NCT02218268|588982387|FG001|24 Hour Washout|Physician Decision|9|||
163074865|NCT03651336|588982388|FG000|Overall Study|Withdrawal by Subject|4|||
163074866|NCT01341990|588982389|FG000|Overall Study|Adverse Event|0|||
163074867|NCT01341990|588982390|FG001|Overall Study|Adverse Event|1|||
163074868|NCT01341990|588982389|FG000|Overall Study|Torn Study Lens|1|||
163074869|NCT01341990|588982390|FG001|Overall Study|Torn Study Lens|0|||
163074870|NCT01341990|588982389|FG000|Overall Study|Withdrawal by Subject|2|||
163074871|NCT01341990|588982390|FG001|Overall Study|Withdrawal by Subject|0|||
163074872|NCT01125748|588982392|FG000|Overall Study|Adverse Event|0|||
163074873|NCT01125748|588982393|FG001|Overall Study|Adverse Event|2|||
163218411|NCT00405587|589515805|FG003|Overall Study|Death|1|||
163218412|NCT00405587|589515802|FG000|Overall Study|Disease Progression|22|||
163218413|NCT00405587|589515803|FG001|Overall Study|Disease Progression|23|||
163218414|NCT00405587|589515804|FG002|Overall Study|Disease Progression|21|||
163218415|NCT00405587|589515805|FG003|Overall Study|Disease Progression|17|||
163218416|NCT00405587|589515802|FG000|Overall Study|Physician Decision|3|||
163218417|NCT00405587|589515803|FG001|Overall Study|Physician Decision|2|||
163218418|NCT00405587|589515804|FG002|Overall Study|Physician Decision|0|||
163218419|NCT00405587|589515805|FG003|Overall Study|Physician Decision|0|||
163218420|NCT00405587|589515802|FG000|Overall Study|Adverse Event|1|||
163218421|NCT00405587|589515803|FG001|Overall Study|Adverse Event|0|||
163218422|NCT00405587|589515804|FG002|Overall Study|Adverse Event|0|||
163218423|NCT00405587|589515805|FG003|Overall Study|Adverse Event|0|||
163406400|NCT01783678|590198624|FG003|Overall Study|Randomized but Not Treated|1|||
163074874|NCT01125748|588982392|FG000|Overall Study|Lost to Follow-up|0|||
163406401|NCT01783678|590198625|FG004|Overall Study|Randomized but Not Treated|0|||
163074875|NCT01125748|588982393|FG001|Overall Study|Lost to Follow-up|1|||
163074876|NCT01125748|588982392|FG000|Overall Study|Physician Decision|8|||
163074877|NCT01125748|588982393|FG001|Overall Study|Physician Decision|7|||
163074878|NCT01125748|588982392|FG000|Overall Study|Patient Decision to Withdraw|2|||
163074879|NCT01125748|588982393|FG001|Overall Study|Patient Decision to Withdraw|4|||
163074880|NCT01028391|588982394|FG000|Overall Study|Adverse Event|4|||
163218424|NCT00405587|589515802|FG000|Overall Study|Lost to Follow-up|0|||
163406402|NCT01783678|590198626|FG005|Overall Study|Randomized but Not Treated|0|||
163074881|NCT01028391|588982395|FG001|Overall Study|Adverse Event|0|||
163074882|NCT01028391|588982394|FG000|Overall Study|Lack of Efficacy|0|||
163074883|NCT01028391|588982395|FG001|Overall Study|Lack of Efficacy|2|||
163074884|NCT01028391|588982394|FG000|Overall Study|Lost to Follow-up|3|||
163074885|NCT01028391|588982395|FG001|Overall Study|Lost to Follow-up|4|||
163074886|NCT01028391|588982394|FG000|Overall Study|Physician Decision|0|||
163074887|NCT01028391|588982395|FG001|Overall Study|Physician Decision|1|||
163074888|NCT01028391|588982394|FG000|Overall Study|Withdrawal by Subject|6|||
163074889|NCT01028391|588982395|FG001|Overall Study|Withdrawal by Subject|3|||
163074890|NCT01028391|588982394|FG000|Overall Study|Needed excluded medication|1|||
163074891|NCT01028391|588982395|FG001|Overall Study|Needed excluded medication|1|||
163074892|NCT01107457|588982396|FG000|Part A|Adverse Event|1|||
163074893|NCT01107457|588982397|FG001|Part A|Adverse Event|2|||
163074894|NCT01107457|588982398|FG002|Part A|Adverse Event|1|||
163074895|NCT01107457|588982399|FG003|Part A|Adverse Event|0|||
163074896|NCT01107457|588982400|FG004|Part A|Adverse Event|0|||
163074897|NCT01107457|588982401|FG005|Part A|Adverse Event|0|||
163074898|NCT01107457|588982396|FG000|Part A|Withdrawal by Subject|3|||
163074899|NCT01107457|588982397|FG001|Part A|Withdrawal by Subject|3|||
163074900|NCT01107457|588982398|FG002|Part A|Withdrawal by Subject|0|||
163074901|NCT01107457|588982399|FG003|Part A|Withdrawal by Subject|3|||
163074902|NCT01107457|588982400|FG004|Part A|Withdrawal by Subject|1|||
163074903|NCT01107457|588982401|FG005|Part A|Withdrawal by Subject|0|||
163074904|NCT01107457|588982396|FG000|Part A|Lost to Follow-up|0|||
163074905|NCT01107457|588982397|FG001|Part A|Lost to Follow-up|1|||
163074906|NCT01107457|588982398|FG002|Part A|Lost to Follow-up|0|||
163074907|NCT01107457|588982399|FG003|Part A|Lost to Follow-up|0|||
163074908|NCT01107457|588982400|FG004|Part A|Lost to Follow-up|0|||
163074909|NCT01107457|588982401|FG005|Part A|Lost to Follow-up|0|||
163074910|NCT01107457|588982396|FG000|Part A|Lack of Efficacy|1|||
163074911|NCT01107457|588982397|FG001|Part A|Lack of Efficacy|0|||
163074912|NCT01107457|588982398|FG002|Part A|Lack of Efficacy|0|||
163074913|NCT01107457|588982399|FG003|Part A|Lack of Efficacy|0|||
163074914|NCT01107457|588982400|FG004|Part A|Lack of Efficacy|0|||
163074915|NCT01107457|588982401|FG005|Part A|Lack of Efficacy|0|||
163074916|NCT01107457|588982396|FG000|Part A|Protocol Violation|0|||
163074917|NCT01107457|588982397|FG001|Part A|Protocol Violation|1|||
163074918|NCT01107457|588982398|FG002|Part A|Protocol Violation|0|||
163074919|NCT01107457|588982399|FG003|Part A|Protocol Violation|0|||
163074920|NCT01107457|588982400|FG004|Part A|Protocol Violation|0|||
163074921|NCT01107457|588982401|FG005|Part A|Protocol Violation|0|||
163074922|NCT01107457|588982396|FG000|Part B and C|Adverse Event|0|||
163074923|NCT01107457|588982397|FG001|Part B and C|Adverse Event|0|||
163074924|NCT01107457|588982398|FG002|Part B and C|Adverse Event|0|||
163074925|NCT01107457|588982399|FG003|Part B and C|Adverse Event|0|||
163074926|NCT01107457|588982400|FG004|Part B and C|Adverse Event|0|||
163074927|NCT01107457|588982401|FG005|Part B and C|Adverse Event|12|||
163074928|NCT01107457|588982396|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
163074929|NCT01107457|588982397|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
163074930|NCT01107457|588982398|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
163074931|NCT01107457|588982399|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
163074932|NCT01107457|588982400|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
163218425|NCT00405587|589515803|FG001|Overall Study|Lost to Follow-up|1|||
163218426|NCT00405587|589515804|FG002|Overall Study|Lost to Follow-up|1|||
163218427|NCT00405587|589515805|FG003|Overall Study|Lost to Follow-up|0|||
163218428|NCT00405587|589515802|FG000|Overall Study|Radiation induced necrosis|0|||
163218429|NCT00405587|589515803|FG001|Overall Study|Radiation induced necrosis|1|||
163218430|NCT00405587|589515804|FG002|Overall Study|Radiation induced necrosis|0|||
163218431|NCT00405587|589515805|FG003|Overall Study|Radiation induced necrosis|0|||
163406403|NCT01783678|590198621|FG000|Overall Study|Lack of Efficacy|1|||
163406404|NCT01783678|590198622|FG001|Overall Study|Lack of Efficacy|13|||
163074933|NCT01107457|588982401|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
163074934|NCT01107457|588982396|FG000|Part B and C|Physician Decision|0|||
163074935|NCT01107457|588982397|FG001|Part B and C|Physician Decision|0|||
163074936|NCT01107457|588982398|FG002|Part B and C|Physician Decision|0|||
163074937|NCT01107457|588982399|FG003|Part B and C|Physician Decision|0|||
163074938|NCT01107457|588982400|FG004|Part B and C|Physician Decision|0|||
163074939|NCT01107457|588982401|FG005|Part B and C|Physician Decision|3|||
163074940|NCT01107457|588982396|FG000|Part B and C|Lack of Efficacy|0|||
163074941|NCT01107457|588982397|FG001|Part B and C|Lack of Efficacy|0|||
163218432|NCT00405587|589515802|FG000|Overall Study|Withdrawal by Subject|0|||
163074942|NCT01107457|588982398|FG002|Part B and C|Lack of Efficacy|0|||
163074943|NCT01107457|588982399|FG003|Part B and C|Lack of Efficacy|0|||
163074944|NCT01107457|588982400|FG004|Part B and C|Lack of Efficacy|0|||
163074945|NCT01107457|588982401|FG005|Part B and C|Lack of Efficacy|7|||
163074946|NCT01107457|588982396|FG000|Part B and C|Lost to Follow-up|0|||
163074947|NCT01107457|588982397|FG001|Part B and C|Lost to Follow-up|0|||
163074948|NCT01107457|588982398|FG002|Part B and C|Lost to Follow-up|0|||
163218433|NCT00405587|589515803|FG001|Overall Study|Withdrawal by Subject|0|||
163074949|NCT01107457|588982399|FG003|Part B and C|Lost to Follow-up|0|||
163074950|NCT01107457|588982400|FG004|Part B and C|Lost to Follow-up|0|||
163074951|NCT01107457|588982401|FG005|Part B and C|Lost to Follow-up|10|||
163074952|NCT01107457|588982396|FG000|Part B and C|Protocol Violation|0|||
163074953|NCT01107457|588982397|FG001|Part B and C|Protocol Violation|0|||
163074954|NCT01107457|588982398|FG002|Part B and C|Protocol Violation|0|||
163074955|NCT01107457|588982399|FG003|Part B and C|Protocol Violation|0|||
163074956|NCT01107457|588982400|FG004|Part B and C|Protocol Violation|0|||
163074957|NCT01107457|588982401|FG005|Part B and C|Protocol Violation|1|||
163074958|NCT01107457|588982396|FG000|Part B and C|Sponsor Decision|0|||
163074959|NCT01107457|588982397|FG001|Part B and C|Sponsor Decision|0|||
163074960|NCT01107457|588982398|FG002|Part B and C|Sponsor Decision|0|||
163074961|NCT01107457|588982399|FG003|Part B and C|Sponsor Decision|0|||
163074962|NCT01107457|588982400|FG004|Part B and C|Sponsor Decision|0|||
163074963|NCT01107457|588982401|FG005|Part B and C|Sponsor Decision|66|||
163074964|NCT01107457|588982396|FG000|Part B and C|Withdrawal by Subject|0|||
163074965|NCT01107457|588982397|FG001|Part B and C|Withdrawal by Subject|0|||
163074966|NCT01107457|588982398|FG002|Part B and C|Withdrawal by Subject|0|||
163074967|NCT01107457|588982399|FG003|Part B and C|Withdrawal by Subject|0|||
163074968|NCT01107457|588982400|FG004|Part B and C|Withdrawal by Subject|0|||
163074969|NCT01107457|588982401|FG005|Part B and C|Withdrawal by Subject|16|||
163074970|NCT01107457|588982396|FG000|Part B and C|Clinical Relapse|0|||
163074971|NCT01107457|588982397|FG001|Part B and C|Clinical Relapse|0|||
163074972|NCT01107457|588982398|FG002|Part B and C|Clinical Relapse|0|||
163074973|NCT01107457|588982399|FG003|Part B and C|Clinical Relapse|0|||
163074974|NCT01107457|588982400|FG004|Part B and C|Clinical Relapse|0|||
163074975|NCT01107457|588982401|FG005|Part B and C|Clinical Relapse|4|||
163074976|NCT00694161|588982402|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
163074977|NCT00694161|588982402|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
163074978|NCT00694161|588982402|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
163074979|NCT03601052|588982403|FG000|Overall Study|Lost to Follow-up|2|||
163074980|NCT01227395|588982404|FG000|Overall Study|Protocol Violation|0|||
163074981|NCT01227395|588982405|FG001|Overall Study|Protocol Violation|1|||
163074982|NCT00105508|588982406|FG000|Overall Study|Prephase Dropout|1|||
163074983|NCT00105508|588982407|FG001|Overall Study|Prephase Dropout|0|||
163074984|NCT00105508|588982406|FG000|Overall Study|Adverse Event|16|||
163074985|NCT00105508|588982407|FG001|Overall Study|Adverse Event|19|||
163074986|NCT00105508|588982406|FG000|Overall Study|Insufficient Efficacy|1|||
163074987|NCT00105508|588982407|FG001|Overall Study|Insufficient Efficacy|0|||
163074988|NCT00105508|588982406|FG000|Overall Study|Withdrawal by Subject|10|||
163074989|NCT00105508|588982407|FG001|Overall Study|Withdrawal by Subject|6|||
163074990|NCT00105508|588982406|FG000|Overall Study|Lost to Follow-up|3|||
163074991|NCT00105508|588982407|FG001|Overall Study|Lost to Follow-up|0|||
163074992|NCT00105508|588982406|FG000|Overall Study|Protocol Violation|1|||
163074993|NCT00105508|588982407|FG001|Overall Study|Protocol Violation|2|||
163074994|NCT00105508|588982406|FG000|Overall Study|Other|8|||
163074995|NCT00105508|588982407|FG001|Overall Study|Other|9|||
163074996|NCT00683384|588982408|FG000|Overall Study|Death|1|||
163074997|NCT00683384|588982408|FG000|Overall Study|Adverse Event|1|||
163074998|NCT00120874|588982409|FG000|Overall Study|Death|0|||
163074999|NCT00120874|588982410|FG001|Overall Study|Death|1|||
163075000|NCT01108055|588982411|FG000|Overall Study|Ineligible|11|||
163075001|NCT01108055|588982411|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
163075002|NCT01049828|588982414|FG000|Overall Study|Claustrophibia and Frustration|2|||
163075003|NCT02015104|588982415|FG000|Overall Study|Withdrew consent after first dose drug|1|||
163075004|NCT02015104|588982416|FG001|Overall Study|Withdrew consent after first dose drug|0|||
163075005|NCT02015104|588982415|FG000|Overall Study|Withdrew consent prior to treatment|0|||
163075006|NCT02015104|588982416|FG001|Overall Study|Withdrew consent prior to treatment|1|||
163075007|NCT03011372|588982417|FG000|Overall Study|Death|16|||
163075008|NCT03011372|588982417|FG000|Overall Study|Lost to Follow-up|2|||
163075009|NCT03011372|588982417|FG000|Overall Study|Sponsor Decision|17|||
163075010|NCT03011372|588982417|FG000|Overall Study|Withdrawal by Subject|7|||
163075011|NCT03011372|588982417|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
163075012|NCT03011372|588982417|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
163075013|NCT03011372|588982417|FG000|Overall Study|Sponsor's Decision|2|||
163075014|NCT03572218|588982418|FG000|Overall Study|Lost to Follow-up|3|||
163075015|NCT03572218|588982419|FG001|Overall Study|Lost to Follow-up|2|||
163075016|NCT03572218|588982418|FG000|Overall Study|No longer available for study visits|2|||
163075017|NCT03572218|588982419|FG001|Overall Study|No longer available for study visits|1|||
163075018|NCT03572218|588982418|FG000|Overall Study|No longer interested|1|||
163075019|NCT03572218|588982419|FG001|Overall Study|No longer interested|2|||
163075020|NCT00853047|588982420|FG000|Core Phase|Participant Request|0|||
163075021|NCT00853047|588982421|FG001|Core Phase|Participant Request|0|||
163075022|NCT00853047|588982422|FG002|Core Phase|Participant Request|0|||
163075023|NCT00853047|588982423|FG003|Core Phase|Participant Request|1|||
163075024|NCT00853047|588982424|FG004|Core Phase|Participant Request|0|||
163218434|NCT00405587|589515804|FG002|Overall Study|Withdrawal by Subject|0|||
163075025|NCT00853047|588982425|FG005|Core Phase|Participant Request|0|||
163075026|NCT00853047|588982420|FG000|Open-Label Extension Phase|Participant Request|0|||
163075027|NCT00853047|588982421|FG001|Open-Label Extension Phase|Participant Request|0|||
163075028|NCT00853047|588982422|FG002|Open-Label Extension Phase|Participant Request|0|||
163075029|NCT00853047|588982423|FG003|Open-Label Extension Phase|Participant Request|0|||
163075030|NCT00853047|588982424|FG004|Open-Label Extension Phase|Participant Request|0|||
163075031|NCT00853047|588982425|FG005|Open-Label Extension Phase|Participant Request|7|||
163075032|NCT00853047|588982420|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
163075033|NCT00853047|588982421|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
163075034|NCT00853047|588982422|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
163075035|NCT00853047|588982423|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
163075036|NCT00853047|588982424|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
163075037|NCT00853047|588982425|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
163218435|NCT00405587|589515805|FG003|Overall Study|Withdrawal by Subject|2|||
163218436|NCT00405587|589515802|FG000|Overall Study|Participant not dosed|0|||
163218437|NCT00405587|589515803|FG001|Overall Study|Participant not dosed|1|||
163218438|NCT00405587|589515804|FG002|Overall Study|Participant not dosed|0|||
163218439|NCT00405587|589515805|FG003|Overall Study|Participant not dosed|0|||
163218440|NCT00507442|589515808|FG000|Overall Study|Adverse Event|8|||
163218441|NCT00507442|589515809|FG001|Overall Study|Adverse Event|11|||
163218442|NCT00507442|589515810|FG002|Overall Study|Adverse Event|4|||
163218443|NCT00507442|589515811|FG003|Overall Study|Adverse Event|1|||
163218444|NCT00507442|589515808|FG000|Overall Study|Protocol Violation|0|||
163218445|NCT00507442|589515809|FG001|Overall Study|Protocol Violation|1|||
163218446|NCT00507442|589515810|FG002|Overall Study|Protocol Violation|0|||
163218447|NCT00507442|589515811|FG003|Overall Study|Protocol Violation|0|||
163218448|NCT00507442|589515808|FG000|Overall Study|Lost to Follow-up|0|||
163218449|NCT00507442|589515809|FG001|Overall Study|Lost to Follow-up|0|||
163218450|NCT00507442|589515810|FG002|Overall Study|Lost to Follow-up|1|||
163218451|NCT00507442|589515811|FG003|Overall Study|Lost to Follow-up|0|||
163218452|NCT00507442|589515808|FG000|Overall Study|Physician Decision|0|||
163218453|NCT00507442|589515809|FG001|Overall Study|Physician Decision|2|||
163218454|NCT00507442|589515810|FG002|Overall Study|Physician Decision|4|||
163218455|NCT00507442|589515811|FG003|Overall Study|Physician Decision|1|||
163218456|NCT00507442|589515808|FG000|Overall Study|Progressive Disease|2|||
163218457|NCT00507442|589515809|FG001|Overall Study|Progressive Disease|4|||
163331462|NCT05349721|589923975|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
163331463|NCT05349721|589923976|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
163331464|NCT05349721|589923975|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
163331465|NCT05349721|589923976|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
163331466|NCT00108355|589923978|FG000|Overall Study|Peritonitis at index paracentesis|1|||
163331467|NCT00108355|589923979|FG001|Overall Study|Peritonitis at index paracentesis|1|||
163331468|NCT00108355|589923978|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
163331469|NCT00108355|589923979|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
163331470|NCT01583166|589923980|FG000|Overall Study|Withdrawal by Subject|4|||
163331471|NCT01583166|589923981|FG001|Overall Study|Withdrawal by Subject|6|||
163331472|NCT04652869|589923984|FG000|Overall Study|Withdrawal by Subject|0|||
163331473|NCT04652869|589923985|FG001|Overall Study|Withdrawal by Subject|2|||
163331474|NCT04652869|589923986|FG002|Overall Study|Withdrawal by Subject|0|||
163331475|NCT01372085|589923987|FG000|Washout Period 2|Physician Decision|0|||
163331476|NCT01372085|589923988|FG001|Washout Period 2|Physician Decision|0|||
163331477|NCT01372085|589923989|FG002|Washout Period 2|Physician Decision|0|||
163331478|NCT01372085|589923990|FG003|Washout Period 2|Physician Decision|0|||
163331479|NCT01372085|589923991|FG004|Washout Period 2|Physician Decision|1|||
163331480|NCT01372085|589923992|FG005|Washout Period 2|Physician Decision|0|||
163331481|NCT01372085|589923993|FG006|Washout Period 2|Physician Decision|0|||
163331482|NCT01372085|589923994|FG007|Washout Period 2|Physician Decision|0|||
163331483|NCT01372085|589923995|FG008|Washout Period 2|Physician Decision|0|||
163331484|NCT01372085|589923996|FG009|Washout Period 2|Physician Decision|0|||
163331485|NCT01372085|589923987|FG000|Washout Period 3|Withdrawal by Subject|0|||
163331486|NCT01372085|589923988|FG001|Washout Period 3|Withdrawal by Subject|0|||
163331487|NCT01372085|589923989|FG002|Washout Period 3|Withdrawal by Subject|0|||
163331488|NCT01372085|589923990|FG003|Washout Period 3|Withdrawal by Subject|0|||
163331489|NCT01372085|589923991|FG004|Washout Period 3|Withdrawal by Subject|0|||
163331490|NCT01372085|589923992|FG005|Washout Period 3|Withdrawal by Subject|2|||
163075038|NCT00853047|588982420|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
163075039|NCT00853047|588982421|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
163075040|NCT00853047|588982422|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
163075041|NCT00853047|588982423|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
163218458|NCT00507442|589515810|FG002|Overall Study|Progressive Disease|2|||
163218459|NCT00507442|589515811|FG003|Overall Study|Progressive Disease|0|||
163218460|NCT00507442|589515808|FG000|Overall Study|Withdrawal by Subject|4|||
163218461|NCT00507442|589515809|FG001|Overall Study|Withdrawal by Subject|4|||
163218462|NCT00507442|589515810|FG002|Overall Study|Withdrawal by Subject|2|||
163331491|NCT01372085|589923993|FG006|Washout Period 3|Withdrawal by Subject|0|||
163331492|NCT01372085|589923994|FG007|Washout Period 3|Withdrawal by Subject|0|||
163331493|NCT01372085|589923995|FG008|Washout Period 3|Withdrawal by Subject|0|||
163075042|NCT00853047|588982424|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
163075043|NCT00853047|588982425|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
163075044|NCT00853047|588982420|FG000|Open-Label Extension Phase|Investigator Decision|0|||
163075045|NCT00853047|588982421|FG001|Open-Label Extension Phase|Investigator Decision|0|||
163075046|NCT00853047|588982422|FG002|Open-Label Extension Phase|Investigator Decision|0|||
163075047|NCT00853047|588982423|FG003|Open-Label Extension Phase|Investigator Decision|0|||
163075048|NCT00853047|588982424|FG004|Open-Label Extension Phase|Investigator Decision|0|||
163075049|NCT00853047|588982425|FG005|Open-Label Extension Phase|Investigator Decision|1|||
163075050|NCT00853047|588982420|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
163075051|NCT00853047|588982421|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
163075052|NCT00853047|588982422|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
163075053|NCT00853047|588982423|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
163075054|NCT00853047|588982424|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
163075055|NCT00853047|588982425|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
163075056|NCT02638493|588982426|FG000|Overall Study|Inability to provide semen samples|2|||
163075057|NCT02638493|588982427|FG001|Overall Study|Inability to provide semen samples|0|||
163075058|NCT02638493|588982428|FG002|Overall Study|Inability to provide semen samples|0|||
163075059|NCT01569763|588984596|FG000|Overall Study|Lack of Efficacy|2|||
163075060|NCT01569763|588984597|FG001|Overall Study|Lack of Efficacy|7|||
163075061|NCT01569763|588984596|FG000|Overall Study|Adverse Event|1|||
163075062|NCT01569763|588984597|FG001|Overall Study|Adverse Event|0|||
163075063|NCT01926509|588984598|FG000|Overall Study|vital sign met discontinuation criteria|1|||
163075064|NCT01926509|588984599|FG001|Overall Study|vital sign met discontinuation criteria|0|||
163075065|NCT01926509|588984600|FG002|Overall Study|vital sign met discontinuation criteria|0|||
163075066|NCT01926509|588984601|FG003|Overall Study|vital sign met discontinuation criteria|0|||
163075067|NCT02730169|588984602|FG000|Overall Study|Protocol Violation|1|||
163075068|NCT02730169|588984603|FG001|Overall Study|Protocol Violation|0|||
163075069|NCT02730169|588984604|FG002|Overall Study|Protocol Violation|0|||
163075070|NCT02730169|588984605|FG003|Overall Study|Protocol Violation|1|||
163075071|NCT02730169|588984602|FG000|Overall Study|Adverse Event|2|||
163075072|NCT02730169|588984603|FG001|Overall Study|Adverse Event|3|||
163075073|NCT02730169|588984604|FG002|Overall Study|Adverse Event|3|||
163075074|NCT02730169|588984605|FG003|Overall Study|Adverse Event|0|||
163075075|NCT02730169|588984602|FG000|Overall Study|Adverse Event of Special Interest|0|||
163075076|NCT02730169|588984603|FG001|Overall Study|Adverse Event of Special Interest|1|||
163075077|NCT02730169|588984604|FG002|Overall Study|Adverse Event of Special Interest|2|||
163075078|NCT02730169|588984605|FG003|Overall Study|Adverse Event of Special Interest|0|||
163075079|NCT02730169|588984602|FG000|Overall Study|Withdrawal by Subject|6|||
163075080|NCT02730169|588984603|FG001|Overall Study|Withdrawal by Subject|11|||
163075081|NCT02730169|588984604|FG002|Overall Study|Withdrawal by Subject|6|||
163075082|NCT02730169|588984605|FG003|Overall Study|Withdrawal by Subject|8|||
163075083|NCT02730169|588984602|FG000|Overall Study|Lost to Follow-up|5|||
163075084|NCT02730169|588984603|FG001|Overall Study|Lost to Follow-up|6|||
163075085|NCT02730169|588984604|FG002|Overall Study|Lost to Follow-up|5|||
163075086|NCT02730169|588984605|FG003|Overall Study|Lost to Follow-up|6|||
163075087|NCT02730169|588984602|FG000|Overall Study|Other|0|||
163218463|NCT00507442|589515811|FG003|Overall Study|Withdrawal by Subject|1|||
163218464|NCT00507442|589515808|FG000|Overall Study|Other|2|||
163218465|NCT00507442|589515809|FG001|Overall Study|Other|5|||
163218466|NCT00507442|589515810|FG002|Overall Study|Other|2|||
163218467|NCT00507442|589515811|FG003|Overall Study|Other|2|||
163218468|NCT02255981|589515813|FG000|Overall Study|Lost to Follow-up|3|||
163075088|NCT02730169|588984603|FG001|Overall Study|Other|0|||
163075089|NCT02730169|588984604|FG002|Overall Study|Other|1|||
163075090|NCT02730169|588984605|FG003|Overall Study|Other|1|||
163075091|NCT03004183|588984606|FG000|Overall Study|Adverse Event|7|||
163075092|NCT03004183|588984606|FG000|Overall Study|Lost to Follow-up|1|||
163075093|NCT03004183|588984606|FG000|Overall Study|Physician Decision|40|||
163075094|NCT03004183|588984606|FG000|Overall Study|Withdrawal by Subject|1|||
163075095|NCT03004183|588984606|FG000|Overall Study|COVID-19|1|||
163075096|NCT02698787|588984610|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
163075097|NCT02698787|588984611|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
163075098|NCT02168439|588984615|FG000|Overall Study|Protocol Violation|0|||
163075099|NCT02168439|588984616|FG001|Overall Study|Protocol Violation|2|||
163075100|NCT02004275|588984617|FG000|Phase 1|Ineligible|0|||
163406405|NCT01783678|590198623|FG002|Overall Study|Lack of Efficacy|1|||
163075101|NCT02004275|588984618|FG001|Phase 1|Ineligible|0|||
163075102|NCT02004275|588984619|FG002|Phase 1|Ineligible|0|||
163075103|NCT02004275|588984620|FG003|Phase 1|Ineligible|1|||
163075104|NCT02004275|588984621|FG004|Phase 1|Ineligible|1|||
163075105|NCT02004275|588984622|FG005|Phase 1|Ineligible|0|||
163075106|NCT02004275|588984617|FG000|Phase 1|Protocol Violation|0|||
163075107|NCT02004275|588984618|FG001|Phase 1|Protocol Violation|0|||
163075108|NCT02004275|588984619|FG002|Phase 1|Protocol Violation|0|||
163075109|NCT02004275|588984620|FG003|Phase 1|Protocol Violation|1|||
163218469|NCT02255981|589515813|FG000|Overall Study|Withdrawal by Subject|1|||
163218470|NCT02672423|589515814|FG000|Period 1|Adverse Event|0|||
163331494|NCT01372085|589923996|FG009|Washout Period 3|Withdrawal by Subject|0|||
163331495|NCT00562094|589923997|FG000|Overall Study|Lost to Follow-up|62|||
163075110|NCT02004275|588984621|FG004|Phase 1|Protocol Violation|0|||
163075111|NCT02004275|588984622|FG005|Phase 1|Protocol Violation|5|||
163075112|NCT02004275|588984617|FG000|Phase 2 Part 1|Ineligible|6|||
163075113|NCT02004275|588984618|FG001|Phase 2 Part 1|Ineligible|9|||
163075114|NCT02004275|588984619|FG002|Phase 2 Part 1|Ineligible|0|||
163075115|NCT02004275|588984620|FG003|Phase 2 Part 1|Ineligible|0|||
163075116|NCT02004275|588984621|FG004|Phase 2 Part 1|Ineligible|0|||
163075117|NCT02004275|588984622|FG005|Phase 2 Part 1|Ineligible|0|||
163075118|NCT02004275|588984617|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
163075119|NCT02004275|588984618|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
163075120|NCT02004275|588984619|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
163075121|NCT02004275|588984620|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
163075122|NCT02004275|588984621|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
163075123|NCT02004275|588984622|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
163075124|NCT02533674|588984623|FG000|Dose Level I|Progressive disease|1|||
163075125|NCT02533674|588984624|FG001|Dose Level I|Progressive disease|0|||
163075126|NCT02533674|588984625|FG002|Dose Level I|Progressive disease|0|||
163075127|NCT02533674|588984626|FG003|Dose Level I|Progressive disease|0|||
163075128|NCT02533674|588984627|FG004|Dose Level I|Progressive disease|0|||
163075129|NCT02533674|588984628|FG005|Dose Level I|Progressive disease|0|||
163075130|NCT02533674|588984629|FG006|Dose Level I|Progressive disease|0|||
163075131|NCT02533674|588984630|FG007|Dose Level I|Progressive disease|0|||
163075132|NCT02533674|588984623|FG000|Dose Level I|Withdrawal by Subject|1|||
163075133|NCT02533674|588984624|FG001|Dose Level I|Withdrawal by Subject|0|||
163075134|NCT02533674|588984625|FG002|Dose Level I|Withdrawal by Subject|0|||
163075135|NCT02533674|588984626|FG003|Dose Level I|Withdrawal by Subject|0|||
163075136|NCT02533674|588984627|FG004|Dose Level I|Withdrawal by Subject|0|||
163075137|NCT02533674|588984628|FG005|Dose Level I|Withdrawal by Subject|0|||
163075138|NCT02533674|588984629|FG006|Dose Level I|Withdrawal by Subject|0|||
163075139|NCT02533674|588984630|FG007|Dose Level I|Withdrawal by Subject|0|||
163075140|NCT02533674|588984623|FG000|Dose Level I|Physician Decision|1|||
163075141|NCT02533674|588984624|FG001|Dose Level I|Physician Decision|0|||
163075142|NCT02533674|588984625|FG002|Dose Level I|Physician Decision|0|||
163075143|NCT02533674|588984626|FG003|Dose Level I|Physician Decision|0|||
163075144|NCT02533674|588984627|FG004|Dose Level I|Physician Decision|0|||
163075145|NCT02533674|588984628|FG005|Dose Level I|Physician Decision|0|||
163075146|NCT02533674|588984629|FG006|Dose Level I|Physician Decision|0|||
163075147|NCT02533674|588984630|FG007|Dose Level I|Physician Decision|0|||
163075148|NCT02533674|588984623|FG000|Dose Level I|Death|1|||
163075149|NCT02533674|588984624|FG001|Dose Level I|Death|0|||
163075150|NCT02533674|588984625|FG002|Dose Level I|Death|0|||
163075151|NCT02533674|588984626|FG003|Dose Level I|Death|0|||
163075152|NCT02533674|588984627|FG004|Dose Level I|Death|0|||
163075153|NCT02533674|588984628|FG005|Dose Level I|Death|0|||
163075154|NCT02533674|588984629|FG006|Dose Level I|Death|0|||
163075155|NCT02533674|588984630|FG007|Dose Level I|Death|0|||
163075156|NCT02533674|588984623|FG000|Dose Level I|Never Treated|1|||
163075157|NCT02533674|588984624|FG001|Dose Level I|Never Treated|0|||
163075158|NCT02533674|588984625|FG002|Dose Level I|Never Treated|0|||
163075159|NCT02533674|588984626|FG003|Dose Level I|Never Treated|0|||
163075160|NCT02533674|588984627|FG004|Dose Level I|Never Treated|0|||
163075161|NCT02533674|588984628|FG005|Dose Level I|Never Treated|0|||
163075162|NCT02533674|588984629|FG006|Dose Level I|Never Treated|0|||
163075163|NCT02533674|588984630|FG007|Dose Level I|Never Treated|0|||
163075164|NCT02533674|588984623|FG000|Dose Level II|Progressive disease|0|||
163075165|NCT02533674|588984624|FG001|Dose Level II|Progressive disease|3|||
163075166|NCT02533674|588984625|FG002|Dose Level II|Progressive disease|0|||
163075167|NCT02533674|588984626|FG003|Dose Level II|Progressive disease|0|||
163075168|NCT02533674|588984627|FG004|Dose Level II|Progressive disease|0|||
163075169|NCT02533674|588984628|FG005|Dose Level II|Progressive disease|0|||
163075170|NCT02533674|588984629|FG006|Dose Level II|Progressive disease|0|||
163331496|NCT03960645|589923998|FG000|Overall Study|Protocol Violation|1|||
163075171|NCT02533674|588984630|FG007|Dose Level II|Progressive disease|0|||
163075172|NCT02533674|588984623|FG000|Dose Level II|Withdrawal by Subject|0|||
163075173|NCT02533674|588984624|FG001|Dose Level II|Withdrawal by Subject|1|||
163075174|NCT02533674|588984625|FG002|Dose Level II|Withdrawal by Subject|0|||
163075175|NCT02533674|588984626|FG003|Dose Level II|Withdrawal by Subject|0|||
163075176|NCT02533674|588984627|FG004|Dose Level II|Withdrawal by Subject|0|||
163075177|NCT02533674|588984628|FG005|Dose Level II|Withdrawal by Subject|0|||
163075178|NCT02533674|588984629|FG006|Dose Level II|Withdrawal by Subject|0|||
163075179|NCT02533674|588984630|FG007|Dose Level II|Withdrawal by Subject|0|||
163075180|NCT02533674|588984623|FG000|Dose Level II|Treatment-related AE|0|||
163075181|NCT02533674|588984624|FG001|Dose Level II|Treatment-related AE|1|||
163075182|NCT02533674|588984625|FG002|Dose Level II|Treatment-related AE|0|||
163075183|NCT02533674|588984626|FG003|Dose Level II|Treatment-related AE|0|||
163075184|NCT02533674|588984627|FG004|Dose Level II|Treatment-related AE|0|||
163075185|NCT02533674|588984628|FG005|Dose Level II|Treatment-related AE|0|||
163331497|NCT03960645|589923999|FG001|Overall Study|Protocol Violation|0|||
163218471|NCT02672423|589515815|FG001|Period 1|Adverse Event|0|||
163218472|NCT02672423|589515816|FG002|Period 1|Adverse Event|0|||
163218473|NCT02672423|589515817|FG003|Period 1|Adverse Event|0|||
163218474|NCT02672423|589515818|FG004|Period 1|Adverse Event|1|||
163075186|NCT02533674|588984629|FG006|Dose Level II|Treatment-related AE|0|||
163075187|NCT02533674|588984630|FG007|Dose Level II|Treatment-related AE|0|||
163075188|NCT02533674|588984623|FG000|Dose Level II|Physician Decision|0|||
163075189|NCT02533674|588984624|FG001|Dose Level II|Physician Decision|1|||
163075190|NCT02533674|588984625|FG002|Dose Level II|Physician Decision|0|||
163075191|NCT02533674|588984626|FG003|Dose Level II|Physician Decision|0|||
163075192|NCT02533674|588984627|FG004|Dose Level II|Physician Decision|0|||
163075193|NCT02533674|588984628|FG005|Dose Level II|Physician Decision|0|||
163075194|NCT02533674|588984629|FG006|Dose Level II|Physician Decision|0|||
163075195|NCT02533674|588984630|FG007|Dose Level II|Physician Decision|0|||
163075196|NCT02533674|588984623|FG000|Dose Level II|Non-treatment-related AE|0|||
163075197|NCT02533674|588984624|FG001|Dose Level II|Non-treatment-related AE|1|||
163075198|NCT02533674|588984625|FG002|Dose Level II|Non-treatment-related AE|0|||
163075199|NCT02533674|588984626|FG003|Dose Level II|Non-treatment-related AE|0|||
163075200|NCT02533674|588984627|FG004|Dose Level II|Non-treatment-related AE|0|||
163075201|NCT02533674|588984628|FG005|Dose Level II|Non-treatment-related AE|0|||
163075202|NCT02533674|588984629|FG006|Dose Level II|Non-treatment-related AE|0|||
163075203|NCT02533674|588984630|FG007|Dose Level II|Non-treatment-related AE|0|||
163075204|NCT02533674|588984623|FG000|Dose Level III|Progressive disease|0|||
163075205|NCT02533674|588984624|FG001|Dose Level III|Progressive disease|0|||
163075206|NCT02533674|588984625|FG002|Dose Level III|Progressive disease|2|||
163075207|NCT02533674|588984626|FG003|Dose Level III|Progressive disease|0|||
163075208|NCT02533674|588984627|FG004|Dose Level III|Progressive disease|0|||
163075209|NCT02533674|588984628|FG005|Dose Level III|Progressive disease|0|||
163075210|NCT02533674|588984629|FG006|Dose Level III|Progressive disease|0|||
163075211|NCT02533674|588984630|FG007|Dose Level III|Progressive disease|0|||
163075212|NCT02533674|588984623|FG000|Dose Level III|Withdrawal by Subject|0|||
163075213|NCT02533674|588984624|FG001|Dose Level III|Withdrawal by Subject|0|||
163075214|NCT02533674|588984625|FG002|Dose Level III|Withdrawal by Subject|1|||
163075215|NCT02533674|588984626|FG003|Dose Level III|Withdrawal by Subject|0|||
163075216|NCT02533674|588984627|FG004|Dose Level III|Withdrawal by Subject|0|||
163075217|NCT02533674|588984628|FG005|Dose Level III|Withdrawal by Subject|0|||
163075218|NCT02533674|588984629|FG006|Dose Level III|Withdrawal by Subject|0|||
163075219|NCT02533674|588984630|FG007|Dose Level III|Withdrawal by Subject|0|||
163075220|NCT02533674|588984623|FG000|Dose Level III|Treatment-related AE|0|||
163075221|NCT02533674|588984624|FG001|Dose Level III|Treatment-related AE|0|||
163075222|NCT02533674|588984625|FG002|Dose Level III|Treatment-related AE|1|||
163075223|NCT02533674|588984626|FG003|Dose Level III|Treatment-related AE|0|||
163075224|NCT02533674|588984627|FG004|Dose Level III|Treatment-related AE|0|||
163075225|NCT02533674|588984628|FG005|Dose Level III|Treatment-related AE|0|||
163075226|NCT02533674|588984629|FG006|Dose Level III|Treatment-related AE|0|||
163075227|NCT02533674|588984630|FG007|Dose Level III|Treatment-related AE|0|||
163075228|NCT02533674|588984623|FG000|Dose Level IV|Progressive disease|0|||
163075229|NCT02533674|588984624|FG001|Dose Level IV|Progressive disease|0|||
163075230|NCT02533674|588984625|FG002|Dose Level IV|Progressive disease|0|||
163075231|NCT02533674|588984626|FG003|Dose Level IV|Progressive disease|3|||
163075232|NCT02533674|588984627|FG004|Dose Level IV|Progressive disease|0|||
163075233|NCT02533674|588984628|FG005|Dose Level IV|Progressive disease|0|||
163075234|NCT02533674|588984629|FG006|Dose Level IV|Progressive disease|0|||
163075235|NCT02533674|588984630|FG007|Dose Level IV|Progressive disease|0|||
163075236|NCT02533674|588984623|FG000|Dose Level IV|Withdrawal by Subject|0|||
163075237|NCT02533674|588984624|FG001|Dose Level IV|Withdrawal by Subject|0|||
163075238|NCT02533674|588984625|FG002|Dose Level IV|Withdrawal by Subject|0|||
163075239|NCT02533674|588984626|FG003|Dose Level IV|Withdrawal by Subject|1|||
163075240|NCT02533674|588984627|FG004|Dose Level IV|Withdrawal by Subject|0|||
163075241|NCT02533674|588984628|FG005|Dose Level IV|Withdrawal by Subject|0|||
163075242|NCT02533674|588984629|FG006|Dose Level IV|Withdrawal by Subject|0|||
163075243|NCT02533674|588984630|FG007|Dose Level IV|Withdrawal by Subject|0|||
163075244|NCT02533674|588984623|FG000|Dose Level IV|Physician Decision|0|||
163075245|NCT02533674|588984624|FG001|Dose Level IV|Physician Decision|0|||
163075246|NCT02533674|588984625|FG002|Dose Level IV|Physician Decision|0|||
163075247|NCT02533674|588984626|FG003|Dose Level IV|Physician Decision|1|||
163075248|NCT02533674|588984627|FG004|Dose Level IV|Physician Decision|0|||
163075249|NCT02533674|588984628|FG005|Dose Level IV|Physician Decision|0|||
163075250|NCT02533674|588984629|FG006|Dose Level IV|Physician Decision|0|||
163075251|NCT02533674|588984630|FG007|Dose Level IV|Physician Decision|0|||
163075252|NCT02533674|588984623|FG000|Dose Level V|Progressive disease|0|||
163075253|NCT02533674|588984624|FG001|Dose Level V|Progressive disease|0|||
163218475|NCT02672423|589515819|FG005|Period 1|Adverse Event|0|||
163218476|NCT02672423|589515820|FG006|Period 1|Adverse Event|0|||
163218477|NCT02672423|589515821|FG007|Period 1|Adverse Event|0|||
163218478|NCT02672423|589515822|FG008|Period 1|Adverse Event|0|||
163218479|NCT02672423|589515823|FG009|Period 1|Adverse Event|0|||
163218480|NCT02672423|589515814|FG000|Period 2|Withdrawal by Subject|0|||
163075254|NCT02533674|588984625|FG002|Dose Level V|Progressive disease|0|||
163075255|NCT02533674|588984626|FG003|Dose Level V|Progressive disease|0|||
163075256|NCT02533674|588984627|FG004|Dose Level V|Progressive disease|3|||
163075257|NCT02533674|588984628|FG005|Dose Level V|Progressive disease|0|||
163075258|NCT02533674|588984629|FG006|Dose Level V|Progressive disease|0|||
163075259|NCT02533674|588984630|FG007|Dose Level V|Progressive disease|0|||
163075260|NCT02533674|588984623|FG000|Dose Level V|Withdrawal by Subject|0|||
163075261|NCT02533674|588984624|FG001|Dose Level V|Withdrawal by Subject|0|||
163075262|NCT02533674|588984625|FG002|Dose Level V|Withdrawal by Subject|0|||
163075263|NCT02533674|588984626|FG003|Dose Level V|Withdrawal by Subject|0|||
163075264|NCT02533674|588984627|FG004|Dose Level V|Withdrawal by Subject|1|||
163075265|NCT02533674|588984628|FG005|Dose Level V|Withdrawal by Subject|0|||
163075266|NCT02533674|588984629|FG006|Dose Level V|Withdrawal by Subject|0|||
163075267|NCT02533674|588984630|FG007|Dose Level V|Withdrawal by Subject|0|||
163075268|NCT02533674|588984623|FG000|Dose Level V|Physician Decision|0|||
163075269|NCT02533674|588984624|FG001|Dose Level V|Physician Decision|0|||
163075270|NCT02533674|588984625|FG002|Dose Level V|Physician Decision|0|||
163075271|NCT02533674|588984626|FG003|Dose Level V|Physician Decision|0|||
163075272|NCT02533674|588984627|FG004|Dose Level V|Physician Decision|1|||
163075273|NCT02533674|588984628|FG005|Dose Level V|Physician Decision|0|||
163075274|NCT02533674|588984629|FG006|Dose Level V|Physician Decision|0|||
163075275|NCT02533674|588984630|FG007|Dose Level V|Physician Decision|0|||
163075276|NCT02533674|588984623|FG000|Dose Level VI|Progressive disease|0|||
163075277|NCT02533674|588984624|FG001|Dose Level VI|Progressive disease|0|||
163075278|NCT02533674|588984625|FG002|Dose Level VI|Progressive disease|0|||
163075279|NCT02533674|588984626|FG003|Dose Level VI|Progressive disease|0|||
163075280|NCT02533674|588984627|FG004|Dose Level VI|Progressive disease|0|||
163075281|NCT02533674|588984628|FG005|Dose Level VI|Progressive disease|7|||
163075282|NCT02533674|588984629|FG006|Dose Level VI|Progressive disease|0|||
163075283|NCT02533674|588984630|FG007|Dose Level VI|Progressive disease|0|||
163075284|NCT02533674|588984623|FG000|Dose Level VI|Withdrawal by Subject|0|||
163075285|NCT02533674|588984624|FG001|Dose Level VI|Withdrawal by Subject|0|||
163075286|NCT02533674|588984625|FG002|Dose Level VI|Withdrawal by Subject|0|||
163075287|NCT02533674|588984626|FG003|Dose Level VI|Withdrawal by Subject|0|||
163075288|NCT02533674|588984627|FG004|Dose Level VI|Withdrawal by Subject|0|||
163075289|NCT02533674|588984628|FG005|Dose Level VI|Withdrawal by Subject|1|||
163075290|NCT02533674|588984629|FG006|Dose Level VI|Withdrawal by Subject|0|||
163075291|NCT02533674|588984630|FG007|Dose Level VI|Withdrawal by Subject|0|||
163075292|NCT02533674|588984623|FG000|Dose Level VI|Treatment-related AE|0|||
163075293|NCT02533674|588984624|FG001|Dose Level VI|Treatment-related AE|0|||
163075294|NCT02533674|588984625|FG002|Dose Level VI|Treatment-related AE|0|||
163075295|NCT02533674|588984626|FG003|Dose Level VI|Treatment-related AE|0|||
163075296|NCT02533674|588984627|FG004|Dose Level VI|Treatment-related AE|0|||
163075297|NCT02533674|588984628|FG005|Dose Level VI|Treatment-related AE|1|||
163075298|NCT02533674|588984629|FG006|Dose Level VI|Treatment-related AE|0|||
163075299|NCT02533674|588984630|FG007|Dose Level VI|Treatment-related AE|0|||
163075300|NCT02533674|588984623|FG000|Dose Level VII|Progressive disease|0|||
163075301|NCT02533674|588984624|FG001|Dose Level VII|Progressive disease|0|||
163075302|NCT02533674|588984625|FG002|Dose Level VII|Progressive disease|0|||
163075303|NCT02533674|588984626|FG003|Dose Level VII|Progressive disease|0|||
163075304|NCT02533674|588984627|FG004|Dose Level VII|Progressive disease|0|||
163075305|NCT02533674|588984628|FG005|Dose Level VII|Progressive disease|0|||
163075306|NCT02533674|588984629|FG006|Dose Level VII|Progressive disease|10|||
163075307|NCT02533674|588984630|FG007|Dose Level VII|Progressive disease|0|||
163075308|NCT02533674|588984623|FG000|Dose Level VII|Withdrawal by Subject|0|||
163075309|NCT02533674|588984624|FG001|Dose Level VII|Withdrawal by Subject|0|||
163075310|NCT02533674|588984625|FG002|Dose Level VII|Withdrawal by Subject|0|||
163075311|NCT02533674|588984626|FG003|Dose Level VII|Withdrawal by Subject|0|||
163075312|NCT02533674|588984627|FG004|Dose Level VII|Withdrawal by Subject|0|||
163075313|NCT02533674|588984628|FG005|Dose Level VII|Withdrawal by Subject|0|||
163075314|NCT02533674|588984629|FG006|Dose Level VII|Withdrawal by Subject|3|||
163075315|NCT02533674|588984630|FG007|Dose Level VII|Withdrawal by Subject|0|||
163075316|NCT02533674|588984623|FG000|Dose Level VII|Treatment-related AE|0|||
163075317|NCT02533674|588984624|FG001|Dose Level VII|Treatment-related AE|0|||
163075318|NCT02533674|588984625|FG002|Dose Level VII|Treatment-related AE|0|||
163075319|NCT02533674|588984626|FG003|Dose Level VII|Treatment-related AE|0|||
163075320|NCT02533674|588984627|FG004|Dose Level VII|Treatment-related AE|0|||
163075321|NCT02533674|588984628|FG005|Dose Level VII|Treatment-related AE|0|||
163075322|NCT02533674|588984629|FG006|Dose Level VII|Treatment-related AE|1|||
163075323|NCT02533674|588984630|FG007|Dose Level VII|Treatment-related AE|0|||
163075324|NCT02533674|588984623|FG000|Dose Level VII|Death|0|||
163075325|NCT02533674|588984624|FG001|Dose Level VII|Death|0|||
163075326|NCT02533674|588984625|FG002|Dose Level VII|Death|0|||
163075327|NCT02533674|588984626|FG003|Dose Level VII|Death|0|||
163075328|NCT02533674|588984627|FG004|Dose Level VII|Death|0|||
163075329|NCT02533674|588984628|FG005|Dose Level VII|Death|0|||
163075330|NCT02533674|588984629|FG006|Dose Level VII|Death|2|||
163075331|NCT02533674|588984630|FG007|Dose Level VII|Death|0|||
163218481|NCT02672423|589515815|FG001|Period 2|Withdrawal by Subject|0|||
163218482|NCT02672423|589515816|FG002|Period 2|Withdrawal by Subject|1|||
163218483|NCT02672423|589515817|FG003|Period 2|Withdrawal by Subject|0|||
163218484|NCT02672423|589515818|FG004|Period 2|Withdrawal by Subject|0|||
163028054|NCT04021121|588805390|FG000|Overall Study|Death|3|||
163028055|NCT04021121|588805391|FG001|Overall Study|Death|3|||
163028056|NCT04021121|588805392|FG002|Overall Study|Death|5|||
163028057|NCT04021121|588805393|FG003|Overall Study|Death|4|||
163028058|NCT01597375|588805401|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
163028059|NCT01597375|588805402|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
163028060|NCT01597375|588805401|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
163028061|NCT01597375|588805402|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
163028062|NCT01597375|588805401|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
163028063|NCT01597375|588805402|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
163028064|NCT01597375|588805401|FG000|Washout (2 Weeks)|Adverse Event|1|||
163028065|NCT01597375|588805402|FG001|Washout (2 Weeks)|Adverse Event|0|||
163028066|NCT01597375|588805401|FG000|Second Intervention|Failed to react at both Aspirin|1|||
163028067|NCT01597375|588805402|FG001|Second Intervention|Failed to react at both Aspirin|1|||
163028068|NCT02375555|588805403|FG000|Induction Period|Adverse Event|7|||
163028069|NCT02375555|588805403|FG000|Induction Period|Withdrawal by Subject|2|||
163028070|NCT02375555|588805403|FG000|Induction Period|Other|1|||
163028071|NCT02375555|588805403|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
163028072|NCT02375555|588805403|FG000|Maintenance Period|Adverse Event|2|||
163028073|NCT02375555|588805403|FG000|Maintenance Period|Withdrawal by Subject|4|||
163028074|NCT02375555|588805403|FG000|Maintenance Period|Death|1|||
163028075|NCT02375555|588805403|FG000|Maintenance Period|Disease Progression|5|||
163028076|NCT02375555|588805403|FG000|Maintenance Period|Patient Non-compliance|1|||
163028077|NCT02375555|588805403|FG000|Maintenance Period|Still on maintenance|16|||
163028078|NCT02091986|588805405|FG000|Overall Study|7 rand in error 1 patient decision|2|||
163028079|NCT02091986|588805406|FG001|Overall Study|7 rand in error 1 patient decision|3|||
163028080|NCT02091986|588805407|FG002|Overall Study|7 rand in error 1 patient decision|3|||
163028081|NCT02091986|588805405|FG000|Overall Study|Lost to Follow-up|1|||
163028082|NCT02091986|588805406|FG001|Overall Study|Lost to Follow-up|0|||
163028083|NCT02091986|588805407|FG002|Overall Study|Lost to Follow-up|0|||
163028084|NCT02091986|588805405|FG000|Overall Study|Withdrawal by Subject|4|||
163028085|NCT02091986|588805406|FG001|Overall Study|Withdrawal by Subject|8|||
163028086|NCT02091986|588805407|FG002|Overall Study|Withdrawal by Subject|3|||
163028087|NCT02091986|588805405|FG000|Overall Study|Adverse Event|0|||
163028088|NCT02091986|588805406|FG001|Overall Study|Adverse Event|0|||
163028089|NCT02091986|588805407|FG002|Overall Study|Adverse Event|2|||
163028090|NCT00915876|588805410|FG000|Overall Study|Adverse Event|0|||
163028091|NCT00915876|588805411|FG001|Overall Study|Adverse Event|1|||
163028092|NCT02496091|588805417|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
163028093|NCT02272842|588805418|FG000|Overall Study|Lost to Follow-up|8|||
163028094|NCT02272842|588805419|FG001|Overall Study|Lost to Follow-up|8|||
163028095|NCT02272842|588805418|FG000|Overall Study|Withdrawal by Subject|8|||
163028096|NCT02272842|588805419|FG001|Overall Study|Withdrawal by Subject|2|||
163028097|NCT01984892|588805422|FG000|Overall Study|Progressive disease|7|||
163028098|NCT04464720|588805423|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
163028099|NCT05723328|588805425|FG000|Overall Study|Investigator's Decision|5|||
163028100|NCT05723328|588805426|FG001|Overall Study|Investigator's Decision|2|||
163028101|NCT02000882|588807191|FG000|Overall Study|Adverse Event|3|||
163028102|NCT02000882|588807191|FG000|Overall Study|Physician Decision|2|||
163028103|NCT02000882|588807191|FG000|Overall Study|Withdrawal by Subject|1|||
163028104|NCT02417961|588807192|FG000|Overall Study|Adverse Event|1|||
163028105|NCT02417961|588807192|FG000|Overall Study|Lost to Follow-up|1|||
163028106|NCT02417961|588807192|FG000|Overall Study|Withdrawal by Subject|2|||
163028107|NCT01390428|588807193|FG000|Overall Study|Elective Surgery|0|||
163028108|NCT01390428|588807194|FG001|Overall Study|Elective Surgery|0|||
163028109|NCT01390428|588807195|FG002|Overall Study|Elective Surgery|0|||
163028110|NCT01390428|588807196|FG003|Overall Study|Elective Surgery|0|||
163028111|NCT01390428|588807197|FG004|Overall Study|Elective Surgery|1|||
163028112|NCT01390428|588807198|FG005|Overall Study|Elective Surgery|0|||
163028113|NCT01390428|588807193|FG000|Overall Study|Withdrawal by Subject|0|||
163028114|NCT01390428|588807194|FG001|Overall Study|Withdrawal by Subject|0|||
163028115|NCT01390428|588807195|FG002|Overall Study|Withdrawal by Subject|1|||
163028116|NCT01390428|588807196|FG003|Overall Study|Withdrawal by Subject|0|||
163028117|NCT01390428|588807197|FG004|Overall Study|Withdrawal by Subject|0|||
163028118|NCT01390428|588807198|FG005|Overall Study|Withdrawal by Subject|0|||
163028119|NCT05897827|588807199|FG000|Overall Study|Lost to Follow-up|33|||
163028120|NCT05897827|588807200|FG001|Overall Study|Lost to Follow-up|14|||
163028121|NCT05897827|588807199|FG000|Overall Study|Withdrawal by Subject|1|||
163028122|NCT05897827|588807200|FG001|Overall Study|Withdrawal by Subject|1|||
163028123|NCT04599933|588807201|FG000|Overall Study|Adverse Event|4|||
163331498|NCT03732807|589924004|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
163331499|NCT03732807|589924005|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
163331500|NCT03732807|589924006|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
163331501|NCT03732807|589924007|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
163331502|NCT03732807|589924008|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
163331503|NCT03732807|589924009|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
163331504|NCT03732807|589924010|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
163331505|NCT03732807|589924004|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
163331506|NCT03732807|589924005|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
163331507|NCT03732807|589924006|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
163331508|NCT03732807|589924007|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
163331509|NCT03732807|589924008|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
163331510|NCT03732807|589924009|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
163331511|NCT03732807|589924010|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
163331512|NCT03732807|589924004|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
163331513|NCT03732807|589924005|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
163331514|NCT03732807|589924006|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
163331515|NCT03732807|589924007|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
163331516|NCT03732807|589924008|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
163331517|NCT03732807|589924009|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
163331518|NCT03732807|589924010|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
163331519|NCT03732807|589924004|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
163331520|NCT03732807|589924005|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
163331521|NCT03732807|589924006|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
163331522|NCT03732807|589924007|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
163331523|NCT03732807|589924008|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
163331524|NCT03732807|589924009|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
163331525|NCT03732807|589924010|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
163331526|NCT03732807|589924004|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
163331527|NCT03732807|589924005|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
163331528|NCT03732807|589924006|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
163331529|NCT03732807|589924007|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
163331530|NCT03732807|589924008|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
163028124|NCT04599933|588807202|FG001|Overall Study|Adverse Event|1|||
163028125|NCT04599933|588807201|FG000|Overall Study|Withdrawal by Subject|4|||
163028126|NCT04599933|588807202|FG001|Overall Study|Withdrawal by Subject|2|||
163028127|NCT04599933|588807201|FG000|Overall Study|Lost to Follow-up|0|||
163028128|NCT04599933|588807202|FG001|Overall Study|Lost to Follow-up|1|||
163028129|NCT04599933|588807201|FG000|Overall Study|Physician Decision|0|||
163028130|NCT04599933|588807202|FG001|Overall Study|Physician Decision|1|||
163028131|NCT04599933|588807201|FG000|Overall Study|Screen Failure|1|||
163028132|NCT04599933|588807202|FG001|Overall Study|Screen Failure|2|||
163028133|NCT01358578|588807210|FG000|Induction Period|Adverse Event|2|||
163028134|NCT01358578|588807211|FG001|Induction Period|Adverse Event|4|||
163028135|NCT01358578|588807212|FG002|Induction Period|Adverse Event|2|||
163028136|NCT01358578|588807213|FG003|Induction Period|Adverse Event|6|||
163028137|NCT01358578|588807214|FG004|Induction Period|Adverse Event|0|||
163028138|NCT01358578|588807215|FG005|Induction Period|Adverse Event|0|||
163028139|NCT01358578|588807210|FG000|Induction Period|Lack of Efficacy|0|||
163028140|NCT01358578|588807211|FG001|Induction Period|Lack of Efficacy|0|||
163028141|NCT01358578|588807212|FG002|Induction Period|Lack of Efficacy|9|||
163028142|NCT01358578|588807213|FG003|Induction Period|Lack of Efficacy|1|||
163028143|NCT01358578|588807214|FG004|Induction Period|Lack of Efficacy|0|||
163028144|NCT01358578|588807215|FG005|Induction Period|Lack of Efficacy|0|||
163028145|NCT01358578|588807210|FG000|Induction Period|Lost to Follow-up|0|||
163028146|NCT01358578|588807211|FG001|Induction Period|Lost to Follow-up|0|||
163028147|NCT01358578|588807212|FG002|Induction Period|Lost to Follow-up|1|||
163028148|NCT01358578|588807213|FG003|Induction Period|Lost to Follow-up|4|||
163028149|NCT01358578|588807214|FG004|Induction Period|Lost to Follow-up|0|||
163028150|NCT01358578|588807215|FG005|Induction Period|Lost to Follow-up|0|||
163028151|NCT01358578|588807210|FG000|Induction Period|Physician Decision|2|||
163028152|NCT01358578|588807211|FG001|Induction Period|Physician Decision|1|||
163028153|NCT01358578|588807212|FG002|Induction Period|Physician Decision|2|||
163028154|NCT01358578|588807213|FG003|Induction Period|Physician Decision|0|||
163028155|NCT01358578|588807214|FG004|Induction Period|Physician Decision|0|||
163028156|NCT01358578|588807215|FG005|Induction Period|Physician Decision|0|||
163028157|NCT01358578|588807210|FG000|Induction Period|Protocol Deviation|3|||
163028158|NCT01358578|588807211|FG001|Induction Period|Protocol Deviation|5|||
163028159|NCT01358578|588807212|FG002|Induction Period|Protocol Deviation|0|||
163028160|NCT01358578|588807213|FG003|Induction Period|Protocol Deviation|3|||
163028161|NCT01358578|588807214|FG004|Induction Period|Protocol Deviation|0|||
163028162|NCT01358578|588807215|FG005|Induction Period|Protocol Deviation|0|||
163028163|NCT01358578|588807210|FG000|Induction Period|technical problems|0|||
163075332|NCT02533674|588984623|FG000|Dose Level VIII|Progressive disease|0|||
163075333|NCT02533674|588984624|FG001|Dose Level VIII|Progressive disease|0|||
163075334|NCT02533674|588984625|FG002|Dose Level VIII|Progressive disease|0|||
163075335|NCT02533674|588984626|FG003|Dose Level VIII|Progressive disease|0|||
163075336|NCT02533674|588984627|FG004|Dose Level VIII|Progressive disease|0|||
163075337|NCT02533674|588984628|FG005|Dose Level VIII|Progressive disease|0|||
163075338|NCT02533674|588984629|FG006|Dose Level VIII|Progressive disease|0|||
163075339|NCT02533674|588984630|FG007|Dose Level VIII|Progressive disease|3|||
163075340|NCT02533674|588984623|FG000|Dose Level VIII|Withdrawal by Subject|0|||
163075341|NCT02533674|588984624|FG001|Dose Level VIII|Withdrawal by Subject|0|||
163075342|NCT02533674|588984625|FG002|Dose Level VIII|Withdrawal by Subject|0|||
163075343|NCT02533674|588984626|FG003|Dose Level VIII|Withdrawal by Subject|0|||
163075344|NCT02533674|588984627|FG004|Dose Level VIII|Withdrawal by Subject|0|||
163075345|NCT02533674|588984628|FG005|Dose Level VIII|Withdrawal by Subject|0|||
163075346|NCT02533674|588984629|FG006|Dose Level VIII|Withdrawal by Subject|0|||
163075347|NCT02533674|588984630|FG007|Dose Level VIII|Withdrawal by Subject|1|||
163075348|NCT02533674|588984623|FG000|Dose Level VIII|Treatment-related AE|0|||
163075349|NCT02533674|588984624|FG001|Dose Level VIII|Treatment-related AE|0|||
163075350|NCT02533674|588984625|FG002|Dose Level VIII|Treatment-related AE|0|||
163075351|NCT02533674|588984626|FG003|Dose Level VIII|Treatment-related AE|0|||
163075352|NCT02533674|588984627|FG004|Dose Level VIII|Treatment-related AE|0|||
163075353|NCT02533674|588984628|FG005|Dose Level VIII|Treatment-related AE|0|||
163075354|NCT02533674|588984629|FG006|Dose Level VIII|Treatment-related AE|0|||
163075355|NCT02533674|588984630|FG007|Dose Level VIII|Treatment-related AE|1|||
163075356|NCT02533674|588984623|FG000|Dose Level VIII|Never treated|0|||
163075357|NCT02533674|588984624|FG001|Dose Level VIII|Never treated|0|||
163075358|NCT02533674|588984625|FG002|Dose Level VIII|Never treated|0|||
163075359|NCT02533674|588984626|FG003|Dose Level VIII|Never treated|0|||
163075360|NCT02533674|588984627|FG004|Dose Level VIII|Never treated|0|||
163075361|NCT02533674|588984628|FG005|Dose Level VIII|Never treated|0|||
163075362|NCT02533674|588984629|FG006|Dose Level VIII|Never treated|0|||
163075363|NCT02533674|588984630|FG007|Dose Level VIII|Never treated|1|||
163075364|NCT01908699|588984638|FG000|Overall Study|Adverse Event|8|||
163075365|NCT01908699|588984639|FG001|Overall Study|Adverse Event|12|||
163075366|NCT01908699|588984638|FG000|Overall Study|Lack of Efficacy|2|||
163075367|NCT01908699|588984639|FG001|Overall Study|Lack of Efficacy|2|||
163075368|NCT01908699|588984638|FG000|Overall Study|Lost to Follow-up|2|||
163075369|NCT01908699|588984639|FG001|Overall Study|Lost to Follow-up|4|||
163075370|NCT01908699|588984638|FG000|Overall Study|Physician Decision|8|||
163075371|NCT01908699|588984639|FG001|Overall Study|Physician Decision|8|||
163075372|NCT01908699|588984638|FG000|Overall Study|Withdrawal by Subject|15|||
163075373|NCT01908699|588984639|FG001|Overall Study|Withdrawal by Subject|10|||
163075374|NCT01908699|588984638|FG000|Overall Study|Pregnancy|0|||
163075375|NCT01908699|588984639|FG001|Overall Study|Pregnancy|1|||
163075376|NCT01908699|588984638|FG000|Overall Study|Randomized in Error|1|||
163075377|NCT01908699|588984639|FG001|Overall Study|Randomized in Error|0|||
163075378|NCT01908699|588984638|FG000|Overall Study|Death|9|||
163075379|NCT01908699|588984639|FG001|Overall Study|Death|12|||
163075380|NCT01908699|588984638|FG000|Overall Study|Progressive Disease|30|||
163075381|NCT01908699|588984639|FG001|Overall Study|Progressive Disease|29|||
163075382|NCT01697501|588984640|FG000|Overall Study|Protocol Violation|2|||
163075383|NCT02242903|588984641|FG000|Overall Study|Withdrawal by Subject|1|||
163075384|NCT02242903|588984642|FG001|Overall Study|Withdrawal by Subject|0|||
163075385|NCT02242903|588984643|FG002|Overall Study|Withdrawal by Subject|0|||
163406406|NCT01783678|590198624|FG003|Overall Study|Lack of Efficacy|3|||
163075386|NCT02242903|588984644|FG003|Overall Study|Withdrawal by Subject|0|||
163075387|NCT02242903|588984645|FG004|Overall Study|Withdrawal by Subject|0|||
163075388|NCT02242903|588984646|FG005|Overall Study|Withdrawal by Subject|0|||
163075389|NCT02242903|588984647|FG006|Overall Study|Withdrawal by Subject|0|||
163075390|NCT02105012|588984648|FG000|Overall Study|Withdrawal by Subject|11|||
163075391|NCT02105012|588984648|FG000|Overall Study|Protocol Specified Criteria|9|||
163075392|NCT02105012|588984648|FG000|Overall Study|Lost to Follow-up|4|||
163218485|NCT02672423|589515819|FG005|Period 2|Withdrawal by Subject|0|||
163075393|NCT02105012|588984648|FG000|Overall Study|Protocol Violation|4|||
163075394|NCT02105012|588984648|FG000|Overall Study|Physician Decision|3|||
163075395|NCT02105012|588984648|FG000|Overall Study|Adverse Event|1|||
163218486|NCT02672423|589515820|FG006|Period 2|Withdrawal by Subject|0|||
163406407|NCT01783678|590198625|FG004|Overall Study|Lack of Efficacy|6|||
163075396|NCT02105012|588984648|FG000|Overall Study|Lack of Efficacy|1|||
163406408|NCT01783678|590198626|FG005|Overall Study|Lack of Efficacy|5|||
163218487|NCT02672423|589515821|FG007|Period 2|Withdrawal by Subject|0|||
163075397|NCT00493285|588984649|FG000|Overall Study|Lost to Follow-up|0|||
163075398|NCT00493285|588984650|FG001|Overall Study|Lost to Follow-up|0|||
163075399|NCT00493285|588984651|FG002|Overall Study|Lost to Follow-up|0|||
163218488|NCT02672423|589515822|FG008|Period 2|Withdrawal by Subject|0|||
163075400|NCT00493285|588984652|FG003|Overall Study|Lost to Follow-up|0|||
163075401|NCT00493285|588984653|FG004|Overall Study|Lost to Follow-up|1|||
163075402|NCT00493285|588984654|FG005|Overall Study|Lost to Follow-up|0|||
163406409|NCT01783678|590198621|FG000|Overall Study|Lost to Follow-up|0|||
163075403|NCT03021005|588984655|FG000|Overall Study|Lost to Follow-up|39|||
163075404|NCT03021005|588984656|FG001|Overall Study|Lost to Follow-up|26|||
163075405|NCT00779909|588984659|FG000|Overall Study|Lost to Follow-up|1|||
163075406|NCT00779909|588984660|FG001|Overall Study|Lost to Follow-up|0|||
163075407|NCT00779909|588984661|FG002|Overall Study|Lost to Follow-up|0|||
163075408|NCT00779909|588984662|FG003|Overall Study|Lost to Follow-up|1|||
163075409|NCT00779909|588984659|FG000|Overall Study|Withdrawal by Subject|0|||
163075410|NCT00779909|588984660|FG001|Overall Study|Withdrawal by Subject|1|||
163075411|NCT00779909|588984661|FG002|Overall Study|Withdrawal by Subject|0|||
163075412|NCT00779909|588984662|FG003|Overall Study|Withdrawal by Subject|0|||
163075413|NCT01174459|588984666|FG000|Overall Study|case report form (CRF) not collected|5|||
163075414|NCT00290758|588984667|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
163075415|NCT00290758|588984668|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
163075416|NCT00290758|588984667|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
163075417|NCT00290758|588984668|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
163075418|NCT00290758|588984667|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
163075419|NCT00290758|588984668|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
163075420|NCT00290758|588984667|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
163075421|NCT00290758|588984668|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
163075422|NCT00290758|588984667|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
163075423|NCT00290758|588984668|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
163075424|NCT00290758|588984667|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
163218489|NCT02672423|589515823|FG009|Period 2|Withdrawal by Subject|0|||
163218490|NCT02672423|589515814|FG000|Period 3|Withdrawal by Subject|0|||
163218491|NCT02672423|589515815|FG001|Period 3|Withdrawal by Subject|0|||
163028164|NCT01358578|588807211|FG001|Induction Period|technical problems|0|||
163028165|NCT01358578|588807212|FG002|Induction Period|technical problems|1|||
163028166|NCT01358578|588807213|FG003|Induction Period|technical problems|1|||
163028167|NCT01358578|588807214|FG004|Induction Period|technical problems|0|||
163028168|NCT01358578|588807215|FG005|Induction Period|technical problems|0|||
163028169|NCT01358578|588807210|FG000|Induction Period|Withdrawal by Subject|5|||
163028170|NCT01358578|588807211|FG001|Induction Period|Withdrawal by Subject|5|||
163028171|NCT01358578|588807212|FG002|Induction Period|Withdrawal by Subject|10|||
163028172|NCT01358578|588807213|FG003|Induction Period|Withdrawal by Subject|6|||
163028173|NCT01358578|588807214|FG004|Induction Period|Withdrawal by Subject|0|||
163028174|NCT01358578|588807215|FG005|Induction Period|Withdrawal by Subject|0|||
163028175|NCT01358578|588807210|FG000|Maintenance Period|Adverse Event|2|||
163028176|NCT01358578|588807211|FG001|Maintenance Period|Adverse Event|7|||
163028177|NCT01358578|588807212|FG002|Maintenance Period|Adverse Event|0|||
163028178|NCT01358578|588807213|FG003|Maintenance Period|Adverse Event|6|||
163028179|NCT01358578|588807214|FG004|Maintenance Period|Adverse Event|4|||
163028180|NCT01358578|588807215|FG005|Maintenance Period|Adverse Event|3|||
163028181|NCT01358578|588807210|FG000|Maintenance Period|Lack of Efficacy|10|||
163028182|NCT01358578|588807211|FG001|Maintenance Period|Lack of Efficacy|2|||
163028183|NCT01358578|588807212|FG002|Maintenance Period|Lack of Efficacy|0|||
163028184|NCT01358578|588807213|FG003|Maintenance Period|Lack of Efficacy|11|||
163028185|NCT01358578|588807214|FG004|Maintenance Period|Lack of Efficacy|3|||
163028186|NCT01358578|588807215|FG005|Maintenance Period|Lack of Efficacy|0|||
163028187|NCT01358578|588807210|FG000|Maintenance Period|Lost to Follow-up|4|||
163028188|NCT01358578|588807211|FG001|Maintenance Period|Lost to Follow-up|0|||
163028189|NCT01358578|588807212|FG002|Maintenance Period|Lost to Follow-up|0|||
163028190|NCT01358578|588807213|FG003|Maintenance Period|Lost to Follow-up|5|||
163028191|NCT01358578|588807214|FG004|Maintenance Period|Lost to Follow-up|1|||
163028192|NCT01358578|588807215|FG005|Maintenance Period|Lost to Follow-up|1|||
163028193|NCT01358578|588807210|FG000|Maintenance Period|Non-compliance with study treatment|3|||
163028194|NCT01358578|588807211|FG001|Maintenance Period|Non-compliance with study treatment|1|||
163028195|NCT01358578|588807212|FG002|Maintenance Period|Non-compliance with study treatment|0|||
163028196|NCT01358578|588807213|FG003|Maintenance Period|Non-compliance with study treatment|2|||
163028197|NCT01358578|588807214|FG004|Maintenance Period|Non-compliance with study treatment|1|||
163028198|NCT01358578|588807215|FG005|Maintenance Period|Non-compliance with study treatment|2|||
163028199|NCT01358578|588807210|FG000|Maintenance Period|Physician Decision|0|||
163028200|NCT01358578|588807211|FG001|Maintenance Period|Physician Decision|1|||
163028201|NCT01358578|588807212|FG002|Maintenance Period|Physician Decision|0|||
163028202|NCT01358578|588807213|FG003|Maintenance Period|Physician Decision|1|||
163028203|NCT01358578|588807214|FG004|Maintenance Period|Physician Decision|0|||
163028204|NCT01358578|588807215|FG005|Maintenance Period|Physician Decision|0|||
163028205|NCT01358578|588807210|FG000|Maintenance Period|Pregnancy|1|||
163028206|NCT01358578|588807211|FG001|Maintenance Period|Pregnancy|0|||
163028207|NCT01358578|588807212|FG002|Maintenance Period|Pregnancy|0|||
163028208|NCT01358578|588807213|FG003|Maintenance Period|Pregnancy|0|||
163028209|NCT01358578|588807214|FG004|Maintenance Period|Pregnancy|0|||
163075425|NCT00290758|588984668|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
163218492|NCT02672423|589515816|FG002|Period 3|Withdrawal by Subject|0|||
163218493|NCT02672423|589515817|FG003|Period 3|Withdrawal by Subject|0|||
163331531|NCT03732807|589924009|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
163331532|NCT03732807|589924010|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
163028210|NCT01358578|588807215|FG005|Maintenance Period|Pregnancy|0|||
163028211|NCT01358578|588807210|FG000|Maintenance Period|Protocol deviation|7|||
163028212|NCT01358578|588807211|FG001|Maintenance Period|Protocol deviation|4|||
163028213|NCT01358578|588807212|FG002|Maintenance Period|Protocol deviation|0|||
163028214|NCT01358578|588807213|FG003|Maintenance Period|Protocol deviation|2|||
163028215|NCT01358578|588807214|FG004|Maintenance Period|Protocol deviation|2|||
163028216|NCT01358578|588807215|FG005|Maintenance Period|Protocol deviation|2|||
163028217|NCT01358578|588807210|FG000|Maintenance Period|Withdrawal by Subject|12|||
163028218|NCT01358578|588807211|FG001|Maintenance Period|Withdrawal by Subject|7|||
163028219|NCT01358578|588807212|FG002|Maintenance Period|Withdrawal by Subject|2|||
163028220|NCT01358578|588807213|FG003|Maintenance Period|Withdrawal by Subject|15|||
163028221|NCT01358578|588807214|FG004|Maintenance Period|Withdrawal by Subject|6|||
163028222|NCT01358578|588807215|FG005|Maintenance Period|Withdrawal by Subject|3|||
163028223|NCT01358578|588807210|FG000|Follow-up Period|Adverse Event|1|||
163028224|NCT01358578|588807211|FG001|Follow-up Period|Adverse Event|1|||
163028225|NCT01358578|588807212|FG002|Follow-up Period|Adverse Event|0|||
163028226|NCT01358578|588807213|FG003|Follow-up Period|Adverse Event|0|||
163028227|NCT01358578|588807214|FG004|Follow-up Period|Adverse Event|0|||
163028228|NCT01358578|588807215|FG005|Follow-up Period|Adverse Event|0|||
163028229|NCT01358578|588807210|FG000|Follow-up Period|Lack of Efficacy|3|||
163028230|NCT01358578|588807211|FG001|Follow-up Period|Lack of Efficacy|0|||
163028231|NCT01358578|588807212|FG002|Follow-up Period|Lack of Efficacy|4|||
163028232|NCT01358578|588807213|FG003|Follow-up Period|Lack of Efficacy|1|||
163028233|NCT01358578|588807214|FG004|Follow-up Period|Lack of Efficacy|0|||
163028234|NCT01358578|588807215|FG005|Follow-up Period|Lack of Efficacy|0|||
163028235|NCT01358578|588807210|FG000|Follow-up Period|Lost to Follow-up|0|||
163028236|NCT01358578|588807211|FG001|Follow-up Period|Lost to Follow-up|1|||
163028237|NCT01358578|588807212|FG002|Follow-up Period|Lost to Follow-up|0|||
163028238|NCT01358578|588807213|FG003|Follow-up Period|Lost to Follow-up|4|||
163028239|NCT01358578|588807214|FG004|Follow-up Period|Lost to Follow-up|0|||
163028240|NCT01358578|588807215|FG005|Follow-up Period|Lost to Follow-up|0|||
163028241|NCT01358578|588807210|FG000|Follow-up Period|non- compliance with study treatment|1|||
163028242|NCT01358578|588807211|FG001|Follow-up Period|non- compliance with study treatment|0|||
163028243|NCT01358578|588807212|FG002|Follow-up Period|non- compliance with study treatment|0|||
163028244|NCT01358578|588807213|FG003|Follow-up Period|non- compliance with study treatment|0|||
163028245|NCT01358578|588807214|FG004|Follow-up Period|non- compliance with study treatment|0|||
163028246|NCT01358578|588807215|FG005|Follow-up Period|non- compliance with study treatment|0|||
163028247|NCT01358578|588807210|FG000|Follow-up Period|Pregnancy|1|||
163028248|NCT01358578|588807211|FG001|Follow-up Period|Pregnancy|0|||
163028249|NCT01358578|588807212|FG002|Follow-up Period|Pregnancy|0|||
163028250|NCT01358578|588807213|FG003|Follow-up Period|Pregnancy|0|||
163028251|NCT01358578|588807214|FG004|Follow-up Period|Pregnancy|0|||
163028252|NCT01358578|588807215|FG005|Follow-up Period|Pregnancy|0|||
163028253|NCT01358578|588807210|FG000|Follow-up Period|Withdrawal by Subject|3|||
163028254|NCT01358578|588807211|FG001|Follow-up Period|Withdrawal by Subject|3|||
163028255|NCT01358578|588807212|FG002|Follow-up Period|Withdrawal by Subject|1|||
163028256|NCT01358578|588807213|FG003|Follow-up Period|Withdrawal by Subject|12|||
163028257|NCT01358578|588807214|FG004|Follow-up Period|Withdrawal by Subject|0|||
163028258|NCT01358578|588807215|FG005|Follow-up Period|Withdrawal by Subject|0|||
163028259|NCT01358578|588807210|FG000|Follow-up Period|Physician Decision|1|||
163028260|NCT01358578|588807211|FG001|Follow-up Period|Physician Decision|1|||
163028261|NCT01358578|588807212|FG002|Follow-up Period|Physician Decision|0|||
163028262|NCT01358578|588807213|FG003|Follow-up Period|Physician Decision|2|||
163028263|NCT01358578|588807214|FG004|Follow-up Period|Physician Decision|0|||
163028264|NCT01358578|588807215|FG005|Follow-up Period|Physician Decision|0|||
163028265|NCT01643798|588807216|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
163028266|NCT01643798|588807217|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
163028267|NCT03605849|588807218|FG000|Overall Study|Adverse Event|20|||
163028268|NCT03605849|588807219|FG001|Overall Study|Adverse Event|21|||
163028269|NCT03605849|588807220|FG002|Overall Study|Adverse Event|29|||
163028270|NCT03605849|588807221|FG003|Overall Study|Adverse Event|11|||
163028271|NCT03605849|588807218|FG000|Overall Study|Lack of Efficacy|4|||
163028272|NCT03605849|588807219|FG001|Overall Study|Lack of Efficacy|7|||
163028273|NCT03605849|588807220|FG002|Overall Study|Lack of Efficacy|9|||
163028274|NCT03605849|588807221|FG003|Overall Study|Lack of Efficacy|2|||
163028275|NCT03605849|588807218|FG000|Overall Study|Lost to Follow-up|8|||
163028276|NCT03605849|588807219|FG001|Overall Study|Lost to Follow-up|8|||
163028277|NCT03605849|588807220|FG002|Overall Study|Lost to Follow-up|14|||
163028278|NCT03605849|588807221|FG003|Overall Study|Lost to Follow-up|11|||
163028279|NCT03605849|588807218|FG000|Overall Study|Non-compliance With IMP|6|||
163028280|NCT03605849|588807219|FG001|Overall Study|Non-compliance With IMP|5|||
163028281|NCT03605849|588807220|FG002|Overall Study|Non-compliance With IMP|2|||
163028282|NCT03605849|588807221|FG003|Overall Study|Non-compliance With IMP|1|||
163028283|NCT03605849|588807218|FG000|Overall Study|Protocol Deviation|1|||
163075426|NCT00290758|588984667|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
163075427|NCT00290758|588984668|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
163075428|NCT00290758|588984667|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
163075429|NCT00290758|588984668|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
163075430|NCT01111292|588984670|FG000|Treatment|Physician Decision|1|||
163075431|NCT01111292|588984671|FG001|Treatment|Physician Decision|1|||
163075432|NCT00215553|588984672|FG000|Overall Study|Adverse Event|0|||
163075433|NCT00215553|588984673|FG001|Overall Study|Adverse Event|1|||
163075434|NCT00215553|588984674|FG002|Overall Study|Adverse Event|2|||
163075435|NCT00215553|588984675|FG003|Overall Study|Adverse Event|1|||
163075436|NCT00215553|588984676|FG004|Overall Study|Adverse Event|2|||
163075437|NCT00215553|588984677|FG005|Overall Study|Adverse Event|6|||
163075438|NCT00215553|588984678|FG006|Overall Study|Adverse Event|0|||
163075439|NCT03142334|588984679|FG000|Overall Study|Death|18|||
163075440|NCT03142334|588984680|FG001|Overall Study|Death|33|||
163331533|NCT03732807|589924004|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
163331534|NCT03732807|589924005|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
163331535|NCT03732807|589924006|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
163331536|NCT03732807|589924007|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
163331537|NCT03732807|589924008|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
163331538|NCT03732807|589924009|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
163331539|NCT03732807|589924010|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
163331540|NCT03732807|589924004|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
163331541|NCT03732807|589924005|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
163331542|NCT03732807|589924006|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
163331543|NCT03732807|589924007|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
163331544|NCT03732807|589924008|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
163331545|NCT03732807|589924009|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
163331546|NCT03732807|589924010|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
163331547|NCT03732807|589924004|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
163331548|NCT03732807|589924005|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
163331549|NCT03732807|589924006|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
163331550|NCT03732807|589924007|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
163331551|NCT03732807|589924008|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
163331552|NCT03732807|589924009|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
163331553|NCT03732807|589924010|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
163331554|NCT03732807|589924004|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
163331555|NCT03732807|589924005|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
163331556|NCT03732807|589924006|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
163331557|NCT03732807|589924007|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
163331558|NCT03732807|589924008|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
163331559|NCT03732807|589924009|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
163331560|NCT03732807|589924010|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
163331561|NCT03732807|589924004|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
163331562|NCT03732807|589924005|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
163331563|NCT03732807|589924006|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
163331564|NCT03732807|589924007|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
163331565|NCT03732807|589924008|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
163331566|NCT03732807|589924009|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
163331567|NCT03732807|589924010|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
163331568|NCT03732807|589924004|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
163331569|NCT03732807|589924005|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
163331570|NCT03732807|589924006|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
163331571|NCT03732807|589924007|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
163331572|NCT03732807|589924008|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
163331573|NCT03732807|589924009|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
163331574|NCT03732807|589924010|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
163331575|NCT03732807|589924004|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
163331576|NCT03732807|589924005|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
163331577|NCT03732807|589924006|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
163331578|NCT03732807|589924007|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
163331579|NCT03732807|589924008|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
163331580|NCT03732807|589924009|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
163331581|NCT03732807|589924010|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
163331582|NCT03732807|589924004|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
163075441|NCT03142334|588984679|FG000|Overall Study|Withdrawal by Subject|15|||
163075442|NCT03142334|588984680|FG001|Overall Study|Withdrawal by Subject|11|||
163075443|NCT03142334|588984679|FG000|Overall Study|Ongoing on trial follow up|463|||
163075444|NCT03142334|588984680|FG001|Overall Study|Ongoing on trial follow up|454|||
163075445|NCT01217047|588984681|FG000|Overall Study|Lost to Follow-up|0|||
163075446|NCT01217047|588984682|FG001|Overall Study|Lost to Follow-up|1|||
163075447|NCT01217047|588984683|FG002|Overall Study|Lost to Follow-up|0|||
163075448|NCT03835117|588984684|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
163075449|NCT03835117|588984685|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
163075450|NCT03225989|588984689|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
163075451|NCT03225989|588984690|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
163075452|NCT03225989|588984691|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
163075453|NCT03225989|588984689|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
163075454|NCT03225989|588984690|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
163075455|NCT03225989|588984691|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
163075456|NCT03225989|588984689|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
163075457|NCT03225989|588984690|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
163075458|NCT03225989|588984691|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
163075459|NCT03225989|588984689|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
163075460|NCT03225989|588984690|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
163075461|NCT03225989|588984691|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
163075462|NCT03225989|588984689|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
163075463|NCT03225989|588984690|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
163075464|NCT03225989|588984691|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
163075465|NCT03225989|588984689|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
163075466|NCT03225989|588984690|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
163075467|NCT03225989|588984691|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
163075468|NCT03225989|588984689|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
163075469|NCT03225989|588984690|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
163075470|NCT03225989|588984691|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
163075471|NCT03225989|588984689|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
163075472|NCT03225989|588984690|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
163075473|NCT03225989|588984691|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
163075474|NCT03225989|588984689|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
163075475|NCT03225989|588984690|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
163075476|NCT03225989|588984691|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
163075477|NCT03225989|588984689|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
163075478|NCT03225989|588984690|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
163075479|NCT03225989|588984691|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
163075480|NCT03225989|588984689|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
163075481|NCT03225989|588984690|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
163075482|NCT03225989|588984691|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
163075483|NCT03225989|588984689|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
163075484|NCT03225989|588984690|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
163075485|NCT03225989|588984691|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
163075486|NCT03093870|588984695|FG000|Overall Study|Withdrawal by Subject|2|||
163075487|NCT03093870|588984696|FG001|Overall Study|Withdrawal by Subject|6|||
163075488|NCT03093870|588984697|FG002|Overall Study|Withdrawal by Subject|5|||
163075489|NCT03093870|588984695|FG000|Overall Study|Death|1|||
163075490|NCT03093870|588984696|FG001|Overall Study|Death|35|||
163075491|NCT03093870|588984697|FG002|Overall Study|Death|35|||
163075492|NCT03093870|588984695|FG000|Overall Study|Radiographic disease progression|10|||
163075493|NCT03093870|588984696|FG001|Overall Study|Radiographic disease progression|0|||
163075494|NCT03093870|588984697|FG002|Overall Study|Radiographic disease progression|0|||
163075495|NCT03093870|588984695|FG000|Overall Study|Clinical disease progression|1|||
163075496|NCT03093870|588984696|FG001|Overall Study|Clinical disease progression|0|||
163075497|NCT03093870|588984697|FG002|Overall Study|Clinical disease progression|0|||
163075498|NCT03093870|588984695|FG000|Overall Study|Physician Decision|2|||
163075499|NCT03093870|588984696|FG001|Overall Study|Physician Decision|0|||
163075500|NCT03093870|588984697|FG002|Overall Study|Physician Decision|0|||
163075501|NCT03093870|588984695|FG000|Overall Study|Adverse Event|7|||
163075502|NCT03093870|588984696|FG001|Overall Study|Adverse Event|0|||
163075503|NCT03093870|588984697|FG002|Overall Study|Adverse Event|0|||
163075504|NCT03093870|588984695|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
163075505|NCT03093870|588984696|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
163075506|NCT03093870|588984697|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
163218494|NCT02672423|589515818|FG004|Period 3|Withdrawal by Subject|0|||
163218495|NCT02672423|589515819|FG005|Period 3|Withdrawal by Subject|0|||
163218496|NCT02672423|589515820|FG006|Period 3|Withdrawal by Subject|0|||
163218497|NCT02672423|589515821|FG007|Period 3|Withdrawal by Subject|1|||
163218498|NCT02672423|589515822|FG008|Period 3|Withdrawal by Subject|0|||
163075507|NCT03093870|588984695|FG000|Overall Study|Lost to Follow-up|0|||
163075508|NCT03093870|588984696|FG001|Overall Study|Lost to Follow-up|0|||
163075509|NCT03093870|588984697|FG002|Overall Study|Lost to Follow-up|1|||
163075510|NCT01530997|588984698|FG000|Overall Study|Physician Decision|1|||
163075511|NCT01530997|588984698|FG000|Overall Study|Withdrawal by Subject|1|||
163075512|NCT02318277|588984700|FG000|Overall Study|Physician Decision|0|||
163075513|NCT02318277|588984701|FG001|Overall Study|Physician Decision|0|||
163075514|NCT02318277|588984702|FG002|Overall Study|Physician Decision|0|||
163075515|NCT02318277|588984703|FG003|Overall Study|Physician Decision|0|||
163075516|NCT02318277|588984704|FG004|Overall Study|Physician Decision|0|||
163075517|NCT02318277|588984705|FG005|Overall Study|Physician Decision|0|||
163075518|NCT02318277|588984706|FG006|Overall Study|Physician Decision|0|||
163075519|NCT02318277|588984707|FG007|Overall Study|Physician Decision|1|||
163075520|NCT02318277|588984700|FG000|Overall Study|Other|0|||
163075521|NCT02318277|588984701|FG001|Overall Study|Other|0|||
163075522|NCT02318277|588984702|FG002|Overall Study|Other|0|||
163075523|NCT02318277|588984703|FG003|Overall Study|Other|0|||
163075524|NCT02318277|588984704|FG004|Overall Study|Other|0|||
163075525|NCT02318277|588984705|FG005|Overall Study|Other|0|||
163075526|NCT02318277|588984706|FG006|Overall Study|Other|1|||
163075527|NCT02318277|588984707|FG007|Overall Study|Other|0|||
163075528|NCT02318277|588984700|FG000|Overall Study|Withdrawal by Subject|0|||
163075529|NCT02318277|588984701|FG001|Overall Study|Withdrawal by Subject|0|||
163075530|NCT02318277|588984702|FG002|Overall Study|Withdrawal by Subject|1|||
163075531|NCT02318277|588984703|FG003|Overall Study|Withdrawal by Subject|0|||
163075532|NCT02318277|588984704|FG004|Overall Study|Withdrawal by Subject|1|||
163075533|NCT02318277|588984705|FG005|Overall Study|Withdrawal by Subject|1|||
163075534|NCT02318277|588984706|FG006|Overall Study|Withdrawal by Subject|6|||
163075535|NCT02318277|588984707|FG007|Overall Study|Withdrawal by Subject|14|||
163075536|NCT02318277|588984700|FG000|Overall Study|Participant trial terminated by sponsor|0|||
163075537|NCT02318277|588984701|FG001|Overall Study|Participant trial terminated by sponsor|0|||
163075538|NCT02318277|588984702|FG002|Overall Study|Participant trial terminated by sponsor|1|||
163075539|NCT02318277|588984703|FG003|Overall Study|Participant trial terminated by sponsor|0|||
163075540|NCT02318277|588984704|FG004|Overall Study|Participant trial terminated by sponsor|1|||
163075541|NCT02318277|588984705|FG005|Overall Study|Participant trial terminated by sponsor|2|||
163075542|NCT02318277|588984706|FG006|Overall Study|Participant trial terminated by sponsor|5|||
163075543|NCT02318277|588984707|FG007|Overall Study|Participant trial terminated by sponsor|16|||
163075544|NCT02318277|588984700|FG000|Overall Study|Lost to Follow-up|1|||
163075545|NCT02318277|588984701|FG001|Overall Study|Lost to Follow-up|0|||
163075546|NCT02318277|588984702|FG002|Overall Study|Lost to Follow-up|1|||
163075547|NCT02318277|588984703|FG003|Overall Study|Lost to Follow-up|0|||
163075548|NCT02318277|588984704|FG004|Overall Study|Lost to Follow-up|0|||
163075549|NCT02318277|588984705|FG005|Overall Study|Lost to Follow-up|0|||
163075550|NCT02318277|588984706|FG006|Overall Study|Lost to Follow-up|3|||
163075551|NCT02318277|588984707|FG007|Overall Study|Lost to Follow-up|4|||
163218499|NCT02672423|589515823|FG009|Period 3|Withdrawal by Subject|0|||
163218500|NCT02672423|589515814|FG000|Period 3|Physician Decision|0|||
163075552|NCT02318277|588984700|FG000|Overall Study|Death|5|||
163075553|NCT02318277|588984701|FG001|Overall Study|Death|3|||
163075554|NCT02318277|588984702|FG002|Overall Study|Death|1|||
163075555|NCT02318277|588984703|FG003|Overall Study|Death|4|||
163075556|NCT02318277|588984704|FG004|Overall Study|Death|6|||
163075557|NCT02318277|588984705|FG005|Overall Study|Death|5|||
163075558|NCT02318277|588984706|FG006|Overall Study|Death|34|||
163075559|NCT02318277|588984707|FG007|Overall Study|Death|58|||
163075560|NCT02318277|588984700|FG000|Overall Study|Transitioned to Hospice|0|||
163075561|NCT02318277|588984701|FG001|Overall Study|Transitioned to Hospice|0|||
163075562|NCT02318277|588984702|FG002|Overall Study|Transitioned to Hospice|0|||
163075563|NCT02318277|588984703|FG003|Overall Study|Transitioned to Hospice|0|||
163218501|NCT02672423|589515815|FG001|Period 3|Physician Decision|0|||
163218502|NCT02672423|589515816|FG002|Period 3|Physician Decision|0|||
163218503|NCT02672423|589515817|FG003|Period 3|Physician Decision|0|||
163218504|NCT02672423|589515818|FG004|Period 3|Physician Decision|0|||
163218505|NCT02672423|589515819|FG005|Period 3|Physician Decision|1|||
163218506|NCT02672423|589515820|FG006|Period 3|Physician Decision|0|||
163218507|NCT02672423|589515821|FG007|Period 3|Physician Decision|0|||
163218508|NCT02672423|589515822|FG008|Period 3|Physician Decision|0|||
163218509|NCT02672423|589515823|FG009|Period 3|Physician Decision|0|||
163218510|NCT01454570|589515832|FG000|Overall Study|Withdrawal by Subject|2|||
163218511|NCT01454570|589515832|FG000|Overall Study|Screen Failure|7|||
163218512|NCT00885755|589515833|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
163218513|NCT00885755|589515834|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
163218514|NCT00885755|589515835|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
163218515|NCT00885755|589515833|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
163218516|NCT00885755|589515834|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
163218517|NCT00885755|589515835|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
163218518|NCT00885755|589515833|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
163218519|NCT00885755|589515834|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
163075564|NCT02318277|588984704|FG004|Overall Study|Transitioned to Hospice|0|||
163075565|NCT02318277|588984705|FG005|Overall Study|Transitioned to Hospice|1|||
163075566|NCT02318277|588984706|FG006|Overall Study|Transitioned to Hospice|0|||
163075567|NCT02318277|588984707|FG007|Overall Study|Transitioned to Hospice|0|||
163075568|NCT02006654|588984708|FG000|Overall Study|Withdrawal before treatment|4|||
163075569|NCT02006654|588984709|FG001|Overall Study|Withdrawal before treatment|2|||
163075570|NCT02006654|588984708|FG000|Overall Study|Adverse Event|16|||
163075571|NCT02006654|588984709|FG001|Overall Study|Adverse Event|17|||
163075572|NCT02006654|588984708|FG000|Overall Study|Death|1|||
163075573|NCT02006654|588984709|FG001|Overall Study|Death|0|||
163075574|NCT02006654|588984708|FG000|Overall Study|Withdrawal by Subject|14|||
163075575|NCT02006654|588984709|FG001|Overall Study|Withdrawal by Subject|12|||
163075576|NCT02006654|588984708|FG000|Overall Study|Protocol Violation|5|||
163075577|NCT02006654|588984709|FG001|Overall Study|Protocol Violation|8|||
163075578|NCT02006654|588984708|FG000|Overall Study|Lost to Follow-up|1|||
163075579|NCT02006654|588984709|FG001|Overall Study|Lost to Follow-up|0|||
163075580|NCT02006654|588984708|FG000|Overall Study|patient's will|2|||
163075581|NCT02006654|588984709|FG001|Overall Study|patient's will|1|||
163075582|NCT02006654|588984708|FG000|Overall Study|insufficient compliance|1|||
163075583|NCT02006654|588984709|FG001|Overall Study|insufficient compliance|0|||
163075584|NCT02006654|588984708|FG000|Overall Study|worsening cognitive condition|0|||
163075585|NCT02006654|588984709|FG001|Overall Study|worsening cognitive condition|1|||
163075586|NCT02006654|588984708|FG000|Overall Study|faecal incontinence|0|||
163075587|NCT02006654|588984709|FG001|Overall Study|faecal incontinence|1|||
163075588|NCT02006654|588984708|FG000|Overall Study|mood disorder|0|||
163075589|NCT02006654|588984709|FG001|Overall Study|mood disorder|1|||
163075590|NCT02006654|588984708|FG000|Overall Study|disallowed medication|1|||
163075591|NCT02006654|588984709|FG001|Overall Study|disallowed medication|0|||
163075592|NCT02006654|588984708|FG000|Overall Study|moving out of state|0|||
163075593|NCT02006654|588984709|FG001|Overall Study|moving out of state|1|||
163075594|NCT04193527|588984710|FG000|Overall Study|Other|1|||
163075595|NCT04193527|588984711|FG001|Overall Study|Other|1|||
163075596|NCT04193527|588984712|FG002|Overall Study|Other|0|||
163075597|NCT03808909|588984713|FG000|Overall Study|Lost to Follow-up|3|||
163075598|NCT03808909|588984714|FG001|Overall Study|Lost to Follow-up|0|||
163075599|NCT00676689|588984717|FG000|Overall Study|Screen Failure|2|||
163075600|NCT00676689|588984717|FG000|Overall Study|Death|2|||
163075601|NCT00676689|588984717|FG000|Overall Study|Lost to Follow-up|4|||
163075602|NCT00676689|588984717|FG000|Overall Study|Physician Decision|1|||
163075603|NCT00676689|588984717|FG000|Overall Study|Withdrawal by Subject|3|||
163075604|NCT00676689|588984717|FG000|Overall Study|Continuing FU|49|||
163075605|NCT01827943|588984718|FG000|Overall Study|Protocol Violation|8|||
163075606|NCT01827943|588984718|FG000|Overall Study|Never treated because of an rapid progression|1|||
163075607|NCT00501085|588984719|FG000|Overall Study|Lost to Follow-up|195|||
163075608|NCT00501085|588984719|FG000|Overall Study|Withdrawal by Subject|34|||
163075609|NCT00501085|588984719|FG000|Overall Study|Subject Decision|1|||
163075610|NCT00501085|588984719|FG000|Overall Study|Revision Surgery|7|||
163075611|NCT00501085|588984719|FG000|Overall Study|Explantation Surgery|26|||
163075612|NCT00501085|588984719|FG000|Overall Study|Adverse Event|4|||
163075613|NCT00501085|588984719|FG000|Overall Study|Non-Compliance|24|||
163075614|NCT00501085|588984719|FG000|Overall Study|Study closed by sponsor|109|||
163075615|NCT00501085|588984719|FG000|Overall Study|Other loss to follow-up|32|||
163075616|NCT01487161|588984720|FG000|Overall Study|Adverse Event|1|||
163075617|NCT01487161|588984721|FG001|Overall Study|Adverse Event|0|||
163075618|NCT01487161|588984722|FG002|Overall Study|Adverse Event|0|||
163075619|NCT01487161|588984723|FG003|Overall Study|Adverse Event|0|||
163075620|NCT01487161|588984720|FG000|Overall Study|Withdrawal by Subject|1|||
163075621|NCT01487161|588984721|FG001|Overall Study|Withdrawal by Subject|1|||
163075622|NCT01487161|588984722|FG002|Overall Study|Withdrawal by Subject|1|||
163075623|NCT01487161|588984723|FG003|Overall Study|Withdrawal by Subject|2|||
163075624|NCT01487161|588984720|FG000|Overall Study|missing data|0|||
163075625|NCT01487161|588984721|FG001|Overall Study|missing data|1|||
163075626|NCT01487161|588984722|FG002|Overall Study|missing data|0|||
163075627|NCT01487161|588984723|FG003|Overall Study|missing data|0|||
163075628|NCT01084135|588984724|FG000|20 Week|Physician Decision|0|||
163075629|NCT01084135|588984725|FG001|20 Week|Physician Decision|1|||
163075630|NCT00663351|588984726|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
163075631|NCT00663351|588984727|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
163075632|NCT00663351|588984726|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
163075633|NCT00663351|588984727|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
163075634|NCT00663351|588984726|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
163075635|NCT00663351|588984727|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
163075636|NCT00663351|588984726|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
163075637|NCT00663351|588984727|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
163075638|NCT00663351|588984726|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
163075639|NCT00663351|588984727|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
163075640|NCT00663351|588984726|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
163075641|NCT00663351|588984727|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
163075642|NCT02366130|588984728|FG000|Overall Study|Withdrawal by Subject|3|||
163075643|NCT02366130|588984728|FG000|Overall Study|Ineligible|6|||
163075644|NCT01608308|588984729|FG000|Overall Study|pretreatment medical and billing reasons|0|||
163075645|NCT01608308|588984730|FG001|Overall Study|pretreatment medical and billing reasons|2|||
163075646|NCT03113136|588984731|FG000|Overall Study|Lost to Follow-up|22|||
163075647|NCT03113136|588984732|FG001|Overall Study|Lost to Follow-up|47|||
163075648|NCT03113136|588984733|FG002|Overall Study|Lost to Follow-up|54|||
163075649|NCT03113136|588984731|FG000|Overall Study|Withdrawal by Subject|4|||
163075650|NCT03113136|588984732|FG001|Overall Study|Withdrawal by Subject|13|||
163075651|NCT03113136|588984733|FG002|Overall Study|Withdrawal by Subject|14|||
163075652|NCT03113136|588984731|FG000|Overall Study|Ineligible|0|||
163075653|NCT03113136|588984732|FG001|Overall Study|Ineligible|2|||
163075654|NCT03113136|588984733|FG002|Overall Study|Ineligible|1|||
163075655|NCT03113136|588984731|FG000|Overall Study|Study Team Decision|1|||
163075656|NCT03113136|588984732|FG001|Overall Study|Study Team Decision|4|||
163075657|NCT03113136|588984733|FG002|Overall Study|Study Team Decision|0|||
163075658|NCT02675452|588984740|FG000|Overall Study|Sponsor decision|0|||
163075659|NCT02675452|588984741|FG001|Overall Study|Sponsor decision|0|||
163075660|NCT02675452|588984742|FG002|Overall Study|Sponsor decision|0|||
163075661|NCT02675452|588984743|FG003|Overall Study|Sponsor decision|0|||
163075662|NCT02675452|588984744|FG004|Overall Study|Sponsor decision|0|||
163075663|NCT02675452|588984745|FG005|Overall Study|Sponsor decision|0|||
163218520|NCT00885755|589515835|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
163218521|NCT00885755|589515833|FG000|Part I: Trastuzumab+Taxane|Death|0|||
163218522|NCT00885755|589515834|FG001|Part I: Trastuzumab+Taxane|Death|0|||
163218523|NCT00885755|589515835|FG002|Part I: Trastuzumab+Taxane|Death|1|||
163218524|NCT00885755|589515833|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
163028284|NCT03605849|588807219|FG001|Overall Study|Protocol Deviation|2|||
163028285|NCT03605849|588807220|FG002|Overall Study|Protocol Deviation|1|||
163028286|NCT03605849|588807221|FG003|Overall Study|Protocol Deviation|3|||
163028287|NCT03605849|588807218|FG000|Overall Study|Withdrawal by Subject|33|||
163028288|NCT03605849|588807219|FG001|Overall Study|Withdrawal by Subject|28|||
163028289|NCT03605849|588807220|FG002|Overall Study|Withdrawal by Subject|30|||
163028290|NCT03605849|588807221|FG003|Overall Study|Withdrawal by Subject|28|||
163028291|NCT03605849|588807218|FG000|Overall Study|Site Terminated by Sponsor|0|||
163028292|NCT03605849|588807219|FG001|Overall Study|Site Terminated by Sponsor|0|||
163028293|NCT03605849|588807220|FG002|Overall Study|Site Terminated by Sponsor|0|||
163028294|NCT03605849|588807221|FG003|Overall Study|Site Terminated by Sponsor|1|||
163028295|NCT03605849|588807218|FG000|Overall Study|Physician Decision|2|||
163028296|NCT03605849|588807219|FG001|Overall Study|Physician Decision|1|||
163028297|NCT03605849|588807220|FG002|Overall Study|Physician Decision|2|||
163028298|NCT03605849|588807221|FG003|Overall Study|Physician Decision|1|||
163028299|NCT03605849|588807218|FG000|Overall Study|Enrolled, but not Treated|2|||
163028300|NCT03605849|588807219|FG001|Overall Study|Enrolled, but not Treated|2|||
163028301|NCT03605849|588807220|FG002|Overall Study|Enrolled, but not Treated|3|||
163028302|NCT03605849|588807221|FG003|Overall Study|Enrolled, but not Treated|2|||
163028303|NCT03605849|588807218|FG000|Overall Study|Other (COVID-19 Related)|0|||
163028304|NCT03605849|588807219|FG001|Overall Study|Other (COVID-19 Related)|1|||
163028305|NCT03605849|588807220|FG002|Overall Study|Other (COVID-19 Related)|1|||
163028306|NCT03605849|588807221|FG003|Overall Study|Other (COVID-19 Related)|0|||
163028307|NCT03605849|588807218|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
163028308|NCT03605849|588807219|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
163028309|NCT03605849|588807220|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
163028310|NCT03605849|588807221|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
163028311|NCT01911780|588807222|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
163028312|NCT01911780|588807223|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
163028313|NCT01911780|588807222|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
163028314|NCT01911780|588807223|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
163028315|NCT01911780|588807222|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
163028316|NCT01911780|588807223|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
163028317|NCT01911780|588807222|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
163028318|NCT01911780|588807223|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
163028319|NCT01911780|588807222|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
163028320|NCT01911780|588807223|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
163028321|NCT01911780|588807222|FG000|Extension Period (52 Weeks)|Personal reason|1|||
163028322|NCT01911780|588807223|FG001|Extension Period (52 Weeks)|Personal reason|1|||
163028323|NCT06303167|588807230|FG000|Overall Study|Ineligible|1|||
163028324|NCT06303167|588807230|FG000|Overall Study|Never start protocol therapy|2|||
163028325|NCT06303167|588807230|FG000|Overall Study|Disease progression|16|||
163028326|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Death|117|||
163028327|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Death|197|||
163028328|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
163075664|NCT02675452|588984746|FG006|Overall Study|Sponsor decision|0|||
163075665|NCT02675452|588984747|FG007|Overall Study|Sponsor decision|0|||
163075666|NCT02675452|588984748|FG008|Overall Study|Sponsor decision|0|||
163075667|NCT02675452|588984749|FG009|Overall Study|Sponsor decision|1|||
163075668|NCT02675452|588984750|FG010|Overall Study|Sponsor decision|0|||
163075669|NCT02675452|588984751|FG011|Overall Study|Sponsor decision|0|||
163075670|NCT02675452|588984752|FG012|Overall Study|Sponsor decision|0|||
163075671|NCT02675452|588984753|FG013|Overall Study|Sponsor decision|2|||
163075672|NCT02675452|588984754|FG014|Overall Study|Sponsor decision|1|||
163075673|NCT02675452|588984755|FG015|Overall Study|Sponsor decision|0|||
163075674|NCT02675452|588984756|FG016|Overall Study|Sponsor decision|1|||
163075675|NCT02675452|588984757|FG017|Overall Study|Sponsor decision|0|||
163075676|NCT02675452|588984758|FG018|Overall Study|Sponsor decision|0|||
163075677|NCT02675452|588984759|FG019|Overall Study|Sponsor decision|0|||
163075678|NCT02675452|588984760|FG020|Overall Study|Sponsor decision|0|||
163075679|NCT02675452|588984761|FG021|Overall Study|Sponsor decision|0|||
163075680|NCT02675452|588984762|FG022|Overall Study|Sponsor decision|0|||
163075681|NCT02675452|588984763|FG023|Overall Study|Sponsor decision|0|||
163075682|NCT02675452|588984764|FG024|Overall Study|Sponsor decision|0|||
163075683|NCT02675452|588984765|FG025|Overall Study|Sponsor decision|0|||
163075684|NCT02675452|588984766|FG026|Overall Study|Sponsor decision|2|||
163075685|NCT02675452|588984767|FG027|Overall Study|Sponsor decision|0|||
163075686|NCT02675452|588984768|FG028|Overall Study|Sponsor decision|0|||
163075687|NCT02675452|588984740|FG000|Overall Study|Withdrawal by Subject|0|||
163075688|NCT02675452|588984741|FG001|Overall Study|Withdrawal by Subject|0|||
163075689|NCT02675452|588984742|FG002|Overall Study|Withdrawal by Subject|0|||
163075690|NCT02675452|588984743|FG003|Overall Study|Withdrawal by Subject|0|||
163075691|NCT02675452|588984744|FG004|Overall Study|Withdrawal by Subject|0|||
163075692|NCT02675452|588984745|FG005|Overall Study|Withdrawal by Subject|0|||
163075693|NCT02675452|588984746|FG006|Overall Study|Withdrawal by Subject|0|||
163075694|NCT02675452|588984747|FG007|Overall Study|Withdrawal by Subject|0|||
163075695|NCT02675452|588984748|FG008|Overall Study|Withdrawal by Subject|0|||
163075696|NCT02675452|588984749|FG009|Overall Study|Withdrawal by Subject|1|||
163075697|NCT02675452|588984750|FG010|Overall Study|Withdrawal by Subject|0|||
163075698|NCT02675452|588984751|FG011|Overall Study|Withdrawal by Subject|1|||
163075699|NCT02675452|588984752|FG012|Overall Study|Withdrawal by Subject|0|||
163075700|NCT02675452|588984753|FG013|Overall Study|Withdrawal by Subject|1|||
163075701|NCT02675452|588984754|FG014|Overall Study|Withdrawal by Subject|1|||
163075702|NCT02675452|588984755|FG015|Overall Study|Withdrawal by Subject|0|||
163075703|NCT02675452|588984756|FG016|Overall Study|Withdrawal by Subject|2|||
163075704|NCT02675452|588984757|FG017|Overall Study|Withdrawal by Subject|0|||
163075705|NCT02675452|588984758|FG018|Overall Study|Withdrawal by Subject|0|||
163075706|NCT02675452|588984759|FG019|Overall Study|Withdrawal by Subject|0|||
163075707|NCT02675452|588984760|FG020|Overall Study|Withdrawal by Subject|0|||
163075708|NCT02675452|588984761|FG021|Overall Study|Withdrawal by Subject|0|||
163075709|NCT02675452|588984762|FG022|Overall Study|Withdrawal by Subject|3|||
163075710|NCT02675452|588984763|FG023|Overall Study|Withdrawal by Subject|0|||
163075711|NCT02675452|588984764|FG024|Overall Study|Withdrawal by Subject|1|||
163075712|NCT02675452|588984765|FG025|Overall Study|Withdrawal by Subject|0|||
163075713|NCT02675452|588984766|FG026|Overall Study|Withdrawal by Subject|1|||
163075714|NCT02675452|588984767|FG027|Overall Study|Withdrawal by Subject|3|||
163075715|NCT02675452|588984768|FG028|Overall Study|Withdrawal by Subject|4|||
163075716|NCT02675452|588984740|FG000|Overall Study|Death|0|||
163075717|NCT02675452|588984741|FG001|Overall Study|Death|0|||
163075718|NCT02675452|588984742|FG002|Overall Study|Death|1|||
163075719|NCT02675452|588984743|FG003|Overall Study|Death|0|||
163075720|NCT02675452|588984744|FG004|Overall Study|Death|0|||
163075721|NCT02675452|588984745|FG005|Overall Study|Death|1|||
163075722|NCT02675452|588984746|FG006|Overall Study|Death|0|||
163075723|NCT02675452|588984747|FG007|Overall Study|Death|0|||
163075724|NCT02675452|588984748|FG008|Overall Study|Death|1|||
163075725|NCT02675452|588984749|FG009|Overall Study|Death|0|||
163075726|NCT02675452|588984750|FG010|Overall Study|Death|0|||
163075727|NCT02675452|588984751|FG011|Overall Study|Death|0|||
163075728|NCT02675452|588984752|FG012|Overall Study|Death|1|||
163075729|NCT02675452|588984753|FG013|Overall Study|Death|0|||
163075730|NCT02675452|588984754|FG014|Overall Study|Death|0|||
163075731|NCT02675452|588984755|FG015|Overall Study|Death|2|||
163075732|NCT02675452|588984756|FG016|Overall Study|Death|0|||
163075733|NCT02675452|588984757|FG017|Overall Study|Death|0|||
163075734|NCT02675452|588984758|FG018|Overall Study|Death|4|||
163075735|NCT02675452|588984759|FG019|Overall Study|Death|3|||
163075736|NCT02675452|588984760|FG020|Overall Study|Death|3|||
163075737|NCT02675452|588984761|FG021|Overall Study|Death|3|||
163075738|NCT02675452|588984762|FG022|Overall Study|Death|7|||
163218525|NCT00885755|589515834|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
163218526|NCT00885755|589515835|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
163075739|NCT02675452|588984763|FG023|Overall Study|Death|5|||
163075740|NCT02675452|588984764|FG024|Overall Study|Death|3|||
163075741|NCT02675452|588984765|FG025|Overall Study|Death|4|||
163075742|NCT02675452|588984766|FG026|Overall Study|Death|7|||
163075743|NCT02675452|588984767|FG027|Overall Study|Death|6|||
163075744|NCT02675452|588984768|FG028|Overall Study|Death|9|||
163075745|NCT02675452|588984740|FG000|Overall Study|Lost to Follow-up|0|||
163075746|NCT02675452|588984741|FG001|Overall Study|Lost to Follow-up|1|||
163075747|NCT02675452|588984742|FG002|Overall Study|Lost to Follow-up|0|||
163075748|NCT02675452|588984743|FG003|Overall Study|Lost to Follow-up|0|||
163075749|NCT02675452|588984744|FG004|Overall Study|Lost to Follow-up|0|||
163075750|NCT02675452|588984745|FG005|Overall Study|Lost to Follow-up|0|||
163075751|NCT02675452|588984746|FG006|Overall Study|Lost to Follow-up|0|||
163075752|NCT02675452|588984747|FG007|Overall Study|Lost to Follow-up|0|||
163075753|NCT02675452|588984748|FG008|Overall Study|Lost to Follow-up|0|||
163075754|NCT02675452|588984749|FG009|Overall Study|Lost to Follow-up|0|||
163075755|NCT02675452|588984750|FG010|Overall Study|Lost to Follow-up|0|||
163075756|NCT02675452|588984751|FG011|Overall Study|Lost to Follow-up|0|||
163075757|NCT02675452|588984752|FG012|Overall Study|Lost to Follow-up|1|||
163075758|NCT02675452|588984753|FG013|Overall Study|Lost to Follow-up|0|||
163075759|NCT02675452|588984754|FG014|Overall Study|Lost to Follow-up|0|||
163075760|NCT02675452|588984755|FG015|Overall Study|Lost to Follow-up|0|||
163075761|NCT02675452|588984756|FG016|Overall Study|Lost to Follow-up|0|||
163075762|NCT02675452|588984757|FG017|Overall Study|Lost to Follow-up|0|||
163075763|NCT02675452|588984758|FG018|Overall Study|Lost to Follow-up|0|||
163075764|NCT02675452|588984759|FG019|Overall Study|Lost to Follow-up|0|||
163075765|NCT02675452|588984760|FG020|Overall Study|Lost to Follow-up|0|||
163075766|NCT02675452|588984761|FG021|Overall Study|Lost to Follow-up|0|||
163075767|NCT02675452|588984762|FG022|Overall Study|Lost to Follow-up|0|||
163218527|NCT00325754|589515836|FG000|Overall Study|Adverse Event|4|||
163218528|NCT00325754|589515837|FG001|Overall Study|Adverse Event|1|||
163075768|NCT02675452|588984763|FG023|Overall Study|Lost to Follow-up|0|||
163075769|NCT02675452|588984764|FG024|Overall Study|Lost to Follow-up|0|||
163075770|NCT02675452|588984765|FG025|Overall Study|Lost to Follow-up|0|||
163075771|NCT02675452|588984766|FG026|Overall Study|Lost to Follow-up|1|||
163075772|NCT02675452|588984767|FG027|Overall Study|Lost to Follow-up|0|||
163075773|NCT02675452|588984768|FG028|Overall Study|Lost to Follow-up|0|||
163218529|NCT02625090|589515844|FG000|Overall Study|Participant wants to be pregnant|2|||
163218530|NCT02625090|589515844|FG000|Overall Study|For the Promoter|1|||
163218531|NCT02625090|589515844|FG000|Overall Study|Sponsor's Decision|9|||
163218532|NCT02625090|589515844|FG000|Overall Study|Somnolence|1|||
163218533|NCT02625090|589515844|FG000|Overall Study|Study terminated by Sponsor|7|||
163218534|NCT02625090|589515844|FG000|Overall Study|Negative Benefit/Risk|1|||
163218535|NCT02625090|589515844|FG000|Overall Study|Protocol Deviation|2|||
163218536|NCT02625090|589515844|FG000|Overall Study|Lack of Efficacy|16|||
163218537|NCT02625090|589515844|FG000|Overall Study|Adverse Event|3|||
163218538|NCT04649164|589515845|FG000|Overall Study|Withdrawal by Subject|1|||
163218539|NCT04649164|589515846|FG001|Overall Study|Withdrawal by Subject|1|||
163218540|NCT04649164|589515847|FG002|Overall Study|Withdrawal by Subject|2|||
163218541|NCT04649164|589515845|FG000|Overall Study|Participant's care recipient expired|0|||
163218542|NCT04649164|589515846|FG001|Overall Study|Participant's care recipient expired|0|||
163218543|NCT04649164|589515847|FG002|Overall Study|Participant's care recipient expired|2|||
163218544|NCT03168464|589515848|FG000|Overall Study|Death|9|||
163218545|NCT03168464|589515848|FG000|Overall Study|Progression of disease|6|||
163218546|NCT02250443|589515849|FG000|Overall Study|Administrative problems|7|||
163218547|NCT02250443|589515849|FG000|Overall Study|Adverse Event|3|||
163218548|NCT01549964|589515850|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
163218549|NCT01549964|589515851|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
163218550|NCT01549964|589515852|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
163218551|NCT01549964|589515853|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
163218552|NCT01549964|589515850|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
163218553|NCT01549964|589515851|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
163218554|NCT01549964|589515852|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
163218555|NCT01549964|589515853|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
163218556|NCT01549964|589515850|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
163218557|NCT01549964|589515851|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
163218558|NCT01549964|589515852|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
163218559|NCT01549964|589515853|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
163218560|NCT01549964|589515850|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
163218561|NCT01549964|589515851|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
163218562|NCT01549964|589515852|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
163218563|NCT01549964|589515853|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
163218564|NCT01549964|589515850|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
163218565|NCT01549964|589515851|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
163218566|NCT01549964|589515852|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
163218567|NCT01549964|589515853|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
163218568|NCT01549964|589515850|FG000|24-Week Treatment Period|Other|1|||
163218569|NCT01549964|589515851|FG001|24-Week Treatment Period|Other|0|||
163218570|NCT01549964|589515852|FG002|24-Week Treatment Period|Other|1|||
163075774|NCT02675452|588984740|FG000|Overall Study|Other|0|||
163075775|NCT02675452|588984741|FG001|Overall Study|Other|0|||
163075776|NCT02675452|588984742|FG002|Overall Study|Other|0|||
163075777|NCT02675452|588984743|FG003|Overall Study|Other|0|||
163075778|NCT02675452|588984744|FG004|Overall Study|Other|0|||
163075779|NCT02675452|588984745|FG005|Overall Study|Other|0|||
163075780|NCT02675452|588984746|FG006|Overall Study|Other|0|||
163075781|NCT02675452|588984747|FG007|Overall Study|Other|0|||
163075782|NCT02675452|588984748|FG008|Overall Study|Other|0|||
163075783|NCT02675452|588984749|FG009|Overall Study|Other|0|||
163075784|NCT02675452|588984750|FG010|Overall Study|Other|0|||
163075785|NCT02675452|588984751|FG011|Overall Study|Other|0|||
163075786|NCT02675452|588984752|FG012|Overall Study|Other|0|||
163075787|NCT02675452|588984753|FG013|Overall Study|Other|0|||
163075788|NCT02675452|588984754|FG014|Overall Study|Other|0|||
163075789|NCT02675452|588984755|FG015|Overall Study|Other|0|||
163075790|NCT02675452|588984756|FG016|Overall Study|Other|0|||
163075791|NCT02675452|588984757|FG017|Overall Study|Other|0|||
163075792|NCT02675452|588984758|FG018|Overall Study|Other|0|||
163075793|NCT02675452|588984759|FG019|Overall Study|Other|0|||
163075794|NCT02675452|588984760|FG020|Overall Study|Other|0|||
163075795|NCT02675452|588984761|FG021|Overall Study|Other|0|||
163218571|NCT01549964|589515853|FG003|24-Week Treatment Period|Other|0|||
163218572|NCT01549964|589515850|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
163218573|NCT01549964|589515851|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
163075796|NCT02675452|588984762|FG022|Overall Study|Other|0|||
163075797|NCT02675452|588984763|FG023|Overall Study|Other|0|||
163075798|NCT02675452|588984764|FG024|Overall Study|Other|0|||
163218574|NCT01549964|589515852|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
163218575|NCT01549964|589515853|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
163218576|NCT01549964|589515850|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
163218577|NCT01549964|589515851|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
163218578|NCT01549964|589515852|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
163218579|NCT01549964|589515853|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
163218580|NCT01549964|589515850|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
163218581|NCT01549964|589515851|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
163218582|NCT01549964|589515852|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
163218583|NCT01549964|589515853|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
163218584|NCT01549964|589515850|FG000|80-Week Extension Period|Pregnancy|0|||
163218585|NCT01549964|589515851|FG001|80-Week Extension Period|Pregnancy|0|||
163218586|NCT01549964|589515852|FG002|80-Week Extension Period|Pregnancy|1|||
163218587|NCT01549964|589515853|FG003|80-Week Extension Period|Pregnancy|0|||
163218588|NCT01549964|589515850|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
163218589|NCT01549964|589515851|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
163218590|NCT01549964|589515852|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
163218591|NCT01549964|589515853|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
163218592|NCT01549964|589515850|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
163218593|NCT01549964|589515851|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
163218594|NCT01549964|589515852|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
163218595|NCT01549964|589515853|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
163218596|NCT01549964|589515850|FG000|80-Week Extension Period|Lost to Follow-up|1|||
163218597|NCT01549964|589515851|FG001|80-Week Extension Period|Lost to Follow-up|0|||
163218598|NCT01549964|589515852|FG002|80-Week Extension Period|Lost to Follow-up|2|||
163218599|NCT01549964|589515853|FG003|80-Week Extension Period|Lost to Follow-up|1|||
163218600|NCT01549964|589515850|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
163218601|NCT01549964|589515851|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
163218602|NCT01549964|589515852|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
163218603|NCT01549964|589515853|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
163218604|NCT00634088|589515854|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
163218605|NCT00634088|589515855|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
163218606|NCT00634088|589515856|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
163218607|NCT00634088|589515857|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
163218608|NCT00634088|589515854|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
163218609|NCT00634088|589515855|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
163218610|NCT00634088|589515856|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
163218611|NCT00634088|589515857|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
163075799|NCT02675452|588984765|FG025|Overall Study|Other|0|||
163075800|NCT02675452|588984766|FG026|Overall Study|Other|1|||
163075801|NCT02675452|588984767|FG027|Overall Study|Other|0|||
163075802|NCT02675452|588984768|FG028|Overall Study|Other|0|||
163075803|NCT00977561|588984769|FG000|Overall Study|Death|3|||
163075804|NCT00977561|588984770|FG001|Overall Study|Death|2|||
163075805|NCT00977561|588984769|FG000|Overall Study|Study terminated|0|||
163075806|NCT00977561|588984770|FG001|Overall Study|Study terminated|2|||
163075807|NCT00977561|588984769|FG000|Overall Study|Other|2|||
163075808|NCT00977561|588984770|FG001|Overall Study|Other|0|||
163331583|NCT03732807|589924005|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
163331584|NCT03732807|589924006|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
163331585|NCT03732807|589924007|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
163331586|NCT03732807|589924008|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
163331587|NCT03732807|589924009|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
163331588|NCT03732807|589924010|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
163331589|NCT03732807|589924004|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
163331590|NCT03732807|589924005|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
163331591|NCT03732807|589924006|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
163331592|NCT03732807|589924007|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
163331593|NCT03732807|589924008|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
163331594|NCT03732807|589924009|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
163331595|NCT03732807|589924010|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
163331596|NCT03345979|589924011|FG000|Overall Study|Withdrawal by Subject|20|||
163331597|NCT03345979|589924012|FG001|Overall Study|Withdrawal by Subject|31|||
163331598|NCT03345979|589924011|FG000|Overall Study|Adverse Event|10|||
163331599|NCT03345979|589924012|FG001|Overall Study|Adverse Event|11|||
163331600|NCT03345979|589924011|FG000|Overall Study|Lost to Follow-up|8|||
163218612|NCT00634088|589515854|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
163218613|NCT00634088|589515855|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
163218614|NCT00634088|589515856|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
163218615|NCT00634088|589515857|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
163218616|NCT00634088|589515854|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
163218617|NCT00634088|589515855|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
163218618|NCT00634088|589515856|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
163218619|NCT00634088|589515857|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
163218620|NCT00634088|589515854|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
163218621|NCT00634088|589515855|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
163218622|NCT00634088|589515856|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
163218623|NCT00634088|589515857|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
163218624|NCT00634088|589515854|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
163218625|NCT00634088|589515855|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
163218626|NCT00634088|589515856|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
163218627|NCT00634088|589515857|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
163218628|NCT02290821|589515862|FG000|Overall Study|Withdrawal by Subject|1|||
163218629|NCT02290821|589515863|FG001|Overall Study|Withdrawal by Subject|1|||
163218630|NCT02290821|589515862|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
163218631|NCT02290821|589515863|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
163218632|NCT02290821|589515862|FG000|Overall Study|Lost to Follow-up|3|||
163218633|NCT02290821|589515863|FG001|Overall Study|Lost to Follow-up|2|||
163218634|NCT02438722|589515869|FG000|Overall Study|Adverse Event|12|||
163218635|NCT02438722|589515870|FG001|Overall Study|Adverse Event|9|||
163218636|NCT02438722|589515869|FG000|Overall Study|Refusal unrelated to AE|2|||
163218637|NCT02438722|589515870|FG001|Overall Study|Refusal unrelated to AE|5|||
163218638|NCT02438722|589515869|FG000|Overall Study|Disease progression/relapse|46|||
163218639|NCT02438722|589515870|FG001|Overall Study|Disease progression/relapse|51|||
163218640|NCT02438722|589515869|FG000|Overall Study|Death|0|||
163218641|NCT02438722|589515870|FG001|Overall Study|Death|3|||
163218642|NCT02438722|589515869|FG000|Overall Study|Physician Decision|2|||
163218643|NCT02438722|589515870|FG001|Overall Study|Physician Decision|2|||
163218644|NCT02438722|589515869|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
163218645|NCT02438722|589515870|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
163218646|NCT02438722|589515869|FG000|Overall Study|Withdrawal by Subject|0|||
163218647|NCT02438722|589515870|FG001|Overall Study|Withdrawal by Subject|1|||
163218648|NCT02438722|589515869|FG000|Overall Study|On protocol treatment|15|||
163218649|NCT02438722|589515870|FG001|Overall Study|On protocol treatment|14|||
163218650|NCT02438722|589515869|FG000|Overall Study|Did not receive protocol treatment|5|||
163218651|NCT02438722|589515870|FG001|Overall Study|Did not receive protocol treatment|0|||
163218652|NCT03343483|589515871|FG000|Overall Study|Death|0|||
163218653|NCT03343483|589515872|FG001|Overall Study|Death|3|||
163218654|NCT03343483|589515871|FG000|Overall Study|Lost to Follow-up|9|||
163218655|NCT03343483|589515872|FG001|Overall Study|Lost to Follow-up|13|||
163218656|NCT03343483|589515871|FG000|Overall Study|Withdrawal by Subject|8|||
163218657|NCT03343483|589515872|FG001|Overall Study|Withdrawal by Subject|17|||
163218658|NCT01488097|589515875|FG000|Overall Study|Lost to Follow-up|1|||
163218659|NCT01577758|589515876|FG000|Dose Escalation Phase|Adverse Event|0|||
163331601|NCT03345979|589924012|FG001|Overall Study|Lost to Follow-up|9|||
163218660|NCT01577758|589515877|FG001|Dose Escalation Phase|Adverse Event|0|||
163218661|NCT01577758|589515878|FG002|Dose Escalation Phase|Adverse Event|0|||
163218662|NCT01577758|589515879|FG003|Dose Escalation Phase|Adverse Event|0|||
163331602|NCT03345979|589924011|FG000|Overall Study|Lack of Efficacy|4|||
163331603|NCT03345979|589924012|FG001|Overall Study|Lack of Efficacy|2|||
163218663|NCT01577758|589515880|FG004|Dose Escalation Phase|Adverse Event|0|||
163075809|NCT04595370|588984771|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
163075810|NCT04595370|588984772|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
163075811|NCT04595370|588984773|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
163075812|NCT04595370|588984774|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
163075813|NCT04595370|588984775|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
163075814|NCT04595370|588984776|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
163075815|NCT04595370|588984771|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
163075816|NCT04595370|588984772|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
163075817|NCT04595370|588984773|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
163075818|NCT04595370|588984774|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
163075819|NCT04595370|588984775|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
163075820|NCT04595370|588984776|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
163075821|NCT04595370|588984771|FG000|Overall Study|Adverse Event|0|||
163075822|NCT04595370|588984772|FG001|Overall Study|Adverse Event|4|||
163075823|NCT04595370|588984773|FG002|Overall Study|Adverse Event|3|||
163075824|NCT04595370|588984774|FG003|Overall Study|Adverse Event|1|||
163075825|NCT04595370|588984775|FG004|Overall Study|Adverse Event|1|||
163075826|NCT04595370|588984776|FG005|Overall Study|Adverse Event|1|||
163075827|NCT04595370|588984771|FG000|Overall Study|Withdrawal of Consent|1|||
163075828|NCT04595370|588984772|FG001|Overall Study|Withdrawal of Consent|1|||
163075829|NCT04595370|588984773|FG002|Overall Study|Withdrawal of Consent|1|||
163075830|NCT04595370|588984774|FG003|Overall Study|Withdrawal of Consent|0|||
163075831|NCT04595370|588984775|FG004|Overall Study|Withdrawal of Consent|0|||
163075832|NCT04595370|588984776|FG005|Overall Study|Withdrawal of Consent|0|||
163075833|NCT04595370|588984771|FG000|Overall Study|Death|0|||
163075834|NCT04595370|588984772|FG001|Overall Study|Death|1|||
163075835|NCT04595370|588984773|FG002|Overall Study|Death|0|||
163075836|NCT04595370|588984774|FG003|Overall Study|Death|0|||
163075837|NCT04595370|588984775|FG004|Overall Study|Death|1|||
163075838|NCT04595370|588984776|FG005|Overall Study|Death|0|||
163075839|NCT04595370|588984771|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163075840|NCT04595370|588984772|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163075841|NCT04595370|588984773|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
163075842|NCT04595370|588984774|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163075843|NCT04595370|588984775|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163075844|NCT04595370|588984776|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163075845|NCT04595370|588984771|FG000|Overall Study|Withdrawal by Subject|0|||
163075846|NCT04595370|588984772|FG001|Overall Study|Withdrawal by Subject|0|||
163075847|NCT04595370|588984773|FG002|Overall Study|Withdrawal by Subject|1|||
163075848|NCT04595370|588984774|FG003|Overall Study|Withdrawal by Subject|0|||
163075849|NCT04595370|588984775|FG004|Overall Study|Withdrawal by Subject|2|||
163075850|NCT04595370|588984776|FG005|Overall Study|Withdrawal by Subject|0|||
163075851|NCT04595370|588984771|FG000|Overall Study|Lost to Follow-up|0|||
163075852|NCT04595370|588984772|FG001|Overall Study|Lost to Follow-up|0|||
163075853|NCT04595370|588984773|FG002|Overall Study|Lost to Follow-up|0|||
163075854|NCT04595370|588984774|FG003|Overall Study|Lost to Follow-up|0|||
163075855|NCT04595370|588984775|FG004|Overall Study|Lost to Follow-up|1|||
163075856|NCT04595370|588984776|FG005|Overall Study|Lost to Follow-up|0|||
163075857|NCT04595370|588984771|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
163075858|NCT04595370|588984772|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
163075859|NCT04595370|588984773|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
163075860|NCT04595370|588984774|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
163075861|NCT04595370|588984775|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
163075862|NCT04595370|588984776|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
163075863|NCT03520387|588984777|FG000|Pre-Randomization|Withdrawal by Subject|1|||
163075864|NCT03520387|588984778|FG001|Pre-Randomization|Withdrawal by Subject|0|||
163075865|NCT03520387|588984779|FG002|Pre-Randomization|Withdrawal by Subject|0|||
163075866|NCT03520387|588984780|FG003|Pre-Randomization|Withdrawal by Subject|0|||
163075867|NCT03520387|588984781|FG004|Pre-Randomization|Withdrawal by Subject|0|||
163075868|NCT03520387|588984777|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
163075869|NCT03520387|588984778|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
163075870|NCT03520387|588984779|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
163075871|NCT03520387|588984780|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
163075872|NCT03520387|588984781|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
163075873|NCT00541775|588984782|FG000|Overall Study|Adverse Event|3|||
163075874|NCT00541775|588984783|FG001|Overall Study|Adverse Event|2|||
163075875|NCT00541775|588984784|FG002|Overall Study|Adverse Event|1|||
163075876|NCT00541775|588984782|FG000|Overall Study|Lack of Efficacy|0|||
163075877|NCT00541775|588984783|FG001|Overall Study|Lack of Efficacy|0|||
163075878|NCT00541775|588984784|FG002|Overall Study|Lack of Efficacy|3|||
163075879|NCT00541775|588984782|FG000|Overall Study|Lost to Follow-up|0|||
163075880|NCT00541775|588984783|FG001|Overall Study|Lost to Follow-up|0|||
163075881|NCT00541775|588984784|FG002|Overall Study|Lost to Follow-up|2|||
163075882|NCT00541775|588984782|FG000|Overall Study|Protocol Violation|1|||
163075883|NCT00541775|588984783|FG001|Overall Study|Protocol Violation|0|||
163075884|NCT00541775|588984784|FG002|Overall Study|Protocol Violation|0|||
163075885|NCT00541775|588984782|FG000|Overall Study|Withdrawal by Subject and Other|5|||
163075886|NCT00541775|588984783|FG001|Overall Study|Withdrawal by Subject and Other|0|||
163075887|NCT00541775|588984784|FG002|Overall Study|Withdrawal by Subject and Other|2|||
163075888|NCT01945242|588984785|FG000|Overall Study|Physician Decision|3|||
163075889|NCT01945242|588984786|FG001|Overall Study|Physician Decision|3|||
163075890|NCT04913675|588984788|FG000|Main Study (Up to Week 36)|Death|0|||
163075891|NCT04913675|588984789|FG001|Main Study (Up to Week 36)|Death|2|||
163075892|NCT04913675|588984790|FG002|Main Study (Up to Week 36)|Death|2|||
163075893|NCT04913675|588984791|FG003|Main Study (Up to Week 36)|Death|0|||
163075894|NCT04913675|588984788|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
163075895|NCT04913675|588984789|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
163075896|NCT04913675|588984790|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
163075897|NCT04913675|588984791|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
163075898|NCT04913675|588984788|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
163075899|NCT04913675|588984789|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
163075900|NCT04913675|588984790|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
163075901|NCT04913675|588984791|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
163075902|NCT04913675|588984788|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
163075903|NCT04913675|588984789|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
163075904|NCT04913675|588984790|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
163075905|NCT04913675|588984791|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
163075906|NCT04913675|588984788|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
163075907|NCT04913675|588984789|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
163075908|NCT04913675|588984790|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
163075909|NCT04913675|588984791|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
163075910|NCT05660538|588984792|FG000|Overall Study|Adverse Event|0|||
163075911|NCT05660538|588984793|FG001|Overall Study|Adverse Event|0|||
163075912|NCT05660538|588984794|FG002|Overall Study|Adverse Event|1|||
163075913|NCT05660538|588984795|FG003|Overall Study|Adverse Event|0|||
163075914|NCT05660538|588984792|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
163075915|NCT05660538|588984793|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
163075916|NCT05660538|588984794|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
163075917|NCT05660538|588984795|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
163075918|NCT05660538|588984792|FG000|Overall Study|Lost to Follow-up|0|||
163075919|NCT05660538|588984793|FG001|Overall Study|Lost to Follow-up|0|||
163075920|NCT05660538|588984794|FG002|Overall Study|Lost to Follow-up|1|||
163075921|NCT05660538|588984795|FG003|Overall Study|Lost to Follow-up|1|||
163075922|NCT05660538|588984792|FG000|Overall Study|Death|0|||
163075923|NCT05660538|588984793|FG001|Overall Study|Death|0|||
163075924|NCT05660538|588984794|FG002|Overall Study|Death|1|||
163075925|NCT05660538|588984795|FG003|Overall Study|Death|0|||
163075926|NCT05660538|588984792|FG000|Overall Study|Physician Decision|0|||
163075927|NCT05660538|588984793|FG001|Overall Study|Physician Decision|0|||
163075928|NCT05660538|588984794|FG002|Overall Study|Physician Decision|0|||
163075929|NCT05660538|588984795|FG003|Overall Study|Physician Decision|1|||
163075930|NCT05660538|588984792|FG000|Overall Study|Sponsor Decision|1|||
163075931|NCT05660538|588984793|FG001|Overall Study|Sponsor Decision|0|||
163075932|NCT05660538|588984794|FG002|Overall Study|Sponsor Decision|0|||
163075933|NCT05660538|588984795|FG003|Overall Study|Sponsor Decision|0|||
163075934|NCT05660538|588984792|FG000|Overall Study|Other|1|||
163075935|NCT05660538|588984793|FG001|Overall Study|Other|0|||
163075936|NCT05660538|588984794|FG002|Overall Study|Other|0|||
163075937|NCT05660538|588984795|FG003|Overall Study|Other|1|||
163075938|NCT05660538|588984792|FG000|Overall Study|Randomized but did not receive study drug|1|||
163075939|NCT05660538|588984793|FG001|Overall Study|Randomized but did not receive study drug|0|||
163075940|NCT05660538|588984794|FG002|Overall Study|Randomized but did not receive study drug|0|||
163075941|NCT05660538|588984795|FG003|Overall Study|Randomized but did not receive study drug|1|||
163075942|NCT05660538|588984792|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
163075943|NCT05660538|588984793|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
163075944|NCT05660538|588984794|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
163075945|NCT05660538|588984795|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
163075946|NCT04648241|588984796|FG000|Overall Study|Lost to Follow-up|1|||
163075947|NCT04648241|588984797|FG001|Overall Study|Lost to Follow-up|0|||
163075948|NCT02489045|588984798|FG000|Overall Study|unable to collect usable data|53|||
163075949|NCT02489045|588984798|FG000|Follow-up|Lost to Follow-up|10|||
163075950|NCT00837330|588984801|FG000|Overall Study|Lost to Follow-up|1|||
163331604|NCT03345979|589924011|FG000|Overall Study|Protocol Violation|1|||
163331605|NCT03345979|589924012|FG001|Overall Study|Protocol Violation|3|||
163331606|NCT03345979|589924011|FG000|Overall Study|Physician Decision|0|||
163331607|NCT03345979|589924012|FG001|Overall Study|Physician Decision|2|||
163028329|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
163028330|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
163028331|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
163028332|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
163028333|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
163028334|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
163028335|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
163028336|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
163028337|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
163028338|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
163028339|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
163028340|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
163028341|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
163028342|NCT02677896|588807231|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
163028343|NCT02677896|588807232|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
163028344|NCT02677896|588807231|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
163028345|NCT02677896|588807232|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
163028346|NCT02677896|588807231|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
163028347|NCT02677896|588807232|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
163028348|NCT02677896|588807231|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
163028349|NCT02677896|588807232|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
163028350|NCT02677896|588807231|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
163028351|NCT02677896|588807232|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
163028352|NCT02677896|588807231|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
163028353|NCT02677896|588807232|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
163028354|NCT00348790|588807238|FG000|Completed Treatment|Withdrawal by Subject|4|||
163028355|NCT00348790|588807238|FG000|Completed Treatment|Disease progression|14|||
163028356|NCT00348790|588807238|FG000|Completed Treatment|Adverse Event|4|||
163028357|NCT00348790|588807238|FG000|Completed Treatment|Required surgery|2|||
163028358|NCT00348790|588807238|FG000|Completed Treatment|Unable to travel to study site|1|||
163028359|NCT01185509|588807239|FG000|Overall Study|Progression/Relapse|9|||
163028360|NCT01185509|588807240|FG001|Overall Study|Progression/Relapse|15|||
163028361|NCT01185509|588807239|FG000|Overall Study|Physician Decision|2|||
163028362|NCT01185509|588807240|FG001|Overall Study|Physician Decision|2|||
163028363|NCT01185509|588807239|FG000|Overall Study|Withdrawal by Subject|0|||
163028364|NCT01185509|588807240|FG001|Overall Study|Withdrawal by Subject|1|||
163028365|NCT01185509|588807239|FG000|Overall Study|Death|0|||
163028366|NCT01185509|588807240|FG001|Overall Study|Death|1|||
163028367|NCT01185509|588807239|FG000|Overall Study|Intercurrent Illness|0|||
163028368|NCT01185509|588807240|FG001|Overall Study|Intercurrent Illness|1|||
163028369|NCT03687372|588807241|FG000|Overall Study|Lost to Follow-up|12|||
163028370|NCT03687372|588807242|FG001|Overall Study|Lost to Follow-up|21|||
163028371|NCT03687372|588807241|FG000|Overall Study|Withdrawal by Subject|4|||
163028372|NCT03687372|588807242|FG001|Overall Study|Withdrawal by Subject|17|||
163028373|NCT03687372|588807241|FG000|Overall Study|Investigator Decision|1|||
163028374|NCT03687372|588807242|FG001|Overall Study|Investigator Decision|1|||
163028375|NCT00655733|588807243|FG000|Overall Study|Lost to Follow-up|2|||
163028376|NCT00655733|588807244|FG001|Overall Study|Lost to Follow-up|2|||
163028377|NCT00655733|588807243|FG000|Overall Study|Adverse Event|2|||
163028378|NCT00655733|588807244|FG001|Overall Study|Adverse Event|2|||
163028379|NCT00655733|588807243|FG000|Overall Study|Withdrawal by Subject|3|||
163028380|NCT00655733|588807244|FG001|Overall Study|Withdrawal by Subject|3|||
163028381|NCT00655733|588807243|FG000|Overall Study|Physician Decision|0|||
163028382|NCT00655733|588807244|FG001|Overall Study|Physician Decision|1|||
163028383|NCT01482962|588807248|FG000|Overall Study|Progressive Disease|65|||
163028384|NCT01482962|588807249|FG001|Overall Study|Progressive Disease|53|||
163028385|NCT01482962|588807248|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
163331608|NCT00734578|589924014|FG000|Overall Study|Adverse Event|4|||
163028386|NCT01482962|588807249|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
163028387|NCT01482962|588807248|FG000|Overall Study|Adverse Event|18|||
163028388|NCT01482962|588807249|FG001|Overall Study|Adverse Event|22|||
163028389|NCT01482962|588807248|FG000|Overall Study|Withdrawal by Participant|8|||
163028390|NCT01482962|588807249|FG001|Overall Study|Withdrawal by Participant|13|||
163028391|NCT01482962|588807248|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
163028392|NCT01482962|588807249|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
163028393|NCT01482962|588807248|FG000|Overall Study|Other Reason|1|||
163028394|NCT01482962|588807249|FG001|Overall Study|Other Reason|5|||
163331609|NCT00734578|589924015|FG001|Overall Study|Adverse Event|6|||
163075951|NCT00837330|588984802|FG001|Overall Study|Lost to Follow-up|3|||
163028395|NCT01482962|588807248|FG000|Overall Study|Study Terminated by Sponsor|5|||
163028396|NCT01482962|588807249|FG001|Overall Study|Study Terminated by Sponsor|2|||
163028397|NCT01482962|588807248|FG000|Overall Study|Did not Receive Study Drug|1|||
163028398|NCT01482962|588807249|FG001|Overall Study|Did not Receive Study Drug|6|||
163028399|NCT02407457|588807250|FG000|1 Month|Death|3|||
163028400|NCT02407457|588807251|FG001|1 Month|Death|0|||
163028401|NCT02407457|588807250|FG000|1 Month|Lost to Follow-up|1|||
163028402|NCT02407457|588807251|FG001|1 Month|Lost to Follow-up|1|||
163028403|NCT02407457|588807250|FG000|1 Month|missed visit|2|||
163028404|NCT02407457|588807251|FG001|1 Month|missed visit|5|||
163028405|NCT02407457|588807250|FG000|6-Month|Death|2|||
163028406|NCT02407457|588807251|FG001|6-Month|Death|8|||
163028407|NCT02407457|588807250|FG000|6-Month|Lost to Follow-up|2|||
163028408|NCT02407457|588807251|FG001|6-Month|Lost to Follow-up|2|||
163028409|NCT02407457|588807250|FG000|6-Month|missed visit|16|||
163028410|NCT02407457|588807251|FG001|6-Month|missed visit|14|||
163028411|NCT02407457|588807250|FG000|6-Month|Open Repair|0|||
163028412|NCT02407457|588807251|FG001|6-Month|Open Repair|1|||
163028413|NCT02407457|588807250|FG000|1 Year|Death|6|||
163028414|NCT02407457|588807251|FG001|1 Year|Death|11|||
163028415|NCT02407457|588807250|FG000|1 Year|Lost to Follow-up|3|||
163028416|NCT02407457|588807251|FG001|1 Year|Lost to Follow-up|2|||
163028417|NCT02407457|588807250|FG000|1 Year|Missed Visit|24|||
163028418|NCT02407457|588807251|FG001|1 Year|Missed Visit|14|||
163028419|NCT02407457|588807250|FG000|1 Year|Open Repair|0|||
163028420|NCT02407457|588807251|FG001|1 Year|Open Repair|1|||
163028421|NCT02407457|588807250|FG000|2-year|Death|14|||
163028422|NCT02407457|588807251|FG001|2-year|Death|8|||
163028423|NCT02407457|588807250|FG000|2-year|Lost to Follow-up|7|||
163028424|NCT02407457|588807251|FG001|2-year|Lost to Follow-up|10|||
163028425|NCT02407457|588807250|FG000|2-year|Missed Visit|13|||
163028426|NCT02407457|588807251|FG001|2-year|Missed Visit|15|||
163028427|NCT02407457|588807250|FG000|2-year|Open Repair|0|||
163028428|NCT02407457|588807251|FG001|2-year|Open Repair|2|||
163028429|NCT02407457|588807250|FG000|3-year|Death|11|||
163028430|NCT02407457|588807251|FG001|3-year|Death|10|||
163028431|NCT02407457|588807250|FG000|3-year|Lost to Follow-up|9|||
163028432|NCT02407457|588807251|FG001|3-year|Lost to Follow-up|10|||
163028433|NCT02407457|588807250|FG000|3-year|Missed Visit|19|||
163028434|NCT02407457|588807251|FG001|3-year|Missed Visit|16|||
163028435|NCT02407457|588807250|FG000|4-year|Death|18|||
163028436|NCT02407457|588807251|FG001|4-year|Death|10|||
163028437|NCT02407457|588807250|FG000|4-year|Lost to Follow-up|10|||
163028438|NCT02407457|588807251|FG001|4-year|Lost to Follow-up|12|||
163028439|NCT02407457|588807250|FG000|4-year|Missed Visit|18|||
163028440|NCT02407457|588807251|FG001|4-year|Missed Visit|16|||
163028441|NCT02407457|588807250|FG000|5-year|Death|10|||
163028442|NCT02407457|588807251|FG001|5-year|Death|3|||
163028443|NCT02407457|588807250|FG000|5-year|Lost to Follow-up|22|||
163028444|NCT02407457|588807251|FG001|5-year|Lost to Follow-up|13|||
163028445|NCT02407457|588807250|FG000|5-year|Missed Visit|9|||
163028446|NCT02407457|588807251|FG001|5-year|Missed Visit|1|||
163028447|NCT02954653|588807256|FG000|Overall Study|Death|3|||
163028448|NCT02954653|588807257|FG001|Overall Study|Death|1|||
163028449|NCT02954653|588807258|FG002|Overall Study|Death|0|||
163028450|NCT02954653|588807259|FG003|Overall Study|Death|0|||
163028451|NCT02954653|588807260|FG004|Overall Study|Death|0|||
163028452|NCT02954653|588807261|FG005|Overall Study|Death|0|||
163028453|NCT02954653|588807262|FG006|Overall Study|Death|0|||
163028454|NCT02954653|588807263|FG007|Overall Study|Death|0|||
163028455|NCT02954653|588807264|FG008|Overall Study|Death|0|||
163028456|NCT02954653|588807256|FG000|Overall Study|Randomized but did not receive treatment|1|||
163028457|NCT02954653|588807257|FG001|Overall Study|Randomized but did not receive treatment|0|||
163028458|NCT02954653|588807258|FG002|Overall Study|Randomized but did not receive treatment|0|||
163028459|NCT02954653|588807259|FG003|Overall Study|Randomized but did not receive treatment|0|||
163028460|NCT02954653|588807260|FG004|Overall Study|Randomized but did not receive treatment|0|||
163028461|NCT02954653|588807261|FG005|Overall Study|Randomized but did not receive treatment|0|||
163028462|NCT02954653|588807262|FG006|Overall Study|Randomized but did not receive treatment|0|||
163075952|NCT02774278|588984803|FG000|Overall Study|Lack of Efficacy|199|||
163028463|NCT02954653|588807263|FG007|Overall Study|Randomized but did not receive treatment|0|||
163028464|NCT02954653|588807264|FG008|Overall Study|Randomized but did not receive treatment|0|||
163028465|NCT02954653|588807256|FG000|Overall Study|Started another anti-cancer therapy|0|||
163028466|NCT02954653|588807257|FG001|Overall Study|Started another anti-cancer therapy|1|||
163028467|NCT02954653|588807258|FG002|Overall Study|Started another anti-cancer therapy|0|||
163028468|NCT02954653|588807259|FG003|Overall Study|Started another anti-cancer therapy|0|||
163028469|NCT02954653|588807260|FG004|Overall Study|Started another anti-cancer therapy|0|||
163028470|NCT02954653|588807261|FG005|Overall Study|Started another anti-cancer therapy|0|||
163028471|NCT02954653|588807262|FG006|Overall Study|Started another anti-cancer therapy|0|||
163028472|NCT02954653|588807263|FG007|Overall Study|Started another anti-cancer therapy|0|||
163028473|NCT02954653|588807264|FG008|Overall Study|Started another anti-cancer therapy|0|||
163028474|NCT02954653|588807256|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
163075953|NCT02774278|588984803|FG000|Overall Study|Death|29|||
163075954|NCT02774278|588984803|FG000|Overall Study|Adverse event/intercurrent illness|16|||
163075955|NCT02774278|588984803|FG000|Overall Study|Refused treatment/did not cooperate|9|||
163331610|NCT00734578|589924016|FG002|Overall Study|Adverse Event|1|||
163331611|NCT00734578|589924014|FG000|Overall Study|Protocol Violation|8|||
163331612|NCT00734578|589924015|FG001|Overall Study|Protocol Violation|6|||
163331613|NCT00734578|589924016|FG002|Overall Study|Protocol Violation|3|||
163331614|NCT00734578|589924014|FG000|Overall Study|Withdrawal by Subject|7|||
163331615|NCT00734578|589924015|FG001|Overall Study|Withdrawal by Subject|8|||
163331616|NCT00734578|589924016|FG002|Overall Study|Withdrawal by Subject|11|||
163331617|NCT00734578|589924014|FG000|Overall Study|Lost to Follow-up|9|||
163331618|NCT00734578|589924015|FG001|Overall Study|Lost to Follow-up|3|||
163331619|NCT00734578|589924016|FG002|Overall Study|Lost to Follow-up|5|||
163331620|NCT00734578|589924014|FG000|Overall Study|Lack of Efficacy|3|||
163331621|NCT00734578|589924015|FG001|Overall Study|Lack of Efficacy|2|||
163331622|NCT00734578|589924016|FG002|Overall Study|Lack of Efficacy|5|||
163331623|NCT00734578|589924014|FG000|Overall Study|Randomized in error|1|||
163331624|NCT00734578|589924015|FG001|Overall Study|Randomized in error|0|||
163331625|NCT00734578|589924016|FG002|Overall Study|Randomized in error|0|||
163331626|NCT00734578|589924014|FG000|Overall Study|Exclusion criteria|1|||
163331627|NCT00734578|589924015|FG001|Overall Study|Exclusion criteria|0|||
163331628|NCT00734578|589924016|FG002|Overall Study|Exclusion criteria|0|||
163331629|NCT00999596|589924017|FG000|Overall Study|Statistical population not required|101|||
163331630|NCT03389802|589924022|FG000|Overall Study|Lack of Efficacy|3|||
163331631|NCT03389802|589924023|FG001|Overall Study|Lack of Efficacy|3|||
163331632|NCT03389802|589924024|FG002|Overall Study|Lack of Efficacy|13|||
163331633|NCT03389802|589924025|FG003|Overall Study|Lack of Efficacy|6|||
163331634|NCT03389802|589924026|FG004|Overall Study|Lack of Efficacy|1|||
163331635|NCT03389802|589924022|FG000|Overall Study|Adverse Event|0|||
163331636|NCT03389802|589924023|FG001|Overall Study|Adverse Event|0|||
163331637|NCT03389802|589924024|FG002|Overall Study|Adverse Event|1|||
163331638|NCT03389802|589924025|FG003|Overall Study|Adverse Event|0|||
163331639|NCT03389802|589924026|FG004|Overall Study|Adverse Event|4|||
163331640|NCT03389802|589924022|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
163331641|NCT03389802|589924023|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
163331642|NCT03389802|589924024|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
163331643|NCT03389802|589924025|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
163331644|NCT03389802|589924026|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
163331645|NCT02426138|589924027|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
163331646|NCT02426138|589924028|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
163331647|NCT04677738|589924029|FG000|Overall Study|Withdrawal by Subject|4|||
163331648|NCT04677738|589924030|FG001|Overall Study|Withdrawal by Subject|2|||
163331649|NCT00467272|589924036|FG000|Overall Study|Pneumonia|2|||
163331650|NCT00467272|589924036|FG000|Overall Study|Thrombophlebitis|1|||
163331651|NCT00914966|589924037|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
163331652|NCT00914966|589924037|FG000|Step 1: 1500 Units|Physician Decision|1|||
163331653|NCT00914966|589924037|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
163331654|NCT01701401|589924038|FG000|Overall Study|Randomized But Not Treated|3|||
163331655|NCT01701401|589924039|FG001|Overall Study|Randomized But Not Treated|1|||
163331656|NCT01701401|589924040|FG002|Overall Study|Randomized But Not Treated|0|||
163331657|NCT01701401|589924041|FG003|Overall Study|Randomized But Not Treated|1|||
163331658|NCT01701401|589924038|FG000|Overall Study|Lost to Follow-up|5|||
163331659|NCT01701401|589924039|FG001|Overall Study|Lost to Follow-up|5|||
163331660|NCT01701401|589924040|FG002|Overall Study|Lost to Follow-up|1|||
163331661|NCT01701401|589924041|FG003|Overall Study|Lost to Follow-up|3|||
163331662|NCT01701401|589924038|FG000|Overall Study|Withdrew Consent|0|||
163331663|NCT01701401|589924039|FG001|Overall Study|Withdrew Consent|3|||
163331664|NCT01701401|589924040|FG002|Overall Study|Withdrew Consent|1|||
163331665|NCT01701401|589924041|FG003|Overall Study|Withdrew Consent|2|||
163331666|NCT01701401|589924038|FG000|Overall Study|Lack of Efficacy|1|||
163331667|NCT01701401|589924039|FG001|Overall Study|Lack of Efficacy|0|||
163075956|NCT02774278|588984803|FG000|Overall Study|Administrative reasons|6|||
163075957|NCT02774278|588984803|FG000|Overall Study|Withdrawal by Subject|3|||
163075958|NCT02774278|588984803|FG000|Overall Study|Protocol Violation|2|||
163075959|NCT00694122|588984806|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
163331668|NCT01701401|589924040|FG002|Overall Study|Lack of Efficacy|2|||
163331669|NCT01701401|589924041|FG003|Overall Study|Lack of Efficacy|0|||
163331670|NCT01701401|589924038|FG000|Overall Study|Adverse Event|1|||
163331671|NCT01701401|589924039|FG001|Overall Study|Adverse Event|0|||
163331672|NCT01701401|589924040|FG002|Overall Study|Adverse Event|0|||
163331673|NCT01701401|589924041|FG003|Overall Study|Adverse Event|0|||
163331674|NCT01701401|589924038|FG000|Overall Study|Protocol Violation|0|||
163331675|NCT01701401|589924039|FG001|Overall Study|Protocol Violation|0|||
163331676|NCT01701401|589924040|FG002|Overall Study|Protocol Violation|1|||
163331677|NCT01701401|589924041|FG003|Overall Study|Protocol Violation|0|||
163331678|NCT02409680|589924045|FG000|Overall Study|Lost to Follow-up|15|||
163331679|NCT02409680|589924046|FG001|Overall Study|Lost to Follow-up|30|||
163331680|NCT04827732|589924047|FG000|Overall Study|Did not start treatment|0|||
163331681|NCT04827732|589924048|FG001|Overall Study|Did not start treatment|1|||
163075960|NCT00694122|588984807|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
163075961|NCT00694122|588984806|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
163075962|NCT00694122|588984807|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
163075963|NCT00694122|588984806|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
163075964|NCT00694122|588984807|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
163075965|NCT03339453|588984815|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
163075966|NCT03339453|588984816|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
163075967|NCT03632720|588984825|FG000|Overall Study|Adverse Event|2|||
163075968|NCT03632720|588984826|FG001|Overall Study|Adverse Event|0|||
163075969|NCT03632720|588984827|FG002|Overall Study|Adverse Event|0|||
163075970|NCT03632720|588984825|FG000|Overall Study|Lost to Follow-up|0|||
163075971|NCT03632720|588984826|FG001|Overall Study|Lost to Follow-up|1|||
163075972|NCT03632720|588984827|FG002|Overall Study|Lost to Follow-up|0|||
163075973|NCT03632720|588984825|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
163075974|NCT03632720|588984826|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
163075975|NCT03632720|588984827|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
163075976|NCT03632720|588984825|FG000|Overall Study|Screen failure|0|||
163075977|NCT03632720|588984826|FG001|Overall Study|Screen failure|1|||
163075978|NCT03632720|588984827|FG002|Overall Study|Screen failure|0|||
163075979|NCT00290238|588984830|FG000|Overall Study|Study terminated|27|||
163075980|NCT00290238|588984831|FG001|Overall Study|Study terminated|27|||
163075981|NCT00290238|588984830|FG000|Overall Study|Lost to Follow-up|0|||
163075982|NCT00290238|588984831|FG001|Overall Study|Lost to Follow-up|1|||
163075983|NCT00290238|588984830|FG000|Overall Study|Withdrawal by Subject|15|||
163075984|NCT00290238|588984831|FG001|Overall Study|Withdrawal by Subject|13|||
163075985|NCT03834883|588984832|FG000|Second Treatment|Withdrawal by Subject|1|||
163075986|NCT03834883|588984833|FG001|Second Treatment|Withdrawal by Subject|0|||
163075987|NCT03834883|588984834|FG002|Second Treatment|Withdrawal by Subject|0|||
163075988|NCT03834883|588984835|FG003|Second Treatment|Withdrawal by Subject|0|||
163075989|NCT03834883|588984832|FG000|Second Treatment|COVID-19 pandemic|1|||
163075990|NCT03834883|588984833|FG001|Second Treatment|COVID-19 pandemic|0|||
163075991|NCT03834883|588984834|FG002|Second Treatment|COVID-19 pandemic|1|||
163075992|NCT03834883|588984835|FG003|Second Treatment|COVID-19 pandemic|1|||
163075993|NCT01179399|588984836|FG000|Overall Study|Adverse Event|1|||
163075994|NCT01179399|588984836|FG000|Overall Study|Lack of Efficacy|30|||
163075995|NCT01179399|588984836|FG000|Overall Study|Withdrawal by Subject|1|||
163075996|NCT03738215|588984837|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
163075997|NCT03738215|588984838|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
163075998|NCT03738215|588984839|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
163075999|NCT03738215|588984837|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
163076000|NCT03738215|588984838|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
163076001|NCT03738215|588984839|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
163076002|NCT03738215|588984837|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
163076003|NCT03738215|588984838|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
163076004|NCT03738215|588984839|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
163076005|NCT03738215|588984837|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
163076006|NCT03738215|588984838|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
163076007|NCT03738215|588984839|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
163076008|NCT03738215|588984837|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
163076009|NCT03738215|588984838|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
163076010|NCT03738215|588984839|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
163076011|NCT03738215|588984837|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
163076012|NCT03738215|588984838|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
163076013|NCT03738215|588984839|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
163076014|NCT03738215|588984837|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
163076015|NCT03738215|588984838|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
163076016|NCT03738215|588984839|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
163076017|NCT03738215|588984837|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
163218664|NCT01577758|589515881|FG005|Dose Escalation Phase|Adverse Event|2|||
163218665|NCT01577758|589515882|FG006|Dose Escalation Phase|Adverse Event|1|||
163218666|NCT01577758|589515883|FG007|Dose Escalation Phase|Adverse Event|0|||
163218667|NCT01577758|589515876|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
163076018|NCT03738215|588984838|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
163076019|NCT03738215|588984839|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
163076020|NCT03738215|588984837|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
163076021|NCT03738215|588984838|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
163076022|NCT03738215|588984839|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
163076023|NCT03738215|588984837|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
163218668|NCT01577758|589515877|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
163406410|NCT01783678|590198622|FG001|Overall Study|Lost to Follow-up|4|||
163076024|NCT03738215|588984838|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
163076025|NCT03738215|588984839|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
163076026|NCT00394472|588986838|FG000|Overall Study|Protocol Violation|1|||
163076027|NCT00394472|588986839|FG001|Overall Study|Protocol Violation|3|||
163076028|NCT00394472|588986838|FG000|Overall Study|incorrect enrolment|4|||
163076029|NCT00394472|588986839|FG001|Overall Study|incorrect enrolment|2|||
163076030|NCT00394472|588986838|FG000|Overall Study|Adverse Event|4|||
163076031|NCT00394472|588986839|FG001|Overall Study|Adverse Event|2|||
163076032|NCT00394472|588986838|FG000|Overall Study|Withdrawal by Subject|0|||
163076033|NCT00394472|588986839|FG001|Overall Study|Withdrawal by Subject|2|||
163076034|NCT00394472|588986838|FG000|Overall Study|Physician Decision|0|||
163076035|NCT00394472|588986839|FG001|Overall Study|Physician Decision|1|||
163076036|NCT00394472|588986838|FG000|Overall Study|Lost to Follow-up|0|||
163076037|NCT00394472|588986839|FG001|Overall Study|Lost to Follow-up|1|||
163076038|NCT03211858|588986840|FG000|Overall Study|Adverse Event|8|||
163076039|NCT03211858|588986841|FG001|Overall Study|Adverse Event|6|||
163076040|NCT03211858|588986840|FG000|Overall Study|Lack of Efficacy|0|||
163076041|NCT03211858|588986841|FG001|Overall Study|Lack of Efficacy|4|||
163076042|NCT03211858|588986840|FG000|Overall Study|Poor compliance to protocol|6|||
163076043|NCT03211858|588986841|FG001|Overall Study|Poor compliance to protocol|2|||
163076044|NCT03211858|588986840|FG000|Overall Study|Non-serious Hypoglycemia|1|||
163076045|NCT03211858|588986841|FG001|Overall Study|Non-serious Hypoglycemia|0|||
163076046|NCT03211858|588986840|FG000|Overall Study|Other than specified above|22|||
163076047|NCT03211858|588986841|FG001|Overall Study|Other than specified above|21|||
163076048|NCT00004228|588986842|FG000|Overall Study|Adverse Event|0|||
163076049|NCT00004228|588986843|FG001|Overall Study|Adverse Event|1|||
163076050|NCT00004228|588986844|FG002|Overall Study|Adverse Event|0|||
163076051|NCT00004228|588986845|FG003|Overall Study|Adverse Event|0|||
163076052|NCT00004228|588986846|FG004|Overall Study|Adverse Event|1|||
163076053|NCT00004228|588986847|FG005|Overall Study|Adverse Event|0|||
163076054|NCT00004228|588986848|FG006|Overall Study|Adverse Event|0|||
163076055|NCT00004228|588986842|FG000|Overall Study|Death|0|||
163076056|NCT00004228|588986843|FG001|Overall Study|Death|1|||
163076057|NCT00004228|588986844|FG002|Overall Study|Death|2|||
163076058|NCT00004228|588986845|FG003|Overall Study|Death|0|||
163076059|NCT00004228|588986846|FG004|Overall Study|Death|1|||
163076060|NCT00004228|588986847|FG005|Overall Study|Death|0|||
163076061|NCT00004228|588986848|FG006|Overall Study|Death|0|||
163076062|NCT00004228|588986842|FG000|Overall Study|Lack of Efficacy|1|||
163076063|NCT00004228|588986843|FG001|Overall Study|Lack of Efficacy|6|||
163076064|NCT00004228|588986844|FG002|Overall Study|Lack of Efficacy|5|||
163076065|NCT00004228|588986845|FG003|Overall Study|Lack of Efficacy|3|||
163076066|NCT00004228|588986846|FG004|Overall Study|Lack of Efficacy|9|||
163076067|NCT00004228|588986847|FG005|Overall Study|Lack of Efficacy|8|||
163076068|NCT00004228|588986848|FG006|Overall Study|Lack of Efficacy|4|||
163076069|NCT00004228|588986842|FG000|Overall Study|Lost to Follow-up|0|||
163076070|NCT00004228|588986843|FG001|Overall Study|Lost to Follow-up|0|||
163076071|NCT00004228|588986844|FG002|Overall Study|Lost to Follow-up|1|||
163076072|NCT00004228|588986845|FG003|Overall Study|Lost to Follow-up|0|||
163076073|NCT00004228|588986846|FG004|Overall Study|Lost to Follow-up|0|||
163076074|NCT00004228|588986847|FG005|Overall Study|Lost to Follow-up|0|||
163076075|NCT00004228|588986848|FG006|Overall Study|Lost to Follow-up|0|||
163076076|NCT00004228|588986842|FG000|Overall Study|Physician Decision|1|||
163076077|NCT00004228|588986843|FG001|Overall Study|Physician Decision|0|||
163076078|NCT00004228|588986844|FG002|Overall Study|Physician Decision|3|||
163076079|NCT00004228|588986845|FG003|Overall Study|Physician Decision|2|||
163076080|NCT00004228|588986846|FG004|Overall Study|Physician Decision|1|||
163076081|NCT00004228|588986847|FG005|Overall Study|Physician Decision|1|||
163218669|NCT01577758|589515878|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
163218670|NCT01577758|589515879|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
163218671|NCT01577758|589515880|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
163218672|NCT01577758|589515881|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
163218673|NCT01577758|589515882|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
163076082|NCT00004228|588986848|FG006|Overall Study|Physician Decision|1|||
163076083|NCT00004228|588986842|FG000|Overall Study|Protocol Violation|0|||
163076084|NCT00004228|588986843|FG001|Overall Study|Protocol Violation|5|||
163218674|NCT01577758|589515883|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
163076085|NCT00004228|588986844|FG002|Overall Study|Protocol Violation|2|||
163076086|NCT00004228|588986845|FG003|Overall Study|Protocol Violation|1|||
163076087|NCT00004228|588986846|FG004|Overall Study|Protocol Violation|1|||
163076088|NCT00004228|588986847|FG005|Overall Study|Protocol Violation|2|||
163076089|NCT00004228|588986848|FG006|Overall Study|Protocol Violation|0|||
163076090|NCT00004228|588986842|FG000|Overall Study|Withdrawal by Subject|3|||
163076091|NCT00004228|588986843|FG001|Overall Study|Withdrawal by Subject|0|||
163076092|NCT00004228|588986844|FG002|Overall Study|Withdrawal by Subject|1|||
163076093|NCT00004228|588986845|FG003|Overall Study|Withdrawal by Subject|0|||
163076094|NCT00004228|588986846|FG004|Overall Study|Withdrawal by Subject|2|||
163218675|NCT01577758|589515876|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
163218676|NCT01577758|589515877|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
163076095|NCT00004228|588986847|FG005|Overall Study|Withdrawal by Subject|1|||
163076096|NCT00004228|588986848|FG006|Overall Study|Withdrawal by Subject|2|||
163076097|NCT00004228|588986842|FG000|Overall Study|Other|0|||
163076098|NCT00004228|588986843|FG001|Overall Study|Other|0|||
163076099|NCT00004228|588986844|FG002|Overall Study|Other|1|||
163076100|NCT00004228|588986845|FG003|Overall Study|Other|0|||
163076101|NCT00004228|588986846|FG004|Overall Study|Other|0|||
163076102|NCT00004228|588986847|FG005|Overall Study|Other|0|||
163076103|NCT00004228|588986848|FG006|Overall Study|Other|0|||
163076104|NCT00004228|588986842|FG000|Overall Study|ineligible|4|||
163076105|NCT00004228|588986843|FG001|Overall Study|ineligible|2|||
163076106|NCT00004228|588986844|FG002|Overall Study|ineligible|4|||
163076107|NCT00004228|588986845|FG003|Overall Study|ineligible|1|||
163076108|NCT00004228|588986846|FG004|Overall Study|ineligible|1|||
163076109|NCT00004228|588986847|FG005|Overall Study|ineligible|2|||
163076110|NCT00004228|588986848|FG006|Overall Study|ineligible|5|||
163076111|NCT01529112|588986849|FG000|Overall Study|Adverse Event|2|||
163218677|NCT01577758|589515878|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
163218678|NCT01577758|589515879|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
163406411|NCT01783678|590198623|FG002|Overall Study|Lost to Follow-up|0|||
163406412|NCT01783678|590198624|FG003|Overall Study|Lost to Follow-up|2|||
163028475|NCT02954653|588807257|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
163028476|NCT02954653|588807258|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
163028477|NCT02954653|588807259|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
163028478|NCT02954653|588807260|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
163028479|NCT02954653|588807261|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
163028480|NCT02954653|588807262|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
163028481|NCT02954653|588807263|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
163028482|NCT02954653|588807264|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
163028483|NCT04329091|588807267|FG000|Overall Study|Physician Decision|5|||
163028484|NCT00423189|588807270|FG000|Overall Study|Death|0|||
163028485|NCT00423189|588807271|FG001|Overall Study|Death|1|||
163028486|NCT00423189|588807272|FG002|Overall Study|Death|0|||
163028487|NCT03787303|588807273|FG000|Overall Study|Death|1|||
163028488|NCT03787303|588807273|FG000|Overall Study|Premature Termination of Study|1|||
163028489|NCT01210495|588807278|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
163028490|NCT01210495|588807279|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
163028491|NCT01210495|588807280|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
163028492|NCT01210495|588807281|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
163028493|NCT01210495|588807278|FG000|Overall Study|Death|14|||
163028494|NCT01210495|588807279|FG001|Overall Study|Death|7|||
163028495|NCT01210495|588807280|FG002|Overall Study|Death|112|||
163028496|NCT01210495|588807281|FG003|Overall Study|Death|54|||
163028497|NCT01210495|588807278|FG000|Overall Study|Study Terminated by Sponsor|0|||
163028498|NCT01210495|588807279|FG001|Overall Study|Study Terminated by Sponsor|0|||
163028499|NCT01210495|588807280|FG002|Overall Study|Study Terminated by Sponsor|4|||
163028500|NCT01210495|588807281|FG003|Overall Study|Study Terminated by Sponsor|11|||
163028501|NCT01210495|588807278|FG000|Overall Study|Lost to Follow-up|0|||
163028502|NCT01210495|588807279|FG001|Overall Study|Lost to Follow-up|0|||
163028503|NCT01210495|588807280|FG002|Overall Study|Lost to Follow-up|1|||
163028504|NCT01210495|588807281|FG003|Overall Study|Lost to Follow-up|1|||
163028505|NCT01210495|588807278|FG000|Overall Study|Other unspecified|0|||
163028506|NCT01210495|588807279|FG001|Overall Study|Other unspecified|0|||
163028507|NCT01210495|588807280|FG002|Overall Study|Other unspecified|6|||
163028508|NCT01210495|588807281|FG003|Overall Study|Other unspecified|0|||
163028509|NCT01826370|588807286|FG000|Overall Study|Protocol Violation|6|||
163028510|NCT01826370|588807286|FG000|Overall Study|Lost to Follow-up|12|||
163028511|NCT01826370|588807286|FG000|Overall Study|Other reason not defined above|2|||
163028512|NCT04416737|588807287|FG000|Week 1 (First Injection)|Physician Decision|0|||
163028513|NCT04416737|588807288|FG001|Week 1 (First Injection)|Physician Decision|1|||
163028514|NCT03332628|588807289|FG000|Overall Study|Physician Decision|2|||
163028515|NCT02543892|588807297|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
163028516|NCT02543892|588807298|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
163028517|NCT02543892|588807299|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
163028518|NCT02543892|588807300|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
163028519|NCT02543892|588807301|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
163028520|NCT02543892|588807302|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
163028521|NCT02543892|588807303|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
163028522|NCT02543892|588807304|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
163076112|NCT01529112|588986850|FG001|Overall Study|Adverse Event|0|||
163076113|NCT01529112|588986849|FG000|Overall Study|Death|59|||
163076114|NCT01529112|588986850|FG001|Overall Study|Death|38|||
163076115|NCT01529112|588986849|FG000|Overall Study|Protocol Violation|1|||
163076116|NCT01529112|588986850|FG001|Overall Study|Protocol Violation|0|||
163076117|NCT01529112|588986849|FG000|Overall Study|Withdrawal by Subject|7|||
163076118|NCT01529112|588986850|FG001|Overall Study|Withdrawal by Subject|3|||
163076119|NCT00107614|588986851|FG000|Overall Study|Physician Decision|10|||
163076120|NCT00107614|588986851|FG000|Overall Study|Death|2|||
163076121|NCT01013870|588986852|FG000|Overall Study|Lost to Follow-up|1|||
163076122|NCT01013870|588986853|FG001|Overall Study|Lost to Follow-up|3|||
163076123|NCT02457546|588986855|FG000|Overall Study|Other reasons|4|||
163076124|NCT02457546|588986856|FG001|Overall Study|Other reasons|1|||
163076125|NCT02457546|588986855|FG000|Overall Study|Refused to complete study/procedures|1|||
163076126|NCT02457546|588986856|FG001|Overall Study|Refused to complete study/procedures|1|||
163076127|NCT02457546|588986855|FG000|Overall Study|Lost to Follow-up|4|||
163076128|NCT02457546|588986856|FG001|Overall Study|Lost to Follow-up|1|||
163076129|NCT02457546|588986855|FG000|Overall Study|Adverse Event|0|||
163076130|NCT02457546|588986856|FG001|Overall Study|Adverse Event|1|||
163076131|NCT00474968|588986861|FG000|Overall Study|Withdrawal by Subject|8|||
163076132|NCT00474968|588986862|FG001|Overall Study|Withdrawal by Subject|7|||
163076133|NCT00474968|588986861|FG000|Overall Study|Protocol Violation|9|||
163076134|NCT00474968|588986862|FG001|Overall Study|Protocol Violation|8|||
163076135|NCT00474968|588986861|FG000|Overall Study|Sample not collected|1|||
163076136|NCT00474968|588986862|FG001|Overall Study|Sample not collected|1|||
163076137|NCT04914000|588986863|FG000|Overall Study|Lost to Follow-up|8|||
163076138|NCT04914000|588986863|FG000|Overall Study|Withdrawal by Subject|1|||
163076139|NCT01096186|588986865|FG000|Overall Study|Adverse Event|16|||
163076140|NCT01096186|588986865|FG000|Overall Study|Death|4|||
163076141|NCT01096186|588986865|FG000|Overall Study|Lack of Efficacy|4|||
163076142|NCT01096186|588986865|FG000|Overall Study|Lost to Follow-up|2|||
163076143|NCT01096186|588986865|FG000|Overall Study|Withdrawal by Subject|22|||
163076144|NCT01096186|588986865|FG000|Overall Study|Physician Decision|1|||
163076145|NCT01096186|588986865|FG000|Overall Study|Noncompliance with study drug|1|||
163076146|NCT01896986|588986866|FG000|Overall Study|samples lost|14|||
163218679|NCT01577758|589515880|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
163331682|NCT04827732|589924049|FG002|Overall Study|Did not start treatment|0|||
163331683|NCT04827732|589924050|FG003|Overall Study|Did not start treatment|1|||
163331684|NCT05366751|589924051|FG000|Overall Study|Adverse Event|25|||
163331685|NCT05366751|589924051|FG000|Overall Study|Physician Decision|3|||
163331686|NCT05366751|589924051|FG000|Overall Study|Lost to Follow-up|2|||
163331687|NCT05366751|589924051|FG000|Overall Study|Withdrawal by Subject|14|||
163331688|NCT05366751|589924051|FG000|Overall Study|Study Terminated by Sponsor|50|||
163331689|NCT05366751|589924051|FG000|Overall Study|Site Terminated by Sponsor|3|||
163331690|NCT01690624|589924056|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
163331691|NCT01690624|589924057|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
163331692|NCT01690624|589924058|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
163331693|NCT01690624|589924059|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
163331694|NCT01690624|589924056|FG000|Overall Study|Adverse event (other than DLT)|3|||
163331695|NCT01690624|589924057|FG001|Overall Study|Adverse event (other than DLT)|1|||
163331696|NCT01690624|589924058|FG002|Overall Study|Adverse event (other than DLT)|1|||
163331697|NCT01690624|589924059|FG003|Overall Study|Adverse event (other than DLT)|1|||
163331698|NCT01690624|589924056|FG000|Overall Study|Withdrawal by Subject|0|||
163331699|NCT01690624|589924057|FG001|Overall Study|Withdrawal by Subject|0|||
163331700|NCT01690624|589924058|FG002|Overall Study|Withdrawal by Subject|1|||
163331701|NCT01690624|589924059|FG003|Overall Study|Withdrawal by Subject|0|||
163331702|NCT01690624|589924056|FG000|Overall Study|Sponsor is ending trial|0|||
163331703|NCT01690624|589924057|FG001|Overall Study|Sponsor is ending trial|0|||
163331704|NCT01690624|589924058|FG002|Overall Study|Sponsor is ending trial|0|||
163331705|NCT01690624|589924059|FG003|Overall Study|Sponsor is ending trial|1|||
163331706|NCT01690624|589924056|FG000|Overall Study|Physician Decision|0|||
163331707|NCT01690624|589924057|FG001|Overall Study|Physician Decision|0|||
163331708|NCT01690624|589924058|FG002|Overall Study|Physician Decision|0|||
163331709|NCT01690624|589924059|FG003|Overall Study|Physician Decision|1|||
163331710|NCT01690624|589924056|FG000|Overall Study|Withdrawal by Subject|0|||
163406413|NCT01783678|590198625|FG004|Overall Study|Lost to Follow-up|1|||
163076147|NCT01896986|588986867|FG001|Overall Study|samples lost|23|||
163076148|NCT01750281|588986868|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
163076149|NCT01750281|588986869|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
163076150|NCT01750281|588986870|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
163076151|NCT01750281|588986868|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
163076152|NCT01750281|588986869|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
163076153|NCT01750281|588986870|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
163218680|NCT01577758|589515881|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
163218681|NCT01577758|589515882|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
163218682|NCT01577758|589515883|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
163218683|NCT01577758|589515876|FG000|Dose Escalation Phase|Progression Disease|2|||
163218684|NCT01577758|589515877|FG001|Dose Escalation Phase|Progression Disease|2|||
163218685|NCT01577758|589515878|FG002|Dose Escalation Phase|Progression Disease|1|||
163218686|NCT01577758|589515879|FG003|Dose Escalation Phase|Progression Disease|2|||
163218687|NCT01577758|589515880|FG004|Dose Escalation Phase|Progression Disease|5|||
163218688|NCT01577758|589515881|FG005|Dose Escalation Phase|Progression Disease|0|||
163218689|NCT01577758|589515882|FG006|Dose Escalation Phase|Progression Disease|0|||
163076154|NCT01750281|588986868|FG000|Overall Study|Did not receive treatment|0|||
163076155|NCT01750281|588986869|FG001|Overall Study|Did not receive treatment|1|||
163076156|NCT01750281|588986870|FG002|Overall Study|Did not receive treatment|0|||
163076157|NCT01658735|588986874|FG000|Overall Study|Lack of Efficacy|1|||
163076158|NCT01658735|588986875|FG001|Overall Study|Lack of Efficacy|0|||
163076159|NCT01658735|588986876|FG002|Overall Study|Lack of Efficacy|1|||
163076160|NCT01658735|588986874|FG000|Overall Study|Lost to Follow-up|1|||
163076161|NCT01658735|588986875|FG001|Overall Study|Lost to Follow-up|1|||
163076162|NCT01658735|588986876|FG002|Overall Study|Lost to Follow-up|0|||
163076163|NCT01658735|588986874|FG000|Overall Study|Protocol Violation|0|||
163076164|NCT01658735|588986875|FG001|Overall Study|Protocol Violation|1|||
163076165|NCT01658735|588986876|FG002|Overall Study|Protocol Violation|0|||
163076166|NCT01658735|588986874|FG000|Overall Study|Withdrawal by Subject|3|||
163076167|NCT01658735|588986875|FG001|Overall Study|Withdrawal by Subject|5|||
163076168|NCT01658735|588986876|FG002|Overall Study|Withdrawal by Subject|3|||
163076169|NCT03302936|588986878|FG000|Overall Study|Protocol Violation|3|||
163076170|NCT03302936|588986879|FG001|Overall Study|Protocol Violation|4|||
163076171|NCT01379937|588986880|FG000|Overall Study|Protocol Violation|0|||
163076172|NCT01379937|588986881|FG001|Overall Study|Protocol Violation|0|||
163076173|NCT01379937|588986882|FG002|Overall Study|Protocol Violation|0|||
163076174|NCT01379937|588986883|FG003|Overall Study|Protocol Violation|1|||
163076175|NCT01379937|588986880|FG000|Overall Study|Consent withdrawal|0|||
163076176|NCT01379937|588986881|FG001|Overall Study|Consent withdrawal|1|||
163076177|NCT01379937|588986882|FG002|Overall Study|Consent withdrawal|0|||
163076178|NCT01379937|588986883|FG003|Overall Study|Consent withdrawal|0|||
163076179|NCT01379937|588986880|FG000|Overall Study|Lost to Follow-up|1|||
163076180|NCT01379937|588986881|FG001|Overall Study|Lost to Follow-up|2|||
163076181|NCT01379937|588986882|FG002|Overall Study|Lost to Follow-up|2|||
163076182|NCT01379937|588986883|FG003|Overall Study|Lost to Follow-up|0|||
163076183|NCT00079781|588986884|FG000|Pre-implant Period|Withdrawal by Subject|2|||
163076184|NCT00079781|588986885|FG001|Pre-implant Period|Withdrawal by Subject|0|||
163076185|NCT00079781|588986886|FG002|Pre-implant Period|Withdrawal by Subject|0|||
163076186|NCT00079781|588986884|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
163076187|NCT00079781|588986885|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
163076188|NCT00079781|588986886|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
163076189|NCT00079781|588986884|FG000|Follow-up Period|Withdrawal by Subject|3|||
163076190|NCT00079781|588986885|FG001|Follow-up Period|Withdrawal by Subject|0|||
163076191|NCT00079781|588986886|FG002|Follow-up Period|Withdrawal by Subject|1|||
163076192|NCT00079781|588986884|FG000|Follow-up Period|Lost to Follow-up|1|||
163076193|NCT00079781|588986885|FG001|Follow-up Period|Lost to Follow-up|0|||
163076194|NCT00079781|588986886|FG002|Follow-up Period|Lost to Follow-up|0|||
163076195|NCT00079781|588986884|FG000|Follow-up Period|Death|0|||
163076196|NCT00079781|588986885|FG001|Follow-up Period|Death|0|||
163076197|NCT00079781|588986886|FG002|Follow-up Period|Death|1|||
163076198|NCT00564070|588986887|FG000|Overall Study|Lost to Follow-up|9|||
163076199|NCT00564070|588986888|FG001|Overall Study|Lost to Follow-up|7|||
163076200|NCT00564070|588986887|FG000|Overall Study|Worsening depression, referred to care|3|||
163076201|NCT00564070|588986888|FG001|Overall Study|Worsening depression, referred to care|0|||
163076202|NCT02264821|588986891|FG000|Overall Study|Protocol Violation|1|||
163076203|NCT02264821|588986892|FG001|Overall Study|Protocol Violation|3|||
163076204|NCT02264821|588986893|FG002|Overall Study|Protocol Violation|6|||
163076205|NCT02067156|588986895|FG000|Overall Study|Lost to Follow-up|4|||
163076206|NCT01853280|588986896|FG000|Overall Study|Lack of Efficacy|2|||
163076207|NCT01853280|588986897|FG001|Overall Study|Lack of Efficacy|2|||
163076208|NCT01853280|588986896|FG000|Overall Study|Lost to Follow-up|0|||
163076209|NCT01853280|588986897|FG001|Overall Study|Lost to Follow-up|1|||
163076210|NCT01853280|588986896|FG000|Overall Study|Physician Decision|0|||
163076211|NCT01853280|588986897|FG001|Overall Study|Physician Decision|1|||
163076212|NCT01853280|588986896|FG000|Overall Study|Withdrawal by Subject|0|||
163076213|NCT01853280|588986897|FG001|Overall Study|Withdrawal by Subject|1|||
163076214|NCT01853280|588986896|FG000|Overall Study|Ineligible|0|||
163331711|NCT01690624|589924057|FG001|Overall Study|Withdrawal by Subject|1|||
163331712|NCT01690624|589924058|FG002|Overall Study|Withdrawal by Subject|0|||
163331713|NCT01690624|589924059|FG003|Overall Study|Withdrawal by Subject|0|||
163076215|NCT01853280|588986897|FG001|Overall Study|Ineligible|1|||
163076216|NCT01655069|588986898|FG000|Overall Study|Physician Decision|0|||
163076217|NCT01655069|588986899|FG001|Overall Study|Physician Decision|0|||
163076218|NCT01655069|588986900|FG002|Overall Study|Physician Decision|0|||
163331714|NCT01690624|589924056|FG000|Overall Study|Lack of Efficacy|1|||
163076219|NCT01655069|588986901|FG003|Overall Study|Physician Decision|1|||
163076220|NCT01655069|588986898|FG000|Overall Study|Adverse Event|6|||
163331715|NCT01690624|589924057|FG001|Overall Study|Lack of Efficacy|1|||
163076221|NCT01655069|588986899|FG001|Overall Study|Adverse Event|7|||
163076222|NCT01655069|588986900|FG002|Overall Study|Adverse Event|2|||
163076223|NCT01655069|588986901|FG003|Overall Study|Adverse Event|3|||
163076224|NCT01655069|588986898|FG000|Overall Study|Lack of Efficacy|0|||
163076225|NCT01655069|588986899|FG001|Overall Study|Lack of Efficacy|1|||
163076226|NCT01655069|588986900|FG002|Overall Study|Lack of Efficacy|0|||
163076227|NCT01655069|588986901|FG003|Overall Study|Lack of Efficacy|0|||
163076228|NCT01655069|588986898|FG000|Overall Study|No Treatment Needed|0|||
163076229|NCT01655069|588986899|FG001|Overall Study|No Treatment Needed|1|||
163076230|NCT01655069|588986900|FG002|Overall Study|No Treatment Needed|0|||
163076231|NCT01655069|588986901|FG003|Overall Study|No Treatment Needed|0|||
163076232|NCT01655069|588986898|FG000|Overall Study|Withdrawal by Subject|2|||
163076233|NCT01655069|588986899|FG001|Overall Study|Withdrawal by Subject|3|||
163076234|NCT01655069|588986900|FG002|Overall Study|Withdrawal by Subject|0|||
163076235|NCT01655069|588986901|FG003|Overall Study|Withdrawal by Subject|0|||
163076236|NCT00835042|588986902|FG000|First Intervention|Withdrawal by Subject|3|||
163331716|NCT01690624|589924058|FG002|Overall Study|Lack of Efficacy|3|||
163331717|NCT01690624|589924059|FG003|Overall Study|Lack of Efficacy|0|||
163331718|NCT05293717|589924064|FG000|Overall Study|Physician Decision|1|||
163331719|NCT04693637|589925553|FG000|Overall Study|Death|4|||
163331720|NCT04693637|589925553|FG000|Overall Study|Withdrawal by Subject|3|||
163331721|NCT04693637|589925553|FG000|Overall Study|Physician Decision|2|||
163331722|NCT04693637|589925553|FG000|Overall Study|Lost to Follow-up|1|||
163331723|NCT03052517|589925554|FG000|Overall Study|Study Terminated By Sponsor|928|||
163331724|NCT03052517|589925555|FG001|Overall Study|Study Terminated By Sponsor|938|||
163331725|NCT03052517|589925556|FG002|Overall Study|Study Terminated By Sponsor|296|||
163331726|NCT03052517|589925554|FG000|Overall Study|Subject/Guardian Decision|50|||
163331727|NCT03052517|589925555|FG001|Overall Study|Subject/Guardian Decision|45|||
163331728|NCT03052517|589925556|FG002|Overall Study|Subject/Guardian Decision|22|||
163028523|NCT02543892|588807297|FG000|Received Vaccination 2|Physician Decision|0|||
163028524|NCT02543892|588807298|FG001|Received Vaccination 2|Physician Decision|0|||
163028525|NCT02543892|588807299|FG002|Received Vaccination 2|Physician Decision|0|||
163028526|NCT02543892|588807300|FG003|Received Vaccination 2|Physician Decision|0|||
163028527|NCT02543892|588807301|FG004|Received Vaccination 2|Physician Decision|0|||
163028528|NCT02543892|588807302|FG005|Received Vaccination 2|Physician Decision|1|||
163028529|NCT02543892|588807303|FG006|Received Vaccination 2|Physician Decision|0|||
163028530|NCT02543892|588807304|FG007|Received Vaccination 2|Physician Decision|0|||
163028531|NCT02543892|588807297|FG000|Received Vaccination 2|Adverse Event|0|||
163028532|NCT02543892|588807298|FG001|Received Vaccination 2|Adverse Event|1|||
163028533|NCT02543892|588807299|FG002|Received Vaccination 2|Adverse Event|0|||
163028534|NCT02543892|588807300|FG003|Received Vaccination 2|Adverse Event|0|||
163028535|NCT02543892|588807301|FG004|Received Vaccination 2|Adverse Event|0|||
163028536|NCT02543892|588807302|FG005|Received Vaccination 2|Adverse Event|0|||
163028537|NCT02543892|588807303|FG006|Received Vaccination 2|Adverse Event|0|||
163028538|NCT02543892|588807304|FG007|Received Vaccination 2|Adverse Event|0|||
163028539|NCT02543892|588807297|FG000|Had Immunology Data|Withdrawal by Subject|0|||
163028540|NCT02543892|588807298|FG001|Had Immunology Data|Withdrawal by Subject|0|||
163028541|NCT02543892|588807299|FG002|Had Immunology Data|Withdrawal by Subject|0|||
163028542|NCT02543892|588807300|FG003|Had Immunology Data|Withdrawal by Subject|0|||
163028543|NCT02543892|588807301|FG004|Had Immunology Data|Withdrawal by Subject|0|||
163028544|NCT02543892|588807302|FG005|Had Immunology Data|Withdrawal by Subject|0|||
163028545|NCT02543892|588807303|FG006|Had Immunology Data|Withdrawal by Subject|1|||
163028546|NCT02543892|588807304|FG007|Had Immunology Data|Withdrawal by Subject|0|||
163028547|NCT01199822|588807305|FG000|Overall Study|Investigator discontinued therapy|0|||
163028548|NCT01199822|588807306|FG001|Overall Study|Investigator discontinued therapy|1|||
163028549|NCT01199822|588807307|FG002|Overall Study|Investigator discontinued therapy|0|||
163028550|NCT01500213|588807308|FG000|Overall Study|Adverse Event|35|||
163028551|NCT01500213|588807309|FG001|Overall Study|Adverse Event|35|||
163028552|NCT01500213|588807308|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
163028553|NCT01500213|588807309|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
163028554|NCT01500213|588807308|FG000|Overall Study|Withdrawal by Subject|28|||
163028555|NCT01500213|588807309|FG001|Overall Study|Withdrawal by Subject|37|||
163028556|NCT01500213|588807308|FG000|Overall Study|Death|7|||
163028557|NCT01500213|588807309|FG001|Overall Study|Death|3|||
163028558|NCT01500213|588807308|FG000|Overall Study|Disease Progression|13|||
163028559|NCT01500213|588807309|FG001|Overall Study|Disease Progression|21|||
163028560|NCT01500213|588807308|FG000|Overall Study|Protocol Violation|19|||
163028561|NCT01500213|588807309|FG001|Overall Study|Protocol Violation|19|||
163028562|NCT01500213|588807308|FG000|Overall Study|Physician Decision|12|||
163028563|NCT01500213|588807309|FG001|Overall Study|Physician Decision|10|||
163028564|NCT01500213|588807308|FG000|Overall Study|Lack of Efficacy|9|||
163028565|NCT01500213|588807309|FG001|Overall Study|Lack of Efficacy|7|||
163028566|NCT01500213|588807308|FG000|Overall Study|Lost to Follow-up|3|||
163028567|NCT01500213|588807309|FG001|Overall Study|Lost to Follow-up|6|||
163028568|NCT01500213|588807308|FG000|Overall Study|Other Reasons|7|||
163028569|NCT01500213|588807309|FG001|Overall Study|Other Reasons|5|||
163028570|NCT04027075|588807310|FG000|Overall Study|Lost to Follow-up|41|||
163028571|NCT04027075|588807311|FG001|Overall Study|Lost to Follow-up|22|||
163028572|NCT01195844|588807312|FG000|Overall Study|Fecal sample not collected|40|||
163028573|NCT00581542|588807313|FG000|Overall Study|they met an exclusion criteria|2|||
163028574|NCT00581542|588807314|FG001|Overall Study|they met an exclusion criteria|2|||
163028575|NCT00581542|588807313|FG000|Overall Study|Lost to Follow-up|9|||
163331729|NCT03052517|589925554|FG000|Overall Study|Lack of Efficacy|23|||
163076237|NCT00835042|588986903|FG001|First Intervention|Withdrawal by Subject|0|||
163076238|NCT00835042|588986902|FG000|First Intervention|Adverse Event|1|||
163076239|NCT00835042|588986903|FG001|First Intervention|Adverse Event|2|||
163076240|NCT00835042|588986902|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
163076241|NCT00835042|588986903|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
163076242|NCT02453191|588986905|FG000|Overall Study|Withdrawal by Subject|1|||
163076243|NCT02571244|588986906|FG000|Overall Study|Lost to Follow-up|0|||
163076244|NCT02571244|588986907|FG001|Overall Study|Lost to Follow-up|1|||
163076245|NCT02571244|588986906|FG000|Overall Study|Unable to reach out post discharge|3|||
163076246|NCT02571244|588986907|FG001|Overall Study|Unable to reach out post discharge|0|||
163076247|NCT01696214|588986910|FG000|Overall Study|Lost to Follow-up|1|||
163076248|NCT01696214|588986911|FG001|Overall Study|Lost to Follow-up|0|||
163028576|NCT00581542|588807314|FG001|Overall Study|Lost to Follow-up|21|||
163028577|NCT01801280|588807315|FG000|Period 1|Withdrawal by Subject|0|||
163028578|NCT01801280|588807316|FG001|Period 1|Withdrawal by Subject|1|||
163028579|NCT01801280|588807317|FG002|Period 1|Withdrawal by Subject|0|||
163028580|NCT01801280|588807318|FG003|Period 1|Withdrawal by Subject|0|||
163028581|NCT01801280|588807315|FG000|Period 2|Withdrawal by Subject|1|||
163028582|NCT01801280|588807316|FG001|Period 2|Withdrawal by Subject|0|||
163028583|NCT01801280|588807317|FG002|Period 2|Withdrawal by Subject|0|||
163028584|NCT01801280|588807318|FG003|Period 2|Withdrawal by Subject|0|||
163028585|NCT01801280|588807315|FG000|Period 4|Protocol Violation|0|||
163028586|NCT01801280|588807316|FG001|Period 4|Protocol Violation|0|||
163028587|NCT01801280|588807317|FG002|Period 4|Protocol Violation|1|||
163028588|NCT01801280|588807318|FG003|Period 4|Protocol Violation|0|||
163028589|NCT00176644|588807319|FG000|Overall Study|Withdrawal by Subject|1|||
163028590|NCT05020366|588807320|FG000|Overall Study|Lost to Follow-up|2|||
163028591|NCT05020366|588807321|FG001|Overall Study|Lost to Follow-up|0|||
163028592|NCT05020366|588807320|FG000|Overall Study|Withdrawal by Subject|2|||
163028593|NCT05020366|588807321|FG001|Overall Study|Withdrawal by Subject|0|||
163028594|NCT00195494|588807323|FG000|Year 1|Adverse Event|0|||
163028595|NCT00195494|588807324|FG001|Year 1|Adverse Event|0|||
163028596|NCT00195494|588807325|FG002|Year 1|Adverse Event|0|||
163028597|NCT00195494|588807326|FG003|Year 1|Adverse Event|0|||
163028598|NCT00195494|588807327|FG004|Year 1|Adverse Event|34|||
163028599|NCT00195494|588807328|FG005|Year 1|Adverse Event|27|||
163028600|NCT00195494|588807323|FG000|Year 1|System Toxicity|0|||
163028601|NCT00195494|588807324|FG001|Year 1|System Toxicity|0|||
163028602|NCT00195494|588807325|FG002|Year 1|System Toxicity|0|||
163028603|NCT00195494|588807326|FG003|Year 1|System Toxicity|0|||
163028604|NCT00195494|588807327|FG004|Year 1|System Toxicity|0|||
163028605|NCT00195494|588807328|FG005|Year 1|System Toxicity|1|||
163028606|NCT00195494|588807323|FG000|Year 1|Lack of Efficacy|0|||
163028607|NCT00195494|588807324|FG001|Year 1|Lack of Efficacy|0|||
163028608|NCT00195494|588807325|FG002|Year 1|Lack of Efficacy|0|||
163028609|NCT00195494|588807326|FG003|Year 1|Lack of Efficacy|0|||
163028610|NCT00195494|588807327|FG004|Year 1|Lack of Efficacy|24|||
163028611|NCT00195494|588807328|FG005|Year 1|Lack of Efficacy|9|||
163028612|NCT00195494|588807323|FG000|Year 1|Compliance|0|||
163028613|NCT00195494|588807324|FG001|Year 1|Compliance|0|||
163028614|NCT00195494|588807325|FG002|Year 1|Compliance|0|||
163028615|NCT00195494|588807326|FG003|Year 1|Compliance|0|||
163028616|NCT00195494|588807327|FG004|Year 1|Compliance|5|||
163028617|NCT00195494|588807328|FG005|Year 1|Compliance|1|||
163028618|NCT00195494|588807323|FG000|Year 1|Lost to Follow-up|0|||
163028619|NCT00195494|588807324|FG001|Year 1|Lost to Follow-up|0|||
163028620|NCT00195494|588807325|FG002|Year 1|Lost to Follow-up|0|||
163028621|NCT00195494|588807326|FG003|Year 1|Lost to Follow-up|0|||
163028622|NCT00195494|588807327|FG004|Year 1|Lost to Follow-up|1|||
163028623|NCT00195494|588807328|FG005|Year 1|Lost to Follow-up|0|||
163028624|NCT00195494|588807323|FG000|Year 1|Missed >4 consecutive doses|0|||
163028625|NCT00195494|588807324|FG001|Year 1|Missed >4 consecutive doses|0|||
163028626|NCT00195494|588807325|FG002|Year 1|Missed >4 consecutive doses|0|||
163028627|NCT00195494|588807326|FG003|Year 1|Missed >4 consecutive doses|0|||
163028628|NCT00195494|588807327|FG004|Year 1|Missed >4 consecutive doses|3|||
163028629|NCT00195494|588807328|FG005|Year 1|Missed >4 consecutive doses|2|||
163028630|NCT00195494|588807323|FG000|Year 1|Protocol deviation|0|||
163028631|NCT00195494|588807324|FG001|Year 1|Protocol deviation|0|||
163028632|NCT00195494|588807325|FG002|Year 1|Protocol deviation|0|||
163028633|NCT00195494|588807326|FG003|Year 1|Protocol deviation|0|||
163028634|NCT00195494|588807327|FG004|Year 1|Protocol deviation|2|||
163028635|NCT00195494|588807328|FG005|Year 1|Protocol deviation|3|||
163028636|NCT00195494|588807323|FG000|Year 1|Physician Decision|0|||
163028637|NCT00195494|588807324|FG001|Year 1|Physician Decision|0|||
163028638|NCT00195494|588807325|FG002|Year 1|Physician Decision|0|||
163028639|NCT00195494|588807326|FG003|Year 1|Physician Decision|0|||
163028640|NCT00195494|588807327|FG004|Year 1|Physician Decision|1|||
163028641|NCT00195494|588807328|FG005|Year 1|Physician Decision|0|||
163028642|NCT00195494|588807323|FG000|Year 1|Withdrawal by Subject|0|||
163028643|NCT00195494|588807324|FG001|Year 1|Withdrawal by Subject|0|||
163028644|NCT00195494|588807325|FG002|Year 1|Withdrawal by Subject|0|||
163028645|NCT00195494|588807326|FG003|Year 1|Withdrawal by Subject|0|||
163028646|NCT00195494|588807327|FG004|Year 1|Withdrawal by Subject|8|||
163028647|NCT00195494|588807328|FG005|Year 1|Withdrawal by Subject|9|||
163076249|NCT01696214|588986912|FG002|Overall Study|Lost to Follow-up|0|||
163331730|NCT03052517|589925555|FG001|Overall Study|Lack of Efficacy|14|||
163331731|NCT03052517|589925556|FG002|Overall Study|Lack of Efficacy|7|||
163331732|NCT03052517|589925554|FG000|Overall Study|Adverse Event|6|||
163331733|NCT03052517|589925555|FG001|Overall Study|Adverse Event|5|||
163331734|NCT03052517|589925556|FG002|Overall Study|Adverse Event|0|||
163331735|NCT03052517|589925554|FG000|Overall Study|Physician Decision|4|||
163331736|NCT03052517|589925555|FG001|Overall Study|Physician Decision|5|||
163331737|NCT03052517|589925556|FG002|Overall Study|Physician Decision|1|||
163331738|NCT03052517|589925554|FG000|Overall Study|Death|3|||
163331739|NCT03052517|589925555|FG001|Overall Study|Death|0|||
163331740|NCT03052517|589925556|FG002|Overall Study|Death|1|||
163331741|NCT03052517|589925554|FG000|Overall Study|Lost to Follow-up|2|||
163028648|NCT00195494|588807323|FG000|Year 1|Protocol Violation|0|||
163028649|NCT00195494|588807324|FG001|Year 1|Protocol Violation|0|||
163028650|NCT00195494|588807325|FG002|Year 1|Protocol Violation|0|||
163028651|NCT00195494|588807326|FG003|Year 1|Protocol Violation|0|||
163028652|NCT00195494|588807327|FG004|Year 1|Protocol Violation|1|||
163028653|NCT00195494|588807328|FG005|Year 1|Protocol Violation|1|||
163028654|NCT00195494|588807323|FG000|Year 2|Adverse Event|3|||
163028655|NCT00195494|588807324|FG001|Year 2|Adverse Event|7|||
163028656|NCT00195494|588807325|FG002|Year 2|Adverse Event|5|||
163028657|NCT00195494|588807326|FG003|Year 2|Adverse Event|9|||
163028658|NCT00195494|588807327|FG004|Year 2|Adverse Event|0|||
163028659|NCT00195494|588807328|FG005|Year 2|Adverse Event|0|||
163028660|NCT00195494|588807323|FG000|Year 2|Lack of Efficacy|0|||
163028661|NCT00195494|588807324|FG001|Year 2|Lack of Efficacy|1|||
163028662|NCT00195494|588807325|FG002|Year 2|Lack of Efficacy|7|||
163028663|NCT00195494|588807326|FG003|Year 2|Lack of Efficacy|7|||
163028664|NCT00195494|588807327|FG004|Year 2|Lack of Efficacy|0|||
163028665|NCT00195494|588807328|FG005|Year 2|Lack of Efficacy|0|||
163028666|NCT00195494|588807323|FG000|Year 2|Compliance|1|||
163028667|NCT00195494|588807324|FG001|Year 2|Compliance|0|||
163028668|NCT00195494|588807325|FG002|Year 2|Compliance|0|||
163028669|NCT00195494|588807326|FG003|Year 2|Compliance|2|||
163028670|NCT00195494|588807327|FG004|Year 2|Compliance|0|||
163028671|NCT00195494|588807328|FG005|Year 2|Compliance|0|||
163028672|NCT00195494|588807323|FG000|Year 2|Lost to Follow-up|0|||
163028673|NCT00195494|588807324|FG001|Year 2|Lost to Follow-up|0|||
163028674|NCT00195494|588807325|FG002|Year 2|Lost to Follow-up|1|||
163028675|NCT00195494|588807326|FG003|Year 2|Lost to Follow-up|1|||
163028676|NCT00195494|588807327|FG004|Year 2|Lost to Follow-up|0|||
163028677|NCT00195494|588807328|FG005|Year 2|Lost to Follow-up|0|||
163028678|NCT00195494|588807323|FG000|Year 2|Missed >4 consecutive doses|1|||
163028679|NCT00195494|588807324|FG001|Year 2|Missed >4 consecutive doses|1|||
163028680|NCT00195494|588807325|FG002|Year 2|Missed >4 consecutive doses|1|||
163028681|NCT00195494|588807326|FG003|Year 2|Missed >4 consecutive doses|0|||
163028682|NCT00195494|588807327|FG004|Year 2|Missed >4 consecutive doses|0|||
163028683|NCT00195494|588807328|FG005|Year 2|Missed >4 consecutive doses|0|||
163028684|NCT00195494|588807323|FG000|Year 2|Protocol deviation|0|||
163028685|NCT00195494|588807324|FG001|Year 2|Protocol deviation|1|||
163028686|NCT00195494|588807325|FG002|Year 2|Protocol deviation|0|||
163028687|NCT00195494|588807326|FG003|Year 2|Protocol deviation|0|||
163028688|NCT00195494|588807327|FG004|Year 2|Protocol deviation|0|||
163028689|NCT00195494|588807328|FG005|Year 2|Protocol deviation|0|||
163028690|NCT00195494|588807323|FG000|Year 2|Physician Decision|1|||
163028691|NCT00195494|588807324|FG001|Year 2|Physician Decision|1|||
163028692|NCT00195494|588807325|FG002|Year 2|Physician Decision|0|||
163028693|NCT00195494|588807326|FG003|Year 2|Physician Decision|0|||
163028694|NCT00195494|588807327|FG004|Year 2|Physician Decision|0|||
163028695|NCT00195494|588807328|FG005|Year 2|Physician Decision|0|||
163028696|NCT00195494|588807323|FG000|Year 2|Withdrawal by Subject|1|||
163028697|NCT00195494|588807324|FG001|Year 2|Withdrawal by Subject|5|||
163028698|NCT00195494|588807325|FG002|Year 2|Withdrawal by Subject|4|||
163028699|NCT00195494|588807326|FG003|Year 2|Withdrawal by Subject|3|||
163028700|NCT00195494|588807327|FG004|Year 2|Withdrawal by Subject|0|||
163028701|NCT00195494|588807328|FG005|Year 2|Withdrawal by Subject|0|||
163028702|NCT00195494|588807323|FG000|Year 2|System toxicity|0|||
163076250|NCT01696214|588986913|FG003|Overall Study|Lost to Follow-up|0|||
163028703|NCT00195494|588807324|FG001|Year 2|System toxicity|0|||
163028704|NCT00195494|588807325|FG002|Year 2|System toxicity|0|||
163028705|NCT00195494|588807326|FG003|Year 2|System toxicity|1|||
163028706|NCT00195494|588807327|FG004|Year 2|System toxicity|0|||
163028707|NCT00195494|588807328|FG005|Year 2|System toxicity|0|||
163028708|NCT00381043|588807333|FG000|Overall Study|Lost to Follow-up|8|||
163028709|NCT00381043|588807334|FG001|Overall Study|Lost to Follow-up|6|||
163331742|NCT03052517|589925555|FG001|Overall Study|Lost to Follow-up|4|||
163331743|NCT03052517|589925556|FG002|Overall Study|Lost to Follow-up|0|||
163331744|NCT03052517|589925554|FG000|Overall Study|Pregnancy|1|||
163028710|NCT00381043|588807333|FG000|Overall Study|Withdrawal by Subject|3|||
163028711|NCT00381043|588807334|FG001|Overall Study|Withdrawal by Subject|1|||
163028712|NCT00381043|588807333|FG000|Overall Study|wanted more care|0|||
163028713|NCT00381043|588807334|FG001|Overall Study|wanted more care|1|||
163028714|NCT00381043|588807333|FG000|Overall Study|incarcerated|1|||
163028715|NCT00381043|588807334|FG001|Overall Study|incarcerated|0|||
163076251|NCT02134028|588986914|FG000|Overall Study|Lack of Efficacy|1|||
163076252|NCT02134028|588986915|FG001|Overall Study|Lack of Efficacy|0|||
163076253|NCT02134028|588986916|FG002|Overall Study|Lack of Efficacy|3|||
163076254|NCT02134028|588986917|FG003|Overall Study|Lack of Efficacy|2|||
163076255|NCT02134028|588986918|FG004|Overall Study|Lack of Efficacy|1|||
163076256|NCT02134028|588986919|FG005|Overall Study|Lack of Efficacy|2|||
163076257|NCT02134028|588986920|FG006|Overall Study|Lack of Efficacy|1|||
163076258|NCT02134028|588986921|FG007|Overall Study|Lack of Efficacy|0|||
163076259|NCT02134028|588986914|FG000|Overall Study|Poor compliance to protocol|1|||
163076260|NCT02134028|588986915|FG001|Overall Study|Poor compliance to protocol|1|||
163076261|NCT02134028|588986916|FG002|Overall Study|Poor compliance to protocol|3|||
163076262|NCT02134028|588986917|FG003|Overall Study|Poor compliance to protocol|7|||
163218690|NCT01577758|589515883|FG007|Dose Escalation Phase|Progression Disease|0|||
163218691|NCT01577758|589515876|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
163218692|NCT01577758|589515877|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
163218693|NCT01577758|589515878|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
163218694|NCT01577758|589515879|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
163218695|NCT01577758|589515880|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
163218696|NCT01577758|589515881|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
163331745|NCT03052517|589925555|FG001|Overall Study|Pregnancy|0|||
163331746|NCT03052517|589925556|FG002|Overall Study|Pregnancy|1|||
163331747|NCT03052517|589925554|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
163028716|NCT03045276|588807337|FG000|Intervention Phase|Withdrawal by Subject|7|||
163028717|NCT03045276|588807338|FG001|Intervention Phase|Withdrawal by Subject|2|||
163028718|NCT03045276|588807339|FG002|Intervention Phase|Withdrawal by Subject|3|||
163028719|NCT03045276|588807340|FG003|Intervention Phase|Withdrawal by Subject|7|||
163028720|NCT03045276|588807337|FG000|Intervention Phase|Developed exclusionary criteria|3|||
163028721|NCT03045276|588807338|FG001|Intervention Phase|Developed exclusionary criteria|3|||
163028722|NCT03045276|588807339|FG002|Intervention Phase|Developed exclusionary criteria|0|||
163028723|NCT03045276|588807340|FG003|Intervention Phase|Developed exclusionary criteria|0|||
163028724|NCT03045276|588807337|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
163028725|NCT03045276|588807338|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
163028726|NCT03045276|588807339|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
163028727|NCT03045276|588807340|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
163028728|NCT03045276|588807337|FG000|Follow-Up Phase|Lost to Follow-up|0|||
163028729|NCT03045276|588807338|FG001|Follow-Up Phase|Lost to Follow-up|1|||
163028730|NCT03045276|588807339|FG002|Follow-Up Phase|Lost to Follow-up|0|||
163028731|NCT03045276|588807340|FG003|Follow-Up Phase|Lost to Follow-up|1|||
163028732|NCT03045276|588807337|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
163028733|NCT03045276|588807338|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
163028734|NCT03045276|588807339|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
163028735|NCT03045276|588807340|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
163028736|NCT00347919|588807343|FG000|Overall Study|Lost to Follow-up|11|||
163028737|NCT00347919|588807344|FG001|Overall Study|Lost to Follow-up|13|||
163028738|NCT00347919|588807345|FG002|Overall Study|Lost to Follow-up|0|||
163028739|NCT00347919|588807343|FG000|Overall Study|Withdrawal by Subject|6|||
163028740|NCT00347919|588807344|FG001|Overall Study|Withdrawal by Subject|8|||
163028741|NCT00347919|588807345|FG002|Overall Study|Withdrawal by Subject|0|||
163028742|NCT00347919|588807343|FG000|Overall Study|Physician Decision|1|||
163028743|NCT00347919|588807344|FG001|Overall Study|Physician Decision|1|||
163028744|NCT00347919|588807345|FG002|Overall Study|Physician Decision|0|||
163028745|NCT00347919|588807343|FG000|Overall Study|Sponsor terminated study|15|||
163028746|NCT00347919|588807344|FG001|Overall Study|Sponsor terminated study|10|||
163028747|NCT00347919|588807345|FG002|Overall Study|Sponsor terminated study|16|||
163028748|NCT00347919|588807343|FG000|Overall Study|Death|35|||
163028749|NCT00347919|588807344|FG001|Overall Study|Death|42|||
163028750|NCT00347919|588807345|FG002|Overall Study|Death|19|||
163028751|NCT00347919|588807343|FG000|Overall Study|Par. Started Other Treatment|1|||
163028752|NCT00347919|588807344|FG001|Overall Study|Par. Started Other Treatment|1|||
163028753|NCT00347919|588807345|FG002|Overall Study|Par. Started Other Treatment|1|||
163028754|NCT00347919|588807343|FG000|Overall Study|Missing|2|||
163028755|NCT00347919|588807344|FG001|Overall Study|Missing|1|||
163028756|NCT00347919|588807345|FG002|Overall Study|Missing|2|||
163028757|NCT00533702|588807351|FG000|Overall Study|Withdrawal by Subject|3|||
163028758|NCT00533702|588807352|FG001|Overall Study|Withdrawal by Subject|1|||
163028759|NCT00533702|588807351|FG000|Overall Study|Found ineligible after randomization|2|||
163028760|NCT00533702|588807352|FG001|Overall Study|Found ineligible after randomization|1|||
163028761|NCT01970475|588807355|FG000|Overall Study|Withdrawal by Subject|11|||
163028762|NCT01970475|588807356|FG001|Overall Study|Withdrawal by Subject|6|||
163028763|NCT01970475|588807355|FG000|Overall Study|Adverse Event|7|||
163218697|NCT01577758|589515882|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
163218698|NCT01577758|589515883|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
163331748|NCT03052517|589925555|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
163028764|NCT01970475|588807356|FG001|Overall Study|Adverse Event|3|||
163028765|NCT01970475|588807355|FG000|Overall Study|Lost to Follow-up|2|||
163028766|NCT01970475|588807356|FG001|Overall Study|Lost to Follow-up|2|||
163076263|NCT02134028|588986918|FG004|Overall Study|Poor compliance to protocol|1|||
163076264|NCT02134028|588986919|FG005|Overall Study|Poor compliance to protocol|1|||
163076265|NCT02134028|588986920|FG006|Overall Study|Poor compliance to protocol|0|||
163076266|NCT02134028|588986921|FG007|Overall Study|Poor compliance to protocol|0|||
163076267|NCT02134028|588986914|FG000|Overall Study|Other unspecified|4|||
163076268|NCT02134028|588986915|FG001|Overall Study|Other unspecified|22|||
163076269|NCT02134028|588986916|FG002|Overall Study|Other unspecified|33|||
163076270|NCT02134028|588986917|FG003|Overall Study|Other unspecified|64|||
163076271|NCT02134028|588986918|FG004|Overall Study|Other unspecified|8|||
163076272|NCT02134028|588986919|FG005|Overall Study|Other unspecified|6|||
163076273|NCT02134028|588986920|FG006|Overall Study|Other unspecified|2|||
163076274|NCT02134028|588986921|FG007|Overall Study|Other unspecified|1|||
163076275|NCT02134028|588986914|FG000|Overall Study|Adverse Event|3|||
163076276|NCT02134028|588986915|FG001|Overall Study|Adverse Event|19|||
163076277|NCT02134028|588986916|FG002|Overall Study|Adverse Event|13|||
163076278|NCT02134028|588986917|FG003|Overall Study|Adverse Event|32|||
163076279|NCT02134028|588986918|FG004|Overall Study|Adverse Event|4|||
163076280|NCT02134028|588986919|FG005|Overall Study|Adverse Event|5|||
163076281|NCT02134028|588986920|FG006|Overall Study|Adverse Event|1|||
163076282|NCT02134028|588986921|FG007|Overall Study|Adverse Event|2|||
163076283|NCT01309100|588986924|FG000|Overall Study|Protocol Violation|1|||
163076284|NCT01309100|588986924|FG000|Overall Study|Positive Slit lamp finding|1|||
163076285|NCT03722030|588986925|FG000|Overall Study|Withdrawal by Subject|1|||
163076286|NCT03722030|588986926|FG001|Overall Study|Withdrawal by Subject|0|||
163076287|NCT01663987|588986928|FG000|Overall Study|Adverse Event|7|||
163076288|NCT01663987|588986929|FG001|Overall Study|Adverse Event|2|||
163076289|NCT01663987|588986928|FG000|Overall Study|Lost to Follow-up|1|||
163076290|NCT01663987|588986929|FG001|Overall Study|Lost to Follow-up|1|||
163076291|NCT01663987|588986928|FG000|Overall Study|Withdrawal by Subject|2|||
163076292|NCT01663987|588986929|FG001|Overall Study|Withdrawal by Subject|3|||
163076293|NCT01663987|588986928|FG000|Overall Study|Other reason not defined above|3|||
163076294|NCT01663987|588986929|FG001|Overall Study|Other reason not defined above|0|||
163076295|NCT01065766|588986930|FG000|Overall Study|Assessed before the contracted date|1|||
163076296|NCT01065766|588986930|FG000|Overall Study|Contraindication to administration|6|||
163076297|NCT01065766|588986930|FG000|Overall Study|Violated dosage/administration|25|||
163076298|NCT02362412|588986934|FG000|Treatment Period III|Lost to Follow-up|0|||
163076299|NCT02362412|588986935|FG001|Treatment Period III|Lost to Follow-up|1|||
163076300|NCT00545948|588986936|FG000|Overall Study|Not Treated|1|||
163076301|NCT00545948|588986937|FG001|Overall Study|Not Treated|1|||
163076302|NCT00545948|588986938|FG002|Overall Study|Not Treated|7|||
163076303|NCT01541254|588986942|FG000|Overall Study|Withdrawal by Subject|1|||
163076304|NCT01541254|588986942|FG000|Overall Study|excluded - metal allergy|1|||
163076305|NCT01541254|588986942|FG000|Overall Study|enrolled after study closed|1|||
163076306|NCT01541254|588986942|FG000|Overall Study|GI bleed prior to procedure|1|||
163076307|NCT01541254|588986942|FG000|Overall Study|stent not required|1|||
163076308|NCT01541254|588986942|FG000|Overall Study|alternate stent used|1|||
163076309|NCT04518410|588986943|FG000|Overall Study|Lost to Follow-up|1|||
163076310|NCT04518410|588986944|FG001|Overall Study|Lost to Follow-up|1|||
163076311|NCT04518410|588986945|FG002|Overall Study|Lost to Follow-up|8|||
163076312|NCT04518410|588986946|FG003|Overall Study|Lost to Follow-up|5|||
163076313|NCT04518410|588986947|FG004|Overall Study|Lost to Follow-up|92|||
163076314|NCT04518410|588986948|FG005|Overall Study|Lost to Follow-up|25|||
163076315|NCT04518410|588986949|FG006|Overall Study|Lost to Follow-up|25|||
163076316|NCT04518410|588986950|FG007|Overall Study|Lost to Follow-up|3|||
163076317|NCT04518410|588986951|FG008|Overall Study|Lost to Follow-up|2|||
163076318|NCT04518410|588986952|FG009|Overall Study|Lost to Follow-up|13|||
163076319|NCT04518410|588986953|FG010|Overall Study|Lost to Follow-up|9|||
163076320|NCT04518410|588986954|FG011|Overall Study|Lost to Follow-up|13|||
163076321|NCT04518410|588986955|FG012|Overall Study|Lost to Follow-up|9|||
163076322|NCT04518410|588986956|FG013|Overall Study|Lost to Follow-up|13|||
163076323|NCT04518410|588986957|FG014|Overall Study|Lost to Follow-up|8|||
163076324|NCT04518410|588986958|FG015|Overall Study|Lost to Follow-up|10|||
163076325|NCT04518410|588986959|FG016|Overall Study|Lost to Follow-up|6|||
163076326|NCT04518410|588986960|FG017|Overall Study|Lost to Follow-up|13|||
163076327|NCT04518410|588986961|FG018|Overall Study|Lost to Follow-up|21|||
163076328|NCT04518410|588986962|FG019|Overall Study|Lost to Follow-up|6|||
163076329|NCT04518410|588986963|FG020|Overall Study|Lost to Follow-up|7|||
163076330|NCT04518410|588986964|FG021|Overall Study|Lost to Follow-up|21|||
163076331|NCT04518410|588986965|FG022|Overall Study|Lost to Follow-up|1|||
163076332|NCT04518410|588986966|FG023|Overall Study|Lost to Follow-up|7|||
163076333|NCT04518410|588986967|FG024|Overall Study|Lost to Follow-up|6|||
163076334|NCT04518410|588986943|FG000|Overall Study|Withdrawal by Subject|1|||
163076335|NCT04518410|588986944|FG001|Overall Study|Withdrawal by Subject|2|||
163076336|NCT04518410|588986945|FG002|Overall Study|Withdrawal by Subject|2|||
163076337|NCT04518410|588986946|FG003|Overall Study|Withdrawal by Subject|3|||
163076338|NCT04518410|588986947|FG004|Overall Study|Withdrawal by Subject|20|||
163076339|NCT04518410|588986948|FG005|Overall Study|Withdrawal by Subject|20|||
163076340|NCT04518410|588986949|FG006|Overall Study|Withdrawal by Subject|25|||
163076341|NCT04518410|588986950|FG007|Overall Study|Withdrawal by Subject|6|||
163076342|NCT04518410|588986951|FG008|Overall Study|Withdrawal by Subject|1|||
163331749|NCT03052517|589925556|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
163331750|NCT03052517|589925554|FG000|Overall Study|Technical Problems|0|||
163331751|NCT03052517|589925555|FG001|Overall Study|Technical Problems|1|||
163331752|NCT03052517|589925556|FG002|Overall Study|Technical Problems|0|||
163331753|NCT04885998|589925559|FG000|Overall Study|Withdrawal by Subject|0|||
163331754|NCT04885998|589925560|FG001|Overall Study|Withdrawal by Subject|2|||
163331755|NCT04885998|589925561|FG002|Overall Study|Withdrawal by Subject|0|||
163331756|NCT04885998|589925562|FG003|Overall Study|Withdrawal by Subject|3|||
163331757|NCT04885998|589925559|FG000|Overall Study|Lost to Follow-up|1|||
163331758|NCT04885998|589925560|FG001|Overall Study|Lost to Follow-up|1|||
163331759|NCT04885998|589925561|FG002|Overall Study|Lost to Follow-up|0|||
163331760|NCT04885998|589925562|FG003|Overall Study|Lost to Follow-up|0|||
163331761|NCT04885998|589925559|FG000|Overall Study|Death|2|||
163331762|NCT04885998|589925560|FG001|Overall Study|Death|1|||
163331763|NCT04885998|589925561|FG002|Overall Study|Death|2|||
163331764|NCT04885998|589925562|FG003|Overall Study|Death|2|||
163331765|NCT04885998|589925559|FG000|Overall Study|Decision by sponsor|1|||
163331766|NCT04885998|589925560|FG001|Overall Study|Decision by sponsor|1|||
163331767|NCT04885998|589925561|FG002|Overall Study|Decision by sponsor|0|||
163331768|NCT04885998|589925562|FG003|Overall Study|Decision by sponsor|0|||
163331769|NCT05260437|589925564|FG000|Overall Study|Lost to Follow-up|5|||
163331770|NCT05260437|589925565|FG001|Overall Study|Lost to Follow-up|2|||
163331771|NCT05260437|589925566|FG002|Overall Study|Lost to Follow-up|1|||
163331772|NCT05260437|589925567|FG003|Overall Study|Lost to Follow-up|2|||
163331773|NCT05260437|589925568|FG004|Overall Study|Lost to Follow-up|2|||
163331774|NCT05260437|589925564|FG000|Overall Study|Withdrawal by Subject|3|||
163028767|NCT01970475|588807355|FG000|Overall Study|Protocol Violation|1|||
163028768|NCT01970475|588807356|FG001|Overall Study|Protocol Violation|0|||
163028769|NCT04413552|588807361|FG000|Overall Study|Adverse Event|0|||
163028770|NCT04413552|588807362|FG001|Overall Study|Adverse Event|0|||
163028771|NCT04413552|588807363|FG002|Overall Study|Adverse Event|0|||
163028772|NCT04413552|588807364|FG003|Overall Study|Adverse Event|0|||
163028773|NCT04413552|588807365|FG004|Overall Study|Adverse Event|0|||
163028774|NCT04413552|588807366|FG005|Overall Study|Adverse Event|0|||
163028775|NCT04413552|588807367|FG006|Overall Study|Adverse Event|1|||
163028776|NCT04413552|588807368|FG007|Overall Study|Adverse Event|0|||
163028777|NCT04413552|588807369|FG008|Overall Study|Adverse Event|0|||
163028778|NCT04413552|588807370|FG009|Overall Study|Adverse Event|0|||
163028779|NCT01317797|588807371|FG000|Overall Study|Other|0|||
163028780|NCT01317797|588807372|FG001|Overall Study|Other|1|||
163028781|NCT01317797|588807373|FG002|Overall Study|Other|0|||
163028782|NCT01317797|588807371|FG000|Overall Study|Withdrawal of Patient|0|||
163028783|NCT01317797|588807372|FG001|Overall Study|Withdrawal of Patient|0|||
163028784|NCT01317797|588807373|FG002|Overall Study|Withdrawal of Patient|1|||
163028785|NCT03026530|588807374|FG000|Overall Study|Lost to Follow-up|19|||
163028786|NCT03026530|588807375|FG001|Overall Study|Lost to Follow-up|24|||
163028787|NCT03026530|588807374|FG000|Overall Study|Protocol Violation|2|||
163028788|NCT03026530|588807375|FG001|Overall Study|Protocol Violation|5|||
163028789|NCT03721835|588807377|FG000|Overall Study|Participant not able to return|1|||
163028790|NCT03721835|588807377|FG000|Overall Study|Lost to Follow-up|1|||
163028791|NCT03721835|588807377|FG000|Overall Study|Revision of the components of the study device|2|||
163028792|NCT03721835|588807377|FG000|Overall Study|Sponsor terminated study|6|||
163028793|NCT03721835|588807377|FG000|Overall Study|Death|1|||
163028794|NCT03721835|588807377|FG000|Overall Study|Sponsor decision|1|||
163028795|NCT03495154|588807378|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
163028796|NCT03495154|588807378|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
163028797|NCT03495154|588807378|FG000|Overall Study|Screen Failures During Surgery|6|||
163028798|NCT03495154|588807378|FG000|Overall Study|Death|2|||
163028799|NCT03495154|588807378|FG000|Overall Study|Lost to Follow-up|16|||
163028800|NCT03495154|588807378|FG000|Overall Study|Withdrawal by Subject|2|||
163028801|NCT03495154|588807378|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
163028802|NCT01294696|588807382|FG000|Overall Study|Screening failures|7|||
163028803|NCT01294696|588807382|FG000|Overall Study|Protocol Violation|8|||
163028804|NCT01294696|588807382|FG000|Overall Study|Missing BPI Response|7|||
163028805|NCT01294696|588807382|FG000|Overall Study|Site closure|52|||
163028806|NCT05079750|588808764|FG000|Overall Study|Lost to Follow-up|0|||
163331775|NCT05260437|589925565|FG001|Overall Study|Withdrawal by Subject|0|||
163028807|NCT05079750|588808765|FG001|Overall Study|Lost to Follow-up|0|||
163028808|NCT05079750|588808766|FG002|Overall Study|Lost to Follow-up|1|||
163331776|NCT05260437|589925566|FG002|Overall Study|Withdrawal by Subject|4|||
163331777|NCT05260437|589925567|FG003|Overall Study|Withdrawal by Subject|5|||
163331778|NCT05260437|589925568|FG004|Overall Study|Withdrawal by Subject|0|||
163331779|NCT05260437|589925564|FG000|Overall Study|Vaccine Not Administered|0|||
163331780|NCT05260437|589925565|FG001|Overall Study|Vaccine Not Administered|1|||
163028809|NCT05091346|588808769|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
163028810|NCT05091346|588808770|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
163028811|NCT05091346|588808771|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
163028812|NCT05091346|588808772|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
163076343|NCT04518410|588986952|FG009|Overall Study|Withdrawal by Subject|12|||
163076344|NCT04518410|588986953|FG010|Overall Study|Withdrawal by Subject|5|||
163076345|NCT04518410|588986954|FG011|Overall Study|Withdrawal by Subject|7|||
163076346|NCT04518410|588986955|FG012|Overall Study|Withdrawal by Subject|2|||
163076347|NCT04518410|588986956|FG013|Overall Study|Withdrawal by Subject|13|||
163076348|NCT04518410|588986957|FG014|Overall Study|Withdrawal by Subject|4|||
163076349|NCT04518410|588986958|FG015|Overall Study|Withdrawal by Subject|9|||
163076350|NCT04518410|588986959|FG016|Overall Study|Withdrawal by Subject|0|||
163076351|NCT04518410|588986960|FG017|Overall Study|Withdrawal by Subject|15|||
163076352|NCT04518410|588986961|FG018|Overall Study|Withdrawal by Subject|12|||
163076353|NCT04518410|588986962|FG019|Overall Study|Withdrawal by Subject|9|||
163076354|NCT04518410|588986963|FG020|Overall Study|Withdrawal by Subject|14|||
163076355|NCT04518410|588986964|FG021|Overall Study|Withdrawal by Subject|3|||
163076356|NCT04518410|588986965|FG022|Overall Study|Withdrawal by Subject|2|||
163076357|NCT04518410|588986966|FG023|Overall Study|Withdrawal by Subject|9|||
163076358|NCT04518410|588986967|FG024|Overall Study|Withdrawal by Subject|8|||
163076359|NCT04518410|588986943|FG000|Overall Study|Other|1|||
163076360|NCT04518410|588986944|FG001|Overall Study|Other|0|||
163076361|NCT04518410|588986945|FG002|Overall Study|Other|0|||
163076362|NCT04518410|588986946|FG003|Overall Study|Other|1|||
163076363|NCT04518410|588986947|FG004|Overall Study|Other|6|||
163076364|NCT04518410|588986948|FG005|Overall Study|Other|6|||
163076365|NCT04518410|588986949|FG006|Overall Study|Other|5|||
163076366|NCT04518410|588986950|FG007|Overall Study|Other|2|||
163076367|NCT04518410|588986951|FG008|Overall Study|Other|0|||
163076368|NCT04518410|588986952|FG009|Overall Study|Other|1|||
163076369|NCT04518410|588986953|FG010|Overall Study|Other|0|||
163076370|NCT04518410|588986954|FG011|Overall Study|Other|2|||
163076371|NCT04518410|588986955|FG012|Overall Study|Other|0|||
163218699|NCT01577758|589515876|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
163218700|NCT01577758|589515877|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
163028813|NCT05091346|588808773|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
163028814|NCT05091346|588808769|FG000|Overall Study|Death|6|||
163028815|NCT05091346|588808770|FG001|Overall Study|Death|5|||
163028816|NCT05091346|588808771|FG002|Overall Study|Death|8|||
163028817|NCT05091346|588808772|FG003|Overall Study|Death|16|||
163028818|NCT05091346|588808773|FG004|Overall Study|Death|26|||
163028819|NCT05091346|588808769|FG000|Overall Study|Lost to Follow-up|0|||
163028820|NCT05091346|588808770|FG001|Overall Study|Lost to Follow-up|0|||
163028821|NCT05091346|588808771|FG002|Overall Study|Lost to Follow-up|0|||
163028822|NCT05091346|588808772|FG003|Overall Study|Lost to Follow-up|1|||
163028823|NCT05091346|588808773|FG004|Overall Study|Lost to Follow-up|0|||
163028824|NCT05091346|588808769|FG000|Overall Study|Withdrawal by Subject|0|||
163028825|NCT05091346|588808770|FG001|Overall Study|Withdrawal by Subject|1|||
163028826|NCT05091346|588808771|FG002|Overall Study|Withdrawal by Subject|2|||
163028827|NCT05091346|588808772|FG003|Overall Study|Withdrawal by Subject|2|||
163028828|NCT05091346|588808773|FG004|Overall Study|Withdrawal by Subject|1|||
163028829|NCT02339155|588808776|FG000|Overall Study|Adverse Event|0|||
163028830|NCT02339155|588808777|FG001|Overall Study|Adverse Event|6|||
163028831|NCT02339155|588808776|FG000|Overall Study|Death|1|||
163028832|NCT02339155|588808777|FG001|Overall Study|Death|1|||
163028833|NCT02339155|588808776|FG000|Overall Study|Lost to Follow-up|8|||
163028834|NCT02339155|588808777|FG001|Overall Study|Lost to Follow-up|9|||
163028835|NCT02339155|588808776|FG000|Overall Study|Physician Decision|2|||
163028836|NCT02339155|588808777|FG001|Overall Study|Physician Decision|1|||
163028837|NCT02339155|588808776|FG000|Overall Study|Withdrawal by Subject|4|||
163028838|NCT02339155|588808777|FG001|Overall Study|Withdrawal by Subject|4|||
163028839|NCT03226678|588808784|FG000|Part A (Core Study Phase)|Adverse Event|0|||
163028840|NCT03226678|588808785|FG001|Part A (Core Study Phase)|Adverse Event|1|||
163028841|NCT03226678|588808786|FG002|Part A (Core Study Phase)|Adverse Event|0|||
163028842|NCT03226678|588808787|FG003|Part A (Core Study Phase)|Adverse Event|0|||
163028843|NCT03226678|588808788|FG004|Part A (Core Study Phase)|Adverse Event|0|||
163028844|NCT03226678|588808789|FG005|Part A (Core Study Phase)|Adverse Event|0|||
163028845|NCT03226678|588808784|FG000|Part A (Core Study Phase)|Death|0|||
163028846|NCT03226678|588808785|FG001|Part A (Core Study Phase)|Death|0|||
163028847|NCT03226678|588808786|FG002|Part A (Core Study Phase)|Death|1|||
163028848|NCT03226678|588808787|FG003|Part A (Core Study Phase)|Death|0|||
163028849|NCT03226678|588808788|FG004|Part A (Core Study Phase)|Death|0|||
163028850|NCT03226678|588808789|FG005|Part A (Core Study Phase)|Death|0|||
163028851|NCT03226678|588808784|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
163028852|NCT03226678|588808785|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
163028853|NCT03226678|588808786|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
163028854|NCT03226678|588808787|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
163028855|NCT03226678|588808788|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
163076372|NCT04518410|588986956|FG013|Overall Study|Other|0|||
163076373|NCT04518410|588986957|FG014|Overall Study|Other|0|||
163076374|NCT04518410|588986958|FG015|Overall Study|Other|3|||
163076375|NCT04518410|588986959|FG016|Overall Study|Other|1|||
163076376|NCT04518410|588986960|FG017|Overall Study|Other|1|||
163331781|NCT05260437|589925566|FG002|Overall Study|Vaccine Not Administered|0|||
163331782|NCT05260437|589925567|FG003|Overall Study|Vaccine Not Administered|0|||
163331783|NCT05260437|589925568|FG004|Overall Study|Vaccine Not Administered|0|||
163331784|NCT00910962|589925569|FG000|Overall Study|Adverse Event|5|||
163331785|NCT00910962|589925570|FG001|Overall Study|Adverse Event|20|||
163331786|NCT00910962|589925571|FG002|Overall Study|Adverse Event|17|||
163331787|NCT00910962|589925569|FG000|Overall Study|Protocol Violation|1|||
163331788|NCT00910962|589925570|FG001|Overall Study|Protocol Violation|3|||
163331789|NCT00910962|589925571|FG002|Overall Study|Protocol Violation|3|||
163331790|NCT00910962|589925569|FG000|Overall Study|Lost to Follow-up|0|||
163331791|NCT00910962|589925570|FG001|Overall Study|Lost to Follow-up|3|||
163331792|NCT00910962|589925571|FG002|Overall Study|Lost to Follow-up|1|||
163331793|NCT00910962|589925569|FG000|Overall Study|Physician Decision|0|||
163331794|NCT00910962|589925570|FG001|Overall Study|Physician Decision|6|||
163331795|NCT00910962|589925571|FG002|Overall Study|Physician Decision|6|||
163331796|NCT00910962|589925569|FG000|Overall Study|Withdrawal by Subject|25|||
163331797|NCT00910962|589925570|FG001|Overall Study|Withdrawal by Subject|32|||
163331798|NCT00910962|589925571|FG002|Overall Study|Withdrawal by Subject|32|||
163331799|NCT00910962|589925569|FG000|Overall Study|Reached defined stopping criteria|12|||
163331800|NCT00910962|589925570|FG001|Overall Study|Reached defined stopping criteria|14|||
163331801|NCT00910962|589925571|FG002|Overall Study|Reached defined stopping criteria|17|||
163331802|NCT00195819|589925572|FG000|Double-Blind|Withdrawal by Subject|1|||
163331803|NCT00195819|589925573|FG001|Double-Blind|Withdrawal by Subject|0|||
163331804|NCT00195819|589925572|FG000|Double-Blind|Moved|1|||
163076377|NCT04518410|588986961|FG018|Overall Study|Other|1|||
163076378|NCT04518410|588986962|FG019|Overall Study|Other|0|||
163076379|NCT04518410|588986963|FG020|Overall Study|Other|1|||
163076380|NCT04518410|588986964|FG021|Overall Study|Other|0|||
163076381|NCT04518410|588986965|FG022|Overall Study|Other|1|||
163076382|NCT04518410|588986966|FG023|Overall Study|Other|2|||
163076383|NCT04518410|588986967|FG024|Overall Study|Other|2|||
163076384|NCT04518410|588986943|FG000|Overall Study|Protocol Violation|0|||
163076385|NCT04518410|588986944|FG001|Overall Study|Protocol Violation|0|||
163076386|NCT04518410|588986945|FG002|Overall Study|Protocol Violation|0|||
163076387|NCT04518410|588986946|FG003|Overall Study|Protocol Violation|2|||
163076388|NCT04518410|588986947|FG004|Overall Study|Protocol Violation|17|||
163076389|NCT04518410|588986948|FG005|Overall Study|Protocol Violation|1|||
163076390|NCT04518410|588986949|FG006|Overall Study|Protocol Violation|2|||
163076391|NCT04518410|588986950|FG007|Overall Study|Protocol Violation|1|||
163076392|NCT04518410|588986951|FG008|Overall Study|Protocol Violation|0|||
163076393|NCT04518410|588986952|FG009|Overall Study|Protocol Violation|0|||
163076394|NCT04518410|588986953|FG010|Overall Study|Protocol Violation|0|||
163076395|NCT04518410|588986954|FG011|Overall Study|Protocol Violation|0|||
163076396|NCT04518410|588986955|FG012|Overall Study|Protocol Violation|0|||
163076397|NCT04518410|588986956|FG013|Overall Study|Protocol Violation|0|||
163076398|NCT04518410|588986957|FG014|Overall Study|Protocol Violation|0|||
163331805|NCT00195819|589925573|FG001|Double-Blind|Moved|0|||
163331806|NCT00195819|589925572|FG000|Open-label|Adverse Event|0|||
163331807|NCT00195819|589925573|FG001|Open-label|Adverse Event|9|||
163331808|NCT00195819|589925572|FG000|Open-label|Lack of Efficacy|0|||
163331809|NCT00195819|589925573|FG001|Open-label|Lack of Efficacy|2|||
163076399|NCT04518410|588986958|FG015|Overall Study|Protocol Violation|0|||
163076400|NCT04518410|588986959|FG016|Overall Study|Protocol Violation|1|||
163076401|NCT04518410|588986960|FG017|Overall Study|Protocol Violation|1|||
163331810|NCT00195819|589925572|FG000|Open-label|Pregnancy|0|||
163076402|NCT04518410|588986961|FG018|Overall Study|Protocol Violation|0|||
163076403|NCT04518410|588986962|FG019|Overall Study|Protocol Violation|0|||
163076404|NCT04518410|588986963|FG020|Overall Study|Protocol Violation|1|||
163076405|NCT04518410|588986964|FG021|Overall Study|Protocol Violation|2|||
163076406|NCT04518410|588986965|FG022|Overall Study|Protocol Violation|0|||
163076407|NCT04518410|588986966|FG023|Overall Study|Protocol Violation|3|||
163076408|NCT04518410|588986967|FG024|Overall Study|Protocol Violation|0|||
163076409|NCT04518410|588986943|FG000|Overall Study|Death|0|||
163076410|NCT04518410|588986944|FG001|Overall Study|Death|0|||
163076411|NCT04518410|588986945|FG002|Overall Study|Death|0|||
163076412|NCT04518410|588986946|FG003|Overall Study|Death|0|||
163076413|NCT04518410|588986947|FG004|Overall Study|Death|12|||
163331811|NCT00195819|589925573|FG001|Open-label|Pregnancy|1|||
163331812|NCT00195819|589925572|FG000|Open-label|Protocol Violation|0|||
163331813|NCT00195819|589925573|FG001|Open-label|Protocol Violation|2|||
163331814|NCT00195819|589925572|FG000|Open-label|Moved|0|||
163331815|NCT00195819|589925573|FG001|Open-label|Moved|1|||
163331816|NCT00195819|589925572|FG000|Open-label|Withdrawal by Subject|0|||
163331817|NCT00195819|589925573|FG001|Open-label|Withdrawal by Subject|5|||
163331818|NCT00787176|589925574|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
163331819|NCT00787176|589925575|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
163331820|NCT00787176|589925576|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
163331821|NCT00787176|589925577|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
163076414|NCT04518410|588986948|FG005|Overall Study|Death|2|||
163076415|NCT04518410|588986949|FG006|Overall Study|Death|11|||
163076416|NCT04518410|588986950|FG007|Overall Study|Death|0|||
163406414|NCT01783678|590198626|FG005|Overall Study|Lost to Follow-up|0|||
163076417|NCT04518410|588986951|FG008|Overall Study|Death|1|||
163076418|NCT04518410|588986952|FG009|Overall Study|Death|0|||
163076419|NCT04518410|588986953|FG010|Overall Study|Death|0|||
163076420|NCT04518410|588986954|FG011|Overall Study|Death|0|||
163076421|NCT04518410|588986955|FG012|Overall Study|Death|0|||
163076422|NCT04518410|588986956|FG013|Overall Study|Death|1|||
163076423|NCT04518410|588986957|FG014|Overall Study|Death|1|||
163076424|NCT04518410|588986958|FG015|Overall Study|Death|0|||
163076425|NCT04518410|588986959|FG016|Overall Study|Death|0|||
163076426|NCT04518410|588986960|FG017|Overall Study|Death|1|||
163076427|NCT04518410|588986961|FG018|Overall Study|Death|4|||
163076428|NCT04518410|588986962|FG019|Overall Study|Death|4|||
163076429|NCT04518410|588986963|FG020|Overall Study|Death|1|||
163076430|NCT04518410|588986964|FG021|Overall Study|Death|0|||
163076431|NCT04518410|588986965|FG022|Overall Study|Death|0|||
163076432|NCT04518410|588986966|FG023|Overall Study|Death|0|||
163076433|NCT04518410|588986967|FG024|Overall Study|Death|0|||
163076434|NCT04518410|588986943|FG000|Overall Study|Requirement to start alternative therapy|0|||
163076435|NCT04518410|588986944|FG001|Overall Study|Requirement to start alternative therapy|0|||
163076436|NCT04518410|588986945|FG002|Overall Study|Requirement to start alternative therapy|1|||
163076437|NCT04518410|588986946|FG003|Overall Study|Requirement to start alternative therapy|0|||
163076438|NCT04518410|588986947|FG004|Overall Study|Requirement to start alternative therapy|0|||
163076439|NCT04518410|588986948|FG005|Overall Study|Requirement to start alternative therapy|0|||
163076440|NCT04518410|588986949|FG006|Overall Study|Requirement to start alternative therapy|0|||
163076441|NCT04518410|588986950|FG007|Overall Study|Requirement to start alternative therapy|0|||
163076442|NCT04518410|588986951|FG008|Overall Study|Requirement to start alternative therapy|0|||
163076443|NCT04518410|588986952|FG009|Overall Study|Requirement to start alternative therapy|0|||
163076444|NCT04518410|588986953|FG010|Overall Study|Requirement to start alternative therapy|0|||
163076445|NCT04518410|588986954|FG011|Overall Study|Requirement to start alternative therapy|0|||
163076446|NCT04518410|588986955|FG012|Overall Study|Requirement to start alternative therapy|0|||
163076447|NCT04518410|588986956|FG013|Overall Study|Requirement to start alternative therapy|0|||
163076448|NCT04518410|588986957|FG014|Overall Study|Requirement to start alternative therapy|0|||
163076449|NCT04518410|588986958|FG015|Overall Study|Requirement to start alternative therapy|0|||
163076450|NCT04518410|588986959|FG016|Overall Study|Requirement to start alternative therapy|0|||
163076451|NCT04518410|588986960|FG017|Overall Study|Requirement to start alternative therapy|0|||
163076452|NCT04518410|588986961|FG018|Overall Study|Requirement to start alternative therapy|0|||
163076453|NCT04518410|588986962|FG019|Overall Study|Requirement to start alternative therapy|0|||
163076454|NCT04518410|588986963|FG020|Overall Study|Requirement to start alternative therapy|0|||
163076455|NCT04518410|588986964|FG021|Overall Study|Requirement to start alternative therapy|0|||
163076456|NCT04518410|588986965|FG022|Overall Study|Requirement to start alternative therapy|0|||
163076457|NCT04518410|588986966|FG023|Overall Study|Requirement to start alternative therapy|0|||
163076458|NCT04518410|588986967|FG024|Overall Study|Requirement to start alternative therapy|0|||
163218701|NCT01577758|589515878|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
163076459|NCT04518410|588986943|FG000|Overall Study|Randomized but not treated|0|||
163076460|NCT04518410|588986944|FG001|Overall Study|Randomized but not treated|0|||
163076461|NCT04518410|588986945|FG002|Overall Study|Randomized but not treated|0|||
163076462|NCT04518410|588986946|FG003|Overall Study|Randomized but not treated|2|||
163076463|NCT04518410|588986947|FG004|Overall Study|Randomized but not treated|6|||
163076464|NCT04518410|588986948|FG005|Overall Study|Randomized but not treated|4|||
163076465|NCT04518410|588986949|FG006|Overall Study|Randomized but not treated|3|||
163076466|NCT04518410|588986950|FG007|Overall Study|Randomized but not treated|3|||
163076467|NCT04518410|588986951|FG008|Overall Study|Randomized but not treated|0|||
163076468|NCT04518410|588986952|FG009|Overall Study|Randomized but not treated|4|||
163076469|NCT04518410|588986953|FG010|Overall Study|Randomized but not treated|0|||
163076470|NCT04518410|588986954|FG011|Overall Study|Randomized but not treated|0|||
163076471|NCT04518410|588986955|FG012|Overall Study|Randomized but not treated|1|||
163076472|NCT04518410|588986956|FG013|Overall Study|Randomized but not treated|3|||
163076473|NCT04518410|588986957|FG014|Overall Study|Randomized but not treated|3|||
163076474|NCT04518410|588986958|FG015|Overall Study|Randomized but not treated|3|||
163076475|NCT04518410|588986959|FG016|Overall Study|Randomized but not treated|4|||
163076476|NCT04518410|588986960|FG017|Overall Study|Randomized but not treated|5|||
163218702|NCT01577758|589515879|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
163076477|NCT04518410|588986961|FG018|Overall Study|Randomized but not treated|4|||
163076478|NCT04518410|588986962|FG019|Overall Study|Randomized but not treated|0|||
163076479|NCT04518410|588986963|FG020|Overall Study|Randomized but not treated|0|||
163218703|NCT01577758|589515880|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
163218704|NCT01577758|589515881|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
163218705|NCT01577758|589515882|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
163218706|NCT01577758|589515883|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
163218707|NCT01577758|589515876|FG000|mCRC Expansion Phase|Progression Disease|0|||
163218708|NCT01577758|589515877|FG001|mCRC Expansion Phase|Progression Disease|0|||
163218709|NCT01577758|589515878|FG002|mCRC Expansion Phase|Progression Disease|0|||
163331822|NCT01124045|589925578|FG000|Overall Study|Lost to Follow-up|0|||
163331823|NCT01124045|589925579|FG001|Overall Study|Lost to Follow-up|1|||
163331824|NCT01124045|589925578|FG000|Overall Study|Physician Decision|0|||
163331825|NCT01124045|589925579|FG001|Overall Study|Physician Decision|2|||
163331826|NCT03298087|589925585|FG000|Overall Study|Withdrawal by Subject|4|||
163331827|NCT01079806|589925586|FG000|Day 1 to Week 96|Adverse Event|0|||
163331828|NCT01079806|589925587|FG001|Day 1 to Week 96|Adverse Event|3|||
163331829|NCT01079806|589925586|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
163331830|NCT01079806|589925587|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
163331831|NCT01079806|589925586|FG000|Day 1 to Week 96|Pregnancy|0|||
163331832|NCT01079806|589925587|FG001|Day 1 to Week 96|Pregnancy|1|||
163331833|NCT01079806|589925586|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
163331834|NCT01079806|589925587|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
163331835|NCT01079806|589925586|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
163331836|NCT01079806|589925587|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
163331837|NCT01079806|589925586|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
163331838|NCT01079806|589925587|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
163331839|NCT01079806|589925586|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
163331840|NCT01079806|589925587|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
163331841|NCT01079806|589925586|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
163331842|NCT01079806|589925587|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
163331843|NCT01079806|589925586|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
163331844|NCT01079806|589925587|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
163331845|NCT01079806|589925586|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
163406415|NCT01783678|590198621|FG000|Overall Study|Withdrew Consent|1|||
163406416|NCT01783678|590198622|FG001|Overall Study|Withdrew Consent|1|||
163076480|NCT04518410|588986964|FG021|Overall Study|Randomized but not treated|5|||
163076481|NCT04518410|588986965|FG022|Overall Study|Randomized but not treated|0|||
163076482|NCT04518410|588986966|FG023|Overall Study|Randomized but not treated|3|||
163076483|NCT04518410|588986967|FG024|Overall Study|Randomized but not treated|1|||
163076484|NCT04518410|588986943|FG000|Overall Study|Screen Fail but Randomized|0|||
163076485|NCT04518410|588986944|FG001|Overall Study|Screen Fail but Randomized|0|||
163076486|NCT04518410|588986945|FG002|Overall Study|Screen Fail but Randomized|0|||
163076487|NCT04518410|588986946|FG003|Overall Study|Screen Fail but Randomized|0|||
163076488|NCT04518410|588986947|FG004|Overall Study|Screen Fail but Randomized|2|||
163076489|NCT04518410|588986948|FG005|Overall Study|Screen Fail but Randomized|0|||
163076490|NCT04518410|588986949|FG006|Overall Study|Screen Fail but Randomized|0|||
163076491|NCT04518410|588986950|FG007|Overall Study|Screen Fail but Randomized|0|||
163076492|NCT04518410|588986951|FG008|Overall Study|Screen Fail but Randomized|0|||
163076493|NCT04518410|588986952|FG009|Overall Study|Screen Fail but Randomized|0|||
163076494|NCT04518410|588986953|FG010|Overall Study|Screen Fail but Randomized|0|||
163076495|NCT04518410|588986954|FG011|Overall Study|Screen Fail but Randomized|0|||
163076496|NCT04518410|588986955|FG012|Overall Study|Screen Fail but Randomized|0|||
163076497|NCT04518410|588986956|FG013|Overall Study|Screen Fail but Randomized|0|||
163076498|NCT04518410|588986957|FG014|Overall Study|Screen Fail but Randomized|0|||
163076499|NCT04518410|588986958|FG015|Overall Study|Screen Fail but Randomized|0|||
163076500|NCT04518410|588986959|FG016|Overall Study|Screen Fail but Randomized|0|||
163076501|NCT04518410|588986960|FG017|Overall Study|Screen Fail but Randomized|0|||
163076502|NCT04518410|588986961|FG018|Overall Study|Screen Fail but Randomized|0|||
163076503|NCT04518410|588986962|FG019|Overall Study|Screen Fail but Randomized|0|||
163076504|NCT04518410|588986963|FG020|Overall Study|Screen Fail but Randomized|0|||
163076505|NCT04518410|588986964|FG021|Overall Study|Screen Fail but Randomized|0|||
163076506|NCT04518410|588986965|FG022|Overall Study|Screen Fail but Randomized|0|||
163076507|NCT04518410|588986966|FG023|Overall Study|Screen Fail but Randomized|0|||
163076508|NCT04518410|588986967|FG024|Overall Study|Screen Fail but Randomized|0|||
163076509|NCT04518410|588986943|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
163076510|NCT04518410|588986944|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
163076511|NCT04518410|588986945|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
163076512|NCT04518410|588986946|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
163076513|NCT04518410|588986947|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
163331846|NCT01079806|589925587|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
163331847|NCT03739866|589925593|FG000|Overall Study|Lost to Follow-up|0|||
163406417|NCT01783678|590198623|FG002|Overall Study|Withdrew Consent|0|||
163076514|NCT04518410|588986948|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
163076515|NCT04518410|588986949|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
163076516|NCT04518410|588986950|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
163154803|NCT00521079|589281440|FG000|Overall Study|Withdrawal by Subject|5|||
163331848|NCT03739866|589925594|FG001|Overall Study|Lost to Follow-up|0|||
163406418|NCT01783678|590198624|FG003|Overall Study|Withdrew Consent|2|||
163218710|NCT01577758|589515879|FG003|mCRC Expansion Phase|Progression Disease|0|||
163218711|NCT01577758|589515880|FG004|mCRC Expansion Phase|Progression Disease|0|||
163406419|NCT01783678|590198625|FG004|Overall Study|Withdrew Consent|0|||
163406420|NCT01783678|590198626|FG005|Overall Study|Withdrew Consent|0|||
163076517|NCT04518410|588986951|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
163076518|NCT04518410|588986952|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
163076519|NCT04518410|588986953|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
163076520|NCT04518410|588986954|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
163076521|NCT04518410|588986955|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
163076522|NCT04518410|588986956|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
163076523|NCT04518410|588986957|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
163076524|NCT04518410|588986958|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
163076525|NCT04518410|588986959|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
163076526|NCT04518410|588986960|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
163076527|NCT04518410|588986961|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
163076528|NCT04518410|588986962|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
163076529|NCT04518410|588986963|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
163076530|NCT04518410|588986964|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
163076531|NCT04518410|588986965|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
163076532|NCT04518410|588986966|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
163076533|NCT04518410|588986967|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
163076534|NCT04518410|588986943|FG000|Overall Study|Dual Enrolled Subject|0|||
163076535|NCT04518410|588986944|FG001|Overall Study|Dual Enrolled Subject|0|||
163076536|NCT04518410|588986945|FG002|Overall Study|Dual Enrolled Subject|0|||
163076537|NCT04518410|588986946|FG003|Overall Study|Dual Enrolled Subject|0|||
163076538|NCT04518410|588986947|FG004|Overall Study|Dual Enrolled Subject|0|||
163076539|NCT04518410|588986948|FG005|Overall Study|Dual Enrolled Subject|0|||
163076540|NCT04518410|588986949|FG006|Overall Study|Dual Enrolled Subject|0|||
163076541|NCT04518410|588986950|FG007|Overall Study|Dual Enrolled Subject|0|||
163076542|NCT04518410|588986951|FG008|Overall Study|Dual Enrolled Subject|0|||
163076543|NCT04518410|588986952|FG009|Overall Study|Dual Enrolled Subject|0|||
163076544|NCT04518410|588986953|FG010|Overall Study|Dual Enrolled Subject|0|||
163076545|NCT04518410|588986954|FG011|Overall Study|Dual Enrolled Subject|0|||
163076546|NCT04518410|588986955|FG012|Overall Study|Dual Enrolled Subject|0|||
163076547|NCT04518410|588986956|FG013|Overall Study|Dual Enrolled Subject|0|||
163076548|NCT04518410|588986957|FG014|Overall Study|Dual Enrolled Subject|0|||
163076549|NCT04518410|588986958|FG015|Overall Study|Dual Enrolled Subject|0|||
163076550|NCT04518410|588986959|FG016|Overall Study|Dual Enrolled Subject|0|||
163076551|NCT04518410|588986960|FG017|Overall Study|Dual Enrolled Subject|1|||
163076552|NCT04518410|588986961|FG018|Overall Study|Dual Enrolled Subject|0|||
163076553|NCT04518410|588986962|FG019|Overall Study|Dual Enrolled Subject|0|||
163076554|NCT04518410|588986963|FG020|Overall Study|Dual Enrolled Subject|0|||
163076555|NCT04518410|588986964|FG021|Overall Study|Dual Enrolled Subject|0|||
163076556|NCT04518410|588986965|FG022|Overall Study|Dual Enrolled Subject|0|||
163218712|NCT01577758|589515881|FG005|mCRC Expansion Phase|Progression Disease|0|||
163218713|NCT01577758|589515882|FG006|mCRC Expansion Phase|Progression Disease|0|||
163218714|NCT01577758|589515883|FG007|mCRC Expansion Phase|Progression Disease|19|||
163218715|NCT04969224|589515888|FG000|Overall Study|Adverse Event|1|||
163218716|NCT04969224|589515888|FG000|Overall Study|Enrolled but never dosed|1|||
163218717|NCT02726074|589515892|FG000|Overall Study|Withdrawal by Subject|4|||
163218718|NCT02726074|589515892|FG000|Overall Study|Adverse Event|14|||
163406421|NCT01408147|590198627|FG000|Overall Study|Withdrawal by Subject|0|||
163406422|NCT01408147|590198628|FG001|Overall Study|Withdrawal by Subject|1|||
163076557|NCT04518410|588986966|FG023|Overall Study|Dual Enrolled Subject|0|||
163076558|NCT04518410|588986967|FG024|Overall Study|Dual Enrolled Subject|0|||
163076559|NCT05737745|588986968|FG000|Overall Study|Withdrawal by Subject|0|||
163076560|NCT05737745|588986969|FG001|Overall Study|Withdrawal by Subject|6|||
163076561|NCT05737745|588986970|FG002|Overall Study|Withdrawal by Subject|1|||
163076562|NCT02569242|588986971|FG000|Overall Study|Death|1|||
163076563|NCT02569242|588986972|FG001|Overall Study|Death|0|||
163076564|NCT02569242|588986971|FG000|Overall Study|Withdrawal by Subject|0|||
163076565|NCT02569242|588986972|FG001|Overall Study|Withdrawal by Subject|1|||
163076566|NCT02057666|588986973|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
163218719|NCT02726074|589515892|FG000|Overall Study|Protocol Violation|3|||
163076567|NCT02057666|588986974|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
163076568|NCT02057666|588986973|FG000|Double Blind Treatment Period|Poor tolerability|7|||
163076569|NCT02057666|588986974|FG001|Double Blind Treatment Period|Poor tolerability|2|||
163076570|NCT02057666|588986973|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
163076571|NCT02057666|588986974|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
163076572|NCT02057666|588986973|FG000|Double Blind Treatment Period|Physician Decision|1|||
163076573|NCT02057666|588986974|FG001|Double Blind Treatment Period|Physician Decision|0|||
163076574|NCT02057666|588986973|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
163076575|NCT02057666|588986974|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
163076576|NCT02057666|588986973|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
163076577|NCT02057666|588986974|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
163076578|NCT02057666|588986973|FG000|Double Blind Treatment Period|Sponsor's request|70|||
163076579|NCT02057666|588986974|FG001|Double Blind Treatment Period|Sponsor's request|34|||
163076580|NCT02057666|588986973|FG000|Open-Label Treatment Period|Poor tolerability|0|||
163076581|NCT02057666|588986974|FG001|Open-Label Treatment Period|Poor tolerability|1|||
163076582|NCT02057666|588986973|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
163076583|NCT02057666|588986974|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
163076584|NCT02057666|588986973|FG000|Open-Label Treatment Period|Sponsor's request|0|||
163076585|NCT02057666|588986974|FG001|Open-Label Treatment Period|Sponsor's request|4|||
163076586|NCT05661734|588986975|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
163076587|NCT05661734|588986975|FG000|Overall Study|Lost to Follow-up|13|||
163076588|NCT05661734|588986975|FG000|Overall Study|Enrolled but not dosed|2|||
163076589|NCT01348490|588986980|FG000|Overall Study|Death|1|||
163076590|NCT01348490|588986980|FG000|Overall Study|Adverse Event|3|||
163076591|NCT01348490|588986980|FG000|Overall Study|Consent withdrawn|7|||
163076592|NCT01348490|588986980|FG000|Overall Study|Disease progression|3|||
163076593|NCT01348490|588986980|FG000|Overall Study|Lost to Follow-up|1|||
163076594|NCT01348490|588986980|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
163076595|NCT01348490|588986980|FG000|Overall Study|Other Unspecified|8|||
163076596|NCT00300495|588986981|FG000|Overall Study|Protocol Violation|4|||
163076597|NCT00300495|588986982|FG001|Overall Study|Protocol Violation|1|||
163076598|NCT02487199|588986985|FG000|Overall Study|Withdrew Consent|0|||
163076599|NCT02487199|588986986|FG001|Overall Study|Withdrew Consent|1|||
163076600|NCT00286455|588986987|FG000|Overall Study|Hyperglycemia rescue|19|||
163076601|NCT00286455|588986988|FG001|Overall Study|Hyperglycemia rescue|13|||
163076602|NCT00286455|588986989|FG002|Overall Study|Hyperglycemia rescue|10|||
163076603|NCT00286455|588986987|FG000|Overall Study|Adverse Event|1|||
163076604|NCT00286455|588986988|FG001|Overall Study|Adverse Event|3|||
163076605|NCT00286455|588986989|FG002|Overall Study|Adverse Event|2|||
163076606|NCT00286455|588986987|FG000|Overall Study|Lost to Follow-up|0|||
163076607|NCT00286455|588986988|FG001|Overall Study|Lost to Follow-up|3|||
163076608|NCT00286455|588986989|FG002|Overall Study|Lost to Follow-up|3|||
163076609|NCT00286455|588986987|FG000|Overall Study|Physician Decision|3|||
163076610|NCT00286455|588986988|FG001|Overall Study|Physician Decision|0|||
163076611|NCT00286455|588986989|FG002|Overall Study|Physician Decision|2|||
163076612|NCT00286455|588986987|FG000|Overall Study|Protocol Violation|1|||
163076613|NCT00286455|588986988|FG001|Overall Study|Protocol Violation|1|||
163076614|NCT00286455|588986989|FG002|Overall Study|Protocol Violation|0|||
163076615|NCT00286455|588986987|FG000|Overall Study|Participant Non-compliance|1|||
163076616|NCT00286455|588986988|FG001|Overall Study|Participant Non-compliance|0|||
163076617|NCT00286455|588986989|FG002|Overall Study|Participant Non-compliance|0|||
163076618|NCT00286455|588986987|FG000|Overall Study|Withdrawal by Subject|0|||
163076619|NCT00286455|588986988|FG001|Overall Study|Withdrawal by Subject|8|||
163076620|NCT00286455|588986989|FG002|Overall Study|Withdrawal by Subject|7|||
163076621|NCT01213251|588988965|FG000|Overall Study|Death|2|||
163076622|NCT01213251|588988966|FG001|Overall Study|Death|1|||
163076623|NCT01213251|588988967|FG002|Overall Study|Death|2|||
163076624|NCT01213251|588988965|FG000|Overall Study|Exit|3|||
163076625|NCT01213251|588988966|FG001|Overall Study|Exit|2|||
163076626|NCT01213251|588988967|FG002|Overall Study|Exit|8|||
163076627|NCT01213251|588988965|FG000|Overall Study|Protocol Violation|1|||
163076628|NCT01213251|588988966|FG001|Overall Study|Protocol Violation|1|||
163218720|NCT02726074|589515892|FG000|Overall Study|Lost to Follow-up|2|||
163218721|NCT02726074|589515892|FG000|Overall Study|Others|3|||
163076629|NCT01213251|588988967|FG002|Overall Study|Protocol Violation|0|||
163218722|NCT00579826|589515893|FG000|Overall Study|Withdrawal by Subject|5|||
163218723|NCT00579826|589515894|FG001|Overall Study|Withdrawal by Subject|3|||
163076630|NCT01213251|588988965|FG000|Overall Study|Missed 18-Month Follow-up|0|||
163076631|NCT01213251|588988966|FG001|Overall Study|Missed 18-Month Follow-up|0|||
163076632|NCT01213251|588988967|FG002|Overall Study|Missed 18-Month Follow-up|1|||
163076633|NCT02933151|588988968|FG000|Overall Study|Lost to Follow-up|19|||
163076634|NCT02933151|588988969|FG001|Overall Study|Lost to Follow-up|18|||
163076635|NCT02933151|588988968|FG000|Overall Study|Death|1732|||
163076636|NCT02933151|588988969|FG001|Overall Study|Death|1827|||
163076637|NCT02933151|588988968|FG000|Overall Study|Transplant|210|||
163076638|NCT02933151|588988969|FG001|Overall Study|Transplant|278|||
163028856|NCT03226678|588808789|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
163076639|NCT02933151|588988968|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
163076640|NCT02933151|588988969|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
163076641|NCT02933151|588988968|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
163076642|NCT02933151|588988969|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
163076643|NCT02933151|588988968|FG000|Overall Study|Recovered Kidney Function|47|||
163076644|NCT02933151|588988969|FG001|Overall Study|Recovered Kidney Function|29|||
163076645|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
163076646|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
163028857|NCT03226678|588808784|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
163028858|NCT03226678|588808785|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
163028859|NCT03226678|588808786|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
163028860|NCT03226678|588808787|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
163028861|NCT03226678|588808788|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
163028862|NCT03226678|588808789|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
163028863|NCT03226678|588808784|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
163028864|NCT03226678|588808785|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
163028865|NCT03226678|588808786|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
163028866|NCT03226678|588808787|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
163028867|NCT03226678|588808788|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
163028868|NCT03226678|588808789|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
163028869|NCT03226678|588808784|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
163028870|NCT03226678|588808785|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
163028871|NCT03226678|588808786|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
163028872|NCT03226678|588808787|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
163028873|NCT03226678|588808788|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
163028874|NCT03226678|588808789|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
163028875|NCT03226678|588808784|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
163028876|NCT03226678|588808785|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
163028877|NCT03226678|588808786|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
163028878|NCT03226678|588808787|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
163028879|NCT03226678|588808788|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
163028880|NCT03226678|588808789|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
163028881|NCT03226678|588808784|FG000|Part B (Long-Term Extension Phase)|Death|0|||
163028882|NCT03226678|588808785|FG001|Part B (Long-Term Extension Phase)|Death|0|||
163028883|NCT03226678|588808786|FG002|Part B (Long-Term Extension Phase)|Death|0|||
163028884|NCT03226678|588808787|FG003|Part B (Long-Term Extension Phase)|Death|0|||
163028885|NCT03226678|588808788|FG004|Part B (Long-Term Extension Phase)|Death|0|||
163028886|NCT03226678|588808789|FG005|Part B (Long-Term Extension Phase)|Death|1|||
163028887|NCT03226678|588808784|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
163028888|NCT03226678|588808785|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
163028889|NCT03226678|588808786|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
163028890|NCT03226678|588808787|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
163028891|NCT03226678|588808788|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
163028892|NCT03226678|588808789|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
163028893|NCT03226678|588808784|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
163028894|NCT03226678|588808785|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
163028895|NCT03226678|588808786|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
163028896|NCT03226678|588808787|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
163028897|NCT03226678|588808788|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
163028898|NCT03226678|588808789|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
163028899|NCT03226678|588808784|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
163028900|NCT03226678|588808785|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
163028901|NCT03226678|588808786|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
163028902|NCT03226678|588808787|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
163028903|NCT03226678|588808788|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
163028904|NCT03226678|588808789|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
163028905|NCT05014815|588808794|FG000|Overall Study|Death|63|||
163028906|NCT05014815|588808795|FG001|Overall Study|Death|70|||
163028907|NCT05014815|588808794|FG000|Overall Study|Withdrawal by Subject|10|||
163028908|NCT05014815|588808795|FG001|Overall Study|Withdrawal by Subject|10|||
163028909|NCT05014815|588808794|FG000|Overall Study|Lost to Follow-up|4|||
163028910|NCT05014815|588808795|FG001|Overall Study|Lost to Follow-up|2|||
163028911|NCT05014815|588808794|FG000|Overall Study|Physician Decision|2|||
163028912|NCT05014815|588808795|FG001|Overall Study|Physician Decision|4|||
163028913|NCT00916344|588808804|FG000|Overall Study|Death|2|||
163028914|NCT00916344|588808804|FG000|Overall Study|ICD upgrade|1|||
163076647|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
163218724|NCT04191382|589515895|FG000|Overall Study|Withdrawal by Subject|1|||
163218725|NCT04191382|589515896|FG001|Overall Study|Withdrawal by Subject|0|||
163218726|NCT04191382|589515897|FG002|Overall Study|Withdrawal by Subject|0|||
163218727|NCT00454987|589515900|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
163028915|NCT00916344|588808804|FG000|Overall Study|Drop-out|5|||
163028916|NCT03602391|588808805|FG000|Overall Study|COVID-19|7|||
163028917|NCT03602391|588808806|FG001|Overall Study|COVID-19|6|||
163028918|NCT00108485|588808811|FG000|Overall Study|Withdrawal by Subject|3|||
163028919|NCT00108485|588808812|FG001|Overall Study|Withdrawal by Subject|0|||
163028920|NCT00108485|588808811|FG000|Overall Study|Lost to Follow-up|0|||
163028921|NCT00108485|588808812|FG001|Overall Study|Lost to Follow-up|2|||
163028922|NCT00878969|588808817|FG000|Overall Study|Physician Decision|5|||
163028923|NCT00878969|588808818|FG001|Overall Study|Physician Decision|3|||
163028924|NCT00878969|588808819|FG002|Overall Study|Physician Decision|2|||
163028925|NCT00878969|588808817|FG000|Overall Study|Withdrawal by Subject|1|||
163028926|NCT00878969|588808818|FG001|Overall Study|Withdrawal by Subject|6|||
163028927|NCT00878969|588808819|FG002|Overall Study|Withdrawal by Subject|3|||
163028928|NCT00878969|588808817|FG000|Overall Study|kidney transplant|2|||
163028929|NCT00878969|588808818|FG001|Overall Study|kidney transplant|3|||
163028930|NCT00878969|588808819|FG002|Overall Study|kidney transplant|2|||
163028931|NCT00878969|588808817|FG000|Overall Study|Adverse Event|3|||
163028932|NCT00878969|588808818|FG001|Overall Study|Adverse Event|1|||
163028933|NCT00878969|588808819|FG002|Overall Study|Adverse Event|2|||
163028934|NCT00878969|588808817|FG000|Overall Study|Lost to Follow-up|2|||
163028935|NCT00878969|588808818|FG001|Overall Study|Lost to Follow-up|1|||
163028936|NCT00878969|588808819|FG002|Overall Study|Lost to Follow-up|0|||
163028937|NCT00878969|588808817|FG000|Overall Study|Protocol Violation|2|||
163028938|NCT00878969|588808818|FG001|Overall Study|Protocol Violation|0|||
163028939|NCT00878969|588808819|FG002|Overall Study|Protocol Violation|0|||
163028940|NCT00878969|588808817|FG000|Overall Study|Death|0|||
163028941|NCT00878969|588808818|FG001|Overall Study|Death|0|||
163028942|NCT00878969|588808819|FG002|Overall Study|Death|2|||
163028943|NCT00878969|588808817|FG000|Overall Study|Pregnancy|0|||
163028944|NCT00878969|588808818|FG001|Overall Study|Pregnancy|1|||
163028945|NCT00878969|588808819|FG002|Overall Study|Pregnancy|0|||
163028946|NCT01527487|588808822|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
163028947|NCT01527487|588808823|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
163028948|NCT01527487|588808822|FG000|Overall Study|Disease Progression|4|||
163028949|NCT01527487|588808823|FG001|Overall Study|Disease Progression|1|||
163028950|NCT01527487|588808822|FG000|Overall Study|Adverse Event|1|||
163028951|NCT01527487|588808823|FG001|Overall Study|Adverse Event|1|||
163028952|NCT01527487|588808822|FG000|Overall Study|Death|0|||
163028953|NCT01527487|588808823|FG001|Overall Study|Death|1|||
163028954|NCT01384019|588808824|FG000|Overall Study|Withdrawal by Subject|3|||
163028955|NCT01384019|588808825|FG001|Overall Study|Withdrawal by Subject|0|||
163028956|NCT01384019|588808824|FG000|Overall Study|Death|1|||
163028957|NCT01384019|588808825|FG001|Overall Study|Death|0|||
163028958|NCT01384019|588808824|FG000|Overall Study|MRI refusal|6|||
163028959|NCT01384019|588808825|FG001|Overall Study|MRI refusal|6|||
163028960|NCT04489381|588808831|FG000|Overall Study|Lost to Follow-up|2|||
163028961|NCT04489381|588808832|FG001|Overall Study|Lost to Follow-up|3|||
163028962|NCT04489381|588808831|FG000|Overall Study|Withdrawal by Subject|1|||
163028963|NCT04489381|588808832|FG001|Overall Study|Withdrawal by Subject|0|||
163028964|NCT03199612|588808835|FG000|Overall Study|Adverse Event|1|||
163028965|NCT03199612|588808836|FG001|Overall Study|Adverse Event|0|||
163028966|NCT00785213|588808839|FG000|Quinine Sulfate Alone|Adverse Event|4|||
163028967|NCT00785213|588808839|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
163028968|NCT02386345|588808840|FG000|Overall Study|Not treated|14|||
163028969|NCT02386345|588808840|FG000|Overall Study|Lost to Follow-up|1|||
163028970|NCT02386345|588808840|FG000|Overall Study|Adverse Event|5|||
163028971|NCT02386345|588808840|FG000|Overall Study|Repeat Procedure|10|||
163028972|NCT02386345|588808840|FG000|Overall Study|Did not complete 12-month follow-up|72|||
163028973|NCT03448939|588808842|FG000|Overall Study|Adverse Event|5|||
163028974|NCT03448939|588808843|FG001|Overall Study|Adverse Event|1|||
163028975|NCT03448939|588808842|FG000|Overall Study|Lost to Follow-up|6|||
163028976|NCT03448939|588808843|FG001|Overall Study|Lost to Follow-up|6|||
163028977|NCT03448939|588808842|FG000|Overall Study|Pregnancy|1|||
163028978|NCT03448939|588808843|FG001|Overall Study|Pregnancy|1|||
163028979|NCT03448939|588808842|FG000|Overall Study|Withdrawal by Subject|9|||
163028980|NCT03448939|588808843|FG001|Overall Study|Withdrawal by Subject|3|||
163028981|NCT01259375|588808844|FG000|Overall Study|Adverse Event|1|||
163028982|NCT00986986|588808845|FG000|Overall Study|Lost to Follow-up|0|||
163028983|NCT00986986|588808846|FG001|Overall Study|Lost to Follow-up|1|||
163218728|NCT00454987|589515901|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
163218729|NCT00454987|589515902|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
163218730|NCT00454987|589515900|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
163218731|NCT00454987|589515901|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
163218732|NCT00454987|589515902|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
163218733|NCT00454987|589515900|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
163331849|NCT03739866|589925595|FG002|Overall Study|Lost to Follow-up|0|||
163331850|NCT03739866|589925596|FG003|Overall Study|Lost to Follow-up|1|||
163331851|NCT03739866|589925597|FG004|Overall Study|Lost to Follow-up|0|||
163331852|NCT03739866|589925598|FG005|Overall Study|Lost to Follow-up|0|||
163331853|NCT03739866|589925599|FG006|Overall Study|Lost to Follow-up|0|||
163331854|NCT03739866|589925600|FG007|Overall Study|Lost to Follow-up|0|||
163331855|NCT03739866|589925593|FG000|Overall Study|Enrolled but not treated|0|||
163331856|NCT03739866|589925594|FG001|Overall Study|Enrolled but not treated|0|||
163028984|NCT00628095|588808847|FG000|Overall Study|Adverse Event|5|||
163028985|NCT00628095|588808848|FG001|Overall Study|Adverse Event|3|||
163028986|NCT00628095|588808847|FG000|Overall Study|Lack of Efficacy|0|||
163028987|NCT00628095|588808848|FG001|Overall Study|Lack of Efficacy|3|||
163028988|NCT00628095|588808847|FG000|Overall Study|Withdrawal by Subject|2|||
163028989|NCT00628095|588808848|FG001|Overall Study|Withdrawal by Subject|0|||
163028990|NCT00628095|588808847|FG000|Overall Study|Other|0|||
163028991|NCT00628095|588808848|FG001|Overall Study|Other|1|||
163028992|NCT01043705|588808853|FG000|Overall Study|Death|28|||
163028993|NCT01043705|588808854|FG001|Overall Study|Death|60|||
163028994|NCT01043705|588808855|FG002|Overall Study|Death|26|||
163028995|NCT01043705|588808853|FG000|Overall Study|Lost to Follow-up|27|||
163028996|NCT01043705|588808854|FG001|Overall Study|Lost to Follow-up|12|||
163028997|NCT01043705|588808855|FG002|Overall Study|Lost to Follow-up|0|||
163028998|NCT01043705|588808853|FG000|Overall Study|Multiple Reasons|4|||
163028999|NCT01043705|588808854|FG001|Overall Study|Multiple Reasons|7|||
163029000|NCT01043705|588808855|FG002|Overall Study|Multiple Reasons|0|||
163029001|NCT01043705|588808853|FG000|Overall Study|Protocol Violation|2|||
163029002|NCT01043705|588808854|FG001|Overall Study|Protocol Violation|1|||
163029003|NCT01043705|588808855|FG002|Overall Study|Protocol Violation|0|||
163029004|NCT01043705|588808853|FG000|Overall Study|Withdrawal by Subject|8|||
163029005|NCT01043705|588808854|FG001|Overall Study|Withdrawal by Subject|6|||
163029006|NCT01043705|588808855|FG002|Overall Study|Withdrawal by Subject|0|||
163029007|NCT01043705|588808853|FG000|Overall Study|Site Closure|8|||
163029008|NCT01043705|588808854|FG001|Overall Study|Site Closure|0|||
163029009|NCT01043705|588808855|FG002|Overall Study|Site Closure|0|||
163029010|NCT01043705|588808853|FG000|Overall Study|Subsequent Procedure|9|||
163029011|NCT01043705|588808854|FG001|Overall Study|Subsequent Procedure|24|||
163029012|NCT01043705|588808855|FG002|Overall Study|Subsequent Procedure|29|||
163029013|NCT01043705|588808853|FG000|Overall Study|Adverse Event|0|||
163029014|NCT01043705|588808854|FG001|Overall Study|Adverse Event|2|||
163029015|NCT01043705|588808855|FG002|Overall Study|Adverse Event|0|||
163029016|NCT01043705|588808853|FG000|Overall Study|Screen Fail|21|||
163029017|NCT01043705|588808854|FG001|Overall Study|Screen Fail|0|||
163029018|NCT01043705|588808855|FG002|Overall Study|Screen Fail|0|||
163029019|NCT01043705|588808853|FG000|Overall Study|Other|0|||
163029020|NCT01043705|588808854|FG001|Overall Study|Other|19|||
163029021|NCT01043705|588808855|FG002|Overall Study|Other|25|||
163029022|NCT02003963|588808859|FG000|Overall Study|Lost to Follow-up|2|||
163029023|NCT02003963|588808860|FG001|Overall Study|Lost to Follow-up|1|||
163029024|NCT04050124|588808869|FG000|Overall Study|Death|1|||
163029025|NCT04050124|588808870|FG001|Overall Study|Death|0|||
163029026|NCT05083923|588808875|FG000|Overall Study|Adverse Event|2|||
163029027|NCT05083923|588808876|FG001|Overall Study|Adverse Event|0|||
163029028|NCT05083923|588808875|FG000|Overall Study|Lack of Efficacy|1|||
163029029|NCT05083923|588808876|FG001|Overall Study|Lack of Efficacy|3|||
163029030|NCT05083923|588808875|FG000|Overall Study|Withdrawal by Subject|2|||
163029031|NCT05083923|588808876|FG001|Overall Study|Withdrawal by Subject|6|||
163029032|NCT05083923|588808875|FG000|Overall Study|Reason Not Specified|0|||
163029033|NCT05083923|588808876|FG001|Overall Study|Reason Not Specified|1|||
163029034|NCT01785849|588808883|FG000|Overall Study|Death|7|||
163029035|NCT01785849|588808884|FG001|Overall Study|Death|9|||
163029036|NCT01785849|588808883|FG000|Overall Study|Protocol Specified Criteria|29|||
163029037|NCT01785849|588808884|FG001|Overall Study|Protocol Specified Criteria|1|||
163029038|NCT01785849|588808883|FG000|Overall Study|Withdrawal by Subject|15|||
163029039|NCT01785849|588808884|FG001|Overall Study|Withdrawal by Subject|12|||
163029040|NCT01785849|588808883|FG000|Overall Study|Sponsor Decision|0|||
163029041|NCT01785849|588808884|FG001|Overall Study|Sponsor Decision|1|||
163029042|NCT01785849|588808883|FG000|Overall Study|Lost to Follow-up|10|||
163029043|NCT01785849|588808884|FG001|Overall Study|Lost to Follow-up|11|||
163029044|NCT02880865|588808885|FG000|Overall Study|Adverse Event|1|||
163029045|NCT02880865|588808886|FG001|Overall Study|Adverse Event|0|||
163029046|NCT02880865|588808885|FG000|Overall Study|Withdrawal by Subject|0|||
163029047|NCT02880865|588808886|FG001|Overall Study|Withdrawal by Subject|2|||
163029048|NCT02880865|588808885|FG000|Overall Study|Physician Decision|0|||
163029049|NCT02880865|588808886|FG001|Overall Study|Physician Decision|1|||
163331857|NCT03739866|589925595|FG002|Overall Study|Enrolled but not treated|1|||
163029050|NCT03379753|588808887|FG000|Overall Study|Withdrawal by Subject|2|||
163029051|NCT03379753|588808888|FG001|Overall Study|Withdrawal by Subject|1|||
163029052|NCT03379753|588808887|FG000|Overall Study|not having correct procedure|1|||
163029053|NCT03379753|588808888|FG001|Overall Study|not having correct procedure|2|||
163029054|NCT03379753|588808887|FG000|Overall Study|No primary outcome|12|||
163076648|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
163076649|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
163076650|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
163076651|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
163076652|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
163076653|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
163076654|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
163076655|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
163076656|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
163076657|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
163076658|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
163076659|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
163076660|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
163076661|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
163076662|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
163076663|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
163076664|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
163076665|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
163076666|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
163076667|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
163076668|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
163076669|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
163076670|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
163076671|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
163076672|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
163076673|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
163076674|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
163076675|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
163076676|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
163076677|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
163076678|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
163076679|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
163076680|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
163076681|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
163076682|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
163076683|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
163076684|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
163076685|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
163076686|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
163076687|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
163076688|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
163076689|NCT03280615|588988974|FG000|Overall Study|Lost to Follow-up|1|||
163076690|NCT03280615|588988975|FG001|Overall Study|Lost to Follow-up|2|||
163076691|NCT03280615|588988974|FG000|Overall Study|Adverse Event|1|||
163076692|NCT03280615|588988975|FG001|Overall Study|Adverse Event|1|||
163076693|NCT03280615|588988974|FG000|Overall Study|Withdrawal by Subject|2|||
163076694|NCT03280615|588988975|FG001|Overall Study|Withdrawal by Subject|2|||
163076695|NCT00090402|588988980|FG000|Overall Study|Death|1|||
163076696|NCT00090402|588988981|FG001|Overall Study|Death|1|||
163076697|NCT00090402|588988982|FG002|Overall Study|Death|0|||
163076698|NCT00090402|588988980|FG000|Overall Study|subject moved|0|||
163076699|NCT00090402|588988981|FG001|Overall Study|subject moved|1|||
163076700|NCT00090402|588988982|FG002|Overall Study|subject moved|0|||
163076701|NCT00090402|588988980|FG000|Overall Study|stopped taking study medication|1|||
163076702|NCT00090402|588988981|FG001|Overall Study|stopped taking study medication|0|||
163076703|NCT00090402|588988982|FG002|Overall Study|stopped taking study medication|1|||
163076704|NCT01530256|588988983|FG000|Overall Study|Death|2|||
163076705|NCT00862277|588988984|FG000|Overall Study|Protocol Violation|1|||
163076706|NCT00862277|588988985|FG001|Overall Study|Protocol Violation|2|||
163331858|NCT03739866|589925596|FG003|Overall Study|Enrolled but not treated|0|||
163076707|NCT00862277|588988986|FG002|Overall Study|Protocol Violation|5|||
163076708|NCT04432298|588988989|FG000|Overall Study|Other than specified|1|||
163076709|NCT04432298|588988990|FG001|Overall Study|Other than specified|0|||
163076710|NCT04432298|588988989|FG000|Overall Study|Lost to Follow-up|0|||
163076711|NCT04432298|588988990|FG001|Overall Study|Lost to Follow-up|1|||
163076712|NCT04432298|588988989|FG000|Overall Study|Death|3|||
163076713|NCT04432298|588988990|FG001|Overall Study|Death|2|||
163076714|NCT04432298|588988989|FG000|Overall Study|Withdrawal by Subject|2|||
163331859|NCT03739866|589925597|FG004|Overall Study|Enrolled but not treated|1|||
163076715|NCT04432298|588988990|FG001|Overall Study|Withdrawal by Subject|0|||
163331860|NCT03739866|589925598|FG005|Overall Study|Enrolled but not treated|0|||
163331861|NCT03739866|589925599|FG006|Overall Study|Enrolled but not treated|0|||
163331862|NCT03739866|589925600|FG007|Overall Study|Enrolled but not treated|0|||
163331863|NCT01034306|589925601|FG000|Overall Study|Adverse Event|1|||
163331864|NCT01034306|589925602|FG001|Overall Study|Adverse Event|0|||
163331865|NCT01034306|589925601|FG000|Overall Study|Lost to Follow-up|0|||
163331866|NCT01034306|589925602|FG001|Overall Study|Lost to Follow-up|1|||
163331867|NCT01034306|589925601|FG000|Overall Study|Withdrawal by Subject|2|||
163331868|NCT01034306|589925602|FG001|Overall Study|Withdrawal by Subject|2|||
163331869|NCT01034306|589925601|FG000|Overall Study|hospitalized and decided to stop|1|||
163331870|NCT01034306|589925602|FG001|Overall Study|hospitalized and decided to stop|0|||
163331871|NCT01034306|589925601|FG000|Overall Study|Noncomplience|1|||
163331872|NCT01034306|589925602|FG001|Overall Study|Noncomplience|0|||
163331873|NCT00836498|589925603|FG000|Overall Study|Adverse Event|1|||
163331874|NCT00836498|589925604|FG001|Overall Study|Adverse Event|0|||
163076716|NCT02451007|588988993|FG000|Overall Study|Withdrawal by Subject|4|||
163076717|NCT02451007|588988993|FG000|Overall Study|Adverse Event|1|||
163076718|NCT02451007|588988993|FG000|Overall Study|Disease Progression|2|||
163076719|NCT00348374|588988994|FG000|Overall Study|Adverse Event|1|||
163076720|NCT00348374|588988995|FG001|Overall Study|Adverse Event|4|||
163076721|NCT00348374|588988994|FG000|Overall Study|Lost to Follow-up|1|||
163076722|NCT00348374|588988995|FG001|Overall Study|Lost to Follow-up|3|||
163076723|NCT00348374|588988994|FG000|Overall Study|Withdrawal by Subject|5|||
163076724|NCT00348374|588988995|FG001|Overall Study|Withdrawal by Subject|5|||
163076725|NCT00348374|588988994|FG000|Overall Study|Other|11|||
163076726|NCT00348374|588988995|FG001|Overall Study|Other|12|||
163076727|NCT00348374|588988994|FG000|Overall Study|ongoing at date of cutoff|1|||
163076728|NCT00348374|588988995|FG001|Overall Study|ongoing at date of cutoff|1|||
163076729|NCT00348374|588988994|FG000|Overall Study|randomized but did not receive treatment|0|||
163076730|NCT00348374|588988995|FG001|Overall Study|randomized but did not receive treatment|7|||
163076731|NCT02123511|588989001|FG000|Overall Study|Cancelled treatment|1|||
163076732|NCT02123511|588989002|FG001|Overall Study|Cancelled treatment|0|||
163076733|NCT02123511|588989001|FG000|Overall Study|Incomplete data|1|||
163076734|NCT02123511|588989002|FG001|Overall Study|Incomplete data|3|||
163076735|NCT02123511|588989001|FG000|Overall Study|Ineligible|0|||
163076736|NCT02123511|588989002|FG001|Overall Study|Ineligible|1|||
163076737|NCT01423084|588989003|FG000|Overall Study|Adverse Event|0|||
163076738|NCT01423084|588989004|FG001|Overall Study|Adverse Event|1|||
163076739|NCT01423084|588989003|FG000|Overall Study|Withdrawal by Subject|2|||
163076740|NCT01423084|588989004|FG001|Overall Study|Withdrawal by Subject|3|||
163076741|NCT01133977|588989008|FG000|Overall Study|Adverse Event|0|||
163076742|NCT01133977|588989009|FG001|Overall Study|Adverse Event|0|||
163076743|NCT01133977|588989010|FG002|Overall Study|Adverse Event|1|||
163076744|NCT01133977|588989011|FG003|Overall Study|Adverse Event|0|||
163076745|NCT01133977|588989012|FG004|Overall Study|Adverse Event|0|||
163076746|NCT01133977|588989008|FG000|Overall Study|Death|1|||
163076747|NCT01133977|588989009|FG001|Overall Study|Death|1|||
163076748|NCT01133977|588989010|FG002|Overall Study|Death|1|||
163076749|NCT01133977|588989011|FG003|Overall Study|Death|7|||
163076750|NCT01133977|588989012|FG004|Overall Study|Death|3|||
163076751|NCT01133977|588989008|FG000|Overall Study|Started a New Line of Therapy|2|||
163076752|NCT01133977|588989009|FG001|Overall Study|Started a New Line of Therapy|6|||
163076753|NCT01133977|588989010|FG002|Overall Study|Started a New Line of Therapy|4|||
163076754|NCT01133977|588989011|FG003|Overall Study|Started a New Line of Therapy|25|||
163076755|NCT01133977|588989012|FG004|Overall Study|Started a New Line of Therapy|33|||
163076756|NCT01133977|588989008|FG000|Overall Study|Lost to Follow-up|0|||
163076757|NCT01133977|588989009|FG001|Overall Study|Lost to Follow-up|0|||
163076758|NCT01133977|588989010|FG002|Overall Study|Lost to Follow-up|0|||
163076759|NCT01133977|588989011|FG003|Overall Study|Lost to Follow-up|2|||
163076760|NCT01133977|588989012|FG004|Overall Study|Lost to Follow-up|1|||
163076761|NCT01133977|588989008|FG000|Overall Study|Withdrawal by Subject|0|||
163076762|NCT01133977|588989009|FG001|Overall Study|Withdrawal by Subject|0|||
163076763|NCT01133977|588989010|FG002|Overall Study|Withdrawal by Subject|0|||
163076764|NCT01133977|588989011|FG003|Overall Study|Withdrawal by Subject|5|||
163076765|NCT01133977|588989012|FG004|Overall Study|Withdrawal by Subject|1|||
163076766|NCT02462057|588989013|FG000|Overall Study|Left Vitality|32|||
163076767|NCT02462057|588989014|FG001|Overall Study|Left Vitality|27|||
163076768|NCT02462057|588989015|FG002|Overall Study|Left Vitality|23|||
163076769|NCT02462057|588989016|FG003|Overall Study|Left Vitality|35|||
163076770|NCT02462057|588989017|FG004|Overall Study|Left Vitality|33|||
163331875|NCT00836498|589925603|FG000|Overall Study|Lost to Follow-up|1|||
163331876|NCT00836498|589925604|FG001|Overall Study|Lost to Follow-up|0|||
163331877|NCT00836498|589925603|FG000|Overall Study|Withdrawal by Subject|2|||
163331878|NCT00836498|589925604|FG001|Overall Study|Withdrawal by Subject|1|||
163076771|NCT02462057|588989013|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
163076772|NCT02462057|588989014|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
163076773|NCT02462057|588989015|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
163076774|NCT02462057|588989016|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
163331879|NCT03057600|589925605|FG000|Overall Study|Adverse Event|0|||
163331880|NCT03057600|589925606|FG001|Overall Study|Adverse Event|0|||
163029055|NCT03379753|588808888|FG001|Overall Study|No primary outcome|22|||
163029056|NCT01190267|588808893|FG000|Overall Study|Adverse Event|10|||
163029057|NCT01190267|588808894|FG001|Overall Study|Adverse Event|0|||
163029058|NCT01190267|588808893|FG000|Overall Study|Treatment Failure|8|||
163029059|NCT01190267|588808894|FG001|Overall Study|Treatment Failure|2|||
163029060|NCT01190267|588808893|FG000|Overall Study|Lost to Follow-up|2|||
163029061|NCT01190267|588808894|FG001|Overall Study|Lost to Follow-up|0|||
163029062|NCT01190267|588808893|FG000|Overall Study|Withdrawal by Subject|13|||
163029063|NCT01190267|588808894|FG001|Overall Study|Withdrawal by Subject|1|||
163029064|NCT01190267|588808893|FG000|Overall Study|Protocol Violation|8|||
163029065|NCT01190267|588808894|FG001|Overall Study|Protocol Violation|1|||
163029066|NCT05513703|588808898|FG000|Overall Study|Death|4|||
163029067|NCT05513703|588808898|FG000|Overall Study|Study terminated by sponsor|5|||
163029068|NCT04450407|588808906|FG000|Overall Study|Withdrawal by Subject|10|||
163029069|NCT04450407|588808907|FG001|Overall Study|Withdrawal by Subject|1|||
163029070|NCT04450407|588808908|FG002|Overall Study|Withdrawal by Subject|4|||
163029071|NCT04450407|588808906|FG000|Overall Study|Adverse Event|0|||
163029072|NCT04450407|588808907|FG001|Overall Study|Adverse Event|0|||
163029073|NCT04450407|588808908|FG002|Overall Study|Adverse Event|1|||
163029074|NCT04450407|588808906|FG000|Overall Study|Lost to Follow-up|1|||
163029075|NCT04450407|588808907|FG001|Overall Study|Lost to Follow-up|0|||
163029076|NCT04450407|588808908|FG002|Overall Study|Lost to Follow-up|0|||
163029077|NCT04450407|588808906|FG000|Overall Study|Physician Decision|0|||
163029078|NCT04450407|588808907|FG001|Overall Study|Physician Decision|0|||
163029079|NCT04450407|588808908|FG002|Overall Study|Physician Decision|1|||
163029080|NCT04450407|588808906|FG000|Overall Study|Pregnancy|1|||
163029081|NCT04450407|588808907|FG001|Overall Study|Pregnancy|0|||
163029082|NCT04450407|588808908|FG002|Overall Study|Pregnancy|0|||
163029083|NCT04450407|588808906|FG000|Overall Study|Protocol Violation|2|||
163029084|NCT04450407|588808907|FG001|Overall Study|Protocol Violation|0|||
163029085|NCT04450407|588808908|FG002|Overall Study|Protocol Violation|0|||
163029086|NCT04450407|588808906|FG000|Overall Study|Investigational site terminated by sponsor|3|||
163029087|NCT04450407|588808907|FG001|Overall Study|Investigational site terminated by sponsor|0|||
163029088|NCT04450407|588808908|FG002|Overall Study|Investigational site terminated by sponsor|2|||
163029089|NCT04696354|588808911|FG000|Overall Study|Study termination|6|||
163029090|NCT04696354|588808912|FG001|Overall Study|Study termination|6|||
163029091|NCT05741346|588810325|FG000|Overall Study|Withdrawn due to termination of study|28|||
163029092|NCT04439357|588810326|FG000|Overall Study|Disease Progression|4|||
163029093|NCT01668966|588810335|FG000|Overall Study|Withdrawal by Subject|1|||
163029094|NCT01668966|588810335|FG000|Overall Study|Death|1|||
163029095|NCT01668966|588810335|FG000|Overall Study|Not treated|2|||
163029096|NCT01573767|588810336|FG000|Overall Study|Adverse Event|0|||
163029097|NCT01573767|588810337|FG001|Overall Study|Adverse Event|1|||
163029098|NCT01573767|588810338|FG002|Overall Study|Adverse Event|0|||
163029099|NCT01573767|588810339|FG003|Overall Study|Adverse Event|1|||
163029100|NCT01573767|588810336|FG000|Overall Study|Lack of Efficacy|18|||
163029101|NCT01573767|588810337|FG001|Overall Study|Lack of Efficacy|15|||
163029102|NCT01573767|588810338|FG002|Overall Study|Lack of Efficacy|12|||
163029103|NCT01573767|588810339|FG003|Overall Study|Lack of Efficacy|17|||
163029104|NCT01573767|588810336|FG000|Overall Study|Protocol Violation|3|||
163029105|NCT01573767|588810337|FG001|Overall Study|Protocol Violation|1|||
163029106|NCT01573767|588810338|FG002|Overall Study|Protocol Violation|1|||
163029107|NCT01573767|588810339|FG003|Overall Study|Protocol Violation|3|||
163029108|NCT01573767|588810336|FG000|Overall Study|Lost to Follow-up|0|||
163029109|NCT01573767|588810337|FG001|Overall Study|Lost to Follow-up|1|||
163029110|NCT01573767|588810338|FG002|Overall Study|Lost to Follow-up|1|||
163029111|NCT01573767|588810339|FG003|Overall Study|Lost to Follow-up|1|||
163029112|NCT01573767|588810336|FG000|Overall Study|Physician Decision|1|||
163029113|NCT01573767|588810337|FG001|Overall Study|Physician Decision|2|||
163029114|NCT01573767|588810338|FG002|Overall Study|Physician Decision|0|||
163029115|NCT01573767|588810339|FG003|Overall Study|Physician Decision|2|||
163029116|NCT01573767|588810336|FG000|Overall Study|Withdrawal by Subject|0|||
163029117|NCT01573767|588810337|FG001|Overall Study|Withdrawal by Subject|1|||
163029118|NCT01573767|588810338|FG002|Overall Study|Withdrawal by Subject|0|||
163029119|NCT01573767|588810339|FG003|Overall Study|Withdrawal by Subject|0|||
163029120|NCT04247880|588810340|FG000|Overall Study|Lost to Follow-up|24|||
163029121|NCT04247880|588810341|FG001|Overall Study|Lost to Follow-up|17|||
163029122|NCT04247880|588810340|FG000|Overall Study|Withdrawal by Subject|3|||
163029123|NCT04247880|588810341|FG001|Overall Study|Withdrawal by Subject|0|||
163029124|NCT01701193|588810342|FG000|Overall Study|Withdrawal by Subject|2|||
163029125|NCT01701193|588810343|FG001|Overall Study|Withdrawal by Subject|2|||
163029126|NCT01701193|588810344|FG002|Overall Study|Withdrawal by Subject|1|||
163029127|NCT01701193|588810345|FG003|Overall Study|Withdrawal by Subject|2|||
163029128|NCT01701193|588810342|FG000|Overall Study|Adverse Event|1|||
163029129|NCT01701193|588810343|FG001|Overall Study|Adverse Event|0|||
163029130|NCT01701193|588810344|FG002|Overall Study|Adverse Event|0|||
163029131|NCT01701193|588810345|FG003|Overall Study|Adverse Event|0|||
163218734|NCT00454987|589515901|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
163218735|NCT00454987|589515902|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
163218736|NCT03054870|589515904|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
163218737|NCT03054870|589515904|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
163218738|NCT02009046|589515905|FG000|Overall Study|Lost to Follow-up|256|||
163218739|NCT02009046|589515906|FG001|Overall Study|Lost to Follow-up|206|||
163218740|NCT00003641|589515915|FG000|Overall Study|Withdrawal by Subject|0|||
163218741|NCT00003641|589515916|FG001|Overall Study|Withdrawal by Subject|100|||
163218742|NCT00003641|589515915|FG000|Overall Study|Adverse Event|0|||
163218743|NCT00003641|589515916|FG001|Overall Study|Adverse Event|38|||
163218744|NCT00003641|589515915|FG000|Overall Study|Disease progression|0|||
163218745|NCT00003641|589515916|FG001|Overall Study|Disease progression|2|||
163029132|NCT03054064|588810346|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
163029133|NCT03054064|588810346|FG000|Overall Study|Investigator Decision|2|||
163029134|NCT03054064|588810346|FG000|Overall Study|Bladder Issue|1|||
163029135|NCT03054064|588810346|FG000|Overall Study|High Blood Pressure|1|||
163029136|NCT03054064|588810346|FG000|Overall Study|Change in Status|1|||
163029137|NCT00081731|588810349|FG000|Overall Study|scientific integrity issue|8|||
163029138|NCT00081731|588810350|FG001|Overall Study|scientific integrity issue|8|||
163029139|NCT01629823|588810354|FG000|Trial Period|Missed visit|11|||
163029140|NCT01629823|588810355|FG001|Trial Period|Missed visit|9|||
163029141|NCT01629823|588810356|FG002|Trial Period|Missed visit|8|||
163029142|NCT01629823|588810354|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
163029143|NCT01629823|588810355|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
163029144|NCT01629823|588810356|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
163029145|NCT01629823|588810354|FG000|Trial Period|Pregnancy|1|||
163029146|NCT01629823|588810355|FG001|Trial Period|Pregnancy|0|||
163029147|NCT01629823|588810356|FG002|Trial Period|Pregnancy|0|||
163029148|NCT01629823|588810354|FG000|Trial Period|Adverse Event|0|||
163029149|NCT01629823|588810355|FG001|Trial Period|Adverse Event|1|||
163029150|NCT01629823|588810356|FG002|Trial Period|Adverse Event|0|||
163029151|NCT01629823|588810354|FG000|Trial Period|Out-of-window visit|0|||
163029152|NCT01629823|588810355|FG001|Trial Period|Out-of-window visit|2|||
163029153|NCT01629823|588810356|FG002|Trial Period|Out-of-window visit|0|||
163029154|NCT01629823|588810354|FG000|Trial Period|Failed to hold medication|0|||
163029155|NCT01629823|588810355|FG001|Trial Period|Failed to hold medication|0|||
163029156|NCT01629823|588810356|FG002|Trial Period|Failed to hold medication|1|||
163029157|NCT01629823|588810354|FG000|Washout Period|Safety|2|||
163029158|NCT01629823|588810355|FG001|Washout Period|Safety|5|||
163029159|NCT01629823|588810356|FG002|Washout Period|Safety|0|||
163029160|NCT01629823|588810354|FG000|Washout Period|Pregnancy|1|||
163029161|NCT01629823|588810355|FG001|Washout Period|Pregnancy|0|||
163029162|NCT01629823|588810356|FG002|Washout Period|Pregnancy|0|||
163029163|NCT01629823|588810354|FG000|Washout Period|Protocol Violation|0|||
163029164|NCT01629823|588810355|FG001|Washout Period|Protocol Violation|1|||
163029165|NCT01629823|588810356|FG002|Washout Period|Protocol Violation|0|||
163029166|NCT00526331|588810358|FG000|Overall Study|Sponsor Termination|55|||
163029167|NCT00455520|588810359|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
163029168|NCT00455520|588810360|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
163029169|NCT00455520|588810359|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
163029170|NCT00455520|588810360|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
163029171|NCT00455520|588810359|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
163029172|NCT00455520|588810360|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
163029173|NCT00455520|588810359|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
163029174|NCT00455520|588810360|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
163029175|NCT00455520|588810359|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
163029176|NCT00455520|588810360|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
163029177|NCT00455520|588810359|FG000|Open Label Tapentadol Extended Release|All other|33|||
163029178|NCT00455520|588810360|FG001|Open Label Tapentadol Extended Release|All other|0|||
163029179|NCT00455520|588810359|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
163029180|NCT00455520|588810360|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
163029181|NCT00455520|588810359|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
163029182|NCT00455520|588810360|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
163029183|NCT00455520|588810359|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
163029184|NCT00455520|588810360|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
163029185|NCT00455520|588810359|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
163029186|NCT00455520|588810360|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
163029187|NCT00455520|588810359|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
163029188|NCT00455520|588810360|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
163029189|NCT00455520|588810359|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
163029190|NCT00455520|588810360|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
163029191|NCT03973918|588810361|FG000|Overall Study|Adverse Event|0|||
163029192|NCT03973918|588810362|FG001|Overall Study|Adverse Event|0|||
163029193|NCT03973918|588810363|FG002|Overall Study|Adverse Event|0|||
163076775|NCT02462057|588989017|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
163076776|NCT01682603|588989018|FG000|Overall Study|Lost to Follow-up|3|||
163076777|NCT01791205|588989019|FG000|Phase II|Lack of Efficacy|6|||
163076778|NCT01791205|588989020|FG001|Phase II|Lack of Efficacy|0|||
163076779|NCT01791205|588989019|FG000|Phase II|Adverse Event|2|||
163076780|NCT01791205|588989020|FG001|Phase II|Adverse Event|0|||
163076781|NCT01791205|588989019|FG000|Phase II|Safety|1|||
163076782|NCT01791205|588989020|FG001|Phase II|Safety|0|||
163076783|NCT01791205|588989019|FG000|Phase II|Lost to Follow-up|1|||
163076784|NCT01791205|588989020|FG001|Phase II|Lost to Follow-up|0|||
163076785|NCT01791205|588989019|FG000|Phase II|Remission of disease|1|||
163076786|NCT01791205|588989020|FG001|Phase II|Remission of disease|0|||
163076787|NCT01791205|588989019|FG000|Phase II|Physician's decision|1|||
163076788|NCT01791205|588989020|FG001|Phase II|Physician's decision|0|||
163076789|NCT05345405|588989031|FG000|Overall Study|Withdrawal by Subject|2|||
163076790|NCT05345405|588989032|FG001|Overall Study|Withdrawal by Subject|0|||
163076791|NCT05345405|588989033|FG002|Overall Study|Withdrawal by Subject|0|||
163076792|NCT05345405|588989031|FG000|Overall Study|Did not meet eligibility criteria|0|||
163076793|NCT05345405|588989032|FG001|Overall Study|Did not meet eligibility criteria|2|||
163076794|NCT05345405|588989033|FG002|Overall Study|Did not meet eligibility criteria|0|||
163076795|NCT05345405|588989031|FG000|Overall Study|Lost to Follow-up|0|||
163076796|NCT05345405|588989032|FG001|Overall Study|Lost to Follow-up|0|||
163076797|NCT05345405|588989033|FG002|Overall Study|Lost to Follow-up|1|||
163076798|NCT04189588|588989034|FG000|Overall Study|Death|0|||
163076799|NCT04189588|588989035|FG001|Overall Study|Death|1|||
163076800|NCT04189588|588989034|FG000|Overall Study|Lost to Follow-up|0|||
163076801|NCT04189588|588989035|FG001|Overall Study|Lost to Follow-up|1|||
163076802|NCT03757715|588989038|FG000|Overall Study|Lost to Follow-up|4|||
163076803|NCT03757715|588989039|FG001|Overall Study|Lost to Follow-up|9|||
163076804|NCT03757715|588989038|FG000|Overall Study|Withdrawal by Subject|1|||
163076805|NCT03757715|588989039|FG001|Overall Study|Withdrawal by Subject|1|||
163076806|NCT00281580|588989040|FG000|Overall Study|Adverse Event|2|||
163076807|NCT00281580|588989041|FG001|Overall Study|Adverse Event|0|||
163076808|NCT00281580|588989042|FG002|Overall Study|Adverse Event|2|||
163076809|NCT00281580|588989043|FG003|Overall Study|Adverse Event|4|||
163076810|NCT00281580|588989044|FG004|Overall Study|Adverse Event|1|||
163076811|NCT00281580|588989045|FG005|Overall Study|Adverse Event|0|||
163076812|NCT00281580|588989046|FG006|Overall Study|Adverse Event|1|||
163076813|NCT00281580|588989047|FG007|Overall Study|Adverse Event|0|||
163076814|NCT00281580|588989048|FG008|Overall Study|Adverse Event|1|||
163076815|NCT00281580|588989049|FG009|Overall Study|Adverse Event|6|||
163076816|NCT00281580|588989050|FG010|Overall Study|Adverse Event|0|||
163076817|NCT00281580|588989051|FG011|Overall Study|Adverse Event|5|||
163076818|NCT00281580|588989052|FG012|Overall Study|Adverse Event|8|||
163076819|NCT00281580|588989053|FG013|Overall Study|Adverse Event|2|||
163076820|NCT00281580|588989054|FG014|Overall Study|Adverse Event|3|||
163076821|NCT00281580|588989055|FG015|Overall Study|Adverse Event|3|||
163076822|NCT00281580|588989040|FG000|Overall Study|Protocol Violation|0|||
163076823|NCT00281580|588989041|FG001|Overall Study|Protocol Violation|0|||
163076824|NCT00281580|588989042|FG002|Overall Study|Protocol Violation|1|||
163076825|NCT00281580|588989043|FG003|Overall Study|Protocol Violation|1|||
163076826|NCT00281580|588989044|FG004|Overall Study|Protocol Violation|0|||
163076827|NCT00281580|588989045|FG005|Overall Study|Protocol Violation|0|||
163029194|NCT03973918|588810364|FG003|Overall Study|Adverse Event|1|||
163029195|NCT03973918|588810361|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
163029196|NCT03973918|588810362|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
163029197|NCT03973918|588810363|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
163029198|NCT03973918|588810364|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
163029199|NCT04601103|588810367|FG000|Overall Study|Needed crown & cleaning|0|||
163029200|NCT04601103|588810368|FG001|Overall Study|Needed crown & cleaning|0|||
163029201|NCT04601103|588810369|FG002|Overall Study|Needed crown & cleaning|1|||
163029202|NCT04601103|588810367|FG000|Overall Study|study was terminated|18|||
163029203|NCT04601103|588810368|FG001|Overall Study|study was terminated|18|||
163029204|NCT04601103|588810369|FG002|Overall Study|study was terminated|16|||
163029205|NCT01068626|588810377|FG000|Overall Study|Adverse Event|3|||
163029206|NCT01068626|588810378|FG001|Overall Study|Adverse Event|0|||
163029207|NCT01068626|588810377|FG000|Overall Study|Withdrawal by Subject|0|||
163029208|NCT01068626|588810378|FG001|Overall Study|Withdrawal by Subject|2|||
163076828|NCT00281580|588989046|FG006|Overall Study|Protocol Violation|1|||
163076829|NCT00281580|588989047|FG007|Overall Study|Protocol Violation|0|||
163076830|NCT00281580|588989048|FG008|Overall Study|Protocol Violation|2|||
163076831|NCT00281580|588989049|FG009|Overall Study|Protocol Violation|0|||
163076832|NCT00281580|588989050|FG010|Overall Study|Protocol Violation|1|||
163076833|NCT00281580|588989051|FG011|Overall Study|Protocol Violation|2|||
163076834|NCT00281580|588989052|FG012|Overall Study|Protocol Violation|0|||
163076835|NCT00281580|588989053|FG013|Overall Study|Protocol Violation|1|||
163076836|NCT00281580|588989054|FG014|Overall Study|Protocol Violation|1|||
163076837|NCT00281580|588989055|FG015|Overall Study|Protocol Violation|3|||
163076838|NCT00281580|588989040|FG000|Overall Study|Withdrawal by Subject|3|||
163076839|NCT00281580|588989041|FG001|Overall Study|Withdrawal by Subject|0|||
163076840|NCT00281580|588989042|FG002|Overall Study|Withdrawal by Subject|1|||
163076841|NCT00281580|588989043|FG003|Overall Study|Withdrawal by Subject|1|||
163076842|NCT00281580|588989044|FG004|Overall Study|Withdrawal by Subject|1|||
163076843|NCT00281580|588989045|FG005|Overall Study|Withdrawal by Subject|2|||
163076844|NCT00281580|588989046|FG006|Overall Study|Withdrawal by Subject|2|||
163076845|NCT00281580|588989047|FG007|Overall Study|Withdrawal by Subject|0|||
163076846|NCT00281580|588989048|FG008|Overall Study|Withdrawal by Subject|1|||
163076847|NCT00281580|588989049|FG009|Overall Study|Withdrawal by Subject|4|||
163076848|NCT00281580|588989050|FG010|Overall Study|Withdrawal by Subject|1|||
163076849|NCT00281580|588989051|FG011|Overall Study|Withdrawal by Subject|1|||
163076850|NCT00281580|588989052|FG012|Overall Study|Withdrawal by Subject|2|||
163076851|NCT00281580|588989053|FG013|Overall Study|Withdrawal by Subject|2|||
163076852|NCT00281580|588989054|FG014|Overall Study|Withdrawal by Subject|1|||
163076853|NCT00281580|588989055|FG015|Overall Study|Withdrawal by Subject|5|||
163076854|NCT00281580|588989040|FG000|Overall Study|Lack of Efficacy|2|||
163076855|NCT00281580|588989041|FG001|Overall Study|Lack of Efficacy|1|||
163076856|NCT00281580|588989042|FG002|Overall Study|Lack of Efficacy|1|||
163076857|NCT00281580|588989043|FG003|Overall Study|Lack of Efficacy|6|||
163076858|NCT00281580|588989044|FG004|Overall Study|Lack of Efficacy|2|||
163076859|NCT00281580|588989045|FG005|Overall Study|Lack of Efficacy|0|||
163076860|NCT00281580|588989046|FG006|Overall Study|Lack of Efficacy|0|||
163076861|NCT00281580|588989047|FG007|Overall Study|Lack of Efficacy|0|||
163076862|NCT00281580|588989048|FG008|Overall Study|Lack of Efficacy|0|||
163076863|NCT00281580|588989049|FG009|Overall Study|Lack of Efficacy|0|||
163076864|NCT00281580|588989050|FG010|Overall Study|Lack of Efficacy|0|||
163076865|NCT00281580|588989051|FG011|Overall Study|Lack of Efficacy|1|||
163076866|NCT00281580|588989052|FG012|Overall Study|Lack of Efficacy|0|||
163076867|NCT00281580|588989053|FG013|Overall Study|Lack of Efficacy|2|||
163076868|NCT00281580|588989054|FG014|Overall Study|Lack of Efficacy|1|||
163076869|NCT00281580|588989055|FG015|Overall Study|Lack of Efficacy|0|||
163076870|NCT00281580|588989040|FG000|Overall Study|Lost to Follow-up|0|||
163076871|NCT00281580|588989041|FG001|Overall Study|Lost to Follow-up|0|||
163076872|NCT00281580|588989042|FG002|Overall Study|Lost to Follow-up|0|||
163076873|NCT00281580|588989043|FG003|Overall Study|Lost to Follow-up|3|||
163076874|NCT00281580|588989044|FG004|Overall Study|Lost to Follow-up|0|||
163076875|NCT00281580|588989045|FG005|Overall Study|Lost to Follow-up|1|||
163076876|NCT00281580|588989046|FG006|Overall Study|Lost to Follow-up|0|||
163076877|NCT00281580|588989047|FG007|Overall Study|Lost to Follow-up|1|||
163076878|NCT00281580|588989048|FG008|Overall Study|Lost to Follow-up|2|||
163076879|NCT00281580|588989049|FG009|Overall Study|Lost to Follow-up|1|||
163076880|NCT00281580|588989050|FG010|Overall Study|Lost to Follow-up|1|||
163076881|NCT00281580|588989051|FG011|Overall Study|Lost to Follow-up|0|||
163076882|NCT00281580|588989052|FG012|Overall Study|Lost to Follow-up|1|||
163076883|NCT00281580|588989053|FG013|Overall Study|Lost to Follow-up|0|||
163076884|NCT00281580|588989054|FG014|Overall Study|Lost to Follow-up|0|||
163076885|NCT00281580|588989055|FG015|Overall Study|Lost to Follow-up|0|||
163076886|NCT00281580|588989040|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
163076887|NCT00281580|588989041|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
163076888|NCT00281580|588989042|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
163076889|NCT00281580|588989043|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
163076890|NCT00281580|588989044|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
163076891|NCT00281580|588989045|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
163076892|NCT00281580|588989046|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
163076893|NCT00281580|588989047|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
163076894|NCT00281580|588989048|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
163076895|NCT00281580|588989049|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
163076896|NCT00281580|588989050|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
163076897|NCT00281580|588989051|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
163076898|NCT00281580|588989052|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
163076899|NCT00281580|588989053|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
163218746|NCT00003641|589515915|FG000|Overall Study|Unknown/missing|0|||
163218747|NCT00003641|589515916|FG001|Overall Study|Unknown/missing|22|||
163218748|NCT00003641|589515915|FG000|Overall Study|Should not receive interferon therapy|2|||
163218749|NCT00003641|589515916|FG001|Overall Study|Should not receive interferon therapy|0|||
163218750|NCT00003641|589515915|FG000|Overall Study|Never started interferon|567|||
163218751|NCT00003641|589515916|FG001|Overall Study|Never started interferon|12|||
163218752|NCT01082965|589515917|FG000|Overall Study|Protocol Violation|0|||
163218753|NCT01082965|589515918|FG001|Overall Study|Protocol Violation|1|||
163076900|NCT00281580|588989054|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
163076901|NCT00281580|588989055|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
163076902|NCT01122680|588989056|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
163076903|NCT01122680|588989057|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
163218754|NCT01082965|589515917|FG000|Overall Study|Other|1|||
163218755|NCT01082965|589515918|FG001|Overall Study|Other|1|||
163218756|NCT05198843|589515920|FG000|Overall Study|Lack of Efficacy|1|||
163218757|NCT00902564|589517291|FG000|Overall Study|Withdrawal by Subject|2|||
163218758|NCT02474199|589517292|FG000|Overall Study|Lost to Follow-up|1|||
163218759|NCT02474199|589517293|FG001|Overall Study|Lost to Follow-up|0|||
163218760|NCT02474199|589517294|FG002|Overall Study|Lost to Follow-up|0|||
163218761|NCT02474199|589517295|FG003|Overall Study|Lost to Follow-up|0|||
163218762|NCT02474199|589517292|FG000|Overall Study|Withdrawal by Subject|1|||
163218763|NCT02474199|589517293|FG001|Overall Study|Withdrawal by Subject|2|||
163218764|NCT02474199|589517294|FG002|Overall Study|Withdrawal by Subject|0|||
163218765|NCT02474199|589517295|FG003|Overall Study|Withdrawal by Subject|1|||
163076904|NCT01122680|588989058|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
163076905|NCT01122680|588989059|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
163076906|NCT01122680|588989056|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
163076907|NCT01122680|588989057|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
163076908|NCT01122680|588989058|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
163076909|NCT01122680|588989059|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
163076910|NCT01122680|588989056|FG000|Period 1 (4 Weeks)|Other|1|||
163076911|NCT01122680|588989057|FG001|Period 1 (4 Weeks)|Other|1|||
163076912|NCT01122680|588989058|FG002|Period 1 (4 Weeks)|Other|0|||
163076913|NCT01122680|588989059|FG003|Period 1 (4 Weeks)|Other|0|||
163076914|NCT01122680|588989056|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
163076915|NCT01122680|588989057|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
163076916|NCT01122680|588989058|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
163076917|NCT01122680|588989059|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
163076918|NCT01122680|588989056|FG000|Period 2 (4 Weeks)|Other|1|||
163076919|NCT01122680|588989057|FG001|Period 2 (4 Weeks)|Other|0|||
163076920|NCT01122680|588989058|FG002|Period 2 (4 Weeks)|Other|0|||
163331881|NCT03057600|589925607|FG002|Overall Study|Adverse Event|4|||
163331882|NCT03057600|589925608|FG003|Overall Study|Adverse Event|0|||
163331883|NCT03057600|589925605|FG000|Overall Study|Radiologic Disease Progression|8|||
163331884|NCT03057600|589925606|FG001|Overall Study|Radiologic Disease Progression|7|||
163331885|NCT03057600|589925607|FG002|Overall Study|Radiologic Disease Progression|13|||
163331886|NCT03057600|589925608|FG003|Overall Study|Radiologic Disease Progression|10|||
163331887|NCT03057600|589925605|FG000|Overall Study|Symptomatic Deterioration|0|||
163331888|NCT03057600|589925606|FG001|Overall Study|Symptomatic Deterioration|1|||
163331889|NCT03057600|589925607|FG002|Overall Study|Symptomatic Deterioration|1|||
163331890|NCT03057600|589925608|FG003|Overall Study|Symptomatic Deterioration|0|||
163331891|NCT03057600|589925605|FG000|Overall Study|Investigator Decision|0|||
163076921|NCT01122680|588989059|FG003|Period 2 (4 Weeks)|Other|0|||
163076922|NCT01122680|588989056|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
163076923|NCT01122680|588989057|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
163076924|NCT01122680|588989058|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
163076925|NCT01122680|588989059|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
163076926|NCT01122680|588989056|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
163076927|NCT01122680|588989057|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
163076928|NCT01122680|588989058|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
163076929|NCT01122680|588989059|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
163076930|NCT00104884|588989061|FG000|Overall Study|Disease progression|4|||
163076931|NCT03473301|588989062|FG000|Overall Study|Protocol Violation|4|||
163076932|NCT03473301|588989063|FG001|Overall Study|Protocol Violation|0|||
163076933|NCT03473301|588989064|FG002|Overall Study|Protocol Violation|0|||
163076934|NCT03473301|588989062|FG000|Overall Study|Withdrawal by Subject|0|||
163218766|NCT02474199|589517292|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
163218767|NCT02474199|589517293|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
163218768|NCT02474199|589517294|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
163218769|NCT02474199|589517295|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
163218770|NCT02474199|589517292|FG000|Overall Study|Did not meet eligibility criteria|0|||
163218771|NCT02474199|589517293|FG001|Overall Study|Did not meet eligibility criteria|0|||
163218772|NCT02474199|589517294|FG002|Overall Study|Did not meet eligibility criteria|2|||
163218773|NCT02474199|589517295|FG003|Overall Study|Did not meet eligibility criteria|2|||
163218774|NCT03314584|589517302|FG000|Overall Study|Withdrawal by Subject|3|||
163218775|NCT03314584|589517303|FG001|Overall Study|Withdrawal by Subject|3|||
163218776|NCT03314584|589517302|FG000|Overall Study|Lost to Follow-up|4|||
163218777|NCT03314584|589517303|FG001|Overall Study|Lost to Follow-up|0|||
163218778|NCT06134817|589517304|FG000|Overall Study|Physician Departure - termination of study|1|||
163218779|NCT03406858|589517311|FG000|Overall Study|Failure to receive treatment drug.|1|||
163331892|NCT03057600|589925606|FG001|Overall Study|Investigator Decision|0|||
163331893|NCT03057600|589925607|FG002|Overall Study|Investigator Decision|1|||
163331894|NCT03057600|589925608|FG003|Overall Study|Investigator Decision|0|||
163076935|NCT03473301|588989063|FG001|Overall Study|Withdrawal by Subject|1|||
163076936|NCT03473301|588989064|FG002|Overall Study|Withdrawal by Subject|0|||
163076937|NCT03473301|588989062|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
163076938|NCT03473301|588989063|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
163076939|NCT03473301|588989064|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
163076940|NCT05529173|588989065|FG000|Overall Study|Physician Decision|3|||
163076941|NCT05529173|588989066|FG001|Overall Study|Physician Decision|6|||
163076942|NCT05529173|588989065|FG000|Overall Study|Sample shipment delay more than one day|4|||
163076943|NCT05529173|588989066|FG001|Overall Study|Sample shipment delay more than one day|0|||
163076944|NCT03760081|588989069|FG000|Overall Study|Miscellaneous|0|||
163076945|NCT03760081|588989070|FG001|Overall Study|Miscellaneous|1|||
163076946|NCT03760081|588989069|FG000|Overall Study|Progressive Disease|5|||
163076947|NCT03760081|588989070|FG001|Overall Study|Progressive Disease|10|||
163076948|NCT03760081|588989069|FG000|Overall Study|Death|1|||
163076949|NCT03760081|588989070|FG001|Overall Study|Death|1|||
163076950|NCT04034056|588989071|FG000|Overall Study|Withdrawal by Subject|2|||
163076951|NCT04034056|588989071|FG000|Overall Study|Reason Not Specified|13|||
163076952|NCT04034056|588989071|FG000|Overall Study|Adverse Event|56|||
163076953|NCT04135352|588989072|FG000|Overall Study|Not treated-randomization error|0|||
163076954|NCT04135352|588989073|FG001|Overall Study|Not treated-randomization error|0|||
163076955|NCT04135352|588989074|FG002|Overall Study|Not treated-randomization error|1|||
163076956|NCT04135352|588989075|FG003|Overall Study|Not treated-randomization error|0|||
163076957|NCT04135352|588989076|FG004|Overall Study|Not treated-randomization error|0|||
163076958|NCT04135352|588989077|FG005|Overall Study|Not treated-randomization error|0|||
163076959|NCT04135352|588989078|FG006|Overall Study|Not treated-randomization error|0|||
163076960|NCT04135352|588989079|FG007|Overall Study|Not treated-randomization error|0|||
163076961|NCT04135352|588989072|FG000|Overall Study|Withdrawal by Subject|0|||
163076962|NCT04135352|588989073|FG001|Overall Study|Withdrawal by Subject|0|||
163076963|NCT04135352|588989074|FG002|Overall Study|Withdrawal by Subject|2|||
163076964|NCT04135352|588989075|FG003|Overall Study|Withdrawal by Subject|0|||
163076965|NCT04135352|588989076|FG004|Overall Study|Withdrawal by Subject|0|||
163076966|NCT04135352|588989077|FG005|Overall Study|Withdrawal by Subject|0|||
163076967|NCT04135352|588989078|FG006|Overall Study|Withdrawal by Subject|0|||
163076968|NCT04135352|588989079|FG007|Overall Study|Withdrawal by Subject|0|||
163076969|NCT04135352|588989072|FG000|Overall Study|Sponsor Decision|0|||
163076970|NCT04135352|588989073|FG001|Overall Study|Sponsor Decision|0|||
163076971|NCT04135352|588989074|FG002|Overall Study|Sponsor Decision|2|||
163076972|NCT04135352|588989075|FG003|Overall Study|Sponsor Decision|5|||
163076973|NCT04135352|588989076|FG004|Overall Study|Sponsor Decision|1|||
163076974|NCT04135352|588989077|FG005|Overall Study|Sponsor Decision|4|||
163076975|NCT04135352|588989078|FG006|Overall Study|Sponsor Decision|0|||
163076976|NCT04135352|588989079|FG007|Overall Study|Sponsor Decision|0|||
163076977|NCT04135352|588989072|FG000|Overall Study|Physician Decision|0|||
163076978|NCT04135352|588989073|FG001|Overall Study|Physician Decision|0|||
163076979|NCT04135352|588989074|FG002|Overall Study|Physician Decision|1|||
163076980|NCT04135352|588989075|FG003|Overall Study|Physician Decision|0|||
163076981|NCT04135352|588989076|FG004|Overall Study|Physician Decision|1|||
163076982|NCT04135352|588989077|FG005|Overall Study|Physician Decision|0|||
163076983|NCT04135352|588989078|FG006|Overall Study|Physician Decision|0|||
163076984|NCT04135352|588989079|FG007|Overall Study|Physician Decision|0|||
163076985|NCT04135352|588989072|FG000|Overall Study|Death|3|||
163076986|NCT04135352|588989073|FG001|Overall Study|Death|4|||
163076987|NCT04135352|588989074|FG002|Overall Study|Death|7|||
163076988|NCT04135352|588989075|FG003|Overall Study|Death|0|||
163076989|NCT04135352|588989076|FG004|Overall Study|Death|3|||
163076990|NCT04135352|588989077|FG005|Overall Study|Death|1|||
163076991|NCT04135352|588989078|FG006|Overall Study|Death|0|||
163076992|NCT04135352|588989079|FG007|Overall Study|Death|0|||
163076993|NCT01210443|588989080|FG000|Overall Study|Study terminated by sponsor|2|||
163076994|NCT02807181|588989081|FG000|Overall Study|Death|28|||
163076995|NCT02807181|588989082|FG001|Overall Study|Death|24|||
163076996|NCT02807181|588989081|FG000|Overall Study|Withdrawal by Subject|1|||
163076997|NCT02807181|588989082|FG001|Overall Study|Withdrawal by Subject|1|||
163076998|NCT02807181|588989081|FG000|Overall Study|Lost to Follow-up|0|||
163076999|NCT02807181|588989082|FG001|Overall Study|Lost to Follow-up|2|||
163077000|NCT02807181|588989081|FG000|Overall Study|Subject decision|1|||
163077001|NCT02807181|588989082|FG001|Overall Study|Subject decision|0|||
163077002|NCT02807181|588989081|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
163077003|NCT02807181|588989082|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
163077004|NCT02807181|588989081|FG000|Overall Study|In Study|3|||
163077005|NCT02807181|588989082|FG001|Overall Study|In Study|3|||
163077006|NCT02807181|588989081|FG000|Overall Study|Post Progression|3|||
163077007|NCT02807181|588989082|FG001|Overall Study|Post Progression|2|||
163077008|NCT01452789|588989085|FG000|Overall Study|Withdrawal by Subject|3|||
163077009|NCT01452789|588989086|FG001|Overall Study|Withdrawal by Subject|2|||
163406423|NCT00621504|590198629|FG000|Overall Study|Adverse Event|1|||
163077010|NCT00066170|588989087|FG000|Overall Study|Adverse Event|2|||
163077011|NCT00066170|588989088|FG001|Overall Study|Adverse Event|4|||
163077012|NCT00066170|588989089|FG002|Overall Study|Adverse Event|1|||
163077013|NCT00066170|588989090|FG003|Overall Study|Adverse Event|7|||
163077014|NCT00066170|588989087|FG000|Overall Study|Serious Adverse Event|0|||
163077015|NCT00066170|588989088|FG001|Overall Study|Serious Adverse Event|0|||
163077016|NCT00066170|588989089|FG002|Overall Study|Serious Adverse Event|1|||
163077017|NCT00066170|588989090|FG003|Overall Study|Serious Adverse Event|1|||
163406424|NCT00621504|590198630|FG001|Overall Study|Adverse Event|3|||
163077018|NCT00066170|588989087|FG000|Overall Study|Lost to Follow-up|0|||
163077019|NCT00066170|588989088|FG001|Overall Study|Lost to Follow-up|1|||
163077020|NCT00066170|588989089|FG002|Overall Study|Lost to Follow-up|0|||
163077021|NCT00066170|588989090|FG003|Overall Study|Lost to Follow-up|0|||
163077022|NCT00066170|588989087|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
163077023|NCT00066170|588989088|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
163077024|NCT00066170|588989089|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
163077025|NCT00066170|588989090|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
163077026|NCT00066170|588989087|FG000|Overall Study|Protocol Violation|3|||
163077027|NCT00066170|588989088|FG001|Overall Study|Protocol Violation|0|||
163077028|NCT00066170|588989089|FG002|Overall Study|Protocol Violation|0|||
163077029|NCT00066170|588989090|FG003|Overall Study|Protocol Violation|0|||
163077030|NCT00066170|588989087|FG000|Overall Study|Other|1|||
163077031|NCT00066170|588989088|FG001|Overall Study|Other|5|||
163077032|NCT00066170|588989089|FG002|Overall Study|Other|2|||
163077033|NCT00066170|588989090|FG003|Overall Study|Other|0|||
163077034|NCT01089543|588989093|FG000|Overall Study|Withdrawal by Subject|2|||
163077035|NCT01089543|588989094|FG001|Overall Study|Withdrawal by Subject|3|||
163077036|NCT01089543|588989095|FG002|Overall Study|Withdrawal by Subject|3|||
163077037|NCT01089543|588989096|FG003|Overall Study|Withdrawal by Subject|1|||
163077038|NCT01089543|588989093|FG000|Overall Study|Physician Decision|1|||
163077039|NCT01089543|588989094|FG001|Overall Study|Physician Decision|0|||
163077040|NCT01089543|588989095|FG002|Overall Study|Physician Decision|0|||
163077041|NCT01089543|588989096|FG003|Overall Study|Physician Decision|1|||
163077042|NCT01089543|588989093|FG000|Overall Study|Adverse Event|0|||
163077043|NCT01089543|588989094|FG001|Overall Study|Adverse Event|1|||
163077044|NCT01089543|588989095|FG002|Overall Study|Adverse Event|0|||
163077045|NCT01089543|588989096|FG003|Overall Study|Adverse Event|0|||
163077046|NCT00754559|588989097|FG000|Overall Study|Adverse Event|15|||
163077047|NCT00754559|588989097|FG000|Overall Study|Protocol Violation|11|||
163077048|NCT00754559|588989097|FG000|Overall Study|Lack of Efficacy|10|||
163077049|NCT00754559|588989097|FG000|Overall Study|Lost to Follow-up|2|||
163077050|NCT00754559|588989097|FG000|Overall Study|Administrative reason|1|||
163077051|NCT00754559|588989097|FG000|Overall Study|Other|5|||
163077052|NCT00754559|588989097|FG000|Overall Study|Withdrawal by Subject|3|||
163077053|NCT01248468|588989098|FG000|Overall Study|Administrative problem|1|||
163077054|NCT01248468|588989099|FG001|Overall Study|Administrative problem|0|||
163077055|NCT01248468|588989100|FG002|Overall Study|Administrative problem|0|||
163077056|NCT01248468|588989098|FG000|Overall Study|Lost to Follow-up|9|||
163077057|NCT01248468|588989099|FG001|Overall Study|Lost to Follow-up|12|||
163077058|NCT01248468|588989100|FG002|Overall Study|Lost to Follow-up|4|||
163077059|NCT01248468|588989098|FG000|Overall Study|Pregnancy|1|||
163077060|NCT01248468|588989099|FG001|Overall Study|Pregnancy|0|||
163077061|NCT01248468|588989100|FG002|Overall Study|Pregnancy|0|||
163077062|NCT01248468|588989098|FG000|Overall Study|Withdrawal by Subject|4|||
163077063|NCT01248468|588989099|FG001|Overall Study|Withdrawal by Subject|2|||
163077064|NCT01248468|588989100|FG002|Overall Study|Withdrawal by Subject|0|||
163077065|NCT00468546|588989102|FG000|Week 24 Analysis|Lack of Efficacy|83|||
163077066|NCT00468546|588989103|FG001|Week 24 Analysis|Lack of Efficacy|37|||
163077067|NCT00468546|588989102|FG000|Week 24 Analysis|Refused treatment|5|||
163077068|NCT00468546|588989103|FG001|Week 24 Analysis|Refused treatment|5|||
163077069|NCT00468546|588989102|FG000|Week 24 Analysis|Adverse Event|1|||
163077070|NCT00468546|588989103|FG001|Week 24 Analysis|Adverse Event|8|||
163077071|NCT00468546|588989102|FG000|Week 24 Analysis|Failure to return|3|||
163077072|NCT00468546|588989103|FG001|Week 24 Analysis|Failure to return|4|||
163077073|NCT00468546|588989102|FG000|Week 24 Analysis|Rescue therapy|2|||
163077074|NCT00468546|588989103|FG001|Week 24 Analysis|Rescue therapy|0|||
163077075|NCT00468546|588989102|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
163077076|NCT00468546|588989103|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
163077077|NCT00468546|588989102|FG000|Week 24 Analysis|Due to clinical hold|1|||
163077078|NCT00468546|588989103|FG001|Week 24 Analysis|Due to clinical hold|0|||
163077079|NCT00468546|588989102|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
163077080|NCT00468546|588989103|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
163077081|NCT00468546|588989102|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
163077082|NCT00468546|588989103|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
163077083|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
163077084|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
163077085|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Death|1|||
163077086|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Death|0|||
163331895|NCT03057600|589925605|FG000|Overall Study|Study Termination by Sponsor|0|||
163077087|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
163077088|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
163077089|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
163077090|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
163077091|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
163077092|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
163331896|NCT03057600|589925606|FG001|Overall Study|Study Termination by Sponsor|0|||
163077093|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
163077094|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
163077095|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
163077096|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
163077097|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Other|17|||
163077098|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Other|14|||
163077099|NCT04000724|588989106|FG000|Overall Study|Withdrawal by Subject|5|||
163077100|NCT04000724|588989107|FG001|Overall Study|Withdrawal by Subject|3|||
163077101|NCT04000724|588989108|FG002|Overall Study|Withdrawal by Subject|4|||
163077102|NCT04000724|588989106|FG000|Overall Study|Lost to Follow-up|11|||
163077103|NCT04000724|588989107|FG001|Overall Study|Lost to Follow-up|7|||
163077104|NCT04000724|588989108|FG002|Overall Study|Lost to Follow-up|13|||
163077105|NCT00455455|588989109|FG000|Washout|Withdrawal by Subject|0|||
163077106|NCT00455455|588989110|FG001|Washout|Withdrawal by Subject|1|||
163077107|NCT00455455|588989109|FG000|Washout|Withdrawal by Subject|1|||
163077108|NCT00455455|588989110|FG001|Washout|Withdrawal by Subject|0|||
163077109|NCT00472641|588989111|FG000|Overall Study|Lack of Efficacy|3|||
163077110|NCT00472641|588989111|FG000|Overall Study|Adverse Event|3|||
163077111|NCT00472641|588989111|FG000|Overall Study|Lost to Follow-up|1|||
163077112|NCT01370538|588989112|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
163077113|NCT01370538|588989113|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
163077114|NCT01370538|588989112|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163077115|NCT01370538|588989113|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163077116|NCT01370538|588989112|FG000|Overall Study|Adverse Event|1|||
163077117|NCT01370538|588989113|FG001|Overall Study|Adverse Event|0|||
163077118|NCT01370538|588989112|FG000|Overall Study|Protocol Violation|8|||
163077119|NCT01370538|588989113|FG001|Overall Study|Protocol Violation|5|||
163077120|NCT01370538|588989112|FG000|Overall Study|Development of study specific withdrawal|1|||
163077121|NCT01370538|588989113|FG001|Overall Study|Development of study specific withdrawal|1|||
163077122|NCT01370538|588989112|FG000|Overall Study|Lost to follow up|6|||
163077123|NCT01370538|588989113|FG001|Overall Study|Lost to follow up|10|||
163077124|NCT00309244|588989114|FG000|Overall Study|Adverse Event|29|||
163077125|NCT00309244|588989115|FG001|Overall Study|Adverse Event|12|||
163077126|NCT00309244|588989114|FG000|Overall Study|Lost to Follow-up|6|||
163077127|NCT00309244|588989115|FG001|Overall Study|Lost to Follow-up|22|||
163077128|NCT00309244|588989114|FG000|Overall Study|Physician Decision|5|||
163077129|NCT00309244|588989115|FG001|Overall Study|Physician Decision|8|||
163077130|NCT00309244|588989114|FG000|Overall Study|Protocol Violation|6|||
163077131|NCT00309244|588989115|FG001|Overall Study|Protocol Violation|3|||
163077132|NCT00309244|588989114|FG000|Overall Study|Withdrawal by Subject|50|||
163077133|NCT00309244|588989115|FG001|Overall Study|Withdrawal by Subject|32|||
163077134|NCT00309244|588989114|FG000|Overall Study|Various|7|||
163077135|NCT00309244|588989115|FG001|Overall Study|Various|7|||
163077136|NCT00309244|588989114|FG000|Overall Study|Randomized but not dosed|11|||
163077137|NCT00309244|588989115|FG001|Overall Study|Randomized but not dosed|12|||
163077138|NCT00309244|588989114|FG000|Overall Study|Death|4|||
163077139|NCT00309244|588989115|FG001|Overall Study|Death|1|||
163077140|NCT01905267|588989116|FG000|Overall Study|Physician Decision|2|||
163077141|NCT01905267|588989117|FG001|Overall Study|Physician Decision|2|||
163077142|NCT03438656|588989118|FG000|Overall Study|Lost to Follow-up|2|||
163077143|NCT03335566|588989119|FG000|Overall Study|Adverse Event|0|||
163077144|NCT03335566|588989120|FG001|Overall Study|Adverse Event|1|||
163077145|NCT03335566|588989119|FG000|Overall Study|Lost to Follow-up|1|||
163077146|NCT03335566|588989120|FG001|Overall Study|Lost to Follow-up|0|||
163077147|NCT03335566|588989119|FG000|Overall Study|Technical Problems|1|||
163077148|NCT03335566|588989120|FG001|Overall Study|Technical Problems|0|||
163077149|NCT03335566|588989119|FG000|Overall Study|Protocol Violation|1|||
163077150|NCT03335566|588989120|FG001|Overall Study|Protocol Violation|0|||
163077151|NCT03335566|588989119|FG000|Overall Study|Other than specified above|1|||
163077152|NCT03335566|588989120|FG001|Overall Study|Other than specified above|2|||
163077153|NCT04223687|588989121|FG000|Overall Study|Missing primary outcome|1|||
163077154|NCT04223687|588989122|FG001|Overall Study|Missing primary outcome|0|||
163077155|NCT02945046|588989124|FG000|Overall Study|Adverse Event|1|||
163077156|NCT02945046|588989125|FG001|Overall Study|Adverse Event|0|||
163077157|NCT02945046|588989126|FG002|Overall Study|Adverse Event|2|||
163077158|NCT02945046|588989124|FG000|Overall Study|Withdrawal by Subject|3|||
163077159|NCT02945046|588989125|FG001|Overall Study|Withdrawal by Subject|3|||
163077160|NCT02945046|588989126|FG002|Overall Study|Withdrawal by Subject|3|||
163077161|NCT02945046|588989124|FG000|Overall Study|Protocol Violation|2|||
163077162|NCT02945046|588989125|FG001|Overall Study|Protocol Violation|3|||
163077163|NCT02945046|588989126|FG002|Overall Study|Protocol Violation|2|||
163077164|NCT02945046|588989124|FG000|Overall Study|Lost to Follow-up|1|||
163077165|NCT02945046|588989125|FG001|Overall Study|Lost to Follow-up|1|||
163077166|NCT02945046|588989126|FG002|Overall Study|Lost to Follow-up|0|||
163077167|NCT02945046|588989124|FG000|Overall Study|Lack of Efficacy|1|||
163077168|NCT02945046|588989125|FG001|Overall Study|Lack of Efficacy|2|||
163077169|NCT02945046|588989126|FG002|Overall Study|Lack of Efficacy|1|||
163077170|NCT02945046|588989124|FG000|Overall Study|Other than specified|5|||
163077171|NCT02945046|588989125|FG001|Overall Study|Other than specified|4|||
163077172|NCT02945046|588989126|FG002|Overall Study|Other than specified|7|||
163077173|NCT03259308|588989132|FG000|Overall Study|Adverse Event|5|||
163077174|NCT03259308|588989133|FG001|Overall Study|Adverse Event|4|||
163077175|NCT03259308|588989134|FG002|Overall Study|Adverse Event|1|||
163077176|NCT03259308|588989132|FG000|Overall Study|Withdrawal by Subject|2|||
163077177|NCT03259308|588989133|FG001|Overall Study|Withdrawal by Subject|1|||
163077178|NCT03259308|588989134|FG002|Overall Study|Withdrawal by Subject|3|||
163077179|NCT03259308|588989132|FG000|Overall Study|Lost to Follow-up|0|||
163077180|NCT03259308|588989133|FG001|Overall Study|Lost to Follow-up|0|||
163077181|NCT03259308|588989134|FG002|Overall Study|Lost to Follow-up|1|||
163077182|NCT03259308|588989132|FG000|Overall Study|Pregnancy|0|||
163077183|NCT03259308|588989133|FG001|Overall Study|Pregnancy|0|||
163077184|NCT03259308|588989134|FG002|Overall Study|Pregnancy|1|||
163077185|NCT03259308|588989132|FG000|Overall Study|Protocol Deviation|0|||
163077186|NCT03259308|588989133|FG001|Overall Study|Protocol Deviation|3|||
163077187|NCT03259308|588989134|FG002|Overall Study|Protocol Deviation|0|||
163077188|NCT03259308|588989132|FG000|Overall Study|Lack of Efficacy|0|||
163077189|NCT03259308|588989133|FG001|Overall Study|Lack of Efficacy|0|||
163077190|NCT03259308|588989134|FG002|Overall Study|Lack of Efficacy|1|||
163077191|NCT06868667|588989146|FG000|Overall Study|Death|0|||
163077192|NCT06868667|588989147|FG001|Overall Study|Death|4|||
163077193|NCT06868667|588989146|FG000|Overall Study|Lost to Follow-up|0|||
163077194|NCT06868667|588989147|FG001|Overall Study|Lost to Follow-up|1|||
163077195|NCT06868667|588989146|FG000|Overall Study|Withdrawal by Subject|1|||
163077196|NCT06868667|588989147|FG001|Overall Study|Withdrawal by Subject|0|||
163077197|NCT06868667|588989146|FG000|Overall Study|Ongoing|9|||
163077198|NCT06868667|588989147|FG001|Overall Study|Ongoing|9|||
163077199|NCT01251965|588991192|FG000|Overall Study|Participant/physician decision|1|||
163077200|NCT01251965|588991193|FG001|Overall Study|Participant/physician decision|2|||
163077201|NCT01251965|588991194|FG002|Overall Study|Participant/physician decision|0|||
163077202|NCT01251965|588991192|FG000|Overall Study|Death|0|||
163077203|NCT01251965|588991193|FG001|Overall Study|Death|0|||
163077204|NCT01251965|588991194|FG002|Overall Study|Death|11|||
163077205|NCT01027754|588991195|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
163077206|NCT01027754|588991196|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
163077207|NCT01027754|588991195|FG000|Overall Study|Withdrawal by Subject|0|||
163077208|NCT01027754|588991196|FG001|Overall Study|Withdrawal by Subject|5|||
163077209|NCT02529488|588991197|FG000|Overall Study|Adverse Event|1|||
163077210|NCT02529488|588991197|FG000|Overall Study|Death|3|||
163077211|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
163077212|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
163077213|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
163077214|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
163077215|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
163077216|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
163077217|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
163077218|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
163077219|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
163077220|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
163077221|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
163077222|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
163077223|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
163077224|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
163077225|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
163077226|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
163077227|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
163077228|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
163077229|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
163077230|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
163077231|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
163077232|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
163077233|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
163077234|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
163077235|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
163077236|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
163077237|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
163077238|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
163077239|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
163154804|NCT00521079|589281441|FG001|Overall Study|Withdrawal by Subject|3|||
163154805|NCT04123470|589281442|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
163077240|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
163077241|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
163077242|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
163077243|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
163077244|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
163077245|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
163077246|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
163077247|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
163077248|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
163077249|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
163077250|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
163077251|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
163077252|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
163077253|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
163077254|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
163077255|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
163077256|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
163077257|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
163077258|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
163077259|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
163077260|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
163077261|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
163077262|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
163077263|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
163077264|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
163077265|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
163077266|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
163077267|NCT01557244|588991204|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
163077268|NCT01557244|588991205|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
163077269|NCT01557244|588991206|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
163077270|NCT01557244|588991207|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
163077271|NCT01557244|588991208|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
163077272|NCT01557244|588991209|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
163077273|NCT01557244|588991210|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
163077274|NCT01557244|588991204|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
163077275|NCT01557244|588991205|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
163077276|NCT01557244|588991206|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
163077277|NCT01557244|588991207|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
163077278|NCT01557244|588991208|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
163077279|NCT01557244|588991209|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
163077280|NCT01557244|588991210|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
163077281|NCT01557244|588991204|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
163077282|NCT01557244|588991205|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
163077283|NCT01557244|588991206|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
163077284|NCT01557244|588991207|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
163077285|NCT01557244|588991208|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
163077286|NCT01557244|588991209|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
163077287|NCT01557244|588991210|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
163077288|NCT01557244|588991204|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
163077289|NCT01557244|588991205|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
163077290|NCT01557244|588991206|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
163077291|NCT01557244|588991207|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
163077292|NCT01557244|588991208|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
163077293|NCT01557244|588991209|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
163077294|NCT01557244|588991210|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
163077295|NCT01313676|588991211|FG000|Overall Study|Adverse Event|395|||
163077296|NCT01313676|588991212|FG001|Overall Study|Adverse Event|365|||
163077297|NCT01313676|588991213|FG002|Overall Study|Adverse Event|372|||
163077298|NCT01313676|588991214|FG003|Overall Study|Adverse Event|333|||
163077299|NCT01313676|588991211|FG000|Overall Study|Lack of Efficacy|98|||
163077300|NCT01313676|588991212|FG001|Overall Study|Lack of Efficacy|90|||
163077301|NCT01313676|588991213|FG002|Overall Study|Lack of Efficacy|65|||
163077302|NCT01313676|588991214|FG003|Overall Study|Lack of Efficacy|46|||
163077303|NCT01313676|588991211|FG000|Overall Study|Protocol Violation|37|||
163077304|NCT01313676|588991212|FG001|Overall Study|Protocol Violation|44|||
163077305|NCT01313676|588991213|FG002|Overall Study|Protocol Violation|46|||
163077306|NCT01313676|588991214|FG003|Overall Study|Protocol Violation|44|||
163077307|NCT01313676|588991211|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
163077308|NCT01313676|588991212|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
163077309|NCT01313676|588991213|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
163077310|NCT01313676|588991214|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
163077311|NCT01313676|588991211|FG000|Overall Study|Study Closed/terminated|7|||
163077312|NCT01313676|588991212|FG001|Overall Study|Study Closed/terminated|6|||
163077313|NCT01313676|588991213|FG002|Overall Study|Study Closed/terminated|9|||
163077314|NCT01313676|588991214|FG003|Overall Study|Study Closed/terminated|9|||
163077315|NCT01313676|588991211|FG000|Overall Study|Lost to Follow-up|0|||
163077316|NCT01313676|588991212|FG001|Overall Study|Lost to Follow-up|0|||
163077317|NCT01313676|588991213|FG002|Overall Study|Lost to Follow-up|1|||
163077318|NCT01313676|588991214|FG003|Overall Study|Lost to Follow-up|0|||
163077319|NCT01313676|588991211|FG000|Overall Study|Physician Decision|53|||
163077320|NCT01313676|588991212|FG001|Overall Study|Physician Decision|64|||
163077321|NCT01313676|588991213|FG002|Overall Study|Physician Decision|62|||
163077322|NCT01313676|588991214|FG003|Overall Study|Physician Decision|48|||
163077323|NCT01313676|588991211|FG000|Overall Study|Decision by Participant or Proxy|643|||
163077324|NCT01313676|588991212|FG001|Overall Study|Decision by Participant or Proxy|527|||
163077325|NCT01313676|588991213|FG002|Overall Study|Decision by Participant or Proxy|515|||
163077326|NCT01313676|588991214|FG003|Overall Study|Decision by Participant or Proxy|492|||
163077327|NCT01313676|588991211|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
163077328|NCT01313676|588991212|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
163077329|NCT01313676|588991213|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
163077330|NCT01313676|588991214|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
163077331|NCT01313676|588991211|FG000|Overall Study|Investigator Site Closed|12|||
163077332|NCT01313676|588991212|FG001|Overall Study|Investigator Site Closed|11|||
163077333|NCT01313676|588991213|FG002|Overall Study|Investigator Site Closed|15|||
163077334|NCT01313676|588991214|FG003|Overall Study|Investigator Site Closed|10|||
163077335|NCT01313676|588991211|FG000|Overall Study|Missing|1|||
163077336|NCT01313676|588991212|FG001|Overall Study|Missing|1|||
163077337|NCT01313676|588991213|FG002|Overall Study|Missing|1|||
163077338|NCT01313676|588991214|FG003|Overall Study|Missing|0|||
163077339|NCT00326495|588991215|FG000|Overall Study|Switched to alternative treatment|1|||
163077340|NCT00326495|588991215|FG000|Overall Study|Disease progression before treatment|1|||
163077341|NCT00326495|588991215|FG000|Overall Study|Refused further treatment|2|||
163077342|NCT00326495|588991215|FG000|Overall Study|Subject off study before assessment|1|||
163077343|NCT01654250|588991216|FG000|Overall Study|Lost to Follow-up|1|||
163077344|NCT01654250|588991217|FG001|Overall Study|Lost to Follow-up|0|||
163077345|NCT01897896|588991220|FG000|Overall Study|Death|1|||
163077346|NCT01897896|588991221|FG001|Overall Study|Death|0|||
163077347|NCT01897896|588991220|FG000|Overall Study|Adverse Event|11|||
163077348|NCT01897896|588991221|FG001|Overall Study|Adverse Event|1|||
163077349|NCT01897896|588991220|FG000|Overall Study|Lost to Follow-up|1|||
163077350|NCT01897896|588991221|FG001|Overall Study|Lost to Follow-up|0|||
163077351|NCT01897896|588991220|FG000|Overall Study|Non-compliance with study drug dosing|1|||
163077352|NCT01897896|588991221|FG001|Overall Study|Non-compliance with study drug dosing|1|||
163077353|NCT01897896|588991220|FG000|Overall Study|Withdrawal by Subject|7|||
163077354|NCT01897896|588991221|FG001|Overall Study|Withdrawal by Subject|1|||
163077355|NCT01897896|588991220|FG000|Overall Study|Require drug that interfere with study|1|||
163077356|NCT01897896|588991221|FG001|Overall Study|Require drug that interfere with study|4|||
163077357|NCT01897896|588991220|FG000|Overall Study|Protocol Violation|1|||
163077358|NCT01897896|588991221|FG001|Overall Study|Protocol Violation|1|||
163077359|NCT01897896|588991220|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
163077360|NCT01897896|588991221|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
163077361|NCT01897896|588991220|FG000|Overall Study|Caregiver can no longer participate|0|||
163077362|NCT01897896|588991221|FG001|Overall Study|Caregiver can no longer participate|2|||
163077363|NCT01897896|588991220|FG000|Overall Study|Other than specified|2|||
163077364|NCT01897896|588991221|FG001|Overall Study|Other than specified|1|||
163406425|NCT00621504|590198629|FG000|Overall Study|At the request of sponsor/investigator|1|||
163077365|NCT01716559|588991231|FG000|Overall Study|Adverse Event|11|||
163077366|NCT01716559|588991231|FG000|Overall Study|Death|21|||
163077367|NCT01716559|588991231|FG000|Overall Study|Withdrawal by Subject|4|||
163077368|NCT01716559|588991231|FG000|Overall Study|Other withdrawal reason|75|||
163077369|NCT00458705|588991237|FG000|Overall Study|Adverse Event|4|||
163077370|NCT00458705|588991237|FG000|Overall Study|Not Treated|1|||
163077371|NCT02180672|588991238|FG000|Overall Study|Lost to Follow-up|5|||
163077372|NCT02180672|588991239|FG001|Overall Study|Lost to Follow-up|7|||
163077373|NCT00378560|588991243|FG000|Overall Study|Adverse Event|1|||
163077374|NCT00378560|588991244|FG001|Overall Study|Adverse Event|0|||
163077375|NCT00378560|588991243|FG000|Overall Study|Lost to Follow-up|24|||
163077376|NCT00378560|588991244|FG001|Overall Study|Lost to Follow-up|29|||
163077377|NCT00378560|588991243|FG000|Overall Study|Protocol Violation|2|||
163077378|NCT00378560|588991244|FG001|Overall Study|Protocol Violation|0|||
163077379|NCT00378560|588991243|FG000|Overall Study|Withdrawal by Subject|17|||
163077380|NCT00378560|588991244|FG001|Overall Study|Withdrawal by Subject|21|||
163077381|NCT00378560|588991243|FG000|Overall Study|Moved|4|||
163077382|NCT00378560|588991244|FG001|Overall Study|Moved|3|||
163406426|NCT00621504|590198630|FG001|Overall Study|At the request of sponsor/investigator|0|||
163077383|NCT00378560|588991243|FG000|Overall Study|Pregnancy|7|||
163077384|NCT00378560|588991244|FG001|Overall Study|Pregnancy|5|||
163077385|NCT00378560|588991243|FG000|Overall Study|Laboratory test values abnormal|1|||
163077386|NCT00378560|588991244|FG001|Overall Study|Laboratory test values abnormal|0|||
163077387|NCT02070380|588991245|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
163077388|NCT02070380|588991246|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
163077389|NCT02070380|588991247|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
163077390|NCT02070380|588991248|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
163077391|NCT02070380|588991245|FG000|Second Injection|Image sets missing or technically inadeq|0|||
163077392|NCT02070380|588991246|FG001|Second Injection|Image sets missing or technically inadeq|1|||
163077393|NCT02070380|588991247|FG002|Second Injection|Image sets missing or technically inadeq|0|||
163077394|NCT02070380|588991248|FG003|Second Injection|Image sets missing or technically inadeq|0|||
163077395|NCT02070380|588991245|FG000|Second Injection|Protocol Violation|0|||
163077396|NCT02070380|588991246|FG001|Second Injection|Protocol Violation|1|||
163077397|NCT02070380|588991247|FG002|Second Injection|Protocol Violation|1|||
163077398|NCT02070380|588991248|FG003|Second Injection|Protocol Violation|5|||
163077399|NCT05463705|588991265|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
163077400|NCT05463705|588991266|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
163077401|NCT05463705|588991267|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
163077402|NCT05463705|588991268|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
163077403|NCT05463705|588991269|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
163077404|NCT05463705|588991270|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
163077405|NCT00552279|588991275|FG000|Overall Study|Adverse Event|0|||
163077406|NCT00552279|588991276|FG001|Overall Study|Adverse Event|1|||
163077407|NCT00552279|588991275|FG000|Overall Study|Withdrawal by Subject|12|||
163077408|NCT00552279|588991276|FG001|Overall Study|Withdrawal by Subject|1|||
163077409|NCT00552279|588991275|FG000|Overall Study|Lost to Follow-up|1|||
163077410|NCT00552279|588991276|FG001|Overall Study|Lost to Follow-up|0|||
163077411|NCT00552279|588991275|FG000|Overall Study|Other|1|||
163077412|NCT00552279|588991276|FG001|Overall Study|Other|1|||
163077413|NCT03596983|588991277|FG000|Overall Study|Withdrawal by Subject|3|||
163077414|NCT03071965|588991278|FG000|Overall Study|Adverse Event|0|||
163077415|NCT03071965|588991279|FG001|Overall Study|Adverse Event|0|||
163077416|NCT03071965|588991280|FG002|Overall Study|Adverse Event|1|||
163077417|NCT03071965|588991281|FG003|Overall Study|Adverse Event|0|||
163077418|NCT03071965|588991278|FG000|Overall Study|Death|0|||
163077419|NCT03071965|588991279|FG001|Overall Study|Death|0|||
163077420|NCT03071965|588991280|FG002|Overall Study|Death|1|||
163077421|NCT03071965|588991281|FG003|Overall Study|Death|1|||
163077422|NCT03071965|588991278|FG000|Overall Study|COVID-19|0|||
163077423|NCT03071965|588991279|FG001|Overall Study|COVID-19|1|||
163077424|NCT03071965|588991280|FG002|Overall Study|COVID-19|0|||
163077425|NCT03071965|588991281|FG003|Overall Study|COVID-19|1|||
163077426|NCT03071965|588991278|FG000|Overall Study|Other Health Reason|0|||
163077427|NCT03071965|588991279|FG001|Overall Study|Other Health Reason|0|||
163077428|NCT03071965|588991280|FG002|Overall Study|Other Health Reason|0|||
163077429|NCT03071965|588991281|FG003|Overall Study|Other Health Reason|1|||
163077430|NCT02346370|588991282|FG000|Overall Study|Not treated|1|||
163077431|NCT02346370|588991283|FG001|Overall Study|Not treated|0|||
163077432|NCT02346370|588991284|FG002|Overall Study|Not treated|0|||
163077433|NCT02346370|588991282|FG000|Overall Study|Withdrawal of consent|1|||
163077434|NCT02346370|588991283|FG001|Overall Study|Withdrawal of consent|0|||
163077435|NCT02346370|588991284|FG002|Overall Study|Withdrawal of consent|0|||
163077436|NCT02346370|588991282|FG000|Overall Study|Death|1|||
163077437|NCT02346370|588991283|FG001|Overall Study|Death|3|||
163077438|NCT02346370|588991284|FG002|Overall Study|Death|1|||
163077439|NCT02346370|588991282|FG000|Overall Study|Sponsor discontinued study|5|||
163218780|NCT03406858|589517311|FG000|Overall Study|ineligible|1|||
163077440|NCT02346370|588991283|FG001|Overall Study|Sponsor discontinued study|0|||
163077441|NCT02346370|588991284|FG002|Overall Study|Sponsor discontinued study|2|||
163077442|NCT02346370|588991282|FG000|Overall Study|Radiologic progression|0|||
163077443|NCT02346370|588991283|FG001|Overall Study|Radiologic progression|0|||
163077444|NCT02346370|588991284|FG002|Overall Study|Radiologic progression|1|||
163077445|NCT02346370|588991282|FG000|Overall Study|Physician Decision|0|||
163077446|NCT02346370|588991283|FG001|Overall Study|Physician Decision|1|||
163077447|NCT02346370|588991284|FG002|Overall Study|Physician Decision|0|||
163077448|NCT06399471|588991285|FG000|Overall Study|Withdrawal by Subject|1|||
163077449|NCT02662582|588991286|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
163077450|NCT02662582|588991287|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
163077451|NCT02662582|588991286|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
163077452|NCT02662582|588991287|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
163077453|NCT02662582|588991286|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
163077454|NCT02662582|588991287|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
163077455|NCT02662582|588991286|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163077456|NCT02662582|588991287|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163077457|NCT00609973|588991289|FG000|Overall Study|Adverse Event|2|||
163077458|NCT00609973|588991290|FG001|Overall Study|Adverse Event|1|||
163077459|NCT00609973|588991289|FG000|Overall Study|Protocol Violation|4|||
163077460|NCT00609973|588991290|FG001|Overall Study|Protocol Violation|3|||
163077461|NCT00609973|588991289|FG000|Overall Study|Lost to Follow-up|2|||
163077462|NCT00609973|588991290|FG001|Overall Study|Lost to Follow-up|1|||
163077463|NCT00609973|588991289|FG000|Overall Study|Withdrawal by Subject|0|||
163077464|NCT00609973|588991290|FG001|Overall Study|Withdrawal by Subject|1|||
163077465|NCT01362270|588991293|FG000|Overall Study|Withdrawal by Subject|1|||
163077466|NCT01362270|588991294|FG001|Overall Study|Withdrawal by Subject|0|||
163077467|NCT01362270|588991293|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
163077468|NCT01362270|588991294|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
163077469|NCT01362270|588991293|FG000|Overall Study|Met excl. criteria before 1st session|1|||
163077470|NCT01362270|588991294|FG001|Overall Study|Met excl. criteria before 1st session|1|||
163077471|NCT01691482|588991295|FG000|Treatment Period 2|Adverse Event|0|||
163077472|NCT01691482|588991296|FG001|Treatment Period 2|Adverse Event|1|||
163077473|NCT01691482|588991295|FG000|Treatment Period 2|Protocol Violation|1|||
163077474|NCT01691482|588991296|FG001|Treatment Period 2|Protocol Violation|1|||
163077475|NCT01953354|588991297|FG000|Overall Study|Withdrawal by Subject|0|||
163077476|NCT01953354|588991298|FG001|Overall Study|Withdrawal by Subject|1|||
163077477|NCT01953354|588991297|FG000|Overall Study|Decision of Sponsor|0|||
163077478|NCT01953354|588991298|FG001|Overall Study|Decision of Sponsor|1|||
163077479|NCT01953354|588991297|FG000|Overall Study|Disease Exacerbation|1|||
163077480|NCT01953354|588991298|FG001|Overall Study|Disease Exacerbation|0|||
163077481|NCT01392495|588991299|FG000|Overall Study|Death|3|||
163077482|NCT01392495|588991299|FG000|Overall Study|Administrative problems|8|||
163077483|NCT01392495|588991299|FG000|Overall Study|Withdrawal by Subject|2|||
163077484|NCT01392495|588991299|FG000|Overall Study|Adverse Event|3|||
163077485|NCT00806026|588991300|FG000|Overall Study|Death|0|||
163077486|NCT00806026|588991301|FG001|Overall Study|Death|0|||
163077487|NCT00806026|588991302|FG002|Overall Study|Death|0|||
163077488|NCT00806026|588991303|FG003|Overall Study|Death|1|||
163077489|NCT00806026|588991304|FG004|Overall Study|Death|0|||
163077490|NCT00806026|588991305|FG005|Overall Study|Death|0|||
163077491|NCT00806026|588991300|FG000|Overall Study|Did not meet entrance criteria|4|||
163077492|NCT00806026|588991301|FG001|Overall Study|Did not meet entrance criteria|1|||
163077493|NCT00806026|588991302|FG002|Overall Study|Did not meet entrance criteria|2|||
163077494|NCT00806026|588991303|FG003|Overall Study|Did not meet entrance criteria|1|||
163077495|NCT00806026|588991304|FG004|Overall Study|Did not meet entrance criteria|0|||
163077496|NCT00806026|588991305|FG005|Overall Study|Did not meet entrance criteria|0|||
163077497|NCT00806026|588991300|FG000|Overall Study|Lack of Efficacy|5|||
163077498|NCT00806026|588991301|FG001|Overall Study|Lack of Efficacy|18|||
163077499|NCT00806026|588991302|FG002|Overall Study|Lack of Efficacy|13|||
163077500|NCT00806026|588991303|FG003|Overall Study|Lack of Efficacy|4|||
163077501|NCT00806026|588991304|FG004|Overall Study|Lack of Efficacy|8|||
163077502|NCT00806026|588991305|FG005|Overall Study|Lack of Efficacy|7|||
163077503|NCT00806026|588991300|FG000|Overall Study|Lost to Follow-up|8|||
163077504|NCT00806026|588991301|FG001|Overall Study|Lost to Follow-up|15|||
163077505|NCT00806026|588991302|FG002|Overall Study|Lost to Follow-up|8|||
163077506|NCT00806026|588991303|FG003|Overall Study|Lost to Follow-up|2|||
163077507|NCT00806026|588991304|FG004|Overall Study|Lost to Follow-up|6|||
163077508|NCT00806026|588991305|FG005|Overall Study|Lost to Follow-up|6|||
163218781|NCT06027866|589517312|FG000|Overall Study|Withdrawal by Subject|2|||
163218782|NCT00930579|589517313|FG000|Overall Study|Withdrawal by Subject|1|||
163077509|NCT00806026|588991300|FG000|Overall Study|Withdrawal by Subject|14|||
163077510|NCT00806026|588991301|FG001|Overall Study|Withdrawal by Subject|17|||
163077511|NCT00806026|588991302|FG002|Overall Study|Withdrawal by Subject|9|||
163077512|NCT00806026|588991303|FG003|Overall Study|Withdrawal by Subject|2|||
163077513|NCT00806026|588991304|FG004|Overall Study|Withdrawal by Subject|5|||
163077514|NCT00806026|588991305|FG005|Overall Study|Withdrawal by Subject|3|||
163077515|NCT00806026|588991300|FG000|Overall Study|Other|3|||
163077516|NCT00806026|588991301|FG001|Overall Study|Other|6|||
163077517|NCT00806026|588991302|FG002|Overall Study|Other|8|||
163077518|NCT00806026|588991303|FG003|Overall Study|Other|2|||
163077519|NCT00806026|588991304|FG004|Overall Study|Other|0|||
163218783|NCT00930579|589517313|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
163218784|NCT01046682|589517320|FG000|Overall Study|Adverse Event|2|||
163218785|NCT01046682|589517321|FG001|Overall Study|Adverse Event|0|||
163218786|NCT05071183|589517324|FG000|Overall Study|Death|1|||
163218787|NCT05071183|589517325|FG001|Overall Study|Death|2|||
163218788|NCT05071183|589517326|FG002|Overall Study|Death|0|||
163218789|NCT05071183|589517324|FG000|Overall Study|Other Reasons|1|||
163077520|NCT00806026|588991305|FG005|Overall Study|Other|4|||
163077521|NCT00806026|588991300|FG000|Overall Study|Protocol Violation|6|||
163077522|NCT00806026|588991301|FG001|Overall Study|Protocol Violation|9|||
163077523|NCT00806026|588991302|FG002|Overall Study|Protocol Violation|9|||
163077524|NCT00806026|588991303|FG003|Overall Study|Protocol Violation|0|||
163077525|NCT00806026|588991304|FG004|Overall Study|Protocol Violation|2|||
163077526|NCT00806026|588991305|FG005|Overall Study|Protocol Violation|3|||
163077527|NCT00806026|588991300|FG000|Overall Study|Adverse Event|52|||
163077528|NCT00806026|588991301|FG001|Overall Study|Adverse Event|35|||
163077529|NCT00806026|588991302|FG002|Overall Study|Adverse Event|44|||
163077530|NCT00806026|588991303|FG003|Overall Study|Adverse Event|17|||
163077531|NCT00806026|588991304|FG004|Overall Study|Adverse Event|9|||
163077532|NCT00806026|588991305|FG005|Overall Study|Adverse Event|9|||
163077533|NCT00147537|588991317|FG000|Phase 1b|Death|0|||
163077534|NCT00147537|588991318|FG001|Phase 1b|Death|1|||
163077535|NCT00147537|588991319|FG002|Phase 1b|Death|2|||
163077536|NCT00147537|588991320|FG003|Phase 1b|Death|1|||
163077537|NCT00147537|588991321|FG004|Phase 1b|Death|2|||
163077538|NCT00147537|588991322|FG005|Phase 1b|Death|2|||
163077539|NCT00147537|588991323|FG006|Phase 1b|Death|1|||
163077540|NCT00147537|588991324|FG007|Phase 1b|Death|3|||
163077541|NCT00147537|588991325|FG008|Phase 1b|Death|9|||
163077542|NCT00147537|588991326|FG009|Phase 1b|Death|0|||
163077543|NCT00147537|588991327|FG010|Phase 1b|Death|0|||
163077544|NCT00147537|588991317|FG000|Phase 1b|Lost to Follow-up|2|||
163077545|NCT00147537|588991318|FG001|Phase 1b|Lost to Follow-up|1|||
163077546|NCT00147537|588991319|FG002|Phase 1b|Lost to Follow-up|0|||
163077547|NCT00147537|588991320|FG003|Phase 1b|Lost to Follow-up|0|||
163077548|NCT00147537|588991321|FG004|Phase 1b|Lost to Follow-up|0|||
163077549|NCT00147537|588991322|FG005|Phase 1b|Lost to Follow-up|0|||
163077550|NCT00147537|588991323|FG006|Phase 1b|Lost to Follow-up|2|||
163077551|NCT00147537|588991324|FG007|Phase 1b|Lost to Follow-up|0|||
163077552|NCT00147537|588991325|FG008|Phase 1b|Lost to Follow-up|1|||
163077553|NCT00147537|588991326|FG009|Phase 1b|Lost to Follow-up|0|||
163077554|NCT00147537|588991327|FG010|Phase 1b|Lost to Follow-up|0|||
163077555|NCT00147537|588991317|FG000|Phase 1b|Other|0|||
163077556|NCT00147537|588991318|FG001|Phase 1b|Other|0|||
163077557|NCT00147537|588991319|FG002|Phase 1b|Other|2|||
163077558|NCT00147537|588991320|FG003|Phase 1b|Other|1|||
163077559|NCT00147537|588991321|FG004|Phase 1b|Other|1|||
163077560|NCT00147537|588991322|FG005|Phase 1b|Other|1|||
163077561|NCT00147537|588991323|FG006|Phase 1b|Other|14|||
163077562|NCT00147537|588991324|FG007|Phase 1b|Other|4|||
163077563|NCT00147537|588991325|FG008|Phase 1b|Other|4|||
163077564|NCT00147537|588991326|FG009|Phase 1b|Other|0|||
163077565|NCT00147537|588991327|FG010|Phase 1b|Other|0|||
163077566|NCT00147537|588991317|FG000|Phase 1b|Withdrawal by Subject|0|||
163077567|NCT00147537|588991318|FG001|Phase 1b|Withdrawal by Subject|0|||
163077568|NCT00147537|588991319|FG002|Phase 1b|Withdrawal by Subject|0|||
163077569|NCT00147537|588991320|FG003|Phase 1b|Withdrawal by Subject|0|||
163077570|NCT00147537|588991321|FG004|Phase 1b|Withdrawal by Subject|0|||
163077571|NCT00147537|588991322|FG005|Phase 1b|Withdrawal by Subject|0|||
163077572|NCT00147537|588991323|FG006|Phase 1b|Withdrawal by Subject|0|||
163077573|NCT00147537|588991324|FG007|Phase 1b|Withdrawal by Subject|0|||
163077574|NCT00147537|588991325|FG008|Phase 1b|Withdrawal by Subject|2|||
163077575|NCT00147537|588991326|FG009|Phase 1b|Withdrawal by Subject|0|||
163077576|NCT00147537|588991327|FG010|Phase 1b|Withdrawal by Subject|0|||
163077577|NCT00147537|588991317|FG000|Phase 1b|Randomized but not treated|0|||
163077578|NCT00147537|588991318|FG001|Phase 1b|Randomized but not treated|0|||
163077579|NCT00147537|588991319|FG002|Phase 1b|Randomized but not treated|0|||
163077580|NCT00147537|588991320|FG003|Phase 1b|Randomized but not treated|0|||
163077581|NCT00147537|588991321|FG004|Phase 1b|Randomized but not treated|0|||
163077582|NCT00147537|588991322|FG005|Phase 1b|Randomized but not treated|0|||
163077583|NCT00147537|588991323|FG006|Phase 1b|Randomized but not treated|1|||
163077584|NCT00147537|588991324|FG007|Phase 1b|Randomized but not treated|0|||
163077585|NCT00147537|588991325|FG008|Phase 1b|Randomized but not treated|1|||
163077586|NCT00147537|588991326|FG009|Phase 1b|Randomized but not treated|0|||
163029209|NCT03932331|588810380|FG000|Overall Study|Death|0|||
163077587|NCT00147537|588991327|FG010|Phase 1b|Randomized but not treated|0|||
163077588|NCT00147537|588991317|FG000|Phase 2|Death|0|||
163029210|NCT03932331|588810381|FG001|Overall Study|Death|7|||
163029211|NCT03932331|588810382|FG002|Overall Study|Death|2|||
163029212|NCT03932331|588810380|FG000|Overall Study|Withdrawal by Subject|0|||
163029213|NCT03932331|588810381|FG001|Overall Study|Withdrawal by Subject|3|||
163029214|NCT03932331|588810382|FG002|Overall Study|Withdrawal by Subject|0|||
163029215|NCT03932331|588810380|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
163029216|NCT03932331|588810381|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
163029217|NCT03932331|588810382|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
163029218|NCT03932331|588810380|FG000|Overall Study|Progressive disease|3|||
163029219|NCT03932331|588810381|FG001|Overall Study|Progressive disease|0|||
163029220|NCT03932331|588810382|FG002|Overall Study|Progressive disease|0|||
163029221|NCT03932331|588810380|FG000|Overall Study|Lung infection|1|||
163029222|NCT03932331|588810381|FG001|Overall Study|Lung infection|0|||
163077589|NCT00147537|588991318|FG001|Phase 2|Death|0|||
163077590|NCT00147537|588991319|FG002|Phase 2|Death|0|||
163077591|NCT00147537|588991320|FG003|Phase 2|Death|0|||
163077592|NCT00147537|588991321|FG004|Phase 2|Death|0|||
163077593|NCT00147537|588991322|FG005|Phase 2|Death|0|||
163077594|NCT00147537|588991323|FG006|Phase 2|Death|0|||
163077595|NCT00147537|588991324|FG007|Phase 2|Death|0|||
163077596|NCT00147537|588991325|FG008|Phase 2|Death|0|||
163077597|NCT00147537|588991326|FG009|Phase 2|Death|85|||
163077598|NCT00147537|588991327|FG010|Phase 2|Death|31|||
163077599|NCT00147537|588991317|FG000|Phase 2|Lost to Follow-up|0|||
163077600|NCT00147537|588991318|FG001|Phase 2|Lost to Follow-up|0|||
163077601|NCT00147537|588991319|FG002|Phase 2|Lost to Follow-up|0|||
163077602|NCT00147537|588991320|FG003|Phase 2|Lost to Follow-up|0|||
163077603|NCT00147537|588991321|FG004|Phase 2|Lost to Follow-up|0|||
163077604|NCT00147537|588991322|FG005|Phase 2|Lost to Follow-up|0|||
163077605|NCT00147537|588991323|FG006|Phase 2|Lost to Follow-up|0|||
163077606|NCT00147537|588991324|FG007|Phase 2|Lost to Follow-up|0|||
163077607|NCT00147537|588991325|FG008|Phase 2|Lost to Follow-up|0|||
163077608|NCT00147537|588991326|FG009|Phase 2|Lost to Follow-up|12|||
163077609|NCT00147537|588991327|FG010|Phase 2|Lost to Follow-up|4|||
163077610|NCT00147537|588991317|FG000|Phase 2|Other|0|||
163077611|NCT00147537|588991318|FG001|Phase 2|Other|0|||
163077612|NCT00147537|588991319|FG002|Phase 2|Other|0|||
163077613|NCT00147537|588991320|FG003|Phase 2|Other|0|||
163077614|NCT00147537|588991321|FG004|Phase 2|Other|0|||
163077615|NCT00147537|588991322|FG005|Phase 2|Other|0|||
163077616|NCT00147537|588991323|FG006|Phase 2|Other|0|||
163077617|NCT00147537|588991324|FG007|Phase 2|Other|0|||
163218790|NCT05071183|589517325|FG001|Overall Study|Other Reasons|3|||
163218791|NCT05071183|589517326|FG002|Overall Study|Other Reasons|2|||
163218792|NCT02046148|589517327|FG000|Overall Study|Lost to Follow-up|1|||
163218793|NCT02046148|589517328|FG001|Overall Study|Lost to Follow-up|1|||
163218794|NCT02046148|589517327|FG000|Overall Study|Withdrawal by Subject|0|||
163218795|NCT02046148|589517328|FG001|Overall Study|Withdrawal by Subject|2|||
163218796|NCT03506373|589517330|FG000|Overall Study|Adverse Event|6|||
163218797|NCT03506373|589517330|FG000|Overall Study|Withdrawal by Subject|2|||
163218798|NCT03506373|589517330|FG000|Overall Study|Disease progression|5|||
163218799|NCT03506373|589517330|FG000|Overall Study|Other|3|||
163218800|NCT02939560|589517332|FG000|Overall Study|Withdrawal by Subject|2|||
163218801|NCT02939560|589517332|FG000|Overall Study|Protocol Violation|1|||
163218802|NCT03340025|589517333|FG000|Overall Study|Lost to Follow-up|2|||
163218803|NCT03340025|589517334|FG001|Overall Study|Lost to Follow-up|2|||
163218804|NCT02420691|589517335|FG000|Overall Study|Adverse Event|3|||
163218805|NCT02420691|589517335|FG000|Overall Study|Withdrawal by Subject|3|||
163218806|NCT01852812|589517336|FG000|Overall Study|Adverse Event|0|||
163218807|NCT01852812|589517337|FG001|Overall Study|Adverse Event|0|||
163077618|NCT00147537|588991325|FG008|Phase 2|Other|0|||
163077619|NCT00147537|588991326|FG009|Phase 2|Other|47|||
163077620|NCT00147537|588991327|FG010|Phase 2|Other|12|||
163077621|NCT00147537|588991317|FG000|Phase 2|Withdrawal by Subject|0|||
163077622|NCT00147537|588991318|FG001|Phase 2|Withdrawal by Subject|0|||
163077623|NCT00147537|588991319|FG002|Phase 2|Withdrawal by Subject|0|||
163077624|NCT00147537|588991320|FG003|Phase 2|Withdrawal by Subject|0|||
163077625|NCT00147537|588991321|FG004|Phase 2|Withdrawal by Subject|0|||
163077626|NCT00147537|588991322|FG005|Phase 2|Withdrawal by Subject|0|||
163077627|NCT00147537|588991323|FG006|Phase 2|Withdrawal by Subject|0|||
163077628|NCT00147537|588991324|FG007|Phase 2|Withdrawal by Subject|0|||
163077629|NCT00147537|588991325|FG008|Phase 2|Withdrawal by Subject|0|||
163077630|NCT00147537|588991326|FG009|Phase 2|Withdrawal by Subject|16|||
163077631|NCT00147537|588991327|FG010|Phase 2|Withdrawal by Subject|4|||
163077632|NCT00147537|588991317|FG000|Phase 2|Randomized but not treated|0|||
163077633|NCT00147537|588991318|FG001|Phase 2|Randomized but not treated|0|||
163077634|NCT00147537|588991319|FG002|Phase 2|Randomized but not treated|0|||
163077635|NCT00147537|588991320|FG003|Phase 2|Randomized but not treated|0|||
163218808|NCT01852812|589517338|FG002|Overall Study|Adverse Event|1|||
163218809|NCT01852812|589517336|FG000|Overall Study|Non-compliance With Study Drug|0|||
163218810|NCT01852812|589517337|FG001|Overall Study|Non-compliance With Study Drug|1|||
163218811|NCT01852812|589517338|FG002|Overall Study|Non-compliance With Study Drug|0|||
163077636|NCT00147537|588991321|FG004|Phase 2|Randomized but not treated|0|||
163077637|NCT00147537|588991322|FG005|Phase 2|Randomized but not treated|0|||
163077638|NCT00147537|588991323|FG006|Phase 2|Randomized but not treated|0|||
163077639|NCT00147537|588991324|FG007|Phase 2|Randomized but not treated|0|||
163077640|NCT00147537|588991325|FG008|Phase 2|Randomized but not treated|0|||
163077641|NCT00147537|588991326|FG009|Phase 2|Randomized but not treated|1|||
163077642|NCT00147537|588991327|FG010|Phase 2|Randomized but not treated|1|||
163077643|NCT01927861|588991328|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
163077644|NCT01927861|588991329|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
163077645|NCT01927861|588991328|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
163077646|NCT01927861|588991329|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
163077647|NCT00987935|588991330|FG000|Overall Study|Progressive disease|3|||
163077648|NCT00987935|588991331|FG001|Overall Study|Progressive disease|2|||
163077649|NCT00987935|588991332|FG002|Overall Study|Progressive disease|3|||
163077650|NCT00987935|588991333|FG003|Overall Study|Progressive disease|2|||
163077651|NCT00987935|588991334|FG004|Overall Study|Progressive disease|5|||
163077652|NCT00987935|588991335|FG005|Overall Study|Progressive disease|3|||
163077653|NCT00987935|588991336|FG006|Overall Study|Progressive disease|9|||
163077654|NCT00987935|588991337|FG007|Overall Study|Progressive disease|48|||
163077655|NCT00987935|588991338|FG008|Overall Study|Progressive disease|23|||
163077656|NCT00987935|588991330|FG000|Overall Study|Adverse Event|0|||
163077657|NCT00987935|588991331|FG001|Overall Study|Adverse Event|1|||
163077658|NCT00987935|588991332|FG002|Overall Study|Adverse Event|0|||
163077659|NCT00987935|588991333|FG003|Overall Study|Adverse Event|1|||
163077660|NCT00987935|588991334|FG004|Overall Study|Adverse Event|1|||
163077661|NCT00987935|588991335|FG005|Overall Study|Adverse Event|0|||
163077662|NCT00987935|588991336|FG006|Overall Study|Adverse Event|2|||
163077663|NCT00987935|588991337|FG007|Overall Study|Adverse Event|10|||
163077664|NCT00987935|588991338|FG008|Overall Study|Adverse Event|6|||
163077665|NCT00987935|588991330|FG000|Overall Study|Refused to continue taking trial med.|1|||
163077666|NCT00987935|588991331|FG001|Overall Study|Refused to continue taking trial med.|0|||
163077667|NCT00987935|588991332|FG002|Overall Study|Refused to continue taking trial med.|0|||
163077668|NCT00987935|588991333|FG003|Overall Study|Refused to continue taking trial med.|0|||
163077669|NCT00987935|588991334|FG004|Overall Study|Refused to continue taking trial med.|1|||
163077670|NCT00987935|588991335|FG005|Overall Study|Refused to continue taking trial med.|0|||
163077671|NCT00987935|588991336|FG006|Overall Study|Refused to continue taking trial med.|4|||
163077672|NCT00987935|588991337|FG007|Overall Study|Refused to continue taking trial med.|4|||
163077673|NCT00987935|588991338|FG008|Overall Study|Refused to continue taking trial med.|2|||
163077674|NCT00987935|588991330|FG000|Overall Study|Reason other than those specified above|0|||
163077675|NCT00987935|588991331|FG001|Overall Study|Reason other than those specified above|0|||
163077676|NCT00987935|588991332|FG002|Overall Study|Reason other than those specified above|0|||
163077677|NCT00987935|588991333|FG003|Overall Study|Reason other than those specified above|0|||
163077678|NCT00987935|588991334|FG004|Overall Study|Reason other than those specified above|0|||
163077679|NCT00987935|588991335|FG005|Overall Study|Reason other than those specified above|0|||
163077680|NCT00987935|588991336|FG006|Overall Study|Reason other than those specified above|0|||
163077681|NCT00987935|588991337|FG007|Overall Study|Reason other than those specified above|0|||
163077682|NCT00987935|588991338|FG008|Overall Study|Reason other than those specified above|1|||
163077683|NCT00452530|588991339|FG000|Overall Study|Death|1|||
163077684|NCT00452530|588991340|FG001|Overall Study|Death|0|||
163077685|NCT00452530|588991339|FG000|Overall Study|Adverse Event|40|||
163077686|NCT00452530|588991340|FG001|Overall Study|Adverse Event|44|||
163077687|NCT00452530|588991339|FG000|Overall Study|Withdrawal by Subject|68|||
163077688|NCT00452530|588991340|FG001|Overall Study|Withdrawal by Subject|57|||
163077689|NCT00452530|588991339|FG000|Overall Study|Lost to Follow-up|1|||
163077690|NCT00452530|588991340|FG001|Overall Study|Lost to Follow-up|0|||
163077691|NCT00452530|588991339|FG000|Overall Study|Poor compliance/noncompliance|1|||
163077692|NCT00452530|588991340|FG001|Overall Study|Poor compliance/noncompliance|2|||
163077693|NCT00452530|588991339|FG000|Overall Study|No longer met study criteria|18|||
163077694|NCT00452530|588991340|FG001|Overall Study|No longer met study criteria|22|||
163218812|NCT01293240|589517342|FG000|Overall Study|Noncompliance|2|||
163218813|NCT01520363|589517343|FG000|Overall Study|Withdrawal by Subject|2|||
163218814|NCT01520363|589517344|FG001|Overall Study|Withdrawal by Subject|0|||
163218815|NCT03165110|589517348|FG000|Overall Study|Anroid phone software incompatibility|1|||
163218816|NCT01498952|589517349|FG000|Overall Study|Death|2|||
163218817|NCT01498952|589517350|FG001|Overall Study|Death|2|||
163218818|NCT01498952|589517351|FG002|Overall Study|Death|0|||
163218819|NCT01498952|589517352|FG003|Overall Study|Death|0|||
163218820|NCT01498952|589517353|FG004|Overall Study|Death|0|||
163218821|NCT05533632|589517354|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
163218822|NCT05533632|589517354|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
163218823|NCT05533632|589517354|FG000|Overall Study|Lost to Follow-up|1|||
163218824|NCT05533632|589517354|FG000|Overall Study|Withdrawal by Subject|4|||
163218825|NCT05533632|589517354|FG000|Overall Study|Adverse Event|4|||
163218826|NCT00304356|589517355|FG000|Nitazoxanide|Physician Decision|5|||
163218827|NCT00304356|589517355|FG000|Nitazoxanide|Physician Decision|1|||
163218828|NCT00304356|589517355|FG000|Nitazoxanide|number is 0|1|||
163218829|NCT00304356|589517355|FG000|Nitazoxanide|Physician Decision|1|||
163218830|NCT00304356|589517355|FG000|Nitazoxanide|Physician Decision|1|||
163406427|NCT00621504|590198629|FG000|Overall Study|Withdrew consent|9|||
163218831|NCT00304356|589517355|FG000|Nitazoxanide|Physician Decision|1|||
163218832|NCT00973479|589517358|FG000|Overall Study|Lost to Follow-up|0|||
163218833|NCT00973479|589517359|FG001|Overall Study|Lost to Follow-up|3|||
163077695|NCT00452530|588991339|FG000|Overall Study|Other|7|||
163077696|NCT00452530|588991340|FG001|Overall Study|Other|11|||
163077697|NCT02191397|588991342|FG000|Overall Study|Adverse Event|28|||
163077698|NCT02191397|588991343|FG001|Overall Study|Adverse Event|17|||
163077699|NCT02191397|588991342|FG000|Overall Study|Lack of Efficacy|10|||
163077700|NCT02191397|588991343|FG001|Overall Study|Lack of Efficacy|5|||
163218834|NCT00973479|589517358|FG000|Overall Study|Death|2|||
163077701|NCT02191397|588991342|FG000|Overall Study|Protocol Violation|0|||
163077702|NCT02191397|588991343|FG001|Overall Study|Protocol Violation|3|||
163077703|NCT02191397|588991342|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
163077704|NCT02191397|588991343|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
163077705|NCT02191397|588991342|FG000|Overall Study|Lost to Follow-up|10|||
163077706|NCT02191397|588991343|FG001|Overall Study|Lost to Follow-up|11|||
163077707|NCT02191397|588991342|FG000|Overall Study|Physician Decision|8|||
163077708|NCT02191397|588991343|FG001|Overall Study|Physician Decision|3|||
163077709|NCT02191397|588991342|FG000|Overall Study|Withdrawal by Subject|22|||
163077710|NCT02191397|588991343|FG001|Overall Study|Withdrawal by Subject|27|||
163077711|NCT00728182|588991345|FG000|Overall Study|Adverse Event|1|||
163077712|NCT00728182|588991346|FG001|Overall Study|Adverse Event|0|||
163077713|NCT00728182|588991345|FG000|Overall Study|Lost to Follow-up|2|||
163077714|NCT00728182|588991346|FG001|Overall Study|Lost to Follow-up|0|||
163077715|NCT00728182|588991345|FG000|Overall Study|Death|0|||
163077716|NCT00728182|588991346|FG001|Overall Study|Death|2|||
163077717|NCT00728182|588991345|FG000|Overall Study|Protocol Noncompliance|0|||
163077718|NCT00728182|588991346|FG001|Overall Study|Protocol Noncompliance|1|||
163077719|NCT01898091|588991349|FG000|Overall Study|Lost to Follow-up|1|||
163077720|NCT01898091|588991350|FG001|Overall Study|Lost to Follow-up|1|||
163077721|NCT01898091|588991349|FG000|Overall Study|Withdrawal by Subject|1|||
163077722|NCT01898091|588991350|FG001|Overall Study|Withdrawal by Subject|5|||
163077723|NCT03888482|588991353|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
163077724|NCT03888482|588991354|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
163077725|NCT03888482|588991353|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
163077726|NCT03888482|588991354|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
163077727|NCT02294019|588991355|FG000|Overall Study|Adverse Event|2|||
163077728|NCT02294019|588991355|FG000|Overall Study|Protocol Violation|68|||
163077729|NCT02294019|588991355|FG000|Overall Study|Lost to Follow-up|31|||
163077730|NCT02294019|588991355|FG000|Overall Study|Other|1|||
163077731|NCT02294019|588991355|FG000|Overall Study|Withdrawal by Subject|1|||
163077732|NCT01189227|588991357|FG000|Overall Study|Study terminated due to low accrual|6|||
163077733|NCT01189227|588991358|FG001|Overall Study|Study terminated due to low accrual|3|||
163077734|NCT01016015|588991359|FG000|Overall Study|Not Treated|3|||
163077735|NCT01016015|588991359|FG000|Overall Study|Withdrawal by Subject|1|||
163077736|NCT01016015|588991359|FG000|Overall Study|Adverse Event|15|||
163077737|NCT00362609|588991365|FG000|Overall Study|Withdrawal by Subject|0|||
163077738|NCT00362609|588991366|FG001|Overall Study|Withdrawal by Subject|1|||
163077739|NCT00362609|588991365|FG000|Overall Study|Protocol Violation|0|||
163077740|NCT00362609|588991366|FG001|Overall Study|Protocol Violation|1|||
163077741|NCT02205359|588991367|FG000|Overall Study|Death|293|||
163077742|NCT02205359|588991368|FG001|Overall Study|Death|327|||
163077743|NCT02205359|588991367|FG000|Overall Study|Lost to Follow-up|182|||
163077744|NCT02205359|588991368|FG001|Overall Study|Lost to Follow-up|162|||
163077745|NCT02205359|588991367|FG000|Overall Study|Physician Decision|51|||
163077746|NCT02205359|588991368|FG001|Overall Study|Physician Decision|53|||
163077747|NCT02205359|588991367|FG000|Overall Study|Withdrawal by Subject|167|||
163077748|NCT02205359|588991368|FG001|Overall Study|Withdrawal by Subject|169|||
163077749|NCT00236197|588991369|FG000|Overall Study|Withdrawal by Subject|3|||
163077750|NCT00236197|588991370|FG001|Overall Study|Withdrawal by Subject|2|||
163077751|NCT00236197|588991369|FG000|Overall Study|Lost to Follow-up|1|||
163077752|NCT00236197|588991370|FG001|Overall Study|Lost to Follow-up|5|||
163077753|NCT00236197|588991369|FG000|Overall Study|Protocol Violation|0|||
163077754|NCT00236197|588991370|FG001|Overall Study|Protocol Violation|3|||
163077755|NCT00236197|588991369|FG000|Overall Study|Medication non-compliance|1|||
163077756|NCT00236197|588991370|FG001|Overall Study|Medication non-compliance|2|||
163077757|NCT00236197|588991369|FG000|Overall Study|Other|0|||
163077758|NCT00236197|588991370|FG001|Overall Study|Other|2|||
163077759|NCT00480025|588991371|FG000|Overall Study|Protocol Violation|12|||
163077760|NCT00480025|588991372|FG001|Overall Study|Protocol Violation|7|||
163077761|NCT00480025|588991371|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
163077762|NCT00480025|588991372|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
163077763|NCT00480025|588991371|FG000|Overall Study|Disease Progression / Recurrence|449|||
163077764|NCT00480025|588991372|FG001|Overall Study|Disease Progression / Recurrence|224|||
163077765|NCT00480025|588991371|FG000|Overall Study|Adverse Event|44|||
163077766|NCT00480025|588991372|FG001|Overall Study|Adverse Event|12|||
163077767|NCT00480025|588991371|FG000|Overall Study|Other|70|||
163077768|NCT00480025|588991372|FG001|Overall Study|Other|29|||
163077769|NCT00480025|588991371|FG000|Overall Study|SAE including intercurrent illness|76|||
163077770|NCT00480025|588991372|FG001|Overall Study|SAE including intercurrent illness|42|||
163077771|NCT03681093|588992987|FG000|Overall Study|Subject decision|0|||
163077772|NCT03681093|588992988|FG001|Overall Study|Subject decision|2|||
163077773|NCT03681093|588992989|FG002|Overall Study|Subject decision|1|||
163077774|NCT00368849|588992992|FG000|Overall Study|Withdrawal by Subject|0|||
163077775|NCT00368849|588992993|FG001|Overall Study|Withdrawal by Subject|1|||
163077776|NCT00368849|588992992|FG000|Overall Study|Physician Decision|0|||
163077777|NCT00368849|588992993|FG001|Overall Study|Physician Decision|1|||
163218835|NCT00973479|589517359|FG001|Overall Study|Death|2|||
163406428|NCT00621504|590198630|FG001|Overall Study|Withdrew consent|6|||
163077778|NCT01902303|588992994|FG000|Overall Study|Adverse Event|0|||
163077779|NCT01902303|588992995|FG001|Overall Study|Adverse Event|1|||
163077780|NCT01902303|588992994|FG000|Overall Study|Lost to Follow-up|0|||
163077781|NCT01902303|588992995|FG001|Overall Study|Lost to Follow-up|1|||
163077782|NCT01902303|588992994|FG000|Overall Study|Protocol Violation|2|||
163077783|NCT01902303|588992995|FG001|Overall Study|Protocol Violation|2|||
163077784|NCT01902303|588992994|FG000|Overall Study|subject lost investigational product|0|||
163077785|NCT01902303|588992995|FG001|Overall Study|subject lost investigational product|1|||
163077786|NCT01902303|588992994|FG000|Overall Study|Did not develop a cold sore|21|||
163077787|NCT01902303|588992995|FG001|Overall Study|Did not develop a cold sore|19|||
163077788|NCT01699685|588992996|FG000|Period 1|Adverse Event|1|||
163077789|NCT01699685|588992997|FG001|Period 1|Adverse Event|1|||
163077790|NCT01699685|588992996|FG000|Period 1|Medical or ethical, noncompliance|2|||
163077791|NCT01699685|588992997|FG001|Period 1|Medical or ethical, noncompliance|0|||
163077792|NCT01699685|588992996|FG000|Period 1|Other|0|||
163077793|NCT01699685|588992997|FG001|Period 1|Other|1|||
163077794|NCT01699685|588992996|FG000|Period 1|Patient request|0|||
163077795|NCT01699685|588992997|FG001|Period 1|Patient request|1|||
163077796|NCT01699685|588992996|FG000|Period 2|Lost to Follow-up|1|||
163077797|NCT01699685|588992997|FG001|Period 2|Lost to Follow-up|0|||
163077798|NCT03635996|588992998|FG000|Overall Study|Study terminated by Sponsor|94|||
163077799|NCT03635996|588992998|FG000|Overall Study|Withdrawal by Subject|20|||
163077800|NCT03635996|588992998|FG000|Overall Study|Ablation|26|||
163077801|NCT03635996|588992998|FG000|Overall Study|Adverse Event|7|||
163077802|NCT03635996|588992998|FG000|Overall Study|Physician Decision|3|||
163077803|NCT03635996|588992998|FG000|Overall Study|Prohibited medication|5|||
163077804|NCT03635996|588992998|FG000|Overall Study|Did not meet eligibility criteria|5|||
163077805|NCT03635996|588992998|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
163077806|NCT03635996|588992998|FG000|Overall Study|Protocol Violation|1|||
163077807|NCT03635996|588992998|FG000|Overall Study|Lost to Follow-up|1|||
163077808|NCT02821000|588992999|FG000|Overall Study|Death|89|||
163077809|NCT02821000|588992999|FG000|Overall Study|Sponsor Decision|12|||
163077810|NCT02821000|588992999|FG000|Overall Study|Withdrawal by Subject|2|||
163077811|NCT05058456|588993000|FG000|Overall Study|Death|1|||
163077812|NCT05058456|588993000|FG000|Overall Study|End of Study data not yet due for release|34|||
163077813|NCT02802865|588993001|FG000|Overall Study|Pregnancy|1|||
163077814|NCT02802865|588993002|FG001|Overall Study|Pregnancy|1|||
163077815|NCT02802865|588993001|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
163077816|NCT02802865|588993002|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
163077817|NCT01862029|588993003|FG000|Overall Study|Physician Decision|1|||
163077818|NCT03931785|588993004|FG000|Overall Study|Lost to Follow-up|4|||
163077819|NCT03931785|588993005|FG001|Overall Study|Lost to Follow-up|1|||
163077820|NCT03931785|588993006|FG002|Overall Study|Lost to Follow-up|4|||
163077821|NCT03931785|588993007|FG003|Overall Study|Lost to Follow-up|3|||
163077822|NCT03931785|588993004|FG000|Overall Study|Adverse Event|1|||
163077823|NCT03931785|588993005|FG001|Overall Study|Adverse Event|0|||
163077824|NCT03931785|588993006|FG002|Overall Study|Adverse Event|3|||
163077825|NCT03931785|588993007|FG003|Overall Study|Adverse Event|4|||
163077826|NCT03931785|588993004|FG000|Overall Study|Protocol Violation|0|||
163077827|NCT03931785|588993005|FG001|Overall Study|Protocol Violation|1|||
163077828|NCT03931785|588993006|FG002|Overall Study|Protocol Violation|0|||
163077829|NCT03931785|588993007|FG003|Overall Study|Protocol Violation|0|||
163077830|NCT03931785|588993004|FG000|Overall Study|Noncompliance With Study drug|0|||
163077831|NCT03931785|588993005|FG001|Overall Study|Noncompliance With Study drug|1|||
163077832|NCT03931785|588993006|FG002|Overall Study|Noncompliance With Study drug|0|||
163218836|NCT00973479|589517358|FG000|Overall Study|Withdrawal by Subject|15|||
163218837|NCT00973479|589517359|FG001|Overall Study|Withdrawal by Subject|16|||
163218838|NCT00973479|589517358|FG000|Overall Study|Lack of Efficacy|5|||
163218839|NCT00973479|589517359|FG001|Overall Study|Lack of Efficacy|7|||
163218840|NCT00973479|589517358|FG000|Overall Study|Adverse Event|12|||
163077833|NCT03931785|588993007|FG003|Overall Study|Noncompliance With Study drug|0|||
163077834|NCT03931785|588993004|FG000|Overall Study|Other Not specified|0|||
163077835|NCT03931785|588993005|FG001|Overall Study|Other Not specified|2|||
163077836|NCT03931785|588993006|FG002|Overall Study|Other Not specified|2|||
163077837|NCT03931785|588993007|FG003|Overall Study|Other Not specified|2|||
163077838|NCT03931785|588993004|FG000|Overall Study|Withdrawal by Subject|0|||
163077839|NCT03931785|588993005|FG001|Overall Study|Withdrawal by Subject|2|||
163077840|NCT03931785|588993006|FG002|Overall Study|Withdrawal by Subject|4|||
163077841|NCT03931785|588993007|FG003|Overall Study|Withdrawal by Subject|1|||
163077842|NCT03931785|588993004|FG000|Overall Study|Pregnancy|0|||
163077843|NCT03931785|588993005|FG001|Overall Study|Pregnancy|0|||
163077844|NCT03931785|588993006|FG002|Overall Study|Pregnancy|0|||
163077845|NCT03931785|588993007|FG003|Overall Study|Pregnancy|1|||
163077846|NCT01832038|588993008|FG000|Overall Study|Death|5|||
163077847|NCT01832038|588993008|FG000|Overall Study|Adverse Event|50|||
163077848|NCT01832038|588993008|FG000|Overall Study|Lack of Efficacy|81|||
163077849|NCT01832038|588993008|FG000|Overall Study|Protocol Violation|7|||
163077850|NCT01832038|588993008|FG000|Overall Study|Lost to Follow-up|10|||
163077851|NCT01832038|588993008|FG000|Overall Study|Withdrawal by Subject|49|||
163077852|NCT01832038|588993008|FG000|Overall Study|Visit non-compliance|2|||
163077853|NCT01832038|588993008|FG000|Overall Study|Subject refused to return visit|2|||
163077854|NCT01832038|588993008|FG000|Overall Study|Not convenient to come back to site|2|||
163077855|NCT01832038|588993008|FG000|Overall Study|Participant was asked to quit|5|||
163077856|NCT01832038|588993008|FG000|Overall Study|Back home|1|||
163077857|NCT01832038|588993008|FG000|Overall Study|Pregnancy|1|||
163077858|NCT01832038|588993008|FG000|Overall Study|Low compliance|3|||
163077859|NCT01832038|588993008|FG000|Overall Study|Prohibit procedure|2|||
163077860|NCT01832038|588993008|FG000|Overall Study|Not possible to visit the hospital|1|||
163077861|NCT01832038|588993008|FG000|Overall Study|Changes of implementation system|3|||
163077862|NCT01832038|588993008|FG000|Overall Study|Plan to pregnancy|7|||
163077863|NCT01832038|588993008|FG000|Overall Study|Bad mood and has suicidal thought|1|||
163077864|NCT01832038|588993008|FG000|Overall Study|Prohibited concomitant medication|1|||
163077865|NCT01832038|588993008|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
163077866|NCT01832038|588993008|FG000|Overall Study|Subject considered the efficacy was poor|1|||
163077867|NCT03810365|588993009|FG000|Overall Study|Lost to Follow-up|2|||
163077868|NCT03810365|588993010|FG001|Overall Study|Lost to Follow-up|2|||
163077869|NCT03810365|588993009|FG000|Overall Study|Withdrawal by Subject|4|||
163077870|NCT03810365|588993010|FG001|Overall Study|Withdrawal by Subject|5|||
163077871|NCT01292473|588993011|FG000|Overall Study|Adverse Event|1|||
163077872|NCT01292473|588993012|FG001|Overall Study|Adverse Event|0|||
163077873|NCT01292473|588993013|FG002|Overall Study|Adverse Event|1|||
163077874|NCT01292473|588993014|FG003|Overall Study|Adverse Event|1|||
163077875|NCT01292473|588993011|FG000|Overall Study|Lost to Follow-up|1|||
163077876|NCT01292473|588993012|FG001|Overall Study|Lost to Follow-up|1|||
163077877|NCT01292473|588993013|FG002|Overall Study|Lost to Follow-up|2|||
163077878|NCT01292473|588993014|FG003|Overall Study|Lost to Follow-up|2|||
163077879|NCT01292473|588993011|FG000|Overall Study|Withdrawal by Subject|3|||
163077880|NCT01292473|588993012|FG001|Overall Study|Withdrawal by Subject|4|||
163077881|NCT01292473|588993013|FG002|Overall Study|Withdrawal by Subject|3|||
163077882|NCT01292473|588993014|FG003|Overall Study|Withdrawal by Subject|3|||
163077883|NCT01292473|588993011|FG000|Overall Study|Physician Decision|0|||
163077884|NCT01292473|588993012|FG001|Overall Study|Physician Decision|1|||
163077885|NCT01292473|588993013|FG002|Overall Study|Physician Decision|0|||
163077886|NCT01292473|588993014|FG003|Overall Study|Physician Decision|0|||
163077887|NCT01292473|588993011|FG000|Overall Study|Disease Progression|0|||
163077888|NCT01292473|588993012|FG001|Overall Study|Disease Progression|1|||
163077889|NCT01292473|588993013|FG002|Overall Study|Disease Progression|3|||
163077890|NCT01292473|588993014|FG003|Overall Study|Disease Progression|6|||
163077891|NCT00449787|588993015|FG000|Overall Study|Lost to Follow-up|10|||
163077892|NCT00449787|588993016|FG001|Overall Study|Lost to Follow-up|8|||
163077893|NCT00449787|588993015|FG000|Overall Study|Did not require medication|95|||
163077894|NCT00449787|588993016|FG001|Overall Study|Did not require medication|92|||
163077895|NCT03574389|588993021|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
163077896|NCT03574389|588993022|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
163077897|NCT03574389|588993023|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
163077898|NCT03574389|588993024|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
163077899|NCT03574389|588993025|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
163077900|NCT03574389|588993026|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
163077901|NCT03574389|588993027|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
163077902|NCT03574389|588993021|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
163077903|NCT03574389|588993022|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
163077904|NCT03574389|588993023|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
163077905|NCT03574389|588993024|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
163077906|NCT03574389|588993025|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
163077907|NCT03574389|588993026|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
163077908|NCT03574389|588993027|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
163077909|NCT03574389|588993021|FG000|Vaccination Period|Other|6|||
163077910|NCT03574389|588993022|FG001|Vaccination Period|Other|0|||
163077911|NCT03574389|588993023|FG002|Vaccination Period|Other|0|||
163218841|NCT00973479|589517359|FG001|Overall Study|Adverse Event|32|||
163218842|NCT00973479|589517358|FG000|Overall Study|Protocol Violation|2|||
163077912|NCT03574389|588993024|FG003|Vaccination Period|Other|0|||
163077913|NCT03574389|588993025|FG004|Vaccination Period|Other|0|||
163077914|NCT03574389|588993026|FG005|Vaccination Period|Other|0|||
163218843|NCT00973479|589517359|FG001|Overall Study|Protocol Violation|2|||
163077915|NCT03574389|588993027|FG006|Vaccination Period|Other|0|||
163077916|NCT03574389|588993021|FG000|Vaccination Period|Adverse Event|0|||
163077917|NCT03574389|588993022|FG001|Vaccination Period|Adverse Event|1|||
163077918|NCT03574389|588993023|FG002|Vaccination Period|Adverse Event|0|||
163077919|NCT03574389|588993024|FG003|Vaccination Period|Adverse Event|0|||
163077920|NCT03574389|588993025|FG004|Vaccination Period|Adverse Event|0|||
163077921|NCT03574389|588993026|FG005|Vaccination Period|Adverse Event|0|||
163077922|NCT03574389|588993027|FG006|Vaccination Period|Adverse Event|0|||
163218844|NCT00973479|589517358|FG000|Overall Study|Other|1|||
163218845|NCT00973479|589517359|FG001|Overall Study|Other|7|||
163077923|NCT03574389|588993021|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
163077924|NCT03574389|588993022|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
163077925|NCT03574389|588993023|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
163077926|NCT03574389|588993024|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
163077927|NCT03574389|588993025|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
163077928|NCT03574389|588993026|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
163077929|NCT03574389|588993027|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
163077930|NCT02094885|588993032|FG000|Overall Study|Death|1|||
163077931|NCT02094885|588993033|FG001|Overall Study|Death|5|||
163077932|NCT02094885|588993032|FG000|Overall Study|Withdrawn due to age|1|||
163077933|NCT02094885|588993033|FG001|Overall Study|Withdrawn due to age|0|||
163077934|NCT00337194|588993034|FG000|Overall Study|Adverse Event|5|||
163077935|NCT00337194|588993035|FG001|Overall Study|Adverse Event|1|||
163077936|NCT00337194|588993034|FG000|Overall Study|Death|2|||
163077937|NCT00337194|588993035|FG001|Overall Study|Death|0|||
163077938|NCT00337194|588993034|FG000|Overall Study|Withdrawal by Subject|1|||
163077939|NCT00337194|588993035|FG001|Overall Study|Withdrawal by Subject|0|||
163077940|NCT00337194|588993034|FG000|Overall Study|Disease progression|1|||
163077941|NCT00337194|588993035|FG001|Overall Study|Disease progression|2|||
163077942|NCT00337194|588993034|FG000|Overall Study|Subsequent non-protocol therapy|3|||
163077943|NCT00337194|588993035|FG001|Overall Study|Subsequent non-protocol therapy|1|||
163077944|NCT01061710|588993038|FG000|Overall Study|Protocol Violation|14|||
163077945|NCT01903720|588993039|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
163077946|NCT01903720|588993039|FG000|Overall Study|Adverse Event|1|||
163077947|NCT01903720|588993039|FG000|Overall Study|Rescinding of informed consent|2|||
163077948|NCT01903720|588993039|FG000|Overall Study|Lost to Follow-up|2|||
163077949|NCT01903720|588993039|FG000|Overall Study|Treatment with alternative drug|1|||
163077950|NCT00159874|588993040|FG000|Overall Study|Adverse Event|2|||
163077951|NCT00159874|588993041|FG001|Overall Study|Adverse Event|2|||
163077952|NCT00159874|588993042|FG002|Overall Study|Adverse Event|5|||
163077953|NCT00159874|588993043|FG003|Overall Study|Adverse Event|1|||
163077954|NCT00159874|588993044|FG004|Overall Study|Adverse Event|1|||
163077955|NCT00159874|588993045|FG005|Overall Study|Adverse Event|2|||
163077956|NCT00159874|588993046|FG006|Overall Study|Adverse Event|0|||
163077957|NCT00159874|588993040|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
163077958|NCT00159874|588993041|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
163077959|NCT00159874|588993042|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
163077960|NCT00159874|588993043|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
163077961|NCT00159874|588993044|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
163077962|NCT00159874|588993045|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
163077963|NCT00159874|588993046|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
163077964|NCT00159874|588993040|FG000|Overall Study|Lack of Efficacy|2|||
163077965|NCT00159874|588993041|FG001|Overall Study|Lack of Efficacy|0|||
163077966|NCT00159874|588993042|FG002|Overall Study|Lack of Efficacy|1|||
163077967|NCT00159874|588993043|FG003|Overall Study|Lack of Efficacy|1|||
163077968|NCT00159874|588993044|FG004|Overall Study|Lack of Efficacy|0|||
163077969|NCT00159874|588993045|FG005|Overall Study|Lack of Efficacy|3|||
163077970|NCT00159874|588993046|FG006|Overall Study|Lack of Efficacy|0|||
163077971|NCT00159874|588993040|FG000|Overall Study|Lost to Follow-up|1|||
163077972|NCT00159874|588993041|FG001|Overall Study|Lost to Follow-up|0|||
163077973|NCT00159874|588993042|FG002|Overall Study|Lost to Follow-up|3|||
163077974|NCT00159874|588993043|FG003|Overall Study|Lost to Follow-up|0|||
163077975|NCT00159874|588993044|FG004|Overall Study|Lost to Follow-up|1|||
163077976|NCT00159874|588993045|FG005|Overall Study|Lost to Follow-up|2|||
163077977|NCT00159874|588993046|FG006|Overall Study|Lost to Follow-up|1|||
163077978|NCT00159874|588993040|FG000|Overall Study|Other|8|||
163077979|NCT00159874|588993041|FG001|Overall Study|Other|8|||
163077980|NCT00159874|588993042|FG002|Overall Study|Other|8|||
163077981|NCT00159874|588993043|FG003|Overall Study|Other|0|||
163077982|NCT00159874|588993044|FG004|Overall Study|Other|2|||
163077983|NCT00159874|588993045|FG005|Overall Study|Other|1|||
163077984|NCT00159874|588993046|FG006|Overall Study|Other|3|||
163077985|NCT00159874|588993040|FG000|Overall Study|Protocol Violation|0|||
163077986|NCT00159874|588993041|FG001|Overall Study|Protocol Violation|5|||
163077987|NCT00159874|588993042|FG002|Overall Study|Protocol Violation|2|||
163077988|NCT00159874|588993043|FG003|Overall Study|Protocol Violation|0|||
163077989|NCT00159874|588993044|FG004|Overall Study|Protocol Violation|0|||
163077990|NCT00159874|588993045|FG005|Overall Study|Protocol Violation|0|||
163077991|NCT00159874|588993046|FG006|Overall Study|Protocol Violation|0|||
163077992|NCT00159874|588993040|FG000|Overall Study|Death|3|||
163077993|NCT00159874|588993041|FG001|Overall Study|Death|8|||
163077994|NCT00159874|588993042|FG002|Overall Study|Death|15|||
163406429|NCT00621504|590198629|FG000|Overall Study|Lost to Follow-up|8|||
163077995|NCT00159874|588993043|FG003|Overall Study|Death|0|||
163077996|NCT00159874|588993044|FG004|Overall Study|Death|1|||
163077997|NCT00159874|588993045|FG005|Overall Study|Death|2|||
163077998|NCT00159874|588993046|FG006|Overall Study|Death|0|||
163077999|NCT00159874|588993040|FG000|Overall Study|Withdrawal by Subject|2|||
163078000|NCT00159874|588993041|FG001|Overall Study|Withdrawal by Subject|6|||
163331897|NCT03057600|589925607|FG002|Overall Study|Study Termination by Sponsor|0|||
163331898|NCT03057600|589925608|FG003|Overall Study|Study Termination by Sponsor|2|||
163331899|NCT03057600|589925605|FG000|Overall Study|Withdrawal by Subject|0|||
163331900|NCT03057600|589925606|FG001|Overall Study|Withdrawal by Subject|1|||
163331901|NCT03057600|589925607|FG002|Overall Study|Withdrawal by Subject|0|||
163331902|NCT03057600|589925608|FG003|Overall Study|Withdrawal by Subject|0|||
163331903|NCT03057600|589925605|FG000|Overall Study|Other, Not Specified|1|||
163331904|NCT03057600|589925606|FG001|Overall Study|Other, Not Specified|1|||
163331905|NCT03057600|589925607|FG002|Overall Study|Other, Not Specified|1|||
163331906|NCT03057600|589925608|FG003|Overall Study|Other, Not Specified|1|||
163331907|NCT02091752|589925609|FG000|Overall Study|Study terminated by Sponsor|2|||
163331908|NCT02091752|589925609|FG000|Overall Study|Adverse Event|1|||
163331909|NCT01604824|589925616|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
163331910|NCT01604824|589925617|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
163331911|NCT01604824|589925618|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
163331912|NCT01604824|589925619|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
163331913|NCT01604824|589925620|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
163331914|NCT01604824|589925621|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
163331915|NCT01604824|589925616|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
163331916|NCT01604824|589925617|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
163331917|NCT01604824|589925618|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
163331918|NCT01604824|589925619|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
163331919|NCT01604824|589925620|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
163331920|NCT01604824|589925621|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
163331921|NCT02630966|589925622|FG000|Overall Study|Adverse Event|1|||
163029223|NCT03932331|588810382|FG002|Overall Study|Lung infection|0|||
163029224|NCT03932331|588810380|FG000|Overall Study|Other|0|||
163029225|NCT03932331|588810381|FG001|Overall Study|Other|0|||
163029226|NCT03932331|588810382|FG002|Overall Study|Other|58|||
163029227|NCT01032239|588810383|FG000|Overall Study|Lost to Follow-up|3|||
163029228|NCT01032239|588810384|FG001|Overall Study|Lost to Follow-up|2|||
163029229|NCT01032239|588810383|FG000|Overall Study|Withdrawal by Subject|2|||
163029230|NCT01032239|588810384|FG001|Overall Study|Withdrawal by Subject|3|||
163029231|NCT01032239|588810383|FG000|Overall Study|Death|1|||
163029232|NCT01032239|588810384|FG001|Overall Study|Death|0|||
163029233|NCT01032239|588810383|FG000|Overall Study|Protocol Violation|1|||
163029234|NCT01032239|588810384|FG001|Overall Study|Protocol Violation|0|||
163029235|NCT00204477|588810385|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
163029236|NCT00204477|588810386|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
163029237|NCT00204477|588810385|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
163029238|NCT00204477|588810386|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
163029239|NCT01940900|588810389|FG000|Overall Study|Physician Decision|4|||
163029240|NCT01940900|588810390|FG001|Overall Study|Physician Decision|0|||
163029241|NCT01940900|588810389|FG000|Overall Study|Adverse Event|10|||
163029242|NCT01940900|588810390|FG001|Overall Study|Adverse Event|15|||
163029243|NCT01940900|588810389|FG000|Overall Study|Withdrawal by Subject|11|||
163029244|NCT01940900|588810390|FG001|Overall Study|Withdrawal by Subject|15|||
163029245|NCT01940900|588810389|FG000|Overall Study|Lost to Follow-up|1|||
163029246|NCT01940900|588810390|FG001|Overall Study|Lost to Follow-up|0|||
163029247|NCT01940900|588810389|FG000|Overall Study|Sponsor Decision|1|||
163029248|NCT01940900|588810390|FG001|Overall Study|Sponsor Decision|0|||
163029249|NCT01940900|588810389|FG000|Overall Study|subject non-compliance|1|||
163029250|NCT01940900|588810390|FG001|Overall Study|subject non-compliance|1|||
163029251|NCT01940900|588810389|FG000|Overall Study|other|1|||
163029252|NCT01940900|588810390|FG001|Overall Study|other|0|||
163029253|NCT04713592|588810391|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
163029254|NCT04713592|588810392|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
163029255|NCT04713592|588810393|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
163029256|NCT04713592|588810394|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
163029257|NCT04713592|588810391|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
163029258|NCT04713592|588810392|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
163029259|NCT04713592|588810393|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
163029260|NCT04713592|588810394|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
163029261|NCT04713592|588810391|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
163029262|NCT04713592|588810392|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
163029263|NCT04713592|588810393|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
163029264|NCT04713592|588810394|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
163029265|NCT04713592|588810391|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163029266|NCT04713592|588810392|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163331922|NCT02630966|589925623|FG001|Overall Study|Adverse Event|3|||
163029267|NCT04713592|588810393|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
163078001|NCT00159874|588993042|FG002|Overall Study|Withdrawal by Subject|8|||
163078002|NCT00159874|588993043|FG003|Overall Study|Withdrawal by Subject|4|||
163078003|NCT00159874|588993044|FG004|Overall Study|Withdrawal by Subject|3|||
163078004|NCT00159874|588993045|FG005|Overall Study|Withdrawal by Subject|2|||
163078005|NCT00159874|588993046|FG006|Overall Study|Withdrawal by Subject|1|||
163078006|NCT00159874|588993040|FG000|Overall Study|Pregnancy|1|||
163078007|NCT00159874|588993041|FG001|Overall Study|Pregnancy|1|||
163078008|NCT00159874|588993042|FG002|Overall Study|Pregnancy|0|||
163078009|NCT00159874|588993043|FG003|Overall Study|Pregnancy|0|||
163078010|NCT00159874|588993044|FG004|Overall Study|Pregnancy|0|||
163078011|NCT00159874|588993045|FG005|Overall Study|Pregnancy|0|||
163078012|NCT00159874|588993046|FG006|Overall Study|Pregnancy|0|||
163078013|NCT01104870|588993047|FG000|Overall Study|Adverse Event|1|||
163078014|NCT01104870|588993048|FG001|Overall Study|Adverse Event|1|||
163078015|NCT01104870|588993049|FG002|Overall Study|Adverse Event|0|||
163078016|NCT01104870|588993047|FG000|Overall Study|Death|0|||
163078017|NCT01104870|588993048|FG001|Overall Study|Death|0|||
163078018|NCT01104870|588993049|FG002|Overall Study|Death|1|||
163078019|NCT01104870|588993047|FG000|Overall Study|Withdrawal by Subject|0|||
163078020|NCT01104870|588993048|FG001|Overall Study|Withdrawal by Subject|0|||
163078021|NCT01104870|588993049|FG002|Overall Study|Withdrawal by Subject|1|||
163078022|NCT02771145|588993051|FG000|Overall Study|Adverse Event|3|||
163078023|NCT02771145|588993051|FG000|Overall Study|Lost to Follow-up|1|||
163078024|NCT00276380|588993052|FG000|Overall Study|Adverse Event|5|||
163078025|NCT00276380|588993053|FG001|Overall Study|Adverse Event|3|||
163078026|NCT00276380|588993052|FG000|Overall Study|Lost to Follow-up|1|||
163078027|NCT00276380|588993053|FG001|Overall Study|Lost to Follow-up|1|||
163078028|NCT00276380|588993052|FG000|Overall Study|Withdrawal by Subject|3|||
163078029|NCT00276380|588993053|FG001|Overall Study|Withdrawal by Subject|6|||
163078030|NCT00276380|588993052|FG000|Overall Study|Death|5|||
163078031|NCT00276380|588993053|FG001|Overall Study|Death|3|||
163078032|NCT00276380|588993052|FG000|Overall Study|Abnormal aPPT Levels|0|||
163078033|NCT00276380|588993053|FG001|Overall Study|Abnormal aPPT Levels|1|||
163078034|NCT03654326|588993054|FG000|Overall Study|Withdrawal by Subject|5|||
163078035|NCT03654326|588993055|FG001|Overall Study|Withdrawal by Subject|3|||
163078036|NCT03654326|588993054|FG000|Overall Study|Physician Decision|0|||
163078037|NCT03654326|588993055|FG001|Overall Study|Physician Decision|1|||
163078038|NCT03654326|588993054|FG000|Overall Study|Unable to adhere to study schedule|0|||
163078039|NCT03654326|588993055|FG001|Overall Study|Unable to adhere to study schedule|1|||
163078040|NCT03654326|588993054|FG000|Overall Study|Lost to Follow-up|1|||
163078041|NCT03654326|588993055|FG001|Overall Study|Lost to Follow-up|1|||
163078042|NCT05287685|588993056|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
163078043|NCT05287685|588993057|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
163078044|NCT05287685|588993056|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
163078045|NCT05287685|588993057|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
163078046|NCT04829214|588993058|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
163078047|NCT04829214|588993059|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
163078048|NCT04829214|588993058|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
163078049|NCT04829214|588993059|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
163078050|NCT04008069|588993060|FG000|Open-Label Period|Adverse Event|1|||
163078051|NCT04008069|588993061|FG001|Open-Label Period|Adverse Event|0|||
163078052|NCT04008069|588993062|FG002|Open-Label Period|Adverse Event|0|||
163078053|NCT04008069|588993060|FG000|Open-Label Period|Lack of Efficacy|4|||
163078054|NCT04008069|588993061|FG001|Open-Label Period|Lack of Efficacy|0|||
163078055|NCT04008069|588993062|FG002|Open-Label Period|Lack of Efficacy|0|||
163078056|NCT04008069|588993060|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
163078057|NCT04008069|588993061|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
163078058|NCT04008069|588993062|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
163331923|NCT02630966|589925622|FG000|Overall Study|Significant Protocol Deviation|0|||
163331924|NCT02630966|589925623|FG001|Overall Study|Significant Protocol Deviation|2|||
163331925|NCT02630966|589925622|FG000|Overall Study|Voluntary Withdrawal|1|||
163331926|NCT02630966|589925623|FG001|Overall Study|Voluntary Withdrawal|1|||
163331927|NCT02630966|589925622|FG000|Overall Study|Lack of Efficacy|0|||
163078059|NCT04008069|588993060|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
163078060|NCT04008069|588993061|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
163078061|NCT04008069|588993062|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
163078062|NCT00511199|588993063|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
163078063|NCT00511199|588993064|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
163078064|NCT00511199|588993063|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
163078065|NCT00511199|588993064|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
163078066|NCT00511199|588993063|FG000|Overall Study|Withdrawal of Informed Consent|19|||
163078067|NCT00511199|588993064|FG001|Overall Study|Withdrawal of Informed Consent|4|||
163331928|NCT02630966|589925623|FG001|Overall Study|Lack of Efficacy|2|||
163331929|NCT02060487|589925652|FG000|Overall Study|Other|1|||
163078068|NCT00511199|588993063|FG000|Overall Study|Pregnancy|6|||
163331930|NCT02060487|589925653|FG001|Overall Study|Other|2|||
163331931|NCT02060487|589925654|FG002|Overall Study|Other|1|||
163331932|NCT02060487|589925652|FG000|Overall Study|Lack of Efficacy|0|||
163331933|NCT02060487|589925653|FG001|Overall Study|Lack of Efficacy|1|||
163078069|NCT00511199|588993064|FG001|Overall Study|Pregnancy|3|||
163078070|NCT00511199|588993063|FG000|Overall Study|Pregnancy Wish|16|||
163078071|NCT00511199|588993064|FG001|Overall Study|Pregnancy Wish|8|||
163078072|NCT00511199|588993063|FG000|Overall Study|Lost to Follow-up|40|||
163078073|NCT00511199|588993064|FG001|Overall Study|Lost to Follow-up|17|||
163078074|NCT00511199|588993063|FG000|Overall Study|Other Reason|78|||
163078075|NCT00511199|588993064|FG001|Overall Study|Other Reason|37|||
163078076|NCT01570192|588993072|FG000|Overall Study|no qualifying organism|6|||
163078077|NCT01570192|588993073|FG001|Overall Study|no qualifying organism|12|||
163078078|NCT01570192|588993072|FG000|Overall Study|changed to palliative care|1|||
163078079|NCT01570192|588993073|FG001|Overall Study|changed to palliative care|0|||
163078080|NCT01570192|588993072|FG000|Overall Study|Physician Decision|0|||
163078081|NCT01570192|588993073|FG001|Overall Study|Physician Decision|1|||
163078082|NCT02965976|588993074|FG000|Overall Study|Withdrawal by Subject|2|||
163078083|NCT02965976|588993075|FG001|Overall Study|Withdrawal by Subject|0|||
163078084|NCT00819832|588993076|FG000|Overall Study|Sponsor Termination of Study|3|||
163078085|NCT00819832|588993077|FG001|Overall Study|Sponsor Termination of Study|0|||
163078086|NCT00819832|588993078|FG002|Overall Study|Sponsor Termination of Study|0|||
163078087|NCT00819832|588993079|FG003|Overall Study|Sponsor Termination of Study|0|||
163078088|NCT00819832|588993080|FG004|Overall Study|Sponsor Termination of Study|0|||
163078089|NCT00819832|588993081|FG005|Overall Study|Sponsor Termination of Study|0|||
163078090|NCT01063881|588993082|FG000|Overall Study|Adverse Event|12|||
163078091|NCT01063881|588993083|FG001|Overall Study|Adverse Event|2|||
163078092|NCT01063881|588993084|FG002|Overall Study|Adverse Event|0|||
163078093|NCT01063881|588993082|FG000|Overall Study|Lost to Follow-up|13|||
163078094|NCT01063881|588993083|FG001|Overall Study|Lost to Follow-up|7|||
163078095|NCT01063881|588993084|FG002|Overall Study|Lost to Follow-up|1|||
163078096|NCT01063881|588993082|FG000|Overall Study|Withdrawal by Subject|25|||
163078097|NCT01063881|588993083|FG001|Overall Study|Withdrawal by Subject|1|||
163078098|NCT01063881|588993084|FG002|Overall Study|Withdrawal by Subject|0|||
163078099|NCT01063881|588993082|FG000|Overall Study|Reason for not completed not specified|5|||
163078100|NCT01063881|588993083|FG001|Overall Study|Reason for not completed not specified|1|||
163078101|NCT01063881|588993084|FG002|Overall Study|Reason for not completed not specified|0|||
163078102|NCT00407030|588993085|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
163078103|NCT00407030|588993086|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
163078104|NCT00407030|588993087|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
163078105|NCT00407030|588993085|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
163078106|NCT00407030|588993086|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
163078107|NCT00407030|588993087|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
163078108|NCT00407030|588993085|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
163078109|NCT00407030|588993086|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
163078110|NCT00407030|588993087|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
163078111|NCT00407030|588993085|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
163078112|NCT00407030|588993086|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
163078113|NCT00407030|588993087|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
163078114|NCT00407030|588993085|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
163078115|NCT00407030|588993086|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
163078116|NCT00407030|588993087|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
163078117|NCT00407030|588993085|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
163078118|NCT00407030|588993086|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
163078119|NCT00407030|588993087|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
163078120|NCT00407030|588993085|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
163078121|NCT00407030|588993086|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
163078122|NCT00407030|588993087|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
163078123|NCT00407030|588993085|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
163078124|NCT00407030|588993086|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
163078125|NCT00407030|588993087|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
163078126|NCT00407030|588993085|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
163078127|NCT00407030|588993086|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
163078128|NCT00407030|588993087|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
163078129|NCT00407030|588993085|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
163078130|NCT00407030|588993086|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
163078131|NCT00407030|588993087|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
163078132|NCT00407030|588993085|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
163078133|NCT00407030|588993086|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
163078134|NCT00407030|588993087|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
163078135|NCT00407030|588993085|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
163331934|NCT02060487|589925654|FG002|Overall Study|Lack of Efficacy|0|||
163331935|NCT02060487|589925652|FG000|Overall Study|Withdrawal by Subject|3|||
163078136|NCT00407030|588993086|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
163078137|NCT00407030|588993087|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
163078138|NCT00407030|588993085|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
163078139|NCT00407030|588993086|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
163078140|NCT00407030|588993087|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
163078141|NCT00736476|588993088|FG000|Overall Study|Adverse Event|1|||
163078142|NCT00736476|588993089|FG001|Overall Study|Adverse Event|0|||
163078143|NCT01370642|588993090|FG000|Overall Study|Adverse Event|2|||
163078144|NCT01370642|588993091|FG001|Overall Study|Adverse Event|1|||
163078145|NCT01370642|588993092|FG002|Overall Study|Adverse Event|1|||
163078146|NCT01370642|588993090|FG000|Overall Study|Detectable HCV RNA|0|||
163078147|NCT01370642|588993091|FG001|Overall Study|Detectable HCV RNA|0|||
163078148|NCT01370642|588993092|FG002|Overall Study|Detectable HCV RNA|22|||
163078149|NCT01370642|588993090|FG000|Overall Study|Lost to Follow-up|0|||
163078150|NCT01370642|588993091|FG001|Overall Study|Lost to Follow-up|0|||
163406430|NCT00621504|590198630|FG001|Overall Study|Lost to Follow-up|10|||
163406431|NCT00621504|590198629|FG000|Overall Study|Other|1|||
163406432|NCT00621504|590198630|FG001|Overall Study|Other|0|||
163406433|NCT00621504|590198629|FG000|Overall Study|Death|6|||
163406434|NCT00621504|590198630|FG001|Overall Study|Death|6|||
163406435|NCT03311711|590198635|FG000|Overall Study|Death|1|||
163406436|NCT03311711|590198636|FG001|Overall Study|Death|0|||
163406437|NCT03311711|590198637|FG002|Overall Study|Death|0|||
163406438|NCT03311711|590198638|FG003|Overall Study|Death|0|||
163406439|NCT03311711|590198639|FG004|Overall Study|Death|0|||
163406440|NCT03311711|590198640|FG005|Overall Study|Death|0|||
163078151|NCT01370642|588993092|FG002|Overall Study|Lost to Follow-up|1|||
163078152|NCT01370642|588993090|FG000|Overall Study|Physician Decision|4|||
163078153|NCT01370642|588993091|FG001|Overall Study|Physician Decision|1|||
163078154|NCT01370642|588993092|FG002|Overall Study|Physician Decision|2|||
163078155|NCT01370642|588993090|FG000|Overall Study|Withdrawal by Subject|2|||
163078156|NCT01370642|588993091|FG001|Overall Study|Withdrawal by Subject|4|||
163078157|NCT01370642|588993092|FG002|Overall Study|Withdrawal by Subject|3|||
163078158|NCT01796470|588993093|FG000|Overall Study|Adverse Event|4|||
163078159|NCT01796470|588993094|FG001|Overall Study|Adverse Event|2|||
163078160|NCT01796470|588993095|FG002|Overall Study|Adverse Event|2|||
163078161|NCT01796470|588993096|FG003|Overall Study|Adverse Event|1|||
163078162|NCT01796470|588993097|FG004|Overall Study|Adverse Event|3|||
163078163|NCT01796470|588993093|FG000|Overall Study|Death|2|||
163078164|NCT01796470|588993094|FG001|Overall Study|Death|0|||
163078165|NCT01796470|588993095|FG002|Overall Study|Death|0|||
163078166|NCT01796470|588993096|FG003|Overall Study|Death|0|||
163078167|NCT01796470|588993097|FG004|Overall Study|Death|1|||
163078168|NCT01796470|588993093|FG000|Overall Study|Initiated New Therapy|9|||
163078169|NCT01796470|588993094|FG001|Overall Study|Initiated New Therapy|0|||
163078170|NCT01796470|588993095|FG002|Overall Study|Initiated New Therapy|0|||
163078171|NCT01796470|588993096|FG003|Overall Study|Initiated New Therapy|0|||
163078172|NCT01796470|588993097|FG004|Overall Study|Initiated New Therapy|2|||
163078173|NCT01796470|588993093|FG000|Overall Study|Lost to Follow-up|0|||
163078174|NCT01796470|588993094|FG001|Overall Study|Lost to Follow-up|1|||
163078175|NCT01796470|588993095|FG002|Overall Study|Lost to Follow-up|0|||
163078176|NCT01796470|588993096|FG003|Overall Study|Lost to Follow-up|0|||
163078177|NCT01796470|588993097|FG004|Overall Study|Lost to Follow-up|0|||
163078178|NCT01796470|588993093|FG000|Overall Study|Physician Decision|5|||
163078179|NCT01796470|588993094|FG001|Overall Study|Physician Decision|4|||
163078180|NCT01796470|588993095|FG002|Overall Study|Physician Decision|1|||
163078181|NCT01796470|588993096|FG003|Overall Study|Physician Decision|0|||
163218846|NCT05075850|589517360|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
163218847|NCT04256785|589517361|FG000|Overall Study|Adverse Event|8|||
163078182|NCT01796470|588993097|FG004|Overall Study|Physician Decision|1|||
163078183|NCT01796470|588993093|FG000|Overall Study|Progressive Disease|7|||
163078184|NCT01796470|588993094|FG001|Overall Study|Progressive Disease|7|||
163078185|NCT01796470|588993095|FG002|Overall Study|Progressive Disease|3|||
163078186|NCT01796470|588993096|FG003|Overall Study|Progressive Disease|2|||
163078187|NCT01796470|588993097|FG004|Overall Study|Progressive Disease|0|||
163078188|NCT01796470|588993093|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
163078189|NCT01796470|588993094|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
163078190|NCT01796470|588993095|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
163078191|NCT01796470|588993096|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
163078192|NCT01796470|588993097|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
163218848|NCT04256785|589517362|FG001|Overall Study|Adverse Event|6|||
163078193|NCT01796470|588993093|FG000|Overall Study|Withdrawal by Subject|7|||
163078194|NCT01796470|588993094|FG001|Overall Study|Withdrawal by Subject|0|||
163078195|NCT01796470|588993095|FG002|Overall Study|Withdrawal by Subject|0|||
163078196|NCT01796470|588993096|FG003|Overall Study|Withdrawal by Subject|0|||
163078197|NCT01796470|588993097|FG004|Overall Study|Withdrawal by Subject|1|||
163406441|NCT03311711|590198641|FG006|Overall Study|Death|1|||
163406442|NCT03311711|590198642|FG007|Overall Study|Death|0|||
163406443|NCT03311711|590198643|FG008|Overall Study|Death|1|||
163078198|NCT04818086|588993104|FG000|Overall Study|Physician Decision|1|||
163078199|NCT04818086|588993105|FG001|Overall Study|Physician Decision|0|||
163078200|NCT04818086|588993104|FG000|Overall Study|Withdrawal by Subject|0|||
163078201|NCT04818086|588993105|FG001|Overall Study|Withdrawal by Subject|1|||
163078202|NCT04128228|588993107|FG000|Overall Study|Withdrawal by Subject|3|||
163078203|NCT04128228|588993108|FG001|Overall Study|Withdrawal by Subject|3|||
163078204|NCT04128228|588993109|FG002|Overall Study|Withdrawal by Subject|0|||
163078205|NCT04128228|588993110|FG003|Overall Study|Withdrawal by Subject|0|||
163078206|NCT04128228|588993107|FG000|Overall Study|noncompliance|2|||
163078207|NCT04128228|588993108|FG001|Overall Study|noncompliance|2|||
163078208|NCT04128228|588993109|FG002|Overall Study|noncompliance|0|||
163078209|NCT04128228|588993110|FG003|Overall Study|noncompliance|0|||
163078210|NCT01117350|588993111|FG000|Comparative Period|Not Treated|5|||
163078211|NCT01117350|588993112|FG001|Comparative Period|Not Treated|8|||
163078212|NCT01117350|588993111|FG000|Comparative Period|Adverse Event|6|||
163078213|NCT01117350|588993112|FG001|Comparative Period|Adverse Event|33|||
163078214|NCT01117350|588993111|FG000|Comparative Period|Lost to Follow-up|11|||
163078215|NCT01117350|588993112|FG001|Comparative Period|Lost to Follow-up|7|||
163078216|NCT01117350|588993111|FG000|Comparative Period|Withdrawal by Subject|9|||
163078217|NCT01117350|588993112|FG001|Comparative Period|Withdrawal by Subject|13|||
163078218|NCT01117350|588993111|FG000|Comparative Period|Protocol Violation|8|||
163078219|NCT01117350|588993112|FG001|Comparative Period|Protocol Violation|12|||
163078220|NCT01117350|588993111|FG000|Comparative Period|Lack of Efficacy|1|||
163078221|NCT01117350|588993112|FG001|Comparative Period|Lack of Efficacy|0|||
163078222|NCT01117350|588993111|FG000|Comparative Period|Physician Decision|0|||
163078223|NCT01117350|588993112|FG001|Comparative Period|Physician Decision|1|||
163078224|NCT01117350|588993111|FG000|Comparative Period|Move to another city/country|2|||
163078225|NCT01117350|588993112|FG001|Comparative Period|Move to another city/country|1|||
163078226|NCT01117350|588993111|FG000|Extension Period|Not included in extension, not treated|0|||
163078227|NCT01117350|588993112|FG001|Extension Period|Not included in extension, not treated|50|||
163078228|NCT01117350|588993111|FG000|Extension Period|Adverse Event|0|||
163078229|NCT01117350|588993112|FG001|Extension Period|Adverse Event|2|||
163078230|NCT01117350|588993111|FG000|Extension Period|Protocol Violation|0|||
163078231|NCT01117350|588993112|FG001|Extension Period|Protocol Violation|2|||
163078232|NCT01117350|588993111|FG000|Extension Period|Lost to Follow-up|0|||
163078233|NCT01117350|588993112|FG001|Extension Period|Lost to Follow-up|2|||
163078234|NCT01117350|588993111|FG000|Extension Period|Withdrawal by Subject|0|||
163078235|NCT01117350|588993112|FG001|Extension Period|Withdrawal by Subject|3|||
163078236|NCT01117350|588993111|FG000|Extension Period|Lack of Efficacy|0|||
163078237|NCT01117350|588993112|FG001|Extension Period|Lack of Efficacy|2|||
163078238|NCT01117350|588993111|FG000|Extension Period|Inclusion criteria not respected|0|||
163078239|NCT01117350|588993112|FG001|Extension Period|Inclusion criteria not respected|1|||
163078240|NCT01117350|588993111|FG000|Extension Period|Prohibited medication|0|||
163078241|NCT01117350|588993112|FG001|Extension Period|Prohibited medication|1|||
163078242|NCT03760666|588993113|FG000|Overall Study|Adverse Event|2|||
163078243|NCT03760666|588993114|FG001|Overall Study|Adverse Event|4|||
163078244|NCT03760666|588993115|FG002|Overall Study|Adverse Event|1|||
163078245|NCT03760666|588993113|FG000|Overall Study|AML Disease Progression|3|||
163078246|NCT03760666|588993114|FG001|Overall Study|AML Disease Progression|3|||
163078247|NCT03760666|588993115|FG002|Overall Study|AML Disease Progression|0|||
163078248|NCT03760666|588993113|FG000|Overall Study|Physician Decision|0|||
163078249|NCT03760666|588993114|FG001|Overall Study|Physician Decision|3|||
163078250|NCT03760666|588993115|FG002|Overall Study|Physician Decision|0|||
163078251|NCT03760666|588993113|FG000|Overall Study|Withdrawal by Subject|0|||
163078252|NCT03760666|588993114|FG001|Overall Study|Withdrawal by Subject|1|||
163078253|NCT03760666|588993115|FG002|Overall Study|Withdrawal by Subject|0|||
163078254|NCT01800058|588993121|FG000|Overall Study|Lost to Follow-up|1|||
163078255|NCT01064622|588993122|FG000|Randomized Phase II|Withdrawal by Subject|2|||
163078256|NCT01064622|588993123|FG001|Randomized Phase II|Withdrawal by Subject|2|||
163078257|NCT01064622|588993122|FG000|Randomized Phase II|Protocol Violation|0|||
163078258|NCT01064622|588993123|FG001|Randomized Phase II|Protocol Violation|1|||
163078259|NCT05330429|588993126|FG000|Overall Study|Study Terminated by Sponsor|4|||
163078260|NCT05330429|588993127|FG001|Overall Study|Study Terminated by Sponsor|33|||
163078261|NCT05330429|588993128|FG002|Overall Study|Study Terminated by Sponsor|12|||
163078262|NCT05330429|588993126|FG000|Overall Study|Death|5|||
163078263|NCT05330429|588993127|FG001|Overall Study|Death|2|||
163078264|NCT05330429|588993128|FG002|Overall Study|Death|4|||
163078265|NCT05330429|588993126|FG000|Overall Study|Withdrew Consent|0|||
163078266|NCT05330429|588993127|FG001|Overall Study|Withdrew Consent|5|||
163078267|NCT05330429|588993128|FG002|Overall Study|Withdrew Consent|4|||
163078268|NCT05330429|588993126|FG000|Overall Study|Investigator's Discretion|0|||
163078269|NCT05330429|588993127|FG001|Overall Study|Investigator's Discretion|1|||
163078270|NCT05330429|588993128|FG002|Overall Study|Investigator's Discretion|3|||
163078271|NCT05330429|588993126|FG000|Overall Study|Subject Decision|1|||
163078272|NCT05330429|588993127|FG001|Overall Study|Subject Decision|2|||
163078273|NCT05330429|588993128|FG002|Overall Study|Subject Decision|0|||
163078274|NCT05330429|588993126|FG000|Overall Study|Lost to Follow-up|0|||
163078275|NCT05330429|588993127|FG001|Overall Study|Lost to Follow-up|1|||
163078276|NCT05330429|588993128|FG002|Overall Study|Lost to Follow-up|0|||
163078277|NCT02931539|588993132|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
163078278|NCT02931539|588993133|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
163078279|NCT02931539|588993134|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
163078280|NCT02931539|588993132|FG000|Period 1: Treatment Phase|Adverse Event|5|||
163078281|NCT02931539|588993133|FG001|Period 1: Treatment Phase|Adverse Event|1|||
163078282|NCT02931539|588993134|FG002|Period 1: Treatment Phase|Adverse Event|0|||
163078283|NCT02931539|588993132|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
163078284|NCT02931539|588993133|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
163078285|NCT02931539|588993134|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
163078286|NCT02931539|588993132|FG000|Period 1: Treatment Phase|Death|8|||
163078287|NCT02931539|588993133|FG001|Period 1: Treatment Phase|Death|24|||
163078288|NCT02931539|588993134|FG002|Period 1: Treatment Phase|Death|0|||
163078289|NCT02931539|588993132|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
163078290|NCT02931539|588993133|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
163078291|NCT02931539|588993134|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
163078292|NCT02931539|588993132|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
163078293|NCT02931539|588993133|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
163078294|NCT02931539|588993134|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
163078295|NCT02931539|588993132|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
163078296|NCT02931539|588993133|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
163078297|NCT02931539|588993134|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
163078298|NCT02931539|588993132|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
163078299|NCT02931539|588993133|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
163078300|NCT02931539|588993134|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
163078301|NCT06097273|588993137|FG000|Overall Study|Death|2|||
163078302|NCT06097273|588993138|FG001|Overall Study|Death|1|||
163078303|NCT06097273|588993139|FG002|Overall Study|Death|2|||
163078304|NCT06097273|588993140|FG003|Overall Study|Death|2|||
163078305|NCT06097273|588993137|FG000|Overall Study|Lost to Follow-up|27|||
163078306|NCT06097273|588993138|FG001|Overall Study|Lost to Follow-up|18|||
163078307|NCT06097273|588993139|FG002|Overall Study|Lost to Follow-up|36|||
163078308|NCT06097273|588993140|FG003|Overall Study|Lost to Follow-up|31|||
163078309|NCT06097273|588993137|FG000|Overall Study|Physician Decision|0|||
163078310|NCT06097273|588993138|FG001|Overall Study|Physician Decision|1|||
163078311|NCT06097273|588993139|FG002|Overall Study|Physician Decision|0|||
163078312|NCT06097273|588993140|FG003|Overall Study|Physician Decision|3|||
163078313|NCT06097273|588993137|FG000|Overall Study|Protocol Violation|1|||
163078314|NCT06097273|588993138|FG001|Overall Study|Protocol Violation|1|||
163078315|NCT06097273|588993139|FG002|Overall Study|Protocol Violation|2|||
163078316|NCT06097273|588993140|FG003|Overall Study|Protocol Violation|1|||
163078317|NCT06097273|588993137|FG000|Overall Study|Withdrawal by Subject|14|||
163078318|NCT06097273|588993138|FG001|Overall Study|Withdrawal by Subject|11|||
163078319|NCT06097273|588993139|FG002|Overall Study|Withdrawal by Subject|14|||
163078320|NCT06097273|588993140|FG003|Overall Study|Withdrawal by Subject|15|||
163078321|NCT06097273|588993137|FG000|Overall Study|Other Than Specified|7|||
163078322|NCT06097273|588993138|FG001|Overall Study|Other Than Specified|3|||
163078323|NCT06097273|588993139|FG002|Overall Study|Other Than Specified|11|||
163078324|NCT06097273|588993140|FG003|Overall Study|Other Than Specified|6|||
163078325|NCT02562040|588994959|FG000|Overall Study|Lost to Follow-up|20|||
163078326|NCT02562040|588994960|FG001|Overall Study|Lost to Follow-up|28|||
163078327|NCT02562040|588994959|FG000|Overall Study|Withdrawal by Subject|8|||
163078328|NCT02562040|588994960|FG001|Overall Study|Withdrawal by Subject|7|||
163078329|NCT02562040|588994959|FG000|Overall Study|Adverse Event|1|||
163078330|NCT02562040|588994960|FG001|Overall Study|Adverse Event|0|||
163078331|NCT04359680|588994963|FG000|Overall Study|Withdrawal by Subject|29|||
163078332|NCT04359680|588994964|FG001|Overall Study|Withdrawal by Subject|24|||
163078333|NCT04359680|588994963|FG000|Overall Study|Adverse Event|6|||
163078334|NCT04359680|588994964|FG001|Overall Study|Adverse Event|2|||
163078335|NCT04359680|588994963|FG000|Overall Study|Lost to Follow-up|56|||
163078336|NCT04359680|588994964|FG001|Overall Study|Lost to Follow-up|59|||
163078337|NCT04359680|588994963|FG000|Overall Study|Protocol Violation|3|||
163218849|NCT04256785|589517361|FG000|Overall Study|Lack of Efficacy|3|||
163218850|NCT04256785|589517362|FG001|Overall Study|Lack of Efficacy|4|||
163218851|NCT04256785|589517361|FG000|Overall Study|Lost to Follow-up|7|||
163078338|NCT04359680|588994964|FG001|Overall Study|Protocol Violation|5|||
163078339|NCT04359680|588994963|FG000|Overall Study|Physician Decision|1|||
163218852|NCT04256785|589517362|FG001|Overall Study|Lost to Follow-up|7|||
163078340|NCT04359680|588994964|FG001|Overall Study|Physician Decision|1|||
163078341|NCT04359680|588994963|FG000|Overall Study|Sponsor Decision|0|||
163078342|NCT04359680|588994964|FG001|Overall Study|Sponsor Decision|1|||
163078343|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
163078344|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
163078345|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
163218853|NCT04256785|589517361|FG000|Overall Study|Protocol Violation|1|||
163331936|NCT02060487|589925653|FG001|Overall Study|Withdrawal by Subject|10|||
163331937|NCT02060487|589925654|FG002|Overall Study|Withdrawal by Subject|4|||
163331938|NCT02060487|589925652|FG000|Overall Study|Study Terminated By Sponsor|87|||
163331939|NCT02060487|589925653|FG001|Overall Study|Study Terminated By Sponsor|89|||
163078346|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
163078347|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
163078348|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
163078349|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
163078350|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
163078351|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
163078352|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
163078353|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
163078354|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
163078355|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
163078356|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
163078357|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
163078358|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
163078359|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
163078360|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
163078361|NCT01755156|588994966|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
163078362|NCT01755156|588994967|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
163078363|NCT01755156|588994966|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
163078364|NCT01755156|588994967|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
163078365|NCT03142451|588994968|FG000|Overall Study|Adverse Event|5|||
163078366|NCT03142451|588994969|FG001|Overall Study|Adverse Event|2|||
163078367|NCT03142451|588994968|FG000|Overall Study|Lost to Follow-up|25|||
163078368|NCT03142451|588994969|FG001|Overall Study|Lost to Follow-up|8|||
163078369|NCT03142451|588994968|FG000|Overall Study|Participant request|24|||
163078370|NCT03142451|588994969|FG001|Overall Study|Participant request|12|||
163078371|NCT03142451|588994968|FG000|Overall Study|Protocol Violation|3|||
163078372|NCT03142451|588994969|FG001|Overall Study|Protocol Violation|1|||
163078373|NCT03142451|588994968|FG000|Overall Study|Other|1|||
163078374|NCT03142451|588994969|FG001|Overall Study|Other|1|||
163078375|NCT05333965|588994970|FG000|First Intervention|Adverse Event|0|||
163078376|NCT05333965|588994971|FG001|First Intervention|Adverse Event|1|||
163078377|NCT05333965|588994970|FG000|First Intervention|Withdrawal by Subject|0|||
163078378|NCT05333965|588994971|FG001|First Intervention|Withdrawal by Subject|1|||
163078379|NCT03048019|588994972|FG000|Overall Study|Adverse Event|1|||
163078380|NCT03048019|588994973|FG001|Overall Study|Adverse Event|0|||
163078381|NCT01730729|588994974|FG000|Overall Study|Adverse Event|1|||
163078382|NCT01730729|588994974|FG000|Overall Study|Death|1|||
163078383|NCT01730729|588994974|FG000|Overall Study|Progressive Disease|12|||
163078384|NCT00382863|588994975|FG000|Overall Study|Death|9|||
163078385|NCT00382863|588994976|FG001|Overall Study|Death|9|||
163078386|NCT00382863|588994975|FG000|Overall Study|Lost to Follow-up|1|||
163078387|NCT00382863|588994976|FG001|Overall Study|Lost to Follow-up|2|||
163078388|NCT00382863|588994975|FG000|Overall Study|Withdrawal by Subject|5|||
163078389|NCT00382863|588994976|FG001|Overall Study|Withdrawal by Subject|25|||
163078390|NCT00203242|588994979|FG000|Overall Study|Lost to Follow-up|1|||
163078391|NCT02595437|588994980|FG000|Triferic Via IV|Withdrawal by Subject|1|||
163078392|NCT02150863|588994988|FG000|Overall Study|Lost to Follow-up|0|||
163078393|NCT02150863|588994989|FG001|Overall Study|Lost to Follow-up|1|||
163078394|NCT02150863|588994990|FG002|Overall Study|Lost to Follow-up|0|||
163078395|NCT01651208|588994991|FG000|Overall Study|Lost to Follow-up|14|||
163078396|NCT01651208|588994992|FG001|Overall Study|Lost to Follow-up|16|||
163078397|NCT00986102|588995009|FG000|Overall Study|Lost to Follow-up|0|||
163078398|NCT00986102|588995010|FG001|Overall Study|Lost to Follow-up|1|||
163078399|NCT00986102|588995011|FG002|Overall Study|Lost to Follow-up|0|||
163078400|NCT00986102|588995012|FG003|Overall Study|Lost to Follow-up|1|||
163078401|NCT00986102|588995009|FG000|Overall Study|Withdrawal by Subject|1|||
163078402|NCT00986102|588995010|FG001|Overall Study|Withdrawal by Subject|1|||
163078403|NCT00986102|588995011|FG002|Overall Study|Withdrawal by Subject|0|||
163078404|NCT00986102|588995012|FG003|Overall Study|Withdrawal by Subject|0|||
163078405|NCT02314247|588995013|FG000|Overall Study|Adverse Event|2|||
163078406|NCT02314247|588995014|FG001|Overall Study|Adverse Event|1|||
163078407|NCT02314247|588995015|FG002|Overall Study|Adverse Event|0|||
163078408|NCT02314247|588995013|FG000|Overall Study|Withdrawal by Subject|1|||
163078409|NCT02314247|588995014|FG001|Overall Study|Withdrawal by Subject|3|||
163078410|NCT02314247|588995015|FG002|Overall Study|Withdrawal by Subject|1|||
163078411|NCT02314247|588995013|FG000|Overall Study|Progression of Disease|6|||
163078412|NCT02314247|588995014|FG001|Overall Study|Progression of Disease|2|||
163078413|NCT02314247|588995015|FG002|Overall Study|Progression of Disease|0|||
163078414|NCT01260311|588995023|FG000|Overall Study|Adverse Event|11|||
163331940|NCT02060487|589925654|FG002|Overall Study|Study Terminated By Sponsor|100|||
163078415|NCT01260311|588995023|FG000|Overall Study|Lack of Efficacy|4|||
163078416|NCT01260311|588995023|FG000|Overall Study|Lost to Follow-up|25|||
163078417|NCT01260311|588995023|FG000|Overall Study|Withdrawal by Subject|6|||
163078418|NCT01260311|588995023|FG000|Overall Study|Financial Constraints|77|||
163078419|NCT01260311|588995023|FG000|Overall Study|Gone to Province|2|||
163078420|NCT01260311|588995023|FG000|Overall Study|Medication Stopped|1|||
163078421|NCT01260311|588995023|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
163078422|NCT01340170|588995024|FG000|Overall Study|Lost to Follow-up|2|||
163078423|NCT01340170|588995025|FG001|Overall Study|Lost to Follow-up|4|||
163078424|NCT01340170|588995026|FG002|Overall Study|Lost to Follow-up|0|||
163078425|NCT01340170|588995024|FG000|Overall Study|Implant failure|1|||
163078426|NCT01340170|588995025|FG001|Overall Study|Implant failure|3|||
163078427|NCT01340170|588995026|FG002|Overall Study|Implant failure|0|||
163078428|NCT03878602|588995027|FG000|Overall Study|cord blood donation|7|||
163078429|NCT03878602|588995028|FG001|Overall Study|cord blood donation|1|||
163078430|NCT03878602|588995027|FG000|Overall Study|incomplete data collection|2|||
163331941|NCT02060487|589925652|FG000|Overall Study|Randomized in error|1|||
163331942|NCT02060487|589925653|FG001|Overall Study|Randomized in error|0|||
163331943|NCT02060487|589925654|FG002|Overall Study|Randomized in error|0|||
163331944|NCT02060487|589925652|FG000|Overall Study|Protocol Violation|0|||
163078431|NCT03878602|588995028|FG001|Overall Study|incomplete data collection|0|||
163078432|NCT02633527|588995029|FG000|Overall Study|Failed to meet eligibility|0|||
163078433|NCT02633527|588995030|FG001|Overall Study|Failed to meet eligibility|1|||
163078434|NCT02633527|588995031|FG002|Overall Study|Failed to meet eligibility|1|||
163078435|NCT02633527|588995032|FG003|Overall Study|Failed to meet eligibility|0|||
163078436|NCT02633527|588995033|FG004|Overall Study|Failed to meet eligibility|1|||
163078437|NCT02633527|588995029|FG000|Overall Study|Adverse Event|0|||
163078438|NCT02633527|588995030|FG001|Overall Study|Adverse Event|4|||
163078439|NCT02633527|588995031|FG002|Overall Study|Adverse Event|3|||
163078440|NCT02633527|588995032|FG003|Overall Study|Adverse Event|1|||
163078441|NCT02633527|588995033|FG004|Overall Study|Adverse Event|5|||
163078442|NCT02633527|588995029|FG000|Overall Study|Lost to Follow-up|1|||
163078443|NCT02633527|588995030|FG001|Overall Study|Lost to Follow-up|2|||
163078444|NCT02633527|588995031|FG002|Overall Study|Lost to Follow-up|5|||
163078445|NCT02633527|588995032|FG003|Overall Study|Lost to Follow-up|5|||
163078446|NCT02633527|588995033|FG004|Overall Study|Lost to Follow-up|4|||
163078447|NCT02633527|588995029|FG000|Overall Study|Withdrawal by Subject|0|||
163078448|NCT02633527|588995030|FG001|Overall Study|Withdrawal by Subject|3|||
163078449|NCT02633527|588995031|FG002|Overall Study|Withdrawal by Subject|5|||
163078450|NCT02633527|588995032|FG003|Overall Study|Withdrawal by Subject|4|||
163078451|NCT02633527|588995033|FG004|Overall Study|Withdrawal by Subject|4|||
163078452|NCT02633527|588995029|FG000|Overall Study|Protocol Violation|0|||
163078453|NCT02633527|588995030|FG001|Overall Study|Protocol Violation|1|||
163078454|NCT02633527|588995031|FG002|Overall Study|Protocol Violation|1|||
163078455|NCT02633527|588995032|FG003|Overall Study|Protocol Violation|1|||
163078456|NCT02633527|588995033|FG004|Overall Study|Protocol Violation|1|||
163078457|NCT02633527|588995029|FG000|Overall Study|Physician Decision|0|||
163078458|NCT02633527|588995030|FG001|Overall Study|Physician Decision|0|||
163078459|NCT02633527|588995031|FG002|Overall Study|Physician Decision|0|||
163078460|NCT02633527|588995032|FG003|Overall Study|Physician Decision|0|||
163078461|NCT02633527|588995033|FG004|Overall Study|Physician Decision|1|||
163078462|NCT02633527|588995029|FG000|Overall Study|Administrative reason|1|||
163078463|NCT02633527|588995030|FG001|Overall Study|Administrative reason|0|||
163078464|NCT02633527|588995031|FG002|Overall Study|Administrative reason|0|||
163078465|NCT02633527|588995032|FG003|Overall Study|Administrative reason|1|||
163078466|NCT02633527|588995033|FG004|Overall Study|Administrative reason|0|||
163078467|NCT02633527|588995029|FG000|Overall Study|Multiple reasons|1|||
163078468|NCT02633527|588995030|FG001|Overall Study|Multiple reasons|0|||
163078469|NCT02633527|588995031|FG002|Overall Study|Multiple reasons|2|||
163078470|NCT02633527|588995032|FG003|Overall Study|Multiple reasons|2|||
163078471|NCT02633527|588995033|FG004|Overall Study|Multiple reasons|1|||
163078472|NCT06091956|588995034|FG000|Overall Study|Withdrawal by Subject|1|||
163078473|NCT06091956|588995034|FG000|Overall Study|Complicating Disease|1|||
163078474|NCT02176525|588995037|FG000|Overall Study|Adverse Event|0|||
163078475|NCT02176525|588995038|FG001|Overall Study|Adverse Event|0|||
163078476|NCT02176525|588995039|FG002|Overall Study|Adverse Event|0|||
163078477|NCT02176525|588995040|FG003|Overall Study|Adverse Event|1|||
163078478|NCT02176525|588995041|FG004|Overall Study|Adverse Event|1|||
163078479|NCT02176525|588995042|FG005|Overall Study|Adverse Event|0|||
163078480|NCT02176525|588995043|FG006|Overall Study|Adverse Event|1|||
163078481|NCT02176525|588995044|FG007|Overall Study|Adverse Event|0|||
163078482|NCT02176525|588995037|FG000|Overall Study|not treated|1|||
163078483|NCT02176525|588995038|FG001|Overall Study|not treated|0|||
163078484|NCT02176525|588995039|FG002|Overall Study|not treated|0|||
163078485|NCT02176525|588995040|FG003|Overall Study|not treated|0|||
163078486|NCT02176525|588995041|FG004|Overall Study|not treated|0|||
163078487|NCT02176525|588995042|FG005|Overall Study|not treated|1|||
163078488|NCT02176525|588995043|FG006|Overall Study|not treated|0|||
163078489|NCT02176525|588995044|FG007|Overall Study|not treated|0|||
163078490|NCT02100644|588995047|FG000|LTG Escalation Phase|Adverse Event|9|||
163331945|NCT02060487|589925653|FG001|Overall Study|Protocol Violation|1|||
163331946|NCT02060487|589925654|FG002|Overall Study|Protocol Violation|1|||
163078491|NCT02100644|588995048|FG001|LTG Escalation Phase|Adverse Event|0|||
163078492|NCT02100644|588995049|FG002|LTG Escalation Phase|Adverse Event|0|||
163078493|NCT02100644|588995047|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
163078494|NCT02100644|588995048|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
163078495|NCT02100644|588995049|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
163078496|NCT02100644|588995047|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
163078497|NCT02100644|588995048|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
163078498|NCT02100644|588995049|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
163078499|NCT00478140|588995050|FG000|Overall Study|Clinical Disease Progression|1|||
163078500|NCT03163264|588995054|FG000|Overall Study|Withdrawal by Subject|13|||
163078501|NCT03163264|588995055|FG001|Overall Study|Withdrawal by Subject|3|||
163078502|NCT03163264|588995056|FG002|Overall Study|Withdrawal by Subject|4|||
163078503|NCT03163264|588995057|FG003|Overall Study|Withdrawal by Subject|2|||
163078504|NCT03163264|588995054|FG000|Overall Study|Lost to Follow-up|17|||
163078505|NCT03163264|588995055|FG001|Overall Study|Lost to Follow-up|20|||
163078506|NCT03163264|588995056|FG002|Overall Study|Lost to Follow-up|0|||
163078507|NCT03163264|588995057|FG003|Overall Study|Lost to Follow-up|0|||
163078508|NCT03163264|588995054|FG000|Overall Study|Death|0|||
163078509|NCT03163264|588995055|FG001|Overall Study|Death|2|||
163078510|NCT03163264|588995056|FG002|Overall Study|Death|0|||
163078511|NCT03163264|588995057|FG003|Overall Study|Death|0|||
163078512|NCT02614066|588995058|FG000|Overall Study|Death|6|||
163078513|NCT02614066|588995059|FG001|Overall Study|Death|14|||
163078514|NCT02614066|588995060|FG002|Overall Study|Death|11|||
163078515|NCT02614066|588995061|FG003|Overall Study|Death|29|||
163078516|NCT02614066|588995058|FG000|Overall Study|Full consent withdrawn|0|||
163078517|NCT02614066|588995059|FG001|Overall Study|Full consent withdrawn|1|||
163078518|NCT02614066|588995060|FG002|Overall Study|Full consent withdrawn|0|||
163078519|NCT02614066|588995061|FG003|Overall Study|Full consent withdrawn|8|||
163078520|NCT02614066|588995058|FG000|Overall Study|Lost to Follow-up|0|||
163078521|NCT02614066|588995059|FG001|Overall Study|Lost to Follow-up|2|||
163078522|NCT02614066|588995060|FG002|Overall Study|Lost to Follow-up|2|||
163078523|NCT02614066|588995061|FG003|Overall Study|Lost to Follow-up|2|||
163078524|NCT02614066|588995058|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
163078525|NCT02614066|588995059|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
163078526|NCT02614066|588995060|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
163078527|NCT02614066|588995061|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
163078528|NCT02614066|588995058|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
163078529|NCT02614066|588995059|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
163078530|NCT02614066|588995060|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
163078531|NCT02614066|588995061|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
163078532|NCT02614066|588995058|FG000|Overall Study|Reason not specified|0|||
163078533|NCT02614066|588995059|FG001|Overall Study|Reason not specified|2|||
163078534|NCT02614066|588995060|FG002|Overall Study|Reason not specified|1|||
163078535|NCT02614066|588995061|FG003|Overall Study|Reason not specified|1|||
163078536|NCT04565756|588995062|FG000|Overall Study|Withdrawal by Subject|0|||
163078537|NCT04565756|588995063|FG001|Overall Study|Withdrawal by Subject|0|||
163078538|NCT04565756|588995064|FG002|Overall Study|Withdrawal by Subject|0|||
163078539|NCT04565756|588995065|FG003|Overall Study|Withdrawal by Subject|0|||
163078540|NCT04565756|588995066|FG004|Overall Study|Withdrawal by Subject|1|||
163078541|NCT04565756|588995067|FG005|Overall Study|Withdrawal by Subject|0|||
163078542|NCT04565756|588995062|FG000|Overall Study|Protocol Violation|0|||
163078543|NCT04565756|588995063|FG001|Overall Study|Protocol Violation|0|||
163078544|NCT04565756|588995064|FG002|Overall Study|Protocol Violation|0|||
163078545|NCT04565756|588995065|FG003|Overall Study|Protocol Violation|0|||
163078546|NCT04565756|588995066|FG004|Overall Study|Protocol Violation|0|||
163078547|NCT04565756|588995067|FG005|Overall Study|Protocol Violation|1|||
163078548|NCT00968968|588995072|FG000|Overall Study|Study closed/terminated|10|||
163078549|NCT00968968|588995073|FG001|Overall Study|Study closed/terminated|10|||
163078550|NCT00968968|588995072|FG000|Overall Study|Protocol defined stopping criteria|3|||
163078551|NCT00968968|588995073|FG001|Overall Study|Protocol defined stopping criteria|1|||
163078552|NCT00968968|588995072|FG000|Overall Study|Withdrawal by Subject|2|||
163078553|NCT00968968|588995073|FG001|Overall Study|Withdrawal by Subject|0|||
163078554|NCT00968968|588995072|FG000|Overall Study|Physician Decision|1|||
163078555|NCT00968968|588995073|FG001|Overall Study|Physician Decision|2|||
163078556|NCT00968968|588995072|FG000|Overall Study|Lost to Follow-up|0|||
163078557|NCT00968968|588995073|FG001|Overall Study|Lost to Follow-up|1|||
163078558|NCT04401293|588995074|FG000|Overall Study|Withdrawal by Subject|1|||
163078559|NCT04401293|588995075|FG001|Overall Study|Withdrawal by Subject|3|||
163078560|NCT01026038|588995076|FG000|Overall Study|Lost to Follow-up|1|||
163078561|NCT01026038|588995077|FG001|Overall Study|Lost to Follow-up|1|||
163078562|NCT01026038|588995078|FG002|Overall Study|Lost to Follow-up|0|||
163078563|NCT03679884|588995079|FG000|Overall Study|Other|12|||
163078564|NCT03679884|588995080|FG001|Overall Study|Other|12|||
163078565|NCT03679884|588995081|FG002|Overall Study|Other|12|||
163078566|NCT03679884|588995082|FG003|Overall Study|Other|7|||
163078567|NCT03679884|588995083|FG004|Overall Study|Other|8|||
163078568|NCT03679884|588995079|FG000|Overall Study|Lack of Efficacy|15|||
163078569|NCT03679884|588995080|FG001|Overall Study|Lack of Efficacy|29|||
163078570|NCT03679884|588995081|FG002|Overall Study|Lack of Efficacy|13|||
163078571|NCT03679884|588995082|FG003|Overall Study|Lack of Efficacy|29|||
163078572|NCT03679884|588995083|FG004|Overall Study|Lack of Efficacy|10|||
163078573|NCT03679884|588995079|FG000|Overall Study|Death|1|||
163078574|NCT03679884|588995080|FG001|Overall Study|Death|0|||
163078575|NCT03679884|588995081|FG002|Overall Study|Death|0|||
163078576|NCT03679884|588995082|FG003|Overall Study|Death|0|||
163078577|NCT03679884|588995083|FG004|Overall Study|Death|0|||
163078578|NCT03679884|588995079|FG000|Overall Study|Adverse Event|2|||
163078579|NCT03679884|588995080|FG001|Overall Study|Adverse Event|10|||
163078580|NCT03679884|588995081|FG002|Overall Study|Adverse Event|9|||
163078581|NCT03679884|588995082|FG003|Overall Study|Adverse Event|6|||
163078582|NCT03679884|588995083|FG004|Overall Study|Adverse Event|6|||
163078583|NCT03679884|588995079|FG000|Overall Study|Withdrawal by Subject|12|||
163078584|NCT03679884|588995080|FG001|Overall Study|Withdrawal by Subject|23|||
163078585|NCT03679884|588995081|FG002|Overall Study|Withdrawal by Subject|8|||
163078586|NCT03679884|588995082|FG003|Overall Study|Withdrawal by Subject|8|||
163078587|NCT03679884|588995083|FG004|Overall Study|Withdrawal by Subject|9|||
163078588|NCT03679884|588995079|FG000|Overall Study|Lost to Follow-up|1|||
163078589|NCT03679884|588995080|FG001|Overall Study|Lost to Follow-up|4|||
163078590|NCT03679884|588995081|FG002|Overall Study|Lost to Follow-up|2|||
163078591|NCT03679884|588995082|FG003|Overall Study|Lost to Follow-up|0|||
163078592|NCT03679884|588995083|FG004|Overall Study|Lost to Follow-up|3|||
163078593|NCT01783938|588995092|FG000|Overall Study|Disease Progression|18|||
163078594|NCT01783938|588995093|FG001|Overall Study|Disease Progression|41|||
163078595|NCT01783938|588995092|FG000|Overall Study|Study Drug Toxicity|27|||
163078596|NCT01783938|588995093|FG001|Overall Study|Study Drug Toxicity|14|||
163078597|NCT01783938|588995092|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
163078598|NCT01783938|588995093|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
163078599|NCT01783938|588995092|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
163078600|NCT01783938|588995093|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
163078601|NCT01783938|588995092|FG000|Overall Study|Participant Withdrew Consent|2|||
163078602|NCT01783938|588995093|FG001|Overall Study|Participant Withdrew Consent|0|||
163078603|NCT01783938|588995092|FG000|Overall Study|Maximum Clinical Benefit|1|||
163078604|NCT01783938|588995093|FG001|Overall Study|Maximum Clinical Benefit|0|||
163078605|NCT01783938|588995092|FG000|Overall Study|Other Reasons|3|||
163078606|NCT01783938|588995093|FG001|Overall Study|Other Reasons|1|||
163078607|NCT00930176|588995095|FG000|Overall Study|Death|1|||
163078608|NCT01712074|588995100|FG000|Placebo Run-in Period|Adverse Event|2|||
163078609|NCT01712074|588995101|FG001|Placebo Run-in Period|Adverse Event|0|||
163078610|NCT01712074|588995102|FG002|Placebo Run-in Period|Adverse Event|0|||
163078611|NCT01712074|588995100|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
163078612|NCT01712074|588995101|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
163078613|NCT01712074|588995102|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
163078614|NCT01712074|588995100|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
163078615|NCT01712074|588995101|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
163078616|NCT01712074|588995102|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
163078617|NCT01712074|588995100|FG000|Placebo Run-in Period|Other|1|||
163078618|NCT01712074|588995101|FG001|Placebo Run-in Period|Other|0|||
163078619|NCT01712074|588995102|FG002|Placebo Run-in Period|Other|0|||
163078620|NCT01712074|588995100|FG000|Placebo Run-in Period|No longer willing to participate|1|||
163078621|NCT01712074|588995101|FG001|Placebo Run-in Period|No longer willing to participate|0|||
163078622|NCT01712074|588995102|FG002|Placebo Run-in Period|No longer willing to participate|0|||
163078623|NCT01712074|588995100|FG000|Double Blind Period|Adverse Event|0|||
163078624|NCT01712074|588995101|FG001|Double Blind Period|Adverse Event|2|||
163078625|NCT01712074|588995102|FG002|Double Blind Period|Adverse Event|1|||
163078626|NCT01712074|588995100|FG000|Double Blind Period|No longer willing to participate|0|||
163218854|NCT04256785|589517362|FG001|Overall Study|Protocol Violation|0|||
163406444|NCT03311711|590198644|FG009|Overall Study|Death|0|||
163406445|NCT03311711|590198635|FG000|Overall Study|Death of dyad partner|0|||
163406446|NCT03311711|590198636|FG001|Overall Study|Death of dyad partner|1|||
163078627|NCT01712074|588995101|FG001|Double Blind Period|No longer willing to participate|2|||
163078628|NCT01712074|588995102|FG002|Double Blind Period|No longer willing to participate|4|||
163078629|NCT01712074|588995100|FG000|Double Blind Period|Death|0|||
163078630|NCT01712074|588995101|FG001|Double Blind Period|Death|1|||
163078631|NCT01712074|588995102|FG002|Double Blind Period|Death|0|||
163218855|NCT04256785|589517361|FG000|Overall Study|Withdrawal by Subject|4|||
163218856|NCT04256785|589517362|FG001|Overall Study|Withdrawal by Subject|1|||
163218857|NCT04256785|589517361|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
163218858|NCT04256785|589517362|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
163218859|NCT01154218|589517363|FG000|Third Intervention Period|Adverse Event|0|||
163218860|NCT01154218|589517364|FG001|Third Intervention Period|Adverse Event|1|||
163218861|NCT01154218|589517365|FG002|Third Intervention Period|Adverse Event|0|||
163218862|NCT01154218|589517366|FG003|Third Intervention Period|Adverse Event|0|||
163078632|NCT01712074|588995100|FG000|Double Blind Period|Lost to Follow-up|0|||
163078633|NCT01712074|588995101|FG001|Double Blind Period|Lost to Follow-up|2|||
163078634|NCT01712074|588995102|FG002|Double Blind Period|Lost to Follow-up|1|||
163078635|NCT01712074|588995100|FG000|Double Blind Period|Other|0|||
163078636|NCT01712074|588995101|FG001|Double Blind Period|Other|4|||
163078637|NCT01712074|588995102|FG002|Double Blind Period|Other|1|||
163078638|NCT01712074|588995100|FG000|Double Blind Period|Protocol Violation|0|||
163078639|NCT01712074|588995101|FG001|Double Blind Period|Protocol Violation|0|||
163078640|NCT01712074|588995102|FG002|Double Blind Period|Protocol Violation|1|||
163078641|NCT01712074|588995100|FG000|Double Blind Period|No longer met eligibility criteria|0|||
163078642|NCT01712074|588995101|FG001|Double Blind Period|No longer met eligibility criteria|3|||
163078643|NCT01712074|588995102|FG002|Double Blind Period|No longer met eligibility criteria|0|||
163078644|NCT03478787|588995103|FG000|Overall Study|Adverse Event|5|||
163078645|NCT03478787|588995104|FG001|Overall Study|Adverse Event|1|||
163078646|NCT03478787|588995103|FG000|Overall Study|Protocol Violation|3|||
163078647|NCT03478787|588995104|FG001|Overall Study|Protocol Violation|0|||
163078648|NCT03478787|588995103|FG000|Overall Study|Lack of Efficacy|7|||
163078649|NCT03478787|588995104|FG001|Overall Study|Lack of Efficacy|1|||
163218863|NCT01154218|589517363|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
163218864|NCT01154218|589517364|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
163218865|NCT01154218|589517365|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
163218866|NCT01154218|589517366|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
163218867|NCT01154218|589517363|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
163218868|NCT01154218|589517364|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
163218869|NCT01154218|589517365|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
163218870|NCT01154218|589517366|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
163218871|NCT01265849|589517367|FG000|Overall Study|Randomized//Treatment not initiated|1|||
163218872|NCT01265849|589517368|FG001|Overall Study|Randomized//Treatment not initiated|4|||
163218873|NCT01265849|589517369|FG002|Overall Study|Randomized//Treatment not initiated|0|||
163218874|NCT01265849|589517367|FG000|Overall Study|Physician Decision|1|||
163218875|NCT01265849|589517368|FG001|Overall Study|Physician Decision|2|||
163218876|NCT01265849|589517369|FG002|Overall Study|Physician Decision|0|||
163218877|NCT01265849|589517367|FG000|Overall Study|Lost to Follow-up|18|||
163218878|NCT01265849|589517368|FG001|Overall Study|Lost to Follow-up|15|||
163218879|NCT01265849|589517369|FG002|Overall Study|Lost to Follow-up|5|||
163218880|NCT01265849|589517367|FG000|Overall Study|Not otherwise specified|1|||
163218881|NCT01265849|589517368|FG001|Overall Study|Not otherwise specified|6|||
163218882|NCT01265849|589517369|FG002|Overall Study|Not otherwise specified|1|||
163218883|NCT01265849|589517367|FG000|Overall Study|Withdrawal by Subject|25|||
163218884|NCT01265849|589517368|FG001|Overall Study|Withdrawal by Subject|34|||
163218885|NCT01265849|589517369|FG002|Overall Study|Withdrawal by Subject|13|||
163218886|NCT00362115|589517370|FG000|Overall Study|Adverse Event|0|||
163218887|NCT00362115|589517371|FG001|Overall Study|Adverse Event|1|||
163218888|NCT00362115|589517372|FG002|Overall Study|Adverse Event|1|||
163218889|NCT00362115|589517373|FG003|Overall Study|Adverse Event|1|||
163218890|NCT00362115|589517374|FG004|Overall Study|Adverse Event|2|||
163029268|NCT04713592|588810394|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
163029269|NCT04713592|588810391|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
163029270|NCT04713592|588810392|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
163029271|NCT04713592|588810393|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
163029272|NCT04713592|588810394|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
163029273|NCT04713592|588810391|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163029274|NCT04713592|588810392|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163029275|NCT04713592|588810393|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
163029276|NCT04713592|588810394|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
163029277|NCT04713592|588810391|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
163029278|NCT04713592|588810392|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
163029279|NCT04713592|588810393|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
163029280|NCT04713592|588810394|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
163029281|NCT02225366|588810399|FG000|Overall Study|Lack of Efficacy|1|||
163029282|NCT02225366|588810400|FG001|Overall Study|Lack of Efficacy|0|||
163029283|NCT03782298|588810403|FG000|Overall Study|Protocol Deviation|4|||
163029284|NCT02431806|588810404|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
163029285|NCT02431806|588810405|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
163029286|NCT02431806|588810406|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
163029287|NCT02431806|588810407|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
163029288|NCT02431806|588810404|FG000|Double-blind Treatment Period|Adverse Event|4|||
163029289|NCT02431806|588810405|FG001|Double-blind Treatment Period|Adverse Event|7|||
163078650|NCT03478787|588995103|FG000|Overall Study|Lost to Follow-up|9|||
163218891|NCT00362115|589517375|FG005|Overall Study|Adverse Event|2|||
163218892|NCT00362115|589517376|FG006|Overall Study|Adverse Event|1|||
163218893|NCT00362115|589517370|FG000|Overall Study|Protocol Violation|0|||
163218894|NCT00362115|589517371|FG001|Overall Study|Protocol Violation|0|||
163331947|NCT02060487|589925652|FG000|Overall Study|Lost to Follow-up|3|||
163331948|NCT02060487|589925653|FG001|Overall Study|Lost to Follow-up|0|||
163331949|NCT02060487|589925654|FG002|Overall Study|Lost to Follow-up|2|||
163331950|NCT02060487|589925652|FG000|Overall Study|Death|34|||
163331951|NCT02060487|589925653|FG001|Overall Study|Death|25|||
163331952|NCT02060487|589925654|FG002|Overall Study|Death|19|||
163331953|NCT02060487|589925652|FG000|Overall Study|Adverse Event|0|||
163331954|NCT02060487|589925653|FG001|Overall Study|Adverse Event|0|||
163331955|NCT02060487|589925654|FG002|Overall Study|Adverse Event|1|||
163331956|NCT03697603|589925659|FG000|Overall Study|Adverse Event|3|||
163331957|NCT03697603|589925660|FG001|Overall Study|Adverse Event|18|||
163331958|NCT03697603|589925661|FG002|Overall Study|Adverse Event|3|||
163331959|NCT03697603|589925659|FG000|Overall Study|Physician Decision|1|||
163331960|NCT03697603|589925660|FG001|Overall Study|Physician Decision|0|||
163331961|NCT03697603|589925661|FG002|Overall Study|Physician Decision|2|||
163331962|NCT03697603|589925659|FG000|Overall Study|Protocol Violation|3|||
163331963|NCT03697603|589925660|FG001|Overall Study|Protocol Violation|8|||
163331964|NCT03697603|589925661|FG002|Overall Study|Protocol Violation|5|||
163331965|NCT03697603|589925659|FG000|Overall Study|Withdrawal by Subject|5|||
163331966|NCT03697603|589925660|FG001|Overall Study|Withdrawal by Subject|1|||
163331967|NCT03697603|589925661|FG002|Overall Study|Withdrawal by Subject|1|||
163331968|NCT03697603|589925659|FG000|Overall Study|Protocol Violation|0|||
163331969|NCT03697603|589925660|FG001|Overall Study|Protocol Violation|0|||
163029290|NCT02431806|588810406|FG002|Double-blind Treatment Period|Adverse Event|11|||
163029291|NCT02431806|588810407|FG003|Double-blind Treatment Period|Adverse Event|7|||
163029292|NCT02431806|588810404|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
163029293|NCT02431806|588810405|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
163029294|NCT02431806|588810406|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
163029295|NCT02431806|588810407|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
163029296|NCT02431806|588810404|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
163029297|NCT02431806|588810405|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
163029298|NCT02431806|588810406|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
163029299|NCT02431806|588810407|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
163029300|NCT02431806|588810404|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
163029301|NCT02431806|588810405|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
163029302|NCT02431806|588810406|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
163029303|NCT02431806|588810407|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
163029304|NCT02431806|588810404|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
163029305|NCT02431806|588810405|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
163029306|NCT02431806|588810406|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
163029307|NCT02431806|588810407|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
163029308|NCT02431806|588810404|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
163029309|NCT02431806|588810405|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
163029310|NCT02431806|588810406|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
163029311|NCT02431806|588810407|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
163029312|NCT00742508|588810408|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
163029313|NCT00742508|588810409|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
163029314|NCT00742508|588810408|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
163029315|NCT00742508|588810409|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
163029316|NCT00742508|588810408|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
163029317|NCT00742508|588810409|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
163029318|NCT00742508|588810408|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
163029319|NCT00742508|588810409|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
163029320|NCT00742508|588810408|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
163029321|NCT00742508|588810409|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
163029322|NCT01382225|588810410|FG000|Overall Study|Adverse Event|3|||
163029323|NCT01382225|588810411|FG001|Overall Study|Adverse Event|2|||
163029324|NCT01382225|588810410|FG000|Overall Study|Protocol Violation|2|||
163029325|NCT01382225|588810411|FG001|Overall Study|Protocol Violation|1|||
163029326|NCT01382225|588810410|FG000|Overall Study|Subject Withdrew Consent|5|||
163029327|NCT01382225|588810411|FG001|Overall Study|Subject Withdrew Consent|2|||
163029328|NCT01382225|588810410|FG000|Overall Study|Other|4|||
163029329|NCT01382225|588810411|FG001|Overall Study|Other|2|||
163029330|NCT01797081|588810412|FG000|Overall Study|Adverse Event|1|||
163029331|NCT01797081|588810413|FG001|Overall Study|Adverse Event|0|||
163331970|NCT03697603|589925661|FG002|Overall Study|Protocol Violation|1|||
163331971|NCT04218864|589925662|FG000|Overall Study|Lost to Follow-up|8|||
163331972|NCT04218864|589925663|FG001|Overall Study|Lost to Follow-up|4|||
163331973|NCT04218864|589925662|FG000|Overall Study|Withdrawal by Subject|1|||
163331974|NCT04218864|589925663|FG001|Overall Study|Withdrawal by Subject|3|||
163331975|NCT03683030|589925664|FG000|Overall Study|Enrolled but screen failures|12|||
163331976|NCT03683030|589925665|FG001|Overall Study|Enrolled but screen failures|7|||
163331977|NCT03683030|589925664|FG000|Overall Study|Enrolled but no catheter inserted|11|||
163331978|NCT03683030|589925665|FG001|Overall Study|Enrolled but no catheter inserted|13|||
163331979|NCT03683030|589925664|FG000|Overall Study|Withdrawal by Subject|0|||
163331980|NCT03683030|589925665|FG001|Overall Study|Withdrawal by Subject|2|||
163331981|NCT03683030|589925664|FG000|Overall Study|Early termination by subject|1|||
163331982|NCT03683030|589925665|FG001|Overall Study|Early termination by subject|0|||
163331983|NCT03683030|589925664|FG000|Overall Study|Lost to Follow-up|0|||
163331984|NCT03683030|589925665|FG001|Overall Study|Lost to Follow-up|6|||
163331985|NCT03683030|589925664|FG000|Overall Study|Death|0|||
163331986|NCT03683030|589925665|FG001|Overall Study|Death|2|||
163331987|NCT03683030|589925664|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
163331988|NCT03683030|589925665|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
163331989|NCT02222493|589925668|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
163331990|NCT02222493|589925669|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
163331991|NCT02222493|589925668|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
163331992|NCT02222493|589925669|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
163331993|NCT02222493|589925668|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
163331994|NCT02222493|589925669|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
163331995|NCT02222493|589925668|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
163331996|NCT02222493|589925669|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
163331997|NCT02222493|589925668|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
163331998|NCT02222493|589925669|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
163331999|NCT02222493|589925668|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
163332000|NCT02222493|589925669|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
163332001|NCT02222493|589925668|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
163332002|NCT02222493|589925669|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
163332003|NCT02222493|589925668|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
163332004|NCT02222493|589925669|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
163332005|NCT02222493|589925668|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
163332006|NCT02222493|589925669|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
163332007|NCT02222493|589925668|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
163332008|NCT02222493|589925669|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
163332009|NCT02222493|589925668|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
163332010|NCT02222493|589925669|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
163332011|NCT02222493|589925668|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
163332012|NCT02222493|589925669|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
163332013|NCT02222493|589925668|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
163332014|NCT02222493|589925669|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
163332015|NCT02222493|589925668|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
163332016|NCT02222493|589925669|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
163332017|NCT02222493|589925668|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
163332018|NCT02222493|589925669|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
163332019|NCT02222493|589925668|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
163332020|NCT02222493|589925669|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
163332021|NCT02222493|589925668|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
163332022|NCT02222493|589925669|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
163332023|NCT02222493|589925668|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
163332024|NCT02222493|589925669|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
163332025|NCT02222493|589925668|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
163029332|NCT01797081|588810414|FG002|Overall Study|Adverse Event|1|||
163029333|NCT01797081|588810415|FG003|Overall Study|Adverse Event|0|||
163029334|NCT01797081|588810412|FG000|Overall Study|Pregnancy|1|||
163029335|NCT01797081|588810413|FG001|Overall Study|Pregnancy|0|||
163029336|NCT01797081|588810414|FG002|Overall Study|Pregnancy|0|||
163029337|NCT01797081|588810415|FG003|Overall Study|Pregnancy|0|||
163029338|NCT01797081|588810412|FG000|Overall Study|Personal Reasons|12|||
163029339|NCT01797081|588810413|FG001|Overall Study|Personal Reasons|4|||
163029340|NCT01797081|588810414|FG002|Overall Study|Personal Reasons|4|||
163029341|NCT01797081|588810415|FG003|Overall Study|Personal Reasons|8|||
163029342|NCT01797081|588810412|FG000|Overall Study|Protocol Violation|0|||
163029343|NCT01797081|588810413|FG001|Overall Study|Protocol Violation|0|||
163029344|NCT01797081|588810414|FG002|Overall Study|Protocol Violation|0|||
163029345|NCT01797081|588810415|FG003|Overall Study|Protocol Violation|1|||
163029346|NCT02484651|588810423|FG000|Overall Study|Patients' data files were corrupted.|1|||
163029347|NCT02484651|588810424|FG001|Overall Study|Patients' data files were corrupted.|1|||
163029348|NCT02484651|588810423|FG000|Overall Study|BIS monitoring failed.|1|||
163029349|NCT02484651|588810424|FG001|Overall Study|BIS monitoring failed.|1|||
163029350|NCT02484651|588810423|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
163332026|NCT02222493|589925669|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
163078651|NCT03478787|588995104|FG001|Overall Study|Lost to Follow-up|5|||
163078652|NCT03478787|588995103|FG000|Overall Study|Withdrawal by Subject|2|||
163078653|NCT03478787|588995104|FG001|Overall Study|Withdrawal by Subject|6|||
163078654|NCT03478787|588995103|FG000|Overall Study|Other, Not Specified|3|||
163078655|NCT03478787|588995104|FG001|Overall Study|Other, Not Specified|0|||
163078656|NCT02792257|588995109|FG000|Overall Study|Lost to Follow-up|3|||
163078657|NCT02792257|588995110|FG001|Overall Study|Lost to Follow-up|4|||
163078658|NCT02792257|588995109|FG000|Overall Study|Allergy|0|||
163078659|NCT02792257|588995110|FG001|Overall Study|Allergy|1|||
163078660|NCT02792257|588995109|FG000|Overall Study|Protocol Violation|2|||
163078661|NCT02792257|588995110|FG001|Overall Study|Protocol Violation|0|||
163078662|NCT02792257|588995109|FG000|Overall Study|Excessive Agitation|0|||
163078663|NCT02792257|588995110|FG001|Overall Study|Excessive Agitation|1|||
163078664|NCT02792257|588995109|FG000|Overall Study|Not Feeling Well|0|||
163078665|NCT02792257|588995110|FG001|Overall Study|Not Feeling Well|1|||
163078666|NCT02766478|588995112|FG000|Overall Study|Withdrawal by Subject|1|||
163078667|NCT02766478|588995113|FG001|Overall Study|Withdrawal by Subject|1|||
163078668|NCT01093573|588995114|FG000|Overall Study|Physician Decision|0|||
163078669|NCT01093573|588995115|FG001|Overall Study|Physician Decision|0|||
163078670|NCT01093573|588995116|FG002|Overall Study|Physician Decision|1|||
163078671|NCT01093573|588995114|FG000|Overall Study|Insurance Denied|0|||
163078672|NCT01093573|588995115|FG001|Overall Study|Insurance Denied|0|||
163078673|NCT01093573|588995116|FG002|Overall Study|Insurance Denied|1|||
163078674|NCT05626686|588995117|FG000|Overall Study|Protocol Violation|3|||
163078675|NCT05626686|588995117|FG000|Overall Study|Withdrawal by Subject|3|||
163078676|NCT00682435|588995118|FG000|Overall Study|Insufficient data|5|||
163078677|NCT00682435|588995118|FG000|Overall Study|Erroneously enrolled twice|2|||
163078678|NCT00089583|588995119|FG000|Overall Study|Adverse Event|0|||
163078679|NCT00089583|588995120|FG001|Overall Study|Adverse Event|3|||
163078680|NCT00089583|588995119|FG000|Overall Study|Insufficient Viral Load Response|5|||
163078681|NCT00089583|588995120|FG001|Overall Study|Insufficient Viral Load Response|5|||
163078682|NCT00089583|588995119|FG000|Overall Study|Withdrawal by Subject|0|||
163078683|NCT00089583|588995120|FG001|Overall Study|Withdrawal by Subject|4|||
163078684|NCT00089583|588995119|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
163078685|NCT00089583|588995120|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
163078686|NCT00089583|588995119|FG000|Overall Study|Participant Refused Study Medication|0|||
163078687|NCT00089583|588995120|FG001|Overall Study|Participant Refused Study Medication|2|||
163078688|NCT00089583|588995119|FG000|Overall Study|Non-Compliance|0|||
163078689|NCT00089583|588995120|FG001|Overall Study|Non-Compliance|4|||
163078690|NCT00089583|588995119|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
163078691|NCT00089583|588995120|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
163078692|NCT00089583|588995119|FG000|Overall Study|Participant Management Criteria Met|0|||
163078693|NCT00089583|588995120|FG001|Overall Study|Participant Management Criteria Met|1|||
163078694|NCT00089583|588995119|FG000|Overall Study|Reason Not Provided|0|||
163078695|NCT00089583|588995120|FG001|Overall Study|Reason Not Provided|1|||
163078696|NCT00089583|588995119|FG000|Overall Study|Protocol Violation|0|||
163078697|NCT00089583|588995120|FG001|Overall Study|Protocol Violation|3|||
163078698|NCT00089583|588995119|FG000|Overall Study|Principal Investigator Decision|0|||
163078699|NCT00089583|588995120|FG001|Overall Study|Principal Investigator Decision|10|||
163078700|NCT00089583|588995119|FG000|Overall Study|Start of Disallowed Medication|0|||
163078701|NCT00089583|588995120|FG001|Overall Study|Start of Disallowed Medication|1|||
163332027|NCT02222493|589925668|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
163332028|NCT02222493|589925669|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
163332029|NCT02222493|589925668|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
163332030|NCT02222493|589925669|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
163332031|NCT02222493|589925668|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
163332032|NCT02222493|589925669|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
163078702|NCT00089583|588995119|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
163078703|NCT00089583|588995120|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
163078704|NCT00089583|588995119|FG000|Overall Study|Participant Incarcerated|0|||
163078705|NCT00089583|588995120|FG001|Overall Study|Participant Incarcerated|1|||
163078706|NCT01412983|588995121|FG000|1st Period|Ineligible|0|||
163078707|NCT01412983|588995122|FG001|1st Period|Ineligible|1|||
163078708|NCT01412983|588995121|FG000|1st Period|Positive slit lamp finding|0|||
163078709|NCT01412983|588995122|FG001|1st Period|Positive slit lamp finding|1|||
163078710|NCT01412983|588995121|FG000|1st Period|Unacceptable lens movement|0|||
163078711|NCT01412983|588995122|FG001|1st Period|Unacceptable lens movement|1|||
163078712|NCT01412983|588995121|FG000|1st Period|Inability to maintain wear|0|||
163078713|NCT01412983|588995122|FG001|1st Period|Inability to maintain wear|1|||
163078714|NCT02946996|588995123|FG000|Overall Study|non-evaluable|3|||
163078715|NCT02946996|588995124|FG001|Overall Study|non-evaluable|6|||
163078716|NCT02946996|588995125|FG002|Overall Study|non-evaluable|5|||
163078717|NCT00176254|588995126|FG000|Overall Study|Lost to Follow-up|1|||
163078718|NCT03289741|588995127|FG000|Overall Study|Adverse Event|1|||
163078719|NCT03289741|588995128|FG001|Overall Study|Adverse Event|1|||
163078720|NCT03289741|588995127|FG000|Overall Study|Physician Decision|2|||
163078721|NCT03289741|588995128|FG001|Overall Study|Physician Decision|2|||
163078722|NCT03289741|588995127|FG000|Overall Study|Withdrawal by Subject|1|||
163078723|NCT03289741|588995128|FG001|Overall Study|Withdrawal by Subject|0|||
163078724|NCT00992394|588995133|FG000|Overall Study|Lack of Efficacy|6|||
163078725|NCT00992394|588995134|FG001|Overall Study|Lack of Efficacy|3|||
163078726|NCT00992394|588995133|FG000|Overall Study|Adverse Event|4|||
163078727|NCT00992394|588995134|FG001|Overall Study|Adverse Event|5|||
163078728|NCT00992394|588995133|FG000|Overall Study|Withdrawal by Subject|8|||
163078729|NCT00992394|588995134|FG001|Overall Study|Withdrawal by Subject|2|||
163078730|NCT00992394|588995133|FG000|Overall Study|Physician Decision|1|||
163078731|NCT00992394|588995134|FG001|Overall Study|Physician Decision|0|||
163078732|NCT00992394|588995133|FG000|Overall Study|Protocol Violation|2|||
163078733|NCT00992394|588995134|FG001|Overall Study|Protocol Violation|4|||
163078734|NCT00992394|588995133|FG000|Overall Study|Lost to Follow-up|2|||
163078735|NCT00992394|588995134|FG001|Overall Study|Lost to Follow-up|0|||
163078736|NCT00992394|588995133|FG000|Overall Study|Other event|1|||
163078737|NCT00992394|588995134|FG001|Overall Study|Other event|0|||
163078738|NCT01245049|588995135|FG000|Overall Study|Migrated/moved from study area|0|||
163078739|NCT01245049|588995136|FG001|Overall Study|Migrated/moved from study area|1|||
163078740|NCT01245049|588995135|FG000|Overall Study|Withdrawal by Subject|0|||
163078741|NCT01245049|588995136|FG001|Overall Study|Withdrawal by Subject|1|||
163078742|NCT01245049|588995135|FG000|Overall Study|Lost to Follow-up|1|||
163078743|NCT01245049|588995136|FG001|Overall Study|Lost to Follow-up|2|||
163078744|NCT00450749|588995137|FG000|Overall Study|Withdrawal by Subject|0|||
163078745|NCT00450749|588995138|FG001|Overall Study|Withdrawal by Subject|0|||
163078746|NCT00450749|588995139|FG002|Overall Study|Withdrawal by Subject|2|||
163078747|NCT00450749|588995137|FG000|Overall Study|Noncompliant|0|||
163078748|NCT00450749|588995138|FG001|Overall Study|Noncompliant|1|||
163078749|NCT00450749|588995139|FG002|Overall Study|Noncompliant|0|||
163078750|NCT02568254|588995140|FG000|Period 2|Adverse Event|0|||
163078751|NCT02568254|588995141|FG001|Period 2|Adverse Event|0|||
163078752|NCT02568254|588995142|FG002|Period 2|Adverse Event|1|||
163078753|NCT02568254|588995143|FG003|Period 2|Adverse Event|0|||
163078754|NCT02568254|588995144|FG004|Period 2|Adverse Event|0|||
163078755|NCT02568254|588995145|FG005|Period 2|Adverse Event|0|||
163078756|NCT02568254|588995140|FG000|Period 3|Unstatisfactory Lens fitting|0|||
163078757|NCT02568254|588995141|FG001|Period 3|Unstatisfactory Lens fitting|0|||
163078758|NCT02568254|588995142|FG002|Period 3|Unstatisfactory Lens fitting|0|||
163078759|NCT02568254|588995143|FG003|Period 3|Unstatisfactory Lens fitting|0|||
163078760|NCT02568254|588995144|FG004|Period 3|Unstatisfactory Lens fitting|1|||
163078761|NCT02568254|588995145|FG005|Period 3|Unstatisfactory Lens fitting|0|||
163078762|NCT01197300|588996824|FG000|Overall Study|Lost to Follow-up|0|||
163078763|NCT01197300|588996825|FG001|Overall Study|Lost to Follow-up|1|||
163078764|NCT01197300|588996824|FG000|Overall Study|Protocol Violation|0|||
163078765|NCT01197300|588996825|FG001|Overall Study|Protocol Violation|1|||
163078766|NCT02113878|588996828|FG000|Overall Study|Adverse Event|1|||
163078767|NCT02113878|588996829|FG001|Overall Study|Adverse Event|0|||
163078768|NCT02113878|588996828|FG000|Overall Study|Withdrawal by Subject|1|||
163078769|NCT02113878|588996829|FG001|Overall Study|Withdrawal by Subject|0|||
163078770|NCT02113878|588996828|FG000|Overall Study|patient non-compliance|1|||
163078771|NCT02113878|588996829|FG001|Overall Study|patient non-compliance|0|||
163078772|NCT02255279|588996830|FG000|Overall Study|Lost to Follow-up|2|||
163078773|NCT02255279|588996831|FG001|Overall Study|Lost to Follow-up|2|||
163078774|NCT02255279|588996830|FG000|Overall Study|Protocol Violation|0|||
163078775|NCT02255279|588996831|FG001|Overall Study|Protocol Violation|1|||
163078776|NCT02255279|588996830|FG000|Overall Study|Withdrawal by Subject|3|||
163078777|NCT02255279|588996831|FG001|Overall Study|Withdrawal by Subject|6|||
163078778|NCT02144337|588996853|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
163078779|NCT02144337|588996854|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
163078780|NCT02144337|588996853|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
163078781|NCT02144337|588996854|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
163078782|NCT02144337|588996853|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
163078783|NCT02144337|588996854|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
163078784|NCT02144337|588996853|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
163078785|NCT02144337|588996854|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
163078786|NCT02144337|588996853|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
163078787|NCT02144337|588996854|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
163078788|NCT01052428|588996857|FG000|Overall Study|Death|1|||
163078789|NCT01052428|588996858|FG001|Overall Study|Death|0|||
163078790|NCT01052428|588996857|FG000|Overall Study|Withdrawal by Subject|0|||
163078791|NCT01052428|588996858|FG001|Overall Study|Withdrawal by Subject|1|||
163078792|NCT00871000|588996859|FG000|Overall Study|Withdrawal by Subject|1|||
163078793|NCT00871000|588996860|FG001|Overall Study|Withdrawal by Subject|0|||
163078794|NCT03400787|588996861|FG000|Overall Study|Lost to Follow-up|1|||
163078795|NCT03400787|588996862|FG001|Overall Study|Lost to Follow-up|0|||
163078796|NCT03400787|588996861|FG000|Overall Study|Death|1|||
163078797|NCT03400787|588996862|FG001|Overall Study|Death|0|||
163078798|NCT03400787|588996861|FG000|Overall Study|Protocol Violation|0|||
163078799|NCT03400787|588996862|FG001|Overall Study|Protocol Violation|2|||
163078800|NCT03400787|588996861|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
163078801|NCT03400787|588996862|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
163078802|NCT02402907|588996865|FG000|Overall Study|Delivered vaginally|9|||
163078803|NCT02402907|588996866|FG001|Overall Study|Delivered vaginally|3|||
163078804|NCT02402907|588996865|FG000|Overall Study|Delivered outside of Sinai|1|||
163078805|NCT02402907|588996866|FG001|Overall Study|Delivered outside of Sinai|1|||
163078806|NCT02402907|588996865|FG000|Overall Study|Lost to follow up after C-Section|10|||
163078807|NCT02402907|588996866|FG001|Overall Study|Lost to follow up after C-Section|23|||
163078808|NCT02837952|588996868|FG000|Overall Study|Adverse Event|0|||
163078809|NCT02837952|588996869|FG001|Overall Study|Adverse Event|1|||
163078810|NCT02837952|588996868|FG000|Overall Study|Withdrawal by Subject|4|||
163078811|NCT02837952|588996869|FG001|Overall Study|Withdrawal by Subject|5|||
163078812|NCT02837952|588996868|FG000|Overall Study|Medication Error|1|||
163078813|NCT02837952|588996869|FG001|Overall Study|Medication Error|0|||
163078814|NCT01959919|588996870|FG000|Overall Study|Did not meet the eligibility criteria|2|||
163078815|NCT03439072|588996871|FG000|Overall Study|Withdrawal by Subject|2|||
163078816|NCT03439072|588996872|FG001|Overall Study|Withdrawal by Subject|3|||
163078817|NCT03439072|588996871|FG000|Overall Study|Physician Decision|0|||
163078818|NCT03439072|588996872|FG001|Overall Study|Physician Decision|1|||
163078819|NCT02003898|588996874|FG000|Overall Study|Death|3|||
163078820|NCT02003898|588996874|FG000|Overall Study|Lost to Follow-up|12|||
163078821|NCT02003898|588996874|FG000|Overall Study|Withdrawal by Subject|52|||
163078822|NCT00128492|588996875|FG000|Overall Study|AE unrelated to study|2|||
163078823|NCT00128492|588996876|FG001|Overall Study|AE unrelated to study|9|||
163078824|NCT00128492|588996875|FG000|Overall Study|Study drug intolerance (AE)|2|||
163078825|NCT00128492|588996876|FG001|Overall Study|Study drug intolerance (AE)|8|||
163078826|NCT00128492|588996875|FG000|Overall Study|AE related to study|1|||
163078827|NCT00128492|588996876|FG001|Overall Study|AE related to study|4|||
163078828|NCT00128492|588996875|FG000|Overall Study|Death|1|||
163078829|NCT00128492|588996876|FG001|Overall Study|Death|0|||
163078830|NCT00128492|588996875|FG000|Overall Study|Lost to Follow-up|1|||
163078831|NCT00128492|588996876|FG001|Overall Study|Lost to Follow-up|5|||
163078832|NCT00128492|588996875|FG000|Overall Study|Noncompliance|0|||
163078833|NCT00128492|588996876|FG001|Overall Study|Noncompliance|5|||
163078834|NCT00128492|588996875|FG000|Overall Study|Personal or administrative|10|||
163078835|NCT00128492|588996876|FG001|Overall Study|Personal or administrative|22|||
163078836|NCT00128492|588996875|FG000|Overall Study|Withdrawal by Subject|3|||
163078837|NCT00128492|588996876|FG001|Overall Study|Withdrawal by Subject|5|||
163078838|NCT00128492|588996875|FG000|Overall Study|Pregnancy|0|||
163078839|NCT00128492|588996876|FG001|Overall Study|Pregnancy|1|||
163078840|NCT03436420|588996877|FG000|Overall Study|Lack of Efficacy|3|||
163078841|NCT00756314|588996878|FG000|Overall Study|Lost to Follow-up|2|||
163078842|NCT00756314|588996879|FG001|Overall Study|Lost to Follow-up|59|||
163078843|NCT02605967|588996880|FG000|Overall Study|subject / guardian decision|1|||
163078844|NCT02605967|588996881|FG001|Overall Study|subject / guardian decision|2|||
163078845|NCT02605967|588996880|FG000|Overall Study|Physician Decision|10|||
163078846|NCT02605967|588996881|FG001|Overall Study|Physician Decision|1|||
163078847|NCT02605967|588996880|FG000|Overall Study|Death|4|||
163078848|NCT02605967|588996881|FG001|Overall Study|Death|2|||
163078849|NCT02605967|588996880|FG000|Overall Study|Adverse Event|1|||
163078850|NCT02605967|588996881|FG001|Overall Study|Adverse Event|0|||
163078851|NCT02605967|588996880|FG000|Overall Study|progressive disease|66|||
163078852|NCT02605967|588996881|FG001|Overall Study|progressive disease|35|||
163078853|NCT03627468|588996882|FG000|Overall Study|Adverse Event|5|||
163078854|NCT03627468|588996883|FG001|Overall Study|Adverse Event|33|||
163078855|NCT03627468|588996882|FG000|Overall Study|Withdrawal by Subject|13|||
163078856|NCT03627468|588996883|FG001|Overall Study|Withdrawal by Subject|23|||
163078857|NCT03627468|588996882|FG000|Overall Study|Physician Decision|1|||
163078858|NCT03627468|588996883|FG001|Overall Study|Physician Decision|0|||
163078859|NCT03627468|588996882|FG000|Overall Study|Protocol Violation|0|||
163078860|NCT03627468|588996883|FG001|Overall Study|Protocol Violation|2|||
163078861|NCT03627468|588996882|FG000|Overall Study|Lost to Follow-up|10|||
163078862|NCT03627468|588996883|FG001|Overall Study|Lost to Follow-up|16|||
163078863|NCT03627468|588996882|FG000|Overall Study|Death|1|||
163078864|NCT03627468|588996883|FG001|Overall Study|Death|0|||
163078865|NCT03627468|588996882|FG000|Overall Study|Pregnancy|1|||
163078866|NCT03627468|588996883|FG001|Overall Study|Pregnancy|1|||
163078867|NCT03627468|588996882|FG000|Overall Study|Lack of Efficacy|0|||
163078868|NCT03627468|588996883|FG001|Overall Study|Lack of Efficacy|2|||
163078869|NCT03627468|588996882|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
163078870|NCT03627468|588996883|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
163078871|NCT01475825|588996887|FG000|Overall Study|Adverse Event|41|||
163078872|NCT01475825|588996888|FG001|Overall Study|Adverse Event|15|||
163078873|NCT01475825|588996889|FG002|Overall Study|Adverse Event|27|||
163078874|NCT01475825|588996890|FG003|Overall Study|Adverse Event|11|||
163332033|NCT00933270|589925672|FG000|Overall Study|Withdrawal by Subject|26|||
163332034|NCT00933270|589925672|FG000|Overall Study|Insufficient Follow-up|10|||
163332035|NCT00933270|589925672|FG000|Overall Study|Lost to Follow-up|14|||
163332036|NCT00933270|589925672|FG000|Overall Study|Adverse Event|1|||
163332037|NCT00933270|589925672|FG000|Overall Study|Missed Visit|2|||
163332038|NCT00933270|589925672|FG000|Overall Study|Death|24|||
163332039|NCT00933270|589925672|FG000|Overall Study|Moved or would not return|10|||
163332040|NCT02542943|589925673|FG000|Overall Study|Lost to Follow-up|1|||
163332041|NCT02542943|589925674|FG001|Overall Study|Lost to Follow-up|0|||
163332042|NCT02542943|589925675|FG002|Overall Study|Lost to Follow-up|0|||
163332043|NCT02542943|589925673|FG000|Overall Study|Withdrawal by Subject|0|||
163332044|NCT02542943|589925674|FG001|Overall Study|Withdrawal by Subject|1|||
163332045|NCT02542943|589925675|FG002|Overall Study|Withdrawal by Subject|0|||
163332046|NCT05824559|589925678|FG000|Overall Study|Adverse Event|2|||
163332047|NCT05824559|589925678|FG000|Overall Study|Physician Decision|2|||
163332048|NCT05824559|589925678|FG000|Overall Study|Progressive Disease|16|||
163332049|NCT05824559|589925678|FG000|Overall Study|Study Terminated by Sponsor|1|||
163332050|NCT05824559|589925678|FG000|Overall Study|Withdrawal by Subject|2|||
163332051|NCT04701203|589925683|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
163332052|NCT04701203|589925684|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
163332053|NCT04701203|589925685|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
163332054|NCT04701203|589925683|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
163332055|NCT04701203|589925684|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
163332056|NCT04701203|589925685|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
163332057|NCT04701203|589925683|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
163332058|NCT04701203|589925684|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
163332059|NCT04701203|589925685|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
163029351|NCT02484651|588810424|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
163029352|NCT01698879|588810425|FG000|Overall Study|Withdrawal by Subject|1|||
163029353|NCT01698879|588810426|FG001|Overall Study|Withdrawal by Subject|0|||
163029354|NCT01698879|588810427|FG002|Overall Study|Withdrawal by Subject|0|||
163029355|NCT04972968|588810428|FG000|Overall Study|Adverse Event|3|||
163029356|NCT04972968|588810429|FG001|Overall Study|Adverse Event|1|||
163029357|NCT04972968|588810430|FG002|Overall Study|Adverse Event|1|||
163029358|NCT04972968|588810431|FG003|Overall Study|Adverse Event|7|||
163029359|NCT04972968|588810428|FG000|Overall Study|Lack of Efficacy|2|||
163029360|NCT04972968|588810429|FG001|Overall Study|Lack of Efficacy|1|||
163029361|NCT04972968|588810430|FG002|Overall Study|Lack of Efficacy|0|||
163029362|NCT04972968|588810431|FG003|Overall Study|Lack of Efficacy|0|||
163029363|NCT04972968|588810428|FG000|Overall Study|Withdrawal by Subject|7|||
163029364|NCT04972968|588810429|FG001|Overall Study|Withdrawal by Subject|4|||
163029365|NCT04972968|588810430|FG002|Overall Study|Withdrawal by Subject|3|||
163029366|NCT04972968|588810431|FG003|Overall Study|Withdrawal by Subject|2|||
163029367|NCT04972968|588810428|FG000|Overall Study|Study Terminated by Sponsor|25|||
163029368|NCT04972968|588810429|FG001|Overall Study|Study Terminated by Sponsor|28|||
163029369|NCT04972968|588810430|FG002|Overall Study|Study Terminated by Sponsor|32|||
163029370|NCT04972968|588810431|FG003|Overall Study|Study Terminated by Sponsor|27|||
163029371|NCT04972968|588810428|FG000|Overall Study|Other|1|||
163029372|NCT04972968|588810429|FG001|Overall Study|Other|0|||
163029373|NCT04972968|588810430|FG002|Overall Study|Other|1|||
163029374|NCT04972968|588810431|FG003|Overall Study|Other|1|||
163029375|NCT00150800|588810432|FG000|Overall Study|Adverse Event|89|||
163029376|NCT00150800|588810432|FG000|Overall Study|Death|18|||
163029377|NCT00150800|588810432|FG000|Overall Study|Lack of Efficacy|166|||
163029378|NCT00150800|588810432|FG000|Overall Study|Lost to Follow-up|58|||
163029379|NCT00150800|588810432|FG000|Overall Study|Subject's choice|90|||
163029380|NCT00150800|588810432|FG000|Overall Study|No compliance|18|||
163029381|NCT00150800|588810432|FG000|Overall Study|IP misshandling|1|||
163029382|NCT00150800|588810432|FG000|Overall Study|Site closure|24|||
163029383|NCT00150800|588810432|FG000|Overall Study|Protocol non-adherence|2|||
163029384|NCT00150800|588810432|FG000|Overall Study|Nobody to accompany patient|1|||
163029385|NCT00150800|588810432|FG000|Overall Study|Distance too long for patient|1|||
163029386|NCT00150800|588810432|FG000|Overall Study|Neurosurgery|2|||
163029387|NCT00150800|588810432|FG000|Overall Study|BRV monotherapy|1|||
163029388|NCT00150800|588810432|FG000|Overall Study|Visit refusal|3|||
163332060|NCT04701203|589925683|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
163332061|NCT04701203|589925684|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
163029389|NCT00150800|588810432|FG000|Overall Study|Sponsor's request|2|||
163029390|NCT00150800|588810432|FG000|Overall Study|Generalized Epilepsy|1|||
163029391|NCT00150800|588810432|FG000|Overall Study|Moved from area/country|8|||
163029392|NCT00150800|588810432|FG000|Overall Study|PI retiring|2|||
163029393|NCT00150800|588810432|FG000|Overall Study|PI leaving site|2|||
163029394|NCT00150800|588810432|FG000|Overall Study|Patient insurance|1|||
163029395|NCT00150800|588810432|FG000|Overall Study|Surgical intervention|4|||
163332062|NCT04701203|589925685|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
163332063|NCT01563185|589925688|FG000|Overall Study|Withdrawal by Subject|1|||
163332064|NCT01563185|589925688|FG000|Overall Study|Non-Compliance with study drug|1|||
163332065|NCT04577651|589925689|FG000|Overall Study|Screen Failure|7|||
163332066|NCT04577651|589925689|FG000|Overall Study|Adverse Event|1|||
163332067|NCT04577651|589925689|FG000|Overall Study|Death|1|||
163078875|NCT01475825|588996887|FG000|Overall Study|Death|1|||
163078876|NCT01475825|588996888|FG001|Overall Study|Death|0|||
163078877|NCT01475825|588996889|FG002|Overall Study|Death|1|||
163078878|NCT01475825|588996890|FG003|Overall Study|Death|0|||
163078879|NCT01475825|588996887|FG000|Overall Study|Lack of Efficacy|0|||
163078880|NCT01475825|588996888|FG001|Overall Study|Lack of Efficacy|0|||
163078881|NCT01475825|588996889|FG002|Overall Study|Lack of Efficacy|1|||
163078882|NCT01475825|588996890|FG003|Overall Study|Lack of Efficacy|0|||
163078883|NCT01475825|588996887|FG000|Overall Study|Lost to Follow-up|0|||
163078884|NCT01475825|588996888|FG001|Overall Study|Lost to Follow-up|0|||
163078885|NCT01475825|588996889|FG002|Overall Study|Lost to Follow-up|3|||
163078886|NCT01475825|588996890|FG003|Overall Study|Lost to Follow-up|1|||
163078887|NCT01475825|588996887|FG000|Overall Study|Non-compliance with Study Drug|1|||
163078888|NCT01475825|588996888|FG001|Overall Study|Non-compliance with Study Drug|2|||
163078889|NCT01475825|588996889|FG002|Overall Study|Non-compliance with Study Drug|4|||
163078890|NCT01475825|588996890|FG003|Overall Study|Non-compliance with Study Drug|0|||
163078891|NCT01475825|588996887|FG000|Overall Study|Other: Not available|0|||
163078892|NCT01475825|588996888|FG001|Overall Study|Other: Not available|0|||
163078893|NCT01475825|588996889|FG002|Overall Study|Other: Not available|2|||
163078894|NCT01475825|588996890|FG003|Overall Study|Other: Not available|0|||
163078895|NCT01475825|588996887|FG000|Overall Study|Protocol Violation|1|||
163078896|NCT01475825|588996888|FG001|Overall Study|Protocol Violation|0|||
163078897|NCT01475825|588996889|FG002|Overall Study|Protocol Violation|0|||
163078898|NCT01475825|588996890|FG003|Overall Study|Protocol Violation|0|||
163078899|NCT01475825|588996887|FG000|Overall Study|Physician Decision|0|||
163078900|NCT01475825|588996888|FG001|Overall Study|Physician Decision|1|||
163078901|NCT01475825|588996889|FG002|Overall Study|Physician Decision|0|||
163078902|NCT01475825|588996890|FG003|Overall Study|Physician Decision|0|||
163078903|NCT01475825|588996887|FG000|Overall Study|Withdrawal by Subject|8|||
163078904|NCT01475825|588996888|FG001|Overall Study|Withdrawal by Subject|3|||
163078905|NCT01475825|588996889|FG002|Overall Study|Withdrawal by Subject|11|||
163078906|NCT01475825|588996890|FG003|Overall Study|Withdrawal by Subject|7|||
163078907|NCT01475825|588996887|FG000|Overall Study|Did not enter OLC|15|||
163078908|NCT01475825|588996888|FG001|Overall Study|Did not enter OLC|11|||
163078909|NCT01475825|588996889|FG002|Overall Study|Did not enter OLC|15|||
163078910|NCT01475825|588996890|FG003|Overall Study|Did not enter OLC|11|||
163078911|NCT01903733|588996893|FG000|Overall Study|Death|23|||
163078912|NCT01903733|588996894|FG001|Overall Study|Death|54|||
163078913|NCT01903733|588996895|FG002|Overall Study|Death|30|||
163078914|NCT01903733|588996896|FG003|Overall Study|Death|98|||
163078915|NCT01903733|588996893|FG000|Overall Study|Participant refused further follow-up|35|||
163078916|NCT01903733|588996894|FG001|Overall Study|Participant refused further follow-up|38|||
163078917|NCT01903733|588996895|FG002|Overall Study|Participant refused further follow-up|13|||
163078918|NCT01903733|588996896|FG003|Overall Study|Participant refused further follow-up|9|||
163078919|NCT01903733|588996893|FG000|Overall Study|Lost to Follow-up|18|||
163078920|NCT01903733|588996894|FG001|Overall Study|Lost to Follow-up|19|||
163078921|NCT01903733|588996895|FG002|Overall Study|Lost to Follow-up|6|||
163078922|NCT01903733|588996896|FG003|Overall Study|Lost to Follow-up|9|||
163078923|NCT01903733|588996893|FG000|Overall Study|Other|10|||
163078924|NCT01903733|588996894|FG001|Overall Study|Other|15|||
163078925|NCT01903733|588996895|FG002|Overall Study|Other|12|||
163078926|NCT01903733|588996896|FG003|Overall Study|Other|3|||
163078927|NCT01903733|588996893|FG000|Overall Study|Missing|2|||
163078928|NCT01903733|588996894|FG001|Overall Study|Missing|0|||
163332068|NCT04577651|589925689|FG000|Overall Study|Physician Decision|1|||
163332069|NCT04577651|589925689|FG000|Overall Study|Withdrawal by Subject|3|||
163332070|NCT00647387|589925692|FG000|Overall Study|Lost to Follow-up|6|||
163078929|NCT01903733|588996895|FG002|Overall Study|Missing|0|||
163078930|NCT01903733|588996896|FG003|Overall Study|Missing|0|||
163078931|NCT01903733|588996893|FG000|Overall Study|Investigator request|18|||
163078932|NCT01903733|588996894|FG001|Overall Study|Investigator request|0|||
163078933|NCT01903733|588996895|FG002|Overall Study|Investigator request|0|||
163078934|NCT01903733|588996896|FG003|Overall Study|Investigator request|0|||
163078935|NCT03721107|588996899|FG000|Overall Study|Adverse Event|1|||
163078936|NCT03721107|588996900|FG001|Overall Study|Adverse Event|1|||
163078937|NCT03721107|588996901|FG002|Overall Study|Adverse Event|6|||
163078938|NCT03721107|588996902|FG003|Overall Study|Adverse Event|5|||
163332071|NCT00647387|589925692|FG000|Overall Study|Unsuccessful implant|5|||
163078939|NCT03721107|588996899|FG000|Overall Study|Lost to Follow-up|2|||
163332072|NCT00647387|589925692|FG000|Overall Study|Device explanted|3|||
163332073|NCT00647387|589925692|FG000|Overall Study|Other Reason|3|||
163078940|NCT03721107|588996900|FG001|Overall Study|Lost to Follow-up|0|||
163078941|NCT03721107|588996901|FG002|Overall Study|Lost to Follow-up|3|||
163078942|NCT03721107|588996902|FG003|Overall Study|Lost to Follow-up|0|||
163078943|NCT03721107|588996899|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
163078944|NCT03721107|588996900|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
163332074|NCT00647387|589925692|FG000|Overall Study|Death|2|||
163332075|NCT03147287|589925693|FG000|Overall Study|Randomized Not Treated|2|||
163332076|NCT03147287|589925694|FG001|Overall Study|Randomized Not Treated|1|||
163332077|NCT03147287|589925695|FG002|Overall Study|Randomized Not Treated|1|||
163332078|NCT03147287|589925693|FG000|Overall Study|Progressive Disease RECIST|31|||
163332079|NCT03147287|589925694|FG001|Overall Study|Progressive Disease RECIST|72|||
163332080|NCT03147287|589925695|FG002|Overall Study|Progressive Disease RECIST|32|||
163029396|NCT00150800|588810432|FG000|Overall Study|Pregnancy planned|1|||
163029397|NCT00150800|588810432|FG000|Overall Study|PI discontinuation request|1|||
163029398|NCT03649178|588810433|FG000|Overall Study|Adverse Event|1|||
163029399|NCT03649178|588810434|FG001|Overall Study|Adverse Event|2|||
163029400|NCT03649178|588810433|FG000|Overall Study|Withdrawal by Subject|0|||
163029401|NCT03649178|588810434|FG001|Overall Study|Withdrawal by Subject|2|||
163029402|NCT03649178|588810433|FG000|Overall Study|COVID regulation required halt in protocol|1|||
163029403|NCT03649178|588810434|FG001|Overall Study|COVID regulation required halt in protocol|0|||
163029404|NCT03619902|588810436|FG000|Overall Study|Termination of Study by Investigator|1|||
163029405|NCT03619902|588810436|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
163029406|NCT00794040|588810440|FG000|Overall Study|Withdrawal by Subject|3|||
163029407|NCT00794040|588810441|FG001|Overall Study|Withdrawal by Subject|4|||
163029408|NCT00794040|588810440|FG000|Overall Study|Physician Decision|0|||
163029409|NCT00794040|588810441|FG001|Overall Study|Physician Decision|1|||
163029410|NCT04687072|588810442|FG000|Overall Study|Adverse Event|2|||
163029411|NCT04687072|588810443|FG001|Overall Study|Adverse Event|0|||
163029412|NCT04687072|588810442|FG000|Overall Study|Death|1|||
163029413|NCT04687072|588810443|FG001|Overall Study|Death|0|||
163029414|NCT04687072|588810442|FG000|Overall Study|Lack of Efficacy|2|||
163029415|NCT04687072|588810443|FG001|Overall Study|Lack of Efficacy|1|||
163029416|NCT04687072|588810442|FG000|Overall Study|Physician Decision|1|||
163029417|NCT04687072|588810443|FG001|Overall Study|Physician Decision|0|||
163029418|NCT04687072|588810442|FG000|Overall Study|Pregnancy|1|||
163029419|NCT04687072|588810443|FG001|Overall Study|Pregnancy|0|||
163029420|NCT04687072|588810442|FG000|Overall Study|Requires Prohibited Medication|2|||
163029421|NCT04687072|588810443|FG001|Overall Study|Requires Prohibited Medication|0|||
163029422|NCT04687072|588810442|FG000|Overall Study|Withdrawal of Consent|11|||
163029423|NCT04687072|588810443|FG001|Overall Study|Withdrawal of Consent|6|||
163029424|NCT04687072|588810442|FG000|Overall Study|Miscellaneous|4|||
163029425|NCT04687072|588810443|FG001|Overall Study|Miscellaneous|1|||
163029426|NCT01263782|588810444|FG000|Overall Study|Death|0|||
163029427|NCT01263782|588810445|FG001|Overall Study|Death|0|||
163029428|NCT01263782|588810446|FG002|Overall Study|Death|1|||
163029429|NCT01263782|588810447|FG003|Overall Study|Death|0|||
163029430|NCT01263782|588810444|FG000|Overall Study|Progressive disease|0|||
163029431|NCT01263782|588810445|FG001|Overall Study|Progressive disease|0|||
163029432|NCT01263782|588810446|FG002|Overall Study|Progressive disease|0|||
163029433|NCT01263782|588810447|FG003|Overall Study|Progressive disease|1|||
163029434|NCT01263782|588810444|FG000|Overall Study|Too early|0|||
163029435|NCT01263782|588810445|FG001|Overall Study|Too early|0|||
163029436|NCT01263782|588810446|FG002|Overall Study|Too early|1|||
163029437|NCT01263782|588810447|FG003|Overall Study|Too early|0|||
163029438|NCT01263782|588810444|FG000|Overall Study|Inevaluable|0|||
163029439|NCT01263782|588810445|FG001|Overall Study|Inevaluable|0|||
163029440|NCT01263782|588810446|FG002|Overall Study|Inevaluable|1|||
163029441|NCT01263782|588810447|FG003|Overall Study|Inevaluable|0|||
163029442|NCT04545567|588810449|FG000|Overall Study|tested positive for SARS-co-V2|1|||
163029443|NCT04545567|588810450|FG001|Overall Study|tested positive for SARS-co-V2|1|||
163029444|NCT04545567|588810449|FG000|Overall Study|Withdrawal by Subject|0|||
163029445|NCT04545567|588810450|FG001|Overall Study|Withdrawal by Subject|1|||
163029446|NCT03626363|588810456|FG000|Overall Study|Protocol Violation|4|||
163029447|NCT03626363|588810457|FG001|Overall Study|Protocol Violation|0|||
163029448|NCT03626363|588810456|FG000|Overall Study|Lost to Follow-up|5|||
163029449|NCT03626363|588810457|FG001|Overall Study|Lost to Follow-up|7|||
163029450|NCT00965341|588810461|FG000|Overall Study|Withdrew consent|1|||
163029451|NCT00965341|588810462|FG001|Overall Study|Withdrew consent|5|||
163029452|NCT00965341|588810461|FG000|Overall Study|Lost to Follow-up|1|||
163029453|NCT00965341|588810462|FG001|Overall Study|Lost to Follow-up|0|||
163029454|NCT00965341|588810461|FG000|Overall Study|Transportation issues|4|||
163029455|NCT00965341|588810462|FG001|Overall Study|Transportation issues|3|||
163029456|NCT00960986|588810463|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
163029457|NCT00960986|588810464|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
163029458|NCT00960986|588810465|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
163029459|NCT00960986|588810466|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
163029460|NCT00960986|588810463|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
163029461|NCT00960986|588810464|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
163029462|NCT00960986|588810465|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
163029463|NCT00960986|588810466|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
163078945|NCT03721107|588996901|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
163078946|NCT03721107|588996902|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
163078947|NCT03721107|588996899|FG000|Overall Study|Physician Decision|0|||
163078948|NCT03721107|588996900|FG001|Overall Study|Physician Decision|1|||
163078949|NCT03721107|588996901|FG002|Overall Study|Physician Decision|0|||
163078950|NCT03721107|588996902|FG003|Overall Study|Physician Decision|0|||
163078951|NCT03721107|588996899|FG000|Overall Study|Pregnancy|0|||
163078952|NCT03721107|588996900|FG001|Overall Study|Pregnancy|0|||
163078953|NCT03721107|588996901|FG002|Overall Study|Pregnancy|1|||
163078954|NCT03721107|588996902|FG003|Overall Study|Pregnancy|0|||
163078955|NCT03721107|588996899|FG000|Overall Study|Withdrawal by Subject|1|||
163078956|NCT03721107|588996900|FG001|Overall Study|Withdrawal by Subject|1|||
163078957|NCT03721107|588996901|FG002|Overall Study|Withdrawal by Subject|5|||
163078958|NCT03721107|588996902|FG003|Overall Study|Withdrawal by Subject|5|||
163078959|NCT03721107|588996899|FG000|Overall Study|Other|1|||
163078960|NCT03721107|588996900|FG001|Overall Study|Other|0|||
163078961|NCT03721107|588996901|FG002|Overall Study|Other|0|||
163078962|NCT03721107|588996902|FG003|Overall Study|Other|1|||
163078963|NCT02991859|588996908|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078964|NCT02991859|588996909|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
163078965|NCT02991859|588996910|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078966|NCT02991859|588996911|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078967|NCT02991859|588996912|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
163078968|NCT02991859|588996913|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078969|NCT02991859|588996914|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078970|NCT02991859|588996915|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078971|NCT02991859|588996916|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078972|NCT02991859|588996917|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078973|NCT02991859|588996918|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078974|NCT02991859|588996919|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078975|NCT02991859|588996920|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078976|NCT02991859|588996921|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078977|NCT02991859|588996922|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078978|NCT02991859|588996923|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078979|NCT02991859|588996924|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078980|NCT02991859|588996908|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078981|NCT02991859|588996909|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078982|NCT02991859|588996910|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078983|NCT02991859|588996911|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078984|NCT02991859|588996912|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078985|NCT02991859|588996913|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078986|NCT02991859|588996914|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078987|NCT02991859|588996915|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078988|NCT02991859|588996916|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078989|NCT02991859|588996917|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078990|NCT02991859|588996918|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078991|NCT02991859|588996919|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078992|NCT02991859|588996920|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
163078993|NCT02991859|588996921|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
163078994|NCT02991859|588996922|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078995|NCT02991859|588996923|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078996|NCT02991859|588996924|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163332081|NCT03147287|589925693|FG000|Overall Study|Progressive Disease not RECIST|13|||
163332082|NCT03147287|589925694|FG001|Overall Study|Progressive Disease not RECIST|21|||
163332083|NCT03147287|589925695|FG002|Overall Study|Progressive Disease not RECIST|13|||
163332084|NCT03147287|589925693|FG000|Overall Study|Physician Decision|1|||
163332085|NCT03147287|589925694|FG001|Overall Study|Physician Decision|2|||
163332086|NCT03147287|589925695|FG002|Overall Study|Physician Decision|1|||
163332087|NCT03147287|589925693|FG000|Overall Study|Intercurrent illness|0|||
163332088|NCT03147287|589925694|FG001|Overall Study|Intercurrent illness|1|||
163332089|NCT03147287|589925695|FG002|Overall Study|Intercurrent illness|0|||
163406447|NCT03311711|590198637|FG002|Overall Study|Death of dyad partner|0|||
163406448|NCT03311711|590198638|FG003|Overall Study|Death of dyad partner|0|||
163078997|NCT02991859|588996908|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163078998|NCT02991859|588996909|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163078999|NCT02991859|588996910|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079000|NCT02991859|588996911|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163332090|NCT03147287|589925693|FG000|Overall Study|Withdrawal by Subject|2|||
163332091|NCT03147287|589925694|FG001|Overall Study|Withdrawal by Subject|3|||
163332092|NCT03147287|589925695|FG002|Overall Study|Withdrawal by Subject|2|||
163332093|NCT03147287|589925693|FG000|Overall Study|Patient Non-Compliance|0|||
163332094|NCT03147287|589925694|FG001|Overall Study|Patient Non-Compliance|2|||
163332095|NCT03147287|589925695|FG002|Overall Study|Patient Non-Compliance|0|||
163079001|NCT02991859|588996912|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079002|NCT02991859|588996913|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
163079003|NCT02991859|588996914|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079004|NCT02991859|588996915|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079005|NCT02991859|588996916|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079006|NCT02991859|588996917|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079007|NCT02991859|588996918|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079008|NCT02991859|588996919|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079009|NCT02991859|588996920|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079010|NCT02991859|588996921|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079011|NCT02991859|588996922|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079012|NCT02991859|588996923|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079013|NCT02991859|588996924|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079014|NCT02991859|588996908|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079015|NCT02991859|588996909|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079016|NCT02991859|588996910|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079017|NCT02991859|588996911|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079018|NCT02991859|588996912|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079019|NCT02991859|588996913|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079020|NCT02991859|588996914|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079021|NCT02991859|588996915|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079022|NCT02991859|588996916|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079023|NCT02991859|588996917|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
163079024|NCT02991859|588996918|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079025|NCT02991859|588996919|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079026|NCT02991859|588996920|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079027|NCT02991859|588996921|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079028|NCT02991859|588996922|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079029|NCT02991859|588996923|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079030|NCT02991859|588996924|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079031|NCT02991859|588996908|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163218895|NCT00362115|589517372|FG002|Overall Study|Protocol Violation|0|||
163218896|NCT00362115|589517373|FG003|Overall Study|Protocol Violation|0|||
163218897|NCT00362115|589517374|FG004|Overall Study|Protocol Violation|0|||
163218898|NCT00362115|589517375|FG005|Overall Study|Protocol Violation|1|||
163218899|NCT00362115|589517376|FG006|Overall Study|Protocol Violation|0|||
163218900|NCT00362115|589517370|FG000|Overall Study|Lost to Follow-up|0|||
163218901|NCT00362115|589517371|FG001|Overall Study|Lost to Follow-up|1|||
163218902|NCT00362115|589517372|FG002|Overall Study|Lost to Follow-up|0|||
163218903|NCT00362115|589517373|FG003|Overall Study|Lost to Follow-up|0|||
163218904|NCT00362115|589517374|FG004|Overall Study|Lost to Follow-up|2|||
163218905|NCT00362115|589517375|FG005|Overall Study|Lost to Follow-up|0|||
163218906|NCT00362115|589517376|FG006|Overall Study|Lost to Follow-up|1|||
163218907|NCT00362115|589517370|FG000|Overall Study|Withdrawal by Subject|1|||
163218908|NCT00362115|589517371|FG001|Overall Study|Withdrawal by Subject|3|||
163218909|NCT00362115|589517372|FG002|Overall Study|Withdrawal by Subject|1|||
163218910|NCT00362115|589517373|FG003|Overall Study|Withdrawal by Subject|0|||
163332096|NCT03147287|589925693|FG000|Overall Study|Patient moved|0|||
163332097|NCT03147287|589925694|FG001|Overall Study|Patient moved|1|||
163332098|NCT03147287|589925695|FG002|Overall Study|Patient moved|0|||
163332099|NCT03147287|589925693|FG000|Overall Study|Arm A crossover without PD|1|||
163332100|NCT03147287|589925694|FG001|Overall Study|Arm A crossover without PD|0|||
163029464|NCT00960986|588810463|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
163029465|NCT00960986|588810464|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
163029466|NCT00960986|588810465|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
163029467|NCT00960986|588810466|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
163029468|NCT00960986|588810463|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
163029469|NCT00960986|588810464|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
163029470|NCT00960986|588810465|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
163029471|NCT00960986|588810466|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
163079032|NCT02991859|588996909|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079033|NCT02991859|588996910|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079034|NCT02991859|588996911|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079035|NCT02991859|588996912|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079036|NCT02991859|588996913|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163218911|NCT00362115|589517374|FG004|Overall Study|Withdrawal by Subject|1|||
163218912|NCT00362115|589517375|FG005|Overall Study|Withdrawal by Subject|3|||
163332101|NCT03147287|589925695|FG002|Overall Study|Arm A crossover without PD|0|||
163079037|NCT02991859|588996914|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079038|NCT02991859|588996915|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079039|NCT02991859|588996916|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
163079040|NCT02991859|588996917|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079041|NCT02991859|588996918|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079042|NCT02991859|588996919|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079043|NCT02991859|588996920|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079044|NCT02991859|588996921|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079045|NCT02991859|588996922|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079046|NCT02991859|588996923|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163332102|NCT03147287|589925693|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
163079047|NCT02991859|588996924|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079048|NCT00425854|588996932|FG000|Overall Study|Progressive Disease|19|||
163079049|NCT00425854|588996933|FG001|Overall Study|Progressive Disease|12|||
163079050|NCT00425854|588996932|FG000|Overall Study|Dose reduction toxicity AE|8|||
163079051|NCT00425854|588996933|FG001|Overall Study|Dose reduction toxicity AE|7|||
163079052|NCT00425854|588996932|FG000|Overall Study|Other Adverse Event|2|||
163079053|NCT00425854|588996933|FG001|Overall Study|Other Adverse Event|2|||
163079054|NCT01630811|588996934|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
163079055|NCT01630811|588996935|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
163079056|NCT01725308|588996938|FG000|Treatment Period I|Did Not Receive Drug|1|||
163079057|NCT01725308|588996939|FG001|Treatment Period I|Did Not Receive Drug|0|||
163079058|NCT01725308|588996940|FG002|Treatment Period I|Did Not Receive Drug|0|||
163079059|NCT01725308|588996938|FG000|Treatment Period I|Adverse Event|5|||
163079060|NCT01725308|588996939|FG001|Treatment Period I|Adverse Event|4|||
163079061|NCT01725308|588996940|FG002|Treatment Period I|Adverse Event|21|||
163079062|NCT01725308|588996938|FG000|Treatment Period I|Insufficient Response|7|||
163079063|NCT01725308|588996939|FG001|Treatment Period I|Insufficient Response|0|||
163079064|NCT01725308|588996940|FG002|Treatment Period I|Insufficient Response|5|||
163079065|NCT01725308|588996938|FG000|Treatment Period I|Worsening of the Target Disease|8|||
163079066|NCT01725308|588996939|FG001|Treatment Period I|Worsening of the Target Disease|0|||
163079067|NCT01725308|588996940|FG002|Treatment Period I|Worsening of the Target Disease|2|||
163079068|NCT01725308|588996938|FG000|Treatment Period I|Changes in the Episodes|3|||
163079069|NCT01725308|588996939|FG001|Treatment Period I|Changes in the Episodes|0|||
163079070|NCT01725308|588996940|FG002|Treatment Period I|Changes in the Episodes|2|||
163079071|NCT01725308|588996938|FG000|Treatment Period I|Withdrawal of Consent|12|||
163079072|NCT01725308|588996939|FG001|Treatment Period I|Withdrawal of Consent|7|||
163079073|NCT01725308|588996940|FG002|Treatment Period I|Withdrawal of Consent|5|||
163079074|NCT01725308|588996938|FG000|Treatment Period I|Lost to Follow-up|3|||
163079075|NCT01725308|588996939|FG001|Treatment Period I|Lost to Follow-up|2|||
163079076|NCT01725308|588996940|FG002|Treatment Period I|Lost to Follow-up|2|||
163079077|NCT01725308|588996938|FG000|Treatment Period I|Protocol Deviations|3|||
163079078|NCT01725308|588996939|FG001|Treatment Period I|Protocol Deviations|1|||
163079079|NCT01725308|588996940|FG002|Treatment Period I|Protocol Deviations|1|||
163079080|NCT01725308|588996938|FG000|Treatment Period I|Miscellaneous|2|||
163079081|NCT01725308|588996939|FG001|Treatment Period I|Miscellaneous|0|||
163079082|NCT01725308|588996940|FG002|Treatment Period I|Miscellaneous|3|||
163079083|NCT01725308|588996938|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
163079084|NCT01725308|588996939|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
163079085|NCT01725308|588996940|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
163079086|NCT01725308|588996938|FG000|Treatment Period II|Did Not Receive Drug|4|||
163079087|NCT01725308|588996939|FG001|Treatment Period II|Did Not Receive Drug|0|||
163079088|NCT01725308|588996940|FG002|Treatment Period II|Did Not Receive Drug|0|||
163332103|NCT03147287|589925694|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
163332104|NCT03147287|589925695|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
163079089|NCT01725308|588996938|FG000|Treatment Period II|Adverse Event|13|||
163079090|NCT01725308|588996939|FG001|Treatment Period II|Adverse Event|8|||
163079091|NCT01725308|588996940|FG002|Treatment Period II|Adverse Event|20|||
163332105|NCT00302211|589925696|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
163332106|NCT00302211|589925697|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
163332107|NCT00302211|589925698|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
163332108|NCT00302211|589925699|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
163332109|NCT00302211|589925700|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
163332110|NCT00302211|589925696|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
163332111|NCT00302211|589925697|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
163079092|NCT01725308|588996938|FG000|Treatment Period II|Insufficient Response|2|||
163079093|NCT01725308|588996939|FG001|Treatment Period II|Insufficient Response|4|||
163079094|NCT01725308|588996940|FG002|Treatment Period II|Insufficient Response|6|||
163079095|NCT01725308|588996938|FG000|Treatment Period II|Worsening of the Target Disease|1|||
163079096|NCT01725308|588996939|FG001|Treatment Period II|Worsening of the Target Disease|4|||
163332112|NCT00302211|589925698|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
163332113|NCT00302211|589925699|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
163332114|NCT00302211|589925700|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
163332115|NCT00302211|589925696|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
163332116|NCT00302211|589925697|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
163332117|NCT00302211|589925698|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
163332118|NCT00302211|589925699|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
163332119|NCT00302211|589925700|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
163332120|NCT00302211|589925696|FG000|Double Blind Period (New Patients)|Disease progression|0|||
163332121|NCT00302211|589925697|FG001|Double Blind Period (New Patients)|Disease progression|1|||
163332122|NCT00302211|589925698|FG002|Double Blind Period (New Patients)|Disease progression|1|||
163332123|NCT00302211|589925699|FG003|Double Blind Period (New Patients)|Disease progression|0|||
163332124|NCT00302211|589925700|FG004|Double Blind Period (New Patients)|Disease progression|0|||
163332125|NCT00302211|589925696|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
163332126|NCT00302211|589925697|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
163332127|NCT00302211|589925698|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
163332128|NCT00302211|589925699|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
163332129|NCT00302211|589925700|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
163332130|NCT00302211|589925696|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
163332131|NCT00302211|589925697|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
163332132|NCT00302211|589925698|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
163332133|NCT00302211|589925699|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
163332134|NCT00302211|589925700|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
163079097|NCT01725308|588996940|FG002|Treatment Period II|Worsening of the Target Disease|2|||
163079098|NCT01725308|588996938|FG000|Treatment Period II|Changes in the Episodes|1|||
163079099|NCT01725308|588996939|FG001|Treatment Period II|Changes in the Episodes|0|||
163079100|NCT01725308|588996940|FG002|Treatment Period II|Changes in the Episodes|5|||
163079101|NCT01725308|588996938|FG000|Treatment Period II|Withdrawal of Consent|28|||
163079102|NCT01725308|588996939|FG001|Treatment Period II|Withdrawal of Consent|2|||
163079103|NCT01725308|588996940|FG002|Treatment Period II|Withdrawal of Consent|16|||
163079104|NCT01725308|588996938|FG000|Treatment Period II|Lost to Follow-up|1|||
163079105|NCT01725308|588996939|FG001|Treatment Period II|Lost to Follow-up|5|||
163079106|NCT01725308|588996940|FG002|Treatment Period II|Lost to Follow-up|3|||
163079107|NCT01725308|588996938|FG000|Treatment Period II|Protocol Deviations|0|||
163079108|NCT01725308|588996939|FG001|Treatment Period II|Protocol Deviations|0|||
163079109|NCT01725308|588996940|FG002|Treatment Period II|Protocol Deviations|1|||
163079110|NCT01725308|588996938|FG000|Treatment Period II|Miscellaneous|5|||
163079111|NCT01725308|588996939|FG001|Treatment Period II|Miscellaneous|3|||
163079112|NCT01725308|588996940|FG002|Treatment Period II|Miscellaneous|7|||
163079113|NCT05652140|588996942|FG000|Overall Study|Lost to Follow-up|7|||
163079114|NCT05652140|588996943|FG001|Overall Study|Lost to Follow-up|16|||
163079115|NCT05652140|588996944|FG002|Overall Study|Lost to Follow-up|22|||
163079116|NCT05652140|588996945|FG003|Overall Study|Lost to Follow-up|31|||
163079117|NCT06048705|588996949|FG000|Overall Study|Physician Decision|1|||
163079118|NCT06048705|588996950|FG001|Overall Study|Physician Decision|0|||
163079119|NCT06048705|588996951|FG002|Overall Study|Physician Decision|0|||
163079120|NCT06048705|588996949|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
163079121|NCT06048705|588996950|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
163079122|NCT06048705|588996951|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
163079123|NCT06048705|588996949|FG000|Overall Study|Death prior to lymphodepletion|0|||
163079124|NCT06048705|588996950|FG001|Overall Study|Death prior to lymphodepletion|0|||
163079125|NCT06048705|588996951|FG002|Overall Study|Death prior to lymphodepletion|1|||
163079126|NCT02413346|588996952|FG000|Overall Study|Adverse Event|6|||
163079127|NCT02413346|588996953|FG001|Overall Study|Adverse Event|6|||
163079128|NCT02413346|588996952|FG000|Overall Study|Withdrawal by Subject|30|||
163218913|NCT00362115|589517376|FG006|Overall Study|Withdrawal by Subject|4|||
163079129|NCT02413346|588996953|FG001|Overall Study|Withdrawal by Subject|40|||
163079130|NCT02413346|588996952|FG000|Overall Study|Lost to Follow-up|17|||
163079131|NCT02413346|588996953|FG001|Overall Study|Lost to Follow-up|21|||
163079132|NCT02413346|588996952|FG000|Overall Study|Protocol Violation|2|||
163079133|NCT02413346|588996953|FG001|Overall Study|Protocol Violation|0|||
163079134|NCT02413346|588996952|FG000|Overall Study|Other Miscellaneous Reasons|4|||
163218914|NCT00362115|589517370|FG000|Overall Study|Lack of Efficacy|1|||
163218915|NCT00362115|589517371|FG001|Overall Study|Lack of Efficacy|0|||
163218916|NCT00362115|589517372|FG002|Overall Study|Lack of Efficacy|5|||
163218917|NCT00362115|589517373|FG003|Overall Study|Lack of Efficacy|2|||
163218918|NCT00362115|589517374|FG004|Overall Study|Lack of Efficacy|2|||
163218919|NCT00362115|589517375|FG005|Overall Study|Lack of Efficacy|0|||
163218920|NCT00362115|589517376|FG006|Overall Study|Lack of Efficacy|3|||
163218921|NCT00362115|589517370|FG000|Overall Study|Physician Decision|0|||
163218922|NCT00362115|589517371|FG001|Overall Study|Physician Decision|0|||
163218923|NCT00362115|589517372|FG002|Overall Study|Physician Decision|0|||
163332135|NCT00302211|589925696|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
163332136|NCT00302211|589925697|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
163332137|NCT00302211|589925698|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
163332138|NCT00302211|589925699|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
163332139|NCT00302211|589925700|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
163332140|NCT00302211|589925696|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
163332141|NCT00302211|589925697|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
163332142|NCT00302211|589925698|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
163406449|NCT03311711|590198639|FG004|Overall Study|Death of dyad partner|0|||
163406450|NCT03311711|590198640|FG005|Overall Study|Death of dyad partner|0|||
163406451|NCT03311711|590198641|FG006|Overall Study|Death of dyad partner|0|||
163029472|NCT00960986|588810463|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
163029473|NCT00960986|588810464|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
163029474|NCT00960986|588810465|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
163029475|NCT00960986|588810466|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
163029476|NCT00960986|588810463|FG000|Period 3 (7-week Therapy Period)|Death|0|||
163029477|NCT00960986|588810464|FG001|Period 3 (7-week Therapy Period)|Death|0|||
163029478|NCT00960986|588810465|FG002|Period 3 (7-week Therapy Period)|Death|1|||
163029479|NCT00960986|588810466|FG003|Period 3 (7-week Therapy Period)|Death|0|||
163029480|NCT00960986|588810463|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
163029481|NCT00960986|588810464|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
163029482|NCT00960986|588810465|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
163029483|NCT00960986|588810466|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
163029484|NCT00960986|588810463|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
163029485|NCT00960986|588810464|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
163029486|NCT00960986|588810465|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
163029487|NCT00960986|588810466|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
163029488|NCT00960986|588810463|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
163029489|NCT00960986|588810464|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
163029490|NCT00960986|588810465|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
163029491|NCT00960986|588810466|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
163029492|NCT00960986|588810463|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
163029493|NCT00960986|588810464|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
163029494|NCT00960986|588810465|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
163029495|NCT00960986|588810466|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
163029496|NCT01077739|588810467|FG000|Overall Study|Premature withdrawal|1|||
163029497|NCT01077739|588810468|FG001|Overall Study|Premature withdrawal|3|||
163029498|NCT01077739|588810467|FG000|Overall Study|Withdrawal by Subject|1|||
163029499|NCT01077739|588810468|FG001|Overall Study|Withdrawal by Subject|0|||
163029500|NCT01077739|588810467|FG000|Overall Study|Death|0|||
163029501|NCT01077739|588810468|FG001|Overall Study|Death|3|||
163029502|NCT01077739|588810467|FG000|Overall Study|Unacceptable toxicity|1|||
163029503|NCT01077739|588810468|FG001|Overall Study|Unacceptable toxicity|2|||
163029504|NCT01077739|588810467|FG000|Overall Study|Other|2|||
163029505|NCT01077739|588810468|FG001|Overall Study|Other|2|||
163029506|NCT00877071|588810469|FG000|Overall Study|disease progression|2|||
163029507|NCT02100670|588810475|FG000|Overall Study|Adverse Event|10|||
163029508|NCT02100670|588810476|FG001|Overall Study|Adverse Event|3|||
163029509|NCT02100670|588810477|FG002|Overall Study|Adverse Event|3|||
163029510|NCT02100670|588810478|FG003|Overall Study|Adverse Event|0|||
163029511|NCT02100670|588810475|FG000|Overall Study|Lost to Follow-up|1|||
163029512|NCT02100670|588810476|FG001|Overall Study|Lost to Follow-up|0|||
163029513|NCT02100670|588810477|FG002|Overall Study|Lost to Follow-up|0|||
163029514|NCT02100670|588810478|FG003|Overall Study|Lost to Follow-up|0|||
163029515|NCT02100670|588810475|FG000|Overall Study|Protocol Violation|0|||
163029516|NCT02100670|588810476|FG001|Overall Study|Protocol Violation|1|||
163029517|NCT02100670|588810477|FG002|Overall Study|Protocol Violation|0|||
163029518|NCT02100670|588810478|FG003|Overall Study|Protocol Violation|1|||
163029519|NCT02100670|588810475|FG000|Overall Study|Withdrawal of Consent|0|||
163029520|NCT02100670|588810476|FG001|Overall Study|Withdrawal of Consent|1|||
163029521|NCT02100670|588810477|FG002|Overall Study|Withdrawal of Consent|1|||
163029522|NCT02100670|588810478|FG003|Overall Study|Withdrawal of Consent|0|||
163029523|NCT02100670|588810475|FG000|Overall Study|No swelling no pain|1|||
163029524|NCT02100670|588810476|FG001|Overall Study|No swelling no pain|0|||
163029525|NCT02100670|588810477|FG002|Overall Study|No swelling no pain|0|||
163029526|NCT02100670|588810478|FG003|Overall Study|No swelling no pain|0|||
163029527|NCT02100670|588810475|FG000|Overall Study|Poor Efficacy|0|||
163029528|NCT02100670|588810476|FG001|Overall Study|Poor Efficacy|1|||
163029529|NCT02100670|588810477|FG002|Overall Study|Poor Efficacy|0|||
163029530|NCT02100670|588810478|FG003|Overall Study|Poor Efficacy|0|||
163029531|NCT02100670|588810475|FG000|Overall Study|Physician Decision|0|||
163029532|NCT02100670|588810476|FG001|Overall Study|Physician Decision|1|||
163029533|NCT02100670|588810477|FG002|Overall Study|Physician Decision|0|||
163029534|NCT02100670|588810478|FG003|Overall Study|Physician Decision|0|||
163079135|NCT02413346|588996953|FG001|Overall Study|Other Miscellaneous Reasons|3|||
163079136|NCT00562861|588996958|FG000|Overall Study|Adverse Event|1|||
163079137|NCT00562861|588996959|FG001|Overall Study|Adverse Event|1|||
163079138|NCT00562861|588996958|FG000|Overall Study|Lack of Efficacy|5|||
163079139|NCT00562861|588996959|FG001|Overall Study|Lack of Efficacy|5|||
163079140|NCT00562861|588996958|FG000|Overall Study|noncompliance, moved|7|||
163079141|NCT00562861|588996959|FG001|Overall Study|noncompliance, moved|2|||
163079142|NCT00562861|588996958|FG000|Overall Study|Lost to Follow-up|7|||
163079143|NCT00562861|588996959|FG001|Overall Study|Lost to Follow-up|3|||
163079144|NCT00655356|588996962|FG000|Overall Study|Withdrawal by Subject|3|||
163079145|NCT00655356|588996963|FG001|Overall Study|Withdrawal by Subject|4|||
163079146|NCT00655356|588996962|FG000|Overall Study|Sponsor Request|10|||
163079147|NCT00655356|588996963|FG001|Overall Study|Sponsor Request|4|||
163079148|NCT00655356|588996962|FG000|Overall Study|Adverse Event|1|||
163079149|NCT00655356|588996963|FG001|Overall Study|Adverse Event|1|||
163079150|NCT00655356|588996962|FG000|Overall Study|Protocol Violation|2|||
163079151|NCT00655356|588996963|FG001|Overall Study|Protocol Violation|1|||
163079152|NCT00655356|588996962|FG000|Overall Study|Other Reason|1|||
163079153|NCT00655356|588996963|FG001|Overall Study|Other Reason|0|||
163079154|NCT01623154|588996966|FG000|Overall Study|Did not drink Pranactin Citric|4|||
163079155|NCT04349098|588996967|FG000|Overall Study|Death|16|||
163079156|NCT04349098|588996968|FG001|Overall Study|Death|8|||
163079157|NCT04349098|588996967|FG000|Overall Study|Lost to Follow-up|11|||
163079158|NCT04349098|588996968|FG001|Overall Study|Lost to Follow-up|8|||
163079159|NCT04349098|588996967|FG000|Overall Study|Withdrawal by Subject|8|||
163079160|NCT04349098|588996968|FG001|Overall Study|Withdrawal by Subject|5|||
163079161|NCT04349098|588996967|FG000|Overall Study|Other|3|||
163079162|NCT04349098|588996968|FG001|Overall Study|Other|5|||
163079163|NCT00800384|588996969|FG000|Overall Study|Withdrawal by Subject|24|||
163079164|NCT00800384|588996970|FG001|Overall Study|Withdrawal by Subject|17|||
163079165|NCT00800384|588996969|FG000|Overall Study|Lost to Follow-up|17|||
163079166|NCT00800384|588996970|FG001|Overall Study|Lost to Follow-up|26|||
163079167|NCT02151604|588996972|FG000|Overall Study|Lost to Follow-up|3|||
163079168|NCT02151604|588996972|FG000|Overall Study|Withdrawal by Subject|2|||
163079169|NCT02151604|588996972|FG000|Overall Study|Physician Decision|3|||
163079170|NCT02151604|588996972|FG000|Overall Study|Death|1|||
163079171|NCT00537082|588996973|FG000|Overall Study|Adverse Event|6|||
163079172|NCT00537082|588996974|FG001|Overall Study|Adverse Event|6|||
163079173|NCT00537082|588996975|FG002|Overall Study|Adverse Event|3|||
163079174|NCT00537082|588996973|FG000|Overall Study|Protocol Violation|0|||
163079175|NCT00537082|588996974|FG001|Overall Study|Protocol Violation|2|||
163079176|NCT00537082|588996975|FG002|Overall Study|Protocol Violation|1|||
163079177|NCT00537082|588996973|FG000|Overall Study|Lack of Efficacy|0|||
163079178|NCT00537082|588996974|FG001|Overall Study|Lack of Efficacy|0|||
163079179|NCT00537082|588996975|FG002|Overall Study|Lack of Efficacy|2|||
163079180|NCT00537082|588996973|FG000|Overall Study|Withdrawal by Subject|0|||
163079181|NCT00537082|588996974|FG001|Overall Study|Withdrawal by Subject|1|||
163079182|NCT00537082|588996975|FG002|Overall Study|Withdrawal by Subject|0|||
163079183|NCT00537082|588996973|FG000|Overall Study|Discontinued before initiating treatment|3|||
163079184|NCT00537082|588996974|FG001|Overall Study|Discontinued before initiating treatment|0|||
163079185|NCT00537082|588996975|FG002|Overall Study|Discontinued before initiating treatment|0|||
163079186|NCT04495478|588996977|FG000|Overall Study|Withdrawal by Subject|0|||
163079187|NCT04495478|588996978|FG001|Overall Study|Withdrawal by Subject|0|||
163079188|NCT04495478|588996979|FG002|Overall Study|Withdrawal by Subject|0|||
163079189|NCT04495478|588996980|FG003|Overall Study|Withdrawal by Subject|1|||
163079190|NCT04495478|588996981|FG004|Overall Study|Withdrawal by Subject|0|||
163079191|NCT04495478|588996982|FG005|Overall Study|Withdrawal by Subject|0|||
163079192|NCT04495478|588996983|FG006|Overall Study|Withdrawal by Subject|0|||
163079193|NCT04495478|588996977|FG000|Overall Study|Physician Decision|0|||
163079194|NCT04495478|588996978|FG001|Overall Study|Physician Decision|1|||
163218924|NCT00362115|589517373|FG003|Overall Study|Physician Decision|0|||
163218925|NCT00362115|589517374|FG004|Overall Study|Physician Decision|0|||
163079195|NCT04495478|588996979|FG002|Overall Study|Physician Decision|0|||
163079196|NCT04495478|588996980|FG003|Overall Study|Physician Decision|0|||
163079197|NCT04495478|588996981|FG004|Overall Study|Physician Decision|1|||
163079198|NCT04495478|588996982|FG005|Overall Study|Physician Decision|0|||
163079199|NCT04495478|588996983|FG006|Overall Study|Physician Decision|0|||
163079200|NCT00655746|588996984|FG000|Overall Study|Withdrawal by Subject|1|||
163079201|NCT00561821|588996985|FG000|Overall Study|Not treated|0|||
163079202|NCT00561821|588996986|FG001|Overall Study|Not treated|0|||
163079203|NCT00561821|588996987|FG002|Overall Study|Not treated|1|||
163079204|NCT00561821|588996988|FG003|Overall Study|Not treated|0|||
163079205|NCT00561821|588996985|FG000|Overall Study|Withdrawal by Subject|0|||
163079206|NCT00561821|588996986|FG001|Overall Study|Withdrawal by Subject|1|||
163079207|NCT00561821|588996987|FG002|Overall Study|Withdrawal by Subject|0|||
163218926|NCT00362115|589517375|FG005|Overall Study|Physician Decision|0|||
163218927|NCT00362115|589517376|FG006|Overall Study|Physician Decision|3|||
163218928|NCT00362115|589517370|FG000|Overall Study|Other|0|||
163218929|NCT00362115|589517371|FG001|Overall Study|Other|1|||
163079208|NCT00561821|588996988|FG003|Overall Study|Withdrawal by Subject|2|||
163079209|NCT00561821|588996985|FG000|Overall Study|Reasons not related to trial|2|||
163079210|NCT00561821|588996986|FG001|Overall Study|Reasons not related to trial|1|||
163079211|NCT00561821|588996987|FG002|Overall Study|Reasons not related to trial|0|||
163079212|NCT00561821|588996988|FG003|Overall Study|Reasons not related to trial|0|||
163079213|NCT00561821|588996985|FG000|Overall Study|Other (reason not specified)|1|||
163079214|NCT00561821|588996986|FG001|Overall Study|Other (reason not specified)|1|||
163079215|NCT00561821|588996987|FG002|Overall Study|Other (reason not specified)|0|||
163079216|NCT00561821|588996988|FG003|Overall Study|Other (reason not specified)|0|||
163079217|NCT00561821|588996985|FG000|Overall Study|Adverse Event|2|||
163079218|NCT00561821|588996986|FG001|Overall Study|Adverse Event|3|||
163079219|NCT00561821|588996987|FG002|Overall Study|Adverse Event|1|||
163079220|NCT00561821|588996988|FG003|Overall Study|Adverse Event|1|||
163079221|NCT03178942|588996989|FG000|Overall Study|Withdrawal by Subject|2|||
163079222|NCT03178942|588996990|FG001|Overall Study|Withdrawal by Subject|0|||
163079223|NCT03178942|588996989|FG000|Overall Study|Lost to Follow-up|1|||
163079224|NCT03178942|588996990|FG001|Overall Study|Lost to Follow-up|2|||
163079225|NCT04280783|588999178|FG000|Overall Study|Family issues unrelated to the study.|1|||
163079226|NCT04280783|588999179|FG001|Overall Study|Family issues unrelated to the study.|0|||
163079227|NCT04280783|588999178|FG000|Overall Study|Withdrawal by Subject|0|||
163079228|NCT04280783|588999179|FG001|Overall Study|Withdrawal by Subject|1|||
163079229|NCT03443401|588999186|FG000|Overall Study|Lost to Follow-up|13|||
163079230|NCT03443401|588999186|FG000|Overall Study|Influential outlier|1|||
163079231|NCT02363283|588999187|FG000|Overall Study|Withdrawal by Subject|1|||
163079232|NCT02363283|588999187|FG000|Overall Study|Not eligible due to transaminitis|1|||
163079233|NCT00530257|588999193|FG000|Overall Study|Lost to Follow-up|1|||
163079234|NCT04110145|588999197|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
163079235|NCT04110145|588999198|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
163079236|NCT04110145|588999199|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
163079237|NCT04110145|588999200|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
163079238|NCT04110145|588999201|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
163079239|NCT05401409|588999202|FG000|Overall Study|Lost to Follow-up|1|||
163079240|NCT05401409|588999203|FG001|Overall Study|Lost to Follow-up|0|||
163079241|NCT00432991|588999206|FG000|Overall Study|Protocol Violation|7|||
163079242|NCT00432991|588999207|FG001|Overall Study|Protocol Violation|12|||
163079243|NCT00363467|588999208|FG000|Overall Study|Physician Decision|1|||
163079244|NCT03160573|588999211|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
163079245|NCT03160573|588999212|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
163079246|NCT03160573|588999213|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
163079247|NCT03160573|588999214|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
163079248|NCT02715856|588999219|FG000|Overall Study|Software Issues|12|||
163079249|NCT02715856|588999220|FG001|Overall Study|Software Issues|7|||
163079250|NCT02715856|588999219|FG000|Overall Study|Death|6|||
163079251|NCT02715856|588999220|FG001|Overall Study|Death|5|||
163079252|NCT02715856|588999219|FG000|Overall Study|Non- Compliant|0|||
163079253|NCT02715856|588999220|FG001|Overall Study|Non- Compliant|40|||
163079254|NCT02336555|588999221|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163079255|NCT02336555|588999222|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
163079256|NCT02336555|588999221|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
163079257|NCT02336555|588999222|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
163079258|NCT02336555|588999221|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
163079259|NCT02336555|588999222|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
163079260|NCT01537432|588999223|FG000|Overall Study|Lost to Follow-up|3|||
163079261|NCT01537432|588999224|FG001|Overall Study|Lost to Follow-up|1|||
163332143|NCT00302211|589925699|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
163332144|NCT00302211|589925700|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
163332145|NCT00302211|589925696|FG000|Open Label-Patients From Double-Blind|Death|0|||
163332146|NCT00302211|589925697|FG001|Open Label-Patients From Double-Blind|Death|0|||
163332147|NCT00302211|589925698|FG002|Open Label-Patients From Double-Blind|Death|0|||
163332148|NCT00302211|589925699|FG003|Open Label-Patients From Double-Blind|Death|1|||
163079262|NCT01537432|588999223|FG000|Overall Study|Withdrawal by Subject|0|||
163332149|NCT00302211|589925700|FG004|Open Label-Patients From Double-Blind|Death|1|||
163079263|NCT01537432|588999224|FG001|Overall Study|Withdrawal by Subject|1|||
163079264|NCT01537432|588999223|FG000|Overall Study|Administrative problems|1|||
163079265|NCT01537432|588999224|FG001|Overall Study|Administrative problems|0|||
163079266|NCT01537432|588999223|FG000|Overall Study|Adverse Event|1|||
163079267|NCT01537432|588999224|FG001|Overall Study|Adverse Event|0|||
163079268|NCT01537432|588999223|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163079269|NCT01537432|588999224|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163079270|NCT03682367|588999227|FG000|Overall Study|Protocol Violation|2|||
163079271|NCT03682367|588999228|FG001|Overall Study|Protocol Violation|1|||
163079272|NCT03682367|588999227|FG000|Overall Study|Closed Study Early|0|||
163079273|NCT03682367|588999228|FG001|Overall Study|Closed Study Early|3|||
163079274|NCT05166902|588999229|FG000|First Intervention|Lost to Follow-up|0|||
163079275|NCT05166902|588999230|FG001|First Intervention|Lost to Follow-up|1|||
163079276|NCT04157738|588999239|FG000|Overall Study|Moved out of state|0|||
163079277|NCT04157738|588999240|FG001|Overall Study|Moved out of state|2|||
163079278|NCT04157738|588999239|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
163079279|NCT04157738|588999240|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
163079280|NCT00309946|588999241|FG000|Overall Study|Withdrawal by Subject|1|||
163079281|NCT02244957|588999242|FG000|Overall Study|Lack of Efficacy|1|||
163079282|NCT02244957|588999243|FG001|Overall Study|Lack of Efficacy|0|||
163079283|NCT01347086|588999244|FG000|Overall Study|failed screening visit|0|||
163079284|NCT01347086|588999245|FG001|Overall Study|failed screening visit|0|||
163079285|NCT01347086|588999246|FG002|Overall Study|failed screening visit|1|||
163079286|NCT01347086|588999247|FG003|Overall Study|failed screening visit|0|||
163079287|NCT01347086|588999248|FG004|Overall Study|failed screening visit|0|||
163079288|NCT01347086|588999249|FG005|Overall Study|failed screening visit|0|||
163079289|NCT01347086|588999250|FG006|Overall Study|failed screening visit|1|||
163079290|NCT01347086|588999251|FG007|Overall Study|failed screening visit|1|||
163079291|NCT01347086|588999252|FG008|Overall Study|failed screening visit|0|||
163079292|NCT01347086|588999253|FG009|Overall Study|failed screening visit|1|||
163079293|NCT03111108|588999256|FG000|Overall Study|Death|0|||
163079294|NCT03111108|588999257|FG001|Overall Study|Death|1|||
163079295|NCT03111108|588999256|FG000|Overall Study|Withdrawal by Subject|1|||
163079296|NCT03111108|588999257|FG001|Overall Study|Withdrawal by Subject|0|||
163079297|NCT01514357|588999258|FG000|Overall Study|Screen failure|2|||
163079298|NCT01514357|588999259|FG001|Overall Study|Screen failure|0|||
163079299|NCT01514357|588999258|FG000|Overall Study|Withdrawal by Subject|2|||
163079300|NCT01514357|588999259|FG001|Overall Study|Withdrawal by Subject|0|||
163079301|NCT04691115|588999260|FG000|Overall Study|Withdrawal by Subject|0|||
163079302|NCT04691115|588999261|FG001|Overall Study|Withdrawal by Subject|0|||
163079303|NCT04691115|588999262|FG002|Overall Study|Withdrawal by Subject|0|||
163079304|NCT04691115|588999263|FG003|Overall Study|Withdrawal by Subject|0|||
163079305|NCT04691115|588999264|FG004|Overall Study|Withdrawal by Subject|0|||
163079306|NCT04691115|588999265|FG005|Overall Study|Withdrawal by Subject|1|||
163079307|NCT04691115|588999266|FG006|Overall Study|Withdrawal by Subject|0|||
163079308|NCT04691115|588999267|FG007|Overall Study|Withdrawal by Subject|0|||
163079309|NCT04691115|588999268|FG008|Overall Study|Withdrawal by Subject|0|||
163079310|NCT04691115|588999269|FG009|Overall Study|Withdrawal by Subject|0|||
163079311|NCT04691115|588999270|FG010|Overall Study|Withdrawal by Subject|0|||
163079312|NCT04691115|588999271|FG011|Overall Study|Withdrawal by Subject|0|||
163079313|NCT04691115|588999272|FG012|Overall Study|Withdrawal by Subject|0|||
163079314|NCT04691115|588999273|FG013|Overall Study|Withdrawal by Subject|0|||
163079315|NCT00830336|588999277|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
163079316|NCT00830336|588999278|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
163079317|NCT00347269|588999283|FG000|Overall Study|Lost to Follow-up|74|||
163079318|NCT00347269|588999284|FG001|Overall Study|Lost to Follow-up|65|||
163079319|NCT00347269|588999283|FG000|Overall Study|Withdrawal by Subject|18|||
163079320|NCT00347269|588999284|FG001|Overall Study|Withdrawal by Subject|38|||
163079321|NCT00347269|588999283|FG000|Overall Study|Death|2|||
163079322|NCT00347269|588999284|FG001|Overall Study|Death|3|||
163079323|NCT00835549|588999285|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
163079324|NCT00835549|588999286|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
163079325|NCT01725282|588999291|FG000|Overall Study|Adverse Event|1|||
163079326|NCT01725282|588999292|FG001|Overall Study|Adverse Event|3|||
163079327|NCT01725282|588999293|FG002|Overall Study|Adverse Event|6|||
163079328|NCT01725282|588999294|FG003|Overall Study|Adverse Event|4|||
163079329|NCT01725282|588999291|FG000|Overall Study|Exacerbation of Target Disease|1|||
163079330|NCT01725282|588999292|FG001|Overall Study|Exacerbation of Target Disease|0|||
163079331|NCT01725282|588999293|FG002|Overall Study|Exacerbation of Target Disease|0|||
163079332|NCT01725282|588999294|FG003|Overall Study|Exacerbation of Target Disease|1|||
163079333|NCT01725282|588999291|FG000|Overall Study|Met Exclusion Criteria|0|||
163079334|NCT01725282|588999292|FG001|Overall Study|Met Exclusion Criteria|0|||
163079335|NCT01725282|588999293|FG002|Overall Study|Met Exclusion Criteria|1|||
163079336|NCT01725282|588999294|FG003|Overall Study|Met Exclusion Criteria|0|||
163079337|NCT01725282|588999291|FG000|Overall Study|Study Site Withdrawal|0|||
163079338|NCT01725282|588999292|FG001|Overall Study|Study Site Withdrawal|1|||
163079339|NCT01725282|588999293|FG002|Overall Study|Study Site Withdrawal|0|||
163079340|NCT01725282|588999294|FG003|Overall Study|Study Site Withdrawal|0|||
163079341|NCT01725282|588999291|FG000|Overall Study|Withdrawal by Subject|0|||
163079342|NCT01725282|588999292|FG001|Overall Study|Withdrawal by Subject|0|||
163079343|NCT01725282|588999293|FG002|Overall Study|Withdrawal by Subject|1|||
163079344|NCT01725282|588999294|FG003|Overall Study|Withdrawal by Subject|1|||
163079345|NCT01725282|588999291|FG000|Overall Study|Lack of Efficacy|0|||
163079346|NCT01725282|588999292|FG001|Overall Study|Lack of Efficacy|1|||
163079347|NCT01725282|588999293|FG002|Overall Study|Lack of Efficacy|0|||
163079348|NCT01725282|588999294|FG003|Overall Study|Lack of Efficacy|1|||
163079349|NCT05071027|588999295|FG000|Overall Study|Lost to Follow-up|1|||
163079350|NCT05071027|588999296|FG001|Overall Study|Lost to Follow-up|4|||
163079351|NCT04576481|588999297|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
163079352|NCT04576481|588999298|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
163079353|NCT04576481|588999299|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
163079354|NCT04576481|588999300|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
163079355|NCT05463952|588999304|FG000|Treatment|Progressive disease|4|||
163079356|NCT05463952|588999304|FG000|Treatment|Ongoing|2|||
163079357|NCT02739828|588999306|FG000|Overall Study|Adverse Event|1|||
163079358|NCT02739828|588999306|FG000|Overall Study|Lost to Follow-up|4|||
163079359|NCT00489359|588999307|FG000|Overall Study|Death|0|||
163079360|NCT00489359|588999308|FG001|Overall Study|Death|2|||
163079361|NCT00489359|588999307|FG000|Overall Study|Progressive Disease|5|||
163079362|NCT00489359|588999308|FG001|Overall Study|Progressive Disease|6|||
163079363|NCT00489359|588999307|FG000|Overall Study|Lost to Follow-up|1|||
163079364|NCT00489359|588999308|FG001|Overall Study|Lost to Follow-up|0|||
163079365|NCT00489359|588999307|FG000|Overall Study|Withdrawal by Subject|1|||
163079366|NCT00489359|588999308|FG001|Overall Study|Withdrawal by Subject|5|||
163079367|NCT00489359|588999307|FG000|Overall Study|Adverse Event|0|||
163079368|NCT00489359|588999308|FG001|Overall Study|Adverse Event|16|||
163079369|NCT03180138|588999309|FG000|Overall Study|Mobile-phone could not be verified|2|||
163079370|NCT03180138|588999310|FG001|Overall Study|Mobile-phone could not be verified|13|||
163079371|NCT03180138|588999311|FG002|Overall Study|Mobile-phone could not be verified|15|||
163079372|NCT03180138|588999309|FG000|Overall Study|No prior immunization records|17|||
163079373|NCT03180138|588999310|FG001|Overall Study|No prior immunization records|0|||
163079374|NCT03180138|588999311|FG002|Overall Study|No prior immunization records|6|||
163079375|NCT03180138|588999309|FG000|Overall Study|Found to be >24 mon after randomization|3|||
163079376|NCT03180138|588999310|FG001|Overall Study|Found to be >24 mon after randomization|0|||
163079377|NCT03180138|588999311|FG002|Overall Study|Found to be >24 mon after randomization|3|||
163079378|NCT04191733|588999313|FG000|Overall Study|Withdrawn due to study closure|13|||
163079379|NCT04191733|588999314|FG001|Overall Study|Withdrawn due to study closure|14|||
163079380|NCT04191733|588999313|FG000|Overall Study|Withdrawal by Subject|2|||
163079381|NCT04191733|588999314|FG001|Overall Study|Withdrawal by Subject|4|||
163079382|NCT04191733|588999313|FG000|Overall Study|Physician Decision|1|||
163079383|NCT04191733|588999314|FG001|Overall Study|Physician Decision|1|||
163079384|NCT04191733|588999313|FG000|Overall Study|Lost to Follow-up|5|||
163079385|NCT04191733|588999314|FG001|Overall Study|Lost to Follow-up|6|||
163079386|NCT04191733|588999313|FG000|Overall Study|Death|0|||
163079387|NCT04191733|588999314|FG001|Overall Study|Death|1|||
163079388|NCT02202577|588999317|FG000|Overall Study|Lost to Follow-up|6|||
163079389|NCT02202577|588999318|FG001|Overall Study|Lost to Follow-up|16|||
163079390|NCT02202577|588999317|FG000|Overall Study|Protocol Violation|7|||
163079391|NCT02202577|588999318|FG001|Overall Study|Protocol Violation|3|||
163079392|NCT01714063|588999319|FG000|Overall Study|Equipment malfunction|2|||
163079393|NCT01646216|588999320|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
163079394|NCT01646216|588999321|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
163079395|NCT01646216|588999320|FG000|Overall Study|Did not complete training|0|||
163079396|NCT01646216|588999321|FG001|Overall Study|Did not complete training|2|||
163079397|NCT01646216|588999320|FG000|Overall Study|Investigator decision|1|||
163079398|NCT01646216|588999321|FG001|Overall Study|Investigator decision|1|||
163079399|NCT02369159|588999322|FG000|Overall Study|Adverse Event|0|||
163079400|NCT02369159|588999323|FG001|Overall Study|Adverse Event|1|||
163079401|NCT02369159|588999322|FG000|Overall Study|Lost to Follow-up|1|||
163079402|NCT02369159|588999323|FG001|Overall Study|Lost to Follow-up|1|||
163079403|NCT02369159|588999322|FG000|Overall Study|Withdrawal by Subject|7|||
163079404|NCT02369159|588999323|FG001|Overall Study|Withdrawal by Subject|0|||
163079405|NCT00563316|588999324|FG000|Overall Study|Adverse Event|2|||
163079406|NCT00563316|588999324|FG000|Overall Study|Physician Decision|1|||
163332150|NCT00302211|589925696|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
163332151|NCT00302211|589925697|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
163332152|NCT00302211|589925698|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
163332153|NCT00302211|589925699|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
163332154|NCT00302211|589925700|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
163079407|NCT00563316|588999324|FG000|Overall Study|Lost to Follow-up|2|||
163079408|NCT00563316|588999324|FG000|Overall Study|Death|1|||
163079409|NCT00563316|588999324|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
163079410|NCT00563316|588999324|FG000|Overall Study|Other|1|||
163079411|NCT01514422|588999325|FG000|Overall Study|Lost to Follow-up|1|||
163079412|NCT03511209|588999326|FG000|Overall Study|Withdrawal by Subject|2|||
163079413|NCT03511209|588999327|FG001|Overall Study|Withdrawal by Subject|4|||
163079414|NCT03511209|588999326|FG000|Overall Study|Death|1|||
163079415|NCT03511209|588999327|FG001|Overall Study|Death|0|||
163079416|NCT03511209|588999326|FG000|Overall Study|Lost to Follow-up|0|||
163079417|NCT03511209|588999327|FG001|Overall Study|Lost to Follow-up|2|||
163079418|NCT02757963|588999330|FG000|Overall Study|Adverse Event|3|||
163079419|NCT02757963|588999330|FG000|Overall Study|Reached Stopping Criteria|1054|||
163079420|NCT02757963|588999330|FG000|Overall Study|Lost to Follow-up|5|||
163079421|NCT02757963|588999330|FG000|Overall Study|Physician Decision|1|||
163079422|NCT02757963|588999330|FG000|Overall Study|Withdrawal by Subject|34|||
163079423|NCT03769467|588999331|FG000|Overall Study|Adverse Event|1|||
163079424|NCT03769467|588999332|FG001|Overall Study|Adverse Event|1|||
163079425|NCT03769467|588999333|FG002|Overall Study|Adverse Event|0|||
163079426|NCT03769467|588999331|FG000|Overall Study|Death|3|||
163079427|NCT03769467|588999332|FG001|Overall Study|Death|3|||
163079428|NCT03769467|588999333|FG002|Overall Study|Death|0|||
163079429|NCT03769467|588999331|FG000|Overall Study|Study Terminated By Sponsor|2|||
163079430|NCT03769467|588999332|FG001|Overall Study|Study Terminated By Sponsor|1|||
163079431|NCT03769467|588999333|FG002|Overall Study|Study Terminated By Sponsor|0|||
163079432|NCT03769467|588999331|FG000|Overall Study|Withdrawal by Subject|0|||
163079433|NCT03769467|588999332|FG001|Overall Study|Withdrawal by Subject|1|||
163079434|NCT03769467|588999333|FG002|Overall Study|Withdrawal by Subject|0|||
163079435|NCT01887600|588999334|FG000|Overall Study|Death|39|||
163079436|NCT01887600|588999335|FG001|Overall Study|Death|16|||
163079437|NCT01887600|588999334|FG000|Overall Study|Lack of Efficacy|3|||
163079438|NCT01887600|588999335|FG001|Overall Study|Lack of Efficacy|26|||
163079439|NCT01887600|588999334|FG000|Overall Study|Lost to Follow-up|5|||
163079440|NCT01887600|588999335|FG001|Overall Study|Lost to Follow-up|1|||
163079441|NCT01887600|588999334|FG000|Overall Study|Physician Decision|7|||
163079442|NCT01887600|588999335|FG001|Overall Study|Physician Decision|8|||
163079443|NCT01887600|588999334|FG000|Overall Study|Protocol Deviation|3|||
163079444|NCT01887600|588999335|FG001|Overall Study|Protocol Deviation|0|||
163079445|NCT01887600|588999334|FG000|Overall Study|Withdrawal by Subject|58|||
163079446|NCT01887600|588999335|FG001|Overall Study|Withdrawal by Subject|52|||
163079447|NCT01887600|588999334|FG000|Overall Study|Adverse Event|21|||
163079448|NCT01887600|588999335|FG001|Overall Study|Adverse Event|9|||
163079449|NCT01887600|588999334|FG000|Overall Study|Non-compliance with study drug|3|||
163079450|NCT01887600|588999335|FG001|Overall Study|Non-compliance with study drug|0|||
163079451|NCT01887600|588999334|FG000|Overall Study|Miscellaneous|6|||
163079452|NCT01887600|588999335|FG001|Overall Study|Miscellaneous|2|||
163079453|NCT01887600|588999334|FG000|Overall Study|Progressive Disease|1|||
163079454|NCT01887600|588999335|FG001|Overall Study|Progressive Disease|0|||
163079455|NCT03688139|588999336|FG000|Overall Study|Lost to Follow-up|2|||
163079456|NCT03688139|588999337|FG001|Overall Study|Lost to Follow-up|0|||
163079457|NCT03688139|588999336|FG000|Overall Study|Physician Decision|0|||
163079458|NCT03688139|588999337|FG001|Overall Study|Physician Decision|1|||
163079459|NCT03688139|588999336|FG000|Overall Study|Withdrawal by Subject|2|||
163079460|NCT03688139|588999337|FG001|Overall Study|Withdrawal by Subject|3|||
163079461|NCT00127933|588999338|FG000|Overall Study|Randomized but not dosed|1|||
163079462|NCT00127933|588999339|FG001|Overall Study|Randomized but not dosed|0|||
163079463|NCT00498485|588999340|FG000|Overall Study|Adverse Event|1|||
163079464|NCT00498485|588999341|FG001|Overall Study|Adverse Event|5|||
163079465|NCT01943825|588999342|FG000|Overall Study|Lost to Follow-up|9|||
163079466|NCT01943825|588999343|FG001|Overall Study|Lost to Follow-up|3|||
163079467|NCT01943825|588999344|FG002|Overall Study|Lost to Follow-up|12|||
163079468|NCT01943825|588999345|FG003|Overall Study|Lost to Follow-up|8|||
163079469|NCT01943825|588999342|FG000|Overall Study|Withdrawal by Subject|1|||
163079470|NCT01943825|588999343|FG001|Overall Study|Withdrawal by Subject|0|||
163079471|NCT01943825|588999344|FG002|Overall Study|Withdrawal by Subject|3|||
163079472|NCT01943825|588999345|FG003|Overall Study|Withdrawal by Subject|2|||
163079473|NCT01943825|588999342|FG000|Overall Study|Other than specified above|0|||
163079474|NCT01943825|588999343|FG001|Overall Study|Other than specified above|1|||
163079475|NCT01943825|588999344|FG002|Overall Study|Other than specified above|0|||
163079476|NCT01943825|588999345|FG003|Overall Study|Other than specified above|1|||
163079477|NCT00452400|588999346|FG000|Overall Study|Adverse Event|1|||
163079478|NCT00452400|588999347|FG001|Overall Study|Adverse Event|1|||
163079479|NCT00452400|588999348|FG002|Overall Study|Adverse Event|5|||
163079480|NCT00452400|588999349|FG003|Overall Study|Adverse Event|0|||
163079481|NCT00452400|588999350|FG004|Overall Study|Adverse Event|2|||
163079482|NCT00452400|588999346|FG000|Overall Study|Protocol Violation|0|||
163079483|NCT00452400|588999347|FG001|Overall Study|Protocol Violation|0|||
163079484|NCT00452400|588999348|FG002|Overall Study|Protocol Violation|1|||
163079485|NCT00452400|588999349|FG003|Overall Study|Protocol Violation|0|||
163079486|NCT00452400|588999350|FG004|Overall Study|Protocol Violation|0|||
163079487|NCT00452400|588999346|FG000|Overall Study|Lost to Follow-up|1|||
163079488|NCT00452400|588999347|FG001|Overall Study|Lost to Follow-up|0|||
163079489|NCT00452400|588999348|FG002|Overall Study|Lost to Follow-up|0|||
163079490|NCT00452400|588999349|FG003|Overall Study|Lost to Follow-up|0|||
163079491|NCT00452400|588999350|FG004|Overall Study|Lost to Follow-up|0|||
163079492|NCT00452400|588999346|FG000|Overall Study|Withdrawal by Subject|1|||
163079493|NCT00452400|588999347|FG001|Overall Study|Withdrawal by Subject|0|||
163079494|NCT00452400|588999348|FG002|Overall Study|Withdrawal by Subject|1|||
163079495|NCT00452400|588999349|FG003|Overall Study|Withdrawal by Subject|0|||
163079496|NCT00452400|588999350|FG004|Overall Study|Withdrawal by Subject|0|||
163079497|NCT00452400|588999346|FG000|Overall Study|Lack of Efficacy|2|||
163079498|NCT00452400|588999347|FG001|Overall Study|Lack of Efficacy|0|||
163079499|NCT00452400|588999348|FG002|Overall Study|Lack of Efficacy|0|||
163332155|NCT00302211|589925696|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
163332156|NCT00302211|589925697|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
163332157|NCT00302211|589925698|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
163332158|NCT00302211|589925699|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
163079500|NCT00452400|588999349|FG003|Overall Study|Lack of Efficacy|0|||
163079501|NCT00452400|588999350|FG004|Overall Study|Lack of Efficacy|0|||
163079502|NCT00452400|588999346|FG000|Overall Study|Other reasons not listed above|0|||
163332159|NCT00302211|589925700|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
163332160|NCT00302211|589925696|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
163332161|NCT00302211|589925697|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
163332162|NCT00302211|589925698|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
163332163|NCT00302211|589925699|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
163332164|NCT00302211|589925700|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
163332165|NCT03137459|589927565|FG000|2-month Assessment|Withdrawal by Subject|13|||
163332166|NCT03137459|589927566|FG001|2-month Assessment|Withdrawal by Subject|3|||
163332167|NCT03137459|589927565|FG000|2-month Assessment|Unable to reach|42|||
163332168|NCT03137459|589927566|FG001|2-month Assessment|Unable to reach|32|||
163332169|NCT03137459|589927565|FG000|2-month Assessment|Refused assessment|7|||
163332170|NCT03137459|589927566|FG001|2-month Assessment|Refused assessment|5|||
163332171|NCT03137459|589927565|FG000|2-month Assessment|Acutely ill|6|||
163332172|NCT03137459|589927566|FG001|2-month Assessment|Acutely ill|2|||
163332173|NCT03137459|589927565|FG000|4-month Assessment|Death|4|||
163332174|NCT03137459|589927566|FG001|4-month Assessment|Death|2|||
163332175|NCT03137459|589927565|FG000|4-month Assessment|Withdrawal by Subject|4|||
163332176|NCT03137459|589927566|FG001|4-month Assessment|Withdrawal by Subject|2|||
163332177|NCT03137459|589927565|FG000|4-month Assessment|Unable to reach|44|||
163332178|NCT03137459|589927566|FG001|4-month Assessment|Unable to reach|29|||
163332179|NCT03137459|589927565|FG000|4-month Assessment|Refused assessment|24|||
163332180|NCT03137459|589927566|FG001|4-month Assessment|Refused assessment|10|||
163332181|NCT03137459|589927565|FG000|4-month Assessment|Acutely ill|2|||
163332182|NCT03137459|589927566|FG001|4-month Assessment|Acutely ill|3|||
163332183|NCT03137459|589927565|FG000|6-months|Lost to Follow-up|14|||
163332184|NCT03137459|589927566|FG001|6-months|Lost to Follow-up|11|||
163332185|NCT03137459|589927565|FG000|6-months|Death|0|||
163332186|NCT03137459|589927566|FG001|6-months|Death|2|||
163332187|NCT03137459|589927565|FG000|6-months|Refused assessment|6|||
163332188|NCT03137459|589927566|FG001|6-months|Refused assessment|3|||
163332189|NCT03137459|589927565|FG000|6-months|Acutely ill|1|||
163332190|NCT03137459|589927566|FG001|6-months|Acutely ill|1|||
163332191|NCT06571695|589927567|FG000|Overall Study|Lost to Follow-up|1|||
163332192|NCT06571695|589927568|FG001|Overall Study|Lost to Follow-up|6|||
163332193|NCT04921358|589927569|FG000|Overall Study|Withdrawal by Subject|6|||
163332194|NCT04921358|589927570|FG001|Overall Study|Withdrawal by Subject|13|||
163332195|NCT04921358|589927569|FG000|Overall Study|Lost to Follow-up|3|||
163029535|NCT02100670|588810475|FG000|Overall Study|Withdrawal by Subject|1|||
163029536|NCT02100670|588810476|FG001|Overall Study|Withdrawal by Subject|0|||
163029537|NCT02100670|588810477|FG002|Overall Study|Withdrawal by Subject|0|||
163029538|NCT02100670|588810478|FG003|Overall Study|Withdrawal by Subject|0|||
163029539|NCT01556997|588811804|FG000|Overall Study|Adverse Event|10|||
163029540|NCT01556997|588811805|FG001|Overall Study|Adverse Event|12|||
163029541|NCT01556997|588811806|FG002|Overall Study|Adverse Event|12|||
163029542|NCT01556997|588811804|FG000|Overall Study|Lost to Follow-up|6|||
163029543|NCT01556997|588811805|FG001|Overall Study|Lost to Follow-up|6|||
163029544|NCT01556997|588811806|FG002|Overall Study|Lost to Follow-up|4|||
163029545|NCT01556997|588811804|FG000|Overall Study|Physician Decision|1|||
163029546|NCT01556997|588811805|FG001|Overall Study|Physician Decision|1|||
163029547|NCT01556997|588811806|FG002|Overall Study|Physician Decision|1|||
163029548|NCT01556997|588811804|FG000|Overall Study|Withdrawal by Subject|7|||
163029549|NCT01556997|588811805|FG001|Overall Study|Withdrawal by Subject|6|||
163029550|NCT01556997|588811806|FG002|Overall Study|Withdrawal by Subject|8|||
163029551|NCT01556997|588811804|FG000|Overall Study|Other|2|||
163029552|NCT01556997|588811805|FG001|Overall Study|Other|3|||
163029553|NCT01556997|588811806|FG002|Overall Study|Other|7|||
163029554|NCT05459558|588811807|FG000|Overall Study|Adverse Event|1|||
163029555|NCT05459558|588811808|FG001|Overall Study|Adverse Event|0|||
163029556|NCT05459558|588811809|FG002|Overall Study|Adverse Event|0|||
163029557|NCT05459558|588811807|FG000|Overall Study|Scheduling issue|0|||
163029558|NCT05459558|588811808|FG001|Overall Study|Scheduling issue|1|||
163029559|NCT05459558|588811809|FG002|Overall Study|Scheduling issue|3|||
163079503|NCT00452400|588999347|FG001|Overall Study|Other reasons not listed above|0|||
163079504|NCT00452400|588999348|FG002|Overall Study|Other reasons not listed above|0|||
163332196|NCT04921358|589927570|FG001|Overall Study|Lost to Follow-up|6|||
163332197|NCT04921358|589927569|FG000|Overall Study|Study Terminated by Sponsor|86|||
163332198|NCT04921358|589927570|FG001|Overall Study|Study Terminated by Sponsor|89|||
163332199|NCT04921358|589927569|FG000|Overall Study|Death|92|||
163332200|NCT04921358|589927570|FG001|Overall Study|Death|82|||
163332201|NCT02278796|589927571|FG000|Overall Study|Death|2|||
163332202|NCT02278796|589927572|FG001|Overall Study|Death|3|||
163332203|NCT04926857|589927573|FG000|Overall Study|Withdrawal by Subject|40|||
163079505|NCT00452400|588999349|FG003|Overall Study|Other reasons not listed above|1|||
163079506|NCT00452400|588999350|FG004|Overall Study|Other reasons not listed above|1|||
163079507|NCT03378635|588999351|FG000|Overall Study|Adverse Event|1|||
163079508|NCT03378635|588999352|FG001|Overall Study|Adverse Event|0|||
163079509|NCT03378635|588999353|FG002|Overall Study|Adverse Event|0|||
163079510|NCT03378635|588999351|FG000|Overall Study|Withdrawal by Subject|1|||
163079511|NCT03378635|588999352|FG001|Overall Study|Withdrawal by Subject|0|||
163079512|NCT03378635|588999353|FG002|Overall Study|Withdrawal by Subject|0|||
163079513|NCT01472835|588999358|FG000|Overall Study|Lost to Follow-up|2|||
163079514|NCT01472835|588999359|FG001|Overall Study|Lost to Follow-up|0|||
163079515|NCT01835431|588999376|FG000|Overall Study|Adverse Event|1|||
163079516|NCT01835431|588999377|FG001|Overall Study|Adverse Event|0|||
163079517|NCT01835431|588999376|FG000|Overall Study|other|0|||
163079518|NCT01835431|588999377|FG001|Overall Study|other|2|||
163079519|NCT01835431|588999376|FG000|Overall Study|Withdrawal by Subject|6|||
163079520|NCT01835431|588999377|FG001|Overall Study|Withdrawal by Subject|10|||
163079521|NCT01835431|588999376|FG000|Overall Study|Protocol Violation|1|||
163079522|NCT01835431|588999377|FG001|Overall Study|Protocol Violation|0|||
163079523|NCT01316900|588999378|FG000|Overall Study|Adverse Event|10|||
163079524|NCT01316900|588999379|FG001|Overall Study|Adverse Event|10|||
163079525|NCT01316900|588999380|FG002|Overall Study|Adverse Event|15|||
163079526|NCT01316900|588999381|FG003|Overall Study|Adverse Event|9|||
163079527|NCT01316900|588999378|FG000|Overall Study|Lack of Efficacy|17|||
163079528|NCT01316900|588999379|FG001|Overall Study|Lack of Efficacy|9|||
163079529|NCT01316900|588999380|FG002|Overall Study|Lack of Efficacy|5|||
163079530|NCT01316900|588999381|FG003|Overall Study|Lack of Efficacy|7|||
163079531|NCT01316900|588999378|FG000|Overall Study|Protocol Violation|7|||
163079532|NCT01316900|588999379|FG001|Overall Study|Protocol Violation|1|||
163079533|NCT01316900|588999380|FG002|Overall Study|Protocol Violation|4|||
163079534|NCT01316900|588999381|FG003|Overall Study|Protocol Violation|0|||
163079535|NCT01316900|588999378|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
163079536|NCT01316900|588999379|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
163079537|NCT01316900|588999380|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
163079538|NCT01316900|588999381|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
163079539|NCT01316900|588999378|FG000|Overall Study|Lost to Follow-up|1|||
163079540|NCT01316900|588999379|FG001|Overall Study|Lost to Follow-up|0|||
163079541|NCT01316900|588999380|FG002|Overall Study|Lost to Follow-up|1|||
163079542|NCT01316900|588999381|FG003|Overall Study|Lost to Follow-up|1|||
163079543|NCT01316900|588999378|FG000|Overall Study|Withdrawal by Subject|7|||
163079544|NCT01316900|588999379|FG001|Overall Study|Withdrawal by Subject|8|||
163079545|NCT01316900|588999380|FG002|Overall Study|Withdrawal by Subject|6|||
163079546|NCT01316900|588999381|FG003|Overall Study|Withdrawal by Subject|9|||
163079547|NCT05346640|588999382|FG000|Overall Study|Lack of Efficacy|2|||
163079548|NCT05346640|588999382|FG000|Overall Study|Lost to Follow-up|14|||
163079549|NCT05346640|588999382|FG000|Overall Study|Protocol Violation|4|||
163079550|NCT05346640|588999382|FG000|Overall Study|Withdrawal by Subject|2|||
163079551|NCT05346640|588999382|FG000|Overall Study|Physiological Complications|3|||
163079552|NCT05346640|588999382|FG000|Overall Study|Other Reason|3|||
163079553|NCT01703221|588999383|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
163079554|NCT01703221|588999384|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
163332204|NCT04926857|589927573|FG000|Overall Study|Death|9|||
163332205|NCT04926857|589927573|FG000|Overall Study|Study product no longer in use|44|||
163079555|NCT01703221|588999385|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
163079556|NCT01703221|588999383|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
163079557|NCT01703221|588999384|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
163332206|NCT04926857|589927573|FG000|Overall Study|Inadequate data to address primary objective|16|||
163332207|NCT02637063|589927574|FG000|Overall Study|Lost to Follow-up|3|||
163332208|NCT02637063|589927575|FG001|Overall Study|Lost to Follow-up|2|||
163079558|NCT01703221|588999385|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
163079559|NCT01703221|588999383|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
163079560|NCT01703221|588999384|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163079561|NCT01703221|588999385|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163079562|NCT01703221|588999383|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
163079563|NCT01703221|588999384|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
163079564|NCT01703221|588999385|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
163079565|NCT01703221|588999383|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163079566|NCT01703221|588999384|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163079567|NCT01703221|588999385|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
163079568|NCT01703221|588999383|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
163079569|NCT01703221|588999384|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
163332209|NCT02637063|589927576|FG002|Overall Study|Lost to Follow-up|3|||
163079570|NCT01703221|588999385|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
163332210|NCT02637063|589927574|FG000|Overall Study|Withdrawal by Subject|2|||
163332211|NCT02637063|589927575|FG001|Overall Study|Withdrawal by Subject|2|||
163079571|NCT01703221|588999383|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
163079572|NCT01703221|588999384|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
163079573|NCT01703221|588999385|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
163079574|NCT01703221|588999383|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
163079575|NCT01703221|588999384|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
163079576|NCT01703221|588999385|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
163079577|NCT01152385|588999386|FG000|Overall Study|Withdrawal by Subject|3|||
163079578|NCT01152385|588999387|FG001|Overall Study|Withdrawal by Subject|1|||
163079579|NCT01152385|588999388|FG002|Overall Study|Withdrawal by Subject|1|||
163079580|NCT01152385|588999389|FG003|Overall Study|Withdrawal by Subject|1|||
163079581|NCT01152385|588999386|FG000|Overall Study|Protocol Violation|0|||
163079582|NCT01152385|588999387|FG001|Overall Study|Protocol Violation|0|||
163079583|NCT01152385|588999388|FG002|Overall Study|Protocol Violation|0|||
163079584|NCT01152385|588999389|FG003|Overall Study|Protocol Violation|1|||
163079585|NCT01152385|588999386|FG000|Overall Study|Adverse Event|1|||
163079586|NCT01152385|588999387|FG001|Overall Study|Adverse Event|1|||
163079587|NCT01152385|588999388|FG002|Overall Study|Adverse Event|0|||
163079588|NCT01152385|588999389|FG003|Overall Study|Adverse Event|0|||
163079589|NCT01152385|588999386|FG000|Overall Study|Study-specific withdrawal criteria|1|||
163079590|NCT01152385|588999387|FG001|Overall Study|Study-specific withdrawal criteria|1|||
163079591|NCT01152385|588999388|FG002|Overall Study|Study-specific withdrawal criteria|2|||
163079592|NCT01152385|588999389|FG003|Overall Study|Study-specific withdrawal criteria|0|||
163079593|NCT01152385|588999386|FG000|Overall Study|Other|4|||
163079594|NCT01152385|588999387|FG001|Overall Study|Other|3|||
163079595|NCT01152385|588999388|FG002|Overall Study|Other|2|||
163079596|NCT01152385|588999389|FG003|Overall Study|Other|3|||
163079597|NCT03927846|588999392|FG000|Overall Study|Lost to Follow-up|10|||
163079598|NCT03927846|588999393|FG001|Overall Study|Lost to Follow-up|11|||
163079599|NCT03061214|588999396|FG000|Overall Study|Withdrawal by Subject|21|||
163079600|NCT03061214|588999397|FG001|Overall Study|Withdrawal by Subject|26|||
163079601|NCT03061214|588999398|FG002|Overall Study|Withdrawal by Subject|9|||
163079602|NCT03061214|588999396|FG000|Overall Study|Lost to Follow-up|3|||
163079603|NCT03061214|588999397|FG001|Overall Study|Lost to Follow-up|1|||
163079604|NCT03061214|588999398|FG002|Overall Study|Lost to Follow-up|1|||
163079605|NCT03061214|588999396|FG000|Overall Study|Death|1|||
163079606|NCT03061214|588999397|FG001|Overall Study|Death|1|||
163079607|NCT03061214|588999398|FG002|Overall Study|Death|0|||
163079608|NCT01394185|589001115|FG000|Overall Study|Withdrawal by Subject|2|||
163079609|NCT01394185|589001116|FG001|Overall Study|Withdrawal by Subject|0|||
163079610|NCT01394185|589001117|FG002|Overall Study|Withdrawal by Subject|0|||
163079611|NCT01394185|589001118|FG003|Overall Study|Withdrawal by Subject|0|||
163079612|NCT01394185|589001119|FG004|Overall Study|Withdrawal by Subject|1|||
163079613|NCT01394185|589001120|FG005|Overall Study|Withdrawal by Subject|0|||
163079614|NCT01394185|589001115|FG000|Overall Study|Change in protocol|3|||
163079615|NCT01394185|589001116|FG001|Overall Study|Change in protocol|0|||
163079616|NCT01394185|589001117|FG002|Overall Study|Change in protocol|0|||
163079617|NCT01394185|589001118|FG003|Overall Study|Change in protocol|0|||
163079618|NCT01394185|589001119|FG004|Overall Study|Change in protocol|3|||
163079619|NCT01394185|589001120|FG005|Overall Study|Change in protocol|0|||
163079620|NCT01394185|589001115|FG000|Overall Study|Protocol Violation|1|||
163079621|NCT01394185|589001116|FG001|Overall Study|Protocol Violation|0|||
163079622|NCT01394185|589001117|FG002|Overall Study|Protocol Violation|0|||
163079623|NCT01394185|589001118|FG003|Overall Study|Protocol Violation|1|||
163079624|NCT01394185|589001119|FG004|Overall Study|Protocol Violation|0|||
163079625|NCT01394185|589001120|FG005|Overall Study|Protocol Violation|1|||
163079626|NCT02371889|589001121|FG000|Overall Study|Adverse medication effect|11|||
163079627|NCT02371889|589001122|FG001|Overall Study|Adverse medication effect|2|||
163079628|NCT02371889|589001121|FG000|Overall Study|Lost to Follow-up|6|||
163079629|NCT02371889|589001122|FG001|Overall Study|Lost to Follow-up|5|||
163218930|NCT00362115|589517372|FG002|Overall Study|Other|0|||
163218931|NCT00362115|589517373|FG003|Overall Study|Other|1|||
163079630|NCT02371889|589001121|FG000|Overall Study|Personal time constraints|2|||
163079631|NCT02371889|589001122|FG001|Overall Study|Personal time constraints|4|||
163079632|NCT02371889|589001121|FG000|Overall Study|Lack of Efficacy|0|||
163079633|NCT02371889|589001122|FG001|Overall Study|Lack of Efficacy|2|||
163079634|NCT02371889|589001121|FG000|Overall Study|Relapse|0|||
163079635|NCT02371889|589001122|FG001|Overall Study|Relapse|1|||
163079636|NCT05130281|589001123|FG000|Overall Study|Withdrawal by Subject|0|||
163079637|NCT05130281|589001124|FG001|Overall Study|Withdrawal by Subject|0|||
163079638|NCT05130281|589001125|FG002|Overall Study|Withdrawal by Subject|1|||
163079639|NCT06844812|589001126|FG000|Overall Study|Lost to Follow-up|5|||
163079640|NCT06844812|589001126|FG000|Overall Study|stigmatization concerns|2|||
163079641|NCT06844812|589001126|FG000|Overall Study|medication refusal|2|||
163079642|NCT06844812|589001126|FG000|Overall Study|concerns about possible side effects|2|||
163218932|NCT00362115|589517374|FG004|Overall Study|Other|0|||
163218933|NCT00362115|589517375|FG005|Overall Study|Other|1|||
163218934|NCT00362115|589517376|FG006|Overall Study|Other|0|||
163218935|NCT01170091|589517377|FG000|Overall Study|Missing efficacy evaluation|3|||
163218936|NCT01170091|589517377|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
163332212|NCT02637063|589927576|FG002|Overall Study|Withdrawal by Subject|3|||
163332213|NCT00491400|589927577|FG000|Overall Study|Withdrawal by Subject|5|||
163332214|NCT00491400|589927578|FG001|Overall Study|Withdrawal by Subject|4|||
163332215|NCT00597376|589927579|FG000|Overall Study|Withdrawal by Subject|4|||
163332216|NCT00597376|589927580|FG001|Overall Study|Withdrawal by Subject|3|||
163332217|NCT00597376|589927579|FG000|Overall Study|Adverse Event|4|||
163332218|NCT00597376|589927580|FG001|Overall Study|Adverse Event|1|||
163332219|NCT01380145|589927581|FG000|Overall Study|Progressive disease|4|||
163332220|NCT01256359|589927583|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
163332221|NCT01256359|589927584|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
163332222|NCT01256359|589927583|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
163332223|NCT01256359|589927584|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
163332224|NCT03737110|589927589|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
163332225|NCT03737110|589927590|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
163332226|NCT03737110|589927591|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
163332227|NCT03737110|589927592|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
163029560|NCT05459558|588811807|FG000|Overall Study|Withdrawal by Subject|0|||
163029561|NCT05459558|588811808|FG001|Overall Study|Withdrawal by Subject|0|||
163029562|NCT05459558|588811809|FG002|Overall Study|Withdrawal by Subject|2|||
163029563|NCT01250171|588811815|FG000|Overall Study|Administrative reasons|1|||
163029564|NCT01250171|588811816|FG001|Overall Study|Administrative reasons|0|||
163029565|NCT01250171|588811817|FG002|Overall Study|Administrative reasons|0|||
163029566|NCT00250458|588811834|FG000|Overall Study|Lost to Follow-up|4|||
163029567|NCT00250458|588811835|FG001|Overall Study|Lost to Follow-up|2|||
163029568|NCT00250458|588811834|FG000|Overall Study|Protocol Violation|0|||
163029569|NCT00250458|588811835|FG001|Overall Study|Protocol Violation|1|||
163029570|NCT00250458|588811834|FG000|Overall Study|Withdrawal by Subject|4|||
163029571|NCT00250458|588811835|FG001|Overall Study|Withdrawal by Subject|2|||
163029572|NCT00250458|588811834|FG000|Overall Study|Lack of Migraine Attack|20|||
163029573|NCT00250458|588811835|FG001|Overall Study|Lack of Migraine Attack|9|||
163029574|NCT00250458|588811834|FG000|Overall Study|Qualifying migraine but did not treat|3|||
163029575|NCT00250458|588811835|FG001|Overall Study|Qualifying migraine but did not treat|3|||
163029576|NCT00250458|588811834|FG000|Overall Study|Other|1|||
163029577|NCT00250458|588811835|FG001|Overall Study|Other|0|||
163029578|NCT00741091|588811836|FG000|Overall Study|Death|13|||
163029579|NCT00741091|588811836|FG000|Overall Study|Lost to Follow-up|16|||
163029580|NCT00741091|588811836|FG000|Overall Study|Withdrawal by Subject|6|||
163029581|NCT00741091|588811836|FG000|Overall Study|Missed Visit|22|||
163029582|NCT01892085|588811839|FG000|Overall Study|Death|4|||
163029583|NCT01892085|588811840|FG001|Overall Study|Death|1|||
163029584|NCT01892085|588811841|FG002|Overall Study|Death|3|||
163029585|NCT01892085|588811839|FG000|Overall Study|Withdrawal by Subject|2|||
163029586|NCT01892085|588811840|FG001|Overall Study|Withdrawal by Subject|0|||
163029587|NCT01892085|588811841|FG002|Overall Study|Withdrawal by Subject|2|||
163029588|NCT01472757|588811842|FG000|Overall Study|Withdrawal by Subject|1|||
163029589|NCT01472757|588811843|FG001|Overall Study|Withdrawal by Subject|2|||
163029590|NCT01472757|588811844|FG002|Overall Study|Withdrawal by Subject|2|||
163029591|NCT01472757|588811845|FG003|Overall Study|Withdrawal by Subject|0|||
163029592|NCT01472757|588811842|FG000|Overall Study|Asthma exacerbation|4|||
163029593|NCT01472757|588811843|FG001|Overall Study|Asthma exacerbation|1|||
163029594|NCT01472757|588811844|FG002|Overall Study|Asthma exacerbation|2|||
163029595|NCT01472757|588811845|FG003|Overall Study|Asthma exacerbation|1|||
163029596|NCT01472757|588811842|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
163029597|NCT01472757|588811843|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
163029598|NCT01472757|588811844|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
163029599|NCT01472757|588811845|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
163029600|NCT01472757|588811842|FG000|Overall Study|Protocol Violation|3|||
163029601|NCT01472757|588811843|FG001|Overall Study|Protocol Violation|2|||
163029602|NCT01472757|588811844|FG002|Overall Study|Protocol Violation|4|||
163029603|NCT01472757|588811845|FG003|Overall Study|Protocol Violation|4|||
163029604|NCT01472757|588811842|FG000|Overall Study|Other reasons|1|||
163029605|NCT01472757|588811843|FG001|Overall Study|Other reasons|0|||
163029606|NCT01472757|588811844|FG002|Overall Study|Other reasons|2|||
163029607|NCT01472757|588811845|FG003|Overall Study|Other reasons|2|||
163029608|NCT00597506|588811846|FG000|Overall Study|Subject is being followed for survival|1|||
163029609|NCT00525902|588811848|FG000|Overall Study|Lack of Efficacy|1|||
163029610|NCT00480493|588811849|FG000|Overall Study|moved|2|||
163332228|NCT03737110|589927593|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
163332229|NCT03737110|589927594|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
163029611|NCT00480493|588811850|FG001|Overall Study|moved|7|||
163029612|NCT03747302|588811851|FG000|Overall Study|Withdrawal by Subject|1|||
163029613|NCT03747302|588811852|FG001|Overall Study|Withdrawal by Subject|2|||
163029614|NCT03769675|588811855|FG000|Overall Study|Lost to Follow-up|1|||
163029615|NCT02844907|588811856|FG000|With Dexamethasone|No IV access|1|||
163029616|NCT00738062|588811857|FG000|Open Label Treatment|Lack of Efficacy|5|||
163332230|NCT03737110|589927589|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
163332231|NCT03737110|589927590|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
163332232|NCT03737110|589927591|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
163332233|NCT03737110|589927592|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
163332234|NCT03737110|589927593|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
163332235|NCT03737110|589927594|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
163332236|NCT03737110|589927589|FG000|Run-in (RI) Period|Adverse Event|4|||
163332237|NCT03737110|589927590|FG001|Run-in (RI) Period|Adverse Event|0|||
163332238|NCT03737110|589927591|FG002|Run-in (RI) Period|Adverse Event|0|||
163332239|NCT03737110|589927592|FG003|Run-in (RI) Period|Adverse Event|0|||
163332240|NCT03737110|589927593|FG004|Run-in (RI) Period|Adverse Event|0|||
163332241|NCT03737110|589927594|FG005|Run-in (RI) Period|Adverse Event|0|||
163332242|NCT03737110|589927589|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
163029617|NCT00738062|588811858|FG001|Open Label Treatment|Lack of Efficacy|0|||
163029618|NCT00738062|588811859|FG002|Open Label Treatment|Lack of Efficacy|0|||
163029619|NCT00738062|588811857|FG000|Open Label Treatment|Adverse Event|11|||
163029620|NCT00738062|588811858|FG001|Open Label Treatment|Adverse Event|0|||
163029621|NCT00738062|588811859|FG002|Open Label Treatment|Adverse Event|0|||
163029622|NCT00738062|588811857|FG000|Open Label Treatment|Protocol Violation|2|||
163029623|NCT00738062|588811858|FG001|Open Label Treatment|Protocol Violation|0|||
163029624|NCT00738062|588811859|FG002|Open Label Treatment|Protocol Violation|0|||
163029625|NCT00738062|588811857|FG000|Open Label Treatment|Withdrawal by Subject|9|||
163029626|NCT00738062|588811858|FG001|Open Label Treatment|Withdrawal by Subject|0|||
163029627|NCT00738062|588811859|FG002|Open Label Treatment|Withdrawal by Subject|0|||
163029628|NCT00738062|588811857|FG000|Open Label Treatment|Investigator Decision|1|||
163029629|NCT00738062|588811858|FG001|Open Label Treatment|Investigator Decision|0|||
163029630|NCT00738062|588811859|FG002|Open Label Treatment|Investigator Decision|0|||
163029631|NCT00738062|588811857|FG000|Open-Label Extension|Adverse Event|5|||
163029632|NCT00738062|588811858|FG001|Open-Label Extension|Adverse Event|0|||
163029633|NCT00738062|588811859|FG002|Open-Label Extension|Adverse Event|0|||
163029634|NCT00738062|588811857|FG000|Open-Label Extension|Physician Decision|1|||
163029635|NCT00738062|588811858|FG001|Open-Label Extension|Physician Decision|0|||
163029636|NCT00738062|588811859|FG002|Open-Label Extension|Physician Decision|0|||
163029637|NCT00738062|588811857|FG000|Open-Label Extension|Lack of Efficacy|2|||
163029638|NCT00738062|588811858|FG001|Open-Label Extension|Lack of Efficacy|0|||
163029639|NCT00738062|588811859|FG002|Open-Label Extension|Lack of Efficacy|0|||
163029640|NCT00738062|588811857|FG000|Open-Label Extension|Withdrawal by Subject|6|||
163029641|NCT00738062|588811858|FG001|Open-Label Extension|Withdrawal by Subject|0|||
163029642|NCT00738062|588811859|FG002|Open-Label Extension|Withdrawal by Subject|0|||
163029643|NCT00738062|588811857|FG000|Open-Label Extension|Protocol Violation|1|||
163029644|NCT00738062|588811858|FG001|Open-Label Extension|Protocol Violation|0|||
163029645|NCT00738062|588811859|FG002|Open-Label Extension|Protocol Violation|0|||
163029646|NCT00738062|588811857|FG000|Open-Label Extension|Study Terminated|2|||
163029647|NCT00738062|588811858|FG001|Open-Label Extension|Study Terminated|0|||
163029648|NCT00738062|588811859|FG002|Open-Label Extension|Study Terminated|0|||
163029649|NCT00033657|588811864|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
163029650|NCT00033657|588811865|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
163029651|NCT00033657|588811864|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
163029652|NCT00033657|588811865|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
163029653|NCT00033657|588811864|FG000|Neoadjuvant Chemotherapy|Death|1|||
163029654|NCT00033657|588811865|FG001|Neoadjuvant Chemotherapy|Death|1|||
163029655|NCT00033657|588811864|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
163029656|NCT00033657|588811865|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
163029657|NCT00033657|588811864|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
163029658|NCT00033657|588811865|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
163029659|NCT00033657|588811864|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
163029660|NCT00033657|588811865|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
163029661|NCT00033657|588811864|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
163029662|NCT00033657|588811865|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
163029663|NCT00033657|588811864|FG000|Surgical Resection|not complete resection|0|||
163029664|NCT00033657|588811865|FG001|Surgical Resection|not complete resection|3|||
163029665|NCT00033657|588811864|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
163029666|NCT00033657|588811865|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
163029667|NCT00033657|588811864|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
163029668|NCT00033657|588811865|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
163029669|NCT00033657|588811864|FG000|Adjuvant Chemotherapy|Death|2|||
163029670|NCT00033657|588811865|FG001|Adjuvant Chemotherapy|Death|1|||
163029671|NCT00033657|588811864|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
163029672|NCT00033657|588811865|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
163029673|NCT00033657|588811864|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
163332243|NCT03737110|589927590|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
163029674|NCT00033657|588811865|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
163079643|NCT06844812|589001126|FG000|Overall Study|wanting to seek another specialist opinion|2|||
163079644|NCT06844812|589001126|FG000|Overall Study|side effects (dizziness)|1|||
163079645|NCT02410200|589001132|FG000|Overall Study|Adverse Event|2|||
163079646|NCT05069415|589001133|FG000|Overall Study|Withdrawal by Subject|2|||
163079647|NCT05069415|589001134|FG001|Overall Study|Withdrawal by Subject|0|||
163079648|NCT05069415|589001133|FG000|Overall Study|Adverse Event|2|||
163079649|NCT05069415|589001134|FG001|Overall Study|Adverse Event|0|||
163079650|NCT00101400|589001135|FG000|Survival Follow-Up|Alive|7|||
163079651|NCT03701074|589001136|FG000|Overall Study|Physician Decision|1|||
163079652|NCT03701074|589001137|FG001|Overall Study|Physician Decision|0|||
163079653|NCT01500135|589001138|FG000|Overall Study|Withdrawal of Consent|4|||
163079654|NCT01500135|589001139|FG001|Overall Study|Withdrawal of Consent|0|||
163079655|NCT01500135|589001138|FG000|Overall Study|Lost to Follow-up|6|||
163079656|NCT01500135|589001139|FG001|Overall Study|Lost to Follow-up|4|||
163079657|NCT01500135|589001138|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
163079658|NCT01500135|589001139|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
163079659|NCT01500135|589001138|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
163079660|NCT01500135|589001139|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
163079661|NCT01500135|589001138|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
163079662|NCT01500135|589001139|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
163079663|NCT01500135|589001138|FG000|Overall Study|Participant was a Safety Concern|1|||
163079664|NCT01500135|589001139|FG001|Overall Study|Participant was a Safety Concern|0|||
163079665|NCT01500135|589001138|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
163079666|NCT01500135|589001139|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
163218937|NCT03194321|589517378|FG000|Overall Study|Withdrawal by Subject|1|||
163218938|NCT03194321|589517378|FG000|Overall Study|Lost to Follow-up|1|||
163218939|NCT03194321|589517378|FG000|Overall Study|Travel for Follow-up|1|||
163218940|NCT02188589|589517379|FG000|Overall Study|Withdrawal by Subject|5|||
163218941|NCT00741039|589517385|FG000|Overall Study|Patient non-compliance|2|||
163218942|NCT00741039|589517386|FG001|Overall Study|Patient non-compliance|0|||
163218943|NCT00878709|589517387|FG000|Overall Study|Withdrawal by Subject|197|||
163218944|NCT00878709|589517388|FG001|Overall Study|Withdrawal by Subject|120|||
163218945|NCT00878709|589517387|FG000|Overall Study|Lost to Follow-up|35|||
163218946|NCT00878709|589517388|FG001|Overall Study|Lost to Follow-up|33|||
163218947|NCT00878709|589517387|FG000|Overall Study|Other Reasons|93|||
163218948|NCT00878709|589517388|FG001|Overall Study|Other Reasons|84|||
163218949|NCT00768300|589517389|FG000|Overall Study|Randomized but not treated|1|||
163218950|NCT00768300|589517390|FG001|Overall Study|Randomized but not treated|1|||
163218951|NCT00768300|589517389|FG000|Overall Study|Adverse Event|10|||
163218952|NCT00768300|589517390|FG001|Overall Study|Adverse Event|2|||
163218953|NCT00768300|589517389|FG000|Overall Study|Protocol Violation|6|||
163218954|NCT00768300|589517390|FG001|Overall Study|Protocol Violation|1|||
163218955|NCT00768300|589517389|FG000|Overall Study|Withdrawal by Subject|13|||
163218956|NCT00768300|589517390|FG001|Overall Study|Withdrawal by Subject|7|||
163218957|NCT00768300|589517389|FG000|Overall Study|Physician Decision|2|||
163218958|NCT00768300|589517390|FG001|Overall Study|Physician Decision|3|||
163218959|NCT00768300|589517389|FG000|Overall Study|Study discontinued by Sponsor|271|||
163218960|NCT00768300|589517390|FG001|Overall Study|Study discontinued by Sponsor|140|||
163218961|NCT00768300|589517389|FG000|Overall Study|Death|21|||
163218962|NCT00768300|589517390|FG001|Overall Study|Death|5|||
163218963|NCT00768300|589517389|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
163218964|NCT00768300|589517390|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
163218965|NCT00768300|589517389|FG000|Overall Study|Screen failure following randomization|1|||
163218966|NCT00768300|589517390|FG001|Overall Study|Screen failure following randomization|0|||
163218967|NCT00768300|589517389|FG000|Overall Study|Received lung transplant|1|||
163218968|NCT00768300|589517390|FG001|Overall Study|Received lung transplant|1|||
163218969|NCT00768300|589517389|FG000|Overall Study|Lost to Follow-up|0|||
163218970|NCT00768300|589517390|FG001|Overall Study|Lost to Follow-up|1|||
163218971|NCT00768300|589517389|FG000|Overall Study|Began prohibited concomitant medication|0|||
163218972|NCT00768300|589517390|FG001|Overall Study|Began prohibited concomitant medication|1|||
163218973|NCT00768300|589517389|FG000|Overall Study|Treated but never dosed with Study drug|1|||
163218974|NCT00768300|589517390|FG001|Overall Study|Treated but never dosed with Study drug|0|||
163218975|NCT00768300|589517389|FG000|Overall Study|Missing data|1|||
163218976|NCT00768300|589517390|FG001|Overall Study|Missing data|0|||
163218977|NCT02068222|589517391|FG000|Overall Study|Lost to Follow-up|1|||
163218978|NCT01374087|589517394|FG000|Overall Study|Adverse Event|1|||
163218979|NCT01374087|589517395|FG001|Overall Study|Adverse Event|0|||
163218980|NCT01374087|589517394|FG000|Overall Study|Disease progression|2|||
163332244|NCT03737110|589927591|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
163079667|NCT01661595|589001140|FG000|Phase 1: Week 0-4|Adverse Event|1|||
163079668|NCT01661595|589001141|FG001|Phase 1: Week 0-4|Adverse Event|0|||
163079669|NCT01661595|589001142|FG002|Phase 1: Week 0-4|Adverse Event|0|||
163218981|NCT01374087|589517395|FG001|Overall Study|Disease progression|2|||
163218982|NCT01374087|589517394|FG000|Overall Study|Study discontinued|13|||
163218983|NCT01374087|589517395|FG001|Overall Study|Study discontinued|13|||
163079670|NCT01661595|589001143|FG003|Phase 1: Week 0-4|Adverse Event|0|||
163079671|NCT01661595|589001140|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
163079672|NCT01661595|589001141|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
163079673|NCT01661595|589001142|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
163079674|NCT01661595|589001143|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
163079675|NCT00661687|589001144|FG000|Overall Study|Study related symptoms and complaints|5|||
163079676|NCT00661687|589001144|FG000|Overall Study|Positive slit lamp findings|4|||
163079677|NCT00661687|589001144|FG000|Overall Study|Inability to maintain wearing schedule|3|||
163079678|NCT00661687|589001144|FG000|Overall Study|Physician Decision|1|||
163079679|NCT00661687|589001144|FG000|Overall Study|Adverse Event|2|||
163079680|NCT00912509|589001145|FG000|Overall Study|Lost to Follow-up|1|||
163079681|NCT00912509|589001146|FG001|Overall Study|Lost to Follow-up|0|||
163079682|NCT00912509|589001145|FG000|Overall Study|Lack of Efficacy|4|||
163079683|NCT00912509|589001146|FG001|Overall Study|Lack of Efficacy|3|||
163079684|NCT05538728|589001147|FG000|Overall Study|Withdrawal by Subject|1|||
163079685|NCT05538728|589001148|FG001|Overall Study|Withdrawal by Subject|1|||
163079686|NCT01362530|589001150|FG000|Base Study (Cycle 1)|Adverse Event|2|||
163079687|NCT01362530|589001151|FG001|Base Study (Cycle 1)|Adverse Event|0|||
163079688|NCT01362530|589001150|FG000|Base Study (Cycle 1)|Physician Decision|0|||
163079689|NCT01362530|589001151|FG001|Base Study (Cycle 1)|Physician Decision|1|||
163079690|NCT01362530|589001150|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
163079691|NCT01362530|589001151|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
163079692|NCT01362530|589001150|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
163079693|NCT01362530|589001151|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
163079694|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
163079695|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
163079696|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
163079697|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
163079698|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
163079699|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
163079700|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
163079701|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
163079702|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
163079703|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
163079704|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
163079705|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
163079706|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
163079707|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
163079708|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
163218984|NCT03011307|589517396|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
163218985|NCT03011307|589517397|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
163218986|NCT03011307|589517396|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
163079709|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
163079710|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
163079711|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
163079712|NCT01557569|589001152|FG000|Overall Study|Adverse Event|2|||
163079713|NCT01557569|589001153|FG001|Overall Study|Adverse Event|0|||
163079714|NCT01557569|589001152|FG000|Overall Study|high blood pressure|0|||
163079715|NCT01557569|589001153|FG001|Overall Study|high blood pressure|1|||
163079716|NCT01557569|589001152|FG000|Overall Study|Withdrawal by Subject|3|||
163079717|NCT01557569|589001153|FG001|Overall Study|Withdrawal by Subject|5|||
163079718|NCT01557569|589001152|FG000|Overall Study|noncompliance with rules of residential|0|||
163218987|NCT03011307|589517397|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
163218988|NCT03011307|589517396|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
163218989|NCT03011307|589517397|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
163218990|NCT00567892|589517401|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
163332245|NCT03737110|589927592|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
163079719|NCT01557569|589001153|FG001|Overall Study|noncompliance with rules of residential|1|||
163079720|NCT02254460|589001154|FG000|Overall Study|Adverse Event|1|||
163079721|NCT02254460|589001155|FG001|Overall Study|Adverse Event|0|||
163079722|NCT01050218|589001156|FG000|Overall Study|Adverse Event|37|||
163079723|NCT01050218|589001156|FG000|Overall Study|Lack of Efficacy|8|||
163079724|NCT01050218|589001156|FG000|Overall Study|Protocol Violation|3|||
163079725|NCT01050218|589001156|FG000|Overall Study|Withdrawal by Subject|18|||
163079726|NCT01050218|589001156|FG000|Overall Study|Discontinued by sponsor|18|||
163079727|NCT01050218|589001156|FG000|Overall Study|Compliance|2|||
163079728|NCT01050218|589001156|FG000|Overall Study|Failed to return|7|||
163079729|NCT01050218|589001156|FG000|Overall Study|Serious Adverse Event|1|||
163079730|NCT01050218|589001156|FG000|Overall Study|Family emergency|1|||
163079731|NCT01772693|589001157|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
163079732|NCT01772693|589001158|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
163079733|NCT01772693|589001157|FG000|Overall Study|Withdrawal by Subject|2|||
163079734|NCT01772693|589001158|FG001|Overall Study|Withdrawal by Subject|0|||
163079735|NCT01772693|589001157|FG000|Overall Study|Alternative Treatment|2|||
163079736|NCT01772693|589001158|FG001|Overall Study|Alternative Treatment|0|||
163079737|NCT01633112|589001159|FG000|Overall Study|Lack of Efficacy|1|||
163079738|NCT01633112|589001160|FG001|Overall Study|Lack of Efficacy|6|||
163079739|NCT01633112|589001161|FG002|Overall Study|Lack of Efficacy|13|||
163079740|NCT01633112|589001159|FG000|Overall Study|Abnormal laboratory value(s)|3|||
163079741|NCT01633112|589001160|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163079742|NCT01633112|589001161|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163079743|NCT01633112|589001159|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163079744|NCT01633112|589001160|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163079745|NCT01633112|589001161|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163079746|NCT01633112|589001159|FG000|Overall Study|Administrative problems|1|||
163079747|NCT01633112|589001160|FG001|Overall Study|Administrative problems|2|||
163079748|NCT01633112|589001161|FG002|Overall Study|Administrative problems|5|||
163079749|NCT01633112|589001159|FG000|Overall Study|Adverse Event|16|||
163079750|NCT01633112|589001160|FG001|Overall Study|Adverse Event|18|||
163079751|NCT01633112|589001161|FG002|Overall Study|Adverse Event|20|||
163218991|NCT00567892|589517402|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
163218992|NCT00567892|589517403|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
163218993|NCT00567892|589517404|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
163218994|NCT00567892|589517401|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
163218995|NCT00567892|589517402|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
163218996|NCT00567892|589517403|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
163218997|NCT00567892|589517404|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
163218998|NCT01344161|589517406|FG000|Overall Study|Lost to Follow-up|4|||
163218999|NCT01344161|589517407|FG001|Overall Study|Lost to Follow-up|1|||
163219000|NCT01344161|589517406|FG000|Overall Study|Pregnancy|0|||
163219001|NCT01344161|589517407|FG001|Overall Study|Pregnancy|1|||
163219002|NCT01344161|589517406|FG000|Overall Study|Protocol Violation|1|||
163219003|NCT01344161|589517407|FG001|Overall Study|Protocol Violation|1|||
163219004|NCT04690751|589517408|FG000|Overall Study|Protocol Violation|0|||
163219005|NCT04690751|589517409|FG001|Overall Study|Protocol Violation|1|||
163219006|NCT04690751|589517410|FG002|Overall Study|Protocol Violation|0|||
163219007|NCT04690751|589517411|FG003|Overall Study|Protocol Violation|1|||
163219008|NCT04690751|589517412|FG004|Overall Study|Protocol Violation|2|||
163219009|NCT04690751|589517413|FG005|Overall Study|Protocol Violation|0|||
163219010|NCT04690751|589517408|FG000|Overall Study|Adverse Event|0|||
163219011|NCT04690751|589517409|FG001|Overall Study|Adverse Event|0|||
163219012|NCT04690751|589517410|FG002|Overall Study|Adverse Event|1|||
163219013|NCT04690751|589517411|FG003|Overall Study|Adverse Event|0|||
163219014|NCT04690751|589517412|FG004|Overall Study|Adverse Event|0|||
163219015|NCT04690751|589517413|FG005|Overall Study|Adverse Event|0|||
163219016|NCT04690751|589517408|FG000|Overall Study|Positive urine drug screen test|0|||
163219017|NCT04690751|589517409|FG001|Overall Study|Positive urine drug screen test|0|||
163219018|NCT04690751|589517410|FG002|Overall Study|Positive urine drug screen test|0|||
163219019|NCT04690751|589517411|FG003|Overall Study|Positive urine drug screen test|0|||
163219020|NCT04690751|589517412|FG004|Overall Study|Positive urine drug screen test|1|||
163219021|NCT04690751|589517413|FG005|Overall Study|Positive urine drug screen test|0|||
163219022|NCT04364620|589517414|FG000|Overall Study|Disease Progression|20|||
163219023|NCT04364620|589517414|FG000|Overall Study|Adverse Event|5|||
163219024|NCT04364620|589517414|FG000|Overall Study|Physician Decision|4|||
163219025|NCT04364620|589517414|FG000|Overall Study|Death|3|||
163219026|NCT04364620|589517414|FG000|Overall Study|Other|2|||
163219027|NCT04364620|589517414|FG000|Overall Study|Withdrawal by Subject|1|||
163219028|NCT01541969|589519334|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
163219029|NCT01541969|589519335|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
163219030|NCT01541969|589519334|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
163219031|NCT01541969|589519335|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
163219032|NCT01541969|589519334|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
163219033|NCT01541969|589519335|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
163219034|NCT01541969|589519334|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
163079752|NCT01633112|589001159|FG000|Overall Study|Lost to Follow-up|7|||
163079753|NCT01633112|589001160|FG001|Overall Study|Lost to Follow-up|19|||
163219035|NCT01541969|589519335|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
163219036|NCT01541969|589519334|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
163219037|NCT01541969|589519335|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
163079754|NCT01633112|589001161|FG002|Overall Study|Lost to Follow-up|6|||
163079755|NCT01633112|589001159|FG000|Overall Study|Protocol Violation|4|||
163079756|NCT01633112|589001160|FG001|Overall Study|Protocol Violation|0|||
163079757|NCT01633112|589001161|FG002|Overall Study|Protocol Violation|2|||
163079758|NCT01633112|589001159|FG000|Overall Study|Subject no longer requires study drug|0|||
163079759|NCT01633112|589001160|FG001|Overall Study|Subject no longer requires study drug|0|||
163079760|NCT01633112|589001161|FG002|Overall Study|Subject no longer requires study drug|1|||
163079761|NCT01633112|589001159|FG000|Overall Study|Withdrawal by Subject|20|||
163079762|NCT01633112|589001160|FG001|Overall Study|Withdrawal by Subject|12|||
163079763|NCT01633112|589001161|FG002|Overall Study|Withdrawal by Subject|41|||
163079764|NCT01633112|589001159|FG000|Overall Study|missing Study Completion CRF|1|||
163079765|NCT01633112|589001160|FG001|Overall Study|missing Study Completion CRF|1|||
163079766|NCT01633112|589001161|FG002|Overall Study|missing Study Completion CRF|4|||
163079767|NCT02872142|589001163|FG000|Overall Study|Adverse Event|2|||
163079768|NCT02872142|589001163|FG000|Overall Study|Death|1|||
163079769|NCT02872142|589001163|FG000|Overall Study|Participant Decision|3|||
163079770|NCT01550965|589001166|FG000|Overall Study|Adverse Event|26|||
163079771|NCT01550965|589001166|FG000|Overall Study|Withdrawal by Subject|10|||
163079772|NCT01550965|589001166|FG000|Overall Study|Lost to Follow-up|2|||
163079773|NCT01550965|589001166|FG000|Overall Study|Lack of Efficacy|59|||
163079774|NCT01550965|589001166|FG000|Overall Study|Other|13|||
163079775|NCT00160563|589001169|FG000|Overall Study|Adverse Event|1|||
163079776|NCT00160563|589001170|FG001|Overall Study|Adverse Event|1|||
163079777|NCT00160563|589001171|FG002|Overall Study|Adverse Event|1|||
163079778|NCT00160563|589001169|FG000|Overall Study|Lost to Follow-up|1|||
163079779|NCT00160563|589001170|FG001|Overall Study|Lost to Follow-up|1|||
163079780|NCT00160563|589001171|FG002|Overall Study|Lost to Follow-up|2|||
163079781|NCT00160563|589001169|FG000|Overall Study|Protocol Violation|0|||
163079782|NCT00160563|589001170|FG001|Overall Study|Protocol Violation|0|||
163079783|NCT00160563|589001171|FG002|Overall Study|Protocol Violation|3|||
163079784|NCT00160563|589001169|FG000|Overall Study|Withdrawal by Subject|1|||
163079785|NCT00160563|589001170|FG001|Overall Study|Withdrawal by Subject|2|||
163079786|NCT00160563|589001171|FG002|Overall Study|Withdrawal by Subject|3|||
163079787|NCT00160563|589001169|FG000|Overall Study|Other (listed in the study report)|48|||
163079788|NCT00160563|589001170|FG001|Overall Study|Other (listed in the study report)|40|||
163079789|NCT00160563|589001171|FG002|Overall Study|Other (listed in the study report)|81|||
163079790|NCT00160563|589001169|FG000|Overall Study|Missing reason|0|||
163079791|NCT00160563|589001170|FG001|Overall Study|Missing reason|1|||
163079792|NCT00160563|589001171|FG002|Overall Study|Missing reason|0|||
163079793|NCT02624687|589001177|FG000|Overall Study|Withdrawal by Subject|1|||
163079794|NCT02624687|589001178|FG001|Overall Study|Withdrawal by Subject|1|||
163079795|NCT02624687|589001177|FG000|Overall Study|medical leave from work|0|||
163079796|NCT02624687|589001178|FG001|Overall Study|medical leave from work|1|||
163079797|NCT00867334|589001181|FG000|Overall Study|Withdrawal by Subject|0|||
163079798|NCT00867334|589001182|FG001|Overall Study|Withdrawal by Subject|1|||
163079799|NCT00867334|589001181|FG000|Overall Study|Withdrawal by Subject|1|||
163079800|NCT00867334|589001182|FG001|Overall Study|Withdrawal by Subject|0|||
163079801|NCT00867334|589001181|FG000|Overall Study|Withdrawal by Subject|1|||
163079802|NCT00867334|589001182|FG001|Overall Study|Withdrawal by Subject|0|||
163079803|NCT01148771|589001183|FG000|Washout Period|Withdrawal by Subject|0|||
163079804|NCT01148771|589001184|FG001|Washout Period|Withdrawal by Subject|1|||
163219038|NCT01541969|589519334|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
163219039|NCT01541969|589519335|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
163219040|NCT01541969|589519334|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
163219041|NCT01541969|589519335|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
163219042|NCT01541969|589519334|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
163219043|NCT01541969|589519335|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
163219044|NCT01541969|589519334|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
163219045|NCT01541969|589519335|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
163219046|NCT01541969|589519334|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
163219047|NCT01541969|589519335|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
163219048|NCT01365507|589519336|FG000|Overall Study|Withdrawal Criteria|8|||
163219049|NCT01365507|589519337|FG001|Overall Study|Withdrawal Criteria|5|||
163219050|NCT01365507|589519336|FG000|Overall Study|Unclassified|1|||
163219051|NCT01365507|589519337|FG001|Overall Study|Unclassified|4|||
163219052|NCT01614990|589519338|FG000|Overall Study|Protocol Violation|1|||
163219053|NCT01614990|589519339|FG001|Overall Study|Protocol Violation|1|||
163219054|NCT02255500|589519346|FG000|Overall Study|Withdrawal by Subject|1|||
163219055|NCT02255500|589519347|FG001|Overall Study|Withdrawal by Subject|0|||
163079805|NCT01437189|589001185|FG000|Overall Study|Adverse Event|3|||
163079806|NCT01437189|589001185|FG000|Overall Study|Lack of Efficacy|4|||
163079807|NCT01437189|589001185|FG000|Overall Study|Withdrawal by Subject|8|||
163079808|NCT01689649|589001186|FG000|Overall Study|Lack of Efficacy|3|||
163079809|NCT01689649|589001186|FG000|Overall Study|Non-compliance|11|||
163079810|NCT01689649|589001186|FG000|Overall Study|Protocol Violation|3|||
163219056|NCT04254978|589519351|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
163219057|NCT04254978|589519351|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
163079811|NCT01689649|589001186|FG000|Overall Study|Lost to Follow-up|5|||
163079812|NCT04893811|589001187|FG000|Vaccination Phase|Death|1|||
163079813|NCT04893811|589001188|FG001|Vaccination Phase|Death|0|||
163079814|NCT04893811|589001187|FG000|Vaccination Phase|Lost to Follow-up|1|||
163079815|NCT04893811|589001188|FG001|Vaccination Phase|Lost to Follow-up|1|||
163079816|NCT04893811|589001187|FG000|Vaccination Phase|Protocol Violation|2|||
163079817|NCT04893811|589001188|FG001|Vaccination Phase|Protocol Violation|0|||
163079818|NCT04893811|589001187|FG000|Vaccination Phase|Withdrawal by Subject|2|||
163079819|NCT04893811|589001188|FG001|Vaccination Phase|Withdrawal by Subject|1|||
163079820|NCT04893811|589001187|FG000|Vaccination Phase|Other|0|||
163079821|NCT04893811|589001188|FG001|Vaccination Phase|Other|1|||
163079822|NCT04893811|589001187|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
163079823|NCT04893811|589001188|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
163079824|NCT04893811|589001187|FG000|Follow-up Phase|Lost to Follow-up|0|||
163079825|NCT04893811|589001188|FG001|Follow-up Phase|Lost to Follow-up|1|||
163079826|NCT03268499|589001189|FG000|Overall Study|Withdrawal by Subject|2|||
163079827|NCT03268499|589001190|FG001|Overall Study|Withdrawal by Subject|1|||
163079828|NCT04064567|589001191|FG000|Overall Study|Lost to Follow-up|23|||
163079829|NCT04064567|589001192|FG001|Overall Study|Lost to Follow-up|22|||
163079830|NCT04064567|589001191|FG000|Overall Study|Withdrawal by Subject|0|||
163079831|NCT04064567|589001192|FG001|Overall Study|Withdrawal by Subject|1|||
163079832|NCT04064567|589001191|FG000|Overall Study|Reincarcerated|7|||
163079833|NCT04064567|589001192|FG001|Overall Study|Reincarcerated|10|||
163079834|NCT04064567|589001191|FG000|Overall Study|Moved out of U.S.|0|||
163079835|NCT04064567|589001192|FG001|Overall Study|Moved out of U.S.|1|||
163079836|NCT03464461|589001195|FG000|Overall Study|exclusionary medication given ,|1|||
163079837|NCT03464461|589001196|FG001|Overall Study|exclusionary medication given ,|2|||
163079838|NCT03464461|589001197|FG002|Overall Study|exclusionary medication given ,|0|||
163079839|NCT03464461|589001195|FG000|Overall Study|Physician Decision|0|||
163079840|NCT03464461|589001196|FG001|Overall Study|Physician Decision|1|||
163079841|NCT03464461|589001197|FG002|Overall Study|Physician Decision|0|||
163079842|NCT05524948|589001198|FG000|Overall Study|Withdrawal by Subject|1|||
163079843|NCT05524948|589001199|FG001|Overall Study|Withdrawal by Subject|0|||
163079844|NCT05524948|589001198|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
163079845|NCT05524948|589001199|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
163079846|NCT03460704|589001202|FG000|Overall Study|Withdrawal by Subject|11|||
163079847|NCT03460704|589001203|FG001|Overall Study|Withdrawal by Subject|14|||
163079848|NCT03460704|589001202|FG000|Overall Study|Study terminated by the Sponsor|29|||
163079849|NCT03460704|589001203|FG001|Overall Study|Study terminated by the Sponsor|19|||
163079850|NCT03460704|589001202|FG000|Overall Study|Adverse Event|10|||
163079851|NCT03460704|589001203|FG001|Overall Study|Adverse Event|5|||
163079852|NCT03460704|589001202|FG000|Overall Study|Death|3|||
163079853|NCT03460704|589001203|FG001|Overall Study|Death|2|||
163079854|NCT03460704|589001202|FG000|Overall Study|Non-Compliance with Study Drug|3|||
163079855|NCT03460704|589001203|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163079856|NCT03460704|589001202|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163079857|NCT03460704|589001203|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
163079858|NCT03460704|589001202|FG000|Overall Study|Other|2|||
163079859|NCT03460704|589001203|FG001|Overall Study|Other|1|||
163079860|NCT02913326|589001204|FG000|Overall Study|Reason not listed|0|||
163079861|NCT02913326|589001205|FG001|Overall Study|Reason not listed|1|||
163079862|NCT02913326|589001204|FG000|Overall Study|Lost to Follow-up|0|||
163079863|NCT02913326|589001205|FG001|Overall Study|Lost to Follow-up|1|||
163079864|NCT02913326|589001204|FG000|Overall Study|Adverse Event|1|||
163079865|NCT02913326|589001205|FG001|Overall Study|Adverse Event|0|||
163079866|NCT01767857|589001206|FG000|Overall Study|Adverse Event|27|||
163079867|NCT01767857|589001207|FG001|Overall Study|Adverse Event|7|||
163079868|NCT01767857|589001206|FG000|Overall Study|Death|28|||
163079869|NCT01767857|589001207|FG001|Overall Study|Death|13|||
163079870|NCT01767857|589001206|FG000|Overall Study|Lack of Efficacy|299|||
163079871|NCT01767857|589001207|FG001|Overall Study|Lack of Efficacy|151|||
163079872|NCT01767857|589001206|FG000|Overall Study|Lost to Follow-up|1|||
163079873|NCT01767857|589001207|FG001|Overall Study|Lost to Follow-up|1|||
163079874|NCT01767857|589001206|FG000|Overall Study|Withdrawal by Subject|38|||
163079875|NCT01767857|589001207|FG001|Overall Study|Withdrawal by Subject|18|||
163079876|NCT01767857|589001206|FG000|Overall Study|Physician Decision|17|||
163079877|NCT01767857|589001207|FG001|Overall Study|Physician Decision|10|||
163079878|NCT01767857|589001206|FG000|Overall Study|Protocol Terminated|1|||
163079879|NCT01767857|589001207|FG001|Overall Study|Protocol Terminated|0|||
163079880|NCT01767857|589001206|FG000|Overall Study|Randomized But Never Treated|19|||
163079881|NCT01767857|589001207|FG001|Overall Study|Randomized But Never Treated|13|||
163079882|NCT01421459|589001208|FG000|Overall Study|Adverse Event|6|||
163079883|NCT01421459|589001209|FG001|Overall Study|Adverse Event|10|||
163079884|NCT01421459|589001208|FG000|Overall Study|Death|1|||
163079885|NCT01421459|589001209|FG001|Overall Study|Death|1|||
163079886|NCT01421459|589001208|FG000|Overall Study|Lack of Efficacy|1|||
163079887|NCT01421459|589001209|FG001|Overall Study|Lack of Efficacy|2|||
163079888|NCT01421459|589001208|FG000|Overall Study|Lost to Follow-up|8|||
163079889|NCT01421459|589001209|FG001|Overall Study|Lost to Follow-up|9|||
163079890|NCT01421459|589001208|FG000|Overall Study|Physician Decision|9|||
163079891|NCT01421459|589001209|FG001|Overall Study|Physician Decision|9|||
163079892|NCT01421459|589001208|FG000|Overall Study|Protocol Violation|8|||
163079893|NCT01421459|589001209|FG001|Overall Study|Protocol Violation|5|||
163079894|NCT01421459|589001208|FG000|Overall Study|Withdrawal by Subject|12|||
163079895|NCT01421459|589001209|FG001|Overall Study|Withdrawal by Subject|16|||
163079896|NCT01422382|589001210|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
163079897|NCT00967499|589001211|FG000|Overall Study|Adverse Event|0|||
163079898|NCT00967499|589001212|FG001|Overall Study|Adverse Event|1|||
163079899|NCT00967499|589001211|FG000|Overall Study|Protocol Violation|1|||
163079900|NCT00967499|589001212|FG001|Overall Study|Protocol Violation|0|||
163079901|NCT00967499|589001211|FG000|Overall Study|Sponsor Decision|1|||
163079902|NCT00967499|589001212|FG001|Overall Study|Sponsor Decision|0|||
163079903|NCT00967499|589001211|FG000|Overall Study|Randomized but not treated|63|||
163079904|NCT00967499|589001212|FG001|Overall Study|Randomized but not treated|59|||
163079905|NCT02899754|589001213|FG000|Overall Study|Lost to Follow-up|7|||
163079906|NCT02899754|589001214|FG001|Overall Study|Lost to Follow-up|9|||
163079907|NCT04818229|589001215|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
163079908|NCT04818229|589001216|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
163079909|NCT04818229|589001217|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
163079910|NCT04818229|589001215|FG000|Overall Study|Adverse Event|3|||
163079911|NCT04818229|589001216|FG001|Overall Study|Adverse Event|1|||
163079912|NCT04818229|589001217|FG002|Overall Study|Adverse Event|1|||
163079913|NCT04818229|589001215|FG000|Overall Study|Withdrawal by Subject|0|||
163079914|NCT04818229|589001216|FG001|Overall Study|Withdrawal by Subject|0|||
163079915|NCT04818229|589001217|FG002|Overall Study|Withdrawal by Subject|2|||
163079916|NCT04818229|589001215|FG000|Overall Study|Lost to Follow-up|0|||
163079917|NCT04818229|589001216|FG001|Overall Study|Lost to Follow-up|0|||
163079918|NCT04818229|589001217|FG002|Overall Study|Lost to Follow-up|1|||
163079919|NCT04082364|589001218|FG000|Overall Study|Death|23|||
163079920|NCT04082364|589001219|FG001|Overall Study|Death|1|||
163079921|NCT04082364|589001220|FG002|Overall Study|Death|1|||
163079922|NCT04082364|589001221|FG003|Overall Study|Death|2|||
163079923|NCT04082364|589001222|FG004|Overall Study|Death|1|||
163079924|NCT04082364|589001218|FG000|Overall Study|Lost to Follow-up|1|||
163079925|NCT04082364|589001219|FG001|Overall Study|Lost to Follow-up|0|||
163079926|NCT04082364|589001220|FG002|Overall Study|Lost to Follow-up|0|||
163079927|NCT04082364|589001221|FG003|Overall Study|Lost to Follow-up|0|||
163079928|NCT04082364|589001222|FG004|Overall Study|Lost to Follow-up|1|||
163079929|NCT04082364|589001218|FG000|Overall Study|Physician Decision|1|||
163079930|NCT04082364|589001219|FG001|Overall Study|Physician Decision|1|||
163079931|NCT04082364|589001220|FG002|Overall Study|Physician Decision|0|||
163079932|NCT04082364|589001221|FG003|Overall Study|Physician Decision|2|||
163079933|NCT04082364|589001222|FG004|Overall Study|Physician Decision|1|||
163079934|NCT04082364|589001218|FG000|Overall Study|Withdrawal by Subject|1|||
163079935|NCT04082364|589001219|FG001|Overall Study|Withdrawal by Subject|1|||
163079936|NCT04082364|589001220|FG002|Overall Study|Withdrawal by Subject|0|||
163079937|NCT04082364|589001221|FG003|Overall Study|Withdrawal by Subject|0|||
163079938|NCT04082364|589001222|FG004|Overall Study|Withdrawal by Subject|1|||
163079939|NCT04082364|589001218|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
163079940|NCT04082364|589001219|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
163079941|NCT04082364|589001220|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
163079942|NCT04082364|589001221|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
163079943|NCT04082364|589001222|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
163079944|NCT04082364|589001218|FG000|Overall Study|Disease progression|0|||
163079945|NCT04082364|589001219|FG001|Overall Study|Disease progression|0|||
163079946|NCT04082364|589001220|FG002|Overall Study|Disease progression|0|||
163079947|NCT04082364|589001221|FG003|Overall Study|Disease progression|1|||
163332246|NCT03737110|589927593|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
163332247|NCT03737110|589927594|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
163079948|NCT04082364|589001222|FG004|Overall Study|Disease progression|0|||
163079949|NCT03186378|589001223|FG000|Overall Study|Lost to Follow-up|1|||
163079950|NCT03186378|589001224|FG001|Overall Study|Lost to Follow-up|0|||
163079951|NCT03247673|589001226|FG000|Overall Study|Withdrawal by Subject|1|||
163079952|NCT03247673|589001227|FG001|Overall Study|Withdrawal by Subject|0|||
163079953|NCT03247673|589001228|FG002|Overall Study|Withdrawal by Subject|3|||
163079954|NCT03247673|589001226|FG000|Overall Study|Lost to Follow-up|0|||
163332248|NCT03737110|589927589|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
163079955|NCT03247673|589001227|FG001|Overall Study|Lost to Follow-up|0|||
163079956|NCT03247673|589001228|FG002|Overall Study|Lost to Follow-up|1|||
163079957|NCT02971137|589001233|FG000|Overall Study|Lost to Follow-up|44|||
163079958|NCT02971137|589001234|FG001|Overall Study|Lost to Follow-up|56|||
163079959|NCT00215657|589001238|FG000|Overall Study|Adverse Event|5|||
163079960|NCT00215657|589001239|FG001|Overall Study|Adverse Event|1|||
163079961|NCT00215657|589001240|FG002|Overall Study|Adverse Event|3|||
163079962|NCT00215657|589001241|FG003|Overall Study|Adverse Event|0|||
163079963|NCT00215657|589001242|FG004|Overall Study|Adverse Event|3|||
163079964|NCT00215657|589001243|FG005|Overall Study|Adverse Event|1|||
163079965|NCT00215657|589001244|FG006|Overall Study|Adverse Event|0|||
163079966|NCT00215657|589001245|FG007|Overall Study|Adverse Event|3|||
163079967|NCT00215657|589001238|FG000|Overall Study|Withdrawal by Subject|6|||
163079968|NCT00215657|589001239|FG001|Overall Study|Withdrawal by Subject|3|||
163079969|NCT00215657|589001240|FG002|Overall Study|Withdrawal by Subject|3|||
163079970|NCT00215657|589001241|FG003|Overall Study|Withdrawal by Subject|1|||
163079971|NCT00215657|589001242|FG004|Overall Study|Withdrawal by Subject|6|||
163079972|NCT00215657|589001243|FG005|Overall Study|Withdrawal by Subject|1|||
163079973|NCT00215657|589001244|FG006|Overall Study|Withdrawal by Subject|10|||
163079974|NCT00215657|589001245|FG007|Overall Study|Withdrawal by Subject|3|||
163079975|NCT00215657|589001238|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
163079976|NCT00215657|589001239|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
163079977|NCT00215657|589001240|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
163079978|NCT00215657|589001241|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
163079979|NCT00215657|589001242|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
163079980|NCT00215657|589001243|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
163079981|NCT00215657|589001244|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
163079982|NCT00215657|589001245|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
163079983|NCT00215657|589001238|FG000|Overall Study|Insufficient testosterone response|5|||
163079984|NCT00215657|589001239|FG001|Overall Study|Insufficient testosterone response|4|||
163079985|NCT00215657|589001240|FG002|Overall Study|Insufficient testosterone response|1|||
163079986|NCT00215657|589001241|FG003|Overall Study|Insufficient testosterone response|12|||
163079987|NCT00215657|589001242|FG004|Overall Study|Insufficient testosterone response|8|||
163079988|NCT00215657|589001243|FG005|Overall Study|Insufficient testosterone response|12|||
163079989|NCT00215657|589001244|FG006|Overall Study|Insufficient testosterone response|4|||
163079990|NCT00215657|589001245|FG007|Overall Study|Insufficient testosterone response|7|||
163219058|NCT04254978|589519351|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
163219059|NCT04254978|589519351|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
163219060|NCT04254978|589519351|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
163219061|NCT04254978|589519351|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
163219062|NCT02449239|589519352|FG000|Induction Phase|Lack of Efficacy|64|||
163219063|NCT02449239|589519352|FG000|Induction Phase|Adverse Event|1|||
163219064|NCT02449239|589519352|FG000|Induction Phase|Lost to Follow-up|1|||
163219065|NCT02449239|589519352|FG000|Induction Phase|Protocol Violation|1|||
163219066|NCT02449239|589519352|FG000|Induction Phase|Physician Decision|1|||
163219067|NCT02449239|589519352|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
163219068|NCT02449239|589519352|FG000|Induction Phase|Withdrawal by Subject|1|||
163219069|NCT02449239|589519352|FG000|Maintenance Month 3|Lack of Efficacy|14|||
163219070|NCT02449239|589519352|FG000|Maintenance Month 6|Lack of Efficacy|10|||
163219071|NCT02449239|589519352|FG000|Maintenance Month 6|Adverse Event|2|||
163219072|NCT02449239|589519352|FG000|Maintenance Month 6|Physician Decision|1|||
163219073|NCT02449239|589519352|FG000|Maintenance Month 9|Lack of Efficacy|2|||
163219074|NCT02449239|589519352|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
163219075|NCT02449239|589519352|FG000|Maintenance Month 12|Lack of Efficacy|5|||
163079991|NCT00215657|589001238|FG000|Overall Study|Other|3|||
163079992|NCT00215657|589001239|FG001|Overall Study|Other|1|||
163079993|NCT00215657|589001240|FG002|Overall Study|Other|2|||
163079994|NCT00215657|589001241|FG003|Overall Study|Other|3|||
163079995|NCT00215657|589001242|FG004|Overall Study|Other|5|||
163079996|NCT00215657|589001243|FG005|Overall Study|Other|4|||
163079997|NCT00215657|589001244|FG006|Overall Study|Other|6|||
163079998|NCT00215657|589001245|FG007|Overall Study|Other|1|||
163079999|NCT04755231|589001246|FG000|Overall Study|Lost to Follow-up|5|||
163080000|NCT04755231|589001246|FG000|Overall Study|Withdrawal by Subject|5|||
163080001|NCT04754399|589001247|FG000|Overall Study|Adverse Event|5|||
163080002|NCT04754399|589001247|FG000|Overall Study|Withdrawal by Subject|6|||
163080003|NCT05259722|589001250|FG000|Overall Study|Adverse Event|2|||
163080004|NCT05259722|589001251|FG001|Overall Study|Adverse Event|24|||
163080005|NCT05259722|589001250|FG000|Overall Study|Lost to Follow-up|5|||
163080006|NCT05259722|589001251|FG001|Overall Study|Lost to Follow-up|1|||
163080007|NCT05259722|589001250|FG000|Overall Study|Lack of Efficacy|8|||
163219076|NCT02449239|589519352|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
163219077|NCT02449239|589519352|FG000|Maintenance Month 12|Subject moved from area|1|||
163219078|NCT02449239|589519352|FG000|Maintenance Month 15|Lack of Efficacy|1|||
163219079|NCT02449239|589519352|FG000|Maintenance Month 21|Lack of Efficacy|1|||
163219080|NCT02449239|589519352|FG000|Maintenance Month 21|Sponsor decision|1|||
163219081|NCT03257631|589519353|FG000|Overall Study|Death|1|||
163080008|NCT05259722|589001251|FG001|Overall Study|Lack of Efficacy|26|||
163080009|NCT05259722|589001250|FG000|Overall Study|Withdrawal by Subject|15|||
163219082|NCT03257631|589519354|FG001|Overall Study|Death|0|||
163219083|NCT03257631|589519355|FG002|Overall Study|Death|1|||
163219084|NCT03257631|589519356|FG003|Overall Study|Death|1|||
163219085|NCT03257631|589519353|FG000|Overall Study|Progressive Disease|10|||
163332249|NCT03737110|589927590|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
163080010|NCT05259722|589001251|FG001|Overall Study|Withdrawal by Subject|33|||
163080011|NCT05259722|589001250|FG000|Overall Study|Various reasons|3|||
163080012|NCT05259722|589001251|FG001|Overall Study|Various reasons|9|||
163080013|NCT05259722|589001250|FG000|Overall Study|Not exposed to IMP|1|||
163080014|NCT05259722|589001251|FG001|Overall Study|Not exposed to IMP|12|||
163080015|NCT05259722|589001250|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
163080016|NCT05259722|589001251|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
163080017|NCT00962650|589001252|FG000|Overall Study|Transgastric DP was not completed|2|||
163080018|NCT00231465|589001253|FG000|Overall Study|Completed only one cycle|1|||
163080019|NCT00231465|589001253|FG000|Overall Study|Did not have follow up CT scans|1|||
163080020|NCT00420056|589001254|FG000|Overall Study|Objective progression or relapse|17|||
163080021|NCT03111732|589001260|FG000|Overall Study|Enrolled in different study|1|||
163080022|NCT03111732|589001260|FG000|Overall Study|Progressive disease|3|||
163080023|NCT03111732|589001260|FG000|Overall Study|Withdrawal by Subject|1|||
163080024|NCT03072875|589001261|FG000|Overall Study|Lost to Follow-up|1|||
163080025|NCT01684033|589001264|FG000|Period 1, First 30 Days|Adverse Event|1|||
163080026|NCT01684033|589001265|FG001|Period 1, First 30 Days|Adverse Event|1|||
163080027|NCT01684033|589001264|FG000|Period 1, First 30 Days|Noncompliance|1|||
163080028|NCT01684033|589001265|FG001|Period 1, First 30 Days|Noncompliance|0|||
163219086|NCT03257631|589519354|FG001|Overall Study|Progressive Disease|9|||
163219087|NCT03257631|589519355|FG002|Overall Study|Progressive Disease|17|||
163219088|NCT03257631|589519356|FG003|Overall Study|Progressive Disease|8|||
163219089|NCT03257631|589519353|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163219090|NCT03257631|589519354|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163219091|NCT03257631|589519355|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
163219092|NCT03257631|589519356|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
163219093|NCT03257631|589519353|FG000|Overall Study|Adverse Event|0|||
163219094|NCT03257631|589519354|FG001|Overall Study|Adverse Event|0|||
163219095|NCT03257631|589519355|FG002|Overall Study|Adverse Event|2|||
163219096|NCT03257631|589519356|FG003|Overall Study|Adverse Event|0|||
163219097|NCT03509675|589519360|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
163219098|NCT03509675|589519361|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
163219099|NCT03509675|589519360|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
163219100|NCT03509675|589519361|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
163219101|NCT03509675|589519360|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
163219102|NCT03509675|589519361|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
163219103|NCT03509675|589519360|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
163219104|NCT03509675|589519361|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
163219105|NCT00277212|589519362|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
163219106|NCT00277212|589519363|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
163219107|NCT00277212|589519364|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
163219108|NCT00277212|589519362|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
163219109|NCT00277212|589519363|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
163219110|NCT00277212|589519364|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
163219111|NCT00277212|589519362|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
163219112|NCT00277212|589519363|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
163219113|NCT00277212|589519364|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
163219114|NCT00277212|589519362|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
163219115|NCT00277212|589519363|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
163219116|NCT00277212|589519364|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
163219117|NCT00277212|589519362|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
163219118|NCT00277212|589519363|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
163219119|NCT00277212|589519364|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
163219120|NCT00277212|589519362|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
163219121|NCT00277212|589519363|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
163219122|NCT00277212|589519364|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
163219123|NCT00277212|589519362|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
163219124|NCT00277212|589519363|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
163219125|NCT00277212|589519364|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
163219126|NCT00277212|589519362|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
163219127|NCT00277212|589519363|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
163219128|NCT00277212|589519364|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
163080029|NCT01684033|589001264|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
163080030|NCT01684033|589001265|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
163219129|NCT00277212|589519362|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
163219130|NCT00277212|589519363|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
163219131|NCT00277212|589519364|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
163219132|NCT00277212|589519362|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
163080031|NCT01684033|589001264|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
163080032|NCT01684033|589001265|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
163080033|NCT01684033|589001264|FG000|Period 2, Second 30 Days|Adverse Event|1|||
163080034|NCT01684033|589001265|FG001|Period 2, Second 30 Days|Adverse Event|0|||
163219133|NCT00277212|589519363|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
163219134|NCT00277212|589519364|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
163219135|NCT00277212|589519362|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
163219136|NCT00277212|589519363|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
163219137|NCT00277212|589519364|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
163219138|NCT00277212|589519362|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
163219139|NCT00277212|589519363|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
163219140|NCT00277212|589519364|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
163219141|NCT00277212|589519362|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
163219142|NCT00277212|589519363|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
163219143|NCT00277212|589519364|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
163219144|NCT00277212|589519362|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
163219145|NCT00277212|589519363|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
163219146|NCT00277212|589519364|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
163219147|NCT00277212|589519362|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
163219148|NCT00277212|589519363|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
163219149|NCT00277212|589519364|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
163219150|NCT00277212|589519362|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
163219151|NCT00277212|589519363|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
163219152|NCT00277212|589519364|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
163219153|NCT00277212|589519362|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
163219154|NCT00277212|589519363|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
163219155|NCT00277212|589519364|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
163219156|NCT00277212|589519362|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
163219157|NCT00277212|589519363|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
163219158|NCT00277212|589519364|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
163219159|NCT03336216|589519367|FG000|Randomization|Not reported|2|||
163219160|NCT03336216|589519368|FG001|Randomization|Not reported|0|||
163219161|NCT03336216|589519369|FG002|Randomization|Not reported|1|||
163219162|NCT03336216|589519370|FG003|Randomization|Not reported|0|||
163219163|NCT03336216|589519367|FG000|Randomization|Other reasons|1|||
163219164|NCT03336216|589519368|FG001|Randomization|Other reasons|1|||
163219165|NCT03336216|589519369|FG002|Randomization|Other reasons|1|||
163219166|NCT03336216|589519370|FG003|Randomization|Other reasons|0|||
163219167|NCT03336216|589519367|FG000|Randomization|Participant no longer meets study criteria|0|||
163219168|NCT03336216|589519368|FG001|Randomization|Participant no longer meets study criteria|2|||
163219169|NCT03336216|589519369|FG002|Randomization|Participant no longer meets study criteria|4|||
163219170|NCT03336216|589519370|FG003|Randomization|Participant no longer meets study criteria|1|||
163219171|NCT03336216|589519367|FG000|Randomization|Lost to Follow-up|1|||
163219172|NCT03336216|589519368|FG001|Randomization|Lost to Follow-up|0|||
163080035|NCT03726879|589001266|FG000|Overall Study|Death|11|||
163080036|NCT03726879|589001267|FG001|Overall Study|Death|13|||
163080037|NCT03726879|589001266|FG000|Overall Study|Physician Decision|0|||
163080038|NCT03726879|589001267|FG001|Overall Study|Physician Decision|2|||
163080039|NCT03726879|589001266|FG000|Overall Study|Protocol Violation|0|||
163080040|NCT03726879|589001267|FG001|Overall Study|Protocol Violation|1|||
163080041|NCT03726879|589001266|FG000|Overall Study|Withdrawal by Subject|5|||
163080042|NCT03726879|589001267|FG001|Overall Study|Withdrawal by Subject|6|||
163080043|NCT03726879|589001266|FG000|Overall Study|TSH result is unstable|0|||
163080044|NCT03726879|589001267|FG001|Overall Study|TSH result is unstable|1|||
163080045|NCT03726879|589001266|FG000|Overall Study|Disease relapse|1|||
163080046|NCT03726879|589001267|FG001|Overall Study|Disease relapse|0|||
163080047|NCT03726879|589001266|FG000|Overall Study|Lost to Follow-up|3|||
163080048|NCT03726879|589001267|FG001|Overall Study|Lost to Follow-up|0|||
163080049|NCT02496156|589001268|FG000|Overall Study|Lost to Follow-up|5|||
163080050|NCT02496156|589001269|FG001|Overall Study|Lost to Follow-up|0|||
163080051|NCT02496156|589001268|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
163080052|NCT02496156|589001269|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
163080053|NCT00507507|589001270|FG000|Treatment Period|Lost to Follow-up|0|||
163080054|NCT00507507|589001271|FG001|Treatment Period|Lost to Follow-up|2|||
163219173|NCT03336216|589519369|FG002|Randomization|Lost to Follow-up|0|||
163219174|NCT03336216|589519370|FG003|Randomization|Lost to Follow-up|0|||
163219175|NCT03336216|589519367|FG000|Randomization|Participant withdrew consent|9|||
163332250|NCT03737110|589927591|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
163080055|NCT00507507|589001270|FG000|Treatment Period|Physician Decision|4|||
163080056|NCT00507507|589001271|FG001|Treatment Period|Physician Decision|1|||
163080057|NCT00507507|589001270|FG000|Treatment Period|Protocol Violation|1|||
163080058|NCT00507507|589001271|FG001|Treatment Period|Protocol Violation|2|||
163332251|NCT03737110|589927592|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
163080059|NCT00507507|589001270|FG000|Treatment Period|Adverse Event|1|||
163080060|NCT00507507|589001271|FG001|Treatment Period|Adverse Event|1|||
163080061|NCT00507507|589001270|FG000|Treatment Period|Withdrawal by Subject|46|||
163080062|NCT00507507|589001271|FG001|Treatment Period|Withdrawal by Subject|47|||
163080063|NCT00507507|589001270|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
163080064|NCT00507507|589001271|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
163080065|NCT00507507|589001270|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
163080066|NCT00507507|589001271|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
163080067|NCT00507507|589001270|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
163080068|NCT00507507|589001271|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
163080069|NCT00289900|589001272|FG000|Overall Study|Adverse Event|28|||
163080070|NCT00289900|589001273|FG001|Overall Study|Adverse Event|40|||
163080071|NCT00289900|589001274|FG002|Overall Study|Adverse Event|13|||
163080072|NCT00289900|589001275|FG003|Overall Study|Adverse Event|19|||
163080073|NCT00289900|589001276|FG004|Overall Study|Adverse Event|20|||
163219176|NCT03336216|589519368|FG001|Randomization|Participant withdrew consent|1|||
163219177|NCT03336216|589519369|FG002|Randomization|Participant withdrew consent|0|||
163219178|NCT03336216|589519370|FG003|Randomization|Participant withdrew consent|0|||
163219179|NCT03336216|589519367|FG000|Randomization|Adverse Event|1|||
163219180|NCT03336216|589519368|FG001|Randomization|Adverse Event|1|||
163219181|NCT03336216|589519369|FG002|Randomization|Adverse Event|0|||
163219182|NCT03336216|589519370|FG003|Randomization|Adverse Event|0|||
163219183|NCT03336216|589519367|FG000|Treatment|Adverse Event|2|||
163219184|NCT03336216|589519368|FG001|Treatment|Adverse Event|3|||
163219185|NCT03336216|589519369|FG002|Treatment|Adverse Event|4|||
163219186|NCT03336216|589519370|FG003|Treatment|Adverse Event|4|||
163219187|NCT03336216|589519367|FG000|Treatment|Participant request to discontinue treatment|2|||
163219188|NCT03336216|589519368|FG001|Treatment|Participant request to discontinue treatment|1|||
163219189|NCT03336216|589519369|FG002|Treatment|Participant request to discontinue treatment|2|||
163219190|NCT03336216|589519370|FG003|Treatment|Participant request to discontinue treatment|2|||
163219191|NCT03336216|589519367|FG000|Treatment|Participant withdrew consent|7|||
163219192|NCT03336216|589519368|FG001|Treatment|Participant withdrew consent|2|||
163219193|NCT03336216|589519369|FG002|Treatment|Participant withdrew consent|3|||
163219194|NCT03336216|589519370|FG003|Treatment|Participant withdrew consent|2|||
163332252|NCT03737110|589927593|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
163332253|NCT03737110|589927594|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
163332254|NCT03737110|589927589|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
163332255|NCT03737110|589927590|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
163332256|NCT03737110|589927591|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
163332257|NCT03737110|589927592|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
163332258|NCT03737110|589927593|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
163029675|NCT00033657|588811864|FG000|Adjuvant Chemotherapy|Other|0|||
163029676|NCT00033657|588811865|FG001|Adjuvant Chemotherapy|Other|2|||
163029677|NCT03235115|588811867|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
163029678|NCT03235115|588811868|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
163029679|NCT03235115|588811869|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
163029680|NCT03235115|588811870|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
163029681|NCT03235115|588811871|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
163029682|NCT03235115|588811872|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
163029683|NCT00503997|588811874|FG000|Overall Study|disease progression|1|||
163029684|NCT00503997|588811874|FG000|Overall Study|Adverse Event|5|||
163029685|NCT00503997|588811874|FG000|Overall Study|Death|1|||
163029686|NCT00503997|588811874|FG000|Overall Study|Withdrawal by Subject|1|||
163029687|NCT01162122|588811879|FG000|Overall Study|Withdrawal by Subject|52|||
163029688|NCT01162122|588811880|FG001|Overall Study|Withdrawal by Subject|43|||
163029689|NCT01162122|588811879|FG000|Overall Study|Lost to Follow-up|73|||
163029690|NCT01162122|588811880|FG001|Overall Study|Lost to Follow-up|91|||
163029691|NCT01162122|588811879|FG000|Overall Study|Adverse Event|3|||
163029692|NCT01162122|588811880|FG001|Overall Study|Adverse Event|2|||
163029693|NCT01162122|588811879|FG000|Overall Study|Death|51|||
163029694|NCT01162122|588811880|FG001|Overall Study|Death|46|||
163029695|NCT01162122|588811879|FG000|Overall Study|Protocol Violation|2|||
163029696|NCT01162122|588811880|FG001|Overall Study|Protocol Violation|2|||
163029697|NCT01162122|588811879|FG000|Overall Study|Inappropriate enrollment|5|||
163080074|NCT00289900|589001277|FG005|Overall Study|Adverse Event|33|||
163080075|NCT00289900|589001272|FG000|Overall Study|Lost to Follow-up|7|||
163219195|NCT03336216|589519367|FG000|Treatment|Death|2|||
163219196|NCT03336216|589519368|FG001|Treatment|Death|3|||
163219197|NCT03336216|589519369|FG002|Treatment|Death|3|||
163219198|NCT03336216|589519370|FG003|Treatment|Death|4|||
163219199|NCT03336216|589519367|FG000|Treatment|Participant no longer meets study criteria|0|||
163029698|NCT01162122|588811880|FG001|Overall Study|Inappropriate enrollment|4|||
163029699|NCT01162122|588811879|FG000|Overall Study|Administrative reason|1|||
163029700|NCT01162122|588811880|FG001|Overall Study|Administrative reason|1|||
163029701|NCT01162122|588811879|FG000|Overall Study|Unable to classify|3|||
163080076|NCT00289900|589001273|FG001|Overall Study|Lost to Follow-up|7|||
163029702|NCT01162122|588811880|FG001|Overall Study|Unable to classify|7|||
163029703|NCT01162122|588811879|FG000|Overall Study|Missing primary reason|1|||
163219200|NCT03336216|589519368|FG001|Treatment|Participant no longer meets study criteria|1|||
163219201|NCT03336216|589519369|FG002|Treatment|Participant no longer meets study criteria|0|||
163219202|NCT03336216|589519370|FG003|Treatment|Participant no longer meets study criteria|0|||
163219203|NCT03336216|589519367|FG000|Treatment|Other reasons|2|||
163219204|NCT03336216|589519368|FG001|Treatment|Other reasons|0|||
163219205|NCT03336216|589519369|FG002|Treatment|Other reasons|0|||
163219206|NCT03336216|589519370|FG003|Treatment|Other reasons|3|||
163219207|NCT03336216|589519367|FG000|Treatment|Disease progression|23|||
163219208|NCT03336216|589519368|FG001|Treatment|Disease progression|34|||
163219209|NCT03336216|589519369|FG002|Treatment|Disease progression|33|||
163219210|NCT03336216|589519370|FG003|Treatment|Disease progression|26|||
163219211|NCT03336216|589519367|FG000|Treatment|Study drug toxicity|0|||
163219212|NCT03336216|589519368|FG001|Treatment|Study drug toxicity|3|||
163219213|NCT03336216|589519369|FG002|Treatment|Study drug toxicity|2|||
163219214|NCT03336216|589519370|FG003|Treatment|Study drug toxicity|0|||
163219215|NCT03336216|589519367|FG000|Treatment|Adverse Event unrelated to study drug|1|||
163219216|NCT03336216|589519368|FG001|Treatment|Adverse Event unrelated to study drug|1|||
163219217|NCT03336216|589519369|FG002|Treatment|Adverse Event unrelated to study drug|1|||
163219218|NCT03336216|589519370|FG003|Treatment|Adverse Event unrelated to study drug|0|||
163219219|NCT03336216|589519367|FG000|Treatment|Disease Recurrence|1|||
163219220|NCT03336216|589519368|FG001|Treatment|Disease Recurrence|0|||
163219221|NCT03336216|589519369|FG002|Treatment|Disease Recurrence|0|||
163219222|NCT03336216|589519370|FG003|Treatment|Disease Recurrence|0|||
163219223|NCT03239470|589519373|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
163219224|NCT03239470|589519374|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
163219225|NCT01023581|589519375|FG000|Overall Study|Adverse Event|4|||
163219226|NCT01023581|589519376|FG001|Overall Study|Adverse Event|4|||
163219227|NCT01023581|589519377|FG002|Overall Study|Adverse Event|7|||
163219228|NCT01023581|589519378|FG003|Overall Study|Adverse Event|3|||
163219229|NCT01023581|589519379|FG004|Overall Study|Adverse Event|2|||
163219230|NCT01023581|589519380|FG005|Overall Study|Adverse Event|5|||
163219231|NCT01023581|589519381|FG006|Overall Study|Adverse Event|11|||
163219232|NCT01023581|589519375|FG000|Overall Study|Major protocol deviation|2|||
163219233|NCT01023581|589519376|FG001|Overall Study|Major protocol deviation|0|||
163219234|NCT01023581|589519377|FG002|Overall Study|Major protocol deviation|3|||
163219235|NCT01023581|589519378|FG003|Overall Study|Major protocol deviation|0|||
163219236|NCT01023581|589519379|FG004|Overall Study|Major protocol deviation|0|||
163219237|NCT01023581|589519380|FG005|Overall Study|Major protocol deviation|0|||
163080077|NCT00289900|589001274|FG002|Overall Study|Lost to Follow-up|8|||
163080078|NCT00289900|589001275|FG003|Overall Study|Lost to Follow-up|8|||
163080079|NCT00289900|589001276|FG004|Overall Study|Lost to Follow-up|4|||
163080080|NCT00289900|589001277|FG005|Overall Study|Lost to Follow-up|8|||
163080081|NCT00289900|589001272|FG000|Overall Study|Participant had flushing|18|||
163080082|NCT00289900|589001273|FG001|Overall Study|Participant had flushing|42|||
163080083|NCT00289900|589001274|FG002|Overall Study|Participant had flushing|1|||
163080084|NCT00289900|589001275|FG003|Overall Study|Participant had flushing|2|||
163080085|NCT00289900|589001276|FG004|Overall Study|Participant had flushing|0|||
163080086|NCT00289900|589001277|FG005|Overall Study|Participant had flushing|4|||
163080087|NCT00289900|589001272|FG000|Overall Study|Other|0|||
163080088|NCT00289900|589001273|FG001|Overall Study|Other|0|||
163080089|NCT00289900|589001274|FG002|Overall Study|Other|0|||
163080090|NCT00289900|589001275|FG003|Overall Study|Other|5|||
163080091|NCT00289900|589001276|FG004|Overall Study|Other|1|||
163080092|NCT00289900|589001277|FG005|Overall Study|Other|0|||
163080093|NCT00289900|589001272|FG000|Overall Study|Participant moved|1|||
163080094|NCT00289900|589001273|FG001|Overall Study|Participant moved|0|||
163080095|NCT00289900|589001274|FG002|Overall Study|Participant moved|0|||
163080096|NCT00289900|589001275|FG003|Overall Study|Participant moved|1|||
163080097|NCT00289900|589001276|FG004|Overall Study|Participant moved|1|||
163080098|NCT00289900|589001277|FG005|Overall Study|Participant moved|1|||
163080099|NCT00289900|589001272|FG000|Overall Study|Withdrawal by Subject|10|||
163219238|NCT01023581|589519381|FG006|Overall Study|Major protocol deviation|0|||
163080100|NCT00289900|589001273|FG001|Overall Study|Withdrawal by Subject|21|||
163080101|NCT00289900|589001274|FG002|Overall Study|Withdrawal by Subject|8|||
163219239|NCT01023581|589519375|FG000|Overall Study|Lost to Follow-up|4|||
163080102|NCT00289900|589001275|FG003|Overall Study|Withdrawal by Subject|18|||
163219240|NCT01023581|589519376|FG001|Overall Study|Lost to Follow-up|8|||
163219241|NCT01023581|589519377|FG002|Overall Study|Lost to Follow-up|7|||
163219242|NCT01023581|589519378|FG003|Overall Study|Lost to Follow-up|2|||
163080103|NCT00289900|589001276|FG004|Overall Study|Withdrawal by Subject|12|||
163080104|NCT00289900|589001277|FG005|Overall Study|Withdrawal by Subject|11|||
163080105|NCT00289900|589001272|FG000|Overall Study|Protocol Violation|3|||
163080106|NCT00289900|589001273|FG001|Overall Study|Protocol Violation|9|||
163219243|NCT01023581|589519379|FG004|Overall Study|Lost to Follow-up|5|||
163219244|NCT01023581|589519380|FG005|Overall Study|Lost to Follow-up|2|||
163219245|NCT01023581|589519381|FG006|Overall Study|Lost to Follow-up|2|||
163080107|NCT00289900|589001274|FG002|Overall Study|Protocol Violation|2|||
163332259|NCT03737110|589927594|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
163332260|NCT03737110|589927589|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
163332261|NCT03737110|589927590|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
163332262|NCT03737110|589927591|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
163332263|NCT03737110|589927592|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
163332264|NCT03737110|589927593|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
163332265|NCT03737110|589927594|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
163332266|NCT03737110|589927589|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
163332267|NCT03737110|589927590|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
163332268|NCT03737110|589927591|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
163332269|NCT03737110|589927592|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
163332270|NCT03737110|589927593|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
163332271|NCT03737110|589927594|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
163332272|NCT00599196|589927599|FG000|Overall Study|Lack of Efficacy|22|||
163332273|NCT00599196|589927599|FG000|Overall Study|Adverse Event|93|||
163332274|NCT00599196|589927599|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
163332275|NCT00599196|589927599|FG000|Overall Study|Subject withdrew consent|43|||
163332276|NCT00599196|589927599|FG000|Overall Study|Study ended per sponsor|197|||
163332277|NCT00599196|589927599|FG000|Overall Study|Lost to Follow-up|17|||
163332278|NCT00599196|589927599|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
163332279|NCT00599196|589927599|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
163332280|NCT00599196|589927599|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
163332281|NCT00599196|589927599|FG000|Overall Study|Other: Pt Moved To Australia|1|||
163332282|NCT00599196|589927599|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
163332283|NCT00599196|589927599|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
163332284|NCT01009645|589927604|FG000|Overall Study|Lost to Follow-up|2|||
163332285|NCT01009645|589927605|FG001|Overall Study|Lost to Follow-up|8|||
163332286|NCT01009645|589927606|FG002|Overall Study|Lost to Follow-up|4|||
163332287|NCT01009645|589927607|FG003|Overall Study|Lost to Follow-up|5|||
163332288|NCT04237792|589927610|FG000|Treatment (Day 1)|Adverse Event|1|||
163332289|NCT04237792|589927611|FG001|Treatment (Day 1)|Adverse Event|0|||
163332290|NCT04237792|589927612|FG002|Treatment (Day 1)|Adverse Event|0|||
163332291|NCT04237792|589927613|FG003|Treatment (Day 1)|Adverse Event|0|||
163332292|NCT04237792|589927614|FG004|Treatment (Day 1)|Adverse Event|1|||
163332293|NCT04237792|589927615|FG005|Treatment (Day 1)|Adverse Event|1|||
163332294|NCT04237792|589927610|FG000|Treatment (Day 1)|Other|0|||
163332295|NCT04237792|589927611|FG001|Treatment (Day 1)|Other|0|||
163332296|NCT04237792|589927612|FG002|Treatment (Day 1)|Other|1|||
163332297|NCT04237792|589927613|FG003|Treatment (Day 1)|Other|0|||
163332298|NCT04237792|589927614|FG004|Treatment (Day 1)|Other|0|||
163332299|NCT04237792|589927615|FG005|Treatment (Day 1)|Other|1|||
163332300|NCT04237792|589927610|FG000|Treatment (Day 1)|Not treated|1|||
163332301|NCT04237792|589927611|FG001|Treatment (Day 1)|Not treated|1|||
163332302|NCT04237792|589927612|FG002|Treatment (Day 1)|Not treated|2|||
163332303|NCT04237792|589927613|FG003|Treatment (Day 1)|Not treated|1|||
163332304|NCT04237792|589927614|FG004|Treatment (Day 1)|Not treated|0|||
163332305|NCT04237792|589927615|FG005|Treatment (Day 1)|Not treated|1|||
163332306|NCT02788981|589927617|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
163332307|NCT02788981|589927618|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
163332308|NCT05553366|589927619|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
163332309|NCT05553366|589927620|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
163332310|NCT05553366|589927621|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
163332311|NCT05553366|589927619|FG000|Overall Study|Lost to Follow-up|3|||
163332312|NCT05553366|589927620|FG001|Overall Study|Lost to Follow-up|3|||
163332313|NCT05553366|589927621|FG002|Overall Study|Lost to Follow-up|3|||
163332314|NCT05553366|589927619|FG000|Overall Study|Other non-compliance|1|||
163332315|NCT05553366|589927620|FG001|Overall Study|Other non-compliance|1|||
163332316|NCT05553366|589927621|FG002|Overall Study|Other non-compliance|0|||
163332317|NCT05553366|589927619|FG000|Overall Study|Randomized but not dosed|0|||
163332318|NCT05553366|589927620|FG001|Overall Study|Randomized but not dosed|0|||
163332319|NCT05553366|589927621|FG002|Overall Study|Randomized but not dosed|2|||
163332320|NCT00249769|589927622|FG000|Overall Study|Withdrawal by Subject|1|||
163332321|NCT00249769|589927623|FG001|Overall Study|Withdrawal by Subject|10|||
163029704|NCT01162122|588811880|FG001|Overall Study|Missing primary reason|0|||
163029705|NCT02020512|588811881|FG000|Overall Study|Adverse Event|1|||
163029706|NCT02020512|588811881|FG000|Overall Study|Lost to Follow-up|3|||
163029707|NCT02020512|588811881|FG000|Overall Study|Protocol Violation|4|||
163029708|NCT00656851|588811884|FG000|Overall Study|Withdrawal by Subject|0|||
163029709|NCT00656851|588811885|FG001|Overall Study|Withdrawal by Subject|4|||
163029710|NCT00835679|588811887|FG000|Overall Study|Withdrawal by Subject|1|||
163029711|NCT00835679|588811888|FG001|Overall Study|Withdrawal by Subject|0|||
163029712|NCT00835679|588811889|FG002|Overall Study|Withdrawal by Subject|0|||
163080108|NCT00289900|589001275|FG003|Overall Study|Protocol Violation|6|||
163080109|NCT00289900|589001276|FG004|Overall Study|Protocol Violation|7|||
163080110|NCT00289900|589001277|FG005|Overall Study|Protocol Violation|4|||
163080111|NCT00289900|589001272|FG000|Overall Study|site terminated|1|||
163080112|NCT00289900|589001273|FG001|Overall Study|site terminated|0|||
163080113|NCT00289900|589001274|FG002|Overall Study|site terminated|1|||
163080114|NCT00289900|589001275|FG003|Overall Study|site terminated|0|||
163080115|NCT00289900|589001276|FG004|Overall Study|site terminated|0|||
163080116|NCT00289900|589001277|FG005|Overall Study|site terminated|0|||
163080117|NCT00289900|589001272|FG000|Overall Study|Not treated|0|||
163080118|NCT00289900|589001273|FG001|Overall Study|Not treated|1|||
163080119|NCT00289900|589001274|FG002|Overall Study|Not treated|0|||
163080120|NCT00289900|589001275|FG003|Overall Study|Not treated|0|||
163080121|NCT00289900|589001276|FG004|Overall Study|Not treated|0|||
163080122|NCT00289900|589001277|FG005|Overall Study|Not treated|0|||
163080123|NCT03249558|589001278|FG000|Overall Study|Lost to Follow-up|2|||
163080124|NCT03249558|589001279|FG001|Overall Study|Lost to Follow-up|1|||
163080125|NCT03249558|589001280|FG002|Overall Study|Lost to Follow-up|4|||
163080126|NCT03249558|589001278|FG000|Overall Study|Physician Decision|1|||
163080127|NCT03249558|589001279|FG001|Overall Study|Physician Decision|0|||
163080128|NCT03249558|589001280|FG002|Overall Study|Physician Decision|0|||
163080129|NCT03249558|589001278|FG000|Overall Study|Withdrawal by Subject|6|||
163080130|NCT03249558|589001279|FG001|Overall Study|Withdrawal by Subject|5|||
163080131|NCT03249558|589001280|FG002|Overall Study|Withdrawal by Subject|7|||
163080132|NCT03249558|589001278|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
163080133|NCT03249558|589001279|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
163080134|NCT03249558|589001280|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
163080135|NCT03249558|589001278|FG000|Overall Study|Protocol Violation|1|||
163080136|NCT03249558|589001279|FG001|Overall Study|Protocol Violation|1|||
163080137|NCT03249558|589001280|FG002|Overall Study|Protocol Violation|2|||
163080138|NCT02656173|589001281|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
163080139|NCT02656173|589001282|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
163080140|NCT02656173|589001281|FG000|Overall Study|Adverse Event|7|||
163080141|NCT02656173|589001282|FG001|Overall Study|Adverse Event|5|||
163080142|NCT02656173|589001281|FG000|Overall Study|Withdrawal by Subject|1|||
163080143|NCT02656173|589001282|FG001|Overall Study|Withdrawal by Subject|3|||
163080144|NCT02656173|589001281|FG000|Overall Study|Protocol Violation|0|||
163080145|NCT02656173|589001282|FG001|Overall Study|Protocol Violation|1|||
163080146|NCT02656173|589001281|FG000|Overall Study|Miscellaneous|2|||
163080147|NCT02656173|589001282|FG001|Overall Study|Miscellaneous|0|||
163080148|NCT03449147|589001284|FG000|52-week Treatment Period|Death|0|||
163080149|NCT03449147|589001285|FG001|52-week Treatment Period|Death|1|||
163080150|NCT03449147|589001286|FG002|52-week Treatment Period|Death|0|||
163080151|NCT03449147|589001284|FG000|52-week Treatment Period|Lost to Follow-up|6|||
163080152|NCT03449147|589001285|FG001|52-week Treatment Period|Lost to Follow-up|2|||
163080153|NCT03449147|589001286|FG002|52-week Treatment Period|Lost to Follow-up|5|||
163080154|NCT03449147|589001284|FG000|52-week Treatment Period|Other|0|||
163080155|NCT03449147|589001285|FG001|52-week Treatment Period|Other|1|||
163080156|NCT03449147|589001286|FG002|52-week Treatment Period|Other|2|||
163080157|NCT03449147|589001284|FG000|52-week Treatment Period|Physician Decision|1|||
163080158|NCT03449147|589001285|FG001|52-week Treatment Period|Physician Decision|0|||
163080159|NCT03449147|589001286|FG002|52-week Treatment Period|Physician Decision|3|||
163080160|NCT03449147|589001284|FG000|52-week Treatment Period|Screen Failure|1|||
163080161|NCT03449147|589001285|FG001|52-week Treatment Period|Screen Failure|2|||
163080162|NCT03449147|589001286|FG002|52-week Treatment Period|Screen Failure|0|||
163080163|NCT03449147|589001284|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
163080164|NCT03449147|589001285|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
163080165|NCT03449147|589001286|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
163080166|NCT03449147|589001284|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
163080167|NCT03449147|589001285|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
163080168|NCT03449147|589001286|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
163080169|NCT03449147|589001284|FG000|12-Week Off-Treatment Durability Period|Other|0|||
163080170|NCT03449147|589001285|FG001|12-Week Off-Treatment Durability Period|Other|1|||
163219246|NCT01023581|589519375|FG000|Overall Study|Withdrawal by Subject|13|||
163219247|NCT01023581|589519376|FG001|Overall Study|Withdrawal by Subject|8|||
163080171|NCT03449147|589001286|FG002|12-Week Off-Treatment Durability Period|Other|0|||
163080172|NCT00954538|589001287|FG000|Part III|Withdrawal by Subject|0|||
163080173|NCT00954538|589001288|FG001|Part III|Withdrawal by Subject|0|||
163080174|NCT00954538|589001289|FG002|Part III|Withdrawal by Subject|0|||
163080175|NCT00954538|589001290|FG003|Part III|Withdrawal by Subject|0|||
163080176|NCT00954538|589001291|FG004|Part III|Withdrawal by Subject|1|||
163080177|NCT00954538|589001292|FG005|Part III|Withdrawal by Subject|0|||
163080178|NCT00974233|589001297|FG000|Induction Chemoimmunotherapy|Death|2|||
163080179|NCT00974233|589001297|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
163080180|NCT00974233|589001297|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
163080181|NCT00974233|589001297|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
163080182|NCT00974233|589001297|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
163029713|NCT00835679|588811890|FG003|Overall Study|Withdrawal by Subject|0|||
163029714|NCT00955968|588811891|FG000|Overall Study|Death|2|||
163029715|NCT00955968|588811892|FG001|Overall Study|Death|4|||
163029716|NCT00955968|588811891|FG000|Overall Study|Withdrawal by Subject|35|||
163029717|NCT00955968|588811892|FG001|Overall Study|Withdrawal by Subject|31|||
163029718|NCT00955968|588811891|FG000|Overall Study|Lost to Follow-up|45|||
163029719|NCT00955968|588811892|FG001|Overall Study|Lost to Follow-up|39|||
163029720|NCT00955968|588811891|FG000|Overall Study|Site closed|55|||
163029721|NCT00955968|588811892|FG001|Overall Study|Site closed|52|||
163029722|NCT05020899|588811893|FG000|8 Week Follow-up|Lost to Follow-up|3|||
163029723|NCT05020899|588811894|FG001|8 Week Follow-up|Lost to Follow-up|6|||
163029724|NCT05020899|588811893|FG000|12 Week Follow-up|Lost to Follow-up|1|||
163029725|NCT05020899|588811894|FG001|12 Week Follow-up|Lost to Follow-up|0|||
163029726|NCT05020899|588811893|FG000|12 Week Follow-up|Death|0|||
163029727|NCT05020899|588811894|FG001|12 Week Follow-up|Death|1|||
163029728|NCT01793688|588811899|FG000|Overall Study|Protocol Violation|2|||
163029729|NCT01419080|588811900|FG000|Overall Study|Withdrawal by Subject|75|||
163029730|NCT01419080|588811900|FG000|Overall Study|Death|30|||
163029731|NCT01419080|588811900|FG000|Overall Study|Lost to Follow-up|23|||
163029732|NCT01419080|588811900|FG000|Overall Study|Too Ill|3|||
163029733|NCT00474045|588811907|FG000|Overall Study|Adverse Event|18|||
163029734|NCT00474045|588811908|FG001|Overall Study|Adverse Event|8|||
163029735|NCT00474045|588811907|FG000|Overall Study|Unclassified|1|||
163029736|NCT00474045|588811908|FG001|Overall Study|Unclassified|3|||
163029737|NCT00474045|588811907|FG000|Overall Study|Lack of Efficacy|0|||
163029738|NCT00474045|588811908|FG001|Overall Study|Lack of Efficacy|9|||
163029739|NCT00474045|588811907|FG000|Overall Study|Lost to Follow-up|1|||
163029740|NCT00474045|588811908|FG001|Overall Study|Lost to Follow-up|1|||
163029741|NCT00474045|588811907|FG000|Overall Study|Protocol Violation|10|||
163029742|NCT00474045|588811908|FG001|Overall Study|Protocol Violation|12|||
163029743|NCT00474045|588811907|FG000|Overall Study|Withdrawal by Subject|16|||
163029744|NCT00474045|588811908|FG001|Overall Study|Withdrawal by Subject|18|||
163029745|NCT00474045|588811907|FG000|Overall Study|Withdrawal criteria|60|||
163029746|NCT00474045|588811908|FG001|Overall Study|Withdrawal criteria|50|||
163029747|NCT02135107|588811909|FG000|Treatment Period|Withdrawal by Subject|11|||
163029748|NCT02135107|588811910|FG001|Treatment Period|Withdrawal by Subject|0|||
163029749|NCT02135107|588811911|FG002|Treatment Period|Withdrawal by Subject|0|||
163029750|NCT02135107|588811912|FG003|Treatment Period|Withdrawal by Subject|0|||
163029751|NCT02135107|588811909|FG000|Treatment Period|Adverse Event|5|||
163029752|NCT02135107|588811910|FG001|Treatment Period|Adverse Event|2|||
163029753|NCT02135107|588811911|FG002|Treatment Period|Adverse Event|0|||
163029754|NCT02135107|588811912|FG003|Treatment Period|Adverse Event|0|||
163029755|NCT02135107|588811909|FG000|Treatment Period|Pregnancy|1|||
163029756|NCT02135107|588811910|FG001|Treatment Period|Pregnancy|0|||
163029757|NCT02135107|588811911|FG002|Treatment Period|Pregnancy|0|||
163029758|NCT02135107|588811912|FG003|Treatment Period|Pregnancy|0|||
163029759|NCT02135107|588811909|FG000|Treatment Period|Other|115|||
163029760|NCT02135107|588811910|FG001|Treatment Period|Other|24|||
163029761|NCT02135107|588811911|FG002|Treatment Period|Other|0|||
163029762|NCT02135107|588811912|FG003|Treatment Period|Other|0|||
163029763|NCT02135107|588811909|FG000|Maintenance Therapy Period|Adverse Event|0|||
163029764|NCT02135107|588811910|FG001|Maintenance Therapy Period|Adverse Event|0|||
163029765|NCT02135107|588811911|FG002|Maintenance Therapy Period|Adverse Event|3|||
163029766|NCT02135107|588811912|FG003|Maintenance Therapy Period|Adverse Event|7|||
163029767|NCT02135107|588811909|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
163029768|NCT02135107|588811910|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
163029769|NCT02135107|588811911|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
163029770|NCT02135107|588811912|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
163029771|NCT02135107|588811909|FG000|Maintenance Therapy Period|Pregnancy|0|||
163029772|NCT02135107|588811910|FG001|Maintenance Therapy Period|Pregnancy|0|||
163332322|NCT00249769|589927624|FG002|Overall Study|Withdrawal by Subject|6|||
163029773|NCT02135107|588811911|FG002|Maintenance Therapy Period|Pregnancy|0|||
163029774|NCT02135107|588811912|FG003|Maintenance Therapy Period|Pregnancy|1|||
163029775|NCT02135107|588811909|FG000|Maintenance Therapy Period|Other|0|||
163029776|NCT02135107|588811910|FG001|Maintenance Therapy Period|Other|0|||
163029777|NCT02135107|588811911|FG002|Maintenance Therapy Period|Other|7|||
163029778|NCT02135107|588811912|FG003|Maintenance Therapy Period|Other|8|||
163029779|NCT02278120|588811915|FG000|Treatment Period|Progressive disease|234|||
163029780|NCT02278120|588811916|FG001|Treatment Period|Progressive disease|260|||
163029781|NCT02278120|588811915|FG000|Treatment Period|Subject/guardian decision|23|||
163029782|NCT02278120|588811916|FG001|Treatment Period|Subject/guardian decision|20|||
163029783|NCT02278120|588811915|FG000|Treatment Period|Adverse Event|16|||
163029784|NCT02278120|588811916|FG001|Treatment Period|Adverse Event|14|||
163029785|NCT02278120|588811915|FG000|Treatment Period|Physician Decision|14|||
163029786|NCT02278120|588811916|FG001|Treatment Period|Physician Decision|27|||
163029787|NCT02278120|588811915|FG000|Treatment Period|Death|3|||
163029788|NCT02278120|588811916|FG001|Treatment Period|Death|3|||
163029789|NCT02278120|588811915|FG000|Treatment Period|Lost to Follow-up|2|||
163029790|NCT02278120|588811916|FG001|Treatment Period|Lost to Follow-up|0|||
163332323|NCT00249769|589927622|FG000|Overall Study|Migration from Study Area|1|||
163080183|NCT00974233|589001297|FG000|Maintenance Lenalidomide|Adverse Event|8|||
163080184|NCT05520333|589002744|FG000|Overall Study|Lost to Follow-up|3|||
163080185|NCT05520333|589002745|FG001|Overall Study|Lost to Follow-up|6|||
163080186|NCT02904265|589002748|FG000|Overall Study|Physician Decision|1|||
163080187|NCT02904265|589002749|FG001|Overall Study|Physician Decision|2|||
163080188|NCT00185614|589002754|FG000|Inter-treatment Period|Physician Decision|1|||
163080189|NCT00185614|589002754|FG000|Inter-treatment Period|Relapse|2|||
163080190|NCT00185614|589002754|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
163080191|NCT01034657|589002763|FG000|Core Phase|Withdrawal by Subject|1|||
163080192|NCT01034657|589002764|FG001|Core Phase|Withdrawal by Subject|0|||
163080193|NCT01034657|589002765|FG002|Core Phase|Withdrawal by Subject|0|||
163080194|NCT01034657|589002763|FG000|Core Phase|Lack of Efficacy|2|||
163080195|NCT01034657|589002764|FG001|Core Phase|Lack of Efficacy|0|||
163080196|NCT01034657|589002765|FG002|Core Phase|Lack of Efficacy|0|||
163080197|NCT01034657|589002763|FG000|Core Phase|Abnormal laboratory value|1|||
163080198|NCT01034657|589002764|FG001|Core Phase|Abnormal laboratory value|0|||
163080199|NCT01034657|589002765|FG002|Core Phase|Abnormal laboratory value|0|||
163080200|NCT01034657|589002763|FG000|Core Phase|Adverse Event|8|||
163080201|NCT01034657|589002764|FG001|Core Phase|Adverse Event|0|||
163080202|NCT01034657|589002765|FG002|Core Phase|Adverse Event|0|||
163080203|NCT01034657|589002763|FG000|Core Phase|Protocol Violation|2|||
163080204|NCT01034657|589002764|FG001|Core Phase|Protocol Violation|0|||
163080205|NCT01034657|589002765|FG002|Core Phase|Protocol Violation|0|||
163080206|NCT01034657|589002763|FG000|Randomized Phase|Withdrawal by Subject|0|||
163080207|NCT01034657|589002764|FG001|Randomized Phase|Withdrawal by Subject|2|||
163080208|NCT01034657|589002765|FG002|Randomized Phase|Withdrawal by Subject|0|||
163080209|NCT01034657|589002763|FG000|Randomized Phase|Lack of Efficacy|5|||
163080210|NCT01034657|589002764|FG001|Randomized Phase|Lack of Efficacy|1|||
163080211|NCT01034657|589002765|FG002|Randomized Phase|Lack of Efficacy|0|||
163080212|NCT01034657|589002763|FG000|Randomized Phase|Abnormal laboratory value|0|||
163080213|NCT01034657|589002764|FG001|Randomized Phase|Abnormal laboratory value|1|||
163080214|NCT01034657|589002765|FG002|Randomized Phase|Abnormal laboratory value|0|||
163080215|NCT01034657|589002763|FG000|Randomized Phase|Adverse Event|0|||
163080216|NCT01034657|589002764|FG001|Randomized Phase|Adverse Event|2|||
163080217|NCT01034657|589002765|FG002|Randomized Phase|Adverse Event|1|||
163080218|NCT01517178|589002766|FG000|Period 1|Adverse Event|1|||
163080219|NCT01517178|589002767|FG001|Period 1|Adverse Event|2|||
163080220|NCT01517178|589002766|FG000|Period 1|Lack of Efficacy|0|||
163080221|NCT01517178|589002767|FG001|Period 1|Lack of Efficacy|1|||
163080222|NCT01517178|589002766|FG000|Period 1|E.g. study termination|3|||
163080223|NCT01517178|589002767|FG001|Period 1|E.g. study termination|1|||
163080224|NCT01517178|589002766|FG000|Period 1|Withdrawal by Subject|0|||
163080225|NCT01517178|589002767|FG001|Period 1|Withdrawal by Subject|1|||
163080226|NCT01517178|589002766|FG000|Period 2|Adverse Event|1|||
163080227|NCT01517178|589002767|FG001|Period 2|Adverse Event|0|||
163080228|NCT01517178|589002766|FG000|Period 2|Withdrawal by Subject|3|||
163080229|NCT01517178|589002767|FG001|Period 2|Withdrawal by Subject|0|||
163080230|NCT01517178|589002766|FG000|Period 2|E.g. study termination|2|||
163080231|NCT01517178|589002767|FG001|Period 2|E.g. study termination|2|||
163080232|NCT01225952|589002781|FG000|Overall Study|Lost to Follow-up|1|||
163080233|NCT01225952|589002782|FG001|Overall Study|Lost to Follow-up|0|||
163080234|NCT01225952|589002783|FG002|Overall Study|Lost to Follow-up|0|||
163080235|NCT01225952|589002781|FG000|Overall Study|Study Eye Explanted|0|||
163080236|NCT01225952|589002782|FG001|Overall Study|Study Eye Explanted|0|||
163080237|NCT01225952|589002783|FG002|Overall Study|Study Eye Explanted|1|||
163332324|NCT00249769|589927623|FG001|Overall Study|Migration from Study Area|3|||
163332325|NCT00249769|589927624|FG002|Overall Study|Migration from Study Area|14|||
163332326|NCT00249769|589927622|FG000|Overall Study|Miscellaneous|0|||
163332327|NCT00249769|589927623|FG001|Overall Study|Miscellaneous|2|||
163332328|NCT00249769|589927624|FG002|Overall Study|Miscellaneous|2|||
163332329|NCT00249769|589927622|FG000|Overall Study|Adverse Event|0|||
163332330|NCT00249769|589927623|FG001|Overall Study|Adverse Event|0|||
163332331|NCT00249769|589927624|FG002|Overall Study|Adverse Event|1|||
163080238|NCT01225952|589002781|FG000|Overall Study|Withdrawal by Subject|4|||
163080239|NCT01225952|589002782|FG001|Overall Study|Withdrawal by Subject|4|||
163080240|NCT01225952|589002783|FG002|Overall Study|Withdrawal by Subject|5|||
163080241|NCT01225952|589002781|FG000|Overall Study|Surgical complications|1|||
163080242|NCT01225952|589002782|FG001|Overall Study|Surgical complications|0|||
163080243|NCT01225952|589002783|FG002|Overall Study|Surgical complications|0|||
163080244|NCT00889005|589002784|FG000|Overall Study|Lost to Follow-up|4|||
163080245|NCT00889005|589002785|FG001|Overall Study|Lost to Follow-up|2|||
163080246|NCT00889005|589002784|FG000|Overall Study|Withdrawal by Subject|4|||
163080247|NCT00889005|589002785|FG001|Overall Study|Withdrawal by Subject|0|||
163080248|NCT01998477|589002788|FG000|Overall Study|Lost to Follow-up|4|||
163080249|NCT01998477|589002789|FG001|Overall Study|Lost to Follow-up|5|||
163080250|NCT01998477|589002788|FG000|Overall Study|Withdrawal by Subject|6|||
163080251|NCT01998477|589002789|FG001|Overall Study|Withdrawal by Subject|0|||
163080252|NCT00129974|589002790|FG000|Overall Study|Other|1|||
163332332|NCT00249769|589927622|FG000|Overall Study|Physician Decision|0|||
163080253|NCT05122143|589002791|FG000|Overall Study|Adverse Event|1|||
163080254|NCT05122143|589002792|FG001|Overall Study|Adverse Event|0|||
163080255|NCT05122143|589002793|FG002|Overall Study|Adverse Event|0|||
163080256|NCT05122143|589002794|FG003|Overall Study|Adverse Event|0|||
163080257|NCT05122143|589002795|FG004|Overall Study|Adverse Event|1|||
163080258|NCT05122143|589002796|FG005|Overall Study|Adverse Event|0|||
163080259|NCT05122143|589002791|FG000|Overall Study|Protocol non-compliance|0|||
163080260|NCT05122143|589002792|FG001|Overall Study|Protocol non-compliance|0|||
163080261|NCT05122143|589002793|FG002|Overall Study|Protocol non-compliance|1|||
163080262|NCT05122143|589002794|FG003|Overall Study|Protocol non-compliance|0|||
163080263|NCT05122143|589002795|FG004|Overall Study|Protocol non-compliance|0|||
163080264|NCT05122143|589002796|FG005|Overall Study|Protocol non-compliance|0|||
163080265|NCT05122143|589002791|FG000|Overall Study|Covid contact|0|||
163080266|NCT05122143|589002792|FG001|Overall Study|Covid contact|0|||
163080267|NCT05122143|589002793|FG002|Overall Study|Covid contact|0|||
163080268|NCT05122143|589002794|FG003|Overall Study|Covid contact|0|||
163080269|NCT05122143|589002795|FG004|Overall Study|Covid contact|1|||
163080270|NCT05122143|589002796|FG005|Overall Study|Covid contact|0|||
163080271|NCT00692237|589002797|FG000|Overall Study|Withdrawal by Subject|1|||
163080272|NCT00692237|589002798|FG001|Overall Study|Withdrawal by Subject|3|||
163080273|NCT00692237|589002797|FG000|Overall Study|Adverse Event|0|||
163080274|NCT00692237|589002798|FG001|Overall Study|Adverse Event|1|||
163080275|NCT00395447|589002799|FG000|Overall Study|Death|37|||
163080276|NCT00395447|589002800|FG001|Overall Study|Death|32|||
163080277|NCT00395447|589002799|FG000|Overall Study|Lost to Follow-up|52|||
163080278|NCT00395447|589002800|FG001|Overall Study|Lost to Follow-up|43|||
163080279|NCT00395447|589002799|FG000|Overall Study|Withdrawal by Subject|24|||
163080280|NCT00395447|589002800|FG001|Overall Study|Withdrawal by Subject|19|||
163080281|NCT00395447|589002799|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
163080282|NCT00395447|589002800|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
163080283|NCT03766906|589002801|FG000|Overall Study|Withdrawal by Subject|6|||
163219248|NCT01023581|589519377|FG002|Overall Study|Withdrawal by Subject|16|||
163219249|NCT01023581|589519378|FG003|Overall Study|Withdrawal by Subject|10|||
163219250|NCT01023581|589519379|FG004|Overall Study|Withdrawal by Subject|6|||
163219251|NCT01023581|589519380|FG005|Overall Study|Withdrawal by Subject|8|||
163219252|NCT01023581|589519381|FG006|Overall Study|Withdrawal by Subject|5|||
163219253|NCT01023581|589519375|FG000|Overall Study|Pregnancy|0|||
163219254|NCT01023581|589519376|FG001|Overall Study|Pregnancy|0|||
163219255|NCT01023581|589519377|FG002|Overall Study|Pregnancy|0|||
163219256|NCT01023581|589519378|FG003|Overall Study|Pregnancy|2|||
163219257|NCT01023581|589519379|FG004|Overall Study|Pregnancy|0|||
163080284|NCT00836901|589002802|FG000|First Intervention|Withdrawal by Subject|1|||
163080285|NCT00836901|589002803|FG001|First Intervention|Withdrawal by Subject|0|||
163080286|NCT01047540|589002806|FG000|Overall Study|Protocol Violation|1|||
163080287|NCT01047540|589002807|FG001|Overall Study|Protocol Violation|0|||
163080288|NCT01047540|589002808|FG002|Overall Study|Protocol Violation|0|||
163080289|NCT01047540|589002809|FG003|Overall Study|Protocol Violation|0|||
163080290|NCT01047540|589002810|FG004|Overall Study|Protocol Violation|0|||
163080291|NCT01047540|589002806|FG000|Overall Study|Lost to Follow-up|1|||
163080292|NCT01047540|589002807|FG001|Overall Study|Lost to Follow-up|0|||
163080293|NCT01047540|589002808|FG002|Overall Study|Lost to Follow-up|0|||
163080294|NCT01047540|589002809|FG003|Overall Study|Lost to Follow-up|0|||
163080295|NCT01047540|589002810|FG004|Overall Study|Lost to Follow-up|0|||
163080296|NCT01047540|589002806|FG000|Overall Study|Withdrawal by Subject|1|||
163080297|NCT01047540|589002807|FG001|Overall Study|Withdrawal by Subject|0|||
163080298|NCT01047540|589002808|FG002|Overall Study|Withdrawal by Subject|3|||
163080299|NCT01047540|589002809|FG003|Overall Study|Withdrawal by Subject|0|||
163080300|NCT01047540|589002810|FG004|Overall Study|Withdrawal by Subject|1|||
163080301|NCT01047540|589002806|FG000|Overall Study|Pregnancy|1|||
163080302|NCT01047540|589002807|FG001|Overall Study|Pregnancy|0|||
163080303|NCT01047540|589002808|FG002|Overall Study|Pregnancy|0|||
163080304|NCT01047540|589002809|FG003|Overall Study|Pregnancy|0|||
163219258|NCT01023581|589519380|FG005|Overall Study|Pregnancy|1|||
163219259|NCT01023581|589519381|FG006|Overall Study|Pregnancy|0|||
163219260|NCT01023581|589519375|FG000|Overall Study|Lack of Efficacy|9|||
163219261|NCT01023581|589519376|FG001|Overall Study|Lack of Efficacy|3|||
163219262|NCT01023581|589519377|FG002|Overall Study|Lack of Efficacy|6|||
163080305|NCT01047540|589002810|FG004|Overall Study|Pregnancy|0|||
163080306|NCT01047540|589002806|FG000|Overall Study|Adverse Event|1|||
163080307|NCT01047540|589002807|FG001|Overall Study|Adverse Event|0|||
163080308|NCT01047540|589002808|FG002|Overall Study|Adverse Event|0|||
163080309|NCT01047540|589002809|FG003|Overall Study|Adverse Event|0|||
163080310|NCT01047540|589002810|FG004|Overall Study|Adverse Event|0|||
163080311|NCT03032484|589002816|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
163080312|NCT03032484|589002817|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
163080313|NCT03032484|589002816|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
163080314|NCT03032484|589002817|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
163080315|NCT00595075|589002824|FG000|Overall Study|Withdrawal by Subject|1|||
163219263|NCT01023581|589519378|FG003|Overall Study|Lack of Efficacy|2|||
163080316|NCT00595075|589002825|FG001|Overall Study|Withdrawal by Subject|0|||
163080317|NCT05261490|589002827|FG000|Overall Study|Other|1|||
163080318|NCT05261490|589002828|FG001|Overall Study|Other|0|||
163080319|NCT05261490|589002829|FG002|Overall Study|Other|0|||
163080320|NCT05261490|589002827|FG000|Overall Study|Study Terminated by Sponsor|1|||
163080321|NCT05261490|589002828|FG001|Overall Study|Study Terminated by Sponsor|1|||
163080322|NCT05261490|589002829|FG002|Overall Study|Study Terminated by Sponsor|4|||
163080323|NCT05261490|589002827|FG000|Overall Study|Death|1|||
163080324|NCT05261490|589002828|FG001|Overall Study|Death|2|||
163080325|NCT05261490|589002829|FG002|Overall Study|Death|0|||
163080326|NCT01335685|589002833|FG000|Overall Study|Study Terminated by Sponsor|2|||
163080327|NCT01335685|589002834|FG001|Overall Study|Study Terminated by Sponsor|1|||
163080328|NCT01335685|589002835|FG002|Overall Study|Study Terminated by Sponsor|1|||
163080329|NCT01335685|589002836|FG003|Overall Study|Study Terminated by Sponsor|10|||
163080330|NCT01335685|589002837|FG004|Overall Study|Study Terminated by Sponsor|0|||
163080331|NCT01335685|589002838|FG005|Overall Study|Study Terminated by Sponsor|4|||
163080332|NCT01335685|589002839|FG006|Overall Study|Study Terminated by Sponsor|2|||
163080333|NCT01335685|589002840|FG007|Overall Study|Study Terminated by Sponsor|3|||
163080334|NCT01335685|589002833|FG000|Overall Study|Withdrawal by Subject|1|||
163080335|NCT01335685|589002834|FG001|Overall Study|Withdrawal by Subject|0|||
163080336|NCT01335685|589002835|FG002|Overall Study|Withdrawal by Subject|0|||
163080337|NCT01335685|589002836|FG003|Overall Study|Withdrawal by Subject|1|||
163080338|NCT01335685|589002837|FG004|Overall Study|Withdrawal by Subject|0|||
163080339|NCT01335685|589002838|FG005|Overall Study|Withdrawal by Subject|0|||
163080340|NCT01335685|589002839|FG006|Overall Study|Withdrawal by Subject|0|||
163080341|NCT01335685|589002840|FG007|Overall Study|Withdrawal by Subject|0|||
163080342|NCT01335685|589002833|FG000|Overall Study|Reason not Specified|0|||
163080343|NCT01335685|589002834|FG001|Overall Study|Reason not Specified|0|||
163080344|NCT01335685|589002835|FG002|Overall Study|Reason not Specified|1|||
163080345|NCT01335685|589002836|FG003|Overall Study|Reason not Specified|0|||
163080346|NCT01335685|589002837|FG004|Overall Study|Reason not Specified|0|||
163080347|NCT01335685|589002838|FG005|Overall Study|Reason not Specified|1|||
163080348|NCT01335685|589002839|FG006|Overall Study|Reason not Specified|0|||
163080349|NCT01335685|589002840|FG007|Overall Study|Reason not Specified|0|||
163080350|NCT02554474|589002841|FG000|Overall Study|Protocol Violation|1|||
163080351|NCT02554474|589002842|FG001|Overall Study|Protocol Violation|1|||
163080352|NCT02554474|589002841|FG000|Overall Study|Health issue not related to the study|1|||
163080353|NCT02554474|589002842|FG001|Overall Study|Health issue not related to the study|0|||
163080354|NCT02554474|589002841|FG000|Overall Study|Withdrawal by Subject|1|||
163080355|NCT02554474|589002842|FG001|Overall Study|Withdrawal by Subject|1|||
163080356|NCT03211832|589002845|FG000|Overall Study|No longer with agency|32|||
163080357|NCT03211832|589002846|FG001|Overall Study|No longer with agency|49|||
163080358|NCT03211832|589002847|FG002|Overall Study|No longer with agency|30|||
163080359|NCT03211832|589002845|FG000|Overall Study|Declined survey|3|||
163080360|NCT03211832|589002846|FG001|Overall Study|Declined survey|3|||
163080361|NCT03211832|589002847|FG002|Overall Study|Declined survey|2|||
163080362|NCT03211832|589002845|FG000|Overall Study|Not available during data collection|1|||
163080363|NCT03211832|589002846|FG001|Overall Study|Not available during data collection|0|||
163080364|NCT03211832|589002847|FG002|Overall Study|Not available during data collection|2|||
163080365|NCT03777020|589002851|FG000|Overall Study|Withdrawal by Subject|4|||
163080366|NCT03777020|589002852|FG001|Overall Study|Withdrawal by Subject|4|||
163080367|NCT03777020|589002851|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
163080368|NCT03777020|589002852|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
163080369|NCT00489476|589002853|FG000|Overall Study|Lost to Follow-up|0|||
163080370|NCT00489476|589002854|FG001|Overall Study|Lost to Follow-up|1|||
163080371|NCT00489476|589002855|FG002|Overall Study|Lost to Follow-up|0|||
163080372|NCT00489476|589002856|FG003|Overall Study|Lost to Follow-up|0|||
163080373|NCT04003389|589002859|FG000|Overall Study|Adverse Event|27|||
163080374|NCT04003389|589002860|FG001|Overall Study|Adverse Event|34|||
163219264|NCT01023581|589519379|FG004|Overall Study|Lack of Efficacy|1|||
163080375|NCT04003389|589002861|FG002|Overall Study|Adverse Event|28|||
163080376|NCT04003389|589002859|FG000|Overall Study|Lost to Follow-up|39|||
163080377|NCT04003389|589002860|FG001|Overall Study|Lost to Follow-up|30|||
163080378|NCT04003389|589002861|FG002|Overall Study|Lost to Follow-up|33|||
163080379|NCT04003389|589002859|FG000|Overall Study|Protocol Violation|1|||
163080380|NCT04003389|589002860|FG001|Overall Study|Protocol Violation|6|||
163080381|NCT04003389|589002861|FG002|Overall Study|Protocol Violation|5|||
163080382|NCT04003389|589002859|FG000|Overall Study|Withdrawal by Subject|119|||
163080383|NCT04003389|589002860|FG001|Overall Study|Withdrawal by Subject|79|||
163080384|NCT04003389|589002861|FG002|Overall Study|Withdrawal by Subject|85|||
163080385|NCT04003389|589002859|FG000|Overall Study|Miscellaneous|14|||
163080386|NCT04003389|589002860|FG001|Overall Study|Miscellaneous|11|||
163080387|NCT04003389|589002861|FG002|Overall Study|Miscellaneous|14|||
163219265|NCT01023581|589519380|FG005|Overall Study|Lack of Efficacy|2|||
163219266|NCT01023581|589519381|FG006|Overall Study|Lack of Efficacy|1|||
163219267|NCT01023581|589519375|FG000|Overall Study|Physician Decision|2|||
163219268|NCT01023581|589519376|FG001|Overall Study|Physician Decision|0|||
163080388|NCT04003389|589002859|FG000|Overall Study|Participant did not receive study drug|1|||
163080389|NCT04003389|589002860|FG001|Overall Study|Participant did not receive study drug|0|||
163080390|NCT04003389|589002861|FG002|Overall Study|Participant did not receive study drug|0|||
163080391|NCT02514746|589002866|FG000|Overall Study|Chronically Ill|1|||
163080392|NCT02514746|589002867|FG001|Overall Study|Chronically Ill|2|||
163080393|NCT02514746|589002866|FG000|Overall Study|Physician Decision|4|||
163080394|NCT02514746|589002867|FG001|Overall Study|Physician Decision|2|||
163080395|NCT02514746|589002866|FG000|Overall Study|Withdrawal by Subject|12|||
163080396|NCT02514746|589002867|FG001|Overall Study|Withdrawal by Subject|10|||
163080397|NCT02514746|589002866|FG000|Overall Study|Other|5|||
163080398|NCT02514746|589002867|FG001|Overall Study|Other|1|||
163080399|NCT04003142|589002871|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
163080400|NCT04003142|589002872|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
163080401|NCT04003142|589002873|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
163080402|NCT04003142|589002874|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
163080403|NCT04003142|589002875|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
163080404|NCT04003142|589002871|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
163080405|NCT04003142|589002872|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
163080406|NCT04003142|589002873|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
163080407|NCT04003142|589002874|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
163080408|NCT04003142|589002875|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
163080409|NCT04003142|589002871|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
163080410|NCT04003142|589002872|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
163080411|NCT04003142|589002873|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
163080412|NCT04003142|589002874|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
163080413|NCT04003142|589002875|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
163080414|NCT04003142|589002871|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
163080415|NCT04003142|589002872|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
163080416|NCT04003142|589002873|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
163080417|NCT04003142|589002874|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
163080418|NCT04003142|589002875|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
163080419|NCT04003142|589002871|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
163080420|NCT04003142|589002872|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
163080421|NCT04003142|589002873|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
163080422|NCT04003142|589002874|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
163080423|NCT04003142|589002875|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
163080424|NCT04003142|589002871|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
163080425|NCT04003142|589002872|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
163080426|NCT04003142|589002873|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
163080427|NCT04003142|589002874|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
163080428|NCT04003142|589002875|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
163080429|NCT04003142|589002871|FG000|Extension Period (40 Weeks)|Death|0|||
163080430|NCT04003142|589002872|FG001|Extension Period (40 Weeks)|Death|0|||
163080431|NCT04003142|589002873|FG002|Extension Period (40 Weeks)|Death|0|||
163080432|NCT04003142|589002874|FG003|Extension Period (40 Weeks)|Death|0|||
163080433|NCT04003142|589002875|FG004|Extension Period (40 Weeks)|Death|1|||
163080434|NCT04003142|589002871|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
163080435|NCT04003142|589002872|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
163080436|NCT04003142|589002873|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
163080437|NCT04003142|589002874|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
163080438|NCT04003142|589002875|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
163080439|NCT04003142|589002871|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
163080440|NCT04003142|589002872|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
163080441|NCT04003142|589002873|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
163080442|NCT04003142|589002874|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
163080443|NCT04003142|589002875|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
163080444|NCT04003142|589002871|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
163080445|NCT04003142|589002872|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
163080446|NCT04003142|589002873|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
163080447|NCT04003142|589002874|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
163080448|NCT04003142|589002875|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
163080449|NCT04003142|589002871|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
163080450|NCT04003142|589002872|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
163080451|NCT04003142|589002873|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
163080452|NCT04003142|589002874|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
163080453|NCT04003142|589002875|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
163080454|NCT04806373|589002876|FG000|Overall Study|Withdrawal by Subject|1|||
163080455|NCT04806373|589002877|FG001|Overall Study|Withdrawal by Subject|1|||
163080456|NCT03382873|589002878|FG000|Overall Study|Lost to Follow-up|9|||
163080457|NCT03382873|589002879|FG001|Overall Study|Lost to Follow-up|10|||
163080458|NCT03382873|589002878|FG000|Overall Study|Withdrawal by Subject|6|||
163080459|NCT03382873|589002879|FG001|Overall Study|Withdrawal by Subject|11|||
163219269|NCT01023581|589519377|FG002|Overall Study|Physician Decision|2|||
163080460|NCT03382873|589002878|FG000|Overall Study|Visit not completed due to pandemic|16|||
163080461|NCT03382873|589002879|FG001|Overall Study|Visit not completed due to pandemic|41|||
163080462|NCT03624036|589002880|FG000|Overall Study|Death|2|||
163080463|NCT03624036|589002881|FG001|Overall Study|Death|3|||
163080464|NCT03624036|589002882|FG002|Overall Study|Death|0|||
163080465|NCT03624036|589002883|FG003|Overall Study|Death|1|||
163080466|NCT03624036|589002880|FG000|Overall Study|Withdrawal by Subject|1|||
163080467|NCT03624036|589002881|FG001|Overall Study|Withdrawal by Subject|0|||
163080468|NCT03624036|589002882|FG002|Overall Study|Withdrawal by Subject|1|||
163080469|NCT03624036|589002883|FG003|Overall Study|Withdrawal by Subject|0|||
163080470|NCT03624036|589002880|FG000|Overall Study|Enrolled but Never Treated|1|||
163080471|NCT03624036|589002881|FG001|Overall Study|Enrolled but Never Treated|0|||
163080472|NCT03624036|589002882|FG002|Overall Study|Enrolled but Never Treated|0|||
163080473|NCT03624036|589002883|FG003|Overall Study|Enrolled but Never Treated|0|||
163080474|NCT03624036|589002880|FG000|Overall Study|Reason not Specified|3|||
163080475|NCT03624036|589002881|FG001|Overall Study|Reason not Specified|0|||
163080476|NCT03624036|589002882|FG002|Overall Study|Reason not Specified|2|||
163080477|NCT03624036|589002883|FG003|Overall Study|Reason not Specified|2|||
163080478|NCT01185366|589002892|FG000|First Line Therapy|Insurance Coverage Denied|1|||
163080479|NCT01185366|589002893|FG001|First Line Therapy|Insurance Coverage Denied|1|||
163080480|NCT01185366|589002892|FG000|First Line Therapy|Withdrawal by Subject|1|||
163080481|NCT01185366|589002893|FG001|First Line Therapy|Withdrawal by Subject|0|||
163080482|NCT01185366|589002892|FG000|First Line Therapy|Lack of Metastatic Site|1|||
163080483|NCT01185366|589002893|FG001|First Line Therapy|Lack of Metastatic Site|0|||
163080484|NCT01185366|589002892|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
163080485|NCT01185366|589002893|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
163080486|NCT01185366|589002892|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
163080487|NCT01185366|589002893|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
163080488|NCT01185366|589002892|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
163080489|NCT01185366|589002893|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
163080490|NCT01185366|589002892|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
163080491|NCT01185366|589002893|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
163080492|NCT02539394|589002898|FG000|Overall Study|Protocol Violation|1|||
163080493|NCT02539394|589002899|FG001|Overall Study|Protocol Violation|3|||
163080494|NCT02539394|589002898|FG000|Overall Study|Lost to Follow-up|1|||
163080495|NCT02539394|589002899|FG001|Overall Study|Lost to Follow-up|2|||
163080496|NCT02539394|589002898|FG000|Overall Study|Incomplete dataset|6|||
163080497|NCT02539394|589002899|FG001|Overall Study|Incomplete dataset|6|||
163080498|NCT03425188|589002901|FG000|Overall Study|Withdrawal by Subject|1|||
163080499|NCT00834587|589002907|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
163080500|NCT00834587|589002908|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
163080501|NCT01691092|589002909|FG000|Overall Study|Lost to Follow-up|10|||
163080502|NCT01691092|589002909|FG000|Overall Study|Physician Decision|4|||
163080503|NCT01691092|589002909|FG000|Overall Study|Withdrawal by Subject|3|||
163080504|NCT01691092|589002909|FG000|Overall Study|non-compliance|3|||
163080505|NCT01691092|589002909|FG000|Overall Study|used for different study|2|||
163080506|NCT01691092|589002909|FG000|Overall Study|screen fail|19|||
163219270|NCT01023581|589519378|FG003|Overall Study|Physician Decision|1|||
163219271|NCT01023581|589519379|FG004|Overall Study|Physician Decision|1|||
163219272|NCT01023581|589519380|FG005|Overall Study|Physician Decision|1|||
163219273|NCT01023581|589519381|FG006|Overall Study|Physician Decision|1|||
163219274|NCT01023581|589519375|FG000|Overall Study|Other|1|||
163219275|NCT01023581|589519376|FG001|Overall Study|Other|0|||
163219276|NCT01023581|589519377|FG002|Overall Study|Other|1|||
163219277|NCT01023581|589519378|FG003|Overall Study|Other|0|||
163219278|NCT01023581|589519379|FG004|Overall Study|Other|1|||
163219279|NCT01023581|589519380|FG005|Overall Study|Other|0|||
163219280|NCT01023581|589519381|FG006|Overall Study|Other|0|||
163219281|NCT00922766|589519382|FG000|Overall Study|Death|3|||
163219282|NCT00922766|589519382|FG000|Overall Study|Withdrawal by Subject|2|||
163219283|NCT00922766|589519382|FG000|Overall Study|Other|1|||
163219284|NCT00922766|589519382|FG000|Overall Study|Adverse Event|1|||
163219285|NCT02658890|589519391|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219286|NCT02658890|589519392|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219287|NCT02658890|589519393|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219288|NCT02658890|589519394|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219289|NCT02658890|589519395|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219290|NCT02658890|589519396|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219291|NCT02658890|589519397|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219292|NCT02658890|589519398|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219293|NCT02658890|589519399|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
163219294|NCT02658890|589519400|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219295|NCT02658890|589519401|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219296|NCT02658890|589519402|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163080507|NCT01657942|589002910|FG000|Overall Study|Alternative Treatment|7|||
163080508|NCT01657942|589002910|FG000|Overall Study|Lost to Follow-up|1|||
163080509|NCT00581100|589004131|FG000|Overall Study|Death|1|||
163080510|NCT00581100|589004132|FG001|Overall Study|Death|0|||
163080511|NCT00581100|589004131|FG000|Overall Study|Adverse Event|2|||
163080512|NCT00581100|589004132|FG001|Overall Study|Adverse Event|1|||
163080513|NCT00581100|589004131|FG000|Overall Study|Withdrawal by Subject|1|||
163080514|NCT00581100|589004132|FG001|Overall Study|Withdrawal by Subject|4|||
163080515|NCT00581100|589004131|FG000|Overall Study|Other|3|||
163080516|NCT00581100|589004132|FG001|Overall Study|Other|0|||
163080517|NCT04129398|589004133|FG000|Overall Study|Physician Decision|2|||
163080518|NCT00590317|589004134|FG000|Overall Study|Lack of Efficacy|1|||
163080519|NCT00590317|589004135|FG001|Overall Study|Lack of Efficacy|5|||
163080520|NCT00993473|589004139|FG000|Overall Study|Adverse Event|0|||
163080521|NCT00993473|589004140|FG001|Overall Study|Adverse Event|2|||
163080522|NCT00993473|589004139|FG000|Overall Study|Protocol Violation|1|||
163080523|NCT00993473|589004140|FG001|Overall Study|Protocol Violation|2|||
163080524|NCT00993473|589004139|FG000|Overall Study|Lost to Follow-up|1|||
163080525|NCT00993473|589004140|FG001|Overall Study|Lost to Follow-up|0|||
163080526|NCT00993473|589004139|FG000|Overall Study|Withdrawal by Subject|1|||
163080527|NCT00993473|589004140|FG001|Overall Study|Withdrawal by Subject|5|||
163080528|NCT00993473|589004139|FG000|Overall Study|Technical problem with CGM device|0|||
163080529|NCT00993473|589004140|FG001|Overall Study|Technical problem with CGM device|1|||
163080530|NCT00993473|589004139|FG000|Overall Study|Family event|1|||
163080531|NCT00993473|589004140|FG001|Overall Study|Family event|0|||
163080532|NCT00770679|589004149|FG000|Overall Study|Lost to Follow-up|3|||
163080533|NCT00770679|589004149|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
163080534|NCT00069953|589004152|FG000|Overall Study|Protocol Violation|2|||
163080535|NCT00113373|589004155|FG000|Overall Study|Ineligible: wrong primary|1|||
163080536|NCT00113373|589004155|FG000|Overall Study|Ineligible: second primary|1|||
163080537|NCT00113373|589004155|FG000|Overall Study|Never Treated|1|||
163080538|NCT02395627|589004156|FG000|Overall Study|Withdrawal by Subject|0|||
163080539|NCT02395627|589004157|FG001|Overall Study|Withdrawal by Subject|2|||
163080540|NCT02395627|589004158|FG002|Overall Study|Withdrawal by Subject|0|||
163080541|NCT02395627|589004156|FG000|Overall Study|Did not receive pembrolizumab|3|||
163080542|NCT02395627|589004157|FG001|Overall Study|Did not receive pembrolizumab|1|||
163080543|NCT02395627|589004158|FG002|Overall Study|Did not receive pembrolizumab|0|||
163080544|NCT03253627|589004159|FG000|Overall Study|Lost to Follow-up|1|||
163080545|NCT03253627|589004160|FG001|Overall Study|Lost to Follow-up|2|||
163080546|NCT03253627|589004159|FG000|Overall Study|Withdrawal by Subject|0|||
163080547|NCT03253627|589004160|FG001|Overall Study|Withdrawal by Subject|2|||
163080548|NCT03253627|589004159|FG000|Overall Study|Inability to complete MRI|1|||
163080549|NCT03253627|589004160|FG001|Overall Study|Inability to complete MRI|0|||
163080550|NCT04629521|589004167|FG000|Overall Study|Death|1|||
163080551|NCT04629521|589004167|FG000|Overall Study|Lost to Follow-up|3|||
163080552|NCT04629521|589004167|FG000|Overall Study|Subject withdrew consent|3|||
163080553|NCT04629521|589004167|FG000|Overall Study|Enrolled in error|1|||
163080554|NCT03163667|589004168|FG000|Overall Study|Death|15|||
163080555|NCT03163667|589004169|FG001|Overall Study|Death|27|||
163080556|NCT03163667|589004168|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
163080557|NCT03163667|589004169|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
163080558|NCT00979407|589004170|FG000|Overall Study|Withdrawal by Subject|3|||
163080559|NCT00979407|589004171|FG001|Overall Study|Withdrawal by Subject|4|||
163080560|NCT00979407|589004170|FG000|Overall Study|Lost to Follow-up|3|||
163080561|NCT00979407|589004171|FG001|Overall Study|Lost to Follow-up|3|||
163080562|NCT00855166|589004172|FG000|Overall Study|Adverse Event|0|||
163080563|NCT00855166|589004173|FG001|Overall Study|Adverse Event|2|||
163080564|NCT00855166|589004172|FG000|Overall Study|Death|0|||
163080565|NCT00855166|589004173|FG001|Overall Study|Death|1|||
163219297|NCT02658890|589519403|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219298|NCT02658890|589519404|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219299|NCT02658890|589519405|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219300|NCT02658890|589519406|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219301|NCT02658890|589519407|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219302|NCT02658890|589519408|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219303|NCT02658890|589519409|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219304|NCT02658890|589519410|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163080566|NCT00855166|589004172|FG000|Overall Study|Withdrawal by Subject|1|||
163219305|NCT02658890|589519411|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219306|NCT02658890|589519412|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219307|NCT02658890|589519413|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163080567|NCT00855166|589004173|FG001|Overall Study|Withdrawal by Subject|4|||
163080568|NCT00855166|589004172|FG000|Overall Study|Poor/non-compliance|2|||
163080569|NCT00855166|589004173|FG001|Overall Study|Poor/non-compliance|0|||
163080570|NCT00855166|589004172|FG000|Overall Study|Administrative reasons by sponsor|1|||
163080571|NCT00855166|589004173|FG001|Overall Study|Administrative reasons by sponsor|0|||
163080572|NCT00855166|589004172|FG000|Overall Study|Subject no longer meets study criteria|1|||
163080573|NCT00855166|589004173|FG001|Overall Study|Subject no longer meets study criteria|1|||
163080574|NCT02940223|589004174|FG000|Overall Study|Failed Requirement|2|||
163080575|NCT02940223|589004175|FG001|Overall Study|Failed Requirement|0|||
163080576|NCT03769116|589004179|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
163080577|NCT03769116|589004180|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
163080578|NCT03769116|589004179|FG000|Part 3 - Open Label|Physician Decision|1|||
163080579|NCT03769116|589004180|FG001|Part 3 - Open Label|Physician Decision|0|||
163080580|NCT03769116|589004179|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
163080581|NCT03769116|589004180|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
163080582|NCT05810597|589004182|FG000|Period 1|Adverse Event|2|||
163080583|NCT05810597|589004183|FG001|Period 1|Adverse Event|0|||
163080584|NCT05810597|589004182|FG000|Period 1|Physician Decision|1|||
163080585|NCT05810597|589004183|FG001|Period 1|Physician Decision|0|||
163080586|NCT01450631|589004184|FG000|Overall Study|Lost to Follow-up|2|||
163080587|NCT01450631|589004185|FG001|Overall Study|Lost to Follow-up|4|||
163080588|NCT01450631|589004184|FG000|Overall Study|Withdrawal by Subject|1|||
163080589|NCT01450631|589004185|FG001|Overall Study|Withdrawal by Subject|0|||
163080590|NCT04903093|589004191|FG000|Overall Study|Withdrawal by Subject|0|||
163080591|NCT04903093|589004192|FG001|Overall Study|Withdrawal by Subject|0|||
163080592|NCT04903093|589004193|FG002|Overall Study|Withdrawal by Subject|0|||
163080593|NCT04903093|589004194|FG003|Overall Study|Withdrawal by Subject|1|||
163080594|NCT04903093|589004195|FG004|Overall Study|Withdrawal by Subject|0|||
163080595|NCT04903093|589004196|FG005|Overall Study|Withdrawal by Subject|0|||
163080596|NCT01390584|589004209|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
163080597|NCT01390584|589004210|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
163080598|NCT01390584|589004211|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
163080599|NCT00025233|589004212|FG000|Overall Study|Ineligible: wrong cell type|1|||
163080600|NCT00025233|589004212|FG000|Overall Study|Ineligible: wrong primary|1|||
163080601|NCT00025233|589004212|FG000|Overall Study|Ineligible: improper prior treatment|1|||
163080602|NCT00025233|589004212|FG000|Overall Study|Never treated|1|||
163080603|NCT00401830|589004213|FG000|Overall Study|Adverse Event|10|||
163080604|NCT00401830|589004214|FG001|Overall Study|Adverse Event|18|||
163080605|NCT00401830|589004213|FG000|Overall Study|Lack of Efficacy|11|||
163080606|NCT00401830|589004214|FG001|Overall Study|Lack of Efficacy|5|||
163080607|NCT00401830|589004213|FG000|Overall Study|Withdrawal by Subject|4|||
163080608|NCT00401830|589004214|FG001|Overall Study|Withdrawal by Subject|3|||
163080609|NCT00401830|589004213|FG000|Overall Study|Protocol Violation|3|||
163080610|NCT00401830|589004214|FG001|Overall Study|Protocol Violation|3|||
163080611|NCT00401830|589004213|FG000|Overall Study|Non-compliance with drug study|1|||
163080612|NCT00401830|589004214|FG001|Overall Study|Non-compliance with drug study|0|||
163080613|NCT00401830|589004213|FG000|Overall Study|Lost to Follow-up|1|||
163080614|NCT00401830|589004214|FG001|Overall Study|Lost to Follow-up|3|||
163080615|NCT00401830|589004213|FG000|Overall Study|Other: Personal / Family problems|1|||
163080616|NCT00401830|589004214|FG001|Overall Study|Other: Personal / Family problems|0|||
163080617|NCT01720602|589004215|FG000|Overall Study|Adverse Event|3|||
163080618|NCT01720602|589004215|FG000|Overall Study|Progressive disease on therapy|2|||
163080619|NCT01539525|589004216|FG000|Overall Study|Lost to Follow-up|19|||
163080620|NCT01539525|589004217|FG001|Overall Study|Lost to Follow-up|12|||
163080621|NCT01539525|589004218|FG002|Overall Study|Lost to Follow-up|11|||
163080622|NCT01539525|589004216|FG000|Overall Study|Withdrawal by Subject|0|||
163080623|NCT01539525|589004217|FG001|Overall Study|Withdrawal by Subject|3|||
163080624|NCT01539525|589004218|FG002|Overall Study|Withdrawal by Subject|2|||
163080625|NCT01539525|589004216|FG000|Overall Study|Protocol Violation|1|||
163080626|NCT01539525|589004217|FG001|Overall Study|Protocol Violation|1|||
163080627|NCT01539525|589004218|FG002|Overall Study|Protocol Violation|4|||
163080628|NCT02268851|589004219|FG000|Overall Study|Death|0|||
163080629|NCT02268851|589004220|FG001|Overall Study|Death|0|||
163080630|NCT02268851|589004221|FG002|Overall Study|Death|0|||
163080631|NCT02268851|589004222|FG003|Overall Study|Death|1|||
163080632|NCT02268851|589004223|FG004|Overall Study|Death|2|||
163080633|NCT02268851|589004224|FG005|Overall Study|Death|1|||
163080634|NCT02268851|589004219|FG000|Overall Study|Adverse Event|0|||
163080635|NCT02268851|589004220|FG001|Overall Study|Adverse Event|0|||
163332333|NCT00249769|589927623|FG001|Overall Study|Physician Decision|0|||
163080636|NCT02268851|589004221|FG002|Overall Study|Adverse Event|0|||
163080637|NCT02268851|589004222|FG003|Overall Study|Adverse Event|0|||
163080638|NCT02268851|589004223|FG004|Overall Study|Adverse Event|2|||
163080639|NCT02268851|589004224|FG005|Overall Study|Adverse Event|2|||
163080640|NCT02268851|589004219|FG000|Overall Study|Withdrawal by Subject|0|||
163080641|NCT02268851|589004220|FG001|Overall Study|Withdrawal by Subject|0|||
163080642|NCT02268851|589004221|FG002|Overall Study|Withdrawal by Subject|0|||
163080643|NCT02268851|589004222|FG003|Overall Study|Withdrawal by Subject|2|||
163332334|NCT00249769|589927624|FG002|Overall Study|Physician Decision|2|||
163332335|NCT00249769|589927622|FG000|Overall Study|Lost to Follow-up|0|||
163332336|NCT00249769|589927623|FG001|Overall Study|Lost to Follow-up|0|||
163080644|NCT02268851|589004223|FG004|Overall Study|Withdrawal by Subject|0|||
163080645|NCT02268851|589004224|FG005|Overall Study|Withdrawal by Subject|1|||
163080646|NCT02268851|589004219|FG000|Overall Study|Progressive Disease|1|||
163080647|NCT02268851|589004220|FG001|Overall Study|Progressive Disease|3|||
163080648|NCT02268851|589004221|FG002|Overall Study|Progressive Disease|0|||
163080649|NCT02268851|589004222|FG003|Overall Study|Progressive Disease|0|||
163080650|NCT02268851|589004223|FG004|Overall Study|Progressive Disease|1|||
163080651|NCT02268851|589004224|FG005|Overall Study|Progressive Disease|4|||
163080652|NCT02268851|589004219|FG000|Overall Study|Physician Decision|0|||
163080653|NCT02268851|589004220|FG001|Overall Study|Physician Decision|0|||
163080654|NCT02268851|589004221|FG002|Overall Study|Physician Decision|1|||
163080655|NCT02268851|589004222|FG003|Overall Study|Physician Decision|0|||
163080656|NCT02268851|589004223|FG004|Overall Study|Physician Decision|0|||
163080657|NCT02268851|589004224|FG005|Overall Study|Physician Decision|1|||
163080658|NCT02268851|589004219|FG000|Overall Study|Patient Compliance|0|||
163080659|NCT02268851|589004220|FG001|Overall Study|Patient Compliance|0|||
163080660|NCT02268851|589004221|FG002|Overall Study|Patient Compliance|0|||
163080661|NCT02268851|589004222|FG003|Overall Study|Patient Compliance|0|||
163080662|NCT02268851|589004223|FG004|Overall Study|Patient Compliance|1|||
163080663|NCT02268851|589004224|FG005|Overall Study|Patient Compliance|1|||
163080664|NCT02268851|589004219|FG000|Overall Study|Co-Morbid Condition|0|||
163080665|NCT02268851|589004220|FG001|Overall Study|Co-Morbid Condition|0|||
163080666|NCT02268851|589004221|FG002|Overall Study|Co-Morbid Condition|0|||
163080667|NCT02268851|589004222|FG003|Overall Study|Co-Morbid Condition|0|||
163080668|NCT02268851|589004223|FG004|Overall Study|Co-Morbid Condition|1|||
163080669|NCT02268851|589004224|FG005|Overall Study|Co-Morbid Condition|1|||
163080670|NCT02184442|589004225|FG000|Overall Study|Death|61|||
163080671|NCT02184442|589004226|FG001|Overall Study|Death|65|||
163080672|NCT02184442|589004225|FG000|Overall Study|Withdrawal by Subject|3|||
163080673|NCT02184442|589004226|FG001|Overall Study|Withdrawal by Subject|11|||
163080674|NCT02691494|589004227|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
163080675|NCT02691494|589004228|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
163080676|NCT02691494|589004229|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
163080677|NCT02691494|589004227|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
163080678|NCT02691494|589004228|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
163080679|NCT02691494|589004229|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
163080680|NCT02691494|589004227|FG000|Post-Treatment Follow-Up Period|Other|2|||
163080681|NCT02691494|589004228|FG001|Post-Treatment Follow-Up Period|Other|1|||
163080682|NCT02691494|589004229|FG002|Post-Treatment Follow-Up Period|Other|1|||
163080683|NCT02691494|589004227|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
163080684|NCT02691494|589004228|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
163080685|NCT02691494|589004229|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
163080686|NCT02691494|589004227|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
163080687|NCT02691494|589004228|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
163080688|NCT02691494|589004229|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
163080689|NCT04634331|589004230|FG000|Overall Study|Withdrawal by Subject|2|||
163080690|NCT04634331|589004231|FG001|Overall Study|Withdrawal by Subject|2|||
163080691|NCT00461812|589004235|FG000|Overall Study|study terminated|10|||
163219308|NCT02658890|589519414|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219309|NCT02658890|589519415|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219310|NCT02658890|589519416|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219311|NCT02658890|589519417|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219312|NCT02658890|589519391|FG000|Treatment Phase|Adverse Event|0|||
163219313|NCT02658890|589519392|FG001|Treatment Phase|Adverse Event|1|||
163219314|NCT02658890|589519393|FG002|Treatment Phase|Adverse Event|2|||
163219315|NCT02658890|589519394|FG003|Treatment Phase|Adverse Event|2|||
163219316|NCT02658890|589519395|FG004|Treatment Phase|Adverse Event|1|||
163219317|NCT02658890|589519396|FG005|Treatment Phase|Adverse Event|0|||
163219318|NCT02658890|589519397|FG006|Treatment Phase|Adverse Event|0|||
163219319|NCT02658890|589519398|FG007|Treatment Phase|Adverse Event|2|||
163219320|NCT02658890|589519399|FG008|Treatment Phase|Adverse Event|1|||
163219321|NCT02658890|589519400|FG009|Treatment Phase|Adverse Event|2|||
163219322|NCT02658890|589519401|FG010|Treatment Phase|Adverse Event|3|||
163219323|NCT02658890|589519402|FG011|Treatment Phase|Adverse Event|0|||
163219324|NCT02658890|589519403|FG012|Treatment Phase|Adverse Event|1|||
163080692|NCT02916433|589004236|FG000|Overall Study|Withdrawal by Subject|1|||
163080693|NCT02916433|589004237|FG001|Overall Study|Withdrawal by Subject|0|||
163080694|NCT02916433|589004236|FG000|Overall Study|Physician Decision|1|||
163080695|NCT02916433|589004237|FG001|Overall Study|Physician Decision|0|||
163080696|NCT01694771|589004238|FG000|Overall Study|Adverse Event|18|||
163219325|NCT02658890|589519404|FG013|Treatment Phase|Adverse Event|4|||
163332337|NCT00249769|589927624|FG002|Overall Study|Lost to Follow-up|3|||
163080697|NCT01694771|589004239|FG001|Overall Study|Adverse Event|16|||
163080698|NCT01694771|589004238|FG000|Overall Study|Lack of Efficacy|1|||
163080699|NCT01694771|589004239|FG001|Overall Study|Lack of Efficacy|0|||
163080700|NCT01694771|589004238|FG000|Overall Study|Non compliance protocol|7|||
163332338|NCT02022657|589927629|FG000|Overall Study|Withdrawal by Subject|2|||
163080701|NCT01694771|589004239|FG001|Overall Study|Non compliance protocol|6|||
163080702|NCT01694771|589004238|FG000|Overall Study|Lost to Follow-up|2|||
163080703|NCT01694771|589004239|FG001|Overall Study|Lost to Follow-up|3|||
163080704|NCT01694771|589004238|FG000|Overall Study|Consent withdrawn|7|||
163080705|NCT01694771|589004239|FG001|Overall Study|Consent withdrawn|9|||
163080706|NCT01694771|589004238|FG000|Overall Study|Other reasons|5|||
163080707|NCT01694771|589004239|FG001|Overall Study|Other reasons|6|||
163080708|NCT00890097|589004240|FG000|Overall Study|Adverse Event|21|||
163080709|NCT00890097|589004241|FG001|Overall Study|Adverse Event|32|||
163080710|NCT00890097|589004242|FG002|Overall Study|Adverse Event|28|||
163080711|NCT00890097|589004240|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
163080712|NCT00890097|589004241|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
163080713|NCT00890097|589004242|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
163080714|NCT00890097|589004240|FG000|Overall Study|Withdrew Consent|9|||
163080715|NCT00890097|589004241|FG001|Overall Study|Withdrew Consent|6|||
163080716|NCT00890097|589004242|FG002|Overall Study|Withdrew Consent|9|||
163080717|NCT00890097|589004240|FG000|Overall Study|Lost to Follow-up|5|||
163080718|NCT00890097|589004241|FG001|Overall Study|Lost to Follow-up|5|||
163080719|NCT00890097|589004242|FG002|Overall Study|Lost to Follow-up|5|||
163080720|NCT00890097|589004240|FG000|Overall Study|Noncompliance|0|||
163080721|NCT00890097|589004241|FG001|Overall Study|Noncompliance|4|||
163080722|NCT00890097|589004242|FG002|Overall Study|Noncompliance|4|||
163080723|NCT00890097|589004240|FG000|Overall Study|Sponsor Decision|7|||
163080724|NCT00890097|589004241|FG001|Overall Study|Sponsor Decision|11|||
163080725|NCT00890097|589004242|FG002|Overall Study|Sponsor Decision|7|||
163080726|NCT00890097|589004240|FG000|Overall Study|Did not attend final visit|2|||
163080727|NCT00890097|589004241|FG001|Overall Study|Did not attend final visit|3|||
163332339|NCT02022657|589927630|FG001|Overall Study|Withdrawal by Subject|0|||
163332340|NCT02022657|589927631|FG002|Overall Study|Withdrawal by Subject|1|||
163332341|NCT02022657|589927632|FG003|Overall Study|Withdrawal by Subject|0|||
163332342|NCT02022657|589927633|FG004|Overall Study|Withdrawal by Subject|0|||
163332343|NCT02022657|589927634|FG005|Overall Study|Withdrawal by Subject|0|||
163332344|NCT02022657|589927629|FG000|Overall Study|Physician Decision|0|||
163332345|NCT02022657|589927630|FG001|Overall Study|Physician Decision|0|||
163332346|NCT02022657|589927631|FG002|Overall Study|Physician Decision|0|||
163332347|NCT02022657|589927632|FG003|Overall Study|Physician Decision|0|||
163332348|NCT02022657|589927633|FG004|Overall Study|Physician Decision|0|||
163332349|NCT02022657|589927634|FG005|Overall Study|Physician Decision|1|||
163332350|NCT03274076|589927635|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
163332351|NCT03274076|589927636|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
163332352|NCT03274076|589927637|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
163332353|NCT03274076|589927638|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
163332354|NCT03274076|589927635|FG000|24 Weeks Open Label|Adverse Event|0|||
163332355|NCT03274076|589927636|FG001|24 Weeks Open Label|Adverse Event|0|||
163332356|NCT03274076|589927637|FG002|24 Weeks Open Label|Adverse Event|2|||
163332357|NCT03274076|589927638|FG003|24 Weeks Open Label|Adverse Event|0|||
163332358|NCT03274076|589927635|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
163332359|NCT03274076|589927636|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
163332360|NCT03274076|589927637|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
163332361|NCT03274076|589927638|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
163332362|NCT00795184|589927640|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
163332363|NCT00795184|589927641|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
163332364|NCT01629589|589927642|FG000|Overall Study|Protocol Violation|4|||
163080728|NCT00890097|589004242|FG002|Overall Study|Did not attend final visit|0|||
163080729|NCT00890097|589004240|FG000|Overall Study|Subject Decision|3|||
163080730|NCT00890097|589004241|FG001|Overall Study|Subject Decision|2|||
163080731|NCT00890097|589004242|FG002|Overall Study|Subject Decision|6|||
163080732|NCT00890097|589004240|FG000|Overall Study|Randomization Error|2|||
163080733|NCT00890097|589004241|FG001|Overall Study|Randomization Error|0|||
163080734|NCT00890097|589004242|FG002|Overall Study|Randomization Error|0|||
163080735|NCT00890097|589004240|FG000|Overall Study|Failed inclusion criteria|3|||
163332365|NCT01629589|589927643|FG001|Overall Study|Protocol Violation|2|||
163332366|NCT01629589|589927642|FG000|Overall Study|Lost to Follow-up|2|||
163332367|NCT01629589|589927643|FG001|Overall Study|Lost to Follow-up|1|||
163332368|NCT01629589|589927642|FG000|Overall Study|Withdrawal by Subject|2|||
163080736|NCT00890097|589004241|FG001|Overall Study|Failed inclusion criteria|4|||
163332369|NCT01629589|589927643|FG001|Overall Study|Withdrawal by Subject|3|||
163332370|NCT01629589|589927642|FG000|Overall Study|Did not receive study vaccine|0|||
163080737|NCT00890097|589004242|FG002|Overall Study|Failed inclusion criteria|0|||
163080738|NCT00890097|589004240|FG000|Overall Study|Transportation|0|||
163080739|NCT00890097|589004241|FG001|Overall Study|Transportation|2|||
163080740|NCT00890097|589004242|FG002|Overall Study|Transportation|0|||
163080741|NCT00890097|589004240|FG000|Overall Study|Subject Moved|0|||
163080742|NCT00890097|589004241|FG001|Overall Study|Subject Moved|4|||
163080743|NCT00890097|589004242|FG002|Overall Study|Subject Moved|0|||
163080744|NCT00890097|589004240|FG000|Overall Study|Protocol Deviation|1|||
163080745|NCT00890097|589004241|FG001|Overall Study|Protocol Deviation|1|||
163080746|NCT00890097|589004242|FG002|Overall Study|Protocol Deviation|1|||
163080747|NCT03878069|589004247|FG000|Overall Study|Death|0|||
163080748|NCT03878069|589004248|FG001|Overall Study|Death|1|||
163080749|NCT03878069|589004249|FG002|Overall Study|Death|0|||
163080750|NCT03810495|589004250|FG000|Overall Study|Lost to Follow-up|2|||
163080751|NCT03810495|589004250|FG000|Overall Study|Withdrawal by Subject|1|||
163080752|NCT02536339|589004252|FG000|Overall Study|Death|20|||
163080753|NCT02536339|589004252|FG000|Overall Study|Withdrawal by Subject|3|||
163332371|NCT01629589|589927643|FG001|Overall Study|Did not receive study vaccine|1|||
163332372|NCT01530334|589927644|FG000|Overall Study|Adverse Event|3|||
163332373|NCT01530334|589927644|FG000|Overall Study|unknown reason|1|||
163332374|NCT01530334|589927644|FG000|Overall Study|Progressive disease|47|||
163332375|NCT03781375|589927645|FG000|Double-blind Phase|Adverse Event|0|||
163332376|NCT03781375|589927646|FG001|Double-blind Phase|Adverse Event|1|||
163332377|NCT03781375|589927645|FG000|Double-blind Phase|Lack of Response|6|||
163332378|NCT03781375|589927646|FG001|Double-blind Phase|Lack of Response|2|||
163332379|NCT03781375|589927645|FG000|Double-blind Phase|Other|1|||
163332380|NCT03781375|589927646|FG001|Double-blind Phase|Other|3|||
163332381|NCT03781375|589927645|FG000|Open-label Phase|Protocol Issues|0|||
163332382|NCT03781375|589927646|FG001|Open-label Phase|Protocol Issues|1|||
163332383|NCT03781375|589927645|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
163332384|NCT03781375|589927646|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
163332385|NCT03781375|589927645|FG000|Open-label Phase|Other|2|||
163080754|NCT02536339|589004252|FG000|Overall Study|Lost to Follow-up|2|||
163080755|NCT02536339|589004252|FG000|Overall Study|Treatment discontinued|2|||
163080756|NCT02536339|589004252|FG000|Overall Study|Physician Decision|1|||
163080757|NCT03759379|589005954|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
163080758|NCT03759379|589005955|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
163080759|NCT03759379|589005954|FG000|Treatment Period|Death|2|||
163080760|NCT03759379|589005955|FG001|Treatment Period|Death|3|||
163080761|NCT03759379|589005954|FG000|Treatment Period|Lost to Follow-up|1|||
163080762|NCT03759379|589005955|FG001|Treatment Period|Lost to Follow-up|0|||
163080763|NCT03759379|589005954|FG000|Treatment Period|Physician Decision|0|||
163080764|NCT03759379|589005955|FG001|Treatment Period|Physician Decision|1|||
163080765|NCT04924608|589005956|FG000|Overall Study|Adverse Event|10|||
163080766|NCT04924608|589005957|FG001|Overall Study|Adverse Event|6|||
163080767|NCT04924608|589005956|FG000|Overall Study|Lost to Follow-up|1|||
163080768|NCT04924608|589005957|FG001|Overall Study|Lost to Follow-up|1|||
163080769|NCT04924608|589005956|FG000|Overall Study|Ongoing at the data cut-off date|54|||
163080770|NCT04924608|589005957|FG001|Overall Study|Ongoing at the data cut-off date|60|||
163080771|NCT04924608|589005956|FG000|Overall Study|Progressive Disease|2|||
163080772|NCT04924608|589005957|FG001|Overall Study|Progressive Disease|0|||
163080773|NCT04924608|589005956|FG000|Overall Study|Withdrawal by Subject|3|||
163080774|NCT04924608|589005957|FG001|Overall Study|Withdrawal by Subject|6|||
163080775|NCT04924608|589005956|FG000|Overall Study|Other reason|1|||
163080776|NCT04924608|589005957|FG001|Overall Study|Other reason|1|||
163080777|NCT05415215|589005958|FG000|Neoadjuvant Phase|Adverse Event|0|||
163080778|NCT05415215|589005959|FG001|Neoadjuvant Phase|Adverse Event|8|||
163080779|NCT05415215|589005960|FG002|Neoadjuvant Phase|Adverse Event|0|||
163080780|NCT05415215|589005961|FG003|Neoadjuvant Phase|Adverse Event|0|||
163080781|NCT05415215|589005962|FG004|Neoadjuvant Phase|Adverse Event|0|||
163080782|NCT05415215|589005963|FG005|Neoadjuvant Phase|Adverse Event|0|||
163080783|NCT05415215|589005964|FG006|Neoadjuvant Phase|Adverse Event|0|||
163080784|NCT05415215|589005965|FG007|Neoadjuvant Phase|Adverse Event|0|||
163080785|NCT05415215|589005958|FG000|Neoadjuvant Phase|Death|0|||
163080786|NCT05415215|589005959|FG001|Neoadjuvant Phase|Death|4|||
163080787|NCT05415215|589005960|FG002|Neoadjuvant Phase|Death|0|||
163080788|NCT05415215|589005961|FG003|Neoadjuvant Phase|Death|0|||
163080789|NCT05415215|589005962|FG004|Neoadjuvant Phase|Death|0|||
163332386|NCT03781375|589927646|FG001|Open-label Phase|Other|2|||
163332387|NCT01303510|589927648|FG000|Overall Study|Lost to Follow-up|1|||
163080790|NCT05415215|589005963|FG005|Neoadjuvant Phase|Death|0|||
163332388|NCT01303510|589927649|FG001|Overall Study|Lost to Follow-up|0|||
163332389|NCT02079649|589927650|FG000|Overall Study|Lost to Follow-up|0|||
163080791|NCT05415215|589005964|FG006|Neoadjuvant Phase|Death|0|||
163080792|NCT05415215|589005965|FG007|Neoadjuvant Phase|Death|0|||
163080793|NCT05415215|589005958|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
163080794|NCT05415215|589005959|FG001|Neoadjuvant Phase|Withdrawal by Subject|11|||
163080795|NCT05415215|589005960|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
163080796|NCT05415215|589005961|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
163332390|NCT02079649|589927651|FG001|Overall Study|Lost to Follow-up|0|||
163332391|NCT02079649|589927652|FG002|Overall Study|Lost to Follow-up|0|||
163332392|NCT02079649|589927653|FG003|Overall Study|Lost to Follow-up|1|||
163332393|NCT02079649|589927650|FG000|Overall Study|Withdrawal by Subject|0|||
163080797|NCT05415215|589005962|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
163080798|NCT05415215|589005963|FG005|Neoadjuvant Phase|Withdrawal by Subject|0|||
163080799|NCT05415215|589005964|FG006|Neoadjuvant Phase|Withdrawal by Subject|0|||
163080800|NCT05415215|589005965|FG007|Neoadjuvant Phase|Withdrawal by Subject|0|||
163332394|NCT02079649|589927651|FG001|Overall Study|Withdrawal by Subject|0|||
163219326|NCT02658890|589519405|FG014|Treatment Phase|Adverse Event|0|||
163219327|NCT02658890|589519406|FG015|Treatment Phase|Adverse Event|0|||
163029791|NCT02278120|588811915|FG000|Treatment Period|Protocol deviation|0|||
163029792|NCT02278120|588811916|FG001|Treatment Period|Protocol deviation|2|||
163029793|NCT02278120|588811915|FG000|Treatment Period|Study terminated as per protocol|43|||
163029794|NCT02278120|588811916|FG001|Treatment Period|Study terminated as per protocol|11|||
163029795|NCT02278120|588811915|FG000|Post-treatment Efficacy Follow-up|Death|0|||
163029796|NCT02278120|588811916|FG001|Post-treatment Efficacy Follow-up|Death|1|||
163029797|NCT02278120|588811915|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
163029798|NCT02278120|588811916|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
163029799|NCT02278120|588811915|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
163029800|NCT02278120|588811916|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
163029801|NCT02278120|588811915|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
163029802|NCT02278120|588811916|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
163029803|NCT02278120|588811915|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
163029804|NCT02278120|588811916|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
163029805|NCT00808639|588811918|FG000|Overall Study|Disease progression before surgery.|1|||
163029806|NCT01966068|588811921|FG000|Overall Study|Withdrawal by Subject|57|||
163029807|NCT01966068|588811921|FG000|Overall Study|Lost to Follow-up|81|||
163029808|NCT03197324|588811922|FG000|Overall Study|Adverse Event|0|||
163029809|NCT03197324|588811923|FG001|Overall Study|Adverse Event|1|||
163029810|NCT03589976|588811930|FG000|Overall Study|Death|5|||
163029811|NCT03589976|588811931|FG001|Overall Study|Death|1|||
163029812|NCT03589976|588811930|FG000|Overall Study|Adverse Event|5|||
163029813|NCT03589976|588811931|FG001|Overall Study|Adverse Event|1|||
163029814|NCT03589976|588811930|FG000|Overall Study|Withdrawal by Subject|4|||
163219328|NCT02658890|589519407|FG016|Treatment Phase|Adverse Event|0|||
163219329|NCT02658890|589519408|FG017|Treatment Phase|Adverse Event|0|||
163219330|NCT02658890|589519409|FG018|Treatment Phase|Adverse Event|5|||
163219331|NCT02658890|589519410|FG019|Treatment Phase|Adverse Event|1|||
163219332|NCT02658890|589519411|FG020|Treatment Phase|Adverse Event|3|||
163219333|NCT02658890|589519412|FG021|Treatment Phase|Adverse Event|0|||
163219334|NCT02658890|589519413|FG022|Treatment Phase|Adverse Event|5|||
163219335|NCT02658890|589519414|FG023|Treatment Phase|Adverse Event|0|||
163219336|NCT02658890|589519415|FG024|Treatment Phase|Adverse Event|0|||
163219337|NCT02658890|589519416|FG025|Treatment Phase|Adverse Event|2|||
163219338|NCT02658890|589519417|FG026|Treatment Phase|Adverse Event|1|||
163219339|NCT02658890|589519391|FG000|Treatment Phase|Death|0|||
163219340|NCT02658890|589519392|FG001|Treatment Phase|Death|0|||
163219341|NCT02658890|589519393|FG002|Treatment Phase|Death|0|||
163219342|NCT02658890|589519394|FG003|Treatment Phase|Death|0|||
163219343|NCT02658890|589519395|FG004|Treatment Phase|Death|0|||
163219344|NCT02658890|589519396|FG005|Treatment Phase|Death|0|||
163219345|NCT02658890|589519397|FG006|Treatment Phase|Death|0|||
163219346|NCT02658890|589519398|FG007|Treatment Phase|Death|0|||
163219347|NCT02658890|589519399|FG008|Treatment Phase|Death|0|||
163219348|NCT02658890|589519400|FG009|Treatment Phase|Death|0|||
163219349|NCT02658890|589519401|FG010|Treatment Phase|Death|0|||
163219350|NCT02658890|589519402|FG011|Treatment Phase|Death|0|||
163219351|NCT02658890|589519403|FG012|Treatment Phase|Death|0|||
163219352|NCT02658890|589519404|FG013|Treatment Phase|Death|0|||
163219353|NCT02658890|589519405|FG014|Treatment Phase|Death|0|||
163219354|NCT02658890|589519406|FG015|Treatment Phase|Death|0|||
163219355|NCT02658890|589519407|FG016|Treatment Phase|Death|0|||
163219356|NCT02658890|589519408|FG017|Treatment Phase|Death|0|||
163219357|NCT02658890|589519409|FG018|Treatment Phase|Death|1|||
163219358|NCT02658890|589519410|FG019|Treatment Phase|Death|0|||
163219359|NCT02658890|589519411|FG020|Treatment Phase|Death|0|||
163219360|NCT02658890|589519412|FG021|Treatment Phase|Death|0|||
163219361|NCT02658890|589519413|FG022|Treatment Phase|Death|0|||
163219362|NCT02658890|589519414|FG023|Treatment Phase|Death|0|||
163219363|NCT02658890|589519415|FG024|Treatment Phase|Death|0|||
163219364|NCT02658890|589519416|FG025|Treatment Phase|Death|0|||
163219365|NCT02658890|589519417|FG026|Treatment Phase|Death|0|||
163219366|NCT02658890|589519391|FG000|Treatment Phase|Lost to Follow-up|0|||
163219367|NCT02658890|589519392|FG001|Treatment Phase|Lost to Follow-up|0|||
163219368|NCT02658890|589519393|FG002|Treatment Phase|Lost to Follow-up|0|||
163219369|NCT02658890|589519394|FG003|Treatment Phase|Lost to Follow-up|0|||
163219370|NCT02658890|589519395|FG004|Treatment Phase|Lost to Follow-up|0|||
163219371|NCT02658890|589519396|FG005|Treatment Phase|Lost to Follow-up|0|||
163219372|NCT02658890|589519397|FG006|Treatment Phase|Lost to Follow-up|1|||
163219373|NCT02658890|589519398|FG007|Treatment Phase|Lost to Follow-up|0|||
163219374|NCT02658890|589519399|FG008|Treatment Phase|Lost to Follow-up|0|||
163219375|NCT02658890|589519400|FG009|Treatment Phase|Lost to Follow-up|0|||
163219376|NCT02658890|589519401|FG010|Treatment Phase|Lost to Follow-up|0|||
163219377|NCT02658890|589519402|FG011|Treatment Phase|Lost to Follow-up|0|||
163219378|NCT02658890|589519403|FG012|Treatment Phase|Lost to Follow-up|0|||
163219379|NCT02658890|589519404|FG013|Treatment Phase|Lost to Follow-up|0|||
163080801|NCT05415215|589005958|FG000|Neoadjuvant Phase|Progressive Disease|0|||
163080802|NCT05415215|589005959|FG001|Neoadjuvant Phase|Progressive Disease|2|||
163080803|NCT05415215|589005960|FG002|Neoadjuvant Phase|Progressive Disease|0|||
163080804|NCT05415215|589005961|FG003|Neoadjuvant Phase|Progressive Disease|0|||
163080805|NCT05415215|589005962|FG004|Neoadjuvant Phase|Progressive Disease|0|||
163080806|NCT05415215|589005963|FG005|Neoadjuvant Phase|Progressive Disease|0|||
163080807|NCT05415215|589005964|FG006|Neoadjuvant Phase|Progressive Disease|0|||
163080808|NCT05415215|589005965|FG007|Neoadjuvant Phase|Progressive Disease|0|||
163080809|NCT05415215|589005958|FG000|Neoadjuvant Phase|Reason not Specified|1|||
163080810|NCT05415215|589005959|FG001|Neoadjuvant Phase|Reason not Specified|4|||
163080811|NCT05415215|589005960|FG002|Neoadjuvant Phase|Reason not Specified|0|||
163080812|NCT05415215|589005961|FG003|Neoadjuvant Phase|Reason not Specified|0|||
163080813|NCT05415215|589005962|FG004|Neoadjuvant Phase|Reason not Specified|0|||
163080814|NCT05415215|589005963|FG005|Neoadjuvant Phase|Reason not Specified|0|||
163080815|NCT05415215|589005964|FG006|Neoadjuvant Phase|Reason not Specified|0|||
163080816|NCT05415215|589005965|FG007|Neoadjuvant Phase|Reason not Specified|0|||
163080817|NCT05415215|589005958|FG000|Neoadjuvant Phase|Treatment Intolerance|1|||
163080818|NCT05415215|589005959|FG001|Neoadjuvant Phase|Treatment Intolerance|1|||
163080819|NCT05415215|589005960|FG002|Neoadjuvant Phase|Treatment Intolerance|0|||
163080820|NCT05415215|589005961|FG003|Neoadjuvant Phase|Treatment Intolerance|0|||
163080821|NCT05415215|589005962|FG004|Neoadjuvant Phase|Treatment Intolerance|0|||
163080822|NCT05415215|589005963|FG005|Neoadjuvant Phase|Treatment Intolerance|0|||
163080823|NCT05415215|589005964|FG006|Neoadjuvant Phase|Treatment Intolerance|0|||
163080824|NCT05415215|589005965|FG007|Neoadjuvant Phase|Treatment Intolerance|0|||
163080825|NCT05415215|589005958|FG000|Neoadjuvant Phase|Lost to Follow-up|1|||
163080826|NCT05415215|589005959|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
163080827|NCT05415215|589005960|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
163080828|NCT05415215|589005961|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
163080829|NCT05415215|589005962|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
163080830|NCT05415215|589005963|FG005|Neoadjuvant Phase|Lost to Follow-up|0|||
163080831|NCT05415215|589005964|FG006|Neoadjuvant Phase|Lost to Follow-up|0|||
163080832|NCT05415215|589005965|FG007|Neoadjuvant Phase|Lost to Follow-up|0|||
163080833|NCT05415215|589005958|FG000|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
163080834|NCT05415215|589005959|FG001|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
163080835|NCT05415215|589005960|FG002|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
163080836|NCT05415215|589005961|FG003|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
163080837|NCT05415215|589005962|FG004|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
163080838|NCT05415215|589005963|FG005|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
163080839|NCT05415215|589005964|FG006|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
163080840|NCT05415215|589005965|FG007|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
163080841|NCT05415215|589005958|FG000|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
163080842|NCT05415215|589005959|FG001|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
163080843|NCT05415215|589005960|FG002|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
163080844|NCT05415215|589005961|FG003|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
163080845|NCT05415215|589005962|FG004|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
163080846|NCT05415215|589005963|FG005|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
163080847|NCT05415215|589005964|FG006|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
163080848|NCT05415215|589005965|FG007|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
163080849|NCT05415215|589005958|FG000|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
163080850|NCT05415215|589005959|FG001|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
163080851|NCT05415215|589005960|FG002|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
163080852|NCT05415215|589005961|FG003|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
163080853|NCT05415215|589005962|FG004|Adjuvant Phase: Cross-over Period|Treatment Intolerance|1|||
163080854|NCT05415215|589005963|FG005|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
163080855|NCT05415215|589005964|FG006|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
163080856|NCT05415215|589005965|FG007|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
163080857|NCT05415215|589005958|FG000|Adjuvant Phase: Continuation Period|Adverse Event|0|||
163080858|NCT05415215|589005959|FG001|Adjuvant Phase: Continuation Period|Adverse Event|0|||
163080859|NCT05415215|589005960|FG002|Adjuvant Phase: Continuation Period|Adverse Event|0|||
163080860|NCT05415215|589005961|FG003|Adjuvant Phase: Continuation Period|Adverse Event|0|||
163080861|NCT05415215|589005962|FG004|Adjuvant Phase: Continuation Period|Adverse Event|0|||
163080862|NCT05415215|589005963|FG005|Adjuvant Phase: Continuation Period|Adverse Event|0|||
163080863|NCT05415215|589005964|FG006|Adjuvant Phase: Continuation Period|Adverse Event|1|||
163080864|NCT05415215|589005965|FG007|Adjuvant Phase: Continuation Period|Adverse Event|0|||
163080865|NCT05415215|589005958|FG000|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
163080866|NCT05415215|589005959|FG001|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
163080867|NCT05415215|589005960|FG002|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
163080868|NCT05415215|589005961|FG003|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
163080869|NCT05415215|589005962|FG004|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
163080870|NCT05415215|589005963|FG005|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|1|||
163080871|NCT05415215|589005964|FG006|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
163080872|NCT05415215|589005965|FG007|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
163080873|NCT05415215|589005958|FG000|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
163080874|NCT05415215|589005959|FG001|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
163080875|NCT05415215|589005960|FG002|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
163080876|NCT05415215|589005961|FG003|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
163080877|NCT05415215|589005962|FG004|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
163080878|NCT05415215|589005963|FG005|Adjuvant Phase: Continuation Period|Withdrawal by Subject|1|||
163080879|NCT05415215|589005964|FG006|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
163080880|NCT05415215|589005965|FG007|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
163080881|NCT05415215|589005958|FG000|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
163080882|NCT05415215|589005959|FG001|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
163080883|NCT05415215|589005960|FG002|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
163080884|NCT05415215|589005961|FG003|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
163080885|NCT05415215|589005962|FG004|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
163080886|NCT05415215|589005963|FG005|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
163080887|NCT05415215|589005964|FG006|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
163080888|NCT05415215|589005965|FG007|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
163080889|NCT05415215|589005958|FG000|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
163080890|NCT05415215|589005959|FG001|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
163080891|NCT05415215|589005960|FG002|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
163080892|NCT05415215|589005961|FG003|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
163080893|NCT05415215|589005962|FG004|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
163080894|NCT05415215|589005963|FG005|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
163080895|NCT05415215|589005964|FG006|Adjuvant Phase: Continuation Period|Reason not Specified|1|||
163080896|NCT05415215|589005965|FG007|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
163080897|NCT05415215|589005958|FG000|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
163080898|NCT05415215|589005959|FG001|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
163080899|NCT05415215|589005960|FG002|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
163080900|NCT05415215|589005961|FG003|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
163080901|NCT05415215|589005962|FG004|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
163080902|NCT05415215|589005963|FG005|Adjuvant Phase: Continuation Period|Ongoing in Treatment|11|||
163080903|NCT05415215|589005964|FG006|Adjuvant Phase: Continuation Period|Ongoing in Treatment|9|||
163080904|NCT05415215|589005965|FG007|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
163080905|NCT05415215|589005958|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
163080906|NCT05415215|589005959|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
163080907|NCT05415215|589005960|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
163080908|NCT05415215|589005961|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
163080909|NCT05415215|589005962|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
163080910|NCT05415215|589005963|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
163080911|NCT05415215|589005964|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
163080912|NCT05415215|589005965|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|5|||
163080913|NCT05415215|589005958|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
163080914|NCT05415215|589005959|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
163080915|NCT05415215|589005960|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
163080916|NCT05415215|589005961|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
163080917|NCT05415215|589005962|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
163080918|NCT05415215|589005963|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
163080919|NCT05415215|589005964|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
163080920|NCT05415215|589005965|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Death|1|||
163080921|NCT05415215|589005958|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
163080922|NCT05415215|589005959|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
163080923|NCT05415215|589005960|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
163080924|NCT05415215|589005961|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
163080925|NCT05415215|589005962|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
163080926|NCT05415215|589005963|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
163080927|NCT05415215|589005964|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
163080928|NCT05415215|589005965|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|2|||
163080929|NCT05415215|589005958|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
163080930|NCT05415215|589005959|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
163080931|NCT05415215|589005960|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
163080932|NCT05415215|589005961|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
163080933|NCT05415215|589005962|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
163080934|NCT05415215|589005963|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
163080935|NCT05415215|589005964|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
163080936|NCT05415215|589005965|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|1|||
163080937|NCT05415215|589005958|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
163080938|NCT05415215|589005959|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
163080939|NCT05415215|589005960|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
163080940|NCT05415215|589005961|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
163080941|NCT05415215|589005962|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
163080942|NCT05415215|589005963|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
163080943|NCT05415215|589005964|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
163080944|NCT05415215|589005965|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|2|||
163080945|NCT05415215|589005958|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
163080946|NCT05415215|589005959|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
163080947|NCT05415215|589005960|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
163080948|NCT05415215|589005961|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
163080949|NCT05415215|589005962|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
163080950|NCT05415215|589005963|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
163080951|NCT05415215|589005964|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
163080952|NCT05415215|589005965|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|4|||
163080953|NCT05415215|589005958|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
163080954|NCT05415215|589005959|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
163080955|NCT05415215|589005960|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
163080956|NCT05415215|589005961|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
163080957|NCT05415215|589005962|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
163080958|NCT05415215|589005963|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
163080959|NCT05415215|589005964|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
163080960|NCT05415215|589005965|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|25|||
163080961|NCT05415215|589005958|FG000|Follow-up Period|Ongoing in Follow-up|0|||
163080962|NCT05415215|589005959|FG001|Follow-up Period|Ongoing in Follow-up|0|||
163080963|NCT05415215|589005960|FG002|Follow-up Period|Ongoing in Follow-up|0|||
163080964|NCT05415215|589005961|FG003|Follow-up Period|Ongoing in Follow-up|0|||
163080965|NCT05415215|589005962|FG004|Follow-up Period|Ongoing in Follow-up|0|||
163080966|NCT05415215|589005963|FG005|Follow-up Period|Ongoing in Follow-up|44|||
163080967|NCT05415215|589005964|FG006|Follow-up Period|Ongoing in Follow-up|45|||
163080968|NCT05415215|589005965|FG007|Follow-up Period|Ongoing in Follow-up|51|||
163080969|NCT05415215|589005958|FG000|Follow-up Period|Adverse Event|0|||
163080970|NCT05415215|589005959|FG001|Follow-up Period|Adverse Event|0|||
163080971|NCT05415215|589005960|FG002|Follow-up Period|Adverse Event|0|||
163080972|NCT05415215|589005961|FG003|Follow-up Period|Adverse Event|0|||
163080973|NCT05415215|589005962|FG004|Follow-up Period|Adverse Event|0|||
163080974|NCT05415215|589005963|FG005|Follow-up Period|Adverse Event|0|||
163080975|NCT05415215|589005964|FG006|Follow-up Period|Adverse Event|1|||
163080976|NCT05415215|589005965|FG007|Follow-up Period|Adverse Event|0|||
163080977|NCT05415215|589005958|FG000|Follow-up Period|Lost to Follow-up|0|||
163080978|NCT05415215|589005959|FG001|Follow-up Period|Lost to Follow-up|0|||
163080979|NCT05415215|589005960|FG002|Follow-up Period|Lost to Follow-up|0|||
163080980|NCT05415215|589005961|FG003|Follow-up Period|Lost to Follow-up|0|||
163080981|NCT05415215|589005962|FG004|Follow-up Period|Lost to Follow-up|0|||
163080982|NCT05415215|589005963|FG005|Follow-up Period|Lost to Follow-up|1|||
163080983|NCT05415215|589005964|FG006|Follow-up Period|Lost to Follow-up|1|||
163080984|NCT05415215|589005965|FG007|Follow-up Period|Lost to Follow-up|0|||
163080985|NCT05415215|589005958|FG000|Follow-up Period|Withdrawal by Subject|0|||
163080986|NCT05415215|589005959|FG001|Follow-up Period|Withdrawal by Subject|0|||
163080987|NCT05415215|589005960|FG002|Follow-up Period|Withdrawal by Subject|0|||
163080988|NCT05415215|589005961|FG003|Follow-up Period|Withdrawal by Subject|0|||
163080989|NCT05415215|589005962|FG004|Follow-up Period|Withdrawal by Subject|0|||
163080990|NCT05415215|589005963|FG005|Follow-up Period|Withdrawal by Subject|0|||
163080991|NCT05415215|589005964|FG006|Follow-up Period|Withdrawal by Subject|0|||
163080992|NCT05415215|589005965|FG007|Follow-up Period|Withdrawal by Subject|2|||
163080993|NCT03727022|589005966|FG000|Phase A|Lost to Follow-up|2|||
163080994|NCT03727022|589005967|FG001|Phase A|Lost to Follow-up|3|||
163080995|NCT03727022|589005966|FG000|Phase A|Withdrawal by Subject|10|||
163080996|NCT03727022|589005967|FG001|Phase A|Withdrawal by Subject|9|||
163080997|NCT03727022|589005966|FG000|Phase B|Lost to Follow-up|0|||
163080998|NCT03727022|589005967|FG001|Phase B|Lost to Follow-up|1|||
163080999|NCT03727022|589005966|FG000|Phase B|Subject Non-Compliance|1|||
163081000|NCT03727022|589005967|FG001|Phase B|Subject Non-Compliance|0|||
163081001|NCT03727022|589005966|FG000|Phase B|Withdrawal by Subject|3|||
163081002|NCT03727022|589005967|FG001|Phase B|Withdrawal by Subject|3|||
163081003|NCT03727022|589005966|FG000|Phase B|Site Closure|4|||
163081004|NCT03727022|589005967|FG001|Phase B|Site Closure|0|||
163081005|NCT05550818|589005968|FG000|Overall Study|Protocol Violation|1|||
163081006|NCT05550818|589005969|FG001|Overall Study|Protocol Violation|1|||
163081007|NCT05550818|589005968|FG000|Overall Study|Withdrawal by Subject|2|||
163081008|NCT05550818|589005969|FG001|Overall Study|Withdrawal by Subject|1|||
163081009|NCT02797522|589005970|FG000|Overall Study|Study Terminated by Sponsor|0|||
163081010|NCT02797522|589005971|FG001|Overall Study|Study Terminated by Sponsor|0|||
163081011|NCT02797522|589005972|FG002|Overall Study|Study Terminated by Sponsor|0|||
163081012|NCT02797522|589005973|FG003|Overall Study|Study Terminated by Sponsor|0|||
163081013|NCT02797522|589005974|FG004|Overall Study|Study Terminated by Sponsor|0|||
163081014|NCT02797522|589005975|FG005|Overall Study|Study Terminated by Sponsor|0|||
163081015|NCT02797522|589005976|FG006|Overall Study|Study Terminated by Sponsor|0|||
163081016|NCT02797522|589005977|FG007|Overall Study|Study Terminated by Sponsor|4|||
163081017|NCT02797522|589005978|FG008|Overall Study|Study Terminated by Sponsor|2|||
163081018|NCT02797522|589005979|FG009|Overall Study|Study Terminated by Sponsor|4|||
163081019|NCT02797522|589005980|FG010|Overall Study|Study Terminated by Sponsor|1|||
163081020|NCT03031912|589005981|FG000|Overall Study|Lost to Follow-up|1|||
163081021|NCT03031912|589005982|FG001|Overall Study|Lost to Follow-up|1|||
163081022|NCT03031912|589005983|FG002|Overall Study|Lost to Follow-up|0|||
163081023|NCT03031912|589005984|FG003|Overall Study|Lost to Follow-up|1|||
163081024|NCT03031912|589005985|FG004|Overall Study|Lost to Follow-up|0|||
163081025|NCT03031912|589005986|FG005|Overall Study|Lost to Follow-up|0|||
163081026|NCT03031912|589005987|FG006|Overall Study|Lost to Follow-up|0|||
163081027|NCT03031912|589005988|FG007|Overall Study|Lost to Follow-up|0|||
163081028|NCT03031912|589005989|FG008|Overall Study|Lost to Follow-up|0|||
163081029|NCT03031912|589005990|FG009|Overall Study|Lost to Follow-up|0|||
163081030|NCT04097743|589005993|FG000|Overall Study|Non-compliance of the study instruction.|1|||
163081031|NCT04097743|589005994|FG001|Overall Study|Non-compliance of the study instruction.|0|||
163081032|NCT02932410|589005997|FG000|Overall Study|Death|7|||
163081033|NCT02932410|589005998|FG001|Overall Study|Death|6|||
163081034|NCT02932410|589005999|FG002|Overall Study|Death|0|||
163081035|NCT02932410|589006000|FG003|Overall Study|Death|0|||
163081036|NCT02932410|589005997|FG000|Overall Study|Lost to Follow-up|1|||
163081037|NCT02932410|589005998|FG001|Overall Study|Lost to Follow-up|2|||
163081038|NCT02932410|589005999|FG002|Overall Study|Lost to Follow-up|0|||
163081039|NCT02932410|589006000|FG003|Overall Study|Lost to Follow-up|0|||
163081040|NCT02932410|589005997|FG000|Overall Study|Parent/Subjects decision|6|||
163081041|NCT02932410|589005998|FG001|Overall Study|Parent/Subjects decision|6|||
163081042|NCT02932410|589005999|FG002|Overall Study|Parent/Subjects decision|1|||
163081043|NCT02932410|589006000|FG003|Overall Study|Parent/Subjects decision|0|||
163081044|NCT02932410|589005997|FG000|Overall Study|Physician Decision|0|||
163081045|NCT02932410|589005998|FG001|Overall Study|Physician Decision|1|||
163081046|NCT02932410|589005999|FG002|Overall Study|Physician Decision|0|||
163081047|NCT02932410|589006000|FG003|Overall Study|Physician Decision|0|||
163081048|NCT04557735|589006003|FG000|Treatment Period (26 Weeks)|Withdrawal by Subject|1|||
163081049|NCT04557735|589006003|FG000|Treatment Period (26 Weeks)|Physician Decision|4|||
163081050|NCT04557735|589006003|FG000|Treatment Period (26 Weeks)|Death|5|||
163081051|NCT04557735|589006003|FG000|Treatment Period (26 Weeks)|Adverse Event|2|||
163081052|NCT04557735|589006003|FG000|Follow-Up Period (26 Weeks)|Physician Decision|1|||
163081053|NCT04557735|589006003|FG000|Follow-Up Period (26 Weeks)|Death|4|||
163081054|NCT05562934|589006004|FG000|Overall Study|Adverse Event|0|||
163081055|NCT05562934|589006005|FG001|Overall Study|Adverse Event|2|||
163081056|NCT05562934|589006006|FG002|Overall Study|Adverse Event|0|||
163081057|NCT05562934|589006007|FG003|Overall Study|Adverse Event|0|||
163081058|NCT05562934|589006008|FG004|Overall Study|Adverse Event|2|||
163081059|NCT05562934|589006004|FG000|Overall Study|Lost to Follow-up|0|||
163081060|NCT05562934|589006005|FG001|Overall Study|Lost to Follow-up|0|||
163081061|NCT05562934|589006006|FG002|Overall Study|Lost to Follow-up|0|||
163081062|NCT05562934|589006007|FG003|Overall Study|Lost to Follow-up|0|||
163081063|NCT05562934|589006008|FG004|Overall Study|Lost to Follow-up|1|||
163081064|NCT05562934|589006004|FG000|Overall Study|Protocol Violation|0|||
163081065|NCT05562934|589006005|FG001|Overall Study|Protocol Violation|0|||
163081066|NCT05562934|589006006|FG002|Overall Study|Protocol Violation|0|||
163081067|NCT05562934|589006007|FG003|Overall Study|Protocol Violation|1|||
163081068|NCT05562934|589006008|FG004|Overall Study|Protocol Violation|1|||
163081069|NCT05562934|589006004|FG000|Overall Study|Withdrawal by Subject|0|||
163081070|NCT05562934|589006005|FG001|Overall Study|Withdrawal by Subject|0|||
163081071|NCT05562934|589006006|FG002|Overall Study|Withdrawal by Subject|1|||
163081072|NCT05562934|589006007|FG003|Overall Study|Withdrawal by Subject|1|||
163081073|NCT05562934|589006008|FG004|Overall Study|Withdrawal by Subject|0|||
163081074|NCT05365217|589006009|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163081075|NCT05365217|589006010|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163081076|NCT03997383|589006014|FG000|Double-blind Treatment Period|Adverse Event|4|||
163081077|NCT03997383|589006015|FG001|Double-blind Treatment Period|Adverse Event|3|||
163081078|NCT03997383|589006014|FG000|Double-blind Treatment Period|Death|4|||
163081079|NCT03997383|589006015|FG001|Double-blind Treatment Period|Death|4|||
163081080|NCT03997383|589006014|FG000|Double-blind Treatment Period|Physician Decision|2|||
163081081|NCT03997383|589006015|FG001|Double-blind Treatment Period|Physician Decision|0|||
163081082|NCT03997383|589006014|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
163081083|NCT03997383|589006015|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
163081084|NCT03997383|589006014|FG000|Open-label Extension Period|Ongoing|148|||
163081085|NCT03997383|589006015|FG001|Open-label Extension Period|Ongoing|151|||
163081086|NCT03997383|589006014|FG000|Open-label Extension Period|Adverse Event|4|||
163081087|NCT03997383|589006015|FG001|Open-label Extension Period|Adverse Event|1|||
163081088|NCT03997383|589006014|FG000|Open-label Extension Period|Death|8|||
163081089|NCT03997383|589006015|FG001|Open-label Extension Period|Death|9|||
163081090|NCT03997383|589006014|FG000|Open-label Extension Period|Physician Decision|1|||
163081091|NCT03997383|589006015|FG001|Open-label Extension Period|Physician Decision|1|||
163081092|NCT03997383|589006014|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
163081093|NCT03997383|589006015|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
163081094|NCT03997383|589006014|FG000|Open-label Extension Period|Reason Not Specified|2|||
163081095|NCT03997383|589006015|FG001|Open-label Extension Period|Reason Not Specified|0|||
163081096|NCT05451329|589006022|FG000|Overall Study|Adverse Event|1|||
163081097|NCT05451329|589006023|FG001|Overall Study|Adverse Event|1|||
163081098|NCT05451329|589006024|FG002|Overall Study|Adverse Event|0|||
163081099|NCT05451329|589006022|FG000|Overall Study|Withdrawal by Subject|1|||
163081100|NCT05451329|589006023|FG001|Overall Study|Withdrawal by Subject|0|||
163081101|NCT05451329|589006024|FG002|Overall Study|Withdrawal by Subject|0|||
163081102|NCT05451329|589006022|FG000|Overall Study|Investigational Product Lot exchange|1|||
163081103|NCT05451329|589006023|FG001|Overall Study|Investigational Product Lot exchange|1|||
163081104|NCT05451329|589006024|FG002|Overall Study|Investigational Product Lot exchange|0|||
163081105|NCT03019406|589006027|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
163081106|NCT03019406|589006028|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
163081107|NCT03019406|589006029|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
163081108|NCT03019406|589006030|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
163081109|NCT02556736|589006031|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
163081110|NCT02556736|589006032|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
163081111|NCT02556736|589006033|FG002|Open Label Treatment Period|Withdrawal by Subject|1|||
163081112|NCT02556736|589006034|FG003|Open Label Treatment Period|Withdrawal by Subject|1|||
163081113|NCT02556736|589006031|FG000|Open Label Treatment Period|Adverse Event|0|||
163081114|NCT02556736|589006032|FG001|Open Label Treatment Period|Adverse Event|0|||
163081115|NCT02556736|589006033|FG002|Open Label Treatment Period|Adverse Event|0|||
163081116|NCT02556736|589006034|FG003|Open Label Treatment Period|Adverse Event|1|||
163081117|NCT02556736|589006031|FG000|Long-Term Follow-up|Lost to Follow-up|1|||
163081118|NCT02556736|589006032|FG001|Long-Term Follow-up|Lost to Follow-up|0|||
163081119|NCT02556736|589006033|FG002|Long-Term Follow-up|Lost to Follow-up|0|||
163081120|NCT02556736|589006034|FG003|Long-Term Follow-up|Lost to Follow-up|1|||
163081121|NCT01302834|589006042|FG000|Overall Study|Protocol Violation|17|||
163081122|NCT01302834|589006043|FG001|Overall Study|Protocol Violation|23|||
163081123|NCT01302834|589006042|FG000|Overall Study|HIV positive|1|||
163081124|NCT01302834|589006043|FG001|Overall Study|HIV positive|3|||
163081125|NCT05528510|589006044|FG000|Overall Study|Death|1|||
163081126|NCT05528510|589006045|FG001|Overall Study|Death|0|||
163081127|NCT05528510|589006046|FG002|Overall Study|Death|0|||
163081128|NCT05528510|589006044|FG000|Overall Study|Lost to Follow-up|1|||
163081129|NCT05528510|589006045|FG001|Overall Study|Lost to Follow-up|0|||
163081130|NCT05528510|589006046|FG002|Overall Study|Lost to Follow-up|0|||
163081131|NCT05528510|589006044|FG000|Overall Study|Withdrawal by Subject|4|||
163081132|NCT05528510|589006045|FG001|Overall Study|Withdrawal by Subject|1|||
163081133|NCT05528510|589006046|FG002|Overall Study|Withdrawal by Subject|3|||
163081134|NCT05528510|589006044|FG000|Overall Study|Other|2|||
163081135|NCT05528510|589006045|FG001|Overall Study|Other|2|||
163081136|NCT05528510|589006046|FG002|Overall Study|Other|1|||
163081137|NCT01856478|589006049|FG000|Overall Study|Not treated|0|||
163081138|NCT01856478|589006050|FG001|Overall Study|Not treated|8|||
163081139|NCT01856478|589006049|FG000|Overall Study|Progressive disease per RECIST|146|||
163081140|NCT01856478|589006050|FG001|Overall Study|Progressive disease per RECIST|49|||
163081141|NCT01856478|589006049|FG000|Overall Study|Worsening of underlying cancer|6|||
163081142|NCT01856478|589006050|FG001|Overall Study|Worsening of underlying cancer|2|||
163081143|NCT01856478|589006049|FG000|Overall Study|Adverse events|57|||
163332395|NCT02079649|589927652|FG002|Overall Study|Withdrawal by Subject|0|||
163332396|NCT02079649|589927653|FG003|Overall Study|Withdrawal by Subject|1|||
163332397|NCT02079649|589927650|FG000|Overall Study|Randomization error (prior to treatment)|1|||
163332398|NCT02079649|589927651|FG001|Overall Study|Randomization error (prior to treatment)|0|||
163332399|NCT02079649|589927652|FG002|Overall Study|Randomization error (prior to treatment)|1|||
163081144|NCT01856478|589006050|FG001|Overall Study|Adverse events|30|||
163081145|NCT01856478|589006049|FG000|Overall Study|Non-compliant with protocol|1|||
163081146|NCT01856478|589006050|FG001|Overall Study|Non-compliant with protocol|1|||
163081147|NCT01856478|589006049|FG000|Overall Study|Lost to Follow-up|1|||
163081148|NCT01856478|589006050|FG001|Overall Study|Lost to Follow-up|1|||
163081149|NCT01856478|589006049|FG000|Overall Study|Refused to continue trial medication|13|||
163081150|NCT01856478|589006050|FG001|Overall Study|Refused to continue trial medication|11|||
163081151|NCT01856478|589006049|FG000|Overall Study|Other reason than listed|4|||
163081152|NCT01856478|589006050|FG001|Overall Study|Other reason than listed|10|||
163081153|NCT05032820|589006051|FG000|Overall Study|Lost to Follow-up|1|||
163081154|NCT05032820|589006051|FG000|Overall Study|Withdrawal by Subject|1|||
163081155|NCT04108208|589006052|FG000|Overall Study|Withdrawal by Subject|2|||
163081156|NCT04108208|589006053|FG001|Overall Study|Withdrawal by Subject|6|||
163081157|NCT04108208|589006052|FG000|Overall Study|other-ongoing|20|||
163081158|NCT04108208|589006053|FG001|Overall Study|other-ongoing|40|||
163081159|NCT04108208|589006052|FG000|Overall Study|Death|1|||
163081160|NCT04108208|589006053|FG001|Overall Study|Death|4|||
163081161|NCT04108208|589006052|FG000|Overall Study|Lost to Follow-up|2|||
163081162|NCT04108208|589006053|FG001|Overall Study|Lost to Follow-up|0|||
163081163|NCT04936308|589006054|FG000|Overall Study|Death|0|||
163081164|NCT04936308|589006055|FG001|Overall Study|Death|0|||
163081165|NCT04936308|589006056|FG002|Overall Study|Death|1|||
163081166|NCT04936308|589006054|FG000|Overall Study|Withdrawal by Subject|6|||
163081167|NCT04936308|589006055|FG001|Overall Study|Withdrawal by Subject|3|||
163081168|NCT04936308|589006056|FG002|Overall Study|Withdrawal by Subject|0|||
163081169|NCT04936308|589006054|FG000|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|0|||
163081170|NCT04936308|589006055|FG001|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
163081171|NCT04936308|589006056|FG002|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
163081172|NCT04936308|589006054|FG000|Overall Study|Completed protocol-required follow-up|1|||
163081173|NCT04936308|589006055|FG001|Overall Study|Completed protocol-required follow-up|2|||
163081174|NCT04936308|589006056|FG002|Overall Study|Completed protocol-required follow-up|2|||
163081175|NCT04936308|589006054|FG000|Overall Study|Discontinued study intervention and were being followed|2|||
163081176|NCT04936308|589006055|FG001|Overall Study|Discontinued study intervention and were being followed|2|||
163081177|NCT04936308|589006056|FG002|Overall Study|Discontinued study intervention and were being followed|4|||
163081178|NCT04936308|589006054|FG000|Overall Study|Other|3|||
163081179|NCT04936308|589006055|FG001|Overall Study|Other|0|||
163081180|NCT04936308|589006056|FG002|Overall Study|Other|2|||
163081181|NCT04770272|589006057|FG000|Overall Study|Death|1|||
163081182|NCT04770272|589006058|FG001|Overall Study|Death|0|||
163081183|NCT04770272|589006057|FG000|Overall Study|Withdrawal by Subject|11|||
163081184|NCT04770272|589006058|FG001|Overall Study|Withdrawal by Subject|12|||
163081185|NCT04770272|589006057|FG000|Overall Study|Protocol Violation|0|||
163081186|NCT04770272|589006058|FG001|Overall Study|Protocol Violation|2|||
163081187|NCT04770272|589006057|FG000|Overall Study|Adverse Event|23|||
163081188|NCT04770272|589006058|FG001|Overall Study|Adverse Event|21|||
163081189|NCT04770272|589006057|FG000|Overall Study|Physician Decision|7|||
163081190|NCT04770272|589006058|FG001|Overall Study|Physician Decision|3|||
163081191|NCT04770272|589006057|FG000|Overall Study|Disease progression|4|||
163081192|NCT04770272|589006058|FG001|Overall Study|Disease progression|8|||
163081193|NCT04770272|589006057|FG000|Overall Study|Switched to other therapy.|0|||
163081194|NCT04770272|589006058|FG001|Overall Study|Switched to other therapy.|2|||
163081195|NCT02363946|589006059|FG000|Overall Study|Lost to Follow-up|0|||
163081196|NCT02363946|589006060|FG001|Overall Study|Lost to Follow-up|0|||
163081197|NCT02363946|589006061|FG002|Overall Study|Lost to Follow-up|0|||
163081198|NCT02363946|589006062|FG003|Overall Study|Lost to Follow-up|0|||
163081199|NCT02363946|589006063|FG004|Overall Study|Lost to Follow-up|0|||
163081200|NCT02363946|589006064|FG005|Overall Study|Lost to Follow-up|0|||
163081201|NCT02363946|589006065|FG006|Overall Study|Lost to Follow-up|0|||
163081202|NCT02363946|589006066|FG007|Overall Study|Lost to Follow-up|1|||
163081203|NCT02363946|589006067|FG008|Overall Study|Lost to Follow-up|0|||
163081204|NCT02363946|589006068|FG009|Overall Study|Lost to Follow-up|0|||
163081205|NCT02363946|589006069|FG010|Overall Study|Lost to Follow-up|0|||
163081206|NCT02363946|589006070|FG011|Overall Study|Lost to Follow-up|0|||
163081207|NCT02363946|589006071|FG012|Overall Study|Lost to Follow-up|0|||
163081208|NCT03030261|589006072|FG000|Overall Study|Still receiving continuation therapy|5|||
163081209|NCT01615029|589006073|FG000|Overall Study|Adverse Event|1|||
163081210|NCT01615029|589006074|FG001|Overall Study|Adverse Event|0|||
163081211|NCT01615029|589006075|FG002|Overall Study|Adverse Event|3|||
163081212|NCT01615029|589006076|FG003|Overall Study|Adverse Event|0|||
163081213|NCT01615029|589006077|FG004|Overall Study|Adverse Event|4|||
163081214|NCT01615029|589006073|FG000|Overall Study|Progressive disease|1|||
163081215|NCT01615029|589006074|FG001|Overall Study|Progressive disease|1|||
163081216|NCT01615029|589006075|FG002|Overall Study|Progressive disease|1|||
163081217|NCT01615029|589006076|FG003|Overall Study|Progressive disease|1|||
163081218|NCT01615029|589006077|FG004|Overall Study|Progressive disease|10|||
163081219|NCT01615029|589006073|FG000|Overall Study|Physician Decision|0|||
163081220|NCT01615029|589006074|FG001|Overall Study|Physician Decision|0|||
163081221|NCT01615029|589006075|FG002|Overall Study|Physician Decision|0|||
163081222|NCT01615029|589006076|FG003|Overall Study|Physician Decision|0|||
163081223|NCT01615029|589006077|FG004|Overall Study|Physician Decision|2|||
163081224|NCT05213624|589006078|FG000|Overall Study|Adverse Event|0|||
163081225|NCT05213624|589006079|FG001|Overall Study|Adverse Event|3|||
163081226|NCT05213624|589006080|FG002|Overall Study|Adverse Event|0|||
163081227|NCT05213624|589006081|FG003|Overall Study|Adverse Event|0|||
163081228|NCT05213624|589006078|FG000|Overall Study|Protocol deviation|0|||
163081229|NCT05213624|589006079|FG001|Overall Study|Protocol deviation|2|||
163081230|NCT05213624|589006080|FG002|Overall Study|Protocol deviation|0|||
163081231|NCT05213624|589006081|FG003|Overall Study|Protocol deviation|0|||
163081232|NCT05213624|589006078|FG000|Overall Study|Withdrawal by Subject|0|||
163029815|NCT03589976|588811931|FG001|Overall Study|Withdrawal by Subject|1|||
163029816|NCT03589976|588811930|FG000|Overall Study|Lost to Follow-up|1|||
163029817|NCT03589976|588811931|FG001|Overall Study|Lost to Follow-up|0|||
163029818|NCT03589976|588811930|FG000|Overall Study|Other|4|||
163029819|NCT03589976|588811931|FG001|Overall Study|Other|3|||
163029820|NCT00710684|588811932|FG000|Overall Study|Adverse Event|11|||
163029821|NCT00710684|588811933|FG001|Overall Study|Adverse Event|19|||
163029822|NCT00710684|588811934|FG002|Overall Study|Adverse Event|16|||
163029823|NCT00710684|588811932|FG000|Overall Study|Lack of Efficacy|4|||
163029824|NCT00710684|588811933|FG001|Overall Study|Lack of Efficacy|3|||
163029825|NCT00710684|588811934|FG002|Overall Study|Lack of Efficacy|5|||
163029826|NCT00710684|588811932|FG000|Overall Study|Protocol Violation|5|||
163029827|NCT00710684|588811933|FG001|Overall Study|Protocol Violation|5|||
163029828|NCT00710684|588811934|FG002|Overall Study|Protocol Violation|5|||
163029829|NCT00710684|588811932|FG000|Overall Study|Lost to Follow-up|4|||
163029830|NCT00710684|588811933|FG001|Overall Study|Lost to Follow-up|6|||
163029831|NCT00710684|588811934|FG002|Overall Study|Lost to Follow-up|7|||
163029832|NCT00710684|588811932|FG000|Overall Study|Physician Decision|0|||
163029833|NCT00710684|588811933|FG001|Overall Study|Physician Decision|2|||
163029834|NCT00710684|588811934|FG002|Overall Study|Physician Decision|4|||
163029835|NCT00710684|588811932|FG000|Overall Study|Withdrawal by Subject|24|||
163029836|NCT00710684|588811933|FG001|Overall Study|Withdrawal by Subject|18|||
163029837|NCT00710684|588811934|FG002|Overall Study|Withdrawal by Subject|11|||
163029838|NCT00710684|588811932|FG000|Overall Study|Missing|1|||
163029839|NCT00710684|588811933|FG001|Overall Study|Missing|0|||
163029840|NCT00710684|588811934|FG002|Overall Study|Missing|0|||
163029841|NCT00710684|588811932|FG000|Overall Study|Did not continue after week 24|25|||
163029842|NCT00710684|588811933|FG001|Overall Study|Did not continue after week 24|21|||
163029843|NCT00710684|588811934|FG002|Overall Study|Did not continue after week 24|16|||
163029844|NCT04778059|588811935|FG000|Overall Study|Death|2|||
163029845|NCT04778059|588811936|FG001|Overall Study|Death|2|||
163029846|NCT04778059|588811937|FG002|Overall Study|Death|1|||
163029847|NCT04778059|588811938|FG003|Overall Study|Death|1|||
163029848|NCT04778059|588811939|FG004|Overall Study|Death|1|||
163029849|NCT04778059|588811935|FG000|Overall Study|Lost to Follow-up|0|||
163029850|NCT04778059|588811936|FG001|Overall Study|Lost to Follow-up|0|||
163029851|NCT04778059|588811937|FG002|Overall Study|Lost to Follow-up|0|||
163029852|NCT04778059|588811938|FG003|Overall Study|Lost to Follow-up|0|||
163029853|NCT04778059|588811939|FG004|Overall Study|Lost to Follow-up|1|||
163029854|NCT04778059|588811935|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
163029855|NCT04778059|588811936|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
163029856|NCT04778059|588811937|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
163029857|NCT04778059|588811938|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
163029858|NCT04778059|588811939|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
163029859|NCT02832375|588811940|FG000|Overall Study|Lost to Follow-up|1|||
163029860|NCT02832375|588811941|FG001|Overall Study|Lost to Follow-up|0|||
163029861|NCT02832375|588811940|FG000|Overall Study|Withdrawal of Consent|1|||
163029862|NCT02832375|588811941|FG001|Overall Study|Withdrawal of Consent|0|||
163029863|NCT00514904|588811942|FG000|Overall Study|Withdrawal by Subject|3|||
163029864|NCT00514904|588811943|FG001|Overall Study|Withdrawal by Subject|2|||
163029865|NCT00514904|588811942|FG000|Overall Study|Lost to Follow-up|21|||
163029866|NCT00514904|588811943|FG001|Overall Study|Lost to Follow-up|3|||
163029867|NCT00084318|588811944|FG000|Overall Study|Withdrawal by Subject|5|||
163029868|NCT00084318|588811945|FG001|Overall Study|Withdrawal by Subject|2|||
163029869|NCT00084318|588811944|FG000|Overall Study|Protocol Violation|15|||
163029870|NCT00084318|588811945|FG001|Overall Study|Protocol Violation|11|||
163029871|NCT00084318|588811944|FG000|Overall Study|No protocol treatment|2|||
163029872|NCT00084318|588811945|FG001|Overall Study|No protocol treatment|0|||
163029873|NCT00549601|588813708|FG000|Randomized|Protocol Violation|0|||
163029874|NCT00549601|588813709|FG001|Randomized|Protocol Violation|0|||
163029875|NCT00549601|588813710|FG002|Randomized|Protocol Violation|1|||
163029876|NCT00549601|588813708|FG000|Randomized|Withdrawal by Subject|0|||
163029877|NCT00549601|588813709|FG001|Randomized|Withdrawal by Subject|1|||
163029878|NCT00549601|588813710|FG002|Randomized|Withdrawal by Subject|1|||
163029879|NCT00549601|588813708|FG000|Received Study Drug|Adverse Event|2|||
163029880|NCT00549601|588813709|FG001|Received Study Drug|Adverse Event|5|||
163029881|NCT00549601|588813710|FG002|Received Study Drug|Adverse Event|1|||
163029882|NCT00549601|588813708|FG000|Received Study Drug|Death|0|||
163029883|NCT00549601|588813709|FG001|Received Study Drug|Death|1|||
163029884|NCT00549601|588813710|FG002|Received Study Drug|Death|0|||
163029885|NCT00549601|588813708|FG000|Received Study Drug|Lost to Follow-up|0|||
163029886|NCT00549601|588813709|FG001|Received Study Drug|Lost to Follow-up|1|||
163029887|NCT00549601|588813710|FG002|Received Study Drug|Lost to Follow-up|1|||
163029888|NCT00549601|588813708|FG000|Received Study Drug|Protocol Violation|3|||
163029889|NCT00549601|588813709|FG001|Received Study Drug|Protocol Violation|4|||
163029890|NCT00549601|588813710|FG002|Received Study Drug|Protocol Violation|1|||
163029891|NCT00549601|588813708|FG000|Received Study Drug|Withdrawal by Subject|2|||
163029892|NCT00549601|588813709|FG001|Received Study Drug|Withdrawal by Subject|0|||
163219380|NCT02658890|589519405|FG014|Treatment Phase|Lost to Follow-up|0|||
163081233|NCT05213624|589006079|FG001|Overall Study|Withdrawal by Subject|0|||
163081234|NCT05213624|589006080|FG002|Overall Study|Withdrawal by Subject|0|||
163081235|NCT05213624|589006081|FG003|Overall Study|Withdrawal by Subject|1|||
163081236|NCT05213624|589006078|FG000|Overall Study|Not treated|0|||
163081237|NCT05213624|589006079|FG001|Overall Study|Not treated|1|||
163081238|NCT05213624|589006080|FG002|Overall Study|Not treated|2|||
163081239|NCT05213624|589006081|FG003|Overall Study|Not treated|2|||
163081240|NCT01602380|589006082|FG000|Overall Study|Death|147|||
163081241|NCT01602380|589006083|FG001|Overall Study|Death|145|||
163081242|NCT01602380|589006082|FG000|Overall Study|Withdrawal by Subject|39|||
163081243|NCT01602380|589006083|FG001|Overall Study|Withdrawal by Subject|41|||
163081244|NCT01602380|589006082|FG000|Overall Study|Lost to Follow-up|15|||
163081245|NCT01602380|589006083|FG001|Overall Study|Lost to Follow-up|12|||
163081246|NCT01602380|589006082|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
163081247|NCT01602380|589006083|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
163081248|NCT01602380|589006082|FG000|Overall Study|Other|2|||
163081249|NCT01602380|589006083|FG001|Overall Study|Other|0|||
163081250|NCT01044459|589006085|FG000|Overall Study|Withdrawal by Subject|21|||
163081251|NCT01044459|589006086|FG001|Overall Study|Withdrawal by Subject|28|||
163081252|NCT01044459|589006085|FG000|Overall Study|Terminated by Sponsor|22|||
163081253|NCT01044459|589006086|FG001|Overall Study|Terminated by Sponsor|21|||
163081254|NCT01044459|589006085|FG000|Overall Study|Adverse Event|22|||
163081255|NCT01044459|589006086|FG001|Overall Study|Adverse Event|20|||
163081256|NCT01044459|589006085|FG000|Overall Study|Lack of Efficacy|23|||
163081257|NCT01044459|589006086|FG001|Overall Study|Lack of Efficacy|12|||
163081258|NCT01044459|589006085|FG000|Overall Study|Protocol Violation|11|||
163081259|NCT01044459|589006086|FG001|Overall Study|Protocol Violation|16|||
163081260|NCT01044459|589006085|FG000|Overall Study|Other Reason|7|||
163081261|NCT01044459|589006086|FG001|Overall Study|Other Reason|14|||
163081262|NCT01044459|589006085|FG000|Overall Study|COPD exacerbation|9|||
163081263|NCT01044459|589006086|FG001|Overall Study|COPD exacerbation|8|||
163081264|NCT01044459|589006085|FG000|Overall Study|Lost to Follow-up|18|||
163081265|NCT01044459|589006086|FG001|Overall Study|Lost to Follow-up|12|||
163081266|NCT00787800|589006091|FG000|Overall Study|Withdrawal by Subject|3|||
163081267|NCT00787800|589006092|FG001|Overall Study|Withdrawal by Subject|5|||
163081268|NCT00787800|589006091|FG000|Overall Study|Death|0|||
163219381|NCT02658890|589519406|FG015|Treatment Phase|Lost to Follow-up|0|||
163219382|NCT02658890|589519407|FG016|Treatment Phase|Lost to Follow-up|0|||
163219383|NCT02658890|589519408|FG017|Treatment Phase|Lost to Follow-up|0|||
163219384|NCT02658890|589519409|FG018|Treatment Phase|Lost to Follow-up|0|||
163219385|NCT02658890|589519410|FG019|Treatment Phase|Lost to Follow-up|0|||
163219386|NCT02658890|589519411|FG020|Treatment Phase|Lost to Follow-up|0|||
163219387|NCT02658890|589519412|FG021|Treatment Phase|Lost to Follow-up|0|||
163219388|NCT02658890|589519413|FG022|Treatment Phase|Lost to Follow-up|0|||
163332400|NCT02079649|589927653|FG003|Overall Study|Randomization error (prior to treatment)|0|||
163332401|NCT01932970|589927676|FG000|Overall Study|Withdrawal by Subject|5|||
163332402|NCT01932970|589927676|FG000|Overall Study|Death|1|||
163332403|NCT01932970|589927676|FG000|Overall Study|Lost to Follow-up|2|||
163332404|NCT01932970|589927676|FG000|Overall Study|Protocol Specified Criteria|10|||
163332405|NCT00822900|589927677|FG000|Overall Study|Withdrawal by Subject|14|||
163332406|NCT00822900|589927678|FG001|Overall Study|Withdrawal by Subject|14|||
163332407|NCT00822900|589927677|FG000|Overall Study|Lost to Follow-up|9|||
163332408|NCT00822900|589927678|FG001|Overall Study|Lost to Follow-up|9|||
163332409|NCT00822900|589927677|FG000|Overall Study|Death|83|||
163332410|NCT00822900|589927678|FG001|Overall Study|Death|69|||
163332411|NCT00822900|589927677|FG000|Overall Study|Became a ward of the state|2|||
163081269|NCT00787800|589006092|FG001|Overall Study|Death|2|||
163081270|NCT03369704|589006096|FG000|Treatment Epoch|technical problems|1|||
163081271|NCT03369704|589006097|FG001|Treatment Epoch|technical problems|0|||
163081272|NCT03369704|589006096|FG000|Treatment Epoch|Protocol Violation|1|||
163081273|NCT03369704|589006097|FG001|Treatment Epoch|Protocol Violation|0|||
163081274|NCT03369704|589006096|FG000|Treatment Epoch|Lost to Follow-up|0|||
163081275|NCT03369704|589006097|FG001|Treatment Epoch|Lost to Follow-up|1|||
163081276|NCT03369704|589006096|FG000|Treatment Epoch|Lack of Efficacy|0|||
163219389|NCT02658890|589519414|FG023|Treatment Phase|Lost to Follow-up|0|||
163332412|NCT00822900|589927678|FG001|Overall Study|Became a ward of the state|1|||
163332413|NCT01968967|589927679|FG000|Treatment Period|Other|22|||
163332414|NCT01968967|589927680|FG001|Treatment Period|Other|22|||
163081277|NCT03369704|589006097|FG001|Treatment Epoch|Lack of Efficacy|2|||
163081278|NCT03369704|589006096|FG000|Treatment Epoch|Adverse Event|2|||
163081279|NCT03369704|589006097|FG001|Treatment Epoch|Adverse Event|0|||
163081280|NCT03369704|589006096|FG000|Follow-up Epoch|Lost to Follow-up|1|||
163081281|NCT03369704|589006097|FG001|Follow-up Epoch|Lost to Follow-up|0|||
163081282|NCT01905683|589006101|FG000|Overall Study|Protocol Violation|1|||
163081283|NCT01905683|589006101|FG000|Overall Study|Re-injection criteria not met; others|13|||
163081284|NCT01905683|589006101|FG000|Overall Study|Physician Decision|1|||
163081285|NCT01905683|589006101|FG000|Overall Study|Lack of Efficacy|8|||
163219390|NCT02658890|589519415|FG024|Treatment Phase|Lost to Follow-up|0|||
163219391|NCT02658890|589519416|FG025|Treatment Phase|Lost to Follow-up|0|||
163332415|NCT01968967|589927681|FG002|Treatment Period|Other|0|||
163081286|NCT01905683|589006101|FG000|Overall Study|Withdrawal by Subject|20|||
163081287|NCT01905683|589006101|FG000|Overall Study|Adverse Event|4|||
163081288|NCT01905683|589006101|FG000|Overall Study|Lost to Follow-up|4|||
163081289|NCT02037984|589006104|FG000|Overall Study|Lack of Efficacy|0|||
163081290|NCT02037984|589006105|FG001|Overall Study|Lack of Efficacy|0|||
163081291|NCT02037984|589006106|FG002|Overall Study|Lack of Efficacy|3|||
163081292|NCT02037984|589006107|FG003|Overall Study|Lack of Efficacy|10|||
163081293|NCT02037984|589006108|FG004|Overall Study|Lack of Efficacy|2|||
163081294|NCT02037984|589006109|FG005|Overall Study|Lack of Efficacy|2|||
163081295|NCT02037984|589006110|FG006|Overall Study|Lack of Efficacy|4|||
163081296|NCT02037984|589006111|FG007|Overall Study|Lack of Efficacy|3|||
163081297|NCT02037984|589006104|FG000|Overall Study|Lost to Follow-up|1|||
163081298|NCT02037984|589006105|FG001|Overall Study|Lost to Follow-up|0|||
163081299|NCT02037984|589006106|FG002|Overall Study|Lost to Follow-up|3|||
163081300|NCT02037984|589006107|FG003|Overall Study|Lost to Follow-up|5|||
163081301|NCT02037984|589006108|FG004|Overall Study|Lost to Follow-up|2|||
163081302|NCT02037984|589006109|FG005|Overall Study|Lost to Follow-up|2|||
163081303|NCT02037984|589006110|FG006|Overall Study|Lost to Follow-up|2|||
163081304|NCT02037984|589006111|FG007|Overall Study|Lost to Follow-up|4|||
163081305|NCT02037984|589006104|FG000|Overall Study|Physician Decision|0|||
163081306|NCT02037984|589006105|FG001|Overall Study|Physician Decision|0|||
163081307|NCT02037984|589006106|FG002|Overall Study|Physician Decision|0|||
163081308|NCT02037984|589006107|FG003|Overall Study|Physician Decision|0|||
163081309|NCT02037984|589006108|FG004|Overall Study|Physician Decision|0|||
163081310|NCT02037984|589006109|FG005|Overall Study|Physician Decision|0|||
163081311|NCT02037984|589006110|FG006|Overall Study|Physician Decision|1|||
163081312|NCT02037984|589006111|FG007|Overall Study|Physician Decision|0|||
163081313|NCT02037984|589006104|FG000|Overall Study|Protocol Violation|0|||
163081314|NCT02037984|589006105|FG001|Overall Study|Protocol Violation|0|||
163081315|NCT02037984|589006106|FG002|Overall Study|Protocol Violation|0|||
163081316|NCT02037984|589006107|FG003|Overall Study|Protocol Violation|0|||
163081317|NCT02037984|589006108|FG004|Overall Study|Protocol Violation|0|||
163081318|NCT02037984|589006109|FG005|Overall Study|Protocol Violation|1|||
163081319|NCT02037984|589006110|FG006|Overall Study|Protocol Violation|2|||
163081320|NCT02037984|589006111|FG007|Overall Study|Protocol Violation|0|||
163081321|NCT02037984|589006104|FG000|Overall Study|Technical Problems|0|||
163081322|NCT02037984|589006105|FG001|Overall Study|Technical Problems|0|||
163081323|NCT02037984|589006106|FG002|Overall Study|Technical Problems|3|||
163081324|NCT02037984|589006107|FG003|Overall Study|Technical Problems|3|||
163081325|NCT02037984|589006108|FG004|Overall Study|Technical Problems|2|||
163029893|NCT00549601|588813710|FG002|Received Study Drug|Withdrawal by Subject|1|||
163029894|NCT00908596|588813714|FG000|Overall Study|Other reasons|46|||
163029895|NCT00908596|588813715|FG001|Overall Study|Other reasons|6|||
163029896|NCT00908596|588813716|FG002|Overall Study|Other reasons|2|||
163029897|NCT00908596|588813717|FG003|Overall Study|Other reasons|0|||
163029898|NCT00908596|588813714|FG000|Overall Study|Lost to Follow-up|0|||
163029899|NCT00908596|588813715|FG001|Overall Study|Lost to Follow-up|1|||
163029900|NCT00908596|588813716|FG002|Overall Study|Lost to Follow-up|12|||
163029901|NCT00908596|588813717|FG003|Overall Study|Lost to Follow-up|4|||
163029902|NCT00908596|588813714|FG000|Overall Study|Death|0|||
163029903|NCT00908596|588813715|FG001|Overall Study|Death|5|||
163029904|NCT00908596|588813716|FG002|Overall Study|Death|57|||
163029905|NCT00908596|588813717|FG003|Overall Study|Death|32|||
163029906|NCT00908596|588813714|FG000|Overall Study|Protocol Violation|1|||
163029907|NCT00908596|588813715|FG001|Overall Study|Protocol Violation|0|||
163029908|NCT00908596|588813716|FG002|Overall Study|Protocol Violation|0|||
163029909|NCT00908596|588813717|FG003|Overall Study|Protocol Violation|0|||
163029910|NCT00908596|588813714|FG000|Overall Study|Withdrawal by Subject|0|||
163029911|NCT00908596|588813715|FG001|Overall Study|Withdrawal by Subject|1|||
163029912|NCT00908596|588813716|FG002|Overall Study|Withdrawal by Subject|3|||
163029913|NCT00908596|588813717|FG003|Overall Study|Withdrawal by Subject|1|||
163029914|NCT00224406|588813718|FG000|Overall Study|Re-transplant|0|||
163029915|NCT00224406|588813719|FG001|Overall Study|Re-transplant|2|||
163029916|NCT00224406|588813718|FG000|Overall Study|Death|0|||
163029917|NCT00224406|588813719|FG001|Overall Study|Death|1|||
163029918|NCT00224406|588813718|FG000|Overall Study|Transplant cancelled|0|||
163029919|NCT00224406|588813719|FG001|Overall Study|Transplant cancelled|4|||
163029920|NCT00224406|588813718|FG000|Overall Study|Drug not delivered|2|||
163029921|NCT00224406|588813719|FG001|Overall Study|Drug not delivered|0|||
163029922|NCT00224406|588813718|FG000|Overall Study|Other|4|||
163029923|NCT00224406|588813719|FG001|Overall Study|Other|0|||
163029924|NCT00224406|588813718|FG000|Overall Study|Transplant cancelled|3|||
163219392|NCT02658890|589519417|FG026|Treatment Phase|Lost to Follow-up|0|||
163029925|NCT00224406|588813719|FG001|Overall Study|Transplant cancelled|0|||
163029926|NCT04823130|588813724|FG000|Overall Study|Withdrawal by Subject|2|||
163029927|NCT04823130|588813725|FG001|Overall Study|Withdrawal by Subject|3|||
163029928|NCT04823130|588813724|FG000|Overall Study|Failure to meet inclusion criteria|6|||
163029929|NCT04823130|588813725|FG001|Overall Study|Failure to meet inclusion criteria|4|||
163081326|NCT02037984|589006109|FG005|Overall Study|Technical Problems|3|||
163081327|NCT02037984|589006110|FG006|Overall Study|Technical Problems|4|||
163081328|NCT02037984|589006111|FG007|Overall Study|Technical Problems|2|||
163219393|NCT02658890|589519391|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
163219394|NCT02658890|589519392|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
163219395|NCT02658890|589519393|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
163219396|NCT02658890|589519394|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
163219397|NCT02658890|589519395|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
163219398|NCT02658890|589519396|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
163219399|NCT02658890|589519397|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
163219400|NCT02658890|589519398|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
163219401|NCT02658890|589519399|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
163332416|NCT01968967|589927682|FG003|Treatment Period|Other|0|||
163029930|NCT04823130|588813724|FG000|Overall Study|Other-unspecified|1|||
163029931|NCT04823130|588813725|FG001|Overall Study|Other-unspecified|0|||
163029932|NCT03315455|588813727|FG000|Overall Study|Ongoing in the Study|13|||
163029933|NCT03315455|588813728|FG001|Overall Study|Ongoing in the Study|24|||
163029934|NCT03315455|588813729|FG002|Overall Study|Ongoing in the Study|17|||
163029935|NCT03315455|588813730|FG003|Overall Study|Ongoing in the Study|15|||
163029936|NCT03315455|588813727|FG000|Overall Study|Withdrawal by Subject|0|||
163029937|NCT03315455|588813728|FG001|Overall Study|Withdrawal by Subject|1|||
163029938|NCT03315455|588813729|FG002|Overall Study|Withdrawal by Subject|0|||
163029939|NCT03315455|588813730|FG003|Overall Study|Withdrawal by Subject|0|||
163029940|NCT01846221|588813733|FG000|Overall Study|Catheter Failure|2|||
163029941|NCT01846221|588813734|FG001|Overall Study|Catheter Failure|0|||
163029942|NCT01846221|588813733|FG000|Overall Study|Age Exclusion|1|||
163029943|NCT01846221|588813734|FG001|Overall Study|Age Exclusion|0|||
163029944|NCT03427268|588813735|FG000|Overall Study|Progressive disease|25|||
163029945|NCT03427268|588813735|FG000|Overall Study|Never treated|2|||
163029946|NCT03427268|588813735|FG000|Overall Study|Compassionate use|1|||
163029947|NCT03427268|588813735|FG000|Overall Study|Withdrawal by Subject|1|||
163029948|NCT03427268|588813735|FG000|Overall Study|Adverse Event|3|||
163029949|NCT02304380|588813737|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
163029950|NCT02304380|588813738|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
163029951|NCT02304380|588813739|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
163029952|NCT02304380|588813740|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
163029953|NCT02304380|588813741|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
163029954|NCT02304380|588813742|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
163029955|NCT01027897|588813743|FG000|Overall Study|Protocol Violation|1|||
163029956|NCT01027897|588813743|FG000|Overall Study|Withdrawal by Subject|1|||
163029957|NCT00328094|588813744|FG000|Overall Study|Physician Decision|3|||
163029958|NCT00328094|588813745|FG001|Overall Study|Physician Decision|3|||
163029959|NCT00473824|588813746|FG000|Overall Study|Virologic Breakthrough|1|||
163029960|NCT00473824|588813747|FG001|Overall Study|Virologic Breakthrough|0|||
163029961|NCT00473824|588813746|FG000|Overall Study|Adverse Event|1|||
163029962|NCT00473824|588813747|FG001|Overall Study|Adverse Event|0|||
163029963|NCT00473824|588813746|FG000|Overall Study|Death|1|||
163029964|NCT00473824|588813747|FG001|Overall Study|Death|0|||
163029965|NCT00473824|588813746|FG000|Overall Study|Lost to Follow-up|1|||
163029966|NCT00473824|588813747|FG001|Overall Study|Lost to Follow-up|0|||
163029967|NCT00473824|588813746|FG000|Overall Study|Withdrawal by physician|1|||
163029968|NCT00473824|588813747|FG001|Overall Study|Withdrawal by physician|0|||
163029969|NCT01349322|588813748|FG000|Overall Study|Protocol Violation|45|||
163029970|NCT01349322|588813749|FG001|Overall Study|Protocol Violation|47|||
163029971|NCT04076059|588813755|FG000|Double Blind Phase|Progressive disease|22|||
163029972|NCT04076059|588813756|FG001|Double Blind Phase|Progressive disease|26|||
163029973|NCT04076059|588813757|FG002|Double Blind Phase|Progressive disease|0|||
163029974|NCT04076059|588813755|FG000|Double Blind Phase|Withdrawal by Subject|4|||
163029975|NCT04076059|588813756|FG001|Double Blind Phase|Withdrawal by Subject|11|||
163029976|NCT04076059|588813757|FG002|Double Blind Phase|Withdrawal by Subject|0|||
163029977|NCT04076059|588813755|FG000|Double Blind Phase|Death|1|||
163029978|NCT04076059|588813756|FG001|Double Blind Phase|Death|1|||
163029979|NCT04076059|588813757|FG002|Double Blind Phase|Death|0|||
163029980|NCT04076059|588813755|FG000|Double Blind Phase|Lost to Follow-up|1|||
163029981|NCT04076059|588813756|FG001|Double Blind Phase|Lost to Follow-up|0|||
163029982|NCT04076059|588813757|FG002|Double Blind Phase|Lost to Follow-up|0|||
163029983|NCT04076059|588813755|FG000|Double Blind Phase|Adverse Event|5|||
163029984|NCT04076059|588813756|FG001|Double Blind Phase|Adverse Event|1|||
163029985|NCT04076059|588813757|FG002|Double Blind Phase|Adverse Event|0|||
163029986|NCT04076059|588813755|FG000|Double Blind Phase|Ongoing Participants|82|||
163029987|NCT04076059|588813756|FG001|Double Blind Phase|Ongoing Participants|18|||
163029988|NCT04076059|588813757|FG002|Double Blind Phase|Ongoing Participants|0|||
163219402|NCT02658890|589519400|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
163332417|NCT01968967|589927683|FG004|Treatment Period|Other|0|||
163029989|NCT04076059|588813755|FG000|Double Blind Phase|Miscellaneous|3|||
163029990|NCT04076059|588813756|FG001|Double Blind Phase|Miscellaneous|1|||
163029991|NCT04076059|588813757|FG002|Double Blind Phase|Miscellaneous|0|||
163029992|NCT04076059|588813755|FG000|Double Blind Phase|Protocol Deviation|1|||
163029993|NCT04076059|588813756|FG001|Double Blind Phase|Protocol Deviation|1|||
163029994|NCT04076059|588813757|FG002|Double Blind Phase|Protocol Deviation|0|||
163219403|NCT02658890|589519401|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
163219404|NCT02658890|589519402|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
163406452|NCT03311711|590198642|FG007|Overall Study|Death of dyad partner|1|||
163029995|NCT04076059|588813755|FG000|Double Blind Phase|Did not take study drug|1|||
163029996|NCT04076059|588813756|FG001|Double Blind Phase|Did not take study drug|1|||
163029997|NCT04076059|588813757|FG002|Double Blind Phase|Did not take study drug|0|||
163029998|NCT04076059|588813755|FG000|Open Label Phase|Progressive disease|0|||
163029999|NCT04076059|588813756|FG001|Open Label Phase|Progressive disease|0|||
163030000|NCT04076059|588813757|FG002|Open Label Phase|Progressive disease|7|||
163030001|NCT04076059|588813755|FG000|Open Label Phase|Withdrawal by Subject|0|||
163030002|NCT04076059|588813756|FG001|Open Label Phase|Withdrawal by Subject|0|||
163030003|NCT04076059|588813757|FG002|Open Label Phase|Withdrawal by Subject|3|||
163030004|NCT04076059|588813755|FG000|Open Label Phase|Death|0|||
163030005|NCT04076059|588813756|FG001|Open Label Phase|Death|0|||
163030006|NCT04076059|588813757|FG002|Open Label Phase|Death|2|||
163030007|NCT04076059|588813755|FG000|Open Label Phase|Ongoing Participants|0|||
163030008|NCT04076059|588813756|FG001|Open Label Phase|Ongoing Participants|0|||
163030009|NCT04076059|588813757|FG002|Open Label Phase|Ongoing Participants|11|||
163030010|NCT04186806|588813758|FG000|Period 1: 7 Days|Adverse Event|1|||
163030011|NCT04186806|588813759|FG001|Period 1: 7 Days|Adverse Event|0|||
163030012|NCT02720744|588813761|FG000|Overall Study|Protocol Violation|0|||
163030013|NCT02720744|588813762|FG001|Overall Study|Protocol Violation|2|||
163030014|NCT02720744|588813761|FG000|Overall Study|Pregnancy|2|||
163030015|NCT02720744|588813762|FG001|Overall Study|Pregnancy|0|||
163030016|NCT02720744|588813761|FG000|Overall Study|Lack of Efficacy|2|||
163030017|NCT02720744|588813762|FG001|Overall Study|Lack of Efficacy|8|||
163030018|NCT02720744|588813761|FG000|Overall Study|Adverse Event|21|||
163030019|NCT02720744|588813762|FG001|Overall Study|Adverse Event|3|||
163030020|NCT02720744|588813761|FG000|Overall Study|Withdrawal by Subject|11|||
163030021|NCT02720744|588813762|FG001|Overall Study|Withdrawal by Subject|11|||
163030022|NCT02720744|588813761|FG000|Overall Study|Lost to follow up|2|||
163030023|NCT02720744|588813762|FG001|Overall Study|Lost to follow up|0|||
163030024|NCT02720744|588813761|FG000|Overall Study|Non Compliance with Investigational Product|0|||
163030025|NCT02720744|588813762|FG001|Overall Study|Non Compliance with Investigational Product|1|||
163030026|NCT02720744|588813761|FG000|Overall Study|Excluded Concomitant Medication|0|||
163030027|NCT02720744|588813762|FG001|Overall Study|Excluded Concomitant Medication|1|||
163030028|NCT02122770|588813763|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
163030029|NCT02122770|588813764|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
163030030|NCT02122770|588813765|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
163030031|NCT02122770|588813766|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
163030032|NCT02122770|588813767|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
163030033|NCT02122770|588813768|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
163030034|NCT02122770|588813763|FG000|Part A: Drug-drug Interaction 2|Other|0|||
163030035|NCT02122770|588813764|FG001|Part A: Drug-drug Interaction 2|Other|0|||
163030036|NCT02122770|588813765|FG002|Part A: Drug-drug Interaction 2|Other|1|||
163030037|NCT02122770|588813766|FG003|Part A: Drug-drug Interaction 2|Other|0|||
163030038|NCT02122770|588813767|FG004|Part A: Drug-drug Interaction 2|Other|0|||
163030039|NCT02122770|588813768|FG005|Part A: Drug-drug Interaction 2|Other|0|||
163030040|NCT02122770|588813763|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
163030041|NCT02122770|588813764|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
163030042|NCT02122770|588813765|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
163030043|NCT02122770|588813766|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
163030044|NCT02122770|588813767|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
163030045|NCT02122770|588813768|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
163030046|NCT02122770|588813763|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
163030047|NCT02122770|588813764|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
163030048|NCT02122770|588813765|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
163030049|NCT02122770|588813766|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
163030050|NCT02122770|588813767|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
163030051|NCT02122770|588813768|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
163030052|NCT02122770|588813763|FG000|Part B: Standard of Care|Adverse Event|0|||
163030053|NCT02122770|588813764|FG001|Part B: Standard of Care|Adverse Event|0|||
163030054|NCT02122770|588813765|FG002|Part B: Standard of Care|Adverse Event|0|||
163030055|NCT02122770|588813766|FG003|Part B: Standard of Care|Adverse Event|0|||
163030056|NCT02122770|588813767|FG004|Part B: Standard of Care|Adverse Event|4|||
163030057|NCT02122770|588813768|FG005|Part B: Standard of Care|Adverse Event|1|||
163030058|NCT02122770|588813763|FG000|Part B: Standard of Care|Other|0|||
163030059|NCT02122770|588813764|FG001|Part B: Standard of Care|Other|0|||
163030060|NCT02122770|588813765|FG002|Part B: Standard of Care|Other|0|||
163030061|NCT02122770|588813766|FG003|Part B: Standard of Care|Other|0|||
163030062|NCT02122770|588813767|FG004|Part B: Standard of Care|Other|0|||
163030063|NCT02122770|588813768|FG005|Part B: Standard of Care|Other|2|||
163030064|NCT02122770|588813763|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
163030065|NCT02122770|588813764|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
163081329|NCT02037984|589006104|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163081330|NCT02037984|589006105|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163081331|NCT02037984|589006106|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
163081332|NCT02037984|589006107|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
163081333|NCT02037984|589006108|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
163081334|NCT02037984|589006109|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
163081335|NCT02037984|589006110|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
163081336|NCT02037984|589006111|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
163081337|NCT02037984|589006104|FG000|Overall Study|Withdrawal by Subject|0|||
163081338|NCT02037984|589006105|FG001|Overall Study|Withdrawal by Subject|0|||
163081339|NCT02037984|589006106|FG002|Overall Study|Withdrawal by Subject|0|||
163081340|NCT02037984|589006107|FG003|Overall Study|Withdrawal by Subject|1|||
163081341|NCT02037984|589006108|FG004|Overall Study|Withdrawal by Subject|1|||
163081342|NCT02037984|589006109|FG005|Overall Study|Withdrawal by Subject|3|||
163081343|NCT02037984|589006110|FG006|Overall Study|Withdrawal by Subject|0|||
163081344|NCT02037984|589006111|FG007|Overall Study|Withdrawal by Subject|1|||
163081345|NCT04693715|589006977|FG000|Overall Study|Adverse Events Leading to Death|2|||
163081346|NCT04693715|589006978|FG001|Overall Study|Adverse Events Leading to Death|2|||
163081347|NCT04693715|589006979|FG002|Overall Study|Adverse Events Leading to Death|4|||
163081348|NCT04693715|589006977|FG000|Overall Study|Lost to Follow-up|0|||
163081349|NCT04693715|589006978|FG001|Overall Study|Lost to Follow-up|2|||
163081350|NCT04693715|589006979|FG002|Overall Study|Lost to Follow-up|2|||
163081351|NCT04693715|589006977|FG000|Overall Study|Physician Decision|0|||
163081352|NCT04693715|589006978|FG001|Overall Study|Physician Decision|1|||
163081353|NCT04693715|589006979|FG002|Overall Study|Physician Decision|0|||
163081354|NCT04693715|589006977|FG000|Overall Study|Withdrawal by Legal Authorized Representative|0|||
163081355|NCT04693715|589006978|FG001|Overall Study|Withdrawal by Legal Authorized Representative|1|||
163081356|NCT04693715|589006979|FG002|Overall Study|Withdrawal by Legal Authorized Representative|0|||
163081357|NCT04693715|589006977|FG000|Overall Study|Withdrawal by Subject|0|||
163081358|NCT04693715|589006978|FG001|Overall Study|Withdrawal by Subject|0|||
163081359|NCT04693715|589006979|FG002|Overall Study|Withdrawal by Subject|1|||
163081360|NCT06433908|589006980|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|1|||
163081361|NCT06433908|589006981|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
163081362|NCT06433908|589006982|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
163081363|NCT06433908|589006983|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
163081364|NCT06433908|589006980|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
163081365|NCT06433908|589006981|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|1|||
163081366|NCT06433908|589006982|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
163081367|NCT06433908|589006983|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
163081368|NCT06433908|589006980|FG000|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
163081369|NCT06433908|589006981|FG001|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
163081370|NCT06433908|589006982|FG002|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|1|||
163081371|NCT06433908|589006983|FG003|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
163081372|NCT04403880|589006984|FG000|Overall Study|Death|1|||
163081373|NCT04403880|589006985|FG001|Overall Study|Death|0|||
163081374|NCT04403880|589006986|FG002|Overall Study|Death|2|||
163081375|NCT04403880|589006987|FG003|Overall Study|Death|0|||
163081376|NCT04403880|589006988|FG004|Overall Study|Death|0|||
163219405|NCT02658890|589519403|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
163219406|NCT02658890|589519404|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
163219407|NCT02658890|589519405|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
163219408|NCT02658890|589519406|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
163219409|NCT02658890|589519407|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
163219410|NCT02658890|589519408|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
163219411|NCT02658890|589519409|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
163219412|NCT02658890|589519410|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
163219413|NCT02658890|589519411|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
163219414|NCT02658890|589519412|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
163219415|NCT02658890|589519413|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
163219416|NCT02658890|589519414|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
163219417|NCT02658890|589519415|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
163081377|NCT04403880|589006989|FG005|Overall Study|Death|0|||
163081378|NCT04403880|589006990|FG006|Overall Study|Death|0|||
163081379|NCT04403880|589006984|FG000|Overall Study|Physician Decision|0|||
163081380|NCT04403880|589006985|FG001|Overall Study|Physician Decision|0|||
163081381|NCT04403880|589006986|FG002|Overall Study|Physician Decision|0|||
163081382|NCT04403880|589006987|FG003|Overall Study|Physician Decision|0|||
163081383|NCT04403880|589006988|FG004|Overall Study|Physician Decision|1|||
163081384|NCT04403880|589006989|FG005|Overall Study|Physician Decision|0|||
163081385|NCT04403880|589006990|FG006|Overall Study|Physician Decision|0|||
163081386|NCT04403880|589006984|FG000|Overall Study|Lost to Follow-up|4|||
163081387|NCT04403880|589006985|FG001|Overall Study|Lost to Follow-up|3|||
163081388|NCT04403880|589006986|FG002|Overall Study|Lost to Follow-up|8|||
163081389|NCT04403880|589006987|FG003|Overall Study|Lost to Follow-up|7|||
163081390|NCT04403880|589006988|FG004|Overall Study|Lost to Follow-up|8|||
163081391|NCT04403880|589006989|FG005|Overall Study|Lost to Follow-up|1|||
163081392|NCT04403880|589006990|FG006|Overall Study|Lost to Follow-up|8|||
163081393|NCT04403880|589006984|FG000|Overall Study|Withdrawal by Subject|8|||
163081394|NCT04403880|589006985|FG001|Overall Study|Withdrawal by Subject|9|||
163081395|NCT04403880|589006986|FG002|Overall Study|Withdrawal by Subject|22|||
163081396|NCT04403880|589006987|FG003|Overall Study|Withdrawal by Subject|16|||
163081397|NCT04403880|589006988|FG004|Overall Study|Withdrawal by Subject|16|||
163081398|NCT04403880|589006989|FG005|Overall Study|Withdrawal by Subject|8|||
163081399|NCT04403880|589006990|FG006|Overall Study|Withdrawal by Subject|11|||
163081400|NCT04403880|589006984|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
163081401|NCT04403880|589006985|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|5|||
163081402|NCT04403880|589006986|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|12|||
163081403|NCT04403880|589006987|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
163081404|NCT04403880|589006988|FG004|Overall Study|Participant Unable to Adhere to Visit Schedule|8|||
163081405|NCT04403880|589006989|FG005|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
163081406|NCT04403880|589006990|FG006|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
163081407|NCT04403880|589006984|FG000|Overall Study|Participant Unable to Comply with Study Procedure|7|||
163081408|NCT04403880|589006985|FG001|Overall Study|Participant Unable to Comply with Study Procedure|1|||
163081409|NCT04403880|589006986|FG002|Overall Study|Participant Unable to Comply with Study Procedure|7|||
163081410|NCT04403880|589006987|FG003|Overall Study|Participant Unable to Comply with Study Procedure|9|||
163081411|NCT04403880|589006988|FG004|Overall Study|Participant Unable to Comply with Study Procedure|8|||
163081412|NCT04403880|589006989|FG005|Overall Study|Participant Unable to Comply with Study Procedure|8|||
163081413|NCT04403880|589006990|FG006|Overall Study|Participant Unable to Comply with Study Procedure|19|||
163081414|NCT04403880|589006984|FG000|Overall Study|Pregnancy|2|||
163081415|NCT04403880|589006985|FG001|Overall Study|Pregnancy|0|||
163081416|NCT04403880|589006986|FG002|Overall Study|Pregnancy|5|||
163081417|NCT04403880|589006987|FG003|Overall Study|Pregnancy|0|||
163081418|NCT04403880|589006988|FG004|Overall Study|Pregnancy|1|||
163081419|NCT04403880|589006989|FG005|Overall Study|Pregnancy|0|||
163081420|NCT04403880|589006990|FG006|Overall Study|Pregnancy|1|||
163081421|NCT04403880|589006984|FG000|Overall Study|Sponsor Decision|2|||
163081422|NCT04403880|589006985|FG001|Overall Study|Sponsor Decision|0|||
163081423|NCT04403880|589006986|FG002|Overall Study|Sponsor Decision|14|||
163081424|NCT04403880|589006987|FG003|Overall Study|Sponsor Decision|1|||
163081425|NCT04403880|589006988|FG004|Overall Study|Sponsor Decision|1|||
163081426|NCT04403880|589006989|FG005|Overall Study|Sponsor Decision|0|||
163081427|NCT04403880|589006990|FG006|Overall Study|Sponsor Decision|2|||
163081428|NCT04403880|589006984|FG000|Overall Study|Other|18|||
163081429|NCT04403880|589006985|FG001|Overall Study|Other|9|||
163081430|NCT04403880|589006986|FG002|Overall Study|Other|14|||
163081431|NCT04403880|589006987|FG003|Overall Study|Other|10|||
163081432|NCT04403880|589006988|FG004|Overall Study|Other|11|||
163081433|NCT04403880|589006989|FG005|Overall Study|Other|12|||
163081434|NCT04403880|589006990|FG006|Overall Study|Other|15|||
163081435|NCT04138277|589006991|FG000|Pretreatment|Withdrawal by Subject|1|||
163081436|NCT04138277|589006992|FG001|Pretreatment|Withdrawal by Subject|0|||
163081437|NCT04138277|589006991|FG000|Treatment|Adverse Event|6|||
163081438|NCT04138277|589006992|FG001|Treatment|Adverse Event|2|||
163081439|NCT04138277|589006991|FG000|Treatment|Lost to Follow-up|1|||
163081440|NCT04138277|589006992|FG001|Treatment|Lost to Follow-up|0|||
163081441|NCT04138277|589006991|FG000|Treatment|Pregnancy|3|||
163081442|NCT04138277|589006992|FG001|Treatment|Pregnancy|0|||
163081443|NCT04138277|589006991|FG000|Treatment|COVID-19 pandemic|1|||
163081444|NCT04138277|589006992|FG001|Treatment|COVID-19 pandemic|0|||
163081445|NCT04138277|589006991|FG000|Treatment|Withdrawal by Subject|9|||
163081446|NCT04138277|589006992|FG001|Treatment|Withdrawal by Subject|3|||
163081447|NCT04138277|589006991|FG000|Treatment|Sponsor decision|1|||
163081448|NCT04138277|589006992|FG001|Treatment|Sponsor decision|0|||
163081449|NCT04138277|589006991|FG000|Treatment|Physician Decision|1|||
163081450|NCT04138277|589006992|FG001|Treatment|Physician Decision|0|||
163219418|NCT02658890|589519416|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
163081451|NCT04138277|589006991|FG000|Treatment|Worsening of condition|1|||
163081452|NCT04138277|589006992|FG001|Treatment|Worsening of condition|2|||
163081453|NCT03768414|589006993|FG000|Overall Study|Adverse Event or side effects|72|||
163081454|NCT03768414|589006994|FG001|Overall Study|Adverse Event or side effects|28|||
163081455|NCT03768414|589006993|FG000|Overall Study|Refusal unrelated to adverse event|33|||
163081456|NCT03768414|589006994|FG001|Overall Study|Refusal unrelated to adverse event|33|||
163081457|NCT03768414|589006993|FG000|Overall Study|Progression/relapse|132|||
163081458|NCT03768414|589006994|FG001|Overall Study|Progression/relapse|60|||
163081459|NCT03768414|589006993|FG000|Overall Study|Death|9|||
163081460|NCT03768414|589006994|FG001|Overall Study|Death|6|||
163081461|NCT03768414|589006993|FG000|Overall Study|Other - not protocol specified|45|||
163081462|NCT03768414|589006994|FG001|Overall Study|Other - not protocol specified|18|||
163081463|NCT03768414|589006993|FG000|Overall Study|Reason under review|3|||
163219419|NCT02658890|589519417|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
163219420|NCT02658890|589519391|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
163219421|NCT02658890|589519392|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
163219422|NCT02658890|589519393|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
163219423|NCT02658890|589519394|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
163219424|NCT02658890|589519395|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
163219425|NCT02658890|589519396|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
163030066|NCT02122770|588813765|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
163030067|NCT02122770|588813766|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
163030068|NCT02122770|588813767|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
163030069|NCT02122770|588813768|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
163030070|NCT02122770|588813763|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
163030071|NCT02122770|588813764|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
163030072|NCT02122770|588813765|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
163030073|NCT02122770|588813766|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
163030074|NCT02122770|588813767|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
163030075|NCT02122770|588813768|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
163030076|NCT02122770|588813763|FG000|Part B: Standard of Care|Progressive Disease|0|||
163030077|NCT02122770|588813764|FG001|Part B: Standard of Care|Progressive Disease|0|||
163030078|NCT02122770|588813765|FG002|Part B: Standard of Care|Progressive Disease|0|||
163030079|NCT02122770|588813766|FG003|Part B: Standard of Care|Progressive Disease|0|||
163030080|NCT02122770|588813767|FG004|Part B: Standard of Care|Progressive Disease|10|||
163030081|NCT02122770|588813768|FG005|Part B: Standard of Care|Progressive Disease|8|||
163030082|NCT06137703|588813769|FG000|Overall Study|Other|0|||
163030083|NCT06137703|588813770|FG001|Overall Study|Other|1|||
163030084|NCT06137703|588813771|FG002|Overall Study|Other|0|||
163030085|NCT06137703|588813772|FG003|Overall Study|Other|0|||
163030086|NCT06137703|588813769|FG000|Overall Study|Adverse Event|0|||
163030087|NCT06137703|588813770|FG001|Overall Study|Adverse Event|0|||
163030088|NCT06137703|588813771|FG002|Overall Study|Adverse Event|1|||
163030089|NCT06137703|588813772|FG003|Overall Study|Adverse Event|0|||
163030090|NCT01801358|588813773|FG000|Overall Study|Adverse Event|0|||
163030091|NCT01801358|588813774|FG001|Overall Study|Adverse Event|2|||
163030092|NCT01801358|588813775|FG002|Overall Study|Adverse Event|1|||
163030093|NCT01801358|588813776|FG003|Overall Study|Adverse Event|0|||
163030094|NCT01801358|588813777|FG004|Overall Study|Adverse Event|0|||
163030095|NCT01801358|588813778|FG005|Overall Study|Adverse Event|1|||
163030096|NCT01801358|588813773|FG000|Overall Study|Physician Decision|0|||
163030097|NCT01801358|588813774|FG001|Overall Study|Physician Decision|0|||
163030098|NCT01801358|588813775|FG002|Overall Study|Physician Decision|1|||
163030099|NCT01801358|588813776|FG003|Overall Study|Physician Decision|0|||
163030100|NCT01801358|588813777|FG004|Overall Study|Physician Decision|0|||
163030101|NCT01801358|588813778|FG005|Overall Study|Physician Decision|0|||
163030102|NCT01801358|588813773|FG000|Overall Study|Progressive Disease|6|||
163030103|NCT01801358|588813774|FG001|Overall Study|Progressive Disease|4|||
163030104|NCT01801358|588813775|FG002|Overall Study|Progressive Disease|4|||
163030105|NCT01801358|588813776|FG003|Overall Study|Progressive Disease|5|||
163030106|NCT01801358|588813777|FG004|Overall Study|Progressive Disease|6|||
163030107|NCT01801358|588813778|FG005|Overall Study|Progressive Disease|5|||
163030108|NCT01801358|588813773|FG000|Overall Study|Withdrawal by Subject|0|||
163030109|NCT01801358|588813774|FG001|Overall Study|Withdrawal by Subject|0|||
163030110|NCT01801358|588813775|FG002|Overall Study|Withdrawal by Subject|0|||
163030111|NCT01801358|588813776|FG003|Overall Study|Withdrawal by Subject|1|||
163030112|NCT01801358|588813777|FG004|Overall Study|Withdrawal by Subject|0|||
163030113|NCT01801358|588813778|FG005|Overall Study|Withdrawal by Subject|2|||
163030114|NCT00767039|588813779|FG000|Overall Study|Death|5|||
163030115|NCT00767039|588813780|FG001|Overall Study|Death|2|||
163030116|NCT02505334|588813781|FG000|Main Treatment Period|Adverse Event|3|||
163030117|NCT02505334|588813782|FG001|Main Treatment Period|Adverse Event|3|||
163030118|NCT02505334|588813781|FG000|Main Treatment Period|Lack of Efficacy|7|||
163030119|NCT02505334|588813782|FG001|Main Treatment Period|Lack of Efficacy|17|||
163030120|NCT02505334|588813781|FG000|Main Treatment Period|Protocol Violation|0|||
163030121|NCT02505334|588813782|FG001|Main Treatment Period|Protocol Violation|1|||
163030122|NCT02505334|588813781|FG000|Main Treatment Period|Withdrawal by Subject|1|||
163030123|NCT02505334|588813782|FG001|Main Treatment Period|Withdrawal by Subject|8|||
163030124|NCT02505334|588813781|FG000|Main Treatment Period|Unclassified|4|||
163219426|NCT02658890|589519397|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
163219427|NCT02658890|589519398|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
163219428|NCT02658890|589519399|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
163219429|NCT02658890|589519400|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
163219430|NCT02658890|589519401|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
163219431|NCT02658890|589519402|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
163219432|NCT02658890|589519403|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
163219433|NCT02658890|589519404|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
163081464|NCT03768414|589006994|FG001|Overall Study|Reason under review|2|||
163081465|NCT00124306|589006996|FG000|Overall Study|Adverse Event|7|||
163081466|NCT00124306|589006997|FG001|Overall Study|Adverse Event|2|||
163081467|NCT00124306|589006996|FG000|Overall Study|Lost to Follow-up|10|||
163081468|NCT00124306|589006997|FG001|Overall Study|Lost to Follow-up|6|||
163081469|NCT00124306|589006996|FG000|Overall Study|Lack of Efficacy|3|||
163081470|NCT00124306|589006997|FG001|Overall Study|Lack of Efficacy|6|||
163081471|NCT00124306|589006996|FG000|Overall Study|Personal constraints|0|||
163081472|NCT00124306|589006997|FG001|Overall Study|Personal constraints|2|||
163081473|NCT00124306|589006996|FG000|Overall Study|Use of unacceptable medication|1|||
163081474|NCT00124306|589006997|FG001|Overall Study|Use of unacceptable medication|0|||
163081475|NCT00124306|589006996|FG000|Overall Study|Abnormal lab result|0|||
163081476|NCT00124306|589006997|FG001|Overall Study|Abnormal lab result|1|||
163081477|NCT00124306|589006996|FG000|Overall Study|Other|2|||
163081478|NCT00124306|589006997|FG001|Overall Study|Other|0|||
163081479|NCT04153149|589006999|FG000|Double Blind Period|Death|63|||
163081480|NCT04153149|589007000|FG001|Double Blind Period|Death|49|||
163081481|NCT04153149|589007001|FG002|Double Blind Period|Death|0|||
163081482|NCT04153149|589007002|FG003|Double Blind Period|Death|0|||
163081483|NCT04153149|589006999|FG000|Double Blind Period|Withdrawal by Subject|16|||
163081484|NCT04153149|589007000|FG001|Double Blind Period|Withdrawal by Subject|11|||
163081485|NCT04153149|589007001|FG002|Double Blind Period|Withdrawal by Subject|0|||
163081486|NCT04153149|589007002|FG003|Double Blind Period|Withdrawal by Subject|0|||
163081487|NCT04153149|589006999|FG000|Double Blind Period|Adverse Event|6|||
163081488|NCT04153149|589007000|FG001|Double Blind Period|Adverse Event|2|||
163081489|NCT04153149|589007001|FG002|Double Blind Period|Adverse Event|0|||
163081490|NCT04153149|589007002|FG003|Double Blind Period|Adverse Event|0|||
163081491|NCT04153149|589006999|FG000|Double Blind Period|Lost to Follow-up|2|||
163081492|NCT04153149|589007000|FG001|Double Blind Period|Lost to Follow-up|1|||
163081493|NCT04153149|589007001|FG002|Double Blind Period|Lost to Follow-up|0|||
163081494|NCT04153149|589007002|FG003|Double Blind Period|Lost to Follow-up|0|||
163081495|NCT04153149|589006999|FG000|Double Blind Period|Withdrawal by guardian|0|||
163081496|NCT04153149|589007000|FG001|Double Blind Period|Withdrawal by guardian|2|||
163081497|NCT04153149|589007001|FG002|Double Blind Period|Withdrawal by guardian|0|||
163081498|NCT04153149|589007002|FG003|Double Blind Period|Withdrawal by guardian|0|||
163081499|NCT04153149|589006999|FG000|Double Blind Period|Reason Not Specified|5|||
163081500|NCT04153149|589007000|FG001|Double Blind Period|Reason Not Specified|4|||
163081501|NCT04153149|589007001|FG002|Double Blind Period|Reason Not Specified|0|||
163081502|NCT04153149|589007002|FG003|Double Blind Period|Reason Not Specified|0|||
163081503|NCT04153149|589006999|FG000|Double Blind Period|Physician Decision|2|||
163081504|NCT04153149|589007000|FG001|Double Blind Period|Physician Decision|0|||
163081505|NCT04153149|589007001|FG002|Double Blind Period|Physician Decision|0|||
163081506|NCT04153149|589007002|FG003|Double Blind Period|Physician Decision|0|||
163081507|NCT04153149|589006999|FG000|Open Label Extension Period|Death|0|||
163081508|NCT04153149|589007000|FG001|Open Label Extension Period|Death|0|||
163081509|NCT04153149|589007001|FG002|Open Label Extension Period|Death|7|||
163081510|NCT04153149|589007002|FG003|Open Label Extension Period|Death|3|||
163081511|NCT04153149|589006999|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
163081512|NCT04153149|589007000|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
163081513|NCT04153149|589007001|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
163081514|NCT04153149|589007002|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
163081515|NCT04153149|589006999|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
163081516|NCT04153149|589007000|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
163081517|NCT04153149|589007001|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
163081518|NCT04153149|589007002|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
163081519|NCT04153149|589006999|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
163081520|NCT04153149|589007000|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
163081521|NCT04153149|589007001|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
163081522|NCT04153149|589007002|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
163081523|NCT00866775|589008006|FG000|Overall Study|Adverse Event|5|||
163081524|NCT00866775|589008007|FG001|Overall Study|Adverse Event|19|||
163081525|NCT00866775|589008006|FG000|Overall Study|Death|1|||
163081526|NCT00866775|589008007|FG001|Overall Study|Death|0|||
163081527|NCT00866775|589008006|FG000|Overall Study|Lost to Follow-up|0|||
163081528|NCT00866775|589008007|FG001|Overall Study|Lost to Follow-up|4|||
163081529|NCT00866775|589008006|FG000|Overall Study|Physician Decision|0|||
163081530|NCT00866775|589008007|FG001|Overall Study|Physician Decision|3|||
163081531|NCT00866775|589008006|FG000|Overall Study|Protocol Violation|3|||
163081532|NCT00866775|589008007|FG001|Overall Study|Protocol Violation|4|||
163081533|NCT00866775|589008006|FG000|Overall Study|Withdrawal by Subject|4|||
163081534|NCT00866775|589008007|FG001|Overall Study|Withdrawal by Subject|4|||
163081535|NCT00866775|589008006|FG000|Overall Study|met exit criteria|23|||
163081536|NCT00866775|589008007|FG001|Overall Study|met exit criteria|17|||
163081537|NCT00866775|589008006|FG000|Overall Study|discontinued due to communication error|0|||
163332418|NCT01968967|589927679|FG000|Treatment Period|Withdrawal by Subject|71|||
163332419|NCT01968967|589927680|FG001|Treatment Period|Withdrawal by Subject|61|||
163332420|NCT01968967|589927681|FG002|Treatment Period|Withdrawal by Subject|0|||
163332421|NCT01968967|589927682|FG003|Treatment Period|Withdrawal by Subject|0|||
163081538|NCT00866775|589008007|FG001|Overall Study|discontinued due to communication error|1|||
163081539|NCT00833703|589008008|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
163081540|NCT00833703|589008009|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
163081541|NCT00003907|589008010|FG000|Overall Study|Adverse Event|2|||
163081542|NCT00003907|589008011|FG001|Overall Study|Adverse Event|11|||
163081543|NCT00003907|589008010|FG000|Overall Study|Death|2|||
163081544|NCT00003907|589008011|FG001|Overall Study|Death|0|||
163081545|NCT00003907|589008010|FG000|Overall Study|Withdrawal by Subject|1|||
163081546|NCT00003907|589008011|FG001|Overall Study|Withdrawal by Subject|3|||
163081547|NCT00003907|589008010|FG000|Overall Study|Progressive disease|4|||
163081548|NCT00003907|589008011|FG001|Overall Study|Progressive disease|4|||
163081549|NCT00003907|589008010|FG000|Overall Study|Complicating disease|1|||
163081550|NCT00003907|589008011|FG001|Overall Study|Complicating disease|0|||
163081551|NCT00003907|589008010|FG000|Overall Study|Other|1|||
163081552|NCT00003907|589008011|FG001|Overall Study|Other|3|||
163081553|NCT00003907|589008010|FG000|Overall Study|ineligible or not treated|2|||
163081554|NCT00003907|589008011|FG001|Overall Study|ineligible or not treated|2|||
163081555|NCT00266032|589008014|FG000|Treatment|Adverse Event|42|||
163081556|NCT00266032|589008015|FG001|Treatment|Adverse Event|26|||
163081557|NCT00266032|589008016|FG002|Treatment|Adverse Event|10|||
163081558|NCT00266032|589008014|FG000|Treatment|Lost to Follow-up|19|||
163081559|NCT00266032|589008015|FG001|Treatment|Lost to Follow-up|4|||
163081560|NCT00266032|589008016|FG002|Treatment|Lost to Follow-up|2|||
163081561|NCT00266032|589008014|FG000|Treatment|Pregnancy|3|||
163081562|NCT00266032|589008015|FG001|Treatment|Pregnancy|2|||
163081563|NCT00266032|589008016|FG002|Treatment|Pregnancy|2|||
163081564|NCT00266032|589008014|FG000|Treatment|Protocol Violation|6|||
163081565|NCT00266032|589008015|FG001|Treatment|Protocol Violation|14|||
163081566|NCT00266032|589008016|FG002|Treatment|Protocol Violation|13|||
163081567|NCT00266032|589008014|FG000|Treatment|Withdrawal by Subject|28|||
163081568|NCT00266032|589008015|FG001|Treatment|Withdrawal by Subject|13|||
163081569|NCT00266032|589008016|FG002|Treatment|Withdrawal by Subject|12|||
163081570|NCT00266032|589008014|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
163081571|NCT00266032|589008015|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
163081572|NCT00266032|589008016|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
163081573|NCT00266032|589008014|FG000|Open-label Safety Extension|Adverse Event|5|||
163081574|NCT00266032|589008015|FG001|Open-label Safety Extension|Adverse Event|0|||
163081575|NCT00266032|589008016|FG002|Open-label Safety Extension|Adverse Event|4|||
163081576|NCT00266032|589008014|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
163081577|NCT00266032|589008015|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
163081578|NCT00266032|589008016|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
163081579|NCT00266032|589008014|FG000|Open-label Safety Extension|Pregnancy|4|||
163081580|NCT00266032|589008015|FG001|Open-label Safety Extension|Pregnancy|1|||
163081581|NCT00266032|589008016|FG002|Open-label Safety Extension|Pregnancy|2|||
163081582|NCT00266032|589008014|FG000|Open-label Safety Extension|Protocol Violation|1|||
163081583|NCT00266032|589008015|FG001|Open-label Safety Extension|Protocol Violation|3|||
163081584|NCT00266032|589008016|FG002|Open-label Safety Extension|Protocol Violation|2|||
163081585|NCT00266032|589008014|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
163081586|NCT00266032|589008015|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
163081587|NCT00266032|589008016|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
163081588|NCT00266032|589008014|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
163081589|NCT00266032|589008015|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
163332422|NCT01968967|589927683|FG004|Treatment Period|Withdrawal by Subject|0|||
163332423|NCT01968967|589927679|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
163332424|NCT01968967|589927680|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
163332425|NCT01968967|589927681|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
163081590|NCT00266032|589008016|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
163081591|NCT00124657|589008018|FG000|Overall Study|Toxicity|0|||
163081592|NCT00124657|589008019|FG001|Overall Study|Toxicity|0|||
163081593|NCT00124657|589008020|FG002|Overall Study|Toxicity|1|||
163332426|NCT01968967|589927682|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
163081594|NCT00124657|589008018|FG000|Overall Study|Non-compliance|1|||
163081595|NCT00124657|589008019|FG001|Overall Study|Non-compliance|0|||
163081596|NCT00124657|589008020|FG002|Overall Study|Non-compliance|4|||
163081597|NCT00124657|589008018|FG000|Overall Study|Progressive disease|14|||
163081598|NCT00124657|589008019|FG001|Overall Study|Progressive disease|5|||
163081599|NCT00124657|589008020|FG002|Overall Study|Progressive disease|27|||
163081600|NCT00124657|589008018|FG000|Overall Study|Intercurrent illness|1|||
163081601|NCT00124657|589008019|FG001|Overall Study|Intercurrent illness|0|||
163081602|NCT00124657|589008020|FG002|Overall Study|Intercurrent illness|0|||
163081603|NCT02367885|589008023|FG000|Overall Study|Lost to Follow-up|1|||
163081604|NCT02367885|589008024|FG001|Overall Study|Lost to Follow-up|0|||
163081605|NCT02367885|589008025|FG002|Overall Study|Lost to Follow-up|0|||
163081606|NCT02367885|589008023|FG000|Overall Study|Withdrawal by Subject|1|||
163081607|NCT02367885|589008024|FG001|Overall Study|Withdrawal by Subject|0|||
163081608|NCT02367885|589008025|FG002|Overall Study|Withdrawal by Subject|0|||
163081609|NCT01378195|589008026|FG000|Overall Study|Lost to Follow-up|29|||
163081610|NCT01378195|589008027|FG001|Overall Study|Lost to Follow-up|18|||
163081611|NCT00752219|589008028|FG000|Overall Study|Clinical failure|0|||
163081612|NCT00752219|589008029|FG001|Overall Study|Clinical failure|1|||
163081613|NCT00752219|589008028|FG000|Overall Study|Adverse Event|5|||
163081614|NCT00752219|589008029|FG001|Overall Study|Adverse Event|3|||
163081615|NCT00752219|589008028|FG000|Overall Study|Protocol deviation|1|||
163081616|NCT00752219|589008029|FG001|Overall Study|Protocol deviation|0|||
163081617|NCT00752219|589008028|FG000|Overall Study|Lost to Follow-up|1|||
163081618|NCT00752219|589008029|FG001|Overall Study|Lost to Follow-up|2|||
163081619|NCT00752219|589008028|FG000|Overall Study|Randomized but not treated|1|||
163081620|NCT00752219|589008029|FG001|Overall Study|Randomized but not treated|0|||
163081621|NCT00752219|589008028|FG000|Overall Study|Other|3|||
163081622|NCT00752219|589008029|FG001|Overall Study|Other|0|||
163081623|NCT03533491|589008031|FG000|Overall Study|Lost to Follow-up|2|||
163081624|NCT05418426|589008035|FG000|Overall Study|Adverse Event|0|||
163081625|NCT05418426|589008036|FG001|Overall Study|Adverse Event|1|||
163081626|NCT05418426|589008037|FG002|Overall Study|Adverse Event|0|||
163081627|NCT05418426|589008035|FG000|Overall Study|Withdrawal by Subject|0|||
163081628|NCT05418426|589008036|FG001|Overall Study|Withdrawal by Subject|1|||
163081629|NCT05418426|589008037|FG002|Overall Study|Withdrawal by Subject|0|||
163081630|NCT05418426|589008035|FG000|Overall Study|Protocol Violation|0|||
163081631|NCT05418426|589008036|FG001|Overall Study|Protocol Violation|0|||
163081632|NCT05418426|589008037|FG002|Overall Study|Protocol Violation|1|||
163081633|NCT03829683|589008042|FG000|Overall Study|Lost to Follow-up|1|||
163081634|NCT03829683|589008043|FG001|Overall Study|Lost to Follow-up|0|||
163081635|NCT03829683|589008042|FG000|Overall Study|Physician Decision|3|||
163081636|NCT03829683|589008043|FG001|Overall Study|Physician Decision|1|||
163081637|NCT03829683|589008042|FG000|Overall Study|Withdrawal by Subject|0|||
163081638|NCT03829683|589008043|FG001|Overall Study|Withdrawal by Subject|1|||
163081639|NCT03829683|589008042|FG000|Overall Study|Discharge from hospital|1|||
163081640|NCT03829683|589008043|FG001|Overall Study|Discharge from hospital|0|||
163081641|NCT00803049|589008048|FG000|Overall Study|Adverse Event|21|||
163081642|NCT00803049|589008049|FG001|Overall Study|Adverse Event|33|||
163081643|NCT00803049|589008050|FG002|Overall Study|Adverse Event|13|||
163081644|NCT00803049|589008051|FG003|Overall Study|Adverse Event|27|||
163081645|NCT00803049|589008048|FG000|Overall Study|Lack of Efficacy|10|||
163081646|NCT00803049|589008049|FG001|Overall Study|Lack of Efficacy|19|||
163332427|NCT01968967|589927683|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
163081647|NCT00803049|589008050|FG002|Overall Study|Lack of Efficacy|6|||
163081648|NCT00803049|589008051|FG003|Overall Study|Lack of Efficacy|13|||
163081649|NCT00803049|589008048|FG000|Overall Study|Lost to Follow-up|0|||
163081650|NCT00803049|589008049|FG001|Overall Study|Lost to Follow-up|2|||
163081651|NCT00803049|589008050|FG002|Overall Study|Lost to Follow-up|0|||
163081652|NCT00803049|589008051|FG003|Overall Study|Lost to Follow-up|3|||
163081653|NCT00803049|589008048|FG000|Overall Study|Death|2|||
163081654|NCT00803049|589008049|FG001|Overall Study|Death|1|||
163081655|NCT00803049|589008050|FG002|Overall Study|Death|0|||
163081656|NCT00803049|589008051|FG003|Overall Study|Death|2|||
163081657|NCT00803049|589008048|FG000|Overall Study|Progressive Disease|6|||
163081658|NCT00803049|589008049|FG001|Overall Study|Progressive Disease|10|||
163081659|NCT00803049|589008050|FG002|Overall Study|Progressive Disease|6|||
163081660|NCT00803049|589008051|FG003|Overall Study|Progressive Disease|6|||
163081661|NCT00803049|589008048|FG000|Overall Study|Withdrawal by Subject|19|||
163332428|NCT01968967|589927679|FG000|Treatment Period|Lost to Follow-up|26|||
163081662|NCT00803049|589008049|FG001|Overall Study|Withdrawal by Subject|43|||
163081663|NCT00803049|589008050|FG002|Overall Study|Withdrawal by Subject|16|||
163081664|NCT00803049|589008051|FG003|Overall Study|Withdrawal by Subject|44|||
163081665|NCT00803049|589008048|FG000|Overall Study|Protocol Violation|0|||
163332429|NCT01968967|589927680|FG001|Treatment Period|Lost to Follow-up|31|||
163081666|NCT00803049|589008049|FG001|Overall Study|Protocol Violation|1|||
163081667|NCT00803049|589008050|FG002|Overall Study|Protocol Violation|1|||
163081668|NCT00803049|589008051|FG003|Overall Study|Protocol Violation|0|||
163081669|NCT00803049|589008048|FG000|Overall Study|Randomized and Not Treated|0|||
163081670|NCT00803049|589008049|FG001|Overall Study|Randomized and Not Treated|0|||
163081671|NCT00803049|589008050|FG002|Overall Study|Randomized and Not Treated|0|||
163332430|NCT01968967|589927681|FG002|Treatment Period|Lost to Follow-up|0|||
163081672|NCT00803049|589008051|FG003|Overall Study|Randomized and Not Treated|2|||
163081673|NCT00803049|589008048|FG000|Overall Study|Other than Specified Above|3|||
163081674|NCT00803049|589008049|FG001|Overall Study|Other than Specified Above|9|||
163081675|NCT00803049|589008050|FG002|Overall Study|Other than Specified Above|2|||
163081676|NCT00803049|589008051|FG003|Overall Study|Other than Specified Above|5|||
163081677|NCT01272219|589008052|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
163081678|NCT01272219|589008053|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
163081679|NCT01272219|589008054|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
163081680|NCT01272219|589008055|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
163081681|NCT01272219|589008056|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
163081682|NCT01272219|589008057|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
163081683|NCT01272219|589008052|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
163081684|NCT01272219|589008053|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
163081685|NCT01272219|589008054|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
163081686|NCT01272219|589008055|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
163081687|NCT01272219|589008056|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
163081688|NCT01272219|589008057|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
163081689|NCT01272219|589008052|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
163081690|NCT01272219|589008053|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
163081691|NCT01272219|589008054|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
163081692|NCT01272219|589008055|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
163081693|NCT01272219|589008056|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
163081694|NCT01272219|589008057|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
163081695|NCT01272219|589008052|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
163081696|NCT01272219|589008053|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
163081697|NCT01272219|589008054|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
163081698|NCT01272219|589008055|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
163081699|NCT01272219|589008056|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
163081700|NCT01272219|589008057|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
163081701|NCT01272219|589008052|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
163081702|NCT01272219|589008053|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
163081703|NCT01272219|589008054|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
163081704|NCT01272219|589008055|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
163081705|NCT01272219|589008056|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
163081706|NCT01272219|589008057|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
163081707|NCT01272219|589008052|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
163081708|NCT01272219|589008053|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
163081709|NCT01272219|589008054|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
163081710|NCT01272219|589008055|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
163081711|NCT01272219|589008056|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
163081712|NCT01272219|589008057|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
163081713|NCT01272219|589008052|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
163081714|NCT01272219|589008053|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
163081715|NCT01272219|589008054|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
163081716|NCT01272219|589008055|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
163081717|NCT01272219|589008056|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
163081718|NCT01272219|589008057|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
163081719|NCT01272219|589008052|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
163081720|NCT01272219|589008053|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
163081721|NCT01272219|589008054|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
163081722|NCT01272219|589008055|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
163081723|NCT01272219|589008056|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
163081724|NCT01272219|589008057|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
163081725|NCT01272219|589008052|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
163081726|NCT01272219|589008053|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
163081727|NCT01272219|589008054|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
163081728|NCT01272219|589008055|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
163081729|NCT01272219|589008056|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
163081730|NCT01272219|589008057|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
163081731|NCT01272219|589008052|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
163081732|NCT01272219|589008053|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
163081733|NCT01272219|589008054|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
163081734|NCT01272219|589008055|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
163081735|NCT01272219|589008056|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
163081736|NCT01272219|589008057|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
163081737|NCT01272219|589008052|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
163081738|NCT01272219|589008053|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
163081739|NCT01272219|589008054|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
163081740|NCT01272219|589008055|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
163081741|NCT01272219|589008056|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
163219434|NCT02658890|589519405|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
163219435|NCT02658890|589519406|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
163219436|NCT02658890|589519407|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
163219437|NCT02658890|589519408|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
163081742|NCT01272219|589008057|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
163081743|NCT01272219|589008052|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
163081744|NCT01272219|589008053|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
163081745|NCT01272219|589008054|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
163081746|NCT01272219|589008055|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
163081747|NCT01272219|589008056|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
163081748|NCT01272219|589008057|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
163081749|NCT01272219|589008052|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
163081750|NCT01272219|589008053|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
163081751|NCT01272219|589008054|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
163081752|NCT01272219|589008055|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
163081753|NCT01272219|589008056|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
163081754|NCT01272219|589008057|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
163081755|NCT01272219|589008052|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
163081756|NCT01272219|589008053|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
163081757|NCT01272219|589008054|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
163081758|NCT01272219|589008055|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
163081759|NCT01272219|589008056|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
163081760|NCT01272219|589008057|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
163081761|NCT01272219|589008052|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
163081762|NCT01272219|589008053|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
163081763|NCT01272219|589008054|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
163081764|NCT01272219|589008055|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
163081765|NCT01272219|589008056|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
163081766|NCT01272219|589008057|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
163081767|NCT01272219|589008052|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
163081768|NCT01272219|589008053|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
163081769|NCT01272219|589008054|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
163081770|NCT01272219|589008055|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
163081771|NCT01272219|589008056|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
163081772|NCT01272219|589008057|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
163081773|NCT03301415|589008062|FG000|Overall Study|Lost to Follow-up|2|||
163081774|NCT03301415|589008062|FG000|Overall Study|Unable to comply with visit schedule|2|||
163081775|NCT00392288|589008063|FG000|Overall Study|Adverse Event|17|||
163081776|NCT00392288|589008064|FG001|Overall Study|Adverse Event|7|||
163081777|NCT00392288|589008065|FG002|Overall Study|Adverse Event|8|||
163081778|NCT00392288|589008063|FG000|Overall Study|Lack of Efficacy|8|||
163081779|NCT00392288|589008064|FG001|Overall Study|Lack of Efficacy|5|||
163081780|NCT00392288|589008065|FG002|Overall Study|Lack of Efficacy|3|||
163081781|NCT00392288|589008063|FG000|Overall Study|Protocol Violation|1|||
163081782|NCT00392288|589008064|FG001|Overall Study|Protocol Violation|3|||
163081783|NCT00392288|589008065|FG002|Overall Study|Protocol Violation|1|||
163081784|NCT00392288|589008063|FG000|Overall Study|Lost to Follow-up|1|||
163081785|NCT00392288|589008064|FG001|Overall Study|Lost to Follow-up|1|||
163081786|NCT00392288|589008065|FG002|Overall Study|Lost to Follow-up|1|||
163081787|NCT00392288|589008063|FG000|Overall Study|Withdrawal by Subject|1|||
163081788|NCT00392288|589008064|FG001|Overall Study|Withdrawal by Subject|0|||
163081789|NCT00392288|589008065|FG002|Overall Study|Withdrawal by Subject|2|||
163081790|NCT00392288|589008063|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
163081791|NCT00392288|589008064|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
163081792|NCT00392288|589008065|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
163081793|NCT00392288|589008063|FG000|Overall Study|Other|3|||
163081794|NCT00392288|589008064|FG001|Overall Study|Other|4|||
163081795|NCT00392288|589008065|FG002|Overall Study|Other|1|||
163081796|NCT02544763|589008066|FG000|Overall Study|Adverse Event|8|||
163081797|NCT02544763|589008067|FG001|Overall Study|Adverse Event|8|||
163081798|NCT02544763|589008068|FG002|Overall Study|Adverse Event|0|||
163081799|NCT02544763|589008066|FG000|Overall Study|Withdrawn by parent/guardian|1|||
163081800|NCT02544763|589008067|FG001|Overall Study|Withdrawn by parent/guardian|1|||
163081801|NCT02544763|589008068|FG002|Overall Study|Withdrawn by parent/guardian|1|||
163081802|NCT02544763|589008066|FG000|Overall Study|Met withdrawal criteria|0|||
163081803|NCT02544763|589008067|FG001|Overall Study|Met withdrawal criteria|2|||
163081804|NCT02544763|589008068|FG002|Overall Study|Met withdrawal criteria|0|||
163332431|NCT01968967|589927682|FG003|Treatment Period|Lost to Follow-up|0|||
163332432|NCT01968967|589927683|FG004|Treatment Period|Lost to Follow-up|0|||
163332433|NCT01968967|589927679|FG000|Treatment Period|Protocol Violation|1|||
163081805|NCT02544763|589008066|FG000|Overall Study|Physician Decision|0|||
163081806|NCT02544763|589008067|FG001|Overall Study|Physician Decision|1|||
163081807|NCT02544763|589008068|FG002|Overall Study|Physician Decision|0|||
163081808|NCT02544763|589008066|FG000|Overall Study|Difficulties taking IMP|1|||
163332434|NCT01968967|589927680|FG001|Treatment Period|Protocol Violation|2|||
163332435|NCT01968967|589927681|FG002|Treatment Period|Protocol Violation|0|||
163081809|NCT02544763|589008067|FG001|Overall Study|Difficulties taking IMP|0|||
163081810|NCT02544763|589008068|FG002|Overall Study|Difficulties taking IMP|0|||
163081811|NCT02097225|589008069|FG000|Dose Level 4|Adverse Event|0|||
163081812|NCT02097225|589008070|FG001|Dose Level 4|Adverse Event|0|||
163081813|NCT02097225|589008071|FG002|Dose Level 4|Adverse Event|0|||
163081814|NCT02097225|589008072|FG003|Dose Level 4|Adverse Event|0|||
163081815|NCT02097225|589008073|FG004|Dose Level 4|Adverse Event|1|||
163081816|NCT02528305|589008078|FG000|Overall Study|Withdrawal by Subject|1|||
163081817|NCT02528305|589008078|FG000|Overall Study|Adverse Event|1|||
163081818|NCT02528305|589008078|FG000|Overall Study|Physician Decision|1|||
163081819|NCT01308788|589008079|FG000|2-year Treatment|medication change by treating physician|4|||
163081820|NCT01308788|589008080|FG001|2-year Treatment|medication change by treating physician|11|||
163081821|NCT00322218|589008081|FG000|Overall Study|Death|3|||
163081822|NCT00322218|589008082|FG001|Overall Study|Death|6|||
163081823|NCT03596645|589008092|FG000|Overall Study|Adverse Event|17|||
163081824|NCT03596645|589008093|FG001|Overall Study|Adverse Event|0|||
163081825|NCT03596645|589008092|FG000|Overall Study|Lack of Efficacy|8|||
163081826|NCT03596645|589008093|FG001|Overall Study|Lack of Efficacy|0|||
163081827|NCT03596645|589008092|FG000|Overall Study|Lost to Follow-up|1|||
163081828|NCT03596645|589008093|FG001|Overall Study|Lost to Follow-up|1|||
163081829|NCT03596645|589008092|FG000|Overall Study|Physician Decision|1|||
163081830|NCT03596645|589008093|FG001|Overall Study|Physician Decision|1|||
163081831|NCT03596645|589008092|FG000|Overall Study|Protocol Violation|1|||
163081832|NCT03596645|589008093|FG001|Overall Study|Protocol Violation|0|||
163081833|NCT03596645|589008092|FG000|Overall Study|Initiated Prohibited Medication|1|||
163081834|NCT03596645|589008093|FG001|Overall Study|Initiated Prohibited Medication|0|||
163081835|NCT03596645|589008092|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163081836|NCT03596645|589008093|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163081837|NCT03596645|589008092|FG000|Overall Study|No mucosal healing achieved|1|||
163081838|NCT03596645|589008093|FG001|Overall Study|No mucosal healing achieved|0|||
163081839|NCT03596645|589008092|FG000|Overall Study|Disease progression|1|||
163081840|NCT03596645|589008093|FG001|Overall Study|Disease progression|0|||
163081841|NCT03596645|589008092|FG000|Overall Study|Ongoing|37|||
163081842|NCT03596645|589008093|FG001|Overall Study|Ongoing|12|||
163081843|NCT03596645|589008092|FG000|Overall Study|Randomized but not treated|0|||
163081844|NCT03596645|589008093|FG001|Overall Study|Randomized but not treated|1|||
163081845|NCT04101331|589009569|FG000|Overall Study|Adverse Event|9|||
163081846|NCT04101331|589009569|FG000|Overall Study|Disease progression|82|||
163081847|NCT04101331|589009569|FG000|Overall Study|Withdrawal by Subject|1|||
163081848|NCT04101331|589009569|FG000|Overall Study|Investigator decision|6|||
163081849|NCT04101331|589009569|FG000|Overall Study|Death|6|||
163081850|NCT04101331|589009569|FG000|Overall Study|Allogenic transplant|1|||
163081851|NCT04616196|589009570|FG000|Overall Study|Progressive Disease|3|||
163081852|NCT04616196|589009571|FG001|Overall Study|Progressive Disease|0|||
163081853|NCT04616196|589009572|FG002|Overall Study|Progressive Disease|4|||
163081854|NCT04616196|589009573|FG003|Overall Study|Progressive Disease|1|||
163081855|NCT04616196|589009570|FG000|Overall Study|Death|2|||
163081856|NCT04616196|589009571|FG001|Overall Study|Death|4|||
163081857|NCT04616196|589009572|FG002|Overall Study|Death|1|||
163081858|NCT04616196|589009573|FG003|Overall Study|Death|0|||
163081859|NCT04616196|589009570|FG000|Overall Study|Withdrawal by Subject|0|||
163081860|NCT04616196|589009571|FG001|Overall Study|Withdrawal by Subject|2|||
163081861|NCT04616196|589009572|FG002|Overall Study|Withdrawal by Subject|0|||
163081862|NCT04616196|589009573|FG003|Overall Study|Withdrawal by Subject|0|||
163081863|NCT04616196|589009570|FG000|Overall Study|Lost to Follow-up|1|||
163081864|NCT04616196|589009571|FG001|Overall Study|Lost to Follow-up|0|||
163081865|NCT04616196|589009572|FG002|Overall Study|Lost to Follow-up|0|||
163081866|NCT04616196|589009573|FG003|Overall Study|Lost to Follow-up|0|||
163081867|NCT04616196|589009570|FG000|Overall Study|Sponsor request|2|||
163081868|NCT04616196|589009571|FG001|Overall Study|Sponsor request|1|||
163081869|NCT04616196|589009572|FG002|Overall Study|Sponsor request|1|||
163081870|NCT04616196|589009573|FG003|Overall Study|Sponsor request|2|||
163081871|NCT06790303|589009576|FG000|Overall Study|Study Terminated by sponsor|4|||
163081872|NCT06790303|589009576|FG000|Overall Study|Death|4|||
163081873|NCT02579759|589009579|FG000|Overall Study|Protocol Violation|2|||
163081874|NCT02579759|589009580|FG001|Overall Study|Protocol Violation|0|||
163081875|NCT02579759|589009581|FG002|Overall Study|Protocol Violation|0|||
163081876|NCT02579759|589009579|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
163081877|NCT02579759|589009580|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
163081878|NCT02579759|589009581|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
163081879|NCT02579759|589009579|FG000|Overall Study|BfArM hold|13|||
163081880|NCT02579759|589009580|FG001|Overall Study|BfArM hold|12|||
163081881|NCT02579759|589009581|FG002|Overall Study|BfArM hold|12|||
163081882|NCT02579759|589009579|FG000|Overall Study|Sponsor stopped Dose 2|0|||
163081883|NCT02579759|589009580|FG001|Overall Study|Sponsor stopped Dose 2|41|||
163081884|NCT02579759|589009581|FG002|Overall Study|Sponsor stopped Dose 2|0|||
163081885|NCT02579759|589009579|FG000|Overall Study|Non compliance|0|||
163081886|NCT02579759|589009580|FG001|Overall Study|Non compliance|1|||
163081887|NCT02579759|589009581|FG002|Overall Study|Non compliance|0|||
163081888|NCT02579759|589009579|FG000|Overall Study|Pregnancy|0|||
163081889|NCT02579759|589009580|FG001|Overall Study|Pregnancy|1|||
163081890|NCT02579759|589009581|FG002|Overall Study|Pregnancy|0|||
163081891|NCT02579759|589009579|FG000|Overall Study|Inclusion/exclusion criteria|0|||
163081892|NCT02579759|589009580|FG001|Overall Study|Inclusion/exclusion criteria|0|||
163081893|NCT02579759|589009581|FG002|Overall Study|Inclusion/exclusion criteria|1|||
163081894|NCT02579759|589009579|FG000|Overall Study|Adverse Event|4|||
163081895|NCT02579759|589009580|FG001|Overall Study|Adverse Event|3|||
163081896|NCT02579759|589009581|FG002|Overall Study|Adverse Event|1|||
163081897|NCT02579759|589009579|FG000|Overall Study|Withdrawal by Subject|3|||
163081898|NCT02579759|589009580|FG001|Overall Study|Withdrawal by Subject|3|||
163081899|NCT02579759|589009581|FG002|Overall Study|Withdrawal by Subject|5|||
163081900|NCT02579759|589009579|FG000|Overall Study|Lost to Follow-up|2|||
163081901|NCT02579759|589009580|FG001|Overall Study|Lost to Follow-up|2|||
163081902|NCT02579759|589009581|FG002|Overall Study|Lost to Follow-up|2|||
163081903|NCT01904279|589009586|FG000|Overall Study|Lack of Efficacy|2|||
163081904|NCT01904279|589009587|FG001|Overall Study|Lack of Efficacy|3|||
163081905|NCT01904279|589009586|FG000|Overall Study|Withdrawal by Subject|1|||
163081906|NCT01904279|589009587|FG001|Overall Study|Withdrawal by Subject|0|||
163081907|NCT03283241|589009590|FG000|Overall Study|Adverse Event|4|||
163081908|NCT03283241|589009591|FG001|Overall Study|Adverse Event|1|||
163081909|NCT03283241|589009590|FG000|Overall Study|Withdrawal by Subject|0|||
163081910|NCT03283241|589009591|FG001|Overall Study|Withdrawal by Subject|1|||
163081911|NCT03283241|589009590|FG000|Overall Study|Subject relocated to Finland|0|||
163081912|NCT03283241|589009591|FG001|Overall Study|Subject relocated to Finland|1|||
163081913|NCT00666263|589009592|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
163219438|NCT02658890|589519409|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
163219439|NCT02658890|589519410|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
163219440|NCT02658890|589519411|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
163219441|NCT02658890|589519412|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
163219442|NCT02658890|589519413|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
163219443|NCT02658890|589519414|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
163219444|NCT02658890|589519415|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
163219445|NCT02658890|589519416|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
163219446|NCT02658890|589519417|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
163219447|NCT02658890|589519391|FG000|Treatment Phase|Other Reasons|0|||
163219448|NCT02658890|589519392|FG001|Treatment Phase|Other Reasons|0|||
163219449|NCT02658890|589519393|FG002|Treatment Phase|Other Reasons|0|||
163219450|NCT02658890|589519394|FG003|Treatment Phase|Other Reasons|0|||
163219451|NCT02658890|589519395|FG004|Treatment Phase|Other Reasons|0|||
163219452|NCT02658890|589519396|FG005|Treatment Phase|Other Reasons|0|||
163219453|NCT02658890|589519397|FG006|Treatment Phase|Other Reasons|1|||
163219454|NCT02658890|589519398|FG007|Treatment Phase|Other Reasons|0|||
163219455|NCT02658890|589519399|FG008|Treatment Phase|Other Reasons|1|||
163219456|NCT02658890|589519400|FG009|Treatment Phase|Other Reasons|0|||
163219457|NCT02658890|589519401|FG010|Treatment Phase|Other Reasons|0|||
163219458|NCT02658890|589519402|FG011|Treatment Phase|Other Reasons|0|||
163219459|NCT02658890|589519403|FG012|Treatment Phase|Other Reasons|0|||
163219460|NCT02658890|589519404|FG013|Treatment Phase|Other Reasons|2|||
163219461|NCT02658890|589519405|FG014|Treatment Phase|Other Reasons|0|||
163219462|NCT02658890|589519406|FG015|Treatment Phase|Other Reasons|0|||
163219463|NCT02658890|589519407|FG016|Treatment Phase|Other Reasons|0|||
163219464|NCT02658890|589519408|FG017|Treatment Phase|Other Reasons|0|||
163219465|NCT02658890|589519409|FG018|Treatment Phase|Other Reasons|1|||
163219466|NCT02658890|589519410|FG019|Treatment Phase|Other Reasons|0|||
163219467|NCT02658890|589519411|FG020|Treatment Phase|Other Reasons|0|||
163219468|NCT02658890|589519412|FG021|Treatment Phase|Other Reasons|0|||
163219469|NCT02658890|589519413|FG022|Treatment Phase|Other Reasons|0|||
163219470|NCT02658890|589519414|FG023|Treatment Phase|Other Reasons|0|||
163219471|NCT02658890|589519415|FG024|Treatment Phase|Other Reasons|1|||
163219472|NCT02658890|589519416|FG025|Treatment Phase|Other Reasons|0|||
163219473|NCT02658890|589519417|FG026|Treatment Phase|Other Reasons|1|||
163219474|NCT02658890|589519391|FG000|Treatment Phase|Progressive Disease|6|||
163219475|NCT02658890|589519392|FG001|Treatment Phase|Progressive Disease|7|||
163219476|NCT02658890|589519393|FG002|Treatment Phase|Progressive Disease|6|||
163219477|NCT02658890|589519394|FG003|Treatment Phase|Progressive Disease|12|||
163219478|NCT02658890|589519395|FG004|Treatment Phase|Progressive Disease|6|||
163219479|NCT02658890|589519396|FG005|Treatment Phase|Progressive Disease|18|||
163219480|NCT02658890|589519397|FG006|Treatment Phase|Progressive Disease|12|||
163219481|NCT02658890|589519398|FG007|Treatment Phase|Progressive Disease|19|||
163219482|NCT02658890|589519399|FG008|Treatment Phase|Progressive Disease|26|||
163219483|NCT02658890|589519400|FG009|Treatment Phase|Progressive Disease|8|||
163219484|NCT02658890|589519401|FG010|Treatment Phase|Progressive Disease|7|||
163219485|NCT02658890|589519402|FG011|Treatment Phase|Progressive Disease|9|||
163219486|NCT02658890|589519403|FG012|Treatment Phase|Progressive Disease|8|||
163332436|NCT01968967|589927682|FG003|Treatment Period|Protocol Violation|0|||
163332437|NCT01968967|589927683|FG004|Treatment Period|Protocol Violation|0|||
163332438|NCT01968967|589927679|FG000|Treatment Period|Adverse Event|9|||
163332439|NCT01968967|589927680|FG001|Treatment Period|Adverse Event|8|||
163332440|NCT01968967|589927681|FG002|Treatment Period|Adverse Event|0|||
163332441|NCT01968967|589927682|FG003|Treatment Period|Adverse Event|0|||
163332442|NCT01968967|589927683|FG004|Treatment Period|Adverse Event|0|||
163332443|NCT01968967|589927679|FG000|Treatment Period|Death|9|||
163332444|NCT01968967|589927680|FG001|Treatment Period|Death|2|||
163332445|NCT01968967|589927681|FG002|Treatment Period|Death|0|||
163332446|NCT01968967|589927682|FG003|Treatment Period|Death|0|||
163332447|NCT01968967|589927683|FG004|Treatment Period|Death|0|||
163332448|NCT01968967|589927679|FG000|Treatment Period|Randomized Not Treated|6|||
163332449|NCT01968967|589927680|FG001|Treatment Period|Randomized Not Treated|5|||
163332450|NCT01968967|589927681|FG002|Treatment Period|Randomized Not Treated|0|||
163332451|NCT01968967|589927682|FG003|Treatment Period|Randomized Not Treated|0|||
163332452|NCT01968967|589927683|FG004|Treatment Period|Randomized Not Treated|0|||
163332453|NCT01968967|589927679|FG000|Extension Period|Withdrew Consent|0|||
163332454|NCT01968967|589927680|FG001|Extension Period|Withdrew Consent|0|||
163332455|NCT01968967|589927681|FG002|Extension Period|Withdrew Consent|2|||
163332456|NCT01968967|589927682|FG003|Extension Period|Withdrew Consent|0|||
163332457|NCT01968967|589927683|FG004|Extension Period|Withdrew Consent|5|||
163332458|NCT03489369|589927684|FG000|Overall Study|Documented Progressive Disease|3|||
163332459|NCT03489369|589927685|FG001|Overall Study|Documented Progressive Disease|2|||
163332460|NCT03489369|589927686|FG002|Overall Study|Documented Progressive Disease|3|||
163332461|NCT03489369|589927687|FG003|Overall Study|Documented Progressive Disease|6|||
163332462|NCT03489369|589927684|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
163332463|NCT03489369|589927685|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
163332464|NCT03489369|589927686|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
163332465|NCT03489369|589927687|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
163332466|NCT02022670|589927690|FG000|Overall Study|Adverse Event|1|||
163332467|NCT02022670|589927691|FG001|Overall Study|Adverse Event|0|||
163332468|NCT02022670|589927692|FG002|Overall Study|Adverse Event|1|||
163332469|NCT02113449|589927693|FG000|Overall Study|Adverse Event|4|||
163332470|NCT00109031|589927694|FG000|Overall Study|Adverse Event|0|||
163081914|NCT00666263|589009593|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
163081915|NCT00666263|589009592|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
163081916|NCT00666263|589009593|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
163081917|NCT00666263|589009592|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
163081918|NCT00666263|589009593|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
163081919|NCT02439957|589009594|FG000|Overall Study|Study Terminated|3|||
163081920|NCT02439957|589009595|FG001|Overall Study|Study Terminated|3|||
163081921|NCT00586157|589009596|FG000|First Intervention|Worsening behavior|1|||
163081922|NCT00586157|589009597|FG001|First Intervention|Worsening behavior|0|||
163081923|NCT00586157|589009596|FG000|Second Intervention|Withdrawal by Subject|1|||
163081924|NCT00586157|589009597|FG001|Second Intervention|Withdrawal by Subject|0|||
163081925|NCT00586157|589009596|FG000|Second Intervention|Worsening behavior|1|||
163081926|NCT00586157|589009597|FG001|Second Intervention|Worsening behavior|0|||
163081927|NCT00586157|589009596|FG000|Second Intervention|Adverse Event|0|||
163081928|NCT00586157|589009597|FG001|Second Intervention|Adverse Event|1|||
163081929|NCT00414609|589009598|FG000|Core Study|Adverse Event|9|||
163081930|NCT00414609|589009599|FG001|Core Study|Adverse Event|11|||
163081931|NCT00414609|589009600|FG002|Core Study|Adverse Event|0|||
163081932|NCT00414609|589009598|FG000|Core Study|Abnormal laboratory values|0|||
163081933|NCT00414609|589009599|FG001|Core Study|Abnormal laboratory values|1|||
163081934|NCT00414609|589009600|FG002|Core Study|Abnormal laboratory values|0|||
163081935|NCT00414609|589009598|FG000|Core Study|Abnormal test procedure results|1|||
163081936|NCT00414609|589009599|FG001|Core Study|Abnormal test procedure results|1|||
163081937|NCT00414609|589009600|FG002|Core Study|Abnormal test procedure results|0|||
163081938|NCT00414609|589009598|FG000|Core Study|Protocol deviation|0|||
163081939|NCT00414609|589009599|FG001|Core Study|Protocol deviation|1|||
163332471|NCT00109031|589927695|FG001|Overall Study|Adverse Event|0|||
163081940|NCT00414609|589009600|FG002|Core Study|Protocol deviation|0|||
163081941|NCT00414609|589009598|FG000|Core Study|Patient withdrew consent|10|||
163081942|NCT00414609|589009599|FG001|Core Study|Patient withdrew consent|11|||
163081943|NCT00414609|589009600|FG002|Core Study|Patient withdrew consent|0|||
163332472|NCT00109031|589927696|FG002|Overall Study|Adverse Event|1|||
163332473|NCT00109031|589927697|FG003|Overall Study|Adverse Event|0|||
163332474|NCT00109031|589927694|FG000|Overall Study|Withdrawal by Subject|0|||
163081944|NCT00414609|589009598|FG000|Core Study|Lost to Follow-up|7|||
163081945|NCT00414609|589009599|FG001|Core Study|Lost to Follow-up|4|||
163081946|NCT00414609|589009600|FG002|Core Study|Lost to Follow-up|0|||
163081947|NCT00414609|589009598|FG000|Core Study|Administrative problems|0|||
163332475|NCT00109031|589927695|FG001|Overall Study|Withdrawal by Subject|1|||
163332476|NCT00109031|589927696|FG002|Overall Study|Withdrawal by Subject|0|||
163332477|NCT00109031|589927697|FG003|Overall Study|Withdrawal by Subject|0|||
163332478|NCT00109031|589927694|FG000|Overall Study|Physician Decision|0|||
163081948|NCT00414609|589009599|FG001|Core Study|Administrative problems|2|||
163081949|NCT00414609|589009600|FG002|Core Study|Administrative problems|0|||
163081950|NCT00414609|589009598|FG000|Core Study|Death|7|||
163081951|NCT00414609|589009599|FG001|Core Study|Death|14|||
163081952|NCT00414609|589009600|FG002|Core Study|Death|0|||
163081953|NCT00414609|589009598|FG000|Extension Study|Adverse Event|0|||
163081954|NCT00414609|589009599|FG001|Extension Study|Adverse Event|0|||
163081955|NCT00414609|589009600|FG002|Extension Study|Adverse Event|14|||
163081956|NCT00414609|589009598|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
163081957|NCT00414609|589009599|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
163081958|NCT00414609|589009600|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
163081959|NCT00414609|589009598|FG000|Extension Study|Withdrawal by Subject|0|||
163081960|NCT00414609|589009599|FG001|Extension Study|Withdrawal by Subject|0|||
163081961|NCT00414609|589009600|FG002|Extension Study|Withdrawal by Subject|13|||
163081962|NCT00414609|589009598|FG000|Extension Study|Lost to Follow-up|0|||
163081963|NCT00414609|589009599|FG001|Extension Study|Lost to Follow-up|0|||
163081964|NCT00414609|589009600|FG002|Extension Study|Lost to Follow-up|10|||
163081965|NCT00414609|589009598|FG000|Extension Study|Administrative problems|0|||
163081966|NCT00414609|589009599|FG001|Extension Study|Administrative problems|0|||
163081967|NCT00414609|589009600|FG002|Extension Study|Administrative problems|1|||
163081968|NCT00414609|589009598|FG000|Extension Study|Death|0|||
163081969|NCT00414609|589009599|FG001|Extension Study|Death|0|||
163081970|NCT00414609|589009600|FG002|Extension Study|Death|17|||
163081971|NCT02853136|589009603|FG000|Wash-out|Adverse Event|0|||
163081972|NCT02853136|589009604|FG001|Wash-out|Adverse Event|0|||
163081973|NCT02853136|589009605|FG002|Wash-out|Adverse Event|0|||
163081974|NCT02853136|589009606|FG003|Wash-out|Adverse Event|1|||
163081975|NCT00841815|589009607|FG000|Washout|Withdrawal by Subject|0|||
163081976|NCT00841815|589009608|FG001|Washout|Withdrawal by Subject|1|||
163081977|NCT02758626|589009618|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
163081978|NCT02758626|589009619|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
163081979|NCT02758626|589009618|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
163081980|NCT02758626|589009619|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
163081981|NCT02758626|589009618|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
163081982|NCT02758626|589009619|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
163081983|NCT02758626|589009618|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
163081984|NCT02758626|589009619|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
163081985|NCT01682720|589009624|FG000|Overall Study|Randomized but Not Treated|0|||
163081986|NCT01682720|589009625|FG001|Overall Study|Randomized but Not Treated|1|||
163081987|NCT01682720|589009626|FG002|Overall Study|Randomized but Not Treated|1|||
163081988|NCT01682720|589009627|FG003|Overall Study|Randomized but Not Treated|0|||
163081989|NCT01682720|589009624|FG000|Overall Study|Terminated by Sponsor|83|||
163081990|NCT01682720|589009625|FG001|Overall Study|Terminated by Sponsor|0|||
163081991|NCT01682720|589009626|FG002|Overall Study|Terminated by Sponsor|0|||
163081992|NCT01682720|589009627|FG003|Overall Study|Terminated by Sponsor|0|||
163081993|NCT01682720|589009624|FG000|Overall Study|Efficacy Failure|0|||
163081994|NCT01682720|589009625|FG001|Overall Study|Efficacy Failure|3|||
163081995|NCT01682720|589009626|FG002|Overall Study|Efficacy Failure|3|||
163081996|NCT01682720|589009627|FG003|Overall Study|Efficacy Failure|30|||
163081997|NCT01682720|589009624|FG000|Overall Study|Lost to Follow-up|1|||
163081998|NCT01682720|589009625|FG001|Overall Study|Lost to Follow-up|1|||
163081999|NCT01682720|589009626|FG002|Overall Study|Lost to Follow-up|0|||
163082000|NCT01682720|589009627|FG003|Overall Study|Lost to Follow-up|6|||
163082001|NCT01682720|589009624|FG000|Overall Study|Subject Withdrew Consent|0|||
163082002|NCT01682720|589009625|FG001|Overall Study|Subject Withdrew Consent|0|||
163082003|NCT01682720|589009626|FG002|Overall Study|Subject Withdrew Consent|2|||
163082004|NCT01682720|589009627|FG003|Overall Study|Subject Withdrew Consent|2|||
163082005|NCT01682720|589009624|FG000|Overall Study|Adverse Event|1|||
163082006|NCT01682720|589009625|FG001|Overall Study|Adverse Event|0|||
163082007|NCT01682720|589009626|FG002|Overall Study|Adverse Event|1|||
163082008|NCT01682720|589009627|FG003|Overall Study|Adverse Event|1|||
163082009|NCT01687595|589009628|FG000|Overall Study|Withdrawal by Subject|8|||
163082010|NCT01687595|589009629|FG001|Overall Study|Withdrawal by Subject|0|||
163082011|NCT01687595|589009628|FG000|Overall Study|Lost to Follow-up|3|||
163082012|NCT01687595|589009629|FG001|Overall Study|Lost to Follow-up|1|||
163082013|NCT01687595|589009628|FG000|Overall Study|Investigator's decision|1|||
163082014|NCT01687595|589009629|FG001|Overall Study|Investigator's decision|0|||
163082015|NCT01687595|589009628|FG000|Overall Study|Sponsor's decision|1|||
163219487|NCT02658890|589519404|FG013|Treatment Phase|Progressive Disease|29|||
163219488|NCT02658890|589519405|FG014|Treatment Phase|Progressive Disease|6|||
163219489|NCT02658890|589519406|FG015|Treatment Phase|Progressive Disease|2|||
163219490|NCT02658890|589519407|FG016|Treatment Phase|Progressive Disease|32|||
163082016|NCT01687595|589009629|FG001|Overall Study|Sponsor's decision|0|||
163082017|NCT01687595|589009628|FG000|Overall Study|Noncompliance|1|||
163082018|NCT01687595|589009629|FG001|Overall Study|Noncompliance|2|||
163082019|NCT01687595|589009628|FG000|Overall Study|Other than specified|56|||
163219491|NCT02658890|589519408|FG017|Treatment Phase|Progressive Disease|14|||
163332479|NCT00109031|589927695|FG001|Overall Study|Physician Decision|1|||
163332480|NCT00109031|589927696|FG002|Overall Study|Physician Decision|0|||
163332481|NCT00109031|589927697|FG003|Overall Study|Physician Decision|0|||
163332482|NCT00109031|589927694|FG000|Overall Study|Protocol Violation|0|||
163332483|NCT00109031|589927695|FG001|Overall Study|Protocol Violation|0|||
163332484|NCT00109031|589927696|FG002|Overall Study|Protocol Violation|1|||
163332485|NCT00109031|589927697|FG003|Overall Study|Protocol Violation|0|||
163332486|NCT02208843|589927698|FG000|Overall Study|Clinical symptoms of progression|2|||
163332487|NCT02208843|589927698|FG000|Overall Study|Progression disease according to RECIST|24|||
163332488|NCT02208843|589927698|FG000|Overall Study|Adverse Event|12|||
163332489|NCT02208843|589927698|FG000|Overall Study|Protocol Violation|1|||
163332490|NCT02208843|589927698|FG000|Overall Study|Withdrawal by Subject|1|||
163332491|NCT02208843|589927698|FG000|Overall Study|Switched to commercial afatinib|20|||
163332492|NCT00665392|589927700|FG000|Overall Study|not treated|1|||
163332493|NCT00243867|589927701|FG000|Overall Study|Adverse Event|24|||
163332494|NCT00243867|589927702|FG001|Overall Study|Adverse Event|34|||
163332495|NCT00243867|589927701|FG000|Overall Study|Lack of Efficacy|115|||
163332496|NCT00243867|589927702|FG001|Overall Study|Lack of Efficacy|78|||
163030125|NCT02505334|588813782|FG001|Main Treatment Period|Unclassified|10|||
163030126|NCT02505334|588813781|FG000|Extension Treatment Period|Adverse Event|5|||
163030127|NCT02505334|588813782|FG001|Extension Treatment Period|Adverse Event|0|||
163030128|NCT02505334|588813781|FG000|Extension Treatment Period|Lack of Efficacy|4|||
163030129|NCT02505334|588813782|FG001|Extension Treatment Period|Lack of Efficacy|0|||
163030130|NCT02505334|588813781|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
163030131|NCT02505334|588813782|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
163030132|NCT02505334|588813781|FG000|Extension Treatment Period|Unclassified|3|||
163030133|NCT02505334|588813782|FG001|Extension Treatment Period|Unclassified|0|||
163030134|NCT01549041|588813785|FG000|Overall Study|Lack of Efficacy|2|||
163030135|NCT01549041|588813786|FG001|Overall Study|Lack of Efficacy|4|||
163030136|NCT01549041|588813785|FG000|Overall Study|Adverse Event|0|||
163030137|NCT01549041|588813786|FG001|Overall Study|Adverse Event|4|||
163030138|NCT04093492|588813789|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
163030139|NCT04093492|588813790|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
163030140|NCT04093492|588813791|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
163030141|NCT04093492|588813792|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
163030142|NCT04093492|588813789|FG000|25 Weeks Gestational Age (GA)|No response|5|||
163030143|NCT04093492|588813790|FG001|25 Weeks Gestational Age (GA)|No response|5|||
163030144|NCT04093492|588813791|FG002|25 Weeks Gestational Age (GA)|No response|5|||
163030145|NCT04093492|588813792|FG003|25 Weeks Gestational Age (GA)|No response|2|||
163030146|NCT04093492|588813789|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
163030147|NCT04093492|588813790|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
163030148|NCT04093492|588813791|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
163030149|NCT04093492|588813792|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
163030150|NCT04093492|588813789|FG000|30 Weeks GA|Delivered before assessment|1|||
163030151|NCT04093492|588813790|FG001|30 Weeks GA|Delivered before assessment|2|||
163030152|NCT04093492|588813791|FG002|30 Weeks GA|Delivered before assessment|0|||
163030153|NCT04093492|588813792|FG003|30 Weeks GA|Delivered before assessment|0|||
163030154|NCT04093492|588813789|FG000|30 Weeks GA|No response|7|||
163030155|NCT04093492|588813790|FG001|30 Weeks GA|No response|5|||
163030156|NCT04093492|588813791|FG002|30 Weeks GA|No response|5|||
163030157|NCT04093492|588813792|FG003|30 Weeks GA|No response|2|||
163030158|NCT04093492|588813789|FG000|30 Weeks GA|Lost to Follow-up|0|||
163030159|NCT04093492|588813790|FG001|30 Weeks GA|Lost to Follow-up|1|||
163030160|NCT04093492|588813791|FG002|30 Weeks GA|Lost to Follow-up|0|||
163030161|NCT04093492|588813792|FG003|30 Weeks GA|Lost to Follow-up|0|||
163030162|NCT04093492|588813789|FG000|34 Weeks GA|Delivered before assessment|6|||
163030163|NCT04093492|588813790|FG001|34 Weeks GA|Delivered before assessment|3|||
163030164|NCT04093492|588813791|FG002|34 Weeks GA|Delivered before assessment|0|||
163030165|NCT04093492|588813792|FG003|34 Weeks GA|Delivered before assessment|0|||
163030166|NCT04093492|588813789|FG000|34 Weeks GA|No response|0|||
163030167|NCT04093492|588813790|FG001|34 Weeks GA|No response|7|||
163030168|NCT04093492|588813791|FG002|34 Weeks GA|No response|5|||
163030169|NCT04093492|588813792|FG003|34 Weeks GA|No response|3|||
163030170|NCT04093492|588813789|FG000|34 Weeks GA|Lost to Follow-up|0|||
163030171|NCT04093492|588813790|FG001|34 Weeks GA|Lost to Follow-up|1|||
163030172|NCT04093492|588813791|FG002|34 Weeks GA|Lost to Follow-up|0|||
163030173|NCT04093492|588813792|FG003|34 Weeks GA|Lost to Follow-up|0|||
163030174|NCT02945254|588813797|FG000|Overall Study|Lost to Follow-up|1|||
163030175|NCT02945254|588813798|FG001|Overall Study|Lost to Follow-up|0|||
163030176|NCT02945254|588813797|FG000|Overall Study|Withdrawal by Subject|1|||
163030177|NCT02945254|588813798|FG001|Overall Study|Withdrawal by Subject|0|||
163030178|NCT01711619|588813799|FG000|Overall Study|Early study termination|10|||
163030179|NCT01711619|588813800|FG001|Overall Study|Early study termination|14|||
163030180|NCT01711619|588813799|FG000|Overall Study|Withdrawal by Subject|3|||
163030181|NCT01711619|588813800|FG001|Overall Study|Withdrawal by Subject|7|||
163030182|NCT01711619|588813799|FG000|Overall Study|Protocol Violation|2|||
163332497|NCT00243867|589927701|FG000|Overall Study|Withdrawal by Subject|11|||
163030183|NCT01711619|588813800|FG001|Overall Study|Protocol Violation|3|||
163030184|NCT01711619|588813799|FG000|Overall Study|Adverse Event|2|||
163030185|NCT01711619|588813800|FG001|Overall Study|Adverse Event|0|||
163030186|NCT01711619|588813799|FG000|Overall Study|Lost to Follow-up|1|||
163030187|NCT01711619|588813800|FG001|Overall Study|Lost to Follow-up|0|||
163030188|NCT00783224|588813801|FG000|Overall Study|Adverse Event|0|||
163030189|NCT00783224|588813802|FG001|Overall Study|Adverse Event|0|||
163030190|NCT00783224|588813803|FG002|Overall Study|Adverse Event|1|||
163030191|NCT00783224|588813804|FG003|Overall Study|Adverse Event|0|||
163082020|NCT01687595|589009629|FG001|Overall Study|Other than specified|7|||
163082021|NCT04204902|589009630|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
163082022|NCT04204902|589009631|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
163082023|NCT02096354|589009632|FG000|Overall Study|Physician Decision|4|||
163082024|NCT02096354|589009633|FG001|Overall Study|Physician Decision|5|||
163082025|NCT02096354|589009634|FG002|Overall Study|Physician Decision|0|||
163082026|NCT02096354|589009632|FG000|Overall Study|Withdrawal by Subject|3|||
163082027|NCT02096354|589009633|FG001|Overall Study|Withdrawal by Subject|1|||
163082028|NCT02096354|589009634|FG002|Overall Study|Withdrawal by Subject|0|||
163082029|NCT02096354|589009632|FG000|Overall Study|Adverse Event|7|||
163082030|NCT02096354|589009633|FG001|Overall Study|Adverse Event|4|||
163082031|NCT02096354|589009634|FG002|Overall Study|Adverse Event|0|||
163082032|NCT02096354|589009632|FG000|Overall Study|Ineligible|0|||
163082033|NCT02096354|589009633|FG001|Overall Study|Ineligible|0|||
163082034|NCT02096354|589009634|FG002|Overall Study|Ineligible|11|||
163082035|NCT03715829|589009635|FG000|Dose Ranging Period|Adverse Event|2|||
163082036|NCT03715829|589009636|FG001|Dose Ranging Period|Adverse Event|4|||
163082037|NCT03715829|589009637|FG002|Dose Ranging Period|Adverse Event|5|||
163082038|NCT03715829|589009638|FG003|Dose Ranging Period|Adverse Event|2|||
163082039|NCT03715829|589009639|FG004|Dose Ranging Period|Adverse Event|3|||
163082040|NCT03715829|589009640|FG005|Dose Ranging Period|Adverse Event|3|||
163082041|NCT03715829|589009641|FG006|Dose Ranging Period|Adverse Event|0|||
163082042|NCT03715829|589009642|FG007|Dose Ranging Period|Adverse Event|0|||
163082043|NCT03715829|589009643|FG008|Dose Ranging Period|Adverse Event|0|||
163082044|NCT03715829|589009644|FG009|Dose Ranging Period|Adverse Event|0|||
163082045|NCT03715829|589009645|FG010|Dose Ranging Period|Adverse Event|0|||
163082046|NCT03715829|589009635|FG000|Dose Ranging Period|Lack of Efficacy|0|||
163082047|NCT03715829|589009636|FG001|Dose Ranging Period|Lack of Efficacy|1|||
163082048|NCT03715829|589009637|FG002|Dose Ranging Period|Lack of Efficacy|0|||
163082049|NCT03715829|589009638|FG003|Dose Ranging Period|Lack of Efficacy|1|||
163082050|NCT03715829|589009639|FG004|Dose Ranging Period|Lack of Efficacy|0|||
163082051|NCT03715829|589009640|FG005|Dose Ranging Period|Lack of Efficacy|0|||
163082052|NCT03715829|589009641|FG006|Dose Ranging Period|Lack of Efficacy|0|||
163082053|NCT03715829|589009642|FG007|Dose Ranging Period|Lack of Efficacy|0|||
163082054|NCT03715829|589009643|FG008|Dose Ranging Period|Lack of Efficacy|0|||
163082055|NCT03715829|589009644|FG009|Dose Ranging Period|Lack of Efficacy|0|||
163082056|NCT03715829|589009645|FG010|Dose Ranging Period|Lack of Efficacy|0|||
163082057|NCT03715829|589009635|FG000|Dose Ranging Period|Lost to Follow-up|2|||
163082058|NCT03715829|589009636|FG001|Dose Ranging Period|Lost to Follow-up|0|||
163082059|NCT03715829|589009637|FG002|Dose Ranging Period|Lost to Follow-up|1|||
163082060|NCT03715829|589009638|FG003|Dose Ranging Period|Lost to Follow-up|1|||
163082061|NCT03715829|589009639|FG004|Dose Ranging Period|Lost to Follow-up|1|||
163082062|NCT03715829|589009640|FG005|Dose Ranging Period|Lost to Follow-up|2|||
163082063|NCT03715829|589009641|FG006|Dose Ranging Period|Lost to Follow-up|0|||
163082064|NCT03715829|589009642|FG007|Dose Ranging Period|Lost to Follow-up|0|||
163082065|NCT03715829|589009643|FG008|Dose Ranging Period|Lost to Follow-up|0|||
163082066|NCT03715829|589009644|FG009|Dose Ranging Period|Lost to Follow-up|0|||
163082067|NCT03715829|589009645|FG010|Dose Ranging Period|Lost to Follow-up|0|||
163219492|NCT02658890|589519409|FG018|Treatment Phase|Progressive Disease|40|||
163082068|NCT03715829|589009635|FG000|Dose Ranging Period|Protocol Violation|0|||
163219493|NCT02658890|589519410|FG019|Treatment Phase|Progressive Disease|32|||
163030192|NCT00783224|588813801|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
163082069|NCT03715829|589009636|FG001|Dose Ranging Period|Protocol Violation|0|||
163082070|NCT03715829|589009637|FG002|Dose Ranging Period|Protocol Violation|0|||
163082071|NCT03715829|589009638|FG003|Dose Ranging Period|Protocol Violation|1|||
163082072|NCT03715829|589009639|FG004|Dose Ranging Period|Protocol Violation|0|||
163082073|NCT03715829|589009640|FG005|Dose Ranging Period|Protocol Violation|0|||
163082074|NCT03715829|589009641|FG006|Dose Ranging Period|Protocol Violation|0|||
163082075|NCT03715829|589009642|FG007|Dose Ranging Period|Protocol Violation|0|||
163219494|NCT02658890|589519411|FG020|Treatment Phase|Progressive Disease|19|||
163030193|NCT00783224|588813802|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
163219495|NCT02658890|589519412|FG021|Treatment Phase|Progressive Disease|30|||
163219496|NCT02658890|589519413|FG022|Treatment Phase|Progressive Disease|15|||
163219497|NCT02658890|589519414|FG023|Treatment Phase|Progressive Disease|0|||
163219498|NCT02658890|589519415|FG024|Treatment Phase|Progressive Disease|0|||
163219499|NCT02658890|589519416|FG025|Treatment Phase|Progressive Disease|14|||
163219500|NCT02658890|589519417|FG026|Treatment Phase|Progressive Disease|11|||
163219501|NCT02658890|589519391|FG000|Treatment Phase|Study Drug Toxicity|0|||
163082076|NCT03715829|589009643|FG008|Dose Ranging Period|Protocol Violation|0|||
163082077|NCT03715829|589009644|FG009|Dose Ranging Period|Protocol Violation|0|||
163082078|NCT03715829|589009645|FG010|Dose Ranging Period|Protocol Violation|0|||
163082079|NCT03715829|589009635|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
163082080|NCT03715829|589009636|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
163082081|NCT03715829|589009637|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
163082082|NCT03715829|589009638|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
163082083|NCT03715829|589009639|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
163082084|NCT03715829|589009640|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
163082085|NCT03715829|589009641|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
163082086|NCT03715829|589009642|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
163082087|NCT03715829|589009643|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
163082088|NCT03715829|589009644|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
163082089|NCT03715829|589009645|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
163082090|NCT03715829|589009635|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082091|NCT03715829|589009636|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082092|NCT03715829|589009637|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
163082093|NCT03715829|589009638|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082094|NCT03715829|589009639|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082095|NCT03715829|589009640|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082096|NCT03715829|589009641|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082097|NCT03715829|589009642|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082098|NCT03715829|589009643|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082099|NCT03715829|589009644|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082100|NCT03715829|589009645|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082101|NCT03715829|589009635|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082102|NCT03715829|589009636|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082103|NCT03715829|589009637|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
163082104|NCT03715829|589009638|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082105|NCT03715829|589009639|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
163082106|NCT03715829|589009640|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082107|NCT03715829|589009641|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082108|NCT03715829|589009642|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082109|NCT03715829|589009643|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082110|NCT03715829|589009644|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082111|NCT03715829|589009645|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082112|NCT03715829|589009635|FG000|Dose Ranging Period|Other|0|||
163082113|NCT03715829|589009636|FG001|Dose Ranging Period|Other|0|||
163082114|NCT03715829|589009637|FG002|Dose Ranging Period|Other|2|||
163082115|NCT03715829|589009638|FG003|Dose Ranging Period|Other|0|||
163082116|NCT03715829|589009639|FG004|Dose Ranging Period|Other|0|||
163082117|NCT03715829|589009640|FG005|Dose Ranging Period|Other|3|||
163082118|NCT03715829|589009641|FG006|Dose Ranging Period|Other|0|||
163082119|NCT03715829|589009642|FG007|Dose Ranging Period|Other|0|||
163082120|NCT03715829|589009643|FG008|Dose Ranging Period|Other|0|||
163082121|NCT03715829|589009644|FG009|Dose Ranging Period|Other|0|||
163082122|NCT03715829|589009645|FG010|Dose Ranging Period|Other|0|||
163082123|NCT03715829|589009635|FG000|Extension Period|Adverse Event|0|||
163082124|NCT03715829|589009636|FG001|Extension Period|Adverse Event|0|||
163082125|NCT03715829|589009637|FG002|Extension Period|Adverse Event|0|||
163082126|NCT03715829|589009638|FG003|Extension Period|Adverse Event|0|||
163082127|NCT03715829|589009639|FG004|Extension Period|Adverse Event|0|||
163082128|NCT03715829|589009640|FG005|Extension Period|Adverse Event|0|||
163082129|NCT03715829|589009641|FG006|Extension Period|Adverse Event|3|||
163082130|NCT03715829|589009642|FG007|Extension Period|Adverse Event|1|||
163082131|NCT03715829|589009643|FG008|Extension Period|Adverse Event|6|||
163082132|NCT03715829|589009644|FG009|Extension Period|Adverse Event|0|||
163082133|NCT03715829|589009645|FG010|Extension Period|Adverse Event|0|||
163082134|NCT03715829|589009635|FG000|Extension Period|Lack of Efficacy|0|||
163082135|NCT03715829|589009636|FG001|Extension Period|Lack of Efficacy|0|||
163082136|NCT03715829|589009637|FG002|Extension Period|Lack of Efficacy|0|||
163082137|NCT03715829|589009638|FG003|Extension Period|Lack of Efficacy|0|||
163082138|NCT03715829|589009639|FG004|Extension Period|Lack of Efficacy|0|||
163082139|NCT03715829|589009640|FG005|Extension Period|Lack of Efficacy|0|||
163082140|NCT03715829|589009641|FG006|Extension Period|Lack of Efficacy|1|||
163082141|NCT03715829|589009642|FG007|Extension Period|Lack of Efficacy|9|||
163082142|NCT03715829|589009643|FG008|Extension Period|Lack of Efficacy|2|||
163082143|NCT03715829|589009644|FG009|Extension Period|Lack of Efficacy|0|||
163082144|NCT03715829|589009645|FG010|Extension Period|Lack of Efficacy|0|||
163082145|NCT03715829|589009635|FG000|Extension Period|Lost to Follow-up|0|||
163082146|NCT03715829|589009636|FG001|Extension Period|Lost to Follow-up|0|||
163082147|NCT03715829|589009637|FG002|Extension Period|Lost to Follow-up|0|||
163332498|NCT00243867|589927702|FG001|Overall Study|Withdrawal by Subject|23|||
163332499|NCT00243867|589927701|FG000|Overall Study|Lost to Follow-up|2|||
163082148|NCT03715829|589009638|FG003|Extension Period|Lost to Follow-up|0|||
163082149|NCT03715829|589009639|FG004|Extension Period|Lost to Follow-up|0|||
163082150|NCT03715829|589009640|FG005|Extension Period|Lost to Follow-up|0|||
163082151|NCT03715829|589009641|FG006|Extension Period|Lost to Follow-up|0|||
163082152|NCT03715829|589009642|FG007|Extension Period|Lost to Follow-up|0|||
163082153|NCT03715829|589009643|FG008|Extension Period|Lost to Follow-up|2|||
163082154|NCT03715829|589009644|FG009|Extension Period|Lost to Follow-up|0|||
163082155|NCT03715829|589009645|FG010|Extension Period|Lost to Follow-up|0|||
163082156|NCT03715829|589009635|FG000|Extension Period|Protocol Violation|0|||
163082157|NCT03715829|589009636|FG001|Extension Period|Protocol Violation|0|||
163082158|NCT03715829|589009637|FG002|Extension Period|Protocol Violation|0|||
163082159|NCT03715829|589009638|FG003|Extension Period|Protocol Violation|0|||
163082160|NCT03715829|589009639|FG004|Extension Period|Protocol Violation|0|||
163082161|NCT03715829|589009640|FG005|Extension Period|Protocol Violation|0|||
163082162|NCT03715829|589009641|FG006|Extension Period|Protocol Violation|0|||
163082163|NCT03715829|589009642|FG007|Extension Period|Protocol Violation|0|||
163082164|NCT03715829|589009643|FG008|Extension Period|Protocol Violation|1|||
163082165|NCT03715829|589009644|FG009|Extension Period|Protocol Violation|0|||
163082166|NCT03715829|589009645|FG010|Extension Period|Protocol Violation|0|||
163082167|NCT03715829|589009635|FG000|Extension Period|Withdrawal by Subject|0|||
163082168|NCT03715829|589009636|FG001|Extension Period|Withdrawal by Subject|0|||
163082169|NCT03715829|589009637|FG002|Extension Period|Withdrawal by Subject|0|||
163082170|NCT03715829|589009638|FG003|Extension Period|Withdrawal by Subject|0|||
163082171|NCT03715829|589009639|FG004|Extension Period|Withdrawal by Subject|0|||
163082172|NCT03715829|589009640|FG005|Extension Period|Withdrawal by Subject|0|||
163082173|NCT03715829|589009641|FG006|Extension Period|Withdrawal by Subject|3|||
163082174|NCT03715829|589009642|FG007|Extension Period|Withdrawal by Subject|3|||
163082175|NCT03715829|589009643|FG008|Extension Period|Withdrawal by Subject|12|||
163082176|NCT03715829|589009644|FG009|Extension Period|Withdrawal by Subject|3|||
163082177|NCT03715829|589009645|FG010|Extension Period|Withdrawal by Subject|0|||
163082178|NCT03715829|589009635|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082179|NCT03715829|589009636|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082180|NCT03715829|589009637|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082181|NCT03715829|589009638|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082182|NCT03715829|589009639|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082183|NCT03715829|589009640|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082184|NCT03715829|589009641|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082185|NCT03715829|589009642|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
163082186|NCT03715829|589009643|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
163082187|NCT03715829|589009644|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082188|NCT03715829|589009645|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082189|NCT03715829|589009635|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082190|NCT03715829|589009636|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082191|NCT03715829|589009637|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082192|NCT03715829|589009638|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082193|NCT03715829|589009639|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082194|NCT03715829|589009640|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082195|NCT03715829|589009641|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082196|NCT03715829|589009642|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082197|NCT03715829|589009643|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
163082198|NCT03715829|589009644|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082199|NCT03715829|589009645|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082200|NCT03715829|589009635|FG000|Extension Period|Other|0|||
163082201|NCT03715829|589009636|FG001|Extension Period|Other|0|||
163082202|NCT03715829|589009637|FG002|Extension Period|Other|0|||
163082203|NCT03715829|589009638|FG003|Extension Period|Other|0|||
163082204|NCT03715829|589009639|FG004|Extension Period|Other|0|||
163082205|NCT03715829|589009640|FG005|Extension Period|Other|0|||
163082206|NCT03715829|589009641|FG006|Extension Period|Other|1|||
163082207|NCT03715829|589009642|FG007|Extension Period|Other|2|||
163082208|NCT03715829|589009643|FG008|Extension Period|Other|4|||
163082209|NCT03715829|589009644|FG009|Extension Period|Other|0|||
163219502|NCT02658890|589519392|FG001|Treatment Phase|Study Drug Toxicity|0|||
163219503|NCT02658890|589519393|FG002|Treatment Phase|Study Drug Toxicity|2|||
163082210|NCT03715829|589009645|FG010|Extension Period|Other|0|||
163082211|NCT03647137|589009647|FG000|Overall Study|Scan Limitation|2|||
163082212|NCT03647137|589009648|FG001|Overall Study|Scan Limitation|1|||
163082213|NCT03647137|589009649|FG002|Overall Study|Scan Limitation|1|||
163082214|NCT03647137|589009650|FG003|Overall Study|Scan Limitation|2|||
163082215|NCT03579719|589009651|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
163082216|NCT01443026|589009652|FG000|Overall Study|Physician Decision|1|||
163219504|NCT02658890|589519394|FG003|Treatment Phase|Study Drug Toxicity|0|||
163082217|NCT01443026|589009653|FG001|Overall Study|Physician Decision|0|||
163082218|NCT01443026|589009652|FG000|Overall Study|Death|0|||
163082219|NCT01443026|589009653|FG001|Overall Study|Death|1|||
163082220|NCT01443026|589009652|FG000|Overall Study|Withdrawal by Subject|0|||
163082221|NCT01443026|589009653|FG001|Overall Study|Withdrawal by Subject|3|||
163082222|NCT01443026|589009652|FG000|Overall Study|Lost to Follow-up|2|||
163082223|NCT01443026|589009653|FG001|Overall Study|Lost to Follow-up|1|||
163082224|NCT03900650|589009654|FG000|Overall Study|Withdrawal by Subject|1|||
163082225|NCT03900650|589009655|FG001|Overall Study|Withdrawal by Subject|1|||
163082226|NCT03900650|589009656|FG002|Overall Study|Withdrawal by Subject|0|||
163082227|NCT03900650|589009657|FG003|Overall Study|Withdrawal by Subject|0|||
163082228|NCT03900650|589009654|FG000|Overall Study|Withdrawn by staff|1|||
163082229|NCT03900650|589009655|FG001|Overall Study|Withdrawn by staff|0|||
163082230|NCT03900650|589009656|FG002|Overall Study|Withdrawn by staff|0|||
163082231|NCT03900650|589009657|FG003|Overall Study|Withdrawn by staff|0|||
163082232|NCT00829868|589009658|FG000|Washout|Physician Decision|1|||
163082233|NCT00829868|589009659|FG001|Washout|Physician Decision|0|||
163082234|NCT01554904|589009663|FG000|Overall Study|Withdrawal by Subject|3|||
163082235|NCT01554904|589009663|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
163082236|NCT01681849|589009666|FG000|Overall Study|Protocol Violation|2|||
163082237|NCT01681849|589009667|FG001|Overall Study|Protocol Violation|0|||
163082238|NCT01681849|589009668|FG002|Overall Study|Protocol Violation|0|||
163082239|NCT01681849|589009666|FG000|Overall Study|Withdrawal by Subject|3|||
163082240|NCT01681849|589009667|FG001|Overall Study|Withdrawal by Subject|5|||
163082241|NCT01681849|589009668|FG002|Overall Study|Withdrawal by Subject|33|||
163082242|NCT01681849|589009666|FG000|Overall Study|Lost to Follow-up|3|||
163082243|NCT01681849|589009667|FG001|Overall Study|Lost to Follow-up|2|||
163082244|NCT01681849|589009668|FG002|Overall Study|Lost to Follow-up|6|||
163082245|NCT04525183|589009669|FG000|Overall Study|Withdrawal by Subject|0|||
163219505|NCT02658890|589519395|FG004|Treatment Phase|Study Drug Toxicity|0|||
163219506|NCT02658890|589519396|FG005|Treatment Phase|Study Drug Toxicity|0|||
163406453|NCT03311711|590198643|FG008|Overall Study|Death of dyad partner|0|||
163406454|NCT03311711|590198644|FG009|Overall Study|Death of dyad partner|1|||
163406455|NCT03311711|590198635|FG000|Overall Study|Lost to Follow-up|2|||
163082246|NCT04525183|589009670|FG001|Overall Study|Withdrawal by Subject|0|||
163082247|NCT04525183|589009671|FG002|Overall Study|Withdrawal by Subject|3|||
163219507|NCT02658890|589519397|FG006|Treatment Phase|Study Drug Toxicity|0|||
163082248|NCT04525183|589009669|FG000|Overall Study|Study non-compliance|0|||
163082249|NCT04525183|589009670|FG001|Overall Study|Study non-compliance|0|||
163082250|NCT04525183|589009671|FG002|Overall Study|Study non-compliance|1|||
163082251|NCT04525183|589009669|FG000|Overall Study|Recurrent disease before starting on study|0|||
163082252|NCT04525183|589009670|FG001|Overall Study|Recurrent disease before starting on study|0|||
163219508|NCT02658890|589519398|FG007|Treatment Phase|Study Drug Toxicity|0|||
163219509|NCT02658890|589519399|FG008|Treatment Phase|Study Drug Toxicity|3|||
163219510|NCT02658890|589519400|FG009|Treatment Phase|Study Drug Toxicity|0|||
163219511|NCT02658890|589519401|FG010|Treatment Phase|Study Drug Toxicity|1|||
163219512|NCT02658890|589519402|FG011|Treatment Phase|Study Drug Toxicity|1|||
163219513|NCT02658890|589519403|FG012|Treatment Phase|Study Drug Toxicity|2|||
163219514|NCT02658890|589519404|FG013|Treatment Phase|Study Drug Toxicity|9|||
163219515|NCT02658890|589519405|FG014|Treatment Phase|Study Drug Toxicity|0|||
163219516|NCT02658890|589519406|FG015|Treatment Phase|Study Drug Toxicity|1|||
163219517|NCT02658890|589519407|FG016|Treatment Phase|Study Drug Toxicity|1|||
163219518|NCT02658890|589519408|FG017|Treatment Phase|Study Drug Toxicity|0|||
163219519|NCT02658890|589519409|FG018|Treatment Phase|Study Drug Toxicity|8|||
163219520|NCT02658890|589519410|FG019|Treatment Phase|Study Drug Toxicity|3|||
163219521|NCT02658890|589519411|FG020|Treatment Phase|Study Drug Toxicity|2|||
163219522|NCT02658890|589519412|FG021|Treatment Phase|Study Drug Toxicity|0|||
163219523|NCT02658890|589519413|FG022|Treatment Phase|Study Drug Toxicity|8|||
163219524|NCT02658890|589519414|FG023|Treatment Phase|Study Drug Toxicity|0|||
163219525|NCT02658890|589519415|FG024|Treatment Phase|Study Drug Toxicity|0|||
163219526|NCT02658890|589519416|FG025|Treatment Phase|Study Drug Toxicity|2|||
163219527|NCT02658890|589519417|FG026|Treatment Phase|Study Drug Toxicity|0|||
163219528|NCT02658890|589519391|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219529|NCT02658890|589519392|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219530|NCT02658890|589519393|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219531|NCT02658890|589519394|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
163219532|NCT02658890|589519395|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219533|NCT02658890|589519396|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219534|NCT02658890|589519397|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219535|NCT02658890|589519398|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219536|NCT02658890|589519399|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219537|NCT02658890|589519400|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
163219538|NCT02658890|589519401|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163082253|NCT04525183|589009671|FG002|Overall Study|Recurrent disease before starting on study|1|||
163082254|NCT05014919|589009673|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
163082255|NCT05014919|589009674|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
163082256|NCT05014919|589009675|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
163082257|NCT05014919|589009673|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
163082258|NCT05014919|589009674|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
163082259|NCT05014919|589009675|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
163082260|NCT05014919|589009673|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
163082261|NCT05014919|589009674|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
163082262|NCT05014919|589009675|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
163082263|NCT05014919|589009673|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
163082264|NCT05014919|589009674|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
163082265|NCT05014919|589009675|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
163082266|NCT05014919|589009673|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
163082267|NCT05014919|589009674|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
163082268|NCT05014919|589009675|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
163082269|NCT05014919|589009673|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
163082270|NCT05014919|589009674|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
163082271|NCT05014919|589009675|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
163082272|NCT05014919|589009673|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
163082273|NCT05014919|589009674|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
163082274|NCT05014919|589009675|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
163082275|NCT05014919|589009673|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
163082276|NCT05014919|589009674|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
163082277|NCT05014919|589009675|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
163082278|NCT04126174|589009681|FG000|Overall Study|Lost to Follow-up|3|||
163082279|NCT04126174|589009682|FG001|Overall Study|Lost to Follow-up|3|||
163082280|NCT03773562|589009683|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
163082281|NCT03773562|589009683|FG000|Overall Study|Lost to Follow-up|10|||
163082282|NCT03773562|589009683|FG000|Overall Study|Withdrawal by Subject|1|||
163082283|NCT05305651|589009684|FG000|Overall Study|Death|1|||
163082284|NCT05305651|589009684|FG000|Overall Study|Withdrawal by Subject|4|||
163082285|NCT05305651|589009684|FG000|Overall Study|Lost to Follow-up|4|||
163082286|NCT01491919|589009687|FG000|Overall Study|Insufficient PK sampling|1|||
163082287|NCT01491919|589009688|FG001|Overall Study|Insufficient PK sampling|2|||
163082288|NCT01491919|589009689|FG002|Overall Study|Insufficient PK sampling|1|||
163082289|NCT05021224|589009693|FG000|Overall Study|Did not complete all survey items|4|||
163082290|NCT05021224|589009694|FG001|Overall Study|Did not complete all survey items|1|||
163082291|NCT05021224|589009695|FG002|Overall Study|Did not complete all survey items|0|||
163082292|NCT05021224|589009696|FG003|Overall Study|Did not complete all survey items|2|||
163082293|NCT03996395|589009697|FG000|Overall Study|Lost to Follow-up|4|||
163082294|NCT03996395|589009697|FG000|Overall Study|Withdrawal by Subject|1|||
163082295|NCT03996395|589009697|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
163082296|NCT05375929|589009700|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
163082297|NCT05375929|589009701|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
163082298|NCT05375929|589009702|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
163082299|NCT05375929|589009703|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
163082300|NCT05375929|589009700|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
163082301|NCT05375929|589009701|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
163082302|NCT05375929|589009702|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
163082303|NCT05375929|589009703|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
163082304|NCT05375929|589009700|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
163082305|NCT05375929|589009701|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
163082306|NCT05375929|589009702|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
163082307|NCT05375929|589009703|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
163082308|NCT05375929|589009700|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
163082309|NCT05375929|589009701|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
163082310|NCT05375929|589009702|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
163082311|NCT05375929|589009703|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
163082312|NCT05375929|589009700|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
163082313|NCT05375929|589009701|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
163332500|NCT00243867|589927702|FG001|Overall Study|Lost to Follow-up|1|||
163332501|NCT00243867|589927701|FG000|Overall Study|Physician Decision|2|||
163332502|NCT00243867|589927702|FG001|Overall Study|Physician Decision|7|||
163332503|NCT00243867|589927701|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
163332504|NCT00243867|589927702|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
163332505|NCT04399837|589927703|FG000|Overall Study|Other than listed|0|||
163082314|NCT05375929|589009702|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
163082315|NCT05375929|589009703|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
163082316|NCT05375929|589009700|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
163082317|NCT05375929|589009701|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
163082318|NCT05375929|589009702|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
163082319|NCT05375929|589009703|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
163082320|NCT05375929|589009700|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
163082321|NCT05375929|589009701|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
163082322|NCT05375929|589009702|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
163082323|NCT05375929|589009703|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
163082324|NCT05375929|589009700|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
163082325|NCT05375929|589009701|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
163082326|NCT05375929|589009702|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
163082327|NCT05375929|589009703|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
163082328|NCT05375929|589009700|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
163082329|NCT05375929|589009701|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
163082330|NCT05375929|589009702|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
163082331|NCT05375929|589009703|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
163082332|NCT05375929|589009700|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
163082333|NCT05375929|589009701|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
163082334|NCT05375929|589009702|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
163082335|NCT05375929|589009703|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
163082336|NCT03973489|589009709|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
163082337|NCT03973489|589009710|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
163082338|NCT03973489|589009711|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
163082339|NCT03973489|589009712|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
163082340|NCT03973489|589009713|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
163082341|NCT03973489|589009714|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
163082342|NCT03973489|589009715|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
163082343|NCT03973489|589009716|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
163082344|NCT03973489|589009709|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
163082345|NCT03973489|589009710|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
163082346|NCT03973489|589009711|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
163082347|NCT03973489|589009712|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
163082348|NCT03973489|589009713|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
163082349|NCT03973489|589009714|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
163082350|NCT03973489|589009715|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
163082351|NCT03973489|589009716|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
163082352|NCT03973489|589009709|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
163082353|NCT03973489|589009710|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
163082354|NCT03973489|589009711|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
163082355|NCT03973489|589009712|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
163082356|NCT03973489|589009713|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
163082357|NCT03973489|589009714|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
163082358|NCT03973489|589009715|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
163082359|NCT03973489|589009716|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
163082360|NCT03973489|589009709|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
163082361|NCT03973489|589009710|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
163082362|NCT03973489|589009711|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
163082363|NCT03973489|589009712|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
163082364|NCT03973489|589009713|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
163082365|NCT03973489|589009714|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
163082366|NCT03973489|589009715|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
163082367|NCT03973489|589009716|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
163082368|NCT03973489|589009709|FG000|Second Intervention (1 Day)|Adverse Event|0|||
163082369|NCT03973489|589009710|FG001|Second Intervention (1 Day)|Adverse Event|0|||
163082370|NCT03973489|589009711|FG002|Second Intervention (1 Day)|Adverse Event|0|||
163082371|NCT03973489|589009712|FG003|Second Intervention (1 Day)|Adverse Event|1|||
163082372|NCT03973489|589009713|FG004|Second Intervention (1 Day)|Adverse Event|0|||
163082373|NCT03973489|589009714|FG005|Second Intervention (1 Day)|Adverse Event|0|||
163219539|NCT02658890|589519402|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219540|NCT02658890|589519403|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219541|NCT02658890|589519404|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219542|NCT02658890|589519405|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219543|NCT02658890|589519406|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163082374|NCT03973489|589009715|FG006|Second Intervention (1 Day)|Adverse Event|0|||
163082375|NCT03973489|589009716|FG007|Second Intervention (1 Day)|Adverse Event|0|||
163082376|NCT04573881|589009717|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
163082377|NCT03379870|589011986|FG000|Overall Study|Lost to Follow-up|1|||
163082378|NCT03379870|589011987|FG001|Overall Study|Lost to Follow-up|0|||
163082379|NCT03379870|589011986|FG000|Overall Study|Protocol Violation|1|||
163082380|NCT03379870|589011987|FG001|Overall Study|Protocol Violation|1|||
163082381|NCT00003645|589011988|FG000|Overall Study|Death|4|||
163082382|NCT00003645|589011989|FG001|Overall Study|Death|1|||
163082383|NCT00003645|589011988|FG000|Overall Study|Lost to Follow-up|7|||
163082384|NCT00003645|589011989|FG001|Overall Study|Lost to Follow-up|8|||
163082385|NCT00003645|589011988|FG000|Overall Study|Withdrawal by Subject|1|||
163082386|NCT00003645|589011989|FG001|Overall Study|Withdrawal by Subject|3|||
163082387|NCT01373281|589011990|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
163082388|NCT01373281|589011991|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
163082389|NCT01373281|589011990|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
163082390|NCT01373281|589011991|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
163082391|NCT01373281|589011990|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
163082392|NCT01373281|589011991|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
163082393|NCT01373281|589011990|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
163082394|NCT01373281|589011991|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
163082395|NCT01373281|589011990|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
163082396|NCT01373281|589011991|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
163082397|NCT01373281|589011990|FG000|Surveillance Expansion Period|Protocol Violation|9|||
163082398|NCT01373281|589011991|FG001|Surveillance Expansion Period|Protocol Violation|1|||
163082399|NCT01373281|589011990|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
163082400|NCT01373281|589011991|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
163082401|NCT01373281|589011990|FG000|Surveillance Expansion Period|Serious adverse event|3|||
163082402|NCT01373281|589011991|FG001|Surveillance Expansion Period|Serious adverse event|4|||
163082403|NCT03502681|589011992|FG000|Overall Study|Adverse Event|1|||
163082404|NCT03502681|589011993|FG001|Overall Study|Adverse Event|1|||
163082405|NCT03502681|589011992|FG000|Overall Study|Disease Progression|2|||
163082406|NCT03502681|589011993|FG001|Overall Study|Disease Progression|1|||
163082407|NCT02254291|589011994|FG000|Overall Study|Withdrawal by Subject|0|||
163082408|NCT02254291|589011995|FG001|Overall Study|Withdrawal by Subject|3|||
163082409|NCT02254291|589011996|FG002|Overall Study|Withdrawal by Subject|1|||
163082410|NCT02254291|589011994|FG000|Overall Study|Missing follow-up information|0|||
163082411|NCT02254291|589011995|FG001|Overall Study|Missing follow-up information|0|||
163082412|NCT02254291|589011996|FG002|Overall Study|Missing follow-up information|1|||
163082413|NCT03436732|589011999|FG000|Overall Study|Not treated-enrolled in different study|1|||
163082414|NCT03436732|589012000|FG001|Overall Study|Not treated-enrolled in different study|0|||
163082415|NCT03436732|589011999|FG000|Overall Study|Off study after cycle 1|1|||
163082416|NCT03436732|589012000|FG001|Overall Study|Off study after cycle 1|0|||
163082417|NCT03436732|589011999|FG000|Overall Study|Adverse Event|2|||
163082418|NCT03436732|589012000|FG001|Overall Study|Adverse Event|0|||
163082419|NCT03436732|589011999|FG000|Overall Study|Death|0|||
163082420|NCT03436732|589012000|FG001|Overall Study|Death|1|||
163082421|NCT03257657|589012003|FG000|Overall Study|Lost to Follow-up|0|||
163082422|NCT03257657|589012004|FG001|Overall Study|Lost to Follow-up|3|||
163082423|NCT03257657|589012003|FG000|Overall Study|Withdrawn|0|||
163082424|NCT03257657|589012004|FG001|Overall Study|Withdrawn|1|||
163082425|NCT03257657|589012003|FG000|Overall Study|Noted not eligible right after enrolled|0|||
163082426|NCT03257657|589012004|FG001|Overall Study|Noted not eligible right after enrolled|1|||
163082427|NCT02801578|589012005|FG000|Overall Study|Adverse Event|2|||
163082428|NCT00668642|589012011|FG000|First Off-cycle|Cancer progression|1|||
163082429|NCT00668642|589012012|FG001|First Off-cycle|Cancer progression|0|||
163082430|NCT00668642|589012011|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
163082431|NCT00668642|589012012|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
163082432|NCT02014467|589012013|FG000|Overall Study|Adverse Event|4|||
163082433|NCT02014467|589012014|FG001|Overall Study|Adverse Event|0|||
163082434|NCT02014467|589012013|FG000|Overall Study|Protocol Violation|3|||
163332506|NCT04399837|589927704|FG001|Overall Study|Other than listed|2|||
163332507|NCT04399837|589927705|FG002|Overall Study|Other than listed|2|||
163332508|NCT04399837|589927706|FG003|Overall Study|Other than listed|3|||
163332509|NCT04399837|589927703|FG000|Overall Study|Withdrawal by Subject|1|||
163082435|NCT02014467|589012014|FG001|Overall Study|Protocol Violation|0|||
163082436|NCT02014467|589012013|FG000|Overall Study|Physician Decision|2|||
163082437|NCT02014467|589012014|FG001|Overall Study|Physician Decision|3|||
163082438|NCT02014467|589012013|FG000|Overall Study|Withdrawal by Subject|16|||
163082439|NCT02014467|589012014|FG001|Overall Study|Withdrawal by Subject|4|||
163082440|NCT01217892|589012016|FG000|Overall Study|Adverse Event|1|||
163082441|NCT01217892|589012017|FG001|Overall Study|Adverse Event|1|||
163082442|NCT01217892|589012018|FG002|Overall Study|Adverse Event|1|||
163082443|NCT01217892|589012019|FG003|Overall Study|Adverse Event|0|||
163082444|NCT01217892|589012016|FG000|Overall Study|Withdrawal by Subject|0|||
163406456|NCT03311711|590198636|FG001|Overall Study|Lost to Follow-up|2|||
163082445|NCT01217892|589012017|FG001|Overall Study|Withdrawal by Subject|2|||
163082446|NCT01217892|589012018|FG002|Overall Study|Withdrawal by Subject|1|||
163082447|NCT01217892|589012019|FG003|Overall Study|Withdrawal by Subject|0|||
163082448|NCT01217892|589012016|FG000|Overall Study|Lab value|1|||
163082449|NCT01217892|589012017|FG001|Overall Study|Lab value|0|||
163082450|NCT01217892|589012018|FG002|Overall Study|Lab value|1|||
163082451|NCT01217892|589012019|FG003|Overall Study|Lab value|0|||
163082452|NCT01217892|589012016|FG000|Overall Study|Subject no longer meets study criteria|5|||
163082453|NCT01217892|589012017|FG001|Overall Study|Subject no longer meets study criteria|2|||
163082454|NCT01217892|589012018|FG002|Overall Study|Subject no longer meets study criteria|4|||
163082455|NCT01217892|589012019|FG003|Overall Study|Subject no longer meets study criteria|8|||
163082456|NCT01217892|589012016|FG000|Overall Study|Incorrect enrollment|0|||
163082457|NCT01217892|589012017|FG001|Overall Study|Incorrect enrollment|1|||
163082458|NCT01217892|589012018|FG002|Overall Study|Incorrect enrollment|1|||
163082459|NCT01217892|589012019|FG003|Overall Study|Incorrect enrollment|0|||
163082460|NCT01217892|589012016|FG000|Overall Study|Poor/Non-Compliance|0|||
163082461|NCT01217892|589012017|FG001|Overall Study|Poor/Non-Compliance|0|||
163082462|NCT01217892|589012018|FG002|Overall Study|Poor/Non-Compliance|1|||
163082463|NCT01217892|589012019|FG003|Overall Study|Poor/Non-Compliance|0|||
163082464|NCT00831389|589012021|FG000|Overall Study|Withdrawal by Subject|0|||
163082465|NCT00831389|589012022|FG001|Overall Study|Withdrawal by Subject|1|||
163082466|NCT00278161|589012024|FG000|Overall Study|Death|11|||
163082467|NCT01817777|589012025|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
163082468|NCT01817777|589012026|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
163082469|NCT01817777|589012027|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
163082470|NCT01817777|589012025|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
163082471|NCT01817777|589012026|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
163082472|NCT01817777|589012027|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
163082473|NCT01817777|589012025|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
163082474|NCT01817777|589012026|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
163082475|NCT01817777|589012027|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
163082476|NCT01817777|589012025|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
163082477|NCT01817777|589012026|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
163082478|NCT01817777|589012027|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
163082479|NCT01817777|589012025|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
163082480|NCT01817777|589012026|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
163082481|NCT01817777|589012027|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
163082482|NCT00443456|589012028|FG000|Overall Study|Adverse Event|16|||
163082483|NCT00443456|589012028|FG000|Overall Study|Move|1|||
163082484|NCT00443456|589012028|FG000|Overall Study|Withdrawal by Subject|1|||
163082485|NCT03242434|589012029|FG000|Overall Study|Death|0|||
163082486|NCT03242434|589012030|FG001|Overall Study|Death|2|||
163082487|NCT01592747|589012036|FG000|Overall Study|Loss of Therapeutic Response|107|||
163082488|NCT01592747|589012037|FG001|Overall Study|Loss of Therapeutic Response|108|||
163082489|NCT01592747|589012038|FG002|Overall Study|Loss of Therapeutic Response|100|||
163082490|NCT01592747|589012036|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
163082491|NCT01592747|589012037|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
163082492|NCT01592747|589012038|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
163082493|NCT01592747|589012036|FG000|Overall Study|Adverse Event|1|||
163082494|NCT01592747|589012037|FG001|Overall Study|Adverse Event|0|||
163082495|NCT01592747|589012038|FG002|Overall Study|Adverse Event|0|||
163082496|NCT01592747|589012036|FG000|Overall Study|Protocol Violation|4|||
163082497|NCT01592747|589012037|FG001|Overall Study|Protocol Violation|0|||
163082498|NCT01592747|589012038|FG002|Overall Study|Protocol Violation|4|||
163082499|NCT01592747|589012036|FG000|Overall Study|Lack of Efficacy|0|||
163082500|NCT01592747|589012037|FG001|Overall Study|Lack of Efficacy|1|||
163082501|NCT01592747|589012038|FG002|Overall Study|Lack of Efficacy|0|||
163082502|NCT01592747|589012036|FG000|Overall Study|Withdrawal by Subject|2|||
163082503|NCT01592747|589012037|FG001|Overall Study|Withdrawal by Subject|0|||
163082504|NCT01592747|589012038|FG002|Overall Study|Withdrawal by Subject|2|||
163082505|NCT01592747|589012036|FG000|Overall Study|Lost to Follow-up|1|||
163082506|NCT01592747|589012037|FG001|Overall Study|Lost to Follow-up|0|||
163082507|NCT01592747|589012038|FG002|Overall Study|Lost to Follow-up|1|||
163082508|NCT01592747|589012036|FG000|Overall Study|Other Reasons|1|||
163082509|NCT01592747|589012037|FG001|Overall Study|Other Reasons|1|||
163082510|NCT01592747|589012038|FG002|Overall Study|Other Reasons|0|||
163082511|NCT01935947|589012041|FG000|Overall Study|Adverse Event|0|||
163082512|NCT01935947|589012042|FG001|Overall Study|Adverse Event|2|||
163082513|NCT01935947|589012043|FG002|Overall Study|Adverse Event|0|||
163082514|NCT01935947|589012041|FG000|Overall Study|Diease Progression|2|||
163082515|NCT01935947|589012042|FG001|Overall Study|Diease Progression|2|||
163082516|NCT01935947|589012043|FG002|Overall Study|Diease Progression|2|||
163082517|NCT01935947|589012041|FG000|Overall Study|Death|1|||
163082518|NCT01935947|589012042|FG001|Overall Study|Death|0|||
163082519|NCT01935947|589012043|FG002|Overall Study|Death|0|||
163082520|NCT02327169|589012044|FG000|Overall Study|Progressive Disease|1|||
163082521|NCT02327169|589012045|FG001|Overall Study|Progressive Disease|3|||
163082522|NCT02327169|589012046|FG002|Overall Study|Progressive Disease|4|||
163082523|NCT02327169|589012047|FG003|Overall Study|Progressive Disease|3|||
163082524|NCT02327169|589012048|FG004|Overall Study|Progressive Disease|4|||
163082525|NCT02327169|589012049|FG005|Overall Study|Progressive Disease|3|||
163082526|NCT02327169|589012050|FG006|Overall Study|Progressive Disease|3|||
163082527|NCT02327169|589012051|FG007|Overall Study|Progressive Disease|3|||
163082528|NCT02327169|589012052|FG008|Overall Study|Progressive Disease|4|||
163082529|NCT02327169|589012053|FG009|Overall Study|Progressive Disease|4|||
163082530|NCT02327169|589012054|FG010|Overall Study|Progressive Disease|4|||
163082531|NCT02327169|589012055|FG011|Overall Study|Progressive Disease|3|||
163082532|NCT02327169|589012056|FG012|Overall Study|Progressive Disease|1|||
163082533|NCT02327169|589012057|FG013|Overall Study|Progressive Disease|3|||
163082534|NCT02327169|589012058|FG014|Overall Study|Progressive Disease|3|||
163082535|NCT02327169|589012044|FG000|Overall Study|Adverse Event|2|||
163082536|NCT02327169|589012045|FG001|Overall Study|Adverse Event|0|||
163082537|NCT02327169|589012046|FG002|Overall Study|Adverse Event|1|||
163082538|NCT02327169|589012047|FG003|Overall Study|Adverse Event|0|||
163082539|NCT02327169|589012048|FG004|Overall Study|Adverse Event|1|||
163082540|NCT02327169|589012049|FG005|Overall Study|Adverse Event|0|||
163082541|NCT02327169|589012050|FG006|Overall Study|Adverse Event|0|||
163082542|NCT02327169|589012051|FG007|Overall Study|Adverse Event|0|||
163082543|NCT02327169|589012052|FG008|Overall Study|Adverse Event|0|||
163082544|NCT02327169|589012053|FG009|Overall Study|Adverse Event|2|||
163082545|NCT02327169|589012054|FG010|Overall Study|Adverse Event|0|||
163082546|NCT02327169|589012055|FG011|Overall Study|Adverse Event|3|||
163082547|NCT02327169|589012056|FG012|Overall Study|Adverse Event|0|||
163082548|NCT02327169|589012057|FG013|Overall Study|Adverse Event|2|||
163082549|NCT02327169|589012058|FG014|Overall Study|Adverse Event|1|||
163082550|NCT02327169|589012044|FG000|Overall Study|Symptomatic Deterioration|0|||
163082551|NCT02327169|589012045|FG001|Overall Study|Symptomatic Deterioration|0|||
163082552|NCT02327169|589012046|FG002|Overall Study|Symptomatic Deterioration|1|||
163082553|NCT02327169|589012047|FG003|Overall Study|Symptomatic Deterioration|0|||
163082554|NCT02327169|589012048|FG004|Overall Study|Symptomatic Deterioration|1|||
163082555|NCT02327169|589012049|FG005|Overall Study|Symptomatic Deterioration|1|||
163082556|NCT02327169|589012050|FG006|Overall Study|Symptomatic Deterioration|0|||
163082557|NCT02327169|589012051|FG007|Overall Study|Symptomatic Deterioration|0|||
163082558|NCT02327169|589012052|FG008|Overall Study|Symptomatic Deterioration|2|||
163082559|NCT02327169|589012053|FG009|Overall Study|Symptomatic Deterioration|1|||
163082560|NCT02327169|589012054|FG010|Overall Study|Symptomatic Deterioration|0|||
163082561|NCT02327169|589012055|FG011|Overall Study|Symptomatic Deterioration|0|||
163082562|NCT02327169|589012056|FG012|Overall Study|Symptomatic Deterioration|0|||
163082563|NCT02327169|589012057|FG013|Overall Study|Symptomatic Deterioration|2|||
163082564|NCT02327169|589012058|FG014|Overall Study|Symptomatic Deterioration|1|||
163082565|NCT02327169|589012044|FG000|Overall Study|Reason Not Specified|0|||
163082566|NCT02327169|589012045|FG001|Overall Study|Reason Not Specified|0|||
163082567|NCT02327169|589012046|FG002|Overall Study|Reason Not Specified|1|||
163082568|NCT02327169|589012047|FG003|Overall Study|Reason Not Specified|0|||
163082569|NCT02327169|589012048|FG004|Overall Study|Reason Not Specified|0|||
163082570|NCT02327169|589012049|FG005|Overall Study|Reason Not Specified|0|||
163082571|NCT02327169|589012050|FG006|Overall Study|Reason Not Specified|0|||
163082572|NCT02327169|589012051|FG007|Overall Study|Reason Not Specified|0|||
163219544|NCT02658890|589519407|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219545|NCT02658890|589519408|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219546|NCT02658890|589519409|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
163219547|NCT02658890|589519410|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219548|NCT02658890|589519411|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219549|NCT02658890|589519412|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163406457|NCT03311711|590198637|FG002|Overall Study|Lost to Follow-up|0|||
163082573|NCT02327169|589012052|FG008|Overall Study|Reason Not Specified|0|||
163082574|NCT02327169|589012053|FG009|Overall Study|Reason Not Specified|1|||
163082575|NCT02327169|589012054|FG010|Overall Study|Reason Not Specified|2|||
163082576|NCT02327169|589012055|FG011|Overall Study|Reason Not Specified|1|||
163082577|NCT02327169|589012056|FG012|Overall Study|Reason Not Specified|0|||
163082578|NCT02327169|589012057|FG013|Overall Study|Reason Not Specified|0|||
163082579|NCT02327169|589012058|FG014|Overall Study|Reason Not Specified|2|||
163082580|NCT02327169|589012044|FG000|Overall Study|Withdrawal by Subject|1|||
163082581|NCT02327169|589012045|FG001|Overall Study|Withdrawal by Subject|0|||
163082582|NCT02327169|589012046|FG002|Overall Study|Withdrawal by Subject|0|||
163082583|NCT02327169|589012047|FG003|Overall Study|Withdrawal by Subject|0|||
163082584|NCT02327169|589012048|FG004|Overall Study|Withdrawal by Subject|1|||
163082585|NCT02327169|589012049|FG005|Overall Study|Withdrawal by Subject|0|||
163082586|NCT02327169|589012050|FG006|Overall Study|Withdrawal by Subject|0|||
163082587|NCT02327169|589012051|FG007|Overall Study|Withdrawal by Subject|1|||
163219550|NCT02658890|589519413|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
163082588|NCT02327169|589012052|FG008|Overall Study|Withdrawal by Subject|0|||
163082589|NCT02327169|589012053|FG009|Overall Study|Withdrawal by Subject|0|||
163082590|NCT02327169|589012054|FG010|Overall Study|Withdrawal by Subject|0|||
163082591|NCT02327169|589012055|FG011|Overall Study|Withdrawal by Subject|0|||
163082592|NCT02327169|589012056|FG012|Overall Study|Withdrawal by Subject|0|||
163082593|NCT02327169|589012057|FG013|Overall Study|Withdrawal by Subject|0|||
163082594|NCT02327169|589012058|FG014|Overall Study|Withdrawal by Subject|3|||
163082595|NCT02327169|589012044|FG000|Overall Study|Lost to Follow-up|0|||
163082596|NCT02327169|589012045|FG001|Overall Study|Lost to Follow-up|0|||
163082597|NCT02327169|589012046|FG002|Overall Study|Lost to Follow-up|0|||
163082598|NCT02327169|589012047|FG003|Overall Study|Lost to Follow-up|0|||
163082599|NCT02327169|589012048|FG004|Overall Study|Lost to Follow-up|1|||
163082600|NCT02327169|589012049|FG005|Overall Study|Lost to Follow-up|0|||
163082601|NCT02327169|589012050|FG006|Overall Study|Lost to Follow-up|0|||
163082602|NCT02327169|589012051|FG007|Overall Study|Lost to Follow-up|0|||
163082603|NCT02327169|589012052|FG008|Overall Study|Lost to Follow-up|0|||
163082604|NCT02327169|589012053|FG009|Overall Study|Lost to Follow-up|0|||
163082605|NCT02327169|589012054|FG010|Overall Study|Lost to Follow-up|0|||
163082606|NCT02327169|589012055|FG011|Overall Study|Lost to Follow-up|0|||
163082607|NCT02327169|589012056|FG012|Overall Study|Lost to Follow-up|0|||
163082608|NCT02327169|589012057|FG013|Overall Study|Lost to Follow-up|0|||
163082609|NCT02327169|589012058|FG014|Overall Study|Lost to Follow-up|0|||
163082610|NCT03787615|589012059|FG000|Overall Study|Withdrawal by Subject|2|||
163082611|NCT03787615|589012059|FG000|Overall Study|Lost to Follow-up|2|||
163082612|NCT01229111|589012061|FG000|Overall Study|Death|1|||
163082613|NCT04102514|589012062|FG000|Overall Study|Death|3|||
163082614|NCT04102514|589012063|FG001|Overall Study|Death|0|||
163082615|NCT04102514|589012064|FG002|Overall Study|Death|0|||
163082616|NCT04102514|589012065|FG003|Overall Study|Death|0|||
163082617|NCT04102514|589012062|FG000|Overall Study|Lost to Follow-up|0|||
163082618|NCT04102514|589012063|FG001|Overall Study|Lost to Follow-up|0|||
163082619|NCT04102514|589012064|FG002|Overall Study|Lost to Follow-up|3|||
163082620|NCT04102514|589012065|FG003|Overall Study|Lost to Follow-up|0|||
163082621|NCT04102514|589012062|FG000|Overall Study|Physician Decision|0|||
163082622|NCT04102514|589012063|FG001|Overall Study|Physician Decision|0|||
163082623|NCT04102514|589012064|FG002|Overall Study|Physician Decision|1|||
163082624|NCT04102514|589012065|FG003|Overall Study|Physician Decision|0|||
163082625|NCT04102514|589012062|FG000|Overall Study|Withdrawal by Subject|7|||
163082626|NCT04102514|589012063|FG001|Overall Study|Withdrawal by Subject|13|||
163082627|NCT04102514|589012064|FG002|Overall Study|Withdrawal by Subject|7|||
163082628|NCT04102514|589012065|FG003|Overall Study|Withdrawal by Subject|14|||
163082629|NCT04102514|589012062|FG000|Overall Study|Moved to longterm care facility|6|||
163082630|NCT04102514|589012063|FG001|Overall Study|Moved to longterm care facility|0|||
163082631|NCT04102514|589012064|FG002|Overall Study|Moved to longterm care facility|4|||
163082632|NCT04102514|589012065|FG003|Overall Study|Moved to longterm care facility|0|||
163082633|NCT00619918|589012066|FG000|Overall Study|Withdrawal by Subject|4|||
163082634|NCT00619918|589012067|FG001|Overall Study|Withdrawal by Subject|3|||
163082635|NCT00619918|589012066|FG000|Overall Study|Physician Decision|2|||
163082636|NCT00619918|589012067|FG001|Overall Study|Physician Decision|4|||
163082637|NCT00619918|589012066|FG000|Overall Study|Transfer to outside facility|3|||
163082638|NCT00619918|589012067|FG001|Overall Study|Transfer to outside facility|3|||
163082639|NCT00619918|589012066|FG000|Overall Study|Left before receiving first dose|7|||
163082640|NCT00619918|589012067|FG001|Overall Study|Left before receiving first dose|6|||
163082641|NCT00619918|589012066|FG000|Overall Study|ICU admission|4|||
163082642|NCT00619918|589012067|FG001|Overall Study|ICU admission|6|||
163082643|NCT00456365|589012070|FG000|Overall Study|Lost to Follow-up|1|||
163082644|NCT00456365|589012071|FG001|Overall Study|Lost to Follow-up|3|||
163082645|NCT00456365|589012070|FG000|Overall Study|Withdrawal by Subject|4|||
163082646|NCT00456365|589012071|FG001|Overall Study|Withdrawal by Subject|7|||
163082647|NCT00456365|589012070|FG000|Overall Study|Pregnancy|1|||
163082648|NCT00456365|589012071|FG001|Overall Study|Pregnancy|1|||
163082649|NCT00456365|589012070|FG000|Overall Study|oncologic diagnosis|1|||
163082650|NCT00456365|589012071|FG001|Overall Study|oncologic diagnosis|1|||
163082651|NCT00721110|589012078|FG000|Overall Study|Ultram use|1|||
163082652|NCT00721110|589012079|FG001|Overall Study|Ultram use|0|||
163082653|NCT00721110|589012080|FG002|Overall Study|Ultram use|0|||
163082654|NCT00721110|589012081|FG003|Overall Study|Ultram use|0|||
163082655|NCT00721110|589012078|FG000|Overall Study|vertical incision|0|||
163082656|NCT00721110|589012079|FG001|Overall Study|vertical incision|0|||
163082657|NCT00721110|589012080|FG002|Overall Study|vertical incision|1|||
163082658|NCT00721110|589012081|FG003|Overall Study|vertical incision|0|||
163082659|NCT01051661|589012084|FG000|Overall Study|Adverse Event|1|||
163082660|NCT01051661|589012085|FG001|Overall Study|Adverse Event|1|||
163082661|NCT01051661|589012086|FG002|Overall Study|Adverse Event|1|||
163082662|NCT01051661|589012087|FG003|Overall Study|Adverse Event|1|||
163082663|NCT01051661|589012088|FG004|Overall Study|Adverse Event|0|||
163082664|NCT01051661|589012089|FG005|Overall Study|Adverse Event|0|||
163082665|NCT01051661|589012084|FG000|Overall Study|Lost to Follow-up|13|||
163082666|NCT01051661|589012085|FG001|Overall Study|Lost to Follow-up|22|||
163082667|NCT01051661|589012086|FG002|Overall Study|Lost to Follow-up|15|||
163082668|NCT01051661|589012087|FG003|Overall Study|Lost to Follow-up|17|||
163082669|NCT01051661|589012088|FG004|Overall Study|Lost to Follow-up|10|||
163082670|NCT01051661|589012089|FG005|Overall Study|Lost to Follow-up|24|||
163082671|NCT01051661|589012084|FG000|Overall Study|Migrated/moved from study area|1|||
163082672|NCT01051661|589012085|FG001|Overall Study|Migrated/moved from study area|6|||
163082673|NCT01051661|589012086|FG002|Overall Study|Migrated/moved from study area|6|||
163082674|NCT01051661|589012087|FG003|Overall Study|Migrated/moved from study area|8|||
163082675|NCT01051661|589012088|FG004|Overall Study|Migrated/moved from study area|7|||
163082676|NCT01051661|589012089|FG005|Overall Study|Migrated/moved from study area|3|||
163082677|NCT01051661|589012084|FG000|Overall Study|Refused blood sampling|0|||
163082678|NCT01051661|589012085|FG001|Overall Study|Refused blood sampling|0|||
163082679|NCT01051661|589012086|FG002|Overall Study|Refused blood sampling|0|||
163082680|NCT01051661|589012087|FG003|Overall Study|Refused blood sampling|0|||
163082681|NCT01051661|589012088|FG004|Overall Study|Refused blood sampling|0|||
163082682|NCT01051661|589012089|FG005|Overall Study|Refused blood sampling|1|||
163082683|NCT01051661|589012084|FG000|Overall Study|Data not reliable|1|||
163082684|NCT01051661|589012085|FG001|Overall Study|Data not reliable|0|||
163082685|NCT01051661|589012086|FG002|Overall Study|Data not reliable|0|||
163082686|NCT01051661|589012087|FG003|Overall Study|Data not reliable|0|||
163082687|NCT01051661|589012088|FG004|Overall Study|Data not reliable|0|||
163082688|NCT01051661|589012089|FG005|Overall Study|Data not reliable|1|||
163082689|NCT01051661|589012084|FG000|Overall Study|Unable to attend visit(s)|2|||
163082690|NCT01051661|589012085|FG001|Overall Study|Unable to attend visit(s)|4|||
163082691|NCT01051661|589012086|FG002|Overall Study|Unable to attend visit(s)|2|||
163082692|NCT01051661|589012087|FG003|Overall Study|Unable to attend visit(s)|1|||
163082693|NCT01051661|589012088|FG004|Overall Study|Unable to attend visit(s)|3|||
163082694|NCT01051661|589012089|FG005|Overall Study|Unable to attend visit(s)|2|||
163082695|NCT01051661|589012084|FG000|Overall Study|Consent not received from both parents|0|||
163082696|NCT01051661|589012085|FG001|Overall Study|Consent not received from both parents|0|||
163082697|NCT01051661|589012086|FG002|Overall Study|Consent not received from both parents|0|||
163082698|NCT01051661|589012087|FG003|Overall Study|Consent not received from both parents|0|||
163082699|NCT01051661|589012088|FG004|Overall Study|Consent not received from both parents|0|||
163082700|NCT01051661|589012089|FG005|Overall Study|Consent not received from both parents|1|||
163082701|NCT01051661|589012084|FG000|Overall Study|Failure to comply with protocol|0|||
163082702|NCT01051661|589012085|FG001|Overall Study|Failure to comply with protocol|0|||
163082703|NCT01051661|589012086|FG002|Overall Study|Failure to comply with protocol|2|||
163082704|NCT01051661|589012087|FG003|Overall Study|Failure to comply with protocol|0|||
163082705|NCT01051661|589012088|FG004|Overall Study|Failure to comply with protocol|0|||
163082706|NCT01051661|589012089|FG005|Overall Study|Failure to comply with protocol|0|||
163082707|NCT01051661|589012084|FG000|Overall Study|Subject lost legal representation|0|||
163082708|NCT01051661|589012085|FG001|Overall Study|Subject lost legal representation|0|||
163082709|NCT01051661|589012086|FG002|Overall Study|Subject lost legal representation|0|||
163082710|NCT01051661|589012087|FG003|Overall Study|Subject lost legal representation|0|||
163082711|NCT01051661|589012088|FG004|Overall Study|Subject lost legal representation|1|||
163082712|NCT01051661|589012089|FG005|Overall Study|Subject lost legal representation|0|||
163082713|NCT01051661|589012084|FG000|Overall Study|Protocol Violation|0|||
163082714|NCT01051661|589012085|FG001|Overall Study|Protocol Violation|0|||
163082715|NCT01051661|589012086|FG002|Overall Study|Protocol Violation|0|||
163082716|NCT01051661|589012087|FG003|Overall Study|Protocol Violation|1|||
163082717|NCT01051661|589012088|FG004|Overall Study|Protocol Violation|2|||
163082718|NCT01051661|589012089|FG005|Overall Study|Protocol Violation|1|||
163082719|NCT01051661|589012084|FG000|Overall Study|Withdrawal by Subject|16|||
163082720|NCT01051661|589012085|FG001|Overall Study|Withdrawal by Subject|30|||
163082721|NCT01051661|589012086|FG002|Overall Study|Withdrawal by Subject|13|||
163082722|NCT01051661|589012087|FG003|Overall Study|Withdrawal by Subject|28|||
163082723|NCT01051661|589012088|FG004|Overall Study|Withdrawal by Subject|12|||
163082724|NCT01051661|589012089|FG005|Overall Study|Withdrawal by Subject|34|||
163082725|NCT02852005|589012091|FG000|Overall Study|Lost to Follow-up|0|||
163082726|NCT02852005|589012092|FG001|Overall Study|Lost to Follow-up|0|||
163082727|NCT02852005|589012093|FG002|Overall Study|Lost to Follow-up|0|||
163082728|NCT02852005|589012094|FG003|Overall Study|Lost to Follow-up|0|||
163082729|NCT02852005|589012095|FG004|Overall Study|Lost to Follow-up|1|||
163082730|NCT02852005|589012091|FG000|Overall Study|Withdrawal by Subject|1|||
163082731|NCT02852005|589012092|FG001|Overall Study|Withdrawal by Subject|0|||
163082732|NCT02852005|589012093|FG002|Overall Study|Withdrawal by Subject|0|||
163082733|NCT02852005|589012094|FG003|Overall Study|Withdrawal by Subject|0|||
163082734|NCT02852005|589012095|FG004|Overall Study|Withdrawal by Subject|0|||
163082735|NCT01922895|589012096|FG000|Overall Study|Death|0|||
163082736|NCT01922895|589012097|FG001|Overall Study|Death|1|||
163082737|NCT01922895|589012096|FG000|Overall Study|Withdrawal by Subject|1|||
163082738|NCT01922895|589012097|FG001|Overall Study|Withdrawal by Subject|2|||
163082739|NCT01922895|589012096|FG000|Overall Study|Lost to Follow-up|5|||
163082740|NCT01922895|589012097|FG001|Overall Study|Lost to Follow-up|11|||
163082741|NCT01916226|589012098|FG000|Overall Study|Adverse Event|1|||
163082742|NCT01916226|589012099|FG001|Overall Study|Adverse Event|0|||
163082743|NCT01916226|589012100|FG002|Overall Study|Adverse Event|1|||
163082744|NCT01916226|589012101|FG003|Overall Study|Adverse Event|1|||
163082745|NCT01916226|589012098|FG000|Overall Study|Lack of Efficacy|0|||
163082746|NCT01916226|589012099|FG001|Overall Study|Lack of Efficacy|0|||
163082747|NCT01916226|589012100|FG002|Overall Study|Lack of Efficacy|2|||
163082748|NCT01916226|589012101|FG003|Overall Study|Lack of Efficacy|1|||
163082749|NCT01916226|589012098|FG000|Overall Study|Protocol Violation|0|||
163082750|NCT01916226|589012099|FG001|Overall Study|Protocol Violation|1|||
163406458|NCT03311711|590198638|FG003|Overall Study|Lost to Follow-up|0|||
163082751|NCT01916226|589012100|FG002|Overall Study|Protocol Violation|0|||
163082752|NCT01916226|589012101|FG003|Overall Study|Protocol Violation|1|||
163082753|NCT01916226|589012098|FG000|Overall Study|Physician Decision|0|||
163082754|NCT01916226|589012099|FG001|Overall Study|Physician Decision|0|||
163082755|NCT01916226|589012100|FG002|Overall Study|Physician Decision|0|||
163082756|NCT01916226|589012101|FG003|Overall Study|Physician Decision|1|||
163082757|NCT01166646|589012104|FG000|Overall Study|Protocol Violation|0|||
163082758|NCT01166646|589012105|FG001|Overall Study|Protocol Violation|1|||
163082759|NCT01166646|589012104|FG000|Overall Study|Adverse Event|1|||
163082760|NCT01166646|589012105|FG001|Overall Study|Adverse Event|0|||
163082761|NCT05142306|589012106|FG000|Overall Study|Withdrawal by Subject|0|||
163082762|NCT05142306|589012107|FG001|Overall Study|Withdrawal by Subject|0|||
163082763|NCT05142306|589012108|FG002|Overall Study|Withdrawal by Subject|1|||
163082764|NCT04079920|589012109|FG000|Overall Study|Adverse event, not related to study drug|2|||
163082765|NCT04079920|589012109|FG000|Overall Study|Adverse event related to study drug|10|||
163082766|NCT04079920|589012109|FG000|Overall Study|Death|2|||
163082767|NCT04079920|589012109|FG000|Overall Study|Lost to Follow-up|22|||
163082768|NCT04079920|589012109|FG000|Overall Study|Physician Decision|1|||
163082769|NCT04079920|589012109|FG000|Overall Study|Withdrawal by Subject|11|||
163082770|NCT03760068|589012110|FG000|Overall Study|Withdrawal by Subject|7|||
163082771|NCT03760068|589012111|FG001|Overall Study|Withdrawal by Subject|8|||
163082772|NCT03760068|589012110|FG000|Overall Study|Adverse Event|1|||
163082773|NCT03760068|589012111|FG001|Overall Study|Adverse Event|2|||
163082774|NCT03760068|589012110|FG000|Overall Study|Administrative Decision by Sponsor|0|||
163082775|NCT03760068|589012111|FG001|Overall Study|Administrative Decision by Sponsor|2|||
163082776|NCT03760068|589012110|FG000|Overall Study|Physician Decision|1|||
163082777|NCT03760068|589012111|FG001|Overall Study|Physician Decision|2|||
163082778|NCT03760068|589012110|FG000|Overall Study|Lost to Follow-up|4|||
163082779|NCT03760068|589012111|FG001|Overall Study|Lost to Follow-up|9|||
163082780|NCT03760068|589012110|FG000|Overall Study|Subject Moved Out of State|1|||
163082781|NCT03760068|589012111|FG001|Overall Study|Subject Moved Out of State|0|||
163082782|NCT05430919|589012112|FG000|Overall Study|Protocol Violation|0|||
163082783|NCT05430919|589012113|FG001|Overall Study|Protocol Violation|0|||
163082784|NCT05430919|589012114|FG002|Overall Study|Protocol Violation|1|||
163082785|NCT05430919|589012115|FG003|Overall Study|Protocol Violation|0|||
163082786|NCT05430919|589012112|FG000|Overall Study|Lost to Follow-up|0|||
163082787|NCT05430919|589012113|FG001|Overall Study|Lost to Follow-up|1|||
163082788|NCT05430919|589012114|FG002|Overall Study|Lost to Follow-up|0|||
163082789|NCT05430919|589012115|FG003|Overall Study|Lost to Follow-up|0|||
163082790|NCT05430919|589012112|FG000|Overall Study|Withdrawal by Subject|3|||
163082791|NCT05430919|589012113|FG001|Overall Study|Withdrawal by Subject|0|||
163082792|NCT05430919|589012114|FG002|Overall Study|Withdrawal by Subject|0|||
163082793|NCT05430919|589012115|FG003|Overall Study|Withdrawal by Subject|1|||
163082794|NCT03204812|589012136|FG000|Overall Study|Adverse Event|3|||
163082795|NCT01027351|589012137|FG000|Overall Study|Withdrawal by Subject|1|||
163082796|NCT01027351|589012138|FG001|Overall Study|Withdrawal by Subject|0|||
163082797|NCT01027351|589012139|FG002|Overall Study|Withdrawal by Subject|1|||
163082798|NCT01027351|589012140|FG003|Overall Study|Withdrawal by Subject|0|||
163082799|NCT01027351|589012141|FG004|Overall Study|Withdrawal by Subject|3|||
163082800|NCT01027351|589012142|FG005|Overall Study|Withdrawal by Subject|5|||
163082801|NCT01027351|589012137|FG000|Overall Study|Lost to Follow-up|1|||
163082802|NCT01027351|589012138|FG001|Overall Study|Lost to Follow-up|1|||
163082803|NCT01027351|589012139|FG002|Overall Study|Lost to Follow-up|0|||
163082804|NCT01027351|589012140|FG003|Overall Study|Lost to Follow-up|1|||
163082805|NCT01027351|589012141|FG004|Overall Study|Lost to Follow-up|6|||
163082806|NCT01027351|589012142|FG005|Overall Study|Lost to Follow-up|0|||
163082807|NCT01027351|589012137|FG000|Overall Study|Inappropriate enrollment|0|||
163082808|NCT01027351|589012138|FG001|Overall Study|Inappropriate enrollment|0|||
163082809|NCT01027351|589012139|FG002|Overall Study|Inappropriate enrollment|0|||
163082810|NCT01027351|589012140|FG003|Overall Study|Inappropriate enrollment|0|||
163082811|NCT01027351|589012141|FG004|Overall Study|Inappropriate enrollment|1|||
163082812|NCT01027351|589012142|FG005|Overall Study|Inappropriate enrollment|0|||
163219551|NCT02658890|589519414|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163082813|NCT01027351|589012137|FG000|Overall Study|Protocol Violation|1|||
163082814|NCT01027351|589012138|FG001|Overall Study|Protocol Violation|0|||
163082815|NCT01027351|589012139|FG002|Overall Study|Protocol Violation|0|||
163082816|NCT01027351|589012140|FG003|Overall Study|Protocol Violation|1|||
163082817|NCT01027351|589012141|FG004|Overall Study|Protocol Violation|1|||
163082818|NCT01027351|589012142|FG005|Overall Study|Protocol Violation|0|||
163082819|NCT00911157|589012143|FG000|Overall Study|Adverse Event|4|||
163082820|NCT00911157|589012144|FG001|Overall Study|Adverse Event|1|||
163082821|NCT00911157|589012143|FG000|Overall Study|Withdrawal by Subject|1|||
163082822|NCT00911157|589012144|FG001|Overall Study|Withdrawal by Subject|1|||
163082823|NCT00911157|589012143|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
163082824|NCT00911157|589012144|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
163082825|NCT00911157|589012143|FG000|Overall Study|Need to treat for lung cancer|1|||
163082826|NCT00911157|589012144|FG001|Overall Study|Need to treat for lung cancer|0|||
163082827|NCT04650893|589012145|FG000|Overall Study|Lost to Follow-up|11|||
163082828|NCT04650893|589012146|FG001|Overall Study|Lost to Follow-up|10|||
163082829|NCT04650893|589012147|FG002|Overall Study|Lost to Follow-up|11|||
163082830|NCT01852214|589012148|FG000|Period 1|Adverse Event|1|||
163082831|NCT01852214|589012149|FG001|Period 1|Adverse Event|2|||
163082832|NCT01852214|589012148|FG000|Period 1|Withdrawal by Subject|0|||
163082833|NCT01852214|589012149|FG001|Period 1|Withdrawal by Subject|1|||
163082834|NCT01852214|589012148|FG000|Washout Period|Withdrawal by Subject|0|||
163082835|NCT01852214|589012149|FG001|Washout Period|Withdrawal by Subject|1|||
163082836|NCT04091438|589012150|FG000|Treatment Period 1 (1 Day)|Other|1|||
163082837|NCT04091438|589012151|FG001|Treatment Period 1 (1 Day)|Other|0|||
163082838|NCT04091438|589012150|FG000|Washout Period (1 Day)|Protocol deviation|0|||
163082839|NCT04091438|589012151|FG001|Washout Period (1 Day)|Protocol deviation|1|||
163082840|NCT04091438|589012150|FG000|Washout Period (1 Day)|Other|0|||
163082841|NCT04091438|589012151|FG001|Washout Period (1 Day)|Other|1|||
163082842|NCT00421408|589012152|FG000|Overall Study|Lost to Follow-up|30|||
163082843|NCT00421408|589012153|FG001|Overall Study|Lost to Follow-up|20|||
163082844|NCT00421408|589012152|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
163082845|NCT00421408|589012153|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
163082846|NCT04105725|589012154|FG000|Primary Intervention|Lost to Follow-up|0|||
163082847|NCT04105725|589012155|FG001|Primary Intervention|Lost to Follow-up|2|||
163082848|NCT04105725|589012154|FG000|Primary Intervention|Withdrawal by Subject|0|||
163082849|NCT04105725|589012155|FG001|Primary Intervention|Withdrawal by Subject|1|||
163082850|NCT00553475|589012160|FG000|Overall Study|Adverse Event|7|||
163082851|NCT00553475|589012161|FG001|Overall Study|Adverse Event|17|||
163082852|NCT00553475|589012162|FG002|Overall Study|Adverse Event|13|||
163082853|NCT00553475|589012160|FG000|Overall Study|Lack of Efficacy|7|||
163082854|NCT00553475|589012161|FG001|Overall Study|Lack of Efficacy|1|||
163082855|NCT00553475|589012162|FG002|Overall Study|Lack of Efficacy|0|||
163082856|NCT00553475|589012160|FG000|Overall Study|Withdrawal by Subject|1|||
163082857|NCT00553475|589012161|FG001|Overall Study|Withdrawal by Subject|1|||
163082858|NCT00553475|589012162|FG002|Overall Study|Withdrawal by Subject|0|||
163082859|NCT00553475|589012160|FG000|Overall Study|Physician Decision|1|||
163082860|NCT00553475|589012161|FG001|Overall Study|Physician Decision|0|||
163082861|NCT00553475|589012162|FG002|Overall Study|Physician Decision|0|||
163082862|NCT00553475|589012160|FG000|Overall Study|Due to moving|0|||
163082863|NCT00553475|589012161|FG001|Overall Study|Due to moving|1|||
163082864|NCT00553475|589012162|FG002|Overall Study|Due to moving|0|||
163082865|NCT00773461|589012163|FG000|Overall Study|Adverse Event|1|||
163082866|NCT00773461|589012164|FG001|Overall Study|Adverse Event|3|||
163082867|NCT00773461|589012163|FG000|Overall Study|Withdrawal by Subject|4|||
163082868|NCT00773461|589012164|FG001|Overall Study|Withdrawal by Subject|1|||
163082869|NCT00913835|589012165|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
163082870|NCT00913835|589012166|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
163082871|NCT00913835|589012165|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
163082872|NCT00913835|589012166|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
163082873|NCT00913835|589012165|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
163082874|NCT00913835|589012166|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
163332510|NCT04399837|589927704|FG001|Overall Study|Withdrawal by Subject|2|||
163332511|NCT04399837|589927705|FG002|Overall Study|Withdrawal by Subject|1|||
163082875|NCT00913835|589012165|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
163082876|NCT00913835|589012166|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
163082877|NCT00913835|589012165|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
163082878|NCT00913835|589012166|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
163082879|NCT03058952|589013536|FG000|Overall Study|Adverse Event|1|||
163082880|NCT03058952|589013537|FG001|Overall Study|Adverse Event|0|||
163082881|NCT03058952|589013536|FG000|Overall Study|Lost to Follow-up|15|||
163082882|NCT03058952|589013537|FG001|Overall Study|Lost to Follow-up|15|||
163332512|NCT04399837|589927706|FG003|Overall Study|Withdrawal by Subject|1|||
163332513|NCT04224272|589927713|FG000|Part 1 - Dose Finding|Death|4|||
163332514|NCT04224272|589927713|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
163082883|NCT03058952|589013536|FG000|Overall Study|Withdrawal by Subject|7|||
163082884|NCT03058952|589013537|FG001|Overall Study|Withdrawal by Subject|11|||
163082885|NCT02296476|589013540|FG000|Overall Study|Disease Progression|6|||
163082886|NCT02296476|589013541|FG001|Overall Study|Disease Progression|4|||
163082887|NCT02296476|589013542|FG002|Overall Study|Disease Progression|2|||
163082888|NCT00980044|589013547|FG000|Overall Study|Withdrawal by Subject|5|||
163332515|NCT04224272|589927713|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
163082889|NCT00980044|589013548|FG001|Overall Study|Withdrawal by Subject|7|||
163082890|NCT00980044|589013549|FG002|Overall Study|Withdrawal by Subject|3|||
163082891|NCT00980044|589013547|FG000|Overall Study|Protocol Violation|0|||
163082892|NCT00980044|589013548|FG001|Overall Study|Protocol Violation|0|||
163082893|NCT00980044|589013549|FG002|Overall Study|Protocol Violation|2|||
163082894|NCT00442702|589013550|FG000|Titration Period|Adverse Event|2|||
163082895|NCT00442702|589013551|FG001|Titration Period|Adverse Event|0|||
163082896|NCT00442702|589013550|FG000|Titration Period|Death|3|||
163082897|NCT00442702|589013551|FG001|Titration Period|Death|2|||
163082898|NCT00442702|589013550|FG000|Titration Period|Insufficient Therapeutic Response|1|||
163082899|NCT00442702|589013551|FG001|Titration Period|Insufficient Therapeutic Response|0|||
163082900|NCT00442702|589013550|FG000|Titration Period|Refused Treatment|4|||
163082901|NCT00442702|589013551|FG001|Titration Period|Refused Treatment|1|||
163082902|NCT00442702|589013550|FG000|Titration Period|Failure to return|1|||
163082903|NCT00442702|589013551|FG001|Titration Period|Failure to return|0|||
163082904|NCT00442702|589013550|FG000|Titration Period|Hospitalized in another hospital|1|||
163082905|NCT00442702|589013551|FG001|Titration Period|Hospitalized in another hospital|0|||
163082906|NCT00442702|589013550|FG000|Evaluation Period|Adverse Event|1|||
163082907|NCT00442702|589013551|FG001|Evaluation Period|Adverse Event|0|||
163082908|NCT00442702|589013550|FG000|Evaluation Period|Death|1|||
163082909|NCT00442702|589013551|FG001|Evaluation Period|Death|1|||
163082910|NCT00442702|589013550|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
163082911|NCT00442702|589013551|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
163082912|NCT00442702|589013550|FG000|Evaluation Period|Refused treatment|1|||
163082913|NCT00442702|589013551|FG001|Evaluation Period|Refused treatment|1|||
163082914|NCT00442702|589013550|FG000|Evaluation Period|Renal transplant|0|||
163082915|NCT00442702|589013551|FG001|Evaluation Period|Renal transplant|1|||
163082916|NCT00442702|589013550|FG000|Evaluation Period|Failure to return|1|||
163082917|NCT00442702|589013551|FG001|Evaluation Period|Failure to return|0|||
163082918|NCT00442702|589013550|FG000|Evaluation Period|Site closure|0|||
163082919|NCT00442702|589013551|FG001|Evaluation Period|Site closure|1|||
163082920|NCT03345550|589013553|FG000|Overall Study|Withdrawal by Subject|1|||
163082921|NCT03345550|589013554|FG001|Overall Study|Withdrawal by Subject|0|||
163082922|NCT03345550|589013553|FG000|Overall Study|Lost to Follow-up|4|||
163082923|NCT03345550|589013554|FG001|Overall Study|Lost to Follow-up|5|||
163082924|NCT01149460|589013560|FG000|Overall Study|Withdrawal by Subject|0|||
163082925|NCT01149460|589013561|FG001|Overall Study|Withdrawal by Subject|2|||
163082926|NCT03014089|589013562|FG000|Overall Study|Withdrawal by Subject|0|||
163082927|NCT03014089|589013563|FG001|Overall Study|Withdrawal by Subject|1|||
163082928|NCT03014089|589013564|FG002|Overall Study|Withdrawal by Subject|1|||
163082929|NCT03014089|589013565|FG003|Overall Study|Withdrawal by Subject|1|||
163082930|NCT03014089|589013562|FG000|Overall Study|Lost to Follow-up|1|||
163082931|NCT03014089|589013563|FG001|Overall Study|Lost to Follow-up|0|||
163082932|NCT03014089|589013564|FG002|Overall Study|Lost to Follow-up|0|||
163082933|NCT03014089|589013565|FG003|Overall Study|Lost to Follow-up|0|||
163082934|NCT03014089|589013562|FG000|Overall Study|Adverse Event|1|||
163082935|NCT03014089|589013563|FG001|Overall Study|Adverse Event|0|||
163082936|NCT03014089|589013564|FG002|Overall Study|Adverse Event|1|||
163082937|NCT03014089|589013565|FG003|Overall Study|Adverse Event|0|||
163082938|NCT00321932|589013566|FG000|Overall Study|Death|3|||
163082939|NCT00321932|589013567|FG001|Overall Study|Death|6|||
163082940|NCT00321932|589013566|FG000|Overall Study|Withdrawal by Subject|3|||
163082941|NCT00321932|589013567|FG001|Overall Study|Withdrawal by Subject|6|||
163082942|NCT00321932|589013566|FG000|Overall Study|Early relapse|2|||
163082943|NCT00321932|589013567|FG001|Overall Study|Early relapse|8|||
163082944|NCT00321932|589013566|FG000|Overall Study|Missing data|2|||
163082945|NCT00321932|589013567|FG001|Overall Study|Missing data|1|||
163082946|NCT00734032|589013568|FG000|Overall Study|Adverse Event|0|||
163082947|NCT00734032|589013569|FG001|Overall Study|Adverse Event|1|||
163082948|NCT00734032|589013570|FG002|Overall Study|Adverse Event|0|||
163082949|NCT00734032|589013571|FG003|Overall Study|Adverse Event|0|||
163082950|NCT03468998|589013574|FG000|Overall Study|Withdrawal by Subject|1|||
163082951|NCT03468998|589013575|FG001|Overall Study|Withdrawal by Subject|1|||
163082952|NCT03468998|589013576|FG002|Overall Study|Withdrawal by Subject|0|||
163332516|NCT04224272|589927713|FG000|Part 2 - Dose Expansion|Death|10|||
163332517|NCT04224272|589927713|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
163332518|NCT02609048|589927714|FG000|Overall Study|Adverse Event|3|||
163082953|NCT03468998|589013577|FG003|Overall Study|Withdrawal by Subject|4|||
163082954|NCT03468998|589013578|FG004|Overall Study|Withdrawal by Subject|1|||
163082955|NCT03468998|589013579|FG005|Overall Study|Withdrawal by Subject|0|||
163082956|NCT00137449|589013580|FG000|Overall Study|Disease Progression|8|||
163082957|NCT00137449|589013581|FG001|Overall Study|Disease Progression|13|||
163082958|NCT00137449|589013580|FG000|Overall Study|Death|4|||
163082959|NCT00137449|589013581|FG001|Overall Study|Death|3|||
163082960|NCT00137449|589013580|FG000|Overall Study|Adverse Event|3|||
163082961|NCT00137449|589013581|FG001|Overall Study|Adverse Event|1|||
163082962|NCT00137449|589013580|FG000|Overall Study|Withdrawal by Subject|1|||
163082963|NCT00137449|589013581|FG001|Overall Study|Withdrawal by Subject|1|||
163332519|NCT02609048|589927715|FG001|Overall Study|Adverse Event|0|||
163332520|NCT02609048|589927716|FG002|Overall Study|Adverse Event|0|||
163082964|NCT01356940|589013584|FG000|First Intervention (28 Days)|Adverse Event|1|||
163082965|NCT01356940|589013585|FG001|First Intervention (28 Days)|Adverse Event|0|||
163082966|NCT01356940|589013584|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
163082967|NCT01356940|589013585|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
163082968|NCT03412591|589013586|FG000|Overall Study|Withdrawal by Subject|1|||
163082969|NCT03412591|589013587|FG001|Overall Study|Withdrawal by Subject|8|||
163082970|NCT03412591|589013586|FG000|Overall Study|Adverse Event|0|||
163082971|NCT03412591|589013587|FG001|Overall Study|Adverse Event|1|||
163082972|NCT02272985|589013588|FG000|Overall Study|Withdrawal by Subject|1|||
163082973|NCT02272985|589013588|FG000|Overall Study|hip fracture|1|||
163082974|NCT02272985|589013588|FG000|Overall Study|kidney transplantation|1|||
163082975|NCT02489279|589013591|FG000|Overall Study|Lost to Follow-up|12|||
163082976|NCT02489279|589013592|FG001|Overall Study|Lost to Follow-up|10|||
163082977|NCT03440411|589013593|FG000|Overall Study|Adverse Event|0|||
163082978|NCT03440411|589013594|FG001|Overall Study|Adverse Event|0|||
163082979|NCT03440411|589013595|FG002|Overall Study|Adverse Event|1|||
163082980|NCT03440411|589013596|FG003|Overall Study|Adverse Event|0|||
163082981|NCT03440411|589013593|FG000|Overall Study|PD|2|||
163082982|NCT03440411|589013594|FG001|Overall Study|PD|1|||
163082983|NCT03440411|589013595|FG002|Overall Study|PD|1|||
163082984|NCT03440411|589013596|FG003|Overall Study|PD|1|||
163082985|NCT03440411|589013593|FG000|Overall Study|Withdrawal by Subject|1|||
163082986|NCT03440411|589013594|FG001|Overall Study|Withdrawal by Subject|0|||
163082987|NCT03440411|589013595|FG002|Overall Study|Withdrawal by Subject|0|||
163082988|NCT03440411|589013596|FG003|Overall Study|Withdrawal by Subject|0|||
163082989|NCT03440411|589013593|FG000|Overall Study|Closed study by sponsor|0|||
163082990|NCT03440411|589013594|FG001|Overall Study|Closed study by sponsor|0|||
163082991|NCT03440411|589013595|FG002|Overall Study|Closed study by sponsor|0|||
163082992|NCT03440411|589013596|FG003|Overall Study|Closed study by sponsor|1|||
163082993|NCT00505687|589013597|FG000|Overall Study|Important protocol violation|2|||
163082994|NCT00505687|589013597|FG000|Overall Study|Lack of Efficacy|15|||
163082995|NCT00505687|589013597|FG000|Overall Study|Adverse Event|48|||
163082996|NCT00505687|589013597|FG000|Overall Study|Subject withdrew consent|15|||
163082997|NCT00505687|589013597|FG000|Overall Study|Lost to Follow-up|1|||
163082998|NCT00505687|589013597|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
163082999|NCT00505687|589013597|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
163083000|NCT00505687|589013597|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
163083001|NCT00505687|589013597|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
163083002|NCT00505687|589013597|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
163083003|NCT00505687|589013597|FG000|Overall Study|Other: Disease Progression|1|||
163083004|NCT00505687|589013597|FG000|Overall Study|Other: As Per Sponsor|8|||
163083005|NCT03707821|589013598|FG000|Overall Study|Protocol Violation|0|||
163083006|NCT03707821|589013599|FG001|Overall Study|Protocol Violation|1|||
163083007|NCT03707821|589013598|FG000|Overall Study|Unsatisfactory Visual Response|1|||
163083008|NCT03707821|589013599|FG001|Overall Study|Unsatisfactory Visual Response|0|||
163083009|NCT03707821|589013598|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
163083010|NCT03707821|589013599|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
163083011|NCT01432444|589013600|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
163083012|NCT01432444|589013601|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
163083013|NCT01432444|589013602|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
163083014|NCT01432444|589013600|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
163083015|NCT01432444|589013601|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
163083016|NCT01432444|589013602|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
163083017|NCT01432444|589013600|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
163083018|NCT01432444|589013601|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
163083019|NCT01432444|589013602|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
163083020|NCT01432444|589013600|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
163332521|NCT02609048|589927714|FG000|Overall Study|Randomized but never treated|1|||
163332522|NCT02609048|589927715|FG001|Overall Study|Randomized but never treated|1|||
163332523|NCT02609048|589927716|FG002|Overall Study|Randomized but never treated|1|||
163332524|NCT02609048|589927714|FG000|Overall Study|Withdrawal of informed consent|1|||
163083021|NCT01432444|589013601|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
163083022|NCT01432444|589013602|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
163083023|NCT01432444|589013600|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
163083024|NCT01432444|589013601|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
163083025|NCT01432444|589013602|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
163083026|NCT01432444|589013600|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
163083027|NCT01432444|589013601|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
163083028|NCT01432444|589013602|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
163083029|NCT01432444|589013600|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
163083030|NCT01432444|589013601|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
163083031|NCT01432444|589013602|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
163083032|NCT01432444|589013600|FG000|Treatment Phase|Lost to Follow-up|0|||
163083033|NCT01432444|589013601|FG001|Treatment Phase|Lost to Follow-up|33|||
163083034|NCT01432444|589013602|FG002|Treatment Phase|Lost to Follow-up|0|||
163083035|NCT01432444|589013600|FG000|Treatment Phase|Adverse Event|0|||
163083036|NCT01432444|589013601|FG001|Treatment Phase|Adverse Event|37|||
163083037|NCT01432444|589013602|FG002|Treatment Phase|Adverse Event|0|||
163083038|NCT01432444|589013600|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
163083039|NCT01432444|589013601|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
163083040|NCT01432444|589013602|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
163083041|NCT01432444|589013600|FG000|Treatment Phase|Physician Decision|0|||
163083042|NCT01432444|589013601|FG001|Treatment Phase|Physician Decision|5|||
163083043|NCT01432444|589013602|FG002|Treatment Phase|Physician Decision|0|||
163083044|NCT01432444|589013600|FG000|Treatment Phase|Withdrawal by Subject|0|||
163083045|NCT01432444|589013601|FG001|Treatment Phase|Withdrawal by Subject|41|||
163083046|NCT01432444|589013602|FG002|Treatment Phase|Withdrawal by Subject|0|||
163083047|NCT01432444|589013600|FG000|Treatment Phase|Protocol Deviation|0|||
163083048|NCT01432444|589013601|FG001|Treatment Phase|Protocol Deviation|3|||
163083049|NCT01432444|589013602|FG002|Treatment Phase|Protocol Deviation|0|||
163083050|NCT01432444|589013600|FG000|Treatment Phase|Lack of Efficacy|0|||
163083051|NCT01432444|589013601|FG001|Treatment Phase|Lack of Efficacy|10|||
163083052|NCT01432444|589013602|FG002|Treatment Phase|Lack of Efficacy|0|||
163083053|NCT01432444|589013600|FG000|Extension Phase|Lost to Follow-up|0|||
163083054|NCT01432444|589013601|FG001|Extension Phase|Lost to Follow-up|0|||
163083055|NCT01432444|589013602|FG002|Extension Phase|Lost to Follow-up|17|||
163083056|NCT01432444|589013600|FG000|Extension Phase|Adverse Event|0|||
163083057|NCT01432444|589013601|FG001|Extension Phase|Adverse Event|0|||
163083058|NCT01432444|589013602|FG002|Extension Phase|Adverse Event|10|||
163083059|NCT01432444|589013600|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
163083060|NCT01432444|589013601|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
163083061|NCT01432444|589013602|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
163083062|NCT01432444|589013600|FG000|Extension Phase|Met Withdrawal Criteria|0|||
163083063|NCT01432444|589013601|FG001|Extension Phase|Met Withdrawal Criteria|0|||
163083064|NCT01432444|589013602|FG002|Extension Phase|Met Withdrawal Criteria|144|||
163083065|NCT01432444|589013600|FG000|Extension Phase|Physician Decision|0|||
163083066|NCT01432444|589013601|FG001|Extension Phase|Physician Decision|0|||
163083067|NCT01432444|589013602|FG002|Extension Phase|Physician Decision|1|||
163083068|NCT01432444|589013600|FG000|Extension Phase|Withdrawal by Subject|0|||
163083069|NCT01432444|589013601|FG001|Extension Phase|Withdrawal by Subject|0|||
163083070|NCT01432444|589013602|FG002|Extension Phase|Withdrawal by Subject|13|||
163083071|NCT03673176|589013603|FG000|Overall Study|Death prior to intervention|1|||
163083072|NCT03673176|589013603|FG000|Overall Study|Death following intervention|3|||
163083073|NCT03673176|589013603|FG000|Overall Study|Withdrawal by Subject|1|||
163083074|NCT02378480|589013604|FG000|Overall Study|Physician Decision|1|||
163083075|NCT02378480|589013605|FG001|Overall Study|Physician Decision|1|||
163083076|NCT02378480|589013604|FG000|Overall Study|Death|1|||
163083077|NCT02378480|589013605|FG001|Overall Study|Death|2|||
163083078|NCT02378480|589013604|FG000|Overall Study|Randomized, but Not Treated|6|||
163083079|NCT02378480|589013605|FG001|Overall Study|Randomized, but Not Treated|4|||
163083080|NCT02378480|589013604|FG000|Overall Study|Adverse Event|0|||
163083081|NCT02378480|589013605|FG001|Overall Study|Adverse Event|1|||
163083082|NCT02378480|589013604|FG000|Overall Study|Missed EOT/PTE Visit|1|||
163083083|NCT02378480|589013605|FG001|Overall Study|Missed EOT/PTE Visit|2|||
163083084|NCT02378480|589013604|FG000|Overall Study|Withdrawal by Subject|9|||
163083085|NCT02378480|589013605|FG001|Overall Study|Withdrawal by Subject|4|||
163083086|NCT02378480|589013604|FG000|Overall Study|Lost to Follow-up|10|||
163083087|NCT02378480|589013605|FG001|Overall Study|Lost to Follow-up|18|||
163083088|NCT01230060|589013609|FG000|Overall Study|Withdrawal by Subject|1|||
163083089|NCT03802916|589013610|FG000|Overall Study|Adverse Event|0|||
163083090|NCT03802916|589013611|FG001|Overall Study|Adverse Event|1|||
163083091|NCT03802916|589013610|FG000|Overall Study|Withdrawal by Subject|0|||
163083092|NCT03802916|589013611|FG001|Overall Study|Withdrawal by Subject|1|||
163083093|NCT00480532|589013612|FG000|Overall Study|Withdrawal by Subject|2|||
163083094|NCT00480532|589013613|FG001|Overall Study|Withdrawal by Subject|4|||
163083095|NCT00480532|589013614|FG002|Overall Study|Withdrawal by Subject|3|||
163083096|NCT00480532|589013615|FG003|Overall Study|Withdrawal by Subject|1|||
163083097|NCT00480532|589013612|FG000|Overall Study|Protocol Violation|0|||
163083098|NCT00480532|589013613|FG001|Overall Study|Protocol Violation|0|||
163083099|NCT00480532|589013614|FG002|Overall Study|Protocol Violation|1|||
163083100|NCT00480532|589013615|FG003|Overall Study|Protocol Violation|0|||
163083101|NCT01285102|589013616|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
163083102|NCT02157610|589013617|FG000|Overall Study|Death|4|||
163083103|NCT02157610|589013618|FG001|Overall Study|Death|4|||
163083104|NCT00814983|589013619|FG000|Overall Study|Screen failure|1|||
163083105|NCT00814983|589013620|FG001|Overall Study|Screen failure|0|||
163083106|NCT00814983|589013619|FG000|Overall Study|Withdrawal by Subject|1|||
163083107|NCT00814983|589013620|FG001|Overall Study|Withdrawal by Subject|0|||
163083108|NCT00814983|589013619|FG000|Overall Study|Graft failure|1|||
163083109|NCT00814983|589013620|FG001|Overall Study|Graft failure|0|||
163083110|NCT02697448|589013621|FG000|Overall Study|Protocol Violation|2|||
163083111|NCT02697448|589013622|FG001|Overall Study|Protocol Violation|4|||
163083112|NCT02697448|589013621|FG000|Overall Study|Clinical concerns during ablation|1|||
163083113|NCT02697448|589013622|FG001|Overall Study|Clinical concerns during ablation|1|||
163083114|NCT02697448|589013621|FG000|Overall Study|No data collected|2|||
163083115|NCT02697448|589013622|FG001|Overall Study|No data collected|0|||
163083116|NCT05473715|589013623|FG000|Overall Study|Trial terminate|2|||
163083117|NCT05473715|589013624|FG001|Overall Study|Trial terminate|1|||
163083118|NCT02743221|589013625|FG000|Overall Study|Progressive disease|29|||
163083119|NCT02743221|589013626|FG001|Overall Study|Progressive disease|38|||
163083120|NCT02743221|589013625|FG000|Overall Study|Adverse Event|17|||
163083121|NCT02743221|589013626|FG001|Overall Study|Adverse Event|14|||
163083122|NCT02743221|589013625|FG000|Overall Study|non medical reason|8|||
163083123|NCT02743221|589013626|FG001|Overall Study|non medical reason|2|||
163083124|NCT02743221|589013625|FG000|Overall Study|Physician Decision|2|||
163083125|NCT02743221|589013626|FG001|Overall Study|Physician Decision|5|||
163083126|NCT02743221|589013625|FG000|Overall Study|Patient not eligible, not treated|0|||
163083127|NCT02743221|589013626|FG001|Overall Study|Patient not eligible, not treated|1|||
163083128|NCT01946880|589013629|FG000|Overall Study|Lost to Follow-up|1|||
163083129|NCT01946880|589013630|FG001|Overall Study|Lost to Follow-up|0|||
163083130|NCT01946880|589013629|FG000|Overall Study|Physician Decision|1|||
163083131|NCT01946880|589013630|FG001|Overall Study|Physician Decision|1|||
163083132|NCT01946880|589013629|FG000|Overall Study|Withdrawal by Subject|3|||
163083133|NCT01946880|589013630|FG001|Overall Study|Withdrawal by Subject|2|||
163083134|NCT01946880|589013629|FG000|Overall Study|Met Primary Endpoint|1|||
163083135|NCT01946880|589013630|FG001|Overall Study|Met Primary Endpoint|0|||
163083136|NCT01946880|589013629|FG000|Overall Study|Personal and Family Issues|1|||
163083137|NCT01946880|589013630|FG001|Overall Study|Personal and Family Issues|0|||
163083138|NCT02609503|589013631|FG000|Overall Study|Adverse Event|1|||
163083139|NCT02609503|589013631|FG000|Overall Study|Death|1|||
163083140|NCT02609503|589013631|FG000|Overall Study|Withdrawal by Subject|1|||
163083141|NCT02609503|589013631|FG000|Overall Study|Disease progression|1|||
163083142|NCT01969409|589013634|FG000|Overall Study|Death|2|||
163083143|NCT01969409|589013635|FG001|Overall Study|Death|2|||
163083144|NCT01969409|589013634|FG000|Overall Study|Transplant|1|||
163083145|NCT01969409|589013635|FG001|Overall Study|Transplant|1|||
163083146|NCT01969409|589013634|FG000|Overall Study|Withdrawal by Subject|0|||
163083147|NCT01969409|589013635|FG001|Overall Study|Withdrawal by Subject|1|||
163083148|NCT02799043|589013636|FG000|Overall Study|Adverse Event|0|||
163083149|NCT02799043|589013637|FG001|Overall Study|Adverse Event|1|||
163083150|NCT02799043|589013636|FG000|Overall Study|Death|1|||
163083151|NCT02799043|589013637|FG001|Overall Study|Death|1|||
163083152|NCT02799043|589013636|FG000|Overall Study|Lost to Follow-up|3|||
163083153|NCT02799043|589013637|FG001|Overall Study|Lost to Follow-up|6|||
163083154|NCT02799043|589013636|FG000|Overall Study|Withdrawal by Subject|4|||
163083155|NCT02799043|589013637|FG001|Overall Study|Withdrawal by Subject|4|||
163083156|NCT02799043|589013636|FG000|Overall Study|Moved to different country|0|||
163083157|NCT02799043|589013637|FG001|Overall Study|Moved to different country|1|||
163083158|NCT02799043|589013636|FG000|Overall Study|Trial Screen Failure|1|||
163083159|NCT02799043|589013637|FG001|Overall Study|Trial Screen Failure|0|||
163083160|NCT02799043|589013636|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
163083161|NCT02799043|589013637|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
163083162|NCT04642079|589013638|FG000|Overall Study|Lost to Follow-up|2|||
163083163|NCT04642079|589013639|FG001|Overall Study|Lost to Follow-up|5|||
163083164|NCT04642079|589013640|FG002|Overall Study|Lost to Follow-up|2|||
163083165|NCT04642079|589013641|FG003|Overall Study|Lost to Follow-up|0|||
163083166|NCT04642079|589013638|FG000|Overall Study|Withdrawal by Subject|0|||
163083167|NCT04642079|589013639|FG001|Overall Study|Withdrawal by Subject|4|||
163083168|NCT04642079|589013640|FG002|Overall Study|Withdrawal by Subject|1|||
163083169|NCT04642079|589013641|FG003|Overall Study|Withdrawal by Subject|2|||
163083170|NCT04642079|589013638|FG000|Overall Study|Other|0|||
163083171|NCT04642079|589013639|FG001|Overall Study|Other|0|||
163083172|NCT04642079|589013640|FG002|Overall Study|Other|0|||
163083173|NCT04642079|589013641|FG003|Overall Study|Other|1|||
163083174|NCT04642079|589013638|FG000|Overall Study|No longer met eligibility criteria|1|||
163083175|NCT04642079|589013639|FG001|Overall Study|No longer met eligibility criteria|0|||
163083176|NCT04642079|589013640|FG002|Overall Study|No longer met eligibility criteria|1|||
163083177|NCT04642079|589013641|FG003|Overall Study|No longer met eligibility criteria|1|||
163083178|NCT02226653|589013644|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
163083179|NCT02226653|589013645|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
163083180|NCT02226653|589013644|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
163083181|NCT02226653|589013645|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
163083182|NCT00680914|589013646|FG000|Overall Study|Consent withdrawal|6|||
163083183|NCT00680914|589013647|FG001|Overall Study|Consent withdrawal|3|||
163083184|NCT00680914|589013646|FG000|Overall Study|Lost to Follow-up|4|||
163083185|NCT00680914|589013647|FG001|Overall Study|Lost to Follow-up|0|||
163219552|NCT02658890|589519415|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219553|NCT02658890|589519416|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163083186|NCT00680914|589013646|FG000|Overall Study|serious adverse event (SAE)|0|||
163083187|NCT00680914|589013647|FG001|Overall Study|serious adverse event (SAE)|1|||
163083188|NCT03131479|589013648|FG000|Overall Study|Adverse Event|0|||
163083189|NCT03131479|589013649|FG001|Overall Study|Adverse Event|0|||
163083190|NCT03131479|589013650|FG002|Overall Study|Adverse Event|1|||
163083191|NCT03131479|589013651|FG003|Overall Study|Adverse Event|1|||
163083192|NCT03131479|589013652|FG004|Overall Study|Adverse Event|0|||
163083193|NCT03131479|589013648|FG000|Overall Study|Subject/Guardian Decision|0|||
163083194|NCT03131479|589013649|FG001|Overall Study|Subject/Guardian Decision|0|||
163083195|NCT03131479|589013650|FG002|Overall Study|Subject/Guardian Decision|0|||
163083196|NCT03131479|589013651|FG003|Overall Study|Subject/Guardian Decision|1|||
163083197|NCT03131479|589013652|FG004|Overall Study|Subject/Guardian Decision|0|||
163083198|NCT04439903|589013653|FG000|Overall Study|Withdrawal by Subject|2|||
163083199|NCT04439903|589013653|FG000|Overall Study|Screen Failure|1|||
163083200|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
163083201|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
163083202|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
163083203|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
163083204|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
163083205|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
163083206|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
163083207|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
163083208|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
163083209|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
163083210|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
163083211|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
163083212|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
163083213|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
163083214|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
163083215|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
163083216|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
163083217|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
163083218|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
163083219|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
163083220|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
163083221|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
163083222|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
163083223|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
163083224|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
163083225|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
163083226|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
163083227|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
163083228|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
163083229|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
163083230|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
163083231|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
163083232|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
163083233|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
163083234|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
163083235|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
163083236|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
163083237|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
163083238|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
163083239|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
163083240|NCT01111552|589013654|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163083241|NCT01111552|589013655|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163083242|NCT01111552|589013656|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163219554|NCT02658890|589519417|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163219555|NCT02658890|589519391|FG000|Treatment Phase|Withdrawal by Subject|0|||
163219556|NCT02658890|589519392|FG001|Treatment Phase|Withdrawal by Subject|1|||
163219557|NCT02658890|589519393|FG002|Treatment Phase|Withdrawal by Subject|0|||
163219558|NCT02658890|589519394|FG003|Treatment Phase|Withdrawal by Subject|0|||
163219559|NCT02658890|589519395|FG004|Treatment Phase|Withdrawal by Subject|0|||
163219560|NCT02658890|589519396|FG005|Treatment Phase|Withdrawal by Subject|0|||
163219561|NCT02658890|589519397|FG006|Treatment Phase|Withdrawal by Subject|1|||
163083243|NCT01111552|589013657|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
163083244|NCT01111552|589013658|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163083245|NCT01111552|589013654|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
163083246|NCT01111552|589013655|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
163083247|NCT01111552|589013656|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
163083248|NCT01111552|589013657|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
163083249|NCT01111552|589013658|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
163083250|NCT01111552|589013654|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
163083251|NCT01111552|589013655|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
163083252|NCT01111552|589013656|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
163083253|NCT01111552|589013657|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
163083254|NCT01111552|589013658|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
163083255|NCT01111552|589013654|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
163083256|NCT01111552|589013655|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
163083257|NCT01111552|589013656|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
163083258|NCT01111552|589013657|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
163083259|NCT01111552|589013658|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
163083260|NCT01111552|589013654|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
163083261|NCT01111552|589013655|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
163083262|NCT01111552|589013656|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
163083263|NCT01111552|589013657|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
163083264|NCT01111552|589013658|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
163083265|NCT01111552|589013654|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
163083266|NCT01111552|589013655|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
163083267|NCT01111552|589013656|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
163083268|NCT01111552|589013657|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
163083269|NCT01111552|589013658|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
163083270|NCT04309500|589013661|FG000|Overall Study|Lost to Follow-up|1|||
163083271|NCT04309500|589013662|FG001|Overall Study|Lost to Follow-up|0|||
163083272|NCT04309500|589013663|FG002|Overall Study|Lost to Follow-up|0|||
163083273|NCT04309500|589013664|FG003|Overall Study|Lost to Follow-up|0|||
163083274|NCT00637156|589013665|FG000|Overall Study|Withdrawal by Subject|0|||
163083275|NCT00637156|589013666|FG001|Overall Study|Withdrawal by Subject|7|||
163083276|NCT00637156|589013665|FG000|Overall Study|Death|0|||
163083277|NCT00637156|589013666|FG001|Overall Study|Death|1|||
163083278|NCT00637156|589013665|FG000|Overall Study|Lost to Follow-up|10|||
163083279|NCT00637156|589013666|FG001|Overall Study|Lost to Follow-up|16|||
163083280|NCT02679274|589013667|FG000|Overall Study|Withdrawal by Subject|1|||
163083281|NCT02679274|589013668|FG001|Overall Study|Withdrawal by Subject|0|||
163083282|NCT03193437|589013675|FG000|Overall Study|Adverse Event|4|||
163083283|NCT03193437|589013675|FG000|Overall Study|Withdrawal by Subject|2|||
163083284|NCT03193437|589013675|FG000|Overall Study|Disease Progression|2|||
163083285|NCT04976855|589013676|FG000|Part I|Withdrawal by Subject|0|||
163083286|NCT04976855|589013677|FG001|Part I|Withdrawal by Subject|1|||
163083287|NCT04976855|589013678|FG002|Part I|Withdrawal by Subject|0|||
163083288|NCT04976855|589013679|FG003|Part I|Withdrawal by Subject|0|||
163083289|NCT04976855|589013680|FG004|Part I|Withdrawal by Subject|0|||
163083290|NCT04976855|589013681|FG005|Part I|Withdrawal by Subject|0|||
163083291|NCT04976855|589013682|FG006|Part I|Withdrawal by Subject|0|||
163083292|NCT04976855|589013676|FG000|Part II|Adverse Event|0|||
163083293|NCT04976855|589013677|FG001|Part II|Adverse Event|0|||
163083294|NCT04976855|589013678|FG002|Part II|Adverse Event|0|||
163083295|NCT04976855|589013679|FG003|Part II|Adverse Event|1|||
163083296|NCT04976855|589013680|FG004|Part II|Adverse Event|0|||
163083297|NCT04976855|589013681|FG005|Part II|Adverse Event|0|||
163083298|NCT04976855|589013682|FG006|Part II|Adverse Event|0|||
163083299|NCT04976855|589013676|FG000|Part II|Withdrawal by Subject|0|||
163083300|NCT04976855|589013677|FG001|Part II|Withdrawal by Subject|0|||
163219562|NCT02658890|589519398|FG007|Treatment Phase|Withdrawal by Subject|0|||
163219563|NCT02658890|589519399|FG008|Treatment Phase|Withdrawal by Subject|0|||
163219564|NCT02658890|589519400|FG009|Treatment Phase|Withdrawal by Subject|1|||
163219565|NCT02658890|589519401|FG010|Treatment Phase|Withdrawal by Subject|0|||
163219566|NCT02658890|589519402|FG011|Treatment Phase|Withdrawal by Subject|0|||
163219567|NCT02658890|589519403|FG012|Treatment Phase|Withdrawal by Subject|1|||
163219568|NCT02658890|589519404|FG013|Treatment Phase|Withdrawal by Subject|3|||
163219569|NCT02658890|589519405|FG014|Treatment Phase|Withdrawal by Subject|0|||
163219570|NCT02658890|589519406|FG015|Treatment Phase|Withdrawal by Subject|0|||
163219571|NCT02658890|589519407|FG016|Treatment Phase|Withdrawal by Subject|1|||
163332525|NCT02609048|589927715|FG001|Overall Study|Withdrawal of informed consent|0|||
163083301|NCT04976855|589013678|FG002|Part II|Withdrawal by Subject|0|||
163083302|NCT04976855|589013679|FG003|Part II|Withdrawal by Subject|0|||
163083303|NCT04976855|589013680|FG004|Part II|Withdrawal by Subject|1|||
163083304|NCT04976855|589013681|FG005|Part II|Withdrawal by Subject|0|||
163083305|NCT04976855|589013682|FG006|Part II|Withdrawal by Subject|0|||
163083306|NCT04976855|589013676|FG000|Part II|Lost to Follow-up|0|||
163083307|NCT04976855|589013677|FG001|Part II|Lost to Follow-up|0|||
163083308|NCT04976855|589013678|FG002|Part II|Lost to Follow-up|0|||
163083309|NCT04976855|589013679|FG003|Part II|Lost to Follow-up|0|||
163083310|NCT04976855|589013680|FG004|Part II|Lost to Follow-up|0|||
163083311|NCT04976855|589013681|FG005|Part II|Lost to Follow-up|1|||
163083312|NCT04976855|589013682|FG006|Part II|Lost to Follow-up|0|||
163083313|NCT02038036|589013683|FG000|Core Study|Adverse Event|7|||
163083314|NCT02038036|589013684|FG001|Core Study|Adverse Event|7|||
163083315|NCT02038036|589013683|FG000|Core Study|Death|1|||
163083316|NCT02038036|589013684|FG001|Core Study|Death|1|||
163083317|NCT02038036|589013683|FG000|Core Study|Disease progression|2|||
163083318|NCT02038036|589013684|FG001|Core Study|Disease progression|2|||
163083319|NCT02038036|589013683|FG000|Core Study|Lost to Follow-up|0|||
163083320|NCT02038036|589013684|FG001|Core Study|Lost to Follow-up|1|||
163083321|NCT02038036|589013683|FG000|Core Study|Physician Decision|2|||
163083322|NCT02038036|589013684|FG001|Core Study|Physician Decision|1|||
163083323|NCT02038036|589013683|FG000|Core Study|Subject/guardian decision|0|||
163083324|NCT02038036|589013684|FG001|Core Study|Subject/guardian decision|1|||
163083325|NCT02038036|589013683|FG000|Core Study|Withdrawal by Subject|3|||
163083326|NCT02038036|589013684|FG001|Core Study|Withdrawal by Subject|1|||
163083327|NCT02038036|589013683|FG000|Crossover Period|Withdrawal by Subject|0|||
163083328|NCT02038036|589013684|FG001|Crossover Period|Withdrawal by Subject|3|||
163083329|NCT02038036|589013683|FG000|Crossover Period|Adverse Event|0|||
163083330|NCT02038036|589013684|FG001|Crossover Period|Adverse Event|9|||
163083331|NCT02038036|589013683|FG000|Crossover Period|Death|0|||
163083332|NCT02038036|589013684|FG001|Crossover Period|Death|2|||
163083333|NCT02038036|589013683|FG000|Crossover Period|Disease progression|0|||
163083334|NCT02038036|589013684|FG001|Crossover Period|Disease progression|3|||
163083335|NCT02038036|589013683|FG000|Crossover Period|Lost to Follow-up|0|||
163083336|NCT02038036|589013684|FG001|Crossover Period|Lost to Follow-up|1|||
163083337|NCT02038036|589013683|FG000|Crossover Period|Physician Decision|0|||
163083338|NCT02038036|589013684|FG001|Crossover Period|Physician Decision|2|||
163083339|NCT00908141|589013693|FG000|Overall Study|Withdrawal by Subject|0|||
163083340|NCT00908141|589013694|FG001|Overall Study|Withdrawal by Subject|1|||
163083341|NCT02657356|589015215|FG000|Overall Study|Death|1|||
163083342|NCT02657356|589015216|FG001|Overall Study|Death|0|||
163083343|NCT02657356|589015215|FG000|Overall Study|Withdrawal by Subject|5|||
163083344|NCT02657356|589015216|FG001|Overall Study|Withdrawal by Subject|6|||
163083345|NCT02657356|589015215|FG000|Overall Study|Terminated by Sponsor|8|||
163083346|NCT02657356|589015216|FG001|Overall Study|Terminated by Sponsor|5|||
163083347|NCT02657356|589015215|FG000|Overall Study|Rolled over to EAP study|6|||
163083348|NCT02657356|589015216|FG001|Overall Study|Rolled over to EAP study|4|||
163083349|NCT03768336|589015219|FG000|Overall Study|Lost to Follow-up|3|||
163083350|NCT03768336|589015220|FG001|Overall Study|Lost to Follow-up|2|||
163083351|NCT03768336|589015219|FG000|Overall Study|Became Ineligible|2|||
163083352|NCT03768336|589015220|FG001|Overall Study|Became Ineligible|0|||
163083353|NCT03768336|589015219|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
163083354|NCT03768336|589015220|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
163083355|NCT03768336|589015219|FG000|Overall Study|Missed final survey (post-treatment|0|||
163083356|NCT03768336|589015220|FG001|Overall Study|Missed final survey (post-treatment|1|||
163083357|NCT02278003|589015221|FG000|Overall Study|Withdrawal by Subject|11|||
163083358|NCT02278003|589015222|FG001|Overall Study|Withdrawal by Subject|0|||
163083359|NCT02278003|589015221|FG000|Overall Study|Not Treated|1|||
163083360|NCT02278003|589015222|FG001|Overall Study|Not Treated|0|||
163083361|NCT02278003|589015221|FG000|Overall Study|Recognition task improperly completed|7|||
163083362|NCT02278003|589015222|FG001|Overall Study|Recognition task improperly completed|0|||
163083363|NCT01444781|589015223|FG000|Overall Study|Lost to Follow-up|0|||
163083364|NCT01444781|589015224|FG001|Overall Study|Lost to Follow-up|3|||
163083365|NCT01444781|589015225|FG002|Overall Study|Lost to Follow-up|1|||
163083366|NCT01444781|589015223|FG000|Overall Study|Withdrawal by Subject|3|||
163083367|NCT01444781|589015224|FG001|Overall Study|Withdrawal by Subject|1|||
163083368|NCT01444781|589015225|FG002|Overall Study|Withdrawal by Subject|2|||
163332526|NCT02609048|589927716|FG002|Overall Study|Withdrawal of informed consent|0|||
163332527|NCT02609048|589927714|FG000|Overall Study|Reason not specified|6|||
163083369|NCT00500331|589015227|FG000|Overall Study|Adverse Event|0|||
163083370|NCT00500331|589015228|FG001|Overall Study|Adverse Event|2|||
163083371|NCT00500331|589015229|FG002|Overall Study|Adverse Event|0|||
163083372|NCT00500331|589015230|FG003|Overall Study|Adverse Event|1|||
163083373|NCT00500331|589015231|FG004|Overall Study|Adverse Event|2|||
163083374|NCT00500331|589015232|FG005|Overall Study|Adverse Event|2|||
163083375|NCT00500331|589015233|FG006|Overall Study|Adverse Event|0|||
163083376|NCT00500331|589015227|FG000|Overall Study|Lost to Follow-up|1|||
163083377|NCT00500331|589015228|FG001|Overall Study|Lost to Follow-up|1|||
163083378|NCT00500331|589015229|FG002|Overall Study|Lost to Follow-up|1|||
163083379|NCT00500331|589015230|FG003|Overall Study|Lost to Follow-up|2|||
163083380|NCT00500331|589015231|FG004|Overall Study|Lost to Follow-up|1|||
163083381|NCT00500331|589015232|FG005|Overall Study|Lost to Follow-up|0|||
163083382|NCT00500331|589015233|FG006|Overall Study|Lost to Follow-up|0|||
163083383|NCT00500331|589015227|FG000|Overall Study|Protocol Violation|3|||
163083384|NCT00500331|589015228|FG001|Overall Study|Protocol Violation|1|||
163083385|NCT00500331|589015229|FG002|Overall Study|Protocol Violation|1|||
163083386|NCT00500331|589015230|FG003|Overall Study|Protocol Violation|0|||
163083387|NCT00500331|589015231|FG004|Overall Study|Protocol Violation|1|||
163083388|NCT00500331|589015232|FG005|Overall Study|Protocol Violation|1|||
163083389|NCT00500331|589015233|FG006|Overall Study|Protocol Violation|1|||
163083390|NCT00500331|589015227|FG000|Overall Study|Withdrawal by Subject|4|||
163083391|NCT00500331|589015228|FG001|Overall Study|Withdrawal by Subject|0|||
163083392|NCT00500331|589015229|FG002|Overall Study|Withdrawal by Subject|1|||
163083393|NCT00500331|589015230|FG003|Overall Study|Withdrawal by Subject|5|||
163083394|NCT00500331|589015231|FG004|Overall Study|Withdrawal by Subject|0|||
163083395|NCT00500331|589015232|FG005|Overall Study|Withdrawal by Subject|1|||
163083396|NCT00500331|589015233|FG006|Overall Study|Withdrawal by Subject|1|||
163083397|NCT00500331|589015227|FG000|Overall Study|Lack of Efficacy|3|||
163083398|NCT00500331|589015228|FG001|Overall Study|Lack of Efficacy|1|||
163083399|NCT00500331|589015229|FG002|Overall Study|Lack of Efficacy|0|||
163083400|NCT00500331|589015230|FG003|Overall Study|Lack of Efficacy|0|||
163083401|NCT00500331|589015231|FG004|Overall Study|Lack of Efficacy|0|||
163083402|NCT00500331|589015232|FG005|Overall Study|Lack of Efficacy|0|||
163083403|NCT00500331|589015233|FG006|Overall Study|Lack of Efficacy|0|||
163083404|NCT00500331|589015227|FG000|Overall Study|Liver function test abnormality|0|||
163083405|NCT00500331|589015228|FG001|Overall Study|Liver function test abnormality|0|||
163083406|NCT00500331|589015229|FG002|Overall Study|Liver function test abnormality|1|||
163083407|NCT00500331|589015230|FG003|Overall Study|Liver function test abnormality|0|||
163083408|NCT00500331|589015231|FG004|Overall Study|Liver function test abnormality|0|||
163083409|NCT00500331|589015232|FG005|Overall Study|Liver function test abnormality|0|||
163083410|NCT00500331|589015233|FG006|Overall Study|Liver function test abnormality|0|||
163083411|NCT00500331|589015227|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
163083412|NCT00500331|589015228|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
163083413|NCT00500331|589015229|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
163083414|NCT00500331|589015230|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
163083415|NCT00500331|589015231|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
163083416|NCT00500331|589015232|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
163083417|NCT00500331|589015233|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
163083418|NCT00500331|589015227|FG000|Overall Study|Didn't return for continuation of study|1|||
163083419|NCT00500331|589015228|FG001|Overall Study|Didn't return for continuation of study|0|||
163083420|NCT00500331|589015229|FG002|Overall Study|Didn't return for continuation of study|0|||
163083421|NCT00500331|589015230|FG003|Overall Study|Didn't return for continuation of study|0|||
163083422|NCT00500331|589015231|FG004|Overall Study|Didn't return for continuation of study|0|||
163083423|NCT00500331|589015232|FG005|Overall Study|Didn't return for continuation of study|0|||
163083424|NCT00500331|589015233|FG006|Overall Study|Didn't return for continuation of study|0|||
163083425|NCT00500331|589015227|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
163083426|NCT00500331|589015228|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
163083427|NCT00500331|589015229|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
163083428|NCT00500331|589015230|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
163083429|NCT00500331|589015231|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
163083430|NCT00500331|589015232|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
163083431|NCT00500331|589015233|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
163083432|NCT00500331|589015227|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
163083433|NCT00500331|589015228|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
163083434|NCT00500331|589015229|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
163083435|NCT00500331|589015230|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
163083436|NCT00500331|589015231|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
163083437|NCT00500331|589015232|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
163083438|NCT00500331|589015233|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
163083439|NCT00500331|589015227|FG000|Overall Study|Participant was randomized by mistake|1|||
163083440|NCT00500331|589015228|FG001|Overall Study|Participant was randomized by mistake|0|||
163083441|NCT00500331|589015229|FG002|Overall Study|Participant was randomized by mistake|0|||
163083442|NCT00500331|589015230|FG003|Overall Study|Participant was randomized by mistake|0|||
163083443|NCT00500331|589015231|FG004|Overall Study|Participant was randomized by mistake|0|||
163083444|NCT00500331|589015232|FG005|Overall Study|Participant was randomized by mistake|0|||
163083445|NCT00500331|589015233|FG006|Overall Study|Participant was randomized by mistake|0|||
163083446|NCT00500331|589015227|FG000|Overall Study|Diabetologist nurse in the study|0|||
163083447|NCT00500331|589015228|FG001|Overall Study|Diabetologist nurse in the study|0|||
163083448|NCT00500331|589015229|FG002|Overall Study|Diabetologist nurse in the study|1|||
163083449|NCT00500331|589015230|FG003|Overall Study|Diabetologist nurse in the study|0|||
163083450|NCT00500331|589015231|FG004|Overall Study|Diabetologist nurse in the study|0|||
163083451|NCT00500331|589015232|FG005|Overall Study|Diabetologist nurse in the study|0|||
163083452|NCT00500331|589015233|FG006|Overall Study|Diabetologist nurse in the study|0|||
163083453|NCT00500331|589015227|FG000|Overall Study|State ban of biological samples export|0|||
163083454|NCT00500331|589015228|FG001|Overall Study|State ban of biological samples export|0|||
163083455|NCT00500331|589015229|FG002|Overall Study|State ban of biological samples export|0|||
163083456|NCT00500331|589015230|FG003|Overall Study|State ban of biological samples export|1|||
163083457|NCT00500331|589015231|FG004|Overall Study|State ban of biological samples export|0|||
163083458|NCT00500331|589015232|FG005|Overall Study|State ban of biological samples export|0|||
163083459|NCT00500331|589015233|FG006|Overall Study|State ban of biological samples export|0|||
163083460|NCT00500331|589015227|FG000|Overall Study|Protocol violated|0|||
163083461|NCT00500331|589015228|FG001|Overall Study|Protocol violated|0|||
163083462|NCT00500331|589015229|FG002|Overall Study|Protocol violated|0|||
163083463|NCT00500331|589015230|FG003|Overall Study|Protocol violated|1|||
163083464|NCT00500331|589015231|FG004|Overall Study|Protocol violated|0|||
163083465|NCT00500331|589015232|FG005|Overall Study|Protocol violated|0|||
163083466|NCT00500331|589015233|FG006|Overall Study|Protocol violated|0|||
163083467|NCT00856557|589015240|FG000|Overall Study|No patients with contextual flags|12|||
163083468|NCT00856557|589015241|FG001|Overall Study|No patients with contextual flags|16|||
163083469|NCT02301897|589015242|FG000|Treatment Course 1|Non-Compliance|0|||
163083470|NCT02301897|589015243|FG001|Treatment Course 1|Non-Compliance|0|||
163083471|NCT02301897|589015244|FG002|Treatment Course 1|Non-Compliance|1|||
163083472|NCT02301897|589015242|FG000|Treatment Course 1|Adverse Event|1|||
163083473|NCT02301897|589015243|FG001|Treatment Course 1|Adverse Event|1|||
163083474|NCT02301897|589015244|FG002|Treatment Course 1|Adverse Event|0|||
163083475|NCT02301897|589015242|FG000|Treatment Course 1|Lost to Follow-up|1|||
163083476|NCT02301897|589015243|FG001|Treatment Course 1|Lost to Follow-up|2|||
163083477|NCT02301897|589015244|FG002|Treatment Course 1|Lost to Follow-up|1|||
163083478|NCT02301897|589015242|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
163083479|NCT02301897|589015243|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
163083480|NCT02301897|589015244|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
163083481|NCT02301897|589015242|FG000|Treatment Course 1|Withdrawal by Subject|0|||
163083482|NCT02301897|589015243|FG001|Treatment Course 1|Withdrawal by Subject|0|||
163083483|NCT02301897|589015244|FG002|Treatment Course 1|Withdrawal by Subject|2|||
163083484|NCT02301897|589015242|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
163083485|NCT02301897|589015243|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
163083486|NCT02301897|589015244|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
163083487|NCT02301897|589015242|FG000|Treatment Course 2|Lost to Follow-up|0|||
163083488|NCT02301897|589015243|FG001|Treatment Course 2|Lost to Follow-up|2|||
163083489|NCT02301897|589015244|FG002|Treatment Course 2|Lost to Follow-up|0|||
163083490|NCT02301897|589015242|FG000|Treatment Course 2|Pregnancy|0|||
163083491|NCT02301897|589015243|FG001|Treatment Course 2|Pregnancy|1|||
163083492|NCT02301897|589015244|FG002|Treatment Course 2|Pregnancy|1|||
163083493|NCT02301897|589015242|FG000|Treatment Course 2|Withdrawal by Subject|0|||
163083494|NCT02301897|589015243|FG001|Treatment Course 2|Withdrawal by Subject|2|||
163083495|NCT02301897|589015244|FG002|Treatment Course 2|Withdrawal by Subject|0|||
163083496|NCT02301897|589015242|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
163083497|NCT02301897|589015243|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
163083498|NCT02301897|589015244|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
163083499|NCT00337168|589015245|FG000|Overall Study|Death|5|||
163083500|NCT00337168|589015245|FG000|Overall Study|Not protocol specified|2|||
163083501|NCT00337168|589015245|FG000|Overall Study|Did not start therapy|1|||
163083502|NCT02684461|589015248|FG000|Overall Study|Adverse Event|1|||
163083503|NCT02684461|589015249|FG001|Overall Study|Adverse Event|0|||
163083504|NCT02684461|589015250|FG002|Overall Study|Adverse Event|0|||
163083505|NCT02684461|589015248|FG000|Overall Study|Lack of Efficacy|1|||
163083506|NCT02684461|589015249|FG001|Overall Study|Lack of Efficacy|2|||
163083507|NCT02684461|589015250|FG002|Overall Study|Lack of Efficacy|0|||
163083508|NCT03663582|589015251|FG000|Overall Study|Physician Decision|1|||
163083509|NCT00557440|589015263|FG000|Treatment Period 1|Adverse Event|0|||
163083510|NCT00557440|589015264|FG001|Treatment Period 1|Adverse Event|0|||
163083511|NCT00557440|589015265|FG002|Treatment Period 1|Adverse Event|1|||
163083512|NCT04507763|589015266|FG000|Overall Study|Participants did not meet entrance criteria|201|||
163083513|NCT03322566|589015267|FG000|Overall Study|Death|34|||
163083514|NCT03322566|589015268|FG001|Overall Study|Death|35|||
163083515|NCT03322566|589015269|FG002|Overall Study|Death|23|||
163083516|NCT03322566|589015267|FG000|Overall Study|Physician Decision|6|||
163083517|NCT03322566|589015268|FG001|Overall Study|Physician Decision|7|||
163083518|NCT03322566|589015269|FG002|Overall Study|Physician Decision|2|||
163083519|NCT03322566|589015267|FG000|Overall Study|Withdrawal by Subject|4|||
163083520|NCT03322566|589015268|FG001|Overall Study|Withdrawal by Subject|3|||
163083521|NCT03322566|589015269|FG002|Overall Study|Withdrawal by Subject|6|||
163083522|NCT03322566|589015267|FG000|Overall Study|Lost to Follow-up|0|||
163083523|NCT03322566|589015268|FG001|Overall Study|Lost to Follow-up|0|||
163083524|NCT03322566|589015269|FG002|Overall Study|Lost to Follow-up|1|||
163083525|NCT03322566|589015267|FG000|Overall Study|Study terminated by sponsor|1|||
163083526|NCT03322566|589015268|FG001|Overall Study|Study terminated by sponsor|0|||
163083527|NCT03322566|589015269|FG002|Overall Study|Study terminated by sponsor|1|||
163083528|NCT01602484|589015270|FG000|Overall Study|Airway issues unrelated to study|0|||
163083529|NCT01602484|589015271|FG001|Overall Study|Airway issues unrelated to study|1|||
163083530|NCT00425555|589015274|FG000|Overall Study|Withdrawal by Subject|11|||
163083531|NCT00425555|589015275|FG001|Overall Study|Withdrawal by Subject|8|||
163083532|NCT00425555|589015274|FG000|Overall Study|Lost to Follow-up|0|||
163083533|NCT00425555|589015275|FG001|Overall Study|Lost to Follow-up|1|||
163083534|NCT00425555|589015274|FG000|Overall Study|Administrative problems|3|||
163083535|NCT00425555|589015275|FG001|Overall Study|Administrative problems|0|||
163083536|NCT00425555|589015274|FG000|Overall Study|Death|1|||
163083537|NCT00425555|589015275|FG001|Overall Study|Death|2|||
163083538|NCT00425555|589015274|FG000|Overall Study|New cancer therapy|2|||
163083539|NCT00425555|589015275|FG001|Overall Study|New cancer therapy|1|||
163083540|NCT00425555|589015274|FG000|Overall Study|Disease progression|36|||
163083541|NCT00425555|589015275|FG001|Overall Study|Disease progression|33|||
163083542|NCT00425555|589015274|FG000|Overall Study|Adverse Event|25|||
163083543|NCT00425555|589015275|FG001|Overall Study|Adverse Event|15|||
163083544|NCT00425555|589015274|FG000|Overall Study|Protocol Violation|1|||
163083545|NCT00425555|589015275|FG001|Overall Study|Protocol Violation|0|||
163083546|NCT05763381|589015276|FG000|Overall Study|Lost to Follow-up|2|||
163083547|NCT05763381|589015277|FG001|Overall Study|Lost to Follow-up|3|||
163083548|NCT05763381|589015276|FG000|Overall Study|Withdrawal by Subject|1|||
163083549|NCT05763381|589015277|FG001|Overall Study|Withdrawal by Subject|2|||
163083550|NCT02592863|589015282|FG000|Overall Study|Withdrawal by Subject|2|||
163083551|NCT02592863|589015283|FG001|Overall Study|Withdrawal by Subject|2|||
163083552|NCT02592863|589015282|FG000|Overall Study|Lost to Follow-up|1|||
163083553|NCT02592863|589015283|FG001|Overall Study|Lost to Follow-up|1|||
163083554|NCT01674062|589015291|FG000|Overall Study|Insufficient Therapeutic Response|56|||
163083555|NCT01674062|589015292|FG001|Overall Study|Insufficient Therapeutic Response|26|||
163083556|NCT01674062|589015291|FG000|Overall Study|Other|8|||
163083557|NCT01674062|589015292|FG001|Overall Study|Other|1|||
163083558|NCT01674062|589015291|FG000|Overall Study|Adverse Event|1|||
163083559|NCT01674062|589015292|FG001|Overall Study|Adverse Event|1|||
163083560|NCT01674062|589015291|FG000|Overall Study|Death|0|||
163083561|NCT01674062|589015292|FG001|Overall Study|Death|1|||
163083562|NCT01674062|589015291|FG000|Overall Study|Programming Error|1|||
163083563|NCT01674062|589015292|FG001|Overall Study|Programming Error|0|||
163083564|NCT04661839|589015293|FG000|Overall Study|Not Treated|0|||
163083565|NCT04661839|589015294|FG001|Overall Study|Not Treated|0|||
163083566|NCT04661839|589015295|FG002|Overall Study|Not Treated|1|||
163083567|NCT04661839|589015296|FG003|Overall Study|Not Treated|0|||
163083568|NCT04661839|589015293|FG000|Overall Study|Lost to Follow-up|1|||
163083569|NCT04661839|589015294|FG001|Overall Study|Lost to Follow-up|0|||
163083570|NCT04661839|589015295|FG002|Overall Study|Lost to Follow-up|0|||
163083571|NCT04661839|589015296|FG003|Overall Study|Lost to Follow-up|1|||
163083572|NCT03895372|589015297|FG000|Investigational Treatment Period|Adverse Event|1|||
163083573|NCT03895372|589015298|FG001|Investigational Treatment Period|Adverse Event|0|||
163083574|NCT03895372|589015299|FG002|Investigational Treatment Period|Adverse Event|0|||
163083575|NCT03895372|589015300|FG003|Investigational Treatment Period|Adverse Event|0|||
163083576|NCT03895372|589015301|FG004|Investigational Treatment Period|Adverse Event|0|||
163083577|NCT03895372|589015302|FG005|Investigational Treatment Period|Adverse Event|0|||
163083578|NCT03895372|589015303|FG006|Investigational Treatment Period|Adverse Event|4|||
163083579|NCT03895372|589015304|FG007|Investigational Treatment Period|Adverse Event|3|||
163083580|NCT03895372|589015297|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
163083581|NCT03895372|589015298|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
163083582|NCT03895372|589015299|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
163083583|NCT03895372|589015300|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
163083584|NCT03895372|589015301|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
163083585|NCT03895372|589015302|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
163332528|NCT02609048|589927715|FG001|Overall Study|Reason not specified|9|||
163332529|NCT02609048|589927716|FG002|Overall Study|Reason not specified|9|||
163332530|NCT04445831|589927717|FG000|Overall Study|Withdrawal by Subject|2|||
163332531|NCT04445831|589927718|FG001|Overall Study|Withdrawal by Subject|1|||
163083586|NCT03895372|589015303|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
163332532|NCT04445831|589927719|FG002|Overall Study|Withdrawal by Subject|1|||
163332533|NCT04445831|589927720|FG003|Overall Study|Withdrawal by Subject|0|||
163083587|NCT03895372|589015304|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
163083588|NCT03895372|589015297|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
163083589|NCT03895372|589015298|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
163332534|NCT04445831|589927721|FG004|Overall Study|Withdrawal by Subject|0|||
163083590|NCT03895372|589015299|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
163083591|NCT03895372|589015300|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
163083592|NCT03895372|589015301|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
163083593|NCT03895372|589015302|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
163083594|NCT03895372|589015303|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
163083595|NCT03895372|589015304|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
163083596|NCT03895372|589015297|FG000|Investigational Treatment Period|Other|0|||
163083597|NCT03895372|589015298|FG001|Investigational Treatment Period|Other|0|||
163083598|NCT03895372|589015299|FG002|Investigational Treatment Period|Other|0|||
163083599|NCT03895372|589015300|FG003|Investigational Treatment Period|Other|0|||
163083600|NCT03895372|589015301|FG004|Investigational Treatment Period|Other|0|||
163083601|NCT03895372|589015302|FG005|Investigational Treatment Period|Other|1|||
163083602|NCT03895372|589015303|FG006|Investigational Treatment Period|Other|0|||
163083603|NCT03895372|589015304|FG007|Investigational Treatment Period|Other|2|||
163083604|NCT03895372|589015297|FG000|Investigational Treatment Period|Protocol Violation|0|||
163083605|NCT03895372|589015298|FG001|Investigational Treatment Period|Protocol Violation|0|||
163083606|NCT03895372|589015299|FG002|Investigational Treatment Period|Protocol Violation|0|||
163083607|NCT03895372|589015300|FG003|Investigational Treatment Period|Protocol Violation|1|||
163083608|NCT03895372|589015301|FG004|Investigational Treatment Period|Protocol Violation|0|||
163083609|NCT03895372|589015302|FG005|Investigational Treatment Period|Protocol Violation|0|||
163083610|NCT03895372|589015303|FG006|Investigational Treatment Period|Protocol Violation|0|||
163083611|NCT03895372|589015304|FG007|Investigational Treatment Period|Protocol Violation|0|||
163083612|NCT03895372|589015297|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
163083613|NCT03895372|589015298|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
163083614|NCT03895372|589015299|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
163083615|NCT03895372|589015300|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
163083616|NCT03895372|589015301|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
163083617|NCT03895372|589015302|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
163083618|NCT03895372|589015303|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
163083619|NCT03895372|589015304|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
163083620|NCT03895372|589015297|FG000|Extension Treatment Period|Adverse Event|0|||
163083621|NCT03895372|589015298|FG001|Extension Treatment Period|Adverse Event|1|||
163083622|NCT03895372|589015299|FG002|Extension Treatment Period|Adverse Event|0|||
163083623|NCT03895372|589015300|FG003|Extension Treatment Period|Adverse Event|1|||
163083624|NCT03895372|589015301|FG004|Extension Treatment Period|Adverse Event|0|||
163083625|NCT03895372|589015302|FG005|Extension Treatment Period|Adverse Event|0|||
163083626|NCT03895372|589015303|FG006|Extension Treatment Period|Adverse Event|3|||
163083627|NCT03895372|589015304|FG007|Extension Treatment Period|Adverse Event|3|||
163083628|NCT03895372|589015297|FG000|Extension Treatment Period|Other|1|||
163083629|NCT03895372|589015298|FG001|Extension Treatment Period|Other|3|||
163083630|NCT03895372|589015299|FG002|Extension Treatment Period|Other|0|||
163083631|NCT03895372|589015300|FG003|Extension Treatment Period|Other|0|||
163083632|NCT03895372|589015301|FG004|Extension Treatment Period|Other|1|||
163083633|NCT03895372|589015302|FG005|Extension Treatment Period|Other|0|||
163083634|NCT03895372|589015303|FG006|Extension Treatment Period|Other|0|||
163083635|NCT03895372|589015304|FG007|Extension Treatment Period|Other|2|||
163083636|NCT03895372|589015297|FG000|Extension Treatment Period|Pregnancy|0|||
163083637|NCT03895372|589015298|FG001|Extension Treatment Period|Pregnancy|0|||
163083638|NCT03895372|589015299|FG002|Extension Treatment Period|Pregnancy|0|||
163083639|NCT03895372|589015300|FG003|Extension Treatment Period|Pregnancy|0|||
163083640|NCT03895372|589015301|FG004|Extension Treatment Period|Pregnancy|1|||
163083641|NCT03895372|589015302|FG005|Extension Treatment Period|Pregnancy|0|||
163083642|NCT03895372|589015303|FG006|Extension Treatment Period|Pregnancy|0|||
163083643|NCT03895372|589015304|FG007|Extension Treatment Period|Pregnancy|0|||
163083644|NCT03895372|589015297|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
163083645|NCT03895372|589015298|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
163083646|NCT03895372|589015299|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
163083647|NCT03895372|589015300|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
163083648|NCT03895372|589015301|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
163083649|NCT03895372|589015302|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
163083650|NCT03895372|589015303|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
163083651|NCT03895372|589015304|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
163083652|NCT03685149|589015305|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
163083653|NCT03685149|589015306|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
163083654|NCT03685149|589015305|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163083655|NCT03685149|589015306|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
163083656|NCT03685149|589015305|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
163083657|NCT03685149|589015306|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
163083658|NCT02951819|589015308|FG000|Overall Study|Death|9|||
163083659|NCT02951819|589015309|FG001|Overall Study|Death|7|||
163083660|NCT02951819|589015308|FG000|Overall Study|Withdrawal by Subject|3|||
163083661|NCT02951819|589015309|FG001|Overall Study|Withdrawal by Subject|0|||
163083662|NCT02951819|589015308|FG000|Overall Study|Adverse Event|1|||
163083663|NCT02951819|589015309|FG001|Overall Study|Adverse Event|0|||
163083664|NCT02951819|589015308|FG000|Overall Study|Lack of Efficacy|4|||
163083665|NCT02951819|589015309|FG001|Overall Study|Lack of Efficacy|0|||
163083666|NCT02951819|589015308|FG000|Overall Study|Lost to Follow-up|1|||
163083667|NCT02951819|589015309|FG001|Overall Study|Lost to Follow-up|0|||
163406459|NCT03311711|590198639|FG004|Overall Study|Lost to Follow-up|0|||
163406460|NCT03311711|590198640|FG005|Overall Study|Lost to Follow-up|0|||
163083668|NCT02951819|589015308|FG000|Overall Study|Progressive Disease|1|||
163083669|NCT02951819|589015309|FG001|Overall Study|Progressive Disease|0|||
163083670|NCT02951819|589015308|FG000|Overall Study|Other|9|||
163083671|NCT02951819|589015309|FG001|Overall Study|Other|0|||
163083672|NCT00581919|589015313|FG000|Overall Study|Adverse Event|8|||
163083673|NCT00581919|589015313|FG000|Overall Study|Death|1|||
163083674|NCT00581919|589015313|FG000|Overall Study|Disease Progression|10|||
163083675|NCT00581919|589015313|FG000|Overall Study|Physician Decision|1|||
163083676|NCT00581919|589015313|FG000|Overall Study|Other Complicating Disease|1|||
163083677|NCT00581919|589015313|FG000|Overall Study|Started Non-Protocol Therapy|2|||
163083678|NCT00581919|589015313|FG000|Overall Study|Withdrawal by Subject|1|||
163083679|NCT02034565|589015314|FG000|Overall Study|Adverse Event|1|||
163083680|NCT02034565|589015315|FG001|Overall Study|Adverse Event|0|||
163219572|NCT02658890|589519408|FG017|Treatment Phase|Withdrawal by Subject|0|||
163219573|NCT02658890|589519409|FG018|Treatment Phase|Withdrawal by Subject|4|||
163219574|NCT02658890|589519410|FG019|Treatment Phase|Withdrawal by Subject|3|||
163219575|NCT02658890|589519411|FG020|Treatment Phase|Withdrawal by Subject|0|||
163219576|NCT02658890|589519412|FG021|Treatment Phase|Withdrawal by Subject|4|||
163219577|NCT02658890|589519413|FG022|Treatment Phase|Withdrawal by Subject|1|||
163219578|NCT02658890|589519414|FG023|Treatment Phase|Withdrawal by Subject|1|||
163219579|NCT02658890|589519415|FG024|Treatment Phase|Withdrawal by Subject|0|||
163219580|NCT02658890|589519416|FG025|Treatment Phase|Withdrawal by Subject|0|||
163219581|NCT02658890|589519417|FG026|Treatment Phase|Withdrawal by Subject|0|||
163219582|NCT02404311|589519418|FG000|Part A: Month 0-18|Death|2|||
163219583|NCT02404311|589519419|FG001|Part A: Month 0-18|Death|0|||
163219584|NCT02404311|589519420|FG002|Part A: Month 0-18|Death|0|||
163219585|NCT02404311|589519421|FG003|Part A: Month 0-18|Death|0|||
163219586|NCT02404311|589519422|FG004|Part A: Month 0-18|Death|0|||
163219587|NCT02404311|589519418|FG000|Part A: Month 0-18|Physician Decision|1|||
163219588|NCT02404311|589519419|FG001|Part A: Month 0-18|Physician Decision|0|||
163219589|NCT02404311|589519420|FG002|Part A: Month 0-18|Physician Decision|0|||
163219590|NCT02404311|589519421|FG003|Part A: Month 0-18|Physician Decision|0|||
163219591|NCT02404311|589519422|FG004|Part A: Month 0-18|Physician Decision|0|||
163219592|NCT02404311|589519418|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
163219593|NCT02404311|589519419|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
163219594|NCT02404311|589519420|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
163219595|NCT02404311|589519421|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
163219596|NCT02404311|589519422|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
163219597|NCT02404311|589519418|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
163219598|NCT02404311|589519419|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
163219599|NCT02404311|589519420|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
163219600|NCT02404311|589519421|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
163219601|NCT02404311|589519422|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
163219602|NCT02404311|589519418|FG000|Part A: Month 0-18|HIV Infection|6|||
163219603|NCT02404311|589519419|FG001|Part A: Month 0-18|HIV Infection|2|||
163219604|NCT02404311|589519420|FG002|Part A: Month 0-18|HIV Infection|0|||
163219605|NCT02404311|589519421|FG003|Part A: Month 0-18|HIV Infection|0|||
163219606|NCT02404311|589519422|FG004|Part A: Month 0-18|HIV Infection|0|||
163219607|NCT02404311|589519418|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
163219608|NCT02404311|589519419|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
163219609|NCT02404311|589519420|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
163219610|NCT02404311|589519421|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
163219611|NCT02404311|589519422|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
163219612|NCT00159588|589519423|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
163219613|NCT00159588|589519424|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
163219614|NCT00159588|589519425|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
163219615|NCT00107198|589519437|FG000|Overall Study|Lack of Efficacy|28|||
163219616|NCT00107198|589519437|FG000|Overall Study|Lost to Follow-up|12|||
163219617|NCT00107198|589519437|FG000|Overall Study|Protocol Violation|1|||
163219618|NCT00107198|589519437|FG000|Overall Study|Withdrawal by Subject|6|||
163219619|NCT00107198|589519437|FG000|Overall Study|Ineligible|5|||
163219620|NCT02532647|589519440|FG000|Overall Study|Did not receive trial medication|1|||
163219621|NCT02532647|589519441|FG001|Overall Study|Did not receive trial medication|0|||
163219622|NCT02532647|589519442|FG002|Overall Study|Did not receive trial medication|1|||
163219623|NCT03897179|589519452|FG000|Overall Study|Withdrawal by Subject|1|||
163219624|NCT01480076|589519453|FG000|Overall Study|Run-in Failure|52|||
163083681|NCT03232567|589015318|FG000|Overall Study|Withdrawal by Subject|0|||
163083682|NCT03232567|589015319|FG001|Overall Study|Withdrawal by Subject|1|||
163083683|NCT03232567|589015320|FG002|Overall Study|Withdrawal by Subject|0|||
163083684|NCT03232567|589015321|FG003|Overall Study|Withdrawal by Subject|0|||
163083685|NCT02655601|589015322|FG000|Overall Study|Adverse Event|0|||
163219625|NCT01480076|589519453|FG000|Overall Study|Adverse Event|39|||
163219626|NCT01480076|589519453|FG000|Overall Study|Death|2|||
163219627|NCT01480076|589519453|FG000|Overall Study|Disease Progression|5|||
163219628|NCT01480076|589519453|FG000|Overall Study|Non-compliance With Study Protocol|15|||
163219629|NCT01480076|589519453|FG000|Overall Study|Withdrawal by Subject|105|||
163219630|NCT01480076|589519453|FG000|Overall Study|Lost to Follow-up|7|||
163083686|NCT02655601|589015323|FG001|Overall Study|Adverse Event|0|||
163083687|NCT02655601|589015324|FG002|Overall Study|Adverse Event|0|||
163083688|NCT02655601|589015325|FG003|Overall Study|Adverse Event|1|||
163083689|NCT02655601|589015326|FG004|Overall Study|Adverse Event|1|||
163083690|NCT02655601|589015327|FG005|Overall Study|Adverse Event|0|||
163083691|NCT02655601|589015322|FG000|Overall Study|Physician Decision|0|||
163083692|NCT02655601|589015323|FG001|Overall Study|Physician Decision|0|||
163083693|NCT02655601|589015324|FG002|Overall Study|Physician Decision|0|||
163083694|NCT02655601|589015325|FG003|Overall Study|Physician Decision|0|||
163083695|NCT02655601|589015326|FG004|Overall Study|Physician Decision|1|||
163083696|NCT02655601|589015327|FG005|Overall Study|Physician Decision|1|||
163332535|NCT04445831|589927722|FG005|Overall Study|Withdrawal by Subject|0|||
163083697|NCT02655601|589015322|FG000|Overall Study|Withdrawal by Subject|0|||
163083698|NCT02655601|589015323|FG001|Overall Study|Withdrawal by Subject|0|||
163083699|NCT02655601|589015324|FG002|Overall Study|Withdrawal by Subject|0|||
163083700|NCT02655601|589015325|FG003|Overall Study|Withdrawal by Subject|0|||
163083701|NCT02655601|589015326|FG004|Overall Study|Withdrawal by Subject|4|||
163083702|NCT02655601|589015327|FG005|Overall Study|Withdrawal by Subject|8|||
163083703|NCT02655601|589015322|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
163083704|NCT02655601|589015323|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
163083705|NCT02655601|589015324|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
163083706|NCT02655601|589015325|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
163083707|NCT02655601|589015326|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
163083708|NCT02655601|589015327|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
163083709|NCT05837481|589015328|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
163083710|NCT05837481|589015329|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
163083711|NCT02014376|589015330|FG000|Overall Study|Adverse Event|1|||
163083712|NCT02014376|589015331|FG001|Overall Study|Adverse Event|1|||
163083713|NCT02014376|589015332|FG002|Overall Study|Adverse Event|0|||
163083714|NCT02014376|589015330|FG000|Overall Study|Lost to Follow-up|2|||
163083715|NCT02014376|589015331|FG001|Overall Study|Lost to Follow-up|0|||
163083716|NCT02014376|589015332|FG002|Overall Study|Lost to Follow-up|0|||
163083717|NCT00759395|589015335|FG000|Overall Study|Adverse Event|1|||
163083718|NCT00759395|589015336|FG001|Overall Study|Adverse Event|0|||
163083719|NCT00759395|589015335|FG000|Overall Study|Withdrawal by Subject|1|||
163083720|NCT00759395|589015336|FG001|Overall Study|Withdrawal by Subject|0|||
163083721|NCT00759395|589015335|FG000|Overall Study|Lack of Efficacy|0|||
163083722|NCT00759395|589015336|FG001|Overall Study|Lack of Efficacy|2|||
163083723|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
163083724|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
163083725|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
163083726|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
163332536|NCT04445831|589927723|FG006|Overall Study|Withdrawal by Subject|0|||
163332537|NCT04445831|589927717|FG000|Overall Study|Subject withdrawal by caregiver|0|||
163332538|NCT04445831|589927718|FG001|Overall Study|Subject withdrawal by caregiver|1|||
163332539|NCT04445831|589927719|FG002|Overall Study|Subject withdrawal by caregiver|0|||
163332540|NCT04445831|589927720|FG003|Overall Study|Subject withdrawal by caregiver|0|||
163332541|NCT04445831|589927721|FG004|Overall Study|Subject withdrawal by caregiver|0|||
163332542|NCT04445831|589927722|FG005|Overall Study|Subject withdrawal by caregiver|0|||
163332543|NCT04445831|589927723|FG006|Overall Study|Subject withdrawal by caregiver|0|||
163332544|NCT04912856|589927727|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
163332545|NCT04912856|589927728|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
163332546|NCT04912856|589927727|FG000|Overall Study|Not reported in synoptic CSR.|0|||
163332547|NCT04912856|589927728|FG001|Overall Study|Not reported in synoptic CSR.|1|||
163332554|NCT02434328|589927731|FG000|Overall Study|Adverse Event|9|||
163083727|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
163083728|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
163083729|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
163083730|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
163083731|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
163083732|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
163083733|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
163083734|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
163083735|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
163332555|NCT02434328|589927732|FG001|Overall Study|Adverse Event|4|||
163332556|NCT02434328|589927731|FG000|Overall Study|Lack of Efficacy|0|||
163083736|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
163083737|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
163083738|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
163083739|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
163083740|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
163083741|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
163083742|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
163083743|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
163083744|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
163083745|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
163083746|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
163083747|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
163083748|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
163083749|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
163083750|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
163083751|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
163083752|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
163083753|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
163083754|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
163083755|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
163083756|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
163083757|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
163083758|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
163083759|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
163083760|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
163083761|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
163083762|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
163083763|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
163083764|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
163083765|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
163083766|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
163083767|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
163083768|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
163083769|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
163083770|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
163083771|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
163083772|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
163083773|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
163083774|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
163083775|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
163083776|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
163083777|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
163083778|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
163083779|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
163083780|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
163083781|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
163083782|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
163083783|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
163083784|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
163083785|NCT02420314|589015342|FG000|Overall Study|Withdrawal by Subject|1|||
163083786|NCT02420314|589015342|FG000|Overall Study|Protocol Violation|1|||
163083787|NCT02251041|589015343|FG000|Overall Study|Did not receive intervention|15|||
163083788|NCT02251041|589015344|FG001|Overall Study|Did not receive intervention|4|||
163083789|NCT01618708|589015347|FG000|Overall Study|Adverse Event|10|||
163083790|NCT01618708|589015348|FG001|Overall Study|Adverse Event|10|||
163083791|NCT01618708|589015347|FG000|Overall Study|Lost to Follow-up|3|||
163083792|NCT01618708|589015348|FG001|Overall Study|Lost to Follow-up|3|||
163083793|NCT01618708|589015347|FG000|Overall Study|Withdrawal by Subject|17|||
163083794|NCT01618708|589015348|FG001|Overall Study|Withdrawal by Subject|22|||
163083795|NCT01618708|589015347|FG000|Overall Study|Lack of Efficacy|8|||
163219631|NCT01480076|589519453|FG000|Overall Study|Investigator Decision|13|||
163219632|NCT01480076|589519453|FG000|Overall Study|Other|52|||
163083796|NCT01618708|589015348|FG001|Overall Study|Lack of Efficacy|8|||
163219633|NCT02503332|589519454|FG000|Overall Study|Adverse Event|17|||
163219634|NCT02503332|589519455|FG001|Overall Study|Adverse Event|5|||
163219635|NCT02503332|589519456|FG002|Overall Study|Adverse Event|3|||
163219636|NCT02503332|589519457|FG003|Overall Study|Adverse Event|1|||
163219637|NCT02503332|589519454|FG000|Overall Study|Investigator's Decision|5|||
163219638|NCT02503332|589519455|FG001|Overall Study|Investigator's Decision|1|||
163219639|NCT02503332|589519456|FG002|Overall Study|Investigator's Decision|0|||
163083797|NCT01618708|589015347|FG000|Overall Study|Technical problems|2|||
163083798|NCT01618708|589015348|FG001|Overall Study|Technical problems|0|||
163083799|NCT01618708|589015347|FG000|Overall Study|Other than specified above|1|||
163083800|NCT01618708|589015348|FG001|Overall Study|Other than specified above|1|||
163083801|NCT01618708|589015347|FG000|Overall Study|Randomized but not treated|3|||
163083802|NCT01618708|589015348|FG001|Overall Study|Randomized but not treated|2|||
163083803|NCT01848457|589015351|FG000|Overall Study|Death|1|||
163083804|NCT01848457|589015352|FG001|Overall Study|Death|0|||
163083805|NCT01848457|589015353|FG002|Overall Study|Death|0|||
163083806|NCT01848457|589015354|FG003|Overall Study|Death|0|||
163083807|NCT02181413|589015356|FG000|Overall Study|Withdrawal by Subject|45|||
163083808|NCT02181413|589015357|FG001|Overall Study|Withdrawal by Subject|61|||
163083809|NCT02181413|589015356|FG000|Overall Study|Reason Not Specified|2|||
163083810|NCT02181413|589015357|FG001|Overall Study|Reason Not Specified|5|||
163083811|NCT02181413|589015356|FG000|Overall Study|Lost to Follow-up|8|||
163083812|NCT02181413|589015357|FG001|Overall Study|Lost to Follow-up|7|||
163083813|NCT02298946|589015359|FG000|Overall Study|Did not receive treatment|2|||
163083814|NCT02298946|589015360|FG001|Overall Study|Did not receive treatment|0|||
163083815|NCT02298946|589015359|FG000|Overall Study|Unevaluable|2|||
163083816|NCT02298946|589015360|FG001|Overall Study|Unevaluable|1|||
163083817|NCT00050011|589015361|FG000|Overall Study|Adverse Event|41|||
163083818|NCT00050011|589015362|FG001|Overall Study|Adverse Event|46|||
163083819|NCT00050011|589015361|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163083820|NCT00050011|589015362|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163083821|NCT00050011|589015361|FG000|Overall Study|Abnormal test procedure results|0|||
163083822|NCT00050011|589015362|FG001|Overall Study|Abnormal test procedure results|1|||
163083823|NCT00050011|589015361|FG000|Overall Study|Lack of Efficacy|16|||
163083824|NCT00050011|589015362|FG001|Overall Study|Lack of Efficacy|21|||
163083825|NCT00050011|589015361|FG000|Overall Study|Participant condition no longer required|1|||
163083826|NCT00050011|589015362|FG001|Overall Study|Participant condition no longer required|0|||
163083827|NCT00050011|589015361|FG000|Overall Study|Protocol Violation|4|||
163083828|NCT00050011|589015362|FG001|Overall Study|Protocol Violation|10|||
163083829|NCT00050011|589015361|FG000|Overall Study|Withdrawal by Subject|34|||
163083830|NCT00050011|589015362|FG001|Overall Study|Withdrawal by Subject|26|||
163083831|NCT00050011|589015361|FG000|Overall Study|Lost to Follow-up|7|||
163083832|NCT00050011|589015362|FG001|Overall Study|Lost to Follow-up|9|||
163083833|NCT00050011|589015361|FG000|Overall Study|Administrative problems|10|||
163083834|NCT00050011|589015362|FG001|Overall Study|Administrative problems|6|||
163083835|NCT00050011|589015361|FG000|Overall Study|Death|7|||
163083836|NCT00050011|589015362|FG001|Overall Study|Death|4|||
163083837|NCT00050011|589015361|FG000|Overall Study|Unknown - Reason is missing|0|||
163083838|NCT00050011|589015362|FG001|Overall Study|Unknown - Reason is missing|2|||
163083839|NCT03034044|589015363|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
163083840|NCT02412436|589015364|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
163083841|NCT02412436|589015364|FG000|Overall Study|Lost to Follow-up|6|||
163083842|NCT02412436|589015364|FG000|Overall Study|Unable to get to clinic|3|||
163083843|NCT02412436|589015364|FG000|Overall Study|Death|1|||
163083844|NCT02412436|589015364|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
163083845|NCT03514134|589016773|FG000|Overall Study|Lost to Follow-up|0|||
163083846|NCT03514134|589016774|FG001|Overall Study|Lost to Follow-up|1|||
163083847|NCT00462826|589016775|FG000|Overall Study|Ineligible - second primary|1|||
163083848|NCT00462826|589016775|FG000|Overall Study|Ineligible - wrong cell type|1|||
163083849|NCT00462826|589016775|FG000|Overall Study|Ineligible - wrong primary|2|||
163083850|NCT00462826|589016775|FG000|Overall Study|Never treated|1|||
163083851|NCT04976777|589016776|FG000|Overall Study|COVID-19 Infection|1|||
163083852|NCT04976777|589016777|FG001|Overall Study|COVID-19 Infection|0|||
163083853|NCT05654181|589016778|FG000|Overall Study|Adverse Event|1|||
163083854|NCT05654181|589016779|FG001|Overall Study|Adverse Event|0|||
163083855|NCT05654181|589016780|FG002|Overall Study|Adverse Event|0|||
163083856|NCT05654181|589016781|FG003|Overall Study|Adverse Event|0|||
163083857|NCT05654181|589016782|FG004|Overall Study|Adverse Event|0|||
163083858|NCT05654181|589016783|FG005|Overall Study|Adverse Event|0|||
163083859|NCT05654181|589016784|FG006|Overall Study|Adverse Event|0|||
163083860|NCT05654181|589016785|FG007|Overall Study|Adverse Event|1|||
163083861|NCT05654181|589016786|FG008|Overall Study|Adverse Event|0|||
163083862|NCT05654181|589016787|FG009|Overall Study|Adverse Event|0|||
163083863|NCT05654181|589016778|FG000|Overall Study|Withdrawal by Subject|0|||
163083864|NCT05654181|589016779|FG001|Overall Study|Withdrawal by Subject|0|||
163083865|NCT05654181|589016780|FG002|Overall Study|Withdrawal by Subject|0|||
163083866|NCT05654181|589016781|FG003|Overall Study|Withdrawal by Subject|0|||
163083867|NCT05654181|589016782|FG004|Overall Study|Withdrawal by Subject|0|||
163083868|NCT05654181|589016783|FG005|Overall Study|Withdrawal by Subject|0|||
163083869|NCT05654181|589016784|FG006|Overall Study|Withdrawal by Subject|0|||
163083870|NCT05654181|589016785|FG007|Overall Study|Withdrawal by Subject|1|||
163083871|NCT05654181|589016786|FG008|Overall Study|Withdrawal by Subject|0|||
163083872|NCT05654181|589016787|FG009|Overall Study|Withdrawal by Subject|0|||
163083873|NCT05654181|589016778|FG000|Overall Study|Other|0|||
163083874|NCT05654181|589016779|FG001|Overall Study|Other|0|||
163083875|NCT05654181|589016780|FG002|Overall Study|Other|0|||
163083876|NCT05654181|589016781|FG003|Overall Study|Other|0|||
163083877|NCT05654181|589016782|FG004|Overall Study|Other|1|||
163083878|NCT05654181|589016783|FG005|Overall Study|Other|1|||
163332557|NCT02434328|589927732|FG001|Overall Study|Lack of Efficacy|2|||
163332558|NCT02434328|589927731|FG000|Overall Study|Physician Decision|0|||
163332559|NCT02434328|589927732|FG001|Overall Study|Physician Decision|1|||
163332560|NCT02434328|589927731|FG000|Overall Study|Withdrawal by Subject|12|||
163083879|NCT05654181|589016784|FG006|Overall Study|Other|0|||
163083880|NCT05654181|589016785|FG007|Overall Study|Other|0|||
163083881|NCT05654181|589016786|FG008|Overall Study|Other|0|||
163083882|NCT05654181|589016787|FG009|Overall Study|Other|0|||
163083883|NCT01397253|589016788|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
163083884|NCT01397253|589016789|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
163083885|NCT03033784|589016795|FG000|Overall Study|Anxiety related to MRI scanner|0|||
163083886|NCT03033784|589016796|FG001|Overall Study|Anxiety related to MRI scanner|1|||
163083887|NCT03033784|589016797|FG002|Overall Study|Anxiety related to MRI scanner|0|||
163083888|NCT03033784|589016798|FG003|Overall Study|Anxiety related to MRI scanner|0|||
163083889|NCT03033784|589016799|FG004|Overall Study|Anxiety related to MRI scanner|0|||
163083890|NCT03033784|589016800|FG005|Overall Study|Anxiety related to MRI scanner|0|||
163083891|NCT03033784|589016801|FG006|Overall Study|Anxiety related to MRI scanner|0|||
163083892|NCT03033784|589016802|FG007|Overall Study|Anxiety related to MRI scanner|0|||
163083893|NCT03033784|589016803|FG008|Overall Study|Anxiety related to MRI scanner|0|||
163083894|NCT03033784|589016804|FG009|Overall Study|Anxiety related to MRI scanner|0|||
163083895|NCT03033784|589016805|FG010|Overall Study|Anxiety related to MRI scanner|0|||
163083896|NCT03033784|589016806|FG011|Overall Study|Anxiety related to MRI scanner|0|||
163083897|NCT03033784|589016807|FG012|Overall Study|Anxiety related to MRI scanner|0|||
163083898|NCT03033784|589016795|FG000|Overall Study|Withdrawal by Subject|0|||
163083899|NCT03033784|589016796|FG001|Overall Study|Withdrawal by Subject|0|||
163083900|NCT03033784|589016797|FG002|Overall Study|Withdrawal by Subject|0|||
163083901|NCT03033784|589016798|FG003|Overall Study|Withdrawal by Subject|0|||
163083902|NCT03033784|589016799|FG004|Overall Study|Withdrawal by Subject|0|||
163083903|NCT03033784|589016800|FG005|Overall Study|Withdrawal by Subject|0|||
163083904|NCT03033784|589016801|FG006|Overall Study|Withdrawal by Subject|0|||
163083905|NCT03033784|589016802|FG007|Overall Study|Withdrawal by Subject|0|||
163083906|NCT03033784|589016803|FG008|Overall Study|Withdrawal by Subject|0|||
163083907|NCT03033784|589016804|FG009|Overall Study|Withdrawal by Subject|0|||
163083908|NCT03033784|589016805|FG010|Overall Study|Withdrawal by Subject|0|||
163083909|NCT03033784|589016806|FG011|Overall Study|Withdrawal by Subject|0|||
163083910|NCT03033784|589016807|FG012|Overall Study|Withdrawal by Subject|2|||
163083911|NCT00267488|589016808|FG000|Overall Study|Sponsor Terminated Study|9|||
163083912|NCT00267488|589016808|FG000|Overall Study|Protocol Violation|1|||
163083913|NCT00267488|589016808|FG000|Overall Study|Other (Disease Progression)|1|||
163083914|NCT02093520|589016809|FG000|Overall Study|Not treated|6|||
163083915|NCT02093520|589016810|FG001|Overall Study|Not treated|22|||
163083916|NCT00851084|589016811|FG000|Overall Study|Randomized but not treated|1|||
163083917|NCT00851084|589016812|FG001|Overall Study|Randomized but not treated|0|||
163083918|NCT00851084|589016811|FG000|Overall Study|Adverse Event|26|||
163083919|NCT00851084|589016812|FG001|Overall Study|Adverse Event|36|||
163083920|NCT00851084|589016811|FG000|Overall Study|Disease progression|52|||
163083921|NCT00851084|589016812|FG001|Overall Study|Disease progression|47|||
163083922|NCT00851084|589016811|FG000|Overall Study|Poor compliance to protocol|1|||
163083923|NCT00851084|589016812|FG001|Overall Study|Poor compliance to protocol|1|||
163083924|NCT00851084|589016811|FG000|Overall Study|Physician Decision|13|||
163083925|NCT00851084|589016812|FG001|Overall Study|Physician Decision|14|||
163083926|NCT00851084|589016811|FG000|Overall Study|Consent withdrawn|0|||
163083927|NCT00851084|589016812|FG001|Overall Study|Consent withdrawn|2|||
163083928|NCT00851084|589016811|FG000|Overall Study|Withdrawal by Subject|11|||
163083929|NCT00851084|589016812|FG001|Overall Study|Withdrawal by Subject|12|||
163083930|NCT00851084|589016811|FG000|Overall Study|Metastatic surgery|6|||
163083931|NCT00851084|589016812|FG001|Overall Study|Metastatic surgery|6|||
163083932|NCT00851084|589016811|FG000|Overall Study|Other|7|||
163083933|NCT00851084|589016812|FG001|Overall Study|Other|1|||
163332561|NCT02434328|589927732|FG001|Overall Study|Withdrawal by Subject|21|||
163083934|NCT01892189|589016815|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
163083935|NCT01892189|589016816|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
163083936|NCT01892189|589016817|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
163083937|NCT01892189|589016818|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
163083938|NCT01892189|589016819|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
163083939|NCT01892189|589016820|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
163083940|NCT01892189|589016821|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
163083941|NCT01892189|589016822|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
163083942|NCT01892189|589016823|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
163083943|NCT01892189|589016815|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163083944|NCT01892189|589016816|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163332562|NCT02434328|589927731|FG000|Overall Study|Death|4|||
163083945|NCT01892189|589016817|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
163083946|NCT01892189|589016818|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
163083947|NCT01892189|589016819|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163083948|NCT01892189|589016820|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163083949|NCT01892189|589016821|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
163083950|NCT01892189|589016822|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163083951|NCT01892189|589016823|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
163083952|NCT01892189|589016815|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083953|NCT01892189|589016816|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083954|NCT01892189|589016817|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083955|NCT01892189|589016818|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083956|NCT01892189|589016819|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083957|NCT01892189|589016820|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
163083958|NCT01892189|589016821|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083959|NCT01892189|589016822|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083960|NCT01892189|589016823|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083961|NCT02263547|589016826|FG000|Overall Study|Adverse Event|1|||
163083962|NCT02263547|589016826|FG000|Overall Study|Lost to Follow-up|2|||
163083963|NCT02332928|589016827|FG000|Overall Study|Withdrawal by Subject|0|||
163083964|NCT02332928|589016828|FG001|Overall Study|Withdrawal by Subject|2|||
163083965|NCT02332928|589016827|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
163083966|NCT02332928|589016828|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
163083967|NCT01497197|589016829|FG000|Overall Study|Lost to Follow-up|1|||
163083968|NCT01497197|589016830|FG001|Overall Study|Lost to Follow-up|0|||
163083969|NCT01497197|589016829|FG000|Overall Study|Protocol Violation|0|||
163083970|NCT01497197|589016830|FG001|Overall Study|Protocol Violation|2|||
163083971|NCT01497197|589016829|FG000|Overall Study|Withdrawal by Subject|2|||
163083972|NCT01497197|589016830|FG001|Overall Study|Withdrawal by Subject|1|||
163083973|NCT01497197|589016829|FG000|Overall Study|Excessive/lack of response to treatment|1|||
163083974|NCT01497197|589016830|FG001|Overall Study|Excessive/lack of response to treatment|0|||
163083975|NCT01497197|589016829|FG000|Overall Study|Risk of OHSS|1|||
163083976|NCT01497197|589016830|FG001|Overall Study|Risk of OHSS|0|||
163083977|NCT01497197|589016829|FG000|Overall Study|No oocytes retrieved|3|||
163083978|NCT01497197|589016830|FG001|Overall Study|No oocytes retrieved|2|||
163083979|NCT01497197|589016829|FG000|Overall Study|No fertilisation|6|||
163083980|NCT01497197|589016830|FG001|Overall Study|No fertilisation|5|||
163083981|NCT01497197|589016829|FG000|Overall Study|Intention to freeze all embryos|0|||
163083982|NCT01497197|589016830|FG001|Overall Study|Intention to freeze all embryos|1|||
163083983|NCT01497197|589016829|FG000|Overall Study|All embryos discarded|0|||
163083984|NCT01497197|589016830|FG001|Overall Study|All embryos discarded|3|||
163083985|NCT01497197|589016829|FG000|Overall Study|Other|3|||
163083986|NCT01497197|589016830|FG001|Overall Study|Other|1|||
163083987|NCT01052779|589016832|FG000|Overall Study|Adverse Event|1|||
163083988|NCT01052779|589016833|FG001|Overall Study|Adverse Event|4|||
163083989|NCT01052779|589016832|FG000|Overall Study|Withdrawal by Subject|1|||
163083990|NCT01052779|589016833|FG001|Overall Study|Withdrawal by Subject|2|||
163083991|NCT01052779|589016832|FG000|Overall Study|Other-Protocol Violation|1|||
163083992|NCT01052779|589016833|FG001|Overall Study|Other-Protocol Violation|1|||
163083993|NCT01052779|589016832|FG000|Overall Study|Other-Surgery|0|||
163083994|NCT01052779|589016833|FG001|Overall Study|Other-Surgery|2|||
163083995|NCT01052779|589016832|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
163083996|NCT01052779|589016833|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
163083997|NCT03580044|589016834|FG000|Overall Study|Death|2|||
163083998|NCT03580044|589016835|FG001|Overall Study|Death|1|||
163083999|NCT03580044|589016834|FG000|Overall Study|Withdrawal by Subject|1|||
163084000|NCT03580044|589016835|FG001|Overall Study|Withdrawal by Subject|1|||
163332563|NCT02434328|589927732|FG001|Overall Study|Death|7|||
163084001|NCT03524157|589016836|FG000|Overall Study|cytology not readable|0|||
163084002|NCT03524157|589016837|FG001|Overall Study|cytology not readable|0|||
163084003|NCT03524157|589016838|FG002|Overall Study|cytology not readable|1|||
163084004|NCT02743962|589016839|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
163084005|NCT02743962|589016840|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
163084006|NCT06582732|589016844|FG000|Initial Study Period|Adverse Event|0|||
163084007|NCT06582732|589016845|FG001|Initial Study Period|Adverse Event|0|||
163332564|NCT02434328|589927731|FG000|Overall Study|Lost to Follow-up|1|||
163332565|NCT02434328|589927732|FG001|Overall Study|Lost to Follow-up|6|||
163084008|NCT06582732|589016846|FG002|Initial Study Period|Adverse Event|0|||
163084009|NCT06582732|589016847|FG003|Initial Study Period|Adverse Event|2|||
163084010|NCT06582732|589016848|FG004|Initial Study Period|Adverse Event|0|||
163084011|NCT06582732|589016849|FG005|Initial Study Period|Adverse Event|0|||
163084012|NCT06582732|589016850|FG006|Initial Study Period|Adverse Event|0|||
163084013|NCT06582732|589016844|FG000|Initial Study Period|Death|1|||
163084014|NCT06582732|589016845|FG001|Initial Study Period|Death|0|||
163084015|NCT06582732|589016846|FG002|Initial Study Period|Death|0|||
163332566|NCT02434328|589927731|FG000|Overall Study|Other|4|||
163332567|NCT02434328|589927732|FG001|Overall Study|Other|1|||
163084016|NCT06582732|589016847|FG003|Initial Study Period|Death|0|||
163084017|NCT06582732|589016848|FG004|Initial Study Period|Death|1|||
163084018|NCT06582732|589016849|FG005|Initial Study Period|Death|0|||
163084019|NCT06582732|589016850|FG006|Initial Study Period|Death|0|||
163084020|NCT06582732|589016844|FG000|Initial Study Period|Lost to Follow-up|0|||
163084021|NCT06582732|589016845|FG001|Initial Study Period|Lost to Follow-up|0|||
163084022|NCT06582732|589016846|FG002|Initial Study Period|Lost to Follow-up|2|||
163084023|NCT06582732|589016847|FG003|Initial Study Period|Lost to Follow-up|0|||
163084024|NCT06582732|589016848|FG004|Initial Study Period|Lost to Follow-up|0|||
163084025|NCT06582732|589016849|FG005|Initial Study Period|Lost to Follow-up|0|||
163084026|NCT06582732|589016850|FG006|Initial Study Period|Lost to Follow-up|0|||
163084027|NCT06582732|589016844|FG000|Initial Study Period|Withdrawal by Subject|0|||
163084028|NCT06582732|589016845|FG001|Initial Study Period|Withdrawal by Subject|1|||
163084029|NCT06582732|589016846|FG002|Initial Study Period|Withdrawal by Subject|0|||
163084030|NCT06582732|589016847|FG003|Initial Study Period|Withdrawal by Subject|1|||
163084031|NCT06582732|589016848|FG004|Initial Study Period|Withdrawal by Subject|3|||
163084032|NCT06582732|589016849|FG005|Initial Study Period|Withdrawal by Subject|1|||
163084033|NCT06582732|589016850|FG006|Initial Study Period|Withdrawal by Subject|2|||
163084034|NCT06582732|589016844|FG000|Initial Study Period|Moved Away|0|||
163084035|NCT06582732|589016845|FG001|Initial Study Period|Moved Away|0|||
163084036|NCT06582732|589016846|FG002|Initial Study Period|Moved Away|0|||
163084037|NCT06582732|589016847|FG003|Initial Study Period|Moved Away|0|||
163084038|NCT06582732|589016848|FG004|Initial Study Period|Moved Away|1|||
163084039|NCT06582732|589016849|FG005|Initial Study Period|Moved Away|0|||
163084040|NCT06582732|589016850|FG006|Initial Study Period|Moved Away|0|||
163084041|NCT03931330|589016851|FG000|Overall Study|Physician Decision|1|||
163084042|NCT03412929|589016852|FG000|Overall Study|Protocol Violation|3|||
163084043|NCT01381679|589016857|FG000|Overall Study|Adverse Event|3|||
163084044|NCT01381679|589016857|FG000|Overall Study|Lost to Follow-up|885|||
163084045|NCT02135133|589016858|FG000|Overall Study|Adverse Event|10|||
163084046|NCT02135133|589016858|FG000|Overall Study|regulatory mandate|5|||
163084047|NCT03312543|589016869|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
163084048|NCT03312543|589016870|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
163084049|NCT03312543|589016869|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
163084050|NCT03312543|589016870|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
163084051|NCT03312543|589016869|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
163084052|NCT03312543|589016870|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
163084053|NCT03312543|589016869|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
163084054|NCT03312543|589016870|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
163084055|NCT03312543|589016869|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
163084056|NCT03312543|589016870|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
163084057|NCT03312543|589016869|FG000|Regression (Week 12 to Week 24)|Death|0|||
163084058|NCT03312543|589016870|FG001|Regression (Week 12 to Week 24)|Death|1|||
163084059|NCT04507269|589016871|FG000|Overall Study|Withdrawal by Subject|1|||
163084060|NCT04507269|589016872|FG001|Overall Study|Withdrawal by Subject|1|||
163084061|NCT04507269|589016873|FG002|Overall Study|Withdrawal by Subject|0|||
163084062|NCT04507269|589016874|FG003|Overall Study|Withdrawal by Subject|0|||
163084063|NCT04507269|589016875|FG004|Overall Study|Withdrawal by Subject|0|||
163084064|NCT04507269|589016876|FG005|Overall Study|Withdrawal by Subject|0|||
163084065|NCT04507269|589016871|FG000|Overall Study|Lost to Follow-up|0|||
163084066|NCT04507269|589016872|FG001|Overall Study|Lost to Follow-up|0|||
163084067|NCT04507269|589016873|FG002|Overall Study|Lost to Follow-up|0|||
163084068|NCT04507269|589016874|FG003|Overall Study|Lost to Follow-up|0|||
163084069|NCT04507269|589016875|FG004|Overall Study|Lost to Follow-up|1|||
163084070|NCT04507269|589016876|FG005|Overall Study|Lost to Follow-up|0|||
163084071|NCT05852340|589016877|FG000|Period 5|Not completing the meal|0|||
163084072|NCT05852340|589016878|FG001|Period 5|Not completing the meal|1|||
163084073|NCT05852340|589016879|FG002|Period 5|Not completing the meal|0|||
163084074|NCT05852340|589016880|FG003|Period 5|Not completing the meal|0|||
163084075|NCT05852340|589016877|FG000|Period 5|Adverse Event|0|||
163084076|NCT05852340|589016878|FG001|Period 5|Adverse Event|0|||
163084077|NCT05852340|589016879|FG002|Period 5|Adverse Event|0|||
163084078|NCT05852340|589016880|FG003|Period 5|Adverse Event|1|||
163084079|NCT00071032|589016883|FG000|Overall Study|Lost to Follow-up|1|||
163084080|NCT00071032|589016884|FG001|Overall Study|Lost to Follow-up|1|||
163084081|NCT00071032|589016883|FG000|Overall Study|Withdrawal by Subject|8|||
163084082|NCT00071032|589016884|FG001|Overall Study|Withdrawal by Subject|6|||
163084083|NCT00071032|589016883|FG000|Overall Study|Missing Primary Outcome|0|||
163084084|NCT00071032|589016884|FG001|Overall Study|Missing Primary Outcome|1|||
163084085|NCT04197583|589016885|FG000|Overall Study|Study Stent Replacement|34|||
163084086|NCT04197583|589016886|FG001|Overall Study|Study Stent Replacement|8|||
163084087|NCT04197583|589016885|FG000|Overall Study|Lost to Follow-up|14|||
163084088|NCT04197583|589016886|FG001|Overall Study|Lost to Follow-up|3|||
163084089|NCT04197583|589016885|FG000|Overall Study|Death|3|||
163084090|NCT04197583|589016886|FG001|Overall Study|Death|0|||
163084091|NCT04197583|589016885|FG000|Overall Study|Physician Decision|1|||
163084092|NCT04197583|589016886|FG001|Overall Study|Physician Decision|0|||
163084093|NCT04197583|589016885|FG000|Overall Study|Withdrawal by Subject|1|||
163084094|NCT04197583|589016886|FG001|Overall Study|Withdrawal by Subject|1|||
163084095|NCT04197583|589016885|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
163084096|NCT04197583|589016886|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
163084097|NCT04197583|589016885|FG000|Overall Study|Screen Failure|0|||
163084098|NCT04197583|589016886|FG001|Overall Study|Screen Failure|20|||
163084099|NCT04042311|589016893|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
163084100|NCT04042311|589016893|FG000|Overall Study|Unable to tolerate|4|||
163084101|NCT04042311|589016893|FG000|Overall Study|Concurrent illness|2|||
163084102|NCT04042311|589016893|FG000|Overall Study|Adverse Event|2|||
163084103|NCT04042311|589016893|FG000|Overall Study|No longer meeting inclusion criteria|2|||
163084104|NCT04042311|589016893|FG000|Overall Study|No reason given|1|||
163084105|NCT04042311|589016893|FG000|Overall Study|Withdrawal by Subject|4|||
163084106|NCT04134936|589016894|FG000|Overall Study|Adverse Event|3|||
163084107|NCT04134936|589016895|FG001|Overall Study|Adverse Event|2|||
163084108|NCT04134936|589016894|FG000|Overall Study|Withdrawal by Subject|2|||
163084109|NCT04134936|589016895|FG001|Overall Study|Withdrawal by Subject|3|||
163084110|NCT04134936|589016894|FG000|Overall Study|Physician Decision|0|||
163084111|NCT04134936|589016895|FG001|Overall Study|Physician Decision|1|||
163084112|NCT04134936|589016894|FG000|Overall Study|Progressive disease, joined another trial|1|||
163084113|NCT04134936|589016895|FG001|Overall Study|Progressive disease, joined another trial|0|||
163084114|NCT04134936|589016894|FG000|Overall Study|Progressive disease|1|||
163084115|NCT04134936|589016895|FG001|Overall Study|Progressive disease|0|||
163084116|NCT03518060|589016896|FG000|Overall Study|Death|1|||
163084117|NCT03518060|589016896|FG000|Overall Study|Poor adherence|1|||
163084118|NCT03518060|589016896|FG000|Overall Study|Withdrawal of informed consent|2|||
163084119|NCT03518060|589016896|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
163084120|NCT03518060|589016896|FG000|Overall Study|Physician Decision|7|||
163084121|NCT03518060|589016896|FG000|Overall Study|Adverse drug reactions|23|||
163084122|NCT03518060|589016896|FG000|Overall Study|Withdrawal by Subject|25|||
163084123|NCT03518060|589016896|FG000|Overall Study|Lost to Follow-up|13|||
163084124|NCT00323622|589016897|FG000|Overall Study|Other|30|||
163084125|NCT00323622|589016898|FG001|Overall Study|Other|91|||
163084126|NCT00323622|589016899|FG002|Overall Study|Other|4|||
163084127|NCT00323622|589016900|FG003|Overall Study|Other|12|||
163084128|NCT00323622|589016901|FG004|Overall Study|Other|32|||
163084129|NCT00323622|589016902|FG005|Overall Study|Other|74|||
163084130|NCT00323622|589016903|FG006|Overall Study|Other|5|||
163084131|NCT00323622|589016904|FG007|Overall Study|Other|13|||
163084132|NCT00323622|589016897|FG000|Overall Study|Death|1|||
163084133|NCT00323622|589016898|FG001|Overall Study|Death|1|||
163084134|NCT00323622|589016899|FG002|Overall Study|Death|0|||
163084135|NCT00323622|589016900|FG003|Overall Study|Death|0|||
163084136|NCT00323622|589016901|FG004|Overall Study|Death|7|||
163084137|NCT00323622|589016902|FG005|Overall Study|Death|0|||
163084138|NCT00323622|589016903|FG006|Overall Study|Death|0|||
163084139|NCT00323622|589016904|FG007|Overall Study|Death|2|||
163084140|NCT03709472|589016911|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
163084141|NCT03709472|589016912|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
163084142|NCT03709472|589016911|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
163084143|NCT03709472|589016912|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
163084144|NCT00112385|589016915|FG000|Overall Study|Lost to Follow-up|1|||
163084145|NCT00112385|589016916|FG001|Overall Study|Lost to Follow-up|0|||
163084146|NCT00112385|589016915|FG000|Overall Study|Withdrawal by Subject|0|||
163084147|NCT00112385|589016916|FG001|Overall Study|Withdrawal by Subject|1|||
163084148|NCT02613507|589016924|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
163084149|NCT02613507|589016925|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
163084150|NCT02613507|589016924|FG000|Pre-Treamtent|Participant withdrew consent|0|||
163084151|NCT02613507|589016925|FG001|Pre-Treamtent|Participant withdrew consent|4|||
163084152|NCT02613507|589016924|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
163084153|NCT02613507|589016925|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
163084154|NCT02613507|589016924|FG000|Treatment|Not reported|3|||
163084155|NCT02613507|589016925|FG001|Treatment|Not reported|0|||
163084156|NCT02613507|589016924|FG000|Treatment|Other reasons|8|||
163084157|NCT02613507|589016925|FG001|Treatment|Other reasons|0|||
163084158|NCT02613507|589016924|FG000|Treatment|Participant no longer meets criteria|3|||
163084159|NCT02613507|589016925|FG001|Treatment|Participant no longer meets criteria|0|||
163084160|NCT02613507|589016924|FG000|Treatment|Maximum clinical benefit|5|||
163084161|NCT02613507|589016925|FG001|Treatment|Maximum clinical benefit|10|||
163084162|NCT02613507|589016924|FG000|Treatment|Lost to Follow-up|1|||
163084163|NCT02613507|589016925|FG001|Treatment|Lost to Follow-up|0|||
163084164|NCT02613507|589016924|FG000|Treatment|Participant withdrew consent|0|||
163084165|NCT02613507|589016925|FG001|Treatment|Participant withdrew consent|2|||
163084166|NCT02613507|589016924|FG000|Treatment|Participant request to discontinue study treatment|13|||
163084167|NCT02613507|589016925|FG001|Treatment|Participant request to discontinue study treatment|17|||
163084168|NCT02613507|589016924|FG000|Treatment|Adverse event unrelated to study drug|20|||
163084169|NCT02613507|589016925|FG001|Treatment|Adverse event unrelated to study drug|3|||
163084170|NCT02613507|589016924|FG000|Treatment|Death|2|||
163084171|NCT02613507|589016925|FG001|Treatment|Death|0|||
163084172|NCT02613507|589016924|FG000|Treatment|Study drug toxicity|19|||
163084173|NCT02613507|589016925|FG001|Treatment|Study drug toxicity|14|||
163084174|NCT02613507|589016924|FG000|Treatment|Disease progression|263|||
163084175|NCT02613507|589016925|FG001|Treatment|Disease progression|110|||
163084176|NCT02471144|589018419|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
163084177|NCT02471144|589018420|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
163084178|NCT02471144|589018421|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
163084179|NCT02471144|589018422|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
163084180|NCT02471144|589018423|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
163084181|NCT02471144|589018424|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
163084182|NCT02471144|589018425|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
163084183|NCT02471144|589018426|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
163084184|NCT02471144|589018427|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
163084185|NCT02471144|589018428|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
163084186|NCT02471144|589018429|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
163084187|NCT02471144|589018419|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084188|NCT02471144|589018420|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084189|NCT02471144|589018421|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084190|NCT02471144|589018422|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
163084191|NCT02471144|589018423|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084192|NCT02471144|589018424|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084193|NCT02471144|589018425|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084194|NCT02471144|589018426|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084195|NCT02471144|589018427|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084196|NCT02471144|589018428|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084197|NCT02471144|589018429|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084198|NCT02471144|589018419|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084199|NCT02471144|589018420|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084200|NCT02471144|589018421|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
163084201|NCT02471144|589018422|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084202|NCT02471144|589018423|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084203|NCT02471144|589018424|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084204|NCT02471144|589018425|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084205|NCT02471144|589018426|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084206|NCT02471144|589018427|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084207|NCT02471144|589018428|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084208|NCT02471144|589018429|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084209|NCT02471144|589018419|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
163084210|NCT02471144|589018420|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
163084211|NCT02471144|589018421|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084212|NCT02471144|589018422|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084213|NCT02471144|589018423|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084214|NCT02471144|589018424|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084215|NCT02471144|589018425|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084216|NCT02471144|589018426|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084217|NCT02471144|589018427|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084218|NCT02471144|589018428|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084219|NCT02471144|589018429|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084220|NCT02471144|589018419|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084221|NCT02471144|589018420|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084222|NCT02471144|589018421|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084223|NCT02471144|589018422|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084224|NCT02471144|589018423|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
163084225|NCT02471144|589018424|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084226|NCT02471144|589018425|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
163084227|NCT02471144|589018426|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084228|NCT02471144|589018427|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
163084229|NCT02471144|589018428|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084230|NCT02471144|589018429|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084231|NCT02471144|589018419|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084232|NCT02471144|589018420|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084233|NCT02471144|589018421|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084234|NCT02471144|589018422|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084235|NCT02471144|589018423|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084236|NCT02471144|589018424|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
163084237|NCT02471144|589018425|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084238|NCT02471144|589018426|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163332568|NCT01276509|589929831|FG000|Overall Study|Adverse Event|9|||
163332569|NCT01276509|589929832|FG001|Overall Study|Adverse Event|8|||
163332570|NCT01276509|589929833|FG002|Overall Study|Adverse Event|4|||
163332571|NCT01276509|589929834|FG003|Overall Study|Adverse Event|3|||
163332572|NCT01276509|589929831|FG000|Overall Study|Lack of Efficacy|2|||
163332573|NCT01276509|589929832|FG001|Overall Study|Lack of Efficacy|1|||
163332574|NCT01276509|589929833|FG002|Overall Study|Lack of Efficacy|1|||
163332575|NCT01276509|589929834|FG003|Overall Study|Lack of Efficacy|2|||
163332576|NCT01276509|589929831|FG000|Overall Study|Pregnancy|1|||
163332577|NCT01276509|589929832|FG001|Overall Study|Pregnancy|0|||
163332578|NCT01276509|589929833|FG002|Overall Study|Pregnancy|0|||
163332579|NCT01276509|589929834|FG003|Overall Study|Pregnancy|0|||
163332580|NCT01276509|589929831|FG000|Overall Study|Withdrawal by Subject|1|||
163332581|NCT01276509|589929832|FG001|Overall Study|Withdrawal by Subject|2|||
163332582|NCT01276509|589929833|FG002|Overall Study|Withdrawal by Subject|0|||
163332583|NCT01276509|589929834|FG003|Overall Study|Withdrawal by Subject|0|||
163332584|NCT01276509|589929831|FG000|Overall Study|Other|0|||
163332585|NCT01276509|589929832|FG001|Overall Study|Other|1|||
163332586|NCT01276509|589929833|FG002|Overall Study|Other|0|||
163332587|NCT01276509|589929834|FG003|Overall Study|Other|0|||
163332588|NCT00949117|589929835|FG000|Overall Study|Lack of Efficacy|2|||
163332589|NCT00949117|589929836|FG001|Overall Study|Lack of Efficacy|3|||
163332590|NCT00949117|589929835|FG000|Overall Study|Protocol Violation|1|||
163332591|NCT00949117|589929836|FG001|Overall Study|Protocol Violation|1|||
163332592|NCT00949117|589929835|FG000|Overall Study|Adverse Event|0|||
163332593|NCT00949117|589929836|FG001|Overall Study|Adverse Event|1|||
163332594|NCT00985088|589929837|FG000|Overall Study|Serious Adverse Event|1|||
163332595|NCT00985088|589929838|FG001|Overall Study|Serious Adverse Event|1|||
163332596|NCT00985088|589929839|FG002|Overall Study|Serious Adverse Event|0|||
163332597|NCT00985088|589929840|FG003|Overall Study|Serious Adverse Event|0|||
163332598|NCT00985088|589929841|FG004|Overall Study|Serious Adverse Event|0|||
163332599|NCT00985088|589929842|FG005|Overall Study|Serious Adverse Event|0|||
163084239|NCT02471144|589018427|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
163084240|NCT02471144|589018428|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084241|NCT02471144|589018429|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084242|NCT02471144|589018419|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084243|NCT02471144|589018420|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084244|NCT02471144|589018421|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084245|NCT02471144|589018422|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084246|NCT02471144|589018423|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084247|NCT02471144|589018424|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084248|NCT02471144|589018425|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084249|NCT02471144|589018426|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084250|NCT02471144|589018427|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
163084251|NCT02471144|589018428|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084252|NCT02471144|589018429|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084253|NCT02471144|589018419|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084254|NCT02471144|589018420|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084255|NCT02471144|589018421|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084256|NCT02471144|589018422|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084257|NCT02471144|589018423|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084258|NCT02471144|589018424|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084259|NCT02471144|589018425|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084260|NCT02471144|589018426|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
163332600|NCT00985088|589929843|FG006|Overall Study|Serious Adverse Event|0|||
163332601|NCT00985088|589929844|FG007|Overall Study|Serious Adverse Event|1|||
163084261|NCT02471144|589018427|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
163084262|NCT02471144|589018428|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084263|NCT02471144|589018429|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084264|NCT02471144|589018419|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084265|NCT02471144|589018420|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084266|NCT02471144|589018421|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084267|NCT02471144|589018422|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084268|NCT02471144|589018423|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163332602|NCT00985088|589929837|FG000|Overall Study|Adverse Event|0|||
163332603|NCT00985088|589929838|FG001|Overall Study|Adverse Event|0|||
163332604|NCT00985088|589929839|FG002|Overall Study|Adverse Event|1|||
163332605|NCT00985088|589929840|FG003|Overall Study|Adverse Event|0|||
163332606|NCT00985088|589929841|FG004|Overall Study|Adverse Event|0|||
163332607|NCT00985088|589929842|FG005|Overall Study|Adverse Event|0|||
163084269|NCT02471144|589018424|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084270|NCT02471144|589018425|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084271|NCT02471144|589018426|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084272|NCT02471144|589018427|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084273|NCT02471144|589018428|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
163084274|NCT02471144|589018429|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
163084275|NCT02471144|589018419|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084276|NCT02471144|589018420|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084277|NCT02471144|589018421|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084278|NCT02471144|589018422|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084279|NCT02471144|589018423|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084280|NCT02471144|589018424|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084281|NCT02471144|589018425|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084282|NCT02471144|589018426|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084283|NCT02471144|589018427|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084284|NCT02471144|589018428|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
163084285|NCT02471144|589018429|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084286|NCT02471144|589018419|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084287|NCT02471144|589018420|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084288|NCT02471144|589018421|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084289|NCT02471144|589018422|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084290|NCT02471144|589018423|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084291|NCT02471144|589018424|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084292|NCT02471144|589018425|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084293|NCT02471144|589018426|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084294|NCT02471144|589018427|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084295|NCT02471144|589018428|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084296|NCT02471144|589018429|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
163084297|NCT02471144|589018419|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084298|NCT02471144|589018420|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084299|NCT02471144|589018421|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084300|NCT02471144|589018422|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084301|NCT02471144|589018423|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084302|NCT02471144|589018424|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084303|NCT02471144|589018425|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084304|NCT02471144|589018426|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084305|NCT02471144|589018427|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084306|NCT02471144|589018428|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
163084307|NCT02471144|589018429|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
163084308|NCT02471144|589018419|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084309|NCT02471144|589018420|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084310|NCT02471144|589018421|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084311|NCT02471144|589018422|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084312|NCT02471144|589018423|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084313|NCT02471144|589018424|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084314|NCT02471144|589018425|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084315|NCT02471144|589018426|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084316|NCT02471144|589018427|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084317|NCT02471144|589018428|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
163084318|NCT02471144|589018429|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084319|NCT02471144|589018419|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084320|NCT02471144|589018420|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084321|NCT02471144|589018421|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084322|NCT02471144|589018422|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084323|NCT02471144|589018423|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084324|NCT02471144|589018424|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084325|NCT02471144|589018425|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084326|NCT02471144|589018426|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084327|NCT02471144|589018427|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084328|NCT02471144|589018428|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
163084329|NCT02471144|589018429|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
163084330|NCT03977155|589018434|FG000|Overall Study|Adverse Event|3|||
163084331|NCT03977155|589018435|FG001|Overall Study|Adverse Event|0|||
163084332|NCT03977155|589018436|FG002|Overall Study|Adverse Event|0|||
163084333|NCT03977155|589018434|FG000|Overall Study|Lost to Follow-up|0|||
163084334|NCT03977155|589018435|FG001|Overall Study|Lost to Follow-up|1|||
163084335|NCT03977155|589018436|FG002|Overall Study|Lost to Follow-up|0|||
163084336|NCT03977155|589018434|FG000|Overall Study|Withdrawal by Subject|1|||
163084337|NCT03977155|589018435|FG001|Overall Study|Withdrawal by Subject|1|||
163084338|NCT03977155|589018436|FG002|Overall Study|Withdrawal by Subject|2|||
163084339|NCT03977155|589018434|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
163084340|NCT03977155|589018435|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
163084341|NCT03977155|589018436|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
163084342|NCT00936936|589018437|FG000|Overall Study|Adverse Event|7|||
163084343|NCT00936936|589018438|FG001|Overall Study|Adverse Event|1|||
163084344|NCT00936936|589018437|FG000|Overall Study|Disease Progression|2|||
163084345|NCT00936936|589018438|FG001|Overall Study|Disease Progression|2|||
163084346|NCT00936936|589018437|FG000|Overall Study|Unrelated|3|||
163084347|NCT00936936|589018438|FG001|Overall Study|Unrelated|1|||
163084348|NCT03440385|589018448|FG000|Overall Study|Other Reason|4|||
163084349|NCT03440385|589018449|FG001|Overall Study|Other Reason|1|||
163084350|NCT03440385|589018448|FG000|Overall Study|Site Closed|1|||
163084351|NCT03440385|589018449|FG001|Overall Study|Site Closed|0|||
163084352|NCT03440385|589018448|FG000|Overall Study|Lost to Follow-up|2|||
163084353|NCT03440385|589018449|FG001|Overall Study|Lost to Follow-up|0|||
163084354|NCT03440385|589018448|FG000|Overall Study|Withdrawal by Subject|12|||
163084355|NCT03440385|589018449|FG001|Overall Study|Withdrawal by Subject|6|||
163084356|NCT03440385|589018448|FG000|Overall Study|Lack of Efficacy|9|||
163084357|NCT03440385|589018449|FG001|Overall Study|Lack of Efficacy|2|||
163084358|NCT03440385|589018448|FG000|Overall Study|Adverse Event|15|||
163084359|NCT03440385|589018449|FG001|Overall Study|Adverse Event|11|||
163084360|NCT00488293|589018450|FG000|Overall Study|Lost to Follow-up|28|||
163084361|NCT00488293|589018451|FG001|Overall Study|Lost to Follow-up|25|||
163084362|NCT00488293|589018450|FG000|Overall Study|Withdrawal by Subject|5|||
163084363|NCT00488293|589018451|FG001|Overall Study|Withdrawal by Subject|3|||
163084364|NCT00488293|589018450|FG000|Overall Study|Death|2|||
163084365|NCT00488293|589018451|FG001|Overall Study|Death|1|||
163084366|NCT00488293|589018450|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
163084367|NCT00488293|589018451|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
163084368|NCT00939185|589018452|FG000|Overall Study|Adverse Event|3|||
163084369|NCT00939185|589018452|FG000|Overall Study|Lack of Efficacy|1|||
163084370|NCT00939185|589018452|FG000|Overall Study|Lost to Follow-up|6|||
163084371|NCT00939185|589018452|FG000|Overall Study|Other|3|||
163084372|NCT00939185|589018452|FG000|Overall Study|Withdrawal by Subject|2|||
163084373|NCT00939185|589018452|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
163084374|NCT00363298|589018453|FG000|First Study Week|Lack of Efficacy|6|||
163084375|NCT00363298|589018454|FG001|First Study Week|Lack of Efficacy|5|||
163084376|NCT00363298|589018453|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
163084377|NCT00363298|589018454|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
163084378|NCT02374255|589018455|FG000|Overall Study|Withdrawal by Subject|2|||
163084379|NCT02374255|589018456|FG001|Overall Study|Withdrawal by Subject|0|||
163084380|NCT02374255|589018457|FG002|Overall Study|Withdrawal by Subject|0|||
163084381|NCT02374255|589018458|FG003|Overall Study|Withdrawal by Subject|0|||
163084382|NCT00730327|589018459|FG000|Overall Study|Lost to Follow-up|14|||
163084383|NCT00730327|589018460|FG001|Overall Study|Lost to Follow-up|16|||
163084384|NCT00730327|589018459|FG000|Overall Study|Adverse Event|8|||
163084385|NCT00730327|589018460|FG001|Overall Study|Adverse Event|1|||
163084386|NCT00730327|589018459|FG000|Overall Study|Withdrawal by Subject|3|||
163084387|NCT00730327|589018460|FG001|Overall Study|Withdrawal by Subject|13|||
163084388|NCT00730327|589018459|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
163084389|NCT00730327|589018460|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
163084390|NCT00095576|589018461|FG000|Overall Study|Adverse Event|5|||
163084391|NCT00095576|589018462|FG001|Overall Study|Adverse Event|3|||
163084392|NCT00095576|589018461|FG000|Overall Study|Lost to Follow-up|233|||
163219640|NCT02503332|589519457|FG003|Overall Study|Investigator's Decision|0|||
163219641|NCT02503332|589519454|FG000|Overall Study|Sponsor's Decision|1|||
163219642|NCT02503332|589519455|FG001|Overall Study|Sponsor's Decision|0|||
163219643|NCT02503332|589519456|FG002|Overall Study|Sponsor's Decision|0|||
163084393|NCT00095576|589018462|FG001|Overall Study|Lost to Follow-up|229|||
163084394|NCT00095576|589018461|FG000|Overall Study|Protocol Violation|1|||
163084395|NCT00095576|589018462|FG001|Overall Study|Protocol Violation|0|||
163084396|NCT00095576|589018461|FG000|Overall Study|Withdrawal by Subject|34|||
163084397|NCT00095576|589018462|FG001|Overall Study|Withdrawal by Subject|47|||
163084398|NCT00095576|589018461|FG000|Overall Study|Option to switch to a rollover study|1097|||
163219644|NCT02503332|589519457|FG003|Overall Study|Sponsor's Decision|1|||
163219645|NCT02503332|589519454|FG000|Overall Study|Subject Request|6|||
163219646|NCT02503332|589519455|FG001|Overall Study|Subject Request|5|||
163084399|NCT00095576|589018462|FG001|Overall Study|Option to switch to a rollover study|1099|||
163084400|NCT00095576|589018461|FG000|Overall Study|Site terminated|75|||
163084401|NCT00095576|589018462|FG001|Overall Study|Site terminated|67|||
163084402|NCT00095576|589018461|FG000|Overall Study|Subject moved|30|||
163219647|NCT02503332|589519456|FG002|Overall Study|Subject Request|2|||
163084403|NCT00095576|589018462|FG001|Overall Study|Subject moved|36|||
163084404|NCT01425814|589018465|FG000|Period 1|Stability criteria not fulfilled|0|||
163219648|NCT02503332|589519457|FG003|Overall Study|Subject Request|1|||
163084405|NCT01425814|589018466|FG001|Period 1|Stability criteria not fulfilled|1|||
163084406|NCT01425814|589018467|FG002|Period 1|Stability criteria not fulfilled|0|||
163084407|NCT01425814|589018468|FG003|Period 1|Stability criteria not fulfilled|0|||
163084408|NCT01425814|589018469|FG004|Period 1|Stability criteria not fulfilled|0|||
163084409|NCT01425814|589018470|FG005|Period 1|Stability criteria not fulfilled|0|||
163084410|NCT01425814|589018465|FG000|Period 2|Stability criteria not fulfilled|0|||
163084411|NCT01425814|589018466|FG001|Period 2|Stability criteria not fulfilled|1|||
163084412|NCT01425814|589018467|FG002|Period 2|Stability criteria not fulfilled|0|||
163084413|NCT01425814|589018468|FG003|Period 2|Stability criteria not fulfilled|0|||
163084414|NCT01425814|589018469|FG004|Period 2|Stability criteria not fulfilled|0|||
163084415|NCT01425814|589018470|FG005|Period 2|Stability criteria not fulfilled|0|||
163084416|NCT01425814|589018465|FG000|Period 3|Adverse Event|0|||
163084417|NCT01425814|589018466|FG001|Period 3|Adverse Event|0|||
163084418|NCT01425814|589018467|FG002|Period 3|Adverse Event|0|||
163084419|NCT01425814|589018468|FG003|Period 3|Adverse Event|0|||
163084420|NCT01425814|589018469|FG004|Period 3|Adverse Event|0|||
163084421|NCT01425814|589018470|FG005|Period 3|Adverse Event|1|||
163084422|NCT01425814|589018465|FG000|Period 4|Adverse Event|1|||
163084423|NCT01425814|589018466|FG001|Period 4|Adverse Event|0|||
163084424|NCT01425814|589018467|FG002|Period 4|Adverse Event|1|||
163084425|NCT01425814|589018468|FG003|Period 4|Adverse Event|0|||
163084426|NCT01425814|589018469|FG004|Period 4|Adverse Event|0|||
163084427|NCT01425814|589018470|FG005|Period 4|Adverse Event|0|||
163084428|NCT01425814|589018465|FG000|Period 5|Stability criteria not fulfilled|0|||
163084429|NCT01425814|589018466|FG001|Period 5|Stability criteria not fulfilled|0|||
163084430|NCT01425814|589018467|FG002|Period 5|Stability criteria not fulfilled|1|||
163084431|NCT01425814|589018468|FG003|Period 5|Stability criteria not fulfilled|0|||
163084432|NCT01425814|589018469|FG004|Period 5|Stability criteria not fulfilled|0|||
163084433|NCT01425814|589018470|FG005|Period 5|Stability criteria not fulfilled|1|||
163219649|NCT02503332|589519454|FG000|Overall Study|Death|0|||
163084434|NCT01358734|589018471|FG000|Overall Study|Adverse Event|4|||
163084435|NCT01358734|589018472|FG001|Overall Study|Adverse Event|7|||
163084436|NCT01358734|589018473|FG002|Overall Study|Adverse Event|3|||
163084437|NCT01358734|589018471|FG000|Overall Study|Lack of Efficacy|0|||
163219650|NCT02503332|589519455|FG001|Overall Study|Death|2|||
163219651|NCT02503332|589519456|FG002|Overall Study|Death|2|||
163219652|NCT02503332|589519457|FG003|Overall Study|Death|0|||
163219653|NCT02503332|589519454|FG000|Overall Study|Other|5|||
163219654|NCT02503332|589519455|FG001|Overall Study|Other|6|||
163219655|NCT02503332|589519456|FG002|Overall Study|Other|1|||
163219656|NCT02503332|589519457|FG003|Overall Study|Other|1|||
163219657|NCT05694546|589519459|FG000|Overall Study|Lost to Follow-up|11|||
163219658|NCT02120950|589519460|FG000|Overall Study|Adverse Event|5|||
163219659|NCT02120950|589519461|FG001|Overall Study|Adverse Event|4|||
163219660|NCT02120950|589519462|FG002|Overall Study|Adverse Event|3|||
163219661|NCT02120950|589519460|FG000|Overall Study|Death|3|||
163219662|NCT02120950|589519461|FG001|Overall Study|Death|0|||
163219663|NCT02120950|589519462|FG002|Overall Study|Death|1|||
163219664|NCT02120950|589519460|FG000|Overall Study|Withdrawal by Subject|6|||
163219665|NCT02120950|589519461|FG001|Overall Study|Withdrawal by Subject|3|||
163219666|NCT02120950|589519462|FG002|Overall Study|Withdrawal by Subject|2|||
163219667|NCT02120950|589519460|FG000|Overall Study|Protocol Violation|1|||
163219668|NCT02120950|589519461|FG001|Overall Study|Protocol Violation|1|||
163219669|NCT02120950|589519462|FG002|Overall Study|Protocol Violation|7|||
163219670|NCT02120950|589519460|FG000|Overall Study|Other reasons|5|||
163219671|NCT02120950|589519461|FG001|Overall Study|Other reasons|4|||
163219672|NCT02120950|589519462|FG002|Overall Study|Other reasons|1|||
163219673|NCT02120950|589519460|FG000|Overall Study|Lost to Follow-up|0|||
163219674|NCT02120950|589519461|FG001|Overall Study|Lost to Follow-up|2|||
163219675|NCT02120950|589519462|FG002|Overall Study|Lost to Follow-up|1|||
163219676|NCT02424383|589519463|FG000|Overall Study|Withdrawal by Subject|32|||
163219677|NCT02424383|589519463|FG000|Overall Study|Death|170|||
163219678|NCT02424383|589519463|FG000|Overall Study|Sponsor's decision|3|||
163219679|NCT02424383|589519463|FG000|Overall Study|Investigator's decision|44|||
163219680|NCT02424383|589519463|FG000|Overall Study|Lost to Follow-up|81|||
163219681|NCT02424383|589519463|FG000|Overall Study|Other|7|||
163219682|NCT02424383|589519463|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
163219683|NCT03412084|589519467|FG000|Overall Study|Withdrawal by Subject|2|||
163219684|NCT03412084|589519468|FG001|Overall Study|Withdrawal by Subject|0|||
163219685|NCT03412084|589519467|FG000|Overall Study|Participant moved|1|||
163219686|NCT03412084|589519468|FG001|Overall Study|Participant moved|0|||
163219687|NCT03412084|589519467|FG000|Overall Study|Lost to Follow-up|1|||
163219688|NCT03412084|589519468|FG001|Overall Study|Lost to Follow-up|1|||
163219689|NCT01928862|589519475|FG000|Overall Study|Lost to Follow-up|1|||
163219690|NCT01928862|589519476|FG001|Overall Study|Lost to Follow-up|0|||
163219691|NCT01928862|589519477|FG002|Overall Study|Lost to Follow-up|0|||
163219692|NCT01928862|589519478|FG003|Overall Study|Lost to Follow-up|0|||
163219693|NCT01928862|589519479|FG004|Overall Study|Lost to Follow-up|1|||
163219694|NCT01752855|589519480|FG000|Overall Study|Adverse Event|1|||
163084438|NCT01358734|589018472|FG001|Overall Study|Lack of Efficacy|1|||
163084439|NCT01358734|589018473|FG002|Overall Study|Lack of Efficacy|3|||
163084440|NCT01358734|589018471|FG000|Overall Study|Withdrawal by Subject|1|||
163084441|NCT01358734|589018472|FG001|Overall Study|Withdrawal by Subject|6|||
163084442|NCT01358734|589018473|FG002|Overall Study|Withdrawal by Subject|3|||
163084443|NCT01358734|589018471|FG000|Overall Study|Death|3|||
163084444|NCT01358734|589018472|FG001|Overall Study|Death|7|||
163084445|NCT01358734|589018473|FG002|Overall Study|Death|2|||
163084446|NCT01358734|589018471|FG000|Overall Study|Progressive Disease|5|||
163084447|NCT01358734|589018472|FG001|Overall Study|Progressive Disease|13|||
163084448|NCT01358734|589018473|FG002|Overall Study|Progressive Disease|16|||
163084449|NCT01358734|589018471|FG000|Overall Study|Non-compliance with study drug|0|||
163084450|NCT01358734|589018472|FG001|Overall Study|Non-compliance with study drug|0|||
163084451|NCT01358734|589018473|FG002|Overall Study|Non-compliance with study drug|1|||
163084452|NCT01358734|589018471|FG000|Overall Study|Other|2|||
163084453|NCT01358734|589018472|FG001|Overall Study|Other|5|||
163084454|NCT01358734|589018473|FG002|Overall Study|Other|4|||
163084455|NCT01358734|589018471|FG000|Overall Study|Protocol Violation|0|||
163084456|NCT01358734|589018472|FG001|Overall Study|Protocol Violation|0|||
163084457|NCT01358734|589018473|FG002|Overall Study|Protocol Violation|2|||
163084458|NCT03427619|589018476|FG000|Overall Study|Physician Decision|3|||
163084459|NCT03427619|589018476|FG000|Overall Study|Withdrawal by Subject|4|||
163084460|NCT03427619|589018476|FG000|Overall Study|Lost to Follow-up|5|||
163084461|NCT03427619|589018476|FG000|Overall Study|Administrative|4|||
163084462|NCT03427619|589018476|FG000|Overall Study|Other|2|||
163084463|NCT03427619|589018476|FG000|Overall Study|Unknown or Missing Completion Status|48|||
163084464|NCT01055028|589018485|FG000|Screening|Screen Failure|1|||
163084465|NCT01055028|589018486|FG001|Screening|Screen Failure|1|||
163084466|NCT01055028|589018485|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
163084467|NCT01055028|589018486|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
163084468|NCT01055028|589018485|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
163084469|NCT01055028|589018486|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
163084470|NCT01055028|589018485|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
163084471|NCT01055028|589018486|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
163084472|NCT02919618|589018490|FG000|Overall Study|Death|1|||
163084473|NCT03528902|589018491|FG000|Overall Study|Adverse Event|1|||
163084474|NCT03528902|589018492|FG001|Overall Study|Adverse Event|0|||
163084475|NCT03411044|589018493|FG000|Overall Study|Death|30|||
163084476|NCT03411044|589018493|FG000|Overall Study|Withdrawal by Subject|48|||
163084477|NCT03411044|589018493|FG000|Overall Study|Lost to Follow-up|78|||
163084478|NCT03411044|589018493|FG000|Overall Study|Adverse Event|30|||
163084479|NCT03411044|589018493|FG000|Overall Study|Missing status|4|||
163084480|NCT04620668|589018494|FG000|Overall Study|Withdrawal by Subject|2|||
163084481|NCT04620668|589018495|FG001|Overall Study|Withdrawal by Subject|0|||
163084482|NCT04620668|589018494|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
163084483|NCT04620668|589018495|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
163084484|NCT04620668|589018494|FG000|Overall Study|Removed before analysis: missing data|2|||
163084485|NCT04620668|589018495|FG001|Overall Study|Removed before analysis: missing data|0|||
163084486|NCT04620668|589018494|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
163084487|NCT04620668|589018495|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
163084488|NCT04620668|589018494|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
163084489|NCT04620668|589018495|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
163084490|NCT00427700|589018502|FG000|Overall Study|Lost to Follow-up|2|||
163084491|NCT00427700|589018503|FG001|Overall Study|Lost to Follow-up|5|||
163084492|NCT00427700|589018502|FG000|Overall Study|no induction of menses|1|||
163084493|NCT00427700|589018503|FG001|Overall Study|no induction of menses|4|||
163084494|NCT00427700|589018502|FG000|Overall Study|Pregnancy|0|||
163219695|NCT01752855|589519481|FG001|Overall Study|Adverse Event|0|||
163219696|NCT01752855|589519480|FG000|Overall Study|Withdrew Consent|0|||
163084495|NCT00427700|589018503|FG001|Overall Study|Pregnancy|2|||
163084496|NCT04581395|589018504|FG000|Overall Study|Protocol Violation|4|||
163084497|NCT04581395|589018505|FG001|Overall Study|Protocol Violation|3|||
163084498|NCT04581395|589018506|FG002|Overall Study|Protocol Violation|2|||
163084499|NCT04581395|589018504|FG000|Overall Study|Physician Decision|0|||
163084500|NCT04581395|589018505|FG001|Overall Study|Physician Decision|1|||
163084501|NCT04581395|589018506|FG002|Overall Study|Physician Decision|0|||
163084502|NCT00815633|589018511|FG000|Overall Study|study terminated|1|||
163084503|NCT02259231|589018515|FG000|Overall Study|Adverse Event|1|||
163084504|NCT02259231|589018516|FG001|Overall Study|Adverse Event|1|||
163084505|NCT02259231|589018517|FG002|Overall Study|Adverse Event|2|||
163084506|NCT02259231|589018518|FG003|Overall Study|Adverse Event|0|||
163084507|NCT02259231|589018519|FG004|Overall Study|Adverse Event|0|||
163084508|NCT02259231|589018520|FG005|Overall Study|Adverse Event|0|||
163084509|NCT02259231|589018521|FG006|Overall Study|Adverse Event|0|||
163084510|NCT02259231|589018515|FG000|Overall Study|Progressive Disease|4|||
163084511|NCT02259231|589018516|FG001|Overall Study|Progressive Disease|5|||
163084512|NCT02259231|589018517|FG002|Overall Study|Progressive Disease|4|||
163084513|NCT02259231|589018518|FG003|Overall Study|Progressive Disease|5|||
163084514|NCT02259231|589018519|FG004|Overall Study|Progressive Disease|4|||
163084515|NCT02259231|589018520|FG005|Overall Study|Progressive Disease|5|||
163084516|NCT02259231|589018521|FG006|Overall Study|Progressive Disease|4|||
163084517|NCT02259231|589018515|FG000|Overall Study|Sponsor termination of study|1|||
163084518|NCT02259231|589018516|FG001|Overall Study|Sponsor termination of study|0|||
163084519|NCT02259231|589018517|FG002|Overall Study|Sponsor termination of study|0|||
163084520|NCT02259231|589018518|FG003|Overall Study|Sponsor termination of study|1|||
163084521|NCT02259231|589018519|FG004|Overall Study|Sponsor termination of study|2|||
163084522|NCT02259231|589018520|FG005|Overall Study|Sponsor termination of study|1|||
163084523|NCT02259231|589018521|FG006|Overall Study|Sponsor termination of study|1|||
163084524|NCT03238196|589018522|FG000|Overall Study|Adverse Event|3|||
163084525|NCT03238196|589018523|FG001|Overall Study|Adverse Event|0|||
163084526|NCT03238196|589018524|FG002|Overall Study|Adverse Event|2|||
163084527|NCT03238196|589018525|FG003|Overall Study|Adverse Event|2|||
163084528|NCT03238196|589018522|FG000|Overall Study|Withdrawal by Subject|4|||
163084529|NCT03238196|589018523|FG001|Overall Study|Withdrawal by Subject|1|||
163084530|NCT03238196|589018524|FG002|Overall Study|Withdrawal by Subject|1|||
163084531|NCT03238196|589018525|FG003|Overall Study|Withdrawal by Subject|0|||
163084532|NCT03238196|589018522|FG000|Overall Study|Disease progression|14|||
163084533|NCT03238196|589018523|FG001|Overall Study|Disease progression|2|||
163084534|NCT03238196|589018524|FG002|Overall Study|Disease progression|3|||
163084535|NCT03238196|589018525|FG003|Overall Study|Disease progression|2|||
163084536|NCT03238196|589018522|FG000|Overall Study|Still on treatment|1|||
163084537|NCT03238196|589018523|FG001|Overall Study|Still on treatment|0|||
163084538|NCT03238196|589018524|FG002|Overall Study|Still on treatment|0|||
163084539|NCT03238196|589018525|FG003|Overall Study|Still on treatment|0|||
163084540|NCT05081843|589018526|FG000|Overall Study|Lost to Follow-up|135|||
163084541|NCT05081843|589018527|FG001|Overall Study|Lost to Follow-up|145|||
163084542|NCT04629196|589018528|FG000|Overall Study|Subject discontinued study drug|1|||
163084543|NCT04629196|589018529|FG001|Overall Study|Subject discontinued study drug|0|||
163084544|NCT04629196|589018528|FG000|Overall Study|Subject study drug dosing increased|1|||
163084545|NCT04629196|589018529|FG001|Overall Study|Subject study drug dosing increased|1|||
163084546|NCT04629196|589018528|FG000|Overall Study|Withdrawal by Subject|1|||
163084547|NCT04629196|589018529|FG001|Overall Study|Withdrawal by Subject|2|||
163084548|NCT00835354|589018533|FG000|First Intervention|Adverse Event|0|||
163084549|NCT00835354|589018534|FG001|First Intervention|Adverse Event|1|||
163084550|NCT02061085|589018535|FG000|Overall Study|Adverse Event|8|||
163084551|NCT05487378|589018536|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
163084552|NCT05487378|589018537|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
163084553|NCT05487378|589018536|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
163084554|NCT05487378|589018537|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
163084555|NCT01385995|589018539|FG000|Period 1, 2 Months|Physician Decision|1|||
163084556|NCT01385995|589018540|FG001|Period 1, 2 Months|Physician Decision|0|||
163084557|NCT02414841|589018541|FG000|Overall Study|Withdrawal by Subject|7|||
163084558|NCT02414841|589018542|FG001|Overall Study|Withdrawal by Subject|5|||
163084559|NCT02414841|589018541|FG000|Overall Study|Lost to Follow-up|13|||
163084560|NCT02414841|589018542|FG001|Overall Study|Lost to Follow-up|6|||
163084561|NCT02414841|589018541|FG000|Overall Study|Death|17|||
163084562|NCT02414841|589018542|FG001|Overall Study|Death|14|||
163084563|NCT02414841|589018541|FG000|Overall Study|Received a Kidney Transplant|13|||
163084564|NCT02414841|589018542|FG001|Overall Study|Received a Kidney Transplant|4|||
163084565|NCT02414841|589018541|FG000|Overall Study|Randomized But Not Treated|6|||
163084566|NCT02414841|589018542|FG001|Overall Study|Randomized But Not Treated|4|||
163084567|NCT03164356|589018547|FG000|Overall Study|Lost to Follow-up|1|||
163084568|NCT03164356|589018548|FG001|Overall Study|Lost to Follow-up|1|||
163084569|NCT03164356|589018549|FG002|Overall Study|Lost to Follow-up|2|||
163084570|NCT03164356|589018550|FG003|Overall Study|Lost to Follow-up|1|||
163084571|NCT03164356|589018547|FG000|Overall Study|Physician Decision|0|||
163084572|NCT03164356|589018548|FG001|Overall Study|Physician Decision|0|||
163084573|NCT03164356|589018549|FG002|Overall Study|Physician Decision|3|||
163084574|NCT03164356|589018550|FG003|Overall Study|Physician Decision|0|||
163084575|NCT03164356|589018547|FG000|Overall Study|Protocol Violation|2|||
163084576|NCT03164356|589018548|FG001|Overall Study|Protocol Violation|1|||
163084577|NCT03164356|589018549|FG002|Overall Study|Protocol Violation|0|||
163084578|NCT03164356|589018550|FG003|Overall Study|Protocol Violation|0|||
163084579|NCT03164356|589018547|FG000|Overall Study|Withdrawal by Subject|1|||
163084580|NCT03164356|589018548|FG001|Overall Study|Withdrawal by Subject|0|||
163084581|NCT03164356|589018549|FG002|Overall Study|Withdrawal by Subject|0|||
163084582|NCT03164356|589018550|FG003|Overall Study|Withdrawal by Subject|0|||
163084583|NCT03164356|589018547|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
163084584|NCT03164356|589018548|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
163084585|NCT03164356|589018549|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
163219697|NCT01752855|589519481|FG001|Overall Study|Withdrew Consent|2|||
163219698|NCT01752855|589519480|FG000|Overall Study|Lack of Efficacy|0|||
163219699|NCT01752855|589519481|FG001|Overall Study|Lack of Efficacy|2|||
163084586|NCT03164356|589018550|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
163084587|NCT03164356|589018547|FG000|Overall Study|Subject Incarcerated|0|||
163084588|NCT03164356|589018548|FG001|Overall Study|Subject Incarcerated|1|||
163084589|NCT03164356|589018549|FG002|Overall Study|Subject Incarcerated|0|||
163084590|NCT03164356|589018550|FG003|Overall Study|Subject Incarcerated|0|||
163084591|NCT03164356|589018547|FG000|Overall Study|Prosthetist unable to participate|0|||
163084592|NCT03164356|589018548|FG001|Overall Study|Prosthetist unable to participate|2|||
163084593|NCT03164356|589018549|FG002|Overall Study|Prosthetist unable to participate|1|||
163084594|NCT03164356|589018550|FG003|Overall Study|Prosthetist unable to participate|0|||
163084595|NCT03648372|589018553|FG000|Overall Study|Withdrawal by Subject|2|||
163084596|NCT03648372|589018554|FG001|Overall Study|Withdrawal by Subject|0|||
163084597|NCT03648372|589018555|FG002|Overall Study|Withdrawal by Subject|0|||
163084598|NCT03648372|589018556|FG003|Overall Study|Withdrawal by Subject|0|||
163084599|NCT03648372|589018557|FG004|Overall Study|Withdrawal by Subject|0|||
163084600|NCT03648372|589018558|FG005|Overall Study|Withdrawal by Subject|1|||
163084601|NCT03648372|589018559|FG006|Overall Study|Withdrawal by Subject|2|||
163084602|NCT03648372|589018560|FG007|Overall Study|Withdrawal by Subject|0|||
163084603|NCT03648372|589018561|FG008|Overall Study|Withdrawal by Subject|0|||
163084604|NCT03648372|589018562|FG009|Overall Study|Withdrawal by Subject|0|||
163084605|NCT03648372|589018563|FG010|Overall Study|Withdrawal by Subject|2|||
163084606|NCT03648372|589018564|FG011|Overall Study|Withdrawal by Subject|0|||
163084607|NCT03648372|589018565|FG012|Overall Study|Withdrawal by Subject|2|||
163084608|NCT03648372|589018566|FG013|Overall Study|Withdrawal by Subject|0|||
163084609|NCT03648372|589018567|FG014|Overall Study|Withdrawal by Subject|0|||
163084610|NCT03648372|589018568|FG015|Overall Study|Withdrawal by Subject|0|||
163084611|NCT03648372|589018569|FG016|Overall Study|Withdrawal by Subject|1|||
163084612|NCT03648372|589018570|FG017|Overall Study|Withdrawal by Subject|0|||
163084613|NCT03648372|589018571|FG018|Overall Study|Withdrawal by Subject|0|||
163084614|NCT03648372|589018572|FG019|Overall Study|Withdrawal by Subject|0|||
163084615|NCT03648372|589018573|FG020|Overall Study|Withdrawal by Subject|0|||
163219700|NCT01478321|589519483|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
163219701|NCT01478321|589519483|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
163084616|NCT03648372|589018553|FG000|Overall Study|Progressive Disease|2|||
163084617|NCT03648372|589018554|FG001|Overall Study|Progressive Disease|3|||
163084618|NCT03648372|589018555|FG002|Overall Study|Progressive Disease|4|||
163084619|NCT03648372|589018556|FG003|Overall Study|Progressive Disease|3|||
163084620|NCT03648372|589018557|FG004|Overall Study|Progressive Disease|2|||
163084621|NCT03648372|589018558|FG005|Overall Study|Progressive Disease|2|||
163084622|NCT03648372|589018559|FG006|Overall Study|Progressive Disease|3|||
163084623|NCT03648372|589018560|FG007|Overall Study|Progressive Disease|3|||
163084624|NCT03648372|589018561|FG008|Overall Study|Progressive Disease|5|||
163084625|NCT03648372|589018562|FG009|Overall Study|Progressive Disease|5|||
163084626|NCT03648372|589018563|FG010|Overall Study|Progressive Disease|2|||
163084627|NCT03648372|589018564|FG011|Overall Study|Progressive Disease|3|||
163084628|NCT03648372|589018565|FG012|Overall Study|Progressive Disease|3|||
163084629|NCT03648372|589018566|FG013|Overall Study|Progressive Disease|3|||
163084630|NCT03648372|589018567|FG014|Overall Study|Progressive Disease|6|||
163084631|NCT03648372|589018568|FG015|Overall Study|Progressive Disease|0|||
163332608|NCT00985088|589929843|FG006|Overall Study|Adverse Event|0|||
163332609|NCT00985088|589929844|FG007|Overall Study|Adverse Event|0|||
163332610|NCT00985088|589929837|FG000|Overall Study|Withdrawal by Subject|4|||
163332611|NCT00985088|589929838|FG001|Overall Study|Withdrawal by Subject|0|||
163332612|NCT00985088|589929839|FG002|Overall Study|Withdrawal by Subject|0|||
163332613|NCT00985088|589929840|FG003|Overall Study|Withdrawal by Subject|1|||
163219702|NCT01478321|589519483|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
163219703|NCT01478321|589519483|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
163219704|NCT01478321|589519483|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
163219705|NCT01478321|589519483|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
163332614|NCT00985088|589929841|FG004|Overall Study|Withdrawal by Subject|3|||
163332615|NCT00985088|589929842|FG005|Overall Study|Withdrawal by Subject|2|||
163219706|NCT01478321|589519483|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
163332616|NCT00985088|589929843|FG006|Overall Study|Withdrawal by Subject|1|||
163332617|NCT00985088|589929844|FG007|Overall Study|Withdrawal by Subject|2|||
163332618|NCT00985088|589929837|FG000|Overall Study|Migrated/moved from study area|0|||
163406461|NCT03311711|590198641|FG006|Overall Study|Lost to Follow-up|1|||
163084632|NCT03648372|589018569|FG016|Overall Study|Progressive Disease|0|||
163084633|NCT03648372|589018570|FG017|Overall Study|Progressive Disease|0|||
163084634|NCT03648372|589018571|FG018|Overall Study|Progressive Disease|0|||
163084635|NCT03648372|589018572|FG019|Overall Study|Progressive Disease|0|||
163084636|NCT03648372|589018573|FG020|Overall Study|Progressive Disease|0|||
163084637|NCT03648372|589018553|FG000|Overall Study|Other|0|||
163084638|NCT03648372|589018554|FG001|Overall Study|Other|0|||
163084639|NCT03648372|589018555|FG002|Overall Study|Other|0|||
163084640|NCT03648372|589018556|FG003|Overall Study|Other|0|||
163084641|NCT03648372|589018557|FG004|Overall Study|Other|1|||
163084642|NCT03648372|589018558|FG005|Overall Study|Other|0|||
163084643|NCT03648372|589018559|FG006|Overall Study|Other|0|||
163084644|NCT03648372|589018560|FG007|Overall Study|Other|0|||
163084645|NCT03648372|589018561|FG008|Overall Study|Other|0|||
163084646|NCT03648372|589018562|FG009|Overall Study|Other|0|||
163084647|NCT03648372|589018563|FG010|Overall Study|Other|1|||
163084648|NCT03648372|589018564|FG011|Overall Study|Other|2|||
163084649|NCT03648372|589018565|FG012|Overall Study|Other|1|||
163084650|NCT03648372|589018566|FG013|Overall Study|Other|3|||
163084651|NCT03648372|589018567|FG014|Overall Study|Other|0|||
163084652|NCT03648372|589018568|FG015|Overall Study|Other|5|||
163084653|NCT03648372|589018569|FG016|Overall Study|Other|1|||
163084654|NCT03648372|589018570|FG017|Overall Study|Other|5|||
163084655|NCT03648372|589018571|FG018|Overall Study|Other|0|||
163084656|NCT03648372|589018572|FG019|Overall Study|Other|1|||
163084657|NCT03648372|589018573|FG020|Overall Study|Other|0|||
163084658|NCT03648372|589018553|FG000|Overall Study|Lost to Follow-up|0|||
163084659|NCT03648372|589018554|FG001|Overall Study|Lost to Follow-up|0|||
163084660|NCT03648372|589018555|FG002|Overall Study|Lost to Follow-up|0|||
163084661|NCT03648372|589018556|FG003|Overall Study|Lost to Follow-up|0|||
163084662|NCT03648372|589018557|FG004|Overall Study|Lost to Follow-up|0|||
163084663|NCT03648372|589018558|FG005|Overall Study|Lost to Follow-up|0|||
163084664|NCT03648372|589018559|FG006|Overall Study|Lost to Follow-up|0|||
163084665|NCT03648372|589018560|FG007|Overall Study|Lost to Follow-up|0|||
163084666|NCT03648372|589018561|FG008|Overall Study|Lost to Follow-up|0|||
163084667|NCT03648372|589018562|FG009|Overall Study|Lost to Follow-up|0|||
163084668|NCT03648372|589018563|FG010|Overall Study|Lost to Follow-up|0|||
163084669|NCT03648372|589018564|FG011|Overall Study|Lost to Follow-up|0|||
163084670|NCT03648372|589018565|FG012|Overall Study|Lost to Follow-up|0|||
163084671|NCT03648372|589018566|FG013|Overall Study|Lost to Follow-up|1|||
163084672|NCT03648372|589018567|FG014|Overall Study|Lost to Follow-up|0|||
163084673|NCT03648372|589018568|FG015|Overall Study|Lost to Follow-up|1|||
163084674|NCT03648372|589018569|FG016|Overall Study|Lost to Follow-up|0|||
163084675|NCT03648372|589018570|FG017|Overall Study|Lost to Follow-up|1|||
163084676|NCT03648372|589018571|FG018|Overall Study|Lost to Follow-up|0|||
163084677|NCT03648372|589018572|FG019|Overall Study|Lost to Follow-up|0|||
163084678|NCT03648372|589018573|FG020|Overall Study|Lost to Follow-up|0|||
163084679|NCT03648372|589018553|FG000|Overall Study|Start of a New Systemic Treatment|0|||
163084680|NCT03648372|589018554|FG001|Overall Study|Start of a New Systemic Treatment|0|||
163084681|NCT03648372|589018555|FG002|Overall Study|Start of a New Systemic Treatment|0|||
163084682|NCT03648372|589018556|FG003|Overall Study|Start of a New Systemic Treatment|0|||
163084683|NCT03648372|589018557|FG004|Overall Study|Start of a New Systemic Treatment|0|||
163084684|NCT03648372|589018558|FG005|Overall Study|Start of a New Systemic Treatment|0|||
163084685|NCT03648372|589018559|FG006|Overall Study|Start of a New Systemic Treatment|0|||
163084686|NCT03648372|589018560|FG007|Overall Study|Start of a New Systemic Treatment|2|||
163084687|NCT03648372|589018561|FG008|Overall Study|Start of a New Systemic Treatment|0|||
163084688|NCT03648372|589018562|FG009|Overall Study|Start of a New Systemic Treatment|0|||
163084689|NCT03648372|589018563|FG010|Overall Study|Start of a New Systemic Treatment|1|||
163084690|NCT03648372|589018564|FG011|Overall Study|Start of a New Systemic Treatment|0|||
163084691|NCT03648372|589018565|FG012|Overall Study|Start of a New Systemic Treatment|0|||
163084692|NCT03648372|589018566|FG013|Overall Study|Start of a New Systemic Treatment|0|||
163084693|NCT03648372|589018567|FG014|Overall Study|Start of a New Systemic Treatment|0|||
163084694|NCT03648372|589018568|FG015|Overall Study|Start of a New Systemic Treatment|0|||
163084695|NCT03648372|589018569|FG016|Overall Study|Start of a New Systemic Treatment|0|||
163084696|NCT03648372|589018570|FG017|Overall Study|Start of a New Systemic Treatment|0|||
163084697|NCT03648372|589018571|FG018|Overall Study|Start of a New Systemic Treatment|0|||
163084698|NCT03648372|589018572|FG019|Overall Study|Start of a New Systemic Treatment|0|||
163084699|NCT03648372|589018573|FG020|Overall Study|Start of a New Systemic Treatment|0|||
163406462|NCT03311711|590198642|FG007|Overall Study|Lost to Follow-up|1|||
163084700|NCT03332056|589020230|FG000|Overall Study|Incomplete questionnaires|8|||
163084701|NCT03332056|589020231|FG001|Overall Study|Incomplete questionnaires|9|||
163084702|NCT03332056|589020230|FG000|Overall Study|Passed stone prior to surgery date|1|||
163084703|NCT03332056|589020231|FG001|Overall Study|Passed stone prior to surgery date|0|||
163084704|NCT03332056|589020230|FG000|Overall Study|Did not require a ureteral stent|0|||
163084705|NCT03332056|589020231|FG001|Overall Study|Did not require a ureteral stent|1|||
163084706|NCT03360344|589020234|FG000|Overall Study|Withdrawal by Subject|0|||
163084707|NCT03360344|589020235|FG001|Overall Study|Withdrawal by Subject|1|||
163084708|NCT03360344|589020236|FG002|Overall Study|Withdrawal by Subject|1|||
163084709|NCT00133705|589020241|FG000|Overall Study|Withdrawal by Subject|2|||
163084710|NCT00133705|589020242|FG001|Overall Study|Withdrawal by Subject|3|||
163084711|NCT00959049|589020243|FG000|Overall Study|Adverse Event|1|||
163084712|NCT00959049|589020244|FG001|Overall Study|Adverse Event|0|||
163084713|NCT00959049|589020245|FG002|Overall Study|Adverse Event|0|||
163084714|NCT00959049|589020246|FG003|Overall Study|Adverse Event|0|||
163084715|NCT00959049|589020247|FG004|Overall Study|Adverse Event|0|||
163084716|NCT00959049|589020248|FG005|Overall Study|Adverse Event|0|||
163084717|NCT00959049|589020243|FG000|Overall Study|Lost to Follow-up|17|||
163084718|NCT00959049|589020244|FG001|Overall Study|Lost to Follow-up|5|||
163084719|NCT00959049|589020245|FG002|Overall Study|Lost to Follow-up|1|||
163084720|NCT00959049|589020246|FG003|Overall Study|Lost to Follow-up|10|||
163084721|NCT00959049|589020247|FG004|Overall Study|Lost to Follow-up|9|||
163084722|NCT00959049|589020248|FG005|Overall Study|Lost to Follow-up|1|||
163084723|NCT00959049|589020243|FG000|Overall Study|Contraindicated medication|0|||
163084724|NCT00959049|589020244|FG001|Overall Study|Contraindicated medication|0|||
163084725|NCT00959049|589020245|FG002|Overall Study|Contraindicated medication|0|||
163084726|NCT00959049|589020246|FG003|Overall Study|Contraindicated medication|1|||
163084727|NCT00959049|589020247|FG004|Overall Study|Contraindicated medication|0|||
163084728|NCT00959049|589020248|FG005|Overall Study|Contraindicated medication|0|||
163084729|NCT00959049|589020243|FG000|Overall Study|Withdrawal by Subject|0|||
163084730|NCT00959049|589020244|FG001|Overall Study|Withdrawal by Subject|2|||
163084731|NCT00959049|589020245|FG002|Overall Study|Withdrawal by Subject|0|||
163084732|NCT00959049|589020246|FG003|Overall Study|Withdrawal by Subject|0|||
163084733|NCT00959049|589020247|FG004|Overall Study|Withdrawal by Subject|0|||
163084734|NCT00959049|589020248|FG005|Overall Study|Withdrawal by Subject|0|||
163084735|NCT00688740|589020256|FG000|Overall Study|Adverse Event|45|||
163084736|NCT00688740|589020257|FG001|Overall Study|Adverse Event|8|||
163084737|NCT00688740|589020256|FG000|Overall Study|Death|2|||
163084738|NCT00688740|589020257|FG001|Overall Study|Death|2|||
163084739|NCT00688740|589020256|FG000|Overall Study|Lost to Follow-up|0|||
163084740|NCT00688740|589020257|FG001|Overall Study|Lost to Follow-up|1|||
163084741|NCT00688740|589020256|FG000|Overall Study|Consent Withdrawn|17|||
163084742|NCT00688740|589020257|FG001|Overall Study|Consent Withdrawn|17|||
163084743|NCT00688740|589020256|FG000|Overall Study|Breast Cancer Relapse|1|||
163084744|NCT00688740|589020257|FG001|Overall Study|Breast Cancer Relapse|4|||
163084745|NCT00688740|589020256|FG000|Overall Study|Violation of Inclusion Criteria|1|||
163084746|NCT00688740|589020257|FG001|Overall Study|Violation of Inclusion Criteria|3|||
163084747|NCT04484857|589020258|FG000|Overall Study|Adverse Event|2|||
163084748|NCT04484857|589020258|FG000|Overall Study|Death|10|||
163084749|NCT04484857|589020258|FG000|Overall Study|Withdrawal by Subject|3|||
163084750|NCT04484857|589020258|FG000|Overall Study|Transferred/Relocation|5|||
163084751|NCT04484857|589020258|FG000|Overall Study|Kidney Transplant|7|||
163084752|NCT04484857|589020258|FG000|Overall Study|Other than specified|4|||
163084753|NCT04484857|589020258|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
163084754|NCT00565747|589020259|FG000|Overall Study|No embryo transfer|67|||
163084755|NCT00565747|589020260|FG001|Overall Study|No embryo transfer|73|||
163084756|NCT04507204|589020261|FG000|Overall Study|Adverse Event|8|||
163084757|NCT04507204|589020262|FG001|Overall Study|Adverse Event|13|||
163084758|NCT04507204|589020261|FG000|Overall Study|Death|0|||
163084759|NCT04507204|589020262|FG001|Overall Study|Death|1|||
163084760|NCT04507204|589020261|FG000|Overall Study|Lost to Follow-up|15|||
163084761|NCT04507204|589020262|FG001|Overall Study|Lost to Follow-up|14|||
163084762|NCT04507204|589020261|FG000|Overall Study|Poor Compliance with Protocol|2|||
163084763|NCT04507204|589020262|FG001|Overall Study|Poor Compliance with Protocol|4|||
163084764|NCT04507204|589020261|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
163084765|NCT04507204|589020262|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
163084766|NCT04507204|589020261|FG000|Overall Study|Withdrawal of Patient Consent|21|||
163084767|NCT04507204|589020262|FG001|Overall Study|Withdrawal of Patient Consent|13|||
163084768|NCT01206517|589020263|FG000|Overall Study|Withdrawal by Subject|0|||
163084769|NCT01206517|589020264|FG001|Overall Study|Withdrawal by Subject|0|||
163084770|NCT01206517|589020265|FG002|Overall Study|Withdrawal by Subject|2|||
163084771|NCT01206517|589020266|FG003|Overall Study|Withdrawal by Subject|0|||
163084772|NCT01206517|589020267|FG004|Overall Study|Withdrawal by Subject|1|||
163084773|NCT01206517|589020268|FG005|Overall Study|Withdrawal by Subject|0|||
163084774|NCT01905540|589020271|FG000|Period 3|Other|1|||
163084775|NCT01905540|589020272|FG001|Period 3|Other|0|||
163084776|NCT01905540|589020273|FG002|Period 3|Other|1|||
163084777|NCT01905540|589020274|FG003|Period 3|Other|1|||
163084778|NCT03729609|589020275|FG000|Overall Study|Protocol Violation|1|||
163084779|NCT04770285|589020278|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
163084780|NCT04770285|589020279|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
163084781|NCT04770285|589020278|FG000|Overall Study|Lack of Efficacy|0|||
163084782|NCT04770285|589020279|FG001|Overall Study|Lack of Efficacy|1|||
163084783|NCT04770285|589020278|FG000|Overall Study|Lost to Follow-up|11|||
163084784|NCT04770285|589020279|FG001|Overall Study|Lost to Follow-up|8|||
163219707|NCT01478321|589519483|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
163219708|NCT00314574|589519484|FG000|Overall Study|Death|3|||
163084785|NCT04770285|589020278|FG000|Overall Study|Protocol Deviation|6|||
163084786|NCT04770285|589020279|FG001|Overall Study|Protocol Deviation|6|||
163084787|NCT04770285|589020278|FG000|Overall Study|Technical Problem|0|||
163084788|NCT04770285|589020279|FG001|Overall Study|Technical Problem|1|||
163084789|NCT04770285|589020278|FG000|Overall Study|Withdrawal by Subject|9|||
163084790|NCT04770285|589020279|FG001|Overall Study|Withdrawal by Subject|8|||
163084791|NCT04770285|589020278|FG000|Overall Study|Reason Not Specified|0|||
163084792|NCT04770285|589020279|FG001|Overall Study|Reason Not Specified|1|||
163084793|NCT00645658|589020280|FG000|Overall Study|Withdrawal by Subject|1|||
163084794|NCT00645658|589020281|FG001|Overall Study|Withdrawal by Subject|0|||
163084795|NCT00645658|589020280|FG000|Overall Study|Did not complete all assesments|0|||
163332619|NCT00985088|589929838|FG001|Overall Study|Migrated/moved from study area|0|||
163332620|NCT00985088|589929839|FG002|Overall Study|Migrated/moved from study area|1|||
163332621|NCT00985088|589929840|FG003|Overall Study|Migrated/moved from study area|0|||
163332622|NCT00985088|589929841|FG004|Overall Study|Migrated/moved from study area|0|||
163332623|NCT00985088|589929842|FG005|Overall Study|Migrated/moved from study area|0|||
163332624|NCT00985088|589929843|FG006|Overall Study|Migrated/moved from study area|0|||
163332625|NCT00985088|589929844|FG007|Overall Study|Migrated/moved from study area|1|||
163332626|NCT00985088|589929837|FG000|Overall Study|Lost to Follow-up|6|||
163332627|NCT00985088|589929838|FG001|Overall Study|Lost to Follow-up|1|||
163332628|NCT00985088|589929839|FG002|Overall Study|Lost to Follow-up|2|||
163332629|NCT00985088|589929840|FG003|Overall Study|Lost to Follow-up|6|||
163332630|NCT00985088|589929841|FG004|Overall Study|Lost to Follow-up|6|||
163332631|NCT00985088|589929842|FG005|Overall Study|Lost to Follow-up|5|||
163332632|NCT00985088|589929843|FG006|Overall Study|Lost to Follow-up|3|||
163332633|NCT00985088|589929844|FG007|Overall Study|Lost to Follow-up|2|||
163332634|NCT01970878|589929846|FG000|Overall Study|Withdrawal by Subject|11|||
163332635|NCT01970878|589929847|FG001|Overall Study|Withdrawal by Subject|10|||
163332636|NCT01970878|589929848|FG002|Overall Study|Withdrawal by Subject|14|||
163332637|NCT01970878|589929849|FG003|Overall Study|Withdrawal by Subject|7|||
163332638|NCT01970878|589929846|FG000|Overall Study|Lost to Follow-up|1|||
163332639|NCT01970878|589929847|FG001|Overall Study|Lost to Follow-up|3|||
163332640|NCT01970878|589929848|FG002|Overall Study|Lost to Follow-up|2|||
163332641|NCT01970878|589929849|FG003|Overall Study|Lost to Follow-up|4|||
163332642|NCT01970878|589929846|FG000|Overall Study|Administrative Reasons|1|||
163332643|NCT01970878|589929847|FG001|Overall Study|Administrative Reasons|0|||
163332644|NCT01970878|589929848|FG002|Overall Study|Administrative Reasons|0|||
163332645|NCT01970878|589929849|FG003|Overall Study|Administrative Reasons|4|||
163332646|NCT01970878|589929846|FG000|Overall Study|Lack of Efficacy|2|||
163332647|NCT01970878|589929847|FG001|Overall Study|Lack of Efficacy|1|||
163332648|NCT01970878|589929848|FG002|Overall Study|Lack of Efficacy|2|||
163332649|NCT01970878|589929849|FG003|Overall Study|Lack of Efficacy|0|||
163332650|NCT01970878|589929846|FG000|Overall Study|Adverse Event|12|||
163332651|NCT01970878|589929847|FG001|Overall Study|Adverse Event|7|||
163332652|NCT01970878|589929848|FG002|Overall Study|Adverse Event|4|||
163332653|NCT01970878|589929849|FG003|Overall Study|Adverse Event|3|||
163084796|NCT00645658|589020281|FG001|Overall Study|Did not complete all assesments|2|||
163084797|NCT02457065|589020288|FG000|Overall Study|Lost to Follow-up|9|||
163084798|NCT02457065|589020289|FG001|Overall Study|Lost to Follow-up|11|||
163084799|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
163084800|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
163084801|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
163084802|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
163084803|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
163084804|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
163084805|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
163084806|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
163084807|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
163084808|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
163084809|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
163084810|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
163084811|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
163084812|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
163084813|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
163084814|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
163084815|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
163084816|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
163084817|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
163084818|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
163084819|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
163084820|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
163332654|NCT01970878|589929846|FG000|Overall Study|Protocol Specified Criteria|10|||
163332655|NCT01970878|589929847|FG001|Overall Study|Protocol Specified Criteria|4|||
163084821|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
163084822|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
163332656|NCT01970878|589929848|FG002|Overall Study|Protocol Specified Criteria|3|||
163332657|NCT01970878|589929849|FG003|Overall Study|Protocol Specified Criteria|6|||
163332658|NCT01970878|589929846|FG000|Overall Study|Physician Decision|0|||
163406463|NCT03311711|590198643|FG008|Overall Study|Lost to Follow-up|0|||
163332659|NCT01970878|589929847|FG001|Overall Study|Physician Decision|1|||
163332660|NCT01970878|589929848|FG002|Overall Study|Physician Decision|1|||
163332661|NCT01970878|589929849|FG003|Overall Study|Physician Decision|0|||
163332662|NCT01970878|589929846|FG000|Overall Study|No Completion Status|0|||
163332663|NCT01970878|589929847|FG001|Overall Study|No Completion Status|1|||
163332664|NCT01970878|589929848|FG002|Overall Study|No Completion Status|0|||
163406464|NCT03311711|590198644|FG009|Overall Study|Lost to Follow-up|0|||
163332665|NCT01970878|589929849|FG003|Overall Study|No Completion Status|0|||
163332666|NCT02014402|589929850|FG000|Overall Study|Adverse Event|1|||
163332667|NCT02014402|589929851|FG001|Overall Study|Adverse Event|0|||
163332668|NCT02014402|589929852|FG002|Overall Study|Adverse Event|0|||
163332669|NCT02014402|589929853|FG003|Overall Study|Adverse Event|0|||
163332670|NCT02014402|589929850|FG000|Overall Study|Withdrawal by Subject|1|||
163332671|NCT02014402|589929851|FG001|Overall Study|Withdrawal by Subject|2|||
163332672|NCT02014402|589929852|FG002|Overall Study|Withdrawal by Subject|2|||
163332673|NCT02014402|589929853|FG003|Overall Study|Withdrawal by Subject|1|||
163332674|NCT02014402|589929850|FG000|Overall Study|Subject did not have transportation|0|||
163332675|NCT02014402|589929851|FG001|Overall Study|Subject did not have transportation|1|||
163332676|NCT02014402|589929852|FG002|Overall Study|Subject did not have transportation|0|||
163332677|NCT02014402|589929853|FG003|Overall Study|Subject did not have transportation|0|||
163332678|NCT02014402|589929850|FG000|Overall Study|Lost to Follow-up|0|||
163332679|NCT02014402|589929851|FG001|Overall Study|Lost to Follow-up|0|||
163332680|NCT02014402|589929852|FG002|Overall Study|Lost to Follow-up|1|||
163332681|NCT02014402|589929853|FG003|Overall Study|Lost to Follow-up|2|||
163332682|NCT04992273|589929857|FG000|Overall Study|Lost to Follow-up|0|||
163332683|NCT04992273|589929858|FG001|Overall Study|Lost to Follow-up|1|||
163332684|NCT01364597|589929859|FG000|Overall Study|Adverse Event|4|||
163332685|NCT01364597|589929860|FG001|Overall Study|Adverse Event|5|||
163332686|NCT01364597|589929861|FG002|Overall Study|Adverse Event|16|||
163084823|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
163084824|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
163084825|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
163084826|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
163084827|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
163084828|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
163084829|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
163084830|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
163084831|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
163084832|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
163084833|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
163084834|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
163084835|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
163084836|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
163084837|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
163084838|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
163084839|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
163084840|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
163084841|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
163084842|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
163084843|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
163084844|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
163084845|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
163084846|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
163084847|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
163084848|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
163084849|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
163084850|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
163084851|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
163084852|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
163084853|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
163084854|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
163084855|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Death on study|0|||
163084856|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Death on study|0|||
163084857|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Death on study|0|||
163084858|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Death on study|1|||
163332687|NCT01364597|589929862|FG003|Overall Study|Adverse Event|7|||
163332688|NCT01364597|589929859|FG000|Overall Study|Lack of Efficacy|4|||
163084859|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Death on study|0|||
163084860|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Death on study|0|||
163084861|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Death on study|0|||
163084862|NCT01362790|589020290|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
163084863|NCT01362790|589020291|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
163219709|NCT00314574|589519485|FG001|Overall Study|Death|0|||
163219710|NCT00314574|589519484|FG000|Overall Study|Adverse Event|11|||
163219711|NCT00314574|589519485|FG001|Overall Study|Adverse Event|16|||
163219712|NCT00314574|589519484|FG000|Overall Study|Lost to Follow-up|19|||
163219713|NCT00314574|589519485|FG001|Overall Study|Lost to Follow-up|25|||
163219714|NCT00314574|589519484|FG000|Overall Study|Withdrawal by Subject|33|||
163219715|NCT00314574|589519485|FG001|Overall Study|Withdrawal by Subject|22|||
163219716|NCT00314574|589519484|FG000|Overall Study|Physician Decision|22|||
163406465|NCT03311711|590198635|FG000|Overall Study|Withdrawal by Subject|1|||
163406466|NCT03311711|590198636|FG001|Overall Study|Withdrawal by Subject|1|||
163406467|NCT03311711|590198637|FG002|Overall Study|Withdrawal by Subject|0|||
163406468|NCT03311711|590198638|FG003|Overall Study|Withdrawal by Subject|0|||
163406469|NCT03311711|590198639|FG004|Overall Study|Withdrawal by Subject|0|||
163406470|NCT03311711|590198640|FG005|Overall Study|Withdrawal by Subject|0|||
163406471|NCT03311711|590198641|FG006|Overall Study|Withdrawal by Subject|3|||
163406472|NCT03311711|590198642|FG007|Overall Study|Withdrawal by Subject|3|||
163084864|NCT01362790|589020292|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
163084865|NCT01362790|589020293|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
163084866|NCT01362790|589020294|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
163084867|NCT01362790|589020295|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
163084868|NCT01362790|589020296|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
163084869|NCT01362790|589020290|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
163084870|NCT01362790|589020291|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
163084871|NCT01362790|589020292|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
163084872|NCT01362790|589020293|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
163084873|NCT01362790|589020294|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
163084874|NCT01362790|589020295|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
163084875|NCT01362790|589020296|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
163084876|NCT01362790|589020290|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
163084877|NCT01362790|589020291|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
163084878|NCT01362790|589020292|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
163084879|NCT01362790|589020293|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
163084880|NCT01362790|589020294|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
163084881|NCT01362790|589020295|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
163084882|NCT01362790|589020296|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
163084883|NCT03038087|589020297|FG000|Overall Study|lost data|1|||
163084884|NCT00654355|589020298|FG000|Overall Study|Lost to Follow-up|2|||
163084885|NCT00654355|589020299|FG001|Overall Study|Lost to Follow-up|2|||
163084886|NCT01435356|589020301|FG000|Overall Study|Adverse Event|2|||
163084887|NCT01435356|589020302|FG001|Overall Study|Adverse Event|0|||
163084888|NCT01435356|589020301|FG000|Overall Study|Disease progression/recurrence|17|||
163084889|NCT01435356|589020302|FG001|Overall Study|Disease progression/recurrence|10|||
163084890|NCT01435356|589020301|FG000|Overall Study|Protocol Violation|0|||
163084891|NCT01435356|589020302|FG001|Overall Study|Protocol Violation|1|||
163084892|NCT01435356|589020301|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
163084893|NCT01435356|589020302|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
163084894|NCT01435356|589020301|FG000|Overall Study|Withdrawal by Subject|1|||
163084895|NCT01435356|589020302|FG001|Overall Study|Withdrawal by Subject|1|||
163084896|NCT01435356|589020301|FG000|Overall Study|Facial palsy|1|||
163084897|NCT01435356|589020302|FG001|Overall Study|Facial palsy|0|||
163084898|NCT01435356|589020301|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
163084899|NCT01435356|589020302|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
163084900|NCT01435356|589020301|FG000|Overall Study|Physician Decision|1|||
163084901|NCT01435356|589020302|FG001|Overall Study|Physician Decision|0|||
163084902|NCT01435356|589020301|FG000|Overall Study|Patient decision|3|||
163084903|NCT01435356|589020302|FG001|Overall Study|Patient decision|0|||
163084904|NCT01435356|589020301|FG000|Overall Study|Patient moved to another city|1|||
163084905|NCT01435356|589020302|FG001|Overall Study|Patient moved to another city|1|||
163084906|NCT02796651|589020303|FG000|Overall Study|Adverse Event|6|||
163084907|NCT02796651|589020303|FG000|Overall Study|Lost to Follow-up|1|||
163084908|NCT02796651|589020303|FG000|Overall Study|Withdrawal by Subject|4|||
163084909|NCT02796651|589020303|FG000|Overall Study|Protocol Violation|4|||
163084910|NCT02796651|589020303|FG000|Overall Study|Lack of Efficacy|1|||
163084911|NCT02796651|589020303|FG000|Overall Study|Other|10|||
163084912|NCT05360784|589020304|FG000|Overall Study|Discontinued|25|||
163084913|NCT05360784|589020305|FG001|Overall Study|Discontinued|11|||
163219717|NCT00314574|589519485|FG001|Overall Study|Physician Decision|15|||
163219718|NCT00314574|589519484|FG000|Overall Study|Pregnancy|6|||
163219719|NCT00314574|589519485|FG001|Overall Study|Pregnancy|4|||
163219720|NCT00314574|589519484|FG000|Overall Study|Data unknown at database lock|0|||
163219721|NCT00314574|589519485|FG001|Overall Study|Data unknown at database lock|1|||
163219722|NCT02053753|589519486|FG000|Overall Study|Withdrawal by Subject|2|||
163219723|NCT02053753|589519487|FG001|Overall Study|Withdrawal by Subject|4|||
163219724|NCT02053753|589519486|FG000|Overall Study|Decision by Sponsor|1|||
163219725|NCT02053753|589519487|FG001|Overall Study|Decision by Sponsor|1|||
163219726|NCT02053753|589519486|FG000|Overall Study|Lost to Follow-up|4|||
163219727|NCT02053753|589519487|FG001|Overall Study|Lost to Follow-up|3|||
163219728|NCT02439320|589519488|FG000|Overall Study|Adverse Event|0|||
163219729|NCT02439320|589519489|FG001|Overall Study|Adverse Event|2|||
163219730|NCT02439320|589519490|FG002|Overall Study|Adverse Event|0|||
163219731|NCT02439320|589519488|FG000|Overall Study|Lost to Follow-up|37|||
163219732|NCT02439320|589519489|FG001|Overall Study|Lost to Follow-up|34|||
163084914|NCT00437073|589020306|FG000|Overall Study|Sponsor Terminated Study|1|||
163084915|NCT00437073|589020307|FG001|Overall Study|Sponsor Terminated Study|0|||
163084916|NCT00437073|589020306|FG000|Overall Study|Physician Decision|0|||
163084917|NCT00437073|589020307|FG001|Overall Study|Physician Decision|1|||
163084918|NCT03485157|589020308|FG000|Double Blind Phase|Lost to Follow-up|4|||
163084919|NCT03485157|589020309|FG001|Double Blind Phase|Lost to Follow-up|4|||
163084920|NCT03485157|589020308|FG000|Double Blind Phase|Adverse Event|2|||
163084921|NCT03485157|589020309|FG001|Double Blind Phase|Adverse Event|1|||
163084922|NCT03485157|589020308|FG000|Double Blind Phase|Withdrawal by Subject|6|||
163084923|NCT03485157|589020309|FG001|Double Blind Phase|Withdrawal by Subject|9|||
163084924|NCT03485157|589020308|FG000|Double Blind Phase|Removal by PI|3|||
163084925|NCT03485157|589020309|FG001|Double Blind Phase|Removal by PI|7|||
163084926|NCT03485157|589020308|FG000|Open Label Phase|Lost to Follow-up|1|||
163084927|NCT03485157|589020309|FG001|Open Label Phase|Lost to Follow-up|2|||
163084928|NCT03485157|589020308|FG000|Open Label Phase|Adverse Event|0|||
163084929|NCT03485157|589020309|FG001|Open Label Phase|Adverse Event|1|||
163084930|NCT03485157|589020308|FG000|Open Label Phase|Withdrawal by Subject|1|||
163084931|NCT03485157|589020309|FG001|Open Label Phase|Withdrawal by Subject|2|||
163084932|NCT03485157|589020308|FG000|Open Label Phase|Removal by PI|2|||
163084933|NCT03485157|589020309|FG001|Open Label Phase|Removal by PI|0|||
163084934|NCT04918771|589020310|FG000|Overall Study|Withdrawal by Subject|4|||
163084935|NCT04918771|589020311|FG001|Overall Study|Withdrawal by Subject|5|||
163084936|NCT04918771|589020310|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
163084937|NCT04918771|589020311|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
163084938|NCT02971163|589020312|FG000|Overall Study|Lost to Follow-up|4|||
163084939|NCT02971163|589020313|FG001|Overall Study|Lost to Follow-up|2|||
163084940|NCT01849276|589020314|FG000|Followed for Survival for 5 Years|Death|1|||
163084941|NCT01849276|589020314|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
163084942|NCT02657343|589020317|FG000|Overall Study|Death|0|||
163084943|NCT02657343|589020318|FG001|Overall Study|Death|2|||
163084944|NCT02657343|589020319|FG002|Overall Study|Death|0|||
163084945|NCT02657343|589020320|FG003|Overall Study|Death|0|||
163084946|NCT02657343|589020321|FG004|Overall Study|Death|0|||
163084947|NCT02657343|589020322|FG005|Overall Study|Death|0|||
163084948|NCT02657343|589020317|FG000|Overall Study|Patient went to hospice|1|||
163084949|NCT02657343|589020318|FG001|Overall Study|Patient went to hospice|0|||
163084950|NCT02657343|589020319|FG002|Overall Study|Patient went to hospice|0|||
163084951|NCT02657343|589020320|FG003|Overall Study|Patient went to hospice|0|||
163084952|NCT02657343|589020321|FG004|Overall Study|Patient went to hospice|0|||
163084953|NCT02657343|589020322|FG005|Overall Study|Patient went to hospice|0|||
163084954|NCT02657343|589020317|FG000|Overall Study|Withdrawal by Subject|0|||
163084955|NCT02657343|589020318|FG001|Overall Study|Withdrawal by Subject|0|||
163084956|NCT02657343|589020319|FG002|Overall Study|Withdrawal by Subject|0|||
163084957|NCT02657343|589020320|FG003|Overall Study|Withdrawal by Subject|0|||
163084958|NCT02657343|589020321|FG004|Overall Study|Withdrawal by Subject|1|||
163084959|NCT02657343|589020322|FG005|Overall Study|Withdrawal by Subject|0|||
163084960|NCT01813357|589020329|FG000|Overall Study|Lost to Follow-up|5|||
163084961|NCT01813357|589020330|FG001|Overall Study|Lost to Follow-up|6|||
163084962|NCT02607722|589020342|FG000|Overall Study|No data reliability|1|||
163084963|NCT02607722|589020342|FG000|Overall Study|no patient visit|18|||
163084964|NCT02607722|589020342|FG000|Overall Study|missing info in CRF|13|||
163084965|NCT02607722|589020342|FG000|Overall Study|Withdrawal by Subject|616|||
163084966|NCT02607722|589020342|FG000|Overall Study|Lost to Follow-up|312|||
163084967|NCT02607722|589020342|FG000|Overall Study|Improved|22|||
163084968|NCT02607722|589020342|FG000|Overall Study|Lack of Efficacy|316|||
163084969|NCT02607722|589020342|FG000|Overall Study|Adverse Event|2553|||
163084970|NCT02607722|589020342|FG000|Overall Study|Not treated|1|||
163084971|NCT02607722|589020342|FG000|Overall Study|No CRF collected|138|||
163084972|NCT02607722|589020342|FG000|Overall Study|without CRF|4225|||
163084973|NCT02607722|589020342|FG000|Overall Study|Physician Decision|367|||
163084974|NCT04347538|589020343|FG000|Overall Study|Lost to Follow-up|4|||
163084975|NCT04347538|589020344|FG001|Overall Study|Lost to Follow-up|5|||
163084976|NCT04347538|589020345|FG002|Overall Study|Lost to Follow-up|7|||
163084977|NCT02871219|589020346|FG000|Overall Study|Adverse Event|15|||
163084978|NCT02871219|589020346|FG000|Overall Study|Death|3|||
163084979|NCT02871219|589020346|FG000|Overall Study|Progression|3|||
163084980|NCT02871219|589020346|FG000|Overall Study|Infections|7|||
163084981|NCT02871219|589020346|FG000|Overall Study|Infusion Related|4|||
163084982|NCT04938427|589020347|FG000|Overall Study|Adverse Event|5|||
163084983|NCT04938427|589020348|FG001|Overall Study|Adverse Event|19|||
163084984|NCT04938427|589020347|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
163084985|NCT04938427|589020348|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163084986|NCT04938427|589020347|FG000|Overall Study|Withdrawal by Subject|1|||
163084987|NCT04938427|589020348|FG001|Overall Study|Withdrawal by Subject|0|||
163084988|NCT04938427|589020347|FG000|Overall Study|Reason Not Specified|2|||
163084989|NCT04938427|589020348|FG001|Overall Study|Reason Not Specified|1|||
163084990|NCT01107496|589020354|FG000|Overall Study|Adverse Event|1|||
163084991|NCT01107496|589020355|FG001|Overall Study|Adverse Event|0|||
163084992|NCT01107496|589020354|FG000|Overall Study|Lack of Efficacy|1|||
163084993|NCT01107496|589020355|FG001|Overall Study|Lack of Efficacy|0|||
163030194|NCT00783224|588813803|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
163030195|NCT00783224|588813804|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
163030196|NCT00783224|588813801|FG000|Overall Study|Inappropriate as a study subject|0|||
163030197|NCT00783224|588813802|FG001|Overall Study|Inappropriate as a study subject|0|||
163030198|NCT00783224|588813803|FG002|Overall Study|Inappropriate as a study subject|0|||
163030199|NCT00783224|588813804|FG003|Overall Study|Inappropriate as a study subject|1|||
163030200|NCT03422159|588813805|FG000|Overall Study|Exclusion due to terminal disease|2|||
163030201|NCT03422159|588813806|FG001|Overall Study|Exclusion due to terminal disease|1|||
163030202|NCT04631107|588813807|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
163030203|NCT04631107|588813807|FG000|Second Intervention (1 Night)|Adverse Event|1|||
163030204|NCT04631107|588813807|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
163030205|NCT04631107|588813807|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
163030206|NCT00087126|588813811|FG000|Overall Study|Ineligible - second primary|1|||
163030207|NCT00087126|588813811|FG000|Overall Study|Never treated|1|||
163030208|NCT01432275|588813812|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
163030209|NCT01432275|588813813|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
163030210|NCT01432275|588813812|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
163030211|NCT01432275|588813813|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
163030212|NCT01432275|588813812|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
163030213|NCT01432275|588813813|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
163030214|NCT01432275|588813812|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
163030215|NCT01432275|588813813|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
163030216|NCT01432275|588813812|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
163030217|NCT01432275|588813813|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
163030218|NCT01432275|588813812|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
163030219|NCT01432275|588813813|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
163030220|NCT01432275|588813812|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
163030221|NCT01432275|588813813|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
163030222|NCT01432275|588813812|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
163030223|NCT01432275|588813813|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
163030224|NCT01432275|588813812|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
163030225|NCT01432275|588813813|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
163030226|NCT01935700|588813818|FG000|Overall Study|Withdrawal by Subject|1|||
163030227|NCT01935700|588813819|FG001|Overall Study|Withdrawal by Subject|0|||
163030228|NCT01935700|588813818|FG000|Overall Study|Physician Decision|4|||
163030229|NCT01935700|588813819|FG001|Overall Study|Physician Decision|0|||
163030230|NCT01935128|588813822|FG000|Overall Study|Death|1|||
163030231|NCT01935128|588813822|FG000|Overall Study|Adverse Event|6|||
163030232|NCT00096993|588813823|FG000|Overall Study|Death|1|||
163030233|NCT00096993|588813824|FG001|Overall Study|Death|0|||
163030234|NCT00096993|588813823|FG000|Overall Study|Disease progression|56|||
163030235|NCT00096993|588813824|FG001|Overall Study|Disease progression|53|||
163030236|NCT00096993|588813823|FG000|Overall Study|Adverse Event|2|||
163030237|NCT00096993|588813824|FG001|Overall Study|Adverse Event|8|||
163030238|NCT00096993|588813823|FG000|Overall Study|Subject's decision|3|||
163030239|NCT00096993|588813824|FG001|Overall Study|Subject's decision|1|||
163030240|NCT00096993|588813823|FG000|Overall Study|Physician Decision|2|||
163030241|NCT00096993|588813824|FG001|Overall Study|Physician Decision|1|||
163030242|NCT00096993|588813823|FG000|Overall Study|Non-compliance|0|||
163030243|NCT00096993|588813824|FG001|Overall Study|Non-compliance|1|||
163030244|NCT00096993|588813823|FG000|Overall Study|Other unspecified|1|||
163030245|NCT00096993|588813824|FG001|Overall Study|Other unspecified|1|||
163030246|NCT01438814|588813826|FG000|Overall Study|Adverse Event|3|||
163030247|NCT01438814|588813827|FG001|Overall Study|Adverse Event|3|||
163332689|NCT01364597|589929860|FG001|Overall Study|Lack of Efficacy|4|||
163030248|NCT01438814|588813826|FG000|Overall Study|Protocol Violation|1|||
163030249|NCT01438814|588813827|FG001|Overall Study|Protocol Violation|2|||
163030250|NCT01438814|588813826|FG000|Overall Study|Lost to Follow-up|4|||
163084994|NCT01107496|589020354|FG000|Overall Study|Protocol Violation|0|||
163332690|NCT01364597|589929861|FG002|Overall Study|Lack of Efficacy|23|||
163030251|NCT01438814|588813827|FG001|Overall Study|Lost to Follow-up|3|||
163030252|NCT01438814|588813826|FG000|Overall Study|Withdrawal by Subject|4|||
163030253|NCT01438814|588813827|FG001|Overall Study|Withdrawal by Subject|2|||
163030254|NCT01438814|588813826|FG000|Overall Study|Other|2|||
163030255|NCT01438814|588813827|FG001|Overall Study|Other|4|||
163084995|NCT01107496|589020355|FG001|Overall Study|Protocol Violation|1|||
163030256|NCT01739764|588813828|FG000|Overall Study|Adverse Event|0|||
163030257|NCT01739764|588813829|FG001|Overall Study|Adverse Event|3|||
163030258|NCT01739764|588813830|FG002|Overall Study|Adverse Event|4|||
163030259|NCT01739764|588813828|FG000|Overall Study|Death|4|||
163030260|NCT01739764|588813829|FG001|Overall Study|Death|6|||
163084996|NCT01107496|589020354|FG000|Overall Study|Lost to Follow-up|0|||
163084997|NCT01107496|589020355|FG001|Overall Study|Lost to Follow-up|1|||
163030261|NCT01739764|588813830|FG002|Overall Study|Death|38|||
163030262|NCT01739764|588813828|FG000|Overall Study|Lost to Follow-up|0|||
163030263|NCT01739764|588813829|FG001|Overall Study|Lost to Follow-up|0|||
163030264|NCT01739764|588813830|FG002|Overall Study|Lost to Follow-up|5|||
163030265|NCT01739764|588813828|FG000|Overall Study|Non-Compliance|0|||
163030266|NCT01739764|588813829|FG001|Overall Study|Non-Compliance|0|||
163030267|NCT01739764|588813830|FG002|Overall Study|Non-Compliance|1|||
163030268|NCT01739764|588813828|FG000|Overall Study|Multiple Reasons|3|||
163030269|NCT01739764|588813829|FG001|Overall Study|Multiple Reasons|2|||
163030270|NCT01739764|588813830|FG002|Overall Study|Multiple Reasons|3|||
163030271|NCT01739764|588813828|FG000|Overall Study|Physician Decision|2|||
163030272|NCT01739764|588813829|FG001|Overall Study|Physician Decision|2|||
163030273|NCT01739764|588813830|FG002|Overall Study|Physician Decision|4|||
163030274|NCT01739764|588813828|FG000|Overall Study|Progressive Disease|3|||
163030275|NCT01739764|588813829|FG001|Overall Study|Progressive Disease|5|||
163030276|NCT01739764|588813830|FG002|Overall Study|Progressive Disease|16|||
163030277|NCT01739764|588813828|FG000|Overall Study|Protocol Violation|0|||
163030278|NCT01739764|588813829|FG001|Overall Study|Protocol Violation|0|||
163030279|NCT01739764|588813830|FG002|Overall Study|Protocol Violation|2|||
163030280|NCT01739764|588813828|FG000|Overall Study|Study Terminated by Sponsor|8|||
163030281|NCT01739764|588813829|FG001|Overall Study|Study Terminated by Sponsor|13|||
163030282|NCT01739764|588813830|FG002|Overall Study|Study Terminated by Sponsor|26|||
163030283|NCT01739764|588813828|FG000|Overall Study|Withdrawal by Subject|6|||
163030284|NCT01739764|588813829|FG001|Overall Study|Withdrawal by Subject|5|||
163030285|NCT01739764|588813830|FG002|Overall Study|Withdrawal by Subject|27|||
163030286|NCT00404924|588813831|FG000|Overall Study|Adverse Event|75|||
163030287|NCT00404924|588813832|FG001|Overall Study|Adverse Event|16|||
163030288|NCT00404924|588813831|FG000|Overall Study|Condition under investigation worsened|475|||
163030289|NCT00404924|588813832|FG001|Overall Study|Condition under investigation worsened|264|||
163030290|NCT00404924|588813831|FG000|Overall Study|Lost to Follow-up|1|||
163030291|NCT00404924|588813832|FG001|Overall Study|Lost to Follow-up|1|||
163219733|NCT02439320|589519490|FG002|Overall Study|Lost to Follow-up|42|||
163219734|NCT02439320|589519488|FG000|Overall Study|Death|0|||
163219735|NCT02439320|589519489|FG001|Overall Study|Death|1|||
163030292|NCT00404924|588813831|FG000|Overall Study|Withdrawal by Subject|26|||
163030293|NCT00404924|588813832|FG001|Overall Study|Withdrawal by Subject|13|||
163030294|NCT00404924|588813831|FG000|Overall Study|Other|25|||
163030295|NCT00404924|588813832|FG001|Overall Study|Other|11|||
163030296|NCT00404924|588813831|FG000|Overall Study|Randomised but not received treatment|1|||
163030297|NCT00404924|588813832|FG001|Overall Study|Randomised but not received treatment|1|||
163030298|NCT00513357|588813837|FG000|Overall Study|did not receive allocated placebo|2|||
163030299|NCT00513357|588813838|FG001|Overall Study|did not receive allocated placebo|3|||
163030300|NCT00513357|588813837|FG000|Overall Study|Adverse Event|4|||
163030301|NCT00513357|588813838|FG001|Overall Study|Adverse Event|2|||
163030302|NCT00513357|588813837|FG000|Overall Study|Death|2|||
163030303|NCT00513357|588813838|FG001|Overall Study|Death|0|||
163030304|NCT00513357|588813837|FG000|Overall Study|Withdrawal by Subject|5|||
163030305|NCT00513357|588813838|FG001|Overall Study|Withdrawal by Subject|4|||
163030306|NCT00513357|588813837|FG000|Overall Study|Disease Progression|2|||
163030307|NCT00513357|588813838|FG001|Overall Study|Disease Progression|1|||
163030308|NCT05238025|588813842|FG000|Overall Study|Adverse Event|2|||
163030309|NCT05238025|588813843|FG001|Overall Study|Adverse Event|2|||
163030310|NCT05238025|588813842|FG000|Overall Study|Lost to Follow-up|334|||
163030311|NCT05238025|588813843|FG001|Overall Study|Lost to Follow-up|339|||
163030312|NCT05238025|588813842|FG000|Overall Study|Withdrawal by Subject|203|||
163030313|NCT05238025|588813843|FG001|Overall Study|Withdrawal by Subject|222|||
163030314|NCT05238025|588813842|FG000|Overall Study|Physician Decision|20|||
163030315|NCT05238025|588813843|FG001|Overall Study|Physician Decision|8|||
163030316|NCT05238025|588813842|FG000|Overall Study|Protocol Violation|6|||
163030317|NCT05238025|588813843|FG001|Overall Study|Protocol Violation|2|||
163030318|NCT05238025|588813842|FG000|Overall Study|Death|38|||
163030319|NCT05238025|588813843|FG001|Overall Study|Death|32|||
163030320|NCT05238025|588813842|FG000|Overall Study|Study terminated by Sponsor|6358|||
163030321|NCT05238025|588813843|FG001|Overall Study|Study terminated by Sponsor|6358|||
163030322|NCT05238025|588813842|FG000|Overall Study|Other Reason|669|||
163219736|NCT02439320|589519490|FG002|Overall Study|Death|0|||
163219737|NCT02439320|589519488|FG000|Overall Study|Noncompliance with Protocol|10|||
163030323|NCT05238025|588813843|FG001|Overall Study|Other Reason|690|||
163030324|NCT03814720|588813846|FG000|Overall Study|Lost to Follow-up|0|||
163030325|NCT03814720|588813847|FG001|Overall Study|Lost to Follow-up|1|||
163030326|NCT03814720|588813848|FG002|Overall Study|Lost to Follow-up|0|||
163030327|NCT03814720|588813849|FG003|Overall Study|Lost to Follow-up|0|||
163030328|NCT03814720|588813850|FG004|Overall Study|Lost to Follow-up|0|||
163030329|NCT02419612|588813851|FG000|Short-term Treatment Period|Adverse Event|1|||
163030330|NCT02419612|588813852|FG001|Short-term Treatment Period|Adverse Event|1|||
163030331|NCT02419612|588813851|FG000|Short-term Treatment Period|Death|0|||
163030332|NCT02419612|588813852|FG001|Short-term Treatment Period|Death|2|||
163030333|NCT02419612|588813851|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
163030334|NCT02419612|588813852|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
163030335|NCT02419612|588813851|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
163030336|NCT02419612|588813852|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
163030337|NCT02419612|588813851|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
163030338|NCT02419612|588813852|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
163030339|NCT02419612|588813851|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
163030340|NCT02419612|588813852|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
163030341|NCT02419612|588813851|FG000|Short-term Treatment Period|Worsening of liver function|0|||
163030342|NCT02419612|588813852|FG001|Short-term Treatment Period|Worsening of liver function|1|||
163030343|NCT02419612|588813851|FG000|Short-term Treatment Period|Subject moved out of state|0|||
163030344|NCT02419612|588813852|FG001|Short-term Treatment Period|Subject moved out of state|1|||
163030345|NCT02419612|588813851|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
163030346|NCT02419612|588813852|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
163030347|NCT02419612|588813851|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
163030348|NCT02419612|588813852|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
163030349|NCT02419612|588813851|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
163030350|NCT02419612|588813852|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
163030351|NCT02419612|588813851|FG000|Long-term Treatment Period|Death|0|||
163030352|NCT02419612|588813852|FG001|Long-term Treatment Period|Death|1|||
163030353|NCT02419612|588813851|FG000|Long-term Treatment Period|Adverse Event|0|||
163030354|NCT02419612|588813852|FG001|Long-term Treatment Period|Adverse Event|5|||
163030355|NCT02419612|588813851|FG000|Long-term Treatment Period|Other|4|||
163030356|NCT02419612|588813852|FG001|Long-term Treatment Period|Other|4|||
163030357|NCT02419612|588813851|FG000|Long-term Treatment Period|Subject Decision|2|||
163030358|NCT02419612|588813852|FG001|Long-term Treatment Period|Subject Decision|4|||
163030359|NCT02419612|588813851|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
163030360|NCT02419612|588813852|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
163030361|NCT01095978|588813853|FG000|Overall Study|Did not take Klacid SR|2|||
163030362|NCT01095978|588813853|FG000|Overall Study|Adverse Event|1|||
163030363|NCT02009397|588813855|FG000|Overall Study|Protocol Violation|6|||
163030364|NCT02009397|588813855|FG000|Overall Study|Death|8|||
163030365|NCT02009397|588813855|FG000|Overall Study|Lost to Follow-up|6|||
163030366|NCT00191282|588813856|FG000|Overall Study|Adverse Event|5|||
163030367|NCT00191282|588813857|FG001|Overall Study|Adverse Event|6|||
163030368|NCT00191282|588813856|FG000|Overall Study|Death|51|||
163030369|NCT00191282|588813857|FG001|Overall Study|Death|51|||
163030370|NCT00191282|588813856|FG000|Overall Study|Lack of Efficacy|11|||
163030371|NCT00191282|588813857|FG001|Overall Study|Lack of Efficacy|6|||
163030372|NCT00191282|588813856|FG000|Overall Study|Noncompliance|14|||
163030373|NCT00191282|588813857|FG001|Overall Study|Noncompliance|17|||
163030374|NCT00191282|588813856|FG000|Overall Study|Patient moved|11|||
163030375|NCT00191282|588813857|FG001|Overall Study|Patient moved|14|||
163030376|NCT00191282|588813856|FG000|Overall Study|Withdrawal by Subject|59|||
163219738|NCT02439320|589519489|FG001|Overall Study|Noncompliance with Protocol|11|||
163030377|NCT00191282|588813857|FG001|Overall Study|Withdrawal by Subject|44|||
163030378|NCT00191282|588813856|FG000|Overall Study|Physician Decision|18|||
163219739|NCT02439320|589519490|FG002|Overall Study|Noncompliance with Protocol|7|||
163030379|NCT00191282|588813857|FG001|Overall Study|Physician Decision|15|||
163030380|NCT00191282|588813856|FG000|Overall Study|Protocol entry criteria not met|14|||
163030381|NCT00191282|588813857|FG001|Overall Study|Protocol entry criteria not met|9|||
163030382|NCT00191282|588813856|FG000|Overall Study|Protocol Violation|9|||
163219740|NCT02439320|589519488|FG000|Overall Study|Pregnancy|0|||
163219741|NCT02439320|589519489|FG001|Overall Study|Pregnancy|1|||
163219742|NCT02439320|589519490|FG002|Overall Study|Pregnancy|1|||
163219743|NCT02439320|589519488|FG000|Overall Study|Withdrawal by Subject|12|||
163219744|NCT02439320|589519489|FG001|Overall Study|Withdrawal by Subject|16|||
163219745|NCT02439320|589519490|FG002|Overall Study|Withdrawal by Subject|14|||
163219746|NCT02439320|589519488|FG000|Overall Study|Physician Decision|2|||
163219747|NCT02439320|589519489|FG001|Overall Study|Physician Decision|1|||
163219748|NCT02439320|589519490|FG002|Overall Study|Physician Decision|0|||
163219749|NCT02439320|589519488|FG000|Overall Study|Sponsor Request|0|||
163219750|NCT02439320|589519489|FG001|Overall Study|Sponsor Request|2|||
163219751|NCT02439320|589519490|FG002|Overall Study|Sponsor Request|1|||
163219752|NCT02439320|589519488|FG000|Overall Study|Randomization Failure|35|||
163219753|NCT02439320|589519489|FG001|Overall Study|Randomization Failure|46|||
163219754|NCT02439320|589519490|FG002|Overall Study|Randomization Failure|34|||
163219755|NCT01505608|589519491|FG000|Phase I|Lack of Efficacy|0|||
163219756|NCT01505608|589519492|FG001|Phase I|Lack of Efficacy|4|||
163219757|NCT01505608|589519491|FG000|Phase I|Adverse Event|0|||
163219758|NCT01505608|589519492|FG001|Phase I|Adverse Event|1|||
163219759|NCT01505608|589519491|FG000|Phase I|Withdrawal by Subject|0|||
163219760|NCT01505608|589519492|FG001|Phase I|Withdrawal by Subject|1|||
163219761|NCT01505608|589519491|FG000|Phase II|Lack of Efficacy|2|||
163219762|NCT01505608|589519492|FG001|Phase II|Lack of Efficacy|1|||
163219763|NCT01505608|589519491|FG000|Phase II|Protocol Violation|0|||
163219764|NCT01505608|589519492|FG001|Phase II|Protocol Violation|1|||
163219765|NCT01251380|589519495|FG000|Overall Study|Other (Not otherwise specified)|12|||
163030383|NCT00191282|588813857|FG001|Overall Study|Protocol Violation|12|||
163030384|NCT00191282|588813856|FG000|Overall Study|Severity of outcome|2|||
163030385|NCT00191282|588813857|FG001|Overall Study|Severity of outcome|5|||
163030386|NCT00191282|588813856|FG000|Overall Study|Sponsor's decision|2|||
163030387|NCT00191282|588813857|FG001|Overall Study|Sponsor's decision|2|||
163030388|NCT00191282|588813856|FG000|Overall Study|Lost to Follow-up|24|||
163030389|NCT00191282|588813857|FG001|Overall Study|Lost to Follow-up|31|||
163030390|NCT00102531|588813858|FG000|Overall Study|Adverse Event|0|||
163030391|NCT00102531|588813859|FG001|Overall Study|Adverse Event|1|||
163030392|NCT00102531|588813858|FG000|Overall Study|Disease Progression|5|||
163030393|NCT00102531|588813859|FG001|Overall Study|Disease Progression|9|||
163030394|NCT00102531|588813858|FG000|Overall Study|Physician Decision|0|||
163030395|NCT00102531|588813859|FG001|Overall Study|Physician Decision|1|||
163030396|NCT04756154|588813860|FG000|Overall Study|Did not meet treatment day baseline|30|||
163030397|NCT04756154|588813861|FG001|Overall Study|Did not meet treatment day baseline|28|||
163030398|NCT04756154|588813862|FG002|Overall Study|Did not meet treatment day baseline|7|||
163030399|NCT04756154|588813860|FG000|Overall Study|Did not return for final sample collection|1|||
163030400|NCT04756154|588813861|FG001|Overall Study|Did not return for final sample collection|1|||
163030401|NCT04756154|588813862|FG002|Overall Study|Did not return for final sample collection|0|||
163030402|NCT01790828|588813863|FG000|Overall Study|Other|34|||
163030403|NCT02089334|588813865|FG000|Overall Study|Withdrawal by Subject|0|||
163030404|NCT02089334|588813866|FG001|Overall Study|Withdrawal by Subject|0|||
163030405|NCT02089334|588813867|FG002|Overall Study|Withdrawal by Subject|0|||
163030406|NCT02089334|588813868|FG003|Overall Study|Withdrawal by Subject|2|||
163030407|NCT02089334|588813865|FG000|Overall Study|Adverse Event|0|||
163030408|NCT02089334|588813866|FG001|Overall Study|Adverse Event|0|||
163030409|NCT02089334|588813867|FG002|Overall Study|Adverse Event|0|||
163030410|NCT02089334|588813868|FG003|Overall Study|Adverse Event|2|||
163030411|NCT02089334|588813865|FG000|Overall Study|Progressive disease|0|||
163030412|NCT02089334|588813866|FG001|Overall Study|Progressive disease|0|||
163030413|NCT02089334|588813867|FG002|Overall Study|Progressive disease|0|||
163030414|NCT02089334|588813868|FG003|Overall Study|Progressive disease|2|||
163030415|NCT02089334|588813865|FG000|Overall Study|Physician Decision|0|||
163030416|NCT02089334|588813866|FG001|Overall Study|Physician Decision|0|||
163030417|NCT02089334|588813867|FG002|Overall Study|Physician Decision|1|||
163030418|NCT02089334|588813868|FG003|Overall Study|Physician Decision|1|||
163030419|NCT02824562|588815893|FG000|Overall Study|Lost to Follow-up|3|||
163030420|NCT02824562|588815894|FG001|Overall Study|Lost to Follow-up|4|||
163030421|NCT02824562|588815893|FG000|Overall Study|Death|0|||
163030422|NCT02824562|588815894|FG001|Overall Study|Death|1|||
163030423|NCT02921750|588815895|FG000|Overall Study|Adverse Event|1|||
163030424|NCT02921750|588815896|FG001|Overall Study|Adverse Event|2|||
163030425|NCT02921750|588815895|FG000|Overall Study|Withdrawal by Subject|1|||
163030426|NCT02921750|588815896|FG001|Overall Study|Withdrawal by Subject|1|||
163030427|NCT02921750|588815895|FG000|Overall Study|Lost to Follow-up|3|||
163030428|NCT02921750|588815896|FG001|Overall Study|Lost to Follow-up|3|||
163030429|NCT02921750|588815895|FG000|Overall Study|Wound healed|3|||
163030430|NCT02921750|588815896|FG001|Overall Study|Wound healed|3|||
163030431|NCT02921750|588815895|FG000|Overall Study|Serious Adverse Event|1|||
163030432|NCT02921750|588815896|FG001|Overall Study|Serious Adverse Event|2|||
163030433|NCT04676412|588815897|FG000|Overall Study|Death|28|||
163030434|NCT04676412|588815898|FG001|Overall Study|Death|31|||
163030435|NCT04676412|588815897|FG000|Overall Study|Lost to Follow-up|1|||
163030436|NCT04676412|588815898|FG001|Overall Study|Lost to Follow-up|2|||
163030437|NCT04676412|588815897|FG000|Overall Study|Sponsor Decision|20|||
163030438|NCT04676412|588815898|FG001|Overall Study|Sponsor Decision|23|||
163219766|NCT01251380|589519495|FG000|Overall Study|Withdrawal by Subject|6|||
163219767|NCT01251380|589519495|FG000|Overall Study|Lack of Efficacy|1|||
163030439|NCT04676412|588815897|FG000|Overall Study|Withdrawal by Subject|0|||
163030440|NCT04676412|588815898|FG001|Overall Study|Withdrawal by Subject|2|||
163030441|NCT04550832|588815899|FG000|Overall Study|Adverse Event|0|||
163030442|NCT04550832|588815900|FG001|Overall Study|Adverse Event|0|||
163030443|NCT04550832|588815901|FG002|Overall Study|Adverse Event|2|||
163030444|NCT04550832|588815902|FG003|Overall Study|Adverse Event|0|||
163030445|NCT04550832|588815903|FG004|Overall Study|Adverse Event|1|||
163030446|NCT01458951|588815907|FG000|Overall Study|Other|1|||
163030447|NCT01458951|588815908|FG001|Overall Study|Other|0|||
163219768|NCT01251380|589519495|FG000|Overall Study|Adverse Event|1|||
163219769|NCT01251380|589519495|FG000|Overall Study|Lost to Follow-up|2|||
163219770|NCT02404350|589519499|FG000|Overall Study|Adverse Event|2|||
163219771|NCT02404350|589519500|FG001|Overall Study|Adverse Event|2|||
163219772|NCT02404350|589519501|FG002|Overall Study|Adverse Event|3|||
163219773|NCT02404350|589519502|FG003|Overall Study|Adverse Event|9|||
163219774|NCT02404350|589519499|FG000|Overall Study|Lack of Efficacy|3|||
163219775|NCT02404350|589519500|FG001|Overall Study|Lack of Efficacy|1|||
163219776|NCT02404350|589519501|FG002|Overall Study|Lack of Efficacy|0|||
163219777|NCT02404350|589519502|FG003|Overall Study|Lack of Efficacy|3|||
163219778|NCT02404350|589519499|FG000|Overall Study|Lost to Follow-up|2|||
163219779|NCT02404350|589519500|FG001|Overall Study|Lost to Follow-up|0|||
163030448|NCT01458951|588815909|FG002|Overall Study|Other|0|||
163030449|NCT01458951|588815907|FG000|Overall Study|Protocol Violation|5|||
163030450|NCT01458951|588815908|FG001|Overall Study|Protocol Violation|1|||
163030451|NCT01458951|588815909|FG002|Overall Study|Protocol Violation|0|||
163030452|NCT01458951|588815907|FG000|Overall Study|Withdrawal by Subject|2|||
163030453|NCT01458951|588815908|FG001|Overall Study|Withdrawal by Subject|0|||
163030454|NCT01458951|588815909|FG002|Overall Study|Withdrawal by Subject|2|||
163030455|NCT01458951|588815907|FG000|Overall Study|Adverse Event|7|||
163030456|NCT01458951|588815908|FG001|Overall Study|Adverse Event|0|||
163030457|NCT01458951|588815909|FG002|Overall Study|Adverse Event|2|||
163030458|NCT01458951|588815907|FG000|Overall Study|Insufficient Clinical Response|17|||
163030459|NCT01458951|588815908|FG001|Overall Study|Insufficient Clinical Response|0|||
163030460|NCT01458951|588815909|FG002|Overall Study|Insufficient Clinical Response|11|||
163030461|NCT04392167|588815912|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
163030462|NCT03309696|588815913|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
163030463|NCT03309696|588815914|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
163030464|NCT03309696|588815915|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
163030465|NCT03309696|588815916|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
163030466|NCT02638129|588815917|FG000|Overall Study|Study terminated|28|||
163030467|NCT02638129|588815918|FG001|Overall Study|Study terminated|30|||
163030468|NCT03117881|588815919|FG000|Baseline|Withdrawal by Subject|21|||
163030469|NCT03117881|588815920|FG001|Baseline|Withdrawal by Subject|10|||
163030470|NCT03117881|588815921|FG002|Baseline|Withdrawal by Subject|0|||
163030471|NCT03117881|588815919|FG000|Baseline|Lost to Follow-up|22|||
163030472|NCT03117881|588815920|FG001|Baseline|Lost to Follow-up|25|||
163030473|NCT03117881|588815921|FG002|Baseline|Lost to Follow-up|0|||
163030474|NCT03117881|588815919|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
163030475|NCT03117881|588815920|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
163030476|NCT03117881|588815921|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
163030477|NCT03117881|588815919|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
163030478|NCT03117881|588815920|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
163030479|NCT03117881|588815921|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
163030480|NCT03117881|588815919|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
163030481|NCT03117881|588815920|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
163030482|NCT03117881|588815921|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
163030483|NCT03117881|588815919|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
163030484|NCT03117881|588815920|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
163030485|NCT03117881|588815921|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
163030486|NCT03117881|588815919|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
163030487|NCT03117881|588815920|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
163030488|NCT03117881|588815921|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
163030489|NCT03117881|588815919|FG000|6-Month Follow-Up|Did not complete test|53|||
163030490|NCT03117881|588815920|FG001|6-Month Follow-Up|Did not complete test|25|||
163030491|NCT03117881|588815921|FG002|6-Month Follow-Up|Did not complete test|7|||
163030492|NCT03117881|588815919|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
163030493|NCT03117881|588815920|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
163030494|NCT03117881|588815921|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
163030495|NCT03117881|588815919|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
163030496|NCT03117881|588815920|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
163030497|NCT03117881|588815921|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
163030498|NCT03117881|588815919|FG000|12-Month Follow-Up|Did not complete test|40|||
163030499|NCT03117881|588815920|FG001|12-Month Follow-Up|Did not complete test|0|||
163030500|NCT03117881|588815921|FG002|12-Month Follow-Up|Did not complete test|0|||
163030501|NCT00577005|588815924|FG000|Overall Study|Lost to Follow-up|3|||
163030502|NCT00577005|588815925|FG001|Overall Study|Lost to Follow-up|2|||
163030503|NCT00577005|588815924|FG000|Overall Study|Withdrawal by Subject|2|||
163030504|NCT00577005|588815925|FG001|Overall Study|Withdrawal by Subject|1|||
163030505|NCT02667626|588815926|FG000|Overall Study|Withdrawal by Subject|0|||
163030506|NCT02667626|588815927|FG001|Overall Study|Withdrawal by Subject|1|||
163030507|NCT02309723|588815928|FG000|Overall Study|Withdrawal by Subject|24|||
163030508|NCT02309723|588815929|FG001|Overall Study|Withdrawal by Subject|23|||
163030509|NCT02309723|588815930|FG002|Overall Study|Withdrawal by Subject|24|||
163030510|NCT02560623|588815931|FG000|Overall Study|Unable to swallow sponge|0|||
163030511|NCT02560623|588815932|FG001|Overall Study|Unable to swallow sponge|1|||
163030512|NCT02560623|588815933|FG002|Overall Study|Unable to swallow sponge|0|||
163030513|NCT02560623|588815934|FG003|Overall Study|Unable to swallow sponge|0|||
163030514|NCT02560623|588815931|FG000|Overall Study|Intervention prior to sponge administration|0|||
163030515|NCT02560623|588815932|FG001|Overall Study|Intervention prior to sponge administration|1|||
163030516|NCT02560623|588815933|FG002|Overall Study|Intervention prior to sponge administration|0|||
163030517|NCT02560623|588815934|FG003|Overall Study|Intervention prior to sponge administration|0|||
163030518|NCT02453282|588815935|FG000|Overall Study|Death|275|||
163030519|NCT02453282|588815936|FG001|Overall Study|Death|277|||
163219780|NCT02404350|589519501|FG002|Overall Study|Lost to Follow-up|0|||
163030520|NCT02453282|588815937|FG002|Overall Study|Death|296|||
163332691|NCT01364597|589929862|FG003|Overall Study|Lack of Efficacy|8|||
163332692|NCT01364597|589929859|FG000|Overall Study|Protocol Violation|0|||
163332693|NCT01364597|589929860|FG001|Overall Study|Protocol Violation|0|||
163030521|NCT02453282|588815935|FG000|Overall Study|Lost to Follow-up|1|||
163030522|NCT02453282|588815936|FG001|Overall Study|Lost to Follow-up|0|||
163030523|NCT02453282|588815937|FG002|Overall Study|Lost to Follow-up|2|||
163030524|NCT02453282|588815935|FG000|Overall Study|Withdrawal by Subject|12|||
163030525|NCT02453282|588815936|FG001|Overall Study|Withdrawal by Subject|10|||
163030526|NCT02453282|588815937|FG002|Overall Study|Withdrawal by Subject|11|||
163030527|NCT02453282|588815935|FG000|Overall Study|Participants ongoing at data cut-off|85|||
163030528|NCT02453282|588815936|FG001|Overall Study|Participants ongoing at data cut-off|84|||
163030529|NCT02453282|588815937|FG002|Overall Study|Participants ongoing at data cut-off|62|||
163030530|NCT02453282|588815935|FG000|Overall Study|Other|1|||
163030531|NCT02453282|588815936|FG001|Overall Study|Other|1|||
163030532|NCT02453282|588815937|FG002|Overall Study|Other|1|||
163030533|NCT01143064|588815938|FG000|Overall Study|Death|109|||
163030534|NCT01143064|588815939|FG001|Overall Study|Death|91|||
163030535|NCT01143064|588815938|FG000|Overall Study|Adverse Event|0|||
163030536|NCT01143064|588815939|FG001|Overall Study|Adverse Event|1|||
163030537|NCT01143064|588815938|FG000|Overall Study|Withdrawal by Subject|7|||
163030538|NCT01143064|588815939|FG001|Overall Study|Withdrawal by Subject|5|||
163030539|NCT01143064|588815938|FG000|Overall Study|Lost to Follow-up|17|||
163030540|NCT01143064|588815939|FG001|Overall Study|Lost to Follow-up|14|||
163030541|NCT01143064|588815938|FG000|Overall Study|Physician Decision|0|||
163030542|NCT01143064|588815939|FG001|Overall Study|Physician Decision|4|||
163030543|NCT00985426|588815940|FG000|Overall Study|Adverse Event|0|||
163030544|NCT00985426|588815941|FG001|Overall Study|Adverse Event|1|||
163030545|NCT00985426|588815940|FG000|Overall Study|Subject Non-Compliance|3|||
163030546|NCT00985426|588815941|FG001|Overall Study|Subject Non-Compliance|3|||
163030547|NCT00985426|588815940|FG000|Overall Study|Withdrawal by Subject|12|||
163030548|NCT00985426|588815941|FG001|Overall Study|Withdrawal by Subject|16|||
163030549|NCT00985426|588815940|FG000|Overall Study|Lost to Follow-up|8|||
163030550|NCT00985426|588815941|FG001|Overall Study|Lost to Follow-up|10|||
163030551|NCT00985426|588815940|FG000|Overall Study|Death|7|||
163030552|NCT00985426|588815941|FG001|Overall Study|Death|3|||
163030553|NCT00985426|588815940|FG000|Overall Study|Protocol Violation|2|||
163030554|NCT00985426|588815941|FG001|Overall Study|Protocol Violation|0|||
163030555|NCT00985426|588815940|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
163030556|NCT00985426|588815941|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
163030557|NCT02327013|588815944|FG000|Overall Study|Adverse Event|4|||
163030558|NCT02327013|588815945|FG001|Overall Study|Adverse Event|4|||
163030559|NCT02327013|588815946|FG002|Overall Study|Adverse Event|3|||
163030560|NCT02327013|588815947|FG003|Overall Study|Adverse Event|0|||
163030561|NCT02327013|588815948|FG004|Overall Study|Adverse Event|1|||
163030562|NCT02327013|588815944|FG000|Overall Study|Lack of Efficacy|2|||
163030563|NCT02327013|588815945|FG001|Overall Study|Lack of Efficacy|0|||
163030564|NCT02327013|588815946|FG002|Overall Study|Lack of Efficacy|5|||
163030565|NCT02327013|588815947|FG003|Overall Study|Lack of Efficacy|0|||
163030566|NCT02327013|588815948|FG004|Overall Study|Lack of Efficacy|1|||
163030567|NCT02327013|588815944|FG000|Overall Study|Non-compliance with IMP|1|||
163030568|NCT02327013|588815945|FG001|Overall Study|Non-compliance with IMP|2|||
163030569|NCT02327013|588815946|FG002|Overall Study|Non-compliance with IMP|7|||
163030570|NCT02327013|588815947|FG003|Overall Study|Non-compliance with IMP|0|||
163030571|NCT02327013|588815948|FG004|Overall Study|Non-compliance with IMP|0|||
163030572|NCT02327013|588815944|FG000|Overall Study|Withdrawal of Consent|1|||
163030573|NCT02327013|588815945|FG001|Overall Study|Withdrawal of Consent|0|||
163030574|NCT02327013|588815946|FG002|Overall Study|Withdrawal of Consent|3|||
163030575|NCT02327013|588815947|FG003|Overall Study|Withdrawal of Consent|0|||
163030576|NCT02327013|588815948|FG004|Overall Study|Withdrawal of Consent|0|||
163030577|NCT02327013|588815944|FG000|Overall Study|Lost to Follow-up|2|||
163030578|NCT02327013|588815945|FG001|Overall Study|Lost to Follow-up|4|||
163030579|NCT02327013|588815946|FG002|Overall Study|Lost to Follow-up|5|||
163332694|NCT01364597|589929861|FG002|Overall Study|Protocol Violation|2|||
163030580|NCT02327013|588815947|FG003|Overall Study|Lost to Follow-up|0|||
163030581|NCT02327013|588815948|FG004|Overall Study|Lost to Follow-up|0|||
163030582|NCT02327013|588815944|FG000|Overall Study|Administrative or other reason(s)|1|||
163030583|NCT02327013|588815945|FG001|Overall Study|Administrative or other reason(s)|5|||
163030584|NCT02327013|588815946|FG002|Overall Study|Administrative or other reason(s)|11|||
163030585|NCT02327013|588815947|FG003|Overall Study|Administrative or other reason(s)|1|||
163030586|NCT02327013|588815948|FG004|Overall Study|Administrative or other reason(s)|1|||
163030587|NCT02327013|588815944|FG000|Overall Study|Protocol Violation|0|||
163030588|NCT02327013|588815945|FG001|Overall Study|Protocol Violation|0|||
163030589|NCT02327013|588815946|FG002|Overall Study|Protocol Violation|3|||
163030590|NCT02327013|588815947|FG003|Overall Study|Protocol Violation|0|||
163030591|NCT02327013|588815948|FG004|Overall Study|Protocol Violation|1|||
163030592|NCT02327013|588815944|FG000|Overall Study|Withdrawal before treatment|2|||
163332695|NCT01364597|589929862|FG003|Overall Study|Protocol Violation|0|||
163332696|NCT01364597|589929859|FG000|Overall Study|Lost to Follow-up|0|||
163030593|NCT02327013|588815945|FG001|Overall Study|Withdrawal before treatment|1|||
163030594|NCT02327013|588815946|FG002|Overall Study|Withdrawal before treatment|5|||
163030595|NCT02327013|588815947|FG003|Overall Study|Withdrawal before treatment|0|||
163030596|NCT02327013|588815948|FG004|Overall Study|Withdrawal before treatment|0|||
163030597|NCT02380859|588815949|FG000|Overall Study|Withdrawal by Subject|2|||
163030598|NCT02380859|588815950|FG001|Overall Study|Withdrawal by Subject|0|||
163030599|NCT01661933|588815951|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
163030600|NCT01661933|588815951|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
163030601|NCT03385304|588815952|FG000|Overall Study|Death|19|||
163030602|NCT03385304|588815953|FG001|Overall Study|Death|7|||
163030603|NCT03385304|588815952|FG000|Overall Study|Lost to Follow-up|17|||
163030604|NCT03385304|588815953|FG001|Overall Study|Lost to Follow-up|14|||
163030605|NCT03385304|588815952|FG000|Overall Study|Withdrawal by Subject|3|||
163030606|NCT03385304|588815953|FG001|Overall Study|Withdrawal by Subject|2|||
163030607|NCT03385304|588815952|FG000|Overall Study|Incarceration|2|||
163030608|NCT03385304|588815953|FG001|Overall Study|Incarceration|3|||
163030609|NCT01565668|588815954|FG000|Overall Study|Death|2|||
163030610|NCT01565668|588815955|FG001|Overall Study|Death|1|||
163030611|NCT01565668|588815954|FG000|Overall Study|Lack of Efficacy|4|||
163030612|NCT01565668|588815955|FG001|Overall Study|Lack of Efficacy|2|||
163030613|NCT01565668|588815954|FG000|Overall Study|Participant went on Hospice Care|1|||
163030614|NCT01565668|588815955|FG001|Overall Study|Participant went on Hospice Care|0|||
163030615|NCT01565668|588815954|FG000|Overall Study|Adverse Event|6|||
163030616|NCT01565668|588815955|FG001|Overall Study|Adverse Event|1|||
163030617|NCT01565668|588815954|FG000|Overall Study|Randomized, but never received drug|0|||
163030618|NCT01565668|588815955|FG001|Overall Study|Randomized, but never received drug|2|||
163030619|NCT01565668|588815954|FG000|Overall Study|Progressive disease|13|||
163030620|NCT01565668|588815955|FG001|Overall Study|Progressive disease|14|||
163030621|NCT01565668|588815954|FG000|Overall Study|Withdrawal by Subject|1|||
163030622|NCT01565668|588815955|FG001|Overall Study|Withdrawal by Subject|3|||
163030623|NCT01565668|588815954|FG000|Overall Study|HSCT Transplant|11|||
163030624|NCT01565668|588815955|FG001|Overall Study|HSCT Transplant|15|||
163030625|NCT01097421|588815956|FG000|Overall Study|Adverse Event|8|||
163030626|NCT01097421|588815956|FG000|Overall Study|Protocol Violation|2|||
163030627|NCT01097421|588815956|FG000|Overall Study|Lost to Follow-up|1|||
163030628|NCT01097421|588815956|FG000|Overall Study|Withdrawal by Subject|3|||
163030629|NCT04258254|588815957|FG000|Overall Study|Withdrawal by Subject|0|||
163030630|NCT04258254|588815958|FG001|Overall Study|Withdrawal by Subject|1|||
163030631|NCT04258254|588815959|FG002|Overall Study|Withdrawal by Subject|0|||
163030632|NCT01120249|588815960|FG000|Overall Study|No protocol treatment received|21|||
163030633|NCT01120249|588815961|FG001|Overall Study|No protocol treatment received|15|||
163030634|NCT01120249|588815960|FG000|Overall Study|Disease recurrence|107|||
163030635|NCT01120249|588815961|FG001|Overall Study|Disease recurrence|57|||
163030636|NCT01120249|588815960|FG000|Overall Study|Death|1|||
163030637|NCT01120249|588815961|FG001|Overall Study|Death|0|||
163030638|NCT01120249|588815960|FG000|Overall Study|Adverse Event|40|||
163030639|NCT01120249|588815961|FG001|Overall Study|Adverse Event|276|||
163030640|NCT01120249|588815960|FG000|Overall Study|Participant refusal|34|||
163030641|NCT01120249|588815961|FG001|Overall Study|Participant refusal|42|||
163030642|NCT01120249|588815960|FG000|Overall Study|Other reasons, not protocol specified|29|||
163030643|NCT01120249|588815961|FG001|Overall Study|Other reasons, not protocol specified|22|||
163030644|NCT00723190|588815966|FG000|Overall Study|Withdrawal by Subject|45|||
163030645|NCT00723190|588815966|FG000|Overall Study|Lost to Follow-up|37|||
163030646|NCT00723190|588815966|FG000|Overall Study|Adverse Event|18|||
163030647|NCT00723190|588815966|FG000|Overall Study|Lack of Efficacy|16|||
163030648|NCT00723190|588815966|FG000|Overall Study|Protocol Violation|15|||
163030649|NCT00723190|588815966|FG000|Overall Study|Other-Premature Discontinuation|9|||
163030650|NCT00723190|588815966|FG000|Overall Study|Other-Not included in safety population|2|||
163030651|NCT04472026|588815972|FG000|Overall Study|Lost to Follow-up|5|||
163030652|NCT01404208|588815973|FG000|Overall Study|Discontinued|3|||
163030653|NCT01404208|588815974|FG001|Overall Study|Discontinued|0|||
163030654|NCT02772276|588815977|FG000|Overall Study|Lost to Follow-up|0|||
163030655|NCT02772276|588815978|FG001|Overall Study|Lost to Follow-up|0|||
163030656|NCT02772276|588815979|FG002|Overall Study|Lost to Follow-up|0|||
163030657|NCT02772276|588815980|FG003|Overall Study|Lost to Follow-up|0|||
163030658|NCT02772276|588815981|FG004|Overall Study|Lost to Follow-up|0|||
163030659|NCT02772276|588815982|FG005|Overall Study|Lost to Follow-up|0|||
163030660|NCT02772276|588815983|FG006|Overall Study|Lost to Follow-up|1|||
163030661|NCT02772276|588815984|FG007|Overall Study|Lost to Follow-up|0|||
163030662|NCT02772276|588815985|FG008|Overall Study|Lost to Follow-up|0|||
163030663|NCT02772276|588815986|FG009|Overall Study|Lost to Follow-up|0|||
163030664|NCT02772276|588815987|FG010|Overall Study|Lost to Follow-up|0|||
163030665|NCT02772276|588815988|FG011|Overall Study|Lost to Follow-up|0|||
163030666|NCT02772276|588815989|FG012|Overall Study|Lost to Follow-up|0|||
163030667|NCT02772276|588815977|FG000|Overall Study|Withdrew consent|0|||
163030668|NCT02772276|588815978|FG001|Overall Study|Withdrew consent|0|||
163030669|NCT02772276|588815979|FG002|Overall Study|Withdrew consent|0|||
163030670|NCT02772276|588815980|FG003|Overall Study|Withdrew consent|0|||
163030671|NCT02772276|588815981|FG004|Overall Study|Withdrew consent|0|||
163030672|NCT02772276|588815982|FG005|Overall Study|Withdrew consent|0|||
163030673|NCT02772276|588815983|FG006|Overall Study|Withdrew consent|0|||
163030674|NCT02772276|588815984|FG007|Overall Study|Withdrew consent|1|||
163030675|NCT02772276|588815985|FG008|Overall Study|Withdrew consent|0|||
163030676|NCT02772276|588815986|FG009|Overall Study|Withdrew consent|0|||
163030677|NCT02772276|588815987|FG010|Overall Study|Withdrew consent|0|||
163030678|NCT02772276|588815988|FG011|Overall Study|Withdrew consent|0|||
163030679|NCT02772276|588815989|FG012|Overall Study|Withdrew consent|0|||
163030680|NCT00550862|588815990|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
163030681|NCT00550862|588815991|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
163030682|NCT00550862|588815992|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
163030683|NCT00550862|588815993|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
163030684|NCT00550862|588815994|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
163030685|NCT00550862|588815990|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
163030686|NCT00550862|588815991|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
163030687|NCT00550862|588815992|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
163030688|NCT00550862|588815993|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
163030689|NCT00550862|588815994|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
163030690|NCT00550862|588815990|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
163030691|NCT00550862|588815991|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
163030692|NCT00550862|588815992|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
163030693|NCT00550862|588815993|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
163030694|NCT00550862|588815994|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
163030695|NCT00550862|588815990|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
163030696|NCT00550862|588815991|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
163030697|NCT00550862|588815992|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
163030698|NCT00550862|588815993|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
163030699|NCT00550862|588815994|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
163030700|NCT00550862|588815990|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
163030701|NCT00550862|588815991|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
163030702|NCT00550862|588815992|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
163030703|NCT00550862|588815993|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
163030704|NCT00550862|588815994|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
163030705|NCT00550862|588815990|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
163030706|NCT00550862|588815991|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
163030707|NCT00550862|588815992|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
163030708|NCT00550862|588815993|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
163030709|NCT00550862|588815994|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
163030710|NCT00550862|588815990|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
163030711|NCT00550862|588815991|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
163030712|NCT00550862|588815992|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
163030713|NCT00550862|588815993|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
163030714|NCT00550862|588815994|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
163030715|NCT00550862|588815990|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
163030716|NCT00550862|588815991|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
163030717|NCT00550862|588815992|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
163030718|NCT00550862|588815993|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
163030719|NCT00550862|588815994|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
163030720|NCT00550862|588815990|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
163030721|NCT00550862|588815991|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
163030722|NCT00550862|588815992|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
163030723|NCT00550862|588815993|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
163030724|NCT00550862|588815994|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
163030725|NCT00550862|588815990|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
163030726|NCT00550862|588815991|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
163030727|NCT00550862|588815992|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
163084998|NCT03559556|589020356|FG000|Overall Study|Withdrawal by Subject|1|||
163084999|NCT02496000|589020357|FG000|Overall Study|Withdrawal by Subject|1|||
163332697|NCT01364597|589929860|FG001|Overall Study|Lost to Follow-up|0|||
163332698|NCT01364597|589929861|FG002|Overall Study|Lost to Follow-up|5|||
163332699|NCT01364597|589929862|FG003|Overall Study|Lost to Follow-up|3|||
163332700|NCT01364597|589929859|FG000|Overall Study|Withdrawal by Subject|4|||
163332701|NCT01364597|589929860|FG001|Overall Study|Withdrawal by Subject|1|||
163332702|NCT01364597|589929861|FG002|Overall Study|Withdrawal by Subject|18|||
163030728|NCT00550862|588815993|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
163030729|NCT00550862|588815994|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
163030730|NCT02248974|588815995|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
163030731|NCT02248974|588815996|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
163030732|NCT02248974|588815995|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
163030733|NCT02248974|588815996|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
163030734|NCT02248974|588815995|FG000|1-Day Follow-Up|Enrolled in another study|1|||
163030735|NCT02248974|588815996|FG001|1-Day Follow-Up|Enrolled in another study|0|||
163030736|NCT02248974|588815995|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
163030737|NCT02248974|588815996|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
163030738|NCT02248974|588815995|FG000|1-Week Follow-Up|Enrolled in another study|1|||
163030739|NCT02248974|588815996|FG001|1-Week Follow-Up|Enrolled in another study|1|||
163030740|NCT02248974|588815995|FG000|1-Week Follow-Up|Transferred to another facility|1|||
163030741|NCT02248974|588815996|FG001|1-Week Follow-Up|Transferred to another facility|0|||
163030742|NCT02248974|588815995|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
163030743|NCT02248974|588815996|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
163030744|NCT02248974|588815995|FG000|1-Week Follow-Up|Death|1|||
163030745|NCT02248974|588815996|FG001|1-Week Follow-Up|Death|1|||
163030746|NCT02248974|588815995|FG000|1-Week Follow-Up|Excluded because of age|0|||
163030747|NCT02248974|588815996|FG001|1-Week Follow-Up|Excluded because of age|1|||
163030748|NCT02248974|588815995|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
163030749|NCT02248974|588815996|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
163030750|NCT02248974|588815995|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
163030751|NCT02248974|588815996|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
163030752|NCT02248974|588815995|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
163030753|NCT02248974|588815996|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
163030754|NCT02248974|588815995|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
163030755|NCT02248974|588815996|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
163030756|NCT02248974|588815995|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
163030757|NCT02248974|588815996|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
163030758|NCT03488225|588815997|FG000|Overall Study|Off Protocol Therapy|2|||
163030759|NCT03488225|588815997|FG000|Overall Study|Stem Cell Transplant|2|||
163030760|NCT03436199|588816000|FG000|Overall Study|Adverse Event|15|||
163030761|NCT03436199|588816001|FG001|Overall Study|Adverse Event|40|||
163030762|NCT03436199|588816002|FG002|Overall Study|Adverse Event|7|||
163030763|NCT03436199|588816000|FG000|Overall Study|Withdrawal by Subject|4|||
163030764|NCT03436199|588816001|FG001|Overall Study|Withdrawal by Subject|10|||
163030765|NCT03436199|588816002|FG002|Overall Study|Withdrawal by Subject|3|||
163030766|NCT03436199|588816000|FG000|Overall Study|Lost to Follow-up|1|||
163030767|NCT03436199|588816001|FG001|Overall Study|Lost to Follow-up|0|||
163030768|NCT03436199|588816002|FG002|Overall Study|Lost to Follow-up|2|||
163030769|NCT03436199|588816000|FG000|Overall Study|Protocol Violation|1|||
163030770|NCT03436199|588816001|FG001|Overall Study|Protocol Violation|1|||
163030771|NCT03436199|588816002|FG002|Overall Study|Protocol Violation|0|||
163219781|NCT02404350|589519502|FG003|Overall Study|Lost to Follow-up|1|||
163219782|NCT02404350|589519499|FG000|Overall Study|Physician Decision|1|||
163219783|NCT02404350|589519500|FG001|Overall Study|Physician Decision|0|||
163219784|NCT02404350|589519501|FG002|Overall Study|Physician Decision|0|||
163219785|NCT02404350|589519502|FG003|Overall Study|Physician Decision|2|||
163219786|NCT02404350|589519499|FG000|Overall Study|Pregnancy|0|||
163219787|NCT02404350|589519500|FG001|Overall Study|Pregnancy|0|||
163219788|NCT02404350|589519501|FG002|Overall Study|Pregnancy|0|||
163219789|NCT02404350|589519502|FG003|Overall Study|Pregnancy|1|||
163219790|NCT02404350|589519499|FG000|Overall Study|Withdrawal by Subject|7|||
163219791|NCT02404350|589519500|FG001|Overall Study|Withdrawal by Subject|3|||
163219792|NCT02404350|589519501|FG002|Overall Study|Withdrawal by Subject|3|||
163219793|NCT02404350|589519502|FG003|Overall Study|Withdrawal by Subject|19|||
163219794|NCT02404350|589519499|FG000|Overall Study|Due to Non-compliance with treatment|0|||
163219795|NCT02404350|589519500|FG001|Overall Study|Due to Non-compliance with treatment|0|||
163219796|NCT02404350|589519501|FG002|Overall Study|Due to Non-compliance with treatment|0|||
163219797|NCT02404350|589519502|FG003|Overall Study|Due to Non-compliance with treatment|1|||
163219798|NCT02404350|589519499|FG000|Overall Study|Due to Technical problems|0|||
163219799|NCT02404350|589519500|FG001|Overall Study|Due to Technical problems|0|||
163219800|NCT02404350|589519501|FG002|Overall Study|Due to Technical problems|0|||
163030772|NCT03436199|588816000|FG000|Overall Study|Physician Decision|0|||
163030773|NCT03436199|588816001|FG001|Overall Study|Physician Decision|1|||
163030774|NCT03436199|588816002|FG002|Overall Study|Physician Decision|0|||
163030775|NCT03436199|588816000|FG000|Overall Study|Could not return to clinic|1|||
163030776|NCT03436199|588816001|FG001|Overall Study|Could not return to clinic|0|||
163030777|NCT03436199|588816002|FG002|Overall Study|Could not return to clinic|0|||
163030778|NCT03436199|588816000|FG000|Overall Study|Withdrawn per physician|0|||
163030779|NCT03436199|588816001|FG001|Overall Study|Withdrawn per physician|1|||
163030780|NCT03436199|588816002|FG002|Overall Study|Withdrawn per physician|0|||
163219801|NCT02404350|589519502|FG003|Overall Study|Due to Technical problems|1|||
163219802|NCT05389657|589519503|FG000|Overall Study|Lost to Follow-up|7|||
163332703|NCT01364597|589929862|FG003|Overall Study|Withdrawal by Subject|6|||
163332704|NCT01364597|589929859|FG000|Overall Study|Non compliance|1|||
163332705|NCT01364597|589929860|FG001|Overall Study|Non compliance|0|||
163030781|NCT00085098|588816003|FG000|Overall Study|Withdrawal by Subject|0|||
163030782|NCT00085098|588816004|FG001|Overall Study|Withdrawal by Subject|1|||
163030783|NCT00085098|588816003|FG000|Overall Study|Ineligible|1|||
163030784|NCT00085098|588816004|FG001|Overall Study|Ineligible|1|||
163030785|NCT00926536|588816006|FG000|Overall Study|Physician Decision|1|||
163030786|NCT00926536|588816007|FG001|Overall Study|Physician Decision|2|||
163030787|NCT00435487|588816008|FG000|Overall Study|Death|3|||
163030788|NCT00435487|588816009|FG001|Overall Study|Death|4|||
163030789|NCT00435487|588816008|FG000|Overall Study|Adverse Event|0|||
163030790|NCT00435487|588816009|FG001|Overall Study|Adverse Event|3|||
163030791|NCT00435487|588816008|FG000|Overall Study|Lost to Follow-up|2|||
163030792|NCT00435487|588816009|FG001|Overall Study|Lost to Follow-up|2|||
163030793|NCT00435487|588816008|FG000|Overall Study|Other|5|||
163030794|NCT00435487|588816009|FG001|Overall Study|Other|2|||
163030795|NCT00435487|588816008|FG000|Overall Study|Withdrawal by Subject|2|||
163030796|NCT00435487|588816009|FG001|Overall Study|Withdrawal by Subject|1|||
163030797|NCT00435487|588816008|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
163030798|NCT00435487|588816009|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
163030799|NCT00435487|588816008|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
163030800|NCT00435487|588816009|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
163030801|NCT05087966|588816010|FG000|Overall Study|Lost to Follow-up|1|||
163030802|NCT05087966|588816010|FG000|Overall Study|Withdrawal by Subject|5|||
163030803|NCT00954512|588816025|FG000|Overall Study|Withdrawal by Subject|0|||
163030804|NCT00954512|588816026|FG001|Overall Study|Withdrawal by Subject|0|||
163030805|NCT00954512|588816027|FG002|Overall Study|Withdrawal by Subject|0|||
163030806|NCT00954512|588816028|FG003|Overall Study|Withdrawal by Subject|0|||
163030807|NCT00954512|588816029|FG004|Overall Study|Withdrawal by Subject|0|||
163030808|NCT00954512|588816030|FG005|Overall Study|Withdrawal by Subject|1|||
163030809|NCT00954512|588816025|FG000|Overall Study|Adverse Event|0|||
163030810|NCT00954512|588816026|FG001|Overall Study|Adverse Event|0|||
163030811|NCT00954512|588816027|FG002|Overall Study|Adverse Event|0|||
163030812|NCT00954512|588816028|FG003|Overall Study|Adverse Event|0|||
163030813|NCT00954512|588816029|FG004|Overall Study|Adverse Event|1|||
163030814|NCT00954512|588816030|FG005|Overall Study|Adverse Event|2|||
163030815|NCT00954512|588816025|FG000|Overall Study|Physician Decision|0|||
163030816|NCT00954512|588816026|FG001|Overall Study|Physician Decision|1|||
163030817|NCT00954512|588816027|FG002|Overall Study|Physician Decision|0|||
163030818|NCT00954512|588816028|FG003|Overall Study|Physician Decision|1|||
163030819|NCT00954512|588816029|FG004|Overall Study|Physician Decision|0|||
163030820|NCT00954512|588816030|FG005|Overall Study|Physician Decision|0|||
163030821|NCT00954512|588816025|FG000|Overall Study|Symptomatic Deterioration|0|||
163030822|NCT00954512|588816026|FG001|Overall Study|Symptomatic Deterioration|1|||
163030823|NCT00954512|588816027|FG002|Overall Study|Symptomatic Deterioration|0|||
163030824|NCT00954512|588816028|FG003|Overall Study|Symptomatic Deterioration|0|||
163030825|NCT00954512|588816029|FG004|Overall Study|Symptomatic Deterioration|2|||
163030826|NCT00954512|588816030|FG005|Overall Study|Symptomatic Deterioration|0|||
163030827|NCT00954512|588816025|FG000|Overall Study|Progression of Disease|2|||
163030828|NCT00954512|588816026|FG001|Overall Study|Progression of Disease|1|||
163030829|NCT00954512|588816027|FG002|Overall Study|Progression of Disease|0|||
163030830|NCT00954512|588816028|FG003|Overall Study|Progression of Disease|1|||
163030831|NCT00954512|588816029|FG004|Overall Study|Progression of Disease|1|||
163030832|NCT00954512|588816030|FG005|Overall Study|Progression of Disease|1|||
163030833|NCT04814368|588816035|FG000|Overall Study|Study Terminated by Sponsor|0|||
163030834|NCT04814368|588816036|FG001|Overall Study|Study Terminated by Sponsor|3|||
163030835|NCT04814368|588816037|FG002|Overall Study|Study Terminated by Sponsor|0|||
163030836|NCT04814368|588816038|FG003|Overall Study|Study Terminated by Sponsor|2|||
163030837|NCT04814368|588816035|FG000|Overall Study|Subject Decision|1|||
163030838|NCT04814368|588816036|FG001|Overall Study|Subject Decision|2|||
163332706|NCT01364597|589929861|FG002|Overall Study|Non compliance|1|||
163332707|NCT01364597|589929862|FG003|Overall Study|Non compliance|0|||
163030839|NCT04814368|588816037|FG002|Overall Study|Subject Decision|0|||
163332708|NCT01364597|589929859|FG000|Overall Study|Lack of compliance|1|||
163030840|NCT04814368|588816038|FG003|Overall Study|Subject Decision|0|||
163332709|NCT01364597|589929860|FG001|Overall Study|Lack of compliance|0|||
163030841|NCT01173055|588816039|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
163030842|NCT01173055|588816040|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
163030843|NCT01173055|588816039|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
163030844|NCT01173055|588816040|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
163030845|NCT04216589|588816042|FG000|Overall Study|Withdrawal by Subject|2|||
163030846|NCT04216589|588816042|FG000|Overall Study|Protocol Violation|1|||
163030847|NCT04216589|588816042|FG000|Overall Study|Incarceration|1|||
163030848|NCT02987972|588816045|FG000|Overall Study|Adverse Event|1|||
163030849|NCT02987972|588816046|FG001|Overall Study|Adverse Event|1|||
163332710|NCT01364597|589929861|FG002|Overall Study|Lack of compliance|0|||
163332711|NCT01364597|589929862|FG003|Overall Study|Lack of compliance|0|||
163030850|NCT02987972|588816047|FG002|Overall Study|Adverse Event|0|||
163030851|NCT02987972|588816045|FG000|Overall Study|Death|1|||
163332712|NCT01364597|589929859|FG000|Overall Study|End of treatment epilepsy|1|||
163332713|NCT01364597|589929860|FG001|Overall Study|End of treatment epilepsy|0|||
163030852|NCT02987972|588816046|FG001|Overall Study|Death|0|||
163030853|NCT02987972|588816047|FG002|Overall Study|Death|0|||
163030854|NCT02987972|588816045|FG000|Overall Study|Lack of Efficacy|9|||
163030855|NCT02987972|588816046|FG001|Overall Study|Lack of Efficacy|12|||
163030856|NCT02987972|588816047|FG002|Overall Study|Lack of Efficacy|12|||
163030857|NCT02987972|588816045|FG000|Overall Study|Lost to Follow-up|7|||
163030858|NCT02987972|588816046|FG001|Overall Study|Lost to Follow-up|8|||
163030859|NCT02987972|588816047|FG002|Overall Study|Lost to Follow-up|4|||
163030860|NCT02987972|588816045|FG000|Overall Study|Physician Decision|1|||
163030861|NCT02987972|588816046|FG001|Overall Study|Physician Decision|6|||
163030862|NCT02987972|588816047|FG002|Overall Study|Physician Decision|0|||
163030863|NCT02987972|588816045|FG000|Overall Study|Protocol Violation|2|||
163030864|NCT02987972|588816046|FG001|Overall Study|Protocol Violation|1|||
163030865|NCT02987972|588816047|FG002|Overall Study|Protocol Violation|5|||
163030866|NCT02987972|588816045|FG000|Overall Study|Withdrawal by Subject|22|||
163030867|NCT02987972|588816046|FG001|Overall Study|Withdrawal by Subject|17|||
163030868|NCT02987972|588816047|FG002|Overall Study|Withdrawal by Subject|21|||
163030869|NCT02342548|588816048|FG000|Overall Study|Adverse Event|12|||
163030870|NCT02342548|588816049|FG001|Overall Study|Adverse Event|17|||
163030871|NCT02342548|588816050|FG002|Overall Study|Adverse Event|13|||
163030872|NCT02342548|588816048|FG000|Overall Study|Lost to Follow-up|0|||
163030873|NCT02342548|588816049|FG001|Overall Study|Lost to Follow-up|1|||
163030874|NCT02342548|588816050|FG002|Overall Study|Lost to Follow-up|0|||
163030875|NCT02342548|588816048|FG000|Overall Study|Study terminated by sponsor|20|||
163030876|NCT02342548|588816049|FG001|Overall Study|Study terminated by sponsor|39|||
163030877|NCT02342548|588816050|FG002|Overall Study|Study terminated by sponsor|25|||
163030878|NCT02342548|588816048|FG000|Overall Study|Protocol Violation|0|||
163030879|NCT02342548|588816049|FG001|Overall Study|Protocol Violation|1|||
163030880|NCT02342548|588816050|FG002|Overall Study|Protocol Violation|0|||
163030881|NCT02342548|588816048|FG000|Overall Study|Withdrawal by Subject|1|||
163030882|NCT02342548|588816049|FG001|Overall Study|Withdrawal by Subject|3|||
163030883|NCT02342548|588816050|FG002|Overall Study|Withdrawal by Subject|4|||
163030884|NCT02342548|588816048|FG000|Overall Study|Other|1|||
163030885|NCT02342548|588816049|FG001|Overall Study|Other|1|||
163030886|NCT02342548|588816050|FG002|Overall Study|Other|1|||
163030887|NCT01047332|588816053|FG000|Overall Study|SEMS Obstruction|11|||
163030888|NCT01047332|588816054|FG001|Overall Study|SEMS Obstruction|20|||
163030889|NCT01047332|588816053|FG000|Overall Study|Died Unobstructed|38|||
163030890|NCT01047332|588816054|FG001|Overall Study|Died Unobstructed|41|||
163030891|NCT01047332|588816053|FG000|Overall Study|Lost to Follow-up|8|||
163030892|NCT01047332|588816054|FG001|Overall Study|Lost to Follow-up|3|||
163030893|NCT03521817|588816055|FG000|Overall Study|Protocol Violation|0|||
163030894|NCT03521817|588816056|FG001|Overall Study|Protocol Violation|1|||
163030895|NCT00787917|588816057|FG000|Blinded Treatment|Adverse Event|1|||
163030896|NCT00787917|588816058|FG001|Blinded Treatment|Adverse Event|0|||
163030897|NCT00787917|588816057|FG000|Blinded Treatment|Lack of Efficacy|1|||
163030898|NCT00787917|588816058|FG001|Blinded Treatment|Lack of Efficacy|0|||
163030899|NCT00787917|588816057|FG000|Blinded Treatment|Administrative problems|3|||
163030900|NCT00787917|588816058|FG001|Blinded Treatment|Administrative problems|2|||
163030901|NCT00787917|588816057|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
163030902|NCT00787917|588816058|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
163030903|NCT00787917|588816057|FG000|Open Label|Administrative problems|3|||
163030904|NCT00787917|588816058|FG001|Open Label|Administrative problems|0|||
163030905|NCT05685732|588816060|FG000|Overall Study|Withdrawal by Subject|2|||
163030906|NCT05685732|588816061|FG001|Overall Study|Withdrawal by Subject|0|||
163030907|NCT05685732|588816062|FG002|Overall Study|Withdrawal by Subject|2|||
163030908|NCT05685732|588816063|FG003|Overall Study|Withdrawal by Subject|3|||
163030909|NCT05685732|588816060|FG000|Overall Study|Protocol Violation|1|||
163030910|NCT05685732|588816061|FG001|Overall Study|Protocol Violation|2|||
163030911|NCT05685732|588816062|FG002|Overall Study|Protocol Violation|4|||
163030912|NCT05685732|588816063|FG003|Overall Study|Protocol Violation|1|||
163030913|NCT05685732|588816060|FG000|Overall Study|Lost to Follow-up|5|||
163030914|NCT05685732|588816061|FG001|Overall Study|Lost to Follow-up|1|||
163332714|NCT01364597|589929861|FG002|Overall Study|End of treatment epilepsy|0|||
163332715|NCT01364597|589929862|FG003|Overall Study|End of treatment epilepsy|0|||
163332716|NCT01364597|589929859|FG000|Overall Study|No Seizures|1|||
163030915|NCT05685732|588816062|FG002|Overall Study|Lost to Follow-up|3|||
163030916|NCT05685732|588816063|FG003|Overall Study|Lost to Follow-up|1|||
163030917|NCT05685732|588816060|FG000|Overall Study|Adverse Event|2|||
163030918|NCT05685732|588816061|FG001|Overall Study|Adverse Event|1|||
163030919|NCT05685732|588816062|FG002|Overall Study|Adverse Event|0|||
163030920|NCT05685732|588816063|FG003|Overall Study|Adverse Event|0|||
163030921|NCT05685732|588816060|FG000|Overall Study|Physician Decision|1|||
163030922|NCT05685732|588816061|FG001|Overall Study|Physician Decision|0|||
163030923|NCT05685732|588816062|FG002|Overall Study|Physician Decision|0|||
163332717|NCT01364597|589929860|FG001|Overall Study|No Seizures|0|||
163332718|NCT01364597|589929861|FG002|Overall Study|No Seizures|0|||
163332719|NCT01364597|589929862|FG003|Overall Study|No Seizures|0|||
163332720|NCT01364597|589929859|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
163332721|NCT01364597|589929860|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
163332722|NCT01364597|589929861|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
163332723|NCT01364597|589929862|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
163332724|NCT01364597|589929859|FG000|Overall Study|Cure|1|||
163332725|NCT01364597|589929860|FG001|Overall Study|Cure|0|||
163332726|NCT01364597|589929861|FG002|Overall Study|Cure|0|||
163030924|NCT05685732|588816063|FG003|Overall Study|Physician Decision|0|||
163030925|NCT02640404|588816064|FG000|Overall Study|Protocol Violation|1|||
163030926|NCT02640404|588816065|FG001|Overall Study|Protocol Violation|0|||
163030927|NCT02640404|588816064|FG000|Overall Study|Withdrawal by Subject|1|||
163030928|NCT02640404|588816065|FG001|Overall Study|Withdrawal by Subject|0|||
163030929|NCT00778102|588816066|FG000|Overall Study|Adverse Event|8|||
163030930|NCT00778102|588816067|FG001|Overall Study|Adverse Event|5|||
163030931|NCT00778102|588816066|FG000|Overall Study|Death|1|||
163030932|NCT00778102|588816067|FG001|Overall Study|Death|1|||
163030933|NCT00778102|588816066|FG000|Overall Study|Lost to Follow-up|1|||
163030934|NCT00778102|588816067|FG001|Overall Study|Lost to Follow-up|0|||
163030935|NCT00778102|588816066|FG000|Overall Study|Violation of Selection Criteria|1|||
163030936|NCT00778102|588816067|FG001|Overall Study|Violation of Selection Criteria|1|||
163030937|NCT00778102|588816066|FG000|Overall Study|Protocol Violation|0|||
163030938|NCT00778102|588816067|FG001|Overall Study|Protocol Violation|1|||
163030939|NCT00778102|588816066|FG000|Overall Study|Refused Treatment|2|||
163030940|NCT00778102|588816067|FG001|Overall Study|Refused Treatment|3|||
163030941|NCT00778102|588816066|FG000|Overall Study|Withdrawal by Subject|1|||
163030942|NCT00778102|588816067|FG001|Overall Study|Withdrawal by Subject|1|||
163030943|NCT00778102|588816066|FG000|Overall Study|Administrative Reason|7|||
163030944|NCT00778102|588816067|FG001|Overall Study|Administrative Reason|10|||
163030945|NCT05397171|588816068|FG000|Overall Study|Death|2|||
163030946|NCT05397171|588816069|FG001|Overall Study|Death|3|||
163030947|NCT05397171|588816070|FG002|Overall Study|Death|3|||
163030948|NCT05397171|588816068|FG000|Overall Study|Study Terminated By Sponsor|1|||
163030949|NCT05397171|588816069|FG001|Overall Study|Study Terminated By Sponsor|2|||
163030950|NCT05397171|588816070|FG002|Overall Study|Study Terminated By Sponsor|3|||
163030951|NCT05397171|588816068|FG000|Overall Study|Withdrawal by Subject|0|||
163030952|NCT05397171|588816069|FG001|Overall Study|Withdrawal by Subject|1|||
163332727|NCT01364597|589929862|FG003|Overall Study|Cure|0|||
163332728|NCT01364597|589929859|FG000|Overall Study|Patient was moving|0|||
163332729|NCT01364597|589929860|FG001|Overall Study|Patient was moving|1|||
163332730|NCT01364597|589929861|FG002|Overall Study|Patient was moving|0|||
163332731|NCT01364597|589929862|FG003|Overall Study|Patient was moving|0|||
163332732|NCT01364597|589929859|FG000|Overall Study|Seizures resolved|0|||
163332733|NCT01364597|589929860|FG001|Overall Study|Seizures resolved|0|||
163332734|NCT01364597|589929861|FG002|Overall Study|Seizures resolved|1|||
163332735|NCT01364597|589929862|FG003|Overall Study|Seizures resolved|0|||
163332736|NCT01364597|589929859|FG000|Overall Study|Patient became seizure-free after surgery|0|||
163332737|NCT01364597|589929860|FG001|Overall Study|Patient became seizure-free after surgery|0|||
163332738|NCT01364597|589929861|FG002|Overall Study|Patient became seizure-free after surgery|1|||
163332739|NCT01364597|589929862|FG003|Overall Study|Patient became seizure-free after surgery|0|||
163332740|NCT01364597|589929859|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
163332741|NCT01364597|589929860|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
163332742|NCT01364597|589929861|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
163332743|NCT01364597|589929862|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
163332744|NCT01364597|589929859|FG000|Overall Study|Patient cured from Epilepsy|0|||
163332745|NCT01364597|589929860|FG001|Overall Study|Patient cured from Epilepsy|0|||
163030953|NCT05397171|588816070|FG002|Overall Study|Withdrawal by Subject|1|||
163332746|NCT01364597|589929861|FG002|Overall Study|Patient cured from Epilepsy|1|||
163332747|NCT01364597|589929862|FG003|Overall Study|Patient cured from Epilepsy|0|||
163332748|NCT01364597|589929859|FG000|Overall Study|Investigator decision|0|||
163030954|NCT01328548|588816071|FG000|Overall Study|Death|3|||
163030955|NCT01328548|588816072|FG001|Overall Study|Death|0|||
163030956|NCT01328548|588816071|FG000|Overall Study|Protocol Violation|1|||
163030957|NCT01328548|588816072|FG001|Overall Study|Protocol Violation|0|||
163332749|NCT01364597|589929860|FG001|Overall Study|Investigator decision|0|||
163332750|NCT01364597|589929861|FG002|Overall Study|Investigator decision|1|||
163030958|NCT04643964|588818353|FG000|Overall Study|Lost to Follow-up|55|||
163030959|NCT04643964|588818354|FG001|Overall Study|Lost to Follow-up|59|||
163030960|NCT04643964|588818355|FG002|Overall Study|Lost to Follow-up|54|||
163030961|NCT04643964|588818356|FG003|Overall Study|Lost to Follow-up|129|||
163030962|NCT04643964|588818357|FG004|Overall Study|Lost to Follow-up|48|||
163332751|NCT01364597|589929862|FG003|Overall Study|Investigator decision|0|||
163030963|NCT04643964|588818353|FG000|Overall Study|Failed attention check|1|||
163030964|NCT04643964|588818354|FG001|Overall Study|Failed attention check|8|||
163030965|NCT04643964|588818355|FG002|Overall Study|Failed attention check|2|||
163030966|NCT04643964|588818356|FG003|Overall Study|Failed attention check|14|||
163030967|NCT04643964|588818357|FG004|Overall Study|Failed attention check|11|||
163030968|NCT02368210|588818358|FG000|Overall Study|Withdrawal by Subject|1|||
163030969|NCT02368210|588818359|FG001|Overall Study|Withdrawal by Subject|0|||
163030970|NCT02368210|588818358|FG000|Overall Study|Adverse Event|0|||
163030971|NCT02368210|588818359|FG001|Overall Study|Adverse Event|1|||
163030972|NCT00078949|588818360|FG000|Overall Study|No treated|4|||
163030973|NCT00078949|588818361|FG001|Overall Study|No treated|5|||
163030974|NCT00078949|588818362|FG002|Overall Study|No treated|3|||
163030975|NCT00078949|588818363|FG003|Overall Study|No treated|3|||
163030976|NCT00590538|588818364|FG000|Overall Study|Study terminated before completed|2|||
163030977|NCT01125813|588818365|FG000|Overall Study|Death|1|||
163030978|NCT01125813|588818365|FG000|Overall Study|Withdrawal by Subject|1|||
163030979|NCT01125813|588818365|FG000|Overall Study|Screen Failures|4|||
163030980|NCT02539134|588818368|FG000|Overall Study|Lost to Follow-up|1|||
163030981|NCT02539134|588818369|FG001|Overall Study|Lost to Follow-up|0|||
163030982|NCT02539134|588818370|FG002|Overall Study|Lost to Follow-up|0|||
163030983|NCT02539134|588818371|FG003|Overall Study|Lost to Follow-up|0|||
163030984|NCT02539134|588818372|FG004|Overall Study|Lost to Follow-up|0|||
163030985|NCT02539134|588818373|FG005|Overall Study|Lost to Follow-up|0|||
163030986|NCT02255552|588818374|FG000|Overall Study|Participants enrolled into another study|0|||
163030987|NCT02255552|588818375|FG001|Overall Study|Participants enrolled into another study|11|||
163030988|NCT02255552|588818374|FG000|Overall Study|Withdrawal by Subject|1|||
163030989|NCT02255552|588818375|FG001|Overall Study|Withdrawal by Subject|4|||
163030990|NCT00558896|588818376|FG000|Overall Study|Adverse Event|1|||
163030991|NCT00558896|588818377|FG001|Overall Study|Adverse Event|1|||
163030992|NCT00558896|588818378|FG002|Overall Study|Adverse Event|1|||
163030993|NCT00558896|588818379|FG003|Overall Study|Adverse Event|3|||
163030994|NCT00558896|588818380|FG004|Overall Study|Adverse Event|4|||
163030995|NCT00558896|588818381|FG005|Overall Study|Adverse Event|10|||
163030996|NCT00558896|588818382|FG006|Overall Study|Adverse Event|3|||
163030997|NCT00558896|588818376|FG000|Overall Study|Death|3|||
163030998|NCT00558896|588818377|FG001|Overall Study|Death|0|||
163030999|NCT00558896|588818378|FG002|Overall Study|Death|2|||
163031000|NCT00558896|588818379|FG003|Overall Study|Death|3|||
163031001|NCT00558896|588818380|FG004|Overall Study|Death|2|||
163031002|NCT00558896|588818381|FG005|Overall Study|Death|2|||
163031003|NCT00558896|588818382|FG006|Overall Study|Death|6|||
163031004|NCT00558896|588818376|FG000|Overall Study|Withdrawal by Subject|2|||
163031005|NCT00558896|588818377|FG001|Overall Study|Withdrawal by Subject|1|||
163031006|NCT00558896|588818378|FG002|Overall Study|Withdrawal by Subject|1|||
163031007|NCT00558896|588818379|FG003|Overall Study|Withdrawal by Subject|1|||
163031008|NCT00558896|588818380|FG004|Overall Study|Withdrawal by Subject|1|||
163031009|NCT00558896|588818381|FG005|Overall Study|Withdrawal by Subject|5|||
163031010|NCT00558896|588818382|FG006|Overall Study|Withdrawal by Subject|5|||
163031011|NCT00558896|588818376|FG000|Overall Study|Alternative Treatment|2|||
163031012|NCT00558896|588818377|FG001|Overall Study|Alternative Treatment|2|||
163031013|NCT00558896|588818378|FG002|Overall Study|Alternative Treatment|0|||
163031014|NCT00558896|588818379|FG003|Overall Study|Alternative Treatment|2|||
163031015|NCT00558896|588818380|FG004|Overall Study|Alternative Treatment|6|||
163031016|NCT00558896|588818381|FG005|Overall Study|Alternative Treatment|7|||
163031017|NCT00558896|588818382|FG006|Overall Study|Alternative Treatment|1|||
163031018|NCT00558896|588818376|FG000|Overall Study|Physician discretion|3|||
163031019|NCT00558896|588818377|FG001|Overall Study|Physician discretion|2|||
163031020|NCT00558896|588818378|FG002|Overall Study|Physician discretion|1|||
163031021|NCT00558896|588818379|FG003|Overall Study|Physician discretion|2|||
163031022|NCT00558896|588818380|FG004|Overall Study|Physician discretion|1|||
163031023|NCT00558896|588818381|FG005|Overall Study|Physician discretion|3|||
163031024|NCT00558896|588818382|FG006|Overall Study|Physician discretion|3|||
163031025|NCT00558896|588818376|FG000|Overall Study|Continues on treatment|10|||
163031026|NCT00558896|588818377|FG001|Overall Study|Continues on treatment|1|||
163031027|NCT00558896|588818378|FG002|Overall Study|Continues on treatment|0|||
163031028|NCT00558896|588818379|FG003|Overall Study|Continues on treatment|1|||
163031029|NCT00558896|588818380|FG004|Overall Study|Continues on treatment|9|||
163031030|NCT00558896|588818381|FG005|Overall Study|Continues on treatment|25|||
163031031|NCT00558896|588818382|FG006|Overall Study|Continues on treatment|6|||
163031032|NCT03181503|588818383|FG000|Overall Study|Adverse Event|2|||
163031033|NCT03181503|588818384|FG001|Overall Study|Adverse Event|2|||
163031034|NCT03181503|588818383|FG000|Overall Study|Protocol Violation|1|||
163031035|NCT03181503|588818384|FG001|Overall Study|Protocol Violation|0|||
163031036|NCT03181503|588818383|FG000|Overall Study|Withdrawal by Subject|3|||
163031037|NCT03181503|588818384|FG001|Overall Study|Withdrawal by Subject|0|||
163031038|NCT03181503|588818383|FG000|Overall Study|Lost to Follow-up|1|||
163031039|NCT03181503|588818384|FG001|Overall Study|Lost to Follow-up|1|||
163031040|NCT02382796|588818387|FG000|Overall Study|Global deterioration of health status|1|||
163031041|NCT02382796|588818387|FG000|Overall Study|Objective progression or relapse|3|||
163031042|NCT02382796|588818387|FG000|Overall Study|Commercial dacomitinib became available|3|||
163031043|NCT03077659|588818388|FG000|Overall Study|Withdrawal by Subject|0|||
163085000|NCT02496000|589020358|FG001|Overall Study|Withdrawal by Subject|2|||
163085001|NCT02496000|589020359|FG002|Overall Study|Withdrawal by Subject|0|||
163085002|NCT02496000|589020357|FG000|Overall Study|Lost to Follow-up|1|||
163085003|NCT02496000|589020358|FG001|Overall Study|Lost to Follow-up|0|||
163085004|NCT02496000|589020359|FG002|Overall Study|Lost to Follow-up|1|||
163085005|NCT02496000|589020357|FG000|Overall Study|Protocol Violation|0|||
163085006|NCT02496000|589020358|FG001|Overall Study|Protocol Violation|0|||
163085007|NCT02496000|589020359|FG002|Overall Study|Protocol Violation|1|||
163085008|NCT02496000|589020357|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
163085009|NCT02496000|589020358|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
163085010|NCT02496000|589020359|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
163085011|NCT02496000|589020357|FG000|Overall Study|undetermined|0|||
163085012|NCT02496000|589020358|FG001|Overall Study|undetermined|1|||
163085013|NCT02496000|589020359|FG002|Overall Study|undetermined|0|||
163085014|NCT01877278|589020360|FG000|Overall Study|Lost to Follow-up|3|||
163085015|NCT01877278|589020361|FG001|Overall Study|Lost to Follow-up|3|||
163085016|NCT01969058|589020362|FG000|Overall Study|Withdrawal by Subject|2|||
163085017|NCT01969058|589020363|FG001|Overall Study|Withdrawal by Subject|0|||
163085018|NCT01969058|589020362|FG000|Overall Study|Adverse Event|1|||
163085019|NCT01969058|589020363|FG001|Overall Study|Adverse Event|0|||
163085020|NCT04090749|589020364|FG000|Open Label Pilot|Lost to Follow-up|1|||
163085021|NCT04090749|589020365|FG001|Open Label Pilot|Lost to Follow-up|0|||
163085022|NCT04090749|589020366|FG002|Open Label Pilot|Lost to Follow-up|0|||
163085023|NCT04090749|589020364|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
163085024|NCT04090749|589020365|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
163085025|NCT04090749|589020366|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
163085026|NCT04090749|589020364|FG000|Pilot Trial|Lost to Follow-up|0|||
163085027|NCT04090749|589020365|FG001|Pilot Trial|Lost to Follow-up|1|||
163332752|NCT01364597|589929859|FG000|Overall Study|Sponsor recommended discontinuation|0|||
163332753|NCT01364597|589929860|FG001|Overall Study|Sponsor recommended discontinuation|0|||
163332754|NCT01364597|589929861|FG002|Overall Study|Sponsor recommended discontinuation|0|||
163332755|NCT01364597|589929862|FG003|Overall Study|Sponsor recommended discontinuation|1|||
163332756|NCT01364597|589929859|FG000|Overall Study|Parents went abroad with the patient|0|||
163332757|NCT01364597|589929860|FG001|Overall Study|Parents went abroad with the patient|0|||
163031044|NCT03077659|588818389|FG001|Overall Study|Withdrawal by Subject|0|||
163031045|NCT03077659|588818390|FG002|Overall Study|Withdrawal by Subject|1|||
163031046|NCT02258542|588818397|FG000|Overall Study|eg. not made to the visit|7|||
163031047|NCT02258542|588818398|FG001|Overall Study|eg. not made to the visit|4|||
163031048|NCT02258542|588818399|FG002|Overall Study|eg. not made to the visit|0|||
163031049|NCT02258542|588818400|FG003|Overall Study|eg. not made to the visit|1|||
163031050|NCT02258542|588818397|FG000|Overall Study|study specific discount. criteria|1|||
163031051|NCT02258542|588818398|FG001|Overall Study|study specific discount. criteria|1|||
163031052|NCT02258542|588818399|FG002|Overall Study|study specific discount. criteria|0|||
163031053|NCT02258542|588818400|FG003|Overall Study|study specific discount. criteria|0|||
163031054|NCT02258542|588818397|FG000|Overall Study|Withdrawal by Subject|20|||
163031055|NCT02258542|588818398|FG001|Overall Study|Withdrawal by Subject|20|||
163031056|NCT02258542|588818399|FG002|Overall Study|Withdrawal by Subject|7|||
163031057|NCT02258542|588818400|FG003|Overall Study|Withdrawal by Subject|1|||
163031058|NCT02258542|588818397|FG000|Overall Study|Lost to Follow-up|5|||
163031059|NCT02258542|588818398|FG001|Overall Study|Lost to Follow-up|12|||
163031060|NCT02258542|588818399|FG002|Overall Study|Lost to Follow-up|1|||
163031061|NCT02258542|588818400|FG003|Overall Study|Lost to Follow-up|2|||
163031062|NCT02258542|588818397|FG000|Overall Study|Death|5|||
163031063|NCT02258542|588818398|FG001|Overall Study|Death|4|||
163031064|NCT02258542|588818399|FG002|Overall Study|Death|0|||
163031065|NCT02258542|588818400|FG003|Overall Study|Death|1|||
163031066|NCT02258542|588818397|FG000|Overall Study|Adverse Event|3|||
163031067|NCT02258542|588818398|FG001|Overall Study|Adverse Event|4|||
163031068|NCT02258542|588818399|FG002|Overall Study|Adverse Event|0|||
163031069|NCT02258542|588818400|FG003|Overall Study|Adverse Event|0|||
163031070|NCT02258542|588818397|FG000|Overall Study|Protocol Violation|1|||
163031071|NCT02258542|588818398|FG001|Overall Study|Protocol Violation|2|||
163031072|NCT02258542|588818399|FG002|Overall Study|Protocol Violation|0|||
163031073|NCT02258542|588818400|FG003|Overall Study|Protocol Violation|0|||
163085028|NCT04090749|589020366|FG002|Pilot Trial|Lost to Follow-up|1|||
163085029|NCT03510715|589020367|FG000|Overall Study|Adverse Event|1|||
163085030|NCT03510715|589020368|FG001|Overall Study|Adverse Event|0|||
163085031|NCT01972659|589020370|FG000|Overall Study|Protocol Violation|2|||
163085032|NCT01972659|589020371|FG001|Overall Study|Protocol Violation|2|||
163085033|NCT01972659|589020370|FG000|Overall Study|problems realted to acceleromyograph|2|||
163085034|NCT01972659|589020371|FG001|Overall Study|problems realted to acceleromyograph|1|||
163031074|NCT02258542|588818397|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163031075|NCT02258542|588818398|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
163031076|NCT02258542|588818399|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
163031077|NCT02258542|588818400|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
163406473|NCT03311711|590198643|FG008|Overall Study|Withdrawal by Subject|0|||
163031078|NCT04068688|588818401|FG000|Overall Study|Lost to Follow-up|1|||
163031079|NCT04068688|588818402|FG001|Overall Study|Lost to Follow-up|1|||
163031080|NCT04068688|588818403|FG002|Overall Study|Lost to Follow-up|0|||
163031081|NCT04068688|588818404|FG003|Overall Study|Lost to Follow-up|0|||
163031082|NCT04068688|588818405|FG004|Overall Study|Lost to Follow-up|5|||
163031083|NCT04068688|588818406|FG005|Overall Study|Lost to Follow-up|5|||
163031084|NCT04068688|588818407|FG006|Overall Study|Lost to Follow-up|0|||
163031085|NCT04068688|588818408|FG007|Overall Study|Lost to Follow-up|0|||
163031086|NCT04068688|588818409|FG008|Overall Study|Lost to Follow-up|1|||
163031087|NCT04068688|588818410|FG009|Overall Study|Lost to Follow-up|0|||
163031088|NCT04068688|588818401|FG000|Overall Study|Withdrawal by Subject|1|||
163031089|NCT04068688|588818402|FG001|Overall Study|Withdrawal by Subject|1|||
163031090|NCT04068688|588818403|FG002|Overall Study|Withdrawal by Subject|0|||
163031091|NCT04068688|588818404|FG003|Overall Study|Withdrawal by Subject|0|||
163031092|NCT04068688|588818405|FG004|Overall Study|Withdrawal by Subject|0|||
163031093|NCT04068688|588818406|FG005|Overall Study|Withdrawal by Subject|0|||
163031094|NCT04068688|588818407|FG006|Overall Study|Withdrawal by Subject|0|||
163031095|NCT04068688|588818408|FG007|Overall Study|Withdrawal by Subject|0|||
163031096|NCT04068688|588818409|FG008|Overall Study|Withdrawal by Subject|0|||
163031097|NCT04068688|588818410|FG009|Overall Study|Withdrawal by Subject|0|||
163031098|NCT04068688|588818401|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
163031099|NCT04068688|588818402|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
163031100|NCT04068688|588818403|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031101|NCT04068688|588818404|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031102|NCT04068688|588818405|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031103|NCT04068688|588818406|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031104|NCT04068688|588818407|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031105|NCT04068688|588818408|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031106|NCT04068688|588818409|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031107|NCT04068688|588818410|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031108|NCT04679051|588818411|FG000|Overall Study|felt tired after restricted time in bed|3|||
163031109|NCT04679051|588818412|FG001|Overall Study|felt tired after restricted time in bed|0|||
163031110|NCT04679051|588818411|FG000|Overall Study|discomfort with blood pressure cuff|2|||
163031111|NCT04679051|588818412|FG001|Overall Study|discomfort with blood pressure cuff|0|||
163031112|NCT04679051|588818411|FG000|Overall Study|scheduling conflict|1|||
163031113|NCT04679051|588818412|FG001|Overall Study|scheduling conflict|1|||
163031114|NCT04679051|588818411|FG000|Overall Study|Protocol Violation|0|||
163031115|NCT04679051|588818412|FG001|Overall Study|Protocol Violation|4|||
163031116|NCT00980018|588818419|FG000|Overall Study|Adverse Event|8|||
163031117|NCT00980018|588818419|FG000|Overall Study|Patient withdrew consent|3|||
163031118|NCT00980018|588818419|FG000|Overall Study|Lost to Follow-up|1|||
163031119|NCT00772005|588818422|FG000|Overall Study|Adverse Event|9|||
163031120|NCT00772005|588818423|FG001|Overall Study|Adverse Event|14|||
163031121|NCT00772005|588818424|FG002|Overall Study|Adverse Event|10|||
163031122|NCT00772005|588818425|FG003|Overall Study|Adverse Event|13|||
163031123|NCT00772005|588818422|FG000|Overall Study|Lack of Efficacy|0|||
163031124|NCT00772005|588818423|FG001|Overall Study|Lack of Efficacy|1|||
163031125|NCT00772005|588818424|FG002|Overall Study|Lack of Efficacy|0|||
163031126|NCT00772005|588818425|FG003|Overall Study|Lack of Efficacy|0|||
163031127|NCT00772005|588818422|FG000|Overall Study|Withdrawal by Subject|3|||
163031128|NCT00772005|588818423|FG001|Overall Study|Withdrawal by Subject|7|||
163031129|NCT00772005|588818424|FG002|Overall Study|Withdrawal by Subject|10|||
163031130|NCT00772005|588818425|FG003|Overall Study|Withdrawal by Subject|2|||
163031131|NCT00772005|588818422|FG000|Overall Study|Protocol Violation|2|||
163031132|NCT00772005|588818423|FG001|Overall Study|Protocol Violation|4|||
163031133|NCT00772005|588818424|FG002|Overall Study|Protocol Violation|1|||
163031134|NCT00772005|588818425|FG003|Overall Study|Protocol Violation|6|||
163031135|NCT00772005|588818422|FG000|Overall Study|Lost to Follow-up|7|||
163031136|NCT00772005|588818423|FG001|Overall Study|Lost to Follow-up|3|||
163031137|NCT00772005|588818424|FG002|Overall Study|Lost to Follow-up|6|||
163031138|NCT00772005|588818425|FG003|Overall Study|Lost to Follow-up|3|||
163031139|NCT00772005|588818422|FG000|Overall Study|Non-compliance with study procedures|1|||
163031140|NCT00772005|588818423|FG001|Overall Study|Non-compliance with study procedures|1|||
163031141|NCT00772005|588818424|FG002|Overall Study|Non-compliance with study procedures|0|||
163031142|NCT00772005|588818425|FG003|Overall Study|Non-compliance with study procedures|1|||
163031143|NCT00772005|588818422|FG000|Overall Study|Non-compliance with drug administration|3|||
163031144|NCT00772005|588818423|FG001|Overall Study|Non-compliance with drug administration|0|||
163031145|NCT00772005|588818424|FG002|Overall Study|Non-compliance with drug administration|1|||
163031146|NCT00772005|588818425|FG003|Overall Study|Non-compliance with drug administration|1|||
163031147|NCT01273155|588818429|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
163031148|NCT01273155|588818430|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
163332758|NCT01364597|589929861|FG002|Overall Study|Parents went abroad with the patient|1|||
163332759|NCT01364597|589929862|FG003|Overall Study|Parents went abroad with the patient|0|||
163332760|NCT01364597|589929859|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
163332761|NCT01364597|589929860|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
163031149|NCT01273155|588818431|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
163031150|NCT01273155|588818432|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
163031151|NCT01273155|588818433|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
163031152|NCT01273155|588818434|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
163031153|NCT01273155|588818435|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
163031154|NCT01273155|588818429|FG000|Overall Study|Change in liver function/no longer eval.|0|||
163031155|NCT01273155|588818430|FG001|Overall Study|Change in liver function/no longer eval.|1|||
163031156|NCT01273155|588818431|FG002|Overall Study|Change in liver function/no longer eval.|0|||
163031157|NCT01273155|588818432|FG003|Overall Study|Change in liver function/no longer eval.|0|||
163031158|NCT01273155|588818433|FG004|Overall Study|Change in liver function/no longer eval.|1|||
163031159|NCT01273155|588818434|FG005|Overall Study|Change in liver function/no longer eval.|0|||
163031160|NCT01273155|588818435|FG006|Overall Study|Change in liver function/no longer eval.|0|||
163031161|NCT01273155|588818429|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
163031162|NCT01273155|588818430|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
163031163|NCT01273155|588818431|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
163031164|NCT01273155|588818432|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
163031165|NCT01273155|588818433|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
163031166|NCT01273155|588818434|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
163031167|NCT01273155|588818435|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
163031168|NCT01273155|588818429|FG000|Overall Study|Died during Cycle 1|0|||
163031169|NCT01273155|588818430|FG001|Overall Study|Died during Cycle 1|0|||
163031170|NCT01273155|588818431|FG002|Overall Study|Died during Cycle 1|1|||
163031171|NCT01273155|588818432|FG003|Overall Study|Died during Cycle 1|1|||
163031172|NCT01273155|588818433|FG004|Overall Study|Died during Cycle 1|0|||
163031173|NCT01273155|588818434|FG005|Overall Study|Died during Cycle 1|2|||
163031174|NCT01273155|588818435|FG006|Overall Study|Died during Cycle 1|2|||
163031175|NCT01273155|588818429|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
163031176|NCT01273155|588818430|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
163031177|NCT01273155|588818431|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
163031178|NCT01273155|588818432|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
163031179|NCT01273155|588818433|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
163031180|NCT01273155|588818434|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
163031181|NCT01273155|588818435|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
163031182|NCT01256385|588818436|FG000|Overall Study|Physician Decision|1|||
163031183|NCT01256385|588818437|FG001|Overall Study|Physician Decision|1|||
163031184|NCT01256385|588818436|FG000|Overall Study|Withdrawal by Subject|2|||
163031185|NCT01256385|588818437|FG001|Overall Study|Withdrawal by Subject|2|||
163031186|NCT01440569|588818438|FG000|Main Study|Enrolled but not treated|1|||
163031187|NCT01440569|588818439|FG001|Main Study|Enrolled but not treated|0|||
163031188|NCT01440569|588818438|FG000|Main Study|Adverse Event|9|||
163031189|NCT01440569|588818439|FG001|Main Study|Adverse Event|0|||
163031190|NCT01440569|588818438|FG000|Main Study|Pregnancy|1|||
163031191|NCT01440569|588818439|FG001|Main Study|Pregnancy|0|||
163031192|NCT01440569|588818438|FG000|Main Study|Investigator's Discretion|1|||
163031193|NCT01440569|588818439|FG001|Main Study|Investigator's Discretion|1|||
163031194|NCT01440569|588818438|FG000|Main Study|Withdrew Consent|7|||
163031195|NCT01440569|588818439|FG001|Main Study|Withdrew Consent|1|||
163031196|NCT01440569|588818438|FG000|Main Study|Lost to Follow-up|13|||
163031197|NCT01440569|588818439|FG001|Main Study|Lost to Follow-up|2|||
163031198|NCT01440569|588818438|FG000|Main Study|Subject Non-Compliance|3|||
163031199|NCT01440569|588818439|FG001|Main Study|Subject Non-Compliance|0|||
163031200|NCT01440569|588818438|FG000|Main Study|Protocol Violation|1|||
163031201|NCT01440569|588818439|FG001|Main Study|Protocol Violation|0|||
163031202|NCT01440569|588818438|FG000|Open-Label Rollover Phase|Adverse Event|3|||
163031203|NCT01440569|588818439|FG001|Open-Label Rollover Phase|Adverse Event|0|||
163031204|NCT01440569|588818438|FG000|Open-Label Rollover Phase|Pregnancy|1|||
163031205|NCT01440569|588818439|FG001|Open-Label Rollover Phase|Pregnancy|0|||
163031206|NCT01440569|588818438|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
163031207|NCT01440569|588818439|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
163031208|NCT01440569|588818438|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
163031209|NCT01440569|588818439|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
163332762|NCT01364597|589929861|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
163332763|NCT01364597|589929862|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
163332764|NCT01364597|589929859|FG000|Overall Study|BRV administration dropout|0|||
163332765|NCT01364597|589929860|FG001|Overall Study|BRV administration dropout|0|||
163031210|NCT01440569|588818438|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
163031211|NCT01440569|588818439|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
163031212|NCT01440569|588818438|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
163031213|NCT01440569|588818439|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
163031214|NCT01440569|588818438|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
163031215|NCT01440569|588818439|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
163031216|NCT03887117|588818447|FG000|Overall Study|Discontinued prematurely|0|||
163031217|NCT03887117|588818448|FG001|Overall Study|Discontinued prematurely|1|||
163031218|NCT03887117|588818449|FG002|Overall Study|Discontinued prematurely|1|||
163031219|NCT03887117|588818450|FG003|Overall Study|Discontinued prematurely|2|||
163031220|NCT02584959|588818451|FG000|Period 1|Withdrawn from study|3|||
163031221|NCT02584959|588818452|FG001|Period 1|Withdrawn from study|4|||
163031222|NCT02584959|588818453|FG002|Period 1|Withdrawn from study|0|||
163031223|NCT02584959|588818451|FG000|Period 2|Withdrawn from study|6|||
163031224|NCT02584959|588818452|FG001|Period 2|Withdrawn from study|1|||
163031225|NCT02584959|588818453|FG002|Period 2|Withdrawn from study|2|||
163031226|NCT04908475|588818454|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
163031227|NCT04908475|588818455|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163031228|NCT04908475|588818456|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163031229|NCT04908475|588818457|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163031230|NCT04908475|588818458|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163031231|NCT04908475|588818459|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163031232|NCT04908475|588818454|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
163031233|NCT04908475|588818455|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
163031234|NCT04908475|588818456|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
163031235|NCT04908475|588818457|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
163031236|NCT04908475|588818458|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
163031237|NCT04908475|588818459|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
163031238|NCT04908475|588818454|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
163332766|NCT01364597|589929861|FG002|Overall Study|BRV administration dropout|1|||
163332767|NCT01364597|589929862|FG003|Overall Study|BRV administration dropout|0|||
163031239|NCT04908475|588818455|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
163031240|NCT04908475|588818456|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
163031241|NCT04908475|588818457|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
163031242|NCT04908475|588818458|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
163031243|NCT04908475|588818459|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
163031244|NCT04908475|588818454|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
163031245|NCT04908475|588818455|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
163031246|NCT04908475|588818456|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
163031247|NCT04908475|588818457|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
163031248|NCT04908475|588818458|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
163031249|NCT04908475|588818459|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
163031250|NCT04908475|588818454|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
163031251|NCT04908475|588818455|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
163031252|NCT04908475|588818456|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
163031253|NCT04908475|588818457|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
163031254|NCT04908475|588818458|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
163031255|NCT04908475|588818459|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
163031256|NCT04908475|588818454|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
163031257|NCT04908475|588818455|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
163031258|NCT04908475|588818456|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
163031259|NCT04908475|588818457|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
163031260|NCT04908475|588818458|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
163332768|NCT01364597|589929859|FG000|Overall Study|Dropout|0|||
163332769|NCT01364597|589929860|FG001|Overall Study|Dropout|0|||
163332770|NCT01364597|589929861|FG002|Overall Study|Dropout|3|||
163332771|NCT01364597|589929862|FG003|Overall Study|Dropout|1|||
163332772|NCT01364597|589929859|FG000|Overall Study|Unreliable subject|0|||
163332773|NCT01364597|589929860|FG001|Overall Study|Unreliable subject|0|||
163332774|NCT01364597|589929861|FG002|Overall Study|Unreliable subject|0|||
163332775|NCT01364597|589929862|FG003|Overall Study|Unreliable subject|1|||
163332776|NCT01364597|589929859|FG000|Overall Study|Other|0|||
163332777|NCT01364597|589929860|FG001|Overall Study|Other|0|||
163332778|NCT01364597|589929861|FG002|Overall Study|Other|0|||
163332779|NCT01364597|589929862|FG003|Overall Study|Other|1|||
163031261|NCT04908475|588818459|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
163031262|NCT01267201|588818465|FG000|First Intervention Period|Withdrawal by Subject|1|||
163031263|NCT01267201|588818466|FG001|First Intervention Period|Withdrawal by Subject|0|||
163031264|NCT01267201|588818467|FG002|First Intervention Period|Withdrawal by Subject|0|||
163031265|NCT01267201|588818468|FG003|First Intervention Period|Withdrawal by Subject|0|||
163031266|NCT01267201|588818469|FG004|First Intervention Period|Withdrawal by Subject|0|||
163085035|NCT02457793|589020373|FG000|Overall Study|Reason not specified|0|||
163332780|NCT03214081|589929863|FG000|Overall Study|Case Report Forms Uncollected|9|||
163332781|NCT03214081|589929863|FG000|Overall Study|Protocol Deviation|54|||
163031267|NCT01267201|588818470|FG005|First Intervention Period|Withdrawal by Subject|0|||
163031268|NCT01267201|588818465|FG000|Second Intervention Period|Withdrawal by Subject|0|||
163031269|NCT01267201|588818466|FG001|Second Intervention Period|Withdrawal by Subject|1|||
163031270|NCT01267201|588818467|FG002|Second Intervention Period|Withdrawal by Subject|0|||
163031271|NCT01267201|588818468|FG003|Second Intervention Period|Withdrawal by Subject|0|||
163031272|NCT01267201|588818469|FG004|Second Intervention Period|Withdrawal by Subject|0|||
163031273|NCT01267201|588818470|FG005|Second Intervention Period|Withdrawal by Subject|0|||
163332782|NCT02962284|589929864|FG000|Overall Study|Death|2|||
163332783|NCT02962284|589929865|FG001|Overall Study|Death|0|||
163332784|NCT02962284|589929864|FG000|Overall Study|Progressive disease|2|||
163031274|NCT00483704|588818471|FG000|Randomization|Withdrawal by Subject|19|||
163031275|NCT00483704|588818472|FG001|Randomization|Withdrawal by Subject|28|||
163031276|NCT00483704|588818473|FG002|Randomization|Withdrawal by Subject|18|||
163031277|NCT00483704|588818471|FG000|Randomization|Protocol Violation|14|||
163031278|NCT00483704|588818472|FG001|Randomization|Protocol Violation|25|||
163031279|NCT00483704|588818473|FG002|Randomization|Protocol Violation|22|||
163031280|NCT00483704|588818471|FG000|Randomization|Lost to Follow-up|14|||
163031281|NCT00483704|588818472|FG001|Randomization|Lost to Follow-up|14|||
163031282|NCT00483704|588818473|FG002|Randomization|Lost to Follow-up|19|||
163031283|NCT00483704|588818471|FG000|Randomization|Pregnancy|1|||
163031284|NCT00483704|588818472|FG001|Randomization|Pregnancy|0|||
163031285|NCT00483704|588818473|FG002|Randomization|Pregnancy|0|||
163031286|NCT00483704|588818471|FG000|Randomization|Physician Decision|2|||
163031287|NCT00483704|588818472|FG001|Randomization|Physician Decision|4|||
163031288|NCT00483704|588818473|FG002|Randomization|Physician Decision|0|||
163031289|NCT00483704|588818471|FG000|Randomization|Progressive disease|0|||
163031290|NCT00483704|588818472|FG001|Randomization|Progressive disease|0|||
163031291|NCT00483704|588818473|FG002|Randomization|Progressive disease|1|||
163031292|NCT00483704|588818471|FG000|Randomization|Lack of qualifying migraines|21|||
163031293|NCT00483704|588818472|FG001|Randomization|Lack of qualifying migraines|25|||
163332785|NCT02962284|589929865|FG001|Overall Study|Progressive disease|3|||
163332786|NCT02962284|589929864|FG000|Overall Study|Withdrawal by Subject|1|||
163332787|NCT02962284|589929865|FG001|Overall Study|Withdrawal by Subject|0|||
163031294|NCT00483704|588818473|FG002|Randomization|Lack of qualifying migraines|31|||
163031295|NCT00483704|588818471|FG000|Treatment|Lack of qualifying migraines|101|||
163031296|NCT00483704|588818472|FG001|Treatment|Lack of qualifying migraines|99|||
163031297|NCT00483704|588818473|FG002|Treatment|Lack of qualifying migraines|116|||
163031298|NCT00483704|588818471|FG000|Treatment|Adverse Event|3|||
163031299|NCT00483704|588818472|FG001|Treatment|Adverse Event|5|||
163031300|NCT00483704|588818473|FG002|Treatment|Adverse Event|4|||
163031301|NCT00483704|588818471|FG000|Treatment|Withdrawal by Subject|16|||
163031302|NCT00483704|588818472|FG001|Treatment|Withdrawal by Subject|12|||
163031303|NCT00483704|588818473|FG002|Treatment|Withdrawal by Subject|21|||
163031304|NCT00483704|588818471|FG000|Treatment|Protocol Violation|6|||
163031305|NCT00483704|588818472|FG001|Treatment|Protocol Violation|3|||
163031306|NCT00483704|588818473|FG002|Treatment|Protocol Violation|5|||
163031307|NCT00483704|588818471|FG000|Treatment|Lost to Follow-up|2|||
163031308|NCT00483704|588818472|FG001|Treatment|Lost to Follow-up|7|||
163031309|NCT00483704|588818473|FG002|Treatment|Lost to Follow-up|5|||
163031310|NCT00483704|588818471|FG000|Treatment|Lack of Efficacy|1|||
163031311|NCT00483704|588818472|FG001|Treatment|Lack of Efficacy|1|||
163031312|NCT00483704|588818473|FG002|Treatment|Lack of Efficacy|1|||
163031313|NCT00483704|588818471|FG000|Treatment|Pregnancy|0|||
163031314|NCT00483704|588818472|FG001|Treatment|Pregnancy|1|||
163031315|NCT00483704|588818473|FG002|Treatment|Pregnancy|0|||
163031316|NCT00483704|588818471|FG000|Treatment|Physician Decision|0|||
163031317|NCT00483704|588818472|FG001|Treatment|Physician Decision|1|||
163031318|NCT00483704|588818473|FG002|Treatment|Physician Decision|4|||
163031319|NCT04272606|588818474|FG000|Overall Study|Protocol Violation|1|||
163332788|NCT03493282|589929869|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
163031320|NCT04272606|588818475|FG001|Overall Study|Protocol Violation|1|||
163031321|NCT04272606|588818474|FG000|Overall Study|Physician Decision|0|||
163031322|NCT04272606|588818475|FG001|Overall Study|Physician Decision|1|||
163031323|NCT03912428|588818476|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
163031324|NCT03912428|588818477|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
163031325|NCT03912428|588818478|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
163031326|NCT03912428|588818479|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
163031327|NCT03912428|588818476|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
163031328|NCT03912428|588818477|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
163031329|NCT03912428|588818478|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
163031330|NCT03912428|588818479|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
163031331|NCT03912428|588818476|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
163031332|NCT03912428|588818477|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
163031333|NCT03912428|588818478|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
163031334|NCT03912428|588818479|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
163031335|NCT02537431|588818480|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
163332789|NCT03493282|589929870|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
163332790|NCT03493282|589929871|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
163332791|NCT03493282|589929869|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
163332792|NCT03493282|589929870|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
163332793|NCT03493282|589929871|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
163332794|NCT00670449|589929872|FG000|Overall Study|Adverse Event|6|||
163332795|NCT00670449|589929873|FG001|Overall Study|Adverse Event|2|||
163332796|NCT00670449|589929874|FG002|Overall Study|Adverse Event|8|||
163332797|NCT00670449|589929875|FG003|Overall Study|Adverse Event|5|||
163332798|NCT00670449|589929872|FG000|Overall Study|Protocol Deviation|1|||
163406474|NCT03311711|590198644|FG009|Overall Study|Withdrawal by Subject|0|||
163406475|NCT02229552|590198645|FG000|Baseline|Withdrawal by Subject|6|||
163406476|NCT02229552|590198645|FG000|1-year Follow up|Withdrawal by Subject|7|||
163406477|NCT02229552|590198645|FG000|1-year Follow up|Lost to Follow-up|18|||
163406478|NCT02229552|590198645|FG000|2-Year Follow up|Withdrawal by Subject|9|||
163406479|NCT02229552|590198645|FG000|2-Year Follow up|Lost to Follow-up|17|||
163406480|NCT00706134|590198646|FG000|Overall Study|Adverse Event|8|||
163406481|NCT00706134|590198647|FG001|Overall Study|Adverse Event|7|||
163406482|NCT00706134|590198648|FG002|Overall Study|Adverse Event|2|||
163406483|NCT00706134|590198649|FG003|Overall Study|Adverse Event|3|||
163406484|NCT00706134|590198646|FG000|Overall Study|Lost to Follow-up|0|||
163406485|NCT00706134|590198647|FG001|Overall Study|Lost to Follow-up|1|||
163406486|NCT00706134|590198648|FG002|Overall Study|Lost to Follow-up|0|||
163406487|NCT00706134|590198649|FG003|Overall Study|Lost to Follow-up|0|||
163406488|NCT00706134|590198646|FG000|Overall Study|Protocol Violation|0|||
163406489|NCT00706134|590198647|FG001|Overall Study|Protocol Violation|6|||
163406490|NCT00706134|590198648|FG002|Overall Study|Protocol Violation|0|||
163406491|NCT00706134|590198649|FG003|Overall Study|Protocol Violation|3|||
163406492|NCT00706134|590198646|FG000|Overall Study|Withdrawal by Subject|1|||
163406493|NCT00706134|590198647|FG001|Overall Study|Withdrawal by Subject|2|||
163406494|NCT00706134|590198648|FG002|Overall Study|Withdrawal by Subject|1|||
163406495|NCT00706134|590198649|FG003|Overall Study|Withdrawal by Subject|0|||
163406496|NCT00706134|590198646|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
163406497|NCT00706134|590198647|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
163406498|NCT00706134|590198648|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
163031336|NCT01037127|588818487|FG000|Overall Study|Lost to Follow-up|2|||
163031337|NCT01037127|588818488|FG001|Overall Study|Lost to Follow-up|4|||
163031338|NCT01037127|588818487|FG000|Overall Study|Physician Decision|1|||
163031339|NCT01037127|588818488|FG001|Overall Study|Physician Decision|0|||
163031340|NCT01037127|588818487|FG000|Overall Study|Study Closed Terminated|2|||
163031341|NCT01037127|588818488|FG001|Overall Study|Study Closed Terminated|17|||
163031342|NCT04325698|588818489|FG000|Overall Study|Study Terminated By Sponsor|1|||
163406499|NCT00706134|590198649|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
163031343|NCT04325698|588818490|FG001|Overall Study|Study Terminated By Sponsor|1|||
163031344|NCT04325698|588818489|FG000|Overall Study|Withdrawal by Subject|0|||
163031345|NCT04325698|588818490|FG001|Overall Study|Withdrawal by Subject|2|||
163031346|NCT04253782|588818491|FG000|Overall Study|Death|2|||
163031347|NCT04253782|588818492|FG001|Overall Study|Death|0|||
163031348|NCT02326298|588818497|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031349|NCT02326298|588818498|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031350|NCT02326298|588818499|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
163031351|NCT02326298|588818500|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031352|NCT02326298|588818501|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031353|NCT02326298|588818502|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031354|NCT02326298|588818503|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031355|NCT02326298|588818504|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031356|NCT02326298|588818505|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031357|NCT02326298|588818506|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031358|NCT02326298|588818507|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031359|NCT02326298|588818508|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031360|NCT02326298|588818509|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163332799|NCT00670449|589929873|FG001|Overall Study|Protocol Deviation|2|||
163332800|NCT00670449|589929874|FG002|Overall Study|Protocol Deviation|0|||
163406500|NCT00706134|590198646|FG000|Overall Study|Did not meet study criteria|2|||
163406501|NCT00706134|590198647|FG001|Overall Study|Did not meet study criteria|0|||
163406502|NCT00706134|590198648|FG002|Overall Study|Did not meet study criteria|0|||
163332801|NCT00670449|589929875|FG003|Overall Study|Protocol Deviation|1|||
163031361|NCT02326298|588818510|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031362|NCT02326298|588818497|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
163031363|NCT02326298|588818498|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163332802|NCT00670449|589929872|FG000|Overall Study|Administrative Problems|0|||
163332803|NCT00670449|589929873|FG001|Overall Study|Administrative Problems|2|||
163406503|NCT00706134|590198649|FG003|Overall Study|Did not meet study criteria|0|||
163406504|NCT01391000|590198659|FG000|Overall Study|Lost to Follow-up|2|||
163406505|NCT01391000|590198660|FG001|Overall Study|Lost to Follow-up|0|||
163031364|NCT02326298|588818499|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031365|NCT02326298|588818500|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031366|NCT02326298|588818501|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031367|NCT02326298|588818502|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031368|NCT02326298|588818503|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031369|NCT02326298|588818504|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031370|NCT02326298|588818505|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031371|NCT02326298|588818506|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031372|NCT02326298|588818507|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031373|NCT02326298|588818508|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031374|NCT02326298|588818509|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031375|NCT02326298|588818510|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031376|NCT02326298|588818497|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
163031377|NCT02326298|588818498|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
163031378|NCT02326298|588818499|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031379|NCT02326298|588818500|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031380|NCT02326298|588818501|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031381|NCT02326298|588818502|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031382|NCT02326298|588818503|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031383|NCT02326298|588818504|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031384|NCT02326298|588818505|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163332804|NCT00670449|589929874|FG002|Overall Study|Administrative Problems|0|||
163332805|NCT00670449|589929875|FG003|Overall Study|Administrative Problems|1|||
163332806|NCT00670449|589929872|FG000|Overall Study|Subject Withdrew Consent|0|||
163332807|NCT00670449|589929873|FG001|Overall Study|Subject Withdrew Consent|2|||
163332808|NCT00670449|589929874|FG002|Overall Study|Subject Withdrew Consent|0|||
163332809|NCT00670449|589929875|FG003|Overall Study|Subject Withdrew Consent|1|||
163332810|NCT00670449|589929872|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
163332811|NCT00670449|589929873|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163332812|NCT00670449|589929874|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
163332813|NCT00670449|589929875|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163332814|NCT00670449|589929872|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
163332815|NCT00670449|589929873|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
163332816|NCT00670449|589929874|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
163332817|NCT00670449|589929875|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
163332818|NCT02634307|589929876|FG000|Overall Study|Adverse Event|50|||
163332819|NCT02634307|589929877|FG001|Overall Study|Adverse Event|24|||
163332820|NCT02634307|589929878|FG002|Overall Study|Adverse Event|14|||
163332821|NCT02634307|589929876|FG000|Overall Study|Lost to Follow-up|21|||
163332822|NCT02634307|589929877|FG001|Overall Study|Lost to Follow-up|5|||
163332823|NCT02634307|589929878|FG002|Overall Study|Lost to Follow-up|6|||
163332824|NCT02634307|589929876|FG000|Overall Study|Pregnancy|5|||
163332825|NCT02634307|589929877|FG001|Overall Study|Pregnancy|1|||
163332826|NCT02634307|589929878|FG002|Overall Study|Pregnancy|3|||
163332827|NCT02634307|589929876|FG000|Overall Study|Withdrawal by Subject|38|||
163332828|NCT02634307|589929877|FG001|Overall Study|Withdrawal by Subject|24|||
163332829|NCT02634307|589929878|FG002|Overall Study|Withdrawal by Subject|18|||
163332830|NCT02634307|589929876|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163332831|NCT02634307|589929877|FG001|Overall Study|Non-Compliance with Study Drug|2|||
163332832|NCT02634307|589929878|FG002|Overall Study|Non-Compliance with Study Drug|2|||
163332833|NCT02634307|589929876|FG000|Overall Study|Lack of Efficacy|1|||
163332834|NCT02634307|589929877|FG001|Overall Study|Lack of Efficacy|5|||
163332835|NCT02634307|589929878|FG002|Overall Study|Lack of Efficacy|3|||
163332836|NCT02634307|589929876|FG000|Overall Study|Physician Decision|7|||
163332837|NCT02634307|589929877|FG001|Overall Study|Physician Decision|5|||
163332838|NCT02634307|589929878|FG002|Overall Study|Physician Decision|5|||
163332839|NCT02634307|589929876|FG000|Overall Study|Reason not Specified|3|||
163332840|NCT02634307|589929877|FG001|Overall Study|Reason not Specified|5|||
163332841|NCT02634307|589929878|FG002|Overall Study|Reason not Specified|10|||
163031385|NCT02326298|588818506|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031386|NCT02326298|588818507|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163219803|NCT05389657|589519504|FG001|Overall Study|Lost to Follow-up|8|||
163219804|NCT05237206|589519506|FG000|Overall Study|screen failure-did not receive treatment|8|||
163332842|NCT00413283|589929883|FG000|Overall Study|Withdrawal by Subject|1|||
163332843|NCT00413283|589929884|FG001|Overall Study|Withdrawal by Subject|0|||
163332844|NCT00413283|589929885|FG002|Overall Study|Withdrawal by Subject|0|||
163332845|NCT00413283|589929886|FG003|Overall Study|Withdrawal by Subject|1|||
163332846|NCT00413283|589929883|FG000|Overall Study|Death|0|||
163332847|NCT00413283|589929884|FG001|Overall Study|Death|0|||
163332848|NCT00413283|589929885|FG002|Overall Study|Death|1|||
163332849|NCT00413283|589929886|FG003|Overall Study|Death|1|||
163332850|NCT00413283|589929883|FG000|Overall Study|Adverse Event|0|||
163332851|NCT00413283|589929884|FG001|Overall Study|Adverse Event|0|||
163031387|NCT02326298|588818508|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031388|NCT02326298|588818509|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031389|NCT02326298|588818510|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031390|NCT02326298|588818497|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
163031391|NCT02326298|588818498|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
163031392|NCT02326298|588818499|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031393|NCT02326298|588818500|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031394|NCT02326298|588818501|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031395|NCT02326298|588818502|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031396|NCT02326298|588818503|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031397|NCT02326298|588818504|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031398|NCT02326298|588818505|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031399|NCT02326298|588818506|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031400|NCT02326298|588818507|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031401|NCT02326298|588818508|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031402|NCT02326298|588818509|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031403|NCT02326298|588818510|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031404|NCT02326298|588818497|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031405|NCT02326298|588818498|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031406|NCT02326298|588818499|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
163031407|NCT02326298|588818500|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031408|NCT02326298|588818501|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031409|NCT02326298|588818502|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031410|NCT02326298|588818503|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031411|NCT02326298|588818504|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031412|NCT02326298|588818505|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031413|NCT02326298|588818506|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031414|NCT02326298|588818507|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031415|NCT02326298|588818508|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031416|NCT02326298|588818509|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031417|NCT02326298|588818510|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031418|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031419|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031420|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031421|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031422|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031423|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163031424|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
163031425|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163031426|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163031427|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163031428|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031429|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031430|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031431|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031432|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031433|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031434|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031435|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031436|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031437|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
163031438|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
163031439|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031440|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
163031441|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031442|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031443|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163085036|NCT02457793|589020374|FG001|Overall Study|Reason not specified|0|||
163085037|NCT02457793|589020375|FG002|Overall Study|Reason not specified|0|||
163085038|NCT02457793|589020376|FG003|Overall Study|Reason not specified|1|||
163085039|NCT02457793|589020377|FG004|Overall Study|Reason not specified|1|||
163031444|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031445|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031446|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031447|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031448|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031449|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031450|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031451|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
163031452|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031453|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031454|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031455|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031456|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031457|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031458|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031459|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031460|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031461|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031462|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031463|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031464|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031465|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031466|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
163031467|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031468|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031469|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031470|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031471|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031472|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031473|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031474|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031475|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031476|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031477|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031478|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031479|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031480|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031481|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
163031482|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031483|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031484|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031485|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031486|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031487|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031488|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031489|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031490|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031491|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031492|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031493|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031494|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
163031495|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
163031496|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031497|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031498|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163332852|NCT00413283|589929885|FG002|Overall Study|Adverse Event|0|||
163332853|NCT00413283|589929886|FG003|Overall Study|Adverse Event|1|||
163332854|NCT00413283|589929883|FG000|Overall Study|Ineligibility determined|0|||
163031499|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031500|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031501|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163332855|NCT00413283|589929884|FG001|Overall Study|Ineligibility determined|0|||
163332856|NCT00413283|589929885|FG002|Overall Study|Ineligibility determined|0|||
163031502|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031503|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031504|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031505|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031506|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031507|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031508|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031509|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
163031510|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031511|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031512|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031513|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031514|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031515|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031516|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031517|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031518|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031519|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031520|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031521|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
163031522|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031523|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031524|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031525|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031526|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031527|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031528|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031529|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031530|NCT02326298|588818497|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
163031531|NCT02326298|588818498|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
163031532|NCT02326298|588818499|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
163031533|NCT02326298|588818500|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
163031534|NCT02326298|588818501|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
163031535|NCT02326298|588818502|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
163031536|NCT02326298|588818503|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
163031537|NCT02326298|588818504|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
163031538|NCT02326298|588818505|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
163031539|NCT02326298|588818506|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
163031540|NCT02326298|588818507|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
163031541|NCT02326298|588818508|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
163031542|NCT02326298|588818509|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
163031543|NCT02326298|588818510|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
163031544|NCT02326298|588818497|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031545|NCT02326298|588818498|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031546|NCT02326298|588818499|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031547|NCT02326298|588818500|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031548|NCT02326298|588818501|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031549|NCT02326298|588818502|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031550|NCT02326298|588818503|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031551|NCT02326298|588818504|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031552|NCT02326298|588818505|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031553|NCT02326298|588818506|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031554|NCT02326298|588818507|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031555|NCT02326298|588818508|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
163085040|NCT02457793|589020378|FG005|Overall Study|Reason not specified|1|||
163085041|NCT02457793|589020373|FG000|Overall Study|Withdrawal by Subject|0|||
163085042|NCT02457793|589020374|FG001|Overall Study|Withdrawal by Subject|4|||
163085043|NCT02457793|589020375|FG002|Overall Study|Withdrawal by Subject|2|||
163219805|NCT05237206|589519506|FG000|Overall Study|did not receive treatment|3|||
163219806|NCT02154581|589519510|FG000|Overall Study|Lost to Follow-up|7|||
163219807|NCT02154581|589519511|FG001|Overall Study|Lost to Follow-up|8|||
163219808|NCT00076011|589521316|FG000|Overall Study|Death|1|||
163219809|NCT00076011|589521316|FG000|Overall Study|Adverse Event|10|||
163219810|NCT00076011|589521316|FG000|Overall Study|Lack of Efficacy|25|||
163219811|NCT00076011|589521316|FG000|Overall Study|Withdrawal by Subject|1|||
163406506|NCT03860961|590198664|FG000|Overall Study|Withdrawal by Subject|6|||
163031556|NCT02326298|588818509|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
163031557|NCT02326298|588818510|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031558|NCT02326298|588818497|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031559|NCT02326298|588818498|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031560|NCT02326298|588818499|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031561|NCT02326298|588818500|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031562|NCT02326298|588818501|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031563|NCT02326298|588818502|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031564|NCT02326298|588818503|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031565|NCT02326298|588818504|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031566|NCT02326298|588818505|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031567|NCT02326298|588818506|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031568|NCT02326298|588818507|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031569|NCT02326298|588818508|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
163031570|NCT02326298|588818509|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
163031571|NCT02326298|588818510|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031572|NCT02326298|588818497|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031573|NCT02326298|588818498|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031574|NCT02326298|588818499|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031575|NCT02326298|588818500|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031576|NCT02326298|588818501|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031577|NCT02326298|588818502|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031578|NCT02326298|588818503|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031579|NCT02326298|588818504|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031580|NCT02326298|588818505|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031581|NCT02326298|588818506|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163219812|NCT00076011|589521316|FG000|Overall Study|Study terminated by sponsor|3|||
163219813|NCT00076011|589521316|FG000|Overall Study|Other|11|||
163219814|NCT00076011|589521316|FG000|Overall Study|Ongoing|1|||
163219815|NCT02864251|589521320|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
163219816|NCT02864251|589521321|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
163219817|NCT02864251|589521322|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
163219818|NCT02864251|589521320|FG000|Pre-Treatment|Withdrawal by Participant|0|||
163219819|NCT02864251|589521321|FG001|Pre-Treatment|Withdrawal by Participant|0|||
163219820|NCT02864251|589521322|FG002|Pre-Treatment|Withdrawal by Participant|4|||
163219821|NCT02864251|589521320|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
163219822|NCT02864251|589521321|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
163219823|NCT02864251|589521322|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
163219824|NCT02864251|589521320|FG000|Pre-Treatment|Other Reasons|0|||
163219825|NCT02864251|589521321|FG001|Pre-Treatment|Other Reasons|1|||
163219826|NCT02864251|589521322|FG002|Pre-Treatment|Other Reasons|1|||
163219827|NCT02864251|589521320|FG000|Treatment|Disease Progression|109|||
163219828|NCT02864251|589521321|FG001|Treatment|Disease Progression|52|||
163219829|NCT02864251|589521322|FG002|Treatment|Disease Progression|101|||
163219830|NCT02864251|589521320|FG000|Treatment|Study Drug Toxicity|9|||
163219831|NCT02864251|589521321|FG001|Treatment|Study Drug Toxicity|4|||
163219832|NCT02864251|589521322|FG002|Treatment|Study Drug Toxicity|10|||
163219833|NCT02864251|589521320|FG000|Treatment|Death|0|||
163219834|NCT02864251|589521321|FG001|Treatment|Death|2|||
163219835|NCT02864251|589521322|FG002|Treatment|Death|3|||
163219836|NCT02864251|589521320|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
163219837|NCT02864251|589521321|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
163219838|NCT02864251|589521322|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
163219839|NCT02864251|589521320|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
163219840|NCT02864251|589521321|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
163219841|NCT02864251|589521322|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
163219842|NCT02864251|589521320|FG000|Treatment|Withdrawal by Participant|8|||
163219843|NCT02864251|589521321|FG001|Treatment|Withdrawal by Participant|5|||
163219844|NCT02864251|589521322|FG002|Treatment|Withdrawal by Participant|13|||
163219845|NCT02864251|589521320|FG000|Treatment|Maximum Clinical Benefit|1|||
163219846|NCT02864251|589521321|FG001|Treatment|Maximum Clinical Benefit|0|||
163219847|NCT02864251|589521322|FG002|Treatment|Maximum Clinical Benefit|1|||
163219848|NCT02864251|589521320|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
163219849|NCT02864251|589521321|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
163219850|NCT02864251|589521322|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
163219851|NCT02864251|589521320|FG000|Treatment|Other Reasons|1|||
163219852|NCT02864251|589521321|FG001|Treatment|Other Reasons|1|||
163219853|NCT02864251|589521322|FG002|Treatment|Other Reasons|4|||
163085044|NCT02457793|589020376|FG003|Overall Study|Withdrawal by Subject|2|||
163085045|NCT02457793|589020377|FG004|Overall Study|Withdrawal by Subject|2|||
163085046|NCT02457793|589020378|FG005|Overall Study|Withdrawal by Subject|2|||
163085047|NCT02457793|589020373|FG000|Overall Study|Adverse Event|0|||
163085048|NCT02457793|589020374|FG001|Overall Study|Adverse Event|0|||
163085049|NCT02457793|589020375|FG002|Overall Study|Adverse Event|0|||
163085050|NCT02457793|589020376|FG003|Overall Study|Adverse Event|1|||
163085051|NCT02457793|589020377|FG004|Overall Study|Adverse Event|0|||
163085052|NCT02457793|589020378|FG005|Overall Study|Adverse Event|0|||
163085053|NCT02457793|589020373|FG000|Overall Study|Physician Decision|1|||
163085054|NCT02457793|589020374|FG001|Overall Study|Physician Decision|0|||
163332857|NCT00413283|589929886|FG003|Overall Study|Ineligibility determined|1|||
163332858|NCT00413283|589929883|FG000|Overall Study|Protocol deviation|0|||
163332859|NCT00413283|589929884|FG001|Overall Study|Protocol deviation|1|||
163332860|NCT00413283|589929885|FG002|Overall Study|Protocol deviation|0|||
163332861|NCT00413283|589929886|FG003|Overall Study|Protocol deviation|0|||
163332862|NCT00413283|589929883|FG000|Overall Study|Requirement for alternative therapy|0|||
163031582|NCT02326298|588818507|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031583|NCT02326298|588818508|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031584|NCT02326298|588818509|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031585|NCT02326298|588818510|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
163031586|NCT02326298|588818497|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031587|NCT02326298|588818498|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031588|NCT02326298|588818499|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031589|NCT02326298|588818500|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031590|NCT02326298|588818501|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031591|NCT02326298|588818502|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031592|NCT02326298|588818503|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031593|NCT02326298|588818504|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031594|NCT02326298|588818505|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031595|NCT02326298|588818506|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031596|NCT02326298|588818507|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031597|NCT02326298|588818508|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
163031598|NCT02326298|588818509|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
163031599|NCT02326298|588818510|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
163031600|NCT02326298|588818497|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031601|NCT02326298|588818498|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031602|NCT02326298|588818499|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031603|NCT02326298|588818500|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031604|NCT02326298|588818501|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031605|NCT02326298|588818502|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031606|NCT02326298|588818503|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031607|NCT02326298|588818504|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031608|NCT02326298|588818505|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031609|NCT02326298|588818506|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031610|NCT02326298|588818507|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031611|NCT02326298|588818508|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
163031612|NCT02326298|588818509|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
163031613|NCT02326298|588818510|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
163031614|NCT02326298|588818497|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031615|NCT02326298|588818498|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031616|NCT02326298|588818499|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031617|NCT02326298|588818500|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031618|NCT02326298|588818501|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031619|NCT02326298|588818502|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031620|NCT02326298|588818503|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031621|NCT02326298|588818504|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031622|NCT02326298|588818505|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031623|NCT02326298|588818506|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031624|NCT02326298|588818507|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031625|NCT02326298|588818508|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
163031626|NCT02326298|588818509|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
163085055|NCT02457793|589020375|FG002|Overall Study|Physician Decision|1|||
163085056|NCT02457793|589020376|FG003|Overall Study|Physician Decision|1|||
163085057|NCT02457793|589020377|FG004|Overall Study|Physician Decision|1|||
163332863|NCT00413283|589929884|FG001|Overall Study|Requirement for alternative therapy|2|||
163332864|NCT00413283|589929885|FG002|Overall Study|Requirement for alternative therapy|0|||
163031627|NCT02326298|588818510|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
163031628|NCT02889835|588818511|FG000|Overall Study|Lost to Follow-up|13|||
163031629|NCT02889835|588818512|FG001|Overall Study|Lost to Follow-up|13|||
163031630|NCT02889835|588818513|FG002|Overall Study|Lost to Follow-up|13|||
163031631|NCT02889835|588818511|FG000|Overall Study|Withdrawal by Subject|2|||
163031632|NCT02889835|588818512|FG001|Overall Study|Withdrawal by Subject|2|||
163031633|NCT02889835|588818513|FG002|Overall Study|Withdrawal by Subject|2|||
163031634|NCT02889835|588818511|FG000|Overall Study|Protocol Violation|1|||
163031635|NCT02889835|588818512|FG001|Overall Study|Protocol Violation|1|||
163031636|NCT02889835|588818513|FG002|Overall Study|Protocol Violation|1|||
163031637|NCT02889835|588818511|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
163031638|NCT02889835|588818512|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
163031639|NCT02889835|588818513|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
163031640|NCT02889835|588818511|FG000|Overall Study|Death|1|||
163031641|NCT02889835|588818512|FG001|Overall Study|Death|1|||
163031642|NCT02889835|588818513|FG002|Overall Study|Death|1|||
163031643|NCT01709864|588820257|FG000|Overall Study|Physician Decision|0|||
163031644|NCT01709864|588820258|FG001|Overall Study|Physician Decision|1|||
163031645|NCT01709864|588820257|FG000|Overall Study|subject/guardian decision|5|||
163031646|NCT01709864|588820258|FG001|Overall Study|subject/guardian decision|6|||
163031647|NCT01709864|588820257|FG000|Overall Study|Lost to Follow-up|1|||
163031648|NCT01709864|588820258|FG001|Overall Study|Lost to Follow-up|0|||
163031649|NCT01709864|588820257|FG000|Overall Study|non-compliance with study treatment|1|||
163031650|NCT01709864|588820258|FG001|Overall Study|non-compliance with study treatment|1|||
163031651|NCT01709864|588820257|FG000|Overall Study|Adverse Event|0|||
163031652|NCT01709864|588820258|FG001|Overall Study|Adverse Event|2|||
163031653|NCT01709864|588820257|FG000|Overall Study|Death|0|||
163031654|NCT01709864|588820258|FG001|Overall Study|Death|1|||
163031655|NCT01066793|588820259|FG000|Overall Study|Death|4|||
163031656|NCT01066793|588820260|FG001|Overall Study|Death|1|||
163031657|NCT01066793|588820261|FG002|Overall Study|Death|1|||
163031658|NCT01066793|588820262|FG003|Overall Study|Death|0|||
163031659|NCT01066793|588820263|FG004|Overall Study|Death|0|||
163031660|NCT01066793|588820264|FG005|Overall Study|Death|0|||
163031661|NCT01066793|588820259|FG000|Overall Study|Lack of Efficacy|2|||
163031662|NCT01066793|588820260|FG001|Overall Study|Lack of Efficacy|1|||
163031663|NCT01066793|588820261|FG002|Overall Study|Lack of Efficacy|0|||
163031664|NCT01066793|588820262|FG003|Overall Study|Lack of Efficacy|0|||
163031665|NCT01066793|588820263|FG004|Overall Study|Lack of Efficacy|0|||
163031666|NCT01066793|588820264|FG005|Overall Study|Lack of Efficacy|0|||
163031667|NCT01066793|588820259|FG000|Overall Study|Lost to Follow-up|180|||
163031668|NCT01066793|588820260|FG001|Overall Study|Lost to Follow-up|39|||
163031669|NCT01066793|588820261|FG002|Overall Study|Lost to Follow-up|82|||
163031670|NCT01066793|588820262|FG003|Overall Study|Lost to Follow-up|16|||
163031671|NCT01066793|588820263|FG004|Overall Study|Lost to Follow-up|0|||
163031672|NCT01066793|588820264|FG005|Overall Study|Lost to Follow-up|1|||
163031673|NCT01066793|588820259|FG000|Overall Study|Physician Decision|3|||
163332865|NCT00413283|589929886|FG003|Overall Study|Requirement for alternative therapy|0|||
163332866|NCT00413283|589929883|FG000|Overall Study|Other|0|||
163332867|NCT00413283|589929884|FG001|Overall Study|Other|0|||
163332868|NCT00413283|589929885|FG002|Overall Study|Other|1|||
163332869|NCT00413283|589929886|FG003|Overall Study|Other|0|||
163332870|NCT00667017|589929887|FG000|Overall Study|Withdrawal by Subject|1|||
163332871|NCT01823224|589929888|FG000|Overall Study|Lost to Follow-up|5|||
163031674|NCT01066793|588820260|FG001|Overall Study|Physician Decision|0|||
163031675|NCT01066793|588820261|FG002|Overall Study|Physician Decision|0|||
163031676|NCT01066793|588820262|FG003|Overall Study|Physician Decision|0|||
163031677|NCT01066793|588820263|FG004|Overall Study|Physician Decision|0|||
163031678|NCT01066793|588820264|FG005|Overall Study|Physician Decision|0|||
163031679|NCT01066793|588820259|FG000|Overall Study|Protocol Violation|3|||
163031680|NCT01066793|588820260|FG001|Overall Study|Protocol Violation|2|||
163085058|NCT02457793|589020378|FG005|Overall Study|Physician Decision|3|||
163031681|NCT01066793|588820261|FG002|Overall Study|Protocol Violation|2|||
163031682|NCT01066793|588820262|FG003|Overall Study|Protocol Violation|0|||
163031683|NCT01066793|588820263|FG004|Overall Study|Protocol Violation|0|||
163332872|NCT01823224|589929889|FG001|Overall Study|Lost to Follow-up|6|||
163031684|NCT01066793|588820264|FG005|Overall Study|Protocol Violation|0|||
163031685|NCT01066793|588820259|FG000|Overall Study|Withdrawal by Subject|7|||
163031686|NCT01066793|588820260|FG001|Overall Study|Withdrawal by Subject|4|||
163031687|NCT01066793|588820261|FG002|Overall Study|Withdrawal by Subject|1|||
163031688|NCT01066793|588820262|FG003|Overall Study|Withdrawal by Subject|0|||
163031689|NCT01066793|588820263|FG004|Overall Study|Withdrawal by Subject|0|||
163031690|NCT01066793|588820264|FG005|Overall Study|Withdrawal by Subject|0|||
163031691|NCT01066793|588820259|FG000|Overall Study|Early Termination|3|||
163031692|NCT01066793|588820260|FG001|Overall Study|Early Termination|0|||
163031693|NCT01066793|588820261|FG002|Overall Study|Early Termination|0|||
163031694|NCT01066793|588820262|FG003|Overall Study|Early Termination|0|||
163031695|NCT01066793|588820263|FG004|Overall Study|Early Termination|0|||
163332873|NCT01823224|589929888|FG000|Overall Study|didn't qualify|1|||
163332874|NCT01823224|589929889|FG001|Overall Study|didn't qualify|2|||
163332875|NCT01823224|589929888|FG000|Overall Study|pharmacy error|0|||
163332876|NCT01823224|589929889|FG001|Overall Study|pharmacy error|1|||
163332877|NCT01823224|589929888|FG000|Overall Study|missed med dose|0|||
163332878|NCT01823224|589929889|FG001|Overall Study|missed med dose|1|||
163332879|NCT01823224|589929888|FG000|Overall Study|Withdrawal by Subject|0|||
163332880|NCT01823224|589929889|FG001|Overall Study|Withdrawal by Subject|1|||
163332881|NCT01532648|589929898|FG000|Overall Study|Lost to Follow-up|3|||
163332882|NCT01532648|589929899|FG001|Overall Study|Lost to Follow-up|4|||
163332883|NCT01532648|589929898|FG000|Overall Study|Lack of Efficacy|4|||
163332884|NCT01532648|589929899|FG001|Overall Study|Lack of Efficacy|1|||
163332885|NCT01532648|589929898|FG000|Overall Study|Protocol Violation|1|||
163332886|NCT01532648|589929899|FG001|Overall Study|Protocol Violation|1|||
163332887|NCT01532648|589929898|FG000|Overall Study|Adverse Event|12|||
163031696|NCT01066793|588820264|FG005|Overall Study|Early Termination|0|||
163031697|NCT01066793|588820259|FG000|Overall Study|Lab test not done|7|||
163031698|NCT01066793|588820260|FG001|Overall Study|Lab test not done|0|||
163332888|NCT01532648|589929899|FG001|Overall Study|Adverse Event|9|||
163031699|NCT01066793|588820261|FG002|Overall Study|Lab test not done|0|||
163031700|NCT01066793|588820262|FG003|Overall Study|Lab test not done|1|||
163031701|NCT01066793|588820263|FG004|Overall Study|Lab test not done|0|||
163031702|NCT01066793|588820264|FG005|Overall Study|Lab test not done|0|||
163031703|NCT01066793|588820259|FG000|Overall Study|Miscellaneous|4|||
163031704|NCT01066793|588820260|FG001|Overall Study|Miscellaneous|5|||
163031705|NCT01066793|588820261|FG002|Overall Study|Miscellaneous|6|||
163031706|NCT01066793|588820262|FG003|Overall Study|Miscellaneous|0|||
163031707|NCT01066793|588820263|FG004|Overall Study|Miscellaneous|0|||
163031708|NCT01066793|588820264|FG005|Overall Study|Miscellaneous|0|||
163031709|NCT01066793|588820259|FG000|Overall Study|Non-responders|104|||
163031710|NCT01066793|588820260|FG001|Overall Study|Non-responders|5|||
163031711|NCT01066793|588820261|FG002|Overall Study|Non-responders|11|||
163031712|NCT01066793|588820262|FG003|Overall Study|Non-responders|25|||
163031713|NCT01066793|588820263|FG004|Overall Study|Non-responders|0|||
163031714|NCT01066793|588820264|FG005|Overall Study|Non-responders|0|||
163031715|NCT01066793|588820259|FG000|Overall Study|Other|15|||
163031716|NCT01066793|588820260|FG001|Overall Study|Other|5|||
163031717|NCT01066793|588820261|FG002|Overall Study|Other|6|||
163031718|NCT01066793|588820262|FG003|Overall Study|Other|2|||
163031719|NCT01066793|588820263|FG004|Overall Study|Other|0|||
163031720|NCT01066793|588820264|FG005|Overall Study|Other|0|||
163031721|NCT01066793|588820259|FG000|Overall Study|Relapse|20|||
163031722|NCT01066793|588820260|FG001|Overall Study|Relapse|8|||
163031723|NCT01066793|588820261|FG002|Overall Study|Relapse|2|||
163031724|NCT01066793|588820262|FG003|Overall Study|Relapse|3|||
163031725|NCT01066793|588820263|FG004|Overall Study|Relapse|0|||
163031726|NCT01066793|588820264|FG005|Overall Study|Relapse|0|||
163031727|NCT01066793|588820259|FG000|Overall Study|Result Not Available|1|||
163031728|NCT01066793|588820260|FG001|Overall Study|Result Not Available|0|||
163031729|NCT01066793|588820261|FG002|Overall Study|Result Not Available|0|||
163031730|NCT01066793|588820262|FG003|Overall Study|Result Not Available|0|||
163031731|NCT01066793|588820263|FG004|Overall Study|Result Not Available|0|||
163031732|NCT01066793|588820264|FG005|Overall Study|Result Not Available|0|||
163031733|NCT01066793|588820259|FG000|Overall Study|Treatment Interrupted|1|||
163031734|NCT01066793|588820260|FG001|Overall Study|Treatment Interrupted|1|||
163031735|NCT01066793|588820261|FG002|Overall Study|Treatment Interrupted|0|||
163031736|NCT01066793|588820262|FG003|Overall Study|Treatment Interrupted|0|||
163031737|NCT01066793|588820263|FG004|Overall Study|Treatment Interrupted|0|||
163031738|NCT01066793|588820264|FG005|Overall Study|Treatment Interrupted|0|||
163031739|NCT01066793|588820259|FG000|Overall Study|Treatment Never Started|18|||
163031740|NCT01066793|588820260|FG001|Overall Study|Treatment Never Started|5|||
163031741|NCT01066793|588820261|FG002|Overall Study|Treatment Never Started|4|||
163031742|NCT01066793|588820262|FG003|Overall Study|Treatment Never Started|1|||
163031743|NCT01066793|588820263|FG004|Overall Study|Treatment Never Started|0|||
163031744|NCT01066793|588820264|FG005|Overall Study|Treatment Never Started|0|||
163031745|NCT01066793|588820259|FG000|Overall Study|Treatment Stopped|2|||
163332889|NCT01532648|589929898|FG000|Overall Study|Withdrawal by Subject|16|||
163332890|NCT01532648|589929899|FG001|Overall Study|Withdrawal by Subject|2|||
163332891|NCT02148705|589929900|FG000|Overall Study|Death|2|||
163332892|NCT02148705|589929901|FG001|Overall Study|Death|0|||
163031746|NCT01066793|588820260|FG001|Overall Study|Treatment Stopped|1|||
163031747|NCT01066793|588820261|FG002|Overall Study|Treatment Stopped|0|||
163031748|NCT01066793|588820262|FG003|Overall Study|Treatment Stopped|1|||
163031749|NCT01066793|588820263|FG004|Overall Study|Treatment Stopped|0|||
163031750|NCT01066793|588820264|FG005|Overall Study|Treatment Stopped|0|||
163031751|NCT02697916|588820265|FG000|Overall Study|Death|357|||
163031752|NCT02697916|588820266|FG001|Overall Study|Death|315|||
163031753|NCT02697916|588820265|FG000|Overall Study|Withdrawal by Subject|221|||
163031754|NCT02697916|588820266|FG001|Overall Study|Withdrawal by Subject|393|||
163031755|NCT02864316|588820267|FG000|Overall Study|Progressive Disease|2|||
163031756|NCT02864316|588820268|FG001|Overall Study|Progressive Disease|1|||
163031757|NCT02864316|588820267|FG000|Overall Study|Adverse Event|0|||
163332893|NCT02148705|589929902|FG002|Overall Study|Death|0|||
163031758|NCT02864316|588820268|FG001|Overall Study|Adverse Event|1|||
163031759|NCT02607280|588820270|FG000|Overall Study|Adverse Event|4|||
163031760|NCT02607280|588820271|FG001|Overall Study|Adverse Event|0|||
163031761|NCT02607280|588820270|FG000|Overall Study|Decrease in CrCl <15|0|||
163031762|NCT02607280|588820271|FG001|Overall Study|Decrease in CrCl <15|1|||
163031763|NCT01447446|588820272|FG000|Overall Study|Death|6|||
163031764|NCT01447446|588820273|FG001|Overall Study|Death|3|||
163031765|NCT01447446|588820274|FG002|Overall Study|Death|2|||
163031766|NCT01447446|588820275|FG003|Overall Study|Death|1|||
163031767|NCT01447446|588820276|FG004|Overall Study|Death|7|||
163031768|NCT01447446|588820277|FG005|Overall Study|Death|0|||
163031769|NCT01447446|588820272|FG000|Overall Study|Adverse Event|3|||
163031770|NCT01447446|588820273|FG001|Overall Study|Adverse Event|0|||
163031771|NCT01447446|588820274|FG002|Overall Study|Adverse Event|1|||
163031772|NCT01447446|588820275|FG003|Overall Study|Adverse Event|0|||
163031773|NCT01447446|588820276|FG004|Overall Study|Adverse Event|2|||
163031774|NCT01447446|588820277|FG005|Overall Study|Adverse Event|0|||
163031775|NCT01447446|588820272|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
163031776|NCT01447446|588820273|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
163031777|NCT01447446|588820274|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
163031778|NCT01447446|588820275|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
163031779|NCT01447446|588820276|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
163031780|NCT01447446|588820277|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
163031781|NCT01447446|588820272|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
163031782|NCT01447446|588820273|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
163031783|NCT01447446|588820274|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
163031784|NCT01447446|588820275|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
163031785|NCT01447446|588820276|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
163031786|NCT01447446|588820277|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
163031787|NCT01447446|588820272|FG000|Overall Study|Administrative/Other|34|||
163031788|NCT01447446|588820273|FG001|Overall Study|Administrative/Other|9|||
163031789|NCT01447446|588820274|FG002|Overall Study|Administrative/Other|10|||
163031790|NCT01447446|588820275|FG003|Overall Study|Administrative/Other|2|||
163031791|NCT01447446|588820276|FG004|Overall Study|Administrative/Other|33|||
163031792|NCT01447446|588820277|FG005|Overall Study|Administrative/Other|4|||
163031793|NCT01447446|588820272|FG000|Overall Study|SVR12 Assessment|13|||
163031794|NCT01447446|588820273|FG001|Overall Study|SVR12 Assessment|1|||
163031795|NCT01447446|588820274|FG002|Overall Study|SVR12 Assessment|2|||
163031796|NCT01447446|588820275|FG003|Overall Study|SVR12 Assessment|1|||
163031797|NCT01447446|588820276|FG004|Overall Study|SVR12 Assessment|5|||
163031798|NCT01447446|588820277|FG005|Overall Study|SVR12 Assessment|5|||
163031799|NCT01447446|588820272|FG000|Overall Study|New Treatment Started|8|||
163031800|NCT01447446|588820273|FG001|Overall Study|New Treatment Started|2|||
163031801|NCT01447446|588820274|FG002|Overall Study|New Treatment Started|1|||
163031802|NCT01447446|588820275|FG003|Overall Study|New Treatment Started|0|||
163031803|NCT01447446|588820276|FG004|Overall Study|New Treatment Started|2|||
163031804|NCT01447446|588820277|FG005|Overall Study|New Treatment Started|0|||
163031805|NCT01447446|588820272|FG000|Overall Study|Reason not Specified|1|||
163031806|NCT01447446|588820273|FG001|Overall Study|Reason not Specified|1|||
163031807|NCT01447446|588820274|FG002|Overall Study|Reason not Specified|1|||
163031808|NCT01447446|588820275|FG003|Overall Study|Reason not Specified|1|||
163031809|NCT01447446|588820276|FG004|Overall Study|Reason not Specified|1|||
163031810|NCT01447446|588820277|FG005|Overall Study|Reason not Specified|0|||
163085059|NCT00791648|589022209|FG000|Overall Study|Physician Decision|0|||
163085060|NCT00791648|589022210|FG001|Overall Study|Physician Decision|1|||
163085061|NCT00791648|589022209|FG000|Overall Study|Withdrawal by Subject|0|||
163332894|NCT02148705|589929900|FG000|Overall Study|Lost to Follow-up|13|||
163332895|NCT02148705|589929901|FG001|Overall Study|Lost to Follow-up|4|||
163332896|NCT02148705|589929902|FG002|Overall Study|Lost to Follow-up|10|||
163332897|NCT02148705|589929900|FG000|Overall Study|Withdrawal by Subject|3|||
163332898|NCT02148705|589929901|FG001|Overall Study|Withdrawal by Subject|0|||
163085062|NCT00791648|589022210|FG001|Overall Study|Withdrawal by Subject|1|||
163085063|NCT03396445|589022211|FG000|Treatment Period|Death|2|||
163085064|NCT03396445|589022212|FG001|Treatment Period|Death|2|||
163085065|NCT03396445|589022213|FG002|Treatment Period|Death|1|||
163085066|NCT03396445|589022214|FG003|Treatment Period|Death|1|||
163332899|NCT02148705|589929902|FG002|Overall Study|Withdrawal by Subject|2|||
163332900|NCT02148705|589929900|FG000|Overall Study|Not Treated|0|||
163332901|NCT02148705|589929901|FG001|Overall Study|Not Treated|1|||
163031811|NCT02052596|588820278|FG000|Active Phase|Adverse Event|3|||
163031812|NCT02052596|588820279|FG001|Active Phase|Adverse Event|2|||
163332902|NCT02148705|589929902|FG002|Overall Study|Not Treated|5|||
163332903|NCT01737021|589929905|FG000|Overall Study|Lost to Follow-up|5|||
163332904|NCT01737021|589929906|FG001|Overall Study|Lost to Follow-up|3|||
163031813|NCT02052596|588820278|FG000|Active Phase|Lost to Follow-up|8|||
163031814|NCT02052596|588820279|FG001|Active Phase|Lost to Follow-up|11|||
163085067|NCT03396445|589022215|FG004|Treatment Period|Death|3|||
163085068|NCT03396445|589022216|FG005|Treatment Period|Death|2|||
163085069|NCT03396445|589022217|FG006|Treatment Period|Death|5|||
163085070|NCT03396445|589022218|FG007|Treatment Period|Death|3|||
163085071|NCT03396445|589022219|FG008|Treatment Period|Death|3|||
163085072|NCT03396445|589022220|FG009|Treatment Period|Death|3|||
163085073|NCT03396445|589022221|FG010|Treatment Period|Death|7|||
163085074|NCT03396445|589022222|FG011|Treatment Period|Death|12|||
163085075|NCT03396445|589022223|FG012|Treatment Period|Death|28|||
163219854|NCT02864251|589521320|FG000|Treatment|Administrative Reason by Sponsor|1|||
163031815|NCT02052596|588820278|FG000|Active Phase|Protocol Violation|1|||
163031816|NCT02052596|588820279|FG001|Active Phase|Protocol Violation|2|||
163031817|NCT02052596|588820278|FG000|Active Phase|Withdrawal by Subject|3|||
163031818|NCT02052596|588820279|FG001|Active Phase|Withdrawal by Subject|4|||
163031819|NCT02052596|588820278|FG000|Active Phase|Enrolled in error|1|||
163031820|NCT02052596|588820279|FG001|Active Phase|Enrolled in error|0|||
163031821|NCT02052596|588820278|FG000|Active Phase|Lost due to Crohn's disease|0|||
163031822|NCT02052596|588820279|FG001|Active Phase|Lost due to Crohn's disease|1|||
163031823|NCT02052596|588820278|FG000|Safety Phase|Adverse Event|6|||
163031824|NCT02052596|588820279|FG001|Safety Phase|Adverse Event|3|||
163031825|NCT02052596|588820278|FG000|Safety Phase|Lost to Follow-up|11|||
163031826|NCT02052596|588820279|FG001|Safety Phase|Lost to Follow-up|18|||
163031827|NCT02052596|588820278|FG000|Safety Phase|Protocol Violation|1|||
163031828|NCT02052596|588820279|FG001|Safety Phase|Protocol Violation|2|||
163031829|NCT02052596|588820278|FG000|Safety Phase|Withdrawal by Subject|8|||
163031830|NCT02052596|588820279|FG001|Safety Phase|Withdrawal by Subject|11|||
163031831|NCT02052596|588820278|FG000|Safety Phase|Enrolled in error|1|||
163031832|NCT02052596|588820279|FG001|Safety Phase|Enrolled in error|0|||
163031833|NCT02052596|588820278|FG000|Safety Phase|Lost due to Crohn's disease|0|||
163031834|NCT02052596|588820279|FG001|Safety Phase|Lost due to Crohn's disease|1|||
163031835|NCT04829331|588820282|FG000|Overall Study|Lost to Follow-up|1|||
163031836|NCT04829331|588820283|FG001|Overall Study|Lost to Follow-up|0|||
163031837|NCT04526574|588820287|FG000|Overall Study|Protocol Violation|3|||
163031838|NCT04526574|588820288|FG001|Overall Study|Protocol Violation|1|||
163031839|NCT04526574|588820287|FG000|Overall Study|Withdrawal by Subject|12|||
163031840|NCT04526574|588820288|FG001|Overall Study|Withdrawal by Subject|9|||
163031841|NCT04526574|588820287|FG000|Overall Study|Other|1|||
163031842|NCT04526574|588820288|FG001|Overall Study|Other|2|||
163031843|NCT04526574|588820287|FG000|Overall Study|Adverse Event|1|||
163031844|NCT04526574|588820288|FG001|Overall Study|Adverse Event|1|||
163031845|NCT04526574|588820287|FG000|Overall Study|Death|2|||
163031846|NCT04526574|588820288|FG001|Overall Study|Death|3|||
163031847|NCT04526574|588820287|FG000|Overall Study|Lost to Follow-up|9|||
163031848|NCT04526574|588820288|FG001|Overall Study|Lost to Follow-up|9|||
163031849|NCT04526574|588820287|FG000|Overall Study|No longer meets eligibility criteria|8|||
163031850|NCT04526574|588820288|FG001|Overall Study|No longer meets eligibility criteria|8|||
163031851|NCT01032070|588820289|FG000|Overall Study|Disease progression|13|||
163031852|NCT01032070|588820290|FG001|Overall Study|Disease progression|8|||
163031853|NCT01032070|588820289|FG000|Overall Study|Medical or ethical reasons|0|||
163031854|NCT01032070|588820290|FG001|Overall Study|Medical or ethical reasons|2|||
163031855|NCT01032070|588820289|FG000|Overall Study|Withdrawal by Subject|0|||
163031856|NCT01032070|588820290|FG001|Overall Study|Withdrawal by Subject|2|||
163031857|NCT02554318|588820291|FG000|Overall Study|Withdrawal by Subject|10|||
163031858|NCT02554318|588820292|FG001|Overall Study|Withdrawal by Subject|8|||
163031859|NCT01472965|588820295|FG000|Overall Study|Withdrawal by Subject|1|||
163031860|NCT01472965|588820296|FG001|Overall Study|Withdrawal by Subject|0|||
163031861|NCT00396877|588820300|FG000|Overall Study|Lost to Follow-up|2|||
163031862|NCT00396877|588820301|FG001|Overall Study|Lost to Follow-up|1|||
163031863|NCT00396877|588820300|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
163031864|NCT00396877|588820301|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
163031865|NCT00334802|588820302|FG000|Overall Study|Progressive Disease|2|||
163031866|NCT00334802|588820303|FG001|Overall Study|Progressive Disease|24|||
163031867|NCT00334802|588820302|FG000|Overall Study|Toxicity|1|||
163031868|NCT00334802|588820303|FG001|Overall Study|Toxicity|5|||
163031869|NCT00334802|588820302|FG000|Overall Study|Lack of Efficacy|1|||
163031870|NCT00334802|588820303|FG001|Overall Study|Lack of Efficacy|3|||
163031871|NCT00334802|588820302|FG000|Overall Study|Patient Condition Aggrevated|1|||
163031872|NCT00334802|588820303|FG001|Overall Study|Patient Condition Aggrevated|0|||
163031873|NCT00334802|588820302|FG000|Overall Study|Physician Decision|1|||
163031874|NCT00334802|588820303|FG001|Overall Study|Physician Decision|0|||
163031875|NCT00334802|588820302|FG000|Overall Study|Withdrawal by Subject|0|||
163031876|NCT00334802|588820303|FG001|Overall Study|Withdrawal by Subject|4|||
163031877|NCT00334802|588820302|FG000|Overall Study|Adverse Event|0|||
163031878|NCT00334802|588820303|FG001|Overall Study|Adverse Event|3|||
163031879|NCT00334802|588820302|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
163031880|NCT00334802|588820303|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
163031881|NCT01886781|588820307|FG000|Overall Study|Protocol Violation|5|||
163085076|NCT03396445|589022224|FG013|Treatment Period|Death|14|||
163085077|NCT03396445|589022225|FG014|Treatment Period|Death|10|||
163085078|NCT03396445|589022226|FG015|Treatment Period|Death|8|||
163085079|NCT03396445|589022227|FG016|Treatment Period|Death|18|||
163031882|NCT01886781|588820308|FG001|Overall Study|Protocol Violation|0|||
163031883|NCT01886781|588820307|FG000|Overall Study|Adverse Event|1|||
163031884|NCT01886781|588820308|FG001|Overall Study|Adverse Event|0|||
163031885|NCT01886781|588820307|FG000|Overall Study|Lost to Follow-up|5|||
163031886|NCT01886781|588820308|FG001|Overall Study|Lost to Follow-up|0|||
163031887|NCT01886781|588820307|FG000|Overall Study|Withdrawal by Subject|2|||
163031888|NCT01886781|588820308|FG001|Overall Study|Withdrawal by Subject|1|||
163031889|NCT01886781|588820307|FG000|Overall Study|Worsening of symptoms|1|||
163031890|NCT01886781|588820308|FG001|Overall Study|Worsening of symptoms|1|||
163031891|NCT00551161|588820309|FG000|Overall Study|Withdrawal by Subject|1|||
163031892|NCT00934856|588820310|FG000|Feasibility Part|Progressive disease|4|||
163031893|NCT00934856|588820311|FG001|Feasibility Part|Progressive disease|4|||
163031894|NCT00934856|588820312|FG002|Feasibility Part|Progressive disease|2|||
163031895|NCT00934856|588820313|FG003|Feasibility Part|Progressive disease|3|||
163031896|NCT00934856|588820314|FG004|Feasibility Part|Progressive disease|0|||
163031897|NCT00934856|588820315|FG005|Feasibility Part|Progressive disease|0|||
163031898|NCT00934856|588820310|FG000|Feasibility Part|Physician Decision|0|||
163031899|NCT00934856|588820311|FG001|Feasibility Part|Physician Decision|0|||
163031900|NCT00934856|588820312|FG002|Feasibility Part|Physician Decision|1|||
163031901|NCT00934856|588820313|FG003|Feasibility Part|Physician Decision|0|||
163031902|NCT00934856|588820314|FG004|Feasibility Part|Physician Decision|0|||
163031903|NCT00934856|588820315|FG005|Feasibility Part|Physician Decision|0|||
163031904|NCT00934856|588820310|FG000|Feasibility Part|Adverse Event|1|||
163031905|NCT00934856|588820311|FG001|Feasibility Part|Adverse Event|1|||
163031906|NCT00934856|588820312|FG002|Feasibility Part|Adverse Event|0|||
163031907|NCT00934856|588820313|FG003|Feasibility Part|Adverse Event|1|||
163031908|NCT00934856|588820314|FG004|Feasibility Part|Adverse Event|0|||
163031909|NCT00934856|588820315|FG005|Feasibility Part|Adverse Event|2|||
163031910|NCT00934856|588820310|FG000|Feasibility Part|Withdrawal by Subject|0|||
163031911|NCT00934856|588820311|FG001|Feasibility Part|Withdrawal by Subject|0|||
163031912|NCT00934856|588820312|FG002|Feasibility Part|Withdrawal by Subject|0|||
163031913|NCT00934856|588820313|FG003|Feasibility Part|Withdrawal by Subject|1|||
163031914|NCT00934856|588820314|FG004|Feasibility Part|Withdrawal by Subject|0|||
163031915|NCT00934856|588820315|FG005|Feasibility Part|Withdrawal by Subject|1|||
163031916|NCT00934856|588820310|FG000|Extension Part|Adverse Event|0|||
163031917|NCT00934856|588820311|FG001|Extension Part|Adverse Event|0|||
163031918|NCT00934856|588820312|FG002|Extension Part|Adverse Event|0|||
163031919|NCT00934856|588820313|FG003|Extension Part|Adverse Event|1|||
163031920|NCT00934856|588820314|FG004|Extension Part|Adverse Event|4|||
163031921|NCT00934856|588820315|FG005|Extension Part|Adverse Event|4|||
163031922|NCT00934856|588820310|FG000|Extension Part|Progressive disease|0|||
163031923|NCT00934856|588820311|FG001|Extension Part|Progressive disease|0|||
163031924|NCT00934856|588820312|FG002|Extension Part|Progressive disease|0|||
163031925|NCT00934856|588820313|FG003|Extension Part|Progressive disease|1|||
163031926|NCT00934856|588820314|FG004|Extension Part|Progressive disease|0|||
163031927|NCT00934856|588820315|FG005|Extension Part|Progressive disease|0|||
163031928|NCT00934856|588820310|FG000|Extension Part|Non-compliance with drug|0|||
163031929|NCT00934856|588820311|FG001|Extension Part|Non-compliance with drug|0|||
163031930|NCT00934856|588820312|FG002|Extension Part|Non-compliance with drug|0|||
163031931|NCT00934856|588820313|FG003|Extension Part|Non-compliance with drug|0|||
163031932|NCT00934856|588820314|FG004|Extension Part|Non-compliance with drug|0|||
163031933|NCT00934856|588820315|FG005|Extension Part|Non-compliance with drug|1|||
163031934|NCT02273908|588820318|FG000|Overall Study|Adverse Event|16|||
163031935|NCT02273908|588820319|FG001|Overall Study|Adverse Event|0|||
163031936|NCT02273908|588820318|FG000|Overall Study|Lost to Follow-up|10|||
163031937|NCT02273908|588820319|FG001|Overall Study|Lost to Follow-up|1|||
163031938|NCT02273908|588820318|FG000|Overall Study|Did not meet entrance criteria|3|||
163031939|NCT02273908|588820319|FG001|Overall Study|Did not meet entrance criteria|2|||
163031940|NCT02273908|588820318|FG000|Overall Study|Withdrawal by Subject|4|||
163031941|NCT02273908|588820319|FG001|Overall Study|Withdrawal by Subject|2|||
163031942|NCT00422422|588820320|FG000|Overall Study|Lack of Efficacy|1|||
163031943|NCT00422422|588820320|FG000|Overall Study|Protocol Violation|1|||
163031944|NCT00422422|588820320|FG000|Overall Study|Withdrawal by Subject|2|||
163031945|NCT00422422|588820320|FG000|Overall Study|SAE, non-fatal|1|||
163031946|NCT00422422|588820320|FG000|Overall Study|AE, non-serious non-fatal|5|||
163031947|NCT03301844|588820321|FG000|Overall Study|suspected colon cancer|1|||
163031948|NCT03301844|588820322|FG001|Overall Study|suspected colon cancer|1|||
163031949|NCT00501059|588820323|FG000|Overall Study|Protocol Violation|80|||
163031950|NCT00501059|588820324|FG001|Overall Study|Protocol Violation|69|||
163031951|NCT00501059|588820323|FG000|Overall Study|Death|140|||
163031952|NCT00501059|588820324|FG001|Overall Study|Death|137|||
163031953|NCT00501059|588820323|FG000|Overall Study|Other|236|||
163031954|NCT00501059|588820324|FG001|Overall Study|Other|239|||
163031955|NCT00501059|588820323|FG000|Overall Study|Missing end-of-study page|91|||
163332905|NCT01673594|589929907|FG000|Overall Study|Adverse Event|3|||
163031956|NCT00501059|588820324|FG001|Overall Study|Missing end-of-study page|92|||
163031957|NCT00501059|588820323|FG000|Overall Study|Clinical endpoint reached|110|||
163031958|NCT00501059|588820324|FG001|Overall Study|Clinical endpoint reached|123|||
163031959|NCT00501059|588820323|FG000|Overall Study|Insufficient therapeutic effect|4|||
163031960|NCT00501059|588820324|FG001|Overall Study|Insufficient therapeutic effect|5|||
163031961|NCT00501059|588820323|FG000|Overall Study|Consent withdrawn by subject|817|||
163031962|NCT00501059|588820324|FG001|Overall Study|Consent withdrawn by subject|873|||
163031963|NCT00501059|588820323|FG000|Overall Study|Non-compliant with study treatment|23|||
163031964|NCT00501059|588820324|FG001|Overall Study|Non-compliant with study treatment|16|||
163031965|NCT00501059|588820323|FG000|Overall Study|Reason not given|3|||
163031966|NCT00501059|588820324|FG001|Overall Study|Reason not given|1|||
163031967|NCT00501059|588820323|FG000|Overall Study|Adverse Event|129|||
163031968|NCT00501059|588820324|FG001|Overall Study|Adverse Event|122|||
163031969|NCT00501059|588820323|FG000|Overall Study|Lost to Follow-up|210|||
163031970|NCT00501059|588820324|FG001|Overall Study|Lost to Follow-up|198|||
163031971|NCT00501059|588820323|FG000|Overall Study|Not treated|25|||
163031972|NCT00501059|588820324|FG001|Overall Study|Not treated|17|||
163031973|NCT02124759|588820325|FG000|Overall Study|Withdrawal by Subject|3|||
163031974|NCT02124759|588820326|FG001|Overall Study|Withdrawal by Subject|1|||
163031975|NCT02124759|588820327|FG002|Overall Study|Withdrawal by Subject|1|||
163031976|NCT02124759|588820325|FG000|Overall Study|Screen Fail|2|||
163031977|NCT02124759|588820326|FG001|Overall Study|Screen Fail|2|||
163031978|NCT02124759|588820327|FG002|Overall Study|Screen Fail|3|||
163031979|NCT02968433|588820329|FG000|Overall Study|Withdrawal by Subject|1|||
163031980|NCT00875433|588820330|FG000|Overall Study|Progressive disease|41|||
163031981|NCT00875433|588820330|FG000|Overall Study|Other Adverse Event|14|||
163031982|NCT00875433|588820330|FG000|Overall Study|Withdrawal by Subject|2|||
163031983|NCT00875433|588820330|FG000|Overall Study|Other|3|||
163031984|NCT00725101|588820331|FG000|Overall Study|Death|3|||
163031985|NCT00725101|588820331|FG000|Overall Study|Lost to Follow-up|353|||
163031986|NCT00725101|588820331|FG000|Overall Study|Protocol Violation|1|||
163031987|NCT00725101|588820331|FG000|Overall Study|Withdrawal by Subject|127|||
163031988|NCT00725101|588820331|FG000|Overall Study|not specified/no reason given|11|||
163031989|NCT03325894|588820332|FG000|Overall Study|Adverse Event|2|||
163031990|NCT03325894|588820333|FG001|Overall Study|Adverse Event|3|||
163031991|NCT03325894|588820332|FG000|Overall Study|Protocol Violation|1|||
163031992|NCT03325894|588820333|FG001|Overall Study|Protocol Violation|2|||
163031993|NCT03325894|588820332|FG000|Overall Study|Withdrawal by Subject|10|||
163031994|NCT03325894|588820333|FG001|Overall Study|Withdrawal by Subject|6|||
163031995|NCT03325894|588820332|FG000|Overall Study|Lost to Follow-up|4|||
163031996|NCT03325894|588820333|FG001|Overall Study|Lost to Follow-up|9|||
163031997|NCT03325894|588820332|FG000|Overall Study|Lack of Efficacy|8|||
163031998|NCT03325894|588820333|FG001|Overall Study|Lack of Efficacy|14|||
163031999|NCT03325894|588820332|FG000|Overall Study|Study Terminated by Sponsor|38|||
163032000|NCT03325894|588820333|FG001|Overall Study|Study Terminated by Sponsor|43|||
163032001|NCT03325894|588820332|FG000|Overall Study|Other (Not received Treatment)|1|||
163032002|NCT03325894|588820333|FG001|Overall Study|Other (Not received Treatment)|0|||
163032003|NCT03482167|588820336|FG000|Allocated to Intervention|Physician Decision|1|||
163032004|NCT03482167|588820337|FG001|Allocated to Intervention|Physician Decision|2|||
163032005|NCT03482167|588820336|FG000|Received Intervention|Adverse Event|3|||
163032006|NCT03482167|588820337|FG001|Received Intervention|Adverse Event|1|||
163085080|NCT03396445|589022228|FG017|Treatment Period|Death|0|||
163085081|NCT03396445|589022229|FG018|Treatment Period|Death|0|||
163085082|NCT03396445|589022230|FG019|Treatment Period|Death|0|||
163085083|NCT03396445|589022231|FG020|Treatment Period|Death|0|||
163085084|NCT03396445|589022232|FG021|Treatment Period|Death|0|||
163085085|NCT03396445|589022233|FG022|Treatment Period|Death|0|||
163085086|NCT03396445|589022234|FG023|Treatment Period|Death|0|||
163085087|NCT03396445|589022235|FG024|Treatment Period|Death|0|||
163085088|NCT03396445|589022236|FG025|Treatment Period|Death|0|||
163085089|NCT03396445|589022211|FG000|Treatment Period|Lost to Follow-up|0|||
163085090|NCT03396445|589022212|FG001|Treatment Period|Lost to Follow-up|0|||
163085091|NCT03396445|589022213|FG002|Treatment Period|Lost to Follow-up|0|||
163085092|NCT03396445|589022214|FG003|Treatment Period|Lost to Follow-up|0|||
163085093|NCT03396445|589022215|FG004|Treatment Period|Lost to Follow-up|0|||
163085094|NCT03396445|589022216|FG005|Treatment Period|Lost to Follow-up|0|||
163085095|NCT03396445|589022217|FG006|Treatment Period|Lost to Follow-up|0|||
163085096|NCT03396445|589022218|FG007|Treatment Period|Lost to Follow-up|0|||
163085097|NCT03396445|589022219|FG008|Treatment Period|Lost to Follow-up|0|||
163032007|NCT03482167|588820336|FG000|Received Intervention|Physician Decision|1|||
163032008|NCT03482167|588820337|FG001|Received Intervention|Physician Decision|1|||
163032009|NCT03482167|588820336|FG000|Received Intervention|Withdrawal by Subject|1|||
163032010|NCT03482167|588820337|FG001|Received Intervention|Withdrawal by Subject|0|||
163032011|NCT00819780|588820339|FG000|Overall Study|Did not receive study drug|3|||
163032012|NCT00819780|588820340|FG001|Overall Study|Did not receive study drug|4|||
163032013|NCT00819780|588820339|FG000|Overall Study|Still in treatment|25|||
163032014|NCT00819780|588820340|FG001|Overall Study|Still in treatment|17|||
163032015|NCT00622336|588820341|FG000|Treatment Phase|Progression of Disease|181|||
163032016|NCT00622336|588820341|FG000|Treatment Phase|Adverse Event|46|||
163032017|NCT00622336|588820341|FG000|Treatment Phase|Other|40|||
163032018|NCT00622336|588820341|FG000|Treatment Phase|Death|14|||
163085098|NCT03396445|589022220|FG009|Treatment Period|Lost to Follow-up|0|||
163032019|NCT00622336|588820341|FG000|Treatment Phase|Lack of therapeutic effect|13|||
163032020|NCT00622336|588820341|FG000|Treatment Phase|Withdrawal by Subject|13|||
163032021|NCT00622336|588820341|FG000|Treatment Phase|Lost to Follow-up|2|||
163032022|NCT00622336|588820341|FG000|Extension Phase|Adverse Event|2|||
163032023|NCT00622336|588820341|FG000|Extension Phase|Progressive Disease|6|||
163032024|NCT00622336|588820341|FG000|Extension Phase|Lack of therapeutic effect|2|||
163032025|NCT00622336|588820341|FG000|Extension Phase|Withdrawal by Subject|1|||
163032026|NCT00622336|588820341|FG000|Extension Phase|Lost to Follow-up|1|||
163032027|NCT00622336|588820341|FG000|Extension Phase|Other|9|||
163032028|NCT04148287|588820346|FG000|Overall Study|Death|2|||
163032029|NCT03430895|588820348|FG000|Overall Study|Not Treated|2|||
163032030|NCT01645891|588820352|FG000|Overall Study|Adverse Event|6|||
163032031|NCT01645891|588820353|FG001|Overall Study|Adverse Event|10|||
163032032|NCT01645891|588820352|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
163032033|NCT01645891|588820353|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
163032034|NCT01645891|588820352|FG000|Overall Study|Withdrawal by Subject|3|||
163032035|NCT01645891|588820353|FG001|Overall Study|Withdrawal by Subject|3|||
163032036|NCT01645891|588820352|FG000|Overall Study|Protocol Violation|4|||
163032037|NCT01645891|588820353|FG001|Overall Study|Protocol Violation|0|||
163032038|NCT01645891|588820352|FG000|Overall Study|Lost to Follow-up|4|||
163032039|NCT01645891|588820353|FG001|Overall Study|Lost to Follow-up|1|||
163032040|NCT01645891|588820352|FG000|Overall Study|Death|0|||
163032041|NCT01645891|588820353|FG001|Overall Study|Death|2|||
163032042|NCT00138073|588820356|FG000|Overall Study|lack of resources|55|||
163032043|NCT03301740|588820357|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
163032044|NCT03301740|588820358|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
163032045|NCT03301740|588820357|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
163032046|NCT03301740|588820358|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
163032047|NCT02847182|588820359|FG000|Overall Study|Withdrawal by Subject|0|||
163032048|NCT02847182|588820360|FG001|Overall Study|Withdrawal by Subject|1|||
163032049|NCT00962091|588820361|FG000|Overall Study|Withdrawal by Subject|1|||
163032050|NCT00962091|588820362|FG001|Overall Study|Withdrawal by Subject|2|||
163032051|NCT00962091|588820363|FG002|Overall Study|Withdrawal by Subject|1|||
163032052|NCT00962091|588820364|FG003|Overall Study|Withdrawal by Subject|1|||
163032053|NCT00962091|588820365|FG004|Overall Study|Withdrawal by Subject|0|||
163032054|NCT00962091|588820366|FG005|Overall Study|Withdrawal by Subject|1|||
163032055|NCT00962091|588820367|FG006|Overall Study|Withdrawal by Subject|0|||
163032056|NCT00962091|588820361|FG000|Overall Study|Adverse Event|0|||
163032057|NCT00962091|588820362|FG001|Overall Study|Adverse Event|0|||
163032058|NCT00962091|588820363|FG002|Overall Study|Adverse Event|0|||
163032059|NCT00962091|588820364|FG003|Overall Study|Adverse Event|0|||
163032060|NCT00962091|588820365|FG004|Overall Study|Adverse Event|0|||
163032061|NCT00962091|588820366|FG005|Overall Study|Adverse Event|0|||
163032062|NCT00962091|588820367|FG006|Overall Study|Adverse Event|1|||
163032063|NCT01306045|588820370|FG000|Met General Eligibility Criteria|Screen failures|193|||
163032064|NCT01306045|588820371|FG001|Met General Eligibility Criteria|Screen failures|11|||
163032065|NCT01306045|588820372|FG002|Met General Eligibility Criteria|Screen failures|8|||
163032066|NCT05072964|588820373|FG000|Overall Study|Withdrawal by Subject|4|||
163032067|NCT05072964|588820373|FG000|Overall Study|Death|1|||
163032068|NCT02172040|588820375|FG000|Overall Study|Adverse Event|0|||
163032069|NCT02172040|588820376|FG001|Overall Study|Adverse Event|2|||
163032070|NCT02172040|588820377|FG002|Overall Study|Adverse Event|0|||
163032071|NCT02172040|588820378|FG003|Overall Study|Adverse Event|0|||
163032072|NCT02172040|588820375|FG000|Overall Study|Protocol Violation|0|||
163032073|NCT02172040|588820376|FG001|Overall Study|Protocol Violation|1|||
163032074|NCT02172040|588820377|FG002|Overall Study|Protocol Violation|0|||
163032075|NCT02172040|588820378|FG003|Overall Study|Protocol Violation|0|||
163032076|NCT02172040|588820375|FG000|Overall Study|Withdrawal by Subject|0|||
163032077|NCT02172040|588820376|FG001|Overall Study|Withdrawal by Subject|0|||
163032078|NCT02172040|588820377|FG002|Overall Study|Withdrawal by Subject|1|||
163032079|NCT02172040|588820378|FG003|Overall Study|Withdrawal by Subject|0|||
163032080|NCT02172040|588820375|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
163032081|NCT02172040|588820376|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
163085099|NCT03396445|589022221|FG010|Treatment Period|Lost to Follow-up|0|||
163085100|NCT03396445|589022222|FG011|Treatment Period|Lost to Follow-up|0|||
163032082|NCT02172040|588820377|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
163032083|NCT02172040|588820378|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
163032084|NCT02172040|588820375|FG000|Overall Study|Family emergency abroad|0|||
163032085|NCT02172040|588820376|FG001|Overall Study|Family emergency abroad|0|||
163032086|NCT02172040|588820377|FG002|Overall Study|Family emergency abroad|0|||
163332906|NCT01673594|589929908|FG001|Overall Study|Adverse Event|1|||
163332907|NCT01673594|589929907|FG000|Overall Study|Lost to Follow-up|1|||
163032087|NCT02172040|588820378|FG003|Overall Study|Family emergency abroad|1|||
163332908|NCT01673594|589929908|FG001|Overall Study|Lost to Follow-up|0|||
163032088|NCT04908202|588820383|FG000|Pre-Treatment Period|OTHER REASONS|3|||
163032089|NCT04908202|588820384|FG001|Pre-Treatment Period|OTHER REASONS|1|||
163032090|NCT04908202|588820385|FG002|Pre-Treatment Period|OTHER REASONS|0|||
163032091|NCT04908202|588820386|FG003|Pre-Treatment Period|OTHER REASONS|0|||
163032092|NCT04908202|588820383|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
163032093|NCT04908202|588820384|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
163032094|NCT04908202|588820385|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
163032095|NCT04908202|588820386|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
163032096|NCT04908202|588820383|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
163032097|NCT04908202|588820384|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
163032098|NCT04908202|588820385|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
163032099|NCT04908202|588820386|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
163032100|NCT04908202|588820383|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
163032101|NCT04908202|588820384|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
163032102|NCT04908202|588820385|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
163032103|NCT04908202|588820386|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
163032104|NCT04908202|588820383|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
163332909|NCT01673594|589929907|FG000|Overall Study|Physician Decision|2|||
163332910|NCT01673594|589929908|FG001|Overall Study|Physician Decision|4|||
163332911|NCT01673594|589929907|FG000|Overall Study|Withdrawal by Subject|0|||
163332912|NCT01673594|589929908|FG001|Overall Study|Withdrawal by Subject|1|||
163332913|NCT02824198|589929909|FG000|Overall Study|Non-compliance with the protocol|5|||
163332914|NCT02824198|589929910|FG001|Overall Study|Non-compliance with the protocol|1|||
163332915|NCT02824198|589929909|FG000|Overall Study|Lost to Follow-up|5|||
163332916|NCT02824198|589929910|FG001|Overall Study|Lost to Follow-up|2|||
163332917|NCT02824198|589929909|FG000|Overall Study|Withdrawal by Subject|5|||
163332918|NCT02824198|589929910|FG001|Overall Study|Withdrawal by Subject|0|||
163332919|NCT03883828|589929911|FG000|Overall Study|Did not start radiotherapy|1|||
163332920|NCT03883828|589929912|FG001|Overall Study|Did not start radiotherapy|2|||
163332921|NCT02575365|589929913|FG000|Overall Study|Lost to Follow-up|4|||
163332922|NCT02736188|589929928|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
163332923|NCT02736188|589929928|FG000|Overall Study|Adverse Event|1|||
163332924|NCT02736188|589929928|FG000|Overall Study|Withdrawal by Subject|1|||
163332925|NCT02736188|589929928|FG000|Overall Study|Other|6|||
163332926|NCT01698918|589929929|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
163332927|NCT01698918|589929929|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
163332928|NCT01698918|589929929|FG000|First Line Treatment (Core+Extension)|Death|2|||
163332929|NCT01698918|589929929|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
163332930|NCT01698918|589929929|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
163332931|NCT01698918|589929929|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
163332932|NCT01698918|589929929|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
163332933|NCT01698918|589929929|FG000|Second Line Treatment (Core+Extension)|Death|1|||
163332934|NCT01698918|589929929|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
163332935|NCT01698918|589929929|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
163332936|NCT03176407|589929930|FG000|Overall Study|Protocol Violation|1|||
163332937|NCT03176407|589929930|FG000|Overall Study|human failure|1|||
163332938|NCT03176407|589929930|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
163332939|NCT01428583|589929932|FG000|Overall Study|Adverse Event|75|||
163332940|NCT01428583|589929932|FG000|Overall Study|Withdrawal by Subject|51|||
163332941|NCT01428583|589929932|FG000|Overall Study|Lack of Efficacy|37|||
163332942|NCT01428583|589929932|FG000|Overall Study|Lost to Follow-up|17|||
163332943|NCT01428583|589929932|FG000|Overall Study|Death|1|||
163332944|NCT01428583|589929932|FG000|Overall Study|Pregnancy|1|||
163332945|NCT01428583|589929932|FG000|Overall Study|Protocol Violation|1|||
163332946|NCT01428583|589929932|FG000|Overall Study|Physician Decision|12|||
163332947|NCT01428583|589929932|FG000|Overall Study|Non-compliant|25|||
163332948|NCT01428583|589929932|FG000|Overall Study|Confirmed positive urine drug test|8|||
163332949|NCT01428583|589929932|FG000|Overall Study|Sponsor's request|3|||
163332950|NCT01428583|589929932|FG000|Overall Study|Other|6|||
163332951|NCT00768755|589929936|FG000|Phase 1|Death|6|||
163332952|NCT00768755|589929937|FG001|Phase 1|Death|0|||
163406507|NCT03860961|590198665|FG001|Overall Study|Withdrawal by Subject|11|||
163032105|NCT04908202|588820384|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
163032106|NCT04908202|588820385|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163032107|NCT04908202|588820386|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163032108|NCT04908202|588820383|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
163032109|NCT04908202|588820384|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
163032110|NCT04908202|588820385|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
163332953|NCT00768755|589929938|FG002|Phase 1|Death|0|||
163332954|NCT00768755|589929939|FG003|Phase 1|Death|0|||
163332955|NCT00768755|589929936|FG000|Phase 1|Other|4|||
163332956|NCT00768755|589929937|FG001|Phase 1|Other|0|||
163332957|NCT00768755|589929938|FG002|Phase 1|Other|0|||
163332958|NCT00768755|589929939|FG003|Phase 1|Other|0|||
163332959|NCT00768755|589929936|FG000|Phase 2|Death|0|||
163032111|NCT04908202|588820386|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
163032112|NCT04908202|588820383|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
163032113|NCT04908202|588820384|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
163032114|NCT04908202|588820385|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
163032115|NCT04908202|588820386|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
163032116|NCT04908202|588820383|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
163032117|NCT04908202|588820384|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
163032118|NCT04908202|588820385|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
163032119|NCT04908202|588820386|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
163032120|NCT04908202|588820383|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
163032121|NCT04908202|588820384|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
163032122|NCT04908202|588820385|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
163032123|NCT04908202|588820386|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
163032124|NCT04908202|588820383|FG000|Active Treatment Period|OTHER REASONS|0|||
163032125|NCT04908202|588820384|FG001|Active Treatment Period|OTHER REASONS|0|||
163032126|NCT04908202|588820385|FG002|Active Treatment Period|OTHER REASONS|1|||
163032127|NCT04908202|588820386|FG003|Active Treatment Period|OTHER REASONS|3|||
163032128|NCT04908202|588820383|FG000|Active Treatment Period|Lack of Efficacy|0|||
163032129|NCT04908202|588820384|FG001|Active Treatment Period|Lack of Efficacy|0|||
163032130|NCT04908202|588820385|FG002|Active Treatment Period|Lack of Efficacy|4|||
163032131|NCT04908202|588820386|FG003|Active Treatment Period|Lack of Efficacy|5|||
163032132|NCT04908202|588820383|FG000|Active Treatment Period|Adverse Event|0|||
163032133|NCT04908202|588820384|FG001|Active Treatment Period|Adverse Event|0|||
163032134|NCT04908202|588820385|FG002|Active Treatment Period|Adverse Event|5|||
163032135|NCT04908202|588820386|FG003|Active Treatment Period|Adverse Event|8|||
163032136|NCT04908202|588820383|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163032137|NCT04908202|588820384|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163032138|NCT04908202|588820385|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
163032139|NCT04908202|588820386|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
163032140|NCT04908202|588820383|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
163032141|NCT04908202|588820384|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
163032142|NCT04908202|588820385|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
163032143|NCT04908202|588820386|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
163032144|NCT04908202|588820383|FG000|Active Treatment Period|Lost to Follow-up|0|||
163032145|NCT04908202|588820384|FG001|Active Treatment Period|Lost to Follow-up|0|||
163032146|NCT04908202|588820385|FG002|Active Treatment Period|Lost to Follow-up|2|||
163032147|NCT04908202|588820386|FG003|Active Treatment Period|Lost to Follow-up|2|||
163032148|NCT04908202|588820383|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
163032149|NCT04908202|588820384|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
163032150|NCT04908202|588820385|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
163032151|NCT04908202|588820386|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
163032152|NCT04908202|588820383|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
163032153|NCT04908202|588820384|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
163032154|NCT04908202|588820385|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
163032155|NCT04908202|588820386|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
163032156|NCT04908202|588820383|FG000|Active Treatment Period|ONGOING Treatment|0|||
163032157|NCT04908202|588820384|FG001|Active Treatment Period|ONGOING Treatment|0|||
163032158|NCT04908202|588820385|FG002|Active Treatment Period|ONGOING Treatment|117|||
163032159|NCT04908202|588820386|FG003|Active Treatment Period|ONGOING Treatment|114|||
163032160|NCT04506905|588820389|FG000|Overall Study|Lost to Follow-up|1|||
163032161|NCT04506905|588820390|FG001|Overall Study|Lost to Follow-up|0|||
163032162|NCT04506905|588820391|FG002|Overall Study|Lost to Follow-up|0|||
163032163|NCT04506905|588820392|FG003|Overall Study|Lost to Follow-up|1|||
163032164|NCT04506905|588820393|FG004|Overall Study|Lost to Follow-up|0|||
163032165|NCT04506905|588820394|FG005|Overall Study|Lost to Follow-up|0|||
163032166|NCT04506905|588820395|FG006|Overall Study|Lost to Follow-up|0|||
163032167|NCT04506905|588820396|FG007|Overall Study|Lost to Follow-up|0|||
163032168|NCT04506905|588820397|FG008|Overall Study|Lost to Follow-up|0|||
163032169|NCT04506905|588820389|FG000|Overall Study|Withdrawal by Subject|0|||
163032170|NCT04506905|588820390|FG001|Overall Study|Withdrawal by Subject|0|||
163032171|NCT04506905|588820391|FG002|Overall Study|Withdrawal by Subject|0|||
163032172|NCT04506905|588820392|FG003|Overall Study|Withdrawal by Subject|2|||
163032173|NCT04506905|588820393|FG004|Overall Study|Withdrawal by Subject|0|||
163032174|NCT04506905|588820394|FG005|Overall Study|Withdrawal by Subject|0|||
163032175|NCT04506905|588820395|FG006|Overall Study|Withdrawal by Subject|0|||
163032176|NCT04506905|588820396|FG007|Overall Study|Withdrawal by Subject|0|||
163032177|NCT04506905|588820397|FG008|Overall Study|Withdrawal by Subject|0|||
163032178|NCT03030118|588822128|FG000|Overall Study|Achieved SLE Diagnosis|11|||
163032179|NCT03030118|588822129|FG001|Overall Study|Achieved SLE Diagnosis|10|||
163032180|NCT03030118|588822128|FG000|Overall Study|Adverse Event|1|||
163032181|NCT03030118|588822129|FG001|Overall Study|Adverse Event|1|||
163032182|NCT03030118|588822128|FG000|Overall Study|Pregnancy|2|||
163032183|NCT03030118|588822129|FG001|Overall Study|Pregnancy|2|||
163032184|NCT03030118|588822128|FG000|Overall Study|Lost to Follow-up|5|||
163032185|NCT03030118|588822129|FG001|Overall Study|Lost to Follow-up|6|||
163032186|NCT03030118|588822128|FG000|Overall Study|Concomitant Medications|1|||
163032187|NCT03030118|588822129|FG001|Overall Study|Concomitant Medications|1|||
163032188|NCT03030118|588822128|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
163032189|NCT03030118|588822129|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
163032190|NCT03030118|588822128|FG000|Overall Study|Other|2|||
163032191|NCT03030118|588822129|FG001|Overall Study|Other|0|||
163032192|NCT03030118|588822128|FG000|Overall Study|Withdrawal by Subject|26|||
163032193|NCT03030118|588822129|FG001|Overall Study|Withdrawal by Subject|21|||
163032194|NCT03030118|588822128|FG000|Overall Study|Protocol Violation|1|||
163032195|NCT03030118|588822129|FG001|Overall Study|Protocol Violation|6|||
163032196|NCT02949908|588822130|FG000|Overall Study|Study termination|2|||
163032197|NCT05323994|588822131|FG000|Overall Study|Protocol Violation|1|||
163032198|NCT00454818|588822134|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
163032199|NCT00454818|588822135|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
163032200|NCT00454818|588822136|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
163032201|NCT00454818|588822137|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
163085101|NCT03396445|589022223|FG012|Treatment Period|Lost to Follow-up|1|||
163085102|NCT03396445|589022224|FG013|Treatment Period|Lost to Follow-up|0|||
163085103|NCT03396445|589022225|FG014|Treatment Period|Lost to Follow-up|1|||
163085104|NCT03396445|589022226|FG015|Treatment Period|Lost to Follow-up|0|||
163085105|NCT03396445|589022227|FG016|Treatment Period|Lost to Follow-up|0|||
163085106|NCT03396445|589022228|FG017|Treatment Period|Lost to Follow-up|0|||
163085107|NCT03396445|589022229|FG018|Treatment Period|Lost to Follow-up|0|||
163332960|NCT00768755|589929937|FG001|Phase 2|Death|37|||
163332961|NCT00768755|589929938|FG002|Phase 2|Death|48|||
163332962|NCT00768755|589929939|FG003|Phase 2|Death|31|||
163332963|NCT00768755|589929936|FG000|Phase 2|Protocol Violation|0|||
163332964|NCT00768755|589929937|FG001|Phase 2|Protocol Violation|2|||
163332965|NCT00768755|589929938|FG002|Phase 2|Protocol Violation|0|||
163332966|NCT00768755|589929939|FG003|Phase 2|Protocol Violation|1|||
163332967|NCT00768755|589929936|FG000|Phase 2|Lost to Follow-up|0|||
163332968|NCT00768755|589929937|FG001|Phase 2|Lost to Follow-up|1|||
163332969|NCT00768755|589929938|FG002|Phase 2|Lost to Follow-up|1|||
163332970|NCT00768755|589929939|FG003|Phase 2|Lost to Follow-up|4|||
163332971|NCT00768755|589929936|FG000|Phase 2|Withdrawal by Subject|0|||
163332972|NCT00768755|589929937|FG001|Phase 2|Withdrawal by Subject|1|||
163332973|NCT00768755|589929938|FG002|Phase 2|Withdrawal by Subject|0|||
163332974|NCT00768755|589929939|FG003|Phase 2|Withdrawal by Subject|1|||
163332975|NCT00768755|589929936|FG000|Phase 2|Other|0|||
163332976|NCT00768755|589929937|FG001|Phase 2|Other|1|||
163332977|NCT00768755|589929938|FG002|Phase 2|Other|2|||
163332978|NCT00768755|589929939|FG003|Phase 2|Other|4|||
163332979|NCT00768755|589929936|FG000|Phase 2|Study Terminated by Sponsor|0|||
163332980|NCT00768755|589929937|FG001|Phase 2|Study Terminated by Sponsor|13|||
163332981|NCT00768755|589929938|FG002|Phase 2|Study Terminated by Sponsor|7|||
163332982|NCT00768755|589929939|FG003|Phase 2|Study Terminated by Sponsor|14|||
163332983|NCT00768755|589929936|FG000|Phase 2|Randomized but not treated|0|||
163332984|NCT00768755|589929937|FG001|Phase 2|Randomized but not treated|0|||
163332985|NCT00768755|589929938|FG002|Phase 2|Randomized but not treated|0|||
163332986|NCT00768755|589929939|FG003|Phase 2|Randomized but not treated|2|||
163332987|NCT00670488|589929940|FG000|Overall Study|Adverse Event|0|||
163332988|NCT00670488|589929941|FG001|Overall Study|Adverse Event|7|||
163332989|NCT00670488|589929942|FG002|Overall Study|Adverse Event|0|||
163332990|NCT00670488|589929943|FG003|Overall Study|Adverse Event|3|||
163332991|NCT00670488|589929944|FG004|Overall Study|Adverse Event|1|||
163332992|NCT00670488|589929945|FG005|Overall Study|Adverse Event|1|||
163332993|NCT00670488|589929946|FG006|Overall Study|Adverse Event|5|||
163332994|NCT00670488|589929947|FG007|Overall Study|Adverse Event|1|||
163032202|NCT00454818|588822138|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
163032203|NCT00454818|588822134|FG000|Phase I: Open-label Dose-escalation|Death|0|||
163085108|NCT03396445|589022230|FG019|Treatment Period|Lost to Follow-up|0|||
163085109|NCT03396445|589022231|FG020|Treatment Period|Lost to Follow-up|0|||
163332995|NCT00670488|589929948|FG008|Overall Study|Adverse Event|0|||
163332996|NCT00670488|589929949|FG009|Overall Study|Adverse Event|1|||
163332997|NCT00670488|589929940|FG000|Overall Study|Physician Decision|1|||
163332998|NCT00670488|589929941|FG001|Overall Study|Physician Decision|9|||
163332999|NCT00670488|589929942|FG002|Overall Study|Physician Decision|0|||
163333000|NCT00670488|589929943|FG003|Overall Study|Physician Decision|1|||
163333001|NCT00670488|589929944|FG004|Overall Study|Physician Decision|0|||
163333002|NCT00670488|589929945|FG005|Overall Study|Physician Decision|0|||
163333003|NCT00670488|589929946|FG006|Overall Study|Physician Decision|0|||
163333004|NCT00670488|589929947|FG007|Overall Study|Physician Decision|0|||
163333005|NCT00670488|589929948|FG008|Overall Study|Physician Decision|0|||
163032204|NCT00454818|588822135|FG001|Phase I: Open-label Dose-escalation|Death|1|||
163032205|NCT00454818|588822136|FG002|Phase I: Open-label Dose-escalation|Death|0|||
163085110|NCT03396445|589022232|FG021|Treatment Period|Lost to Follow-up|0|||
163085111|NCT03396445|589022233|FG022|Treatment Period|Lost to Follow-up|0|||
163085112|NCT03396445|589022234|FG023|Treatment Period|Lost to Follow-up|0|||
163085113|NCT03396445|589022235|FG024|Treatment Period|Lost to Follow-up|0|||
163085114|NCT03396445|589022236|FG025|Treatment Period|Lost to Follow-up|0|||
163085115|NCT03396445|589022211|FG000|Treatment Period|Physician Decision|0|||
163085116|NCT03396445|589022212|FG001|Treatment Period|Physician Decision|0|||
163085117|NCT03396445|589022213|FG002|Treatment Period|Physician Decision|0|||
163085118|NCT03396445|589022214|FG003|Treatment Period|Physician Decision|0|||
163085119|NCT03396445|589022215|FG004|Treatment Period|Physician Decision|1|||
163032206|NCT00454818|588822137|FG003|Phase I: Open-label Dose-escalation|Death|0|||
163032207|NCT00454818|588822138|FG004|Phase I: Open-label Dose-escalation|Death|0|||
163032208|NCT00454818|588822134|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
163032209|NCT00454818|588822135|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
163032210|NCT00454818|588822136|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
163032211|NCT00454818|588822137|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
163032212|NCT00454818|588822138|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
163032213|NCT00454818|588822134|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
163032214|NCT00454818|588822135|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
163032215|NCT00454818|588822136|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
163032216|NCT00454818|588822137|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
163032217|NCT00454818|588822138|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
163032218|NCT00454818|588822134|FG000|Phase 2: Randomized Double-blind|Death|0|||
163032219|NCT00454818|588822135|FG001|Phase 2: Randomized Double-blind|Death|1|||
163032220|NCT00454818|588822136|FG002|Phase 2: Randomized Double-blind|Death|0|||
163032221|NCT00454818|588822137|FG003|Phase 2: Randomized Double-blind|Death|0|||
163032222|NCT00454818|588822138|FG004|Phase 2: Randomized Double-blind|Death|1|||
163032223|NCT00454818|588822134|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
163032224|NCT00454818|588822135|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
163032225|NCT00454818|588822136|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
163032226|NCT00454818|588822137|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
163032227|NCT00454818|588822138|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
163032228|NCT00454818|588822134|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
163032229|NCT00454818|588822135|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
163032230|NCT00454818|588822136|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
163032231|NCT00454818|588822137|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
163032232|NCT00454818|588822138|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
163032233|NCT00766467|588822140|FG000|Overall Study|Withdrawal by Subject|7|||
163032234|NCT00766467|588822141|FG001|Overall Study|Withdrawal by Subject|2|||
163032235|NCT00766467|588822140|FG000|Overall Study|Adverse Event|1|||
163032236|NCT00766467|588822141|FG001|Overall Study|Adverse Event|1|||
163032237|NCT00766467|588822140|FG000|Overall Study|Protocol Violation|2|||
163032238|NCT00766467|588822141|FG001|Overall Study|Protocol Violation|4|||
163032239|NCT00766467|588822140|FG000|Overall Study|Tumor Progression on Study|0|||
163032240|NCT00766467|588822141|FG001|Overall Study|Tumor Progression on Study|1|||
163032241|NCT00766467|588822140|FG000|Overall Study|Physician Decision|1|||
163032242|NCT00766467|588822141|FG001|Overall Study|Physician Decision|0|||
163032243|NCT00943670|588822143|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
163032244|NCT00943670|588822143|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
163032245|NCT00943670|588822143|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
163032246|NCT00943670|588822143|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
163032247|NCT00943670|588822143|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
163032248|NCT00943670|588822143|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
163032249|NCT00943670|588822143|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
163032250|NCT00943670|588822143|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
163032251|NCT00943670|588822143|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
163032252|NCT00943670|588822143|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
163032253|NCT02604550|588822144|FG000|Overall Study|Lost to Follow-up|7|||
163032254|NCT02604550|588822145|FG001|Overall Study|Lost to Follow-up|6|||
163032255|NCT02604550|588822144|FG000|Overall Study|Withdrawal by Subject|0|||
163032256|NCT02604550|588822145|FG001|Overall Study|Withdrawal by Subject|1|||
163032257|NCT02604550|588822144|FG000|Overall Study|Incomplete data using paper journal|18|||
163085120|NCT03396445|589022216|FG005|Treatment Period|Physician Decision|0|||
163085121|NCT03396445|589022217|FG006|Treatment Period|Physician Decision|0|||
163085122|NCT03396445|589022218|FG007|Treatment Period|Physician Decision|0|||
163333006|NCT00670488|589929949|FG009|Overall Study|Physician Decision|0|||
163333007|NCT00670488|589929940|FG000|Overall Study|Progressive Disease|2|||
163333008|NCT00670488|589929941|FG001|Overall Study|Progressive Disease|41|||
163333009|NCT00670488|589929942|FG002|Overall Study|Progressive Disease|3|||
163219855|NCT02864251|589521321|FG001|Treatment|Administrative Reason by Sponsor|0|||
163219856|NCT02864251|589521322|FG002|Treatment|Administrative Reason by Sponsor|0|||
163219857|NCT04343521|589521325|FG000|Overall Study|Adverse Event|0|||
163219858|NCT04343521|589521326|FG001|Overall Study|Adverse Event|2|||
163219859|NCT04343521|589521325|FG000|Overall Study|Death|1|||
163219860|NCT04343521|589521326|FG001|Overall Study|Death|2|||
163219861|NCT04343521|589521325|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
163219862|NCT04343521|589521326|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
163219863|NCT04343521|589521325|FG000|Overall Study|Withdrawal by Subject|70|||
163219864|NCT04343521|589521326|FG001|Overall Study|Withdrawal by Subject|95|||
163219865|NCT04343521|589521325|FG000|Overall Study|Withdrawal by study team|6|||
163219866|NCT04343521|589521326|FG001|Overall Study|Withdrawal by study team|12|||
163032258|NCT02604550|588822145|FG001|Overall Study|Incomplete data using paper journal|19|||
163032259|NCT00908076|588822146|FG000|Overall Study|Lack of Efficacy|1|||
163032260|NCT00908076|588822147|FG001|Overall Study|Lack of Efficacy|1|||
163032261|NCT02332239|588822148|FG000|Overall Study|Lost to Follow-up|4|||
163032262|NCT02332239|588822149|FG001|Overall Study|Lost to Follow-up|6|||
163032263|NCT00894790|588822150|FG000|Overall Study|Protocol Violation|0|||
163032264|NCT00894790|588822151|FG001|Overall Study|Protocol Violation|1|||
163032265|NCT00894790|588822150|FG000|Overall Study|Lost to Follow-up|0|||
163032266|NCT00894790|588822151|FG001|Overall Study|Lost to Follow-up|1|||
163032267|NCT00894790|588822150|FG000|Overall Study|Did not meet entrance criteria|1|||
163032268|NCT00894790|588822151|FG001|Overall Study|Did not meet entrance criteria|0|||
163032269|NCT00662558|588822152|FG000|Overall Study|Adverse Event|21|||
163032270|NCT00662558|588822153|FG001|Overall Study|Adverse Event|59|||
163032271|NCT00662558|588822152|FG000|Overall Study|Lack of Efficacy|4|||
163032272|NCT00662558|588822153|FG001|Overall Study|Lack of Efficacy|7|||
163032273|NCT00662558|588822152|FG000|Overall Study|Lost to Follow-up|13|||
163032274|NCT00662558|588822153|FG001|Overall Study|Lost to Follow-up|10|||
163032275|NCT00662558|588822152|FG000|Overall Study|Other|9|||
163032276|NCT00662558|588822153|FG001|Overall Study|Other|14|||
163032277|NCT00662558|588822152|FG000|Overall Study|Withdrawal by Subject|7|||
163032278|NCT00662558|588822153|FG001|Overall Study|Withdrawal by Subject|12|||
163032279|NCT00662558|588822152|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
163032280|NCT00662558|588822153|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
163032281|NCT03329248|588822163|FG000|Overall Study|Progressive Disease|6|||
163032282|NCT00987402|588822164|FG000|Overall Study|Insufficient data entry|86|||
163032283|NCT00987402|588822165|FG001|Overall Study|Insufficient data entry|98|||
163032284|NCT03000530|588822166|FG000|Overall Study|Adverse Event|0|||
163032285|NCT03000530|588822167|FG001|Overall Study|Adverse Event|0|||
163032286|NCT03000530|588822168|FG002|Overall Study|Adverse Event|2|||
163032287|NCT03000530|588822166|FG000|Overall Study|Lost to Follow-up|0|||
163032288|NCT03000530|588822167|FG001|Overall Study|Lost to Follow-up|3|||
163032289|NCT03000530|588822168|FG002|Overall Study|Lost to Follow-up|1|||
163032290|NCT03000530|588822166|FG000|Overall Study|Withdrawal by Subject|0|||
163032291|NCT03000530|588822167|FG001|Overall Study|Withdrawal by Subject|2|||
163032292|NCT03000530|588822168|FG002|Overall Study|Withdrawal by Subject|1|||
163032293|NCT01672294|588822172|FG000|Overall Study|Withdrawal by Subject|4|||
163032294|NCT01672294|588822173|FG001|Overall Study|Withdrawal by Subject|4|||
163032295|NCT01672294|588822174|FG002|Overall Study|Withdrawal by Subject|4|||
163032296|NCT01672294|588822175|FG003|Overall Study|Withdrawal by Subject|4|||
163032297|NCT01672294|588822172|FG000|Overall Study|Excluded by study|1|||
163032298|NCT01672294|588822173|FG001|Overall Study|Excluded by study|1|||
163085123|NCT03396445|589022219|FG008|Treatment Period|Physician Decision|0|||
163219867|NCT02211131|589521327|FG000|Overall Study|Death|26|||
163219868|NCT02211131|589521328|FG001|Overall Study|Death|16|||
163219869|NCT02211131|589521327|FG000|Overall Study|Lost to Follow-up|4|||
163219870|NCT02211131|589521328|FG001|Overall Study|Lost to Follow-up|3|||
163219871|NCT02211131|589521327|FG000|Overall Study|Decision by Sponsor|1|||
163219872|NCT02211131|589521328|FG001|Overall Study|Decision by Sponsor|1|||
163219873|NCT02211131|589521327|FG000|Overall Study|Withdrawal by Subject|3|||
163219874|NCT02211131|589521328|FG001|Overall Study|Withdrawal by Subject|8|||
163219875|NCT05664490|589521329|FG000|Overall Study|Withdrawal by Subject|0|||
163333010|NCT00670488|589929943|FG003|Overall Study|Progressive Disease|2|||
163032299|NCT01672294|588822174|FG002|Overall Study|Excluded by study|0|||
163032300|NCT01672294|588822175|FG003|Overall Study|Excluded by study|0|||
163032301|NCT01672294|588822172|FG000|Overall Study|Lost to Follow-up|1|||
163032302|NCT01672294|588822173|FG001|Overall Study|Lost to Follow-up|16|||
163032303|NCT01672294|588822174|FG002|Overall Study|Lost to Follow-up|7|||
163032304|NCT01672294|588822175|FG003|Overall Study|Lost to Follow-up|9|||
163032305|NCT01285492|588822176|FG000|Overall Study|Adverse Event|11|||
163032306|NCT01285492|588822177|FG001|Overall Study|Adverse Event|0|||
163032307|NCT01285492|588822176|FG000|Overall Study|Protocol Violation|3|||
163032308|NCT01285492|588822177|FG001|Overall Study|Protocol Violation|0|||
163032309|NCT01285492|588822176|FG000|Overall Study|Withdrawal by Subject|2|||
163219876|NCT05664490|589521330|FG001|Overall Study|Withdrawal by Subject|1|||
163219877|NCT05664490|589521329|FG000|Overall Study|Lost to Follow-up|14|||
163219878|NCT05664490|589521330|FG001|Overall Study|Lost to Follow-up|22|||
163032310|NCT01285492|588822177|FG001|Overall Study|Withdrawal by Subject|1|||
163032311|NCT01285492|588822176|FG000|Overall Study|Death|1|||
163032312|NCT01285492|588822177|FG001|Overall Study|Death|0|||
163032313|NCT03379792|588822178|FG000|Overall Study|Physician Decision|0|||
163032314|NCT03379792|588822179|FG001|Overall Study|Physician Decision|0|||
163032315|NCT03379792|588822180|FG002|Overall Study|Physician Decision|0|||
163032316|NCT03379792|588822181|FG003|Overall Study|Physician Decision|1|||
163032317|NCT03379792|588822182|FG004|Overall Study|Physician Decision|0|||
163032318|NCT03379792|588822183|FG005|Overall Study|Physician Decision|0|||
163032319|NCT03379792|588822178|FG000|Overall Study|Withdrawal by Subject|0|||
163032320|NCT03379792|588822179|FG001|Overall Study|Withdrawal by Subject|0|||
163032321|NCT03379792|588822180|FG002|Overall Study|Withdrawal by Subject|0|||
163032322|NCT03379792|588822181|FG003|Overall Study|Withdrawal by Subject|0|||
163032323|NCT03379792|588822182|FG004|Overall Study|Withdrawal by Subject|1|||
163032324|NCT03379792|588822183|FG005|Overall Study|Withdrawal by Subject|1|||
163032325|NCT01121536|588822185|FG000|Overall Study|Adverse Event|63|||
163032326|NCT01121536|588822185|FG000|Overall Study|Lack of Efficacy|35|||
163032327|NCT01121536|588822185|FG000|Overall Study|Withdrawal by Subject|65|||
163032328|NCT01121536|588822185|FG000|Overall Study|Protocol Violation|20|||
163032329|NCT01121536|588822185|FG000|Overall Study|Noncompliance with study medication|12|||
163032330|NCT01121536|588822185|FG000|Overall Study|Noncompliance with study procedures|9|||
163032331|NCT01121536|588822185|FG000|Overall Study|Lost to Follow-up|39|||
163085124|NCT03396445|589022220|FG009|Treatment Period|Physician Decision|1|||
163085125|NCT03396445|589022221|FG010|Treatment Period|Physician Decision|0|||
163085126|NCT03396445|589022222|FG011|Treatment Period|Physician Decision|0|||
163085127|NCT03396445|589022223|FG012|Treatment Period|Physician Decision|0|||
163085128|NCT03396445|589022224|FG013|Treatment Period|Physician Decision|0|||
163085129|NCT03396445|589022225|FG014|Treatment Period|Physician Decision|0|||
163406508|NCT03860961|590198664|FG000|Overall Study|Death|10|||
163032332|NCT01121536|588822185|FG000|Overall Study|Other|118|||
163032333|NCT02649426|588822186|FG000|Overall Study|Follow-up on going|1|||
163032334|NCT02649426|588822187|FG001|Overall Study|Follow-up on going|26|||
163032335|NCT02649426|588822188|FG002|Overall Study|Follow-up on going|28|||
163032336|NCT02649426|588822189|FG003|Overall Study|Follow-up on going|31|||
163032337|NCT00306787|588822190|FG000|Overall Study|Discontinued without taking study drug|208|||
163032338|NCT00306787|588822191|FG001|Overall Study|Discontinued without taking study drug|215|||
163032339|NCT00306787|588822190|FG000|Overall Study|Adverse Event|1|||
163032340|NCT00306787|588822191|FG001|Overall Study|Adverse Event|1|||
163032341|NCT00306787|588822190|FG000|Overall Study|Lack of Efficacy|1|||
163032342|NCT00306787|588822191|FG001|Overall Study|Lack of Efficacy|0|||
163032343|NCT00306787|588822190|FG000|Overall Study|Protocol Violation|8|||
163032344|NCT00306787|588822191|FG001|Overall Study|Protocol Violation|10|||
163032345|NCT00306787|588822190|FG000|Overall Study|Withdrawal by Subject|2|||
163032346|NCT00306787|588822191|FG001|Overall Study|Withdrawal by Subject|9|||
163032347|NCT00306787|588822190|FG000|Overall Study|Lost to Follow-up|9|||
163032348|NCT00306787|588822191|FG001|Overall Study|Lost to Follow-up|6|||
163032349|NCT00306787|588822190|FG000|Overall Study|Administrative problems|4|||
163032350|NCT00306787|588822191|FG001|Overall Study|Administrative problems|0|||
163032351|NCT00306787|588822190|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163032352|NCT00306787|588822191|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163032353|NCT00369161|588822197|FG000|Overall Study|Adverse Event|15|||
163032354|NCT00369161|588822198|FG001|Overall Study|Adverse Event|13|||
163032355|NCT00369161|588822197|FG000|Overall Study|Abnormal laboratory value|0|||
163032356|NCT00369161|588822198|FG001|Overall Study|Abnormal laboratory value|1|||
163032357|NCT00369161|588822197|FG000|Overall Study|Lack of Efficacy|3|||
163032358|NCT00369161|588822198|FG001|Overall Study|Lack of Efficacy|1|||
163032359|NCT00369161|588822197|FG000|Overall Study|Protocol Violation|0|||
163032360|NCT00369161|588822198|FG001|Overall Study|Protocol Violation|2|||
163032361|NCT00369161|588822197|FG000|Overall Study|Withdrawal by Subject|2|||
163032362|NCT00369161|588822198|FG001|Overall Study|Withdrawal by Subject|3|||
163032363|NCT00369161|588822197|FG000|Overall Study|Death|1|||
163032364|NCT00369161|588822198|FG001|Overall Study|Death|2|||
163032365|NCT00369161|588822197|FG000|Overall Study|Graft loss|4|||
163032366|NCT00369161|588822198|FG001|Overall Study|Graft loss|0|||
163032367|NCT00369161|588822197|FG000|Overall Study|Administrative Problem|2|||
163032368|NCT00369161|588822198|FG001|Overall Study|Administrative Problem|2|||
163032369|NCT01870297|588822201|FG000|Overall Study|Adverse Event|0|||
163032370|NCT01870297|588822202|FG001|Overall Study|Adverse Event|0|||
163032371|NCT01870297|588822203|FG002|Overall Study|Adverse Event|0|||
163085130|NCT03396445|589022226|FG015|Treatment Period|Physician Decision|0|||
163406509|NCT03860961|590198665|FG001|Overall Study|Death|6|||
163032372|NCT01870297|588822204|FG003|Overall Study|Adverse Event|0|||
163032373|NCT01870297|588822205|FG004|Overall Study|Adverse Event|2|||
163032374|NCT01870297|588822206|FG005|Overall Study|Adverse Event|0|||
163032375|NCT01870297|588822207|FG006|Overall Study|Adverse Event|0|||
163032376|NCT01870297|588822201|FG000|Overall Study|Lost to Follow-up|0|||
163085131|NCT03396445|589022227|FG016|Treatment Period|Physician Decision|0|||
163406510|NCT03860961|590198664|FG000|Overall Study|Incomplete two-year data|4|||
163032377|NCT01870297|588822202|FG001|Overall Study|Lost to Follow-up|1|||
163032378|NCT01870297|588822203|FG002|Overall Study|Lost to Follow-up|1|||
163032379|NCT01870297|588822204|FG003|Overall Study|Lost to Follow-up|0|||
163032380|NCT01870297|588822205|FG004|Overall Study|Lost to Follow-up|0|||
163032381|NCT01870297|588822206|FG005|Overall Study|Lost to Follow-up|0|||
163032382|NCT01870297|588822207|FG006|Overall Study|Lost to Follow-up|0|||
163032383|NCT01870297|588822201|FG000|Overall Study|Withdrawal by Subject|0|||
163032384|NCT01870297|588822202|FG001|Overall Study|Withdrawal by Subject|0|||
163032385|NCT01870297|588822203|FG002|Overall Study|Withdrawal by Subject|0|||
163032386|NCT01870297|588822204|FG003|Overall Study|Withdrawal by Subject|0|||
163032387|NCT01870297|588822205|FG004|Overall Study|Withdrawal by Subject|1|||
163032388|NCT01870297|588822206|FG005|Overall Study|Withdrawal by Subject|1|||
163032389|NCT01870297|588822207|FG006|Overall Study|Withdrawal by Subject|1|||
163032390|NCT01870297|588822201|FG000|Overall Study|Sponsor Decision|0|||
163032391|NCT01870297|588822202|FG001|Overall Study|Sponsor Decision|6|||
163032392|NCT01870297|588822203|FG002|Overall Study|Sponsor Decision|0|||
163032393|NCT01870297|588822204|FG003|Overall Study|Sponsor Decision|0|||
163032394|NCT01870297|588822205|FG004|Overall Study|Sponsor Decision|0|||
163032395|NCT01870297|588822206|FG005|Overall Study|Sponsor Decision|0|||
163032396|NCT01870297|588822207|FG006|Overall Study|Sponsor Decision|1|||
163032397|NCT04249622|588822210|FG000|Overall Study|Withdrawal by Subject|1|||
163032398|NCT04249622|588822211|FG001|Overall Study|Withdrawal by Subject|1|||
163032399|NCT04249622|588822210|FG000|Overall Study|Alternative therapy|1|||
163032400|NCT04249622|588822211|FG001|Overall Study|Alternative therapy|0|||
163032401|NCT04249622|588822210|FG000|Overall Study|Discontinuation of pertuzumab|1|||
163032402|NCT04249622|588822211|FG001|Overall Study|Discontinuation of pertuzumab|0|||
163032403|NCT03689543|588822213|FG000|Overall Study|Adverse Event|0|||
163032404|NCT03689543|588822214|FG001|Overall Study|Adverse Event|0|||
163032405|NCT03689543|588822215|FG002|Overall Study|Adverse Event|1|||
163032406|NCT00586508|588822216|FG000|Overall Study|Progressive disease|52|||
163032407|NCT00586508|588822217|FG001|Overall Study|Progressive disease|8|||
163032408|NCT00586508|588822216|FG000|Overall Study|Death|0|||
163032409|NCT00586508|588822217|FG001|Overall Study|Death|1|||
163032410|NCT00586508|588822216|FG000|Overall Study|Adverse Event|12|||
163032411|NCT00586508|588822217|FG001|Overall Study|Adverse Event|4|||
163032412|NCT00586508|588822216|FG000|Overall Study|Withdrawal by Subject|4|||
163032413|NCT00586508|588822217|FG001|Overall Study|Withdrawal by Subject|0|||
163032414|NCT01294371|588822218|FG000|Overall Study|Adverse Event|1|||
163032415|NCT01294371|588822218|FG000|Overall Study|Withdrawal by Subject|12|||
163032416|NCT01294371|588822218|FG000|Overall Study|Lost to Follow-up|6|||
163032417|NCT01294371|588822218|FG000|Overall Study|Administrative Reason|1|||
163032418|NCT01294371|588822218|FG000|Overall Study|Other|14|||
163032419|NCT05619536|588822219|FG000|Overall Study|Withdrawal by Subject|0|||
163032420|NCT05619536|588822220|FG001|Overall Study|Withdrawal by Subject|1|||
163032421|NCT05619536|588822221|FG002|Overall Study|Withdrawal by Subject|0|||
163032422|NCT05619536|588822222|FG003|Overall Study|Withdrawal by Subject|1|||
163032423|NCT05619536|588822219|FG000|Overall Study|Lost to Follow-up|0|||
163032424|NCT05619536|588822220|FG001|Overall Study|Lost to Follow-up|1|||
163032425|NCT05619536|588822221|FG002|Overall Study|Lost to Follow-up|1|||
163032426|NCT05619536|588822222|FG003|Overall Study|Lost to Follow-up|0|||
163032427|NCT00106639|588822223|FG000|Overall Study|Adverse Event|3|||
163032428|NCT00106639|588822224|FG001|Overall Study|Adverse Event|4|||
163032429|NCT00106639|588822225|FG002|Overall Study|Adverse Event|1|||
163032430|NCT00106639|588822223|FG000|Overall Study|Protocol Violation|0|||
163032431|NCT00106639|588822224|FG001|Overall Study|Protocol Violation|1|||
163032432|NCT00106639|588822225|FG002|Overall Study|Protocol Violation|0|||
163032433|NCT00106639|588822223|FG000|Overall Study|Withdrawal by Subject|0|||
163032434|NCT00106639|588822224|FG001|Overall Study|Withdrawal by Subject|1|||
163032435|NCT00106639|588822225|FG002|Overall Study|Withdrawal by Subject|0|||
163032436|NCT00106639|588822223|FG000|Overall Study|Participant defaulted|0|||
163032437|NCT00106639|588822224|FG001|Overall Study|Participant defaulted|1|||
163032438|NCT00106639|588822225|FG002|Overall Study|Participant defaulted|1|||
163032439|NCT02637713|588822233|FG000|Overall Study|Screen Failure|2|||
163032440|NCT02345889|588822234|FG000|Overall Study|Inadequate Bowel Prep|17|||
163032441|NCT02345889|588822235|FG001|Overall Study|Inadequate Bowel Prep|16|||
163032442|NCT02345889|588822236|FG002|Overall Study|Inadequate Bowel Prep|18|||
163032443|NCT02345889|588822237|FG003|Overall Study|Inadequate Bowel Prep|14|||
163032444|NCT02345889|588822234|FG000|Overall Study|Polyposis identified during procedure|1|||
163032445|NCT02345889|588822235|FG001|Overall Study|Polyposis identified during procedure|1|||
163032446|NCT02345889|588822236|FG002|Overall Study|Polyposis identified during procedure|0|||
163032447|NCT02345889|588822237|FG003|Overall Study|Polyposis identified during procedure|1|||
163032448|NCT02345889|588822234|FG000|Overall Study|Recognized ineligible post-randomization|1|||
163032449|NCT02345889|588822235|FG001|Overall Study|Recognized ineligible post-randomization|0|||
163032450|NCT02345889|588822236|FG002|Overall Study|Recognized ineligible post-randomization|2|||
163032451|NCT02345889|588822237|FG003|Overall Study|Recognized ineligible post-randomization|1|||
163032452|NCT02345889|588822234|FG000|Overall Study|Ulcerative Colitis identified|1|||
163032453|NCT02345889|588822235|FG001|Overall Study|Ulcerative Colitis identified|0|||
163032454|NCT02345889|588822236|FG002|Overall Study|Ulcerative Colitis identified|0|||
163032455|NCT02345889|588822237|FG003|Overall Study|Ulcerative Colitis identified|0|||
163032456|NCT02345889|588822234|FG000|Overall Study|Cecum not intubated|1|||
163032457|NCT02345889|588822235|FG001|Overall Study|Cecum not intubated|0|||
163032458|NCT02345889|588822236|FG002|Overall Study|Cecum not intubated|0|||
163032459|NCT02345889|588822237|FG003|Overall Study|Cecum not intubated|0|||
163032460|NCT03191864|588822239|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
163032461|NCT03191864|588822240|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
163032462|NCT03191864|588822241|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
163032463|NCT03191864|588822242|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
163032464|NCT03191864|588822243|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
163032465|NCT03191864|588822244|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
163032466|NCT03191864|588822239|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
163032467|NCT03191864|588822240|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
163032468|NCT03191864|588822241|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
163032469|NCT03191864|588822242|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
163032470|NCT03191864|588822243|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
163032471|NCT03191864|588822244|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
163032472|NCT03191864|588822239|FG000|Baseline Symptom Assessment|Adverse Event|0|||
163032473|NCT03191864|588822240|FG001|Baseline Symptom Assessment|Adverse Event|0|||
163032474|NCT03191864|588822241|FG002|Baseline Symptom Assessment|Adverse Event|0|||
163032475|NCT03191864|588822242|FG003|Baseline Symptom Assessment|Adverse Event|0|||
163032476|NCT03191864|588822243|FG004|Baseline Symptom Assessment|Adverse Event|0|||
163032477|NCT03191864|588822244|FG005|Baseline Symptom Assessment|Adverse Event|2|||
163032478|NCT03191864|588822239|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
163032479|NCT03191864|588822240|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
163032480|NCT03191864|588822241|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
163032481|NCT03191864|588822242|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
163032482|NCT03191864|588822243|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
163032483|NCT03191864|588822244|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
163032484|NCT03191864|588822239|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
163032485|NCT03191864|588822240|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
163032486|NCT03191864|588822241|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
163032487|NCT03191864|588822242|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
163032488|NCT03191864|588822243|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
163032489|NCT03191864|588822244|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
163032490|NCT03191864|588822239|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
163032491|NCT03191864|588822240|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
163032492|NCT03191864|588822241|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
163032493|NCT03191864|588822242|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
163032494|NCT03191864|588822243|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
163032495|NCT03191864|588822244|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
163032496|NCT03191864|588822239|FG000|Part 1 - Induction|Adverse Event|0|||
163032497|NCT03191864|588822240|FG001|Part 1 - Induction|Adverse Event|2|||
163032498|NCT03191864|588822241|FG002|Part 1 - Induction|Adverse Event|0|||
163032499|NCT03191864|588822242|FG003|Part 1 - Induction|Adverse Event|1|||
163032500|NCT03191864|588822243|FG004|Part 1 - Induction|Adverse Event|0|||
163032501|NCT03191864|588822244|FG005|Part 1 - Induction|Adverse Event|2|||
163032502|NCT03191864|588822239|FG000|Part 1 - Induction|Randomized but never dosed|0|||
163032503|NCT03191864|588822240|FG001|Part 1 - Induction|Randomized but never dosed|0|||
163032504|NCT03191864|588822241|FG002|Part 1 - Induction|Randomized but never dosed|1|||
163032505|NCT03191864|588822242|FG003|Part 1 - Induction|Randomized but never dosed|0|||
163032506|NCT03191864|588822243|FG004|Part 1 - Induction|Randomized but never dosed|0|||
163032507|NCT03191864|588822244|FG005|Part 1 - Induction|Randomized but never dosed|0|||
163032508|NCT03191864|588822239|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
163032509|NCT03191864|588822240|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
163032510|NCT03191864|588822241|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
163333011|NCT00670488|589929944|FG004|Overall Study|Progressive Disease|2|||
163333012|NCT00670488|589929945|FG005|Overall Study|Progressive Disease|4|||
163333013|NCT00670488|589929946|FG006|Overall Study|Progressive Disease|11|||
163032511|NCT03191864|588822242|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
163032512|NCT03191864|588822243|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
163219879|NCT03144180|589521334|FG000|Overall Study|STAT Delivery|1|||
163032513|NCT03191864|588822244|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
163219880|NCT03144180|589521335|FG001|Overall Study|STAT Delivery|1|||
163219881|NCT03144180|589521334|FG000|Overall Study|Provider forgot to fill out forms|1|||
163219882|NCT03144180|589521335|FG001|Overall Study|Provider forgot to fill out forms|3|||
163219883|NCT03144180|589521334|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
163219884|NCT03144180|589521335|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
163219885|NCT03144180|589521334|FG000|Overall Study|Scrub tech removed tube cap|0|||
163219886|NCT03144180|589521335|FG001|Overall Study|Scrub tech removed tube cap|1|||
163219887|NCT00751348|589521340|FG000|Overall Study|Withdrawal by Subject|5|||
163032514|NCT03191864|588822239|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
163032515|NCT03191864|588822240|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
163032516|NCT03191864|588822241|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
163032517|NCT03191864|588822242|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
163032518|NCT03191864|588822243|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
163032519|NCT03191864|588822244|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
163032520|NCT03191864|588822239|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
163032521|NCT03191864|588822240|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
163032522|NCT03191864|588822241|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
163032523|NCT03191864|588822242|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
163032524|NCT03191864|588822243|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
163032525|NCT03191864|588822244|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
163032526|NCT03191864|588822239|FG000|Part 2 - Maintenance|Physician Decision|1|||
163032527|NCT03191864|588822240|FG001|Part 2 - Maintenance|Physician Decision|0|||
163032528|NCT03191864|588822241|FG002|Part 2 - Maintenance|Physician Decision|0|||
163032529|NCT03191864|588822242|FG003|Part 2 - Maintenance|Physician Decision|0|||
163032530|NCT03191864|588822243|FG004|Part 2 - Maintenance|Physician Decision|0|||
163032531|NCT03191864|588822244|FG005|Part 2 - Maintenance|Physician Decision|0|||
163032532|NCT03191864|588822239|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
163032533|NCT03191864|588822240|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
163032534|NCT03191864|588822241|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
163032535|NCT03191864|588822242|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
163032536|NCT03191864|588822243|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
163032537|NCT03191864|588822244|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
163032538|NCT03191864|588822239|FG000|Part 2 - Maintenance|Adverse Event|0|||
163032539|NCT03191864|588822240|FG001|Part 2 - Maintenance|Adverse Event|0|||
163032540|NCT03191864|588822241|FG002|Part 2 - Maintenance|Adverse Event|0|||
163032541|NCT03191864|588822242|FG003|Part 2 - Maintenance|Adverse Event|0|||
163032542|NCT03191864|588822243|FG004|Part 2 - Maintenance|Adverse Event|1|||
163032543|NCT03191864|588822244|FG005|Part 2 - Maintenance|Adverse Event|0|||
163032544|NCT03191864|588822239|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
163032545|NCT03191864|588822240|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
163032546|NCT03191864|588822241|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
163032547|NCT03191864|588822242|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
163032548|NCT03191864|588822243|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
163032549|NCT03191864|588822244|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
163032550|NCT03191864|588822239|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
163032551|NCT03191864|588822240|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
163032552|NCT03191864|588822241|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
163032553|NCT03191864|588822242|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
163032554|NCT03191864|588822243|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
163032555|NCT03191864|588822244|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
163032556|NCT02044874|588822247|FG000|Overall Study|Adverse Event|5|||
163032557|NCT02044874|588822248|FG001|Overall Study|Adverse Event|6|||
163032558|NCT02044874|588822249|FG002|Overall Study|Adverse Event|6|||
163032559|NCT02044874|588822247|FG000|Overall Study|Withdrawal by Subject|8|||
163032560|NCT02044874|588822248|FG001|Overall Study|Withdrawal by Subject|16|||
163032561|NCT02044874|588822249|FG002|Overall Study|Withdrawal by Subject|23|||
163032562|NCT02044874|588822247|FG000|Overall Study|Physician Decision|0|||
163032563|NCT02044874|588822248|FG001|Overall Study|Physician Decision|2|||
163032564|NCT02044874|588822249|FG002|Overall Study|Physician Decision|1|||
163032565|NCT02044874|588822247|FG000|Overall Study|Lost to Follow-up|10|||
163032566|NCT02044874|588822248|FG001|Overall Study|Lost to Follow-up|27|||
163032567|NCT02044874|588822249|FG002|Overall Study|Lost to Follow-up|21|||
163085132|NCT03396445|589022228|FG017|Treatment Period|Physician Decision|0|||
163219888|NCT00751348|589521341|FG001|Overall Study|Withdrawal by Subject|2|||
163219889|NCT00751348|589521340|FG000|Overall Study|Migration from study area|1|||
163219890|NCT00751348|589521341|FG001|Overall Study|Migration from study area|0|||
163219891|NCT00743652|589521343|FG000|Overall Study|Parent/Legal Guardian Request|3|||
163219892|NCT00743652|589521344|FG001|Overall Study|Parent/Legal Guardian Request|2|||
163219893|NCT00743652|589521345|FG002|Overall Study|Parent/Legal Guardian Request|2|||
163219894|NCT00743652|589521346|FG003|Overall Study|Parent/Legal Guardian Request|2|||
163219895|NCT00743652|589521347|FG004|Overall Study|Parent/Legal Guardian Request|0|||
163219896|NCT00743652|589521343|FG000|Overall Study|Adverse Event|3|||
163219897|NCT00743652|589521344|FG001|Overall Study|Adverse Event|0|||
163219898|NCT00743652|589521345|FG002|Overall Study|Adverse Event|0|||
163219899|NCT00743652|589521346|FG003|Overall Study|Adverse Event|0|||
163219900|NCT00743652|589521347|FG004|Overall Study|Adverse Event|0|||
163219901|NCT00743652|589521343|FG000|Overall Study|Death|2|||
163219902|NCT00743652|589521344|FG001|Overall Study|Death|0|||
163032568|NCT02044874|588822247|FG000|Overall Study|Sponsor Decision|0|||
163032569|NCT02044874|588822248|FG001|Overall Study|Sponsor Decision|1|||
163032570|NCT02044874|588822249|FG002|Overall Study|Sponsor Decision|1|||
163032571|NCT02044874|588822247|FG000|Overall Study|Other|7|||
163032572|NCT02044874|588822248|FG001|Overall Study|Other|3|||
163032573|NCT02044874|588822249|FG002|Overall Study|Other|8|||
163032574|NCT00415597|588822250|FG000|Enrollment|Withdrawal by Subject|1|||
163032575|NCT00415597|588822250|FG000|Enrollment|Protocol Violation|1|||
163032576|NCT00415597|588822250|FG000|Treatment|Adverse Event|110|||
163032577|NCT00415597|588822250|FG000|Treatment|Lack of Efficacy|39|||
163032578|NCT00415597|588822250|FG000|Treatment|Protocol Violation|67|||
163032579|NCT00415597|588822250|FG000|Treatment|Physician Decision|3|||
163032580|NCT00415597|588822250|FG000|Treatment|Withdrawal by Subject|51|||
163032581|NCT00415597|588822250|FG000|Treatment|Lost to Follow-up|28|||
163032582|NCT00415597|588822250|FG000|Treatment|Drug Screen|2|||
163032583|NCT00415597|588822250|FG000|Treatment|Administrative|3|||
163032584|NCT00415597|588822250|FG000|Treatment|Sponsor Decision|1|||
163032585|NCT00415597|588822250|FG000|Treatment|Multiple Reasons|1|||
163032586|NCT02093390|588822253|FG000|Overall Study|Withdrawal by Subject|0|||
163032587|NCT02093390|588822254|FG001|Overall Study|Withdrawal by Subject|1|||
163032588|NCT00073983|588822255|FG000|Overall Study|not evaluable|1|||
163032589|NCT03976323|588822258|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
163032590|NCT03976323|588822259|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
163032591|NCT03976323|588822260|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
163032592|NCT03976323|588822258|FG000|Induction Phase|Death|80|||
163032593|NCT03976323|588822259|FG001|Induction Phase|Death|0|||
163032594|NCT03976323|588822260|FG002|Induction Phase|Death|0|||
163032595|NCT03976323|588822258|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
163032596|NCT03976323|588822259|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
163032597|NCT03976323|588822260|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
163032598|NCT03976323|588822258|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163032599|NCT03976323|588822259|FG001|Maintenance Phase|Withdrawal by Subject|9|||
163032600|NCT03976323|588822260|FG002|Maintenance Phase|Withdrawal by Subject|3|||
163032601|NCT03976323|588822258|FG000|Maintenance Phase|Physician Decision|0|||
163032602|NCT03976323|588822259|FG001|Maintenance Phase|Physician Decision|0|||
163032603|NCT03976323|588822260|FG002|Maintenance Phase|Physician Decision|1|||
163032604|NCT03976323|588822258|FG000|Maintenance Phase|Death|0|||
163032605|NCT03976323|588822259|FG001|Maintenance Phase|Death|228|||
163032606|NCT03976323|588822260|FG002|Maintenance Phase|Death|234|||
163032607|NCT02294461|588822261|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
163032608|NCT02294461|588822262|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
163032609|NCT02294461|588822263|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
163032610|NCT02294461|588822261|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
163032611|NCT02294461|588822262|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
163032612|NCT02294461|588822263|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
163219903|NCT00743652|589521345|FG002|Overall Study|Death|0|||
163219904|NCT00743652|589521346|FG003|Overall Study|Death|0|||
163219905|NCT00743652|589521347|FG004|Overall Study|Death|0|||
163219906|NCT00743652|589521343|FG000|Overall Study|Investigator Request|0|||
163219907|NCT00743652|589521344|FG001|Overall Study|Investigator Request|0|||
163219908|NCT00743652|589521345|FG002|Overall Study|Investigator Request|0|||
163219909|NCT00743652|589521346|FG003|Overall Study|Investigator Request|2|||
163219910|NCT00743652|589521347|FG004|Overall Study|Investigator Request|0|||
163219911|NCT00743652|589521343|FG000|Overall Study|Other|1|||
163219912|NCT00743652|589521344|FG001|Overall Study|Other|1|||
163219913|NCT00743652|589521345|FG002|Overall Study|Other|0|||
163219914|NCT00743652|589521346|FG003|Overall Study|Other|0|||
163219915|NCT00743652|589521347|FG004|Overall Study|Other|0|||
163219916|NCT00743652|589521343|FG000|Overall Study|Lost to Follow-up|1|||
163219917|NCT00743652|589521344|FG001|Overall Study|Lost to Follow-up|0|||
163032613|NCT02294461|588822261|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
163032614|NCT02294461|588822262|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
163032615|NCT02294461|588822263|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
163219918|NCT00743652|589521345|FG002|Overall Study|Lost to Follow-up|0|||
163219919|NCT00743652|589521346|FG003|Overall Study|Lost to Follow-up|0|||
163032616|NCT02294461|588822261|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
163032617|NCT02294461|588822262|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
163032618|NCT02294461|588822263|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
163032619|NCT02294461|588822261|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
163032620|NCT02294461|588822262|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
163032621|NCT02294461|588822263|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
163219920|NCT00743652|589521347|FG004|Overall Study|Lost to Follow-up|0|||
163219921|NCT03261947|589521348|FG000|Overall Study|Death|10|||
163219922|NCT03261947|589521349|FG001|Overall Study|Death|13|||
163219923|NCT03261947|589521350|FG002|Overall Study|Death|17|||
163219924|NCT03261947|589521351|FG003|Overall Study|Death|12|||
163219925|NCT03261947|589521352|FG004|Overall Study|Death|8|||
163032622|NCT02294461|588822261|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
163032623|NCT02294461|588822262|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
163032624|NCT02294461|588822263|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
163032625|NCT02294461|588822261|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
163032626|NCT02294461|588822262|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
163032627|NCT02294461|588822263|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
163032628|NCT02294461|588822261|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
163032629|NCT02294461|588822262|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
163032630|NCT02294461|588822263|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
163032631|NCT02294461|588822261|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
163032632|NCT02294461|588822262|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
163032633|NCT02294461|588822263|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
163032634|NCT02294461|588822261|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
163032635|NCT02294461|588822262|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
163032636|NCT02294461|588822263|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
163032637|NCT02294461|588822261|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
163032638|NCT02294461|588822262|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
163032639|NCT02294461|588822263|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
163032640|NCT02294461|588822261|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
163032641|NCT02294461|588822262|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
163032642|NCT02294461|588822263|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
163032643|NCT02294461|588822261|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
163032644|NCT02294461|588822262|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
163219926|NCT03261947|589521348|FG000|Overall Study|Lost to Follow-up|0|||
163032645|NCT02294461|588822263|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
163032646|NCT02294461|588822261|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
163032647|NCT02294461|588822262|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
163032648|NCT02294461|588822263|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
163032649|NCT03800836|588822264|FG000|Overall Study|Other|2|||
163032650|NCT03800836|588822265|FG001|Overall Study|Other|1|||
163032651|NCT03800836|588822266|FG002|Overall Study|Other|0|||
163085133|NCT03396445|589022229|FG018|Treatment Period|Physician Decision|0|||
163219927|NCT03261947|589521349|FG001|Overall Study|Lost to Follow-up|0|||
163219928|NCT03261947|589521350|FG002|Overall Study|Lost to Follow-up|2|||
163219929|NCT03261947|589521351|FG003|Overall Study|Lost to Follow-up|1|||
163219930|NCT03261947|589521352|FG004|Overall Study|Lost to Follow-up|0|||
163219931|NCT03261947|589521348|FG000|Overall Study|Withdrawal by Subject|0|||
163219932|NCT03261947|589521349|FG001|Overall Study|Withdrawal by Subject|0|||
163219933|NCT03261947|589521350|FG002|Overall Study|Withdrawal by Subject|3|||
163219934|NCT03261947|589521351|FG003|Overall Study|Withdrawal by Subject|0|||
163219935|NCT03261947|589521352|FG004|Overall Study|Withdrawal by Subject|1|||
163219936|NCT03261947|589521348|FG000|Overall Study|Site Terminated by Sponsor|0|||
163219937|NCT03261947|589521349|FG001|Overall Study|Site Terminated by Sponsor|0|||
163219938|NCT03261947|589521350|FG002|Overall Study|Site Terminated by Sponsor|4|||
163219939|NCT03261947|589521351|FG003|Overall Study|Site Terminated by Sponsor|7|||
163219940|NCT03261947|589521352|FG004|Overall Study|Site Terminated by Sponsor|5|||
163219941|NCT03261947|589521348|FG000|Overall Study|Reason not Specified|2|||
163219942|NCT03261947|589521349|FG001|Overall Study|Reason not Specified|0|||
163219943|NCT03261947|589521350|FG002|Overall Study|Reason not Specified|4|||
163219944|NCT03261947|589521351|FG003|Overall Study|Reason not Specified|1|||
163219945|NCT03261947|589521352|FG004|Overall Study|Reason not Specified|3|||
163219946|NCT03969992|589521353|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
163219947|NCT03969992|589521354|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
163219948|NCT03969992|589521355|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
163219949|NCT03969992|589521353|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
163219950|NCT03969992|589521354|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
163219951|NCT03969992|589521355|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
163219952|NCT03969992|589521353|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
163219953|NCT03969992|589521354|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
163219954|NCT03969992|589521355|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
163219955|NCT03969992|589521353|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
163219956|NCT03969992|589521354|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
163219957|NCT03969992|589521355|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
163219958|NCT03969992|589521353|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
163219959|NCT03969992|589521354|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
163219960|NCT03969992|589521355|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
163219961|NCT00228917|589521356|FG000|Overall Study|Migrated/moved from study area|0|||
163219962|NCT00228917|589521357|FG001|Overall Study|Migrated/moved from study area|0|||
163219963|NCT00228917|589521358|FG002|Overall Study|Migrated/moved from study area|0|||
163219964|NCT00228917|589521359|FG003|Overall Study|Migrated/moved from study area|0|||
163219965|NCT00228917|589521360|FG004|Overall Study|Migrated/moved from study area|0|||
163219966|NCT00228917|589521361|FG005|Overall Study|Migrated/moved from study area|2|||
163219967|NCT00228917|589521362|FG006|Overall Study|Migrated/moved from study area|0|||
163219968|NCT00228917|589521363|FG007|Overall Study|Migrated/moved from study area|0|||
163219969|NCT02063737|589521366|FG000|Overall Study|Lost to Follow-up|11|||
163032652|NCT03800836|588822267|FG003|Overall Study|Other|2|||
163032653|NCT03800836|588822268|FG004|Overall Study|Other|0|||
163032654|NCT03800836|588822269|FG005|Overall Study|Other|1|||
163032655|NCT03800836|588822264|FG000|Overall Study|Lost to Follow-up|2|||
163032656|NCT03800836|588822265|FG001|Overall Study|Lost to Follow-up|0|||
163032657|NCT03800836|588822266|FG002|Overall Study|Lost to Follow-up|1|||
163032658|NCT03800836|588822267|FG003|Overall Study|Lost to Follow-up|1|||
163032659|NCT03800836|588822268|FG004|Overall Study|Lost to Follow-up|3|||
163032660|NCT03800836|588822269|FG005|Overall Study|Lost to Follow-up|0|||
163032661|NCT03800836|588822264|FG000|Overall Study|Withdrawal by Subject|1|||
163032662|NCT03800836|588822265|FG001|Overall Study|Withdrawal by Subject|0|||
163032663|NCT03800836|588822266|FG002|Overall Study|Withdrawal by Subject|0|||
163032664|NCT03800836|588822267|FG003|Overall Study|Withdrawal by Subject|0|||
163032665|NCT03800836|588822268|FG004|Overall Study|Withdrawal by Subject|0|||
163032666|NCT03800836|588822269|FG005|Overall Study|Withdrawal by Subject|0|||
163032667|NCT03800836|588822264|FG000|Overall Study|Physician Decision|31|||
163032668|NCT03800836|588822265|FG001|Overall Study|Physician Decision|3|||
163032669|NCT03800836|588822266|FG002|Overall Study|Physician Decision|6|||
163032670|NCT03800836|588822267|FG003|Overall Study|Physician Decision|4|||
163032671|NCT03800836|588822268|FG004|Overall Study|Physician Decision|4|||
163032672|NCT03800836|588822269|FG005|Overall Study|Physician Decision|5|||
163032673|NCT03800836|588822264|FG000|Overall Study|Death|34|||
163032674|NCT03800836|588822265|FG001|Overall Study|Death|16|||
163032675|NCT03800836|588822266|FG002|Overall Study|Death|5|||
163032676|NCT03800836|588822267|FG003|Overall Study|Death|5|||
163032677|NCT03800836|588822268|FG004|Overall Study|Death|10|||
163032678|NCT03800836|588822269|FG005|Overall Study|Death|0|||
163032679|NCT03800836|588822264|FG000|Overall Study|Symptomatic Deterioration|1|||
163032680|NCT03800836|588822265|FG001|Overall Study|Symptomatic Deterioration|0|||
163032681|NCT03800836|588822266|FG002|Overall Study|Symptomatic Deterioration|1|||
163032682|NCT03800836|588822267|FG003|Overall Study|Symptomatic Deterioration|0|||
163032683|NCT03800836|588822268|FG004|Overall Study|Symptomatic Deterioration|0|||
163032684|NCT03800836|588822269|FG005|Overall Study|Symptomatic Deterioration|0|||
163032685|NCT00441363|588824412|FG000|Overall Study|Adverse Event|4|||
163032686|NCT00441363|588824413|FG001|Overall Study|Adverse Event|2|||
163032687|NCT00441363|588824412|FG000|Overall Study|Withdrawal by Subject|3|||
163032688|NCT00441363|588824413|FG001|Overall Study|Withdrawal by Subject|4|||
163032689|NCT00441363|588824412|FG000|Overall Study|Physician Decision|6|||
163032690|NCT00441363|588824413|FG001|Overall Study|Physician Decision|7|||
163032691|NCT00441363|588824412|FG000|Overall Study|Lost to Follow-up|2|||
163032692|NCT00441363|588824413|FG001|Overall Study|Lost to Follow-up|2|||
163032693|NCT00441363|588824412|FG000|Overall Study|Other|2|||
163032694|NCT00441363|588824413|FG001|Overall Study|Other|0|||
163032695|NCT03774394|588824416|FG000|Overall Study|Withdrawal by Subject|2|||
163032696|NCT03774394|588824417|FG001|Overall Study|Withdrawal by Subject|0|||
163032697|NCT03334422|588824418|FG000|Overall Study|Adverse Event|1|||
163032698|NCT03334422|588824419|FG001|Overall Study|Adverse Event|3|||
163032699|NCT03334422|588824420|FG002|Overall Study|Adverse Event|2|||
163032700|NCT03334422|588824421|FG003|Overall Study|Adverse Event|2|||
163219970|NCT02063737|589521367|FG001|Overall Study|Lost to Follow-up|4|||
163219971|NCT04372602|589521370|FG000|Overall Study|Withdrawal by Subject|1|||
163219972|NCT04372602|589521371|FG001|Overall Study|Withdrawal by Subject|1|||
163219973|NCT04372602|589521370|FG000|Overall Study|Adverse Event|0|||
163333014|NCT00670488|589929947|FG007|Overall Study|Progressive Disease|2|||
163333015|NCT00670488|589929948|FG008|Overall Study|Progressive Disease|2|||
163333016|NCT00670488|589929949|FG009|Overall Study|Progressive Disease|1|||
163032701|NCT03334422|588824418|FG000|Overall Study|Lack of Efficacy|10|||
163032702|NCT03334422|588824419|FG001|Overall Study|Lack of Efficacy|2|||
163032703|NCT03334422|588824420|FG002|Overall Study|Lack of Efficacy|7|||
163032704|NCT03334422|588824421|FG003|Overall Study|Lack of Efficacy|3|||
163032705|NCT03334422|588824418|FG000|Overall Study|Withdrawal by Subject|8|||
163032706|NCT03334422|588824419|FG001|Overall Study|Withdrawal by Subject|3|||
163032707|NCT03334422|588824420|FG002|Overall Study|Withdrawal by Subject|1|||
163032708|NCT03334422|588824421|FG003|Overall Study|Withdrawal by Subject|0|||
163032709|NCT03334422|588824418|FG000|Overall Study|Lost to Follow-up|0|||
163032710|NCT03334422|588824419|FG001|Overall Study|Lost to Follow-up|0|||
163219974|NCT04372602|589521371|FG001|Overall Study|Adverse Event|1|||
163333017|NCT00670488|589929940|FG000|Overall Study|Withdrawal by Subject|0|||
163032711|NCT03334422|588824420|FG002|Overall Study|Lost to Follow-up|0|||
163032712|NCT03334422|588824421|FG003|Overall Study|Lost to Follow-up|1|||
163219975|NCT04372602|589521370|FG000|Overall Study|Transitioned to comfort care|0|||
163333018|NCT00670488|589929941|FG001|Overall Study|Withdrawal by Subject|1|||
163032713|NCT03334422|588824418|FG000|Overall Study|Inability to obtain laboratory samples|0|||
163032714|NCT03334422|588824419|FG001|Overall Study|Inability to obtain laboratory samples|1|||
163032715|NCT03334422|588824420|FG002|Overall Study|Inability to obtain laboratory samples|0|||
163032716|NCT03334422|588824421|FG003|Overall Study|Inability to obtain laboratory samples|0|||
163032717|NCT03334422|588824418|FG000|Overall Study|Pregnancy|0|||
163032718|NCT03334422|588824419|FG001|Overall Study|Pregnancy|1|||
163032719|NCT03334422|588824420|FG002|Overall Study|Pregnancy|0|||
163032720|NCT03334422|588824421|FG003|Overall Study|Pregnancy|0|||
163032721|NCT01313221|588824422|FG000|Overall Study|Protocol Violation|0|||
163032722|NCT01313221|588824423|FG001|Overall Study|Protocol Violation|1|||
163032723|NCT01313221|588824424|FG002|Overall Study|Protocol Violation|1|||
163032724|NCT01313221|588824422|FG000|Overall Study|Non-compliance|3|||
163032725|NCT01313221|588824423|FG001|Overall Study|Non-compliance|0|||
163032726|NCT01313221|588824424|FG002|Overall Study|Non-compliance|2|||
163032727|NCT01313221|588824422|FG000|Overall Study|Withdrawal by Subject|2|||
163032728|NCT01313221|588824423|FG001|Overall Study|Withdrawal by Subject|3|||
163032729|NCT01313221|588824424|FG002|Overall Study|Withdrawal by Subject|5|||
163032730|NCT01313221|588824422|FG000|Overall Study|Requirement for alternative therapy|0|||
163032731|NCT01313221|588824423|FG001|Overall Study|Requirement for alternative therapy|1|||
163032732|NCT01313221|588824424|FG002|Overall Study|Requirement for alternative therapy|1|||
163032733|NCT01313221|588824422|FG000|Overall Study|Lost to Follow-up|6|||
163085134|NCT03396445|589022230|FG019|Treatment Period|Physician Decision|0|||
163085135|NCT03396445|589022231|FG020|Treatment Period|Physician Decision|0|||
163085136|NCT03396445|589022232|FG021|Treatment Period|Physician Decision|0|||
163333019|NCT00670488|589929942|FG002|Overall Study|Withdrawal by Subject|0|||
163333020|NCT00670488|589929943|FG003|Overall Study|Withdrawal by Subject|1|||
163333021|NCT00670488|589929944|FG004|Overall Study|Withdrawal by Subject|0|||
163333022|NCT00670488|589929945|FG005|Overall Study|Withdrawal by Subject|0|||
163333023|NCT00670488|589929946|FG006|Overall Study|Withdrawal by Subject|1|||
163333024|NCT00670488|589929947|FG007|Overall Study|Withdrawal by Subject|0|||
163333025|NCT00670488|589929948|FG008|Overall Study|Withdrawal by Subject|1|||
163333026|NCT00670488|589929949|FG009|Overall Study|Withdrawal by Subject|0|||
163333027|NCT00878189|589929950|FG000|Overall Study|Death|0|||
163333028|NCT00878189|589929951|FG001|Overall Study|Death|1|||
163333029|NCT00878189|589929952|FG002|Overall Study|Death|0|||
163333030|NCT00878189|589929953|FG003|Overall Study|Death|1|||
163333031|NCT00878189|589929954|FG004|Overall Study|Death|0|||
163333032|NCT00878189|589929955|FG005|Overall Study|Death|0|||
163333033|NCT00878189|589929956|FG006|Overall Study|Death|0|||
163333034|NCT00878189|589929957|FG007|Overall Study|Death|0|||
163333035|NCT00878189|589929958|FG008|Overall Study|Death|1|||
163333036|NCT00878189|589929950|FG000|Overall Study|Participant Refused to Follow-up|0|||
163333037|NCT00878189|589929951|FG001|Overall Study|Participant Refused to Follow-up|0|||
163333038|NCT00878189|589929952|FG002|Overall Study|Participant Refused to Follow-up|0|||
163333039|NCT00878189|589929953|FG003|Overall Study|Participant Refused to Follow-up|0|||
163333040|NCT00878189|589929954|FG004|Overall Study|Participant Refused to Follow-up|0|||
163333041|NCT00878189|589929955|FG005|Overall Study|Participant Refused to Follow-up|4|||
163333042|NCT00878189|589929956|FG006|Overall Study|Participant Refused to Follow-up|0|||
163333043|NCT00878189|589929957|FG007|Overall Study|Participant Refused to Follow-up|0|||
163333044|NCT00878189|589929958|FG008|Overall Study|Participant Refused to Follow-up|0|||
163333045|NCT00878189|589929950|FG000|Overall Study|Other|3|||
163333046|NCT00878189|589929951|FG001|Overall Study|Other|2|||
163333047|NCT00878189|589929952|FG002|Overall Study|Other|4|||
163333048|NCT00878189|589929953|FG003|Overall Study|Other|7|||
163333049|NCT00878189|589929954|FG004|Overall Study|Other|4|||
163333050|NCT00878189|589929955|FG005|Overall Study|Other|18|||
163333051|NCT00878189|589929956|FG006|Overall Study|Other|15|||
163333052|NCT00878189|589929957|FG007|Overall Study|Other|3|||
163333053|NCT00878189|589929958|FG008|Overall Study|Other|4|||
163333054|NCT00878189|589929950|FG000|Overall Study|Lost to Follow-up|0|||
163333055|NCT00878189|589929951|FG001|Overall Study|Lost to Follow-up|0|||
163333056|NCT00878189|589929952|FG002|Overall Study|Lost to Follow-up|0|||
163333057|NCT00878189|589929953|FG003|Overall Study|Lost to Follow-up|0|||
163333058|NCT00878189|589929954|FG004|Overall Study|Lost to Follow-up|0|||
163032734|NCT01313221|588824423|FG001|Overall Study|Lost to Follow-up|3|||
163032735|NCT01313221|588824424|FG002|Overall Study|Lost to Follow-up|1|||
163085137|NCT03396445|589022233|FG022|Treatment Period|Physician Decision|0|||
163333059|NCT00878189|589929955|FG005|Overall Study|Lost to Follow-up|1|||
163333060|NCT00878189|589929956|FG006|Overall Study|Lost to Follow-up|1|||
163333061|NCT00878189|589929957|FG007|Overall Study|Lost to Follow-up|0|||
163333062|NCT00878189|589929958|FG008|Overall Study|Lost to Follow-up|0|||
163333063|NCT00878189|589929950|FG000|Overall Study|Objection Progression or Relapse|0|||
163333064|NCT00878189|589929951|FG001|Overall Study|Objection Progression or Relapse|0|||
163333065|NCT00878189|589929952|FG002|Overall Study|Objection Progression or Relapse|0|||
163406511|NCT03860961|590198665|FG001|Overall Study|Incomplete two-year data|0|||
163032736|NCT01313221|588824422|FG000|Overall Study|Other|1|||
163032737|NCT01313221|588824423|FG001|Overall Study|Other|0|||
163333066|NCT00878189|589929953|FG003|Overall Study|Objection Progression or Relapse|0|||
163032738|NCT01313221|588824424|FG002|Overall Study|Other|0|||
163032739|NCT01313221|588824422|FG000|Overall Study|Adverse Event|0|||
163032740|NCT01313221|588824423|FG001|Overall Study|Adverse Event|0|||
163032741|NCT01313221|588824424|FG002|Overall Study|Adverse Event|7|||
163032742|NCT01313221|588824422|FG000|Overall Study|Disease progression|0|||
163032743|NCT01313221|588824423|FG001|Overall Study|Disease progression|0|||
163032744|NCT01313221|588824424|FG002|Overall Study|Disease progression|2|||
163032745|NCT01313221|588824422|FG000|Overall Study|Physician Decision|0|||
163032746|NCT01313221|588824423|FG001|Overall Study|Physician Decision|0|||
163032747|NCT01313221|588824424|FG002|Overall Study|Physician Decision|2|||
163032748|NCT01313221|588824422|FG000|Overall Study|Pregnancy|0|||
163032749|NCT01313221|588824423|FG001|Overall Study|Pregnancy|0|||
163032750|NCT01313221|588824424|FG002|Overall Study|Pregnancy|2|||
163032751|NCT00994214|588824425|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
163032752|NCT00994214|588824426|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
163032753|NCT00994214|588824427|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
163032754|NCT00994214|588824428|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
163032755|NCT00994214|588824425|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
163032756|NCT00994214|588824426|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
163032757|NCT00994214|588824427|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
163032758|NCT00994214|588824428|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
163032759|NCT00994214|588824425|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
163032760|NCT00994214|588824426|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
163032761|NCT00994214|588824427|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
163032762|NCT00994214|588824428|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
163032763|NCT00994214|588824425|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
163032764|NCT00994214|588824426|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
163032765|NCT00994214|588824427|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
163032766|NCT00994214|588824428|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
163032767|NCT00994214|588824425|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
163032768|NCT00994214|588824426|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
163032769|NCT00994214|588824427|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
163032770|NCT00994214|588824428|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
163032771|NCT00994214|588824425|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
163032772|NCT00994214|588824426|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
163032773|NCT00994214|588824427|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
163032774|NCT00994214|588824428|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
163032775|NCT03246061|588824429|FG000|Overall Study|Still in follow-up|15|||
163032776|NCT03246061|588824430|FG001|Overall Study|Still in follow-up|21|||
163032777|NCT04710368|588824435|FG000|Overall Study|Withdrawal by Subject|9|||
163032778|NCT04710368|588824435|FG000|Overall Study|Lost to Follow-up|4|||
163032779|NCT04710368|588824435|FG000|Overall Study|Death|2|||
163032780|NCT04710368|588824435|FG000|Overall Study|Patient preference|11|||
163032781|NCT04710368|588824435|FG000|Overall Study|Treatment discontinuation|1|||
163032782|NCT01777139|588824438|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
163032783|NCT01777139|588824439|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
163032784|NCT01777139|588824438|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
163032785|NCT01777139|588824439|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
163032786|NCT01777139|588824438|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
163032787|NCT01777139|588824439|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
163032788|NCT01777139|588824438|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
163032789|NCT01777139|588824439|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
163032790|NCT01777139|588824438|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
163032791|NCT01777139|588824439|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
163032792|NCT01777139|588824438|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
163032793|NCT01777139|588824439|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
163032794|NCT01777139|588824438|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
163032795|NCT01777139|588824439|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
163032796|NCT01777139|588824438|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
163032797|NCT01777139|588824439|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
163032798|NCT01887288|588824441|FG000|Overall Study|The study was terminated and the PI has|16|||
163032799|NCT00290693|588824442|FG000|Overall Study|Withdrawal by Subject|2|||
163032800|NCT05625477|588824443|FG000|Overall Study|Lost to Follow-up|2|||
163032801|NCT05625477|588824444|FG001|Overall Study|Lost to Follow-up|2|||
163032802|NCT05625477|588824445|FG002|Overall Study|Lost to Follow-up|1|||
163032803|NCT05625477|588824446|FG003|Overall Study|Lost to Follow-up|1|||
163032804|NCT05625477|588824447|FG004|Overall Study|Lost to Follow-up|0|||
163032805|NCT05625477|588824443|FG000|Overall Study|Covid quarantine|1|||
163032806|NCT05625477|588824444|FG001|Overall Study|Covid quarantine|0|||
163406512|NCT03189446|590198666|FG000|Overall Study|Adverse Event|2|||
163406513|NCT03189446|590198666|FG000|Overall Study|Withdrawal by Subject|2|||
163406514|NCT03189446|590198666|FG000|Overall Study|Physician Decision|1|||
163406515|NCT00883337|590198667|FG000|Core Treatment Period|Adverse Event|9|||
163406516|NCT00883337|590198668|FG001|Core Treatment Period|Adverse Event|12|||
163406517|NCT00883337|590198669|FG002|Core Treatment Period|Adverse Event|22|||
163406518|NCT00883337|590198667|FG000|Core Treatment Period|Lack of Efficacy|7|||
163406519|NCT00883337|590198668|FG001|Core Treatment Period|Lack of Efficacy|4|||
163406520|NCT00883337|590198669|FG002|Core Treatment Period|Lack of Efficacy|2|||
163406521|NCT00883337|590198667|FG000|Core Treatment Period|Lost to Follow-up|1|||
163406522|NCT00883337|590198668|FG001|Core Treatment Period|Lost to Follow-up|1|||
163406523|NCT00883337|590198669|FG002|Core Treatment Period|Lost to Follow-up|0|||
163406524|NCT00883337|590198667|FG000|Core Treatment Period|Withdrawal by Subject|2|||
163406525|NCT00883337|590198668|FG001|Core Treatment Period|Withdrawal by Subject|2|||
163406526|NCT00883337|590198669|FG002|Core Treatment Period|Withdrawal by Subject|6|||
163406527|NCT00883337|590198667|FG000|Core Treatment Period|Wish to be pregnant|1|||
163406528|NCT00883337|590198668|FG001|Core Treatment Period|Wish to be pregnant|2|||
163406529|NCT00883337|590198669|FG002|Core Treatment Period|Wish to be pregnant|1|||
163406530|NCT00883337|590198667|FG000|Core Treatment Period|Poor compliance to protocol|0|||
163406531|NCT00883337|590198668|FG001|Core Treatment Period|Poor compliance to protocol|0|||
163406532|NCT00883337|590198669|FG002|Core Treatment Period|Poor compliance to protocol|1|||
163406533|NCT00883337|590198667|FG000|Core Treatment Period|Other than above|0|||
163406534|NCT00883337|590198668|FG001|Core Treatment Period|Other than above|1|||
163406535|NCT00883337|590198669|FG002|Core Treatment Period|Other than above|1|||
163406536|NCT00883337|590198667|FG000|Extension Treatment Period|Adverse Event|8|||
163406537|NCT00883337|590198668|FG001|Extension Treatment Period|Adverse Event|5|||
163406538|NCT00883337|590198669|FG002|Extension Treatment Period|Adverse Event|5|||
163406539|NCT00883337|590198667|FG000|Extension Treatment Period|Lack of Efficacy|8|||
163406540|NCT00883337|590198668|FG001|Extension Treatment Period|Lack of Efficacy|8|||
163406541|NCT00883337|590198669|FG002|Extension Treatment Period|Lack of Efficacy|8|||
163406542|NCT00883337|590198667|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
163406543|NCT00883337|590198668|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
163406544|NCT00883337|590198669|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
163406545|NCT00883337|590198667|FG000|Extension Treatment Period|Lost to Follow-up|1|||
163406546|NCT00883337|590198668|FG001|Extension Treatment Period|Lost to Follow-up|0|||
163406547|NCT00883337|590198669|FG002|Extension Treatment Period|Lost to Follow-up|0|||
163406548|NCT00883337|590198667|FG000|Extension Treatment Period|Other than above|10|||
163406549|NCT00883337|590198668|FG001|Extension Treatment Period|Other than above|9|||
163406550|NCT00883337|590198669|FG002|Extension Treatment Period|Other than above|5|||
163406551|NCT00763139|590198670|FG000|Overall Study|Adverse Event|4|||
163406552|NCT00763139|590198671|FG001|Overall Study|Adverse Event|2|||
163406553|NCT00763139|590198670|FG000|Overall Study|Withdrawal by Subject|0|||
163406554|NCT00763139|590198671|FG001|Overall Study|Withdrawal by Subject|1|||
163406555|NCT00763139|590198670|FG000|Overall Study|med change not allowed by protocol|1|||
163406556|NCT00763139|590198671|FG001|Overall Study|med change not allowed by protocol|0|||
163406557|NCT05634577|590198672|FG000|Overall Study|Lost to Follow-up|1|||
163406558|NCT05634577|590198672|FG000|Overall Study|Withdrawal by Subject|1|||
163032807|NCT05625477|588824445|FG002|Overall Study|Covid quarantine|0|||
163032808|NCT05625477|588824446|FG003|Overall Study|Covid quarantine|0|||
163032809|NCT05625477|588824447|FG004|Overall Study|Covid quarantine|0|||
163032810|NCT04849416|588824450|FG000|Overall Study|Ongoing Treatment|12|||
163032811|NCT04849416|588824451|FG001|Overall Study|Ongoing Treatment|5|||
163032812|NCT04849416|588824452|FG002|Overall Study|Ongoing Treatment|3|||
163406559|NCT03468309|590198673|FG000|Overall Study|Lost to Follow-up|4|||
163406560|NCT03468309|590198673|FG000|Overall Study|Withdrawal by Subject|2|||
163406561|NCT02631200|590198677|FG000|First Period|Death|1|||
163406562|NCT02631200|590198678|FG001|First Period|Death|2|||
163406563|NCT02631200|590198677|FG000|First Period|Patient ill-health|2|||
163032813|NCT04849416|588824450|FG000|Overall Study|On Post-Treatment Follow-up|8|||
163032814|NCT04849416|588824451|FG001|Overall Study|On Post-Treatment Follow-up|9|||
163032815|NCT04849416|588824452|FG002|Overall Study|On Post-Treatment Follow-up|10|||
163032816|NCT04849416|588824450|FG000|Overall Study|Withdrawal by Subject|0|||
163032817|NCT04849416|588824451|FG001|Overall Study|Withdrawal by Subject|0|||
163085138|NCT03396445|589022234|FG023|Treatment Period|Physician Decision|0|||
163085139|NCT03396445|589022235|FG024|Treatment Period|Physician Decision|0|||
163085140|NCT03396445|589022236|FG025|Treatment Period|Physician Decision|0|||
163032818|NCT04849416|588824452|FG002|Overall Study|Withdrawal by Subject|1|||
163085141|NCT03396445|589022211|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085142|NCT03396445|589022212|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163406564|NCT02631200|590198678|FG001|First Period|Patient ill-health|4|||
163406565|NCT02631200|590198677|FG000|First Period|Withdrawal by Subject|4|||
163406566|NCT02631200|590198678|FG001|First Period|Withdrawal by Subject|1|||
163032819|NCT04849416|588824450|FG000|Overall Study|Lost to Follow-up|1|||
163406567|NCT02631200|590198677|FG000|Deferred Period|Death|0|||
163406568|NCT02631200|590198678|FG001|Deferred Period|Death|1|||
163032820|NCT04849416|588824451|FG001|Overall Study|Lost to Follow-up|0|||
163032821|NCT04849416|588824452|FG002|Overall Study|Lost to Follow-up|0|||
163032822|NCT01092637|588824453|FG000|Overall Study|Death|47|||
163032823|NCT01092637|588824454|FG001|Overall Study|Death|49|||
163032824|NCT01716520|588824455|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
163032825|NCT01716520|588824456|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
163032826|NCT01716520|588824457|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
163032827|NCT01716520|588824458|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
163032828|NCT01716520|588824459|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
163032829|NCT01716520|588824460|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
163032830|NCT01716520|588824455|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
163032831|NCT01716520|588824456|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
163032832|NCT01716520|588824457|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
163032833|NCT01716520|588824458|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
163032834|NCT01716520|588824459|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
163032835|NCT01716520|588824460|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
163032836|NCT01716520|588824455|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163032837|NCT01716520|588824456|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163032838|NCT01716520|588824457|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163032839|NCT01716520|588824458|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163032840|NCT01716520|588824459|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163032841|NCT01716520|588824460|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163032842|NCT01716520|588824455|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
163032843|NCT01716520|588824456|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
163032844|NCT01716520|588824457|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
163032845|NCT01716520|588824458|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
163032846|NCT01716520|588824459|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
163032847|NCT01716520|588824460|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
163032848|NCT01716520|588824455|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163032849|NCT01716520|588824456|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163032850|NCT01716520|588824457|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163032851|NCT01716520|588824458|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163032852|NCT01716520|588824459|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163032853|NCT01716520|588824460|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
163032854|NCT01716520|588824455|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
163032855|NCT01716520|588824456|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
163032856|NCT01716520|588824457|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
163032857|NCT01716520|588824458|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
163032858|NCT01716520|588824459|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
163032859|NCT01716520|588824460|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
163032860|NCT01716520|588824455|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
163032861|NCT01716520|588824456|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
163032862|NCT01716520|588824457|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
163032863|NCT01716520|588824458|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
163032864|NCT01716520|588824459|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
163032865|NCT01716520|588824460|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
163032866|NCT01716520|588824455|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163032867|NCT01716520|588824456|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163032868|NCT01716520|588824457|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163032869|NCT01716520|588824458|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163032870|NCT01716520|588824459|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
163032871|NCT01716520|588824460|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163032872|NCT01716520|588824455|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
163032873|NCT01716520|588824456|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
163032874|NCT01716520|588824457|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
163032875|NCT01716520|588824458|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
163032876|NCT01716520|588824459|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
163032877|NCT01716520|588824460|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
163032878|NCT01716520|588824455|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
163032879|NCT01716520|588824456|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
163032880|NCT01716520|588824457|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
163032881|NCT01716520|588824458|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
163032882|NCT01716520|588824459|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
163032883|NCT01716520|588824460|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
163032884|NCT01716520|588824455|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
163032885|NCT01716520|588824456|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
163032886|NCT01716520|588824457|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
163032887|NCT01716520|588824458|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
163219976|NCT04372602|589521371|FG001|Overall Study|Transitioned to comfort care|1|||
163219977|NCT01085097|589521372|FG000|Overall Study|Adverse Event|0|||
163219978|NCT01085097|589521373|FG001|Overall Study|Adverse Event|0|||
163219979|NCT01085097|589521374|FG002|Overall Study|Adverse Event|2|||
163219980|NCT01085097|589521372|FG000|Overall Study|Treatment failure|2|||
163219981|NCT01085097|589521373|FG001|Overall Study|Treatment failure|0|||
163219982|NCT01085097|589521374|FG002|Overall Study|Treatment failure|0|||
163219983|NCT04120974|589521375|FG000|Overall Study|Death|1|||
163219984|NCT04120974|589521375|FG000|Overall Study|Physician Decision|1|||
163219985|NCT04120974|589521375|FG000|Overall Study|Lost to Follow-up|6|||
163219986|NCT06049043|589521376|FG000|Overall Study|Lost to Follow-up|11|||
163219987|NCT06049043|589521377|FG001|Overall Study|Lost to Follow-up|9|||
163219988|NCT00129129|589521378|FG000|Primary Phase|Adverse Event|2|||
163219989|NCT00129129|589521379|FG001|Primary Phase|Adverse Event|1|||
163219990|NCT00129129|589521380|FG002|Primary Phase|Adverse Event|0|||
163219991|NCT00129129|589521381|FG003|Primary Phase|Adverse Event|0|||
163219992|NCT00129129|589521382|FG004|Primary Phase|Adverse Event|0|||
163219993|NCT00129129|589521378|FG000|Primary Phase|Withdrawal by Subject|12|||
163219994|NCT00129129|589521379|FG001|Primary Phase|Withdrawal by Subject|10|||
163219995|NCT00129129|589521380|FG002|Primary Phase|Withdrawal by Subject|0|||
163219996|NCT00129129|589521381|FG003|Primary Phase|Withdrawal by Subject|0|||
163219997|NCT00129129|589521382|FG004|Primary Phase|Withdrawal by Subject|0|||
163219998|NCT00129129|589521378|FG000|Primary Phase|Migration from study area|1|||
163219999|NCT00129129|589521379|FG001|Primary Phase|Migration from study area|3|||
163220000|NCT00129129|589521380|FG002|Primary Phase|Migration from study area|0|||
163220001|NCT00129129|589521381|FG003|Primary Phase|Migration from study area|0|||
163220002|NCT00129129|589521382|FG004|Primary Phase|Migration from study area|0|||
163220003|NCT00129129|589521378|FG000|Primary Phase|Lost to Follow-up|8|||
163220004|NCT00129129|589521379|FG001|Primary Phase|Lost to Follow-up|6|||
163220005|NCT00129129|589521380|FG002|Primary Phase|Lost to Follow-up|0|||
163220006|NCT00129129|589521381|FG003|Primary Phase|Lost to Follow-up|0|||
163220007|NCT00129129|589521382|FG004|Primary Phase|Lost to Follow-up|0|||
163220008|NCT00129129|589521378|FG000|Primary Phase|Other|2|||
163333067|NCT00878189|589929954|FG004|Overall Study|Objection Progression or Relapse|0|||
163333068|NCT00878189|589929955|FG005|Overall Study|Objection Progression or Relapse|0|||
163333069|NCT00878189|589929956|FG006|Overall Study|Objection Progression or Relapse|0|||
163333070|NCT00878189|589929957|FG007|Overall Study|Objection Progression or Relapse|0|||
163333071|NCT00878189|589929958|FG008|Overall Study|Objection Progression or Relapse|3|||
163333072|NCT02708498|589929959|FG000|Overall Study|Death|20|||
163085143|NCT03396445|589022213|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085144|NCT03396445|589022214|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085145|NCT03396445|589022215|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085146|NCT03396445|589022216|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085147|NCT03396445|589022217|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085148|NCT03396445|589022218|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085149|NCT03396445|589022219|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085150|NCT03396445|589022220|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085151|NCT03396445|589022221|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085152|NCT03396445|589022222|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085153|NCT03396445|589022223|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
163085154|NCT03396445|589022224|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085155|NCT03396445|589022225|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
163085156|NCT03396445|589022226|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163220009|NCT00129129|589521379|FG001|Primary Phase|Other|5|||
163333073|NCT02708498|589929960|FG001|Overall Study|Death|19|||
163333074|NCT02708498|589929961|FG002|Overall Study|Death|0|||
163333075|NCT02708498|589929962|FG003|Overall Study|Death|0|||
163333076|NCT02708498|589929963|FG004|Overall Study|Death|1|||
163333077|NCT02708498|589929964|FG005|Overall Study|Death|0|||
163333078|NCT02708498|589929965|FG006|Overall Study|Death|0|||
163333079|NCT02708498|589929966|FG007|Overall Study|Death|0|||
163333080|NCT02708498|589929959|FG000|Overall Study|Unknown reason, missing data|0|||
163220010|NCT00129129|589521380|FG002|Primary Phase|Other|0|||
163220011|NCT00129129|589521381|FG003|Primary Phase|Other|0|||
163333081|NCT02708498|589929960|FG001|Overall Study|Unknown reason, missing data|0|||
163333082|NCT02708498|589929961|FG002|Overall Study|Unknown reason, missing data|62|||
163333083|NCT02708498|589929962|FG003|Overall Study|Unknown reason, missing data|51|||
163220012|NCT00129129|589521382|FG004|Primary Phase|Other|0|||
163220013|NCT00129129|589521378|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
163220014|NCT00129129|589521379|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
163220015|NCT00129129|589521380|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
163220016|NCT00129129|589521381|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
163220017|NCT00129129|589521382|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
163220018|NCT00129129|589521378|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
163333084|NCT02708498|589929963|FG004|Overall Study|Unknown reason, missing data|195|||
163333085|NCT02708498|589929964|FG005|Overall Study|Unknown reason, missing data|132|||
163333086|NCT02708498|589929965|FG006|Overall Study|Unknown reason, missing data|0|||
163333087|NCT02708498|589929966|FG007|Overall Study|Unknown reason, missing data|0|||
163333088|NCT01829711|589929967|FG000|Overall Study|Lost to Follow-up|2|||
163333089|NCT01829711|589929967|FG000|Overall Study|Withdrawal by Subject|3|||
163333090|NCT01829711|589929967|FG000|Overall Study|Death|4|||
163333091|NCT01829711|589929967|FG000|Overall Study|Started new therapies|17|||
163333092|NCT01829711|589929967|FG000|Overall Study|Adverse Event|3|||
163333093|NCT01829711|589929967|FG000|Overall Study|Due to progression of disease|13|||
163333094|NCT01829711|589929967|FG000|Overall Study|Due to lack of response|1|||
163333095|NCT01480258|589929968|FG000|Infant Series|Protocol Violation|2|||
163333096|NCT01480258|589929969|FG001|Infant Series|Protocol Violation|0|||
163333097|NCT01480258|589929968|FG000|Infant Series|Physician Decision|0|||
163333098|NCT01480258|589929969|FG001|Infant Series|Physician Decision|1|||
163333099|NCT01480258|589929968|FG000|Infant Series|Not Vaccinated|3|||
163333100|NCT01480258|589929969|FG001|Infant Series|Not Vaccinated|0|||
163333101|NCT01480258|589929968|FG000|Infant Series|Adverse Event|1|||
163333102|NCT01480258|589929969|FG001|Infant Series|Adverse Event|1|||
163333103|NCT01480258|589929968|FG000|Infant Series|Withdrawal by Subject|1|||
163333104|NCT01480258|589929969|FG001|Infant Series|Withdrawal by Subject|6|||
163333105|NCT01480258|589929968|FG000|Interim Period|Lost to Follow-up|0|||
163333106|NCT01480258|589929969|FG001|Interim Period|Lost to Follow-up|2|||
163333107|NCT01480258|589929968|FG000|Interim Period|Physician Decision|1|||
163333108|NCT01480258|589929969|FG001|Interim Period|Physician Decision|0|||
163333109|NCT01480258|589929968|FG000|Interim Period|Protocol Violation|0|||
163333110|NCT01480258|589929969|FG001|Interim Period|Protocol Violation|1|||
163333111|NCT01480258|589929968|FG000|Interim Period|Withdrawal by Subject|9|||
163333112|NCT01480258|589929969|FG001|Interim Period|Withdrawal by Subject|6|||
163333113|NCT00701415|589929980|FG000|Overall Study|Adverse Event|0|||
163333114|NCT00701415|589929981|FG001|Overall Study|Adverse Event|1|||
163333115|NCT00701415|589929980|FG000|Overall Study|Social/family issues and needle phobia|1|||
163333116|NCT00701415|589929981|FG001|Overall Study|Social/family issues and needle phobia|0|||
163333117|NCT02106884|589929990|FG000|Overall Study|Change of diagnosis/exclusion|0|||
163333118|NCT02106884|589929991|FG001|Overall Study|Change of diagnosis/exclusion|1|||
163333119|NCT00659373|589929993|FG000|Overall Study|Withdrawal by Subject|3|||
163333120|NCT00659373|589929994|FG001|Overall Study|Withdrawal by Subject|5|||
163333121|NCT00659373|589929993|FG000|Overall Study|Assessment Missed|2|||
163333122|NCT00659373|589929994|FG001|Overall Study|Assessment Missed|2|||
163333123|NCT03042767|589929997|FG000|Overall Study|Lost to Follow-up|1|||
163333124|NCT03042767|589929998|FG001|Overall Study|Lost to Follow-up|2|||
163333125|NCT01543204|589930000|FG000|Overall Study|Non-compliance|1|||
163333126|NCT01543204|589930000|FG000|Overall Study|Adverse Event|1|||
163333127|NCT01543204|589930000|FG000|Overall Study|Withdrawal by Subject|4|||
163333128|NCT01543204|589930000|FG000|Overall Study|Requirement for Alternative Therapy|1|||
163333129|NCT01543204|589930000|FG000|Overall Study|Lost to Follow-up|1|||
163333130|NCT04638816|589930001|FG000|Overall Study|Withdrawal by Subject|0|||
163333131|NCT04638816|589930002|FG001|Overall Study|Withdrawal by Subject|1|||
163333132|NCT04638816|589930001|FG000|Overall Study|Lost to Follow-up|0|||
163333133|NCT04638816|589930002|FG001|Overall Study|Lost to Follow-up|1|||
163333134|NCT01328496|589930005|FG000|Overall Study|Significant Change in Health Status|1|||
163333135|NCT01328496|589930006|FG001|Overall Study|Significant Change in Health Status|0|||
163333136|NCT02686658|589930009|FG000|Overall Study|Adverse Event|0|||
163333137|NCT02686658|589930010|FG001|Overall Study|Adverse Event|0|||
163333138|NCT02686658|589930011|FG002|Overall Study|Adverse Event|1|||
163085157|NCT03396445|589022227|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085158|NCT03396445|589022228|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163333139|NCT02686658|589930012|FG003|Overall Study|Adverse Event|1|||
163333140|NCT02686658|589930013|FG004|Overall Study|Adverse Event|2|||
163333141|NCT02686658|589930014|FG005|Overall Study|Adverse Event|1|||
163406569|NCT02631200|590198677|FG000|Deferred Period|Received kidney transplant|0|||
163085159|NCT03396445|589022229|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085160|NCT03396445|589022230|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085161|NCT03396445|589022231|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085162|NCT03396445|589022232|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163333142|NCT02686658|589930009|FG000|Overall Study|Investigator decision|0|||
163333143|NCT02686658|589930010|FG001|Overall Study|Investigator decision|0|||
163333144|NCT02686658|589930011|FG002|Overall Study|Investigator decision|0|||
163333145|NCT02686658|589930012|FG003|Overall Study|Investigator decision|1|||
163333146|NCT02686658|589930013|FG004|Overall Study|Investigator decision|2|||
163333147|NCT02686658|589930014|FG005|Overall Study|Investigator decision|1|||
163333148|NCT02686658|589930009|FG000|Overall Study|Sponsor decision|1|||
163333149|NCT02686658|589930010|FG001|Overall Study|Sponsor decision|2|||
163333150|NCT02686658|589930011|FG002|Overall Study|Sponsor decision|1|||
163333151|NCT02686658|589930012|FG003|Overall Study|Sponsor decision|5|||
163333152|NCT02686658|589930013|FG004|Overall Study|Sponsor decision|13|||
163333153|NCT02686658|589930014|FG005|Overall Study|Sponsor decision|2|||
163085163|NCT03396445|589022233|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085164|NCT03396445|589022234|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085165|NCT03396445|589022235|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163406570|NCT02631200|590198678|FG001|Deferred Period|Received kidney transplant|1|||
163406571|NCT02631200|590198677|FG000|Deferred Period|Withdrawal by Subject|0|||
163406572|NCT02631200|590198678|FG001|Deferred Period|Withdrawal by Subject|2|||
163406573|NCT02631200|590198677|FG000|Deferred Period|Lost to Follow-up|0|||
163406574|NCT02631200|590198678|FG001|Deferred Period|Lost to Follow-up|1|||
163406575|NCT02669017|590198681|FG000|Overall Study|Death|1|||
163406576|NCT02669017|590198682|FG001|Overall Study|Death|2|||
163406577|NCT02669017|590198683|FG002|Overall Study|Death|2|||
163406578|NCT02669017|590198684|FG003|Overall Study|Death|3|||
163406579|NCT02669017|590198685|FG004|Overall Study|Death|8|||
163406580|NCT02669017|590198686|FG005|Overall Study|Death|18|||
163406581|NCT02669017|590198687|FG006|Overall Study|Death|10|||
163406582|NCT02669017|590198688|FG007|Overall Study|Death|47|||
163406583|NCT02669017|590198689|FG008|Overall Study|Death|20|||
163406584|NCT02669017|590198681|FG000|Overall Study|Withdrawal by Subject|0|||
163406585|NCT02669017|590198682|FG001|Overall Study|Withdrawal by Subject|0|||
163406586|NCT02669017|590198683|FG002|Overall Study|Withdrawal by Subject|0|||
163406587|NCT02669017|590198684|FG003|Overall Study|Withdrawal by Subject|1|||
163406588|NCT02669017|590198685|FG004|Overall Study|Withdrawal by Subject|2|||
163085166|NCT03396445|589022236|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085167|NCT03396445|589022211|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
163085168|NCT03396445|589022212|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
163085169|NCT03396445|589022213|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
163085170|NCT03396445|589022214|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
163085171|NCT03396445|589022215|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
163085172|NCT03396445|589022216|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085173|NCT03396445|589022217|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
163333154|NCT02686658|589930009|FG000|Overall Study|Lost to Follow-up|0|||
163333155|NCT02686658|589930010|FG001|Overall Study|Lost to Follow-up|0|||
163333156|NCT02686658|589930011|FG002|Overall Study|Lost to Follow-up|2|||
163333157|NCT02686658|589930012|FG003|Overall Study|Lost to Follow-up|0|||
163333158|NCT02686658|589930013|FG004|Overall Study|Lost to Follow-up|0|||
163333159|NCT02686658|589930014|FG005|Overall Study|Lost to Follow-up|1|||
163333160|NCT02686658|589930009|FG000|Overall Study|Death|1|||
163333161|NCT02686658|589930010|FG001|Overall Study|Death|0|||
163333162|NCT02686658|589930011|FG002|Overall Study|Death|0|||
163333163|NCT02686658|589930012|FG003|Overall Study|Death|1|||
163333164|NCT02686658|589930013|FG004|Overall Study|Death|1|||
163333165|NCT02686658|589930014|FG005|Overall Study|Death|1|||
163333166|NCT02686658|589930009|FG000|Overall Study|Withdrawal by Subject|2|||
163333167|NCT02686658|589930010|FG001|Overall Study|Withdrawal by Subject|5|||
163333168|NCT02686658|589930011|FG002|Overall Study|Withdrawal by Subject|4|||
163333169|NCT02686658|589930012|FG003|Overall Study|Withdrawal by Subject|4|||
163333170|NCT02686658|589930013|FG004|Overall Study|Withdrawal by Subject|17|||
163333171|NCT02686658|589930014|FG005|Overall Study|Withdrawal by Subject|8|||
163333172|NCT02686658|589930009|FG000|Overall Study|Placed in hospice care|0|||
163333173|NCT02686658|589930010|FG001|Overall Study|Placed in hospice care|0|||
163333174|NCT02686658|589930011|FG002|Overall Study|Placed in hospice care|1|||
163333175|NCT02686658|589930012|FG003|Overall Study|Placed in hospice care|0|||
163333176|NCT02686658|589930013|FG004|Overall Study|Placed in hospice care|0|||
163333177|NCT02686658|589930014|FG005|Overall Study|Placed in hospice care|0|||
163333178|NCT02686658|589930009|FG000|Overall Study|Participant non-compliance|0|||
163333179|NCT02686658|589930010|FG001|Overall Study|Participant non-compliance|0|||
163333180|NCT02686658|589930011|FG002|Overall Study|Participant non-compliance|0|||
163333181|NCT02686658|589930012|FG003|Overall Study|Participant non-compliance|0|||
163406589|NCT02669017|590198686|FG005|Overall Study|Withdrawal by Subject|0|||
163406590|NCT02669017|590198687|FG006|Overall Study|Withdrawal by Subject|0|||
163406591|NCT02669017|590198688|FG007|Overall Study|Withdrawal by Subject|2|||
163333182|NCT02686658|589930013|FG004|Overall Study|Participant non-compliance|0|||
163333183|NCT02686658|589930014|FG005|Overall Study|Participant non-compliance|1|||
163333184|NCT02686658|589930009|FG000|Overall Study|Concern over coronavirus disease care|0|||
163333185|NCT02686658|589930010|FG001|Overall Study|Concern over coronavirus disease care|0|||
163333186|NCT02686658|589930011|FG002|Overall Study|Concern over coronavirus disease care|0|||
163333187|NCT02686658|589930012|FG003|Overall Study|Concern over coronavirus disease care|0|||
163333188|NCT02686658|589930013|FG004|Overall Study|Concern over coronavirus disease care|2|||
163333189|NCT02686658|589930014|FG005|Overall Study|Concern over coronavirus disease care|1|||
163333190|NCT03476798|589930018|FG000|Overall Study|Death|1|||
163406592|NCT02669017|590198689|FG008|Overall Study|Withdrawal by Subject|2|||
163406593|NCT02669017|590198681|FG000|Overall Study|Lost to Follow-up|0|||
163406594|NCT02669017|590198682|FG001|Overall Study|Lost to Follow-up|0|||
163406595|NCT02669017|590198683|FG002|Overall Study|Lost to Follow-up|0|||
163406596|NCT02669017|590198684|FG003|Overall Study|Lost to Follow-up|0|||
163406597|NCT02669017|590198685|FG004|Overall Study|Lost to Follow-up|0|||
163406598|NCT02669017|590198686|FG005|Overall Study|Lost to Follow-up|0|||
163406599|NCT02669017|590198687|FG006|Overall Study|Lost to Follow-up|0|||
163406600|NCT02669017|590198688|FG007|Overall Study|Lost to Follow-up|0|||
163406601|NCT02669017|590198689|FG008|Overall Study|Lost to Follow-up|1|||
163406602|NCT02669017|590198681|FG000|Overall Study|Miscellaneous|0|||
163406603|NCT02669017|590198682|FG001|Overall Study|Miscellaneous|0|||
163406604|NCT02669017|590198683|FG002|Overall Study|Miscellaneous|0|||
163406605|NCT02669017|590198684|FG003|Overall Study|Miscellaneous|0|||
163406606|NCT02669017|590198685|FG004|Overall Study|Miscellaneous|2|||
163406607|NCT02669017|590198686|FG005|Overall Study|Miscellaneous|1|||
163406608|NCT02669017|590198687|FG006|Overall Study|Miscellaneous|1|||
163406609|NCT02669017|590198688|FG007|Overall Study|Miscellaneous|13|||
163406610|NCT02669017|590198689|FG008|Overall Study|Miscellaneous|2|||
163406611|NCT04091087|590198690|FG000|Overall Study|Not treated|1|||
163406612|NCT04091087|590198691|FG001|Overall Study|Not treated|0|||
163406613|NCT04091087|590198690|FG000|Overall Study|Adverse Event|4|||
163406614|NCT04091087|590198691|FG001|Overall Study|Adverse Event|4|||
163406615|NCT04091087|590198690|FG000|Overall Study|Protocol Violation|0|||
163406616|NCT04091087|590198691|FG001|Overall Study|Protocol Violation|1|||
163406617|NCT04091087|590198690|FG000|Overall Study|Withdrawal by Subject|5|||
163406618|NCT04091087|590198691|FG001|Overall Study|Withdrawal by Subject|2|||
163406619|NCT04152161|590198692|FG000|Overall Study|Death|0|||
163406620|NCT04152161|590198693|FG001|Overall Study|Death|1|||
163406621|NCT04152161|590198692|FG000|Overall Study|Physician Decision|0|||
163406622|NCT04152161|590198693|FG001|Overall Study|Physician Decision|1|||
163406623|NCT04152161|590198692|FG000|Overall Study|Lost to Follow-up|9|||
163406624|NCT04152161|590198693|FG001|Overall Study|Lost to Follow-up|3|||
163406625|NCT04152161|590198692|FG000|Overall Study|Protocol Violation|1|||
163406626|NCT04152161|590198693|FG001|Overall Study|Protocol Violation|0|||
163406627|NCT04152161|590198692|FG000|Overall Study|Withdrawal by Subject|29|||
163406628|NCT04152161|590198693|FG001|Overall Study|Withdrawal by Subject|28|||
163406629|NCT04152161|590198692|FG000|Overall Study|Sponsor termination of study|750|||
163406630|NCT04152161|590198693|FG001|Overall Study|Sponsor termination of study|755|||
163406631|NCT04152161|590198692|FG000|Overall Study|Other|20|||
163406632|NCT04152161|590198693|FG001|Overall Study|Other|18|||
163406633|NCT03363321|590198695|FG000|Overall Study|Withdrawal by Subject|0|||
163406634|NCT03363321|590198696|FG001|Overall Study|Withdrawal by Subject|1|||
163406635|NCT03363321|590198697|FG002|Overall Study|Withdrawal by Subject|0|||
163406636|NCT03363321|590198698|FG003|Overall Study|Withdrawal by Subject|1|||
163406637|NCT03363321|590198699|FG004|Overall Study|Withdrawal by Subject|0|||
163406638|NCT00915681|590198700|FG000|Overall Study|Screening failures|46|||
163406639|NCT02559687|590198703|FG000|Overall Study|Death|112|||
163406640|NCT02559687|590198703|FG000|Overall Study|Sponsor Decision|5|||
163406641|NCT02559687|590198703|FG000|Overall Study|Withdrawal by Subject|4|||
163406642|NCT01780831|590198704|FG000|Overall Study|Withdrawal by Subject|0|||
163406643|NCT01780831|590198705|FG001|Overall Study|Withdrawal by Subject|0|||
163406644|NCT01780831|590198706|FG002|Overall Study|Withdrawal by Subject|4|||
163406645|NCT01780831|590198707|FG003|Overall Study|Withdrawal by Subject|0|||
163406646|NCT01780831|590198704|FG000|Overall Study|Lost to Follow-up|0|||
163406647|NCT01780831|590198705|FG001|Overall Study|Lost to Follow-up|0|||
163406648|NCT01780831|590198706|FG002|Overall Study|Lost to Follow-up|0|||
163406649|NCT01780831|590198707|FG003|Overall Study|Lost to Follow-up|1|||
163032888|NCT01716520|588824459|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
163032889|NCT01716520|588824460|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
163032890|NCT01716520|588824455|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
163032891|NCT01716520|588824456|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
163032892|NCT01716520|588824457|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
163032893|NCT01716520|588824458|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
163032894|NCT01716520|588824459|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
163032895|NCT01716520|588824460|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
163406650|NCT01784861|590198719|FG000|Overall Study|Adverse Event|0|||
163406651|NCT01784861|590198720|FG001|Overall Study|Adverse Event|0|||
163406652|NCT01784861|590198721|FG002|Overall Study|Adverse Event|1|||
163406653|NCT01784861|590198722|FG003|Overall Study|Adverse Event|2|||
163406654|NCT01784861|590198723|FG004|Overall Study|Adverse Event|1|||
163406655|NCT01784861|590198724|FG005|Overall Study|Adverse Event|0|||
163406656|NCT01784861|590198719|FG000|Overall Study|Withdrawal by Subject|0|||
163406657|NCT01784861|590198720|FG001|Overall Study|Withdrawal by Subject|0|||
163406658|NCT01784861|590198721|FG002|Overall Study|Withdrawal by Subject|0|||
163406659|NCT01784861|590198722|FG003|Overall Study|Withdrawal by Subject|1|||
163406660|NCT01784861|590198723|FG004|Overall Study|Withdrawal by Subject|0|||
163406661|NCT01784861|590198724|FG005|Overall Study|Withdrawal by Subject|0|||
163406662|NCT01784861|590198719|FG000|Overall Study|Physician Decision|0|||
163220019|NCT00129129|589521379|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
163220020|NCT00129129|589521380|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
163220021|NCT00129129|589521381|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
163220022|NCT00129129|589521382|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
163220023|NCT00129129|589521378|FG000|Fourth Dose Phase|Migration from study area|0|||
163220024|NCT00129129|589521379|FG001|Fourth Dose Phase|Migration from study area|0|||
163220025|NCT00129129|589521380|FG002|Fourth Dose Phase|Migration from study area|0|||
163220026|NCT00129129|589521381|FG003|Fourth Dose Phase|Migration from study area|0|||
163220027|NCT00129129|589521382|FG004|Fourth Dose Phase|Migration from study area|2|||
163220028|NCT00129129|589521378|FG000|Fourth Dose Phase|Other|0|||
163220029|NCT00129129|589521379|FG001|Fourth Dose Phase|Other|0|||
163220030|NCT00129129|589521380|FG002|Fourth Dose Phase|Other|0|||
163220031|NCT00129129|589521381|FG003|Fourth Dose Phase|Other|1|||
163220032|NCT00129129|589521382|FG004|Fourth Dose Phase|Other|1|||
163220033|NCT00129129|589521378|FG000|Fourth Dose Phase|Protocol Violation|0|||
163220034|NCT00129129|589521379|FG001|Fourth Dose Phase|Protocol Violation|0|||
163220035|NCT00129129|589521380|FG002|Fourth Dose Phase|Protocol Violation|0|||
163220036|NCT00129129|589521381|FG003|Fourth Dose Phase|Protocol Violation|1|||
163220037|NCT00129129|589521382|FG004|Fourth Dose Phase|Protocol Violation|0|||
163220038|NCT03089606|589521385|FG000|Overall Study|Progression after Cycle 1|1|||
163220039|NCT00335972|589521386|FG000|Overall Study|not given treatments|0|||
163220040|NCT00335972|589521387|FG001|Overall Study|not given treatments|3|||
163220041|NCT03965962|589521389|FG000|Overall Study|Adverse Event|1|||
163220042|NCT03965962|589521390|FG001|Overall Study|Adverse Event|0|||
163220043|NCT03965962|589521391|FG002|Overall Study|Adverse Event|0|||
163220044|NCT03965962|589521392|FG003|Overall Study|Adverse Event|0|||
163333191|NCT03476798|589930018|FG000|Overall Study|Withdrawal by Subject|2|||
163333192|NCT03476798|589930018|FG000|Overall Study|Protocol Violation|2|||
163032896|NCT01716520|588824455|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
163032897|NCT01716520|588824456|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
163032898|NCT01716520|588824457|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
163032899|NCT01716520|588824458|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
163032900|NCT01716520|588824459|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
163032901|NCT01716520|588824460|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
163032902|NCT01716520|588824455|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163032903|NCT01716520|588824456|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163032904|NCT01716520|588824457|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163032905|NCT01716520|588824458|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163032906|NCT01716520|588824459|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163032907|NCT01716520|588824460|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
163032908|NCT01716520|588824455|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163032909|NCT01716520|588824456|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163032910|NCT01716520|588824457|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
163032911|NCT01716520|588824458|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163032912|NCT01716520|588824459|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163085174|NCT03396445|589022218|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085175|NCT03396445|589022219|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085176|NCT03396445|589022220|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085177|NCT03396445|589022221|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085178|NCT03396445|589022222|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085179|NCT03396445|589022223|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085180|NCT03396445|589022224|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085181|NCT03396445|589022225|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085182|NCT03396445|589022226|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085183|NCT03396445|589022227|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085184|NCT03396445|589022228|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085185|NCT03396445|589022229|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085186|NCT03396445|589022230|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085187|NCT03396445|589022231|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085188|NCT03396445|589022232|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163220045|NCT03965962|589521389|FG000|Overall Study|Protocol Violation|21|||
163220046|NCT03965962|589521390|FG001|Overall Study|Protocol Violation|4|||
163220047|NCT03965962|589521391|FG002|Overall Study|Protocol Violation|10|||
163220048|NCT03965962|589521392|FG003|Overall Study|Protocol Violation|5|||
163220049|NCT03965962|589521389|FG000|Overall Study|Lost to Follow-up|0|||
163032913|NCT01716520|588824460|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163032914|NCT05916131|588824465|FG000|Overall Study|Lost to Follow-up|0|||
163032915|NCT05916131|588824466|FG001|Overall Study|Lost to Follow-up|0|||
163032916|NCT05916131|588824467|FG002|Overall Study|Lost to Follow-up|1|||
163032917|NCT05916131|588824468|FG003|Overall Study|Lost to Follow-up|0|||
163032918|NCT02278367|588824469|FG000|Overall Study|Physician Decision|5|||
163032919|NCT02278367|588824470|FG001|Overall Study|Physician Decision|0|||
163032920|NCT02278367|588824469|FG000|Overall Study|Withdrawal by Subject|5|||
163032921|NCT02278367|588824470|FG001|Overall Study|Withdrawal by Subject|0|||
163032922|NCT04105010|588824471|FG000|Overall Study|Death|3|||
163032923|NCT04105010|588824472|FG001|Overall Study|Death|1|||
163032924|NCT04105010|588824473|FG002|Overall Study|Death|1|||
163032925|NCT04105010|588824474|FG003|Overall Study|Death|54|||
163032926|NCT04105010|588824471|FG000|Overall Study|Lost to Follow-up|0|||
163032927|NCT04105010|588824472|FG001|Overall Study|Lost to Follow-up|0|||
163032928|NCT04105010|588824473|FG002|Overall Study|Lost to Follow-up|0|||
163032929|NCT04105010|588824474|FG003|Overall Study|Lost to Follow-up|4|||
163032930|NCT04105010|588824471|FG000|Overall Study|Withdrawal by Subject|8|||
163032931|NCT04105010|588824472|FG001|Overall Study|Withdrawal by Subject|1|||
163032932|NCT04105010|588824473|FG002|Overall Study|Withdrawal by Subject|1|||
163032933|NCT04105010|588824474|FG003|Overall Study|Withdrawal by Subject|4|||
163032934|NCT04105010|588824471|FG000|Overall Study|Other reason|4|||
163032935|NCT04105010|588824472|FG001|Overall Study|Other reason|7|||
163032936|NCT04105010|588824473|FG002|Overall Study|Other reason|0|||
163032937|NCT04105010|588824474|FG003|Overall Study|Other reason|19|||
163333193|NCT06269003|589930019|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
163333194|NCT06269003|589930020|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
163333195|NCT06269003|589930021|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
163333196|NCT06269003|589930022|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
163333197|NCT03964974|589931174|FG000|Overall Study|Lost to Follow-up|3|||
163333198|NCT03964974|589931175|FG001|Overall Study|Lost to Follow-up|2|||
163333199|NCT03964974|589931174|FG000|Overall Study|Withdrawal by Subject|0|||
163333200|NCT03964974|589931175|FG001|Overall Study|Withdrawal by Subject|3|||
163333201|NCT02698475|589931179|FG000|Main Study Period|Lack of Efficacy|1|||
163333202|NCT02698475|589931179|FG000|Main Study Period|Protocol Violation|2|||
163333203|NCT02698475|589931179|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
163333204|NCT02698475|589931179|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
163333205|NCT02698475|589931179|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
163333206|NCT02698475|589931179|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
163333207|NCT02698475|589931179|FG000|Long-Term Extension Period|Other|1|||
163333208|NCT02038049|589931180|FG000|Overall Study|Lost to Follow-up|1|||
163333209|NCT02038049|589931181|FG001|Overall Study|Lost to Follow-up|0|||
163333210|NCT02660086|589931183|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
163333211|NCT02660086|589931184|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
163333212|NCT02660086|589931183|FG000|Overall Study- 12-month|Left full-time employment|12|||
163333213|NCT02660086|589931184|FG001|Overall Study- 12-month|Left full-time employment|20|||
163333214|NCT02660086|589931183|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
163333215|NCT02660086|589931184|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
163333216|NCT02660086|589931183|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
163333217|NCT02660086|589931184|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
163333218|NCT02660086|589931183|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
163333219|NCT02660086|589931184|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
163333220|NCT02660086|589931183|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
163333221|NCT02660086|589931184|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
163333222|NCT01377844|589931185|FG000|Overall Study|Withdrawal by Subject|25|||
163333223|NCT01377844|589931186|FG001|Overall Study|Withdrawal by Subject|28|||
163333224|NCT01377844|589931185|FG000|Overall Study|Protocol Violation|2|||
163333225|NCT01377844|589931186|FG001|Overall Study|Protocol Violation|3|||
163333226|NCT01377844|589931185|FG000|Overall Study|Adverse Event|3|||
163333227|NCT01377844|589931186|FG001|Overall Study|Adverse Event|0|||
163333228|NCT01377844|589931185|FG000|Overall Study|Physician Decision|6|||
163333229|NCT01377844|589931186|FG001|Overall Study|Physician Decision|3|||
163333230|NCT01377844|589931185|FG000|Overall Study|Study terminated by Sponsor|0|||
163333231|NCT01377844|589931186|FG001|Overall Study|Study terminated by Sponsor|1|||
163333232|NCT01214200|589931190|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
163333233|NCT01214200|589931190|FG000|Overall Study|Withdrawal by Subject|2|||
163333234|NCT00587171|589931191|FG000|Overall Study|Lost to Follow-up|1|||
163333235|NCT00587171|589931192|FG001|Overall Study|Lost to Follow-up|1|||
163333236|NCT02310581|589931193|FG000|Overall Study|Adverse Event|1|||
163333237|NCT02310581|589931194|FG001|Overall Study|Adverse Event|1|||
163032938|NCT01211483|588824475|FG000|Phase 1b|Death|6|||
163032939|NCT01211483|588824476|FG001|Phase 1b|Death|0|||
163032940|NCT01211483|588824477|FG002|Phase 1b|Death|0|||
163032941|NCT01211483|588824478|FG003|Phase 1b|Death|0|||
163406663|NCT01784861|590198720|FG001|Overall Study|Physician Decision|0|||
163406664|NCT01784861|590198721|FG002|Overall Study|Physician Decision|0|||
163406665|NCT01784861|590198722|FG003|Overall Study|Physician Decision|2|||
163406666|NCT01784861|590198723|FG004|Overall Study|Physician Decision|0|||
163406667|NCT01784861|590198724|FG005|Overall Study|Physician Decision|1|||
163085189|NCT03396445|589022233|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085190|NCT03396445|589022234|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085191|NCT03396445|589022235|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163333238|NCT02310581|589931195|FG002|Overall Study|Adverse Event|1|||
163333239|NCT02310581|589931196|FG003|Overall Study|Adverse Event|0|||
163333240|NCT02310581|589931193|FG000|Overall Study|Withdrawal by Subject|2|||
163333241|NCT02310581|589931194|FG001|Overall Study|Withdrawal by Subject|1|||
163333242|NCT02310581|589931195|FG002|Overall Study|Withdrawal by Subject|0|||
163333243|NCT02310581|589931196|FG003|Overall Study|Withdrawal by Subject|1|||
163333244|NCT00887224|589931197|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
163333245|NCT00887224|589931198|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
163333246|NCT00887224|589931199|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
163333247|NCT00887224|589931197|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
163333248|NCT00887224|589931198|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
163333249|NCT00887224|589931199|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
163333250|NCT00887224|589931197|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
163333251|NCT00887224|589931198|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
163333252|NCT00887224|589931199|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
163333253|NCT00887224|589931197|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
163333254|NCT00887224|589931198|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
163333255|NCT00887224|589931199|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
163333256|NCT00887224|589931197|FG000|Open-label Response (OLR) Phase|Other|1|||
163333257|NCT00887224|589931198|FG001|Open-label Response (OLR) Phase|Other|0|||
163333258|NCT00887224|589931199|FG002|Open-label Response (OLR) Phase|Other|0|||
163333259|NCT00887224|589931197|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
163333260|NCT00887224|589931198|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
163333261|NCT00887224|589931199|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
163333262|NCT00887224|589931197|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
163333263|NCT00887224|589931198|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
163333264|NCT00887224|589931199|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
163333265|NCT00887224|589931197|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
163333266|NCT00887224|589931198|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
163333267|NCT00887224|589931199|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
163333268|NCT00887224|589931197|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
163333269|NCT00887224|589931198|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
163333270|NCT00887224|589931199|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
163333271|NCT00887224|589931197|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
163333272|NCT00887224|589931198|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
163333273|NCT00887224|589931199|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
163333274|NCT00887224|589931197|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
163333275|NCT00887224|589931198|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
163333276|NCT00887224|589931199|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
163333277|NCT00887224|589931197|FG000|Open-label Stability (OLS) Phase|Other|1|||
163333278|NCT00887224|589931198|FG001|Open-label Stability (OLS) Phase|Other|0|||
163333279|NCT00887224|589931199|FG002|Open-label Stability (OLS) Phase|Other|0|||
163333280|NCT00887224|589931197|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
163333281|NCT00887224|589931198|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
163333282|NCT00887224|589931199|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
163333283|NCT00887224|589931197|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
163333284|NCT00887224|589931198|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
163333285|NCT00887224|589931199|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
163333286|NCT00887224|589931197|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
163333287|NCT00887224|589931198|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
163333288|NCT00887224|589931199|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
163333289|NCT00887224|589931197|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
163333290|NCT00887224|589931198|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
163333291|NCT00887224|589931199|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
163333292|NCT00887224|589931197|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
163333293|NCT00887224|589931198|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
163333294|NCT00887224|589931199|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
163406668|NCT02599961|590198725|FG000|Overall Study|Withdrawal by Subject|1|||
163333295|NCT00887224|589931197|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
163333296|NCT00887224|589931198|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
163406669|NCT02599961|590198725|FG000|Overall Study|Subject Non-Compliance|2|||
163333297|NCT00887224|589931199|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
163333298|NCT00887224|589931197|FG000|OL Taper Phase / OL Follow Up|Other|30|||
163333299|NCT00887224|589931198|FG001|OL Taper Phase / OL Follow Up|Other|0|||
163333300|NCT00887224|589931199|FG002|OL Taper Phase / OL Follow Up|Other|0|||
163032942|NCT01211483|588824475|FG000|Phase 1b|Withdrawal by Subject|1|||
163032943|NCT01211483|588824476|FG001|Phase 1b|Withdrawal by Subject|0|||
163032944|NCT01211483|588824477|FG002|Phase 1b|Withdrawal by Subject|0|||
163032945|NCT01211483|588824478|FG003|Phase 1b|Withdrawal by Subject|0|||
163032946|NCT01211483|588824475|FG000|Phase 2|Lost to Follow-up|0|||
163032947|NCT01211483|588824476|FG001|Phase 2|Lost to Follow-up|1|||
163032948|NCT01211483|588824477|FG002|Phase 2|Lost to Follow-up|1|||
163032949|NCT01211483|588824478|FG003|Phase 2|Lost to Follow-up|2|||
163032950|NCT01211483|588824475|FG000|Phase 2|Death|0|||
163032951|NCT01211483|588824476|FG001|Phase 2|Death|64|||
163032952|NCT01211483|588824477|FG002|Phase 2|Death|53|||
163032953|NCT01211483|588824478|FG003|Phase 2|Death|53|||
163032954|NCT01211483|588824475|FG000|Phase 2|Withdrawal by Subject|0|||
163032955|NCT01211483|588824476|FG001|Phase 2|Withdrawal by Subject|1|||
163032956|NCT01211483|588824477|FG002|Phase 2|Withdrawal by Subject|10|||
163032957|NCT01211483|588824478|FG003|Phase 2|Withdrawal by Subject|5|||
163032958|NCT01211483|588824475|FG000|Phase 2|Study terminated by Sponsor|0|||
163032959|NCT01211483|588824476|FG001|Phase 2|Study terminated by Sponsor|6|||
163032960|NCT01211483|588824477|FG002|Phase 2|Study terminated by Sponsor|8|||
163032961|NCT01211483|588824478|FG003|Phase 2|Study terminated by Sponsor|11|||
163032962|NCT01675154|588824479|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
163032963|NCT01675154|588824480|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
163032964|NCT01675154|588824481|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
163032965|NCT01675154|588824482|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
163032966|NCT02971800|588824485|FG000|Overall Study|Protocol Violation|1|||
163032967|NCT02971800|588824485|FG000|Overall Study|Withdrawal by Subject|1|||
163032968|NCT02971800|588824485|FG000|Overall Study|Exclusion criteria prior intervention|1|||
163032969|NCT02971800|588824485|FG000|Overall Study|Number evaluable participant already reached|4|||
163032970|NCT00616603|588824486|FG000|Overall Study|Physician Decision|2|||
163032971|NCT00616603|588824487|FG001|Overall Study|Physician Decision|0|||
163032972|NCT00616603|588824488|FG002|Overall Study|Physician Decision|2|||
163032973|NCT00006305|588824493|FG000|Overall Study|Withdrawal by Subject|17|||
163032974|NCT00006305|588824494|FG001|Overall Study|Withdrawal by Subject|10|||
163032975|NCT00006305|588824495|FG002|Overall Study|Withdrawal by Subject|15|||
163032976|NCT00006305|588824496|FG003|Overall Study|Withdrawal by Subject|14|||
163032977|NCT00329641|588824497|FG000|Overall Study|Did not start treatment|1|||
163032978|NCT00329641|588824497|FG000|Overall Study|Not eligible|1|||
163032979|NCT00329641|588824497|FG000|Overall Study|Adverse Event|3|||
163032980|NCT00329641|588824497|FG000|Overall Study|Other reason, not protocol specified|1|||
163032981|NCT00115037|588824498|FG000|Phase1|Lost to Follow-up|16|||
163032982|NCT00115037|588824499|FG001|Phase1|Lost to Follow-up|23|||
163032983|NCT00115037|588824500|FG002|Phase1|Lost to Follow-up|0|||
163032984|NCT00115037|588824501|FG003|Phase1|Lost to Follow-up|0|||
163032985|NCT00115037|588824502|FG004|Phase1|Lost to Follow-up|0|||
163032986|NCT00115037|588824503|FG005|Phase1|Lost to Follow-up|0|||
163032987|NCT00115037|588824498|FG000|Phase1|Withdrawal by Subject|9|||
163032988|NCT00115037|588824499|FG001|Phase1|Withdrawal by Subject|4|||
163032989|NCT00115037|588824500|FG002|Phase1|Withdrawal by Subject|0|||
163032990|NCT00115037|588824501|FG003|Phase1|Withdrawal by Subject|0|||
163032991|NCT00115037|588824502|FG004|Phase1|Withdrawal by Subject|0|||
163032992|NCT00115037|588824503|FG005|Phase1|Withdrawal by Subject|0|||
163032993|NCT00115037|588824498|FG000|Phase2|Death|0|||
163032994|NCT00115037|588824499|FG001|Phase2|Death|0|||
163032995|NCT00115037|588824500|FG002|Phase2|Death|1|||
163032996|NCT00115037|588824501|FG003|Phase2|Death|0|||
163032997|NCT00115037|588824502|FG004|Phase2|Death|0|||
163032998|NCT00115037|588824503|FG005|Phase2|Death|1|||
163032999|NCT00115037|588824498|FG000|Phase2|Withdrawal by Subject|0|||
163033000|NCT00115037|588824499|FG001|Phase2|Withdrawal by Subject|0|||
163033001|NCT00115037|588824500|FG002|Phase2|Withdrawal by Subject|2|||
163033002|NCT00115037|588824501|FG003|Phase2|Withdrawal by Subject|1|||
163033003|NCT00115037|588824502|FG004|Phase2|Withdrawal by Subject|2|||
163033004|NCT00115037|588824503|FG005|Phase2|Withdrawal by Subject|1|||
163033005|NCT00115037|588824498|FG000|Phase2|Lost to Follow-up|0|||
163033006|NCT00115037|588824499|FG001|Phase2|Lost to Follow-up|0|||
163033007|NCT00115037|588824500|FG002|Phase2|Lost to Follow-up|12|||
163033008|NCT00115037|588824501|FG003|Phase2|Lost to Follow-up|14|||
163033009|NCT00115037|588824502|FG004|Phase2|Lost to Follow-up|4|||
163033010|NCT00115037|588824503|FG005|Phase2|Lost to Follow-up|10|||
163033011|NCT01398410|588824504|FG000|Overall Study|Adverse Event|12|||
163033012|NCT01398410|588824505|FG001|Overall Study|Adverse Event|16|||
163033013|NCT01398410|588824504|FG000|Overall Study|Participants Choice|8|||
163033014|NCT01398410|588824505|FG001|Overall Study|Participants Choice|11|||
163333301|NCT00887224|589931197|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
163033015|NCT01398410|588824504|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
163033016|NCT01398410|588824505|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
163033017|NCT01398410|588824504|FG000|Overall Study|Other|36|||
163033018|NCT01398410|588824505|FG001|Overall Study|Other|29|||
163033019|NCT02470403|588824506|FG000|Overall Study|Adverse Event|1|||
163033020|NCT02470403|588824507|FG001|Overall Study|Adverse Event|0|||
163033021|NCT02470403|588824508|FG002|Overall Study|Adverse Event|0|||
163033022|NCT02470403|588824509|FG003|Overall Study|Adverse Event|0|||
163033023|NCT02470403|588824510|FG004|Overall Study|Adverse Event|0|||
163033024|NCT02470403|588824506|FG000|Overall Study|Lost to Follow-up|0|||
163033025|NCT02470403|588824507|FG001|Overall Study|Lost to Follow-up|1|||
163033026|NCT02470403|588824508|FG002|Overall Study|Lost to Follow-up|0|||
163033027|NCT02470403|588824509|FG003|Overall Study|Lost to Follow-up|0|||
163033028|NCT02470403|588824510|FG004|Overall Study|Lost to Follow-up|0|||
163033029|NCT02470403|588824506|FG000|Overall Study|Subject/guardian decision|1|||
163033030|NCT02470403|588824507|FG001|Overall Study|Subject/guardian decision|0|||
163033031|NCT02470403|588824508|FG002|Overall Study|Subject/guardian decision|0|||
163033032|NCT02470403|588824509|FG003|Overall Study|Subject/guardian decision|4|||
163033033|NCT02470403|588824510|FG004|Overall Study|Subject/guardian decision|0|||
163033034|NCT02631070|588824511|FG000|Overall Study|Withdrawal by Subject|35|||
163033035|NCT02631070|588824512|FG001|Overall Study|Withdrawal by Subject|13|||
163033036|NCT02631070|588824511|FG000|Overall Study|Death|45|||
163033037|NCT02631070|588824512|FG001|Overall Study|Death|24|||
163033038|NCT02631070|588824511|FG000|Overall Study|Lost to Follow-up|5|||
163033039|NCT02631070|588824512|FG001|Overall Study|Lost to Follow-up|1|||
163033040|NCT02631070|588824511|FG000|Overall Study|Transition to rollover protocol|52|||
163033041|NCT02631070|588824512|FG001|Overall Study|Transition to rollover protocol|21|||
163033042|NCT02631070|588824511|FG000|Overall Study|Other reasons|12|||
163033043|NCT02631070|588824512|FG001|Overall Study|Other reasons|5|||
163033044|NCT03515629|588824513|FG000|Overall Study|Death|0|||
163033045|NCT03515629|588824514|FG001|Overall Study|Death|1|||
163033046|NCT03515629|588824515|FG002|Overall Study|Death|1|||
163033047|NCT03515629|588824513|FG000|Overall Study|Progressive disease|0|||
163033048|NCT03515629|588824514|FG001|Overall Study|Progressive disease|1|||
163033049|NCT03515629|588824515|FG002|Overall Study|Progressive disease|0|||
163033050|NCT03597022|588824518|FG000|Overall Study|Premature termination of the study|7|||
163033051|NCT03597022|588824519|FG001|Overall Study|Premature termination of the study|7|||
163033052|NCT03597022|588824520|FG002|Overall Study|Premature termination of the study|8|||
163033053|NCT03597022|588824518|FG000|Overall Study|Serious adverse event|1|||
163033054|NCT03597022|588824519|FG001|Overall Study|Serious adverse event|1|||
163033055|NCT03597022|588824520|FG002|Overall Study|Serious adverse event|0|||
163033056|NCT01430624|588824521|FG000|Overall Study|Lost to Follow-up|23|||
163033057|NCT01430624|588824522|FG001|Overall Study|Lost to Follow-up|29|||
163033058|NCT01430624|588824523|FG002|Overall Study|Lost to Follow-up|27|||
163033059|NCT01430624|588824521|FG000|Overall Study|technical or eligibility|5|||
163033060|NCT01430624|588824522|FG001|Overall Study|technical or eligibility|5|||
163033061|NCT01430624|588824523|FG002|Overall Study|technical or eligibility|2|||
163033062|NCT00401960|588824528|FG000|Overall Study|Lost to Follow-up|3|||
163033063|NCT00401960|588824529|FG001|Overall Study|Lost to Follow-up|0|||
163033064|NCT00401960|588824528|FG000|Overall Study|Death|2|||
163033065|NCT00401960|588824529|FG001|Overall Study|Death|0|||
163033066|NCT01606202|588824530|FG000|Overall Study|Adverse Event|5|||
163033067|NCT01606202|588824531|FG001|Overall Study|Adverse Event|0|||
163033068|NCT01606202|588824530|FG000|Overall Study|Withdrawal by Subject|2|||
163033069|NCT01606202|588824531|FG001|Overall Study|Withdrawal by Subject|1|||
163033070|NCT01606202|588824530|FG000|Overall Study|Personal problems|0|||
163033071|NCT01606202|588824531|FG001|Overall Study|Personal problems|1|||
163085192|NCT03396445|589022236|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085193|NCT03396445|589022211|FG000|Treatment Period|Withdrawal by Subject|0|||
163085194|NCT03396445|589022212|FG001|Treatment Period|Withdrawal by Subject|0|||
163085195|NCT03396445|589022213|FG002|Treatment Period|Withdrawal by Subject|0|||
163085196|NCT03396445|589022214|FG003|Treatment Period|Withdrawal by Subject|0|||
163085197|NCT03396445|589022215|FG004|Treatment Period|Withdrawal by Subject|0|||
163085198|NCT03396445|589022216|FG005|Treatment Period|Withdrawal by Subject|0|||
163033072|NCT01606202|588824530|FG000|Overall Study|Problems with administration|0|||
163085199|NCT03396445|589022217|FG006|Treatment Period|Withdrawal by Subject|0|||
163085200|NCT03396445|589022218|FG007|Treatment Period|Withdrawal by Subject|0|||
163085201|NCT03396445|589022219|FG008|Treatment Period|Withdrawal by Subject|0|||
163085202|NCT03396445|589022220|FG009|Treatment Period|Withdrawal by Subject|0|||
163085203|NCT03396445|589022221|FG010|Treatment Period|Withdrawal by Subject|0|||
163085204|NCT03396445|589022222|FG011|Treatment Period|Withdrawal by Subject|0|||
163085205|NCT03396445|589022223|FG012|Treatment Period|Withdrawal by Subject|0|||
163085206|NCT03396445|589022224|FG013|Treatment Period|Withdrawal by Subject|0|||
163085207|NCT03396445|589022225|FG014|Treatment Period|Withdrawal by Subject|1|||
163085208|NCT03396445|589022226|FG015|Treatment Period|Withdrawal by Subject|0|||
163085209|NCT03396445|589022227|FG016|Treatment Period|Withdrawal by Subject|1|||
163085210|NCT03396445|589022228|FG017|Treatment Period|Withdrawal by Subject|0|||
163033073|NCT01606202|588824531|FG001|Overall Study|Problems with administration|1|||
163085211|NCT03396445|589022229|FG018|Treatment Period|Withdrawal by Subject|0|||
163033074|NCT01593254|588824537|FG000|Overall Study|Disease progression|2|||
163033075|NCT01593254|588824538|FG001|Overall Study|Disease progression|7|||
163033076|NCT01593254|588824537|FG000|Overall Study|Study drug toxicity|6|||
163033077|NCT01593254|588824538|FG001|Overall Study|Study drug toxicity|20|||
163033078|NCT01593254|588824537|FG000|Overall Study|Death|3|||
163033079|NCT01593254|588824538|FG001|Overall Study|Death|3|||
163033080|NCT01593254|588824537|FG000|Overall Study|AE unrelated to study drug|0|||
163033081|NCT01593254|588824538|FG001|Overall Study|AE unrelated to study drug|1|||
163033082|NCT01593254|588824537|FG000|Overall Study|participant request to discontinue study treatment|1|||
163033083|NCT01593254|588824538|FG001|Overall Study|participant request to discontinue study treatment|3|||
163033084|NCT01593254|588824537|FG000|Overall Study|participant withdrew consent|0|||
163033085|NCT01593254|588824538|FG001|Overall Study|participant withdrew consent|9|||
163033086|NCT01593254|588824537|FG000|Overall Study|lost to follow up|1|||
163033087|NCT01593254|588824538|FG001|Overall Study|lost to follow up|6|||
163033088|NCT01593254|588824537|FG000|Overall Study|maximum clinical benefit|1|||
163033089|NCT01593254|588824538|FG001|Overall Study|maximum clinical benefit|2|||
163033090|NCT01593254|588824537|FG000|Overall Study|Poor/non compliance|1|||
163033091|NCT01593254|588824538|FG001|Overall Study|Poor/non compliance|1|||
163033092|NCT01593254|588824537|FG000|Overall Study|Pregnancy|0|||
163033093|NCT01593254|588824538|FG001|Overall Study|Pregnancy|3|||
163033094|NCT01593254|588824537|FG000|Overall Study|participant no longer meets study criteria|1|||
163033095|NCT01593254|588824538|FG001|Overall Study|participant no longer meets study criteria|1|||
163033096|NCT01593254|588824537|FG000|Overall Study|Admin reason by sponsor|7|||
163033097|NCT01593254|588824538|FG001|Overall Study|Admin reason by sponsor|3|||
163033098|NCT01593254|588824537|FG000|Overall Study|Imatinib treatment failure|2|||
163033099|NCT01593254|588824538|FG001|Overall Study|Imatinib treatment failure|0|||
163033100|NCT01593254|588824537|FG000|Overall Study|Other Reasons|61|||
163033101|NCT01593254|588824538|FG001|Overall Study|Other Reasons|115|||
163033102|NCT00932451|588824539|FG000|Overall Study|Withdrawal by Subject|69|||
163033103|NCT00932451|588824539|FG000|Overall Study|Lost to Follow-up|22|||
163033104|NCT00932451|588824539|FG000|Overall Study|Death|726|||
163033105|NCT00932451|588824539|FG000|Overall Study|Other reasons|5|||
163033106|NCT03627416|588824540|FG000|Overall Study|Adverse Event|0|||
163033107|NCT03627416|588824541|FG001|Overall Study|Adverse Event|1|||
163033108|NCT02079636|588824542|FG000|Overall Study|Death|2|||
163033109|NCT02079636|588824543|FG001|Overall Study|Death|1|||
163033110|NCT02079636|588824544|FG002|Overall Study|Death|0|||
163033111|NCT02079636|588824545|FG003|Overall Study|Death|5|||
163033112|NCT02079636|588824546|FG004|Overall Study|Death|1|||
163033113|NCT02079636|588824547|FG005|Overall Study|Death|2|||
163033114|NCT02079636|588824548|FG006|Overall Study|Death|1|||
163033115|NCT02079636|588824549|FG007|Overall Study|Death|0|||
163033116|NCT02079636|588824550|FG008|Overall Study|Death|0|||
163033117|NCT02079636|588824551|FG009|Overall Study|Death|0|||
163033118|NCT02079636|588824552|FG010|Overall Study|Death|0|||
163033119|NCT02079636|588824553|FG011|Overall Study|Death|1|||
163033120|NCT02079636|588824554|FG012|Overall Study|Death|1|||
163033121|NCT02079636|588824555|FG013|Overall Study|Death|0|||
163033122|NCT02079636|588824556|FG014|Overall Study|Death|2|||
163033123|NCT02079636|588824542|FG000|Overall Study|Adverse Event|1|||
163033124|NCT02079636|588824543|FG001|Overall Study|Adverse Event|1|||
163033125|NCT02079636|588824544|FG002|Overall Study|Adverse Event|0|||
163033126|NCT02079636|588824545|FG003|Overall Study|Adverse Event|1|||
163033127|NCT02079636|588824546|FG004|Overall Study|Adverse Event|1|||
163033128|NCT02079636|588824547|FG005|Overall Study|Adverse Event|2|||
163033129|NCT02079636|588824548|FG006|Overall Study|Adverse Event|0|||
163033130|NCT02079636|588824549|FG007|Overall Study|Adverse Event|0|||
163033131|NCT02079636|588824550|FG008|Overall Study|Adverse Event|0|||
163033132|NCT02079636|588824551|FG009|Overall Study|Adverse Event|0|||
163033133|NCT02079636|588824552|FG010|Overall Study|Adverse Event|0|||
163033134|NCT02079636|588824553|FG011|Overall Study|Adverse Event|0|||
163033135|NCT02079636|588824554|FG012|Overall Study|Adverse Event|0|||
163033136|NCT02079636|588824555|FG013|Overall Study|Adverse Event|0|||
163033137|NCT02079636|588824556|FG014|Overall Study|Adverse Event|0|||
163033138|NCT02079636|588824542|FG000|Overall Study|Progressive disease|0|||
163033139|NCT02079636|588824543|FG001|Overall Study|Progressive disease|0|||
163033140|NCT02079636|588824544|FG002|Overall Study|Progressive disease|0|||
163033141|NCT02079636|588824545|FG003|Overall Study|Progressive disease|2|||
163033142|NCT02079636|588824546|FG004|Overall Study|Progressive disease|0|||
163033143|NCT02079636|588824547|FG005|Overall Study|Progressive disease|0|||
163033144|NCT02079636|588824548|FG006|Overall Study|Progressive disease|0|||
163033145|NCT02079636|588824549|FG007|Overall Study|Progressive disease|0|||
163033146|NCT02079636|588824550|FG008|Overall Study|Progressive disease|0|||
163033147|NCT02079636|588824551|FG009|Overall Study|Progressive disease|0|||
163033148|NCT02079636|588824552|FG010|Overall Study|Progressive disease|0|||
163033149|NCT02079636|588824553|FG011|Overall Study|Progressive disease|0|||
163033150|NCT02079636|588824554|FG012|Overall Study|Progressive disease|1|||
163033151|NCT02079636|588824555|FG013|Overall Study|Progressive disease|0|||
163033152|NCT02079636|588824556|FG014|Overall Study|Progressive disease|0|||
163085212|NCT03396445|589022230|FG019|Treatment Period|Withdrawal by Subject|0|||
163220050|NCT03965962|589521390|FG001|Overall Study|Lost to Follow-up|1|||
163333302|NCT00887224|589931198|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
163333303|NCT00887224|589931199|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
163333304|NCT00887224|589931197|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
163333305|NCT00887224|589931198|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
163333306|NCT00887224|589931199|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
163333307|NCT00887224|589931197|FG000|Double-blind (DB) Phase|Adverse Event|0|||
163333308|NCT00887224|589931198|FG001|Double-blind (DB) Phase|Adverse Event|7|||
163333309|NCT00887224|589931199|FG002|Double-blind (DB) Phase|Adverse Event|2|||
163333310|NCT00887224|589931197|FG000|Double-blind (DB) Phase|Failed to return|0|||
163333311|NCT00887224|589931198|FG001|Double-blind (DB) Phase|Failed to return|2|||
163333312|NCT00887224|589931199|FG002|Double-blind (DB) Phase|Failed to return|2|||
163333313|NCT00887224|589931197|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
163333314|NCT00887224|589931198|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
163333315|NCT00887224|589931199|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
163333316|NCT00887224|589931197|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
163333317|NCT00887224|589931198|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
163333318|NCT00887224|589931199|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
163333319|NCT00887224|589931197|FG000|Double-blind (DB) Phase|Other|0|||
163333320|NCT00887224|589931198|FG001|Double-blind (DB) Phase|Other|2|||
163333321|NCT00887224|589931199|FG002|Double-blind (DB) Phase|Other|0|||
163333322|NCT00887224|589931197|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
163333323|NCT00887224|589931198|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
163333324|NCT00887224|589931199|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
163333325|NCT00887224|589931197|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
163333326|NCT00887224|589931198|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
163333327|NCT00887224|589931199|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
163333328|NCT00887224|589931197|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
163333329|NCT00887224|589931198|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
163333330|NCT00887224|589931199|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
163333331|NCT00887224|589931197|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
163333332|NCT00887224|589931198|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
163333333|NCT00887224|589931199|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
163333334|NCT00887224|589931197|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
163406670|NCT02599961|590198725|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
163406671|NCT02599961|590198725|FG000|Overall Study|Other, Not Specified|3|||
163033153|NCT02079636|588824542|FG000|Overall Study|Withdrawal by Subject|0|||
163033154|NCT02079636|588824543|FG001|Overall Study|Withdrawal by Subject|0|||
163033155|NCT02079636|588824544|FG002|Overall Study|Withdrawal by Subject|0|||
163033156|NCT02079636|588824545|FG003|Overall Study|Withdrawal by Subject|4|||
163033157|NCT02079636|588824546|FG004|Overall Study|Withdrawal by Subject|0|||
163033158|NCT02079636|588824547|FG005|Overall Study|Withdrawal by Subject|1|||
163033159|NCT02079636|588824548|FG006|Overall Study|Withdrawal by Subject|0|||
163033160|NCT02079636|588824549|FG007|Overall Study|Withdrawal by Subject|0|||
163033161|NCT02079636|588824550|FG008|Overall Study|Withdrawal by Subject|0|||
163033162|NCT02079636|588824551|FG009|Overall Study|Withdrawal by Subject|2|||
163033163|NCT02079636|588824552|FG010|Overall Study|Withdrawal by Subject|1|||
163033164|NCT02079636|588824553|FG011|Overall Study|Withdrawal by Subject|1|||
163033165|NCT02079636|588824554|FG012|Overall Study|Withdrawal by Subject|1|||
163033166|NCT02079636|588824555|FG013|Overall Study|Withdrawal by Subject|0|||
163033167|NCT02079636|588824556|FG014|Overall Study|Withdrawal by Subject|2|||
163033168|NCT02079636|588824542|FG000|Overall Study|Physician Decision|0|||
163033169|NCT02079636|588824543|FG001|Overall Study|Physician Decision|0|||
163033170|NCT02079636|588824544|FG002|Overall Study|Physician Decision|0|||
163033171|NCT02079636|588824545|FG003|Overall Study|Physician Decision|0|||
163033172|NCT02079636|588824546|FG004|Overall Study|Physician Decision|0|||
163033173|NCT02079636|588824547|FG005|Overall Study|Physician Decision|1|||
163033174|NCT02079636|588824548|FG006|Overall Study|Physician Decision|0|||
163033175|NCT02079636|588824549|FG007|Overall Study|Physician Decision|0|||
163033176|NCT02079636|588824550|FG008|Overall Study|Physician Decision|0|||
163033177|NCT02079636|588824551|FG009|Overall Study|Physician Decision|1|||
163033178|NCT02079636|588824552|FG010|Overall Study|Physician Decision|1|||
163033179|NCT02079636|588824553|FG011|Overall Study|Physician Decision|0|||
163033180|NCT02079636|588824554|FG012|Overall Study|Physician Decision|0|||
163033181|NCT02079636|588824555|FG013|Overall Study|Physician Decision|0|||
163033182|NCT02079636|588824556|FG014|Overall Study|Physician Decision|1|||
163033183|NCT02079636|588824542|FG000|Overall Study|Lost to Follow-up|0|||
163033184|NCT02079636|588824543|FG001|Overall Study|Lost to Follow-up|0|||
163033185|NCT02079636|588824544|FG002|Overall Study|Lost to Follow-up|0|||
163033186|NCT02079636|588824545|FG003|Overall Study|Lost to Follow-up|0|||
163033187|NCT02079636|588824546|FG004|Overall Study|Lost to Follow-up|0|||
163033188|NCT02079636|588824547|FG005|Overall Study|Lost to Follow-up|0|||
163033189|NCT02079636|588824548|FG006|Overall Study|Lost to Follow-up|0|||
163033190|NCT02079636|588824549|FG007|Overall Study|Lost to Follow-up|1|||
163033191|NCT02079636|588824550|FG008|Overall Study|Lost to Follow-up|0|||
163033192|NCT02079636|588824551|FG009|Overall Study|Lost to Follow-up|0|||
163085213|NCT03396445|589022231|FG020|Treatment Period|Withdrawal by Subject|0|||
163085214|NCT03396445|589022232|FG021|Treatment Period|Withdrawal by Subject|0|||
163085215|NCT03396445|589022233|FG022|Treatment Period|Withdrawal by Subject|0|||
163085216|NCT03396445|589022234|FG023|Treatment Period|Withdrawal by Subject|0|||
163085217|NCT03396445|589022235|FG024|Treatment Period|Withdrawal by Subject|0|||
163085218|NCT03396445|589022236|FG025|Treatment Period|Withdrawal by Subject|0|||
163085219|NCT03396445|589022211|FG000|Switch-over Period|Death|0|||
163085220|NCT03396445|589022212|FG001|Switch-over Period|Death|0|||
163085221|NCT03396445|589022213|FG002|Switch-over Period|Death|0|||
163085222|NCT03396445|589022214|FG003|Switch-over Period|Death|0|||
163085223|NCT03396445|589022215|FG004|Switch-over Period|Death|0|||
163085224|NCT03396445|589022216|FG005|Switch-over Period|Death|0|||
163085225|NCT03396445|589022217|FG006|Switch-over Period|Death|0|||
163085226|NCT03396445|589022218|FG007|Switch-over Period|Death|0|||
163085227|NCT03396445|589022219|FG008|Switch-over Period|Death|0|||
163085228|NCT03396445|589022220|FG009|Switch-over Period|Death|0|||
163085229|NCT03396445|589022221|FG010|Switch-over Period|Death|0|||
163085230|NCT03396445|589022222|FG011|Switch-over Period|Death|0|||
163085231|NCT03396445|589022223|FG012|Switch-over Period|Death|0|||
163085232|NCT03396445|589022224|FG013|Switch-over Period|Death|0|||
163085233|NCT03396445|589022225|FG014|Switch-over Period|Death|0|||
163085234|NCT03396445|589022226|FG015|Switch-over Period|Death|0|||
163085235|NCT03396445|589022227|FG016|Switch-over Period|Death|0|||
163085236|NCT03396445|589022228|FG017|Switch-over Period|Death|0|||
163085237|NCT03396445|589022229|FG018|Switch-over Period|Death|1|||
163085238|NCT03396445|589022230|FG019|Switch-over Period|Death|2|||
163085239|NCT03396445|589022231|FG020|Switch-over Period|Death|2|||
163085240|NCT03396445|589022232|FG021|Switch-over Period|Death|1|||
163085241|NCT03396445|589022233|FG022|Switch-over Period|Death|2|||
163085242|NCT03396445|589022234|FG023|Switch-over Period|Death|0|||
163085243|NCT03396445|589022235|FG024|Switch-over Period|Death|1|||
163085244|NCT03396445|589022236|FG025|Switch-over Period|Death|6|||
163085245|NCT03396445|589022211|FG000|Switch-over Period|Lost to Follow-up|0|||
163085246|NCT03396445|589022212|FG001|Switch-over Period|Lost to Follow-up|0|||
163085247|NCT03396445|589022213|FG002|Switch-over Period|Lost to Follow-up|0|||
163085248|NCT03396445|589022214|FG003|Switch-over Period|Lost to Follow-up|0|||
163085249|NCT03396445|589022215|FG004|Switch-over Period|Lost to Follow-up|0|||
163085250|NCT03396445|589022216|FG005|Switch-over Period|Lost to Follow-up|0|||
163085251|NCT03396445|589022217|FG006|Switch-over Period|Lost to Follow-up|0|||
163085252|NCT03396445|589022218|FG007|Switch-over Period|Lost to Follow-up|0|||
163085253|NCT03396445|589022219|FG008|Switch-over Period|Lost to Follow-up|0|||
163085254|NCT03396445|589022220|FG009|Switch-over Period|Lost to Follow-up|0|||
163085255|NCT03396445|589022221|FG010|Switch-over Period|Lost to Follow-up|0|||
163085256|NCT03396445|589022222|FG011|Switch-over Period|Lost to Follow-up|0|||
163085257|NCT03396445|589022223|FG012|Switch-over Period|Lost to Follow-up|0|||
163085258|NCT03396445|589022224|FG013|Switch-over Period|Lost to Follow-up|0|||
163085259|NCT03396445|589022225|FG014|Switch-over Period|Lost to Follow-up|0|||
163085260|NCT03396445|589022226|FG015|Switch-over Period|Lost to Follow-up|0|||
163085261|NCT03396445|589022227|FG016|Switch-over Period|Lost to Follow-up|0|||
163085262|NCT03396445|589022228|FG017|Switch-over Period|Lost to Follow-up|0|||
163085263|NCT03396445|589022229|FG018|Switch-over Period|Lost to Follow-up|0|||
163085264|NCT03396445|589022230|FG019|Switch-over Period|Lost to Follow-up|0|||
163085265|NCT03396445|589022231|FG020|Switch-over Period|Lost to Follow-up|0|||
163085266|NCT03396445|589022232|FG021|Switch-over Period|Lost to Follow-up|0|||
163085267|NCT03396445|589022233|FG022|Switch-over Period|Lost to Follow-up|0|||
163085268|NCT03396445|589022234|FG023|Switch-over Period|Lost to Follow-up|1|||
163085269|NCT03396445|589022235|FG024|Switch-over Period|Lost to Follow-up|0|||
163085270|NCT03396445|589022236|FG025|Switch-over Period|Lost to Follow-up|0|||
163085271|NCT04123704|589022240|FG000|Overall Study|Disease progression|2|||
163085272|NCT00836706|589022241|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
163085273|NCT00836706|589022242|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
163085274|NCT02989857|589022243|FG000|Randomization Phase|Not Treated|3|||
163085275|NCT02989857|589022244|FG001|Randomization Phase|Not Treated|2|||
163085276|NCT02989857|589022245|FG002|Randomization Phase|Not Treated|0|||
163085277|NCT01992757|589022246|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
163085278|NCT01344356|589022253|FG000|Overall Study|Physician Decision|0|||
163085279|NCT01344356|589022254|FG001|Overall Study|Physician Decision|3|||
163085280|NCT01344356|589022253|FG000|Overall Study|Lost to Follow-up|0|||
163085281|NCT01344356|589022254|FG001|Overall Study|Lost to Follow-up|6|||
163085282|NCT00366457|589022262|FG000|Overall Study|never began study therapy|2|||
163085283|NCT02829996|589022263|FG000|Overall Study|Withdrawal by Subject|1|||
163085284|NCT02829996|589022264|FG001|Overall Study|Withdrawal by Subject|0|||
163085285|NCT02829996|589022265|FG002|Overall Study|Withdrawal by Subject|0|||
163085286|NCT02829996|589022266|FG003|Overall Study|Withdrawal by Subject|0|||
163085287|NCT02829996|589022267|FG004|Overall Study|Withdrawal by Subject|0|||
163085288|NCT02390076|589022276|FG000|Overall Study|Lost to Follow-up|2|||
163085289|NCT02390076|589022277|FG001|Overall Study|Lost to Follow-up|1|||
163085290|NCT02390076|589022278|FG002|Overall Study|Lost to Follow-up|4|||
163085291|NCT02095106|589022281|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
163085292|NCT02095106|589022282|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
163085293|NCT00725985|589022283|FG000|ITP- Treatment Disposition|Adverse Event|20|||
163085294|NCT00725985|589022284|FG001|ITP- Treatment Disposition|Adverse Event|10|||
163085295|NCT00725985|589022285|FG002|ITP- Treatment Disposition|Adverse Event|5|||
163085296|NCT00725985|589022286|FG003|ITP- Treatment Disposition|Adverse Event|0|||
163085297|NCT00725985|589022287|FG004|ITP- Treatment Disposition|Adverse Event|0|||
163085298|NCT00725985|589022288|FG005|ITP- Treatment Disposition|Adverse Event|0|||
163085299|NCT00725985|589022289|FG006|ITP- Treatment Disposition|Adverse Event|0|||
163085300|NCT00725985|589022290|FG007|ITP- Treatment Disposition|Adverse Event|0|||
163085301|NCT00725985|589022291|FG008|ITP- Treatment Disposition|Adverse Event|0|||
163085302|NCT00725985|589022292|FG009|ITP- Treatment Disposition|Adverse Event|0|||
163085303|NCT00725985|589022293|FG010|ITP- Treatment Disposition|Adverse Event|0|||
163333335|NCT00887224|589931198|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
163333336|NCT00887224|589931199|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
163333337|NCT00887224|589931197|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
163333338|NCT00887224|589931198|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
163333339|NCT00887224|589931199|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
163333340|NCT00887224|589931197|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
163333341|NCT00887224|589931198|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
163333342|NCT00887224|589931199|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
163333343|NCT00887224|589931197|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
163333344|NCT00887224|589931198|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
163333345|NCT00887224|589931199|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
163333346|NCT00887224|589931197|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
163333347|NCT00887224|589931198|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
163333348|NCT00887224|589931199|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
163333349|NCT01353274|589931200|FG000|Overall Study|No case report form (CRF) collected|28|||
163333350|NCT00022672|589931202|FG000|Main Phase: 24 Months|Adverse Event|6|||
163333351|NCT00022672|589931203|FG001|Main Phase: 24 Months|Adverse Event|0|||
163333352|NCT00022672|589931202|FG000|Main Phase: 24 Months|Death|0|||
163333353|NCT00022672|589931203|FG001|Main Phase: 24 Months|Death|3|||
163333354|NCT00022672|589931202|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
163333355|NCT00022672|589931203|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
163333356|NCT00022672|589931202|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
163333357|NCT00022672|589931203|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
163333358|NCT00022672|589931202|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
163333359|NCT00022672|589931203|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
163333360|NCT00022672|589931202|FG000|Main Phase: 24 Months|Refused Treatment|3|||
163333361|NCT00022672|589931203|FG001|Main Phase: 24 Months|Refused Treatment|4|||
163333362|NCT00022672|589931202|FG000|Main Phase: 24 Months|Failure to Return|1|||
163333363|NCT00022672|589931203|FG001|Main Phase: 24 Months|Failure to Return|1|||
163333364|NCT00022672|589931202|FG000|Main Phase: 24 Months|Other|1|||
163333365|NCT00022672|589931203|FG001|Main Phase: 24 Months|Other|0|||
163333366|NCT00022672|589931202|FG000|Extension Phase|Adverse Event|1|||
163333367|NCT00022672|589931203|FG001|Extension Phase|Adverse Event|3|||
163333368|NCT00022672|589931202|FG000|Extension Phase|Death|0|||
163333369|NCT00022672|589931203|FG001|Extension Phase|Death|1|||
163333370|NCT00022672|589931202|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
163333371|NCT00022672|589931203|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
163333372|NCT00022672|589931202|FG000|Extension Phase|Refused Treatment|0|||
163333373|NCT00022672|589931203|FG001|Extension Phase|Refused Treatment|2|||
163333374|NCT00022672|589931202|FG000|Extension Phase|Other|1|||
163333375|NCT00022672|589931203|FG001|Extension Phase|Other|1|||
163333376|NCT00403494|589931204|FG000|Overall Study|Adverse Event|10|||
163333377|NCT00403494|589931205|FG001|Overall Study|Adverse Event|8|||
163333378|NCT00403494|589931204|FG000|Overall Study|Withdrew Consent|3|||
163333379|NCT00403494|589931205|FG001|Overall Study|Withdrew Consent|2|||
163333380|NCT00403494|589931204|FG000|Overall Study|Inappropriately enrolled|0|||
163333381|NCT00403494|589931205|FG001|Overall Study|Inappropriately enrolled|1|||
163333382|NCT00403494|589931204|FG000|Overall Study|Lost to Follow-up|0|||
163333383|NCT00403494|589931205|FG001|Overall Study|Lost to Follow-up|2|||
163333384|NCT00403494|589931204|FG000|Overall Study|Protocol noncompliance|0|||
163333385|NCT00403494|589931205|FG001|Overall Study|Protocol noncompliance|1|||
163333386|NCT00403494|589931204|FG000|Overall Study|Death|1|||
163333387|NCT00403494|589931205|FG001|Overall Study|Death|0|||
163333388|NCT00403494|589931204|FG000|Overall Study|Sponsor Request|1|||
163333389|NCT00403494|589931205|FG001|Overall Study|Sponsor Request|0|||
163333390|NCT05005247|589931206|FG000|Overall Study|Withdrawal by Subject|0|||
163333391|NCT05005247|589931207|FG001|Overall Study|Withdrawal by Subject|1|||
163333392|NCT05005247|589931208|FG002|Overall Study|Withdrawal by Subject|0|||
163333393|NCT03648541|589931211|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
163333394|NCT03648541|589931212|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
163333395|NCT03648541|589931211|FG000|Re-induction Period Only|Lack of Efficacy|7|||
163333396|NCT03648541|589931212|FG001|Re-induction Period Only|Lack of Efficacy|0|||
163406672|NCT01857869|590198726|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
163406673|NCT01857869|590198727|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
163406674|NCT01857869|590198728|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
163085304|NCT00725985|589022294|FG011|ITP- Treatment Disposition|Adverse Event|0|||
163333397|NCT03648541|589931211|FG000|Maintenance Period Only|Missing|0|||
163333398|NCT03648541|589931212|FG001|Maintenance Period Only|Missing|1|||
163333399|NCT03648541|589931211|FG000|Maintenance Period Only|Other not listed below|0|||
163333400|NCT03648541|589931212|FG001|Maintenance Period Only|Other not listed below|4|||
163333401|NCT03648541|589931211|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
163333402|NCT03648541|589931212|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
163333403|NCT03648541|589931211|FG000|Maintenance Period Only|Protocol Violation|0|||
163333404|NCT03648541|589931212|FG001|Maintenance Period Only|Protocol Violation|1|||
163333405|NCT03648541|589931211|FG000|Maintenance Period Only|Lack of Efficacy|0|||
163333406|NCT03648541|589931212|FG001|Maintenance Period Only|Lack of Efficacy|18|||
163333407|NCT03648541|589931211|FG000|Maintenance Period Only|Adverse Event|0|||
163333408|NCT03648541|589931212|FG001|Maintenance Period Only|Adverse Event|4|||
163333409|NCT03648541|589931211|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
163333410|NCT03648541|589931212|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
163333411|NCT03490032|589931213|FG000|Overall Study|family issue (child custody)|1|||
163333412|NCT03490032|589931214|FG001|Overall Study|family issue (child custody)|0|||
163333413|NCT03490032|589931215|FG002|Overall Study|family issue (child custody)|0|||
163333414|NCT00487240|589931218|FG000|Overall Study|Withdrawal by Subject|12|||
163333415|NCT00487240|589931219|FG001|Overall Study|Withdrawal by Subject|6|||
163333416|NCT00487240|589931218|FG000|Overall Study|Lost to Follow-up|7|||
163333417|NCT00487240|589931219|FG001|Overall Study|Lost to Follow-up|6|||
163333418|NCT00487240|589931218|FG000|Overall Study|Adverse Event|0|||
163333419|NCT00487240|589931219|FG001|Overall Study|Adverse Event|4|||
163333420|NCT00487240|589931218|FG000|Overall Study|Protocol Violation|5|||
163333421|NCT00487240|589931219|FG001|Overall Study|Protocol Violation|5|||
163333422|NCT00487240|589931218|FG000|Overall Study|Entry Criteria Not Met|3|||
163333423|NCT00487240|589931219|FG001|Overall Study|Entry Criteria Not Met|4|||
163333424|NCT00487240|589931218|FG000|Overall Study|Sponsor Decision|2|||
163333425|NCT00487240|589931219|FG001|Overall Study|Sponsor Decision|1|||
163333426|NCT00487240|589931218|FG000|Overall Study|Physician Decision|2|||
163406675|NCT01857869|590198729|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
163406676|NCT01857869|590198730|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
163406677|NCT01857869|590198731|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
163406678|NCT01857869|590198732|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
163406679|NCT01857869|590198733|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
163406680|NCT01857869|590198734|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
163406681|NCT01857869|590198735|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
163406682|NCT01857869|590198726|FG000|Primary/Challenge Phase|Pregnancy|1|||
163406683|NCT01857869|590198727|FG001|Primary/Challenge Phase|Pregnancy|0|||
163406684|NCT01857869|590198728|FG002|Primary/Challenge Phase|Pregnancy|0|||
163406685|NCT01857869|590198729|FG003|Primary/Challenge Phase|Pregnancy|0|||
163406686|NCT01857869|590198730|FG004|Primary/Challenge Phase|Pregnancy|0|||
163406687|NCT01857869|590198731|FG005|Primary/Challenge Phase|Pregnancy|0|||
163406688|NCT01857869|590198732|FG006|Primary/Challenge Phase|Pregnancy|0|||
163406689|NCT01857869|590198733|FG007|Primary/Challenge Phase|Pregnancy|0|||
163406690|NCT01857869|590198734|FG008|Primary/Challenge Phase|Pregnancy|0|||
163406691|NCT01857869|590198735|FG009|Primary/Challenge Phase|Pregnancy|0|||
163406692|NCT01857869|590198726|FG000|Primary/Challenge Phase|Protocol Violation|1|||
163406693|NCT01857869|590198727|FG001|Primary/Challenge Phase|Protocol Violation|0|||
163406694|NCT01857869|590198728|FG002|Primary/Challenge Phase|Protocol Violation|0|||
163406695|NCT01857869|590198729|FG003|Primary/Challenge Phase|Protocol Violation|0|||
163406696|NCT01857869|590198730|FG004|Primary/Challenge Phase|Protocol Violation|0|||
163406697|NCT01857869|590198731|FG005|Primary/Challenge Phase|Protocol Violation|0|||
163406698|NCT01857869|590198732|FG006|Primary/Challenge Phase|Protocol Violation|0|||
163406699|NCT01857869|590198733|FG007|Primary/Challenge Phase|Protocol Violation|0|||
163406700|NCT01857869|590198734|FG008|Primary/Challenge Phase|Protocol Violation|0|||
163406701|NCT01857869|590198735|FG009|Primary/Challenge Phase|Protocol Violation|0|||
163406702|NCT01857869|590198726|FG000|Primary/Challenge Phase|Other|1|||
163406703|NCT01857869|590198727|FG001|Primary/Challenge Phase|Other|1|||
163406704|NCT01857869|590198728|FG002|Primary/Challenge Phase|Other|0|||
163085305|NCT00725985|589022283|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
163333427|NCT00487240|589931219|FG001|Overall Study|Physician Decision|0|||
163333428|NCT01858688|589931220|FG000|Overall Study|Withdrawal by Subject|8|||
163333429|NCT01858688|589931220|FG000|Overall Study|Participant began another therapy|3|||
163406705|NCT01857869|590198729|FG003|Primary/Challenge Phase|Other|0|||
163406706|NCT01857869|590198730|FG004|Primary/Challenge Phase|Other|0|||
163406707|NCT01857869|590198731|FG005|Primary/Challenge Phase|Other|0|||
163406708|NCT01857869|590198732|FG006|Primary/Challenge Phase|Other|0|||
163406709|NCT01857869|590198733|FG007|Primary/Challenge Phase|Other|0|||
163406710|NCT01857869|590198734|FG008|Primary/Challenge Phase|Other|0|||
163406711|NCT01857869|590198735|FG009|Primary/Challenge Phase|Other|0|||
163085306|NCT00725985|589022284|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085307|NCT00725985|589022285|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
163085308|NCT00725985|589022286|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085309|NCT00725985|589022287|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085310|NCT00725985|589022288|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085311|NCT00725985|589022289|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085312|NCT00725985|589022290|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085313|NCT00725985|589022291|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085314|NCT00725985|589022292|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085315|NCT00725985|589022293|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085316|NCT00725985|589022294|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085317|NCT00725985|589022283|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
163085318|NCT00725985|589022284|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
163085319|NCT00725985|589022285|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
163085320|NCT00725985|589022286|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
163085321|NCT00725985|589022287|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
163085322|NCT00725985|589022288|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
163085323|NCT00725985|589022289|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
163085324|NCT00725985|589022290|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
163085325|NCT00725985|589022291|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
163085326|NCT00725985|589022292|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
163085327|NCT00725985|589022293|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
163085328|NCT00725985|589022294|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
163085329|NCT00725985|589022283|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
163085330|NCT00725985|589022284|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
163085331|NCT00725985|589022285|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
163085332|NCT00725985|589022286|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
163085333|NCT00725985|589022287|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
163085334|NCT00725985|589022288|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
163085335|NCT00725985|589022289|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
163033193|NCT02079636|588824552|FG010|Overall Study|Lost to Follow-up|0|||
163033194|NCT02079636|588824553|FG011|Overall Study|Lost to Follow-up|0|||
163033195|NCT02079636|588824554|FG012|Overall Study|Lost to Follow-up|0|||
163033196|NCT02079636|588824555|FG013|Overall Study|Lost to Follow-up|0|||
163033197|NCT02079636|588824556|FG014|Overall Study|Lost to Follow-up|0|||
163033198|NCT00561470|588824557|FG000|Overall Study|Adverse Event|74|||
163033199|NCT00561470|588824558|FG001|Overall Study|Adverse Event|163|||
163033200|NCT00561470|588824557|FG000|Overall Study|Disease progression|437|||
163033201|NCT00561470|588824558|FG001|Overall Study|Disease progression|305|||
163033202|NCT00561470|588824557|FG000|Overall Study|poor compliance to protocol|4|||
163033203|NCT00561470|588824558|FG001|Overall Study|poor compliance to protocol|4|||
163033204|NCT00561470|588824557|FG000|Overall Study|Lost to Follow-up|2|||
163033205|NCT00561470|588824558|FG001|Overall Study|Lost to Follow-up|0|||
163033206|NCT00561470|588824557|FG000|Overall Study|Physician Decision|21|||
163033207|NCT00561470|588824558|FG001|Overall Study|Physician Decision|20|||
163033208|NCT00561470|588824557|FG000|Overall Study|Consent Withdrawn|2|||
163033209|NCT00561470|588824558|FG001|Overall Study|Consent Withdrawn|6|||
163033210|NCT00561470|588824557|FG000|Overall Study|Subject request|43|||
163033211|NCT00561470|588824558|FG001|Overall Study|Subject request|77|||
163033212|NCT00561470|588824557|FG000|Overall Study|Metastatic surgery|10|||
163033213|NCT00561470|588824558|FG001|Overall Study|Metastatic surgery|12|||
163033214|NCT00561470|588824557|FG000|Overall Study|Unauthorized procedure|3|||
163033215|NCT00561470|588824558|FG001|Overall Study|Unauthorized procedure|1|||
163033216|NCT00561470|588824557|FG000|Overall Study|Randomized but not treated|5|||
163033217|NCT00561470|588824558|FG001|Overall Study|Randomized but not treated|5|||
163033218|NCT00561470|588824557|FG000|Overall Study|Missed visit window|1|||
163033219|NCT00561470|588824558|FG001|Overall Study|Missed visit window|4|||
163033220|NCT00561470|588824557|FG000|Overall Study|Planning surgery|1|||
163033221|NCT00561470|588824558|FG001|Overall Study|Planning surgery|1|||
163033222|NCT00561470|588824557|FG000|Overall Study|Ongoing Treatment|11|||
163033223|NCT00561470|588824558|FG001|Overall Study|Ongoing Treatment|14|||
163033224|NCT00637806|588824559|FG000|Double-blind Phase|Study Discontinued|2|||
163333430|NCT01858688|589931220|FG000|Overall Study|Physician Decision|2|||
163333431|NCT01858688|589931220|FG000|Overall Study|Progressive Disease|2|||
163033225|NCT00637806|588824560|FG001|Double-blind Phase|Study Discontinued|0|||
163085336|NCT00725985|589022290|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
163085337|NCT00725985|589022291|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
163333432|NCT01858688|589931220|FG000|Overall Study|Reason not reproted|5|||
163085338|NCT00725985|589022292|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
163033226|NCT00637806|588824561|FG002|Double-blind Phase|Study Discontinued|1|||
163333433|NCT04248868|589931221|FG000|Overall Study|Death|1|||
163033227|NCT00637806|588824562|FG003|Double-blind Phase|Study Discontinued|0|||
163033228|NCT00637806|588824559|FG000|Extension Phase|Study Discontinued|0|||
163033229|NCT00637806|588824560|FG001|Extension Phase|Study Discontinued|0|||
163033230|NCT00637806|588824561|FG002|Extension Phase|Study Discontinued|0|||
163333434|NCT04248868|589931221|FG000|Overall Study|Lost to Follow-up|3|||
163333435|NCT04248868|589931221|FG000|Overall Study|Protocol Violation|2|||
163333436|NCT01074242|589931229|FG000|Overall Study|Case report before date of contract|40|||
163333437|NCT01074242|589931229|FG000|Overall Study|Lost to Follow-up|1|||
163333438|NCT01074242|589931229|FG000|Overall Study|Case report unclear|6|||
163333439|NCT01074242|589931229|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
163333440|NCT01074242|589931229|FG000|Overall Study|Duplicate Case Report Form|5|||
163333441|NCT01957163|589931230|FG000|Overall Study|Adverse Event|5|||
163333442|NCT01957163|589931231|FG001|Overall Study|Adverse Event|2|||
163333443|NCT01957163|589931232|FG002|Overall Study|Adverse Event|4|||
163333444|NCT01957163|589931230|FG000|Overall Study|Lack of Efficacy|5|||
163333445|NCT01957163|589931231|FG001|Overall Study|Lack of Efficacy|4|||
163333446|NCT01957163|589931232|FG002|Overall Study|Lack of Efficacy|9|||
163333447|NCT01957163|589931230|FG000|Overall Study|Protocol Violation|1|||
163033231|NCT00637806|588824562|FG003|Extension Phase|Study Discontinued|1|||
163033232|NCT01592292|588824563|FG000|Overall Study|Follow-up loss|3|||
163033233|NCT01592292|588824564|FG001|Overall Study|Follow-up loss|3|||
163033234|NCT01592292|588824565|FG002|Overall Study|Follow-up loss|1|||
163033235|NCT01592292|588824566|FG003|Overall Study|Follow-up loss|0|||
163033236|NCT01592292|588824563|FG000|Overall Study|Withdrew consent|2|||
163033237|NCT01592292|588824564|FG001|Overall Study|Withdrew consent|1|||
163033238|NCT01592292|588824565|FG002|Overall Study|Withdrew consent|0|||
163033239|NCT01592292|588824566|FG003|Overall Study|Withdrew consent|0|||
163033240|NCT01592292|588824563|FG000|Overall Study|Other|1|||
163033241|NCT01592292|588824564|FG001|Overall Study|Other|1|||
163033242|NCT01592292|588824565|FG002|Overall Study|Other|2|||
163033243|NCT01592292|588824566|FG003|Overall Study|Other|1|||
163033244|NCT02923245|588824570|FG000|Overall Study|ultrasound order was cancelled|2|||
163033245|NCT02923245|588824571|FG001|Overall Study|ultrasound order was cancelled|1|||
163033246|NCT02680834|588824572|FG000|Overall Study|Physician Decision|5|||
163033247|NCT02680834|588824573|FG001|Overall Study|Physician Decision|2|||
163033248|NCT02680834|588824572|FG000|Overall Study|Withdrawal by Subject|6|||
163033249|NCT02680834|588824573|FG001|Overall Study|Withdrawal by Subject|0|||
163033250|NCT02680834|588824572|FG000|Overall Study|Lost to Follow-up|0|||
163033251|NCT02680834|588824573|FG001|Overall Study|Lost to Follow-up|1|||
163033252|NCT02520427|588824574|FG000|Overall Study|Decision by sponsor|0|||
163033253|NCT02520427|588824575|FG001|Overall Study|Decision by sponsor|0|||
163033254|NCT02520427|588824576|FG002|Overall Study|Decision by sponsor|0|||
163033255|NCT02520427|588824577|FG003|Overall Study|Decision by sponsor|0|||
163033256|NCT02520427|588824578|FG004|Overall Study|Decision by sponsor|0|||
163033257|NCT02520427|588824579|FG005|Overall Study|Decision by sponsor|0|||
163033258|NCT02520427|588824580|FG006|Overall Study|Decision by sponsor|0|||
163033259|NCT02520427|588824581|FG007|Overall Study|Decision by sponsor|0|||
163033260|NCT02520427|588824582|FG008|Overall Study|Decision by sponsor|1|||
163033261|NCT02520427|588824583|FG009|Overall Study|Decision by sponsor|1|||
163033262|NCT02520427|588824584|FG010|Overall Study|Decision by sponsor|0|||
163033263|NCT02520427|588824585|FG011|Overall Study|Decision by sponsor|0|||
163033264|NCT02520427|588824586|FG012|Overall Study|Decision by sponsor|0|||
163033265|NCT02520427|588824587|FG013|Overall Study|Decision by sponsor|0|||
163033266|NCT02520427|588824588|FG014|Overall Study|Decision by sponsor|0|||
163033267|NCT02520427|588824589|FG015|Overall Study|Decision by sponsor|0|||
163033268|NCT02520427|588824590|FG016|Overall Study|Decision by sponsor|0|||
163033269|NCT02520427|588824591|FG017|Overall Study|Decision by sponsor|0|||
163033270|NCT02520427|588824592|FG018|Overall Study|Decision by sponsor|0|||
163033271|NCT02520427|588824593|FG019|Overall Study|Decision by sponsor|0|||
163033272|NCT02520427|588824594|FG020|Overall Study|Decision by sponsor|0|||
163033273|NCT02520427|588824595|FG021|Overall Study|Decision by sponsor|0|||
163333448|NCT01957163|589931231|FG001|Overall Study|Protocol Violation|2|||
163333449|NCT01957163|589931232|FG002|Overall Study|Protocol Violation|0|||
163033274|NCT02520427|588824596|FG022|Overall Study|Decision by sponsor|0|||
163033275|NCT02520427|588824597|FG023|Overall Study|Decision by sponsor|0|||
163033276|NCT02520427|588824598|FG024|Overall Study|Decision by sponsor|0|||
163033277|NCT02520427|588824599|FG025|Overall Study|Decision by sponsor|0|||
163033278|NCT02520427|588824574|FG000|Overall Study|Withdrawal by Subject|0|||
163033279|NCT02520427|588824575|FG001|Overall Study|Withdrawal by Subject|0|||
163033280|NCT02520427|588824576|FG002|Overall Study|Withdrawal by Subject|1|||
163033281|NCT02520427|588824577|FG003|Overall Study|Withdrawal by Subject|0|||
163033282|NCT02520427|588824578|FG004|Overall Study|Withdrawal by Subject|0|||
163033283|NCT02520427|588824579|FG005|Overall Study|Withdrawal by Subject|0|||
163033284|NCT02520427|588824580|FG006|Overall Study|Withdrawal by Subject|0|||
163033285|NCT02520427|588824581|FG007|Overall Study|Withdrawal by Subject|0|||
163033286|NCT02520427|588824582|FG008|Overall Study|Withdrawal by Subject|0|||
163033287|NCT02520427|588824583|FG009|Overall Study|Withdrawal by Subject|0|||
163033288|NCT02520427|588824584|FG010|Overall Study|Withdrawal by Subject|0|||
163033289|NCT02520427|588824585|FG011|Overall Study|Withdrawal by Subject|0|||
163033290|NCT02520427|588824586|FG012|Overall Study|Withdrawal by Subject|1|||
163033291|NCT02520427|588824587|FG013|Overall Study|Withdrawal by Subject|1|||
163033292|NCT02520427|588824588|FG014|Overall Study|Withdrawal by Subject|1|||
163085339|NCT00725985|589022293|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
163085340|NCT00725985|589022294|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
163085341|NCT00725985|589022283|FG000|ITP- Treatment Disposition|Other|50|||
163085342|NCT00725985|589022284|FG001|ITP- Treatment Disposition|Other|38|||
163085343|NCT00725985|589022285|FG002|ITP- Treatment Disposition|Other|24|||
163085344|NCT00725985|589022286|FG003|ITP- Treatment Disposition|Other|0|||
163085345|NCT00725985|589022287|FG004|ITP- Treatment Disposition|Other|0|||
163085346|NCT00725985|589022288|FG005|ITP- Treatment Disposition|Other|0|||
163085347|NCT00725985|589022289|FG006|ITP- Treatment Disposition|Other|0|||
163085348|NCT00725985|589022290|FG007|ITP- Treatment Disposition|Other|0|||
163085349|NCT00725985|589022291|FG008|ITP- Treatment Disposition|Other|0|||
163085350|NCT00725985|589022292|FG009|ITP- Treatment Disposition|Other|0|||
163085351|NCT00725985|589022293|FG010|ITP- Treatment Disposition|Other|0|||
163085352|NCT00725985|589022294|FG011|ITP- Treatment Disposition|Other|0|||
163085353|NCT00725985|589022283|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085354|NCT00725985|589022284|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085355|NCT00725985|589022285|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085356|NCT00725985|589022286|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
163085357|NCT00725985|589022287|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
163085358|NCT00725985|589022288|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
163085359|NCT00725985|589022289|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085360|NCT00725985|589022290|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085361|NCT00725985|589022291|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085362|NCT00725985|589022292|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085363|NCT00725985|589022293|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085364|NCT00725985|589022294|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085365|NCT00725985|589022283|FG000|OLMP (Up to 96 Weeks)|Death|0|||
163085366|NCT00725985|589022284|FG001|OLMP (Up to 96 Weeks)|Death|0|||
163085367|NCT00725985|589022285|FG002|OLMP (Up to 96 Weeks)|Death|0|||
163085368|NCT00725985|589022286|FG003|OLMP (Up to 96 Weeks)|Death|0|||
163085369|NCT00725985|589022287|FG004|OLMP (Up to 96 Weeks)|Death|1|||
163085370|NCT00725985|589022288|FG005|OLMP (Up to 96 Weeks)|Death|0|||
163085371|NCT00725985|589022289|FG006|OLMP (Up to 96 Weeks)|Death|0|||
163085372|NCT00725985|589022290|FG007|OLMP (Up to 96 Weeks)|Death|0|||
163085373|NCT00725985|589022291|FG008|OLMP (Up to 96 Weeks)|Death|0|||
163085374|NCT00725985|589022292|FG009|OLMP (Up to 96 Weeks)|Death|0|||
163085375|NCT00725985|589022293|FG010|OLMP (Up to 96 Weeks)|Death|0|||
163085376|NCT00725985|589022294|FG011|OLMP (Up to 96 Weeks)|Death|0|||
163085377|NCT00725985|589022283|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085378|NCT00725985|589022284|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085379|NCT00725985|589022285|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085380|NCT00725985|589022286|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
163085381|NCT00725985|589022287|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085382|NCT00725985|589022288|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085383|NCT00725985|589022289|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085384|NCT00725985|589022290|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085385|NCT00725985|589022291|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085386|NCT00725985|589022292|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085387|NCT00725985|589022293|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085388|NCT00725985|589022294|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085389|NCT00725985|589022283|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085390|NCT00725985|589022284|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085391|NCT00725985|589022285|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085392|NCT00725985|589022286|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085393|NCT00725985|589022287|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085394|NCT00725985|589022288|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
163085395|NCT00725985|589022289|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085396|NCT00725985|589022290|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085397|NCT00725985|589022291|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085398|NCT00725985|589022292|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085399|NCT00725985|589022293|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085400|NCT00725985|589022294|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085401|NCT00725985|589022283|FG000|OLMP (Up to 96 Weeks)|Other|0|||
163085402|NCT00725985|589022284|FG001|OLMP (Up to 96 Weeks)|Other|0|||
163085403|NCT00725985|589022285|FG002|OLMP (Up to 96 Weeks)|Other|0|||
163085404|NCT00725985|589022286|FG003|OLMP (Up to 96 Weeks)|Other|15|||
163085405|NCT00725985|589022287|FG004|OLMP (Up to 96 Weeks)|Other|20|||
163085406|NCT00725985|589022288|FG005|OLMP (Up to 96 Weeks)|Other|44|||
163085407|NCT00725985|589022289|FG006|OLMP (Up to 96 Weeks)|Other|0|||
163085408|NCT00725985|589022290|FG007|OLMP (Up to 96 Weeks)|Other|0|||
163085409|NCT00725985|589022291|FG008|OLMP (Up to 96 Weeks)|Other|0|||
163085410|NCT00725985|589022292|FG009|OLMP (Up to 96 Weeks)|Other|0|||
163085411|NCT00725985|589022293|FG010|OLMP (Up to 96 Weeks)|Other|0|||
163085412|NCT00725985|589022294|FG011|OLMP (Up to 96 Weeks)|Other|0|||
163085413|NCT00725985|589022283|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085414|NCT00725985|589022284|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085415|NCT00725985|589022285|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163406712|NCT01857869|590198726|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163406713|NCT01857869|590198727|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163406714|NCT01857869|590198728|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163406715|NCT01857869|590198729|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
163406716|NCT01857869|590198730|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163406717|NCT01857869|590198731|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163406718|NCT01857869|590198732|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163406719|NCT01857869|590198733|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163406720|NCT01857869|590198734|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163406721|NCT01857869|590198735|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163406722|NCT01857869|590198726|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163406723|NCT01857869|590198727|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163406724|NCT01857869|590198728|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163406725|NCT01857869|590198729|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
163406726|NCT01857869|590198730|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163406727|NCT01857869|590198731|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163406728|NCT01857869|590198732|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163406729|NCT01857869|590198733|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163033293|NCT02520427|588824589|FG015|Overall Study|Withdrawal by Subject|0|||
163033294|NCT02520427|588824590|FG016|Overall Study|Withdrawal by Subject|1|||
163033295|NCT02520427|588824591|FG017|Overall Study|Withdrawal by Subject|0|||
163033296|NCT02520427|588824592|FG018|Overall Study|Withdrawal by Subject|0|||
163033297|NCT02520427|588824593|FG019|Overall Study|Withdrawal by Subject|3|||
163033298|NCT02520427|588824594|FG020|Overall Study|Withdrawal by Subject|2|||
163033299|NCT02520427|588824595|FG021|Overall Study|Withdrawal by Subject|0|||
163033300|NCT02520427|588824596|FG022|Overall Study|Withdrawal by Subject|0|||
163033301|NCT02520427|588824597|FG023|Overall Study|Withdrawal by Subject|0|||
163033302|NCT02520427|588824598|FG024|Overall Study|Withdrawal by Subject|0|||
163033303|NCT02520427|588824599|FG025|Overall Study|Withdrawal by Subject|0|||
163033304|NCT02520427|588824574|FG000|Overall Study|Death|1|||
163033305|NCT02520427|588824575|FG001|Overall Study|Death|0|||
163033306|NCT02520427|588824576|FG002|Overall Study|Death|0|||
163033307|NCT02520427|588824577|FG003|Overall Study|Death|0|||
163033308|NCT02520427|588824578|FG004|Overall Study|Death|0|||
163033309|NCT02520427|588824579|FG005|Overall Study|Death|0|||
163033310|NCT02520427|588824580|FG006|Overall Study|Death|0|||
163033311|NCT02520427|588824581|FG007|Overall Study|Death|0|||
163033312|NCT02520427|588824582|FG008|Overall Study|Death|0|||
163033313|NCT02520427|588824583|FG009|Overall Study|Death|0|||
163033314|NCT02520427|588824584|FG010|Overall Study|Death|0|||
163033315|NCT02520427|588824585|FG011|Overall Study|Death|0|||
163033316|NCT02520427|588824586|FG012|Overall Study|Death|0|||
163033317|NCT02520427|588824587|FG013|Overall Study|Death|0|||
163033318|NCT02520427|588824588|FG014|Overall Study|Death|0|||
163033319|NCT02520427|588824589|FG015|Overall Study|Death|0|||
163033320|NCT02520427|588824590|FG016|Overall Study|Death|2|||
163033321|NCT02520427|588824591|FG017|Overall Study|Death|1|||
163033322|NCT02520427|588824592|FG018|Overall Study|Death|3|||
163033323|NCT02520427|588824593|FG019|Overall Study|Death|2|||
163033324|NCT02520427|588824594|FG020|Overall Study|Death|0|||
163033325|NCT02520427|588824595|FG021|Overall Study|Death|0|||
163033326|NCT02520427|588824596|FG022|Overall Study|Death|1|||
163033327|NCT02520427|588824597|FG023|Overall Study|Death|0|||
163033328|NCT02520427|588824598|FG024|Overall Study|Death|1|||
163033329|NCT02520427|588824599|FG025|Overall Study|Death|0|||
163033330|NCT00793624|588824600|FG000|Overall Study|Adverse Event|18|||
163033331|NCT00793624|588824601|FG001|Overall Study|Adverse Event|16|||
163033332|NCT00793624|588824602|FG002|Overall Study|Adverse Event|15|||
163033333|NCT00793624|588824603|FG003|Overall Study|Adverse Event|20|||
163033334|NCT00793624|588824600|FG000|Overall Study|Lost to Follow-up|2|||
163033335|NCT00793624|588824601|FG001|Overall Study|Lost to Follow-up|2|||
163033336|NCT00793624|588824602|FG002|Overall Study|Lost to Follow-up|4|||
163033337|NCT00793624|588824603|FG003|Overall Study|Lost to Follow-up|0|||
163033338|NCT00793624|588824600|FG000|Overall Study|Withdrawal by Subject|20|||
163033339|NCT00793624|588824601|FG001|Overall Study|Withdrawal by Subject|9|||
163033340|NCT00793624|588824602|FG002|Overall Study|Withdrawal by Subject|11|||
163085416|NCT00725985|589022286|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085417|NCT00725985|589022287|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163033341|NCT00793624|588824603|FG003|Overall Study|Withdrawal by Subject|14|||
163033342|NCT00793624|588824600|FG000|Overall Study|Lack of Efficacy|9|||
163033343|NCT00793624|588824601|FG001|Overall Study|Lack of Efficacy|2|||
163033344|NCT00793624|588824602|FG002|Overall Study|Lack of Efficacy|1|||
163033345|NCT00793624|588824603|FG003|Overall Study|Lack of Efficacy|3|||
163033346|NCT00793624|588824600|FG000|Overall Study|Non compliance with protocol|2|||
163033347|NCT00793624|588824601|FG001|Overall Study|Non compliance with protocol|3|||
163033348|NCT00793624|588824602|FG002|Overall Study|Non compliance with protocol|2|||
163033349|NCT00793624|588824603|FG003|Overall Study|Non compliance with protocol|3|||
163085418|NCT00725985|589022288|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085419|NCT00725985|589022289|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085420|NCT00725985|589022290|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
163085421|NCT00725985|589022291|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085422|NCT00725985|589022292|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085423|NCT00725985|589022293|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163333450|NCT01957163|589931230|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
163333451|NCT01957163|589931231|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
163333452|NCT01957163|589931232|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
163333453|NCT01957163|589931230|FG000|Overall Study|Lost to Follow-up|0|||
163333454|NCT01957163|589931231|FG001|Overall Study|Lost to Follow-up|1|||
163333455|NCT01957163|589931232|FG002|Overall Study|Lost to Follow-up|0|||
163333456|NCT01957163|589931230|FG000|Overall Study|Withdrawal by Subject|4|||
163333457|NCT01957163|589931231|FG001|Overall Study|Withdrawal by Subject|2|||
163333458|NCT01957163|589931232|FG002|Overall Study|Withdrawal by Subject|4|||
163333459|NCT03822832|589931237|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
163333460|NCT03822832|589931238|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
163333461|NCT03822832|589931237|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
163333462|NCT03822832|589931238|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
163333463|NCT03822832|589931237|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
163333464|NCT03822832|589931238|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
163333465|NCT03822832|589931237|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
163333466|NCT03822832|589931238|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
163333467|NCT03822832|589931237|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
163333468|NCT03822832|589931238|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
163333469|NCT03822832|589931237|FG000|Re-allocation|Not re-allocated to open label period|2|||
163333470|NCT03822832|589931238|FG001|Re-allocation|Not re-allocated to open label period|6|||
163333471|NCT03822832|589931237|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
163333472|NCT03822832|589931238|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
163333473|NCT03822832|589931237|FG000|Period 2 - Open Label Period|Adverse Event|0|||
163333474|NCT03822832|589931238|FG001|Period 2 - Open Label Period|Adverse Event|3|||
163333475|NCT01668719|589931239|FG000|Phase I|On treatment|1|||
163333476|NCT01668719|589931240|FG001|Phase I|On treatment|0|||
163333477|NCT01668719|589931241|FG002|Phase I|On treatment|0|||
163085424|NCT00725985|589022294|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085425|NCT00725985|589022283|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085426|NCT00725985|589022284|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085427|NCT00725985|589022285|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085428|NCT00725985|589022286|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085429|NCT00725985|589022287|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085430|NCT00725985|589022288|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085431|NCT00725985|589022289|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085432|NCT00725985|589022290|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085433|NCT00725985|589022291|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
163085434|NCT00725985|589022292|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085435|NCT00725985|589022293|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085436|NCT00725985|589022294|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163333478|NCT01668719|589931239|FG000|Phase I|Adverse Event|2|||
163333479|NCT01668719|589931240|FG001|Phase I|Adverse Event|0|||
163333480|NCT01668719|589931241|FG002|Phase I|Adverse Event|0|||
163333481|NCT01668719|589931239|FG000|Phase I|Progression/relapse|1|||
163333482|NCT01668719|589931240|FG001|Phase I|Progression/relapse|0|||
163333483|NCT01668719|589931241|FG002|Phase I|Progression/relapse|0|||
163333484|NCT01668719|589931239|FG000|Phase I|not protocol specified|2|||
163333485|NCT01668719|589931240|FG001|Phase I|not protocol specified|0|||
163333486|NCT01668719|589931241|FG002|Phase I|not protocol specified|0|||
163333487|NCT01668719|589931239|FG000|Phase II|On treatment|0|||
163333488|NCT01668719|589931240|FG001|Phase II|On treatment|4|||
163333489|NCT01668719|589931241|FG002|Phase II|On treatment|3|||
163333490|NCT01668719|589931239|FG000|Phase II|Adverse Event|0|||
163333491|NCT01668719|589931240|FG001|Phase II|Adverse Event|18|||
163333492|NCT01668719|589931241|FG002|Phase II|Adverse Event|18|||
163333493|NCT01668719|589931239|FG000|Phase II|Refusal unrelated to adverse event|0|||
163333494|NCT01668719|589931240|FG001|Phase II|Refusal unrelated to adverse event|4|||
163333495|NCT01668719|589931241|FG002|Phase II|Refusal unrelated to adverse event|1|||
163333496|NCT01668719|589931239|FG000|Phase II|Progression/relapse|0|||
163333497|NCT01668719|589931240|FG001|Phase II|Progression/relapse|13|||
163333498|NCT01668719|589931241|FG002|Phase II|Progression/relapse|17|||
163333499|NCT01668719|589931239|FG000|Phase II|Death|0|||
163333500|NCT01668719|589931240|FG001|Phase II|Death|0|||
163333501|NCT01668719|589931241|FG002|Phase II|Death|2|||
163333502|NCT01668719|589931239|FG000|Phase II|not protocol specified|0|||
163333503|NCT01668719|589931240|FG001|Phase II|not protocol specified|13|||
163333504|NCT01668719|589931241|FG002|Phase II|not protocol specified|7|||
163333505|NCT03539055|589931242|FG000|Overall Study|Death|4|||
163333506|NCT03539055|589931242|FG000|Overall Study|Lost to Follow-up|1|||
163333507|NCT03539055|589931242|FG000|Overall Study|Withdrawal by Subject|2|||
163333508|NCT03539055|589931242|FG000|Overall Study|Screen Fail|7|||
163333509|NCT03539055|589931242|FG000|Overall Study|Drug Intolerance|2|||
163333510|NCT01321073|589931244|FG000|Overall Study|Did not attempt implant|4|||
163333511|NCT01321073|589931244|FG000|Overall Study|Death|3|||
163333512|NCT01638000|589931245|FG000|Overall Study|Randomized but Never Received Drug|7|||
163333513|NCT01638000|589931246|FG001|Overall Study|Randomized but Never Received Drug|10|||
163333514|NCT01638000|589931245|FG000|Overall Study|Adverse Event|14|||
163333515|NCT01638000|589931246|FG001|Overall Study|Adverse Event|16|||
163333516|NCT01638000|589931245|FG000|Overall Study|Lack of Efficacy|5|||
163333517|NCT01638000|589931246|FG001|Overall Study|Lack of Efficacy|6|||
163333518|NCT01638000|589931245|FG000|Overall Study|Protocol Violation|11|||
163333519|NCT01638000|589931246|FG001|Overall Study|Protocol Violation|13|||
163333520|NCT01638000|589931245|FG000|Overall Study|Withdrawal by Subject|21|||
163333521|NCT01638000|589931246|FG001|Overall Study|Withdrawal by Subject|24|||
163333522|NCT01638000|589931245|FG000|Overall Study|Miscellaneous|2|||
163333523|NCT01638000|589931246|FG001|Overall Study|Miscellaneous|2|||
163333524|NCT04248803|589931247|FG000|Overall Study|Lost to Follow-up|7|||
163333525|NCT04248803|589931248|FG001|Overall Study|Lost to Follow-up|7|||
163333526|NCT04248803|589931249|FG002|Overall Study|Lost to Follow-up|7|||
163333527|NCT04248803|589931250|FG003|Overall Study|Lost to Follow-up|7|||
163333528|NCT04248803|589931251|FG004|Overall Study|Lost to Follow-up|7|||
163333529|NCT04248803|589931252|FG005|Overall Study|Lost to Follow-up|7|||
163333530|NCT02309294|589931255|FG000|Overall Study|Withdrawal by Subject|2|||
163333531|NCT01227421|589931256|FG000|Overall Study|Lost to Follow-up|6|||
163333532|NCT01227421|589931257|FG001|Overall Study|Lost to Follow-up|7|||
163333533|NCT01227421|589931258|FG002|Overall Study|Lost to Follow-up|5|||
163033350|NCT00793624|588824600|FG000|Overall Study|Other reason not described above|6|||
163033351|NCT00793624|588824601|FG001|Overall Study|Other reason not described above|4|||
163033352|NCT00793624|588824602|FG002|Overall Study|Other reason not described above|6|||
163033353|NCT00793624|588824603|FG003|Overall Study|Other reason not described above|3|||
163033354|NCT00157248|588824604|FG000|Overall Study|Adverse Event|36|||
163033355|NCT00157248|588824605|FG001|Overall Study|Adverse Event|25|||
163033356|NCT00157248|588824606|FG002|Overall Study|Adverse Event|13|||
163033357|NCT00157248|588824607|FG003|Overall Study|Adverse Event|33|||
163033358|NCT00157248|588824604|FG000|Overall Study|Protocol Violation|4|||
163033359|NCT00157248|588824605|FG001|Overall Study|Protocol Violation|0|||
163033360|NCT00157248|588824606|FG002|Overall Study|Protocol Violation|2|||
163033361|NCT00157248|588824607|FG003|Overall Study|Protocol Violation|2|||
163033362|NCT00157248|588824604|FG000|Overall Study|Lost to Follow-up|0|||
163033363|NCT00157248|588824605|FG001|Overall Study|Lost to Follow-up|1|||
163033364|NCT00157248|588824606|FG002|Overall Study|Lost to Follow-up|0|||
163033365|NCT00157248|588824607|FG003|Overall Study|Lost to Follow-up|0|||
163033366|NCT00157248|588824604|FG000|Overall Study|Withdrawal by Subject|1|||
163033367|NCT00157248|588824605|FG001|Overall Study|Withdrawal by Subject|4|||
163033368|NCT00157248|588824606|FG002|Overall Study|Withdrawal by Subject|3|||
163033369|NCT00157248|588824607|FG003|Overall Study|Withdrawal by Subject|3|||
163033370|NCT00157248|588824604|FG000|Overall Study|site closures, subject moving|7|||
163033371|NCT00157248|588824605|FG001|Overall Study|site closures, subject moving|7|||
163033372|NCT00157248|588824606|FG002|Overall Study|site closures, subject moving|3|||
163033373|NCT00157248|588824607|FG003|Overall Study|site closures, subject moving|9|||
163033374|NCT01712334|588824608|FG000|Treatment Period 1|Randomized in Error|0|||
163033375|NCT01712334|588824609|FG001|Treatment Period 1|Randomized in Error|2|||
163033376|NCT00232596|588824610|FG000|6-Week Titration Phase|Adverse Event|6|||
163033377|NCT00232596|588824611|FG001|6-Week Titration Phase|Adverse Event|19|||
163033378|NCT00232596|588824610|FG000|6-Week Titration Phase|Failed to Return|2|||
163033379|NCT00232596|588824611|FG001|6-Week Titration Phase|Failed to Return|1|||
163033380|NCT00232596|588824610|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
163033381|NCT00232596|588824611|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
163033382|NCT00232596|588824610|FG000|6-Week Titration Phase|Protocol Violation|1|||
163033383|NCT00232596|588824611|FG001|6-Week Titration Phase|Protocol Violation|3|||
163033384|NCT00232596|588824610|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
163033385|NCT00232596|588824611|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
163033386|NCT00232596|588824610|FG000|6-Week Titration Phase|Other|3|||
163033387|NCT00232596|588824611|FG001|6-Week Titration Phase|Other|3|||
163033388|NCT00232596|588824610|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
163033389|NCT00232596|588824611|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
163033390|NCT00232596|588824610|FG000|12-Week Maintenance Phase|Adverse Event|7|||
163033391|NCT00232596|588824611|FG001|12-Week Maintenance Phase|Adverse Event|22|||
163033392|NCT00232596|588824610|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
163033393|NCT00232596|588824611|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
163333534|NCT01227421|589931256|FG000|Overall Study|Adverse Event|2|||
163333535|NCT01227421|589931257|FG001|Overall Study|Adverse Event|7|||
163333536|NCT01227421|589931258|FG002|Overall Study|Adverse Event|2|||
163333537|NCT01227421|589931256|FG000|Overall Study|Withdrawal by Subject|1|||
163333538|NCT01227421|589931257|FG001|Overall Study|Withdrawal by Subject|2|||
163333539|NCT01227421|589931258|FG002|Overall Study|Withdrawal by Subject|1|||
163333540|NCT01227421|589931256|FG000|Overall Study|Protocol Violation|1|||
163333541|NCT01227421|589931257|FG001|Overall Study|Protocol Violation|1|||
163333542|NCT01227421|589931258|FG002|Overall Study|Protocol Violation|2|||
163333543|NCT01227421|589931256|FG000|Overall Study|Randomized in error|1|||
163333544|NCT01227421|589931257|FG001|Overall Study|Randomized in error|1|||
163333545|NCT01227421|589931258|FG002|Overall Study|Randomized in error|0|||
163333546|NCT01000805|589931262|FG000|Overall Study|Adverse Event|21|||
163333547|NCT01000805|589931263|FG001|Overall Study|Adverse Event|9|||
163333548|NCT01000805|589931262|FG000|Overall Study|Lack of Efficacy|5|||
163333549|NCT01000805|589931263|FG001|Overall Study|Lack of Efficacy|16|||
163333550|NCT01000805|589931262|FG000|Overall Study|Lost to Follow-up|16|||
163333551|NCT01000805|589931263|FG001|Overall Study|Lost to Follow-up|21|||
163333552|NCT01000805|589931262|FG000|Overall Study|Physician Decision|0|||
163333553|NCT01000805|589931263|FG001|Overall Study|Physician Decision|1|||
163333554|NCT01000805|589931262|FG000|Overall Study|Protocol Violation|12|||
163333555|NCT01000805|589931263|FG001|Overall Study|Protocol Violation|8|||
163333556|NCT01000805|589931262|FG000|Overall Study|Withdrawal by Subject|16|||
163333557|NCT01000805|589931263|FG001|Overall Study|Withdrawal by Subject|6|||
163333558|NCT01000805|589931262|FG000|Overall Study|Sponsor Decision|0|||
163333559|NCT01000805|589931263|FG001|Overall Study|Sponsor Decision|1|||
163333560|NCT03343704|589931266|FG000|Overall Study|Refused to complete follow up|0|||
163333561|NCT03343704|589931267|FG001|Overall Study|Refused to complete follow up|1|||
163333562|NCT03343704|589931266|FG000|Overall Study|Death|0|||
163333563|NCT03343704|589931267|FG001|Overall Study|Death|1|||
163333564|NCT03343704|589931266|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
163333565|NCT03343704|589931267|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
163333566|NCT02969356|589931269|FG000|Overall Study|Adverse Event|7|||
163333567|NCT02969356|589931269|FG000|Overall Study|Consent withdrawn|2|||
163333568|NCT02969356|589931269|FG000|Overall Study|Lost to Follow-up|3|||
163333569|NCT02969356|589931269|FG000|Overall Study|Did not need to be reinjected|6|||
163333570|NCT02969356|589931269|FG000|Overall Study|Personal reasons|5|||
163333571|NCT05432986|589931282|FG000|Overall Study|Withdrawal by Subject|2|||
163333572|NCT05432986|589931282|FG000|Overall Study|incomplete measurement|7|||
163333573|NCT02830893|589933014|FG000|Overall Study|Relocation to out of the country|1|||
163333574|NCT02830893|589933015|FG001|Overall Study|Relocation to out of the country|0|||
163333575|NCT02830893|589933014|FG000|Overall Study|Lost to Follow-up|0|||
163333576|NCT02830893|589933015|FG001|Overall Study|Lost to Follow-up|2|||
163085437|NCT00725985|589022283|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085438|NCT00725985|589022284|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085439|NCT00725985|589022285|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085440|NCT00725985|589022286|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085441|NCT00725985|589022287|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085442|NCT00725985|589022288|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085443|NCT00725985|589022289|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
163085444|NCT00725985|589022290|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
163085445|NCT00725985|589022291|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
163085446|NCT00725985|589022292|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085447|NCT00725985|589022293|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085448|NCT00725985|589022294|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085449|NCT00725985|589022283|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085450|NCT00725985|589022284|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085451|NCT00725985|589022285|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085452|NCT00725985|589022286|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085453|NCT00725985|589022287|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085454|NCT00725985|589022288|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085455|NCT00725985|589022289|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085456|NCT00725985|589022290|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085457|NCT00725985|589022291|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163333577|NCT02830893|589933014|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
163333578|NCT02830893|589933015|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
163085458|NCT00725985|589022292|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
163085459|NCT00725985|589022293|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
163085460|NCT00725985|589022294|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
163085461|NCT02546323|589022295|FG000|Overall Study|Withdrawal by Subject|36|||
163333579|NCT01277302|589933016|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
163333580|NCT01277302|589933017|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
163333581|NCT01277302|589933018|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
163333582|NCT01277302|589933016|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
163333583|NCT01277302|589933017|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
163085462|NCT02546323|589022296|FG001|Overall Study|Withdrawal by Subject|33|||
163085463|NCT02546323|589022295|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
163333584|NCT01277302|589933018|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
163333585|NCT01277302|589933016|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
163333586|NCT01277302|589933017|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
163333587|NCT01277302|589933018|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
163333588|NCT01277302|589933016|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
163333589|NCT01277302|589933017|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
163333590|NCT01277302|589933018|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
163333591|NCT01277302|589933016|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
163333592|NCT01277302|589933017|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
163333593|NCT01277302|589933018|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
163333594|NCT01277302|589933016|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
163333595|NCT01277302|589933017|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
163333596|NCT01277302|589933018|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
163333597|NCT01277302|589933016|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
163333598|NCT01277302|589933017|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
163333599|NCT01277302|589933018|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
163333600|NCT01277302|589933016|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
163333601|NCT01277302|589933017|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
163333602|NCT01277302|589933018|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
163333603|NCT01277302|589933016|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
163333604|NCT01277302|589933017|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
163333605|NCT01277302|589933018|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
163333606|NCT02710669|589933021|FG000|Overall Study|Physician Decision|2|||
163333607|NCT02710669|589933022|FG001|Overall Study|Physician Decision|1|||
163333608|NCT02710669|589933023|FG002|Overall Study|Physician Decision|0|||
163333609|NCT02710669|589933021|FG000|Overall Study|Institutional delays (including COVID)|2|||
163333610|NCT02710669|589933022|FG001|Overall Study|Institutional delays (including COVID)|2|||
163333611|NCT02710669|589933023|FG002|Overall Study|Institutional delays (including COVID)|0|||
163333612|NCT02710669|589933021|FG000|Overall Study|arrived in afib/aflutter|10|||
163333613|NCT02710669|589933022|FG001|Overall Study|arrived in afib/aflutter|8|||
163333614|NCT02710669|589933023|FG002|Overall Study|arrived in afib/aflutter|2|||
163333615|NCT01567852|589933024|FG000|Overall Study|Withdrawal by Subject|3|||
163333616|NCT01567852|589933025|FG001|Overall Study|Withdrawal by Subject|6|||
163333617|NCT01567852|589933024|FG000|Overall Study|ECT discontinued|1|||
163333618|NCT01567852|589933025|FG001|Overall Study|ECT discontinued|1|||
163333619|NCT03332589|589933026|FG000|Overall Study|Lack of Efficacy|2|||
163333620|NCT03332589|589933027|FG001|Overall Study|Lack of Efficacy|0|||
163333621|NCT03332589|589933028|FG002|Overall Study|Lack of Efficacy|0|||
163333622|NCT03332589|589933026|FG000|Overall Study|Adverse Event|1|||
163333623|NCT03332589|589933027|FG001|Overall Study|Adverse Event|0|||
163333624|NCT03332589|589933028|FG002|Overall Study|Adverse Event|0|||
163333625|NCT03332589|589933026|FG000|Overall Study|Death|1|||
163333626|NCT03332589|589933027|FG001|Overall Study|Death|0|||
163333627|NCT03332589|589933028|FG002|Overall Study|Death|0|||
163333628|NCT01190124|589933030|FG000|Overall Study|Death|3|||
163333629|NCT01190124|589933031|FG001|Overall Study|Death|0|||
163333630|NCT01190124|589933032|FG002|Overall Study|Death|0|||
163333631|NCT01190124|589933030|FG000|Overall Study|Therapeutic Failure|12|||
163333632|NCT01190124|589933031|FG001|Overall Study|Therapeutic Failure|0|||
163333633|NCT01190124|589933032|FG002|Overall Study|Therapeutic Failure|1|||
163333634|NCT01190124|589933030|FG000|Overall Study|Lost to Follow-up|2|||
163333635|NCT01190124|589933031|FG001|Overall Study|Lost to Follow-up|0|||
163406730|NCT01857869|590198734|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163406731|NCT01857869|590198735|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163333636|NCT01190124|589933032|FG002|Overall Study|Lost to Follow-up|0|||
163333637|NCT01719172|589933033|FG000|Overall Study|Lost to Follow-up|1|||
163333638|NCT01719172|589933033|FG000|Overall Study|Death|1|||
163333639|NCT03469258|589933036|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
163333640|NCT02605174|589933043|FG000|Overall Study|Adverse Event|0|||
163333641|NCT02605174|589933044|FG001|Overall Study|Adverse Event|0|||
163333642|NCT02605174|589933045|FG002|Overall Study|Adverse Event|1|||
163333643|NCT02605174|589933046|FG003|Overall Study|Adverse Event|0|||
163333644|NCT02605174|589933047|FG004|Overall Study|Adverse Event|4|||
163406732|NCT03016325|590198749|FG000|Treatment Period|Participant withdrew consent|0|||
163085464|NCT02546323|589022296|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
163333645|NCT02605174|589933048|FG005|Overall Study|Adverse Event|0|||
163333646|NCT02605174|589933049|FG006|Overall Study|Adverse Event|0|||
163333647|NCT02605174|589933043|FG000|Overall Study|Lost to Follow-up|20|||
163333648|NCT02605174|589933044|FG001|Overall Study|Lost to Follow-up|7|||
163333649|NCT02605174|589933045|FG002|Overall Study|Lost to Follow-up|27|||
163333650|NCT02605174|589933046|FG003|Overall Study|Lost to Follow-up|10|||
163333651|NCT02605174|589933047|FG004|Overall Study|Lost to Follow-up|20|||
163333652|NCT02605174|589933048|FG005|Overall Study|Lost to Follow-up|10|||
163085465|NCT02546323|589022295|FG000|Overall Study|Adverse Event|17|||
163085466|NCT02546323|589022296|FG001|Overall Study|Adverse Event|11|||
163085467|NCT02546323|589022295|FG000|Overall Study|Patient Specific Reasons|1|||
163085468|NCT02546323|589022296|FG001|Overall Study|Patient Specific Reasons|2|||
163085469|NCT02546323|589022295|FG000|Overall Study|Lost to Follow-up|2|||
163085470|NCT02546323|589022296|FG001|Overall Study|Lost to Follow-up|3|||
163085471|NCT02546323|589022295|FG000|Overall Study|Non-compliance with Study Drug|2|||
163085472|NCT02546323|589022296|FG001|Overall Study|Non-compliance with Study Drug|2|||
163085473|NCT02546323|589022295|FG000|Overall Study|Met Withdrawal Criteria|2|||
163085474|NCT02546323|589022296|FG001|Overall Study|Met Withdrawal Criteria|14|||
163085475|NCT04476784|589022297|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
163085476|NCT04476784|589022298|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
163085477|NCT00863304|589022305|FG000|Overall Study|Adverse Event|10|||
163085478|NCT00863304|589022306|FG001|Overall Study|Adverse Event|4|||
163085479|NCT00863304|589022307|FG002|Overall Study|Adverse Event|14|||
163085480|NCT00863304|589022308|FG003|Overall Study|Adverse Event|16|||
163085481|NCT00863304|589022305|FG000|Overall Study|Lost to Follow-up|1|||
163085482|NCT00863304|589022306|FG001|Overall Study|Lost to Follow-up|5|||
163085483|NCT00863304|589022307|FG002|Overall Study|Lost to Follow-up|4|||
163085484|NCT00863304|589022308|FG003|Overall Study|Lost to Follow-up|2|||
163085485|NCT00863304|589022305|FG000|Overall Study|Lack of Efficacy|57|||
163085486|NCT00863304|589022306|FG001|Overall Study|Lack of Efficacy|26|||
163085487|NCT00863304|589022307|FG002|Overall Study|Lack of Efficacy|30|||
163085488|NCT00863304|589022308|FG003|Overall Study|Lack of Efficacy|28|||
163085489|NCT00863304|589022305|FG000|Overall Study|Withdrawal by Subject|19|||
163085490|NCT00863304|589022306|FG001|Overall Study|Withdrawal by Subject|14|||
163085491|NCT00863304|589022307|FG002|Overall Study|Withdrawal by Subject|20|||
163085492|NCT00863304|589022308|FG003|Overall Study|Withdrawal by Subject|18|||
163085493|NCT00863304|589022305|FG000|Overall Study|Other|1|||
163085494|NCT00863304|589022306|FG001|Overall Study|Other|0|||
163085495|NCT00863304|589022307|FG002|Overall Study|Other|0|||
163085496|NCT00863304|589022308|FG003|Overall Study|Other|1|||
163085497|NCT00863304|589022305|FG000|Overall Study|Protocol Violation|2|||
163085498|NCT00863304|589022306|FG001|Overall Study|Protocol Violation|6|||
163085499|NCT00863304|589022307|FG002|Overall Study|Protocol Violation|2|||
163085500|NCT00863304|589022308|FG003|Overall Study|Protocol Violation|0|||
163085501|NCT00863304|589022305|FG000|Overall Study|Randomized, but not Treated|3|||
163085502|NCT00863304|589022306|FG001|Overall Study|Randomized, but not Treated|1|||
163085503|NCT00863304|589022307|FG002|Overall Study|Randomized, but not Treated|4|||
163033394|NCT00232596|588824610|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
163033395|NCT00232596|588824611|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
163033396|NCT00232596|588824610|FG000|12-Week Maintenance Phase|Other|1|||
163033397|NCT00232596|588824611|FG001|12-Week Maintenance Phase|Other|3|||
163033398|NCT03467763|588824614|FG000|Overall Study|Lost to Follow-up|1|||
163033399|NCT03467763|588824614|FG000|Overall Study|Protocol Violation|2|||
163033400|NCT02073565|588824615|FG000|Cohort A|Withdrawal by Subject|1|||
163033401|NCT02073565|588824616|FG001|Cohort A|Withdrawal by Subject|0|||
163033402|NCT02073565|588824615|FG000|Cohort B|Withdrawal by Subject|1|||
163033403|NCT02073565|588824616|FG001|Cohort B|Withdrawal by Subject|2|||
163033404|NCT02073565|588824615|FG000|Cohort C|Withdrawal by Subject|0|||
163033405|NCT02073565|588824616|FG001|Cohort C|Withdrawal by Subject|2|||
163033406|NCT02073565|588824615|FG000|Cohort C|Lost to Follow-up|0|||
163033407|NCT02073565|588824616|FG001|Cohort C|Lost to Follow-up|2|||
163033408|NCT04102865|588824617|FG000|Overall Study|Adverse Event|4|||
163033409|NCT04102865|588824618|FG001|Overall Study|Adverse Event|0|||
163033410|NCT04102865|588824617|FG000|Overall Study|Lost to Follow-up|1|||
163033411|NCT04102865|588824618|FG001|Overall Study|Lost to Follow-up|0|||
163333653|NCT02605174|589933049|FG006|Overall Study|Lost to Follow-up|29|||
163333654|NCT02605174|589933043|FG000|Overall Study|Protocol Violation|10|||
163333655|NCT02605174|589933044|FG001|Overall Study|Protocol Violation|4|||
163333656|NCT02605174|589933045|FG002|Overall Study|Protocol Violation|14|||
163333657|NCT02605174|589933046|FG003|Overall Study|Protocol Violation|6|||
163333658|NCT02605174|589933047|FG004|Overall Study|Protocol Violation|7|||
163333659|NCT02605174|589933048|FG005|Overall Study|Protocol Violation|7|||
163033412|NCT04102865|588824617|FG000|Overall Study|Withdrawal by Subject|2|||
163033413|NCT04102865|588824618|FG001|Overall Study|Withdrawal by Subject|0|||
163033414|NCT01764997|588824623|FG000|Run-in Period|Adverse Event|15|||
163033415|NCT01764997|588824624|FG001|Run-in Period|Adverse Event|0|||
163033416|NCT01764997|588824625|FG002|Run-in Period|Adverse Event|0|||
163033417|NCT01764997|588824626|FG003|Run-in Period|Adverse Event|0|||
163033418|NCT01764997|588824627|FG004|Run-in Period|Adverse Event|0|||
163033419|NCT01764997|588824623|FG000|Run-in Period|Lack of Efficacy|5|||
163033420|NCT01764997|588824624|FG001|Run-in Period|Lack of Efficacy|0|||
163085504|NCT00863304|589022308|FG003|Overall Study|Randomized, but not Treated|1|||
163333660|NCT02605174|589933049|FG006|Overall Study|Protocol Violation|12|||
163033421|NCT01764997|588824625|FG002|Run-in Period|Lack of Efficacy|0|||
163033422|NCT01764997|588824626|FG003|Run-in Period|Lack of Efficacy|0|||
163033423|NCT01764997|588824627|FG004|Run-in Period|Lack of Efficacy|0|||
163033424|NCT01764997|588824623|FG000|Run-in Period|Poor compliance to protocol|1|||
163033425|NCT01764997|588824624|FG001|Run-in Period|Poor compliance to protocol|0|||
163033426|NCT01764997|588824625|FG002|Run-in Period|Poor compliance to protocol|0|||
163033427|NCT01764997|588824626|FG003|Run-in Period|Poor compliance to protocol|0|||
163033428|NCT01764997|588824627|FG004|Run-in Period|Poor compliance to protocol|0|||
163033429|NCT01764997|588824623|FG000|Run-in Period|Other than specified above|17|||
163033430|NCT01764997|588824624|FG001|Run-in Period|Other than specified above|0|||
163033431|NCT01764997|588824625|FG002|Run-in Period|Other than specified above|0|||
163333661|NCT02605174|589933043|FG000|Overall Study|Pregnancy|1|||
163333662|NCT02605174|589933044|FG001|Overall Study|Pregnancy|0|||
163333663|NCT02605174|589933045|FG002|Overall Study|Pregnancy|0|||
163333664|NCT02605174|589933046|FG003|Overall Study|Pregnancy|2|||
163333665|NCT02605174|589933047|FG004|Overall Study|Pregnancy|0|||
163333666|NCT02605174|589933048|FG005|Overall Study|Pregnancy|0|||
163333667|NCT02605174|589933049|FG006|Overall Study|Pregnancy|0|||
163333668|NCT02605174|589933043|FG000|Overall Study|Withdrawal by Subject|9|||
163333669|NCT02605174|589933044|FG001|Overall Study|Withdrawal by Subject|6|||
163333670|NCT02605174|589933045|FG002|Overall Study|Withdrawal by Subject|14|||
163333671|NCT02605174|589933046|FG003|Overall Study|Withdrawal by Subject|11|||
163333672|NCT02605174|589933047|FG004|Overall Study|Withdrawal by Subject|6|||
163333673|NCT02605174|589933048|FG005|Overall Study|Withdrawal by Subject|4|||
163333674|NCT02605174|589933049|FG006|Overall Study|Withdrawal by Subject|15|||
163333675|NCT02605174|589933043|FG000|Overall Study|Physician Decision|2|||
163333676|NCT02605174|589933044|FG001|Overall Study|Physician Decision|0|||
163333677|NCT02605174|589933045|FG002|Overall Study|Physician Decision|0|||
163333678|NCT02605174|589933046|FG003|Overall Study|Physician Decision|0|||
163333679|NCT02605174|589933047|FG004|Overall Study|Physician Decision|0|||
163333680|NCT02605174|589933048|FG005|Overall Study|Physician Decision|0|||
163333681|NCT02605174|589933049|FG006|Overall Study|Physician Decision|3|||
163333682|NCT02605174|589933043|FG000|Overall Study|Randomization Failure|22|||
163333683|NCT02605174|589933044|FG001|Overall Study|Randomization Failure|6|||
163333684|NCT02605174|589933045|FG002|Overall Study|Randomization Failure|20|||
163333685|NCT02605174|589933046|FG003|Overall Study|Randomization Failure|7|||
163333686|NCT02605174|589933047|FG004|Overall Study|Randomization Failure|16|||
163333687|NCT02605174|589933048|FG005|Overall Study|Randomization Failure|11|||
163333688|NCT02605174|589933049|FG006|Overall Study|Randomization Failure|30|||
163333689|NCT04250636|589933052|FG000|Overall Study|Lost to Follow-up|2|||
163333690|NCT01128959|589933053|FG000|Lead in Period|Adverse Event|3|||
163333691|NCT01128959|589933053|FG000|Treatment Period|Adverse Event|3|||
163333692|NCT01128959|589933053|FG000|Treatment Period|Withdrawal by Subject|1|||
163333693|NCT01409837|589933054|FG000|Overall Study|Withdrawal by Subject|2|||
163333694|NCT01409837|589933055|FG001|Overall Study|Withdrawal by Subject|1|||
163333695|NCT01409837|589933054|FG000|Overall Study|Lost to Follow-up|1|||
163333696|NCT01409837|589933055|FG001|Overall Study|Lost to Follow-up|0|||
163333697|NCT01409837|589933054|FG000|Overall Study|Physician Decision|0|||
163333698|NCT01409837|589933055|FG001|Overall Study|Physician Decision|1|||
163033432|NCT01764997|588824626|FG003|Run-in Period|Other than specified above|0|||
163033433|NCT01764997|588824627|FG004|Run-in Period|Other than specified above|0|||
163033434|NCT01764997|588824623|FG000|Study Drug Treatment Period|Adverse Event|0|||
163033435|NCT01764997|588824624|FG001|Study Drug Treatment Period|Adverse Event|1|||
163033436|NCT01764997|588824625|FG002|Study Drug Treatment Period|Adverse Event|0|||
163033437|NCT01764997|588824626|FG003|Study Drug Treatment Period|Adverse Event|0|||
163033438|NCT01764997|588824627|FG004|Study Drug Treatment Period|Adverse Event|24|||
163033439|NCT01764997|588824623|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
163033440|NCT01764997|588824624|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
163033441|NCT01764997|588824625|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
163033442|NCT01764997|588824626|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
163033443|NCT01764997|588824627|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
163033444|NCT01764997|588824623|FG000|Study Drug Treatment Period|Other than specified above|0|||
163033445|NCT01764997|588824624|FG001|Study Drug Treatment Period|Other than specified above|0|||
163033446|NCT01764997|588824625|FG002|Study Drug Treatment Period|Other than specified above|0|||
163033447|NCT01764997|588824626|FG003|Study Drug Treatment Period|Other than specified above|0|||
163033448|NCT01764997|588824627|FG004|Study Drug Treatment Period|Other than specified above|10|||
163033449|NCT02913105|588826589|FG000|Overall Study|Adverse Event|11|||
163033450|NCT02913105|588826590|FG001|Overall Study|Adverse Event|0|||
163033451|NCT02913105|588826591|FG002|Overall Study|Adverse Event|4|||
163033452|NCT02913105|588826589|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163033453|NCT02913105|588826590|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163033454|NCT02913105|588826591|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163033455|NCT02913105|588826589|FG000|Overall Study|Reason Not Specified|3|||
163033456|NCT02913105|588826590|FG001|Overall Study|Reason Not Specified|1|||
163033457|NCT02913105|588826591|FG002|Overall Study|Reason Not Specified|1|||
163033458|NCT02913105|588826589|FG000|Overall Study|Physician Decision|1|||
163033459|NCT02913105|588826590|FG001|Overall Study|Physician Decision|1|||
163033460|NCT02913105|588826591|FG002|Overall Study|Physician Decision|0|||
163033461|NCT02913105|588826589|FG000|Overall Study|Withdrawal by Subject|0|||
163033462|NCT02913105|588826590|FG001|Overall Study|Withdrawal by Subject|3|||
163033463|NCT02913105|588826591|FG002|Overall Study|Withdrawal by Subject|1|||
163085505|NCT00863304|589022305|FG000|Overall Study|Entered extension study|101|||
163085506|NCT00863304|589022306|FG001|Overall Study|Entered extension study|129|||
163085507|NCT00863304|589022307|FG002|Overall Study|Entered extension study|113|||
163085508|NCT00863304|589022308|FG003|Overall Study|Entered extension study|125|||
163085509|NCT01182350|589022310|FG000|Overall Study|Adverse Event|5|||
163085510|NCT01182350|589022311|FG001|Overall Study|Adverse Event|0|||
163085511|NCT01182350|589022312|FG002|Overall Study|Adverse Event|0|||
163085512|NCT01182350|589022313|FG003|Overall Study|Adverse Event|0|||
163085513|NCT01182350|589022314|FG004|Overall Study|Adverse Event|0|||
163085514|NCT01182350|589022310|FG000|Overall Study|Disease Progression|15|||
163085515|NCT01182350|589022311|FG001|Overall Study|Disease Progression|12|||
163085516|NCT01182350|589022312|FG002|Overall Study|Disease Progression|0|||
163085517|NCT01182350|589022313|FG003|Overall Study|Disease Progression|1|||
163033464|NCT02168777|588826592|FG000|Overall Study|Withdrawal by Subject|1|||
163033465|NCT02168777|588826593|FG001|Overall Study|Withdrawal by Subject|0|||
163085518|NCT01182350|589022314|FG004|Overall Study|Disease Progression|0|||
163085519|NCT01182350|589022310|FG000|Overall Study|Death|0|||
163085520|NCT01182350|589022311|FG001|Overall Study|Death|1|||
163085521|NCT01182350|589022312|FG002|Overall Study|Death|1|||
163085522|NCT01182350|589022313|FG003|Overall Study|Death|0|||
163033466|NCT02168777|588826594|FG002|Overall Study|Withdrawal by Subject|2|||
163033467|NCT02168777|588826592|FG000|Overall Study|Adverse Event|1|||
163085523|NCT01182350|589022314|FG004|Overall Study|Death|0|||
163085524|NCT01182350|589022310|FG000|Overall Study|Withdrawal by Subject|3|||
163085525|NCT01182350|589022311|FG001|Overall Study|Withdrawal by Subject|1|||
163085526|NCT01182350|589022312|FG002|Overall Study|Withdrawal by Subject|0|||
163085527|NCT01182350|589022313|FG003|Overall Study|Withdrawal by Subject|1|||
163085528|NCT01182350|589022314|FG004|Overall Study|Withdrawal by Subject|0|||
163085529|NCT01182350|589022310|FG000|Overall Study|Alternative Therapy|2|||
163085530|NCT01182350|589022311|FG001|Overall Study|Alternative Therapy|0|||
163085531|NCT01182350|589022312|FG002|Overall Study|Alternative Therapy|1|||
163085532|NCT01182350|589022313|FG003|Overall Study|Alternative Therapy|0|||
163085533|NCT01182350|589022314|FG004|Overall Study|Alternative Therapy|0|||
163085534|NCT01182350|589022310|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
163085535|NCT01182350|589022311|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
163085536|NCT01182350|589022312|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
163085537|NCT01182350|589022313|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
163085538|NCT01182350|589022314|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
163085539|NCT01182350|589022310|FG000|Overall Study|Unevaluable for Biopsy|0|||
163085540|NCT01182350|589022311|FG001|Overall Study|Unevaluable for Biopsy|0|||
163085541|NCT01182350|589022312|FG002|Overall Study|Unevaluable for Biopsy|0|||
163085542|NCT01182350|589022313|FG003|Overall Study|Unevaluable for Biopsy|0|||
163085543|NCT01182350|589022314|FG004|Overall Study|Unevaluable for Biopsy|3|||
163085544|NCT04023487|589022315|FG000|Overall Study|Lost to Follow-up|5|||
163033468|NCT02168777|588826593|FG001|Overall Study|Adverse Event|0|||
163033469|NCT02168777|588826594|FG002|Overall Study|Adverse Event|1|||
163033470|NCT02168777|588826592|FG000|Overall Study|Disease recurrence|0|||
163033471|NCT02168777|588826593|FG001|Overall Study|Disease recurrence|0|||
163033472|NCT02168777|588826594|FG002|Overall Study|Disease recurrence|1|||
163033473|NCT02168777|588826592|FG000|Overall Study|Radiological disease progression|0|||
163033474|NCT02168777|588826593|FG001|Overall Study|Radiological disease progression|5|||
163033475|NCT02168777|588826594|FG002|Overall Study|Radiological disease progression|5|||
163033476|NCT02168777|588826592|FG000|Overall Study|Clinical disease progression|0|||
163033477|NCT02168777|588826593|FG001|Overall Study|Clinical disease progression|1|||
163033478|NCT02168777|588826594|FG002|Overall Study|Clinical disease progression|2|||
163033479|NCT02168777|588826592|FG000|Overall Study|Other reason|0|||
163033480|NCT02168777|588826593|FG001|Overall Study|Other reason|1|||
163033481|NCT02168777|588826594|FG002|Overall Study|Other reason|0|||
163033482|NCT05243563|588826595|FG000|Overall Study|Withdrawal by Subject|1|||
163033483|NCT05243563|588826596|FG001|Overall Study|Withdrawal by Subject|0|||
163033484|NCT05243563|588826595|FG000|Overall Study|Physician Decision|1|||
163085545|NCT04023487|589022316|FG001|Overall Study|Lost to Follow-up|4|||
163085546|NCT04023487|589022315|FG000|Overall Study|Pregnancy|1|||
163085547|NCT04023487|589022316|FG001|Overall Study|Pregnancy|2|||
163085548|NCT04023487|589022315|FG000|Overall Study|Withdrawal by Subject|4|||
163085549|NCT04023487|589022316|FG001|Overall Study|Withdrawal by Subject|5|||
163085550|NCT04023487|589022315|FG000|Overall Study|Partially completed testing|8|||
163085551|NCT04023487|589022316|FG001|Overall Study|Partially completed testing|4|||
163085552|NCT00605189|589022317|FG000|Overall Study|Adverse Event|1|||
163085553|NCT00605189|589022318|FG001|Overall Study|Adverse Event|0|||
163085554|NCT00605189|589022319|FG002|Overall Study|Adverse Event|0|||
163085555|NCT00605189|589022317|FG000|Overall Study|Other|2|||
163085556|NCT00605189|589022318|FG001|Overall Study|Other|2|||
163085557|NCT00605189|589022319|FG002|Overall Study|Other|0|||
163033485|NCT05243563|588826596|FG001|Overall Study|Physician Decision|0|||
163085558|NCT03898180|589022320|FG000|Overall Study|Death|178|||
163085559|NCT03898180|589022321|FG001|Overall Study|Death|173|||
163085560|NCT03898180|589022320|FG000|Overall Study|Physician Decision|1|||
163085561|NCT03898180|589022321|FG001|Overall Study|Physician Decision|0|||
163085562|NCT03898180|589022320|FG000|Overall Study|Sponsor Decision|3|||
163085563|NCT03898180|589022321|FG001|Overall Study|Sponsor Decision|0|||
163085564|NCT03898180|589022320|FG000|Overall Study|Lost to Follow-up|1|||
163085565|NCT03898180|589022321|FG001|Overall Study|Lost to Follow-up|0|||
163085566|NCT03898180|589022320|FG000|Overall Study|Withdrawal by Subject|5|||
163085567|NCT03898180|589022321|FG001|Overall Study|Withdrawal by Subject|4|||
163085568|NCT05030766|589022323|FG000|Phase 1 Participants|Lost to Follow-up|12|||
163085569|NCT05030766|589022324|FG001|Phase 1 Participants|Lost to Follow-up|22|||
163085570|NCT05030766|589022325|FG002|Phase 1 Participants|Lost to Follow-up|0|||
163085571|NCT05030766|589022326|FG003|Phase 1 Participants|Lost to Follow-up|0|||
163085572|NCT05030766|589022323|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
163033486|NCT02437188|588826599|FG000|Overall Study|Randomized but did not receive surgery|4|||
163033487|NCT02437188|588826600|FG001|Overall Study|Randomized but did not receive surgery|8|||
163033488|NCT02437188|588826599|FG000|Overall Study|Adverse Event|0|||
163033489|NCT02437188|588826600|FG001|Overall Study|Adverse Event|1|||
163033490|NCT01663857|588826601|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
163033491|NCT01663857|588826602|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
163033492|NCT01663857|588826603|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
163033493|NCT01663857|588826604|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
163033494|NCT01663857|588826601|FG000|Overall Study|Lost to Follow-up|0|||
163033495|NCT01663857|588826602|FG001|Overall Study|Lost to Follow-up|0|||
163033496|NCT01663857|588826603|FG002|Overall Study|Lost to Follow-up|3|||
163033497|NCT01663857|588826604|FG003|Overall Study|Lost to Follow-up|1|||
163033498|NCT01172808|588826607|FG000|Overall Study|Adverse Event|8|||
163033499|NCT01172808|588826608|FG001|Overall Study|Adverse Event|4|||
163033500|NCT01172808|588826609|FG002|Overall Study|Adverse Event|8|||
163033501|NCT01172808|588826610|FG003|Overall Study|Adverse Event|3|||
163033502|NCT01172808|588826607|FG000|Overall Study|Lack of Efficacy|1|||
163033503|NCT01172808|588826608|FG001|Overall Study|Lack of Efficacy|0|||
163033504|NCT01172808|588826609|FG002|Overall Study|Lack of Efficacy|0|||
163033505|NCT01172808|588826610|FG003|Overall Study|Lack of Efficacy|0|||
163033506|NCT01172808|588826607|FG000|Overall Study|Protocol Violation|2|||
163033507|NCT01172808|588826608|FG001|Overall Study|Protocol Violation|2|||
163033508|NCT01172808|588826609|FG002|Overall Study|Protocol Violation|2|||
163033509|NCT01172808|588826610|FG003|Overall Study|Protocol Violation|0|||
163033510|NCT01172808|588826607|FG000|Overall Study|Lost to Follow-up|0|||
163033511|NCT01172808|588826608|FG001|Overall Study|Lost to Follow-up|1|||
163033512|NCT01172808|588826609|FG002|Overall Study|Lost to Follow-up|1|||
163033513|NCT01172808|588826610|FG003|Overall Study|Lost to Follow-up|3|||
163033514|NCT01172808|588826607|FG000|Overall Study|Withdrawal by Subject|4|||
163033515|NCT01172808|588826608|FG001|Overall Study|Withdrawal by Subject|1|||
163033516|NCT01172808|588826609|FG002|Overall Study|Withdrawal by Subject|3|||
163033517|NCT01172808|588826610|FG003|Overall Study|Withdrawal by Subject|2|||
163033518|NCT01172808|588826607|FG000|Overall Study|Other|6|||
163033519|NCT01172808|588826608|FG001|Overall Study|Other|5|||
163033520|NCT01172808|588826609|FG002|Overall Study|Other|9|||
163033521|NCT01172808|588826610|FG003|Overall Study|Other|7|||
163033522|NCT02578940|588826615|FG000|Overall Study|Screening failure|5|||
163033523|NCT02578940|588826615|FG000|Overall Study|Lost to Follow-up|1|||
163033524|NCT01911793|588826616|FG000|Overall Study|Physician Decision|1|||
163033525|NCT01911793|588826617|FG001|Overall Study|Physician Decision|5|||
163033526|NCT03959488|588826624|FG000|Season 1|Other|6|||
163033527|NCT03959488|588826625|FG001|Season 1|Other|7|||
163033528|NCT03959488|588826626|FG002|Season 1|Other|0|||
163033529|NCT03959488|588826627|FG003|Season 1|Other|0|||
163033530|NCT03959488|588826628|FG004|Season 1|Other|0|||
163033531|NCT03959488|588826624|FG000|Season 1|Withdrawal by parent/guardian|43|||
163033532|NCT03959488|588826625|FG001|Season 1|Withdrawal by parent/guardian|28|||
163033533|NCT03959488|588826626|FG002|Season 1|Withdrawal by parent/guardian|0|||
163033534|NCT03959488|588826627|FG003|Season 1|Withdrawal by parent/guardian|0|||
163033535|NCT03959488|588826628|FG004|Season 1|Withdrawal by parent/guardian|0|||
163033536|NCT03959488|588826624|FG000|Season 1|Due to COVID-19 pandemic|2|||
163033537|NCT03959488|588826625|FG001|Season 1|Due to COVID-19 pandemic|3|||
163033538|NCT03959488|588826626|FG002|Season 1|Due to COVID-19 pandemic|0|||
163033539|NCT03959488|588826627|FG003|Season 1|Due to COVID-19 pandemic|0|||
163033540|NCT03959488|588826628|FG004|Season 1|Due to COVID-19 pandemic|0|||
163033541|NCT03959488|588826624|FG000|Season 1|Lost to Follow-up|17|||
163033542|NCT03959488|588826625|FG001|Season 1|Lost to Follow-up|7|||
163033543|NCT03959488|588826626|FG002|Season 1|Lost to Follow-up|0|||
163033544|NCT03959488|588826627|FG003|Season 1|Lost to Follow-up|0|||
163085573|NCT05030766|589022324|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
163220051|NCT03965962|589521391|FG002|Overall Study|Lost to Follow-up|0|||
163033545|NCT03959488|588826628|FG004|Season 1|Lost to Follow-up|0|||
163033546|NCT03959488|588826624|FG000|Season 1|Death|5|||
163033547|NCT03959488|588826625|FG001|Season 1|Death|1|||
163033548|NCT03959488|588826626|FG002|Season 1|Death|0|||
163033549|NCT03959488|588826627|FG003|Season 1|Death|0|||
163033550|NCT03959488|588826628|FG004|Season 1|Death|0|||
163033551|NCT03959488|588826624|FG000|Season 2|Other|0|||
163033552|NCT03959488|588826625|FG001|Season 2|Other|0|||
163033553|NCT03959488|588826626|FG002|Season 2|Other|2|||
163033554|NCT03959488|588826627|FG003|Season 2|Other|0|||
163033555|NCT03959488|588826628|FG004|Season 2|Other|0|||
163033556|NCT03959488|588826624|FG000|Season 2|Withdrawal by parent/guardian|0|||
163033557|NCT03959488|588826625|FG001|Season 2|Withdrawal by parent/guardian|0|||
163033558|NCT03959488|588826626|FG002|Season 2|Withdrawal by parent/guardian|3|||
163033559|NCT03959488|588826627|FG003|Season 2|Withdrawal by parent/guardian|1|||
163033560|NCT03959488|588826628|FG004|Season 2|Withdrawal by parent/guardian|1|||
163033561|NCT03959488|588826624|FG000|Season 2|Lost to Follow-up|0|||
163033562|NCT03959488|588826625|FG001|Season 2|Lost to Follow-up|0|||
163033563|NCT03959488|588826626|FG002|Season 2|Lost to Follow-up|1|||
163033564|NCT03959488|588826627|FG003|Season 2|Lost to Follow-up|0|||
163033565|NCT03959488|588826628|FG004|Season 2|Lost to Follow-up|1|||
163033566|NCT03341936|588826629|FG000|Overall Study|Ineligible|1|||
163033567|NCT03341936|588826629|FG000|Overall Study|Disease Progression|2|||
163033568|NCT03341936|588826629|FG000|Overall Study|Withdrew Consent|4|||
163033569|NCT03341936|588826629|FG000|Overall Study|Non-Compliance|1|||
163033570|NCT03341936|588826629|FG000|Overall Study|Physician Decision|1|||
163033571|NCT03341936|588826629|FG000|Overall Study|Withdrawal by Subject|1|||
163033572|NCT03341936|588826629|FG000|Overall Study|Other|1|||
163033573|NCT02542293|588826630|FG000|Overall Study|Death|367|||
163033574|NCT02542293|588826631|FG001|Overall Study|Death|377|||
163033575|NCT02542293|588826630|FG000|Overall Study|Withdrawal by Subject|8|||
163033576|NCT02542293|588826631|FG001|Overall Study|Withdrawal by Subject|19|||
163033577|NCT04529850|588826632|FG000|Overall Study|Death|2|||
163033578|NCT04529850|588826632|FG000|Overall Study|Physician Decision|1|||
163033579|NCT04529850|588826632|FG000|Overall Study|Withdrawal by Subject|2|||
163033580|NCT00593606|588826635|FG000|Overall Study|Adverse Event|13|||
163033581|NCT00593606|588826635|FG000|Overall Study|Withdrawal by Subject|1|||
163033582|NCT00593606|588826635|FG000|Overall Study|Protocol Violation|3|||
163033583|NCT00593606|588826635|FG000|Overall Study|Lost to Follow-up|2|||
163033584|NCT00593606|588826635|FG000|Overall Study|Run-In Failure|5|||
163033585|NCT00593606|588826635|FG000|Overall Study|Screen Failure|3|||
163033586|NCT00869557|588826638|FG000|Randomized Phase|Lost to Follow-up|2|||
163033587|NCT00869557|588826639|FG001|Randomized Phase|Lost to Follow-up|1|||
163033588|NCT00869557|588826638|FG000|Randomized Phase|Investigator's Discretion|1|||
163033589|NCT00869557|588826639|FG001|Randomized Phase|Investigator's Discretion|0|||
163033590|NCT00869557|588826638|FG000|Randomized Phase|Withdrew Consent|0|||
163033591|NCT00869557|588826639|FG001|Randomized Phase|Withdrew Consent|1|||
163033592|NCT00869557|588826638|FG000|Extension Phase|Adverse Event|2|||
163033593|NCT00869557|588826639|FG001|Extension Phase|Adverse Event|2|||
163033594|NCT00869557|588826638|FG000|Extension Phase|Lack of Efficacy|1|||
163033595|NCT00869557|588826639|FG001|Extension Phase|Lack of Efficacy|0|||
163033596|NCT00869557|588826638|FG000|Extension Phase|Lost to Follow-up|3|||
163033597|NCT00869557|588826639|FG001|Extension Phase|Lost to Follow-up|1|||
163033598|NCT00869557|588826638|FG000|Extension Phase|Investigator's Discretion|2|||
163033599|NCT00869557|588826639|FG001|Extension Phase|Investigator's Discretion|0|||
163033600|NCT00869557|588826638|FG000|Extension Phase|Withdrew Consent|2|||
163033601|NCT00869557|588826639|FG001|Extension Phase|Withdrew Consent|0|||
163033602|NCT01472939|588826640|FG000|Overall Study|Adverse Event|3|||
163033603|NCT01472939|588826641|FG001|Overall Study|Adverse Event|7|||
163033604|NCT01472939|588826642|FG002|Overall Study|Adverse Event|7|||
163033605|NCT01472939|588826643|FG003|Overall Study|Adverse Event|14|||
163033606|NCT01472939|588826640|FG000|Overall Study|Lack of Efficacy|1|||
163033607|NCT01472939|588826641|FG001|Overall Study|Lack of Efficacy|0|||
163033608|NCT01472939|588826642|FG002|Overall Study|Lack of Efficacy|0|||
163033609|NCT01472939|588826643|FG003|Overall Study|Lack of Efficacy|1|||
163033610|NCT01472939|588826640|FG000|Overall Study|Lost to Follow-up|3|||
163033611|NCT01472939|588826641|FG001|Overall Study|Lost to Follow-up|0|||
163033612|NCT01472939|588826642|FG002|Overall Study|Lost to Follow-up|2|||
163033613|NCT01472939|588826643|FG003|Overall Study|Lost to Follow-up|0|||
163033614|NCT01472939|588826640|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
163033615|NCT01472939|588826641|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
163033616|NCT01472939|588826642|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
163033617|NCT01472939|588826643|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
163033618|NCT01472939|588826640|FG000|Overall Study|Prohibited Medication|0|||
163033619|NCT01472939|588826641|FG001|Overall Study|Prohibited Medication|1|||
163033620|NCT01472939|588826642|FG002|Overall Study|Prohibited Medication|0|||
163033621|NCT01472939|588826643|FG003|Overall Study|Prohibited Medication|0|||
163033622|NCT01472939|588826640|FG000|Overall Study|Withdrawal By PI|1|||
163033623|NCT01472939|588826641|FG001|Overall Study|Withdrawal By PI|0|||
163033624|NCT01472939|588826642|FG002|Overall Study|Withdrawal By PI|0|||
163033625|NCT01472939|588826643|FG003|Overall Study|Withdrawal By PI|0|||
163033626|NCT01472939|588826640|FG000|Overall Study|Protocol Violation|3|||
163033627|NCT01472939|588826641|FG001|Overall Study|Protocol Violation|3|||
163033628|NCT01472939|588826642|FG002|Overall Study|Protocol Violation|0|||
163033629|NCT01472939|588826643|FG003|Overall Study|Protocol Violation|1|||
163033630|NCT01472939|588826640|FG000|Overall Study|Withdrawal by Subject|9|||
163033631|NCT01472939|588826641|FG001|Overall Study|Withdrawal by Subject|3|||
163033632|NCT01472939|588826642|FG002|Overall Study|Withdrawal by Subject|1|||
163033633|NCT01472939|588826643|FG003|Overall Study|Withdrawal by Subject|4|||
163033634|NCT00114738|588826644|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
163033635|NCT00114738|588826645|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
163033636|NCT00114738|588826646|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
163033637|NCT00114738|588826644|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
163033638|NCT00114738|588826645|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
163033639|NCT00114738|588826646|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
163033640|NCT00114738|588826644|FG000|Screening for Randomization|Neuropathy|17|||
163033641|NCT00114738|588826645|FG001|Screening for Randomization|Neuropathy|0|||
163033642|NCT00114738|588826646|FG002|Screening for Randomization|Neuropathy|0|||
163033643|NCT00114738|588826644|FG000|Screening for Randomization|Progressive disease|2|||
163033644|NCT00114738|588826645|FG001|Screening for Randomization|Progressive disease|0|||
163033645|NCT00114738|588826646|FG002|Screening for Randomization|Progressive disease|0|||
163033646|NCT00114738|588826644|FG000|Screening for Randomization|CNS Hemorrhage|1|||
163033647|NCT00114738|588826645|FG001|Screening for Randomization|CNS Hemorrhage|0|||
163033648|NCT00114738|588826646|FG002|Screening for Randomization|CNS Hemorrhage|0|||
163033649|NCT00114738|588826644|FG000|Screening for Randomization|Other|1|||
163033650|NCT00114738|588826645|FG001|Screening for Randomization|Other|0|||
163033651|NCT00114738|588826646|FG002|Screening for Randomization|Other|0|||
163033652|NCT05940077|588826647|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
163033653|NCT01492101|588826648|FG000|Overall Study|Death|323|||
163033654|NCT01492101|588826649|FG001|Overall Study|Death|322|||
163033655|NCT01492101|588826648|FG000|Overall Study|Withdrawal by Subject|14|||
163033656|NCT01492101|588826649|FG001|Overall Study|Withdrawal by Subject|18|||
163033657|NCT01492101|588826648|FG000|Overall Study|Lost to Follow-up|0|||
163033658|NCT01492101|588826649|FG001|Overall Study|Lost to Follow-up|2|||
163033659|NCT01004432|588826650|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
163033660|NCT01004432|588826651|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
163033661|NCT01004432|588826652|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
163033662|NCT01004432|588826653|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
163033663|NCT01004432|588826654|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
163033664|NCT01004432|588826650|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
163333699|NCT04938453|589933058|FG000|Washout Period 1|Adverse Event|1|||
163333700|NCT04938453|589933059|FG001|Washout Period 1|Adverse Event|0|||
163333701|NCT04938453|589933058|FG000|Washout Period 1|Physician Decision|0|||
163333702|NCT04938453|589933059|FG001|Washout Period 1|Physician Decision|1|||
163333703|NCT03292406|589933061|FG000|Overall Study|Progressive Disease|6|||
163333704|NCT03292406|589933062|FG001|Overall Study|Progressive Disease|3|||
163333705|NCT03292406|589933063|FG002|Overall Study|Progressive Disease|4|||
163333706|NCT03292406|589933061|FG000|Overall Study|Adverse Event|7|||
163333707|NCT03292406|589933062|FG001|Overall Study|Adverse Event|1|||
163333708|NCT03292406|589933063|FG002|Overall Study|Adverse Event|4|||
163333709|NCT03292406|589933061|FG000|Overall Study|Withdrawal by Subject|0|||
163333710|NCT03292406|589933062|FG001|Overall Study|Withdrawal by Subject|7|||
163333711|NCT03292406|589933063|FG002|Overall Study|Withdrawal by Subject|2|||
163333712|NCT03292406|589933061|FG000|Overall Study|Protocol Violation|0|||
163333713|NCT03292406|589933062|FG001|Overall Study|Protocol Violation|1|||
163333714|NCT03292406|589933063|FG002|Overall Study|Protocol Violation|1|||
163333715|NCT03292406|589933061|FG000|Overall Study|Other|0|||
163333716|NCT03292406|589933062|FG001|Overall Study|Other|1|||
163333717|NCT03292406|589933063|FG002|Overall Study|Other|2|||
163333718|NCT00308308|589933064|FG000|Overall Study|Adverse Event|17|||
163033665|NCT01004432|588826651|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
163033666|NCT01004432|588826652|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
163033667|NCT01004432|588826653|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
163033668|NCT01004432|588826654|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
163033669|NCT01004432|588826650|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
163033670|NCT01004432|588826651|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
163333719|NCT00308308|589933065|FG001|Overall Study|Adverse Event|2|||
163333720|NCT00308308|589933064|FG000|Overall Study|Lost to Follow-up|5|||
163333721|NCT00308308|589933065|FG001|Overall Study|Lost to Follow-up|5|||
163333722|NCT00308308|589933064|FG000|Overall Study|Physician Decision|15|||
163333723|NCT00308308|589933065|FG001|Overall Study|Physician Decision|7|||
163333724|NCT00308308|589933064|FG000|Overall Study|Protocol Violation|3|||
163333725|NCT00308308|589933065|FG001|Overall Study|Protocol Violation|14|||
163333726|NCT00308308|589933064|FG000|Overall Study|Withdrawal by Subject|47|||
163033671|NCT01004432|588826652|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
163085574|NCT05030766|589022325|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
163033672|NCT01004432|588826653|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
163333727|NCT00308308|589933065|FG001|Overall Study|Withdrawal by Subject|19|||
163333728|NCT00308308|589933064|FG000|Overall Study|Various|7|||
163333729|NCT00308308|589933065|FG001|Overall Study|Various|5|||
163333730|NCT00308308|589933064|FG000|Overall Study|Randomized but not dosed|8|||
163333731|NCT00308308|589933065|FG001|Overall Study|Randomized but not dosed|16|||
163333732|NCT00308308|589933064|FG000|Overall Study|Other|1|||
163333733|NCT00308308|589933065|FG001|Overall Study|Other|0|||
163333734|NCT01852045|589933068|FG000|Overall Study|Adverse Event|1|||
163333735|NCT01852045|589933069|FG001|Overall Study|Adverse Event|0|||
163333736|NCT01852045|589933070|FG002|Overall Study|Adverse Event|0|||
163333737|NCT01852045|589933068|FG000|Overall Study|Lack of Efficacy|3|||
163333738|NCT01852045|589933069|FG001|Overall Study|Lack of Efficacy|0|||
163333739|NCT01852045|589933070|FG002|Overall Study|Lack of Efficacy|0|||
163333740|NCT01852045|589933068|FG000|Overall Study|Lost to Follow-up|0|||
163333741|NCT01852045|589933069|FG001|Overall Study|Lost to Follow-up|1|||
163333742|NCT01852045|589933070|FG002|Overall Study|Lost to Follow-up|1|||
163333743|NCT01852045|589933068|FG000|Overall Study|Withdrawal by Subject|1|||
163333744|NCT01852045|589933069|FG001|Overall Study|Withdrawal by Subject|0|||
163333745|NCT01852045|589933070|FG002|Overall Study|Withdrawal by Subject|1|||
163333746|NCT01852045|589933068|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163333747|NCT01852045|589933069|FG001|Overall Study|Other Miscellaneous Reasons|3|||
163333748|NCT01852045|589933070|FG002|Overall Study|Other Miscellaneous Reasons|2|||
163333749|NCT01951703|589933071|FG000|First Intervention|Withdrawal by Subject|1|||
163333750|NCT01951703|589933072|FG001|First Intervention|Withdrawal by Subject|0|||
163333751|NCT01951703|589933071|FG000|First Intervention|Subject was not compliant|1|||
163333752|NCT01951703|589933072|FG001|First Intervention|Subject was not compliant|1|||
163333753|NCT01951703|589933071|FG000|First Intervention|Physician Decision|1|||
163333754|NCT01951703|589933072|FG001|First Intervention|Physician Decision|0|||
163333755|NCT01951703|589933071|FG000|Second Intervention|Protocol Violation|0|||
163333756|NCT01951703|589933072|FG001|Second Intervention|Protocol Violation|1|||
163333757|NCT01951703|589933071|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
163333758|NCT01951703|589933072|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
163333759|NCT02827201|589933073|FG000|Overall Study|Death|1|||
163333760|NCT02827201|589933074|FG001|Overall Study|Death|2|||
163333761|NCT02827201|589933073|FG000|Overall Study|Patients not treated|1|||
163333762|NCT02827201|589933074|FG001|Overall Study|Patients not treated|1|||
163333763|NCT00240994|589933075|FG000|Overall Study|Lost to Follow-up|1|||
163333764|NCT00240994|589933075|FG000|Overall Study|Protocol Violation|1|||
163333765|NCT00240994|589933075|FG000|Overall Study|Graft failure|1|||
163333766|NCT02630186|589933077|FG000|Overall Study|Withdrawal by Subject|1|||
163333767|NCT00439218|589933078|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
163333768|NCT03142932|589933079|FG000|Overall Study|Lost to Follow-up|2|||
163333769|NCT03142932|589933080|FG001|Overall Study|Lost to Follow-up|11|||
163333770|NCT02128269|589933081|FG000|Treatment Period|Adverse Event|1|||
163333771|NCT02128269|589933081|FG000|Treatment Period|Physician Decision|1|||
163333772|NCT01021748|589933082|FG000|Overall Study|Adverse Event|2|||
163333773|NCT01021748|589933083|FG001|Overall Study|Adverse Event|1|||
163333774|NCT01021748|589933084|FG002|Overall Study|Adverse Event|2|||
163333775|NCT01021748|589933085|FG003|Overall Study|Adverse Event|0|||
163333776|NCT01021748|589933086|FG004|Overall Study|Adverse Event|2|||
163333777|NCT01021748|589933087|FG005|Overall Study|Adverse Event|0|||
163333778|NCT01021748|589933088|FG006|Overall Study|Adverse Event|1|||
163333779|NCT01021748|589933089|FG007|Overall Study|Adverse Event|0|||
163333780|NCT01021748|589933090|FG008|Overall Study|Adverse Event|7|||
163333781|NCT01021748|589933082|FG000|Overall Study|Physician Decision|1|||
163333782|NCT01021748|589933083|FG001|Overall Study|Physician Decision|0|||
163333783|NCT01021748|589933084|FG002|Overall Study|Physician Decision|1|||
163333784|NCT01021748|589933085|FG003|Overall Study|Physician Decision|1|||
163333785|NCT01021748|589933086|FG004|Overall Study|Physician Decision|0|||
163333786|NCT01021748|589933087|FG005|Overall Study|Physician Decision|0|||
163333787|NCT01021748|589933088|FG006|Overall Study|Physician Decision|1|||
163333788|NCT01021748|589933089|FG007|Overall Study|Physician Decision|1|||
163333789|NCT01021748|589933090|FG008|Overall Study|Physician Decision|2|||
163033673|NCT01004432|588826654|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
163033674|NCT01004432|588826650|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
163033675|NCT01004432|588826651|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
163033676|NCT01004432|588826652|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
163333790|NCT01021748|589933082|FG000|Overall Study|Progressive Disease|3|||
163333791|NCT01021748|589933083|FG001|Overall Study|Progressive Disease|3|||
163333792|NCT01021748|589933084|FG002|Overall Study|Progressive Disease|4|||
163333793|NCT01021748|589933085|FG003|Overall Study|Progressive Disease|6|||
163333794|NCT01021748|589933086|FG004|Overall Study|Progressive Disease|7|||
163333795|NCT01021748|589933087|FG005|Overall Study|Progressive Disease|3|||
163333796|NCT01021748|589933088|FG006|Overall Study|Progressive Disease|0|||
163033677|NCT01004432|588826653|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
163333797|NCT01021748|589933089|FG007|Overall Study|Progressive Disease|5|||
163333798|NCT01021748|589933090|FG008|Overall Study|Progressive Disease|6|||
163333799|NCT01021748|589933082|FG000|Overall Study|Withdrawal by Subject|0|||
163333800|NCT01021748|589933083|FG001|Overall Study|Withdrawal by Subject|0|||
163333801|NCT01021748|589933084|FG002|Overall Study|Withdrawal by Subject|0|||
163033678|NCT01004432|588826654|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
163033679|NCT01004432|588826650|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
163033680|NCT01004432|588826651|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
163333802|NCT01021748|589933085|FG003|Overall Study|Withdrawal by Subject|0|||
163333803|NCT01021748|589933086|FG004|Overall Study|Withdrawal by Subject|0|||
163333804|NCT01021748|589933087|FG005|Overall Study|Withdrawal by Subject|0|||
163333805|NCT01021748|589933088|FG006|Overall Study|Withdrawal by Subject|1|||
163333806|NCT01021748|589933089|FG007|Overall Study|Withdrawal by Subject|0|||
163333807|NCT01021748|589933090|FG008|Overall Study|Withdrawal by Subject|1|||
163333808|NCT01021748|589933082|FG000|Overall Study|Not Treated|0|||
163333809|NCT01021748|589933083|FG001|Overall Study|Not Treated|1|||
163333810|NCT01021748|589933084|FG002|Overall Study|Not Treated|0|||
163333811|NCT01021748|589933085|FG003|Overall Study|Not Treated|0|||
163333812|NCT01021748|589933086|FG004|Overall Study|Not Treated|0|||
163333813|NCT01021748|589933087|FG005|Overall Study|Not Treated|0|||
163333814|NCT01021748|589933088|FG006|Overall Study|Not Treated|0|||
163333815|NCT01021748|589933089|FG007|Overall Study|Not Treated|0|||
163333816|NCT01021748|589933090|FG008|Overall Study|Not Treated|0|||
163333817|NCT01640288|589933093|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
163333818|NCT01640288|589933094|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
163333819|NCT01640288|589933093|FG000|Overall Study|Screen Failure|20|||
163333820|NCT01640288|589933094|FG001|Overall Study|Screen Failure|18|||
163333821|NCT01640288|589933093|FG000|Overall Study|Withdrawn by PI|5|||
163333822|NCT01640288|589933094|FG001|Overall Study|Withdrawn by PI|0|||
163333823|NCT01640288|589933093|FG000|Overall Study|Withdrawal by Subject|1|||
163333824|NCT01640288|589933094|FG001|Overall Study|Withdrawal by Subject|0|||
163333825|NCT01485887|589933097|FG000|Overall Study|Withdrawal by Subject|2|||
163333826|NCT01485887|589933097|FG000|Overall Study|Adverse Event|8|||
163333827|NCT01485887|589933097|FG000|Overall Study|Deterioration of primary disease|1|||
163333828|NCT01485887|589933097|FG000|Overall Study|Primary disease markedly improved|1|||
163333829|NCT02234141|589933098|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
163333830|NCT02234141|589933099|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
163333831|NCT02234141|589933100|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
163333832|NCT02234141|589933101|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
163333833|NCT02234141|589933102|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
163333834|NCT02234141|589933103|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
163333835|NCT02234141|589933104|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
163333836|NCT02234141|589933098|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
163333837|NCT02234141|589933099|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
163333838|NCT02234141|589933100|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
163333839|NCT02234141|589933101|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
163333840|NCT02234141|589933102|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
163333841|NCT02234141|589933103|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
163333842|NCT02234141|589933104|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
163333843|NCT02234141|589933098|FG000|Treatment Period (24 Weeks)|Death|1|||
163333844|NCT02234141|589933099|FG001|Treatment Period (24 Weeks)|Death|2|||
163333845|NCT02234141|589933100|FG002|Treatment Period (24 Weeks)|Death|0|||
163333846|NCT02234141|589933101|FG003|Treatment Period (24 Weeks)|Death|1|||
163333847|NCT02234141|589933102|FG004|Treatment Period (24 Weeks)|Death|0|||
163333848|NCT02234141|589933103|FG005|Treatment Period (24 Weeks)|Death|0|||
163333849|NCT02234141|589933104|FG006|Treatment Period (24 Weeks)|Death|0|||
163333850|NCT02234141|589933098|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
163333851|NCT02234141|589933099|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
163333852|NCT02234141|589933100|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
163333853|NCT02234141|589933101|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
163333854|NCT02234141|589933102|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
163333855|NCT02234141|589933103|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
163333856|NCT02234141|589933104|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
163333857|NCT02234141|589933098|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
163333858|NCT02234141|589933099|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
163333859|NCT02234141|589933100|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
163333860|NCT02234141|589933101|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
163333861|NCT02234141|589933102|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
163333862|NCT02234141|589933103|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
163333863|NCT02234141|589933104|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
163333864|NCT02234141|589933098|FG000|Long-Term Treatment Period|Death|0|||
163333865|NCT02234141|589933099|FG001|Long-Term Treatment Period|Death|0|||
163333866|NCT02234141|589933100|FG002|Long-Term Treatment Period|Death|0|||
163033681|NCT01004432|588826652|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
163333867|NCT02234141|589933101|FG003|Long-Term Treatment Period|Death|0|||
163333868|NCT02234141|589933102|FG004|Long-Term Treatment Period|Death|0|||
163333869|NCT02234141|589933103|FG005|Long-Term Treatment Period|Death|1|||
163333870|NCT02234141|589933104|FG006|Long-Term Treatment Period|Death|0|||
163333871|NCT02234141|589933098|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
163033682|NCT01004432|588826653|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
163033683|NCT01004432|588826654|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
163033684|NCT01004432|588826650|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
163033685|NCT01004432|588826651|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
163033686|NCT01004432|588826652|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
163033687|NCT01004432|588826653|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
163033688|NCT01004432|588826654|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
163033689|NCT01004432|588826650|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
163033690|NCT01004432|588826651|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
163033691|NCT01004432|588826652|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
163033692|NCT01004432|588826653|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
163033693|NCT01004432|588826654|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
163033694|NCT01004432|588826650|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
163033695|NCT01004432|588826651|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
163033696|NCT01004432|588826652|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
163033697|NCT01004432|588826653|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
163033698|NCT01004432|588826654|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
163033699|NCT01004432|588826650|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
163033700|NCT01004432|588826651|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
163033701|NCT01004432|588826652|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
163033702|NCT01004432|588826653|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
163033703|NCT01004432|588826654|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
163033704|NCT01004432|588826650|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
163033705|NCT01004432|588826651|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
163033706|NCT01004432|588826652|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
163033707|NCT01004432|588826653|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
163033708|NCT01004432|588826654|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
163033709|NCT01004432|588826650|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
163033710|NCT01004432|588826651|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
163033711|NCT01004432|588826652|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
163033712|NCT01004432|588826653|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
163033713|NCT01004432|588826654|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
163033714|NCT01004432|588826650|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
163033715|NCT01004432|588826651|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
163033716|NCT01004432|588826652|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
163033717|NCT01004432|588826653|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
163033718|NCT01004432|588826654|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
163033719|NCT01004432|588826650|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
163033720|NCT01004432|588826651|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
163033721|NCT01004432|588826652|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
163033722|NCT01004432|588826653|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
163033723|NCT01004432|588826654|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
163033724|NCT01004432|588826650|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
163033725|NCT01004432|588826651|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
163033726|NCT01004432|588826652|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
163033727|NCT01004432|588826653|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
163033728|NCT01004432|588826654|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
163033729|NCT01004432|588826650|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
163033730|NCT01004432|588826651|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
163033731|NCT01004432|588826652|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
163033732|NCT01004432|588826653|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
163033733|NCT01004432|588826654|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
163033734|NCT01149421|588826656|FG000|Overall Study|Adverse Event|22|||
163333872|NCT02234141|589933099|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
163033735|NCT01149421|588826657|FG001|Overall Study|Adverse Event|6|||
163033736|NCT01149421|588826658|FG002|Overall Study|Adverse Event|11|||
163033737|NCT01149421|588826656|FG000|Overall Study|Withdrawal by Subject|20|||
163033738|NCT01149421|588826657|FG001|Overall Study|Withdrawal by Subject|12|||
163033739|NCT01149421|588826658|FG002|Overall Study|Withdrawal by Subject|13|||
163033740|NCT01149421|588826656|FG000|Overall Study|Sponsor Decision|0|||
163033741|NCT01149421|588826657|FG001|Overall Study|Sponsor Decision|1|||
163033742|NCT01149421|588826658|FG002|Overall Study|Sponsor Decision|1|||
163033743|NCT01149421|588826656|FG000|Overall Study|Lost to Follow-up|2|||
163033744|NCT01149421|588826657|FG001|Overall Study|Lost to Follow-up|4|||
163033745|NCT01149421|588826658|FG002|Overall Study|Lost to Follow-up|5|||
163333873|NCT02234141|589933100|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
163333874|NCT02234141|589933101|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
163333875|NCT02234141|589933102|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
163333876|NCT02234141|589933103|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
163333877|NCT02234141|589933104|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
163333878|NCT02234141|589933098|FG000|Long-Term Treatment Period|Adverse Event|4|||
163333879|NCT02234141|589933099|FG001|Long-Term Treatment Period|Adverse Event|0|||
163033746|NCT01149421|588826656|FG000|Overall Study|Physician Decision|5|||
163033747|NCT01149421|588826657|FG001|Overall Study|Physician Decision|3|||
163033748|NCT01149421|588826658|FG002|Overall Study|Physician Decision|6|||
163033749|NCT01149421|588826656|FG000|Overall Study|Entry Criteria Not Met|1|||
163033750|NCT01149421|588826657|FG001|Overall Study|Entry Criteria Not Met|1|||
163033751|NCT01149421|588826658|FG002|Overall Study|Entry Criteria Not Met|2|||
163033752|NCT01149421|588826656|FG000|Overall Study|Protocol Violation|2|||
163033753|NCT01149421|588826657|FG001|Overall Study|Protocol Violation|2|||
163033754|NCT01149421|588826658|FG002|Overall Study|Protocol Violation|6|||
163033755|NCT03738800|588826661|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
163033756|NCT03738800|588826662|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
163033757|NCT03738800|588826663|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
163033758|NCT03738800|588826661|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
163033759|NCT03738800|588826662|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
163033760|NCT03738800|588826663|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
163033761|NCT03738800|588826661|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
163033762|NCT03738800|588826662|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
163033763|NCT03738800|588826663|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
163033764|NCT02223819|588826666|FG000|Overall Study|Lost to Follow-up|2|||
163033765|NCT01917344|588826668|FG000|Overall Study|Withdrawal by Subject|1|||
163033766|NCT03435224|588826669|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
163033767|NCT00367484|588826670|FG000|Overall Study|Adverse Event|7|||
163033768|NCT00367484|588826670|FG000|Overall Study|Withdrew informed consent|5|||
163033769|NCT00367484|588826670|FG000|Overall Study|Travel to USA|1|||
163033770|NCT00367484|588826670|FG000|Overall Study|Lost to Follow-up|1|||
163033771|NCT00367484|588826670|FG000|Overall Study|Protocol Violation|1|||
163033772|NCT00367484|588826670|FG000|Overall Study|The choice of the patient|1|||
163033773|NCT00367484|588826670|FG000|Overall Study|Lack of Efficacy|1|||
163033774|NCT01777295|588826671|FG000|Overall Study|Withdrawal by Subject|2|||
163033775|NCT01777295|588826672|FG001|Overall Study|Withdrawal by Subject|2|||
163033776|NCT01777295|588826671|FG000|Overall Study|Pregnancy|0|||
163033777|NCT01777295|588826672|FG001|Overall Study|Pregnancy|1|||
163033778|NCT01777295|588826671|FG000|Overall Study|Personal problem|1|||
163033779|NCT01777295|588826672|FG001|Overall Study|Personal problem|0|||
163033780|NCT01777295|588826671|FG000|Overall Study|Investigator call for AEs check|1|||
163033781|NCT01777295|588826672|FG001|Overall Study|Investigator call for AEs check|0|||
163033782|NCT00412217|588826673|FG000|Overall Study|Insufficient Data Available|8|||
163033783|NCT00412217|588826674|FG001|Overall Study|Insufficient Data Available|3|||
163033784|NCT00412217|588826673|FG000|Overall Study|Death|5|||
163033785|NCT00412217|588826674|FG001|Overall Study|Death|4|||
163033786|NCT00412217|588826673|FG000|Overall Study|Disease Progression|2|||
163033787|NCT00412217|588826674|FG001|Overall Study|Disease Progression|3|||
163033788|NCT00412217|588826673|FG000|Overall Study|Investigator Decision|1|||
163033789|NCT00412217|588826674|FG001|Overall Study|Investigator Decision|0|||
163033790|NCT00412217|588826673|FG000|Overall Study|Withdrawal by Subject|2|||
163033791|NCT00412217|588826674|FG001|Overall Study|Withdrawal by Subject|0|||
163033792|NCT00412217|588826673|FG000|Overall Study|Lost to Follow-up|1|||
163033793|NCT00412217|588826674|FG001|Overall Study|Lost to Follow-up|4|||
163033794|NCT00412217|588826673|FG000|Overall Study|Study Terminated by Sponsor|26|||
163033795|NCT00412217|588826674|FG001|Overall Study|Study Terminated by Sponsor|33|||
163033796|NCT00412217|588826673|FG000|Overall Study|Other|1|||
163033797|NCT00412217|588826674|FG001|Overall Study|Other|1|||
163033798|NCT02609724|588826675|FG000|Overall Study|Death|2|||
163033799|NCT02609724|588826676|FG001|Overall Study|Death|0|||
163033800|NCT02609724|588826677|FG002|Overall Study|Death|1|||
163033801|NCT02609724|588826675|FG000|Overall Study|Withdrawal by Subject|1|||
163033802|NCT02609724|588826676|FG001|Overall Study|Withdrawal by Subject|2|||
163033803|NCT02609724|588826677|FG002|Overall Study|Withdrawal by Subject|3|||
163033804|NCT02609724|588826675|FG000|Overall Study|Illness|2|||
163033805|NCT02609724|588826676|FG001|Overall Study|Illness|1|||
163033806|NCT02609724|588826677|FG002|Overall Study|Illness|0|||
163033807|NCT04007107|588826682|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
163033808|NCT04007107|588826683|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
163154806|NCT04123470|589281443|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
163333880|NCT02234141|589933100|FG002|Long-Term Treatment Period|Adverse Event|5|||
163333881|NCT02234141|589933101|FG003|Long-Term Treatment Period|Adverse Event|0|||
163033809|NCT04007107|588826684|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
163033810|NCT04007107|588826685|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
163033811|NCT00426660|588826691|FG000|Overall Study|Death|14|||
163033812|NCT00426660|588826691|FG000|Overall Study|Adverse Event|23|||
163033813|NCT00426660|588826691|FG000|Overall Study|Insufficient Clinical Response|22|||
163333882|NCT02234141|589933102|FG004|Long-Term Treatment Period|Adverse Event|1|||
163333883|NCT02234141|589933103|FG005|Long-Term Treatment Period|Adverse Event|1|||
163333884|NCT02234141|589933104|FG006|Long-Term Treatment Period|Adverse Event|1|||
163333885|NCT02234141|589933098|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
163333886|NCT02234141|589933099|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
163333887|NCT02234141|589933100|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
163333888|NCT02234141|589933101|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
163333889|NCT02234141|589933102|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
163333890|NCT02234141|589933103|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
163333891|NCT02234141|589933104|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
163333892|NCT02234141|589933098|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
163333893|NCT02234141|589933099|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
163333894|NCT02234141|589933100|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
163333895|NCT02234141|589933101|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
163333896|NCT02234141|589933102|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
163333897|NCT02234141|589933103|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
163333898|NCT02234141|589933104|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
163333899|NCT00895245|589933105|FG000|Overall Study|Lack of Efficacy|6|||
163333900|NCT01972776|589933106|FG000|Part 1|Withdrawal by Subject|0|||
163333901|NCT01972776|589933107|FG001|Part 1|Withdrawal by Subject|0|||
163333902|NCT01972776|589933108|FG002|Part 1|Withdrawal by Subject|1|||
163333903|NCT01972776|589933109|FG003|Part 1|Withdrawal by Subject|0|||
163333904|NCT01972776|589933110|FG004|Part 1|Withdrawal by Subject|0|||
163333905|NCT01972776|589933111|FG005|Part 1|Withdrawal by Subject|0|||
163333906|NCT01972776|589933106|FG000|Part 1|Adverse Event|0|||
163333907|NCT01972776|589933107|FG001|Part 1|Adverse Event|0|||
163333908|NCT01972776|589933108|FG002|Part 1|Adverse Event|1|||
163333909|NCT01972776|589933109|FG003|Part 1|Adverse Event|1|||
163333910|NCT01972776|589933110|FG004|Part 1|Adverse Event|0|||
163333911|NCT01972776|589933111|FG005|Part 1|Adverse Event|0|||
163333912|NCT01972776|589933106|FG000|Part 2|Adverse Event|0|||
163333913|NCT01972776|589933107|FG001|Part 2|Adverse Event|0|||
163333914|NCT01972776|589933108|FG002|Part 2|Adverse Event|0|||
163333915|NCT01972776|589933109|FG003|Part 2|Adverse Event|0|||
163333916|NCT01972776|589933110|FG004|Part 2|Adverse Event|3|||
163333917|NCT01972776|589933111|FG005|Part 2|Adverse Event|0|||
163333918|NCT01972776|589933106|FG000|Part 2|Administrative problems|0|||
163333919|NCT01972776|589933107|FG001|Part 2|Administrative problems|0|||
163333920|NCT01972776|589933108|FG002|Part 2|Administrative problems|0|||
163333921|NCT01972776|589933109|FG003|Part 2|Administrative problems|0|||
163333922|NCT01972776|589933110|FG004|Part 2|Administrative problems|10|||
163333923|NCT01972776|589933111|FG005|Part 2|Administrative problems|7|||
163333924|NCT01228734|589933112|FG000|Overall Study|Randomized, but not treated|0|||
163333925|NCT01228734|589933113|FG001|Overall Study|Randomized, but not treated|4|||
163333926|NCT02382640|589933117|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
163333927|NCT02382640|589933118|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
163333928|NCT02382640|589933119|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
163333929|NCT02382640|589933120|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
163333930|NCT01220999|589933121|FG000|Overall Study|Progressive disease|0|||
163333931|NCT01220999|589933122|FG001|Overall Study|Progressive disease|0|||
163333932|NCT01220999|589933123|FG002|Overall Study|Progressive disease|1|||
163333933|NCT01220999|589933124|FG003|Overall Study|Progressive disease|0|||
163333934|NCT01220999|589933125|FG004|Overall Study|Progressive disease|0|||
163033814|NCT00426660|588826691|FG000|Overall Study|Lost to Follow-up|15|||
163333935|NCT01560429|589933126|FG000|Overall Study|Protocol Violation|3|||
163333936|NCT01560429|589933127|FG001|Overall Study|Protocol Violation|6|||
163333937|NCT02449902|589933128|FG000|Overall Study|Adverse Event|0|||
163333938|NCT02449902|589933129|FG001|Overall Study|Adverse Event|1|||
163333939|NCT02449902|589933128|FG000|Overall Study|Withdrawal by Subject|0|||
163333940|NCT02449902|589933129|FG001|Overall Study|Withdrawal by Subject|1|||
163333941|NCT01365546|589933130|FG000|Overall Study|Withdrawal by Subject|1|||
163333942|NCT01365546|589933130|FG000|Overall Study|Screen failure|9|||
163333943|NCT01365546|589933130|FG000|Overall Study|Study termination|1|||
163333944|NCT03326856|589933131|FG000|Overall Study|Lost to Follow-up|1|||
163406733|NCT03016325|590198750|FG001|Treatment Period|Participant withdrew consent|1|||
163333945|NCT03326856|589933132|FG001|Overall Study|Lost to Follow-up|1|||
163333946|NCT03326856|589933133|FG002|Overall Study|Lost to Follow-up|0|||
163333947|NCT03326856|589933134|FG003|Overall Study|Lost to Follow-up|0|||
163406734|NCT03016325|590198751|FG002|Treatment Period|Participant withdrew consent|0|||
163033815|NCT00426660|588826691|FG000|Overall Study|Other|23|||
163033816|NCT00426660|588826691|FG000|Overall Study|Withdrawal by Subject|18|||
163033817|NCT00426660|588826691|FG000|Overall Study|Protocol Violation|1|||
163033818|NCT00426660|588826691|FG000|Overall Study|Enrolled Not Treated|15|||
163333948|NCT03326856|589933135|FG004|Overall Study|Lost to Follow-up|0|||
163333949|NCT03162614|589933136|FG000|Overall Study|Lost to Follow-up|2|||
163033819|NCT03114657|588826692|FG000|Overall Study|Adverse Event|9|||
163033820|NCT03114657|588826693|FG001|Overall Study|Adverse Event|6|||
163033821|NCT03114657|588826692|FG000|Overall Study|Death|4|||
163333950|NCT03162614|589933137|FG001|Overall Study|Lost to Follow-up|1|||
163333951|NCT03162614|589933138|FG002|Overall Study|Lost to Follow-up|1|||
163333952|NCT03162614|589933139|FG003|Overall Study|Lost to Follow-up|1|||
163333953|NCT03162614|589933140|FG004|Overall Study|Lost to Follow-up|2|||
163333954|NCT03162614|589933141|FG005|Overall Study|Lost to Follow-up|0|||
163333955|NCT03162614|589933136|FG000|Overall Study|Protocol Violation|0|||
163333956|NCT03162614|589933137|FG001|Overall Study|Protocol Violation|1|||
163333957|NCT03162614|589933138|FG002|Overall Study|Protocol Violation|0|||
163333958|NCT03162614|589933139|FG003|Overall Study|Protocol Violation|1|||
163333959|NCT03162614|589933140|FG004|Overall Study|Protocol Violation|0|||
163333960|NCT03162614|589933141|FG005|Overall Study|Protocol Violation|0|||
163333961|NCT03162614|589933136|FG000|Overall Study|Withdrawal by Subject|2|||
163333962|NCT03162614|589933137|FG001|Overall Study|Withdrawal by Subject|1|||
163333963|NCT03162614|589933138|FG002|Overall Study|Withdrawal by Subject|1|||
163333964|NCT03162614|589933139|FG003|Overall Study|Withdrawal by Subject|1|||
163333965|NCT03162614|589933140|FG004|Overall Study|Withdrawal by Subject|0|||
163333966|NCT03162614|589933141|FG005|Overall Study|Withdrawal by Subject|0|||
163333967|NCT03162614|589933136|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
163333968|NCT03162614|589933137|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
163333969|NCT03162614|589933138|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
163333970|NCT03162614|589933139|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
163333971|NCT03162614|589933140|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
163333972|NCT03162614|589933141|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
163333973|NCT03861234|589933142|FG000|Overall Study|Not treated|0|||
163333974|NCT03861234|589933143|FG001|Overall Study|Not treated|0|||
163333975|NCT03861234|589933144|FG002|Overall Study|Not treated|0|||
163333976|NCT03861234|589933145|FG003|Overall Study|Not treated|0|||
163333977|NCT03861234|589933146|FG004|Overall Study|Not treated|0|||
163333978|NCT03861234|589933147|FG005|Overall Study|Not treated|1|||
163333979|NCT03861234|589933148|FG006|Overall Study|Not treated|0|||
163333980|NCT03861234|589933149|FG007|Overall Study|Not treated|0|||
163333981|NCT03861234|589933142|FG000|Overall Study|Adverse Event|0|||
163333982|NCT03861234|589933143|FG001|Overall Study|Adverse Event|0|||
163333983|NCT03861234|589933144|FG002|Overall Study|Adverse Event|0|||
163333984|NCT03861234|589933145|FG003|Overall Study|Adverse Event|0|||
163333985|NCT03861234|589933146|FG004|Overall Study|Adverse Event|0|||
163333986|NCT03861234|589933147|FG005|Overall Study|Adverse Event|1|||
163333987|NCT03861234|589933148|FG006|Overall Study|Adverse Event|0|||
163333988|NCT03861234|589933149|FG007|Overall Study|Adverse Event|0|||
163333989|NCT03861234|589933142|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
163333990|NCT03861234|589933143|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
163333991|NCT03861234|589933144|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
163333992|NCT03861234|589933145|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
163033822|NCT03114657|588826693|FG001|Overall Study|Death|0|||
163033823|NCT03114657|588826692|FG000|Overall Study|Multiple Reasons|1|||
163033824|NCT03114657|588826693|FG001|Overall Study|Multiple Reasons|2|||
163033825|NCT03114657|588826692|FG000|Overall Study|Physician Decision|2|||
163033826|NCT03114657|588826693|FG001|Overall Study|Physician Decision|2|||
163033827|NCT03114657|588826692|FG000|Overall Study|Study Terminated By Sponsor|355|||
163033828|NCT03114657|588826693|FG001|Overall Study|Study Terminated By Sponsor|374|||
163033829|NCT03114657|588826692|FG000|Overall Study|Symptomatic Deterioration|0|||
163033830|NCT03114657|588826693|FG001|Overall Study|Symptomatic Deterioration|1|||
163033831|NCT03114657|588826692|FG000|Overall Study|Withdrawal by Subject|28|||
163033832|NCT03114657|588826693|FG001|Overall Study|Withdrawal by Subject|22|||
163033833|NCT04245202|588826694|FG000|Overall Study|Lack of Efficacy|10|||
163033834|NCT04245202|588826695|FG001|Overall Study|Lack of Efficacy|1|||
163033835|NCT00717275|588826696|FG000|Overall Study|Premature study termination.|3|||
163033836|NCT01522235|588826700|FG000|Overall Study|Physician Decision|1|||
163033837|NCT01522235|588826701|FG001|Overall Study|Physician Decision|1|||
163033838|NCT03769194|588826702|FG000|Overall Study|Withdrawal by Subject|0|||
163033839|NCT03769194|588826703|FG001|Overall Study|Withdrawal by Subject|7|||
163033840|NCT03769194|588826704|FG002|Overall Study|Withdrawal by Subject|4|||
163033841|NCT03769194|588826705|FG003|Overall Study|Withdrawal by Subject|1|||
163033842|NCT03769194|588826702|FG000|Overall Study|moved from study area|0|||
163033843|NCT03769194|588826703|FG001|Overall Study|moved from study area|2|||
163033844|NCT03769194|588826704|FG002|Overall Study|moved from study area|1|||
163333993|NCT03861234|589933146|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
163033845|NCT03769194|588826705|FG003|Overall Study|moved from study area|1|||
163033846|NCT03769194|588826702|FG000|Overall Study|Lost to Follow-up|3|||
163033847|NCT03769194|588826703|FG001|Overall Study|Lost to Follow-up|6|||
163033848|NCT03769194|588826704|FG002|Overall Study|Lost to Follow-up|3|||
163033849|NCT03769194|588826705|FG003|Overall Study|Lost to Follow-up|6|||
163033850|NCT03769194|588826702|FG000|Overall Study|other|1|||
163033851|NCT03769194|588826703|FG001|Overall Study|other|3|||
163033852|NCT03769194|588826704|FG002|Overall Study|other|0|||
163033853|NCT03769194|588826705|FG003|Overall Study|other|1|||
163033854|NCT00312572|588826707|FG000|Overall Study|Adverse Event|10|||
163033855|NCT00312572|588826708|FG001|Overall Study|Adverse Event|16|||
163033856|NCT00312572|588826707|FG000|Overall Study|Lost to Follow-up|1|||
163033857|NCT00312572|588826708|FG001|Overall Study|Lost to Follow-up|1|||
163033858|NCT00312572|588826707|FG000|Overall Study|Administrative|4|||
163033859|NCT00312572|588826708|FG001|Overall Study|Administrative|2|||
163033860|NCT00312572|588826707|FG000|Overall Study|Lack of Efficacy|1|||
163033861|NCT00312572|588826708|FG001|Overall Study|Lack of Efficacy|2|||
163033862|NCT05385224|588826709|FG000|Overall Study|Unable to swallow capsule|2|||
163033863|NCT05385224|588826709|FG000|Overall Study|Withdrawal by Subject|2|||
163033864|NCT05385224|588826709|FG000|Overall Study|Did not meet study criteria|1|||
163033865|NCT04521114|588826716|FG000|Overall Study|Lost to Follow-up|1|||
163033866|NCT04521114|588826717|FG001|Overall Study|Lost to Follow-up|2|||
163033867|NCT04521114|588826718|FG002|Overall Study|Lost to Follow-up|0|||
163033868|NCT04521114|588826716|FG000|Overall Study|Withdrawal by Subject|1|||
163033869|NCT04521114|588826717|FG001|Overall Study|Withdrawal by Subject|2|||
163033870|NCT04521114|588826718|FG002|Overall Study|Withdrawal by Subject|2|||
163033871|NCT04521114|588826716|FG000|Overall Study|Adverse Event|1|||
163033872|NCT04521114|588826717|FG001|Overall Study|Adverse Event|0|||
163033873|NCT04521114|588826718|FG002|Overall Study|Adverse Event|0|||
163333994|NCT03861234|589933147|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
163033874|NCT04521114|588826716|FG000|Overall Study|Sponsor Wish|1|||
163033875|NCT04521114|588826717|FG001|Overall Study|Sponsor Wish|0|||
163033876|NCT04521114|588826718|FG002|Overall Study|Sponsor Wish|0|||
163033877|NCT04521114|588826716|FG000|Overall Study|Withdrawal of Consent|2|||
163033878|NCT04521114|588826717|FG001|Overall Study|Withdrawal of Consent|2|||
163033879|NCT04521114|588826718|FG002|Overall Study|Withdrawal of Consent|0|||
163033880|NCT01362517|588826719|FG000|Overall Study|Protocol Violation|1|||
163033881|NCT01362517|588826719|FG000|Overall Study|Lost to Follow-up|1|||
163033882|NCT01133288|588826722|FG000|Eligibility Assessment|met exclusion criteria|5|||
163033883|NCT01133288|588826722|FG000|Intervention Allocation|study terminated|2|||
163033884|NCT02614131|588826723|FG000|Overall Study|Withdrawal by Subject|1|||
163033885|NCT02614131|588826724|FG001|Overall Study|Withdrawal by Subject|0|||
163033886|NCT02614131|588826725|FG002|Overall Study|Withdrawal by Subject|0|||
163033887|NCT02614131|588826726|FG003|Overall Study|Withdrawal by Subject|0|||
163033888|NCT02614131|588826727|FG004|Overall Study|Withdrawal by Subject|0|||
163033889|NCT02614131|588826728|FG005|Overall Study|Withdrawal by Subject|0|||
163033890|NCT02614131|588826729|FG006|Overall Study|Withdrawal by Subject|0|||
163033891|NCT02614131|588826723|FG000|Overall Study|Adverse Event|0|||
163033892|NCT02614131|588826724|FG001|Overall Study|Adverse Event|0|||
163033893|NCT02614131|588826725|FG002|Overall Study|Adverse Event|0|||
163033894|NCT02614131|588826726|FG003|Overall Study|Adverse Event|0|||
163033895|NCT02614131|588826727|FG004|Overall Study|Adverse Event|0|||
163033896|NCT02614131|588826728|FG005|Overall Study|Adverse Event|0|||
163033897|NCT02614131|588826729|FG006|Overall Study|Adverse Event|1|||
163033898|NCT03209518|588826730|FG000|Overall Study|Case Report Forms Uncollected|1|||
163033899|NCT03209518|588826730|FG000|Overall Study|Protocol Deviation|1|||
163033900|NCT00337779|588826731|FG000|Overall Study|Withdrawal by Subject|10|||
163033901|NCT00337779|588826732|FG001|Overall Study|Withdrawal by Subject|12|||
163033902|NCT00337779|588826731|FG000|Overall Study|Sponsor decision|1|||
163033903|NCT00337779|588826732|FG001|Overall Study|Sponsor decision|1|||
163033904|NCT00337779|588826731|FG000|Overall Study|Physician Decision|3|||
163033905|NCT00337779|588826732|FG001|Overall Study|Physician Decision|6|||
163033906|NCT00337779|588826731|FG000|Overall Study|Protocol Violation|1|||
163033907|NCT00337779|588826732|FG001|Overall Study|Protocol Violation|1|||
163033908|NCT00337779|588826731|FG000|Overall Study|Lost to Follow-up|6|||
163033909|NCT00337779|588826732|FG001|Overall Study|Lost to Follow-up|5|||
163154807|NCT04123470|589281442|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
163033910|NCT00337779|588826731|FG000|Overall Study|Adverse Event|28|||
163033911|NCT00337779|588826732|FG001|Overall Study|Adverse Event|51|||
163033912|NCT00337779|588826731|FG000|Overall Study|Pregnancy|3|||
163033913|NCT00337779|588826732|FG001|Overall Study|Pregnancy|2|||
163033914|NCT00337779|588826731|FG000|Overall Study|Death|0|||
163033915|NCT00337779|588826732|FG001|Overall Study|Death|1|||
163033916|NCT02028169|588826745|FG000|Overall Study|Lost to Follow-up|21|||
163033917|NCT02028169|588826745|FG000|Overall Study|Lack of Efficacy|2|||
163033918|NCT02028169|588826745|FG000|Overall Study|Withdrawal by Subject|2|||
163033919|NCT02028169|588826745|FG000|Overall Study|Adverse Event|1|||
163033920|NCT02028169|588826745|FG000|Overall Study|Cessation of Drug|1|||
163033921|NCT02028169|588826745|FG000|Overall Study|Concomitant Medication Usage|1|||
163033922|NCT02240069|588826750|FG000|Overall Study|Withdrawal by Subject|5|||
163033923|NCT02240069|588826751|FG001|Overall Study|Withdrawal by Subject|5|||
163033924|NCT02240069|588826752|FG002|Overall Study|Withdrawal by Subject|2|||
163033925|NCT01876979|588826753|FG000|Overall Study|Physician Decision|2|||
163033926|NCT01876979|588826754|FG001|Overall Study|Physician Decision|3|||
163033927|NCT01096589|588826755|FG000|Overall Study|Adverse Event|2|||
163033928|NCT01096589|588826756|FG001|Overall Study|Adverse Event|1|||
163033929|NCT01096589|588826757|FG002|Overall Study|Adverse Event|2|||
163333995|NCT03861234|589933148|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
163333996|NCT03861234|589933149|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
163333997|NCT03861234|589933142|FG000|Overall Study|As per sponsor decision|0|||
163333998|NCT03861234|589933143|FG001|Overall Study|As per sponsor decision|0|||
163333999|NCT03861234|589933144|FG002|Overall Study|As per sponsor decision|0|||
163334000|NCT03861234|589933145|FG003|Overall Study|As per sponsor decision|0|||
163334001|NCT03861234|589933146|FG004|Overall Study|As per sponsor decision|0|||
163334002|NCT03861234|589933147|FG005|Overall Study|As per sponsor decision|0|||
163334003|NCT03861234|589933148|FG006|Overall Study|As per sponsor decision|1|||
163334004|NCT03861234|589933149|FG007|Overall Study|As per sponsor decision|0|||
163334005|NCT03861234|589933142|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
163334006|NCT03861234|589933143|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
163334007|NCT03861234|589933144|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
163334008|NCT03861234|589933145|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
163334009|NCT03861234|589933146|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
163334010|NCT03861234|589933147|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
163334011|NCT03861234|589933148|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
163334012|NCT03861234|589933149|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
163334013|NCT00621842|589933150|FG000|Overall Study|Adverse Event|6|||
163334014|NCT00621842|589933150|FG000|Overall Study|Withdrawal by Subject|7|||
163334015|NCT00621842|589933150|FG000|Overall Study|Protocol Violation|4|||
163334016|NCT00621842|589933150|FG000|Overall Study|Lack of Efficacy|2|||
163334017|NCT05169684|589933153|FG000|Overall Study|Adverse Event|1|||
163334018|NCT05169684|589933154|FG001|Overall Study|Adverse Event|3|||
163334019|NCT05169684|589933153|FG000|Overall Study|Physician Decision|0|||
163334020|NCT05169684|589933154|FG001|Overall Study|Physician Decision|1|||
163334021|NCT05169684|589933153|FG000|Overall Study|Progressive Disease|1|||
163334022|NCT05169684|589933154|FG001|Overall Study|Progressive Disease|1|||
163334023|NCT05169684|589933153|FG000|Overall Study|Participant request to discontinue treatment|0|||
163334024|NCT05169684|589933154|FG001|Overall Study|Participant request to discontinue treatment|1|||
163334025|NCT05169684|589933153|FG000|Overall Study|Other Reason|0|||
163334026|NCT05169684|589933154|FG001|Overall Study|Other Reason|1|||
163334027|NCT05352230|589933155|FG000|First Intervention (3 Months)|study terminated|2|||
163334028|NCT05352230|589933156|FG001|First Intervention (3 Months)|study terminated|2|||
163334029|NCT00875706|589933163|FG000|Overall Study|Withdrawal by Subject|1|||
163334030|NCT00875706|589933164|FG001|Overall Study|Withdrawal by Subject|0|||
163334031|NCT00875706|589933165|FG002|Overall Study|Withdrawal by Subject|0|||
163334032|NCT03775213|589933166|FG000|Overall Study|Withdrawal by Subject|51|||
163334033|NCT03775213|589933167|FG001|Overall Study|Withdrawal by Subject|53|||
163334034|NCT03775213|589933166|FG000|Overall Study|Incomplete Survey|7|||
163334035|NCT03775213|589933167|FG001|Overall Study|Incomplete Survey|7|||
163334036|NCT00786188|589933168|FG000|Overall Study|Adverse Event|3|||
163334037|NCT00786188|589933169|FG001|Overall Study|Adverse Event|1|||
163334038|NCT00786188|589933168|FG000|Overall Study|Withdrawal by Subject|2|||
163334039|NCT00786188|589933169|FG001|Overall Study|Withdrawal by Subject|0|||
163334040|NCT00326183|589933170|FG000|Overall Study|Lost to Follow-up|104|||
163334041|NCT00326183|589933171|FG001|Overall Study|Lost to Follow-up|56|||
163334042|NCT00326183|589933170|FG000|Overall Study|Protocol Violation|6|||
163334043|NCT00326183|589933171|FG001|Overall Study|Protocol Violation|3|||
163334044|NCT00326183|589933170|FG000|Overall Study|Withdrawal by Subject|35|||
163334045|NCT00326183|589933171|FG001|Overall Study|Withdrawal by Subject|7|||
163334046|NCT00326183|589933170|FG000|Overall Study|Subject Moved|7|||
163334047|NCT00326183|589933171|FG001|Overall Study|Subject Moved|4|||
163334048|NCT00326183|589933170|FG000|Overall Study|Other|47|||
163334049|NCT00326183|589933171|FG001|Overall Study|Other|13|||
163334050|NCT00326183|589933170|FG000|Overall Study|Adverse Event|1|||
163334051|NCT00326183|589933171|FG001|Overall Study|Adverse Event|0|||
163334052|NCT01827839|589933175|FG000|Overall Study|Adverse Event|1|||
163334053|NCT01827839|589933175|FG000|Overall Study|Consent Withdrawal|2|||
163334054|NCT00570505|589933176|FG000|Overall Study|Adverse Event|7|||
163334055|NCT00570505|589933176|FG000|Overall Study|Withdrawal by Subject|7|||
163033930|NCT01096589|588826758|FG003|Overall Study|Adverse Event|1|||
163033931|NCT01096589|588826755|FG000|Overall Study|Withdrawal by Subject|2|||
163334056|NCT00570505|589933176|FG000|Overall Study|Lost to Follow-up|23|||
163334057|NCT00570505|589933176|FG000|Overall Study|Other loss to follow-up|4|||
163334058|NCT00614614|589933177|FG000|Primary Vaccination Phase|Adverse Event|6|||
163334059|NCT00614614|589933178|FG001|Primary Vaccination Phase|Adverse Event|0|||
163334060|NCT00614614|589933179|FG002|Primary Vaccination Phase|Adverse Event|0|||
163334061|NCT00614614|589933180|FG003|Primary Vaccination Phase|Adverse Event|0|||
163334062|NCT00614614|589933181|FG004|Primary Vaccination Phase|Adverse Event|0|||
163334063|NCT00614614|589933177|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
163334064|NCT00614614|589933178|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
163334065|NCT00614614|589933179|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
163334066|NCT00614614|589933180|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
163334067|NCT00614614|589933181|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
163334068|NCT00614614|589933177|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
163334069|NCT00614614|589933178|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
163334070|NCT00614614|589933179|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
163334071|NCT00614614|589933180|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
163334072|NCT00614614|589933181|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
163334073|NCT00614614|589933177|FG000|Primary Vaccination Phase|Protocol Violation|9|||
163334074|NCT00614614|589933178|FG001|Primary Vaccination Phase|Protocol Violation|3|||
163334075|NCT00614614|589933179|FG002|Primary Vaccination Phase|Protocol Violation|0|||
163334076|NCT00614614|589933180|FG003|Primary Vaccination Phase|Protocol Violation|0|||
163334077|NCT00614614|589933181|FG004|Primary Vaccination Phase|Protocol Violation|0|||
163334078|NCT00614614|589933177|FG000|Primary Vaccination Phase|Other|4|||
163334079|NCT00614614|589933178|FG001|Primary Vaccination Phase|Other|0|||
163334080|NCT00614614|589933179|FG002|Primary Vaccination Phase|Other|0|||
163334081|NCT00614614|589933180|FG003|Primary Vaccination Phase|Other|0|||
163334082|NCT00614614|589933181|FG004|Primary Vaccination Phase|Other|0|||
163334083|NCT00614614|589933177|FG000|Booster Vaccination Phase|Adverse Event|0|||
163334084|NCT00614614|589933178|FG001|Booster Vaccination Phase|Adverse Event|0|||
163334085|NCT00614614|589933179|FG002|Booster Vaccination Phase|Adverse Event|1|||
163334086|NCT00614614|589933180|FG003|Booster Vaccination Phase|Adverse Event|1|||
163334087|NCT00614614|589933181|FG004|Booster Vaccination Phase|Adverse Event|0|||
163334088|NCT00614614|589933177|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
163334089|NCT00614614|589933178|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
163334090|NCT00614614|589933179|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
163334091|NCT00614614|589933180|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
163334092|NCT00614614|589933181|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
163334093|NCT00614614|589933177|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
163334094|NCT00614614|589933178|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
163334095|NCT00614614|589933179|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
163334096|NCT00614614|589933180|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
163334097|NCT00614614|589933181|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
163334098|NCT00614614|589933177|FG000|Booster Vaccination Phase|Protocol Violation|0|||
163334099|NCT00614614|589933178|FG001|Booster Vaccination Phase|Protocol Violation|0|||
163334100|NCT00614614|589933179|FG002|Booster Vaccination Phase|Protocol Violation|2|||
163406735|NCT03016325|590198752|FG003|Treatment Period|Participant withdrew consent|0|||
163406736|NCT03016325|590198753|FG004|Treatment Period|Participant withdrew consent|0|||
163406737|NCT03016325|590198754|FG005|Treatment Period|Participant withdrew consent|0|||
163406738|NCT03016325|590198755|FG006|Treatment Period|Participant withdrew consent|0|||
163033932|NCT01096589|588826756|FG001|Overall Study|Withdrawal by Subject|1|||
163033933|NCT01096589|588826757|FG002|Overall Study|Withdrawal by Subject|1|||
163033934|NCT01096589|588826758|FG003|Overall Study|Withdrawal by Subject|1|||
163033935|NCT01096589|588826755|FG000|Overall Study|Compliance with protocol|0|||
163033936|NCT01096589|588826756|FG001|Overall Study|Compliance with protocol|0|||
163033937|NCT01096589|588826757|FG002|Overall Study|Compliance with protocol|1|||
163033938|NCT01096589|588826758|FG003|Overall Study|Compliance with protocol|0|||
163033939|NCT01096589|588826755|FG000|Overall Study|found treatment exhausting|0|||
163033940|NCT01096589|588826756|FG001|Overall Study|found treatment exhausting|0|||
163033941|NCT01096589|588826757|FG002|Overall Study|found treatment exhausting|0|||
163033942|NCT01096589|588826758|FG003|Overall Study|found treatment exhausting|1|||
163033943|NCT00948506|588826759|FG000|Overall Study|Withdrawal by Subject|3|||
163033944|NCT00948506|588826760|FG001|Overall Study|Withdrawal by Subject|1|||
163033945|NCT03233204|588826762|FG000|Overall Study|Adverse Event|1|||
163033946|NCT03233204|588826762|FG000|Overall Study|Death|1|||
163033947|NCT03233204|588826762|FG000|Overall Study|Withdrawal by Subject|1|||
163033948|NCT03233204|588826762|FG000|Overall Study|Progressive Disease|3|||
163033949|NCT02227368|588828412|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
163033950|NCT02227368|588828413|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
163033951|NCT02227368|588828412|FG000|Overall Study|Lost to Follow-up|1|||
163033952|NCT02227368|588828413|FG001|Overall Study|Lost to Follow-up|0|||
163033953|NCT02227368|588828412|FG000|Overall Study|Adverse Event|1|||
163033954|NCT02227368|588828413|FG001|Overall Study|Adverse Event|0|||
163406739|NCT03016325|590198756|FG007|Treatment Period|Participant withdrew consent|0|||
163033955|NCT03046056|588828415|FG000|Overall Study|Non-responder at Week 10|6|||
163033956|NCT03046056|588828416|FG001|Overall Study|Non-responder at Week 10|6|||
163033957|NCT03046056|588828417|FG002|Overall Study|Non-responder at Week 10|4|||
163033958|NCT03046056|588828415|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
163033959|NCT03046056|588828416|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
163334101|NCT00614614|589933180|FG003|Booster Vaccination Phase|Protocol Violation|3|||
163334102|NCT00614614|589933181|FG004|Booster Vaccination Phase|Protocol Violation|0|||
163033960|NCT03046056|588828417|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
163033961|NCT03046056|588828415|FG000|Overall Study|Adverse Event|1|||
163085575|NCT05030766|589022326|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
163334103|NCT00614614|589933177|FG000|Booster Vaccination Phase|Other|0|||
163334104|NCT00614614|589933178|FG001|Booster Vaccination Phase|Other|1|||
163334105|NCT00614614|589933179|FG002|Booster Vaccination Phase|Other|3|||
163334106|NCT00614614|589933180|FG003|Booster Vaccination Phase|Other|2|||
163334107|NCT00614614|589933181|FG004|Booster Vaccination Phase|Other|1|||
163334108|NCT05426109|589933182|FG000|Overall Study|Withdrawal by Subject|0|||
163033962|NCT03046056|588828416|FG001|Overall Study|Adverse Event|5|||
163033963|NCT03046056|588828417|FG002|Overall Study|Adverse Event|0|||
163334109|NCT05426109|589933183|FG001|Overall Study|Withdrawal by Subject|1|||
163334110|NCT05212285|589933184|FG000|Overall Study|Lack of Efficacy|12|||
163334111|NCT05212285|589933185|FG001|Overall Study|Lack of Efficacy|8|||
163334112|NCT05212285|589933184|FG000|Overall Study|Withdrawal by Subject|8|||
163334113|NCT05212285|589933185|FG001|Overall Study|Withdrawal by Subject|1|||
163334114|NCT05212285|589933184|FG000|Overall Study|Lost to Follow-up|13|||
163334115|NCT05212285|589933185|FG001|Overall Study|Lost to Follow-up|1|||
163334116|NCT05212285|589933184|FG000|Overall Study|miss data|21|||
163334117|NCT05212285|589933185|FG001|Overall Study|miss data|2|||
163334118|NCT04118894|589933189|FG000|Overall Study|Lost to Follow-up|21|||
163334119|NCT04118894|589933189|FG000|Overall Study|Withdrawal by Subject|10|||
163334120|NCT04118894|589933189|FG000|Overall Study|Adverse Event|4|||
163334121|NCT04493424|589934300|FG000|Overall Study|Termination of the trial by the sponsor|89|||
163334122|NCT04493424|589934300|FG000|Overall Study|Withdrawal by Subject|9|||
163334123|NCT04493424|589934300|FG000|Overall Study|Lost to Follow-up|2|||
163334124|NCT04493424|589934300|FG000|Overall Study|Lack of Efficacy|3|||
163334125|NCT04493424|589934300|FG000|Overall Study|Adverse Event|5|||
163334126|NCT03769090|589934302|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
163334127|NCT03769090|589934303|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
163334128|NCT03769090|589934304|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
163334129|NCT03769090|589934302|FG000|Overall Study|Withdrawal by Subject|52|||
163334130|NCT03769090|589934303|FG001|Overall Study|Withdrawal by Subject|62|||
163334131|NCT03769090|589934304|FG002|Overall Study|Withdrawal by Subject|74|||
163334132|NCT03769090|589934302|FG000|Overall Study|Death|4|||
163334133|NCT03769090|589934303|FG001|Overall Study|Death|2|||
163334134|NCT03769090|589934304|FG002|Overall Study|Death|2|||
163334135|NCT03769090|589934302|FG000|Overall Study|Adverse Event|7|||
163334136|NCT03769090|589934303|FG001|Overall Study|Adverse Event|7|||
163334137|NCT03769090|589934304|FG002|Overall Study|Adverse Event|8|||
163334138|NCT03769090|589934302|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
163334139|NCT03769090|589934303|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
163334140|NCT03769090|589934304|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
163334141|NCT03769090|589934302|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
163334142|NCT03769090|589934303|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
163334143|NCT03769090|589934304|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
163334144|NCT03769090|589934302|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
163334145|NCT03769090|589934303|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
163334146|NCT03769090|589934304|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
163334147|NCT03769090|589934302|FG000|Overall Study|Protocol Violation|5|||
163334148|NCT03769090|589934303|FG001|Overall Study|Protocol Violation|6|||
163334149|NCT03769090|589934304|FG002|Overall Study|Protocol Violation|8|||
163334150|NCT03769090|589934302|FG000|Overall Study|Pregnancy|1|||
163334151|NCT03769090|589934303|FG001|Overall Study|Pregnancy|0|||
163334152|NCT03769090|589934304|FG002|Overall Study|Pregnancy|3|||
163334153|NCT03769090|589934302|FG000|Overall Study|Lost to Follow-up|19|||
163334154|NCT03769090|589934303|FG001|Overall Study|Lost to Follow-up|25|||
163334155|NCT03769090|589934304|FG002|Overall Study|Lost to Follow-up|21|||
163334156|NCT03769090|589934302|FG000|Overall Study|Condition under investigation worsened|2|||
163334157|NCT03769090|589934303|FG001|Overall Study|Condition under investigation worsened|0|||
163334158|NCT03769090|589934304|FG002|Overall Study|Condition under investigation worsened|1|||
163334159|NCT03769090|589934302|FG000|Overall Study|Lack of Efficacy|1|||
163334160|NCT03769090|589934303|FG001|Overall Study|Lack of Efficacy|2|||
163334161|NCT03769090|589934304|FG002|Overall Study|Lack of Efficacy|2|||
163334162|NCT03769090|589934302|FG000|Overall Study|Other reasons|8|||
163334163|NCT03769090|589934303|FG001|Overall Study|Other reasons|12|||
163334164|NCT03769090|589934304|FG002|Overall Study|Other reasons|15|||
163334165|NCT02713594|589934305|FG000|Overall Study|Withdrawal by Subject|32|||
163033964|NCT03046056|588828415|FG000|Overall Study|Non-compliance With Study Drug|0|||
163033965|NCT03046056|588828416|FG001|Overall Study|Non-compliance With Study Drug|0|||
163334166|NCT02713594|589934306|FG001|Overall Study|Withdrawal by Subject|22|||
163334167|NCT02713594|589934305|FG000|Overall Study|Lost to Follow-up|358|||
163033966|NCT03046056|588828417|FG002|Overall Study|Non-compliance With Study Drug|2|||
163334168|NCT02713594|589934306|FG001|Overall Study|Lost to Follow-up|374|||
163334169|NCT03690219|589934307|FG000|Overall Study|no injuries|9|||
163334170|NCT03690219|589934308|FG001|Overall Study|no injuries|20|||
163033967|NCT03046056|588828415|FG000|Overall Study|Protocol Violation|1|||
163033968|NCT03046056|588828416|FG001|Overall Study|Protocol Violation|1|||
163033969|NCT03046056|588828417|FG002|Overall Study|Protocol Violation|0|||
163033970|NCT03046056|588828415|FG000|Overall Study|Investigator's Discretion|0|||
163334171|NCT03690219|589934307|FG000|Overall Study|missing information|7|||
163334172|NCT03690219|589934308|FG001|Overall Study|missing information|7|||
163334173|NCT01523392|589934309|FG000|Treatment Period 1|Withdrawal by Subject|2|||
163334174|NCT01523392|589934310|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163334175|NCT01523392|589934309|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
163334176|NCT01523392|589934310|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
163334177|NCT01523392|589934309|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
163334178|NCT01523392|589934310|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
163334179|NCT02771366|589934311|FG000|Period 1|Withdrawal by Subject|0|||
163334180|NCT02771366|589934312|FG001|Period 1|Withdrawal by Subject|2|||
163334181|NCT02771366|589934311|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
163334182|NCT02771366|589934312|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
163334183|NCT02092285|589934314|FG000|Induction Phase|Adverse Event|7|||
163334184|NCT02092285|589934314|FG000|Induction Phase|Physician Decision|4|||
163334185|NCT02092285|589934314|FG000|Induction Phase|Pregnancy|1|||
163334186|NCT02092285|589934314|FG000|Induction Phase|Relapse/Recurrence|7|||
163334187|NCT02092285|589934314|FG000|Induction Phase|Withdrawal by Subject|2|||
163334188|NCT02092285|589934314|FG000|Induction Phase|Lack of Efficacy|14|||
163334189|NCT02092285|589934314|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
163334190|NCT02092285|589934314|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
163334191|NCT02092285|589934314|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
163334192|NCT02092285|589934314|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
163334193|NCT02092285|589934314|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
163334194|NCT02092285|589934314|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
163334195|NCT02092285|589934314|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
163334196|NCT02092285|589934314|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
163334197|NCT02092285|589934314|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
163334198|NCT01185340|589934317|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
163334199|NCT01185340|589934318|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163334200|NCT01185340|589934319|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163334201|NCT01185340|589934320|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163334202|NCT01185340|589934317|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
163334203|NCT01185340|589934318|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163334204|NCT01185340|589934319|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163334205|NCT01185340|589934320|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163334206|NCT01185340|589934317|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
163334207|NCT01185340|589934318|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163334208|NCT01185340|589934319|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163334209|NCT01185340|589934320|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163334210|NCT01185340|589934317|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
163334211|NCT01185340|589934318|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163334212|NCT01185340|589934319|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163334213|NCT01185340|589934320|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163334214|NCT01185340|589934317|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
163334215|NCT01185340|589934318|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163334216|NCT01185340|589934319|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163334217|NCT01185340|589934320|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163334218|NCT01185340|589934317|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
163334219|NCT01185340|589934318|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163334220|NCT01185340|589934319|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163334221|NCT01185340|589934320|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163334222|NCT01185340|589934317|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
163334223|NCT01185340|589934318|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163033971|NCT03046056|588828416|FG001|Overall Study|Investigator's Discretion|1|||
163033972|NCT03046056|588828417|FG002|Overall Study|Investigator's Discretion|0|||
163033973|NCT03046056|588828415|FG000|Overall Study|Withdrew Consent|1|||
163033974|NCT03046056|588828416|FG001|Overall Study|Withdrew Consent|0|||
163085576|NCT05030766|589022323|FG000|Phase 2 Participants|Lost to Follow-up|0|||
163085577|NCT05030766|589022324|FG001|Phase 2 Participants|Lost to Follow-up|0|||
163085578|NCT05030766|589022325|FG002|Phase 2 Participants|Lost to Follow-up|6|||
163085579|NCT05030766|589022326|FG003|Phase 2 Participants|Lost to Follow-up|2|||
163033975|NCT03046056|588828417|FG002|Overall Study|Withdrew Consent|0|||
163033976|NCT03089853|588828418|FG000|Overall Study|Lost to Follow-up|2|||
163033977|NCT03089853|588828419|FG001|Overall Study|Lost to Follow-up|1|||
163334224|NCT01185340|589934319|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163334225|NCT01185340|589934320|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163334226|NCT01185340|589934317|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
163033978|NCT01317004|588828420|FG000|Overall Study|Withdrawal by Subject|1|||
163033979|NCT01317004|588828421|FG001|Overall Study|Withdrawal by Subject|4|||
163033980|NCT01317004|588828420|FG000|Overall Study|Protocol Violation|0|||
163085580|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
163033981|NCT01317004|588828421|FG001|Overall Study|Protocol Violation|2|||
163334227|NCT01185340|589934318|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
163334228|NCT01185340|589934319|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
163334229|NCT01185340|589934320|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
163334230|NCT01185340|589934317|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
163334231|NCT01185340|589934318|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
163334232|NCT01185340|589934319|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
163334233|NCT01185340|589934320|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
163334234|NCT01185340|589934317|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
163334235|NCT01185340|589934318|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
163334236|NCT01185340|589934319|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
163334237|NCT01185340|589934320|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
163334238|NCT01185340|589934317|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
163334239|NCT01185340|589934318|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
163334240|NCT01185340|589934319|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
163334241|NCT01185340|589934320|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
163334242|NCT01185340|589934317|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
163334243|NCT01185340|589934318|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
163334244|NCT01185340|589934319|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
163334245|NCT01185340|589934320|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
163334246|NCT01185340|589934317|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
163334247|NCT01185340|589934318|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
163334248|NCT01185340|589934319|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
163334249|NCT01185340|589934320|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
163334250|NCT01185340|589934317|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
163334251|NCT01185340|589934318|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
163334252|NCT01185340|589934319|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
163334253|NCT01185340|589934320|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
163334254|NCT00087516|589934321|FG000|Overall Study|Adverse Event|10|||
163334255|NCT00087516|589934322|FG001|Overall Study|Adverse Event|10|||
163334256|NCT00087516|589934323|FG002|Overall Study|Adverse Event|3|||
163334257|NCT00087516|589934324|FG003|Overall Study|Adverse Event|6|||
163334258|NCT00087516|589934321|FG000|Overall Study|Lack of Efficacy|82|||
163334259|NCT00087516|589934322|FG001|Overall Study|Lack of Efficacy|80|||
163334260|NCT00087516|589934323|FG002|Overall Study|Lack of Efficacy|39|||
163334261|NCT00087516|589934324|FG003|Overall Study|Lack of Efficacy|29|||
163334262|NCT00087516|589934321|FG000|Overall Study|Lost to Follow-up|8|||
163334263|NCT00087516|589934322|FG001|Overall Study|Lost to Follow-up|6|||
163033982|NCT01317004|588828420|FG000|Overall Study|Adverse Event|3|||
163033983|NCT01317004|588828421|FG001|Overall Study|Adverse Event|3|||
163033984|NCT01980628|588828424|FG000|Overall Study|Adverse Event|12|||
163033985|NCT01980628|588828424|FG000|Overall Study|Physician Decision|5|||
163033986|NCT01980628|588828424|FG000|Overall Study|Withdrawal by Subject|4|||
163033987|NCT01980628|588828424|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
163033988|NCT05437640|588828427|FG000|Washout (1 Week)|Adverse Event|1|||
163033989|NCT05437640|588828428|FG001|Washout (1 Week)|Adverse Event|0|||
163033990|NCT02474355|588828429|FG000|Overall Study|Other|43|||
163033991|NCT02474355|588828429|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
163033992|NCT02474355|588828429|FG000|Overall Study|Lost to Follow-up|98|||
163033993|NCT02474355|588828429|FG000|Overall Study|Withdrawal by Subject|124|||
163033994|NCT02474355|588828429|FG000|Overall Study|Death|1361|||
163033995|NCT03015194|588828431|FG000|Overall Study|Death|10|||
163033996|NCT03015194|588828431|FG000|Overall Study|Withdrawal by Subject|2|||
163033997|NCT01698268|588828435|FG000|Overall Study|Physician Decision|2|||
163033998|NCT01698268|588828436|FG001|Overall Study|Physician Decision|1|||
163033999|NCT02263729|588828437|FG000|Overall Study|Lost to Follow-up|1|||
163034000|NCT02263729|588828438|FG001|Overall Study|Lost to Follow-up|1|||
163034001|NCT04591015|588828439|FG000|Overall Study|Death|6|||
163034002|NCT04591015|588828440|FG001|Overall Study|Death|4|||
163034003|NCT04591015|588828439|FG000|Overall Study|Withdrawal by Subject|6|||
163034004|NCT04591015|588828440|FG001|Overall Study|Withdrawal by Subject|3|||
163034005|NCT04591015|588828439|FG000|Overall Study|Lost to Follow-up|16|||
163034006|NCT04591015|588828440|FG001|Overall Study|Lost to Follow-up|11|||
163034007|NCT02509078|588828441|FG000|Overall Study|Protocol Violation|1|||
163034008|NCT02509078|588828442|FG001|Overall Study|Protocol Violation|1|||
163034009|NCT00981058|588828454|FG000|Overall Study|Progressive Disease|38|||
163334264|NCT00087516|589934323|FG002|Overall Study|Lost to Follow-up|5|||
163334265|NCT00087516|589934324|FG003|Overall Study|Lost to Follow-up|5|||
163334266|NCT00087516|589934321|FG000|Overall Study|Protocol Violation|4|||
163334267|NCT00087516|589934322|FG001|Overall Study|Protocol Violation|8|||
163034010|NCT00981058|588828455|FG001|Overall Study|Progressive Disease|31|||
163034011|NCT00981058|588828454|FG000|Overall Study|Lost to Follow-up|3|||
163034012|NCT00981058|588828455|FG001|Overall Study|Lost to Follow-up|2|||
163034013|NCT00981058|588828454|FG000|Overall Study|Physician Decision|4|||
163334268|NCT00087516|589934323|FG002|Overall Study|Protocol Violation|3|||
163334269|NCT00087516|589934324|FG003|Overall Study|Protocol Violation|6|||
163334270|NCT00087516|589934321|FG000|Overall Study|Withdrawal by Subject|16|||
163334271|NCT00087516|589934322|FG001|Overall Study|Withdrawal by Subject|27|||
163334272|NCT00087516|589934323|FG002|Overall Study|Withdrawal by Subject|11|||
163334273|NCT00087516|589934324|FG003|Overall Study|Withdrawal by Subject|12|||
163334274|NCT00087516|589934321|FG000|Overall Study|Site terminated|0|||
163334275|NCT00087516|589934322|FG001|Overall Study|Site terminated|2|||
163334276|NCT00087516|589934323|FG002|Overall Study|Site terminated|1|||
163334277|NCT00087516|589934324|FG003|Overall Study|Site terminated|0|||
163334278|NCT00087516|589934321|FG000|Overall Study|Protocol specified discontinuation|35|||
163334279|NCT00087516|589934322|FG001|Overall Study|Protocol specified discontinuation|33|||
163334280|NCT00087516|589934323|FG002|Overall Study|Protocol specified discontinuation|33|||
163334281|NCT00087516|589934324|FG003|Overall Study|Protocol specified discontinuation|26|||
163334282|NCT00087516|589934321|FG000|Overall Study|Patient moved|3|||
163334283|NCT00087516|589934322|FG001|Overall Study|Patient moved|2|||
163334284|NCT00087516|589934323|FG002|Overall Study|Patient moved|1|||
163334285|NCT00087516|589934324|FG003|Overall Study|Patient moved|0|||
163334286|NCT00087516|589934321|FG000|Overall Study|Patient was non-compliant|3|||
163334287|NCT00087516|589934322|FG001|Overall Study|Patient was non-compliant|1|||
163334288|NCT00087516|589934323|FG002|Overall Study|Patient was non-compliant|0|||
163334289|NCT00087516|589934324|FG003|Overall Study|Patient was non-compliant|0|||
163334290|NCT00087516|589934321|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
163334291|NCT00087516|589934322|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
163334292|NCT00087516|589934323|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
163334293|NCT00087516|589934324|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
163334294|NCT00087516|589934321|FG000|Overall Study|Other|0|||
163406740|NCT03016325|590198749|FG000|Treatment Period|Death|0|||
163406741|NCT03016325|590198750|FG001|Treatment Period|Death|0|||
163406742|NCT03016325|590198751|FG002|Treatment Period|Death|0|||
163406743|NCT03016325|590198752|FG003|Treatment Period|Death|0|||
163406744|NCT03016325|590198753|FG004|Treatment Period|Death|2|||
163406745|NCT03016325|590198754|FG005|Treatment Period|Death|0|||
163034014|NCT00981058|588828455|FG001|Overall Study|Physician Decision|5|||
163034015|NCT00981058|588828454|FG000|Overall Study|Randomization Error|0|||
163034016|NCT00981058|588828455|FG001|Overall Study|Randomization Error|1|||
163034017|NCT00981058|588828454|FG000|Overall Study|Withdrawal by Subject|24|||
163034018|NCT00981058|588828455|FG001|Overall Study|Withdrawal by Subject|22|||
163034019|NCT02667587|588828456|FG000|Pre-Treatment|Not reported|1|||
163034020|NCT02667587|588828457|FG001|Pre-Treatment|Not reported|0|||
163034021|NCT02667587|588828456|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
163034022|NCT02667587|588828457|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
163034023|NCT02667587|588828456|FG000|Pre-Treatment|Participant withdrew consent|0|||
163034024|NCT02667587|588828457|FG001|Pre-Treatment|Participant withdrew consent|1|||
163034025|NCT02667587|588828456|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
163034026|NCT02667587|588828457|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
163034027|NCT02667587|588828456|FG000|End of Treatment|Disease Progression|193|||
163034028|NCT02667587|588828457|FG001|End of Treatment|Disease Progression|226|||
163034029|NCT02667587|588828456|FG000|End of Treatment|Study Drug Toxicity|75|||
163085581|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
163085582|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
163085583|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
163085584|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
163085585|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
163085586|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
163085587|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
163085588|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
163085589|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
163085590|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
163085591|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
163085592|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
163334295|NCT00087516|589934322|FG001|Overall Study|Other|0|||
163334296|NCT00087516|589934323|FG002|Overall Study|Other|1|||
163334297|NCT00087516|589934324|FG003|Overall Study|Other|0|||
163406746|NCT03016325|590198755|FG006|Treatment Period|Death|0|||
163034030|NCT02667587|588828457|FG001|End of Treatment|Study Drug Toxicity|19|||
163034031|NCT02667587|588828456|FG000|End of Treatment|Death|2|||
163334298|NCT00246129|589934325|FG000|Overall Study|Lost to Follow-up|1|||
163334299|NCT00246129|589934326|FG001|Overall Study|Lost to Follow-up|0|||
163334300|NCT00246129|589934325|FG000|Overall Study|Death|2|||
163406747|NCT03016325|590198756|FG007|Treatment Period|Death|0|||
163034032|NCT02667587|588828457|FG001|End of Treatment|Death|1|||
163034033|NCT02667587|588828456|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
163334301|NCT00246129|589934326|FG001|Overall Study|Death|1|||
163334302|NCT00246129|589934325|FG000|Overall Study|suffered primary non-function|1|||
163334303|NCT00246129|589934326|FG001|Overall Study|suffered primary non-function|0|||
163334304|NCT00246129|589934325|FG000|Overall Study|grafts failed|3|||
163334305|NCT00246129|589934326|FG001|Overall Study|grafts failed|1|||
163334306|NCT01779050|589934327|FG000|Overall Study|Withdrawal by Subject|1|||
163334307|NCT01779050|589934328|FG001|Overall Study|Withdrawal by Subject|0|||
163334308|NCT03403036|589934329|FG000|Overall Study|Lack of Efficacy|5|||
163334309|NCT02392507|589934337|FG000|Induction Regimen|Death|3|||
163334310|NCT02392507|589934337|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
163334311|NCT02392507|589934337|FG000|Induction Regimen|Physician Decision|1|||
163034034|NCT02667587|588828457|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
163034035|NCT02667587|588828456|FG000|End of Treatment|participant request to discontinue treatment|33|||
163034036|NCT02667587|588828457|FG001|End of Treatment|participant request to discontinue treatment|35|||
163034037|NCT02667587|588828456|FG000|End of Treatment|participant withdrew consent|5|||
163034038|NCT02667587|588828457|FG001|End of Treatment|participant withdrew consent|6|||
163034039|NCT02667587|588828456|FG000|End of Treatment|Lost to Follow-up|1|||
163034040|NCT02667587|588828457|FG001|End of Treatment|Lost to Follow-up|2|||
163034041|NCT02667587|588828456|FG000|End of Treatment|maximum clinical benefit|4|||
163034042|NCT02667587|588828457|FG001|End of Treatment|maximum clinical benefit|4|||
163034043|NCT02667587|588828456|FG000|End of Treatment|poor or non compliant|0|||
163034044|NCT02667587|588828457|FG001|End of Treatment|poor or non compliant|1|||
163034045|NCT02667587|588828456|FG000|End of Treatment|participant no longer meets study criteria|1|||
163034046|NCT02667587|588828457|FG001|End of Treatment|participant no longer meets study criteria|1|||
163034047|NCT02667587|588828456|FG000|End of Treatment|administrative reason by sponsor|1|||
163034048|NCT02667587|588828457|FG001|End of Treatment|administrative reason by sponsor|29|||
163034049|NCT02667587|588828456|FG000|End of Treatment|other reasonse|21|||
163034050|NCT02667587|588828457|FG001|End of Treatment|other reasonse|10|||
163034051|NCT02696434|588828461|FG000|Overall Study|Adverse Event|3|||
163034052|NCT02696434|588828462|FG001|Overall Study|Adverse Event|1|||
163034053|NCT02696434|588828461|FG000|Overall Study|Lost to Follow-up|5|||
163034054|NCT02696434|588828462|FG001|Overall Study|Lost to Follow-up|4|||
163034055|NCT02696434|588828461|FG000|Overall Study|Withdrawal by Subject|14|||
163034056|NCT02696434|588828462|FG001|Overall Study|Withdrawal by Subject|12|||
163034057|NCT02696434|588828461|FG000|Overall Study|Physician Decision|0|||
163034058|NCT02696434|588828462|FG001|Overall Study|Physician Decision|1|||
163034059|NCT03570554|588828468|FG000|Overall Study|Non-compliance with study drug|0|||
163034060|NCT03570554|588828469|FG001|Overall Study|Non-compliance with study drug|0|||
163034061|NCT03570554|588828470|FG002|Overall Study|Non-compliance with study drug|1|||
163034062|NCT03570554|588828471|FG003|Overall Study|Non-compliance with study drug|0|||
163034063|NCT03570554|588828468|FG000|Overall Study|Adverse Event|0|||
163085593|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
163085594|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
163085595|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
163085596|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
163085597|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
163085598|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
163085599|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
163085600|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
163085601|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
163085602|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
163085603|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
163085604|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
163334312|NCT02392507|589934337|FG000|Induction Regimen|Withdrawal by Subject|2|||
163334313|NCT02392507|589934337|FG000|Maintenance Regimen|Death|1|||
163334314|NCT02392507|589934337|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
163034064|NCT03570554|588828469|FG001|Overall Study|Adverse Event|0|||
163034065|NCT03570554|588828470|FG002|Overall Study|Adverse Event|0|||
163034066|NCT03570554|588828471|FG003|Overall Study|Adverse Event|1|||
163034067|NCT02719353|588828474|FG000|First Intervention|Physician Decision|0|||
163034068|NCT02719353|588828475|FG001|First Intervention|Physician Decision|1|||
163034069|NCT00980174|588828477|FG000|Overall Study|Withdrawal by Subject|1|||
163034070|NCT00980174|588828478|FG001|Overall Study|Withdrawal by Subject|4|||
163034071|NCT00980174|588828477|FG000|Overall Study|Adverse Event|0|||
163034072|NCT00980174|588828478|FG001|Overall Study|Adverse Event|3|||
163034073|NCT00980174|588828477|FG000|Overall Study|Ineligibility determined|2|||
163034074|NCT00980174|588828478|FG001|Overall Study|Ineligibility determined|1|||
163034075|NCT00980174|588828477|FG000|Overall Study|Death|1|||
163034076|NCT00980174|588828478|FG001|Overall Study|Death|1|||
163034077|NCT00980174|588828477|FG000|Overall Study|Other|0|||
163034078|NCT00980174|588828478|FG001|Overall Study|Other|1|||
163034079|NCT01546038|588828480|FG000|Overall Study|Death|15|||
163034080|NCT01546038|588828481|FG001|Overall Study|Death|6|||
163034081|NCT01546038|588828482|FG002|Overall Study|Death|4|||
163034082|NCT01546038|588828483|FG003|Overall Study|Death|2|||
163034083|NCT01546038|588828484|FG004|Overall Study|Death|9|||
163034084|NCT01546038|588828485|FG005|Overall Study|Death|3|||
163034085|NCT01546038|588828486|FG006|Overall Study|Death|46|||
163034086|NCT01546038|588828487|FG007|Overall Study|Death|76|||
163034087|NCT01546038|588828488|FG008|Overall Study|Death|39|||
163034088|NCT01546038|588828480|FG000|Overall Study|Lost to Follow-up|0|||
163034089|NCT01546038|588828481|FG001|Overall Study|Lost to Follow-up|0|||
163034090|NCT01546038|588828482|FG002|Overall Study|Lost to Follow-up|0|||
163034091|NCT01546038|588828483|FG003|Overall Study|Lost to Follow-up|0|||
163034092|NCT01546038|588828484|FG004|Overall Study|Lost to Follow-up|1|||
163034093|NCT01546038|588828485|FG005|Overall Study|Lost to Follow-up|0|||
163034094|NCT01546038|588828486|FG006|Overall Study|Lost to Follow-up|2|||
163034095|NCT01546038|588828487|FG007|Overall Study|Lost to Follow-up|1|||
163034096|NCT01546038|588828488|FG008|Overall Study|Lost to Follow-up|0|||
163034097|NCT01546038|588828480|FG000|Overall Study|Withdrawal by Subject|1|||
163034098|NCT01546038|588828481|FG001|Overall Study|Withdrawal by Subject|0|||
163034099|NCT01546038|588828482|FG002|Overall Study|Withdrawal by Subject|0|||
163034100|NCT01546038|588828483|FG003|Overall Study|Withdrawal by Subject|1|||
163034101|NCT01546038|588828484|FG004|Overall Study|Withdrawal by Subject|0|||
163034102|NCT01546038|588828485|FG005|Overall Study|Withdrawal by Subject|1|||
163034103|NCT01546038|588828486|FG006|Overall Study|Withdrawal by Subject|3|||
163034104|NCT01546038|588828487|FG007|Overall Study|Withdrawal by Subject|3|||
163034105|NCT01546038|588828488|FG008|Overall Study|Withdrawal by Subject|1|||
163034106|NCT01546038|588828480|FG000|Overall Study|: Randomized, not treated|0|||
163034107|NCT01546038|588828481|FG001|Overall Study|: Randomized, not treated|0|||
163034108|NCT01546038|588828482|FG002|Overall Study|: Randomized, not treated|0|||
163034109|NCT01546038|588828483|FG003|Overall Study|: Randomized, not treated|0|||
163034110|NCT01546038|588828484|FG004|Overall Study|: Randomized, not treated|0|||
163034111|NCT01546038|588828485|FG005|Overall Study|: Randomized, not treated|0|||
163034112|NCT01546038|588828486|FG006|Overall Study|: Randomized, not treated|2|||
163034113|NCT01546038|588828487|FG007|Overall Study|: Randomized, not treated|4|||
163034114|NCT01546038|588828488|FG008|Overall Study|: Randomized, not treated|3|||
163034115|NCT00424021|588828489|FG000|NCT00046319 Study Period|Adverse Event|1|||
163034116|NCT00424021|588828490|FG001|NCT00046319 Study Period|Adverse Event|0|||
163034117|NCT00424021|588828491|FG002|NCT00046319 Study Period|Adverse Event|1|||
163034118|NCT00424021|588828492|FG003|NCT00046319 Study Period|Adverse Event|1|||
163034119|NCT00424021|588828489|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
163034120|NCT00424021|588828490|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
163034121|NCT00424021|588828491|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
163034122|NCT00424021|588828492|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
163034123|NCT00424021|588828489|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
163034124|NCT00424021|588828490|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
163034125|NCT00424021|588828491|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
163034126|NCT00424021|588828492|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
163034127|NCT00424021|588828489|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
163034128|NCT00424021|588828490|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
163034129|NCT00424021|588828491|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
163334315|NCT00273052|589934338|FG000|Overall Study|Withdrawal by Subject|16|||
163334316|NCT00273052|589934339|FG001|Overall Study|Withdrawal by Subject|19|||
163334317|NCT00273052|589934338|FG000|Overall Study|Adverse Event|21|||
163334318|NCT00273052|589934339|FG001|Overall Study|Adverse Event|19|||
163334319|NCT00273052|589934338|FG000|Overall Study|Protocol Violation|14|||
163334320|NCT00273052|589934339|FG001|Overall Study|Protocol Violation|18|||
163334321|NCT00273052|589934338|FG000|Overall Study|Lost to Follow-up|7|||
163334322|NCT00273052|589934339|FG001|Overall Study|Lost to Follow-up|25|||
163034130|NCT00424021|588828492|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
163034131|NCT00424021|588828489|FG000|AMB-220-E Study Period|Adverse Event|1|||
163034132|NCT00424021|588828490|FG001|AMB-220-E Study Period|Adverse Event|1|||
163034133|NCT00424021|588828491|FG002|AMB-220-E Study Period|Adverse Event|3|||
163034134|NCT00424021|588828492|FG003|AMB-220-E Study Period|Adverse Event|7|||
163034135|NCT00424021|588828489|FG000|AMB-220-E Study Period|Death|0|||
163034136|NCT00424021|588828490|FG001|AMB-220-E Study Period|Death|0|||
163034137|NCT00424021|588828491|FG002|AMB-220-E Study Period|Death|1|||
163034138|NCT00424021|588828492|FG003|AMB-220-E Study Period|Death|1|||
163034139|NCT00424021|588828489|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
163034140|NCT00424021|588828490|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
163034141|NCT00424021|588828491|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
163034142|NCT00424021|588828492|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
163034143|NCT00424021|588828489|FG000|AMB-220-E Study Period|Physician Decision|0|||
163034144|NCT00424021|588828490|FG001|AMB-220-E Study Period|Physician Decision|0|||
163034145|NCT00424021|588828491|FG002|AMB-220-E Study Period|Physician Decision|0|||
163034146|NCT00424021|588828492|FG003|AMB-220-E Study Period|Physician Decision|1|||
163334323|NCT00273052|589934338|FG000|Overall Study|Lack of Efficacy|6|||
163034147|NCT01832818|588828493|FG000|Overall Study|Lost to Follow-up|6|||
163334324|NCT00273052|589934339|FG001|Overall Study|Lack of Efficacy|4|||
163334325|NCT00273052|589934338|FG000|Overall Study|Non-Compliance|3|||
163334326|NCT00273052|589934339|FG001|Overall Study|Non-Compliance|1|||
163334327|NCT00273052|589934338|FG000|Overall Study|Other|2|||
163334328|NCT00273052|589934339|FG001|Overall Study|Other|0|||
163334329|NCT00273052|589934338|FG000|Overall Study|Worsening serum lipid levels|0|||
163334330|NCT00273052|589934339|FG001|Overall Study|Worsening serum lipid levels|2|||
163334331|NCT00704340|589934340|FG000|Overall Study|Lost to Follow-up|2|||
163334332|NCT00704340|589934341|FG001|Overall Study|Lost to Follow-up|1|||
163334333|NCT00704340|589934340|FG000|Overall Study|Death|0|||
163334334|NCT00704340|589934341|FG001|Overall Study|Death|1|||
163334335|NCT00403845|589934350|FG000|Treatment Period 1|Subject withdrew consent|1|||
163334336|NCT00403845|589934351|FG001|Treatment Period 1|Subject withdrew consent|0|||
163334337|NCT00403845|589934352|FG002|Treatment Period 1|Subject withdrew consent|0|||
163334338|NCT00403845|589934353|FG003|Treatment Period 1|Subject withdrew consent|0|||
163334339|NCT00403845|589934350|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
163334340|NCT00403845|589934351|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
163334341|NCT00403845|589934352|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
163334342|NCT00403845|589934353|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
163334343|NCT00403845|589934350|FG000|Treatment Period 2|Subject withdrew consent|1|||
163334344|NCT00403845|589934351|FG001|Treatment Period 2|Subject withdrew consent|0|||
163334345|NCT00403845|589934352|FG002|Treatment Period 2|Subject withdrew consent|0|||
163334346|NCT00403845|589934353|FG003|Treatment Period 2|Subject withdrew consent|0|||
163334347|NCT00403845|589934350|FG000|Treatment Period 3|Subject withdrew consent|0|||
163334348|NCT00403845|589934351|FG001|Treatment Period 3|Subject withdrew consent|0|||
163334349|NCT00403845|589934352|FG002|Treatment Period 3|Subject withdrew consent|0|||
163334350|NCT00403845|589934353|FG003|Treatment Period 3|Subject withdrew consent|1|||
163334351|NCT00403845|589934350|FG000|Treatment Period 3|Adverse Event|0|||
163334352|NCT00403845|589934351|FG001|Treatment Period 3|Adverse Event|0|||
163334353|NCT00403845|589934352|FG002|Treatment Period 3|Adverse Event|0|||
163334354|NCT00403845|589934353|FG003|Treatment Period 3|Adverse Event|1|||
163334355|NCT03316170|589934354|FG000|Overall Study|Death|1|||
163334356|NCT03316170|589934355|FG001|Overall Study|Death|0|||
163334357|NCT03316170|589934354|FG000|Overall Study|Lost to Follow-up|6|||
163334358|NCT03316170|589934355|FG001|Overall Study|Lost to Follow-up|7|||
163334359|NCT02935673|589934356|FG000|Overall Study|Adverse Event|0|||
163334360|NCT02935673|589934357|FG001|Overall Study|Adverse Event|1|||
163334361|NCT02935673|589934358|FG002|Overall Study|Adverse Event|0|||
163334362|NCT02935673|589934356|FG000|Overall Study|Withdrawal by Subject|1|||
163334363|NCT02935673|589934357|FG001|Overall Study|Withdrawal by Subject|2|||
163334364|NCT02935673|589934358|FG002|Overall Study|Withdrawal by Subject|0|||
163334365|NCT01836523|589934359|FG000|Overall Study|Adverse Event|15|||
163334366|NCT01836523|589934360|FG001|Overall Study|Adverse Event|41|||
163334367|NCT01836523|589934361|FG002|Overall Study|Adverse Event|49|||
163334368|NCT01836523|589934362|FG003|Overall Study|Adverse Event|14|||
163334369|NCT01836523|589934359|FG000|Overall Study|Protocol Violation|6|||
163334370|NCT01836523|589934360|FG001|Overall Study|Protocol Violation|3|||
163334371|NCT01836523|589934361|FG002|Overall Study|Protocol Violation|2|||
163334372|NCT01836523|589934362|FG003|Overall Study|Protocol Violation|4|||
163334373|NCT01836523|589934359|FG000|Overall Study|Met Withdrawal Criteria|13|||
163334374|NCT01836523|589934360|FG001|Overall Study|Met Withdrawal Criteria|13|||
163334375|NCT01836523|589934361|FG002|Overall Study|Met Withdrawal Criteria|21|||
163334376|NCT01836523|589934362|FG003|Overall Study|Met Withdrawal Criteria|27|||
163334377|NCT01836523|589934359|FG000|Overall Study|Unclassified|17|||
163334378|NCT01836523|589934360|FG001|Overall Study|Unclassified|28|||
163334379|NCT01836523|589934361|FG002|Overall Study|Unclassified|19|||
163334380|NCT01836523|589934362|FG003|Overall Study|Unclassified|29|||
163334381|NCT02095678|589934363|FG000|Overall Study|Withdrawal by Subject|0|||
163334382|NCT02095678|589934364|FG001|Overall Study|Withdrawal by Subject|1|||
163334383|NCT02095678|589934363|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
163334384|NCT02095678|589934364|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
163334385|NCT02095678|589934363|FG000|Overall Study|lesion impacted by previous treatment|1|||
163334386|NCT02095678|589934364|FG001|Overall Study|lesion impacted by previous treatment|1|||
163334387|NCT02095678|589934363|FG000|Overall Study|No Confirmed Diagnosis|0|||
163034148|NCT00236899|588828494|FG000|Overall Study|Adverse Event (Study Related)|1|||
163334388|NCT02095678|589934364|FG001|Overall Study|No Confirmed Diagnosis|3|||
163334389|NCT02095678|589934363|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
163034149|NCT00236899|588828495|FG001|Overall Study|Adverse Event (Study Related)|1|||
163334390|NCT02095678|589934364|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
163334391|NCT02095678|589934363|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
163334392|NCT02095678|589934364|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
163334393|NCT03418545|589934365|FG000|Overall Study|Withdrawal by Participant|2|||
163034150|NCT00236899|588828496|FG002|Overall Study|Adverse Event (Study Related)|2|||
163334394|NCT03418545|589934366|FG001|Overall Study|Withdrawal by Participant|4|||
163334395|NCT03418545|589934365|FG000|Overall Study|Lost to Follow-up|3|||
163334396|NCT03418545|589934366|FG001|Overall Study|Lost to Follow-up|5|||
163034151|NCT00236899|588828497|FG003|Overall Study|Adverse Event (Study Related)|1|||
163034152|NCT00236899|588828494|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
163034153|NCT00236899|588828495|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
163034154|NCT00236899|588828496|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
163034155|NCT00236899|588828497|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
163034156|NCT00236899|588828494|FG000|Overall Study|Death (Study Disease)|1|||
163034157|NCT00236899|588828495|FG001|Overall Study|Death (Study Disease)|4|||
163034158|NCT00236899|588828496|FG002|Overall Study|Death (Study Disease)|0|||
163034159|NCT00236899|588828497|FG003|Overall Study|Death (Study Disease)|0|||
163034160|NCT00236899|588828494|FG000|Overall Study|Death (Not Study Related)|2|||
163034161|NCT00236899|588828495|FG001|Overall Study|Death (Not Study Related)|0|||
163034162|NCT00236899|588828496|FG002|Overall Study|Death (Not Study Related)|0|||
163034163|NCT00236899|588828497|FG003|Overall Study|Death (Not Study Related)|0|||
163034164|NCT00236899|588828494|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
163034165|NCT00236899|588828495|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
163034166|NCT00236899|588828496|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
163034167|NCT00236899|588828497|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
163034168|NCT00236899|588828494|FG000|Overall Study|Lost to Follow-up|0|||
163034169|NCT00236899|588828495|FG001|Overall Study|Lost to Follow-up|1|||
163034170|NCT00236899|588828496|FG002|Overall Study|Lost to Follow-up|0|||
163034171|NCT00236899|588828497|FG003|Overall Study|Lost to Follow-up|0|||
163034172|NCT00236899|588828494|FG000|Overall Study|Entry Criteria Exclusion|0|||
163034173|NCT00236899|588828495|FG001|Overall Study|Entry Criteria Exclusion|1|||
163034174|NCT00236899|588828496|FG002|Overall Study|Entry Criteria Exclusion|1|||
163034175|NCT00236899|588828497|FG003|Overall Study|Entry Criteria Exclusion|0|||
163034176|NCT00236899|588828494|FG000|Overall Study|Protocol Violation|1|||
163034177|NCT00236899|588828495|FG001|Overall Study|Protocol Violation|0|||
163034178|NCT00236899|588828496|FG002|Overall Study|Protocol Violation|0|||
163034179|NCT00236899|588828497|FG003|Overall Study|Protocol Violation|0|||
163034180|NCT00236899|588828494|FG000|Overall Study|Withdrawal by Subject|6|||
163034181|NCT00236899|588828495|FG001|Overall Study|Withdrawal by Subject|4|||
163034182|NCT00236899|588828496|FG002|Overall Study|Withdrawal by Subject|5|||
163034183|NCT00236899|588828497|FG003|Overall Study|Withdrawal by Subject|2|||
163034184|NCT00236899|588828494|FG000|Overall Study|Physician Decision|7|||
163034185|NCT00236899|588828495|FG001|Overall Study|Physician Decision|8|||
163034186|NCT00236899|588828496|FG002|Overall Study|Physician Decision|7|||
163034187|NCT00236899|588828497|FG003|Overall Study|Physician Decision|6|||
163034188|NCT00236899|588828494|FG000|Overall Study|Satisfactory Response|2|||
163034189|NCT00236899|588828495|FG001|Overall Study|Satisfactory Response|0|||
163334397|NCT03418545|589934365|FG000|Overall Study|Reason Not Specified|0|||
163334398|NCT03418545|589934366|FG001|Overall Study|Reason Not Specified|1|||
163334399|NCT03418545|589934365|FG000|Overall Study|Missing Completion Status|0|||
163334400|NCT03418545|589934366|FG001|Overall Study|Missing Completion Status|1|||
163334401|NCT02706483|589934367|FG000|Overall Study|Adverse Event|97|||
163334402|NCT02706483|589934367|FG000|Overall Study|Death|1|||
163334403|NCT02706483|589934367|FG000|Overall Study|Lack of Efficacy|39|||
163334404|NCT02706483|589934367|FG000|Overall Study|Lost to Follow-up|101|||
163334405|NCT02706483|589934367|FG000|Overall Study|Non-compliance with study drug|15|||
163334406|NCT02706483|589934367|FG000|Overall Study|Physician Decision|6|||
163034190|NCT00236899|588828496|FG002|Overall Study|Satisfactory Response|0|||
163334407|NCT02706483|589934367|FG000|Overall Study|Pregnancy|6|||
163334408|NCT02706483|589934367|FG000|Overall Study|Protocol Violation|18|||
163334409|NCT02706483|589934367|FG000|Overall Study|Withdrawal by Subject|136|||
163334410|NCT02706483|589934367|FG000|Overall Study|Non-compliance with visits|6|||
163334411|NCT02706483|589934367|FG000|Overall Study|Site closure|4|||
163334412|NCT02706483|589934367|FG000|Overall Study|Subject moved|1|||
163334413|NCT04660799|589934368|FG000|Overall Study|Progressive Disease|1|||
163034191|NCT00236899|588828497|FG003|Overall Study|Satisfactory Response|1|||
163034192|NCT00236899|588828494|FG000|Overall Study|Lack of Efficacy|18|||
163034193|NCT00236899|588828495|FG001|Overall Study|Lack of Efficacy|18|||
163034194|NCT00236899|588828496|FG002|Overall Study|Lack of Efficacy|25|||
163034195|NCT00236899|588828497|FG003|Overall Study|Lack of Efficacy|23|||
163034196|NCT02565706|588828502|FG000|Overall Study|Withdrawal by Subject|5|||
163034197|NCT02565706|588828503|FG001|Overall Study|Withdrawal by Subject|7|||
163034198|NCT02565706|588828504|FG002|Overall Study|Withdrawal by Subject|7|||
163034199|NCT02565706|588828505|FG003|Overall Study|Withdrawal by Subject|11|||
163034200|NCT02565706|588828502|FG000|Overall Study|Lost to Follow-up|72|||
163034201|NCT02565706|588828503|FG001|Overall Study|Lost to Follow-up|75|||
163034202|NCT02565706|588828504|FG002|Overall Study|Lost to Follow-up|82|||
163034203|NCT02565706|588828505|FG003|Overall Study|Lost to Follow-up|74|||
163034204|NCT00568334|588828506|FG000|Overall Study|Withdrawal by Subject|0|||
163034205|NCT00568334|588828507|FG001|Overall Study|Withdrawal by Subject|1|||
163334414|NCT04660799|589934369|FG001|Overall Study|Progressive Disease|1|||
163334415|NCT04660799|589934368|FG000|Overall Study|Death|2|||
163334416|NCT04660799|589934369|FG001|Overall Study|Death|1|||
163034206|NCT00568334|588828506|FG000|Overall Study|Lost to Follow-up|1|||
163034207|NCT00568334|588828507|FG001|Overall Study|Lost to Follow-up|0|||
163034208|NCT01897571|588828508|FG000|Overall Study|Lost to Follow-up|3|||
163034209|NCT01897571|588828509|FG001|Overall Study|Lost to Follow-up|0|||
163034210|NCT01897571|588828510|FG002|Overall Study|Lost to Follow-up|0|||
163034211|NCT01897571|588828511|FG003|Overall Study|Lost to Follow-up|0|||
163034212|NCT01897571|588828512|FG004|Overall Study|Lost to Follow-up|2|||
163034213|NCT01897571|588828513|FG005|Overall Study|Lost to Follow-up|0|||
163034214|NCT01897571|588828514|FG006|Overall Study|Lost to Follow-up|0|||
163034215|NCT01897571|588828515|FG007|Overall Study|Lost to Follow-up|0|||
163034216|NCT01897571|588828516|FG008|Overall Study|Lost to Follow-up|1|||
163034217|NCT01897571|588828517|FG009|Overall Study|Lost to Follow-up|2|||
163034218|NCT01897571|588828518|FG010|Overall Study|Lost to Follow-up|4|||
163034219|NCT01897571|588828508|FG000|Overall Study|Withdrawal by Subject|0|||
163034220|NCT01897571|588828509|FG001|Overall Study|Withdrawal by Subject|0|||
163034221|NCT01897571|588828510|FG002|Overall Study|Withdrawal by Subject|0|||
163034222|NCT01897571|588828511|FG003|Overall Study|Withdrawal by Subject|0|||
163034223|NCT01897571|588828512|FG004|Overall Study|Withdrawal by Subject|0|||
163034224|NCT01897571|588828513|FG005|Overall Study|Withdrawal by Subject|0|||
163034225|NCT01897571|588828514|FG006|Overall Study|Withdrawal by Subject|0|||
163034226|NCT01897571|588828515|FG007|Overall Study|Withdrawal by Subject|1|||
163034227|NCT01897571|588828516|FG008|Overall Study|Withdrawal by Subject|4|||
163034228|NCT01897571|588828517|FG009|Overall Study|Withdrawal by Subject|3|||
163034229|NCT01897571|588828518|FG010|Overall Study|Withdrawal by Subject|1|||
163034230|NCT01897571|588828508|FG000|Overall Study|Other|1|||
163034231|NCT01897571|588828509|FG001|Overall Study|Other|0|||
163034232|NCT01897571|588828510|FG002|Overall Study|Other|0|||
163034233|NCT01897571|588828511|FG003|Overall Study|Other|3|||
163034234|NCT01897571|588828512|FG004|Overall Study|Other|3|||
163034235|NCT01897571|588828513|FG005|Overall Study|Other|4|||
163034236|NCT01897571|588828514|FG006|Overall Study|Other|7|||
163034237|NCT01897571|588828515|FG007|Overall Study|Other|0|||
163034238|NCT01897571|588828516|FG008|Overall Study|Other|0|||
163034239|NCT01897571|588828517|FG009|Overall Study|Other|0|||
163034240|NCT01897571|588828518|FG010|Overall Study|Other|0|||
163034241|NCT01897571|588828508|FG000|Overall Study|Enrolled in rollover study|0|||
163034242|NCT01897571|588828509|FG001|Overall Study|Enrolled in rollover study|0|||
163034243|NCT01897571|588828510|FG002|Overall Study|Enrolled in rollover study|0|||
163034244|NCT01897571|588828511|FG003|Overall Study|Enrolled in rollover study|0|||
163034245|NCT01897571|588828512|FG004|Overall Study|Enrolled in rollover study|0|||
163034246|NCT01897571|588828513|FG005|Overall Study|Enrolled in rollover study|0|||
163034247|NCT01897571|588828514|FG006|Overall Study|Enrolled in rollover study|0|||
163034248|NCT01897571|588828515|FG007|Overall Study|Enrolled in rollover study|9|||
163034249|NCT01897571|588828516|FG008|Overall Study|Enrolled in rollover study|7|||
163034250|NCT01897571|588828517|FG009|Overall Study|Enrolled in rollover study|9|||
163034251|NCT01897571|588828518|FG010|Overall Study|Enrolled in rollover study|1|||
163034252|NCT01897571|588828508|FG000|Overall Study|Death|2|||
163034253|NCT01897571|588828509|FG001|Overall Study|Death|2|||
163034254|NCT01897571|588828510|FG002|Overall Study|Death|3|||
163034255|NCT01897571|588828511|FG003|Overall Study|Death|6|||
163034256|NCT01897571|588828512|FG004|Overall Study|Death|7|||
163034257|NCT01897571|588828513|FG005|Overall Study|Death|9|||
163034258|NCT01897571|588828514|FG006|Overall Study|Death|5|||
163034259|NCT01897571|588828515|FG007|Overall Study|Death|22|||
163034260|NCT01897571|588828516|FG008|Overall Study|Death|23|||
163034261|NCT01897571|588828517|FG009|Overall Study|Death|129|||
163034262|NCT01897571|588828518|FG010|Overall Study|Death|59|||
163034263|NCT01797094|588828519|FG000|Overall Study|Adverse Event|1|||
163034264|NCT01797094|588828520|FG001|Overall Study|Adverse Event|1|||
163034265|NCT01797094|588828519|FG000|Overall Study|Personal Reasons|4|||
163034266|NCT01797094|588828520|FG001|Overall Study|Personal Reasons|0|||
163034267|NCT01797094|588828519|FG000|Overall Study|Protocol Violation|0|||
163034268|NCT01797094|588828520|FG001|Overall Study|Protocol Violation|1|||
163034269|NCT01797094|588828519|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163034270|NCT01797094|588828520|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163034271|NCT03217968|588828523|FG000|Overall Study|Withdrawal by Subject|4|||
163034272|NCT03217968|588828523|FG000|Overall Study|Lost to Follow-up|1|||
163034273|NCT03217968|588828523|FG000|Overall Study|Protocol Violation|6|||
163034274|NCT03008278|588828524|FG000|Overall Study|Progressive Disease|0|||
163034275|NCT03008278|588828525|FG001|Overall Study|Progressive Disease|0|||
163034276|NCT03008278|588828526|FG002|Overall Study|Progressive Disease|32|||
163034277|NCT03008278|588828524|FG000|Overall Study|Adverse Event|0|||
163034278|NCT03008278|588828525|FG001|Overall Study|Adverse Event|0|||
163034279|NCT03008278|588828526|FG002|Overall Study|Adverse Event|4|||
163034280|NCT03008278|588828524|FG000|Overall Study|Withdrawal by Subject|0|||
163034281|NCT03008278|588828525|FG001|Overall Study|Withdrawal by Subject|0|||
163034282|NCT03008278|588828526|FG002|Overall Study|Withdrawal by Subject|3|||
163034283|NCT03008278|588828524|FG000|Overall Study|Physician Decision|0|||
163034284|NCT03008278|588828525|FG001|Overall Study|Physician Decision|2|||
163034285|NCT03008278|588828526|FG002|Overall Study|Physician Decision|0|||
163034286|NCT01074255|588828527|FG000|Overall Study|Did not receive EMEND|2|||
163334417|NCT04660799|589934368|FG000|Overall Study|Adverse Event|2|||
163334418|NCT04660799|589934369|FG001|Overall Study|Adverse Event|1|||
163334419|NCT04660799|589934368|FG000|Overall Study|Withdrawal by Subject|2|||
163334420|NCT04660799|589934369|FG001|Overall Study|Withdrawal by Subject|5|||
163334421|NCT03131713|589934372|FG000|Overall Study|Lost to Follow-up|5|||
163334422|NCT03131713|589934373|FG001|Overall Study|Lost to Follow-up|0|||
163334423|NCT04748341|589934383|FG000|Overall Study|Lost to Follow-up|1|||
163334424|NCT04748341|589934384|FG001|Overall Study|Lost to Follow-up|1|||
163334425|NCT02334215|589934387|FG000|Overall Study|Death|1|||
163334426|NCT02334215|589934388|FG001|Overall Study|Death|1|||
163334427|NCT02334215|589934389|FG002|Overall Study|Death|0|||
163334428|NCT02334215|589934387|FG000|Overall Study|Lost to Follow-up|1|||
163334429|NCT02334215|589934388|FG001|Overall Study|Lost to Follow-up|0|||
163334430|NCT02334215|589934389|FG002|Overall Study|Lost to Follow-up|4|||
163334431|NCT02334215|589934387|FG000|Overall Study|Withdrawal by Subject|2|||
163334432|NCT02334215|589934388|FG001|Overall Study|Withdrawal by Subject|2|||
163334433|NCT02334215|589934389|FG002|Overall Study|Withdrawal by Subject|1|||
163334434|NCT02334215|589934387|FG000|Overall Study|Not released from incarceration on time|3|||
163334435|NCT02334215|589934388|FG001|Overall Study|Not released from incarceration on time|3|||
163334436|NCT02334215|589934389|FG002|Overall Study|Not released from incarceration on time|3|||
163334437|NCT02334215|589934387|FG000|Overall Study|Incarcerated|0|||
163334438|NCT02334215|589934388|FG001|Overall Study|Incarcerated|0|||
163334439|NCT02334215|589934389|FG002|Overall Study|Incarcerated|7|||
163334440|NCT05865392|589934392|FG000|Overall Study|Withdrawal by Subject|4|||
163334441|NCT05865392|589934393|FG001|Overall Study|Withdrawal by Subject|0|||
163334442|NCT05865392|589934392|FG000|Overall Study|Didn't meet inclusion criteria|4|||
163334443|NCT05865392|589934393|FG001|Overall Study|Didn't meet inclusion criteria|0|||
163334444|NCT02159989|589934394|FG000|Overall Study|Adverse Event|1|||
163334445|NCT02159989|589934395|FG001|Overall Study|Adverse Event|0|||
163334446|NCT02159989|589934396|FG002|Overall Study|Adverse Event|0|||
163334447|NCT02159989|589934397|FG003|Overall Study|Adverse Event|0|||
163334448|NCT02159989|589934398|FG004|Overall Study|Adverse Event|1|||
163334449|NCT02159989|589934399|FG005|Overall Study|Adverse Event|0|||
163334450|NCT02159989|589934400|FG006|Overall Study|Adverse Event|1|||
163334451|NCT02159989|589934401|FG007|Overall Study|Adverse Event|2|||
163334452|NCT02159989|589934402|FG008|Overall Study|Adverse Event|0|||
163334453|NCT02159989|589934403|FG009|Overall Study|Adverse Event|2|||
163334454|NCT02159989|589934404|FG010|Overall Study|Adverse Event|1|||
163334455|NCT02159989|589934394|FG000|Overall Study|Death|0|||
163334456|NCT02159989|589934395|FG001|Overall Study|Death|0|||
163334457|NCT02159989|589934396|FG002|Overall Study|Death|0|||
163334458|NCT02159989|589934397|FG003|Overall Study|Death|0|||
163334459|NCT02159989|589934398|FG004|Overall Study|Death|0|||
163334460|NCT02159989|589934399|FG005|Overall Study|Death|0|||
163334461|NCT02159989|589934400|FG006|Overall Study|Death|0|||
163334462|NCT02159989|589934401|FG007|Overall Study|Death|0|||
163334463|NCT02159989|589934402|FG008|Overall Study|Death|0|||
163334464|NCT02159989|589934403|FG009|Overall Study|Death|0|||
163334465|NCT02159989|589934404|FG010|Overall Study|Death|1|||
163334466|NCT02159989|589934394|FG000|Overall Study|Lack of Efficacy|2|||
163334467|NCT02159989|589934395|FG001|Overall Study|Lack of Efficacy|3|||
163334468|NCT02159989|589934396|FG002|Overall Study|Lack of Efficacy|3|||
163406748|NCT03016325|590198749|FG000|Treatment Period|Participant refuses assessments|0|||
163406749|NCT03016325|590198750|FG001|Treatment Period|Participant refuses assessments|0|||
163406750|NCT03016325|590198751|FG002|Treatment Period|Participant refuses assessments|1|||
163406751|NCT03016325|590198752|FG003|Treatment Period|Participant refuses assessments|0|||
163406752|NCT03016325|590198753|FG004|Treatment Period|Participant refuses assessments|0|||
163334469|NCT02159989|589934397|FG003|Overall Study|Lack of Efficacy|0|||
163334470|NCT02159989|589934398|FG004|Overall Study|Lack of Efficacy|2|||
163334471|NCT02159989|589934399|FG005|Overall Study|Lack of Efficacy|3|||
163334472|NCT02159989|589934400|FG006|Overall Study|Lack of Efficacy|3|||
163334473|NCT02159989|589934401|FG007|Overall Study|Lack of Efficacy|1|||
163334474|NCT02159989|589934402|FG008|Overall Study|Lack of Efficacy|3|||
163334475|NCT02159989|589934403|FG009|Overall Study|Lack of Efficacy|6|||
163334476|NCT02159989|589934404|FG010|Overall Study|Lack of Efficacy|7|||
163334477|NCT02159989|589934394|FG000|Overall Study|Lost to Follow-up|0|||
163334478|NCT02159989|589934395|FG001|Overall Study|Lost to Follow-up|0|||
163334479|NCT02159989|589934396|FG002|Overall Study|Lost to Follow-up|0|||
163406753|NCT03016325|590198754|FG005|Treatment Period|Participant refuses assessments|0|||
163334480|NCT02159989|589934397|FG003|Overall Study|Lost to Follow-up|1|||
163334481|NCT02159989|589934398|FG004|Overall Study|Lost to Follow-up|0|||
163334482|NCT02159989|589934399|FG005|Overall Study|Lost to Follow-up|0|||
163034287|NCT01389258|588828528|FG000|Overall Study|Lost to Follow-up|5|||
163334483|NCT02159989|589934400|FG006|Overall Study|Lost to Follow-up|0|||
163334484|NCT02159989|589934401|FG007|Overall Study|Lost to Follow-up|0|||
163334485|NCT02159989|589934402|FG008|Overall Study|Lost to Follow-up|0|||
163334486|NCT02159989|589934403|FG009|Overall Study|Lost to Follow-up|0|||
163334487|NCT02159989|589934404|FG010|Overall Study|Lost to Follow-up|1|||
163334488|NCT02159989|589934394|FG000|Overall Study|Withdrawal by Subject|2|||
163334489|NCT02159989|589934395|FG001|Overall Study|Withdrawal by Subject|0|||
163334490|NCT02159989|589934396|FG002|Overall Study|Withdrawal by Subject|0|||
163334491|NCT02159989|589934397|FG003|Overall Study|Withdrawal by Subject|2|||
163334492|NCT02159989|589934398|FG004|Overall Study|Withdrawal by Subject|1|||
163334493|NCT02159989|589934399|FG005|Overall Study|Withdrawal by Subject|0|||
163334494|NCT02159989|589934400|FG006|Overall Study|Withdrawal by Subject|3|||
163334495|NCT02159989|589934401|FG007|Overall Study|Withdrawal by Subject|1|||
163334496|NCT02159989|589934402|FG008|Overall Study|Withdrawal by Subject|0|||
163334497|NCT02159989|589934403|FG009|Overall Study|Withdrawal by Subject|0|||
163334498|NCT02159989|589934404|FG010|Overall Study|Withdrawal by Subject|0|||
163334499|NCT02159989|589934394|FG000|Overall Study|New treatment|0|||
163334500|NCT02159989|589934395|FG001|Overall Study|New treatment|1|||
163334501|NCT02159989|589934396|FG002|Overall Study|New treatment|0|||
163334502|NCT02159989|589934397|FG003|Overall Study|New treatment|0|||
163334503|NCT02159989|589934398|FG004|Overall Study|New treatment|0|||
163334504|NCT02159989|589934399|FG005|Overall Study|New treatment|0|||
163334505|NCT02159989|589934400|FG006|Overall Study|New treatment|0|||
163334506|NCT02159989|589934401|FG007|Overall Study|New treatment|0|||
163334507|NCT02159989|589934402|FG008|Overall Study|New treatment|0|||
163334508|NCT02159989|589934403|FG009|Overall Study|New treatment|0|||
163334509|NCT02159989|589934404|FG010|Overall Study|New treatment|0|||
163334510|NCT02159989|589934394|FG000|Overall Study|Insurance Issues|0|||
163334511|NCT02159989|589934395|FG001|Overall Study|Insurance Issues|0|||
163334512|NCT02159989|589934396|FG002|Overall Study|Insurance Issues|0|||
163334513|NCT02159989|589934397|FG003|Overall Study|Insurance Issues|0|||
163334514|NCT02159989|589934398|FG004|Overall Study|Insurance Issues|0|||
163334515|NCT02159989|589934399|FG005|Overall Study|Insurance Issues|0|||
163334516|NCT02159989|589934400|FG006|Overall Study|Insurance Issues|0|||
163334517|NCT02159989|589934401|FG007|Overall Study|Insurance Issues|0|||
163334518|NCT02159989|589934402|FG008|Overall Study|Insurance Issues|0|||
163334519|NCT02159989|589934403|FG009|Overall Study|Insurance Issues|1|||
163334520|NCT02159989|589934404|FG010|Overall Study|Insurance Issues|0|||
163334521|NCT02485925|589934406|FG000|Overall Study|Withdrawal by Subject|3|||
163334522|NCT02485925|589934406|FG000|Overall Study|Death|1|||
163334523|NCT02485925|589934406|FG000|Overall Study|Lost to Follow-up|11|||
163334524|NCT05995977|589934407|FG000|Overall Study|Withdrawal by Subject|1|||
163334525|NCT05995977|589934408|FG001|Overall Study|Withdrawal by Subject|4|||
163334526|NCT05995977|589934407|FG000|Overall Study|Lost to Follow-up|2|||
163334527|NCT05995977|589934408|FG001|Overall Study|Lost to Follow-up|0|||
163334528|NCT04181788|589934409|FG000|TREATMENT|Adverse Event|0|||
163334529|NCT04181788|589934410|FG001|TREATMENT|Adverse Event|2|||
163334530|NCT04181788|589934411|FG002|TREATMENT|Adverse Event|1|||
163334531|NCT04181788|589934412|FG003|TREATMENT|Adverse Event|0|||
163334532|NCT04181788|589934413|FG004|TREATMENT|Adverse Event|1|||
163334533|NCT04181788|589934414|FG005|TREATMENT|Adverse Event|3|||
163334534|NCT04181788|589934409|FG000|TREATMENT|Death|0|||
163334535|NCT04181788|589934410|FG001|TREATMENT|Death|0|||
163334536|NCT04181788|589934411|FG002|TREATMENT|Death|0|||
163334537|NCT04181788|589934412|FG003|TREATMENT|Death|0|||
163334538|NCT04181788|589934413|FG004|TREATMENT|Death|8|||
163334539|NCT04181788|589934414|FG005|TREATMENT|Death|8|||
163334540|NCT04181788|589934409|FG000|TREATMENT|Physician Decision|0|||
163334541|NCT04181788|589934410|FG001|TREATMENT|Physician Decision|0|||
163334542|NCT04181788|589934411|FG002|TREATMENT|Physician Decision|0|||
163334543|NCT04181788|589934412|FG003|TREATMENT|Physician Decision|0|||
163334544|NCT04181788|589934413|FG004|TREATMENT|Physician Decision|0|||
163334545|NCT04181788|589934414|FG005|TREATMENT|Physician Decision|1|||
163334546|NCT04181788|589934409|FG000|TREATMENT|Progressive disease|3|||
163334547|NCT04181788|589934410|FG001|TREATMENT|Progressive disease|3|||
163334548|NCT04181788|589934411|FG002|TREATMENT|Progressive disease|5|||
163334549|NCT04181788|589934412|FG003|TREATMENT|Progressive disease|7|||
163334550|NCT04181788|589934413|FG004|TREATMENT|Progressive disease|20|||
163334551|NCT04181788|589934414|FG005|TREATMENT|Progressive disease|38|||
163406754|NCT03016325|590198755|FG006|Treatment Period|Participant refuses assessments|0|||
163034288|NCT03313310|588828530|FG000|Phase 2|Lost to Follow-up|4|||
163034289|NCT03313310|588828531|FG001|Phase 2|Lost to Follow-up|0|||
163334552|NCT04181788|589934409|FG000|TREATMENT|Global deterioration of health status|0|||
163334553|NCT04181788|589934410|FG001|TREATMENT|Global deterioration of health status|2|||
163334554|NCT04181788|589934411|FG002|TREATMENT|Global deterioration of health status|0|||
163334555|NCT04181788|589934412|FG003|TREATMENT|Global deterioration of health status|0|||
163334556|NCT04181788|589934413|FG004|TREATMENT|Global deterioration of health status|2|||
163334557|NCT04181788|589934414|FG005|TREATMENT|Global deterioration of health status|8|||
163334558|NCT04181788|589934409|FG000|TREATMENT|Withdrawal by Subject|1|||
163334559|NCT04181788|589934410|FG001|TREATMENT|Withdrawal by Subject|2|||
163334560|NCT04181788|589934411|FG002|TREATMENT|Withdrawal by Subject|0|||
163334561|NCT04181788|589934412|FG003|TREATMENT|Withdrawal by Subject|0|||
163034290|NCT03313310|588828530|FG000|Phase 3|Lost to Follow-up|0|||
163334562|NCT04181788|589934413|FG004|TREATMENT|Withdrawal by Subject|3|||
163334563|NCT04181788|589934414|FG005|TREATMENT|Withdrawal by Subject|5|||
163334564|NCT04181788|589934409|FG000|TREATMENT|Other unspecified|0|||
163334565|NCT04181788|589934410|FG001|TREATMENT|Other unspecified|0|||
163334566|NCT04181788|589934411|FG002|TREATMENT|Other unspecified|0|||
163406755|NCT03016325|590198756|FG007|Treatment Period|Participant refuses assessments|0|||
163406756|NCT03016325|590198749|FG000|32-Day Follow-Up Period|Death|2|||
163406757|NCT03016325|590198750|FG001|32-Day Follow-Up Period|Death|0|||
163406758|NCT03016325|590198751|FG002|32-Day Follow-Up Period|Death|5|||
163406759|NCT03016325|590198752|FG003|32-Day Follow-Up Period|Death|6|||
163406760|NCT03016325|590198753|FG004|32-Day Follow-Up Period|Death|3|||
163406761|NCT03016325|590198754|FG005|32-Day Follow-Up Period|Death|0|||
163406762|NCT03016325|590198755|FG006|32-Day Follow-Up Period|Death|0|||
163406763|NCT03016325|590198756|FG007|32-Day Follow-Up Period|Death|0|||
163406764|NCT03016325|590198749|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
163406765|NCT03016325|590198750|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
163406766|NCT03016325|590198751|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
163406767|NCT03016325|590198752|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
163406768|NCT03016325|590198753|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
163406769|NCT03016325|590198754|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
163406770|NCT03016325|590198755|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
163406771|NCT03016325|590198756|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
163406772|NCT03016325|590198749|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
163406773|NCT03016325|590198750|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
163406774|NCT03016325|590198751|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
163406775|NCT03016325|590198752|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
163406776|NCT03016325|590198753|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
163406777|NCT03016325|590198754|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
163406778|NCT03016325|590198755|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
163406779|NCT03016325|590198756|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
163406780|NCT03016325|590198749|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
163406781|NCT03016325|590198750|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
163406782|NCT03016325|590198751|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
163406783|NCT03016325|590198752|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
163034291|NCT03313310|588828531|FG001|Phase 3|Lost to Follow-up|1|||
163034292|NCT01281956|588828534|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
163034293|NCT01281956|588828535|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
163034294|NCT03677934|588828538|FG000|Overall Study|Adverse Event|1|||
163034295|NCT03677934|588828539|FG001|Overall Study|Adverse Event|1|||
163034296|NCT03677934|588828538|FG000|Overall Study|Death|8|||
163034297|NCT03677934|588828539|FG001|Overall Study|Death|4|||
163034298|NCT03677934|588828538|FG000|Overall Study|Lost to Follow-up|3|||
163034299|NCT03677934|588828539|FG001|Overall Study|Lost to Follow-up|0|||
163034300|NCT03677934|588828538|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163034301|NCT03677934|588828539|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163034302|NCT03677934|588828538|FG000|Overall Study|Physician Decision|0|||
163034303|NCT03677934|588828539|FG001|Overall Study|Physician Decision|1|||
163034304|NCT03677934|588828538|FG000|Overall Study|Withdrawal by Subject|1|||
163034305|NCT03677934|588828539|FG001|Overall Study|Withdrawal by Subject|7|||
163034306|NCT04769739|588828540|FG000|Overall Study|Colorectal cancer obstruction|2|||
163034307|NCT04769739|588828541|FG001|Overall Study|Colorectal cancer obstruction|0|||
163034308|NCT04769739|588828542|FG002|Overall Study|Colorectal cancer obstruction|0|||
163034309|NCT04769739|588828543|FG003|Overall Study|Colorectal cancer obstruction|0|||
163034310|NCT04769739|588828540|FG000|Overall Study|Failed cecal intubation|1|||
163034311|NCT04769739|588828541|FG001|Overall Study|Failed cecal intubation|0|||
163034312|NCT04769739|588828542|FG002|Overall Study|Failed cecal intubation|0|||
163034313|NCT04769739|588828543|FG003|Overall Study|Failed cecal intubation|1|||
163034314|NCT04769739|588828540|FG000|Overall Study|Poor bowel preparation|0|||
163034315|NCT04769739|588828541|FG001|Overall Study|Poor bowel preparation|0|||
163034316|NCT04769739|588828542|FG002|Overall Study|Poor bowel preparation|0|||
163034317|NCT04769739|588828543|FG003|Overall Study|Poor bowel preparation|1|||
163034318|NCT02407054|588828565|FG000|Overall Study|Adverse Event|1|||
163034319|NCT02407054|588828566|FG001|Overall Study|Adverse Event|4|||
163034320|NCT02407054|588828567|FG002|Overall Study|Adverse Event|1|||
163034321|NCT02407054|588828565|FG000|Overall Study|Non-compliance with Study|0|||
163034322|NCT02407054|588828566|FG001|Overall Study|Non-compliance with Study|2|||
163034323|NCT02407054|588828567|FG002|Overall Study|Non-compliance with Study|1|||
163034324|NCT02407054|588828565|FG000|Overall Study|Physician Decision|1|||
163034325|NCT02407054|588828566|FG001|Overall Study|Physician Decision|3|||
163034326|NCT02407054|588828567|FG002|Overall Study|Physician Decision|3|||
163034327|NCT02407054|588828565|FG000|Overall Study|Withdrawal by Subject|5|||
163034328|NCT02407054|588828566|FG001|Overall Study|Withdrawal by Subject|9|||
163034329|NCT02407054|588828567|FG002|Overall Study|Withdrawal by Subject|2|||
163034330|NCT00932698|588828570|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
163034331|NCT00932698|588828571|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
163034332|NCT00932698|588828572|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
163034333|NCT00932698|588828573|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
163034334|NCT00932698|588828574|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
163406784|NCT03016325|590198753|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
163406785|NCT03016325|590198754|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
163034335|NCT00932698|588828575|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
163034336|NCT00932698|588828576|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
163034337|NCT00932698|588828577|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
163034338|NCT00932698|588828578|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
163034339|NCT00932698|588828579|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
163034340|NCT00932698|588828580|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
163034341|NCT00932698|588828570|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
163034342|NCT00932698|588828571|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
163034343|NCT00932698|588828572|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
163034344|NCT00932698|588828573|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
163034345|NCT00932698|588828574|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
163034346|NCT00932698|588828575|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
163034347|NCT00932698|588828576|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
163034348|NCT00932698|588828577|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
163034349|NCT00932698|588828578|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
163034350|NCT00932698|588828579|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
163034351|NCT00932698|588828580|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
163034352|NCT00932698|588828570|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
163034353|NCT00932698|588828571|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
163034354|NCT00932698|588828572|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
163034355|NCT00932698|588828573|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
163034356|NCT00932698|588828574|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
163034357|NCT00932698|588828575|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
163034358|NCT00932698|588828576|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
163034359|NCT00932698|588828577|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
163034360|NCT00932698|588828578|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
163034361|NCT00932698|588828579|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
163034362|NCT00932698|588828580|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
163034363|NCT00932698|588828570|FG000|Part 1 (Dose Escalation)|Other|0|||
163034364|NCT00932698|588828571|FG001|Part 1 (Dose Escalation)|Other|0|||
163034365|NCT00932698|588828572|FG002|Part 1 (Dose Escalation)|Other|1|||
163034366|NCT00932698|588828573|FG003|Part 1 (Dose Escalation)|Other|0|||
163034367|NCT00932698|588828574|FG004|Part 1 (Dose Escalation)|Other|0|||
163034368|NCT00932698|588828575|FG005|Part 1 (Dose Escalation)|Other|0|||
163034369|NCT00932698|588828576|FG006|Part 1 (Dose Escalation)|Other|1|||
163034370|NCT00932698|588828577|FG007|Part 1 (Dose Escalation)|Other|0|||
163034371|NCT00932698|588828578|FG008|Part 1 (Dose Escalation)|Other|0|||
163034372|NCT00932698|588828579|FG009|Part 1 (Dose Escalation)|Other|0|||
163034373|NCT00932698|588828580|FG010|Part 1 (Dose Escalation)|Other|0|||
163034374|NCT00932698|588828570|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
163034375|NCT00932698|588828571|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
163034376|NCT00932698|588828572|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
163034377|NCT00932698|588828573|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
163034378|NCT00932698|588828574|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
163034379|NCT00932698|588828575|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
163034380|NCT00932698|588828576|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
163034381|NCT00932698|588828577|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
163034382|NCT00932698|588828578|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
163034383|NCT00932698|588828579|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
163034384|NCT00932698|588828580|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
163034385|NCT00932698|588828570|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
163334567|NCT04181788|589934412|FG003|TREATMENT|Other unspecified|0|||
163334568|NCT04181788|589934413|FG004|TREATMENT|Other unspecified|0|||
163334569|NCT04181788|589934414|FG005|TREATMENT|Other unspecified|2|||
163334570|NCT04181788|589934409|FG000|TREATMENT|Ongoing|0|||
163334571|NCT04181788|589934410|FG001|TREATMENT|Ongoing|3|||
163334572|NCT04181788|589934411|FG002|TREATMENT|Ongoing|0|||
163334573|NCT04181788|589934412|FG003|TREATMENT|Ongoing|5|||
163334574|NCT04181788|589934413|FG004|TREATMENT|Ongoing|7|||
163334575|NCT04181788|589934414|FG005|TREATMENT|Ongoing|15|||
163406786|NCT03016325|590198755|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
163334576|NCT04181788|589934409|FG000|FOLLOW-UP|Death|0|||
163334577|NCT04181788|589934410|FG001|FOLLOW-UP|Death|0|||
163406787|NCT03016325|590198756|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
163406788|NCT03016325|590198749|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
163406789|NCT03016325|590198750|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
163406790|NCT03016325|590198751|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
163034386|NCT00932698|588828571|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
163034387|NCT00932698|588828572|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
163034388|NCT00932698|588828573|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
163034389|NCT00932698|588828574|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
163034390|NCT00932698|588828575|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
163334578|NCT04181788|589934411|FG002|FOLLOW-UP|Death|1|||
163334579|NCT04181788|589934412|FG003|FOLLOW-UP|Death|2|||
163334580|NCT04181788|589934413|FG004|FOLLOW-UP|Death|8|||
163334581|NCT04181788|589934414|FG005|FOLLOW-UP|Death|20|||
163334582|NCT04181788|589934409|FG000|FOLLOW-UP|Lost to Follow-up|0|||
163334583|NCT04181788|589934410|FG001|FOLLOW-UP|Lost to Follow-up|0|||
163334584|NCT04181788|589934411|FG002|FOLLOW-UP|Lost to Follow-up|0|||
163334585|NCT04181788|589934412|FG003|FOLLOW-UP|Lost to Follow-up|0|||
163334586|NCT04181788|589934413|FG004|FOLLOW-UP|Lost to Follow-up|0|||
163034391|NCT00932698|588828576|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
163034392|NCT00932698|588828577|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
163034393|NCT00932698|588828578|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
163034394|NCT00932698|588828579|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
163034395|NCT00932698|588828580|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
163034396|NCT00932698|588828570|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
163334587|NCT04181788|589934414|FG005|FOLLOW-UP|Lost to Follow-up|2|||
163034397|NCT00932698|588828571|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
163034398|NCT00932698|588828572|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
163034399|NCT00932698|588828573|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
163034400|NCT00932698|588828574|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
163034401|NCT00932698|588828575|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
163034402|NCT00932698|588828576|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
163034403|NCT00932698|588828577|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
163034404|NCT00932698|588828578|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
163034405|NCT00932698|588828579|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
163034406|NCT00932698|588828580|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
163034407|NCT01447927|588828581|FG000|Overall Study|Adverse Event|4|||
163034408|NCT01447927|588828582|FG001|Overall Study|Adverse Event|3|||
163034409|NCT01447927|588828581|FG000|Overall Study|Withdrawal by Subject|1|||
163034410|NCT01447927|588828582|FG001|Overall Study|Withdrawal by Subject|0|||
163034411|NCT00642954|588830368|FG000|Overall Study|Progressive Disease|3|||
163034412|NCT00642954|588830369|FG001|Overall Study|Progressive Disease|3|||
163085605|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
163085606|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
163085607|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
163085608|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
163085609|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
163085610|NCT03093415|589022327|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
163085611|NCT03093415|589022328|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
163085612|NCT03093415|589022329|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
163085613|NCT03559530|589022330|FG000|Overall Study|non-location of medical records|44|||
163085614|NCT03559530|589022331|FG001|Overall Study|non-location of medical records|0|||
163334588|NCT04181788|589934409|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
163334589|NCT04181788|589934410|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
163334590|NCT04181788|589934411|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
163034413|NCT00642954|588830370|FG002|Overall Study|Progressive Disease|3|||
163034414|NCT00642954|588830371|FG003|Overall Study|Progressive Disease|3|||
163034415|NCT00642954|588830372|FG004|Overall Study|Progressive Disease|9|||
163034416|NCT00642954|588830368|FG000|Overall Study|Withdrawal by Subject|0|||
163034417|NCT00642954|588830369|FG001|Overall Study|Withdrawal by Subject|0|||
163034418|NCT00642954|588830370|FG002|Overall Study|Withdrawal by Subject|0|||
163034419|NCT00642954|588830371|FG003|Overall Study|Withdrawal by Subject|0|||
163034420|NCT00642954|588830372|FG004|Overall Study|Withdrawal by Subject|1|||
163034421|NCT00642954|588830368|FG000|Overall Study|Adverse Event|1|||
163034422|NCT00642954|588830369|FG001|Overall Study|Adverse Event|1|||
163034423|NCT00642954|588830370|FG002|Overall Study|Adverse Event|0|||
163034424|NCT00642954|588830371|FG003|Overall Study|Adverse Event|0|||
163034425|NCT00642954|588830372|FG004|Overall Study|Adverse Event|6|||
163034426|NCT01344759|588830373|FG000|Overall Study|Patients failed to reach sedation level|0|||
163034427|NCT01344759|588830374|FG001|Overall Study|Patients failed to reach sedation level|2|||
163034428|NCT01890759|588830375|FG000|Overall Study|Protocol Violation|0|||
163034429|NCT01890759|588830376|FG001|Overall Study|Protocol Violation|2|||
163034430|NCT01890759|588830375|FG000|Overall Study|Lost to Follow-up|0|||
163334591|NCT04181788|589934412|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
163334592|NCT04181788|589934413|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
163334593|NCT04181788|589934414|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
163034431|NCT01890759|588830376|FG001|Overall Study|Lost to Follow-up|2|||
163034432|NCT01890759|588830375|FG000|Overall Study|Withdrawal by Subject|2|||
163034433|NCT01890759|588830376|FG001|Overall Study|Withdrawal by Subject|8|||
163034434|NCT04114656|588830379|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
163034435|NCT04114656|588830380|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
163034436|NCT04114656|588830379|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
163034437|NCT04114656|588830380|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
163034438|NCT04114656|588830379|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
163034439|NCT04114656|588830380|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
163334594|NCT04181788|589934409|FG000|FOLLOW-UP|Other unspecified|0|||
163334595|NCT04181788|589934410|FG001|FOLLOW-UP|Other unspecified|1|||
163334596|NCT04181788|589934411|FG002|FOLLOW-UP|Other unspecified|0|||
163334597|NCT04181788|589934412|FG003|FOLLOW-UP|Other unspecified|0|||
163334598|NCT04181788|589934413|FG004|FOLLOW-UP|Other unspecified|0|||
163334599|NCT04181788|589934414|FG005|FOLLOW-UP|Other unspecified|3|||
163334600|NCT04181788|589934409|FG000|FOLLOW-UP|Ongoing|0|||
163334601|NCT04181788|589934410|FG001|FOLLOW-UP|Ongoing|0|||
163034440|NCT04114656|588830379|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
163034441|NCT04114656|588830380|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
163034442|NCT04114656|588830379|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
163034443|NCT04114656|588830380|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
163034444|NCT00703326|588830381|FG000|Overall Study|Lost to Follow-up|47|||
163034445|NCT00703326|588830382|FG001|Overall Study|Lost to Follow-up|18|||
163034446|NCT00703326|588830381|FG000|Overall Study|Withdrawal by Subject|54|||
163034447|NCT00703326|588830382|FG001|Overall Study|Withdrawal by Subject|20|||
163034448|NCT00703326|588830381|FG000|Overall Study|Adverse Event|1|||
163034449|NCT00703326|588830382|FG001|Overall Study|Adverse Event|0|||
163034450|NCT02661061|588830383|FG000|Overall Study|Lack of Efficacy|1|||
163034451|NCT02661061|588830384|FG001|Overall Study|Lack of Efficacy|1|||
163034452|NCT02661061|588830383|FG000|Overall Study|Withdrawal by Subject|1|||
163034453|NCT02661061|588830384|FG001|Overall Study|Withdrawal by Subject|1|||
163034454|NCT02732015|588830385|FG000|Overall Study|Lost to Follow-up|0|||
163034455|NCT02732015|588830386|FG001|Overall Study|Lost to Follow-up|1|||
163034456|NCT03052920|588830387|FG000|Overall Study|Withdrawal by Subject|1|||
163034457|NCT01937715|588830388|FG000|Overall Study|Death|0|||
163034458|NCT01937715|588830389|FG001|Overall Study|Death|0|||
163034459|NCT01937715|588830390|FG002|Overall Study|Death|0|||
163034460|NCT01937715|588830391|FG003|Overall Study|Death|1|||
163034461|NCT01937715|588830392|FG004|Overall Study|Death|0|||
163034462|NCT01937715|588830388|FG000|Overall Study|Withdrawal by Subject|0|||
163034463|NCT01937715|588830389|FG001|Overall Study|Withdrawal by Subject|1|||
163034464|NCT01937715|588830390|FG002|Overall Study|Withdrawal by Subject|0|||
163034465|NCT01937715|588830391|FG003|Overall Study|Withdrawal by Subject|0|||
163034466|NCT01937715|588830392|FG004|Overall Study|Withdrawal by Subject|2|||
163034467|NCT01937715|588830388|FG000|Overall Study|Other|0|||
163034468|NCT01937715|588830389|FG001|Overall Study|Other|0|||
163034469|NCT01937715|588830390|FG002|Overall Study|Other|0|||
163034470|NCT01937715|588830391|FG003|Overall Study|Other|3|||
163034471|NCT01937715|588830392|FG004|Overall Study|Other|0|||
163034472|NCT00433017|588830395|FG000|Overall Study|Adverse Event|5|||
163034473|NCT00433017|588830396|FG001|Overall Study|Adverse Event|3|||
163034474|NCT00433017|588830395|FG000|Overall Study|Withdrawal by Subject|4|||
163034475|NCT00433017|588830396|FG001|Overall Study|Withdrawal by Subject|5|||
163034476|NCT00433017|588830395|FG000|Overall Study|Lost to Follow-up|3|||
163034477|NCT00433017|588830396|FG001|Overall Study|Lost to Follow-up|4|||
163034478|NCT00433017|588830395|FG000|Overall Study|Administrative problems|80|||
163034479|NCT00433017|588830396|FG001|Overall Study|Administrative problems|86|||
163034480|NCT00433017|588830395|FG000|Overall Study|Protocol Violation|1|||
163034481|NCT00433017|588830396|FG001|Overall Study|Protocol Violation|0|||
163034482|NCT00433017|588830395|FG000|Overall Study|Death|2|||
163034483|NCT00433017|588830396|FG001|Overall Study|Death|2|||
163034484|NCT00433017|588830395|FG000|Overall Study|Subject no longer requires study drug|1|||
163034485|NCT00433017|588830396|FG001|Overall Study|Subject no longer requires study drug|1|||
163034486|NCT00153816|588830397|FG000|Overall Study|Death|6|||
163034487|NCT00153816|588830398|FG001|Overall Study|Death|5|||
163034488|NCT00153816|588830399|FG002|Overall Study|Death|4|||
163034489|NCT00153816|588830400|FG003|Overall Study|Death|6|||
163034490|NCT00153816|588830401|FG004|Overall Study|Death|0|||
163034491|NCT00153816|588830402|FG005|Overall Study|Death|2|||
163034492|NCT00153816|588830397|FG000|Overall Study|Lost to Follow-up|7|||
163034493|NCT00153816|588830398|FG001|Overall Study|Lost to Follow-up|8|||
163334602|NCT04181788|589934411|FG002|FOLLOW-UP|Ongoing|1|||
163334603|NCT04181788|589934412|FG003|FOLLOW-UP|Ongoing|3|||
163334604|NCT04181788|589934413|FG004|FOLLOW-UP|Ongoing|2|||
163334605|NCT04181788|589934414|FG005|FOLLOW-UP|Ongoing|2|||
163034494|NCT00153816|588830399|FG002|Overall Study|Lost to Follow-up|5|||
163034495|NCT00153816|588830400|FG003|Overall Study|Lost to Follow-up|8|||
163034496|NCT00153816|588830401|FG004|Overall Study|Lost to Follow-up|7|||
163034497|NCT00153816|588830402|FG005|Overall Study|Lost to Follow-up|9|||
163034498|NCT00153816|588830397|FG000|Overall Study|Withdrawal by Subject|9|||
163085615|NCT03559530|589022330|FG000|Overall Study|culture results not considered for treat|29|||
163334606|NCT04937504|589934415|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
163334607|NCT04937504|589934416|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
163034499|NCT00153816|588830398|FG001|Overall Study|Withdrawal by Subject|9|||
163034500|NCT00153816|588830399|FG002|Overall Study|Withdrawal by Subject|9|||
163034501|NCT00153816|588830400|FG003|Overall Study|Withdrawal by Subject|4|||
163034502|NCT00153816|588830401|FG004|Overall Study|Withdrawal by Subject|1|||
163334608|NCT04937504|589934415|FG000|9 Months Assessment|Lost to Follow-up|3|||
163334609|NCT04937504|589934416|FG001|9 Months Assessment|Lost to Follow-up|2|||
163334610|NCT04535414|589934417|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
163334611|NCT04535414|589934418|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
163334612|NCT04535414|589934417|FG000|Overall Study|Cancelled appointment|1|||
163334613|NCT04535414|589934418|FG001|Overall Study|Cancelled appointment|0|||
163334614|NCT04535414|589934417|FG000|Overall Study|cancelled - food in stomach|2|||
163334615|NCT04535414|589934418|FG001|Overall Study|cancelled - food in stomach|0|||
163334616|NCT04535414|589934417|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
163334617|NCT04535414|589934418|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
163334618|NCT04535414|589934417|FG000|Overall Study|Withdrawal by Subject|0|||
163334619|NCT04535414|589934418|FG001|Overall Study|Withdrawal by Subject|1|||
163334620|NCT03662659|589934419|FG000|Pre-treatment|Participant no longer met study criteria|1|||
163334621|NCT03662659|589934420|FG001|Pre-treatment|Participant no longer met study criteria|1|||
163334622|NCT03662659|589934419|FG000|Pre-treatment|Other reasons|1|||
163334623|NCT03662659|589934420|FG001|Pre-treatment|Other reasons|0|||
163334624|NCT03662659|589934419|FG000|Treatment|Completed Treatment|0|||
163334625|NCT03662659|589934420|FG001|Treatment|Completed Treatment|2|||
163334626|NCT03662659|589934419|FG000|Treatment|Disease Progression|85|||
163334627|NCT03662659|589934420|FG001|Treatment|Disease Progression|97|||
163334628|NCT03662659|589934419|FG000|Treatment|Study Drug Toxicity|19|||
163334629|NCT03662659|589934420|FG001|Treatment|Study Drug Toxicity|9|||
163034503|NCT00153816|588830402|FG005|Overall Study|Withdrawal by Subject|5|||
163034504|NCT00153816|588830397|FG000|Overall Study|Follow-up exam not done|8|||
163034505|NCT00153816|588830398|FG001|Overall Study|Follow-up exam not done|7|||
163034506|NCT00153816|588830399|FG002|Overall Study|Follow-up exam not done|11|||
163034507|NCT00153816|588830400|FG003|Overall Study|Follow-up exam not done|10|||
163034508|NCT00153816|588830401|FG004|Overall Study|Follow-up exam not done|8|||
163034509|NCT00153816|588830402|FG005|Overall Study|Follow-up exam not done|9|||
163034510|NCT00153816|588830397|FG000|Overall Study|Follow-up exam done, histology missing|2|||
163034511|NCT00153816|588830398|FG001|Overall Study|Follow-up exam done, histology missing|3|||
163034512|NCT00153816|588830399|FG002|Overall Study|Follow-up exam done, histology missing|3|||
163034513|NCT00153816|588830400|FG003|Overall Study|Follow-up exam done, histology missing|3|||
163034514|NCT00153816|588830401|FG004|Overall Study|Follow-up exam done, histology missing|1|||
163034515|NCT00153816|588830402|FG005|Overall Study|Follow-up exam done, histology missing|2|||
163034516|NCT03594955|588830406|FG000|Overall Study|Adverse Event|1|||
163034517|NCT03594955|588830406|FG000|Overall Study|Progressive disease|5|||
163034518|NCT03594955|588830406|FG000|Overall Study|Sponsor's decision|1|||
163034519|NCT03539484|588830408|FG000|Overall Study|Death|1|||
163034520|NCT03539484|588830409|FG001|Overall Study|Death|0|||
163034521|NCT03539484|588830410|FG002|Overall Study|Death|0|||
163034522|NCT03539484|588830411|FG003|Overall Study|Death|2|||
163034523|NCT03539484|588830412|FG004|Overall Study|Death|8|||
163034524|NCT03539484|588830413|FG005|Overall Study|Death|3|||
163034525|NCT03539484|588830414|FG006|Overall Study|Death|0|||
163034526|NCT03539484|588830408|FG000|Overall Study|Lost to Follow-up|0|||
163034527|NCT03539484|588830409|FG001|Overall Study|Lost to Follow-up|1|||
163034528|NCT03539484|588830410|FG002|Overall Study|Lost to Follow-up|0|||
163034529|NCT03539484|588830411|FG003|Overall Study|Lost to Follow-up|0|||
163034530|NCT03539484|588830412|FG004|Overall Study|Lost to Follow-up|1|||
163034531|NCT03539484|588830413|FG005|Overall Study|Lost to Follow-up|0|||
163034532|NCT03539484|588830414|FG006|Overall Study|Lost to Follow-up|0|||
163034533|NCT03539484|588830408|FG000|Overall Study|Withdrawal by Subject|0|||
163034534|NCT03539484|588830409|FG001|Overall Study|Withdrawal by Subject|0|||
163034535|NCT03539484|588830410|FG002|Overall Study|Withdrawal by Subject|0|||
163034536|NCT03539484|588830411|FG003|Overall Study|Withdrawal by Subject|0|||
163034537|NCT03539484|588830412|FG004|Overall Study|Withdrawal by Subject|2|||
163034538|NCT03539484|588830413|FG005|Overall Study|Withdrawal by Subject|0|||
163034539|NCT03539484|588830414|FG006|Overall Study|Withdrawal by Subject|1|||
163034540|NCT03539484|588830408|FG000|Overall Study|Study Terminated by Sponsor|0|||
163034541|NCT03539484|588830409|FG001|Overall Study|Study Terminated by Sponsor|0|||
163034542|NCT03539484|588830410|FG002|Overall Study|Study Terminated by Sponsor|1|||
163034543|NCT03539484|588830411|FG003|Overall Study|Study Terminated by Sponsor|1|||
163034544|NCT03539484|588830412|FG004|Overall Study|Study Terminated by Sponsor|2|||
163034545|NCT03539484|588830413|FG005|Overall Study|Study Terminated by Sponsor|2|||
163034546|NCT03539484|588830414|FG006|Overall Study|Study Terminated by Sponsor|1|||
163034547|NCT02131636|588830420|FG000|Overall Study|Personal Reasons|4|||
163034548|NCT02131636|588830421|FG001|Overall Study|Personal Reasons|4|||
163034549|NCT02131636|588830420|FG000|Overall Study|Lost to Follow-up|4|||
163034550|NCT02131636|588830421|FG001|Overall Study|Lost to Follow-up|0|||
163034551|NCT02131636|588830420|FG000|Overall Study|Adverse Event|4|||
163034552|NCT02131636|588830421|FG001|Overall Study|Adverse Event|1|||
163034553|NCT02173379|588830422|FG000|Overall Study|Lost to Follow-up|89|||
163334630|NCT03662659|589934419|FG000|Treatment|Death|11|||
163034554|NCT02173379|588830423|FG001|Overall Study|Lost to Follow-up|81|||
163034555|NCT02173379|588830422|FG000|Overall Study|Withdrawal by Subject|24|||
163334631|NCT03662659|589934420|FG001|Treatment|Death|9|||
163406791|NCT03016325|590198752|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
163406792|NCT03016325|590198753|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
163406793|NCT03016325|590198754|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
163406794|NCT03016325|590198755|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
163406795|NCT03016325|590198756|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
163406796|NCT03016325|590198749|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
163406797|NCT03016325|590198750|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
163406798|NCT03016325|590198751|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
163406799|NCT03016325|590198752|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
163406800|NCT03016325|590198753|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
163406801|NCT03016325|590198754|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
163406802|NCT03016325|590198755|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
163406803|NCT03016325|590198756|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
163406804|NCT03016325|590198749|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
163406805|NCT03016325|590198750|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
163406806|NCT03016325|590198751|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
163406807|NCT03016325|590198752|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
163406808|NCT03016325|590198753|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
163406809|NCT03016325|590198754|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
163406810|NCT03016325|590198755|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
163406811|NCT03016325|590198756|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
163406812|NCT03016325|590198749|FG000|182-Day Follow-Up Period|Death|3|||
163406813|NCT03016325|590198750|FG001|182-Day Follow-Up Period|Death|3|||
163406814|NCT03016325|590198751|FG002|182-Day Follow-Up Period|Death|11|||
163406815|NCT03016325|590198752|FG003|182-Day Follow-Up Period|Death|12|||
163406816|NCT03016325|590198753|FG004|182-Day Follow-Up Period|Death|9|||
163406817|NCT03016325|590198754|FG005|182-Day Follow-Up Period|Death|0|||
163406818|NCT03016325|590198755|FG006|182-Day Follow-Up Period|Death|0|||
163406819|NCT03016325|590198756|FG007|182-Day Follow-Up Period|Death|1|||
163406820|NCT03016325|590198749|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
163406821|NCT03016325|590198750|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
163406822|NCT03016325|590198751|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
163406823|NCT03016325|590198752|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
163406824|NCT03016325|590198753|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
163406825|NCT03016325|590198754|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
163406826|NCT03016325|590198755|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
163406827|NCT03016325|590198756|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
163406828|NCT03016325|590198749|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
163406829|NCT03016325|590198750|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
163406830|NCT03016325|590198751|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
163406831|NCT03016325|590198752|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
163406832|NCT03016325|590198753|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
163406833|NCT03016325|590198754|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
163406834|NCT03016325|590198755|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
163406835|NCT03016325|590198756|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
163406836|NCT03016325|590198749|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
163406837|NCT03016325|590198750|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
163406838|NCT03016325|590198751|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
163034556|NCT02173379|588830423|FG001|Overall Study|Withdrawal by Subject|29|||
163034557|NCT02173379|588830422|FG000|Overall Study|Physician Decision|8|||
163034558|NCT02173379|588830423|FG001|Overall Study|Physician Decision|8|||
163034559|NCT02173379|588830422|FG000|Overall Study|Death|75|||
163034560|NCT02173379|588830423|FG001|Overall Study|Death|72|||
163034561|NCT02173379|588830422|FG000|Overall Study|Other Reason|1|||
163034562|NCT02173379|588830423|FG001|Overall Study|Other Reason|0|||
163034563|NCT06226649|588830425|FG000|Overall Study|Withdrawal by Subject|4|||
163034564|NCT06226649|588830426|FG001|Overall Study|Withdrawal by Subject|1|||
163034565|NCT00631163|588830431|FG000|Number of Participants in Year 1|Adverse Event|12|||
163220052|NCT03965962|589521392|FG003|Overall Study|Lost to Follow-up|0|||
163406839|NCT03016325|590198752|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
163406840|NCT03016325|590198753|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
163406841|NCT03016325|590198754|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
163406842|NCT03016325|590198755|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
163406843|NCT03016325|590198756|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
163406844|NCT03016325|590198749|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
163406845|NCT03016325|590198750|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
163406846|NCT03016325|590198751|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
163406847|NCT03016325|590198752|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
163034566|NCT00631163|588830431|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
163034567|NCT00631163|588830431|FG000|Number of Participants in Year 1|Death|6|||
163034568|NCT00631163|588830431|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
163034569|NCT00631163|588830431|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
163034570|NCT00631163|588830431|FG000|Number of Participants in Year 1|Administrative problems|6|||
163034571|NCT00631163|588830431|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
163034572|NCT00631163|588830431|FG000|Number of Participants in Year 2|Adverse Event|1|||
163034573|NCT00631163|588830431|FG000|Number of Participants in Year 2|Protocol Violation|1|||
163034574|NCT00631163|588830431|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
163034575|NCT02290925|588830432|FG000|First Period of Three Months|Lost to Follow-up|2|||
163034576|NCT02290925|588830433|FG001|First Period of Three Months|Lost to Follow-up|1|||
163034577|NCT02290925|588830432|FG000|First Period of Three Months|Death|1|||
163034578|NCT02290925|588830433|FG001|First Period of Three Months|Death|0|||
163034579|NCT02290925|588830432|FG000|First Period of Three Months|Insulin Started|1|||
163034580|NCT02290925|588830433|FG001|First Period of Three Months|Insulin Started|1|||
163034581|NCT02290925|588830432|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
163034582|NCT02290925|588830433|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
163034583|NCT02290925|588830432|FG000|Second Period of 3 Months|insulin started|0|||
163034584|NCT02290925|588830433|FG001|Second Period of 3 Months|insulin started|1|||
163034585|NCT02305446|588830441|FG000|Overall Study|Adverse Event|1|||
163034586|NCT01636947|588830443|FG000|Overall Study|Not Treated|2|||
163034587|NCT01636947|588830444|FG001|Overall Study|Not Treated|2|||
163034588|NCT01636947|588830443|FG000|Overall Study|Lost to Follow-up|4|||
163034589|NCT01636947|588830444|FG001|Overall Study|Lost to Follow-up|0|||
163085616|NCT03559530|589022331|FG001|Overall Study|culture results not considered for treat|0|||
163085617|NCT03559530|589022330|FG000|Overall Study|duplicate cases|8|||
163085618|NCT03559530|589022331|FG001|Overall Study|duplicate cases|0|||
163085619|NCT03559530|589022330|FG000|Overall Study|other species of Acinetobacte|7|||
163085620|NCT03559530|589022331|FG001|Overall Study|other species of Acinetobacte|0|||
163034590|NCT01636947|588830443|FG000|Overall Study|Protocol Violation|1|||
163034591|NCT01636947|588830444|FG001|Overall Study|Protocol Violation|1|||
163034592|NCT01636947|588830443|FG000|Overall Study|Withdrawal by Subject|3|||
163034593|NCT01636947|588830444|FG001|Overall Study|Withdrawal by Subject|3|||
163034594|NCT01636947|588830443|FG000|Overall Study|Adverse Event|1|||
163034595|NCT01636947|588830444|FG001|Overall Study|Adverse Event|1|||
163034596|NCT01636947|588830443|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
163034597|NCT01636947|588830444|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
163034598|NCT00388297|588830447|FG000|Overall Study|Lost to Follow-up|16|||
163034599|NCT00388297|588830448|FG001|Overall Study|Lost to Follow-up|12|||
163034600|NCT00388297|588830449|FG002|Overall Study|Lost to Follow-up|11|||
163034601|NCT00388297|588830450|FG003|Overall Study|Lost to Follow-up|8|||
163034602|NCT00316914|588830452|FG000|Overall Study|Withdrawal by Subject|5|||
163034603|NCT00316914|588830453|FG001|Overall Study|Withdrawal by Subject|3|||
163034604|NCT00316914|588830452|FG000|Overall Study|Adverse Event|8|||
163034605|NCT00316914|588830453|FG001|Overall Study|Adverse Event|7|||
163034606|NCT00316914|588830452|FG000|Overall Study|Other Problems|6|||
163034607|NCT00316914|588830453|FG001|Overall Study|Other Problems|11|||
163034608|NCT00316914|588830452|FG000|Overall Study|Missing end of treatment documentation|14|||
163034609|NCT00316914|588830453|FG001|Overall Study|Missing end of treatment documentation|15|||
163034610|NCT00427999|588830458|FG000|Overall Study|Adverse Event|6|||
163034611|NCT00427999|588830458|FG000|Overall Study|Abnormal laboratory values|1|||
163034612|NCT00427999|588830458|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
163034613|NCT00427999|588830458|FG000|Overall Study|Protocol Violation|2|||
163034614|NCT00427999|588830458|FG000|Overall Study|Withdrawal by Subject|9|||
163034615|NCT00427999|588830458|FG000|Overall Study|Death|1|||
163034616|NCT02284568|588830459|FG000|Overall Study|Adverse Event|2|||
163085621|NCT03559530|589022330|FG000|Overall Study|contamination / colonization|3|||
163085622|NCT03559530|589022331|FG001|Overall Study|contamination / colonization|0|||
163034617|NCT02284568|588830460|FG001|Overall Study|Adverse Event|9|||
163034618|NCT02284568|588830461|FG002|Overall Study|Adverse Event|4|||
163034619|NCT02284568|588830459|FG000|Overall Study|Withdrawal by Subject|22|||
163034620|NCT02284568|588830460|FG001|Overall Study|Withdrawal by Subject|21|||
163034621|NCT02284568|588830461|FG002|Overall Study|Withdrawal by Subject|1|||
163034622|NCT02284568|588830459|FG000|Overall Study|Noncompliance with study drug admin|1|||
163034623|NCT02284568|588830460|FG001|Overall Study|Noncompliance with study drug admin|2|||
163034624|NCT02284568|588830461|FG002|Overall Study|Noncompliance with study drug admin|0|||
163034625|NCT02284568|588830459|FG000|Overall Study|Noncompliance|1|||
163034626|NCT02284568|588830460|FG001|Overall Study|Noncompliance|0|||
163034627|NCT02284568|588830461|FG002|Overall Study|Noncompliance|0|||
163034628|NCT02284568|588830459|FG000|Overall Study|Protocol Violation|0|||
163034629|NCT02284568|588830460|FG001|Overall Study|Protocol Violation|1|||
163034630|NCT02284568|588830461|FG002|Overall Study|Protocol Violation|0|||
163034631|NCT02284568|588830459|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
163034632|NCT02284568|588830460|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
163034633|NCT02284568|588830461|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
163034634|NCT02284568|588830459|FG000|Overall Study|Lost to Follow-up|0|||
163034635|NCT02284568|588830460|FG001|Overall Study|Lost to Follow-up|3|||
163034636|NCT02284568|588830461|FG002|Overall Study|Lost to Follow-up|0|||
163034637|NCT02284568|588830459|FG000|Overall Study|Lack of Efficacy|4|||
163034638|NCT02284568|588830460|FG001|Overall Study|Lack of Efficacy|7|||
163034639|NCT02284568|588830461|FG002|Overall Study|Lack of Efficacy|0|||
163034640|NCT02284568|588830459|FG000|Overall Study|Other|1|||
163085623|NCT01472185|589022332|FG000|Overall Study|Randomized but Not Treated|0|||
163085624|NCT01472185|589022333|FG001|Overall Study|Randomized but Not Treated|1|||
163085625|NCT01472185|589022332|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
163085626|NCT01472185|589022333|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
163085627|NCT01472185|589022332|FG000|Overall Study|Hyperglycemia|5|||
163085628|NCT01472185|589022333|FG001|Overall Study|Hyperglycemia|2|||
163085629|NCT01472185|589022332|FG000|Overall Study|Investigator's Discretion|3|||
163085630|NCT01472185|589022333|FG001|Overall Study|Investigator's Discretion|1|||
163085631|NCT01472185|589022332|FG000|Overall Study|Lost to Follow-up|4|||
163085632|NCT01472185|589022333|FG001|Overall Study|Lost to Follow-up|1|||
163085633|NCT01472185|589022332|FG000|Overall Study|Protocol Violation|5|||
163085634|NCT01472185|589022333|FG001|Overall Study|Protocol Violation|1|||
163085635|NCT01472185|589022332|FG000|Overall Study|Subject Noncompliance|8|||
163085636|NCT01472185|589022333|FG001|Overall Study|Subject Noncompliance|15|||
163085637|NCT01472185|589022332|FG000|Overall Study|Subject Withdrew Consent|6|||
163085638|NCT01472185|589022333|FG001|Overall Study|Subject Withdrew Consent|3|||
163085639|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085640|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
163085641|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085642|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
163034641|NCT02284568|588830460|FG001|Overall Study|Other|2|||
163034642|NCT02284568|588830461|FG002|Overall Study|Other|0|||
163034643|NCT02284568|588830459|FG000|Overall Study|Withdrew before taking study drug|0|||
163034644|NCT02284568|588830460|FG001|Overall Study|Withdrew before taking study drug|1|||
163034645|NCT02284568|588830461|FG002|Overall Study|Withdrew before taking study drug|0|||
163034646|NCT00460265|588830462|FG000|Overall Study|Lost to Follow-up|14|||
163034647|NCT00460265|588830463|FG001|Overall Study|Lost to Follow-up|15|||
163034648|NCT00460265|588830462|FG000|Overall Study|Physician Decision|1|||
163034649|NCT00460265|588830463|FG001|Overall Study|Physician Decision|2|||
163034650|NCT00460265|588830462|FG000|Overall Study|Withdrawal by Subject|10|||
163034651|NCT00460265|588830463|FG001|Overall Study|Withdrawal by Subject|25|||
163034652|NCT00460265|588830462|FG000|Overall Study|Ongoing|60|||
163034653|NCT00460265|588830463|FG001|Overall Study|Ongoing|47|||
163034654|NCT02956057|588830477|FG000|Overall Study|Discontinued intervention|14|||
163034655|NCT02956057|588830478|FG001|Overall Study|Discontinued intervention|10|||
163034656|NCT02956057|588830479|FG002|Overall Study|Discontinued intervention|7|||
163034657|NCT02956057|588830480|FG003|Overall Study|Discontinued intervention|14|||
163034658|NCT02956057|588830481|FG004|Overall Study|Discontinued intervention|4|||
163034659|NCT02956057|588830482|FG005|Overall Study|Discontinued intervention|17|||
163034660|NCT02956057|588830477|FG000|Overall Study|Lost to Follow-up|0|||
163034661|NCT02956057|588830478|FG001|Overall Study|Lost to Follow-up|2|||
163085643|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
163085644|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
163034662|NCT02956057|588830479|FG002|Overall Study|Lost to Follow-up|1|||
163034663|NCT02956057|588830480|FG003|Overall Study|Lost to Follow-up|1|||
163034664|NCT02956057|588830481|FG004|Overall Study|Lost to Follow-up|1|||
163034665|NCT02956057|588830482|FG005|Overall Study|Lost to Follow-up|0|||
163034666|NCT01420679|588830487|FG000|Overall Study|Disease Progression|3|||
163034667|NCT01420679|588830488|FG001|Overall Study|Disease Progression|2|||
163034668|NCT01420679|588830487|FG000|Overall Study|Adverse Event|4|||
163034669|NCT01420679|588830488|FG001|Overall Study|Adverse Event|0|||
163034670|NCT01420679|588830487|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
163034671|NCT01420679|588830488|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
163034672|NCT01420679|588830487|FG000|Overall Study|Patient Decision|1|||
163085645|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
163085646|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085647|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163334632|NCT03662659|589934419|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
163034673|NCT01420679|588830488|FG001|Overall Study|Patient Decision|0|||
163085648|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085649|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085650|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085651|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163034674|NCT01420679|588830487|FG000|Overall Study|Investigator Decision|1|||
163034675|NCT01420679|588830488|FG001|Overall Study|Investigator Decision|2|||
163034676|NCT01420679|588830487|FG000|Overall Study|Sponsor Decision|3|||
163034677|NCT01420679|588830488|FG001|Overall Study|Sponsor Decision|3|||
163034678|NCT01420679|588830487|FG000|Overall Study|Other|1|||
163034679|NCT01420679|588830488|FG001|Overall Study|Other|0|||
163034680|NCT03956615|588830489|FG000|Overall Study|No multiple myeloma confirmed|2|||
163034681|NCT03956615|588830489|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
163034682|NCT03956615|588830489|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
163034683|NCT03956615|588830489|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
163034684|NCT01069419|588830490|FG000|Overall Study|Adverse Event|233|||
163334633|NCT03662659|589934420|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
163334634|NCT03662659|589934419|FG000|Treatment|Withdrawal by Subject|1|||
163334635|NCT03662659|589934420|FG001|Treatment|Withdrawal by Subject|1|||
163334636|NCT03662659|589934419|FG000|Treatment|Poor/Non-compliance|1|||
163334637|NCT03662659|589934420|FG001|Treatment|Poor/Non-compliance|0|||
163334638|NCT03662659|589934419|FG000|Treatment|Participant no longer meets study criteria|1|||
163334639|NCT03662659|589934420|FG001|Treatment|Participant no longer meets study criteria|0|||
163334640|NCT03662659|589934419|FG000|Treatment|Other reasons|10|||
163334641|NCT03662659|589934420|FG001|Treatment|Other reasons|8|||
163334642|NCT03662659|589934419|FG000|Treatment|Administrative reasons by sponsor|1|||
163334643|NCT03662659|589934420|FG001|Treatment|Administrative reasons by sponsor|0|||
163334644|NCT03662659|589934419|FG000|Treatment|maximum clinical benefit|0|||
163334645|NCT03662659|589934420|FG001|Treatment|maximum clinical benefit|2|||
163334646|NCT04369664|589936041|FG000|Overall Study|Physician Decision|1|||
163334647|NCT04369664|589936042|FG001|Overall Study|Physician Decision|0|||
163334648|NCT03840200|589936043|FG000|Overall Study|Death|6|||
163334649|NCT03840200|589936044|FG001|Overall Study|Death|3|||
163334650|NCT03840200|589936045|FG002|Overall Study|Death|6|||
163334651|NCT03840200|589936046|FG003|Overall Study|Death|10|||
163334652|NCT03840200|589936043|FG000|Overall Study|Reason Not Specified|2|||
163334653|NCT03840200|589936044|FG001|Overall Study|Reason Not Specified|2|||
163334654|NCT03840200|589936045|FG002|Overall Study|Reason Not Specified|1|||
163334655|NCT03840200|589936046|FG003|Overall Study|Reason Not Specified|15|||
163334656|NCT03840200|589936043|FG000|Overall Study|Physician Decision|0|||
163334657|NCT03840200|589936044|FG001|Overall Study|Physician Decision|0|||
163334658|NCT03840200|589936045|FG002|Overall Study|Physician Decision|0|||
163334659|NCT03840200|589936046|FG003|Overall Study|Physician Decision|2|||
163334660|NCT03840200|589936043|FG000|Overall Study|Progressive Disease|0|||
163334661|NCT03840200|589936044|FG001|Overall Study|Progressive Disease|0|||
163334662|NCT03840200|589936045|FG002|Overall Study|Progressive Disease|0|||
163334663|NCT03840200|589936046|FG003|Overall Study|Progressive Disease|1|||
163334664|NCT03840200|589936043|FG000|Overall Study|Withdrawal by Subject|0|||
163334665|NCT03840200|589936044|FG001|Overall Study|Withdrawal by Subject|1|||
163334666|NCT03840200|589936045|FG002|Overall Study|Withdrawal by Subject|0|||
163334667|NCT03840200|589936046|FG003|Overall Study|Withdrawal by Subject|2|||
163334668|NCT01450007|589936048|FG000|Overall Study|Late exclusion before treatment|2|||
163334669|NCT01450007|589936049|FG001|Overall Study|Late exclusion before treatment|3|||
163334670|NCT01450007|589936050|FG002|Overall Study|Late exclusion before treatment|2|||
163334671|NCT01450007|589936048|FG000|Overall Study|Protocol Violation|0|||
163334672|NCT01450007|589936049|FG001|Overall Study|Protocol Violation|1|||
163334673|NCT01450007|589936050|FG002|Overall Study|Protocol Violation|1|||
163334674|NCT01450007|589936048|FG000|Overall Study|Adverse Event|0|||
163334675|NCT01450007|589936049|FG001|Overall Study|Adverse Event|1|||
163334676|NCT01450007|589936050|FG002|Overall Study|Adverse Event|0|||
163334677|NCT03851094|589936051|FG000|Overall Study|Withdrawal by Subject|0|||
163334678|NCT03851094|589936052|FG001|Overall Study|Withdrawal by Subject|1|||
163334679|NCT03851094|589936051|FG000|Overall Study|Participant lost device|0|||
163334680|NCT03851094|589936052|FG001|Overall Study|Participant lost device|1|||
163334681|NCT03851094|589936051|FG000|Overall Study|Participant returned device|0|||
163334682|NCT03851094|589936052|FG001|Overall Study|Participant returned device|2|||
163334683|NCT00484198|589936053|FG000|Overall Study|Participant Withdrew Consent|12|||
163334684|NCT00484198|589936054|FG001|Overall Study|Participant Withdrew Consent|21|||
163334685|NCT00484198|589936055|FG002|Overall Study|Participant Withdrew Consent|47|||
163334686|NCT00484198|589936056|FG003|Overall Study|Participant Withdrew Consent|59|||
163334687|NCT00484198|589936053|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
163334688|NCT00484198|589936054|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
163334689|NCT00484198|589936055|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
163334690|NCT00484198|589936056|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
163334691|NCT00484198|589936053|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
163334692|NCT00484198|589936054|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
163334693|NCT00484198|589936055|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
163334694|NCT00484198|589936056|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
163334695|NCT00484198|589936053|FG000|Overall Study|Adverse Event|3|||
163334696|NCT00484198|589936054|FG001|Overall Study|Adverse Event|11|||
163334697|NCT00484198|589936055|FG002|Overall Study|Adverse Event|32|||
163334698|NCT00484198|589936056|FG003|Overall Study|Adverse Event|31|||
163334699|NCT00484198|589936053|FG000|Overall Study|Protocol Violation|0|||
163334700|NCT00484198|589936054|FG001|Overall Study|Protocol Violation|5|||
163034685|NCT01069419|588830490|FG000|Overall Study|Lack of Efficacy|332|||
163034686|NCT01069419|588830490|FG000|Overall Study|Lost to Follow-up|49|||
163034687|NCT01069419|588830490|FG000|Overall Study|Remission of disease|11|||
163034688|NCT01069419|588830490|FG000|Overall Study|Withdrawal by Subject|34|||
163034689|NCT01069419|588830490|FG000|Overall Study|Other Reason|43|||
163034690|NCT01069419|588830490|FG000|Overall Study|Missing termination information|13|||
163034691|NCT01179737|588830493|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
163034692|NCT01179737|588830494|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
163034693|NCT01179737|588830495|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
163034694|NCT01179737|588830496|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
163034695|NCT01179737|588830493|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
163034696|NCT01179737|588830494|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
163034697|NCT01179737|588830495|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
163034698|NCT01179737|588830496|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
163034699|NCT01179737|588830493|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
163034700|NCT01179737|588830494|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
163034701|NCT01179737|588830495|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
163034702|NCT01179737|588830496|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
163034703|NCT01179737|588830493|FG000|Cohort 1 & Cohort 2|Death|0|||
163034704|NCT01179737|588830494|FG001|Cohort 1 & Cohort 2|Death|0|||
163034705|NCT01179737|588830495|FG002|Cohort 1 & Cohort 2|Death|1|||
163034706|NCT01179737|588830496|FG003|Cohort 1 & Cohort 2|Death|0|||
163034707|NCT01179737|588830493|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
163034708|NCT01179737|588830494|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
163034709|NCT01179737|588830495|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
163034710|NCT01179737|588830496|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
163034711|NCT01179737|588830493|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
163034712|NCT01179737|588830494|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
163034713|NCT01179737|588830495|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
163034714|NCT01179737|588830496|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
163034715|NCT01179737|588830493|FG000|Extension|The study was terminated|3|||
163034716|NCT01179737|588830494|FG001|Extension|The study was terminated|0|||
163034717|NCT01179737|588830495|FG002|Extension|The study was terminated|0|||
163034718|NCT01179737|588830496|FG003|Extension|The study was terminated|0|||
163034719|NCT01254721|588830497|FG000|Overall Study|Lost to Follow-up|0|||
163034720|NCT01254721|588830498|FG001|Overall Study|Lost to Follow-up|4|||
163034721|NCT01254721|588830497|FG000|Overall Study|Lack of Efficacy|4|||
163034722|NCT01254721|588830498|FG001|Overall Study|Lack of Efficacy|2|||
163034723|NCT01254721|588830497|FG000|Overall Study|Death|0|||
163034724|NCT01254721|588830498|FG001|Overall Study|Death|1|||
163034725|NCT01254721|588830497|FG000|Overall Study|technical problum|1|||
163034726|NCT01254721|588830498|FG001|Overall Study|technical problum|0|||
163034727|NCT01254721|588830497|FG000|Overall Study|Adverse Event|2|||
163034728|NCT01254721|588830498|FG001|Overall Study|Adverse Event|3|||
163034729|NCT01254721|588830497|FG000|Overall Study|Withdrawal by Subject|8|||
163034730|NCT01254721|588830498|FG001|Overall Study|Withdrawal by Subject|11|||
163034731|NCT01254721|588830497|FG000|Overall Study|Wrongly randomization|0|||
163034732|NCT01254721|588830498|FG001|Overall Study|Wrongly randomization|1|||
163034733|NCT00904839|588830499|FG000|Overall Study|Adverse Event|0|||
163034734|NCT00904839|588830500|FG001|Overall Study|Adverse Event|5|||
163034735|NCT00904839|588830501|FG002|Overall Study|Adverse Event|4|||
163034736|NCT00904839|588830499|FG000|Overall Study|Protocol Violation|0|||
163034737|NCT00904839|588830500|FG001|Overall Study|Protocol Violation|1|||
163034738|NCT00904839|588830501|FG002|Overall Study|Protocol Violation|1|||
163034739|NCT00904839|588830499|FG000|Overall Study|Lost to Follow-up|0|||
163034740|NCT00904839|588830500|FG001|Overall Study|Lost to Follow-up|1|||
163034741|NCT00904839|588830501|FG002|Overall Study|Lost to Follow-up|2|||
163034742|NCT00904839|588830499|FG000|Overall Study|Withdrawal by Subject|0|||
163034743|NCT00904839|588830500|FG001|Overall Study|Withdrawal by Subject|2|||
163034744|NCT00904839|588830501|FG002|Overall Study|Withdrawal by Subject|0|||
163034745|NCT00904839|588830499|FG000|Overall Study|Not treated|1|||
163034746|NCT00904839|588830500|FG001|Overall Study|Not treated|0|||
163034747|NCT00904839|588830501|FG002|Overall Study|Not treated|1|||
163034748|NCT00904839|588830499|FG000|Overall Study|Other than above|0|||
163034749|NCT00904839|588830500|FG001|Overall Study|Other than above|9|||
163034750|NCT00904839|588830501|FG002|Overall Study|Other than above|7|||
163034751|NCT01904903|588830505|FG000|Overall Study|Withdrawal by Subject|1|||
163034752|NCT01634659|588830507|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
163034753|NCT01634659|588830508|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
163034754|NCT01634659|588830507|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
163034755|NCT01634659|588830508|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
163034756|NCT04395274|588830509|FG000|Overall Study|Lost to Follow-up|20|||
163034757|NCT04395274|588830510|FG001|Overall Study|Lost to Follow-up|11|||
163034758|NCT04395274|588830509|FG000|Overall Study|Withdrawal by Subject|13|||
163034759|NCT04395274|588830510|FG001|Overall Study|Withdrawal by Subject|10|||
163034760|NCT04395274|588830509|FG000|Overall Study|Moved Abroad|0|||
163034761|NCT04395274|588830510|FG001|Overall Study|Moved Abroad|1|||
163034762|NCT00335959|588830511|FG000|Overall Study|Adverse Event|2|||
163034763|NCT00335959|588830511|FG000|Overall Study|Ineligible|1|||
163034764|NCT00824382|588830514|FG000|Overall Study|Adverse Event|4|||
163034765|NCT00824382|588830515|FG001|Overall Study|Adverse Event|1|||
163034766|NCT00824382|588830516|FG002|Overall Study|Adverse Event|1|||
163034767|NCT00824382|588830517|FG003|Overall Study|Adverse Event|4|||
163034768|NCT00824382|588830514|FG000|Overall Study|Protocol Violation|1|||
163085652|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085653|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085654|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085655|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
163085656|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
163085657|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
163085658|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
163085659|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
163034769|NCT00824382|588830515|FG001|Overall Study|Protocol Violation|0|||
163034770|NCT00824382|588830516|FG002|Overall Study|Protocol Violation|0|||
163034771|NCT00824382|588830517|FG003|Overall Study|Protocol Violation|1|||
163034772|NCT00824382|588830514|FG000|Overall Study|Investigator's decision|0|||
163034773|NCT00824382|588830515|FG001|Overall Study|Investigator's decision|1|||
163034774|NCT00824382|588830516|FG002|Overall Study|Investigator's decision|2|||
163034775|NCT00824382|588830517|FG003|Overall Study|Investigator's decision|0|||
163034776|NCT02908074|588830519|FG000|Overall Study|sponsor/ICON decision|0|||
163034777|NCT02908074|588830520|FG001|Overall Study|sponsor/ICON decision|0|||
163034778|NCT02908074|588830521|FG002|Overall Study|sponsor/ICON decision|1|||
163034779|NCT02908074|588830522|FG003|Overall Study|sponsor/ICON decision|0|||
163034780|NCT02908074|588830523|FG004|Overall Study|sponsor/ICON decision|0|||
163034781|NCT02908074|588830524|FG005|Overall Study|sponsor/ICON decision|0|||
163034782|NCT02908074|588830519|FG000|Overall Study|Protocol Violation|0|||
163034783|NCT02908074|588830520|FG001|Overall Study|Protocol Violation|1|||
163034784|NCT02908074|588830521|FG002|Overall Study|Protocol Violation|0|||
163034785|NCT02908074|588830522|FG003|Overall Study|Protocol Violation|0|||
163034786|NCT02908074|588830523|FG004|Overall Study|Protocol Violation|0|||
163034787|NCT02908074|588830524|FG005|Overall Study|Protocol Violation|0|||
163034788|NCT02908074|588830519|FG000|Overall Study|Adverse Event|5|||
163034789|NCT02908074|588830520|FG001|Overall Study|Adverse Event|2|||
163034790|NCT02908074|588830521|FG002|Overall Study|Adverse Event|0|||
163034791|NCT02908074|588830522|FG003|Overall Study|Adverse Event|0|||
163034792|NCT02908074|588830523|FG004|Overall Study|Adverse Event|1|||
163034793|NCT02908074|588830524|FG005|Overall Study|Adverse Event|0|||
163034794|NCT02908074|588830519|FG000|Overall Study|AESI|1|||
163034795|NCT02908074|588830520|FG001|Overall Study|AESI|0|||
163034796|NCT02908074|588830521|FG002|Overall Study|AESI|1|||
163034797|NCT02908074|588830522|FG003|Overall Study|AESI|0|||
163034798|NCT02908074|588830523|FG004|Overall Study|AESI|1|||
163034799|NCT02908074|588830524|FG005|Overall Study|AESI|0|||
163034800|NCT02908074|588830519|FG000|Overall Study|Discontinuation criteria per protocol|0|||
163034801|NCT02908074|588830520|FG001|Overall Study|Discontinuation criteria per protocol|0|||
163034802|NCT02908074|588830521|FG002|Overall Study|Discontinuation criteria per protocol|1|||
163334701|NCT00484198|589936055|FG002|Overall Study|Protocol Violation|6|||
163334702|NCT00484198|589936056|FG003|Overall Study|Protocol Violation|8|||
163334703|NCT00484198|589936053|FG000|Overall Study|Other|7|||
163334704|NCT00484198|589936054|FG001|Overall Study|Other|10|||
163334705|NCT00484198|589936055|FG002|Overall Study|Other|31|||
163334706|NCT00484198|589936056|FG003|Overall Study|Other|28|||
163334707|NCT01536704|589936057|FG000|Washout Period 1|Withdrawal by Subject|1|||
163334708|NCT01536704|589936058|FG001|Washout Period 1|Withdrawal by Subject|2|||
163334709|NCT01536704|589936059|FG002|Washout Period 1|Withdrawal by Subject|0|||
163334710|NCT01536704|589936060|FG003|Washout Period 1|Withdrawal by Subject|0|||
163334711|NCT01536704|589936057|FG000|Washout Period 2|Adverse Event|1|||
163034803|NCT02908074|588830522|FG003|Overall Study|Discontinuation criteria per protocol|0|||
163034804|NCT02908074|588830523|FG004|Overall Study|Discontinuation criteria per protocol|0|||
163034805|NCT02908074|588830524|FG005|Overall Study|Discontinuation criteria per protocol|1|||
163034806|NCT02908074|588830519|FG000|Overall Study|Withdrawal by Subject|3|||
163034807|NCT02908074|588830520|FG001|Overall Study|Withdrawal by Subject|2|||
163034808|NCT02908074|588830521|FG002|Overall Study|Withdrawal by Subject|2|||
163034809|NCT02908074|588830522|FG003|Overall Study|Withdrawal by Subject|2|||
163034810|NCT02908074|588830523|FG004|Overall Study|Withdrawal by Subject|2|||
163034811|NCT02908074|588830524|FG005|Overall Study|Withdrawal by Subject|2|||
163034812|NCT02908074|588830519|FG000|Overall Study|Lost to Follow-up|0|||
163034813|NCT02908074|588830520|FG001|Overall Study|Lost to Follow-up|1|||
163034814|NCT02908074|588830521|FG002|Overall Study|Lost to Follow-up|1|||
163034815|NCT02908074|588830522|FG003|Overall Study|Lost to Follow-up|1|||
163334712|NCT01536704|589936058|FG001|Washout Period 2|Adverse Event|0|||
163334713|NCT01536704|589936059|FG002|Washout Period 2|Adverse Event|0|||
163334714|NCT01536704|589936060|FG003|Washout Period 2|Adverse Event|0|||
163334715|NCT01536704|589936057|FG000|Washout Period 2|Withdrawal by Subject|0|||
163034816|NCT02908074|588830523|FG004|Overall Study|Lost to Follow-up|0|||
163034817|NCT02908074|588830524|FG005|Overall Study|Lost to Follow-up|1|||
163034818|NCT01393106|588831973|FG000|Overall Study|Adverse Event|3|||
163034819|NCT01393106|588831973|FG000|Overall Study|Withdrawal by Subject|1|||
163034820|NCT01393106|588831973|FG000|Overall Study|Lack of Efficacy|1|||
163034821|NCT01955109|588831975|FG000|Overall Study|Adverse Event|2|||
163034822|NCT01955109|588831976|FG001|Overall Study|Adverse Event|0|||
163034823|NCT01955109|588831975|FG000|Overall Study|Participant unwilling to continue|35|||
163034824|NCT01955109|588831976|FG001|Overall Study|Participant unwilling to continue|7|||
163034825|NCT01955109|588831975|FG000|Overall Study|Physician Decision|2|||
163034826|NCT01955109|588831976|FG001|Overall Study|Physician Decision|0|||
163034827|NCT01955109|588831975|FG000|Overall Study|Lost to Follow-up|3|||
163034828|NCT01955109|588831976|FG001|Overall Study|Lost to Follow-up|1|||
163034829|NCT01955109|588831975|FG000|Overall Study|Non-compliance|3|||
163034830|NCT01955109|588831976|FG001|Overall Study|Non-compliance|1|||
163034831|NCT01853696|588831977|FG000|Overall Study|Withdrawal by Subject|1|||
163034832|NCT01853696|588831978|FG001|Overall Study|Withdrawal by Subject|1|||
163034833|NCT01853696|588831977|FG000|Overall Study|Lost to Follow-up|5|||
163034834|NCT01853696|588831978|FG001|Overall Study|Lost to Follow-up|4|||
163034835|NCT03003000|588831979|FG000|Overall Study|Adverse Event|1|||
163034836|NCT03003000|588831980|FG001|Overall Study|Adverse Event|2|||
163034837|NCT03003000|588831981|FG002|Overall Study|Adverse Event|3|||
163034838|NCT03003000|588831979|FG000|Overall Study|Lack of Efficacy|1|||
163034839|NCT03003000|588831980|FG001|Overall Study|Lack of Efficacy|0|||
163034840|NCT03003000|588831981|FG002|Overall Study|Lack of Efficacy|0|||
163034841|NCT03003000|588831979|FG000|Overall Study|Non-compliant with protocol|0|||
163034842|NCT03003000|588831980|FG001|Overall Study|Non-compliant with protocol|1|||
163034843|NCT03003000|588831981|FG002|Overall Study|Non-compliant with protocol|1|||
163034844|NCT03003000|588831979|FG000|Overall Study|Refused to continue medication|2|||
163034845|NCT03003000|588831980|FG001|Overall Study|Refused to continue medication|0|||
163034846|NCT03003000|588831981|FG002|Overall Study|Refused to continue medication|0|||
163034847|NCT03003000|588831979|FG000|Overall Study|Other than listed|1|||
163034848|NCT03003000|588831980|FG001|Overall Study|Other than listed|1|||
163034849|NCT03003000|588831981|FG002|Overall Study|Other than listed|1|||
163034850|NCT04933617|588831982|FG000|Dose Escalation|Early closure of study|0|||
163034851|NCT04933617|588831983|FG001|Dose Escalation|Early closure of study|3|||
163034852|NCT04933617|588831984|FG002|Dose Escalation|Early closure of study|0|||
163034853|NCT04933617|588831985|FG003|Dose Escalation|Early closure of study|0|||
163034854|NCT04933617|588831986|FG004|Dose Escalation|Early closure of study|0|||
163034855|NCT02191046|588831987|FG000|Overall Study|low compliance|5|||
163034856|NCT02191046|588831988|FG001|Overall Study|low compliance|1|||
163034857|NCT02147067|588831989|FG000|Overall Study|Withdrawal by Subject|2|||
163034858|NCT02147067|588831990|FG001|Overall Study|Withdrawal by Subject|2|||
163034859|NCT00089635|588831991|FG000|Overall Study|Adverse Event|2|||
163034860|NCT00089635|588831991|FG000|Overall Study|Death|17|||
163034861|NCT00089635|588831991|FG000|Overall Study|Disease Progression|12|||
163034862|NCT00089635|588831991|FG000|Overall Study|Lost to Follow-up|3|||
163034863|NCT00089635|588831991|FG000|Overall Study|Withdrawal by Subject|6|||
163034864|NCT00089635|588831991|FG000|Overall Study|Ineligibility determined|1|||
163034865|NCT00089635|588831991|FG000|Overall Study|Other|2|||
163034866|NCT02943785|588831992|FG000|Overall Study|Adverse Event|112|||
163034867|NCT02943785|588831993|FG001|Overall Study|Adverse Event|97|||
163034868|NCT02943785|588831992|FG000|Overall Study|Withdrawal by Subject|63|||
163034869|NCT02943785|588831993|FG001|Overall Study|Withdrawal by Subject|126|||
163034870|NCT02943785|588831992|FG000|Overall Study|Physician Decision|23|||
163034871|NCT02943785|588831993|FG001|Overall Study|Physician Decision|47|||
163034872|NCT02943785|588831992|FG000|Overall Study|Death|46|||
163034873|NCT02943785|588831993|FG001|Overall Study|Death|46|||
163034874|NCT02943785|588831992|FG000|Overall Study|Lost to Follow-up|1|||
163034875|NCT02943785|588831993|FG001|Overall Study|Lost to Follow-up|0|||
163034876|NCT02943785|588831992|FG000|Overall Study|Other|16|||
163034877|NCT02943785|588831993|FG001|Overall Study|Other|19|||
163034878|NCT02943785|588831992|FG000|Overall Study|Did not receive any study medication|21|||
163034879|NCT02943785|588831993|FG001|Overall Study|Did not receive any study medication|28|||
163034880|NCT02603107|588831994|FG000|Randomized Phase|Withdrew consent|8|||
163034881|NCT02603107|588831995|FG001|Randomized Phase|Withdrew consent|15|||
163034882|NCT02603107|588831994|FG000|Randomized Phase|Lost to Follow-up|1|||
163034883|NCT02603107|588831995|FG001|Randomized Phase|Lost to Follow-up|3|||
163034884|NCT02603107|588831994|FG000|Randomized Phase|Adverse Event|2|||
163034885|NCT02603107|588831995|FG001|Randomized Phase|Adverse Event|0|||
163034886|NCT02603107|588831994|FG000|Randomized Phase|Death|1|||
163034887|NCT02603107|588831995|FG001|Randomized Phase|Death|1|||
163034888|NCT02603107|588831994|FG000|Randomized Phase|Non-compliance with study drug|1|||
163034889|NCT02603107|588831995|FG001|Randomized Phase|Non-compliance with study drug|1|||
163034890|NCT02603107|588831994|FG000|Randomized Phase|Investigator's discretion|0|||
163034891|NCT02603107|588831995|FG001|Randomized Phase|Investigator's discretion|1|||
163034892|NCT02603107|588831994|FG000|Randomized Phase|Lack of Efficacy|1|||
163034893|NCT02603107|588831995|FG001|Randomized Phase|Lack of Efficacy|0|||
163034894|NCT02603107|588831994|FG000|Randomized Phase|Protocol Violation|1|||
163034895|NCT02603107|588831995|FG001|Randomized Phase|Protocol Violation|0|||
163034896|NCT02603107|588831994|FG000|Optional Extension Phase|Lost to Follow-up|3|||
163034897|NCT02603107|588831995|FG001|Optional Extension Phase|Lost to Follow-up|3|||
163034898|NCT02603107|588831994|FG000|Optional Extension Phase|Withdrew consent|3|||
163034899|NCT02603107|588831995|FG001|Optional Extension Phase|Withdrew consent|2|||
163034900|NCT02603107|588831994|FG000|Optional Extension Phase|Investigator's discretion|2|||
163034901|NCT02603107|588831995|FG001|Optional Extension Phase|Investigator's discretion|2|||
163034902|NCT02603107|588831994|FG000|Optional Extension Phase|Pregnancy|0|||
163034903|NCT02603107|588831995|FG001|Optional Extension Phase|Pregnancy|3|||
163034904|NCT02603107|588831994|FG000|Optional Extension Phase|Adverse Event|0|||
163034905|NCT02603107|588831995|FG001|Optional Extension Phase|Adverse Event|2|||
163034906|NCT02603107|588831994|FG000|Optional Extension Phase|Not treated in extension phase|0|||
163034907|NCT02603107|588831995|FG001|Optional Extension Phase|Not treated in extension phase|1|||
163034908|NCT02603107|588831994|FG000|Optional Extension Phase|Protocol Violation|1|||
163034909|NCT02603107|588831995|FG001|Optional Extension Phase|Protocol Violation|0|||
163034910|NCT00821015|588831996|FG000|Overall Study|Lost to Follow-up|12|||
163034911|NCT03170609|588831999|FG000|Overall Study|Death|0|||
163034912|NCT03170609|588832000|FG001|Overall Study|Death|0|||
163034913|NCT03170609|588832001|FG002|Overall Study|Death|1|||
163034914|NCT03170609|588832002|FG003|Overall Study|Death|0|||
163034915|NCT03170609|588832003|FG004|Overall Study|Death|0|||
163034916|NCT03170609|588832004|FG005|Overall Study|Death|0|||
163034917|NCT03170609|588832005|FG006|Overall Study|Death|0|||
163034918|NCT03170609|588831999|FG000|Overall Study|Withdrawal by Subject|1|||
163034919|NCT03170609|588832000|FG001|Overall Study|Withdrawal by Subject|2|||
163034920|NCT03170609|588832001|FG002|Overall Study|Withdrawal by Subject|0|||
163034921|NCT03170609|588832002|FG003|Overall Study|Withdrawal by Subject|0|||
163034922|NCT03170609|588832003|FG004|Overall Study|Withdrawal by Subject|0|||
163034923|NCT03170609|588832004|FG005|Overall Study|Withdrawal by Subject|0|||
163034924|NCT03170609|588832005|FG006|Overall Study|Withdrawal by Subject|1|||
163034925|NCT03170609|588831999|FG000|Overall Study|Lost to Follow-up|1|||
163034926|NCT03170609|588832000|FG001|Overall Study|Lost to Follow-up|0|||
163034927|NCT03170609|588832001|FG002|Overall Study|Lost to Follow-up|5|||
163034928|NCT03170609|588832002|FG003|Overall Study|Lost to Follow-up|2|||
163034929|NCT03170609|588832003|FG004|Overall Study|Lost to Follow-up|1|||
163034930|NCT03170609|588832004|FG005|Overall Study|Lost to Follow-up|1|||
163034931|NCT03170609|588832005|FG006|Overall Study|Lost to Follow-up|0|||
163034932|NCT03170609|588831999|FG000|Overall Study|Other|1|||
163034933|NCT03170609|588832000|FG001|Overall Study|Other|0|||
163034934|NCT03170609|588832001|FG002|Overall Study|Other|0|||
163034935|NCT03170609|588832002|FG003|Overall Study|Other|0|||
163034936|NCT03170609|588832003|FG004|Overall Study|Other|0|||
163034937|NCT03170609|588832004|FG005|Overall Study|Other|1|||
163034938|NCT03170609|588832005|FG006|Overall Study|Other|0|||
163034939|NCT01887678|588832012|FG000|Overall Study|Adverse Event|4|||
163034940|NCT01887678|588832013|FG001|Overall Study|Adverse Event|6|||
163034941|NCT01887678|588832012|FG000|Overall Study|Exceeded rescue medication dosage|4|||
163034942|NCT01887678|588832013|FG001|Overall Study|Exceeded rescue medication dosage|5|||
163034943|NCT01887678|588832012|FG000|Overall Study|Withdrawal of consent|3|||
163034944|NCT01887678|588832013|FG001|Overall Study|Withdrawal of consent|4|||
163334716|NCT01536704|589936058|FG001|Washout Period 2|Withdrawal by Subject|0|||
163334717|NCT01536704|589936059|FG002|Washout Period 2|Withdrawal by Subject|0|||
163334718|NCT01536704|589936060|FG003|Washout Period 2|Withdrawal by Subject|1|||
163334719|NCT01536704|589936057|FG000|Period 3|Adverse Event|0|||
163334720|NCT01536704|589936058|FG001|Period 3|Adverse Event|0|||
163334721|NCT01536704|589936059|FG002|Period 3|Adverse Event|0|||
163334722|NCT01536704|589936060|FG003|Period 3|Adverse Event|1|||
163334723|NCT01536704|589936057|FG000|Washout Period 3|Adverse Event|0|||
163034945|NCT01887678|588832012|FG000|Overall Study|Lost to Follow-up|4|||
163085660|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
163334724|NCT01536704|589936058|FG001|Washout Period 3|Adverse Event|0|||
163334725|NCT01536704|589936059|FG002|Washout Period 3|Adverse Event|1|||
163334726|NCT01536704|589936060|FG003|Washout Period 3|Adverse Event|0|||
163334727|NCT04658784|589936061|FG000|6-month Follow-up|Lost to Follow-up|2|||
163334728|NCT04658784|589936062|FG001|6-month Follow-up|Lost to Follow-up|5|||
163334729|NCT02958553|589936063|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
163334730|NCT02958553|589936063|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
163334731|NCT04311983|589936065|FG000|Overall Study|Lost to Follow-up|421|||
163334732|NCT04311983|589936066|FG001|Overall Study|Lost to Follow-up|456|||
163334733|NCT04311983|589936065|FG000|Overall Study|Incomplete survey|7|||
163334734|NCT04311983|589936066|FG001|Overall Study|Incomplete survey|9|||
163334735|NCT04311983|589936065|FG000|Overall Study|Death|1|||
163334736|NCT04311983|589936066|FG001|Overall Study|Death|0|||
163034946|NCT01887678|588832013|FG001|Overall Study|Lost to Follow-up|2|||
163034947|NCT01887678|588832012|FG000|Overall Study|Deterioration of clinical condition|0|||
163034948|NCT01887678|588832013|FG001|Overall Study|Deterioration of clinical condition|4|||
163034949|NCT01887678|588832012|FG000|Overall Study|Lack of Efficacy|1|||
163034950|NCT01887678|588832013|FG001|Overall Study|Lack of Efficacy|2|||
163085661|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
163085662|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
163085663|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
163085664|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
163085665|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
163085666|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
163085667|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
163085668|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
163085669|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
163085670|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
163034951|NCT01887678|588832012|FG000|Overall Study|Non-compliance|0|||
163085671|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
163034952|NCT01887678|588832013|FG001|Overall Study|Non-compliance|3|||
163034953|NCT01887678|588832012|FG000|Overall Study|Specified|1|||
163034954|NCT01887678|588832013|FG001|Overall Study|Specified|2|||
163034955|NCT00791492|588832016|FG000|Overall Study|Withdrawal by Subject|1|||
163034956|NCT00791492|588832017|FG001|Overall Study|Withdrawal by Subject|2|||
163034957|NCT00791492|588832016|FG000|Overall Study|Liver transplantation|5|||
163034958|NCT00791492|588832017|FG001|Overall Study|Liver transplantation|1|||
163034959|NCT00090987|588832018|FG000|Overall Study|Adverse Event|5|||
163034960|NCT00090987|588832018|FG000|Overall Study|Lack of Efficacy|7|||
163034961|NCT00090987|588832018|FG000|Overall Study|Withdrawal by Subject|3|||
163034962|NCT00090987|588832018|FG000|Overall Study|alternative therapy|1|||
163034963|NCT00090987|588832018|FG000|Overall Study|Non-compliance|4|||
163034964|NCT00090987|588832018|FG000|Overall Study|Incarcerated|1|||
163034965|NCT00990665|588832023|FG000|Overall Study|Unsuccessful Implant|8|||
163034966|NCT00990665|588832023|FG000|Overall Study|Death|29|||
163034967|NCT00990665|588832023|FG000|Overall Study|Heart Transplant|1|||
163034968|NCT00990665|588832023|FG000|Overall Study|Withdrawal by Subject|6|||
163034969|NCT00990665|588832023|FG000|Overall Study|Lost to Follow-up|1|||
163034970|NCT00990665|588832023|FG000|Overall Study|System Explant|3|||
163034971|NCT02603562|588832024|FG000|Overall Study|Lost to Follow-up|1|||
163034972|NCT00270231|588832025|FG000|First Intervention|Lost to Follow-up|1|||
163034973|NCT00270231|588832026|FG001|First Intervention|Lost to Follow-up|1|||
163034974|NCT00270231|588832025|FG000|Washout Period|Lost to Follow-up|1|||
163034975|NCT00270231|588832026|FG001|Washout Period|Lost to Follow-up|0|||
163034976|NCT00270231|588832025|FG000|Second Intervention|Lost to Follow-up|0|||
163034977|NCT00270231|588832026|FG001|Second Intervention|Lost to Follow-up|1|||
163034978|NCT00574795|588832028|FG000|Infant Series|Withdrawal by Subject|2|||
163034979|NCT00574795|588832028|FG000|Infant Series|Protocol Violation|2|||
163034980|NCT00574795|588832028|FG000|Infant Series|Adverse Event|1|||
163034981|NCT00574795|588832028|FG000|After Infant Series|Withdrawal by Subject|1|||
163034982|NCT00574795|588832028|FG000|After Infant Series|Adverse Event|2|||
163034983|NCT00574795|588832028|FG000|Toddler Dose|Withdrawal by Subject|1|||
163034984|NCT02638259|588832029|FG000|Treatment Period 1|Adverse Event|1|||
163034985|NCT02638259|588832030|FG001|Treatment Period 1|Adverse Event|5|||
163034986|NCT02638259|588832029|FG000|Treatment Period 1|Death|0|||
163034987|NCT02638259|588832030|FG001|Treatment Period 1|Death|1|||
163034988|NCT02638259|588832029|FG000|Treatment Period 1|Lack of Efficacy|0|||
163034989|NCT02638259|588832030|FG001|Treatment Period 1|Lack of Efficacy|1|||
163034990|NCT02638259|588832029|FG000|Treatment Period 1|Protocol Violation|0|||
163034991|NCT02638259|588832030|FG001|Treatment Period 1|Protocol Violation|3|||
163034992|NCT02638259|588832029|FG000|Treatment Period 1|Withdrawal by Subject|4|||
163034993|NCT02638259|588832030|FG001|Treatment Period 1|Withdrawal by Subject|6|||
163034994|NCT02638259|588832029|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
163034995|NCT02638259|588832030|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
163034996|NCT02638259|588832029|FG000|Treatment Period 2|Adverse Event|5|||
163034997|NCT02638259|588832030|FG001|Treatment Period 2|Adverse Event|4|||
163034998|NCT02638259|588832029|FG000|Treatment Period 2|Withdrawal by Subject|1|||
163034999|NCT02638259|588832030|FG001|Treatment Period 2|Withdrawal by Subject|7|||
163035000|NCT04299048|588832031|FG000|Overall Study|Death|1|||
163035001|NCT04299048|588832031|FG000|Overall Study|Global deterioration of health status|2|||
163085672|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
163085673|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085674|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085675|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085676|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163035002|NCT04299048|588832031|FG000|Overall Study|Enrolled and not treated|1|||
163035003|NCT00314132|588832032|FG000|Overall Study|Lost to Follow-up|3|||
163035004|NCT00314132|588832033|FG001|Overall Study|Lost to Follow-up|13|||
163035005|NCT00314132|588832032|FG000|Overall Study|Withdrawal by Subject|3|||
163035006|NCT00314132|588832033|FG001|Overall Study|Withdrawal by Subject|5|||
163035007|NCT00314132|588832032|FG000|Overall Study|Adverse Event|1|||
163035008|NCT00314132|588832033|FG001|Overall Study|Adverse Event|0|||
163035009|NCT00314132|588832032|FG000|Overall Study|Physician Decision|1|||
163035010|NCT00314132|588832033|FG001|Overall Study|Physician Decision|0|||
163035011|NCT00957905|588832034|FG000|Part B|Not Treated|0|||
163334737|NCT00703092|589936067|FG000|Overall Study|Withdrawal by Subject|2|||
163334738|NCT02007070|589936068|FG000|Overall Study|Adverse Event|4|||
163334739|NCT02007070|589936068|FG000|Overall Study|Clinical Progression|4|||
163334740|NCT02007070|589936068|FG000|Overall Study|Death|1|||
163334741|NCT02007070|589936068|FG000|Overall Study|Protocol Violation|2|||
163334742|NCT02007070|589936068|FG000|Overall Study|Physician Decision|1|||
163334743|NCT02007070|589936068|FG000|Overall Study|Progressive Disease|21|||
163334744|NCT04070105|589936069|FG000|Overall Study|Lost to Follow-up|0|||
163334745|NCT04070105|589936070|FG001|Overall Study|Lost to Follow-up|0|||
163334746|NCT04070105|589936071|FG002|Overall Study|Lost to Follow-up|0|||
163334747|NCT04070105|589936072|FG003|Overall Study|Lost to Follow-up|0|||
163334748|NCT04070105|589936073|FG004|Overall Study|Lost to Follow-up|0|||
163334749|NCT04070105|589936074|FG005|Overall Study|Lost to Follow-up|1|||
163334750|NCT00749944|589936075|FG000|Overall Study|Lost to Follow-up|2|||
163334751|NCT00749944|589936076|FG001|Overall Study|Lost to Follow-up|1|||
163334752|NCT00749944|589936075|FG000|Overall Study|Other|1|||
163334753|NCT00749944|589936076|FG001|Overall Study|Other|0|||
163334754|NCT00749944|589936075|FG000|Overall Study|Withdrawal by Subject|2|||
163406848|NCT03016325|590198753|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
163406849|NCT03016325|590198754|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
163035012|NCT00957905|588832035|FG001|Part B|Not Treated|1|||
163035013|NCT00957905|588832034|FG000|Part B|Physician Decision|0|||
163035014|NCT00957905|588832035|FG001|Part B|Physician Decision|1|||
163035015|NCT00957905|588832034|FG000|Part B|Death|0|||
163035016|NCT00957905|588832035|FG001|Part B|Death|1|||
163035017|NCT00957905|588832034|FG000|Part B|Protocol Violation|0|||
163035018|NCT00957905|588832035|FG001|Part B|Protocol Violation|1|||
163035019|NCT01260584|588832052|FG000|Period 1|Protocol Violation|0|||
163035020|NCT01260584|588832053|FG001|Period 1|Protocol Violation|0|||
163035021|NCT01260584|588832054|FG002|Period 1|Protocol Violation|1|||
163035022|NCT01260584|588832055|FG003|Period 1|Protocol Violation|1|||
163035023|NCT01260584|588832052|FG000|Period 1|Adverse Event|0|||
163035024|NCT01260584|588832053|FG001|Period 1|Adverse Event|0|||
163035025|NCT01260584|588832054|FG002|Period 1|Adverse Event|1|||
163035026|NCT01260584|588832055|FG003|Period 1|Adverse Event|0|||
163035027|NCT01260584|588832052|FG000|Period 2|Protocol Violation|0|||
163035028|NCT01260584|588832053|FG001|Period 2|Protocol Violation|2|||
163035029|NCT01260584|588832054|FG002|Period 2|Protocol Violation|3|||
163035030|NCT01260584|588832055|FG003|Period 2|Protocol Violation|1|||
163035031|NCT01260584|588832052|FG000|Period 2|Adverse Event|1|||
163035032|NCT01260584|588832053|FG001|Period 2|Adverse Event|0|||
163035033|NCT01260584|588832054|FG002|Period 2|Adverse Event|2|||
163035034|NCT01260584|588832055|FG003|Period 2|Adverse Event|0|||
163035035|NCT01260584|588832052|FG000|Period 2|Withdrawal by Subject|0|||
163035036|NCT01260584|588832053|FG001|Period 2|Withdrawal by Subject|1|||
163035037|NCT01260584|588832054|FG002|Period 2|Withdrawal by Subject|0|||
163035038|NCT01260584|588832055|FG003|Period 2|Withdrawal by Subject|0|||
163035039|NCT00045734|588832056|FG000|Overall Study|Protocol Violation|1|||
163035040|NCT02069093|588832057|FG000|Overall Study|Disease progression|14|||
163035041|NCT02069093|588832057|FG000|Overall Study|New cancer therapy|1|||
163035042|NCT02069093|588832057|FG000|Overall Study|Death|1|||
163035043|NCT02069093|588832057|FG000|Overall Study|Administrative problems|1|||
163035044|NCT02069093|588832057|FG000|Overall Study|Withdrawal by Subject|2|||
163035045|NCT02069093|588832057|FG000|Overall Study|Abnormal laboratory values|1|||
163035046|NCT02069093|588832057|FG000|Overall Study|Adverse Event|10|||
163035047|NCT03434249|588832060|FG000|Overall Study|Adverse Event|1|||
163035048|NCT03434249|588832061|FG001|Overall Study|Adverse Event|0|||
163035049|NCT03434249|588832060|FG000|Overall Study|Lost to Follow-up|0|||
163035050|NCT03434249|588832061|FG001|Overall Study|Lost to Follow-up|1|||
163035051|NCT03434249|588832060|FG000|Overall Study|Non-compliance of family|2|||
163035052|NCT03434249|588832061|FG001|Overall Study|Non-compliance of family|1|||
163035053|NCT03434249|588832060|FG000|Overall Study|Difficulties in completing daily diary|2|||
163035054|NCT03434249|588832061|FG001|Overall Study|Difficulties in completing daily diary|1|||
163035055|NCT02918552|588832062|FG000|Overall Study|Failed Pharmacokinetics|1|||
163035056|NCT02918552|588832063|FG001|Overall Study|Failed Pharmacokinetics|0|||
163035057|NCT02918552|588832062|FG000|Overall Study|Withdrawal by Subject|0|||
163035058|NCT02918552|588832063|FG001|Overall Study|Withdrawal by Subject|1|||
163035059|NCT02918552|588832062|FG000|Overall Study|Lost to Follow-up|0|||
163035060|NCT02918552|588832063|FG001|Overall Study|Lost to Follow-up|1|||
163035061|NCT01001598|588832064|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
163035062|NCT01001598|588832064|FG000|Overall Study|Adverse Event|1|||
163035063|NCT01969084|588832069|FG000|Overall Study|Adverse Event|0|||
163035064|NCT01969084|588832070|FG001|Overall Study|Adverse Event|1|||
163035065|NCT02920177|588832071|FG000|Overall Study|Withdrawal by Subject|1|||
163035066|NCT02920177|588832072|FG001|Overall Study|Withdrawal by Subject|1|||
163035067|NCT02920177|588832071|FG000|Overall Study|Physician Decision|1|||
163035068|NCT02920177|588832072|FG001|Overall Study|Physician Decision|0|||
163035069|NCT02920177|588832071|FG000|Overall Study|Lost to Follow-up|0|||
163334755|NCT00749944|589936076|FG001|Overall Study|Withdrawal by Subject|0|||
163334756|NCT00624377|589936077|FG000|Overall Study|Lost to Follow-up|355|||
163334757|NCT00624377|589936077|FG000|Overall Study|Withdrawal by Subject|100|||
163085677|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085678|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085679|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085680|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085681|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085682|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085683|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085684|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085685|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085686|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085687|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
163085688|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085689|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
163085690|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
163085691|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
163085692|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
163085693|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
163085694|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085695|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085696|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085697|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085698|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085699|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085700|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085701|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085702|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085703|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085704|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085705|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085706|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
163085707|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085708|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085709|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
163085710|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085711|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085712|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085713|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085714|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085715|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085716|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085717|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085718|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085719|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085720|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085721|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
163085722|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085723|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085724|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085725|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163334758|NCT00624377|589936077|FG000|Overall Study|Adverse Event|14|||
163334759|NCT00624377|589936077|FG000|Overall Study|Other|91|||
163334760|NCT00624377|589936077|FG000|Overall Study|Non-evaluable population|84|||
163334761|NCT00089791|589936086|FG000|Overall Study|Physician Decision|6|||
163035070|NCT02920177|588832072|FG001|Overall Study|Lost to Follow-up|1|||
163035071|NCT03164265|588832073|FG000|Overall Study|Physician Decision|3|||
163035072|NCT04907227|588832074|FG000|Overall Study|Death|12|||
163035073|NCT04907227|588832075|FG001|Overall Study|Death|8|||
163334762|NCT00089791|589936087|FG001|Overall Study|Physician Decision|3|||
163334763|NCT00089791|589936086|FG000|Overall Study|Adverse Event|81|||
163035074|NCT04907227|588832074|FG000|Overall Study|Withdrawal by Subject|2|||
163035075|NCT04907227|588832075|FG001|Overall Study|Withdrawal by Subject|2|||
163035076|NCT04907227|588832074|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
163035077|NCT04907227|588832075|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
163035078|NCT04907227|588832074|FG000|Overall Study|Sponsor Decision|25|||
163035079|NCT04907227|588832075|FG001|Overall Study|Sponsor Decision|30|||
163035080|NCT04907227|588832074|FG000|Overall Study|Physician Decision|1|||
163035081|NCT04907227|588832075|FG001|Overall Study|Physician Decision|0|||
163035082|NCT03673345|588832076|FG000|Overall Study|Lost to Follow-up|1|||
163035083|NCT03673345|588832077|FG001|Overall Study|Lost to Follow-up|0|||
163035084|NCT03673345|588832078|FG002|Overall Study|Lost to Follow-up|3|||
163035085|NCT03673345|588832079|FG003|Overall Study|Lost to Follow-up|3|||
163035086|NCT03673345|588832080|FG004|Overall Study|Lost to Follow-up|2|||
163035087|NCT03673345|588832081|FG005|Overall Study|Lost to Follow-up|1|||
163035088|NCT03673345|588832082|FG006|Overall Study|Lost to Follow-up|0|||
163035089|NCT03673345|588832083|FG007|Overall Study|Lost to Follow-up|0|||
163035090|NCT03673345|588832076|FG000|Overall Study|Withdrawal by Subject|1|||
163035091|NCT03673345|588832077|FG001|Overall Study|Withdrawal by Subject|0|||
163035092|NCT03673345|588832078|FG002|Overall Study|Withdrawal by Subject|4|||
163035093|NCT03673345|588832079|FG003|Overall Study|Withdrawal by Subject|2|||
163035094|NCT03673345|588832080|FG004|Overall Study|Withdrawal by Subject|0|||
163035095|NCT03673345|588832081|FG005|Overall Study|Withdrawal by Subject|0|||
163035096|NCT03673345|588832082|FG006|Overall Study|Withdrawal by Subject|0|||
163035097|NCT03673345|588832083|FG007|Overall Study|Withdrawal by Subject|0|||
163035098|NCT03673345|588832076|FG000|Overall Study|Physician Decision|0|||
163035099|NCT03673345|588832077|FG001|Overall Study|Physician Decision|0|||
163035100|NCT03673345|588832078|FG002|Overall Study|Physician Decision|2|||
163035101|NCT03673345|588832079|FG003|Overall Study|Physician Decision|0|||
163035102|NCT03673345|588832080|FG004|Overall Study|Physician Decision|0|||
163035103|NCT03673345|588832081|FG005|Overall Study|Physician Decision|0|||
163085726|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085727|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085728|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085729|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085730|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085731|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085732|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085733|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085734|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085735|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
163085736|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
163085737|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
163085738|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085739|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085740|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085741|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085742|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085743|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085744|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085745|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163334764|NCT00089791|589936087|FG001|Overall Study|Adverse Event|93|||
163334765|NCT00089791|589936086|FG000|Overall Study|Withdrawal by Subject|403|||
163334766|NCT00089791|589936087|FG001|Overall Study|Withdrawal by Subject|344|||
163334767|NCT00089791|589936086|FG000|Overall Study|Death|78|||
163334768|NCT00089791|589936087|FG001|Overall Study|Death|62|||
163334769|NCT00089791|589936086|FG000|Overall Study|Disease progression|7|||
163334770|NCT00089791|589936087|FG001|Overall Study|Disease progression|3|||
163334771|NCT00089791|589936086|FG000|Overall Study|Ineligibility determined|12|||
163334772|NCT00089791|589936087|FG001|Overall Study|Ineligibility determined|9|||
163334773|NCT00089791|589936086|FG000|Overall Study|Lost to Follow-up|57|||
163334774|NCT00089791|589936087|FG001|Overall Study|Lost to Follow-up|57|||
163334775|NCT00089791|589936086|FG000|Overall Study|Noncompliance|17|||
163334776|NCT00089791|589936087|FG001|Overall Study|Noncompliance|13|||
163334777|NCT00089791|589936086|FG000|Overall Study|Other|20|||
163334778|NCT00089791|589936087|FG001|Overall Study|Other|32|||
163406850|NCT03016325|590198755|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
163035104|NCT03673345|588832082|FG006|Overall Study|Physician Decision|0|||
163085746|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085747|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085748|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163334779|NCT00089791|589936086|FG000|Overall Study|Protocol deviation|12|||
163334780|NCT00089791|589936087|FG001|Overall Study|Protocol deviation|10|||
163334781|NCT00089791|589936086|FG000|Overall Study|Requirement for alternative therapy|7|||
163334782|NCT00089791|589936087|FG001|Overall Study|Requirement for alternative therapy|4|||
163035105|NCT03673345|588832083|FG007|Overall Study|Physician Decision|0|||
163035106|NCT01362244|588832084|FG000|Overall Study|Adverse Event|3|||
163035107|NCT01362244|588832085|FG001|Overall Study|Adverse Event|5|||
163035108|NCT01362244|588832084|FG000|Overall Study|Lack of Efficacy|5|||
163035109|NCT01362244|588832085|FG001|Overall Study|Lack of Efficacy|11|||
163035110|NCT01362244|588832084|FG000|Overall Study|Lost to Follow-up|0|||
163035111|NCT01362244|588832085|FG001|Overall Study|Lost to Follow-up|2|||
163035112|NCT01362244|588832084|FG000|Overall Study|Protocol Violation|5|||
163035113|NCT01362244|588832085|FG001|Overall Study|Protocol Violation|1|||
163035114|NCT01362244|588832084|FG000|Overall Study|Withdrawal by Subject|2|||
163035115|NCT01362244|588832085|FG001|Overall Study|Withdrawal by Subject|1|||
163035116|NCT01362244|588832084|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
163035117|NCT01362244|588832085|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
163035118|NCT01362244|588832084|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
163035119|NCT01362244|588832085|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
163035120|NCT01253174|588832086|FG000|Period 1|Randomized but not treated|0|||
163035121|NCT01253174|588832087|FG001|Period 1|Randomized but not treated|1|||
163035122|NCT01253174|588832088|FG002|Period 1|Randomized but not treated|1|||
163035123|NCT01253174|588832089|FG003|Period 1|Randomized but not treated|0|||
163035124|NCT01253174|588832090|FG004|Period 1|Randomized but not treated|1|||
163035125|NCT01253174|588832091|FG005|Period 1|Randomized but not treated|0|||
163035126|NCT01253174|588832086|FG000|Period 2|Adverse Event|0|||
163035127|NCT01253174|588832087|FG001|Period 2|Adverse Event|0|||
163035128|NCT01253174|588832088|FG002|Period 2|Adverse Event|1|||
163035129|NCT01253174|588832089|FG003|Period 2|Adverse Event|0|||
163035130|NCT01253174|588832090|FG004|Period 2|Adverse Event|0|||
163035131|NCT01253174|588832091|FG005|Period 2|Adverse Event|0|||
163035132|NCT01253174|588832086|FG000|Period 3|Withdrawal by Subject|0|||
163035133|NCT01253174|588832087|FG001|Period 3|Withdrawal by Subject|1|||
163035134|NCT01253174|588832088|FG002|Period 3|Withdrawal by Subject|0|||
163334783|NCT02161458|589936088|FG000|Overall Study|Withdrawal by Subject|0|||
163334784|NCT02161458|589936089|FG001|Overall Study|Withdrawal by Subject|4|||
163334785|NCT02161458|589936090|FG002|Overall Study|Withdrawal by Subject|4|||
163035135|NCT01253174|588832089|FG003|Period 3|Withdrawal by Subject|0|||
163035136|NCT01253174|588832090|FG004|Period 3|Withdrawal by Subject|1|||
163035137|NCT01253174|588832091|FG005|Period 3|Withdrawal by Subject|0|||
163035138|NCT01253174|588832086|FG000|Period 3|Pregnancy|0|||
163035139|NCT01253174|588832087|FG001|Period 3|Pregnancy|0|||
163035140|NCT01253174|588832088|FG002|Period 3|Pregnancy|1|||
163035141|NCT01253174|588832089|FG003|Period 3|Pregnancy|0|||
163035142|NCT01253174|588832090|FG004|Period 3|Pregnancy|0|||
163035143|NCT01253174|588832091|FG005|Period 3|Pregnancy|0|||
163035144|NCT02267135|588832092|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
163035145|NCT02267135|588832093|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
163035146|NCT02267135|588832092|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
163035147|NCT02267135|588832093|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
163035148|NCT02267135|588832092|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
163035149|NCT02267135|588832093|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
163035150|NCT02267135|588832092|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
163035151|NCT02267135|588832093|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
163035152|NCT02267135|588832092|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
163035153|NCT02267135|588832093|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
163035154|NCT03806231|588832094|FG000|Overall Study|Physician Decision|1|||
163035155|NCT03806231|588832095|FG001|Overall Study|Physician Decision|0|||
163035156|NCT03806231|588832094|FG000|Overall Study|Withdrawal by Subject|1|||
163035157|NCT03806231|588832095|FG001|Overall Study|Withdrawal by Subject|0|||
163035158|NCT02919267|588832096|FG000|Overall Study|Protocol Violation|0|||
163035159|NCT02919267|588832097|FG001|Overall Study|Protocol Violation|3|||
163035160|NCT02919267|588832098|FG002|Overall Study|Protocol Violation|3|||
163035161|NCT02919267|588832099|FG003|Overall Study|Protocol Violation|4|||
163035162|NCT04608344|588832100|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
163035163|NCT04608344|588832101|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
163035164|NCT04608344|588832100|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
163035165|NCT04608344|588832101|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
163035166|NCT00467961|588832102|FG000|Overall Study|Technical Failures|5|||
163035167|NCT00467961|588832102|FG000|Overall Study|Disease Progression|2|||
163035168|NCT02429310|588832104|FG000|Overall Study|Lost to Follow-up|1|||
163334786|NCT02161458|589936091|FG003|Overall Study|Withdrawal by Subject|0|||
163334787|NCT02161458|589936088|FG000|Overall Study|Lost to Follow-up|0|||
163035169|NCT02429310|588832105|FG001|Overall Study|Lost to Follow-up|2|||
163035170|NCT02429310|588832104|FG000|Overall Study|Protocol Violation|1|||
163035171|NCT02429310|588832105|FG001|Overall Study|Protocol Violation|1|||
163035172|NCT00394433|588832106|FG000|Overall Study|Adverse Event|2|||
163035173|NCT00394433|588832106|FG000|Overall Study|Alternative Therapy|1|||
163334788|NCT02161458|589936089|FG001|Overall Study|Lost to Follow-up|2|||
163035174|NCT03646305|588832107|FG000|Overall Study|Lost to Follow-up|4|||
163035175|NCT03646305|588832108|FG001|Overall Study|Lost to Follow-up|2|||
163035176|NCT03646305|588832109|FG002|Overall Study|Lost to Follow-up|2|||
163035177|NCT03646305|588832110|FG003|Overall Study|Lost to Follow-up|1|||
163035178|NCT03646305|588832107|FG000|Overall Study|Withdrawal by Subject|1|||
163035179|NCT03646305|588832108|FG001|Overall Study|Withdrawal by Subject|0|||
163334789|NCT02161458|589936090|FG002|Overall Study|Lost to Follow-up|1|||
163334790|NCT02161458|589936091|FG003|Overall Study|Lost to Follow-up|0|||
163035180|NCT03646305|588832109|FG002|Overall Study|Withdrawal by Subject|0|||
163035181|NCT03646305|588832110|FG003|Overall Study|Withdrawal by Subject|1|||
163334791|NCT02362789|589936099|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
163334792|NCT02362789|589936100|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
163334793|NCT02362789|589936101|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
163334794|NCT02362789|589936099|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
163334795|NCT02362789|589936100|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
163035182|NCT01554176|588832111|FG000|Treatment Phase|Protocol Violation|1|||
163035183|NCT01554176|588832112|FG001|Treatment Phase|Protocol Violation|2|||
163035184|NCT01554176|588832113|FG002|Treatment Phase|Protocol Violation|0|||
163035185|NCT01554176|588832114|FG003|Treatment Phase|Protocol Violation|0|||
163035186|NCT01554176|588832115|FG004|Treatment Phase|Protocol Violation|0|||
163035187|NCT01554176|588832111|FG000|Treatment Phase|Physician Decision|1|||
163035188|NCT01554176|588832112|FG001|Treatment Phase|Physician Decision|1|||
163035189|NCT01554176|588832113|FG002|Treatment Phase|Physician Decision|0|||
163035190|NCT01554176|588832114|FG003|Treatment Phase|Physician Decision|0|||
163035191|NCT01554176|588832115|FG004|Treatment Phase|Physician Decision|0|||
163035192|NCT01554176|588832111|FG000|Treatment Phase|Lack of Efficacy|0|||
163035193|NCT01554176|588832112|FG001|Treatment Phase|Lack of Efficacy|1|||
163035194|NCT01554176|588832113|FG002|Treatment Phase|Lack of Efficacy|0|||
163035195|NCT01554176|588832114|FG003|Treatment Phase|Lack of Efficacy|0|||
163035196|NCT01554176|588832115|FG004|Treatment Phase|Lack of Efficacy|0|||
163035197|NCT01554176|588832111|FG000|Treatment Phase|Adverse event, non-fatal|1|||
163035198|NCT01554176|588832112|FG001|Treatment Phase|Adverse event, non-fatal|1|||
163035199|NCT01554176|588832113|FG002|Treatment Phase|Adverse event, non-fatal|0|||
163035200|NCT01554176|588832114|FG003|Treatment Phase|Adverse event, non-fatal|0|||
163035201|NCT01554176|588832115|FG004|Treatment Phase|Adverse event, non-fatal|0|||
163035202|NCT01554176|588832111|FG000|Treatment Phase|Non-compliance with study drug|1|||
163035203|NCT01554176|588832112|FG001|Treatment Phase|Non-compliance with study drug|0|||
163035204|NCT01554176|588832113|FG002|Treatment Phase|Non-compliance with study drug|0|||
163035205|NCT01554176|588832114|FG003|Treatment Phase|Non-compliance with study drug|0|||
163035206|NCT01554176|588832115|FG004|Treatment Phase|Non-compliance with study drug|0|||
163035207|NCT01554176|588832111|FG000|Treatment Phase|Withdrawal by Subject|1|||
163035208|NCT01554176|588832112|FG001|Treatment Phase|Withdrawal by Subject|0|||
163035209|NCT01554176|588832113|FG002|Treatment Phase|Withdrawal by Subject|0|||
163035210|NCT01554176|588832114|FG003|Treatment Phase|Withdrawal by Subject|0|||
163035211|NCT01554176|588832115|FG004|Treatment Phase|Withdrawal by Subject|0|||
163035212|NCT01554176|588832111|FG000|Treatment Phase|Lost to Follow-up|3|||
163035213|NCT01554176|588832112|FG001|Treatment Phase|Lost to Follow-up|0|||
163035214|NCT01554176|588832113|FG002|Treatment Phase|Lost to Follow-up|0|||
163035215|NCT01554176|588832114|FG003|Treatment Phase|Lost to Follow-up|0|||
163035216|NCT01554176|588832115|FG004|Treatment Phase|Lost to Follow-up|0|||
163035217|NCT01554176|588832111|FG000|Run-out Phase|Protocol Violation|0|||
163035218|NCT01554176|588832112|FG001|Run-out Phase|Protocol Violation|0|||
163035219|NCT01554176|588832113|FG002|Run-out Phase|Protocol Violation|0|||
163035220|NCT01554176|588832114|FG003|Run-out Phase|Protocol Violation|1|||
163035221|NCT01554176|588832115|FG004|Run-out Phase|Protocol Violation|0|||
163035222|NCT02678000|588832118|FG000|PART 2|Adverse Event|0|||
163035223|NCT02678000|588832119|FG001|PART 2|Adverse Event|0|||
163035224|NCT02678000|588832120|FG002|PART 2|Adverse Event|2|||
163035225|NCT02678000|588832121|FG003|PART 2|Adverse Event|1|||
163035226|NCT02678000|588832122|FG004|PART 2|Adverse Event|0|||
163035227|NCT02678000|588832118|FG000|PART 2|Withdrawal by Subject|0|||
163035228|NCT02678000|588832119|FG001|PART 2|Withdrawal by Subject|0|||
163035229|NCT02678000|588832120|FG002|PART 2|Withdrawal by Subject|1|||
163035230|NCT02678000|588832121|FG003|PART 2|Withdrawal by Subject|0|||
163035231|NCT02678000|588832122|FG004|PART 2|Withdrawal by Subject|0|||
163035232|NCT02190721|588834246|FG000|Overall Study|Patient was out of the city|0|||
163035233|NCT02190721|588834247|FG001|Overall Study|Patient was out of the city|1|||
163035234|NCT02190721|588834248|FG002|Overall Study|Patient was out of the city|0|||
163035235|NCT01760447|588834249|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
163035236|NCT01760447|588834250|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
163035237|NCT01760447|588834251|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
163035238|NCT01760447|588834252|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
163035239|NCT01760447|588834249|FG000|Weeks 0-20|Withdrawal by Subject|2|||
163035240|NCT01760447|588834250|FG001|Weeks 0-20|Withdrawal by Subject|0|||
163035241|NCT01760447|588834251|FG002|Weeks 0-20|Withdrawal by Subject|1|||
163035242|NCT01760447|588834252|FG003|Weeks 0-20|Withdrawal by Subject|0|||
163035243|NCT01760447|588834249|FG000|Weeks 0-20|Lost to Follow-up|1|||
163035244|NCT01760447|588834250|FG001|Weeks 0-20|Lost to Follow-up|0|||
163035245|NCT01760447|588834251|FG002|Weeks 0-20|Lost to Follow-up|1|||
163035246|NCT01760447|588834252|FG003|Weeks 0-20|Lost to Follow-up|1|||
163035247|NCT01760447|588834249|FG000|Weeks 0-20|Randomized but not treated|0|||
163035248|NCT01760447|588834250|FG001|Weeks 0-20|Randomized but not treated|0|||
163035249|NCT01760447|588834251|FG002|Weeks 0-20|Randomized but not treated|2|||
163035250|NCT01760447|588834252|FG003|Weeks 0-20|Randomized but not treated|0|||
163035251|NCT01760447|588834249|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
163035252|NCT01760447|588834250|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
163334796|NCT02362789|589936101|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
163334797|NCT02362789|589936099|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
163334798|NCT02362789|589936100|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
163334799|NCT02362789|589936101|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
163334800|NCT02362789|589936099|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
163334801|NCT02362789|589936100|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
163035253|NCT01760447|588834251|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
163035254|NCT01760447|588834252|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
163035255|NCT01760447|588834249|FG000|Weeks 20-54|Withdrawal by Subject|2|||
163035256|NCT01760447|588834250|FG001|Weeks 20-54|Withdrawal by Subject|1|||
163035257|NCT01760447|588834251|FG002|Weeks 20-54|Withdrawal by Subject|1|||
163035258|NCT01760447|588834252|FG003|Weeks 20-54|Withdrawal by Subject|2|||
163035259|NCT01760447|588834249|FG000|Weeks 20-54|Lost to Follow-up|0|||
163035260|NCT01760447|588834250|FG001|Weeks 20-54|Lost to Follow-up|0|||
163035261|NCT01760447|588834251|FG002|Weeks 20-54|Lost to Follow-up|1|||
163035262|NCT01760447|588834252|FG003|Weeks 20-54|Lost to Follow-up|2|||
163035263|NCT01214668|588834253|FG000|Overall Study|Adverse Event|0|||
163035264|NCT01214668|588834254|FG001|Overall Study|Adverse Event|1|||
163035265|NCT01214668|588834255|FG002|Overall Study|Adverse Event|0|||
163035266|NCT01214668|588834256|FG003|Overall Study|Adverse Event|2|||
163035267|NCT01214668|588834257|FG004|Overall Study|Adverse Event|1|||
163035268|NCT01214668|588834258|FG005|Overall Study|Adverse Event|1|||
163035269|NCT01214668|588834253|FG000|Overall Study|Death|0|||
163035270|NCT01214668|588834254|FG001|Overall Study|Death|0|||
163035271|NCT01214668|588834255|FG002|Overall Study|Death|1|||
163035272|NCT01214668|588834256|FG003|Overall Study|Death|0|||
163035273|NCT01214668|588834257|FG004|Overall Study|Death|0|||
163035274|NCT01214668|588834258|FG005|Overall Study|Death|0|||
163035275|NCT01214668|588834253|FG000|Overall Study|Progressive Disease|4|||
163035276|NCT01214668|588834254|FG001|Overall Study|Progressive Disease|2|||
163035277|NCT01214668|588834255|FG002|Overall Study|Progressive Disease|5|||
163035278|NCT01214668|588834256|FG003|Overall Study|Progressive Disease|4|||
163035279|NCT01214668|588834257|FG004|Overall Study|Progressive Disease|4|||
163035280|NCT01214668|588834258|FG005|Overall Study|Progressive Disease|5|||
163035281|NCT01214668|588834253|FG000|Overall Study|Withdrawal by Subject|0|||
163035282|NCT01214668|588834254|FG001|Overall Study|Withdrawal by Subject|0|||
163035283|NCT01214668|588834255|FG002|Overall Study|Withdrawal by Subject|0|||
163035284|NCT01214668|588834256|FG003|Overall Study|Withdrawal by Subject|0|||
163035285|NCT01214668|588834257|FG004|Overall Study|Withdrawal by Subject|1|||
163035286|NCT01214668|588834258|FG005|Overall Study|Withdrawal by Subject|0|||
163035287|NCT02907619|588834259|FG000|Overall Study|Study terminated by sponsor|18|||
163035288|NCT02907619|588834260|FG001|Overall Study|Study terminated by sponsor|18|||
163035289|NCT02907619|588834261|FG002|Overall Study|Study terminated by sponsor|19|||
163035290|NCT02907619|588834259|FG000|Overall Study|Death|0|||
163035291|NCT02907619|588834260|FG001|Overall Study|Death|0|||
163035292|NCT02907619|588834261|FG002|Overall Study|Death|1|||
163035293|NCT02907619|588834259|FG000|Overall Study|Withdrawal by Subject|1|||
163035294|NCT02907619|588834260|FG001|Overall Study|Withdrawal by Subject|1|||
163035295|NCT02907619|588834261|FG002|Overall Study|Withdrawal by Subject|0|||
163035296|NCT02907619|588834259|FG000|Overall Study|Other|0|||
163035297|NCT02907619|588834260|FG001|Overall Study|Other|1|||
163035298|NCT02907619|588834261|FG002|Overall Study|Other|0|||
163035299|NCT03326518|588834262|FG000|Overall Study|Protocol Violation|1|||
163035300|NCT03326518|588834263|FG001|Overall Study|Protocol Violation|0|||
163035301|NCT03326518|588834264|FG002|Overall Study|Protocol Violation|0|||
163035302|NCT03326518|588834262|FG000|Overall Study|Withdrawal by Subject|1|||
163035303|NCT03326518|588834263|FG001|Overall Study|Withdrawal by Subject|0|||
163035304|NCT03326518|588834264|FG002|Overall Study|Withdrawal by Subject|0|||
163035305|NCT03326518|588834262|FG000|Overall Study|Lost to Follow-up|1|||
163035306|NCT03326518|588834263|FG001|Overall Study|Lost to Follow-up|0|||
163035307|NCT03326518|588834264|FG002|Overall Study|Lost to Follow-up|1|||
163035308|NCT06439095|588834265|FG000|Overall Study|Lost to Follow-up|2|||
163035309|NCT03484403|588834267|FG000|Overall Study|Withdrawal by Subject|6|||
163035310|NCT03484403|588834268|FG001|Overall Study|Withdrawal by Subject|4|||
163035311|NCT01937884|588834269|FG000|Overall Study|Withdrawal by Subject|1|||
163035312|NCT01937884|588834270|FG001|Overall Study|Withdrawal by Subject|0|||
163035313|NCT01167634|588834275|FG000|Overall Study|Lost to Follow-up|1|||
163035314|NCT01167634|588834276|FG001|Overall Study|Lost to Follow-up|3|||
163035315|NCT01167634|588834277|FG002|Overall Study|Lost to Follow-up|3|||
163035316|NCT01167634|588834278|FG003|Overall Study|Lost to Follow-up|4|||
163035317|NCT01167634|588834275|FG000|Overall Study|Withdrawal by Subject|1|||
163334802|NCT02362789|589936101|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
163334803|NCT02362789|589936099|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
163035318|NCT01167634|588834276|FG001|Overall Study|Withdrawal by Subject|1|||
163035319|NCT01167634|588834277|FG002|Overall Study|Withdrawal by Subject|0|||
163035320|NCT01167634|588834278|FG003|Overall Study|Withdrawal by Subject|0|||
163035321|NCT00553358|588834279|FG000|Overall Study|Randomized but did not receive treatment|3|||
163035322|NCT00553358|588834280|FG001|Overall Study|Randomized but did not receive treatment|3|||
163035323|NCT00553358|588834281|FG002|Overall Study|Randomized but did not receive treatment|1|||
163035324|NCT00553358|588834279|FG000|Overall Study|Lost to Follow-up|22|||
163035325|NCT00553358|588834280|FG001|Overall Study|Lost to Follow-up|26|||
163035326|NCT00553358|588834281|FG002|Overall Study|Lost to Follow-up|18|||
163035327|NCT00553358|588834279|FG000|Overall Study|Withdrew completely|23|||
163035328|NCT00553358|588834280|FG001|Overall Study|Withdrew completely|33|||
163035329|NCT00553358|588834281|FG002|Overall Study|Withdrew completely|34|||
163035330|NCT00553358|588834279|FG000|Overall Study|Died during clinical follow-up|25|||
163035331|NCT00553358|588834280|FG001|Overall Study|Died during clinical follow-up|29|||
163035332|NCT00553358|588834281|FG002|Overall Study|Died during clinical follow-up|32|||
163035333|NCT00553358|588834279|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
163035334|NCT00553358|588834280|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
163035335|NCT00553358|588834281|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
163035336|NCT00553358|588834279|FG000|Overall Study|Died after clinical follow-up ended|1|||
163035337|NCT00553358|588834280|FG001|Overall Study|Died after clinical follow-up ended|2|||
163035338|NCT00553358|588834281|FG002|Overall Study|Died after clinical follow-up ended|0|||
163035339|NCT00553358|588834279|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
163035340|NCT00553358|588834280|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
163035341|NCT00553358|588834281|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
163035342|NCT02854605|588834286|FG000|Overall Study|Adverse Event|1|||
163035343|NCT02854605|588834287|FG001|Overall Study|Adverse Event|5|||
163035344|NCT02854605|588834288|FG002|Overall Study|Adverse Event|2|||
163035345|NCT02854605|588834286|FG000|Overall Study|Lost to Follow-up|0|||
163035346|NCT02854605|588834287|FG001|Overall Study|Lost to Follow-up|2|||
163035347|NCT02854605|588834288|FG002|Overall Study|Lost to Follow-up|0|||
163035348|NCT02854605|588834286|FG000|Overall Study|Withdrew Consent|1|||
163035349|NCT02854605|588834287|FG001|Overall Study|Withdrew Consent|0|||
163035350|NCT02854605|588834288|FG002|Overall Study|Withdrew Consent|1|||
163035351|NCT02854605|588834286|FG000|Overall Study|Investigator's Discretion|1|||
163035352|NCT02854605|588834287|FG001|Overall Study|Investigator's Discretion|0|||
163035353|NCT02854605|588834288|FG002|Overall Study|Investigator's Discretion|0|||
163035354|NCT02854605|588834286|FG000|Overall Study|Protocol Violation|0|||
163035355|NCT02854605|588834287|FG001|Overall Study|Protocol Violation|0|||
163035356|NCT02854605|588834288|FG002|Overall Study|Protocol Violation|1|||
163035357|NCT05268016|588834289|FG000|Overall Study|Unacceptable toxicity or AE|2|||
163035358|NCT05268016|588834290|FG001|Overall Study|Unacceptable toxicity or AE|2|||
163035359|NCT05268016|588834291|FG002|Overall Study|Unacceptable toxicity or AE|4|||
163035360|NCT05268016|588834292|FG003|Overall Study|Unacceptable toxicity or AE|3|||
163035361|NCT05268016|588834293|FG004|Overall Study|Unacceptable toxicity or AE|1|||
163035362|NCT05268016|588834289|FG000|Overall Study|Withdrawal by Subject|1|||
163035363|NCT05268016|588834290|FG001|Overall Study|Withdrawal by Subject|3|||
163035364|NCT05268016|588834291|FG002|Overall Study|Withdrawal by Subject|2|||
163035365|NCT05268016|588834292|FG003|Overall Study|Withdrawal by Subject|2|||
163035366|NCT05268016|588834293|FG004|Overall Study|Withdrawal by Subject|1|||
163035367|NCT05268016|588834289|FG000|Overall Study|Lost to Follow-up|4|||
163035368|NCT05268016|588834290|FG001|Overall Study|Lost to Follow-up|7|||
163035369|NCT05268016|588834291|FG002|Overall Study|Lost to Follow-up|1|||
163035370|NCT05268016|588834292|FG003|Overall Study|Lost to Follow-up|3|||
163035371|NCT05268016|588834293|FG004|Overall Study|Lost to Follow-up|5|||
163035372|NCT05268016|588834289|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
163035373|NCT05268016|588834290|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
163035374|NCT05268016|588834291|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
163035375|NCT05268016|588834292|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
163035376|NCT05268016|588834293|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
163035377|NCT05268016|588834289|FG000|Overall Study|Lack of Efficacy|0|||
163035378|NCT05268016|588834290|FG001|Overall Study|Lack of Efficacy|0|||
163035379|NCT05268016|588834291|FG002|Overall Study|Lack of Efficacy|0|||
163035380|NCT05268016|588834292|FG003|Overall Study|Lack of Efficacy|0|||
163035381|NCT05268016|588834293|FG004|Overall Study|Lack of Efficacy|4|||
163035382|NCT05268016|588834289|FG000|Overall Study|Physician Decision|0|||
163035383|NCT05268016|588834290|FG001|Overall Study|Physician Decision|0|||
163035384|NCT05268016|588834291|FG002|Overall Study|Physician Decision|0|||
163035385|NCT05268016|588834292|FG003|Overall Study|Physician Decision|1|||
163035386|NCT05268016|588834293|FG004|Overall Study|Physician Decision|0|||
163035387|NCT05268016|588834289|FG000|Overall Study|Other|1|||
163035388|NCT05268016|588834290|FG001|Overall Study|Other|0|||
163035389|NCT05268016|588834291|FG002|Overall Study|Other|1|||
163035390|NCT05268016|588834292|FG003|Overall Study|Other|2|||
163035391|NCT05268016|588834293|FG004|Overall Study|Other|0|||
163035392|NCT01964716|588834294|FG000|Overall Study|Withdrawal by Subject|2|||
163085749|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163035393|NCT01964716|588834295|FG001|Overall Study|Withdrawal by Subject|3|||
163035394|NCT01964716|588834294|FG000|Overall Study|Lost to Follow-up|1|||
163334804|NCT02362789|589936100|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
163334805|NCT02362789|589936101|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
163334806|NCT02037568|589936102|FG000|Overall Study|Withdrawal by Subject|17|||
163334807|NCT02037568|589936103|FG001|Overall Study|Withdrawal by Subject|24|||
163334808|NCT02037568|589936102|FG000|Overall Study|Lost to Follow-up|16|||
163334809|NCT02037568|589936103|FG001|Overall Study|Lost to Follow-up|13|||
163334810|NCT02037568|589936102|FG000|Overall Study|Screen Failure|3|||
163334811|NCT02037568|589936103|FG001|Overall Study|Screen Failure|1|||
163334812|NCT02037568|589936102|FG000|Overall Study|Patient did not receive transplant|0|||
163334813|NCT02037568|589936103|FG001|Overall Study|Patient did not receive transplant|1|||
163334814|NCT05074433|589936108|FG000|Overall Study|Adverse Event|0|||
163334815|NCT05074433|589936109|FG001|Overall Study|Adverse Event|2|||
163334816|NCT05074433|589936110|FG002|Overall Study|Adverse Event|0|||
163334817|NCT05074433|589936111|FG003|Overall Study|Adverse Event|1|||
163334818|NCT05074433|589936108|FG000|Overall Study|Sponsor Request|0|||
163334819|NCT05074433|589936109|FG001|Overall Study|Sponsor Request|1|||
163334820|NCT05074433|589936110|FG002|Overall Study|Sponsor Request|1|||
163334821|NCT05074433|589936111|FG003|Overall Study|Sponsor Request|0|||
163334822|NCT05074433|589936108|FG000|Overall Study|Death|1|||
163334823|NCT05074433|589936109|FG001|Overall Study|Death|0|||
163334824|NCT05074433|589936110|FG002|Overall Study|Death|0|||
163334825|NCT05074433|589936111|FG003|Overall Study|Death|0|||
163334826|NCT05074433|589936108|FG000|Overall Study|Lost to Follow-up|0|||
163334827|NCT05074433|589936109|FG001|Overall Study|Lost to Follow-up|0|||
163334828|NCT05074433|589936110|FG002|Overall Study|Lost to Follow-up|2|||
163334829|NCT05074433|589936111|FG003|Overall Study|Lost to Follow-up|0|||
163035395|NCT01964716|588834295|FG001|Overall Study|Lost to Follow-up|2|||
163035396|NCT01964716|588834294|FG000|Overall Study|No longer met eligibility criteria|1|||
163035397|NCT01964716|588834295|FG001|Overall Study|No longer met eligibility criteria|1|||
163035398|NCT01964716|588834294|FG000|Overall Study|Death|1|||
163035399|NCT01964716|588834295|FG001|Overall Study|Death|0|||
163035400|NCT03013985|588834296|FG000|Overall Study|Protocol Violation|2|||
163035401|NCT03013985|588834297|FG001|Overall Study|Protocol Violation|2|||
163035402|NCT03013985|588834296|FG000|Overall Study|Withdrawal by Subject|14|||
163035403|NCT03013985|588834297|FG001|Overall Study|Withdrawal by Subject|17|||
163035404|NCT01370616|588834298|FG000|Overall Study|Adverse Event|11|||
163035405|NCT01370616|588834299|FG001|Overall Study|Adverse Event|16|||
163035406|NCT01370616|588834298|FG000|Overall Study|Death|1|||
163035407|NCT01370616|588834299|FG001|Overall Study|Death|0|||
163035408|NCT01370616|588834298|FG000|Overall Study|Lack of Efficacy|6|||
163035409|NCT01370616|588834299|FG001|Overall Study|Lack of Efficacy|2|||
163035410|NCT01370616|588834298|FG000|Overall Study|Lost to Follow-up|0|||
163035411|NCT01370616|588834299|FG001|Overall Study|Lost to Follow-up|3|||
163035412|NCT01370616|588834298|FG000|Overall Study|Physician Decision|6|||
163035413|NCT01370616|588834299|FG001|Overall Study|Physician Decision|6|||
163035414|NCT01370616|588834298|FG000|Overall Study|Progressive Disease|0|||
163035415|NCT01370616|588834299|FG001|Overall Study|Progressive Disease|1|||
163035416|NCT01370616|588834298|FG000|Overall Study|Recovery|1|||
163035417|NCT01370616|588834299|FG001|Overall Study|Recovery|0|||
163035418|NCT01370616|588834298|FG000|Overall Study|Technical Problems|3|||
163035419|NCT01370616|588834299|FG001|Overall Study|Technical Problems|5|||
163035420|NCT01370616|588834298|FG000|Overall Study|Withdrawal by Subject|34|||
163035421|NCT01370616|588834299|FG001|Overall Study|Withdrawal by Subject|34|||
163035422|NCT00076999|588834304|FG000|Overall Study|Adverse Event|2|||
163035423|NCT00076999|588834305|FG001|Overall Study|Adverse Event|8|||
163035424|NCT00076999|588834306|FG002|Overall Study|Adverse Event|6|||
163035425|NCT00076999|588834307|FG003|Overall Study|Adverse Event|0|||
163035426|NCT00076999|588834308|FG004|Overall Study|Adverse Event|2|||
163035427|NCT00076999|588834304|FG000|Overall Study|Protocol Violation|0|||
163035428|NCT00076999|588834305|FG001|Overall Study|Protocol Violation|3|||
163035429|NCT00076999|588834306|FG002|Overall Study|Protocol Violation|4|||
163035430|NCT00076999|588834307|FG003|Overall Study|Protocol Violation|0|||
163035431|NCT00076999|588834308|FG004|Overall Study|Protocol Violation|9|||
163035432|NCT00076999|588834304|FG000|Overall Study|Lost to Follow-up|2|||
163035433|NCT00076999|588834305|FG001|Overall Study|Lost to Follow-up|1|||
163035434|NCT00076999|588834306|FG002|Overall Study|Lost to Follow-up|0|||
163035435|NCT00076999|588834307|FG003|Overall Study|Lost to Follow-up|0|||
163035436|NCT00076999|588834308|FG004|Overall Study|Lost to Follow-up|0|||
163035437|NCT00076999|588834304|FG000|Overall Study|Withdrawal by Subject|0|||
163035438|NCT00076999|588834305|FG001|Overall Study|Withdrawal by Subject|4|||
163035439|NCT00076999|588834306|FG002|Overall Study|Withdrawal by Subject|3|||
163035440|NCT00076999|588834307|FG003|Overall Study|Withdrawal by Subject|0|||
163035441|NCT00076999|588834308|FG004|Overall Study|Withdrawal by Subject|1|||
163035442|NCT00076999|588834304|FG000|Overall Study|Other reason (not specified)|8|||
163035443|NCT00076999|588834305|FG001|Overall Study|Other reason (not specified)|8|||
163035444|NCT00076999|588834306|FG002|Overall Study|Other reason (not specified)|4|||
163035445|NCT00076999|588834307|FG003|Overall Study|Other reason (not specified)|1|||
163035446|NCT00076999|588834308|FG004|Overall Study|Other reason (not specified)|13|||
163334830|NCT05074433|589936108|FG000|Overall Study|Subject Decision|8|||
163035447|NCT01217385|588834310|FG000|Overall Study|Withdrawal by Subject|3|||
163035448|NCT01217385|588834310|FG000|Overall Study|DOSI not performed/not eval|12|||
163035449|NCT01217385|588834310|FG000|Overall Study|Central Path not Available|1|||
163035450|NCT01217385|588834310|FG000|Overall Study|Normal Breast TOI not available|10|||
163035451|NCT01534208|588834311|FG000|Overall Study|Lost to Follow-up|19|||
163035452|NCT01534208|588834312|FG001|Overall Study|Lost to Follow-up|14|||
163035453|NCT01534208|588834311|FG000|Overall Study|Withdrawal by Subject|6|||
163035454|NCT01534208|588834312|FG001|Overall Study|Withdrawal by Subject|20|||
163035455|NCT01534208|588834311|FG000|Overall Study|Adverse Event|15|||
163035456|NCT01534208|588834312|FG001|Overall Study|Adverse Event|8|||
163035457|NCT01534208|588834311|FG000|Overall Study|Physician Decision|2|||
163035458|NCT01534208|588834312|FG001|Overall Study|Physician Decision|0|||
163035459|NCT01534208|588834311|FG000|Overall Study|Lack of Efficacy|0|||
163035460|NCT01534208|588834312|FG001|Overall Study|Lack of Efficacy|3|||
163035461|NCT01534208|588834311|FG000|Overall Study|Protocol Violation|2|||
163035462|NCT01534208|588834312|FG001|Overall Study|Protocol Violation|2|||
163035463|NCT01534208|588834311|FG000|Overall Study|Sponsor decision|4|||
163035464|NCT01534208|588834312|FG001|Overall Study|Sponsor decision|1|||
163035465|NCT01534208|588834311|FG000|Overall Study|Subject relocation|2|||
163035466|NCT01534208|588834312|FG001|Overall Study|Subject relocation|0|||
163035467|NCT01534208|588834311|FG000|Overall Study|Lab assessment|2|||
163035468|NCT01534208|588834312|FG001|Overall Study|Lab assessment|1|||
163035469|NCT01534208|588834311|FG000|Overall Study|Eligibility error|3|||
163035470|NCT01534208|588834312|FG001|Overall Study|Eligibility error|0|||
163035471|NCT01534208|588834311|FG000|Overall Study|PCP decision|1|||
163035472|NCT01534208|588834312|FG001|Overall Study|PCP decision|0|||
163035473|NCT01534208|588834311|FG000|Overall Study|Needed prohibited meds|1|||
163035474|NCT01534208|588834312|FG001|Overall Study|Needed prohibited meds|0|||
163035475|NCT02117713|588834323|FG000|Week 48|Adverse Event|4|||
163035476|NCT02117713|588834323|FG000|Week 48|Withdrawal by caregiver|2|||
163035477|NCT02117713|588834323|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
163035478|NCT02117713|588834323|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
163035479|NCT02117713|588834323|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
163035480|NCT02117713|588834323|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
163035481|NCT00672841|588834324|FG000|Overall Study|Comfort care|1|||
163035482|NCT00672841|588834325|FG001|Overall Study|Comfort care|4|||
163035483|NCT00672841|588834324|FG000|Overall Study|icteric specimens|0|||
163035484|NCT00672841|588834325|FG001|Overall Study|icteric specimens|3|||
163035485|NCT00672841|588834324|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
163035486|NCT00672841|588834325|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
163035487|NCT00672841|588834324|FG000|Overall Study|Adverse Event|0|||
163035488|NCT00672841|588834325|FG001|Overall Study|Adverse Event|3|||
163035489|NCT00672841|588834324|FG000|Overall Study|Pregnancy|0|||
163035490|NCT00672841|588834325|FG001|Overall Study|Pregnancy|1|||
163035491|NCT03578146|588834326|FG000|Overall Study|Did Not Receive Treatment|1|||
163035492|NCT03578146|588834327|FG001|Overall Study|Did Not Receive Treatment|0|||
163035493|NCT03578146|588834328|FG002|Overall Study|Did Not Receive Treatment|0|||
163035494|NCT03578146|588834329|FG003|Overall Study|Did Not Receive Treatment|0|||
163035495|NCT03578146|588834330|FG004|Overall Study|Did Not Receive Treatment|0|||
163035496|NCT03578146|588834331|FG005|Overall Study|Did Not Receive Treatment|2|||
163334831|NCT05074433|589936109|FG001|Overall Study|Subject Decision|6|||
163035497|NCT03578146|588834326|FG000|Overall Study|Lost to Follow-up|0|||
163035498|NCT03578146|588834327|FG001|Overall Study|Lost to Follow-up|1|||
163035499|NCT03578146|588834328|FG002|Overall Study|Lost to Follow-up|1|||
163035500|NCT03578146|588834329|FG003|Overall Study|Lost to Follow-up|0|||
163035501|NCT03578146|588834330|FG004|Overall Study|Lost to Follow-up|0|||
163035502|NCT03578146|588834331|FG005|Overall Study|Lost to Follow-up|1|||
163035503|NCT01094782|588834333|FG000|Overall Study|Withdrawal by Subject|5|||
163035504|NCT01094782|588834334|FG001|Overall Study|Withdrawal by Subject|5|||
163035505|NCT01094782|588834335|FG002|Overall Study|Withdrawal by Subject|1|||
163035506|NCT01094782|588834336|FG003|Overall Study|Withdrawal by Subject|5|||
163035507|NCT01094782|588834337|FG004|Overall Study|Withdrawal by Subject|5|||
163035508|NCT01094782|588834338|FG005|Overall Study|Withdrawal by Subject|0|||
163035509|NCT01094782|588834333|FG000|Overall Study|Lost to Follow-up|1|||
163035510|NCT01094782|588834334|FG001|Overall Study|Lost to Follow-up|0|||
163035511|NCT01094782|588834335|FG002|Overall Study|Lost to Follow-up|0|||
163035512|NCT01094782|588834336|FG003|Overall Study|Lost to Follow-up|2|||
163035513|NCT01094782|588834337|FG004|Overall Study|Lost to Follow-up|1|||
163035514|NCT01094782|588834338|FG005|Overall Study|Lost to Follow-up|4|||
163035515|NCT01094782|588834333|FG000|Overall Study|Positive Drug Screen|2|||
163035516|NCT01094782|588834334|FG001|Overall Study|Positive Drug Screen|2|||
163035517|NCT01094782|588834335|FG002|Overall Study|Positive Drug Screen|1|||
163035518|NCT01094782|588834336|FG003|Overall Study|Positive Drug Screen|1|||
163035519|NCT01094782|588834337|FG004|Overall Study|Positive Drug Screen|3|||
163035520|NCT01094782|588834338|FG005|Overall Study|Positive Drug Screen|2|||
163035521|NCT01094782|588834333|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
163035522|NCT01094782|588834334|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
163035523|NCT01094782|588834335|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
163035524|NCT01094782|588834336|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
163035525|NCT01094782|588834337|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
163085750|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085751|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
163085752|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
163035526|NCT01094782|588834338|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
163035527|NCT01094782|588834333|FG000|Overall Study|Unable to Complete Questionnaires|0|||
163035528|NCT01094782|588834334|FG001|Overall Study|Unable to Complete Questionnaires|1|||
163035529|NCT01094782|588834335|FG002|Overall Study|Unable to Complete Questionnaires|0|||
163035530|NCT01094782|588834336|FG003|Overall Study|Unable to Complete Questionnaires|0|||
163035531|NCT01094782|588834337|FG004|Overall Study|Unable to Complete Questionnaires|0|||
163035532|NCT01094782|588834338|FG005|Overall Study|Unable to Complete Questionnaires|0|||
163035533|NCT01094782|588834333|FG000|Overall Study|Healthy Subject Had Pain|0|||
163035534|NCT01094782|588834334|FG001|Overall Study|Healthy Subject Had Pain|1|||
163035535|NCT01094782|588834335|FG002|Overall Study|Healthy Subject Had Pain|0|||
163035536|NCT01094782|588834336|FG003|Overall Study|Healthy Subject Had Pain|0|||
163035537|NCT01094782|588834337|FG004|Overall Study|Healthy Subject Had Pain|0|||
163035538|NCT01094782|588834338|FG005|Overall Study|Healthy Subject Had Pain|0|||
163035539|NCT01094782|588834333|FG000|Overall Study|Hypertension|0|||
163035540|NCT01094782|588834334|FG001|Overall Study|Hypertension|0|||
163035541|NCT01094782|588834335|FG002|Overall Study|Hypertension|1|||
163035542|NCT01094782|588834336|FG003|Overall Study|Hypertension|0|||
163035543|NCT01094782|588834337|FG004|Overall Study|Hypertension|0|||
163035544|NCT01094782|588834338|FG005|Overall Study|Hypertension|0|||
163035545|NCT01094782|588834333|FG000|Overall Study|Wrong Pain Condition|0|||
163035546|NCT01094782|588834334|FG001|Overall Study|Wrong Pain Condition|0|||
163035547|NCT01094782|588834335|FG002|Overall Study|Wrong Pain Condition|0|||
163035548|NCT01094782|588834336|FG003|Overall Study|Wrong Pain Condition|2|||
163035549|NCT01094782|588834337|FG004|Overall Study|Wrong Pain Condition|1|||
163035550|NCT01094782|588834338|FG005|Overall Study|Wrong Pain Condition|1|||
163035551|NCT01094782|588834333|FG000|Overall Study|Recent Interventional Injection|0|||
163035552|NCT01094782|588834334|FG001|Overall Study|Recent Interventional Injection|0|||
163035553|NCT01094782|588834335|FG002|Overall Study|Recent Interventional Injection|0|||
163035554|NCT01094782|588834336|FG003|Overall Study|Recent Interventional Injection|0|||
163035555|NCT01094782|588834337|FG004|Overall Study|Recent Interventional Injection|0|||
163035556|NCT01094782|588834338|FG005|Overall Study|Recent Interventional Injection|1|||
163035557|NCT01094782|588834333|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
163035558|NCT01094782|588834334|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
163035559|NCT01094782|588834335|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
163035560|NCT01094782|588834336|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
163035561|NCT01094782|588834337|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
163035562|NCT01094782|588834338|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
163085753|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
163085754|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
163085755|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
163085756|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
163085757|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
163085758|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
163085759|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
163085760|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
163085761|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
163085762|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
163085763|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
163085764|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
163085765|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
163085766|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
163085767|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085768|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085769|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085770|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085771|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
163085772|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085773|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085774|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085775|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163035563|NCT01094782|588834333|FG000|Overall Study|Noncompliance With Study Schedule|0|||
163035564|NCT01094782|588834334|FG001|Overall Study|Noncompliance With Study Schedule|0|||
163035565|NCT01094782|588834335|FG002|Overall Study|Noncompliance With Study Schedule|0|||
163035566|NCT01094782|588834336|FG003|Overall Study|Noncompliance With Study Schedule|1|||
163035567|NCT01094782|588834337|FG004|Overall Study|Noncompliance With Study Schedule|0|||
163035568|NCT01094782|588834338|FG005|Overall Study|Noncompliance With Study Schedule|0|||
163035569|NCT00634049|588834339|FG000|Overall Study|Never received study drug|1|||
163035570|NCT00634049|588834339|FG000|Overall Study|Died prior to receiving study drug|1|||
163035571|NCT00634049|588834339|FG000|Overall Study|Screening failure|1|||
163035572|NCT01717391|588834340|FG000|Overall Study|Withdrawal by Subject|5|||
163035573|NCT01717391|588834340|FG000|Overall Study|Physician Decision|1|||
163035574|NCT01717391|588834340|FG000|Overall Study|FLT technical failure|3|||
163035575|NCT02450552|588834344|FG000|Overall Study|Withdrawal by Subject|4|||
163035576|NCT02450552|588834345|FG001|Overall Study|Withdrawal by Subject|0|||
163035577|NCT02450552|588834346|FG002|Overall Study|Withdrawal by Subject|4|||
163035578|NCT02450552|588834344|FG000|Overall Study|Physician Decision|1|||
163035579|NCT02450552|588834345|FG001|Overall Study|Physician Decision|0|||
163035580|NCT02450552|588834346|FG002|Overall Study|Physician Decision|1|||
163035581|NCT01524783|588834347|FG000|Blinded Period|Adverse Event|64|||
163035582|NCT01524783|588834348|FG001|Blinded Period|Adverse Event|7|||
163035583|NCT01524783|588834349|FG002|Blinded Period|Adverse Event|0|||
163035584|NCT01524783|588834347|FG000|Blinded Period|Disease Progression|89|||
163035585|NCT01524783|588834348|FG001|Blinded Period|Disease Progression|75|||
163035586|NCT01524783|588834349|FG002|Blinded Period|Disease Progression|0|||
163035587|NCT01524783|588834347|FG000|Blinded Period|Withdrawal by Subject|19|||
163035588|NCT01524783|588834348|FG001|Blinded Period|Withdrawal by Subject|6|||
163035589|NCT01524783|588834349|FG002|Blinded Period|Withdrawal by Subject|0|||
163035590|NCT01524783|588834347|FG000|Blinded Period|Protocol deviation|2|||
163035591|NCT01524783|588834348|FG001|Blinded Period|Protocol deviation|1|||
163035592|NCT01524783|588834349|FG002|Blinded Period|Protocol deviation|0|||
163035593|NCT01524783|588834347|FG000|Blinded Period|Death|5|||
163035594|NCT01524783|588834348|FG001|Blinded Period|Death|2|||
163035595|NCT01524783|588834349|FG002|Blinded Period|Death|0|||
163035596|NCT01524783|588834347|FG000|Open-label Period|Disease progression|13|||
163035597|NCT01524783|588834348|FG001|Open-label Period|Disease progression|0|||
163035598|NCT01524783|588834349|FG002|Open-label Period|Disease progression|2|||
163035599|NCT01524783|588834347|FG000|Open-label Period|Administrative problems|5|||
163035600|NCT01524783|588834348|FG001|Open-label Period|Administrative problems|0|||
163035601|NCT01524783|588834349|FG002|Open-label Period|Administrative problems|2|||
163035602|NCT01524783|588834347|FG000|Open-label Period|Adverse Event|5|||
163035603|NCT01524783|588834348|FG001|Open-label Period|Adverse Event|0|||
163035604|NCT01524783|588834349|FG002|Open-label Period|Adverse Event|1|||
163035605|NCT01524783|588834347|FG000|Open-label Period|Withdrawal by Subject|2|||
163035606|NCT01524783|588834348|FG001|Open-label Period|Withdrawal by Subject|0|||
163035607|NCT01524783|588834349|FG002|Open-label Period|Withdrawal by Subject|1|||
163035608|NCT01524783|588834347|FG000|Open-label Period|Protocol deviation|1|||
163035609|NCT01524783|588834348|FG001|Open-label Period|Protocol deviation|0|||
163035610|NCT01524783|588834349|FG002|Open-label Period|Protocol deviation|0|||
163035611|NCT01625689|588834350|FG000|Overall Study|Migration|2|||
163035612|NCT01625689|588834351|FG001|Overall Study|Migration|1|||
163035613|NCT03723070|588834356|FG000|Overall Study|Lost to Follow-up|2|||
163035614|NCT03723070|588834356|FG000|Overall Study|Physician Decision|1|||
163035615|NCT03723070|588834356|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
163035616|NCT02208050|588834357|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
163035617|NCT02208050|588834358|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
163035618|NCT00721279|588834362|FG000|Overall Study|Lack of Efficacy|6|||
163035619|NCT00721279|588834363|FG001|Overall Study|Lack of Efficacy|3|||
163035620|NCT00721279|588834362|FG000|Overall Study|Tolerability insufficient|5|||
163035621|NCT00721279|588834363|FG001|Overall Study|Tolerability insufficient|2|||
163035622|NCT00721279|588834362|FG000|Overall Study|Withdrawal by Subject|13|||
163035623|NCT00721279|588834363|FG001|Overall Study|Withdrawal by Subject|3|||
163035624|NCT00721279|588834362|FG000|Overall Study|Other|12|||
163035625|NCT00721279|588834363|FG001|Overall Study|Other|16|||
163035626|NCT05153148|588834364|FG000|Overall Study|Adverse Event|1|||
163035627|NCT05153148|588834365|FG001|Overall Study|Adverse Event|0|||
163035628|NCT05153148|588834366|FG002|Overall Study|Adverse Event|3|||
163035629|NCT05153148|588834367|FG003|Overall Study|Adverse Event|5|||
163035630|NCT05153148|588834364|FG000|Overall Study|Lost to Follow-up|1|||
163035631|NCT05153148|588834365|FG001|Overall Study|Lost to Follow-up|1|||
163085776|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163334832|NCT05074433|589936110|FG002|Overall Study|Subject Decision|4|||
163334833|NCT05074433|589936111|FG003|Overall Study|Subject Decision|5|||
163334834|NCT04397263|589936112|FG000|Overall Study|Withdrawal by Subject|2|||
163334835|NCT01989689|589936113|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
163085777|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085778|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085779|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085780|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163334836|NCT01989689|589936114|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
163035632|NCT05153148|588834366|FG002|Overall Study|Lost to Follow-up|2|||
163035633|NCT05153148|588834367|FG003|Overall Study|Lost to Follow-up|0|||
163035634|NCT05153148|588834364|FG000|Overall Study|Withdrawal by Subject|6|||
163035635|NCT05153148|588834365|FG001|Overall Study|Withdrawal by Subject|8|||
163035636|NCT05153148|588834366|FG002|Overall Study|Withdrawal by Subject|6|||
163035637|NCT05153148|588834367|FG003|Overall Study|Withdrawal by Subject|8|||
163035638|NCT05153148|588834364|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
163035639|NCT05153148|588834365|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
163035640|NCT05153148|588834366|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
163035641|NCT05153148|588834367|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
163035642|NCT05153148|588834364|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
163035643|NCT05153148|588834365|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
163035644|NCT05153148|588834366|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
163035645|NCT05153148|588834367|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
163035646|NCT05153148|588834364|FG000|Overall Study|Reason not Specified|1|||
163035647|NCT05153148|588834365|FG001|Overall Study|Reason not Specified|1|||
163035648|NCT05153148|588834366|FG002|Overall Study|Reason not Specified|1|||
163035649|NCT05153148|588834367|FG003|Overall Study|Reason not Specified|1|||
163035650|NCT01732471|588834368|FG000|Overall Study|Withdrawal by Subject|1|||
163035651|NCT00474786|588834369|FG000|Overall Study|Not Meeting Study Criteria|0|||
163035652|NCT00474786|588834370|FG001|Overall Study|Not Meeting Study Criteria|1|||
163035653|NCT00474786|588834369|FG000|Overall Study|Investigator Request|2|||
163035654|NCT00474786|588834370|FG001|Overall Study|Investigator Request|1|||
163035655|NCT00474786|588834369|FG000|Overall Study|Death|189|||
163035656|NCT00474786|588834370|FG001|Overall Study|Death|170|||
163035657|NCT00474786|588834369|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
163035658|NCT00474786|588834370|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
163035659|NCT00474786|588834369|FG000|Overall Study|Lost to Follow-up|4|||
163035660|NCT00474786|588834370|FG001|Overall Study|Lost to Follow-up|7|||
163035661|NCT00474786|588834369|FG000|Overall Study|Protocol Violation|2|||
163035662|NCT00474786|588834370|FG001|Overall Study|Protocol Violation|0|||
163035663|NCT00474786|588834369|FG000|Overall Study|Withdrawal by Subject|15|||
163035664|NCT00474786|588834370|FG001|Overall Study|Withdrawal by Subject|15|||
163035665|NCT00474786|588834369|FG000|Overall Study|Other|5|||
163035666|NCT00474786|588834370|FG001|Overall Study|Other|0|||
163035667|NCT02892513|588834371|FG000|Overall Study|Withdrawal by Subject|0|||
163035668|NCT02892513|588834372|FG001|Overall Study|Withdrawal by Subject|1|||
163035669|NCT00900731|588834373|FG000|Overall Study|Adverse Event|31|||
163035670|NCT00900731|588834374|FG001|Overall Study|Adverse Event|27|||
163035671|NCT00900731|588834373|FG000|Overall Study|Withdrawal by Subject|8|||
163035672|NCT00900731|588834374|FG001|Overall Study|Withdrawal by Subject|7|||
163035673|NCT00900731|588834373|FG000|Overall Study|Protocol Deviation|8|||
163035674|NCT00900731|588834374|FG001|Overall Study|Protocol Deviation|11|||
163035675|NCT00900731|588834373|FG000|Overall Study|Administrative Problems|5|||
163035676|NCT00900731|588834374|FG001|Overall Study|Administrative Problems|4|||
163035677|NCT00900731|588834373|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
163035678|NCT00900731|588834374|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
163035679|NCT00900731|588834373|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
163035680|NCT00900731|588834374|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
163035681|NCT00900731|588834373|FG000|Overall Study|Lost to Follow-up|2|||
163035682|NCT00900731|588834374|FG001|Overall Study|Lost to Follow-up|3|||
163035683|NCT00900731|588834373|FG000|Overall Study|Lack of Efficacy|1|||
163035684|NCT00900731|588834374|FG001|Overall Study|Lack of Efficacy|3|||
163035685|NCT00900731|588834373|FG000|Overall Study|Death|0|||
163035686|NCT00900731|588834374|FG001|Overall Study|Death|2|||
163035687|NCT00131365|588834375|FG000|Overall Study|Withdrawal by Subject|1|||
163035688|NCT00131365|588834375|FG000|Overall Study|Alternative treatment|3|||
163035689|NCT05249127|588834376|FG000|Overall Study|Protocol Violation|13|||
163035690|NCT05249127|588834376|FG000|Overall Study|Physician Decision|4|||
163035691|NCT05249127|588834376|FG000|Overall Study|Withdrawal by Subject|2|||
163035692|NCT05249127|588834376|FG000|Overall Study|Participant Non-compliance|1|||
163035693|NCT03053427|588834377|FG000|Overall Study|Adverse Event|4|||
163035694|NCT03053427|588834378|FG001|Overall Study|Adverse Event|4|||
163035695|NCT03053427|588834377|FG000|Overall Study|Lack of Efficacy|1|||
163035696|NCT03053427|588834378|FG001|Overall Study|Lack of Efficacy|3|||
163035697|NCT03053427|588834377|FG000|Overall Study|Lost to Follow-up|2|||
163035698|NCT03053427|588834378|FG001|Overall Study|Lost to Follow-up|2|||
163035699|NCT03053427|588834377|FG000|Overall Study|Worsening of the target disease|0|||
163035700|NCT03053427|588834378|FG001|Overall Study|Worsening of the target disease|1|||
163035701|NCT03053427|588834377|FG000|Overall Study|Protocol Deviation|3|||
163035702|NCT03053427|588834378|FG001|Overall Study|Protocol Deviation|3|||
163035703|NCT03053427|588834377|FG000|Overall Study|Withdrawal by Subject|3|||
163035704|NCT03053427|588834378|FG001|Overall Study|Withdrawal by Subject|2|||
163035705|NCT03053427|588834377|FG000|Overall Study|Miscellaneous|0|||
163035706|NCT03053427|588834378|FG001|Overall Study|Miscellaneous|1|||
163035707|NCT01324570|588834381|FG000|Overall Study|Adverse Event|4|||
163035708|NCT01324570|588834382|FG001|Overall Study|Adverse Event|7|||
163035709|NCT01324570|588834381|FG000|Overall Study|Withdrawal by Subject|0|||
163035710|NCT01324570|588834382|FG001|Overall Study|Withdrawal by Subject|3|||
163035711|NCT01324570|588834381|FG000|Overall Study|Lack of Efficacy|0|||
163406851|NCT03016325|590198756|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
163406852|NCT03016325|590198749|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
163406853|NCT03016325|590198750|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
163406854|NCT03016325|590198751|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
163406855|NCT03016325|590198752|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
163406856|NCT03016325|590198753|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
163406857|NCT03016325|590198754|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
163406858|NCT03016325|590198755|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
163406859|NCT03016325|590198756|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
163406860|NCT03016325|590198749|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
163406861|NCT03016325|590198750|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
163406862|NCT03016325|590198751|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
163406863|NCT03016325|590198752|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
163406864|NCT03016325|590198753|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
163406865|NCT03016325|590198754|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
163406866|NCT03016325|590198755|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
163406867|NCT03016325|590198756|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
163085781|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085782|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163035712|NCT01324570|588834382|FG001|Overall Study|Lack of Efficacy|1|||
163035713|NCT01324570|588834381|FG000|Overall Study|Confirmed or suspected diversion|0|||
163035714|NCT01324570|588834382|FG001|Overall Study|Confirmed or suspected diversion|1|||
163035715|NCT01324570|588834381|FG000|Overall Study|Administrative|0|||
163035716|NCT01324570|588834382|FG001|Overall Study|Administrative|2|||
163035717|NCT02607306|588834383|FG000|Overall Study|Adverse Event|8|||
163035718|NCT02607306|588834384|FG001|Overall Study|Adverse Event|6|||
163035719|NCT02607306|588834385|FG002|Overall Study|Adverse Event|6|||
163035720|NCT02607306|588834383|FG000|Overall Study|Unclassified|1|||
163035721|NCT02607306|588834384|FG001|Overall Study|Unclassified|4|||
163035722|NCT02607306|588834385|FG002|Overall Study|Unclassified|0|||
163035723|NCT02607306|588834383|FG000|Overall Study|Withdrawal by Subject|8|||
163035724|NCT02607306|588834384|FG001|Overall Study|Withdrawal by Subject|10|||
163035725|NCT02607306|588834385|FG002|Overall Study|Withdrawal by Subject|2|||
163035726|NCT02607306|588834383|FG000|Overall Study|Lack of Efficacy|0|||
163035727|NCT02607306|588834384|FG001|Overall Study|Lack of Efficacy|1|||
163035728|NCT02607306|588834385|FG002|Overall Study|Lack of Efficacy|1|||
163035729|NCT02607306|588834383|FG000|Overall Study|Protocol Violation|4|||
163035730|NCT02607306|588834384|FG001|Overall Study|Protocol Violation|2|||
163035731|NCT02607306|588834385|FG002|Overall Study|Protocol Violation|1|||
163035732|NCT02360475|588834388|FG000|Overall Study|Lost to Follow-up|4|||
163035733|NCT02360475|588834389|FG001|Overall Study|Lost to Follow-up|12|||
163035734|NCT02360475|588834390|FG002|Overall Study|Lost to Follow-up|6|||
163035735|NCT02360475|588834391|FG003|Overall Study|Lost to Follow-up|4|||
163035736|NCT02360475|588834388|FG000|Overall Study|Withdrawal by Subject|0|||
163035737|NCT02360475|588834389|FG001|Overall Study|Withdrawal by Subject|1|||
163035738|NCT02360475|588834390|FG002|Overall Study|Withdrawal by Subject|2|||
163035739|NCT02360475|588834391|FG003|Overall Study|Withdrawal by Subject|0|||
163035740|NCT02360475|588834388|FG000|Overall Study|Migrated/moved from study area|0|||
163035741|NCT02360475|588834389|FG001|Overall Study|Migrated/moved from study area|0|||
163035742|NCT02360475|588834390|FG002|Overall Study|Migrated/moved from study area|0|||
163035743|NCT02360475|588834391|FG003|Overall Study|Migrated/moved from study area|1|||
163035744|NCT02510820|588836056|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
163035745|NCT02510820|588836057|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163035746|NCT02510820|588836056|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
163035747|NCT02510820|588836057|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
163035748|NCT01859949|588836058|FG000|Overall Study|Family Matters|0|||
163035749|NCT01859949|588836059|FG001|Overall Study|Family Matters|1|||
163035750|NCT01859949|588836058|FG000|Overall Study|Physician Decision|2|||
163035751|NCT01859949|588836059|FG001|Overall Study|Physician Decision|4|||
163035752|NCT01859949|588836058|FG000|Overall Study|Withdrawal by Subject|11|||
163035753|NCT01859949|588836059|FG001|Overall Study|Withdrawal by Subject|10|||
163035754|NCT01859949|588836058|FG000|Overall Study|Protocol Violation|1|||
163035755|NCT01859949|588836059|FG001|Overall Study|Protocol Violation|1|||
163035756|NCT01859949|588836058|FG000|Overall Study|Adverse Event|0|||
163035757|NCT01859949|588836059|FG001|Overall Study|Adverse Event|1|||
163035758|NCT01153009|588836060|FG000|Overall Study|Adverse Event|4|||
163035759|NCT01153009|588836061|FG001|Overall Study|Adverse Event|14|||
163035760|NCT01153009|588836062|FG002|Overall Study|Adverse Event|14|||
163035761|NCT01153009|588836063|FG003|Overall Study|Adverse Event|10|||
163406868|NCT03016325|590198749|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
163406869|NCT03016325|590198750|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
163035762|NCT01153009|588836060|FG000|Overall Study|Lack of Efficacy|9|||
163035763|NCT01153009|588836061|FG001|Overall Study|Lack of Efficacy|0|||
163035764|NCT01153009|588836062|FG002|Overall Study|Lack of Efficacy|2|||
163035765|NCT01153009|588836063|FG003|Overall Study|Lack of Efficacy|1|||
163035766|NCT01153009|588836060|FG000|Overall Study|Noncompliance with Study Medication|1|||
163035767|NCT01153009|588836061|FG001|Overall Study|Noncompliance with Study Medication|3|||
163035768|NCT01153009|588836062|FG002|Overall Study|Noncompliance with Study Medication|4|||
163035769|NCT01153009|588836063|FG003|Overall Study|Noncompliance with Study Medication|1|||
163035770|NCT01153009|588836060|FG000|Overall Study|Protocol Deviations|4|||
163035771|NCT01153009|588836061|FG001|Overall Study|Protocol Deviations|3|||
163035772|NCT01153009|588836062|FG002|Overall Study|Protocol Deviations|3|||
163035773|NCT01153009|588836063|FG003|Overall Study|Protocol Deviations|2|||
163035774|NCT01153009|588836060|FG000|Overall Study|Withdrawal of Consent|5|||
163035775|NCT01153009|588836061|FG001|Overall Study|Withdrawal of Consent|5|||
163035776|NCT01153009|588836062|FG002|Overall Study|Withdrawal of Consent|4|||
163035777|NCT01153009|588836063|FG003|Overall Study|Withdrawal of Consent|6|||
163035778|NCT01153009|588836060|FG000|Overall Study|Lost to Follow-up|8|||
163035779|NCT01153009|588836061|FG001|Overall Study|Lost to Follow-up|8|||
163035780|NCT01153009|588836062|FG002|Overall Study|Lost to Follow-up|11|||
163035781|NCT01153009|588836063|FG003|Overall Study|Lost to Follow-up|15|||
163035782|NCT01153009|588836060|FG000|Overall Study|Other|1|||
163035783|NCT01153009|588836061|FG001|Overall Study|Other|1|||
163035784|NCT01153009|588836062|FG002|Overall Study|Other|3|||
163035785|NCT01153009|588836063|FG003|Overall Study|Other|2|||
163035786|NCT03307837|588836068|FG000|Overall Study|Withdrawal by Subject|0|||
163035787|NCT03307837|588836069|FG001|Overall Study|Withdrawal by Subject|0|||
163035788|NCT03307837|588836070|FG002|Overall Study|Withdrawal by Subject|1|||
163035789|NCT03307837|588836071|FG003|Overall Study|Withdrawal by Subject|0|||
163035790|NCT03307837|588836072|FG004|Overall Study|Withdrawal by Subject|0|||
163035791|NCT03307837|588836073|FG005|Overall Study|Withdrawal by Subject|1|||
163035792|NCT03307837|588836068|FG000|Overall Study|Lost to Follow-up|1|||
163035793|NCT03307837|588836069|FG001|Overall Study|Lost to Follow-up|1|||
163035794|NCT03307837|588836070|FG002|Overall Study|Lost to Follow-up|0|||
163035795|NCT03307837|588836071|FG003|Overall Study|Lost to Follow-up|0|||
163035796|NCT03307837|588836072|FG004|Overall Study|Lost to Follow-up|0|||
163035797|NCT03307837|588836073|FG005|Overall Study|Lost to Follow-up|1|||
163035798|NCT01744483|588836074|FG000|Overall Study|Death|9|||
163035799|NCT01744483|588836075|FG001|Overall Study|Death|4|||
163035800|NCT01744483|588836076|FG002|Overall Study|Death|11|||
163035801|NCT01744483|588836074|FG000|Overall Study|Lost to Follow-up|8|||
163035802|NCT01744483|588836075|FG001|Overall Study|Lost to Follow-up|9|||
163035803|NCT01744483|588836076|FG002|Overall Study|Lost to Follow-up|11|||
163035804|NCT01744483|588836074|FG000|Overall Study|Protocol Violation|1|||
163035805|NCT01744483|588836075|FG001|Overall Study|Protocol Violation|2|||
163035806|NCT01744483|588836076|FG002|Overall Study|Protocol Violation|1|||
163035807|NCT01744483|588836074|FG000|Overall Study|Withdrawal by Subject|4|||
163035808|NCT01744483|588836075|FG001|Overall Study|Withdrawal by Subject|6|||
163035809|NCT01744483|588836076|FG002|Overall Study|Withdrawal by Subject|2|||
163035810|NCT01744483|588836074|FG000|Overall Study|No ICU Admit|5|||
163035811|NCT01744483|588836075|FG001|Overall Study|No ICU Admit|1|||
163035812|NCT01744483|588836076|FG002|Overall Study|No ICU Admit|2|||
163035813|NCT01744483|588836074|FG000|Overall Study|Routed to OSH|2|||
163035814|NCT01744483|588836075|FG001|Overall Study|Routed to OSH|0|||
163035815|NCT01744483|588836076|FG002|Overall Study|Routed to OSH|1|||
163035816|NCT03041467|588836077|FG000|Overall Study|Death|46|||
163035817|NCT03041467|588836078|FG001|Overall Study|Death|39|||
163035818|NCT03041467|588836077|FG000|Overall Study|Withdrawal by Subject|36|||
163035819|NCT03041467|588836078|FG001|Overall Study|Withdrawal by Subject|37|||
163035820|NCT03041467|588836077|FG000|Overall Study|Lost to Follow-up|6|||
163035821|NCT03041467|588836078|FG001|Overall Study|Lost to Follow-up|8|||
163035822|NCT03041467|588836077|FG000|Overall Study|Declined consent for study extension|21|||
163035823|NCT03041467|588836078|FG001|Overall Study|Declined consent for study extension|33|||
163035824|NCT03041467|588836077|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
163035825|NCT03041467|588836078|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
163035826|NCT02469168|588836083|FG000|Overall Study|Trial closed|1|||
163035827|NCT02469168|588836084|FG001|Overall Study|Trial closed|0|||
163035828|NCT00298363|588836085|FG000|Overall Study|Lost to Follow-up|0|||
163035829|NCT00298363|588836086|FG001|Overall Study|Lost to Follow-up|0|||
163035830|NCT00298363|588836087|FG002|Overall Study|Lost to Follow-up|1|||
163035831|NCT00298363|588836085|FG000|Overall Study|Physician Decision|4|||
163035832|NCT00298363|588836086|FG001|Overall Study|Physician Decision|1|||
163035833|NCT00298363|588836087|FG002|Overall Study|Physician Decision|0|||
163035834|NCT00298363|588836085|FG000|Overall Study|Protocol Violation|1|||
163035835|NCT00298363|588836086|FG001|Overall Study|Protocol Violation|1|||
163035836|NCT00298363|588836087|FG002|Overall Study|Protocol Violation|0|||
163035837|NCT00298363|588836085|FG000|Overall Study|Withdrawal by Subject|5|||
163035838|NCT00298363|588836086|FG001|Overall Study|Withdrawal by Subject|1|||
163035839|NCT00298363|588836087|FG002|Overall Study|Withdrawal by Subject|3|||
163035840|NCT00298363|588836085|FG000|Overall Study|Adverse Event|5|||
163035841|NCT00298363|588836086|FG001|Overall Study|Adverse Event|2|||
163035842|NCT00298363|588836087|FG002|Overall Study|Adverse Event|2|||
163035843|NCT00298363|588836085|FG000|Overall Study|Lack of Efficacy|2|||
163035844|NCT00298363|588836086|FG001|Overall Study|Lack of Efficacy|3|||
163035845|NCT00298363|588836087|FG002|Overall Study|Lack of Efficacy|0|||
163035846|NCT00135356|588836088|FG000|Overall Study|Adverse Event|6|||
163035847|NCT00135356|588836089|FG001|Overall Study|Adverse Event|2|||
163035848|NCT00135356|588836088|FG000|Overall Study|Lack of Efficacy|2|||
163035849|NCT00135356|588836089|FG001|Overall Study|Lack of Efficacy|0|||
163035850|NCT00135356|588836088|FG000|Overall Study|Lost to Follow-up|3|||
163035851|NCT00135356|588836089|FG001|Overall Study|Lost to Follow-up|1|||
163035852|NCT00135356|588836088|FG000|Overall Study|Surgery for abdominal fat|1|||
163035853|NCT00135356|588836089|FG001|Overall Study|Surgery for abdominal fat|0|||
163035854|NCT00135356|588836088|FG000|Overall Study|Change in antiviral regimen|0|||
163035855|NCT00135356|588836089|FG001|Overall Study|Change in antiviral regimen|1|||
163035856|NCT00135356|588836088|FG000|Overall Study|Poor/noncompliance|1|||
163035857|NCT00135356|588836089|FG001|Overall Study|Poor/noncompliance|1|||
163035858|NCT00135356|588836088|FG000|Overall Study|No longer meets study criteria|2|||
163035859|NCT00135356|588836089|FG001|Overall Study|No longer meets study criteria|0|||
163035860|NCT00135356|588836088|FG000|Overall Study|Withdrawal by Subject|2|||
163035861|NCT00135356|588836089|FG001|Overall Study|Withdrawal by Subject|4|||
163035862|NCT01533688|588836090|FG000|Overall Study|Withdrawal by Subject|5|||
163035863|NCT01533688|588836091|FG001|Overall Study|Withdrawal by Subject|4|||
163035864|NCT01533688|588836092|FG002|Overall Study|Withdrawal by Subject|3|||
163035865|NCT01533688|588836090|FG000|Overall Study|Medically unstable|1|||
163035866|NCT01533688|588836091|FG001|Overall Study|Medically unstable|3|||
163035867|NCT01533688|588836092|FG002|Overall Study|Medically unstable|3|||
163035868|NCT01533688|588836090|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
163035869|NCT01533688|588836091|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
163035870|NCT01533688|588836092|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
163035871|NCT01306214|588836094|FG000|Overall Study|Death|0|||
163035872|NCT01306214|588836095|FG001|Overall Study|Death|0|||
163035873|NCT01306214|588836096|FG002|Overall Study|Death|1|||
163035874|NCT01306214|588836094|FG000|Overall Study|Lost to Follow-up|3|||
163035875|NCT01306214|588836095|FG001|Overall Study|Lost to Follow-up|5|||
163035876|NCT01306214|588836096|FG002|Overall Study|Lost to Follow-up|4|||
163035877|NCT01306214|588836094|FG000|Overall Study|Withdrawal by Subject|24|||
163035878|NCT01306214|588836095|FG001|Overall Study|Withdrawal by Subject|22|||
163035879|NCT01306214|588836096|FG002|Overall Study|Withdrawal by Subject|16|||
163035880|NCT01306214|588836094|FG000|Overall Study|Not treated|1|||
163035881|NCT01306214|588836095|FG001|Overall Study|Not treated|1|||
163035882|NCT01306214|588836096|FG002|Overall Study|Not treated|1|||
163035883|NCT02686814|588836097|FG000|Overall Study|Physician Decision|14|||
163035884|NCT02686814|588836097|FG000|Overall Study|Withdrawal by Subject|4|||
163035885|NCT02686814|588836097|FG000|Overall Study|Death|1|||
163035886|NCT02065518|588836098|FG000|Overall Study|Lost to Follow-up|3|||
163035887|NCT02065518|588836099|FG001|Overall Study|Lost to Follow-up|4|||
163035888|NCT02065518|588836100|FG002|Overall Study|Lost to Follow-up|0|||
163035889|NCT02065518|588836101|FG003|Overall Study|Lost to Follow-up|3|||
163035890|NCT02065518|588836098|FG000|Overall Study|Withdrawal by Subject|3|||
163035891|NCT02065518|588836099|FG001|Overall Study|Withdrawal by Subject|4|||
163035892|NCT02065518|588836100|FG002|Overall Study|Withdrawal by Subject|9|||
163035893|NCT02065518|588836101|FG003|Overall Study|Withdrawal by Subject|2|||
163035894|NCT01090050|588836103|FG000|Overall Study|Lost to Follow-up|0|||
163035895|NCT01090050|588836104|FG001|Overall Study|Lost to Follow-up|1|||
163035896|NCT01090050|588836103|FG000|Overall Study|Lack of Efficacy|1|||
163035897|NCT01090050|588836104|FG001|Overall Study|Lack of Efficacy|5|||
163035898|NCT01090050|588836103|FG000|Overall Study|Physician Decision|0|||
163035899|NCT01090050|588836104|FG001|Overall Study|Physician Decision|1|||
163035900|NCT00571103|588836105|FG000|Overall Study|Withdrawal by Subject|1|||
163035901|NCT00571103|588836105|FG000|Overall Study|Lost to Follow-up|1|||
163035902|NCT02368886|588836106|FG000|Overall Study|Cancel|1|||
163035903|NCT02368886|588836107|FG001|Overall Study|Cancel|1|||
163035904|NCT02368886|588836108|FG002|Overall Study|Cancel|1|||
163035905|NCT02368886|588836109|FG003|Overall Study|Cancel|3|||
163035906|NCT02368886|588836106|FG000|Overall Study|Ineligible|0|||
163035907|NCT02368886|588836107|FG001|Overall Study|Ineligible|0|||
163035908|NCT02368886|588836108|FG002|Overall Study|Ineligible|0|||
163035909|NCT02368886|588836109|FG003|Overall Study|Ineligible|1|||
163035910|NCT04767529|588836110|FG000|Overall Study|Adverse Event|0|||
163035911|NCT04767529|588836111|FG001|Overall Study|Adverse Event|4|||
163035912|NCT04767529|588836112|FG002|Overall Study|Adverse Event|3|||
163035913|NCT04767529|588836110|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
163035914|NCT04767529|588836111|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
163035915|NCT04767529|588836112|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
163035916|NCT04767529|588836110|FG000|Overall Study|Required use of a prohibited medication|0|||
163035917|NCT04767529|588836111|FG001|Overall Study|Required use of a prohibited medication|1|||
163035918|NCT04767529|588836112|FG002|Overall Study|Required use of a prohibited medication|0|||
163085783|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085784|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085785|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085786|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085787|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085788|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085789|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085790|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
163085791|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
163085792|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
163085793|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085794|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
163085795|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
163085796|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
163085797|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
163085798|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
163085799|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085800|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085801|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085802|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085803|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085804|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085805|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085806|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085807|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
163085808|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
163085809|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085810|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
163085811|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085812|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
163085813|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085814|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
163085815|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085816|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085817|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085818|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085819|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085820|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085821|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085822|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085823|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085824|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
163085825|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085826|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085827|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085828|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085829|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085830|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
163085831|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085832|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085833|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163334837|NCT01989689|589936113|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
163334838|NCT01989689|589936114|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
163334839|NCT02066636|589936115|FG000|Overall Study|Disease progression|51|||
163334840|NCT02066636|589936116|FG001|Overall Study|Disease progression|60|||
163334841|NCT02066636|589936117|FG002|Overall Study|Disease progression|700|||
163334842|NCT02066636|589936115|FG000|Overall Study|Study drug toxicity|13|||
163334843|NCT02066636|589936116|FG001|Overall Study|Study drug toxicity|2|||
163334844|NCT02066636|589936117|FG002|Overall Study|Study drug toxicity|58|||
163334845|NCT02066636|589936115|FG000|Overall Study|Death|4|||
163334846|NCT02066636|589936116|FG001|Overall Study|Death|2|||
163334847|NCT02066636|589936117|FG002|Overall Study|Death|158|||
163334848|NCT02066636|589936115|FG000|Overall Study|Adverse event unrelated to study drug|6|||
163334849|NCT02066636|589936116|FG001|Overall Study|Adverse event unrelated to study drug|4|||
163085834|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085835|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085836|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085837|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163334850|NCT02066636|589936117|FG002|Overall Study|Adverse event unrelated to study drug|45|||
163085838|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085839|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085840|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085841|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085842|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
163085843|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
163085844|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
163085845|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
163085846|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
163085847|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
163085848|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
163085849|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
163085850|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
163085851|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
163085852|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
163085853|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
163085854|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
163085855|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
163085856|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
163085857|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
163085858|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
163085859|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
163085860|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
163085861|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
163085862|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
163085863|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085864|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085865|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085866|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085867|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085868|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085869|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085870|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085871|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085872|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085873|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085874|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085875|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085876|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
163085877|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085878|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085879|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085880|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085881|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085882|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085883|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085884|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085885|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085886|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085887|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085888|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085889|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085890|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085891|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085892|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
163085893|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085894|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085895|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085896|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085897|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085898|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085899|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085900|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085901|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085902|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163406870|NCT03016325|590198751|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
163406871|NCT03016325|590198752|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
163406872|NCT03016325|590198753|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
163406873|NCT03016325|590198754|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
163406874|NCT03016325|590198755|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
163406875|NCT03016325|590198756|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
163406876|NCT02728830|590198757|FG000|Overall Study|Exclusionary Surgery|9|||
163406877|NCT02728830|590198757|FG000|Overall Study|Exclusionary Pathology|6|||
163406878|NCT02728830|590198757|FG000|Overall Study|Physician Decision|3|||
163406879|NCT02728830|590198757|FG000|Overall Study|Withdrawal by Subject|2|||
163406880|NCT02728830|590198757|FG000|Overall Study|Lost to Follow-up|1|||
163406881|NCT02728830|590198757|FG000|Overall Study|Exclusionary Lab Values|1|||
163406882|NCT02728830|590198757|FG000|Overall Study|Contraindicated Illness|1|||
163406883|NCT02728830|590198757|FG000|Overall Study|Language Barrier|1|||
163406884|NCT01152021|590198758|FG000|Overall Study|Adverse Event|4|||
163406885|NCT01152021|590198759|FG001|Overall Study|Adverse Event|4|||
163406886|NCT01152021|590198758|FG000|Overall Study|Study drug had expired|1|||
163406887|NCT01152021|590198759|FG001|Overall Study|Study drug had expired|0|||
163406888|NCT01152021|590198758|FG000|Overall Study|Physician Decision|1|||
163035919|NCT04767529|588836110|FG000|Overall Study|Withdrawal by Subject|7|||
163035920|NCT04767529|588836111|FG001|Overall Study|Withdrawal by Subject|5|||
163085903|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085904|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
163085905|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085906|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085907|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085908|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085909|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085910|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085911|NCT01309230|589022350|FG000|Overall Study|Withdrawal by Subject|0|||
163085912|NCT01309230|589022351|FG001|Overall Study|Withdrawal by Subject|2|||
163085913|NCT01309230|589022350|FG000|Overall Study|Observation arm closed|0|||
163085914|NCT01309230|589022351|FG001|Overall Study|Observation arm closed|2|||
163085915|NCT02661815|589022352|FG000|Overall Study|Withdrawal by Subject|1|||
163085916|NCT02661815|589022353|FG001|Overall Study|Withdrawal by Subject|0|||
163085917|NCT02661815|589022354|FG002|Overall Study|Withdrawal by Subject|0|||
163085918|NCT02661815|589022355|FG003|Overall Study|Withdrawal by Subject|0|||
163085919|NCT00635050|589022358|FG000|Overall Study|Withdrawal by Subject|1|||
163085920|NCT04380142|589022363|FG000|LD/CD Stabilization Period|Adverse Event|3|||
163085921|NCT04380142|589022364|FG001|LD/CD Stabilization Period|Adverse Event|0|||
163085922|NCT04380142|589022365|FG002|LD/CD Stabilization Period|Adverse Event|0|||
163085923|NCT04380142|589022363|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
163085924|NCT04380142|589022364|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
163085925|NCT04380142|589022365|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
163085926|NCT04380142|589022363|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
163085927|NCT04380142|589022364|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
163085928|NCT04380142|589022365|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
163085929|NCT04380142|589022363|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
163035921|NCT04767529|588836112|FG002|Overall Study|Withdrawal by Subject|4|||
163035922|NCT04767529|588836110|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
163035923|NCT04767529|588836111|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
163035924|NCT04767529|588836112|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
163035925|NCT04767529|588836110|FG000|Overall Study|Lost to Follow-up|0|||
163035926|NCT04767529|588836111|FG001|Overall Study|Lost to Follow-up|2|||
163035927|NCT04767529|588836112|FG002|Overall Study|Lost to Follow-up|3|||
163035928|NCT00004088|588836114|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
163035929|NCT00004088|588836114|FG000|Overall Study|Withdrawal by Subject|1|||
163035930|NCT00004088|588836114|FG000|Overall Study|Protocol Violation|3|||
163035931|NCT00004088|588836114|FG000|Overall Study|Physician Decision|1|||
163035932|NCT02636699|588836115|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
163035933|NCT02636699|588836116|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
163085930|NCT04380142|589022364|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
163085931|NCT04380142|589022365|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
163406889|NCT01152021|590198759|FG001|Overall Study|Physician Decision|1|||
163406890|NCT01152021|590198758|FG000|Overall Study|No access to study drug in Pharmacy|0|||
163406891|NCT01152021|590198759|FG001|Overall Study|No access to study drug in Pharmacy|1|||
163406892|NCT00513500|590198760|FG000|Overall Study|Lost to Follow-up|35|||
163406893|NCT00513500|590198761|FG001|Overall Study|Lost to Follow-up|39|||
163406894|NCT00513500|590198760|FG000|Overall Study|Death|2|||
163406895|NCT00513500|590198761|FG001|Overall Study|Death|1|||
163406896|NCT00513500|590198760|FG000|Overall Study|Hospitalized|4|||
163334851|NCT02066636|589936115|FG000|Overall Study|Participant request to discontinue treatment|12|||
163334852|NCT02066636|589936116|FG001|Overall Study|Participant request to discontinue treatment|12|||
163334853|NCT02066636|589936117|FG002|Overall Study|Participant request to discontinue treatment|70|||
163334854|NCT02066636|589936115|FG000|Overall Study|Participant withdrew consent|10|||
163334855|NCT02066636|589936116|FG001|Overall Study|Participant withdrew consent|18|||
163334856|NCT02066636|589936117|FG002|Overall Study|Participant withdrew consent|61|||
163334857|NCT02066636|589936115|FG000|Overall Study|Lost to Follow-up|0|||
163334858|NCT02066636|589936116|FG001|Overall Study|Lost to Follow-up|2|||
163334859|NCT02066636|589936117|FG002|Overall Study|Lost to Follow-up|2|||
163334860|NCT02066636|589936115|FG000|Overall Study|Maximum clinical benefit|2|||
163334861|NCT02066636|589936116|FG001|Overall Study|Maximum clinical benefit|2|||
163334862|NCT02066636|589936117|FG002|Overall Study|Maximum clinical benefit|3|||
163334863|NCT02066636|589936115|FG000|Overall Study|Poor/non-compliance|2|||
163334864|NCT02066636|589936116|FG001|Overall Study|Poor/non-compliance|1|||
163334865|NCT02066636|589936117|FG002|Overall Study|Poor/non-compliance|1|||
163334866|NCT02066636|589936115|FG000|Overall Study|Participant no loner meets study criteria|3|||
163334867|NCT02066636|589936116|FG001|Overall Study|Participant no loner meets study criteria|2|||
163334868|NCT02066636|589936117|FG002|Overall Study|Participant no loner meets study criteria|28|||
163334869|NCT02066636|589936115|FG000|Overall Study|Administrative reasons by sponsor|8|||
163334870|NCT02066636|589936116|FG001|Overall Study|Administrative reasons by sponsor|5|||
163334871|NCT02066636|589936117|FG002|Overall Study|Administrative reasons by sponsor|0|||
163334872|NCT02066636|589936115|FG000|Overall Study|Other reasons|16|||
163035934|NCT02636699|588836117|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
163334873|NCT02066636|589936116|FG001|Overall Study|Other reasons|15|||
163334874|NCT02066636|589936117|FG002|Overall Study|Other reasons|50|||
163334875|NCT00391170|589936124|FG000|Overall Study|Withdrawal by Subject|1|||
163334876|NCT00391170|589936125|FG001|Overall Study|Withdrawal by Subject|0|||
163334877|NCT00391170|589936124|FG000|Overall Study|Adverse Event|3|||
163334878|NCT00391170|589936125|FG001|Overall Study|Adverse Event|2|||
163334879|NCT00391170|589936124|FG000|Overall Study|Physician Decision|2|||
163334880|NCT00391170|589936125|FG001|Overall Study|Physician Decision|2|||
163035935|NCT02636699|588836115|FG000|Screening Period|Withdrawal by Subject|0|||
163035936|NCT02636699|588836116|FG001|Screening Period|Withdrawal by Subject|0|||
163035937|NCT02636699|588836117|FG002|Screening Period|Withdrawal by Subject|23|||
163035938|NCT02636699|588836115|FG000|Screening Period|Adverse Event|0|||
163035939|NCT02636699|588836116|FG001|Screening Period|Adverse Event|0|||
163035940|NCT02636699|588836117|FG002|Screening Period|Adverse Event|1|||
163035941|NCT02636699|588836115|FG000|Screening Period|Other not specified|0|||
163035942|NCT02636699|588836116|FG001|Screening Period|Other not specified|0|||
163035943|NCT02636699|588836117|FG002|Screening Period|Other not specified|3|||
163035944|NCT02636699|588836115|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
163035945|NCT02636699|588836116|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
163035946|NCT02636699|588836117|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
163035947|NCT02636699|588836115|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
163035948|NCT02636699|588836116|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
163035949|NCT02636699|588836117|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
163035950|NCT02636699|588836115|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
163035951|NCT02636699|588836116|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
163035952|NCT02636699|588836117|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
163035953|NCT02636699|588836115|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
163035954|NCT02636699|588836116|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
163035955|NCT02636699|588836117|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
163035956|NCT02636699|588836115|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
163035957|NCT02636699|588836116|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
163035958|NCT02636699|588836117|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
163035959|NCT02636699|588836115|FG000|Treatment and Follow-up Periods|Other|3|||
163035960|NCT02636699|588836116|FG001|Treatment and Follow-up Periods|Other|1|||
163035961|NCT02636699|588836117|FG002|Treatment and Follow-up Periods|Other|0|||
163035962|NCT03624569|588836118|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
163035963|NCT03624569|588836119|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
163035964|NCT03624569|588836118|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
163035965|NCT03624569|588836119|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
163035966|NCT03004924|588836146|FG000|Overall Study|Adverse Event|6|||
163035967|NCT03004924|588836147|FG001|Overall Study|Adverse Event|5|||
163035968|NCT03004924|588836148|FG002|Overall Study|Adverse Event|10|||
163035969|NCT03004924|588836146|FG000|Overall Study|Protocol Violation|4|||
163035970|NCT03004924|588836147|FG001|Overall Study|Protocol Violation|0|||
163035971|NCT03004924|588836148|FG002|Overall Study|Protocol Violation|1|||
163035972|NCT03004924|588836146|FG000|Overall Study|Withdrawal by Subject|5|||
163035973|NCT03004924|588836147|FG001|Overall Study|Withdrawal by Subject|3|||
163334881|NCT03567616|589936126|FG000|Overall Study|Disease progression|4|||
163334882|NCT03567616|589936126|FG000|Overall Study|Withdrawal by Subject|1|||
163035974|NCT03004924|588836148|FG002|Overall Study|Withdrawal by Subject|5|||
163035975|NCT03004924|588836146|FG000|Overall Study|Lost to Follow-up|6|||
163035976|NCT03004924|588836147|FG001|Overall Study|Lost to Follow-up|1|||
163035977|NCT03004924|588836148|FG002|Overall Study|Lost to Follow-up|4|||
163035978|NCT03004924|588836146|FG000|Overall Study|Lack of Efficacy|2|||
163035979|NCT03004924|588836147|FG001|Overall Study|Lack of Efficacy|4|||
163035980|NCT03004924|588836148|FG002|Overall Study|Lack of Efficacy|2|||
163035981|NCT03004924|588836146|FG000|Overall Study|Physician Decision|1|||
163035982|NCT03004924|588836147|FG001|Overall Study|Physician Decision|0|||
163035983|NCT03004924|588836148|FG002|Overall Study|Physician Decision|1|||
163035984|NCT03004924|588836146|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163035985|NCT03004924|588836147|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163035986|NCT03004924|588836148|FG002|Overall Study|Withdrawal by parent/guardian|2|||
163035987|NCT03004924|588836146|FG000|Overall Study|Screen Failure|1|||
163035988|NCT03004924|588836147|FG001|Overall Study|Screen Failure|0|||
163035989|NCT03004924|588836148|FG002|Overall Study|Screen Failure|0|||
163035990|NCT03004924|588836146|FG000|Overall Study|Pregnancy|0|||
163035991|NCT03004924|588836147|FG001|Overall Study|Pregnancy|1|||
163035992|NCT03004924|588836148|FG002|Overall Study|Pregnancy|0|||
163035993|NCT03004924|588836146|FG000|Overall Study|Terminated by Sponsor|0|||
163035994|NCT03004924|588836147|FG001|Overall Study|Terminated by Sponsor|0|||
163035995|NCT03004924|588836148|FG002|Overall Study|Terminated by Sponsor|1|||
163035996|NCT03004924|588836146|FG000|Overall Study|Missed Study Visit|0|||
163035997|NCT03004924|588836147|FG001|Overall Study|Missed Study Visit|0|||
163035998|NCT03004924|588836148|FG002|Overall Study|Missed Study Visit|2|||
163035999|NCT03004924|588836146|FG000|Overall Study|HSV1 Positive|1|||
163036000|NCT03004924|588836147|FG001|Overall Study|HSV1 Positive|0|||
163036001|NCT03004924|588836148|FG002|Overall Study|HSV1 Positive|0|||
163036002|NCT03411902|588836164|FG000|Overall Study|Lost to Follow-up|3|||
163036003|NCT03411902|588836165|FG001|Overall Study|Lost to Follow-up|0|||
163036004|NCT01693185|588836168|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
163036005|NCT01693185|588836169|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
163036006|NCT00419159|588836170|FG000|Overall Study|Adverse Event|7|||
163036007|NCT00419159|588836171|FG001|Overall Study|Adverse Event|15|||
163036008|NCT00419159|588836170|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163036009|NCT00419159|588836171|FG001|Overall Study|Abnormal laboratory value(s)|2|||
163036010|NCT00419159|588836170|FG000|Overall Study|Subject's no longer requires study drug|0|||
163036011|NCT00419159|588836171|FG001|Overall Study|Subject's no longer requires study drug|1|||
163036012|NCT00419159|588836170|FG000|Overall Study|Protocol Violation|1|||
163036013|NCT00419159|588836171|FG001|Overall Study|Protocol Violation|0|||
163085932|NCT04380142|589022363|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
163085933|NCT04380142|589022364|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
163085934|NCT04380142|589022365|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
163085935|NCT04380142|589022363|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
163085936|NCT04380142|589022364|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
163085937|NCT04380142|589022365|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
163085938|NCT04380142|589022363|FG000|Double-Blind Treatment Period|Adverse Event|0|||
163085939|NCT04380142|589022364|FG001|Double-Blind Treatment Period|Adverse Event|1|||
163085940|NCT04380142|589022365|FG002|Double-Blind Treatment Period|Adverse Event|14|||
163085941|NCT04380142|589022363|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
163085942|NCT04380142|589022364|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
163085943|NCT04380142|589022365|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
163085944|NCT04380142|589022363|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
163085945|NCT04380142|589022364|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
163085946|NCT04380142|589022365|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
163085947|NCT04380142|589022363|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
163036014|NCT00419159|588836170|FG000|Overall Study|Withdrawal by Subject|10|||
163036015|NCT00419159|588836171|FG001|Overall Study|Withdrawal by Subject|3|||
163085948|NCT04380142|589022364|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
163085949|NCT04380142|589022365|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
163036016|NCT00419159|588836170|FG000|Overall Study|Lost to Follow-up|0|||
163036017|NCT00419159|588836171|FG001|Overall Study|Lost to Follow-up|1|||
163036018|NCT00419159|588836170|FG000|Overall Study|Death|2|||
163036019|NCT00419159|588836171|FG001|Overall Study|Death|2|||
163036020|NCT00419159|588836170|FG000|Overall Study|Disease progression|79|||
163036021|NCT00419159|588836171|FG001|Overall Study|Disease progression|76|||
163036022|NCT01017601|588836172|FG000|Overall Study|Disease Progression|12|||
163085950|NCT04380142|589022363|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
163085951|NCT04380142|589022364|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
163334883|NCT03567616|589936126|FG000|Overall Study|Physician Decision|1|||
163334884|NCT03567616|589936126|FG000|Overall Study|Death|1|||
163036023|NCT01017601|588836173|FG001|Overall Study|Disease Progression|12|||
163036024|NCT01017601|588836172|FG000|Overall Study|Withdrawal by Subject|0|||
163036025|NCT01017601|588836173|FG001|Overall Study|Withdrawal by Subject|1|||
163036026|NCT00803205|588836175|FG000|Overall Study|Adverse Event|7|||
163085952|NCT04380142|589022365|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
163085953|NCT04380142|589022363|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
163085954|NCT04380142|589022364|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
163085955|NCT04380142|589022365|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
163085956|NCT00209131|589022366|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
163085957|NCT00209131|589022367|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
163085958|NCT04875533|589022368|FG000|Overall Study|Adverse Event|6|||
163085959|NCT04875533|589022369|FG001|Overall Study|Adverse Event|4|||
163085960|NCT04875533|589022368|FG000|Overall Study|Protocol Violation|4|||
163085961|NCT04875533|589022369|FG001|Overall Study|Protocol Violation|0|||
163085962|NCT04875533|589022368|FG000|Overall Study|Withdrawal by Subject|8|||
163085963|NCT04875533|589022369|FG001|Overall Study|Withdrawal by Subject|5|||
163085964|NCT04875533|589022368|FG000|Overall Study|No longer meets eligibility criteria|1|||
163085965|NCT04875533|589022369|FG001|Overall Study|No longer meets eligibility criteria|0|||
163085966|NCT04875533|589022368|FG000|Overall Study|Other|0|||
163085967|NCT04875533|589022369|FG001|Overall Study|Other|2|||
163085968|NCT01299961|589022370|FG000|Overall Study|Adverse Event|3|||
163085969|NCT01299961|589022370|FG000|Overall Study|Lack of Efficacy|2|||
163085970|NCT01299961|589022370|FG000|Overall Study|Lost to Follow-up|1|||
163085971|NCT02904096|589022371|FG000|Overall Study|Adverse Event|1|||
163085972|NCT02904096|589022372|FG001|Overall Study|Adverse Event|0|||
163085973|NCT02904096|589022371|FG000|Overall Study|Withdrawal by Subject|4|||
163085974|NCT02904096|589022372|FG001|Overall Study|Withdrawal by Subject|3|||
163085975|NCT02904096|589022371|FG000|Overall Study|Lost to Follow-up|10|||
163085976|NCT02904096|589022372|FG001|Overall Study|Lost to Follow-up|17|||
163085977|NCT02904096|589022371|FG000|Overall Study|Non-compliant|3|||
163085978|NCT02904096|589022372|FG001|Overall Study|Non-compliant|1|||
163085979|NCT02904096|589022371|FG000|Overall Study|Sponsor instructed|1|||
163085980|NCT02904096|589022372|FG001|Overall Study|Sponsor instructed|0|||
163085981|NCT00980798|589022373|FG000|Overall Study|Adverse Event|7|||
163085982|NCT00980798|589022374|FG001|Overall Study|Adverse Event|36|||
163085983|NCT00980798|589022373|FG000|Overall Study|Lack of Efficacy|16|||
163085984|NCT00980798|589022374|FG001|Overall Study|Lack of Efficacy|5|||
163085985|NCT00980798|589022373|FG000|Overall Study|Lost to Follow-up|0|||
163085986|NCT00980798|589022374|FG001|Overall Study|Lost to Follow-up|1|||
163085987|NCT00980798|589022373|FG000|Overall Study|Physician Decision|2|||
163085988|NCT00980798|589022374|FG001|Overall Study|Physician Decision|1|||
163085989|NCT00980798|589022373|FG000|Overall Study|Withdrawal by Subject|8|||
163036027|NCT00803205|588836176|FG001|Overall Study|Adverse Event|2|||
163036028|NCT00803205|588836175|FG000|Overall Study|Lost to Follow-up|1|||
163036029|NCT00803205|588836176|FG001|Overall Study|Lost to Follow-up|0|||
163036030|NCT00803205|588836175|FG000|Overall Study|Withdrawal by Subject|9|||
163036031|NCT00803205|588836176|FG001|Overall Study|Withdrawal by Subject|9|||
163036032|NCT00803205|588836175|FG000|Overall Study|Physician Decision|1|||
163036033|NCT00803205|588836176|FG001|Overall Study|Physician Decision|0|||
163036034|NCT00803205|588836175|FG000|Overall Study|Protocol Violation|1|||
163036035|NCT00803205|588836176|FG001|Overall Study|Protocol Violation|1|||
163036036|NCT00803205|588836175|FG000|Overall Study|Medical Monitor Decision|1|||
163036037|NCT00803205|588836176|FG001|Overall Study|Medical Monitor Decision|0|||
163036038|NCT00803205|588836175|FG000|Overall Study|Acquired a Lung Infection|0|||
163036039|NCT00803205|588836176|FG001|Overall Study|Acquired a Lung Infection|1|||
163036040|NCT00803205|588836175|FG000|Overall Study|Sponsor Decision|0|||
163036041|NCT00803205|588836176|FG001|Overall Study|Sponsor Decision|1|||
163036042|NCT01857102|588836177|FG000|Period 1|No longer meets Eligibility Criteria|0|||
163036043|NCT01857102|588836178|FG001|Period 1|No longer meets Eligibility Criteria|2|||
163036044|NCT01857102|588836177|FG000|Period 1|Lost to Follow-up|0|||
163036045|NCT01857102|588836178|FG001|Period 1|Lost to Follow-up|3|||
163036046|NCT01857102|588836177|FG000|Period 1|Unsatisfactory Lens Fit|1|||
163036047|NCT01857102|588836178|FG001|Period 1|Unsatisfactory Lens Fit|0|||
163036048|NCT01857102|588836177|FG000|Period 1|Unsatisfactory Visual Response|1|||
163036049|NCT01857102|588836178|FG001|Period 1|Unsatisfactory Visual Response|0|||
163036050|NCT01857102|588836177|FG000|Period 1|Physician Decision|1|||
163036051|NCT01857102|588836178|FG001|Period 1|Physician Decision|0|||
163036052|NCT01857102|588836177|FG000|Period 2|Lens Discomfort|1|||
163036053|NCT01857102|588836178|FG001|Period 2|Lens Discomfort|0|||
163036054|NCT01857102|588836177|FG000|Period 2|Unsatisfactory Lens Fit|1|||
163036055|NCT01857102|588836178|FG001|Period 2|Unsatisfactory Lens Fit|0|||
163036056|NCT02735096|588836184|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
163036057|NCT01080391|588836192|FG000|Overall Study|Randomized but not treated|7|||
163036058|NCT01080391|588836193|FG001|Overall Study|Randomized but not treated|4|||
163036059|NCT02083653|588836199|FG000|Overall Study|Randomized but not Treated|0|||
163036060|NCT02083653|588836200|FG001|Overall Study|Randomized but not Treated|2|||
163036061|NCT02083653|588836201|FG002|Overall Study|Randomized but not Treated|7|||
163036062|NCT02083653|588836199|FG000|Overall Study|Adverse Event|12|||
163036063|NCT02083653|588836200|FG001|Overall Study|Adverse Event|5|||
163036064|NCT02083653|588836201|FG002|Overall Study|Adverse Event|4|||
163036065|NCT02083653|588836199|FG000|Overall Study|Lost to Follow-up|1|||
163036066|NCT02083653|588836200|FG001|Overall Study|Lost to Follow-up|0|||
163036067|NCT02083653|588836201|FG002|Overall Study|Lost to Follow-up|0|||
163036068|NCT02083653|588836199|FG000|Overall Study|Death|2|||
163036069|NCT02083653|588836200|FG001|Overall Study|Death|2|||
163036070|NCT02083653|588836201|FG002|Overall Study|Death|2|||
163036071|NCT02083653|588836199|FG000|Overall Study|Progressive Disease|65|||
163036072|NCT02083653|588836200|FG001|Overall Study|Progressive Disease|73|||
163036073|NCT02083653|588836201|FG002|Overall Study|Progressive Disease|63|||
163036074|NCT02083653|588836199|FG000|Overall Study|Withdrawal by Subject|2|||
163036075|NCT02083653|588836200|FG001|Overall Study|Withdrawal by Subject|1|||
163036076|NCT02083653|588836201|FG002|Overall Study|Withdrawal by Subject|2|||
163036077|NCT02083653|588836199|FG000|Overall Study|Other Events|0|||
163036078|NCT02083653|588836200|FG001|Overall Study|Other Events|2|||
163036079|NCT02083653|588836201|FG002|Overall Study|Other Events|2|||
163036080|NCT02083653|588836199|FG000|Overall Study|Reason Missing|0|||
163036081|NCT02083653|588836200|FG001|Overall Study|Reason Missing|0|||
163036082|NCT02083653|588836201|FG002|Overall Study|Reason Missing|4|||
163036083|NCT02073656|588836202|FG000|Primary Study|Lost to Follow-up|6|||
163036084|NCT02073656|588836202|FG000|Primary Study|Death|1|||
163036085|NCT02073656|588836202|FG000|Primary Study|Withdrew Consent|1|||
163036086|NCT02536781|588836205|FG000|Overall Study|Lost to Follow-up|2|||
163036087|NCT02536781|588836206|FG001|Overall Study|Lost to Follow-up|0|||
163036088|NCT03423147|588836207|FG000|Overall Study|Lost to Follow-up|5|||
163036089|NCT03423147|588836208|FG001|Overall Study|Lost to Follow-up|8|||
163036090|NCT03423147|588836207|FG000|Overall Study|Withdrawal by Subject|1|||
163036091|NCT03423147|588836208|FG001|Overall Study|Withdrawal by Subject|0|||
163036092|NCT03423147|588836207|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
163036093|NCT03423147|588836208|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
163036094|NCT03423147|588836207|FG000|Overall Study|Age < 18|1|||
163036095|NCT03423147|588836208|FG001|Overall Study|Age < 18|0|||
163036096|NCT03423147|588836207|FG000|Overall Study|No Trial of Labor|0|||
163036097|NCT03423147|588836208|FG001|Overall Study|No Trial of Labor|1|||
163036098|NCT00539032|588836210|FG000|Overall Study|Withdrawal by Subject|2|||
163036099|NCT00539032|588836211|FG001|Overall Study|Withdrawal by Subject|1|||
163036100|NCT03611582|588836212|FG000|Overall Study|Adverse Event|26|||
163036101|NCT03611582|588836213|FG001|Overall Study|Adverse Event|6|||
163036102|NCT03611582|588836212|FG000|Overall Study|Protocol Violation|0|||
163036103|NCT03611582|588836213|FG001|Overall Study|Protocol Violation|1|||
163036104|NCT03611582|588836212|FG000|Overall Study|Pregnancy|1|||
163036105|NCT03611582|588836213|FG001|Overall Study|Pregnancy|2|||
163036106|NCT03611582|588836212|FG000|Overall Study|Lack of Efficacy|0|||
163036107|NCT03611582|588836213|FG001|Overall Study|Lack of Efficacy|1|||
163036108|NCT03611582|588836212|FG000|Overall Study|At the discretion of the investigator|1|||
163036109|NCT03611582|588836213|FG001|Overall Study|At the discretion of the investigator|0|||
163036110|NCT03611582|588836212|FG000|Overall Study|Safety concern as judged by the investigator|1|||
163036111|NCT03611582|588836213|FG001|Overall Study|Safety concern as judged by the investigator|2|||
163036112|NCT03611582|588836212|FG000|Overall Study|Withdrawal by Subject|4|||
163036113|NCT03611582|588836213|FG001|Overall Study|Withdrawal by Subject|3|||
163036114|NCT03611582|588836212|FG000|Overall Study|Lost to Follow-up|18|||
163036115|NCT03611582|588836213|FG001|Overall Study|Lost to Follow-up|7|||
163036116|NCT03611582|588836212|FG000|Overall Study|other|17|||
163036117|NCT03611582|588836213|FG001|Overall Study|other|16|||
163036118|NCT04438499|588836214|FG000|Overall Study|Lack of Efficacy|3|||
163036119|NCT04494425|588837839|FG000|Overall Study|Death|160|||
163036120|NCT04494425|588837840|FG001|Overall Study|Death|166|||
163036121|NCT04494425|588837839|FG000|Overall Study|Withdrawal by Subject|10|||
163036122|NCT04494425|588837840|FG001|Overall Study|Withdrawal by Subject|40|||
163036123|NCT04494425|588837839|FG000|Overall Study|Other|1|||
163036124|NCT04494425|588837840|FG001|Overall Study|Other|1|||
163036125|NCT04494425|588837839|FG000|Overall Study|Ongoing at the time of PCD|265|||
163036126|NCT04494425|588837840|FG001|Overall Study|Ongoing at the time of PCD|223|||
163036127|NCT01270321|588837842|FG000|Overall Study|Death|3|||
163036128|NCT01270321|588837843|FG001|Overall Study|Death|1|||
163036129|NCT01270321|588837844|FG002|Overall Study|Death|4|||
163036130|NCT01270321|588837842|FG000|Overall Study|Adverse Event|7|||
163036131|NCT01270321|588837843|FG001|Overall Study|Adverse Event|9|||
163036132|NCT01270321|588837844|FG002|Overall Study|Adverse Event|5|||
163036133|NCT04003623|588837848|FG000|Overall Study|Withdrawal by Subject|1|||
163036134|NCT04003623|588837849|FG001|Overall Study|Withdrawal by Subject|0|||
163036135|NCT01190189|588837853|FG000|Overall Study|Lost to Follow-up|4|||
163036136|NCT01190189|588837853|FG000|Overall Study|Withdrawal by Subject|1|||
163036137|NCT01190189|588837853|FG000|Overall Study|Migrated/moved from study area|1|||
163036138|NCT00762034|588837857|FG000|Induction Period|Protocol Violation|1|||
163036139|NCT00762034|588837858|FG001|Induction Period|Protocol Violation|2|||
163036140|NCT00762034|588837857|FG000|Induction Period|Entry Criterion Not Met|12|||
163085990|NCT00980798|589022374|FG001|Overall Study|Withdrawal by Subject|11|||
163085991|NCT00980798|589022373|FG000|Overall Study|Other|0|||
163085992|NCT00980798|589022374|FG001|Overall Study|Other|1|||
163085993|NCT00526799|589022375|FG000|Overall Study|Withdrawal by Subject|1|||
163085994|NCT00526799|589022376|FG001|Overall Study|Withdrawal by Subject|0|||
163085995|NCT00526799|589022375|FG000|Overall Study|Intercurrent Complicating Disease|0|||
163085996|NCT00526799|589022376|FG001|Overall Study|Intercurrent Complicating Disease|1|||
163085997|NCT03633058|589022377|FG000|Overall Study|Adverse Event|0|||
163085998|NCT03633058|589022378|FG001|Overall Study|Adverse Event|0|||
163085999|NCT03633058|589022379|FG002|Overall Study|Adverse Event|1|||
163086000|NCT03633058|589022380|FG003|Overall Study|Adverse Event|0|||
163086001|NCT02757768|589022381|FG000|Overall Study|Randomized Never Received Study Drug|3|||
163086002|NCT02757768|589022382|FG001|Overall Study|Randomized Never Received Study Drug|4|||
163086003|NCT02757768|589022381|FG000|Overall Study|Adverse Event|5|||
163086004|NCT02757768|589022382|FG001|Overall Study|Adverse Event|3|||
163086005|NCT02757768|589022381|FG000|Overall Study|Lack of Efficacy|2|||
163086006|NCT02757768|589022382|FG001|Overall Study|Lack of Efficacy|1|||
163086007|NCT02757768|589022381|FG000|Overall Study|Lost to Follow-up|1|||
163086008|NCT02757768|589022382|FG001|Overall Study|Lost to Follow-up|0|||
163086009|NCT02757768|589022381|FG000|Overall Study|Protocol Deviation|2|||
163086010|NCT02757768|589022382|FG001|Overall Study|Protocol Deviation|9|||
163086011|NCT02757768|589022381|FG000|Overall Study|Withdrawal by Subject|16|||
163086012|NCT02757768|589022382|FG001|Overall Study|Withdrawal by Subject|9|||
163086013|NCT02757768|589022381|FG000|Overall Study|Miscellaneous|4|||
163086014|NCT02757768|589022382|FG001|Overall Study|Miscellaneous|2|||
163086015|NCT00835367|589022383|FG000|Washout|Adverse Event|2|||
163086016|NCT00835367|589022384|FG001|Washout|Adverse Event|0|||
163086017|NCT00835367|589022383|FG000|Washout|Withdrawal by Subject|1|||
163086018|NCT00835367|589022384|FG001|Washout|Withdrawal by Subject|0|||
163086019|NCT00835367|589022383|FG000|Second Intervention|Adverse Event|1|||
163086020|NCT00835367|589022384|FG001|Second Intervention|Adverse Event|1|||
163086021|NCT00835172|589022385|FG000|Washout|Protocol Violation|0|||
163086022|NCT00835172|589022386|FG001|Washout|Protocol Violation|1|||
163086023|NCT04734210|589024265|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
163086024|NCT04734210|589024266|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
163086025|NCT04734210|589024267|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
163086026|NCT04734210|589024265|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
163086027|NCT04734210|589024266|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
163086028|NCT04734210|589024267|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
163086029|NCT04734210|589024265|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
163086030|NCT04734210|589024266|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
163086031|NCT04734210|589024267|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
163086032|NCT04734210|589024265|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
163086033|NCT04734210|589024266|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
163086034|NCT04734210|589024267|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
163086035|NCT00573768|589024268|FG000|Overall Study|Adverse Event|1|||
163086036|NCT00573768|589024269|FG001|Overall Study|Adverse Event|1|||
163086037|NCT00573768|589024270|FG002|Overall Study|Adverse Event|2|||
163086038|NCT00573768|589024268|FG000|Overall Study|Protocol Violation|1|||
163086039|NCT00573768|589024269|FG001|Overall Study|Protocol Violation|0|||
163086040|NCT00573768|589024270|FG002|Overall Study|Protocol Violation|1|||
163086041|NCT00573768|589024268|FG000|Overall Study|Withdrawal by Subject|0|||
163086042|NCT00573768|589024269|FG001|Overall Study|Withdrawal by Subject|1|||
163086043|NCT00573768|589024270|FG002|Overall Study|Withdrawal by Subject|0|||
163086044|NCT00573768|589024268|FG000|Overall Study|Lost to Follow-up|0|||
163086045|NCT00573768|589024269|FG001|Overall Study|Lost to Follow-up|0|||
163086046|NCT00573768|589024270|FG002|Overall Study|Lost to Follow-up|1|||
163086047|NCT00553254|589024278|FG000|Overall Study|Death|3|||
163086048|NCT00553254|589024279|FG001|Overall Study|Death|6|||
163086049|NCT00553254|589024280|FG002|Overall Study|Death|25|||
163086050|NCT00553254|589024278|FG000|Overall Study|Lost to Follow-up|0|||
163086051|NCT00553254|589024279|FG001|Overall Study|Lost to Follow-up|0|||
163036141|NCT00762034|588837858|FG001|Induction Period|Entry Criterion Not Met|11|||
163036142|NCT00762034|588837857|FG000|Induction Period|Adverse Event|27|||
163036143|NCT00762034|588837858|FG001|Induction Period|Adverse Event|38|||
163036144|NCT00762034|588837857|FG000|Induction Period|Lost to Follow-up|1|||
163036145|NCT00762034|588837858|FG001|Induction Period|Lost to Follow-up|1|||
163036146|NCT00762034|588837857|FG000|Induction Period|Progressive Disease|73|||
163036147|NCT00762034|588837858|FG001|Induction Period|Progressive Disease|55|||
163036148|NCT00762034|588837857|FG000|Induction Period|Physician Decision|21|||
163036149|NCT00762034|588837858|FG001|Induction Period|Physician Decision|20|||
163036150|NCT00762034|588837857|FG000|Induction Period|Withdrawal by Subject|15|||
163086052|NCT00553254|589024280|FG002|Overall Study|Lost to Follow-up|2|||
163086053|NCT00553254|589024278|FG000|Overall Study|Withdrawal by Subject|2|||
163086054|NCT00553254|589024279|FG001|Overall Study|Withdrawal by Subject|0|||
163086055|NCT00553254|589024280|FG002|Overall Study|Withdrawal by Subject|2|||
163086056|NCT00553254|589024278|FG000|Overall Study|Study terminated by Sponsor|0|||
163086057|NCT00553254|589024279|FG001|Overall Study|Study terminated by Sponsor|0|||
163086058|NCT00553254|589024280|FG002|Overall Study|Study terminated by Sponsor|1|||
163086059|NCT00553254|589024278|FG000|Overall Study|Other|1|||
163086060|NCT00553254|589024279|FG001|Overall Study|Other|0|||
163086061|NCT00553254|589024280|FG002|Overall Study|Other|13|||
163086062|NCT02314923|589024283|FG000|Overall Study|Death|0|||
163086063|NCT02314923|589024284|FG001|Overall Study|Death|0|||
163086064|NCT02314923|589024285|FG002|Overall Study|Death|0|||
163086065|NCT02314923|589024286|FG003|Overall Study|Death|1|||
163086066|NCT02314923|589024287|FG004|Overall Study|Death|0|||
163086067|NCT02314923|589024288|FG005|Overall Study|Death|0|||
163086068|NCT02314923|589024289|FG006|Overall Study|Death|0|||
163086069|NCT02314923|589024290|FG007|Overall Study|Death|0|||
163086070|NCT02314923|589024291|FG008|Overall Study|Death|0|||
163086071|NCT02314923|589024292|FG009|Overall Study|Death|0|||
163086072|NCT02314923|589024283|FG000|Overall Study|Lost to Follow-up|2|||
163086073|NCT02314923|589024284|FG001|Overall Study|Lost to Follow-up|3|||
163086074|NCT02314923|589024285|FG002|Overall Study|Lost to Follow-up|1|||
163086075|NCT02314923|589024286|FG003|Overall Study|Lost to Follow-up|0|||
163086076|NCT02314923|589024287|FG004|Overall Study|Lost to Follow-up|0|||
163086077|NCT02314923|589024288|FG005|Overall Study|Lost to Follow-up|0|||
163086078|NCT02314923|589024289|FG006|Overall Study|Lost to Follow-up|3|||
163086079|NCT02314923|589024290|FG007|Overall Study|Lost to Follow-up|4|||
163086080|NCT02314923|589024291|FG008|Overall Study|Lost to Follow-up|2|||
163086081|NCT02314923|589024292|FG009|Overall Study|Lost to Follow-up|0|||
163086082|NCT02314923|589024283|FG000|Overall Study|Withdrawal by Subject|0|||
163086083|NCT02314923|589024284|FG001|Overall Study|Withdrawal by Subject|0|||
163086084|NCT02314923|589024285|FG002|Overall Study|Withdrawal by Subject|1|||
163086085|NCT02314923|589024286|FG003|Overall Study|Withdrawal by Subject|0|||
163086086|NCT02314923|589024287|FG004|Overall Study|Withdrawal by Subject|1|||
163086087|NCT02314923|589024288|FG005|Overall Study|Withdrawal by Subject|0|||
163086088|NCT02314923|589024289|FG006|Overall Study|Withdrawal by Subject|1|||
163086089|NCT02314923|589024290|FG007|Overall Study|Withdrawal by Subject|0|||
163086090|NCT02314923|589024291|FG008|Overall Study|Withdrawal by Subject|0|||
163086091|NCT02314923|589024292|FG009|Overall Study|Withdrawal by Subject|0|||
163086092|NCT02314923|589024283|FG000|Overall Study|Physician Decision|0|||
163086093|NCT02314923|589024284|FG001|Overall Study|Physician Decision|1|||
163086094|NCT02314923|589024285|FG002|Overall Study|Physician Decision|0|||
163086095|NCT02314923|589024286|FG003|Overall Study|Physician Decision|0|||
163086096|NCT02314923|589024287|FG004|Overall Study|Physician Decision|0|||
163086097|NCT02314923|589024288|FG005|Overall Study|Physician Decision|0|||
163086098|NCT02314923|589024289|FG006|Overall Study|Physician Decision|0|||
163086099|NCT02314923|589024290|FG007|Overall Study|Physician Decision|0|||
163086100|NCT02314923|589024291|FG008|Overall Study|Physician Decision|0|||
163086101|NCT02314923|589024292|FG009|Overall Study|Physician Decision|0|||
163086102|NCT02314923|589024283|FG000|Overall Study|Participant unavailable|0|||
163086103|NCT02314923|589024284|FG001|Overall Study|Participant unavailable|0|||
163086104|NCT02314923|589024285|FG002|Overall Study|Participant unavailable|0|||
163086105|NCT02314923|589024286|FG003|Overall Study|Participant unavailable|0|||
163086106|NCT02314923|589024287|FG004|Overall Study|Participant unavailable|0|||
163086107|NCT02314923|589024288|FG005|Overall Study|Participant unavailable|1|||
163334885|NCT03567616|589936126|FG000|Overall Study|Adverse Event|1|||
163334886|NCT00380250|589936128|FG000|Overall Study|Withdrawal by Subject|39|||
163334887|NCT00380250|589936129|FG001|Overall Study|Withdrawal by Subject|28|||
163334888|NCT00380250|589936128|FG000|Overall Study|Adverse Event|20|||
163334889|NCT00380250|589936129|FG001|Overall Study|Adverse Event|9|||
163334890|NCT00380250|589936128|FG000|Overall Study|Lack of Efficacy|10|||
163334891|NCT00380250|589936129|FG001|Overall Study|Lack of Efficacy|8|||
163086108|NCT02314923|589024289|FG006|Overall Study|Participant unavailable|0|||
163086109|NCT02314923|589024290|FG007|Overall Study|Participant unavailable|0|||
163086110|NCT02314923|589024291|FG008|Overall Study|Participant unavailable|0|||
163086111|NCT02314923|589024292|FG009|Overall Study|Participant unavailable|0|||
163086112|NCT02314923|589024283|FG000|Overall Study|Screen failure|0|||
163086113|NCT02314923|589024284|FG001|Overall Study|Screen failure|0|||
163086114|NCT02314923|589024285|FG002|Overall Study|Screen failure|0|||
163086115|NCT02314923|589024286|FG003|Overall Study|Screen failure|0|||
163086116|NCT02314923|589024287|FG004|Overall Study|Screen failure|0|||
163086117|NCT02314923|589024288|FG005|Overall Study|Screen failure|0|||
163086118|NCT02314923|589024289|FG006|Overall Study|Screen failure|1|||
163086119|NCT02314923|589024290|FG007|Overall Study|Screen failure|0|||
163086120|NCT02314923|589024291|FG008|Overall Study|Screen failure|0|||
163086121|NCT02314923|589024292|FG009|Overall Study|Screen failure|0|||
163086122|NCT02314923|589024283|FG000|Overall Study|Participant relocation|1|||
163334892|NCT00380250|589936128|FG000|Overall Study|Protocol Violation|15|||
163334893|NCT00380250|589936129|FG001|Overall Study|Protocol Violation|5|||
163086123|NCT02314923|589024284|FG001|Overall Study|Participant relocation|0|||
163036151|NCT00762034|588837858|FG001|Induction Period|Withdrawal by Subject|19|||
163036152|NCT00762034|588837857|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
163036153|NCT00762034|588837858|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
163036154|NCT00762034|588837857|FG000|Induction Period|Deaths Due to Study Disease|9|||
163036155|NCT00762034|588837858|FG001|Induction Period|Deaths Due to Study Disease|9|||
163036156|NCT00762034|588837857|FG000|Maintenance Period|Protocol Violation|1|||
163036157|NCT00762034|588837858|FG001|Maintenance Period|Protocol Violation|3|||
163036158|NCT00762034|588837857|FG000|Maintenance Period|Entry Criterion Not Met|0|||
163036159|NCT00762034|588837858|FG001|Maintenance Period|Entry Criterion Not Met|2|||
163036160|NCT00762034|588837857|FG000|Maintenance Period|Adverse Event|42|||
163036161|NCT00762034|588837858|FG001|Maintenance Period|Adverse Event|26|||
163036162|NCT00762034|588837857|FG000|Maintenance Period|Progressive Disease|186|||
163036163|NCT00762034|588837858|FG001|Maintenance Period|Progressive Disease|224|||
163036164|NCT00762034|588837857|FG000|Maintenance Period|Physician Decision|25|||
163036165|NCT00762034|588837858|FG001|Maintenance Period|Physician Decision|20|||
163036166|NCT00762034|588837857|FG000|Maintenance Period|Withdrawal by Subject|34|||
163036167|NCT00762034|588837858|FG001|Maintenance Period|Withdrawal by Subject|14|||
163036168|NCT00762034|588837857|FG000|Maintenance Period|Death not due to study disease|2|||
163036169|NCT00762034|588837858|FG001|Maintenance Period|Death not due to study disease|5|||
163036170|NCT00762034|588837857|FG000|Maintenance Period|Death due to study disease|3|||
163036171|NCT00762034|588837858|FG001|Maintenance Period|Death due to study disease|3|||
163036172|NCT00762034|588837857|FG000|Maintenance Period|Other|1|||
163036173|NCT00762034|588837858|FG001|Maintenance Period|Other|1|||
163036174|NCT00734656|588837859|FG000|Lab Session 1|Withdrawal by Subject|2|||
163036175|NCT00734656|588837860|FG001|Lab Session 1|Withdrawal by Subject|0|||
163036176|NCT00734656|588837861|FG002|Lab Session 1|Withdrawal by Subject|0|||
163036177|NCT00734656|588837862|FG003|Lab Session 1|Withdrawal by Subject|0|||
163036178|NCT00734656|588837859|FG000|Washout 1|Withdrawal by Subject|1|||
163036179|NCT00734656|588837860|FG001|Washout 1|Withdrawal by Subject|5|||
163036180|NCT00734656|588837861|FG002|Washout 1|Withdrawal by Subject|2|||
163036181|NCT00734656|588837862|FG003|Washout 1|Withdrawal by Subject|3|||
163036182|NCT00734656|588837859|FG000|Lab Session 2|Withdrawal by Subject|1|||
163036183|NCT00734656|588837860|FG001|Lab Session 2|Withdrawal by Subject|0|||
163036184|NCT00734656|588837861|FG002|Lab Session 2|Withdrawal by Subject|0|||
163036185|NCT00734656|588837862|FG003|Lab Session 2|Withdrawal by Subject|1|||
163036186|NCT00734656|588837859|FG000|Washout 2|Withdrawal by Subject|1|||
163036187|NCT00734656|588837860|FG001|Washout 2|Withdrawal by Subject|1|||
163036188|NCT00734656|588837861|FG002|Washout 2|Withdrawal by Subject|1|||
163036189|NCT00734656|588837862|FG003|Washout 2|Withdrawal by Subject|0|||
163036190|NCT00734656|588837859|FG000|Washout 3|Withdrawal by Subject|1|||
163036191|NCT00734656|588837860|FG001|Washout 3|Withdrawal by Subject|0|||
163036192|NCT00734656|588837861|FG002|Washout 3|Withdrawal by Subject|0|||
163036193|NCT00734656|588837862|FG003|Washout 3|Withdrawal by Subject|1|||
163036194|NCT00734656|588837859|FG000|Lab Session 4|Withdrawal by Subject|0|||
163036195|NCT00734656|588837860|FG001|Lab Session 4|Withdrawal by Subject|0|||
163036196|NCT00734656|588837861|FG002|Lab Session 4|Withdrawal by Subject|0|||
163036197|NCT00734656|588837862|FG003|Lab Session 4|Withdrawal by Subject|1|||
163036198|NCT03214679|588837865|FG000|Overall Study|Lost to Follow-up|12|||
163036199|NCT03214679|588837866|FG001|Overall Study|Lost to Follow-up|14|||
163036200|NCT03214679|588837865|FG000|Overall Study|not eligible|2|||
163036201|NCT03214679|588837866|FG001|Overall Study|not eligible|0|||
163036202|NCT01754766|588837874|FG000|Overall Study|Personal reasons|1|||
163036203|NCT01754766|588837875|FG001|Overall Study|Personal reasons|1|||
163036204|NCT01754766|588837876|FG002|Overall Study|Personal reasons|0|||
163036205|NCT02412878|588837877|FG000|Overall Study|Withdrawal by Subject|19|||
163036206|NCT02412878|588837878|FG001|Overall Study|Withdrawal by Subject|10|||
163036207|NCT02412878|588837877|FG000|Overall Study|Lost to Follow-up|2|||
163036208|NCT02412878|588837878|FG001|Overall Study|Lost to Follow-up|3|||
163036209|NCT04676152|588837879|FG000|Overall Study|screen fail|9|||
163036210|NCT01026818|588837887|FG000|Screening Period|Entry Criteria Not Met|105|||
163036211|NCT01026818|588837888|FG001|Screening Period|Entry Criteria Not Met|0|||
163036212|NCT01026818|588837889|FG002|Screening Period|Entry Criteria Not Met|0|||
163036213|NCT01026818|588837890|FG003|Screening Period|Entry Criteria Not Met|0|||
163036214|NCT01026818|588837887|FG000|Screening Period|Withdrawal by Subject|49|||
163036215|NCT01026818|588837888|FG001|Screening Period|Withdrawal by Subject|0|||
163036216|NCT01026818|588837889|FG002|Screening Period|Withdrawal by Subject|0|||
163036217|NCT01026818|588837890|FG003|Screening Period|Withdrawal by Subject|0|||
163036218|NCT01026818|588837887|FG000|Screening Period|Protocol Deviation|3|||
163036219|NCT01026818|588837888|FG001|Screening Period|Protocol Deviation|0|||
163036220|NCT01026818|588837889|FG002|Screening Period|Protocol Deviation|0|||
163036221|NCT01026818|588837890|FG003|Screening Period|Protocol Deviation|0|||
163036222|NCT01026818|588837887|FG000|Screening Period|Adverse Event|2|||
163036223|NCT01026818|588837888|FG001|Screening Period|Adverse Event|0|||
163036224|NCT01026818|588837889|FG002|Screening Period|Adverse Event|0|||
163036225|NCT01026818|588837890|FG003|Screening Period|Adverse Event|0|||
163036226|NCT01026818|588837887|FG000|Screening Period|Physician Decision|1|||
163406897|NCT00513500|590198761|FG001|Overall Study|Hospitalized|14|||
163406898|NCT04288154|590198762|FG000|Overall Study|Withdrawal by Subject|9|||
163406899|NCT04288154|590198763|FG001|Overall Study|Withdrawal by Subject|9|||
163406900|NCT00790907|590198768|FG000|Overall Study|Adverse Event|9|||
163406901|NCT00790907|590198769|FG001|Overall Study|Adverse Event|7|||
163406902|NCT00790907|590198770|FG002|Overall Study|Adverse Event|6|||
163406903|NCT00790907|590198768|FG000|Overall Study|Physician Decision|304|||
163406904|NCT00790907|590198769|FG001|Overall Study|Physician Decision|271|||
163406905|NCT00790907|590198770|FG002|Overall Study|Physician Decision|255|||
163406906|NCT00790907|590198768|FG000|Overall Study|Withdrawal by Subject|1|||
163406907|NCT00790907|590198769|FG001|Overall Study|Withdrawal by Subject|7|||
163406908|NCT00790907|590198770|FG002|Overall Study|Withdrawal by Subject|5|||
163406909|NCT00790907|590198768|FG000|Overall Study|Bleeding Event|11|||
163406910|NCT00790907|590198769|FG001|Overall Study|Bleeding Event|16|||
163406911|NCT00790907|590198770|FG002|Overall Study|Bleeding Event|21|||
163406912|NCT00790907|590198768|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
163406913|NCT00790907|590198769|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
163406914|NCT00790907|590198770|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
163406915|NCT00790907|590198768|FG000|Overall Study|Qualifying Condition Not Present|29|||
163406916|NCT00790907|590198769|FG001|Overall Study|Qualifying Condition Not Present|14|||
163406917|NCT00790907|590198770|FG002|Overall Study|Qualifying Condition Not Present|16|||
163406918|NCT00790907|590198768|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
163406919|NCT00790907|590198769|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
163406920|NCT00790907|590198770|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
163406921|NCT00790907|590198768|FG000|Overall Study|Did Not Receive Study Drug|10|||
163406922|NCT00790907|590198769|FG001|Overall Study|Did Not Receive Study Drug|0|||
163406923|NCT00790907|590198770|FG002|Overall Study|Did Not Receive Study Drug|0|||
163406924|NCT01902290|590198771|FG000|Overall Study|Withdrawal by Subject|19|||
163406925|NCT01902290|590198772|FG001|Overall Study|Withdrawal by Subject|27|||
163406926|NCT01902290|590198771|FG000|Overall Study|Lost to Follow-up|2|||
163406927|NCT01902290|590198772|FG001|Overall Study|Lost to Follow-up|2|||
163406928|NCT01902290|590198771|FG000|Overall Study|Death|1|||
163406929|NCT01902290|590198772|FG001|Overall Study|Death|0|||
163406930|NCT01902290|590198771|FG000|Overall Study|Sponsor Decision|26|||
163406931|NCT01902290|590198772|FG001|Overall Study|Sponsor Decision|24|||
163406932|NCT00774345|590198773|FG000|Pre-treatment|Other reasons|2|||
163406933|NCT00774345|590198774|FG001|Pre-treatment|Other reasons|0|||
163406934|NCT00774345|590198773|FG000|Treatment|Adverse Event|61|||
163406935|NCT00774345|590198774|FG001|Treatment|Adverse Event|15|||
163406936|NCT00774345|590198773|FG000|Treatment|Progressive Disease without histologic transformation|51|||
163406937|NCT00774345|590198774|FG001|Treatment|Progressive Disease without histologic transformation|111|||
163406938|NCT00774345|590198773|FG000|Treatment|Progressive Disease with histologic transformation|4|||
163406939|NCT00774345|590198774|FG001|Treatment|Progressive Disease with histologic transformation|2|||
163406940|NCT00774345|590198773|FG000|Treatment|Withdrawal by Subject|5|||
163406941|NCT00774345|590198774|FG001|Treatment|Withdrawal by Subject|2|||
163406942|NCT00774345|590198773|FG000|Treatment|Lost to Follow-up|1|||
163406943|NCT00774345|590198774|FG001|Treatment|Lost to Follow-up|1|||
163406944|NCT00774345|590198773|FG000|Treatment|Death|4|||
163406945|NCT00774345|590198774|FG001|Treatment|Death|0|||
163406946|NCT00774345|590198773|FG000|Treatment|Other Reasons|32|||
163406947|NCT00774345|590198774|FG001|Treatment|Other Reasons|26|||
163406948|NCT01015768|590198776|FG000|Overall Study|Some subject data unuseable|4|||
163406949|NCT01015768|590198777|FG001|Overall Study|Some subject data unuseable|4|||
163406950|NCT01627860|590198778|FG000|Overall Study|Adverse Event|9|||
163406951|NCT01627860|590198779|FG001|Overall Study|Adverse Event|4|||
163406952|NCT01627860|590198778|FG000|Overall Study|Withdrawal by Subject|2|||
163036227|NCT01026818|588837888|FG001|Screening Period|Physician Decision|0|||
163036228|NCT01026818|588837889|FG002|Screening Period|Physician Decision|0|||
163406953|NCT01627860|590198779|FG001|Overall Study|Withdrawal by Subject|1|||
163406954|NCT01627860|590198778|FG000|Overall Study|Seizure frequency doubled|0|||
163406955|NCT01627860|590198779|FG001|Overall Study|Seizure frequency doubled|1|||
163406956|NCT01627860|590198778|FG000|Overall Study|Protocol Violation|1|||
163406957|NCT01627860|590198779|FG001|Overall Study|Protocol Violation|0|||
163036229|NCT01026818|588837890|FG003|Screening Period|Physician Decision|0|||
163036230|NCT01026818|588837887|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
163036231|NCT01026818|588837888|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
163036232|NCT01026818|588837889|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
163036233|NCT01026818|588837890|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
163406958|NCT01225731|590198780|FG000|Part 1|Did not meet eligibility criteria|1|||
163406959|NCT01225731|590198781|FG001|Part 1|Did not meet eligibility criteria|0|||
163406960|NCT01225731|590198782|FG002|Part 1|Did not meet eligibility criteria|0|||
163406961|NCT01225731|590198783|FG003|Part 1|Did not meet eligibility criteria|0|||
163406962|NCT01225731|590198784|FG004|Part 1|Did not meet eligibility criteria|1|||
163406963|NCT01225731|590198785|FG005|Part 1|Did not meet eligibility criteria|0|||
163406964|NCT01225731|590198786|FG006|Part 1|Did not meet eligibility criteria|0|||
163406965|NCT01225731|590198787|FG007|Part 1|Did not meet eligibility criteria|0|||
163086124|NCT02314923|589024285|FG002|Overall Study|Participant relocation|0|||
163086125|NCT02314923|589024286|FG003|Overall Study|Participant relocation|0|||
163086126|NCT02314923|589024287|FG004|Overall Study|Participant relocation|0|||
163086127|NCT02314923|589024288|FG005|Overall Study|Participant relocation|0|||
163086128|NCT02314923|589024289|FG006|Overall Study|Participant relocation|0|||
163086129|NCT02314923|589024290|FG007|Overall Study|Participant relocation|1|||
163086130|NCT02314923|589024291|FG008|Overall Study|Participant relocation|0|||
163086131|NCT02314923|589024292|FG009|Overall Study|Participant relocation|0|||
163086132|NCT00976456|589024295|FG000|Overall Study|Adverse Event|17|||
163086133|NCT00976456|589024296|FG001|Overall Study|Adverse Event|22|||
163086134|NCT00976456|589024295|FG000|Overall Study|Death|7|||
163086135|NCT00976456|589024296|FG001|Overall Study|Death|9|||
163086136|NCT00976456|589024295|FG000|Overall Study|Lack of Efficacy|5|||
163086137|NCT00976456|589024296|FG001|Overall Study|Lack of Efficacy|2|||
163086138|NCT00976456|589024295|FG000|Overall Study|Withdrawal by Subject|3|||
163086139|NCT00976456|589024296|FG001|Overall Study|Withdrawal by Subject|1|||
163086140|NCT00976456|589024295|FG000|Overall Study|screening failure, unknown|11|||
163086141|NCT00976456|589024296|FG001|Overall Study|screening failure, unknown|4|||
163086142|NCT00478257|589024297|FG000|Overall Study|Withdrawal by Subject|8|||
163086143|NCT00478257|589024298|FG001|Overall Study|Withdrawal by Subject|3|||
163086144|NCT00806585|589024299|FG000|Overall Study|Study terminated by Sponsor|0|||
163086145|NCT00806585|589024300|FG001|Overall Study|Study terminated by Sponsor|0|||
163086146|NCT00806585|589024301|FG002|Overall Study|Study terminated by Sponsor|1|||
163086147|NCT00806585|589024302|FG003|Overall Study|Study terminated by Sponsor|2|||
163086148|NCT00806585|589024303|FG004|Overall Study|Study terminated by Sponsor|0|||
163086149|NCT00806585|589024299|FG000|Overall Study|Protocol Violation|3|||
163086150|NCT00806585|589024300|FG001|Overall Study|Protocol Violation|1|||
163086151|NCT00806585|589024301|FG002|Overall Study|Protocol Violation|2|||
163086152|NCT00806585|589024302|FG003|Overall Study|Protocol Violation|0|||
163086153|NCT00806585|589024303|FG004|Overall Study|Protocol Violation|0|||
163086154|NCT00806585|589024299|FG000|Overall Study|Physician Decision|0|||
163086155|NCT00806585|589024300|FG001|Overall Study|Physician Decision|2|||
163086156|NCT00806585|589024301|FG002|Overall Study|Physician Decision|3|||
163086157|NCT00806585|589024302|FG003|Overall Study|Physician Decision|0|||
163086158|NCT00806585|589024303|FG004|Overall Study|Physician Decision|1|||
163086159|NCT00806585|589024299|FG000|Overall Study|Lost to Follow-up|2|||
163086160|NCT00806585|589024300|FG001|Overall Study|Lost to Follow-up|1|||
163086161|NCT00806585|589024301|FG002|Overall Study|Lost to Follow-up|2|||
163086162|NCT00806585|589024302|FG003|Overall Study|Lost to Follow-up|2|||
163086163|NCT00806585|589024303|FG004|Overall Study|Lost to Follow-up|5|||
163086164|NCT00806585|589024299|FG000|Overall Study|Lack of Efficacy|1|||
163086165|NCT00806585|589024300|FG001|Overall Study|Lack of Efficacy|0|||
163086166|NCT00806585|589024301|FG002|Overall Study|Lack of Efficacy|0|||
163086167|NCT00806585|589024302|FG003|Overall Study|Lack of Efficacy|0|||
163086168|NCT00806585|589024303|FG004|Overall Study|Lack of Efficacy|0|||
163086169|NCT00806585|589024299|FG000|Overall Study|Adverse Event|1|||
163086170|NCT00806585|589024300|FG001|Overall Study|Adverse Event|5|||
163086171|NCT00806585|589024301|FG002|Overall Study|Adverse Event|3|||
163086172|NCT00806585|589024302|FG003|Overall Study|Adverse Event|4|||
163086173|NCT00806585|589024303|FG004|Overall Study|Adverse Event|2|||
163086174|NCT00806585|589024299|FG000|Overall Study|Withdrawal by Subject|10|||
163086175|NCT00806585|589024300|FG001|Overall Study|Withdrawal by Subject|8|||
163086176|NCT00806585|589024301|FG002|Overall Study|Withdrawal by Subject|9|||
163086177|NCT00806585|589024302|FG003|Overall Study|Withdrawal by Subject|3|||
163086178|NCT00806585|589024303|FG004|Overall Study|Withdrawal by Subject|11|||
163086179|NCT00806585|589024299|FG000|Overall Study|Completion status unknown|15|||
163086180|NCT00806585|589024300|FG001|Overall Study|Completion status unknown|14|||
163086181|NCT00806585|589024301|FG002|Overall Study|Completion status unknown|12|||
163086182|NCT00806585|589024302|FG003|Overall Study|Completion status unknown|4|||
163086183|NCT00806585|589024303|FG004|Overall Study|Completion status unknown|12|||
163086184|NCT02507934|589024304|FG000|Overall Study|Lost to Follow-up|2|||
163086185|NCT02507934|589024305|FG001|Overall Study|Lost to Follow-up|0|||
163086186|NCT02507934|589024304|FG000|Overall Study|Withdrawal by Subject|2|||
163086187|NCT02507934|589024305|FG001|Overall Study|Withdrawal by Subject|0|||
163086188|NCT03766399|589024306|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086189|NCT03766399|589024307|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086190|NCT03766399|589024308|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163334894|NCT00380250|589936128|FG000|Overall Study|Lost to Follow-up|14|||
163086191|NCT03766399|589024309|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086192|NCT03766399|589024310|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086193|NCT03766399|589024311|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086194|NCT03766399|589024312|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086195|NCT03766399|589024313|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086196|NCT03766399|589024314|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086197|NCT03766399|589024315|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086198|NCT03766399|589024316|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086199|NCT03766399|589024317|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086200|NCT03766399|589024318|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086201|NCT03766399|589024319|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
163086202|NCT03766399|589024320|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086203|NCT03766399|589024321|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086204|NCT03766399|589024322|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086205|NCT03766399|589024323|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086206|NCT03331354|589024324|FG000|Overall Study|Withdrawal by Subject|1|||
163086207|NCT03331354|589024325|FG001|Overall Study|Withdrawal by Subject|3|||
163086208|NCT03331354|589024324|FG000|Overall Study|Lost to Follow-up|3|||
163086209|NCT03331354|589024325|FG001|Overall Study|Lost to Follow-up|3|||
163086210|NCT03331354|589024324|FG000|Overall Study|Found employment before initiated active intervention|0|||
163086211|NCT03331354|589024325|FG001|Overall Study|Found employment before initiated active intervention|4|||
163086212|NCT05889468|589024328|FG000|Overall Study|Lost to Follow-up|9|||
163086213|NCT05889468|589024329|FG001|Overall Study|Lost to Follow-up|2|||
163086214|NCT05889468|589024328|FG000|Overall Study|Withdrawal by Subject|2|||
163086215|NCT05889468|589024329|FG001|Overall Study|Withdrawal by Subject|2|||
163086216|NCT01767987|589024332|FG000|Overall Study|Physician Decision|4|||
163086217|NCT01767987|589024333|FG001|Overall Study|Physician Decision|1|||
163086218|NCT01153516|589024334|FG000|Overall Study|Both subjects refused surgery|2|||
163086219|NCT01153516|589024335|FG001|Overall Study|Both subjects refused surgery|0|||
163086220|NCT01605097|589024344|FG000|Overall Study|Protocol Violation|1|||
163086221|NCT02284893|589024352|FG000|26 Week (Short Term)|Adverse Event|1|||
163086222|NCT02284893|589024353|FG001|26 Week (Short Term)|Adverse Event|9|||
163086223|NCT02284893|589024352|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
163086224|NCT02284893|589024353|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
163086225|NCT02284893|589024352|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
163086226|NCT02284893|589024353|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
163086227|NCT02284893|589024352|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
163086228|NCT02284893|589024353|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
163086229|NCT02284893|589024352|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
163086230|NCT02284893|589024353|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
163086231|NCT02284893|589024352|FG000|26 Week (Short Term)|Other|1|||
163086232|NCT02284893|589024353|FG001|26 Week (Short Term)|Other|1|||
163086233|NCT02284893|589024352|FG000|52 Week (Long Term)|Adverse Event|3|||
163086234|NCT02284893|589024353|FG001|52 Week (Long Term)|Adverse Event|1|||
163086235|NCT02284893|589024352|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
163086236|NCT02284893|589024353|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
163086237|NCT02284893|589024352|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
163086238|NCT02284893|589024353|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
163086239|NCT02284893|589024352|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
163086240|NCT02284893|589024353|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
163086241|NCT02284893|589024352|FG000|52 Week (Long Term)|Non-Compliance|2|||
163086242|NCT02284893|589024353|FG001|52 Week (Long Term)|Non-Compliance|3|||
163086243|NCT03038620|589024356|FG000|Overall Study|Lost to Follow-up|18|||
163086244|NCT03038620|589024357|FG001|Overall Study|Lost to Follow-up|23|||
163086245|NCT03038620|589024356|FG000|Overall Study|Withdrawal by Subject|0|||
163334895|NCT00380250|589936129|FG001|Overall Study|Lost to Follow-up|5|||
163334896|NCT00380250|589936128|FG000|Overall Study|Physician Decision|1|||
163334897|NCT00380250|589936129|FG001|Overall Study|Physician Decision|0|||
163334898|NCT01989104|589936130|FG000|Overall Study|Withdrawal by Subject|3|||
163334899|NCT01989104|589936131|FG001|Overall Study|Withdrawal by Subject|0|||
163334900|NCT01989104|589936132|FG002|Overall Study|Withdrawal by Subject|0|||
163086246|NCT03038620|589024357|FG001|Overall Study|Withdrawal by Subject|15|||
163086247|NCT03038620|589024356|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
163086248|NCT03038620|589024357|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
163086249|NCT00539500|589024363|FG000|Overall Study|Disease Progression|1|||
163086250|NCT00539500|589024363|FG000|Overall Study|Lost to Follow-up|2|||
163086251|NCT02011542|589024365|FG000|Overall Study|Physician Decision|1|||
163086252|NCT03261505|589024366|FG000|Overall Study|Withdrawal by Subject|2|||
163086253|NCT03261505|589024367|FG001|Overall Study|Withdrawal by Subject|3|||
163086254|NCT03261505|589024368|FG002|Overall Study|Withdrawal by Subject|4|||
163086255|NCT03261505|589024369|FG003|Overall Study|Withdrawal by Subject|3|||
163086256|NCT03261505|589024366|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
163086257|NCT03261505|589024367|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
163086258|NCT03261505|589024368|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
163086259|NCT03261505|589024369|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
163086260|NCT03261505|589024366|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
163086261|NCT03261505|589024367|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
163334901|NCT01989104|589936133|FG003|Overall Study|Withdrawal by Subject|0|||
163086262|NCT03261505|589024368|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
163086263|NCT03261505|589024369|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
163086264|NCT03261505|589024366|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
163086265|NCT03261505|589024367|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
163086266|NCT03261505|589024368|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
163086267|NCT03261505|589024369|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
163086268|NCT00663260|589024371|FG000|Overall Study|Lack of Efficacy|2|||
163086269|NCT00663260|589024372|FG001|Overall Study|Lack of Efficacy|0|||
163086270|NCT00663260|589024373|FG002|Overall Study|Lack of Efficacy|0|||
163086271|NCT00663260|589024371|FG000|Overall Study|Adverse Event|12|||
163086272|NCT00663260|589024372|FG001|Overall Study|Adverse Event|7|||
163086273|NCT00663260|589024373|FG002|Overall Study|Adverse Event|6|||
163086274|NCT00663260|589024371|FG000|Overall Study|Withdrawal by Subject|3|||
163086275|NCT00663260|589024372|FG001|Overall Study|Withdrawal by Subject|1|||
163086276|NCT00663260|589024373|FG002|Overall Study|Withdrawal by Subject|6|||
163086277|NCT00663260|589024371|FG000|Overall Study|Death|1|||
163086278|NCT00663260|589024372|FG001|Overall Study|Death|0|||
163086279|NCT00663260|589024373|FG002|Overall Study|Death|1|||
163086280|NCT00663260|589024371|FG000|Overall Study|Lost to Follow-up|0|||
163086281|NCT00663260|589024372|FG001|Overall Study|Lost to Follow-up|1|||
163086282|NCT00663260|589024373|FG002|Overall Study|Lost to Follow-up|0|||
163086283|NCT00663260|589024371|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
163086284|NCT00663260|589024372|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
163086285|NCT00663260|589024373|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
163086286|NCT00522379|589024374|FG000|Overall Study|Adverse Event|12|||
163086287|NCT00522379|589024375|FG001|Overall Study|Adverse Event|15|||
163086288|NCT00522379|589024376|FG002|Overall Study|Adverse Event|12|||
163086289|NCT00522379|589024377|FG003|Overall Study|Adverse Event|5|||
163086290|NCT00522379|589024378|FG004|Overall Study|Adverse Event|17|||
163086291|NCT00522379|589024374|FG000|Overall Study|Lack of Efficacy|3|||
163086292|NCT00522379|589024375|FG001|Overall Study|Lack of Efficacy|0|||
163086293|NCT00522379|589024376|FG002|Overall Study|Lack of Efficacy|2|||
163086294|NCT00522379|589024377|FG003|Overall Study|Lack of Efficacy|2|||
163086295|NCT00522379|589024378|FG004|Overall Study|Lack of Efficacy|7|||
163086296|NCT00522379|589024374|FG000|Overall Study|Withdrawal by Subject|2|||
163086297|NCT00522379|589024375|FG001|Overall Study|Withdrawal by Subject|3|||
163086298|NCT00522379|589024376|FG002|Overall Study|Withdrawal by Subject|1|||
163086299|NCT00522379|589024377|FG003|Overall Study|Withdrawal by Subject|2|||
163086300|NCT00522379|589024378|FG004|Overall Study|Withdrawal by Subject|0|||
163086301|NCT00522379|589024374|FG000|Overall Study|Protocol Violation|1|||
163086302|NCT00522379|589024375|FG001|Overall Study|Protocol Violation|1|||
163086303|NCT00522379|589024376|FG002|Overall Study|Protocol Violation|2|||
163086304|NCT00522379|589024377|FG003|Overall Study|Protocol Violation|0|||
163086305|NCT00522379|589024378|FG004|Overall Study|Protocol Violation|0|||
163086306|NCT00522379|589024374|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
163086307|NCT00522379|589024375|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
163086308|NCT00522379|589024376|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
163086309|NCT00522379|589024377|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
163086310|NCT00522379|589024378|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
163086311|NCT00522379|589024374|FG000|Overall Study|Lost to Follow-up|1|||
163086312|NCT00522379|589024375|FG001|Overall Study|Lost to Follow-up|0|||
163086313|NCT00522379|589024376|FG002|Overall Study|Lost to Follow-up|4|||
163086314|NCT00522379|589024377|FG003|Overall Study|Lost to Follow-up|2|||
163086315|NCT00522379|589024378|FG004|Overall Study|Lost to Follow-up|2|||
163086316|NCT00522379|589024374|FG000|Overall Study|Randomization error|0|||
163086317|NCT00522379|589024375|FG001|Overall Study|Randomization error|0|||
163086318|NCT00522379|589024376|FG002|Overall Study|Randomization error|0|||
163086319|NCT00522379|589024377|FG003|Overall Study|Randomization error|0|||
163086320|NCT00522379|589024378|FG004|Overall Study|Randomization error|1|||
163086321|NCT00522379|589024374|FG000|Overall Study|Dispensing error|1|||
163086322|NCT00522379|589024375|FG001|Overall Study|Dispensing error|0|||
163086323|NCT00522379|589024376|FG002|Overall Study|Dispensing error|0|||
163086324|NCT00522379|589024377|FG003|Overall Study|Dispensing error|1|||
163086325|NCT00522379|589024378|FG004|Overall Study|Dispensing error|0|||
163334902|NCT01989104|589936134|FG004|Overall Study|Withdrawal by Subject|0|||
163334903|NCT02833948|589936135|FG000|Overall Study|Death|2|||
163334904|NCT02833948|589936136|FG001|Overall Study|Death|3|||
163334905|NCT02833948|589936135|FG000|Overall Study|were not scanned|8|||
163334906|NCT02833948|589936136|FG001|Overall Study|were not scanned|13|||
163334907|NCT02833948|589936135|FG000|Overall Study|scans could not be evaluated|5|||
163086326|NCT00522379|589024374|FG000|Overall Study|Subject Moved|1|||
163086327|NCT00522379|589024375|FG001|Overall Study|Subject Moved|1|||
163086328|NCT00522379|589024376|FG002|Overall Study|Subject Moved|0|||
163086329|NCT00522379|589024377|FG003|Overall Study|Subject Moved|0|||
163086330|NCT00522379|589024378|FG004|Overall Study|Subject Moved|0|||
163334908|NCT02833948|589936136|FG001|Overall Study|scans could not be evaluated|2|||
163086331|NCT00522379|589024374|FG000|Overall Study|Sponsor Request|0|||
163086332|NCT00522379|589024375|FG001|Overall Study|Sponsor Request|1|||
163086333|NCT00522379|589024376|FG002|Overall Study|Sponsor Request|0|||
163086334|NCT00522379|589024377|FG003|Overall Study|Sponsor Request|0|||
163086335|NCT00522379|589024378|FG004|Overall Study|Sponsor Request|0|||
163086336|NCT00522379|589024374|FG000|Overall Study|Family Problem|0|||
163086337|NCT00522379|589024375|FG001|Overall Study|Family Problem|0|||
163086338|NCT00522379|589024376|FG002|Overall Study|Family Problem|1|||
163086339|NCT00522379|589024377|FG003|Overall Study|Family Problem|0|||
163086340|NCT00522379|589024378|FG004|Overall Study|Family Problem|0|||
163086341|NCT00522379|589024374|FG000|Overall Study|Site Closed|0|||
163086342|NCT00522379|589024375|FG001|Overall Study|Site Closed|0|||
163086343|NCT00522379|589024376|FG002|Overall Study|Site Closed|0|||
163086344|NCT00522379|589024377|FG003|Overall Study|Site Closed|1|||
163086345|NCT00522379|589024378|FG004|Overall Study|Site Closed|0|||
163086346|NCT00522379|589024374|FG000|Overall Study|Subject Withdrawal|0|||
163086347|NCT00522379|589024375|FG001|Overall Study|Subject Withdrawal|0|||
163086348|NCT00522379|589024376|FG002|Overall Study|Subject Withdrawal|0|||
163086349|NCT00522379|589024377|FG003|Overall Study|Subject Withdrawal|1|||
163086350|NCT00522379|589024378|FG004|Overall Study|Subject Withdrawal|0|||
163086351|NCT03213509|589024379|FG000|Overall Study|Did not consent for verbal autopsy|4|||
163086352|NCT03213509|589024380|FG001|Overall Study|Did not consent for verbal autopsy|5|||
163086353|NCT04562090|589024381|FG000|Overall Study|Withdrawal by Subject|3|||
163086354|NCT04562090|589024382|FG001|Overall Study|Withdrawal by Subject|4|||
163086355|NCT04562090|589024381|FG000|Overall Study|Protocol Violation|2|||
163086356|NCT04562090|589024382|FG001|Overall Study|Protocol Violation|0|||
163086357|NCT04562090|589024381|FG000|Overall Study|Lack of Efficacy|0|||
163086358|NCT04562090|589024382|FG001|Overall Study|Lack of Efficacy|1|||
163086359|NCT04562090|589024381|FG000|Overall Study|Adverse Event|1|||
163086360|NCT04562090|589024382|FG001|Overall Study|Adverse Event|4|||
163086361|NCT04562090|589024381|FG000|Overall Study|Miscellaneous|0|||
163086362|NCT04562090|589024382|FG001|Overall Study|Miscellaneous|3|||
163086363|NCT00847730|589024383|FG000|Overall Study|Multiple interruptions in therapy|8|||
163086364|NCT00432965|589024384|FG000|Overall Study|Lost to Follow-up|22|||
163086365|NCT00432965|589024385|FG001|Overall Study|Lost to Follow-up|19|||
163086366|NCT00432965|589024384|FG000|Overall Study|Withdrawal by Subject|13|||
163086367|NCT00432965|589024385|FG001|Overall Study|Withdrawal by Subject|13|||
163086368|NCT00432965|589024384|FG000|Overall Study|Physician Decision|14|||
163086369|NCT00432965|589024385|FG001|Overall Study|Physician Decision|13|||
163086370|NCT00432965|589024384|FG000|Overall Study|Lack of Efficacy|8|||
163086371|NCT00432965|589024385|FG001|Overall Study|Lack of Efficacy|13|||
163086372|NCT00432965|589024384|FG000|Overall Study|Non-compliance|7|||
163086373|NCT00432965|589024385|FG001|Overall Study|Non-compliance|0|||
163086374|NCT00432965|589024384|FG000|Overall Study|Adverse Event|22|||
163086375|NCT00432965|589024385|FG001|Overall Study|Adverse Event|19|||
163086376|NCT00432965|589024384|FG000|Overall Study|Death|3|||
163086377|NCT00432965|589024385|FG001|Overall Study|Death|4|||
163086378|NCT00432965|589024384|FG000|Overall Study|Exclusionary Methods|1|||
163086379|NCT00432965|589024385|FG001|Overall Study|Exclusionary Methods|2|||
163086380|NCT00432965|589024384|FG000|Overall Study|Incomplete Data|4|||
163086381|NCT00432965|589024385|FG001|Overall Study|Incomplete Data|3|||
163086382|NCT01889251|589024386|FG000|Overall Study|Adverse Event|1|||
163086383|NCT01889251|589024387|FG001|Overall Study|Adverse Event|0|||
163086384|NCT01903863|589024388|FG000|Overall Study|Physician Decision|2|||
163086385|NCT01903863|589024389|FG001|Overall Study|Physician Decision|0|||
163086386|NCT01722669|589024396|FG000|Overall Study|Withdrawal by Subject|0|||
163086387|NCT01722669|589024397|FG001|Overall Study|Withdrawal by Subject|0|||
163086388|NCT01722669|589024398|FG002|Overall Study|Withdrawal by Subject|0|||
163086389|NCT01722669|589024399|FG003|Overall Study|Withdrawal by Subject|0|||
163086390|NCT01722669|589024400|FG004|Overall Study|Withdrawal by Subject|0|||
163086391|NCT01722669|589024401|FG005|Overall Study|Withdrawal by Subject|2|||
163086392|NCT01344226|589024402|FG000|Overall Study|Protocol Violation|2|||
163086393|NCT01344226|589024402|FG000|Overall Study|Withdrawal by Subject|3|||
163086394|NCT01344226|589024402|FG000|Overall Study|Lack of Efficacy|3|||
163086395|NCT03909971|589024409|FG000|Overall Study|Participant transition to rollover study|26|||
163086396|NCT03909971|589024410|FG001|Overall Study|Participant transition to rollover study|9|||
163086397|NCT03909971|589024409|FG000|Overall Study|Global Deterioration of Health Status|2|||
163086398|NCT03909971|589024410|FG001|Overall Study|Global Deterioration of Health Status|2|||
163086399|NCT03909971|589024409|FG000|Overall Study|Progressive Disease|28|||
163086400|NCT03909971|589024410|FG001|Overall Study|Progressive Disease|21|||
163086401|NCT03909971|589024409|FG000|Overall Study|Death|6|||
163086402|NCT03909971|589024410|FG001|Overall Study|Death|6|||
163086403|NCT03909971|589024409|FG000|Overall Study|Adverse Event|1|||
163086404|NCT03909971|589024410|FG001|Overall Study|Adverse Event|2|||
163086405|NCT03909971|589024409|FG000|Overall Study|Withdrawal by Subject|2|||
163086406|NCT03909971|589024410|FG001|Overall Study|Withdrawal by Subject|1|||
163086407|NCT03909971|589024409|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
163086408|NCT03909971|589024410|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
163036234|NCT01026818|588837887|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
163036235|NCT01026818|588837888|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
163036236|NCT01026818|588837889|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
163036237|NCT01026818|588837890|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
163036238|NCT01026818|588837887|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
163036239|NCT01026818|588837888|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
163036240|NCT01026818|588837889|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
163036241|NCT01026818|588837890|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
163036242|NCT01026818|588837887|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
163036243|NCT01026818|588837888|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
163036244|NCT01026818|588837889|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
163036245|NCT01026818|588837890|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
163036246|NCT01026818|588837887|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
163036247|NCT01026818|588837888|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
163036248|NCT01026818|588837889|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
163036249|NCT01026818|588837890|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
163036250|NCT01026818|588837887|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
163036251|NCT01026818|588837888|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
163036252|NCT01026818|588837889|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
163036253|NCT01026818|588837890|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
163036254|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
163036255|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
163036256|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
163036257|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
163036258|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
163036259|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
163036260|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
163036261|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
163036262|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
163036263|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
163036264|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
163036265|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
163036266|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
163036267|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
163036268|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
163036269|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
163036270|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
163036271|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
163036272|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
163036273|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
163036274|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
163036275|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
163036276|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
163036277|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
163036278|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
163036279|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
163036280|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
163036281|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
163036282|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
163036283|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
163036284|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
163036285|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
163036286|NCT01026818|588837887|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
163036287|NCT01026818|588837888|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
163036288|NCT01026818|588837889|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
163036289|NCT01026818|588837890|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
163036290|NCT01026818|588837887|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
163036291|NCT01026818|588837888|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
163036292|NCT01026818|588837889|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
163036293|NCT01026818|588837890|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
163036294|NCT01026818|588837887|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
163036295|NCT01026818|588837888|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
163036296|NCT01026818|588837889|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
163036297|NCT01026818|588837890|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
163036298|NCT01026818|588837887|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
163036299|NCT01026818|588837888|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
163086409|NCT03909971|589024409|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
163086410|NCT03909971|589024410|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
163086411|NCT04727151|589024414|FG000|Overall Study|Death|0|||
163086412|NCT04727151|589024415|FG001|Overall Study|Death|0|||
163086413|NCT04727151|589024416|FG002|Overall Study|Death|0|||
163086414|NCT04727151|589024417|FG003|Overall Study|Death|0|||
163086415|NCT04727151|589024418|FG004|Overall Study|Death|3|||
163086416|NCT04727151|589024414|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
163086417|NCT04727151|589024415|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
163086418|NCT04727151|589024416|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
163086419|NCT04727151|589024417|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
163086420|NCT04727151|589024418|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
163086421|NCT01587196|589024419|FG000|Overall Study|Lost to Follow-up|50|||
163086422|NCT01587196|589024419|FG000|Overall Study|Withdrawal by Subject|4|||
163086423|NCT00642759|589024420|FG000|Overall Study|Protocol Violation|1|||
163086424|NCT03612570|589024424|FG000|Overall Study|Lost to Follow-up|1|||
163086425|NCT05318287|589024429|FG000|Overall Study|Lost to Follow-up|8|||
163086426|NCT05185453|589024430|FG000|Overall Study|Lost to Follow-up|13|||
163086427|NCT05185453|589024431|FG001|Overall Study|Lost to Follow-up|3|||
163086428|NCT03537508|589024444|FG000|Overall Study|Adverse Event|2|||
163086429|NCT03537508|589024445|FG001|Overall Study|Adverse Event|1|||
163086430|NCT03537508|589024444|FG000|Overall Study|Protocol Violation|65|||
163086431|NCT03537508|589024445|FG001|Overall Study|Protocol Violation|48|||
163086432|NCT03537508|589024444|FG000|Overall Study|Lost to Follow-up|86|||
163086433|NCT03537508|589024445|FG001|Overall Study|Lost to Follow-up|60|||
163086434|NCT03537508|589024444|FG000|Overall Study|Withdrawal by parent/guardian|263|||
163086435|NCT03537508|589024445|FG001|Overall Study|Withdrawal by parent/guardian|149|||
163086436|NCT03814044|589024453|FG000|Overall Study|Protocol deviation|1|||
163086437|NCT02495883|589024465|FG000|Overall Study|Excessive head motion|1|||
163086438|NCT02495883|589024466|FG001|Overall Study|Excessive head motion|0|||
163086439|NCT00964678|589024470|FG000|Overall Study|Physician Decision|4|||
163086440|NCT03359395|589024471|FG000|First Intervention A / B|Withdrawal by Subject|1|||
163086441|NCT03359395|589024472|FG001|First Intervention A / B|Withdrawal by Subject|0|||
163086442|NCT03359395|589024471|FG000|First Intervention A / B|Lost to Follow-up|2|||
163086443|NCT03359395|589024472|FG001|First Intervention A / B|Lost to Follow-up|3|||
163086444|NCT03359395|589024471|FG000|Second Intervention B/A|Exclusion criteria|0|||
163086445|NCT03359395|589024472|FG001|Second Intervention B/A|Exclusion criteria|1|||
163086446|NCT03359395|589024471|FG000|Second Intervention B/A|Lost to Follow-up|3|||
163086447|NCT03359395|589024472|FG001|Second Intervention B/A|Lost to Follow-up|2|||
163086448|NCT01323192|589025943|FG000|Overall Study|Adverse Event|6|||
163086449|NCT01323192|589025944|FG001|Overall Study|Adverse Event|1|||
163086450|NCT01323192|589025943|FG000|Overall Study|Withdrawal by Subject|3|||
163086451|NCT01323192|589025944|FG001|Overall Study|Withdrawal by Subject|1|||
163086452|NCT01323192|589025943|FG000|Overall Study|Noncompliance with study medication|0|||
163086453|NCT01323192|589025944|FG001|Overall Study|Noncompliance with study medication|3|||
163086454|NCT01323192|589025943|FG000|Overall Study|Nonmedical reasons|0|||
163086455|NCT01323192|589025944|FG001|Overall Study|Nonmedical reasons|1|||
163086456|NCT03552029|589025945|FG000|Overall Study|Death|3|||
163086457|NCT03552029|589025946|FG001|Overall Study|Death|0|||
163086458|NCT03552029|589025945|FG000|Overall Study|Adverse Event|1|||
163086459|NCT03552029|589025946|FG001|Overall Study|Adverse Event|0|||
163086460|NCT03552029|589025945|FG000|Overall Study|Lack of Efficacy|0|||
163086461|NCT03552029|589025946|FG001|Overall Study|Lack of Efficacy|2|||
163086462|NCT03552029|589025945|FG000|Overall Study|Physician Decision|0|||
163086463|NCT03552029|589025946|FG001|Overall Study|Physician Decision|1|||
163086464|NCT03552029|589025945|FG000|Overall Study|Study terminated by Sponsor|0|||
163086465|NCT03552029|589025946|FG001|Overall Study|Study terminated by Sponsor|1|||
163086466|NCT03552029|589025945|FG000|Overall Study|Other|0|||
163086467|NCT03552029|589025946|FG001|Overall Study|Other|2|||
163086468|NCT01168596|589025949|FG000|Overall Study|Withdrawal by Subject|3|||
163086469|NCT01168596|589025950|FG001|Overall Study|Withdrawal by Subject|1|||
163086470|NCT01276704|589025951|FG000|Overall Study|Lost to Follow-up|2|||
163086471|NCT01276704|589025952|FG001|Overall Study|Lost to Follow-up|3|||
163086472|NCT01276704|589025951|FG000|Overall Study|Non-compliant|2|||
163086473|NCT01276704|589025952|FG001|Overall Study|Non-compliant|2|||
163086474|NCT01276704|589025951|FG000|Overall Study|Withdrawal by Subject|7|||
163086475|NCT01276704|589025952|FG001|Overall Study|Withdrawal by Subject|1|||
163086476|NCT01276704|589025951|FG000|Overall Study|Physician Decision|3|||
163086477|NCT01276704|589025952|FG001|Overall Study|Physician Decision|5|||
163086478|NCT00710593|589025953|FG000|Overall Study|Incarceration|1|||
163086479|NCT00710593|589025954|FG001|Overall Study|Incarceration|0|||
163086480|NCT00710593|589025953|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
163086481|NCT00710593|589025954|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
163086482|NCT00710593|589025953|FG000|Overall Study|Lost to Follow-up|3|||
163086483|NCT00710593|589025954|FG001|Overall Study|Lost to Follow-up|1|||
163086484|NCT00710593|589025953|FG000|Overall Study|Moved out of area|1|||
163086485|NCT00710593|589025954|FG001|Overall Study|Moved out of area|0|||
163406966|NCT01225731|590198788|FG008|Part 1|Did not meet eligibility criteria|0|||
163406967|NCT01225731|590198789|FG009|Part 1|Did not meet eligibility criteria|0|||
163406968|NCT01225731|590198790|FG010|Part 1|Did not meet eligibility criteria|0|||
163406969|NCT01225731|590198791|FG011|Part 1|Did not meet eligibility criteria|0|||
163406970|NCT01225731|590198792|FG012|Part 1|Did not meet eligibility criteria|0|||
163406971|NCT01225731|590198780|FG000|Part 1|Adverse Event|1|||
163406972|NCT01225731|590198781|FG001|Part 1|Adverse Event|2|||
163406973|NCT01225731|590198782|FG002|Part 1|Adverse Event|1|||
163406974|NCT01225731|590198783|FG003|Part 1|Adverse Event|1|||
163406975|NCT01225731|590198784|FG004|Part 1|Adverse Event|1|||
163406976|NCT01225731|590198785|FG005|Part 1|Adverse Event|0|||
163406977|NCT01225731|590198786|FG006|Part 1|Adverse Event|0|||
163406978|NCT01225731|590198787|FG007|Part 1|Adverse Event|0|||
163406979|NCT01225731|590198788|FG008|Part 1|Adverse Event|0|||
163406980|NCT01225731|590198789|FG009|Part 1|Adverse Event|0|||
163406981|NCT01225731|590198790|FG010|Part 1|Adverse Event|0|||
163406982|NCT01225731|590198791|FG011|Part 1|Adverse Event|0|||
163406983|NCT01225731|590198792|FG012|Part 1|Adverse Event|0|||
163406984|NCT01225731|590198780|FG000|Part 1|Withdrawal by Subject|0|||
163406985|NCT01225731|590198781|FG001|Part 1|Withdrawal by Subject|3|||
163406986|NCT01225731|590198782|FG002|Part 1|Withdrawal by Subject|0|||
163406987|NCT01225731|590198783|FG003|Part 1|Withdrawal by Subject|0|||
163406988|NCT01225731|590198784|FG004|Part 1|Withdrawal by Subject|4|||
163406989|NCT01225731|590198785|FG005|Part 1|Withdrawal by Subject|0|||
163406990|NCT01225731|590198786|FG006|Part 1|Withdrawal by Subject|0|||
163406991|NCT01225731|590198787|FG007|Part 1|Withdrawal by Subject|0|||
163406992|NCT01225731|590198788|FG008|Part 1|Withdrawal by Subject|0|||
163406993|NCT01225731|590198789|FG009|Part 1|Withdrawal by Subject|0|||
163406994|NCT01225731|590198790|FG010|Part 1|Withdrawal by Subject|0|||
163406995|NCT01225731|590198791|FG011|Part 1|Withdrawal by Subject|0|||
163406996|NCT01225731|590198792|FG012|Part 1|Withdrawal by Subject|0|||
163406997|NCT01225731|590198780|FG000|Part 1|Protocol Violation|0|||
163406998|NCT01225731|590198781|FG001|Part 1|Protocol Violation|0|||
163406999|NCT01225731|590198782|FG002|Part 1|Protocol Violation|0|||
163407000|NCT01225731|590198783|FG003|Part 1|Protocol Violation|1|||
163407001|NCT01225731|590198784|FG004|Part 1|Protocol Violation|0|||
163407002|NCT01225731|590198785|FG005|Part 1|Protocol Violation|0|||
163407003|NCT01225731|590198786|FG006|Part 1|Protocol Violation|0|||
163407004|NCT01225731|590198787|FG007|Part 1|Protocol Violation|0|||
163407005|NCT01225731|590198788|FG008|Part 1|Protocol Violation|0|||
163036300|NCT01026818|588837889|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
163036301|NCT01026818|588837890|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
163036302|NCT01026818|588837887|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
163036303|NCT01026818|588837888|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
163036304|NCT01026818|588837889|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
163036305|NCT01026818|588837890|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
163036306|NCT01375374|588837891|FG000|Overall Study|Adverse Event|1|||
163036307|NCT01908582|588837892|FG000|Period 2|Physician Decision|1|||
163036308|NCT01908582|588837892|FG000|Period 2|Withdrawal by Subject|1|||
163036309|NCT00424593|588837893|FG000|Acute Double-Blind Period|Adverse Event|16|||
163036310|NCT00424593|588837894|FG001|Acute Double-Blind Period|Adverse Event|7|||
163036311|NCT00424593|588837893|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
163036312|NCT00424593|588837894|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
163036313|NCT00424593|588837893|FG000|Acute Double-Blind Period|Protocol Violation|2|||
163036314|NCT00424593|588837894|FG001|Acute Double-Blind Period|Protocol Violation|2|||
163036315|NCT00424593|588837893|FG000|Acute Double-Blind Period|Physician Decision|1|||
163036316|NCT00424593|588837894|FG001|Acute Double-Blind Period|Physician Decision|2|||
163036317|NCT00424593|588837893|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
163036318|NCT00424593|588837894|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
163036319|NCT00424593|588837893|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
163036320|NCT00424593|588837894|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
163036321|NCT00424593|588837893|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
163407006|NCT01225731|590198789|FG009|Part 1|Protocol Violation|0|||
163407007|NCT01225731|590198790|FG010|Part 1|Protocol Violation|0|||
163407008|NCT01225731|590198791|FG011|Part 1|Protocol Violation|0|||
163407009|NCT01225731|590198792|FG012|Part 1|Protocol Violation|0|||
163407010|NCT01225731|590198780|FG000|Part 2|Protocol Violation|0|||
163407011|NCT01225731|590198781|FG001|Part 2|Protocol Violation|0|||
163407012|NCT01225731|590198782|FG002|Part 2|Protocol Violation|0|||
163407013|NCT01225731|590198783|FG003|Part 2|Protocol Violation|0|||
163407014|NCT01225731|590198784|FG004|Part 2|Protocol Violation|0|||
163407015|NCT01225731|590198785|FG005|Part 2|Protocol Violation|1|||
163407016|NCT01225731|590198786|FG006|Part 2|Protocol Violation|0|||
163407017|NCT01225731|590198787|FG007|Part 2|Protocol Violation|0|||
163407018|NCT01225731|590198788|FG008|Part 2|Protocol Violation|1|||
163036322|NCT00424593|588837894|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
163036323|NCT00424593|588837893|FG000|Dose-Blind Extension Period|Adverse Event|18|||
163407019|NCT01225731|590198789|FG009|Part 2|Protocol Violation|0|||
163407020|NCT01225731|590198790|FG010|Part 2|Protocol Violation|0|||
163407021|NCT01225731|590198791|FG011|Part 2|Protocol Violation|0|||
163086486|NCT00710593|589025953|FG000|Overall Study|Failure to adhere or complete study eval|1|||
163086487|NCT00710593|589025954|FG001|Overall Study|Failure to adhere or complete study eval|1|||
163086488|NCT00710593|589025953|FG000|Overall Study|Protocol Violation|1|||
163086489|NCT00710593|589025954|FG001|Overall Study|Protocol Violation|1|||
163086490|NCT00710593|589025953|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
163086491|NCT00710593|589025954|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
163086492|NCT04490278|589025955|FG000|Overall Study|Lost to Follow-up|6|||
163086493|NCT00183248|589025965|FG000|Overall Study|Lost to Follow-up|0|||
163086494|NCT00183248|589025966|FG001|Overall Study|Lost to Follow-up|1|||
163086495|NCT00183248|589025965|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
163086496|NCT00183248|589025966|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
163086497|NCT03801525|589025967|FG000|Overall Study|Adverse Event|17|||
163086498|NCT03801525|589025968|FG001|Overall Study|Adverse Event|1|||
163086499|NCT03801525|589025969|FG002|Overall Study|Adverse Event|0|||
163086500|NCT03801525|589025967|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
163086501|NCT03801525|589025968|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
163086502|NCT03801525|589025969|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
163036324|NCT00424593|588837894|FG001|Dose-Blind Extension Period|Adverse Event|0|||
163036325|NCT00424593|588837893|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
163036326|NCT00424593|588837894|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
163036327|NCT00424593|588837893|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
163036328|NCT00424593|588837894|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
163036329|NCT00424593|588837893|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
163036330|NCT00424593|588837894|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
163036331|NCT00424593|588837893|FG000|Dose-Blind Extension Period|Physician Decision|3|||
163036332|NCT00424593|588837894|FG001|Dose-Blind Extension Period|Physician Decision|0|||
163036333|NCT01066663|588837895|FG000|Overall Study|Adverse Event|0|||
163086503|NCT03801525|589025967|FG000|Overall Study|Death|29|||
163086504|NCT03801525|589025968|FG001|Overall Study|Death|1|||
163086505|NCT03801525|589025969|FG002|Overall Study|Death|4|||
163086506|NCT03801525|589025967|FG000|Overall Study|Disease Progression|6|||
163036334|NCT01066663|588837896|FG001|Overall Study|Adverse Event|0|||
163036335|NCT01066663|588837897|FG002|Overall Study|Adverse Event|1|||
163086507|NCT03801525|589025968|FG001|Overall Study|Disease Progression|0|||
163086508|NCT03801525|589025969|FG002|Overall Study|Disease Progression|1|||
163086509|NCT03801525|589025967|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
163086510|NCT03801525|589025968|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
163086511|NCT03801525|589025969|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
163086512|NCT03801525|589025967|FG000|Overall Study|Investigator Decision|18|||
163086513|NCT03801525|589025968|FG001|Overall Study|Investigator Decision|1|||
163086514|NCT03801525|589025969|FG002|Overall Study|Investigator Decision|0|||
163086515|NCT03801525|589025967|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
163086516|NCT03801525|589025968|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
163086517|NCT03801525|589025969|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
163086518|NCT03801525|589025967|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
163086519|NCT03801525|589025968|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
163086520|NCT03801525|589025969|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
163086521|NCT03801525|589025967|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
163086522|NCT03801525|589025968|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
163086523|NCT03801525|589025969|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
163086524|NCT03801525|589025967|FG000|Overall Study|Withdrawal of Subject Consent|38|||
163086525|NCT03801525|589025968|FG001|Overall Study|Withdrawal of Subject Consent|2|||
163086526|NCT03801525|589025969|FG002|Overall Study|Withdrawal of Subject Consent|1|||
163036336|NCT02232061|588837898|FG000|Overall Study|Administrative problems|1|||
163036337|NCT02232061|588837898|FG000|Overall Study|Withdrawal by Subject|1|||
163036338|NCT03297021|588837899|FG000|Overall Study|Incomplete/illegible data sheet|4|||
163036339|NCT03297021|588837900|FG001|Overall Study|Incomplete/illegible data sheet|2|||
163036340|NCT03297021|588837901|FG002|Overall Study|Incomplete/illegible data sheet|3|||
163036341|NCT03297021|588837899|FG000|Overall Study|Missing Post-Op Data|1|||
163036342|NCT03297021|588837900|FG001|Overall Study|Missing Post-Op Data|2|||
163036343|NCT03297021|588837901|FG002|Overall Study|Missing Post-Op Data|1|||
163036344|NCT02784288|588837902|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
163086527|NCT03801525|589025967|FG000|Overall Study|Reason not Specified|4|||
163086528|NCT03801525|589025968|FG001|Overall Study|Reason not Specified|0|||
163036345|NCT00560703|588837903|FG000|Overall Study|Adverse Event|0|||
163036346|NCT00560703|588837904|FG001|Overall Study|Adverse Event|2|||
163036347|NCT00560703|588837903|FG000|Overall Study|Protocol Violation|0|||
163036348|NCT00560703|588837904|FG001|Overall Study|Protocol Violation|2|||
163407022|NCT01225731|590198792|FG012|Part 2|Protocol Violation|0|||
163036349|NCT00560703|588837903|FG000|Overall Study|Withdrawal by Subject|0|||
163036350|NCT00560703|588837904|FG001|Overall Study|Withdrawal by Subject|1|||
163334909|NCT00680771|589936139|FG000|Overall Study|Withdrawal by Subject|1|||
163086529|NCT03801525|589025969|FG002|Overall Study|Reason not Specified|4|||
163086530|NCT03309202|589025970|FG000|Overall Study|Lost to Follow-up|1|||
163086531|NCT03309202|589025971|FG001|Overall Study|Lost to Follow-up|0|||
163086532|NCT03309202|589025972|FG002|Overall Study|Lost to Follow-up|0|||
163086533|NCT03309202|589025973|FG003|Overall Study|Lost to Follow-up|0|||
163086534|NCT03243084|589025975|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
163086535|NCT03243084|589025976|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
163086536|NCT01500317|589025982|FG000|Overall Study|Withdrawal by Subject|3|||
163086537|NCT01500317|589025983|FG001|Overall Study|Withdrawal by Subject|2|||
163086538|NCT01500317|589025984|FG002|Overall Study|Withdrawal by Subject|0|||
163086539|NCT00335829|589025985|FG000|Overall Study|Withdrawal by Subject|1|||
163334910|NCT00680771|589936140|FG001|Overall Study|Withdrawal by Subject|0|||
163334911|NCT00680771|589936139|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
163334912|NCT00680771|589936140|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
163334913|NCT00680771|589936139|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
163334914|NCT00680771|589936140|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
163334915|NCT02691702|589936141|FG000|Overall Study|Adverse Event|1|||
163334916|NCT02691702|589936142|FG001|Overall Study|Adverse Event|0|||
163334917|NCT02691702|589936143|FG002|Overall Study|Adverse Event|0|||
163334918|NCT02691702|589936144|FG003|Overall Study|Adverse Event|0|||
163334919|NCT02691702|589936145|FG004|Overall Study|Adverse Event|0|||
163334920|NCT02691702|589936146|FG005|Overall Study|Adverse Event|0|||
163334921|NCT02691702|589936147|FG006|Overall Study|Adverse Event|0|||
163334922|NCT02691702|589936148|FG007|Overall Study|Adverse Event|0|||
163334923|NCT02691702|589936149|FG008|Overall Study|Adverse Event|1|||
163334924|NCT02691702|589936150|FG009|Overall Study|Adverse Event|0|||
163334925|NCT02691702|589936151|FG010|Overall Study|Adverse Event|1|||
163334926|NCT02691702|589936141|FG000|Overall Study|Lost to Follow-up|0|||
163334927|NCT02691702|589936142|FG001|Overall Study|Lost to Follow-up|0|||
163334928|NCT02691702|589936143|FG002|Overall Study|Lost to Follow-up|1|||
163334929|NCT02691702|589936144|FG003|Overall Study|Lost to Follow-up|0|||
163334930|NCT02691702|589936145|FG004|Overall Study|Lost to Follow-up|0|||
163334931|NCT02691702|589936146|FG005|Overall Study|Lost to Follow-up|2|||
163334932|NCT02691702|589936147|FG006|Overall Study|Lost to Follow-up|0|||
163334933|NCT02691702|589936148|FG007|Overall Study|Lost to Follow-up|0|||
163334934|NCT02691702|589936149|FG008|Overall Study|Lost to Follow-up|0|||
163334935|NCT02691702|589936150|FG009|Overall Study|Lost to Follow-up|0|||
163334936|NCT02691702|589936151|FG010|Overall Study|Lost to Follow-up|1|||
163334937|NCT02691702|589936141|FG000|Overall Study|Withdrawal by Subject|1|||
163334938|NCT02691702|589936142|FG001|Overall Study|Withdrawal by Subject|1|||
163334939|NCT02691702|589936143|FG002|Overall Study|Withdrawal by Subject|0|||
163334940|NCT02691702|589936144|FG003|Overall Study|Withdrawal by Subject|0|||
163334941|NCT02691702|589936145|FG004|Overall Study|Withdrawal by Subject|0|||
163334942|NCT02691702|589936146|FG005|Overall Study|Withdrawal by Subject|1|||
163334943|NCT02691702|589936147|FG006|Overall Study|Withdrawal by Subject|2|||
163334944|NCT02691702|589936148|FG007|Overall Study|Withdrawal by Subject|0|||
163334945|NCT02691702|589936149|FG008|Overall Study|Withdrawal by Subject|0|||
163334946|NCT02691702|589936150|FG009|Overall Study|Withdrawal by Subject|0|||
163334947|NCT02691702|589936151|FG010|Overall Study|Withdrawal by Subject|0|||
163334948|NCT02691702|589936141|FG000|Overall Study|Other|0|||
163334949|NCT02691702|589936142|FG001|Overall Study|Other|0|||
163334950|NCT02691702|589936143|FG002|Overall Study|Other|0|||
163334951|NCT02691702|589936144|FG003|Overall Study|Other|0|||
163334952|NCT02691702|589936145|FG004|Overall Study|Other|0|||
163334953|NCT02691702|589936146|FG005|Overall Study|Other|0|||
163334954|NCT02691702|589936147|FG006|Overall Study|Other|1|||
163334955|NCT02691702|589936148|FG007|Overall Study|Other|0|||
163334956|NCT02691702|589936149|FG008|Overall Study|Other|1|||
163086540|NCT00335829|589025985|FG000|Overall Study|Lost to Follow-up|1|||
163334957|NCT02691702|589936150|FG009|Overall Study|Other|0|||
163334958|NCT02691702|589936151|FG010|Overall Study|Other|0|||
163334959|NCT02691702|589936141|FG000|Overall Study|Protocol Violation|0|||
163334960|NCT02691702|589936142|FG001|Overall Study|Protocol Violation|0|||
163334961|NCT02691702|589936143|FG002|Overall Study|Protocol Violation|0|||
163334962|NCT02691702|589936144|FG003|Overall Study|Protocol Violation|0|||
163334963|NCT02691702|589936145|FG004|Overall Study|Protocol Violation|0|||
163334964|NCT02691702|589936146|FG005|Overall Study|Protocol Violation|0|||
163334965|NCT02691702|589936147|FG006|Overall Study|Protocol Violation|0|||
163334966|NCT02691702|589936148|FG007|Overall Study|Protocol Violation|0|||
163334967|NCT02691702|589936149|FG008|Overall Study|Protocol Violation|0|||
163334968|NCT02691702|589936150|FG009|Overall Study|Protocol Violation|2|||
163086541|NCT00335829|589025985|FG000|Overall Study|Adverse Event|1|||
163086542|NCT04562116|589025986|FG000|Overall Study|Lost to Follow-up|1|||
163086543|NCT04562116|589025986|FG000|Overall Study|Withdrawal by Subject|3|||
163086544|NCT01559935|589025987|FG000|Car Phase|Toxicity|4|||
163334969|NCT02691702|589936151|FG010|Overall Study|Protocol Violation|0|||
163334970|NCT05613088|589936152|FG000|Treatment|Ongoing Study Treatment|9|||
163334971|NCT05613088|589936153|FG001|Treatment|Ongoing Study Treatment|2|||
163334972|NCT05613088|589936152|FG000|Treatment|Adverse Event|3|||
163407023|NCT01225731|590198780|FG000|Part 2|Adverse Event|0|||
163036351|NCT00560703|588837903|FG000|Overall Study|non-compliance|0|||
163036352|NCT00560703|588837904|FG001|Overall Study|non-compliance|1|||
163036353|NCT02095197|588837905|FG000|Overall Study|Lost to Follow-up|0|||
163036354|NCT02095197|588837906|FG001|Overall Study|Lost to Follow-up|3|||
163036355|NCT04278924|588837908|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
163036356|NCT04278924|588837909|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
163036357|NCT04278924|588837910|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
163036358|NCT04278924|588837911|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
163036359|NCT04278924|588837912|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
163036360|NCT04278924|588837913|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
163036361|NCT04278924|588837914|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
163036362|NCT04278924|588837908|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
163036363|NCT04278924|588837909|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
163036364|NCT04278924|588837910|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
163036365|NCT04278924|588837911|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
163036366|NCT04278924|588837912|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
163036367|NCT04278924|588837913|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
163036368|NCT04278924|588837914|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
163036369|NCT04847232|588837915|FG000|Overall Study|Death|123|||
163036370|NCT04847232|588837916|FG001|Overall Study|Death|115|||
163036371|NCT04847232|588837915|FG000|Overall Study|Lost to Follow-up|3|||
163036372|NCT04847232|588837916|FG001|Overall Study|Lost to Follow-up|10|||
163036373|NCT04847232|588837915|FG000|Overall Study|Withdrawal by Subject|73|||
163036374|NCT04847232|588837916|FG001|Overall Study|Withdrawal by Subject|101|||
163036375|NCT04847232|588837915|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
163036376|NCT04847232|588837916|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
163036377|NCT02476916|588837917|FG000|Core Period|Adverse Event|2|||
163036378|NCT02476916|588837918|FG001|Core Period|Adverse Event|2|||
163036379|NCT02476916|588837917|FG000|Core Period|Investigator decision|1|||
163036380|NCT02476916|588837918|FG001|Core Period|Investigator decision|1|||
163036381|NCT02476916|588837917|FG000|Core Period|Withdrawal by Subject|3|||
163036382|NCT02476916|588837918|FG001|Core Period|Withdrawal by Subject|0|||
163036383|NCT02476916|588837917|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
163036384|NCT02476916|588837918|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
163036385|NCT02476916|588837917|FG000|Extension Period|On Treatment|12|||
163036386|NCT02476916|588837918|FG001|Extension Period|On Treatment|17|||
163036387|NCT06010732|588837919|FG000|Crossover Period 1|Protocol Violation|0|||
163036388|NCT06010732|588837920|FG001|Crossover Period 1|Protocol Violation|0|||
163036389|NCT06010732|588837921|FG002|Crossover Period 1|Protocol Violation|1|||
163036390|NCT06010732|588837922|FG003|Crossover Period 1|Protocol Violation|0|||
163036391|NCT06010732|588837923|FG004|Crossover Period 1|Protocol Violation|1|||
163036392|NCT06010732|588837924|FG005|Crossover Period 1|Protocol Violation|0|||
163036393|NCT06010732|588837919|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
163036394|NCT06010732|588837920|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
163036395|NCT06010732|588837921|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
163036396|NCT06010732|588837922|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
163036397|NCT06010732|588837923|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
163036398|NCT06010732|588837924|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
163036399|NCT06010732|588837919|FG000|Crossover Period 2|Adverse Event|0|||
163036400|NCT06010732|588837920|FG001|Crossover Period 2|Adverse Event|1|||
163036401|NCT06010732|588837921|FG002|Crossover Period 2|Adverse Event|0|||
163036402|NCT06010732|588837922|FG003|Crossover Period 2|Adverse Event|0|||
163036403|NCT06010732|588837923|FG004|Crossover Period 2|Adverse Event|0|||
163036404|NCT06010732|588837924|FG005|Crossover Period 2|Adverse Event|0|||
163036405|NCT06010732|588837919|FG000|Crossover Period 2|broken denture|0|||
163036406|NCT06010732|588837920|FG001|Crossover Period 2|broken denture|0|||
163036407|NCT06010732|588837921|FG002|Crossover Period 2|broken denture|1|||
163036408|NCT06010732|588837922|FG003|Crossover Period 2|broken denture|0|||
163036409|NCT06010732|588837923|FG004|Crossover Period 2|broken denture|0|||
163036410|NCT06010732|588837924|FG005|Crossover Period 2|broken denture|0|||
163036411|NCT00253370|588837926|FG000|Overall Study|Adverse Event|18|||
163036412|NCT00253370|588837926|FG000|Overall Study|Disease progression|13|||
163036413|NCT00253370|588837926|FG000|Overall Study|Death|2|||
163036414|NCT00253370|588837926|FG000|Overall Study|Withdrawal by Subject|6|||
163036415|NCT00253370|588837926|FG000|Overall Study|Non-protocol therapy|1|||
163036416|NCT00253370|588837926|FG000|Overall Study|Physician Decision|1|||
163036417|NCT00253370|588837926|FG000|Overall Study|Protocol Violation|1|||
163036418|NCT00253370|588837926|FG000|Overall Study|Abdominal pain due to disease|1|||
163036419|NCT03699540|588837927|FG000|Overall Study|Lost to Follow-up|1|||
163036420|NCT02697591|588837928|FG000|Overall Study|Lost to Follow-up|0|||
163036421|NCT02697591|588837929|FG001|Overall Study|Lost to Follow-up|0|||
163036422|NCT02697591|588837930|FG002|Overall Study|Lost to Follow-up|0|||
163036423|NCT02697591|588837931|FG003|Overall Study|Lost to Follow-up|0|||
163036424|NCT02697591|588837932|FG004|Overall Study|Lost to Follow-up|0|||
163036425|NCT02697591|588837933|FG005|Overall Study|Lost to Follow-up|1|||
163036426|NCT02697591|588837934|FG006|Overall Study|Lost to Follow-up|1|||
163036427|NCT02697591|588837935|FG007|Overall Study|Lost to Follow-up|0|||
163036428|NCT02697591|588837936|FG008|Overall Study|Lost to Follow-up|0|||
163036429|NCT02697591|588837937|FG009|Overall Study|Lost to Follow-up|1|||
163036430|NCT02697591|588837928|FG000|Overall Study|Withdrawal by Subject|1|||
163036431|NCT02697591|588837929|FG001|Overall Study|Withdrawal by Subject|1|||
163036432|NCT02697591|588837930|FG002|Overall Study|Withdrawal by Subject|2|||
163036433|NCT02697591|588837931|FG003|Overall Study|Withdrawal by Subject|1|||
163036434|NCT02697591|588837932|FG004|Overall Study|Withdrawal by Subject|7|||
163036435|NCT02697591|588837933|FG005|Overall Study|Withdrawal by Subject|6|||
163036436|NCT02697591|588837934|FG006|Overall Study|Withdrawal by Subject|9|||
163036437|NCT02697591|588837935|FG007|Overall Study|Withdrawal by Subject|1|||
163036438|NCT02697591|588837936|FG008|Overall Study|Withdrawal by Subject|6|||
163036439|NCT02697591|588837937|FG009|Overall Study|Withdrawal by Subject|10|||
163036440|NCT02697591|588837928|FG000|Overall Study|Physician Decision|1|||
163036441|NCT02697591|588837929|FG001|Overall Study|Physician Decision|0|||
163036442|NCT02697591|588837930|FG002|Overall Study|Physician Decision|0|||
163036443|NCT02697591|588837931|FG003|Overall Study|Physician Decision|0|||
163036444|NCT02697591|588837932|FG004|Overall Study|Physician Decision|1|||
163036445|NCT02697591|588837933|FG005|Overall Study|Physician Decision|2|||
163036446|NCT02697591|588837934|FG006|Overall Study|Physician Decision|0|||
163036447|NCT02697591|588837935|FG007|Overall Study|Physician Decision|0|||
163036448|NCT02697591|588837936|FG008|Overall Study|Physician Decision|1|||
163036449|NCT02697591|588837937|FG009|Overall Study|Physician Decision|1|||
163036450|NCT02697591|588837928|FG000|Overall Study|Death|2|||
163036451|NCT02697591|588837929|FG001|Overall Study|Death|3|||
163036452|NCT02697591|588837930|FG002|Overall Study|Death|1|||
163036453|NCT02697591|588837931|FG003|Overall Study|Death|1|||
163036454|NCT02697591|588837932|FG004|Overall Study|Death|4|||
163036455|NCT02697591|588837933|FG005|Overall Study|Death|5|||
163036456|NCT02697591|588837934|FG006|Overall Study|Death|3|||
163036457|NCT02697591|588837935|FG007|Overall Study|Death|1|||
163036458|NCT02697591|588837936|FG008|Overall Study|Death|1|||
163036459|NCT02697591|588837937|FG009|Overall Study|Death|5|||
163036460|NCT02697591|588837928|FG000|Overall Study|Reason not Specified|0|||
163036461|NCT02697591|588837929|FG001|Overall Study|Reason not Specified|0|||
163036462|NCT02697591|588837930|FG002|Overall Study|Reason not Specified|0|||
163036463|NCT02697591|588837931|FG003|Overall Study|Reason not Specified|1|||
163036464|NCT02697591|588837932|FG004|Overall Study|Reason not Specified|1|||
163036465|NCT02697591|588837933|FG005|Overall Study|Reason not Specified|2|||
163036466|NCT02697591|588837934|FG006|Overall Study|Reason not Specified|3|||
163036467|NCT02697591|588837935|FG007|Overall Study|Reason not Specified|1|||
163036468|NCT02697591|588837936|FG008|Overall Study|Reason not Specified|1|||
163036469|NCT02697591|588837937|FG009|Overall Study|Reason not Specified|3|||
163036470|NCT00624832|588837938|FG000|Overall Study|Adverse Event|0|||
163036471|NCT00624832|588837939|FG001|Overall Study|Adverse Event|1|||
163036472|NCT00624832|588837940|FG002|Overall Study|Adverse Event|0|||
163036473|NCT00624832|588837941|FG003|Overall Study|Adverse Event|1|||
163036474|NCT00624832|588837938|FG000|Overall Study|Abnormal Laboratory Value|2|||
163036475|NCT00624832|588837939|FG001|Overall Study|Abnormal Laboratory Value|0|||
163036476|NCT00624832|588837940|FG002|Overall Study|Abnormal Laboratory Value|0|||
163036477|NCT00624832|588837941|FG003|Overall Study|Abnormal Laboratory Value|0|||
163036478|NCT01939223|588837942|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
163036479|NCT01939223|588837943|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
163036480|NCT01939223|588837942|FG000|Overall Study|Disease recurrence (radiological)|1|||
163036481|NCT01939223|588837943|FG001|Overall Study|Disease recurrence (radiological)|3|||
163036482|NCT01939223|588837942|FG000|Overall Study|Study stopped by Sponsor|5|||
163036483|NCT01939223|588837943|FG001|Overall Study|Study stopped by Sponsor|7|||
163036484|NCT01939223|588837942|FG000|Overall Study|Withdrawal by Subject|6|||
163036485|NCT01939223|588837943|FG001|Overall Study|Withdrawal by Subject|0|||
163036486|NCT04379700|588837944|FG000|Overall Study|Withdrawal by Subject|10|||
163036487|NCT04379700|588837944|FG000|Overall Study|Screen Fail|4|||
163036488|NCT04379700|588837944|FG000|Overall Study|Lost to Follow-up|3|||
163036489|NCT01464619|588837948|FG000|Overall Study|Lost to Follow-up|3|||
163036490|NCT01464619|588837949|FG001|Overall Study|Lost to Follow-up|4|||
163036491|NCT01048099|588837956|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
163036492|NCT01048099|588837956|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
163036493|NCT01731470|588837958|FG000|Overall Study|Withdrawal by Subject|1|||
163036494|NCT01731470|588837958|FG000|Overall Study|Did not meet study criteria|1|||
163036495|NCT02258334|588837961|FG000|Overall Study|Adverse Event|1|||
163036496|NCT02258334|588837962|FG001|Overall Study|Adverse Event|0|||
163036497|NCT02258334|588837963|FG002|Overall Study|Adverse Event|0|||
163036498|NCT02258334|588837964|FG003|Overall Study|Adverse Event|0|||
163036499|NCT03564795|588837971|FG000|Overall Study|Withdrawal by Subject|3|||
163036500|NCT03564795|588837971|FG000|Overall Study|Lost to Follow-up|6|||
163036501|NCT03564795|588837971|FG000|Overall Study|Physician Decision|2|||
163036502|NCT05079230|588837972|FG000|Overall Study|Study Terminated by Sponsor|101|||
163407024|NCT01225731|590198781|FG001|Part 2|Adverse Event|0|||
163407025|NCT01225731|590198782|FG002|Part 2|Adverse Event|0|||
163407026|NCT01225731|590198783|FG003|Part 2|Adverse Event|0|||
163407027|NCT01225731|590198784|FG004|Part 2|Adverse Event|0|||
163407028|NCT01225731|590198785|FG005|Part 2|Adverse Event|0|||
163407029|NCT01225731|590198786|FG006|Part 2|Adverse Event|4|||
163407030|NCT01225731|590198787|FG007|Part 2|Adverse Event|4|||
163407031|NCT01225731|590198788|FG008|Part 2|Adverse Event|2|||
163407032|NCT01225731|590198789|FG009|Part 2|Adverse Event|0|||
163407033|NCT01225731|590198790|FG010|Part 2|Adverse Event|0|||
163407034|NCT01225731|590198791|FG011|Part 2|Adverse Event|0|||
163407035|NCT01225731|590198792|FG012|Part 2|Adverse Event|0|||
163407036|NCT01225731|590198780|FG000|Part 2|Lack of Efficacy|0|||
163407037|NCT01225731|590198781|FG001|Part 2|Lack of Efficacy|0|||
163407038|NCT01225731|590198782|FG002|Part 2|Lack of Efficacy|0|||
163407039|NCT01225731|590198783|FG003|Part 2|Lack of Efficacy|0|||
163407040|NCT01225731|590198784|FG004|Part 2|Lack of Efficacy|0|||
163407041|NCT01225731|590198785|FG005|Part 2|Lack of Efficacy|1|||
163407042|NCT01225731|590198786|FG006|Part 2|Lack of Efficacy|0|||
163407043|NCT01225731|590198787|FG007|Part 2|Lack of Efficacy|12|||
163407044|NCT01225731|590198788|FG008|Part 2|Lack of Efficacy|3|||
163407045|NCT01225731|590198789|FG009|Part 2|Lack of Efficacy|0|||
163407046|NCT01225731|590198790|FG010|Part 2|Lack of Efficacy|0|||
163407047|NCT01225731|590198791|FG011|Part 2|Lack of Efficacy|0|||
163407048|NCT01225731|590198792|FG012|Part 2|Lack of Efficacy|0|||
163407049|NCT01225731|590198780|FG000|Part 2|Pregnancy|0|||
163407050|NCT01225731|590198781|FG001|Part 2|Pregnancy|0|||
163407051|NCT01225731|590198782|FG002|Part 2|Pregnancy|0|||
163407052|NCT01225731|590198783|FG003|Part 2|Pregnancy|0|||
163407053|NCT01225731|590198784|FG004|Part 2|Pregnancy|0|||
163407054|NCT01225731|590198785|FG005|Part 2|Pregnancy|0|||
163086545|NCT01559935|589025987|FG000|Car Phase|Death|1|||
163086546|NCT01559935|589025987|FG000|Car Phase|Lack of Efficacy|2|||
163086547|NCT01559935|589025987|FG000|Car Phase|Lost to Follow-up|1|||
163086548|NCT01559935|589025987|FG000|Car Phase|Physician Decision|1|||
163086549|NCT01559935|589025987|FG000|Car Phase|Withdrawal by Subject|2|||
163086550|NCT01559935|589025987|FG000|Car Phase|Per protocol|1|||
163086551|NCT01559935|589025987|FG000|Car Phase|Insurance|1|||
163086552|NCT01559935|589025987|FG000|Car Phase|non-compliance|1|||
163086553|NCT01559935|589025987|FG000|BiRD Phase|Toxicity|1|||
163086554|NCT01559935|589025987|FG000|BiRD Phase|Lack of Efficacy|1|||
163086555|NCT01559935|589025987|FG000|BiRD Phase|Withdrawal by Subject|2|||
163086556|NCT01559935|589025987|FG000|Maintenance Phase|Remains on study|28|||
163086557|NCT01559935|589025987|FG000|Maintenance Phase|Toxicity|1|||
163086558|NCT01559935|589025987|FG000|Maintenance Phase|Lack of Efficacy|18|||
163086559|NCT01559935|589025987|FG000|Maintenance Phase|Withdrawal by Subject|5|||
163086560|NCT01559935|589025987|FG000|Maintenance Phase|Non-compliance|2|||
163086561|NCT03078868|589025989|FG000|Overall Study|Physician Decision|3|||
163086562|NCT00105066|589025993|FG000|Overall Study|Adverse Event|2|||
163086563|NCT00105066|589025994|FG001|Overall Study|Adverse Event|5|||
163086564|NCT01506726|589025999|FG000|Overall Study|Adverse Event|1|||
163086565|NCT01506726|589026000|FG001|Overall Study|Adverse Event|2|||
163086566|NCT02231580|589026007|FG000|Overall Study|Adverse Event|5|||
163086567|NCT02231580|589026008|FG001|Overall Study|Adverse Event|0|||
163086568|NCT04079738|589026010|FG000|Study Treatment|Death|1|||
163086569|NCT04079738|589026011|FG001|Study Treatment|Death|0|||
163086570|NCT04079738|589026012|FG002|Study Treatment|Death|0|||
163086571|NCT04079738|589026013|FG003|Study Treatment|Death|0|||
163086572|NCT04079738|589026010|FG000|Study Treatment|Adverse Event|2|||
163086573|NCT04079738|589026011|FG001|Study Treatment|Adverse Event|0|||
163086574|NCT04079738|589026012|FG002|Study Treatment|Adverse Event|0|||
163086575|NCT04079738|589026013|FG003|Study Treatment|Adverse Event|0|||
163086576|NCT04079738|589026010|FG000|Study Treatment|withdrawal before treatment|1|||
163086577|NCT04079738|589026011|FG001|Study Treatment|withdrawal before treatment|0|||
163086578|NCT04079738|589026012|FG002|Study Treatment|withdrawal before treatment|0|||
163086579|NCT04079738|589026013|FG003|Study Treatment|withdrawal before treatment|0|||
163086580|NCT04079738|589026010|FG000|Study Treatment|symptomatic deterioration|2|||
163407055|NCT01225731|590198786|FG006|Part 2|Pregnancy|1|||
163407056|NCT01225731|590198787|FG007|Part 2|Pregnancy|0|||
163407057|NCT01225731|590198788|FG008|Part 2|Pregnancy|1|||
163407058|NCT01225731|590198789|FG009|Part 2|Pregnancy|0|||
163407059|NCT01225731|590198790|FG010|Part 2|Pregnancy|0|||
163407060|NCT01225731|590198791|FG011|Part 2|Pregnancy|0|||
163407061|NCT01225731|590198792|FG012|Part 2|Pregnancy|0|||
163407062|NCT01225731|590198780|FG000|Part 2|Lost to Follow-up|0|||
163407063|NCT01225731|590198781|FG001|Part 2|Lost to Follow-up|0|||
163407064|NCT01225731|590198782|FG002|Part 2|Lost to Follow-up|0|||
163086581|NCT04079738|589026011|FG001|Study Treatment|symptomatic deterioration|0|||
163086582|NCT04079738|589026012|FG002|Study Treatment|symptomatic deterioration|0|||
163407065|NCT01225731|590198783|FG003|Part 2|Lost to Follow-up|0|||
163407066|NCT01225731|590198784|FG004|Part 2|Lost to Follow-up|0|||
163407067|NCT01225731|590198785|FG005|Part 2|Lost to Follow-up|0|||
163407068|NCT01225731|590198786|FG006|Part 2|Lost to Follow-up|0|||
163407069|NCT01225731|590198787|FG007|Part 2|Lost to Follow-up|3|||
163407070|NCT01225731|590198788|FG008|Part 2|Lost to Follow-up|1|||
163407071|NCT01225731|590198789|FG009|Part 2|Lost to Follow-up|0|||
163086583|NCT04079738|589026013|FG003|Study Treatment|symptomatic deterioration|0|||
163086584|NCT04079738|589026010|FG000|Study Treatment|Disease Progression|1|||
163086585|NCT04079738|589026011|FG001|Study Treatment|Disease Progression|0|||
163086586|NCT04079738|589026012|FG002|Study Treatment|Disease Progression|0|||
163086587|NCT04079738|589026013|FG003|Study Treatment|Disease Progression|0|||
163086588|NCT04079738|589026010|FG000|Study Treatment|withdrawal after treatment|1|||
163086589|NCT04079738|589026011|FG001|Study Treatment|withdrawal after treatment|0|||
163086590|NCT04079738|589026012|FG002|Study Treatment|withdrawal after treatment|0|||
163086591|NCT04079738|589026013|FG003|Study Treatment|withdrawal after treatment|0|||
163086592|NCT04079738|589026010|FG000|Follow up|Withdrawal by Subject|3|||
163086593|NCT04079738|589026011|FG001|Follow up|Withdrawal by Subject|0|||
163086594|NCT04079738|589026012|FG002|Follow up|Withdrawal by Subject|0|||
163086595|NCT04079738|589026013|FG003|Follow up|Withdrawal by Subject|0|||
163086596|NCT04079738|589026010|FG000|Follow up|Death|5|||
163086597|NCT04079738|589026011|FG001|Follow up|Death|0|||
163086598|NCT04079738|589026012|FG002|Follow up|Death|0|||
163086599|NCT04079738|589026013|FG003|Follow up|Death|0|||
163086600|NCT05552859|589026016|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
163086601|NCT05552859|589026017|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
163086602|NCT01380080|589026018|FG000|Overall Study|Death|36|||
163086603|NCT01380080|589026019|FG001|Overall Study|Death|44|||
163086604|NCT01380080|589026018|FG000|Overall Study|Site is closing|28|||
163086605|NCT01380080|589026019|FG001|Overall Study|Site is closing|31|||
163086606|NCT01380080|589026018|FG000|Overall Study|Not able to get to clinic|7|||
163086607|NCT01380080|589026019|FG001|Overall Study|Not able to get to clinic|1|||
163086608|NCT01380080|589026018|FG000|Overall Study|Not willing to adhere to requirements|6|||
163086609|NCT01380080|589026019|FG001|Overall Study|Not willing to adhere to requirements|2|||
163086610|NCT01380080|589026018|FG000|Overall Study|Withdrawal by Subject|5|||
163086611|NCT01380080|589026019|FG001|Overall Study|Withdrawal by Subject|2|||
163086612|NCT01380080|589026018|FG000|Overall Study|Lost to Follow-up|3|||
163086613|NCT01380080|589026019|FG001|Overall Study|Lost to Follow-up|3|||
163086614|NCT02303821|589026022|FG000|Overall Study|Withdrawal by Subject|0|||
163086615|NCT02303821|589026023|FG001|Overall Study|Withdrawal by Subject|0|||
163086616|NCT02303821|589026024|FG002|Overall Study|Withdrawal by Subject|0|||
163086617|NCT02303821|589026025|FG003|Overall Study|Withdrawal by Subject|0|||
163086618|NCT02303821|589026026|FG004|Overall Study|Withdrawal by Subject|0|||
163086619|NCT02303821|589026027|FG005|Overall Study|Withdrawal by Subject|0|||
163086620|NCT02303821|589026028|FG006|Overall Study|Withdrawal by Subject|0|||
163086621|NCT02303821|589026029|FG007|Overall Study|Withdrawal by Subject|2|||
163086622|NCT02303821|589026022|FG000|Overall Study|Death|0|||
163086623|NCT02303821|589026023|FG001|Overall Study|Death|2|||
163086624|NCT02303821|589026024|FG002|Overall Study|Death|0|||
163086625|NCT02303821|589026025|FG003|Overall Study|Death|0|||
163086626|NCT02303821|589026026|FG004|Overall Study|Death|0|||
163086627|NCT02303821|589026027|FG005|Overall Study|Death|3|||
163086628|NCT02303821|589026028|FG006|Overall Study|Death|41|||
163086629|NCT02303821|589026029|FG007|Overall Study|Death|29|||
163086630|NCT02303821|589026022|FG000|Overall Study|Lost to Follow-up|0|||
163086631|NCT02303821|589026023|FG001|Overall Study|Lost to Follow-up|0|||
163086632|NCT02303821|589026024|FG002|Overall Study|Lost to Follow-up|0|||
163086633|NCT02303821|589026025|FG003|Overall Study|Lost to Follow-up|0|||
163086634|NCT02303821|589026026|FG004|Overall Study|Lost to Follow-up|0|||
163086635|NCT02303821|589026027|FG005|Overall Study|Lost to Follow-up|0|||
163086636|NCT02303821|589026028|FG006|Overall Study|Lost to Follow-up|1|||
163086637|NCT02303821|589026029|FG007|Overall Study|Lost to Follow-up|0|||
163086638|NCT02303821|589026022|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
163086639|NCT02303821|589026023|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
163086640|NCT02303821|589026024|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
163086641|NCT02303821|589026025|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
163086642|NCT02303821|589026026|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
163334973|NCT05613088|589936153|FG001|Treatment|Adverse Event|1|||
163334974|NCT05613088|589936152|FG000|Treatment|Other Reasons|0|||
163334975|NCT05613088|589936153|FG001|Treatment|Other Reasons|1|||
163334976|NCT05613088|589936152|FG000|Treatment|Progressive Disease|58|||
163334977|NCT05613088|589936153|FG001|Treatment|Progressive Disease|26|||
163334978|NCT05613088|589936152|FG000|Treatment|Withdrawal by Subject|0|||
163334979|NCT05613088|589936153|FG001|Treatment|Withdrawal by Subject|4|||
163086643|NCT02303821|589026027|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
163086644|NCT02303821|589026028|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
163086645|NCT02303821|589026029|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
163086646|NCT02303821|589026022|FG000|Overall Study|Decision by sponsor|0|||
163086647|NCT02303821|589026023|FG001|Overall Study|Decision by sponsor|0|||
163086648|NCT02303821|589026024|FG002|Overall Study|Decision by sponsor|0|||
163086649|NCT02303821|589026025|FG003|Overall Study|Decision by sponsor|0|||
163086650|NCT02303821|589026026|FG004|Overall Study|Decision by sponsor|0|||
163086651|NCT02303821|589026027|FG005|Overall Study|Decision by sponsor|1|||
163086652|NCT02303821|589026028|FG006|Overall Study|Decision by sponsor|0|||
163086653|NCT02303821|589026029|FG007|Overall Study|Decision by sponsor|0|||
163086654|NCT02303821|589026022|FG000|Overall Study|Protocol-specified criteria|0|||
163086655|NCT02303821|589026023|FG001|Overall Study|Protocol-specified criteria|1|||
163086656|NCT02303821|589026024|FG002|Overall Study|Protocol-specified criteria|0|||
163086657|NCT02303821|589026025|FG003|Overall Study|Protocol-specified criteria|0|||
163086658|NCT02303821|589026026|FG004|Overall Study|Protocol-specified criteria|0|||
163086659|NCT02303821|589026027|FG005|Overall Study|Protocol-specified criteria|1|||
163086660|NCT02303821|589026028|FG006|Overall Study|Protocol-specified criteria|0|||
163086661|NCT02303821|589026029|FG007|Overall Study|Protocol-specified criteria|0|||
163086662|NCT00210132|589026030|FG000|Overall Study|Protocol Violation|1|||
163086663|NCT00210132|589026031|FG001|Overall Study|Protocol Violation|4|||
163086664|NCT02711202|589026034|FG000|Overall Study|Adverse Event|3|||
163086665|NCT02711202|589026035|FG001|Overall Study|Adverse Event|0|||
163086666|NCT02711202|589026034|FG000|Overall Study|graft loss|1|||
163086667|NCT02711202|589026035|FG001|Overall Study|graft loss|0|||
163086668|NCT02255656|589026043|FG000|Overall Study|Adverse Event|11|||
163086669|NCT02255656|589026043|FG000|Overall Study|Poor compliance to protocol|3|||
163086670|NCT02255656|589026043|FG000|Overall Study|Lost to Follow-up|30|||
163086671|NCT02255656|589026043|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
163086672|NCT02255656|589026043|FG000|Overall Study|Other|126|||
163086673|NCT03734536|589026044|FG000|Overall Study|Withdrew Consent|1|||
163086674|NCT03734536|589026045|FG001|Overall Study|Withdrew Consent|5|||
163086675|NCT03734536|589026044|FG000|Overall Study|Lost to Follow-up|10|||
163086676|NCT03734536|589026045|FG001|Overall Study|Lost to Follow-up|7|||
163086677|NCT03448393|589026046|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
163086678|NCT03448393|589026047|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
163086679|NCT03448393|589026048|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
163086680|NCT03448393|589026049|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
163086681|NCT03448393|589026050|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
163086682|NCT03448393|589026051|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
163086683|NCT03448393|589026052|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
163086684|NCT03448393|589026053|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
163086685|NCT03448393|589026054|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
163086686|NCT03448393|589026046|FG000|Dose Expansion|Not treated - screen failure|0|||
163086687|NCT03448393|589026047|FG001|Dose Expansion|Not treated - screen failure|0|||
163086688|NCT03448393|589026048|FG002|Dose Expansion|Not treated - screen failure|0|||
163086689|NCT03448393|589026049|FG003|Dose Expansion|Not treated - screen failure|0|||
163086690|NCT03448393|589026050|FG004|Dose Expansion|Not treated - screen failure|0|||
163086691|NCT03448393|589026051|FG005|Dose Expansion|Not treated - screen failure|0|||
163086692|NCT03448393|589026052|FG006|Dose Expansion|Not treated - screen failure|0|||
163086693|NCT03448393|589026053|FG007|Dose Expansion|Not treated - screen failure|0|||
163086694|NCT03448393|589026054|FG008|Dose Expansion|Not treated - screen failure|7|||
163086695|NCT04144517|589026068|FG000|Overall Study|Physician Decision|0|||
163086696|NCT04144517|589026069|FG001|Overall Study|Physician Decision|1|||
163086697|NCT04144517|589026068|FG000|Overall Study|Other|2|||
163086698|NCT04144517|589026069|FG001|Overall Study|Other|2|||
163086699|NCT04144517|589026068|FG000|Overall Study|Death|6|||
163086700|NCT04144517|589026069|FG001|Overall Study|Death|3|||
163086701|NCT05929326|589026074|FG000|Overall Study|unqualified sample|2|||
163086702|NCT05929326|589026075|FG001|Overall Study|unqualified sample|3|||
163086703|NCT05929326|589026076|FG002|Overall Study|unqualified sample|7|||
163086704|NCT05212168|589026086|FG000|Overall Study|Lost to Follow-up|0|||
163086705|NCT05212168|589026087|FG001|Overall Study|Lost to Follow-up|3|||
163086706|NCT05212168|589026086|FG000|Overall Study|Study terminated by sponsor|30|||
163086707|NCT05212168|589026087|FG001|Overall Study|Study terminated by sponsor|27|||
163086708|NCT05212168|589026086|FG000|Overall Study|Other|4|||
163086709|NCT05212168|589026087|FG001|Overall Study|Other|7|||
163086710|NCT03941093|589026089|FG000|Overall Study|Protocol Violation|0|||
163086711|NCT03941093|589026090|FG001|Overall Study|Protocol Violation|1|||
163086712|NCT03941093|589026089|FG000|Overall Study|Withdrawal by Subject|9|||
163086713|NCT03941093|589026090|FG001|Overall Study|Withdrawal by Subject|6|||
163086714|NCT02333799|589027829|FG000|Treatment Period|Withdrawal by Subject|1|||
163086715|NCT02333799|589027829|FG000|Treatment Period|Death|6|||
163086716|NCT02333799|589027829|FG000|6 Month Follow Up Period|Physician Decision|1|||
163086717|NCT02333799|589027829|FG000|6 Month Follow Up Period|Death|1|||
163086718|NCT02333799|589027829|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
163086719|NCT02333799|589027829|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
163086720|NCT05847686|589027830|FG000|Overall Study|Withdrawal by Subject|3|||
163086721|NCT05484895|589027831|FG000|Overall Study|Lost to Follow-up|63|||
163086722|NCT05484895|589027832|FG001|Overall Study|Lost to Follow-up|64|||
163086723|NCT04795531|589027834|FG000|Overall Study|Withdrawal by Subject|4|||
163086724|NCT04795531|589027835|FG001|Overall Study|Withdrawal by Subject|4|||
163086725|NCT04795531|589027834|FG000|Overall Study|Lost to Follow-up|0|||
163086726|NCT04795531|589027835|FG001|Overall Study|Lost to Follow-up|1|||
163086727|NCT04795531|589027834|FG000|Overall Study|Physician Decision|0|||
163036503|NCT05079230|588837973|FG001|Overall Study|Study Terminated by Sponsor|102|||
163036504|NCT05079230|588837972|FG000|Overall Study|Death|72|||
163036505|NCT05079230|588837973|FG001|Overall Study|Death|66|||
163036506|NCT05079230|588837972|FG000|Overall Study|Withdrew Consent|16|||
163036507|NCT05079230|588837973|FG001|Overall Study|Withdrew Consent|18|||
163036508|NCT05079230|588837972|FG000|Overall Study|Lost to Follow-up|0|||
163036509|NCT05079230|588837973|FG001|Overall Study|Lost to Follow-up|3|||
163036510|NCT00564395|588837978|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
163036511|NCT00564395|588837979|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
163036512|NCT00564395|588837978|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
163036513|NCT00564395|588837979|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
163036514|NCT02054910|588837981|FG000|Overall Study|Lost to Follow-up|4|||
163036515|NCT02054910|588837982|FG001|Overall Study|Lost to Follow-up|1|||
163036516|NCT00477607|588837987|FG000|Overall Study|Lost to Follow-up|7|||
163036517|NCT00477607|588837988|FG001|Overall Study|Lost to Follow-up|7|||
163036518|NCT00432276|588837989|FG000|Overall Study|Hyperglycemic Rescue|44|||
163036519|NCT00432276|588837990|FG001|Overall Study|Hyperglycemic Rescue|87|||
163036520|NCT00432276|588837989|FG000|Overall Study|Adverse Event|13|||
163036521|NCT00432276|588837990|FG001|Overall Study|Adverse Event|16|||
163036522|NCT00432276|588837989|FG000|Overall Study|Protocol Violation|25|||
163036523|NCT00432276|588837990|FG001|Overall Study|Protocol Violation|20|||
163036524|NCT00432276|588837989|FG000|Overall Study|Lost to Follow-up|6|||
163036525|NCT00432276|588837990|FG001|Overall Study|Lost to Follow-up|2|||
163036526|NCT00432276|588837989|FG000|Overall Study|Withdrawal by Subject|25|||
163036527|NCT00432276|588837990|FG001|Overall Study|Withdrawal by Subject|20|||
163036528|NCT00432276|588837989|FG000|Overall Study|Physician Decision|6|||
163036529|NCT00432276|588837990|FG001|Overall Study|Physician Decision|8|||
163036530|NCT00432276|588837989|FG000|Overall Study|Other|2|||
163036531|NCT00432276|588837990|FG001|Overall Study|Other|3|||
163036532|NCT00594386|588837991|FG000|Overall Study|Major protocol violation|2|||
163036533|NCT00594386|588837991|FG000|Overall Study|Lack of Efficacy|12|||
163036534|NCT00594386|588837991|FG000|Overall Study|Adverse Event|68|||
163036535|NCT00594386|588837991|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
163036536|NCT00594386|588837991|FG000|Overall Study|Subject withdrew consent|35|||
163036537|NCT00594386|588837991|FG000|Overall Study|Study ended per sponsor|115|||
163036538|NCT00594386|588837991|FG000|Overall Study|Lost to Follow-up|6|||
163036539|NCT00594386|588837991|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
163036540|NCT00594386|588837991|FG000|Overall Study|Other: Subject moved to Seattle|1|||
163036541|NCT00594386|588837991|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
163036542|NCT00594386|588837991|FG000|Overall Study|Other: Study terminated per investigator|2|||
163036543|NCT00594386|588837991|FG000|Overall Study|Other: Sponsor closure of study|1|||
163036544|NCT00594386|588837991|FG000|Overall Study|Other: Site terminated participation|1|||
163036545|NCT00594386|588837991|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
163036546|NCT00594386|588837991|FG000|Overall Study|Other: Loss of drivers license|1|||
163036547|NCT01210144|588837995|FG000|Overall Study|Lack of ovarian response|1|||
163036548|NCT01210144|588837996|FG001|Overall Study|Lack of ovarian response|0|||
163036549|NCT01210144|588837995|FG000|Overall Study|No fertilization|1|||
163036550|NCT01210144|588837996|FG001|Overall Study|No fertilization|0|||
163036551|NCT01210144|588837995|FG000|Overall Study|No transfer|1|||
163036552|NCT01210144|588837996|FG001|Overall Study|No transfer|0|||
163036553|NCT00207727|588838001|FG000|Overall Study|Withdrawal by Subject|0|||
163036554|NCT00207727|588838002|FG001|Overall Study|Withdrawal by Subject|0|||
163036555|NCT00207727|588838003|FG002|Overall Study|Withdrawal by Subject|0|||
163036556|NCT00207727|588838004|FG003|Overall Study|Withdrawal by Subject|0|||
163036557|NCT00207727|588838005|FG004|Overall Study|Withdrawal by Subject|1|||
163036558|NCT00207727|588838001|FG000|Overall Study|Lost to Follow-up|0|||
163036559|NCT00207727|588838002|FG001|Overall Study|Lost to Follow-up|1|||
163036560|NCT00207727|588838003|FG002|Overall Study|Lost to Follow-up|0|||
163036561|NCT00207727|588838004|FG003|Overall Study|Lost to Follow-up|0|||
163036562|NCT00207727|588838005|FG004|Overall Study|Lost to Follow-up|0|||
163036563|NCT00207727|588838001|FG000|Overall Study|Other|38|||
163036564|NCT00207727|588838002|FG001|Overall Study|Other|41|||
163036565|NCT00207727|588838003|FG002|Overall Study|Other|41|||
163036566|NCT00207727|588838004|FG003|Overall Study|Other|37|||
163036567|NCT00207727|588838005|FG004|Overall Study|Other|33|||
163036568|NCT03759366|588838006|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
163036569|NCT03759366|588838006|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
163036570|NCT03759366|588838006|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
163036571|NCT03759366|588838006|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
163036572|NCT03759366|588838006|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
163036573|NCT03759366|588838006|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
163036574|NCT03759366|588838006|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
163036575|NCT00505661|588838011|FG000|Overall Study|Not Eligible|4|||
163036576|NCT01573754|588838015|FG000|Overall Study|Noncompliance or remission not achieved|3|||
163036577|NCT01573754|588838016|FG001|Overall Study|Noncompliance or remission not achieved|15|||
163086728|NCT04795531|589027835|FG001|Overall Study|Physician Decision|2|||
163086729|NCT04795531|589027834|FG000|Overall Study|Death|2|||
163086730|NCT04795531|589027835|FG001|Overall Study|Death|1|||
163086731|NCT03698279|589027836|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163086732|NCT03698279|589027837|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163086733|NCT03698279|589027838|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163086734|NCT03698279|589027839|FG003|Overall Study|Withdrawal by parent/guardian|1|||
163086735|NCT03698279|589027840|FG004|Overall Study|Withdrawal by parent/guardian|0|||
163086736|NCT03698279|589027841|FG005|Overall Study|Withdrawal by parent/guardian|0|||
163086737|NCT03698279|589027836|FG000|Overall Study|Protocol deviation|1|||
163086738|NCT03698279|589027837|FG001|Overall Study|Protocol deviation|0|||
163086739|NCT03698279|589027838|FG002|Overall Study|Protocol deviation|1|||
163086740|NCT03698279|589027839|FG003|Overall Study|Protocol deviation|0|||
163086741|NCT03698279|589027840|FG004|Overall Study|Protocol deviation|0|||
163086742|NCT03698279|589027841|FG005|Overall Study|Protocol deviation|0|||
163086743|NCT03698279|589027836|FG000|Overall Study|Withdrawal by Subject|0|||
163086744|NCT03698279|589027837|FG001|Overall Study|Withdrawal by Subject|0|||
163086745|NCT03698279|589027838|FG002|Overall Study|Withdrawal by Subject|1|||
163086746|NCT03698279|589027839|FG003|Overall Study|Withdrawal by Subject|0|||
163086747|NCT03698279|589027840|FG004|Overall Study|Withdrawal by Subject|0|||
163086748|NCT03698279|589027841|FG005|Overall Study|Withdrawal by Subject|0|||
163086749|NCT03698279|589027836|FG000|Overall Study|Lost to Follow-up|3|||
163086750|NCT03698279|589027837|FG001|Overall Study|Lost to Follow-up|1|||
163086751|NCT03698279|589027838|FG002|Overall Study|Lost to Follow-up|4|||
163086752|NCT03698279|589027839|FG003|Overall Study|Lost to Follow-up|5|||
163086753|NCT03698279|589027840|FG004|Overall Study|Lost to Follow-up|0|||
163086754|NCT03698279|589027841|FG005|Overall Study|Lost to Follow-up|0|||
163086755|NCT02552225|589027842|FG000|Overall Study|Withdrawal by Subject|1|||
163086756|NCT02552225|589027843|FG001|Overall Study|Withdrawal by Subject|0|||
163086757|NCT03122184|589027844|FG000|Overall Study|Lost to Follow-up|4|||
163086758|NCT03122184|589027845|FG001|Overall Study|Lost to Follow-up|6|||
163086759|NCT03122184|589027844|FG000|Overall Study|Withdrawal by Subject|3|||
163086760|NCT03122184|589027845|FG001|Overall Study|Withdrawal by Subject|0|||
163086761|NCT03122184|589027844|FG000|Overall Study|Terminated due to cognitive problem|1|||
163086762|NCT03122184|589027845|FG001|Overall Study|Terminated due to cognitive problem|0|||
163086763|NCT00633126|589027846|FG000|Overall Study|Did not receive full dose|1|||
163086764|NCT00876447|589027847|FG000|Overall Study|Other miscellaneous reasons|3|||
163086765|NCT00876447|589027848|FG001|Overall Study|Other miscellaneous reasons|8|||
163086766|NCT00876447|589027847|FG000|Overall Study|Site closure|19|||
163086767|NCT00876447|589027848|FG001|Overall Study|Site closure|14|||
163086768|NCT00876447|589027847|FG000|Overall Study|Protocol Violation|9|||
163086769|NCT00876447|589027848|FG001|Overall Study|Protocol Violation|3|||
163086770|NCT00876447|589027847|FG000|Overall Study|Personal reasons|30|||
163086771|NCT00876447|589027848|FG001|Overall Study|Personal reasons|28|||
163086772|NCT00876447|589027847|FG000|Overall Study|Lost to Follow-up|6|||
163086773|NCT00876447|589027848|FG001|Overall Study|Lost to Follow-up|15|||
163086774|NCT00876447|589027847|FG000|Overall Study|Pregnancy|4|||
163086775|NCT00876447|589027848|FG001|Overall Study|Pregnancy|2|||
163086776|NCT00876447|589027847|FG000|Overall Study|Lack of Efficacy|5|||
163086777|NCT00876447|589027848|FG001|Overall Study|Lack of Efficacy|3|||
163086778|NCT00876447|589027847|FG000|Overall Study|Adverse Event|4|||
163086779|NCT00876447|589027848|FG001|Overall Study|Adverse Event|8|||
163086780|NCT00567502|589027849|FG000|Overall Study|Lost to Follow-up|91|||
163086781|NCT00567502|589027850|FG001|Overall Study|Lost to Follow-up|14|||
163086782|NCT00567502|589027851|FG002|Overall Study|Lost to Follow-up|351|||
163086783|NCT00567502|589027852|FG003|Overall Study|Lost to Follow-up|2|||
163086784|NCT00567502|589027849|FG000|Overall Study|Death|65|||
163086785|NCT00567502|589027850|FG001|Overall Study|Death|16|||
163086786|NCT00567502|589027851|FG002|Overall Study|Death|360|||
163086787|NCT00567502|589027852|FG003|Overall Study|Death|5|||
163086788|NCT00567502|589027849|FG000|Overall Study|Other|64|||
163086789|NCT00567502|589027850|FG001|Overall Study|Other|2|||
163086790|NCT00567502|589027851|FG002|Overall Study|Other|134|||
163086791|NCT00567502|589027852|FG003|Overall Study|Other|6|||
163086792|NCT00567502|589027849|FG000|Overall Study|Participant request|12|||
163086793|NCT00567502|589027850|FG001|Overall Study|Participant request|1|||
163086794|NCT00567502|589027851|FG002|Overall Study|Participant request|33|||
163086795|NCT00567502|589027852|FG003|Overall Study|Participant request|1|||
163086796|NCT00567502|589027849|FG000|Overall Study|Sponsor request|9|||
163086797|NCT00567502|589027850|FG001|Overall Study|Sponsor request|0|||
163086798|NCT00567502|589027851|FG002|Overall Study|Sponsor request|30|||
163086799|NCT00567502|589027852|FG003|Overall Study|Sponsor request|1|||
163086800|NCT00567502|589027849|FG000|Overall Study|Never Initiated Treatment|0|||
163086801|NCT00567502|589027850|FG001|Overall Study|Never Initiated Treatment|0|||
163086802|NCT00567502|589027851|FG002|Overall Study|Never Initiated Treatment|0|||
163086803|NCT00567502|589027852|FG003|Overall Study|Never Initiated Treatment|72|||
163086804|NCT02297516|589027853|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
163086805|NCT02297516|589027854|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
163086806|NCT02297516|589027853|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
163407072|NCT01225731|590198790|FG010|Part 2|Lost to Follow-up|0|||
163407073|NCT01225731|590198791|FG011|Part 2|Lost to Follow-up|0|||
163407074|NCT01225731|590198792|FG012|Part 2|Lost to Follow-up|0|||
163407075|NCT01225731|590198780|FG000|Part 2|Physician Decision|0|||
163407076|NCT01225731|590198781|FG001|Part 2|Physician Decision|0|||
163407077|NCT01225731|590198782|FG002|Part 2|Physician Decision|0|||
163407078|NCT01225731|590198783|FG003|Part 2|Physician Decision|0|||
163407079|NCT01225731|590198784|FG004|Part 2|Physician Decision|0|||
163407080|NCT01225731|590198785|FG005|Part 2|Physician Decision|0|||
163407081|NCT01225731|590198786|FG006|Part 2|Physician Decision|0|||
163407082|NCT01225731|590198787|FG007|Part 2|Physician Decision|2|||
163407083|NCT01225731|590198788|FG008|Part 2|Physician Decision|2|||
163407084|NCT01225731|590198789|FG009|Part 2|Physician Decision|0|||
163407085|NCT01225731|590198790|FG010|Part 2|Physician Decision|0|||
163407086|NCT01225731|590198791|FG011|Part 2|Physician Decision|0|||
163407087|NCT01225731|590198792|FG012|Part 2|Physician Decision|0|||
163407088|NCT01225731|590198780|FG000|Part 2|Withdrawal by Subject|0|||
163407089|NCT01225731|590198781|FG001|Part 2|Withdrawal by Subject|0|||
163407090|NCT01225731|590198782|FG002|Part 2|Withdrawal by Subject|0|||
163407091|NCT01225731|590198783|FG003|Part 2|Withdrawal by Subject|0|||
163407092|NCT01225731|590198784|FG004|Part 2|Withdrawal by Subject|0|||
163407093|NCT01225731|590198785|FG005|Part 2|Withdrawal by Subject|1|||
163407094|NCT01225731|590198786|FG006|Part 2|Withdrawal by Subject|3|||
163407095|NCT01225731|590198787|FG007|Part 2|Withdrawal by Subject|4|||
163036578|NCT00463840|588838018|FG000|Overall Study|Disease progression|7|||
163036579|NCT00463840|588838018|FG000|Overall Study|Withdrawal by Subject|2|||
163036580|NCT00463840|588838018|FG000|Overall Study|Adverse Event|3|||
163036581|NCT04228965|588840165|FG000|Overall Study|Lost to Follow-up|26|||
163036582|NCT04228965|588840166|FG001|Overall Study|Lost to Follow-up|11|||
163036583|NCT04228965|588840165|FG000|Overall Study|Withdrawal by Subject|18|||
163036584|NCT04228965|588840166|FG001|Overall Study|Withdrawal by Subject|5|||
163036585|NCT02442206|588840167|FG000|Period 1|Adverse Event|1|||
163036586|NCT02442206|588840168|FG001|Period 1|Adverse Event|1|||
163036587|NCT02442206|588840167|FG000|Period 1|withdrew consent|0|||
163036588|NCT02442206|588840168|FG001|Period 1|withdrew consent|1|||
163036589|NCT02442206|588840167|FG000|Period 1|COPD exacerbation|0|||
163036590|NCT02442206|588840168|FG001|Period 1|COPD exacerbation|1|||
163036591|NCT02442206|588840167|FG000|Period 2|Adverse Event|1|||
163036592|NCT02442206|588840168|FG001|Period 2|Adverse Event|0|||
163036593|NCT01471444|588840169|FG000|Overall Study|Physician Decision|3|||
163036594|NCT01471444|588840170|FG001|Overall Study|Physician Decision|2|||
163036595|NCT01471444|588840169|FG000|Overall Study|Withdrawal by Subject|0|||
163036596|NCT01471444|588840170|FG001|Overall Study|Withdrawal by Subject|1|||
163036597|NCT03915626|588840171|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
163036598|NCT01709409|588840174|FG000|Overall Study|Protocol Violation|1|||
163036599|NCT01709409|588840175|FG001|Overall Study|Protocol Violation|0|||
163036600|NCT04571385|588840176|FG000|Overall Study|Participant non-compliance|1|||
163036601|NCT04571385|588840177|FG001|Overall Study|Participant non-compliance|0|||
163036602|NCT04571385|588840178|FG002|Overall Study|Participant non-compliance|0|||
163036603|NCT04571385|588840176|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
163036604|NCT04571385|588840177|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
163036605|NCT04571385|588840178|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
163036606|NCT04571385|588840176|FG000|Overall Study|Screen failure|0|||
163036607|NCT04571385|588840177|FG001|Overall Study|Screen failure|0|||
163036608|NCT04571385|588840178|FG002|Overall Study|Screen failure|1|||
163036609|NCT01928199|588840181|FG000|Overall Study|Lost to Follow-up|2|||
163036610|NCT01928199|588840182|FG001|Overall Study|Lost to Follow-up|1|||
163036611|NCT01928199|588840181|FG000|Overall Study|Withdrawal by Subject|3|||
163036612|NCT01928199|588840182|FG001|Overall Study|Withdrawal by Subject|5|||
163036613|NCT01641471|588840183|FG000|Overall Study|Withdrawal by Subject|19|||
163036614|NCT01641471|588840184|FG001|Overall Study|Withdrawal by Subject|19|||
163036615|NCT01641471|588840183|FG000|Overall Study|Lost to Follow-up|2|||
163036616|NCT01641471|588840184|FG001|Overall Study|Lost to Follow-up|4|||
163036617|NCT01641471|588840183|FG000|Overall Study|Protocol Violation|2|||
163036618|NCT01641471|588840184|FG001|Overall Study|Protocol Violation|4|||
163036619|NCT03300050|588840187|FG000|Overall Study|Lost to Follow-up|2|||
163036620|NCT03300050|588840188|FG001|Overall Study|Lost to Follow-up|1|||
163036621|NCT03300050|588840189|FG002|Overall Study|Lost to Follow-up|0|||
163036622|NCT03300050|588840190|FG003|Overall Study|Lost to Follow-up|0|||
163036623|NCT03300050|588840191|FG004|Overall Study|Lost to Follow-up|1|||
163036624|NCT03300050|588840187|FG000|Overall Study|Withdrawal by Subject|1|||
163036625|NCT03300050|588840188|FG001|Overall Study|Withdrawal by Subject|1|||
163407096|NCT01225731|590198788|FG008|Part 2|Withdrawal by Subject|1|||
163407097|NCT01225731|590198789|FG009|Part 2|Withdrawal by Subject|0|||
163407098|NCT01225731|590198790|FG010|Part 2|Withdrawal by Subject|0|||
163036626|NCT03300050|588840189|FG002|Overall Study|Withdrawal by Subject|1|||
163036627|NCT03300050|588840190|FG003|Overall Study|Withdrawal by Subject|0|||
163407099|NCT01225731|590198791|FG011|Part 2|Withdrawal by Subject|0|||
163407100|NCT01225731|590198792|FG012|Part 2|Withdrawal by Subject|0|||
163407101|NCT01225731|590198780|FG000|Part 3|Adverse Event|0|||
163086807|NCT02297516|589027854|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
163086808|NCT02297516|589027853|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
163086809|NCT02297516|589027854|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
163086810|NCT00582907|589027857|FG000|1st Course|Withdrawal by Subject|1|||
163086811|NCT00582907|589027858|FG001|1st Course|Withdrawal by Subject|0|||
163086812|NCT00582907|589027859|FG002|1st Course|Withdrawal by Subject|0|||
163086813|NCT00582907|589027860|FG003|1st Course|Withdrawal by Subject|0|||
163086814|NCT00582907|589027857|FG000|1st Course|Lost to Follow-up|0|||
163086815|NCT00582907|589027858|FG001|1st Course|Lost to Follow-up|0|||
163086816|NCT00582907|589027859|FG002|1st Course|Lost to Follow-up|0|||
163086817|NCT00582907|589027860|FG003|1st Course|Lost to Follow-up|1|||
163086818|NCT00582907|589027857|FG000|2nd Course|Lack of Efficacy|1|||
163086819|NCT00582907|589027858|FG001|2nd Course|Lack of Efficacy|0|||
163086820|NCT00582907|589027859|FG002|2nd Course|Lack of Efficacy|0|||
163086821|NCT00582907|589027860|FG003|2nd Course|Lack of Efficacy|0|||
163086822|NCT02538614|589027861|FG000|Overall Study|Progressive Disease|2|||
163086823|NCT01441960|589027863|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
163086824|NCT01441960|589027864|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
163086825|NCT01441960|589027863|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
163086826|NCT01441960|589027864|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
163086827|NCT01441960|589027863|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
163086828|NCT01441960|589027864|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
163086829|NCT00189423|589027865|FG000|Overall Study|Death|746|||
163086830|NCT00189423|589027866|FG001|Overall Study|Death|747|||
163086831|NCT00189423|589027865|FG000|Overall Study|Withdrawal by Subject|9|||
163086832|NCT00189423|589027866|FG001|Overall Study|Withdrawal by Subject|9|||
163086833|NCT00189423|589027865|FG000|Overall Study|Lost to Follow-up|10|||
163086834|NCT00189423|589027866|FG001|Overall Study|Lost to Follow-up|10|||
163086835|NCT00415636|589027867|FG000|Overall Study|Symptomatic deterioration|1|||
163086836|NCT00415636|589027868|FG001|Overall Study|Symptomatic deterioration|0|||
163086837|NCT00415636|589027869|FG002|Overall Study|Symptomatic deterioration|1|||
163086838|NCT00415636|589027870|FG003|Overall Study|Symptomatic deterioration|2|||
163086839|NCT00415636|589027871|FG004|Overall Study|Symptomatic deterioration|0|||
163086840|NCT00415636|589027872|FG005|Overall Study|Symptomatic deterioration|1|||
163086841|NCT00415636|589027867|FG000|Overall Study|Adverse Event|0|||
163086842|NCT00415636|589027868|FG001|Overall Study|Adverse Event|0|||
163086843|NCT00415636|589027869|FG002|Overall Study|Adverse Event|0|||
163086844|NCT00415636|589027870|FG003|Overall Study|Adverse Event|1|||
163086845|NCT00415636|589027871|FG004|Overall Study|Adverse Event|1|||
163086846|NCT00415636|589027872|FG005|Overall Study|Adverse Event|0|||
163086847|NCT00415636|589027867|FG000|Overall Study|Withdrawal by Subject|0|||
163086848|NCT00415636|589027868|FG001|Overall Study|Withdrawal by Subject|0|||
163086849|NCT00415636|589027869|FG002|Overall Study|Withdrawal by Subject|0|||
163086850|NCT00415636|589027870|FG003|Overall Study|Withdrawal by Subject|0|||
163086851|NCT00415636|589027871|FG004|Overall Study|Withdrawal by Subject|1|||
163086852|NCT00415636|589027872|FG005|Overall Study|Withdrawal by Subject|0|||
163086853|NCT00415636|589027867|FG000|Overall Study|Disease progression|0|||
163086854|NCT00415636|589027868|FG001|Overall Study|Disease progression|0|||
163086855|NCT00415636|589027869|FG002|Overall Study|Disease progression|0|||
163086856|NCT00415636|589027870|FG003|Overall Study|Disease progression|3|||
163086857|NCT00415636|589027871|FG004|Overall Study|Disease progression|0|||
163086858|NCT00415636|589027872|FG005|Overall Study|Disease progression|1|||
163086859|NCT01263119|589027873|FG000|Period 1|Protocol Violation|2|||
163086860|NCT01263119|589027873|FG000|Period 2|Adverse Event|2|||
163086861|NCT02138825|589027874|FG000|Main Study Treatment|Adverse Event|11|||
163086862|NCT02138825|589027875|FG001|Main Study Treatment|Adverse Event|3|||
163086863|NCT02138825|589027874|FG000|Main Study Treatment|Death|1|||
163086864|NCT02138825|589027875|FG001|Main Study Treatment|Death|2|||
163086865|NCT02138825|589027874|FG000|Main Study Treatment|Protocol Violation|2|||
163086866|NCT02138825|589027875|FG001|Main Study Treatment|Protocol Violation|2|||
163086867|NCT02138825|589027874|FG000|Main Study Treatment|Sponsor decision|12|||
163086868|NCT02138825|589027875|FG001|Main Study Treatment|Sponsor decision|18|||
163086869|NCT02138825|589027874|FG000|Main Study Treatment|Study terminated by sponsor|10|||
163086870|NCT02138825|589027875|FG001|Main Study Treatment|Study terminated by sponsor|9|||
163086871|NCT02138825|589027874|FG000|Main Study Treatment|Withdrawal by Subject|3|||
163086872|NCT02138825|589027875|FG001|Main Study Treatment|Withdrawal by Subject|1|||
163086873|NCT02138825|589027874|FG000|Main Study Treatment|Medical decision|1|||
163086874|NCT02138825|589027875|FG001|Main Study Treatment|Medical decision|0|||
163086875|NCT02138825|589027874|FG000|Long-term Extension|Study termination by sponsor|32|||
163086876|NCT02138825|589027875|FG001|Long-term Extension|Study termination by sponsor|38|||
163086877|NCT02138825|589027874|FG000|Safety Follow-up|Adverse Event|4|||
163086878|NCT02138825|589027875|FG001|Safety Follow-up|Adverse Event|3|||
163086879|NCT02138825|589027874|FG000|Safety Follow-up|Death|11|||
163086880|NCT02138825|589027875|FG001|Safety Follow-up|Death|5|||
163086881|NCT02138825|589027874|FG000|Safety Follow-up|Withdrawal by Subject|5|||
163086882|NCT02138825|589027875|FG001|Safety Follow-up|Withdrawal by Subject|3|||
163086883|NCT02138825|589027874|FG000|Safety Follow-up|clinic worsening|1|||
163086884|NCT02138825|589027875|FG001|Safety Follow-up|clinic worsening|0|||
163086885|NCT02138825|589027874|FG000|Safety Follow-up|withdrawal by PI|1|||
163086886|NCT02138825|589027875|FG001|Safety Follow-up|withdrawal by PI|0|||
163086887|NCT02138825|589027874|FG000|Safety Follow-up|logistical difficulties|0|||
163086888|NCT02138825|589027875|FG001|Safety Follow-up|logistical difficulties|1|||
163086889|NCT02138825|589027874|FG000|Safety Follow-up|progressive disease|0|||
163086890|NCT02138825|589027875|FG001|Safety Follow-up|progressive disease|2|||
163086891|NCT02138825|589027874|FG000|Safety Follow-up|too unwell to attend the visit|0|||
163086892|NCT02138825|589027875|FG001|Safety Follow-up|too unwell to attend the visit|1|||
163086893|NCT02138825|589027874|FG000|Safety Follow-up|treatment unblinded|0|||
163086894|NCT02138825|589027875|FG001|Safety Follow-up|treatment unblinded|1|||
163086895|NCT02138825|589027874|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
163086896|NCT02138825|589027875|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
163086897|NCT01702298|589027881|FG000|Overall Study|Withdrawal by Subject|1|||
163086898|NCT01822925|589027887|FG000|Overall Study|Adverse Event|1|||
163086899|NCT01822925|589027888|FG001|Overall Study|Adverse Event|1|||
163086900|NCT01822925|589027889|FG002|Overall Study|Adverse Event|1|||
163086901|NCT01822925|589027890|FG003|Overall Study|Adverse Event|1|||
163086902|NCT01822925|589027887|FG000|Overall Study|Lost to Follow-up|0|||
163086903|NCT01822925|589027888|FG001|Overall Study|Lost to Follow-up|1|||
163086904|NCT01822925|589027889|FG002|Overall Study|Lost to Follow-up|0|||
163086905|NCT01822925|589027890|FG003|Overall Study|Lost to Follow-up|0|||
163086906|NCT01822925|589027887|FG000|Overall Study|Protocol Violation|1|||
163086907|NCT01822925|589027888|FG001|Overall Study|Protocol Violation|0|||
163086908|NCT01822925|589027889|FG002|Overall Study|Protocol Violation|0|||
163086909|NCT01822925|589027890|FG003|Overall Study|Protocol Violation|1|||
163086910|NCT01822925|589027887|FG000|Overall Study|Withdrawal by Subject|2|||
163086911|NCT01822925|589027888|FG001|Overall Study|Withdrawal by Subject|0|||
163086912|NCT01822925|589027889|FG002|Overall Study|Withdrawal by Subject|2|||
163086913|NCT01822925|589027890|FG003|Overall Study|Withdrawal by Subject|2|||
163086914|NCT01822925|589027887|FG000|Overall Study|Taking prohibited medication|2|||
163086915|NCT01822925|589027888|FG001|Overall Study|Taking prohibited medication|0|||
163086916|NCT01822925|589027889|FG002|Overall Study|Taking prohibited medication|0|||
163086917|NCT01822925|589027890|FG003|Overall Study|Taking prohibited medication|1|||
163086918|NCT03847519|589027893|FG000|Overall Study|Death|5|||
163086919|NCT03847519|589027894|FG001|Overall Study|Death|8|||
163086920|NCT03847519|589027895|FG002|Overall Study|Death|1|||
163086921|NCT03847519|589027893|FG000|Overall Study|Lost to Follow-up|1|||
163086922|NCT03847519|589027894|FG001|Overall Study|Lost to Follow-up|2|||
163086923|NCT03847519|589027895|FG002|Overall Study|Lost to Follow-up|0|||
163086924|NCT03847519|589027893|FG000|Overall Study|Study Terminated by Sponsor|0|||
163086925|NCT03847519|589027894|FG001|Overall Study|Study Terminated by Sponsor|3|||
163086926|NCT03847519|589027895|FG002|Overall Study|Study Terminated by Sponsor|2|||
163086927|NCT02090764|589027896|FG000|Overall Study|Adverse Event|1|||
163086928|NCT02090764|589027897|FG001|Overall Study|Adverse Event|3|||
163086929|NCT02090764|589027896|FG000|Overall Study|Lack of Efficacy|0|||
163086930|NCT02090764|589027897|FG001|Overall Study|Lack of Efficacy|13|||
163086931|NCT02090764|589027896|FG000|Overall Study|Withdrawal by Subject|2|||
163086932|NCT02090764|589027897|FG001|Overall Study|Withdrawal by Subject|1|||
163086933|NCT02090764|589027896|FG000|Overall Study|Intercurrent illness and other|1|||
163086934|NCT02090764|589027897|FG001|Overall Study|Intercurrent illness and other|1|||
163086935|NCT02090764|589027896|FG000|Overall Study|Lost to Follow-up|2|||
163086936|NCT02090764|589027897|FG001|Overall Study|Lost to Follow-up|2|||
163086937|NCT02300233|589027900|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
163334980|NCT05484661|589936161|FG000|Overall Study|Withdrawal by Subject|1|||
163334981|NCT05484661|589936162|FG001|Overall Study|Withdrawal by Subject|0|||
163334982|NCT03652610|589936163|FG000|Overall Study|Lost to Follow-up|1|||
163334983|NCT03652610|589936164|FG001|Overall Study|Lost to Follow-up|0|||
163334984|NCT03652610|589936163|FG000|Overall Study|Withdrawal by Subject|3|||
163086938|NCT02300233|589027901|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
163334985|NCT03652610|589936164|FG001|Overall Study|Withdrawal by Subject|5|||
163086939|NCT02300233|589027902|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
163086940|NCT02300233|589027900|FG000|Overall Study|Withdrawal by Subject|1|||
163086941|NCT02300233|589027901|FG001|Overall Study|Withdrawal by Subject|0|||
163086942|NCT02300233|589027902|FG002|Overall Study|Withdrawal by Subject|3|||
163086943|NCT02300233|589027900|FG000|Overall Study|Investigator Judgement|0|||
163086944|NCT02300233|589027901|FG001|Overall Study|Investigator Judgement|0|||
163086945|NCT02300233|589027902|FG002|Overall Study|Investigator Judgement|1|||
163086946|NCT02300233|589027900|FG000|Overall Study|Reason Not Specified|0|||
163086947|NCT02300233|589027901|FG001|Overall Study|Reason Not Specified|0|||
163086948|NCT02300233|589027902|FG002|Overall Study|Reason Not Specified|5|||
163086949|NCT00833690|589027903|FG000|Overall Study|Withdrawal by Subject|1|||
163086950|NCT00833690|589027904|FG001|Overall Study|Withdrawal by Subject|0|||
163334986|NCT05615363|589936165|FG000|Overall Study|Adverse Event|0|||
163334987|NCT05615363|589936166|FG001|Overall Study|Adverse Event|4|||
163086951|NCT00833690|589027905|FG002|Overall Study|Withdrawal by Subject|0|||
163086952|NCT00833690|589027903|FG000|Overall Study|Discontinued study drug|3|||
163086953|NCT00833690|589027904|FG001|Overall Study|Discontinued study drug|2|||
163086954|NCT00833690|589027905|FG002|Overall Study|Discontinued study drug|0|||
163086955|NCT00744861|589027906|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
163086956|NCT00744861|589027907|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
163086957|NCT00744861|589027908|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
163086958|NCT00744861|589027909|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
163086959|NCT00744861|589027906|FG000|Feasibility Stage 1|Pregnancy|0|||
163086960|NCT00744861|589027907|FG001|Feasibility Stage 1|Pregnancy|1|||
163086961|NCT00744861|589027908|FG002|Feasibility Stage 1|Pregnancy|0|||
163086962|NCT00744861|589027909|FG003|Feasibility Stage 1|Pregnancy|0|||
163086963|NCT00744861|589027906|FG000|Pivotal Stage 2|Adverse Event|0|||
163086964|NCT00744861|589027907|FG001|Pivotal Stage 2|Adverse Event|0|||
163086965|NCT00744861|589027908|FG002|Pivotal Stage 2|Adverse Event|6|||
163086966|NCT00744861|589027909|FG003|Pivotal Stage 2|Adverse Event|11|||
163086967|NCT00744861|589027906|FG000|Pivotal Stage 2|Death|0|||
163086968|NCT00744861|589027907|FG001|Pivotal Stage 2|Death|0|||
163086969|NCT00744861|589027908|FG002|Pivotal Stage 2|Death|0|||
163086970|NCT00744861|589027909|FG003|Pivotal Stage 2|Death|1|||
163086971|NCT00744861|589027906|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
163086972|NCT00744861|589027907|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
163086973|NCT00744861|589027908|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
163086974|NCT00744861|589027909|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
163086975|NCT00744861|589027906|FG000|Pivotal Stage 2|Physician Decision|0|||
163086976|NCT00744861|589027907|FG001|Pivotal Stage 2|Physician Decision|0|||
163086977|NCT00744861|589027908|FG002|Pivotal Stage 2|Physician Decision|3|||
163086978|NCT00744861|589027909|FG003|Pivotal Stage 2|Physician Decision|1|||
163086979|NCT00744861|589027906|FG000|Pivotal Stage 2|Protocol Violation|0|||
163086980|NCT00744861|589027907|FG001|Pivotal Stage 2|Protocol Violation|0|||
163086981|NCT00744861|589027908|FG002|Pivotal Stage 2|Protocol Violation|0|||
163086982|NCT00744861|589027909|FG003|Pivotal Stage 2|Protocol Violation|1|||
163086983|NCT00744861|589027906|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
163086984|NCT00744861|589027907|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
163086985|NCT00744861|589027908|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
163086986|NCT00744861|589027909|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
163086987|NCT00744861|589027906|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
163086988|NCT00744861|589027907|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
163086989|NCT00744861|589027908|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
163086990|NCT00744861|589027909|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
163086991|NCT04856527|589027910|FG000|Overall Study|Unable to complete experimental task|2|||
163086992|NCT04856527|589027911|FG001|Overall Study|Unable to complete experimental task|0|||
163086993|NCT03605693|589027914|FG000|Overall Study|Lost to Follow-up|4|||
163086994|NCT03605693|589027915|FG001|Overall Study|Lost to Follow-up|0|||
163086995|NCT03605693|589027914|FG000|Overall Study|Physician Decision|1|||
163086996|NCT03605693|589027915|FG001|Overall Study|Physician Decision|0|||
163086997|NCT04752566|589027916|FG000|Overall Study|Protocol Violation|0|||
163086998|NCT04752566|589027917|FG001|Overall Study|Protocol Violation|1|||
163086999|NCT04752566|589027916|FG000|Overall Study|Death|1|||
163087000|NCT04752566|589027917|FG001|Overall Study|Death|0|||
163087001|NCT04752566|589027916|FG000|Overall Study|Adverse Event|1|||
163087002|NCT04752566|589027917|FG001|Overall Study|Adverse Event|0|||
163087003|NCT04752566|589027916|FG000|Overall Study|Withdrawal by Subject|2|||
163087004|NCT04752566|589027917|FG001|Overall Study|Withdrawal by Subject|0|||
163087005|NCT04752566|589027916|FG000|Overall Study|Physician Decision|1|||
163087006|NCT04752566|589027917|FG001|Overall Study|Physician Decision|1|||
163087007|NCT05134649|589027918|FG000|Overall Study|Lost to Follow-up|12|||
163087008|NCT05134649|589027918|FG000|Overall Study|Withdrawal by Subject|14|||
163087009|NCT05134649|589027918|FG000|Overall Study|Pregnancy|1|||
163087010|NCT05134649|589027918|FG000|Overall Study|Other, not specified|3|||
163087011|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
163087012|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
163087013|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
163087014|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
163087015|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
163087016|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
163087017|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
163087018|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
163087019|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
163087020|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
163087021|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
163087022|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
163087023|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
163087024|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
163087025|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
163087026|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
163036628|NCT03300050|588840191|FG004|Overall Study|Withdrawal by Subject|0|||
163087027|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
163087028|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
163087029|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
163087030|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
163087031|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
163087032|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
163087033|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
163087034|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
163087035|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
163087036|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
163087037|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
163087038|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
163087039|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
163087040|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
163087041|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
163087042|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
163087043|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
163087044|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
163087045|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
163087046|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
163087047|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
163087048|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
163087049|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
163087050|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
163087051|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
163087052|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
163087053|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
163087054|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
163087055|NCT04392154|589027921|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
163087056|NCT04392154|589027922|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
163087057|NCT04392154|589027923|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
163087058|NCT04392154|589027924|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
163087059|NCT04392154|589027921|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
163087060|NCT04392154|589027922|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
163087061|NCT04392154|589027923|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
163087062|NCT04392154|589027924|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
163087063|NCT04392154|589027921|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
163087064|NCT04392154|589027922|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
163087065|NCT04392154|589027923|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
163087066|NCT04392154|589027924|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
163087067|NCT02038647|589027926|FG000|Overall Study|Progressive Disease|50|||
163036629|NCT03300050|588840187|FG000|Overall Study|Death|0|||
163036630|NCT03300050|588840188|FG001|Overall Study|Death|0|||
163036631|NCT03300050|588840189|FG002|Overall Study|Death|1|||
163036632|NCT03300050|588840190|FG003|Overall Study|Death|0|||
163036633|NCT03300050|588840191|FG004|Overall Study|Death|0|||
163036634|NCT03300050|588840187|FG000|Overall Study|Not Eligible at Randomization|0|||
163036635|NCT03300050|588840188|FG001|Overall Study|Not Eligible at Randomization|0|||
163036636|NCT03300050|588840189|FG002|Overall Study|Not Eligible at Randomization|1|||
163036637|NCT03300050|588840190|FG003|Overall Study|Not Eligible at Randomization|1|||
163036638|NCT03300050|588840191|FG004|Overall Study|Not Eligible at Randomization|0|||
163036639|NCT02499263|588840192|FG000|Overall Study|Lost to Follow-up|9|||
163036640|NCT02499263|588840192|FG000|Overall Study|Participant's withdrawal of consent|4|||
163036641|NCT02499263|588840192|FG000|Overall Study|Lack of Efficacy|22|||
163036642|NCT02499263|588840192|FG000|Overall Study|investigator's judgment|12|||
163036643|NCT02499263|588840192|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
163036644|NCT02499263|588840192|FG000|Overall Study|Participant's decision|3|||
163036645|NCT02499263|588840192|FG000|Overall Study|Pregnancy|1|||
163036646|NCT01108237|588840193|FG000|Overall Study|No alignment data|2|||
163036647|NCT01108237|588840194|FG001|Overall Study|No alignment data|15|||
163036648|NCT01108237|588840193|FG000|Overall Study|Did not meet criteria for analysis|7|||
163036649|NCT01108237|588840194|FG001|Overall Study|Did not meet criteria for analysis|0|||
163036650|NCT02734862|588840196|FG000|Part A|Death|3|||
163036651|NCT02734862|588840197|FG001|Part A|Death|4|||
163036652|NCT02734862|588840198|FG002|Part A|Death|6|||
163036653|NCT02734862|588840196|FG000|Part A|Lost to Follow-up|2|||
163036654|NCT02734862|588840197|FG001|Part A|Lost to Follow-up|1|||
163036655|NCT02734862|588840198|FG002|Part A|Lost to Follow-up|1|||
163036656|NCT02734862|588840196|FG000|Part A|Withdrawal by Subject|1|||
163334988|NCT05615363|589936167|FG002|Overall Study|Adverse Event|4|||
163087068|NCT02038647|589027927|FG001|Overall Study|Progressive Disease|59|||
163087069|NCT02038647|589027926|FG000|Overall Study|Adverse Event|18|||
163087070|NCT02038647|589027927|FG001|Overall Study|Adverse Event|10|||
163087071|NCT02038647|589027926|FG000|Overall Study|Symptomatic Deterioration|7|||
163087072|NCT02038647|589027927|FG001|Overall Study|Symptomatic Deterioration|7|||
163087073|NCT02038647|589027926|FG000|Overall Study|Withdrawal by Subject|5|||
163087074|NCT02038647|589027927|FG001|Overall Study|Withdrawal by Subject|2|||
163087075|NCT02038647|589027926|FG000|Overall Study|Not Reported|0|||
163087076|NCT02038647|589027927|FG001|Overall Study|Not Reported|1|||
163087077|NCT02038647|589027926|FG000|Overall Study|Ongoing at Datacut|9|||
163087078|NCT02038647|589027927|FG001|Overall Study|Ongoing at Datacut|10|||
163087079|NCT02757430|589027928|FG000|Overall Study|Physician Decision|6|||
163087080|NCT02757430|589027928|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
163087081|NCT02757430|589027928|FG000|Overall Study|No informed consent|1|||
163087082|NCT02757430|589027928|FG000|Overall Study|No procedure performed|2|||
163087083|NCT01983111|589027931|FG000|Overall Study|Withdrawal by Subject|8|||
163087084|NCT01983111|589027932|FG001|Overall Study|Withdrawal by Subject|6|||
163087085|NCT01983111|589027931|FG000|Overall Study|Adverse Event|4|||
163087086|NCT01983111|589027932|FG001|Overall Study|Adverse Event|0|||
163087087|NCT01983111|589027931|FG000|Overall Study|Protocol Violation|0|||
163087088|NCT01983111|589027932|FG001|Overall Study|Protocol Violation|1|||
163087089|NCT03502200|589027933|FG000|Overall Study|Adverse Event|1|||
163087090|NCT03502200|589027934|FG001|Overall Study|Adverse Event|0|||
163087091|NCT03502200|589027933|FG000|Overall Study|Lost to Follow-up|36|||
163087092|NCT03502200|589027934|FG001|Overall Study|Lost to Follow-up|38|||
163087093|NCT03502200|589027933|FG000|Overall Study|Study Team Decision|1|||
163087094|NCT03502200|589027934|FG001|Overall Study|Study Team Decision|1|||
163087095|NCT03502200|589027933|FG000|Overall Study|Withdrawal by Subject|5|||
163087096|NCT03502200|589027934|FG001|Overall Study|Withdrawal by Subject|7|||
163087097|NCT03502200|589027933|FG000|Overall Study|Death|0|||
163087098|NCT03502200|589027934|FG001|Overall Study|Death|2|||
163087099|NCT00855335|589027935|FG000|Overall Study|Lost to Follow-up|0|||
163087100|NCT00855335|589027936|FG001|Overall Study|Lost to Follow-up|0|||
163087101|NCT00855335|589027937|FG002|Overall Study|Lost to Follow-up|3|||
163087102|NCT00855335|589027938|FG003|Overall Study|Lost to Follow-up|1|||
163087103|NCT00855335|589027939|FG004|Overall Study|Lost to Follow-up|0|||
163087104|NCT00855335|589027935|FG000|Overall Study|Withdrawal by Subject|0|||
163087105|NCT00855335|589027936|FG001|Overall Study|Withdrawal by Subject|0|||
163087106|NCT00855335|589027937|FG002|Overall Study|Withdrawal by Subject|0|||
163087107|NCT00855335|589027938|FG003|Overall Study|Withdrawal by Subject|1|||
163087108|NCT00855335|589027939|FG004|Overall Study|Withdrawal by Subject|0|||
163087109|NCT00855335|589027935|FG000|Overall Study|Adverse Event|2|||
163087110|NCT00855335|589027936|FG001|Overall Study|Adverse Event|0|||
163087111|NCT00855335|589027937|FG002|Overall Study|Adverse Event|0|||
163087112|NCT00855335|589027938|FG003|Overall Study|Adverse Event|0|||
163087113|NCT00855335|589027939|FG004|Overall Study|Adverse Event|0|||
163087114|NCT00855335|589027935|FG000|Overall Study|Physician Decision|1|||
163087115|NCT00855335|589027936|FG001|Overall Study|Physician Decision|1|||
163087116|NCT00855335|589027937|FG002|Overall Study|Physician Decision|0|||
163087117|NCT00855335|589027938|FG003|Overall Study|Physician Decision|0|||
163087118|NCT00855335|589027939|FG004|Overall Study|Physician Decision|0|||
163087119|NCT00855335|589027935|FG000|Overall Study|Other|2|||
163087120|NCT00855335|589027936|FG001|Overall Study|Other|1|||
163087121|NCT00855335|589027937|FG002|Overall Study|Other|2|||
163087122|NCT00855335|589027938|FG003|Overall Study|Other|5|||
163087123|NCT00855335|589027939|FG004|Overall Study|Other|1|||
163087124|NCT03097289|589027941|FG000|Overall Study|Adverse Event|1|||
163087125|NCT03097289|589027941|FG000|Overall Study|Equipment failure|2|||
163087126|NCT03097289|589027941|FG000|Overall Study|Collected platelet product unusable|3|||
163087127|NCT02526290|589027944|FG000|Overall Study|Adverse Event|3|||
163334989|NCT05615363|589936168|FG003|Overall Study|Adverse Event|3|||
163334990|NCT05615363|589936169|FG004|Overall Study|Adverse Event|1|||
163087128|NCT02526290|589027944|FG000|Overall Study|Withdrawal by Subject|4|||
163087129|NCT02526290|589027944|FG000|Overall Study|Physician Decision|1|||
163087130|NCT02082977|589027947|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
163087131|NCT02082977|589027948|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
163087132|NCT02082977|589027949|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
163087133|NCT02082977|589027950|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
163087134|NCT02082977|589027951|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
163087135|NCT02082977|589027952|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
163087136|NCT02082977|589027953|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
163087137|NCT02082977|589027954|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
163087138|NCT02082977|589027955|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
163087139|NCT02082977|589027956|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
163087140|NCT02082977|589027947|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163334991|NCT05615363|589936165|FG000|Overall Study|Physician Decision|2|||
163087141|NCT02082977|589027948|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163087142|NCT02082977|589027949|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163334992|NCT05615363|589936166|FG001|Overall Study|Physician Decision|0|||
163087143|NCT02082977|589027950|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163087144|NCT02082977|589027951|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163087145|NCT02082977|589027952|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163087146|NCT02082977|589027953|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163087147|NCT02082977|589027954|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
163087148|NCT02082977|589027955|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163087149|NCT02082977|589027956|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163087150|NCT02082977|589027947|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087151|NCT02082977|589027948|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087152|NCT02082977|589027949|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087153|NCT02082977|589027950|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087154|NCT02082977|589027951|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087155|NCT02082977|589027952|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
163087156|NCT02082977|589027953|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087157|NCT02082977|589027954|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087158|NCT02082977|589027955|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087159|NCT02082977|589027956|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087160|NCT02082977|589027947|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
163087161|NCT02082977|589027948|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
163087162|NCT02082977|589027949|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
163087163|NCT02082977|589027950|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
163087164|NCT02082977|589027951|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
163087165|NCT02082977|589027952|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
163087166|NCT02082977|589027953|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
163087167|NCT02082977|589027954|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
163087168|NCT02082977|589027955|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
163087169|NCT02082977|589027956|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
163087170|NCT02082977|589027947|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087171|NCT02082977|589027948|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087172|NCT02082977|589027949|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087173|NCT02082977|589027950|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087174|NCT02082977|589027951|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087175|NCT02082977|589027952|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087176|NCT02082977|589027953|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087177|NCT02082977|589027954|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
163087178|NCT02082977|589027955|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087179|NCT02082977|589027956|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087180|NCT00049543|589027957|FG000|Overall Study|still on treatment|2|||
163087181|NCT00049543|589027958|FG001|Overall Study|still on treatment|9|||
163087182|NCT02402647|589027968|FG000|Overall Study|Lost to Follow-up|13|||
163087183|NCT02402647|589027969|FG001|Overall Study|Lost to Follow-up|7|||
163087184|NCT02402647|589027968|FG000|Overall Study|Protocol Violation|1|||
163087185|NCT02402647|589027969|FG001|Overall Study|Protocol Violation|1|||
163087186|NCT02402647|589027968|FG000|Overall Study|scheduled and timed out|2|||
163087187|NCT02402647|589027969|FG001|Overall Study|scheduled and timed out|1|||
163087188|NCT02402647|589027968|FG000|Overall Study|medical illness|2|||
163087189|NCT02402647|589027969|FG001|Overall Study|medical illness|4|||
163087190|NCT02402647|589027968|FG000|Overall Study|Moved|2|||
163036657|NCT02734862|588840197|FG001|Part A|Withdrawal by Subject|1|||
163036658|NCT02734862|588840198|FG002|Part A|Withdrawal by Subject|2|||
163036659|NCT02734862|588840196|FG000|Part A|Physician Decision|2|||
163036660|NCT02734862|588840197|FG001|Part A|Physician Decision|0|||
163036661|NCT02734862|588840198|FG002|Part A|Physician Decision|1|||
163036662|NCT02734862|588840196|FG000|Part A|Adverse Event|2|||
163036663|NCT02734862|588840197|FG001|Part A|Adverse Event|0|||
163036664|NCT02734862|588840198|FG002|Part A|Adverse Event|1|||
163036665|NCT02734862|588840196|FG000|Part A|Noncompliance|1|||
163036666|NCT02734862|588840197|FG001|Part A|Noncompliance|1|||
163036667|NCT02734862|588840198|FG002|Part A|Noncompliance|0|||
163036668|NCT02734862|588840196|FG000|Part A|Other|1|||
163036669|NCT02734862|588840197|FG001|Part A|Other|1|||
163334993|NCT05615363|589936167|FG002|Overall Study|Physician Decision|4|||
163036670|NCT02734862|588840198|FG002|Part A|Other|3|||
163036671|NCT02734862|588840196|FG000|Part B|Death|8|||
163087191|NCT02402647|589027969|FG001|Overall Study|Moved|0|||
163087192|NCT02402647|589027968|FG000|Overall Study|loved one illness|1|||
163087193|NCT02402647|589027969|FG001|Overall Study|loved one illness|0|||
163087194|NCT02402647|589027968|FG000|Overall Study|deceased preexisting condition|2|||
163087195|NCT02402647|589027969|FG001|Overall Study|deceased preexisting condition|0|||
163087196|NCT02402647|589027968|FG000|Overall Study|Other|2|||
163334994|NCT05615363|589936168|FG003|Overall Study|Physician Decision|1|||
163036672|NCT02734862|588840197|FG001|Part B|Death|3|||
163087197|NCT02402647|589027969|FG001|Overall Study|Other|1|||
163036673|NCT02734862|588840198|FG002|Part B|Death|5|||
163036674|NCT02734862|588840196|FG000|Part B|Lost to Follow-up|2|||
163036675|NCT02734862|588840197|FG001|Part B|Lost to Follow-up|2|||
163036676|NCT02734862|588840198|FG002|Part B|Lost to Follow-up|0|||
163334995|NCT05615363|589936169|FG004|Overall Study|Physician Decision|3|||
163087198|NCT03557502|589027973|FG000|Protocol 2|Withdrawal by Subject|1|||
163087199|NCT03557502|589027974|FG001|Protocol 2|Withdrawal by Subject|1|||
163087200|NCT03557502|589027973|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
163087201|NCT03557502|589027974|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
163087202|NCT00618787|589027978|FG000|Overall Study|Adverse Event|0|||
163087203|NCT00618787|589027979|FG001|Overall Study|Adverse Event|1|||
163087204|NCT00618787|589027978|FG000|Overall Study|Withdrawal by Subject|2|||
163087205|NCT00618787|589027979|FG001|Overall Study|Withdrawal by Subject|1|||
163087206|NCT00618787|589027978|FG000|Overall Study|Lost to Follow-up|1|||
163087207|NCT00618787|589027979|FG001|Overall Study|Lost to Follow-up|0|||
163087208|NCT01994876|589027980|FG000|Test Period 1|Withdrawal by Subject|0|||
163087209|NCT01994876|589027981|FG001|Test Period 1|Withdrawal by Subject|1|||
163087210|NCT01994876|589027980|FG000|Test Period 1|Adverse Event|0|||
163087211|NCT01994876|589027981|FG001|Test Period 1|Adverse Event|1|||
163087212|NCT01994876|589027980|FG000|Test Period 2|Adverse Event|1|||
163087213|NCT01994876|589027981|FG001|Test Period 2|Adverse Event|0|||
163087214|NCT01994876|589027980|FG000|Test Period 2|Protocol Violation|0|||
163087215|NCT01994876|589027981|FG001|Test Period 2|Protocol Violation|1|||
163087216|NCT05819398|589027982|FG000|Overall Study|Withdrawal by Subject|11|||
163087217|NCT05819398|589027983|FG001|Overall Study|Withdrawal by Subject|7|||
163087218|NCT05819398|589027984|FG002|Overall Study|Withdrawal by Subject|6|||
163087219|NCT05819398|589027985|FG003|Overall Study|Withdrawal by Subject|6|||
163087220|NCT05819398|589027982|FG000|Overall Study|Lost to Follow-up|0|||
163087221|NCT05819398|589027983|FG001|Overall Study|Lost to Follow-up|2|||
163087222|NCT05819398|589027984|FG002|Overall Study|Lost to Follow-up|0|||
163087223|NCT05819398|589027985|FG003|Overall Study|Lost to Follow-up|1|||
163087224|NCT05819398|589027982|FG000|Overall Study|Adverse Event|1|||
163087225|NCT05819398|589027983|FG001|Overall Study|Adverse Event|3|||
163087226|NCT05819398|589027984|FG002|Overall Study|Adverse Event|4|||
163087227|NCT05819398|589027985|FG003|Overall Study|Adverse Event|5|||
163087228|NCT05819398|589027982|FG000|Overall Study|Other than listed|0|||
163087229|NCT05819398|589027983|FG001|Overall Study|Other than listed|2|||
163087230|NCT05819398|589027984|FG002|Overall Study|Other than listed|2|||
163087231|NCT05819398|589027985|FG003|Overall Study|Other than listed|0|||
163087232|NCT05819398|589027982|FG000|Overall Study|Lack of Efficacy|0|||
163087233|NCT05819398|589027983|FG001|Overall Study|Lack of Efficacy|1|||
163087234|NCT05819398|589027984|FG002|Overall Study|Lack of Efficacy|0|||
163087235|NCT05819398|589027985|FG003|Overall Study|Lack of Efficacy|0|||
163087236|NCT05819398|589027982|FG000|Overall Study|Study terminated by sponsor|20|||
163087237|NCT05819398|589027983|FG001|Overall Study|Study terminated by sponsor|18|||
163087238|NCT05819398|589027984|FG002|Overall Study|Study terminated by sponsor|20|||
163087239|NCT05819398|589027985|FG003|Overall Study|Study terminated by sponsor|22|||
163087240|NCT02520154|589027986|FG000|Overall Study|Death|1|||
163087241|NCT02520154|589027986|FG000|Overall Study|Withdrawal by Subject|2|||
163087242|NCT02520154|589027986|FG000|Overall Study|Physician Decision|2|||
163087243|NCT06022107|589027987|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
163087244|NCT06022107|589027987|FG000|Overall Study|Dropped out of study for higher level of care|1|||
163087245|NCT06022107|589027987|FG000|Overall Study|Lost to Follow-up|2|||
163087246|NCT03716830|589030275|FG000|Overall Study|Withdrawal by Subject|2|||
163087247|NCT03716830|589030276|FG001|Overall Study|Withdrawal by Subject|2|||
163087248|NCT03716830|589030277|FG002|Overall Study|Withdrawal by Subject|6|||
163087249|NCT03716830|589030278|FG003|Overall Study|Withdrawal by Subject|5|||
163087250|NCT03716830|589030275|FG000|Overall Study|Adverse Event|1|||
163087251|NCT03716830|589030276|FG001|Overall Study|Adverse Event|2|||
163087252|NCT03716830|589030277|FG002|Overall Study|Adverse Event|0|||
163087253|NCT03716830|589030278|FG003|Overall Study|Adverse Event|1|||
163087254|NCT03716830|589030275|FG000|Overall Study|Lost to Follow-up|1|||
163087255|NCT03716830|589030276|FG001|Overall Study|Lost to Follow-up|1|||
163087256|NCT03716830|589030277|FG002|Overall Study|Lost to Follow-up|0|||
163087257|NCT03716830|589030278|FG003|Overall Study|Lost to Follow-up|0|||
163087258|NCT04887831|589030279|FG000|Overall Study|Death|26|||
163087259|NCT04887831|589030280|FG001|Overall Study|Death|26|||
163087260|NCT04887831|589030279|FG000|Overall Study|Lost to Follow-up|0|||
163087261|NCT04887831|589030280|FG001|Overall Study|Lost to Follow-up|1|||
163087262|NCT04887831|589030279|FG000|Overall Study|Withdrawal by Subject|2|||
163087263|NCT04887831|589030280|FG001|Overall Study|Withdrawal by Subject|1|||
163087264|NCT04887831|589030279|FG000|Overall Study|Study Terminated by Sponsor|18|||
163087265|NCT04887831|589030280|FG001|Overall Study|Study Terminated by Sponsor|17|||
163087266|NCT04887831|589030279|FG000|Overall Study|Other|1|||
163087267|NCT04887831|589030280|FG001|Overall Study|Other|0|||
163087268|NCT02276040|589030286|FG000|Overall Study|Physician Decision|15|||
163087269|NCT02835690|589030287|FG000|Overall Study|Death|12|||
163087270|NCT02835690|589030288|FG001|Overall Study|Death|11|||
163087271|NCT02835690|589030289|FG002|Overall Study|Death|13|||
163087272|NCT02835690|589030287|FG000|Overall Study|Transferred to Extension Study|2|||
163087273|NCT02835690|589030288|FG001|Overall Study|Transferred to Extension Study|2|||
163087274|NCT02835690|589030289|FG002|Overall Study|Transferred to Extension Study|1|||
163087275|NCT02835690|589030287|FG000|Overall Study|Did Not Continue on Extension Study|0|||
163087276|NCT02835690|589030288|FG001|Overall Study|Did Not Continue on Extension Study|0|||
163087277|NCT02835690|589030289|FG002|Overall Study|Did Not Continue on Extension Study|1|||
163087278|NCT02835690|589030287|FG000|Overall Study|Not Treated|0|||
163087279|NCT02835690|589030288|FG001|Overall Study|Not Treated|2|||
163087280|NCT02835690|589030289|FG002|Overall Study|Not Treated|0|||
163087281|NCT03728933|589030290|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
163087282|NCT03728933|589030291|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163087283|NCT03728933|589030292|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163087284|NCT03728933|589030290|FG000|Overall Study|Withdrawal by Subject|0|||
163087285|NCT03728933|589030291|FG001|Overall Study|Withdrawal by Subject|0|||
163087286|NCT03728933|589030292|FG002|Overall Study|Withdrawal by Subject|1|||
163087287|NCT03728933|589030290|FG000|Overall Study|Lost to Follow-up|0|||
163087288|NCT03728933|589030291|FG001|Overall Study|Lost to Follow-up|1|||
163087289|NCT03728933|589030292|FG002|Overall Study|Lost to Follow-up|0|||
163087290|NCT03728933|589030290|FG000|Overall Study|Adverse Event|1|||
163087291|NCT03728933|589030291|FG001|Overall Study|Adverse Event|0|||
163334996|NCT05615363|589936165|FG000|Overall Study|Protocol Violation|2|||
163334997|NCT05615363|589936166|FG001|Overall Study|Protocol Violation|0|||
163334998|NCT05615363|589936167|FG002|Overall Study|Protocol Violation|0|||
163334999|NCT05615363|589936168|FG003|Overall Study|Protocol Violation|0|||
163335000|NCT05615363|589936169|FG004|Overall Study|Protocol Violation|1|||
163335001|NCT05615363|589936165|FG000|Overall Study|Withdrawal by Subject|0|||
163335002|NCT05615363|589936166|FG001|Overall Study|Withdrawal by Subject|0|||
163335003|NCT05615363|589936167|FG002|Overall Study|Withdrawal by Subject|1|||
163335004|NCT05615363|589936168|FG003|Overall Study|Withdrawal by Subject|0|||
163335005|NCT05615363|589936169|FG004|Overall Study|Withdrawal by Subject|0|||
163335006|NCT03905642|589936170|FG000|Overall Study|Withdrawal by Subject|3|||
163335007|NCT03905642|589936170|FG000|Overall Study|Pregnancy|1|||
163335008|NCT03905642|589936170|FG000|Overall Study|Adverse Event|1|||
163335009|NCT03905642|589936170|FG000|Overall Study|Lack of Efficacy|1|||
163335010|NCT03905642|589936170|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
163335011|NCT04447027|589936175|FG000|Dose Escalation|Withdrawal by Subject|1|||
163335012|NCT04447027|589936176|FG001|Dose Escalation|Withdrawal by Subject|4|||
163335013|NCT04447027|589936177|FG002|Dose Escalation|Withdrawal by Subject|3|||
163335014|NCT04447027|589936178|FG003|Dose Escalation|Withdrawal by Subject|3|||
163335015|NCT04447027|589936179|FG004|Dose Escalation|Withdrawal by Subject|1|||
163335016|NCT04447027|589936180|FG005|Dose Escalation|Withdrawal by Subject|0|||
163335017|NCT04447027|589936181|FG006|Dose Escalation|Withdrawal by Subject|0|||
163335018|NCT04447027|589936182|FG007|Dose Escalation|Withdrawal by Subject|0|||
163335019|NCT04447027|589936183|FG008|Dose Escalation|Withdrawal by Subject|0|||
163335020|NCT04447027|589936175|FG000|Dose Escalation|Refused further treatment|0|||
163335021|NCT04447027|589936176|FG001|Dose Escalation|Refused further treatment|1|||
163335022|NCT04447027|589936177|FG002|Dose Escalation|Refused further treatment|1|||
163335023|NCT04447027|589936178|FG003|Dose Escalation|Refused further treatment|0|||
163335024|NCT04447027|589936179|FG004|Dose Escalation|Refused further treatment|0|||
163335025|NCT04447027|589936180|FG005|Dose Escalation|Refused further treatment|0|||
163335026|NCT04447027|589936181|FG006|Dose Escalation|Refused further treatment|0|||
163335027|NCT04447027|589936182|FG007|Dose Escalation|Refused further treatment|0|||
163335028|NCT04447027|589936183|FG008|Dose Escalation|Refused further treatment|0|||
163335029|NCT04447027|589936175|FG000|Dose Expansion|Withdrawal by Subject|0|||
163335030|NCT04447027|589936176|FG001|Dose Expansion|Withdrawal by Subject|0|||
163335031|NCT04447027|589936177|FG002|Dose Expansion|Withdrawal by Subject|0|||
163335032|NCT04447027|589936178|FG003|Dose Expansion|Withdrawal by Subject|0|||
163335033|NCT04447027|589936179|FG004|Dose Expansion|Withdrawal by Subject|0|||
163335034|NCT04447027|589936180|FG005|Dose Expansion|Withdrawal by Subject|2|||
163335035|NCT04447027|589936181|FG006|Dose Expansion|Withdrawal by Subject|0|||
163335036|NCT04447027|589936182|FG007|Dose Expansion|Withdrawal by Subject|2|||
163335037|NCT04447027|589936183|FG008|Dose Expansion|Withdrawal by Subject|0|||
163335038|NCT00671853|589938686|FG000|Overall Study|Lack of Efficacy|3|||
163335039|NCT00671853|589938687|FG001|Overall Study|Lack of Efficacy|7|||
163335040|NCT00671853|589938686|FG000|Overall Study|Adverse Event|7|||
163335041|NCT00671853|589938687|FG001|Overall Study|Adverse Event|1|||
163335042|NCT00671853|589938686|FG000|Overall Study|Withdrawal by Subject|1|||
163335043|NCT00671853|589938687|FG001|Overall Study|Withdrawal by Subject|5|||
163335044|NCT00671853|589938686|FG000|Overall Study|Lost to Follow-up|8|||
163087292|NCT03728933|589030292|FG002|Overall Study|Adverse Event|0|||
163087293|NCT03674281|589030293|FG000|Overall Study|screen failure|2|||
163087294|NCT03674281|589030294|FG001|Overall Study|screen failure|0|||
163087295|NCT03674281|589030295|FG002|Overall Study|screen failure|0|||
163335045|NCT00671853|589938687|FG001|Overall Study|Lost to Follow-up|8|||
163335046|NCT00671853|589938686|FG000|Overall Study|Physician Decision|0|||
163335047|NCT00671853|589938687|FG001|Overall Study|Physician Decision|2|||
163335048|NCT00671853|589938686|FG000|Overall Study|Non-adherence with study procedures|1|||
163335049|NCT00671853|589938687|FG001|Overall Study|Non-adherence with study procedures|4|||
163335050|NCT02354417|589938688|FG000|Overall Study|Physician Decision|1|||
163335051|NCT01848483|589938689|FG000|Overall Study|Death|2|||
163087296|NCT03674281|589030293|FG000|Overall Study|Withdrawal by Subject|1|||
163087297|NCT03674281|589030294|FG001|Overall Study|Withdrawal by Subject|3|||
163087298|NCT03674281|589030295|FG002|Overall Study|Withdrawal by Subject|3|||
163087299|NCT04622592|589030301|FG000|Overall Study|Death|0|||
163087300|NCT04622592|589030302|FG001|Overall Study|Death|0|||
163087301|NCT04622592|589030303|FG002|Overall Study|Death|1|||
163087302|NCT04622592|589030304|FG003|Overall Study|Death|0|||
163087303|NCT04622592|589030305|FG004|Overall Study|Death|0|||
163087304|NCT04622592|589030306|FG005|Overall Study|Death|0|||
163087305|NCT04622592|589030307|FG006|Overall Study|Death|0|||
163087306|NCT04622592|589030308|FG007|Overall Study|Death|1|||
163087307|NCT04622592|589030301|FG000|Overall Study|Lost to Follow-up|0|||
163087308|NCT04622592|589030302|FG001|Overall Study|Lost to Follow-up|0|||
163036677|NCT02734862|588840196|FG000|Part B|Withdrawal by Subject|3|||
163036678|NCT02734862|588840197|FG001|Part B|Withdrawal by Subject|1|||
163036679|NCT02734862|588840198|FG002|Part B|Withdrawal by Subject|0|||
163036680|NCT02734862|588840196|FG000|Part B|Other|0|||
163036681|NCT02734862|588840197|FG001|Part B|Other|1|||
163036682|NCT02734862|588840198|FG002|Part B|Other|0|||
163036683|NCT02757625|588840199|FG000|Overall Study|Investigator's discretion|0|||
163036684|NCT02757625|588840200|FG001|Overall Study|Investigator's discretion|0|||
163036685|NCT02757625|588840201|FG002|Overall Study|Investigator's discretion|1|||
163036686|NCT02757625|588840202|FG003|Overall Study|Investigator's discretion|0|||
163036687|NCT02757625|588840199|FG000|Overall Study|Adverse Event|0|||
163036688|NCT02757625|588840200|FG001|Overall Study|Adverse Event|0|||
163036689|NCT02757625|588840201|FG002|Overall Study|Adverse Event|1|||
163036690|NCT02757625|588840202|FG003|Overall Study|Adverse Event|0|||
163036691|NCT00564278|588840203|FG000|Overall Study|Lost to Follow-up|35|||
163036692|NCT00564278|588840204|FG001|Overall Study|Lost to Follow-up|33|||
163036693|NCT00564278|588840203|FG000|Overall Study|Physician Decision|1|||
163036694|NCT00564278|588840204|FG001|Overall Study|Physician Decision|2|||
163036695|NCT00564278|588840203|FG000|Overall Study|Withdrawal by Subject|11|||
163036696|NCT00564278|588840204|FG001|Overall Study|Withdrawal by Subject|7|||
163036697|NCT02779075|588840205|FG000|Overall Study|Withdrawal by Subject|1|||
163036698|NCT02779075|588840206|FG001|Overall Study|Withdrawal by Subject|3|||
163036699|NCT02779075|588840205|FG000|Overall Study|IV lost during 2nd study|1|||
163036700|NCT02779075|588840206|FG001|Overall Study|IV lost during 2nd study|0|||
163036701|NCT00790556|588840207|FG000|Treatment Period 1|Physician Decision|1|||
163036702|NCT00790556|588840208|FG001|Treatment Period 1|Physician Decision|0|||
163036703|NCT00790556|588840207|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163036704|NCT00790556|588840208|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163036705|NCT03077607|588840209|FG000|Period 1 (15 Days)|Adverse Event|1|||
163036706|NCT03077607|588840210|FG001|Period 1 (15 Days)|Adverse Event|0|||
163036707|NCT03077607|588840209|FG000|Period 1 (15 Days)|Death|1|||
163036708|NCT03077607|588840210|FG001|Period 1 (15 Days)|Death|0|||
163036709|NCT03077607|588840209|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
163036710|NCT03077607|588840210|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
163036711|NCT03077607|588840209|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
163036712|NCT03077607|588840210|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
163036713|NCT04401202|588840212|FG000|Overall Study|Lost to Follow-up|2|||
163036714|NCT04401202|588840213|FG001|Overall Study|Lost to Follow-up|2|||
163036715|NCT04401202|588840212|FG000|Overall Study|Adverse Event|0|||
163036716|NCT04401202|588840213|FG001|Overall Study|Adverse Event|1|||
163036717|NCT04401202|588840212|FG000|Overall Study|Hospitalized|4|||
163036718|NCT04401202|588840213|FG001|Overall Study|Hospitalized|1|||
163036719|NCT02714036|588840214|FG000|Overall Study|Adverse Event|9|||
163036720|NCT02714036|588840215|FG001|Overall Study|Adverse Event|2|||
163036721|NCT02714036|588840214|FG000|Overall Study|Withdrawal by Subject|3|||
163036722|NCT02714036|588840215|FG001|Overall Study|Withdrawal by Subject|2|||
163036723|NCT05697627|588840219|FG000|Overall Study|Adverse Event|1|||
163036724|NCT04122625|588840220|FG000|Part A (up to 2.92 Years)|Death|2|||
163036725|NCT04122625|588840221|FG001|Part A (up to 2.92 Years)|Death|4|||
163036726|NCT04122625|588840222|FG002|Part A (up to 2.92 Years)|Death|0|||
163036727|NCT04122625|588840223|FG003|Part A (up to 2.92 Years)|Death|0|||
163036728|NCT04122625|588840224|FG004|Part A (up to 2.92 Years)|Death|0|||
163087309|NCT04622592|589030303|FG002|Overall Study|Lost to Follow-up|0|||
163036729|NCT04122625|588840225|FG005|Part A (up to 2.92 Years)|Death|0|||
163036730|NCT04122625|588840220|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
163036731|NCT04122625|588840221|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
163036732|NCT04122625|588840222|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
163036733|NCT04122625|588840223|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
163036734|NCT04122625|588840224|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
163036735|NCT04122625|588840225|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
163036736|NCT04122625|588840220|FG000|Part B (up to 2.33 Years)|Death|0|||
163036737|NCT04122625|588840221|FG001|Part B (up to 2.33 Years)|Death|0|||
163036738|NCT04122625|588840222|FG002|Part B (up to 2.33 Years)|Death|5|||
163087310|NCT04622592|589030304|FG003|Overall Study|Lost to Follow-up|3|||
163087311|NCT04622592|589030305|FG004|Overall Study|Lost to Follow-up|1|||
163087312|NCT04622592|589030306|FG005|Overall Study|Lost to Follow-up|0|||
163087313|NCT04622592|589030307|FG006|Overall Study|Lost to Follow-up|2|||
163335052|NCT01848483|589938690|FG001|Overall Study|Death|1|||
163335053|NCT01848483|589938689|FG000|Overall Study|Lost to Follow-up|6|||
163335054|NCT01848483|589938690|FG001|Overall Study|Lost to Follow-up|8|||
163335055|NCT01848483|589938689|FG000|Overall Study|Withdrawal by Subject|1|||
163335056|NCT01848483|589938690|FG001|Overall Study|Withdrawal by Subject|0|||
163335057|NCT01848483|589938689|FG000|Overall Study|Incarceration|2|||
163335058|NCT01848483|589938690|FG001|Overall Study|Incarceration|2|||
163335059|NCT02236611|589938693|FG000|Overall Study|Adverse Event|10|||
163087314|NCT04622592|589030308|FG007|Overall Study|Lost to Follow-up|2|||
163087315|NCT04622592|589030301|FG000|Overall Study|Physician Decision|0|||
163087316|NCT04622592|589030302|FG001|Overall Study|Physician Decision|0|||
163087317|NCT04622592|589030303|FG002|Overall Study|Physician Decision|0|||
163087318|NCT04622592|589030304|FG003|Overall Study|Physician Decision|0|||
163087319|NCT04622592|589030305|FG004|Overall Study|Physician Decision|1|||
163087320|NCT04622592|589030306|FG005|Overall Study|Physician Decision|0|||
163087321|NCT04622592|589030307|FG006|Overall Study|Physician Decision|0|||
163087322|NCT04622592|589030308|FG007|Overall Study|Physician Decision|0|||
163087323|NCT04622592|589030301|FG000|Overall Study|Withdrawal by Subject|1|||
163087324|NCT04622592|589030302|FG001|Overall Study|Withdrawal by Subject|0|||
163087325|NCT04622592|589030303|FG002|Overall Study|Withdrawal by Subject|2|||
163087326|NCT04622592|589030304|FG003|Overall Study|Withdrawal by Subject|0|||
163335060|NCT02236611|589938694|FG001|Overall Study|Adverse Event|16|||
163335061|NCT02236611|589938693|FG000|Overall Study|Lack of Efficacy|4|||
163335062|NCT02236611|589938694|FG001|Overall Study|Lack of Efficacy|7|||
163335063|NCT02236611|589938693|FG000|Overall Study|Lost to Follow-up|0|||
163335064|NCT02236611|589938694|FG001|Overall Study|Lost to Follow-up|2|||
163335065|NCT02236611|589938693|FG000|Overall Study|Protocol deviation|3|||
163335066|NCT02236611|589938694|FG001|Overall Study|Protocol deviation|5|||
163335067|NCT02236611|589938693|FG000|Overall Study|Withdrew consent|9|||
163335068|NCT02236611|589938694|FG001|Overall Study|Withdrew consent|4|||
163335069|NCT03041090|589938695|FG000|Overall Study|technical error|0|||
163335070|NCT03041090|589938696|FG001|Overall Study|technical error|3|||
163335071|NCT02202317|589938697|FG000|Overall Study|Lost to Follow-up|1|||
163335072|NCT02338999|589938698|FG000|First Intervention|Withdrawal by Subject|3|||
163335073|NCT02338999|589938699|FG001|First Intervention|Withdrawal by Subject|1|||
163335074|NCT02338999|589938698|FG000|Washout Period|Withdrawal by Subject|0|||
163335075|NCT02338999|589938699|FG001|Washout Period|Withdrawal by Subject|2|||
163335076|NCT02338999|589938698|FG000|Second Intervention|Withdrawal by Subject|0|||
163335077|NCT02338999|589938699|FG001|Second Intervention|Withdrawal by Subject|2|||
163335078|NCT02701296|589938700|FG000|Overall Study|Incomplete Data|0|||
163335079|NCT02701296|589938701|FG001|Overall Study|Incomplete Data|2|||
163335080|NCT01332266|589938702|FG000|Phase 1b|Death|3|||
163335081|NCT01332266|589938703|FG001|Phase 1b|Death|3|||
163335082|NCT01332266|589938704|FG002|Phase 1b|Death|2|||
163335083|NCT01332266|589938705|FG003|Phase 1b|Death|0|||
163335084|NCT01332266|589938706|FG004|Phase 1b|Death|0|||
163087327|NCT04622592|589030305|FG004|Overall Study|Withdrawal by Subject|0|||
163087328|NCT04622592|589030306|FG005|Overall Study|Withdrawal by Subject|0|||
163087329|NCT04622592|589030307|FG006|Overall Study|Withdrawal by Subject|1|||
163087330|NCT04622592|589030308|FG007|Overall Study|Withdrawal by Subject|4|||
163087331|NCT04622592|589030301|FG000|Overall Study|Other than specified above|0|||
163087332|NCT04622592|589030302|FG001|Overall Study|Other than specified above|0|||
163087333|NCT04622592|589030303|FG002|Overall Study|Other than specified above|1|||
163087334|NCT04622592|589030304|FG003|Overall Study|Other than specified above|0|||
163087335|NCT04622592|589030305|FG004|Overall Study|Other than specified above|0|||
163087336|NCT04622592|589030306|FG005|Overall Study|Other than specified above|0|||
163087337|NCT04622592|589030307|FG006|Overall Study|Other than specified above|0|||
163087338|NCT04622592|589030308|FG007|Overall Study|Other than specified above|0|||
163087339|NCT00560508|589030311|FG000|12 Week Double-blind Period|Adverse Event|3|||
163087340|NCT00560508|589030312|FG001|12 Week Double-blind Period|Adverse Event|2|||
163087341|NCT00560508|589030311|FG000|12 Week Double-blind Period|Protocol Violation|1|||
163087342|NCT00560508|589030312|FG001|12 Week Double-blind Period|Protocol Violation|0|||
163087343|NCT00560508|589030311|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
163335085|NCT01332266|589938702|FG000|Phase 1b|Lost to Follow-up|0|||
163335086|NCT01332266|589938703|FG001|Phase 1b|Lost to Follow-up|1|||
163335087|NCT01332266|589938704|FG002|Phase 1b|Lost to Follow-up|0|||
163335088|NCT01332266|589938705|FG003|Phase 1b|Lost to Follow-up|0|||
163087344|NCT00560508|589030312|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
163087345|NCT00560508|589030311|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
163087346|NCT00560508|589030312|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
163087347|NCT00560508|589030311|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
163087348|NCT00560508|589030312|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
163335089|NCT01332266|589938706|FG004|Phase 1b|Lost to Follow-up|0|||
163335090|NCT01332266|589938702|FG000|Phase 1b|Withdrawal by Subject|1|||
163087349|NCT00560508|589030311|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
163335091|NCT01332266|589938703|FG001|Phase 1b|Withdrawal by Subject|1|||
163335092|NCT01332266|589938704|FG002|Phase 1b|Withdrawal by Subject|1|||
163335093|NCT01332266|589938705|FG003|Phase 1b|Withdrawal by Subject|0|||
163335094|NCT01332266|589938706|FG004|Phase 1b|Withdrawal by Subject|0|||
163335095|NCT01332266|589938702|FG000|Phase 2|Death|0|||
163335096|NCT01332266|589938703|FG001|Phase 2|Death|0|||
163335097|NCT01332266|589938704|FG002|Phase 2|Death|0|||
163335098|NCT01332266|589938705|FG003|Phase 2|Death|33|||
163335099|NCT01332266|589938706|FG004|Phase 2|Death|36|||
163335100|NCT01332266|589938702|FG000|Phase 2|Lost to Follow-up|0|||
163335101|NCT01332266|589938703|FG001|Phase 2|Lost to Follow-up|0|||
163335102|NCT01332266|589938704|FG002|Phase 2|Lost to Follow-up|0|||
163335103|NCT01332266|589938705|FG003|Phase 2|Lost to Follow-up|2|||
163335104|NCT01332266|589938706|FG004|Phase 2|Lost to Follow-up|0|||
163335105|NCT01332266|589938702|FG000|Phase 2|Physician Decision|0|||
163335106|NCT01332266|589938703|FG001|Phase 2|Physician Decision|0|||
163335107|NCT01332266|589938704|FG002|Phase 2|Physician Decision|0|||
163335108|NCT01332266|589938705|FG003|Phase 2|Physician Decision|3|||
163335109|NCT01332266|589938706|FG004|Phase 2|Physician Decision|1|||
163335110|NCT01332266|589938702|FG000|Phase 2|Symptomatic deterioration|0|||
163335111|NCT01332266|589938703|FG001|Phase 2|Symptomatic deterioration|0|||
163335112|NCT01332266|589938704|FG002|Phase 2|Symptomatic deterioration|0|||
163335113|NCT01332266|589938705|FG003|Phase 2|Symptomatic deterioration|0|||
163335114|NCT01332266|589938706|FG004|Phase 2|Symptomatic deterioration|1|||
163335115|NCT01332266|589938702|FG000|Phase 2|Progression Disease|0|||
163335116|NCT01332266|589938703|FG001|Phase 2|Progression Disease|0|||
163335117|NCT01332266|589938704|FG002|Phase 2|Progression Disease|0|||
163335118|NCT01332266|589938705|FG003|Phase 2|Progression Disease|2|||
163335119|NCT01332266|589938706|FG004|Phase 2|Progression Disease|1|||
163335120|NCT01332266|589938702|FG000|Phase 2|Withdrawal by Subject|0|||
163335121|NCT01332266|589938703|FG001|Phase 2|Withdrawal by Subject|0|||
163335122|NCT01332266|589938704|FG002|Phase 2|Withdrawal by Subject|0|||
163335123|NCT01332266|589938705|FG003|Phase 2|Withdrawal by Subject|2|||
163335124|NCT01332266|589938706|FG004|Phase 2|Withdrawal by Subject|2|||
163335125|NCT01686152|589938709|FG000|Overall Study|Withdrawal by Subject|11|||
163335126|NCT01686152|589938710|FG001|Overall Study|Withdrawal by Subject|11|||
163335127|NCT01686152|589938711|FG002|Overall Study|Withdrawal by Subject|3|||
163335128|NCT01686152|589938709|FG000|Overall Study|Drug Code Unblinded|0|||
163335129|NCT01686152|589938710|FG001|Overall Study|Drug Code Unblinded|1|||
163335130|NCT01686152|589938711|FG002|Overall Study|Drug Code Unblinded|0|||
163335131|NCT01686152|589938709|FG000|Overall Study|Protocol Violation|6|||
163335132|NCT01686152|589938710|FG001|Overall Study|Protocol Violation|1|||
163335133|NCT01686152|589938711|FG002|Overall Study|Protocol Violation|0|||
163335134|NCT01686152|589938709|FG000|Overall Study|Adverse Event|12|||
163335135|NCT01686152|589938710|FG001|Overall Study|Adverse Event|11|||
163335136|NCT01686152|589938711|FG002|Overall Study|Adverse Event|0|||
163335137|NCT01686152|589938709|FG000|Overall Study|Lack of Efficacy|0|||
163335138|NCT01686152|589938710|FG001|Overall Study|Lack of Efficacy|0|||
163335139|NCT01686152|589938711|FG002|Overall Study|Lack of Efficacy|1|||
163335140|NCT01686152|589938709|FG000|Overall Study|IP Non-compliance|5|||
163335141|NCT01686152|589938710|FG001|Overall Study|IP Non-compliance|5|||
163335142|NCT01686152|589938711|FG002|Overall Study|IP Non-compliance|0|||
163335143|NCT01686152|589938709|FG000|Overall Study|Lost to Follow-up|7|||
163335144|NCT01686152|589938710|FG001|Overall Study|Lost to Follow-up|6|||
163036739|NCT04122625|588840223|FG003|Part B (up to 2.33 Years)|Death|7|||
163036740|NCT04122625|588840224|FG004|Part B (up to 2.33 Years)|Death|6|||
163036741|NCT04122625|588840225|FG005|Part B (up to 2.33 Years)|Death|7|||
163036742|NCT04165135|588840228|FG000|Overall Study|Protocol Violation|10|||
163036743|NCT04165135|588840228|FG000|Overall Study|Participants withdrawal of consent|5|||
163036744|NCT00530790|588840229|FG000|Overall Study|Adverse Event|2|||
163036745|NCT00530790|588840229|FG000|Overall Study|Withdrawal by Subject|2|||
163036746|NCT00530790|588840229|FG000|Overall Study|Physician Decision|1|||
163036747|NCT01618916|588840234|FG000|Overall Study|Adverse Event|1|||
163036748|NCT01618916|588840235|FG001|Overall Study|Adverse Event|0|||
163036749|NCT01618916|588840236|FG002|Overall Study|Adverse Event|0|||
163036750|NCT01618916|588840237|FG003|Overall Study|Adverse Event|0|||
163036751|NCT01618916|588840238|FG004|Overall Study|Adverse Event|0|||
163036752|NCT01618916|588840239|FG005|Overall Study|Adverse Event|0|||
163335145|NCT01686152|589938711|FG002|Overall Study|Lost to Follow-up|5|||
163335146|NCT01802333|589938712|FG000|Overall Study|Ineligible|2|||
163335147|NCT01802333|589938713|FG001|Overall Study|Ineligible|6|||
163335148|NCT01802333|589938714|FG002|Overall Study|Ineligible|8|||
163036753|NCT01618916|588840234|FG000|Overall Study|Withdrawal by Subject|0|||
163036754|NCT01618916|588840235|FG001|Overall Study|Withdrawal by Subject|1|||
163335149|NCT01802333|589938712|FG000|Overall Study|Adverse Event|1|||
163335150|NCT01802333|589938713|FG001|Overall Study|Adverse Event|8|||
163335151|NCT01802333|589938714|FG002|Overall Study|Adverse Event|8|||
163335152|NCT01802333|589938712|FG000|Overall Study|Withdrawal by Subject|6|||
163335153|NCT01802333|589938713|FG001|Overall Study|Withdrawal by Subject|6|||
163335154|NCT01802333|589938714|FG002|Overall Study|Withdrawal by Subject|5|||
163335155|NCT01802333|589938712|FG000|Overall Study|Progression/relapse|1|||
163335156|NCT01802333|589938713|FG001|Overall Study|Progression/relapse|3|||
163335157|NCT01802333|589938714|FG002|Overall Study|Progression/relapse|0|||
163335158|NCT01802333|589938712|FG000|Overall Study|Death|7|||
163407102|NCT01225731|590198781|FG001|Part 3|Adverse Event|0|||
163407103|NCT01225731|590198782|FG002|Part 3|Adverse Event|0|||
163407104|NCT01225731|590198783|FG003|Part 3|Adverse Event|0|||
163407105|NCT01225731|590198784|FG004|Part 3|Adverse Event|0|||
163407106|NCT01225731|590198785|FG005|Part 3|Adverse Event|0|||
163407107|NCT01225731|590198786|FG006|Part 3|Adverse Event|0|||
163407108|NCT01225731|590198787|FG007|Part 3|Adverse Event|0|||
163407109|NCT01225731|590198788|FG008|Part 3|Adverse Event|0|||
163407110|NCT01225731|590198789|FG009|Part 3|Adverse Event|0|||
163407111|NCT01225731|590198790|FG010|Part 3|Adverse Event|1|||
163407112|NCT01225731|590198791|FG011|Part 3|Adverse Event|1|||
163407113|NCT01225731|590198792|FG012|Part 3|Adverse Event|0|||
163407114|NCT01225731|590198780|FG000|Part 3|Lost to Follow-up|0|||
163407115|NCT01225731|590198781|FG001|Part 3|Lost to Follow-up|0|||
163407116|NCT01225731|590198782|FG002|Part 3|Lost to Follow-up|0|||
163407117|NCT01225731|590198783|FG003|Part 3|Lost to Follow-up|0|||
163407118|NCT01225731|590198784|FG004|Part 3|Lost to Follow-up|0|||
163407119|NCT01225731|590198785|FG005|Part 3|Lost to Follow-up|0|||
163407120|NCT01225731|590198786|FG006|Part 3|Lost to Follow-up|0|||
163407121|NCT01225731|590198787|FG007|Part 3|Lost to Follow-up|0|||
163407122|NCT01225731|590198788|FG008|Part 3|Lost to Follow-up|0|||
163407123|NCT01225731|590198789|FG009|Part 3|Lost to Follow-up|0|||
163407124|NCT01225731|590198790|FG010|Part 3|Lost to Follow-up|1|||
163407125|NCT01225731|590198791|FG011|Part 3|Lost to Follow-up|2|||
163407126|NCT01225731|590198792|FG012|Part 3|Lost to Follow-up|1|||
163407127|NCT01225731|590198780|FG000|Part 3|Physician Decision|0|||
163407128|NCT01225731|590198781|FG001|Part 3|Physician Decision|0|||
163407129|NCT01225731|590198782|FG002|Part 3|Physician Decision|0|||
163407130|NCT01225731|590198783|FG003|Part 3|Physician Decision|0|||
163407131|NCT01225731|590198784|FG004|Part 3|Physician Decision|0|||
163407132|NCT01225731|590198785|FG005|Part 3|Physician Decision|0|||
163407133|NCT01225731|590198786|FG006|Part 3|Physician Decision|0|||
163407134|NCT01225731|590198787|FG007|Part 3|Physician Decision|0|||
163407135|NCT01225731|590198788|FG008|Part 3|Physician Decision|0|||
163407136|NCT01225731|590198789|FG009|Part 3|Physician Decision|0|||
163407137|NCT01225731|590198790|FG010|Part 3|Physician Decision|0|||
163407138|NCT01225731|590198791|FG011|Part 3|Physician Decision|1|||
163407139|NCT01225731|590198792|FG012|Part 3|Physician Decision|2|||
163407140|NCT01225731|590198780|FG000|Part 3|Withdrawal by Subject|0|||
163407141|NCT01225731|590198781|FG001|Part 3|Withdrawal by Subject|0|||
163407142|NCT01225731|590198782|FG002|Part 3|Withdrawal by Subject|0|||
163407143|NCT01225731|590198783|FG003|Part 3|Withdrawal by Subject|0|||
163407144|NCT01225731|590198784|FG004|Part 3|Withdrawal by Subject|0|||
163407145|NCT01225731|590198785|FG005|Part 3|Withdrawal by Subject|0|||
163407146|NCT01225731|590198786|FG006|Part 3|Withdrawal by Subject|0|||
163407147|NCT01225731|590198787|FG007|Part 3|Withdrawal by Subject|0|||
163407148|NCT01225731|590198788|FG008|Part 3|Withdrawal by Subject|0|||
163407149|NCT01225731|590198789|FG009|Part 3|Withdrawal by Subject|0|||
163407150|NCT01225731|590198790|FG010|Part 3|Withdrawal by Subject|4|||
163407151|NCT01225731|590198791|FG011|Part 3|Withdrawal by Subject|6|||
163407152|NCT01225731|590198792|FG012|Part 3|Withdrawal by Subject|4|||
163407153|NCT00577642|590198793|FG000|Overall Study|Clinical Disease Progression|1|||
163407154|NCT00542269|590198799|FG000|Overall Study|Adverse Event|10|||
163087350|NCT00560508|589030312|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
163087351|NCT00560508|589030311|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
163087352|NCT00560508|589030312|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
163407155|NCT00542269|590198800|FG001|Overall Study|Adverse Event|4|||
163087353|NCT02448381|589030315|FG000|Overall Study|Adverse Event|2|||
163087354|NCT02448381|589030316|FG001|Overall Study|Adverse Event|0|||
163087355|NCT02448381|589030315|FG000|Overall Study|Lost to Follow-up|16|||
163087356|NCT02448381|589030316|FG001|Overall Study|Lost to Follow-up|9|||
163087357|NCT02448381|589030315|FG000|Overall Study|Physician Decision|1|||
163087358|NCT02448381|589030316|FG001|Overall Study|Physician Decision|1|||
163087359|NCT02448381|589030315|FG000|Overall Study|Pregnancy|1|||
163087360|NCT02448381|589030316|FG001|Overall Study|Pregnancy|0|||
163087361|NCT02448381|589030315|FG000|Overall Study|Withdrawal by Subject|13|||
163087362|NCT02448381|589030316|FG001|Overall Study|Withdrawal by Subject|9|||
163087363|NCT02448381|589030315|FG000|Overall Study|Noncompliance with Study Procedures|2|||
163087364|NCT02448381|589030316|FG001|Overall Study|Noncompliance with Study Procedures|0|||
163407156|NCT00542269|590198801|FG002|Overall Study|Adverse Event|5|||
163407157|NCT00542269|590198799|FG000|Overall Study|Protocol Violation|1|||
163407158|NCT00542269|590198800|FG001|Overall Study|Protocol Violation|1|||
163407159|NCT00542269|590198801|FG002|Overall Study|Protocol Violation|0|||
163407160|NCT00542269|590198799|FG000|Overall Study|Withdrawal by Subject|1|||
163407161|NCT00542269|590198800|FG001|Overall Study|Withdrawal by Subject|0|||
163407162|NCT00542269|590198801|FG002|Overall Study|Withdrawal by Subject|0|||
163407163|NCT00542269|590198799|FG000|Overall Study|Administrative problems|1|||
163407164|NCT00542269|590198800|FG001|Overall Study|Administrative problems|1|||
163407165|NCT00542269|590198801|FG002|Overall Study|Administrative problems|1|||
163407166|NCT00490451|590198802|FG000|Overall Study|Adverse Event|3|||
163407167|NCT00490451|590198803|FG001|Overall Study|Adverse Event|3|||
163407168|NCT00490451|590198802|FG000|Overall Study|Death|3|||
163407169|NCT00490451|590198803|FG001|Overall Study|Death|1|||
163407170|NCT00490451|590198802|FG000|Overall Study|Withdrawal by Subject|2|||
163407171|NCT00490451|590198803|FG001|Overall Study|Withdrawal by Subject|0|||
163407172|NCT00490451|590198802|FG000|Overall Study|Investigator Decision|1|||
163407173|NCT00490451|590198803|FG001|Overall Study|Investigator Decision|0|||
163407174|NCT00490451|590198802|FG000|Overall Study|Protocol Violation|1|||
163407175|NCT00490451|590198803|FG001|Overall Study|Protocol Violation|0|||
163407176|NCT00490451|590198802|FG000|Overall Study|Progressive Disease|53|||
163407177|NCT00490451|590198803|FG001|Overall Study|Progressive Disease|34|||
163407178|NCT00550680|590198806|FG000|Overall Study|Administrative Reasons|1|||
163407179|NCT00550680|590198806|FG000|Overall Study|Adverse Event|5|||
163407180|NCT00550680|590198806|FG000|Overall Study|Death|3|||
163407181|NCT00550680|590198806|FG000|Overall Study|Early Improvement|1|||
163407182|NCT00550680|590198806|FG000|Overall Study|Lost to Follow-up|3|||
163407183|NCT00550680|590198806|FG000|Overall Study|Lack of Efficacy|1|||
163407184|NCT00550680|590198806|FG000|Overall Study|Other|10|||
163407185|NCT00550680|590198806|FG000|Overall Study|Protocol Violation|7|||
163407186|NCT00550680|590198806|FG000|Overall Study|Refused Treatment|19|||
163407187|NCT00550680|590198806|FG000|Overall Study|Screen Failure|6|||
163407188|NCT01967550|590198807|FG000|Overall Study|Withdrawal by Subject|1|||
163407189|NCT01967550|590198808|FG001|Overall Study|Withdrawal by Subject|0|||
163407190|NCT01967550|590198807|FG000|Overall Study|Adverse Event|2|||
163407191|NCT01967550|590198808|FG001|Overall Study|Adverse Event|0|||
163087365|NCT04617860|589030319|FG000|Overall Study|Adverse Event|0|||
163087366|NCT04617860|589030320|FG001|Overall Study|Adverse Event|2|||
163087367|NCT04617860|589030321|FG002|Overall Study|Adverse Event|2|||
163087368|NCT04617860|589030319|FG000|Overall Study|Withdrawal by Subject|0|||
163087369|NCT04617860|589030320|FG001|Overall Study|Withdrawal by Subject|0|||
163087370|NCT04617860|589030321|FG002|Overall Study|Withdrawal by Subject|2|||
163087371|NCT04617860|589030319|FG000|Overall Study|Physician Decision|0|||
163087372|NCT04617860|589030320|FG001|Overall Study|Physician Decision|1|||
163087373|NCT04617860|589030321|FG002|Overall Study|Physician Decision|0|||
163087374|NCT04617860|589030319|FG000|Overall Study|Sponsor Decision|0|||
163087375|NCT04617860|589030320|FG001|Overall Study|Sponsor Decision|3|||
163087376|NCT04617860|589030321|FG002|Overall Study|Sponsor Decision|1|||
163087377|NCT04617860|589030319|FG000|Overall Study|Termination of Study by Sponsor|8|||
163087378|NCT04617860|589030320|FG001|Overall Study|Termination of Study by Sponsor|4|||
163087379|NCT04617860|589030321|FG002|Overall Study|Termination of Study by Sponsor|13|||
163087380|NCT02735200|589030326|FG000|Overall Study|Lost to Follow-up|0|||
163087381|NCT02735200|589030327|FG001|Overall Study|Lost to Follow-up|5|||
163087382|NCT02735200|589030326|FG000|Overall Study|Withdrawal by Subject|8|||
163087383|NCT02735200|589030327|FG001|Overall Study|Withdrawal by Subject|0|||
163087384|NCT02115321|589030331|FG000|Overall Study|Death|1|||
163087385|NCT02115321|589030332|FG001|Overall Study|Death|0|||
163087386|NCT04403919|589030333|FG000|Overall Study|Lost to Follow-up|0|||
163087387|NCT04403919|589030334|FG001|Overall Study|Lost to Follow-up|0|||
163087388|NCT04403919|589030335|FG002|Overall Study|Lost to Follow-up|0|||
163087389|NCT04403919|589030336|FG003|Overall Study|Lost to Follow-up|1|||
163087390|NCT00023595|589030339|FG000|5 Year Follow up|Lost to Follow-up|2|||
163087391|NCT00023595|589030340|FG001|5 Year Follow up|Lost to Follow-up|2|||
163087392|NCT00023595|589030341|FG002|5 Year Follow up|Lost to Follow-up|1|||
163087393|NCT00023595|589030342|FG003|5 Year Follow up|Lost to Follow-up|7|||
163087394|NCT00023595|589030343|FG004|5 Year Follow up|Lost to Follow-up|3|||
163087395|NCT00023595|589030339|FG000|10 Year Follow up|Lost to Follow-up|12|||
163087396|NCT00023595|589030340|FG001|10 Year Follow up|Lost to Follow-up|10|||
163087397|NCT00023595|589030341|FG002|10 Year Follow up|Lost to Follow-up|3|||
163087398|NCT00023595|589030342|FG003|10 Year Follow up|Lost to Follow-up|0|||
163087399|NCT00023595|589030343|FG004|10 Year Follow up|Lost to Follow-up|0|||
163087400|NCT02106832|589030346|FG000|Overall Study|Adverse Event|1|||
163087401|NCT02106832|589030347|FG001|Overall Study|Adverse Event|2|||
163087402|NCT02106832|589030348|FG002|Overall Study|Adverse Event|3|||
163087403|NCT02106832|589030349|FG003|Overall Study|Adverse Event|0|||
163407192|NCT01967550|590198807|FG000|Overall Study|Protocol Violation|2|||
163407193|NCT01967550|590198808|FG001|Overall Study|Protocol Violation|1|||
163087404|NCT02106832|589030346|FG000|Overall Study|Death|4|||
163087405|NCT02106832|589030347|FG001|Overall Study|Death|4|||
163087406|NCT02106832|589030348|FG002|Overall Study|Death|1|||
163087407|NCT02106832|589030349|FG003|Overall Study|Death|4|||
163087408|NCT02106832|589030346|FG000|Overall Study|Deterioration of general conditions|0|||
163087409|NCT02106832|589030347|FG001|Overall Study|Deterioration of general conditions|0|||
163407194|NCT01967550|590198807|FG000|Overall Study|Non Compliance|0|||
163087410|NCT02106832|589030348|FG002|Overall Study|Deterioration of general conditions|1|||
163087411|NCT02106832|589030349|FG003|Overall Study|Deterioration of general conditions|0|||
163087412|NCT02106832|589030346|FG000|Overall Study|Lost to Follow-up|0|||
163087413|NCT02106832|589030347|FG001|Overall Study|Lost to Follow-up|1|||
163087414|NCT02106832|589030348|FG002|Overall Study|Lost to Follow-up|1|||
163407195|NCT01967550|590198808|FG001|Overall Study|Non Compliance|1|||
163407196|NCT04099251|590200751|FG000|Pre-Treatment|Other reasons|1|||
163407197|NCT04099251|590200752|FG001|Pre-Treatment|Other reasons|0|||
163087415|NCT02106832|589030349|FG003|Overall Study|Lost to Follow-up|3|||
163087416|NCT02106832|589030346|FG000|Overall Study|Physician Decision|1|||
163087417|NCT02106832|589030347|FG001|Overall Study|Physician Decision|0|||
163087418|NCT02106832|589030348|FG002|Overall Study|Physician Decision|0|||
163087419|NCT02106832|589030349|FG003|Overall Study|Physician Decision|0|||
163087420|NCT02106832|589030346|FG000|Overall Study|Protocol Violation|0|||
163087421|NCT02106832|589030347|FG001|Overall Study|Protocol Violation|0|||
163087422|NCT02106832|589030348|FG002|Overall Study|Protocol Violation|0|||
163087423|NCT02106832|589030349|FG003|Overall Study|Protocol Violation|1|||
163087424|NCT02106832|589030346|FG000|Overall Study|Withdrawal by Subject|17|||
163087425|NCT02106832|589030347|FG001|Overall Study|Withdrawal by Subject|17|||
163087426|NCT02106832|589030348|FG002|Overall Study|Withdrawal by Subject|10|||
163087427|NCT02106832|589030349|FG003|Overall Study|Withdrawal by Subject|7|||
163087428|NCT02106832|589030346|FG000|Overall Study|Technical problems|0|||
163087429|NCT02106832|589030347|FG001|Overall Study|Technical problems|1|||
163087430|NCT02106832|589030348|FG002|Overall Study|Technical problems|0|||
163087431|NCT02106832|589030349|FG003|Overall Study|Technical problems|0|||
163087432|NCT00619866|589030366|FG000|Weeks 1 - 12|Adverse Event|0|||
163087433|NCT00619866|589030367|FG001|Weeks 1 - 12|Adverse Event|1|||
163087434|NCT00619866|589030368|FG002|Weeks 1 - 12|Adverse Event|2|||
163087435|NCT00619866|589030369|FG003|Weeks 1 - 12|Adverse Event|0|||
163087436|NCT00619866|589030370|FG004|Weeks 1 - 12|Adverse Event|0|||
163087437|NCT00619866|589030366|FG000|Weeks 1 - 12|Non-compliance|0|||
163087438|NCT00619866|589030367|FG001|Weeks 1 - 12|Non-compliance|0|||
163087439|NCT00619866|589030368|FG002|Weeks 1 - 12|Non-compliance|1|||
163087440|NCT00619866|589030369|FG003|Weeks 1 - 12|Non-compliance|0|||
163087441|NCT00619866|589030370|FG004|Weeks 1 - 12|Non-compliance|0|||
163087442|NCT00619866|589030366|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
163087443|NCT00619866|589030367|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
163087444|NCT00619866|589030368|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
163087445|NCT00619866|589030369|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
163087446|NCT00619866|589030370|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
163087447|NCT00619866|589030366|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
163087448|NCT00619866|589030367|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
163087449|NCT00619866|589030368|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
163087450|NCT00619866|589030369|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
163087451|NCT00619866|589030370|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
163087452|NCT00619866|589030366|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
163087453|NCT00619866|589030367|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
163087454|NCT00619866|589030368|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
163087455|NCT00619866|589030369|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
163087456|NCT00619866|589030370|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
163087457|NCT00619866|589030366|FG000|Weeks 1 - 12|Sponsor Decision|0|||
163087458|NCT00619866|589030367|FG001|Weeks 1 - 12|Sponsor Decision|1|||
163087459|NCT00619866|589030368|FG002|Weeks 1 - 12|Sponsor Decision|0|||
163087460|NCT00619866|589030369|FG003|Weeks 1 - 12|Sponsor Decision|0|||
163087461|NCT00619866|589030370|FG004|Weeks 1 - 12|Sponsor Decision|0|||
163087462|NCT00619866|589030366|FG000|Weeks 13 - 24|Adverse Event|0|||
163087463|NCT00619866|589030367|FG001|Weeks 13 - 24|Adverse Event|0|||
163087464|NCT00619866|589030368|FG002|Weeks 13 - 24|Adverse Event|2|||
163087465|NCT00619866|589030369|FG003|Weeks 13 - 24|Adverse Event|1|||
163087466|NCT00619866|589030370|FG004|Weeks 13 - 24|Adverse Event|0|||
163087467|NCT00619866|589030366|FG000|Weeks 13 - 24|Protocol Deviation|0|||
163087468|NCT00619866|589030367|FG001|Weeks 13 - 24|Protocol Deviation|0|||
163087469|NCT00619866|589030368|FG002|Weeks 13 - 24|Protocol Deviation|0|||
163087470|NCT00619866|589030369|FG003|Weeks 13 - 24|Protocol Deviation|1|||
163087471|NCT00619866|589030370|FG004|Weeks 13 - 24|Protocol Deviation|0|||
163087472|NCT00619866|589030366|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
163036755|NCT01618916|588840236|FG002|Overall Study|Withdrawal by Subject|1|||
163036756|NCT01618916|588840237|FG003|Overall Study|Withdrawal by Subject|0|||
163036757|NCT01618916|588840238|FG004|Overall Study|Withdrawal by Subject|1|||
163036758|NCT01618916|588840239|FG005|Overall Study|Withdrawal by Subject|0|||
163036759|NCT01618916|588840234|FG000|Overall Study|Lost to Follow-up|1|||
163036760|NCT01618916|588840235|FG001|Overall Study|Lost to Follow-up|0|||
163036761|NCT01618916|588840236|FG002|Overall Study|Lost to Follow-up|0|||
163036762|NCT01618916|588840237|FG003|Overall Study|Lost to Follow-up|2|||
163036763|NCT01618916|588840238|FG004|Overall Study|Lost to Follow-up|0|||
163036764|NCT01618916|588840239|FG005|Overall Study|Lost to Follow-up|0|||
163036765|NCT00849290|588840246|FG000|Overall Study|Adverse Event|3|||
163036766|NCT00849290|588840246|FG000|Overall Study|Death|14|||
163087473|NCT00619866|589030367|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
163087474|NCT00619866|589030368|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
163087475|NCT00619866|589030369|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
163087476|NCT00619866|589030370|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
163087477|NCT00619866|589030366|FG000|Weeks 13 - 24|Non-compliance|0|||
163087478|NCT00619866|589030367|FG001|Weeks 13 - 24|Non-compliance|1|||
163087479|NCT00619866|589030368|FG002|Weeks 13 - 24|Non-compliance|1|||
163087480|NCT00619866|589030369|FG003|Weeks 13 - 24|Non-compliance|0|||
163087481|NCT00619866|589030370|FG004|Weeks 13 - 24|Non-compliance|0|||
163036767|NCT00849290|588840246|FG000|Overall Study|Withdrawal by Subject|11|||
163087482|NCT00619866|589030366|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
163087483|NCT00619866|589030367|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
163087484|NCT00619866|589030368|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
163087485|NCT00619866|589030369|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
163087486|NCT00619866|589030370|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
163087487|NCT01656161|589030371|FG000|Overall Study|Death|3|||
163087488|NCT01656161|589030371|FG000|Overall Study|Adverse Event|2|||
163087489|NCT01656161|589030371|FG000|Overall Study|Protocol Violation|1|||
163087490|NCT01656161|589030371|FG000|Overall Study|Withdrawal by Subject|1|||
163087491|NCT03510273|589030376|FG000|Overall Study|Withdrawal by Subject|2|||
163087492|NCT03510273|589030376|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
163087493|NCT03510273|589030376|FG000|Overall Study|Moved away from study area|4|||
163087494|NCT02589938|589030380|FG000|Overall Study|Withdrawal by Subject|11|||
163087495|NCT02589938|589030381|FG001|Overall Study|Withdrawal by Subject|5|||
163087496|NCT02589938|589030382|FG002|Overall Study|Withdrawal by Subject|6|||
163087497|NCT02589938|589030380|FG000|Overall Study|Lost to Follow-up|3|||
163087498|NCT02589938|589030381|FG001|Overall Study|Lost to Follow-up|3|||
163087499|NCT02589938|589030382|FG002|Overall Study|Lost to Follow-up|3|||
163087500|NCT02589938|589030380|FG000|Overall Study|Death|1|||
163087501|NCT02589938|589030381|FG001|Overall Study|Death|0|||
163087502|NCT02589938|589030382|FG002|Overall Study|Death|1|||
163087503|NCT02589938|589030380|FG000|Overall Study|Protocol Violation|6|||
163087504|NCT02589938|589030381|FG001|Overall Study|Protocol Violation|2|||
163087505|NCT02589938|589030382|FG002|Overall Study|Protocol Violation|3|||
163087506|NCT02589938|589030380|FG000|Overall Study|Physician Decision|1|||
163087507|NCT02589938|589030381|FG001|Overall Study|Physician Decision|0|||
163087508|NCT02589938|589030382|FG002|Overall Study|Physician Decision|0|||
163087509|NCT02589938|589030380|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
163087510|NCT02589938|589030381|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
163087511|NCT02589938|589030382|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
163087512|NCT04716894|589030383|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
163087513|NCT04716894|589030383|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
163087514|NCT05205616|589030390|FG000|Overall Study|Lost to Follow-up|4|||
163087515|NCT05205616|589030391|FG001|Overall Study|Lost to Follow-up|4|||
163087516|NCT01467466|589030393|FG000|Overall Study|Withdrawal by Subject|15|||
163087517|NCT01467466|589030394|FG001|Overall Study|Withdrawal by Subject|18|||
163087518|NCT01467466|589030395|FG002|Overall Study|Withdrawal by Subject|13|||
163087519|NCT01467466|589030396|FG003|Overall Study|Withdrawal by Subject|11|||
163087520|NCT01467466|589030393|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
163087521|NCT01467466|589030394|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
163087522|NCT01467466|589030395|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
163087523|NCT01467466|589030396|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
163087524|NCT01467466|589030393|FG000|Overall Study|Procedure Cancelled|46|||
163087525|NCT01467466|589030394|FG001|Overall Study|Procedure Cancelled|45|||
163087526|NCT01467466|589030395|FG002|Overall Study|Procedure Cancelled|25|||
163087527|NCT01467466|589030396|FG003|Overall Study|Procedure Cancelled|29|||
163087528|NCT01467466|589030393|FG000|Overall Study|No Endpoint Blood Draw|38|||
163087529|NCT01467466|589030394|FG001|Overall Study|No Endpoint Blood Draw|32|||
163087530|NCT01467466|589030395|FG002|Overall Study|No Endpoint Blood Draw|51|||
163087531|NCT01467466|589030396|FG003|Overall Study|No Endpoint Blood Draw|43|||
163087532|NCT00787150|589030397|FG000|Overall Study|Adverse Event|4|||
163087533|NCT00787150|589030398|FG001|Overall Study|Adverse Event|4|||
163087534|NCT00787150|589030399|FG002|Overall Study|Adverse Event|4|||
163087535|NCT00787150|589030397|FG000|Overall Study|Physician Decision|1|||
163087536|NCT00787150|589030398|FG001|Overall Study|Physician Decision|2|||
163087537|NCT00787150|589030399|FG002|Overall Study|Physician Decision|1|||
163087538|NCT00787150|589030397|FG000|Overall Study|Withdrawal by Subject|2|||
163087539|NCT00787150|589030398|FG001|Overall Study|Withdrawal by Subject|1|||
163087540|NCT00787150|589030399|FG002|Overall Study|Withdrawal by Subject|0|||
163087541|NCT00787150|589030397|FG000|Overall Study|Dosing incorrect study durg|2|||
163087542|NCT00787150|589030398|FG001|Overall Study|Dosing incorrect study durg|0|||
163087543|NCT00787150|589030399|FG002|Overall Study|Dosing incorrect study durg|0|||
163087544|NCT00982280|589030407|FG000|Observation Period|Not eligible to be dosed|19|||
163087545|NCT00982280|589030407|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
163087546|NCT00982280|589030407|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
163407198|NCT04099251|590200751|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
163087547|NCT00982280|589030407|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
163087548|NCT00982280|589030407|FG000|Maintenance Period|Adverse Event|1|||
163087549|NCT01979185|589030413|FG000|Period 2|Other|0|||
163087550|NCT01979185|589030414|FG001|Period 2|Other|1|||
163087551|NCT01121757|589030415|FG000|First Drug|Death|1|||
163087552|NCT01121757|589030416|FG001|First Drug|Death|0|||
163087553|NCT01121757|589030415|FG000|First Drug|Disease Progression|0|||
163087554|NCT01121757|589030416|FG001|First Drug|Disease Progression|2|||
163087555|NCT01121757|589030415|FG000|Combination|Physician Decision|0|||
163087556|NCT01121757|589030416|FG001|Combination|Physician Decision|1|||
163335159|NCT01802333|589938713|FG001|Overall Study|Death|14|||
163335160|NCT01802333|589938714|FG002|Overall Study|Death|13|||
163335161|NCT01802333|589938712|FG000|Overall Study|Other - not protocol specified|32|||
163335162|NCT01802333|589938713|FG001|Overall Study|Other - not protocol specified|22|||
163335163|NCT01802333|589938714|FG002|Overall Study|Other - not protocol specified|24|||
163335164|NCT01802333|589938712|FG000|Overall Study|Did not start treatment|0|||
163335165|NCT01802333|589938713|FG001|Overall Study|Did not start treatment|2|||
163335166|NCT01802333|589938714|FG002|Overall Study|Did not start treatment|5|||
163335167|NCT01947491|589938718|FG000|Overall Study|Lost to Follow-up|5|||
163335168|NCT01947491|589938719|FG001|Overall Study|Lost to Follow-up|3|||
163335169|NCT01947491|589938720|FG002|Overall Study|Lost to Follow-up|1|||
163335170|NCT01947491|589938721|FG003|Overall Study|Lost to Follow-up|2|||
163335171|NCT01947491|589938718|FG000|Overall Study|Lack of Efficacy|1|||
163335172|NCT01947491|589938719|FG001|Overall Study|Lack of Efficacy|0|||
163335173|NCT01947491|589938720|FG002|Overall Study|Lack of Efficacy|0|||
163335174|NCT01947491|589938721|FG003|Overall Study|Lack of Efficacy|1|||
163335175|NCT01947491|589938718|FG000|Overall Study|Protocol Violation|1|||
163335176|NCT01947491|589938719|FG001|Overall Study|Protocol Violation|0|||
163335177|NCT01947491|589938720|FG002|Overall Study|Protocol Violation|0|||
163335178|NCT01947491|589938721|FG003|Overall Study|Protocol Violation|0|||
163335179|NCT01947491|589938718|FG000|Overall Study|Withdrawal by Subject|1|||
163335180|NCT01947491|589938719|FG001|Overall Study|Withdrawal by Subject|1|||
163335181|NCT01947491|589938720|FG002|Overall Study|Withdrawal by Subject|1|||
163335182|NCT01947491|589938721|FG003|Overall Study|Withdrawal by Subject|0|||
163335183|NCT01947491|589938718|FG000|Overall Study|Worsening of condition|0|||
163335184|NCT01947491|589938719|FG001|Overall Study|Worsening of condition|1|||
163335185|NCT01947491|589938720|FG002|Overall Study|Worsening of condition|0|||
163335186|NCT01947491|589938721|FG003|Overall Study|Worsening of condition|0|||
163335187|NCT01947491|589938718|FG000|Overall Study|Adverse Event|0|||
163335188|NCT01947491|589938719|FG001|Overall Study|Adverse Event|1|||
163335189|NCT01947491|589938720|FG002|Overall Study|Adverse Event|0|||
163335190|NCT01947491|589938721|FG003|Overall Study|Adverse Event|2|||
163335191|NCT02224755|589938722|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
163335192|NCT02224755|589938723|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
163335193|NCT02224755|589938722|FG000|Two Year Follow up Post-implant|Death|103|||
163335194|NCT02224755|589938723|FG001|Two Year Follow up Post-implant|Death|98|||
163335195|NCT02224755|589938722|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
163335196|NCT02224755|589938723|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
163335197|NCT02224755|589938722|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
163335198|NCT02224755|589938723|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
163335199|NCT02224755|589938722|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
163335200|NCT02224755|589938723|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
163335201|NCT02067663|589938724|FG000|Overall Study|Lost to Follow-up|13|||
163335202|NCT02067663|589938725|FG001|Overall Study|Lost to Follow-up|14|||
163335203|NCT01205126|589938726|FG000|Titration Phase|Adverse Event|5|||
163036768|NCT00849290|588840246|FG000|Overall Study|Lost to Follow-up|2|||
163036769|NCT00849290|588840246|FG000|Overall Study|Protocol Violation|5|||
163036770|NCT00849290|588840246|FG000|Overall Study|Disease Progression|20|||
163036771|NCT00938587|588840247|FG000|Overall Study|Adverse Event|2|||
163036772|NCT00938587|588840248|FG001|Overall Study|Adverse Event|0|||
163036773|NCT00938587|588840249|FG002|Overall Study|Adverse Event|0|||
163036774|NCT00938587|588840250|FG003|Overall Study|Adverse Event|2|||
163036775|NCT00938587|588840247|FG000|Overall Study|Did not meet entrance criteria|0|||
163036776|NCT00938587|588840248|FG001|Overall Study|Did not meet entrance criteria|0|||
163036777|NCT00938587|588840249|FG002|Overall Study|Did not meet entrance criteria|1|||
163036778|NCT00938587|588840250|FG003|Overall Study|Did not meet entrance criteria|0|||
163036779|NCT00938587|588840247|FG000|Overall Study|Withdrawal by Subject|1|||
163036780|NCT00938587|588840248|FG001|Overall Study|Withdrawal by Subject|1|||
163036781|NCT00938587|588840249|FG002|Overall Study|Withdrawal by Subject|0|||
163036782|NCT00938587|588840250|FG003|Overall Study|Withdrawal by Subject|0|||
163036783|NCT02819440|588840255|FG000|Overall Study|Adverse Event|3|||
163036784|NCT02819440|588840256|FG001|Overall Study|Adverse Event|1|||
163036785|NCT02819440|588840255|FG000|Overall Study|Lost to Follow-up|1|||
163036786|NCT02819440|588840256|FG001|Overall Study|Lost to Follow-up|3|||
163036787|NCT02819440|588840255|FG000|Overall Study|Withdrawal by Subject|9|||
163036788|NCT02819440|588840256|FG001|Overall Study|Withdrawal by Subject|8|||
163036789|NCT02334384|588840264|FG000|Overall Study|Lost to Follow-up|1|||
163036790|NCT02334384|588840265|FG001|Overall Study|Lost to Follow-up|1|||
163036791|NCT00055497|588840266|FG000|Overall Study|Adverse Event|1|||
163036792|NCT00055497|588840267|FG001|Overall Study|Adverse Event|1|||
163036793|NCT00055497|588840268|FG002|Overall Study|Adverse Event|1|||
163036794|NCT00055497|588840269|FG003|Overall Study|Adverse Event|28|||
163036795|NCT00055497|588840266|FG000|Overall Study|Withdrawal by Subject|3|||
163036796|NCT00055497|588840267|FG001|Overall Study|Withdrawal by Subject|1|||
163036797|NCT00055497|588840268|FG002|Overall Study|Withdrawal by Subject|1|||
163087557|NCT01121757|589030415|FG000|Combination|Disease Progression|2|||
163087558|NCT01121757|589030416|FG001|Combination|Disease Progression|0|||
163087559|NCT03620981|589030427|FG000|Overall Study|Adverse Event|14|||
163087560|NCT03620981|589030428|FG001|Overall Study|Adverse Event|38|||
163087561|NCT03620981|589030429|FG002|Overall Study|Adverse Event|25|||
163087562|NCT03620981|589030427|FG000|Overall Study|Lack of Efficacy|2|||
163087563|NCT03620981|589030428|FG001|Overall Study|Lack of Efficacy|1|||
163087564|NCT03620981|589030429|FG002|Overall Study|Lack of Efficacy|1|||
163087565|NCT03620981|589030427|FG000|Overall Study|Physician Decision|7|||
163087566|NCT03620981|589030428|FG001|Overall Study|Physician Decision|4|||
163087567|NCT03620981|589030429|FG002|Overall Study|Physician Decision|4|||
163087568|NCT03620981|589030427|FG000|Overall Study|Protocol Violation|1|||
163087569|NCT03620981|589030428|FG001|Overall Study|Protocol Violation|2|||
163087570|NCT03620981|589030429|FG002|Overall Study|Protocol Violation|1|||
163087571|NCT03620981|589030427|FG000|Overall Study|Withdrawal by Legal Representative|2|||
163087572|NCT03620981|589030428|FG001|Overall Study|Withdrawal by Legal Representative|1|||
163087573|NCT03620981|589030429|FG002|Overall Study|Withdrawal by Legal Representative|1|||
163087574|NCT03620981|589030427|FG000|Overall Study|Withdrawal by Care Giver|2|||
163087575|NCT03620981|589030428|FG001|Overall Study|Withdrawal by Care Giver|0|||
163087576|NCT03620981|589030429|FG002|Overall Study|Withdrawal by Care Giver|1|||
163087577|NCT03620981|589030427|FG000|Overall Study|Non-compliance with Study Drug|1|||
163087578|NCT03620981|589030428|FG001|Overall Study|Non-compliance with Study Drug|1|||
163087579|NCT03620981|589030429|FG002|Overall Study|Non-compliance with Study Drug|0|||
163087580|NCT05852470|589030436|FG000|Overall Study|Withdrawal by Subject|0|||
163087581|NCT05852470|589030437|FG001|Overall Study|Withdrawal by Subject|1|||
163087582|NCT06071104|589030438|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
163087583|NCT04116489|589030443|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
163087584|NCT04116489|589030443|FG000|Overall Study|Withdrawal by Subject|1|||
163087585|NCT03781570|589030444|FG000|Overall Study|Technical Issues (equipment failure)|31|||
163087586|NCT03781570|589030444|FG000|Overall Study|Withdrawal by Subject|7|||
163087587|NCT03781570|589030444|FG000|Overall Study|Physical Constraints|11|||
163087588|NCT06028464|589030448|FG000|Washout|Positive drug test.|1|||
163087589|NCT03636022|589030449|FG000|Overall Study|Withdrawal by Subject|1|||
163087590|NCT03636022|589030450|FG001|Overall Study|Withdrawal by Subject|3|||
163087591|NCT03330847|589030451|FG000|Overall Study|Patients ongoing study|62|||
163087592|NCT03330847|589030452|FG001|Overall Study|Patients ongoing study|65|||
163087593|NCT03330847|589030453|FG002|Overall Study|Patients ongoing study|15|||
163087594|NCT01346592|589030456|FG000|Overall Study|Lost to Follow-up|62|||
163087595|NCT01346592|589030457|FG001|Overall Study|Lost to Follow-up|29|||
163087596|NCT01346592|589030458|FG002|Overall Study|Lost to Follow-up|29|||
163087597|NCT01346592|589030456|FG000|Overall Study|Protocol Violation|2|||
163087598|NCT01346592|589030457|FG001|Overall Study|Protocol Violation|1|||
163087599|NCT01346592|589030458|FG002|Overall Study|Protocol Violation|0|||
163087600|NCT01346592|589030456|FG000|Overall Study|Death|1|||
163087601|NCT01346592|589030457|FG001|Overall Study|Death|3|||
163087602|NCT01346592|589030458|FG002|Overall Study|Death|4|||
163087603|NCT01346592|589030456|FG000|Overall Study|Adverse Event|0|||
163087604|NCT01346592|589030457|FG001|Overall Study|Adverse Event|1|||
163087605|NCT01346592|589030458|FG002|Overall Study|Adverse Event|0|||
163087606|NCT01346592|589030456|FG000|Overall Study|Withdrawal by Subject|77|||
163087607|NCT01346592|589030457|FG001|Overall Study|Withdrawal by Subject|51|||
163087608|NCT01346592|589030458|FG002|Overall Study|Withdrawal by Subject|38|||
163087609|NCT01346592|589030456|FG000|Overall Study|Inappropriate enrollment|3|||
163087610|NCT01346592|589030457|FG001|Overall Study|Inappropriate enrollment|1|||
163087611|NCT01346592|589030458|FG002|Overall Study|Inappropriate enrollment|1|||
163407199|NCT04099251|590200752|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
163407200|NCT04099251|590200751|FG000|Blinded Treatment Phase|Other reasons|16|||
163407201|NCT04099251|590200752|FG001|Blinded Treatment Phase|Other reasons|7|||
163407202|NCT04099251|590200751|FG000|Blinded Treatment Phase|Disease recurrence|26|||
163407203|NCT04099251|590200752|FG001|Blinded Treatment Phase|Disease recurrence|41|||
163407204|NCT04099251|590200751|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
163407205|NCT04099251|590200752|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
163407206|NCT04099251|590200751|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
163087612|NCT01346592|589030456|FG000|Overall Study|Administrative reason|1|||
163087613|NCT01346592|589030457|FG001|Overall Study|Administrative reason|0|||
163087614|NCT01346592|589030458|FG002|Overall Study|Administrative reason|0|||
163087615|NCT01346592|589030456|FG000|Overall Study|Unable to Classify|7|||
163087616|NCT01346592|589030457|FG001|Overall Study|Unable to Classify|3|||
163087617|NCT01346592|589030458|FG002|Overall Study|Unable to Classify|6|||
163087618|NCT05943990|589030459|FG000|Overall Study|Study Terminated by Sponsor|0|||
163087619|NCT05943990|589030460|FG001|Overall Study|Study Terminated by Sponsor|0|||
163087620|NCT05943990|589030461|FG002|Overall Study|Study Terminated by Sponsor|1|||
163087621|NCT04696146|589031919|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
163087622|NCT04696146|589031920|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
163087623|NCT04696146|589031919|FG000|Overall Study|Off hours issue with product|1|||
163087624|NCT04696146|589031920|FG001|Overall Study|Off hours issue with product|0|||
163087625|NCT00276419|589031925|FG000|First Intervention|Adverse Event|1|||
163087626|NCT00276419|589031926|FG001|First Intervention|Adverse Event|0|||
163087627|NCT00276419|589031925|FG000|First Intervention|Withdrawal by Subject|0|||
163087628|NCT00276419|589031926|FG001|First Intervention|Withdrawal by Subject|2|||
163087629|NCT03493958|589031927|FG000|Overall Study|Withdrawal by Subject|6|||
163087630|NCT03493958|589031927|FG000|Overall Study|Lost to Follow-up|7|||
163087631|NCT03493958|589031927|FG000|Overall Study|Did not complete all required study procedures|2|||
163087632|NCT02367456|589031928|FG000|Overall Study|Death|8|||
163087633|NCT02367456|589031929|FG001|Overall Study|Death|24|||
163087634|NCT02367456|589031930|FG002|Overall Study|Death|17|||
163087635|NCT02367456|589031928|FG000|Overall Study|Lost to Follow-up|1|||
163087636|NCT02367456|589031929|FG001|Overall Study|Lost to Follow-up|3|||
163087637|NCT02367456|589031930|FG002|Overall Study|Lost to Follow-up|1|||
163087638|NCT02367456|589031928|FG000|Overall Study|Other reason|3|||
163087639|NCT02367456|589031929|FG001|Overall Study|Other reason|3|||
163087640|NCT02367456|589031930|FG002|Overall Study|Other reason|9|||
163087641|NCT02367456|589031928|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
163087642|NCT02367456|589031929|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
163087643|NCT02367456|589031930|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
163087644|NCT01645176|589031935|FG000|Overall Study|Lack of Efficacy|4|||
163087645|NCT01645176|589031935|FG000|Overall Study|did not complete final MRI|1|||
163087646|NCT02569853|589031936|FG000|Overall Study|Adverse Event|2|||
163087647|NCT02569853|589031937|FG001|Overall Study|Adverse Event|0|||
163087648|NCT02569853|589031936|FG000|Overall Study|Withdrawal by Subject|3|||
163087649|NCT02569853|589031937|FG001|Overall Study|Withdrawal by Subject|2|||
163087650|NCT02569853|589031936|FG000|Overall Study|Lost to Follow-up|3|||
163087651|NCT02569853|589031937|FG001|Overall Study|Lost to Follow-up|3|||
163087652|NCT02569853|589031936|FG000|Overall Study|Protocol Violation|1|||
163087653|NCT02569853|589031937|FG001|Overall Study|Protocol Violation|1|||
163087654|NCT02569853|589031936|FG000|Overall Study|Did not experience migraine attack|10|||
163087655|NCT02569853|589031937|FG001|Overall Study|Did not experience migraine attack|7|||
163087656|NCT02569853|589031936|FG000|Overall Study|Physician Decision|1|||
163087657|NCT02569853|589031937|FG001|Overall Study|Physician Decision|1|||
163087658|NCT00402987|589031938|FG000|Overall Study|Lack of Efficacy|0|||
163087659|NCT00402987|589031939|FG001|Overall Study|Lack of Efficacy|0|||
163087660|NCT00402987|589031940|FG002|Overall Study|Lack of Efficacy|1|||
163087661|NCT00402987|589031941|FG003|Overall Study|Lack of Efficacy|0|||
163087662|NCT01668004|589031942|FG000|Overall Study|Adverse Event|7|||
163087663|NCT01668004|589031942|FG000|Overall Study|Withdrawal by Subject|2|||
163087664|NCT01668004|589031942|FG000|Overall Study|Lost to Follow-up|5|||
163087665|NCT01668004|589031942|FG000|Overall Study|Lack of Efficacy|9|||
163087666|NCT01668004|589031942|FG000|Overall Study|Non-compliance with treatment|2|||
163087667|NCT01493414|589031947|FG000|Overall Study|Adverse Event|405|||
163087668|NCT01493414|589031947|FG000|Overall Study|Disease progression|204|||
163087669|NCT01493414|589031947|FG000|Overall Study|Death|101|||
163087670|NCT01493414|589031947|FG000|Overall Study|Physician Decision|93|||
163087671|NCT01493414|589031947|FG000|Overall Study|Withdrawal by Subject|79|||
163087672|NCT01493414|589031947|FG000|Overall Study|Protocol deviation|27|||
163087673|NCT01493414|589031947|FG000|Overall Study|Administrative problems|25|||
163087674|NCT01493414|589031947|FG000|Overall Study|Lost to Follow-up|16|||
163087675|NCT03773484|589031972|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
163087676|NCT04724837|589031973|FG000|Overall Study|Other|4|||
163087677|NCT04724837|589031974|FG001|Overall Study|Other|16|||
163087678|NCT04724837|589031975|FG002|Overall Study|Other|0|||
163087679|NCT04724837|589031973|FG000|Overall Study|Withdrawal by Subject|2|||
163087680|NCT04724837|589031974|FG001|Overall Study|Withdrawal by Subject|9|||
163087681|NCT04724837|589031975|FG002|Overall Study|Withdrawal by Subject|9|||
163087682|NCT04724837|589031973|FG000|Overall Study|Adverse Event|2|||
163087683|NCT04724837|589031974|FG001|Overall Study|Adverse Event|7|||
163087684|NCT04724837|589031975|FG002|Overall Study|Adverse Event|4|||
163087685|NCT04724837|589031973|FG000|Overall Study|Lost to Follow-up|0|||
163087686|NCT04724837|589031974|FG001|Overall Study|Lost to Follow-up|1|||
163087687|NCT04724837|589031975|FG002|Overall Study|Lost to Follow-up|3|||
163087688|NCT04724837|589031973|FG000|Overall Study|Physician Decision|1|||
163087689|NCT04724837|589031974|FG001|Overall Study|Physician Decision|2|||
163087690|NCT04724837|589031975|FG002|Overall Study|Physician Decision|0|||
163087691|NCT04724837|589031973|FG000|Overall Study|Death|0|||
163087692|NCT04724837|589031974|FG001|Overall Study|Death|0|||
163087693|NCT04724837|589031975|FG002|Overall Study|Death|1|||
163087694|NCT04724837|589031973|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
163087695|NCT04724837|589031974|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
163087696|NCT04724837|589031975|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
163087697|NCT04724837|589031973|FG000|Overall Study|Study Terminated by Sponsor|0|||
163087698|NCT04724837|589031974|FG001|Overall Study|Study Terminated by Sponsor|1|||
163087699|NCT04724837|589031975|FG002|Overall Study|Study Terminated by Sponsor|0|||
163087700|NCT04222673|589031976|FG000|Overall Study|Lost to Follow-up|5|||
163087701|NCT02420717|589031981|FG000|Overall Study|Did not receive all study medication|2|||
163087702|NCT02420717|589031982|FG001|Overall Study|Did not receive all study medication|0|||
163087703|NCT02420717|589031983|FG002|Overall Study|Did not receive all study medication|0|||
163087704|NCT03138564|589031984|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
163087705|NCT03138564|589031985|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
163087706|NCT03138564|589031984|FG000|Overall Study|Lost to Follow-up|16|||
163087707|NCT03138564|589031985|FG001|Overall Study|Lost to Follow-up|2|||
163087708|NCT03138564|589031984|FG000|Overall Study|Withdrawal by Subject|48|||
163087709|NCT03138564|589031985|FG001|Overall Study|Withdrawal by Subject|4|||
163087710|NCT03138564|589031984|FG000|Overall Study|No longer met eligibility criteria|2|||
163087711|NCT03138564|589031985|FG001|Overall Study|No longer met eligibility criteria|0|||
163087712|NCT03138564|589031984|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
163087713|NCT03138564|589031985|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
163087714|NCT03138564|589031984|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
163087715|NCT03138564|589031985|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
163087716|NCT03138564|589031984|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
163087717|NCT03138564|589031985|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
163087718|NCT03138564|589031984|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
163087719|NCT03138564|589031985|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
163087720|NCT05177354|589031987|FG000|Implant to 30-day Visit|Physician Decision|1|||
163087721|NCT05177354|589031987|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
163087722|NCT05177354|589031987|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
163087723|NCT05177354|589031987|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
163087724|NCT02936323|589031988|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
163087725|NCT02936323|589031989|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
163087726|NCT02936323|589031990|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
163087727|NCT02936323|589031991|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
163087728|NCT02936323|589031992|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
163087729|NCT02936323|589031993|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
163087730|NCT02936323|589031994|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
163087731|NCT02936323|589031995|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
163087732|NCT02936323|589031996|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
163087733|NCT02936323|589031997|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
163087734|NCT02936323|589031988|FG000|Phase 1 Dose Escalation|Death|2|||
163087735|NCT02936323|589031989|FG001|Phase 1 Dose Escalation|Death|1|||
163087736|NCT02936323|589031990|FG002|Phase 1 Dose Escalation|Death|3|||
163087737|NCT02936323|589031991|FG003|Phase 1 Dose Escalation|Death|1|||
163087738|NCT02936323|589031992|FG004|Phase 1 Dose Escalation|Death|2|||
163087739|NCT02936323|589031993|FG005|Phase 1 Dose Escalation|Death|3|||
163087740|NCT02936323|589031994|FG006|Phase 1 Dose Escalation|Death|3|||
163087741|NCT02936323|589031995|FG007|Phase 1 Dose Escalation|Death|0|||
163087742|NCT02936323|589031996|FG008|Phase 1 Dose Escalation|Death|0|||
163087743|NCT02936323|589031997|FG009|Phase 1 Dose Escalation|Death|0|||
163087744|NCT02936323|589031988|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087745|NCT02936323|589031989|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087746|NCT02936323|589031990|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087747|NCT02936323|589031991|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087748|NCT02936323|589031992|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087749|NCT02936323|589031993|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
163087750|NCT02936323|589031994|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087751|NCT02936323|589031995|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087752|NCT02936323|589031996|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087753|NCT02936323|589031997|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087754|NCT02936323|589031988|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
163087755|NCT02936323|589031989|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
163087756|NCT02936323|589031990|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
163087757|NCT02936323|589031991|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
163087758|NCT02936323|589031992|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
163087759|NCT02936323|589031993|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
163087760|NCT02936323|589031994|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
163087761|NCT02936323|589031995|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
163087762|NCT02936323|589031996|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
163087763|NCT02936323|589031997|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
163087764|NCT02936323|589031988|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
163087765|NCT02936323|589031989|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
163087766|NCT02936323|589031990|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
163087767|NCT02936323|589031991|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
163087768|NCT02936323|589031992|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
163087769|NCT02936323|589031993|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
163087770|NCT02936323|589031994|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
163087771|NCT02936323|589031995|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
163087772|NCT02936323|589031996|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
163087773|NCT02936323|589031997|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
163087774|NCT02936323|589031988|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087775|NCT02936323|589031989|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087776|NCT02936323|589031990|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087777|NCT02936323|589031991|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087778|NCT02936323|589031992|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087779|NCT02936323|589031993|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087780|NCT02936323|589031994|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087781|NCT02936323|589031995|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
163087782|NCT02936323|589031996|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
163335204|NCT01205126|589938727|FG001|Titration Phase|Adverse Event|3|||
163335205|NCT01205126|589938726|FG000|Titration Phase|Withdrawal by Subject|5|||
163335206|NCT01205126|589938727|FG001|Titration Phase|Withdrawal by Subject|5|||
163335207|NCT01205126|589938726|FG000|Titration Phase|Lost to Follow-up|2|||
163335208|NCT01205126|589938727|FG001|Titration Phase|Lost to Follow-up|2|||
163335209|NCT01205126|589938726|FG000|Titration Phase|No stable titration dose|1|||
163036798|NCT00055497|588840269|FG003|Overall Study|Withdrawal by Subject|15|||
163036799|NCT00055497|588840266|FG000|Overall Study|Lost to Follow-up|0|||
163036800|NCT00055497|588840267|FG001|Overall Study|Lost to Follow-up|1|||
163036801|NCT00055497|588840268|FG002|Overall Study|Lost to Follow-up|0|||
163036802|NCT00055497|588840269|FG003|Overall Study|Lost to Follow-up|5|||
163036803|NCT00055497|588840266|FG000|Overall Study|Protocol Violation|0|||
163036804|NCT00055497|588840267|FG001|Overall Study|Protocol Violation|0|||
163036805|NCT00055497|588840268|FG002|Overall Study|Protocol Violation|0|||
163036806|NCT00055497|588840269|FG003|Overall Study|Protocol Violation|3|||
163036807|NCT00055497|588840266|FG000|Overall Study|Lack of Efficacy|1|||
163036808|NCT00055497|588840267|FG001|Overall Study|Lack of Efficacy|0|||
163036809|NCT00055497|588840268|FG002|Overall Study|Lack of Efficacy|0|||
163036810|NCT00055497|588840269|FG003|Overall Study|Lack of Efficacy|27|||
163036811|NCT00055497|588840266|FG000|Overall Study|Administrative Reasons|0|||
163036812|NCT00055497|588840267|FG001|Overall Study|Administrative Reasons|0|||
163036813|NCT00055497|588840268|FG002|Overall Study|Administrative Reasons|0|||
163036814|NCT00055497|588840269|FG003|Overall Study|Administrative Reasons|1|||
163036815|NCT00055497|588840266|FG000|Overall Study|Other|0|||
163036816|NCT00055497|588840267|FG001|Overall Study|Other|0|||
163036817|NCT00055497|588840268|FG002|Overall Study|Other|0|||
163036818|NCT00055497|588840269|FG003|Overall Study|Other|11|||
163036819|NCT00048165|588840270|FG000|Completed 6 Months Study|Administration/Other|8|||
163036820|NCT00048165|588840271|FG001|Completed 6 Months Study|Administration/Other|8|||
163036821|NCT00048165|588840270|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
163036822|NCT00048165|588840271|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
163036823|NCT00048165|588840270|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
163036824|NCT00048165|588840271|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
163036825|NCT00048165|588840270|FG000|Completed 6 Months Study|Death|12|||
163036826|NCT00048165|588840271|FG001|Completed 6 Months Study|Death|6|||
163036827|NCT00048165|588840270|FG000|Completed 6 Months Study|Insufficient therapy|1|||
163036828|NCT00048165|588840271|FG001|Completed 6 Months Study|Insufficient therapy|4|||
163036829|NCT00048165|588840270|FG000|Completed 6 Months Study|Other violation|4|||
163036830|NCT00048165|588840271|FG001|Completed 6 Months Study|Other violation|6|||
163036831|NCT00048165|588840270|FG000|Completed 6 Months Study|Refused treatment|5|||
163036832|NCT00048165|588840271|FG001|Completed 6 Months Study|Refused treatment|5|||
163036833|NCT00048165|588840270|FG000|Completed 6 Months Study|Violation criteria|0|||
163036834|NCT00048165|588840271|FG001|Completed 6 Months Study|Violation criteria|2|||
163036835|NCT00048165|588840270|FG000|Completed 6 Months Study|Did not receive study drug|6|||
163036836|NCT00048165|588840271|FG001|Completed 6 Months Study|Did not receive study drug|6|||
163036837|NCT00048165|588840270|FG000|Completed 12 Months Study|Administration/Other|0|||
163036838|NCT00048165|588840271|FG001|Completed 12 Months Study|Administration/Other|2|||
163036839|NCT00048165|588840270|FG000|Completed 12 Months Study|Death|2|||
163036840|NCT00048165|588840271|FG001|Completed 12 Months Study|Death|1|||
163036841|NCT00048165|588840270|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
163036842|NCT00048165|588840271|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
163036843|NCT00731731|588840272|FG000|Overall Study|Protocol Violation|0|||
163036844|NCT00731731|588840273|FG001|Overall Study|Protocol Violation|0|||
163036845|NCT00731731|588840274|FG002|Overall Study|Protocol Violation|1|||
163036846|NCT00731731|588840272|FG000|Overall Study|Cancel prior to treatment|0|||
163036847|NCT00731731|588840273|FG001|Overall Study|Cancel prior to treatment|0|||
163036848|NCT00731731|588840274|FG002|Overall Study|Cancel prior to treatment|2|||
163036849|NCT01084538|588840275|FG000|Overall Study|Drug not available|30|||
163036850|NCT01084538|588840275|FG000|Overall Study|Adverse Event|9|||
163036851|NCT01084538|588840275|FG000|Overall Study|Kidney transplant|6|||
163036852|NCT01084538|588840275|FG000|Overall Study|Serious Adverse Event|3|||
163087783|NCT02936323|589031997|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087784|NCT02936323|589031988|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087785|NCT02936323|589031989|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087786|NCT02936323|589031990|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087787|NCT02936323|589031991|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087788|NCT02936323|589031992|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087789|NCT02936323|589031993|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087790|NCT02936323|589031994|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087791|NCT02936323|589031995|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087792|NCT02936323|589031996|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087793|NCT02936323|589031997|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
163087794|NCT02936323|589031988|FG000|Phase 2a Dose Expansion|Death|0|||
163087795|NCT02936323|589031989|FG001|Phase 2a Dose Expansion|Death|0|||
163087796|NCT02936323|589031990|FG002|Phase 2a Dose Expansion|Death|0|||
163087797|NCT02936323|589031991|FG003|Phase 2a Dose Expansion|Death|0|||
163087798|NCT02936323|589031992|FG004|Phase 2a Dose Expansion|Death|0|||
163087799|NCT02936323|589031993|FG005|Phase 2a Dose Expansion|Death|0|||
163087800|NCT02936323|589031994|FG006|Phase 2a Dose Expansion|Death|0|||
163087801|NCT02936323|589031995|FG007|Phase 2a Dose Expansion|Death|4|||
163087802|NCT02936323|589031996|FG008|Phase 2a Dose Expansion|Death|8|||
163087803|NCT02936323|589031997|FG009|Phase 2a Dose Expansion|Death|10|||
163087804|NCT06272383|589031998|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
163087805|NCT06272383|589031999|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
163087806|NCT05715827|589032000|FG000|Overall Study|Physician Decision|0|||
163087807|NCT05715827|589032001|FG001|Overall Study|Physician Decision|1|||
163087808|NCT05715827|589032000|FG000|Overall Study|console communication error|0|||
163087809|NCT05715827|589032001|FG001|Overall Study|console communication error|1|||
163087810|NCT04846868|589032002|FG000|Overall Study|Adverse Event|12|||
163087811|NCT04846868|589032003|FG001|Overall Study|Adverse Event|11|||
163087812|NCT04846868|589032002|FG000|Overall Study|Protocol deviation|6|||
163087813|NCT04846868|589032003|FG001|Overall Study|Protocol deviation|2|||
163087814|NCT04846868|589032002|FG000|Overall Study|Perceived lack of efficacy|3|||
163087815|NCT04846868|589032003|FG001|Overall Study|Perceived lack of efficacy|2|||
163087816|NCT04846868|589032002|FG000|Overall Study|Change of residence|2|||
163087817|NCT04846868|589032003|FG001|Overall Study|Change of residence|3|||
163087818|NCT04846868|589032002|FG000|Overall Study|Burden of study procedures|1|||
163087819|NCT04846868|589032003|FG001|Overall Study|Burden of study procedures|1|||
163087820|NCT04846868|589032002|FG000|Overall Study|No reason available|2|||
163087821|NCT04846868|589032003|FG001|Overall Study|No reason available|5|||
163087822|NCT04846868|589032002|FG000|Overall Study|Other reason listed|20|||
163087823|NCT04846868|589032003|FG001|Overall Study|Other reason listed|10|||
163087824|NCT04846868|589032002|FG000|Overall Study|Not treated|0|||
163087825|NCT04846868|589032003|FG001|Overall Study|Not treated|1|||
163087826|NCT04398706|589032004|FG000|Overall Study|Adverse Event|0|||
163087827|NCT04398706|589032005|FG001|Overall Study|Adverse Event|0|||
163087828|NCT04398706|589032006|FG002|Overall Study|Adverse Event|0|||
163087829|NCT04398706|589032007|FG003|Overall Study|Adverse Event|0|||
163087830|NCT04398706|589032008|FG004|Overall Study|Adverse Event|0|||
163036853|NCT01084538|588840275|FG000|Overall Study|Lack of effectiveness|2|||
163036854|NCT01084538|588840275|FG000|Overall Study|Patient noncompliance|2|||
163036855|NCT01084538|588840275|FG000|Overall Study|Hyperphosphatemia|2|||
163036856|NCT01084538|588840275|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
163036857|NCT01084538|588840275|FG000|Overall Study|Change of residence|2|||
163036858|NCT01084538|588840275|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
163036859|NCT01084538|588840275|FG000|Overall Study|Reason unknown|8|||
163036860|NCT03742258|588840276|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
163036861|NCT03742258|588840277|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
163036862|NCT03742258|588840278|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
163036863|NCT03742258|588840276|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
163036864|NCT03742258|588840277|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
163036865|NCT03742258|588840278|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
163036866|NCT03742258|588840276|FG000|Survival Follow-Up|Still in Follow-up|0|||
163036867|NCT03742258|588840277|FG001|Survival Follow-Up|Still in Follow-up|0|||
163036868|NCT03742258|588840278|FG002|Survival Follow-Up|Still in Follow-up|2|||
163036869|NCT00508157|588840282|FG000|Overall Study|Adverse Event|0|||
163036870|NCT00508157|588840283|FG001|Overall Study|Adverse Event|1|||
163036871|NCT00508157|588840282|FG000|Overall Study|Subject Withdrew Consent|1|||
163087831|NCT04398706|589032009|FG005|Overall Study|Adverse Event|1|||
163087832|NCT04398706|589032010|FG006|Overall Study|Adverse Event|1|||
163036872|NCT00508157|588840283|FG001|Overall Study|Subject Withdrew Consent|0|||
163036873|NCT00508157|588840282|FG000|Overall Study|Lost to Follow-up|1|||
163036874|NCT00508157|588840283|FG001|Overall Study|Lost to Follow-up|0|||
163036875|NCT00508157|588840282|FG000|Overall Study|Subject no longer met study criteria|0|||
163335210|NCT01205126|589938727|FG001|Titration Phase|No stable titration dose|0|||
163087833|NCT04398706|589032011|FG007|Overall Study|Adverse Event|0|||
163087834|NCT04398706|589032004|FG000|Overall Study|Lost to Follow-up|0|||
163087835|NCT04398706|589032005|FG001|Overall Study|Lost to Follow-up|1|||
163087836|NCT04398706|589032006|FG002|Overall Study|Lost to Follow-up|2|||
163087837|NCT04398706|589032007|FG003|Overall Study|Lost to Follow-up|1|||
163087838|NCT04398706|589032008|FG004|Overall Study|Lost to Follow-up|6|||
163087839|NCT04398706|589032009|FG005|Overall Study|Lost to Follow-up|3|||
163087840|NCT04398706|589032010|FG006|Overall Study|Lost to Follow-up|8|||
163087841|NCT04398706|589032011|FG007|Overall Study|Lost to Follow-up|2|||
163087842|NCT04398706|589032004|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163087843|NCT04398706|589032005|FG001|Overall Study|Withdrawal by parent/guardian|2|||
163087844|NCT04398706|589032006|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163087845|NCT04398706|589032007|FG003|Overall Study|Withdrawal by parent/guardian|2|||
163087846|NCT04398706|589032008|FG004|Overall Study|Withdrawal by parent/guardian|19|||
163087847|NCT04398706|589032009|FG005|Overall Study|Withdrawal by parent/guardian|23|||
163087848|NCT04398706|589032010|FG006|Overall Study|Withdrawal by parent/guardian|13|||
163087849|NCT04398706|589032011|FG007|Overall Study|Withdrawal by parent/guardian|11|||
163087850|NCT04398706|589032004|FG000|Overall Study|Protocol deviation|0|||
163087851|NCT04398706|589032005|FG001|Overall Study|Protocol deviation|1|||
163087852|NCT04398706|589032006|FG002|Overall Study|Protocol deviation|0|||
163087853|NCT04398706|589032007|FG003|Overall Study|Protocol deviation|0|||
163087854|NCT04398706|589032008|FG004|Overall Study|Protocol deviation|6|||
163087855|NCT04398706|589032009|FG005|Overall Study|Protocol deviation|4|||
163087856|NCT04398706|589032010|FG006|Overall Study|Protocol deviation|6|||
163087857|NCT04398706|589032011|FG007|Overall Study|Protocol deviation|3|||
163087858|NCT04890509|589032012|FG000|Overall Study|Death|4|||
163087859|NCT04890509|589032013|FG001|Overall Study|Death|4|||
163087860|NCT04116853|589032014|FG000|Overall Study|Adverse Event|1|||
163087861|NCT04116853|589032015|FG001|Overall Study|Adverse Event|3|||
163087862|NCT04116853|589032014|FG000|Overall Study|Lost to Follow-up|2|||
163087863|NCT04116853|589032015|FG001|Overall Study|Lost to Follow-up|0|||
163087864|NCT04116853|589032014|FG000|Overall Study|Incarceration|0|||
163087865|NCT04116853|589032015|FG001|Overall Study|Incarceration|1|||
163087866|NCT04116853|589032014|FG000|Overall Study|Pregnancy|1|||
163087867|NCT04116853|589032015|FG001|Overall Study|Pregnancy|1|||
163087868|NCT04116853|589032014|FG000|Overall Study|Began Other Weight Loss program|4|||
163087869|NCT04116853|589032015|FG001|Overall Study|Began Other Weight Loss program|8|||
163087870|NCT04116853|589032014|FG000|Overall Study|Began Anti-Obesity Medication|3|||
163087871|NCT04116853|589032015|FG001|Overall Study|Began Anti-Obesity Medication|3|||
163087872|NCT04116853|589032014|FG000|Overall Study|Protocol Violation|0|||
163335211|NCT01205126|589938726|FG000|Titration Phase|More than maximum dosage required|2|||
163335212|NCT01205126|589938727|FG001|Titration Phase|More than maximum dosage required|3|||
163335213|NCT01205126|589938726|FG000|Titration Phase|Other|8|||
163335214|NCT01205126|589938727|FG001|Titration Phase|Other|6|||
163335215|NCT01205126|589938726|FG000|Between Titration & Maintenance Phase|Other|0|||
163335216|NCT01205126|589938727|FG001|Between Titration & Maintenance Phase|Other|4|||
163335217|NCT01205126|589938726|FG000|Maintenance Phase|Adverse Event|3|||
163335218|NCT01205126|589938727|FG001|Maintenance Phase|Adverse Event|7|||
163335219|NCT01205126|589938726|FG000|Maintenance Phase|Death|4|||
163335220|NCT01205126|589938727|FG001|Maintenance Phase|Death|4|||
163335221|NCT01205126|589938726|FG000|Maintenance Phase|More than the maximum dosage required|5|||
163335222|NCT01205126|589938727|FG001|Maintenance Phase|More than the maximum dosage required|5|||
163335223|NCT01205126|589938726|FG000|Maintenance Phase|Prohibited drugs used|1|||
163335224|NCT01205126|589938727|FG001|Maintenance Phase|Prohibited drugs used|0|||
163335225|NCT01205126|589938726|FG000|Maintenance Phase|Other|11|||
163335226|NCT01205126|589938727|FG001|Maintenance Phase|Other|8|||
163335227|NCT01205126|589938726|FG000|Maintenance Phase|Lost to Follow-up|5|||
163335228|NCT01205126|589938727|FG001|Maintenance Phase|Lost to Follow-up|5|||
163087873|NCT04116853|589032015|FG001|Overall Study|Protocol Violation|1|||
163087874|NCT03274466|589032016|FG000|Overall Study|Withdrawal by Subject|7|||
163087875|NCT03274466|589032017|FG001|Overall Study|Withdrawal by Subject|3|||
163087876|NCT03274466|589032016|FG000|Overall Study|Protocol Specified Withdrawal|5|||
163087877|NCT03274466|589032017|FG001|Overall Study|Protocol Specified Withdrawal|11|||
163087878|NCT03274466|589032016|FG000|Overall Study|Lost to Follow-up|5|||
163335229|NCT01205126|589938726|FG000|Maintenance Phase|Withdrawal by Subject|8|||
163335230|NCT01205126|589938727|FG001|Maintenance Phase|Withdrawal by Subject|11|||
163087879|NCT03274466|589032017|FG001|Overall Study|Lost to Follow-up|7|||
163087880|NCT03274466|589032016|FG000|Overall Study|Subject Non-compliance|0|||
163087881|NCT03274466|589032017|FG001|Overall Study|Subject Non-compliance|1|||
163087882|NCT03274466|589032016|FG000|Overall Study|Adverse Event|3|||
163087883|NCT03274466|589032017|FG001|Overall Study|Adverse Event|3|||
163087884|NCT03274466|589032016|FG000|Overall Study|Physician Decision|0|||
163087885|NCT03274466|589032017|FG001|Overall Study|Physician Decision|1|||
163087886|NCT03274466|589032016|FG000|Overall Study|Protocol Violation|3|||
163087887|NCT03274466|589032017|FG001|Overall Study|Protocol Violation|3|||
163335231|NCT00923078|589938736|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
163407207|NCT04099251|590200752|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
163407208|NCT04099251|590200751|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
163407209|NCT04099251|590200752|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
163407210|NCT04099251|590200751|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
163407211|NCT04099251|590200752|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
163407212|NCT04099251|590200751|FG000|Blinded Treatment Phase|Death|6|||
163407213|NCT04099251|590200752|FG001|Blinded Treatment Phase|Death|2|||
163407214|NCT04099251|590200751|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
163407215|NCT04099251|590200752|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
163407216|NCT04099251|590200751|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
163407217|NCT04099251|590200752|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
163407218|NCT04099251|590200751|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
163407219|NCT04099251|590200752|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
163407220|NCT04099251|590200751|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
163407221|NCT04099251|590200752|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
163407222|NCT04099251|590200751|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
163407223|NCT04099251|590200752|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
163407224|NCT04099251|590200751|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
163407225|NCT04099251|590200752|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
163407226|NCT04099251|590200751|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
163407227|NCT04099251|590200752|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
163407228|NCT04099251|590200751|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
163407229|NCT04099251|590200752|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
163407230|NCT04099251|590200751|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
163407231|NCT04099251|590200752|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
163407232|NCT04311502|590200753|FG000|Overall Study|Death|1|||
163407233|NCT04311502|590200754|FG001|Overall Study|Death|1|||
163407234|NCT04311502|590200755|FG002|Overall Study|Death|1|||
163407235|NCT04311502|590200753|FG000|Overall Study|Lost to Follow-up|2|||
163407236|NCT04311502|590200754|FG001|Overall Study|Lost to Follow-up|3|||
163407237|NCT04311502|590200755|FG002|Overall Study|Lost to Follow-up|0|||
163407238|NCT04311502|590200753|FG000|Overall Study|Participant is in prison|1|||
163407239|NCT04311502|590200754|FG001|Overall Study|Participant is in prison|0|||
163407240|NCT04311502|590200755|FG002|Overall Study|Participant is in prison|0|||
163407241|NCT04311502|590200753|FG000|Overall Study|Participant moved out of country|1|||
163407242|NCT04311502|590200754|FG001|Overall Study|Participant moved out of country|0|||
163407243|NCT04311502|590200755|FG002|Overall Study|Participant moved out of country|0|||
163407244|NCT04311502|590200753|FG000|Overall Study|Withdrawal by Subject|2|||
163407245|NCT04311502|590200754|FG001|Overall Study|Withdrawal by Subject|0|||
163407246|NCT04311502|590200755|FG002|Overall Study|Withdrawal by Subject|0|||
163407247|NCT04311502|590200753|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
163407248|NCT04311502|590200754|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
163407249|NCT04311502|590200755|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
163407250|NCT05032157|590200762|FG000|Overall Study|Adverse Event|12|||
163407251|NCT05032157|590200763|FG001|Overall Study|Adverse Event|7|||
163036876|NCT00508157|588840283|FG001|Overall Study|Subject no longer met study criteria|1|||
163036877|NCT00508157|588840282|FG000|Overall Study|Other known cause|0|||
163036878|NCT00508157|588840283|FG001|Overall Study|Other known cause|1|||
163036879|NCT01952080|588840285|FG000|Overall Study|Withdrawal by Subject|0|||
163036880|NCT01952080|588840286|FG001|Overall Study|Withdrawal by Subject|0|||
163036881|NCT01952080|588840287|FG002|Overall Study|Withdrawal by Subject|0|||
163036882|NCT01952080|588840288|FG003|Overall Study|Withdrawal by Subject|1|||
163036883|NCT01952080|588840285|FG000|Overall Study|Protocol Non-compliance|0|||
163036884|NCT01952080|588840286|FG001|Overall Study|Protocol Non-compliance|1|||
163036885|NCT01952080|588840287|FG002|Overall Study|Protocol Non-compliance|0|||
163036886|NCT01952080|588840288|FG003|Overall Study|Protocol Non-compliance|0|||
163036887|NCT02134353|588840289|FG000|Overall Study|Adverse Event|10|||
163036888|NCT02134353|588840290|FG001|Overall Study|Adverse Event|6|||
163036889|NCT02134353|588840289|FG000|Overall Study|Lost to Follow-up|1|||
163036890|NCT02134353|588840290|FG001|Overall Study|Lost to Follow-up|1|||
163036891|NCT02134353|588840289|FG000|Overall Study|Lack of Efficacy|2|||
163036892|NCT02134353|588840290|FG001|Overall Study|Lack of Efficacy|1|||
163036893|NCT02134353|588840289|FG000|Overall Study|Withdrawal by Subject|12|||
163036894|NCT02134353|588840290|FG001|Overall Study|Withdrawal by Subject|13|||
163036895|NCT02134353|588840289|FG000|Overall Study|Death|0|||
163036896|NCT02134353|588840290|FG001|Overall Study|Death|1|||
163036897|NCT02134353|588840289|FG000|Overall Study|Pregnancy|0|||
163036898|NCT02134353|588840290|FG001|Overall Study|Pregnancy|1|||
163036899|NCT02134353|588840289|FG000|Overall Study|Relocation|1|||
163036900|NCT02134353|588840290|FG001|Overall Study|Relocation|0|||
163036901|NCT02134353|588840289|FG000|Overall Study|Other - Patient's Choice|0|||
163036902|NCT02134353|588840290|FG001|Overall Study|Other - Patient's Choice|1|||
163087888|NCT01107886|589032023|FG000|Overall Study|Lost to Follow-up|15|||
163087889|NCT01107886|589032024|FG001|Overall Study|Lost to Follow-up|13|||
163087890|NCT01107886|589032023|FG000|Overall Study|Withdrawal by Subject|180|||
163087891|NCT01107886|589032024|FG001|Overall Study|Withdrawal by Subject|196|||
163087892|NCT01107886|589032023|FG000|Overall Study|Administrative withdrawal of consent|7|||
163087893|NCT01107886|589032024|FG001|Overall Study|Administrative withdrawal of consent|5|||
163087894|NCT01346176|589032025|FG000|Recruited|Protocol Violation|1|||
163087895|NCT01346176|589032026|FG001|Recruited|Protocol Violation|0|||
163087896|NCT01346176|589032027|FG002|Recruited|Protocol Violation|0|||
163087897|NCT01346176|589032025|FG000|Completed Advance Directive|Death|3|||
163087898|NCT01346176|589032026|FG001|Completed Advance Directive|Death|2|||
163087899|NCT01346176|589032027|FG002|Completed Advance Directive|Death|2|||
163087900|NCT01346176|589032025|FG000|Completed Advance Directive|Became Ineligible|3|||
163087901|NCT01346176|589032026|FG001|Completed Advance Directive|Became Ineligible|0|||
163087902|NCT01346176|589032027|FG002|Completed Advance Directive|Became Ineligible|1|||
163087903|NCT01346176|589032025|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
163087904|NCT01346176|589032026|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
163087905|NCT01346176|589032027|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
163087906|NCT01346176|589032025|FG000|Completed Satisfaction Survey|Death|3|||
163087907|NCT01346176|589032026|FG001|Completed Satisfaction Survey|Death|0|||
163087908|NCT01346176|589032027|FG002|Completed Satisfaction Survey|Death|2|||
163087909|NCT01346176|589032025|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
163087910|NCT01346176|589032026|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
163087911|NCT01346176|589032027|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
163087912|NCT02581930|589032040|FG000|Overall Study|Withdrawal by Subject|1|||
163087913|NCT02581930|589032040|FG000|Overall Study|patient declined further treatment|1|||
163087914|NCT02776735|589032041|FG000|Overall Study|Adverse Event|0|||
163087915|NCT02776735|589032042|FG001|Overall Study|Adverse Event|0|||
163036903|NCT00655681|588840293|FG000|Overall Study|Lost to Follow-up|1|||
163036904|NCT00655681|588840294|FG001|Overall Study|Lost to Follow-up|1|||
163036905|NCT01783821|588840298|FG000|Overall Study|Screen Failure|1|||
163036906|NCT01783821|588840299|FG001|Overall Study|Screen Failure|1|||
163036907|NCT01653327|588840306|FG000|Overall Study|Withdrawal by Subject|1|||
163036908|NCT00422292|588840307|FG000|Overall Study|Serious adverse events|1|||
163335232|NCT00923078|589938737|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
163335233|NCT00923078|589938738|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
163335234|NCT00923078|589938736|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
163335235|NCT00923078|589938737|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
163335236|NCT00923078|589938738|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
163335237|NCT01072149|589938739|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335238|NCT01072149|589938740|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335239|NCT01072149|589938741|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
163335240|NCT01072149|589938742|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335241|NCT01072149|589938743|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335242|NCT01072149|589938744|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335243|NCT01072149|589938745|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335244|NCT01072149|589938746|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335245|NCT01072149|589938747|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335246|NCT01072149|589938748|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335247|NCT01072149|589938749|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335248|NCT01072149|589938750|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335249|NCT01072149|589938751|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335250|NCT01072149|589938752|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335251|NCT01072149|589938753|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335252|NCT01072149|589938754|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335253|NCT01072149|589938755|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335254|NCT01072149|589938756|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163335255|NCT01072149|589938739|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163335256|NCT01072149|589938740|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163335257|NCT01072149|589938741|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163335258|NCT01072149|589938742|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163335259|NCT01072149|589938743|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163335260|NCT01072149|589938744|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163407252|NCT05032157|590200762|FG000|Overall Study|Pregnancy|0|||
163036909|NCT00422292|588840308|FG001|Overall Study|Serious adverse events|4|||
163087916|NCT02776735|589032043|FG002|Overall Study|Adverse Event|0|||
163087917|NCT02776735|589032044|FG003|Overall Study|Adverse Event|1|||
163087918|NCT02776735|589032045|FG004|Overall Study|Adverse Event|0|||
163036910|NCT00422292|588840309|FG002|Overall Study|Serious adverse events|0|||
163036911|NCT00422292|588840310|FG003|Overall Study|Serious adverse events|0|||
163087919|NCT02776735|589032046|FG005|Overall Study|Adverse Event|1|||
163087920|NCT02776735|589032041|FG000|Overall Study|Lost to Follow-up|0|||
163087921|NCT02776735|589032042|FG001|Overall Study|Lost to Follow-up|0|||
163087922|NCT02776735|589032043|FG002|Overall Study|Lost to Follow-up|0|||
163087923|NCT02776735|589032044|FG003|Overall Study|Lost to Follow-up|1|||
163087924|NCT02776735|589032045|FG004|Overall Study|Lost to Follow-up|0|||
163087925|NCT02776735|589032046|FG005|Overall Study|Lost to Follow-up|0|||
163087926|NCT02776735|589032041|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163087927|NCT02776735|589032042|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163087928|NCT02776735|589032043|FG002|Overall Study|Withdrawal by parent/guardian|2|||
163087929|NCT02776735|589032044|FG003|Overall Study|Withdrawal by parent/guardian|2|||
163087930|NCT02776735|589032045|FG004|Overall Study|Withdrawal by parent/guardian|0|||
163087931|NCT02776735|589032046|FG005|Overall Study|Withdrawal by parent/guardian|0|||
163087932|NCT02776735|589032041|FG000|Overall Study|Withdrawal by Subject|1|||
163087933|NCT02776735|589032042|FG001|Overall Study|Withdrawal by Subject|0|||
163087934|NCT02776735|589032043|FG002|Overall Study|Withdrawal by Subject|0|||
163087935|NCT02776735|589032044|FG003|Overall Study|Withdrawal by Subject|0|||
163087936|NCT02776735|589032045|FG004|Overall Study|Withdrawal by Subject|0|||
163087937|NCT02776735|589032046|FG005|Overall Study|Withdrawal by Subject|1|||
163087938|NCT02776735|589032041|FG000|Overall Study|Other|0|||
163087939|NCT02776735|589032042|FG001|Overall Study|Other|0|||
163087940|NCT02776735|589032043|FG002|Overall Study|Other|3|||
163087941|NCT02776735|589032044|FG003|Overall Study|Other|0|||
163087942|NCT02776735|589032045|FG004|Overall Study|Other|0|||
163087943|NCT02776735|589032046|FG005|Overall Study|Other|0|||
163087944|NCT01576783|589033315|FG000|Overall Study|Change in Medical Care|1|||
163087945|NCT01576783|589033316|FG001|Overall Study|Change in Medical Care|0|||
163087946|NCT01576783|589033315|FG000|Overall Study|Lost to Follow-up|14|||
163087947|NCT01576783|589033316|FG001|Overall Study|Lost to Follow-up|16|||
163087948|NCT01576783|589033315|FG000|Overall Study|Withdrawal by Subject|5|||
163087949|NCT01576783|589033316|FG001|Overall Study|Withdrawal by Subject|1|||
163087950|NCT05489328|589033317|FG000|Overall Study|Lost to Follow-up|0|||
163087951|NCT05489328|589033318|FG001|Overall Study|Lost to Follow-up|0|||
163087952|NCT05489328|589033319|FG002|Overall Study|Lost to Follow-up|1|||
163087953|NCT05489328|589033320|FG003|Overall Study|Lost to Follow-up|0|||
163087954|NCT05489328|589033321|FG004|Overall Study|Lost to Follow-up|2|||
163087955|NCT05489328|589033322|FG005|Overall Study|Lost to Follow-up|0|||
163087956|NCT05489328|589033323|FG006|Overall Study|Lost to Follow-up|0|||
163087957|NCT05489328|589033324|FG007|Overall Study|Lost to Follow-up|1|||
163087958|NCT05489328|589033325|FG008|Overall Study|Lost to Follow-up|0|||
163087959|NCT05489328|589033317|FG000|Overall Study|Withdrawal by Subject|0|||
163087960|NCT05489328|589033318|FG001|Overall Study|Withdrawal by Subject|0|||
163087961|NCT05489328|589033319|FG002|Overall Study|Withdrawal by Subject|0|||
163087962|NCT05489328|589033320|FG003|Overall Study|Withdrawal by Subject|0|||
163087963|NCT05489328|589033321|FG004|Overall Study|Withdrawal by Subject|0|||
163087964|NCT05489328|589033322|FG005|Overall Study|Withdrawal by Subject|0|||
163087965|NCT05489328|589033323|FG006|Overall Study|Withdrawal by Subject|1|||
163087966|NCT05489328|589033324|FG007|Overall Study|Withdrawal by Subject|1|||
163087967|NCT05489328|589033325|FG008|Overall Study|Withdrawal by Subject|0|||
163087968|NCT05489328|589033317|FG000|Overall Study|Other|0|||
163087969|NCT05489328|589033318|FG001|Overall Study|Other|0|||
163087970|NCT05489328|589033319|FG002|Overall Study|Other|0|||
163087971|NCT05489328|589033320|FG003|Overall Study|Other|0|||
163087972|NCT05489328|589033321|FG004|Overall Study|Other|0|||
163087973|NCT05489328|589033322|FG005|Overall Study|Other|0|||
163087974|NCT05489328|589033323|FG006|Overall Study|Other|0|||
163087975|NCT05489328|589033324|FG007|Overall Study|Other|1|||
163087976|NCT05489328|589033325|FG008|Overall Study|Other|1|||
163087977|NCT01083602|589033326|FG000|Overall Study|Adverse Event|11|||
163087978|NCT01083602|589033326|FG000|Overall Study|New Cancer Therapy|2|||
163087979|NCT01083602|589033326|FG000|Overall Study|Death|1|||
163087980|NCT01083602|589033326|FG000|Overall Study|Withdrawal by Subject|5|||
163087981|NCT01083602|589033326|FG000|Overall Study|Lack of Efficacy|36|||
163087982|NCT03021486|589033328|FG000|Overall Study|Withdrawal by Subject|1|||
163087983|NCT03021486|589033329|FG001|Overall Study|Withdrawal by Subject|1|||
163087984|NCT03021486|589033330|FG002|Overall Study|Withdrawal by Subject|3|||
163087985|NCT03021486|589033328|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
163087986|NCT03021486|589033329|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
163087987|NCT03021486|589033330|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
163087988|NCT04043286|589033331|FG000|Overall Study|Withdrawal by Subject|2|||
163087989|NCT04043286|589033332|FG001|Overall Study|Withdrawal by Subject|2|||
163087990|NCT01732536|589033333|FG000|Overall Study|Withdrawal by Subject|1|||
163087991|NCT01732536|589033334|FG001|Overall Study|Withdrawal by Subject|1|||
163087992|NCT02986074|589033335|FG000|First Trial Period|Adverse Event|1|||
163087993|NCT02986074|589033336|FG001|First Trial Period|Adverse Event|0|||
163087994|NCT02986074|589033337|FG002|First Trial Period|Adverse Event|0|||
163087995|NCT02986074|589033338|FG003|First Trial Period|Adverse Event|0|||
163087996|NCT02986074|589033335|FG000|Follow up Period|system explant|0|||
163087997|NCT02986074|589033336|FG001|Follow up Period|system explant|0|||
163087998|NCT02986074|589033337|FG002|Follow up Period|system explant|1|||
163087999|NCT02986074|589033338|FG003|Follow up Period|system explant|2|||
163088000|NCT02986074|589033335|FG000|Follow up Period|Physician Decision|0|||
163088001|NCT02986074|589033336|FG001|Follow up Period|Physician Decision|0|||
163088002|NCT02986074|589033337|FG002|Follow up Period|Physician Decision|0|||
163088003|NCT02986074|589033338|FG003|Follow up Period|Physician Decision|1|||
163088004|NCT03186638|589033339|FG000|Overall Study|Withdrawal by Subject|4|||
163088005|NCT03186638|589033340|FG001|Overall Study|Withdrawal by Subject|4|||
163088006|NCT03186638|589033339|FG000|Overall Study|Withdrawn due to medical problem|3|||
163088007|NCT03186638|589033340|FG001|Overall Study|Withdrawn due to medical problem|2|||
163088008|NCT03186638|589033339|FG000|Overall Study|Lost to Follow-up|1|||
163088009|NCT03186638|589033340|FG001|Overall Study|Lost to Follow-up|0|||
163088010|NCT04099277|589033341|FG000|Overall Study|Physician Decision|1|||
163088011|NCT04099277|589033341|FG000|Overall Study|Withdrawal by Subject|1|||
163088012|NCT00524121|589033342|FG000|Overall Study|Disease progression|6|||
163088013|NCT00524121|589033342|FG000|Overall Study|Adverse Event|4|||
163088014|NCT00524121|589033342|FG000|Overall Study|Patient refused|2|||
163088015|NCT00524121|589033342|FG000|Overall Study|Other|1|||
163088016|NCT00524121|589033342|FG000|Overall Study|Death|1|||
163088017|NCT00524121|589033342|FG000|Overall Study|Not treated (became ineligible)|4|||
163088018|NCT00524121|589033342|FG000|Overall Study|Not treated (changed mind)|1|||
163088019|NCT02410772|589033345|FG000|Overall Study|Death|3|||
163088020|NCT02410772|589033346|FG001|Overall Study|Death|4|||
163088021|NCT02410772|589033347|FG002|Overall Study|Death|8|||
163088022|NCT02410772|589033345|FG000|Overall Study|Lost to Follow-up|31|||
163088023|NCT02410772|589033346|FG001|Overall Study|Lost to Follow-up|23|||
163088024|NCT02410772|589033347|FG002|Overall Study|Lost to Follow-up|22|||
163088025|NCT02410772|589033345|FG000|Overall Study|Pregnancy|8|||
163088026|NCT02410772|589033346|FG001|Overall Study|Pregnancy|4|||
163088027|NCT02410772|589033347|FG002|Overall Study|Pregnancy|5|||
163088028|NCT02410772|589033345|FG000|Overall Study|Protocol Violation|8|||
163088029|NCT02410772|589033346|FG001|Overall Study|Protocol Violation|8|||
163088030|NCT02410772|589033347|FG002|Overall Study|Protocol Violation|4|||
163088031|NCT02410772|589033345|FG000|Overall Study|Baseline Drug Resistance|49|||
163088032|NCT02410772|589033346|FG001|Overall Study|Baseline Drug Resistance|40|||
163088033|NCT02410772|589033347|FG002|Overall Study|Baseline Drug Resistance|51|||
163088034|NCT02410772|589033345|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
163088035|NCT02410772|589033346|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
163088036|NCT02410772|589033347|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
163088037|NCT02410772|589033345|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
163088038|NCT02410772|589033346|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
163088039|NCT02410772|589033347|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
163088040|NCT00904371|589033350|FG000|Overall Study|Adverse Event|2|||
163088041|NCT00904371|589033350|FG000|Overall Study|Lost to Follow-up|4|||
163088042|NCT00904371|589033350|FG000|Overall Study|Discontinued at target blood pressure|2|||
163088043|NCT00904371|589033350|FG000|Overall Study|Continued with Tritace|1|||
163088044|NCT00754572|589033355|FG000|Overall Study|Adverse Event|19|||
163088045|NCT00754572|589033355|FG000|Overall Study|Other|39|||
163088046|NCT00754572|589033355|FG000|Overall Study|Protocol Violation|3|||
163088047|NCT00754572|589033355|FG000|Overall Study|Withdrawal by Subject|3|||
163088048|NCT00754572|589033355|FG000|Overall Study|Lack of Efficacy|2|||
163088049|NCT00754572|589033355|FG000|Overall Study|Death|1|||
163088050|NCT00754572|589033355|FG000|Overall Study|Administrative Reason|3|||
163088051|NCT00754572|589033355|FG000|Overall Study|Lost to Follow-up|1|||
163088052|NCT02493764|589033357|FG000|Overall Study|Adverse Event|2|||
163088053|NCT02493764|589033358|FG001|Overall Study|Adverse Event|2|||
163088054|NCT02493764|589033357|FG000|Overall Study|Death|44|||
163088055|NCT02493764|589033358|FG001|Overall Study|Death|58|||
163088056|NCT02493764|589033357|FG000|Overall Study|Lost to Follow-up|2|||
163088057|NCT02493764|589033358|FG001|Overall Study|Lost to Follow-up|1|||
163335261|NCT01072149|589938745|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163335262|NCT01072149|589938746|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163335263|NCT01072149|589938747|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163088058|NCT02493764|589033357|FG000|Overall Study|Protocol Violation|6|||
163088059|NCT02493764|589033358|FG001|Overall Study|Protocol Violation|7|||
163088060|NCT02493764|589033357|FG000|Overall Study|Physician Decision|1|||
163088061|NCT02493764|589033358|FG001|Overall Study|Physician Decision|1|||
163088062|NCT02493764|589033357|FG000|Overall Study|Participant moved|17|||
163088063|NCT02493764|589033358|FG001|Overall Study|Participant moved|5|||
163088064|NCT02493764|589033357|FG000|Overall Study|Withdrawal parent/guardian|0|||
163088065|NCT02493764|589033358|FG001|Overall Study|Withdrawal parent/guardian|1|||
163088066|NCT02493764|589033357|FG000|Overall Study|Withdrawal by Subject|11|||
163088067|NCT02493764|589033358|FG001|Overall Study|Withdrawal by Subject|7|||
163088068|NCT04846231|589033364|FG000|Overall Study|Lost to Follow-up|1|||
163088069|NCT04846231|589033365|FG001|Overall Study|Lost to Follow-up|0|||
163088070|NCT04846231|589033366|FG002|Overall Study|Lost to Follow-up|0|||
163088071|NCT04846231|589033367|FG003|Overall Study|Lost to Follow-up|0|||
163088072|NCT04846231|589033368|FG004|Overall Study|Lost to Follow-up|0|||
163407253|NCT05032157|590200763|FG001|Overall Study|Pregnancy|2|||
163407254|NCT05032157|590200762|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
163407255|NCT05032157|590200763|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
163407256|NCT05032157|590200762|FG000|Overall Study|Protocol Deviation|8|||
163407257|NCT05032157|590200763|FG001|Overall Study|Protocol Deviation|4|||
163407258|NCT05032157|590200762|FG000|Overall Study|Lost to Follow-up|1|||
163407259|NCT05032157|590200763|FG001|Overall Study|Lost to Follow-up|3|||
163088073|NCT04846231|589033369|FG005|Overall Study|Lost to Follow-up|0|||
163088074|NCT04846231|589033370|FG006|Overall Study|Lost to Follow-up|0|||
163088075|NCT04846231|589033371|FG007|Overall Study|Lost to Follow-up|1|||
163088076|NCT04846231|589033364|FG000|Overall Study|Withdrawal by Subject|0|||
163088077|NCT04846231|589033365|FG001|Overall Study|Withdrawal by Subject|1|||
163088078|NCT04846231|589033366|FG002|Overall Study|Withdrawal by Subject|2|||
163088079|NCT04846231|589033367|FG003|Overall Study|Withdrawal by Subject|1|||
163088080|NCT04846231|589033368|FG004|Overall Study|Withdrawal by Subject|0|||
163088081|NCT04846231|589033369|FG005|Overall Study|Withdrawal by Subject|0|||
163088082|NCT04846231|589033370|FG006|Overall Study|Withdrawal by Subject|0|||
163088083|NCT04846231|589033371|FG007|Overall Study|Withdrawal by Subject|0|||
163088084|NCT04846231|589033364|FG000|Overall Study|Protocol Violation|0|||
163088085|NCT04846231|589033365|FG001|Overall Study|Protocol Violation|1|||
163088086|NCT04846231|589033366|FG002|Overall Study|Protocol Violation|0|||
163088087|NCT04846231|589033367|FG003|Overall Study|Protocol Violation|0|||
163088088|NCT04846231|589033368|FG004|Overall Study|Protocol Violation|0|||
163088089|NCT04846231|589033369|FG005|Overall Study|Protocol Violation|0|||
163088090|NCT04846231|589033370|FG006|Overall Study|Protocol Violation|0|||
163088091|NCT04846231|589033371|FG007|Overall Study|Protocol Violation|0|||
163088092|NCT04846231|589033364|FG000|Overall Study|Adverse Event|0|||
163088093|NCT04846231|589033365|FG001|Overall Study|Adverse Event|0|||
163088094|NCT04846231|589033366|FG002|Overall Study|Adverse Event|0|||
163088095|NCT04846231|589033367|FG003|Overall Study|Adverse Event|0|||
163088096|NCT04846231|589033368|FG004|Overall Study|Adverse Event|0|||
163088097|NCT04846231|589033369|FG005|Overall Study|Adverse Event|0|||
163088098|NCT04846231|589033370|FG006|Overall Study|Adverse Event|1|||
163088099|NCT04846231|589033371|FG007|Overall Study|Adverse Event|1|||
163088100|NCT05448950|589033372|FG000|Overall Study|Death|2|||
163088101|NCT05448950|589033372|FG000|Overall Study|Withdrawal by Subject|1|||
163088102|NCT05448950|589033372|FG000|Overall Study|AVG abandoned|4|||
163088103|NCT01646827|589033373|FG000|Overall Study|Lost to Follow-up|0|||
163088104|NCT01646827|589033374|FG001|Overall Study|Lost to Follow-up|3|||
163088105|NCT01646827|589033373|FG000|Overall Study|Physician Decision|1|||
163088106|NCT01646827|589033374|FG001|Overall Study|Physician Decision|2|||
163088107|NCT01646827|589033373|FG000|Overall Study|Withdrawal by Subject|1|||
163088108|NCT01646827|589033374|FG001|Overall Study|Withdrawal by Subject|0|||
163088109|NCT01143402|589033377|FG000|Overall Study|Rapid clinical decline|1|||
163088110|NCT01143402|589033378|FG001|Overall Study|Rapid clinical decline|1|||
163088111|NCT01143402|589033379|FG002|Overall Study|Rapid clinical decline|0|||
163088112|NCT01143402|589033377|FG000|Overall Study|Not Treated|0|||
163088113|NCT01143402|589033378|FG001|Overall Study|Not Treated|0|||
163088114|NCT01143402|589033379|FG002|Overall Study|Not Treated|1|||
163088115|NCT04462471|589033380|FG000|Overall Study|Adverse Event|0|||
163088116|NCT04462471|589033381|FG001|Overall Study|Adverse Event|1|||
163088117|NCT04462471|589033382|FG002|Overall Study|Adverse Event|0|||
163088118|NCT04462471|589033383|FG003|Overall Study|Adverse Event|0|||
163088119|NCT04462471|589033380|FG000|Overall Study|Disease progression|1|||
163088120|NCT04462471|589033381|FG001|Overall Study|Disease progression|0|||
163088121|NCT04462471|589033382|FG002|Overall Study|Disease progression|0|||
163088122|NCT04462471|589033383|FG003|Overall Study|Disease progression|0|||
163088123|NCT02706392|589033384|FG000|Overall Study|Death|1|||
163088124|NCT02706392|589033385|FG001|Overall Study|Death|0|||
163088125|NCT02706392|589033386|FG002|Overall Study|Death|2|||
163407260|NCT05032157|590200762|FG000|Overall Study|Physician Decision|7|||
163407261|NCT05032157|590200763|FG001|Overall Study|Physician Decision|2|||
163088126|NCT02706392|589033387|FG003|Overall Study|Death|2|||
163088127|NCT02706392|589033388|FG004|Overall Study|Death|5|||
163088128|NCT02706392|589033389|FG005|Overall Study|Death|2|||
163088129|NCT00265122|589033394|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
163088130|NCT00265122|589033395|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
163088131|NCT00265122|589033396|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
163088132|NCT00265122|589033397|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
163088133|NCT00265122|589033398|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
163088134|NCT00265122|589033399|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
163088135|NCT00265122|589033394|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
163088136|NCT00265122|589033395|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
163407262|NCT05032157|590200762|FG000|Overall Study|Patient Decision|38|||
163407263|NCT05032157|590200763|FG001|Overall Study|Patient Decision|19|||
163088137|NCT00265122|589033396|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
163088138|NCT00265122|589033397|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
163407264|NCT03451773|590200764|FG000|Overall Study|Death on study|1|||
163088139|NCT00265122|589033398|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
163088140|NCT00265122|589033399|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
163088141|NCT00265122|589033394|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
163088142|NCT00265122|589033395|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
163088143|NCT00265122|589033396|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
163088144|NCT00265122|589033397|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
163335264|NCT01072149|589938748|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163335265|NCT01072149|589938749|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163335266|NCT01072149|589938750|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163335267|NCT01072149|589938751|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163335268|NCT01072149|589938752|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163335269|NCT01072149|589938753|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163335270|NCT01072149|589938754|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163335271|NCT01072149|589938755|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163335272|NCT01072149|589938756|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
163335273|NCT01072149|589938739|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335274|NCT01072149|589938740|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335275|NCT01072149|589938741|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335276|NCT01072149|589938742|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335277|NCT01072149|589938743|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335278|NCT01072149|589938744|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335279|NCT01072149|589938745|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335280|NCT01072149|589938746|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335281|NCT01072149|589938747|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335282|NCT01072149|589938748|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335283|NCT01072149|589938749|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
163335284|NCT01072149|589938750|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335285|NCT01072149|589938751|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335286|NCT01072149|589938752|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335287|NCT01072149|589938753|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335288|NCT01072149|589938754|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335289|NCT01072149|589938755|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335290|NCT01072149|589938756|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163335291|NCT01072149|589938739|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163088145|NCT00265122|589033398|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
163088146|NCT00265122|589033399|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
163088147|NCT00265122|589033394|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
163088148|NCT00265122|589033395|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
163088149|NCT00265122|589033396|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
163088150|NCT00265122|589033397|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
163088151|NCT00265122|589033398|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
163088152|NCT00265122|589033399|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
163088153|NCT00265122|589033394|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
163088154|NCT00265122|589033395|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
163088155|NCT00265122|589033396|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
163088156|NCT00265122|589033397|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
163088157|NCT00265122|589033398|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
163088158|NCT00265122|589033399|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
163088159|NCT00265122|589033394|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
163088160|NCT00265122|589033395|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
163088161|NCT00265122|589033396|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
163088162|NCT00265122|589033397|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
163088163|NCT00265122|589033398|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
163088164|NCT00265122|589033399|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
163088165|NCT01276106|589033400|FG000|Overall Study|Adverse Event|3|||
163088166|NCT01276106|589033401|FG001|Overall Study|Adverse Event|3|||
163088167|NCT01276106|589033402|FG002|Overall Study|Adverse Event|11|||
163088168|NCT01276106|589033403|FG003|Overall Study|Adverse Event|3|||
163088169|NCT01276106|589033400|FG000|Overall Study|Withdrawal by Subject|6|||
163088170|NCT01276106|589033401|FG001|Overall Study|Withdrawal by Subject|3|||
163088171|NCT01276106|589033402|FG002|Overall Study|Withdrawal by Subject|1|||
163088172|NCT01276106|589033403|FG003|Overall Study|Withdrawal by Subject|6|||
163088173|NCT01276106|589033400|FG000|Overall Study|Lack of Efficacy|0|||
163088174|NCT01276106|589033401|FG001|Overall Study|Lack of Efficacy|1|||
163088175|NCT01276106|589033402|FG002|Overall Study|Lack of Efficacy|0|||
163088176|NCT01276106|589033403|FG003|Overall Study|Lack of Efficacy|1|||
163088177|NCT01276106|589033400|FG000|Overall Study|Lost to Follow-up|2|||
163088178|NCT01276106|589033401|FG001|Overall Study|Lost to Follow-up|1|||
163335292|NCT01072149|589938740|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
163335293|NCT01072149|589938741|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163335294|NCT01072149|589938742|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163335295|NCT01072149|589938743|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163335296|NCT01072149|589938744|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163335297|NCT01072149|589938745|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163335298|NCT01072149|589938746|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163335299|NCT01072149|589938747|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163335300|NCT01072149|589938748|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163335301|NCT01072149|589938749|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163335302|NCT01072149|589938750|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163335303|NCT01072149|589938751|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163335304|NCT01072149|589938752|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163335305|NCT01072149|589938753|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163335306|NCT01072149|589938754|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163335307|NCT01072149|589938755|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163407265|NCT03451773|590200765|FG001|Overall Study|Death on study|5|||
163407266|NCT03451773|590200764|FG000|Overall Study|Death during follow-up period|0|||
163407267|NCT03451773|590200765|FG001|Overall Study|Death during follow-up period|1|||
163088179|NCT01276106|589033402|FG002|Overall Study|Lost to Follow-up|1|||
163088180|NCT01276106|589033403|FG003|Overall Study|Lost to Follow-up|0|||
163088181|NCT01276106|589033400|FG000|Overall Study|Physician Decision|0|||
163088182|NCT01276106|589033401|FG001|Overall Study|Physician Decision|0|||
163088183|NCT01276106|589033402|FG002|Overall Study|Physician Decision|1|||
163088184|NCT01276106|589033403|FG003|Overall Study|Physician Decision|1|||
163088185|NCT01276106|589033400|FG000|Overall Study|Protocol Violation|1|||
163088186|NCT01276106|589033401|FG001|Overall Study|Protocol Violation|1|||
163088187|NCT01276106|589033402|FG002|Overall Study|Protocol Violation|0|||
163088188|NCT01276106|589033403|FG003|Overall Study|Protocol Violation|2|||
163088189|NCT01276106|589033400|FG000|Overall Study|Insufficient therapeutic effects|0|||
163088190|NCT01276106|589033401|FG001|Overall Study|Insufficient therapeutic effects|0|||
163088191|NCT01276106|589033402|FG002|Overall Study|Insufficient therapeutic effects|2|||
163088192|NCT01276106|589033403|FG003|Overall Study|Insufficient therapeutic effects|0|||
163088193|NCT00862940|589033407|FG000|Overall Study|Adverse Event|15|||
163088194|NCT00862940|589033408|FG001|Overall Study|Adverse Event|12|||
163088195|NCT00862940|589033407|FG000|Overall Study|Lack of Efficacy|1|||
163088196|NCT00862940|589033408|FG001|Overall Study|Lack of Efficacy|3|||
163088197|NCT00862940|589033407|FG000|Overall Study|Protocol Violation|2|||
163088198|NCT00862940|589033408|FG001|Overall Study|Protocol Violation|5|||
163088199|NCT00862940|589033407|FG000|Overall Study|Withdrawal by Subject|4|||
163088200|NCT00862940|589033408|FG001|Overall Study|Withdrawal by Subject|6|||
163088201|NCT00862940|589033407|FG000|Overall Study|Non-compliance|4|||
163088202|NCT00862940|589033408|FG001|Overall Study|Non-compliance|0|||
163088203|NCT00862940|589033407|FG000|Overall Study|Lost to Follow-up|0|||
163088204|NCT00862940|589033408|FG001|Overall Study|Lost to Follow-up|1|||
163088205|NCT00862940|589033407|FG000|Overall Study|Administrative or other reason(s)|4|||
163088206|NCT00862940|589033408|FG001|Overall Study|Administrative or other reason(s)|3|||
163088207|NCT00485173|589033409|FG000|Overall Study|Death|4|||
163088208|NCT00485173|589033410|FG001|Overall Study|Death|3|||
163088209|NCT00485173|589033409|FG000|Overall Study|Lost to Follow-up|32|||
163088210|NCT00485173|589033410|FG001|Overall Study|Lost to Follow-up|61|||
163088211|NCT00879398|589033413|FG000|Overall Study|Visit Stop|399|||
163088212|NCT00879398|589033413|FG000|Overall Study|Lack of Efficacy|64|||
163088213|NCT00879398|589033413|FG000|Overall Study|Adverse Event|41|||
163088214|NCT00879398|589033413|FG000|Overall Study|Other Reasons|171|||
163088215|NCT00829244|589033414|FG000|Overall Study|Adverse Event|1|||
163088216|NCT00829244|589033415|FG001|Overall Study|Adverse Event|3|||
163088217|NCT00829244|589033414|FG000|Overall Study|Protocol Violation|1|||
163088218|NCT00829244|589033415|FG001|Overall Study|Protocol Violation|0|||
163088219|NCT00829244|589033414|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
163088220|NCT00829244|589033415|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
163088221|NCT00829244|589033414|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
163088222|NCT00829244|589033415|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
163088223|NCT00829244|589033414|FG000|Overall Study|No fertilization|2|||
163088224|NCT00829244|589033415|FG001|Overall Study|No fertilization|2|||
163088225|NCT00829244|589033414|FG000|Overall Study|All embryos discarded|0|||
163088226|NCT00829244|589033415|FG001|Overall Study|All embryos discarded|3|||
163088227|NCT00829244|589033414|FG000|Overall Study|No embryo cleavage|0|||
163088228|NCT00829244|589033415|FG001|Overall Study|No embryo cleavage|2|||
163088229|NCT04251533|589033422|FG000|Overall Study|Progressive disease|33|||
163088230|NCT04251533|589033423|FG001|Overall Study|Progressive disease|29|||
163088231|NCT04251533|589033424|FG002|Overall Study|Progressive disease|22|||
163088232|NCT04251533|589033422|FG000|Overall Study|Death|5|||
163088233|NCT04251533|589033423|FG001|Overall Study|Death|1|||
163088234|NCT04251533|589033424|FG002|Overall Study|Death|3|||
163088235|NCT04251533|589033422|FG000|Overall Study|Physician Decision|3|||
163088236|NCT04251533|589033423|FG001|Overall Study|Physician Decision|2|||
163088237|NCT04251533|589033424|FG002|Overall Study|Physician Decision|4|||
163088238|NCT04251533|589033422|FG000|Overall Study|Participant decision|1|||
163335308|NCT01072149|589938756|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163088239|NCT04251533|589033423|FG001|Overall Study|Participant decision|3|||
163088240|NCT04251533|589033424|FG002|Overall Study|Participant decision|1|||
163088241|NCT04251533|589033422|FG000|Overall Study|Adverse Event|2|||
163088242|NCT04251533|589033423|FG001|Overall Study|Adverse Event|1|||
163088243|NCT04251533|589033424|FG002|Overall Study|Adverse Event|1|||
163088244|NCT04583618|589033432|FG000|Overall Study|Adverse Event|0|||
163088245|NCT04583618|589033433|FG001|Overall Study|Adverse Event|0|||
163088246|NCT04583618|589033434|FG002|Overall Study|Adverse Event|1|||
163088247|NCT04583618|589033435|FG003|Overall Study|Adverse Event|0|||
163088248|NCT04583618|589033436|FG004|Overall Study|Adverse Event|0|||
163088249|NCT04583618|589033432|FG000|Overall Study|Protocol deviation|1|||
163088250|NCT04583618|589033433|FG001|Overall Study|Protocol deviation|1|||
163088251|NCT04583618|589033434|FG002|Overall Study|Protocol deviation|1|||
163088252|NCT04583618|589033435|FG003|Overall Study|Protocol deviation|0|||
163088253|NCT04583618|589033436|FG004|Overall Study|Protocol deviation|0|||
163088254|NCT04583618|589033432|FG000|Overall Study|Withdrawal by Subject|2|||
163088255|NCT04583618|589033433|FG001|Overall Study|Withdrawal by Subject|1|||
163088256|NCT04583618|589033434|FG002|Overall Study|Withdrawal by Subject|3|||
163088257|NCT04583618|589033435|FG003|Overall Study|Withdrawal by Subject|1|||
163088258|NCT04583618|589033436|FG004|Overall Study|Withdrawal by Subject|1|||
163088259|NCT04583618|589033432|FG000|Overall Study|Lost to Follow-up|0|||
163088260|NCT04583618|589033433|FG001|Overall Study|Lost to Follow-up|1|||
163088261|NCT04583618|589033434|FG002|Overall Study|Lost to Follow-up|3|||
163088262|NCT04583618|589033435|FG003|Overall Study|Lost to Follow-up|1|||
163088263|NCT04583618|589033436|FG004|Overall Study|Lost to Follow-up|1|||
163088264|NCT02302222|589033439|FG000|Overall Study|Physician Decision|0|||
163088265|NCT02302222|589033440|FG001|Overall Study|Physician Decision|4|||
163088266|NCT02302222|589033439|FG000|Overall Study|Lost to Follow-up|1|||
163088267|NCT02302222|589033440|FG001|Overall Study|Lost to Follow-up|0|||
163088268|NCT02302222|589033439|FG000|Overall Study|Treatment discontinued before day 5|0|||
163088269|NCT02302222|589033440|FG001|Overall Study|Treatment discontinued before day 5|1|||
163088270|NCT02302222|589033439|FG000|Overall Study|Withdrawn prior to any treatment|0|||
163088271|NCT02302222|589033440|FG001|Overall Study|Withdrawn prior to any treatment|1|||
163088272|NCT00016354|589033441|FG000|Overall Study|Lack of Efficacy|0|||
163088273|NCT00016354|589033442|FG001|Overall Study|Lack of Efficacy|0|||
163088274|NCT00016354|589033443|FG002|Overall Study|Lack of Efficacy|0|||
163088275|NCT00016354|589033444|FG003|Overall Study|Lack of Efficacy|0|||
163088276|NCT00016354|589033445|FG004|Overall Study|Lack of Efficacy|0|||
163088277|NCT00016354|589033446|FG005|Overall Study|Lack of Efficacy|0|||
163088278|NCT00016354|589033447|FG006|Overall Study|Lack of Efficacy|0|||
163088279|NCT00016354|589033448|FG007|Overall Study|Lack of Efficacy|1|||
163088280|NCT03110562|589033449|FG000|Initial Treatment Period|Disease Progression|1|||
163088281|NCT03110562|589033450|FG001|Initial Treatment Period|Disease Progression|1|||
163088282|NCT03110562|589033451|FG002|Initial Treatment Period|Disease Progression|0|||
163088283|NCT03110562|589033452|FG003|Initial Treatment Period|Disease Progression|0|||
163088284|NCT03110562|589033449|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
163088285|NCT03110562|589033450|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
163088286|NCT03110562|589033451|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
163088287|NCT03110562|589033452|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
163088288|NCT03110562|589033449|FG000|Initial Treatment Period|Adverse Event|1|||
163088289|NCT03110562|589033450|FG001|Initial Treatment Period|Adverse Event|0|||
163088290|NCT03110562|589033451|FG002|Initial Treatment Period|Adverse Event|0|||
163088291|NCT03110562|589033452|FG003|Initial Treatment Period|Adverse Event|0|||
163088292|NCT03110562|589033449|FG000|Initial Treatment Period|Death|74|||
163088293|NCT03110562|589033450|FG001|Initial Treatment Period|Death|82|||
163088294|NCT03110562|589033451|FG002|Initial Treatment Period|Death|0|||
163088295|NCT03110562|589033452|FG003|Initial Treatment Period|Death|0|||
163088296|NCT03110562|589033449|FG000|Initial Treatment Period|Lost to Follow-up|13|||
163088297|NCT03110562|589033450|FG001|Initial Treatment Period|Lost to Follow-up|8|||
163088298|NCT03110562|589033451|FG002|Initial Treatment Period|Lost to Follow-up|0|||
163088299|NCT03110562|589033452|FG003|Initial Treatment Period|Lost to Follow-up|0|||
163088300|NCT03110562|589033449|FG000|Initial Treatment Period|Protocol Deviation|1|||
163088301|NCT03110562|589033450|FG001|Initial Treatment Period|Protocol Deviation|0|||
163088302|NCT03110562|589033451|FG002|Initial Treatment Period|Protocol Deviation|0|||
163088303|NCT03110562|589033452|FG003|Initial Treatment Period|Protocol Deviation|0|||
163088304|NCT03110562|589033449|FG000|Initial Treatment Period|Physician Decision|2|||
163088305|NCT03110562|589033450|FG001|Initial Treatment Period|Physician Decision|1|||
163088306|NCT03110562|589033451|FG002|Initial Treatment Period|Physician Decision|0|||
163088307|NCT03110562|589033452|FG003|Initial Treatment Period|Physician Decision|0|||
163088308|NCT03110562|589033449|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
163088309|NCT03110562|589033450|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
163088310|NCT03110562|589033451|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
163088311|NCT03110562|589033452|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
163088312|NCT03110562|589033449|FG000|Initial Treatment Period|Other|5|||
163088313|NCT03110562|589033450|FG001|Initial Treatment Period|Other|4|||
163088314|NCT03110562|589033451|FG002|Initial Treatment Period|Other|0|||
163088315|NCT03110562|589033452|FG003|Initial Treatment Period|Other|0|||
163088316|NCT03110562|589033449|FG000|Initial Treatment Period|Randomized but never treated|0|||
163088317|NCT03110562|589033450|FG001|Initial Treatment Period|Randomized but never treated|3|||
163088318|NCT03110562|589033451|FG002|Initial Treatment Period|Randomized but never treated|0|||
163088319|NCT03110562|589033452|FG003|Initial Treatment Period|Randomized but never treated|0|||
163088320|NCT03110562|589033449|FG000|Crossover Period|Disease Progression|0|||
163088321|NCT03110562|589033450|FG001|Crossover Period|Disease Progression|0|||
163088322|NCT03110562|589033451|FG002|Crossover Period|Disease Progression|1|||
163088323|NCT03110562|589033452|FG003|Crossover Period|Disease Progression|0|||
163088324|NCT03110562|589033449|FG000|Crossover Period|Withdrawal by Subject|0|||
163088325|NCT03110562|589033450|FG001|Crossover Period|Withdrawal by Subject|0|||
163088326|NCT03110562|589033451|FG002|Crossover Period|Withdrawal by Subject|8|||
163088327|NCT03110562|589033452|FG003|Crossover Period|Withdrawal by Subject|6|||
163088328|NCT03110562|589033449|FG000|Crossover Period|Death|0|||
163088329|NCT03110562|589033450|FG001|Crossover Period|Death|0|||
163088330|NCT03110562|589033451|FG002|Crossover Period|Death|37|||
163088331|NCT03110562|589033452|FG003|Crossover Period|Death|3|||
163088332|NCT03110562|589033449|FG000|Crossover Period|Lost to Follow-up|0|||
163088333|NCT03110562|589033450|FG001|Crossover Period|Lost to Follow-up|0|||
163088334|NCT03110562|589033451|FG002|Crossover Period|Lost to Follow-up|0|||
163088335|NCT03110562|589033452|FG003|Crossover Period|Lost to Follow-up|1|||
163088336|NCT03110562|589033449|FG000|Crossover Period|Other|0|||
163088337|NCT03110562|589033450|FG001|Crossover Period|Other|0|||
163088338|NCT03110562|589033451|FG002|Crossover Period|Other|1|||
163088339|NCT03110562|589033452|FG003|Crossover Period|Other|1|||
163088340|NCT03110562|589033449|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
163088341|NCT03110562|589033450|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
163088342|NCT03110562|589033451|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
163088343|NCT03110562|589033452|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
163088344|NCT02769481|589033456|FG000|Overall Study|Protocol Violation|1|||
163088345|NCT02769481|589033457|FG001|Overall Study|Protocol Violation|0|||
163088346|NCT02769481|589033456|FG000|Overall Study|Adverse Event|3|||
163088347|NCT02769481|589033457|FG001|Overall Study|Adverse Event|6|||
163088348|NCT02769481|589033456|FG000|Overall Study|Entry Criteria Not Met|1|||
163088349|NCT02769481|589033457|FG001|Overall Study|Entry Criteria Not Met|2|||
163088350|NCT02769481|589033456|FG000|Overall Study|Withdrawal by Subject|14|||
163088351|NCT02769481|589033457|FG001|Overall Study|Withdrawal by Subject|16|||
163088352|NCT02769481|589033456|FG000|Overall Study|Lost to Follow-up|9|||
163088353|NCT02769481|589033457|FG001|Overall Study|Lost to Follow-up|9|||
163088354|NCT02769481|589033456|FG000|Overall Study|Physician Decision|0|||
163088355|NCT02769481|589033457|FG001|Overall Study|Physician Decision|1|||
163088356|NCT02769481|589033456|FG000|Overall Study|Terminated by Sponsor|1|||
163088357|NCT02769481|589033457|FG001|Overall Study|Terminated by Sponsor|0|||
163088358|NCT02769481|589033456|FG000|Overall Study|Death|0|||
163088359|NCT02769481|589033457|FG001|Overall Study|Death|1|||
163088360|NCT02769481|589033456|FG000|Overall Study|Undefined|4|||
163088361|NCT02769481|589033457|FG001|Overall Study|Undefined|1|||
163088362|NCT02781558|589033458|FG000|Overall Study|Lost to Follow-up|2|||
163088363|NCT02781558|589033459|FG001|Overall Study|Lost to Follow-up|2|||
163088364|NCT02781558|589033458|FG000|Overall Study|Adverse Event|1|||
163088365|NCT02781558|589033459|FG001|Overall Study|Adverse Event|0|||
163088366|NCT00643279|589033462|FG000|Overall Study|Death|13|||
163088367|NCT00643279|589033463|FG001|Overall Study|Death|11|||
163088368|NCT00643279|589033462|FG000|Overall Study|Withdrawal by Subject|3|||
163088369|NCT00643279|589033463|FG001|Overall Study|Withdrawal by Subject|0|||
163088370|NCT00643279|589033462|FG000|Overall Study|Lost to Follow-up|0|||
163088371|NCT00643279|589033463|FG001|Overall Study|Lost to Follow-up|1|||
163088372|NCT00643279|589033462|FG000|Overall Study|Physician Decision|0|||
163220053|NCT03965962|589521389|FG000|Overall Study|Withdrawal by Subject|3|||
163220054|NCT03965962|589521390|FG001|Overall Study|Withdrawal by Subject|0|||
163220055|NCT03965962|589521391|FG002|Overall Study|Withdrawal by Subject|0|||
163407268|NCT02627495|590200766|FG000|Overall Study|Withdrawal by Subject|4|||
163088373|NCT00643279|589033463|FG001|Overall Study|Physician Decision|1|||
163088374|NCT01334918|589035806|FG000|Overall Study|Did not receive study drug|6|||
163088375|NCT01334918|589035807|FG001|Overall Study|Did not receive study drug|0|||
163088376|NCT01334918|589035806|FG000|Overall Study|Adverse Event|2|||
163088377|NCT01334918|589035807|FG001|Overall Study|Adverse Event|0|||
163088378|NCT01334918|589035806|FG000|Overall Study|Withdrawal by Subject|0|||
163088379|NCT01334918|589035807|FG001|Overall Study|Withdrawal by Subject|1|||
163088380|NCT01657370|589035813|FG000|Overall Study|Withdrawal by Subject|0|||
163088381|NCT01657370|589035814|FG001|Overall Study|Withdrawal by Subject|0|||
163088382|NCT01657370|589035815|FG002|Overall Study|Withdrawal by Subject|1|||
163088383|NCT01657370|589035816|FG003|Overall Study|Withdrawal by Subject|0|||
163088384|NCT01657370|589035817|FG004|Overall Study|Withdrawal by Subject|0|||
163088385|NCT01657370|589035818|FG005|Overall Study|Withdrawal by Subject|1|||
163088386|NCT01657370|589035813|FG000|Overall Study|Physician Decision|2|||
163335309|NCT01072149|589938739|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335310|NCT01072149|589938740|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335311|NCT01072149|589938741|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
163335312|NCT01072149|589938742|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335313|NCT01072149|589938743|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335314|NCT01072149|589938744|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335315|NCT01072149|589938745|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335316|NCT01072149|589938746|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335317|NCT01072149|589938747|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335318|NCT01072149|589938748|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335319|NCT01072149|589938749|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335320|NCT01072149|589938750|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335321|NCT01072149|589938751|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335322|NCT01072149|589938752|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335323|NCT01072149|589938753|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335324|NCT01072149|589938754|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335325|NCT01072149|589938755|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335326|NCT01072149|589938756|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163335327|NCT01072149|589938739|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
163335328|NCT01072149|589938740|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
163335329|NCT01072149|589938741|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
163088387|NCT01657370|589035814|FG001|Overall Study|Physician Decision|3|||
163088388|NCT01657370|589035815|FG002|Overall Study|Physician Decision|1|||
163088389|NCT01657370|589035816|FG003|Overall Study|Physician Decision|2|||
163088390|NCT01657370|589035817|FG004|Overall Study|Physician Decision|5|||
163088391|NCT01657370|589035818|FG005|Overall Study|Physician Decision|0|||
163088392|NCT01657370|589035813|FG000|Overall Study|Lack of Qualifying Event|1|||
163088393|NCT01657370|589035814|FG001|Overall Study|Lack of Qualifying Event|0|||
163088394|NCT01657370|589035815|FG002|Overall Study|Lack of Qualifying Event|3|||
163088395|NCT01657370|589035816|FG003|Overall Study|Lack of Qualifying Event|2|||
163088396|NCT01657370|589035817|FG004|Overall Study|Lack of Qualifying Event|1|||
163088397|NCT01657370|589035818|FG005|Overall Study|Lack of Qualifying Event|2|||
163088398|NCT01657370|589035813|FG000|Overall Study|Adverse Event|0|||
163088399|NCT01657370|589035814|FG001|Overall Study|Adverse Event|0|||
163088400|NCT01657370|589035815|FG002|Overall Study|Adverse Event|0|||
163088401|NCT01657370|589035816|FG003|Overall Study|Adverse Event|0|||
163088402|NCT01657370|589035817|FG004|Overall Study|Adverse Event|1|||
163088403|NCT01657370|589035818|FG005|Overall Study|Adverse Event|0|||
163088404|NCT01657370|589035813|FG000|Overall Study|Protocol Violation|1|||
163088405|NCT01657370|589035814|FG001|Overall Study|Protocol Violation|1|||
163088406|NCT01657370|589035815|FG002|Overall Study|Protocol Violation|1|||
163088407|NCT01657370|589035816|FG003|Overall Study|Protocol Violation|1|||
163088408|NCT01657370|589035817|FG004|Overall Study|Protocol Violation|0|||
163088409|NCT01657370|589035818|FG005|Overall Study|Protocol Violation|0|||
163088410|NCT01657370|589035813|FG000|Overall Study|Lost to Follow-up|2|||
163088411|NCT01657370|589035814|FG001|Overall Study|Lost to Follow-up|0|||
163088412|NCT01657370|589035815|FG002|Overall Study|Lost to Follow-up|1|||
163088413|NCT01657370|589035816|FG003|Overall Study|Lost to Follow-up|0|||
163088414|NCT01657370|589035817|FG004|Overall Study|Lost to Follow-up|0|||
163088415|NCT01657370|589035818|FG005|Overall Study|Lost to Follow-up|1|||
163088416|NCT02777086|589035819|FG000|Overall Study|Lost to Follow-up|96|||
163088417|NCT02777086|589035820|FG001|Overall Study|Lost to Follow-up|99|||
163088418|NCT01133665|589035821|FG000|Overall Study|Physician Decision|2|||
163088419|NCT01819272|589035822|FG000|Overall Study|Adverse Event|1|||
163088420|NCT01819272|589035823|FG001|Overall Study|Adverse Event|0|||
163088421|NCT01819272|589035824|FG002|Overall Study|Adverse Event|0|||
163088422|NCT01819272|589035825|FG003|Overall Study|Adverse Event|2|||
163088423|NCT01819272|589035826|FG004|Overall Study|Adverse Event|0|||
163088424|NCT01819272|589035827|FG005|Overall Study|Adverse Event|0|||
163335330|NCT01072149|589938742|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
163335331|NCT01072149|589938743|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
163335332|NCT01072149|589938744|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
163088425|NCT01819272|589035822|FG000|Overall Study|Lost to Follow-up|3|||
163088426|NCT01819272|589035823|FG001|Overall Study|Lost to Follow-up|0|||
163088427|NCT01819272|589035824|FG002|Overall Study|Lost to Follow-up|1|||
163088428|NCT01819272|589035825|FG003|Overall Study|Lost to Follow-up|0|||
163088429|NCT01819272|589035826|FG004|Overall Study|Lost to Follow-up|0|||
163088430|NCT01819272|589035827|FG005|Overall Study|Lost to Follow-up|3|||
163088431|NCT01819272|589035822|FG000|Overall Study|Protocol Violation|0|||
163088432|NCT01819272|589035823|FG001|Overall Study|Protocol Violation|0|||
163088433|NCT01819272|589035824|FG002|Overall Study|Protocol Violation|0|||
163088434|NCT01819272|589035825|FG003|Overall Study|Protocol Violation|1|||
163088435|NCT01819272|589035826|FG004|Overall Study|Protocol Violation|2|||
163088436|NCT01819272|589035827|FG005|Overall Study|Protocol Violation|3|||
163088437|NCT01819272|589035822|FG000|Overall Study|Physician Decision|0|||
163088438|NCT01819272|589035823|FG001|Overall Study|Physician Decision|1|||
163088439|NCT01819272|589035824|FG002|Overall Study|Physician Decision|0|||
163036912|NCT00422292|588840307|FG000|Overall Study|Adverse Event|1|||
163036913|NCT00422292|588840308|FG001|Overall Study|Adverse Event|0|||
163036914|NCT00422292|588840309|FG002|Overall Study|Adverse Event|1|||
163088440|NCT01819272|589035825|FG003|Overall Study|Physician Decision|0|||
163088441|NCT01819272|589035826|FG004|Overall Study|Physician Decision|0|||
163088442|NCT01819272|589035827|FG005|Overall Study|Physician Decision|0|||
163088443|NCT01819272|589035822|FG000|Overall Study|Withdrawal of Consent|0|||
163088444|NCT01819272|589035823|FG001|Overall Study|Withdrawal of Consent|1|||
163036915|NCT00422292|588840310|FG003|Overall Study|Adverse Event|0|||
163036916|NCT00422292|588840307|FG000|Overall Study|Protocol Violation|4|||
163036917|NCT00422292|588840308|FG001|Overall Study|Protocol Violation|25|||
163036918|NCT00422292|588840309|FG002|Overall Study|Protocol Violation|8|||
163036919|NCT00422292|588840310|FG003|Overall Study|Protocol Violation|5|||
163036920|NCT00422292|588840307|FG000|Overall Study|Lost to Follow-up|6|||
163036921|NCT00422292|588840308|FG001|Overall Study|Lost to Follow-up|12|||
163036922|NCT00422292|588840309|FG002|Overall Study|Lost to Follow-up|6|||
163036923|NCT00422292|588840310|FG003|Overall Study|Lost to Follow-up|6|||
163036924|NCT00422292|588840307|FG000|Overall Study|Withdrawal by Subject|6|||
163036925|NCT00422292|588840308|FG001|Overall Study|Withdrawal by Subject|25|||
163036926|NCT00422292|588840309|FG002|Overall Study|Withdrawal by Subject|7|||
163036927|NCT00422292|588840310|FG003|Overall Study|Withdrawal by Subject|13|||
163036928|NCT02440854|588840311|FG000|Overall Study|Relocation of patient|1|||
163036929|NCT02440854|588840311|FG000|Overall Study|Death|6|||
163036930|NCT02440854|588840311|FG000|Overall Study|Lost to Follow-up|10|||
163036931|NCT02440854|588840311|FG000|Overall Study|Afatinib discontinuation|46|||
163036932|NCT02440854|588840311|FG000|Overall Study|stopped study at earlier timepoint|14|||
163036933|NCT02440854|588840311|FG000|Overall Study|Study medication not received|1|||
163036934|NCT02440854|588840311|FG000|Overall Study|Violation of inclusion criteria|2|||
163036935|NCT02243046|588840312|FG000|Overall Study|Lost to Follow-up|1|||
163036936|NCT02243046|588840313|FG001|Overall Study|Lost to Follow-up|1|||
163036937|NCT02243046|588840314|FG002|Overall Study|Lost to Follow-up|4|||
163036938|NCT02669082|588840315|FG000|Overall Study|Adverse Event|1|||
163036939|NCT04918355|588840316|FG000|Overall Study|no qualifying health encounter|497|||
163036940|NCT04918355|588840317|FG001|Overall Study|no qualifying health encounter|192|||
163036941|NCT04918355|588840318|FG002|Overall Study|no qualifying health encounter|438|||
163036942|NCT04918355|588840319|FG003|Overall Study|no qualifying health encounter|424|||
163036943|NCT04683939|588840323|FG000|Overall Study|Study termination by the sponsor|0|||
163036944|NCT04683939|588840324|FG001|Overall Study|Study termination by the sponsor|1|||
163036945|NCT04683939|588840325|FG002|Overall Study|Study termination by the sponsor|2|||
163036946|NCT04683939|588840326|FG003|Overall Study|Study termination by the sponsor|2|||
163036947|NCT04683939|588840323|FG000|Overall Study|Death|1|||
163036948|NCT04683939|588840324|FG001|Overall Study|Death|1|||
163036949|NCT04683939|588840325|FG002|Overall Study|Death|2|||
163036950|NCT04683939|588840326|FG003|Overall Study|Death|1|||
163036951|NCT04683939|588840323|FG000|Overall Study|Withdrawal by Subject|1|||
163036952|NCT04683939|588840324|FG001|Overall Study|Withdrawal by Subject|0|||
163036953|NCT04683939|588840325|FG002|Overall Study|Withdrawal by Subject|0|||
163036954|NCT04683939|588840326|FG003|Overall Study|Withdrawal by Subject|0|||
163036955|NCT04683939|588840323|FG000|Overall Study|Physician Decision|1|||
163036956|NCT04683939|588840324|FG001|Overall Study|Physician Decision|0|||
163036957|NCT04683939|588840325|FG002|Overall Study|Physician Decision|0|||
163036958|NCT04683939|588840326|FG003|Overall Study|Physician Decision|0|||
163036959|NCT04683939|588840323|FG000|Overall Study|Lost to Follow-up|0|||
163036960|NCT04683939|588840324|FG001|Overall Study|Lost to Follow-up|1|||
163036961|NCT04683939|588840325|FG002|Overall Study|Lost to Follow-up|0|||
163036962|NCT04683939|588840326|FG003|Overall Study|Lost to Follow-up|0|||
163036963|NCT04852276|588840327|FG000|Overall Study|Death|2|||
163036964|NCT04852276|588840328|FG001|Overall Study|Death|0|||
163036965|NCT04852276|588840327|FG000|Overall Study|Lost to Follow-up|15|||
163036966|NCT04852276|588840328|FG001|Overall Study|Lost to Follow-up|9|||
163335333|NCT01072149|589938745|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
163036967|NCT04852276|588840327|FG000|Overall Study|Withdrawal by Subject|26|||
163036968|NCT04852276|588840328|FG001|Overall Study|Withdrawal by Subject|6|||
163036969|NCT01687283|588842320|FG000|Overall Study|Adverse Event|11|||
163036970|NCT01687283|588842321|FG001|Overall Study|Adverse Event|4|||
163036971|NCT01687283|588842320|FG000|Overall Study|Lack of Efficacy|3|||
163036972|NCT01687283|588842321|FG001|Overall Study|Lack of Efficacy|1|||
163036973|NCT01687283|588842320|FG000|Overall Study|Protocol Violation|1|||
163036974|NCT01687283|588842321|FG001|Overall Study|Protocol Violation|3|||
163036975|NCT01687283|588842320|FG000|Overall Study|protocol defined stopping criteria|8|||
163036976|NCT01687283|588842321|FG001|Overall Study|protocol defined stopping criteria|10|||
163036977|NCT01687283|588842320|FG000|Overall Study|Lost to Follow-up|1|||
163036978|NCT01687283|588842321|FG001|Overall Study|Lost to Follow-up|1|||
163036979|NCT01687283|588842320|FG000|Overall Study|Investigator discretion|2|||
163088445|NCT01819272|589035824|FG002|Overall Study|Withdrawal of Consent|2|||
163335334|NCT01072149|589938746|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
163335335|NCT01072149|589938747|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
163335336|NCT01072149|589938748|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
163335337|NCT01072149|589938749|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
163335338|NCT01072149|589938750|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
163335339|NCT01072149|589938751|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
163335340|NCT01072149|589938752|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
163335341|NCT01072149|589938753|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
163335342|NCT01072149|589938754|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
163335343|NCT01072149|589938755|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
163335344|NCT01072149|589938756|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
163335345|NCT01072149|589938739|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
163335346|NCT01072149|589938740|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
163335347|NCT01072149|589938741|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
163335348|NCT01072149|589938742|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
163335349|NCT01072149|589938743|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
163335350|NCT01072149|589938744|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
163335351|NCT01072149|589938745|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
163335352|NCT01072149|589938746|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
163335353|NCT01072149|589938747|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
163335354|NCT01072149|589938748|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
163335355|NCT01072149|589938749|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
163335356|NCT01072149|589938750|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
163335357|NCT01072149|589938751|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
163335358|NCT01072149|589938752|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
163335359|NCT01072149|589938753|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
163335360|NCT01072149|589938754|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
163335361|NCT01072149|589938755|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
163335362|NCT01072149|589938756|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
163335363|NCT01072149|589938739|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163335364|NCT01072149|589938740|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163335365|NCT01072149|589938741|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163335366|NCT01072149|589938742|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163335367|NCT01072149|589938743|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163335368|NCT01072149|589938744|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163335369|NCT01072149|589938745|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163335370|NCT01072149|589938746|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163335371|NCT01072149|589938747|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163335372|NCT01072149|589938748|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163335373|NCT01072149|589938749|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163335374|NCT01072149|589938750|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163036980|NCT01687283|588842321|FG001|Overall Study|Investigator discretion|0|||
163036981|NCT01687283|588842320|FG000|Overall Study|Withdrawal by Subject|9|||
163036982|NCT01687283|588842321|FG001|Overall Study|Withdrawal by Subject|8|||
163036983|NCT00497146|588842322|FG000|Treatment Period|Adverse Event|6|||
163036984|NCT00497146|588842323|FG001|Treatment Period|Adverse Event|2|||
163036985|NCT00497146|588842322|FG000|Treatment Period|Withdrawal by Subject|5|||
163036986|NCT00497146|588842323|FG001|Treatment Period|Withdrawal by Subject|9|||
163036987|NCT00497146|588842322|FG000|Treatment Period|Lost to Follow-up|1|||
163036988|NCT00497146|588842323|FG001|Treatment Period|Lost to Follow-up|3|||
163036989|NCT00497146|588842322|FG000|Treatment Period|Required dialysis|4|||
163036990|NCT00497146|588842323|FG001|Treatment Period|Required dialysis|1|||
163036991|NCT00497146|588842322|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
163036992|NCT00497146|588842323|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
163036993|NCT00497146|588842322|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
163036994|NCT00497146|588842323|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
163036995|NCT00497146|588842322|FG000|Treatment Period|Other Reason|2|||
163036996|NCT00497146|588842323|FG001|Treatment Period|Other Reason|3|||
163036997|NCT00497146|588842322|FG000|Long-term Follow-up Period|Adverse Event|2|||
163036998|NCT00497146|588842323|FG001|Long-term Follow-up Period|Adverse Event|2|||
163036999|NCT00497146|588842322|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
163037000|NCT00497146|588842323|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
163037001|NCT00497146|588842322|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
163037002|NCT00497146|588842323|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
163037003|NCT00497146|588842322|FG000|Long-term Follow-up Period|Other|0|||
163037004|NCT00497146|588842323|FG001|Long-term Follow-up Period|Other|1|||
163037005|NCT04575584|588842324|FG000|Overall Study|Death|6|||
163335375|NCT01072149|589938751|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163335376|NCT01072149|589938752|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163335377|NCT01072149|589938753|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163335378|NCT01072149|589938754|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
163335379|NCT01072149|589938755|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163407269|NCT02543528|590200767|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
163407270|NCT02543528|590200768|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
163037006|NCT04575584|588842325|FG001|Overall Study|Death|4|||
163037007|NCT04575584|588842326|FG002|Overall Study|Death|6|||
163037008|NCT04575584|588842327|FG003|Overall Study|Death|2|||
163037009|NCT04575584|588842328|FG004|Overall Study|Death|0|||
163037010|NCT04575584|588842329|FG005|Overall Study|Death|0|||
163037011|NCT04575584|588842324|FG000|Overall Study|Lost to Follow-up|1|||
163037012|NCT04575584|588842325|FG001|Overall Study|Lost to Follow-up|1|||
163037013|NCT04575584|588842326|FG002|Overall Study|Lost to Follow-up|1|||
163037014|NCT04575584|588842327|FG003|Overall Study|Lost to Follow-up|1|||
163037015|NCT04575584|588842328|FG004|Overall Study|Lost to Follow-up|0|||
163037016|NCT04575584|588842329|FG005|Overall Study|Lost to Follow-up|0|||
163037017|NCT04575584|588842324|FG000|Overall Study|Physician Decision|0|||
163037018|NCT04575584|588842325|FG001|Overall Study|Physician Decision|1|||
163037019|NCT04575584|588842326|FG002|Overall Study|Physician Decision|1|||
163037020|NCT04575584|588842327|FG003|Overall Study|Physician Decision|1|||
163037021|NCT04575584|588842328|FG004|Overall Study|Physician Decision|0|||
163037022|NCT04575584|588842329|FG005|Overall Study|Physician Decision|0|||
163037023|NCT04575584|588842324|FG000|Overall Study|Withdrawal by Subject|7|||
163037024|NCT04575584|588842325|FG001|Overall Study|Withdrawal by Subject|9|||
163037025|NCT04575584|588842326|FG002|Overall Study|Withdrawal by Subject|5|||
163037026|NCT04575584|588842327|FG003|Overall Study|Withdrawal by Subject|3|||
163037027|NCT04575584|588842328|FG004|Overall Study|Withdrawal by Subject|0|||
163037028|NCT04575584|588842329|FG005|Overall Study|Withdrawal by Subject|0|||
163037029|NCT04575584|588842324|FG000|Overall Study|Not recorded|0|||
163037030|NCT04575584|588842325|FG001|Overall Study|Not recorded|0|||
163037031|NCT04575584|588842326|FG002|Overall Study|Not recorded|0|||
163037032|NCT04575584|588842327|FG003|Overall Study|Not recorded|1|||
163037033|NCT04575584|588842328|FG004|Overall Study|Not recorded|0|||
163037034|NCT04575584|588842329|FG005|Overall Study|Not recorded|0|||
163037035|NCT02634801|588842330|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
163037036|NCT02634801|588842331|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
163037037|NCT02634801|588842332|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
163037038|NCT02634801|588842330|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
163037039|NCT02634801|588842331|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
163037040|NCT02634801|588842332|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
163037041|NCT02634801|588842330|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
163037042|NCT02634801|588842331|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
163037043|NCT02634801|588842332|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
163037044|NCT02634801|588842330|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
163037045|NCT02634801|588842331|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
163037046|NCT02634801|588842332|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
163037047|NCT02634801|588842330|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
163037048|NCT02634801|588842331|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
163037049|NCT02634801|588842332|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
163037050|NCT02634801|588842330|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
163037051|NCT02634801|588842331|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
163037052|NCT02634801|588842332|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
163037053|NCT02634801|588842330|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
163037054|NCT02634801|588842331|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
163037055|NCT02634801|588842332|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
163037056|NCT02634801|588842330|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
163037057|NCT02634801|588842331|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
163037058|NCT02634801|588842332|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
163037059|NCT02634801|588842330|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
163037060|NCT02634801|588842331|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
163037061|NCT02634801|588842332|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
163037062|NCT02634801|588842330|FG000|Follow-up Period|Lost to Follow-up|3|||
163037063|NCT02634801|588842331|FG001|Follow-up Period|Lost to Follow-up|1|||
163037064|NCT02634801|588842332|FG002|Follow-up Period|Lost to Follow-up|2|||
163037065|NCT02634801|588842330|FG000|Follow-up Period|Physician Decision|0|||
163037066|NCT02634801|588842331|FG001|Follow-up Period|Physician Decision|0|||
163037067|NCT02634801|588842332|FG002|Follow-up Period|Physician Decision|1|||
163037068|NCT02634801|588842330|FG000|Follow-up Period|Withdrawal by Subject|1|||
163037069|NCT02634801|588842331|FG001|Follow-up Period|Withdrawal by Subject|2|||
163037070|NCT02634801|588842332|FG002|Follow-up Period|Withdrawal by Subject|5|||
163037071|NCT02634801|588842330|FG000|Follow-up Period|Adverse Event|1|||
163037072|NCT02634801|588842331|FG001|Follow-up Period|Adverse Event|5|||
163037073|NCT02634801|588842332|FG002|Follow-up Period|Adverse Event|0|||
163037074|NCT00199849|588842333|FG000|Overall Study|Unrelated illness or complication|0|||
163037075|NCT00199849|588842334|FG001|Overall Study|Unrelated illness or complication|1|||
163037076|NCT00199849|588842335|FG002|Overall Study|Unrelated illness or complication|0|||
163037077|NCT00199849|588842333|FG000|Overall Study|Progressive disease requiring intervention|0|||
163037078|NCT00199849|588842334|FG001|Overall Study|Progressive disease requiring intervention|0|||
163037079|NCT00199849|588842335|FG002|Overall Study|Progressive disease requiring intervention|1|||
163037080|NCT00199849|588842333|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
163037081|NCT00199849|588842334|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
163037082|NCT00199849|588842335|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
163037083|NCT01548768|588842336|FG000|Overall Study|Withdrawal by Subject|0|||
163335380|NCT01072149|589938756|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163335381|NCT01072149|589938739|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
163335382|NCT01072149|589938740|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
163335383|NCT01072149|589938741|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
163335384|NCT01072149|589938742|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
163335385|NCT01072149|589938743|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
163335386|NCT01072149|589938744|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
163335387|NCT01072149|589938745|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
163335388|NCT01072149|589938746|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
163335389|NCT01072149|589938747|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
163335390|NCT01072149|589938748|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
163335391|NCT01072149|589938749|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
163335392|NCT01072149|589938750|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
163335393|NCT01072149|589938751|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
163335394|NCT01072149|589938752|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
163335395|NCT01072149|589938753|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
163335396|NCT01072149|589938754|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
163335397|NCT01072149|589938755|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
163335398|NCT01072149|589938756|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
163335399|NCT01072149|589938739|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335400|NCT01072149|589938740|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335401|NCT01072149|589938741|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335402|NCT01072149|589938742|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335403|NCT01072149|589938743|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335404|NCT01072149|589938744|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335405|NCT01072149|589938745|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335406|NCT01072149|589938746|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335407|NCT01072149|589938747|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335408|NCT01072149|589938748|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335409|NCT01072149|589938749|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335410|NCT01072149|589938750|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335411|NCT01072149|589938751|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
163335412|NCT01072149|589938752|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335413|NCT01072149|589938753|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335414|NCT01072149|589938754|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335415|NCT01072149|589938755|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335416|NCT01072149|589938756|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163335417|NCT01072149|589938739|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335418|NCT01072149|589938740|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335419|NCT01072149|589938741|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
163335420|NCT01072149|589938742|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335421|NCT01072149|589938743|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335422|NCT01072149|589938744|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335423|NCT01072149|589938745|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335424|NCT01072149|589938746|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335425|NCT01072149|589938747|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335426|NCT01072149|589938748|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335427|NCT01072149|589938749|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335428|NCT01072149|589938750|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335429|NCT01072149|589938751|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335430|NCT01072149|589938752|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
163335431|NCT01072149|589938753|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335432|NCT01072149|589938754|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335433|NCT01072149|589938755|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335434|NCT01072149|589938756|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163335435|NCT01768572|589938757|FG000|Overall Study|Adverse Event|7|||
163335436|NCT01768572|589938758|FG001|Overall Study|Adverse Event|8|||
163335437|NCT01768572|589938759|FG002|Overall Study|Adverse Event|4|||
163335438|NCT01768572|589938757|FG000|Overall Study|Lack of Efficacy|1|||
163335439|NCT01768572|589938758|FG001|Overall Study|Lack of Efficacy|3|||
163335440|NCT01768572|589938759|FG002|Overall Study|Lack of Efficacy|1|||
163335441|NCT01768572|589938757|FG000|Overall Study|Other, Not due to an adverse event|1|||
163335442|NCT01768572|589938758|FG001|Overall Study|Other, Not due to an adverse event|1|||
163335443|NCT01768572|589938759|FG002|Overall Study|Other, Not due to an adverse event|1|||
163037084|NCT01548768|588842337|FG001|Overall Study|Withdrawal by Subject|2|||
163037085|NCT01548768|588842338|FG002|Overall Study|Withdrawal by Subject|1|||
163037086|NCT01548768|588842339|FG003|Overall Study|Withdrawal by Subject|0|||
163037087|NCT01548768|588842336|FG000|Overall Study|Physician Decision|1|||
163037088|NCT01548768|588842337|FG001|Overall Study|Physician Decision|0|||
163037089|NCT01548768|588842338|FG002|Overall Study|Physician Decision|0|||
163037090|NCT01548768|588842339|FG003|Overall Study|Physician Decision|0|||
163037091|NCT01548768|588842336|FG000|Overall Study|Adverse Event|0|||
163037092|NCT01548768|588842337|FG001|Overall Study|Adverse Event|0|||
163037093|NCT01548768|588842338|FG002|Overall Study|Adverse Event|0|||
163037094|NCT01548768|588842339|FG003|Overall Study|Adverse Event|1|||
163037095|NCT01548768|588842336|FG000|Overall Study|Non-Compliance|0|||
163037096|NCT01548768|588842337|FG001|Overall Study|Non-Compliance|0|||
163037097|NCT01548768|588842338|FG002|Overall Study|Non-Compliance|0|||
163037098|NCT01548768|588842339|FG003|Overall Study|Non-Compliance|3|||
163037099|NCT02178358|588842342|FG000|Overall Study|Withdrawal by Subject|0|||
163037100|NCT02178358|588842343|FG001|Overall Study|Withdrawal by Subject|2|||
163037101|NCT02178358|588842344|FG002|Overall Study|Withdrawal by Subject|2|||
163037102|NCT02178358|588842342|FG000|Overall Study|Lost to Follow-up|1|||
163037103|NCT02178358|588842343|FG001|Overall Study|Lost to Follow-up|0|||
163037104|NCT02178358|588842344|FG002|Overall Study|Lost to Follow-up|0|||
163037105|NCT00645671|588842346|FG000|Overall Study|Protocol Violation|1|||
163037106|NCT00645671|588842347|FG001|Overall Study|Protocol Violation|0|||
163037107|NCT00645671|588842346|FG000|Overall Study|Withdrawal by Subject|0|||
163037108|NCT00645671|588842347|FG001|Overall Study|Withdrawal by Subject|4|||
163037109|NCT00645671|588842346|FG000|Overall Study|Adverse Event|0|||
163037110|NCT00645671|588842347|FG001|Overall Study|Adverse Event|1|||
163037111|NCT00645671|588842346|FG000|Overall Study|Physician Decision|0|||
163037112|NCT00645671|588842347|FG001|Overall Study|Physician Decision|1|||
163037113|NCT00493311|588842348|FG000|Overall Study|Need for rescue medication|2|||
163037114|NCT00493311|588842349|FG001|Overall Study|Need for rescue medication|2|||
163037115|NCT05600036|588842350|FG000|Overall Study|Adverse Event|0|||
163037116|NCT05600036|588842351|FG001|Overall Study|Adverse Event|2|||
163037117|NCT05600036|588842352|FG002|Overall Study|Adverse Event|1|||
163037118|NCT05600036|588842353|FG003|Overall Study|Adverse Event|0|||
163037119|NCT05600036|588842354|FG004|Overall Study|Adverse Event|1|||
163037120|NCT05600036|588842355|FG005|Overall Study|Adverse Event|0|||
163037121|NCT05600036|588842350|FG000|Overall Study|Lost to Follow-up|0|||
163037122|NCT05600036|588842351|FG001|Overall Study|Lost to Follow-up|2|||
163037123|NCT05600036|588842352|FG002|Overall Study|Lost to Follow-up|1|||
163037124|NCT05600036|588842353|FG003|Overall Study|Lost to Follow-up|1|||
163037125|NCT05600036|588842354|FG004|Overall Study|Lost to Follow-up|0|||
163037126|NCT05600036|588842355|FG005|Overall Study|Lost to Follow-up|0|||
163037127|NCT05600036|588842350|FG000|Overall Study|Protocol Violation|0|||
163037128|NCT05600036|588842351|FG001|Overall Study|Protocol Violation|0|||
163037129|NCT05600036|588842352|FG002|Overall Study|Protocol Violation|2|||
163037130|NCT05600036|588842353|FG003|Overall Study|Protocol Violation|0|||
163037131|NCT05600036|588842354|FG004|Overall Study|Protocol Violation|0|||
163037132|NCT05600036|588842355|FG005|Overall Study|Protocol Violation|0|||
163037133|NCT05600036|588842350|FG000|Overall Study|Withdrawal by Subject|0|||
163037134|NCT05600036|588842351|FG001|Overall Study|Withdrawal by Subject|1|||
163037135|NCT05600036|588842352|FG002|Overall Study|Withdrawal by Subject|2|||
163037136|NCT05600036|588842353|FG003|Overall Study|Withdrawal by Subject|0|||
163037137|NCT05600036|588842354|FG004|Overall Study|Withdrawal by Subject|3|||
163037138|NCT05600036|588842355|FG005|Overall Study|Withdrawal by Subject|5|||
163037139|NCT05600036|588842350|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
163037140|NCT05600036|588842351|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
163037141|NCT05600036|588842352|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
163037142|NCT05600036|588842353|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
163037143|NCT05600036|588842354|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
163037144|NCT05600036|588842355|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
163037145|NCT05600036|588842350|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
163037146|NCT05600036|588842351|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
163037147|NCT05600036|588842352|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
163037148|NCT05600036|588842353|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
163037149|NCT05600036|588842354|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
163037150|NCT05600036|588842355|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
163037151|NCT05600036|588842350|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
163037152|NCT05600036|588842351|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
163037153|NCT05600036|588842352|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
163037154|NCT05600036|588842353|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
163037155|NCT05600036|588842354|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
163037156|NCT05600036|588842355|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
163037157|NCT04348500|588842356|FG000|Overall Study|Death|2|||
163037158|NCT04348500|588842357|FG001|Overall Study|Death|2|||
163037159|NCT04348500|588842356|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
163037160|NCT04348500|588842357|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
163037161|NCT02722746|588842358|FG000|Overall Study|Withdrawal by Subject|0|||
163037162|NCT02722746|588842359|FG001|Overall Study|Withdrawal by Subject|1|||
163037163|NCT02722746|588842360|FG002|Overall Study|Withdrawal by Subject|0|||
163037164|NCT02722746|588842358|FG000|Overall Study|Protocol Violation|8|||
163037165|NCT02722746|588842359|FG001|Overall Study|Protocol Violation|4|||
163037166|NCT02722746|588842360|FG002|Overall Study|Protocol Violation|6|||
163037167|NCT01038752|588842365|FG000|Overall Study|Tumor Progression|2|||
163037168|NCT01038752|588842366|FG001|Overall Study|Tumor Progression|2|||
163037169|NCT01038752|588842365|FG000|Overall Study|Lost to Follow-up|3|||
163037170|NCT01038752|588842366|FG001|Overall Study|Lost to Follow-up|3|||
163037171|NCT02700698|588842373|FG000|Overall Study|Withdrawal by Subject|1|||
163037172|NCT02700698|588842374|FG001|Overall Study|Withdrawal by Subject|0|||
163037173|NCT00703118|588842375|FG000|Overall Study|Adverse Event|1|||
163037174|NCT00703118|588842376|FG001|Overall Study|Adverse Event|2|||
163037175|NCT00703118|588842377|FG002|Overall Study|Adverse Event|2|||
163037176|NCT00703118|588842375|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
163037177|NCT00703118|588842376|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
163037178|NCT00703118|588842377|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
163037179|NCT00703118|588842375|FG000|Overall Study|Lost to Follow-up|6|||
163037180|NCT00703118|588842376|FG001|Overall Study|Lost to Follow-up|4|||
163088446|NCT01819272|589035825|FG003|Overall Study|Withdrawal of Consent|1|||
163088447|NCT01819272|589035826|FG004|Overall Study|Withdrawal of Consent|0|||
163088448|NCT01819272|589035827|FG005|Overall Study|Withdrawal of Consent|1|||
163088449|NCT01819272|589035822|FG000|Overall Study|Loss of Glucose Control|2|||
163088450|NCT01819272|589035823|FG001|Overall Study|Loss of Glucose Control|1|||
163088451|NCT01819272|589035824|FG002|Overall Study|Loss of Glucose Control|0|||
163088452|NCT01819272|589035825|FG003|Overall Study|Loss of Glucose Control|1|||
163088453|NCT01819272|589035826|FG004|Overall Study|Loss of Glucose Control|2|||
163088454|NCT01819272|589035827|FG005|Overall Study|Loss of Glucose Control|0|||
163088455|NCT00805389|589035828|FG000|Overall Study|Adverse Event|0|||
163088456|NCT00805389|589035829|FG001|Overall Study|Adverse Event|0|||
163088457|NCT00805389|589035830|FG002|Overall Study|Adverse Event|1|||
163088458|NCT00805389|589035831|FG003|Overall Study|Adverse Event|2|||
163088459|NCT00805389|589035832|FG004|Overall Study|Adverse Event|0|||
163088460|NCT00805389|589035828|FG000|Overall Study|Lost to Follow-up|4|||
163088461|NCT00805389|589035829|FG001|Overall Study|Lost to Follow-up|3|||
163088462|NCT00805389|589035830|FG002|Overall Study|Lost to Follow-up|6|||
163088463|NCT00805389|589035831|FG003|Overall Study|Lost to Follow-up|10|||
163088464|NCT00805389|589035832|FG004|Overall Study|Lost to Follow-up|9|||
163088465|NCT00805389|589035828|FG000|Overall Study|Protocol Violation|0|||
163088466|NCT00805389|589035829|FG001|Overall Study|Protocol Violation|0|||
163088467|NCT00805389|589035830|FG002|Overall Study|Protocol Violation|1|||
163088468|NCT00805389|589035831|FG003|Overall Study|Protocol Violation|0|||
163088469|NCT00805389|589035832|FG004|Overall Study|Protocol Violation|0|||
163088470|NCT00805389|589035828|FG000|Overall Study|Withdrawal by Subject|3|||
163088471|NCT00805389|589035829|FG001|Overall Study|Withdrawal by Subject|2|||
163088472|NCT00805389|589035830|FG002|Overall Study|Withdrawal by Subject|4|||
163088473|NCT00805389|589035831|FG003|Overall Study|Withdrawal by Subject|5|||
163088474|NCT00805389|589035832|FG004|Overall Study|Withdrawal by Subject|4|||
163088475|NCT01246960|589035833|FG000|Overall Study|Lost to Follow-up|3|||
163088476|NCT01246960|589035834|FG001|Overall Study|Lost to Follow-up|1|||
163088477|NCT01246960|589035833|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
163088478|NCT01246960|589035834|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
163088479|NCT03376516|589035839|FG000|Overall Study|Not treated|1|||
163088480|NCT03376516|589035839|FG000|Overall Study|Consent withdrawn|1|||
163088481|NCT01581684|589035840|FG000|Overall Study|Other reason not defined|0|||
163037181|NCT00703118|588842377|FG002|Overall Study|Lost to Follow-up|4|||
163037182|NCT00703118|588842375|FG000|Overall Study|Withdrawal by Subject|8|||
163037183|NCT00703118|588842376|FG001|Overall Study|Withdrawal by Subject|7|||
163037184|NCT00703118|588842377|FG002|Overall Study|Withdrawal by Subject|13|||
163037185|NCT00703118|588842375|FG000|Overall Study|Other|0|||
163037186|NCT00703118|588842376|FG001|Overall Study|Other|0|||
163088482|NCT01581684|589035841|FG001|Overall Study|Other reason not defined|0|||
163088483|NCT01581684|589035842|FG002|Overall Study|Other reason not defined|0|||
163088484|NCT01581684|589035843|FG003|Overall Study|Other reason not defined|0|||
163088485|NCT01581684|589035844|FG004|Overall Study|Other reason not defined|0|||
163088486|NCT01581684|589035845|FG005|Overall Study|Other reason not defined|0|||
163088487|NCT01581684|589035846|FG006|Overall Study|Other reason not defined|0|||
163088488|NCT01581684|589035847|FG007|Overall Study|Other reason not defined|0|||
163088489|NCT01581684|589035848|FG008|Overall Study|Other reason not defined|1|||
163088490|NCT01581684|589035849|FG009|Overall Study|Other reason not defined|0|||
163088491|NCT02239926|589035852|FG000|Overall Study|Withdrawal by Subject|0|||
163088492|NCT02239926|589035853|FG001|Overall Study|Withdrawal by Subject|1|||
163088493|NCT00598650|589035856|FG000|Overall Study|Withdrawal by Subject|3|||
163088494|NCT00598650|589035856|FG000|Overall Study|Adverse Event|18|||
163088495|NCT00598650|589035856|FG000|Overall Study|No treatment for 3 weeks|1|||
163088496|NCT00598650|589035856|FG000|Overall Study|Not eligible|1|||
163088497|NCT00598650|589035856|FG000|Overall Study|Prohibited Concomitant Medication|2|||
163088498|NCT00598650|589035856|FG000|Overall Study|Physician Decision|2|||
163088499|NCT01628913|589035857|FG000|Overall Study|Adverse Event|12|||
163088500|NCT01628913|589035858|FG001|Overall Study|Adverse Event|5|||
163088501|NCT01628913|589035857|FG000|Overall Study|Disease Progression|11|||
163088502|NCT01628913|589035858|FG001|Overall Study|Disease Progression|14|||
163088503|NCT01628913|589035857|FG000|Overall Study|Protocol Violation|1|||
163088504|NCT01628913|589035858|FG001|Overall Study|Protocol Violation|0|||
163088505|NCT01628913|589035857|FG000|Overall Study|Death|1|||
163088506|NCT01628913|589035858|FG001|Overall Study|Death|0|||
163088507|NCT01628913|589035857|FG000|Overall Study|study terminated by Sponsor|4|||
163088508|NCT01628913|589035858|FG001|Overall Study|study terminated by Sponsor|9|||
163088509|NCT01628913|589035857|FG000|Overall Study|Withdrawal by Subject|1|||
163088510|NCT01628913|589035858|FG001|Overall Study|Withdrawal by Subject|0|||
163088511|NCT01628913|589035857|FG000|Overall Study|Physician Decision|1|||
163088512|NCT01628913|589035858|FG001|Overall Study|Physician Decision|3|||
163088513|NCT05201807|589035862|FG000|Overall Study|Adverse Event|1|||
163088514|NCT05201807|589035862|FG000|Overall Study|COVID-19 Related|1|||
163088515|NCT01664624|589035865|FG000|Overall Study|Adverse Event|0|||
163088516|NCT01664624|589035866|FG001|Overall Study|Adverse Event|1|||
163088517|NCT01664624|589035867|FG002|Overall Study|Adverse Event|0|||
163088518|NCT01664624|589035868|FG003|Overall Study|Adverse Event|0|||
163088519|NCT01029535|589035871|FG000|Overall Study|Lost to Follow-up|24|||
163088520|NCT01029535|589035871|FG000|Overall Study|Protocol Violation|2|||
163088521|NCT01029535|589035871|FG000|Overall Study|Participant Withdrew Consent|2|||
163088522|NCT01029535|589035871|FG000|Overall Study|Adverse Event|1|||
163088523|NCT01029535|589035871|FG000|Overall Study|Use of Another Treatment|1|||
163088524|NCT01029535|589035871|FG000|Overall Study|Death|1|||
163088525|NCT01146613|589035878|FG000|Overall Study|Lost to Follow-up|3|||
163220056|NCT03965962|589521392|FG003|Overall Study|Withdrawal by Subject|1|||
163335444|NCT04766996|589938762|FG000|Overall Study|Withdrawal by Subject|1|||
163037187|NCT00703118|588842377|FG002|Overall Study|Other|1|||
163037188|NCT05053035|588842380|FG000|Overall Study|Withdrawal by Subject|1|||
163037189|NCT05053035|588842381|FG001|Overall Study|Withdrawal by Subject|0|||
163037190|NCT00438256|588842382|FG000|Overall Study|Ineligible for Resection|2|||
163037191|NCT00438256|588842383|FG001|Overall Study|Ineligible for Resection|1|||
163037192|NCT00438256|588842384|FG002|Overall Study|Ineligible for Resection|1|||
163037193|NCT00438256|588842385|FG003|Overall Study|Ineligible for Resection|7|||
163037194|NCT00438256|588842382|FG000|Overall Study|Excluded final Diagnosis|0|||
163037195|NCT00438256|588842383|FG001|Overall Study|Excluded final Diagnosis|0|||
163037196|NCT00438256|588842384|FG002|Overall Study|Excluded final Diagnosis|0|||
163037197|NCT00438256|588842385|FG003|Overall Study|Excluded final Diagnosis|2|||
163037198|NCT02005627|588842389|FG000|Overall Study|Lost to Follow-up|1|||
163037199|NCT02005627|588842390|FG001|Overall Study|Lost to Follow-up|2|||
163037200|NCT02005627|588842389|FG000|Overall Study|Withdrawal by Subject|1|||
163037201|NCT02005627|588842390|FG001|Overall Study|Withdrawal by Subject|2|||
163037202|NCT03760458|588842393|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
163037203|NCT03760458|588842394|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
163037204|NCT03760458|588842395|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
163037205|NCT03760458|588842396|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
163037206|NCT03760458|588842397|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
163037207|NCT00750919|588842398|FG000|Overall Study|Adverse Event|9|||
163037208|NCT00750919|588842398|FG000|Overall Study|Withdrawal by Subject|1|||
163037209|NCT00750919|588842398|FG000|Overall Study|Lack of Efficacy|8|||
163037210|NCT00750919|588842398|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
163037211|NCT00750919|588842398|FG000|Overall Study|Other|36|||
163037212|NCT00048997|588842403|FG000|Overall Study|Protocol Violation|7|||
163037213|NCT00048997|588842404|FG001|Overall Study|Protocol Violation|2|||
163037214|NCT00048997|588842403|FG000|Overall Study|Withdrawal by Subject|6|||
163037215|NCT00048997|588842404|FG001|Overall Study|Withdrawal by Subject|1|||
163037216|NCT00002525|588842411|FG000|Overall Study|Adverse Event|36|||
163037217|NCT00002525|588842412|FG001|Overall Study|Adverse Event|0|||
163037218|NCT00002525|588842411|FG000|Overall Study|Death|5|||
163037219|NCT00002525|588842412|FG001|Overall Study|Death|0|||
163088526|NCT01146613|589035879|FG001|Overall Study|Lost to Follow-up|8|||
163335445|NCT04766996|589938763|FG001|Overall Study|Withdrawal by Subject|0|||
163088527|NCT01146613|589035878|FG000|Overall Study|Lack of Efficacy|0|||
163088528|NCT01146613|589035879|FG001|Overall Study|Lack of Efficacy|1|||
163088529|NCT01146613|589035878|FG000|Overall Study|Death|1|||
163088530|NCT01146613|589035879|FG001|Overall Study|Death|0|||
163088531|NCT01146613|589035878|FG000|Overall Study|Physician Decision|1|||
163088532|NCT01146613|589035879|FG001|Overall Study|Physician Decision|0|||
163088533|NCT01146613|589035878|FG000|Overall Study|Withdrawal by Subject|0|||
163088534|NCT01146613|589035879|FG001|Overall Study|Withdrawal by Subject|3|||
163088535|NCT01146613|589035878|FG000|Overall Study|schedule conflict|1|||
163407271|NCT02543528|590200769|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
163037220|NCT00002525|588842411|FG000|Overall Study|Withdrawal by Subject|11|||
163037221|NCT00002525|588842412|FG001|Overall Study|Withdrawal by Subject|0|||
163037222|NCT00002525|588842411|FG000|Overall Study|Start non-protocol therapy|1|||
163037223|NCT00002525|588842412|FG001|Overall Study|Start non-protocol therapy|0|||
163037224|NCT00002525|588842411|FG000|Overall Study|Other complicating disease|1|||
163037225|NCT00002525|588842412|FG001|Overall Study|Other complicating disease|0|||
163037226|NCT00002525|588842411|FG000|Overall Study|Duke's A, B1, D disease|92|||
163037227|NCT00002525|588842412|FG001|Overall Study|Duke's A, B1, D disease|0|||
163037228|NCT00002525|588842411|FG000|Overall Study|Error|6|||
163037229|NCT00002525|588842412|FG001|Overall Study|Error|0|||
163037230|NCT00002525|588842411|FG000|Overall Study|Other|26|||
163037231|NCT00002525|588842412|FG001|Overall Study|Other|0|||
163037232|NCT00002525|588842411|FG000|Overall Study|Never start protocol therapy|8|||
163037233|NCT00002525|588842412|FG001|Overall Study|Never start protocol therapy|0|||
163037234|NCT03304184|588842413|FG000|Overall Study|Withdrawal by Subject|1|||
163037235|NCT03304184|588842414|FG001|Overall Study|Withdrawal by Subject|2|||
163037236|NCT04527978|588842418|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
163037237|NCT04527978|588842419|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
163037238|NCT02112877|588842421|FG000|Overall Study|Withdrawal by Subject|1|||
163037239|NCT02112877|588842422|FG001|Overall Study|Withdrawal by Subject|7|||
163037240|NCT02112877|588842421|FG000|Overall Study|Visit Missed|1|||
163037241|NCT02112877|588842422|FG001|Overall Study|Visit Missed|6|||
163037242|NCT01490697|588842433|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
163037243|NCT01490697|588842434|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
163037244|NCT00090584|588842435|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
163037245|NCT00090584|588842436|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
163037246|NCT00090584|588842435|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
163037247|NCT00090584|588842436|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
163037248|NCT00379808|588842437|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
163037249|NCT00379808|588842438|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
163037250|NCT01578499|588842439|FG000|Overall Study|Reason not Specified|0|||
163037251|NCT01578499|588842440|FG001|Overall Study|Reason not Specified|1|||
163037252|NCT01578499|588842439|FG000|Overall Study|Lost to Follow-up|2|||
163037253|NCT01578499|588842440|FG001|Overall Study|Lost to Follow-up|1|||
163037254|NCT01578499|588842439|FG000|Overall Study|Withdrawal by Subject|10|||
163037255|NCT01578499|588842440|FG001|Overall Study|Withdrawal by Subject|16|||
163037256|NCT01578499|588842439|FG000|Overall Study|Death|20|||
163037257|NCT01578499|588842440|FG001|Overall Study|Death|25|||
163037258|NCT01578499|588842439|FG000|Overall Study|Died and End of Study Page not Completed|2|||
163037259|NCT01578499|588842440|FG001|Overall Study|Died and End of Study Page not Completed|0|||
163037260|NCT01987232|588842441|FG000|Overall Study|Ongoing in Study|0|||
163037261|NCT01987232|588842442|FG001|Overall Study|Ongoing in Study|0|||
163037262|NCT01987232|588842443|FG002|Overall Study|Ongoing in Study|0|||
163037263|NCT01987232|588842444|FG003|Overall Study|Ongoing in Study|1|||
163037264|NCT01987232|588842445|FG004|Overall Study|Ongoing in Study|0|||
163037265|NCT02791438|588842446|FG000|Treatment Period|Adverse Event|1|||
163037266|NCT02791438|588842447|FG001|Treatment Period|Adverse Event|0|||
163037267|NCT02791438|588842446|FG000|Treatment Period|Withdrawal by Subject|0|||
163037268|NCT02791438|588842447|FG001|Treatment Period|Withdrawal by Subject|1|||
163037269|NCT02791438|588842446|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
163037270|NCT02791438|588842447|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
163037271|NCT01603394|588842448|FG000|Overall Study|Adverse Event|1|||
163037272|NCT00862459|588842449|FG000|Overall Study|Lost to Follow-up|1|||
163037273|NCT00862459|588842450|FG001|Overall Study|Lost to Follow-up|2|||
163037274|NCT00862459|588842451|FG002|Overall Study|Lost to Follow-up|2|||
163037275|NCT00862459|588842449|FG000|Overall Study|Protocol Violation|1|||
163037276|NCT00862459|588842450|FG001|Overall Study|Protocol Violation|0|||
163037277|NCT00862459|588842451|FG002|Overall Study|Protocol Violation|0|||
163037278|NCT00862459|588842449|FG000|Overall Study|Withdrawal by Subject|1|||
163037279|NCT00862459|588842450|FG001|Overall Study|Withdrawal by Subject|1|||
163037280|NCT00862459|588842451|FG002|Overall Study|Withdrawal by Subject|3|||
163037281|NCT00862459|588842449|FG000|Overall Study|Adverse Event|0|||
163037282|NCT00862459|588842450|FG001|Overall Study|Adverse Event|1|||
163037283|NCT00862459|588842451|FG002|Overall Study|Adverse Event|0|||
163037284|NCT00862459|588842449|FG000|Overall Study|Personal reasons|1|||
163037285|NCT00862459|588842450|FG001|Overall Study|Personal reasons|0|||
163037286|NCT00862459|588842451|FG002|Overall Study|Personal reasons|0|||
163037287|NCT00862459|588842449|FG000|Overall Study|Operation|1|||
163037288|NCT00862459|588842450|FG001|Overall Study|Operation|1|||
163037289|NCT00862459|588842451|FG002|Overall Study|Operation|0|||
163037290|NCT00862459|588842449|FG000|Overall Study|Intravenous (IV) site problems|1|||
163037291|NCT00862459|588842450|FG001|Overall Study|Intravenous (IV) site problems|0|||
163037292|NCT00862459|588842451|FG002|Overall Study|Intravenous (IV) site problems|1|||
163088536|NCT01146613|589035879|FG001|Overall Study|schedule conflict|0|||
163088537|NCT01146613|589035878|FG000|Overall Study|Outpatient detox|1|||
163088538|NCT01146613|589035879|FG001|Overall Study|Outpatient detox|0|||
163088539|NCT00949533|589035880|FG000|Overall Study|Lost to Follow-up|0|||
163088540|NCT00949533|589035881|FG001|Overall Study|Lost to Follow-up|1|||
163088541|NCT01493089|589035882|FG000|Overall Study|Protocol Violation|2|||
163088542|NCT01493089|589035883|FG001|Overall Study|Protocol Violation|2|||
163088543|NCT01493089|589035882|FG000|Overall Study|Withdrawal by Subject|1|||
163088544|NCT01493089|589035883|FG001|Overall Study|Withdrawal by Subject|0|||
163088545|NCT01493089|589035882|FG000|Overall Study|Physician Decision|0|||
163088546|NCT01493089|589035883|FG001|Overall Study|Physician Decision|1|||
163088547|NCT02234362|589035884|FG000|Overall Study|Not eligible after first screening visit|17|||
163088548|NCT02234362|589035884|FG000|Overall Study|Lost to Follow-up|6|||
163088549|NCT02234362|589035884|FG000|Overall Study|Withdrawal by Subject|3|||
163088550|NCT02164864|589035885|FG000|Overall Study|Trial disease worsening|7|||
163088551|NCT02164864|589035886|FG001|Overall Study|Trial disease worsening|5|||
163088552|NCT02164864|589035887|FG002|Overall Study|Trial disease worsening|1|||
163088553|NCT02164864|589035885|FG000|Overall Study|Other pre-existing disease worsening|6|||
163088554|NCT02164864|589035886|FG001|Overall Study|Other pre-existing disease worsening|4|||
163088555|NCT02164864|589035887|FG002|Overall Study|Other pre-existing disease worsening|9|||
163088556|NCT02164864|589035885|FG000|Overall Study|Other Adverse Event (AE)|52|||
163088557|NCT02164864|589035886|FG001|Overall Study|Other Adverse Event (AE)|32|||
163088558|NCT02164864|589035887|FG002|Overall Study|Other Adverse Event (AE)|49|||
163088559|NCT02164864|589035885|FG000|Overall Study|Protocol Violation|2|||
163088560|NCT02164864|589035886|FG001|Overall Study|Protocol Violation|4|||
163088561|NCT02164864|589035887|FG002|Overall Study|Protocol Violation|1|||
163088562|NCT02164864|589035885|FG000|Overall Study|Lost to Follow-up|4|||
163088563|NCT02164864|589035886|FG001|Overall Study|Lost to Follow-up|3|||
163088564|NCT02164864|589035887|FG002|Overall Study|Lost to Follow-up|2|||
163088565|NCT02164864|589035885|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
163088566|NCT02164864|589035886|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
163088567|NCT02164864|589035887|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
163088568|NCT02164864|589035885|FG000|Overall Study|Other than stated|3|||
163088569|NCT02164864|589035886|FG001|Overall Study|Other than stated|4|||
163088570|NCT02164864|589035887|FG002|Overall Study|Other than stated|14|||
163088571|NCT01870869|589035888|FG000|Overall Study|Implanted with nonstudy device|1|||
163088572|NCT01870869|589035889|FG001|Overall Study|Implanted with nonstudy device|3|||
163088573|NCT01870869|589035890|FG002|Overall Study|Implanted with nonstudy device|14|||
163088574|NCT01870869|589035891|FG003|Overall Study|Implanted with nonstudy device|4|||
163088575|NCT01870869|589035888|FG000|Overall Study|Death|0|||
163088576|NCT01870869|589035889|FG001|Overall Study|Death|0|||
163088577|NCT01870869|589035890|FG002|Overall Study|Death|7|||
163088578|NCT01870869|589035891|FG003|Overall Study|Death|1|||
163088579|NCT01870869|589035888|FG000|Overall Study|Subject choice|6|||
163088580|NCT01870869|589035889|FG001|Overall Study|Subject choice|2|||
163088581|NCT01870869|589035890|FG002|Overall Study|Subject choice|22|||
163088582|NCT01870869|589035891|FG003|Overall Study|Subject choice|8|||
163088583|NCT01870869|589035888|FG000|Overall Study|Lost to Follow-up|10|||
163088584|NCT01870869|589035889|FG001|Overall Study|Lost to Follow-up|2|||
163088585|NCT01870869|589035890|FG002|Overall Study|Lost to Follow-up|25|||
163088586|NCT01870869|589035891|FG003|Overall Study|Lost to Follow-up|3|||
163088587|NCT01870869|589035888|FG000|Overall Study|Reason not Specified|1|||
163088588|NCT01870869|589035889|FG001|Overall Study|Reason not Specified|2|||
163088589|NCT01870869|589035890|FG002|Overall Study|Reason not Specified|20|||
163088590|NCT01870869|589035891|FG003|Overall Study|Reason not Specified|4|||
163088591|NCT01870869|589035888|FG000|Overall Study|Not evaluable|10|||
163088592|NCT01870869|589035889|FG001|Overall Study|Not evaluable|5|||
163088593|NCT01870869|589035890|FG002|Overall Study|Not evaluable|42|||
163088594|NCT01870869|589035891|FG003|Overall Study|Not evaluable|10|||
163088595|NCT00261833|589035892|FG000|Overall Study|Death|1|||
163088596|NCT00261833|589035893|FG001|Overall Study|Death|3|||
163088597|NCT00261833|589035892|FG000|Overall Study|Adverse Event|1|||
163088598|NCT00261833|589035893|FG001|Overall Study|Adverse Event|4|||
163088599|NCT00261833|589035892|FG000|Overall Study|Withdrawal by Subject|5|||
163088600|NCT00261833|589035893|FG001|Overall Study|Withdrawal by Subject|7|||
163220057|NCT03190889|589521397|FG000|Overall Study|Lost to Follow-up|7|||
163088601|NCT00261833|589035892|FG000|Overall Study|Protocol Violation|0|||
163088602|NCT00261833|589035893|FG001|Overall Study|Protocol Violation|1|||
163088603|NCT00261833|589035892|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
163088604|NCT00261833|589035893|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
163088605|NCT00261833|589035892|FG000|Overall Study|Lung transplantation|1|||
163088606|NCT00261833|589035893|FG001|Overall Study|Lung transplantation|1|||
163088607|NCT00261833|589035892|FG000|Overall Study|Missing reason|1|||
163088608|NCT00261833|589035893|FG001|Overall Study|Missing reason|0|||
163088609|NCT00261833|589035892|FG000|Overall Study|Not interested in being participant|0|||
163088610|NCT00261833|589035893|FG001|Overall Study|Not interested in being participant|1|||
163088611|NCT02131766|589035895|FG000|Overall Study|Withdrawal by Subject|4|||
163220058|NCT03190889|589521398|FG001|Overall Study|Lost to Follow-up|7|||
163088612|NCT02271880|589035897|FG000|Overall Study|Premature discontinuation of study|3|||
163088613|NCT02271880|589035898|FG001|Overall Study|Premature discontinuation of study|4|||
163088614|NCT00474903|589035900|FG000|Overall Study|Protocol Violation|1|||
163088615|NCT00474903|589035901|FG001|Overall Study|Protocol Violation|5|||
163088616|NCT00474903|589035902|FG002|Overall Study|Protocol Violation|2|||
163088617|NCT02006927|589035903|FG000|Overall Study|Adverse Event|2|||
163088618|NCT02006927|589035903|FG000|Overall Study|Withdrawal by Subject|1|||
163088619|NCT00673920|589035906|FG000|Baseline up to Week 48|Withdrew consent|1|||
163088620|NCT00673920|589035907|FG001|Baseline up to Week 48|Withdrew consent|0|||
163088621|NCT00673920|589035908|FG002|Baseline up to Week 48|Withdrew consent|2|||
163088622|NCT00673920|589035909|FG003|Baseline up to Week 48|Withdrew consent|0|||
163088623|NCT00673920|589035910|FG004|Baseline up to Week 48|Withdrew consent|0|||
163088624|NCT00673920|589035911|FG005|Baseline up to Week 48|Withdrew consent|0|||
163088625|NCT00673920|589035912|FG006|Baseline up to Week 48|Withdrew consent|0|||
163088626|NCT00673920|589035913|FG007|Baseline up to Week 48|Withdrew consent|0|||
163088627|NCT00673920|589035906|FG000|Baseline up to Week 48|Refused treatment|1|||
163088628|NCT00673920|589035907|FG001|Baseline up to Week 48|Refused treatment|0|||
163088629|NCT00673920|589035908|FG002|Baseline up to Week 48|Refused treatment|0|||
163088630|NCT00673920|589035909|FG003|Baseline up to Week 48|Refused treatment|0|||
163088631|NCT00673920|589035910|FG004|Baseline up to Week 48|Refused treatment|0|||
163088632|NCT00673920|589035911|FG005|Baseline up to Week 48|Refused treatment|0|||
163088633|NCT00673920|589035912|FG006|Baseline up to Week 48|Refused treatment|0|||
163088634|NCT00673920|589035913|FG007|Baseline up to Week 48|Refused treatment|0|||
163088635|NCT00673920|589035906|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
163088636|NCT00673920|589035907|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
163088637|NCT00673920|589035908|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
163088638|NCT00673920|589035909|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
163088639|NCT00673920|589035910|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
163088640|NCT00673920|589035911|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
163088641|NCT00673920|589035912|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
163088642|NCT00673920|589035913|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
163088643|NCT00673920|589035906|FG000|Baseline up to Week 48|Protocol Violation|0|||
163088644|NCT00673920|589035907|FG001|Baseline up to Week 48|Protocol Violation|0|||
163088645|NCT00673920|589035908|FG002|Baseline up to Week 48|Protocol Violation|1|||
163088646|NCT00673920|589035909|FG003|Baseline up to Week 48|Protocol Violation|0|||
163088647|NCT00673920|589035910|FG004|Baseline up to Week 48|Protocol Violation|0|||
163088648|NCT00673920|589035911|FG005|Baseline up to Week 48|Protocol Violation|0|||
163088649|NCT00673920|589035912|FG006|Baseline up to Week 48|Protocol Violation|0|||
163088650|NCT00673920|589035913|FG007|Baseline up to Week 48|Protocol Violation|0|||
163088651|NCT00673920|589035906|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
163088652|NCT00673920|589035907|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
163088653|NCT00673920|589035908|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
163088654|NCT00673920|589035909|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
163088655|NCT00673920|589035910|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
163088656|NCT00673920|589035911|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
163088657|NCT00673920|589035912|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
163088658|NCT00673920|589035913|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
163088659|NCT00673920|589035906|FG000|Baseline up to Week 48|Administrative/Other|0|||
163335446|NCT04766996|589938764|FG002|Overall Study|Withdrawal by Subject|13|||
163335447|NCT01322386|589938765|FG000|Overall Study|Protocol Violation|0|||
163335448|NCT01322386|589938766|FG001|Overall Study|Protocol Violation|1|||
163335449|NCT01322386|589938765|FG000|Overall Study|Physician Decision|0|||
163335450|NCT01322386|589938766|FG001|Overall Study|Physician Decision|1|||
163335451|NCT01102426|589938767|FG000|Overall Study|Randomized but not treated|4|||
163335452|NCT01102426|589938768|FG001|Overall Study|Randomized but not treated|1|||
163335453|NCT01102426|589938767|FG000|Overall Study|Adverse Events (treatment-related)|15|||
163335454|NCT01102426|589938768|FG001|Overall Study|Adverse Events (treatment-related)|8|||
163335455|NCT01102426|589938767|FG000|Overall Study|Physician Decision|9|||
163335456|NCT01102426|589938768|FG001|Overall Study|Physician Decision|6|||
163335457|NCT01102426|589938767|FG000|Overall Study|Progressive Disease|85|||
163335458|NCT01102426|589938768|FG001|Overall Study|Progressive Disease|44|||
163335459|NCT01102426|589938767|FG000|Overall Study|Adverse Events (unrelated to|9|||
163335460|NCT01102426|589938768|FG001|Overall Study|Adverse Events (unrelated to|1|||
163335461|NCT01102426|589938767|FG000|Overall Study|Patient Refusal|24|||
163335462|NCT01102426|589938768|FG001|Overall Study|Patient Refusal|12|||
163335463|NCT01102426|589938767|FG000|Overall Study|Death (due to adverse events|0|||
163335464|NCT01102426|589938768|FG001|Overall Study|Death (due to adverse events|1|||
163335465|NCT01102426|589938767|FG000|Overall Study|Death (non-related to the study|19|||
163335466|NCT01102426|589938768|FG001|Overall Study|Death (non-related to the study|8|||
163335467|NCT00871494|589938769|FG000|Overall Study|Protocol Violation|5|||
163335468|NCT00871494|589938769|FG000|Overall Study|Lack of Efficacy|4|||
163335469|NCT00871494|589938769|FG000|Overall Study|Adverse Event|4|||
163335470|NCT00871494|589938769|FG000|Overall Study|Lost to Follow-up|1|||
163335471|NCT03265132|589938781|FG000|Overall Study|Adverse Event|0|||
163335472|NCT03265132|589938782|FG001|Overall Study|Adverse Event|1|||
163335473|NCT03265132|589938781|FG000|Overall Study|Lack of Efficacy|0|||
163335474|NCT03265132|589938782|FG001|Overall Study|Lack of Efficacy|2|||
163335475|NCT03265132|589938781|FG000|Overall Study|Progressive disease|0|||
163335476|NCT03265132|589938782|FG001|Overall Study|Progressive disease|2|||
163335477|NCT03265132|589938781|FG000|Overall Study|Withdrawal by Subject|0|||
163335478|NCT03265132|589938782|FG001|Overall Study|Withdrawal by Subject|1|||
163335479|NCT03259568|589938783|FG000|Overall Study|Participant performance was low|3|||
163335480|NCT00681109|589938784|FG000|Overall Study|Lost to Follow-up|2|||
163335481|NCT00681109|589938785|FG001|Overall Study|Lost to Follow-up|6|||
163335482|NCT00681109|589938786|FG002|Overall Study|Lost to Follow-up|0|||
163335483|NCT03128099|589938789|FG000|Overall Study|High dose task was too long|0|||
163407272|NCT02543528|590200770|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
163088660|NCT00673920|589035907|FG001|Baseline up to Week 48|Administrative/Other|1|||
163088661|NCT00673920|589035908|FG002|Baseline up to Week 48|Administrative/Other|2|||
163088662|NCT00673920|589035909|FG003|Baseline up to Week 48|Administrative/Other|0|||
163088663|NCT00673920|589035910|FG004|Baseline up to Week 48|Administrative/Other|0|||
163088664|NCT00673920|589035911|FG005|Baseline up to Week 48|Administrative/Other|0|||
163088665|NCT00673920|589035912|FG006|Baseline up to Week 48|Administrative/Other|0|||
163088666|NCT00673920|589035913|FG007|Baseline up to Week 48|Administrative/Other|0|||
163088667|NCT00673920|589035906|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
163088668|NCT00673920|589035907|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
163088669|NCT00673920|589035908|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
163088670|NCT00673920|589035909|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
163088671|NCT00673920|589035910|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
163088672|NCT00673920|589035911|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
163088673|NCT00673920|589035912|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
163088674|NCT00673920|589035913|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
163088675|NCT00673920|589035906|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
163088676|NCT00673920|589035907|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
163088677|NCT00673920|589035908|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
163088678|NCT00673920|589035909|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
163088679|NCT00673920|589035910|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
163088680|NCT00673920|589035911|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
163088681|NCT00673920|589035912|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
163088682|NCT00673920|589035913|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
163088683|NCT00673920|589035906|FG000|Week 24 to Week 48|Failure to return|0|||
163088684|NCT00673920|589035907|FG001|Week 24 to Week 48|Failure to return|0|||
163088685|NCT00673920|589035908|FG002|Week 24 to Week 48|Failure to return|0|||
163088686|NCT00673920|589035909|FG003|Week 24 to Week 48|Failure to return|0|||
163088687|NCT00673920|589035910|FG004|Week 24 to Week 48|Failure to return|0|||
163088688|NCT00673920|589035911|FG005|Week 24 to Week 48|Failure to return|1|||
163088689|NCT00673920|589035912|FG006|Week 24 to Week 48|Failure to return|0|||
163088690|NCT00673920|589035913|FG007|Week 24 to Week 48|Failure to return|0|||
163088691|NCT00673920|589035906|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
163088692|NCT00673920|589035907|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
163088693|NCT00673920|589035908|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
163088694|NCT00673920|589035909|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
163088695|NCT00673920|589035910|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
163088696|NCT00673920|589035911|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
163088697|NCT00673920|589035912|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
163088698|NCT00673920|589035913|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
163088699|NCT00673920|589035906|FG000|Week 24 to Week 48|Death|0|||
163088700|NCT00673920|589035907|FG001|Week 24 to Week 48|Death|0|||
163088701|NCT00673920|589035908|FG002|Week 24 to Week 48|Death|0|||
163088702|NCT00673920|589035909|FG003|Week 24 to Week 48|Death|0|||
163088703|NCT00673920|589035910|FG004|Week 24 to Week 48|Death|0|||
163088704|NCT00673920|589035911|FG005|Week 24 to Week 48|Death|1|||
163088705|NCT00673920|589035912|FG006|Week 24 to Week 48|Death|0|||
163088706|NCT00673920|589035913|FG007|Week 24 to Week 48|Death|0|||
163407273|NCT02543528|590200771|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
163407274|NCT02543528|590200767|FG000|Adaptation Period|Lens Handling Difficultes|0|||
163088707|NCT00673920|589035906|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
163088708|NCT00673920|589035907|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
163088709|NCT00673920|589035908|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
163088710|NCT00673920|589035909|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
163088711|NCT00673920|589035910|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
163335484|NCT03128099|589938790|FG001|Overall Study|High dose task was too long|4|||
163335485|NCT03128099|589938791|FG002|Overall Study|High dose task was too long|0|||
163335486|NCT03128099|589938789|FG000|Overall Study|Participant got a full time job.|1|||
163335487|NCT03128099|589938790|FG001|Overall Study|Participant got a full time job.|0|||
163088712|NCT00673920|589035911|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
163088713|NCT00673920|589035912|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
163088714|NCT00673920|589035913|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
163088715|NCT02519842|589035914|FG000|Base Study: Cycle 1|Screening Failure|1|||
163335488|NCT03128099|589938791|FG002|Overall Study|Participant got a full time job.|0|||
163335489|NCT03128099|589938789|FG000|Overall Study|Became homeless and lost contact|1|||
163335490|NCT03128099|589938790|FG001|Overall Study|Became homeless and lost contact|0|||
163335491|NCT03128099|589938791|FG002|Overall Study|Became homeless and lost contact|0|||
163335492|NCT03128099|589938789|FG000|Overall Study|Did not complete all the assessments|0|||
163335493|NCT03128099|589938790|FG001|Overall Study|Did not complete all the assessments|0|||
163335494|NCT03128099|589938791|FG002|Overall Study|Did not complete all the assessments|1|||
163335495|NCT00148122|589938792|FG000|Overall Study|Withdrawal by Subject|2|||
163335496|NCT00721734|589938793|FG000|Overall Study|Progressive Disease|3|||
163335497|NCT00721734|589938794|FG001|Overall Study|Progressive Disease|10|||
163335498|NCT00721734|589938795|FG002|Overall Study|Progressive Disease|4|||
163335499|NCT00721734|589938796|FG003|Overall Study|Progressive Disease|5|||
163335500|NCT00721734|589938797|FG004|Overall Study|Progressive Disease|2|||
163335501|NCT00721734|589938793|FG000|Overall Study|Adverse Event|3|||
163335502|NCT00721734|589938794|FG001|Overall Study|Adverse Event|1|||
163335503|NCT00721734|589938795|FG002|Overall Study|Adverse Event|4|||
163335504|NCT00721734|589938796|FG003|Overall Study|Adverse Event|0|||
163335505|NCT00721734|589938797|FG004|Overall Study|Adverse Event|3|||
163335506|NCT00721734|589938793|FG000|Overall Study|Withdrawal by Subject|2|||
163335507|NCT00721734|589938794|FG001|Overall Study|Withdrawal by Subject|1|||
163335508|NCT00721734|589938795|FG002|Overall Study|Withdrawal by Subject|0|||
163335509|NCT00721734|589938796|FG003|Overall Study|Withdrawal by Subject|0|||
163335510|NCT00721734|589938797|FG004|Overall Study|Withdrawal by Subject|1|||
163335511|NCT00721734|589938793|FG000|Overall Study|Other|0|||
163335512|NCT00721734|589938794|FG001|Overall Study|Other|0|||
163335513|NCT00721734|589938795|FG002|Overall Study|Other|0|||
163335514|NCT00721734|589938796|FG003|Overall Study|Other|1|||
163335515|NCT00721734|589938797|FG004|Overall Study|Other|0|||
163335516|NCT02251652|589938798|FG000|Overall Study|Withdrawal by Subject|1|||
163335517|NCT04492475|589938799|FG000|Overall Study|Enrolled but not treated|8|||
163335518|NCT04492475|589938800|FG001|Overall Study|Enrolled but not treated|8|||
163335519|NCT04492475|589938799|FG000|Overall Study|Withdrawal by Subject|4|||
163335520|NCT04492475|589938800|FG001|Overall Study|Withdrawal by Subject|0|||
163335521|NCT04492475|589938799|FG000|Overall Study|Became ineligible after enrollment|2|||
163335522|NCT04492475|589938800|FG001|Overall Study|Became ineligible after enrollment|0|||
163335523|NCT03035942|589938805|FG000|Overall Study|Adverse Event|8|||
163335524|NCT03035942|589938806|FG001|Overall Study|Adverse Event|4|||
163335525|NCT03035942|589938807|FG002|Overall Study|Adverse Event|5|||
163335526|NCT05270460|589938808|FG000|Overall Study|Adverse Event|0|||
163335527|NCT05270460|589938809|FG001|Overall Study|Adverse Event|1|||
163335528|NCT05270460|589938810|FG002|Overall Study|Adverse Event|0|||
163335529|NCT05270460|589938808|FG000|Overall Study|Early Termination|0|||
163335530|NCT05270460|589938809|FG001|Overall Study|Early Termination|1|||
163335531|NCT05270460|589938810|FG002|Overall Study|Early Termination|0|||
163335532|NCT03205488|589938811|FG000|Overall Study|Adverse Event|1|||
163335533|NCT03205488|589938812|FG001|Overall Study|Adverse Event|2|||
163335534|NCT03205488|589938813|FG002|Overall Study|Adverse Event|4|||
163335535|NCT03205488|589938811|FG000|Overall Study|Protocol Violation|0|||
163335536|NCT03205488|589938812|FG001|Overall Study|Protocol Violation|0|||
163335537|NCT03205488|589938813|FG002|Overall Study|Protocol Violation|1|||
163335538|NCT05163353|589938816|FG000|Overall Study|Adverse Event|1|||
163335539|NCT05163353|589938817|FG001|Overall Study|Adverse Event|0|||
163335540|NCT05163353|589938816|FG000|Overall Study|Withdrawal by Subject|21|||
163335541|NCT05163353|589938817|FG001|Overall Study|Withdrawal by Subject|6|||
163335542|NCT05163353|589938816|FG000|Overall Study|Protocol Violation|0|||
163335543|NCT05163353|589938817|FG001|Overall Study|Protocol Violation|1|||
163335544|NCT05163353|589938816|FG000|Overall Study|Lost to Follow-up|13|||
163335545|NCT05163353|589938817|FG001|Overall Study|Lost to Follow-up|2|||
163335546|NCT06086028|589938819|FG000|Overall Study|Withdrawal by Subject|1|||
163335547|NCT06086028|589938820|FG001|Overall Study|Withdrawal by Subject|1|||
163335548|NCT06086028|589938819|FG000|Overall Study|Lost to Follow-up|2|||
163335549|NCT06086028|589938820|FG001|Overall Study|Lost to Follow-up|3|||
163335550|NCT00824408|589938821|FG000|Run-in Phase|Progressive disease|4|||
163088716|NCT02519842|589035915|FG001|Base Study: Cycle 1|Screening Failure|1|||
163335551|NCT00824408|589938822|FG001|Run-in Phase|Progressive disease|4|||
163335552|NCT00824408|589938823|FG002|Run-in Phase|Progressive disease|0|||
163335553|NCT00824408|589938824|FG003|Run-in Phase|Progressive disease|0|||
163335554|NCT00824408|589938825|FG004|Run-in Phase|Progressive disease|0|||
163335555|NCT00824408|589938821|FG000|Run-in Phase|Adverse Event|1|||
163335556|NCT00824408|589938822|FG001|Run-in Phase|Adverse Event|1|||
163335557|NCT00824408|589938823|FG002|Run-in Phase|Adverse Event|0|||
163335558|NCT00824408|589938824|FG003|Run-in Phase|Adverse Event|0|||
163335559|NCT00824408|589938825|FG004|Run-in Phase|Adverse Event|0|||
163335560|NCT00824408|589938821|FG000|Run-in Phase|Refused to continue medication|1|||
163088717|NCT02519842|589035916|FG002|Base Study: Cycle 1|Screening Failure|0|||
163088718|NCT02519842|589035914|FG000|Base Study: Cycle 1|Adverse Event|1|||
163088719|NCT02519842|589035915|FG001|Base Study: Cycle 1|Adverse Event|0|||
163088720|NCT02519842|589035916|FG002|Base Study: Cycle 1|Adverse Event|0|||
163088721|NCT02519842|589035914|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
163088722|NCT02519842|589035915|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
163088723|NCT02519842|589035916|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
163088724|NCT02519842|589035914|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
163088725|NCT02519842|589035915|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
163088726|NCT02519842|589035916|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
163088727|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
163088728|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
163088729|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
163088730|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
163088731|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
163088732|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
163088733|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
163088734|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
163088735|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
163088736|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
163088737|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
163088738|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
163088739|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Death|0|||
163088740|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Death|0|||
163088741|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Death|1|||
163088742|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
163088743|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
163088744|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
163088745|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
163088746|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
163088747|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
163088748|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
163088749|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
163088750|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
163088751|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
163088752|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
163088753|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
163088754|NCT02639390|589035918|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
163088755|NCT02639390|589035919|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
163088756|NCT01561976|589035920|FG000|Period 1|Adverse Event|0|||
163088757|NCT01561976|589035921|FG001|Period 1|Adverse Event|0|||
163088758|NCT01561976|589035922|FG002|Period 1|Adverse Event|1|||
163088759|NCT01561976|589035923|FG003|Period 1|Adverse Event|0|||
163088760|NCT01561976|589035924|FG004|Period 1|Adverse Event|0|||
163088761|NCT01561976|589035925|FG005|Period 1|Adverse Event|0|||
163088762|NCT01561976|589035920|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
163088763|NCT01561976|589035921|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
163088764|NCT01561976|589035922|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
163088765|NCT01561976|589035923|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
163088766|NCT01561976|589035924|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
163088767|NCT01561976|589035925|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
163088768|NCT01561976|589035920|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163088769|NCT01561976|589035921|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163088770|NCT01561976|589035922|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163088771|NCT01561976|589035923|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163088772|NCT01561976|589035924|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163088773|NCT01561976|589035925|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
163088774|NCT01561976|589035920|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
163088775|NCT01561976|589035921|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
163088776|NCT01561976|589035922|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
163088777|NCT01561976|589035923|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
163088778|NCT01561976|589035924|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
163088779|NCT01561976|589035925|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
163088780|NCT01463527|589035926|FG000|Overall Study|Protocol Violation|1|||
163088781|NCT01463527|589035927|FG001|Overall Study|Protocol Violation|1|||
163088782|NCT01463527|589035926|FG000|Overall Study|Crying >20% of sedation|5|||
163088783|NCT01463527|589035927|FG001|Overall Study|Crying >20% of sedation|6|||
163088784|NCT01977222|589035930|FG000|Overall Study|Withdrawal by Subject|1|||
163088785|NCT02980107|589035931|FG000|Overall Study|Withdrawal by Subject|51|||
163088786|NCT02980107|589035932|FG001|Overall Study|Withdrawal by Subject|62|||
163088787|NCT02836249|589035935|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
163037293|NCT00862459|588842449|FG000|Overall Study|Unable to hold still for imaging|0|||
163037294|NCT00862459|588842450|FG001|Overall Study|Unable to hold still for imaging|1|||
163037295|NCT00862459|588842451|FG002|Overall Study|Unable to hold still for imaging|0|||
163037296|NCT00862459|588842449|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
163037297|NCT00862459|588842450|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
163037298|NCT00862459|588842451|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
163037299|NCT00862459|588842449|FG000|Overall Study|Administrative problems|0|||
163037300|NCT00862459|588842450|FG001|Overall Study|Administrative problems|1|||
163037301|NCT00862459|588842451|FG002|Overall Study|Administrative problems|0|||
163037302|NCT01333956|588842462|FG000|Overall Study|Lost to Follow-up|1|||
163037303|NCT01333956|588842463|FG001|Overall Study|Lost to Follow-up|2|||
163037304|NCT01333956|588842464|FG002|Overall Study|Lost to Follow-up|0|||
163037305|NCT01333956|588842465|FG003|Overall Study|Lost to Follow-up|1|||
163037306|NCT01333956|588842462|FG000|Overall Study|Unable to complete study procedure|1|||
163037307|NCT01333956|588842463|FG001|Overall Study|Unable to complete study procedure|0|||
163037308|NCT01333956|588842464|FG002|Overall Study|Unable to complete study procedure|0|||
163037309|NCT01333956|588842465|FG003|Overall Study|Unable to complete study procedure|1|||
163037310|NCT01333956|588842462|FG000|Overall Study|Withdrawal by Subject|0|||
163037311|NCT01333956|588842463|FG001|Overall Study|Withdrawal by Subject|2|||
163037312|NCT01333956|588842464|FG002|Overall Study|Withdrawal by Subject|1|||
163037313|NCT01333956|588842465|FG003|Overall Study|Withdrawal by Subject|0|||
163037314|NCT03426436|588842466|FG000|Overall Study|Incorrect lead placement|12|||
163037315|NCT03426436|588842466|FG000|Overall Study|Withdrawal by Subject|2|||
163037316|NCT03426436|588842466|FG000|Overall Study|Consent issue|1|||
163037317|NCT03426436|588842466|FG000|Overall Study|ECGs not saved|4|||
163037318|NCT03168919|588842467|FG000|Overall Study|Withdrawal by Subject|2|||
163037319|NCT01085136|588842468|FG000|Part A|Other Adverse event|223|||
163037320|NCT01085136|588842469|FG001|Part A|Other Adverse event|0|||
163037321|NCT01085136|588842470|FG002|Part A|Other Adverse event|0|||
163037322|NCT01085136|588842468|FG000|Part A|Protocol Violation|3|||
163037323|NCT01085136|588842469|FG001|Part A|Protocol Violation|0|||
163037324|NCT01085136|588842470|FG002|Part A|Protocol Violation|0|||
163037325|NCT01085136|588842468|FG000|Part A|Lost to Follow-up|3|||
163037326|NCT01085136|588842469|FG001|Part A|Lost to Follow-up|0|||
163037327|NCT01085136|588842470|FG002|Part A|Lost to Follow-up|0|||
163037328|NCT01085136|588842468|FG000|Part A|Refusal to continue trial medication|64|||
163037329|NCT01085136|588842469|FG001|Part A|Refusal to continue trial medication|0|||
163037330|NCT01085136|588842470|FG002|Part A|Refusal to continue trial medication|0|||
163037331|NCT01085136|588842468|FG000|Part A|Other reason not defined above|30|||
163037332|NCT01085136|588842469|FG001|Part A|Other reason not defined above|0|||
163037333|NCT01085136|588842470|FG002|Part A|Other reason not defined above|0|||
163037334|NCT01085136|588842468|FG000|Part B|Other AE|0|||
163037335|NCT01085136|588842469|FG001|Part B|Other AE|29|||
163037336|NCT01085136|588842470|FG002|Part B|Other AE|8|||
163037337|NCT01085136|588842468|FG000|Part B|Refusal to continue trial medication|0|||
163037338|NCT01085136|588842469|FG001|Part B|Refusal to continue trial medication|12|||
163037339|NCT01085136|588842470|FG002|Part B|Refusal to continue trial medication|7|||
163037340|NCT01085136|588842468|FG000|Part B|Not treated|0|||
163037341|NCT01085136|588842469|FG001|Part B|Not treated|4|||
163037342|NCT01085136|588842470|FG002|Part B|Not treated|8|||
163037343|NCT01085136|588842468|FG000|Part B|Other reason not defined above|0|||
163037344|NCT01085136|588842469|FG001|Part B|Other reason not defined above|6|||
163037345|NCT01085136|588842470|FG002|Part B|Other reason not defined above|3|||
163037346|NCT02655419|588842471|FG000|Overall Study|Enrolled but not treated|1|||
163037347|NCT02655419|588842472|FG001|Overall Study|Enrolled but not treated|5|||
163037348|NCT02655419|588842471|FG000|Overall Study|Withdrawal by Subject|4|||
163037349|NCT02655419|588842472|FG001|Overall Study|Withdrawal by Subject|1|||
163037350|NCT02655419|588842471|FG000|Overall Study|Other|0|||
163037351|NCT02655419|588842472|FG001|Overall Study|Other|1|||
163037352|NCT04226495|588842476|FG000|Overall Study|Withdrawal by Subject|3|||
163037353|NCT04226495|588842477|FG001|Overall Study|Withdrawal by Subject|3|||
163037354|NCT04226495|588842476|FG000|Overall Study|PI discretion|3|||
163037355|NCT04226495|588842477|FG001|Overall Study|PI discretion|4|||
163037356|NCT02333383|588842479|FG000|Overall Study|Adalimumab discontinuation|21|||
163037357|NCT02333383|588842479|FG000|Overall Study|Lost to Follow-up|15|||
163037358|NCT02333383|588842479|FG000|Overall Study|Withdrawal by Subject|3|||
163037359|NCT02333383|588842479|FG000|Overall Study|Transfer to another hospital|2|||
163037360|NCT04459598|588842480|FG000|Overall Study|Adverse Event|1|||
163037361|NCT04459598|588842481|FG001|Overall Study|Adverse Event|1|||
163037362|NCT00866333|588842482|FG000|Overall Study|Withdrawal of consent|0|||
163037363|NCT00866333|588842483|FG001|Overall Study|Withdrawal of consent|1|||
163037364|NCT00866333|588842484|FG002|Overall Study|Withdrawal of consent|2|||
163037365|NCT00866333|588842482|FG000|Overall Study|Reason not Specified|3|||
163037366|NCT00866333|588842483|FG001|Overall Study|Reason not Specified|1|||
163037367|NCT00866333|588842484|FG002|Overall Study|Reason not Specified|1|||
163037368|NCT00866333|588842482|FG000|Overall Study|Study Terminated by Sponsor|2|||
163037369|NCT00866333|588842483|FG001|Overall Study|Study Terminated by Sponsor|5|||
163335561|NCT00824408|589938822|FG001|Run-in Phase|Refused to continue medication|0|||
163335562|NCT00824408|589938823|FG002|Run-in Phase|Refused to continue medication|0|||
163335563|NCT00824408|589938824|FG003|Run-in Phase|Refused to continue medication|0|||
163335564|NCT00824408|589938825|FG004|Run-in Phase|Refused to continue medication|0|||
163335565|NCT00824408|589938821|FG000|Run-in Phase|Other reason not defined above|0|||
163335566|NCT00824408|589938822|FG001|Run-in Phase|Other reason not defined above|1|||
163335567|NCT00824408|589938823|FG002|Run-in Phase|Other reason not defined above|0|||
163335568|NCT00824408|589938824|FG003|Run-in Phase|Other reason not defined above|0|||
163335569|NCT00824408|589938825|FG004|Run-in Phase|Other reason not defined above|0|||
163037370|NCT00866333|588842484|FG002|Overall Study|Study Terminated by Sponsor|9|||
163037371|NCT01854879|588842485|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
163037372|NCT01854879|588842485|FG000|Overall Study|screen fail|3|||
163037373|NCT01854879|588842485|FG000|Overall Study|incomplete data set|1|||
163037374|NCT00385827|588844158|FG000|Part 1|Adverse Event|1|||
163037375|NCT00385827|588844159|FG001|Part 1|Adverse Event|0|||
163037376|NCT00385827|588844160|FG002|Part 1|Adverse Event|0|||
163037377|NCT00385827|588844158|FG000|Part 1|Death|2|||
163037378|NCT00385827|588844159|FG001|Part 1|Death|0|||
163037379|NCT00385827|588844160|FG002|Part 1|Death|0|||
163037380|NCT00385827|588844158|FG000|Part 1|Lack of Efficacy|5|||
163037381|NCT00385827|588844159|FG001|Part 1|Lack of Efficacy|0|||
163037382|NCT00385827|588844160|FG002|Part 1|Lack of Efficacy|0|||
163037383|NCT00385827|588844158|FG000|Part 1|Other|1|||
163037384|NCT00385827|588844159|FG001|Part 1|Other|0|||
163037385|NCT00385827|588844160|FG002|Part 1|Other|0|||
163037386|NCT00385827|588844158|FG000|Part 2|Adverse Event|0|||
163037387|NCT00385827|588844159|FG001|Part 2|Adverse Event|6|||
163037388|NCT00385827|588844160|FG002|Part 2|Adverse Event|10|||
163037389|NCT00385827|588844158|FG000|Part 2|Death|0|||
163037390|NCT00385827|588844159|FG001|Part 2|Death|0|||
163037391|NCT00385827|588844160|FG002|Part 2|Death|2|||
163037392|NCT00385827|588844158|FG000|Part 2|Lack of Efficacy|0|||
163037393|NCT00385827|588844159|FG001|Part 2|Lack of Efficacy|14|||
163037394|NCT00385827|588844160|FG002|Part 2|Lack of Efficacy|13|||
163037395|NCT00385827|588844158|FG000|Part 2|Randomized but not treated|0|||
163037396|NCT00385827|588844159|FG001|Part 2|Randomized but not treated|2|||
163037397|NCT00385827|588844160|FG002|Part 2|Randomized but not treated|2|||
163037398|NCT00385827|588844158|FG000|Part 2|Other|0|||
163037399|NCT00385827|588844159|FG001|Part 2|Other|11|||
163037400|NCT00385827|588844160|FG002|Part 2|Other|21|||
163037401|NCT00410072|588844161|FG000|Day 1 to Week 48|Adverse Event|1|||
163037402|NCT00410072|588844162|FG001|Day 1 to Week 48|Adverse Event|2|||
163037403|NCT00410072|588844161|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
163037404|NCT00410072|588844162|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
163037405|NCT00410072|588844161|FG000|Day 1 to Week 48|Other|0|||
163037406|NCT00410072|588844162|FG001|Day 1 to Week 48|Other|1|||
163037407|NCT00410072|588844161|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
163037408|NCT00410072|588844162|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
163037409|NCT00410072|588844161|FG000|Day 1 to Week 48|Pregnancy|0|||
163037410|NCT00410072|588844162|FG001|Day 1 to Week 48|Pregnancy|2|||
163037411|NCT00410072|588844161|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
163037412|NCT00410072|588844162|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
163037413|NCT00410072|588844161|FG000|After Week 48 to Week 96|Adverse Event|1|||
163037414|NCT00410072|588844162|FG001|After Week 48 to Week 96|Adverse Event|2|||
163037415|NCT00410072|588844161|FG000|After Week 48 to Week 96|Death|0|||
163037416|NCT00410072|588844162|FG001|After Week 48 to Week 96|Death|1|||
163037417|NCT00410072|588844161|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
163037418|NCT00410072|588844162|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
163037419|NCT00410072|588844161|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
163037420|NCT00410072|588844162|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
163037421|NCT00410072|588844161|FG000|After Week 48 to Week 96|Other|2|||
163037422|NCT00410072|588844162|FG001|After Week 48 to Week 96|Other|0|||
163037423|NCT00410072|588844161|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
163037424|NCT00410072|588844162|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
163037425|NCT00410072|588844161|FG000|After Week 48 to Week 96|Pregnancy|0|||
163037426|NCT00410072|588844162|FG001|After Week 48 to Week 96|Pregnancy|2|||
163037427|NCT00410072|588844161|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
163037428|NCT00410072|588844162|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
163037429|NCT01421147|588844163|FG000|Treatment Period|Adverse Event|2|||
163037430|NCT01421147|588844164|FG001|Treatment Period|Adverse Event|3|||
163037431|NCT01421147|588844163|FG000|Treatment Period|Lost to Follow-up|2|||
163037432|NCT01421147|588844164|FG001|Treatment Period|Lost to Follow-up|1|||
163037433|NCT01421147|588844163|FG000|Treatment Period|Physician Decision|2|||
163037434|NCT01421147|588844164|FG001|Treatment Period|Physician Decision|2|||
163037435|NCT01421147|588844163|FG000|Treatment Period|Withdrawal by Subject|10|||
163037436|NCT01421147|588844164|FG001|Treatment Period|Withdrawal by Subject|5|||
163037437|NCT01421147|588844163|FG000|Extension Period|Adverse Event|0|||
163037438|NCT01421147|588844164|FG001|Extension Period|Adverse Event|2|||
163037439|NCT01421147|588844163|FG000|Extension Period|Death|0|||
163037440|NCT01421147|588844164|FG001|Extension Period|Death|1|||
163088788|NCT02836249|589035936|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
163037441|NCT01421147|588844163|FG000|Extension Period|Lost to Follow-up|2|||
163037442|NCT01421147|588844164|FG001|Extension Period|Lost to Follow-up|5|||
163037443|NCT01421147|588844163|FG000|Extension Period|Physician Decision|1|||
163037444|NCT01421147|588844164|FG001|Extension Period|Physician Decision|0|||
163037445|NCT01421147|588844163|FG000|Extension Period|Withdrawal by Subject|5|||
163037446|NCT01421147|588844164|FG001|Extension Period|Withdrawal by Subject|3|||
163037447|NCT00904917|588844167|FG000|Overall Study|Lost to Follow-up|2|||
163037448|NCT00904917|588844168|FG001|Overall Study|Lost to Follow-up|2|||
163037449|NCT00904917|588844169|FG002|Overall Study|Lost to Follow-up|2|||
163037450|NCT00904917|588844170|FG003|Overall Study|Lost to Follow-up|2|||
163037451|NCT05025332|588844173|FG000|Screening|Screen failure|12|||
163037452|NCT05025332|588844173|FG000|Treatment & Follow Up|Protocol Violation|1|||
163037453|NCT05025332|588844173|FG000|Treatment & Follow Up|Adverse Event|4|||
163037454|NCT02107313|588844174|FG000|Overall Study|One participant did not do the FED cohor|0|||
163037455|NCT02107313|588844175|FG001|Overall Study|One participant did not do the FED cohor|1|||
163037456|NCT01031004|588844178|FG000|Overall Study|Protocol Violation|0|||
163037457|NCT01031004|588844179|FG001|Overall Study|Protocol Violation|1|||
163037458|NCT01031004|588844178|FG000|Overall Study|Lost to Follow-up|1|||
163037459|NCT01031004|588844179|FG001|Overall Study|Lost to Follow-up|0|||
163037460|NCT00582426|588844187|FG000|Overall Study|Lost to Follow-up|0|||
163037461|NCT00582426|588844188|FG001|Overall Study|Lost to Follow-up|2|||
163037462|NCT00582426|588844187|FG000|Overall Study|Adverse Event|4|||
163037463|NCT00582426|588844188|FG001|Overall Study|Adverse Event|2|||
163037464|NCT00582426|588844187|FG000|Overall Study|Protocol Violation|6|||
163037465|NCT00582426|588844188|FG001|Overall Study|Protocol Violation|2|||
163037466|NCT00582426|588844187|FG000|Overall Study|Death|4|||
163037467|NCT00582426|588844188|FG001|Overall Study|Death|3|||
163037468|NCT00582426|588844187|FG000|Overall Study|Withdrawal by Subject|3|||
163037469|NCT00582426|588844188|FG001|Overall Study|Withdrawal by Subject|2|||
163037470|NCT00582426|588844187|FG000|Overall Study|Disease Progression|2|||
163037471|NCT00582426|588844188|FG001|Overall Study|Disease Progression|2|||
163037472|NCT00582426|588844187|FG000|Overall Study|Use of illicit drugs|1|||
163037473|NCT00582426|588844188|FG001|Overall Study|Use of illicit drugs|0|||
163037474|NCT02164318|588844191|FG000|Overall Study|Withdrawal by Subject|0|||
163037475|NCT02164318|588844192|FG001|Overall Study|Withdrawal by Subject|1|||
163037476|NCT02164318|588844193|FG002|Overall Study|Withdrawal by Subject|0|||
163037477|NCT02164318|588844194|FG003|Overall Study|Withdrawal by Subject|1|||
163037478|NCT00662311|588844195|FG000|Overall Study|Respiratory Infection|1|||
163037479|NCT00662311|588844196|FG001|Overall Study|Respiratory Infection|0|||
163037480|NCT00662311|588844197|FG002|Overall Study|Respiratory Infection|0|||
163037481|NCT04727528|588844198|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
163037482|NCT04727528|588844199|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
163037483|NCT04727528|588844198|FG000|Open-label Period|Randomized who did not receive treatment|1|||
163037484|NCT04727528|588844199|FG001|Open-label Period|Randomized who did not receive treatment|0|||
163037485|NCT04727528|588844198|FG000|Double-blind Treatment Phase|Adverse Event|0|||
163037486|NCT04727528|588844199|FG001|Double-blind Treatment Phase|Adverse Event|1|||
163037487|NCT04727528|588844198|FG000|Double-blind Treatment Phase|Death|0|||
163037488|NCT04727528|588844199|FG001|Double-blind Treatment Phase|Death|1|||
163037489|NCT04727528|588844198|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
163037490|NCT04727528|588844199|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
163037491|NCT04727528|588844198|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
163037492|NCT04727528|588844199|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
163037493|NCT04727528|588844198|FG000|Double-blind Treatment Phase|Physician Decision|0|||
163037494|NCT04727528|588844199|FG001|Double-blind Treatment Phase|Physician Decision|1|||
163037495|NCT04727528|588844198|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
163037496|NCT04727528|588844199|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
163037497|NCT02335346|588844203|FG000|Overall Study|Adverse Event|11|||
163037498|NCT02335346|588844203|FG000|Overall Study|Withdrawal by Subject|1|||
163037499|NCT01964989|588844204|FG000|Overall Study|Protocol Violation|3|||
163037500|NCT01964989|588844205|FG001|Overall Study|Protocol Violation|4|||
163037501|NCT01964989|588844204|FG000|Overall Study|Administrative Reason|103|||
163037502|NCT01964989|588844205|FG001|Overall Study|Administrative Reason|95|||
163037503|NCT01964989|588844204|FG000|Overall Study|Adverse Event|0|||
163037504|NCT01964989|588844205|FG001|Overall Study|Adverse Event|1|||
163037505|NCT01964989|588844204|FG000|Overall Study|Death|1|||
163037506|NCT01964989|588844205|FG001|Overall Study|Death|3|||
163037507|NCT01964989|588844204|FG000|Overall Study|Withdrawal by Subject|156|||
163088789|NCT02836249|589035937|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
163088790|NCT02836249|589035938|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
163037508|NCT01964989|588844205|FG001|Overall Study|Withdrawal by Subject|160|||
163037509|NCT01964989|588844204|FG000|Overall Study|Lost to Follow-up|254|||
163037510|NCT01964989|588844205|FG001|Overall Study|Lost to Follow-up|232|||
163037511|NCT01964989|588844204|FG000|Overall Study|Other|267|||
163335570|NCT00824408|589938821|FG000|Randomized Phase|Not treated|0|||
163335571|NCT00824408|589938822|FG001|Randomized Phase|Not treated|0|||
163335572|NCT00824408|589938823|FG002|Randomized Phase|Not treated|1|||
163335573|NCT00824408|589938824|FG003|Randomized Phase|Not treated|1|||
163335574|NCT00824408|589938825|FG004|Randomized Phase|Not treated|1|||
163335575|NCT00824408|589938821|FG000|Randomized Phase|Progressive disease|0|||
163335576|NCT00824408|589938822|FG001|Randomized Phase|Progressive disease|0|||
163335577|NCT00824408|589938823|FG002|Randomized Phase|Progressive disease|25|||
163335578|NCT00824408|589938824|FG003|Randomized Phase|Progressive disease|36|||
163335579|NCT00824408|589938825|FG004|Randomized Phase|Progressive disease|34|||
163335580|NCT00824408|589938821|FG000|Randomized Phase|Adverse Event|0|||
163335581|NCT00824408|589938822|FG001|Randomized Phase|Adverse Event|0|||
163335582|NCT00824408|589938823|FG002|Randomized Phase|Adverse Event|4|||
163335583|NCT00824408|589938824|FG003|Randomized Phase|Adverse Event|5|||
163335584|NCT00824408|589938825|FG004|Randomized Phase|Adverse Event|5|||
163335585|NCT00824408|589938821|FG000|Randomized Phase|Refused to continue medication|0|||
163335586|NCT00824408|589938822|FG001|Randomized Phase|Refused to continue medication|0|||
163335587|NCT00824408|589938823|FG002|Randomized Phase|Refused to continue medication|2|||
163335588|NCT00824408|589938824|FG003|Randomized Phase|Refused to continue medication|2|||
163335589|NCT00824408|589938825|FG004|Randomized Phase|Refused to continue medication|2|||
163335590|NCT00824408|589938821|FG000|Randomized Phase|Other reason not defined above|0|||
163335591|NCT00824408|589938822|FG001|Randomized Phase|Other reason not defined above|0|||
163335592|NCT00824408|589938823|FG002|Randomized Phase|Other reason not defined above|4|||
163335593|NCT00824408|589938824|FG003|Randomized Phase|Other reason not defined above|2|||
163335594|NCT00824408|589938825|FG004|Randomized Phase|Other reason not defined above|4|||
163335595|NCT01263496|589938832|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
163335596|NCT01263496|589938833|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163335597|NCT01263496|589938834|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163335598|NCT01263496|589938835|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163335599|NCT01263496|589938836|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163335600|NCT01263496|589938837|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163335601|NCT01263496|589938838|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163335602|NCT01263496|589938839|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163335603|NCT01263496|589938840|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163335604|NCT01263496|589938832|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163335605|NCT01263496|589938833|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163335606|NCT01263496|589938834|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163335607|NCT01263496|589938835|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
163335608|NCT01263496|589938836|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
163335609|NCT01263496|589938837|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163335610|NCT01263496|589938838|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163335611|NCT01263496|589938839|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163335612|NCT01263496|589938840|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163335613|NCT01263496|589938832|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
163335614|NCT01263496|589938833|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
163335615|NCT01263496|589938834|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
163335616|NCT01263496|589938835|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
163088791|NCT02836249|589035935|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
163088792|NCT02836249|589035936|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
163088793|NCT02836249|589035937|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
163088794|NCT02836249|589035938|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
163088795|NCT02836249|589035935|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
163088796|NCT02836249|589035936|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
163088797|NCT02836249|589035937|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
163088798|NCT02836249|589035938|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
163088799|NCT02836249|589035935|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
163088800|NCT02836249|589035936|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
163088801|NCT02836249|589035937|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
163088802|NCT02836249|589035938|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
163088803|NCT02836249|589035935|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
163088804|NCT02836249|589035936|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
163088805|NCT02836249|589035937|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
163088806|NCT02836249|589035938|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
163335617|NCT01263496|589938836|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
163335618|NCT01263496|589938837|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
163335619|NCT01263496|589938838|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
163335620|NCT01263496|589938839|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
163335621|NCT01263496|589938840|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
163335622|NCT01263496|589938832|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163335623|NCT01263496|589938833|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
163335624|NCT01263496|589938834|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163335625|NCT01263496|589938835|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163335626|NCT01263496|589938836|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163335627|NCT01263496|589938837|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163037512|NCT01964989|588844205|FG001|Overall Study|Other|252|||
163037513|NCT02769312|588844206|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
163037514|NCT02769312|588844207|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
163037515|NCT02769312|588844206|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
163037516|NCT02769312|588844207|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
163037517|NCT02769312|588844206|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
163037518|NCT02769312|588844207|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
163037519|NCT02769312|588844206|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
163037520|NCT02769312|588844207|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
163037521|NCT02769312|588844206|FG000|Follow-up|Lost to Follow-up|1|||
163037522|NCT02769312|588844207|FG001|Follow-up|Lost to Follow-up|1|||
163037523|NCT01148459|588844210|FG000|Overall Study|Serious Adverse Event|5|||
163037524|NCT01148459|588844211|FG001|Overall Study|Serious Adverse Event|4|||
163037525|NCT01148459|588844210|FG000|Overall Study|Withdrawal by Subject|1|||
163037526|NCT01148459|588844211|FG001|Overall Study|Withdrawal by Subject|0|||
163037527|NCT01148459|588844210|FG000|Overall Study|Migrated/moved from study area|3|||
163037528|NCT01148459|588844211|FG001|Overall Study|Migrated/moved from study area|6|||
163037529|NCT01148459|588844210|FG000|Overall Study|Lost to Follow-up|2|||
163037530|NCT01148459|588844211|FG001|Overall Study|Lost to Follow-up|0|||
163037531|NCT01148459|588844210|FG000|Overall Study|Refusal|1|||
163037532|NCT01148459|588844211|FG001|Overall Study|Refusal|0|||
163037533|NCT01148459|588844210|FG000|Overall Study|Failure to comply with study procedures|0|||
163037534|NCT01148459|588844211|FG001|Overall Study|Failure to comply with study procedures|1|||
163037535|NCT02496039|588844212|FG000|Overall Study|Adverse Event|3|||
163037536|NCT02496039|588844212|FG000|Overall Study|Protocol Violation|1|||
163037537|NCT00948922|588844213|FG000|Overall Study|Did not start study treatment|2|||
163037538|NCT00948922|588844214|FG001|Overall Study|Did not start study treatment|5|||
163037539|NCT00948922|588844215|FG002|Overall Study|Did not start study treatment|0|||
163037540|NCT00948922|588844213|FG000|Overall Study|Withdrawal by Subject|0|||
163037541|NCT00948922|588844214|FG001|Overall Study|Withdrawal by Subject|2|||
163037542|NCT00948922|588844215|FG002|Overall Study|Withdrawal by Subject|1|||
163037543|NCT00948922|588844213|FG000|Overall Study|Death|3|||
163037544|NCT00948922|588844214|FG001|Overall Study|Death|0|||
163037545|NCT00948922|588844215|FG002|Overall Study|Death|0|||
163037546|NCT00948922|588844213|FG000|Overall Study|Disease progression|0|||
163037547|NCT00948922|588844214|FG001|Overall Study|Disease progression|1|||
163037548|NCT00948922|588844215|FG002|Overall Study|Disease progression|0|||
163037549|NCT00948922|588844213|FG000|Overall Study|Insurance issues|1|||
163037550|NCT00948922|588844214|FG001|Overall Study|Insurance issues|0|||
163037551|NCT00948922|588844215|FG002|Overall Study|Insurance issues|0|||
163037552|NCT00948922|588844213|FG000|Overall Study|Transplant eligibility issues|2|||
163037553|NCT00948922|588844214|FG001|Overall Study|Transplant eligibility issues|3|||
163037554|NCT00948922|588844215|FG002|Overall Study|Transplant eligibility issues|0|||
163037555|NCT00948922|588844213|FG000|Overall Study|Not evaluable at time of analysis|0|||
163037556|NCT00948922|588844214|FG001|Overall Study|Not evaluable at time of analysis|3|||
163037557|NCT00948922|588844215|FG002|Overall Study|Not evaluable at time of analysis|0|||
163037558|NCT04854057|588844216|FG000|Overall Study|Adverse Event|0|||
163037559|NCT04854057|588844217|FG001|Overall Study|Adverse Event|1|||
163037560|NCT02131233|588844218|FG000|Overall Study|Not Treated|2|||
163037561|NCT02131233|588844219|FG001|Overall Study|Not Treated|3|||
163037562|NCT02131233|588844218|FG000|Overall Study|Adverse Event|7|||
163037563|NCT02131233|588844219|FG001|Overall Study|Adverse Event|6|||
163037564|NCT02131233|588844218|FG000|Overall Study|Death|0|||
163037565|NCT02131233|588844219|FG001|Overall Study|Death|1|||
163037566|NCT02131233|588844218|FG000|Overall Study|Lack of Efficacy|6|||
163037567|NCT02131233|588844219|FG001|Overall Study|Lack of Efficacy|3|||
163037568|NCT02131233|588844218|FG000|Overall Study|Lost to Follow-up|14|||
163037569|NCT02131233|588844219|FG001|Overall Study|Lost to Follow-up|13|||
163037570|NCT02131233|588844218|FG000|Overall Study|Non-Compliance With Study Drug|8|||
163037571|NCT02131233|588844219|FG001|Overall Study|Non-Compliance With Study Drug|5|||
163037572|NCT02131233|588844218|FG000|Overall Study|Physician Decision|7|||
163037573|NCT02131233|588844219|FG001|Overall Study|Physician Decision|0|||
163037574|NCT02131233|588844218|FG000|Overall Study|Pregnancy|4|||
163037575|NCT02131233|588844219|FG001|Overall Study|Pregnancy|0|||
163037576|NCT02131233|588844218|FG000|Overall Study|Withdrawal by Subject|18|||
163037577|NCT02131233|588844219|FG001|Overall Study|Withdrawal by Subject|11|||
163037578|NCT05114564|588844221|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
163037579|NCT05114564|588844222|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
163037580|NCT05114564|588844221|FG000|First Intervention|Adverse Event|0|||
163037581|NCT05114564|588844222|FG001|First Intervention|Adverse Event|1|||
163037582|NCT00255840|588844223|FG000|Overall Study|Lost to Follow-up|10|||
163037583|NCT00255840|588844224|FG001|Overall Study|Lost to Follow-up|14|||
163088807|NCT02836249|589035935|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
163088808|NCT02836249|589035936|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
163088809|NCT02836249|589035937|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
163088810|NCT02836249|589035938|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
163088811|NCT02836249|589035935|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
163088812|NCT02836249|589035936|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
163088813|NCT02836249|589035937|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
163088814|NCT02836249|589035938|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
163088815|NCT02836249|589035935|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
163088816|NCT02836249|589035936|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
163088817|NCT02836249|589035937|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
163088818|NCT02836249|589035938|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
163088819|NCT02836249|589035935|FG000|Open-Label TAF Treatment Phase|Death|0|||
163088820|NCT02836249|589035936|FG001|Open-Label TAF Treatment Phase|Death|0|||
163088821|NCT02836249|589035937|FG002|Open-Label TAF Treatment Phase|Death|1|||
163088822|NCT02836249|589035938|FG003|Open-Label TAF Treatment Phase|Death|0|||
163088823|NCT02836249|589035935|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
163088824|NCT02836249|589035936|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
163088825|NCT02836249|589035937|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
163088826|NCT02836249|589035938|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
163088827|NCT02836249|589035935|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
163088828|NCT02836249|589035936|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
163088829|NCT02836249|589035937|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
163088830|NCT02836249|589035938|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
163088831|NCT00928668|589035939|FG000|Overall Study|Adverse Event|1|||
163088832|NCT00928668|589035940|FG001|Overall Study|Adverse Event|0|||
163088833|NCT00928668|589035941|FG002|Overall Study|Adverse Event|0|||
163088834|NCT00928668|589035942|FG003|Overall Study|Adverse Event|0|||
163088835|NCT00928668|589035943|FG004|Overall Study|Adverse Event|0|||
163088836|NCT00928668|589035939|FG000|Overall Study|Protocol Violation|0|||
163088837|NCT00928668|589035940|FG001|Overall Study|Protocol Violation|0|||
163088838|NCT00928668|589035941|FG002|Overall Study|Protocol Violation|0|||
163088839|NCT00928668|589035942|FG003|Overall Study|Protocol Violation|0|||
163088840|NCT00928668|589035943|FG004|Overall Study|Protocol Violation|1|||
163088841|NCT00928668|589035939|FG000|Overall Study|Withdrawal by Subject|0|||
163088842|NCT00928668|589035940|FG001|Overall Study|Withdrawal by Subject|1|||
163088843|NCT00928668|589035941|FG002|Overall Study|Withdrawal by Subject|1|||
163088844|NCT00928668|589035942|FG003|Overall Study|Withdrawal by Subject|0|||
163088845|NCT00928668|589035943|FG004|Overall Study|Withdrawal by Subject|0|||
163088846|NCT00928668|589035939|FG000|Overall Study|Other reasons not listed above|0|||
163088847|NCT00928668|589035940|FG001|Overall Study|Other reasons not listed above|0|||
163088848|NCT00928668|589035941|FG002|Overall Study|Other reasons not listed above|0|||
163088849|NCT00928668|589035942|FG003|Overall Study|Other reasons not listed above|1|||
163088850|NCT00928668|589035943|FG004|Overall Study|Other reasons not listed above|0|||
163088851|NCT02943473|589035948|FG000|Overall Study|enrolled but not dosed|1|||
163088852|NCT02943473|589035948|FG000|Overall Study|screen failure|1|||
163088853|NCT02943473|589035948|FG000|Overall Study|Physician Decision|4|||
163088854|NCT04138056|589035949|FG000|Primary Study|Lost to Follow-up|3|||
163088855|NCT04138056|589035950|FG001|Primary Study|Lost to Follow-up|4|||
163088856|NCT04138056|589035951|FG002|Primary Study|Lost to Follow-up|1|||
163088857|NCT04138056|589035952|FG003|Primary Study|Lost to Follow-up|1|||
163088858|NCT04138056|589035953|FG004|Primary Study|Lost to Follow-up|4|||
163088859|NCT04138056|589035949|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
163088860|NCT04138056|589035950|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
163088861|NCT04138056|589035951|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
163088862|NCT04138056|589035952|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
163088863|NCT04138056|589035953|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
163088864|NCT04138056|589035949|FG000|Extension Study|Lost to Follow-up|1|||
163088865|NCT04138056|589035950|FG001|Extension Study|Lost to Follow-up|2|||
163088866|NCT04138056|589035951|FG002|Extension Study|Lost to Follow-up|1|||
163335628|NCT01263496|589938838|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163335629|NCT01263496|589938839|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163088867|NCT04138056|589035952|FG003|Extension Study|Lost to Follow-up|0|||
163088868|NCT04138056|589035953|FG004|Extension Study|Lost to Follow-up|1|||
163088869|NCT01968980|589035957|FG000|Overall Study|Death|0|||
163088870|NCT01968980|589035958|FG001|Overall Study|Death|1|||
163088871|NCT01968980|589035957|FG000|Overall Study|Adverse Event|1|||
163335630|NCT01263496|589938840|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163088872|NCT01968980|589035958|FG001|Overall Study|Adverse Event|3|||
163088873|NCT01968980|589035957|FG000|Overall Study|Does not meet entry criteria|1|||
163088874|NCT01968980|589035958|FG001|Overall Study|Does not meet entry criteria|3|||
163220059|NCT03190889|589521399|FG002|Overall Study|Lost to Follow-up|3|||
163335631|NCT01263496|589938832|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163335632|NCT01263496|589938833|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
163335633|NCT01263496|589938834|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
163088875|NCT01968980|589035957|FG000|Overall Study|Withdrawal by Subject|13|||
163088876|NCT01968980|589035958|FG001|Overall Study|Withdrawal by Subject|5|||
163088877|NCT01968980|589035957|FG000|Overall Study|Other unspecified|1|||
163088878|NCT01968980|589035958|FG001|Overall Study|Other unspecified|2|||
163088879|NCT01242514|589035959|FG000|Overall Study|e.g., project closure|1042|||
163088880|NCT01242514|589035960|FG001|Overall Study|e.g., project closure|305|||
163088881|NCT01242514|589035961|FG002|Overall Study|e.g., project closure|171|||
163088882|NCT01242514|589035959|FG000|Overall Study|Subject decision|33|||
163088883|NCT01242514|589035960|FG001|Overall Study|Subject decision|8|||
163088884|NCT01242514|589035961|FG002|Overall Study|Subject decision|2|||
163088885|NCT01242514|589035959|FG000|Overall Study|Severe non-compliance to protocol|5|||
163088886|NCT01242514|589035960|FG001|Overall Study|Severe non-compliance to protocol|2|||
163088887|NCT01242514|589035961|FG002|Overall Study|Severe non-compliance to protocol|1|||
163088888|NCT01242514|589035959|FG000|Overall Study|Lack of therapeutic response|99|||
163088889|NCT01242514|589035960|FG001|Overall Study|Lack of therapeutic response|16|||
163088890|NCT01242514|589035961|FG002|Overall Study|Lack of therapeutic response|10|||
163088891|NCT01242514|589035959|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
163088892|NCT01242514|589035960|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
163088893|NCT01242514|589035961|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
163088894|NCT01242514|589035959|FG000|Overall Study|Lost to Follow-up|14|||
163088895|NCT01242514|589035960|FG001|Overall Study|Lost to Follow-up|5|||
163088896|NCT01242514|589035961|FG002|Overall Study|Lost to Follow-up|4|||
163088897|NCT01242514|589035959|FG000|Overall Study|Adverse Event|129|||
163088898|NCT01242514|589035960|FG001|Overall Study|Adverse Event|18|||
163088899|NCT01242514|589035961|FG002|Overall Study|Adverse Event|19|||
163088900|NCT05901636|589035965|FG000|Overall Study|Lost to Follow-up|0|||
163088901|NCT05901636|589035966|FG001|Overall Study|Lost to Follow-up|1|||
163088902|NCT05901636|589035967|FG002|Overall Study|Lost to Follow-up|0|||
163088903|NCT05901636|589035968|FG003|Overall Study|Lost to Follow-up|1|||
163088904|NCT05901636|589035969|FG004|Overall Study|Lost to Follow-up|1|||
163088905|NCT05901636|589035970|FG005|Overall Study|Lost to Follow-up|3|||
163088906|NCT05901636|589035971|FG006|Overall Study|Lost to Follow-up|1|||
163088907|NCT05901636|589035965|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
163088908|NCT05901636|589035966|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
163088909|NCT05901636|589035967|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
163088910|NCT05901636|589035968|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
163088911|NCT05901636|589035969|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
163088912|NCT05901636|589035970|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
163088913|NCT05901636|589035971|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
163088914|NCT05901636|589035965|FG000|Overall Study|Withdrawal by Subject|1|||
163088915|NCT05901636|589035966|FG001|Overall Study|Withdrawal by Subject|1|||
163088916|NCT05901636|589035967|FG002|Overall Study|Withdrawal by Subject|0|||
163088917|NCT05901636|589035968|FG003|Overall Study|Withdrawal by Subject|0|||
163088918|NCT05901636|589035969|FG004|Overall Study|Withdrawal by Subject|1|||
163088919|NCT05901636|589035970|FG005|Overall Study|Withdrawal by Subject|1|||
163088920|NCT05901636|589035971|FG006|Overall Study|Withdrawal by Subject|0|||
163088921|NCT05901636|589035965|FG000|Overall Study|Other|0|||
163088922|NCT05901636|589035966|FG001|Overall Study|Other|0|||
163088923|NCT05901636|589035967|FG002|Overall Study|Other|1|||
163088924|NCT05901636|589035968|FG003|Overall Study|Other|1|||
163088925|NCT05901636|589035969|FG004|Overall Study|Other|0|||
163088926|NCT05901636|589035970|FG005|Overall Study|Other|0|||
163088927|NCT05901636|589035971|FG006|Overall Study|Other|0|||
163088928|NCT03193801|589035972|FG000|Overall Study|Physician Decision|2|||
163088929|NCT03193801|589035972|FG000|Overall Study|Withdrawal by Subject|1|||
163088930|NCT05239221|589035977|FG000|Overall Study|Adverse Event|0|||
163088931|NCT05239221|589035978|FG001|Overall Study|Adverse Event|0|||
163088932|NCT05239221|589035979|FG002|Overall Study|Adverse Event|0|||
163088933|NCT05239221|589035980|FG003|Overall Study|Adverse Event|0|||
163088934|NCT05239221|589035981|FG004|Overall Study|Adverse Event|0|||
163088935|NCT05239221|589035982|FG005|Overall Study|Adverse Event|0|||
163088936|NCT05239221|589035983|FG006|Overall Study|Adverse Event|1|||
163088937|NCT05239221|589035984|FG007|Overall Study|Adverse Event|0|||
163088938|NCT05239221|589035985|FG008|Overall Study|Adverse Event|0|||
163335634|NCT01263496|589938835|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
163088939|NCT05239221|589035986|FG009|Overall Study|Adverse Event|0|||
163088940|NCT05239221|589035987|FG010|Overall Study|Adverse Event|1|||
163088941|NCT05239221|589035988|FG011|Overall Study|Adverse Event|1|||
163088942|NCT05239221|589035989|FG012|Overall Study|Adverse Event|0|||
163088943|NCT05239221|589035990|FG013|Overall Study|Adverse Event|0|||
163335635|NCT01263496|589938836|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
163088944|NCT05239221|589035991|FG014|Overall Study|Adverse Event|0|||
163088945|NCT05239221|589035992|FG015|Overall Study|Adverse Event|0|||
163088946|NCT05239221|589035977|FG000|Overall Study|Withdrawal by Subject|0|||
163088947|NCT05239221|589035978|FG001|Overall Study|Withdrawal by Subject|0|||
163088948|NCT05239221|589035979|FG002|Overall Study|Withdrawal by Subject|0|||
163088949|NCT05239221|589035980|FG003|Overall Study|Withdrawal by Subject|0|||
163088950|NCT05239221|589035981|FG004|Overall Study|Withdrawal by Subject|0|||
163088951|NCT05239221|589035982|FG005|Overall Study|Withdrawal by Subject|0|||
163088952|NCT05239221|589035983|FG006|Overall Study|Withdrawal by Subject|0|||
163088953|NCT05239221|589035984|FG007|Overall Study|Withdrawal by Subject|0|||
163088954|NCT05239221|589035985|FG008|Overall Study|Withdrawal by Subject|0|||
163088955|NCT05239221|589035986|FG009|Overall Study|Withdrawal by Subject|0|||
163088956|NCT05239221|589035987|FG010|Overall Study|Withdrawal by Subject|1|||
163088957|NCT05239221|589035988|FG011|Overall Study|Withdrawal by Subject|0|||
163088958|NCT05239221|589035989|FG012|Overall Study|Withdrawal by Subject|0|||
163088959|NCT05239221|589035990|FG013|Overall Study|Withdrawal by Subject|0|||
163088960|NCT05239221|589035991|FG014|Overall Study|Withdrawal by Subject|0|||
163088961|NCT05239221|589035992|FG015|Overall Study|Withdrawal by Subject|1|||
163088962|NCT02114177|589037525|FG000|Overall Study|Lost to Follow-up|1|||
163088963|NCT02114177|589037526|FG001|Overall Study|Lost to Follow-up|2|||
163088964|NCT02114177|589037525|FG000|Overall Study|Withdrawal by Subject|6|||
163088965|NCT02114177|589037526|FG001|Overall Study|Withdrawal by Subject|1|||
163088966|NCT02114177|589037525|FG000|Overall Study|Other|2|||
163088967|NCT02114177|589037526|FG001|Overall Study|Other|1|||
163088968|NCT01897493|589037528|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
163088969|NCT05111145|589037531|FG000|Overall Study|Commercial drug is available for participant|76|||
163088970|NCT05111145|589037531|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
163088971|NCT02336815|589037532|FG000|Overall Study|Disease Progression|45|||
163088972|NCT02336815|589037533|FG001|Overall Study|Disease Progression|70|||
163088973|NCT02336815|589037532|FG000|Overall Study|Adverse Event|18|||
163088974|NCT02336815|589037533|FG001|Overall Study|Adverse Event|39|||
163088975|NCT02336815|589037532|FG000|Overall Study|Physician Decision|11|||
163335636|NCT01263496|589938837|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163335637|NCT01263496|589938838|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163335638|NCT01263496|589938839|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
163335639|NCT01263496|589938840|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163335640|NCT01263496|589938832|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
163335641|NCT01263496|589938833|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
163335642|NCT01263496|589938834|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
163335643|NCT01263496|589938835|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
163335644|NCT01263496|589938836|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
163335645|NCT01263496|589938837|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
163335646|NCT01263496|589938838|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
163335647|NCT01263496|589938839|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
163335648|NCT01263496|589938840|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
163335649|NCT01263496|589938832|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163335650|NCT01263496|589938833|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163335651|NCT01263496|589938834|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163335652|NCT01263496|589938835|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163335653|NCT01263496|589938836|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163335654|NCT01263496|589938837|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163335655|NCT01263496|589938838|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163335656|NCT01263496|589938839|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
163335657|NCT01263496|589938840|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163335658|NCT01218594|589938841|FG000|Overall Study|Death|1|||
163335659|NCT01218594|589938841|FG000|Overall Study|Withdrawal by Subject|3|||
163335660|NCT01218594|589938841|FG000|Overall Study|Adverse Event|2|||
163335661|NCT01218594|589938841|FG000|Overall Study|Physician Decision|6|||
163335662|NCT02203032|589938842|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
163335663|NCT02203032|589938843|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
163335664|NCT02203032|589938844|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
163335665|NCT02203032|589938845|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
163335666|NCT02203032|589938842|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
163335667|NCT02203032|589938843|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
163335668|NCT02203032|589938844|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
163335669|NCT02203032|589938845|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
163335670|NCT02203032|589938842|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
163335671|NCT02203032|589938843|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
163088976|NCT02336815|589037533|FG001|Overall Study|Physician Decision|4|||
163088977|NCT02336815|589037532|FG000|Overall Study|Withdrawal by Subject|3|||
163088978|NCT02336815|589037533|FG001|Overall Study|Withdrawal by Subject|2|||
163088979|NCT02336815|589037532|FG000|Overall Study|Lost to Follow-up|1|||
163088980|NCT02336815|589037533|FG001|Overall Study|Lost to Follow-up|3|||
163088981|NCT02336815|589037532|FG000|Overall Study|Other|1|||
163088982|NCT02336815|589037533|FG001|Overall Study|Other|5|||
163088983|NCT01359956|589037534|FG000|Overall Study|Death|58|||
163088984|NCT01359956|589037535|FG001|Overall Study|Death|60|||
163088985|NCT01359956|589037536|FG002|Overall Study|Death|66|||
163088986|NCT01359956|589037537|FG003|Overall Study|Death|57|||
163088987|NCT01359956|589037534|FG000|Overall Study|Lost to Follow-up|3|||
163088988|NCT01359956|589037535|FG001|Overall Study|Lost to Follow-up|4|||
163088989|NCT01359956|589037536|FG002|Overall Study|Lost to Follow-up|1|||
163088990|NCT01359956|589037537|FG003|Overall Study|Lost to Follow-up|1|||
163088991|NCT01784029|589037538|FG000|Overall Study|Lost to Follow-up|19|||
163088992|NCT01784029|589037539|FG001|Overall Study|Lost to Follow-up|20|||
163088993|NCT01784029|589037540|FG002|Overall Study|Lost to Follow-up|22|||
163088994|NCT03235050|589037543|FG000|Overall Study|Adverse Event|0|||
163088995|NCT03235050|589037544|FG001|Overall Study|Adverse Event|0|||
163088996|NCT03235050|589037545|FG002|Overall Study|Adverse Event|1|||
163088997|NCT03235050|589037546|FG003|Overall Study|Adverse Event|4|||
163088998|NCT03235050|589037547|FG004|Overall Study|Adverse Event|1|||
163088999|NCT03235050|589037543|FG000|Overall Study|Death|0|||
163089000|NCT03235050|589037544|FG001|Overall Study|Death|0|||
163089001|NCT03235050|589037545|FG002|Overall Study|Death|0|||
163089002|NCT03235050|589037546|FG003|Overall Study|Death|2|||
163089003|NCT03235050|589037547|FG004|Overall Study|Death|1|||
163089004|NCT03235050|589037543|FG000|Overall Study|Lost to Follow-up|1|||
163089005|NCT03235050|589037544|FG001|Overall Study|Lost to Follow-up|2|||
163089006|NCT03235050|589037545|FG002|Overall Study|Lost to Follow-up|1|||
163089007|NCT03235050|589037546|FG003|Overall Study|Lost to Follow-up|2|||
163089008|NCT03235050|589037547|FG004|Overall Study|Lost to Follow-up|0|||
163089009|NCT03235050|589037543|FG000|Overall Study|Withdrawal by Subject|3|||
163089010|NCT03235050|589037544|FG001|Overall Study|Withdrawal by Subject|2|||
163089011|NCT03235050|589037545|FG002|Overall Study|Withdrawal by Subject|2|||
163089012|NCT03235050|589037546|FG003|Overall Study|Withdrawal by Subject|5|||
163089013|NCT03235050|589037547|FG004|Overall Study|Withdrawal by Subject|7|||
163089014|NCT03235050|589037543|FG000|Overall Study|Other reasons|0|||
163089015|NCT03235050|589037544|FG001|Overall Study|Other reasons|1|||
163089016|NCT03235050|589037545|FG002|Overall Study|Other reasons|0|||
163089017|NCT03235050|589037546|FG003|Overall Study|Other reasons|1|||
163089018|NCT03235050|589037547|FG004|Overall Study|Other reasons|2|||
163089019|NCT00370292|589037548|FG000|Overall Study|Disease Progression|4|||
163089020|NCT00370292|589037548|FG000|Overall Study|Adverse Event|7|||
163089021|NCT00370292|589037548|FG000|Overall Study|Physician Decision|2|||
163089022|NCT03545672|589037549|FG000|Overall Study|Uncertain diagnosis|2|||
163089023|NCT03545672|589037550|FG001|Overall Study|Uncertain diagnosis|1|||
163089024|NCT03545672|589037549|FG000|Overall Study|Protocol Violation|2|||
163089025|NCT03545672|589037550|FG001|Overall Study|Protocol Violation|2|||
163089026|NCT02415556|589037551|FG000|Overall Study|Adverse Event|3|||
163089027|NCT02415556|589037552|FG001|Overall Study|Adverse Event|4|||
163089028|NCT02415556|589037553|FG002|Overall Study|Adverse Event|2|||
163089029|NCT02415556|589037554|FG003|Overall Study|Adverse Event|4|||
163089030|NCT02415556|589037551|FG000|Overall Study|Lost to Follow-up|4|||
163089031|NCT02415556|589037552|FG001|Overall Study|Lost to Follow-up|5|||
163089032|NCT02415556|589037553|FG002|Overall Study|Lost to Follow-up|4|||
163089033|NCT02415556|589037554|FG003|Overall Study|Lost to Follow-up|1|||
163089034|NCT02415556|589037551|FG000|Overall Study|Withdrawal by Subject|13|||
163089035|NCT02415556|589037552|FG001|Overall Study|Withdrawal by Subject|4|||
163089036|NCT02415556|589037553|FG002|Overall Study|Withdrawal by Subject|14|||
163089037|NCT02415556|589037554|FG003|Overall Study|Withdrawal by Subject|12|||
163089038|NCT02415556|589037551|FG000|Overall Study|Physician Decision|1|||
163089039|NCT02415556|589037552|FG001|Overall Study|Physician Decision|3|||
163089040|NCT02415556|589037553|FG002|Overall Study|Physician Decision|1|||
163089041|NCT02415556|589037554|FG003|Overall Study|Physician Decision|2|||
163089042|NCT02415556|589037551|FG000|Overall Study|Censored - study completion|4|||
163089043|NCT02415556|589037552|FG001|Overall Study|Censored - study completion|5|||
163089044|NCT02415556|589037553|FG002|Overall Study|Censored - study completion|1|||
163335672|NCT02203032|589938844|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
163335673|NCT02203032|589938845|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
163089045|NCT02415556|589037554|FG003|Overall Study|Censored - study completion|0|||
163089046|NCT02415556|589037551|FG000|Overall Study|Family-related issues|0|||
163089047|NCT02415556|589037552|FG001|Overall Study|Family-related issues|0|||
163089048|NCT02415556|589037553|FG002|Overall Study|Family-related issues|0|||
163335674|NCT02203032|589938842|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
163089049|NCT02415556|589037554|FG003|Overall Study|Family-related issues|1|||
163089050|NCT01209767|589037555|FG000|Overall Study|Withdrawal by Subject|1|||
163089051|NCT01209767|589037555|FG000|Overall Study|Lost to Follow-up|3|||
163089052|NCT00105534|589037556|FG000|Overall Study|Adverse Event|2|||
163089053|NCT00105534|589037557|FG001|Overall Study|Adverse Event|5|||
163089054|NCT00105534|589037556|FG000|Overall Study|Protocol Violation|1|||
163089055|NCT00105534|589037557|FG001|Overall Study|Protocol Violation|4|||
163089056|NCT00105534|589037556|FG000|Overall Study|Withdrawal by Subject|6|||
163089057|NCT00105534|589037557|FG001|Overall Study|Withdrawal by Subject|6|||
163335675|NCT02203032|589938843|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
163335676|NCT02203032|589938844|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
163335677|NCT02203032|589938845|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
163335678|NCT02203032|589938842|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
163335679|NCT02203032|589938843|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
163335680|NCT02203032|589938844|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
163335681|NCT02203032|589938845|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
163335682|NCT02203032|589938842|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
163335683|NCT02203032|589938843|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
163335684|NCT02203032|589938844|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
163335685|NCT02203032|589938845|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
163335686|NCT02203032|589938842|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
163335687|NCT02203032|589938843|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
163335688|NCT02203032|589938844|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
163335689|NCT02203032|589938845|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
163335690|NCT02203032|589938842|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
163335691|NCT02203032|589938843|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
163335692|NCT02203032|589938844|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
163335693|NCT02203032|589938845|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
163335694|NCT02203032|589938842|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
163335695|NCT02203032|589938843|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
163335696|NCT02203032|589938844|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
163335697|NCT02203032|589938845|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
163335698|NCT02203032|589938842|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
163335699|NCT02203032|589938843|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
163335700|NCT02203032|589938844|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
163335701|NCT02203032|589938845|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
163335702|NCT02203032|589938842|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
163089058|NCT00105534|589037556|FG000|Overall Study|Lost to Follow-up|5|||
163089059|NCT00105534|589037557|FG001|Overall Study|Lost to Follow-up|1|||
163089060|NCT00105534|589037556|FG000|Overall Study|Lack of Efficacy|7|||
163089061|NCT00105534|589037557|FG001|Overall Study|Lack of Efficacy|15|||
163089062|NCT00105534|589037556|FG000|Overall Study|Treatment unmasked|1|||
163089063|NCT00105534|589037557|FG001|Overall Study|Treatment unmasked|0|||
163089064|NCT00105534|589037556|FG000|Overall Study|Other Reason|0|||
163089065|NCT00105534|589037557|FG001|Overall Study|Other Reason|2|||
163089066|NCT01621178|589037558|FG000|Overall Study|Adverse Event|5|||
163089067|NCT01621178|589037559|FG001|Overall Study|Adverse Event|2|||
163089068|NCT01621178|589037560|FG002|Overall Study|Adverse Event|8|||
163089069|NCT01621178|589037558|FG000|Overall Study|Death|6|||
163089070|NCT01621178|589037559|FG001|Overall Study|Death|7|||
163089071|NCT01621178|589037560|FG002|Overall Study|Death|2|||
163089072|NCT01621178|589037558|FG000|Overall Study|Lost to Follow-up|1|||
163089073|NCT01621178|589037559|FG001|Overall Study|Lost to Follow-up|2|||
163089074|NCT01621178|589037560|FG002|Overall Study|Lost to Follow-up|1|||
163089075|NCT01621178|589037558|FG000|Overall Study|Withdrawal by Subject|14|||
163089076|NCT01621178|589037559|FG001|Overall Study|Withdrawal by Subject|17|||
163089077|NCT01621178|589037560|FG002|Overall Study|Withdrawal by Subject|18|||
163089078|NCT01621178|589037558|FG000|Overall Study|Physician Decision|5|||
163089079|NCT01621178|589037559|FG001|Overall Study|Physician Decision|2|||
163089080|NCT01621178|589037560|FG002|Overall Study|Physician Decision|7|||
163089081|NCT02465931|589037561|FG000|Overall Study|Lost to Follow-up|9|||
163089082|NCT02465931|589037562|FG001|Overall Study|Lost to Follow-up|11|||
163089083|NCT02465931|589037561|FG000|Overall Study|Protocol Violation|1|||
163089084|NCT02465931|589037562|FG001|Overall Study|Protocol Violation|0|||
163089085|NCT02465931|589037561|FG000|Overall Study|Withdrawal by Subject|1|||
163089086|NCT02465931|589037562|FG001|Overall Study|Withdrawal by Subject|0|||
163089087|NCT03423121|589037564|FG000|Overall Study|Lost to Follow-up|2|||
163089088|NCT03423121|589037565|FG001|Overall Study|Lost to Follow-up|6|||
163089089|NCT03423121|589037564|FG000|Overall Study|Adverse Event|1|||
163089090|NCT03423121|589037565|FG001|Overall Study|Adverse Event|0|||
163089091|NCT04102007|589037570|FG000|Overall Study|Adverse Event|4|||
163335703|NCT02203032|589938843|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
163089092|NCT04102007|589037570|FG000|Overall Study|Lost to Follow-up|3|||
163089093|NCT04102007|589037570|FG000|Overall Study|Withdrawal by Subject|12|||
163089094|NCT04102007|589037570|FG000|Overall Study|Eligibility Violation|5|||
163089095|NCT04102007|589037570|FG000|Overall Study|Lack of Efficacy|6|||
163089096|NCT04102007|589037570|FG000|Overall Study|Protocol Deviation|5|||
163089097|NCT04102007|589037570|FG000|Overall Study|Protocol Compliance|1|||
163089098|NCT04102007|589037570|FG000|Overall Study|Withdrew Treatment|2|||
163089099|NCT04102007|589037570|FG000|Overall Study|Pregnancy|1|||
163089100|NCT03289143|589037571|FG000|Overall Study|Caregiver Unavailability|1|||
163089101|NCT03289143|589037572|FG001|Overall Study|Caregiver Unavailability|1|||
163089102|NCT03289143|589037573|FG002|Overall Study|Caregiver Unavailability|0|||
163089103|NCT03289143|589037574|FG003|Overall Study|Caregiver Unavailability|0|||
163089104|NCT03289143|589037571|FG000|Overall Study|Research Department Closure|0|||
163089105|NCT03289143|589037572|FG001|Overall Study|Research Department Closure|0|||
163089106|NCT03289143|589037573|FG002|Overall Study|Research Department Closure|1|||
163089107|NCT03289143|589037574|FG003|Overall Study|Research Department Closure|0|||
163089108|NCT03289143|589037571|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
163089109|NCT03289143|589037572|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
163089110|NCT03289143|589037573|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
163089111|NCT03289143|589037574|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
163089112|NCT03289143|589037571|FG000|Overall Study|Medical Monitor Decision|1|||
163089113|NCT03289143|589037572|FG001|Overall Study|Medical Monitor Decision|0|||
163089114|NCT03289143|589037573|FG002|Overall Study|Medical Monitor Decision|0|||
163089115|NCT03289143|589037574|FG003|Overall Study|Medical Monitor Decision|0|||
163089116|NCT03289143|589037571|FG000|Overall Study|Participant Non-Compliance|0|||
163089117|NCT03289143|589037572|FG001|Overall Study|Participant Non-Compliance|0|||
163089118|NCT03289143|589037573|FG002|Overall Study|Participant Non-Compliance|1|||
163089119|NCT03289143|589037574|FG003|Overall Study|Participant Non-Compliance|0|||
163089120|NCT03289143|589037571|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
163089121|NCT03289143|589037572|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
163089122|NCT03289143|589037573|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
163089123|NCT03289143|589037574|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
163089124|NCT03289143|589037571|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
163089125|NCT03289143|589037572|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
163089126|NCT03289143|589037573|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
163089127|NCT03289143|589037574|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
163089128|NCT03289143|589037571|FG000|Overall Study|Caregiver Passed Away|1|||
163089129|NCT03289143|589037572|FG001|Overall Study|Caregiver Passed Away|0|||
163089130|NCT03289143|589037573|FG002|Overall Study|Caregiver Passed Away|0|||
163089131|NCT03289143|589037574|FG003|Overall Study|Caregiver Passed Away|0|||
163089132|NCT03289143|589037571|FG000|Overall Study|Physician Decision|0|||
163089133|NCT03289143|589037572|FG001|Overall Study|Physician Decision|2|||
163089134|NCT03289143|589037573|FG002|Overall Study|Physician Decision|2|||
163089135|NCT03289143|589037574|FG003|Overall Study|Physician Decision|2|||
163089136|NCT03289143|589037571|FG000|Overall Study|Protocol Deviation|2|||
163089137|NCT03289143|589037572|FG001|Overall Study|Protocol Deviation|1|||
163089138|NCT03289143|589037573|FG002|Overall Study|Protocol Deviation|3|||
163089139|NCT03289143|589037574|FG003|Overall Study|Protocol Deviation|1|||
163089140|NCT03289143|589037571|FG000|Overall Study|Study Terminated By Sponsor|101|||
163089141|NCT03289143|589037572|FG001|Overall Study|Study Terminated By Sponsor|75|||
163089142|NCT03289143|589037573|FG002|Overall Study|Study Terminated By Sponsor|100|||
163089143|NCT03289143|589037574|FG003|Overall Study|Study Terminated By Sponsor|69|||
163089144|NCT03289143|589037571|FG000|Overall Study|Withdrawal by Subject|14|||
163089145|NCT03289143|589037572|FG001|Overall Study|Withdrawal by Subject|6|||
163089146|NCT03289143|589037573|FG002|Overall Study|Withdrawal by Subject|14|||
163089147|NCT03289143|589037574|FG003|Overall Study|Withdrawal by Subject|12|||
163089148|NCT03289143|589037571|FG000|Overall Study|Adverse Event|10|||
163089149|NCT03289143|589037572|FG001|Overall Study|Adverse Event|7|||
163089150|NCT03289143|589037573|FG002|Overall Study|Adverse Event|6|||
163089151|NCT03289143|589037574|FG003|Overall Study|Adverse Event|5|||
163089152|NCT03289143|589037571|FG000|Overall Study|Death|2|||
163089153|NCT03289143|589037572|FG001|Overall Study|Death|0|||
163089154|NCT03289143|589037573|FG002|Overall Study|Death|2|||
163089155|NCT03289143|589037574|FG003|Overall Study|Death|1|||
163089156|NCT03289143|589037571|FG000|Overall Study|Lost to Follow-up|2|||
163089157|NCT03289143|589037572|FG001|Overall Study|Lost to Follow-up|1|||
163089158|NCT03289143|589037573|FG002|Overall Study|Lost to Follow-up|1|||
163089159|NCT03289143|589037574|FG003|Overall Study|Lost to Follow-up|0|||
163089160|NCT03289143|589037571|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
163220060|NCT03190889|589521397|FG000|Overall Study|Withdrawal by Subject|1|||
163220061|NCT03190889|589521398|FG001|Overall Study|Withdrawal by Subject|1|||
163089161|NCT03289143|589037572|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
163089162|NCT03289143|589037573|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
163089163|NCT03289143|589037574|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
163089164|NCT03289143|589037571|FG000|Overall Study|Withdrawal by Caregiver|0|||
163089165|NCT03289143|589037572|FG001|Overall Study|Withdrawal by Caregiver|1|||
163089166|NCT03289143|589037573|FG002|Overall Study|Withdrawal by Caregiver|0|||
163089167|NCT03289143|589037574|FG003|Overall Study|Withdrawal by Caregiver|0|||
163089168|NCT03289143|589037571|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
163089169|NCT03289143|589037572|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
163089170|NCT03289143|589037573|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
163089171|NCT03289143|589037574|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
163220062|NCT03190889|589521399|FG002|Overall Study|Withdrawal by Subject|2|||
163089172|NCT03289143|589037571|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
163089173|NCT03289143|589037572|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
163089174|NCT03289143|589037573|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
163089175|NCT03289143|589037574|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
163089176|NCT00948688|589037575|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
163089177|NCT00948688|589037576|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
163089178|NCT00948688|589037575|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
163089179|NCT00948688|589037576|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
163089180|NCT00948688|589037575|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
163089181|NCT00948688|589037576|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
163089182|NCT00730756|589037577|FG000|Overall Study|Adverse Event|2|||
163089183|NCT00730756|589037578|FG001|Overall Study|Adverse Event|0|||
163089184|NCT00730756|589037577|FG000|Overall Study|Lack of Efficacy|1|||
163089185|NCT00730756|589037578|FG001|Overall Study|Lack of Efficacy|1|||
163089186|NCT00730756|589037577|FG000|Overall Study|Protocol Deviation|1|||
163089187|NCT00730756|589037578|FG001|Overall Study|Protocol Deviation|2|||
163089188|NCT00730756|589037577|FG000|Overall Study|Lost to Follow-up|0|||
163089189|NCT00730756|589037578|FG001|Overall Study|Lost to Follow-up|1|||
163089190|NCT00730756|589037577|FG000|Overall Study|Withdrew Consent|0|||
163089191|NCT00730756|589037578|FG001|Overall Study|Withdrew Consent|1|||
163089192|NCT04388826|589037579|FG000|Overall Study|Lost to Follow-up|3|||
163089193|NCT04388826|589037580|FG001|Overall Study|Lost to Follow-up|2|||
163089194|NCT04388826|589037579|FG000|Overall Study|Adverse Event|1|||
163089195|NCT04388826|589037580|FG001|Overall Study|Adverse Event|0|||
163089196|NCT01840943|589037581|FG000|Overall Study|Withdrawal by Subject|5|||
163089197|NCT01840943|589037582|FG001|Overall Study|Withdrawal by Subject|6|||
163089198|NCT01840943|589037581|FG000|Overall Study|Physician Decision|4|||
163089199|NCT01840943|589037582|FG001|Overall Study|Physician Decision|2|||
163089200|NCT01840943|589037581|FG000|Overall Study|Lost to Follow-up|4|||
163089201|NCT01840943|589037582|FG001|Overall Study|Lost to Follow-up|4|||
163089202|NCT02862574|589037583|FG000|Double-Blind Treatment Period|Adverse Event|0|||
163089203|NCT02862574|589037584|FG001|Double-Blind Treatment Period|Adverse Event|1|||
163089204|NCT02862574|589037585|FG002|Double-Blind Treatment Period|Adverse Event|0|||
163089205|NCT02862574|589037583|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
163089206|NCT02862574|589037584|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
163089207|NCT02862574|589037585|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
163335704|NCT02203032|589938844|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
163335705|NCT02203032|589938845|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
163335706|NCT02203032|589938842|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
163037584|NCT00255840|588844223|FG000|Overall Study|Discontinued intervention|53|||
163037585|NCT00255840|588844224|FG001|Overall Study|Discontinued intervention|56|||
163037586|NCT01005901|588844227|FG000|Overall Study|Withdrawal by Subject|38|||
163037587|NCT01005901|588844228|FG001|Overall Study|Withdrawal by Subject|14|||
163037588|NCT01005901|588844227|FG000|Overall Study|Adverse Event|30|||
163037589|NCT01005901|588844228|FG001|Overall Study|Adverse Event|16|||
163037590|NCT01005901|588844227|FG000|Overall Study|Administrative problems|21|||
163037591|NCT01005901|588844228|FG001|Overall Study|Administrative problems|13|||
163037592|NCT01005901|588844227|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
163037593|NCT01005901|588844228|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
163037594|NCT01005901|588844227|FG000|Overall Study|Protocol Violation|4|||
163037595|NCT01005901|588844228|FG001|Overall Study|Protocol Violation|3|||
163037596|NCT01005901|588844227|FG000|Overall Study|Death|2|||
163037597|NCT01005901|588844228|FG001|Overall Study|Death|3|||
163037598|NCT01005901|588844227|FG000|Overall Study|Lost to Follow-up|1|||
163037599|NCT01005901|588844228|FG001|Overall Study|Lost to Follow-up|2|||
163037600|NCT01005901|588844227|FG000|Overall Study|Patient's inability to use the device|1|||
163037601|NCT01005901|588844228|FG001|Overall Study|Patient's inability to use the device|1|||
163037602|NCT01005901|588844227|FG000|Overall Study|No longer requires study drug|0|||
163037603|NCT01005901|588844228|FG001|Overall Study|No longer requires study drug|1|||
163037604|NCT00715520|588844233|FG000|Overall Study|Screen failure|8|||
163037605|NCT00715520|588844234|FG001|Overall Study|Screen failure|1|||
163037606|NCT00715520|588844235|FG002|Overall Study|Screen failure|1|||
163037607|NCT00715520|588844233|FG000|Overall Study|Withdrawal by Subject|2|||
163037608|NCT00715520|588844234|FG001|Overall Study|Withdrawal by Subject|0|||
163037609|NCT00715520|588844235|FG002|Overall Study|Withdrawal by Subject|1|||
163037610|NCT01006590|588844236|FG000|Overall Study|Adverse Event|2|||
163089208|NCT02862574|589037583|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
163089209|NCT02862574|589037584|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
163089210|NCT02862574|589037585|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
163089211|NCT01446874|589037586|FG000|Overall Study|Not eligible|1|||
163089212|NCT01446874|589037587|FG001|Overall Study|Not eligible|0|||
163089213|NCT01446874|589037588|FG002|Overall Study|Not eligible|0|||
163089214|NCT01446874|589037586|FG000|Overall Study|No surgery/No qualifying surgery|1|||
163089215|NCT01446874|589037587|FG001|Overall Study|No surgery/No qualifying surgery|0|||
163089216|NCT01446874|589037588|FG002|Overall Study|No surgery/No qualifying surgery|12|||
163089217|NCT01446874|589037586|FG000|Overall Study|Non-compliance|0|||
163089218|NCT01446874|589037587|FG001|Overall Study|Non-compliance|4|||
163089219|NCT01446874|589037588|FG002|Overall Study|Non-compliance|0|||
163089220|NCT01446874|589037586|FG000|Overall Study|Antibiotics for pre-op infection|0|||
163089221|NCT01446874|589037587|FG001|Overall Study|Antibiotics for pre-op infection|0|||
163089222|NCT01446874|589037588|FG002|Overall Study|Antibiotics for pre-op infection|2|||
163089223|NCT01446874|589037586|FG000|Overall Study|Withdrawal by Subject|0|||
163089224|NCT01446874|589037587|FG001|Overall Study|Withdrawal by Subject|0|||
163089225|NCT01446874|589037588|FG002|Overall Study|Withdrawal by Subject|4|||
163089226|NCT03639610|589037592|FG000|Overall Study|Adverse Event|7|||
163037611|NCT01006590|588844237|FG001|Overall Study|Adverse Event|3|||
163037612|NCT01006590|588844236|FG000|Overall Study|Death|1|||
163037613|NCT01006590|588844237|FG001|Overall Study|Death|1|||
163037614|NCT01006590|588844236|FG000|Overall Study|Lost to Follow-up|1|||
163037615|NCT01006590|588844237|FG001|Overall Study|Lost to Follow-up|1|||
163037616|NCT01006590|588844236|FG000|Overall Study|Protocol Violation|1|||
163037617|NCT01006590|588844237|FG001|Overall Study|Protocol Violation|0|||
163037618|NCT01006590|588844236|FG000|Overall Study|Withdrawal by Subject|4|||
163037619|NCT01006590|588844237|FG001|Overall Study|Withdrawal by Subject|2|||
163037620|NCT01006590|588844236|FG000|Overall Study|Study specific discontinuation criteria|16|||
163037621|NCT01006590|588844237|FG001|Overall Study|Study specific discontinuation criteria|23|||
163037622|NCT01006590|588844236|FG000|Overall Study|Other|3|||
163037623|NCT01006590|588844237|FG001|Overall Study|Other|2|||
163037624|NCT03332095|588844238|FG000|Overall Study|Lost to Follow-up|1|||
163037625|NCT03332095|588844239|FG001|Overall Study|Lost to Follow-up|0|||
163037626|NCT03332095|588844238|FG000|Overall Study|Pregnancy|0|||
163037627|NCT03332095|588844239|FG001|Overall Study|Pregnancy|1|||
163037628|NCT04942210|588844243|FG000|Overall Study|Adverse Event|0|||
163037629|NCT04942210|588844244|FG001|Overall Study|Adverse Event|1|||
163037630|NCT04942210|588844243|FG000|Overall Study|Protocol Deviation|4|||
163037631|NCT04942210|588844244|FG001|Overall Study|Protocol Deviation|1|||
163037632|NCT04942210|588844243|FG000|Overall Study|Withdrawal by Subject|5|||
163037633|NCT04942210|588844244|FG001|Overall Study|Withdrawal by Subject|2|||
163037634|NCT04942210|588844243|FG000|Overall Study|Lost to Follow-up|16|||
163037635|NCT04942210|588844244|FG001|Overall Study|Lost to Follow-up|7|||
163037636|NCT04942210|588844243|FG000|Overall Study|Ongoing at the time of DBL date|60|||
163037637|NCT04942210|588844244|FG001|Overall Study|Ongoing at the time of DBL date|25|||
163037638|NCT04942210|588844243|FG000|Overall Study|Randomized but did not receive vaccination|3|||
163037639|NCT04942210|588844244|FG001|Overall Study|Randomized but did not receive vaccination|0|||
163037640|NCT02776670|588844245|FG000|Overall Study|Adverse Event|0|||
163037641|NCT02776670|588844246|FG001|Overall Study|Adverse Event|2|||
163037642|NCT02776670|588844245|FG000|Overall Study|Protocol Violation|0|||
163037643|NCT02776670|588844246|FG001|Overall Study|Protocol Violation|2|||
163037644|NCT02776670|588844245|FG000|Overall Study|Withdrawal by Subject|0|||
163037645|NCT02776670|588844246|FG001|Overall Study|Withdrawal by Subject|1|||
163037646|NCT02776670|588844245|FG000|Overall Study|Other - Reason not given|0|||
163037647|NCT02776670|588844246|FG001|Overall Study|Other - Reason not given|1|||
163037648|NCT00957424|588844251|FG000|Overall Study|Lost to Follow-up|19|||
163037649|NCT00957424|588844251|FG000|Overall Study|Protocol Violation|3|||
163037650|NCT00957424|588844251|FG000|Overall Study|Withdrawal by Subject|1|||
163037651|NCT03913104|588844260|FG000|Overall Study|Lost to Follow-up|20|||
163037652|NCT03913104|588844260|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
163037653|NCT03913104|588844260|FG000|Overall Study|Withdrawal by Subject|2|||
163037654|NCT01119846|588844261|FG000|Overall Study|Adverse Event|1|||
163037655|NCT01119846|588844262|FG001|Overall Study|Adverse Event|0|||
163037656|NCT01119846|588844263|FG002|Overall Study|Adverse Event|6|||
163037657|NCT01119846|588844261|FG000|Overall Study|Physician Decision|1|||
163037658|NCT01119846|588844262|FG001|Overall Study|Physician Decision|0|||
163037659|NCT01119846|588844263|FG002|Overall Study|Physician Decision|0|||
163037660|NCT01119846|588844261|FG000|Overall Study|Protocol Violation|0|||
163037661|NCT01119846|588844262|FG001|Overall Study|Protocol Violation|0|||
163037662|NCT01119846|588844263|FG002|Overall Study|Protocol Violation|1|||
163037663|NCT01119846|588844261|FG000|Overall Study|Withdrawal by Subject|0|||
163037664|NCT01119846|588844262|FG001|Overall Study|Withdrawal by Subject|0|||
163037665|NCT01119846|588844263|FG002|Overall Study|Withdrawal by Subject|4|||
163037666|NCT03420222|588844264|FG000|Overall Study|Withdrawal by Subject|5|||
163037667|NCT03420222|588844265|FG001|Overall Study|Withdrawal by Subject|0|||
163037668|NCT03420222|588844264|FG000|Overall Study|Physician Decision|0|||
163037669|NCT03420222|588844265|FG001|Overall Study|Physician Decision|1|||
163037670|NCT00187278|588844270|FG000|Overall Study|Protocol Violation|10|||
163037671|NCT00187278|588844271|FG001|Overall Study|Protocol Violation|13|||
163037672|NCT01380691|588844276|FG000|Washout (7 Days)|Protocol Violation|0|||
163037673|NCT01380691|588844277|FG001|Washout (7 Days)|Protocol Violation|0|||
163037674|NCT01380691|588844278|FG002|Washout (7 Days)|Protocol Violation|0|||
163089227|NCT03639610|589037593|FG001|Overall Study|Adverse Event|1|||
163089228|NCT03639610|589037594|FG002|Overall Study|Adverse Event|0|||
163089229|NCT03639610|589037592|FG000|Overall Study|Physician Decision|3|||
163335707|NCT02203032|589938843|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
163335708|NCT02203032|589938844|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
163335709|NCT02203032|589938845|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
163335710|NCT02241785|589938848|FG000|Overall Study|Sponsor Termination|43|||
163335711|NCT02241785|589938848|FG000|Overall Study|Withdrawal by Subject|1|||
163335712|NCT02241785|589938848|FG000|Overall Study|Lost to Follow-up|2|||
163335713|NCT02241785|589938848|FG000|Overall Study|Adverse Event|1|||
163335714|NCT05289037|589938851|FG000|Overall Study|Withdrawal by Subject|7|||
163335715|NCT05289037|589938852|FG001|Overall Study|Withdrawal by Subject|0|||
163335716|NCT05289037|589938853|FG002|Overall Study|Withdrawal by Subject|3|||
163335717|NCT05289037|589938854|FG003|Overall Study|Withdrawal by Subject|3|||
163335718|NCT05289037|589938855|FG004|Overall Study|Withdrawal by Subject|1|||
163335719|NCT05289037|589938856|FG005|Overall Study|Withdrawal by Subject|5|||
163335720|NCT05289037|589938857|FG006|Overall Study|Withdrawal by Subject|2|||
163335721|NCT05289037|589938858|FG007|Overall Study|Withdrawal by Subject|1|||
163335722|NCT05289037|589938859|FG008|Overall Study|Withdrawal by Subject|2|||
163335723|NCT05289037|589938860|FG009|Overall Study|Withdrawal by Subject|2|||
163335724|NCT05289037|589938861|FG010|Overall Study|Withdrawal by Subject|1|||
163335725|NCT05289037|589938862|FG011|Overall Study|Withdrawal by Subject|0|||
163335726|NCT05289037|589938863|FG012|Overall Study|Withdrawal by Subject|1|||
163335727|NCT05289037|589938864|FG013|Overall Study|Withdrawal by Subject|2|||
163335728|NCT05289037|589938865|FG014|Overall Study|Withdrawal by Subject|0|||
163335729|NCT05289037|589938866|FG015|Overall Study|Withdrawal by Subject|3|||
163335730|NCT05289037|589938867|FG016|Overall Study|Withdrawal by Subject|3|||
163335731|NCT05289037|589938851|FG000|Overall Study|Lost to Follow-up|1|||
163335732|NCT05289037|589938852|FG001|Overall Study|Lost to Follow-up|4|||
163335733|NCT05289037|589938853|FG002|Overall Study|Lost to Follow-up|3|||
163335734|NCT05289037|589938854|FG003|Overall Study|Lost to Follow-up|3|||
163335735|NCT05289037|589938855|FG004|Overall Study|Lost to Follow-up|3|||
163335736|NCT05289037|589938856|FG005|Overall Study|Lost to Follow-up|2|||
163335737|NCT05289037|589938857|FG006|Overall Study|Lost to Follow-up|3|||
163335738|NCT05289037|589938858|FG007|Overall Study|Lost to Follow-up|2|||
163335739|NCT05289037|589938859|FG008|Overall Study|Lost to Follow-up|2|||
163335740|NCT05289037|589938860|FG009|Overall Study|Lost to Follow-up|1|||
163335741|NCT05289037|589938861|FG010|Overall Study|Lost to Follow-up|3|||
163335742|NCT05289037|589938862|FG011|Overall Study|Lost to Follow-up|4|||
163335743|NCT05289037|589938863|FG012|Overall Study|Lost to Follow-up|2|||
163335744|NCT05289037|589938864|FG013|Overall Study|Lost to Follow-up|7|||
163335745|NCT05289037|589938865|FG014|Overall Study|Lost to Follow-up|4|||
163335746|NCT05289037|589938866|FG015|Overall Study|Lost to Follow-up|6|||
163335747|NCT05289037|589938867|FG016|Overall Study|Lost to Follow-up|4|||
163335748|NCT05289037|589938851|FG000|Overall Study|Death|0|||
163335749|NCT05289037|589938852|FG001|Overall Study|Death|0|||
163335750|NCT05289037|589938853|FG002|Overall Study|Death|0|||
163335751|NCT05289037|589938854|FG003|Overall Study|Death|0|||
163335752|NCT05289037|589938855|FG004|Overall Study|Death|0|||
163335753|NCT05289037|589938856|FG005|Overall Study|Death|1|||
163335754|NCT05289037|589938857|FG006|Overall Study|Death|0|||
163335755|NCT05289037|589938858|FG007|Overall Study|Death|0|||
163335756|NCT05289037|589938859|FG008|Overall Study|Death|0|||
163335757|NCT05289037|589938860|FG009|Overall Study|Death|0|||
163335758|NCT05289037|589938861|FG010|Overall Study|Death|0|||
163335759|NCT05289037|589938862|FG011|Overall Study|Death|0|||
163335760|NCT05289037|589938863|FG012|Overall Study|Death|0|||
163335761|NCT05289037|589938864|FG013|Overall Study|Death|0|||
163335762|NCT05289037|589938865|FG014|Overall Study|Death|1|||
163335763|NCT05289037|589938866|FG015|Overall Study|Death|0|||
163335764|NCT05289037|589938867|FG016|Overall Study|Death|0|||
163335765|NCT05289037|589938851|FG000|Overall Study|Did not receive vaccine|0|||
163335766|NCT05289037|589938852|FG001|Overall Study|Did not receive vaccine|3|||
163335767|NCT05289037|589938853|FG002|Overall Study|Did not receive vaccine|0|||
163335768|NCT05289037|589938854|FG003|Overall Study|Did not receive vaccine|0|||
163335769|NCT05289037|589938855|FG004|Overall Study|Did not receive vaccine|1|||
163335770|NCT05289037|589938856|FG005|Overall Study|Did not receive vaccine|1|||
163335771|NCT05289037|589938857|FG006|Overall Study|Did not receive vaccine|1|||
163335772|NCT05289037|589938858|FG007|Overall Study|Did not receive vaccine|0|||
163335773|NCT05289037|589938859|FG008|Overall Study|Did not receive vaccine|0|||
163335774|NCT05289037|589938860|FG009|Overall Study|Did not receive vaccine|0|||
163335775|NCT05289037|589938861|FG010|Overall Study|Did not receive vaccine|0|||
163335776|NCT05289037|589938862|FG011|Overall Study|Did not receive vaccine|0|||
163335777|NCT05289037|589938863|FG012|Overall Study|Did not receive vaccine|0|||
163407275|NCT02543528|590200768|FG001|Adaptation Period|Lens Handling Difficultes|0|||
163037675|NCT01380691|588844279|FG003|Washout (7 Days)|Protocol Violation|1|||
163335778|NCT05289037|589938864|FG013|Overall Study|Did not receive vaccine|0|||
163335779|NCT05289037|589938865|FG014|Overall Study|Did not receive vaccine|1|||
163335780|NCT05289037|589938866|FG015|Overall Study|Did not receive vaccine|0|||
163335781|NCT05289037|589938867|FG016|Overall Study|Did not receive vaccine|0|||
163335782|NCT05289037|589938851|FG000|Overall Study|Unable to make last visit|0|||
163037676|NCT01380691|588844276|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
163037677|NCT01380691|588844277|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
163037678|NCT01380691|588844278|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
163037679|NCT01380691|588844279|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
163037680|NCT03084315|588844284|FG000|Overall Study|Lost to Follow-up|8|||
163037681|NCT03084315|588844285|FG001|Overall Study|Lost to Follow-up|7|||
163037682|NCT03084315|588844284|FG000|Overall Study|Withdrawal by Subject|2|||
163037683|NCT03084315|588844285|FG001|Overall Study|Withdrawal by Subject|2|||
163037684|NCT04424914|588844286|FG000|Overall Study|Other|0|||
163037685|NCT04424914|588844287|FG001|Overall Study|Other|0|||
163037686|NCT04424914|588844288|FG002|Overall Study|Other|28|||
163037687|NCT04424914|588844286|FG000|Overall Study|Withdrawal by Subject|3|||
163037688|NCT04424914|588844287|FG001|Overall Study|Withdrawal by Subject|0|||
163037689|NCT04424914|588844288|FG002|Overall Study|Withdrawal by Subject|0|||
163037690|NCT04424914|588844286|FG000|Overall Study|Study terminated by sponsor|23|||
163037691|NCT04424914|588844287|FG001|Overall Study|Study terminated by sponsor|7|||
163037692|NCT04424914|588844288|FG002|Overall Study|Study terminated by sponsor|0|||
163037693|NCT04424914|588844286|FG000|Overall Study|Lost to Follow-up|0|||
163037694|NCT04424914|588844287|FG001|Overall Study|Lost to Follow-up|0|||
163037695|NCT04424914|588844288|FG002|Overall Study|Lost to Follow-up|1|||
163037696|NCT04424914|588844286|FG000|Overall Study|Death|3|||
163037697|NCT04424914|588844287|FG001|Overall Study|Death|1|||
163037698|NCT04424914|588844288|FG002|Overall Study|Death|0|||
163037699|NCT00460746|588844291|FG000|Overall Study|Adverse Event|1|||
163037700|NCT00460746|588844291|FG000|Overall Study|Lost to Follow-up|1|||
163037701|NCT02195427|588844294|FG000|Overall Study|Did not consent to study extension|13|||
163037702|NCT02195427|588844295|FG001|Overall Study|Did not consent to study extension|9|||
163037703|NCT02195427|588844294|FG000|Overall Study|Withdrawal by Subject|4|||
163037704|NCT02195427|588844295|FG001|Overall Study|Withdrawal by Subject|2|||
163037705|NCT02195427|588844294|FG000|Overall Study|Lost to Follow-up|0|||
163037706|NCT02195427|588844295|FG001|Overall Study|Lost to Follow-up|1|||
163037707|NCT02195427|588844294|FG000|Overall Study|Protocol Violation|7|||
163037708|NCT02195427|588844295|FG001|Overall Study|Protocol Violation|14|||
163037709|NCT02195427|588844294|FG000|Overall Study|Conditional re-treatment at W52|2|||
163037710|NCT02195427|588844295|FG001|Overall Study|Conditional re-treatment at W52|1|||
163037711|NCT03782974|588844298|FG000|Overall Study|Withdrawal by Subject|7|||
163037712|NCT03782974|588844299|FG001|Overall Study|Withdrawal by Subject|7|||
163037713|NCT03782974|588844298|FG000|Overall Study|Pregnancy|1|||
163089230|NCT03639610|589037593|FG001|Overall Study|Physician Decision|1|||
163089231|NCT03639610|589037594|FG002|Overall Study|Physician Decision|0|||
163335783|NCT05289037|589938852|FG001|Overall Study|Unable to make last visit|0|||
163335784|NCT05289037|589938853|FG002|Overall Study|Unable to make last visit|1|||
163335785|NCT05289037|589938854|FG003|Overall Study|Unable to make last visit|0|||
163335786|NCT05289037|589938855|FG004|Overall Study|Unable to make last visit|0|||
163335787|NCT05289037|589938856|FG005|Overall Study|Unable to make last visit|0|||
163335788|NCT05289037|589938857|FG006|Overall Study|Unable to make last visit|0|||
163335789|NCT05289037|589938858|FG007|Overall Study|Unable to make last visit|0|||
163335790|NCT05289037|589938859|FG008|Overall Study|Unable to make last visit|0|||
163335791|NCT05289037|589938860|FG009|Overall Study|Unable to make last visit|0|||
163335792|NCT05289037|589938861|FG010|Overall Study|Unable to make last visit|0|||
163335793|NCT05289037|589938862|FG011|Overall Study|Unable to make last visit|0|||
163335794|NCT05289037|589938863|FG012|Overall Study|Unable to make last visit|0|||
163335795|NCT05289037|589938864|FG013|Overall Study|Unable to make last visit|0|||
163335796|NCT05289037|589938865|FG014|Overall Study|Unable to make last visit|0|||
163335797|NCT05289037|589938866|FG015|Overall Study|Unable to make last visit|0|||
163335798|NCT05289037|589938867|FG016|Overall Study|Unable to make last visit|0|||
163335799|NCT05289037|589938851|FG000|Overall Study|Protocol deviation|0|||
163335800|NCT05289037|589938852|FG001|Overall Study|Protocol deviation|0|||
163335801|NCT05289037|589938853|FG002|Overall Study|Protocol deviation|0|||
163335802|NCT05289037|589938854|FG003|Overall Study|Protocol deviation|0|||
163335803|NCT05289037|589938855|FG004|Overall Study|Protocol deviation|0|||
163335804|NCT05289037|589938856|FG005|Overall Study|Protocol deviation|0|||
163335805|NCT05289037|589938857|FG006|Overall Study|Protocol deviation|0|||
163335806|NCT05289037|589938858|FG007|Overall Study|Protocol deviation|0|||
163335807|NCT05289037|589938859|FG008|Overall Study|Protocol deviation|0|||
163335808|NCT05289037|589938860|FG009|Overall Study|Protocol deviation|0|||
163335809|NCT05289037|589938861|FG010|Overall Study|Protocol deviation|0|||
163335810|NCT05289037|589938862|FG011|Overall Study|Protocol deviation|0|||
163335811|NCT05289037|589938863|FG012|Overall Study|Protocol deviation|0|||
163335812|NCT05289037|589938864|FG013|Overall Study|Protocol deviation|0|||
163335813|NCT05289037|589938865|FG014|Overall Study|Protocol deviation|0|||
163335814|NCT05289037|589938866|FG015|Overall Study|Protocol deviation|1|||
163335815|NCT05289037|589938867|FG016|Overall Study|Protocol deviation|0|||
163335816|NCT04186247|589938868|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
163335817|NCT04186247|589938869|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
163335818|NCT04186247|589938870|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
163335819|NCT04186247|589938871|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
163089232|NCT03639610|589037592|FG000|Overall Study|Disease progression|8|||
163089233|NCT03639610|589037593|FG001|Overall Study|Disease progression|5|||
163089234|NCT03639610|589037594|FG002|Overall Study|Disease progression|3|||
163089235|NCT03639610|589037592|FG000|Overall Study|Study terminated by sponsor|2|||
163089236|NCT03639610|589037593|FG001|Overall Study|Study terminated by sponsor|1|||
163089237|NCT03639610|589037594|FG002|Overall Study|Study terminated by sponsor|1|||
163335820|NCT04186247|589938872|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
163335821|NCT04852978|589938873|FG000|Overall Study|Physician Decision|0|||
163335822|NCT04852978|589938874|FG001|Overall Study|Physician Decision|1|||
163335823|NCT04852978|589938875|FG002|Overall Study|Physician Decision|0|||
163335824|NCT04852978|589938876|FG003|Overall Study|Physician Decision|0|||
163335825|NCT04852978|589938877|FG004|Overall Study|Physician Decision|0|||
163335826|NCT04852978|589938878|FG005|Overall Study|Physician Decision|0|||
163335827|NCT04852978|589938879|FG006|Overall Study|Physician Decision|0|||
163335828|NCT04852978|589938880|FG007|Overall Study|Physician Decision|2|||
163335829|NCT04852978|589938881|FG008|Overall Study|Physician Decision|0|||
163335830|NCT04852978|589938873|FG000|Overall Study|Sponsor request|0|||
163335831|NCT04852978|589938874|FG001|Overall Study|Sponsor request|0|||
163335832|NCT04852978|589938875|FG002|Overall Study|Sponsor request|1|||
163335833|NCT04852978|589938876|FG003|Overall Study|Sponsor request|0|||
163335834|NCT04852978|589938877|FG004|Overall Study|Sponsor request|0|||
163335835|NCT04852978|589938878|FG005|Overall Study|Sponsor request|0|||
163335836|NCT04852978|589938879|FG006|Overall Study|Sponsor request|0|||
163335837|NCT04852978|589938880|FG007|Overall Study|Sponsor request|0|||
163335838|NCT04852978|589938881|FG008|Overall Study|Sponsor request|0|||
163335839|NCT04852978|589938873|FG000|Overall Study|Death|0|||
163335840|NCT04852978|589938874|FG001|Overall Study|Death|0|||
163335841|NCT04852978|589938875|FG002|Overall Study|Death|0|||
163335842|NCT04852978|589938876|FG003|Overall Study|Death|0|||
163335843|NCT04852978|589938877|FG004|Overall Study|Death|0|||
163335844|NCT04852978|589938878|FG005|Overall Study|Death|0|||
163335845|NCT04852978|589938879|FG006|Overall Study|Death|1|||
163335846|NCT04852978|589938880|FG007|Overall Study|Death|0|||
163335847|NCT04852978|589938881|FG008|Overall Study|Death|0|||
163335848|NCT04852978|589938873|FG000|Overall Study|Lost to Follow-up|3|||
163335849|NCT04852978|589938874|FG001|Overall Study|Lost to Follow-up|2|||
163335850|NCT04852978|589938875|FG002|Overall Study|Lost to Follow-up|2|||
163335851|NCT04852978|589938876|FG003|Overall Study|Lost to Follow-up|0|||
163335852|NCT04852978|589938877|FG004|Overall Study|Lost to Follow-up|2|||
163335853|NCT04852978|589938878|FG005|Overall Study|Lost to Follow-up|4|||
163335854|NCT04852978|589938879|FG006|Overall Study|Lost to Follow-up|1|||
163335855|NCT04852978|589938880|FG007|Overall Study|Lost to Follow-up|2|||
163335856|NCT04852978|589938881|FG008|Overall Study|Lost to Follow-up|2|||
163335857|NCT04852978|589938873|FG000|Overall Study|Withdrawal by Subject|4|||
163335858|NCT04852978|589938874|FG001|Overall Study|Withdrawal by Subject|2|||
163335859|NCT04852978|589938875|FG002|Overall Study|Withdrawal by Subject|2|||
163335860|NCT04852978|589938876|FG003|Overall Study|Withdrawal by Subject|1|||
163335861|NCT04852978|589938877|FG004|Overall Study|Withdrawal by Subject|5|||
163335862|NCT04852978|589938878|FG005|Overall Study|Withdrawal by Subject|3|||
163335863|NCT04852978|589938879|FG006|Overall Study|Withdrawal by Subject|2|||
163335864|NCT04852978|589938880|FG007|Overall Study|Withdrawal by Subject|2|||
163335865|NCT04852978|589938881|FG008|Overall Study|Withdrawal by Subject|1|||
163335866|NCT02196259|589940339|FG000|Overall Study|Researcher choice|0|||
163335867|NCT02196259|589940340|FG001|Overall Study|Researcher choice|0|||
163335868|NCT02196259|589940341|FG002|Overall Study|Researcher choice|1|||
163335869|NCT02196259|589940339|FG000|Overall Study|Partial data analysis|0|||
163335870|NCT02196259|589940340|FG001|Overall Study|Partial data analysis|3|||
163335871|NCT02196259|589940341|FG002|Overall Study|Partial data analysis|0|||
163335872|NCT00264576|589940342|FG000|Overall Study|Lost to Follow-up|1|||
163335873|NCT00264576|589940343|FG001|Overall Study|Lost to Follow-up|1|||
163335874|NCT01668355|589940345|FG000|Overall Study|Death|3|||
163335875|NCT01668355|589940346|FG001|Overall Study|Death|1|||
163335876|NCT01668355|589940345|FG000|Overall Study|Withdrawal by Subject|6|||
163335877|NCT01668355|589940346|FG001|Overall Study|Withdrawal by Subject|1|||
163335878|NCT02659059|589940347|FG000|Overall Study|Other reasons|6|||
163335879|NCT02659059|589940348|FG001|Overall Study|Other reasons|1|||
163335880|NCT02659059|589940347|FG000|Overall Study|Disease Progression|143|||
163335881|NCT02659059|589940348|FG001|Overall Study|Disease Progression|16|||
163335882|NCT02659059|589940347|FG000|Overall Study|Study Drug toxicity|56|||
163335883|NCT02659059|589940348|FG001|Overall Study|Study Drug toxicity|9|||
163335884|NCT02659059|589940347|FG000|Overall Study|Death|3|||
163335885|NCT02659059|589940348|FG001|Overall Study|Death|1|||
163335886|NCT02659059|589940347|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
163335887|NCT02659059|589940348|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
163335888|NCT02659059|589940347|FG000|Overall Study|Participant request to discontinue study treatment|5|||
163335889|NCT02659059|589940348|FG001|Overall Study|Participant request to discontinue study treatment|0|||
163089238|NCT03639610|589037592|FG000|Overall Study|Patient request to stop treatment|1|||
163089239|NCT03639610|589037593|FG001|Overall Study|Patient request to stop treatment|2|||
163335890|NCT02659059|589940347|FG000|Overall Study|Participant withdrew consent|6|||
163089240|NCT03639610|589037594|FG002|Overall Study|Patient request to stop treatment|0|||
163089241|NCT05067335|589037598|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
163089242|NCT05067335|589037599|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
163089243|NCT05067335|589037600|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
163335891|NCT02659059|589940348|FG001|Overall Study|Participant withdrew consent|1|||
163335892|NCT00535626|589940349|FG000|Overall Study|Death|15|||
163335893|NCT00535626|589940349|FG000|Overall Study|Lost to Follow-up|29|||
163335894|NCT00535626|589940349|FG000|Overall Study|Withdrawal by Subject|20|||
163335895|NCT00535626|589940349|FG000|Overall Study|Removal/revision of study component|8|||
163335896|NCT00535626|589940349|FG000|Overall Study|Subject terminated|31|||
163335897|NCT00535626|589940349|FG000|Overall Study|Unable to return|2|||
163335898|NCT04633200|589940350|FG000|Overall Study|Lost to Follow-up|3|||
163335899|NCT04633200|589940351|FG001|Overall Study|Lost to Follow-up|5|||
163335900|NCT04809623|589940352|FG000|Overall Study|Study Terminated by Sponsor|1|||
163335901|NCT04809623|589940353|FG001|Overall Study|Study Terminated by Sponsor|0|||
163335902|NCT01808534|589940354|FG000|Overall Study|Disease progression|3|||
163335903|NCT01808534|589940354|FG000|Overall Study|Physician Decision|1|||
163335904|NCT00638456|589940357|FG000|Overall Study|Withdrawal by Subject|6|||
163335905|NCT00638456|589940358|FG001|Overall Study|Withdrawal by Subject|2|||
163335906|NCT03236779|589940359|FG000|Overall Study|Lost to Follow-up|13|||
163335907|NCT03236779|589940360|FG001|Overall Study|Lost to Follow-up|21|||
163335908|NCT00929526|589940362|FG000|Overall Study|Withdrawal by Subject|1|||
163335909|NCT00929526|589940363|FG001|Overall Study|Withdrawal by Subject|11|||
163335910|NCT00929526|589940362|FG000|Overall Study|Lost to Follow-up|8|||
163335911|NCT00929526|589940363|FG001|Overall Study|Lost to Follow-up|12|||
163335912|NCT00929526|589940362|FG000|Overall Study|Other|8|||
163335913|NCT00929526|589940363|FG001|Overall Study|Other|6|||
163335914|NCT00578344|589940364|FG000|Overall Study|Insurance problems|1|||
163335915|NCT00578344|589940364|FG000|Overall Study|Graft failure|1|||
163335916|NCT02169414|589940365|FG000|Overall Study|Withdrawal by Subject|1|||
163335917|NCT02169414|589940366|FG001|Overall Study|Withdrawal by Subject|0|||
163335918|NCT02169414|589940367|FG002|Overall Study|Withdrawal by Subject|0|||
163335919|NCT02169414|589940368|FG003|Overall Study|Withdrawal by Subject|0|||
163335920|NCT02169414|589940365|FG000|Overall Study|Adverse Event|0|||
163335921|NCT02169414|589940366|FG001|Overall Study|Adverse Event|1|||
163335922|NCT02169414|589940367|FG002|Overall Study|Adverse Event|0|||
163335923|NCT02169414|589940368|FG003|Overall Study|Adverse Event|0|||
163335924|NCT03374254|589940371|FG000|Overall Study|Death|5|||
163335925|NCT03374254|589940372|FG001|Overall Study|Death|16|||
163335926|NCT03374254|589940373|FG002|Overall Study|Death|13|||
163335927|NCT03374254|589940374|FG003|Overall Study|Death|11|||
163335928|NCT03374254|589940375|FG004|Overall Study|Death|9|||
163335929|NCT03374254|589940376|FG005|Overall Study|Death|12|||
163335930|NCT03374254|589940377|FG006|Overall Study|Death|11|||
163335931|NCT03374254|589940378|FG007|Overall Study|Death|6|||
163335932|NCT03374254|589940379|FG008|Overall Study|Death|7|||
163335933|NCT03374254|589940371|FG000|Overall Study|Lost to Follow-up|0|||
163335934|NCT03374254|589940372|FG001|Overall Study|Lost to Follow-up|0|||
163335935|NCT03374254|589940373|FG002|Overall Study|Lost to Follow-up|0|||
163335936|NCT03374254|589940374|FG003|Overall Study|Lost to Follow-up|0|||
163335937|NCT03374254|589940375|FG004|Overall Study|Lost to Follow-up|0|||
163335938|NCT03374254|589940376|FG005|Overall Study|Lost to Follow-up|0|||
163335939|NCT03374254|589940377|FG006|Overall Study|Lost to Follow-up|2|||
163335940|NCT03374254|589940378|FG007|Overall Study|Lost to Follow-up|0|||
163335941|NCT03374254|589940379|FG008|Overall Study|Lost to Follow-up|0|||
163335942|NCT03374254|589940371|FG000|Overall Study|Sponsor Decision|1|||
163335943|NCT03374254|589940372|FG001|Overall Study|Sponsor Decision|0|||
163089244|NCT05067335|589037601|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
163089245|NCT05067335|589037598|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
163089246|NCT05067335|589037599|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
163335944|NCT03374254|589940373|FG002|Overall Study|Sponsor Decision|2|||
163335945|NCT03374254|589940374|FG003|Overall Study|Sponsor Decision|3|||
163335946|NCT03374254|589940375|FG004|Overall Study|Sponsor Decision|2|||
163335947|NCT03374254|589940376|FG005|Overall Study|Sponsor Decision|3|||
163335948|NCT03374254|589940377|FG006|Overall Study|Sponsor Decision|3|||
163335949|NCT03374254|589940378|FG007|Overall Study|Sponsor Decision|3|||
163335950|NCT03374254|589940379|FG008|Overall Study|Sponsor Decision|4|||
163335951|NCT03374254|589940371|FG000|Overall Study|Withdrawal by Subject|0|||
163335952|NCT03374254|589940372|FG001|Overall Study|Withdrawal by Subject|0|||
163335953|NCT03374254|589940373|FG002|Overall Study|Withdrawal by Subject|0|||
163335954|NCT03374254|589940374|FG003|Overall Study|Withdrawal by Subject|2|||
163335955|NCT03374254|589940375|FG004|Overall Study|Withdrawal by Subject|0|||
163335956|NCT03374254|589940376|FG005|Overall Study|Withdrawal by Subject|1|||
163335957|NCT03374254|589940377|FG006|Overall Study|Withdrawal by Subject|0|||
163335958|NCT03374254|589940378|FG007|Overall Study|Withdrawal by Subject|0|||
163335959|NCT03374254|589940379|FG008|Overall Study|Withdrawal by Subject|0|||
163335960|NCT02309515|589940381|FG000|Overall Study|Withdrawal by Subject|0|||
163335961|NCT02309515|589940382|FG001|Overall Study|Withdrawal by Subject|1|||
163089247|NCT05067335|589037600|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
163089248|NCT05067335|589037601|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
163089249|NCT05067335|589037598|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
163089250|NCT05067335|589037599|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
163089251|NCT05067335|589037600|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
163089252|NCT05067335|589037601|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
163089253|NCT05067335|589037598|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
163089254|NCT05067335|589037599|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
163089255|NCT05067335|589037600|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
163089256|NCT05067335|589037601|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
163089257|NCT05067335|589037598|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
163089258|NCT05067335|589037599|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
163089259|NCT05067335|589037600|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
163089260|NCT05067335|589037601|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
163089261|NCT05067335|589037598|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
163089262|NCT05067335|589037599|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
163089263|NCT05067335|589037600|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
163089264|NCT05067335|589037601|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
163089265|NCT05067335|589037598|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
163089266|NCT05067335|589037599|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
163089267|NCT05067335|589037600|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
163089268|NCT05067335|589037601|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
163089269|NCT05067335|589037598|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
163089270|NCT05067335|589037599|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
163089271|NCT05067335|589037600|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
163089272|NCT05067335|589037601|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
163089273|NCT05067335|589037598|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
163089274|NCT05067335|589037599|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
163089275|NCT05067335|589037600|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
163089276|NCT05067335|589037601|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
163089277|NCT05067335|589037598|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
163089278|NCT05067335|589037599|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
163089279|NCT05067335|589037600|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
163089280|NCT05067335|589037601|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
163089281|NCT03610048|589037602|FG000|Overall Study|Study terminated by sponsor|84|||
163089282|NCT03610048|589037602|FG000|Overall Study|Adverse Event|32|||
163089283|NCT03610048|589037602|FG000|Overall Study|Withdrawal by Subject|31|||
163089284|NCT03610048|589037602|FG000|Overall Study|Lost to Follow-up|8|||
163089285|NCT03610048|589037602|FG000|Overall Study|Other|4|||
163089286|NCT03610048|589037602|FG000|Overall Study|Physician Decision|1|||
163089287|NCT03610048|589037602|FG000|Overall Study|Pregnancy|1|||
163089288|NCT02136914|589037603|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
163089289|NCT02136914|589037604|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
163089290|NCT02136914|589037603|FG000|Overall Study|Withdrawal by Subject|3|||
163089291|NCT02136914|589037604|FG001|Overall Study|Withdrawal by Subject|10|||
163089292|NCT02136914|589037603|FG000|Overall Study|Subject Unwilling to Proceed|7|||
163089293|NCT02136914|589037604|FG001|Overall Study|Subject Unwilling to Proceed|2|||
163089294|NCT02136914|589037603|FG000|Overall Study|Lost to Follow-up|1|||
163089295|NCT02136914|589037604|FG001|Overall Study|Lost to Follow-up|1|||
163089296|NCT02136914|589037603|FG000|Overall Study|Did Not Receive Study Drug|2|||
163089297|NCT02136914|589037604|FG001|Overall Study|Did Not Receive Study Drug|0|||
163089298|NCT02136914|589037603|FG000|Overall Study|Lack of Efficacy|1|||
163037714|NCT03782974|588844299|FG001|Overall Study|Pregnancy|0|||
163037715|NCT04985942|588845586|FG000|Overall Study|Adverse Event|14|||
163037716|NCT04985942|588845587|FG001|Overall Study|Adverse Event|2|||
163037717|NCT04985942|588845586|FG000|Overall Study|Lack of Efficacy|0|||
163037718|NCT04985942|588845587|FG001|Overall Study|Lack of Efficacy|3|||
163037719|NCT04985942|588845586|FG000|Overall Study|Lost to Follow-up|1|||
163037720|NCT04985942|588845587|FG001|Overall Study|Lost to Follow-up|1|||
163037721|NCT04985942|588845586|FG000|Overall Study|Protocol Violation|1|||
163037722|NCT04985942|588845587|FG001|Overall Study|Protocol Violation|1|||
163037723|NCT04985942|588845586|FG000|Overall Study|Withdrawal by Subject|5|||
163037724|NCT04985942|588845587|FG001|Overall Study|Withdrawal by Subject|4|||
163037725|NCT00171158|588845588|FG000|Core Study|Death|27|||
163037726|NCT00171158|588845588|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
163037727|NCT00171158|588845588|FG000|Core Study|Protocol Violation|4|||
163335962|NCT02547974|589940385|FG000|Overall Study|Withdrawal by Subject|1|||
163335963|NCT02547974|589940386|FG001|Overall Study|Withdrawal by Subject|0|||
163335964|NCT02547974|589940387|FG002|Overall Study|Withdrawal by Subject|0|||
163335965|NCT02547974|589940388|FG003|Overall Study|Withdrawal by Subject|0|||
163335966|NCT02784834|589940390|FG000|Overall Study|Lack of Efficacy|1|||
163335967|NCT02245620|589940391|FG000|Overall Study|Physician Decision|1|||
163335968|NCT02245620|589940392|FG001|Overall Study|Physician Decision|1|||
163335969|NCT02988713|589940403|FG000|Overall Study|Withdrawal by Subject|1|||
163335970|NCT02988713|589940403|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
163335971|NCT00088166|589940404|FG000|Overall Study|Adverse Event|11|||
163335972|NCT00088166|589940405|FG001|Overall Study|Adverse Event|9|||
163335973|NCT00088166|589940404|FG000|Overall Study|Death|3|||
163335974|NCT00088166|589940405|FG001|Overall Study|Death|1|||
163335975|NCT00088166|589940404|FG000|Overall Study|Lost to Follow-up|0|||
163335976|NCT00088166|589940405|FG001|Overall Study|Lost to Follow-up|1|||
163335977|NCT00088166|589940404|FG000|Overall Study|Physician Decision|4|||
163335978|NCT00088166|589940405|FG001|Overall Study|Physician Decision|1|||
163335979|NCT00088166|589940404|FG000|Overall Study|Protocol Violation|1|||
163335980|NCT00088166|589940405|FG001|Overall Study|Protocol Violation|5|||
163335981|NCT00088166|589940404|FG000|Overall Study|Patient deterioration|29|||
163335982|NCT00088166|589940405|FG001|Overall Study|Patient deterioration|39|||
163335983|NCT00088166|589940404|FG000|Overall Study|Withdrawal by Subject|5|||
163037728|NCT00171158|588845588|FG000|Core Study|Administrative problems|1|||
163037729|NCT00171158|588845588|FG000|Core Study|Adverse event, non-fatal|21|||
163037730|NCT00171158|588845588|FG000|Core Study|Consent withdrawn by subject|6|||
163037731|NCT00171158|588845588|FG000|Core Study|No longer required drug (BMT)|14|||
163037732|NCT00171158|588845588|FG000|Core Study|Abnormal Laboratory Values|2|||
163037733|NCT00171158|588845588|FG000|Core Study|Lost to Follow-up|1|||
163037734|NCT00171158|588845588|FG000|E2 Extension|Other|7|||
163037735|NCT02757352|588845589|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
163037736|NCT02757352|588845590|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037737|NCT02757352|588845591|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
163037738|NCT02757352|588845592|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037739|NCT02757352|588845593|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037740|NCT02757352|588845594|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037741|NCT02757352|588845595|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037742|NCT02757352|588845596|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037743|NCT02757352|588845597|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037744|NCT02757352|588845598|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037745|NCT02757352|588845589|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037746|NCT02757352|588845590|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037747|NCT02757352|588845591|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
163037748|NCT02757352|588845592|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037749|NCT02757352|588845593|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037750|NCT02757352|588845594|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037751|NCT02757352|588845595|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037752|NCT02757352|588845596|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037753|NCT02757352|588845597|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037754|NCT02757352|588845598|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037755|NCT02757352|588845589|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
163037756|NCT02757352|588845590|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
163037757|NCT02757352|588845591|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
163037758|NCT02757352|588845592|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
163037759|NCT02757352|588845593|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
163037760|NCT02757352|588845594|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
163037761|NCT02757352|588845595|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
163037762|NCT02757352|588845596|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
163037763|NCT02757352|588845597|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
163037764|NCT02757352|588845598|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
163037765|NCT02757352|588845589|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037766|NCT02757352|588845590|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
163037767|NCT02757352|588845591|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037768|NCT02757352|588845592|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037769|NCT02757352|588845593|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037770|NCT02757352|588845594|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037771|NCT02757352|588845595|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037772|NCT02757352|588845596|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037773|NCT02757352|588845597|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163335984|NCT00088166|589940405|FG001|Overall Study|Withdrawal by Subject|5|||
163089299|NCT02136914|589037604|FG001|Overall Study|Lack of Efficacy|0|||
163089300|NCT02136914|589037603|FG000|Overall Study|Death|0|||
163089301|NCT02136914|589037604|FG001|Overall Study|Death|1|||
163089302|NCT05878067|589037605|FG000|Overall Study|Lost to Follow-up|2|||
163089303|NCT00329030|589037610|FG000|Overall Study|Withdrawal by Subject|1|||
163089304|NCT00329030|589037611|FG001|Overall Study|Withdrawal by Subject|3|||
163089305|NCT00329030|589037610|FG000|Overall Study|Progressive Disease|6|||
163089306|NCT00329030|589037611|FG001|Overall Study|Progressive Disease|2|||
163089307|NCT00329030|589037610|FG000|Overall Study|Ineligible Pathology|1|||
163089308|NCT00329030|589037611|FG001|Overall Study|Ineligible Pathology|1|||
163335985|NCT00666705|589940406|FG000|Overall Study|Withdrawal by Subject|1|||
163335986|NCT01976507|589940407|FG000|Overall Study|Adverse Event|6|||
163335987|NCT01976507|589940407|FG000|Overall Study|ablation not done, drug not given|1|||
163335988|NCT01029704|589940409|FG000|Overall Study|Adverse Event|0|||
163089309|NCT00560417|589037612|FG000|Overall Study|Adverse Event|3|||
163089310|NCT00560417|589037613|FG001|Overall Study|Adverse Event|2|||
163089311|NCT00560417|589037612|FG000|Overall Study|Entry Criteria Not Met|1|||
163089312|NCT00560417|589037613|FG001|Overall Study|Entry Criteria Not Met|0|||
163089313|NCT00560417|589037612|FG000|Overall Study|Lost to Follow-up|0|||
163089314|NCT00560417|589037613|FG001|Overall Study|Lost to Follow-up|1|||
163089315|NCT00560417|589037612|FG000|Overall Study|Physician Decision|2|||
163089316|NCT00560417|589037613|FG001|Overall Study|Physician Decision|6|||
163089317|NCT00560417|589037612|FG000|Overall Study|Protocol Violation|6|||
163089318|NCT00560417|589037613|FG001|Overall Study|Protocol Violation|5|||
163089319|NCT00560417|589037612|FG000|Overall Study|Sponsor Decision|2|||
163089320|NCT00560417|589037613|FG001|Overall Study|Sponsor Decision|0|||
163089321|NCT00560417|589037612|FG000|Overall Study|Withdrawal by Subject|3|||
163089322|NCT00560417|589037613|FG001|Overall Study|Withdrawal by Subject|3|||
163089323|NCT00419744|589037614|FG000|Overall Study|Adverse Event|39|||
163089324|NCT00419744|589037615|FG001|Overall Study|Adverse Event|40|||
163089325|NCT00419744|589037616|FG002|Overall Study|Adverse Event|50|||
163089326|NCT00419744|589037614|FG000|Overall Study|Withdrawal by Subject|45|||
163089327|NCT00419744|589037615|FG001|Overall Study|Withdrawal by Subject|49|||
163089328|NCT00419744|589037616|FG002|Overall Study|Withdrawal by Subject|52|||
163089329|NCT00419744|589037614|FG000|Overall Study|Lost to Follow-up|8|||
163089330|NCT00419744|589037615|FG001|Overall Study|Lost to Follow-up|10|||
163089331|NCT00419744|589037616|FG002|Overall Study|Lost to Follow-up|6|||
163089332|NCT00419744|589037614|FG000|Overall Study|Protocol Violation|4|||
163089333|NCT00419744|589037615|FG001|Overall Study|Protocol Violation|7|||
163089334|NCT00419744|589037616|FG002|Overall Study|Protocol Violation|8|||
163089335|NCT00419744|589037614|FG000|Overall Study|Randomized in error|9|||
163089336|NCT00419744|589037615|FG001|Overall Study|Randomized in error|6|||
163089337|NCT00419744|589037616|FG002|Overall Study|Randomized in error|7|||
163089338|NCT00419744|589037614|FG000|Overall Study|Moving out of state|2|||
163089339|NCT00419744|589037615|FG001|Overall Study|Moving out of state|0|||
163089340|NCT00419744|589037616|FG002|Overall Study|Moving out of state|1|||
163089341|NCT00419744|589037614|FG000|Overall Study|Physician Decision|10|||
163089342|NCT00419744|589037615|FG001|Overall Study|Physician Decision|5|||
163089343|NCT00419744|589037616|FG002|Overall Study|Physician Decision|6|||
163335989|NCT01029704|589940410|FG001|Overall Study|Adverse Event|0|||
163335990|NCT01029704|589940411|FG002|Overall Study|Adverse Event|0|||
163335991|NCT01029704|589940412|FG003|Overall Study|Adverse Event|0|||
163335992|NCT01029704|589940413|FG004|Overall Study|Adverse Event|0|||
163335993|NCT01029704|589940414|FG005|Overall Study|Adverse Event|0|||
163335994|NCT01029704|589940415|FG006|Overall Study|Adverse Event|1|||
163335995|NCT01029704|589940416|FG007|Overall Study|Adverse Event|1|||
163335996|NCT01029704|589940417|FG008|Overall Study|Adverse Event|0|||
163335997|NCT01029704|589940409|FG000|Overall Study|Withdrawal by Subject|0|||
163335998|NCT01029704|589940410|FG001|Overall Study|Withdrawal by Subject|0|||
163335999|NCT01029704|589940411|FG002|Overall Study|Withdrawal by Subject|0|||
163089344|NCT00419744|589037614|FG000|Overall Study|Spirometry mouthpiece issues|0|||
163089345|NCT00419744|589037615|FG001|Overall Study|Spirometry mouthpiece issues|1|||
163089346|NCT00419744|589037616|FG002|Overall Study|Spirometry mouthpiece issues|2|||
163089347|NCT00419744|589037614|FG000|Overall Study|Incorrect medication kit dispensed|0|||
163089348|NCT00419744|589037615|FG001|Overall Study|Incorrect medication kit dispensed|0|||
163089349|NCT00419744|589037616|FG002|Overall Study|Incorrect medication kit dispensed|1|||
163089350|NCT00583219|589037619|FG000|Phase 2|Withdrawal by Subject|1|||
163089351|NCT02037529|589037620|FG000|Overall Study|Withdrawal by Subject|1|||
163089352|NCT02037529|589037621|FG001|Overall Study|Withdrawal by Subject|3|||
163089353|NCT02037529|589037620|FG000|Overall Study|Adverse Event|0|||
163089354|NCT02037529|589037621|FG001|Overall Study|Adverse Event|1|||
163336000|NCT01029704|589940412|FG003|Overall Study|Withdrawal by Subject|0|||
163089355|NCT00718315|589037623|FG000|Overall Study|Adverse Event|1|||
163089356|NCT00718315|589037624|FG001|Overall Study|Adverse Event|2|||
163336001|NCT01029704|589940413|FG004|Overall Study|Withdrawal by Subject|2|||
163336002|NCT01029704|589940414|FG005|Overall Study|Withdrawal by Subject|1|||
163089357|NCT00718315|589037625|FG002|Overall Study|Adverse Event|3|||
163089358|NCT00718315|589037623|FG000|Overall Study|Death|6|||
163336003|NCT01029704|589940415|FG006|Overall Study|Withdrawal by Subject|1|||
163089359|NCT00718315|589037624|FG001|Overall Study|Death|6|||
163089360|NCT00718315|589037625|FG002|Overall Study|Death|5|||
163089361|NCT00718315|589037623|FG000|Overall Study|Lost to Follow-up|2|||
163089362|NCT00718315|589037624|FG001|Overall Study|Lost to Follow-up|3|||
163336004|NCT01029704|589940416|FG007|Overall Study|Withdrawal by Subject|1|||
163336005|NCT01029704|589940417|FG008|Overall Study|Withdrawal by Subject|0|||
163336006|NCT01029704|589940409|FG000|Overall Study|Lost to Follow-up|0|||
163336007|NCT01029704|589940410|FG001|Overall Study|Lost to Follow-up|0|||
163336008|NCT01029704|589940411|FG002|Overall Study|Lost to Follow-up|0|||
163336009|NCT01029704|589940412|FG003|Overall Study|Lost to Follow-up|0|||
163336010|NCT01029704|589940413|FG004|Overall Study|Lost to Follow-up|0|||
163336011|NCT01029704|589940414|FG005|Overall Study|Lost to Follow-up|0|||
163336012|NCT01029704|589940415|FG006|Overall Study|Lost to Follow-up|1|||
163336013|NCT01029704|589940416|FG007|Overall Study|Lost to Follow-up|1|||
163336014|NCT01029704|589940417|FG008|Overall Study|Lost to Follow-up|1|||
163336015|NCT01029704|589940409|FG000|Overall Study|Lack of Efficacy|0|||
163336016|NCT01029704|589940410|FG001|Overall Study|Lack of Efficacy|0|||
163336017|NCT01029704|589940411|FG002|Overall Study|Lack of Efficacy|0|||
163336018|NCT01029704|589940412|FG003|Overall Study|Lack of Efficacy|0|||
163336019|NCT01029704|589940413|FG004|Overall Study|Lack of Efficacy|2|||
163336020|NCT01029704|589940414|FG005|Overall Study|Lack of Efficacy|3|||
163336021|NCT01029704|589940415|FG006|Overall Study|Lack of Efficacy|1|||
163336022|NCT01029704|589940416|FG007|Overall Study|Lack of Efficacy|2|||
163336023|NCT01029704|589940417|FG008|Overall Study|Lack of Efficacy|0|||
163336024|NCT01029704|589940409|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
163336025|NCT01029704|589940410|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
163336026|NCT01029704|589940411|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
163336027|NCT01029704|589940412|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
163336028|NCT01029704|589940413|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
163336029|NCT01029704|589940414|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
163336030|NCT01029704|589940415|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
163336031|NCT01029704|589940416|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
163336032|NCT01029704|589940417|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
163336033|NCT03845517|589940418|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
163336034|NCT03845517|589940419|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
163336035|NCT03845517|589940420|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
163336036|NCT03845517|589940421|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
163336037|NCT03845517|589940418|FG000|Treatment Period (52 Weeks)|Death|0|||
163336038|NCT03845517|589940419|FG001|Treatment Period (52 Weeks)|Death|0|||
163336039|NCT03845517|589940420|FG002|Treatment Period (52 Weeks)|Death|1|||
163336040|NCT03845517|589940421|FG003|Treatment Period (52 Weeks)|Death|0|||
163336041|NCT03845517|589940418|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
163336042|NCT03845517|589940419|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
163336043|NCT03845517|589940420|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
163336044|NCT03845517|589940421|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
163336045|NCT03845517|589940418|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
163336046|NCT03845517|589940419|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
163336047|NCT03845517|589940420|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
163336048|NCT03845517|589940421|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
163336049|NCT03845517|589940418|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
163336050|NCT03845517|589940419|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
163336051|NCT03845517|589940420|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
163336052|NCT03845517|589940421|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
163336053|NCT03845517|589940418|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
163336054|NCT03845517|589940419|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
163089363|NCT00718315|589037625|FG002|Overall Study|Lost to Follow-up|4|||
163089364|NCT00718315|589037623|FG000|Overall Study|Protocol Violation|5|||
163089365|NCT00718315|589037624|FG001|Overall Study|Protocol Violation|5|||
163336055|NCT03845517|589940420|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
163336056|NCT03845517|589940421|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
163336057|NCT03845517|589940418|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
163336058|NCT03845517|589940419|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
163336059|NCT03845517|589940420|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
163089366|NCT00718315|589037625|FG002|Overall Study|Protocol Violation|3|||
163089367|NCT00718315|589037623|FG000|Overall Study|Erlotinib dose decreased|4|||
163336060|NCT03845517|589940421|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
163336061|NCT03845517|589940418|FG000|Treatment Period (52 Weeks)|Other|2|||
163336062|NCT03845517|589940419|FG001|Treatment Period (52 Weeks)|Other|0|||
163336063|NCT03845517|589940420|FG002|Treatment Period (52 Weeks)|Other|0|||
163336064|NCT03845517|589940421|FG003|Treatment Period (52 Weeks)|Other|0|||
163336065|NCT03845517|589940418|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
163336066|NCT03845517|589940419|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
163336067|NCT03845517|589940420|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
163089368|NCT00718315|589037624|FG001|Overall Study|Erlotinib dose decreased|3|||
163089369|NCT00718315|589037625|FG002|Overall Study|Erlotinib dose decreased|1|||
163089370|NCT00718315|589037623|FG000|Overall Study|Use of Minocyclin|1|||
163089371|NCT00718315|589037624|FG001|Overall Study|Use of Minocyclin|1|||
163089372|NCT00718315|589037625|FG002|Overall Study|Use of Minocyclin|1|||
163089373|NCT00718315|589037623|FG000|Overall Study|Disease progression|0|||
163089374|NCT00718315|589037624|FG001|Overall Study|Disease progression|1|||
163089375|NCT00718315|589037625|FG002|Overall Study|Disease progression|1|||
163089376|NCT00718315|589037623|FG000|Overall Study|Other|0|||
163089377|NCT00718315|589037624|FG001|Overall Study|Other|0|||
163089378|NCT00718315|589037625|FG002|Overall Study|Other|1|||
163089379|NCT00718315|589037623|FG000|Overall Study|Use of ATB and Corticoids|0|||
163089380|NCT00718315|589037624|FG001|Overall Study|Use of ATB and Corticoids|1|||
163089381|NCT00718315|589037625|FG002|Overall Study|Use of ATB and Corticoids|2|||
163089382|NCT00399529|589037626|FG000|Overall Study|Off Study Prior to Treatment|2|||
163089383|NCT01164007|589037627|FG000|Overall Study|Adverse Event|5|||
163089384|NCT01164007|589037627|FG000|Overall Study|Progression of Disease|30|||
163089385|NCT01164007|589037627|FG000|Overall Study|Protocol Violation|1|||
163089386|NCT01164007|589037627|FG000|Overall Study|Withdrawal by Subject|1|||
163089387|NCT01164007|589037627|FG000|Overall Study|Medical Decision|3|||
163089388|NCT03746015|589037632|FG000|Overall Study|Withdrawal of Consent|1|||
163089389|NCT03746015|589037633|FG001|Overall Study|Withdrawal of Consent|0|||
163089390|NCT03746015|589037634|FG002|Overall Study|Withdrawal of Consent|0|||
163089391|NCT05200845|589037636|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
163089392|NCT05200845|589037637|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
163089393|NCT05200845|589037638|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
163089394|NCT05200845|589037639|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
163089395|NCT05200845|589037636|FG000|Overall Study|Withdrawal by Subject|0|||
163089396|NCT05200845|589037637|FG001|Overall Study|Withdrawal by Subject|1|||
163089397|NCT05200845|589037638|FG002|Overall Study|Withdrawal by Subject|1|||
163089398|NCT05200845|589037639|FG003|Overall Study|Withdrawal by Subject|0|||
163089399|NCT02303262|589037642|FG000|Overall Study|Withdrawal by Subject|2|||
163089400|NCT02412670|589037643|FG000|Overall Study|Adverse Event|4|||
163089401|NCT02412670|589037644|FG001|Overall Study|Adverse Event|1|||
163089402|NCT02412670|589037643|FG000|Overall Study|Physician Decision|1|||
163089403|NCT02412670|589037644|FG001|Overall Study|Physician Decision|0|||
163089404|NCT02412670|589037643|FG000|Overall Study|Withdrawal by Subject|1|||
163089405|NCT02412670|589037644|FG001|Overall Study|Withdrawal by Subject|0|||
163089406|NCT02412670|589037643|FG000|Overall Study|Ineligible|1|||
163089407|NCT02412670|589037644|FG001|Overall Study|Ineligible|0|||
163089408|NCT01728246|589037650|FG000|Overall Study|Participant needed rescue medication|1|||
163089409|NCT01728246|589037651|FG001|Overall Study|Participant needed rescue medication|5|||
163089410|NCT01728246|589037650|FG000|Overall Study|Protocol Violation|1|||
163089411|NCT01728246|589037651|FG001|Overall Study|Protocol Violation|0|||
163089412|NCT01728246|589037650|FG000|Overall Study|Withdrawal by Subject|2|||
163089413|NCT01728246|589037651|FG001|Overall Study|Withdrawal by Subject|3|||
163089414|NCT01728246|589037650|FG000|Overall Study|Lost to Follow-up|23|||
163089415|NCT01728246|589037651|FG001|Overall Study|Lost to Follow-up|22|||
163089416|NCT01728246|589037650|FG000|Overall Study|Lack of Efficacy|1|||
163089417|NCT01728246|589037651|FG001|Overall Study|Lack of Efficacy|1|||
163089418|NCT01728246|589037650|FG000|Overall Study|Adverse Event|8|||
163089419|NCT01728246|589037651|FG001|Overall Study|Adverse Event|5|||
163089420|NCT05805150|589037652|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
163089421|NCT05805150|589037653|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
163089422|NCT00431964|589037656|FG000|Overall Study|Adverse Event|1|||
163089423|NCT00431964|589037657|FG001|Overall Study|Adverse Event|0|||
163089424|NCT00431964|589037656|FG000|Overall Study|Lost to Follow-up|1|||
163089425|NCT00431964|589037657|FG001|Overall Study|Lost to Follow-up|2|||
163089426|NCT00431964|589037656|FG000|Overall Study|Physician Decision|2|||
163089427|NCT00431964|589037657|FG001|Overall Study|Physician Decision|2|||
163089428|NCT00431964|589037656|FG000|Overall Study|Withdrawal by Subject|2|||
163089429|NCT00431964|589037657|FG001|Overall Study|Withdrawal by Subject|1|||
163089430|NCT00431964|589037656|FG000|Overall Study|Parental Consent Withdrawn|0|||
163089431|NCT00431964|589037657|FG001|Overall Study|Parental Consent Withdrawn|2|||
163089432|NCT00431964|589037656|FG000|Overall Study|Due to Unstable Health|0|||
163089433|NCT00431964|589037657|FG001|Overall Study|Due to Unstable Health|1|||
163089434|NCT03189719|589037658|FG000|Overall Study|Death|325|||
163089435|NCT03189719|589037659|FG001|Overall Study|Death|361|||
163089436|NCT03189719|589037658|FG000|Overall Study|Physician Decision|1|||
163089437|NCT03189719|589037659|FG001|Overall Study|Physician Decision|0|||
163089438|NCT03189719|589037658|FG000|Overall Study|Sponsor Decision|40|||
163089439|NCT03189719|589037659|FG001|Overall Study|Sponsor Decision|12|||
163089440|NCT03189719|589037658|FG000|Overall Study|Withdrawal by Subject|7|||
163089441|NCT03189719|589037659|FG001|Overall Study|Withdrawal by Subject|3|||
163089442|NCT03012880|589037660|FG000|Overall Study|Withdrawal by Subject|1|||
163089443|NCT03012880|589037661|FG001|Overall Study|Withdrawal by Subject|0|||
163336068|NCT03845517|589940421|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
163336069|NCT03845517|589940418|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
163336070|NCT03845517|589940419|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
163336071|NCT03845517|589940420|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
163336072|NCT03845517|589940421|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
163336073|NCT03845517|589940418|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
163336074|NCT03845517|589940419|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
163336075|NCT03845517|589940420|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
163336076|NCT03845517|589940421|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
163336077|NCT03845517|589940418|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
163336078|NCT03845517|589940419|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
163336079|NCT03845517|589940420|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
163336080|NCT03845517|589940421|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
163336081|NCT03845517|589940418|FG000|Follow-up Period (4 Weeks)|Death|0|||
163336082|NCT03845517|589940419|FG001|Follow-up Period (4 Weeks)|Death|0|||
163336083|NCT03845517|589940420|FG002|Follow-up Period (4 Weeks)|Death|1|||
163336084|NCT03845517|589940421|FG003|Follow-up Period (4 Weeks)|Death|1|||
163336085|NCT03845517|589940418|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
163336086|NCT03845517|589940419|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
163336087|NCT03845517|589940420|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
163336088|NCT03845517|589940421|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
163336089|NCT03845517|589940418|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
163336090|NCT03845517|589940419|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
163336091|NCT03845517|589940420|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
163407276|NCT02543528|590200769|FG002|Adaptation Period|Lens Handling Difficultes|0|||
163037774|NCT02757352|588845598|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037775|NCT02757352|588845589|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037776|NCT02757352|588845590|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
163037777|NCT02757352|588845591|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037778|NCT02757352|588845592|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037779|NCT02757352|588845593|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037780|NCT02757352|588845594|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037781|NCT02757352|588845595|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037782|NCT02757352|588845596|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037783|NCT02757352|588845597|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037784|NCT02757352|588845598|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037785|NCT02757352|588845589|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
163037786|NCT02757352|588845590|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
163037787|NCT02757352|588845591|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
163037788|NCT02757352|588845592|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037789|NCT02757352|588845593|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037790|NCT02757352|588845594|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037791|NCT02757352|588845595|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037792|NCT02757352|588845596|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037793|NCT02757352|588845597|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037794|NCT02757352|588845598|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037795|NCT02757352|588845589|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
163037796|NCT02757352|588845590|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
163037797|NCT02757352|588845591|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
163037798|NCT02757352|588845592|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
163037799|NCT02757352|588845593|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
163037800|NCT02757352|588845594|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
163037801|NCT02757352|588845595|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
163037802|NCT02757352|588845596|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
163037803|NCT02757352|588845597|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
163037804|NCT02757352|588845598|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
163037805|NCT02757352|588845589|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
163037806|NCT02757352|588845590|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
163037807|NCT02757352|588845591|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
163037808|NCT02757352|588845592|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
163037809|NCT02757352|588845593|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
163037810|NCT02757352|588845594|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
163037811|NCT02757352|588845595|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
163037812|NCT02757352|588845596|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
163037813|NCT02757352|588845597|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
163037814|NCT02757352|588845598|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
163336092|NCT03845517|589940421|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
163336093|NCT03845517|589940418|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
163336094|NCT03845517|589940419|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
163037815|NCT02757352|588845589|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037816|NCT02757352|588845590|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037817|NCT02757352|588845591|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037818|NCT02757352|588845592|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
163037819|NCT02757352|588845593|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
163037820|NCT02757352|588845594|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
163037821|NCT02757352|588845595|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037822|NCT02757352|588845596|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037823|NCT02757352|588845597|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037824|NCT02757352|588845598|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037825|NCT02757352|588845589|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037826|NCT02757352|588845590|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037827|NCT02757352|588845591|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037828|NCT02757352|588845592|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037829|NCT02757352|588845593|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
163037830|NCT02757352|588845594|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037831|NCT02757352|588845595|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037832|NCT02757352|588845596|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037833|NCT02757352|588845597|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037834|NCT02757352|588845598|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037835|NCT02757352|588845589|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037836|NCT02757352|588845590|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037837|NCT02757352|588845591|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037838|NCT02757352|588845592|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037839|NCT02757352|588845593|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037840|NCT02757352|588845594|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
163037841|NCT02757352|588845595|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037842|NCT02757352|588845596|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037843|NCT02757352|588845597|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037844|NCT02757352|588845598|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037845|NCT02757352|588845589|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037846|NCT02757352|588845590|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037847|NCT02757352|588845591|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037848|NCT02757352|588845592|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
163037849|NCT02757352|588845593|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
163037850|NCT02757352|588845594|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
163037851|NCT02757352|588845595|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037852|NCT02757352|588845596|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037853|NCT02757352|588845597|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037854|NCT02757352|588845598|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037855|NCT02757352|588845589|FG000|Follow-Up Period|Adverse Event|0|||
163037856|NCT02757352|588845590|FG001|Follow-Up Period|Adverse Event|0|||
163037857|NCT02757352|588845591|FG002|Follow-Up Period|Adverse Event|0|||
163037858|NCT02757352|588845592|FG003|Follow-Up Period|Adverse Event|0|||
163037859|NCT02757352|588845593|FG004|Follow-Up Period|Adverse Event|0|||
163037860|NCT02757352|588845594|FG005|Follow-Up Period|Adverse Event|0|||
163037861|NCT02757352|588845595|FG006|Follow-Up Period|Adverse Event|1|||
163037862|NCT02757352|588845596|FG007|Follow-Up Period|Adverse Event|0|||
163037863|NCT02757352|588845597|FG008|Follow-Up Period|Adverse Event|2|||
163037864|NCT02757352|588845598|FG009|Follow-Up Period|Adverse Event|0|||
163037865|NCT02757352|588845589|FG000|Follow-Up Period|Lost to Follow-up|0|||
163037866|NCT02757352|588845590|FG001|Follow-Up Period|Lost to Follow-up|0|||
163037867|NCT02757352|588845591|FG002|Follow-Up Period|Lost to Follow-up|0|||
163037868|NCT02757352|588845592|FG003|Follow-Up Period|Lost to Follow-up|0|||
163037869|NCT02757352|588845593|FG004|Follow-Up Period|Lost to Follow-up|0|||
163037870|NCT02757352|588845594|FG005|Follow-Up Period|Lost to Follow-up|0|||
163037871|NCT02757352|588845595|FG006|Follow-Up Period|Lost to Follow-up|0|||
163037872|NCT02757352|588845596|FG007|Follow-Up Period|Lost to Follow-up|0|||
163037873|NCT02757352|588845597|FG008|Follow-Up Period|Lost to Follow-up|1|||
163037874|NCT02757352|588845598|FG009|Follow-Up Period|Lost to Follow-up|0|||
163037875|NCT02757352|588845589|FG000|Follow-Up Period|Lack of Efficacy|0|||
163037876|NCT02757352|588845590|FG001|Follow-Up Period|Lack of Efficacy|0|||
163037877|NCT02757352|588845591|FG002|Follow-Up Period|Lack of Efficacy|0|||
163037878|NCT02757352|588845592|FG003|Follow-Up Period|Lack of Efficacy|0|||
163037879|NCT02757352|588845593|FG004|Follow-Up Period|Lack of Efficacy|0|||
163089444|NCT03012880|589037660|FG000|Overall Study|Ineligible|1|||
163089445|NCT03012880|589037661|FG001|Overall Study|Ineligible|0|||
163089446|NCT05211596|589037662|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
163089447|NCT05211596|589037662|FG000|Baseline to 6 Months|Death|1|||
163089448|NCT05211596|589037662|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
163089449|NCT05211596|589037662|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
163089450|NCT02293551|589037663|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
163089451|NCT02293551|589037664|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
163089452|NCT02293551|589037665|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
163089453|NCT02293551|589037666|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
163089454|NCT02293551|589037667|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
163089455|NCT02293551|589037668|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
163089456|NCT02293551|589037663|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
163089457|NCT02293551|589037664|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
163089458|NCT02293551|589037665|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
163089459|NCT02293551|589037666|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
163089460|NCT02293551|589037667|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
163089461|NCT02293551|589037668|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
163089462|NCT02293551|589037663|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
163089463|NCT02293551|589037664|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
163089464|NCT02293551|589037665|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
163089465|NCT02293551|589037666|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
163089466|NCT02293551|589037667|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
163089467|NCT02293551|589037668|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
163089468|NCT04532749|589037669|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
163089469|NCT04532749|589037670|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
163089470|NCT04532749|589037669|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
163089471|NCT04532749|589037670|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
163089472|NCT04532749|589037669|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
163089473|NCT04532749|589037670|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
163089474|NCT04532749|589037669|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
163089475|NCT04532749|589037670|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
163089476|NCT04532749|589037669|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
163089477|NCT04532749|589037670|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
163089478|NCT04532749|589037669|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
163089479|NCT04532749|589037670|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
163089480|NCT04532749|589037669|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
163089481|NCT04532749|589037670|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
163089482|NCT04532749|589037669|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
163089483|NCT04532749|589037670|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
163089484|NCT04532749|589037669|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
163089485|NCT04532749|589037670|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
163089486|NCT04532749|589037669|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
163089487|NCT04532749|589037670|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
163089488|NCT00529633|589039481|FG000|Overall Study|Withdrawal by Subject|1|||
163089489|NCT00529633|589039482|FG001|Overall Study|Withdrawal by Subject|1|||
163089490|NCT00069641|589039483|FG000|Overall Study|Death|1|||
163089491|NCT00069641|589039484|FG001|Overall Study|Death|0|||
163336095|NCT03845517|589940420|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
163336096|NCT03845517|589940421|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
163336097|NCT03845517|589940418|FG000|Follow-up Period (4 Weeks)|Other|1|||
163336098|NCT03845517|589940419|FG001|Follow-up Period (4 Weeks)|Other|0|||
163336099|NCT03845517|589940420|FG002|Follow-up Period (4 Weeks)|Other|1|||
163336100|NCT03845517|589940421|FG003|Follow-up Period (4 Weeks)|Other|0|||
163336101|NCT03845517|589940418|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
163037880|NCT02757352|588845594|FG005|Follow-Up Period|Lack of Efficacy|0|||
163037881|NCT02757352|588845595|FG006|Follow-Up Period|Lack of Efficacy|0|||
163037882|NCT02757352|588845596|FG007|Follow-Up Period|Lack of Efficacy|0|||
163037883|NCT02757352|588845597|FG008|Follow-Up Period|Lack of Efficacy|1|||
163037884|NCT02757352|588845598|FG009|Follow-Up Period|Lack of Efficacy|1|||
163037885|NCT02757352|588845589|FG000|Follow-Up Period|Withdrawal by Subject|0|||
163037886|NCT02757352|588845590|FG001|Follow-Up Period|Withdrawal by Subject|0|||
163037887|NCT02757352|588845591|FG002|Follow-Up Period|Withdrawal by Subject|0|||
163037888|NCT02757352|588845592|FG003|Follow-Up Period|Withdrawal by Subject|0|||
163037889|NCT02757352|588845593|FG004|Follow-Up Period|Withdrawal by Subject|0|||
163037890|NCT02757352|588845594|FG005|Follow-Up Period|Withdrawal by Subject|0|||
163037891|NCT02757352|588845595|FG006|Follow-Up Period|Withdrawal by Subject|0|||
163037892|NCT02757352|588845596|FG007|Follow-Up Period|Withdrawal by Subject|1|||
163037893|NCT02757352|588845597|FG008|Follow-Up Period|Withdrawal by Subject|6|||
163037894|NCT02757352|588845598|FG009|Follow-Up Period|Withdrawal by Subject|2|||
163037895|NCT04750278|588845599|FG000|Overall Study|Death|9|||
163037896|NCT04750278|588845600|FG001|Overall Study|Death|10|||
163037897|NCT04750278|588845601|FG002|Overall Study|Death|10|||
163089492|NCT00069641|589039485|FG002|Overall Study|Death|1|||
163089493|NCT02704208|589039486|FG000|Overall Study|Lost to Follow-up|42|||
163089494|NCT02704208|589039487|FG001|Overall Study|Lost to Follow-up|37|||
163089495|NCT02935192|589039488|FG000|Overall Study|Withdrawal by Subject|8|||
163089496|NCT02935192|589039489|FG001|Overall Study|Withdrawal by Subject|4|||
163089497|NCT00492557|589039491|FG000|Overall Study|Subject request|12|||
163089498|NCT00492557|589039492|FG001|Overall Study|Subject request|11|||
163089499|NCT00492557|589039491|FG000|Overall Study|Protocol Violation|7|||
163089500|NCT00492557|589039492|FG001|Overall Study|Protocol Violation|8|||
163089501|NCT00492557|589039491|FG000|Overall Study|Other|2|||
163089502|NCT00492557|589039492|FG001|Overall Study|Other|2|||
163089503|NCT00492557|589039491|FG000|Overall Study|Death|1|||
163089504|NCT00492557|589039492|FG001|Overall Study|Death|1|||
163089505|NCT00492557|589039491|FG000|Overall Study|Adverse Event|1|||
163089506|NCT00492557|589039492|FG001|Overall Study|Adverse Event|0|||
163089507|NCT00492557|589039491|FG000|Overall Study|Failed to return|1|||
163089508|NCT00492557|589039492|FG001|Overall Study|Failed to return|0|||
163089509|NCT00492557|589039491|FG000|Overall Study|Lost to Follow-up|0|||
163089510|NCT00492557|589039492|FG001|Overall Study|Lost to Follow-up|1|||
163089511|NCT04778592|589039496|FG000|Overall Study|Adverse Event|1|||
163089512|NCT04778592|589039497|FG001|Overall Study|Adverse Event|2|||
163089513|NCT04778592|589039496|FG000|Overall Study|Withdrawal by Subject|1|||
163089514|NCT04778592|589039497|FG001|Overall Study|Withdrawal by Subject|2|||
163089515|NCT01354223|589039499|FG000|Overall Study|Withdrawal by Subject|3|||
163089516|NCT01354223|589039500|FG001|Overall Study|Withdrawal by Subject|1|||
163089517|NCT05173974|589039504|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
163089518|NCT05173974|589039505|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
163089519|NCT05173974|589039506|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
163089520|NCT05173974|589039507|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
163089521|NCT05173974|589039504|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
163089522|NCT05173974|589039505|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
163089523|NCT05173974|589039506|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
163089524|NCT05173974|589039507|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
163089525|NCT04047446|589039508|FG000|Overall Study|Physician Decision|1|||
163089526|NCT04047446|589039509|FG001|Overall Study|Physician Decision|0|||
163089527|NCT00329420|589039510|FG000|Re-induction Phase|Lack of Efficacy|0|||
163089528|NCT00329420|589039511|FG001|Re-induction Phase|Lack of Efficacy|1|||
163089529|NCT00329420|589039512|FG002|Re-induction Phase|Lack of Efficacy|0|||
163089530|NCT00329420|589039510|FG000|Re-induction Phase|Withdrawal of Consent|0|||
163089531|NCT00329420|589039511|FG001|Re-induction Phase|Withdrawal of Consent|0|||
163089532|NCT00329420|589039512|FG002|Re-induction Phase|Withdrawal of Consent|1|||
163089533|NCT00329420|589039510|FG000|Re-induction Phase|Did not respond to re-induction|6|||
163089534|NCT00329420|589039511|FG001|Re-induction Phase|Did not respond to re-induction|5|||
163089535|NCT00329420|589039512|FG002|Re-induction Phase|Did not respond to re-induction|7|||
163089536|NCT00329420|589039510|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
163089537|NCT00329420|589039511|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
163089538|NCT00329420|589039512|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
163089539|NCT00329420|589039510|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
163089540|NCT00329420|589039511|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
163089541|NCT00329420|589039512|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
163089542|NCT00329420|589039510|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
163089543|NCT00329420|589039511|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
163089544|NCT00329420|589039512|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
163089545|NCT01135992|589039513|FG000|Overall Study|Adverse Event|1|||
163089546|NCT01135992|589039513|FG000|Overall Study|Lack of Efficacy|1|||
163089547|NCT01135992|589039513|FG000|Overall Study|Protocol Violation|2|||
163089548|NCT01135992|589039513|FG000|Overall Study|Withdrawal criteria|10|||
163089549|NCT01135992|589039513|FG000|Overall Study|Unclassified|7|||
163089550|NCT03983421|589039515|FG000|Overall Study|Lost to Follow-up|1|||
163089551|NCT02660229|589039516|FG000|Overall Study|Adverse Event|2|||
163089552|NCT02660229|589039517|FG001|Overall Study|Adverse Event|0|||
163089553|NCT02660229|589039516|FG000|Overall Study|Withdrawal by Subject|0|||
163089554|NCT02660229|589039517|FG001|Overall Study|Withdrawal by Subject|1|||
163089555|NCT02727322|589039521|FG000|Overall Study|Withdrawal by Subject|1|||
163089556|NCT02727322|589039522|FG001|Overall Study|Withdrawal by Subject|1|||
163089557|NCT02727322|589039521|FG000|Overall Study|Protocol Violation|1|||
163089558|NCT02727322|589039522|FG001|Overall Study|Protocol Violation|0|||
163336102|NCT03845517|589940419|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
163336103|NCT03845517|589940420|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
163089559|NCT01517984|589039523|FG000|Overall Study|Lost to Follow-up|0|||
163089560|NCT01517984|589039524|FG001|Overall Study|Lost to Follow-up|1|||
163089561|NCT01517984|589039525|FG002|Overall Study|Lost to Follow-up|0|||
163089562|NCT01517984|589039526|FG003|Overall Study|Lost to Follow-up|0|||
163089563|NCT01517984|589039523|FG000|Overall Study|Withdrawal by Subject|1|||
163089564|NCT01517984|589039524|FG001|Overall Study|Withdrawal by Subject|8|||
163089565|NCT01517984|589039525|FG002|Overall Study|Withdrawal by Subject|4|||
163089566|NCT01517984|589039526|FG003|Overall Study|Withdrawal by Subject|1|||
163089567|NCT01517984|589039523|FG000|Overall Study|Screen Failure|4|||
163089568|NCT01517984|589039524|FG001|Overall Study|Screen Failure|0|||
163089569|NCT01517984|589039525|FG002|Overall Study|Screen Failure|0|||
163089570|NCT01517984|589039526|FG003|Overall Study|Screen Failure|0|||
163089571|NCT01517984|589039523|FG000|Overall Study|Ineligible for randomization|0|||
163089572|NCT01517984|589039524|FG001|Overall Study|Ineligible for randomization|14|||
163089573|NCT01517984|589039525|FG002|Overall Study|Ineligible for randomization|0|||
163089574|NCT01517984|589039526|FG003|Overall Study|Ineligible for randomization|0|||
163089575|NCT02724839|589039529|FG000|Overall Study|Withdrawal by Subject|1|||
163089576|NCT02724839|589039530|FG001|Overall Study|Withdrawal by Subject|1|||
163089577|NCT02724839|589039531|FG002|Overall Study|Withdrawal by Subject|0|||
163089578|NCT02724839|589039529|FG000|Overall Study|Lost to Follow-up|0|||
163089579|NCT02724839|589039530|FG001|Overall Study|Lost to Follow-up|3|||
163089580|NCT02724839|589039531|FG002|Overall Study|Lost to Follow-up|2|||
163089581|NCT02724839|589039529|FG000|Overall Study|Physician Decision|0|||
163089582|NCT02724839|589039530|FG001|Overall Study|Physician Decision|0|||
163089583|NCT02724839|589039531|FG002|Overall Study|Physician Decision|3|||
163089584|NCT01155050|589039532|FG000|Overall Study|Lost to Follow-up|15|||
163089585|NCT01155050|589039533|FG001|Overall Study|Lost to Follow-up|20|||
163089586|NCT01155050|589039534|FG002|Overall Study|Lost to Follow-up|19|||
163089587|NCT01155050|589039535|FG003|Overall Study|Lost to Follow-up|22|||
163089588|NCT01496287|589039536|FG000|Overall Study|Lost to Follow-up|1|||
163089589|NCT01496287|589039536|FG000|Overall Study|Incomplete anesthesia|5|||
163089590|NCT01959529|589039537|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
163089591|NCT01959529|589039538|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
163089592|NCT01959529|589039537|FG000|Overall Study|Lost to Follow-up|4|||
163089593|NCT01959529|589039538|FG001|Overall Study|Lost to Follow-up|1|||
163089594|NCT01959529|589039537|FG000|Overall Study|Other|70|||
163037898|NCT04750278|588845599|FG000|Overall Study|Withdrawal by Subject|4|||
163037899|NCT04750278|588845600|FG001|Overall Study|Withdrawal by Subject|1|||
163037900|NCT04750278|588845601|FG002|Overall Study|Withdrawal by Subject|2|||
163037901|NCT04750278|588845599|FG000|Overall Study|Lost to Follow-up|1|||
163037902|NCT04750278|588845600|FG001|Overall Study|Lost to Follow-up|1|||
163037903|NCT04750278|588845601|FG002|Overall Study|Lost to Follow-up|1|||
163037904|NCT04750278|588845599|FG000|Overall Study|Pregnancy|1|||
163037905|NCT04750278|588845600|FG001|Overall Study|Pregnancy|0|||
163037906|NCT04750278|588845601|FG002|Overall Study|Pregnancy|0|||
163037907|NCT04750278|588845599|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
163037908|NCT04750278|588845600|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
163037909|NCT04750278|588845601|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
163037910|NCT04750278|588845599|FG000|Overall Study|Non-compliance|0|||
163037911|NCT04750278|588845600|FG001|Overall Study|Non-compliance|0|||
163037912|NCT04750278|588845601|FG002|Overall Study|Non-compliance|1|||
163037913|NCT04750278|588845599|FG000|Overall Study|Transfer to Outside Facility|0|||
163037914|NCT04750278|588845600|FG001|Overall Study|Transfer to Outside Facility|2|||
163037915|NCT04750278|588845601|FG002|Overall Study|Transfer to Outside Facility|1|||
163037916|NCT04750278|588845599|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
163037917|NCT04750278|588845600|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
163037918|NCT04750278|588845601|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
163037919|NCT04750278|588845599|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
163037920|NCT04750278|588845600|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
163037921|NCT04750278|588845601|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
163037922|NCT01212159|588845602|FG000|Overall Study|Withdrawal by Subject|12|||
163037923|NCT01212159|588845603|FG001|Overall Study|Withdrawal by Subject|12|||
163037924|NCT01299896|588845604|FG000|Overall Study|Withdrawal by Subject|1|||
163037925|NCT01299896|588845605|FG001|Overall Study|Withdrawal by Subject|7|||
163037926|NCT01299896|588845604|FG000|Overall Study|Lost to Follow-up|0|||
163037927|NCT01299896|588845605|FG001|Overall Study|Lost to Follow-up|11|||
163037928|NCT01467271|588845608|FG000|Overall Study|Death|84|||
163037929|NCT01467271|588845608|FG000|Overall Study|Lost to Follow-up|83|||
163037930|NCT01467271|588845608|FG000|Overall Study|Retraction of patient's consent|21|||
163037931|NCT01467271|588845608|FG000|Overall Study|Other reason|14|||
163037932|NCT01411319|588845632|FG000|Overall Study|Lost to Follow-up|1|||
163037933|NCT02815267|588845633|FG000|Double-Blind Phase|Adverse Event|0|||
163037934|NCT02815267|588845634|FG001|Double-Blind Phase|Adverse Event|3|||
163037935|NCT02815267|588845633|FG000|Double-Blind Phase|Lost to Follow-up|17|||
163037936|NCT02815267|588845634|FG001|Double-Blind Phase|Lost to Follow-up|9|||
163037937|NCT02815267|588845633|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
163037938|NCT02815267|588845634|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
163089595|NCT01959529|589039538|FG001|Overall Study|Other|68|||
163089596|NCT01959529|589039537|FG000|Overall Study|Hypoglycaemia|1|||
163089597|NCT01959529|589039538|FG001|Overall Study|Hypoglycaemia|1|||
163089598|NCT01959529|589039537|FG000|Overall Study|Lack of glycaemic control|1|||
163407277|NCT02543528|590200770|FG003|Adaptation Period|Lens Handling Difficultes|0|||
163407278|NCT02543528|590200771|FG004|Adaptation Period|Lens Handling Difficultes|8|||
163407279|NCT02543528|590200767|FG000|Adaptation Period|Lost to Follow-up|0|||
163407280|NCT02543528|590200768|FG001|Adaptation Period|Lost to Follow-up|0|||
163407281|NCT02543528|590200769|FG002|Adaptation Period|Lost to Follow-up|0|||
163407282|NCT02543528|590200770|FG003|Adaptation Period|Lost to Follow-up|0|||
163407283|NCT02543528|590200771|FG004|Adaptation Period|Lost to Follow-up|14|||
163407284|NCT02543528|590200767|FG000|Adaptation Period|Adverse Event|0|||
163407285|NCT02543528|590200768|FG001|Adaptation Period|Adverse Event|0|||
163407286|NCT02543528|590200769|FG002|Adaptation Period|Adverse Event|0|||
163407287|NCT02543528|590200770|FG003|Adaptation Period|Adverse Event|0|||
163407288|NCT02543528|590200771|FG004|Adaptation Period|Adverse Event|2|||
163407289|NCT02543528|590200767|FG000|Extended Wear Period|Adverse Event|17|||
163407290|NCT02543528|590200768|FG001|Extended Wear Period|Adverse Event|11|||
163407291|NCT02543528|590200769|FG002|Extended Wear Period|Adverse Event|16|||
163407292|NCT02543528|590200770|FG003|Extended Wear Period|Adverse Event|3|||
163407293|NCT02543528|590200771|FG004|Extended Wear Period|Adverse Event|0|||
163407294|NCT02543528|590200767|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
163407295|NCT02543528|590200768|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
163407296|NCT02543528|590200769|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
163407297|NCT02543528|590200770|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
163407298|NCT02543528|590200771|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
163407299|NCT02543528|590200767|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
163407300|NCT02543528|590200768|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
163407301|NCT02543528|590200769|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
163407302|NCT02543528|590200770|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
163407303|NCT02543528|590200771|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
163407304|NCT02543528|590200767|FG000|Extended Wear Period|Lost to Follow-up|0|||
163407305|NCT02543528|590200768|FG001|Extended Wear Period|Lost to Follow-up|1|||
163407306|NCT02543528|590200769|FG002|Extended Wear Period|Lost to Follow-up|2|||
163407307|NCT02543528|590200770|FG003|Extended Wear Period|Lost to Follow-up|1|||
163407308|NCT02543528|590200771|FG004|Extended Wear Period|Lost to Follow-up|0|||
163407309|NCT02543528|590200767|FG000|Extended Wear Period|Withdrawal by Subject|10|||
163407310|NCT02543528|590200768|FG001|Extended Wear Period|Withdrawal by Subject|9|||
163407311|NCT02543528|590200769|FG002|Extended Wear Period|Withdrawal by Subject|4|||
163407312|NCT02543528|590200770|FG003|Extended Wear Period|Withdrawal by Subject|5|||
163407313|NCT02543528|590200771|FG004|Extended Wear Period|Withdrawal by Subject|0|||
163407314|NCT02049944|590200772|FG000|Overall Study|Protocol Violation|2|||
163407315|NCT01042600|590200773|FG000|Overall Study|Ineligible|1|||
163407316|NCT01042600|590200774|FG001|Overall Study|Ineligible|0|||
163407317|NCT00631371|590200776|FG000|Overall Study|Lost to Follow-up|24|||
163407318|NCT00631371|590200777|FG001|Overall Study|Lost to Follow-up|19|||
163407319|NCT00631371|590200776|FG000|Overall Study|Other reason|5|||
163407320|NCT00631371|590200777|FG001|Overall Study|Other reason|12|||
163407321|NCT00631371|590200776|FG000|Overall Study|subject request|38|||
163407322|NCT00631371|590200777|FG001|Overall Study|subject request|45|||
163407323|NCT00631371|590200776|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
163407324|NCT00631371|590200777|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
163336104|NCT03845517|589940421|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
163336105|NCT03845517|589940418|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
163336106|NCT03845517|589940419|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
163336107|NCT03845517|589940420|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
163336108|NCT03845517|589940421|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
163336109|NCT03845517|589940418|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
163336110|NCT03845517|589940419|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
163336111|NCT03845517|589940420|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
163336112|NCT03845517|589940421|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
163336113|NCT01109979|589940422|FG000|Overall Study|Physician Decision|2|||
163336114|NCT01109979|589940423|FG001|Overall Study|Physician Decision|0|||
163407325|NCT00631371|590200776|FG000|Overall Study|Death|263|||
163407326|NCT00631371|590200777|FG001|Overall Study|Death|239|||
163336115|NCT01109979|589940422|FG000|Overall Study|Withdrawal by Subject|0|||
163407327|NCT01339559|590200778|FG000|Overall Study|Adverse Event|92|||
163407328|NCT01339559|590200778|FG000|Overall Study|Death|5|||
163407329|NCT01339559|590200778|FG000|Overall Study|Lack of Efficacy|164|||
163407330|NCT01339559|590200778|FG000|Overall Study|Lost to Follow-up|22|||
163407331|NCT01339559|590200778|FG000|Overall Study|Subject choice|89|||
163407332|NCT01339559|590200778|FG000|Overall Study|Protocol Violation|15|||
163407333|NCT01339559|590200778|FG000|Overall Study|Study closure at site|1|||
163089599|NCT01959529|589039538|FG001|Overall Study|Lack of glycaemic control|1|||
163336116|NCT01109979|589940423|FG001|Overall Study|Withdrawal by Subject|1|||
163407334|NCT01339559|590200778|FG000|Overall Study|Incarcerated|2|||
163407335|NCT01339559|590200778|FG000|Overall Study|Epilepsy surgery|1|||
163407336|NCT01339559|590200778|FG000|Overall Study|Pregnancy planned|2|||
163089600|NCT00557193|589039546|FG000|Induction|Adverse Event|2|||
163089601|NCT00557193|589039547|FG001|Induction|Adverse Event|0|||
163089602|NCT00557193|589039548|FG002|Induction|Adverse Event|0|||
163089603|NCT00557193|589039549|FG003|Induction|Adverse Event|0|||
163089604|NCT00557193|589039550|FG004|Induction|Adverse Event|0|||
163089605|NCT00557193|589039551|FG005|Induction|Adverse Event|0|||
163089606|NCT00557193|589039546|FG000|Induction|Death|6|||
163089607|NCT00557193|589039547|FG001|Induction|Death|0|||
163089608|NCT00557193|589039548|FG002|Induction|Death|0|||
163089609|NCT00557193|589039549|FG003|Induction|Death|0|||
163089610|NCT00557193|589039550|FG004|Induction|Death|0|||
163089611|NCT00557193|589039551|FG005|Induction|Death|0|||
163089612|NCT00557193|589039546|FG000|Induction|Physician Decision|3|||
163089613|NCT00557193|589039547|FG001|Induction|Physician Decision|0|||
163089614|NCT00557193|589039548|FG002|Induction|Physician Decision|0|||
163089615|NCT00557193|589039549|FG003|Induction|Physician Decision|0|||
163089616|NCT00557193|589039550|FG004|Induction|Physician Decision|0|||
163089617|NCT00557193|589039551|FG005|Induction|Physician Decision|0|||
163089618|NCT00557193|589039546|FG000|Induction|Withdrawal by Subject|1|||
163089619|NCT00557193|589039547|FG001|Induction|Withdrawal by Subject|0|||
163089620|NCT00557193|589039548|FG002|Induction|Withdrawal by Subject|0|||
163089621|NCT00557193|589039549|FG003|Induction|Withdrawal by Subject|0|||
163089622|NCT00557193|589039550|FG004|Induction|Withdrawal by Subject|0|||
163089623|NCT00557193|589039551|FG005|Induction|Withdrawal by Subject|0|||
163089624|NCT00557193|589039546|FG000|Induction|Refusal of Further Protocol Therapy|2|||
163089625|NCT00557193|589039547|FG001|Induction|Refusal of Further Protocol Therapy|0|||
163089626|NCT00557193|589039548|FG002|Induction|Refusal of Further Protocol Therapy|0|||
163089627|NCT00557193|589039549|FG003|Induction|Refusal of Further Protocol Therapy|0|||
163089628|NCT00557193|589039550|FG004|Induction|Refusal of Further Protocol Therapy|0|||
163089629|NCT00557193|589039551|FG005|Induction|Refusal of Further Protocol Therapy|0|||
163089630|NCT00557193|589039546|FG000|Induction|Ineligible|8|||
163089631|NCT00557193|589039547|FG001|Induction|Ineligible|0|||
163089632|NCT00557193|589039548|FG002|Induction|Ineligible|0|||
163089633|NCT00557193|589039549|FG003|Induction|Ineligible|0|||
163089634|NCT00557193|589039550|FG004|Induction|Ineligible|0|||
163089635|NCT00557193|589039551|FG005|Induction|Ineligible|0|||
163089636|NCT00557193|589039546|FG000|Induction|Inevaluable for post Induction|2|||
163089637|NCT00557193|589039547|FG001|Induction|Inevaluable for post Induction|0|||
163089638|NCT00557193|589039548|FG002|Induction|Inevaluable for post Induction|0|||
163089639|NCT00557193|589039549|FG003|Induction|Inevaluable for post Induction|0|||
163089640|NCT00557193|589039550|FG004|Induction|Inevaluable for post Induction|0|||
163089641|NCT00557193|589039551|FG005|Induction|Inevaluable for post Induction|0|||
163089642|NCT00557193|589039546|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
163089643|NCT00557193|589039547|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
163089644|NCT00557193|589039548|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
163089645|NCT00557193|589039549|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
163089646|NCT00557193|589039550|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
163089647|NCT00557193|589039551|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
163089648|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
163089649|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
163089650|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
163089651|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
163089652|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
163089653|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
163089654|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
163089655|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
163089656|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
163089657|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
163089658|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
163089659|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
163089660|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
163089661|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
163089662|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
163089663|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
163089664|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
163089665|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
163089666|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
163089667|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
163089668|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
163220063|NCT03190889|589521397|FG000|Overall Study|Did not complete protocol|4|||
163089669|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
163089670|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
163089671|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
163089672|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
163336117|NCT03136861|589940426|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
163336118|NCT03136861|589940427|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
163336119|NCT03136861|589940428|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
163336120|NCT03136861|589940429|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
163336121|NCT03136861|589940430|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
163336122|NCT03136861|589940431|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
163336123|NCT03136861|589940432|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
163336124|NCT03136861|589940426|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
163336125|NCT03136861|589940427|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
163336126|NCT03136861|589940428|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
163336127|NCT03136861|589940429|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
163336128|NCT03136861|589940430|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
163336129|NCT03136861|589940431|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
163336130|NCT03136861|589940432|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
163336131|NCT03136861|589940426|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
163336132|NCT03136861|589940427|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
163336133|NCT03136861|589940428|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
163336134|NCT03136861|589940429|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
163336135|NCT03136861|589940430|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
163336136|NCT03136861|589940431|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
163336137|NCT03136861|589940432|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
163336138|NCT03136861|589940426|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
163336139|NCT03136861|589940427|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
163336140|NCT03136861|589940428|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
163336141|NCT03136861|589940429|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
163336142|NCT03136861|589940430|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
163336143|NCT03136861|589940431|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
163336144|NCT03136861|589940432|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
163336145|NCT03136861|589940426|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
163336146|NCT03136861|589940427|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
163336147|NCT03136861|589940428|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
163336148|NCT03136861|589940429|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
163336149|NCT03136861|589940430|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
163336150|NCT03136861|589940431|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
163336151|NCT03136861|589940432|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
163336152|NCT03136861|589940426|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
163336153|NCT03136861|589940427|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
163336154|NCT03136861|589940428|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
163336155|NCT03136861|589940429|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
163336156|NCT03136861|589940430|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
163336157|NCT03136861|589940431|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
163336158|NCT03136861|589940432|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
163336159|NCT03136861|589940426|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
163336160|NCT03136861|589940427|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
163336161|NCT03136861|589940428|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
163336162|NCT03136861|589940429|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
163336163|NCT03136861|589940430|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
163336164|NCT03136861|589940431|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
163336165|NCT03136861|589940432|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
163336166|NCT03136861|589940426|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
163336167|NCT03136861|589940427|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
163336168|NCT03136861|589940428|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
163336169|NCT03136861|589940429|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
163336170|NCT03136861|589940430|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
163336171|NCT03136861|589940431|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
163336172|NCT03136861|589940432|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
163336173|NCT03390166|589940433|FG000|Overall Study|Death|0|||
163336174|NCT03390166|589940434|FG001|Overall Study|Death|1|||
163336175|NCT03390166|589940433|FG000|Overall Study|Lost to Follow-up|6|||
163089673|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
163089674|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
163089675|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
163089676|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
163336176|NCT03390166|589940434|FG001|Overall Study|Lost to Follow-up|4|||
163336177|NCT03390166|589940433|FG000|Overall Study|Physician Decision|2|||
163336178|NCT03390166|589940434|FG001|Overall Study|Physician Decision|1|||
163336179|NCT03390166|589940433|FG000|Overall Study|Move from study area|3|||
163336180|NCT03390166|589940434|FG001|Overall Study|Move from study area|2|||
163336181|NCT03390166|589940433|FG000|Overall Study|To militarycamp for conscript|1|||
163336182|NCT03390166|589940434|FG001|Overall Study|To militarycamp for conscript|0|||
163336183|NCT03390166|589940433|FG000|Overall Study|To drug therapy course|0|||
163336184|NCT03390166|589940434|FG001|Overall Study|To drug therapy course|1|||
163336185|NCT03390166|589940433|FG000|Overall Study|Move to work oversea|0|||
163336186|NCT03390166|589940434|FG001|Overall Study|Move to work oversea|1|||
163336187|NCT01328756|589940440|FG000|Overall Study|Protocol Violation|4|||
163336188|NCT01328756|589940440|FG000|Overall Study|Adverse Event|39|||
163336189|NCT01328756|589940440|FG000|Overall Study|Lack of Efficacy|5|||
163336190|NCT01328756|589940440|FG000|Overall Study|Withdrawal by Subject|41|||
163336191|NCT01328756|589940440|FG000|Overall Study|Lost to Follow-up|5|||
163336192|NCT01328756|589940440|FG000|Overall Study|Other|29|||
163336193|NCT03200574|589940455|FG000|Overall Study|Death|4|||
163336194|NCT03200574|589940455|FG000|Overall Study|Withdrawal by Subject|8|||
163336195|NCT03200574|589940455|FG000|Overall Study|Long-Term need for anticoagulation|1|||
163336196|NCT03200574|589940455|FG000|Overall Study|Relocation|2|||
163336197|NCT03200574|589940455|FG000|Overall Study|Lost to Follow-up|2|||
163336198|NCT00705159|589940459|FG000|Overall Study|Withdrawal by Subject|0|||
163336199|NCT00705159|589940460|FG001|Overall Study|Withdrawal by Subject|1|||
163336200|NCT00705159|589940461|FG002|Overall Study|Withdrawal by Subject|1|||
163336201|NCT00705159|589940462|FG003|Overall Study|Withdrawal by Subject|1|||
163336202|NCT00705159|589940459|FG000|Overall Study|Protocol Violation|0|||
163336203|NCT00705159|589940460|FG001|Overall Study|Protocol Violation|1|||
163336204|NCT00705159|589940461|FG002|Overall Study|Protocol Violation|0|||
163336205|NCT00705159|589940462|FG003|Overall Study|Protocol Violation|0|||
163336206|NCT00705159|589940459|FG000|Overall Study|Adverse Event|0|||
163336207|NCT00705159|589940460|FG001|Overall Study|Adverse Event|0|||
163336208|NCT00705159|589940461|FG002|Overall Study|Adverse Event|1|||
163336209|NCT00705159|589940462|FG003|Overall Study|Adverse Event|0|||
163336210|NCT00705159|589940459|FG000|Overall Study|Lost to Follow-up|0|||
163336211|NCT00705159|589940460|FG001|Overall Study|Lost to Follow-up|0|||
163336212|NCT00705159|589940461|FG002|Overall Study|Lost to Follow-up|3|||
163336213|NCT00705159|589940462|FG003|Overall Study|Lost to Follow-up|2|||
163336214|NCT00705159|589940459|FG000|Overall Study|Screen Failure|0|||
163336215|NCT00705159|589940460|FG001|Overall Study|Screen Failure|0|||
163336216|NCT00705159|589940461|FG002|Overall Study|Screen Failure|0|||
163336217|NCT00705159|589940462|FG003|Overall Study|Screen Failure|1|||
163336218|NCT00526994|589940463|FG000|Overall Study|Lost to Follow-up|98|||
163089677|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
163089678|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
163089679|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
163089680|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
163089681|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
163089682|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
163089683|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
163089684|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
163089685|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
163089686|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
163089687|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
163089688|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
163089689|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
163089690|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
163089691|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
163089692|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
163089693|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
163336219|NCT00526994|589940464|FG001|Overall Study|Lost to Follow-up|108|||
163336220|NCT00526994|589940465|FG002|Overall Study|Lost to Follow-up|96|||
163336221|NCT00526994|589940463|FG000|Overall Study|Death|4|||
163336222|NCT00526994|589940464|FG001|Overall Study|Death|3|||
163336223|NCT00526994|589940465|FG002|Overall Study|Death|3|||
163336224|NCT00526994|589940463|FG000|Overall Study|Withdrawal by Subject|2|||
163336225|NCT00526994|589940464|FG001|Overall Study|Withdrawal by Subject|7|||
163336226|NCT00526994|589940465|FG002|Overall Study|Withdrawal by Subject|5|||
163336227|NCT00526994|589940463|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
163336228|NCT00526994|589940464|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
163336229|NCT00526994|589940465|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
163336230|NCT03026166|589940466|FG000|Overall Study|Death|22|||
163336231|NCT03026166|589940467|FG001|Overall Study|Death|7|||
163336232|NCT03026166|589940466|FG000|Overall Study|Physician Decision|2|||
163336233|NCT03026166|589940467|FG001|Overall Study|Physician Decision|0|||
163336234|NCT03026166|589940466|FG000|Overall Study|Withdrawal by Subject|1|||
163336235|NCT03026166|589940467|FG001|Overall Study|Withdrawal by Subject|2|||
163336236|NCT03026166|589940466|FG000|Overall Study|Lost to Follow-up|1|||
163336237|NCT03026166|589940467|FG001|Overall Study|Lost to Follow-up|0|||
163336238|NCT03026166|589940466|FG000|Overall Study|Study Terminated by Sponsor|3|||
163336239|NCT03026166|589940467|FG001|Overall Study|Study Terminated by Sponsor|3|||
163336240|NCT03026166|589940466|FG000|Overall Study|Other|1|||
163336241|NCT03026166|589940467|FG001|Overall Study|Other|0|||
163336242|NCT00266656|589940475|FG000|Overall Study|Death|1|||
163336243|NCT00266656|589940476|FG001|Overall Study|Death|0|||
163336244|NCT00266656|589940475|FG000|Overall Study|Lost to Follow-up|4|||
163336245|NCT00266656|589940476|FG001|Overall Study|Lost to Follow-up|1|||
163336246|NCT00266656|589940475|FG000|Overall Study|Withdrawal by Subject|4|||
163336247|NCT00266656|589940476|FG001|Overall Study|Withdrawal by Subject|2|||
163336248|NCT00266656|589940475|FG000|Overall Study|Did Not Reach Final Height|4|||
163336249|NCT00266656|589940476|FG001|Overall Study|Did Not Reach Final Height|8|||
163336250|NCT00266656|589940475|FG000|Overall Study|Parent/Caregiver Decision|1|||
163336251|NCT00266656|589940476|FG001|Overall Study|Parent/Caregiver Decision|2|||
163336252|NCT00667732|589940478|FG000|Run -In (8 Weeks)|Adverse Event|4|||
163336253|NCT00667732|589940479|FG001|Run -In (8 Weeks)|Adverse Event|0|||
163336254|NCT00667732|589940480|FG002|Run -In (8 Weeks)|Adverse Event|0|||
163336255|NCT00667732|589940478|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
163336256|NCT00667732|589940479|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
163336257|NCT00667732|589940480|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
163336258|NCT00667732|589940478|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
163336259|NCT00667732|589940479|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
163336260|NCT00667732|589940480|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
163336261|NCT03786471|589940485|FG000|Overall Study|Death|254|||
163336262|NCT03786471|589940486|FG001|Overall Study|Death|223|||
163336263|NCT03786471|589940487|FG002|Overall Study|Death|37|||
163336264|NCT03786471|589940485|FG000|Overall Study|Lost to Follow-up|63|||
163336265|NCT03786471|589940486|FG001|Overall Study|Lost to Follow-up|50|||
163336266|NCT03786471|589940487|FG002|Overall Study|Lost to Follow-up|15|||
163336267|NCT03786471|589940485|FG000|Overall Study|Withdrawal by Subject|99|||
163336268|NCT03786471|589940486|FG001|Overall Study|Withdrawal by Subject|81|||
163336269|NCT03786471|589940487|FG002|Overall Study|Withdrawal by Subject|11|||
163336270|NCT05006703|589942285|FG000|Overall Study|Withdrawal by Subject|1|||
163336271|NCT05006703|589942286|FG001|Overall Study|Withdrawal by Subject|0|||
163336272|NCT05006703|589942285|FG000|Overall Study|Lost to Follow-up|13|||
163336273|NCT05006703|589942286|FG001|Overall Study|Lost to Follow-up|5|||
163336274|NCT03924193|589942287|FG000|Overall Study|Adverse Event|10|||
163336275|NCT03924193|589942288|FG001|Overall Study|Adverse Event|0|||
163336276|NCT03924193|589942289|FG002|Overall Study|Adverse Event|10|||
163336277|NCT03924193|589942287|FG000|Overall Study|Withdrawal by Subject|5|||
163336278|NCT03924193|589942288|FG001|Overall Study|Withdrawal by Subject|10|||
163336279|NCT03924193|589942289|FG002|Overall Study|Withdrawal by Subject|2|||
163336280|NCT02489799|589942290|FG000|Overall Study|Lost to Follow-up|4|||
163336281|NCT02489799|589942291|FG001|Overall Study|Lost to Follow-up|1|||
163089694|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
163089695|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
163089696|NCT00652834|589039552|FG000|Overall Study|Withdrawal by Subject|3|||
163089697|NCT00652834|589039552|FG000|Overall Study|Lost to Follow-up|2|||
163089698|NCT00320606|589039553|FG000|Overall Study|Adverse Event|1|||
163089699|NCT00320606|589039553|FG000|Overall Study|Protocol Violation|1|||
163089700|NCT00320606|589039553|FG000|Overall Study|Withdrawal by Subject|1|||
163089701|NCT01948427|589039558|FG000|Overall Study|Serious Adverse Event|3|||
163336282|NCT02489799|589942290|FG000|Overall Study|Failure to Maintain Eligibility|4|||
163336283|NCT02489799|589942291|FG001|Overall Study|Failure to Maintain Eligibility|6|||
163336284|NCT02489799|589942290|FG000|Overall Study|Withdrawal by Subject|1|||
163336285|NCT02489799|589942291|FG001|Overall Study|Withdrawal by Subject|1|||
163336286|NCT02489799|589942290|FG000|Overall Study|Death|0|||
163336287|NCT02489799|589942291|FG001|Overall Study|Death|1|||
163336288|NCT00515112|589942293|FG000|Overall Study|Death|0|||
163336289|NCT00515112|589942294|FG001|Overall Study|Death|1|||
163336290|NCT00515112|589942293|FG000|Overall Study|The study was terminated|3|||
163336291|NCT00515112|589942294|FG001|Overall Study|The study was terminated|2|||
163336292|NCT02002689|589942300|FG000|Overall Study|Disease Progression|7|||
163336293|NCT02002689|589942300|FG000|Overall Study|Adverse Event|3|||
163336294|NCT00278395|589942303|FG000|Overall Study|Adverse Event|2|||
163336295|NCT00278395|589942303|FG000|Overall Study|Nonevaluable|1|||
163336296|NCT01148017|589942304|FG000|Overall Study|Withdrawal by Subject|31|||
163089702|NCT01948427|589039559|FG001|Overall Study|Serious Adverse Event|0|||
163336297|NCT01148017|589942305|FG001|Overall Study|Withdrawal by Subject|14|||
163336298|NCT01148017|589942306|FG002|Overall Study|Withdrawal by Subject|0|||
163336299|NCT01148017|589942307|FG003|Overall Study|Withdrawal by Subject|0|||
163336300|NCT01148017|589942304|FG000|Overall Study|Lost to Follow-up|23|||
163089703|NCT01948427|589039560|FG002|Overall Study|Serious Adverse Event|0|||
163089704|NCT01948427|589039561|FG003|Overall Study|Serious Adverse Event|0|||
163089705|NCT01948427|589039562|FG004|Overall Study|Serious Adverse Event|1|||
163089706|NCT01948427|589039558|FG000|Overall Study|Investigator Request|0|||
163089707|NCT01948427|589039559|FG001|Overall Study|Investigator Request|8|||
163089708|NCT01948427|589039560|FG002|Overall Study|Investigator Request|0|||
163089709|NCT01948427|589039561|FG003|Overall Study|Investigator Request|0|||
163089710|NCT01948427|589039562|FG004|Overall Study|Investigator Request|6|||
163089711|NCT01948427|589039558|FG000|Overall Study|Lost to Follow-up|1|||
163089712|NCT01948427|589039559|FG001|Overall Study|Lost to Follow-up|0|||
163089713|NCT01948427|589039560|FG002|Overall Study|Lost to Follow-up|0|||
163089714|NCT01948427|589039561|FG003|Overall Study|Lost to Follow-up|0|||
163089715|NCT01948427|589039562|FG004|Overall Study|Lost to Follow-up|4|||
163089716|NCT01948427|589039558|FG000|Overall Study|Withdrawal by Subject|2|||
163089717|NCT01948427|589039559|FG001|Overall Study|Withdrawal by Subject|0|||
163089718|NCT01948427|589039560|FG002|Overall Study|Withdrawal by Subject|0|||
163089719|NCT01948427|589039561|FG003|Overall Study|Withdrawal by Subject|0|||
163089720|NCT01948427|589039562|FG004|Overall Study|Withdrawal by Subject|1|||
163089721|NCT01948427|589039558|FG000|Overall Study|Other, Not Specified|1|||
163089722|NCT01948427|589039559|FG001|Overall Study|Other, Not Specified|9|||
163089723|NCT01948427|589039560|FG002|Overall Study|Other, Not Specified|0|||
163089724|NCT01948427|589039561|FG003|Overall Study|Other, Not Specified|0|||
163089725|NCT01948427|589039562|FG004|Overall Study|Other, Not Specified|2|||
163089726|NCT00256126|589039563|FG000|Overall Study|Adverse Event|1|||
163089727|NCT00256126|589039564|FG001|Overall Study|Adverse Event|0|||
163089728|NCT00256126|589039563|FG000|Overall Study|Other|1|||
163089729|NCT00256126|589039564|FG001|Overall Study|Other|2|||
163089730|NCT02434081|589039565|FG000|Overall Study|Death (never started treatment)|2|||
163089731|NCT02434081|589039565|FG000|Overall Study|Death|2|||
163089732|NCT02434081|589039565|FG000|Overall Study|Progression|20|||
163089733|NCT02434081|589039565|FG000|Overall Study|Adverse Event|20|||
163089734|NCT02434081|589039565|FG000|Overall Study|Physician Decision|2|||
163089735|NCT02434081|589039565|FG000|Overall Study|Withdrawal by Subject|1|||
163089736|NCT02434081|589039565|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
163089737|NCT00854360|589039574|FG000|Overall Study|Adverse Event|0|||
163089738|NCT00854360|589039575|FG001|Overall Study|Adverse Event|1|||
163089739|NCT00854360|589039576|FG002|Overall Study|Adverse Event|2|||
163089740|NCT00854360|589039577|FG003|Overall Study|Adverse Event|6|||
163089741|NCT00854360|589039574|FG000|Overall Study|Withdrawal by Subject|0|||
163089742|NCT00854360|589039575|FG001|Overall Study|Withdrawal by Subject|0|||
163089743|NCT00854360|589039576|FG002|Overall Study|Withdrawal by Subject|0|||
163089744|NCT00854360|589039577|FG003|Overall Study|Withdrawal by Subject|1|||
163089745|NCT00854360|589039574|FG000|Overall Study|Pregnancy|0|||
163089746|NCT00854360|589039575|FG001|Overall Study|Pregnancy|1|||
163089747|NCT00854360|589039576|FG002|Overall Study|Pregnancy|0|||
163089748|NCT00854360|589039577|FG003|Overall Study|Pregnancy|0|||
163089749|NCT00854360|589039574|FG000|Overall Study|Lack of Efficacy|2|||
163089750|NCT00854360|589039575|FG001|Overall Study|Lack of Efficacy|1|||
163089751|NCT00854360|589039576|FG002|Overall Study|Lack of Efficacy|0|||
163089752|NCT00854360|589039577|FG003|Overall Study|Lack of Efficacy|0|||
163089753|NCT00854360|589039574|FG000|Overall Study|Other|0|||
163089754|NCT00854360|589039575|FG001|Overall Study|Other|0|||
163089755|NCT00854360|589039576|FG002|Overall Study|Other|0|||
163089756|NCT00854360|589039577|FG003|Overall Study|Other|3|||
163089757|NCT03435380|589039578|FG000|Overall Study|Death|1|||
163089758|NCT03435380|589039579|FG001|Overall Study|Death|2|||
163089759|NCT03435380|589039580|FG002|Overall Study|Death|1|||
163089760|NCT03435380|589039578|FG000|Overall Study|Lost to Follow-up|12|||
163089761|NCT03435380|589039579|FG001|Overall Study|Lost to Follow-up|8|||
163089762|NCT03435380|589039580|FG002|Overall Study|Lost to Follow-up|6|||
163089763|NCT03435380|589039578|FG000|Overall Study|Physician Decision|1|||
163089764|NCT03435380|589039579|FG001|Overall Study|Physician Decision|0|||
163089765|NCT03435380|589039580|FG002|Overall Study|Physician Decision|0|||
163089766|NCT03435380|589039578|FG000|Overall Study|Withdrawal by Subject|0|||
163089767|NCT03435380|589039579|FG001|Overall Study|Withdrawal by Subject|1|||
163089768|NCT03435380|589039580|FG002|Overall Study|Withdrawal by Subject|1|||
163089769|NCT03435380|589039578|FG000|Overall Study|Ineligible|0|||
163089770|NCT03435380|589039579|FG001|Overall Study|Ineligible|1|||
163089771|NCT03435380|589039580|FG002|Overall Study|Ineligible|1|||
163089772|NCT03218917|589039581|FG000|Overall Study|Adverse Event|3|||
163089773|NCT03218917|589039582|FG001|Overall Study|Adverse Event|3|||
163089774|NCT03218917|589039583|FG002|Overall Study|Adverse Event|2|||
163089775|NCT03218917|589039581|FG000|Overall Study|Subject withdrew consent|2|||
163089776|NCT03218917|589039582|FG001|Overall Study|Subject withdrew consent|4|||
163089777|NCT03218917|589039583|FG002|Overall Study|Subject withdrew consent|10|||
163089778|NCT03218917|589039581|FG000|Overall Study|Physician Decision|0|||
163089779|NCT03218917|589039582|FG001|Overall Study|Physician Decision|1|||
163089780|NCT03218917|589039583|FG002|Overall Study|Physician Decision|1|||
163089781|NCT03218917|589039581|FG000|Overall Study|Lost to Follow-up|1|||
163089782|NCT03218917|589039582|FG001|Overall Study|Lost to Follow-up|0|||
163336301|NCT01148017|589942305|FG001|Overall Study|Lost to Follow-up|10|||
163336302|NCT01148017|589942306|FG002|Overall Study|Lost to Follow-up|0|||
163336303|NCT01148017|589942307|FG003|Overall Study|Lost to Follow-up|0|||
163336304|NCT01148017|589942304|FG000|Overall Study|Inappropriate enrollment|1|||
163336305|NCT01148017|589942305|FG001|Overall Study|Inappropriate enrollment|0|||
163336306|NCT01148017|589942306|FG002|Overall Study|Inappropriate enrollment|0|||
163336307|NCT01148017|589942307|FG003|Overall Study|Inappropriate enrollment|0|||
163336308|NCT01148017|589942304|FG000|Overall Study|Administrative reason|22|||
163336309|NCT01148017|589942305|FG001|Overall Study|Administrative reason|9|||
163336310|NCT01148017|589942306|FG002|Overall Study|Administrative reason|0|||
163336311|NCT01148017|589942307|FG003|Overall Study|Administrative reason|0|||
163336312|NCT01148017|589942304|FG000|Overall Study|Unable to classify|3|||
163336313|NCT01148017|589942305|FG001|Overall Study|Unable to classify|1|||
163336314|NCT01148017|589942306|FG002|Overall Study|Unable to classify|0|||
163336315|NCT01148017|589942307|FG003|Overall Study|Unable to classify|0|||
163336316|NCT00569166|589942310|FG000|Overall Study|Withdrawal by Subject|7|||
163336317|NCT00569166|589942311|FG001|Overall Study|Withdrawal by Subject|5|||
163336318|NCT00569166|589942312|FG002|Overall Study|Withdrawal by Subject|3|||
163336319|NCT00569166|589942310|FG000|Overall Study|Lost to Follow-up|2|||
163336320|NCT00569166|589942311|FG001|Overall Study|Lost to Follow-up|1|||
163336321|NCT00569166|589942312|FG002|Overall Study|Lost to Follow-up|1|||
163336322|NCT01853384|589942313|FG000|Randomized|Adverse Event|5|||
163336323|NCT01853384|589942314|FG001|Randomized|Adverse Event|3|||
163336324|NCT01853384|589942313|FG000|Randomized|Death|1|||
163336325|NCT01853384|589942314|FG001|Randomized|Death|2|||
163336326|NCT01853384|589942313|FG000|Randomized|Lost to Follow-up|1|||
163336327|NCT01853384|589942314|FG001|Randomized|Lost to Follow-up|1|||
163336328|NCT01853384|589942313|FG000|Randomized|Withdrawal by Subject|5|||
163336329|NCT01853384|589942314|FG001|Randomized|Withdrawal by Subject|3|||
163336330|NCT01853384|589942313|FG000|Randomized|Sponsor Decision|47|||
163336331|NCT01853384|589942314|FG001|Randomized|Sponsor Decision|34|||
163336332|NCT01853384|589942313|FG000|Randomized|Other|3|||
163336333|NCT01853384|589942314|FG001|Randomized|Other|3|||
163336334|NCT01853384|589942313|FG000|Completed Follow up Visit 1|Early Termination|13|||
163336335|NCT01853384|589942314|FG001|Completed Follow up Visit 1|Early Termination|9|||
163336336|NCT01853384|589942313|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
163336337|NCT01853384|589942314|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
163336338|NCT01853384|589942313|FG000|Completed Follow up Visit 2|Adverse Event|1|||
163336339|NCT01853384|589942314|FG001|Completed Follow up Visit 2|Adverse Event|0|||
163336340|NCT01853384|589942313|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
163336341|NCT01853384|589942314|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
163336342|NCT01853384|589942313|FG000|Completed Follow up Visit 2|Death|1|||
163336343|NCT01853384|589942314|FG001|Completed Follow up Visit 2|Death|0|||
163336344|NCT01853384|589942313|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
163336345|NCT01853384|589942314|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
163336346|NCT01019135|589942318|FG000|Overall Study|Did not receive allocated intervention|12|||
163336347|NCT01019135|589942319|FG001|Overall Study|Did not receive allocated intervention|6|||
163336348|NCT01019135|589942320|FG002|Overall Study|Did not receive allocated intervention|25|||
163336349|NCT01019135|589942318|FG000|Overall Study|Did not attend CR|8|||
163336350|NCT01019135|589942319|FG001|Overall Study|Did not attend CR|13|||
163336351|NCT01019135|589942320|FG002|Overall Study|Did not attend CR|6|||
163336352|NCT00486954|589942321|FG000|Pilot Part|Adverse Event|4|||
163336353|NCT00486954|589942322|FG001|Pilot Part|Adverse Event|0|||
163336354|NCT00486954|589942323|FG002|Pilot Part|Adverse Event|5|||
163336355|NCT00486954|589942324|FG003|Pilot Part|Adverse Event|0|||
163336356|NCT00486954|589942325|FG004|Pilot Part|Adverse Event|0|||
163037939|NCT02815267|588845633|FG000|Double-Blind Phase|Protocol Violation|3|||
163336357|NCT00486954|589942321|FG000|Pilot Part|Disease Progression|2|||
163336358|NCT00486954|589942322|FG001|Pilot Part|Disease Progression|0|||
163336359|NCT00486954|589942323|FG002|Pilot Part|Disease Progression|1|||
163336360|NCT00486954|589942324|FG003|Pilot Part|Disease Progression|0|||
163336361|NCT00486954|589942325|FG004|Pilot Part|Disease Progression|0|||
163336362|NCT00486954|589942321|FG000|Randomized Part|Lost to Follow-up|0|||
163336363|NCT00486954|589942322|FG001|Randomized Part|Lost to Follow-up|0|||
163336364|NCT00486954|589942323|FG002|Randomized Part|Lost to Follow-up|0|||
163336365|NCT00486954|589942324|FG003|Randomized Part|Lost to Follow-up|0|||
163336366|NCT00486954|589942325|FG004|Randomized Part|Lost to Follow-up|1|||
163336367|NCT00486954|589942321|FG000|Randomized Part|Withdrawal by Subject|0|||
163037940|NCT02815267|588845634|FG001|Double-Blind Phase|Protocol Violation|2|||
163037941|NCT02815267|588845633|FG000|Double-Blind Phase|Site withdrawal|1|||
163037942|NCT02815267|588845634|FG001|Double-Blind Phase|Site withdrawal|6|||
163037943|NCT02815267|588845633|FG000|Double-Blind Phase|Received a disallowed medication|1|||
163037944|NCT02815267|588845634|FG001|Double-Blind Phase|Received a disallowed medication|1|||
163037945|NCT02815267|588845633|FG000|Open-Label Phase|Adverse Event|1|||
163037946|NCT02815267|588845634|FG001|Open-Label Phase|Adverse Event|1|||
163037947|NCT02815267|588845633|FG000|Open-Label Phase|Lost to Follow-up|23|||
163336368|NCT00486954|589942322|FG001|Randomized Part|Withdrawal by Subject|0|||
163336369|NCT00486954|589942323|FG002|Randomized Part|Withdrawal by Subject|0|||
163336370|NCT00486954|589942324|FG003|Randomized Part|Withdrawal by Subject|1|||
163336371|NCT00486954|589942325|FG004|Randomized Part|Withdrawal by Subject|0|||
163336372|NCT00486954|589942321|FG000|Randomized Part|Sponsor Terminated Study|0|||
163336373|NCT00486954|589942322|FG001|Randomized Part|Sponsor Terminated Study|0|||
163336374|NCT00486954|589942323|FG002|Randomized Part|Sponsor Terminated Study|0|||
163336375|NCT00486954|589942324|FG003|Randomized Part|Sponsor Terminated Study|19|||
163336376|NCT00486954|589942325|FG004|Randomized Part|Sponsor Terminated Study|13|||
163336377|NCT05124210|589942326|FG000|Overall Study|Lost to Follow-up|1|||
163336378|NCT05124210|589942327|FG001|Overall Study|Lost to Follow-up|0|||
163336379|NCT05124210|589942326|FG000|Overall Study|Withdrawal by Subject|1|||
163336380|NCT05124210|589942327|FG001|Overall Study|Withdrawal by Subject|0|||
163336381|NCT02753075|589942328|FG000|Overall Study|Adverse Event|2|||
163336382|NCT02753075|589942329|FG001|Overall Study|Adverse Event|1|||
163336383|NCT02753075|589942330|FG002|Overall Study|Adverse Event|0|||
163336384|NCT02753075|589942328|FG000|Overall Study|Lost to Follow-up|2|||
163336385|NCT02753075|589942329|FG001|Overall Study|Lost to Follow-up|0|||
163336386|NCT02753075|589942330|FG002|Overall Study|Lost to Follow-up|0|||
163336387|NCT02753075|589942328|FG000|Overall Study|Withdrawal of Consent|1|||
163336388|NCT02753075|589942329|FG001|Overall Study|Withdrawal of Consent|1|||
163336389|NCT02753075|589942330|FG002|Overall Study|Withdrawal of Consent|3|||
163089783|NCT03218917|589039583|FG002|Overall Study|Lost to Follow-up|0|||
163089784|NCT03218917|589039581|FG000|Overall Study|Reason Missing|0|||
163089785|NCT03218917|589039582|FG001|Overall Study|Reason Missing|2|||
163089786|NCT03218917|589039583|FG002|Overall Study|Reason Missing|0|||
163089787|NCT03218917|589039581|FG000|Overall Study|Death|0|||
163089788|NCT03218917|589039582|FG001|Overall Study|Death|1|||
163089789|NCT03218917|589039583|FG002|Overall Study|Death|0|||
163089790|NCT03218917|589039581|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163089791|NCT03218917|589039582|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163089792|NCT03218917|589039583|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163089793|NCT01908140|589039584|FG000|Overall Study|Other or Progressive Disease|5|||
163089794|NCT01908140|589039585|FG001|Overall Study|Other or Progressive Disease|12|||
163089795|NCT01908140|589039584|FG000|Overall Study|Lack of Efficacy|7|||
163089796|NCT01908140|589039585|FG001|Overall Study|Lack of Efficacy|5|||
163089797|NCT01908140|589039584|FG000|Overall Study|Withdrawal by Subject|23|||
163089798|NCT01908140|589039585|FG001|Overall Study|Withdrawal by Subject|24|||
163089799|NCT01908140|589039584|FG000|Overall Study|Lost to Follow-up|1|||
163089800|NCT01908140|589039585|FG001|Overall Study|Lost to Follow-up|6|||
163089801|NCT01908140|589039584|FG000|Overall Study|Protocol Violation|8|||
163089802|NCT01908140|589039585|FG001|Overall Study|Protocol Violation|9|||
163089803|NCT01908140|589039584|FG000|Overall Study|Adverse Event|22|||
163089804|NCT01908140|589039585|FG001|Overall Study|Adverse Event|23|||
163089805|NCT02581891|589039590|FG000|Overall Study|Adverse Event|4|||
163089806|NCT02581891|589039591|FG001|Overall Study|Adverse Event|6|||
163089807|NCT02581891|589039590|FG000|Overall Study|Death|3|||
163089808|NCT02581891|589039591|FG001|Overall Study|Death|4|||
163089809|NCT02581891|589039590|FG000|Overall Study|Lost to Follow-up|1|||
163089810|NCT02581891|589039591|FG001|Overall Study|Lost to Follow-up|2|||
163089811|NCT02581891|589039590|FG000|Overall Study|Physician Decision|0|||
163089812|NCT02581891|589039591|FG001|Overall Study|Physician Decision|1|||
163089813|NCT02581891|589039590|FG000|Overall Study|Withdrawal by Subject|4|||
163089814|NCT02581891|589039591|FG001|Overall Study|Withdrawal by Subject|5|||
163089815|NCT02581891|589039590|FG000|Overall Study|Other Reasons|3|||
163089816|NCT02581891|589039591|FG001|Overall Study|Other Reasons|1|||
163089817|NCT02581891|589039590|FG000|Overall Study|Discontinued during followup|1|||
163336390|NCT02753075|589942328|FG000|Overall Study|Physician Decision|3|||
163336391|NCT02753075|589942329|FG001|Overall Study|Physician Decision|1|||
163336392|NCT02753075|589942330|FG002|Overall Study|Physician Decision|0|||
163336393|NCT02143713|589942331|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
163336394|NCT02143713|589942332|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
163336395|NCT02143713|589942333|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
163336396|NCT02143713|589942334|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
163336397|NCT02143713|589942331|FG000|Treatment Period (6 Months)|Adverse Event|7|||
163336398|NCT02143713|589942332|FG001|Treatment Period (6 Months)|Adverse Event|8|||
163089818|NCT02581891|589039591|FG001|Overall Study|Discontinued during followup|0|||
163089819|NCT01076010|589039592|FG000|Overall Study|Death|15|||
163089820|NCT01076010|589039593|FG001|Overall Study|Death|1|||
163089821|NCT01076010|589039594|FG002|Overall Study|Death|0|||
163089822|NCT01076010|589039592|FG000|Overall Study|Adverse Event|7|||
163089823|NCT01076010|589039593|FG001|Overall Study|Adverse Event|2|||
163089824|NCT01076010|589039594|FG002|Overall Study|Adverse Event|0|||
163089825|NCT01076010|589039592|FG000|Overall Study|Progressive disease|90|||
163089826|NCT01076010|589039593|FG001|Overall Study|Progressive disease|30|||
163089827|NCT01076010|589039594|FG002|Overall Study|Progressive disease|1|||
163089828|NCT01076010|589039592|FG000|Overall Study|Lack of Efficacy|4|||
163089829|NCT01076010|589039593|FG001|Overall Study|Lack of Efficacy|0|||
163089830|NCT01076010|589039594|FG002|Overall Study|Lack of Efficacy|0|||
163336399|NCT02143713|589942333|FG002|Treatment Period (6 Months)|Adverse Event|8|||
163407337|NCT01339559|590200778|FG000|Overall Study|Left the country|1|||
163089831|NCT01076010|589039592|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
163089832|NCT01076010|589039593|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
163089833|NCT01076010|589039594|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
163089834|NCT01076010|589039592|FG000|Overall Study|Significant Surgical Procedure|0|||
163089835|NCT01076010|589039593|FG001|Overall Study|Significant Surgical Procedure|1|||
163089836|NCT01076010|589039594|FG002|Overall Study|Significant Surgical Procedure|0|||
163089837|NCT01076010|589039592|FG000|Overall Study|Protocol Violation|0|||
163089838|NCT01076010|589039593|FG001|Overall Study|Protocol Violation|1|||
163089839|NCT01076010|589039594|FG002|Overall Study|Protocol Violation|0|||
163089840|NCT01076010|589039592|FG000|Overall Study|Noncompliance|1|||
163089841|NCT01076010|589039593|FG001|Overall Study|Noncompliance|1|||
163089842|NCT01076010|589039594|FG002|Overall Study|Noncompliance|0|||
163089843|NCT01076010|589039592|FG000|Overall Study|Withdrawal by Subject|3|||
163089844|NCT01076010|589039593|FG001|Overall Study|Withdrawal by Subject|0|||
163089845|NCT01076010|589039594|FG002|Overall Study|Withdrawal by Subject|1|||
163089846|NCT01076010|589039592|FG000|Overall Study|Other|5|||
163089847|NCT01076010|589039593|FG001|Overall Study|Other|2|||
163089848|NCT01076010|589039594|FG002|Overall Study|Other|0|||
163089849|NCT01612676|589039595|FG000|Overall Study|Adverse Event|2|||
163089850|NCT01612676|589039596|FG001|Overall Study|Adverse Event|3|||
163089851|NCT01612676|589039597|FG002|Overall Study|Adverse Event|1|||
163089852|NCT01612676|589039598|FG003|Overall Study|Adverse Event|3|||
163089853|NCT01612676|589039595|FG000|Overall Study|Protocol Violation|0|||
163089854|NCT01612676|589039596|FG001|Overall Study|Protocol Violation|1|||
163089855|NCT01612676|589039597|FG002|Overall Study|Protocol Violation|0|||
163089856|NCT01612676|589039598|FG003|Overall Study|Protocol Violation|0|||
163089857|NCT00181844|589039605|FG000|Signed Consent|Withdrawal by Subject|5|||
163089858|NCT00181844|589039605|FG000|Signed Consent|Did not meet entrance criteria|7|||
163089859|NCT00181844|589039605|FG000|Exposed to Study Medication|Adverse Event|10|||
163089860|NCT00181844|589039605|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
163089861|NCT00181844|589039605|FG000|Exposed to Study Medication|Non-compliance|2|||
163089862|NCT00181844|589039605|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
163089863|NCT00181844|589039605|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
163089864|NCT01959932|589039609|FG000|Overall Study|Withdrawal by Subject|1|||
163089865|NCT01959932|589039610|FG001|Overall Study|Withdrawal by Subject|0|||
163089866|NCT01959932|589039611|FG002|Overall Study|Withdrawal by Subject|0|||
163089867|NCT00397540|589039612|FG000|Overall Study|short follow-up duration < 12 months|1|||
163089868|NCT00397540|589039613|FG001|Overall Study|short follow-up duration < 12 months|0|||
163089869|NCT00060944|589039616|FG000|Overall Study|Adverse Event|12|||
163089870|NCT00060944|589039617|FG001|Overall Study|Adverse Event|10|||
163089871|NCT00060944|589039616|FG000|Overall Study|Death|2|||
163089872|NCT00060944|589039617|FG001|Overall Study|Death|3|||
163089873|NCT00060944|589039616|FG000|Overall Study|Withdrawal by Subject|18|||
163089874|NCT00060944|589039617|FG001|Overall Study|Withdrawal by Subject|5|||
163089875|NCT00060944|589039616|FG000|Overall Study|Disease Progression|93|||
163089876|NCT00060944|589039617|FG001|Overall Study|Disease Progression|94|||
163089877|NCT00060944|589039616|FG000|Overall Study|Lost to Follow-up|1|||
163089878|NCT00060944|589039617|FG001|Overall Study|Lost to Follow-up|0|||
163089879|NCT00060944|589039616|FG000|Overall Study|Subject Ineligible To Continue|2|||
163089880|NCT00060944|589039617|FG001|Overall Study|Subject Ineligible To Continue|1|||
163089881|NCT00060944|589039616|FG000|Overall Study|Treatment Switch|0|||
163089882|NCT00060944|589039617|FG001|Overall Study|Treatment Switch|13|||
163089883|NCT00060944|589039616|FG000|Overall Study|Other|2|||
163089884|NCT00060944|589039617|FG001|Overall Study|Other|4|||
163089885|NCT00060944|589039616|FG000|Overall Study|randomized but not treated|6|||
163089886|NCT00060944|589039617|FG001|Overall Study|randomized but not treated|4|||
163089887|NCT00776230|589039622|FG000|Overall Study|Lost to Follow-up|2|||
163089888|NCT00776230|589039623|FG001|Overall Study|Lost to Follow-up|1|||
163089889|NCT00776230|589039624|FG002|Overall Study|Lost to Follow-up|5|||
163089890|NCT00776230|589039622|FG000|Overall Study|Not vaccinated at Day 0|1|||
163220064|NCT03190889|589521398|FG001|Overall Study|Did not complete protocol|9|||
163220065|NCT03190889|589521399|FG002|Overall Study|Did not complete protocol|0|||
163220066|NCT03190889|589521397|FG000|Overall Study|COVID-19|1|||
163220067|NCT03190889|589521398|FG001|Overall Study|COVID-19|0|||
163089891|NCT00776230|589039623|FG001|Overall Study|Not vaccinated at Day 0|0|||
163089892|NCT00776230|589039624|FG002|Overall Study|Not vaccinated at Day 0|0|||
163089893|NCT00776230|589039622|FG000|Overall Study|Withdrawal by Subject|0|||
163089894|NCT00776230|589039623|FG001|Overall Study|Withdrawal by Subject|1|||
163089895|NCT00776230|589039624|FG002|Overall Study|Withdrawal by Subject|0|||
163089896|NCT00776230|589039622|FG000|Overall Study|Subject missed Visit 4|0|||
163089897|NCT00776230|589039623|FG001|Overall Study|Subject missed Visit 4|1|||
163089898|NCT00776230|589039624|FG002|Overall Study|Subject missed Visit 4|0|||
163089899|NCT01215851|589039625|FG000|Treatment Period|Adverse Event|1|||
163089900|NCT01215851|589039626|FG001|Treatment Period|Adverse Event|1|||
163089901|NCT01215851|589039627|FG002|Treatment Period|Adverse Event|1|||
163089902|NCT01215851|589039628|FG003|Treatment Period|Adverse Event|3|||
163220068|NCT03190889|589521399|FG002|Overall Study|COVID-19|2|||
163089903|NCT01215851|589039629|FG004|Treatment Period|Adverse Event|0|||
163089904|NCT01215851|589039630|FG005|Treatment Period|Adverse Event|1|||
163089905|NCT01215851|589039625|FG000|Follow up Period|Lost to Follow-up|0|||
163089906|NCT01215851|589039626|FG001|Follow up Period|Lost to Follow-up|0|||
163089907|NCT01215851|589039627|FG002|Follow up Period|Lost to Follow-up|0|||
163089908|NCT01215851|589039628|FG003|Follow up Period|Lost to Follow-up|0|||
163089909|NCT01215851|589039629|FG004|Follow up Period|Lost to Follow-up|0|||
163089910|NCT01215851|589039630|FG005|Follow up Period|Lost to Follow-up|1|||
163089911|NCT03961308|589039631|FG000|Overall Study|Withdrawal by Subject|1|||
163089912|NCT03961308|589039632|FG001|Overall Study|Withdrawal by Subject|0|||
163089913|NCT03961308|589039631|FG000|Overall Study|Other|1|||
163089914|NCT03961308|589039632|FG001|Overall Study|Other|0|||
163089915|NCT03961308|589039631|FG000|Overall Study|Lost to Follow-up|0|||
163089916|NCT03961308|589039632|FG001|Overall Study|Lost to Follow-up|1|||
163089917|NCT03961308|589039631|FG000|Overall Study|Adverse Event|0|||
163089918|NCT03961308|589039632|FG001|Overall Study|Adverse Event|1|||
163089919|NCT02297412|589039638|FG000|Overall Study|Canceled|1|||
163089920|NCT02297412|589039639|FG001|Overall Study|Canceled|1|||
163089921|NCT04549454|589039645|FG000|T1 to T2|Lost to Follow-up|22|||
163089922|NCT04549454|589039646|FG001|T1 to T2|Lost to Follow-up|26|||
163089923|NCT04549454|589039645|FG000|T1 to T3|Lost to Follow-up|31|||
163089924|NCT04549454|589039646|FG001|T1 to T3|Lost to Follow-up|36|||
163089925|NCT01355627|589039652|FG000|Overall Study|Request By the Patient to Discontinue|5|||
163089926|NCT01355627|589039653|FG001|Overall Study|Request By the Patient to Discontinue|7|||
163089927|NCT01355627|589039652|FG000|Overall Study|Lost to Follow-up|8|||
163089928|NCT01355627|589039653|FG001|Overall Study|Lost to Follow-up|7|||
163089929|NCT01355627|589039652|FG000|Overall Study|Fatal Adverse Event|19|||
163089930|NCT01355627|589039653|FG001|Overall Study|Fatal Adverse Event|23|||
163089931|NCT01355627|589039652|FG000|Overall Study|Other|1|||
163089932|NCT01355627|589039653|FG001|Overall Study|Other|1|||
163089933|NCT00545779|589039656|FG000|Overall Study|Violation of selection criteria at entry|8|||
163089934|NCT00545779|589039656|FG000|Overall Study|Other protocol violation|1|||
163089935|NCT00545779|589039656|FG000|Overall Study|Did not cooperate|7|||
163089936|NCT00545779|589039656|FG000|Overall Study|Withdrawal by Subject|20|||
163089937|NCT00545779|589039656|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
163089938|NCT00545779|589039656|FG000|Overall Study|Failure to return|3|||
163089939|NCT01405196|589039657|FG000|Overall Study|Study Terminated by Sponsor|0|||
163089940|NCT01405196|589039658|FG001|Overall Study|Study Terminated by Sponsor|0|||
163089941|NCT01405196|589039659|FG002|Overall Study|Study Terminated by Sponsor|9|||
163089942|NCT01405196|589039660|FG003|Overall Study|Study Terminated by Sponsor|0|||
163089943|NCT01405196|589039657|FG000|Overall Study|Other|2|||
163089944|NCT01405196|589039658|FG001|Overall Study|Other|2|||
163089945|NCT01405196|589039659|FG002|Overall Study|Other|5|||
163089946|NCT01405196|589039660|FG003|Overall Study|Other|0|||
163089947|NCT01405196|589039657|FG000|Overall Study|Withdrawal by Subject|4|||
163089948|NCT01405196|589039658|FG001|Overall Study|Withdrawal by Subject|6|||
163089949|NCT01405196|589039659|FG002|Overall Study|Withdrawal by Subject|3|||
163089950|NCT01405196|589039660|FG003|Overall Study|Withdrawal by Subject|6|||
163089951|NCT01405196|589039657|FG000|Overall Study|Adverse Event|2|||
163089952|NCT01405196|589039658|FG001|Overall Study|Adverse Event|2|||
163089953|NCT01405196|589039659|FG002|Overall Study|Adverse Event|0|||
163089954|NCT01405196|589039660|FG003|Overall Study|Adverse Event|2|||
163089955|NCT01405196|589039657|FG000|Overall Study|Death|1|||
163089956|NCT01405196|589039658|FG001|Overall Study|Death|0|||
163089957|NCT01405196|589039659|FG002|Overall Study|Death|3|||
163089958|NCT01405196|589039660|FG003|Overall Study|Death|0|||
163089959|NCT01405196|589039657|FG000|Overall Study|Lost to Follow-up|2|||
163089960|NCT01405196|589039658|FG001|Overall Study|Lost to Follow-up|2|||
163089961|NCT01405196|589039659|FG002|Overall Study|Lost to Follow-up|3|||
163089962|NCT01405196|589039660|FG003|Overall Study|Lost to Follow-up|1|||
163089963|NCT01542788|589039661|FG000|Overall Study|Randomized but Not Treated|2|||
163089964|NCT01542788|589039662|FG001|Overall Study|Randomized but Not Treated|0|||
163089965|NCT01542788|589039661|FG000|Overall Study|Lack of Efficacy|41|||
163089966|NCT01542788|589039662|FG001|Overall Study|Lack of Efficacy|71|||
163089967|NCT01542788|589039661|FG000|Overall Study|Lost to Follow-up|5|||
163089968|NCT01542788|589039662|FG001|Overall Study|Lost to Follow-up|0|||
163089969|NCT01542788|589039661|FG000|Overall Study|Death|3|||
163089970|NCT01542788|589039662|FG001|Overall Study|Death|0|||
163089971|NCT01542788|589039661|FG000|Overall Study|Protocol Violation|2|||
163089972|NCT01542788|589039662|FG001|Overall Study|Protocol Violation|0|||
163089973|NCT01542788|589039661|FG000|Overall Study|Physician Decision|1|||
163089974|NCT01542788|589039662|FG001|Overall Study|Physician Decision|0|||
163089975|NCT01542788|589039661|FG000|Overall Study|Withdrawal by Subject|1|||
163089976|NCT01542788|589039662|FG001|Overall Study|Withdrawal by Subject|0|||
163089977|NCT01400412|589039663|FG000|Overall Study|Lost to Follow-up|4|||
163089978|NCT01400412|589039664|FG001|Overall Study|Lost to Follow-up|7|||
163089979|NCT01400412|589039663|FG000|Overall Study|Withdrawal by Subject|3|||
163089980|NCT01400412|589039664|FG001|Overall Study|Withdrawal by Subject|4|||
163089981|NCT01400412|589039663|FG000|Overall Study|Unable to complete|3|||
163089982|NCT01400412|589039664|FG001|Overall Study|Unable to complete|3|||
163336400|NCT02143713|589942334|FG003|Treatment Period (6 Months)|Adverse Event|9|||
163336401|NCT02143713|589942331|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
163336402|NCT02143713|589942332|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
163336403|NCT02143713|589942333|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
163336404|NCT02143713|589942334|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
163336405|NCT02143713|589942331|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
163336406|NCT02143713|589942332|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
163336407|NCT02143713|589942333|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
163336408|NCT02143713|589942334|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
163336409|NCT02143713|589942331|FG000|Treatment Period (6 Months)|Pregnancy|0|||
163336410|NCT02143713|589942332|FG001|Treatment Period (6 Months)|Pregnancy|2|||
163336411|NCT02143713|589942333|FG002|Treatment Period (6 Months)|Pregnancy|2|||
163336412|NCT02143713|589942334|FG003|Treatment Period (6 Months)|Pregnancy|0|||
163336413|NCT02143713|589942331|FG000|Treatment Period (6 Months)|Non-compliance|1|||
163336414|NCT02143713|589942332|FG001|Treatment Period (6 Months)|Non-compliance|0|||
163336415|NCT02143713|589942333|FG002|Treatment Period (6 Months)|Non-compliance|0|||
163336416|NCT02143713|589942334|FG003|Treatment Period (6 Months)|Non-compliance|3|||
163336417|NCT02143713|589942331|FG000|Treatment Period (6 Months)|Other|3|||
163336418|NCT02143713|589942332|FG001|Treatment Period (6 Months)|Other|0|||
163336419|NCT02143713|589942333|FG002|Treatment Period (6 Months)|Other|3|||
163336420|NCT02143713|589942334|FG003|Treatment Period (6 Months)|Other|2|||
163336421|NCT02143713|589942331|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
163336422|NCT02143713|589942332|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
163336423|NCT02143713|589942333|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
163336424|NCT02143713|589942334|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
163336425|NCT02143713|589942331|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
163336426|NCT02143713|589942332|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
163336427|NCT02143713|589942333|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
163336428|NCT02143713|589942334|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
163336429|NCT02143713|589942331|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
163336430|NCT02143713|589942332|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
163336431|NCT02143713|589942333|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
163336432|NCT02143713|589942334|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
163336433|NCT02143713|589942331|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
163336434|NCT02143713|589942332|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
163089983|NCT01400412|589039663|FG000|Overall Study|Never started study treatment|0|||
163089984|NCT01400412|589039664|FG001|Overall Study|Never started study treatment|3|||
163089985|NCT01649869|589039665|FG000|Overall Study|Family member illness|1|||
163089986|NCT01649869|589039666|FG001|Overall Study|Family member illness|0|||
163089987|NCT01649869|589039665|FG000|Overall Study|Required treatment outside protocol|1|||
163089988|NCT01649869|589039666|FG001|Overall Study|Required treatment outside protocol|0|||
163089989|NCT01649869|589039665|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
163089990|NCT01649869|589039666|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
163089991|NCT01126190|589041018|FG000|Double-Blind Phase|Death|0|||
163089992|NCT01126190|589041019|FG001|Double-Blind Phase|Death|1|||
163089993|NCT01126190|589041020|FG002|Double-Blind Phase|Death|0|||
163089994|NCT01126190|589041018|FG000|Double-Blind Phase|Adverse Event|1|||
163089995|NCT01126190|589041019|FG001|Double-Blind Phase|Adverse Event|2|||
163089996|NCT01126190|589041020|FG002|Double-Blind Phase|Adverse Event|0|||
163089997|NCT01126190|589041018|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
163089998|NCT01126190|589041019|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
163089999|NCT01126190|589041020|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
163090000|NCT01126190|589041018|FG000|Double-Blind Phase|Request of Investigator|1|||
163090001|NCT01126190|589041019|FG001|Double-Blind Phase|Request of Investigator|0|||
163090002|NCT01126190|589041020|FG002|Double-Blind Phase|Request of Investigator|0|||
163090003|NCT01126190|589041018|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
163090004|NCT01126190|589041019|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
163090005|NCT01126190|589041020|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
163090006|NCT01126190|589041018|FG000|Double-Blind Phase|Non-compliance|1|||
163090007|NCT01126190|589041019|FG001|Double-Blind Phase|Non-compliance|0|||
163090008|NCT01126190|589041020|FG002|Double-Blind Phase|Non-compliance|0|||
163090009|NCT01126190|589041018|FG000|Double-Blind Phase|Lost to Follow-up|1|||
163090010|NCT01126190|589041019|FG001|Double-Blind Phase|Lost to Follow-up|3|||
163336435|NCT02143713|589942333|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
163336436|NCT02143713|589942334|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
163336437|NCT02143713|589942331|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
163336438|NCT02143713|589942332|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
163336439|NCT02143713|589942333|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
163336440|NCT02143713|589942334|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
163336441|NCT02143713|589942331|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
163090011|NCT01126190|589041020|FG002|Double-Blind Phase|Lost to Follow-up|0|||
163090012|NCT01126190|589041018|FG000|Open-Label Phase|Death|0|||
163090013|NCT01126190|589041019|FG001|Open-Label Phase|Death|0|||
163090014|NCT01126190|589041020|FG002|Open-Label Phase|Death|1|||
163090015|NCT01126190|589041018|FG000|Open-Label Phase|Adverse Event|0|||
163090016|NCT01126190|589041019|FG001|Open-Label Phase|Adverse Event|0|||
163090017|NCT01126190|589041020|FG002|Open-Label Phase|Adverse Event|4|||
163090018|NCT01126190|589041018|FG000|Open-Label Phase|Withdrawal by Subject|0|||
163090019|NCT01126190|589041019|FG001|Open-Label Phase|Withdrawal by Subject|0|||
163090020|NCT01126190|589041020|FG002|Open-Label Phase|Withdrawal by Subject|6|||
163090021|NCT01977898|589041021|FG000|Overall Study|Non functioning catheter|1|||
163090022|NCT01977898|589041022|FG001|Overall Study|Non functioning catheter|1|||
163090023|NCT03386773|589041023|FG000|Overall Study|Lost to Follow-up|24|||
163090024|NCT03386773|589041024|FG001|Overall Study|Lost to Follow-up|33|||
163090025|NCT03386773|589041023|FG000|Overall Study|Withdrawal by Subject|3|||
163090026|NCT03386773|589041024|FG001|Overall Study|Withdrawal by Subject|2|||
163090027|NCT01049373|589041025|FG000|Overall Study|Protocol Violation|9|||
163090028|NCT01049373|589041026|FG001|Overall Study|Protocol Violation|9|||
163090029|NCT01049373|589041025|FG000|Overall Study|Withdrawal by Subject|8|||
163090030|NCT01049373|589041026|FG001|Overall Study|Withdrawal by Subject|5|||
163090031|NCT01049373|589041025|FG000|Overall Study|Adverse Event|3|||
163090032|NCT01049373|589041026|FG001|Overall Study|Adverse Event|3|||
163090033|NCT01049373|589041025|FG000|Overall Study|Lost to Follow-up|9|||
163090034|NCT01049373|589041026|FG001|Overall Study|Lost to Follow-up|4|||
163090035|NCT01049373|589041025|FG000|Overall Study|no evaluable study values|9|||
163090036|NCT01049373|589041026|FG001|Overall Study|no evaluable study values|21|||
163090037|NCT01049373|589041025|FG000|Overall Study|Other|1|||
163090038|NCT01049373|589041026|FG001|Overall Study|Other|1|||
163090039|NCT01049373|589041025|FG000|Overall Study|Non-cooperation|0|||
163090040|NCT01049373|589041026|FG001|Overall Study|Non-cooperation|1|||
163090041|NCT04573972|589041027|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
163090042|NCT04573972|589041028|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
163090043|NCT01198587|589041031|FG000|Overall Study|Lost to Follow-up|8|||
163090044|NCT01198587|589041032|FG001|Overall Study|Lost to Follow-up|0|||
163090045|NCT01198587|589041033|FG002|Overall Study|Lost to Follow-up|9|||
163090046|NCT01198587|589041034|FG003|Overall Study|Lost to Follow-up|0|||
163090047|NCT03036852|589041037|FG000|Overall Study|Death|2|||
163090048|NCT03036852|589041037|FG000|Overall Study|Lack of Efficacy|2|||
163090049|NCT03036852|589041037|FG000|Overall Study|Adverse Event|1|||
163090050|NCT03036852|589041037|FG000|Overall Study|Lost to Follow-up|1|||
163090051|NCT03984825|589041038|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
163090052|NCT03984825|589041038|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
163090053|NCT03984825|589041038|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
163090054|NCT00622726|589041039|FG000|March, 2008 to August, 2010|Death|5|||
163090055|NCT00622726|589041040|FG001|March, 2008 to August, 2010|Death|2|||
163090056|NCT00622726|589041039|FG000|August, 2010 to April, 2013|Death|1|||
163090057|NCT00622726|589041040|FG001|August, 2010 to April, 2013|Death|5|||
163090058|NCT00742625|589041041|FG000|Remission Induction|Progression|6|||
163090059|NCT00742625|589041041|FG000|Remission Induction|Failed induction|8|||
163090060|NCT00742625|589041041|FG000|Remission Induction|Adverse Event|3|||
163090061|NCT00742625|589041041|FG000|Remission Induction|Death|10|||
163090062|NCT00742625|589041041|FG000|Remission Induction|Refusal|5|||
163090063|NCT00742625|589041041|FG000|Remission Induction|Non protocol treatment|17|||
163090064|NCT00742625|589041041|FG000|Remission Induction|Other, not specified|5|||
163090065|NCT00742625|589041041|FG000|Consolidation|Progression|5|||
163090066|NCT00742625|589041041|FG000|Consolidation|Adverse Event|1|||
163090067|NCT00742625|589041041|FG000|Consolidation|Death|1|||
163090068|NCT00742625|589041041|FG000|Consolidation|Refused|1|||
163090069|NCT00742625|589041041|FG000|Consolidation|Non protocol therapy|13|||
163090070|NCT01865487|589041042|FG000|Overall Study|Lost to Follow-up|0|||
163090071|NCT01865487|589041043|FG001|Overall Study|Lost to Follow-up|0|||
163336442|NCT02143713|589942332|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
163090072|NCT01865487|589041044|FG002|Overall Study|Lost to Follow-up|0|||
163090073|NCT01865487|589041045|FG003|Overall Study|Lost to Follow-up|1|||
163090074|NCT01865487|589041046|FG004|Overall Study|Lost to Follow-up|0|||
163090075|NCT01865487|589041047|FG005|Overall Study|Lost to Follow-up|0|||
163090076|NCT01865487|589041048|FG006|Overall Study|Lost to Follow-up|1|||
163090077|NCT01865487|589041049|FG007|Overall Study|Lost to Follow-up|0|||
163090078|NCT01865487|589041050|FG008|Overall Study|Lost to Follow-up|0|||
163090079|NCT01865487|589041051|FG009|Overall Study|Lost to Follow-up|0|||
163220069|NCT02140567|589521401|FG000|Overall Study|Problems with recording equipment|6|||
163090080|NCT01865487|589041042|FG000|Overall Study|Withdrawal by Subject|0|||
163090081|NCT01865487|589041043|FG001|Overall Study|Withdrawal by Subject|0|||
163090082|NCT01865487|589041044|FG002|Overall Study|Withdrawal by Subject|0|||
163090083|NCT01865487|589041045|FG003|Overall Study|Withdrawal by Subject|0|||
163090084|NCT01865487|589041046|FG004|Overall Study|Withdrawal by Subject|1|||
163090085|NCT01865487|589041047|FG005|Overall Study|Withdrawal by Subject|0|||
163090086|NCT01865487|589041048|FG006|Overall Study|Withdrawal by Subject|0|||
163407338|NCT01339559|590200778|FG000|Overall Study|Investigator decision|2|||
163407339|NCT01339559|590200778|FG000|Overall Study|Patient didn't wish to continue|1|||
163407340|NCT01339559|590200778|FG000|Overall Study|PI decision|1|||
163407341|NCT00971945|590200779|FG000|Overall Study|Progressive Disease|3|||
163407342|NCT00971945|590200779|FG000|Overall Study|Change in treatment policy|1|||
163407343|NCT00971945|590200779|FG000|Overall Study|Other reasons|2|||
163407344|NCT03354663|590200780|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
163407345|NCT03354663|590200780|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
163407346|NCT03354663|590200780|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
163407347|NCT03354663|590200780|FG000|Completed 30-day Visit|Missed Visit|1|||
163407348|NCT03691974|590200781|FG000|Overall Study|Physician Decision|1|||
163407349|NCT03691974|590200782|FG001|Overall Study|Physician Decision|0|||
163407350|NCT03691974|590200781|FG000|Overall Study|Adverse Event|1|||
163407351|NCT03691974|590200782|FG001|Overall Study|Adverse Event|0|||
163407352|NCT03691974|590200781|FG000|Overall Study|Withdrawal by Subject|11|||
163407353|NCT03691974|590200782|FG001|Overall Study|Withdrawal by Subject|9|||
163407354|NCT03691974|590200781|FG000|Overall Study|Protocol Violation|1|||
163407355|NCT03691974|590200782|FG001|Overall Study|Protocol Violation|0|||
163407356|NCT03691974|590200781|FG000|Overall Study|Lost to Follow-up|8|||
163407357|NCT03691974|590200782|FG001|Overall Study|Lost to Follow-up|7|||
163407358|NCT00746252|590200786|FG000|Overall Study|weight gain >7.5 %|1|||
163407359|NCT00746252|590200787|FG001|Overall Study|weight gain >7.5 %|2|||
163407360|NCT01049035|590200788|FG000|Overall Study|Serious adverse event|0|||
163407361|NCT01049035|590200789|FG001|Overall Study|Serious adverse event|1|||
163407362|NCT01049035|590200790|FG002|Overall Study|Serious adverse event|1|||
163407363|NCT01049035|590200791|FG003|Overall Study|Serious adverse event|2|||
163407364|NCT01049035|590200792|FG004|Overall Study|Serious adverse event|0|||
163407365|NCT01049035|590200793|FG005|Overall Study|Serious adverse event|0|||
163407366|NCT01049035|590200794|FG006|Overall Study|Serious adverse event|0|||
163407367|NCT01049035|590200788|FG000|Overall Study|Other adverse event (AE)|0|||
163407368|NCT01049035|590200789|FG001|Overall Study|Other adverse event (AE)|0|||
163407369|NCT01049035|590200790|FG002|Overall Study|Other adverse event (AE)|0|||
163407370|NCT01049035|590200791|FG003|Overall Study|Other adverse event (AE)|1|||
163407371|NCT01049035|590200792|FG004|Overall Study|Other adverse event (AE)|0|||
163407372|NCT01049035|590200793|FG005|Overall Study|Other adverse event (AE)|0|||
163407373|NCT01049035|590200794|FG006|Overall Study|Other adverse event (AE)|0|||
163407374|NCT01049035|590200788|FG000|Overall Study|Non-compliance with the protocol|12|||
163407375|NCT01049035|590200789|FG001|Overall Study|Non-compliance with the protocol|6|||
163407376|NCT01049035|590200790|FG002|Overall Study|Non-compliance with the protocol|14|||
163407377|NCT01049035|590200791|FG003|Overall Study|Non-compliance with the protocol|5|||
163407378|NCT01049035|590200792|FG004|Overall Study|Non-compliance with the protocol|3|||
163407379|NCT01049035|590200793|FG005|Overall Study|Non-compliance with the protocol|4|||
163407380|NCT01049035|590200794|FG006|Overall Study|Non-compliance with the protocol|10|||
163407381|NCT01049035|590200788|FG000|Overall Study|Lost to Follow-up|5|||
163407382|NCT01049035|590200789|FG001|Overall Study|Lost to Follow-up|4|||
163407383|NCT01049035|590200790|FG002|Overall Study|Lost to Follow-up|4|||
163407384|NCT01049035|590200791|FG003|Overall Study|Lost to Follow-up|1|||
163407385|NCT01049035|590200792|FG004|Overall Study|Lost to Follow-up|0|||
163407386|NCT01049035|590200793|FG005|Overall Study|Lost to Follow-up|3|||
163407387|NCT01049035|590200794|FG006|Overall Study|Lost to Follow-up|3|||
163407388|NCT01049035|590200788|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
163407389|NCT01049035|590200789|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
163407390|NCT01049035|590200790|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
163407391|NCT01049035|590200791|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
163407392|NCT01049035|590200792|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
163407393|NCT01049035|590200793|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
163407394|NCT01049035|590200794|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
163407395|NCT01137773|590200795|FG000|Overall Study|Death|3|||
163407396|NCT01137773|590200796|FG001|Overall Study|Death|3|||
163407397|NCT01137773|590200795|FG000|Overall Study|Lost to Follow-up|6|||
163407398|NCT01137773|590200796|FG001|Overall Study|Lost to Follow-up|0|||
163407399|NCT03548051|590200798|FG000|Overall Study|Death|1|||
163407400|NCT03548051|590200799|FG001|Overall Study|Death|1|||
163407401|NCT03548051|590200798|FG000|Overall Study|Withdrawal by Subject|1|||
163407402|NCT03548051|590200799|FG001|Overall Study|Withdrawal by Subject|0|||
163407403|NCT00082888|590200800|FG000|Overall Study|Ineligible|1|||
163037948|NCT02815267|588845634|FG001|Open-Label Phase|Lost to Follow-up|9|||
163407404|NCT00082888|590200801|FG001|Overall Study|Ineligible|0|||
163407405|NCT00082888|590200802|FG002|Overall Study|Ineligible|0|||
163407406|NCT00817531|590200804|FG000|Overall Study|Adverse Event|1|||
163407407|NCT00817531|590200804|FG000|Overall Study|Lack of Efficacy|1|||
163407408|NCT00812214|590200805|FG000|Overall Study|Lost to Follow-up|3|||
163407409|NCT00812214|590200806|FG001|Overall Study|Lost to Follow-up|1|||
163407410|NCT03325673|590200809|FG000|Overall Study|Adverse Event|4|||
163407411|NCT03325673|590200810|FG001|Overall Study|Adverse Event|0|||
163037949|NCT02815267|588845633|FG000|Open-Label Phase|Withdrawal by Subject|24|||
163090087|NCT01865487|589041049|FG007|Overall Study|Withdrawal by Subject|0|||
163090088|NCT01865487|589041050|FG008|Overall Study|Withdrawal by Subject|0|||
163090089|NCT01865487|589041051|FG009|Overall Study|Withdrawal by Subject|0|||
163090090|NCT01627691|589041052|FG000|Overall Study|Death|11|||
163090091|NCT01627691|589041052|FG000|Overall Study|Lost to Follow-up|3|||
163090092|NCT01627691|589041052|FG000|Overall Study|Withdrawal by Subject|1|||
163090093|NCT01627691|589041052|FG000|Overall Study|Missed the visit|3|||
163090094|NCT01307449|589041053|FG000|Overall Study|Adverse Event|1|||
163090095|NCT01307449|589041054|FG001|Overall Study|Adverse Event|0|||
163090096|NCT01307449|589041055|FG002|Overall Study|Adverse Event|0|||
163090097|NCT01307449|589041056|FG003|Overall Study|Adverse Event|0|||
163090098|NCT01531998|589041062|FG000|Overall Study|Withdrawal by Subject|3|||
163090099|NCT02927795|589041063|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
163090100|NCT02927795|589041063|FG000|Overall Study|Not Treated|4|||
163090101|NCT01156844|589041065|FG000|Overall Study|Adverse Event|0|||
163090102|NCT01156844|589041066|FG001|Overall Study|Adverse Event|0|||
163090103|NCT01156844|589041067|FG002|Overall Study|Adverse Event|1|||
163090104|NCT01156844|589041068|FG003|Overall Study|Adverse Event|1|||
163037950|NCT02815267|588845634|FG001|Open-Label Phase|Withdrawal by Subject|13|||
163037951|NCT02815267|588845633|FG000|Open-Label Phase|Protocol Violation|0|||
163037952|NCT02815267|588845634|FG001|Open-Label Phase|Protocol Violation|1|||
163037953|NCT02815267|588845633|FG000|Open-Label Phase|Administrative|21|||
163037954|NCT02815267|588845634|FG001|Open-Label Phase|Administrative|12|||
163037955|NCT02815267|588845633|FG000|Open-Label Phase|Other|2|||
163037956|NCT02815267|588845634|FG001|Open-Label Phase|Other|5|||
163037957|NCT04126317|588845648|FG000|Overall Study|Adverse Event|0|||
163037958|NCT04126317|588845649|FG001|Overall Study|Adverse Event|1|||
163037959|NCT04126317|588845648|FG000|Overall Study|Withdrawal by Subject|4|||
163037960|NCT04126317|588845649|FG001|Overall Study|Withdrawal by Subject|1|||
163037961|NCT00660595|588845652|FG000|Overall Study|Lost to Follow-up|0|||
163037962|NCT00660595|588845653|FG001|Overall Study|Lost to Follow-up|1|||
163037963|NCT00660595|588845652|FG000|Overall Study|Did not consent to participate in study|12|||
163037964|NCT00660595|588845653|FG001|Overall Study|Did not consent to participate in study|8|||
163037965|NCT00660595|588845652|FG000|Overall Study|Participant left hospital|1|||
163037966|NCT00660595|588845653|FG001|Overall Study|Participant left hospital|0|||
163037967|NCT00660595|588845652|FG000|Overall Study|Non Specified reasons|5|||
163037968|NCT00660595|588845653|FG001|Overall Study|Non Specified reasons|0|||
163037969|NCT01204918|588845683|FG000|Overall Study|Withdrawal by Subject|4|||
163037970|NCT01204918|588845684|FG001|Overall Study|Withdrawal by Subject|10|||
163037971|NCT01204918|588845685|FG002|Overall Study|Withdrawal by Subject|5|||
163037972|NCT01280682|588845690|FG000|Overall Study|Lost to Follow-up|0|||
163037973|NCT01280682|588845691|FG001|Overall Study|Lost to Follow-up|6|||
163037974|NCT01280682|588845690|FG000|Overall Study|Withdrawal by Subject|0|||
163037975|NCT01280682|588845691|FG001|Overall Study|Withdrawal by Subject|7|||
163037976|NCT00269477|588845697|FG000|Overall Study|Protocol Violation|5|||
163037977|NCT00269477|588845698|FG001|Overall Study|Protocol Violation|5|||
163037978|NCT00269477|588845699|FG002|Overall Study|Protocol Violation|1|||
163037979|NCT00269477|588845700|FG003|Overall Study|Protocol Violation|0|||
163037980|NCT00269477|588845697|FG000|Overall Study|Missed post-vaccination blood draw|0|||
163037981|NCT00269477|588845698|FG001|Overall Study|Missed post-vaccination blood draw|1|||
163037982|NCT00269477|588845699|FG002|Overall Study|Missed post-vaccination blood draw|0|||
163037983|NCT00269477|588845700|FG003|Overall Study|Missed post-vaccination blood draw|0|||
163037984|NCT00431067|588845701|FG000|Overall Study|Other Adverse Event|9|||
163037985|NCT00431067|588845701|FG000|Overall Study|Progressive disease|30|||
163037986|NCT00431067|588845701|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
163037987|NCT00548249|588845702|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
163037988|NCT00548249|588845703|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
163037989|NCT00548249|588845704|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
163037990|NCT00548249|588845705|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
163037991|NCT00548249|588845706|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
163037992|NCT00548249|588845702|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
163037993|NCT00548249|588845703|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
163037994|NCT00548249|588845704|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
163037995|NCT00548249|588845705|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
163037996|NCT00548249|588845706|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
163037997|NCT00548249|588845702|FG000|Overall Study|Protocol Violation|1|||
163090105|NCT01156844|589041065|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163037998|NCT00548249|588845703|FG001|Overall Study|Protocol Violation|1|||
163037999|NCT00548249|588845704|FG002|Overall Study|Protocol Violation|4|||
163038000|NCT00548249|588845705|FG003|Overall Study|Protocol Violation|0|||
163038001|NCT00548249|588845706|FG004|Overall Study|Protocol Violation|3|||
163038002|NCT00548249|588845702|FG000|Overall Study|Miscellaneous|2|||
163038003|NCT00548249|588845703|FG001|Overall Study|Miscellaneous|3|||
163038004|NCT00548249|588845704|FG002|Overall Study|Miscellaneous|2|||
163038005|NCT00548249|588845705|FG003|Overall Study|Miscellaneous|0|||
163090106|NCT01156844|589041066|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163090107|NCT01156844|589041067|FG002|Overall Study|Abnormal test procedure result(s)|2|||
163090108|NCT01156844|589041068|FG003|Overall Study|Abnormal test procedure result(s)|2|||
163090109|NCT01156844|589041065|FG000|Overall Study|Withdrawal by Subject|0|||
163090110|NCT01156844|589041066|FG001|Overall Study|Withdrawal by Subject|0|||
163090111|NCT01156844|589041067|FG002|Overall Study|Withdrawal by Subject|2|||
163090112|NCT01156844|589041068|FG003|Overall Study|Withdrawal by Subject|2|||
163090113|NCT01156844|589041065|FG000|Overall Study|Lost to Follow-up|0|||
163090114|NCT01156844|589041066|FG001|Overall Study|Lost to Follow-up|0|||
163090115|NCT01156844|589041067|FG002|Overall Study|Lost to Follow-up|1|||
163090116|NCT01156844|589041068|FG003|Overall Study|Lost to Follow-up|0|||
163090117|NCT01156844|589041065|FG000|Overall Study|Administrative problems|0|||
163090118|NCT01156844|589041066|FG001|Overall Study|Administrative problems|1|||
163090119|NCT01156844|589041067|FG002|Overall Study|Administrative problems|0|||
163090120|NCT01156844|589041068|FG003|Overall Study|Administrative problems|1|||
163090121|NCT01156844|589041065|FG000|Overall Study|Protocol deviation|2|||
163090122|NCT01156844|589041066|FG001|Overall Study|Protocol deviation|0|||
163090123|NCT01156844|589041067|FG002|Overall Study|Protocol deviation|0|||
163090124|NCT01156844|589041068|FG003|Overall Study|Protocol deviation|0|||
163090125|NCT04661033|589041070|FG000|Overall Study|Adverse Event|0|||
163090126|NCT04661033|589041071|FG001|Overall Study|Adverse Event|0|||
163090127|NCT04661033|589041072|FG002|Overall Study|Adverse Event|1|||
163090128|NCT04661033|589041073|FG003|Overall Study|Adverse Event|0|||
163090129|NCT04661033|589041070|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
163090130|NCT04661033|589041071|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
163090131|NCT04661033|589041072|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
163090132|NCT04661033|589041073|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
163090133|NCT04661033|589041070|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
163090134|NCT04661033|589041071|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
163090135|NCT04661033|589041072|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
163090136|NCT04661033|589041073|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
163090137|NCT04661033|589041070|FG000|Overall Study|Early discontinuation as per PI|1|||
163090138|NCT04661033|589041071|FG001|Overall Study|Early discontinuation as per PI|0|||
163090139|NCT04661033|589041072|FG002|Overall Study|Early discontinuation as per PI|0|||
163090140|NCT04661033|589041073|FG003|Overall Study|Early discontinuation as per PI|0|||
163090141|NCT03440008|589041074|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
163090142|NCT03440008|589041075|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
163090143|NCT03440008|589041074|FG000|Overall Study|Withdrawal by Subject|1|||
163090144|NCT03440008|589041075|FG001|Overall Study|Withdrawal by Subject|0|||
163090145|NCT01734902|589041084|FG000|Overall Study|Other than listed|0|||
163090146|NCT01734902|589041085|FG001|Overall Study|Other than listed|2|||
163090147|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
163090148|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
163090149|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
163090150|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Death|0|||
163090151|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Death|0|||
163090152|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Death|1|||
163090153|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
163090154|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
163090155|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
163090156|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
163090157|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
163090158|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
163090159|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
163090160|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
163090161|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
163038006|NCT00548249|588845706|FG004|Overall Study|Miscellaneous|2|||
163038007|NCT00548249|588845702|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
163038008|NCT00548249|588845703|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
163038009|NCT00548249|588845704|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
163038010|NCT00548249|588845705|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
163038011|NCT00548249|588845706|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
163038012|NCT00548249|588845702|FG000|Overall Study|Adverse Event|2|||
163038013|NCT00548249|588845703|FG001|Overall Study|Adverse Event|2|||
163038014|NCT00548249|588845704|FG002|Overall Study|Adverse Event|0|||
163038015|NCT00548249|588845705|FG003|Overall Study|Adverse Event|1|||
163090162|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Graft loss|0|||
163090163|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Graft loss|0|||
163090164|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Graft loss|7|||
163038016|NCT00548249|588845706|FG004|Overall Study|Adverse Event|1|||
163038017|NCT00548249|588845702|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
163336443|NCT02143713|589942333|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
163336444|NCT02143713|589942334|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
163336445|NCT02143713|589942331|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
163336446|NCT02143713|589942332|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
163336447|NCT02143713|589942333|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
163336448|NCT02143713|589942334|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
163336449|NCT02143713|589942331|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
163336450|NCT02143713|589942332|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
163336451|NCT02143713|589942333|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
163336452|NCT02143713|589942334|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
163336453|NCT02143713|589942331|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
163336454|NCT02143713|589942332|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
163336455|NCT02143713|589942333|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
163336456|NCT02143713|589942334|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
163336457|NCT01999335|589942335|FG000|Overall Study|Discontinued before receiving treatment|0|||
163336458|NCT01999335|589942336|FG001|Overall Study|Discontinued before receiving treatment|0|||
163336459|NCT01999335|589942337|FG002|Overall Study|Discontinued before receiving treatment|0|||
163336460|NCT01999335|589942338|FG003|Overall Study|Discontinued before receiving treatment|0|||
163336461|NCT01999335|589942339|FG004|Overall Study|Discontinued before receiving treatment|2|||
163336462|NCT01215253|589942340|FG000|Overall Study|Withdrawal by Subject|57|||
163336463|NCT01215253|589942341|FG001|Overall Study|Withdrawal by Subject|35|||
163336464|NCT01215253|589942340|FG000|Overall Study|Physician Decision|9|||
163336465|NCT01215253|589942341|FG001|Overall Study|Physician Decision|12|||
163336466|NCT01215253|589942340|FG000|Overall Study|Lost to Follow-up|6|||
163336467|NCT01215253|589942341|FG001|Overall Study|Lost to Follow-up|4|||
163336468|NCT01215253|589942340|FG000|Overall Study|Other|14|||
163336469|NCT01215253|589942341|FG001|Overall Study|Other|12|||
163336470|NCT00080119|589942342|FG000|Overall Study|Discontinued because of study closure|0|||
163336471|NCT00080119|589942343|FG001|Overall Study|Discontinued because of study closure|0|||
163336472|NCT00080119|589942344|FG002|Overall Study|Discontinued because of study closure|130|||
163336473|NCT00080119|589942345|FG003|Overall Study|Discontinued because of study closure|141|||
163336474|NCT00080119|589942342|FG000|Overall Study|Unable to get to clinic|24|||
163038018|NCT00548249|588845703|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
163220070|NCT02882854|589521404|FG000|Overall Study|Lost to Follow-up|1|||
163038019|NCT00548249|588845704|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
163038020|NCT00548249|588845705|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
163038021|NCT00548249|588845706|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
163038022|NCT00548249|588845702|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
163038023|NCT00548249|588845703|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
163038024|NCT00548249|588845704|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
163038025|NCT00548249|588845705|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
163038026|NCT00548249|588845706|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
163038027|NCT00548249|588845702|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
163038028|NCT00548249|588845703|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
163038029|NCT00548249|588845704|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
163038030|NCT00548249|588845705|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
163038031|NCT00548249|588845706|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
163038032|NCT00548249|588845702|FG000|Overall Study|Prolonged hospitalization|0|||
163038033|NCT00548249|588845703|FG001|Overall Study|Prolonged hospitalization|0|||
163038034|NCT00548249|588845704|FG002|Overall Study|Prolonged hospitalization|2|||
163038035|NCT00548249|588845705|FG003|Overall Study|Prolonged hospitalization|1|||
163038036|NCT00548249|588845706|FG004|Overall Study|Prolonged hospitalization|0|||
163038037|NCT00548249|588845702|FG000|Overall Study|Withdrawal by Subject|2|||
163038038|NCT00548249|588845703|FG001|Overall Study|Withdrawal by Subject|0|||
163038039|NCT00548249|588845704|FG002|Overall Study|Withdrawal by Subject|0|||
163038040|NCT00548249|588845705|FG003|Overall Study|Withdrawal by Subject|0|||
163038041|NCT00548249|588845706|FG004|Overall Study|Withdrawal by Subject|0|||
163038042|NCT00548249|588845702|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
163038043|NCT00548249|588845703|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
163038044|NCT00548249|588845704|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
163038045|NCT00548249|588845705|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
163038046|NCT00548249|588845706|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
163038047|NCT00548249|588845702|FG000|Overall Study|Sponsor's request|0|||
163038048|NCT00548249|588845703|FG001|Overall Study|Sponsor's request|0|||
163038049|NCT00548249|588845704|FG002|Overall Study|Sponsor's request|0|||
163038050|NCT00548249|588845705|FG003|Overall Study|Sponsor's request|1|||
163038051|NCT00548249|588845706|FG004|Overall Study|Sponsor's request|0|||
163038052|NCT00080483|588845708|FG000|Overall Study|Lost to Follow-up|1|||
163038053|NCT00080483|588845709|FG001|Overall Study|Lost to Follow-up|1|||
163038054|NCT00080483|588845708|FG000|Overall Study|Physician Decision|1|||
163090165|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
163090166|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
163090167|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
163038055|NCT00080483|588845709|FG001|Overall Study|Physician Decision|1|||
163038056|NCT02007278|588845712|FG000|Overall Study|Failure to comply with an eligibility|0|||
163038057|NCT02007278|588845713|FG001|Overall Study|Failure to comply with an eligibility|1|||
163038058|NCT02007278|588845712|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
163038059|NCT02007278|588845713|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
163038060|NCT02007278|588845712|FG000|Overall Study|Incorrect medication administration|1|||
163038061|NCT02007278|588845713|FG001|Overall Study|Incorrect medication administration|0|||
163038062|NCT02007278|588845712|FG000|Overall Study|Mis-randomization|1|||
163038063|NCT02007278|588845713|FG001|Overall Study|Mis-randomization|1|||
163038064|NCT01404949|588845714|FG000|Overall Study|Not Treated|1|||
163038065|NCT02651688|588845718|FG000|Overall Study|Non-compliance|0|||
163038066|NCT02651688|588845719|FG001|Overall Study|Non-compliance|0|||
163038067|NCT02651688|588845720|FG002|Overall Study|Non-compliance|1|||
163038068|NCT02651688|588845718|FG000|Overall Study|Principal Investigator (PI) decision|0|||
163090168|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
163090169|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
163090170|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
163090171|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
163090172|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
163090173|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
163090174|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
163090175|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
163090176|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
163090177|NCT00956293|589041089|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
163090178|NCT00956293|589041090|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
163090179|NCT00956293|589041091|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
163090180|NCT00956293|589041089|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
163090181|NCT00956293|589041090|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
163090182|NCT00956293|589041091|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
163090183|NCT00956293|589041089|FG000|Main Period (Randomization)|Adverse Event|0|||
163090184|NCT00956293|589041090|FG001|Main Period (Randomization)|Adverse Event|15|||
163090185|NCT00956293|589041091|FG002|Main Period (Randomization)|Adverse Event|0|||
163090186|NCT00956293|589041089|FG000|Follow-up Period|Follow-up period was terminated.|20|||
163090187|NCT00956293|589041090|FG001|Follow-up Period|Follow-up period was terminated.|32|||
163090188|NCT00956293|589041091|FG002|Follow-up Period|Follow-up period was terminated.|0|||
163090189|NCT03383666|589041092|FG000|Overall Study|Withdrawal by Subject|2|||
163090190|NCT03383666|589041092|FG000|Overall Study|Lost to Follow-up|2|||
163090191|NCT02359903|589041093|FG000|Overall Study|Adverse Event|0|||
163090192|NCT02359903|589041094|FG001|Overall Study|Adverse Event|2|||
163090193|NCT02536664|589041095|FG000|Overall Study|Inadequate completion of documentation|2|||
163090194|NCT02536664|589041096|FG001|Overall Study|Inadequate completion of documentation|4|||
163090195|NCT02536664|589041095|FG000|Overall Study|Progression|13|||
163090196|NCT02536664|589041096|FG001|Overall Study|Progression|18|||
163090197|NCT02536664|589041095|FG000|Overall Study|Death due to lymphoma|2|||
163090198|NCT02536664|589041096|FG001|Overall Study|Death due to lymphoma|1|||
163090199|NCT02536664|589041095|FG000|Overall Study|Death due to other reason|3|||
163090200|NCT02536664|589041096|FG001|Overall Study|Death due to other reason|2|||
163090201|NCT02536664|589041095|FG000|Overall Study|Intolerability|8|||
163090202|NCT02536664|589041096|FG001|Overall Study|Intolerability|6|||
163090203|NCT02536664|589041095|FG000|Overall Study|Withdrawal by Subject|8|||
163090204|NCT02536664|589041096|FG001|Overall Study|Withdrawal by Subject|5|||
163090205|NCT02536664|589041095|FG000|Overall Study|Other|18|||
163090206|NCT02536664|589041096|FG001|Overall Study|Other|24|||
163090207|NCT02536664|589041095|FG000|Overall Study|Missing|53|||
163090208|NCT02536664|589041096|FG001|Overall Study|Missing|20|||
163090209|NCT03507127|589041099|FG000|Overall Study|Withdrawal by Subject|1|||
163090210|NCT03507127|589041100|FG001|Overall Study|Withdrawal by Subject|0|||
163090211|NCT03507127|589041099|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
163090212|NCT03507127|589041100|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
163090213|NCT02081586|589041102|FG000|Overall Study|Lost to Follow-up|0|||
163090214|NCT02081586|589041103|FG001|Overall Study|Lost to Follow-up|1|||
163090215|NCT02081586|589041104|FG002|Overall Study|Lost to Follow-up|0|||
163090216|NCT02081586|589041105|FG003|Overall Study|Lost to Follow-up|1|||
163090217|NCT02081586|589041102|FG000|Overall Study|Head injury not related to study|0|||
163090218|NCT02081586|589041103|FG001|Overall Study|Head injury not related to study|0|||
163090219|NCT02081586|589041104|FG002|Overall Study|Head injury not related to study|1|||
163090220|NCT02081586|589041105|FG003|Overall Study|Head injury not related to study|0|||
163038069|NCT02651688|588845719|FG001|Overall Study|Principal Investigator (PI) decision|2|||
163090221|NCT04756531|589041111|FG000|Overall Study|Adverse Event|0|||
163090222|NCT04756531|589041112|FG001|Overall Study|Adverse Event|0|||
163090223|NCT04756531|589041113|FG002|Overall Study|Adverse Event|0|||
163336475|NCT00080119|589942343|FG001|Overall Study|Unable to get to clinic|24|||
163090224|NCT04756531|589041114|FG003|Overall Study|Adverse Event|0|||
163090225|NCT04756531|589041115|FG004|Overall Study|Adverse Event|1|||
163090226|NCT04756531|589041116|FG005|Overall Study|Adverse Event|0|||
163090227|NCT04756531|589041117|FG006|Overall Study|Adverse Event|0|||
163220071|NCT02882854|589521405|FG001|Overall Study|Lost to Follow-up|2|||
163336476|NCT00080119|589942344|FG002|Overall Study|Unable to get to clinic|7|||
163336477|NCT00080119|589942345|FG003|Overall Study|Unable to get to clinic|1|||
163336478|NCT00080119|589942342|FG000|Overall Study|Consent withdrawn|13|||
163336479|NCT00080119|589942343|FG001|Overall Study|Consent withdrawn|17|||
163336480|NCT00080119|589942344|FG002|Overall Study|Consent withdrawn|4|||
163336481|NCT00080119|589942345|FG003|Overall Study|Consent withdrawn|6|||
163336482|NCT00080119|589942342|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
163336483|NCT00080119|589942343|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
163336484|NCT00080119|589942344|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
163336485|NCT00080119|589942345|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
163336486|NCT00080119|589942342|FG000|Overall Study|Lost to Follow-up|16|||
163336487|NCT00080119|589942343|FG001|Overall Study|Lost to Follow-up|19|||
163336488|NCT00080119|589942344|FG002|Overall Study|Lost to Follow-up|19|||
163336489|NCT00080119|589942345|FG003|Overall Study|Lost to Follow-up|14|||
163336490|NCT00889863|589942347|FG000|Part I: Open Label|Death|1|||
163336491|NCT00889863|589942348|FG001|Part I: Open Label|Death|0|||
163336492|NCT00889863|589942347|FG000|Part I: Open Label|Adverse Event|4|||
163038070|NCT02651688|588845720|FG002|Overall Study|Principal Investigator (PI) decision|0|||
163038071|NCT02651688|588845718|FG000|Overall Study|Lost to Follow-up|1|||
163038072|NCT02651688|588845719|FG001|Overall Study|Lost to Follow-up|3|||
163038073|NCT02651688|588845720|FG002|Overall Study|Lost to Follow-up|0|||
163038074|NCT02651688|588845718|FG000|Overall Study|Withdrawal by Subject|1|||
163038075|NCT02651688|588845719|FG001|Overall Study|Withdrawal by Subject|0|||
163038076|NCT02651688|588845720|FG002|Overall Study|Withdrawal by Subject|2|||
163038077|NCT01429441|588845721|FG000|Overall Study|Adverse Event|5|||
163038078|NCT01429441|588845722|FG001|Overall Study|Adverse Event|1|||
163038079|NCT01429441|588845721|FG000|Overall Study|Death|0|||
163038080|NCT01429441|588845722|FG001|Overall Study|Death|2|||
163038081|NCT01429441|588845721|FG000|Overall Study|Lost to Follow-up|5|||
163038082|NCT01429441|588845722|FG001|Overall Study|Lost to Follow-up|2|||
163038083|NCT01429441|588845721|FG000|Overall Study|Physician Decision|1|||
163038084|NCT01429441|588845722|FG001|Overall Study|Physician Decision|0|||
163038085|NCT01429441|588845721|FG000|Overall Study|Withdrawal by Subject|27|||
163038086|NCT01429441|588845722|FG001|Overall Study|Withdrawal by Subject|18|||
163038087|NCT02670382|588845724|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
163038088|NCT02670382|588845725|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
163038089|NCT00394771|588845727|FG000|Overall Study|Did not meet protocol requirements|1|||
163038090|NCT00394771|588845728|FG001|Overall Study|Did not meet protocol requirements|0|||
163038091|NCT00394771|588845729|FG002|Overall Study|Did not meet protocol requirements|2|||
163038092|NCT00394771|588845730|FG003|Overall Study|Did not meet protocol requirements|0|||
163038093|NCT00394771|588845727|FG000|Overall Study|Protocol Violation|2|||
163038094|NCT00394771|588845728|FG001|Overall Study|Protocol Violation|4|||
163038095|NCT00394771|588845729|FG002|Overall Study|Protocol Violation|9|||
163038096|NCT00394771|588845730|FG003|Overall Study|Protocol Violation|7|||
163038097|NCT00394771|588845727|FG000|Overall Study|Withdrawal by Subject|10|||
163038098|NCT00394771|588845728|FG001|Overall Study|Withdrawal by Subject|6|||
163038099|NCT00394771|588845729|FG002|Overall Study|Withdrawal by Subject|8|||
163038100|NCT00394771|588845730|FG003|Overall Study|Withdrawal by Subject|12|||
163038101|NCT00394771|588845727|FG000|Overall Study|Adverse Event|10|||
163038102|NCT00394771|588845728|FG001|Overall Study|Adverse Event|5|||
163038103|NCT00394771|588845729|FG002|Overall Study|Adverse Event|12|||
163038104|NCT00394771|588845730|FG003|Overall Study|Adverse Event|8|||
163038105|NCT00394771|588845727|FG000|Overall Study|Participant pregnant|0|||
163038106|NCT00394771|588845728|FG001|Overall Study|Participant pregnant|1|||
163038107|NCT00394771|588845729|FG002|Overall Study|Participant pregnant|2|||
163038108|NCT00394771|588845730|FG003|Overall Study|Participant pregnant|2|||
163038109|NCT00394771|588845727|FG000|Overall Study|Lost to Follow-up|15|||
163038110|NCT00394771|588845728|FG001|Overall Study|Lost to Follow-up|15|||
163038111|NCT00394771|588845729|FG002|Overall Study|Lost to Follow-up|13|||
163038112|NCT00394771|588845730|FG003|Overall Study|Lost to Follow-up|10|||
163038113|NCT00394771|588845727|FG000|Overall Study|Other|3|||
163038114|NCT00394771|588845728|FG001|Overall Study|Other|3|||
163038115|NCT00394771|588845729|FG002|Overall Study|Other|1|||
163336493|NCT00889863|589942348|FG001|Part I: Open Label|Adverse Event|0|||
163336494|NCT00889863|589942347|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
163336495|NCT00889863|589942348|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
163336496|NCT00889863|589942347|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
163038116|NCT00394771|588845730|FG003|Overall Study|Other|0|||
163038117|NCT02906033|588845732|FG000|Baseline|Protocol Violation|37|||
163038118|NCT02906033|588845733|FG001|Baseline|Protocol Violation|33|||
163090228|NCT04756531|589041118|FG007|Overall Study|Adverse Event|0|||
163336497|NCT00889863|589942348|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
163336498|NCT00889863|589942347|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
163336499|NCT00889863|589942348|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
163336500|NCT00889863|589942347|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
163336501|NCT00889863|589942348|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
163336502|NCT00889863|589942347|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
163336503|NCT00889863|589942348|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
163336504|NCT01090739|589942349|FG000|Enrollment|Withdrawal by Subject|24|||
163336505|NCT01090739|589942349|FG000|Enrollment|Protocol Violation|14|||
163336506|NCT01090739|589942349|FG000|Enrollment|Lost to Follow-up|5|||
163336507|NCT01090739|589942349|FG000|Enrollment|Physician Decision|5|||
163336508|NCT01090739|589942349|FG000|Enrollment|Sponsor termination of site|4|||
163336509|NCT01090739|589942349|FG000|Enrollment|Study implant limit reached|2|||
163336510|NCT01090739|589942349|FG000|Enrollment|Adverse Event|1|||
163336511|NCT01090739|589942349|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
163336512|NCT01090739|589942349|FG000|12 Month Follow-up|Lost to Follow-up|1|||
163336513|NCT01090739|589942349|FG000|12 Month Follow-up|Physician Decision|1|||
163336514|NCT01090739|589942349|FG000|12 Month Follow-up|Death|1|||
163336515|NCT01090739|589942349|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
163336516|NCT01090739|589942349|FG000|24 Month Follow-up|Lost to Follow-up|1|||
163336517|NCT01090739|589942349|FG000|24 Month Follow-up|Death|1|||
163336518|NCT01090739|589942349|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
163336519|NCT01090739|589942349|FG000|36 Month Follow-up|Visit still pending|17|||
163336520|NCT00441168|589942350|FG000|Treatment Period|Death|3|||
163336521|NCT00441168|589942351|FG001|Treatment Period|Death|0|||
163336522|NCT00441168|589942350|FG000|Treatment Period|Adverse Event|1|||
163336523|NCT00441168|589942351|FG001|Treatment Period|Adverse Event|2|||
163336524|NCT00441168|589942350|FG000|Treatment Period|Progressive Disease|0|||
163336525|NCT00441168|589942351|FG001|Treatment Period|Progressive Disease|2|||
163336526|NCT00441168|589942350|FG000|Treatment Period|Protocol Violation|0|||
163336527|NCT00441168|589942351|FG001|Treatment Period|Protocol Violation|1|||
163336528|NCT00441168|589942350|FG000|Treatment Period|Lost to Follow-up|0|||
163336529|NCT00441168|589942351|FG001|Treatment Period|Lost to Follow-up|1|||
163336530|NCT00441168|589942350|FG000|Treatment Period|Withdrawal by Subject|3|||
163336531|NCT00441168|589942351|FG001|Treatment Period|Withdrawal by Subject|0|||
163336532|NCT00441168|589942350|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
163336533|NCT00441168|589942351|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
163336534|NCT00441168|589942350|FG000|Treatment Period|refractory disease|1|||
163336535|NCT00441168|589942351|FG001|Treatment Period|refractory disease|0|||
163336536|NCT00441168|589942350|FG000|Follow-up Period|Death|3|||
163336537|NCT00441168|589942351|FG001|Follow-up Period|Death|0|||
163336538|NCT00441168|589942350|FG000|Follow-up Period|Lost to Follow-up|5|||
163336539|NCT00441168|589942351|FG001|Follow-up Period|Lost to Follow-up|6|||
163336540|NCT00441168|589942350|FG000|Follow-up Period|Withdrawal by Subject|3|||
163090229|NCT04756531|589041119|FG008|Overall Study|Adverse Event|0|||
163090230|NCT04756531|589041120|FG009|Overall Study|Adverse Event|0|||
163090231|NCT04756531|589041121|FG010|Overall Study|Adverse Event|0|||
163090232|NCT04756531|589041122|FG011|Overall Study|Adverse Event|0|||
163090233|NCT04756531|589041123|FG012|Overall Study|Adverse Event|0|||
163090234|NCT04756531|589041124|FG013|Overall Study|Adverse Event|0|||
163090235|NCT04756531|589041125|FG014|Overall Study|Adverse Event|0|||
163090236|NCT04756531|589041126|FG015|Overall Study|Adverse Event|0|||
163090237|NCT04756531|589041127|FG016|Overall Study|Adverse Event|0|||
163090238|NCT04756531|589041128|FG017|Overall Study|Adverse Event|0|||
163090239|NCT04756531|589041111|FG000|Overall Study|Withdrawal by Subject|0|||
163090240|NCT04756531|589041112|FG001|Overall Study|Withdrawal by Subject|0|||
163090241|NCT04756531|589041113|FG002|Overall Study|Withdrawal by Subject|0|||
163090242|NCT04756531|589041114|FG003|Overall Study|Withdrawal by Subject|0|||
163090243|NCT04756531|589041115|FG004|Overall Study|Withdrawal by Subject|0|||
163090244|NCT04756531|589041116|FG005|Overall Study|Withdrawal by Subject|0|||
163090245|NCT04756531|589041117|FG006|Overall Study|Withdrawal by Subject|1|||
163090246|NCT04756531|589041118|FG007|Overall Study|Withdrawal by Subject|0|||
163090247|NCT04756531|589041119|FG008|Overall Study|Withdrawal by Subject|0|||
163336541|NCT00441168|589942351|FG001|Follow-up Period|Withdrawal by Subject|0|||
163336542|NCT00441168|589942350|FG000|Follow-up Period|Other|1|||
163336543|NCT00441168|589942351|FG001|Follow-up Period|Other|3|||
163336544|NCT04410445|589942353|FG000|Overall Study|Lost to Follow-up|3|||
163336545|NCT04410445|589942354|FG001|Overall Study|Lost to Follow-up|9|||
163336546|NCT04410445|589942353|FG000|Overall Study|Withdrawal by Subject|27|||
163336547|NCT04410445|589942354|FG001|Overall Study|Withdrawal by Subject|15|||
163336548|NCT02291861|589942355|FG000|Overall Study|Adverse Event|2|||
163336549|NCT02291861|589942356|FG001|Overall Study|Adverse Event|4|||
163336550|NCT02291861|589942357|FG002|Overall Study|Adverse Event|1|||
163336551|NCT02291861|589942358|FG003|Overall Study|Adverse Event|2|||
163090248|NCT04756531|589041120|FG009|Overall Study|Withdrawal by Subject|0|||
163090249|NCT04756531|589041121|FG010|Overall Study|Withdrawal by Subject|0|||
163090250|NCT04756531|589041122|FG011|Overall Study|Withdrawal by Subject|0|||
163090251|NCT04756531|589041123|FG012|Overall Study|Withdrawal by Subject|0|||
163090252|NCT04756531|589041124|FG013|Overall Study|Withdrawal by Subject|0|||
163090253|NCT04756531|589041125|FG014|Overall Study|Withdrawal by Subject|0|||
163090254|NCT04756531|589041126|FG015|Overall Study|Withdrawal by Subject|0|||
163090255|NCT04756531|589041127|FG016|Overall Study|Withdrawal by Subject|0|||
163090256|NCT04756531|589041128|FG017|Overall Study|Withdrawal by Subject|0|||
163090257|NCT00789555|589041131|FG000|Overall Study|Protocol Amendment|78|||
163090258|NCT00789555|589041132|FG001|Overall Study|Protocol Amendment|76|||
163090259|NCT00789555|589041133|FG002|Overall Study|Protocol Amendment|80|||
163090260|NCT00789555|589041131|FG000|Overall Study|Adverse Event|17|||
163090261|NCT00789555|589041132|FG001|Overall Study|Adverse Event|7|||
163090262|NCT00789555|589041133|FG002|Overall Study|Adverse Event|10|||
163090263|NCT00789555|589041131|FG000|Overall Study|Lost to Follow-up|9|||
163090264|NCT00789555|589041132|FG001|Overall Study|Lost to Follow-up|10|||
163090265|NCT00789555|589041133|FG002|Overall Study|Lost to Follow-up|18|||
163090266|NCT00789555|589041131|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
163090267|NCT00789555|589041132|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
163090268|NCT00789555|589041133|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
163090269|NCT00789555|589041131|FG000|Overall Study|Treatment failure|11|||
163090270|NCT00789555|589041132|FG001|Overall Study|Treatment failure|8|||
163090271|NCT00789555|589041133|FG002|Overall Study|Treatment failure|12|||
163090272|NCT00789555|589041131|FG000|Overall Study|Protocol Violation|6|||
163090273|NCT00789555|589041132|FG001|Overall Study|Protocol Violation|9|||
163090274|NCT00789555|589041133|FG002|Overall Study|Protocol Violation|13|||
163090275|NCT04646005|589041137|FG000|Overall Study|Adverse Event|1|||
163090276|NCT04646005|589041137|FG000|Overall Study|Progressive Disease|71|||
163090277|NCT04646005|589041137|FG000|Overall Study|Death|20|||
163090278|NCT04646005|589041137|FG000|Overall Study|Withdrawal by Subject|12|||
163090279|NCT04646005|589041137|FG000|Overall Study|Sponsor Request|9|||
163090280|NCT04712669|589041139|FG000|Double Blind Phase|Adverse Event|4|||
163090281|NCT04712669|589041140|FG001|Double Blind Phase|Adverse Event|4|||
163090282|NCT04712669|589041141|FG002|Double Blind Phase|Adverse Event|3|||
163090283|NCT04712669|589041142|FG003|Double Blind Phase|Adverse Event|0|||
163090284|NCT04712669|589041143|FG004|Double Blind Phase|Adverse Event|0|||
163090285|NCT04712669|589041144|FG005|Double Blind Phase|Adverse Event|0|||
163090286|NCT04712669|589041145|FG006|Double Blind Phase|Adverse Event|0|||
163090287|NCT04712669|589041146|FG007|Double Blind Phase|Adverse Event|0|||
163090288|NCT04712669|589041139|FG000|Double Blind Phase|Physician Decision|1|||
163090289|NCT04712669|589041140|FG001|Double Blind Phase|Physician Decision|0|||
163090290|NCT04712669|589041141|FG002|Double Blind Phase|Physician Decision|0|||
163090291|NCT04712669|589041142|FG003|Double Blind Phase|Physician Decision|0|||
163090292|NCT04712669|589041143|FG004|Double Blind Phase|Physician Decision|0|||
163090293|NCT04712669|589041144|FG005|Double Blind Phase|Physician Decision|0|||
163090294|NCT04712669|589041145|FG006|Double Blind Phase|Physician Decision|0|||
163090295|NCT04712669|589041146|FG007|Double Blind Phase|Physician Decision|0|||
163090296|NCT04712669|589041139|FG000|Double Blind Phase|Withdrawal by Subject|3|||
163090297|NCT04712669|589041140|FG001|Double Blind Phase|Withdrawal by Subject|6|||
163090298|NCT04712669|589041141|FG002|Double Blind Phase|Withdrawal by Subject|0|||
163090299|NCT04712669|589041142|FG003|Double Blind Phase|Withdrawal by Subject|0|||
163090300|NCT04712669|589041143|FG004|Double Blind Phase|Withdrawal by Subject|0|||
163090301|NCT04712669|589041144|FG005|Double Blind Phase|Withdrawal by Subject|0|||
163090302|NCT04712669|589041145|FG006|Double Blind Phase|Withdrawal by Subject|0|||
163090303|NCT04712669|589041146|FG007|Double Blind Phase|Withdrawal by Subject|0|||
163090304|NCT04712669|589041139|FG000|Double Blind Phase|Termination by Sponsor|0|||
163090305|NCT04712669|589041140|FG001|Double Blind Phase|Termination by Sponsor|0|||
163090306|NCT04712669|589041141|FG002|Double Blind Phase|Termination by Sponsor|1|||
163090307|NCT04712669|589041142|FG003|Double Blind Phase|Termination by Sponsor|0|||
163090308|NCT04712669|589041143|FG004|Double Blind Phase|Termination by Sponsor|0|||
163090309|NCT04712669|589041144|FG005|Double Blind Phase|Termination by Sponsor|0|||
163090310|NCT04712669|589041145|FG006|Double Blind Phase|Termination by Sponsor|0|||
163090311|NCT04712669|589041146|FG007|Double Blind Phase|Termination by Sponsor|0|||
163090312|NCT04712669|589041139|FG000|Open Label Phase|Adverse Event|0|||
163090313|NCT04712669|589041140|FG001|Open Label Phase|Adverse Event|0|||
163090314|NCT04712669|589041141|FG002|Open Label Phase|Adverse Event|0|||
163090315|NCT04712669|589041142|FG003|Open Label Phase|Adverse Event|1|||
163090316|NCT04712669|589041143|FG004|Open Label Phase|Adverse Event|1|||
163090317|NCT04712669|589041144|FG005|Open Label Phase|Adverse Event|3|||
163090318|NCT04712669|589041145|FG006|Open Label Phase|Adverse Event|1|||
163090319|NCT04712669|589041146|FG007|Open Label Phase|Adverse Event|2|||
163090320|NCT04712669|589041139|FG000|Open Label Phase|Death|0|||
163090321|NCT04712669|589041140|FG001|Open Label Phase|Death|0|||
163090322|NCT04712669|589041141|FG002|Open Label Phase|Death|0|||
163090323|NCT04712669|589041142|FG003|Open Label Phase|Death|1|||
163090324|NCT04712669|589041143|FG004|Open Label Phase|Death|0|||
163090325|NCT04712669|589041144|FG005|Open Label Phase|Death|0|||
163090326|NCT04712669|589041145|FG006|Open Label Phase|Death|0|||
163090327|NCT04712669|589041146|FG007|Open Label Phase|Death|0|||
163090328|NCT04712669|589041139|FG000|Open Label Phase|Lack of Efficacy|0|||
163090329|NCT04712669|589041140|FG001|Open Label Phase|Lack of Efficacy|0|||
163090330|NCT04712669|589041141|FG002|Open Label Phase|Lack of Efficacy|0|||
163090331|NCT04712669|589041142|FG003|Open Label Phase|Lack of Efficacy|0|||
163090332|NCT04712669|589041143|FG004|Open Label Phase|Lack of Efficacy|1|||
163090333|NCT04712669|589041144|FG005|Open Label Phase|Lack of Efficacy|0|||
163090334|NCT04712669|589041145|FG006|Open Label Phase|Lack of Efficacy|0|||
163090335|NCT04712669|589041146|FG007|Open Label Phase|Lack of Efficacy|0|||
163090336|NCT04712669|589041139|FG000|Open Label Phase|Lost to Follow-up|0|||
163090337|NCT04712669|589041140|FG001|Open Label Phase|Lost to Follow-up|0|||
163090338|NCT04712669|589041141|FG002|Open Label Phase|Lost to Follow-up|0|||
163090339|NCT04712669|589041142|FG003|Open Label Phase|Lost to Follow-up|0|||
163090340|NCT04712669|589041143|FG004|Open Label Phase|Lost to Follow-up|0|||
163090341|NCT04712669|589041144|FG005|Open Label Phase|Lost to Follow-up|0|||
163090342|NCT04712669|589041145|FG006|Open Label Phase|Lost to Follow-up|1|||
163090343|NCT04712669|589041146|FG007|Open Label Phase|Lost to Follow-up|1|||
163090344|NCT04712669|589041139|FG000|Open Label Phase|Physician Decision|0|||
163090345|NCT04712669|589041140|FG001|Open Label Phase|Physician Decision|0|||
163090346|NCT04712669|589041141|FG002|Open Label Phase|Physician Decision|0|||
163090347|NCT04712669|589041142|FG003|Open Label Phase|Physician Decision|1|||
163090348|NCT04712669|589041143|FG004|Open Label Phase|Physician Decision|0|||
163090349|NCT04712669|589041144|FG005|Open Label Phase|Physician Decision|0|||
163090350|NCT04712669|589041145|FG006|Open Label Phase|Physician Decision|0|||
163090351|NCT04712669|589041146|FG007|Open Label Phase|Physician Decision|0|||
163090352|NCT04712669|589041139|FG000|Open Label Phase|Withdrawal by Subject|0|||
163090353|NCT04712669|589041140|FG001|Open Label Phase|Withdrawal by Subject|0|||
163090354|NCT04712669|589041141|FG002|Open Label Phase|Withdrawal by Subject|0|||
163090355|NCT04712669|589041142|FG003|Open Label Phase|Withdrawal by Subject|1|||
163090356|NCT04712669|589041143|FG004|Open Label Phase|Withdrawal by Subject|5|||
163090357|NCT04712669|589041144|FG005|Open Label Phase|Withdrawal by Subject|5|||
163090358|NCT04712669|589041145|FG006|Open Label Phase|Withdrawal by Subject|0|||
163090359|NCT04712669|589041146|FG007|Open Label Phase|Withdrawal by Subject|4|||
163090360|NCT04712669|589041139|FG000|Open Label Phase|Termination by Sponsor|0|||
163090361|NCT04712669|589041140|FG001|Open Label Phase|Termination by Sponsor|0|||
163090362|NCT04712669|589041141|FG002|Open Label Phase|Termination by Sponsor|0|||
163090363|NCT04712669|589041142|FG003|Open Label Phase|Termination by Sponsor|11|||
163336552|NCT02291861|589942355|FG000|Overall Study|Death|0|||
163336553|NCT02291861|589942356|FG001|Overall Study|Death|0|||
163336554|NCT02291861|589942357|FG002|Overall Study|Death|1|||
163090364|NCT04712669|589041143|FG004|Open Label Phase|Termination by Sponsor|9|||
163090365|NCT04712669|589041144|FG005|Open Label Phase|Termination by Sponsor|14|||
163336555|NCT02291861|589942358|FG003|Overall Study|Death|1|||
163336556|NCT02291861|589942355|FG000|Overall Study|Protocol Violation|1|||
163090366|NCT04712669|589041145|FG006|Open Label Phase|Termination by Sponsor|0|||
163090367|NCT04712669|589041146|FG007|Open Label Phase|Termination by Sponsor|14|||
163090368|NCT00639457|589042839|FG000|Overall Study|Withdrawal by Subject|2|||
163090369|NCT00639457|589042840|FG001|Overall Study|Withdrawal by Subject|3|||
163090370|NCT00892008|589042841|FG000|Overall Study|Death|5|||
163090371|NCT00892008|589042841|FG000|Overall Study|Lack of Efficacy|3|||
163090372|NCT00892008|589042841|FG000|Overall Study|Lost to Follow-up|142|||
163090373|NCT00892008|589042841|FG000|Overall Study|Other|378|||
163090374|NCT00892008|589042841|FG000|Overall Study|Adverse Event|37|||
163090375|NCT00355030|589042842|FG000|Study Period 1 Treatment|Adverse Event|1|||
163090376|NCT00355030|589042843|FG001|Study Period 1 Treatment|Adverse Event|1|||
163090377|NCT00355030|589042842|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
163090378|NCT00355030|589042843|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
163336557|NCT02291861|589942356|FG001|Overall Study|Protocol Violation|0|||
163336558|NCT02291861|589942357|FG002|Overall Study|Protocol Violation|0|||
163336559|NCT02291861|589942358|FG003|Overall Study|Protocol Violation|1|||
163336560|NCT02291861|589942355|FG000|Overall Study|Withdrawal by Subject|1|||
163336561|NCT02291861|589942356|FG001|Overall Study|Withdrawal by Subject|2|||
163336562|NCT02291861|589942357|FG002|Overall Study|Withdrawal by Subject|1|||
163336563|NCT02291861|589942358|FG003|Overall Study|Withdrawal by Subject|4|||
163336564|NCT02291861|589942355|FG000|Overall Study|Noncompliance|1|||
163336565|NCT02291861|589942356|FG001|Overall Study|Noncompliance|1|||
163407412|NCT02684981|590200811|FG000|Overall Study|Permanently discontinued the treatment|157|||
163090379|NCT00355030|589042842|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
163090380|NCT00355030|589042843|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
163090381|NCT00355030|589042842|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
163090382|NCT00355030|589042843|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
163090383|NCT00355030|589042842|FG000|Study Period 1 Treatment|Physician Decision|0|||
163090384|NCT00355030|589042843|FG001|Study Period 1 Treatment|Physician Decision|1|||
163090385|NCT00355030|589042842|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
163090386|NCT00355030|589042843|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
163220072|NCT02882854|589521404|FG000|Overall Study|Physician Decision|0|||
163220073|NCT02882854|589521405|FG001|Overall Study|Physician Decision|1|||
163336566|NCT02291861|589942357|FG002|Overall Study|Noncompliance|2|||
163336567|NCT02291861|589942358|FG003|Overall Study|Noncompliance|1|||
163336568|NCT02291861|589942355|FG000|Overall Study|Lost to Follow-up|2|||
163090387|NCT00355030|589042842|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
163090388|NCT00355030|589042843|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
163090389|NCT00355030|589042842|FG000|Study Period 1 Treatment|Other|2|||
163090390|NCT00355030|589042843|FG001|Study Period 1 Treatment|Other|6|||
163090391|NCT00355030|589042842|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
163090392|NCT00355030|589042843|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
163090393|NCT00355030|589042842|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
163090394|NCT00355030|589042843|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
163090395|NCT01693367|589042844|FG000|Overall Study|Withdrawal by Subject|1|||
163090396|NCT01693367|589042845|FG001|Overall Study|Withdrawal by Subject|1|||
163090397|NCT01693367|589042844|FG000|Overall Study|Physician Decision|0|||
163090398|NCT01693367|589042845|FG001|Overall Study|Physician Decision|1|||
163090399|NCT00690794|589042846|FG000|Overall Study|Adverse Event|12|||
163090400|NCT00690794|589042847|FG001|Overall Study|Adverse Event|10|||
163090401|NCT00690794|589042846|FG000|Overall Study|Lost to Follow-up|1|||
163090402|NCT00690794|589042847|FG001|Overall Study|Lost to Follow-up|4|||
163090403|NCT00690794|589042846|FG000|Overall Study|Withdrawal by Subject|0|||
163090404|NCT00690794|589042847|FG001|Overall Study|Withdrawal by Subject|9|||
163090405|NCT00690794|589042846|FG000|Overall Study|Protocol Violation|6|||
163090406|NCT00690794|589042847|FG001|Overall Study|Protocol Violation|7|||
163090407|NCT00690794|589042846|FG000|Overall Study|Noncompliance|1|||
163090408|NCT00690794|589042847|FG001|Overall Study|Noncompliance|2|||
163090409|NCT00690794|589042846|FG000|Overall Study|Other not specified|1|||
163090410|NCT00690794|589042847|FG001|Overall Study|Other not specified|3|||
163090411|NCT00325143|589042848|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
163090412|NCT00325143|589042848|FG000|Overall Study|Migrated/moved from study area|1|||
163090413|NCT00325143|589042848|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
163090414|NCT00325143|589042848|FG000|Overall Study|Withdrawal by Subject|8|||
163090415|NCT02286895|589042849|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
163090416|NCT02286895|589042850|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
163090417|NCT02286895|589042849|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
163090418|NCT02286895|589042850|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
163090419|NCT02286895|589042849|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
163090420|NCT02286895|589042850|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
163090421|NCT00399035|589042852|FG000|Overall Study|Death|289|||
163090422|NCT00399035|589042853|FG001|Overall Study|Death|141|||
163090423|NCT00399035|589042854|FG002|Overall Study|Death|234|||
163090424|NCT00399035|589042852|FG000|Overall Study|Lost to Follow-up|2|||
163090425|NCT00399035|589042853|FG001|Overall Study|Lost to Follow-up|1|||
163090426|NCT00399035|589042854|FG002|Overall Study|Lost to Follow-up|5|||
163090427|NCT00399035|589042852|FG000|Overall Study|Withdrawal by Subject|19|||
163090428|NCT00399035|589042853|FG001|Overall Study|Withdrawal by Subject|15|||
163090429|NCT00399035|589042854|FG002|Overall Study|Withdrawal by Subject|12|||
163090430|NCT00399035|589042852|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
163090431|NCT00399035|589042853|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
163090432|NCT00399035|589042854|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
163090433|NCT00399035|589042852|FG000|Overall Study|Severe non-compliance with protocol|2|||
163090434|NCT00399035|589042853|FG001|Overall Study|Severe non-compliance with protocol|1|||
163090435|NCT00399035|589042854|FG002|Overall Study|Severe non-compliance with protocol|0|||
163090436|NCT02949011|589042857|FG000|Overall Study|Adverse Event|6|||
163090437|NCT02949011|589042858|FG001|Overall Study|Adverse Event|7|||
163090438|NCT02949011|589042859|FG002|Overall Study|Adverse Event|3|||
163090439|NCT02949011|589042857|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
163090440|NCT02949011|589042858|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
163090441|NCT02949011|589042859|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
163090442|NCT02949011|589042857|FG000|Overall Study|Protocol Deviation|5|||
163038119|NCT02906033|588845732|FG000|Follow-up|Lost to Follow-up|46|||
163038120|NCT02906033|588845733|FG001|Follow-up|Lost to Follow-up|62|||
163038121|NCT00358956|588845734|FG000|Overall Study|Adverse Event|3|||
163038122|NCT00358956|588845734|FG000|Overall Study|condition under investigation worsened|4|||
163038123|NCT00358956|588845734|FG000|Overall Study|Withdrawal by Subject|1|||
163038124|NCT03417024|588845737|FG000|Overall Study|Study Termination prior to follow-up|11|||
163038125|NCT03417024|588845737|FG000|Overall Study|Physician Decision|2|||
163090443|NCT02949011|589042858|FG001|Overall Study|Protocol Deviation|3|||
163090444|NCT02949011|589042859|FG002|Overall Study|Protocol Deviation|3|||
163090445|NCT02949011|589042857|FG000|Overall Study|Lack of Efficacy|0|||
163090446|NCT02949011|589042858|FG001|Overall Study|Lack of Efficacy|2|||
163090447|NCT02949011|589042859|FG002|Overall Study|Lack of Efficacy|0|||
163090448|NCT02949011|589042857|FG000|Overall Study|Withdrawal by Subject|13|||
163090449|NCT02949011|589042858|FG001|Overall Study|Withdrawal by Subject|13|||
163090450|NCT02949011|589042859|FG002|Overall Study|Withdrawal by Subject|21|||
163090451|NCT02949011|589042857|FG000|Overall Study|Lost to Follow-up|7|||
163090452|NCT02949011|589042858|FG001|Overall Study|Lost to Follow-up|5|||
163090453|NCT02949011|589042859|FG002|Overall Study|Lost to Follow-up|5|||
163038126|NCT00386425|588845738|FG000|Overall Study|Physician Decision|3|||
163336569|NCT02291861|589942356|FG001|Overall Study|Lost to Follow-up|1|||
163336570|NCT02291861|589942357|FG002|Overall Study|Lost to Follow-up|4|||
163336571|NCT02291861|589942358|FG003|Overall Study|Lost to Follow-up|0|||
163336572|NCT02291861|589942355|FG000|Overall Study|Other|0|||
163336573|NCT02291861|589942356|FG001|Overall Study|Other|0|||
163336574|NCT02291861|589942357|FG002|Overall Study|Other|0|||
163336575|NCT02291861|589942358|FG003|Overall Study|Other|1|||
163336576|NCT02005484|589942361|FG000|Overall Study|Death|1|||
163336577|NCT02005484|589942361|FG000|Overall Study|Disease progression|1|||
163336578|NCT02005484|589942361|FG000|Overall Study|Changed to a Different Study|1|||
163336579|NCT02005484|589942361|FG000|Overall Study|Sponsor decision|1|||
163336580|NCT03547154|589942365|FG000|Overall Study|Disease Progression/Recurrence|6|||
163336581|NCT03547154|589942366|FG001|Overall Study|Disease Progression/Recurrence|14|||
163336582|NCT03547154|589942365|FG000|Overall Study|Adverse Event|26|||
163336583|NCT03547154|589942366|FG001|Overall Study|Adverse Event|31|||
163090454|NCT02949011|589042857|FG000|Overall Study|Death|0|||
163090455|NCT02949011|589042858|FG001|Overall Study|Death|0|||
163090456|NCT02949011|589042859|FG002|Overall Study|Death|1|||
163090457|NCT02949011|589042857|FG000|Overall Study|Miscellaneous|2|||
163090458|NCT02949011|589042858|FG001|Overall Study|Miscellaneous|4|||
163090459|NCT02949011|589042859|FG002|Overall Study|Miscellaneous|6|||
163090460|NCT00163189|589042860|FG000|Overall Study|Other|6|||
163090461|NCT00163189|589042860|FG000|Overall Study|Lost to Follow-up|1|||
163090462|NCT00163189|589042860|FG000|Overall Study|Protocol Violation|2|||
163090463|NCT00163189|589042860|FG000|Overall Study|Death|3|||
163090464|NCT00163189|589042860|FG000|Overall Study|Adverse Event|6|||
163090465|NCT00163189|589042860|FG000|Overall Study|Lack of Efficacy|7|||
163090466|NCT00163189|589042860|FG000|Overall Study|Study terminated by sponsor|11|||
163090467|NCT00163189|589042860|FG000|Overall Study|Withdrawal by Subject|11|||
163090468|NCT00163189|589042860|FG000|Overall Study|Did not meet continuation criterion|16|||
163090469|NCT01170663|589042861|FG000|Overall Study|Lost to Follow-up|3|||
163090470|NCT01170663|589042862|FG001|Overall Study|Lost to Follow-up|9|||
163090471|NCT01170663|589042861|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
163090472|NCT01170663|589042862|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
163090473|NCT00454116|589042863|FG000|Overall Study|Adverse Event|5|||
163090474|NCT00454116|589042864|FG001|Overall Study|Adverse Event|11|||
163090475|NCT00454116|589042865|FG002|Overall Study|Adverse Event|9|||
163090476|NCT00454116|589042863|FG000|Overall Study|Condition under investigation worsened|17|||
163090477|NCT00454116|589042864|FG001|Overall Study|Condition under investigation worsened|13|||
163090478|NCT00454116|589042865|FG002|Overall Study|Condition under investigation worsened|18|||
163090479|NCT00454116|589042863|FG000|Overall Study|Withdrawal by Subject|3|||
163090480|NCT00454116|589042864|FG001|Overall Study|Withdrawal by Subject|3|||
163090481|NCT00454116|589042865|FG002|Overall Study|Withdrawal by Subject|1|||
163090482|NCT00454116|589042863|FG000|Overall Study|Other|2|||
163090483|NCT00454116|589042864|FG001|Overall Study|Other|2|||
163090484|NCT00454116|589042865|FG002|Overall Study|Other|0|||
163336584|NCT03547154|589942365|FG000|Overall Study|Protocol Violation|6|||
163336585|NCT03547154|589942366|FG001|Overall Study|Protocol Violation|1|||
163336586|NCT03547154|589942365|FG000|Overall Study|Physician Decision|4|||
163090485|NCT02746809|589042866|FG000|Enrollment|Inclusion Exclusion not met|9|||
163090486|NCT02746809|589042866|FG000|Enrollment|Withdrawal by Subject|1|||
163090487|NCT02746809|589042866|FG000|Enrollment|Expected Enrollment Met|2|||
163090488|NCT02746809|589042866|FG000|Procedure|Death|1|||
163090489|NCT02746809|589042866|FG000|1-Month|Death|5|||
163090490|NCT02746809|589042866|FG000|6-Month|Death|2|||
163090491|NCT02746809|589042866|FG000|6-Month|Withdrawal by Subject|1|||
163090492|NCT02746809|589042866|FG000|12-Month|Death|3|||
163090493|NCT02746809|589042866|FG000|12-Month|Withdrawal by Subject|2|||
163090494|NCT02746809|589042866|FG000|24-Month|Death|1|||
163090495|NCT02746809|589042866|FG000|24-Month|Withdrawal by Subject|1|||
163090496|NCT02746809|589042866|FG000|36-Month|Death|8|||
163090497|NCT02746809|589042866|FG000|36-Month|Withdrawal by Subject|1|||
163090498|NCT02746809|589042866|FG000|48-Month|Death|7|||
163090499|NCT02746809|589042866|FG000|48-Month|Withdrawal by Subject|1|||
163090500|NCT02746809|589042866|FG000|60-Month|Death|1|||
163090501|NCT02746809|589042866|FG000|60-Month|Lost to Follow-up|2|||
163220074|NCT02039674|589521406|FG000|Overall Study|Adverse Event|0|||
163336587|NCT03547154|589942366|FG001|Overall Study|Physician Decision|3|||
163336588|NCT03547154|589942365|FG000|Overall Study|Insufficient Therapeutic Response|13|||
163336589|NCT03547154|589942366|FG001|Overall Study|Insufficient Therapeutic Response|10|||
163090502|NCT03500211|589042869|FG000|Overall Study|Withdrawal by Subject|1|||
163090503|NCT03500211|589042870|FG001|Overall Study|Withdrawal by Subject|1|||
163090504|NCT02431325|589042871|FG000|Overall Study|Adverse Event|3|||
163090505|NCT02431325|589042872|FG001|Overall Study|Adverse Event|0|||
163090506|NCT02431325|589042871|FG000|Overall Study|Lost to Follow-up|0|||
163090507|NCT02431325|589042872|FG001|Overall Study|Lost to Follow-up|1|||
163090508|NCT02431325|589042871|FG000|Overall Study|Withdrawal by Subject|1|||
163090509|NCT02431325|589042872|FG001|Overall Study|Withdrawal by Subject|2|||
163090510|NCT02431325|589042871|FG000|Overall Study|Declined to take study medication|1|||
163336590|NCT03547154|589942365|FG000|Overall Study|Withdrawal by Subject|10|||
163038127|NCT00386425|588845739|FG001|Overall Study|Physician Decision|0|||
163038128|NCT00386425|588845740|FG002|Overall Study|Physician Decision|0|||
163038129|NCT00386425|588845738|FG000|Overall Study|Withdrawal by Subject|0|||
163038130|NCT00386425|588845739|FG001|Overall Study|Withdrawal by Subject|1|||
163038131|NCT00386425|588845740|FG002|Overall Study|Withdrawal by Subject|0|||
163038132|NCT01907217|588845741|FG000|Overall Study|Withdrawal by Subject|0|||
163038133|NCT01907217|588845742|FG001|Overall Study|Withdrawal by Subject|2|||
163038134|NCT04607980|588845748|FG000|Overall Study|Adverse Event|3|||
163038135|NCT04607980|588845749|FG001|Overall Study|Adverse Event|4|||
163038136|NCT04607980|588845748|FG000|Overall Study|Death|0|||
163038137|NCT04607980|588845749|FG001|Overall Study|Death|1|||
163038138|NCT04607980|588845748|FG000|Overall Study|Withdrawal by Subject|2|||
163038139|NCT04607980|588845749|FG001|Overall Study|Withdrawal by Subject|5|||
163038140|NCT04607980|588845748|FG000|Overall Study|Lost to Follow-up|4|||
163038141|NCT04607980|588845749|FG001|Overall Study|Lost to Follow-up|8|||
163038142|NCT04607980|588845748|FG000|Overall Study|Protocol Violation|0|||
163038143|NCT04607980|588845749|FG001|Overall Study|Protocol Violation|3|||
163038144|NCT04607980|588845748|FG000|Overall Study|Other|3|||
163038145|NCT04607980|588845749|FG001|Overall Study|Other|0|||
163038146|NCT00448812|588845750|FG000|Year 2|Missed visit but remained in study|4|||
163038147|NCT00448812|588845751|FG001|Year 2|Missed visit but remained in study|1|||
163038148|NCT00448812|588845750|FG000|Year 3|Withdrawal by Subject|1|||
163038149|NCT00448812|588845751|FG001|Year 3|Withdrawal by Subject|3|||
163038150|NCT00448812|588845750|FG000|Year 3|Lost to Follow-up|1|||
163038151|NCT00448812|588845751|FG001|Year 3|Lost to Follow-up|0|||
163038152|NCT00448812|588845750|FG000|Year 3|Missed visit but remained in study|2|||
163038153|NCT00448812|588845751|FG001|Year 3|Missed visit but remained in study|0|||
163038154|NCT00448812|588845750|FG000|Year 5|Missed visit but remained in study|1|||
163038155|NCT00448812|588845751|FG001|Year 5|Missed visit but remained in study|0|||
163038156|NCT02012959|588845752|FG000|Treatment Phase A|Adverse Event|2|||
163038157|NCT02012959|588845753|FG001|Treatment Phase A|Adverse Event|0|||
163038158|NCT02012959|588845754|FG002|Treatment Phase A|Adverse Event|0|||
163038159|NCT02012959|588845755|FG003|Treatment Phase A|Adverse Event|0|||
163038160|NCT02012959|588845756|FG004|Treatment Phase A|Adverse Event|0|||
163038161|NCT03396822|588847293|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
163038162|NCT03396822|588847293|FG000|Overall Study|Physician Decision|1|||
163038163|NCT03630705|588847298|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
163038164|NCT03630705|588847299|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
163090511|NCT02431325|589042872|FG001|Overall Study|Declined to take study medication|0|||
163090512|NCT02431325|589042871|FG000|Overall Study|Withdrew before starting study medication|1|||
163090513|NCT02431325|589042872|FG001|Overall Study|Withdrew before starting study medication|0|||
163090514|NCT02431325|589042871|FG000|Overall Study|Placebo shortage|2|||
163090515|NCT02431325|589042872|FG001|Overall Study|Placebo shortage|0|||
163090516|NCT01917318|589042873|FG000|First Treatment|Withdrawal by Subject|0|||
163090517|NCT01917318|589042874|FG001|First Treatment|Withdrawal by Subject|1|||
163090518|NCT01008618|589042875|FG000|Period 1 (Titration Period)|Physician Decision|2|||
163090519|NCT01008618|589042876|FG001|Period 1 (Titration Period)|Physician Decision|0|||
163090520|NCT01008618|589042877|FG002|Period 1 (Titration Period)|Physician Decision|0|||
163090521|NCT01008618|589042875|FG000|Period 1 (Titration Period)|Adverse Event|33|||
163090522|NCT01008618|589042876|FG001|Period 1 (Titration Period)|Adverse Event|0|||
163090523|NCT01008618|589042877|FG002|Period 1 (Titration Period)|Adverse Event|0|||
163090524|NCT01008618|589042875|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
163090525|NCT01008618|589042876|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
163090526|NCT01008618|589042877|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
163090527|NCT01008618|589042875|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
163090528|NCT01008618|589042876|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
163090529|NCT01008618|589042877|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
163090530|NCT01008618|589042875|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
163090531|NCT01008618|589042876|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
163090532|NCT01008618|589042877|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
163090533|NCT01008618|589042875|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
163090534|NCT01008618|589042876|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
163038165|NCT03630705|588847300|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
163038166|NCT03630705|588847301|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163038167|NCT03630705|588847298|FG000|Overall Study|Lost to Follow-up|1|||
163038168|NCT03630705|588847299|FG001|Overall Study|Lost to Follow-up|2|||
163038169|NCT03630705|588847300|FG002|Overall Study|Lost to Follow-up|0|||
163038170|NCT03630705|588847301|FG003|Overall Study|Lost to Follow-up|0|||
163038171|NCT01128400|588847302|FG000|Overall Study|Lost to Follow-up|1|||
163038172|NCT01128400|588847303|FG001|Overall Study|Lost to Follow-up|0|||
163038173|NCT01128400|588847304|FG002|Overall Study|Lost to Follow-up|1|||
163038174|NCT01128400|588847302|FG000|Overall Study|Screening failure|1|||
163038175|NCT01128400|588847303|FG001|Overall Study|Screening failure|0|||
163038176|NCT01128400|588847304|FG002|Overall Study|Screening failure|0|||
163038177|NCT01128400|588847302|FG000|Overall Study|were not invited to participate on taste|0|||
163090535|NCT01008618|589042877|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
163090536|NCT01008618|589042875|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
163090537|NCT01008618|589042876|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
163090538|NCT01008618|589042877|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
163090539|NCT01008618|589042875|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
163090540|NCT01008618|589042876|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
163090541|NCT01008618|589042877|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
163090542|NCT01008618|589042875|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
163090543|NCT01008618|589042876|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
163090544|NCT01008618|589042877|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
163090545|NCT01008618|589042875|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
163090546|NCT01008618|589042876|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
163090547|NCT01008618|589042877|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
163090548|NCT01008618|589042875|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
163090549|NCT01008618|589042876|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
163090550|NCT01008618|589042877|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
163090551|NCT01008618|589042875|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
163090552|NCT01008618|589042876|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
163090553|NCT01008618|589042877|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
163090554|NCT01128569|589042881|FG000|Washout Period 1|Adverse Event|0|||
163090555|NCT01128569|589042882|FG001|Washout Period 1|Adverse Event|0|||
163090556|NCT01128569|589042883|FG002|Washout Period 1|Adverse Event|1|||
163090557|NCT01128569|589042884|FG003|Washout Period 1|Adverse Event|0|||
163090558|NCT01128569|589042885|FG004|Washout Period 1|Adverse Event|0|||
163090559|NCT01128569|589042886|FG005|Washout Period 1|Adverse Event|0|||
163090560|NCT01128569|589042881|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163090561|NCT01128569|589042882|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163090562|NCT01128569|589042883|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163090563|NCT01128569|589042884|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163090564|NCT01128569|589042885|FG004|Treatment Period 2|Withdrawal by Subject|0|||
163090565|NCT01128569|589042886|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163090566|NCT00894387|589042887|FG000|Overall Study|Adverse Event|44|||
163090567|NCT00894387|589042888|FG001|Overall Study|Adverse Event|45|||
163090568|NCT00894387|589042887|FG000|Overall Study|Abnormal Laboratory values|2|||
163090569|NCT00894387|589042888|FG001|Overall Study|Abnormal Laboratory values|2|||
163090570|NCT00894387|589042887|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163090571|NCT00894387|589042888|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163090572|NCT00894387|589042887|FG000|Overall Study|Lost to Follow-up|3|||
163090573|NCT00894387|589042888|FG001|Overall Study|Lost to Follow-up|5|||
163090574|NCT00894387|589042887|FG000|Overall Study|Administrative problems|2|||
163090575|NCT00894387|589042888|FG001|Overall Study|Administrative problems|2|||
163090576|NCT00894387|589042887|FG000|Overall Study|Death|77|||
163090577|NCT00894387|589042888|FG001|Overall Study|Death|76|||
163090578|NCT00894387|589042887|FG000|Overall Study|Protocol Deviation|4|||
163090579|NCT00894387|589042888|FG001|Overall Study|Protocol Deviation|0|||
163090580|NCT00894387|589042887|FG000|Overall Study|Patient's request|25|||
163090581|NCT00894387|589042888|FG001|Overall Study|Patient's request|30|||
163090582|NCT00894387|589042887|FG000|Overall Study|Other (Missing)|5|||
163090583|NCT00894387|589042888|FG001|Overall Study|Other (Missing)|3|||
163090584|NCT00894387|589042887|FG000|Overall Study|Mis-randomized|13|||
163090585|NCT00894387|589042888|FG001|Overall Study|Mis-randomized|9|||
163090586|NCT00894387|589042887|FG000|Overall Study|GCP non-compliance|0|||
163090587|NCT00894387|589042888|FG001|Overall Study|GCP non-compliance|2|||
163090588|NCT03338400|589042889|FG000|Overall Study|Lost to Follow-up|1|||
163090589|NCT03338400|589042890|FG001|Overall Study|Lost to Follow-up|2|||
163090590|NCT00487981|589042893|FG000|Overall Study|Hypothyroidism diagnosis|1|||
163090591|NCT01213082|589042897|FG000|Overall Study|Lost to Follow-up|6|||
163090592|NCT01213082|589042898|FG001|Overall Study|Lost to Follow-up|7|||
163090593|NCT01213082|589042899|FG002|Overall Study|Lost to Follow-up|4|||
163336591|NCT03547154|589942366|FG001|Overall Study|Withdrawal by Subject|6|||
163336592|NCT03547154|589942365|FG000|Overall Study|Not Selected|0|||
163336593|NCT03547154|589942366|FG001|Overall Study|Not Selected|1|||
163336594|NCT03547154|589942365|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
163336595|NCT03547154|589942366|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
163336596|NCT02404441|589942367|FG000|Phase 1 Part|Adverse Event|1|||
163336597|NCT02404441|589942368|FG001|Phase 1 Part|Adverse Event|0|||
163336598|NCT02404441|589942369|FG002|Phase 1 Part|Adverse Event|0|||
163336599|NCT02404441|589942370|FG003|Phase 1 Part|Adverse Event|0|||
163336600|NCT02404441|589942371|FG004|Phase 1 Part|Adverse Event|0|||
163336601|NCT02404441|589942372|FG005|Phase 1 Part|Adverse Event|0|||
163336602|NCT02404441|589942373|FG006|Phase 1 Part|Adverse Event|0|||
163336603|NCT02404441|589942374|FG007|Phase 1 Part|Adverse Event|0|||
163336604|NCT02404441|589942375|FG008|Phase 1 Part|Adverse Event|0|||
163336605|NCT02404441|589942376|FG009|Phase 1 Part|Adverse Event|0|||
163090594|NCT01213082|589042897|FG000|Overall Study|Physician Decision|0|||
163090595|NCT01213082|589042898|FG001|Overall Study|Physician Decision|0|||
163090596|NCT01213082|589042899|FG002|Overall Study|Physician Decision|1|||
163090597|NCT00698828|589042905|FG000|Overall Study|Adverse Event|3|||
163090598|NCT00698828|589042906|FG001|Overall Study|Adverse Event|4|||
163090599|NCT00698828|589042907|FG002|Overall Study|Adverse Event|4|||
163090600|NCT00698828|589042905|FG000|Overall Study|Death|0|||
163090601|NCT00698828|589042906|FG001|Overall Study|Death|0|||
163090602|NCT00698828|589042907|FG002|Overall Study|Death|1|||
163090603|NCT00698828|589042905|FG000|Overall Study|Exacerbation of COPD|1|||
163090604|NCT00698828|589042906|FG001|Overall Study|Exacerbation of COPD|3|||
163090605|NCT00698828|589042907|FG002|Overall Study|Exacerbation of COPD|0|||
163090606|NCT00698828|589042905|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
163090607|NCT00698828|589042906|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
163090608|NCT00698828|589042907|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
163090609|NCT00698828|589042905|FG000|Overall Study|Investigator/Sponsor decision|1|||
163090610|NCT00698828|589042906|FG001|Overall Study|Investigator/Sponsor decision|0|||
163090611|NCT00698828|589042907|FG002|Overall Study|Investigator/Sponsor decision|2|||
163090612|NCT00698828|589042905|FG000|Overall Study|Lost to Follow-up|1|||
163090613|NCT00698828|589042906|FG001|Overall Study|Lost to Follow-up|1|||
163090614|NCT00698828|589042907|FG002|Overall Study|Lost to Follow-up|0|||
163090615|NCT00698828|589042905|FG000|Overall Study|Withdrew consent|0|||
163090616|NCT00698828|589042906|FG001|Overall Study|Withdrew consent|7|||
163090617|NCT00698828|589042907|FG002|Overall Study|Withdrew consent|4|||
163090618|NCT00698828|589042905|FG000|Overall Study|Withdrew consent (not treated)|2|||
163090619|NCT00698828|589042906|FG001|Overall Study|Withdrew consent (not treated)|0|||
163090620|NCT00698828|589042907|FG002|Overall Study|Withdrew consent (not treated)|0|||
163090621|NCT02013609|589042910|FG000|Overall Study|Withdrawal by Subject|9|||
163090622|NCT02013609|589042910|FG000|Overall Study|Lost to Follow-up|3|||
163090623|NCT02013609|589042910|FG000|Overall Study|Adverse Event|3|||
163090624|NCT02013609|589042910|FG000|Overall Study|Met Withdrawal Criteria|3|||
163090625|NCT01816295|589042911|FG000|Double Blind Phase|Adverse Event|11|||
163090626|NCT01816295|589042912|FG001|Double Blind Phase|Adverse Event|8|||
163090627|NCT01816295|589042911|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
163090628|NCT01816295|589042912|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
163090629|NCT01816295|589042911|FG000|Double Blind Phase|Lost to Follow-up|3|||
163090630|NCT01816295|589042912|FG001|Double Blind Phase|Lost to Follow-up|5|||
163090631|NCT01816295|589042911|FG000|Double Blind Phase|Physician Decision|2|||
163090632|NCT01816295|589042912|FG001|Double Blind Phase|Physician Decision|2|||
163090633|NCT01816295|589042911|FG000|Double Blind Phase|Protocol Violation|17|||
163090634|NCT01816295|589042912|FG001|Double Blind Phase|Protocol Violation|11|||
163090635|NCT01816295|589042911|FG000|Double Blind Phase|Sponsor Decision|8|||
163090636|NCT01816295|589042912|FG001|Double Blind Phase|Sponsor Decision|8|||
163090637|NCT01816295|589042911|FG000|Double Blind Phase|Withdrawal by Subject|22|||
163090638|NCT01816295|589042912|FG001|Double Blind Phase|Withdrawal by Subject|20|||
163090639|NCT01816295|589042911|FG000|OLE Phase|Adverse Event|17|||
163090640|NCT01816295|589042912|FG001|OLE Phase|Adverse Event|15|||
163090641|NCT01816295|589042911|FG000|OLE Phase|Death|1|||
163090642|NCT01816295|589042912|FG001|OLE Phase|Death|0|||
163090643|NCT01816295|589042911|FG000|OLE Phase|Entry Criteria Not Met|3|||
163090644|NCT01816295|589042912|FG001|OLE Phase|Entry Criteria Not Met|5|||
163090645|NCT01816295|589042911|FG000|OLE Phase|Lost to Follow-up|5|||
163090646|NCT01816295|589042912|FG001|OLE Phase|Lost to Follow-up|5|||
163090647|NCT01816295|589042911|FG000|OLE Phase|Physician Decision|3|||
163090648|NCT01816295|589042912|FG001|OLE Phase|Physician Decision|1|||
163090649|NCT01816295|589042911|FG000|OLE Phase|Protocol Violation|4|||
163090650|NCT01816295|589042912|FG001|OLE Phase|Protocol Violation|4|||
163090651|NCT01816295|589042911|FG000|OLE Phase|Sponsor Decision|7|||
163090652|NCT01816295|589042912|FG001|OLE Phase|Sponsor Decision|9|||
163090653|NCT01816295|589042911|FG000|OLE Phase|Withdrawal by Subject|10|||
163090654|NCT01816295|589042912|FG001|OLE Phase|Withdrawal by Subject|10|||
163090655|NCT01816295|589042911|FG000|OLE Phase|Lack of Efficacy|3|||
163090656|NCT01816295|589042912|FG001|OLE Phase|Lack of Efficacy|7|||
163090657|NCT01130337|589042914|FG000|Overall Study|Withdrawal by Subject|3|||
163090658|NCT01130337|589042914|FG000|Overall Study|Principal investigator decision|1|||
163090659|NCT01130337|589042914|FG000|Overall Study|Death|1|||
163090660|NCT01130337|589042914|FG000|Overall Study|Disease progression|1|||
163090661|NCT01130337|589042914|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
163090662|NCT01130337|589042914|FG000|Overall Study|Surgical resection (R2)|1|||
163090663|NCT03886493|589042915|FG000|Overall Study|Adverse Event|1|||
163090664|NCT04067011|589042917|FG000|Overall Study|Not Treated|8|||
163090665|NCT04067011|589042918|FG001|Overall Study|Not Treated|7|||
163090666|NCT04067011|589042919|FG002|Overall Study|Not Treated|5|||
163090667|NCT04067011|589042917|FG000|Overall Study|Adverse Event|2|||
163090668|NCT04067011|589042918|FG001|Overall Study|Adverse Event|1|||
163090669|NCT04067011|589042919|FG002|Overall Study|Adverse Event|0|||
163090670|NCT04067011|589042917|FG000|Overall Study|Withdrawal by Subject|6|||
163090671|NCT04067011|589042918|FG001|Overall Study|Withdrawal by Subject|2|||
163090672|NCT04067011|589042919|FG002|Overall Study|Withdrawal by Subject|1|||
163090673|NCT04067011|589042917|FG000|Overall Study|Lost to Follow-up|0|||
163090674|NCT04067011|589042918|FG001|Overall Study|Lost to Follow-up|0|||
163090675|NCT04067011|589042919|FG002|Overall Study|Lost to Follow-up|1|||
163090676|NCT04067011|589042917|FG000|Overall Study|Physician Decision|1|||
163090677|NCT04067011|589042918|FG001|Overall Study|Physician Decision|1|||
163090678|NCT04067011|589042919|FG002|Overall Study|Physician Decision|0|||
163090679|NCT04067011|589042917|FG000|Overall Study|Other Reasons|2|||
163090680|NCT04067011|589042918|FG001|Overall Study|Other Reasons|0|||
163090681|NCT04067011|589042919|FG002|Overall Study|Other Reasons|1|||
163090682|NCT04067011|589042917|FG000|Overall Study|Missing|0|||
163090683|NCT04067011|589042918|FG001|Overall Study|Missing|2|||
163090684|NCT04067011|589042919|FG002|Overall Study|Missing|0|||
163090685|NCT05209386|589042920|FG000|Overall Study|Withdrawal by Subject|8|||
163090686|NCT05209386|589042920|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
163090687|NCT04436744|589042921|FG000|Overall Study|Adverse Event|1|||
163090688|NCT04436744|589042922|FG001|Overall Study|Adverse Event|1|||
163090689|NCT04436744|589042921|FG000|Overall Study|Death|1|||
163090690|NCT04436744|589042922|FG001|Overall Study|Death|0|||
163090691|NCT04436744|589042921|FG000|Overall Study|Lost to Follow-up|0|||
163090692|NCT04436744|589042922|FG001|Overall Study|Lost to Follow-up|2|||
163090693|NCT04436744|589042921|FG000|Overall Study|Physician Decision|0|||
163090694|NCT04436744|589042922|FG001|Overall Study|Physician Decision|1|||
163090695|NCT04436744|589042921|FG000|Overall Study|Progressive Disease|0|||
163090696|NCT04436744|589042922|FG001|Overall Study|Progressive Disease|4|||
163090697|NCT04436744|589042921|FG000|Overall Study|Protocol Deviation|1|||
163090698|NCT04436744|589042922|FG001|Overall Study|Protocol Deviation|1|||
163090699|NCT04436744|589042921|FG000|Overall Study|Withdrawal by Subject|1|||
163090700|NCT04436744|589042922|FG001|Overall Study|Withdrawal by Subject|2|||
163090701|NCT01463033|589042923|FG000|Overall Study|Lost to Follow-up|4|||
163090702|NCT01463033|589042924|FG001|Overall Study|Lost to Follow-up|4|||
163090703|NCT01463033|589042923|FG000|Overall Study|Death|3|||
163090704|NCT01463033|589042924|FG001|Overall Study|Death|2|||
163090705|NCT01240863|589042926|FG000|Open-label Titration Period|Adverse Event|47|||
163090706|NCT01240863|589042927|FG001|Open-label Titration Period|Adverse Event|0|||
163090707|NCT01240863|589042928|FG002|Open-label Titration Period|Adverse Event|0|||
163090708|NCT01240863|589042926|FG000|Open-label Titration Period|Lack of Efficacy|19|||
163090709|NCT01240863|589042927|FG001|Open-label Titration Period|Lack of Efficacy|0|||
163090710|NCT01240863|589042928|FG002|Open-label Titration Period|Lack of Efficacy|0|||
163090711|NCT01240863|589042926|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
163090712|NCT01240863|589042927|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
163090713|NCT01240863|589042928|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
163090714|NCT01240863|589042926|FG000|Open-label Titration Period|Protocol Violation|7|||
163090715|NCT01240863|589042927|FG001|Open-label Titration Period|Protocol Violation|0|||
163090716|NCT01240863|589042928|FG002|Open-label Titration Period|Protocol Violation|0|||
163090717|NCT01240863|589042926|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
163090718|NCT01240863|589042927|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
163090719|NCT01240863|589042928|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
163090720|NCT01240863|589042926|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
163090721|NCT01240863|589042927|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
163090722|NCT01240863|589042928|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
163090723|NCT01240863|589042926|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
163090724|NCT01240863|589042927|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
163090725|NCT01240863|589042928|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
163090726|NCT01240863|589042926|FG000|Open-label Titration Period|Other|7|||
163090727|NCT01240863|589042927|FG001|Open-label Titration Period|Other|0|||
163090728|NCT01240863|589042928|FG002|Open-label Titration Period|Other|0|||
163090729|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
163090730|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
163090731|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
163090732|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
163090733|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
163090734|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
163336606|NCT02404441|589942367|FG000|Phase 1 Part|Physician Decision|0|||
163090735|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163090736|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
163090737|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
163090738|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
163090739|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
163090740|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
163090741|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
163220075|NCT02039674|589521407|FG001|Overall Study|Adverse Event|0|||
163336607|NCT02404441|589942368|FG001|Phase 1 Part|Physician Decision|1|||
163336608|NCT02404441|589942369|FG002|Phase 1 Part|Physician Decision|0|||
163407413|NCT02684981|590200812|FG001|Overall Study|Permanently discontinued the treatment|161|||
163090742|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
163090743|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
163090744|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
163090745|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
163090746|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
163090747|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
163090748|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
163090749|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
163090750|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
163090751|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
163090752|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
163090753|NCT00746811|589042929|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
163090754|NCT00746811|589042930|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
163090755|NCT01538199|589042931|FG000|Overall Study|Lost to Follow-up|1|||
163090756|NCT01538199|589042932|FG001|Overall Study|Lost to Follow-up|2|||
163090757|NCT01538199|589042933|FG002|Overall Study|Lost to Follow-up|1|||
163090758|NCT01538199|589042934|FG003|Overall Study|Lost to Follow-up|0|||
163090759|NCT01538199|589042931|FG000|Overall Study|participant did not have time|1|||
163090760|NCT01538199|589042932|FG001|Overall Study|participant did not have time|0|||
163090761|NCT01538199|589042933|FG002|Overall Study|participant did not have time|0|||
163090762|NCT01538199|589042934|FG003|Overall Study|participant did not have time|2|||
163090763|NCT01538199|589042931|FG000|Overall Study|Lack of Efficacy|0|||
163090764|NCT01538199|589042932|FG001|Overall Study|Lack of Efficacy|1|||
163090765|NCT01538199|589042933|FG002|Overall Study|Lack of Efficacy|0|||
163090766|NCT01538199|589042934|FG003|Overall Study|Lack of Efficacy|0|||
163090767|NCT03358030|589042935|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
163090768|NCT03358030|589042936|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
163090769|NCT03358030|589042937|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
163090770|NCT03358030|589042938|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
163090771|NCT03358030|589042935|FG000|Overall Study|Ineligibility|0|||
163090772|NCT03358030|589042936|FG001|Overall Study|Ineligibility|0|||
163090773|NCT03358030|589042937|FG002|Overall Study|Ineligibility|0|||
163090774|NCT03358030|589042938|FG003|Overall Study|Ineligibility|2|||
163090775|NCT03358030|589042935|FG000|Overall Study|Voluntary Withdrawal|1|||
163090776|NCT03358030|589042936|FG001|Overall Study|Voluntary Withdrawal|1|||
163090777|NCT03358030|589042937|FG002|Overall Study|Voluntary Withdrawal|3|||
163090778|NCT03358030|589042938|FG003|Overall Study|Voluntary Withdrawal|1|||
163090779|NCT03358030|589042935|FG000|Overall Study|Other|0|||
163090780|NCT03358030|589042936|FG001|Overall Study|Other|0|||
163090781|NCT03358030|589042937|FG002|Overall Study|Other|1|||
163090782|NCT03358030|589042938|FG003|Overall Study|Other|0|||
163090783|NCT03342560|589042939|FG000|Overall Study|Lost to Follow-up|2|||
163090784|NCT02604511|589042940|FG000|Overall Study|Adverse Event|3|||
163090785|NCT02604511|589042940|FG000|Overall Study|Disease Progression|4|||
163090786|NCT02604511|589042940|FG000|Overall Study|Withdrawal by Subject|3|||
163090787|NCT02604511|589042940|FG000|Overall Study|Participant ineligible|1|||
163090788|NCT02604511|589042940|FG000|Overall Study|Intercurrent illness|1|||
163090789|NCT03770286|589042941|FG000|Overall Study|Lost to Follow-up|6|||
163090790|NCT03770286|589042942|FG001|Overall Study|Lost to Follow-up|4|||
163090791|NCT03770286|589042943|FG002|Overall Study|Lost to Follow-up|3|||
163090792|NCT03770286|589042941|FG000|Overall Study|Protocol Violation|1|||
163090793|NCT03770286|589042942|FG001|Overall Study|Protocol Violation|0|||
163090794|NCT03770286|589042943|FG002|Overall Study|Protocol Violation|2|||
163090795|NCT02505425|589042944|FG000|Overall Study|Lost to Follow-up|41|||
163090796|NCT02505425|589042945|FG001|Overall Study|Lost to Follow-up|61|||
163090797|NCT02505425|589042946|FG002|Overall Study|Lost to Follow-up|31|||
163090798|NCT02505425|589042947|FG003|Overall Study|Lost to Follow-up|19|||
163090799|NCT02505425|589042944|FG000|Overall Study|Withdrawal by Subject|39|||
163090800|NCT02505425|589042945|FG001|Overall Study|Withdrawal by Subject|9|||
163090801|NCT02505425|589042946|FG002|Overall Study|Withdrawal by Subject|19|||
163090802|NCT02505425|589042947|FG003|Overall Study|Withdrawal by Subject|7|||
163090803|NCT02505425|589042944|FG000|Overall Study|Death|8|||
163090804|NCT02505425|589042945|FG001|Overall Study|Death|12|||
163090805|NCT02505425|589042946|FG002|Overall Study|Death|0|||
163090806|NCT02505425|589042947|FG003|Overall Study|Death|0|||
163090807|NCT05643495|589042954|FG000|Overall Study|Adverse Event|0|||
163090808|NCT05643495|589042955|FG001|Overall Study|Adverse Event|1|||
163090809|NCT05643495|589042954|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
163090810|NCT05643495|589042955|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
163090811|NCT02257528|589042956|FG000|Overall Study|Never received study treatment|1|||
163090812|NCT01729039|589042957|FG000|Overall Study|disqualified|2|||
163090813|NCT01729039|589042958|FG001|Overall Study|disqualified|5|||
163090814|NCT01729039|589042957|FG000|Overall Study|Withdrawal by Subject|8|||
163090815|NCT01729039|589042958|FG001|Overall Study|Withdrawal by Subject|7|||
163090816|NCT00404248|589042961|FG000|Overall Study|pts declining status|0|||
163090817|NCT00404248|589042962|FG001|Overall Study|pts declining status|1|||
163090818|NCT00404248|589042963|FG002|Overall Study|pts declining status|0|||
163090819|NCT00404248|589042964|FG003|Overall Study|pts declining status|0|||
163090820|NCT00404248|589042965|FG004|Overall Study|pts declining status|0|||
163090821|NCT00404248|589042966|FG005|Overall Study|pts declining status|0|||
163090822|NCT00404248|589042967|FG006|Overall Study|pts declining status|0|||
163090823|NCT00404248|589042968|FG007|Overall Study|pts declining status|0|||
163090824|NCT00404248|589042969|FG008|Overall Study|pts declining status|0|||
163090825|NCT00698841|589042970|FG000|Overall Study|Withdrawal by Subject|2|||
163090826|NCT00698841|589042970|FG000|Overall Study|Adverse Event|3|||
163090827|NCT00698841|589042970|FG000|Overall Study|Disease progression|7|||
163090828|NCT00698841|589042970|FG000|Overall Study|Failure to meet eligibility criteria|2|||
163090829|NCT00698841|589042970|FG000|Overall Study|Study drug toxicity|2|||
163090830|NCT00698841|589042970|FG000|Overall Study|Other|2|||
163090831|NCT05788991|589042971|FG000|Overall Study|Not treated with study medication|1|||
163090832|NCT05788991|589042972|FG001|Overall Study|Not treated with study medication|3|||
163090833|NCT05788991|589042971|FG000|Overall Study|Withdrawal by Subject|1|||
163090834|NCT05788991|589042972|FG001|Overall Study|Withdrawal by Subject|0|||
163090835|NCT05788991|589042971|FG000|Overall Study|Lack of Efficacy|0|||
163090836|NCT05788991|589042972|FG001|Overall Study|Lack of Efficacy|1|||
163090837|NCT05788991|589042971|FG000|Overall Study|Protocol Violation|1|||
163090838|NCT05788991|589042972|FG001|Overall Study|Protocol Violation|2|||
163090839|NCT04464473|589042973|FG000|Overall Study|New piercing could not be removed for scanning|0|||
163090840|NCT04464473|589042974|FG001|Overall Study|New piercing could not be removed for scanning|0|||
163090841|NCT04464473|589042975|FG002|Overall Study|New piercing could not be removed for scanning|0|||
163090842|NCT04464473|589042976|FG003|Overall Study|New piercing could not be removed for scanning|1|||
163090843|NCT04464473|589042977|FG004|Overall Study|New piercing could not be removed for scanning|0|||
163090844|NCT04464473|589042978|FG005|Overall Study|New piercing could not be removed for scanning|0|||
163090845|NCT04464473|589042973|FG000|Overall Study|Adverse Event|0|||
163090846|NCT04464473|589042974|FG001|Overall Study|Adverse Event|0|||
163090847|NCT04464473|589042975|FG002|Overall Study|Adverse Event|0|||
163090848|NCT04464473|589042976|FG003|Overall Study|Adverse Event|1|||
163090849|NCT04464473|589042977|FG004|Overall Study|Adverse Event|0|||
163090850|NCT04464473|589042978|FG005|Overall Study|Adverse Event|0|||
163090851|NCT04464473|589042973|FG000|Overall Study|Lost to Follow-up|0|||
163090852|NCT04464473|589042974|FG001|Overall Study|Lost to Follow-up|0|||
163090853|NCT04464473|589042975|FG002|Overall Study|Lost to Follow-up|0|||
163090854|NCT04464473|589042976|FG003|Overall Study|Lost to Follow-up|1|||
163090855|NCT04464473|589042977|FG004|Overall Study|Lost to Follow-up|0|||
163090856|NCT04464473|589042978|FG005|Overall Study|Lost to Follow-up|0|||
163090857|NCT03802396|589042979|FG000|Overall Study|Withdrawal by Subject|2|||
163090858|NCT03802396|589042980|FG001|Overall Study|Withdrawal by Subject|0|||
163090859|NCT03802396|589042979|FG000|Overall Study|Surgery Cancelled|1|||
163090860|NCT03802396|589042980|FG001|Overall Study|Surgery Cancelled|0|||
163090861|NCT04237584|589042991|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
163090862|NCT04237584|589042992|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
163090863|NCT04237584|589042993|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
163090864|NCT04237584|589042994|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
163090865|NCT04237584|589042991|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
163090866|NCT04237584|589042992|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
163090867|NCT04237584|589042993|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
163090868|NCT04237584|589042994|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
163090869|NCT04237584|589042991|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
163090870|NCT04237584|589042992|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
163090871|NCT04237584|589042993|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
163090872|NCT04237584|589042994|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
163090873|NCT04237584|589042991|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
163336609|NCT02404441|589942370|FG003|Phase 1 Part|Physician Decision|0|||
163336610|NCT02404441|589942371|FG004|Phase 1 Part|Physician Decision|0|||
163336611|NCT02404441|589942372|FG005|Phase 1 Part|Physician Decision|0|||
163336612|NCT02404441|589942373|FG006|Phase 1 Part|Physician Decision|0|||
163336613|NCT02404441|589942374|FG007|Phase 1 Part|Physician Decision|0|||
163336614|NCT02404441|589942375|FG008|Phase 1 Part|Physician Decision|0|||
163336615|NCT02404441|589942376|FG009|Phase 1 Part|Physician Decision|0|||
163336616|NCT02404441|589942367|FG000|Phase 1 Part|Progressive Disease|14|||
163336617|NCT02404441|589942368|FG001|Phase 1 Part|Progressive Disease|11|||
163336618|NCT02404441|589942369|FG002|Phase 1 Part|Progressive Disease|7|||
163336619|NCT02404441|589942370|FG003|Phase 1 Part|Progressive Disease|6|||
163336620|NCT02404441|589942371|FG004|Phase 1 Part|Progressive Disease|9|||
163407414|NCT02684981|590200813|FG002|Overall Study|Permanently discontinued the treatment|110|||
163407415|NCT02684981|590200811|FG000|Overall Study|Other|83|||
163090874|NCT04237584|589042992|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
163090875|NCT04237584|589042993|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
163090876|NCT04237584|589042994|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
163090877|NCT04237584|589042991|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
163090878|NCT04237584|589042992|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
163090879|NCT04237584|589042993|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
163090880|NCT04237584|589042994|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
163090881|NCT01150357|589043000|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
163090882|NCT01150357|589043001|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
163090883|NCT01150357|589043002|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
163090884|NCT01150357|589043000|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
163090885|NCT01150357|589043001|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
163090886|NCT01150357|589043002|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
163090887|NCT01150357|589043000|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
163090888|NCT01150357|589043001|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
163090889|NCT01150357|589043002|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
163090890|NCT01150357|589043000|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
163090891|NCT01150357|589043001|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
163090892|NCT01150357|589043002|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
163090893|NCT01150357|589043000|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
163090894|NCT01150357|589043001|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
163090895|NCT01150357|589043002|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
163090896|NCT01150357|589043000|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
163090897|NCT01150357|589043001|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
163090898|NCT01150357|589043002|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
163090899|NCT01150357|589043000|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
163090900|NCT01150357|589043001|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
163090901|NCT01150357|589043002|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
163090902|NCT02661672|589043003|FG000|Overall Study|Lost to Follow-up|1|||
163090903|NCT02661672|589043003|FG000|Overall Study|Death|4|||
163038178|NCT01128400|588847303|FG001|Overall Study|were not invited to participate on taste|0|||
163038179|NCT01128400|588847304|FG002|Overall Study|were not invited to participate on taste|15|||
163038180|NCT01128400|588847302|FG000|Overall Study|Excluded due to sinus problems|0|||
163038181|NCT01128400|588847303|FG001|Overall Study|Excluded due to sinus problems|1|||
163038182|NCT01128400|588847304|FG002|Overall Study|Excluded due to sinus problems|0|||
163038183|NCT03782571|588847310|FG000|Period 1|Withdrawal by Subject|1|||
163038184|NCT03782571|588847311|FG001|Period 1|Withdrawal by Subject|0|||
163038185|NCT03782571|588847312|FG002|Period 1|Withdrawal by Subject|0|||
163038186|NCT03782571|588847313|FG003|Period 1|Withdrawal by Subject|0|||
163336621|NCT02404441|589942372|FG005|Phase 1 Part|Progressive Disease|0|||
163090904|NCT03549338|589044601|FG000|Overall Study|Progressive Disease|1|||
163090905|NCT03549338|589044602|FG001|Overall Study|Progressive Disease|0|||
163090906|NCT03549338|589044603|FG002|Overall Study|Progressive Disease|0|||
163090907|NCT03549338|589044601|FG000|Overall Study|Clinical Progression|0|||
163090908|NCT03549338|589044602|FG001|Overall Study|Clinical Progression|1|||
163090909|NCT03549338|589044603|FG002|Overall Study|Clinical Progression|0|||
163090910|NCT01492426|589044604|FG000|Treatment|Death|0|||
163090911|NCT01492426|589044605|FG001|Treatment|Death|1|||
163090912|NCT01492426|589044604|FG000|Treatment|Other|1|||
163090913|NCT01492426|589044605|FG001|Treatment|Other|0|||
163090914|NCT01492426|589044604|FG000|Treatment|Adverse Event|25|||
163090915|NCT01492426|589044605|FG001|Treatment|Adverse Event|25|||
163090916|NCT01492426|589044604|FG000|Treatment|Lack of Efficacy|38|||
163090917|NCT01492426|589044605|FG001|Treatment|Lack of Efficacy|5|||
163090918|NCT01492426|589044604|FG000|Treatment|Participant withdrew consent|1|||
163090919|NCT01492426|589044605|FG001|Treatment|Participant withdrew consent|2|||
163090920|NCT01492426|589044604|FG000|Treatment|Poor compliance/noncompliance|1|||
163090921|NCT01492426|589044605|FG001|Treatment|Poor compliance/noncompliance|0|||
163090922|NCT01492426|589044604|FG000|Treatment|Subject requested discontinue study drug|7|||
163090923|NCT01492426|589044605|FG001|Treatment|Subject requested discontinue study drug|3|||
163090924|NCT01492426|589044604|FG000|Treatment|Lost to Follow-up|9|||
163090925|NCT01492426|589044605|FG001|Treatment|Lost to Follow-up|4|||
163090926|NCT01492426|589044604|FG000|Treatment|Participant does not meet study criteria|1|||
163090927|NCT01492426|589044605|FG001|Treatment|Participant does not meet study criteria|0|||
163090928|NCT01492426|589044604|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
163336622|NCT02404441|589942373|FG006|Phase 1 Part|Progressive Disease|0|||
163038187|NCT03782571|588847310|FG000|Period 3|Subject Unable to Attend V5|1|||
163038188|NCT03782571|588847311|FG001|Period 3|Subject Unable to Attend V5|0|||
163038189|NCT03782571|588847312|FG002|Period 3|Subject Unable to Attend V5|0|||
163090929|NCT01492426|589044605|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
163336623|NCT02404441|589942374|FG007|Phase 1 Part|Progressive Disease|0|||
163336624|NCT02404441|589942375|FG008|Phase 1 Part|Progressive Disease|0|||
163090930|NCT01492426|589044604|FG000|Follow-Up|Death|1|||
163090931|NCT01492426|589044605|FG001|Follow-Up|Death|0|||
163090932|NCT01492426|589044604|FG000|Follow-Up|Other|4|||
163090933|NCT01492426|589044605|FG001|Follow-Up|Other|2|||
163090934|NCT01492426|589044604|FG000|Follow-Up|Participant Withdrew Consent|6|||
163090935|NCT01492426|589044605|FG001|Follow-Up|Participant Withdrew Consent|1|||
163090936|NCT01492426|589044604|FG000|Follow-Up|Lost to Follow-up|12|||
163090937|NCT01492426|589044605|FG001|Follow-Up|Lost to Follow-up|6|||
163090938|NCT00269113|589044606|FG000|Overall Study|Adverse Event|14|||
163090939|NCT00269113|589044607|FG001|Overall Study|Adverse Event|7|||
163090940|NCT00269113|589044606|FG000|Overall Study|Lack of Efficacy|35|||
163090941|NCT00269113|589044607|FG001|Overall Study|Lack of Efficacy|18|||
163090942|NCT00269113|589044606|FG000|Overall Study|Early Improvement|2|||
163090943|NCT00269113|589044607|FG001|Overall Study|Early Improvement|0|||
163090944|NCT00269113|589044606|FG000|Overall Study|Withdrawal by Subject|0|||
163090945|NCT00269113|589044607|FG001|Overall Study|Withdrawal by Subject|2|||
163090946|NCT00269113|589044606|FG000|Overall Study|Death|6|||
163090947|NCT00269113|589044607|FG001|Overall Study|Death|2|||
163090948|NCT00269113|589044606|FG000|Overall Study|Lost to Follow-up|2|||
163090949|NCT00269113|589044607|FG001|Overall Study|Lost to Follow-up|1|||
163090950|NCT00269113|589044606|FG000|Overall Study|Protocol Violation|15|||
163090951|NCT00269113|589044607|FG001|Overall Study|Protocol Violation|5|||
163090952|NCT00269113|589044606|FG000|Overall Study|Other|0|||
163090953|NCT00269113|589044607|FG001|Overall Study|Other|2|||
163090954|NCT00652743|589044608|FG000|Months 12-18|Lost to Follow-up|1|||
163090955|NCT00652743|589044609|FG001|Months 12-18|Lost to Follow-up|2|||
163090956|NCT00652743|589044610|FG002|Months 12-18|Lost to Follow-up|7|||
163090957|NCT00652743|589044608|FG000|Months 24-30|Other|5|||
163090958|NCT00652743|589044609|FG001|Months 24-30|Other|1|||
163090959|NCT00652743|589044610|FG002|Months 24-30|Other|11|||
163090960|NCT00652743|589044608|FG000|Months 36-42|Serious Adverse Events|0|||
163090961|NCT00652743|589044609|FG001|Months 36-42|Serious Adverse Events|1|||
163090962|NCT00652743|589044610|FG002|Months 36-42|Serious Adverse Events|1|||
163090963|NCT00652743|589044608|FG000|Months 36-42|Withdrawal by Subject|1|||
163090964|NCT00652743|589044609|FG001|Months 36-42|Withdrawal by Subject|1|||
163090965|NCT00652743|589044610|FG002|Months 36-42|Withdrawal by Subject|0|||
163090966|NCT00652743|589044608|FG000|Months 36-42|Lost to Follow-up|0|||
163090967|NCT00652743|589044609|FG001|Months 36-42|Lost to Follow-up|1|||
163090968|NCT00652743|589044610|FG002|Months 36-42|Lost to Follow-up|0|||
163090969|NCT00652743|589044608|FG000|Months 36-42|Migrated/moved from study area|1|||
163090970|NCT00652743|589044609|FG001|Months 36-42|Migrated/moved from study area|0|||
163090971|NCT00652743|589044610|FG002|Months 36-42|Migrated/moved from study area|0|||
163090972|NCT00652743|589044608|FG000|Months 36-42|Other|4|||
163090973|NCT00652743|589044609|FG001|Months 36-42|Other|2|||
163090974|NCT00652743|589044610|FG002|Months 36-42|Other|8|||
163090975|NCT00140140|589044611|FG000|Overall Study|Unacceptable toxicity|1|||
163090976|NCT00140140|589044612|FG001|Overall Study|Unacceptable toxicity|1|||
163090977|NCT00140140|589044613|FG002|Overall Study|Unacceptable toxicity|2|||
163407416|NCT02684981|590200812|FG001|Overall Study|Other|49|||
163407417|NCT02684981|590200813|FG002|Overall Study|Other|17|||
163407418|NCT00820898|590200816|FG000|Overall Study|Inelgible - wrong primary site|1|||
163407419|NCT00452699|590200819|FG000|Overall Study|Adverse Event|10|||
163407420|NCT00452699|590200820|FG001|Overall Study|Adverse Event|3|||
163407421|NCT00452699|590200819|FG000|Overall Study|Lack of Efficacy|6|||
163407422|NCT00452699|590200820|FG001|Overall Study|Lack of Efficacy|4|||
163407423|NCT00452699|590200819|FG000|Overall Study|Lost to Follow-up|6|||
163407424|NCT00452699|590200820|FG001|Overall Study|Lost to Follow-up|9|||
163407425|NCT00452699|590200819|FG000|Overall Study|Protocol Violation|21|||
163407426|NCT00452699|590200820|FG001|Overall Study|Protocol Violation|25|||
163407427|NCT00452699|590200819|FG000|Overall Study|Withdrawal by Subject|26|||
163407428|NCT00452699|590200820|FG001|Overall Study|Withdrawal by Subject|25|||
163407429|NCT00452699|590200819|FG000|Overall Study|Other|12|||
163090978|NCT00140140|589044611|FG000|Overall Study|Physician Decision|1|||
163090979|NCT00140140|589044612|FG001|Overall Study|Physician Decision|1|||
163090980|NCT00140140|589044613|FG002|Overall Study|Physician Decision|0|||
163090981|NCT01248793|589044614|FG000|Overall Study|Lost to Follow-up|0|||
163090982|NCT01248793|589044615|FG001|Overall Study|Lost to Follow-up|1|||
163090983|NCT01248793|589044614|FG000|Overall Study|Adverse Event|1|||
163090984|NCT01248793|589044615|FG001|Overall Study|Adverse Event|1|||
163090985|NCT01248793|589044614|FG000|Overall Study|Protocol Violation|0|||
163090986|NCT01248793|589044615|FG001|Overall Study|Protocol Violation|1|||
163090987|NCT01248793|589044614|FG000|Overall Study|Withdrawal by Subject|3|||
163090988|NCT01248793|589044615|FG001|Overall Study|Withdrawal by Subject|3|||
163090989|NCT00517699|589044616|FG000|Overall Study|Withdrawal by Subject|1|||
163407430|NCT00452699|590200820|FG001|Overall Study|Other|7|||
163407431|NCT00326898|590200823|FG000|Overall Study|Disease progression|52|||
163407432|NCT00326898|590200824|FG001|Overall Study|Disease progression|54|||
163407433|NCT00326898|590200825|FG002|Overall Study|Disease progression|102|||
163090990|NCT00517699|589044616|FG000|Overall Study|Lack of Efficacy|1|||
163090991|NCT00517699|589044616|FG000|Overall Study|Administrative error|1|||
163407434|NCT00326898|590200823|FG000|Overall Study|Adverse Event|124|||
163090992|NCT00517699|589044616|FG000|Overall Study|Study terminated by Sponsor|2|||
163090993|NCT01114737|589044617|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
163090994|NCT01114737|589044618|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
163090995|NCT01114737|589044617|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
163090996|NCT01114737|589044618|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
163090997|NCT01114737|589044617|FG000|Randomized Treatment Period|Pregnancy|1|||
163090998|NCT01114737|589044618|FG001|Randomized Treatment Period|Pregnancy|0|||
163090999|NCT01114737|589044617|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
163091000|NCT01114737|589044618|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
163091001|NCT01114737|589044617|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
163091002|NCT01114737|589044618|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
163091003|NCT01114737|589044617|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
163091004|NCT01114737|589044618|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
163091005|NCT02580877|589044621|FG000|Overall Study|Withdrawal by Subject|1|||
163091006|NCT02580877|589044622|FG001|Overall Study|Withdrawal by Subject|3|||
163091007|NCT02580877|589044621|FG000|Overall Study|Adverse Event|0|||
163091008|NCT02580877|589044622|FG001|Overall Study|Adverse Event|1|||
163091009|NCT01466491|589044623|FG000|Overall Study|Protocol Violation|0|||
163091010|NCT01466491|589044624|FG001|Overall Study|Protocol Violation|3|||
163091011|NCT01466491|589044625|FG002|Overall Study|Protocol Violation|2|||
163091012|NCT01466491|589044626|FG003|Overall Study|Protocol Violation|0|||
163091013|NCT01466491|589044623|FG000|Overall Study|Missing Data|0|||
163091014|NCT01466491|589044624|FG001|Overall Study|Missing Data|0|||
163091015|NCT01466491|589044625|FG002|Overall Study|Missing Data|1|||
163091016|NCT01466491|589044626|FG003|Overall Study|Missing Data|0|||
163091017|NCT01123148|589044627|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
163091018|NCT01123148|589044627|FG000|Overall Study|Didn't meet milestone criteria|1|||
163091019|NCT04460183|589044631|FG000|Overall Study|Lost to Follow-up|3|||
163091020|NCT04460183|589044632|FG001|Overall Study|Lost to Follow-up|1|||
163091021|NCT04460183|589044631|FG000|Overall Study|Withdrawal by Subject|1|||
163091022|NCT04460183|589044632|FG001|Overall Study|Withdrawal by Subject|0|||
163091023|NCT00856609|589044635|FG000|Overall Study|Adverse Event|1|||
163091024|NCT00856609|589044636|FG001|Overall Study|Adverse Event|0|||
163091025|NCT01788943|589044637|FG000|Overall Study|Withdrawal by Subject|1|||
163091026|NCT01788943|589044638|FG001|Overall Study|Withdrawal by Subject|0|||
163091027|NCT01119287|589044639|FG000|Overall Study|Patient Decision, not related to AE|0|||
163091028|NCT01119287|589044640|FG001|Overall Study|Patient Decision, not related to AE|0|||
163091029|NCT01119287|589044641|FG002|Overall Study|Patient Decision, not related to AE|2|||
163091030|NCT01119287|589044642|FG003|Overall Study|Patient Decision, not related to AE|2|||
163091031|NCT01119287|589044643|FG004|Overall Study|Patient Decision, not related to AE|1|||
163091032|NCT01119287|589044644|FG005|Overall Study|Patient Decision, not related to AE|0|||
163091033|NCT00783432|589044645|FG000|Overall Study|Adverse Event|22|||
163091034|NCT00783432|589044646|FG001|Overall Study|Adverse Event|17|||
163091035|NCT00783432|589044645|FG000|Overall Study|Lack of Efficacy|20|||
163091036|NCT00783432|589044646|FG001|Overall Study|Lack of Efficacy|21|||
163091037|NCT00783432|589044645|FG000|Overall Study|Lost to Follow-up|11|||
163091038|NCT00783432|589044646|FG001|Overall Study|Lost to Follow-up|6|||
163091039|NCT00783432|589044645|FG000|Overall Study|Withdrawal by Subject|23|||
163091040|NCT00783432|589044646|FG001|Overall Study|Withdrawal by Subject|20|||
163091041|NCT00783432|589044645|FG000|Overall Study|subject moved|3|||
163091042|NCT00783432|589044646|FG001|Overall Study|subject moved|5|||
163091043|NCT00783432|589044645|FG000|Overall Study|Protocol Violation|6|||
163091044|NCT00783432|589044646|FG001|Overall Study|Protocol Violation|9|||
163091045|NCT00186628|589044647|FG000|Overall Study|Death|2|||
163091046|NCT00186628|589044647|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
163091047|NCT01331681|589044648|FG000|Overall Study|Adverse Event|10|||
163091048|NCT01331681|589044649|FG001|Overall Study|Adverse Event|13|||
163091049|NCT01331681|589044650|FG002|Overall Study|Adverse Event|10|||
163091050|NCT01331681|589044648|FG000|Overall Study|Death|6|||
163091051|NCT01331681|589044649|FG001|Overall Study|Death|6|||
163091052|NCT01331681|589044650|FG002|Overall Study|Death|2|||
163091053|NCT01331681|589044648|FG000|Overall Study|Lack of Efficacy|0|||
163091054|NCT01331681|589044649|FG001|Overall Study|Lack of Efficacy|1|||
163091055|NCT01331681|589044650|FG002|Overall Study|Lack of Efficacy|0|||
163091056|NCT01331681|589044648|FG000|Overall Study|Withdrawal by Subject|12|||
163091057|NCT01331681|589044649|FG001|Overall Study|Withdrawal by Subject|8|||
163091058|NCT01331681|589044650|FG002|Overall Study|Withdrawal by Subject|15|||
163091059|NCT01331681|589044648|FG000|Overall Study|Protocol Violation|1|||
163091060|NCT01331681|589044649|FG001|Overall Study|Protocol Violation|1|||
163336625|NCT02404441|589942376|FG009|Phase 1 Part|Progressive Disease|0|||
163091061|NCT01331681|589044650|FG002|Overall Study|Protocol Violation|0|||
163091062|NCT01331681|589044648|FG000|Overall Study|Lost to Follow-up|2|||
163091063|NCT01331681|589044649|FG001|Overall Study|Lost to Follow-up|4|||
163336626|NCT02404441|589942367|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
163091064|NCT01331681|589044650|FG002|Overall Study|Lost to Follow-up|1|||
163091065|NCT01331681|589044648|FG000|Overall Study|Physician Decision|2|||
163091066|NCT01331681|589044649|FG001|Overall Study|Physician Decision|0|||
163091067|NCT01331681|589044650|FG002|Overall Study|Physician Decision|4|||
163091068|NCT01331681|589044648|FG000|Overall Study|Therapeutic procedure required|1|||
163091069|NCT01331681|589044649|FG001|Overall Study|Therapeutic procedure required|0|||
163091070|NCT01331681|589044650|FG002|Overall Study|Therapeutic procedure required|0|||
163091071|NCT01331681|589044648|FG000|Overall Study|Sponsor decision|1|||
163091072|NCT01331681|589044649|FG001|Overall Study|Sponsor decision|1|||
163091073|NCT01331681|589044650|FG002|Overall Study|Sponsor decision|0|||
163091074|NCT01331681|589044648|FG000|Overall Study|Switching to other therapy|0|||
163091075|NCT01331681|589044649|FG001|Overall Study|Switching to other therapy|0|||
163091076|NCT01331681|589044650|FG002|Overall Study|Switching to other therapy|1|||
163091077|NCT01331681|589044648|FG000|Overall Study|Not Received Study Treatment|0|||
163091078|NCT01331681|589044649|FG001|Overall Study|Not Received Study Treatment|0|||
163091079|NCT01331681|589044650|FG002|Overall Study|Not Received Study Treatment|2|||
163091080|NCT05525910|589044651|FG000|Period 4|Per sponsor due to study timelines|0|||
163091081|NCT05525910|589044652|FG001|Period 4|Per sponsor due to study timelines|0|||
163091082|NCT05525910|589044653|FG002|Period 4|Per sponsor due to study timelines|1|||
163091083|NCT05525910|589044654|FG003|Period 4|Per sponsor due to study timelines|1|||
163091084|NCT05525910|589044655|FG004|Period 4|Per sponsor due to study timelines|1|||
163091085|NCT00107276|589044656|FG000|Overall Study|Progression|46|||
163091086|NCT00107276|589044656|FG000|Overall Study|Adverse Event|6|||
163091087|NCT00107276|589044656|FG000|Overall Study|M.D. decision|2|||
163091088|NCT00107276|589044656|FG000|Overall Study|Patient refusal|1|||
163091089|NCT00107276|589044656|FG000|Overall Study|Death|1|||
163091090|NCT00107276|589044656|FG000|Overall Study|Ineligible|16|||
163091091|NCT03498716|589044666|FG000|Overall Study|Withdrawal by Subject|88|||
163091092|NCT03498716|589044667|FG001|Overall Study|Withdrawal by Subject|73|||
163091093|NCT03498716|589044666|FG000|Overall Study|Study Terminated By Sponsor|933|||
163091094|NCT03498716|589044667|FG001|Overall Study|Study Terminated By Sponsor|927|||
163091095|NCT03498716|589044666|FG000|Overall Study|Lost to Follow-up|15|||
163091096|NCT03498716|589044667|FG001|Overall Study|Lost to Follow-up|26|||
163091097|NCT03498716|589044666|FG000|Overall Study|Disease Relapse|0|||
163091098|NCT03498716|589044667|FG001|Overall Study|Disease Relapse|1|||
163091099|NCT03498716|589044666|FG000|Overall Study|Death|58|||
163091100|NCT03498716|589044667|FG001|Overall Study|Death|72|||
163091101|NCT03498716|589044666|FG000|Overall Study|Physician Decision|4|||
163091102|NCT03498716|589044667|FG001|Overall Study|Physician Decision|2|||
163091103|NCT02284191|589044668|FG000|Overall Study|Withdrawal by Subject|1|||
163091104|NCT02284191|589044669|FG001|Overall Study|Withdrawal by Subject|3|||
163091105|NCT02284191|589044668|FG000|Overall Study|Lost to Follow-up|1|||
163091106|NCT02284191|589044669|FG001|Overall Study|Lost to Follow-up|0|||
163091107|NCT04064905|589044670|FG000|Overall Study|Lost to Follow-up|0|||
163091108|NCT04064905|589044671|FG001|Overall Study|Lost to Follow-up|3|||
163091109|NCT04064905|589044672|FG002|Overall Study|Lost to Follow-up|1|||
163091110|NCT04064905|589044673|FG003|Overall Study|Lost to Follow-up|4|||
163091111|NCT04064905|589044674|FG004|Overall Study|Lost to Follow-up|2|||
163091112|NCT02257684|589044677|FG000|Overall Study|Adverse Event|2|||
163091113|NCT02257684|589044677|FG000|Overall Study|Lack of Efficacy|1|||
163091114|NCT02257684|589044677|FG000|Overall Study|Sponsor's Decision|1|||
163091115|NCT03139448|589044681|FG000|Overall Study|Lack of Efficacy|6|||
163091116|NCT03139448|589044682|FG001|Overall Study|Lack of Efficacy|7|||
163091117|NCT03139448|589044681|FG000|Overall Study|Location of procedure changed|2|||
163091118|NCT03139448|589044682|FG001|Overall Study|Location of procedure changed|8|||
163091119|NCT03139448|589044681|FG000|Overall Study|Withdrawal by Subject|3|||
163091120|NCT03139448|589044682|FG001|Overall Study|Withdrawal by Subject|6|||
163091121|NCT03139448|589044681|FG000|Overall Study|Screen fail|1|||
163091122|NCT03139448|589044682|FG001|Overall Study|Screen fail|3|||
163091123|NCT03139448|589044681|FG000|Overall Study|Physician Decision|0|||
163091124|NCT03139448|589044682|FG001|Overall Study|Physician Decision|2|||
163091125|NCT01987557|589044683|FG000|Overall Study|Protocol Violation|1|||
163091126|NCT01987557|589044684|FG001|Overall Study|Protocol Violation|0|||
163091127|NCT01987557|589044685|FG002|Overall Study|Protocol Violation|1|||
163091128|NCT01987557|589044683|FG000|Overall Study|Withdrawal by Subject|2|||
163091129|NCT01987557|589044684|FG001|Overall Study|Withdrawal by Subject|1|||
163091130|NCT01987557|589044685|FG002|Overall Study|Withdrawal by Subject|2|||
163091131|NCT01987557|589044683|FG000|Overall Study|Adverse Event|0|||
163091132|NCT01987557|589044684|FG001|Overall Study|Adverse Event|2|||
163336627|NCT02404441|589942368|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
163091133|NCT01987557|589044685|FG002|Overall Study|Adverse Event|0|||
163091134|NCT00760552|589044686|FG000|Overall Study|Death|2|||
163091135|NCT00760552|589044687|FG001|Overall Study|Death|0|||
163091136|NCT00760552|589044686|FG000|Overall Study|Lost to Follow-up|11|||
163091137|NCT00760552|589044687|FG001|Overall Study|Lost to Follow-up|10|||
163091138|NCT01038323|589044688|FG000|Overall Study|Withdrawal by Subject|3|||
163091139|NCT01038323|589044689|FG001|Overall Study|Withdrawal by Subject|2|||
163091140|NCT01038323|589044690|FG002|Overall Study|Withdrawal by Subject|4|||
163091141|NCT01832727|589044699|FG000|Overall Study|Adverse Event|4|||
163091142|NCT01832727|589044700|FG001|Overall Study|Adverse Event|6|||
163091143|NCT01832727|589044701|FG002|Overall Study|Adverse Event|1|||
163038190|NCT03782571|588847313|FG003|Period 3|Subject Unable to Attend V5|0|||
163038191|NCT03782571|588847310|FG000|Period 3|Adverse Event|1|||
163038192|NCT03782571|588847311|FG001|Period 3|Adverse Event|0|||
163038193|NCT03782571|588847312|FG002|Period 3|Adverse Event|0|||
163038194|NCT03782571|588847313|FG003|Period 3|Adverse Event|0|||
163038195|NCT03504189|588847314|FG000|Overall Study|Withdrawal by Subject|1|||
163091144|NCT01832727|589044702|FG003|Overall Study|Adverse Event|0|||
163091145|NCT01832727|589044703|FG004|Overall Study|Adverse Event|1|||
163091146|NCT01832727|589044704|FG005|Overall Study|Adverse Event|1|||
163091147|NCT01832727|589044705|FG006|Overall Study|Adverse Event|2|||
163091148|NCT01832727|589044706|FG007|Overall Study|Adverse Event|1|||
163091149|NCT01832727|589044707|FG008|Overall Study|Adverse Event|9|||
163091150|NCT01832727|589044699|FG000|Overall Study|Disease progression|3|||
163091151|NCT01832727|589044700|FG001|Overall Study|Disease progression|0|||
163091152|NCT01832727|589044701|FG002|Overall Study|Disease progression|2|||
163091153|NCT01832727|589044702|FG003|Overall Study|Disease progression|1|||
163091154|NCT01832727|589044703|FG004|Overall Study|Disease progression|3|||
163091155|NCT01832727|589044704|FG005|Overall Study|Disease progression|3|||
163091156|NCT01832727|589044705|FG006|Overall Study|Disease progression|6|||
163091157|NCT01832727|589044706|FG007|Overall Study|Disease progression|2|||
163091158|NCT01832727|589044707|FG008|Overall Study|Disease progression|7|||
163091159|NCT01832727|589044699|FG000|Overall Study|Lost to Follow-up|0|||
163091160|NCT01832727|589044700|FG001|Overall Study|Lost to Follow-up|0|||
163091161|NCT01832727|589044701|FG002|Overall Study|Lost to Follow-up|0|||
163091162|NCT01832727|589044702|FG003|Overall Study|Lost to Follow-up|1|||
163220076|NCT02039674|589521408|FG002|Overall Study|Adverse Event|0|||
163220077|NCT02039674|589521409|FG003|Overall Study|Adverse Event|1|||
163220078|NCT02039674|589521410|FG004|Overall Study|Adverse Event|0|||
163220079|NCT02039674|589521411|FG005|Overall Study|Adverse Event|0|||
163038196|NCT03504189|588847314|FG000|Overall Study|Screening Failure|1|||
163038197|NCT03504189|588847314|FG000|Overall Study|Device Failure|2|||
163038198|NCT03488563|588847315|FG000|Overall Study|Lost to Follow-up|7|||
163038199|NCT03488563|588847316|FG001|Overall Study|Lost to Follow-up|6|||
163038200|NCT03488563|588847317|FG002|Overall Study|Lost to Follow-up|7|||
163038201|NCT03488563|588847315|FG000|Overall Study|Withdrawal by Subject|8|||
163038202|NCT03488563|588847316|FG001|Overall Study|Withdrawal by Subject|7|||
163038203|NCT03488563|588847317|FG002|Overall Study|Withdrawal by Subject|7|||
163038204|NCT03488563|588847315|FG000|Overall Study|Physician Decision|0|||
163038205|NCT03488563|588847316|FG001|Overall Study|Physician Decision|0|||
163038206|NCT03488563|588847317|FG002|Overall Study|Physician Decision|1|||
163038207|NCT03488563|588847315|FG000|Overall Study|Protocol Violation|3|||
163038208|NCT03488563|588847316|FG001|Overall Study|Protocol Violation|2|||
163038209|NCT03488563|588847317|FG002|Overall Study|Protocol Violation|6|||
163038210|NCT03488563|588847315|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
163038211|NCT03488563|588847316|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
163038212|NCT03488563|588847317|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
163038213|NCT03488563|588847315|FG000|Overall Study|Use of prohibited medication|2|||
163038214|NCT03488563|588847316|FG001|Overall Study|Use of prohibited medication|0|||
163038215|NCT03488563|588847317|FG002|Overall Study|Use of prohibited medication|0|||
163038216|NCT03488563|588847315|FG000|Overall Study|Adverse Event|1|||
163038217|NCT03488563|588847316|FG001|Overall Study|Adverse Event|0|||
163038218|NCT03488563|588847317|FG002|Overall Study|Adverse Event|1|||
163038219|NCT03488563|588847315|FG000|Overall Study|Subject returned for ET visit|0|||
163038220|NCT03488563|588847316|FG001|Overall Study|Subject returned for ET visit|1|||
163038221|NCT03488563|588847317|FG002|Overall Study|Subject returned for ET visit|0|||
163091163|NCT01832727|589044703|FG004|Overall Study|Lost to Follow-up|0|||
163091164|NCT01832727|589044704|FG005|Overall Study|Lost to Follow-up|0|||
163091165|NCT01832727|589044705|FG006|Overall Study|Lost to Follow-up|0|||
163091166|NCT01832727|589044706|FG007|Overall Study|Lost to Follow-up|0|||
163220080|NCT02039674|589521412|FG006|Overall Study|Adverse Event|0|||
163220081|NCT02039674|589521413|FG007|Overall Study|Adverse Event|0|||
163220082|NCT02039674|589521414|FG008|Overall Study|Adverse Event|2|||
163220083|NCT02039674|589521415|FG009|Overall Study|Adverse Event|1|||
163220084|NCT02039674|589521416|FG010|Overall Study|Adverse Event|0|||
163220085|NCT02039674|589521417|FG011|Overall Study|Adverse Event|2|||
163220086|NCT02039674|589521418|FG012|Overall Study|Adverse Event|3|||
163220087|NCT02039674|589521419|FG013|Overall Study|Adverse Event|1|||
163220088|NCT02039674|589521406|FG000|Overall Study|Death|2|||
163220089|NCT02039674|589521407|FG001|Overall Study|Death|0|||
163336628|NCT02404441|589942369|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
163336629|NCT02404441|589942370|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
163336630|NCT02404441|589942371|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
163336631|NCT02404441|589942372|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
163336632|NCT02404441|589942373|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
163336633|NCT02404441|589942374|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
163336634|NCT02404441|589942375|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
163336635|NCT02404441|589942376|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
163336636|NCT02404441|589942367|FG000|Phase 1 Part|Death|1|||
163336637|NCT02404441|589942368|FG001|Phase 1 Part|Death|1|||
163038222|NCT03488563|588847315|FG000|Overall Study|Sponsor's decision|0|||
163038223|NCT03488563|588847316|FG001|Overall Study|Sponsor's decision|0|||
163038224|NCT03488563|588847317|FG002|Overall Study|Sponsor's decision|1|||
163038225|NCT02626000|588847334|FG000|Overall Study|Decision by Sponsor|1|||
163038226|NCT02626000|588847334|FG000|Overall Study|Death|29|||
163038227|NCT01796301|588847338|FG000|Overall Study|Withdrawal by Subject|15|||
163038228|NCT01796301|588847339|FG001|Overall Study|Withdrawal by Subject|15|||
163038229|NCT01796301|588847338|FG000|Overall Study|Lost to Follow-up|3|||
163038230|NCT01796301|588847339|FG001|Overall Study|Lost to Follow-up|3|||
163038231|NCT01796301|588847338|FG000|Overall Study|Death|0|||
163038232|NCT01796301|588847339|FG001|Overall Study|Death|1|||
163038233|NCT01796301|588847338|FG000|Overall Study|Decision by Sponsor|0|||
163038234|NCT01796301|588847339|FG001|Overall Study|Decision by Sponsor|1|||
163038235|NCT00339833|588847340|FG000|Overall Study|Withdrawal by Subject|1|||
163038236|NCT00339833|588847341|FG001|Overall Study|Withdrawal by Subject|2|||
163038237|NCT00339833|588847340|FG000|Overall Study|toothache|0|||
163038238|NCT00339833|588847341|FG001|Overall Study|toothache|1|||
163038239|NCT00339833|588847340|FG000|Overall Study|indigestion|0|||
163038240|NCT00339833|588847341|FG001|Overall Study|indigestion|1|||
163038241|NCT00339833|588847340|FG000|Overall Study|Chest pain|0|||
163038242|NCT00339833|588847341|FG001|Overall Study|Chest pain|1|||
163038243|NCT00339833|588847340|FG000|Overall Study|minor infection|0|||
163038244|NCT00339833|588847341|FG001|Overall Study|minor infection|1|||
163038245|NCT00339833|588847340|FG000|Overall Study|Poor venous access|2|||
163038246|NCT00339833|588847341|FG001|Overall Study|Poor venous access|2|||
163038247|NCT00339833|588847340|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
163038248|NCT00339833|588847341|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
163038249|NCT00339833|588847340|FG000|Overall Study|Error in data records|1|||
163038250|NCT00339833|588847341|FG001|Overall Study|Error in data records|0|||
163038251|NCT00217581|588847342|FG000|Overall Study|Withdrawal by Subject|1|||
163038252|NCT02829047|588847343|FG000|Overall Study|Withdrawal by Subject|1|||
163091167|NCT01832727|589044707|FG008|Overall Study|Lost to Follow-up|0|||
163091168|NCT01832727|589044699|FG000|Overall Study|Physician Decision|1|||
163091169|NCT01832727|589044700|FG001|Overall Study|Physician Decision|0|||
163091170|NCT01832727|589044701|FG002|Overall Study|Physician Decision|0|||
163091171|NCT01832727|589044702|FG003|Overall Study|Physician Decision|1|||
163091172|NCT01832727|589044703|FG004|Overall Study|Physician Decision|0|||
163091173|NCT01832727|589044704|FG005|Overall Study|Physician Decision|1|||
163091174|NCT01832727|589044705|FG006|Overall Study|Physician Decision|0|||
163091175|NCT01832727|589044706|FG007|Overall Study|Physician Decision|0|||
163091176|NCT01832727|589044707|FG008|Overall Study|Physician Decision|0|||
163091177|NCT01832727|589044699|FG000|Overall Study|Withdrawal by Subject|1|||
163091178|NCT01832727|589044700|FG001|Overall Study|Withdrawal by Subject|1|||
163091179|NCT01832727|589044701|FG002|Overall Study|Withdrawal by Subject|0|||
163091180|NCT01832727|589044702|FG003|Overall Study|Withdrawal by Subject|1|||
163091181|NCT01832727|589044703|FG004|Overall Study|Withdrawal by Subject|0|||
163091182|NCT01832727|589044704|FG005|Overall Study|Withdrawal by Subject|1|||
163091183|NCT01832727|589044705|FG006|Overall Study|Withdrawal by Subject|0|||
163091184|NCT01832727|589044706|FG007|Overall Study|Withdrawal by Subject|2|||
163091185|NCT01832727|589044707|FG008|Overall Study|Withdrawal by Subject|1|||
163091186|NCT01832727|589044699|FG000|Overall Study|Study terminated by sponsor|0|||
163091187|NCT01832727|589044700|FG001|Overall Study|Study terminated by sponsor|0|||
163091188|NCT01832727|589044701|FG002|Overall Study|Study terminated by sponsor|0|||
163091189|NCT01832727|589044702|FG003|Overall Study|Study terminated by sponsor|0|||
163038253|NCT01597492|588847344|FG000|Overall Study|Withdrawal by Subject|1|||
163038254|NCT01597492|588847345|FG001|Overall Study|Withdrawal by Subject|2|||
163038255|NCT01597492|588847344|FG000|Overall Study|Adverse Event|3|||
163038256|NCT01597492|588847345|FG001|Overall Study|Adverse Event|0|||
163038257|NCT01597492|588847344|FG000|Overall Study|Lost to Follow-up|0|||
163038258|NCT01597492|588847345|FG001|Overall Study|Lost to Follow-up|2|||
163038259|NCT01597492|588847344|FG000|Overall Study|Other Reason|2|||
163038260|NCT01597492|588847345|FG001|Overall Study|Other Reason|0|||
163038261|NCT02570750|588847346|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
163038262|NCT02570750|588847347|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
163220090|NCT02039674|589521408|FG002|Overall Study|Death|2|||
163038263|NCT02570750|588847346|FG000|Overall Study|Protocol deviation|4|||
163038264|NCT02570750|588847347|FG001|Overall Study|Protocol deviation|2|||
163038265|NCT02570750|588847346|FG000|Overall Study|Withdrawal by Subject|5|||
163038266|NCT02570750|588847347|FG001|Overall Study|Withdrawal by Subject|0|||
163407435|NCT00326898|590200824|FG001|Overall Study|Adverse Event|128|||
163038267|NCT02570750|588847346|FG000|Overall Study|Lost to Follow-up|2|||
163038268|NCT02570750|588847347|FG001|Overall Study|Lost to Follow-up|2|||
163038269|NCT02570750|588847346|FG000|Overall Study|Adverse Event|2|||
163038270|NCT02570750|588847347|FG001|Overall Study|Adverse Event|1|||
163038271|NCT01884545|588847348|FG000|Overall Study|Lost to Follow-up|6|||
163091190|NCT01832727|589044703|FG004|Overall Study|Study terminated by sponsor|0|||
163091191|NCT01832727|589044704|FG005|Overall Study|Study terminated by sponsor|0|||
163220091|NCT02039674|589521409|FG003|Overall Study|Death|3|||
163038272|NCT01884545|588847349|FG001|Overall Study|Lost to Follow-up|4|||
163091192|NCT01832727|589044705|FG006|Overall Study|Study terminated by sponsor|0|||
163091193|NCT01832727|589044706|FG007|Overall Study|Study terminated by sponsor|1|||
163091194|NCT01832727|589044707|FG008|Overall Study|Study terminated by sponsor|1|||
163091195|NCT03323164|589044710|FG000|Overall Study|Poor quality imaging/scans|2|||
163091196|NCT03323164|589044711|FG001|Overall Study|Poor quality imaging/scans|2|||
163091197|NCT00461708|589044712|FG000|Overall Study|Adverse Event|17|||
163091198|NCT00461708|589044713|FG001|Overall Study|Adverse Event|7|||
163091199|NCT00461708|589044712|FG000|Overall Study|Lack of Efficacy|68|||
163091200|NCT00461708|589044713|FG001|Overall Study|Lack of Efficacy|20|||
163091201|NCT00461708|589044712|FG000|Overall Study|Physician Decision|10|||
163091202|NCT00461708|589044713|FG001|Overall Study|Physician Decision|4|||
163091203|NCT00461708|589044712|FG000|Overall Study|Withdrawal by Subject|8|||
163091204|NCT00461708|589044713|FG001|Overall Study|Withdrawal by Subject|2|||
163091205|NCT00461708|589044712|FG000|Overall Study|Other|4|||
163091206|NCT00461708|589044713|FG001|Overall Study|Other|4|||
163091207|NCT00461708|589044712|FG000|Overall Study|Death|8|||
163091208|NCT00461708|589044713|FG001|Overall Study|Death|1|||
163091209|NCT00501644|589044714|FG000|Overall Study|Adverse Event|4|||
163091210|NCT00501644|589044714|FG000|Overall Study|Withdrawal by Subject|1|||
163091211|NCT02394561|589044715|FG000|CORE Phase|Adverse Event|7|||
163091212|NCT02394561|589044716|FG001|CORE Phase|Adverse Event|9|||
163091213|NCT02394561|589044715|FG000|CORE Phase|Death|0|||
163091214|NCT02394561|589044716|FG001|CORE Phase|Death|1|||
163091215|NCT02394561|589044715|FG000|CORE Phase|Pregnancy|1|||
163091216|NCT02394561|589044716|FG001|CORE Phase|Pregnancy|0|||
163091217|NCT02394561|589044715|FG000|CORE Phase|Lost to Follow-up|1|||
163091218|NCT02394561|589044716|FG001|CORE Phase|Lost to Follow-up|0|||
163091219|NCT02394561|589044715|FG000|CORE Phase|Physician Decision|1|||
163091220|NCT02394561|589044716|FG001|CORE Phase|Physician Decision|1|||
163091221|NCT02394561|589044715|FG000|CORE Phase|Withdrawal by Subject|2|||
163091222|NCT02394561|589044716|FG001|CORE Phase|Withdrawal by Subject|2|||
163091223|NCT02394561|589044715|FG000|CORE Phase|Lack of Efficacy|1|||
163091224|NCT02394561|589044716|FG001|CORE Phase|Lack of Efficacy|6|||
163091225|NCT02394561|589044715|FG000|Extension Phase|Adverse Event|6|||
163091226|NCT02394561|589044716|FG001|Extension Phase|Adverse Event|1|||
163091227|NCT02394561|589044715|FG000|Extension Phase|Death|0|||
163091228|NCT02394561|589044716|FG001|Extension Phase|Death|1|||
163091229|NCT02394561|589044715|FG000|Extension Phase|Protocol Violation|1|||
163091230|NCT02394561|589044716|FG001|Extension Phase|Protocol Violation|0|||
163091231|NCT02394561|589044715|FG000|Extension Phase|Lost to Follow-up|1|||
163091232|NCT02394561|589044716|FG001|Extension Phase|Lost to Follow-up|0|||
163091233|NCT02394561|589044715|FG000|Extension Phase|Physician Decision|0|||
163091234|NCT02394561|589044716|FG001|Extension Phase|Physician Decision|2|||
163091235|NCT02394561|589044715|FG000|Extension Phase|Withdrawal by Subject|0|||
163091236|NCT02394561|589044716|FG001|Extension Phase|Withdrawal by Subject|5|||
163091237|NCT02394561|589044715|FG000|Extension Phase|Lack of Efficacy|3|||
163091238|NCT02394561|589044716|FG001|Extension Phase|Lack of Efficacy|3|||
163091239|NCT02553629|589044717|FG000|Overall Study|Logistic reasons|3|||
163091240|NCT02553629|589044718|FG001|Overall Study|Logistic reasons|6|||
163091241|NCT03434834|589044719|FG000|Overall Study|unable to swallow OCT probe|16|||
163091242|NCT01823289|589044720|FG000|Overall Study|Lost to Follow-up|5|||
163091243|NCT01823289|589044720|FG000|Overall Study|Adverse Event|5|||
163091244|NCT01823289|589044720|FG000|Overall Study|Lack of Efficacy|1|||
163091245|NCT01823289|589044720|FG000|Overall Study|Physician Decision|9|||
163091246|NCT01823289|589044720|FG000|Overall Study|Administered contraindicated medicine|1|||
163091247|NCT01823289|589044720|FG000|Overall Study|Transaminase increased more than 3 times|1|||
163091248|NCT01823289|589044720|FG000|Overall Study|Drug affected efficacy and safety|1|||
163091249|NCT01823289|589044720|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
163091250|NCT01812057|589044721|FG000|Overall Study|Protocol Violation|1|||
163091251|NCT01812057|589044722|FG001|Overall Study|Protocol Violation|0|||
163091252|NCT01812057|589044721|FG000|Overall Study|Physician Decision|1|||
163091253|NCT01812057|589044722|FG001|Overall Study|Physician Decision|0|||
163091254|NCT01736917|589044723|FG000|Overall Study|Adverse Event|1|||
163091255|NCT01736917|589044723|FG000|Overall Study|Protocol Violation|10|||
163091256|NCT01133847|589044732|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
163091257|NCT01133847|589044733|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
163091258|NCT01133847|589044734|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
163091259|NCT01133847|589044732|FG000|Follow-Up Phase|Lost to Follow-up|1|||
163091260|NCT01133847|589044733|FG001|Follow-Up Phase|Lost to Follow-up|3|||
163091261|NCT01133847|589044734|FG002|Follow-Up Phase|Lost to Follow-up|7|||
163091262|NCT01880957|589044735|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
163091263|NCT01880957|589044736|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
163091264|NCT01880957|589044735|FG000|Overall Study|Lost to Follow-up|11|||
163091265|NCT01880957|589044736|FG001|Overall Study|Lost to Follow-up|0|||
163091266|NCT01880957|589044735|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
163091267|NCT01880957|589044736|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
163091268|NCT01378117|589044737|FG000|Overall Study|withdrawal|2|||
163091269|NCT01378117|589044738|FG001|Overall Study|withdrawal|1|||
163091270|NCT01378117|589044739|FG002|Overall Study|withdrawal|2|||
163091271|NCT01378117|589044737|FG000|Overall Study|discharged before med given|2|||
163091272|NCT01378117|589044738|FG001|Overall Study|discharged before med given|0|||
163091273|NCT01378117|589044739|FG002|Overall Study|discharged before med given|1|||
163091274|NCT01854528|589044740|FG000|Overall Study|Adverse Event|0|||
163091275|NCT01854528|589044741|FG001|Overall Study|Adverse Event|4|||
163091276|NCT01854528|589044740|FG000|Overall Study|Withdrawal by Subject|0|||
163091277|NCT01854528|589044741|FG001|Overall Study|Withdrawal by Subject|2|||
163091278|NCT01854528|589044740|FG000|Overall Study|Virologic Failure|0|||
163091279|NCT01854528|589044741|FG001|Overall Study|Virologic Failure|9|||
163091280|NCT02961244|589044742|FG000|Overall Study|Protocol Violation|0|||
163091281|NCT02961244|589044743|FG001|Overall Study|Protocol Violation|1|||
163091282|NCT02961244|589044742|FG000|Overall Study|Withdrawal by Subject|1|||
163091283|NCT02961244|589044743|FG001|Overall Study|Withdrawal by Subject|2|||
163091284|NCT02961244|589044742|FG000|Overall Study|Surgery plan change after study approval|0|||
163091285|NCT02961244|589044743|FG001|Overall Study|Surgery plan change after study approval|2|||
163091286|NCT02961244|589044742|FG000|Overall Study|Lost to Follow-up|0|||
163091287|NCT02961244|589044743|FG001|Overall Study|Lost to Follow-up|2|||
163091288|NCT02961244|589044742|FG000|Overall Study|İnadequate data|0|||
163091289|NCT02961244|589044743|FG001|Overall Study|İnadequate data|2|||
163091290|NCT01368614|589044744|FG000|Screening Period|Screen Failure|58|||
163091291|NCT01368614|589044745|FG001|Screening Period|Screen Failure|0|||
163091292|NCT01368614|589044746|FG002|Screening Period|Screen Failure|0|||
163091293|NCT01368614|589044747|FG003|Screening Period|Screen Failure|0|||
163091294|NCT01368614|589044744|FG000|Study Period|Withdrawal by Subject|0|||
163091295|NCT01368614|589044745|FG001|Study Period|Withdrawal by Subject|1|||
163091296|NCT01368614|589044746|FG002|Study Period|Withdrawal by Subject|1|||
163091297|NCT01368614|589044747|FG003|Study Period|Withdrawal by Subject|3|||
163091298|NCT01368614|589044744|FG000|Study Period|Lost to Follow-up|0|||
163091299|NCT01368614|589044745|FG001|Study Period|Lost to Follow-up|0|||
163091300|NCT01368614|589044746|FG002|Study Period|Lost to Follow-up|1|||
163091301|NCT01368614|589044747|FG003|Study Period|Lost to Follow-up|0|||
163091302|NCT02561962|589044760|FG000|Overall Study|Withdrawal by Subject|1|||
163091303|NCT02561962|589044761|FG001|Overall Study|Withdrawal by Subject|0|||
163091304|NCT02561962|589044762|FG002|Overall Study|Withdrawal by Subject|0|||
163091305|NCT02561962|589044763|FG003|Overall Study|Withdrawal by Subject|0|||
163091306|NCT02561962|589044764|FG004|Overall Study|Withdrawal by Subject|1|||
163091307|NCT02561962|589044765|FG005|Overall Study|Withdrawal by Subject|1|||
163091308|NCT02561962|589044766|FG006|Overall Study|Withdrawal by Subject|2|||
163091309|NCT02561962|589044767|FG007|Overall Study|Withdrawal by Subject|1|||
163091310|NCT02561962|589044768|FG008|Overall Study|Withdrawal by Subject|0|||
163091311|NCT02561962|589044760|FG000|Overall Study|Decision by sponsor|0|||
163091312|NCT02561962|589044761|FG001|Overall Study|Decision by sponsor|0|||
163091313|NCT02561962|589044762|FG002|Overall Study|Decision by sponsor|0|||
163091314|NCT02561962|589044763|FG003|Overall Study|Decision by sponsor|0|||
163091315|NCT02561962|589044764|FG004|Overall Study|Decision by sponsor|1|||
163091316|NCT02561962|589044765|FG005|Overall Study|Decision by sponsor|1|||
163091317|NCT02561962|589044766|FG006|Overall Study|Decision by sponsor|0|||
163091318|NCT02561962|589044767|FG007|Overall Study|Decision by sponsor|3|||
163091319|NCT02561962|589044768|FG008|Overall Study|Decision by sponsor|0|||
163091320|NCT02561962|589044760|FG000|Overall Study|Lost to Follow-up|0|||
163091321|NCT02561962|589044761|FG001|Overall Study|Lost to Follow-up|0|||
163091322|NCT02561962|589044762|FG002|Overall Study|Lost to Follow-up|0|||
163091323|NCT02561962|589044763|FG003|Overall Study|Lost to Follow-up|0|||
163091324|NCT02561962|589044764|FG004|Overall Study|Lost to Follow-up|0|||
163091325|NCT02561962|589044765|FG005|Overall Study|Lost to Follow-up|1|||
163091326|NCT02561962|589044766|FG006|Overall Study|Lost to Follow-up|0|||
163091327|NCT02561962|589044767|FG007|Overall Study|Lost to Follow-up|0|||
163091328|NCT02561962|589044768|FG008|Overall Study|Lost to Follow-up|0|||
163091329|NCT03586973|589044769|FG000|Overall Study|Death|15|||
163091330|NCT03586973|589044770|FG001|Overall Study|Death|8|||
163091331|NCT03586973|589044769|FG000|Overall Study|Site Terminated by Sponsor|3|||
163091332|NCT03586973|589044770|FG001|Overall Study|Site Terminated by Sponsor|6|||
163091333|NCT03586973|589044769|FG000|Overall Study|Withdrawal by Subject|1|||
163091334|NCT03586973|589044770|FG001|Overall Study|Withdrawal by Subject|0|||
163091335|NCT03586973|589044769|FG000|Overall Study|Lost to Follow-up|1|||
163091336|NCT03586973|589044770|FG001|Overall Study|Lost to Follow-up|0|||
163091337|NCT02735421|589046479|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
163091338|NCT02735421|589046479|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
163091339|NCT02735421|589046479|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
163091340|NCT02735421|589046479|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
163091341|NCT02735421|589046479|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
163091342|NCT02735421|589046479|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
163091343|NCT02735421|589046479|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
163091344|NCT01978145|589046480|FG000|Treatment Period 1|Adverse Event|1|||
163091345|NCT01978145|589046481|FG001|Treatment Period 1|Adverse Event|9|||
163091346|NCT01978145|589046480|FG000|Treatment Period 1|Physician Decision|1|||
163091347|NCT01978145|589046481|FG001|Treatment Period 1|Physician Decision|0|||
163091348|NCT01978145|589046480|FG000|Treatment Period 1|Withdrawal by Subject|5|||
163091349|NCT01978145|589046481|FG001|Treatment Period 1|Withdrawal by Subject|4|||
163091350|NCT01978145|589046480|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
163091351|NCT01978145|589046481|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
163091352|NCT01978145|589046480|FG000|Washout Period 1|Adverse Event|0|||
163091353|NCT01978145|589046481|FG001|Washout Period 1|Adverse Event|1|||
163091354|NCT01978145|589046480|FG000|Washout Period 1|Withdrawal by Subject|1|||
163091355|NCT01978145|589046481|FG001|Washout Period 1|Withdrawal by Subject|1|||
163091356|NCT01978145|589046480|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
163091357|NCT01978145|589046481|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
163091358|NCT01978145|589046480|FG000|Treatment Period 2|Adverse Event|3|||
163091359|NCT01978145|589046481|FG001|Treatment Period 2|Adverse Event|3|||
163091360|NCT01978145|589046480|FG000|Treatment Period 2|Protocol Violation|0|||
163091361|NCT01978145|589046481|FG001|Treatment Period 2|Protocol Violation|1|||
163091362|NCT01978145|589046480|FG000|Treatment Period 2|Lost to Follow-up|1|||
163091363|NCT01978145|589046481|FG001|Treatment Period 2|Lost to Follow-up|1|||
163091364|NCT01978145|589046480|FG000|Treatment Period 2|Withdrawal by Subject|7|||
163091365|NCT01978145|589046481|FG001|Treatment Period 2|Withdrawal by Subject|4|||
163091366|NCT01978145|589046480|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
163091367|NCT01978145|589046481|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
163091368|NCT00322049|589046482|FG000|Overall Study|Moved out of area|0|||
163091369|NCT00322049|589046483|FG001|Overall Study|Moved out of area|0|||
163091370|NCT00322049|589046484|FG002|Overall Study|Moved out of area|0|||
163091371|NCT00322049|589046485|FG003|Overall Study|Moved out of area|1|||
163091372|NCT00322049|589046482|FG000|Overall Study|Infected with Dengue during study|0|||
163091373|NCT00322049|589046483|FG001|Overall Study|Infected with Dengue during study|1|||
163091374|NCT00322049|589046484|FG002|Overall Study|Infected with Dengue during study|0|||
163091375|NCT00322049|589046485|FG003|Overall Study|Infected with Dengue during study|0|||
163091376|NCT00755807|589046486|FG000|Acute Phase|Adverse Event|16|||
163091377|NCT00755807|589046487|FG001|Acute Phase|Adverse Event|5|||
163091378|NCT00755807|589046486|FG000|Acute Phase|Protocol Violation|1|||
163091379|NCT00755807|589046487|FG001|Acute Phase|Protocol Violation|3|||
163091380|NCT00755807|589046486|FG000|Acute Phase|Withdrawal by Subject|1|||
163091381|NCT00755807|589046487|FG001|Acute Phase|Withdrawal by Subject|2|||
163091382|NCT00755807|589046486|FG000|Acute Phase|Lack of Efficacy|0|||
163091383|NCT00755807|589046487|FG001|Acute Phase|Lack of Efficacy|1|||
163091384|NCT00755807|589046486|FG000|Acute Phase|Physician Decision|0|||
163091385|NCT00755807|589046487|FG001|Acute Phase|Physician Decision|1|||
163091386|NCT00755807|589046486|FG000|Open-label Extension Phase|Adverse Event|7|||
163091387|NCT00755807|589046487|FG001|Open-label Extension Phase|Adverse Event|7|||
163091388|NCT00755807|589046486|FG000|Open-label Extension Phase|Protocol Violation|5|||
163091389|NCT00755807|589046487|FG001|Open-label Extension Phase|Protocol Violation|2|||
163091390|NCT00755807|589046486|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
163091391|NCT00755807|589046487|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
163091392|NCT00755807|589046486|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
163091393|NCT00755807|589046487|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
163091394|NCT00755807|589046486|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
163091395|NCT00755807|589046487|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
163091396|NCT00755807|589046486|FG000|Open-label Extension Phase|Sponsor Decision|0|||
163091397|NCT00755807|589046487|FG001|Open-label Extension Phase|Sponsor Decision|1|||
163091398|NCT01585025|589046496|FG000|Overall Study|Withdrawal by Subject|0|||
163091399|NCT01585025|589046497|FG001|Overall Study|Withdrawal by Subject|3|||
163091400|NCT01585025|589046498|FG002|Overall Study|Withdrawal by Subject|4|||
163091401|NCT00503984|589046499|FG000|Overall Study|Protocol Violation|0|||
163091402|NCT00503984|589046500|FG001|Overall Study|Protocol Violation|1|||
163091403|NCT00503984|589046501|FG002|Overall Study|Protocol Violation|0|||
163091404|NCT00503984|589046502|FG003|Overall Study|Protocol Violation|0|||
163091405|NCT00503984|589046503|FG004|Overall Study|Protocol Violation|0|||
163091406|NCT00503984|589046504|FG005|Overall Study|Protocol Violation|0|||
163091407|NCT00503984|589046499|FG000|Overall Study|Adverse Event|0|||
163091408|NCT00503984|589046500|FG001|Overall Study|Adverse Event|1|||
163091409|NCT00503984|589046501|FG002|Overall Study|Adverse Event|0|||
163091410|NCT00503984|589046502|FG003|Overall Study|Adverse Event|0|||
163091411|NCT00503984|589046503|FG004|Overall Study|Adverse Event|0|||
163091412|NCT00503984|589046504|FG005|Overall Study|Adverse Event|0|||
163091413|NCT00503984|589046499|FG000|Overall Study|Death|0|||
163091414|NCT00503984|589046500|FG001|Overall Study|Death|0|||
163091415|NCT00503984|589046501|FG002|Overall Study|Death|0|||
163091416|NCT00503984|589046502|FG003|Overall Study|Death|0|||
163091417|NCT00503984|589046503|FG004|Overall Study|Death|1|||
163091418|NCT00503984|589046504|FG005|Overall Study|Death|0|||
163091419|NCT02122380|589046507|FG000|First Intervention (30 Days)|Adverse Event|1|||
163091420|NCT02122380|589046508|FG001|First Intervention (30 Days)|Adverse Event|0|||
163091421|NCT02122380|589046507|FG000|First Intervention (30 Days)|Physician Decision|0|||
163091422|NCT02122380|589046508|FG001|First Intervention (30 Days)|Physician Decision|1|||
163091423|NCT02122380|589046507|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
163038273|NCT01884545|588847350|FG002|Overall Study|Lost to Follow-up|9|||
163038274|NCT01884545|588847351|FG003|Overall Study|Lost to Follow-up|4|||
163038275|NCT01884545|588847348|FG000|Overall Study|Patient withdrawn|7|||
163038276|NCT01884545|588847349|FG001|Overall Study|Patient withdrawn|12|||
163038277|NCT01884545|588847350|FG002|Overall Study|Patient withdrawn|5|||
163038278|NCT01884545|588847351|FG003|Overall Study|Patient withdrawn|5|||
163038279|NCT01884545|588847348|FG000|Overall Study|Non-adherence|0|||
163038280|NCT01884545|588847349|FG001|Overall Study|Non-adherence|2|||
163038281|NCT01884545|588847350|FG002|Overall Study|Non-adherence|0|||
163038282|NCT01884545|588847351|FG003|Overall Study|Non-adherence|0|||
163038283|NCT01410240|588847352|FG000|Overall Study|Physician Decision|0|||
163038284|NCT01410240|588847353|FG001|Overall Study|Physician Decision|0|||
163038285|NCT01410240|588847354|FG002|Overall Study|Physician Decision|1|||
163038286|NCT01410240|588847352|FG000|Overall Study|Missed week 6 assessments|1|||
163038287|NCT01410240|588847353|FG001|Overall Study|Missed week 6 assessments|1|||
163038288|NCT01410240|588847354|FG002|Overall Study|Missed week 6 assessments|1|||
163038289|NCT00162097|588847356|FG000|Overall Study|Participant no longer met study criteria|0|||
163038290|NCT00162097|588847357|FG001|Overall Study|Participant no longer met study criteria|0|||
163038291|NCT00162097|588847358|FG002|Overall Study|Participant no longer met study criteria|0|||
163038292|NCT00162097|588847359|FG003|Overall Study|Participant no longer met study criteria|1|||
163038293|NCT02886884|588847362|FG000|Follow-up|Withdrawal by Subject|0|||
163038294|NCT02886884|588847363|FG001|Follow-up|Withdrawal by Subject|0|||
163038295|NCT02886884|588847364|FG002|Follow-up|Withdrawal by Subject|0|||
163038296|NCT02886884|588847365|FG003|Follow-up|Withdrawal by Subject|1|||
163038297|NCT00625183|588847368|FG000|Overall Study|Disease Progression|1|||
163038298|NCT02279745|588847369|FG000|Overall Study|Adverse Event|7|||
163038299|NCT02279745|588847369|FG000|Overall Study|Death|6|||
163038300|NCT02279745|588847369|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
163038301|NCT02279745|588847369|FG000|Overall Study|Withdrawal by Subject|2|||
163038302|NCT02279745|588847369|FG000|Overall Study|Pregnancy|1|||
163038303|NCT02279745|588847369|FG000|Overall Study|Study Non-compliance|1|||
163038304|NCT02279745|588847369|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
163038305|NCT01606748|588847370|FG000|Overall Study|Adverse Event|1|||
163038306|NCT01606748|588847371|FG001|Overall Study|Adverse Event|0|||
163038307|NCT01606748|588847370|FG000|Overall Study|Progressive Disease|1|||
163038308|NCT01606748|588847371|FG001|Overall Study|Progressive Disease|0|||
163038309|NCT01606748|588847370|FG000|Overall Study|Withdrawal by Subject|1|||
163038310|NCT01606748|588847371|FG001|Overall Study|Withdrawal by Subject|0|||
163038311|NCT01706575|588847373|FG000|Overall Study|Participant Withdrew Consent|4|||
163038312|NCT01706575|588847373|FG000|Overall Study|Lost to Follow-up|2|||
163038313|NCT01706575|588847373|FG000|Overall Study|Started but not Treated|6|||
163038314|NCT03244618|588847376|FG000|Overall Study|Lost to Follow-up|3|||
163038315|NCT03244618|588847377|FG001|Overall Study|Lost to Follow-up|4|||
163038316|NCT03244618|588847376|FG000|Overall Study|Protocol Violation|4|||
163038317|NCT03244618|588847377|FG001|Overall Study|Protocol Violation|3|||
163038318|NCT03244618|588847376|FG000|Overall Study|Withdrawal by Subject|0|||
163038319|NCT03244618|588847377|FG001|Overall Study|Withdrawal by Subject|2|||
163038320|NCT03469999|588847378|FG000|Overall Study|Lost to Follow-up|2|||
163038321|NCT02155322|588847382|FG000|Overall Study|Adverse Event|1|||
163038322|NCT02155322|588847382|FG000|Overall Study|Physician Decision|1|||
163038323|NCT02155322|588847382|FG000|Overall Study|Relapse/Recurrence|8|||
163038324|NCT02155322|588847382|FG000|Overall Study|Withdrawal by Subject|4|||
163038325|NCT01215435|588847385|FG000|Overall Study|Adverse Event|1|||
163038326|NCT01215435|588847386|FG001|Overall Study|Adverse Event|0|||
163038327|NCT01215435|588847385|FG000|Overall Study|Protocol Violation|2|||
163038328|NCT01215435|588847386|FG001|Overall Study|Protocol Violation|0|||
163336638|NCT02404441|589942369|FG002|Phase 1 Part|Death|1|||
163336639|NCT02404441|589942370|FG003|Phase 1 Part|Death|0|||
163336640|NCT02404441|589942371|FG004|Phase 1 Part|Death|1|||
163336641|NCT02404441|589942372|FG005|Phase 1 Part|Death|0|||
163336642|NCT02404441|589942373|FG006|Phase 1 Part|Death|0|||
163336643|NCT02404441|589942374|FG007|Phase 1 Part|Death|0|||
163038329|NCT01215435|588847385|FG000|Overall Study|Withdrawal Criteria|8|||
163038330|NCT01215435|588847386|FG001|Overall Study|Withdrawal Criteria|11|||
163038331|NCT01215435|588847385|FG000|Overall Study|Lost to Follow-up|3|||
163038332|NCT01215435|588847386|FG001|Overall Study|Lost to Follow-up|0|||
163038333|NCT01215435|588847385|FG000|Overall Study|Unclassified|5|||
163038334|NCT01215435|588847386|FG001|Overall Study|Unclassified|5|||
163038335|NCT03383692|588847387|FG000|Overall Study|Progressive disease as per RECIST|3|||
163038336|NCT03383692|588847388|FG001|Overall Study|Progressive disease as per RECIST|3|||
163038337|NCT03383692|588847387|FG000|Overall Study|Clinical progression|0|||
163038338|NCT03383692|588847388|FG001|Overall Study|Clinical progression|1|||
163038339|NCT03383692|588847387|FG000|Overall Study|Adverse Event|3|||
163038340|NCT03383692|588847388|FG001|Overall Study|Adverse Event|0|||
163038341|NCT01810783|588847392|FG000|Overall Study|Adverse Event|32|||
163038342|NCT01810783|588847392|FG000|Overall Study|Withdrawal by Subject|22|||
163336644|NCT02404441|589942375|FG008|Phase 1 Part|Death|0|||
163336645|NCT02404441|589942376|FG009|Phase 1 Part|Death|0|||
163336646|NCT02404441|589942367|FG000|Phase 2 Part|Adverse Event|0|||
163407436|NCT00326898|590200825|FG002|Overall Study|Adverse Event|33|||
163091424|NCT02122380|589046508|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
163091425|NCT02122380|589046507|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
163091426|NCT02122380|589046508|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
163091427|NCT02122380|589046507|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
163091428|NCT02122380|589046508|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
163091429|NCT01192126|589046509|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
163091430|NCT01192126|589046510|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
163091431|NCT01192126|589046509|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
163091432|NCT01192126|589046510|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
163091433|NCT00688467|589046511|FG000|Treatment Period 1|Adverse Event|2|||
163091434|NCT00688467|589046512|FG001|Treatment Period 1|Adverse Event|1|||
163091435|NCT00688467|589046511|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
163091436|NCT00688467|589046512|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
163091437|NCT00688467|589046511|FG000|Treatment Period 2|Protocol Violation|0|||
163407437|NCT00326898|590200823|FG000|Overall Study|Death|2|||
163407438|NCT00326898|590200824|FG001|Overall Study|Death|0|||
163407439|NCT00326898|590200825|FG002|Overall Study|Death|0|||
163407440|NCT00326898|590200823|FG000|Overall Study|Withdrawal by Subject|134|||
163407441|NCT00326898|590200824|FG001|Overall Study|Withdrawal by Subject|128|||
163407442|NCT00326898|590200825|FG002|Overall Study|Withdrawal by Subject|32|||
163407443|NCT00326898|590200823|FG000|Overall Study|Alternative therapy|1|||
163407444|NCT00326898|590200824|FG001|Overall Study|Alternative therapy|0|||
163407445|NCT00326898|590200825|FG002|Overall Study|Alternative therapy|0|||
163407446|NCT00326898|590200823|FG000|Overall Study|Other complicating disease|5|||
163407447|NCT00326898|590200824|FG001|Overall Study|Other complicating disease|5|||
163407448|NCT00326898|590200825|FG002|Overall Study|Other complicating disease|4|||
163407449|NCT00326898|590200823|FG000|Overall Study|Other/Missing/Unknown|33|||
163407450|NCT00326898|590200824|FG001|Overall Study|Other/Missing/Unknown|28|||
163407451|NCT00326898|590200825|FG002|Overall Study|Other/Missing/Unknown|32|||
163407452|NCT03847987|590200826|FG000|Overall Study|Lost to Follow-up|1|||
163407453|NCT03847987|590200827|FG001|Overall Study|Lost to Follow-up|0|||
163407454|NCT03847987|590200826|FG000|Overall Study|Adverse Event|2|||
163407455|NCT03847987|590200827|FG001|Overall Study|Adverse Event|0|||
163091438|NCT00688467|589046512|FG001|Treatment Period 2|Protocol Violation|1|||
163091439|NCT00688467|589046511|FG000|Treatment Period 2|Adverse Event|0|||
163091440|NCT00688467|589046512|FG001|Treatment Period 2|Adverse Event|1|||
163091441|NCT00387088|589046513|FG000|Overall Study|Adverse Event|143|||
163091442|NCT00387088|589046514|FG001|Overall Study|Adverse Event|156|||
163091443|NCT00387088|589046513|FG000|Overall Study|Protocol Violation|47|||
163091444|NCT00387088|589046514|FG001|Overall Study|Protocol Violation|35|||
163091445|NCT00387088|589046513|FG000|Overall Study|Withdrawal by Subject|20|||
163091446|NCT00387088|589046514|FG001|Overall Study|Withdrawal by Subject|35|||
163091447|NCT00387088|589046513|FG000|Overall Study|Lack of Efficacy|28|||
163407456|NCT00713700|590200828|FG000|Overall Study|Lost to Follow-up|3|||
163407457|NCT00713700|590200828|FG000|Overall Study|Withdrawal by Subject|1|||
163407458|NCT00781456|590200829|FG000|Overall Study|Adverse Event|3|||
163038343|NCT01810783|588847392|FG000|Overall Study|Lack of Efficacy|12|||
163038344|NCT01810783|588847392|FG000|Overall Study|Lost to Follow-up|10|||
163038345|NCT01810783|588847392|FG000|Overall Study|Protocol Violation|5|||
163038346|NCT01810783|588847392|FG000|Overall Study|Non-compliance with IMP|4|||
163038347|NCT01810783|588847392|FG000|Overall Study|Adminstrative or other reason(s)|23|||
163038348|NCT01810783|588847392|FG000|Overall Study|Enrolled, not treated|1|||
163038349|NCT04776018|588847394|FG000|Overall Study|Death|0|||
163038350|NCT04776018|588847395|FG001|Overall Study|Death|1|||
163038351|NCT04776018|588847396|FG002|Overall Study|Death|4|||
163038352|NCT04776018|588847397|FG003|Overall Study|Death|1|||
163038353|NCT04776018|588847398|FG004|Overall Study|Death|4|||
163038354|NCT04776018|588847399|FG005|Overall Study|Death|0|||
163038355|NCT04776018|588847400|FG006|Overall Study|Death|0|||
163038356|NCT04776018|588847394|FG000|Overall Study|Study terminated by sponsor|2|||
163038357|NCT04776018|588847395|FG001|Overall Study|Study terminated by sponsor|1|||
163038358|NCT04776018|588847396|FG002|Overall Study|Study terminated by sponsor|4|||
163038359|NCT04776018|588847397|FG003|Overall Study|Study terminated by sponsor|0|||
163038360|NCT04776018|588847398|FG004|Overall Study|Study terminated by sponsor|3|||
163038361|NCT04776018|588847399|FG005|Overall Study|Study terminated by sponsor|0|||
163038362|NCT04776018|588847400|FG006|Overall Study|Study terminated by sponsor|0|||
163407459|NCT00781456|590200830|FG001|Overall Study|Adverse Event|3|||
163038363|NCT04776018|588847394|FG000|Overall Study|Withdrawal by Subject|1|||
163038364|NCT04776018|588847395|FG001|Overall Study|Withdrawal by Subject|0|||
163038365|NCT04776018|588847396|FG002|Overall Study|Withdrawal by Subject|0|||
163038366|NCT04776018|588847397|FG003|Overall Study|Withdrawal by Subject|2|||
163091448|NCT00387088|589046514|FG001|Overall Study|Lack of Efficacy|67|||
163407460|NCT00781456|590200829|FG000|Overall Study|Withdrawal by Subject|3|||
163407461|NCT00781456|590200830|FG001|Overall Study|Withdrawal by Subject|5|||
163407462|NCT00781456|590200829|FG000|Overall Study|Protocol Violation|4|||
163038367|NCT04776018|588847398|FG004|Overall Study|Withdrawal by Subject|1|||
163407463|NCT00781456|590200830|FG001|Overall Study|Protocol Violation|1|||
163038368|NCT04776018|588847399|FG005|Overall Study|Withdrawal by Subject|0|||
163038369|NCT04776018|588847400|FG006|Overall Study|Withdrawal by Subject|0|||
163038370|NCT04776018|588847394|FG000|Overall Study|Other|0|||
163038371|NCT04776018|588847395|FG001|Overall Study|Other|1|||
163038372|NCT04776018|588847396|FG002|Overall Study|Other|1|||
163038373|NCT04776018|588847397|FG003|Overall Study|Other|0|||
163038374|NCT04776018|588847398|FG004|Overall Study|Other|0|||
163038375|NCT04776018|588847399|FG005|Overall Study|Other|0|||
163038376|NCT04776018|588847400|FG006|Overall Study|Other|0|||
163038377|NCT04776018|588847394|FG000|Overall Study|Lost to Follow-up|0|||
163038378|NCT04776018|588847395|FG001|Overall Study|Lost to Follow-up|0|||
163038379|NCT04776018|588847396|FG002|Overall Study|Lost to Follow-up|1|||
163038380|NCT04776018|588847397|FG003|Overall Study|Lost to Follow-up|0|||
163038381|NCT04776018|588847398|FG004|Overall Study|Lost to Follow-up|0|||
163038382|NCT04776018|588847399|FG005|Overall Study|Lost to Follow-up|0|||
163038383|NCT04776018|588847400|FG006|Overall Study|Lost to Follow-up|0|||
163038384|NCT00793546|588847401|FG000|Overall Study|Death|3|||
163038385|NCT00793546|588847402|FG001|Overall Study|Death|0|||
163038386|NCT00793546|588847401|FG000|Overall Study|Lost to Follow-up|1|||
163038387|NCT00793546|588847402|FG001|Overall Study|Lost to Follow-up|0|||
163038388|NCT00793546|588847401|FG000|Overall Study|Withdrawal by Subject|1|||
163038389|NCT00793546|588847402|FG001|Overall Study|Withdrawal by Subject|1|||
163038390|NCT00793546|588847401|FG000|Overall Study|Study Terminated by Sponsor|8|||
163038391|NCT00793546|588847402|FG001|Overall Study|Study Terminated by Sponsor|27|||
163038392|NCT00793546|588847401|FG000|Overall Study|Other|1|||
163038393|NCT00793546|588847402|FG001|Overall Study|Other|0|||
163038394|NCT00435019|588847404|FG000|Overall Study|Adverse Event|1|||
163038395|NCT00435019|588847405|FG001|Overall Study|Adverse Event|0|||
163038396|NCT00435019|588847404|FG000|Overall Study|Lack of Efficacy|1|||
163038397|NCT00435019|588847405|FG001|Overall Study|Lack of Efficacy|2|||
163038398|NCT00435019|588847404|FG000|Overall Study|Protocol Violation|3|||
163038399|NCT00435019|588847405|FG001|Overall Study|Protocol Violation|1|||
163038400|NCT00435019|588847404|FG000|Overall Study|Personal reasons for withdrawal|8|||
163038401|NCT00435019|588847405|FG001|Overall Study|Personal reasons for withdrawal|7|||
163038402|NCT04503668|588847406|FG000|Overall Study|Incomplete data|4|||
163038403|NCT04503668|588847407|FG001|Overall Study|Incomplete data|3|||
163038404|NCT04503668|588847406|FG000|Overall Study|Withdrawal by Subject|1|||
163038405|NCT04503668|588847407|FG001|Overall Study|Withdrawal by Subject|1|||
163038406|NCT04503668|588847406|FG000|Overall Study|Adverse Event|2|||
163038407|NCT04503668|588847407|FG001|Overall Study|Adverse Event|0|||
163038408|NCT02306694|588847408|FG000|Overall Study|Withdrawal by Subject|3|||
163038409|NCT02306694|588847408|FG000|Overall Study|Lost to Follow-up|1|||
163038410|NCT00742027|588847411|FG000|Overall Study|Disease Progression|76|||
163038411|NCT00742027|588847411|FG000|Overall Study|New Cancer Therapy|19|||
163038412|NCT00742027|588847411|FG000|Overall Study|Withdrawal by Subject|18|||
163038413|NCT00742027|588847411|FG000|Overall Study|Death|7|||
163038414|NCT00742027|588847411|FG000|Overall Study|Lost to Follow-up|4|||
163038415|NCT00742027|588847411|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
163038416|NCT00742027|588847411|FG000|Overall Study|Missing|2|||
163038417|NCT00742027|588847411|FG000|Overall Study|Administrative Problems|1|||
163038418|NCT01180049|588847412|FG000|Overall Study|Other|9|||
163038419|NCT01180049|588847413|FG001|Overall Study|Other|7|||
163038420|NCT01180049|588847412|FG000|Overall Study|Lost to Follow-up|8|||
163038421|NCT01180049|588847413|FG001|Overall Study|Lost to Follow-up|6|||
163038422|NCT01180049|588847412|FG000|Overall Study|Death|36|||
163038423|NCT01180049|588847413|FG001|Overall Study|Death|35|||
163038424|NCT01764659|588847414|FG000|Overall Study|Death|1|||
163038425|NCT01764659|588847414|FG000|Overall Study|Physician Decision|1|||
163038426|NCT01210352|588847415|FG000|Overall Study|Adverse Event|0|||
163038427|NCT01210352|588847416|FG001|Overall Study|Adverse Event|0|||
163038428|NCT01210352|588847417|FG002|Overall Study|Adverse Event|0|||
163038429|NCT01210352|588847418|FG003|Overall Study|Adverse Event|0|||
163038430|NCT01210352|588847419|FG004|Overall Study|Adverse Event|0|||
163038431|NCT01210352|588847420|FG005|Overall Study|Adverse Event|0|||
163038432|NCT01210352|588847421|FG006|Overall Study|Adverse Event|0|||
163038433|NCT01210352|588847422|FG007|Overall Study|Adverse Event|2|||
163038434|NCT01210352|588847423|FG008|Overall Study|Adverse Event|1|||
163038435|NCT01210352|588847415|FG000|Overall Study|Lack of Efficacy|0|||
163038436|NCT01210352|588847416|FG001|Overall Study|Lack of Efficacy|0|||
163038437|NCT01210352|588847417|FG002|Overall Study|Lack of Efficacy|0|||
163038438|NCT01210352|588847418|FG003|Overall Study|Lack of Efficacy|0|||
163038439|NCT01210352|588847419|FG004|Overall Study|Lack of Efficacy|0|||
163038440|NCT01210352|588847420|FG005|Overall Study|Lack of Efficacy|0|||
163038441|NCT01210352|588847421|FG006|Overall Study|Lack of Efficacy|1|||
163038442|NCT01210352|588847422|FG007|Overall Study|Lack of Efficacy|0|||
163038443|NCT01210352|588847423|FG008|Overall Study|Lack of Efficacy|0|||
163038444|NCT01210352|588847415|FG000|Overall Study|Physician Decision|0|||
163038445|NCT01210352|588847416|FG001|Overall Study|Physician Decision|0|||
163038446|NCT01210352|588847417|FG002|Overall Study|Physician Decision|0|||
163038447|NCT01210352|588847418|FG003|Overall Study|Physician Decision|0|||
163407464|NCT00781456|590200829|FG000|Overall Study|Noncompliance With Protocol|1|||
163407465|NCT00781456|590200830|FG001|Overall Study|Noncompliance With Protocol|1|||
163407466|NCT00781456|590200829|FG000|Overall Study|Lost to Follow-up|10|||
163407467|NCT00781456|590200830|FG001|Overall Study|Lost to Follow-up|5|||
163407468|NCT00781456|590200829|FG000|Overall Study|Other Reason, Unknown|0|||
163407469|NCT00781456|590200830|FG001|Overall Study|Other Reason, Unknown|1|||
163407470|NCT03548558|590200832|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
163407471|NCT03548558|590200833|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
163407472|NCT03548558|590200834|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
163407473|NCT03548558|590200835|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
163407474|NCT03548558|590200836|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
163407475|NCT03548558|590200837|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
163407476|NCT03548558|590200838|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
163407477|NCT03548558|590200832|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
163407478|NCT03548558|590200833|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
163407479|NCT03548558|590200834|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
163407480|NCT03548558|590200835|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
163407481|NCT03548558|590200836|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
163407482|NCT03548558|590200837|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
163407483|NCT03548558|590200838|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
163407484|NCT03548558|590200832|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
163407485|NCT03548558|590200833|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
163407486|NCT03548558|590200834|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
163091449|NCT00387088|589046513|FG000|Overall Study|Lost to Follow-up|22|||
163091450|NCT00387088|589046514|FG001|Overall Study|Lost to Follow-up|28|||
163091451|NCT00387088|589046513|FG000|Overall Study|Other|58|||
163091452|NCT00387088|589046514|FG001|Overall Study|Other|52|||
163336647|NCT02404441|589942368|FG001|Phase 2 Part|Adverse Event|0|||
163336648|NCT02404441|589942369|FG002|Phase 2 Part|Adverse Event|0|||
163336649|NCT02404441|589942370|FG003|Phase 2 Part|Adverse Event|0|||
163336650|NCT02404441|589942371|FG004|Phase 2 Part|Adverse Event|0|||
163336651|NCT02404441|589942372|FG005|Phase 2 Part|Adverse Event|2|||
163336652|NCT02404441|589942373|FG006|Phase 2 Part|Adverse Event|3|||
163336653|NCT02404441|589942374|FG007|Phase 2 Part|Adverse Event|3|||
163336654|NCT02404441|589942375|FG008|Phase 2 Part|Adverse Event|6|||
163336655|NCT02404441|589942376|FG009|Phase 2 Part|Adverse Event|1|||
163336656|NCT02404441|589942367|FG000|Phase 2 Part|Physician Decision|0|||
163336657|NCT02404441|589942368|FG001|Phase 2 Part|Physician Decision|0|||
163336658|NCT02404441|589942369|FG002|Phase 2 Part|Physician Decision|0|||
163336659|NCT02404441|589942370|FG003|Phase 2 Part|Physician Decision|0|||
163336660|NCT02404441|589942371|FG004|Phase 2 Part|Physician Decision|0|||
163336661|NCT02404441|589942372|FG005|Phase 2 Part|Physician Decision|7|||
163336662|NCT02404441|589942373|FG006|Phase 2 Part|Physician Decision|9|||
163336663|NCT02404441|589942374|FG007|Phase 2 Part|Physician Decision|2|||
163336664|NCT02404441|589942375|FG008|Phase 2 Part|Physician Decision|1|||
163336665|NCT02404441|589942376|FG009|Phase 2 Part|Physician Decision|3|||
163336666|NCT02404441|589942367|FG000|Phase 2 Part|Progressive disease|0|||
163336667|NCT02404441|589942368|FG001|Phase 2 Part|Progressive disease|0|||
163336668|NCT02404441|589942369|FG002|Phase 2 Part|Progressive disease|0|||
163336669|NCT02404441|589942370|FG003|Phase 2 Part|Progressive disease|0|||
163336670|NCT02404441|589942371|FG004|Phase 2 Part|Progressive disease|0|||
163336671|NCT02404441|589942372|FG005|Phase 2 Part|Progressive disease|43|||
163336672|NCT02404441|589942373|FG006|Phase 2 Part|Progressive disease|32|||
163336673|NCT02404441|589942374|FG007|Phase 2 Part|Progressive disease|31|||
163336674|NCT02404441|589942375|FG008|Phase 2 Part|Progressive disease|39|||
163336675|NCT02404441|589942376|FG009|Phase 2 Part|Progressive disease|27|||
163336676|NCT02404441|589942367|FG000|Phase 2 Part|Subject/guardian decision|0|||
163336677|NCT02404441|589942368|FG001|Phase 2 Part|Subject/guardian decision|0|||
163336678|NCT02404441|589942369|FG002|Phase 2 Part|Subject/guardian decision|0|||
163407487|NCT03548558|590200835|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
163407488|NCT03548558|590200836|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
163407489|NCT03548558|590200837|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
163091453|NCT03604497|589046520|FG000|Overall Study|Protocol Violation|52|||
163091454|NCT00811954|589046521|FG000|Overall Study|Death|10|||
163091455|NCT00811954|589046522|FG001|Overall Study|Death|6|||
163336679|NCT02404441|589942370|FG003|Phase 2 Part|Subject/guardian decision|0|||
163336680|NCT02404441|589942371|FG004|Phase 2 Part|Subject/guardian decision|0|||
163091456|NCT00811954|589046523|FG002|Overall Study|Death|13|||
163091457|NCT00811954|589046521|FG000|Overall Study|Lost to Follow-up|29|||
163336681|NCT02404441|589942372|FG005|Phase 2 Part|Subject/guardian decision|3|||
163336682|NCT02404441|589942373|FG006|Phase 2 Part|Subject/guardian decision|9|||
163336683|NCT02404441|589942374|FG007|Phase 2 Part|Subject/guardian decision|0|||
163336684|NCT02404441|589942375|FG008|Phase 2 Part|Subject/guardian decision|3|||
163336685|NCT02404441|589942376|FG009|Phase 2 Part|Subject/guardian decision|2|||
163091458|NCT00811954|589046522|FG001|Overall Study|Lost to Follow-up|23|||
163336686|NCT02404441|589942367|FG000|Phase 2 Part|Death|0|||
163407490|NCT03548558|590200838|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
163407491|NCT03548558|590200832|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
163407492|NCT03548558|590200833|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
163407493|NCT03548558|590200834|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
163407494|NCT03548558|590200835|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
163407495|NCT03548558|590200836|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
163038448|NCT01210352|588847419|FG004|Overall Study|Physician Decision|0|||
163038449|NCT01210352|588847420|FG005|Overall Study|Physician Decision|0|||
163038450|NCT01210352|588847421|FG006|Overall Study|Physician Decision|0|||
163038451|NCT01210352|588847422|FG007|Overall Study|Physician Decision|1|||
163038452|NCT01210352|588847423|FG008|Overall Study|Physician Decision|2|||
163038453|NCT01210352|588847415|FG000|Overall Study|Withdrawal by Subject|0|||
163038454|NCT01210352|588847416|FG001|Overall Study|Withdrawal by Subject|0|||
163038455|NCT01210352|588847417|FG002|Overall Study|Withdrawal by Subject|1|||
163038456|NCT01210352|588847418|FG003|Overall Study|Withdrawal by Subject|0|||
163038457|NCT01210352|588847419|FG004|Overall Study|Withdrawal by Subject|0|||
163038458|NCT01210352|588847420|FG005|Overall Study|Withdrawal by Subject|0|||
163038459|NCT01210352|588847421|FG006|Overall Study|Withdrawal by Subject|1|||
163038460|NCT01210352|588847422|FG007|Overall Study|Withdrawal by Subject|0|||
163038461|NCT01210352|588847423|FG008|Overall Study|Withdrawal by Subject|1|||
163038462|NCT01210352|588847415|FG000|Overall Study|Patient Discharged Early|0|||
163038463|NCT01210352|588847416|FG001|Overall Study|Patient Discharged Early|0|||
163038464|NCT01210352|588847417|FG002|Overall Study|Patient Discharged Early|1|||
163038465|NCT01210352|588847418|FG003|Overall Study|Patient Discharged Early|0|||
163038466|NCT01210352|588847419|FG004|Overall Study|Patient Discharged Early|0|||
163038467|NCT01210352|588847420|FG005|Overall Study|Patient Discharged Early|0|||
163038468|NCT01210352|588847421|FG006|Overall Study|Patient Discharged Early|0|||
163038469|NCT01210352|588847422|FG007|Overall Study|Patient Discharged Early|0|||
163038470|NCT01210352|588847423|FG008|Overall Study|Patient Discharged Early|0|||
163038471|NCT04227405|588848731|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
163038472|NCT04227405|588848732|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
163038473|NCT04227405|588848731|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
163038474|NCT04227405|588848732|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
163038475|NCT04227405|588848731|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
163038476|NCT04227405|588848732|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
163038477|NCT03536663|588848733|FG000|Endexo|Protocol Violation|1|||
163038478|NCT01502956|588848734|FG000|Overall Study|Death|0|||
163038479|NCT01502956|588848735|FG001|Overall Study|Death|2|||
163038480|NCT01502956|588848734|FG000|Overall Study|Lost to Follow-up|14|||
163038481|NCT01502956|588848735|FG001|Overall Study|Lost to Follow-up|11|||
163038482|NCT01502956|588848734|FG000|Overall Study|Physician Decision|2|||
163038483|NCT01502956|588848735|FG001|Overall Study|Physician Decision|3|||
163038484|NCT01502956|588848734|FG000|Overall Study|Withdrawal by Subject|8|||
163038485|NCT01502956|588848735|FG001|Overall Study|Withdrawal by Subject|10|||
163038486|NCT01616758|588848736|FG000|Overall Study|Adverse Event|1|||
163038487|NCT01616758|588848736|FG000|Overall Study|Withdrawal by Subject|2|||
163038488|NCT01616758|588848736|FG000|Overall Study|Disease progression|18|||
163038489|NCT01616758|588848736|FG000|Overall Study|Study termination by Sponsor|1|||
163038490|NCT02187029|588848737|FG000|Overall Study|Adverse Event|0|||
163038491|NCT02187029|588848738|FG001|Overall Study|Adverse Event|1|||
163038492|NCT02187029|588848739|FG002|Overall Study|Adverse Event|1|||
163038493|NCT02187029|588848740|FG003|Overall Study|Adverse Event|0|||
163038494|NCT02187029|588848737|FG000|Overall Study|Study Terminated by Sponsor|0|||
163038495|NCT02187029|588848738|FG001|Overall Study|Study Terminated by Sponsor|0|||
163038496|NCT02187029|588848739|FG002|Overall Study|Study Terminated by Sponsor|10|||
163038497|NCT02187029|588848740|FG003|Overall Study|Study Terminated by Sponsor|3|||
163038498|NCT02187029|588848737|FG000|Overall Study|Withdrawal by Subject|1|||
163038499|NCT02187029|588848738|FG001|Overall Study|Withdrawal by Subject|0|||
163038500|NCT02187029|588848739|FG002|Overall Study|Withdrawal by Subject|0|||
163038501|NCT02187029|588848740|FG003|Overall Study|Withdrawal by Subject|0|||
163038502|NCT02985021|588848741|FG000|Overall Study|Inability to comply with study procedures|1|||
163038503|NCT04105842|588848742|FG000|Overall Study|Withdrawal by Subject|2|||
163038504|NCT01535443|588848748|FG000|Overall Study|Physician Decision|3|||
163038505|NCT00760487|588848750|FG000|Overall Study|Unilateral implantation|3|||
163038506|NCT00329745|588848751|FG000|Overall Study|Protocol Violation|1|||
163038507|NCT00329745|588848752|FG001|Overall Study|Protocol Violation|0|||
163038508|NCT00329745|588848751|FG000|Overall Study|Withdrawal by Subject|0|||
163038509|NCT00329745|588848752|FG001|Overall Study|Withdrawal by Subject|1|||
163038510|NCT00329745|588848751|FG000|Overall Study|Lost to Follow-up|86|||
163038511|NCT00329745|588848752|FG001|Overall Study|Lost to Follow-up|101|||
163038512|NCT03146741|588848753|FG000|Overall Study|Txp with non-HCV+ heart|4|||
163038513|NCT03146741|588848753|FG000|Overall Study|Listeted for MOT|2|||
163038514|NCT03146741|588848753|FG000|Overall Study|Physician Decision|2|||
163038515|NCT03146741|588848753|FG000|Overall Study|Awaiting txp|2|||
163038516|NCT03224624|588848754|FG000|Overall Study|Lost to Follow-up|9|||
163091459|NCT00811954|589046523|FG002|Overall Study|Lost to Follow-up|34|||
163091460|NCT00811954|589046521|FG000|Overall Study|Not able to get to clinic|28|||
163091461|NCT00811954|589046522|FG001|Overall Study|Not able to get to clinic|35|||
163091462|NCT00811954|589046523|FG002|Overall Study|Not able to get to clinic|30|||
163091463|NCT00811954|589046521|FG000|Overall Study|Not willing to adhere to requirements|12|||
163091464|NCT00811954|589046522|FG001|Overall Study|Not willing to adhere to requirements|2|||
163091465|NCT00811954|589046523|FG002|Overall Study|Not willing to adhere to requirements|16|||
163091466|NCT00811954|589046521|FG000|Overall Study|Withdraw consent prior study completion|4|||
163091467|NCT00811954|589046522|FG001|Overall Study|Withdraw consent prior study completion|6|||
163091468|NCT00811954|589046523|FG002|Overall Study|Withdraw consent prior study completion|5|||
163091469|NCT00811954|589046521|FG000|Overall Study|Site Closure|4|||
163091470|NCT00811954|589046522|FG001|Overall Study|Site Closure|0|||
163091471|NCT00811954|589046523|FG002|Overall Study|Site Closure|1|||
163091472|NCT00811954|589046521|FG000|Overall Study|Severe Debilitation|2|||
163091473|NCT00811954|589046522|FG001|Overall Study|Severe Debilitation|0|||
163091474|NCT00811954|589046523|FG002|Overall Study|Severe Debilitation|1|||
163091475|NCT00811954|589046521|FG000|Overall Study|Complete Protocol: No follow-up|0|||
163091476|NCT00811954|589046522|FG001|Overall Study|Complete Protocol: No follow-up|0|||
163091477|NCT00811954|589046523|FG002|Overall Study|Complete Protocol: No follow-up|1|||
163091478|NCT01534481|589046530|FG000|Overall Study|Lost to Follow-up|29|||
163091479|NCT01534481|589046531|FG001|Overall Study|Lost to Follow-up|24|||
163091480|NCT01534481|589046530|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
163091481|NCT01534481|589046531|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
163091482|NCT00945659|589046535|FG000|Overall Study|Lost to Follow-up|7|||
163091483|NCT00945659|589046536|FG001|Overall Study|Lost to Follow-up|20|||
163091484|NCT00945659|589046537|FG002|Overall Study|Lost to Follow-up|17|||
163091485|NCT00658541|589046538|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
163091486|NCT00658541|589046539|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
163091487|NCT00658541|589046538|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
163091488|NCT00658541|589046539|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
163091489|NCT03179761|589046540|FG000|Overall Study|Death|2|||
163091490|NCT03179761|589046541|FG001|Overall Study|Death|5|||
163091491|NCT03179761|589046540|FG000|Overall Study|Lost to Follow-up|2|||
163091492|NCT03179761|589046541|FG001|Overall Study|Lost to Follow-up|2|||
163091493|NCT03179761|589046540|FG000|Overall Study|Protocol Violation|1|||
163091494|NCT03179761|589046541|FG001|Overall Study|Protocol Violation|0|||
163091495|NCT03179761|589046540|FG000|Overall Study|Withdrawal by Subject|1|||
163091496|NCT03179761|589046541|FG001|Overall Study|Withdrawal by Subject|4|||
163091497|NCT03179761|589046540|FG000|Overall Study|Investigator Request|0|||
163091498|NCT03179761|589046541|FG001|Overall Study|Investigator Request|2|||
163091499|NCT00565409|589046542|FG000|Period 1 Open Label|Adverse Event|17|||
163091500|NCT00565409|589046543|FG001|Period 1 Open Label|Adverse Event|0|||
163091501|NCT00565409|589046544|FG002|Period 1 Open Label|Adverse Event|0|||
163091502|NCT00565409|589046545|FG003|Period 1 Open Label|Adverse Event|0|||
163091503|NCT00565409|589046542|FG000|Period 1 Open Label|Death|2|||
163091504|NCT00565409|589046543|FG001|Period 1 Open Label|Death|0|||
163091505|NCT00565409|589046544|FG002|Period 1 Open Label|Death|0|||
163091506|NCT00565409|589046545|FG003|Period 1 Open Label|Death|0|||
163091507|NCT00565409|589046542|FG000|Period 1 Open Label|Lost to Follow-up|1|||
163091508|NCT00565409|589046543|FG001|Period 1 Open Label|Lost to Follow-up|0|||
163091509|NCT00565409|589046544|FG002|Period 1 Open Label|Lost to Follow-up|0|||
163091510|NCT00565409|589046545|FG003|Period 1 Open Label|Lost to Follow-up|0|||
163091511|NCT00565409|589046542|FG000|Period 1 Open Label|Other|21|||
163091512|NCT00565409|589046543|FG001|Period 1 Open Label|Other|0|||
163091513|NCT00565409|589046544|FG002|Period 1 Open Label|Other|0|||
163091514|NCT00565409|589046545|FG003|Period 1 Open Label|Other|0|||
163091515|NCT00565409|589046542|FG000|Period 1 Open Label|Protocol Violation|14|||
163091516|NCT00565409|589046543|FG001|Period 1 Open Label|Protocol Violation|0|||
163091517|NCT00565409|589046544|FG002|Period 1 Open Label|Protocol Violation|0|||
163091518|NCT00565409|589046545|FG003|Period 1 Open Label|Protocol Violation|0|||
163091519|NCT00565409|589046542|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
163091520|NCT00565409|589046543|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
163091521|NCT00565409|589046544|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
163091522|NCT00565409|589046545|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
163091523|NCT00565409|589046542|FG000|Period 1 Open Label|no conclusion of participation record|1|||
163336687|NCT02404441|589942368|FG001|Phase 2 Part|Death|0|||
163091524|NCT00565409|589046543|FG001|Period 1 Open Label|no conclusion of participation record|0|||
163091525|NCT00565409|589046544|FG002|Period 1 Open Label|no conclusion of participation record|0|||
163091526|NCT00565409|589046545|FG003|Period 1 Open Label|no conclusion of participation record|0|||
163091527|NCT00565409|589046542|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
163091528|NCT00565409|589046543|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
163091529|NCT00565409|589046544|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
163091530|NCT00565409|589046545|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
163091531|NCT00565409|589046542|FG000|Period 2 Double-Blind|Adverse Event|0|||
163091532|NCT00565409|589046543|FG001|Period 2 Double-Blind|Adverse Event|7|||
163336688|NCT02404441|589942369|FG002|Phase 2 Part|Death|0|||
163336689|NCT02404441|589942370|FG003|Phase 2 Part|Death|0|||
163336690|NCT02404441|589942371|FG004|Phase 2 Part|Death|0|||
163336691|NCT02404441|589942372|FG005|Phase 2 Part|Death|4|||
163038517|NCT03224624|588848755|FG001|Overall Study|Lost to Follow-up|4|||
163038518|NCT03224624|588848754|FG000|Overall Study|Death|1|||
163038519|NCT03224624|588848755|FG001|Overall Study|Death|0|||
163038520|NCT00496587|588848758|FG000|Overall Study|Adverse Event|2|||
163038521|NCT00496587|588848758|FG000|Overall Study|Progressive Disease|24|||
163038522|NCT00496587|588848758|FG000|Overall Study|Withdrawal by Subject|2|||
163038523|NCT00496587|588848758|FG000|Overall Study|Death|1|||
163038524|NCT00496587|588848758|FG000|Overall Study|Complications unrelated|2|||
163038525|NCT00482170|588848760|FG000|Overall Study|Adverse Event|5|||
163038526|NCT00482170|588848761|FG001|Overall Study|Adverse Event|14|||
163038527|NCT00482170|588848760|FG000|Overall Study|Withdrawal by Subject|6|||
163336692|NCT02404441|589942373|FG006|Phase 2 Part|Death|8|||
163336693|NCT02404441|589942374|FG007|Phase 2 Part|Death|4|||
163091533|NCT00565409|589046544|FG002|Period 2 Double-Blind|Adverse Event|4|||
163091534|NCT00565409|589046545|FG003|Period 2 Double-Blind|Adverse Event|5|||
163091535|NCT00565409|589046542|FG000|Period 2 Double-Blind|Death|0|||
163091536|NCT00565409|589046543|FG001|Period 2 Double-Blind|Death|2|||
163091537|NCT00565409|589046544|FG002|Period 2 Double-Blind|Death|0|||
163091538|NCT00565409|589046545|FG003|Period 2 Double-Blind|Death|0|||
163091539|NCT00565409|589046542|FG000|Period 2 Double-Blind|Protocol Violation|0|||
163091540|NCT00565409|589046543|FG001|Period 2 Double-Blind|Protocol Violation|4|||
163091541|NCT00565409|589046544|FG002|Period 2 Double-Blind|Protocol Violation|6|||
163091542|NCT00565409|589046545|FG003|Period 2 Double-Blind|Protocol Violation|2|||
163091543|NCT00565409|589046542|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
163091544|NCT00565409|589046543|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
163091545|NCT00565409|589046544|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
163091546|NCT00565409|589046545|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
163091547|NCT00565409|589046542|FG000|Period 2 Double-Blind|Other|0|||
163091548|NCT00565409|589046543|FG001|Period 2 Double-Blind|Other|4|||
163091549|NCT00565409|589046544|FG002|Period 2 Double-Blind|Other|5|||
163091550|NCT00565409|589046545|FG003|Period 2 Double-Blind|Other|9|||
163091551|NCT00565409|589046542|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
163091552|NCT00565409|589046543|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
163091553|NCT00565409|589046544|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
163091554|NCT00565409|589046545|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
163091555|NCT04828707|589046548|FG000|Overall Study|Lost to Follow-up|3|||
163091556|NCT04828707|589046549|FG001|Overall Study|Lost to Follow-up|2|||
163091557|NCT04828707|589046548|FG000|Overall Study|Withdrawal by Subject|2|||
163091558|NCT04828707|589046549|FG001|Overall Study|Withdrawal by Subject|1|||
163091559|NCT01570387|589046556|FG000|Overall Study|Adverse Event|1|||
163091560|NCT01570387|589046557|FG001|Overall Study|Adverse Event|0|||
163091561|NCT01570387|589046558|FG002|Overall Study|Adverse Event|0|||
163091562|NCT01570387|589046559|FG003|Overall Study|Adverse Event|0|||
163091563|NCT01570387|589046556|FG000|Overall Study|Death|0|||
163336694|NCT02404441|589942375|FG008|Phase 2 Part|Death|10|||
163336695|NCT02404441|589942376|FG009|Phase 2 Part|Death|9|||
163336696|NCT03909100|589942378|FG000|Overall Study|Protocol Deviation|2|||
163336697|NCT03909100|589942378|FG000|Overall Study|Technical Problems|4|||
163336698|NCT03909100|589942378|FG000|Overall Study|Withdrawal by Subject|4|||
163336699|NCT03909100|589942378|FG000|Overall Study|Lost to Follow-up|1|||
163336700|NCT03909100|589942378|FG000|Overall Study|Reason not Specified|4|||
163336701|NCT02671266|589942379|FG000|Overall Study|Withdrawal by Subject|1|||
163336702|NCT02671266|589942380|FG001|Overall Study|Withdrawal by Subject|1|||
163336703|NCT01794299|589942384|FG000|Overall Study|ATIR manufacturing not possible|1|||
163336704|NCT01794299|589942384|FG000|Overall Study|Death|14|||
163336705|NCT01794299|589942384|FG000|Overall Study|Graft failure|1|||
163336706|NCT01794299|589942384|FG000|Overall Study|ATIR batch rejected|2|||
163336707|NCT01794299|589942384|FG000|Overall Study|Relapse|2|||
163407496|NCT03548558|590200837|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
163038528|NCT00482170|588848761|FG001|Overall Study|Withdrawal by Subject|1|||
163091564|NCT01570387|589046557|FG001|Overall Study|Death|0|||
163091565|NCT01570387|589046558|FG002|Overall Study|Death|0|||
163091566|NCT01570387|589046559|FG003|Overall Study|Death|1|||
163091567|NCT01570387|589046556|FG000|Overall Study|Withdrawal by Subject|0|||
163038529|NCT00482170|588848760|FG000|Overall Study|Protocol Violation|2|||
163091568|NCT01570387|589046557|FG001|Overall Study|Withdrawal by Subject|0|||
163091569|NCT01570387|589046558|FG002|Overall Study|Withdrawal by Subject|0|||
163091570|NCT01570387|589046559|FG003|Overall Study|Withdrawal by Subject|1|||
163336708|NCT01794299|589942384|FG000|Overall Study|Discontinued from active follow-up|1|||
163336709|NCT01794299|589942384|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
163091571|NCT01876381|589046560|FG000|Overall Study|Lack of Efficacy|5|||
163091572|NCT01876381|589046560|FG000|Overall Study|Physician Decision|1|||
163336710|NCT03006393|589942385|FG000|Overall Study|Withdrawal by Subject|1|||
163336711|NCT03006393|589942386|FG001|Overall Study|Withdrawal by Subject|1|||
163038530|NCT00482170|588848761|FG001|Overall Study|Protocol Violation|3|||
163091573|NCT01876381|589046560|FG000|Overall Study|Withdrawal by Subject|1|||
163091574|NCT02170064|589046561|FG000|Overall Study|Withdrawal by Subject|5|||
163091575|NCT02170064|589046562|FG001|Overall Study|Withdrawal by Subject|1|||
163091576|NCT02170064|589046563|FG002|Overall Study|Withdrawal by Subject|1|||
163091577|NCT02170064|589046561|FG000|Overall Study|Physician Decision|1|||
163091578|NCT02170064|589046562|FG001|Overall Study|Physician Decision|1|||
163091579|NCT02170064|589046563|FG002|Overall Study|Physician Decision|0|||
163091580|NCT04211363|589046564|FG000|Overall Study|Adverse Event|5|||
163091581|NCT04211363|589046565|FG001|Overall Study|Adverse Event|2|||
163091582|NCT04211363|589046564|FG000|Overall Study|Physician Decision|0|||
163091583|NCT04211363|589046565|FG001|Overall Study|Physician Decision|1|||
163091584|NCT04211363|589046564|FG000|Overall Study|Protocol Violation|1|||
163091585|NCT04211363|589046565|FG001|Overall Study|Protocol Violation|0|||
163091586|NCT04211363|589046564|FG000|Overall Study|Pregnancy|1|||
163091587|NCT04211363|589046565|FG001|Overall Study|Pregnancy|0|||
163091588|NCT04211363|589046564|FG000|Overall Study|Lost to Follow-up|12|||
163091589|NCT04211363|589046565|FG001|Overall Study|Lost to Follow-up|4|||
163091590|NCT04211363|589046564|FG000|Overall Study|Withdrawal by Subject|11|||
163091591|NCT04211363|589046565|FG001|Overall Study|Withdrawal by Subject|11|||
163091592|NCT04211363|589046564|FG000|Overall Study|Other|1|||
163091593|NCT04211363|589046565|FG001|Overall Study|Other|2|||
163091594|NCT00654732|589046575|FG000|Overall Study|Adverse Event|4|||
163091595|NCT00654732|589046576|FG001|Overall Study|Adverse Event|6|||
163091596|NCT00518180|589046580|FG000|Overall Study|Withdrawal by Subject|29|||
163091597|NCT00518180|589046581|FG001|Overall Study|Withdrawal by Subject|30|||
163091598|NCT00518180|589046582|FG002|Overall Study|Withdrawal by Subject|42|||
163091599|NCT00518180|589046580|FG000|Overall Study|Lost to Follow-up|30|||
163091600|NCT00518180|589046581|FG001|Overall Study|Lost to Follow-up|28|||
163091601|NCT00518180|589046582|FG002|Overall Study|Lost to Follow-up|34|||
163091602|NCT00518180|589046580|FG000|Overall Study|Administrative reason|0|||
163091603|NCT00518180|589046581|FG001|Overall Study|Administrative reason|2|||
163091604|NCT00518180|589046582|FG002|Overall Study|Administrative reason|2|||
163091605|NCT00518180|589046580|FG000|Overall Study|Protocol Violation|5|||
163091606|NCT00518180|589046581|FG001|Overall Study|Protocol Violation|7|||
163091607|NCT00518180|589046582|FG002|Overall Study|Protocol Violation|4|||
163091608|NCT00518180|589046580|FG000|Overall Study|Unable to classify|0|||
163091609|NCT00518180|589046581|FG001|Overall Study|Unable to classify|2|||
163091610|NCT00518180|589046582|FG002|Overall Study|Unable to classify|0|||
163091611|NCT00518180|589046580|FG000|Overall Study|Adverse Event|1|||
163091612|NCT00518180|589046581|FG001|Overall Study|Adverse Event|0|||
163091613|NCT00518180|589046582|FG002|Overall Study|Adverse Event|0|||
163091614|NCT02347085|589046583|FG000|Overall Study|Adverse Event|2|||
163091615|NCT02347085|589046583|FG000|Overall Study|Lack of Efficacy|1|||
163091616|NCT02347085|589046583|FG000|Overall Study|Withdrawal by Subject|4|||
163091617|NCT02347085|589046583|FG000|Overall Study|Lost to Follow-up|1|||
163336712|NCT03006393|589942385|FG000|Overall Study|Pregnancy|0|||
163336713|NCT03006393|589942386|FG001|Overall Study|Pregnancy|1|||
163336714|NCT03006393|589942385|FG000|Overall Study|Lost to Follow-up|0|||
163336715|NCT03006393|589942386|FG001|Overall Study|Lost to Follow-up|1|||
163336716|NCT00807599|589942389|FG000|Overall Study|Not treated on protocol study|0|||
163336717|NCT00807599|589942390|FG001|Overall Study|Not treated on protocol study|0|||
163336718|NCT00807599|589942391|FG002|Overall Study|Not treated on protocol study|2|||
163336719|NCT00807599|589942389|FG000|Overall Study|Adverse Event|0|||
163336720|NCT00807599|589942390|FG001|Overall Study|Adverse Event|0|||
163336721|NCT00807599|589942391|FG002|Overall Study|Adverse Event|5|||
163336722|NCT00807599|589942389|FG000|Overall Study|Inadequate response to induction|0|||
163336723|NCT00807599|589942390|FG001|Overall Study|Inadequate response to induction|0|||
163336724|NCT00807599|589942391|FG002|Overall Study|Inadequate response to induction|9|||
163336725|NCT00807599|589942389|FG000|Overall Study|Withdrawal by Subject|0|||
163336726|NCT00807599|589942390|FG001|Overall Study|Withdrawal by Subject|0|||
163336727|NCT00807599|589942391|FG002|Overall Study|Withdrawal by Subject|1|||
163336728|NCT01262456|589942392|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
163336729|NCT01262456|589942393|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
163336730|NCT01262456|589942394|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
163336731|NCT01262456|589942392|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
163091618|NCT02347085|589046583|FG000|Overall Study|Protocol Criteria|2|||
163091619|NCT01957865|589046584|FG000|Overall Study|Found HIV negative|0|||
163091620|NCT01957865|589046585|FG001|Overall Study|Found HIV negative|0|||
163091621|NCT01957865|589046586|FG002|Overall Study|Found HIV negative|1|||
163091622|NCT01957865|589046584|FG000|Overall Study|Lost to Follow-up|0|||
163336732|NCT01262456|589942393|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
163091623|NCT01957865|589046585|FG001|Overall Study|Lost to Follow-up|2|||
163091624|NCT01957865|589046586|FG002|Overall Study|Lost to Follow-up|2|||
163091625|NCT01082614|589046587|FG000|Overall Study|Adverse Event|1|||
163091626|NCT01082614|589046588|FG001|Overall Study|Adverse Event|4|||
163091627|NCT01082614|589046587|FG000|Overall Study|Equipment Malfunction|0|||
163091628|NCT01082614|589046588|FG001|Overall Study|Equipment Malfunction|1|||
163091629|NCT01082614|589046587|FG000|Overall Study|Physician Decision|2|||
163336733|NCT01262456|589942394|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
163336734|NCT01262456|589942392|FG000|3-Month Double-Blind Period|Adverse Event|6|||
163336735|NCT01262456|589942393|FG001|3-Month Double-Blind Period|Adverse Event|4|||
163336736|NCT01262456|589942394|FG002|3-Month Double-Blind Period|Adverse Event|8|||
163336737|NCT01262456|589942392|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
163336738|NCT01262456|589942393|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
163336739|NCT01262456|589942394|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
163336740|NCT01262456|589942392|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
163336741|NCT01262456|589942393|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
163336742|NCT01262456|589942394|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
163336743|NCT01262456|589942392|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
163336744|NCT01262456|589942393|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
163336745|NCT01262456|589942394|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
163336746|NCT01262456|589942392|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
163336747|NCT01262456|589942393|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
163336748|NCT01262456|589942394|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
163336749|NCT01262456|589942392|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
163336750|NCT01262456|589942393|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
163336751|NCT01262456|589942394|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
163336752|NCT01262456|589942392|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
163336753|NCT01262456|589942393|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
163336754|NCT01262456|589942394|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
163336755|NCT03938272|589942395|FG000|Overall Study|Withdrawal by Subject|1|||
163336756|NCT03938272|589942396|FG001|Overall Study|Withdrawal by Subject|0|||
163336757|NCT03938272|589942395|FG000|Overall Study|Physician Decision|0|||
163336758|NCT03938272|589942396|FG001|Overall Study|Physician Decision|2|||
163336759|NCT03938272|589942395|FG000|Overall Study|Study termination by sponsor|10|||
163336760|NCT03938272|589942396|FG001|Overall Study|Study termination by sponsor|8|||
163336761|NCT02102724|589942397|FG000|Overall Study|Lost to Follow-up|1|||
163336762|NCT02102724|589942398|FG001|Overall Study|Lost to Follow-up|0|||
163336763|NCT02102724|589942397|FG000|Overall Study|surgery for brain aneurysm|1|||
163336764|NCT02102724|589942398|FG001|Overall Study|surgery for brain aneurysm|1|||
163336765|NCT04821271|589942399|FG000|Period 1|Withdrawal by Subject|2|||
163336766|NCT04821271|589942400|FG001|Period 1|Withdrawal by Subject|0|||
163336767|NCT02521493|589942403|FG000|Overall Study|Death|3|||
163336768|NCT02521493|589942404|FG001|Overall Study|Death|4|||
163336769|NCT02521493|589942405|FG002|Overall Study|Death|1|||
163336770|NCT02521493|589942403|FG000|Overall Study|Physician Decision|19|||
163336771|NCT02521493|589942404|FG001|Overall Study|Physician Decision|1|||
163336772|NCT02521493|589942405|FG002|Overall Study|Physician Decision|2|||
163336773|NCT02521493|589942403|FG000|Overall Study|Withdrawal by Subject|3|||
163336774|NCT02521493|589942404|FG001|Overall Study|Withdrawal by Subject|0|||
163336775|NCT02521493|589942405|FG002|Overall Study|Withdrawal by Subject|0|||
163336776|NCT02521493|589942403|FG000|Overall Study|Ineligible|0|||
163336777|NCT02521493|589942404|FG001|Overall Study|Ineligible|1|||
163336778|NCT02521493|589942405|FG002|Overall Study|Ineligible|0|||
163336779|NCT02521493|589942403|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
163336780|NCT02521493|589942404|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
163336781|NCT02521493|589942405|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
163336782|NCT02521493|589942403|FG000|Overall Study|No MRD result|0|||
163336783|NCT02521493|589942404|FG001|Overall Study|No MRD result|0|||
163336784|NCT02521493|589942405|FG002|Overall Study|No MRD result|4|||
163336785|NCT02008916|589942406|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
163336786|NCT02008916|589942407|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
163336787|NCT02008916|589942408|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
163336788|NCT02008916|589942406|FG000|Week 16 - 156|Adverse Event|4|||
163336789|NCT02008916|589942407|FG001|Week 16 - 156|Adverse Event|2|||
163336790|NCT02008916|589942408|FG002|Week 16 - 156|Adverse Event|3|||
163336791|NCT02008916|589942406|FG000|Week 16 - 156|Withdrawal by Subject|7|||
163336792|NCT02008916|589942407|FG001|Week 16 - 156|Withdrawal by Subject|3|||
163336793|NCT02008916|589942408|FG002|Week 16 - 156|Withdrawal by Subject|5|||
163336794|NCT02008916|589942406|FG000|Week 16 - 156|No longer requires treatment|0|||
163336795|NCT02008916|589942407|FG001|Week 16 - 156|No longer requires treatment|1|||
163336796|NCT02008916|589942408|FG002|Week 16 - 156|No longer requires treatment|0|||
163336797|NCT02008916|589942406|FG000|Week 16 - 156|Lost to Follow-up|5|||
163336798|NCT02008916|589942407|FG001|Week 16 - 156|Lost to Follow-up|0|||
163336799|NCT02008916|589942408|FG002|Week 16 - 156|Lost to Follow-up|0|||
163336800|NCT02008916|589942406|FG000|Week 16 - 156|Lack of Efficacy|3|||
163336801|NCT02008916|589942407|FG001|Week 16 - 156|Lack of Efficacy|5|||
163336802|NCT02008916|589942408|FG002|Week 16 - 156|Lack of Efficacy|2|||
163336803|NCT02008916|589942406|FG000|Week 16 - 156|Pregnancy|0|||
163336804|NCT02008916|589942407|FG001|Week 16 - 156|Pregnancy|1|||
163336805|NCT02008916|589942408|FG002|Week 16 - 156|Pregnancy|0|||
163336806|NCT02008916|589942406|FG000|Week 16 - 156|Physician Decision|0|||
163336807|NCT02008916|589942407|FG001|Week 16 - 156|Physician Decision|1|||
163091630|NCT01082614|589046588|FG001|Overall Study|Physician Decision|0|||
163091631|NCT00950651|589046592|FG000|Overall Study|Adverse Event|17|||
163091632|NCT00950651|589046593|FG001|Overall Study|Adverse Event|20|||
163091633|NCT00950651|589046592|FG000|Overall Study|Death|1|||
163091634|NCT00950651|589046593|FG001|Overall Study|Death|0|||
163091635|NCT00950651|589046592|FG000|Overall Study|Lack of Efficacy|2|||
163091636|NCT00950651|589046593|FG001|Overall Study|Lack of Efficacy|2|||
163091637|NCT00950651|589046592|FG000|Overall Study|Protocol Violation|3|||
163091638|NCT00950651|589046593|FG001|Overall Study|Protocol Violation|4|||
163091639|NCT00950651|589046592|FG000|Overall Study|Withdrawal by Subject|8|||
163091640|NCT00950651|589046593|FG001|Overall Study|Withdrawal by Subject|9|||
163091641|NCT03783780|589046598|FG000|Overall Study|Withdrawn prior to completion|1|||
163336808|NCT02008916|589942408|FG002|Week 16 - 156|Physician Decision|0|||
163336809|NCT01880736|589942409|FG000|Overall Study|Adverse Event|0|||
163336810|NCT01880736|589942410|FG001|Overall Study|Adverse Event|0|||
163336811|NCT01880736|589942411|FG002|Overall Study|Adverse Event|0|||
163336812|NCT01880736|589942412|FG003|Overall Study|Adverse Event|1|||
163336813|NCT01880736|589942409|FG000|Overall Study|Withdrawal Criteria|1|||
163336814|NCT01880736|589942410|FG001|Overall Study|Withdrawal Criteria|2|||
163336815|NCT01880736|589942411|FG002|Overall Study|Withdrawal Criteria|1|||
163336816|NCT01880736|589942412|FG003|Overall Study|Withdrawal Criteria|5|||
163336817|NCT01915914|589942416|FG000|Acute Phase|Withdrawal by Subject|4|||
163091642|NCT03768427|589046599|FG000|Overall Study|Death|0|||
163091643|NCT03768427|589046600|FG001|Overall Study|Death|0|||
163091644|NCT03768427|589046601|FG002|Overall Study|Death|1|||
163091645|NCT03768427|589046602|FG003|Overall Study|Death|0|||
163336818|NCT01915914|589942417|FG001|Acute Phase|Withdrawal by Subject|0|||
163336819|NCT01915914|589942418|FG002|Acute Phase|Withdrawal by Subject|0|||
163336820|NCT01915914|589942419|FG003|Acute Phase|Withdrawal by Subject|0|||
163336821|NCT01915914|589942416|FG000|Acute Phase|Lost to Follow-up|4|||
163336822|NCT01915914|589942417|FG001|Acute Phase|Lost to Follow-up|0|||
163336823|NCT01915914|589942418|FG002|Acute Phase|Lost to Follow-up|0|||
163091646|NCT03768427|589046599|FG000|Overall Study|Lost to Follow-up|2|||
163091647|NCT03768427|589046600|FG001|Overall Study|Lost to Follow-up|0|||
163336824|NCT01915914|589942419|FG003|Acute Phase|Lost to Follow-up|0|||
163336825|NCT01915914|589942416|FG000|Acute Phase|Physician Decision|1|||
163336826|NCT01915914|589942417|FG001|Acute Phase|Physician Decision|0|||
163336827|NCT01915914|589942418|FG002|Acute Phase|Physician Decision|0|||
163336828|NCT01915914|589942419|FG003|Acute Phase|Physician Decision|0|||
163091648|NCT03768427|589046601|FG002|Overall Study|Lost to Follow-up|0|||
163091649|NCT03768427|589046602|FG003|Overall Study|Lost to Follow-up|0|||
163091650|NCT03768427|589046599|FG000|Overall Study|Physician Decision|3|||
163091651|NCT03768427|589046600|FG001|Overall Study|Physician Decision|2|||
163091652|NCT03768427|589046601|FG002|Overall Study|Physician Decision|4|||
163091653|NCT03768427|589046602|FG003|Overall Study|Physician Decision|4|||
163091654|NCT03768427|589046599|FG000|Overall Study|Withdrawal by Subject|7|||
163091655|NCT03768427|589046600|FG001|Overall Study|Withdrawal by Subject|2|||
163336829|NCT01915914|589942416|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
163336830|NCT01915914|589942417|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
163336831|NCT01915914|589942418|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
163336832|NCT01915914|589942419|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
163091656|NCT03768427|589046601|FG002|Overall Study|Withdrawal by Subject|6|||
163091657|NCT03768427|589046602|FG003|Overall Study|Withdrawal by Subject|7|||
163091658|NCT03710889|589046605|FG000|Overall Study|Adverse Event|2|||
163091659|NCT03710889|589046605|FG000|Overall Study|Protocol Deviation|1|||
163091660|NCT00659425|589046607|FG000|Overall Study|Disease progression|1|||
163091661|NCT00659425|589046608|FG001|Overall Study|Disease progression|0|||
163091662|NCT00659425|589046609|FG002|Overall Study|Disease progression|0|||
163091663|NCT00659425|589046610|FG003|Overall Study|Disease progression|1|||
163091664|NCT00659425|589046611|FG004|Overall Study|Disease progression|0|||
163091665|NCT00659425|589046612|FG005|Overall Study|Disease progression|2|||
163091666|NCT00659425|589046613|FG006|Overall Study|Disease progression|4|||
163091667|NCT00659425|589046614|FG007|Overall Study|Disease progression|3|||
163336833|NCT01915914|589942416|FG000|Acute Phase|"Not Achieved treatment success"|1|||
163336834|NCT01915914|589942417|FG001|Acute Phase|"Not Achieved treatment success"|0|||
163336835|NCT01915914|589942418|FG002|Acute Phase|"Not Achieved treatment success"|0|||
163336836|NCT01915914|589942419|FG003|Acute Phase|"Not Achieved treatment success"|0|||
163336837|NCT01915914|589942416|FG000|Acute Phase|Missing|1|||
163336838|NCT01915914|589942417|FG001|Acute Phase|Missing|0|||
163091668|NCT00659425|589046615|FG008|Overall Study|Disease progression|5|||
163091669|NCT00659425|589046616|FG009|Overall Study|Disease progression|3|||
163091670|NCT00659425|589046607|FG000|Overall Study|Death|0|||
163091671|NCT00659425|589046608|FG001|Overall Study|Death|0|||
163091672|NCT00659425|589046609|FG002|Overall Study|Death|0|||
163091673|NCT00659425|589046610|FG003|Overall Study|Death|1|||
163336839|NCT01915914|589942418|FG002|Acute Phase|Missing|0|||
163091674|NCT00659425|589046611|FG004|Overall Study|Death|0|||
163091675|NCT00659425|589046612|FG005|Overall Study|Death|0|||
163091676|NCT00659425|589046613|FG006|Overall Study|Death|1|||
163091677|NCT00659425|589046614|FG007|Overall Study|Death|0|||
163336840|NCT01915914|589942419|FG003|Acute Phase|Missing|0|||
163336841|NCT01915914|589942416|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163336842|NCT01915914|589942417|FG001|Maintenance Phase|Withdrawal by Subject|1|||
163336843|NCT01915914|589942418|FG002|Maintenance Phase|Withdrawal by Subject|1|||
163336844|NCT01915914|589942419|FG003|Maintenance Phase|Withdrawal by Subject|0|||
163336845|NCT01915914|589942416|FG000|Maintenance Phase|Lost to Follow-up|0|||
163336846|NCT01915914|589942417|FG001|Maintenance Phase|Lost to Follow-up|4|||
163336847|NCT01915914|589942418|FG002|Maintenance Phase|Lost to Follow-up|1|||
163336848|NCT01915914|589942419|FG003|Maintenance Phase|Lost to Follow-up|0|||
163336849|NCT01915914|589942416|FG000|Maintenance Phase|Missing|0|||
163336850|NCT01915914|589942417|FG001|Maintenance Phase|Missing|1|||
163336851|NCT01915914|589942418|FG002|Maintenance Phase|Missing|0|||
163336852|NCT01915914|589942419|FG003|Maintenance Phase|Missing|0|||
163336853|NCT01915914|589942416|FG000|Follow-up Phase|Withdrawal by Subject|0|||
163336854|NCT01915914|589942417|FG001|Follow-up Phase|Withdrawal by Subject|0|||
163336855|NCT01915914|589942418|FG002|Follow-up Phase|Withdrawal by Subject|0|||
163336856|NCT01915914|589942419|FG003|Follow-up Phase|Withdrawal by Subject|1|||
163336857|NCT01915914|589942416|FG000|Follow-up Phase|Physician Decision|0|||
163336858|NCT01915914|589942417|FG001|Follow-up Phase|Physician Decision|0|||
163336859|NCT01915914|589942418|FG002|Follow-up Phase|Physician Decision|0|||
163336860|NCT01915914|589942419|FG003|Follow-up Phase|Physician Decision|1|||
163336861|NCT00428714|589942421|FG000|Overall Study|Progressive Disease|28|||
163336862|NCT00428714|589942422|FG001|Overall Study|Progressive Disease|36|||
163336863|NCT00428714|589942421|FG000|Overall Study|Withdrawal by Subject|0|||
163336864|NCT00428714|589942422|FG001|Overall Study|Withdrawal by Subject|3|||
163336865|NCT00428714|589942421|FG000|Overall Study|Adverse Event|0|||
163336866|NCT00428714|589942422|FG001|Overall Study|Adverse Event|2|||
163336867|NCT00428714|589942421|FG000|Overall Study|Physician Decision|1|||
163336868|NCT00428714|589942422|FG001|Overall Study|Physician Decision|1|||
163336869|NCT00428714|589942421|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
163336870|NCT00428714|589942422|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
163336871|NCT00428714|589942421|FG000|Overall Study|Death due to other then PD|1|||
163336872|NCT00428714|589942422|FG001|Overall Study|Death due to other then PD|0|||
163336873|NCT00513071|589942424|FG000|Overall Study|Adverse Event|1|||
163336874|NCT00513071|589942424|FG000|Overall Study|Withdrawal by Subject|1|||
163336875|NCT00513071|589942424|FG000|Overall Study|Physician Decision|3|||
163336876|NCT02106325|589942427|FG000|Phase 1|Lost to Follow-up|2|||
163336877|NCT02106325|589942428|FG001|Phase 1|Lost to Follow-up|2|||
163336878|NCT02106325|589942427|FG000|Phase 2|Lost to Follow-up|2|||
163336879|NCT02106325|589942428|FG001|Phase 2|Lost to Follow-up|3|||
163336880|NCT02106325|589942427|FG000|Phase 3|Lost to Follow-up|2|||
163336881|NCT02106325|589942428|FG001|Phase 3|Lost to Follow-up|1|||
163336882|NCT00452114|589942430|FG000|Overall Study|Physician Decision|3|||
163336883|NCT00452114|589942431|FG001|Overall Study|Physician Decision|3|||
163336884|NCT03242863|589942432|FG000|Study Week 1|Withdrawal by Subject|0|||
163336885|NCT03242863|589942433|FG001|Study Week 1|Withdrawal by Subject|1|||
163336886|NCT03242863|589942434|FG002|Study Week 1|Withdrawal by Subject|0|||
163336887|NCT03242863|589942435|FG003|Study Week 1|Withdrawal by Subject|0|||
163336888|NCT03242863|589942436|FG004|Study Week 1|Withdrawal by Subject|3|||
163336889|NCT03242863|589942437|FG005|Study Week 1|Withdrawal by Subject|0|||
163336890|NCT04602728|589942442|FG000|Overall Study|Lost to Follow-up|4|||
163336891|NCT04602728|589942443|FG001|Overall Study|Lost to Follow-up|4|||
163336892|NCT05338476|589942448|FG000|Period 2|Adverse Event|0|||
163336893|NCT05338476|589942449|FG001|Period 2|Adverse Event|1|||
163336894|NCT02831049|589942452|FG000|Overall Study|Lost to Follow-up|0|||
163336895|NCT02831049|589942453|FG001|Overall Study|Lost to Follow-up|0|||
163336896|NCT02831049|589942454|FG002|Overall Study|Lost to Follow-up|1|||
163336897|NCT02831049|589942452|FG000|Overall Study|Withdrawal by Subject|0|||
163336898|NCT02831049|589942453|FG001|Overall Study|Withdrawal by Subject|1|||
163336899|NCT02831049|589942454|FG002|Overall Study|Withdrawal by Subject|1|||
163336900|NCT02831049|589942452|FG000|Overall Study|Pandemic shutdown|1|||
163336901|NCT02831049|589942453|FG001|Overall Study|Pandemic shutdown|0|||
163336902|NCT02831049|589942454|FG002|Overall Study|Pandemic shutdown|0|||
163336903|NCT00747149|589943500|FG000|Overall Study|Adverse Event|0|||
163336904|NCT00747149|589943501|FG001|Overall Study|Adverse Event|15|||
163336905|NCT00747149|589943500|FG000|Overall Study|Lost to Follow-up|0|||
163336906|NCT00747149|589943501|FG001|Overall Study|Lost to Follow-up|10|||
163336907|NCT00747149|589943500|FG000|Overall Study|Withdrawal by Subject|0|||
163336908|NCT00747149|589943501|FG001|Overall Study|Withdrawal by Subject|6|||
163336909|NCT00747149|589943500|FG000|Overall Study|Did not receive treatment|0|||
163336910|NCT00747149|589943501|FG001|Overall Study|Did not receive treatment|1|||
163407497|NCT03548558|590200838|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
163336911|NCT00747149|589943500|FG000|Overall Study|Incorrect enrollment|0|||
163336912|NCT00747149|589943501|FG001|Overall Study|Incorrect enrollment|6|||
163336913|NCT00747149|589943500|FG000|Overall Study|Severe non-compliance to protocol|0|||
163336914|NCT00747149|589943501|FG001|Overall Study|Severe non-compliance to protocol|1|||
163336915|NCT00747149|589943500|FG000|Overall Study|Not reported|1|||
163336916|NCT00747149|589943501|FG001|Overall Study|Not reported|4|||
163336917|NCT03141177|589943504|FG000|Overall Study|Death|62|||
163407498|NCT03548558|590200832|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
163407499|NCT03548558|590200833|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
163407500|NCT03548558|590200834|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
163407501|NCT03548558|590200835|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
163407502|NCT03548558|590200836|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
163407503|NCT03548558|590200837|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
163407504|NCT03548558|590200838|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
163407505|NCT03548558|590200832|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
163407506|NCT03548558|590200833|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
163407507|NCT03548558|590200834|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
163407508|NCT03548558|590200835|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
163407509|NCT03548558|590200836|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
163407510|NCT03548558|590200837|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
163407511|NCT03548558|590200838|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
163407512|NCT01709149|590200846|FG000|Open-label Lead-in Phase|Adverse Event|109|||
163407513|NCT01709149|590200847|FG001|Open-label Lead-in Phase|Adverse Event|0|||
163407514|NCT01709149|590200848|FG002|Open-label Lead-in Phase|Adverse Event|0|||
163407515|NCT01709149|590200846|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
163407516|NCT01709149|590200847|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
163407517|NCT01709149|590200848|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
163407518|NCT01709149|590200846|FG000|Open-label Lead-in Phase|Death|1|||
163407519|NCT01709149|590200847|FG001|Open-label Lead-in Phase|Death|0|||
163407520|NCT01709149|590200848|FG002|Open-label Lead-in Phase|Death|0|||
163407521|NCT01709149|590200846|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
163407522|NCT01709149|590200847|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
163407523|NCT01709149|590200848|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
163407524|NCT01709149|590200846|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
163407525|NCT01709149|590200847|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
163407526|NCT01709149|590200848|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
163407527|NCT01709149|590200846|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
163407528|NCT01709149|590200847|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
163407529|NCT01709149|590200848|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
163407530|NCT01709149|590200846|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
163407531|NCT01709149|590200847|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
163407532|NCT01709149|590200848|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
163407533|NCT01709149|590200846|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
163407534|NCT01709149|590200847|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
163407535|NCT01709149|590200848|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
163407536|NCT01709149|590200846|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
163407537|NCT01709149|590200847|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
163407538|NCT01709149|590200848|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
163407539|NCT01709149|590200846|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
163407540|NCT01709149|590200847|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
163407541|NCT01709149|590200848|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
163407542|NCT03509350|590200849|FG000|Overall Study|Withdrawal by Subject|0|||
163407543|NCT03509350|590200850|FG001|Overall Study|Withdrawal by Subject|2|||
163407544|NCT00763815|590200851|FG000|Overall Study|Adverse Event|14|||
163407545|NCT00763815|590200852|FG001|Overall Study|Adverse Event|29|||
163336918|NCT03141177|589943505|FG001|Overall Study|Death|13|||
163336919|NCT03141177|589943506|FG002|Overall Study|Death|84|||
163336920|NCT03141177|589943504|FG000|Overall Study|Participant withdrew consent|9|||
163336921|NCT03141177|589943505|FG001|Overall Study|Participant withdrew consent|2|||
163336922|NCT03141177|589943506|FG002|Overall Study|Participant withdrew consent|13|||
163336923|NCT03141177|589943504|FG000|Overall Study|Not reported|1|||
163336924|NCT03141177|589943505|FG001|Overall Study|Not reported|0|||
163336925|NCT03141177|589943506|FG002|Overall Study|Not reported|1|||
163336926|NCT03141177|589943504|FG000|Overall Study|Lost to Follow-up|2|||
163407546|NCT00763815|590200851|FG000|Overall Study|Lack of Efficacy|10|||
163407547|NCT00763815|590200852|FG001|Overall Study|Lack of Efficacy|11|||
163407548|NCT00763815|590200851|FG000|Overall Study|Poor Compliance to Protocol|6|||
163407549|NCT00763815|590200852|FG001|Overall Study|Poor Compliance to Protocol|6|||
163407550|NCT00763815|590200851|FG000|Overall Study|Lost to Follow-up|2|||
163091678|NCT00659425|589046615|FG008|Overall Study|Death|0|||
163336927|NCT03141177|589943505|FG001|Overall Study|Lost to Follow-up|1|||
163336928|NCT03141177|589943506|FG002|Overall Study|Lost to Follow-up|1|||
163336929|NCT03141177|589943504|FG000|Overall Study|Other reasons|4|||
163336930|NCT03141177|589943505|FG001|Overall Study|Other reasons|0|||
163091679|NCT00659425|589046616|FG009|Overall Study|Death|0|||
163336931|NCT03141177|589943506|FG002|Overall Study|Other reasons|11|||
163336932|NCT03141177|589943504|FG000|Overall Study|Participants did not start treatment period|3|||
163091680|NCT00659425|589046607|FG000|Overall Study|Adverse Event|0|||
163091681|NCT00659425|589046608|FG001|Overall Study|Adverse Event|0|||
163091682|NCT00659425|589046609|FG002|Overall Study|Adverse Event|0|||
163091683|NCT00659425|589046610|FG003|Overall Study|Adverse Event|0|||
163091684|NCT00659425|589046611|FG004|Overall Study|Adverse Event|0|||
163091685|NCT00659425|589046612|FG005|Overall Study|Adverse Event|1|||
163091686|NCT00659425|589046613|FG006|Overall Study|Adverse Event|0|||
163091687|NCT00659425|589046614|FG007|Overall Study|Adverse Event|3|||
163091688|NCT00659425|589046615|FG008|Overall Study|Adverse Event|1|||
163091689|NCT00659425|589046616|FG009|Overall Study|Adverse Event|4|||
163091690|NCT00659425|589046607|FG000|Overall Study|Investigator Discretion|0|||
163091691|NCT00659425|589046608|FG001|Overall Study|Investigator Discretion|0|||
163091692|NCT00659425|589046609|FG002|Overall Study|Investigator Discretion|0|||
163091693|NCT00659425|589046610|FG003|Overall Study|Investigator Discretion|0|||
163091694|NCT00659425|589046611|FG004|Overall Study|Investigator Discretion|0|||
163091695|NCT00659425|589046612|FG005|Overall Study|Investigator Discretion|1|||
163091696|NCT00659425|589046613|FG006|Overall Study|Investigator Discretion|0|||
163091697|NCT00659425|589046614|FG007|Overall Study|Investigator Discretion|3|||
163091698|NCT00659425|589046615|FG008|Overall Study|Investigator Discretion|0|||
163091699|NCT00659425|589046616|FG009|Overall Study|Investigator Discretion|0|||
163091700|NCT00659425|589046607|FG000|Overall Study|Other|0|||
163091701|NCT00659425|589046608|FG001|Overall Study|Other|1|||
163091702|NCT00659425|589046609|FG002|Overall Study|Other|1|||
163091703|NCT00659425|589046610|FG003|Overall Study|Other|2|||
163091704|NCT00659425|589046611|FG004|Overall Study|Other|4|||
163091705|NCT00659425|589046612|FG005|Overall Study|Other|0|||
163091706|NCT00659425|589046613|FG006|Overall Study|Other|3|||
163091707|NCT00659425|589046614|FG007|Overall Study|Other|2|||
163091708|NCT00659425|589046615|FG008|Overall Study|Other|0|||
163091709|NCT00659425|589046616|FG009|Overall Study|Other|6|||
163091710|NCT02121509|589046617|FG000|Washout Period (35 Days)|Adverse Event|1|||
163091711|NCT02121509|589046618|FG001|Washout Period (35 Days)|Adverse Event|1|||
163091712|NCT02121509|589046619|FG002|Washout Period (35 Days)|Adverse Event|0|||
163091713|NCT02121509|589046620|FG003|Washout Period (35 Days)|Adverse Event|0|||
163091714|NCT02121509|589046617|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
163091715|NCT02121509|589046618|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
163091716|NCT02121509|589046619|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
163091717|NCT02121509|589046620|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
163091718|NCT02121509|589046617|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
163091719|NCT02121509|589046618|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
163091720|NCT02121509|589046619|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
163091721|NCT02121509|589046620|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
163091722|NCT00636181|589046623|FG000|Overall Study|Withdrawal by Subject|8|||
163091723|NCT00636181|589046624|FG001|Overall Study|Withdrawal by Subject|6|||
163091724|NCT00636181|589046625|FG002|Overall Study|Withdrawal by Subject|10|||
163091725|NCT02993263|589046626|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
163091726|NCT00542178|589046627|FG000|Overall Study|did not complete year 4 follow-up|75|||
163091727|NCT00542178|589046628|FG001|Overall Study|did not complete year 4 follow-up|80|||
163091728|NCT00542178|589046629|FG002|Overall Study|did not complete year 4 follow-up|74|||
163091729|NCT00542178|589046630|FG003|Overall Study|did not complete year 4 follow-up|62|||
163091730|NCT00542178|589046631|FG004|Overall Study|did not complete year 4 follow-up|64|||
163091731|NCT00542178|589046632|FG005|Overall Study|did not complete year 4 follow-up|89|||
163091732|NCT00542178|589046633|FG006|Overall Study|did not complete year 4 follow-up|87|||
163091733|NCT00542178|589046634|FG007|Overall Study|did not complete year 4 follow-up|85|||
163091734|NCT00829998|589046635|FG000|Washout|Adverse Event|0|||
163091735|NCT00829998|589046636|FG001|Washout|Adverse Event|1|||
163091736|NCT01173679|589048341|FG000|Overall Study|Death|1|||
163091737|NCT01250054|589048342|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
163091738|NCT01250054|589048343|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
163091739|NCT02026011|589048344|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
163091740|NCT02026011|589048345|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
163091741|NCT02026011|589048344|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
163091742|NCT02026011|589048345|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
163091743|NCT02026011|589048344|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
163091744|NCT02026011|589048345|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
163091745|NCT02026011|589048344|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
163091746|NCT02026011|589048345|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
163091747|NCT01770743|589048346|FG000|Overall Study|Adverse Event|1|||
163091748|NCT01770743|589048347|FG001|Overall Study|Adverse Event|0|||
163091749|NCT01770743|589048348|FG002|Overall Study|Adverse Event|0|||
163091750|NCT01770743|589048349|FG003|Overall Study|Adverse Event|0|||
163091751|NCT01770743|589048350|FG004|Overall Study|Adverse Event|0|||
163091752|NCT01770743|589048346|FG000|Overall Study|Withdrawal by Subject|0|||
163091753|NCT01770743|589048347|FG001|Overall Study|Withdrawal by Subject|0|||
163091754|NCT01770743|589048348|FG002|Overall Study|Withdrawal by Subject|1|||
163091755|NCT01770743|589048349|FG003|Overall Study|Withdrawal by Subject|1|||
163091756|NCT01770743|589048350|FG004|Overall Study|Withdrawal by Subject|1|||
163091757|NCT01770743|589048346|FG000|Overall Study|Lost to Follow-up|0|||
163091758|NCT01770743|589048347|FG001|Overall Study|Lost to Follow-up|2|||
163091759|NCT01770743|589048348|FG002|Overall Study|Lost to Follow-up|0|||
163091760|NCT01770743|589048349|FG003|Overall Study|Lost to Follow-up|0|||
163091761|NCT01770743|589048350|FG004|Overall Study|Lost to Follow-up|1|||
163091762|NCT01770743|589048346|FG000|Overall Study|Sponsor Terminated Subject|1|||
163091763|NCT01770743|589048347|FG001|Overall Study|Sponsor Terminated Subject|0|||
163091764|NCT01770743|589048348|FG002|Overall Study|Sponsor Terminated Subject|0|||
163091765|NCT01770743|589048349|FG003|Overall Study|Sponsor Terminated Subject|1|||
163091766|NCT01770743|589048350|FG004|Overall Study|Sponsor Terminated Subject|0|||
163091767|NCT01770743|589048346|FG000|Overall Study|Moving Out of State|0|||
163091768|NCT01770743|589048347|FG001|Overall Study|Moving Out of State|1|||
163091769|NCT01770743|589048348|FG002|Overall Study|Moving Out of State|0|||
163091770|NCT01770743|589048349|FG003|Overall Study|Moving Out of State|0|||
163091771|NCT01770743|589048350|FG004|Overall Study|Moving Out of State|0|||
163091772|NCT00939107|589048353|FG000|Overall Study|Lost to Follow-up|14|||
163091773|NCT00939107|589048354|FG001|Overall Study|Lost to Follow-up|12|||
163091774|NCT05010070|589048355|FG000|Overall Study|Lost to Follow-up|1|||
163091775|NCT05010070|589048355|FG000|Overall Study|Withdrawal by Subject|1|||
163091776|NCT00441272|589048357|FG000|Overall Study|Study terminated prior to enrollment|25|||
163091777|NCT00441272|589048358|FG001|Overall Study|Study terminated prior to enrollment|25|||
163091778|NCT00427011|589048359|FG000|Overall Study|Adverse Event|10|||
163091779|NCT00427011|589048359|FG000|Overall Study|Withdrawal by Subject|1|||
163091780|NCT00427011|589048359|FG000|Overall Study|Lack of Efficacy|2|||
163091781|NCT00427011|589048359|FG000|Overall Study|Other|12|||
163091782|NCT00952705|589048360|FG000|Overall Study|Lost to Follow-up|24|||
163091783|NCT00952705|589048361|FG001|Overall Study|Lost to Follow-up|8|||
163091784|NCT00952705|589048362|FG002|Overall Study|Lost to Follow-up|9|||
163091785|NCT00952705|589048360|FG000|Overall Study|Withdrawal by Subject|2|||
163091786|NCT00952705|589048361|FG001|Overall Study|Withdrawal by Subject|1|||
163091787|NCT00952705|589048362|FG002|Overall Study|Withdrawal by Subject|1|||
163091788|NCT00952705|589048360|FG000|Overall Study|Death|2|||
163091789|NCT00952705|589048361|FG001|Overall Study|Death|0|||
163091790|NCT00952705|589048362|FG002|Overall Study|Death|0|||
163091791|NCT00952705|589048360|FG000|Overall Study|Incarcerated post dose|5|||
163091792|NCT00952705|589048361|FG001|Overall Study|Incarcerated post dose|0|||
163091793|NCT00952705|589048362|FG002|Overall Study|Incarcerated post dose|0|||
163091794|NCT00952705|589048360|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
163091795|NCT00952705|589048361|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
163091796|NCT00952705|589048362|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
163091797|NCT02921789|589048363|FG000|Overall Study|Adverse Event|0|||
163091798|NCT02921789|589048364|FG001|Overall Study|Adverse Event|1|||
163091799|NCT02921789|589048363|FG000|Overall Study|Lost to Follow-up|1|||
163091800|NCT02921789|589048364|FG001|Overall Study|Lost to Follow-up|0|||
163091801|NCT02921789|589048363|FG000|Overall Study|Protocol Deviation|2|||
163091802|NCT02921789|589048364|FG001|Overall Study|Protocol Deviation|0|||
163091803|NCT02921789|589048363|FG000|Overall Study|Withdrawal by Subject|2|||
163091804|NCT02921789|589048364|FG001|Overall Study|Withdrawal by Subject|1|||
163091805|NCT02921789|589048363|FG000|Overall Study|Miscellaneous|3|||
163091806|NCT02921789|589048364|FG001|Overall Study|Miscellaneous|2|||
163091807|NCT01944020|589048365|FG000|Overall Study|Withdrawal by Subject|5|||
163091808|NCT01944020|589048366|FG001|Overall Study|Withdrawal by Subject|0|||
163091809|NCT01669902|589048367|FG000|Overall Study|Adverse Event|11|||
163091810|NCT01669902|589048367|FG000|Overall Study|Lack of Efficacy|10|||
163336933|NCT03141177|589943505|FG001|Overall Study|Participants did not start treatment period|0|||
163336934|NCT03141177|589943506|FG002|Overall Study|Participants did not start treatment period|8|||
163336935|NCT00092456|589943509|FG000|Overall Study|Adverse Event|0|||
163336936|NCT00092456|589943510|FG001|Overall Study|Adverse Event|0|||
163336937|NCT00092456|589943511|FG002|Overall Study|Adverse Event|1|||
163336938|NCT00092456|589943512|FG003|Overall Study|Adverse Event|1|||
163336939|NCT00092456|589943509|FG000|Overall Study|Lost to Follow-up|2|||
163091811|NCT01669902|589048367|FG000|Overall Study|Other|8|||
163091812|NCT02391311|589048370|FG000|Overall Study|Lost to Follow-up|2|||
163091813|NCT02391311|589048371|FG001|Overall Study|Lost to Follow-up|1|||
163336940|NCT00092456|589943510|FG001|Overall Study|Lost to Follow-up|2|||
163091814|NCT02391311|589048370|FG000|Overall Study|deemed ineligible after baseline|1|||
163091815|NCT02391311|589048371|FG001|Overall Study|deemed ineligible after baseline|1|||
163091816|NCT02808897|589048374|FG000|Overall Study|Lost to Follow-up|9|||
163091817|NCT02808897|589048375|FG001|Overall Study|Lost to Follow-up|11|||
163091818|NCT00305448|589048376|FG000|Overall Study|Protocol Violation|0|||
163091819|NCT00305448|589048377|FG001|Overall Study|Protocol Violation|1|||
163091820|NCT00305448|589048378|FG002|Overall Study|Protocol Violation|0|||
163336941|NCT00092456|589943511|FG002|Overall Study|Lost to Follow-up|1|||
163091821|NCT00305448|589048376|FG000|Overall Study|Withdrawal by Subject|2|||
163091822|NCT00305448|589048377|FG001|Overall Study|Withdrawal by Subject|0|||
163091823|NCT00305448|589048378|FG002|Overall Study|Withdrawal by Subject|1|||
163336942|NCT00092456|589943512|FG003|Overall Study|Lost to Follow-up|2|||
163336943|NCT00092456|589943509|FG000|Overall Study|Protocol Violation|5|||
163336944|NCT00092456|589943510|FG001|Overall Study|Protocol Violation|7|||
163336945|NCT00092456|589943511|FG002|Overall Study|Protocol Violation|8|||
163336946|NCT00092456|589943512|FG003|Overall Study|Protocol Violation|6|||
163336947|NCT00092456|589943509|FG000|Overall Study|Withdrawal by Subject|13|||
163336948|NCT00092456|589943510|FG001|Overall Study|Withdrawal by Subject|5|||
163336949|NCT00092456|589943511|FG002|Overall Study|Withdrawal by Subject|16|||
163336950|NCT00092456|589943512|FG003|Overall Study|Withdrawal by Subject|6|||
163336951|NCT00092456|589943509|FG000|Overall Study|Moved|1|||
163336952|NCT00092456|589943510|FG001|Overall Study|Moved|1|||
163336953|NCT00092456|589943511|FG002|Overall Study|Moved|0|||
163336954|NCT00092456|589943512|FG003|Overall Study|Moved|1|||
163336955|NCT00092456|589943509|FG000|Overall Study|Other|4|||
163336956|NCT00092456|589943510|FG001|Overall Study|Other|2|||
163336957|NCT00092456|589943511|FG002|Overall Study|Other|3|||
163336958|NCT00092456|589943512|FG003|Overall Study|Other|0|||
163336959|NCT00215943|589943513|FG000|Overall Study|Disease Progression|3|||
163336960|NCT00215943|589943514|FG001|Overall Study|Disease Progression|5|||
163336961|NCT00215943|589943513|FG000|Overall Study|Alternate therapy|0|||
163336962|NCT00215943|589943514|FG001|Overall Study|Alternate therapy|1|||
163336963|NCT00215943|589943513|FG000|Overall Study|Adverse Event|3|||
163336964|NCT00215943|589943514|FG001|Overall Study|Adverse Event|6|||
163336965|NCT00215943|589943513|FG000|Overall Study|Other disease|0|||
163336966|NCT00215943|589943514|FG001|Overall Study|Other disease|1|||
163336967|NCT00215943|589943513|FG000|Overall Study|Other complications|3|||
163336968|NCT00215943|589943514|FG001|Overall Study|Other complications|1|||
163336969|NCT00443820|589943515|FG000|Overall Study|Adverse Event|1|||
163336970|NCT00443820|589943516|FG001|Overall Study|Adverse Event|1|||
163336971|NCT00443820|589943517|FG002|Overall Study|Adverse Event|0|||
163336972|NCT00443820|589943518|FG003|Overall Study|Adverse Event|0|||
163336973|NCT00443820|589943515|FG000|Overall Study|Lack of Efficacy|3|||
163336974|NCT00443820|589943516|FG001|Overall Study|Lack of Efficacy|2|||
163336975|NCT00443820|589943517|FG002|Overall Study|Lack of Efficacy|1|||
163336976|NCT00443820|589943518|FG003|Overall Study|Lack of Efficacy|1|||
163336977|NCT00443820|589943515|FG000|Overall Study|Protocol Violation|2|||
163336978|NCT00443820|589943516|FG001|Overall Study|Protocol Violation|1|||
163336979|NCT00443820|589943517|FG002|Overall Study|Protocol Violation|2|||
163336980|NCT00443820|589943518|FG003|Overall Study|Protocol Violation|1|||
163336981|NCT00443820|589943515|FG000|Overall Study|Withdrawal by Subject|6|||
163336982|NCT00443820|589943516|FG001|Overall Study|Withdrawal by Subject|7|||
163336983|NCT00443820|589943517|FG002|Overall Study|Withdrawal by Subject|8|||
163336984|NCT00443820|589943518|FG003|Overall Study|Withdrawal by Subject|9|||
163091824|NCT00305448|589048376|FG000|Overall Study|Adverse Event|1|||
163091825|NCT00305448|589048377|FG001|Overall Study|Adverse Event|0|||
163091826|NCT00305448|589048378|FG002|Overall Study|Adverse Event|1|||
163091827|NCT00305448|589048376|FG000|Overall Study|Disease Progression|27|||
163091828|NCT00305448|589048377|FG001|Overall Study|Disease Progression|31|||
163091829|NCT00305448|589048378|FG002|Overall Study|Disease Progression|28|||
163091830|NCT00305448|589048376|FG000|Overall Study|Subjective Disease Progression|1|||
163091831|NCT00305448|589048377|FG001|Overall Study|Subjective Disease Progression|2|||
163091832|NCT00305448|589048378|FG002|Overall Study|Subjective Disease Progression|2|||
163091833|NCT00305448|589048376|FG000|Overall Study|Tumor Marker Elevation|0|||
163091834|NCT00305448|589048377|FG001|Overall Study|Tumor Marker Elevation|0|||
163091835|NCT00305448|589048378|FG002|Overall Study|Tumor Marker Elevation|1|||
163091836|NCT00002766|589048379|FG000|Overall Study|Withdrawal by Subject|0|||
163091837|NCT00002766|589048380|FG001|Overall Study|Withdrawal by Subject|1|||
163336985|NCT00443820|589943515|FG000|Overall Study|Lost to Follow-up|9|||
163091838|NCT00002766|589048379|FG000|Overall Study|Patient Not Treated|1|||
163336986|NCT00443820|589943516|FG001|Overall Study|Lost to Follow-up|8|||
163336987|NCT00443820|589943517|FG002|Overall Study|Lost to Follow-up|6|||
163336988|NCT00443820|589943518|FG003|Overall Study|Lost to Follow-up|5|||
163336989|NCT00443820|589943515|FG000|Overall Study|Administrative problems|0|||
163336990|NCT00443820|589943516|FG001|Overall Study|Administrative problems|0|||
163336991|NCT00443820|589943517|FG002|Overall Study|Administrative problems|0|||
163336992|NCT00443820|589943518|FG003|Overall Study|Administrative problems|1|||
163336993|NCT00443820|589943515|FG000|Overall Study|Death|0|||
163091839|NCT00002766|589048380|FG001|Overall Study|Patient Not Treated|2|||
163091840|NCT00002766|589048379|FG000|Overall Study|Adverse Event|1|||
163336994|NCT00443820|589943516|FG001|Overall Study|Death|0|||
163336995|NCT00443820|589943517|FG002|Overall Study|Death|1|||
163336996|NCT00443820|589943518|FG003|Overall Study|Death|0|||
163336997|NCT02121808|589943519|FG000|Overall Study|Technical problem|3|||
163407551|NCT00763815|590200852|FG001|Overall Study|Lost to Follow-up|4|||
163091841|NCT00002766|589048380|FG001|Overall Study|Adverse Event|1|||
163336998|NCT01304940|589943521|FG000|Overall Study|not meet symptom severity requirement|3|||
163336999|NCT01304940|589943522|FG001|Overall Study|not meet symptom severity requirement|0|||
163337000|NCT00304278|589943523|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
163337001|NCT00304278|589943523|FG000|Overall Study|PT had medical condition preventing TX|1|||
163407552|NCT00763815|590200851|FG000|Overall Study|Early Termination|1|||
163038531|NCT00482170|588848760|FG000|Overall Study|Lost to Follow-up|2|||
163038532|NCT00482170|588848761|FG001|Overall Study|Lost to Follow-up|0|||
163038533|NCT00482170|588848760|FG000|Overall Study|Unspecified reason|0|||
163038534|NCT00482170|588848761|FG001|Overall Study|Unspecified reason|2|||
163038535|NCT00592592|588848764|FG000|Overall Study|Patient found ineligible upon chart review|1|||
163038536|NCT01134263|588848765|FG000|Overall Study|Serious adverse event|2|||
163038537|NCT01134263|588848766|FG001|Overall Study|Serious adverse event|1|||
163091842|NCT00002766|589048379|FG000|Overall Study|Protocol Violation|1|||
163337002|NCT02065895|589943526|FG000|Overall Study|Protocol Violation|1|||
163337003|NCT02065895|589943527|FG001|Overall Study|Protocol Violation|0|||
163337004|NCT02065895|589943528|FG002|Overall Study|Protocol Violation|0|||
163337005|NCT02065895|589943529|FG003|Overall Study|Protocol Violation|1|||
163337006|NCT02065895|589943530|FG004|Overall Study|Protocol Violation|0|||
163337007|NCT02065895|589943531|FG005|Overall Study|Protocol Violation|0|||
163337008|NCT02065895|589943526|FG000|Overall Study|Scheduling conflicts|0|||
163337009|NCT02065895|589943527|FG001|Overall Study|Scheduling conflicts|1|||
163337010|NCT02065895|589943528|FG002|Overall Study|Scheduling conflicts|0|||
163337011|NCT02065895|589943529|FG003|Overall Study|Scheduling conflicts|0|||
163337012|NCT02065895|589943530|FG004|Overall Study|Scheduling conflicts|0|||
163337013|NCT02065895|589943531|FG005|Overall Study|Scheduling conflicts|0|||
163337014|NCT03740737|589943532|FG000|Overall Study|Protocol deviation|13|||
163337015|NCT03740737|589943533|FG001|Overall Study|Protocol deviation|0|||
163337016|NCT03740737|589943532|FG000|Overall Study|Adverse Event|2|||
163337017|NCT03740737|589943533|FG001|Overall Study|Adverse Event|0|||
163337018|NCT03740737|589943532|FG000|Overall Study|Lost to Follow-up|1|||
163337019|NCT03740737|589943533|FG001|Overall Study|Lost to Follow-up|0|||
163337020|NCT03740737|589943532|FG000|Overall Study|Randomization failure|1|||
163337021|NCT03740737|589943533|FG001|Overall Study|Randomization failure|0|||
163337022|NCT03740737|589943532|FG000|Overall Study|Participant withdrew consent|1|||
163337023|NCT03740737|589943533|FG001|Overall Study|Participant withdrew consent|0|||
163337024|NCT03740737|589943532|FG000|Overall Study|Participant withdrew from trial|2|||
163337025|NCT03740737|589943533|FG001|Overall Study|Participant withdrew from trial|1|||
163337026|NCT00507429|589943534|FG000|Treatment Phase|Disease Progression|12|||
163337027|NCT00507429|589943535|FG001|Treatment Phase|Disease Progression|5|||
163038538|NCT01134263|588848767|FG002|Overall Study|Serious adverse event|1|||
163091843|NCT00002766|589048380|FG001|Overall Study|Protocol Violation|0|||
163091844|NCT04108273|589048391|FG000|Overall Study|COVID Pandemic|1|||
163091845|NCT04108273|589048392|FG001|Overall Study|COVID Pandemic|0|||
163091846|NCT02441218|589048393|FG000|Overall Study|Death|503|||
163091847|NCT02441218|589048394|FG001|Overall Study|Death|553|||
163337028|NCT00507429|589943534|FG000|Treatment Phase|Adverse Event|12|||
163337029|NCT00507429|589943535|FG001|Treatment Phase|Adverse Event|5|||
163337030|NCT00507429|589943534|FG000|Treatment Phase|Withdrawal by Subject|3|||
163337031|NCT00507429|589943535|FG001|Treatment Phase|Withdrawal by Subject|3|||
163337032|NCT00507429|589943534|FG000|Treatment Phase|Physician Decision|4|||
163337033|NCT00507429|589943535|FG001|Treatment Phase|Physician Decision|2|||
163337034|NCT00507429|589943534|FG000|Treatment Phase|Other|6|||
163337035|NCT00507429|589943535|FG001|Treatment Phase|Other|3|||
163337036|NCT00507429|589943534|FG000|Maintenance Phase|Progressive Disease|14|||
163337037|NCT00507429|589943535|FG001|Maintenance Phase|Progressive Disease|0|||
163337038|NCT03137784|589943537|FG000|Overall Study|Adverse Event|1|||
163337039|NCT03137784|589943538|FG001|Overall Study|Adverse Event|1|||
163337040|NCT03137784|589943539|FG002|Overall Study|Adverse Event|0|||
163337041|NCT03137784|589943540|FG003|Overall Study|Adverse Event|0|||
163337042|NCT03137784|589943541|FG004|Overall Study|Adverse Event|0|||
163337043|NCT03137784|589943542|FG005|Overall Study|Adverse Event|0|||
163337044|NCT03137784|589943537|FG000|Overall Study|Subject/guardian decision|1|||
163038539|NCT01134263|588848768|FG003|Overall Study|Serious adverse event|1|||
163337045|NCT03137784|589943538|FG001|Overall Study|Subject/guardian decision|0|||
163337046|NCT03137784|589943539|FG002|Overall Study|Subject/guardian decision|0|||
163337047|NCT03137784|589943540|FG003|Overall Study|Subject/guardian decision|0|||
163337048|NCT03137784|589943541|FG004|Overall Study|Subject/guardian decision|0|||
163038540|NCT01134263|588848769|FG004|Overall Study|Serious adverse event|1|||
163038541|NCT01134263|588848765|FG000|Overall Study|Other adverse event|1|||
163038542|NCT01134263|588848766|FG001|Overall Study|Other adverse event|2|||
163038543|NCT01134263|588848767|FG002|Overall Study|Other adverse event|5|||
163038544|NCT01134263|588848768|FG003|Overall Study|Other adverse event|3|||
163038545|NCT01134263|588848769|FG004|Overall Study|Other adverse event|0|||
163038546|NCT01134263|588848765|FG000|Overall Study|Protocol Violation|8|||
163038547|NCT01134263|588848766|FG001|Overall Study|Protocol Violation|7|||
163038548|NCT01134263|588848767|FG002|Overall Study|Protocol Violation|2|||
163038549|NCT01134263|588848768|FG003|Overall Study|Protocol Violation|4|||
163038550|NCT01134263|588848769|FG004|Overall Study|Protocol Violation|2|||
163038551|NCT01134263|588848765|FG000|Overall Study|Lost to Follow-up|4|||
163038552|NCT01134263|588848766|FG001|Overall Study|Lost to Follow-up|3|||
163038553|NCT01134263|588848767|FG002|Overall Study|Lost to Follow-up|5|||
163038554|NCT01134263|588848768|FG003|Overall Study|Lost to Follow-up|3|||
163407553|NCT00763815|590200852|FG001|Overall Study|Early Termination|0|||
163407554|NCT00763815|590200851|FG000|Overall Study|Familial and Personal Reasons|9|||
163407555|NCT00763815|590200852|FG001|Overall Study|Familial and Personal Reasons|16|||
163407556|NCT00763815|590200851|FG000|Overall Study|Physician Decision|1|||
163407557|NCT00763815|590200852|FG001|Overall Study|Physician Decision|0|||
163407558|NCT00763815|590200851|FG000|Overall Study|Withdrawal by Subject|7|||
163407559|NCT00763815|590200852|FG001|Overall Study|Withdrawal by Subject|12|||
163407560|NCT00763815|590200851|FG000|Overall Study|Protocol Violation|2|||
163407561|NCT00763815|590200852|FG001|Overall Study|Protocol Violation|5|||
163407562|NCT00763815|590200851|FG000|Overall Study|Sponsor's Decision|0|||
163407563|NCT00763815|590200852|FG001|Overall Study|Sponsor's Decision|1|||
163407564|NCT04951037|590200853|FG000|Overall Study|Lost to Follow-up|16|||
163407565|NCT04951037|590200853|FG000|Overall Study|Withdrawal by Subject|5|||
163407566|NCT04951037|590200853|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
163407567|NCT05630937|590200854|FG000|Overall Study|Study terminated by sponsor|1|||
163407568|NCT05630937|590200855|FG001|Overall Study|Study terminated by sponsor|1|||
163407569|NCT05630937|590200856|FG002|Overall Study|Study terminated by sponsor|8|||
163407570|NCT05630937|590200857|FG003|Overall Study|Study terminated by sponsor|0|||
163407571|NCT05630937|590200854|FG000|Overall Study|Lost to Follow-up|0|||
163407572|NCT05630937|590200855|FG001|Overall Study|Lost to Follow-up|0|||
163407573|NCT05630937|590200856|FG002|Overall Study|Lost to Follow-up|1|||
163407574|NCT05630937|590200857|FG003|Overall Study|Lost to Follow-up|0|||
163407575|NCT05630937|590200854|FG000|Overall Study|Enrolled but not treated|0|||
163407576|NCT05630937|590200855|FG001|Overall Study|Enrolled but not treated|0|||
163407577|NCT05630937|590200856|FG002|Overall Study|Enrolled but not treated|0|||
163407578|NCT05630937|590200857|FG003|Overall Study|Enrolled but not treated|1|||
163407579|NCT02429414|590200858|FG000|Overall Study|Physician Decision|0|||
163407580|NCT02429414|590200859|FG001|Overall Study|Physician Decision|1|||
163407581|NCT03245450|590200860|FG000|Overall Study|Radiological disease progression|3|||
163407582|NCT03245450|590200861|FG001|Overall Study|Radiological disease progression|3|||
163407583|NCT03245450|590200862|FG002|Overall Study|Radiological disease progression|2|||
163407584|NCT03245450|590200863|FG003|Overall Study|Radiological disease progression|2|||
163407585|NCT03245450|590200864|FG004|Overall Study|Radiological disease progression|7|||
163407586|NCT03245450|590200865|FG005|Overall Study|Radiological disease progression|6|||
163407587|NCT03245450|590200866|FG006|Overall Study|Radiological disease progression|6|||
163407588|NCT03245450|590200860|FG000|Overall Study|Clinical disease progression|0|||
163407589|NCT03245450|590200861|FG001|Overall Study|Clinical disease progression|0|||
163407590|NCT03245450|590200862|FG002|Overall Study|Clinical disease progression|1|||
163407591|NCT03245450|590200863|FG003|Overall Study|Clinical disease progression|0|||
163407592|NCT03245450|590200864|FG004|Overall Study|Clinical disease progression|0|||
163407593|NCT03245450|590200865|FG005|Overall Study|Clinical disease progression|2|||
163038555|NCT01134263|588848769|FG004|Overall Study|Lost to Follow-up|1|||
163038556|NCT01134263|588848765|FG000|Overall Study|Withdrawal by Subject|8|||
163038557|NCT01134263|588848766|FG001|Overall Study|Withdrawal by Subject|6|||
163038558|NCT01134263|588848767|FG002|Overall Study|Withdrawal by Subject|16|||
163038559|NCT01134263|588848768|FG003|Overall Study|Withdrawal by Subject|7|||
163038560|NCT01134263|588848769|FG004|Overall Study|Withdrawal by Subject|5|||
163038561|NCT01134263|588848765|FG000|Overall Study|Enrolled, but not treated|1|||
163038562|NCT01134263|588848766|FG001|Overall Study|Enrolled, but not treated|1|||
163038563|NCT01134263|588848767|FG002|Overall Study|Enrolled, but not treated|0|||
163038564|NCT01134263|588848768|FG003|Overall Study|Enrolled, but not treated|1|||
163038565|NCT01134263|588848769|FG004|Overall Study|Enrolled, but not treated|0|||
163038566|NCT01557517|588848770|FG000|Overall Study|Death|1|||
163038567|NCT01557517|588848771|FG001|Overall Study|Death|0|||
163038568|NCT01557517|588848770|FG000|Overall Study|Refused further treatment|0|||
163038569|NCT01557517|588848771|FG001|Overall Study|Refused further treatment|2|||
163038570|NCT01557517|588848770|FG000|Overall Study|Adverse Event|0|||
163038571|NCT01557517|588848771|FG001|Overall Study|Adverse Event|2|||
163038572|NCT01557517|588848770|FG000|Overall Study|Pt declined before treatment started|1|||
163038573|NCT01557517|588848771|FG001|Overall Study|Pt declined before treatment started|0|||
163038574|NCT00770913|588848772|FG000|Overall Study|Adverse Event|1|||
163038575|NCT00770913|588848773|FG001|Overall Study|Adverse Event|3|||
163038576|NCT00770913|588848774|FG002|Overall Study|Adverse Event|6|||
163038577|NCT00770913|588848772|FG000|Overall Study|Refusal to continue participation|6|||
163038578|NCT00770913|588848773|FG001|Overall Study|Refusal to continue participation|4|||
163038579|NCT00770913|588848774|FG002|Overall Study|Refusal to continue participation|5|||
163038580|NCT00770913|588848772|FG000|Overall Study|Physician Decision|0|||
163038581|NCT00770913|588848773|FG001|Overall Study|Physician Decision|1|||
163038582|NCT00770913|588848774|FG002|Overall Study|Physician Decision|1|||
163038583|NCT00770913|588848772|FG000|Overall Study|Protocol Violation|3|||
163038584|NCT00770913|588848773|FG001|Overall Study|Protocol Violation|0|||
163038585|NCT00770913|588848774|FG002|Overall Study|Protocol Violation|1|||
163038586|NCT00770913|588848772|FG000|Overall Study|Incorrect drug was allocated|1|||
163038587|NCT00770913|588848773|FG001|Overall Study|Incorrect drug was allocated|0|||
163038588|NCT00770913|588848774|FG002|Overall Study|Incorrect drug was allocated|0|||
163038589|NCT02347072|588848775|FG000|Overall Study|Adverse Event|2|||
163091848|NCT02441218|589048393|FG000|Overall Study|Withdrawal by Subject|73|||
163091849|NCT02441218|589048394|FG001|Overall Study|Withdrawal by Subject|58|||
163091850|NCT02441218|589048393|FG000|Overall Study|Lost to Follow-up|2|||
163091851|NCT02441218|589048394|FG001|Overall Study|Lost to Follow-up|1|||
163091852|NCT01541371|589048395|FG000|Overall Study|Withdrawal by Subject|14|||
163091853|NCT01541371|589048395|FG000|Overall Study|Lost to Follow-up|21|||
163091854|NCT01541371|589048395|FG000|Overall Study|Adverse Event|15|||
163091855|NCT01541371|589048395|FG000|Overall Study|Lack of Efficacy|12|||
163091856|NCT01541371|589048395|FG000|Overall Study|Protocol Violation|6|||
163337049|NCT03137784|589943542|FG005|Overall Study|Subject/guardian decision|0|||
163337050|NCT03137784|589943537|FG000|Overall Study|Non-compliance with study treatment|0|||
163337051|NCT03137784|589943538|FG001|Overall Study|Non-compliance with study treatment|0|||
163337052|NCT03137784|589943539|FG002|Overall Study|Non-compliance with study treatment|0|||
163337053|NCT03137784|589943540|FG003|Overall Study|Non-compliance with study treatment|0|||
163337054|NCT03137784|589943541|FG004|Overall Study|Non-compliance with study treatment|1|||
163337055|NCT03137784|589943542|FG005|Overall Study|Non-compliance with study treatment|0|||
163337056|NCT04803734|589943545|FG000|Overall Study|Withdrawal by Subject|0|||
163337057|NCT04803734|589943546|FG001|Overall Study|Withdrawal by Subject|1|||
163337058|NCT04803734|589943545|FG000|Overall Study|Protocol Violation|0|||
163337059|NCT04803734|589943546|FG001|Overall Study|Protocol Violation|1|||
163337060|NCT01799993|589943560|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
163337061|NCT01799993|589943561|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
163337062|NCT01799993|589943560|FG000|Overall Study|Death|61|||
163337063|NCT01799993|589943561|FG001|Overall Study|Death|45|||
163337064|NCT01799993|589943560|FG000|Overall Study|Withdrawal by Subject|23|||
163337065|NCT01799993|589943561|FG001|Overall Study|Withdrawal by Subject|24|||
163337066|NCT01799993|589943560|FG000|Overall Study|Lost to Follow-up|5|||
163337067|NCT01799993|589943561|FG001|Overall Study|Lost to Follow-up|8|||
163091857|NCT01541371|589048395|FG000|Overall Study|Study medication non-compliance|3|||
163091858|NCT01541371|589048395|FG000|Overall Study|Other|6|||
163091859|NCT02154061|589048396|FG000|Overall Study|Pregnancy|1|||
163091860|NCT02154061|589048397|FG001|Overall Study|Pregnancy|0|||
163091861|NCT02154061|589048396|FG000|Overall Study|enrolled but not vaccinated|1|||
163091862|NCT02154061|589048397|FG001|Overall Study|enrolled but not vaccinated|0|||
163091863|NCT01936831|589048398|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091864|NCT01936831|589048399|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091865|NCT01936831|589048400|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091866|NCT01936831|589048401|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091867|NCT01936831|589048402|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091868|NCT01936831|589048403|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
163091869|NCT01936831|589048404|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091870|NCT01936831|589048405|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091871|NCT01936831|589048406|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091872|NCT03848416|589048412|FG000|Overall Study|Withdrawal by Subject|1|||
163091873|NCT03848416|589048413|FG001|Overall Study|Withdrawal by Subject|0|||
163091874|NCT03848416|589048414|FG002|Overall Study|Withdrawal by Subject|0|||
163091875|NCT03848416|589048412|FG000|Overall Study|Death|0|||
163091876|NCT03848416|589048413|FG001|Overall Study|Death|0|||
163091877|NCT03848416|589048414|FG002|Overall Study|Death|1|||
163091878|NCT02808429|589048415|FG000|Overall Study|Lost to Follow-up|1|||
163091879|NCT02808429|589048416|FG001|Overall Study|Lost to Follow-up|0|||
163091880|NCT02808429|589048417|FG002|Overall Study|Lost to Follow-up|0|||
163091881|NCT02808429|589048415|FG000|Overall Study|Protocol Violation|0|||
163091882|NCT02808429|589048416|FG001|Overall Study|Protocol Violation|1|||
163091883|NCT02808429|589048417|FG002|Overall Study|Protocol Violation|0|||
163091884|NCT02808429|589048415|FG000|Overall Study|Premature study termination by sponsor|2|||
163091885|NCT02808429|589048416|FG001|Overall Study|Premature study termination by sponsor|0|||
163091886|NCT02808429|589048417|FG002|Overall Study|Premature study termination by sponsor|1|||
163091887|NCT02808429|589048415|FG000|Overall Study|Relocation|0|||
163091888|NCT02808429|589048416|FG001|Overall Study|Relocation|0|||
163337068|NCT01799993|589943560|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
163337069|NCT01799993|589943561|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
163337070|NCT01799993|589943560|FG000|Overall Study|Protocol driven decision point|0|||
163337071|NCT01799993|589943561|FG001|Overall Study|Protocol driven decision point|3|||
163337072|NCT01799993|589943560|FG000|Overall Study|Protocol Violation|1|||
163091889|NCT02808429|589048417|FG002|Overall Study|Relocation|1|||
163091890|NCT01436110|589048418|FG000|Overall Study|Lack of Efficacy|23|||
163091891|NCT01436110|589048419|FG001|Overall Study|Lack of Efficacy|14|||
163091892|NCT01436110|589048420|FG002|Overall Study|Lack of Efficacy|9|||
163091893|NCT01436110|589048418|FG000|Overall Study|Withdrawal by Subject|6|||
163091894|NCT01436110|589048419|FG001|Overall Study|Withdrawal by Subject|8|||
163091895|NCT01436110|589048420|FG002|Overall Study|Withdrawal by Subject|4|||
163091896|NCT01436110|589048418|FG000|Overall Study|Adverse Event|2|||
163337073|NCT01799993|589943561|FG001|Overall Study|Protocol Violation|1|||
163091897|NCT01436110|589048419|FG001|Overall Study|Adverse Event|1|||
163337074|NCT01799993|589943560|FG000|Overall Study|Deterioration of general conditions|2|||
163091898|NCT01436110|589048420|FG002|Overall Study|Adverse Event|2|||
163091899|NCT01436110|589048418|FG000|Overall Study|Physician Decision|3|||
163091900|NCT01436110|589048419|FG001|Overall Study|Physician Decision|1|||
163091901|NCT01436110|589048420|FG002|Overall Study|Physician Decision|1|||
163091902|NCT01436110|589048418|FG000|Overall Study|Lost to Follow-up|1|||
163091903|NCT01436110|589048419|FG001|Overall Study|Lost to Follow-up|1|||
163091904|NCT01436110|589048420|FG002|Overall Study|Lost to Follow-up|3|||
163091905|NCT01436110|589048418|FG000|Overall Study|Protocol Violation|3|||
163091906|NCT01436110|589048419|FG001|Overall Study|Protocol Violation|1|||
163091907|NCT01436110|589048420|FG002|Overall Study|Protocol Violation|1|||
163091908|NCT01436110|589048418|FG000|Overall Study|Did Not Receive Trial Medication|1|||
163091909|NCT01436110|589048419|FG001|Overall Study|Did Not Receive Trial Medication|0|||
163091910|NCT01436110|589048420|FG002|Overall Study|Did Not Receive Trial Medication|3|||
163091911|NCT01088503|589048422|FG000|Overall Study|Withdrawal by Subject|118|||
163091912|NCT01088503|589048423|FG001|Overall Study|Withdrawal by Subject|327|||
163091913|NCT01088503|589048424|FG002|Overall Study|Withdrawal by Subject|10|||
163091914|NCT01088503|589048422|FG000|Overall Study|Death|64|||
163091915|NCT01088503|589048423|FG001|Overall Study|Death|358|||
163091916|NCT01088503|589048424|FG002|Overall Study|Death|7|||
163091917|NCT01847092|589048425|FG000|Overall Study|Adverse Event|12|||
163091918|NCT01847092|589048426|FG001|Overall Study|Adverse Event|3|||
163091919|NCT01847092|589048425|FG000|Overall Study|Withdrawal by Subject|5|||
163091920|NCT01847092|589048426|FG001|Overall Study|Withdrawal by Subject|5|||
163091921|NCT01847092|589048425|FG000|Overall Study|Protocol Specified|8|||
163091922|NCT01847092|589048426|FG001|Overall Study|Protocol Specified|0|||
163091923|NCT01847092|589048425|FG000|Overall Study|Physician Decision|1|||
163091924|NCT01847092|589048426|FG001|Overall Study|Physician Decision|1|||
163091925|NCT01847092|589048425|FG000|Overall Study|Protocol Violation|0|||
163091926|NCT01847092|589048426|FG001|Overall Study|Protocol Violation|2|||
163091927|NCT01664247|589048430|FG000|Overall Study|Adverse Event|5|||
163091928|NCT01664247|589048431|FG001|Overall Study|Adverse Event|3|||
163091929|NCT01664247|589048430|FG000|Overall Study|Protocol Violation|3|||
163091930|NCT01664247|589048431|FG001|Overall Study|Protocol Violation|5|||
163091931|NCT01664247|589048430|FG000|Overall Study|Withdrawal Criteria|1|||
163091932|NCT01664247|589048431|FG001|Overall Study|Withdrawal Criteria|4|||
163091933|NCT01664247|589048430|FG000|Overall Study|Unclassified|5|||
163091934|NCT01664247|589048431|FG001|Overall Study|Unclassified|29|||
163091935|NCT01000506|589048432|FG000|Overall Study|Adverse Event|6|||
163091936|NCT01000506|589048433|FG001|Overall Study|Adverse Event|5|||
163091937|NCT01000506|589048434|FG002|Overall Study|Adverse Event|8|||
163220092|NCT02039674|589521410|FG004|Overall Study|Death|0|||
163220093|NCT02039674|589521411|FG005|Overall Study|Death|0|||
163220094|NCT02039674|589521412|FG006|Overall Study|Death|1|||
163220095|NCT02039674|589521413|FG007|Overall Study|Death|0|||
163220096|NCT02039674|589521414|FG008|Overall Study|Death|2|||
163220097|NCT02039674|589521415|FG009|Overall Study|Death|0|||
163220098|NCT02039674|589521416|FG010|Overall Study|Death|1|||
163220099|NCT02039674|589521417|FG011|Overall Study|Death|3|||
163220100|NCT02039674|589521418|FG012|Overall Study|Death|2|||
163220101|NCT02039674|589521419|FG013|Overall Study|Death|8|||
163220102|NCT02039674|589521406|FG000|Overall Study|Excluded Medication|1|||
163337075|NCT01799993|589943561|FG001|Overall Study|Deterioration of general conditions|0|||
163337076|NCT01799993|589943560|FG000|Overall Study|Screen failure|0|||
163337077|NCT01799993|589943561|FG001|Overall Study|Screen failure|1|||
163337078|NCT01799993|589943560|FG000|Overall Study|Adverse Event|1|||
163337079|NCT01799993|589943561|FG001|Overall Study|Adverse Event|0|||
163337080|NCT01799993|589943560|FG000|Overall Study|Lack of Efficacy|1|||
163337081|NCT01799993|589943561|FG001|Overall Study|Lack of Efficacy|0|||
163337082|NCT01799993|589943560|FG000|Overall Study|Recovery|0|||
163337083|NCT01799993|589943561|FG001|Overall Study|Recovery|1|||
163337084|NCT01799993|589943560|FG000|Overall Study|Logistical difficulties|1|||
163337085|NCT01799993|589943561|FG001|Overall Study|Logistical difficulties|0|||
163337086|NCT01799993|589943560|FG000|Overall Study|Protocol deviation|1|||
163337087|NCT01799993|589943561|FG001|Overall Study|Protocol deviation|0|||
163337088|NCT01799993|589943560|FG000|Overall Study|Non-compliance with medical device|1|||
163337089|NCT01799993|589943561|FG001|Overall Study|Non-compliance with medical device|0|||
163337090|NCT01799993|589943560|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163337091|NCT01799993|589943561|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163337092|NCT01799993|589943560|FG000|Overall Study|Other|1|||
163337093|NCT01799993|589943561|FG001|Overall Study|Other|0|||
163091938|NCT01000506|589048435|FG003|Overall Study|Adverse Event|9|||
163091939|NCT01000506|589048432|FG000|Overall Study|Lack of Efficacy|8|||
163091940|NCT01000506|589048433|FG001|Overall Study|Lack of Efficacy|6|||
163091941|NCT01000506|589048434|FG002|Overall Study|Lack of Efficacy|4|||
163091942|NCT01000506|589048435|FG003|Overall Study|Lack of Efficacy|4|||
163220103|NCT02039674|589521407|FG001|Overall Study|Excluded Medication|1|||
163220104|NCT02039674|589521408|FG002|Overall Study|Excluded Medication|0|||
163220105|NCT02039674|589521409|FG003|Overall Study|Excluded Medication|1|||
163220106|NCT02039674|589521410|FG004|Overall Study|Excluded Medication|0|||
163220107|NCT02039674|589521411|FG005|Overall Study|Excluded Medication|1|||
163337094|NCT01799993|589943560|FG000|Overall Study|Subject didn't return for follow-up|0|||
163038590|NCT02347072|588848775|FG000|Overall Study|Withdrawal by Subject|6|||
163038591|NCT02347072|588848775|FG000|Overall Study|Physician Decision|1|||
163038592|NCT02347072|588848775|FG000|Overall Study|Lost to Follow-up|2|||
163038593|NCT02347072|588848775|FG000|Overall Study|Protocol Violation|1|||
163038594|NCT02347072|588848775|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
163038595|NCT01134393|588848780|FG000|Overall Study|Adverse Event|18|||
163038596|NCT01134393|588848780|FG000|Overall Study|Lack of Efficacy|2|||
163038597|NCT01134393|588848780|FG000|Overall Study|Protocol Violation|12|||
163038598|NCT01134393|588848780|FG000|Overall Study|Lost to Follow-up|3|||
163038599|NCT01134393|588848780|FG000|Overall Study|Withdrawal by Subject|11|||
163038600|NCT01134393|588848780|FG000|Overall Study|Other|6|||
163038601|NCT03230838|588848783|FG000|Overall Study|Withdrawal by Subject|3|||
163038602|NCT03230838|588848784|FG001|Overall Study|Withdrawal by Subject|0|||
163038603|NCT03230838|588848783|FG000|Overall Study|Temperature excursion|1|||
163038604|NCT03230838|588848784|FG001|Overall Study|Temperature excursion|0|||
163038605|NCT00575510|588848787|FG000|Overall Study|Lost to Follow-up|4|||
163038606|NCT00575510|588848788|FG001|Overall Study|Lost to Follow-up|6|||
163038607|NCT00575510|588848789|FG002|Overall Study|Lost to Follow-up|9|||
163038608|NCT00575510|588848787|FG000|Overall Study|Withdrawal by Subject|1|||
163038609|NCT00575510|588848788|FG001|Overall Study|Withdrawal by Subject|0|||
163038610|NCT00575510|588848789|FG002|Overall Study|Withdrawal by Subject|0|||
163038611|NCT00575510|588848787|FG000|Overall Study|Clinic Called Patient|7|||
163038612|NCT00575510|588848788|FG001|Overall Study|Clinic Called Patient|7|||
163038613|NCT00575510|588848789|FG002|Overall Study|Clinic Called Patient|7|||
163038614|NCT00575510|588848787|FG000|Overall Study|Pregnancy|0|||
163038615|NCT00575510|588848788|FG001|Overall Study|Pregnancy|0|||
163038616|NCT00575510|588848789|FG002|Overall Study|Pregnancy|1|||
163038617|NCT02697734|588848790|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
163038618|NCT02697734|588848791|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
163038619|NCT02697734|588848790|FG000|Core Phase - up to Week 48|Adverse Event|1|||
163038620|NCT02697734|588848791|FG001|Core Phase - up to Week 48|Adverse Event|2|||
163038621|NCT02697734|588848790|FG000|Core Phase - up to Week 48|Physician Decision|1|||
163038622|NCT02697734|588848791|FG001|Core Phase - up to Week 48|Physician Decision|0|||
163038623|NCT02697734|588848790|FG000|Optional Extension Phase|Adverse Event|5|||
163038624|NCT02697734|588848791|FG001|Optional Extension Phase|Adverse Event|1|||
163038625|NCT02697734|588848790|FG000|Optional Extension Phase|Physician Decision|0|||
163038626|NCT02697734|588848791|FG001|Optional Extension Phase|Physician Decision|1|||
163038627|NCT02324699|588848792|FG000|Overall Study|study terminated|1|||
163038628|NCT03970200|588848793|FG000|Overall Study|Death|2|||
163038629|NCT03970200|588848794|FG001|Overall Study|Death|2|||
163038630|NCT03970200|588848795|FG002|Overall Study|Death|1|||
163038631|NCT03970200|588848793|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
163038632|NCT03970200|588848794|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
163038633|NCT03970200|588848795|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
163038634|NCT01607346|588848796|FG000|Overall Study|Adverse Event|3|||
163038635|NCT01098162|588848797|FG000|Overall Study|Adverse Event|37|||
163038636|NCT01098162|588848797|FG000|Overall Study|Lack of Efficacy|4|||
163038637|NCT01098162|588848797|FG000|Overall Study|Wish of Patient|7|||
163038638|NCT01098162|588848797|FG000|Overall Study|Lost to Follow-up|9|||
163038639|NCT01098162|588848797|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
163038640|NCT01098162|588848797|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
163038641|NCT01098162|588848797|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
163038642|NCT01098162|588848797|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
163038643|NCT01098162|588848797|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
163038644|NCT01098162|588848797|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
163038645|NCT01098162|588848797|FG000|Overall Study|Other Reason|1|||
163038646|NCT01098162|588848797|FG000|Overall Study|Reason Unknown|26|||
163038647|NCT01605825|588848798|FG000|Overall Study|Adverse Event|4|||
163038648|NCT01605825|588848799|FG001|Overall Study|Adverse Event|2|||
163038649|NCT01605825|588848798|FG000|Overall Study|Withdrawal by Subject|0|||
163038650|NCT01605825|588848799|FG001|Overall Study|Withdrawal by Subject|1|||
163038651|NCT01605825|588848798|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
163038652|NCT01605825|588848799|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
163038653|NCT01605825|588848798|FG000|Overall Study|Non-Compliance with Protocol|3|||
163038654|NCT01605825|588848799|FG001|Overall Study|Non-Compliance with Protocol|0|||
163038655|NCT00380718|588848802|FG000|Overall Study|Adverse Event|1|||
163038656|NCT00380718|588848802|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
163038657|NCT04318132|588848808|FG000|Overall Study|Protocol Violation|0|||
163038658|NCT04318132|588848809|FG001|Overall Study|Protocol Violation|0|||
163038659|NCT04318132|588848810|FG002|Overall Study|Protocol Violation|3|||
163038660|NCT04318132|588848811|FG003|Overall Study|Protocol Violation|0|||
163038661|NCT01863732|588848812|FG000|Overall Study|Adverse Event|2|||
163038662|NCT01863732|588848813|FG001|Overall Study|Adverse Event|0|||
163038663|NCT01863732|588848814|FG002|Overall Study|Adverse Event|3|||
163038664|NCT01863732|588848815|FG003|Overall Study|Adverse Event|3|||
163038665|NCT01863732|588848812|FG000|Overall Study|Lack of Efficacy|1|||
163038666|NCT01863732|588848813|FG001|Overall Study|Lack of Efficacy|0|||
163091943|NCT01000506|589048432|FG000|Overall Study|Protocol Violation|1|||
163091944|NCT01000506|589048433|FG001|Overall Study|Protocol Violation|1|||
163091945|NCT01000506|589048434|FG002|Overall Study|Protocol Violation|0|||
163091946|NCT01000506|589048435|FG003|Overall Study|Protocol Violation|0|||
163091947|NCT01000506|589048432|FG000|Overall Study|Lost to Follow-up|1|||
163091948|NCT01000506|589048433|FG001|Overall Study|Lost to Follow-up|1|||
163091949|NCT01000506|589048434|FG002|Overall Study|Lost to Follow-up|4|||
163091950|NCT01000506|589048435|FG003|Overall Study|Lost to Follow-up|0|||
163091951|NCT01000506|589048432|FG000|Overall Study|Physician Decision|1|||
163091952|NCT01000506|589048433|FG001|Overall Study|Physician Decision|3|||
163091953|NCT01000506|589048434|FG002|Overall Study|Physician Decision|3|||
163091954|NCT01000506|589048435|FG003|Overall Study|Physician Decision|3|||
163091955|NCT01000506|589048432|FG000|Overall Study|Withdrawal by Subject|11|||
163091956|NCT01000506|589048433|FG001|Overall Study|Withdrawal by Subject|8|||
163091957|NCT01000506|589048434|FG002|Overall Study|Withdrawal by Subject|2|||
163091958|NCT01000506|589048435|FG003|Overall Study|Withdrawal by Subject|7|||
163091959|NCT03064074|589048436|FG000|Overall Study|Physician Decision|0|||
163091960|NCT03064074|589048437|FG001|Overall Study|Physician Decision|0|||
163091961|NCT03064074|589048438|FG002|Overall Study|Physician Decision|0|||
163091962|NCT03064074|589048439|FG003|Overall Study|Physician Decision|1|||
163091963|NCT00269087|589048440|FG000|Overall Study|Adverse Event|20|||
163091964|NCT00269087|589048440|FG000|Overall Study|Withdrawal by Subject|1|||
163091965|NCT00269087|589048440|FG000|Overall Study|Exacerbation of COPD|13|||
163091966|NCT01188967|589048446|FG000|Overall Study|Withdrawal by Subject|1|||
163091967|NCT01188967|589048447|FG001|Overall Study|Withdrawal by Subject|1|||
163091968|NCT01188967|589048446|FG000|Overall Study|Physician Decision|1|||
163091969|NCT01188967|589048447|FG001|Overall Study|Physician Decision|1|||
163091970|NCT01188967|589048446|FG000|Overall Study|Lost to Follow-up|3|||
163091971|NCT01188967|589048447|FG001|Overall Study|Lost to Follow-up|2|||
163091972|NCT01448616|589048448|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
163091973|NCT01448616|589048449|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
163091974|NCT01448616|589048450|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
163091975|NCT01448616|589048451|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
163091976|NCT01448616|589048448|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
163091977|NCT01448616|589048449|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
163091978|NCT01448616|589048450|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
163091979|NCT01448616|589048451|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
163091980|NCT01448616|589048448|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
163091981|NCT01448616|589048449|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
163091982|NCT01448616|589048450|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
163091983|NCT01448616|589048451|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
163091984|NCT01448616|589048448|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
163091985|NCT01448616|589048449|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
163091986|NCT01448616|589048450|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
163091987|NCT01448616|589048451|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
163091988|NCT01448616|589048448|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
163091989|NCT01448616|589048449|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
163038667|NCT01863732|588848814|FG002|Overall Study|Lack of Efficacy|2|||
163038668|NCT01863732|588848815|FG003|Overall Study|Lack of Efficacy|1|||
163038669|NCT01863732|588848812|FG000|Overall Study|Lost to Follow-up|2|||
163038670|NCT01863732|588848813|FG001|Overall Study|Lost to Follow-up|2|||
163038671|NCT01863732|588848814|FG002|Overall Study|Lost to Follow-up|1|||
163038672|NCT01863732|588848815|FG003|Overall Study|Lost to Follow-up|1|||
163038673|NCT01863732|588848812|FG000|Overall Study|Physician Decision|1|||
163038674|NCT01863732|588848813|FG001|Overall Study|Physician Decision|0|||
163038675|NCT01863732|588848814|FG002|Overall Study|Physician Decision|1|||
163038676|NCT01863732|588848815|FG003|Overall Study|Physician Decision|0|||
163038677|NCT01863732|588848812|FG000|Overall Study|Pregnancy|0|||
163038678|NCT01863732|588848813|FG001|Overall Study|Pregnancy|0|||
163091990|NCT01448616|589048450|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
163091991|NCT01448616|589048451|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
163038679|NCT01863732|588848814|FG002|Overall Study|Pregnancy|0|||
163407594|NCT03245450|590200866|FG006|Overall Study|Clinical disease progression|0|||
163407595|NCT03245450|590200860|FG000|Overall Study|Other|0|||
163091992|NCT00523978|589048454|FG000|Overall Study|Withdrawal by Subject|3|||
163091993|NCT00523978|589048455|FG001|Overall Study|Withdrawal by Subject|7|||
163091994|NCT00523978|589048454|FG000|Overall Study|Screen Failures|5|||
163091995|NCT00523978|589048455|FG001|Overall Study|Screen Failures|1|||
163091996|NCT00523978|589048454|FG000|Overall Study|Death|1|||
163038680|NCT01863732|588848815|FG003|Overall Study|Pregnancy|1|||
163038681|NCT01863732|588848812|FG000|Overall Study|Technical problems|0|||
163091997|NCT00523978|589048455|FG001|Overall Study|Death|0|||
163091998|NCT01696643|589048460|FG000|Overall Study|Adverse Event|15|||
163091999|NCT01696643|589048461|FG001|Overall Study|Adverse Event|7|||
163038682|NCT01863732|588848813|FG001|Overall Study|Technical problems|1|||
163038683|NCT01863732|588848814|FG002|Overall Study|Technical problems|1|||
163038684|NCT01863732|588848815|FG003|Overall Study|Technical problems|0|||
163038685|NCT01863732|588848812|FG000|Overall Study|Subject/guardian decision|6|||
163038686|NCT01863732|588848813|FG001|Overall Study|Subject/guardian decision|9|||
163038687|NCT01863732|588848814|FG002|Overall Study|Subject/guardian decision|3|||
163038688|NCT01863732|588848815|FG003|Overall Study|Subject/guardian decision|1|||
163038689|NCT01863732|588848812|FG000|Overall Study|Death|1|||
163038690|NCT01863732|588848813|FG001|Overall Study|Death|0|||
163038691|NCT01863732|588848814|FG002|Overall Study|Death|0|||
163038692|NCT01863732|588848815|FG003|Overall Study|Death|1|||
163038693|NCT00840034|588848819|FG000|Acute Treatment Phase|Adverse Event|6|||
163038694|NCT00840034|588848820|FG001|Acute Treatment Phase|Adverse Event|8|||
163038695|NCT00840034|588848819|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
163038696|NCT00840034|588848820|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
163038697|NCT00840034|588848819|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
163038698|NCT00840034|588848820|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
163038699|NCT00840034|588848819|FG000|Acute Treatment Phase|Physician Decision|0|||
163038700|NCT00840034|588848820|FG001|Acute Treatment Phase|Physician Decision|1|||
163038701|NCT00840034|588848819|FG000|Acute Treatment Phase|Protocol Violation|2|||
163038702|NCT00840034|588848820|FG001|Acute Treatment Phase|Protocol Violation|4|||
163038703|NCT00840034|588848819|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
163038704|NCT00840034|588848820|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
163038705|NCT00840034|588848819|FG000|Taper Phase|Adverse Event|1|||
163038706|NCT00840034|588848820|FG001|Taper Phase|Adverse Event|0|||
163038707|NCT00840034|588848819|FG000|Taper Phase|Lost to Follow-up|1|||
163038708|NCT00840034|588848820|FG001|Taper Phase|Lost to Follow-up|1|||
163038709|NCT00840034|588848819|FG000|Taper Phase|Withdrawal by Subject|1|||
163038710|NCT00840034|588848820|FG001|Taper Phase|Withdrawal by Subject|1|||
163038711|NCT02839876|588848827|FG000|Overall Study|Protocol Violation|10|||
163038712|NCT02839876|588848828|FG001|Overall Study|Protocol Violation|11|||
163038713|NCT01156051|588848830|FG000|Overall Study|Lost to Follow-up|1|||
163038714|NCT01156051|588848831|FG001|Overall Study|Lost to Follow-up|0|||
163038715|NCT01156051|588848830|FG000|Overall Study|patient not compliant with protocol|0|||
163038716|NCT01156051|588848831|FG001|Overall Study|patient not compliant with protocol|1|||
163038717|NCT03816007|588848832|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
163038718|NCT03816007|588848833|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
163038719|NCT03816007|588848832|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
163038720|NCT03816007|588848833|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
163038721|NCT03816007|588848832|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
163038722|NCT03816007|588848833|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
163038723|NCT03628716|588848834|FG000|Overall Study|Adverse Event|1|||
163038724|NCT03628716|588848835|FG001|Overall Study|Adverse Event|1|||
163038725|NCT03628716|588848834|FG000|Overall Study|Death|1|||
163038726|NCT03628716|588848835|FG001|Overall Study|Death|0|||
163038727|NCT03628716|588848834|FG000|Overall Study|Lack of Efficacy|15|||
163038728|NCT03628716|588848835|FG001|Overall Study|Lack of Efficacy|20|||
163038729|NCT03628716|588848834|FG000|Overall Study|Withdrawal by Subject|1|||
163038730|NCT03628716|588848835|FG001|Overall Study|Withdrawal by Subject|2|||
163038731|NCT03628716|588848834|FG000|Overall Study|Study Terminated by Sponsor|1|||
163038732|NCT03628716|588848835|FG001|Overall Study|Study Terminated by Sponsor|0|||
163038733|NCT02179749|588848836|FG000|Overall Study|Adverse Event|0|||
163038734|NCT02179749|588848837|FG001|Overall Study|Adverse Event|0|||
163038735|NCT02179749|588848838|FG002|Overall Study|Adverse Event|1|||
163038736|NCT02179749|588848836|FG000|Overall Study|Withdrawal by Subject|0|||
163038737|NCT02179749|588848837|FG001|Overall Study|Withdrawal by Subject|0|||
163038738|NCT02179749|588848838|FG002|Overall Study|Withdrawal by Subject|1|||
163038739|NCT02620384|588848839|FG000|Overall Study|Adverse Event|2|||
163038740|NCT02620384|588848840|FG001|Overall Study|Adverse Event|1|||
163038741|NCT02620384|588848839|FG000|Overall Study|Discharged prior to 2nd dose|2|||
163038742|NCT02620384|588848840|FG001|Overall Study|Discharged prior to 2nd dose|5|||
163038743|NCT02620384|588848839|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
163038744|NCT02620384|588848840|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
163038745|NCT00094536|588848841|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
163038746|NCT00094536|588848841|FG000|Treatment and Follow-up|Adverse Event|4|||
163038747|NCT00094536|588848841|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
163038748|NCT00094536|588848841|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
163038749|NCT00094536|588848841|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
163038750|NCT00094536|588848841|FG000|Treatment and Follow-up|Subject non-compliance|9|||
163038751|NCT00094536|588848841|FG000|Treatment and Follow-up|Unable to attend visits|1|||
163038752|NCT02071082|588848842|FG000|Overall Study|Enrolled and Never Treated|1|||
163038753|NCT02071082|588848843|FG001|Overall Study|Enrolled and Never Treated|1|||
163038754|NCT02071082|588848842|FG000|Overall Study|Adverse Event|0|||
163038755|NCT02071082|588848843|FG001|Overall Study|Adverse Event|1|||
163038756|NCT02071082|588848842|FG000|Overall Study|Withdrew Consent|0|||
163038757|NCT02071082|588848843|FG001|Overall Study|Withdrew Consent|4|||
163092000|NCT01696643|589048460|FG000|Overall Study|Death|1|||
163092001|NCT01696643|589048461|FG001|Overall Study|Death|2|||
163092002|NCT01696643|589048460|FG000|Overall Study|Lack of Efficacy|3|||
163092003|NCT01696643|589048461|FG001|Overall Study|Lack of Efficacy|0|||
163092004|NCT01696643|589048460|FG000|Overall Study|Lost to Follow-up|67|||
163092005|NCT01696643|589048461|FG001|Overall Study|Lost to Follow-up|67|||
163092006|NCT01696643|589048460|FG000|Overall Study|Physician Decision|3|||
163092007|NCT01696643|589048461|FG001|Overall Study|Physician Decision|2|||
163092008|NCT01696643|589048460|FG000|Overall Study|Pregnancy|0|||
163092009|NCT01696643|589048461|FG001|Overall Study|Pregnancy|1|||
163092010|NCT01696643|589048460|FG000|Overall Study|Protocol Violation|7|||
163092011|NCT01696643|589048461|FG001|Overall Study|Protocol Violation|7|||
163092012|NCT01696643|589048460|FG000|Overall Study|Study Terminated by Sponsor|286|||
163092013|NCT01696643|589048461|FG001|Overall Study|Study Terminated by Sponsor|294|||
163092014|NCT01696643|589048460|FG000|Overall Study|Withdrawal by Subject|142|||
163092015|NCT01696643|589048461|FG001|Overall Study|Withdrawal by Subject|149|||
163092016|NCT01696643|589048460|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
163092017|NCT01696643|589048461|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
163092018|NCT01696643|589048460|FG000|Overall Study|Site Error|2|||
163092019|NCT01696643|589048461|FG001|Overall Study|Site Error|1|||
163092020|NCT01696643|589048460|FG000|Overall Study|Participant Incarcerated|0|||
163092021|NCT01696643|589048461|FG001|Overall Study|Participant Incarcerated|1|||
163092022|NCT01696643|589048460|FG000|Overall Study|Medical Monitor Decision|0|||
163092023|NCT01696643|589048461|FG001|Overall Study|Medical Monitor Decision|2|||
163092024|NCT01696643|589048460|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
163092025|NCT01696643|589048461|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
163092026|NCT02951780|589048465|FG000|Period 1|Adverse Event|0|||
163092027|NCT02951780|589048466|FG001|Period 1|Adverse Event|0|||
163092028|NCT02951780|589048467|FG002|Period 1|Adverse Event|0|||
163092029|NCT02951780|589048468|FG003|Period 1|Adverse Event|1|||
163092030|NCT02951780|589048469|FG004|Period 1|Adverse Event|0|||
163092031|NCT02951780|589048470|FG005|Period 1|Adverse Event|0|||
163092032|NCT02951780|589048471|FG006|Period 1|Adverse Event|0|||
163092033|NCT02951780|589048472|FG007|Period 1|Adverse Event|0|||
163092034|NCT02951780|589048473|FG008|Period 1|Adverse Event|0|||
163092035|NCT02951780|589048465|FG000|Period 1|Scheduling Conflicts|0|||
163092036|NCT02951780|589048466|FG001|Period 1|Scheduling Conflicts|0|||
163092037|NCT02951780|589048467|FG002|Period 1|Scheduling Conflicts|0|||
163092038|NCT02951780|589048468|FG003|Period 1|Scheduling Conflicts|0|||
163092039|NCT02951780|589048469|FG004|Period 1|Scheduling Conflicts|0|||
163092040|NCT02951780|589048470|FG005|Period 1|Scheduling Conflicts|0|||
163092041|NCT02951780|589048471|FG006|Period 1|Scheduling Conflicts|0|||
163092042|NCT02951780|589048472|FG007|Period 1|Scheduling Conflicts|1|||
163092043|NCT02951780|589048473|FG008|Period 1|Scheduling Conflicts|0|||
163092044|NCT02951780|589048465|FG000|Period 2|Scheduling Conflicts|0|||
163092045|NCT02951780|589048466|FG001|Period 2|Scheduling Conflicts|0|||
163092046|NCT02951780|589048467|FG002|Period 2|Scheduling Conflicts|0|||
163092047|NCT02951780|589048468|FG003|Period 2|Scheduling Conflicts|0|||
163092048|NCT02951780|589048469|FG004|Period 2|Scheduling Conflicts|0|||
163092049|NCT02951780|589048470|FG005|Period 2|Scheduling Conflicts|0|||
163092050|NCT02951780|589048471|FG006|Period 2|Scheduling Conflicts|0|||
163092051|NCT02951780|589048472|FG007|Period 2|Scheduling Conflicts|1|||
163092052|NCT02951780|589048473|FG008|Period 2|Scheduling Conflicts|0|||
163092053|NCT00546481|589048474|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
163092054|NCT00546481|589048475|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
163092055|NCT00546481|589048476|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
163092056|NCT00546481|589048474|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
163092057|NCT00546481|589048475|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
163092058|NCT00546481|589048476|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
163092059|NCT00546481|589048474|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
163092060|NCT00546481|589048475|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
163092061|NCT00546481|589048476|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
163092062|NCT00546481|589048474|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
163092063|NCT00546481|589048475|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
163092064|NCT00546481|589048476|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
163092065|NCT00546481|589048474|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
163092066|NCT00546481|589048475|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
163092067|NCT00546481|589048476|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
163092068|NCT00546481|589048474|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
163092069|NCT00546481|589048475|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
163092070|NCT00546481|589048476|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
163092071|NCT00546481|589048474|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
163092072|NCT00546481|589048475|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
163092073|NCT00546481|589048476|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
163092074|NCT00546481|589048474|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
163092075|NCT00546481|589048475|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
163092076|NCT00546481|589048476|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
163092077|NCT00546481|589048474|FG000|Maintenance Phase (CERA)|Other Reason|0|||
163092078|NCT00546481|589048475|FG001|Maintenance Phase (CERA)|Other Reason|0|||
163092079|NCT00546481|589048476|FG002|Maintenance Phase (CERA)|Other Reason|1|||
163092080|NCT00244621|589048477|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
163092081|NCT00244621|589048478|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
163092082|NCT00244621|589048479|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
163092083|NCT00244621|589048477|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
163092084|NCT00244621|589048478|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
163092085|NCT00244621|589048479|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
163337095|NCT01799993|589943561|FG001|Overall Study|Subject didn't return for follow-up|1|||
163337096|NCT01320683|589943562|FG000|Overall Study|Positive antibody response|1|||
163337097|NCT04361617|589943563|FG000|Overall Study|Withdrawal by Subject|0|||
163337098|NCT04361617|589943564|FG001|Overall Study|Withdrawal by Subject|1|||
163337099|NCT01263223|589943565|FG000|Period 2|Withdrawal by Subject|0|||
163337100|NCT01263223|589943566|FG001|Period 2|Withdrawal by Subject|1|||
163337101|NCT01263223|589943565|FG000|7-day Follow-up|Withdrawal by Subject|0|||
163337102|NCT01263223|589943566|FG001|7-day Follow-up|Withdrawal by Subject|1|||
163337103|NCT01263223|589943565|FG000|7-day Follow-up|Lost to Follow-up|1|||
163337104|NCT01263223|589943566|FG001|7-day Follow-up|Lost to Follow-up|0|||
163337105|NCT03695185|589943567|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
163337106|NCT03695185|589943567|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
163337107|NCT03695185|589943567|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
163337108|NCT03695185|589943567|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
163337109|NCT03695185|589943567|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
163337110|NCT03695185|589943567|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
163337111|NCT04183491|589943570|FG000|Overall Study|Withdrawal by Subject|0|||
163337112|NCT04183491|589943571|FG001|Overall Study|Withdrawal by Subject|0|||
163337113|NCT04183491|589943572|FG002|Overall Study|Withdrawal by Subject|1|||
163337114|NCT04183491|589943573|FG003|Overall Study|Withdrawal by Subject|0|||
163337115|NCT04183491|589943574|FG004|Overall Study|Withdrawal by Subject|0|||
163337116|NCT04183491|589943575|FG005|Overall Study|Withdrawal by Subject|1|||
163337117|NCT04183491|589943576|FG006|Overall Study|Withdrawal by Subject|0|||
163337118|NCT02538094|589943577|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
163337119|NCT02538094|589943578|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
163337120|NCT02538094|589943577|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
163337121|NCT02538094|589943578|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
163337122|NCT03288506|589943579|FG000|Overall Study|Withdrawal by Subject|52|||
163337123|NCT03692871|589943580|FG000|Overall Study|Death|1|||
163337124|NCT03692871|589943581|FG001|Overall Study|Death|1|||
163337125|NCT03692871|589943580|FG000|Overall Study|Lost to Follow-up|24|||
163337126|NCT03692871|589943581|FG001|Overall Study|Lost to Follow-up|9|||
163337127|NCT03692871|589943580|FG000|Overall Study|Physician Decision|22|||
163337128|NCT03692871|589943581|FG001|Overall Study|Physician Decision|7|||
163337129|NCT03692871|589943580|FG000|Overall Study|Protocol Deviation|1|||
163337130|NCT03692871|589943581|FG001|Overall Study|Protocol Deviation|0|||
163337131|NCT03692871|589943580|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
163337132|NCT03692871|589943581|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
163337133|NCT02852824|589943585|FG000|Overall Study|Withdrawal by Subject|1|||
163337134|NCT02852824|589943586|FG001|Overall Study|Withdrawal by Subject|0|||
163337135|NCT02852824|589943587|FG002|Overall Study|Withdrawal by Subject|0|||
163337136|NCT02852824|589943588|FG003|Overall Study|Withdrawal by Subject|0|||
163337137|NCT02852824|589943589|FG004|Overall Study|Withdrawal by Subject|0|||
163337138|NCT02852824|589943590|FG005|Overall Study|Withdrawal by Subject|0|||
163337139|NCT02852824|589943591|FG006|Overall Study|Withdrawal by Subject|0|||
163337140|NCT02852824|589943585|FG000|Overall Study|Adverse Event|0|||
163337141|NCT02852824|589943586|FG001|Overall Study|Adverse Event|0|||
163337142|NCT02852824|589943587|FG002|Overall Study|Adverse Event|0|||
163337143|NCT02852824|589943588|FG003|Overall Study|Adverse Event|0|||
163337144|NCT02852824|589943589|FG004|Overall Study|Adverse Event|2|||
163407596|NCT03245450|590200861|FG001|Overall Study|Other|0|||
163407597|NCT03245450|590200862|FG002|Overall Study|Other|0|||
163407598|NCT03245450|590200863|FG003|Overall Study|Other|1|||
163092086|NCT00244621|589048477|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
163337145|NCT02852824|589943590|FG005|Overall Study|Adverse Event|0|||
163092087|NCT00244621|589048478|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
163092088|NCT00244621|589048479|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
163337146|NCT02852824|589943591|FG006|Overall Study|Adverse Event|0|||
163337147|NCT01316913|589943592|FG000|Overall Study|Adverse Event|17|||
163337148|NCT01316913|589943593|FG001|Overall Study|Adverse Event|20|||
163337149|NCT01316913|589943594|FG002|Overall Study|Adverse Event|15|||
163337150|NCT01316913|589943595|FG003|Overall Study|Adverse Event|11|||
163337151|NCT01316913|589943592|FG000|Overall Study|Lack of Efficacy|22|||
163407599|NCT03245450|590200864|FG004|Overall Study|Other|1|||
163038758|NCT02071082|588848842|FG000|Overall Study|Lost to Follow-up|1|||
163038759|NCT02071082|588848843|FG001|Overall Study|Lost to Follow-up|1|||
163038760|NCT02526160|588850549|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
163038761|NCT02526160|588850550|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
163038762|NCT02526160|588850549|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
163038763|NCT02526160|588850550|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
163038764|NCT02526160|588850549|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
163038765|NCT02526160|588850550|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
163038766|NCT02526160|588850549|FG000|Open-Label Treatment Extension Period I|Death|0|||
163038767|NCT02526160|588850550|FG001|Open-Label Treatment Extension Period I|Death|1|||
163038768|NCT02526160|588850549|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
163038769|NCT02526160|588850550|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
163038770|NCT02526160|588850549|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
163038771|NCT02526160|588850550|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
163038772|NCT02526160|588850549|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
163038773|NCT02526160|588850550|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
163038774|NCT02526160|588850549|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
163038775|NCT02526160|588850550|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
163038776|NCT01775787|588850551|FG000|First 7-10 Days|Adverse Event|0|||
163038777|NCT01775787|588850552|FG001|First 7-10 Days|Adverse Event|1|||
163038778|NCT01775787|588850551|FG000|First 7-10 Days|family emergency|0|||
163038779|NCT01775787|588850552|FG001|First 7-10 Days|family emergency|1|||
163038780|NCT01775787|588850551|FG000|First 7-10 Days|time commitment|0|||
163038781|NCT01775787|588850552|FG001|First 7-10 Days|time commitment|2|||
163038782|NCT01775787|588850551|FG000|First 7-10 Days|concerns with using IV|1|||
163038783|NCT01775787|588850552|FG001|First 7-10 Days|concerns with using IV|2|||
163038784|NCT01775787|588850551|FG000|Second 7-10 Days|time commitment|0|||
163038785|NCT01775787|588850552|FG001|Second 7-10 Days|time commitment|1|||
163038786|NCT01775787|588850551|FG000|Second 7-10 Days|concerns with using IV|0|||
163038787|NCT01775787|588850552|FG001|Second 7-10 Days|concerns with using IV|1|||
163038788|NCT04076319|588850557|FG000|Overall Study|Withdrawal by Subject|2|||
163038789|NCT04076319|588850558|FG001|Overall Study|Withdrawal by Subject|0|||
163038790|NCT04076319|588850557|FG000|Overall Study|Death|1|||
163038791|NCT04076319|588850558|FG001|Overall Study|Death|0|||
163038792|NCT01054222|588850559|FG000|Overall Study|Lack of Efficacy|1|||
163038793|NCT01054222|588850559|FG000|Overall Study|Lost to Follow-up|4|||
163038794|NCT01054222|588850559|FG000|Overall Study|Withdrawal by Subject|6|||
163038795|NCT03252145|588850563|FG000|Overall Study|Withdrawal by Subject|1|||
163038796|NCT03252145|588850564|FG001|Overall Study|Withdrawal by Subject|0|||
163038797|NCT03252145|588850563|FG000|Overall Study|Complicating Disease|1|||
163038798|NCT03252145|588850564|FG001|Overall Study|Complicating Disease|2|||
163038799|NCT01763827|588850568|FG000|Overall Study|Withdrawal by Subject|1|||
163038800|NCT01763827|588850569|FG001|Overall Study|Withdrawal by Subject|0|||
163038801|NCT01763827|588850570|FG002|Overall Study|Withdrawal by Subject|0|||
163038802|NCT01763827|588850571|FG003|Overall Study|Withdrawal by Subject|0|||
163038803|NCT01763827|588850572|FG004|Overall Study|Withdrawal by Subject|2|||
163038804|NCT01763827|588850573|FG005|Overall Study|Withdrawal by Subject|0|||
163038805|NCT01763827|588850568|FG000|Overall Study|Decision by sponsor|2|||
163038806|NCT01763827|588850569|FG001|Overall Study|Decision by sponsor|0|||
163038807|NCT01763827|588850570|FG002|Overall Study|Decision by sponsor|3|||
163038808|NCT01763827|588850571|FG003|Overall Study|Decision by sponsor|0|||
163038809|NCT01763827|588850572|FG004|Overall Study|Decision by sponsor|2|||
163038810|NCT01763827|588850573|FG005|Overall Study|Decision by sponsor|1|||
163038811|NCT01763827|588850568|FG000|Overall Study|Lost to Follow-up|0|||
163038812|NCT01763827|588850569|FG001|Overall Study|Lost to Follow-up|1|||
163038813|NCT01763827|588850570|FG002|Overall Study|Lost to Follow-up|1|||
163038814|NCT01763827|588850571|FG003|Overall Study|Lost to Follow-up|1|||
163038815|NCT01763827|588850572|FG004|Overall Study|Lost to Follow-up|2|||
163038816|NCT01763827|588850573|FG005|Overall Study|Lost to Follow-up|1|||
163038817|NCT04446429|588850576|FG000|Overall Study|Lost to Follow-up|6|||
163038818|NCT04446429|588850577|FG001|Overall Study|Lost to Follow-up|0|||
163038819|NCT05205005|588850578|FG000|Overall Study|Withdrawal by Subject|1|||
163038820|NCT05205005|588850579|FG001|Overall Study|Withdrawal by Subject|0|||
163038821|NCT05205005|588850578|FG000|Overall Study|Adverse Event|1|||
163038822|NCT05205005|588850579|FG001|Overall Study|Adverse Event|0|||
163038823|NCT01869777|588850580|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
163038824|NCT01951573|588850581|FG000|Washout Period|Adverse Event|0|||
163038825|NCT01951573|588850582|FG001|Washout Period|Adverse Event|1|||
163038826|NCT04399889|588850583|FG000|Overall Study|Death|5|||
163092089|NCT00244621|589048477|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
163038827|NCT04399889|588850584|FG001|Overall Study|Death|1|||
163038828|NCT04399889|588850585|FG002|Overall Study|Death|1|||
163038829|NCT00707980|588850586|FG000|Overall Study|Adverse Event|49|||
163038830|NCT00707980|588850586|FG000|Overall Study|Lack of Efficacy|35|||
163038831|NCT00707980|588850586|FG000|Overall Study|Non-Compliance with Study Drug|28|||
163337152|NCT01316913|589943593|FG001|Overall Study|Lack of Efficacy|12|||
163337153|NCT01316913|589943594|FG002|Overall Study|Lack of Efficacy|9|||
163337154|NCT01316913|589943595|FG003|Overall Study|Lack of Efficacy|13|||
163337155|NCT01316913|589943592|FG000|Overall Study|Protocol Violation|1|||
163337156|NCT01316913|589943593|FG001|Overall Study|Protocol Violation|4|||
163337157|NCT01316913|589943594|FG002|Overall Study|Protocol Violation|4|||
163337158|NCT01316913|589943595|FG003|Overall Study|Protocol Violation|1|||
163337159|NCT01316913|589943592|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
163337160|NCT01316913|589943593|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
163337161|NCT01316913|589943594|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
163337162|NCT01316913|589943595|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
163337163|NCT01316913|589943592|FG000|Overall Study|Lost to Follow-up|0|||
163337164|NCT01316913|589943593|FG001|Overall Study|Lost to Follow-up|1|||
163337165|NCT01316913|589943594|FG002|Overall Study|Lost to Follow-up|0|||
163337166|NCT01316913|589943595|FG003|Overall Study|Lost to Follow-up|2|||
163337167|NCT01316913|589943592|FG000|Overall Study|Withdrawal by Subject|10|||
163337168|NCT01316913|589943593|FG001|Overall Study|Withdrawal by Subject|9|||
163337169|NCT01316913|589943594|FG002|Overall Study|Withdrawal by Subject|10|||
163337170|NCT01316913|589943595|FG003|Overall Study|Withdrawal by Subject|6|||
163337171|NCT01860079|589943596|FG000|Overall Study|Physician Decision|14|||
163337172|NCT01860079|589943597|FG001|Overall Study|Physician Decision|22|||
163337173|NCT02114515|589943599|FG000|Overall Study|Lost to Follow-up|52|||
163337174|NCT02114515|589943600|FG001|Overall Study|Lost to Follow-up|55|||
163337175|NCT02114515|589943599|FG000|Overall Study|Death|12|||
163337176|NCT02114515|589943600|FG001|Overall Study|Death|12|||
163337177|NCT02114515|589943599|FG000|Overall Study|Withdrawal by Subject|4|||
163337178|NCT02114515|589943600|FG001|Overall Study|Withdrawal by Subject|22|||
163337179|NCT02114515|589943599|FG000|Overall Study|Other|65|||
163337180|NCT02114515|589943600|FG001|Overall Study|Other|61|||
163337181|NCT02144285|589943601|FG000|Overall Study|Withdrawal by Subject|0|||
163337182|NCT02144285|589943602|FG001|Overall Study|Withdrawal by Subject|0|||
163337183|NCT02144285|589943603|FG002|Overall Study|Withdrawal by Subject|0|||
163337184|NCT02144285|589943604|FG003|Overall Study|Withdrawal by Subject|0|||
163337185|NCT02144285|589943605|FG004|Overall Study|Withdrawal by Subject|1|||
163337186|NCT02144285|589943606|FG005|Overall Study|Withdrawal by Subject|0|||
163337187|NCT02144285|589943607|FG006|Overall Study|Withdrawal by Subject|0|||
163337188|NCT02144285|589943608|FG007|Overall Study|Withdrawal by Subject|0|||
163337189|NCT02144285|589943609|FG008|Overall Study|Withdrawal by Subject|0|||
163337190|NCT02144285|589943610|FG009|Overall Study|Withdrawal by Subject|0|||
163337191|NCT05522777|589945303|FG000|Overall Study|Lack of Efficacy|1|||
163337192|NCT05522777|589945303|FG000|Overall Study|Withdrawal by Subject|1|||
163337193|NCT05487300|589945304|FG000|Overall Study|Withdrawal by Subject|1|||
163337194|NCT05487300|589945305|FG001|Overall Study|Withdrawal by Subject|0|||
163337195|NCT02507297|589945311|FG000|Overall Study|Withdrawal by Subject|1|||
163337196|NCT02507297|589945312|FG001|Overall Study|Withdrawal by Subject|0|||
163337197|NCT02507297|589945311|FG000|Overall Study|Lost to Follow-up|0|||
163337198|NCT02507297|589945312|FG001|Overall Study|Lost to Follow-up|1|||
163337199|NCT01562275|589945313|FG000|Stage 1|Adverse Event|0|||
163337200|NCT01562275|589945314|FG001|Stage 1|Adverse Event|0|||
163407600|NCT03245450|590200865|FG005|Overall Study|Other|1|||
163407601|NCT03245450|590200866|FG006|Overall Study|Other|1|||
163407602|NCT03245450|590200860|FG000|Overall Study|Withdrawal by Subject|0|||
163407603|NCT03245450|590200861|FG001|Overall Study|Withdrawal by Subject|1|||
163407604|NCT03245450|590200862|FG002|Overall Study|Withdrawal by Subject|0|||
163407605|NCT03245450|590200863|FG003|Overall Study|Withdrawal by Subject|0|||
163407606|NCT03245450|590200864|FG004|Overall Study|Withdrawal by Subject|0|||
163407607|NCT03245450|590200865|FG005|Overall Study|Withdrawal by Subject|0|||
163337201|NCT01562275|589945315|FG002|Stage 1|Adverse Event|0|||
163337202|NCT01562275|589945316|FG003|Stage 1|Adverse Event|1|||
163337203|NCT01562275|589945317|FG004|Stage 1|Adverse Event|1|||
163337204|NCT01562275|589945318|FG005|Stage 1|Adverse Event|0|||
163407608|NCT03245450|590200866|FG006|Overall Study|Withdrawal by Subject|0|||
163407609|NCT03245450|590200860|FG000|Overall Study|Adverse Event|0|||
163092090|NCT00244621|589048478|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
163337205|NCT01562275|589945319|FG006|Stage 1|Adverse Event|0|||
163337206|NCT01562275|589945320|FG007|Stage 1|Adverse Event|0|||
163337207|NCT01562275|589945321|FG008|Stage 1|Adverse Event|0|||
163337208|NCT01562275|589945322|FG009|Stage 1|Adverse Event|1|||
163337209|NCT01562275|589945323|FG010|Stage 1|Adverse Event|0|||
163337210|NCT01562275|589945324|FG011|Stage 1|Adverse Event|0|||
163337211|NCT01562275|589945325|FG012|Stage 1|Adverse Event|0|||
163337212|NCT01562275|589945313|FG000|Stage 1|Death|1|||
163337213|NCT01562275|589945314|FG001|Stage 1|Death|0|||
163337214|NCT01562275|589945315|FG002|Stage 1|Death|0|||
163337215|NCT01562275|589945316|FG003|Stage 1|Death|0|||
163337216|NCT01562275|589945317|FG004|Stage 1|Death|0|||
163337217|NCT01562275|589945318|FG005|Stage 1|Death|0|||
163337218|NCT01562275|589945319|FG006|Stage 1|Death|0|||
163407610|NCT03245450|590200861|FG001|Overall Study|Adverse Event|0|||
163407611|NCT03245450|590200862|FG002|Overall Study|Adverse Event|0|||
163407612|NCT03245450|590200863|FG003|Overall Study|Adverse Event|0|||
163038832|NCT00707980|588850586|FG000|Overall Study|Protocol Deviations|19|||
163038833|NCT00707980|588850586|FG000|Overall Study|Withdrawal of Consent|81|||
163038834|NCT00707980|588850586|FG000|Overall Study|Lost to Follow-up|59|||
163038835|NCT00707980|588850586|FG000|Overall Study|Other|39|||
163038836|NCT01152996|588850587|FG000|Overall Study|Withdrawal by Subject|142|||
163038837|NCT01152996|588850587|FG000|Overall Study|Adverse Event|115|||
163038838|NCT01152996|588850587|FG000|Overall Study|Lost to Follow-up|112|||
163038839|NCT01152996|588850587|FG000|Overall Study|Lack of Efficacy|68|||
163038840|NCT01152996|588850587|FG000|Overall Study|Noncompliance|41|||
163038841|NCT01152996|588850587|FG000|Overall Study|Other|36|||
163038842|NCT01152996|588850587|FG000|Overall Study|Protocol Violation|22|||
163038843|NCT01152996|588850587|FG000|Overall Study|Elevated liver enzymes|1|||
163038844|NCT02260817|588850591|FG000|Overall Study|Lost to Follow-up|0|||
163092091|NCT00244621|589048479|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
163092092|NCT00244621|589048477|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
163092093|NCT00244621|589048478|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
163092094|NCT00244621|589048479|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
163092095|NCT00244621|589048477|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
163092096|NCT00244621|589048478|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
163092097|NCT00244621|589048479|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
163092098|NCT00244621|589048477|FG000|Open-label Treatment Period|Adverse Event|0|||
163092099|NCT00244621|589048478|FG001|Open-label Treatment Period|Adverse Event|0|||
163092100|NCT00244621|589048479|FG002|Open-label Treatment Period|Adverse Event|1|||
163092101|NCT00244621|589048477|FG000|Open-label Treatment Period|Moved abroad|0|||
163092102|NCT00244621|589048478|FG001|Open-label Treatment Period|Moved abroad|0|||
163092103|NCT00244621|589048479|FG002|Open-label Treatment Period|Moved abroad|1|||
163092104|NCT01193101|589048483|FG000|Overall Study|Adverse Event|0|||
163092105|NCT01193101|589048484|FG001|Overall Study|Adverse Event|1|||
163092106|NCT01193101|589048485|FG002|Overall Study|Adverse Event|1|||
163092107|NCT01193101|589048486|FG003|Overall Study|Adverse Event|3|||
163092108|NCT01193101|589048483|FG000|Overall Study|Lack of Efficacy|3|||
163092109|NCT01193101|589048484|FG001|Overall Study|Lack of Efficacy|1|||
163092110|NCT01193101|589048485|FG002|Overall Study|Lack of Efficacy|0|||
163092111|NCT01193101|589048486|FG003|Overall Study|Lack of Efficacy|8|||
163092112|NCT01193101|589048483|FG000|Overall Study|Withdrawal by Subject|2|||
163092113|NCT01193101|589048484|FG001|Overall Study|Withdrawal by Subject|4|||
163092114|NCT01193101|589048485|FG002|Overall Study|Withdrawal by Subject|1|||
163092115|NCT01193101|589048486|FG003|Overall Study|Withdrawal by Subject|1|||
163092116|NCT01193101|589048483|FG000|Overall Study|Administrative problems|0|||
163092117|NCT01193101|589048484|FG001|Overall Study|Administrative problems|0|||
163092118|NCT01193101|589048485|FG002|Overall Study|Administrative problems|1|||
163092119|NCT01193101|589048486|FG003|Overall Study|Administrative problems|0|||
163092120|NCT01193101|589048483|FG000|Overall Study|Abnormal test procedure results|0|||
163092121|NCT01193101|589048484|FG001|Overall Study|Abnormal test procedure results|1|||
163092122|NCT01193101|589048485|FG002|Overall Study|Abnormal test procedure results|0|||
163092123|NCT01193101|589048486|FG003|Overall Study|Abnormal test procedure results|0|||
163092124|NCT02271529|589048487|FG000|Overall Study|Withdrawal by Subject|1|||
163092125|NCT03508050|589048488|FG000|Overall Study|Pleural adhesions|1|||
163092126|NCT03508050|589048489|FG001|Overall Study|Pleural adhesions|0|||
163092127|NCT03508050|589048488|FG000|Overall Study|Mucus plug|1|||
163092128|NCT03508050|589048489|FG001|Overall Study|Mucus plug|0|||
163092129|NCT03508050|589048488|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
163092130|NCT03508050|589048489|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
163092131|NCT03508050|589048488|FG000|Overall Study|Sustained desaturation|0|||
163092132|NCT03508050|589048489|FG001|Overall Study|Sustained desaturation|1|||
163092133|NCT00811720|589048490|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
163092134|NCT00811720|589048491|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
163092135|NCT00811720|589048490|FG000|All Treated Patients|Adverse Event|20|||
163092136|NCT00811720|589048491|FG001|All Treated Patients|Adverse Event|62|||
163092137|NCT00811720|589048490|FG000|All Treated Patients|Lack of Efficacy|22|||
163092138|NCT00811720|589048491|FG001|All Treated Patients|Lack of Efficacy|18|||
163092139|NCT00811720|589048490|FG000|All Treated Patients|Non-compliance|0|||
163092140|NCT00811720|589048491|FG001|All Treated Patients|Non-compliance|14|||
163092141|NCT00811720|589048490|FG000|All Treated Patients|Protocol Violation|9|||
163092142|NCT00811720|589048491|FG001|All Treated Patients|Protocol Violation|16|||
163092143|NCT00811720|589048490|FG000|All Treated Patients|Withdrawal by Subject|28|||
163092144|NCT00811720|589048491|FG001|All Treated Patients|Withdrawal by Subject|34|||
163092145|NCT00811720|589048490|FG000|All Treated Patients|Lost to Follow-up|10|||
163092146|NCT00811720|589048491|FG001|All Treated Patients|Lost to Follow-up|16|||
163092147|NCT00811720|589048490|FG000|All Treated Patients|Other Reason|7|||
163092148|NCT00811720|589048491|FG001|All Treated Patients|Other Reason|4|||
163092149|NCT03894891|589048492|FG000|Overall Study|Withdrawal by Subject|1|||
163038845|NCT02260817|588850592|FG001|Overall Study|Lost to Follow-up|14|||
163092150|NCT03894891|589048492|FG000|Overall Study|Completed protocol treatment per protocol|5|||
163092151|NCT04389866|589048493|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
163220108|NCT02039674|589521412|FG006|Overall Study|Excluded Medication|0|||
163337219|NCT01562275|589945320|FG007|Stage 1|Death|0|||
163337220|NCT01562275|589945321|FG008|Stage 1|Death|0|||
163337221|NCT01562275|589945322|FG009|Stage 1|Death|0|||
163337222|NCT01562275|589945323|FG010|Stage 1|Death|0|||
163337223|NCT01562275|589945324|FG011|Stage 1|Death|0|||
163337224|NCT01562275|589945325|FG012|Stage 1|Death|0|||
163337225|NCT01562275|589945313|FG000|Stage 1|Non Compliance|0|||
163407613|NCT03245450|590200864|FG004|Overall Study|Adverse Event|1|||
163038846|NCT02260817|588850591|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
163038847|NCT02260817|588850592|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
163038848|NCT02260817|588850591|FG000|Overall Study|Observation, no biopsy|0|||
163038849|NCT02260817|588850592|FG001|Overall Study|Observation, no biopsy|1|||
163038850|NCT02260817|588850591|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
163038851|NCT02260817|588850592|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
163038852|NCT02260817|588850591|FG000|Overall Study|Protocol Violation|0|||
163038853|NCT02260817|588850592|FG001|Overall Study|Protocol Violation|14|||
163038854|NCT03299101|588850593|FG000|Overall Study|Lost to Follow-up|1|||
163038855|NCT03299101|588850593|FG000|Overall Study|Withdrawal by Subject|5|||
163038856|NCT03299101|588850593|FG000|Overall Study|Surgery was changed|3|||
163038857|NCT03299101|588850593|FG000|Overall Study|Not enough time to complete prehab|1|||
163038858|NCT04217317|588850596|FG000|Overall Study|Lack of Efficacy|4|||
163038859|NCT04217317|588850596|FG000|Overall Study|Physician Decision|1|||
163038860|NCT01424241|588850597|FG000|Overall Study|Withdrawal by Subject|1|||
163038861|NCT01424241|588850597|FG000|Overall Study|Time constraints|2|||
163038862|NCT05259917|588850602|FG000|Overall Study|Protocol Violation|0|||
163038863|NCT05259917|588850603|FG001|Overall Study|Protocol Violation|0|||
163038864|NCT05259917|588850604|FG002|Overall Study|Protocol Violation|1|||
163038865|NCT05259917|588850605|FG003|Overall Study|Protocol Violation|0|||
163038866|NCT05259917|588850606|FG004|Overall Study|Protocol Violation|0|||
163038867|NCT05259917|588850607|FG005|Overall Study|Protocol Violation|0|||
163038868|NCT05259917|588850602|FG000|Overall Study|Lost to Follow-up|0|||
163038869|NCT05259917|588850603|FG001|Overall Study|Lost to Follow-up|0|||
163038870|NCT05259917|588850604|FG002|Overall Study|Lost to Follow-up|1|||
163038871|NCT05259917|588850605|FG003|Overall Study|Lost to Follow-up|0|||
163038872|NCT05259917|588850606|FG004|Overall Study|Lost to Follow-up|0|||
163038873|NCT05259917|588850607|FG005|Overall Study|Lost to Follow-up|1|||
163038874|NCT05259917|588850602|FG000|Overall Study|Physician Decision|0|||
163038875|NCT05259917|588850603|FG001|Overall Study|Physician Decision|1|||
163038876|NCT05259917|588850604|FG002|Overall Study|Physician Decision|0|||
163038877|NCT05259917|588850605|FG003|Overall Study|Physician Decision|0|||
163038878|NCT05259917|588850606|FG004|Overall Study|Physician Decision|0|||
163038879|NCT05259917|588850607|FG005|Overall Study|Physician Decision|0|||
163038880|NCT05259917|588850602|FG000|Overall Study|Withdrawal by Subject|0|||
163038881|NCT05259917|588850603|FG001|Overall Study|Withdrawal by Subject|1|||
163038882|NCT05259917|588850604|FG002|Overall Study|Withdrawal by Subject|0|||
163038883|NCT05259917|588850605|FG003|Overall Study|Withdrawal by Subject|0|||
163038884|NCT05259917|588850606|FG004|Overall Study|Withdrawal by Subject|1|||
163038885|NCT05259917|588850607|FG005|Overall Study|Withdrawal by Subject|1|||
163038886|NCT05259917|588850602|FG000|Overall Study|Trial Termination by Sponsor|7|||
163038887|NCT05259917|588850603|FG001|Overall Study|Trial Termination by Sponsor|2|||
163038888|NCT05259917|588850604|FG002|Overall Study|Trial Termination by Sponsor|3|||
163038889|NCT05259917|588850605|FG003|Overall Study|Trial Termination by Sponsor|5|||
163038890|NCT05259917|588850606|FG004|Overall Study|Trial Termination by Sponsor|11|||
163038891|NCT05259917|588850607|FG005|Overall Study|Trial Termination by Sponsor|4|||
163038892|NCT05259917|588850602|FG000|Overall Study|Other|1|||
163038893|NCT05259917|588850603|FG001|Overall Study|Other|0|||
163038894|NCT05259917|588850604|FG002|Overall Study|Other|2|||
163038895|NCT05259917|588850605|FG003|Overall Study|Other|0|||
163038896|NCT05259917|588850606|FG004|Overall Study|Other|0|||
163038897|NCT05259917|588850607|FG005|Overall Study|Other|0|||
163038898|NCT00303472|588850612|FG000|Treatment Period|Adverse Event|0|||
163038899|NCT00303472|588850613|FG001|Treatment Period|Adverse Event|0|||
163038900|NCT00303472|588850614|FG002|Treatment Period|Adverse Event|0|||
163038901|NCT00303472|588850615|FG003|Treatment Period|Adverse Event|0|||
163038902|NCT00303472|588850616|FG004|Treatment Period|Adverse Event|1|||
163038903|NCT00303472|588850617|FG005|Treatment Period|Adverse Event|0|||
163038904|NCT00303472|588850618|FG006|Treatment Period|Adverse Event|0|||
163038905|NCT00303472|588850612|FG000|Treatment Period|Death|0|||
163038906|NCT00303472|588850613|FG001|Treatment Period|Death|0|||
163038907|NCT00303472|588850614|FG002|Treatment Period|Death|0|||
163038908|NCT00303472|588850615|FG003|Treatment Period|Death|1|||
163038909|NCT00303472|588850616|FG004|Treatment Period|Death|0|||
163038910|NCT00303472|588850617|FG005|Treatment Period|Death|0|||
163038911|NCT00303472|588850618|FG006|Treatment Period|Death|1|||
163038912|NCT00303472|588850612|FG000|Treatment Period|Withdrawal by Subject|0|||
163038913|NCT00303472|588850613|FG001|Treatment Period|Withdrawal by Subject|0|||
163337226|NCT01562275|589945314|FG001|Stage 1|Non Compliance|0|||
163337227|NCT01562275|589945315|FG002|Stage 1|Non Compliance|1|||
163337228|NCT01562275|589945316|FG003|Stage 1|Non Compliance|0|||
163337229|NCT01562275|589945317|FG004|Stage 1|Non Compliance|0|||
163407614|NCT03245450|590200865|FG005|Overall Study|Adverse Event|0|||
163337230|NCT01562275|589945318|FG005|Stage 1|Non Compliance|0|||
163337231|NCT01562275|589945319|FG006|Stage 1|Non Compliance|0|||
163337232|NCT01562275|589945320|FG007|Stage 1|Non Compliance|0|||
163337233|NCT01562275|589945321|FG008|Stage 1|Non Compliance|0|||
163337234|NCT01562275|589945322|FG009|Stage 1|Non Compliance|0|||
163337235|NCT01562275|589945323|FG010|Stage 1|Non Compliance|0|||
163337236|NCT01562275|589945324|FG011|Stage 1|Non Compliance|0|||
163337237|NCT01562275|589945325|FG012|Stage 1|Non Compliance|0|||
163337238|NCT01562275|589945313|FG000|Stage 1|Physician Decision|0|||
163337239|NCT01562275|589945314|FG001|Stage 1|Physician Decision|0|||
163337240|NCT01562275|589945315|FG002|Stage 1|Physician Decision|0|||
163337241|NCT01562275|589945316|FG003|Stage 1|Physician Decision|0|||
163337242|NCT01562275|589945317|FG004|Stage 1|Physician Decision|1|||
163337243|NCT01562275|589945318|FG005|Stage 1|Physician Decision|0|||
163337244|NCT01562275|589945319|FG006|Stage 1|Physician Decision|1|||
163337245|NCT01562275|589945320|FG007|Stage 1|Physician Decision|0|||
163337246|NCT01562275|589945321|FG008|Stage 1|Physician Decision|1|||
163337247|NCT01562275|589945322|FG009|Stage 1|Physician Decision|0|||
163337248|NCT01562275|589945323|FG010|Stage 1|Physician Decision|0|||
163337249|NCT01562275|589945324|FG011|Stage 1|Physician Decision|0|||
163337250|NCT01562275|589945325|FG012|Stage 1|Physician Decision|0|||
163337251|NCT01562275|589945313|FG000|Stage 1|Progression of Disease|2|||
163337252|NCT01562275|589945314|FG001|Stage 1|Progression of Disease|6|||
163337253|NCT01562275|589945315|FG002|Stage 1|Progression of Disease|2|||
163337254|NCT01562275|589945316|FG003|Stage 1|Progression of Disease|1|||
163337255|NCT01562275|589945317|FG004|Stage 1|Progression of Disease|2|||
163337256|NCT01562275|589945318|FG005|Stage 1|Progression of Disease|4|||
163337257|NCT01562275|589945319|FG006|Stage 1|Progression of Disease|1|||
163337258|NCT01562275|589945320|FG007|Stage 1|Progression of Disease|7|||
163337259|NCT01562275|589945321|FG008|Stage 1|Progression of Disease|2|||
163337260|NCT01562275|589945322|FG009|Stage 1|Progression of Disease|5|||
163337261|NCT01562275|589945323|FG010|Stage 1|Progression of Disease|3|||
163337262|NCT01562275|589945324|FG011|Stage 1|Progression of Disease|0|||
163337263|NCT01562275|589945325|FG012|Stage 1|Progression of Disease|0|||
163337264|NCT01562275|589945313|FG000|Stage 1|Withdrawal by Subject|0|||
163337265|NCT01562275|589945314|FG001|Stage 1|Withdrawal by Subject|1|||
163337266|NCT01562275|589945315|FG002|Stage 1|Withdrawal by Subject|0|||
163337267|NCT01562275|589945316|FG003|Stage 1|Withdrawal by Subject|2|||
163337268|NCT01562275|589945317|FG004|Stage 1|Withdrawal by Subject|0|||
163337269|NCT01562275|589945318|FG005|Stage 1|Withdrawal by Subject|0|||
163337270|NCT01562275|589945319|FG006|Stage 1|Withdrawal by Subject|1|||
163337271|NCT01562275|589945320|FG007|Stage 1|Withdrawal by Subject|0|||
163337272|NCT01562275|589945321|FG008|Stage 1|Withdrawal by Subject|0|||
163337273|NCT01562275|589945322|FG009|Stage 1|Withdrawal by Subject|1|||
163337274|NCT01562275|589945323|FG010|Stage 1|Withdrawal by Subject|0|||
163337275|NCT01562275|589945324|FG011|Stage 1|Withdrawal by Subject|0|||
163337276|NCT01562275|589945325|FG012|Stage 1|Withdrawal by Subject|0|||
163337277|NCT01562275|589945313|FG000|Stage 2|Death|0|||
163337278|NCT01562275|589945314|FG001|Stage 2|Death|0|||
163337279|NCT01562275|589945315|FG002|Stage 2|Death|0|||
163337280|NCT01562275|589945316|FG003|Stage 2|Death|0|||
163337281|NCT01562275|589945317|FG004|Stage 2|Death|0|||
163337282|NCT01562275|589945318|FG005|Stage 2|Death|0|||
163337283|NCT01562275|589945319|FG006|Stage 2|Death|0|||
163337284|NCT01562275|589945320|FG007|Stage 2|Death|0|||
163038914|NCT00303472|588850614|FG002|Treatment Period|Withdrawal by Subject|0|||
163038915|NCT00303472|588850615|FG003|Treatment Period|Withdrawal by Subject|1|||
163038916|NCT00303472|588850616|FG004|Treatment Period|Withdrawal by Subject|0|||
163038917|NCT00303472|588850617|FG005|Treatment Period|Withdrawal by Subject|1|||
163038918|NCT00303472|588850618|FG006|Treatment Period|Withdrawal by Subject|0|||
163038919|NCT00303472|588850612|FG000|Treatment Period|Other|0|||
163038920|NCT00303472|588850613|FG001|Treatment Period|Other|0|||
163038921|NCT00303472|588850614|FG002|Treatment Period|Other|0|||
163038922|NCT00303472|588850615|FG003|Treatment Period|Other|0|||
163038923|NCT00303472|588850616|FG004|Treatment Period|Other|1|||
163038924|NCT00303472|588850617|FG005|Treatment Period|Other|0|||
163038925|NCT00303472|588850618|FG006|Treatment Period|Other|1|||
163038926|NCT00303472|588850612|FG000|Treatment Period|Disease Progression (to AML)|0|||
163038927|NCT00303472|588850613|FG001|Treatment Period|Disease Progression (to AML)|0|||
163038928|NCT00303472|588850614|FG002|Treatment Period|Disease Progression (to AML)|0|||
163038929|NCT00303472|588850615|FG003|Treatment Period|Disease Progression (to AML)|0|||
163038930|NCT00303472|588850616|FG004|Treatment Period|Disease Progression (to AML)|1|||
163038931|NCT00303472|588850617|FG005|Treatment Period|Disease Progression (to AML)|0|||
163038932|NCT00303472|588850618|FG006|Treatment Period|Disease Progression (to AML)|0|||
163038933|NCT00303472|588850612|FG000|Treatment Extension (Optional)|Adverse Event|1|||
163337285|NCT01562275|589945321|FG008|Stage 2|Death|0|||
163337286|NCT01562275|589945322|FG009|Stage 2|Death|0|||
163337287|NCT01562275|589945323|FG010|Stage 2|Death|0|||
163337288|NCT01562275|589945324|FG011|Stage 2|Death|2|||
163337289|NCT01562275|589945325|FG012|Stage 2|Death|1|||
163337290|NCT01562275|589945313|FG000|Stage 2|Progression of Disease|0|||
163337291|NCT01562275|589945314|FG001|Stage 2|Progression of Disease|0|||
163337292|NCT01562275|589945315|FG002|Stage 2|Progression of Disease|0|||
163337293|NCT01562275|589945316|FG003|Stage 2|Progression of Disease|0|||
163337294|NCT01562275|589945317|FG004|Stage 2|Progression of Disease|0|||
163337295|NCT01562275|589945318|FG005|Stage 2|Progression of Disease|0|||
163038934|NCT00303472|588850613|FG001|Treatment Extension (Optional)|Adverse Event|0|||
163038935|NCT00303472|588850614|FG002|Treatment Extension (Optional)|Adverse Event|1|||
163038936|NCT00303472|588850615|FG003|Treatment Extension (Optional)|Adverse Event|0|||
163038937|NCT00303472|588850616|FG004|Treatment Extension (Optional)|Adverse Event|0|||
163038938|NCT00303472|588850617|FG005|Treatment Extension (Optional)|Adverse Event|0|||
163038939|NCT00303472|588850618|FG006|Treatment Extension (Optional)|Adverse Event|0|||
163038940|NCT00303472|588850612|FG000|Treatment Extension (Optional)|Death|2|||
163038941|NCT00303472|588850613|FG001|Treatment Extension (Optional)|Death|0|||
163038942|NCT00303472|588850614|FG002|Treatment Extension (Optional)|Death|1|||
163038943|NCT00303472|588850615|FG003|Treatment Extension (Optional)|Death|0|||
163038944|NCT00303472|588850616|FG004|Treatment Extension (Optional)|Death|0|||
163038945|NCT00303472|588850617|FG005|Treatment Extension (Optional)|Death|0|||
163038946|NCT00303472|588850618|FG006|Treatment Extension (Optional)|Death|0|||
163038947|NCT00303472|588850612|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
163038948|NCT00303472|588850613|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
163038949|NCT00303472|588850614|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
163038950|NCT00303472|588850615|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
163038951|NCT00303472|588850616|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
163038952|NCT00303472|588850617|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
163038953|NCT00303472|588850618|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
163038954|NCT00303472|588850612|FG000|Treatment Extension (Optional)|Physician Decision|0|||
163038955|NCT00303472|588850613|FG001|Treatment Extension (Optional)|Physician Decision|4|||
163038956|NCT00303472|588850614|FG002|Treatment Extension (Optional)|Physician Decision|2|||
163038957|NCT00303472|588850615|FG003|Treatment Extension (Optional)|Physician Decision|3|||
163038958|NCT00303472|588850616|FG004|Treatment Extension (Optional)|Physician Decision|2|||
163038959|NCT00303472|588850617|FG005|Treatment Extension (Optional)|Physician Decision|0|||
163038960|NCT00303472|588850618|FG006|Treatment Extension (Optional)|Physician Decision|0|||
163038961|NCT00303472|588850612|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
163038962|NCT00303472|588850613|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
163038963|NCT00303472|588850614|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
163038964|NCT00303472|588850615|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
163038965|NCT00303472|588850616|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
163038966|NCT00303472|588850617|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
163038967|NCT00303472|588850618|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
163038968|NCT00303472|588850612|FG000|Treatment Extension (Optional)|Other|0|||
163038969|NCT00303472|588850613|FG001|Treatment Extension (Optional)|Other|2|||
163038970|NCT00303472|588850614|FG002|Treatment Extension (Optional)|Other|4|||
163038971|NCT00303472|588850615|FG003|Treatment Extension (Optional)|Other|2|||
163038972|NCT00303472|588850616|FG004|Treatment Extension (Optional)|Other|1|||
163038973|NCT00303472|588850617|FG005|Treatment Extension (Optional)|Other|0|||
163038974|NCT00303472|588850618|FG006|Treatment Extension (Optional)|Other|0|||
163038975|NCT00303472|588850612|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
163038976|NCT00303472|588850613|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
163038977|NCT00303472|588850614|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
163038978|NCT00303472|588850615|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
163038979|NCT00303472|588850616|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
163038980|NCT00303472|588850617|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
163038981|NCT00303472|588850618|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
163038982|NCT03585712|588850626|FG000|Treatment Period 1|Protocol Violation|1|||
163038983|NCT03585712|588850627|FG001|Treatment Period 1|Protocol Violation|0|||
163038984|NCT03585712|588850628|FG002|Treatment Period 1|Protocol Violation|0|||
163038985|NCT03585712|588850626|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
163038986|NCT03585712|588850627|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
163038987|NCT03585712|588850628|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
163038988|NCT03585712|588850626|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
163038989|NCT03585712|588850627|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
163038990|NCT03585712|588850628|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
163038991|NCT03585712|588850626|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
163038992|NCT03585712|588850627|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
163038993|NCT03585712|588850628|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
163038994|NCT03517449|588850629|FG000|Overall Study|Death|184|||
163038995|NCT03517449|588850630|FG001|Overall Study|Death|236|||
163038996|NCT03517449|588850629|FG000|Overall Study|Lost to Follow-up|0|||
163038997|NCT03517449|588850630|FG001|Overall Study|Lost to Follow-up|2|||
163038998|NCT03517449|588850629|FG000|Overall Study|Withdrawal by Subject|7|||
163038999|NCT03517449|588850630|FG001|Overall Study|Withdrawal by Subject|26|||
163039000|NCT03517449|588850629|FG000|Overall Study|Participants Ongoing|220|||
163039001|NCT03517449|588850630|FG001|Overall Study|Participants Ongoing|152|||
163092152|NCT04389866|589048494|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
163092153|NCT00776789|589048502|FG000|Overall Study|Consent refusal|2|||
163092154|NCT00776789|589048503|FG001|Overall Study|Consent refusal|2|||
163337296|NCT01562275|589945319|FG006|Stage 2|Progression of Disease|0|||
163337297|NCT01562275|589945320|FG007|Stage 2|Progression of Disease|0|||
163337298|NCT01562275|589945321|FG008|Stage 2|Progression of Disease|0|||
163337299|NCT01562275|589945322|FG009|Stage 2|Progression of Disease|0|||
163337300|NCT01562275|589945323|FG010|Stage 2|Progression of Disease|0|||
163337301|NCT01562275|589945324|FG011|Stage 2|Progression of Disease|12|||
163337302|NCT01562275|589945325|FG012|Stage 2|Progression of Disease|4|||
163337303|NCT01863368|589945326|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
163337304|NCT01863368|589945327|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
163337305|NCT01863368|589945326|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
163337306|NCT01863368|589945327|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
163337307|NCT01863368|589945326|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
163337308|NCT01863368|589945327|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
163337309|NCT01863368|589945326|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
163337310|NCT01863368|589945327|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
163337311|NCT01863368|589945326|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
163337312|NCT01863368|589945327|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
163337313|NCT01863368|589945326|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
163337314|NCT01863368|589945327|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
163337315|NCT00070707|589945328|FG000|Overall Study|Adverse Event|1|||
163337316|NCT00070707|589945329|FG001|Overall Study|Adverse Event|2|||
163337317|NCT00070707|589945328|FG000|Overall Study|Lack of Efficacy|4|||
163337318|NCT00070707|589945329|FG001|Overall Study|Lack of Efficacy|1|||
163337319|NCT00070707|589945328|FG000|Overall Study|Protocol Violation|8|||
163337320|NCT00070707|589945329|FG001|Overall Study|Protocol Violation|4|||
163337321|NCT00070707|589945328|FG000|Overall Study|Unrelated to Study Medication|1|||
163337322|NCT00070707|589945329|FG001|Overall Study|Unrelated to Study Medication|0|||
163337323|NCT00647699|589945330|FG000|Overall Study|Lost to Follow-up|5|||
163337324|NCT00647699|589945331|FG001|Overall Study|Lost to Follow-up|4|||
163337325|NCT00647699|589945330|FG000|Overall Study|Withdrawal by Subject|3|||
163337326|NCT00647699|589945331|FG001|Overall Study|Withdrawal by Subject|8|||
163337327|NCT04909593|589945332|FG000|Overall Study|Withdrawal by Subject|1|||
163337328|NCT01018992|589945333|FG000|Overall Study|Adverse Event|8|||
163337329|NCT01018992|589945334|FG001|Overall Study|Adverse Event|3|||
163337330|NCT01018992|589945333|FG000|Overall Study|Withdrawal by Subject|3|||
163337331|NCT01018992|589945334|FG001|Overall Study|Withdrawal by Subject|8|||
163337332|NCT01018992|589945333|FG000|Overall Study|Protocol Violation|0|||
163337333|NCT01018992|589945334|FG001|Overall Study|Protocol Violation|4|||
163337334|NCT01018992|589945333|FG000|Overall Study|Lost to Follow-up|5|||
163337335|NCT01018992|589945334|FG001|Overall Study|Lost to Follow-up|1|||
163337336|NCT03029585|589945337|FG000|Overall Study|Death|1|||
163337337|NCT03029585|589945338|FG001|Overall Study|Death|1|||
163337338|NCT03029585|589945337|FG000|Overall Study|Withdrawal by Subject|1|||
163337339|NCT03029585|589945338|FG001|Overall Study|Withdrawal by Subject|0|||
163337340|NCT01241448|589945343|FG000|Overall Study|Adverse Event|1|||
163337341|NCT01241448|589945344|FG001|Overall Study|Adverse Event|0|||
163337342|NCT01241448|589945345|FG002|Overall Study|Adverse Event|2|||
163337343|NCT01241448|589945346|FG003|Overall Study|Adverse Event|2|||
163337344|NCT01241448|589945343|FG000|Overall Study|Lost to Follow-up|2|||
163337345|NCT01241448|589945344|FG001|Overall Study|Lost to Follow-up|1|||
163337346|NCT01241448|589945345|FG002|Overall Study|Lost to Follow-up|1|||
163337347|NCT01241448|589945346|FG003|Overall Study|Lost to Follow-up|1|||
163337348|NCT01241448|589945343|FG000|Overall Study|Physician Decision|0|||
163337349|NCT01241448|589945344|FG001|Overall Study|Physician Decision|2|||
163337350|NCT01241448|589945345|FG002|Overall Study|Physician Decision|0|||
163337351|NCT01241448|589945346|FG003|Overall Study|Physician Decision|0|||
163337352|NCT01241448|589945343|FG000|Overall Study|Protocol Violation|10|||
163337353|NCT01241448|589945344|FG001|Overall Study|Protocol Violation|5|||
163092155|NCT00776789|589048502|FG000|Overall Study|Poor quality video|1|||
163092156|NCT00776789|589048503|FG001|Overall Study|Poor quality video|1|||
163092157|NCT04940130|589048504|FG000|Overall Study|Travel|1|||
163337354|NCT01241448|589945345|FG002|Overall Study|Protocol Violation|3|||
163337355|NCT01241448|589945346|FG003|Overall Study|Protocol Violation|6|||
163337356|NCT01241448|589945343|FG000|Overall Study|Sponsor Decision|17|||
163337357|NCT01241448|589945344|FG001|Overall Study|Sponsor Decision|14|||
163337358|NCT01241448|589945345|FG002|Overall Study|Sponsor Decision|12|||
163337359|NCT01241448|589945346|FG003|Overall Study|Sponsor Decision|6|||
163092158|NCT04940130|589048505|FG001|Overall Study|Travel|0|||
163337360|NCT01241448|589945343|FG000|Overall Study|Withdrawal by Subject|4|||
163337361|NCT01241448|589945344|FG001|Overall Study|Withdrawal by Subject|5|||
163337362|NCT01241448|589945345|FG002|Overall Study|Withdrawal by Subject|3|||
163337363|NCT01241448|589945346|FG003|Overall Study|Withdrawal by Subject|6|||
163337364|NCT01241448|589945343|FG000|Overall Study|Excluded due to data integrity issues|3|||
163337365|NCT01241448|589945344|FG001|Overall Study|Excluded due to data integrity issues|2|||
163407615|NCT03245450|590200866|FG006|Overall Study|Adverse Event|2|||
163039002|NCT01808222|588850634|FG000|Overall Study|mpMR scan was not performed|1|||
163092159|NCT04940130|589048506|FG002|Overall Study|Travel|2|||
163092160|NCT04940130|589048504|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
163092161|NCT04940130|589048505|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
163092162|NCT04940130|589048506|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
163092163|NCT04940130|589048504|FG000|Overall Study|Adverse Event|0|||
163092164|NCT04940130|589048505|FG001|Overall Study|Adverse Event|0|||
163092165|NCT04940130|589048506|FG002|Overall Study|Adverse Event|2|||
163092166|NCT04940130|589048504|FG000|Overall Study|Disease progression/treatment failure|0|||
163092167|NCT04940130|589048505|FG001|Overall Study|Disease progression/treatment failure|0|||
163092168|NCT04940130|589048506|FG002|Overall Study|Disease progression/treatment failure|1|||
163092169|NCT04940130|589048504|FG000|Overall Study|Participant refusal|0|||
163092170|NCT04940130|589048505|FG001|Overall Study|Participant refusal|0|||
163337366|NCT01241448|589945345|FG002|Overall Study|Excluded due to data integrity issues|2|||
163337367|NCT01241448|589945346|FG003|Overall Study|Excluded due to data integrity issues|2|||
163337368|NCT02400749|589945347|FG000|Week 0 -16|Withdrawal by Subject|5|||
163337369|NCT02400749|589945348|FG001|Week 0 -16|Withdrawal by Subject|5|||
163337370|NCT02400749|589945347|FG000|Week 0 -16|Adverse Event|3|||
163337371|NCT02400749|589945348|FG001|Week 0 -16|Adverse Event|1|||
163337372|NCT02400749|589945347|FG000|Week 0 -16|Lost to Follow-up|2|||
163337373|NCT02400749|589945348|FG001|Week 0 -16|Lost to Follow-up|0|||
163337374|NCT02400749|589945347|FG000|Week 0 -16|Protocol Violation|1|||
163337375|NCT02400749|589945348|FG001|Week 0 -16|Protocol Violation|0|||
163337376|NCT02400749|589945347|FG000|Week 17 - 32|Withdrawal by Subject|3|||
163337377|NCT02400749|589945348|FG001|Week 17 - 32|Withdrawal by Subject|2|||
163337378|NCT02400749|589945347|FG000|Week 17 - 32|Adverse Event|2|||
163337379|NCT02400749|589945348|FG001|Week 17 - 32|Adverse Event|1|||
163337380|NCT01825785|589945349|FG000|Overall Study|Adverse Event|0|||
163337381|NCT01825785|589945350|FG001|Overall Study|Adverse Event|0|||
163039003|NCT00621517|588850635|FG000|Overall Study|Lost to Follow-up|3|||
163039004|NCT00621517|588850636|FG001|Overall Study|Lost to Follow-up|3|||
163039005|NCT00621517|588850635|FG000|Overall Study|Withdrawal by Subject|3|||
163039006|NCT00621517|588850636|FG001|Overall Study|Withdrawal by Subject|4|||
163337382|NCT01825785|589945351|FG002|Overall Study|Adverse Event|0|||
163337383|NCT01825785|589945352|FG003|Overall Study|Adverse Event|0|||
163337384|NCT01825785|589945353|FG004|Overall Study|Adverse Event|1|||
163337385|NCT01825785|589945354|FG005|Overall Study|Adverse Event|0|||
163337386|NCT01825785|589945355|FG006|Overall Study|Adverse Event|0|||
163337387|NCT01825785|589945349|FG000|Overall Study|Withdrawal by Subject|0|||
163337388|NCT01825785|589945350|FG001|Overall Study|Withdrawal by Subject|0|||
163337389|NCT01825785|589945351|FG002|Overall Study|Withdrawal by Subject|0|||
163337390|NCT01825785|589945352|FG003|Overall Study|Withdrawal by Subject|0|||
163337391|NCT01825785|589945353|FG004|Overall Study|Withdrawal by Subject|1|||
163337392|NCT01825785|589945354|FG005|Overall Study|Withdrawal by Subject|1|||
163337393|NCT01825785|589945355|FG006|Overall Study|Withdrawal by Subject|0|||
163337394|NCT04025762|589945359|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
163337395|NCT04025762|589945360|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
163337396|NCT03340961|589945364|FG000|Overall Study|Adverse Event|1|||
163337397|NCT03340961|589945365|FG001|Overall Study|Adverse Event|3|||
163337398|NCT03340961|589945366|FG002|Overall Study|Adverse Event|2|||
163337399|NCT03340961|589945367|FG003|Overall Study|Adverse Event|4|||
163337400|NCT03340961|589945364|FG000|Overall Study|Lost to Follow-up|0|||
163337401|NCT03340961|589945365|FG001|Overall Study|Lost to Follow-up|1|||
163337402|NCT03340961|589945366|FG002|Overall Study|Lost to Follow-up|0|||
163337403|NCT03340961|589945367|FG003|Overall Study|Lost to Follow-up|1|||
163039007|NCT00621517|588850635|FG000|Overall Study|Adverse Event|1|||
163039008|NCT00621517|588850636|FG001|Overall Study|Adverse Event|0|||
163039009|NCT00856843|588850637|FG000|Overall Study|Withdrawal by Subject|1|||
163039010|NCT00856843|588850638|FG001|Overall Study|Withdrawal by Subject|5|||
163039011|NCT00856843|588850637|FG000|Overall Study|Lack of Efficacy|1|||
163039012|NCT00856843|588850638|FG001|Overall Study|Lack of Efficacy|0|||
163039013|NCT02101359|588850639|FG000|Overall Study|Not included|23|||
163039014|NCT02101359|588850640|FG001|Overall Study|Not included|13|||
163039015|NCT02101359|588850639|FG000|Overall Study|Withdrawal by Subject|5|||
163039016|NCT02101359|588850640|FG001|Overall Study|Withdrawal by Subject|4|||
163039017|NCT02101359|588850639|FG000|Overall Study|Lost to Follow-up|1|||
163039018|NCT02101359|588850640|FG001|Overall Study|Lost to Follow-up|0|||
163039019|NCT02101359|588850639|FG000|Overall Study|Protocol Violation|0|||
163039020|NCT02101359|588850640|FG001|Overall Study|Protocol Violation|2|||
163039021|NCT00494221|588850641|FG000|Overall Study|Death|15|||
163039022|NCT00494221|588850642|FG001|Overall Study|Death|9|||
163039023|NCT00494221|588850643|FG002|Overall Study|Death|14|||
163039024|NCT00494221|588850641|FG000|Overall Study|Withdrawal by Subject|1|||
163039025|NCT00494221|588850642|FG001|Overall Study|Withdrawal by Subject|2|||
163039026|NCT00494221|588850643|FG002|Overall Study|Withdrawal by Subject|0|||
163039027|NCT01900431|588850647|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
163039028|NCT01900431|588850648|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
163039029|NCT01900431|588850649|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
163092171|NCT04940130|589048506|FG002|Overall Study|Participant refusal|1|||
163092172|NCT00363311|589048509|FG000|Overall Study|Adverse Event|6|||
163092173|NCT00363311|589048510|FG001|Overall Study|Adverse Event|4|||
163092174|NCT00363311|589048509|FG000|Overall Study|Lost to Follow-up|3|||
163092175|NCT00363311|589048510|FG001|Overall Study|Lost to Follow-up|0|||
163092176|NCT00363311|589048509|FG000|Overall Study|Protocol Violation|1|||
163092177|NCT00363311|589048510|FG001|Overall Study|Protocol Violation|2|||
163092178|NCT00363311|589048509|FG000|Overall Study|Withdrawal by Subject|12|||
163092179|NCT00363311|589048510|FG001|Overall Study|Withdrawal by Subject|6|||
163092180|NCT00363311|589048509|FG000|Overall Study|Physician Decision|1|||
163092181|NCT00363311|589048510|FG001|Overall Study|Physician Decision|1|||
163092182|NCT00363311|589048509|FG000|Overall Study|Sponsor Terminated Study|2|||
163092183|NCT00363311|589048510|FG001|Overall Study|Sponsor Terminated Study|2|||
163092184|NCT00363311|589048509|FG000|Overall Study|Disease Progression|46|||
163092185|NCT00363311|589048510|FG001|Overall Study|Disease Progression|26|||
163092186|NCT00363311|589048509|FG000|Overall Study|Non-Compliance|1|||
163092187|NCT00363311|589048510|FG001|Overall Study|Non-Compliance|1|||
163092188|NCT00363311|589048509|FG000|Overall Study|Participant Refused Biopsy|1|||
163092189|NCT00363311|589048510|FG001|Overall Study|Participant Refused Biopsy|0|||
163092190|NCT00363311|589048509|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
163092191|NCT00363311|589048510|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
163092192|NCT00363311|589048509|FG000|Overall Study|Participant Opted for Treatment|1|||
163092193|NCT00363311|589048510|FG001|Overall Study|Participant Opted for Treatment|0|||
163092194|NCT00363311|589048509|FG000|Overall Study|Participant Moved to Another Country|1|||
163092195|NCT00363311|589048510|FG001|Overall Study|Participant Moved to Another Country|0|||
163092196|NCT00363311|589048509|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
163092197|NCT00363311|589048510|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
163092198|NCT00363311|589048509|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
163092199|NCT00363311|589048510|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
163092200|NCT00363311|589048509|FG000|Overall Study|Participant Moved to Louisiana|0|||
163092201|NCT00363311|589048510|FG001|Overall Study|Participant Moved to Louisiana|1|||
163092202|NCT00401843|589048511|FG000|Overall Study|Achieved Complete Response|1|||
163092203|NCT00401843|589048512|FG001|Overall Study|Achieved Complete Response|5|||
163092204|NCT00401843|589048513|FG002|Overall Study|Achieved Complete Response|11|||
163092205|NCT00401843|589048511|FG000|Overall Study|Adverse Event|7|||
163092206|NCT00401843|589048512|FG001|Overall Study|Adverse Event|26|||
163092207|NCT00401843|589048513|FG002|Overall Study|Adverse Event|27|||
163092208|NCT00401843|589048511|FG000|Overall Study|Death|0|||
163092209|NCT00401843|589048512|FG001|Overall Study|Death|8|||
163092210|NCT00401843|589048513|FG002|Overall Study|Death|10|||
163092211|NCT00401843|589048511|FG000|Overall Study|Disease progression|10|||
163092212|NCT00401843|589048512|FG001|Overall Study|Disease progression|60|||
163092213|NCT00401843|589048513|FG002|Overall Study|Disease progression|49|||
163092214|NCT00401843|589048511|FG000|Overall Study|End of Study|1|||
163337404|NCT03340961|589945364|FG000|Overall Study|Withdrawal by Subject|3|||
163337405|NCT03340961|589945365|FG001|Overall Study|Withdrawal by Subject|2|||
163337406|NCT03340961|589945366|FG002|Overall Study|Withdrawal by Subject|4|||
163337407|NCT03340961|589945367|FG003|Overall Study|Withdrawal by Subject|7|||
163337408|NCT03340961|589945364|FG000|Overall Study|Use of prohibited treatment|0|||
163337409|NCT03340961|589945365|FG001|Overall Study|Use of prohibited treatment|3|||
163337410|NCT03340961|589945366|FG002|Overall Study|Use of prohibited treatment|2|||
163337411|NCT03340961|589945367|FG003|Overall Study|Use of prohibited treatment|4|||
163337412|NCT03340961|589945364|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
163337413|NCT03340961|589945365|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
163337414|NCT03340961|589945366|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
163337415|NCT03340961|589945367|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
163337416|NCT03340961|589945364|FG000|Overall Study|Subject developed an exclusion criterion|0|||
163337417|NCT03340961|589945365|FG001|Overall Study|Subject developed an exclusion criterion|1|||
163337418|NCT03340961|589945366|FG002|Overall Study|Subject developed an exclusion criterion|0|||
163337419|NCT03340961|589945367|FG003|Overall Study|Subject developed an exclusion criterion|0|||
163092215|NCT00401843|589048512|FG001|Overall Study|End of Study|1|||
163092216|NCT00401843|589048513|FG002|Overall Study|End of Study|2|||
163407616|NCT01604265|590200869|FG000|Overall Study|Adverse Event|1|||
163407617|NCT01604265|590200870|FG001|Overall Study|Adverse Event|0|||
163407618|NCT01604265|590200869|FG000|Overall Study|Withdrawal by Subject|1|||
163407619|NCT01604265|590200870|FG001|Overall Study|Withdrawal by Subject|0|||
163337420|NCT03340961|589945364|FG000|Overall Study|Protocol Violation|1|||
163337421|NCT03340961|589945365|FG001|Overall Study|Protocol Violation|0|||
163337422|NCT03340961|589945366|FG002|Overall Study|Protocol Violation|1|||
163407620|NCT02706873|590200871|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
163092217|NCT00401843|589048511|FG000|Overall Study|Lost to Follow-up|0|||
163092218|NCT00401843|589048512|FG001|Overall Study|Lost to Follow-up|0|||
163407621|NCT02706873|590200872|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
163092219|NCT00401843|589048513|FG002|Overall Study|Lost to Follow-up|2|||
163092220|NCT00401843|589048511|FG000|Overall Study|Other Unspecified|0|||
163092221|NCT00401843|589048512|FG001|Overall Study|Other Unspecified|3|||
163092222|NCT00401843|589048513|FG002|Overall Study|Other Unspecified|5|||
163092223|NCT00401843|589048511|FG000|Overall Study|Physician Decision|0|||
163092224|NCT00401843|589048512|FG001|Overall Study|Physician Decision|16|||
163092225|NCT00401843|589048513|FG002|Overall Study|Physician Decision|10|||
163092226|NCT00401843|589048511|FG000|Overall Study|Protocol Violation|0|||
163092227|NCT00401843|589048512|FG001|Overall Study|Protocol Violation|0|||
163092228|NCT00401843|589048513|FG002|Overall Study|Protocol Violation|1|||
163092229|NCT00401843|589048511|FG000|Overall Study|Withdrawal by Subject|1|||
163092230|NCT00401843|589048512|FG001|Overall Study|Withdrawal by Subject|5|||
163092231|NCT00401843|589048513|FG002|Overall Study|Withdrawal by Subject|5|||
163092232|NCT00401843|589048511|FG000|Overall Study|Withdrawal of consent to study agent|1|||
163092233|NCT00401843|589048512|FG001|Overall Study|Withdrawal of consent to study agent|15|||
163092234|NCT00401843|589048513|FG002|Overall Study|Withdrawal of consent to study agent|17|||
163092235|NCT00401843|589048511|FG000|Overall Study|Randomized but not Treated|0|||
163092236|NCT00401843|589048512|FG001|Overall Study|Randomized but not Treated|2|||
163092237|NCT00401843|589048513|FG002|Overall Study|Randomized but not Treated|3|||
163092238|NCT00401843|589048511|FG000|Overall Study|Received incorrect treatment|0|||
163092239|NCT00401843|589048512|FG001|Overall Study|Received incorrect treatment|3|||
163092240|NCT00401843|589048513|FG002|Overall Study|Received incorrect treatment|0|||
163092241|NCT04881760|589048516|FG000|Overall Study|Adverse Event|0|||
163092242|NCT04881760|589048517|FG001|Overall Study|Adverse Event|1|||
163092243|NCT04881760|589048518|FG002|Overall Study|Adverse Event|1|||
163092244|NCT04881760|589048519|FG003|Overall Study|Adverse Event|0|||
163092245|NCT04881760|589048520|FG004|Overall Study|Adverse Event|1|||
163092246|NCT04881760|589048521|FG005|Overall Study|Adverse Event|1|||
163092247|NCT04881760|589048522|FG006|Overall Study|Adverse Event|2|||
163092248|NCT04881760|589048516|FG000|Overall Study|Death|0|||
163092249|NCT04881760|589048517|FG001|Overall Study|Death|0|||
163092250|NCT04881760|589048518|FG002|Overall Study|Death|0|||
163092251|NCT04881760|589048519|FG003|Overall Study|Death|1|||
163092252|NCT04881760|589048520|FG004|Overall Study|Death|0|||
163092253|NCT04881760|589048521|FG005|Overall Study|Death|0|||
163092254|NCT04881760|589048522|FG006|Overall Study|Death|0|||
163092255|NCT04881760|589048516|FG000|Overall Study|Lost to Follow-up|5|||
163092256|NCT04881760|589048517|FG001|Overall Study|Lost to Follow-up|7|||
163092257|NCT04881760|589048518|FG002|Overall Study|Lost to Follow-up|5|||
163092258|NCT04881760|589048519|FG003|Overall Study|Lost to Follow-up|1|||
163092259|NCT04881760|589048520|FG004|Overall Study|Lost to Follow-up|2|||
163092260|NCT04881760|589048521|FG005|Overall Study|Lost to Follow-up|4|||
163092261|NCT04881760|589048522|FG006|Overall Study|Lost to Follow-up|4|||
163092262|NCT04881760|589048516|FG000|Overall Study|Withdrawal by Subject|13|||
163092263|NCT04881760|589048517|FG001|Overall Study|Withdrawal by Subject|1|||
163092264|NCT04881760|589048518|FG002|Overall Study|Withdrawal by Subject|1|||
163092265|NCT04881760|589048519|FG003|Overall Study|Withdrawal by Subject|4|||
163092266|NCT04881760|589048520|FG004|Overall Study|Withdrawal by Subject|2|||
163092267|NCT04881760|589048521|FG005|Overall Study|Withdrawal by Subject|1|||
163092268|NCT04881760|589048522|FG006|Overall Study|Withdrawal by Subject|2|||
163092269|NCT04881760|589048516|FG000|Overall Study|Randomized but Never Treated|0|||
163092270|NCT04881760|589048517|FG001|Overall Study|Randomized but Never Treated|0|||
163092271|NCT04881760|589048518|FG002|Overall Study|Randomized but Never Treated|0|||
163092272|NCT04881760|589048519|FG003|Overall Study|Randomized but Never Treated|1|||
163092273|NCT04881760|589048520|FG004|Overall Study|Randomized but Never Treated|0|||
163092274|NCT04881760|589048521|FG005|Overall Study|Randomized but Never Treated|0|||
163092275|NCT04881760|589048522|FG006|Overall Study|Randomized but Never Treated|0|||
163092276|NCT04881760|589048516|FG000|Overall Study|Inadvertent Enrollment|2|||
163092277|NCT04881760|589048517|FG001|Overall Study|Inadvertent Enrollment|0|||
163092278|NCT04881760|589048518|FG002|Overall Study|Inadvertent Enrollment|0|||
163092279|NCT04881760|589048519|FG003|Overall Study|Inadvertent Enrollment|0|||
163092280|NCT04881760|589048520|FG004|Overall Study|Inadvertent Enrollment|0|||
163092281|NCT04881760|589048521|FG005|Overall Study|Inadvertent Enrollment|0|||
163092282|NCT04881760|589048522|FG006|Overall Study|Inadvertent Enrollment|0|||
163092283|NCT04881760|589048516|FG000|Overall Study|Site Closure|0|||
163092284|NCT04881760|589048517|FG001|Overall Study|Site Closure|0|||
163092285|NCT04881760|589048518|FG002|Overall Study|Site Closure|0|||
163092286|NCT04881760|589048519|FG003|Overall Study|Site Closure|1|||
163092287|NCT04881760|589048520|FG004|Overall Study|Site Closure|0|||
163092288|NCT04881760|589048521|FG005|Overall Study|Site Closure|0|||
163092289|NCT04881760|589048522|FG006|Overall Study|Site Closure|0|||
163092290|NCT01182298|589048523|FG000|Overall Study|Lack of Efficacy|4|||
163092291|NCT01182298|589048523|FG000|Overall Study|Withdrawal by Subject|2|||
163092292|NCT01508910|589048524|FG000|Treatment|Death|2|||
163092293|NCT01508910|589048525|FG001|Treatment|Death|3|||
163092294|NCT01508910|589048526|FG002|Treatment|Death|2|||
163092295|NCT01508910|589048527|FG003|Treatment|Death|0|||
163092296|NCT01508910|589048524|FG000|Treatment|Lost to Follow-up|0|||
163092297|NCT01508910|589048525|FG001|Treatment|Lost to Follow-up|0|||
163092298|NCT01508910|589048526|FG002|Treatment|Lost to Follow-up|2|||
163092299|NCT01508910|589048527|FG003|Treatment|Lost to Follow-up|1|||
163337423|NCT03340961|589945367|FG003|Overall Study|Protocol Violation|0|||
163337424|NCT03340961|589945364|FG000|Overall Study|Adverse Event|1|||
163337425|NCT03340961|589945365|FG001|Overall Study|Adverse Event|1|||
163337426|NCT03340961|589945366|FG002|Overall Study|Adverse Event|0|||
163337427|NCT03340961|589945367|FG003|Overall Study|Adverse Event|0|||
163337428|NCT03340961|589945364|FG000|Overall Study|Lack of Efficacy|0|||
163337429|NCT03340961|589945365|FG001|Overall Study|Lack of Efficacy|0|||
163337430|NCT03340961|589945366|FG002|Overall Study|Lack of Efficacy|0|||
163337431|NCT03340961|589945367|FG003|Overall Study|Lack of Efficacy|1|||
163337432|NCT01286311|589945368|FG000|Overall Study|Physician did not want outreach sent|14|||
163337433|NCT01286311|589945369|FG001|Overall Study|Physician did not want outreach sent|0|||
163337434|NCT01437540|589945372|FG000|Overall Study|Not listed below|7|||
163337435|NCT01437540|589945373|FG001|Overall Study|Not listed below|6|||
163337436|NCT01437540|589945372|FG000|Overall Study|COPD exacerbation|13|||
163337437|NCT01437540|589945373|FG001|Overall Study|COPD exacerbation|3|||
163337438|NCT01437540|589945372|FG000|Overall Study|Lost to Follow-up|3|||
163337439|NCT01437540|589945373|FG001|Overall Study|Lost to Follow-up|5|||
163337440|NCT01437540|589945372|FG000|Overall Study|Lack of Efficacy|23|||
163337441|NCT01437540|589945373|FG001|Overall Study|Lack of Efficacy|11|||
163337442|NCT01437540|589945372|FG000|Overall Study|Protocol Violation|24|||
163337443|NCT01437540|589945373|FG001|Overall Study|Protocol Violation|12|||
163337444|NCT01437540|589945372|FG000|Overall Study|Adverse Event|26|||
163337445|NCT01437540|589945373|FG001|Overall Study|Adverse Event|13|||
163337446|NCT01437540|589945372|FG000|Overall Study|Withdrawal by Subject|31|||
163337447|NCT01437540|589945373|FG001|Overall Study|Withdrawal by Subject|15|||
163337448|NCT01381549|589945376|FG000|Overall Study|Ineligible: No organisms isolated|0|||
163337449|NCT01381549|589945377|FG001|Overall Study|Ineligible: No organisms isolated|0|||
163337450|NCT01381549|589945378|FG002|Overall Study|Ineligible: No organisms isolated|1|||
163337451|NCT02152384|589945383|FG000|Period 1|Withdrawal by Subject|0|||
163337452|NCT02152384|589945384|FG001|Period 1|Withdrawal by Subject|1|||
163337453|NCT02152384|589945383|FG000|Period 1|Adverse Event|1|||
163337454|NCT02152384|589945384|FG001|Period 1|Adverse Event|1|||
163337455|NCT02446015|589945385|FG000|Overall Study|Adverse Event|0|||
163337456|NCT02446015|589945386|FG001|Overall Study|Adverse Event|1|||
163337457|NCT02446015|589945385|FG000|Overall Study|Withdrawal by Subject|1|||
163337458|NCT02446015|589945386|FG001|Overall Study|Withdrawal by Subject|0|||
163337459|NCT01393600|589945387|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
163337460|NCT01393600|589945388|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
163337461|NCT01393600|589945389|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
163337462|NCT01393600|589945390|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
163039030|NCT01900431|588850647|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
163039031|NCT01900431|588850648|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
163039032|NCT01900431|588850649|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
163039033|NCT01900431|588850647|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
163039034|NCT01900431|588850648|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
163039035|NCT01900431|588850649|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
163039036|NCT01900431|588850647|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
163039037|NCT01900431|588850648|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
163039038|NCT01900431|588850649|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
163039039|NCT01900431|588850647|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
163039040|NCT01900431|588850648|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
163039041|NCT01900431|588850649|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
163039042|NCT01900431|588850647|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
163039043|NCT01900431|588850648|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
163039044|NCT01900431|588850649|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
163039045|NCT01900431|588850647|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
163039046|NCT01900431|588850648|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
163039047|NCT01900431|588850649|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
163039048|NCT01900431|588850647|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
163039049|NCT01900431|588850648|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
163039050|NCT01900431|588850649|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
163039051|NCT01900431|588850647|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
163039052|NCT01900431|588850648|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
163039053|NCT01900431|588850649|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
163039054|NCT01841567|588850650|FG000|Overall Study|Adverse Event|3|||
163039055|NCT03172364|588850651|FG000|Overall Study|Adverse Event|1|||
163039056|NCT03172364|588850652|FG001|Overall Study|Adverse Event|1|||
163039057|NCT03172364|588850651|FG000|Overall Study|Protocol Violation|1|||
163039058|NCT03172364|588850652|FG001|Overall Study|Protocol Violation|0|||
163039059|NCT00630747|588850653|FG000|Overall Study|Death|1|||
163039060|NCT00630747|588850653|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
163039061|NCT00630747|588850653|FG000|Overall Study|Returned to country of origin|1|||
163337463|NCT01393600|589945387|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
163337464|NCT01393600|589945388|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
163337465|NCT01393600|589945389|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
163337466|NCT01393600|589945390|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
163337467|NCT01393600|589945387|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
163337468|NCT01393600|589945388|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
163337469|NCT01393600|589945389|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
163337470|NCT01393600|589945390|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
163337471|NCT01393600|589945387|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
163337472|NCT01393600|589945388|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
163337473|NCT01393600|589945389|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
163337474|NCT01393600|589945390|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
163337475|NCT01393600|589945387|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
163337476|NCT01393600|589945388|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
163337477|NCT01393600|589945389|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
163337478|NCT01393600|589945390|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
163337479|NCT01393600|589945387|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
163337480|NCT01393600|589945388|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
163337481|NCT01393600|589945389|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
163337482|NCT01393600|589945390|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
163337483|NCT01393600|589945387|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
163337484|NCT01393600|589945388|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
163337485|NCT01393600|589945389|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
163337486|NCT01393600|589945390|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
163337487|NCT00603798|589945391|FG000|Overall Study|Adverse Event|4|||
163337488|NCT00603798|589945392|FG001|Overall Study|Adverse Event|2|||
163337489|NCT00603798|589945393|FG002|Overall Study|Adverse Event|1|||
163337490|NCT00603798|589945391|FG000|Overall Study|Withdrawal by Subject|4|||
163337491|NCT00603798|589945392|FG001|Overall Study|Withdrawal by Subject|3|||
163337492|NCT00603798|589945393|FG002|Overall Study|Withdrawal by Subject|4|||
163337493|NCT00603798|589945391|FG000|Overall Study|Lost to Follow-up|1|||
163337494|NCT00603798|589945392|FG001|Overall Study|Lost to Follow-up|0|||
163337495|NCT00603798|589945393|FG002|Overall Study|Lost to Follow-up|1|||
163337496|NCT00603798|589945391|FG000|Overall Study|Non-compliance with study procedures|0|||
163337497|NCT00603798|589945392|FG001|Overall Study|Non-compliance with study procedures|1|||
163337498|NCT00603798|589945393|FG002|Overall Study|Non-compliance with study procedures|0|||
163337499|NCT00603798|589945391|FG000|Overall Study|Not due to AE|1|||
163337500|NCT00603798|589945392|FG001|Overall Study|Not due to AE|1|||
163337501|NCT00603798|589945393|FG002|Overall Study|Not due to AE|4|||
163337502|NCT00988429|589945397|FG000|Overall Study|Adverse Event|9|||
163337503|NCT00988429|589945398|FG001|Overall Study|Adverse Event|21|||
163337504|NCT00988429|589945399|FG002|Overall Study|Adverse Event|45|||
163337505|NCT00988429|589945397|FG000|Overall Study|Lack of Efficacy|0|||
163337506|NCT00988429|589945398|FG001|Overall Study|Lack of Efficacy|0|||
163337507|NCT00988429|589945399|FG002|Overall Study|Lack of Efficacy|1|||
163337508|NCT00988429|589945397|FG000|Overall Study|Non-Compliance with Study Drug|5|||
163337509|NCT00988429|589945398|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163337510|NCT00988429|589945399|FG002|Overall Study|Non-Compliance with Study Drug|3|||
163337511|NCT00988429|589945397|FG000|Overall Study|Physician Decision|1|||
163337512|NCT00988429|589945398|FG001|Overall Study|Physician Decision|0|||
163337513|NCT00988429|589945399|FG002|Overall Study|Physician Decision|3|||
163337514|NCT00988429|589945397|FG000|Overall Study|Pregnancy|2|||
163337515|NCT00988429|589945398|FG001|Overall Study|Pregnancy|1|||
163337516|NCT00988429|589945399|FG002|Overall Study|Pregnancy|0|||
163337517|NCT00988429|589945397|FG000|Overall Study|Protocol Violation|4|||
163337518|NCT00988429|589945398|FG001|Overall Study|Protocol Violation|3|||
163337519|NCT00988429|589945399|FG002|Overall Study|Protocol Violation|3|||
163337520|NCT00988429|589945397|FG000|Overall Study|Withdrawal by Subject|7|||
163337521|NCT00988429|589945398|FG001|Overall Study|Withdrawal by Subject|7|||
163337522|NCT00988429|589945399|FG002|Overall Study|Withdrawal by Subject|12|||
163337523|NCT00988429|589945397|FG000|Overall Study|Administrative Reasons|1|||
163039062|NCT02732327|588850656|FG000|Overall Study|Protocol Violation|0|||
163039063|NCT02732327|588850657|FG001|Overall Study|Protocol Violation|1|||
163337524|NCT00988429|589945398|FG001|Overall Study|Administrative Reasons|2|||
163337525|NCT00988429|589945399|FG002|Overall Study|Administrative Reasons|1|||
163407622|NCT02706873|590200873|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
163407623|NCT02706873|590200874|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
163407624|NCT02706873|590200871|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
163407625|NCT02706873|590200872|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
163337526|NCT00988429|589945397|FG000|Overall Study|other reasons|8|||
163337527|NCT00988429|589945398|FG001|Overall Study|other reasons|8|||
163337528|NCT00988429|589945399|FG002|Overall Study|other reasons|1|||
163039064|NCT00603382|588850658|FG000|Overall Study|Adverse Event|0|||
163092300|NCT01508910|589048524|FG000|Treatment|Withdrawal by Subject|0|||
163092301|NCT01508910|589048525|FG001|Treatment|Withdrawal by Subject|1|||
163092302|NCT01508910|589048526|FG002|Treatment|Withdrawal by Subject|6|||
163092303|NCT01508910|589048527|FG003|Treatment|Withdrawal by Subject|1|||
163092304|NCT01508910|589048524|FG000|Treatment|Sponsor Decision|0|||
163092305|NCT01508910|589048525|FG001|Treatment|Sponsor Decision|0|||
163092306|NCT01508910|589048526|FG002|Treatment|Sponsor Decision|0|||
163092307|NCT01508910|589048527|FG003|Treatment|Sponsor Decision|1|||
163092308|NCT01595529|589048528|FG000|Overall Study|Adverse Event|2|||
163092309|NCT01595529|589048529|FG001|Overall Study|Adverse Event|0|||
163092310|NCT01595529|589048528|FG000|Overall Study|Subject Non-Compliant|2|||
163337529|NCT02964234|589945400|FG000|Overall Study|Lost to Follow-up|22|||
163337530|NCT02964234|589945401|FG001|Overall Study|Lost to Follow-up|13|||
163337531|NCT01123356|589945402|FG000|Overall Study|Adverse Event|2|||
163337532|NCT01123356|589945402|FG000|Overall Study|Lack of Efficacy|4|||
163337533|NCT01123356|589945402|FG000|Overall Study|Withdrawal by Subject|1|||
163337534|NCT02246647|589945406|FG000|Overall Study|Withdrawal by Subject|1|||
163337535|NCT02246647|589945407|FG001|Overall Study|Withdrawal by Subject|1|||
163337536|NCT01113541|589945412|FG000|Overall Study|Withdrawal by Subject|1|||
163337537|NCT01113541|589945412|FG000|Overall Study|Protocol Violation|1|||
163337538|NCT01113541|589945412|FG000|Overall Study|Study Terminated by Sponsor|7|||
163337539|NCT01113541|589945412|FG000|Overall Study|Adverse Event|4|||
163337540|NCT00687297|589945421|FG000|Randomization|Withdrawal by Subject|2|||
163337541|NCT00687297|589945422|FG001|Randomization|Withdrawal by Subject|0|||
163337542|NCT00687297|589945421|FG000|Randomization|Withdrew before treatment, ineligible|1|||
163337543|NCT00687297|589945422|FG001|Randomization|Withdrew before treatment, ineligible|1|||
163337544|NCT00687297|589945421|FG000|Induction|Withdrawal by Subject|4|||
163337545|NCT00687297|589945422|FG001|Induction|Withdrawal by Subject|4|||
163337546|NCT00687297|589945421|FG000|Induction|Adverse Event|16|||
163337547|NCT00687297|589945422|FG001|Induction|Adverse Event|15|||
163337548|NCT00687297|589945421|FG000|Induction|Death|7|||
163337549|NCT00687297|589945422|FG001|Induction|Death|11|||
163337550|NCT00687297|589945421|FG000|Induction|Lack of Efficacy|17|||
163337551|NCT00687297|589945422|FG001|Induction|Lack of Efficacy|21|||
163337552|NCT00687297|589945421|FG000|Induction|Ineligible|0|||
163337553|NCT00687297|589945422|FG001|Induction|Ineligible|1|||
163337554|NCT00687297|589945421|FG000|Induction|Patient Noncompliance|1|||
163337555|NCT00687297|589945422|FG001|Induction|Patient Noncompliance|0|||
163092311|NCT01595529|589048529|FG001|Overall Study|Subject Non-Compliant|0|||
163092312|NCT01595529|589048528|FG000|Overall Study|Lost to Follow-up|8|||
163092313|NCT01595529|589048529|FG001|Overall Study|Lost to Follow-up|14|||
163337556|NCT00687297|589945421|FG000|Induction|Physician Decision|0|||
163337557|NCT00687297|589945422|FG001|Induction|Physician Decision|2|||
163337558|NCT00687297|589945421|FG000|Induction|Other|0|||
163337559|NCT00687297|589945422|FG001|Induction|Other|1|||
163337560|NCT02525744|589945425|FG000|Period 1|Physician Decision|0|||
163337561|NCT02525744|589945426|FG001|Period 1|Physician Decision|0|||
163337562|NCT02525744|589945427|FG002|Period 1|Physician Decision|1|||
163092314|NCT01595529|589048528|FG000|Overall Study|Protocol Violation|1|||
163092315|NCT01595529|589048529|FG001|Overall Study|Protocol Violation|2|||
163092316|NCT01595529|589048528|FG000|Overall Study|Physician Decision|1|||
163092317|NCT01595529|589048529|FG001|Overall Study|Physician Decision|0|||
163092318|NCT01595529|589048528|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
163092319|NCT01595529|589048529|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
163092320|NCT01595529|589048528|FG000|Overall Study|Administrative Decision|1|||
163092321|NCT01595529|589048529|FG001|Overall Study|Administrative Decision|0|||
163092322|NCT01595529|589048528|FG000|Overall Study|Entry Failure/Screening Failure|6|||
163337563|NCT02525744|589945428|FG003|Period 1|Physician Decision|0|||
163337564|NCT02525744|589945425|FG000|Period 3|Adverse Event|0|||
163337565|NCT02525744|589945426|FG001|Period 3|Adverse Event|1|||
163337566|NCT02525744|589945427|FG002|Period 3|Adverse Event|0|||
163337567|NCT02525744|589945428|FG003|Period 3|Adverse Event|0|||
163407626|NCT02706873|590200873|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
163092323|NCT01595529|589048529|FG001|Overall Study|Entry Failure/Screening Failure|1|||
163092324|NCT04016714|589048530|FG000|Overall Study|Death|1|||
163092325|NCT04016714|589048531|FG001|Overall Study|Death|0|||
163337568|NCT02525744|589945425|FG000|Period 4|Withdrawal by Subject|1|||
163337569|NCT02525744|589945426|FG001|Period 4|Withdrawal by Subject|0|||
163337570|NCT02525744|589945427|FG002|Period 4|Withdrawal by Subject|0|||
163337571|NCT02525744|589945428|FG003|Period 4|Withdrawal by Subject|0|||
163337572|NCT02525744|589945425|FG000|Period 5|Physician Decision|1|||
163092326|NCT04016714|589048530|FG000|Overall Study|Lost to Follow-up|3|||
163092327|NCT04016714|589048531|FG001|Overall Study|Lost to Follow-up|1|||
163092328|NCT04016714|589048530|FG000|Overall Study|Physician Decision|3|||
163092329|NCT04016714|589048531|FG001|Overall Study|Physician Decision|3|||
163092330|NCT04016714|589048530|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
163092331|NCT04016714|589048531|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
163337573|NCT02525744|589945426|FG001|Period 5|Physician Decision|0|||
163337574|NCT02525744|589945427|FG002|Period 5|Physician Decision|0|||
163337575|NCT02525744|589945428|FG003|Period 5|Physician Decision|0|||
163337576|NCT02069379|589945429|FG000|Baseline Measurements|Lost to Follow-up|1|||
163337577|NCT02069379|589945430|FG001|Baseline Measurements|Lost to Follow-up|0|||
163337578|NCT02069379|589945431|FG002|Baseline Measurements|Lost to Follow-up|0|||
163337579|NCT02069379|589945432|FG003|Baseline Measurements|Lost to Follow-up|0|||
163337580|NCT02069379|589945429|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
163337581|NCT02069379|589945430|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
163337582|NCT02069379|589945431|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
163337583|NCT02069379|589945432|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
163039065|NCT00603382|588850659|FG001|Overall Study|Adverse Event|1|||
163039066|NCT00603382|588850660|FG002|Overall Study|Adverse Event|1|||
163039067|NCT00603382|588850661|FG003|Overall Study|Adverse Event|2|||
163039068|NCT00603382|588850662|FG004|Overall Study|Adverse Event|1|||
163039069|NCT00603382|588850663|FG005|Overall Study|Adverse Event|2|||
163039070|NCT00603382|588850658|FG000|Overall Study|Lack of Efficacy|14|||
163039071|NCT00603382|588850659|FG001|Overall Study|Lack of Efficacy|9|||
163039072|NCT00603382|588850660|FG002|Overall Study|Lack of Efficacy|3|||
163039073|NCT00603382|588850661|FG003|Overall Study|Lack of Efficacy|6|||
163039074|NCT00603382|588850662|FG004|Overall Study|Lack of Efficacy|6|||
163039075|NCT00603382|588850663|FG005|Overall Study|Lack of Efficacy|11|||
163039076|NCT00603382|588850658|FG000|Overall Study|Protocol Violation|1|||
163039077|NCT00603382|588850659|FG001|Overall Study|Protocol Violation|0|||
163039078|NCT00603382|588850660|FG002|Overall Study|Protocol Violation|1|||
163039079|NCT00603382|588850661|FG003|Overall Study|Protocol Violation|2|||
163039080|NCT00603382|588850662|FG004|Overall Study|Protocol Violation|1|||
163039081|NCT00603382|588850663|FG005|Overall Study|Protocol Violation|0|||
163039082|NCT00603382|588850658|FG000|Overall Study|Lost to Follow-up|0|||
163039083|NCT00603382|588850659|FG001|Overall Study|Lost to Follow-up|1|||
163039084|NCT00603382|588850660|FG002|Overall Study|Lost to Follow-up|1|||
163039085|NCT00603382|588850661|FG003|Overall Study|Lost to Follow-up|1|||
163039086|NCT00603382|588850662|FG004|Overall Study|Lost to Follow-up|0|||
163039087|NCT00603382|588850663|FG005|Overall Study|Lost to Follow-up|1|||
163039088|NCT00603382|588850658|FG000|Overall Study|Physician Decision|0|||
163039089|NCT00603382|588850659|FG001|Overall Study|Physician Decision|0|||
163039090|NCT00603382|588850660|FG002|Overall Study|Physician Decision|2|||
163039091|NCT00603382|588850661|FG003|Overall Study|Physician Decision|0|||
163039092|NCT00603382|588850662|FG004|Overall Study|Physician Decision|1|||
163039093|NCT00603382|588850663|FG005|Overall Study|Physician Decision|3|||
163039094|NCT00603382|588850658|FG000|Overall Study|Withdrawal by Subject|3|||
163039095|NCT00603382|588850659|FG001|Overall Study|Withdrawal by Subject|3|||
163039096|NCT00603382|588850660|FG002|Overall Study|Withdrawal by Subject|1|||
163039097|NCT00603382|588850661|FG003|Overall Study|Withdrawal by Subject|1|||
163039098|NCT00603382|588850662|FG004|Overall Study|Withdrawal by Subject|0|||
163039099|NCT00603382|588850663|FG005|Overall Study|Withdrawal by Subject|1|||
163039100|NCT00583102|588850664|FG000|Overall Study|Adverse Event|3|||
163039101|NCT01078298|588850669|FG000|Overall Study|Lost to Follow-up|12|||
163039102|NCT01078298|588850670|FG001|Overall Study|Lost to Follow-up|13|||
163039103|NCT01078298|588850669|FG000|Overall Study|Withdrawal by Subject|31|||
163039104|NCT01078298|588850670|FG001|Overall Study|Withdrawal by Subject|33|||
163039105|NCT01078298|588850669|FG000|Overall Study|Protocol Violation|6|||
163039106|NCT01078298|588850670|FG001|Overall Study|Protocol Violation|6|||
163039107|NCT01078298|588850669|FG000|Overall Study|Adverse Event|6|||
163039108|NCT01078298|588850670|FG001|Overall Study|Adverse Event|5|||
163039109|NCT01078298|588850669|FG000|Overall Study|Death|2|||
163039110|NCT01078298|588850670|FG001|Overall Study|Death|0|||
163039111|NCT01078298|588850669|FG000|Overall Study|Did not meet entrance criteria|0|||
163039112|NCT01078298|588850670|FG001|Overall Study|Did not meet entrance criteria|1|||
163039113|NCT01078298|588850669|FG000|Overall Study|Other|24|||
163039114|NCT01078298|588850670|FG001|Overall Study|Other|32|||
163039115|NCT00628927|588850671|FG000|Overall Study|Problems performing blood draw|6|||
163039116|NCT00628927|588850672|FG001|Overall Study|Problems performing blood draw|0|||
163039117|NCT00628927|588850671|FG000|Overall Study|Lost to Follow-up|1|||
163039118|NCT00628927|588850672|FG001|Overall Study|Lost to Follow-up|0|||
163039119|NCT00628927|588850671|FG000|Overall Study|Equipment failure|1|||
163039120|NCT00628927|588850672|FG001|Overall Study|Equipment failure|0|||
163039121|NCT01298141|588850676|FG000|Overall Study|Adverse Event|3|||
163039122|NCT01298141|588850676|FG000|Overall Study|Refusal of Required Study Procedures|1|||
163039123|NCT01298141|588850676|FG000|Overall Study|Withdrawal by Subject|6|||
163039124|NCT01298141|588850676|FG000|Overall Study|Termination of Study by the Investigator|5|||
163039125|NCT01298141|588850676|FG000|Overall Study|Other|5|||
163039126|NCT01298141|588850676|FG000|Overall Study|Lost to Follow-up|1|||
163039127|NCT01298141|588850676|FG000|Overall Study|Death|6|||
163039128|NCT01298141|588850676|FG000|Overall Study|Not treated|4|||
163039129|NCT03338569|588850677|FG000|Overall Study|Physician Decision|8|||
163039130|NCT03338569|588850678|FG001|Overall Study|Physician Decision|3|||
163039131|NCT03338569|588850677|FG000|Overall Study|Withdrawal by Subject|0|||
163039132|NCT03338569|588850678|FG001|Overall Study|Withdrawal by Subject|1|||
163039133|NCT03338569|588850677|FG000|Overall Study|Lost to Follow-up|0|||
163039134|NCT03338569|588850678|FG001|Overall Study|Lost to Follow-up|1|||
163092332|NCT01822665|589048532|FG000|Overall Study|Adverse Event|3|||
163092333|NCT01822665|589048532|FG000|Overall Study|Other Reason|5|||
163092334|NCT00867035|589048533|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
163092335|NCT00867035|589048534|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
163092336|NCT00867035|589048533|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
163092337|NCT00867035|589048534|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
163092338|NCT04592341|589050508|FG000|Overall Study|Physician Decision|5|||
163092339|NCT04592341|589050508|FG000|Overall Study|Study Terminated by Sponsor|5|||
163092340|NCT04592341|589050508|FG000|Overall Study|Withdrawal by Subject|53|||
163092341|NCT04592341|589050508|FG000|Overall Study|Lost to Follow-up|3|||
163092342|NCT04592341|589050508|FG000|Overall Study|Death|1|||
163092343|NCT04592341|589050508|FG000|Overall Study|Adverse Event|5|||
163092344|NCT04592341|589050508|FG000|Overall Study|other|4|||
163092345|NCT01747915|589050509|FG000|Overall Study|Other|1|||
163092346|NCT01747915|589050510|FG001|Overall Study|Other|1|||
163092347|NCT01747915|589050511|FG002|Overall Study|Other|1|||
163092348|NCT01747915|589050509|FG000|Overall Study|Adverse Event|8|||
163092349|NCT01747915|589050510|FG001|Overall Study|Adverse Event|5|||
163092350|NCT01747915|589050511|FG002|Overall Study|Adverse Event|2|||
163092351|NCT01747915|589050509|FG000|Overall Study|Death|0|||
163092352|NCT01747915|589050510|FG001|Overall Study|Death|0|||
163092353|NCT01747915|589050511|FG002|Overall Study|Death|1|||
163092354|NCT01747915|589050509|FG000|Overall Study|Lack of Efficacy|0|||
163092355|NCT01747915|589050510|FG001|Overall Study|Lack of Efficacy|1|||
163092356|NCT01747915|589050511|FG002|Overall Study|Lack of Efficacy|0|||
163092357|NCT01747915|589050509|FG000|Overall Study|Lost to Follow-up|1|||
163092358|NCT01747915|589050510|FG001|Overall Study|Lost to Follow-up|0|||
163092359|NCT01747915|589050511|FG002|Overall Study|Lost to Follow-up|0|||
163092360|NCT01747915|589050509|FG000|Overall Study|Withdrawal by Subject|4|||
163092361|NCT01747915|589050510|FG001|Overall Study|Withdrawal by Subject|4|||
163092362|NCT01747915|589050511|FG002|Overall Study|Withdrawal by Subject|1|||
163092363|NCT01747915|589050509|FG000|Overall Study|Protocol Violation|1|||
163092364|NCT01747915|589050510|FG001|Overall Study|Protocol Violation|0|||
163092365|NCT01747915|589050511|FG002|Overall Study|Protocol Violation|0|||
163092366|NCT01747915|589050509|FG000|Overall Study|Pregnancy|0|||
163092367|NCT01747915|589050510|FG001|Overall Study|Pregnancy|0|||
163092368|NCT01747915|589050511|FG002|Overall Study|Pregnancy|1|||
163092369|NCT06164691|589050517|FG000|Overall Study|Withdrawal by Subject|2|||
163092370|NCT06164691|589050518|FG001|Overall Study|Withdrawal by Subject|0|||
163092371|NCT06164691|589050519|FG002|Overall Study|Withdrawal by Subject|0|||
163092372|NCT00812955|589050520|FG000|Overall Study|Adverse Event|7|||
163092373|NCT00812955|589050521|FG001|Overall Study|Adverse Event|6|||
163092374|NCT00812955|589050522|FG002|Overall Study|Adverse Event|3|||
163092375|NCT00812955|589050523|FG003|Overall Study|Adverse Event|4|||
163092376|NCT00812955|589050520|FG000|Overall Study|Lost to Follow-up|2|||
163092377|NCT00812955|589050521|FG001|Overall Study|Lost to Follow-up|1|||
163092378|NCT00812955|589050522|FG002|Overall Study|Lost to Follow-up|1|||
163092379|NCT00812955|589050523|FG003|Overall Study|Lost to Follow-up|2|||
163092380|NCT00812955|589050520|FG000|Overall Study|Withdrawal by Subject|1|||
163092381|NCT00812955|589050521|FG001|Overall Study|Withdrawal by Subject|0|||
163092382|NCT00812955|589050522|FG002|Overall Study|Withdrawal by Subject|1|||
163092383|NCT00812955|589050523|FG003|Overall Study|Withdrawal by Subject|2|||
163092384|NCT00812955|589050520|FG000|Overall Study|randomized in error|0|||
163092385|NCT00812955|589050521|FG001|Overall Study|randomized in error|0|||
163092386|NCT00812955|589050522|FG002|Overall Study|randomized in error|1|||
163092387|NCT00812955|589050523|FG003|Overall Study|randomized in error|0|||
163092388|NCT03046446|589050524|FG000|Overall Study|Lack of Efficacy|7|||
163039135|NCT00350779|588850679|FG000|Overall Study|Adverse Event|4|||
163039136|NCT00350779|588850680|FG001|Overall Study|Adverse Event|2|||
163039137|NCT00350779|588850679|FG000|Overall Study|Lack of Efficacy|0|||
163039138|NCT00350779|588850680|FG001|Overall Study|Lack of Efficacy|4|||
163039139|NCT00350779|588850679|FG000|Overall Study|Lost to Follow-up|2|||
163039140|NCT00350779|588850680|FG001|Overall Study|Lost to Follow-up|0|||
163039141|NCT00350779|588850679|FG000|Overall Study|Physician Decision|2|||
163092389|NCT03046446|589050524|FG000|Overall Study|Adverse Event|6|||
163092390|NCT03046446|589050524|FG000|Overall Study|Lost to Follow-up|3|||
163092391|NCT03046446|589050524|FG000|Overall Study|Withdrawal by Subject|14|||
163092392|NCT03046446|589050524|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
163092393|NCT03046446|589050524|FG000|Overall Study|Disease Progression (see caveats)|25|||
163092394|NCT03046446|589050524|FG000|Overall Study|Non OA related knee surgery|1|||
163092395|NCT03183063|589050525|FG000|Overall Study|Withdrawal by Subject|2|||
163039142|NCT00350779|588850680|FG001|Overall Study|Physician Decision|4|||
163039143|NCT00350779|588850679|FG000|Overall Study|Protocol Violation|3|||
163092396|NCT03183063|589050526|FG001|Overall Study|Withdrawal by Subject|0|||
163092397|NCT03183063|589050527|FG002|Overall Study|Withdrawal by Subject|0|||
163092398|NCT03183063|589050525|FG000|Overall Study|Physician Decision|3|||
163092399|NCT03183063|589050526|FG001|Overall Study|Physician Decision|4|||
163039144|NCT00350779|588850680|FG001|Overall Study|Protocol Violation|1|||
163092400|NCT03183063|589050527|FG002|Overall Study|Physician Decision|4|||
163092401|NCT00399568|589050528|FG000|Overall Study|Adverse Event|1|||
163337584|NCT02069379|589945429|FG000|First Treatment Arm|Lost to Follow-up|0|||
163337585|NCT02069379|589945430|FG001|First Treatment Arm|Lost to Follow-up|1|||
163337586|NCT02069379|589945431|FG002|First Treatment Arm|Lost to Follow-up|1|||
163337587|NCT02069379|589945432|FG003|First Treatment Arm|Lost to Follow-up|0|||
163337588|NCT02069379|589945429|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
163337589|NCT02069379|589945430|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
163337590|NCT02069379|589945431|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
163337591|NCT02069379|589945432|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
163337592|NCT02069379|589945429|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
163337593|NCT02069379|589945430|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
163337594|NCT02069379|589945431|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
163337595|NCT02069379|589945432|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
163337596|NCT02069379|589945429|FG000|Second Treatment Arm|Lost to Follow-up|0|||
163337597|NCT02069379|589945430|FG001|Second Treatment Arm|Lost to Follow-up|0|||
163337598|NCT02069379|589945431|FG002|Second Treatment Arm|Lost to Follow-up|1|||
163337599|NCT02069379|589945432|FG003|Second Treatment Arm|Lost to Follow-up|0|||
163337600|NCT00274287|589945435|FG000|Overall Study|Withdrawal by Subject|1|||
163337601|NCT00274287|589945435|FG000|Overall Study|subject non-compliance|1|||
163337602|NCT04617847|589945436|FG000|Overall Study|Withdrawal by Subject|1|||
163337603|NCT04617847|589945437|FG001|Overall Study|Withdrawal by Subject|0|||
163337604|NCT04617847|589945436|FG000|Overall Study|Adverse Event|0|||
163337605|NCT04617847|589945437|FG001|Overall Study|Adverse Event|2|||
163337606|NCT04617847|589945436|FG000|Overall Study|Death|0|||
163337607|NCT04617847|589945437|FG001|Overall Study|Death|1|||
163337608|NCT04617847|589945436|FG000|Overall Study|Termination of Study by Sponsor|2|||
163337609|NCT04617847|589945437|FG001|Overall Study|Termination of Study by Sponsor|21|||
163337610|NCT01525875|589945438|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
163337611|NCT01525875|589945439|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
163337612|NCT01525875|589945438|FG000|Open-label Period|Lost to Follow-up|0|||
163337613|NCT01525875|589945439|FG001|Open-label Period|Lost to Follow-up|2|||
163337614|NCT03031782|589945446|FG000|Treatment Period 1|Lack of Efficacy|3|||
163337615|NCT03031782|589945447|FG001|Treatment Period 1|Lack of Efficacy|0|||
163337616|NCT03031782|589945448|FG002|Treatment Period 1|Lack of Efficacy|0|||
163337617|NCT03031782|589945449|FG003|Treatment Period 1|Lack of Efficacy|0|||
163337618|NCT03031782|589945450|FG004|Treatment Period 1|Lack of Efficacy|0|||
163337619|NCT03031782|589945446|FG000|Treatment Period 2|Physician Decision|0|||
163337620|NCT03031782|589945447|FG001|Treatment Period 2|Physician Decision|1|||
163337621|NCT03031782|589945448|FG002|Treatment Period 2|Physician Decision|0|||
163337622|NCT03031782|589945449|FG003|Treatment Period 2|Physician Decision|0|||
163337623|NCT03031782|589945450|FG004|Treatment Period 2|Physician Decision|3|||
163337624|NCT03031782|589945446|FG000|Treatment Period 2|Lack of Efficacy|0|||
163337625|NCT03031782|589945447|FG001|Treatment Period 2|Lack of Efficacy|1|||
163337626|NCT03031782|589945448|FG002|Treatment Period 2|Lack of Efficacy|0|||
163337627|NCT03031782|589945449|FG003|Treatment Period 2|Lack of Efficacy|0|||
163337628|NCT03031782|589945450|FG004|Treatment Period 2|Lack of Efficacy|1|||
163337629|NCT03031782|589945446|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163337630|NCT03031782|589945447|FG001|Treatment Period 2|Withdrawal by Subject|3|||
163092402|NCT00399568|589050529|FG001|Overall Study|Adverse Event|2|||
163092403|NCT00399568|589050528|FG000|Overall Study|Withdrawal by Subject|7|||
163092404|NCT00399568|589050529|FG001|Overall Study|Withdrawal by Subject|3|||
163092405|NCT00399568|589050528|FG000|Overall Study|Protocol non-compliance|2|||
163092406|NCT00399568|589050529|FG001|Overall Study|Protocol non-compliance|2|||
163092407|NCT00399568|589050528|FG000|Overall Study|Lost to Follow-up|2|||
163092408|NCT00399568|589050529|FG001|Overall Study|Lost to Follow-up|2|||
163092409|NCT00925002|589050530|FG000|Overall Study|Other|1|||
163092410|NCT00925002|589050531|FG001|Overall Study|Other|4|||
163092411|NCT00925002|589050532|FG002|Overall Study|Other|0|||
163092412|NCT00925002|589050530|FG000|Overall Study|Death|1|||
163092413|NCT00925002|589050531|FG001|Overall Study|Death|1|||
163092414|NCT00925002|589050532|FG002|Overall Study|Death|5|||
163337631|NCT03031782|589945448|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163337632|NCT03031782|589945449|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163337633|NCT03031782|589945450|FG004|Treatment Period 2|Withdrawal by Subject|1|||
163337634|NCT03031782|589945446|FG000|Treatment Period 2|Adverse Event|0|||
163337635|NCT03031782|589945447|FG001|Treatment Period 2|Adverse Event|1|||
163337636|NCT03031782|589945448|FG002|Treatment Period 2|Adverse Event|2|||
163337637|NCT03031782|589945449|FG003|Treatment Period 2|Adverse Event|0|||
163337638|NCT03031782|589945450|FG004|Treatment Period 2|Adverse Event|0|||
163337639|NCT03031782|589945446|FG000|Treatment Period 3|Withdrawal by Subject|0|||
163337640|NCT03031782|589945447|FG001|Treatment Period 3|Withdrawal by Subject|0|||
163337641|NCT03031782|589945448|FG002|Treatment Period 3|Withdrawal by Subject|0|||
163337642|NCT03031782|589945449|FG003|Treatment Period 3|Withdrawal by Subject|1|||
163337643|NCT03031782|589945450|FG004|Treatment Period 3|Withdrawal by Subject|0|||
163092415|NCT00925002|589050530|FG000|Overall Study|Adverse Event|3|||
163092416|NCT00925002|589050531|FG001|Overall Study|Adverse Event|1|||
163092417|NCT00925002|589050532|FG002|Overall Study|Adverse Event|2|||
163220109|NCT02039674|589521413|FG007|Overall Study|Excluded Medication|0|||
163092418|NCT00925002|589050530|FG000|Overall Study|Participant withdrew consent|1|||
163092419|NCT00925002|589050531|FG001|Overall Study|Participant withdrew consent|3|||
163092420|NCT00925002|589050532|FG002|Overall Study|Participant withdrew consent|3|||
163092421|NCT01343888|589050535|FG000|Overall Study|Adverse Event|12|||
163092422|NCT01343888|589050536|FG001|Overall Study|Adverse Event|22|||
163092423|NCT01343888|589050537|FG002|Overall Study|Adverse Event|5|||
163092424|NCT01343888|589050535|FG000|Overall Study|Lack of Efficacy|9|||
163092425|NCT01343888|589050536|FG001|Overall Study|Lack of Efficacy|9|||
163092426|NCT01343888|589050537|FG002|Overall Study|Lack of Efficacy|13|||
163092427|NCT01343888|589050535|FG000|Overall Study|Lost to Follow-up|0|||
163092428|NCT01343888|589050536|FG001|Overall Study|Lost to Follow-up|2|||
163092429|NCT01343888|589050537|FG002|Overall Study|Lost to Follow-up|1|||
163092430|NCT01343888|589050535|FG000|Overall Study|Protocol Violation|0|||
163092431|NCT01343888|589050536|FG001|Overall Study|Protocol Violation|2|||
163092432|NCT01343888|589050537|FG002|Overall Study|Protocol Violation|0|||
163092433|NCT01343888|589050535|FG000|Overall Study|Withdrawal by Subject|4|||
163092434|NCT01343888|589050536|FG001|Overall Study|Withdrawal by Subject|4|||
163092435|NCT01343888|589050537|FG002|Overall Study|Withdrawal by Subject|2|||
163092436|NCT01343888|589050535|FG000|Overall Study|other than stated above|0|||
163092437|NCT01343888|589050536|FG001|Overall Study|other than stated above|0|||
163092438|NCT01343888|589050537|FG002|Overall Study|other than stated above|1|||
163092439|NCT00558636|589050538|FG000|Treatment|Adverse Event|9|||
163092440|NCT00558636|589050539|FG001|Treatment|Adverse Event|2|||
163092441|NCT00558636|589050538|FG000|Treatment|Withdrawal by Subject|2|||
163092442|NCT00558636|589050539|FG001|Treatment|Withdrawal by Subject|0|||
163092443|NCT00558636|589050538|FG000|Treatment|Premature termination of the study|35|||
163092444|NCT00558636|589050539|FG001|Treatment|Premature termination of the study|37|||
163092445|NCT00558636|589050538|FG000|Treatment|Disease progression|1|||
163092446|NCT00558636|589050539|FG001|Treatment|Disease progression|5|||
163092447|NCT00558636|589050538|FG000|Follow-up|Premature termination of the study|12|||
163092448|NCT00558636|589050539|FG001|Follow-up|Premature termination of the study|7|||
163092449|NCT01990742|589050540|FG000|Overall Study|Withdrawal by facility|407|||
163092450|NCT01990742|589050541|FG001|Overall Study|Withdrawal by facility|1083|||
163092451|NCT01990742|589050540|FG000|Overall Study|Facility closed|0|||
163092452|NCT01990742|589050541|FG001|Overall Study|Facility closed|270|||
163092453|NCT00800735|589050542|FG000|Overall Study|Administrative/Other|2|||
163092454|NCT00800735|589050542|FG000|Overall Study|Insufficient Therapeutic Response|2|||
163092455|NCT00800735|589050542|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
163092456|NCT00800735|589050542|FG000|Overall Study|Withdrew Consent|3|||
163092457|NCT00506142|589050543|FG000|Overall Study|Adverse Event|8|||
163092458|NCT00506142|589050544|FG001|Overall Study|Adverse Event|7|||
163092459|NCT00506142|589050543|FG000|Overall Study|Lack of Efficacy|21|||
163092460|NCT00506142|589050544|FG001|Overall Study|Lack of Efficacy|7|||
163092461|NCT00506142|589050543|FG000|Overall Study|Withdrawal by Subject|4|||
163092462|NCT00506142|589050544|FG001|Overall Study|Withdrawal by Subject|5|||
163092463|NCT00506142|589050543|FG000|Overall Study|Physician Decision|1|||
163092464|NCT00506142|589050544|FG001|Overall Study|Physician Decision|0|||
163092465|NCT00506142|589050543|FG000|Overall Study|New health condition|1|||
163092466|NCT00506142|589050544|FG001|Overall Study|New health condition|0|||
163337644|NCT04867382|589945451|FG000|Overall Study|Did not complete the survey|2|||
163337645|NCT04867382|589945452|FG001|Overall Study|Did not complete the survey|1|||
163337646|NCT05445557|589945453|FG000|Double Blind Part|Lost to Follow-up|1|||
163337647|NCT03803475|589945454|FG000|Overall Study|Physician Decision|1|||
163092467|NCT02133573|589050550|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
163092468|NCT02133573|589050551|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
163092469|NCT02133573|589050550|FG000|Overall Study|Child Deaths|3|||
163092470|NCT02133573|589050551|FG001|Overall Study|Child Deaths|5|||
163092471|NCT02133573|589050550|FG000|Overall Study|Child Declined Follow Ups|2|||
163092472|NCT02133573|589050551|FG001|Overall Study|Child Declined Follow Ups|1|||
163092473|NCT02133573|589050550|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
163092474|NCT02133573|589050551|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
163092475|NCT03273907|589050558|FG000|Overall Study|Death|1|||
163092476|NCT03273907|589050558|FG000|Overall Study|Lost to Follow-up|4|||
163337648|NCT01323790|589945455|FG000|Overall Study|Other|3|||
163337649|NCT01323790|589945456|FG001|Overall Study|Other|2|||
163092477|NCT03273907|589050558|FG000|Overall Study|Withdrawal by Subject|2|||
163092478|NCT03273907|589050558|FG000|Overall Study|COVID 19|2|||
163092479|NCT00110214|589050559|FG000|Overall Study|Never started treatment|21|||
163092480|NCT00110214|589050560|FG001|Overall Study|Never started treatment|20|||
163092481|NCT00110214|589050559|FG000|Overall Study|Disease progression or death|260|||
163092482|NCT00110214|589050560|FG001|Overall Study|Disease progression or death|151|||
163092483|NCT00110214|589050559|FG000|Overall Study|Adverse Event|115|||
163092484|NCT00110214|589050560|FG001|Overall Study|Adverse Event|192|||
163092485|NCT00110214|589050559|FG000|Overall Study|Refused further treatment|52|||
163092486|NCT00110214|589050560|FG001|Overall Study|Refused further treatment|65|||
163092487|NCT00110214|589050559|FG000|Overall Study|Other (not specified)|61|||
163337650|NCT01323790|589945457|FG002|Overall Study|Other|1|||
163092488|NCT00110214|589050560|FG001|Overall Study|Other (not specified)|75|||
163092489|NCT01016067|589050561|FG000|Overall Study|Lost to Follow-up|1|||
163092490|NCT01016067|589050562|FG001|Overall Study|Lost to Follow-up|2|||
163092491|NCT01016067|589050561|FG000|Overall Study|Physician Decision|1|||
163092492|NCT01016067|589050562|FG001|Overall Study|Physician Decision|1|||
163092493|NCT01016067|589050561|FG000|Overall Study|Withdrew due to Relocation|0|||
163092494|NCT01016067|589050562|FG001|Overall Study|Withdrew due to Relocation|1|||
163337651|NCT01323790|589945455|FG000|Overall Study|Lost to Follow-up|11|||
163337652|NCT01323790|589945456|FG001|Overall Study|Lost to Follow-up|9|||
163337653|NCT01323790|589945457|FG002|Overall Study|Lost to Follow-up|9|||
163337654|NCT01323790|589945455|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
163337655|NCT01323790|589945456|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
163337656|NCT01323790|589945457|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
163337657|NCT01323790|589945455|FG000|Overall Study|Lack of Efficacy|3|||
163337658|NCT01323790|589945456|FG001|Overall Study|Lack of Efficacy|0|||
163337659|NCT01323790|589945457|FG002|Overall Study|Lack of Efficacy|3|||
163337660|NCT01323790|589945455|FG000|Overall Study|Adverse Event|11|||
163337661|NCT01323790|589945456|FG001|Overall Study|Adverse Event|24|||
163337662|NCT01323790|589945457|FG002|Overall Study|Adverse Event|12|||
163337663|NCT01323790|589945455|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
163337664|NCT01323790|589945456|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
163337665|NCT01323790|589945457|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
163337666|NCT01323790|589945455|FG000|Overall Study|Withdrawal by Subject|23|||
163337667|NCT01323790|589945456|FG001|Overall Study|Withdrawal by Subject|20|||
163337668|NCT01323790|589945457|FG002|Overall Study|Withdrawal by Subject|13|||
163337669|NCT01323790|589945455|FG000|Overall Study|Did Not Receive Treatment|2|||
163337670|NCT01323790|589945456|FG001|Overall Study|Did Not Receive Treatment|0|||
163337671|NCT01323790|589945457|FG002|Overall Study|Did Not Receive Treatment|1|||
163337672|NCT01323790|589945455|FG000|Overall Study|Severe non-compliance with protocol|2|||
163337673|NCT01323790|589945456|FG001|Overall Study|Severe non-compliance with protocol|2|||
163337674|NCT01323790|589945457|FG002|Overall Study|Severe non-compliance with protocol|2|||
163337675|NCT02915783|589945464|FG000|Overall Study|Death|21|||
163337676|NCT02915783|589945464|FG000|Overall Study|Lost to Follow-up|1|||
163337677|NCT02915783|589945464|FG000|Overall Study|Withdrawal by Subject|2|||
163337678|NCT02950961|589945465|FG000|Overall Study|Study had to stop due to COVID.|7|||
163337679|NCT02432274|589945466|FG000|Overall Study|Death|2|||
163337680|NCT02432274|589945467|FG001|Overall Study|Death|6|||
163337681|NCT02432274|589945468|FG002|Overall Study|Death|7|||
163337682|NCT02432274|589945469|FG003|Overall Study|Death|0|||
163337683|NCT02432274|589945470|FG004|Overall Study|Death|27|||
163337684|NCT02432274|589945471|FG005|Overall Study|Death|7|||
163337685|NCT02432274|589945472|FG006|Overall Study|Death|9|||
163337686|NCT02432274|589945473|FG007|Overall Study|Death|14|||
163337687|NCT02432274|589945466|FG000|Overall Study|Withdrawal of Consent|0|||
163337688|NCT02432274|589945467|FG001|Overall Study|Withdrawal of Consent|0|||
163337689|NCT02432274|589945468|FG002|Overall Study|Withdrawal of Consent|0|||
163337690|NCT02432274|589945469|FG003|Overall Study|Withdrawal of Consent|0|||
163337691|NCT02432274|589945470|FG004|Overall Study|Withdrawal of Consent|2|||
163337692|NCT02432274|589945471|FG005|Overall Study|Withdrawal of Consent|0|||
163337693|NCT02432274|589945472|FG006|Overall Study|Withdrawal of Consent|1|||
163337694|NCT02432274|589945473|FG007|Overall Study|Withdrawal of Consent|2|||
163337695|NCT01736475|589945476|FG000|Overall Study|Adverse Event|4|||
163337696|NCT01736475|589945477|FG001|Overall Study|Adverse Event|0|||
163337697|NCT01736475|589945476|FG000|Overall Study|Withdrawal by Subject|2|||
163337698|NCT01736475|589945477|FG001|Overall Study|Withdrawal by Subject|0|||
163337699|NCT01736475|589945476|FG000|Overall Study|Protocol Violation|4|||
163337700|NCT01736475|589945477|FG001|Overall Study|Protocol Violation|0|||
163337701|NCT01736475|589945476|FG000|Overall Study|Other - Screen failure|1|||
163092495|NCT01673646|589050563|FG000|Overall Study|Adverse Event|2|||
163337702|NCT01736475|589945477|FG001|Overall Study|Other - Screen failure|0|||
163337703|NCT01736475|589945476|FG000|Overall Study|Other - Surgical procedure|1|||
163337704|NCT01736475|589945477|FG001|Overall Study|Other - Surgical procedure|0|||
163092496|NCT01673646|589050564|FG001|Overall Study|Adverse Event|1|||
163092497|NCT01673646|589050565|FG002|Overall Study|Adverse Event|1|||
163337705|NCT02807857|589945478|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
163337706|NCT02807857|589945478|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
163337707|NCT02807857|589945478|FG000|Follow-Up Set|Withdrawal by Subject|8|||
163337708|NCT02807857|589945478|FG000|Follow-Up Set|Lost to Follow-up|7|||
163337709|NCT02807857|589945478|FG000|Follow-Up Set|Physician Decision|6|||
163337710|NCT02807857|589945478|FG000|Follow-Up Set|Adverse Event|3|||
163337711|NCT02807857|589945478|FG000|Follow-Up Set|Death|27|||
163337712|NCT02807857|589945478|FG000|Follow-Up Set|Relocation|2|||
163337713|NCT04197713|589945479|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
163092498|NCT01673646|589050563|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163220110|NCT02039674|589521414|FG008|Overall Study|Excluded Medication|2|||
163337714|NCT04197713|589945480|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
163337715|NCT01079949|589945481|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
163337716|NCT01079949|589945482|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
163092499|NCT01673646|589050564|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163092500|NCT01673646|589050565|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
163092501|NCT01673646|589050563|FG000|Overall Study|Condition no longer requires study drug|0|||
163092502|NCT01673646|589050564|FG001|Overall Study|Condition no longer requires study drug|1|||
163092503|NCT01673646|589050565|FG002|Overall Study|Condition no longer requires study drug|0|||
163092504|NCT01673646|589050563|FG000|Overall Study|Withdrawal by Subject|0|||
163092505|NCT01673646|589050564|FG001|Overall Study|Withdrawal by Subject|2|||
163092506|NCT01673646|589050565|FG002|Overall Study|Withdrawal by Subject|2|||
163092507|NCT01673646|589050563|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
163092508|NCT01673646|589050564|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
163092509|NCT01673646|589050565|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
163092510|NCT00382174|589050569|FG000|Overall Study|Lost to Follow-up|1|||
163092511|NCT00382174|589050570|FG001|Overall Study|Lost to Follow-up|4|||
163092512|NCT00382174|589050571|FG002|Overall Study|Lost to Follow-up|5|||
163092513|NCT00382174|589050569|FG000|Overall Study|Adverse Event|1|||
163092514|NCT00382174|589050570|FG001|Overall Study|Adverse Event|4|||
163092515|NCT00382174|589050571|FG002|Overall Study|Adverse Event|5|||
163092516|NCT00382174|589050569|FG000|Overall Study|Withdrawal by Subject|1|||
163092517|NCT00382174|589050570|FG001|Overall Study|Withdrawal by Subject|4|||
163092518|NCT00382174|589050571|FG002|Overall Study|Withdrawal by Subject|5|||
163092519|NCT00382174|589050569|FG000|Overall Study|Non compliance|1|||
163092520|NCT00382174|589050570|FG001|Overall Study|Non compliance|0|||
163092521|NCT00382174|589050571|FG002|Overall Study|Non compliance|1|||
163092522|NCT00382174|589050569|FG000|Overall Study|Physician Decision|0|||
163092523|NCT00382174|589050570|FG001|Overall Study|Physician Decision|2|||
163092524|NCT00382174|589050571|FG002|Overall Study|Physician Decision|2|||
163092525|NCT00382174|589050569|FG000|Overall Study|Failed to meet criteria|0|||
163092526|NCT00382174|589050570|FG001|Overall Study|Failed to meet criteria|1|||
163092527|NCT00382174|589050571|FG002|Overall Study|Failed to meet criteria|1|||
163092528|NCT00382174|589050569|FG000|Overall Study|Wounds merged|0|||
163092529|NCT00382174|589050570|FG001|Overall Study|Wounds merged|2|||
163092530|NCT00382174|589050571|FG002|Overall Study|Wounds merged|2|||
163092531|NCT04577781|589050572|FG000|Overall Study|Adverse Event|2|||
163092532|NCT04577781|589050573|FG001|Overall Study|Adverse Event|2|||
163092533|NCT04577781|589050572|FG000|Overall Study|Physician Decision|1|||
163092534|NCT04577781|589050573|FG001|Overall Study|Physician Decision|0|||
163092535|NCT01464879|589050574|FG000|Overall Study|Physician Decision|1|||
163092536|NCT01464879|589050574|FG000|Overall Study|Non-compliance|1|||
163092537|NCT01911260|589050575|FG000|Supplementation Period|transference or evasion of school|7|||
163092538|NCT01911260|589050576|FG001|Supplementation Period|transference or evasion of school|9|||
163092539|NCT01911260|589050577|FG002|Supplementation Period|transference or evasion of school|7|||
163092540|NCT01911260|589050578|FG003|Supplementation Period|transference or evasion of school|6|||
163092541|NCT01911260|589050575|FG000|Supplementation Period|Adverse Event|2|||
163092542|NCT01911260|589050576|FG001|Supplementation Period|Adverse Event|0|||
163092543|NCT01911260|589050577|FG002|Supplementation Period|Adverse Event|1|||
163092544|NCT01911260|589050578|FG003|Supplementation Period|Adverse Event|0|||
163092545|NCT01911260|589050575|FG000|Supplementation Period|refused to receive supplement|1|||
163092546|NCT01911260|589050576|FG001|Supplementation Period|refused to receive supplement|0|||
163092547|NCT01911260|589050577|FG002|Supplementation Period|refused to receive supplement|1|||
163092548|NCT01911260|589050578|FG003|Supplementation Period|refused to receive supplement|0|||
163092549|NCT01911260|589050575|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
163092550|NCT01911260|589050576|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
163092551|NCT01911260|589050577|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
163337717|NCT01079949|589945481|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
163337718|NCT01079949|589945482|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
163337719|NCT01079949|589945481|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
163337720|NCT01079949|589945482|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
163337721|NCT01079949|589945481|FG000|Overall Study|Randomized but not treated|1|||
163337722|NCT01079949|589945482|FG001|Overall Study|Randomized but not treated|0|||
163337723|NCT01529632|589945483|FG000|Overall Study|Administrative problem|2|||
163092552|NCT01911260|589050578|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
163092553|NCT01911260|589050575|FG000|Follow-up Period|transference or evasion of school|13|||
163092554|NCT01911260|589050576|FG001|Follow-up Period|transference or evasion of school|20|||
163092555|NCT01911260|589050577|FG002|Follow-up Period|transference or evasion of school|15|||
163092556|NCT01911260|589050578|FG003|Follow-up Period|transference or evasion of school|12|||
163092557|NCT01657305|589050579|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
163092558|NCT01657305|589050579|FG000|Overall Study|Withdrawal by Subject|4|||
163092559|NCT01657305|589050579|FG000|Overall Study|Adverse Event|1|||
163092560|NCT01657305|589050579|FG000|Overall Study|Lost to Follow-up|1|||
163092561|NCT01657305|589050579|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
163220111|NCT02039674|589521415|FG009|Overall Study|Excluded Medication|3|||
163337724|NCT01529632|589945484|FG001|Overall Study|Administrative problem|1|||
163337725|NCT01529632|589945483|FG000|Overall Study|Protocol Violation|0|||
163039145|NCT00350779|588850679|FG000|Overall Study|Withdrawal by Subject|9|||
163039146|NCT00350779|588850680|FG001|Overall Study|Withdrawal by Subject|8|||
163039147|NCT00350779|588850679|FG000|Overall Study|Patient Moved|2|||
163039148|NCT00350779|588850680|FG001|Overall Study|Patient Moved|1|||
163039149|NCT00350779|588850679|FG000|Overall Study|Non-compliance with study procedures|0|||
163039150|NCT00350779|588850680|FG001|Overall Study|Non-compliance with study procedures|1|||
163039151|NCT00528372|588850681|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
163039152|NCT00528372|588850682|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039153|NCT00528372|588850683|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039154|NCT00528372|588850684|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039155|NCT00528372|588850685|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039156|NCT00528372|588850686|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039157|NCT00528372|588850687|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039158|NCT00528372|588850688|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039159|NCT00528372|588850689|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039160|NCT00528372|588850681|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
163039161|NCT00528372|588850682|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
163039162|NCT00528372|588850683|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
163039163|NCT00528372|588850684|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
163039164|NCT00528372|588850685|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
163039165|NCT00528372|588850686|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
163039166|NCT00528372|588850687|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
163039167|NCT00528372|588850688|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
163039168|NCT00528372|588850689|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
163039169|NCT00528372|588850681|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
163039170|NCT00528372|588850682|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
163039171|NCT00528372|588850683|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
163039172|NCT00528372|588850684|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
163039173|NCT00528372|588850685|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
163039174|NCT00528372|588850686|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
163039175|NCT00528372|588850687|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
163039176|NCT00528372|588850688|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
163039177|NCT00528372|588850689|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
163039178|NCT00528372|588850681|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
163039179|NCT00528372|588850682|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
163039180|NCT00528372|588850683|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
163039181|NCT00528372|588850684|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
163039182|NCT00528372|588850685|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
163039183|NCT00528372|588850686|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
163039184|NCT00528372|588850687|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
163039185|NCT00528372|588850688|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
163039186|NCT00528372|588850689|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
163039187|NCT00528372|588850681|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
163039188|NCT00528372|588850682|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
163039189|NCT00528372|588850683|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
163039190|NCT00528372|588850684|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
163039191|NCT00528372|588850685|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
163039192|NCT00528372|588850686|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
163039193|NCT00528372|588850687|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
163039194|NCT00528372|588850688|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
163039195|NCT00528372|588850689|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
163039196|NCT00528372|588850681|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
163039197|NCT00528372|588850682|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
163039198|NCT00528372|588850683|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
163039199|NCT00528372|588850684|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
163039200|NCT00528372|588850685|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
163039201|NCT00528372|588850686|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
163039202|NCT00528372|588850687|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
163092562|NCT00940602|589050581|FG000|Overall Study|Administrative problems|1|||
163092563|NCT00940602|589050582|FG001|Overall Study|Administrative problems|1|||
163092564|NCT00940602|589050581|FG000|Overall Study|Patient/guardian decision|13|||
163092565|NCT00940602|589050582|FG001|Overall Study|Patient/guardian decision|28|||
163092566|NCT00940602|589050581|FG000|Overall Study|Physician Decision|8|||
163092567|NCT00940602|589050582|FG001|Overall Study|Physician Decision|5|||
163092568|NCT00940602|589050581|FG000|Overall Study|Pregnancy|1|||
163092569|NCT00940602|589050582|FG001|Overall Study|Pregnancy|0|||
163092570|NCT00940602|589050581|FG000|Overall Study|Protocol Deviation (untreated)|1|||
163092571|NCT00940602|589050582|FG001|Overall Study|Protocol Deviation (untreated)|0|||
163092572|NCT00940602|589050581|FG000|Overall Study|Disease progression|8|||
163092573|NCT00940602|589050582|FG001|Overall Study|Disease progression|2|||
163092574|NCT00940602|589050581|FG000|Overall Study|Death|38|||
163092575|NCT00940602|589050582|FG001|Overall Study|Death|19|||
163092576|NCT00940602|589050581|FG000|Overall Study|Lost to Follow-up|3|||
163092577|NCT00940602|589050582|FG001|Overall Study|Lost to Follow-up|1|||
163092578|NCT00940602|589050581|FG000|Overall Study|Patient withdrew consent|26|||
163092579|NCT00940602|589050582|FG001|Overall Study|Patient withdrew consent|13|||
163092580|NCT00940602|589050581|FG000|Overall Study|Adverse Event|7|||
163092581|NCT00940602|589050582|FG001|Overall Study|Adverse Event|2|||
163092582|NCT00940602|589050581|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
163092583|NCT00940602|589050582|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
163092584|NCT00575666|589050583|FG000|Overall Study|Withdrawal by Subject|3|||
163092585|NCT00575666|589050584|FG001|Overall Study|Withdrawal by Subject|2|||
163092586|NCT00575666|589050583|FG000|Overall Study|Physician Decision|1|||
163092587|NCT00575666|589050584|FG001|Overall Study|Physician Decision|1|||
163092588|NCT00508482|589050585|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
163092589|NCT00508482|589050586|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
163092590|NCT00508482|589050587|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
163092591|NCT00508482|589050585|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
163092592|NCT00508482|589050586|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
163092593|NCT00508482|589050587|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
163092594|NCT00508482|589050585|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
163092595|NCT00508482|589050586|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
163092596|NCT00508482|589050587|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
163092597|NCT01374425|589050588|FG000|Overall Study|Radiographic Disease Progression|86|||
163092598|NCT01374425|589050589|FG001|Overall Study|Radiographic Disease Progression|81|||
163092599|NCT01374425|589050588|FG000|Overall Study|Clinical Disease Progression|9|||
163092600|NCT01374425|589050589|FG001|Overall Study|Clinical Disease Progression|6|||
163092601|NCT01374425|589050588|FG000|Overall Study|Adverse Event|29|||
163092602|NCT01374425|589050589|FG001|Overall Study|Adverse Event|18|||
163092603|NCT01374425|589050588|FG000|Overall Study|Death (Progression of Disease)|1|||
163092604|NCT01374425|589050589|FG001|Overall Study|Death (Progression of Disease)|0|||
163092605|NCT01374425|589050588|FG000|Overall Study|Death (Adverse Event)|2|||
163092606|NCT01374425|589050589|FG001|Overall Study|Death (Adverse Event)|4|||
163092607|NCT01374425|589050588|FG000|Overall Study|Withdrawal by Subject|6|||
163092608|NCT01374425|589050589|FG001|Overall Study|Withdrawal by Subject|7|||
163092609|NCT01374425|589050588|FG000|Overall Study|Refused Treatment|10|||
163092610|NCT01374425|589050589|FG001|Overall Study|Refused Treatment|24|||
163092611|NCT01374425|589050588|FG000|Overall Study|Protocol Violation|2|||
163092612|NCT01374425|589050589|FG001|Overall Study|Protocol Violation|3|||
163092613|NCT01374425|589050588|FG000|Overall Study|Sponsor Decision|0|||
163092614|NCT01374425|589050589|FG001|Overall Study|Sponsor Decision|1|||
163092615|NCT01374425|589050588|FG000|Overall Study|Lost to Follow-up|2|||
163092616|NCT01374425|589050589|FG001|Overall Study|Lost to Follow-up|1|||
163092617|NCT01374425|589050588|FG000|Overall Study|Other|41|||
163092618|NCT01374425|589050589|FG001|Overall Study|Other|43|||
163092619|NCT02289469|589050590|FG000|Overall Study|Unable to match a control|6|||
163092620|NCT02289469|589050591|FG001|Overall Study|Unable to match a control|0|||
163092621|NCT02750930|589050598|FG000|Overall Study|Study closed/terminated|8|||
163092622|NCT02761642|589050599|FG000|Overall Study|Did not Receive Study Treatment|3|||
163092623|NCT02761642|589050599|FG000|Overall Study|Adverse Event|13|||
163092624|NCT02761642|589050599|FG000|Overall Study|Withdrawal by Subject|2|||
163092625|NCT02761642|589050599|FG000|Overall Study|Non-compliant|7|||
163092626|NCT02761642|589050599|FG000|Overall Study|Death|3|||
163092627|NCT02761642|589050599|FG000|Overall Study|Lack of Efficacy|20|||
163092628|NCT02761642|589050599|FG000|Overall Study|Physician Decision|1|||
163092629|NCT02761642|589050599|FG000|Overall Study|Reason Unspecified|21|||
163092630|NCT01644643|589050602|FG000|Overall Study|Death|1|||
163092631|NCT01644643|589050603|FG001|Overall Study|Death|0|||
163092632|NCT01644643|589050604|FG002|Overall Study|Death|3|||
163092633|NCT01644643|589050605|FG003|Overall Study|Death|3|||
163092634|NCT01644643|589050602|FG000|Overall Study|Lost to Follow-up|0|||
163092635|NCT01644643|589050603|FG001|Overall Study|Lost to Follow-up|0|||
163092636|NCT01644643|589050604|FG002|Overall Study|Lost to Follow-up|0|||
163092637|NCT01644643|589050605|FG003|Overall Study|Lost to Follow-up|4|||
163092638|NCT01644643|589050602|FG000|Overall Study|Withdrawal by Subject|1|||
163092639|NCT01644643|589050603|FG001|Overall Study|Withdrawal by Subject|0|||
163092640|NCT01644643|589050604|FG002|Overall Study|Withdrawal by Subject|2|||
163092641|NCT01644643|589050605|FG003|Overall Study|Withdrawal by Subject|1|||
163092642|NCT01644643|589050602|FG000|Overall Study|Other Eligibility criteria|0|||
163337726|NCT01529632|589945484|FG001|Overall Study|Protocol Violation|1|||
163337727|NCT01529632|589945483|FG000|Overall Study|Adverse Event|1|||
163337728|NCT01529632|589945484|FG001|Overall Study|Adverse Event|1|||
163337729|NCT05184062|589945485|FG000|Overall Study|Lost to Follow-up|5|||
163337730|NCT05184062|589945486|FG001|Overall Study|Lost to Follow-up|1|||
163337731|NCT05184062|589945485|FG000|Overall Study|Withdrawal by Subject|1|||
163337732|NCT05184062|589945486|FG001|Overall Study|Withdrawal by Subject|0|||
163337733|NCT00711555|589947278|FG000|Overall Study|Adverse Event|3|||
163337734|NCT04914897|589947283|FG000|Overall Study|Withdrawal by Subject|3|||
163337735|NCT04914897|589947284|FG001|Overall Study|Withdrawal by Subject|1|||
163337736|NCT04914897|589947285|FG002|Overall Study|Withdrawal by Subject|1|||
163337737|NCT04914897|589947286|FG003|Overall Study|Withdrawal by Subject|1|||
163337738|NCT04914897|589947283|FG000|Overall Study|Poor compliance to protocol|0|||
163092643|NCT01644643|589050603|FG001|Overall Study|Other Eligibility criteria|0|||
163092644|NCT01644643|589050604|FG002|Overall Study|Other Eligibility criteria|0|||
163092645|NCT01644643|589050605|FG003|Overall Study|Other Eligibility criteria|2|||
163092646|NCT02850978|589050606|FG000|Overall Study|Uncollectable CRF|27|||
163092647|NCT02850978|589050606|FG000|Overall Study|No visit since the first visit|35|||
163092648|NCT02850978|589050606|FG000|Overall Study|Adverse Event|81|||
163092649|NCT02850978|589050606|FG000|Overall Study|Lack of Efficacy|40|||
163092650|NCT02850978|589050606|FG000|Overall Study|Improvement in condition|34|||
163092651|NCT02850978|589050606|FG000|Overall Study|Lost to Follow-up|121|||
163092652|NCT02850978|589050606|FG000|Overall Study|Reason not listed|88|||
163092653|NCT00114127|589050607|FG000|Overall Study|Adverse Event|2|||
163092654|NCT00114127|589050608|FG001|Overall Study|Adverse Event|1|||
163092655|NCT00114127|589050607|FG000|Overall Study|Lost to Follow-up|1|||
163092656|NCT00114127|589050608|FG001|Overall Study|Lost to Follow-up|0|||
163092657|NCT00114127|589050607|FG000|Overall Study|Withdrawal by Subject|1|||
163092658|NCT00114127|589050608|FG001|Overall Study|Withdrawal by Subject|3|||
163092659|NCT00421148|589050609|FG000|Overall Study|Lost to Follow-up|0|||
163092660|NCT00421148|589050610|FG001|Overall Study|Lost to Follow-up|0|||
163092661|NCT00421148|589050611|FG002|Overall Study|Lost to Follow-up|0|||
163092662|NCT00421148|589050612|FG003|Overall Study|Lost to Follow-up|0|||
163092663|NCT00421148|589050613|FG004|Overall Study|Lost to Follow-up|0|||
163092664|NCT00421148|589050614|FG005|Overall Study|Lost to Follow-up|0|||
163092665|NCT00421148|589050615|FG006|Overall Study|Lost to Follow-up|0|||
163092666|NCT00421148|589050616|FG007|Overall Study|Lost to Follow-up|0|||
163092667|NCT00421148|589050617|FG008|Overall Study|Lost to Follow-up|0|||
163092668|NCT00421148|589050618|FG009|Overall Study|Lost to Follow-up|0|||
163092669|NCT00421148|589050619|FG010|Overall Study|Lost to Follow-up|0|||
163092670|NCT00421148|589050620|FG011|Overall Study|Lost to Follow-up|0|||
163092671|NCT00421148|589050621|FG012|Overall Study|Lost to Follow-up|0|||
163092672|NCT00421148|589050622|FG013|Overall Study|Lost to Follow-up|0|||
163092673|NCT00421148|589050623|FG014|Overall Study|Lost to Follow-up|0|||
163092674|NCT00421148|589050624|FG015|Overall Study|Lost to Follow-up|0|||
163092675|NCT00421148|589050625|FG016|Overall Study|Lost to Follow-up|0|||
163092676|NCT00421148|589050626|FG017|Overall Study|Lost to Follow-up|1|||
163092677|NCT00421148|589050627|FG018|Overall Study|Lost to Follow-up|0|||
163092678|NCT00421148|589050628|FG019|Overall Study|Lost to Follow-up|0|||
163092679|NCT00421148|589050609|FG000|Overall Study|Withdrawal by Subject|0|||
163092680|NCT00421148|589050610|FG001|Overall Study|Withdrawal by Subject|0|||
163092681|NCT00421148|589050611|FG002|Overall Study|Withdrawal by Subject|0|||
163092682|NCT00421148|589050612|FG003|Overall Study|Withdrawal by Subject|0|||
163337739|NCT04914897|589947284|FG001|Overall Study|Poor compliance to protocol|0|||
163337740|NCT04914897|589947285|FG002|Overall Study|Poor compliance to protocol|1|||
163092683|NCT00421148|589050613|FG004|Overall Study|Withdrawal by Subject|0|||
163092684|NCT00421148|589050614|FG005|Overall Study|Withdrawal by Subject|0|||
163092685|NCT00421148|589050615|FG006|Overall Study|Withdrawal by Subject|0|||
163092686|NCT00421148|589050616|FG007|Overall Study|Withdrawal by Subject|0|||
163092687|NCT00421148|589050617|FG008|Overall Study|Withdrawal by Subject|0|||
163092688|NCT00421148|589050618|FG009|Overall Study|Withdrawal by Subject|0|||
163092689|NCT00421148|589050619|FG010|Overall Study|Withdrawal by Subject|0|||
163092690|NCT00421148|589050620|FG011|Overall Study|Withdrawal by Subject|0|||
163092691|NCT00421148|589050621|FG012|Overall Study|Withdrawal by Subject|0|||
163092692|NCT00421148|589050622|FG013|Overall Study|Withdrawal by Subject|0|||
163092693|NCT00421148|589050623|FG014|Overall Study|Withdrawal by Subject|0|||
163092694|NCT00421148|589050624|FG015|Overall Study|Withdrawal by Subject|0|||
163337741|NCT04914897|589947286|FG003|Overall Study|Poor compliance to protocol|0|||
163337742|NCT04914897|589947283|FG000|Overall Study|Progressive disease|5|||
163337743|NCT04914897|589947284|FG001|Overall Study|Progressive disease|14|||
163092695|NCT00421148|589050625|FG016|Overall Study|Withdrawal by Subject|0|||
163337744|NCT04914897|589947285|FG002|Overall Study|Progressive disease|30|||
163337745|NCT04914897|589947286|FG003|Overall Study|Progressive disease|21|||
163092696|NCT00421148|589050626|FG017|Overall Study|Withdrawal by Subject|1|||
163092697|NCT00421148|589050627|FG018|Overall Study|Withdrawal by Subject|0|||
163092698|NCT00421148|589050628|FG019|Overall Study|Withdrawal by Subject|0|||
163092699|NCT00421148|589050609|FG000|Overall Study|Protocol Violation|0|||
163337746|NCT04914897|589947283|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
163337747|NCT04914897|589947284|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
163337748|NCT04914897|589947285|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
163337749|NCT04914897|589947286|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
163337750|NCT04914897|589947283|FG000|Overall Study|Other|1|||
163337751|NCT04914897|589947284|FG001|Overall Study|Other|0|||
163337752|NCT04914897|589947285|FG002|Overall Study|Other|0|||
163337753|NCT04914897|589947286|FG003|Overall Study|Other|1|||
163337754|NCT04783389|589947296|FG000|Overall Study|Withdrawal by Subject|2|||
163337755|NCT04783389|589947297|FG001|Overall Study|Withdrawal by Subject|0|||
163337756|NCT04783389|589947298|FG002|Overall Study|Withdrawal by Subject|0|||
163337757|NCT04783389|589947296|FG000|Overall Study|Termination of Study by Sponsor|10|||
163337758|NCT04783389|589947297|FG001|Overall Study|Termination of Study by Sponsor|12|||
163337759|NCT04783389|589947298|FG002|Overall Study|Termination of Study by Sponsor|14|||
163337760|NCT02164578|589947300|FG000|Treatment Period|Withdrawal by Subject|3|||
163337761|NCT02164578|589947301|FG001|Treatment Period|Withdrawal by Subject|3|||
163337762|NCT02164578|589947300|FG000|Treatment Period|Adverse Event|13|||
163337763|NCT02164578|589947301|FG001|Treatment Period|Adverse Event|6|||
163337764|NCT02164578|589947300|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
163337765|NCT02164578|589947301|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
163337766|NCT02164578|589947300|FG000|Treatment Period|Protocol Violation|0|||
163337767|NCT02164578|589947301|FG001|Treatment Period|Protocol Violation|2|||
163337768|NCT02164578|589947300|FG000|Extension Period|Withdrawal by Subject|2|||
163337769|NCT02164578|589947301|FG001|Extension Period|Withdrawal by Subject|0|||
163337770|NCT02164578|589947300|FG000|Extension Period|Adverse Event|4|||
163337771|NCT02164578|589947301|FG001|Extension Period|Adverse Event|0|||
163337772|NCT02164578|589947300|FG000|Extension Period|Expiry of study medication|1|||
163337773|NCT02164578|589947301|FG001|Extension Period|Expiry of study medication|0|||
163337774|NCT02164578|589947300|FG000|Extension Period|Protocol Violation|0|||
163337775|NCT02164578|589947301|FG001|Extension Period|Protocol Violation|1|||
163337776|NCT01975701|589947302|FG000|Overall Study|Lost to Follow-up|1|||
163337777|NCT01975701|589947302|FG000|Overall Study|Death|23|||
163337778|NCT01975701|589947302|FG000|Overall Study|Physician Decision|1|||
163337779|NCT00376259|589947303|FG000|Overall Study|Sponsor request - study termination|21|||
163337780|NCT00376259|589947304|FG001|Overall Study|Sponsor request - study termination|21|||
163337781|NCT00376259|589947303|FG000|Overall Study|Patient request|1|||
163337782|NCT00376259|589947304|FG001|Overall Study|Patient request|0|||
163337783|NCT01877720|589947306|FG000|Overall Study|Adverse Event|1|||
163337784|NCT01877720|589947307|FG001|Overall Study|Adverse Event|0|||
163337785|NCT00267956|589947310|FG000|Controlled Period|Adverse Event|4|||
163337786|NCT00267956|589947311|FG001|Controlled Period|Adverse Event|1|||
163337787|NCT00267956|589947312|FG002|Controlled Period|Adverse Event|0|||
163337788|NCT00267956|589947313|FG003|Controlled Period|Adverse Event|0|||
163337789|NCT00267956|589947310|FG000|Controlled Period|Lack of Efficacy|4|||
163337790|NCT00267956|589947311|FG001|Controlled Period|Lack of Efficacy|2|||
163337791|NCT00267956|589947312|FG002|Controlled Period|Lack of Efficacy|0|||
163337792|NCT00267956|589947313|FG003|Controlled Period|Lack of Efficacy|0|||
163337793|NCT00267956|589947310|FG000|Controlled Period|Lost to Follow-up|2|||
163407627|NCT02706873|590200874|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
163092700|NCT00421148|589050610|FG001|Overall Study|Protocol Violation|0|||
163092701|NCT00421148|589050611|FG002|Overall Study|Protocol Violation|0|||
163092702|NCT00421148|589050612|FG003|Overall Study|Protocol Violation|0|||
163092703|NCT00421148|589050613|FG004|Overall Study|Protocol Violation|0|||
163092704|NCT00421148|589050614|FG005|Overall Study|Protocol Violation|1|||
163092705|NCT00421148|589050615|FG006|Overall Study|Protocol Violation|0|||
163092706|NCT00421148|589050616|FG007|Overall Study|Protocol Violation|0|||
163092707|NCT00421148|589050617|FG008|Overall Study|Protocol Violation|0|||
163092708|NCT00421148|589050618|FG009|Overall Study|Protocol Violation|0|||
163092709|NCT00421148|589050619|FG010|Overall Study|Protocol Violation|0|||
163092710|NCT00421148|589050620|FG011|Overall Study|Protocol Violation|0|||
163092711|NCT00421148|589050621|FG012|Overall Study|Protocol Violation|0|||
163092712|NCT00421148|589050622|FG013|Overall Study|Protocol Violation|0|||
163092713|NCT00421148|589050623|FG014|Overall Study|Protocol Violation|0|||
163092714|NCT00421148|589050624|FG015|Overall Study|Protocol Violation|0|||
163092715|NCT00421148|589050625|FG016|Overall Study|Protocol Violation|0|||
163092716|NCT00421148|589050626|FG017|Overall Study|Protocol Violation|0|||
163092717|NCT00421148|589050627|FG018|Overall Study|Protocol Violation|1|||
163092718|NCT00421148|589050628|FG019|Overall Study|Protocol Violation|0|||
163092719|NCT00570713|589050629|FG000|Overall Study|Adverse Event|16|||
163092720|NCT00570713|589050630|FG001|Overall Study|Adverse Event|9|||
163092721|NCT00570713|589050629|FG000|Overall Study|Death|7|||
163092722|NCT00570713|589050630|FG001|Overall Study|Death|7|||
163337794|NCT00267956|589947311|FG001|Controlled Period|Lost to Follow-up|0|||
163337795|NCT00267956|589947312|FG002|Controlled Period|Lost to Follow-up|0|||
163092723|NCT00570713|589050629|FG000|Overall Study|Lack of Efficacy|40|||
163092724|NCT00570713|589050630|FG001|Overall Study|Lack of Efficacy|49|||
163092725|NCT00570713|589050629|FG000|Overall Study|Physician Decision|2|||
163337796|NCT00267956|589947313|FG003|Controlled Period|Lost to Follow-up|0|||
163092726|NCT00570713|589050630|FG001|Overall Study|Physician Decision|2|||
163092727|NCT00570713|589050629|FG000|Overall Study|Withdrawal by Subject|3|||
163092728|NCT00570713|589050630|FG001|Overall Study|Withdrawal by Subject|3|||
163092729|NCT00570713|589050629|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
163092730|NCT00570713|589050630|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
163092731|NCT00469833|589050631|FG000|Overall Study|No IV access|2|||
163092732|NCT03289533|589050632|FG000|Overall Study|Death|12|||
163092733|NCT03289533|589050632|FG000|Overall Study|Terminated from study by sponsor|10|||
163092734|NCT00539240|589050633|FG000|Overall Study|Withdrawal by Subject|0|||
163092735|NCT00539240|589050634|FG001|Overall Study|Withdrawal by Subject|2|||
163092736|NCT00539240|589050635|FG002|Overall Study|Withdrawal by Subject|0|||
163092737|NCT00539240|589050633|FG000|Overall Study|Protocol Violation|1|||
163092738|NCT00539240|589050634|FG001|Overall Study|Protocol Violation|1|||
163092739|NCT00539240|589050635|FG002|Overall Study|Protocol Violation|4|||
163092740|NCT00539240|589050633|FG000|Overall Study|Lost to Follow-up|2|||
163092741|NCT00539240|589050634|FG001|Overall Study|Lost to Follow-up|3|||
163092742|NCT00539240|589050635|FG002|Overall Study|Lost to Follow-up|1|||
163092743|NCT00539240|589050633|FG000|Overall Study|Adverse Event|3|||
163092744|NCT00539240|589050634|FG001|Overall Study|Adverse Event|1|||
163092745|NCT00539240|589050635|FG002|Overall Study|Adverse Event|10|||
163092746|NCT01284959|589050636|FG000|Overall Study|Withdrawal by Subject|1|||
163092747|NCT01284959|589050637|FG001|Overall Study|Withdrawal by Subject|0|||
163092748|NCT01284959|589050638|FG002|Overall Study|Withdrawal by Subject|0|||
163092749|NCT01284959|589050636|FG000|Overall Study|Adverse Event|0|||
163092750|NCT01284959|589050637|FG001|Overall Study|Adverse Event|0|||
163092751|NCT01284959|589050638|FG002|Overall Study|Adverse Event|1|||
163092752|NCT01055613|589050639|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
163092753|NCT01055613|589050640|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
163092754|NCT01055613|589050639|FG000|Overall Study|Unacceptable lens fit|1|||
163092755|NCT01055613|589050640|FG001|Overall Study|Unacceptable lens fit|0|||
163092756|NCT01055613|589050639|FG000|Overall Study|Discomfort|2|||
163092757|NCT01055613|589050640|FG001|Overall Study|Discomfort|1|||
163092758|NCT01055613|589050639|FG000|Overall Study|Lost to Follow-up|1|||
163092759|NCT01055613|589050640|FG001|Overall Study|Lost to Follow-up|1|||
163092760|NCT01055613|589050639|FG000|Overall Study|Protocol Violation|1|||
163092761|NCT01055613|589050640|FG001|Overall Study|Protocol Violation|1|||
163092762|NCT01055613|589050639|FG000|Overall Study|Subject Disinterest|1|||
163092763|NCT01055613|589050640|FG001|Overall Study|Subject Disinterest|1|||
163092764|NCT01677988|589050648|FG000|Overall Study|Lack of Efficacy|2|||
163092765|NCT02629861|589050653|FG000|Overall Study|Adverse Event|7|||
163092766|NCT02629861|589050654|FG001|Overall Study|Adverse Event|5|||
163092767|NCT02629861|589050655|FG002|Overall Study|Adverse Event|4|||
163092768|NCT02629861|589050653|FG000|Overall Study|Withdrawal by Subject|5|||
163092769|NCT02629861|589050654|FG001|Overall Study|Withdrawal by Subject|8|||
163092770|NCT02629861|589050655|FG002|Overall Study|Withdrawal by Subject|13|||
163092771|NCT02629861|589050653|FG000|Overall Study|Protocol Violation|2|||
163092772|NCT02629861|589050654|FG001|Overall Study|Protocol Violation|3|||
163092773|NCT02629861|589050655|FG002|Overall Study|Protocol Violation|7|||
163092774|NCT02629861|589050653|FG000|Overall Study|Lost to Follow-up|12|||
163092775|NCT02629861|589050654|FG001|Overall Study|Lost to Follow-up|9|||
163092776|NCT02629861|589050655|FG002|Overall Study|Lost to Follow-up|4|||
163092777|NCT02629861|589050653|FG000|Overall Study|Other|1|||
163092778|NCT02629861|589050654|FG001|Overall Study|Other|1|||
163092779|NCT02629861|589050655|FG002|Overall Study|Other|0|||
163092780|NCT02629861|589050653|FG000|Overall Study|Pregnancy|2|||
163092781|NCT02629861|589050654|FG001|Overall Study|Pregnancy|1|||
163092782|NCT02629861|589050655|FG002|Overall Study|Pregnancy|0|||
163092783|NCT00271544|589050668|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
163092784|NCT00271544|589050668|FG000|Overall Study|Model 4196 lead not attempted|9|||
163092785|NCT00271544|589050668|FG000|Overall Study|Implant not attempted|4|||
163092786|NCT00902330|589050675|FG000|Overall Study|Too overwhelmed by treatment|2|||
163092787|NCT00902330|589050676|FG001|Overall Study|Too overwhelmed by treatment|5|||
163092788|NCT00902330|589050675|FG000|Overall Study|Adverse Event|1|||
163092789|NCT00902330|589050676|FG001|Overall Study|Adverse Event|0|||
163092790|NCT00902330|589050675|FG000|Overall Study|No post baseline data|1|||
163092791|NCT00902330|589050676|FG001|Overall Study|No post baseline data|0|||
163092792|NCT00165789|589050677|FG000|Overall Study|Adverse Event|0|||
163092793|NCT00165789|589050678|FG001|Overall Study|Adverse Event|3|||
163092794|NCT00165789|589050679|FG002|Overall Study|Adverse Event|0|||
163092795|NCT00165789|589050680|FG003|Overall Study|Adverse Event|12|||
163092796|NCT00165789|589050677|FG000|Overall Study|Withdrawal by Subject|0|||
163092797|NCT00165789|589050678|FG001|Overall Study|Withdrawal by Subject|1|||
163092798|NCT00165789|589050679|FG002|Overall Study|Withdrawal by Subject|1|||
163092799|NCT00165789|589050680|FG003|Overall Study|Withdrawal by Subject|2|||
163092800|NCT03571971|589050681|FG000|Overall Study|Lost to Follow-up|2|||
163092801|NCT03571971|589050682|FG001|Overall Study|Lost to Follow-up|2|||
163092802|NCT03571971|589050681|FG000|Overall Study|Protocol Violation|2|||
163092803|NCT03571971|589050682|FG001|Overall Study|Protocol Violation|3|||
163092804|NCT03571971|589050681|FG000|Overall Study|Withdrawal by Subject|2|||
163092805|NCT03571971|589050682|FG001|Overall Study|Withdrawal by Subject|0|||
163092806|NCT03571971|589050681|FG000|Overall Study|Incomplete primary outcome data|2|||
163092807|NCT03571971|589050682|FG001|Overall Study|Incomplete primary outcome data|0|||
163092808|NCT03950856|589050686|FG000|Overall Study|Death|1|||
163092809|NCT03950856|589050687|FG001|Overall Study|Death|2|||
163092810|NCT03950856|589050688|FG002|Overall Study|Death|0|||
163092811|NCT03950856|589050689|FG003|Overall Study|Death|0|||
163092812|NCT03950856|589050686|FG000|Overall Study|Lost to Follow-up|5|||
163092813|NCT03950856|589050687|FG001|Overall Study|Lost to Follow-up|6|||
163092814|NCT03950856|589050688|FG002|Overall Study|Lost to Follow-up|8|||
163092815|NCT03950856|589050689|FG003|Overall Study|Lost to Follow-up|2|||
163092816|NCT03950856|589050686|FG000|Overall Study|Protocol Violation|2|||
163092817|NCT03950856|589050687|FG001|Overall Study|Protocol Violation|0|||
163092818|NCT03950856|589050688|FG002|Overall Study|Protocol Violation|0|||
163092819|NCT03950856|589050689|FG003|Overall Study|Protocol Violation|1|||
163092820|NCT03950856|589050686|FG000|Overall Study|Withdrawal by Subject|4|||
163092821|NCT03950856|589050687|FG001|Overall Study|Withdrawal by Subject|1|||
163092822|NCT03950856|589050688|FG002|Overall Study|Withdrawal by Subject|3|||
163092823|NCT03950856|589050689|FG003|Overall Study|Withdrawal by Subject|1|||
163092824|NCT03950856|589050686|FG000|Overall Study|Unable to phone|7|||
163092825|NCT03950856|589050687|FG001|Overall Study|Unable to phone|6|||
163092826|NCT03950856|589050688|FG002|Overall Study|Unable to phone|7|||
163092827|NCT03950856|589050689|FG003|Overall Study|Unable to phone|2|||
163092828|NCT01816984|589050690|FG000|Overall Study|declining health status|1|||
163092829|NCT04422431|589050693|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
163092830|NCT04422431|589050693|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
163092831|NCT04422431|589050693|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
163092832|NCT04422431|589050693|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
163092833|NCT04422431|589050693|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
163092834|NCT04422431|589050693|FG000|Extension Period (48 Weeks)|Other than specified|2|||
163092835|NCT01174563|589050694|FG000|Overall Study|Progressive Disease|45|||
163092836|NCT01174563|589050694|FG000|Overall Study|Death|5|||
163092837|NCT01174563|589050694|FG000|Overall Study|Investigator's Discretion|5|||
163092838|NCT01174563|589050694|FG000|Overall Study|Participant Withdrew Consent|3|||
163092839|NCT01174563|589050694|FG000|Overall Study|Rash Adverse Event|1|||
163092840|NCT01174563|589050694|FG000|Overall Study|Sponsor's decision|1|||
163092841|NCT03402841|589050695|FG000|Overall Study|Withdrawal by Subject|3|||
163092842|NCT03402841|589050695|FG000|Overall Study|Lost to Follow-up|2|||
163092843|NCT03402841|589050695|FG000|Overall Study|Death|146|||
163092844|NCT00444106|589050698|FG000|Overall Study|Lost to Follow-up|2|||
163092845|NCT00444106|589050699|FG001|Overall Study|Lost to Follow-up|1|||
163092846|NCT00444106|589050700|FG002|Overall Study|Lost to Follow-up|0|||
163092847|NCT00444106|589050698|FG000|Overall Study|Abnormal Test Procedure Results|0|||
163092848|NCT00444106|589050699|FG001|Overall Study|Abnormal Test Procedure Results|0|||
163092849|NCT00444106|589050700|FG002|Overall Study|Abnormal Test Procedure Results|1|||
163092850|NCT00810277|589052449|FG000|Overall Study|Adverse Event|1|||
163092851|NCT01856322|589052450|FG000|Overall Study|off study due to lack of accrual|0|||
163092852|NCT01856322|589052451|FG001|Overall Study|off study due to lack of accrual|0|||
163092853|NCT01856322|589052452|FG002|Overall Study|off study due to lack of accrual|3|||
163092854|NCT02896257|589052453|FG000|Providers|Without eligible patients|21|||
163092855|NCT02896257|589052454|FG001|Providers|Without eligible patients|28|||
163092856|NCT02896257|589052453|FG000|Patients|PFT entry criteria not met|43|||
163092857|NCT02896257|589052454|FG001|Patients|PFT entry criteria not met|50|||
163092858|NCT02896257|589052453|FG000|Patients|No capacity to review|8|||
163092859|NCT02896257|589052454|FG001|Patients|No capacity to review|11|||
163092860|NCT02896257|589052453|FG000|Patients|Appointment rescheduled/cancelled|5|||
163092861|NCT02896257|589052454|FG001|Patients|Appointment rescheduled/cancelled|7|||
163092862|NCT02896257|589052453|FG000|Patients|PCP not assigned a clinic|4|||
163092863|NCT02896257|589052454|FG001|Patients|PCP not assigned a clinic|0|||
163092864|NCT02896257|589052453|FG000|Patients|No history of COPD|0|||
163092865|NCT02896257|589052454|FG001|Patients|No history of COPD|1|||
163092866|NCT02896257|589052453|FG000|Patients|Deceased between review and index date|0|||
163092867|NCT02896257|589052454|FG001|Patients|Deceased between review and index date|1|||
163092868|NCT02896257|589052453|FG000|Patients|No ICS Rx upon review|1|||
163092869|NCT02896257|589052454|FG001|Patients|No ICS Rx upon review|1|||
163092870|NCT02896257|589052453|FG000|Patients|Protocol Violation|2|||
163092871|NCT02896257|589052454|FG001|Patients|Protocol Violation|1|||
163092872|NCT02896257|589052453|FG000|Patients|Hospice care|0|||
163092873|NCT02896257|589052454|FG001|Patients|Hospice care|1|||
163092874|NCT03423602|589052459|FG000|Overall Study|Death|1|||
163092875|NCT03423602|589052459|FG000|Overall Study|Lost to Follow-up|6|||
163092876|NCT03423602|589052459|FG000|Overall Study|Protocol Violation|1|||
163092877|NCT03423602|589052459|FG000|Overall Study|Withdrawal by Subject|4|||
163092878|NCT00692003|589052460|FG000|Overall Study|Sponsor Decision|5|||
163092879|NCT00692003|589052461|FG001|Overall Study|Sponsor Decision|1|||
163092880|NCT03257358|589052462|FG000|Overall Study|Adverse Event|25|||
163092881|NCT03257358|589052463|FG001|Overall Study|Adverse Event|12|||
163092882|NCT03257358|589052462|FG000|Overall Study|Lack of Efficacy|1|||
163092883|NCT03257358|589052463|FG001|Overall Study|Lack of Efficacy|1|||
163092884|NCT03257358|589052462|FG000|Overall Study|Lost to Follow-up|12|||
163092885|NCT03257358|589052463|FG001|Overall Study|Lost to Follow-up|4|||
163092886|NCT03257358|589052462|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
163092887|NCT03257358|589052463|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
163092888|NCT03257358|589052462|FG000|Overall Study|Physician Decision|2|||
163092889|NCT03257358|589052463|FG001|Overall Study|Physician Decision|2|||
163092890|NCT03257358|589052462|FG000|Overall Study|Protocol Violation|5|||
163092891|NCT03257358|589052463|FG001|Overall Study|Protocol Violation|3|||
163092892|NCT03257358|589052462|FG000|Overall Study|Technical problems|4|||
163092893|NCT03257358|589052463|FG001|Overall Study|Technical problems|1|||
163092894|NCT03257358|589052462|FG000|Overall Study|Withdrawal by Subject|8|||
163092895|NCT03257358|589052463|FG001|Overall Study|Withdrawal by Subject|3|||
163092896|NCT03257358|589052462|FG000|Overall Study|Withdrawal of informed consent|9|||
163092897|NCT03257358|589052463|FG001|Overall Study|Withdrawal of informed consent|5|||
163092898|NCT03257358|589052462|FG000|Overall Study|New therapy for study indication|1|||
163092899|NCT03257358|589052463|FG001|Overall Study|New therapy for study indication|0|||
163407628|NCT02706873|590200871|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
163407629|NCT02706873|590200872|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
163092900|NCT03257358|589052462|FG000|Overall Study|No longer requires treatment|0|||
163092901|NCT03257358|589052463|FG001|Overall Study|No longer requires treatment|1|||
163092902|NCT02332187|589052464|FG000|Overall Study|Withdrawal by Subject|2|||
163092903|NCT02332187|589052465|FG001|Overall Study|Withdrawal by Subject|2|||
163092904|NCT02332187|589052464|FG000|Overall Study|Adverse Event|0|||
163092905|NCT02332187|589052465|FG001|Overall Study|Adverse Event|1|||
163092906|NCT02903823|589052466|FG000|Overall Study|Physician Decision|5|||
163092907|NCT02903823|589052466|FG000|Overall Study|Could not advance catheter|1|||
163092908|NCT02903823|589052466|FG000|Overall Study|Catheter dislodgement|1|||
163092909|NCT02852967|589052467|FG000|Overall Study|Adverse Event|3|||
163092910|NCT02852967|589052468|FG001|Overall Study|Adverse Event|1|||
163092911|NCT02852967|589052469|FG002|Overall Study|Adverse Event|0|||
163092912|NCT02852967|589052470|FG003|Overall Study|Adverse Event|1|||
163092913|NCT02852967|589052471|FG004|Overall Study|Adverse Event|0|||
163092914|NCT02852967|589052467|FG000|Overall Study|Death|1|||
163092915|NCT02852967|589052468|FG001|Overall Study|Death|0|||
163092916|NCT02852967|589052469|FG002|Overall Study|Death|0|||
163092917|NCT02852967|589052470|FG003|Overall Study|Death|0|||
163092918|NCT02852967|589052471|FG004|Overall Study|Death|0|||
163092919|NCT02852967|589052467|FG000|Overall Study|Lost to Follow-up|1|||
163092920|NCT02852967|589052468|FG001|Overall Study|Lost to Follow-up|2|||
163092921|NCT02852967|589052469|FG002|Overall Study|Lost to Follow-up|3|||
163092922|NCT02852967|589052470|FG003|Overall Study|Lost to Follow-up|4|||
163092923|NCT02852967|589052471|FG004|Overall Study|Lost to Follow-up|4|||
163092924|NCT02852967|589052467|FG000|Overall Study|Withdrawal by Subject|6|||
163092925|NCT02852967|589052468|FG001|Overall Study|Withdrawal by Subject|12|||
163092926|NCT02852967|589052469|FG002|Overall Study|Withdrawal by Subject|7|||
163092927|NCT02852967|589052470|FG003|Overall Study|Withdrawal by Subject|10|||
163092928|NCT02852967|589052471|FG004|Overall Study|Withdrawal by Subject|10|||
163092929|NCT02852967|589052467|FG000|Overall Study|SAE|0|||
163092930|NCT02852967|589052468|FG001|Overall Study|SAE|0|||
163092931|NCT02852967|589052469|FG002|Overall Study|SAE|0|||
163092932|NCT02852967|589052470|FG003|Overall Study|SAE|3|||
163092933|NCT02852967|589052471|FG004|Overall Study|SAE|0|||
163092934|NCT02852967|589052467|FG000|Overall Study|Elevated Liver Enzymes|2|||
163092935|NCT02852967|589052468|FG001|Overall Study|Elevated Liver Enzymes|0|||
163092936|NCT02852967|589052469|FG002|Overall Study|Elevated Liver Enzymes|0|||
163092937|NCT02852967|589052470|FG003|Overall Study|Elevated Liver Enzymes|2|||
163092938|NCT02852967|589052471|FG004|Overall Study|Elevated Liver Enzymes|2|||
163092939|NCT02852967|589052467|FG000|Overall Study|Physician Decision|0|||
163092940|NCT02852967|589052468|FG001|Overall Study|Physician Decision|0|||
163092941|NCT02852967|589052469|FG002|Overall Study|Physician Decision|0|||
163092942|NCT02852967|589052470|FG003|Overall Study|Physician Decision|1|||
163092943|NCT02852967|589052471|FG004|Overall Study|Physician Decision|0|||
163092944|NCT02852967|589052467|FG000|Overall Study|Lack of Efficacy|0|||
163092945|NCT02852967|589052468|FG001|Overall Study|Lack of Efficacy|1|||
163092946|NCT02852967|589052469|FG002|Overall Study|Lack of Efficacy|0|||
163092947|NCT02852967|589052470|FG003|Overall Study|Lack of Efficacy|0|||
163092948|NCT02852967|589052471|FG004|Overall Study|Lack of Efficacy|0|||
163092949|NCT02852967|589052467|FG000|Overall Study|Non-compliance|0|||
163092950|NCT02852967|589052468|FG001|Overall Study|Non-compliance|0|||
163092951|NCT02852967|589052469|FG002|Overall Study|Non-compliance|1|||
163092952|NCT02852967|589052470|FG003|Overall Study|Non-compliance|1|||
163092953|NCT02852967|589052471|FG004|Overall Study|Non-compliance|0|||
163092954|NCT02852967|589052467|FG000|Overall Study|Dispensing Drug Violation|0|||
163092955|NCT02852967|589052468|FG001|Overall Study|Dispensing Drug Violation|0|||
163092956|NCT02852967|589052469|FG002|Overall Study|Dispensing Drug Violation|1|||
163092957|NCT02852967|589052470|FG003|Overall Study|Dispensing Drug Violation|0|||
163092958|NCT02852967|589052471|FG004|Overall Study|Dispensing Drug Violation|0|||
163092959|NCT02852967|589052467|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
163092960|NCT02852967|589052468|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
163092961|NCT02852967|589052469|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
163092962|NCT02852967|589052470|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
163092963|NCT02852967|589052471|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
163092964|NCT00339040|589052478|FG000|Stage I|Not able to attend clinic|1|||
163092965|NCT00339040|589052479|FG001|Stage I|Not able to attend clinic|0|||
163092966|NCT00339040|589052478|FG000|Stage I|Protocol Violation|1|||
163092967|NCT00339040|589052479|FG001|Stage I|Protocol Violation|1|||
163092968|NCT00339040|589052478|FG000|Stage II|Lost to Follow-up|3|||
163092969|NCT00339040|589052479|FG001|Stage II|Lost to Follow-up|0|||
163092970|NCT00339040|589052478|FG000|Stage II|Withdrawal by Subject|1|||
163092971|NCT00339040|589052479|FG001|Stage II|Withdrawal by Subject|2|||
163092972|NCT00339040|589052478|FG000|Stage II|Protocol Violation|3|||
163092973|NCT00339040|589052479|FG001|Stage II|Protocol Violation|0|||
163092974|NCT00339040|589052478|FG000|Stage II|Not able to attend clinic|1|||
163092975|NCT00339040|589052479|FG001|Stage II|Not able to attend clinic|0|||
163092976|NCT00339040|589052478|FG000|Stage II|Site closing|2|||
163092977|NCT00339040|589052479|FG001|Stage II|Site closing|0|||
163092978|NCT03341637|589052480|FG000|Overall Study|Lost to Follow-up|1|||
163092979|NCT03341637|589052481|FG001|Overall Study|Lost to Follow-up|0|||
163092980|NCT03341637|589052480|FG000|Overall Study|Withdrawal by Subject|3|||
163092981|NCT03341637|589052481|FG001|Overall Study|Withdrawal by Subject|3|||
163092982|NCT03341637|589052480|FG000|Overall Study|Reason not Specified|1|||
163092983|NCT03341637|589052481|FG001|Overall Study|Reason not Specified|1|||
163092984|NCT01462929|589052488|FG000|Overall Study|Adverse Event|3|||
163092985|NCT01462929|589052489|FG001|Overall Study|Adverse Event|3|||
163092986|NCT01462929|589052490|FG002|Overall Study|Adverse Event|4|||
163092987|NCT01462929|589052488|FG000|Overall Study|Withdrawal by Subject|2|||
163092988|NCT01462929|589052489|FG001|Overall Study|Withdrawal by Subject|1|||
163092989|NCT01462929|589052490|FG002|Overall Study|Withdrawal by Subject|0|||
163092990|NCT01462929|589052488|FG000|Overall Study|Lack of Efficacy|0|||
163092991|NCT01462929|589052489|FG001|Overall Study|Lack of Efficacy|0|||
163092992|NCT01462929|589052490|FG002|Overall Study|Lack of Efficacy|1|||
163092993|NCT00887159|589052491|FG000|Overall Study|Disease progression|6|||
163092994|NCT00887159|589052492|FG001|Overall Study|Disease progression|39|||
163092995|NCT00887159|589052493|FG002|Overall Study|Disease progression|33|||
163092996|NCT00887159|589052491|FG000|Overall Study|Adverse Event|3|||
163092997|NCT00887159|589052492|FG001|Overall Study|Adverse Event|4|||
163092998|NCT00887159|589052493|FG002|Overall Study|Adverse Event|17|||
163092999|NCT00887159|589052491|FG000|Overall Study|Death|2|||
163093000|NCT00887159|589052492|FG001|Overall Study|Death|2|||
163093001|NCT00887159|589052493|FG002|Overall Study|Death|0|||
163093002|NCT00887159|589052491|FG000|Overall Study|Withdrawal by Subject|4|||
163093003|NCT00887159|589052492|FG001|Overall Study|Withdrawal by Subject|4|||
163093004|NCT00887159|589052493|FG002|Overall Study|Withdrawal by Subject|2|||
163093005|NCT00887159|589052491|FG000|Overall Study|Alternative therapy|2|||
163093006|NCT00887159|589052492|FG001|Overall Study|Alternative therapy|0|||
163093007|NCT00887159|589052493|FG002|Overall Study|Alternative therapy|0|||
163093008|NCT00887159|589052491|FG000|Overall Study|Physician Decision|1|||
163093009|NCT00887159|589052492|FG001|Overall Study|Physician Decision|1|||
163093010|NCT00887159|589052493|FG002|Overall Study|Physician Decision|0|||
163093011|NCT00887159|589052491|FG000|Overall Study|Sympomatic deterioration|1|||
163093012|NCT00887159|589052492|FG001|Overall Study|Sympomatic deterioration|0|||
163093013|NCT00887159|589052493|FG002|Overall Study|Sympomatic deterioration|0|||
163093014|NCT00887159|589052491|FG000|Overall Study|Treatment delayed|1|||
163093015|NCT00887159|589052492|FG001|Overall Study|Treatment delayed|1|||
163093016|NCT00887159|589052493|FG002|Overall Study|Treatment delayed|0|||
163093017|NCT00887159|589052491|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
163093018|NCT00887159|589052492|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
163337797|NCT00267956|589947310|FG000|Controlled Period|Withdrew consent|3|||
163337798|NCT00267956|589947311|FG001|Controlled Period|Withdrew consent|1|||
163337799|NCT00267956|589947312|FG002|Controlled Period|Withdrew consent|0|||
163093019|NCT00887159|589052493|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
163093020|NCT00887159|589052491|FG000|Overall Study|Received more tx instead of observation|1|||
163093021|NCT00887159|589052492|FG001|Overall Study|Received more tx instead of observation|0|||
163093022|NCT00887159|589052493|FG002|Overall Study|Received more tx instead of observation|0|||
163093023|NCT00887159|589052491|FG000|Overall Study|Ineligible|5|||
163093024|NCT00887159|589052492|FG001|Overall Study|Ineligible|1|||
163093025|NCT00887159|589052493|FG002|Overall Study|Ineligible|0|||
163093026|NCT00887159|589052491|FG000|Overall Study|Never started assigned therapy|3|||
163093027|NCT00887159|589052492|FG001|Overall Study|Never started assigned therapy|3|||
163093028|NCT00887159|589052493|FG002|Overall Study|Never started assigned therapy|4|||
163337800|NCT00267956|589947313|FG003|Controlled Period|Withdrew consent|0|||
163093029|NCT03443687|589052500|FG000|Overall Study|Lost to Follow-up|3|||
163093030|NCT03443687|589052501|FG001|Overall Study|Lost to Follow-up|5|||
163337801|NCT00267956|589947310|FG000|After Controlled Period|Adverse Event|0|||
163093031|NCT03443687|589052500|FG000|Overall Study|Withdrawal by Subject|1|||
163093032|NCT03443687|589052501|FG001|Overall Study|Withdrawal by Subject|0|||
163093033|NCT03443687|589052500|FG000|Overall Study|Discontinued intervention|1|||
163093034|NCT03443687|589052501|FG001|Overall Study|Discontinued intervention|1|||
163093035|NCT02805790|589052502|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
163093036|NCT02805790|589052503|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
163093037|NCT02071771|589052505|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
163093038|NCT02071771|589052506|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
163093039|NCT02071771|589052505|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
163093040|NCT02071771|589052506|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
163093041|NCT02078752|589052507|FG000|Overall Study|Death|0|||
163093042|NCT02078752|589052508|FG001|Overall Study|Death|3|||
163093043|NCT02078752|589052509|FG002|Overall Study|Death|0|||
163093044|NCT02078752|589052510|FG003|Overall Study|Death|0|||
163093045|NCT02078752|589052511|FG004|Overall Study|Death|0|||
163093046|NCT02078752|589052512|FG005|Overall Study|Death|1|||
163093047|NCT02078752|589052513|FG006|Overall Study|Death|0|||
163093048|NCT02078752|589052514|FG007|Overall Study|Death|1|||
163093049|NCT02078752|589052515|FG008|Overall Study|Death|0|||
163093050|NCT02078752|589052516|FG009|Overall Study|Death|4|||
163093051|NCT02078752|589052507|FG000|Overall Study|Lost to Follow-up|1|||
163093052|NCT02078752|589052508|FG001|Overall Study|Lost to Follow-up|0|||
163093053|NCT02078752|589052509|FG002|Overall Study|Lost to Follow-up|0|||
163093054|NCT02078752|589052510|FG003|Overall Study|Lost to Follow-up|1|||
163093055|NCT02078752|589052511|FG004|Overall Study|Lost to Follow-up|0|||
163093056|NCT02078752|589052512|FG005|Overall Study|Lost to Follow-up|0|||
163093057|NCT02078752|589052513|FG006|Overall Study|Lost to Follow-up|0|||
163093058|NCT02078752|589052514|FG007|Overall Study|Lost to Follow-up|0|||
163093059|NCT02078752|589052515|FG008|Overall Study|Lost to Follow-up|0|||
163093060|NCT02078752|589052516|FG009|Overall Study|Lost to Follow-up|0|||
163093061|NCT02078752|589052507|FG000|Overall Study|Withdrawal by Subject|1|||
163093062|NCT02078752|589052508|FG001|Overall Study|Withdrawal by Subject|1|||
163093063|NCT02078752|589052509|FG002|Overall Study|Withdrawal by Subject|1|||
163093064|NCT02078752|589052510|FG003|Overall Study|Withdrawal by Subject|1|||
163093065|NCT02078752|589052511|FG004|Overall Study|Withdrawal by Subject|0|||
163093066|NCT02078752|589052512|FG005|Overall Study|Withdrawal by Subject|3|||
163093067|NCT02078752|589052513|FG006|Overall Study|Withdrawal by Subject|2|||
163093068|NCT02078752|589052514|FG007|Overall Study|Withdrawal by Subject|1|||
163093069|NCT02078752|589052515|FG008|Overall Study|Withdrawal by Subject|0|||
163093070|NCT02078752|589052516|FG009|Overall Study|Withdrawal by Subject|1|||
163093071|NCT02078752|589052507|FG000|Overall Study|Other|0|||
163093072|NCT02078752|589052508|FG001|Overall Study|Other|3|||
163093073|NCT02078752|589052509|FG002|Overall Study|Other|0|||
163093074|NCT02078752|589052510|FG003|Overall Study|Other|0|||
163093075|NCT02078752|589052511|FG004|Overall Study|Other|1|||
163093076|NCT02078752|589052512|FG005|Overall Study|Other|0|||
163093077|NCT02078752|589052513|FG006|Overall Study|Other|0|||
163093078|NCT02078752|589052514|FG007|Overall Study|Other|1|||
163093079|NCT02078752|589052515|FG008|Overall Study|Other|0|||
163093080|NCT02078752|589052516|FG009|Overall Study|Other|0|||
163093081|NCT02078752|589052507|FG000|Overall Study|Study terminated by sponsor|0|||
163093082|NCT02078752|589052508|FG001|Overall Study|Study terminated by sponsor|0|||
163093083|NCT02078752|589052509|FG002|Overall Study|Study terminated by sponsor|0|||
163093084|NCT02078752|589052510|FG003|Overall Study|Study terminated by sponsor|0|||
163093085|NCT02078752|589052511|FG004|Overall Study|Study terminated by sponsor|0|||
163093086|NCT02078752|589052512|FG005|Overall Study|Study terminated by sponsor|0|||
163093087|NCT02078752|589052513|FG006|Overall Study|Study terminated by sponsor|0|||
163093088|NCT02078752|589052514|FG007|Overall Study|Study terminated by sponsor|0|||
163093089|NCT02078752|589052515|FG008|Overall Study|Study terminated by sponsor|0|||
163093090|NCT02078752|589052516|FG009|Overall Study|Study terminated by sponsor|5|||
163093091|NCT00592631|589052517|FG000|Overall Study|Lost to Follow-up|0|||
163093092|NCT00592631|589052518|FG001|Overall Study|Lost to Follow-up|2|||
163093093|NCT00616642|589052521|FG000|Overall Study|Withdrawal by Subject|0|||
163093094|NCT00616642|589052522|FG001|Overall Study|Withdrawal by Subject|1|||
163093095|NCT00570323|589052523|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
163093096|NCT00570323|589052524|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
163093097|NCT00570323|589052523|FG000|Started Treatment After Randomization|Protocol Violation|1|||
163093098|NCT00570323|589052524|FG001|Started Treatment After Randomization|Protocol Violation|0|||
163093099|NCT00570323|589052523|FG000|Started Treatment After Randomization|Physician Decision|1|||
163093100|NCT00570323|589052524|FG001|Started Treatment After Randomization|Physician Decision|0|||
163093101|NCT00570323|589052523|FG000|Complete Study After Start|Lost to Follow-up|0|||
163093102|NCT00570323|589052524|FG001|Complete Study After Start|Lost to Follow-up|1|||
163093103|NCT00570323|589052523|FG000|Complete Study After Start|Withdrawal by Subject|2|||
163093104|NCT00570323|589052524|FG001|Complete Study After Start|Withdrawal by Subject|0|||
163093105|NCT00570323|589052523|FG000|Complete Study After Start|Physician Decision|1|||
163093106|NCT00570323|589052524|FG001|Complete Study After Start|Physician Decision|0|||
163093107|NCT02266147|589052527|FG000|PART 1: Dose Escalation|Physician Decision|0|||
163093108|NCT02266147|589052528|FG001|PART 1: Dose Escalation|Physician Decision|0|||
163093109|NCT02266147|589052529|FG002|PART 1: Dose Escalation|Physician Decision|1|||
163093110|NCT02266147|589052530|FG003|PART 1: Dose Escalation|Physician Decision|0|||
163093111|NCT02266147|589052527|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
163093112|NCT02266147|589052528|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
163093113|NCT02266147|589052529|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
163093114|NCT02266147|589052530|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
163093115|NCT02266147|589052527|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
163093116|NCT02266147|589052528|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
163093117|NCT02266147|589052529|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
163093118|NCT02266147|589052530|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
163093119|NCT02266147|589052527|FG000|PART 1: Dose Escalation|Other|1|||
163093120|NCT02266147|589052528|FG001|PART 1: Dose Escalation|Other|1|||
163093121|NCT02266147|589052529|FG002|PART 1: Dose Escalation|Other|0|||
163093122|NCT02266147|589052530|FG003|PART 1: Dose Escalation|Other|0|||
163093123|NCT02266147|589052527|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
163093124|NCT02266147|589052528|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
163093125|NCT02266147|589052529|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
163093126|NCT02266147|589052530|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
163093127|NCT02266147|589052527|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
163093128|NCT02266147|589052528|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
163093129|NCT02266147|589052529|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
163093130|NCT02266147|589052530|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
163093131|NCT01567722|589052537|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
163093132|NCT01567722|589052538|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
163093133|NCT01567722|589052539|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
163093134|NCT01567722|589052537|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
163093135|NCT01567722|589052538|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
163093136|NCT01567722|589052539|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
163093137|NCT01567722|589052537|FG000|Overall Study|Protocol closure by the OCG|2|||
163093138|NCT01567722|589052538|FG001|Overall Study|Protocol closure by the OCG|0|||
163093139|NCT01567722|589052539|FG002|Overall Study|Protocol closure by the OCG|0|||
163093140|NCT01567722|589052537|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
163093141|NCT01567722|589052538|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
163093142|NCT01567722|589052539|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
163093143|NCT02259114|589052541|FG000|Overall Study|Progressive Disease|14|||
163093144|NCT02259114|589052542|FG001|Overall Study|Progressive Disease|2|||
163093145|NCT02259114|589052543|FG002|Overall Study|Progressive Disease|10|||
163093146|NCT02259114|589052544|FG003|Overall Study|Progressive Disease|2|||
163093147|NCT02259114|589052545|FG004|Overall Study|Progressive Disease|5|||
163093148|NCT02259114|589052541|FG000|Overall Study|Adverse Event|2|||
163093149|NCT02259114|589052542|FG001|Overall Study|Adverse Event|1|||
163093150|NCT02259114|589052543|FG002|Overall Study|Adverse Event|0|||
163093151|NCT02259114|589052544|FG003|Overall Study|Adverse Event|0|||
163093152|NCT02259114|589052545|FG004|Overall Study|Adverse Event|1|||
163093153|NCT02259114|589052541|FG000|Overall Study|Death|3|||
163093154|NCT02259114|589052542|FG001|Overall Study|Death|0|||
163093155|NCT02259114|589052543|FG002|Overall Study|Death|1|||
163093156|NCT02259114|589052544|FG003|Overall Study|Death|0|||
163093157|NCT02259114|589052545|FG004|Overall Study|Death|0|||
163093158|NCT02259114|589052541|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
163093159|NCT02259114|589052542|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
163093160|NCT02259114|589052543|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
163093161|NCT02259114|589052544|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
163337802|NCT00267956|589947311|FG001|After Controlled Period|Adverse Event|0|||
163337803|NCT00267956|589947312|FG002|After Controlled Period|Adverse Event|2|||
163337804|NCT00267956|589947313|FG003|After Controlled Period|Adverse Event|1|||
163093162|NCT02259114|589052545|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
163093163|NCT02259114|589052541|FG000|Overall Study|Withdrawal by Subject|0|||
163093164|NCT02259114|589052542|FG001|Overall Study|Withdrawal by Subject|0|||
163093165|NCT02259114|589052543|FG002|Overall Study|Withdrawal by Subject|1|||
163093166|NCT02259114|589052544|FG003|Overall Study|Withdrawal by Subject|1|||
163093167|NCT02259114|589052545|FG004|Overall Study|Withdrawal by Subject|0|||
163093168|NCT02259114|589052541|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
163093169|NCT02259114|589052542|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
163093170|NCT02259114|589052543|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
163093171|NCT02259114|589052544|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
163093172|NCT02259114|589052545|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
163093173|NCT02259114|589052541|FG000|Overall Study|Not Treated|1|||
163093174|NCT02259114|589052542|FG001|Overall Study|Not Treated|0|||
163093175|NCT02259114|589052543|FG002|Overall Study|Not Treated|0|||
163093176|NCT02259114|589052544|FG003|Overall Study|Not Treated|0|||
163093177|NCT02259114|589052545|FG004|Overall Study|Not Treated|0|||
163093178|NCT03937479|589052546|FG000|Overall Study|Adverse Event|2|||
163093179|NCT03937479|589052547|FG001|Overall Study|Adverse Event|3|||
163093180|NCT03937479|589052548|FG002|Overall Study|Adverse Event|0|||
163093181|NCT03937479|589052549|FG003|Overall Study|Adverse Event|0|||
163093182|NCT03937479|589052550|FG004|Overall Study|Adverse Event|1|||
163093183|NCT03937479|589052546|FG000|Overall Study|Withdrawal by Subject|3|||
163093184|NCT03937479|589052547|FG001|Overall Study|Withdrawal by Subject|5|||
163093185|NCT03937479|589052548|FG002|Overall Study|Withdrawal by Subject|2|||
163093186|NCT03937479|589052549|FG003|Overall Study|Withdrawal by Subject|2|||
163093187|NCT03937479|589052550|FG004|Overall Study|Withdrawal by Subject|1|||
163093188|NCT03937479|589052546|FG000|Overall Study|Protocol Violation|5|||
163093189|NCT03937479|589052547|FG001|Overall Study|Protocol Violation|6|||
163093190|NCT03937479|589052548|FG002|Overall Study|Protocol Violation|4|||
163093191|NCT03937479|589052549|FG003|Overall Study|Protocol Violation|3|||
163093192|NCT03937479|589052550|FG004|Overall Study|Protocol Violation|2|||
163093193|NCT03937479|589052546|FG000|Overall Study|Lost to Follow-up|0|||
163093194|NCT03937479|589052547|FG001|Overall Study|Lost to Follow-up|1|||
163093195|NCT03937479|589052548|FG002|Overall Study|Lost to Follow-up|0|||
163093196|NCT03937479|589052549|FG003|Overall Study|Lost to Follow-up|1|||
163093197|NCT03937479|589052550|FG004|Overall Study|Lost to Follow-up|0|||
163093198|NCT03937479|589052546|FG000|Overall Study|Physician Decision|0|||
163093199|NCT03937479|589052547|FG001|Overall Study|Physician Decision|0|||
163093200|NCT03937479|589052548|FG002|Overall Study|Physician Decision|1|||
163093201|NCT03937479|589052549|FG003|Overall Study|Physician Decision|0|||
163093202|NCT03937479|589052550|FG004|Overall Study|Physician Decision|1|||
163093203|NCT02712788|589052553|FG000|Overall Study|Physician Decision|1|||
163093204|NCT02712788|589052554|FG001|Overall Study|Physician Decision|0|||
163093205|NCT02712788|589052553|FG000|Overall Study|Protocol Violation|1|||
163093206|NCT02712788|589052554|FG001|Overall Study|Protocol Violation|0|||
163093207|NCT03789292|589052556|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
163093208|NCT03789292|589052557|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
163093209|NCT03789292|589052558|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
163093210|NCT03789292|589052556|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
163093211|NCT03789292|589052557|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
163093212|NCT03789292|589052558|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
163093213|NCT03789292|589052556|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
163093214|NCT03789292|589052557|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
163093215|NCT03789292|589052558|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
163093216|NCT03789292|589052556|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
163093217|NCT03789292|589052557|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
163093218|NCT03789292|589052558|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
163093219|NCT03789292|589052556|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
163093220|NCT03789292|589052557|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
163093221|NCT03789292|589052558|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
163093222|NCT03789292|589052556|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
163093223|NCT03789292|589052557|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
163093224|NCT03789292|589052558|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
163093225|NCT03789292|589052556|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
163093226|NCT03789292|589052557|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
163093227|NCT03789292|589052558|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
163093228|NCT03789292|589052556|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
163093229|NCT03789292|589052557|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
163093230|NCT03789292|589052558|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
163093231|NCT03789292|589052556|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
163093232|NCT03789292|589052557|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
163093233|NCT03789292|589052558|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
163093234|NCT03789292|589052556|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
163093235|NCT03789292|589052557|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
163093236|NCT03789292|589052558|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
163093237|NCT03789292|589052556|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
163093238|NCT03789292|589052557|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
163093239|NCT03789292|589052558|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
163093240|NCT03789292|589052556|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
163093241|NCT03789292|589052557|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
163093242|NCT03789292|589052558|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
163093243|NCT03789292|589052556|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
163093244|NCT03789292|589052557|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
163220112|NCT02039674|589521416|FG010|Overall Study|Excluded Medication|5|||
163093245|NCT03789292|589052558|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
163093246|NCT01904721|589052561|FG000|Overall Study|Other Reasons|0|||
163093247|NCT01904721|589052562|FG001|Overall Study|Other Reasons|0|||
163093248|NCT01904721|589052563|FG002|Overall Study|Other Reasons|1|||
163093249|NCT01904721|589052564|FG003|Overall Study|Other Reasons|1|||
163093250|NCT01904721|589052565|FG004|Overall Study|Other Reasons|2|||
163093251|NCT01904721|589052566|FG005|Overall Study|Other Reasons|2|||
163093252|NCT01904721|589052567|FG006|Overall Study|Other Reasons|2|||
163093253|NCT01904721|589052561|FG000|Overall Study|Personal Reasons|0|||
163093254|NCT01904721|589052562|FG001|Overall Study|Personal Reasons|0|||
163093255|NCT01904721|589052563|FG002|Overall Study|Personal Reasons|0|||
163093256|NCT01904721|589052564|FG003|Overall Study|Personal Reasons|0|||
163093257|NCT01904721|589052565|FG004|Overall Study|Personal Reasons|2|||
163093258|NCT01904721|589052566|FG005|Overall Study|Personal Reasons|3|||
163093259|NCT01904721|589052567|FG006|Overall Study|Personal Reasons|3|||
163337805|NCT00267956|589947310|FG000|After Controlled Period|Lack of Efficacy|0|||
163337806|NCT00267956|589947311|FG001|After Controlled Period|Lack of Efficacy|0|||
163337807|NCT00267956|589947312|FG002|After Controlled Period|Lack of Efficacy|1|||
163337808|NCT00267956|589947313|FG003|After Controlled Period|Lack of Efficacy|1|||
163337809|NCT00267956|589947310|FG000|After Controlled Period|Lost to Follow-up|0|||
163337810|NCT00267956|589947311|FG001|After Controlled Period|Lost to Follow-up|0|||
163337811|NCT00267956|589947312|FG002|After Controlled Period|Lost to Follow-up|1|||
163337812|NCT00267956|589947313|FG003|After Controlled Period|Lost to Follow-up|0|||
163337813|NCT00267956|589947310|FG000|After Controlled Period|Withdrew consent|0|||
163337814|NCT00267956|589947311|FG001|After Controlled Period|Withdrew consent|0|||
163337815|NCT00267956|589947312|FG002|After Controlled Period|Withdrew consent|1|||
163337816|NCT00267956|589947313|FG003|After Controlled Period|Withdrew consent|0|||
163337817|NCT01393964|589947314|FG000|Overall Study|Disease Progression|4|||
163337818|NCT01393964|589947315|FG001|Overall Study|Disease Progression|3|||
163337819|NCT01393964|589947316|FG002|Overall Study|Disease Progression|5|||
163337820|NCT01393964|589947314|FG000|Overall Study|Study drug toxicity|1|||
163337821|NCT01393964|589947315|FG001|Overall Study|Study drug toxicity|0|||
163337822|NCT01393964|589947316|FG002|Overall Study|Study drug toxicity|0|||
163093260|NCT01904721|589052561|FG000|Overall Study|Lost to Follow-up|0|||
163093261|NCT01904721|589052562|FG001|Overall Study|Lost to Follow-up|0|||
163093262|NCT01904721|589052563|FG002|Overall Study|Lost to Follow-up|0|||
163093263|NCT01904721|589052564|FG003|Overall Study|Lost to Follow-up|0|||
163093264|NCT01904721|589052565|FG004|Overall Study|Lost to Follow-up|1|||
163093265|NCT01904721|589052566|FG005|Overall Study|Lost to Follow-up|3|||
163093266|NCT01904721|589052567|FG006|Overall Study|Lost to Follow-up|1|||
163093267|NCT01904721|589052561|FG000|Overall Study|Lack of Efficacy|0|||
163093268|NCT01904721|589052562|FG001|Overall Study|Lack of Efficacy|0|||
163093269|NCT01904721|589052563|FG002|Overall Study|Lack of Efficacy|0|||
163093270|NCT01904721|589052564|FG003|Overall Study|Lack of Efficacy|0|||
163093271|NCT01904721|589052565|FG004|Overall Study|Lack of Efficacy|0|||
163093272|NCT01904721|589052566|FG005|Overall Study|Lack of Efficacy|0|||
163093273|NCT01904721|589052567|FG006|Overall Study|Lack of Efficacy|1|||
163093274|NCT01904721|589052561|FG000|Overall Study|Adverse Event|0|||
163093275|NCT01904721|589052562|FG001|Overall Study|Adverse Event|0|||
163093276|NCT01904721|589052563|FG002|Overall Study|Adverse Event|0|||
163093277|NCT01904721|589052564|FG003|Overall Study|Adverse Event|0|||
163093278|NCT01904721|589052565|FG004|Overall Study|Adverse Event|3|||
163093279|NCT01904721|589052566|FG005|Overall Study|Adverse Event|1|||
163093280|NCT01904721|589052567|FG006|Overall Study|Adverse Event|0|||
163093281|NCT00532844|589052569|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
163093282|NCT00532844|589052570|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
163093283|NCT00532844|589052569|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
163093284|NCT00532844|589052570|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
163093285|NCT00532844|589052569|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
163093286|NCT00532844|589052570|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
163093287|NCT00532844|589052569|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
163093288|NCT00532844|589052570|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
163093289|NCT00532844|589052569|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
163337823|NCT01393964|589947314|FG000|Overall Study|Withdrawal by Subject|0|||
163337824|NCT01393964|589947315|FG001|Overall Study|Withdrawal by Subject|0|||
163337825|NCT01393964|589947316|FG002|Overall Study|Withdrawal by Subject|1|||
163337826|NCT01393964|589947314|FG000|Overall Study|Adverse event unrelated to study drug|0|||
163337827|NCT01393964|589947315|FG001|Overall Study|Adverse event unrelated to study drug|3|||
163337828|NCT01393964|589947316|FG002|Overall Study|Adverse event unrelated to study drug|0|||
163337829|NCT01393964|589947314|FG000|Overall Study|Subject request stop study treatment|0|||
163337830|NCT01393964|589947315|FG001|Overall Study|Subject request stop study treatment|1|||
163337831|NCT01393964|589947316|FG002|Overall Study|Subject request stop study treatment|0|||
163093290|NCT00532844|589052570|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
163093291|NCT01077063|589052571|FG000|Overall Study|Adverse Event|3|||
163093292|NCT01077063|589052572|FG001|Overall Study|Adverse Event|0|||
163093293|NCT01077063|589052571|FG000|Overall Study|Death|1|||
163093294|NCT01077063|589052572|FG001|Overall Study|Death|1|||
163093295|NCT01077063|589052571|FG000|Overall Study|Withdrawal by Subject|0|||
163093296|NCT01077063|589052572|FG001|Overall Study|Withdrawal by Subject|2|||
163093297|NCT00553631|589052574|FG000|Overall Study|Withdrawal by Subject|0|||
163093298|NCT00553631|589052575|FG001|Overall Study|Withdrawal by Subject|1|||
163093299|NCT00553631|589052574|FG000|Overall Study|Lost to Follow-up|1|||
163093300|NCT00553631|589052575|FG001|Overall Study|Lost to Follow-up|0|||
163093301|NCT00251693|589052576|FG000|Overall Study|Adverse Event|17|||
163093302|NCT00251693|589052577|FG001|Overall Study|Adverse Event|9|||
163093303|NCT00251693|589052578|FG002|Overall Study|Adverse Event|9|||
163093304|NCT00251693|589052576|FG000|Overall Study|Protocol Violation|2|||
163093305|NCT00251693|589052577|FG001|Overall Study|Protocol Violation|0|||
163093306|NCT00251693|589052578|FG002|Overall Study|Protocol Violation|2|||
163093307|NCT00251693|589052576|FG000|Overall Study|Lost to Follow-up|12|||
163093308|NCT00251693|589052577|FG001|Overall Study|Lost to Follow-up|7|||
163093309|NCT00251693|589052578|FG002|Overall Study|Lost to Follow-up|8|||
163093310|NCT00251693|589052576|FG000|Overall Study|Withdrawal by Subject|11|||
163093311|NCT00251693|589052577|FG001|Overall Study|Withdrawal by Subject|17|||
163093312|NCT00251693|589052578|FG002|Overall Study|Withdrawal by Subject|14|||
163093313|NCT00251693|589052576|FG000|Overall Study|Lack of Efficacy|0|||
163093314|NCT00251693|589052577|FG001|Overall Study|Lack of Efficacy|1|||
163093315|NCT00251693|589052578|FG002|Overall Study|Lack of Efficacy|0|||
163337832|NCT01393964|589947314|FG000|Overall Study|Subject decided to move to transplant|1|||
163337833|NCT01393964|589947315|FG001|Overall Study|Subject decided to move to transplant|0|||
163337834|NCT01393964|589947316|FG002|Overall Study|Subject decided to move to transplant|0|||
163337835|NCT01393964|589947314|FG000|Overall Study|Subject switched to commercial supply|1|||
163337836|NCT01393964|589947315|FG001|Overall Study|Subject switched to commercial supply|0|||
163337837|NCT01393964|589947316|FG002|Overall Study|Subject switched to commercial supply|2|||
163337838|NCT01393964|589947314|FG000|Overall Study|Subject plateaued in terms of effect|1|||
163093316|NCT00251693|589052576|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
163093317|NCT00251693|589052577|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
163093318|NCT00251693|589052578|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
163093319|NCT00251693|589052576|FG000|Overall Study|Noncompliant|0|||
163093320|NCT00251693|589052577|FG001|Overall Study|Noncompliant|0|||
163093321|NCT00251693|589052578|FG002|Overall Study|Noncompliant|2|||
163093322|NCT00251693|589052576|FG000|Overall Study|Possible Barrett's esophagus|3|||
163093323|NCT00251693|589052577|FG001|Overall Study|Possible Barrett's esophagus|5|||
163093324|NCT00251693|589052578|FG002|Overall Study|Possible Barrett's esophagus|2|||
163093325|NCT00251693|589052576|FG000|Overall Study|Subject request/subject unavailable|1|||
163093326|NCT00251693|589052577|FG001|Overall Study|Subject request/subject unavailable|2|||
163093327|NCT00251693|589052578|FG002|Overall Study|Subject request/subject unavailable|0|||
163093328|NCT00251693|589052576|FG000|Overall Study|Abnormal laboratory findings|0|||
163093329|NCT00251693|589052577|FG001|Overall Study|Abnormal laboratory findings|0|||
163093330|NCT00251693|589052578|FG002|Overall Study|Abnormal laboratory findings|1|||
163093331|NCT01816048|589052581|FG000|Overall Study|Adverse Event|1|||
163093332|NCT01816048|589052581|FG000|Overall Study|Death|1|||
163093333|NCT01816048|589052581|FG000|Overall Study|Withdrawal by Subject|1|||
163093334|NCT01816048|589052581|FG000|Overall Study|Disease Progression|3|||
163093335|NCT02031302|589052582|FG000|Overall Study|Death|115|||
163093336|NCT02031302|589052583|FG001|Overall Study|Death|0|||
163093337|NCT02031302|589052582|FG000|Overall Study|Not treated with study valve system|18|||
163093338|NCT02031302|589052583|FG001|Overall Study|Not treated with study valve system|0|||
163093339|NCT02031302|589052582|FG000|Overall Study|Missed Follow Up|27|||
163093340|NCT02031302|589052583|FG001|Overall Study|Missed Follow Up|0|||
163093341|NCT02031302|589052582|FG000|Overall Study|Lost to Follow-up|4|||
163093342|NCT02031302|589052583|FG001|Overall Study|Lost to Follow-up|0|||
163093343|NCT01847443|589052584|FG000|Study Period 1|Withdrawal by Subject|0|||
163093344|NCT01847443|589052585|FG001|Study Period 1|Withdrawal by Subject|1|||
163093345|NCT01847443|589052586|FG002|Study Period 1|Withdrawal by Subject|0|||
163093346|NCT01847443|589052587|FG003|Study Period 1|Withdrawal by Subject|0|||
163093347|NCT01847443|589052584|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
163093348|NCT01847443|589052585|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
163093349|NCT01847443|589052586|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
163093350|NCT01847443|589052587|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
163093351|NCT01847443|589052584|FG000|Washout Period Before Study Period 2|Other reason|1|||
163093352|NCT01847443|589052585|FG001|Washout Period Before Study Period 2|Other reason|0|||
163093353|NCT01847443|589052586|FG002|Washout Period Before Study Period 2|Other reason|0|||
163093354|NCT01847443|589052587|FG003|Washout Period Before Study Period 2|Other reason|0|||
163093355|NCT01847443|589052584|FG000|Washout Period Before Study Period 3|Other reason|1|||
163337839|NCT01393964|589947315|FG001|Overall Study|Subject plateaued in terms of effect|0|||
163093356|NCT01847443|589052585|FG001|Washout Period Before Study Period 3|Other reason|0|||
163093357|NCT01847443|589052586|FG002|Washout Period Before Study Period 3|Other reason|0|||
163093358|NCT01847443|589052587|FG003|Washout Period Before Study Period 3|Other reason|0|||
163093359|NCT01847443|589052584|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
163337840|NCT01393964|589947316|FG002|Overall Study|Subject plateaued in terms of effect|0|||
163337841|NCT01393964|589947314|FG000|Overall Study|Investigator removed subject from study|0|||
163337842|NCT01393964|589947315|FG001|Overall Study|Investigator removed subject from study|1|||
163337843|NCT01393964|589947316|FG002|Overall Study|Investigator removed subject from study|0|||
163337844|NCT01393964|589947314|FG000|Overall Study|Subject converted to roll-over study|0|||
163337845|NCT01393964|589947315|FG001|Overall Study|Subject converted to roll-over study|1|||
163337846|NCT01393964|589947316|FG002|Overall Study|Subject converted to roll-over study|0|||
163337847|NCT01393964|589947314|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
163337848|NCT01393964|589947315|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
163337849|NCT01393964|589947316|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
163337850|NCT01918033|589947317|FG000|Overall Study|Adverse Event|1|||
163337851|NCT01918033|589947318|FG001|Overall Study|Adverse Event|0|||
163337852|NCT01918033|589947319|FG002|Overall Study|Adverse Event|2|||
163337853|NCT01918033|589947317|FG000|Overall Study|Lost to Follow-up|0|||
163337854|NCT01918033|589947318|FG001|Overall Study|Lost to Follow-up|1|||
163337855|NCT01918033|589947319|FG002|Overall Study|Lost to Follow-up|0|||
163337856|NCT01918033|589947317|FG000|Overall Study|Protocol Violation|2|||
163337857|NCT01918033|589947318|FG001|Overall Study|Protocol Violation|0|||
163337858|NCT01918033|589947319|FG002|Overall Study|Protocol Violation|1|||
163337859|NCT01918033|589947317|FG000|Overall Study|Withdrawal by Subject|2|||
163337860|NCT01918033|589947318|FG001|Overall Study|Withdrawal by Subject|1|||
163337861|NCT01918033|589947319|FG002|Overall Study|Withdrawal by Subject|0|||
163337862|NCT04679675|589947320|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
163337863|NCT04679675|589947321|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
163337864|NCT04679675|589947322|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
163337865|NCT04679675|589947323|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
163337866|NCT04679675|589947320|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
163337867|NCT04679675|589947321|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
163337868|NCT04679675|589947322|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
163337869|NCT04679675|589947323|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
163337870|NCT01494467|589947330|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
163337871|NCT01494467|589947331|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
163337872|NCT01494467|589947330|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
163337873|NCT01494467|589947331|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
163337874|NCT01494467|589947330|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
163337875|NCT01494467|589947331|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
163337876|NCT01494467|589947330|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
163337877|NCT01494467|589947331|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
163337878|NCT01494467|589947330|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
163337879|NCT01494467|589947331|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
163093360|NCT01847443|589052585|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
163093361|NCT01847443|589052586|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
163093362|NCT01847443|589052587|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
163093363|NCT01847443|589052584|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
163093364|NCT01847443|589052585|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
163093365|NCT01847443|589052586|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
163093366|NCT01847443|589052587|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
163093367|NCT04067492|589052588|FG000|Overall Study|Lost to Follow-up|0|||
163093368|NCT04067492|589052589|FG001|Overall Study|Lost to Follow-up|0|||
163093369|NCT04067492|589052590|FG002|Overall Study|Lost to Follow-up|0|||
163093370|NCT04067492|589052591|FG003|Overall Study|Lost to Follow-up|0|||
163093371|NCT04067492|589052592|FG004|Overall Study|Lost to Follow-up|0|||
163093372|NCT04067492|589052593|FG005|Overall Study|Lost to Follow-up|1|||
163093373|NCT04067492|589052588|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
163337880|NCT01494467|589947330|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
163337881|NCT01494467|589947331|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
163337882|NCT01494467|589947330|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
163337883|NCT01494467|589947331|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
163337884|NCT01494467|589947330|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
163337885|NCT01494467|589947331|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
163337886|NCT01494467|589947330|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
163337887|NCT01494467|589947331|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
163337888|NCT01494467|589947330|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
163337889|NCT01494467|589947331|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
163093374|NCT04067492|589052589|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
163093375|NCT04067492|589052590|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
163220113|NCT02039674|589521417|FG011|Overall Study|Excluded Medication|6|||
163093376|NCT04067492|589052591|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
163093377|NCT04067492|589052592|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
163093378|NCT04067492|589052593|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
163093379|NCT04067492|589052588|FG000|Overall Study|COVID-19 epidemiological situation|0|||
163093380|NCT04067492|589052589|FG001|Overall Study|COVID-19 epidemiological situation|0|||
163093381|NCT04067492|589052590|FG002|Overall Study|COVID-19 epidemiological situation|0|||
163093382|NCT04067492|589052591|FG003|Overall Study|COVID-19 epidemiological situation|1|||
163093383|NCT04067492|589052592|FG004|Overall Study|COVID-19 epidemiological situation|0|||
163093384|NCT04067492|589052593|FG005|Overall Study|COVID-19 epidemiological situation|0|||
163093385|NCT05899829|589052600|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
163093386|NCT05899829|589052601|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
163093387|NCT05899829|589052600|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
163093388|NCT05899829|589052601|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
163093389|NCT05076045|589052602|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
163093390|NCT05076045|589052603|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
163093391|NCT00038948|589052608|FG000|Overall Study|Adverse Event|131|||
163093392|NCT00038948|589052609|FG001|Overall Study|Adverse Event|43|||
163337890|NCT01494467|589947330|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
163337891|NCT01494467|589947331|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
163337892|NCT01494467|589947330|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
163337893|NCT01494467|589947331|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
163337894|NCT01494467|589947330|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
163337895|NCT01494467|589947331|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
163337896|NCT01494467|589947330|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
163337897|NCT01494467|589947331|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
163337898|NCT02721147|589947336|FG000|Overall Study|Lost to Follow-up|2|||
163337899|NCT02721147|589947337|FG001|Overall Study|Lost to Follow-up|0|||
163337900|NCT02721147|589947338|FG002|Overall Study|Lost to Follow-up|0|||
163337901|NCT01722097|589947339|FG000|Overall Study|Patient sheets not returned|6|||
163337902|NCT01722097|589947340|FG001|Overall Study|Patient sheets not returned|5|||
163337903|NCT01535261|589947341|FG000|Overall Study|Physician Decision|8|||
163337904|NCT01535261|589947341|FG000|Overall Study|Protocol Violation|3|||
163337905|NCT01535261|589947341|FG000|Overall Study|Death|5|||
163337906|NCT01535261|589947341|FG000|Overall Study|Lost to Follow-up|8|||
163337907|NCT01535261|589947341|FG000|Overall Study|Withdrawal by Subject|14|||
163337908|NCT01535261|589947341|FG000|Overall Study|Adverse Event|12|||
163337909|NCT01137682|589947342|FG000|Overall Study|Adverse Event-CORE|2|||
163337910|NCT01137682|589947343|FG001|Overall Study|Adverse Event-CORE|4|||
163337911|NCT01137682|589947344|FG002|Overall Study|Adverse Event-CORE|0|||
163337912|NCT01137682|589947342|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
163337913|NCT01137682|589947343|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
163337914|NCT01137682|589947344|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
163337915|NCT01137682|589947342|FG000|Overall Study|Administrative problems-CORE|2|||
163337916|NCT01137682|589947343|FG001|Overall Study|Administrative problems-CORE|1|||
163337917|NCT01137682|589947344|FG002|Overall Study|Administrative problems-CORE|0|||
163337918|NCT01137682|589947342|FG000|Overall Study|Protocol Violation-CORE|0|||
163337919|NCT01137682|589947343|FG001|Overall Study|Protocol Violation-CORE|1|||
163337920|NCT01137682|589947344|FG002|Overall Study|Protocol Violation-CORE|1|||
163337921|NCT01137682|589947342|FG000|Overall Study|Adverse Event-Extension|4|||
163337922|NCT01137682|589947343|FG001|Overall Study|Adverse Event-Extension|8|||
163337923|NCT01137682|589947344|FG002|Overall Study|Adverse Event-Extension|7|||
163337924|NCT01137682|589947342|FG000|Overall Study|Lack of Efficacy-Extension|15|||
163337925|NCT01137682|589947343|FG001|Overall Study|Lack of Efficacy-Extension|9|||
163337926|NCT01137682|589947344|FG002|Overall Study|Lack of Efficacy-Extension|13|||
163337927|NCT01137682|589947342|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
163337928|NCT01137682|589947343|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
163337929|NCT01137682|589947344|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
163337930|NCT01137682|589947342|FG000|Overall Study|Lost to Follow Up-Extension|0|||
163093393|NCT00038948|589052608|FG000|Overall Study|Lost to Follow-up|4|||
163337931|NCT01137682|589947343|FG001|Overall Study|Lost to Follow Up-Extension|1|||
163337932|NCT01137682|589947344|FG002|Overall Study|Lost to Follow Up-Extension|0|||
163337933|NCT01137682|589947342|FG000|Overall Study|Administrative problems-Extension|0|||
163337934|NCT01137682|589947343|FG001|Overall Study|Administrative problems-Extension|2|||
163337935|NCT01137682|589947344|FG002|Overall Study|Administrative problems-Extension|0|||
163093394|NCT00038948|589052609|FG001|Overall Study|Lost to Follow-up|4|||
163220114|NCT02039674|589521418|FG012|Overall Study|Excluded Medication|8|||
163337936|NCT01137682|589947342|FG000|Overall Study|Death-Extension|2|||
163407630|NCT02706873|590200873|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
163407631|NCT02706873|590200874|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
163407632|NCT02706873|590200871|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
163220115|NCT02039674|589521419|FG013|Overall Study|Excluded Medication|3|||
163337937|NCT01137682|589947343|FG001|Overall Study|Death-Extension|0|||
163093395|NCT00038948|589052608|FG000|Overall Study|Nonmedical event|5|||
163093396|NCT00038948|589052609|FG001|Overall Study|Nonmedical event|7|||
163093397|NCT00038948|589052608|FG000|Overall Study|Withdrawal by Subject|23|||
163093398|NCT00038948|589052609|FG001|Overall Study|Withdrawal by Subject|10|||
163093399|NCT00038948|589052608|FG000|Overall Study|Protocol Violation|3|||
163093400|NCT00038948|589052609|FG001|Overall Study|Protocol Violation|7|||
163093401|NCT00038948|589052608|FG000|Overall Study|Lack of Efficacy|3|||
163093402|NCT00038948|589052609|FG001|Overall Study|Lack of Efficacy|6|||
163093403|NCT05270863|589052610|FG000|Visit 2 First Intervention|Randomization error|0|||
163093404|NCT05270863|589052611|FG001|Visit 2 First Intervention|Randomization error|0|||
163093405|NCT05270863|589052612|FG002|Visit 2 First Intervention|Randomization error|0|||
163093406|NCT05270863|589052613|FG003|Visit 2 First Intervention|Randomization error|1|||
163093407|NCT05270863|589052614|FG004|Visit 2 First Intervention|Randomization error|0|||
163093408|NCT05270863|589052615|FG005|Visit 2 First Intervention|Randomization error|0|||
163093409|NCT05270863|589052610|FG000|First Washout|Withdrawal by Subject|0|||
163093410|NCT05270863|589052611|FG001|First Washout|Withdrawal by Subject|0|||
163093411|NCT05270863|589052612|FG002|First Washout|Withdrawal by Subject|0|||
163093412|NCT05270863|589052613|FG003|First Washout|Withdrawal by Subject|0|||
163093413|NCT05270863|589052614|FG004|First Washout|Withdrawal by Subject|1|||
163093414|NCT05270863|589052615|FG005|First Washout|Withdrawal by Subject|1|||
163093415|NCT05270863|589052610|FG000|First Washout|Lost to Follow-up|0|||
163093416|NCT05270863|589052611|FG001|First Washout|Lost to Follow-up|0|||
163093417|NCT05270863|589052612|FG002|First Washout|Lost to Follow-up|0|||
163093418|NCT05270863|589052613|FG003|First Washout|Lost to Follow-up|0|||
163093419|NCT05270863|589052614|FG004|First Washout|Lost to Follow-up|0|||
163093420|NCT05270863|589052615|FG005|First Washout|Lost to Follow-up|1|||
163093421|NCT05270863|589052610|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
163093422|NCT05270863|589052611|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
163093423|NCT05270863|589052612|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
163093424|NCT05270863|589052613|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
163093425|NCT05270863|589052614|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
163093426|NCT05270863|589052615|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
163093427|NCT05270863|589052610|FG000|Second Washout|Withdrawal by Subject|1|||
163093428|NCT05270863|589052611|FG001|Second Washout|Withdrawal by Subject|1|||
163093429|NCT05270863|589052612|FG002|Second Washout|Withdrawal by Subject|0|||
163093430|NCT05270863|589052613|FG003|Second Washout|Withdrawal by Subject|0|||
163093431|NCT05270863|589052614|FG004|Second Washout|Withdrawal by Subject|0|||
163093432|NCT05270863|589052615|FG005|Second Washout|Withdrawal by Subject|0|||
163093433|NCT05270863|589052610|FG000|Second Washout|Lost to Follow-up|0|||
163093434|NCT05270863|589052611|FG001|Second Washout|Lost to Follow-up|0|||
163093435|NCT05270863|589052612|FG002|Second Washout|Lost to Follow-up|0|||
163093436|NCT05270863|589052613|FG003|Second Washout|Lost to Follow-up|1|||
163093437|NCT05270863|589052614|FG004|Second Washout|Lost to Follow-up|0|||
163093438|NCT05270863|589052615|FG005|Second Washout|Lost to Follow-up|0|||
163093439|NCT03984188|589052616|FG000|Overall Study|Death|2|||
163093440|NCT03984188|589052617|FG001|Overall Study|Death|4|||
163093441|NCT03984188|589052616|FG000|Overall Study|Physician Decision|0|||
163093442|NCT03984188|589052617|FG001|Overall Study|Physician Decision|2|||
163093443|NCT03984188|589052616|FG000|Overall Study|Lost to Follow-up|3|||
163093444|NCT03984188|589052617|FG001|Overall Study|Lost to Follow-up|2|||
163093445|NCT03984188|589052616|FG000|Overall Study|Withdrawal by Subject|6|||
163093446|NCT03984188|589052617|FG001|Overall Study|Withdrawal by Subject|0|||
163093447|NCT00529243|589054264|FG000|Overall Study|Adverse Event|1|||
163093448|NCT00529243|589054264|FG000|Overall Study|Death|1|||
163093449|NCT00529243|589054264|FG000|Overall Study|Relocated|1|||
163093450|NCT00678288|589054271|FG000|Overall Study|Adverse Event|0|||
163337938|NCT01137682|589947344|FG002|Overall Study|Death-Extension|0|||
163337939|NCT01137682|589947342|FG000|Overall Study|Protocol Violation-Extension|2|||
163337940|NCT01137682|589947343|FG001|Overall Study|Protocol Violation-Extension|1|||
163337941|NCT01137682|589947344|FG002|Overall Study|Protocol Violation-Extension|0|||
163337942|NCT01137682|589947342|FG000|Overall Study|Did not enter extension|2|||
163337943|NCT01137682|589947343|FG001|Overall Study|Did not enter extension|3|||
163337944|NCT01137682|589947344|FG002|Overall Study|Did not enter extension|2|||
163093451|NCT00678288|589054272|FG001|Overall Study|Adverse Event|2|||
163093452|NCT00678288|589054271|FG000|Overall Study|Withdrawal by Subject|1|||
163093453|NCT00678288|589054272|FG001|Overall Study|Withdrawal by Subject|1|||
163337945|NCT01137682|589947342|FG000|Overall Study|Did not receive treatment in extension|0|||
163337946|NCT01137682|589947343|FG001|Overall Study|Did not receive treatment in extension|0|||
163093454|NCT00678288|589054271|FG000|Overall Study|Study terminated by the sponsor|2|||
163093455|NCT00678288|589054272|FG001|Overall Study|Study terminated by the sponsor|0|||
163093456|NCT00678288|589054271|FG000|Overall Study|Not compliant with study medication|0|||
163093457|NCT00678288|589054272|FG001|Overall Study|Not compliant with study medication|1|||
163093458|NCT00678288|589054271|FG000|Overall Study|Switch to commercial drug|0|||
163093459|NCT00678288|589054272|FG001|Overall Study|Switch to commercial drug|1|||
163093460|NCT00678288|589054271|FG000|Overall Study|Reason not reported|1|||
163093461|NCT00678288|589054272|FG001|Overall Study|Reason not reported|0|||
163093462|NCT00678288|589054271|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
163093463|NCT00678288|589054272|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
163093464|NCT04472650|589054283|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
163093465|NCT04472650|589054284|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
163093466|NCT03247829|589054287|FG000|Overall Study|Death|3|||
163093467|NCT03247829|589054288|FG001|Overall Study|Death|4|||
163093468|NCT03247829|589054287|FG000|Overall Study|Enter Hospice Care|1|||
163093469|NCT03247829|589054288|FG001|Overall Study|Enter Hospice Care|0|||
163093470|NCT03247829|589054287|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
163093471|NCT03247829|589054288|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
163093472|NCT03247829|589054287|FG000|Overall Study|LVAD Explant|1|||
163093473|NCT03247829|589054288|FG001|Overall Study|LVAD Explant|1|||
163093474|NCT03247829|589054287|FG000|Overall Study|Transplant|1|||
163093475|NCT03247829|589054288|FG001|Overall Study|Transplant|1|||
163093476|NCT01783444|589054289|FG000|Treatment Phase|Adverse Event|9|||
163093477|NCT01783444|589054290|FG001|Treatment Phase|Adverse Event|20|||
163093478|NCT01783444|589054291|FG002|Treatment Phase|Adverse Event|19|||
163093479|NCT01783444|589054289|FG000|Treatment Phase|Disease Progression|76|||
163093480|NCT01783444|589054290|FG001|Treatment Phase|Disease Progression|66|||
163093481|NCT01783444|589054291|FG002|Treatment Phase|Disease Progression|64|||
163093482|NCT01783444|589054289|FG000|Treatment Phase|Death|2|||
163093483|NCT01783444|589054290|FG001|Treatment Phase|Death|2|||
163093484|NCT01783444|589054291|FG002|Treatment Phase|Death|2|||
163093485|NCT01783444|589054289|FG000|Treatment Phase|Protocol Violation|1|||
163093486|NCT01783444|589054290|FG001|Treatment Phase|Protocol Violation|1|||
163093487|NCT01783444|589054291|FG002|Treatment Phase|Protocol Violation|2|||
163093488|NCT01783444|589054289|FG000|Treatment Phase|Withdrawal by Subject|6|||
163093489|NCT01783444|589054290|FG001|Treatment Phase|Withdrawal by Subject|8|||
163093490|NCT01783444|589054291|FG002|Treatment Phase|Withdrawal by Subject|9|||
163093491|NCT01783444|589054289|FG000|Treatment Phase|Administrative problems|2|||
163093492|NCT01783444|589054290|FG001|Treatment Phase|Administrative problems|0|||
163093493|NCT01783444|589054291|FG002|Treatment Phase|Administrative problems|1|||
163093494|NCT01783444|589054289|FG000|Treatment Phase|Physician Decision|8|||
163093495|NCT01783444|589054290|FG001|Treatment Phase|Physician Decision|6|||
163093496|NCT01783444|589054291|FG002|Treatment Phase|Physician Decision|5|||
163093497|NCT01783444|589054289|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
163093498|NCT01783444|589054290|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
163093499|NCT01783444|589054291|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
163093500|NCT01783444|589054289|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
163093501|NCT01783444|589054290|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
163093502|NCT01783444|589054291|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
163093503|NCT01783444|589054289|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
163093504|NCT01783444|589054290|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
163093505|NCT01783444|589054291|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
163093506|NCT01783444|589054289|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
163093507|NCT01783444|589054290|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
163093508|NCT01783444|589054291|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
163093509|NCT01783444|589054289|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
163093510|NCT01783444|589054290|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
163093511|NCT01783444|589054291|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
163093512|NCT01783444|589054289|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
163093513|NCT01783444|589054290|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
163093514|NCT01783444|589054291|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
163093515|NCT00552071|589054293|FG000|Overall Study|Adverse Event|1|||
163093516|NCT00552071|589054294|FG001|Overall Study|Adverse Event|0|||
163093517|NCT00552071|589054293|FG000|Overall Study|Lack of Efficacy|1|||
163093518|NCT00552071|589054294|FG001|Overall Study|Lack of Efficacy|0|||
163093519|NCT00552071|589054293|FG000|Overall Study|Physician Decision|1|||
163093520|NCT00552071|589054294|FG001|Overall Study|Physician Decision|0|||
163093521|NCT00552071|589054293|FG000|Overall Study|Pregnancy|1|||
163093522|NCT00552071|589054294|FG001|Overall Study|Pregnancy|0|||
163093523|NCT00552071|589054293|FG000|Overall Study|Death|0|||
163093524|NCT00552071|589054294|FG001|Overall Study|Death|1|||
163093525|NCT00552071|589054293|FG000|Overall Study|Withdrawal by Subject|0|||
163093526|NCT00552071|589054294|FG001|Overall Study|Withdrawal by Subject|1|||
163093527|NCT00272792|589054295|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
163093528|NCT00272792|589054296|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
163093529|NCT00272792|589054295|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
163093530|NCT00272792|589054296|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
163093531|NCT00272792|589054295|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
163093532|NCT00272792|589054296|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
163220116|NCT02039674|589521406|FG000|Overall Study|Lost to Follow-up|0|||
163093533|NCT00272792|589054295|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
163093534|NCT00272792|589054296|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
163093535|NCT00937495|589054301|FG000|Overall Study|Protocol Violation|2|||
163093536|NCT02549989|589054302|FG000|Overall Study|Adverse Event|4|||
163093537|NCT02549989|589054302|FG000|Overall Study|Death|1|||
163093538|NCT02549989|589054302|FG000|Overall Study|Lack of Efficacy|19|||
163093539|NCT02549989|589054302|FG000|Overall Study|Withdrawal by Subject|3|||
163093540|NCT02628444|589054306|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
163093541|NCT02628444|589054307|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093542|NCT02628444|589054308|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093543|NCT02628444|589054309|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093544|NCT02628444|589054310|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093545|NCT02628444|589054311|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093546|NCT02628444|589054312|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093547|NCT02628444|589054313|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093548|NCT02628444|589054314|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093549|NCT02628444|589054306|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
163093550|NCT02628444|589054307|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
163093551|NCT02628444|589054308|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
163093552|NCT02628444|589054309|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
163093553|NCT02628444|589054310|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
163337947|NCT01137682|589947344|FG002|Overall Study|Did not receive treatment in extension|1|||
163093554|NCT02628444|589054311|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
163093555|NCT02628444|589054312|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
163093556|NCT02628444|589054313|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
163093557|NCT02628444|589054314|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
163093558|NCT02628444|589054306|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
163093559|NCT02628444|589054307|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
163093560|NCT02628444|589054308|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
163093561|NCT02628444|589054309|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093562|NCT02628444|589054310|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093563|NCT02628444|589054311|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093564|NCT02628444|589054312|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093565|NCT02628444|589054313|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093566|NCT02628444|589054314|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093567|NCT02628444|589054306|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
163093568|NCT02628444|589054307|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
163093569|NCT02628444|589054308|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
163093570|NCT02628444|589054309|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
163093571|NCT02628444|589054310|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
163093572|NCT02628444|589054311|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
163093573|NCT02628444|589054312|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
163093574|NCT02628444|589054313|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
163093575|NCT02628444|589054314|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
163093576|NCT02628444|589054306|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
163093577|NCT02628444|589054307|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
163093578|NCT02628444|589054308|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
163093579|NCT02628444|589054309|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
163093580|NCT02628444|589054310|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
163093581|NCT02628444|589054311|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
163093582|NCT02628444|589054312|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
163093583|NCT02628444|589054313|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
163093584|NCT02628444|589054314|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
163093585|NCT02628444|589054306|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093586|NCT02628444|589054307|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093587|NCT02628444|589054308|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093588|NCT02628444|589054309|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
163093589|NCT02628444|589054310|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093590|NCT02628444|589054311|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093591|NCT02628444|589054312|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093592|NCT02628444|589054313|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093593|NCT02628444|589054314|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093594|NCT02628444|589054306|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
163093595|NCT02628444|589054307|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
163093596|NCT02628444|589054308|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
163093597|NCT02628444|589054309|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
163093598|NCT02628444|589054310|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
163093599|NCT02628444|589054311|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
163093600|NCT02628444|589054312|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
163093601|NCT02628444|589054313|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
163093602|NCT02628444|589054314|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
163093603|NCT02628444|589054306|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093604|NCT02628444|589054307|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093605|NCT02628444|589054308|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093606|NCT02628444|589054309|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
163337948|NCT02009332|589947345|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
163337949|NCT02009332|589947346|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
163337950|NCT02009332|589947347|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
163337951|NCT02009332|589947348|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
163337952|NCT02009332|589947349|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
163337953|NCT02009332|589947350|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
163337954|NCT02009332|589947345|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
163337955|NCT02009332|589947346|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
163337956|NCT02009332|589947347|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
163337957|NCT02009332|589947348|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
163337958|NCT02009332|589947349|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
163337959|NCT02009332|589947350|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
163337960|NCT02009332|589947345|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
163337961|NCT02009332|589947346|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
163337962|NCT02009332|589947347|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
163337963|NCT02009332|589947348|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
163337964|NCT02009332|589947349|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
163337965|NCT02009332|589947350|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
163093607|NCT02628444|589054310|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
163093608|NCT02628444|589054311|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
163093609|NCT02628444|589054312|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
163093610|NCT02628444|589054313|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
163093611|NCT02628444|589054314|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
163093612|NCT02628444|589054306|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
163093613|NCT02628444|589054307|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
163093614|NCT02628444|589054308|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
163093615|NCT02628444|589054309|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
163093616|NCT02628444|589054310|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
163093617|NCT02628444|589054311|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
163093618|NCT02628444|589054312|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
163093619|NCT02628444|589054313|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
163093620|NCT02628444|589054314|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
163093621|NCT02628444|589054306|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
163093622|NCT02628444|589054307|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
163093623|NCT02628444|589054308|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
163093624|NCT02628444|589054309|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
163093625|NCT02628444|589054310|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
163093626|NCT02628444|589054311|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
163093627|NCT02628444|589054312|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
163093628|NCT02628444|589054313|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
163093629|NCT02628444|589054314|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
163093630|NCT00288015|589054315|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
163093631|NCT00288015|589054315|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
163093632|NCT00288015|589054315|FG000|First Response Assessment|Withdrawal by Subject|1|||
163093633|NCT00288015|589054315|FG000|First Response Assessment|Death|1|||
163093634|NCT00288015|589054315|FG000|First Response Assessment|Physician Decision|2|||
163093635|NCT00288015|589054315|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
163093636|NCT00288015|589054315|FG000|Follow up for Survival x 2 Years|Death|13|||
163093637|NCT00288015|589054315|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
163093638|NCT00288015|589054315|FG000|Follow up for Survival x 2 Years|Other|9|||
163093639|NCT00443703|589054318|FG000|Overall Study|Never Treated|3|||
163093640|NCT00443703|589054319|FG001|Overall Study|Never Treated|1|||
163093641|NCT00443703|589054318|FG000|Overall Study|Adverse Event|7|||
163093642|NCT00443703|589054319|FG001|Overall Study|Adverse Event|3|||
163093643|NCT00443703|589054318|FG000|Overall Study|Lack of Efficacy|3|||
163093644|NCT00443703|589054319|FG001|Overall Study|Lack of Efficacy|1|||
163093645|NCT00443703|589054318|FG000|Overall Study|Lost to Follow-up|0|||
163093646|NCT00443703|589054319|FG001|Overall Study|Lost to Follow-up|4|||
163093647|NCT00443703|589054318|FG000|Overall Study|Physician Decision|4|||
163093648|NCT00443703|589054319|FG001|Overall Study|Physician Decision|2|||
163093649|NCT00443703|589054318|FG000|Overall Study|Protocol Violation|1|||
163093650|NCT00443703|589054319|FG001|Overall Study|Protocol Violation|1|||
163093651|NCT00443703|589054318|FG000|Overall Study|Withdrawal by Subject|9|||
163093652|NCT00443703|589054319|FG001|Overall Study|Withdrawal by Subject|6|||
163093653|NCT00443703|589054318|FG000|Overall Study|Progressive Disease|1|||
163093654|NCT00443703|589054319|FG001|Overall Study|Progressive Disease|0|||
163093655|NCT01333722|589054320|FG000|Overall Study|Lack of Efficacy|0|||
163093656|NCT01333722|589054321|FG001|Overall Study|Lack of Efficacy|2|||
163093657|NCT01333722|589054320|FG000|Overall Study|Withdrawal by Subject|0|||
163093658|NCT01333722|589054321|FG001|Overall Study|Withdrawal by Subject|1|||
163093659|NCT00784368|589054322|FG000|Overall Study|Physician Decision|0|||
163093660|NCT00784368|589054323|FG001|Overall Study|Physician Decision|0|||
163093661|NCT00784368|589054324|FG002|Overall Study|Physician Decision|6|||
163093662|NCT00784368|589054322|FG000|Overall Study|Lack of Efficacy|2|||
163093663|NCT00784368|589054323|FG001|Overall Study|Lack of Efficacy|0|||
163093664|NCT00784368|589054324|FG002|Overall Study|Lack of Efficacy|1|||
163093665|NCT00784368|589054322|FG000|Overall Study|Adverse Event|6|||
163093666|NCT00784368|589054323|FG001|Overall Study|Adverse Event|9|||
163093667|NCT00784368|589054324|FG002|Overall Study|Adverse Event|2|||
163093668|NCT00784368|589054322|FG000|Overall Study|Diagnosis of fever|0|||
163093669|NCT00784368|589054323|FG001|Overall Study|Diagnosis of fever|0|||
163093670|NCT00784368|589054324|FG002|Overall Study|Diagnosis of fever|1|||
163093671|NCT00784368|589054322|FG000|Overall Study|Worsening of complications|0|||
163093672|NCT00784368|589054323|FG001|Overall Study|Worsening of complications|0|||
163093673|NCT00784368|589054324|FG002|Overall Study|Worsening of complications|1|||
163093674|NCT00784368|589054322|FG000|Overall Study|Worsening of symptoms|0|||
163093675|NCT00784368|589054323|FG001|Overall Study|Worsening of symptoms|1|||
163093676|NCT00784368|589054324|FG002|Overall Study|Worsening of symptoms|0|||
163093677|NCT00784368|589054322|FG000|Overall Study|Withdrawal of informed consent|0|||
163093678|NCT00784368|589054323|FG001|Overall Study|Withdrawal of informed consent|1|||
163093679|NCT00784368|589054324|FG002|Overall Study|Withdrawal of informed consent|0|||
163093680|NCT02079909|589054325|FG000|Overall Study|Adverse Event|23|||
163093681|NCT02079909|589054326|FG001|Overall Study|Adverse Event|23|||
163093682|NCT02079909|589054327|FG002|Overall Study|Adverse Event|7|||
163093683|NCT02079909|589054325|FG000|Overall Study|Withdrawal by Subject|9|||
163093684|NCT02079909|589054326|FG001|Overall Study|Withdrawal by Subject|17|||
163093685|NCT02079909|589054327|FG002|Overall Study|Withdrawal by Subject|4|||
163093686|NCT02079909|589054325|FG000|Overall Study|Lost to Follow-up|2|||
163093687|NCT02079909|589054326|FG001|Overall Study|Lost to Follow-up|3|||
163093688|NCT02079909|589054327|FG002|Overall Study|Lost to Follow-up|1|||
163093689|NCT02079909|589054325|FG000|Overall Study|Death|2|||
163093690|NCT02079909|589054326|FG001|Overall Study|Death|2|||
163093691|NCT02079909|589054327|FG002|Overall Study|Death|0|||
163093692|NCT02079909|589054325|FG000|Overall Study|Lack of Efficacy|0|||
163093693|NCT02079909|589054326|FG001|Overall Study|Lack of Efficacy|0|||
163093694|NCT02079909|589054327|FG002|Overall Study|Lack of Efficacy|1|||
163093695|NCT02079909|589054325|FG000|Overall Study|Protocol Violation|0|||
163093696|NCT02079909|589054326|FG001|Overall Study|Protocol Violation|1|||
163093697|NCT02079909|589054327|FG002|Overall Study|Protocol Violation|1|||
163093698|NCT02079909|589054325|FG000|Overall Study|Physician Decision|0|||
163093699|NCT02079909|589054326|FG001|Overall Study|Physician Decision|1|||
163093700|NCT02079909|589054327|FG002|Overall Study|Physician Decision|1|||
163337966|NCT01912599|589947351|FG000|Overall Study|Withdrawal by Subject|0|||
163337967|NCT01912599|589947352|FG001|Overall Study|Withdrawal by Subject|1|||
163093701|NCT02079909|589054325|FG000|Overall Study|Relocation etc.|2|||
163093702|NCT02079909|589054326|FG001|Overall Study|Relocation etc.|2|||
163093703|NCT02079909|589054327|FG002|Overall Study|Relocation etc.|3|||
163093704|NCT00720356|589054332|FG000|Registration to Study|Determined to have methylated MGMT|67|||
163093705|NCT00720356|589054332|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
163093706|NCT00720356|589054332|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
163093707|NCT00720356|589054332|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
163093708|NCT00720356|589054332|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
163093709|NCT00720356|589054332|FG000|Follow up Until Death|Withdrawal by Subject|1|||
163093710|NCT00720356|589054332|FG000|Follow up Until Death|Alive at last data collection|4|||
163093711|NCT02237001|589054335|FG000|Overall Study|Lost to Follow-up|2|||
163093712|NCT02237001|589054335|FG000|Overall Study|Withdrawal by Subject|1|||
163093713|NCT02237001|589054335|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
163093714|NCT02237001|589054335|FG000|Overall Study|Re-operation|4|||
163093715|NCT02237001|589054335|FG000|Overall Study|Incarceration|1|||
163093716|NCT01047007|589054336|FG000|Overall Study|Adverse Event|0|||
163093717|NCT01047007|589054337|FG001|Overall Study|Adverse Event|2|||
163093718|NCT01047007|589054338|FG002|Overall Study|Adverse Event|1|||
163093719|NCT01047007|589054339|FG003|Overall Study|Adverse Event|0|||
163093720|NCT01047007|589054336|FG000|Overall Study|Progressive Disease|2|||
163093721|NCT01047007|589054337|FG001|Overall Study|Progressive Disease|4|||
163093722|NCT01047007|589054338|FG002|Overall Study|Progressive Disease|1|||
163093723|NCT01047007|589054339|FG003|Overall Study|Progressive Disease|0|||
163093724|NCT03759600|589054342|FG000|Overall Study|Adverse Event|2|||
163093725|NCT03759600|589054342|FG000|Overall Study|Progressive Disease|15|||
163093726|NCT03759600|589054342|FG000|Overall Study|Site Terminated by Sponsor|3|||
163093727|NCT00457392|589054344|FG000|Overall Study|Objective Progression or Relapse|229|||
163093728|NCT00457392|589054345|FG001|Overall Study|Objective Progression or Relapse|296|||
163093729|NCT00457392|589054344|FG000|Overall Study|Death|106|||
163093730|NCT00457392|589054345|FG001|Overall Study|Death|106|||
163093731|NCT00457392|589054344|FG000|Overall Study|Adverse Event|84|||
163093732|NCT00457392|589054345|FG001|Overall Study|Adverse Event|41|||
163093733|NCT00457392|589054344|FG000|Overall Study|Global Deterioration of Health Status|22|||
163093734|NCT00457392|589054345|FG001|Overall Study|Global Deterioration of Health Status|8|||
163093735|NCT00457392|589054344|FG000|Overall Study|Withdrawal by Subject|14|||
163093736|NCT00457392|589054345|FG001|Overall Study|Withdrawal by Subject|8|||
163093737|NCT00457392|589054344|FG000|Overall Study|Lost to Follow-up|6|||
163093738|NCT00457392|589054345|FG001|Overall Study|Lost to Follow-up|7|||
163093739|NCT00457392|589054344|FG000|Overall Study|Protocol Violation|4|||
163093740|NCT00457392|589054345|FG001|Overall Study|Protocol Violation|3|||
163093741|NCT00457392|589054344|FG000|Overall Study|Other|7|||
163093742|NCT00457392|589054345|FG001|Overall Study|Other|4|||
163093743|NCT00457392|589054344|FG000|Overall Study|Study Terminated by Sponsor|1|||
163093744|NCT00457392|589054345|FG001|Overall Study|Study Terminated by Sponsor|4|||
163093745|NCT00457392|589054344|FG000|Overall Study|Randomized, Not Treated|7|||
163093746|NCT00457392|589054345|FG001|Overall Study|Randomized, Not Treated|3|||
163093747|NCT00756275|589054346|FG000|Overall Study|Lost to Follow-up|25|||
163093748|NCT00756275|589054347|FG001|Overall Study|Lost to Follow-up|21|||
163093749|NCT00756275|589054346|FG000|Overall Study|Withdrawal by Subject|4|||
163093750|NCT00756275|589054347|FG001|Overall Study|Withdrawal by Subject|7|||
163093751|NCT00980148|589054348|FG000|Overall Study|Discharged from facility|89|||
163093752|NCT00980148|589054349|FG001|Overall Study|Discharged from facility|96|||
163093753|NCT00980148|589054348|FG000|Overall Study|Received other antichlamydia treatment|20|||
163093754|NCT00980148|589054349|FG001|Overall Study|Received other antichlamydia treatment|14|||
163093755|NCT00980148|589054348|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
163093756|NCT00980148|589054349|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
163093757|NCT00980148|589054348|FG000|Overall Study|Various other reasons|8|||
163093758|NCT00980148|589054349|FG001|Overall Study|Various other reasons|9|||
163093759|NCT00420381|589054352|FG000|Overall Study|Protocol Violation|1|||
163093760|NCT01244035|589054365|FG000|Part 1: Period 1|Adverse Event|0|||
163093761|NCT01244035|589054366|FG001|Part 1: Period 1|Adverse Event|0|||
163093762|NCT01244035|589054367|FG002|Part 1: Period 1|Adverse Event|0|||
163093763|NCT01244035|589054368|FG003|Part 1: Period 1|Adverse Event|0|||
163093764|NCT01244035|589054369|FG004|Part 1: Period 1|Adverse Event|0|||
163093765|NCT01244035|589054370|FG005|Part 1: Period 1|Adverse Event|1|||
163093766|NCT01244035|589054365|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
163093767|NCT01244035|589054366|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
163093768|NCT01244035|589054367|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
163093769|NCT01244035|589054368|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
163093770|NCT01244035|589054369|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
163093771|NCT01244035|589054370|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
163093772|NCT01244035|589054365|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
163093773|NCT01244035|589054366|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
163093774|NCT01244035|589054367|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
163093775|NCT01244035|589054368|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
163093776|NCT01244035|589054369|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
163093777|NCT01244035|589054370|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
163093778|NCT01244035|589054365|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
163093779|NCT01244035|589054366|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
163093780|NCT01244035|589054367|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
163093781|NCT01244035|589054368|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
163093782|NCT01244035|589054369|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
163093783|NCT01244035|589054370|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
163093784|NCT01244035|589054365|FG000|Part 1: Period 3|Adverse Event|0|||
163093785|NCT01244035|589054366|FG001|Part 1: Period 3|Adverse Event|0|||
163093786|NCT01244035|589054367|FG002|Part 1: Period 3|Adverse Event|0|||
163093787|NCT01244035|589054368|FG003|Part 1: Period 3|Adverse Event|0|||
163093788|NCT01244035|589054369|FG004|Part 1: Period 3|Adverse Event|0|||
163093789|NCT01244035|589054370|FG005|Part 1: Period 3|Adverse Event|1|||
163093790|NCT01244035|589054365|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
163093791|NCT01244035|589054366|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
163093792|NCT01244035|589054367|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
163093793|NCT01244035|589054368|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
163093794|NCT01244035|589054369|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
163093795|NCT01244035|589054370|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
163337968|NCT01757288|589947354|FG000|Overall Study|Consent withdrawal|0|||
163337969|NCT01757288|589947355|FG001|Overall Study|Consent withdrawal|4|||
163337970|NCT01757288|589947356|FG002|Overall Study|Consent withdrawal|4|||
163337971|NCT01757288|589947354|FG000|Overall Study|Patient off study, IRB hold.|0|||
163093796|NCT01244035|589054365|FG000|Part 1: Period 3|Protocol Deviation|0|||
163093797|NCT01244035|589054366|FG001|Part 1: Period 3|Protocol Deviation|1|||
163093798|NCT01244035|589054367|FG002|Part 1: Period 3|Protocol Deviation|0|||
163093799|NCT01244035|589054368|FG003|Part 1: Period 3|Protocol Deviation|0|||
163093800|NCT01244035|589054369|FG004|Part 1: Period 3|Protocol Deviation|0|||
163093801|NCT01244035|589054370|FG005|Part 1: Period 3|Protocol Deviation|0|||
163093802|NCT02776683|589054371|FG000|Pre-switch Period|Protocol Violation|1|||
163093803|NCT02776683|589054372|FG001|Pre-switch Period|Protocol Violation|0|||
163093804|NCT02776683|589054371|FG000|Pre-switch Period|Adverse Event|21|||
163093805|NCT02776683|589054372|FG001|Pre-switch Period|Adverse Event|0|||
163093806|NCT02776683|589054371|FG000|Pre-switch Period|Withdrawal by Subject|9|||
163093807|NCT02776683|589054372|FG001|Pre-switch Period|Withdrawal by Subject|0|||
163093808|NCT02776683|589054371|FG000|Pre-switch Period|Physician Decision|7|||
163093809|NCT02776683|589054372|FG001|Pre-switch Period|Physician Decision|0|||
163093810|NCT02776683|589054371|FG000|Pre-switch Period|Progressive disease|39|||
163093811|NCT02776683|589054372|FG001|Pre-switch Period|Progressive disease|0|||
163093812|NCT02776683|589054371|FG000|Pre-switch Period|Other than listed|3|||
163093813|NCT02776683|589054372|FG001|Pre-switch Period|Other than listed|0|||
163093814|NCT02776683|589054371|FG000|Post-switch Period|Adverse Event|0|||
163093815|NCT02776683|589054372|FG001|Post-switch Period|Adverse Event|3|||
163093816|NCT02776683|589054371|FG000|Post-switch Period|Withdrawal by Subject|0|||
163093817|NCT02776683|589054372|FG001|Post-switch Period|Withdrawal by Subject|2|||
163093818|NCT02776683|589054371|FG000|Post-switch Period|Physician Decision|0|||
163093819|NCT02776683|589054372|FG001|Post-switch Period|Physician Decision|3|||
163093820|NCT02776683|589054371|FG000|Post-switch Period|Progressive disease|0|||
163093821|NCT02776683|589054372|FG001|Post-switch Period|Progressive disease|20|||
163093822|NCT02776683|589054371|FG000|Post-switch Period|Other than listed|0|||
163093823|NCT02776683|589054372|FG001|Post-switch Period|Other than listed|15|||
163093824|NCT03389308|589054373|FG000|Overall Study|Withdrawal by Subject|5|||
163093825|NCT03389308|589054373|FG000|Overall Study|Lost to Follow-up|3|||
163093826|NCT03389308|589054373|FG000|Overall Study|Adverse Event|2|||
163093827|NCT03389308|589054373|FG000|Overall Study|Sponsor Request|2|||
163093828|NCT01023217|589054377|FG000|Overall Study|Withdrawal by Subject|1|||
163093829|NCT01023217|589054378|FG001|Overall Study|Withdrawal by Subject|0|||
163093830|NCT00332696|589054381|FG000|Overall Study|Death|24|||
163093831|NCT00332696|589054382|FG001|Overall Study|Death|14|||
163093832|NCT00332696|589054381|FG000|Overall Study|Insufficient therapeutic effect|4|||
163093833|NCT00332696|589054382|FG001|Overall Study|Insufficient therapeutic effect|11|||
163337972|NCT01757288|589947355|FG001|Overall Study|Patient off study, IRB hold.|0|||
163337973|NCT01757288|589947356|FG002|Overall Study|Patient off study, IRB hold.|1|||
163337974|NCT01757288|589947354|FG000|Overall Study|Patient death prior to starting treatment|0|||
163337975|NCT01757288|589947355|FG001|Overall Study|Patient death prior to starting treatment|0|||
163337976|NCT01757288|589947356|FG002|Overall Study|Patient death prior to starting treatment|1|||
163337977|NCT01757288|589947354|FG000|Overall Study|Wrong medication administered|0|||
163337978|NCT01757288|589947355|FG001|Overall Study|Wrong medication administered|1|||
163093834|NCT00332696|589054381|FG000|Overall Study|Adverse Event|1|||
163337979|NCT01757288|589947356|FG002|Overall Study|Wrong medication administered|0|||
163337980|NCT01757288|589947354|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
163337981|NCT01757288|589947355|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
163337982|NCT01757288|589947356|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
163093835|NCT00332696|589054382|FG001|Overall Study|Adverse Event|2|||
163093836|NCT00332696|589054381|FG000|Overall Study|Condition does not justify treatment|0|||
163093837|NCT00332696|589054382|FG001|Overall Study|Condition does not justify treatment|2|||
163093838|NCT00332696|589054381|FG000|Overall Study|Lost to Follow-up|0|||
163337983|NCT01757288|589947354|FG000|Overall Study|Not meeting protocol constraints|0|||
163093839|NCT00332696|589054382|FG001|Overall Study|Lost to Follow-up|1|||
163093840|NCT00332696|589054381|FG000|Overall Study|Withdrawal by Subject|1|||
163093841|NCT00332696|589054382|FG001|Overall Study|Withdrawal by Subject|0|||
163093842|NCT02216526|589054383|FG000|Overall Study|Adverse Event|1|||
163337984|NCT01757288|589947355|FG001|Overall Study|Not meeting protocol constraints|1|||
163093843|NCT02216526|589054384|FG001|Overall Study|Adverse Event|1|||
163093844|NCT02216526|589054385|FG002|Overall Study|Adverse Event|0|||
163093845|NCT02216526|589054383|FG000|Overall Study|Death|0|||
163093846|NCT02216526|589054384|FG001|Overall Study|Death|1|||
163093847|NCT02216526|589054385|FG002|Overall Study|Death|3|||
163093848|NCT02216526|589054383|FG000|Overall Study|Protocol Violation|2|||
163093849|NCT02216526|589054384|FG001|Overall Study|Protocol Violation|0|||
163093850|NCT02216526|589054385|FG002|Overall Study|Protocol Violation|2|||
163093851|NCT02216526|589054383|FG000|Overall Study|Hospitalization|2|||
163093852|NCT02216526|589054384|FG001|Overall Study|Hospitalization|1|||
163093853|NCT02216526|589054385|FG002|Overall Study|Hospitalization|3|||
163093854|NCT00696878|589054390|FG000|Overall Study|Adverse Event|8|||
163093855|NCT00696878|589054390|FG000|Overall Study|Withdrawal by Subject|87|||
163093856|NCT00696878|589054390|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
163093857|NCT00696878|589054390|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
163093858|NCT00696878|589054390|FG000|Overall Study|Trial stopped|32|||
163093859|NCT00696878|589054390|FG000|Overall Study|Other reason (not specified)|55|||
163093860|NCT04103450|589054391|FG000|Overall Study|Adverse Event|4|||
163093861|NCT04103450|589054392|FG001|Overall Study|Adverse Event|2|||
163093862|NCT04103450|589054391|FG000|Overall Study|Lack of Efficacy|3|||
163093863|NCT04103450|589054392|FG001|Overall Study|Lack of Efficacy|0|||
163093864|NCT04103450|589054391|FG000|Overall Study|Withdrawal by Subject|5|||
163093865|NCT04103450|589054392|FG001|Overall Study|Withdrawal by Subject|3|||
163093866|NCT04103450|589054391|FG000|Overall Study|Lost to Follow-up|1|||
163093867|NCT04103450|589054392|FG001|Overall Study|Lost to Follow-up|2|||
163093868|NCT04103450|589054391|FG000|Overall Study|Physician Decision|1|||
163093869|NCT04103450|589054392|FG001|Overall Study|Physician Decision|2|||
163093870|NCT04103450|589054391|FG000|Overall Study|Protocol Violation|1|||
163093871|NCT04103450|589054392|FG001|Overall Study|Protocol Violation|0|||
163093872|NCT04103450|589054391|FG000|Overall Study|Other|1|||
163093873|NCT04103450|589054392|FG001|Overall Study|Other|1|||
163093874|NCT02230189|589054396|FG000|Overall Study|Withdrawal by Subject|3|||
163093875|NCT02230189|589054397|FG001|Overall Study|Withdrawal by Subject|0|||
163093876|NCT02230189|589054398|FG002|Overall Study|Withdrawal by Subject|1|||
163093877|NCT02230189|589054396|FG000|Overall Study|Lost to Follow-up|1|||
163093878|NCT02230189|589054397|FG001|Overall Study|Lost to Follow-up|0|||
163093879|NCT02230189|589054398|FG002|Overall Study|Lost to Follow-up|0|||
163093880|NCT02230189|589054396|FG000|Overall Study|Physician Decision|1|||
163093881|NCT02230189|589054397|FG001|Overall Study|Physician Decision|0|||
163093882|NCT02230189|589054398|FG002|Overall Study|Physician Decision|0|||
163093883|NCT03188263|589054403|FG000|Overall Study|Withdrawal by Subject|3|||
163093884|NCT03188263|589054404|FG001|Overall Study|Withdrawal by Subject|0|||
163093885|NCT03188263|589054403|FG000|Overall Study|Physician Decision|1|||
163093886|NCT03188263|589054404|FG001|Overall Study|Physician Decision|0|||
163093887|NCT00699413|589054405|FG000|Overall Study|Withdrawal by Subject|0|||
163093888|NCT00699413|589054406|FG001|Overall Study|Withdrawal by Subject|2|||
163093889|NCT00699413|589054405|FG000|Overall Study|Study terminated by sponsor|4|||
163093890|NCT00699413|589054406|FG001|Overall Study|Study terminated by sponsor|2|||
163093891|NCT02779777|589054407|FG000|Overall Study|Disease Progression|1|||
163093892|NCT02779777|589054408|FG001|Overall Study|Disease Progression|0|||
163093893|NCT02779777|589054409|FG002|Overall Study|Disease Progression|0|||
163093894|NCT02779777|589054407|FG000|Overall Study|Adverse Event|3|||
163093895|NCT02779777|589054408|FG001|Overall Study|Adverse Event|1|||
163093896|NCT02779777|589054409|FG002|Overall Study|Adverse Event|0|||
163093897|NCT02779777|589054407|FG000|Overall Study|Physician Decision|9|||
163093898|NCT02779777|589054408|FG001|Overall Study|Physician Decision|0|||
163093899|NCT02779777|589054409|FG002|Overall Study|Physician Decision|1|||
163093900|NCT02779777|589054407|FG000|Overall Study|Withdrawal by Subject|1|||
163093901|NCT02779777|589054408|FG001|Overall Study|Withdrawal by Subject|0|||
163093902|NCT02779777|589054409|FG002|Overall Study|Withdrawal by Subject|0|||
163093903|NCT01030822|589054410|FG000|Overall Study|Moved/migrated from study area|6|||
163093904|NCT01030822|589054411|FG001|Overall Study|Moved/migrated from study area|7|||
163093905|NCT01030822|589054412|FG002|Overall Study|Moved/migrated from study area|3|||
163093906|NCT01030822|589054410|FG000|Overall Study|Withdrawal by Subject|16|||
163093907|NCT01030822|589054411|FG001|Overall Study|Withdrawal by Subject|13|||
163093908|NCT01030822|589054412|FG002|Overall Study|Withdrawal by Subject|16|||
163093909|NCT01030822|589054410|FG000|Overall Study|Lost to Follow-up|9|||
163093910|NCT01030822|589054411|FG001|Overall Study|Lost to Follow-up|4|||
163093911|NCT01030822|589054412|FG002|Overall Study|Lost to Follow-up|7|||
163093912|NCT04540367|589054413|FG000|Overall Study|Withdrawal by Subject|0|||
163093913|NCT04540367|589054414|FG001|Overall Study|Withdrawal by Subject|0|||
163337985|NCT01757288|589947356|FG002|Overall Study|Not meeting protocol constraints|1|||
163337986|NCT01757288|589947354|FG000|Overall Study|Multiple missed appointments|0|||
163337987|NCT01757288|589947355|FG001|Overall Study|Multiple missed appointments|1|||
163093914|NCT04540367|589054415|FG002|Overall Study|Withdrawal by Subject|0|||
163093915|NCT04540367|589054416|FG003|Overall Study|Withdrawal by Subject|2|||
163093916|NCT04540367|589054413|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
163093917|NCT04540367|589054414|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
163093918|NCT04540367|589054415|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
163093919|NCT04540367|589054416|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
163093920|NCT04540367|589054413|FG000|Overall Study|Adverse Event|0|||
163093921|NCT04540367|589054414|FG001|Overall Study|Adverse Event|0|||
163093922|NCT04540367|589054415|FG002|Overall Study|Adverse Event|1|||
163093923|NCT04540367|589054416|FG003|Overall Study|Adverse Event|1|||
163093924|NCT00730886|589054417|FG000|Overall Study|Lost to Follow-up|1|||
163093925|NCT00730886|589054418|FG001|Overall Study|Lost to Follow-up|0|||
163093926|NCT00730886|589054417|FG000|Overall Study|Physician Decision|1|||
163093927|NCT00730886|589054418|FG001|Overall Study|Physician Decision|0|||
163093928|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
163093929|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
163093930|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
163093931|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
163093932|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
163093933|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
163093934|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
163093935|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
163093936|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
163093937|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
163093938|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
163093939|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
163093940|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
163093941|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
163093942|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
163093943|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
163093944|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
163093945|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
163093946|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
163093947|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
163093948|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
163093949|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
163093950|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
163093951|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
163093952|NCT04021290|589054421|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
163093953|NCT04021290|589054422|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
163093954|NCT04021290|589054423|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
163093955|NCT04021290|589054421|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
163093956|NCT04021290|589054422|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
163093957|NCT04021290|589054423|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
163093958|NCT04021290|589054421|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
163093959|NCT04021290|589054422|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
163093960|NCT04021290|589054423|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
163093961|NCT04021290|589054421|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
163093962|NCT04021290|589054422|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
163093963|NCT04021290|589054423|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
163093964|NCT03391882|589054424|FG000|Study Overall|Adverse Event|3|||
163093965|NCT03391882|589054425|FG001|Study Overall|Adverse Event|6|||
163093966|NCT03391882|589054426|FG002|Study Overall|Adverse Event|1|||
163093967|NCT03391882|589054427|FG003|Study Overall|Adverse Event|1|||
163093968|NCT03391882|589054428|FG004|Study Overall|Adverse Event|3|||
163093969|NCT03391882|589054429|FG005|Study Overall|Adverse Event|1|||
163093970|NCT03391882|589054424|FG000|Study Overall|Lack of Efficacy|13|||
163093971|NCT03391882|589054425|FG001|Study Overall|Lack of Efficacy|9|||
163093972|NCT03391882|589054426|FG002|Study Overall|Lack of Efficacy|0|||
163093973|NCT03391882|589054427|FG003|Study Overall|Lack of Efficacy|0|||
163093974|NCT03391882|589054428|FG004|Study Overall|Lack of Efficacy|0|||
163093975|NCT03391882|589054429|FG005|Study Overall|Lack of Efficacy|0|||
163093976|NCT03391882|589054424|FG000|Study Overall|Withdrawal by Subject|3|||
163093977|NCT03391882|589054425|FG001|Study Overall|Withdrawal by Subject|3|||
163093978|NCT03391882|589054426|FG002|Study Overall|Withdrawal by Subject|2|||
163093979|NCT03391882|589054427|FG003|Study Overall|Withdrawal by Subject|2|||
163093980|NCT03391882|589054428|FG004|Study Overall|Withdrawal by Subject|1|||
163093981|NCT03391882|589054429|FG005|Study Overall|Withdrawal by Subject|3|||
163093982|NCT03391882|589054424|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
163093983|NCT03391882|589054425|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
163093984|NCT03391882|589054426|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
163093985|NCT03391882|589054427|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
163407633|NCT02706873|590200872|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
163093986|NCT03391882|589054428|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
163093987|NCT03391882|589054429|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
163093988|NCT03391882|589054424|FG000|Study Overall|Protocol Violation|1|||
163093989|NCT03391882|589054425|FG001|Study Overall|Protocol Violation|0|||
163337988|NCT01757288|589947356|FG002|Overall Study|Multiple missed appointments|0|||
163337989|NCT01757288|589947354|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
163337990|NCT01757288|589947355|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
163337991|NCT01757288|589947356|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
163337992|NCT01757288|589947354|FG000|Overall Study|>2 weeks treatment break|0|||
163337993|NCT01757288|589947355|FG001|Overall Study|>2 weeks treatment break|0|||
163337994|NCT01757288|589947356|FG002|Overall Study|>2 weeks treatment break|1|||
163337995|NCT02825550|589947357|FG000|Overall Study|Physician Decision|1|||
163337996|NCT03386344|589947358|FG000|Overall Study|Adverse Event|6|||
163337997|NCT03386344|589947359|FG001|Overall Study|Adverse Event|3|||
163337998|NCT03386344|589947360|FG002|Overall Study|Adverse Event|1|||
163337999|NCT03386344|589947358|FG000|Overall Study|Poor Compliance to Protocol|0|||
163338000|NCT03386344|589947359|FG001|Overall Study|Poor Compliance to Protocol|1|||
163338001|NCT03386344|589947360|FG002|Overall Study|Poor Compliance to Protocol|0|||
163338002|NCT03386344|589947358|FG000|Overall Study|Study Terminated by Sponsor|101|||
163338003|NCT03386344|589947359|FG001|Overall Study|Study Terminated by Sponsor|102|||
163338004|NCT03386344|589947360|FG002|Overall Study|Study Terminated by Sponsor|106|||
163338005|NCT03386344|589947358|FG000|Overall Study|Lost to Follow-up|3|||
163338006|NCT03386344|589947359|FG001|Overall Study|Lost to Follow-up|2|||
163338007|NCT03386344|589947360|FG002|Overall Study|Lost to Follow-up|1|||
163338008|NCT03386344|589947358|FG000|Overall Study|At the Participant's own Request|7|||
163338009|NCT03386344|589947359|FG001|Overall Study|At the Participant's own Request|7|||
163338010|NCT03386344|589947360|FG002|Overall Study|At the Participant's own Request|8|||
163338011|NCT03386344|589947358|FG000|Overall Study|Reason not Specified|0|||
163338012|NCT03386344|589947359|FG001|Overall Study|Reason not Specified|1|||
163338013|NCT03386344|589947360|FG002|Overall Study|Reason not Specified|0|||
163338014|NCT01077284|589947361|FG000|Overall Study|Adverse Event|2|||
163338015|NCT01077284|589947362|FG001|Overall Study|Adverse Event|0|||
163338016|NCT01077284|589947363|FG002|Overall Study|Adverse Event|1|||
163338017|NCT01077284|589947361|FG000|Overall Study|Lost to Follow-up|1|||
163338018|NCT01077284|589947362|FG001|Overall Study|Lost to Follow-up|2|||
163093990|NCT03391882|589054426|FG002|Study Overall|Protocol Violation|0|||
163093991|NCT03391882|589054427|FG003|Study Overall|Protocol Violation|0|||
163093992|NCT03391882|589054428|FG004|Study Overall|Protocol Violation|0|||
163093993|NCT03391882|589054429|FG005|Study Overall|Protocol Violation|0|||
163093994|NCT03391882|589054424|FG000|Part A - Titration Phase|Adverse Event|3|||
163093995|NCT03391882|589054425|FG001|Part A - Titration Phase|Adverse Event|6|||
163338019|NCT01077284|589947363|FG002|Overall Study|Lost to Follow-up|0|||
163338020|NCT01077284|589947361|FG000|Overall Study|Withdrawal by Subject|2|||
163338021|NCT01077284|589947362|FG001|Overall Study|Withdrawal by Subject|3|||
163338022|NCT01077284|589947363|FG002|Overall Study|Withdrawal by Subject|1|||
163338023|NCT01077284|589947361|FG000|Overall Study|Other|0|||
163338024|NCT01077284|589947362|FG001|Overall Study|Other|0|||
163338025|NCT01077284|589947363|FG002|Overall Study|Other|1|||
163338026|NCT00042939|589947368|FG000|Overall Study|Adverse Event|6|||
163338027|NCT00042939|589947369|FG001|Overall Study|Adverse Event|7|||
163338028|NCT00042939|589947368|FG000|Overall Study|Death|3|||
163338029|NCT00042939|589947369|FG001|Overall Study|Death|2|||
163338030|NCT00042939|589947368|FG000|Overall Study|Withdrawal by Subject|3|||
163338031|NCT00042939|589947369|FG001|Overall Study|Withdrawal by Subject|4|||
163338032|NCT00042939|589947368|FG000|Overall Study|Other disease|1|||
163338033|NCT00042939|589947369|FG001|Overall Study|Other disease|0|||
163338034|NCT00042939|589947368|FG000|Overall Study|Ineligible|2|||
163338035|NCT00042939|589947369|FG001|Overall Study|Ineligible|2|||
163338036|NCT00042939|589947368|FG000|Overall Study|Deterioration of health|3|||
163338037|NCT00042939|589947369|FG001|Overall Study|Deterioration of health|4|||
163338038|NCT00042939|589947368|FG000|Overall Study|QOL diminished|1|||
163407634|NCT02706873|590200873|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
163093996|NCT03391882|589054426|FG002|Part A - Titration Phase|Adverse Event|0|||
163093997|NCT03391882|589054427|FG003|Part A - Titration Phase|Adverse Event|0|||
163093998|NCT03391882|589054428|FG004|Part A - Titration Phase|Adverse Event|0|||
163093999|NCT03391882|589054429|FG005|Part A - Titration Phase|Adverse Event|0|||
163094000|NCT03391882|589054424|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
163338039|NCT00042939|589947369|FG001|Overall Study|QOL diminished|0|||
163338040|NCT00042939|589947368|FG000|Overall Study|Rising ca 19-9|1|||
163338041|NCT00042939|589947369|FG001|Overall Study|Rising ca 19-9|0|||
163338042|NCT00042939|589947368|FG000|Overall Study|Patient non-compliance|1|||
163338043|NCT00042939|589947369|FG001|Overall Study|Patient non-compliance|0|||
163338044|NCT00042939|589947368|FG000|Overall Study|Still on treatment|1|||
163338045|NCT00042939|589947369|FG001|Overall Study|Still on treatment|0|||
163338046|NCT00042939|589947368|FG000|Overall Study|Treatment break > 4 weeks|0|||
163338047|NCT00042939|589947369|FG001|Overall Study|Treatment break > 4 weeks|1|||
163338048|NCT00042939|589947368|FG000|Overall Study|Did not start treatment|2|||
163338049|NCT00042939|589947369|FG001|Overall Study|Did not start treatment|1|||
163338050|NCT03349476|589947370|FG000|Overall Study|Physician Decision|3|||
163094001|NCT03391882|589054425|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
163338051|NCT01182285|589947371|FG000|First Intervention Week 1-10|Disease progression|1|||
163338052|NCT01182285|589947372|FG001|First Intervention Week 1-10|Disease progression|0|||
163338053|NCT01182285|589947373|FG002|First Intervention Week 1-10|Disease progression|0|||
163338054|NCT01182285|589947371|FG000|First Intervention Week 1-10|Adverse Event|1|||
163338055|NCT01182285|589947372|FG001|First Intervention Week 1-10|Adverse Event|0|||
163338056|NCT01182285|589947373|FG002|First Intervention Week 1-10|Adverse Event|0|||
163338057|NCT01182285|589947371|FG000|First Intervention Week 1-10|Non-compliance|1|||
163338058|NCT01182285|589947372|FG001|First Intervention Week 1-10|Non-compliance|0|||
163338059|NCT01182285|589947373|FG002|First Intervention Week 1-10|Non-compliance|0|||
163338060|NCT01182285|589947371|FG000|Third Intervention Week 11-52|Disease Progression|0|||
163338061|NCT01182285|589947372|FG001|Third Intervention Week 11-52|Disease Progression|0|||
163338062|NCT01182285|589947373|FG002|Third Intervention Week 11-52|Disease Progression|6|||
163338063|NCT01182285|589947371|FG000|Third Intervention Week 11-52|Other|0|||
163338064|NCT01182285|589947372|FG001|Third Intervention Week 11-52|Other|0|||
163338065|NCT01182285|589947373|FG002|Third Intervention Week 11-52|Other|2|||
163338066|NCT00472082|589947376|FG000|Overall Study|Study prematurely terminated|5|||
163338067|NCT01762345|589947377|FG000|Overall Study|Adverse Event|5|||
163338068|NCT01762345|589947377|FG000|Overall Study|Protocol Violation|2|||
163338069|NCT00700999|589947378|FG000|Overall Study|Lost to Follow-up|7|||
163338070|NCT00700999|589947379|FG001|Overall Study|Lost to Follow-up|7|||
163338071|NCT00700999|589947378|FG000|Overall Study|Excluded - did not meet study criteria|0|||
163338072|NCT00700999|589947379|FG001|Overall Study|Excluded - did not meet study criteria|1|||
163338073|NCT00700999|589947378|FG000|Overall Study|Withdrawal by Subject|8|||
163338074|NCT00700999|589947379|FG001|Overall Study|Withdrawal by Subject|1|||
163338075|NCT02379078|589947380|FG000|Overall Study|Lost to Follow-up|33|||
163338076|NCT02379078|589947381|FG001|Overall Study|Lost to Follow-up|30|||
163338077|NCT02379078|589947380|FG000|Overall Study|Withdrawal by Subject|6|||
163338078|NCT02379078|589947381|FG001|Overall Study|Withdrawal by Subject|5|||
163338079|NCT03481725|589947382|FG000|Overall Study|Withdrawal by Subject|1|||
163338080|NCT03481725|589947383|FG001|Overall Study|Withdrawal by Subject|0|||
163338081|NCT00244751|589947384|FG000|Overall Study|Adverse Event|7|||
163338082|NCT00244751|589947385|FG001|Overall Study|Adverse Event|7|||
163094002|NCT03391882|589054426|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
163094003|NCT03391882|589054427|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
163094004|NCT03391882|589054428|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
163094005|NCT03391882|589054429|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
163094006|NCT03391882|589054424|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
163094007|NCT03391882|589054425|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
163094008|NCT03391882|589054426|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
163094009|NCT03391882|589054427|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
163094010|NCT03391882|589054428|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
163094011|NCT03391882|589054429|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
163094012|NCT03391882|589054424|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
163094013|NCT03391882|589054425|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
163094014|NCT03391882|589054426|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
163094015|NCT03391882|589054427|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
163094016|NCT03391882|589054428|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
163094017|NCT03391882|589054429|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
163094018|NCT03391882|589054424|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
163094019|NCT03391882|589054425|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
163094020|NCT03391882|589054426|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
163094021|NCT03391882|589054427|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
163094022|NCT03391882|589054428|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
163094023|NCT03391882|589054429|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
163094024|NCT03391882|589054424|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
163094025|NCT03391882|589054425|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
163094026|NCT03391882|589054426|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
163094027|NCT03391882|589054427|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
163094028|NCT03391882|589054428|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
163094029|NCT03391882|589054429|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
163094030|NCT03391882|589054424|FG000|Part B - Treatment Phase|Adverse Event|0|||
163094031|NCT03391882|589054425|FG001|Part B - Treatment Phase|Adverse Event|0|||
163094032|NCT03391882|589054426|FG002|Part B - Treatment Phase|Adverse Event|1|||
163094033|NCT03391882|589054427|FG003|Part B - Treatment Phase|Adverse Event|1|||
163094034|NCT03391882|589054428|FG004|Part B - Treatment Phase|Adverse Event|3|||
163094035|NCT03391882|589054429|FG005|Part B - Treatment Phase|Adverse Event|1|||
163094036|NCT03391882|589054424|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
163094037|NCT03391882|589054425|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
163094038|NCT03391882|589054426|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
163094039|NCT03391882|589054427|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
163094040|NCT03391882|589054428|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
163094041|NCT03391882|589054429|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
163094042|NCT03913130|589054432|FG000|Overall Study|Sponsor Decision|1|||
163094043|NCT04046939|589054435|FG000|Primary Assessment Period|Adverse Event|1|||
163094044|NCT04046939|589054436|FG001|Primary Assessment Period|Adverse Event|0|||
163094045|NCT04046939|589054437|FG002|Primary Assessment Period|Adverse Event|0|||
163094046|NCT04046939|589054438|FG003|Primary Assessment Period|Adverse Event|0|||
163094047|NCT04046939|589054435|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
163094048|NCT04046939|589054436|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
163094049|NCT04046939|589054437|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
163094050|NCT04046939|589054438|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
163094051|NCT04046939|589054435|FG000|Primary Assessment Period|Physician Decision|0|||
163094052|NCT04046939|589054436|FG001|Primary Assessment Period|Physician Decision|0|||
163094053|NCT04046939|589054437|FG002|Primary Assessment Period|Physician Decision|1|||
163094054|NCT04046939|589054438|FG003|Primary Assessment Period|Physician Decision|0|||
163094055|NCT04046939|589054435|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
163094056|NCT04046939|589054436|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
163094057|NCT04046939|589054437|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
163094058|NCT04046939|589054438|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
163094059|NCT04704193|589054439|FG000|Overall Study|Withdrawal by Subject|1|||
163094060|NCT03384875|589054440|FG000|Overall Study|Death|1|||
163094061|NCT03384875|589054441|FG001|Overall Study|Death|1|||
163094062|NCT03384875|589054442|FG002|Overall Study|Death|0|||
163338083|NCT00244751|589947386|FG002|Overall Study|Adverse Event|5|||
163338084|NCT00244751|589947384|FG000|Overall Study|Lost to Follow-up|0|||
163338085|NCT00244751|589947385|FG001|Overall Study|Lost to Follow-up|1|||
163338086|NCT00244751|589947386|FG002|Overall Study|Lost to Follow-up|0|||
163338087|NCT00244751|589947384|FG000|Overall Study|Protocol Violation|1|||
163338088|NCT00244751|589947385|FG001|Overall Study|Protocol Violation|0|||
163338089|NCT00244751|589947386|FG002|Overall Study|Protocol Violation|1|||
163338090|NCT00244751|589947384|FG000|Overall Study|Withdrawal by Subject|7|||
163338091|NCT00244751|589947385|FG001|Overall Study|Withdrawal by Subject|5|||
163338092|NCT00244751|589947386|FG002|Overall Study|Withdrawal by Subject|3|||
163338093|NCT00244751|589947384|FG000|Overall Study|Elevated liver enzymes|1|||
163338094|NCT00244751|589947385|FG001|Overall Study|Elevated liver enzymes|0|||
163338095|NCT00244751|589947386|FG002|Overall Study|Elevated liver enzymes|0|||
163338096|NCT00244751|589947384|FG000|Overall Study|Lack of compliance with protocol|0|||
163338097|NCT00244751|589947385|FG001|Overall Study|Lack of compliance with protocol|1|||
163338098|NCT00244751|589947386|FG002|Overall Study|Lack of compliance with protocol|0|||
163338099|NCT00244751|589947384|FG000|Overall Study|Safety reasons|0|||
163338100|NCT00244751|589947385|FG001|Overall Study|Safety reasons|1|||
163338101|NCT00244751|589947386|FG002|Overall Study|Safety reasons|0|||
163338102|NCT00244751|589947384|FG000|Overall Study|Participant randomized by mistake|0|||
163338103|NCT00244751|589947385|FG001|Overall Study|Participant randomized by mistake|0|||
163338104|NCT00244751|589947386|FG002|Overall Study|Participant randomized by mistake|1|||
163338105|NCT02077374|589947387|FG000|Overall Study|Withdrawal by Subject|0|||
163338106|NCT02077374|589947388|FG001|Overall Study|Withdrawal by Subject|1|||
163338107|NCT02077374|589947387|FG000|Overall Study|Protocol Violation|0|||
163338108|NCT02077374|589947388|FG001|Overall Study|Protocol Violation|1|||
163338109|NCT01777932|589947389|FG000|Overall Study|Disease progression|136|||
163039203|NCT00528372|588850688|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
163094063|NCT03384875|589054440|FG000|Overall Study|Reason not provided|1|||
163094064|NCT03384875|589054441|FG001|Overall Study|Reason not provided|0|||
163094065|NCT03384875|589054442|FG002|Overall Study|Reason not provided|0|||
163094066|NCT04790279|589056772|FG000|Overall Study|Did not meet medication start criteria|27|||
163094067|NCT04790279|589056773|FG001|Overall Study|Did not meet medication start criteria|15|||
163094068|NCT04790279|589056772|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
163094069|NCT04790279|589056773|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
163094070|NCT04790279|589056772|FG000|Overall Study|Protocol Violation|8|||
163094071|NCT04790279|589056773|FG001|Overall Study|Protocol Violation|3|||
163094072|NCT04790279|589056772|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
163094073|NCT04790279|589056773|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
163094074|NCT01713582|589056774|FG000|Overall Study|Disease progression|3|||
163094075|NCT01713582|589056775|FG001|Overall Study|Disease progression|3|||
163094076|NCT01713582|589056776|FG002|Overall Study|Disease progression|3|||
163094077|NCT01713582|589056777|FG003|Overall Study|Disease progression|2|||
163338110|NCT01777932|589947389|FG000|Overall Study|Death|3|||
163338111|NCT01777932|589947389|FG000|Overall Study|Adverse Event|34|||
163338112|NCT01777932|589947389|FG000|Overall Study|Lost to Follow-up|3|||
163338113|NCT01777932|589947389|FG000|Overall Study|Investigator decision|10|||
163039204|NCT00528372|588850689|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
163039205|NCT00528372|588850681|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
163039206|NCT00528372|588850682|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
163039207|NCT00528372|588850683|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
163039208|NCT00528372|588850684|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
163039209|NCT00528372|588850685|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
163039210|NCT00528372|588850686|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
163094078|NCT01713582|589056778|FG004|Overall Study|Disease progression|3|||
163094079|NCT01713582|589056779|FG005|Overall Study|Disease progression|3|||
163094080|NCT01713582|589056780|FG006|Overall Study|Disease progression|3|||
163094081|NCT01713582|589056781|FG007|Overall Study|Disease progression|3|||
163094082|NCT01713582|589056782|FG008|Overall Study|Disease progression|3|||
163094083|NCT01713582|589056783|FG009|Overall Study|Disease progression|11|||
163094084|NCT01713582|589056784|FG010|Overall Study|Disease progression|10|||
163094085|NCT01713582|589056785|FG011|Overall Study|Disease progression|5|||
163094086|NCT01713582|589056786|FG012|Overall Study|Disease progression|3|||
163094087|NCT01713582|589056787|FG013|Overall Study|Disease progression|3|||
163094088|NCT01713582|589056788|FG014|Overall Study|Disease progression|6|||
163094089|NCT01713582|589056789|FG015|Overall Study|Disease progression|6|||
163094090|NCT01713582|589056790|FG016|Overall Study|Disease progression|5|||
163094091|NCT01713582|589056791|FG017|Overall Study|Disease progression|2|||
163094092|NCT01713582|589056792|FG018|Overall Study|Disease progression|3|||
163094093|NCT01713582|589056793|FG019|Overall Study|Disease progression|5|||
163094094|NCT01713582|589056794|FG020|Overall Study|Disease progression|15|||
163094095|NCT01713582|589056774|FG000|Overall Study|Death|0|||
163094096|NCT01713582|589056775|FG001|Overall Study|Death|0|||
163094097|NCT01713582|589056776|FG002|Overall Study|Death|0|||
163094098|NCT01713582|589056777|FG003|Overall Study|Death|1|||
163094099|NCT01713582|589056778|FG004|Overall Study|Death|1|||
163094100|NCT01713582|589056779|FG005|Overall Study|Death|3|||
163094101|NCT01713582|589056780|FG006|Overall Study|Death|3|||
163094102|NCT01713582|589056781|FG007|Overall Study|Death|2|||
163094103|NCT01713582|589056782|FG008|Overall Study|Death|3|||
163094104|NCT01713582|589056783|FG009|Overall Study|Death|4|||
163094105|NCT01713582|589056784|FG010|Overall Study|Death|3|||
163094106|NCT01713582|589056785|FG011|Overall Study|Death|0|||
163094107|NCT01713582|589056786|FG012|Overall Study|Death|0|||
163094108|NCT01713582|589056787|FG013|Overall Study|Death|0|||
163094109|NCT01713582|589056788|FG014|Overall Study|Death|0|||
163094110|NCT01713582|589056789|FG015|Overall Study|Death|0|||
163094111|NCT01713582|589056790|FG016|Overall Study|Death|0|||
163094112|NCT01713582|589056791|FG017|Overall Study|Death|0|||
163094113|NCT01713582|589056792|FG018|Overall Study|Death|0|||
163094114|NCT01713582|589056793|FG019|Overall Study|Death|0|||
163094115|NCT01713582|589056794|FG020|Overall Study|Death|0|||
163094116|NCT01713582|589056774|FG000|Overall Study|Adverse event-related|0|||
163094117|NCT01713582|589056775|FG001|Overall Study|Adverse event-related|0|||
163094118|NCT01713582|589056776|FG002|Overall Study|Adverse event-related|0|||
163094119|NCT01713582|589056777|FG003|Overall Study|Adverse event-related|0|||
163094120|NCT01713582|589056778|FG004|Overall Study|Adverse event-related|0|||
163094121|NCT01713582|589056779|FG005|Overall Study|Adverse event-related|0|||
163094122|NCT01713582|589056780|FG006|Overall Study|Adverse event-related|0|||
163094123|NCT01713582|589056781|FG007|Overall Study|Adverse event-related|0|||
163094124|NCT01713582|589056782|FG008|Overall Study|Adverse event-related|0|||
163094125|NCT01713582|589056783|FG009|Overall Study|Adverse event-related|1|||
163094126|NCT01713582|589056784|FG010|Overall Study|Adverse event-related|1|||
163094127|NCT01713582|589056785|FG011|Overall Study|Adverse event-related|0|||
163094128|NCT01713582|589056786|FG012|Overall Study|Adverse event-related|0|||
163094129|NCT01713582|589056787|FG013|Overall Study|Adverse event-related|0|||
163094130|NCT01713582|589056788|FG014|Overall Study|Adverse event-related|0|||
163094131|NCT01713582|589056789|FG015|Overall Study|Adverse event-related|0|||
163094132|NCT01713582|589056790|FG016|Overall Study|Adverse event-related|0|||
163094133|NCT01713582|589056791|FG017|Overall Study|Adverse event-related|0|||
163094134|NCT01713582|589056792|FG018|Overall Study|Adverse event-related|1|||
163094135|NCT01713582|589056793|FG019|Overall Study|Adverse event-related|0|||
163094136|NCT01713582|589056794|FG020|Overall Study|Adverse event-related|0|||
163094137|NCT01713582|589056774|FG000|Overall Study|Adverse event-unrelated|0|||
163094138|NCT01713582|589056775|FG001|Overall Study|Adverse event-unrelated|0|||
163094139|NCT01713582|589056776|FG002|Overall Study|Adverse event-unrelated|0|||
163094140|NCT01713582|589056777|FG003|Overall Study|Adverse event-unrelated|0|||
163094141|NCT01713582|589056778|FG004|Overall Study|Adverse event-unrelated|0|||
163094142|NCT01713582|589056779|FG005|Overall Study|Adverse event-unrelated|1|||
163094143|NCT01713582|589056780|FG006|Overall Study|Adverse event-unrelated|1|||
163094144|NCT01713582|589056781|FG007|Overall Study|Adverse event-unrelated|1|||
163094145|NCT01713582|589056782|FG008|Overall Study|Adverse event-unrelated|0|||
163094146|NCT01713582|589056783|FG009|Overall Study|Adverse event-unrelated|0|||
163094147|NCT01713582|589056784|FG010|Overall Study|Adverse event-unrelated|0|||
163094148|NCT01713582|589056785|FG011|Overall Study|Adverse event-unrelated|0|||
163094149|NCT01713582|589056786|FG012|Overall Study|Adverse event-unrelated|0|||
163094150|NCT01713582|589056787|FG013|Overall Study|Adverse event-unrelated|1|||
163094151|NCT01713582|589056788|FG014|Overall Study|Adverse event-unrelated|1|||
163094152|NCT01713582|589056789|FG015|Overall Study|Adverse event-unrelated|0|||
163094153|NCT01713582|589056790|FG016|Overall Study|Adverse event-unrelated|0|||
163094154|NCT01713582|589056791|FG017|Overall Study|Adverse event-unrelated|0|||
163094155|NCT01713582|589056792|FG018|Overall Study|Adverse event-unrelated|0|||
163094156|NCT01713582|589056793|FG019|Overall Study|Adverse event-unrelated|0|||
163094157|NCT01713582|589056794|FG020|Overall Study|Adverse event-unrelated|0|||
163094158|NCT01713582|589056774|FG000|Overall Study|Withdrawal of consent|0|||
163094159|NCT01713582|589056775|FG001|Overall Study|Withdrawal of consent|0|||
163094160|NCT01713582|589056776|FG002|Overall Study|Withdrawal of consent|1|||
163094161|NCT01713582|589056777|FG003|Overall Study|Withdrawal of consent|0|||
163094162|NCT01713582|589056778|FG004|Overall Study|Withdrawal of consent|0|||
163094163|NCT01713582|589056779|FG005|Overall Study|Withdrawal of consent|1|||
163094164|NCT01713582|589056780|FG006|Overall Study|Withdrawal of consent|0|||
163094165|NCT01713582|589056781|FG007|Overall Study|Withdrawal of consent|0|||
163094166|NCT01713582|589056782|FG008|Overall Study|Withdrawal of consent|0|||
163094167|NCT01713582|589056783|FG009|Overall Study|Withdrawal of consent|1|||
163094168|NCT01713582|589056784|FG010|Overall Study|Withdrawal of consent|0|||
163094169|NCT01713582|589056785|FG011|Overall Study|Withdrawal of consent|0|||
163094170|NCT01713582|589056786|FG012|Overall Study|Withdrawal of consent|0|||
163094171|NCT01713582|589056787|FG013|Overall Study|Withdrawal of consent|0|||
163094172|NCT01713582|589056788|FG014|Overall Study|Withdrawal of consent|0|||
163094173|NCT01713582|589056789|FG015|Overall Study|Withdrawal of consent|0|||
163094174|NCT01713582|589056790|FG016|Overall Study|Withdrawal of consent|0|||
163094175|NCT01713582|589056791|FG017|Overall Study|Withdrawal of consent|0|||
163094176|NCT01713582|589056792|FG018|Overall Study|Withdrawal of consent|1|||
163094177|NCT01713582|589056793|FG019|Overall Study|Withdrawal of consent|0|||
163094178|NCT01713582|589056794|FG020|Overall Study|Withdrawal of consent|0|||
163094179|NCT01713582|589056774|FG000|Overall Study|Lack of Efficacy|0|||
163094180|NCT01713582|589056775|FG001|Overall Study|Lack of Efficacy|0|||
163094181|NCT01713582|589056776|FG002|Overall Study|Lack of Efficacy|0|||
163094182|NCT01713582|589056777|FG003|Overall Study|Lack of Efficacy|0|||
163094183|NCT01713582|589056778|FG004|Overall Study|Lack of Efficacy|0|||
163094184|NCT01713582|589056779|FG005|Overall Study|Lack of Efficacy|0|||
163094185|NCT01713582|589056780|FG006|Overall Study|Lack of Efficacy|0|||
163094186|NCT01713582|589056781|FG007|Overall Study|Lack of Efficacy|0|||
163094187|NCT01713582|589056782|FG008|Overall Study|Lack of Efficacy|0|||
163094188|NCT01713582|589056783|FG009|Overall Study|Lack of Efficacy|1|||
163094189|NCT01713582|589056784|FG010|Overall Study|Lack of Efficacy|2|||
163094190|NCT01713582|589056785|FG011|Overall Study|Lack of Efficacy|0|||
163094191|NCT01713582|589056786|FG012|Overall Study|Lack of Efficacy|0|||
163094192|NCT01713582|589056787|FG013|Overall Study|Lack of Efficacy|0|||
163094193|NCT01713582|589056788|FG014|Overall Study|Lack of Efficacy|0|||
163094194|NCT01713582|589056789|FG015|Overall Study|Lack of Efficacy|0|||
163094195|NCT01713582|589056790|FG016|Overall Study|Lack of Efficacy|0|||
163094196|NCT01713582|589056791|FG017|Overall Study|Lack of Efficacy|0|||
163094197|NCT01713582|589056792|FG018|Overall Study|Lack of Efficacy|0|||
163094198|NCT01713582|589056793|FG019|Overall Study|Lack of Efficacy|0|||
163094199|NCT01713582|589056794|FG020|Overall Study|Lack of Efficacy|0|||
163094200|NCT01713582|589056774|FG000|Overall Study|Withdrawal by Subject|0|||
163094201|NCT01713582|589056775|FG001|Overall Study|Withdrawal by Subject|0|||
163094202|NCT01713582|589056776|FG002|Overall Study|Withdrawal by Subject|0|||
163094203|NCT01713582|589056777|FG003|Overall Study|Withdrawal by Subject|0|||
163094204|NCT01713582|589056778|FG004|Overall Study|Withdrawal by Subject|0|||
163094205|NCT01713582|589056779|FG005|Overall Study|Withdrawal by Subject|0|||
163094206|NCT01713582|589056780|FG006|Overall Study|Withdrawal by Subject|0|||
163094207|NCT01713582|589056781|FG007|Overall Study|Withdrawal by Subject|0|||
163094208|NCT01713582|589056782|FG008|Overall Study|Withdrawal by Subject|0|||
163094209|NCT01713582|589056783|FG009|Overall Study|Withdrawal by Subject|0|||
163094210|NCT01713582|589056784|FG010|Overall Study|Withdrawal by Subject|0|||
163094211|NCT01713582|589056785|FG011|Overall Study|Withdrawal by Subject|0|||
163094212|NCT01713582|589056786|FG012|Overall Study|Withdrawal by Subject|0|||
163094213|NCT01713582|589056787|FG013|Overall Study|Withdrawal by Subject|0|||
163094214|NCT01713582|589056788|FG014|Overall Study|Withdrawal by Subject|0|||
163094215|NCT01713582|589056789|FG015|Overall Study|Withdrawal by Subject|0|||
163094216|NCT01713582|589056790|FG016|Overall Study|Withdrawal by Subject|0|||
163094217|NCT01713582|589056791|FG017|Overall Study|Withdrawal by Subject|1|||
163094218|NCT01713582|589056792|FG018|Overall Study|Withdrawal by Subject|0|||
163094219|NCT01713582|589056793|FG019|Overall Study|Withdrawal by Subject|0|||
163094220|NCT01713582|589056794|FG020|Overall Study|Withdrawal by Subject|0|||
163094221|NCT01713582|589056774|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
163094222|NCT01713582|589056775|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
163338114|NCT01777932|589947389|FG000|Overall Study|Reimbursement limit|9|||
163338115|NCT01777932|589947389|FG000|Overall Study|Patient refused further treatment|10|||
163094223|NCT01713582|589056776|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
163094224|NCT01713582|589056777|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
163338116|NCT00068107|589947393|FG000|Overall Study|end-stage renal disease|6|||
163094225|NCT01713582|589056778|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
163094226|NCT01713582|589056779|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
163094227|NCT01713582|589056780|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
163094228|NCT01713582|589056781|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
163094229|NCT01713582|589056782|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
163338117|NCT00068107|589947393|FG000|Overall Study|Death|2|||
163338118|NCT00068107|589947393|FG000|Overall Study|Withdrawal by Subject|1|||
163338119|NCT03989232|589947394|FG000|Overall Study|Lost to Follow-up|3|||
163338120|NCT03989232|589947395|FG001|Overall Study|Lost to Follow-up|10|||
163338121|NCT03989232|589947394|FG000|Overall Study|Withdrawal by Subject|6|||
163094230|NCT01713582|589056783|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
163094231|NCT01713582|589056784|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
163094232|NCT01713582|589056785|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
163094233|NCT01713582|589056786|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
163094234|NCT01713582|589056787|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
163094235|NCT01713582|589056788|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
163094236|NCT01713582|589056789|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
163094237|NCT01713582|589056790|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
163094238|NCT01713582|589056791|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
163094239|NCT01713582|589056792|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
163094240|NCT01713582|589056793|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
163094241|NCT01713582|589056794|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
163094242|NCT01713582|589056774|FG000|Overall Study|Disease progression and adverse event|0|||
163094243|NCT01713582|589056775|FG001|Overall Study|Disease progression and adverse event|0|||
163094244|NCT01713582|589056776|FG002|Overall Study|Disease progression and adverse event|0|||
163094245|NCT01713582|589056777|FG003|Overall Study|Disease progression and adverse event|0|||
163094246|NCT01713582|589056778|FG004|Overall Study|Disease progression and adverse event|0|||
163094247|NCT01713582|589056779|FG005|Overall Study|Disease progression and adverse event|0|||
163094248|NCT01713582|589056780|FG006|Overall Study|Disease progression and adverse event|0|||
163094249|NCT01713582|589056781|FG007|Overall Study|Disease progression and adverse event|0|||
163094250|NCT01713582|589056782|FG008|Overall Study|Disease progression and adverse event|0|||
163094251|NCT01713582|589056783|FG009|Overall Study|Disease progression and adverse event|0|||
163094252|NCT01713582|589056784|FG010|Overall Study|Disease progression and adverse event|0|||
163094253|NCT01713582|589056785|FG011|Overall Study|Disease progression and adverse event|0|||
163094254|NCT01713582|589056786|FG012|Overall Study|Disease progression and adverse event|0|||
163094255|NCT01713582|589056787|FG013|Overall Study|Disease progression and adverse event|0|||
163094256|NCT01713582|589056788|FG014|Overall Study|Disease progression and adverse event|0|||
163094257|NCT01713582|589056789|FG015|Overall Study|Disease progression and adverse event|0|||
163094258|NCT01713582|589056790|FG016|Overall Study|Disease progression and adverse event|1|||
163094259|NCT01713582|589056791|FG017|Overall Study|Disease progression and adverse event|0|||
163094260|NCT01713582|589056792|FG018|Overall Study|Disease progression and adverse event|0|||
163094261|NCT01713582|589056793|FG019|Overall Study|Disease progression and adverse event|0|||
163094262|NCT01713582|589056794|FG020|Overall Study|Disease progression and adverse event|0|||
163094263|NCT04551898|589056795|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
163094264|NCT04551898|589056796|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
163094265|NCT04551898|589056797|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
163094266|NCT04551898|589056798|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
163094267|NCT04551898|589056795|FG000|Overall Study|Withdrawal by Subject|5|||
163094268|NCT04551898|589056796|FG001|Overall Study|Withdrawal by Subject|1|||
163094269|NCT04551898|589056797|FG002|Overall Study|Withdrawal by Subject|2|||
163094270|NCT04551898|589056798|FG003|Overall Study|Withdrawal by Subject|2|||
163094271|NCT04551898|589056795|FG000|Overall Study|Lost to Follow-up|2|||
163094272|NCT04551898|589056796|FG001|Overall Study|Lost to Follow-up|1|||
163094273|NCT04551898|589056797|FG002|Overall Study|Lost to Follow-up|2|||
163094274|NCT04551898|589056798|FG003|Overall Study|Lost to Follow-up|2|||
163094275|NCT04551898|589056795|FG000|Overall Study|Death|1|||
163094276|NCT04551898|589056796|FG001|Overall Study|Death|0|||
163094277|NCT04551898|589056797|FG002|Overall Study|Death|0|||
163094278|NCT04551898|589056798|FG003|Overall Study|Death|0|||
163094279|NCT04551898|589056795|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
163094280|NCT04551898|589056796|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
163094281|NCT04551898|589056797|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
163094282|NCT04551898|589056798|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
163094283|NCT03427814|589056799|FG000|Overall Study|Withdrawal by Subject|4|||
163094284|NCT03427814|589056800|FG001|Overall Study|Withdrawal by Subject|4|||
163094285|NCT03427814|589056799|FG000|Overall Study|Lost to Follow-up|0|||
163094286|NCT03427814|589056800|FG001|Overall Study|Lost to Follow-up|2|||
163094287|NCT03427814|589056799|FG000|Overall Study|Death|42|||
163338122|NCT03989232|589947395|FG001|Overall Study|Withdrawal by Subject|6|||
163094288|NCT03427814|589056800|FG001|Overall Study|Death|31|||
163094289|NCT03427814|589056799|FG000|Overall Study|Sponsor's Decision|1|||
163094290|NCT03427814|589056800|FG001|Overall Study|Sponsor's Decision|0|||
163094291|NCT03427814|589056799|FG000|Overall Study|Investigator's Decision|1|||
163094292|NCT03427814|589056800|FG001|Overall Study|Investigator's Decision|2|||
163338123|NCT03989232|589947394|FG000|Overall Study|Death|1|||
163338124|NCT03989232|589947395|FG001|Overall Study|Death|2|||
163338125|NCT01930188|589947396|FG000|Overall Study|unclassified|4|||
163338126|NCT01930188|589947397|FG001|Overall Study|unclassified|5|||
163338127|NCT01930188|589947398|FG002|Overall Study|unclassified|3|||
163338128|NCT01930188|589947396|FG000|Overall Study|Missing follow-up information|2|||
163338129|NCT01930188|589947397|FG001|Overall Study|Missing follow-up information|2|||
163338130|NCT01930188|589947398|FG002|Overall Study|Missing follow-up information|3|||
163338131|NCT01930188|589947396|FG000|Overall Study|Lost to Follow-up|5|||
163338132|NCT01930188|589947397|FG001|Overall Study|Lost to Follow-up|2|||
163338133|NCT01930188|589947398|FG002|Overall Study|Lost to Follow-up|2|||
163338134|NCT01930188|589947396|FG000|Overall Study|Death|2|||
163338135|NCT01930188|589947397|FG001|Overall Study|Death|1|||
163338136|NCT01930188|589947398|FG002|Overall Study|Death|3|||
163338137|NCT01930188|589947396|FG000|Overall Study|Withdrawal by Subject|9|||
163338138|NCT01930188|589947397|FG001|Overall Study|Withdrawal by Subject|11|||
163338139|NCT01930188|589947398|FG002|Overall Study|Withdrawal by Subject|8|||
163094293|NCT03427814|589056799|FG000|Overall Study|Disease progression|1|||
163094294|NCT03427814|589056800|FG001|Overall Study|Disease progression|0|||
163094295|NCT03427814|589056799|FG000|Overall Study|Treatment Completed|0|||
163094296|NCT03427814|589056800|FG001|Overall Study|Treatment Completed|1|||
163094297|NCT03427814|589056799|FG000|Overall Study|Sponsor's Decision to End study|21|||
163094298|NCT03427814|589056800|FG001|Overall Study|Sponsor's Decision to End study|25|||
163094299|NCT03427814|589056799|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
163094300|NCT03427814|589056800|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
163094301|NCT03846427|589056801|FG000|Overall Study|Death|13|||
163094302|NCT03846427|589056801|FG000|Overall Study|Withdrawal by Subject|3|||
163094303|NCT03846427|589056801|FG000|Overall Study|Physician Decision|1|||
163094304|NCT01334554|589056802|FG000|Overall Study|Adverse Event|4|||
163094305|NCT01334554|589056803|FG001|Overall Study|Adverse Event|2|||
163094306|NCT02393859|589056805|FG000|Overall Study|Decision by Sponsor|2|||
163094307|NCT02393859|589056806|FG001|Overall Study|Decision by Sponsor|4|||
163094308|NCT02393859|589056805|FG000|Overall Study|Withdrawal by Subject|11|||
163094309|NCT02393859|589056806|FG001|Overall Study|Withdrawal by Subject|6|||
163094310|NCT02393859|589056805|FG000|Overall Study|Death|27|||
163094311|NCT02393859|589056806|FG001|Overall Study|Death|10|||
163094312|NCT02393859|589056805|FG000|Overall Study|Lost to Follow-up|1|||
163094313|NCT02393859|589056806|FG001|Overall Study|Lost to Follow-up|1|||
163094314|NCT00954447|589056807|FG000|Overall Study|Adverse Event|33|||
163094315|NCT00954447|589056808|FG001|Overall Study|Adverse Event|25|||
163094316|NCT00954447|589056807|FG000|Overall Study|Lack of Efficacy|17|||
163094317|NCT00954447|589056808|FG001|Overall Study|Lack of Efficacy|3|||
163094318|NCT00954447|589056807|FG000|Overall Study|Protocol Violation|5|||
163094319|NCT00954447|589056808|FG001|Overall Study|Protocol Violation|7|||
163094320|NCT00954447|589056807|FG000|Overall Study|Lost to Follow-up|8|||
163094321|NCT00954447|589056808|FG001|Overall Study|Lost to Follow-up|14|||
163094322|NCT00954447|589056807|FG000|Overall Study|Withdrawal by Subject|26|||
163094323|NCT00954447|589056808|FG001|Overall Study|Withdrawal by Subject|21|||
163094324|NCT00954447|589056807|FG000|Overall Study|Other|21|||
163094325|NCT00954447|589056808|FG001|Overall Study|Other|18|||
163094326|NCT01979614|589056809|FG000|Overall Study|Adverse Event|1|||
163094327|NCT01979614|589056810|FG001|Overall Study|Adverse Event|1|||
163094328|NCT00488514|589056811|FG000|Overall Study|Adverse Event|41|||
163094329|NCT00488514|589056811|FG000|Overall Study|Lost to Follow-up|44|||
163094330|NCT00488514|589056811|FG000|Overall Study|Protocol Violation|32|||
163094331|NCT00488514|589056811|FG000|Overall Study|Withdrawal by Subject|106|||
163094332|NCT00488514|589056811|FG000|Overall Study|Lack of Efficacy|28|||
163094333|NCT00488514|589056811|FG000|Overall Study|Did not meet criteria for treatment|30|||
163094334|NCT00488514|589056811|FG000|Overall Study|Postive drug screen|1|||
163094335|NCT00488514|589056811|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
163338140|NCT02170207|589947401|FG000|Overall Study|Case report forms unavailable|5|||
163338141|NCT00657709|589947402|FG000|Overall Study|AE or Death|7|||
163338142|NCT00657709|589947403|FG001|Overall Study|AE or Death|7|||
163338143|NCT00657709|589947404|FG002|Overall Study|AE or Death|6|||
163338144|NCT00657709|589947405|FG003|Overall Study|AE or Death|7|||
163338145|NCT00657709|589947406|FG004|Overall Study|AE or Death|1|||
163338146|NCT00657709|589947402|FG000|Overall Study|Withdrawal by Subject|7|||
163094336|NCT00488514|589056811|FG000|Overall Study|Investigator decision|1|||
163094337|NCT00488514|589056811|FG000|Overall Study|Participant had too few migraines|5|||
163094338|NCT00488514|589056811|FG000|Overall Study|Increase in number of migraines|2|||
163094339|NCT00488514|589056811|FG000|Overall Study|Increased use of concomitant medication|1|||
163338147|NCT00657709|589947403|FG001|Overall Study|Withdrawal by Subject|15|||
163338148|NCT00657709|589947404|FG002|Overall Study|Withdrawal by Subject|15|||
163338149|NCT00657709|589947405|FG003|Overall Study|Withdrawal by Subject|5|||
163338150|NCT00657709|589947406|FG004|Overall Study|Withdrawal by Subject|9|||
163338151|NCT00657709|589947402|FG000|Overall Study|Lost to Follow-up|9|||
163094340|NCT01535287|589056812|FG000|Overall Study|drug not prepared in time|5|||
163094341|NCT01535287|589056813|FG001|Overall Study|drug not prepared in time|6|||
163094342|NCT00305877|589056814|FG000|Overall Study|Lack of Efficacy|6|||
163094343|NCT00305877|589056815|FG001|Overall Study|Lack of Efficacy|9|||
163338152|NCT00657709|589947403|FG001|Overall Study|Lost to Follow-up|9|||
163338153|NCT00657709|589947404|FG002|Overall Study|Lost to Follow-up|7|||
163338154|NCT00657709|589947405|FG003|Overall Study|Lost to Follow-up|1|||
163094344|NCT00305877|589056814|FG000|Overall Study|Adverse Event|9|||
163094345|NCT00305877|589056815|FG001|Overall Study|Adverse Event|14|||
163094346|NCT00305877|589056814|FG000|Overall Study|Death|0|||
163094347|NCT00305877|589056815|FG001|Overall Study|Death|1|||
163094348|NCT00305877|589056814|FG000|Overall Study|Withdrawal by Subject|4|||
163094349|NCT00305877|589056815|FG001|Overall Study|Withdrawal by Subject|2|||
163094350|NCT00305877|589056814|FG000|Overall Study|Physician Decision|1|||
163094351|NCT00305877|589056815|FG001|Overall Study|Physician Decision|1|||
163094352|NCT00305877|589056814|FG000|Overall Study|Never start treatment|2|||
163094353|NCT00305877|589056815|FG001|Overall Study|Never start treatment|5|||
163094354|NCT00305877|589056814|FG000|Overall Study|Ineligible|2|||
163094355|NCT00305877|589056815|FG001|Overall Study|Ineligible|1|||
163094356|NCT00305877|589056814|FG000|Overall Study|Transportation issue with daily RT|0|||
163094357|NCT00305877|589056815|FG001|Overall Study|Transportation issue with daily RT|1|||
163094358|NCT00628446|589056818|FG000|Overall Study|Lost to Follow-up|3|||
163094359|NCT00628446|589056818|FG000|Overall Study|Withdrawal by Subject|1|||
163094360|NCT00628446|589056818|FG000|Overall Study|Protocol Violation|3|||
163094361|NCT04971967|589056819|FG000|Overall Study|Lost to Follow-up|6|||
163094362|NCT04971967|589056820|FG001|Overall Study|Lost to Follow-up|7|||
163094363|NCT00682929|589056823|FG000|Overall Study|Adverse Event|4|||
163094364|NCT00682929|589056824|FG001|Overall Study|Adverse Event|1|||
163094365|NCT00682929|589056825|FG002|Overall Study|Adverse Event|1|||
163094366|NCT00682929|589056823|FG000|Overall Study|Withdrawal by Subject|1|||
163094367|NCT00682929|589056824|FG001|Overall Study|Withdrawal by Subject|2|||
163094368|NCT00682929|589056825|FG002|Overall Study|Withdrawal by Subject|1|||
163094369|NCT00682929|589056823|FG000|Overall Study|dosing compliance < 80%|0|||
163094370|NCT00682929|589056824|FG001|Overall Study|dosing compliance < 80%|2|||
163094371|NCT00682929|589056825|FG002|Overall Study|dosing compliance < 80%|0|||
163094372|NCT00682929|589056823|FG000|Overall Study|lag in DEA renewal|1|||
163094373|NCT00682929|589056824|FG001|Overall Study|lag in DEA renewal|0|||
163094374|NCT00682929|589056825|FG002|Overall Study|lag in DEA renewal|0|||
163094375|NCT00938912|589056826|FG000|Overall Study|Withdrawal by Subject|28|||
163094376|NCT00938912|589056826|FG000|Overall Study|Lost to Follow-up|4|||
163094377|NCT00938912|589056826|FG000|Overall Study|Lack of Efficacy|43|||
163094378|NCT00938912|589056826|FG000|Overall Study|Adverse event, non-fatal|24|||
163094379|NCT00938912|589056826|FG000|Overall Study|Adverse event, fatal|1|||
163094380|NCT00938912|589056826|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
163094381|NCT00938912|589056826|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
163094382|NCT00938912|589056826|FG000|Overall Study|Participant needed prohibit medication|1|||
163094383|NCT00938912|589056826|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
163094384|NCT00938912|589056826|FG000|Overall Study|Did not meet Eligibility criteria|1|||
163094385|NCT00938912|589056826|FG000|Overall Study|Participant relocated not related to AE|1|||
163094386|NCT00938912|589056826|FG000|Overall Study|Participant moved to another city|1|||
163094387|NCT00938912|589056826|FG000|Overall Study|Participant experienced break through seizures|1|||
163094388|NCT00938912|589056826|FG000|Overall Study|No longer wished to participate in the study|1|||
163094389|NCT00938912|589056826|FG000|Overall Study|Protocol Deviation|2|||
163094390|NCT00803738|589056832|FG000|Overall Study|Adverse Event|3|||
163094391|NCT00803738|589056833|FG001|Overall Study|Adverse Event|5|||
163094392|NCT00803738|589056832|FG000|Overall Study|Lost to Follow-up|4|||
163094393|NCT00803738|589056833|FG001|Overall Study|Lost to Follow-up|4|||
163094394|NCT00803738|589056832|FG000|Overall Study|Protocol Violation|18|||
163094395|NCT00803738|589056833|FG001|Overall Study|Protocol Violation|10|||
163094396|NCT00803738|589056832|FG000|Overall Study|Withdrawal by Subject|1|||
163094397|NCT00803738|589056833|FG001|Overall Study|Withdrawal by Subject|4|||
163094398|NCT00803738|589056832|FG000|Overall Study|Lack of Efficacy|10|||
163094399|NCT00803738|589056833|FG001|Overall Study|Lack of Efficacy|16|||
163094400|NCT00803738|589056832|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
163094401|NCT00803738|589056833|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
163338155|NCT00657709|589947406|FG004|Overall Study|Lost to Follow-up|21|||
163338156|NCT00657709|589947402|FG000|Overall Study|Protocol Violation|0|||
163338157|NCT00657709|589947403|FG001|Overall Study|Protocol Violation|2|||
163094402|NCT00803738|589056832|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
163094403|NCT00803738|589056833|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
163094404|NCT02964273|589056834|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
163094405|NCT02964273|589056835|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
163094406|NCT02964273|589056836|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
163094407|NCT02964273|589056837|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
163094408|NCT02964273|589056834|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
163220117|NCT02039674|589521407|FG001|Overall Study|Lost to Follow-up|0|||
163338158|NCT00657709|589947404|FG002|Overall Study|Protocol Violation|0|||
163338159|NCT00657709|589947405|FG003|Overall Study|Protocol Violation|1|||
163338160|NCT00657709|589947406|FG004|Overall Study|Protocol Violation|2|||
163338161|NCT03122860|589947407|FG000|Overall Study|Discontinued Before Treatment|1|||
163338162|NCT03122860|589947408|FG001|Overall Study|Discontinued Before Treatment|1|||
163338163|NCT03122860|589947409|FG002|Overall Study|Discontinued Before Treatment|2|||
163338164|NCT03122860|589947410|FG003|Overall Study|Discontinued Before Treatment|0|||
163338165|NCT03122860|589947411|FG004|Overall Study|Discontinued Before Treatment|1|||
163338166|NCT03122860|589947412|FG005|Overall Study|Discontinued Before Treatment|0|||
163338167|NCT03122860|589947407|FG000|Overall Study|Adverse Event|1|||
163338168|NCT03122860|589947408|FG001|Overall Study|Adverse Event|0|||
163338169|NCT03122860|589947409|FG002|Overall Study|Adverse Event|1|||
163338170|NCT03122860|589947410|FG003|Overall Study|Adverse Event|1|||
163338171|NCT03122860|589947411|FG004|Overall Study|Adverse Event|0|||
163338172|NCT03122860|589947412|FG005|Overall Study|Adverse Event|0|||
163338173|NCT03122860|589947407|FG000|Overall Study|Lost to Follow-up|5|||
163338174|NCT03122860|589947408|FG001|Overall Study|Lost to Follow-up|2|||
163338175|NCT03122860|589947409|FG002|Overall Study|Lost to Follow-up|3|||
163338176|NCT03122860|589947410|FG003|Overall Study|Lost to Follow-up|3|||
163338177|NCT03122860|589947411|FG004|Overall Study|Lost to Follow-up|5|||
163338178|NCT03122860|589947412|FG005|Overall Study|Lost to Follow-up|4|||
163338179|NCT03122860|589947407|FG000|Overall Study|Subject Non-Compliance|0|||
163338180|NCT03122860|589947408|FG001|Overall Study|Subject Non-Compliance|0|||
163338181|NCT03122860|589947409|FG002|Overall Study|Subject Non-Compliance|1|||
163338182|NCT03122860|589947410|FG003|Overall Study|Subject Non-Compliance|0|||
163338183|NCT03122860|589947411|FG004|Overall Study|Subject Non-Compliance|0|||
163338184|NCT03122860|589947412|FG005|Overall Study|Subject Non-Compliance|0|||
163338185|NCT03122860|589947407|FG000|Overall Study|Withdrawal by Subject|3|||
163338186|NCT03122860|589947408|FG001|Overall Study|Withdrawal by Subject|2|||
163338187|NCT03122860|589947409|FG002|Overall Study|Withdrawal by Subject|5|||
163338188|NCT03122860|589947410|FG003|Overall Study|Withdrawal by Subject|7|||
163338189|NCT03122860|589947411|FG004|Overall Study|Withdrawal by Subject|9|||
163338190|NCT03122860|589947412|FG005|Overall Study|Withdrawal by Subject|8|||
163338191|NCT01138657|589947413|FG000|Overall Study|Adverse Event|3|||
163338192|NCT01138657|589947414|FG001|Overall Study|Adverse Event|10|||
163338193|NCT01138657|589947413|FG000|Overall Study|Lack of Efficacy|2|||
163338194|NCT01138657|589947414|FG001|Overall Study|Lack of Efficacy|1|||
163338195|NCT01138657|589947413|FG000|Overall Study|Lost to Follow-up|0|||
163338196|NCT01138657|589947414|FG001|Overall Study|Lost to Follow-up|3|||
163338197|NCT01138657|589947413|FG000|Overall Study|Miscellaneous Reasons|3|||
163338198|NCT01138657|589947414|FG001|Overall Study|Miscellaneous Reasons|4|||
163094409|NCT02964273|589056835|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
163094410|NCT02964273|589056836|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
163094411|NCT02964273|589056837|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
163094412|NCT02964273|589056834|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
163094413|NCT02964273|589056835|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
163094414|NCT02964273|589056836|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
163094415|NCT02964273|589056837|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
163094416|NCT02964273|589056834|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
163094417|NCT02964273|589056835|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
163094418|NCT02964273|589056836|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
163094419|NCT02964273|589056837|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
163094420|NCT02964273|589056834|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
163094421|NCT02964273|589056835|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
163094422|NCT02964273|589056836|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
163094423|NCT02964273|589056837|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
163094424|NCT02964273|589056834|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
163094425|NCT02964273|589056835|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
163094426|NCT02964273|589056836|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
163094427|NCT02964273|589056837|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
163094428|NCT03012334|589056838|FG000|Period 1|Withdrawal by Subject|0|||
163094429|NCT03012334|589056839|FG001|Period 1|Withdrawal by Subject|0|||
163094430|NCT03012334|589056840|FG002|Period 1|Withdrawal by Subject|0|||
163094431|NCT03012334|589056841|FG003|Period 1|Withdrawal by Subject|0|||
163094432|NCT03012334|589056842|FG004|Period 1|Withdrawal by Subject|0|||
163094433|NCT03012334|589056843|FG005|Period 1|Withdrawal by Subject|0|||
163094434|NCT03012334|589056844|FG006|Period 1|Withdrawal by Subject|0|||
163094435|NCT03012334|589056845|FG007|Period 1|Withdrawal by Subject|0|||
163338199|NCT02574286|589947415|FG000|Overall Study|Adverse Event|3|||
163338200|NCT02574286|589947415|FG000|Overall Study|Withdrawal by Subject|2|||
163338201|NCT02399449|589947418|FG000|Overall Study|Withdrawal by Subject|3|||
163338202|NCT02399449|589947419|FG001|Overall Study|Withdrawal by Subject|9|||
163338203|NCT02399449|589947418|FG000|Overall Study|Physician Decision|0|||
163338204|NCT02399449|589947419|FG001|Overall Study|Physician Decision|1|||
163338205|NCT01020435|589947420|FG000|Overall Study|Lost to Follow-up|0|||
163338206|NCT01020435|589947421|FG001|Overall Study|Lost to Follow-up|1|||
163094436|NCT03012334|589056846|FG008|Period 1|Withdrawal by Subject|0|||
163094437|NCT03012334|589056847|FG009|Period 1|Withdrawal by Subject|1|||
163094438|NCT03012334|589056838|FG000|Period 2|Withdrawal by Subject|0|||
163094439|NCT03012334|589056839|FG001|Period 2|Withdrawal by Subject|1|||
163094440|NCT03012334|589056840|FG002|Period 2|Withdrawal by Subject|0|||
163094441|NCT03012334|589056841|FG003|Period 2|Withdrawal by Subject|0|||
163094442|NCT03012334|589056842|FG004|Period 2|Withdrawal by Subject|0|||
163094443|NCT03012334|589056843|FG005|Period 2|Withdrawal by Subject|0|||
163094444|NCT03012334|589056844|FG006|Period 2|Withdrawal by Subject|0|||
163094445|NCT03012334|589056845|FG007|Period 2|Withdrawal by Subject|0|||
163094446|NCT03012334|589056846|FG008|Period 2|Withdrawal by Subject|0|||
163094447|NCT03012334|589056847|FG009|Period 2|Withdrawal by Subject|0|||
163094448|NCT03012334|589056838|FG000|Period 2|Protocol Violation|0|||
163094449|NCT03012334|589056839|FG001|Period 2|Protocol Violation|0|||
163094450|NCT03012334|589056840|FG002|Period 2|Protocol Violation|1|||
163094451|NCT03012334|589056841|FG003|Period 2|Protocol Violation|0|||
163094452|NCT03012334|589056842|FG004|Period 2|Protocol Violation|0|||
163094453|NCT03012334|589056843|FG005|Period 2|Protocol Violation|0|||
163094454|NCT03012334|589056844|FG006|Period 2|Protocol Violation|0|||
163094455|NCT03012334|589056845|FG007|Period 2|Protocol Violation|1|||
163094456|NCT03012334|589056846|FG008|Period 2|Protocol Violation|0|||
163094457|NCT03012334|589056847|FG009|Period 2|Protocol Violation|0|||
163094458|NCT03012334|589056838|FG000|Period 4|Non-Compliance|0|||
163094459|NCT03012334|589056839|FG001|Period 4|Non-Compliance|0|||
163094460|NCT03012334|589056840|FG002|Period 4|Non-Compliance|0|||
163094461|NCT03012334|589056841|FG003|Period 4|Non-Compliance|0|||
163094462|NCT03012334|589056842|FG004|Period 4|Non-Compliance|0|||
163094463|NCT03012334|589056843|FG005|Period 4|Non-Compliance|0|||
163094464|NCT03012334|589056844|FG006|Period 4|Non-Compliance|1|||
163094465|NCT03012334|589056845|FG007|Period 4|Non-Compliance|0|||
163094466|NCT03012334|589056846|FG008|Period 4|Non-Compliance|0|||
163094467|NCT03012334|589056847|FG009|Period 4|Non-Compliance|0|||
163094468|NCT03012334|589056838|FG000|Period 4|Adverse Event|0|||
163094469|NCT03012334|589056839|FG001|Period 4|Adverse Event|0|||
163094470|NCT03012334|589056840|FG002|Period 4|Adverse Event|0|||
163094471|NCT03012334|589056841|FG003|Period 4|Adverse Event|0|||
163094472|NCT03012334|589056842|FG004|Period 4|Adverse Event|0|||
163094473|NCT03012334|589056843|FG005|Period 4|Adverse Event|0|||
163094474|NCT03012334|589056844|FG006|Period 4|Adverse Event|0|||
163094475|NCT03012334|589056845|FG007|Period 4|Adverse Event|0|||
163094476|NCT03012334|589056846|FG008|Period 4|Adverse Event|1|||
163094477|NCT03012334|589056847|FG009|Period 4|Adverse Event|0|||
163094478|NCT01823107|589056848|FG000|Overall Study|Withdrawal by Subject|1|||
163094479|NCT00328172|589056851|FG000|Overall Study|Adverse Event|3|||
163094480|NCT00328172|589056852|FG001|Overall Study|Adverse Event|2|||
163094481|NCT00328172|589056853|FG002|Overall Study|Adverse Event|1|||
163094482|NCT00328172|589056854|FG003|Overall Study|Adverse Event|2|||
163094483|NCT00328172|589056855|FG004|Overall Study|Adverse Event|1|||
163094484|NCT00328172|589056851|FG000|Overall Study|Protocol Violation|0|||
163094485|NCT00328172|589056852|FG001|Overall Study|Protocol Violation|1|||
163094486|NCT00328172|589056853|FG002|Overall Study|Protocol Violation|1|||
163094487|NCT00328172|589056854|FG003|Overall Study|Protocol Violation|0|||
163094488|NCT00328172|589056855|FG004|Overall Study|Protocol Violation|0|||
163094489|NCT00328172|589056851|FG000|Overall Study|Lost to Follow-up|1|||
163094490|NCT00328172|589056852|FG001|Overall Study|Lost to Follow-up|1|||
163094491|NCT00328172|589056853|FG002|Overall Study|Lost to Follow-up|2|||
163094492|NCT00328172|589056854|FG003|Overall Study|Lost to Follow-up|1|||
163094493|NCT00328172|589056855|FG004|Overall Study|Lost to Follow-up|1|||
163094494|NCT00328172|589056851|FG000|Overall Study|Withdrawal by Subject|1|||
163094495|NCT00328172|589056852|FG001|Overall Study|Withdrawal by Subject|1|||
163094496|NCT00328172|589056853|FG002|Overall Study|Withdrawal by Subject|1|||
163094497|NCT00328172|589056854|FG003|Overall Study|Withdrawal by Subject|6|||
163094498|NCT00328172|589056855|FG004|Overall Study|Withdrawal by Subject|0|||
163094499|NCT00328172|589056851|FG000|Overall Study|Lack of Efficacy|14|||
163094500|NCT00328172|589056852|FG001|Overall Study|Lack of Efficacy|9|||
163094501|NCT00328172|589056853|FG002|Overall Study|Lack of Efficacy|4|||
163094502|NCT00328172|589056854|FG003|Overall Study|Lack of Efficacy|4|||
163094503|NCT00328172|589056855|FG004|Overall Study|Lack of Efficacy|3|||
163094504|NCT00328172|589056851|FG000|Overall Study|Other reason (not specified)|3|||
163094505|NCT00328172|589056852|FG001|Overall Study|Other reason (not specified)|0|||
163094506|NCT00328172|589056853|FG002|Overall Study|Other reason (not specified)|1|||
163094507|NCT00328172|589056854|FG003|Overall Study|Other reason (not specified)|0|||
163094508|NCT00328172|589056855|FG004|Overall Study|Other reason (not specified)|0|||
163094509|NCT00077974|589056856|FG000|Overall Study|Adverse Event|22|||
163094510|NCT00077974|589056856|FG000|Overall Study|Protocol Violation|1|||
163094511|NCT00077974|589056856|FG000|Overall Study|Withdrawal by Subject|3|||
163094512|NCT00077974|589056856|FG000|Overall Study|Lack of Efficacy|76|||
163094513|NCT00077974|589056856|FG000|Overall Study|Decision of Sponsor|2|||
163094514|NCT02897115|589056859|FG000|Overall Study|Early termination of study by sponsor|11|||
163094515|NCT02897115|589056860|FG001|Overall Study|Early termination of study by sponsor|8|||
163094516|NCT04512001|589056861|FG000|Week 0 to Week 24|Adverse Event|14|||
163338207|NCT00346398|589947422|FG000|Overall Study|Lost to Follow-up|3|||
163338208|NCT00346398|589947423|FG001|Overall Study|Lost to Follow-up|0|||
163338209|NCT00346398|589947422|FG000|Overall Study|Withdrawal by Subject|0|||
163338210|NCT00346398|589947423|FG001|Overall Study|Withdrawal by Subject|2|||
163338211|NCT02607956|589947424|FG000|Double-Blinded Phase|Withdrew Consent|17|||
163338212|NCT02607956|589947425|FG001|Double-Blinded Phase|Withdrew Consent|19|||
163338213|NCT02607956|589947426|FG002|Double-Blinded Phase|Withdrew Consent|0|||
163338214|NCT02607956|589947427|FG003|Double-Blinded Phase|Withdrew Consent|0|||
163338215|NCT02607956|589947424|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
163338216|NCT02607956|589947425|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
163338217|NCT02607956|589947426|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
163338218|NCT02607956|589947427|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
163338219|NCT02607956|589947424|FG000|Double-Blinded Phase|Randomized but never treated|7|||
163338220|NCT02607956|589947425|FG001|Double-Blinded Phase|Randomized but never treated|5|||
163338221|NCT02607956|589947426|FG002|Double-Blinded Phase|Randomized but never treated|0|||
163338222|NCT02607956|589947427|FG003|Double-Blinded Phase|Randomized but never treated|0|||
163338223|NCT02607956|589947424|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
163338224|NCT02607956|589947425|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
163338225|NCT02607956|589947426|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
163338226|NCT02607956|589947427|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
163338227|NCT02607956|589947424|FG000|Double-Blinded Phase|Death|4|||
163338228|NCT02607956|589947425|FG001|Double-Blinded Phase|Death|4|||
163338229|NCT02607956|589947426|FG002|Double-Blinded Phase|Death|0|||
163338230|NCT02607956|589947427|FG003|Double-Blinded Phase|Death|0|||
163338231|NCT02607956|589947424|FG000|Double-Blinded Phase|Adverse Event|4|||
163338232|NCT02607956|589947425|FG001|Double-Blinded Phase|Adverse Event|3|||
163094517|NCT04512001|589056862|FG001|Week 0 to Week 24|Adverse Event|10|||
163094518|NCT04512001|589056863|FG002|Week 0 to Week 24|Adverse Event|0|||
163094519|NCT04512001|589056864|FG003|Week 0 to Week 24|Adverse Event|0|||
163094520|NCT04512001|589056865|FG004|Week 0 to Week 24|Adverse Event|0|||
163094521|NCT04512001|589056861|FG000|Week 0 to Week 24|Death|0|||
163094522|NCT04512001|589056862|FG001|Week 0 to Week 24|Death|2|||
163094523|NCT04512001|589056863|FG002|Week 0 to Week 24|Death|0|||
163094524|NCT04512001|589056864|FG003|Week 0 to Week 24|Death|0|||
163094525|NCT04512001|589056865|FG004|Week 0 to Week 24|Death|0|||
163094526|NCT04512001|589056861|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
163094527|NCT04512001|589056862|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
163094528|NCT04512001|589056863|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
163094529|NCT04512001|589056864|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
163094530|NCT04512001|589056865|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
163094531|NCT04512001|589056861|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
163094532|NCT04512001|589056862|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
163094533|NCT04512001|589056863|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
163094534|NCT04512001|589056864|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
163094535|NCT04512001|589056865|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
163094536|NCT04512001|589056861|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
163094537|NCT04512001|589056862|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
163094538|NCT04512001|589056863|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
163094539|NCT04512001|589056864|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
163094540|NCT04512001|589056865|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
163094541|NCT04512001|589056861|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
163094542|NCT04512001|589056862|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
163094543|NCT04512001|589056863|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
163094544|NCT04512001|589056864|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
163094545|NCT04512001|589056865|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
163094546|NCT04512001|589056861|FG000|Week 24 to Week 63|Adverse Event|0|||
163094547|NCT04512001|589056862|FG001|Week 24 to Week 63|Adverse Event|0|||
163094548|NCT04512001|589056863|FG002|Week 24 to Week 63|Adverse Event|13|||
163338233|NCT02607956|589947426|FG002|Double-Blinded Phase|Adverse Event|0|||
163338234|NCT02607956|589947427|FG003|Double-Blinded Phase|Adverse Event|0|||
163338235|NCT02607956|589947424|FG000|Double-Blinded Phase|Protocol Violation|3|||
163338236|NCT02607956|589947425|FG001|Double-Blinded Phase|Protocol Violation|1|||
163338237|NCT02607956|589947426|FG002|Double-Blinded Phase|Protocol Violation|0|||
163094549|NCT04512001|589056864|FG003|Week 24 to Week 63|Adverse Event|8|||
163094550|NCT04512001|589056865|FG004|Week 24 to Week 63|Adverse Event|6|||
163094551|NCT04512001|589056861|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
163094552|NCT04512001|589056862|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
163094553|NCT04512001|589056863|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
163338238|NCT02607956|589947427|FG003|Double-Blinded Phase|Protocol Violation|0|||
163338239|NCT02607956|589947424|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
163338240|NCT02607956|589947425|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
163338241|NCT02607956|589947426|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
163338242|NCT02607956|589947427|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
163094554|NCT04512001|589056864|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
163094555|NCT04512001|589056865|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
163094556|NCT04512001|589056861|FG000|Week 24 to Week 63|Death|0|||
163094557|NCT04512001|589056862|FG001|Week 24 to Week 63|Death|0|||
163094558|NCT04512001|589056863|FG002|Week 24 to Week 63|Death|0|||
163094559|NCT04512001|589056864|FG003|Week 24 to Week 63|Death|1|||
163094560|NCT04512001|589056865|FG004|Week 24 to Week 63|Death|1|||
163094561|NCT04512001|589056861|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
163094562|NCT04512001|589056862|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
163094563|NCT04512001|589056863|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
163094564|NCT04512001|589056864|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
163094565|NCT04512001|589056865|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
163094566|NCT04512001|589056861|FG000|Week 24 to Week 63|Miscellaneous|0|||
163094567|NCT04512001|589056862|FG001|Week 24 to Week 63|Miscellaneous|0|||
163094568|NCT04512001|589056863|FG002|Week 24 to Week 63|Miscellaneous|3|||
163094569|NCT04512001|589056864|FG003|Week 24 to Week 63|Miscellaneous|2|||
163094570|NCT04512001|589056865|FG004|Week 24 to Week 63|Miscellaneous|1|||
163094571|NCT03896477|589056871|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
163094572|NCT03896477|589056872|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
163094573|NCT03896477|589056873|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
163094574|NCT03896477|589056871|FG000|Overall Study|Parent Requested Withdrawal|8|||
163094575|NCT03896477|589056872|FG001|Overall Study|Parent Requested Withdrawal|12|||
163094576|NCT03896477|589056873|FG002|Overall Study|Parent Requested Withdrawal|9|||
163094577|NCT03896477|589056871|FG000|Overall Study|Adverse Event|0|||
163094578|NCT03896477|589056872|FG001|Overall Study|Adverse Event|0|||
163094579|NCT03896477|589056873|FG002|Overall Study|Adverse Event|1|||
163094580|NCT03896477|589056871|FG000|Overall Study|Death|1|||
163094581|NCT03896477|589056872|FG001|Overall Study|Death|0|||
163094582|NCT03896477|589056873|FG002|Overall Study|Death|0|||
163094583|NCT03896477|589056871|FG000|Overall Study|Other|5|||
163094584|NCT03896477|589056872|FG001|Overall Study|Other|6|||
163094585|NCT03896477|589056873|FG002|Overall Study|Other|7|||
163094586|NCT03896477|589056871|FG000|Overall Study|Lost to Follow-up|2|||
163094587|NCT03896477|589056872|FG001|Overall Study|Lost to Follow-up|1|||
163094588|NCT03896477|589056873|FG002|Overall Study|Lost to Follow-up|1|||
163094589|NCT01106157|589056877|FG000|Overall Study|Withdrawal by Subject|1|||
163094590|NCT01106157|589056878|FG001|Overall Study|Withdrawal by Subject|0|||
163094591|NCT02298868|589056882|FG000|Overall Study|Adverse Event|1|||
163094592|NCT02298868|589056882|FG000|Overall Study|Death|1|||
163094593|NCT02298868|589056882|FG000|Overall Study|Patient underwent transplant|1|||
163094594|NCT01063348|589056883|FG000|Overall Study|Lost to Follow-up|3|||
163094595|NCT01063348|589056884|FG001|Overall Study|Lost to Follow-up|10|||
163094596|NCT03824392|589056887|FG000|Overall Study|Adverse Event|1|||
163094597|NCT03824392|589056888|FG001|Overall Study|Adverse Event|0|||
163094598|NCT03824392|589056889|FG002|Overall Study|Adverse Event|0|||
163094599|NCT03824392|589056890|FG003|Overall Study|Adverse Event|0|||
163094600|NCT03824392|589056887|FG000|Overall Study|Investigator Decision|0|||
163094601|NCT03824392|589056888|FG001|Overall Study|Investigator Decision|1|||
163094602|NCT03824392|589056889|FG002|Overall Study|Investigator Decision|0|||
163094603|NCT03824392|589056890|FG003|Overall Study|Investigator Decision|0|||
163094604|NCT03824392|589056887|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
163094605|NCT03824392|589056888|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
163094606|NCT03824392|589056889|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
163094607|NCT03824392|589056890|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
163094608|NCT00967616|589056891|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
163094609|NCT00967616|589056892|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
163094610|NCT00967616|589056891|FG000|Overall Study|Death|0|||
163094611|NCT00967616|589056892|FG001|Overall Study|Death|3|||
163094612|NCT00967616|589056891|FG000|Overall Study|Withdrawal by Subject|8|||
163094613|NCT00967616|589056892|FG001|Overall Study|Withdrawal by Subject|4|||
163094614|NCT00967616|589056891|FG000|Overall Study|Progressive Disease|31|||
163094615|NCT00967616|589056892|FG001|Overall Study|Progressive Disease|18|||
163338243|NCT02607956|589947424|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
163338244|NCT02607956|589947425|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
163094616|NCT00967616|589056891|FG000|Overall Study|Other|8|||
163094617|NCT00967616|589056892|FG001|Overall Study|Other|8|||
163094618|NCT00967616|589056891|FG000|Overall Study|Protocol Violation|1|||
163094619|NCT00967616|589056892|FG001|Overall Study|Protocol Violation|0|||
163338245|NCT02607956|589947426|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
163094620|NCT01847755|589056893|FG000|Overall Study|Adverse Event|2|||
163094621|NCT01847755|589056893|FG000|Overall Study|Withdrawal by Subject|2|||
163094622|NCT01847755|589056893|FG000|Overall Study|Physician Decision|1|||
163094623|NCT00120627|589056907|FG000|Overall Study|Withdrawal by Subject|5|||
163094624|NCT00120627|589056908|FG001|Overall Study|Withdrawal by Subject|5|||
163094625|NCT03386435|589056909|FG000|Overall Study|Protocol Violation|5|||
163094626|NCT03386435|589056910|FG001|Overall Study|Protocol Violation|7|||
163094627|NCT04068922|589056911|FG000|Overall Study|Lost to Follow-up|5|||
163094628|NCT04068922|589056911|FG000|Overall Study|Withdrawal by Subject|7|||
163094629|NCT04068922|589056911|FG000|Overall Study|Adverse Event|1|||
163094630|NCT00907621|589056913|FG000|Overall Study|Lost to Follow-up|6|||
163094631|NCT00907621|589056914|FG001|Overall Study|Lost to Follow-up|3|||
163094632|NCT00907621|589056913|FG000|Overall Study|intercurrent febrile illness|1|||
163094633|NCT00907621|589056914|FG001|Overall Study|intercurrent febrile illness|1|||
163094634|NCT00959907|589056915|FG000|Overall Study|Protocol Violation|0|||
163094635|NCT00959907|589056916|FG001|Overall Study|Protocol Violation|1|||
163094636|NCT00959907|589056915|FG000|Overall Study|Adverse Event|1|||
163094637|NCT00959907|589056916|FG001|Overall Study|Adverse Event|0|||
163094638|NCT00959907|589056915|FG000|Overall Study|Withdrawal by Subject|2|||
163094639|NCT00959907|589056916|FG001|Overall Study|Withdrawal by Subject|0|||
163094640|NCT01261975|589056921|FG000|Overall Study|Surgical complication|1|||
163094641|NCT00716274|589056923|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
163094642|NCT00716274|589056924|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
163094643|NCT00716274|589056925|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
163094644|NCT00716274|589056926|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
163094645|NCT00716274|589056927|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
163094646|NCT00716274|589056928|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
163094647|NCT00716274|589056923|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
163094648|NCT00716274|589056924|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
163094649|NCT00716274|589056925|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
163094650|NCT00716274|589056926|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
163094651|NCT00716274|589056927|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
163094652|NCT00716274|589056928|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
163094653|NCT00716274|589056923|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
163094654|NCT00716274|589056924|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
163094655|NCT00716274|589056925|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
163094656|NCT00716274|589056926|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
163094657|NCT00716274|589056927|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
163094658|NCT00716274|589056928|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
163094659|NCT00716274|589056923|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
163094660|NCT00716274|589056924|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
163094661|NCT00716274|589056925|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
163094662|NCT00716274|589056926|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
163094663|NCT00716274|589056927|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
163094664|NCT00716274|589056928|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
163094665|NCT00716274|589056923|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
163094666|NCT00716274|589056924|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
163094667|NCT00716274|589056925|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
163094668|NCT00716274|589056926|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
163094669|NCT00716274|589056927|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
163094670|NCT00716274|589056928|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
163094671|NCT00716274|589056923|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
163094672|NCT00716274|589056924|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
163094673|NCT00716274|589056925|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
163094674|NCT00716274|589056926|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
163094675|NCT00716274|589056927|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
163094676|NCT00716274|589056928|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
163094677|NCT00716274|589056923|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
163094678|NCT00716274|589056924|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
163094679|NCT00716274|589056925|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
163094680|NCT00716274|589056926|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
163094681|NCT00716274|589056927|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
163094682|NCT00716274|589056928|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
163094683|NCT00716274|589056923|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
163094684|NCT00716274|589056924|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
163094685|NCT00716274|589056925|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
163094686|NCT00716274|589056926|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
163094687|NCT00716274|589056927|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
163094688|NCT00716274|589056928|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
163094689|NCT00716274|589056923|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
163094690|NCT00716274|589056924|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
163094691|NCT00716274|589056925|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
163094692|NCT00716274|589056926|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
163094693|NCT00716274|589056927|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
163094694|NCT00716274|589056928|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
163094695|NCT00716274|589056923|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
163094696|NCT00716274|589056924|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
163094697|NCT00716274|589056925|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
163094698|NCT00716274|589056926|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
163338246|NCT02607956|589947427|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
163338247|NCT02607956|589947424|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
163338248|NCT02607956|589947425|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
163338249|NCT02607956|589947426|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
163338250|NCT02607956|589947427|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
163338251|NCT02607956|589947424|FG000|Open-Label Extension Phase|Death|0|||
163338252|NCT02607956|589947425|FG001|Open-Label Extension Phase|Death|0|||
163338253|NCT02607956|589947426|FG002|Open-Label Extension Phase|Death|1|||
163338254|NCT02607956|589947427|FG003|Open-Label Extension Phase|Death|3|||
163338255|NCT02607956|589947424|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
163338256|NCT02607956|589947425|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
163338257|NCT02607956|589947426|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
163338258|NCT02607956|589947427|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
163338259|NCT02607956|589947424|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
163338260|NCT02607956|589947425|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
163338261|NCT02607956|589947426|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
163338262|NCT02607956|589947427|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
163338263|NCT02607956|589947424|FG000|Open-Label Extension Phase|Protocol Violation|0|||
163338264|NCT02607956|589947425|FG001|Open-Label Extension Phase|Protocol Violation|0|||
163338265|NCT02607956|589947426|FG002|Open-Label Extension Phase|Protocol Violation|0|||
163338266|NCT02607956|589947427|FG003|Open-Label Extension Phase|Protocol Violation|2|||
163094699|NCT00716274|589056927|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
163094700|NCT00716274|589056928|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
163094701|NCT01932788|589056929|FG000|Overall Study|Protocol Violation|18|||
163094702|NCT01932788|589056930|FG001|Overall Study|Protocol Violation|0|||
163094703|NCT01932788|589056929|FG000|Overall Study|Lost to Follow-up|18|||
163094704|NCT01932788|589056930|FG001|Overall Study|Lost to Follow-up|46|||
163094705|NCT01932788|589056929|FG000|Overall Study|Lack of Efficacy|2|||
163094706|NCT01932788|589056930|FG001|Overall Study|Lack of Efficacy|0|||
163094707|NCT01932788|589056929|FG000|Overall Study|Withdrawal by Subject|0|||
163094708|NCT01932788|589056930|FG001|Overall Study|Withdrawal by Subject|5|||
163094709|NCT04290624|589056931|FG000|Overall Study|Adverse Event|1|||
163094710|NCT04290624|589056932|FG001|Overall Study|Adverse Event|0|||
163094711|NCT01171677|589056933|FG000|Overall Study|Withdrawal by Subject|0|||
163094712|NCT01171677|589056934|FG001|Overall Study|Withdrawal by Subject|3|||
163094713|NCT01171677|589056933|FG000|Overall Study|Adverse Event|1|||
163094714|NCT01171677|589056934|FG001|Overall Study|Adverse Event|0|||
163094715|NCT01171677|589056933|FG000|Overall Study|completed <70% IntenSati classes|5|||
163094716|NCT01171677|589056934|FG001|Overall Study|completed <70% IntenSati classes|0|||
163094717|NCT00656370|589056935|FG000|Overall Study|Screen Failures|7|||
163094718|NCT00656370|589056935|FG000|Overall Study|Alternates|3|||
163094719|NCT01342094|589056938|FG000|Overall Study|Adverse Event|5|||
163094720|NCT01342094|589056939|FG001|Overall Study|Adverse Event|0|||
163094721|NCT01342094|589056938|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
163094722|NCT01342094|589056939|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
163094723|NCT01342094|589056938|FG000|Overall Study|Withdrawal by Subject|0|||
163094724|NCT01342094|589056939|FG001|Overall Study|Withdrawal by Subject|2|||
163094725|NCT02806414|589056942|FG000|Overall Study|Lost to Follow-up|2|||
163094726|NCT03092479|589056951|FG000|Overall Study|Lost to Follow-up|3|||
163094727|NCT03092479|589056952|FG001|Overall Study|Lost to Follow-up|2|||
163094728|NCT03092479|589056951|FG000|Overall Study|Withdrawal by Subject|4|||
163094729|NCT03092479|589056952|FG001|Overall Study|Withdrawal by Subject|0|||
163094730|NCT05653700|589056953|FG000|Overall Study|Non Responders|9|||
163094731|NCT05653700|589056954|FG001|Overall Study|Non Responders|0|||
163094732|NCT00543985|589056961|FG000|Overall Study|Withdrawal by Subject|4|||
163094733|NCT01634152|589056962|FG000|Overall Study|Adverse Event|2|||
163094734|NCT01634152|589056963|FG001|Overall Study|Adverse Event|0|||
163094735|NCT01634152|589056964|FG002|Overall Study|Adverse Event|2|||
163094736|NCT01634152|589056962|FG000|Overall Study|Consent withdrawn not due to AE|1|||
163094737|NCT01634152|589056963|FG001|Overall Study|Consent withdrawn not due to AE|0|||
163094738|NCT01634152|589056964|FG002|Overall Study|Consent withdrawn not due to AE|1|||
163094739|NCT01634152|589056962|FG000|Overall Study|Not treated|0|||
163094740|NCT01634152|589056963|FG001|Overall Study|Not treated|1|||
163094741|NCT01634152|589056964|FG002|Overall Study|Not treated|0|||
163094742|NCT01634152|589056962|FG000|Overall Study|Other reason not defined above|1|||
163094743|NCT01634152|589056963|FG001|Overall Study|Other reason not defined above|0|||
163094744|NCT01634152|589056964|FG002|Overall Study|Other reason not defined above|1|||
163094745|NCT01900665|589056969|FG000|Placebo Controlled Period|Death|9|||
163094746|NCT01900665|589056970|FG001|Placebo Controlled Period|Death|16|||
163094747|NCT01900665|589056969|FG000|Placebo Controlled Period|Adverse Event|48|||
163094748|NCT01900665|589056970|FG001|Placebo Controlled Period|Adverse Event|39|||
163094749|NCT01900665|589056969|FG000|Placebo Controlled Period|Protocol Violation|1|||
163094750|NCT01900665|589056970|FG001|Placebo Controlled Period|Protocol Violation|7|||
163094751|NCT01900665|589056969|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
163094752|NCT01900665|589056970|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
163094753|NCT01900665|589056969|FG000|Placebo Controlled Period|Physician Decision|11|||
163094754|NCT01900665|589056970|FG001|Placebo Controlled Period|Physician Decision|7|||
163094755|NCT01900665|589056969|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
163094756|NCT01900665|589056970|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
163094757|NCT01900665|589056969|FG000|Placebo Controlled Period|Caregiver Decision|33|||
163094758|NCT01900665|589056970|FG001|Placebo Controlled Period|Caregiver Decision|41|||
163094759|NCT01900665|589056969|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
163094760|NCT01900665|589056970|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
163094761|NCT01900665|589056969|FG000|Open Label Period|Adverse Event|16|||
163094762|NCT01900665|589056970|FG001|Open Label Period|Adverse Event|20|||
163094763|NCT01900665|589056969|FG000|Open Label Period|Death|5|||
163094764|NCT01900665|589056970|FG001|Open Label Period|Death|6|||
163094765|NCT01900665|589056969|FG000|Open Label Period|Lost to Follow-up|1|||
163094766|NCT01900665|589056970|FG001|Open Label Period|Lost to Follow-up|1|||
163094767|NCT01900665|589056969|FG000|Open Label Period|Parent/Caregiver Decision|33|||
163094768|NCT01900665|589056970|FG001|Open Label Period|Parent/Caregiver Decision|34|||
163094769|NCT01900665|589056969|FG000|Open Label Period|Physician Decision|4|||
163094770|NCT01900665|589056970|FG001|Open Label Period|Physician Decision|4|||
163094771|NCT01900665|589056969|FG000|Open Label Period|Protocol Violation|0|||
163094772|NCT01900665|589056970|FG001|Open Label Period|Protocol Violation|1|||
163094773|NCT01900665|589056969|FG000|Open Label Period|Sponsor Decision|802|||
163094774|NCT01900665|589056970|FG001|Open Label Period|Sponsor Decision|765|||
163094775|NCT01900665|589056969|FG000|Open Label Period|Withdrawal by Subject|20|||
163094776|NCT01900665|589056970|FG001|Open Label Period|Withdrawal by Subject|28|||
163094777|NCT02317627|589056974|FG000|Overall Study|Withdrawal by Subject|0|||
163094778|NCT02317627|589056975|FG001|Overall Study|Withdrawal by Subject|1|||
163094779|NCT02317627|589056976|FG002|Overall Study|Withdrawal by Subject|1|||
163094780|NCT02317627|589056974|FG000|Overall Study|Lost to Follow-up|2|||
163094781|NCT02317627|589056975|FG001|Overall Study|Lost to Follow-up|0|||
163094782|NCT02317627|589056976|FG002|Overall Study|Lost to Follow-up|0|||
163094783|NCT02317627|589056974|FG000|Overall Study|Stopped by Investigator|0|||
163094784|NCT02317627|589056975|FG001|Overall Study|Stopped by Investigator|1|||
163094785|NCT02317627|589056976|FG002|Overall Study|Stopped by Investigator|0|||
163094786|NCT02317627|589056974|FG000|Overall Study|Adverse Event|0|||
163094787|NCT02317627|589056975|FG001|Overall Study|Adverse Event|2|||
163094788|NCT02317627|589056976|FG002|Overall Study|Adverse Event|3|||
163094789|NCT02317627|589056974|FG000|Overall Study|Non-compliance with study drug|0|||
163094790|NCT02317627|589056975|FG001|Overall Study|Non-compliance with study drug|1|||
163094791|NCT02317627|589056976|FG002|Overall Study|Non-compliance with study drug|0|||
163094792|NCT00279214|589056977|FG000|Overall Study|Physician Decision|3|||
163094793|NCT00279214|589056978|FG001|Overall Study|Physician Decision|2|||
163094794|NCT04749914|589056979|FG000|Period 1|Adverse Event|1|||
163094795|NCT04749914|589056980|FG001|Period 1|Adverse Event|0|||
163094796|NCT04749914|589056981|FG002|Period 1|Adverse Event|0|||
163094797|NCT04749914|589056982|FG003|Period 1|Adverse Event|0|||
163094798|NCT04749914|589056979|FG000|Period 1|Withdrawal by Subject|1|||
163094799|NCT04749914|589056980|FG001|Period 1|Withdrawal by Subject|0|||
163094800|NCT04749914|589056981|FG002|Period 1|Withdrawal by Subject|1|||
163094801|NCT04749914|589056982|FG003|Period 1|Withdrawal by Subject|0|||
163094802|NCT00403130|589056983|FG000|2 Years From Start of Treatment|Not Eligible|3|||
163094803|NCT00403130|589056983|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
163094804|NCT00403130|589056983|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
163094805|NCT00403130|589056983|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
163094806|NCT01280968|589056984|FG000|Overall Study|Lost to Follow-up|8|||
163094807|NCT01280968|589056985|FG001|Overall Study|Lost to Follow-up|2|||
163094808|NCT01280968|589056984|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
163094809|NCT01280968|589056985|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
163094810|NCT01280968|589056984|FG000|Overall Study|Commuting Problems|2|||
163094811|NCT01280968|589056985|FG001|Overall Study|Commuting Problems|0|||
163094812|NCT01280968|589056984|FG000|Overall Study|Anxiety|2|||
163094813|NCT01280968|589056985|FG001|Overall Study|Anxiety|0|||
163094814|NCT01280968|589056984|FG000|Overall Study|Adverse Event|1|||
163094815|NCT01280968|589056985|FG001|Overall Study|Adverse Event|0|||
163094816|NCT01280968|589056984|FG000|Overall Study|Scheduling Conflicts|1|||
163094817|NCT01280968|589056985|FG001|Overall Study|Scheduling Conflicts|1|||
163338267|NCT02607956|589947424|FG000|Open-Label Extension Phase|Pregnancy|0|||
163094818|NCT01280968|589056984|FG000|Overall Study|Pre-existing Neurological Condition|1|||
163094819|NCT01280968|589056985|FG001|Overall Study|Pre-existing Neurological Condition|0|||
163094820|NCT01280968|589056984|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
163094821|NCT01280968|589056985|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
163094822|NCT00342628|589058505|FG000|Overall Study|Withdrawal by Subject|19|||
163094823|NCT00342628|589058506|FG001|Overall Study|Withdrawal by Subject|19|||
163094824|NCT00342628|589058507|FG002|Overall Study|Withdrawal by Subject|18|||
163094825|NCT00342628|589058505|FG000|Overall Study|Death|1|||
163094826|NCT00342628|589058506|FG001|Overall Study|Death|1|||
163094827|NCT00342628|589058507|FG002|Overall Study|Death|0|||
163338268|NCT02607956|589947425|FG001|Open-Label Extension Phase|Pregnancy|0|||
163338269|NCT02607956|589947426|FG002|Open-Label Extension Phase|Pregnancy|0|||
163338270|NCT02607956|589947427|FG003|Open-Label Extension Phase|Pregnancy|1|||
163338271|NCT00090519|589947434|FG000|Overall Study|Adverse Event|5|||
163338272|NCT00090519|589947435|FG001|Overall Study|Adverse Event|4|||
163338273|NCT00090519|589947434|FG000|Overall Study|Death|9|||
163338274|NCT00090519|589947435|FG001|Overall Study|Death|9|||
163338275|NCT00090519|589947434|FG000|Overall Study|Lost to Follow-up|26|||
163338276|NCT00090519|589947435|FG001|Overall Study|Lost to Follow-up|29|||
163338277|NCT00090519|589947434|FG000|Overall Study|Withdrawal by Subject|28|||
163338278|NCT00090519|589947435|FG001|Overall Study|Withdrawal by Subject|29|||
163338279|NCT00090519|589947434|FG000|Overall Study|Physician Decision|2|||
163338280|NCT00090519|589947435|FG001|Overall Study|Physician Decision|3|||
163338281|NCT00090519|589947434|FG000|Overall Study|Sponsor Decision|3|||
163338282|NCT00090519|589947435|FG001|Overall Study|Sponsor Decision|1|||
163338283|NCT00960206|589947436|FG000|Overall Study|Death|7|||
163338284|NCT00960206|589947437|FG001|Overall Study|Death|4|||
163338285|NCT00960206|589947438|FG002|Overall Study|Death|1|||
163338286|NCT00960206|589947436|FG000|Overall Study|Unwilling/Unable to return|1|||
163338287|NCT00960206|589947437|FG001|Overall Study|Unwilling/Unable to return|2|||
163338288|NCT00960206|589947438|FG002|Overall Study|Unwilling/Unable to return|0|||
163338289|NCT00960206|589947436|FG000|Overall Study|Lost to Follow-up|8|||
163338290|NCT00960206|589947437|FG001|Overall Study|Lost to Follow-up|14|||
163338291|NCT00960206|589947438|FG002|Overall Study|Lost to Follow-up|8|||
163338292|NCT00960206|589947436|FG000|Overall Study|Withdrawal by Subject|2|||
163338293|NCT00960206|589947437|FG001|Overall Study|Withdrawal by Subject|4|||
163338294|NCT00960206|589947438|FG002|Overall Study|Withdrawal by Subject|0|||
163338295|NCT00960206|589947436|FG000|Overall Study|Revision of study component|2|||
163338296|NCT00960206|589947437|FG001|Overall Study|Revision of study component|2|||
163338297|NCT00960206|589947438|FG002|Overall Study|Revision of study component|2|||
163338298|NCT00960206|589947436|FG000|Overall Study|Missing 10 year data|20|||
163338299|NCT00960206|589947437|FG001|Overall Study|Missing 10 year data|1|||
163338300|NCT00960206|589947438|FG002|Overall Study|Missing 10 year data|1|||
163338301|NCT01240590|589947443|FG000|Phase I|Refused further treatment|0|||
163338302|NCT01240590|589947444|FG001|Phase I|Refused further treatment|0|||
163338303|NCT01240590|589947445|FG002|Phase I|Refused further treatment|3|||
163039211|NCT00528372|588850687|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
163039212|NCT00528372|588850688|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
163338304|NCT01240590|589947446|FG003|Phase I|Refused further treatment|0|||
163338305|NCT01240590|589947447|FG004|Phase I|Refused further treatment|0|||
163338306|NCT01240590|589947443|FG000|Phase II|Refused further treatment|0|||
163338307|NCT01240590|589947444|FG001|Phase II|Refused further treatment|0|||
163338308|NCT01240590|589947445|FG002|Phase II|Refused further treatment|0|||
163338309|NCT01240590|589947446|FG003|Phase II|Refused further treatment|2|||
163338310|NCT01240590|589947447|FG004|Phase II|Refused further treatment|1|||
163039213|NCT00528372|588850689|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
163039214|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
163039215|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
163039216|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
163039217|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
163039218|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
163039219|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
163039220|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
163039221|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
163039222|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
163039223|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
163039224|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
163039225|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
163039226|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
163039227|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
163039228|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
163039229|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
163039230|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
163039231|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
163039232|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
163039233|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
163039234|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
163039235|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
163039236|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
163039237|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
163039238|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
163039239|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
163094828|NCT00342628|589058505|FG000|Overall Study|moved residence|0|||
163094829|NCT00342628|589058506|FG001|Overall Study|moved residence|1|||
163094830|NCT00342628|589058507|FG002|Overall Study|moved residence|1|||
163094831|NCT00456755|589058510|FG000|Overall Study|Lost to Follow-up|2|||
163094832|NCT00456755|589058511|FG001|Overall Study|Lost to Follow-up|1|||
163094833|NCT01475721|589058514|FG000|Overall Study|Death|3|||
163094834|NCT01475721|589058515|FG001|Overall Study|Death|6|||
163094835|NCT01475721|589058514|FG000|Overall Study|Withdrawal by Subject|8|||
163094836|NCT01475721|589058515|FG001|Overall Study|Withdrawal by Subject|8|||
163094837|NCT01048242|589058516|FG000|Overall Study|See study flow chart|4|||
163094838|NCT01048242|589058517|FG001|Overall Study|See study flow chart|2|||
163094839|NCT01772550|589058519|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
163094840|NCT01772550|589058520|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
163094841|NCT01772550|589058521|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
163094842|NCT01772550|589058519|FG000|Overall Study|Adverse Event|0|||
163094843|NCT01772550|589058520|FG001|Overall Study|Adverse Event|0|||
163094844|NCT01772550|589058521|FG002|Overall Study|Adverse Event|1|||
163094845|NCT00559104|589058523|FG000|Overall Study|Lack of Efficacy|9|||
163094846|NCT00559104|589058524|FG001|Overall Study|Lack of Efficacy|0|||
163094847|NCT01815424|589058525|FG000|Week 0 to 16|Adverse Event|1|||
163094848|NCT01815424|589058526|FG001|Week 0 to 16|Adverse Event|3|||
163338311|NCT02548585|589947448|FG000|Overall Study|Withdrawal by Subject|0|||
163338312|NCT02548585|589947449|FG001|Overall Study|Withdrawal by Subject|0|||
163338313|NCT02548585|589947450|FG002|Overall Study|Withdrawal by Subject|0|||
163338314|NCT02548585|589947451|FG003|Overall Study|Withdrawal by Subject|0|||
163094849|NCT01815424|589058527|FG002|Week 0 to 16|Adverse Event|3|||
163094850|NCT01815424|589058528|FG003|Week 0 to 16|Adverse Event|0|||
163094851|NCT01815424|589058529|FG004|Week 0 to 16|Adverse Event|0|||
163094852|NCT01815424|589058525|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
163094853|NCT01815424|589058526|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
163094854|NCT01815424|589058527|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
163094855|NCT01815424|589058528|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
163094856|NCT01815424|589058529|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
163094857|NCT01815424|589058525|FG000|Week 0 to 16|Lost to Follow-up|0|||
163094858|NCT01815424|589058526|FG001|Week 0 to 16|Lost to Follow-up|1|||
163094859|NCT01815424|589058527|FG002|Week 0 to 16|Lost to Follow-up|0|||
163094860|NCT01815424|589058528|FG003|Week 0 to 16|Lost to Follow-up|0|||
163094861|NCT01815424|589058529|FG004|Week 0 to 16|Lost to Follow-up|0|||
163094862|NCT01815424|589058525|FG000|Week 0 to 16|Withdrawal by Subject|0|||
163094863|NCT01815424|589058526|FG001|Week 0 to 16|Withdrawal by Subject|0|||
163094864|NCT01815424|589058527|FG002|Week 0 to 16|Withdrawal by Subject|1|||
163094865|NCT01815424|589058528|FG003|Week 0 to 16|Withdrawal by Subject|0|||
163094866|NCT01815424|589058529|FG004|Week 0 to 16|Withdrawal by Subject|0|||
163094867|NCT01815424|589058525|FG000|Week 0 to 16|Other|1|||
163094868|NCT01815424|589058526|FG001|Week 0 to 16|Other|0|||
163094869|NCT01815424|589058527|FG002|Week 0 to 16|Other|3|||
163094870|NCT01815424|589058528|FG003|Week 0 to 16|Other|0|||
163094871|NCT01815424|589058529|FG004|Week 0 to 16|Other|0|||
163094872|NCT01815424|589058525|FG000|Week 0 to 16|Protocol Violation|1|||
163094873|NCT01815424|589058526|FG001|Week 0 to 16|Protocol Violation|0|||
163094874|NCT01815424|589058527|FG002|Week 0 to 16|Protocol Violation|0|||
163094875|NCT01815424|589058528|FG003|Week 0 to 16|Protocol Violation|0|||
163094876|NCT01815424|589058529|FG004|Week 0 to 16|Protocol Violation|0|||
163094877|NCT01815424|589058525|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
163094878|NCT01815424|589058526|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
163094879|NCT01815424|589058527|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
163094880|NCT01815424|589058528|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
163094881|NCT01815424|589058529|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
163094882|NCT01815424|589058525|FG000|Week 16 to 52|Other|0|||
163094883|NCT01815424|589058526|FG001|Week 16 to 52|Other|1|||
163094884|NCT01815424|589058527|FG002|Week 16 to 52|Other|0|||
163094885|NCT01815424|589058528|FG003|Week 16 to 52|Other|0|||
163094886|NCT01815424|589058529|FG004|Week 16 to 52|Other|0|||
163094887|NCT01815424|589058525|FG000|Week 16 to 52|Adverse Event|0|||
163094888|NCT01815424|589058526|FG001|Week 16 to 52|Adverse Event|0|||
163094889|NCT01815424|589058527|FG002|Week 16 to 52|Adverse Event|0|||
163094890|NCT01815424|589058528|FG003|Week 16 to 52|Adverse Event|0|||
163094891|NCT01815424|589058529|FG004|Week 16 to 52|Adverse Event|1|||
163094892|NCT01815424|589058525|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
163094893|NCT01815424|589058526|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
163094894|NCT01815424|589058527|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
163094895|NCT01815424|589058528|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
163094896|NCT01815424|589058529|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
163094897|NCT01815424|589058525|FG000|Week 16 to 52|Lost to Follow-up|0|||
163094898|NCT01815424|589058526|FG001|Week 16 to 52|Lost to Follow-up|2|||
163094899|NCT01815424|589058527|FG002|Week 16 to 52|Lost to Follow-up|0|||
163094900|NCT01815424|589058528|FG003|Week 16 to 52|Lost to Follow-up|2|||
163094901|NCT01815424|589058529|FG004|Week 16 to 52|Lost to Follow-up|1|||
163094902|NCT01815424|589058525|FG000|Week 16 to 52|Withdrawal by Subject|1|||
163094903|NCT01815424|589058526|FG001|Week 16 to 52|Withdrawal by Subject|2|||
163094904|NCT01815424|589058527|FG002|Week 16 to 52|Withdrawal by Subject|0|||
163094905|NCT01815424|589058528|FG003|Week 16 to 52|Withdrawal by Subject|0|||
163094906|NCT01815424|589058529|FG004|Week 16 to 52|Withdrawal by Subject|0|||
163094907|NCT01309204|589058530|FG000|Overall Study|Adverse Event|48|||
163094908|NCT01309204|589058531|FG001|Overall Study|Adverse Event|58|||
163094909|NCT01309204|589058530|FG000|Overall Study|Lost to Follow-up|2|||
163094910|NCT01309204|589058531|FG001|Overall Study|Lost to Follow-up|2|||
163094911|NCT01309204|589058530|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
163094912|NCT01309204|589058531|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
163094913|NCT01309204|589058530|FG000|Overall Study|Inadequate control of IOP|4|||
163094914|NCT01309204|589058531|FG001|Overall Study|Inadequate control of IOP|4|||
163094915|NCT01309204|589058530|FG000|Overall Study|Other|4|||
163094916|NCT01309204|589058531|FG001|Overall Study|Other|1|||
163094917|NCT04723355|589058532|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
163094918|NCT04723355|589058532|FG000|Overall Study|Errors in the informed consent form|2|||
163094919|NCT03374358|589058534|FG000|Overall Study|Withdrawal by Subject|0|||
163094920|NCT03374358|589058535|FG001|Overall Study|Withdrawal by Subject|2|||
163094921|NCT01127633|589058536|FG000|Overall Study|Adverse Event|74|||
163094922|NCT01127633|589058537|FG001|Overall Study|Adverse Event|73|||
163094923|NCT01127633|589058536|FG000|Overall Study|Death|40|||
163338315|NCT02548585|589947452|FG004|Overall Study|Withdrawal by Subject|0|||
163094924|NCT01127633|589058537|FG001|Overall Study|Death|43|||
163094925|NCT01127633|589058536|FG000|Overall Study|Lost to Follow-up|4|||
163094926|NCT01127633|589058537|FG001|Overall Study|Lost to Follow-up|0|||
163094927|NCT01127633|589058536|FG000|Overall Study|Parent/Caregiver Decision|246|||
163094928|NCT01127633|589058537|FG001|Overall Study|Parent/Caregiver Decision|228|||
163094929|NCT01127633|589058536|FG000|Overall Study|Physician Decision|60|||
163094930|NCT01127633|589058537|FG001|Overall Study|Physician Decision|45|||
163094931|NCT01127633|589058536|FG000|Overall Study|Withdrawal by Subject|57|||
163094932|NCT01127633|589058537|FG001|Overall Study|Withdrawal by Subject|72|||
163094933|NCT01127633|589058536|FG000|Overall Study|Sponsor Decision|163|||
163094934|NCT01127633|589058537|FG001|Overall Study|Sponsor Decision|195|||
163094935|NCT01127633|589058536|FG000|Overall Study|Protocol Violation|8|||
163094936|NCT01127633|589058537|FG001|Overall Study|Protocol Violation|16|||
163094937|NCT01127633|589058536|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
163094938|NCT01127633|589058537|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
163094939|NCT01127633|589058536|FG000|Overall Study|Not treated|1|||
163338316|NCT02548585|589947453|FG005|Overall Study|Withdrawal by Subject|1|||
163338317|NCT02548585|589947454|FG006|Overall Study|Withdrawal by Subject|0|||
163338318|NCT02548585|589947448|FG000|Overall Study|Lost to Follow-up|1|||
163338319|NCT02548585|589947449|FG001|Overall Study|Lost to Follow-up|0|||
163338320|NCT02548585|589947450|FG002|Overall Study|Lost to Follow-up|0|||
163338321|NCT02548585|589947451|FG003|Overall Study|Lost to Follow-up|0|||
163338322|NCT02548585|589947452|FG004|Overall Study|Lost to Follow-up|0|||
163338323|NCT02548585|589947453|FG005|Overall Study|Lost to Follow-up|0|||
163338324|NCT02548585|589947454|FG006|Overall Study|Lost to Follow-up|0|||
163338325|NCT02548585|589947448|FG000|Overall Study|Other|1|||
163338326|NCT02548585|589947449|FG001|Overall Study|Other|0|||
163338327|NCT02548585|589947450|FG002|Overall Study|Other|0|||
163338328|NCT02548585|589947451|FG003|Overall Study|Other|2|||
163338329|NCT02548585|589947452|FG004|Overall Study|Other|3|||
163338330|NCT02548585|589947453|FG005|Overall Study|Other|0|||
163338331|NCT02548585|589947454|FG006|Overall Study|Other|1|||
163338332|NCT02548585|589947448|FG000|Overall Study|Randomized but not treated|0|||
163338333|NCT02548585|589947449|FG001|Overall Study|Randomized but not treated|0|||
163338334|NCT02548585|589947450|FG002|Overall Study|Randomized but not treated|0|||
163338335|NCT02548585|589947451|FG003|Overall Study|Randomized but not treated|0|||
163338336|NCT02548585|589947452|FG004|Overall Study|Randomized but not treated|0|||
163338337|NCT02548585|589947453|FG005|Overall Study|Randomized but not treated|1|||
163338338|NCT02548585|589947454|FG006|Overall Study|Randomized but not treated|0|||
163094940|NCT01127633|589058537|FG001|Overall Study|Not treated|0|||
163094941|NCT01073293|589058539|FG000|Overall Study|Lost to Follow-up|0|||
163094942|NCT01073293|589058540|FG001|Overall Study|Lost to Follow-up|1|||
163094943|NCT01073293|589058539|FG000|Overall Study|Withdrawal by Subject|5|||
163338339|NCT01075152|589947455|FG000|Overall Study|Withdrawal by Subject|1|||
163338340|NCT01075152|589947456|FG001|Overall Study|Withdrawal by Subject|0|||
163094944|NCT01073293|589058540|FG001|Overall Study|Withdrawal by Subject|10|||
163094945|NCT00775268|589058550|FG000|Baseline|Drug not synthesize dose|1|||
163094946|NCT00775268|589058551|FG001|Baseline|Drug not synthesize dose|0|||
163094947|NCT00775268|589058550|FG000|Baseline|Not treated-ineligible per CT|0|||
163094948|NCT00775268|589058551|FG001|Baseline|Not treated-ineligible per CT|1|||
163094949|NCT00775268|589058550|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
163220118|NCT02039674|589521408|FG002|Overall Study|Lost to Follow-up|0|||
163338341|NCT03659136|589947463|FG000|Overall Study|Not treated|2|||
163338342|NCT03659136|589947464|FG001|Overall Study|Not treated|0|||
163338343|NCT03659136|589947463|FG000|Overall Study|Covid-19 related|1|||
163094950|NCT00775268|589058551|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
163094951|NCT00775268|589058550|FG000|After Completion|Participant missed scan appointment|1|||
163094952|NCT00775268|589058551|FG001|After Completion|Participant missed scan appointment|0|||
163094953|NCT03745768|589058553|FG000|Overall Study|discontinued study|2|||
163094954|NCT03745768|589058554|FG001|Overall Study|discontinued study|0|||
163094955|NCT00443118|589058555|FG000|Overall Study|unknown primary outcome|3|||
163094956|NCT00443118|589058556|FG001|Overall Study|unknown primary outcome|1|||
163094957|NCT00443118|589058557|FG002|Overall Study|unknown primary outcome|0|||
163094958|NCT00443118|589058555|FG000|Overall Study|Withdrawal by Subject|1|||
163094959|NCT00443118|589058556|FG001|Overall Study|Withdrawal by Subject|0|||
163094960|NCT00443118|589058557|FG002|Overall Study|Withdrawal by Subject|0|||
163094961|NCT00506779|589058560|FG000|Overall Study|Withdrawal by Subject|1|||
163094962|NCT00506779|589058561|FG001|Overall Study|Withdrawal by Subject|0|||
163094963|NCT00506779|589058562|FG002|Overall Study|Withdrawal by Subject|1|||
163094964|NCT00506779|589058563|FG003|Overall Study|Withdrawal by Subject|0|||
163094965|NCT00506779|589058560|FG000|Overall Study|Adverse Event|0|||
163094966|NCT00506779|589058561|FG001|Overall Study|Adverse Event|1|||
163094967|NCT00506779|589058562|FG002|Overall Study|Adverse Event|1|||
163094968|NCT00506779|589058563|FG003|Overall Study|Adverse Event|1|||
163094969|NCT04263766|589058564|FG000|Overall Study|Withdrawal by Subject|6|||
163094970|NCT04263766|589058565|FG001|Overall Study|Withdrawal by Subject|4|||
163094971|NCT04263766|589058564|FG000|Overall Study|Lack of Efficacy|1|||
163094972|NCT04263766|589058565|FG001|Overall Study|Lack of Efficacy|3|||
163094973|NCT04232943|589058566|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
163094974|NCT04232943|589058567|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
163094975|NCT04232943|589058568|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
163094976|NCT04232943|589058566|FG000|Overall Study|Withdrawal by Subject|1|||
163094977|NCT04232943|589058567|FG001|Overall Study|Withdrawal by Subject|1|||
163094978|NCT04232943|589058568|FG002|Overall Study|Withdrawal by Subject|0|||
163094979|NCT02639247|589058569|FG000|Overall Study|Lost to Follow-up|2|||
163094980|NCT02639247|589058570|FG001|Overall Study|Lost to Follow-up|1|||
163094981|NCT02639247|589058569|FG000|Overall Study|Death|2|||
163094982|NCT02639247|589058570|FG001|Overall Study|Death|0|||
163094983|NCT02639247|589058569|FG000|Overall Study|Withdrew Consent|0|||
163094984|NCT02639247|589058570|FG001|Overall Study|Withdrew Consent|1|||
163094985|NCT02639247|589058569|FG000|Overall Study|Protocol Violation|1|||
163094986|NCT02639247|589058570|FG001|Overall Study|Protocol Violation|0|||
163094987|NCT01891396|589058571|FG000|Overall Study|Withdrawal by Subject|4|||
163094988|NCT01891396|589058572|FG001|Overall Study|Withdrawal by Subject|4|||
163094989|NCT01891396|589058573|FG002|Overall Study|Withdrawal by Subject|3|||
163094990|NCT01891396|589058571|FG000|Overall Study|Lost to Follow-up|0|||
163094991|NCT01891396|589058572|FG001|Overall Study|Lost to Follow-up|1|||
163094992|NCT01891396|589058573|FG002|Overall Study|Lost to Follow-up|0|||
163094993|NCT00573391|589058574|FG000|Overall Study|study stopped|2|||
163094994|NCT00573391|589058575|FG001|Overall Study|study stopped|2|||
163094995|NCT00573391|589058574|FG000|Overall Study|Death|1|||
163094996|NCT00573391|589058575|FG001|Overall Study|Death|0|||
163094997|NCT02168101|589058576|FG000|Overall Study|Death|2|||
163094998|NCT02168101|589058577|FG001|Overall Study|Death|2|||
163094999|NCT02168101|589058578|FG002|Overall Study|Death|1|||
163095000|NCT00400517|589058579|FG000|Overall Study|Withdrawal by Subject|1|||
163095001|NCT00400517|589058579|FG000|Overall Study|Physician Decision|1|||
163095002|NCT01194245|589058580|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
163095003|NCT01194245|589058581|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
163095004|NCT01194245|589058582|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
163095005|NCT01194245|589058583|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
163095006|NCT01194245|589058584|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
163095007|NCT01194245|589058580|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
163095008|NCT01194245|589058581|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
163095009|NCT01194245|589058582|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
163095010|NCT01194245|589058583|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
163095011|NCT01194245|589058584|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
163095012|NCT01194245|589058580|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
163095013|NCT01194245|589058581|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
163095014|NCT01194245|589058582|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
163095015|NCT01194245|589058583|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
163095016|NCT01194245|589058584|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
163095017|NCT01194245|589058580|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
163095018|NCT01194245|589058581|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
163095019|NCT01194245|589058582|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
163095020|NCT01194245|589058583|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
163095021|NCT01194245|589058584|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
163095022|NCT01194245|589058580|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163095023|NCT01194245|589058581|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163095024|NCT01194245|589058582|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163095025|NCT01194245|589058583|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163095026|NCT01194245|589058584|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
163095027|NCT01194245|589058580|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163095028|NCT01194245|589058581|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163095029|NCT01194245|589058582|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
163095030|NCT01194245|589058583|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
163095031|NCT01194245|589058584|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
163095032|NCT05518461|589058585|FG000|Overall Study|Lost to Follow-up|25|||
163095033|NCT02457247|589058586|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
163095034|NCT02457247|589058587|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
163095035|NCT02457247|589058588|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
163095036|NCT02457247|589058589|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
163095037|NCT02457247|589058586|FG000|Period 1|Significant Protocol Deviation|1|||
163095038|NCT02457247|589058587|FG001|Period 1|Significant Protocol Deviation|1|||
163095039|NCT02457247|589058588|FG002|Period 1|Significant Protocol Deviation|0|||
163095040|NCT02457247|589058589|FG003|Period 1|Significant Protocol Deviation|0|||
163095041|NCT02457247|589058586|FG000|Period 1|Voluntary Withdrawal|1|||
163095042|NCT02457247|589058587|FG001|Period 1|Voluntary Withdrawal|0|||
163095043|NCT02457247|589058588|FG002|Period 1|Voluntary Withdrawal|0|||
163095044|NCT02457247|589058589|FG003|Period 1|Voluntary Withdrawal|0|||
163095045|NCT02457247|589058586|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
163095046|NCT02457247|589058587|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
163095047|NCT02457247|589058588|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
163095048|NCT02457247|589058589|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
163095049|NCT02457247|589058586|FG000|Period 2|Significant Protocol Deviation|1|||
163095050|NCT02457247|589058587|FG001|Period 2|Significant Protocol Deviation|0|||
163095051|NCT02457247|589058588|FG002|Period 2|Significant Protocol Deviation|0|||
163095052|NCT02457247|589058589|FG003|Period 2|Significant Protocol Deviation|0|||
163095053|NCT02457247|589058586|FG000|Period 2|Lost to Follow-up|0|||
163095054|NCT02457247|589058587|FG001|Period 2|Lost to Follow-up|1|||
163095055|NCT02457247|589058588|FG002|Period 2|Lost to Follow-up|0|||
163095056|NCT02457247|589058589|FG003|Period 2|Lost to Follow-up|0|||
163095057|NCT02457247|589058586|FG000|Period 2|Voluntary Withdrawal|1|||
163095058|NCT02457247|589058587|FG001|Period 2|Voluntary Withdrawal|1|||
163095059|NCT02457247|589058588|FG002|Period 2|Voluntary Withdrawal|0|||
163095060|NCT02457247|589058589|FG003|Period 2|Voluntary Withdrawal|0|||
163095061|NCT00739310|589058590|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
163095062|NCT00739310|589058590|FG000|Overall Study|Withdrawal by Subject|1|||
163095063|NCT00739310|589058590|FG000|Overall Study|Lost to Follow-up|2|||
163095064|NCT02954887|589058591|FG000|Overall Study|Withdrawal by Subject|3|||
163095065|NCT02954887|589058591|FG000|Overall Study|Lack of Efficacy|3|||
163095066|NCT02954887|589058591|FG000|Overall Study|Other|1|||
163095067|NCT01882465|589058593|FG000|Period 1|Lens Discomfort|0|||
163095068|NCT01882465|589058594|FG001|Period 1|Lens Discomfort|0|||
163095069|NCT01882465|589058595|FG002|Period 1|Lens Discomfort|0|||
163095070|NCT01882465|589058596|FG003|Period 1|Lens Discomfort|1|||
163095071|NCT01882465|589058597|FG004|Period 1|Lens Discomfort|0|||
163095072|NCT01882465|589058598|FG005|Period 1|Lens Discomfort|0|||
163095073|NCT01882465|589058599|FG006|Period 1|Lens Discomfort|0|||
163095074|NCT01882465|589058593|FG000|Period 1|Withdrawal by Subject|0|||
163095075|NCT01882465|589058594|FG001|Period 1|Withdrawal by Subject|0|||
163095076|NCT01882465|589058595|FG002|Period 1|Withdrawal by Subject|0|||
163095077|NCT01882465|589058596|FG003|Period 1|Withdrawal by Subject|0|||
163095078|NCT01882465|589058597|FG004|Period 1|Withdrawal by Subject|0|||
163095079|NCT01882465|589058598|FG005|Period 1|Withdrawal by Subject|0|||
163095080|NCT01882465|589058599|FG006|Period 1|Withdrawal by Subject|1|||
163095081|NCT01882465|589058593|FG000|Period 2|Protocol Violation|0|||
163095082|NCT01882465|589058594|FG001|Period 2|Protocol Violation|0|||
163095083|NCT01882465|589058595|FG002|Period 2|Protocol Violation|0|||
163095084|NCT01882465|589058596|FG003|Period 2|Protocol Violation|0|||
163095085|NCT01882465|589058597|FG004|Period 2|Protocol Violation|1|||
163095086|NCT01882465|589058598|FG005|Period 2|Protocol Violation|0|||
163095087|NCT01882465|589058599|FG006|Period 2|Protocol Violation|0|||
163095088|NCT00800982|589058602|FG000|Overall Study|Lost to Follow-up|1|||
163095089|NCT00800982|589058603|FG001|Overall Study|Lost to Follow-up|2|||
163095090|NCT00800982|589058602|FG000|Overall Study|Withdrawal by Subject|0|||
163095091|NCT00800982|589058603|FG001|Overall Study|Withdrawal by Subject|1|||
163095092|NCT00800982|589058602|FG000|Overall Study|Patient moved out of state|1|||
163095093|NCT00800982|589058603|FG001|Overall Study|Patient moved out of state|0|||
163095094|NCT01824290|589058604|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
163095095|NCT01824290|589058605|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
163095096|NCT01824290|589058606|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
163095097|NCT01824290|589058607|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
163095098|NCT01824290|589058604|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
163095099|NCT01824290|589058605|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
163338344|NCT03659136|589947464|FG001|Overall Study|Covid-19 related|1|||
163338345|NCT03659136|589947463|FG000|Overall Study|Withdrawal by Subject|1|||
163338346|NCT03659136|589947464|FG001|Overall Study|Withdrawal by Subject|6|||
163338347|NCT03659136|589947463|FG000|Overall Study|Adverse Event|4|||
163338348|NCT03659136|589947464|FG001|Overall Study|Adverse Event|6|||
163338349|NCT03659136|589947463|FG000|Overall Study|Progressive disease|37|||
163338350|NCT03659136|589947464|FG001|Overall Study|Progressive disease|31|||
163338351|NCT03659136|589947463|FG000|Overall Study|Study closure|2|||
163338352|NCT03659136|589947464|FG001|Overall Study|Study closure|2|||
163338353|NCT03659136|589947463|FG000|Overall Study|Sponsor decision/recommendation|3|||
163338354|NCT03659136|589947464|FG001|Overall Study|Sponsor decision/recommendation|2|||
163338355|NCT03659136|589947463|FG000|Overall Study|Switched to other drug/therapy|2|||
163338356|NCT03659136|589947464|FG001|Overall Study|Switched to other drug/therapy|2|||
163338357|NCT03659136|589947463|FG000|Overall Study|Lack of clinical benefit|0|||
163338358|NCT03659136|589947464|FG001|Overall Study|Lack of clinical benefit|1|||
163338359|NCT05066230|589948889|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
163338360|NCT05066230|589948890|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
163338361|NCT05066230|589948889|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
163338362|NCT05066230|589948890|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
163338363|NCT05066230|589948889|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
163338364|NCT05066230|589948890|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
163338365|NCT05066230|589948889|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
163338366|NCT05066230|589948890|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
163338367|NCT05066230|589948889|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
163338368|NCT05066230|589948890|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
163338369|NCT05066230|589948889|FG000|After Week 48|Adverse Event|1|||
163338370|NCT05066230|589948890|FG001|After Week 48|Adverse Event|0|||
163338371|NCT05066230|589948889|FG000|After Week 48|Non-compliance with study schedule|1|||
163338372|NCT05066230|589948890|FG001|After Week 48|Non-compliance with study schedule|0|||
163338373|NCT05066230|589948889|FG000|After Week 48|Withdrawal by Subject|0|||
163338374|NCT05066230|589948890|FG001|After Week 48|Withdrawal by Subject|1|||
163338375|NCT05066230|589948889|FG000|After Week 48|Lost to Follow-up|3|||
163338376|NCT05066230|589948890|FG001|After Week 48|Lost to Follow-up|3|||
163338377|NCT05066230|589948889|FG000|After Week 48|Sponsor Request|115|||
163338378|NCT05066230|589948890|FG001|After Week 48|Sponsor Request|111|||
163338379|NCT00307489|589948891|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
163338380|NCT00307489|589948892|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
163338381|NCT00307489|589948891|FG000|Baseline Through Week 48|Physician Decision|1|||
163338382|NCT00307489|589948892|FG001|Baseline Through Week 48|Physician Decision|0|||
163338383|NCT00307489|589948891|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
163338384|NCT00307489|589948892|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
163338385|NCT00307489|589948891|FG000|Week 48 Through Week 168|Adverse Event|1|||
163338386|NCT00307489|589948892|FG001|Week 48 Through Week 168|Adverse Event|0|||
163338387|NCT00307489|589948891|FG000|Week 48 Through Week 168|Physician Decision|1|||
163095100|NCT01824290|589058606|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
163095101|NCT01824290|589058607|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
163095102|NCT01824290|589058604|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
163095103|NCT01824290|589058605|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
163095104|NCT01824290|589058606|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
163095105|NCT01824290|589058607|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
163095106|NCT01824290|589058604|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
163095107|NCT01824290|589058605|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
163095108|NCT01824290|589058606|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
163095109|NCT01824290|589058607|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
163095110|NCT01824290|589058604|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
163338388|NCT00307489|589948892|FG001|Week 48 Through Week 168|Physician Decision|0|||
163338389|NCT00307489|589948891|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
163338390|NCT00307489|589948892|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
163338391|NCT00307489|589948891|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
163338392|NCT00307489|589948892|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
163338393|NCT00307489|589948891|FG000|Week 48 Through Week 168|Death|0|||
163338394|NCT00307489|589948892|FG001|Week 48 Through Week 168|Death|1|||
163338395|NCT00307489|589948891|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
163095111|NCT01824290|589058605|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
163095112|NCT01824290|589058606|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
163095113|NCT01824290|589058607|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
163338396|NCT00307489|589948892|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
163338397|NCT00307489|589948891|FG000|Week 48 Through Week 168|Seroconversion|1|||
163095114|NCT01824290|589058604|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
163095115|NCT01824290|589058605|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
163338398|NCT00307489|589948892|FG001|Week 48 Through Week 168|Seroconversion|0|||
163095116|NCT01824290|589058606|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
163095117|NCT01824290|589058607|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
163095118|NCT01490918|589058608|FG000|Overall Study|Lost to Follow-up|2|||
163095119|NCT01490918|589058609|FG001|Overall Study|Lost to Follow-up|1|||
163095120|NCT01490918|589058610|FG002|Overall Study|Lost to Follow-up|0|||
163095121|NCT01490918|589058608|FG000|Overall Study|Withdrawal by Subject|7|||
163095122|NCT01490918|589058609|FG001|Overall Study|Withdrawal by Subject|8|||
163095123|NCT01490918|589058610|FG002|Overall Study|Withdrawal by Subject|3|||
163095124|NCT01490918|589058608|FG000|Overall Study|Adverse Event|0|||
163095125|NCT01490918|589058609|FG001|Overall Study|Adverse Event|0|||
163095126|NCT01490918|589058610|FG002|Overall Study|Adverse Event|1|||
163095127|NCT01490918|589058608|FG000|Overall Study|other cause|4|||
163095128|NCT01490918|589058609|FG001|Overall Study|other cause|5|||
163095129|NCT01490918|589058610|FG002|Overall Study|other cause|8|||
163095130|NCT00003631|589058624|FG000|Overall Study|Patient not treated|1|||
163095131|NCT00003631|589058625|FG001|Overall Study|Patient not treated|0|||
163095132|NCT00003631|589058626|FG002|Overall Study|Patient not treated|1|||
163095133|NCT00003631|589058624|FG000|Overall Study|Protocol Violation|1|||
163095134|NCT00003631|589058625|FG001|Overall Study|Protocol Violation|0|||
163095135|NCT00003631|589058626|FG002|Overall Study|Protocol Violation|0|||
163095136|NCT00003631|589058624|FG000|Overall Study|Adverse Event|1|||
163095137|NCT00003631|589058625|FG001|Overall Study|Adverse Event|1|||
163095138|NCT00003631|589058626|FG002|Overall Study|Adverse Event|5|||
163095139|NCT00003631|589058624|FG000|Overall Study|Death|0|||
163095140|NCT00003631|589058625|FG001|Overall Study|Death|0|||
163095141|NCT00003631|589058626|FG002|Overall Study|Death|1|||
163095142|NCT00003631|589058624|FG000|Overall Study|Evaluable for toxicity only|0|||
163095143|NCT00003631|589058625|FG001|Overall Study|Evaluable for toxicity only|0|||
163095144|NCT00003631|589058626|FG002|Overall Study|Evaluable for toxicity only|2|||
163095145|NCT00806260|589058636|FG000|Period 1 (1 Day)|Adverse Event|0|||
163095146|NCT00806260|589058637|FG001|Period 1 (1 Day)|Adverse Event|0|||
163095147|NCT00806260|589058638|FG002|Period 1 (1 Day)|Adverse Event|0|||
163095148|NCT00806260|589058639|FG003|Period 1 (1 Day)|Adverse Event|0|||
163338399|NCT04425252|589948893|FG000|Overall Study|Withdrawal by Subject|2|||
163338400|NCT04425252|589948894|FG001|Overall Study|Withdrawal by Subject|1|||
163338401|NCT04425252|589948893|FG000|Overall Study|Lost to Follow-up|1|||
163338402|NCT04425252|589948894|FG001|Overall Study|Lost to Follow-up|0|||
163338403|NCT04425252|589948893|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
163338404|NCT04425252|589948894|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
163095149|NCT00806260|589058640|FG004|Period 1 (1 Day)|Adverse Event|3|||
163095150|NCT00806260|589058641|FG005|Period 1 (1 Day)|Adverse Event|0|||
163095151|NCT00806260|589058636|FG000|Period 2|Adverse Event|0|||
163095152|NCT00806260|589058637|FG001|Period 2|Adverse Event|0|||
163095153|NCT00806260|589058638|FG002|Period 2|Adverse Event|0|||
163095154|NCT00806260|589058639|FG003|Period 2|Adverse Event|1|||
163095155|NCT00806260|589058640|FG004|Period 2|Adverse Event|0|||
163095156|NCT00806260|589058641|FG005|Period 2|Adverse Event|0|||
163095157|NCT00806260|589058636|FG000|Period 2|Protocol Violation|1|||
163095158|NCT00806260|589058637|FG001|Period 2|Protocol Violation|0|||
163095159|NCT00806260|589058638|FG002|Period 2|Protocol Violation|1|||
163095160|NCT00806260|589058639|FG003|Period 2|Protocol Violation|0|||
163095161|NCT00806260|589058640|FG004|Period 2|Protocol Violation|0|||
163095162|NCT00806260|589058641|FG005|Period 2|Protocol Violation|0|||
163095163|NCT00806260|589058636|FG000|Period 2|Need to take concomitant medication|1|||
163095164|NCT00806260|589058637|FG001|Period 2|Need to take concomitant medication|0|||
163095165|NCT00806260|589058638|FG002|Period 2|Need to take concomitant medication|0|||
163095166|NCT00806260|589058639|FG003|Period 2|Need to take concomitant medication|0|||
163095167|NCT00806260|589058640|FG004|Period 2|Need to take concomitant medication|0|||
163095168|NCT00806260|589058641|FG005|Period 2|Need to take concomitant medication|0|||
163095169|NCT00806260|589058636|FG000|Period 2|sponsor request|0|||
163095170|NCT00806260|589058637|FG001|Period 2|sponsor request|0|||
163095171|NCT00806260|589058638|FG002|Period 2|sponsor request|1|||
163095172|NCT00806260|589058639|FG003|Period 2|sponsor request|1|||
163095173|NCT00806260|589058640|FG004|Period 2|sponsor request|0|||
163095174|NCT00806260|589058641|FG005|Period 2|sponsor request|0|||
163095175|NCT00806260|589058636|FG000|Period 3|Protocol Violation|0|||
163095176|NCT00806260|589058637|FG001|Period 3|Protocol Violation|1|||
163095177|NCT00806260|589058638|FG002|Period 3|Protocol Violation|1|||
163095178|NCT00806260|589058639|FG003|Period 3|Protocol Violation|0|||
163095179|NCT00806260|589058640|FG004|Period 3|Protocol Violation|0|||
163095180|NCT00806260|589058641|FG005|Period 3|Protocol Violation|0|||
163095181|NCT00806260|589058636|FG000|Period 3|Pregnancy|1|||
163095182|NCT00806260|589058637|FG001|Period 3|Pregnancy|0|||
163095183|NCT00806260|589058638|FG002|Period 3|Pregnancy|0|||
163095184|NCT00806260|589058639|FG003|Period 3|Pregnancy|0|||
163095185|NCT00806260|589058640|FG004|Period 3|Pregnancy|0|||
163095186|NCT00806260|589058641|FG005|Period 3|Pregnancy|0|||
163095187|NCT00953706|589058645|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
163095188|NCT00953706|589058646|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
163338405|NCT02981953|589948895|FG000|Overall Study|Death|9|||
163338406|NCT02981953|589948895|FG000|Overall Study|Withdrawal by Subject|1|||
163338407|NCT02981953|589948895|FG000|Overall Study|Withdrawal to non-compliance|1|||
163338408|NCT02165202|589948900|FG000|Oral Phase|Refused further participation|5|||
163338409|NCT02165202|589948901|FG001|Oral Phase|Refused further participation|1|||
163338410|NCT02165202|589948900|FG000|Oral Phase|Study product Related Toxicity|1|||
163338411|NCT02165202|589948901|FG001|Oral Phase|Study product Related Toxicity|0|||
163338412|NCT02165202|589948900|FG000|Oral Phase|Unable to contact Participant|1|||
163338413|NCT02165202|589948901|FG001|Oral Phase|Unable to contact Participant|1|||
163338414|NCT02165202|589948900|FG000|Oral Phase|Clinical reasons|1|||
163338415|NCT02165202|589948901|FG001|Oral Phase|Clinical reasons|0|||
163338416|NCT02165202|589948900|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
163338417|NCT02165202|589948901|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
163338418|NCT02165202|589948900|FG000|Oral Phase|CMC advised termination|1|||
163338419|NCT02165202|589948901|FG001|Oral Phase|CMC advised termination|0|||
163338420|NCT02165202|589948900|FG000|Oral Phase|Relocated, no follow-up planned|1|||
163338421|NCT02165202|589948901|FG001|Oral Phase|Relocated, no follow-up planned|0|||
163338422|NCT02165202|589948900|FG000|Oral Phase|Abnormal EKG|0|||
163338423|NCT02165202|589948901|FG001|Oral Phase|Abnormal EKG|1|||
163338424|NCT02165202|589948900|FG000|Injection Phase|Abnormal Lab Value|5|||
163338425|NCT02165202|589948901|FG001|Injection Phase|Abnormal Lab Value|1|||
163338426|NCT02165202|589948900|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
163338427|NCT02165202|589948901|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
163338428|NCT02165202|589948900|FG000|Injection Phase|Unable to attend within Visit Window|1|||
163338429|NCT02165202|589948901|FG001|Injection Phase|Unable to attend within Visit Window|0|||
163338430|NCT02165202|589948900|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
163338431|NCT02165202|589948901|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
163338432|NCT02165202|589948900|FG000|Injection Phase|End of Study|2|||
163338433|NCT02165202|589948901|FG001|Injection Phase|End of Study|1|||
163338434|NCT02165202|589948900|FG000|Injection Phase|Study Product related Toxicity|1|||
163338435|NCT02165202|589948901|FG001|Injection Phase|Study Product related Toxicity|0|||
163338436|NCT02165202|589948900|FG000|Injection Phase|No longer interested|0|||
163338437|NCT02165202|589948901|FG001|Injection Phase|No longer interested|1|||
163338438|NCT02165202|589948900|FG000|Injection Phase|Participant unwilling to comply|1|||
163338439|NCT02165202|589948901|FG001|Injection Phase|Participant unwilling to comply|0|||
163338440|NCT04328467|589948907|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
163338441|NCT04328467|589948908|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
163338442|NCT04328467|589948909|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
163338443|NCT00990184|589948910|FG000|Overall Study|Physician Decision|1|||
163338444|NCT01655498|589948911|FG000|Overall Study|Unrelated health issue|2|||
163338445|NCT01655498|589948911|FG000|Overall Study|Protocol Violation|2|||
163338446|NCT01655498|589948911|FG000|Overall Study|Withdrawal by Subject|1|||
163338447|NCT01714947|589948914|FG000|Part B|Progressive Disease|3|||
163338448|NCT01345253|589948918|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
163338449|NCT01345253|589948919|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
163338450|NCT01345253|589948918|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
163338451|NCT01345253|589948919|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
163338452|NCT01345253|589948918|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
163338453|NCT01345253|589948919|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
163338454|NCT01345253|589948918|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
163338455|NCT01345253|589948919|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
163338456|NCT01345253|589948918|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
163338457|NCT01345253|589948919|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
163338458|NCT01345253|589948918|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
163338459|NCT01345253|589948919|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
163338460|NCT01345253|589948918|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
163095189|NCT00953706|589058647|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
163095190|NCT00953706|589058648|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
163095191|NCT00953706|589058645|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
163338461|NCT01345253|589948919|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
163338462|NCT01345253|589948918|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
163338463|NCT01345253|589948919|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
163338464|NCT01345253|589948918|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
163338465|NCT01345253|589948919|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
163338466|NCT01345253|589948918|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
163338467|NCT01345253|589948919|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
163338468|NCT01345253|589948918|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
163338469|NCT01345253|589948919|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
163338470|NCT01345253|589948918|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
163095192|NCT00953706|589058646|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
163095193|NCT00953706|589058647|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
163095194|NCT00953706|589058648|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
163095195|NCT00953706|589058645|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
163095196|NCT00953706|589058646|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
163095197|NCT00953706|589058647|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
163095198|NCT00953706|589058648|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
163095199|NCT00953706|589058645|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
163095200|NCT00953706|589058646|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
163095201|NCT00953706|589058647|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
163095202|NCT00953706|589058648|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
163095203|NCT00953706|589058645|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
163095204|NCT00953706|589058646|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
163095205|NCT00953706|589058647|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
163095206|NCT00953706|589058648|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
163095207|NCT00953706|589058645|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
163095208|NCT00953706|589058646|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
163095209|NCT00953706|589058647|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
163095210|NCT00953706|589058648|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
163095211|NCT00953706|589058645|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
163095212|NCT00953706|589058646|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
163095213|NCT00953706|589058647|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
163095214|NCT00953706|589058648|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
163095215|NCT00953706|589058645|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
163095216|NCT00953706|589058646|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
163095217|NCT00953706|589058647|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
163095218|NCT00953706|589058648|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
163095219|NCT00953706|589058645|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
163095220|NCT00953706|589058646|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
163095221|NCT00953706|589058647|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
163095222|NCT00953706|589058648|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
163095223|NCT00953706|589058645|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
163095224|NCT00953706|589058646|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
163095225|NCT00953706|589058647|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
163095226|NCT00953706|589058648|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
163095227|NCT00953706|589058645|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
163095228|NCT00953706|589058646|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
163095229|NCT00953706|589058647|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
163095230|NCT00953706|589058648|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
163095231|NCT02670473|589058649|FG000|Overall Study|Withdrawal by Subject|1|||
163095232|NCT01404234|589058650|FG000|Overall Study|Withdrawal by Subject|2|||
163095233|NCT01214837|589058651|FG000|Overall Study|Death|0|||
163095234|NCT01214837|589058652|FG001|Overall Study|Death|0|||
163095235|NCT01214837|589058653|FG002|Overall Study|Death|1|||
163095236|NCT01214837|589058651|FG000|Overall Study|Adverse Event|1|||
163095237|NCT01214837|589058652|FG001|Overall Study|Adverse Event|2|||
163095238|NCT01214837|589058653|FG002|Overall Study|Adverse Event|1|||
163095239|NCT01214837|589058651|FG000|Overall Study|Withdrawal by Subject|27|||
163095240|NCT01214837|589058652|FG001|Overall Study|Withdrawal by Subject|36|||
163095241|NCT01214837|589058653|FG002|Overall Study|Withdrawal by Subject|28|||
163095242|NCT01214837|589058651|FG000|Overall Study|Lost to Follow-up|20|||
163095243|NCT01214837|589058652|FG001|Overall Study|Lost to Follow-up|15|||
163095244|NCT01214837|589058653|FG002|Overall Study|Lost to Follow-up|21|||
163095245|NCT01214837|589058651|FG000|Overall Study|Inappropriate Enrolment|0|||
163095246|NCT01214837|589058652|FG001|Overall Study|Inappropriate Enrolment|1|||
163095247|NCT01214837|589058653|FG002|Overall Study|Inappropriate Enrolment|2|||
163095248|NCT01214837|589058651|FG000|Overall Study|Administrative Reason|2|||
163095249|NCT01214837|589058652|FG001|Overall Study|Administrative Reason|6|||
163095250|NCT01214837|589058653|FG002|Overall Study|Administrative Reason|4|||
163095251|NCT01214837|589058651|FG000|Overall Study|Protocol Violation|3|||
163095252|NCT01214837|589058652|FG001|Overall Study|Protocol Violation|1|||
163095253|NCT01214837|589058653|FG002|Overall Study|Protocol Violation|5|||
163095254|NCT01214837|589058651|FG000|Overall Study|Unable to Classify|1|||
163095255|NCT01214837|589058652|FG001|Overall Study|Unable to Classify|3|||
163095256|NCT01214837|589058653|FG002|Overall Study|Unable to Classify|0|||
163095257|NCT05414175|589058654|FG000|Overall Study|Withdrawal by Subject|1|||
163095258|NCT05414175|589058654|FG000|Overall Study|Other Reasons|1|||
163095259|NCT00027560|589058657|FG000|Overall Study|Withdrawal by Subject|1|||
163095260|NCT03559270|589058661|FG000|Overall Study|Adverse Event|6|||
163095261|NCT03559270|589058662|FG001|Overall Study|Adverse Event|5|||
163095262|NCT03559270|589058663|FG002|Overall Study|Adverse Event|3|||
163095263|NCT03559270|589058664|FG003|Overall Study|Adverse Event|0|||
163095264|NCT03559270|589058661|FG000|Overall Study|Lack of Efficacy|34|||
163095265|NCT03559270|589058662|FG001|Overall Study|Lack of Efficacy|52|||
163095266|NCT03559270|589058663|FG002|Overall Study|Lack of Efficacy|37|||
163095267|NCT03559270|589058664|FG003|Overall Study|Lack of Efficacy|2|||
163095268|NCT03559270|589058661|FG000|Overall Study|Death|0|||
163095269|NCT03559270|589058662|FG001|Overall Study|Death|2|||
163095270|NCT03559270|589058663|FG002|Overall Study|Death|0|||
163095271|NCT03559270|589058664|FG003|Overall Study|Death|0|||
163095272|NCT03559270|589058661|FG000|Overall Study|Lost to Follow-up|16|||
163095273|NCT03559270|589058662|FG001|Overall Study|Lost to Follow-up|4|||
163095274|NCT03559270|589058663|FG002|Overall Study|Lost to Follow-up|12|||
163095275|NCT03559270|589058664|FG003|Overall Study|Lost to Follow-up|3|||
163095276|NCT03559270|589058661|FG000|Overall Study|Sponsor Decision|38|||
163095277|NCT03559270|589058662|FG001|Overall Study|Sponsor Decision|31|||
163095278|NCT03559270|589058663|FG002|Overall Study|Sponsor Decision|35|||
163095279|NCT03559270|589058664|FG003|Overall Study|Sponsor Decision|18|||
163095280|NCT03559270|589058661|FG000|Overall Study|Withdrawal by Subject|19|||
163095281|NCT03559270|589058662|FG001|Overall Study|Withdrawal by Subject|21|||
163095282|NCT03559270|589058663|FG002|Overall Study|Withdrawal by Subject|18|||
163095283|NCT03559270|589058664|FG003|Overall Study|Withdrawal by Subject|7|||
163095284|NCT03559270|589058661|FG000|Overall Study|Physician Decision|3|||
163095285|NCT03559270|589058662|FG001|Overall Study|Physician Decision|2|||
163095286|NCT03559270|589058663|FG002|Overall Study|Physician Decision|1|||
163095287|NCT03559270|589058664|FG003|Overall Study|Physician Decision|0|||
163095288|NCT03559270|589058661|FG000|Overall Study|Pregnancy|0|||
163095289|NCT03559270|589058662|FG001|Overall Study|Pregnancy|1|||
163095290|NCT03559270|589058663|FG002|Overall Study|Pregnancy|0|||
163095291|NCT03559270|589058664|FG003|Overall Study|Pregnancy|0|||
163095292|NCT03559270|589058661|FG000|Overall Study|Protocol Violation|1|||
163095293|NCT03559270|589058662|FG001|Overall Study|Protocol Violation|0|||
163095294|NCT03559270|589058663|FG002|Overall Study|Protocol Violation|2|||
163095295|NCT03559270|589058664|FG003|Overall Study|Protocol Violation|0|||
163095296|NCT04776161|589060058|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
163095297|NCT04776161|589060059|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
163095298|NCT04776161|589060060|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
163095299|NCT04776161|589060058|FG000|Overall Study|Withdrawal by Subject|1|||
163095300|NCT04776161|589060059|FG001|Overall Study|Withdrawal by Subject|0|||
163095301|NCT04776161|589060060|FG002|Overall Study|Withdrawal by Subject|1|||
163095302|NCT04776161|589060058|FG000|Overall Study|Adverse Event|0|||
163095303|NCT04776161|589060059|FG001|Overall Study|Adverse Event|1|||
163095304|NCT04776161|589060060|FG002|Overall Study|Adverse Event|1|||
163095305|NCT04567524|589060065|FG000|Overall Study|Adverse Event|1|||
163095306|NCT04567524|589060066|FG001|Overall Study|Adverse Event|1|||
163095307|NCT04567524|589060067|FG002|Overall Study|Adverse Event|0|||
163095308|NCT04567524|589060068|FG003|Overall Study|Adverse Event|0|||
163095309|NCT04567524|589060065|FG000|Overall Study|Withdrawal by Subject|2|||
163095310|NCT04567524|589060066|FG001|Overall Study|Withdrawal by Subject|0|||
163095311|NCT04567524|589060067|FG002|Overall Study|Withdrawal by Subject|0|||
163095312|NCT04567524|589060068|FG003|Overall Study|Withdrawal by Subject|1|||
163095313|NCT02848092|589060069|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
163095314|NCT02848092|589060070|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
163095315|NCT02848092|589060069|FG000|1-month Post-training Follow-up|Adverse Event|2|||
163095316|NCT02848092|589060070|FG001|1-month Post-training Follow-up|Adverse Event|1|||
163095317|NCT02848092|589060069|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
163095318|NCT02848092|589060070|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
163095319|NCT02848092|589060069|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
163095320|NCT02848092|589060070|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
163095321|NCT02848092|589060069|FG000|1-month Post-training Follow-up|fatigue|0|||
163095322|NCT02848092|589060070|FG001|1-month Post-training Follow-up|fatigue|1|||
163095323|NCT02848092|589060069|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
163095324|NCT02848092|589060070|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
163095325|NCT02848092|589060069|FG000|6-month Post-training Follow-up|Adverse Event|1|||
163095326|NCT02848092|589060070|FG001|6-month Post-training Follow-up|Adverse Event|1|||
163095327|NCT02848092|589060069|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
163095328|NCT02848092|589060070|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
163095329|NCT02848092|589060069|FG000|6-month Post-training Follow-up|frustrated with task|1|||
163095330|NCT02848092|589060070|FG001|6-month Post-training Follow-up|frustrated with task|0|||
163095331|NCT02848092|589060069|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
163095332|NCT02848092|589060070|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
163095333|NCT02848092|589060069|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
163095334|NCT02848092|589060070|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
163095335|NCT01147393|589060076|FG000|Dose Level 1|Dose limiting Toxicity|2|||
163338471|NCT01345253|589948919|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
163338472|NCT01345253|589948918|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
163338473|NCT01345253|589948919|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
163338474|NCT01345253|589948918|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
163338475|NCT01345253|589948919|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
163338476|NCT01345253|589948918|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
163338477|NCT01345253|589948919|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
163338478|NCT00759681|589948920|FG000|Overall Study|Death|2|||
163338479|NCT00759681|589948921|FG001|Overall Study|Death|5|||
163338480|NCT00759681|589948920|FG000|Overall Study|Lost to Follow-up|8|||
163338481|NCT00759681|589948921|FG001|Overall Study|Lost to Follow-up|5|||
163338482|NCT00930644|589948922|FG000|Overall Study|Withdrawal by Subject|4|||
163338483|NCT00930644|589948922|FG000|Overall Study|Physician Decision|2|||
163338484|NCT00930644|589948922|FG000|Overall Study|Death|1|||
163338485|NCT00930644|589948922|FG000|Overall Study|Adverse Event|16|||
163338486|NCT01012999|589948923|FG000|Overall Study|Protocol Violation|1|||
163338487|NCT02410278|589948924|FG000|Run-in Period|Adverse Event|5|||
163095336|NCT01147393|589060076|FG000|Dose Level -1|Dose Limited Toxicity|1|||
163095337|NCT03432494|589060079|FG000|Overall Study|Death|1|||
163095338|NCT03432494|589060079|FG000|Overall Study|Noncompliance|1|||
163095339|NCT00825994|589060080|FG000|Overall Study|Withdrawal by Subject|2|||
163095340|NCT00825994|589060080|FG000|Overall Study|Lost to Follow-up|1|||
163095341|NCT00825994|589060080|FG000|Overall Study|Protocol Violation|1|||
163095342|NCT00825994|589060080|FG000|Overall Study|Placebo Responder at V2|1|||
163095343|NCT01833494|589060082|FG000|Overall Study|Adverse Event|24|||
163095344|NCT01833494|589060082|FG000|Overall Study|Physician Decision|6|||
163095345|NCT01833494|589060082|FG000|Overall Study|Withdrawal by Subject|6|||
163095346|NCT01833494|589060082|FG000|Overall Study|Decrease in serum phosphorus|4|||
163095347|NCT01833494|589060082|FG000|Overall Study|Decrease in serum calcium|4|||
163095348|NCT01833494|589060082|FG000|Overall Study|Increase in serum ferritin|1|||
163095349|NCT04011735|589060091|FG000|Overall Study|Withdrawal by Subject|1|||
163095350|NCT04011735|589060092|FG001|Overall Study|Withdrawal by Subject|0|||
163095351|NCT04011735|589060093|FG002|Overall Study|Withdrawal by Subject|1|||
163095352|NCT04011735|589060091|FG000|Overall Study|Met exclusion criteria after study entry|0|||
163095353|NCT04011735|589060092|FG001|Overall Study|Met exclusion criteria after study entry|1|||
163095354|NCT04011735|589060093|FG002|Overall Study|Met exclusion criteria after study entry|0|||
163095355|NCT02831855|589060094|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
163095356|NCT02831855|589060095|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
163095357|NCT02831855|589060096|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
163095358|NCT02831855|589060094|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
163095359|NCT02831855|589060095|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
163095360|NCT02831855|589060096|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
163095361|NCT02831855|589060094|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
163095362|NCT02831855|589060095|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
163095363|NCT02831855|589060096|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
163095364|NCT02831855|589060094|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
163095365|NCT02831855|589060095|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
163095366|NCT02831855|589060096|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
163095367|NCT02831855|589060094|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
163095368|NCT02831855|589060095|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
163095369|NCT02831855|589060096|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
163095370|NCT02831855|589060094|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
163095371|NCT02831855|589060095|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
163095372|NCT02831855|589060096|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
163095373|NCT02831855|589060094|FG000|Open Label Phase (24 Weeks)|Other|4|||
163095374|NCT02831855|589060095|FG001|Open Label Phase (24 Weeks)|Other|0|||
163095375|NCT02831855|589060096|FG002|Open Label Phase (24 Weeks)|Other|0|||
163095376|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
163095377|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
163095378|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
163095379|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Death|0|||
163095380|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Death|0|||
163095381|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Death|2|||
163095382|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
163095383|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
163095384|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
163095385|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
163095386|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
163095387|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
163095388|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
163095389|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
163338488|NCT02410278|589948925|FG001|Run-in Period|Adverse Event|0|||
163338489|NCT02410278|589948926|FG002|Run-in Period|Adverse Event|0|||
163338490|NCT02410278|589948924|FG000|Run-in Period|GSRS Threshold Not Met|30|||
163338491|NCT02410278|589948925|FG001|Run-in Period|GSRS Threshold Not Met|0|||
163338492|NCT02410278|589948926|FG002|Run-in Period|GSRS Threshold Not Met|0|||
163338493|NCT02410278|589948924|FG000|Run-in Period|Lost to Follow-up|1|||
163338494|NCT02410278|589948925|FG001|Run-in Period|Lost to Follow-up|0|||
163338495|NCT02410278|589948926|FG002|Run-in Period|Lost to Follow-up|0|||
163338496|NCT02410278|589948924|FG000|Run-in Period|Withdrawal by Subject|1|||
163338497|NCT02410278|589948925|FG001|Run-in Period|Withdrawal by Subject|0|||
163338498|NCT02410278|589948926|FG002|Run-in Period|Withdrawal by Subject|0|||
163338499|NCT02410278|589948924|FG000|Run-in Period|Pregnancy|1|||
163338500|NCT02410278|589948925|FG001|Run-in Period|Pregnancy|0|||
163338501|NCT02410278|589948926|FG002|Run-in Period|Pregnancy|0|||
163338502|NCT02410278|589948924|FG000|Study Treatment Period|Adverse Event|0|||
163338503|NCT02410278|589948925|FG001|Study Treatment Period|Adverse Event|6|||
163338504|NCT02410278|589948926|FG002|Study Treatment Period|Adverse Event|3|||
163338505|NCT02410278|589948924|FG000|Study Treatment Period|Physician Decision|0|||
163338506|NCT02410278|589948925|FG001|Study Treatment Period|Physician Decision|0|||
163338507|NCT02410278|589948926|FG002|Study Treatment Period|Physician Decision|1|||
163338508|NCT02410278|589948924|FG000|Study Treatment Period|Withdrawal by Subject|0|||
163338509|NCT02410278|589948925|FG001|Study Treatment Period|Withdrawal by Subject|1|||
163338510|NCT02410278|589948926|FG002|Study Treatment Period|Withdrawal by Subject|0|||
163338511|NCT02410278|589948924|FG000|Study Treatment Period|Other|0|||
163338512|NCT02410278|589948925|FG001|Study Treatment Period|Other|3|||
163338513|NCT02410278|589948926|FG002|Study Treatment Period|Other|0|||
163338514|NCT02410278|589948924|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
163338515|NCT02410278|589948925|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
163338516|NCT02410278|589948926|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
163338517|NCT02584257|589948927|FG000|Period 1|Withdrawal by Subject|0|||
163338518|NCT02584257|589948928|FG001|Period 1|Withdrawal by Subject|0|||
163338519|NCT02584257|589948929|FG002|Period 1|Withdrawal by Subject|0|||
163338520|NCT02584257|589948930|FG003|Period 1|Withdrawal by Subject|0|||
163338521|NCT02584257|589948931|FG004|Period 1|Withdrawal by Subject|0|||
163338522|NCT02584257|589948932|FG005|Period 1|Withdrawal by Subject|0|||
163338523|NCT02584257|589948933|FG006|Period 1|Withdrawal by Subject|1|||
163338524|NCT02584257|589948934|FG007|Period 1|Withdrawal by Subject|0|||
163338525|NCT02584257|589948935|FG008|Period 1|Withdrawal by Subject|0|||
163338526|NCT02584257|589948927|FG000|Period 2|Physician Decision|1|||
163338527|NCT02584257|589948928|FG001|Period 2|Physician Decision|0|||
163095390|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
163095391|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Other|0|||
163095392|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Other|2|||
163095393|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Other|5|||
163095394|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
163095395|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
163095396|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
163095397|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
163095398|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
163095399|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
163338528|NCT02584257|589948929|FG002|Period 2|Physician Decision|0|||
163338529|NCT02584257|589948930|FG003|Period 2|Physician Decision|0|||
163338530|NCT02584257|589948931|FG004|Period 2|Physician Decision|0|||
163338531|NCT02584257|589948932|FG005|Period 2|Physician Decision|0|||
163338532|NCT02584257|589948933|FG006|Period 2|Physician Decision|0|||
163338533|NCT02584257|589948934|FG007|Period 2|Physician Decision|0|||
163338534|NCT02584257|589948935|FG008|Period 2|Physician Decision|0|||
163338535|NCT02584257|589948927|FG000|Period 2|Adverse Event|0|||
163338536|NCT02584257|589948928|FG001|Period 2|Adverse Event|1|||
163338537|NCT02584257|589948929|FG002|Period 2|Adverse Event|0|||
163095400|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
163095401|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
163095402|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
163095403|NCT01118780|589060098|FG000|Overall Study|Adverse Event|15|||
163095404|NCT01118780|589060099|FG001|Overall Study|Adverse Event|15|||
163095405|NCT01118780|589060098|FG000|Overall Study|Death|1|||
163338538|NCT02584257|589948930|FG003|Period 2|Adverse Event|0|||
163338539|NCT02584257|589948931|FG004|Period 2|Adverse Event|0|||
163338540|NCT02584257|589948932|FG005|Period 2|Adverse Event|0|||
163338541|NCT02584257|589948933|FG006|Period 2|Adverse Event|0|||
163338542|NCT02584257|589948934|FG007|Period 2|Adverse Event|0|||
163338543|NCT02584257|589948935|FG008|Period 2|Adverse Event|0|||
163338544|NCT01670877|589948936|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
163338545|NCT01670877|589948937|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
163338546|NCT01670877|589948938|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
163338547|NCT01670877|589948939|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
163338548|NCT01670877|589948940|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
163338549|NCT01670877|589948941|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
163338550|NCT01670877|589948936|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
163338551|NCT01670877|589948937|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
163338552|NCT01670877|589948938|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
163338553|NCT01670877|589948939|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
163338554|NCT01670877|589948940|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
163338555|NCT01670877|589948941|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
163338556|NCT01670877|589948936|FG000|Part I and Part 2|Grade 2 vomiting|0|||
163338557|NCT01670877|589948937|FG001|Part I and Part 2|Grade 2 vomiting|0|||
163338558|NCT01670877|589948938|FG002|Part I and Part 2|Grade 2 vomiting|0|||
163338559|NCT01670877|589948939|FG003|Part I and Part 2|Grade 2 vomiting|1|||
163338560|NCT01670877|589948940|FG004|Part I and Part 2|Grade 2 vomiting|0|||
163338561|NCT01670877|589948941|FG005|Part I and Part 2|Grade 2 vomiting|0|||
163338562|NCT01670877|589948936|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
163338563|NCT01670877|589948937|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
163338564|NCT01670877|589948938|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
163338565|NCT01670877|589948939|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
163338566|NCT01670877|589948940|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
163338567|NCT01670877|589948941|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
163338568|NCT01670877|589948936|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
163338569|NCT01670877|589948937|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
163338570|NCT01670877|589948938|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
163338571|NCT01670877|589948939|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
163338572|NCT01670877|589948940|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
163338573|NCT01670877|589948941|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
163338574|NCT00417885|589948942|FG000|Overall Study|Adverse Event|1|||
163338575|NCT00417885|589948942|FG000|Overall Study|Objective Progression or Relapse|3|||
163338576|NCT00417885|589948942|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
163338577|NCT02309892|589948943|FG000|Overall Study|Physician Decision|1|||
163338578|NCT02309892|589948944|FG001|Overall Study|Physician Decision|0|||
163338579|NCT02309892|589948945|FG002|Overall Study|Physician Decision|0|||
163338580|NCT02309892|589948946|FG003|Overall Study|Physician Decision|0|||
163338581|NCT02309892|589948947|FG004|Overall Study|Physician Decision|0|||
163095406|NCT01118780|589060099|FG001|Overall Study|Death|0|||
163095407|NCT01118780|589060098|FG000|Overall Study|Lack of Efficacy|2|||
163095408|NCT01118780|589060099|FG001|Overall Study|Lack of Efficacy|6|||
163095409|NCT01118780|589060098|FG000|Overall Study|Physician Decision|2|||
163095410|NCT01118780|589060099|FG001|Overall Study|Physician Decision|0|||
163095411|NCT01118780|589060098|FG000|Overall Study|Protocol Violation|3|||
163095412|NCT01118780|589060099|FG001|Overall Study|Protocol Violation|6|||
163095413|NCT01118780|589060098|FG000|Overall Study|Withdrawal by Subject|13|||
163095414|NCT01118780|589060099|FG001|Overall Study|Withdrawal by Subject|8|||
163095415|NCT03962855|589060100|FG000|Overall Study|Death|0|||
163095416|NCT03962855|589060101|FG001|Overall Study|Death|1|||
163095417|NCT03962855|589060100|FG000|Overall Study|Lost to Follow-up|0|||
163095418|NCT03962855|589060101|FG001|Overall Study|Lost to Follow-up|1|||
163095419|NCT03962855|589060100|FG000|Overall Study|Adverse Event|0|||
163095420|NCT03962855|589060101|FG001|Overall Study|Adverse Event|1|||
163095421|NCT03962855|589060100|FG000|Overall Study|Physician Decision|0|||
163095422|NCT03962855|589060101|FG001|Overall Study|Physician Decision|2|||
163095423|NCT03326063|589060102|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
163338582|NCT02309892|589948948|FG005|Overall Study|Physician Decision|0|||
163338583|NCT02309892|589948949|FG006|Overall Study|Physician Decision|0|||
163338584|NCT02309892|589948943|FG000|Overall Study|Adverse Event|1|||
163338585|NCT02309892|589948944|FG001|Overall Study|Adverse Event|0|||
163338586|NCT02309892|589948945|FG002|Overall Study|Adverse Event|1|||
163338587|NCT02309892|589948946|FG003|Overall Study|Adverse Event|0|||
163338588|NCT02309892|589948947|FG004|Overall Study|Adverse Event|0|||
163338589|NCT02309892|589948948|FG005|Overall Study|Adverse Event|0|||
163338590|NCT02309892|589948949|FG006|Overall Study|Adverse Event|0|||
163095424|NCT03326063|589060103|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
163095425|NCT02750514|589060104|FG000|Track 1|Disease progression|20|||
163095426|NCT02750514|589060105|FG001|Track 1|Disease progression|1|||
163095427|NCT02750514|589060106|FG002|Track 1|Disease progression|0|||
163338591|NCT02309892|589948943|FG000|Overall Study|Progressive Disease|0|||
163338592|NCT02309892|589948944|FG001|Overall Study|Progressive Disease|1|||
163338593|NCT02309892|589948945|FG002|Overall Study|Progressive Disease|0|||
163095428|NCT02750514|589060107|FG003|Track 1|Disease progression|1|||
163095429|NCT02750514|589060108|FG004|Track 1|Disease progression|0|||
163095430|NCT02750514|589060104|FG000|Track 1|Adverse event unrelated to study drug|1|||
163095431|NCT02750514|589060105|FG001|Track 1|Adverse event unrelated to study drug|0|||
163095432|NCT02750514|589060106|FG002|Track 1|Adverse event unrelated to study drug|0|||
163095433|NCT02750514|589060107|FG003|Track 1|Adverse event unrelated to study drug|0|||
163095434|NCT02750514|589060108|FG004|Track 1|Adverse event unrelated to study drug|0|||
163338594|NCT02309892|589948946|FG003|Overall Study|Progressive Disease|0|||
163338595|NCT02309892|589948947|FG004|Overall Study|Progressive Disease|1|||
163338596|NCT02309892|589948948|FG005|Overall Study|Progressive Disease|0|||
163338597|NCT02309892|589948949|FG006|Overall Study|Progressive Disease|0|||
163338598|NCT02309892|589948943|FG000|Overall Study|Death|0|||
163338599|NCT02309892|589948944|FG001|Overall Study|Death|0|||
163338600|NCT02309892|589948945|FG002|Overall Study|Death|0|||
163338601|NCT02309892|589948946|FG003|Overall Study|Death|0|||
163338602|NCT02309892|589948947|FG004|Overall Study|Death|0|||
163338603|NCT02309892|589948948|FG005|Overall Study|Death|1|||
163338604|NCT02309892|589948949|FG006|Overall Study|Death|0|||
163338605|NCT05376397|589948952|FG000|Overall Study|Lost to Follow-up|1|||
163338606|NCT01280721|589948955|FG000|Overall Study|Adverse Event|4|||
163338607|NCT01280721|589948955|FG000|Overall Study|Physician Decision|3|||
163338608|NCT01280721|589948955|FG000|Overall Study|Withdrawal by Subject|6|||
163338609|NCT01280721|589948955|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
163338610|NCT01280721|589948955|FG000|Overall Study|No tolerability for the lowest dose|2|||
163338611|NCT01180400|589948956|FG000|Overall Study|Withdrawal by Subject|5|||
163338612|NCT01180400|589948957|FG001|Overall Study|Withdrawal by Subject|6|||
163338613|NCT01180400|589948956|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163338614|NCT01180400|589948957|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
163338615|NCT01180400|589948956|FG000|Overall Study|Adverse Event|12|||
163338616|NCT01180400|589948957|FG001|Overall Study|Adverse Event|10|||
163338617|NCT01180400|589948956|FG000|Overall Study|Severe non-compliance to protocol|1|||
163338618|NCT01180400|589948957|FG001|Overall Study|Severe non-compliance to protocol|2|||
163338619|NCT01180400|589948956|FG000|Overall Study|Condition under investigation worsened|2|||
163338620|NCT01180400|589948957|FG001|Overall Study|Condition under investigation worsened|1|||
163338621|NCT01180400|589948956|FG000|Overall Study|Lack of Efficacy|2|||
163338622|NCT01180400|589948957|FG001|Overall Study|Lack of Efficacy|0|||
163338623|NCT01180400|589948956|FG000|Overall Study|Study-specific withdrawal criteria|1|||
163338624|NCT01180400|589948957|FG001|Overall Study|Study-specific withdrawal criteria|2|||
163338625|NCT01180400|589948956|FG000|Overall Study|Lost to Follow-up|2|||
163338626|NCT01180400|589948957|FG001|Overall Study|Lost to Follow-up|3|||
163338627|NCT01180400|589948956|FG000|Overall Study|Other|0|||
163338628|NCT01180400|589948957|FG001|Overall Study|Other|1|||
163338629|NCT00795639|589948958|FG000|Overall Study|Death|1|||
163338630|NCT00795639|589948959|FG001|Overall Study|Death|6|||
163338631|NCT00795639|589948958|FG000|Overall Study|Withdrawal by Subject|1|||
163338632|NCT00795639|589948959|FG001|Overall Study|Withdrawal by Subject|3|||
163338633|NCT00795639|589948958|FG000|Overall Study|Pregnancy|1|||
163338634|NCT00795639|589948959|FG001|Overall Study|Pregnancy|0|||
163338635|NCT00795639|589948958|FG000|Overall Study|Adverse Event|5|||
163338636|NCT00795639|589948959|FG001|Overall Study|Adverse Event|2|||
163338637|NCT00795639|589948958|FG000|Overall Study|Other|0|||
163338638|NCT00795639|589948959|FG001|Overall Study|Other|2|||
163338639|NCT00795639|589948958|FG000|Overall Study|Terminated by sponsor|13|||
163338640|NCT00795639|589948959|FG001|Overall Study|Terminated by sponsor|12|||
163338641|NCT00795639|589948958|FG000|Overall Study|Randomized and not treated|0|||
163095435|NCT02750514|589060104|FG000|Track 1|Study drug toxicity|4|||
163095436|NCT02750514|589060105|FG001|Track 1|Study drug toxicity|1|||
163095437|NCT02750514|589060106|FG002|Track 1|Study drug toxicity|0|||
163095438|NCT02750514|589060107|FG003|Track 1|Study drug toxicity|1|||
163095439|NCT02750514|589060108|FG004|Track 1|Study drug toxicity|0|||
163095440|NCT02750514|589060104|FG000|Track 1|Participant request to discontinue|1|||
163095441|NCT02750514|589060105|FG001|Track 1|Participant request to discontinue|0|||
163095442|NCT02750514|589060106|FG002|Track 1|Participant request to discontinue|0|||
163095443|NCT02750514|589060107|FG003|Track 1|Participant request to discontinue|0|||
163095444|NCT02750514|589060108|FG004|Track 1|Participant request to discontinue|0|||
163095445|NCT02750514|589060104|FG000|Track 1|Other reasons|1|||
163095446|NCT02750514|589060105|FG001|Track 1|Other reasons|0|||
163095447|NCT02750514|589060106|FG002|Track 1|Other reasons|0|||
163095448|NCT02750514|589060107|FG003|Track 1|Other reasons|0|||
163095449|NCT02750514|589060108|FG004|Track 1|Other reasons|0|||
163095450|NCT02750514|589060104|FG000|Track 2|Disease progression|4|||
163095451|NCT02750514|589060105|FG001|Track 2|Disease progression|5|||
163095452|NCT02750514|589060106|FG002|Track 2|Disease progression|2|||
163095453|NCT02750514|589060107|FG003|Track 2|Disease progression|5|||
163095454|NCT02750514|589060108|FG004|Track 2|Disease progression|0|||
163095455|NCT02750514|589060104|FG000|Track 2|Adverse event unrelated to study drug|1|||
163095456|NCT02750514|589060105|FG001|Track 2|Adverse event unrelated to study drug|0|||
163095457|NCT02750514|589060106|FG002|Track 2|Adverse event unrelated to study drug|0|||
163095458|NCT02750514|589060107|FG003|Track 2|Adverse event unrelated to study drug|0|||
163095459|NCT02750514|589060108|FG004|Track 2|Adverse event unrelated to study drug|0|||
163095460|NCT02750514|589060104|FG000|Track 2|Study drug toxicity|1|||
163338642|NCT00795639|589948959|FG001|Overall Study|Randomized and not treated|1|||
163338643|NCT00248794|589948960|FG000|Overall Study|Lost to Follow-up|6|||
163338644|NCT00248794|589948961|FG001|Overall Study|Lost to Follow-up|8|||
163338645|NCT00248794|589948962|FG002|Overall Study|Lost to Follow-up|3|||
163338646|NCT03449979|589948963|FG000|Overall Study|Technical difficulty|0|||
163338647|NCT03449979|589948964|FG001|Overall Study|Technical difficulty|0|||
163338648|NCT03449979|589948965|FG002|Overall Study|Technical difficulty|0|||
163338649|NCT03449979|589948966|FG003|Overall Study|Technical difficulty|1|||
163338650|NCT03444155|589948971|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
163338651|NCT03444155|589948972|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
163338652|NCT02877680|589948973|FG000|Overall Study|Lost to Follow-up|1|||
163338653|NCT02877680|589948974|FG001|Overall Study|Lost to Follow-up|1|||
163407635|NCT02706873|590200874|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
163407636|NCT02706873|590200871|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
163095461|NCT02750514|589060105|FG001|Track 2|Study drug toxicity|2|||
163095462|NCT02750514|589060106|FG002|Track 2|Study drug toxicity|0|||
163095463|NCT02750514|589060107|FG003|Track 2|Study drug toxicity|2|||
163095464|NCT02750514|589060108|FG004|Track 2|Study drug toxicity|0|||
163095465|NCT02750514|589060104|FG000|Track 2|Participant withdrew consent|0|||
163095466|NCT02750514|589060105|FG001|Track 2|Participant withdrew consent|1|||
163095467|NCT02750514|589060106|FG002|Track 2|Participant withdrew consent|0|||
163095468|NCT02750514|589060107|FG003|Track 2|Participant withdrew consent|0|||
163095469|NCT02750514|589060108|FG004|Track 2|Participant withdrew consent|0|||
163095470|NCT02750514|589060104|FG000|Track 3|Disease progression|0|||
163095471|NCT02750514|589060105|FG001|Track 3|Disease progression|24|||
163095472|NCT02750514|589060106|FG002|Track 3|Disease progression|13|||
163095473|NCT02750514|589060107|FG003|Track 3|Disease progression|14|||
163095474|NCT02750514|589060108|FG004|Track 3|Disease progression|0|||
163095475|NCT02750514|589060104|FG000|Track 3|Adverse event unrelated to study drug|0|||
163095476|NCT02750514|589060105|FG001|Track 3|Adverse event unrelated to study drug|1|||
163095477|NCT02750514|589060106|FG002|Track 3|Adverse event unrelated to study drug|1|||
163095478|NCT02750514|589060107|FG003|Track 3|Adverse event unrelated to study drug|1|||
163095479|NCT02750514|589060108|FG004|Track 3|Adverse event unrelated to study drug|0|||
163095480|NCT02750514|589060104|FG000|Track 3|Study drug toxicity|0|||
163095481|NCT02750514|589060105|FG001|Track 3|Study drug toxicity|3|||
163095482|NCT02750514|589060106|FG002|Track 3|Study drug toxicity|0|||
163095483|NCT02750514|589060107|FG003|Track 3|Study drug toxicity|1|||
163095484|NCT02750514|589060108|FG004|Track 3|Study drug toxicity|0|||
163095485|NCT02750514|589060104|FG000|Track 3|Participant request to discontinue|0|||
163095486|NCT02750514|589060105|FG001|Track 3|Participant request to discontinue|2|||
163095487|NCT02750514|589060106|FG002|Track 3|Participant request to discontinue|0|||
163095488|NCT02750514|589060107|FG003|Track 3|Participant request to discontinue|0|||
163095489|NCT02750514|589060108|FG004|Track 3|Participant request to discontinue|0|||
163095490|NCT02750514|589060104|FG000|Track 3|Participant withdrew consent|0|||
163095491|NCT02750514|589060105|FG001|Track 3|Participant withdrew consent|3|||
163095492|NCT02750514|589060106|FG002|Track 3|Participant withdrew consent|1|||
163095493|NCT02750514|589060107|FG003|Track 3|Participant withdrew consent|0|||
163095494|NCT02750514|589060108|FG004|Track 3|Participant withdrew consent|0|||
163095495|NCT02750514|589060104|FG000|Track 3|Other reasons|0|||
163095496|NCT02750514|589060105|FG001|Track 3|Other reasons|3|||
163095497|NCT02750514|589060106|FG002|Track 3|Other reasons|0|||
163095498|NCT02750514|589060107|FG003|Track 3|Other reasons|0|||
163095499|NCT02750514|589060108|FG004|Track 3|Other reasons|0|||
163095500|NCT02750514|589060104|FG000|Track 4|Study drug toxicity|0|||
163095501|NCT02750514|589060105|FG001|Track 4|Study drug toxicity|6|||
163095502|NCT02750514|589060106|FG002|Track 4|Study drug toxicity|0|||
163095503|NCT02750514|589060107|FG003|Track 4|Study drug toxicity|5|||
163095504|NCT02750514|589060108|FG004|Track 4|Study drug toxicity|0|||
163095505|NCT02750514|589060104|FG000|Track 4|Participant request to discontinue|0|||
163095506|NCT02750514|589060105|FG001|Track 4|Participant request to discontinue|1|||
163095507|NCT02750514|589060106|FG002|Track 4|Participant request to discontinue|0|||
163095508|NCT02750514|589060107|FG003|Track 4|Participant request to discontinue|1|||
163095509|NCT02750514|589060108|FG004|Track 4|Participant request to discontinue|0|||
163095510|NCT02750514|589060104|FG000|Track 4|Participant withdrew consent|0|||
163095511|NCT02750514|589060105|FG001|Track 4|Participant withdrew consent|1|||
163095512|NCT02750514|589060106|FG002|Track 4|Participant withdrew consent|0|||
163095513|NCT02750514|589060107|FG003|Track 4|Participant withdrew consent|0|||
163095514|NCT02750514|589060108|FG004|Track 4|Participant withdrew consent|0|||
163095515|NCT02750514|589060104|FG000|Track 4|Other reasons|0|||
163095516|NCT02750514|589060105|FG001|Track 4|Other reasons|5|||
163095517|NCT02750514|589060106|FG002|Track 4|Other reasons|0|||
163095518|NCT02750514|589060107|FG003|Track 4|Other reasons|3|||
163095519|NCT02750514|589060108|FG004|Track 4|Other reasons|0|||
163095520|NCT02750514|589060104|FG000|Track 4|Disease progression|0|||
163095521|NCT02750514|589060105|FG001|Track 4|Disease progression|33|||
163095522|NCT02750514|589060106|FG002|Track 4|Disease progression|0|||
163095523|NCT02750514|589060107|FG003|Track 4|Disease progression|32|||
163095524|NCT02750514|589060108|FG004|Track 4|Disease progression|0|||
163095525|NCT02750514|589060104|FG000|Track 4|Adverse event unrelated to study drug|0|||
163095526|NCT02750514|589060105|FG001|Track 4|Adverse event unrelated to study drug|5|||
163338654|NCT01133678|589948975|FG000|Overall Study|Death|1|||
163407637|NCT02706873|590200872|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
163338655|NCT01133678|589948976|FG001|Overall Study|Death|1|||
163095527|NCT02750514|589060106|FG002|Track 4|Adverse event unrelated to study drug|0|||
163095528|NCT02750514|589060107|FG003|Track 4|Adverse event unrelated to study drug|0|||
163095529|NCT02750514|589060108|FG004|Track 4|Adverse event unrelated to study drug|0|||
163095530|NCT02750514|589060104|FG000|Track 4|Death|0|||
163095531|NCT02750514|589060105|FG001|Track 4|Death|0|||
163095532|NCT02750514|589060106|FG002|Track 4|Death|0|||
163095533|NCT02750514|589060107|FG003|Track 4|Death|1|||
163095534|NCT02750514|589060108|FG004|Track 4|Death|0|||
163095535|NCT02750514|589060104|FG000|Track 5|Disease progression|0|||
163095536|NCT02750514|589060105|FG001|Track 5|Disease progression|0|||
163095537|NCT02750514|589060106|FG002|Track 5|Disease progression|0|||
163095538|NCT02750514|589060107|FG003|Track 5|Disease progression|0|||
163095539|NCT02750514|589060108|FG004|Track 5|Disease progression|34|||
163095540|NCT02750514|589060104|FG000|Track 5|Adverse event unrelated to study drug|0|||
163095541|NCT02750514|589060105|FG001|Track 5|Adverse event unrelated to study drug|0|||
163095542|NCT02750514|589060106|FG002|Track 5|Adverse event unrelated to study drug|0|||
163095543|NCT02750514|589060107|FG003|Track 5|Adverse event unrelated to study drug|0|||
163095544|NCT02750514|589060108|FG004|Track 5|Adverse event unrelated to study drug|2|||
163095545|NCT02750514|589060104|FG000|Track 5|Study drug toxicity|0|||
163095546|NCT02750514|589060105|FG001|Track 5|Study drug toxicity|0|||
163095547|NCT02750514|589060106|FG002|Track 5|Study drug toxicity|0|||
163095548|NCT02750514|589060107|FG003|Track 5|Study drug toxicity|0|||
163095549|NCT02750514|589060108|FG004|Track 5|Study drug toxicity|2|||
163095550|NCT02750514|589060104|FG000|Track 5|Participant request to discontinue|0|||
163095551|NCT02750514|589060105|FG001|Track 5|Participant request to discontinue|0|||
163095552|NCT02750514|589060106|FG002|Track 5|Participant request to discontinue|0|||
163095553|NCT02750514|589060107|FG003|Track 5|Participant request to discontinue|0|||
163095554|NCT02750514|589060108|FG004|Track 5|Participant request to discontinue|3|||
163095555|NCT02750514|589060104|FG000|Track 5|Other reasons|0|||
163095556|NCT02750514|589060105|FG001|Track 5|Other reasons|0|||
163095557|NCT02750514|589060106|FG002|Track 5|Other reasons|0|||
163095558|NCT02750514|589060107|FG003|Track 5|Other reasons|0|||
163095559|NCT02750514|589060108|FG004|Track 5|Other reasons|2|||
163095560|NCT02756403|589060110|FG000|Overall Study|Unable to swallow medication|0|||
163095561|NCT02756403|589060111|FG001|Overall Study|Unable to swallow medication|1|||
163095562|NCT02756403|589060112|FG002|Overall Study|Unable to swallow medication|1|||
163095563|NCT02756403|589060113|FG003|Overall Study|Unable to swallow medication|1|||
163095564|NCT02756403|589060110|FG000|Overall Study|Did not complete Procedure|0|||
163095565|NCT02756403|589060111|FG001|Overall Study|Did not complete Procedure|1|||
163095566|NCT02756403|589060112|FG002|Overall Study|Did not complete Procedure|0|||
163095567|NCT02756403|589060113|FG003|Overall Study|Did not complete Procedure|0|||
163095568|NCT02756403|589060110|FG000|Overall Study|Changed Mind About Procedure|0|||
163095569|NCT02756403|589060111|FG001|Overall Study|Changed Mind About Procedure|0|||
163095570|NCT02756403|589060112|FG002|Overall Study|Changed Mind About Procedure|1|||
163095571|NCT02756403|589060113|FG003|Overall Study|Changed Mind About Procedure|0|||
163095572|NCT02756403|589060110|FG000|Overall Study|Protocol Violation|0|||
163095573|NCT02756403|589060111|FG001|Overall Study|Protocol Violation|1|||
163095574|NCT02756403|589060112|FG002|Overall Study|Protocol Violation|0|||
163095575|NCT02756403|589060113|FG003|Overall Study|Protocol Violation|1|||
163095576|NCT00527618|589060114|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
163095577|NCT00527618|589060115|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
163095578|NCT00527618|589060114|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
163095579|NCT00527618|589060115|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
163095580|NCT00527618|589060114|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
163095581|NCT00527618|589060115|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
163095582|NCT00527618|589060114|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
163095583|NCT00527618|589060115|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
163095584|NCT00527618|589060114|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
163095585|NCT00527618|589060115|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
163095586|NCT00527618|589060114|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
163095587|NCT00527618|589060115|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
163095588|NCT02240121|589060120|FG000|Overall Study|Protocol Violation|1|||
163095589|NCT02240121|589060121|FG001|Overall Study|Protocol Violation|2|||
163095590|NCT02240121|589060120|FG000|Overall Study|Physician Decision|0|||
163095591|NCT02240121|589060121|FG001|Overall Study|Physician Decision|1|||
163095592|NCT02240121|589060120|FG000|Overall Study|Change in protocol interpretation|1|||
163095593|NCT02240121|589060121|FG001|Overall Study|Change in protocol interpretation|0|||
163095594|NCT02240121|589060120|FG000|Overall Study|Lack of Efficacy|2|||
163095595|NCT02240121|589060121|FG001|Overall Study|Lack of Efficacy|3|||
163095596|NCT02240121|589060120|FG000|Overall Study|Site closed|1|||
163095597|NCT02240121|589060121|FG001|Overall Study|Site closed|1|||
163095598|NCT02240121|589060120|FG000|Overall Study|Pregnancy|1|||
163095599|NCT02240121|589060121|FG001|Overall Study|Pregnancy|0|||
163095600|NCT02240121|589060120|FG000|Overall Study|Adverse Event|2|||
163095601|NCT02240121|589060121|FG001|Overall Study|Adverse Event|4|||
163095602|NCT02240121|589060120|FG000|Overall Study|Withdrawal by Subject|6|||
163095603|NCT02240121|589060121|FG001|Overall Study|Withdrawal by Subject|2|||
163095604|NCT02240121|589060120|FG000|Overall Study|Lost to Follow-up|3|||
163095605|NCT02240121|589060121|FG001|Overall Study|Lost to Follow-up|4|||
163095606|NCT02240121|589060120|FG000|Overall Study|Other than specified|1|||
163095607|NCT02240121|589060121|FG001|Overall Study|Other than specified|3|||
163095608|NCT01151020|589060122|FG000|Overall Study|Death|25|||
163095609|NCT01151020|589060122|FG000|Overall Study|Conversion to open repair|1|||
163095610|NCT01151020|589060122|FG000|Overall Study|Lost to Follow-up|4|||
163095611|NCT01151020|589060122|FG000|Overall Study|Withdrawal by Subject|22|||
163095612|NCT01151020|589060122|FG000|Overall Study|Patients did not receive the device|2|||
163095613|NCT00648037|589060123|FG000|Overall Study|Not Treated|1|||
163095614|NCT00648037|589060123|FG000|Overall Study|Withdrawal by Subject|1|||
163095615|NCT00648037|589060123|FG000|Overall Study|Adverse Event|11|||
163095616|NCT00648037|589060123|FG000|Overall Study|Relapse|2|||
163095617|NCT00648037|589060123|FG000|Overall Study|Other|1|||
163095618|NCT01635998|589060124|FG000|Overall Study|Death|1|||
163095619|NCT01635998|589060125|FG001|Overall Study|Death|1|||
163095620|NCT01635998|589060124|FG000|Overall Study|Lost to Follow-up|2|||
163095621|NCT01635998|589060125|FG001|Overall Study|Lost to Follow-up|1|||
163095622|NCT01635998|589060124|FG000|Overall Study|Withdrawal by Subject|1|||
163095623|NCT01635998|589060125|FG001|Overall Study|Withdrawal by Subject|5|||
163095624|NCT00846846|589060126|FG000|Overall Study|Death|56|||
163095625|NCT00846846|589060126|FG000|Overall Study|Withdrawal by Subject|19|||
163095626|NCT04419467|589060127|FG000|Overall Study|Not treated with IP|0|||
163095627|NCT04419467|589060128|FG001|Overall Study|Not treated with IP|0|||
163095628|NCT04419467|589060129|FG002|Overall Study|Not treated with IP|2|||
163095629|NCT04419467|589060127|FG000|Overall Study|Adverse Event|0|||
163095630|NCT04419467|589060128|FG001|Overall Study|Adverse Event|2|||
163095631|NCT04419467|589060129|FG002|Overall Study|Adverse Event|0|||
163095632|NCT04419467|589060127|FG000|Overall Study|Death|1|||
163095633|NCT04419467|589060128|FG001|Overall Study|Death|0|||
163095634|NCT04419467|589060129|FG002|Overall Study|Death|0|||
163095635|NCT04419467|589060127|FG000|Overall Study|Lost to Follow-up|0|||
163095636|NCT04419467|589060128|FG001|Overall Study|Lost to Follow-up|1|||
163095637|NCT04419467|589060129|FG002|Overall Study|Lost to Follow-up|2|||
163095638|NCT04419467|589060127|FG000|Overall Study|Withdrawal by Subject|0|||
163095639|NCT04419467|589060128|FG001|Overall Study|Withdrawal by Subject|0|||
163095640|NCT04419467|589060129|FG002|Overall Study|Withdrawal by Subject|4|||
163095641|NCT04419467|589060127|FG000|Overall Study|Pandemic related|0|||
163095642|NCT04419467|589060128|FG001|Overall Study|Pandemic related|0|||
163095643|NCT04419467|589060129|FG002|Overall Study|Pandemic related|1|||
163095644|NCT04419467|589060127|FG000|Overall Study|Reason not known|1|||
163095645|NCT04419467|589060128|FG001|Overall Study|Reason not known|0|||
163095646|NCT04419467|589060129|FG002|Overall Study|Reason not known|0|||
163095647|NCT02967679|589060132|FG000|Overall Study|Adverse Event|1|||
163095648|NCT00600067|589060135|FG000|Overall Study|Adverse Event|0|||
163095649|NCT00600067|589060136|FG001|Overall Study|Adverse Event|1|||
163095650|NCT00600067|589060135|FG000|Overall Study|Lost to Follow-up|2|||
163095651|NCT00600067|589060136|FG001|Overall Study|Lost to Follow-up|3|||
163095652|NCT00600067|589060135|FG000|Overall Study|protocol non-compliance|0|||
163095653|NCT00600067|589060136|FG001|Overall Study|protocol non-compliance|3|||
163095654|NCT00600067|589060135|FG000|Overall Study|Lack of Efficacy|1|||
163095655|NCT00600067|589060136|FG001|Overall Study|Lack of Efficacy|0|||
163095656|NCT04571060|589060140|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
163095657|NCT04571060|589060141|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
163095658|NCT04571060|589060140|FG000|Overall Study|Never treated migraine|47|||
163095659|NCT04571060|589060141|FG001|Overall Study|Never treated migraine|36|||
163095660|NCT04571060|589060140|FG000|Overall Study|Protocol Violation|4|||
163095661|NCT04571060|589060141|FG001|Overall Study|Protocol Violation|2|||
163095662|NCT04571060|589060140|FG000|Overall Study|Withdrawal by Subject|6|||
163095663|NCT04571060|589060141|FG001|Overall Study|Withdrawal by Subject|2|||
163095664|NCT04571060|589060140|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
163095665|NCT04571060|589060141|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
163338656|NCT02206607|589948977|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
163338657|NCT02206607|589948978|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
163095666|NCT01253369|589060142|FG000|Overall Study|Adverse Event|4|||
163095667|NCT01253369|589060142|FG000|Overall Study|Withdrawal by Subject|2|||
163095668|NCT01253369|589060142|FG000|Overall Study|Death|1|||
163095669|NCT01253369|589060142|FG000|Overall Study|Progressive disease|23|||
163095670|NCT01253369|589060142|FG000|Overall Study|Not Evaluable|3|||
163095671|NCT01220401|589060147|FG000|Overall Study|Withdrawal by Subject|2|||
163095672|NCT01220401|589060147|FG000|Overall Study|Protocol Violation|1|||
163095673|NCT01853462|589060148|FG000|Overall Study|Withdrawal by Subject|1|||
163095674|NCT01853462|589060149|FG001|Overall Study|Withdrawal by Subject|1|||
163095675|NCT02765399|589060151|FG000|Overall Study|Nausea|1|||
163095676|NCT02765399|589060152|FG001|Overall Study|Nausea|0|||
163095677|NCT02103062|589060153|FG000|Overall Study|Adverse Event|1|||
163338658|NCT02206607|589948979|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
163338659|NCT02206607|589948980|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
163338660|NCT02206607|589948981|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
163095678|NCT02103062|589060154|FG001|Overall Study|Adverse Event|2|||
163095679|NCT02103062|589060153|FG000|Overall Study|Progressive Disease|17|||
163095680|NCT02103062|589060154|FG001|Overall Study|Progressive Disease|20|||
163095681|NCT02103062|589060153|FG000|Overall Study|Death|0|||
163095682|NCT02103062|589060154|FG001|Overall Study|Death|1|||
163095683|NCT03958331|589060155|FG000|Overall Study|Withdrawal by Subject|3|||
163095684|NCT03958331|589060156|FG001|Overall Study|Withdrawal by Subject|1|||
163095685|NCT03958331|589060157|FG002|Overall Study|Withdrawal by Subject|5|||
163095686|NCT03958331|589060155|FG000|Overall Study|Weaned from medicine|2|||
163095687|NCT03958331|589060156|FG001|Overall Study|Weaned from medicine|0|||
163095688|NCT03958331|589060157|FG002|Overall Study|Weaned from medicine|0|||
163095689|NCT03958331|589060155|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
163095690|NCT03958331|589060156|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
163095691|NCT03958331|589060157|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
163095692|NCT01991483|589060158|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
163095693|NCT01991483|589060159|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
163095694|NCT01991483|589060160|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
163095695|NCT01991483|589060161|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
163095696|NCT01991483|589060158|FG000|Dose Level 600 mg|Physician Decision|0|||
163095697|NCT01991483|589060159|FG001|Dose Level 600 mg|Physician Decision|0|||
163095698|NCT01991483|589060160|FG002|Dose Level 600 mg|Physician Decision|1|||
163095699|NCT01991483|589060161|FG003|Dose Level 600 mg|Physician Decision|0|||
163095700|NCT01991483|589060158|FG000|Dose Level 1000 mg|Protocol Violation|0|||
163095701|NCT01991483|589060159|FG001|Dose Level 1000 mg|Protocol Violation|0|||
163095702|NCT01991483|589060160|FG002|Dose Level 1000 mg|Protocol Violation|0|||
163095703|NCT01991483|589060161|FG003|Dose Level 1000 mg|Protocol Violation|1|||
163095704|NCT02030821|589060162|FG000|Overall Study|Physician Decision|2|||
163095705|NCT02030821|589060163|FG001|Overall Study|Physician Decision|2|||
163095706|NCT02030821|589060164|FG002|Overall Study|Physician Decision|5|||
163095707|NCT02030821|589060165|FG003|Overall Study|Physician Decision|2|||
163095708|NCT03192137|589060166|FG000|Overall Study|Adverse Event|10|||
163095709|NCT03192137|589060167|FG001|Overall Study|Adverse Event|11|||
163095710|NCT03192137|589060166|FG000|Overall Study|Physician Decision|1|||
163095711|NCT03192137|589060167|FG001|Overall Study|Physician Decision|0|||
163095712|NCT03192137|589060166|FG000|Overall Study|Lack of Efficacy|20|||
163095713|NCT03192137|589060167|FG001|Overall Study|Lack of Efficacy|37|||
163095714|NCT03192137|589060166|FG000|Overall Study|Withdrawal by Subject|3|||
163095715|NCT03192137|589060167|FG001|Overall Study|Withdrawal by Subject|3|||
163095716|NCT03192137|589060166|FG000|Overall Study|Protocol Violation|4|||
163095717|NCT03192137|589060167|FG001|Overall Study|Protocol Violation|3|||
163095718|NCT03192137|589060166|FG000|Overall Study|Surgery Cancelled|4|||
163095719|NCT03192137|589060167|FG001|Overall Study|Surgery Cancelled|1|||
163095720|NCT03192137|589060166|FG000|Overall Study|Other - Various Administrative Reasons|8|||
163095721|NCT03192137|589060167|FG001|Overall Study|Other - Various Administrative Reasons|3|||
163095722|NCT01152437|589060168|FG000|Overall Study|Other Adverse Event|8|||
163095723|NCT01152437|589060169|FG001|Overall Study|Other Adverse Event|1|||
163095724|NCT01152437|589060170|FG002|Overall Study|Other Adverse Event|7|||
163095725|NCT01152437|589060168|FG000|Overall Study|Not treated|0|||
163095726|NCT01152437|589060169|FG001|Overall Study|Not treated|1|||
163095727|NCT01152437|589060170|FG002|Overall Study|Not treated|2|||
163095728|NCT01152437|589060168|FG000|Overall Study|Progressive disease|27|||
163095729|NCT01152437|589060169|FG001|Overall Study|Progressive disease|13|||
163095730|NCT01152437|589060170|FG002|Overall Study|Progressive disease|32|||
163095731|NCT01152437|589060168|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
163095732|NCT01152437|589060169|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
163338661|NCT02206607|589948977|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
163095733|NCT01152437|589060170|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
163095734|NCT02015039|589060171|FG000|Overall Study|Not eligible|0|||
163095735|NCT02015039|589060172|FG001|Overall Study|Not eligible|1|||
163095736|NCT01897532|589060173|FG000|Discontinuation From Treatment|Not Treated|7|||
163095737|NCT01897532|589060174|FG001|Discontinuation From Treatment|Not Treated|5|||
163095738|NCT01897532|589060173|FG000|Discontinuation From Treatment|Other reason than specified|196|||
163095739|NCT01897532|589060174|FG001|Discontinuation From Treatment|Other reason than specified|176|||
163095740|NCT01897532|589060173|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
163095741|NCT01897532|589060174|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
163095742|NCT01897532|589060173|FG000|Discontinuation From Treatment|Non compliance|24|||
163095743|NCT01897532|589060174|FG001|Discontinuation From Treatment|Non compliance|15|||
163095744|NCT01897532|589060173|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
163338662|NCT02206607|589948978|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
163095745|NCT01897532|589060174|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
163095746|NCT01897532|589060173|FG000|Discontinuation From Trial|Not Treated|7|||
163095747|NCT01897532|589060174|FG001|Discontinuation From Trial|Not Treated|5|||
163338663|NCT02206607|589948979|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
163095748|NCT01897532|589060173|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
163095749|NCT01897532|589060174|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
163095750|NCT01074931|589060180|FG000|Overall Study|Economic reasons|1|||
163095751|NCT01074931|589060180|FG000|Overall Study|Death|5|||
163095752|NCT03132467|589060181|FG000|Overall Study|Adverse Event|2|||
163095753|NCT03132467|589060181|FG000|Overall Study|Withdrawal by Subject|2|||
163095754|NCT01088906|589060182|FG000|Overall Study|Inclusion error|1|||
163095755|NCT01088906|589060182|FG000|Overall Study|Did not receive study treatment|3|||
163095756|NCT01088906|589060182|FG000|Overall Study|Missing data|1|||
163095757|NCT00457626|589060185|FG000|Overall Study|Adverse Event|3|||
163095758|NCT00457626|589060185|FG000|Overall Study|Administrative Problems|2|||
163095759|NCT00457626|589060185|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
163095760|NCT03965403|589060186|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
163095761|NCT02364037|589061098|FG000|Overall Study|Withdrawal by Subject|7|||
163095762|NCT02364037|589061099|FG001|Overall Study|Withdrawal by Subject|4|||
163095763|NCT02364037|589061098|FG000|Overall Study|Lost to Follow-up|37|||
163095764|NCT02364037|589061099|FG001|Overall Study|Lost to Follow-up|49|||
163095765|NCT01453036|589061100|FG000|Overall Study|Lost to Follow-up|26|||
163095766|NCT01453036|589061101|FG001|Overall Study|Lost to Follow-up|115|||
163095767|NCT01453036|589061102|FG002|Overall Study|Lost to Follow-up|31|||
163095768|NCT04072835|589061103|FG000|Overall Study|Overall trial ended|603|||
163095769|NCT04072835|589061103|FG000|Overall Study|Ablation|97|||
163095770|NCT04072835|589061103|FG000|Overall Study|Withdrawal of consent|66|||
163095771|NCT04072835|589061103|FG000|Overall Study|Physician Decision|50|||
163095772|NCT04072835|589061103|FG000|Overall Study|Lost to Follow-up|39|||
163095773|NCT04072835|589061103|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
163095774|NCT04072835|589061103|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
163095775|NCT04072835|589061103|FG000|Overall Study|Adverse Event|25|||
163095776|NCT04072835|589061103|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
163095777|NCT04072835|589061103|FG000|Overall Study|Death|11|||
163095778|NCT04072835|589061103|FG000|Overall Study|Participant felt the drug did not work|8|||
163095779|NCT04072835|589061103|FG000|Overall Study|Participant tolerability|5|||
163095780|NCT04072835|589061103|FG000|Overall Study|Missing|5|||
163095781|NCT04072835|589061103|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
163095782|NCT04072835|589061103|FG000|Overall Study|Pregnancy|3|||
163095783|NCT01336712|589061104|FG000|Overall Study|Death|2|||
163095784|NCT01336712|589061104|FG000|Overall Study|Lack of Efficacy|1|||
163095785|NCT00841776|589061105|FG000|Overall Study|Lack of Efficacy|0|||
163095786|NCT00841776|589061106|FG001|Overall Study|Lack of Efficacy|1|||
163095787|NCT00841776|589061105|FG000|Overall Study|Lost to Follow-up|2|||
163095788|NCT00841776|589061106|FG001|Overall Study|Lost to Follow-up|1|||
163095789|NCT00841776|589061105|FG000|Overall Study|Withdrawal by Subject|0|||
163095790|NCT00841776|589061106|FG001|Overall Study|Withdrawal by Subject|1|||
163095791|NCT00856323|589061107|FG000|Overall Study|Withdrawal by Subject|2|||
163095792|NCT01639469|589061108|FG000|Overall Study|Death|4|||
163095793|NCT01639469|589061109|FG001|Overall Study|Death|2|||
163095794|NCT01639469|589061108|FG000|Overall Study|Lost to Follow-up|1|||
163095795|NCT01639469|589061109|FG001|Overall Study|Lost to Follow-up|1|||
163095796|NCT01119443|589061112|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
163095797|NCT01119443|589061113|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
163095798|NCT02329743|589061114|FG000|Overall Study|Adverse Event|1|||
163095799|NCT02329743|589061115|FG001|Overall Study|Adverse Event|1|||
163095800|NCT02329743|589061116|FG002|Overall Study|Adverse Event|3|||
163095801|NCT02329743|589061114|FG000|Overall Study|Lost to Follow-up|1|||
163095802|NCT02329743|589061115|FG001|Overall Study|Lost to Follow-up|0|||
163095803|NCT02329743|589061116|FG002|Overall Study|Lost to Follow-up|1|||
163095804|NCT02329743|589061114|FG000|Overall Study|Withdrawal by Subject|4|||
163095805|NCT02329743|589061115|FG001|Overall Study|Withdrawal by Subject|4|||
163095806|NCT02329743|589061116|FG002|Overall Study|Withdrawal by Subject|1|||
163095807|NCT02329743|589061114|FG000|Overall Study|Other|0|||
163095808|NCT02329743|589061115|FG001|Overall Study|Other|2|||
163095809|NCT02329743|589061116|FG002|Overall Study|Other|3|||
163095810|NCT01428219|589061127|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
163095811|NCT00355368|589061128|FG000|Overall Study|Protocol Violation|8|||
163095812|NCT00355368|589061129|FG001|Overall Study|Protocol Violation|7|||
163095813|NCT00355368|589061128|FG000|Overall Study|cardiac arrest prior to intubation|2|||
163095814|NCT00355368|589061129|FG001|Overall Study|cardiac arrest prior to intubation|2|||
163095815|NCT01694433|589061131|FG000|Overall Study|Adverse Event|7|||
163095816|NCT01694433|589061132|FG001|Overall Study|Adverse Event|0|||
163095817|NCT01694433|589061131|FG000|Overall Study|Physician Decision|1|||
163095818|NCT01694433|589061132|FG001|Overall Study|Physician Decision|0|||
163095819|NCT01694433|589061131|FG000|Overall Study|Withdrawal by Subject|3|||
163095820|NCT01694433|589061132|FG001|Overall Study|Withdrawal by Subject|4|||
163095821|NCT00374595|589061135|FG000|Overall Study|Death|23|||
163095822|NCT00374595|589061135|FG000|Overall Study|Withdrawal by Subject|39|||
163095823|NCT00374595|589061135|FG000|Overall Study|Lost to Follow-up|3|||
163095824|NCT00374595|589061135|FG000|Overall Study|too much time commitment|1|||
163095825|NCT00374595|589061135|FG000|Overall Study|transfer care to other clinical site|1|||
163095826|NCT00374595|589061135|FG000|Overall Study|relocation|3|||
163095827|NCT01665911|589061139|FG000|Overall Study|Protocol Violation|4|||
163095828|NCT01665911|589061139|FG000|Overall Study|Withdrawal by Subject|1|||
163095829|NCT01665911|589061139|FG000|Overall Study|Adverse Event|1|||
163095830|NCT00347932|589061140|FG000|Overall Study|Adverse Event|4|||
163095831|NCT00347932|589061141|FG001|Overall Study|Adverse Event|5|||
163338664|NCT02206607|589948980|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
163338665|NCT02206607|589948981|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
163338666|NCT00761267|589948988|FG000|Overall Study|Death|1|||
163338667|NCT00761267|589948989|FG001|Overall Study|Death|2|||
163338668|NCT00761267|589948990|FG002|Overall Study|Death|5|||
163338669|NCT00761267|589948988|FG000|Overall Study|Lost to Follow-up|0|||
163338670|NCT00761267|589948989|FG001|Overall Study|Lost to Follow-up|0|||
163338671|NCT00761267|589948990|FG002|Overall Study|Lost to Follow-up|1|||
163338672|NCT00761267|589948988|FG000|Overall Study|Randomized but not treated|1|||
163338673|NCT00761267|589948989|FG001|Overall Study|Randomized but not treated|1|||
163338674|NCT00761267|589948990|FG002|Overall Study|Randomized but not treated|0|||
163338675|NCT00761267|589948988|FG000|Overall Study|Withdrawal by Subject|0|||
163338676|NCT00761267|589948989|FG001|Overall Study|Withdrawal by Subject|1|||
163338677|NCT00761267|589948990|FG002|Overall Study|Withdrawal by Subject|0|||
163338678|NCT01864200|589948991|FG000|Overall Study|Lost to Follow-up|1|||
163338679|NCT01864200|589948992|FG001|Overall Study|Lost to Follow-up|3|||
163095832|NCT00347932|589061140|FG000|Overall Study|Lack of Efficacy|3|||
163095833|NCT00347932|589061141|FG001|Overall Study|Lack of Efficacy|14|||
163095834|NCT00347932|589061140|FG000|Overall Study|Lost to Follow-up|10|||
163095835|NCT00347932|589061141|FG001|Overall Study|Lost to Follow-up|9|||
163095836|NCT00347932|589061140|FG000|Overall Study|Withdrawal by Subject|10|||
163095837|NCT00347932|589061141|FG001|Overall Study|Withdrawal by Subject|16|||
163095838|NCT00347932|589061140|FG000|Overall Study|Did not meet inclusion criteria|4|||
163095839|NCT00347932|589061141|FG001|Overall Study|Did not meet inclusion criteria|8|||
163095840|NCT01881009|589061143|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
163095841|NCT01881009|589061144|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
163095842|NCT01492088|589061146|FG000|Overall Study|Withdrawal by Patient|0|||
163095843|NCT01492088|589061147|FG001|Overall Study|Withdrawal by Patient|2|||
163095844|NCT01492088|589061148|FG002|Overall Study|Withdrawal by Patient|0|||
163095845|NCT01492088|589061146|FG000|Overall Study|Death|1|||
163095846|NCT01492088|589061147|FG001|Overall Study|Death|6|||
163095847|NCT01492088|589061148|FG002|Overall Study|Death|2|||
163095848|NCT01492088|589061146|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
163095849|NCT01492088|589061147|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
163095850|NCT01492088|589061148|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
163095851|NCT01492088|589061146|FG000|Overall Study|Alive at Last Follow-up|0|||
163095852|NCT01492088|589061147|FG001|Overall Study|Alive at Last Follow-up|6|||
163095853|NCT01492088|589061148|FG002|Overall Study|Alive at Last Follow-up|11|||
163095854|NCT00889707|589061149|FG000|Overall Study|Adverse Event|1|||
163095855|NCT00889707|589061150|FG001|Overall Study|Adverse Event|0|||
163095856|NCT00889707|589061149|FG000|Overall Study|Withdrawal by Subject|4|||
163095857|NCT00889707|589061150|FG001|Overall Study|Withdrawal by Subject|3|||
163095858|NCT00889707|589061149|FG000|Overall Study|Lost to Follow-up|0|||
163095859|NCT00889707|589061150|FG001|Overall Study|Lost to Follow-up|2|||
163095860|NCT00889707|589061149|FG000|Overall Study|Lack of Efficacy|2|||
163095861|NCT00889707|589061150|FG001|Overall Study|Lack of Efficacy|5|||
163095862|NCT00881894|589061154|FG000|Overall Study|Consent withdrawn|0|||
163095863|NCT00881894|589061155|FG001|Overall Study|Consent withdrawn|1|||
163095864|NCT00881894|589061154|FG000|Overall Study|Other reasons for premature termination|1|||
163095865|NCT00881894|589061155|FG001|Overall Study|Other reasons for premature termination|2|||
163338680|NCT01864200|589948991|FG000|Overall Study|Protocol Violation|1|||
163095866|NCT03943290|589061157|FG000|Overall Study|Sponsor Terminated Study|6|||
163095867|NCT03943290|589061158|FG001|Overall Study|Sponsor Terminated Study|1|||
163095868|NCT03943290|589061159|FG002|Overall Study|Sponsor Terminated Study|11|||
163095869|NCT03943290|589061160|FG003|Overall Study|Sponsor Terminated Study|6|||
163095870|NCT03943290|589061161|FG004|Overall Study|Sponsor Terminated Study|7|||
163095871|NCT03943290|589061162|FG005|Overall Study|Sponsor Terminated Study|6|||
163095872|NCT03943290|589061163|FG006|Overall Study|Sponsor Terminated Study|6|||
163338681|NCT01864200|589948992|FG001|Overall Study|Protocol Violation|0|||
163338682|NCT00963924|589949001|FG000|Overall Study|Adverse Event|1|||
163407638|NCT02706873|590200873|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
163095873|NCT03943290|589061164|FG007|Overall Study|Sponsor Terminated Study|7|||
163095874|NCT03943290|589061165|FG008|Overall Study|Sponsor Terminated Study|8|||
163095875|NCT03943290|589061157|FG000|Overall Study|Lost to Follow-up|1|||
163095876|NCT03943290|589061158|FG001|Overall Study|Lost to Follow-up|0|||
163095877|NCT03943290|589061159|FG002|Overall Study|Lost to Follow-up|1|||
163095878|NCT03943290|589061160|FG003|Overall Study|Lost to Follow-up|0|||
163338683|NCT00963924|589949002|FG001|Overall Study|Adverse Event|0|||
163338684|NCT00963924|589949001|FG000|Overall Study|Withdrawal by Subject|0|||
163338685|NCT00963924|589949002|FG001|Overall Study|Withdrawal by Subject|1|||
163095879|NCT03943290|589061161|FG004|Overall Study|Lost to Follow-up|0|||
163095880|NCT03943290|589061162|FG005|Overall Study|Lost to Follow-up|0|||
163095881|NCT03943290|589061163|FG006|Overall Study|Lost to Follow-up|0|||
163095882|NCT03943290|589061164|FG007|Overall Study|Lost to Follow-up|1|||
163095883|NCT03943290|589061165|FG008|Overall Study|Lost to Follow-up|0|||
163095884|NCT03943290|589061157|FG000|Overall Study|Withdrawal by Subject|0|||
163095885|NCT03943290|589061158|FG001|Overall Study|Withdrawal by Subject|0|||
163095886|NCT03943290|589061159|FG002|Overall Study|Withdrawal by Subject|1|||
163095887|NCT03943290|589061160|FG003|Overall Study|Withdrawal by Subject|0|||
163095888|NCT03943290|589061161|FG004|Overall Study|Withdrawal by Subject|0|||
163095889|NCT03943290|589061162|FG005|Overall Study|Withdrawal by Subject|0|||
163095890|NCT03943290|589061163|FG006|Overall Study|Withdrawal by Subject|0|||
163095891|NCT03943290|589061164|FG007|Overall Study|Withdrawal by Subject|0|||
163095892|NCT03943290|589061165|FG008|Overall Study|Withdrawal by Subject|0|||
163095893|NCT01070979|589061166|FG000|Overall Study|Adverse Event|2|||
163095894|NCT01070979|589061167|FG001|Overall Study|Adverse Event|3|||
163095895|NCT01070979|589061168|FG002|Overall Study|Adverse Event|3|||
163095896|NCT01070979|589061166|FG000|Overall Study|Lost to Follow-up|2|||
163095897|NCT01070979|589061167|FG001|Overall Study|Lost to Follow-up|1|||
163095898|NCT01070979|589061168|FG002|Overall Study|Lost to Follow-up|1|||
163095899|NCT01070979|589061166|FG000|Overall Study|Protocol Violation|0|||
163095900|NCT01070979|589061167|FG001|Overall Study|Protocol Violation|2|||
163095901|NCT01070979|589061168|FG002|Overall Study|Protocol Violation|6|||
163095902|NCT01070979|589061166|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
163095903|NCT01070979|589061167|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
163095904|NCT01070979|589061168|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
163095905|NCT01070979|589061166|FG000|Overall Study|Withdrawal by Subject|3|||
163095906|NCT01070979|589061167|FG001|Overall Study|Withdrawal by Subject|1|||
163095907|NCT01070979|589061168|FG002|Overall Study|Withdrawal by Subject|1|||
163095908|NCT01070979|589061166|FG000|Overall Study|No study drug taken|0|||
163095909|NCT01070979|589061167|FG001|Overall Study|No study drug taken|1|||
163095910|NCT01070979|589061168|FG002|Overall Study|No study drug taken|0|||
163095911|NCT00437268|589061169|FG000|Overall Study|Adverse Event|1|||
163095912|NCT00437268|589061170|FG001|Overall Study|Adverse Event|1|||
163095913|NCT00437268|589061169|FG000|Overall Study|Withdrawal by Subject|2|||
163095914|NCT00437268|589061170|FG001|Overall Study|Withdrawal by Subject|2|||
163095915|NCT00437268|589061169|FG000|Overall Study|Progressive disease|9|||
163095916|NCT00437268|589061170|FG001|Overall Study|Progressive disease|9|||
163095917|NCT00437268|589061169|FG000|Overall Study|Physician Decision|1|||
163095918|NCT00437268|589061170|FG001|Overall Study|Physician Decision|0|||
163095919|NCT00437268|589061169|FG000|Overall Study|Death|0|||
163095920|NCT00437268|589061170|FG001|Overall Study|Death|1|||
163095921|NCT04417257|589061175|FG000|Pilot Phase 2|Adverse Event|2|||
163095922|NCT04417257|589061176|FG001|Pilot Phase 2|Adverse Event|0|||
163095923|NCT04417257|589061175|FG000|Pilot Phase 2|Death|14|||
163095924|NCT04417257|589061176|FG001|Pilot Phase 2|Death|11|||
163095925|NCT04417257|589061175|FG000|Pilot Phase 2|Lost to Follow-up|3|||
163095926|NCT04417257|589061176|FG001|Pilot Phase 2|Lost to Follow-up|5|||
163095927|NCT04417257|589061175|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
163095928|NCT04417257|589061176|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
163095929|NCT04417257|589061175|FG000|Pilot Phase 2|Hepatic impairment|1|||
163095930|NCT04417257|589061176|FG001|Pilot Phase 2|Hepatic impairment|0|||
163095931|NCT04417257|589061175|FG000|Pilot Phase 2|Unblinding|1|||
163095932|NCT04417257|589061176|FG001|Pilot Phase 2|Unblinding|0|||
163095933|NCT04417257|589061175|FG000|Pilot Phase 2|All other|0|||
163095934|NCT04417257|589061176|FG001|Pilot Phase 2|All other|2|||
163095935|NCT04417257|589061175|FG000|Phase 3 Extension|Death|3|||
163095936|NCT04417257|589061176|FG001|Phase 3 Extension|Death|1|||
163095937|NCT04417257|589061175|FG000|Phase 3 Extension|Lost to Follow-up|4|||
163095938|NCT04417257|589061176|FG001|Phase 3 Extension|Lost to Follow-up|2|||
163095939|NCT04417257|589061175|FG000|Phase 3 Extension|Patient withdrawal|2|||
163095940|NCT04417257|589061176|FG001|Phase 3 Extension|Patient withdrawal|2|||
163095941|NCT04417257|589061175|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
163095942|NCT04417257|589061176|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
163095943|NCT03484429|589061180|FG000|Overall Study|Withdrawal by Subject|1|||
163095944|NCT03484429|589061181|FG001|Overall Study|Withdrawal by Subject|0|||
163095945|NCT03484429|589061180|FG000|Overall Study|Adverse Event|2|||
163095946|NCT03484429|589061181|FG001|Overall Study|Adverse Event|0|||
163095947|NCT04466384|589061182|FG000|First Phase|Protocol Violation|1|||
163095948|NCT04466384|589061183|FG001|First Phase|Protocol Violation|0|||
163095949|NCT04466384|589061182|FG000|First Phase|Missing data|1|||
163095950|NCT04466384|589061183|FG001|First Phase|Missing data|0|||
163095951|NCT04466384|589061182|FG000|Cross Over Phase|Physician Decision|1|||
163095952|NCT04466384|589061183|FG001|Cross Over Phase|Physician Decision|0|||
163095953|NCT04466384|589061182|FG000|Cross Over Phase|Withdrawal by Subject|0|||
163095954|NCT04466384|589061183|FG001|Cross Over Phase|Withdrawal by Subject|1|||
163095955|NCT00972023|589062593|FG000|Overall Study|Withdrawal by Subject|1|||
163095956|NCT00532129|589062594|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
163338686|NCT00963924|589949001|FG000|Overall Study|Changed antipsychotic|0|||
163338687|NCT00963924|589949002|FG001|Overall Study|Changed antipsychotic|1|||
163338688|NCT00963924|589949001|FG000|Overall Study|Lost to Follow-up|0|||
163338689|NCT00963924|589949002|FG001|Overall Study|Lost to Follow-up|1|||
163338690|NCT00446095|589949004|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
163338691|NCT00446095|589949005|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
163338692|NCT00446095|589949006|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
163338693|NCT00446095|589949007|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
163338694|NCT00446095|589949008|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
163338695|NCT00446095|589949004|FG000|Phase II (8 Weeks)|Adverse Event|0|||
163338696|NCT00446095|589949005|FG001|Phase II (8 Weeks)|Adverse Event|1|||
163338697|NCT00446095|589949006|FG002|Phase II (8 Weeks)|Adverse Event|1|||
163338698|NCT00446095|589949007|FG003|Phase II (8 Weeks)|Adverse Event|0|||
163338699|NCT00446095|589949008|FG004|Phase II (8 Weeks)|Adverse Event|0|||
163338700|NCT00446095|589949004|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
163338701|NCT00446095|589949005|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
163338702|NCT00446095|589949006|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
163338703|NCT00446095|589949007|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
163338704|NCT00446095|589949008|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
163338705|NCT00446095|589949004|FG000|Phase II (8 Weeks)|Physician Decision|1|||
163338706|NCT00446095|589949005|FG001|Phase II (8 Weeks)|Physician Decision|0|||
163338707|NCT00446095|589949006|FG002|Phase II (8 Weeks)|Physician Decision|0|||
163338708|NCT00446095|589949007|FG003|Phase II (8 Weeks)|Physician Decision|0|||
163338709|NCT00446095|589949008|FG004|Phase II (8 Weeks)|Physician Decision|0|||
163338710|NCT00446095|589949004|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
163338711|NCT00446095|589949005|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
163338712|NCT00446095|589949006|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
163338713|NCT00446095|589949007|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
163338714|NCT00446095|589949008|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
163338715|NCT00446095|589949004|FG000|Phase II (8 Weeks)|Ongoing|0|||
163338716|NCT00446095|589949005|FG001|Phase II (8 Weeks)|Ongoing|0|||
163338717|NCT00446095|589949006|FG002|Phase II (8 Weeks)|Ongoing|1|||
163338718|NCT00446095|589949007|FG003|Phase II (8 Weeks)|Ongoing|0|||
163338719|NCT00446095|589949008|FG004|Phase II (8 Weeks)|Ongoing|0|||
163338720|NCT00446095|589949004|FG000|Phase I (28 Days)|Adverse Event|0|||
163338721|NCT00446095|589949005|FG001|Phase I (28 Days)|Adverse Event|0|||
163338722|NCT00446095|589949006|FG002|Phase I (28 Days)|Adverse Event|0|||
163338723|NCT00446095|589949007|FG003|Phase I (28 Days)|Adverse Event|1|||
163338724|NCT00446095|589949008|FG004|Phase I (28 Days)|Adverse Event|0|||
163338725|NCT00446095|589949004|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
163338726|NCT00446095|589949005|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
163338727|NCT00446095|589949006|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
163095957|NCT00532129|589062594|FG000|Treatment Period|Physician Decision|15|||
163095958|NCT00532129|589062594|FG000|Treatment Period|Disease progression|3|||
163095959|NCT00532129|589062594|FG000|Treatment Period|Protocol Violation|1|||
163095960|NCT00532129|589062594|FG000|Treatment Period|Other|5|||
163095961|NCT00532129|589062594|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
163095962|NCT00532129|589062594|FG000|Follow-up Period|Disease progression|57|||
163095963|NCT00532129|589062594|FG000|Follow-up Period|Lost to Follow-up|1|||
163095964|NCT00532129|589062594|FG000|Follow-up Period|Other|6|||
163095965|NCT03052608|589062595|FG000|Treatment Phase|Adverse Event|10|||
163095966|NCT03052608|589062596|FG001|Treatment Phase|Adverse Event|12|||
163095967|NCT03052608|589062595|FG000|Treatment Phase|Death|6|||
163095968|NCT03052608|589062596|FG001|Treatment Phase|Death|4|||
163095969|NCT03052608|589062595|FG000|Treatment Phase|Withdrawal by Subject|4|||
163095970|NCT03052608|589062596|FG001|Treatment Phase|Withdrawal by Subject|12|||
163095971|NCT03052608|589062595|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
163095972|NCT03052608|589062596|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
163095973|NCT03052608|589062595|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
163338728|NCT00446095|589949007|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
163338729|NCT00446095|589949008|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
163338730|NCT01419184|589949009|FG000|Overall Study|Site data not available|3|||
163338731|NCT01419184|589949010|FG001|Overall Study|Site data not available|2|||
163338732|NCT01419184|589949009|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
163338733|NCT01419184|589949010|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
163338734|NCT01419184|589949009|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
163338735|NCT01419184|589949010|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
163338736|NCT01419184|589949009|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
163338737|NCT01419184|589949010|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
163338738|NCT01419184|589949009|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
163338739|NCT01419184|589949010|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
163095974|NCT03052608|589062596|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
163220119|NCT02039674|589521409|FG003|Overall Study|Lost to Follow-up|0|||
163338740|NCT01419184|589949009|FG000|Overall Study|Participant randomized, not treated|1|||
163338741|NCT01419184|589949010|FG001|Overall Study|Participant randomized, not treated|0|||
163095975|NCT03052608|589062595|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
163095976|NCT03052608|589062596|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
163095977|NCT03052608|589062595|FG000|Treatment Phase|Ongoing|103|||
163095978|NCT03052608|589062596|FG001|Treatment Phase|Ongoing|31|||
163095979|NCT03052608|589062595|FG000|Long-Term Follow-up Phase|Death|23|||
163095980|NCT03052608|589062596|FG001|Long-Term Follow-up Phase|Death|28|||
163095981|NCT03052608|589062595|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
163095982|NCT03052608|589062596|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
163095983|NCT03052608|589062595|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
163095984|NCT03052608|589062596|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
163095985|NCT03052608|589062595|FG000|Long-Term Follow-up Phase|Ongoing|122|||
163095986|NCT03052608|589062596|FG001|Long-Term Follow-up Phase|Ongoing|99|||
163095987|NCT00551031|589062597|FG000|Overall Study|Adverse Event|0|||
163095988|NCT00551031|589062598|FG001|Overall Study|Adverse Event|1|||
163095989|NCT00551031|589062599|FG002|Overall Study|Adverse Event|0|||
163095990|NCT00551031|589062600|FG003|Overall Study|Adverse Event|0|||
163095991|NCT00551031|589062601|FG004|Overall Study|Adverse Event|0|||
163095992|NCT00551031|589062597|FG000|Overall Study|Protocol Violation|1|||
163095993|NCT00551031|589062598|FG001|Overall Study|Protocol Violation|1|||
163095994|NCT00551031|589062599|FG002|Overall Study|Protocol Violation|0|||
163095995|NCT00551031|589062600|FG003|Overall Study|Protocol Violation|0|||
163095996|NCT00551031|589062601|FG004|Overall Study|Protocol Violation|0|||
163095997|NCT00551031|589062597|FG000|Overall Study|Lost to Follow-up|0|||
163095998|NCT00551031|589062598|FG001|Overall Study|Lost to Follow-up|1|||
163095999|NCT00551031|589062599|FG002|Overall Study|Lost to Follow-up|0|||
163096000|NCT00551031|589062600|FG003|Overall Study|Lost to Follow-up|1|||
163096001|NCT00551031|589062601|FG004|Overall Study|Lost to Follow-up|1|||
163096002|NCT00551031|589062597|FG000|Overall Study|Withdrawal by Subject|0|||
163096003|NCT00551031|589062598|FG001|Overall Study|Withdrawal by Subject|4|||
163096004|NCT00551031|589062599|FG002|Overall Study|Withdrawal by Subject|1|||
163096005|NCT00551031|589062600|FG003|Overall Study|Withdrawal by Subject|2|||
163096006|NCT00551031|589062601|FG004|Overall Study|Withdrawal by Subject|0|||
163096007|NCT00551031|589062597|FG000|Overall Study|Serious Adverse Event|0|||
163096008|NCT00551031|589062598|FG001|Overall Study|Serious Adverse Event|2|||
163096009|NCT00551031|589062599|FG002|Overall Study|Serious Adverse Event|1|||
163096010|NCT00551031|589062600|FG003|Overall Study|Serious Adverse Event|0|||
163096011|NCT00551031|589062601|FG004|Overall Study|Serious Adverse Event|0|||
163096012|NCT00551031|589062597|FG000|Overall Study|Did not receive vaccine|1|||
163096013|NCT00551031|589062598|FG001|Overall Study|Did not receive vaccine|2|||
163096014|NCT00551031|589062599|FG002|Overall Study|Did not receive vaccine|0|||
163096015|NCT00551031|589062600|FG003|Overall Study|Did not receive vaccine|0|||
163096016|NCT00551031|589062601|FG004|Overall Study|Did not receive vaccine|0|||
163096017|NCT05554146|589062602|FG000|Overall Study|Adverse Event|0|||
163096018|NCT05554146|589062603|FG001|Overall Study|Adverse Event|1|||
163096019|NCT05554146|589062604|FG002|Overall Study|Adverse Event|0|||
163096020|NCT05554146|589062605|FG003|Overall Study|Adverse Event|0|||
163096021|NCT05554146|589062602|FG000|Overall Study|Protocol Violation|0|||
163096022|NCT05554146|589062603|FG001|Overall Study|Protocol Violation|1|||
163096023|NCT05554146|589062604|FG002|Overall Study|Protocol Violation|0|||
163096024|NCT05554146|589062605|FG003|Overall Study|Protocol Violation|0|||
163096025|NCT05554146|589062602|FG000|Overall Study|No longer interested in participating|0|||
163096026|NCT05554146|589062603|FG001|Overall Study|No longer interested in participating|0|||
163096027|NCT05554146|589062604|FG002|Overall Study|No longer interested in participating|1|||
163096028|NCT05554146|589062605|FG003|Overall Study|No longer interested in participating|0|||
163096029|NCT05554146|589062602|FG000|Overall Study|Lost to Follow-up|1|||
163096030|NCT05554146|589062603|FG001|Overall Study|Lost to Follow-up|0|||
163096031|NCT05554146|589062604|FG002|Overall Study|Lost to Follow-up|0|||
163096032|NCT05554146|589062605|FG003|Overall Study|Lost to Follow-up|0|||
163096033|NCT03073525|589062608|FG000|Overall Study|Withdrawal by Subject|0|||
163096034|NCT03073525|589062609|FG001|Overall Study|Withdrawal by Subject|0|||
163096035|NCT03073525|589062610|FG002|Overall Study|Withdrawal by Subject|3|||
163096036|NCT01976299|589062611|FG000|Overall Study|Withdrawal by Subject|3|||
163096037|NCT01976299|589062612|FG001|Overall Study|Withdrawal by Subject|1|||
163096038|NCT01976299|589062611|FG000|Overall Study|Death|4|||
163096039|NCT01976299|589062612|FG001|Overall Study|Death|2|||
163096040|NCT01976299|589062611|FG000|Overall Study|Lost to Follow-up|7|||
163096041|NCT01976299|589062612|FG001|Overall Study|Lost to Follow-up|1|||
163096042|NCT01976299|589062611|FG000|Overall Study|See clarification above in comments|9|||
163096043|NCT01976299|589062612|FG001|Overall Study|See clarification above in comments|2|||
163096044|NCT01484496|589062614|FG000|Period 1|Protocol Violation|3|||
163096045|NCT01484496|589062615|FG001|Period 1|Protocol Violation|4|||
163096046|NCT01484496|589062616|FG002|Period 1|Protocol Violation|0|||
163096047|NCT01484496|589062617|FG003|Period 1|Protocol Violation|0|||
163096048|NCT01484496|589062614|FG000|Period 1|Physician Decision|5|||
163096049|NCT01484496|589062615|FG001|Period 1|Physician Decision|1|||
163096050|NCT01484496|589062616|FG002|Period 1|Physician Decision|0|||
163096051|NCT01484496|589062617|FG003|Period 1|Physician Decision|0|||
163096052|NCT01484496|589062614|FG000|Period 1|Lack of Efficacy|10|||
163096053|NCT01484496|589062615|FG001|Period 1|Lack of Efficacy|15|||
163096054|NCT01484496|589062616|FG002|Period 1|Lack of Efficacy|0|||
163096055|NCT01484496|589062617|FG003|Period 1|Lack of Efficacy|0|||
163096056|NCT01484496|589062614|FG000|Period 1|Adverse Event|25|||
163096057|NCT01484496|589062615|FG001|Period 1|Adverse Event|40|||
163096058|NCT01484496|589062616|FG002|Period 1|Adverse Event|0|||
163096059|NCT01484496|589062617|FG003|Period 1|Adverse Event|0|||
163096060|NCT01484496|589062614|FG000|Period 1|Withdrawal by Subject|15|||
163096061|NCT01484496|589062615|FG001|Period 1|Withdrawal by Subject|12|||
163096062|NCT01484496|589062616|FG002|Period 1|Withdrawal by Subject|0|||
163096063|NCT01484496|589062617|FG003|Period 1|Withdrawal by Subject|0|||
163096064|NCT01484496|589062614|FG000|Period 1|Lost to Follow-up|2|||
163096065|NCT01484496|589062615|FG001|Period 1|Lost to Follow-up|6|||
163096066|NCT01484496|589062616|FG002|Period 1|Lost to Follow-up|0|||
163096067|NCT01484496|589062617|FG003|Period 1|Lost to Follow-up|0|||
163096068|NCT01484496|589062614|FG000|Period 1|Positive Pregnancy|1|||
163096069|NCT01484496|589062615|FG001|Period 1|Positive Pregnancy|6|||
163096070|NCT01484496|589062616|FG002|Period 1|Positive Pregnancy|0|||
163096071|NCT01484496|589062617|FG003|Period 1|Positive Pregnancy|0|||
163096072|NCT01484496|589062614|FG000|Period 1|Treatment Failure|3|||
163096073|NCT01484496|589062615|FG001|Period 1|Treatment Failure|6|||
163096074|NCT01484496|589062616|FG002|Period 1|Treatment Failure|0|||
163096075|NCT01484496|589062617|FG003|Period 1|Treatment Failure|0|||
163096076|NCT01484496|589062614|FG000|Period 1|Lack of Compliance|2|||
163096077|NCT01484496|589062615|FG001|Period 1|Lack of Compliance|1|||
163096078|NCT01484496|589062616|FG002|Period 1|Lack of Compliance|0|||
163096079|NCT01484496|589062617|FG003|Period 1|Lack of Compliance|0|||
163096080|NCT01484496|589062614|FG000|Period 1|Unable to Visit Site|0|||
163096081|NCT01484496|589062615|FG001|Period 1|Unable to Visit Site|2|||
163096082|NCT01484496|589062616|FG002|Period 1|Unable to Visit Site|0|||
163096083|NCT01484496|589062617|FG003|Period 1|Unable to Visit Site|0|||
163096084|NCT01484496|589062614|FG000|Period 2|Lack of Efficacy|0|||
163096085|NCT01484496|589062615|FG001|Period 2|Lack of Efficacy|0|||
163096086|NCT01484496|589062616|FG002|Period 2|Lack of Efficacy|1|||
163096087|NCT01484496|589062617|FG003|Period 2|Lack of Efficacy|3|||
163096088|NCT01484496|589062614|FG000|Period 2|Adverse Event|0|||
163096089|NCT01484496|589062615|FG001|Period 2|Adverse Event|0|||
163096090|NCT01484496|589062616|FG002|Period 2|Adverse Event|5|||
163096091|NCT01484496|589062617|FG003|Period 2|Adverse Event|13|||
163096092|NCT01484496|589062614|FG000|Period 2|Other|0|||
163096093|NCT01484496|589062615|FG001|Period 2|Other|0|||
163096094|NCT01484496|589062616|FG002|Period 2|Other|9|||
163096095|NCT01484496|589062617|FG003|Period 2|Other|6|||
163096096|NCT01645735|589062618|FG000|Overall Study|Physician Decision|2|||
163096097|NCT01645735|589062619|FG001|Overall Study|Physician Decision|0|||
163096098|NCT01645735|589062618|FG000|Overall Study|Withdrawal by Subject|1|||
163096099|NCT01645735|589062619|FG001|Overall Study|Withdrawal by Subject|0|||
163096100|NCT01645735|589062618|FG000|Overall Study|Protocol Violation|1|||
163096101|NCT01645735|589062619|FG001|Overall Study|Protocol Violation|0|||
163096102|NCT01645735|589062618|FG000|Overall Study|Adverse Event|0|||
163096103|NCT01645735|589062619|FG001|Overall Study|Adverse Event|1|||
163096104|NCT01791517|589062622|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
163096105|NCT01791517|589062623|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
163096106|NCT01791517|589062624|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
163096107|NCT01791517|589062625|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
163096108|NCT01791517|589062626|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
163096109|NCT01791517|589062627|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
163096110|NCT01791517|589062628|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
163338742|NCT02644122|589949017|FG000|Overall Study|Withdrawal by Subject|1|||
163096111|NCT01791517|589062629|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
163096112|NCT01791517|589062630|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
163096113|NCT01791517|589062631|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
163096114|NCT01791517|589062632|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
163096115|NCT01791517|589062633|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
163096116|NCT01791517|589062622|FG000|Phase I: Period 1|Adverse Event|0|||
163096117|NCT01791517|589062623|FG001|Phase I: Period 1|Adverse Event|0|||
163338743|NCT00424476|589949020|FG000|Overall Study|Withdrawal by Subject|7|||
163096118|NCT01791517|589062624|FG002|Phase I: Period 1|Adverse Event|1|||
163096119|NCT01791517|589062625|FG003|Phase I: Period 1|Adverse Event|1|||
163096120|NCT01791517|589062626|FG004|Phase I: Period 1|Adverse Event|0|||
163096121|NCT01791517|589062627|FG005|Phase I: Period 1|Adverse Event|0|||
163096122|NCT01791517|589062628|FG006|Phase I: Period 1|Adverse Event|0|||
163096123|NCT01791517|589062629|FG007|Phase I: Period 1|Adverse Event|0|||
163096124|NCT01791517|589062630|FG008|Phase I: Period 1|Adverse Event|0|||
163096125|NCT01791517|589062631|FG009|Phase I: Period 1|Adverse Event|0|||
163096126|NCT01791517|589062632|FG010|Phase I: Period 1|Adverse Event|0|||
163096127|NCT01791517|589062633|FG011|Phase I: Period 1|Adverse Event|0|||
163096128|NCT01791517|589062622|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
163338744|NCT00424476|589949021|FG001|Overall Study|Withdrawal by Subject|6|||
163096129|NCT01791517|589062623|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096130|NCT01791517|589062624|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096131|NCT01791517|589062625|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096132|NCT01791517|589062626|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096133|NCT01791517|589062627|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096134|NCT01791517|589062628|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096135|NCT01791517|589062629|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096136|NCT01791517|589062630|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096137|NCT01791517|589062631|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096138|NCT01791517|589062632|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096139|NCT01791517|589062633|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096140|NCT01791517|589062622|FG000|Phase I: Period 1|Protocol Violation|0|||
163096141|NCT01791517|589062623|FG001|Phase I: Period 1|Protocol Violation|1|||
163096142|NCT01791517|589062624|FG002|Phase I: Period 1|Protocol Violation|0|||
163096143|NCT01791517|589062625|FG003|Phase I: Period 1|Protocol Violation|0|||
163096144|NCT01791517|589062626|FG004|Phase I: Period 1|Protocol Violation|0|||
163338745|NCT00424476|589949022|FG002|Overall Study|Withdrawal by Subject|3|||
163338746|NCT00424476|589949020|FG000|Overall Study|Adverse Event|19|||
163338747|NCT00424476|589949021|FG001|Overall Study|Adverse Event|16|||
163338748|NCT00424476|589949022|FG002|Overall Study|Adverse Event|15|||
163338749|NCT00424476|589949020|FG000|Overall Study|Lack of Efficacy|16|||
163338750|NCT00424476|589949021|FG001|Overall Study|Lack of Efficacy|12|||
163338751|NCT00424476|589949022|FG002|Overall Study|Lack of Efficacy|12|||
163338752|NCT00424476|589949020|FG000|Overall Study|Lack of Compliance|1|||
163338753|NCT00424476|589949021|FG001|Overall Study|Lack of Compliance|1|||
163338754|NCT00424476|589949022|FG002|Overall Study|Lack of Compliance|1|||
163338755|NCT00424476|589949020|FG000|Overall Study|Lost to Follow-up|4|||
163338756|NCT00424476|589949021|FG001|Overall Study|Lost to Follow-up|6|||
163338757|NCT00424476|589949022|FG002|Overall Study|Lost to Follow-up|3|||
163338758|NCT00424476|589949020|FG000|Overall Study|Protocol Violation|7|||
163338759|NCT00424476|589949021|FG001|Overall Study|Protocol Violation|2|||
163338760|NCT00424476|589949022|FG002|Overall Study|Protocol Violation|3|||
163338761|NCT00424476|589949020|FG000|Overall Study|Physician Decision|3|||
163338762|NCT00424476|589949021|FG001|Overall Study|Physician Decision|2|||
163338763|NCT00424476|589949022|FG002|Overall Study|Physician Decision|3|||
163338764|NCT00424476|589949020|FG000|Overall Study|Other|4|||
163096145|NCT01791517|589062627|FG005|Phase I: Period 1|Protocol Violation|0|||
163096146|NCT01791517|589062628|FG006|Phase I: Period 1|Protocol Violation|0|||
163096147|NCT01791517|589062629|FG007|Phase I: Period 1|Protocol Violation|0|||
163338765|NCT00424476|589949021|FG001|Overall Study|Other|3|||
163338766|NCT00424476|589949022|FG002|Overall Study|Other|9|||
163338767|NCT02514824|589949023|FG000|Overall Study|Withdrawal by Subject|1|||
163338768|NCT02514824|589949024|FG001|Overall Study|Withdrawal by Subject|0|||
163338769|NCT02514824|589949025|FG002|Overall Study|Withdrawal by Subject|0|||
163338770|NCT02514824|589949026|FG003|Overall Study|Withdrawal by Subject|0|||
163338771|NCT02514824|589949023|FG000|Overall Study|Dose-Limiting Toxicity|0|||
163338772|NCT02514824|589949024|FG001|Overall Study|Dose-Limiting Toxicity|1|||
163338773|NCT02514824|589949025|FG002|Overall Study|Dose-Limiting Toxicity|0|||
163338774|NCT02514824|589949026|FG003|Overall Study|Dose-Limiting Toxicity|0|||
163338775|NCT02159352|589949029|FG000|Overall Study|Adverse Event|3|||
163338776|NCT02159352|589949030|FG001|Overall Study|Adverse Event|1|||
163338777|NCT02159352|589949029|FG000|Overall Study|Withdrawal by Subject|0|||
163338778|NCT02159352|589949030|FG001|Overall Study|Withdrawal by Subject|1|||
163338779|NCT00529529|589949031|FG000|Overall Study|Adverse Event|12|||
163338780|NCT00529529|589949032|FG001|Overall Study|Adverse Event|17|||
163338781|NCT00529529|589949033|FG002|Overall Study|Adverse Event|8|||
163338782|NCT00529529|589949031|FG000|Overall Study|Subject withdrew consent|12|||
163338783|NCT00529529|589949032|FG001|Overall Study|Subject withdrew consent|9|||
163338784|NCT00529529|589949033|FG002|Overall Study|Subject withdrew consent|12|||
163338785|NCT00529529|589949031|FG000|Overall Study|Protocol deviation|8|||
163338786|NCT00529529|589949032|FG001|Overall Study|Protocol deviation|12|||
163096148|NCT01791517|589062630|FG008|Phase I: Period 1|Protocol Violation|0|||
163096149|NCT01791517|589062631|FG009|Phase I: Period 1|Protocol Violation|0|||
163338787|NCT00529529|589949033|FG002|Overall Study|Protocol deviation|5|||
163338788|NCT00529529|589949031|FG000|Overall Study|Lost to Follow-up|5|||
163338789|NCT00529529|589949032|FG001|Overall Study|Lost to Follow-up|3|||
163096150|NCT01791517|589062632|FG010|Phase I: Period 1|Protocol Violation|0|||
163338790|NCT00529529|589949033|FG002|Overall Study|Lost to Follow-up|1|||
163338791|NCT00529529|589949031|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163338792|NCT00529529|589949032|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163338793|NCT00529529|589949033|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
163338794|NCT00529529|589949031|FG000|Overall Study|Death|2|||
163338795|NCT00529529|589949032|FG001|Overall Study|Death|0|||
163338796|NCT00529529|589949033|FG002|Overall Study|Death|0|||
163338797|NCT00529529|589949031|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163338798|NCT00529529|589949032|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163096151|NCT01791517|589062633|FG011|Phase I: Period 1|Protocol Violation|0|||
163220120|NCT02039674|589521410|FG004|Overall Study|Lost to Follow-up|1|||
163338799|NCT00529529|589949033|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163096152|NCT01791517|589062622|FG000|Phase I: Period 1|Lost to Follow-up|0|||
163096153|NCT01791517|589062623|FG001|Phase I: Period 1|Lost to Follow-up|0|||
163096154|NCT01791517|589062624|FG002|Phase I: Period 1|Lost to Follow-up|0|||
163096155|NCT01791517|589062625|FG003|Phase I: Period 1|Lost to Follow-up|1|||
163096156|NCT01791517|589062626|FG004|Phase I: Period 1|Lost to Follow-up|0|||
163096157|NCT01791517|589062627|FG005|Phase I: Period 1|Lost to Follow-up|0|||
163096158|NCT01791517|589062628|FG006|Phase I: Period 1|Lost to Follow-up|1|||
163096159|NCT01791517|589062629|FG007|Phase I: Period 1|Lost to Follow-up|0|||
163096160|NCT01791517|589062630|FG008|Phase I: Period 1|Lost to Follow-up|1|||
163096161|NCT01791517|589062631|FG009|Phase I: Period 1|Lost to Follow-up|1|||
163096162|NCT01791517|589062632|FG010|Phase I: Period 1|Lost to Follow-up|0|||
163096163|NCT01791517|589062633|FG011|Phase I: Period 1|Lost to Follow-up|0|||
163096164|NCT01791517|589062622|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096165|NCT01791517|589062623|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096166|NCT01791517|589062624|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096167|NCT01791517|589062625|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096168|NCT01791517|589062626|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096169|NCT01791517|589062627|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096170|NCT01791517|589062628|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096171|NCT01791517|589062629|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096172|NCT01791517|589062630|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096173|NCT01791517|589062631|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096174|NCT01791517|589062632|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096175|NCT01791517|589062633|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
163096176|NCT01791517|589062622|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
163096177|NCT01791517|589062623|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096178|NCT01791517|589062624|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096179|NCT01791517|589062625|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096180|NCT01791517|589062626|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096181|NCT01791517|589062627|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096182|NCT01791517|589062628|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096183|NCT01791517|589062629|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096184|NCT01791517|589062630|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096185|NCT01791517|589062631|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096186|NCT01791517|589062632|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096187|NCT01791517|589062633|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096188|NCT01791517|589062622|FG000|Phase I: Period 2|Protocol Violation|0|||
163096189|NCT01791517|589062623|FG001|Phase I: Period 2|Protocol Violation|0|||
163096190|NCT01791517|589062624|FG002|Phase I: Period 2|Protocol Violation|0|||
163096191|NCT01791517|589062625|FG003|Phase I: Period 2|Protocol Violation|1|||
163096192|NCT01791517|589062626|FG004|Phase I: Period 2|Protocol Violation|0|||
163096193|NCT01791517|589062627|FG005|Phase I: Period 2|Protocol Violation|0|||
163096194|NCT01791517|589062628|FG006|Phase I: Period 2|Protocol Violation|0|||
163096195|NCT01791517|589062629|FG007|Phase I: Period 2|Protocol Violation|0|||
163096196|NCT01791517|589062630|FG008|Phase I: Period 2|Protocol Violation|0|||
163338800|NCT00529529|589949031|FG000|Overall Study|Administrative problems|1|||
163338801|NCT00529529|589949032|FG001|Overall Study|Administrative problems|0|||
163338802|NCT00529529|589949033|FG002|Overall Study|Administrative problems|3|||
163338803|NCT00337610|589949034|FG000|Overall Study|Adverse Event|2|||
163338804|NCT00337610|589949035|FG001|Overall Study|Adverse Event|2|||
163338805|NCT00337610|589949034|FG000|Overall Study|Death|0|||
163338806|NCT00337610|589949035|FG001|Overall Study|Death|1|||
163338807|NCT00337610|589949034|FG000|Overall Study|Lack of Efficacy|6|||
163338808|NCT00337610|589949035|FG001|Overall Study|Lack of Efficacy|3|||
163338809|NCT00337610|589949034|FG000|Overall Study|Lost to Follow-up|3|||
163338810|NCT00337610|589949035|FG001|Overall Study|Lost to Follow-up|3|||
163338811|NCT00337610|589949034|FG000|Overall Study|Withdrawal by Subject|6|||
163338812|NCT00337610|589949035|FG001|Overall Study|Withdrawal by Subject|5|||
163338813|NCT03979040|589949036|FG000|Overall Study|Withdrawal by Subject|24|||
163338814|NCT03979040|589949037|FG001|Overall Study|Withdrawal by Subject|32|||
163338815|NCT03979040|589949036|FG000|Overall Study|randomized but never started treatment|32|||
163096197|NCT01791517|589062631|FG009|Phase I: Period 2|Protocol Violation|0|||
163096198|NCT01791517|589062632|FG010|Phase I: Period 2|Protocol Violation|0|||
163338816|NCT03979040|589949037|FG001|Overall Study|randomized but never started treatment|39|||
163338817|NCT03979040|589949036|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
163338818|NCT03979040|589949037|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
163338819|NCT02279732|589949044|FG000|Overall Study|Death|23|||
163338820|NCT02279732|589949045|FG001|Overall Study|Death|20|||
163096199|NCT01791517|589062633|FG011|Phase I: Period 2|Protocol Violation|0|||
163096200|NCT01791517|589062622|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
163096201|NCT01791517|589062623|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
163096202|NCT01791517|589062624|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
163338821|NCT02279732|589949044|FG000|Overall Study|Disease Progression|13|||
163096203|NCT01791517|589062625|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
163338822|NCT02279732|589949045|FG001|Overall Study|Disease Progression|3|||
163096204|NCT01791517|589062626|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
163096205|NCT01791517|589062627|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
163096206|NCT01791517|589062628|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
163096207|NCT01791517|589062629|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
163096208|NCT01791517|589062630|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
163096209|NCT01791517|589062631|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
163096210|NCT01791517|589062632|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
163096211|NCT01791517|589062633|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
163096212|NCT01791517|589062622|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096213|NCT01791517|589062623|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096214|NCT01791517|589062624|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096215|NCT01791517|589062625|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096216|NCT01791517|589062626|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096217|NCT01791517|589062627|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096218|NCT01791517|589062628|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096219|NCT01791517|589062629|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096220|NCT01791517|589062630|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096221|NCT01791517|589062631|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096222|NCT01791517|589062632|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
163096223|NCT01791517|589062633|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096224|NCT01791517|589062622|FG000|Phase I: Period 2|Lens Discomfort|0|||
163096225|NCT01791517|589062623|FG001|Phase I: Period 2|Lens Discomfort|0|||
163096226|NCT01791517|589062624|FG002|Phase I: Period 2|Lens Discomfort|0|||
163096227|NCT01791517|589062625|FG003|Phase I: Period 2|Lens Discomfort|0|||
163096228|NCT01791517|589062626|FG004|Phase I: Period 2|Lens Discomfort|0|||
163096229|NCT01791517|589062627|FG005|Phase I: Period 2|Lens Discomfort|1|||
163096230|NCT01791517|589062628|FG006|Phase I: Period 2|Lens Discomfort|0|||
163096231|NCT01791517|589062629|FG007|Phase I: Period 2|Lens Discomfort|0|||
163096232|NCT01791517|589062630|FG008|Phase I: Period 2|Lens Discomfort|0|||
163096233|NCT01791517|589062631|FG009|Phase I: Period 2|Lens Discomfort|0|||
163096234|NCT01791517|589062632|FG010|Phase I: Period 2|Lens Discomfort|0|||
163096235|NCT01791517|589062633|FG011|Phase I: Period 2|Lens Discomfort|0|||
163096236|NCT01791517|589062622|FG000|Phase I: Period 2|Lost to Follow-up|0|||
163096237|NCT01791517|589062623|FG001|Phase I: Period 2|Lost to Follow-up|3|||
163096238|NCT01791517|589062624|FG002|Phase I: Period 2|Lost to Follow-up|2|||
163096239|NCT01791517|589062625|FG003|Phase I: Period 2|Lost to Follow-up|0|||
163096240|NCT01791517|589062626|FG004|Phase I: Period 2|Lost to Follow-up|0|||
163096241|NCT01791517|589062627|FG005|Phase I: Period 2|Lost to Follow-up|0|||
163096242|NCT01791517|589062628|FG006|Phase I: Period 2|Lost to Follow-up|0|||
163096243|NCT01791517|589062629|FG007|Phase I: Period 2|Lost to Follow-up|0|||
163096244|NCT01791517|589062630|FG008|Phase I: Period 2|Lost to Follow-up|0|||
163096245|NCT01791517|589062631|FG009|Phase I: Period 2|Lost to Follow-up|0|||
163096246|NCT01791517|589062632|FG010|Phase I: Period 2|Lost to Follow-up|0|||
163096247|NCT01791517|589062633|FG011|Phase I: Period 2|Lost to Follow-up|0|||
163096248|NCT01791517|589062622|FG000|Phase I: Period 3|Lens Discomfort|0|||
163096249|NCT01791517|589062623|FG001|Phase I: Period 3|Lens Discomfort|0|||
163096250|NCT01791517|589062624|FG002|Phase I: Period 3|Lens Discomfort|0|||
163096251|NCT01791517|589062625|FG003|Phase I: Period 3|Lens Discomfort|0|||
163096252|NCT01791517|589062626|FG004|Phase I: Period 3|Lens Discomfort|0|||
163096253|NCT01791517|589062627|FG005|Phase I: Period 3|Lens Discomfort|0|||
163096254|NCT01791517|589062628|FG006|Phase I: Period 3|Lens Discomfort|0|||
163096255|NCT01791517|589062629|FG007|Phase I: Period 3|Lens Discomfort|0|||
163096256|NCT01791517|589062630|FG008|Phase I: Period 3|Lens Discomfort|0|||
163096257|NCT01791517|589062631|FG009|Phase I: Period 3|Lens Discomfort|0|||
163096258|NCT01791517|589062632|FG010|Phase I: Period 3|Lens Discomfort|0|||
163338823|NCT02279732|589949044|FG000|Overall Study|Withdrawal by Subject|2|||
163338824|NCT02279732|589949045|FG001|Overall Study|Withdrawal by Subject|7|||
163338825|NCT02279732|589949044|FG000|Overall Study|Adverse Event|1|||
163338826|NCT02279732|589949045|FG001|Overall Study|Adverse Event|2|||
163338827|NCT02279732|589949044|FG000|Overall Study|Administrative Reason By Sponsor|0|||
163338828|NCT02279732|589949045|FG001|Overall Study|Administrative Reason By Sponsor|2|||
163096259|NCT01791517|589062633|FG011|Phase I: Period 3|Lens Discomfort|1|||
163096260|NCT01791517|589062622|FG000|Phase I: Period 3|Lost to Follow-up|0|||
163096261|NCT01791517|589062623|FG001|Phase I: Period 3|Lost to Follow-up|1|||
163096262|NCT01791517|589062624|FG002|Phase I: Period 3|Lost to Follow-up|0|||
163096263|NCT01791517|589062625|FG003|Phase I: Period 3|Lost to Follow-up|0|||
163096264|NCT01791517|589062626|FG004|Phase I: Period 3|Lost to Follow-up|1|||
163096265|NCT01791517|589062627|FG005|Phase I: Period 3|Lost to Follow-up|0|||
163096266|NCT01791517|589062628|FG006|Phase I: Period 3|Lost to Follow-up|0|||
163096267|NCT01791517|589062629|FG007|Phase I: Period 3|Lost to Follow-up|0|||
163096268|NCT01791517|589062630|FG008|Phase I: Period 3|Lost to Follow-up|0|||
163096269|NCT01791517|589062631|FG009|Phase I: Period 3|Lost to Follow-up|0|||
163096270|NCT01791517|589062632|FG010|Phase I: Period 3|Lost to Follow-up|0|||
163096271|NCT01791517|589062633|FG011|Phase I: Period 3|Lost to Follow-up|0|||
163096272|NCT01791517|589062622|FG000|Phase I: Period 3|Adverse Event|0|||
163096273|NCT01791517|589062623|FG001|Phase I: Period 3|Adverse Event|0|||
163096274|NCT01791517|589062624|FG002|Phase I: Period 3|Adverse Event|0|||
163096275|NCT01791517|589062625|FG003|Phase I: Period 3|Adverse Event|1|||
163096276|NCT01791517|589062626|FG004|Phase I: Period 3|Adverse Event|0|||
163096277|NCT01791517|589062627|FG005|Phase I: Period 3|Adverse Event|0|||
163096278|NCT01791517|589062628|FG006|Phase I: Period 3|Adverse Event|0|||
163096279|NCT01791517|589062629|FG007|Phase I: Period 3|Adverse Event|0|||
163096280|NCT01791517|589062630|FG008|Phase I: Period 3|Adverse Event|0|||
163096281|NCT01791517|589062631|FG009|Phase I: Period 3|Adverse Event|0|||
163096282|NCT01791517|589062632|FG010|Phase I: Period 3|Adverse Event|0|||
163096283|NCT01791517|589062633|FG011|Phase I: Period 3|Adverse Event|0|||
163096284|NCT01791517|589062622|FG000|Phase II|Lost to Follow-up|1|||
163096285|NCT01791517|589062623|FG001|Phase II|Lost to Follow-up|0|||
163096286|NCT01791517|589062624|FG002|Phase II|Lost to Follow-up|1|||
163096287|NCT01791517|589062625|FG003|Phase II|Lost to Follow-up|0|||
163096288|NCT01791517|589062626|FG004|Phase II|Lost to Follow-up|1|||
163096289|NCT01791517|589062627|FG005|Phase II|Lost to Follow-up|2|||
163096290|NCT01791517|589062628|FG006|Phase II|Lost to Follow-up|0|||
163096291|NCT01791517|589062629|FG007|Phase II|Lost to Follow-up|1|||
163096292|NCT01791517|589062630|FG008|Phase II|Lost to Follow-up|1|||
163338829|NCT02279732|589949044|FG000|Overall Study|Study Drug Toxicity|2|||
163096293|NCT01791517|589062631|FG009|Phase II|Lost to Follow-up|1|||
163096294|NCT01791517|589062632|FG010|Phase II|Lost to Follow-up|0|||
163096295|NCT01791517|589062633|FG011|Phase II|Lost to Follow-up|0|||
163096296|NCT01791517|589062622|FG000|Phase II|Withdrawal by Subject|1|||
163096297|NCT01791517|589062623|FG001|Phase II|Withdrawal by Subject|0|||
163338830|NCT02279732|589949045|FG001|Overall Study|Study Drug Toxicity|0|||
163338831|NCT02279732|589949044|FG000|Overall Study|Lost to Follow-up|0|||
163338832|NCT02279732|589949045|FG001|Overall Study|Lost to Follow-up|1|||
163338833|NCT02279732|589949044|FG000|Overall Study|Maximum Clinical Benefit|1|||
163338834|NCT02279732|589949045|FG001|Overall Study|Maximum Clinical Benefit|0|||
163338835|NCT02279732|589949044|FG000|Overall Study|Subject Requested to Discontinue|0|||
163338836|NCT02279732|589949045|FG001|Overall Study|Subject Requested to Discontinue|1|||
163096298|NCT01791517|589062624|FG002|Phase II|Withdrawal by Subject|0|||
163096299|NCT01791517|589062625|FG003|Phase II|Withdrawal by Subject|0|||
163096300|NCT01791517|589062626|FG004|Phase II|Withdrawal by Subject|0|||
163096301|NCT01791517|589062627|FG005|Phase II|Withdrawal by Subject|2|||
163096302|NCT01791517|589062628|FG006|Phase II|Withdrawal by Subject|0|||
163096303|NCT01791517|589062629|FG007|Phase II|Withdrawal by Subject|1|||
163096304|NCT01791517|589062630|FG008|Phase II|Withdrawal by Subject|0|||
163096305|NCT01791517|589062631|FG009|Phase II|Withdrawal by Subject|0|||
163096306|NCT01791517|589062632|FG010|Phase II|Withdrawal by Subject|1|||
163096307|NCT01791517|589062633|FG011|Phase II|Withdrawal by Subject|0|||
163096308|NCT01791517|589062622|FG000|Phase II|Lack of Efficacy|0|||
163096309|NCT01791517|589062623|FG001|Phase II|Lack of Efficacy|0|||
163096310|NCT01791517|589062624|FG002|Phase II|Lack of Efficacy|0|||
163096311|NCT01791517|589062625|FG003|Phase II|Lack of Efficacy|0|||
163096312|NCT01791517|589062626|FG004|Phase II|Lack of Efficacy|1|||
163096313|NCT01791517|589062627|FG005|Phase II|Lack of Efficacy|0|||
163096314|NCT01791517|589062628|FG006|Phase II|Lack of Efficacy|0|||
163096315|NCT01791517|589062629|FG007|Phase II|Lack of Efficacy|0|||
163096316|NCT01791517|589062630|FG008|Phase II|Lack of Efficacy|0|||
163096317|NCT01791517|589062631|FG009|Phase II|Lack of Efficacy|0|||
163096318|NCT01791517|589062632|FG010|Phase II|Lack of Efficacy|0|||
163096319|NCT01791517|589062633|FG011|Phase II|Lack of Efficacy|0|||
163096320|NCT01791517|589062622|FG000|Phase II|Adverse Event|0|||
163096321|NCT01791517|589062623|FG001|Phase II|Adverse Event|0|||
163096322|NCT01791517|589062624|FG002|Phase II|Adverse Event|0|||
163096323|NCT01791517|589062625|FG003|Phase II|Adverse Event|0|||
163407639|NCT02706873|590200874|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
163096324|NCT01791517|589062626|FG004|Phase II|Adverse Event|0|||
163096325|NCT01791517|589062627|FG005|Phase II|Adverse Event|0|||
163096326|NCT01791517|589062628|FG006|Phase II|Adverse Event|2|||
163096327|NCT01791517|589062629|FG007|Phase II|Adverse Event|1|||
163096328|NCT01791517|589062630|FG008|Phase II|Adverse Event|0|||
163096329|NCT01791517|589062631|FG009|Phase II|Adverse Event|1|||
163096330|NCT01791517|589062632|FG010|Phase II|Adverse Event|0|||
163338837|NCT02279732|589949044|FG000|Overall Study|Other|53|||
163338838|NCT02279732|589949045|FG001|Overall Study|Other|67|||
163338839|NCT02279732|589949044|FG000|Overall Study|Other|3|||
163096331|NCT01791517|589062633|FG011|Phase II|Adverse Event|0|||
163096332|NCT01791517|589062622|FG000|Phase II|Lens Handling Difficulties|0|||
163096333|NCT01791517|589062623|FG001|Phase II|Lens Handling Difficulties|0|||
163096334|NCT01791517|589062624|FG002|Phase II|Lens Handling Difficulties|0|||
163096335|NCT01791517|589062625|FG003|Phase II|Lens Handling Difficulties|0|||
163096336|NCT01791517|589062626|FG004|Phase II|Lens Handling Difficulties|0|||
163096337|NCT01791517|589062627|FG005|Phase II|Lens Handling Difficulties|0|||
163096338|NCT01791517|589062628|FG006|Phase II|Lens Handling Difficulties|0|||
163096339|NCT01791517|589062629|FG007|Phase II|Lens Handling Difficulties|0|||
163096340|NCT01791517|589062630|FG008|Phase II|Lens Handling Difficulties|1|||
163096341|NCT01791517|589062631|FG009|Phase II|Lens Handling Difficulties|0|||
163096342|NCT01791517|589062632|FG010|Phase II|Lens Handling Difficulties|0|||
163220121|NCT02039674|589521411|FG005|Overall Study|Lost to Follow-up|1|||
163338840|NCT02279732|589949045|FG001|Overall Study|Other|3|||
163338841|NCT03020914|589951022|FG000|Overall Study|Surgery Cancelled|1|||
163338842|NCT03020914|589951023|FG001|Overall Study|Surgery Cancelled|0|||
163338849|NCT04620733|589951030|FG000|Overall Study|Adverse Event|4|||
163338850|NCT04620733|589951031|FG001|Overall Study|Adverse Event|3|||
163338851|NCT04620733|589951030|FG000|Overall Study|Withdrawal by Subject|2|||
163338852|NCT04620733|589951031|FG001|Overall Study|Withdrawal by Subject|5|||
163338853|NCT04620733|589951030|FG000|Overall Study|Lost to Follow-up|1|||
163338854|NCT04620733|589951031|FG001|Overall Study|Lost to Follow-up|1|||
163338855|NCT04620733|589951030|FG000|Overall Study|Protocol Deviation|1|||
163338856|NCT04620733|589951031|FG001|Overall Study|Protocol Deviation|1|||
163338857|NCT04620733|589951030|FG000|Overall Study|Reason Not Specified|0|||
163338858|NCT04620733|589951031|FG001|Overall Study|Reason Not Specified|1|||
163338859|NCT03976102|589951035|FG000|Overall Study|Withdrawal by Subject|4|||
163338860|NCT03976102|589951036|FG001|Overall Study|Withdrawal by Subject|4|||
163338861|NCT03976102|589951035|FG000|Overall Study|Adverse Event|2|||
163338862|NCT03976102|589951036|FG001|Overall Study|Adverse Event|4|||
163338863|NCT03976102|589951035|FG000|Overall Study|Not related to Covid-19|9|||
163338864|NCT03976102|589951036|FG001|Overall Study|Not related to Covid-19|13|||
163338865|NCT03976102|589951035|FG000|Overall Study|Lost to Follow-up|0|||
163338866|NCT03976102|589951036|FG001|Overall Study|Lost to Follow-up|2|||
163338867|NCT03976102|589951035|FG000|Overall Study|Death|3|||
163338868|NCT03976102|589951036|FG001|Overall Study|Death|2|||
163338869|NCT03976102|589951035|FG000|Overall Study|Physician Decision|1|||
163338870|NCT03976102|589951036|FG001|Overall Study|Physician Decision|1|||
163338871|NCT00451906|589951038|FG000|Overall Study|Adverse Event|515|||
163338872|NCT00451906|589951038|FG000|Overall Study|Lost to Follow-up|31|||
163338873|NCT00451906|589951038|FG000|Overall Study|Withdrawal by Subject|111|||
163338874|NCT00451906|589951038|FG000|Overall Study|Protocol Violation|21|||
163338875|NCT00451906|589951038|FG000|Overall Study|Progressive disease|1328|||
163338876|NCT00451906|589951038|FG000|Overall Study|Termination of the study|108|||
163338877|NCT00451906|589951038|FG000|Overall Study|Other Reasons|121|||
163338878|NCT00451906|589951038|FG000|Overall Study|Did not complete final visit|4|||
163338879|NCT02889900|589951046|FG000|Overall Study|Adverse Event|11|||
163338880|NCT02889900|589951046|FG000|Overall Study|Condition under investigation worsened|32|||
163338881|NCT02889900|589951046|FG000|Overall Study|Other|5|||
163338882|NCT02889900|589951046|FG000|Overall Study|Withdrawal by Subject|7|||
163338883|NCT02889900|589951046|FG000|Overall Study|Not treated|2|||
163338884|NCT00805792|589951047|FG000|Overall Study|Death|3|||
163338885|NCT00805792|589951047|FG000|Overall Study|Lost to Follow-up|2|||
163338886|NCT01416285|589951050|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
163338887|NCT01416285|589951051|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
163338888|NCT01248715|589951058|FG000|Overall Study|Not influenza positive|501|||
163338889|NCT01248715|589951059|FG001|Overall Study|Not influenza positive|510|||
163338890|NCT00813709|589951060|FG000|Double Blind Period|Adverse Event|4|||
163338891|NCT00813709|589951061|FG001|Double Blind Period|Adverse Event|1|||
163338892|NCT00813709|589951062|FG002|Double Blind Period|Adverse Event|4|||
163338893|NCT00813709|589951063|FG003|Double Blind Period|Adverse Event|0|||
163096343|NCT01791517|589062633|FG011|Phase II|Lens Handling Difficulties|0|||
163096344|NCT01791517|589062622|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
163096345|NCT01791517|589062623|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
163096346|NCT01791517|589062624|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
163096347|NCT01791517|589062625|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
163096348|NCT01791517|589062626|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
163338894|NCT00813709|589951064|FG004|Double Blind Period|Adverse Event|0|||
163338895|NCT00813709|589951065|FG005|Double Blind Period|Adverse Event|0|||
163338896|NCT00813709|589951060|FG000|Double Blind Period|Lost to Follow-up|3|||
163338897|NCT00813709|589951061|FG001|Double Blind Period|Lost to Follow-up|2|||
163096349|NCT01791517|589062627|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
163096350|NCT01791517|589062628|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
163338898|NCT00813709|589951062|FG002|Double Blind Period|Lost to Follow-up|2|||
163338899|NCT00813709|589951063|FG003|Double Blind Period|Lost to Follow-up|0|||
163338900|NCT00813709|589951064|FG004|Double Blind Period|Lost to Follow-up|0|||
163338901|NCT00813709|589951065|FG005|Double Blind Period|Lost to Follow-up|0|||
163338902|NCT00813709|589951060|FG000|Double Blind Period|Switched to open label phase|9|||
163338903|NCT00813709|589951061|FG001|Double Blind Period|Switched to open label phase|26|||
163338904|NCT00813709|589951062|FG002|Double Blind Period|Switched to open label phase|18|||
163338905|NCT00813709|589951063|FG003|Double Blind Period|Switched to open label phase|0|||
163338906|NCT00813709|589951064|FG004|Double Blind Period|Switched to open label phase|0|||
163338907|NCT00813709|589951065|FG005|Double Blind Period|Switched to open label phase|0|||
163338908|NCT00813709|589951060|FG000|Double Blind Period|Randomized but not treated|1|||
163338909|NCT00813709|589951061|FG001|Double Blind Period|Randomized but not treated|3|||
163338910|NCT00813709|589951062|FG002|Double Blind Period|Randomized but not treated|1|||
163096351|NCT01791517|589062629|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
163096352|NCT01791517|589062630|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
163096353|NCT01791517|589062631|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
163096354|NCT01791517|589062632|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
163096355|NCT01791517|589062633|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
163096356|NCT01791517|589062622|FG000|Phase II|Pre-Existing Ocular Issue|0|||
163096357|NCT01791517|589062623|FG001|Phase II|Pre-Existing Ocular Issue|0|||
163096358|NCT01791517|589062624|FG002|Phase II|Pre-Existing Ocular Issue|0|||
163096359|NCT01791517|589062625|FG003|Phase II|Pre-Existing Ocular Issue|0|||
163096360|NCT01791517|589062626|FG004|Phase II|Pre-Existing Ocular Issue|0|||
163096361|NCT01791517|589062627|FG005|Phase II|Pre-Existing Ocular Issue|0|||
163096362|NCT01791517|589062628|FG006|Phase II|Pre-Existing Ocular Issue|0|||
163096363|NCT01791517|589062629|FG007|Phase II|Pre-Existing Ocular Issue|0|||
163096364|NCT01791517|589062630|FG008|Phase II|Pre-Existing Ocular Issue|0|||
163096365|NCT01791517|589062631|FG009|Phase II|Pre-Existing Ocular Issue|0|||
163096366|NCT01791517|589062632|FG010|Phase II|Pre-Existing Ocular Issue|0|||
163096367|NCT01791517|589062633|FG011|Phase II|Pre-Existing Ocular Issue|1|||
163096368|NCT00589797|589062634|FG000|Overall Study|Death|1|||
163096369|NCT00589797|589062635|FG001|Overall Study|Death|0|||
163096370|NCT00589797|589062634|FG000|Overall Study|Lost to Follow-up|12|||
163096371|NCT00589797|589062635|FG001|Overall Study|Lost to Follow-up|9|||
163096372|NCT00589797|589062634|FG000|Overall Study|Physician Decision|8|||
163096373|NCT00589797|589062635|FG001|Overall Study|Physician Decision|3|||
163096374|NCT00589797|589062634|FG000|Overall Study|Withdrawal by Subject|6|||
163096375|NCT00589797|589062635|FG001|Overall Study|Withdrawal by Subject|5|||
163096376|NCT00589797|589062634|FG000|Overall Study|Non-Randomized Training Subjects|46|||
163096377|NCT00589797|589062635|FG001|Overall Study|Non-Randomized Training Subjects|6|||
163096378|NCT02141672|589062637|FG000|Overall Study|Adverse Event|0|||
163096379|NCT02141672|589062638|FG001|Overall Study|Adverse Event|1|||
163096380|NCT02141672|589062639|FG002|Overall Study|Adverse Event|0|||
163096381|NCT02141672|589062637|FG000|Overall Study|Death|10|||
163096382|NCT02141672|589062638|FG001|Overall Study|Death|2|||
163096383|NCT02141672|589062639|FG002|Overall Study|Death|1|||
163096384|NCT02141672|589062637|FG000|Overall Study|Lack of Efficacy|0|||
163096385|NCT02141672|589062638|FG001|Overall Study|Lack of Efficacy|0|||
163096386|NCT02141672|589062639|FG002|Overall Study|Lack of Efficacy|2|||
163096387|NCT02141672|589062637|FG000|Overall Study|Lost to Follow-up|1|||
163096388|NCT02141672|589062638|FG001|Overall Study|Lost to Follow-up|1|||
163096389|NCT02141672|589062639|FG002|Overall Study|Lost to Follow-up|3|||
163096390|NCT02141672|589062637|FG000|Overall Study|Physician Decision|1|||
163096391|NCT02141672|589062638|FG001|Overall Study|Physician Decision|2|||
163096392|NCT02141672|589062639|FG002|Overall Study|Physician Decision|5|||
163096393|NCT02141672|589062637|FG000|Overall Study|Protocol Violation|0|||
163096394|NCT02141672|589062638|FG001|Overall Study|Protocol Violation|0|||
163096395|NCT02141672|589062639|FG002|Overall Study|Protocol Violation|1|||
163096396|NCT02141672|589062637|FG000|Overall Study|Withdrawal by Subject|3|||
163096397|NCT02141672|589062638|FG001|Overall Study|Withdrawal by Subject|2|||
163096398|NCT02141672|589062639|FG002|Overall Study|Withdrawal by Subject|5|||
163096399|NCT02141672|589062637|FG000|Overall Study|refused to follow-up|1|||
163096400|NCT02141672|589062638|FG001|Overall Study|refused to follow-up|0|||
163096401|NCT02141672|589062639|FG002|Overall Study|refused to follow-up|1|||
163096402|NCT02688192|589062640|FG000|Overall Study|Lost to Follow-up|11|||
163096403|NCT02688192|589062641|FG001|Overall Study|Lost to Follow-up|5|||
163096404|NCT02688192|589062640|FG000|Overall Study|Physician Decision|1|||
163096405|NCT02688192|589062641|FG001|Overall Study|Physician Decision|0|||
163096406|NCT01773967|589062642|FG000|Overall Study|Lost to Follow-up|15|||
163096407|NCT01773967|589062643|FG001|Overall Study|Lost to Follow-up|13|||
163096408|NCT00579553|589062647|FG000|Overall Study|Lost to Follow-up|16|||
163096409|NCT00579553|589062648|FG001|Overall Study|Lost to Follow-up|13|||
163096410|NCT04860869|589062653|FG000|Overall Study|Withdrawal by Subject|1|||
163096411|NCT04860869|589062654|FG001|Overall Study|Withdrawal by Subject|0|||
163096412|NCT01775553|589062655|FG000|Overall Study|Adverse Event|1|||
163096413|NCT01775553|589062655|FG000|Overall Study|Disease Progression|12|||
163096414|NCT00590967|589062665|FG000|Overall Study|Withdrawal by Subject|1|||
163338911|NCT00813709|589951063|FG003|Double Blind Period|Randomized but not treated|0|||
163338912|NCT00813709|589951064|FG004|Double Blind Period|Randomized but not treated|0|||
163096415|NCT00590967|589062666|FG001|Overall Study|Withdrawal by Subject|1|||
163096416|NCT00590967|589062665|FG000|Overall Study|Ineligible|1|||
163096417|NCT00590967|589062666|FG001|Overall Study|Ineligible|0|||
163096418|NCT00590967|589062665|FG000|Overall Study|Poor performance status|0|||
163096419|NCT00590967|589062666|FG001|Overall Study|Poor performance status|1|||
163096420|NCT00590967|589062665|FG000|Overall Study|Non-compliant|0|||
163096421|NCT00590967|589062666|FG001|Overall Study|Non-compliant|2|||
163096422|NCT00590967|589062665|FG000|Overall Study|Did not sign consent form|0|||
163096423|NCT00590967|589062666|FG001|Overall Study|Did not sign consent form|1|||
163096424|NCT00590967|589062665|FG000|Overall Study|Did not receive chemo per protocol|1|||
163338913|NCT00813709|589951065|FG005|Double Blind Period|Randomized but not treated|0|||
163338914|NCT00813709|589951060|FG000|Double Blind Period|Other|14|||
163338915|NCT00813709|589951061|FG001|Double Blind Period|Other|9|||
163338916|NCT00813709|589951062|FG002|Double Blind Period|Other|6|||
163338917|NCT00813709|589951063|FG003|Double Blind Period|Other|0|||
163338918|NCT00813709|589951064|FG004|Double Blind Period|Other|0|||
163338919|NCT00813709|589951065|FG005|Double Blind Period|Other|0|||
163338920|NCT00813709|589951060|FG000|Open Label Period|Adverse Event|0|||
163338921|NCT00813709|589951061|FG001|Open Label Period|Adverse Event|0|||
163338922|NCT00813709|589951062|FG002|Open Label Period|Adverse Event|0|||
163338923|NCT00813709|589951063|FG003|Open Label Period|Adverse Event|5|||
163338924|NCT00813709|589951064|FG004|Open Label Period|Adverse Event|4|||
163338925|NCT00813709|589951065|FG005|Open Label Period|Adverse Event|3|||
163338926|NCT00813709|589951060|FG000|Open Label Period|Lack of Efficacy|0|||
163338927|NCT00813709|589951061|FG001|Open Label Period|Lack of Efficacy|0|||
163096425|NCT00590967|589062666|FG001|Overall Study|Did not receive chemo per protocol|0|||
163338928|NCT00813709|589951062|FG002|Open Label Period|Lack of Efficacy|0|||
163338929|NCT00813709|589951063|FG003|Open Label Period|Lack of Efficacy|3|||
163338930|NCT00813709|589951064|FG004|Open Label Period|Lack of Efficacy|1|||
163338931|NCT00813709|589951065|FG005|Open Label Period|Lack of Efficacy|1|||
163338932|NCT00813709|589951060|FG000|Open Label Period|Randomized but not treated|0|||
163338933|NCT00813709|589951061|FG001|Open Label Period|Randomized but not treated|0|||
163338934|NCT00813709|589951062|FG002|Open Label Period|Randomized but not treated|0|||
163338935|NCT00813709|589951063|FG003|Open Label Period|Randomized but not treated|1|||
163096426|NCT01881789|589062667|FG000|Overall Study|Withdrawal by Subject|0|||
163096427|NCT01881789|589062668|FG001|Overall Study|Withdrawal by Subject|2|||
163096428|NCT01881789|589062669|FG002|Overall Study|Withdrawal by Subject|1|||
163338936|NCT00813709|589951064|FG004|Open Label Period|Randomized but not treated|0|||
163338937|NCT00813709|589951065|FG005|Open Label Period|Randomized but not treated|1|||
163338938|NCT00813709|589951060|FG000|Open Label Period|Other|0|||
163338939|NCT00813709|589951061|FG001|Open Label Period|Other|0|||
163338940|NCT00813709|589951062|FG002|Open Label Period|Other|0|||
163338941|NCT00813709|589951063|FG003|Open Label Period|Other|11|||
163338942|NCT00813709|589951064|FG004|Open Label Period|Other|5|||
163338943|NCT00813709|589951065|FG005|Open Label Period|Other|6|||
163338944|NCT01807234|589951066|FG000|Overall Study|Lost to Follow-up|2|||
163338945|NCT01807234|589951067|FG001|Overall Study|Lost to Follow-up|5|||
163338946|NCT01807234|589951068|FG002|Overall Study|Lost to Follow-up|1|||
163338947|NCT01807234|589951069|FG003|Overall Study|Lost to Follow-up|1|||
163338948|NCT01807234|589951070|FG004|Overall Study|Lost to Follow-up|1|||
163338949|NCT01807234|589951071|FG005|Overall Study|Lost to Follow-up|2|||
163338950|NCT01807234|589951066|FG000|Overall Study|Withdrawal by Subject|3|||
163338951|NCT01807234|589951067|FG001|Overall Study|Withdrawal by Subject|1|||
163338952|NCT01807234|589951068|FG002|Overall Study|Withdrawal by Subject|1|||
163338953|NCT01807234|589951069|FG003|Overall Study|Withdrawal by Subject|1|||
163338954|NCT01807234|589951070|FG004|Overall Study|Withdrawal by Subject|2|||
163096429|NCT01881789|589062670|FG003|Overall Study|Withdrawal by Subject|0|||
163096430|NCT01881789|589062671|FG004|Overall Study|Withdrawal by Subject|1|||
163096431|NCT01881789|589062672|FG005|Overall Study|Withdrawal by Subject|1|||
163096432|NCT01881789|589062667|FG000|Overall Study|Study Terminated by Sponsor|0|||
163096433|NCT01881789|589062668|FG001|Overall Study|Study Terminated by Sponsor|0|||
163096434|NCT01881789|589062669|FG002|Overall Study|Study Terminated by Sponsor|0|||
163096435|NCT01881789|589062670|FG003|Overall Study|Study Terminated by Sponsor|0|||
163096436|NCT01881789|589062671|FG004|Overall Study|Study Terminated by Sponsor|0|||
163096437|NCT01881789|589062672|FG005|Overall Study|Study Terminated by Sponsor|1|||
163096438|NCT01881789|589062667|FG000|Overall Study|Other|3|||
163096439|NCT01881789|589062668|FG001|Overall Study|Other|5|||
163096440|NCT01881789|589062669|FG002|Overall Study|Other|2|||
163096441|NCT01881789|589062670|FG003|Overall Study|Other|3|||
163096442|NCT01881789|589062671|FG004|Overall Study|Other|1|||
163096443|NCT01881789|589062672|FG005|Overall Study|Other|1|||
163096444|NCT00920556|589062673|FG000|Overall Study|Adverse Event|16|||
163096445|NCT00920556|589062673|FG000|Overall Study|Physician Decision|7|||
163096446|NCT00920556|589062673|FG000|Overall Study|Withdrawal by Subject|1|||
163096447|NCT01299389|589062674|FG000|Double-blind|Adverse Event|45|||
163338955|NCT01807234|589951071|FG005|Overall Study|Withdrawal by Subject|1|||
163338956|NCT01807234|589951066|FG000|Overall Study|Lack of Efficacy|0|||
163338957|NCT01807234|589951067|FG001|Overall Study|Lack of Efficacy|0|||
163338958|NCT01807234|589951068|FG002|Overall Study|Lack of Efficacy|0|||
163338959|NCT01807234|589951069|FG003|Overall Study|Lack of Efficacy|0|||
163338960|NCT01807234|589951070|FG004|Overall Study|Lack of Efficacy|1|||
163338961|NCT01807234|589951071|FG005|Overall Study|Lack of Efficacy|1|||
163338962|NCT01540474|589951072|FG000|Vaccination Period|Lost to Follow-up|0|||
163096448|NCT01299389|589062675|FG001|Double-blind|Adverse Event|27|||
163096449|NCT01299389|589062676|FG002|Double-blind|Adverse Event|0|||
163096450|NCT01299389|589062677|FG003|Double-blind|Adverse Event|0|||
163096451|NCT01299389|589062674|FG000|Double-blind|Lack of Efficacy|45|||
163096452|NCT01299389|589062675|FG001|Double-blind|Lack of Efficacy|21|||
163096453|NCT01299389|589062676|FG002|Double-blind|Lack of Efficacy|0|||
163096454|NCT01299389|589062677|FG003|Double-blind|Lack of Efficacy|0|||
163096455|NCT01299389|589062674|FG000|Double-blind|Lost to Follow-up|2|||
163096456|NCT01299389|589062675|FG001|Double-blind|Lost to Follow-up|1|||
163096457|NCT01299389|589062676|FG002|Double-blind|Lost to Follow-up|0|||
163096458|NCT01299389|589062677|FG003|Double-blind|Lost to Follow-up|0|||
163096459|NCT01299389|589062674|FG000|Double-blind|Withdrawal by Subject|16|||
163096460|NCT01299389|589062675|FG001|Double-blind|Withdrawal by Subject|13|||
163096461|NCT01299389|589062676|FG002|Double-blind|Withdrawal by Subject|0|||
163096462|NCT01299389|589062677|FG003|Double-blind|Withdrawal by Subject|0|||
163096463|NCT01299389|589062674|FG000|Double-blind|Other|1|||
163096464|NCT01299389|589062675|FG001|Double-blind|Other|1|||
163096465|NCT01299389|589062676|FG002|Double-blind|Other|0|||
163096466|NCT01299389|589062677|FG003|Double-blind|Other|0|||
163096467|NCT01299389|589062674|FG000|Double-blind|"fail to meet study population criteria"|0|||
163096468|NCT01299389|589062675|FG001|Double-blind|"fail to meet study population criteria"|1|||
163096469|NCT01299389|589062676|FG002|Double-blind|"fail to meet study population criteria"|0|||
163096470|NCT01299389|589062677|FG003|Double-blind|"fail to meet study population criteria"|0|||
163096471|NCT01299389|589062674|FG000|Post-observational|Other|0|||
163096472|NCT01299389|589062675|FG001|Post-observational|Other|0|||
163096473|NCT01299389|589062676|FG002|Post-observational|Other|12|||
163096474|NCT01299389|589062677|FG003|Post-observational|Other|6|||
163096475|NCT02834819|589062678|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
163096476|NCT02834819|589062679|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
163096477|NCT03637491|589062680|FG000|Overall Study|Death|9|||
163096478|NCT03637491|589062681|FG001|Overall Study|Death|9|||
163096479|NCT03637491|589062682|FG002|Overall Study|Death|5|||
163096480|NCT03637491|589062683|FG003|Overall Study|Death|3|||
163096481|NCT03637491|589062680|FG000|Overall Study|Lost to Follow-up|0|||
163096482|NCT03637491|589062681|FG001|Overall Study|Lost to Follow-up|1|||
163096483|NCT03637491|589062682|FG002|Overall Study|Lost to Follow-up|0|||
163096484|NCT03637491|589062683|FG003|Overall Study|Lost to Follow-up|1|||
163096485|NCT03637491|589062680|FG000|Overall Study|Study Terminated By Sponsor|0|||
163096486|NCT03637491|589062681|FG001|Overall Study|Study Terminated By Sponsor|2|||
163096487|NCT03637491|589062682|FG002|Overall Study|Study Terminated By Sponsor|1|||
163096488|NCT03637491|589062683|FG003|Overall Study|Study Terminated By Sponsor|0|||
163096489|NCT03637491|589062680|FG000|Overall Study|Withdrawal by Subject|1|||
163096490|NCT03637491|589062681|FG001|Overall Study|Withdrawal by Subject|0|||
163096491|NCT03637491|589062682|FG002|Overall Study|Withdrawal by Subject|1|||
163096492|NCT03637491|589062683|FG003|Overall Study|Withdrawal by Subject|2|||
163096493|NCT02185534|589062684|FG000|First Period|Withdrawal by Subject|0|||
163096494|NCT02185534|589062685|FG001|First Period|Withdrawal by Subject|0|||
163096495|NCT02185534|589062686|FG002|First Period|Withdrawal by Subject|0|||
163096496|NCT02185534|589062687|FG003|First Period|Withdrawal by Subject|1|||
163096497|NCT02185534|589062688|FG004|First Period|Withdrawal by Subject|0|||
163096498|NCT02185534|589062689|FG005|First Period|Withdrawal by Subject|0|||
163096499|NCT02185534|589062684|FG000|First Washout Period|Withdrawal by Subject|1|||
163096500|NCT02185534|589062685|FG001|First Washout Period|Withdrawal by Subject|0|||
163096501|NCT02185534|589062686|FG002|First Washout Period|Withdrawal by Subject|0|||
163338963|NCT01540474|589951073|FG001|Vaccination Period|Lost to Follow-up|1|||
163338964|NCT01540474|589951074|FG002|Vaccination Period|Lost to Follow-up|0|||
163338965|NCT01540474|589951075|FG003|Vaccination Period|Lost to Follow-up|0|||
163338966|NCT00857311|589951076|FG000|Overall Study|Lost to Follow-up|1|||
163338967|NCT00857311|589951077|FG001|Overall Study|Lost to Follow-up|0|||
163338968|NCT00857311|589951078|FG002|Overall Study|Lost to Follow-up|0|||
163338969|NCT00857311|589951079|FG003|Overall Study|Lost to Follow-up|0|||
163338970|NCT01587703|589951080|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
163338971|NCT01587703|589951081|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338972|NCT01587703|589951082|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338973|NCT01587703|589951083|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338974|NCT01587703|589951084|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338975|NCT01587703|589951085|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163096502|NCT02185534|589062687|FG003|First Washout Period|Withdrawal by Subject|0|||
163096503|NCT02185534|589062688|FG004|First Washout Period|Withdrawal by Subject|1|||
163096504|NCT02185534|589062689|FG005|First Washout Period|Withdrawal by Subject|0|||
163096505|NCT02185534|589062684|FG000|First Washout Period|Protocol Violation|0|||
163096506|NCT02185534|589062685|FG001|First Washout Period|Protocol Violation|0|||
163096507|NCT02185534|589062686|FG002|First Washout Period|Protocol Violation|0|||
163096508|NCT02185534|589062687|FG003|First Washout Period|Protocol Violation|0|||
163096509|NCT02185534|589062688|FG004|First Washout Period|Protocol Violation|0|||
163096510|NCT02185534|589062689|FG005|First Washout Period|Protocol Violation|1|||
163096511|NCT04179305|589062697|FG000|Overall Study|Death|1|||
163096512|NCT04179305|589062698|FG001|Overall Study|Death|1|||
163096513|NCT04179305|589062699|FG002|Overall Study|Death|0|||
163096514|NCT04179305|589062700|FG003|Overall Study|Death|0|||
163096515|NCT04179305|589062697|FG000|Overall Study|Lost to Follow-up|1|||
163096516|NCT04179305|589062698|FG001|Overall Study|Lost to Follow-up|1|||
163096517|NCT04179305|589062699|FG002|Overall Study|Lost to Follow-up|0|||
163096518|NCT04179305|589062700|FG003|Overall Study|Lost to Follow-up|0|||
163096519|NCT04179305|589062697|FG000|Overall Study|Withdrawal by Subject|0|||
163096520|NCT04179305|589062698|FG001|Overall Study|Withdrawal by Subject|1|||
163096521|NCT04179305|589062699|FG002|Overall Study|Withdrawal by Subject|0|||
163096522|NCT04179305|589062700|FG003|Overall Study|Withdrawal by Subject|0|||
163096523|NCT04179305|589062697|FG000|Overall Study|Did not have scan|1|||
163096524|NCT04179305|589062698|FG001|Overall Study|Did not have scan|0|||
163096525|NCT04179305|589062699|FG002|Overall Study|Did not have scan|0|||
163338976|NCT01587703|589951086|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338977|NCT01587703|589951087|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338978|NCT01587703|589951088|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338979|NCT01587703|589951089|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338980|NCT01587703|589951090|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338981|NCT01587703|589951091|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338982|NCT01587703|589951092|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338983|NCT01587703|589951093|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338984|NCT01587703|589951094|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338985|NCT01587703|589951095|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338986|NCT01587703|589951096|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338987|NCT01587703|589951097|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338988|NCT01587703|589951098|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163338989|NCT01587703|589951080|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163338990|NCT01587703|589951081|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163338991|NCT01587703|589951082|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163338992|NCT01587703|589951083|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163338993|NCT01587703|589951084|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163338994|NCT01587703|589951085|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
163338995|NCT01587703|589951086|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163338996|NCT01587703|589951087|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
163338997|NCT01587703|589951088|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163338998|NCT01587703|589951089|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163338999|NCT01587703|589951090|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163339000|NCT01587703|589951091|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163339001|NCT01587703|589951092|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163339002|NCT01587703|589951093|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163339003|NCT01587703|589951094|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163339004|NCT01587703|589951095|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163339005|NCT01587703|589951096|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163339006|NCT01587703|589951097|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163339007|NCT01587703|589951098|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163339008|NCT01587703|589951080|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163339009|NCT01587703|589951081|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163339010|NCT01587703|589951082|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163339011|NCT01587703|589951083|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163096526|NCT04179305|589062700|FG003|Overall Study|Did not have scan|0|||
163096527|NCT04179305|589062697|FG000|Overall Study|In hospice care|3|||
163096528|NCT04179305|589062698|FG001|Overall Study|In hospice care|0|||
163096529|NCT04179305|589062699|FG002|Overall Study|In hospice care|0|||
163096530|NCT04179305|589062700|FG003|Overall Study|In hospice care|0|||
163096531|NCT01737762|589062703|FG000|Overall Study|Adverse Event|2|||
163096532|NCT01737762|589062704|FG001|Overall Study|Adverse Event|2|||
163096533|NCT01737762|589062703|FG000|Overall Study|Lost to Follow-up|1|||
163096534|NCT01737762|589062704|FG001|Overall Study|Lost to Follow-up|0|||
163096535|NCT01737762|589062703|FG000|Overall Study|Withdrawal by Subject|2|||
163096536|NCT01737762|589062704|FG001|Overall Study|Withdrawal by Subject|2|||
163096537|NCT01737762|589062703|FG000|Overall Study|Progressive disease|1|||
163096538|NCT01737762|589062704|FG001|Overall Study|Progressive disease|2|||
163096539|NCT01737762|589062703|FG000|Overall Study|Physician Decision|1|||
163096540|NCT01737762|589062704|FG001|Overall Study|Physician Decision|1|||
163096541|NCT01737762|589062703|FG000|Overall Study|Moved from area|2|||
163096542|NCT01737762|589062704|FG001|Overall Study|Moved from area|1|||
163096543|NCT01737762|589062703|FG000|Overall Study|Trial termination|11|||
163096544|NCT01737762|589062704|FG001|Overall Study|Trial termination|9|||
163096545|NCT00326599|589062705|FG000|Overall Study|Withdrawal by Subject|1|||
163096546|NCT00326599|589062706|FG001|Overall Study|Withdrawal by Subject|0|||
163096547|NCT00326599|589062707|FG002|Overall Study|Withdrawal by Subject|5|||
163096548|NCT00326599|589062708|FG003|Overall Study|Withdrawal by Subject|2|||
163096549|NCT00326599|589062705|FG000|Overall Study|Adverse Event|1|||
163096550|NCT00326599|589062706|FG001|Overall Study|Adverse Event|0|||
163096551|NCT00326599|589062707|FG002|Overall Study|Adverse Event|32|||
163096552|NCT00326599|589062708|FG003|Overall Study|Adverse Event|3|||
163096553|NCT00326599|589062705|FG000|Overall Study|Disease Progression|3|||
163096554|NCT00326599|589062706|FG001|Overall Study|Disease Progression|1|||
163096555|NCT00326599|589062707|FG002|Overall Study|Disease Progression|13|||
163096556|NCT00326599|589062708|FG003|Overall Study|Disease Progression|11|||
163096557|NCT00326599|589062705|FG000|Overall Study|Alternate Treatment|1|||
163096558|NCT00326599|589062706|FG001|Overall Study|Alternate Treatment|0|||
163096559|NCT00326599|589062707|FG002|Overall Study|Alternate Treatment|0|||
163096560|NCT00326599|589062708|FG003|Overall Study|Alternate Treatment|0|||
163096561|NCT00326599|589062705|FG000|Overall Study|Death|0|||
163096562|NCT00326599|589062706|FG001|Overall Study|Death|0|||
163096563|NCT00326599|589062707|FG002|Overall Study|Death|1|||
163096564|NCT00326599|589062708|FG003|Overall Study|Death|2|||
163096565|NCT00326599|589062705|FG000|Overall Study|Other Unspecified Reason|0|||
163096566|NCT00326599|589062706|FG001|Overall Study|Other Unspecified Reason|0|||
163096567|NCT00326599|589062707|FG002|Overall Study|Other Unspecified Reason|2|||
163096568|NCT00326599|589062708|FG003|Overall Study|Other Unspecified Reason|1|||
163096569|NCT00625586|589062709|FG000|Overall Study|Adverse Event|1|||
163096570|NCT00625586|589062709|FG000|Overall Study|Progressive disease|1|||
163096571|NCT02737501|589062718|FG000|Randomized Phase|Died|41|||
163096572|NCT02737501|589062719|FG001|Randomized Phase|Died|29|||
163096573|NCT02737501|589062720|FG002|Randomized Phase|Died|0|||
163096574|NCT02737501|589062718|FG000|Randomized Phase|Withdrawal by Subject|16|||
163096575|NCT02737501|589062719|FG001|Randomized Phase|Withdrawal by Subject|6|||
163096576|NCT02737501|589062720|FG002|Randomized Phase|Withdrawal by Subject|0|||
163096577|NCT02737501|589062718|FG000|Randomized Phase|Lost to Follow-up|0|||
163096578|NCT02737501|589062719|FG001|Randomized Phase|Lost to Follow-up|1|||
163096579|NCT02737501|589062720|FG002|Randomized Phase|Lost to Follow-up|0|||
163096580|NCT02737501|589062718|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
163096581|NCT02737501|589062719|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
163096582|NCT02737501|589062720|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
163096583|NCT02737501|589062718|FG000|Randomized Phase|Reason not Specified|1|||
163096584|NCT02737501|589062719|FG001|Randomized Phase|Reason not Specified|1|||
163096585|NCT02737501|589062720|FG002|Randomized Phase|Reason not Specified|0|||
163096586|NCT02737501|589062718|FG000|Randomized Phase|Never Treated|1|||
163096587|NCT02737501|589062719|FG001|Randomized Phase|Never Treated|1|||
163096588|NCT02737501|589062720|FG002|Randomized Phase|Never Treated|0|||
163096589|NCT02737501|589062718|FG000|Crossover Phase|Died|0|||
163096590|NCT02737501|589062719|FG001|Crossover Phase|Died|0|||
163096591|NCT02737501|589062720|FG002|Crossover Phase|Died|22|||
163096592|NCT02737501|589062718|FG000|Crossover Phase|Withdrew Consent|0|||
163096593|NCT02737501|589062719|FG001|Crossover Phase|Withdrew Consent|0|||
163096594|NCT02737501|589062720|FG002|Crossover Phase|Withdrew Consent|9|||
163096595|NCT02737501|589062718|FG000|Crossover Phase|Physician Decision|0|||
163096596|NCT02737501|589062719|FG001|Crossover Phase|Physician Decision|0|||
163096597|NCT02737501|589062720|FG002|Crossover Phase|Physician Decision|1|||
163096598|NCT02737501|589062718|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
163096599|NCT02737501|589062719|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
163096600|NCT02737501|589062720|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
163096601|NCT02012218|589062721|FG000|Overall Study|Withdrawal by Subject|1|||
163096602|NCT02012218|589062722|FG001|Overall Study|Withdrawal by Subject|0|||
163096603|NCT02012218|589062723|FG002|Overall Study|Withdrawal by Subject|1|||
163096604|NCT02012218|589062724|FG003|Overall Study|Withdrawal by Subject|1|||
163096605|NCT02012218|589062725|FG004|Overall Study|Withdrawal by Subject|1|||
163096606|NCT02012218|589062721|FG000|Overall Study|Adverse Event|1|||
163096607|NCT02012218|589062722|FG001|Overall Study|Adverse Event|0|||
163096608|NCT02012218|589062723|FG002|Overall Study|Adverse Event|0|||
163096609|NCT02012218|589062724|FG003|Overall Study|Adverse Event|1|||
163339012|NCT01587703|589951084|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163339013|NCT01587703|589951085|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163339014|NCT01587703|589951086|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
163339015|NCT01587703|589951087|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163339016|NCT01587703|589951088|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163339017|NCT01587703|589951089|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163339018|NCT01587703|589951090|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163096610|NCT02012218|589062725|FG004|Overall Study|Adverse Event|0|||
163096611|NCT02012218|589062721|FG000|Overall Study|Lost to Follow-up|0|||
163096612|NCT02012218|589062722|FG001|Overall Study|Lost to Follow-up|1|||
163096613|NCT02012218|589062723|FG002|Overall Study|Lost to Follow-up|1|||
163096614|NCT02012218|589062724|FG003|Overall Study|Lost to Follow-up|0|||
163096615|NCT02012218|589062725|FG004|Overall Study|Lost to Follow-up|0|||
163096616|NCT02012218|589062721|FG000|Overall Study|Protocol Specified|1|||
163096617|NCT02012218|589062722|FG001|Overall Study|Protocol Specified|0|||
163096618|NCT02012218|589062723|FG002|Overall Study|Protocol Specified|0|||
163096619|NCT02012218|589062724|FG003|Overall Study|Protocol Specified|0|||
163096620|NCT02012218|589062725|FG004|Overall Study|Protocol Specified|0|||
163096621|NCT02012218|589062721|FG000|Overall Study|Protocol Deviation|1|||
163096622|NCT02012218|589062722|FG001|Overall Study|Protocol Deviation|0|||
163096623|NCT02012218|589062723|FG002|Overall Study|Protocol Deviation|0|||
163096624|NCT02012218|589062724|FG003|Overall Study|Protocol Deviation|0|||
163096625|NCT02012218|589062725|FG004|Overall Study|Protocol Deviation|0|||
163096626|NCT04819113|589062726|FG000|Overall Study|Withdrawal by parent/guardian|3|||
163096627|NCT04819113|589062726|FG000|Overall Study|Lost to Follow-up|1|||
163096628|NCT04819113|589062726|FG000|Overall Study|Withdrawn before vaccination|2|||
163096629|NCT00786422|589062727|FG000|Rivaroxaban Treatment|Death|2|||
163096630|NCT00786422|589062727|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
163096631|NCT00786422|589062727|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
163096632|NCT00786422|589062727|FG000|Rivaroxaban Treatment|Physician Decision|1|||
163096633|NCT00786422|589062727|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
163096634|NCT00786422|589062727|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
163096635|NCT00786422|589062727|FG000|Rivaroxaban Treatment|Adverse Event|2|||
163096636|NCT00786422|589062727|FG000|Follow-up Period|Death|1|||
163096637|NCT00786422|589062727|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
163096638|NCT01085214|589062728|FG000|Overall Study|Alternate treatment required|1|||
163096639|NCT01985022|589062742|FG000|Overall Study|Lost to Follow-up|0|||
163096640|NCT01985022|589062743|FG001|Overall Study|Lost to Follow-up|1|||
163096641|NCT01985022|589062742|FG000|Overall Study|Protocol Violation|0|||
163096642|NCT01985022|589062743|FG001|Overall Study|Protocol Violation|1|||
163096643|NCT01985022|589062742|FG000|Overall Study|Withdrawal by Subject|4|||
163096644|NCT01985022|589062743|FG001|Overall Study|Withdrawal by Subject|1|||
163096645|NCT03761056|589062748|FG000|Overall Study|Death|8|||
163096646|NCT03761056|589062748|FG000|Overall Study|Enrolled but never treated|2|||
163096647|NCT03761056|589062748|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
163096648|NCT03761056|589062748|FG000|Overall Study|Investigator decision|1|||
163096649|NCT00996658|589062749|FG000|Overall Study|Adverse Event|2|||
163096650|NCT00996658|589062750|FG001|Overall Study|Adverse Event|5|||
163096651|NCT00996658|589062749|FG000|Overall Study|Protocol Violation|0|||
163096652|NCT00996658|589062750|FG001|Overall Study|Protocol Violation|1|||
163096653|NCT00996658|589062749|FG000|Overall Study|Lost to Follow-up|2|||
163096654|NCT00996658|589062750|FG001|Overall Study|Lost to Follow-up|5|||
163096655|NCT00996658|589062749|FG000|Overall Study|Non-compliance issues|3|||
163096656|NCT00996658|589062750|FG001|Overall Study|Non-compliance issues|3|||
163096657|NCT00996658|589062749|FG000|Overall Study|Other|9|||
163096658|NCT00996658|589062750|FG001|Overall Study|Other|7|||
163096659|NCT04749745|589062751|FG000|Overall Study|Withdrawal by Subject|1|||
163096660|NCT04749745|589062752|FG001|Overall Study|Withdrawal by Subject|0|||
163096661|NCT01365455|589062756|FG000|Induction Period|Adverse Event|5|||
163096662|NCT01365455|589062757|FG001|Induction Period|Adverse Event|3|||
163096663|NCT01365455|589062758|FG002|Induction Period|Adverse Event|4|||
163096664|NCT01365455|589062759|FG003|Induction Period|Adverse Event|0|||
163096665|NCT01365455|589062760|FG004|Induction Period|Adverse Event|0|||
163096666|NCT01365455|589062756|FG000|Induction Period|Lack of Efficacy|1|||
163096667|NCT01365455|589062757|FG001|Induction Period|Lack of Efficacy|1|||
163096668|NCT01365455|589062758|FG002|Induction Period|Lack of Efficacy|0|||
163096669|NCT01365455|589062759|FG003|Induction Period|Lack of Efficacy|0|||
163096670|NCT01365455|589062760|FG004|Induction Period|Lack of Efficacy|0|||
163096671|NCT01365455|589062756|FG000|Induction Period|Pregnancy|0|||
163096672|NCT01365455|589062757|FG001|Induction Period|Pregnancy|1|||
163096673|NCT01365455|589062758|FG002|Induction Period|Pregnancy|0|||
163096674|NCT01365455|589062759|FG003|Induction Period|Pregnancy|0|||
163096675|NCT01365455|589062760|FG004|Induction Period|Pregnancy|0|||
163096676|NCT01365455|589062756|FG000|Induction Period|Protocol deviation|0|||
163096677|NCT01365455|589062757|FG001|Induction Period|Protocol deviation|1|||
163096678|NCT01365455|589062758|FG002|Induction Period|Protocol deviation|1|||
163096679|NCT01365455|589062759|FG003|Induction Period|Protocol deviation|0|||
163096680|NCT01365455|589062760|FG004|Induction Period|Protocol deviation|0|||
163096681|NCT01365455|589062756|FG000|Induction Period|Subject/guardian decision|9|||
163096682|NCT01365455|589062757|FG001|Induction Period|Subject/guardian decision|1|||
163096683|NCT01365455|589062758|FG002|Induction Period|Subject/guardian decision|8|||
163096684|NCT01365455|589062759|FG003|Induction Period|Subject/guardian decision|0|||
163096685|NCT01365455|589062760|FG004|Induction Period|Subject/guardian decision|0|||
163096686|NCT01365455|589062756|FG000|Induction Period|Lost to Follow-up|0|||
163096687|NCT01365455|589062757|FG001|Induction Period|Lost to Follow-up|0|||
163096688|NCT01365455|589062758|FG002|Induction Period|Lost to Follow-up|3|||
163096689|NCT01365455|589062759|FG003|Induction Period|Lost to Follow-up|0|||
163096690|NCT01365455|589062760|FG004|Induction Period|Lost to Follow-up|0|||
163096691|NCT01365455|589062756|FG000|Maintenance Period|Adverse Event|12|||
163096692|NCT01365455|589062757|FG001|Maintenance Period|Adverse Event|5|||
163096693|NCT01365455|589062758|FG002|Maintenance Period|Adverse Event|1|||
163096694|NCT01365455|589062759|FG003|Maintenance Period|Adverse Event|2|||
163096695|NCT01365455|589062760|FG004|Maintenance Period|Adverse Event|4|||
163096696|NCT01365455|589062756|FG000|Maintenance Period|Lack of Efficacy|10|||
163096697|NCT01365455|589062757|FG001|Maintenance Period|Lack of Efficacy|2|||
163096698|NCT01365455|589062758|FG002|Maintenance Period|Lack of Efficacy|0|||
163096699|NCT01365455|589062759|FG003|Maintenance Period|Lack of Efficacy|2|||
163096700|NCT01365455|589062760|FG004|Maintenance Period|Lack of Efficacy|2|||
163096701|NCT01365455|589062756|FG000|Maintenance Period|Lost to Follow-up|2|||
163096702|NCT01365455|589062757|FG001|Maintenance Period|Lost to Follow-up|4|||
163096703|NCT01365455|589062758|FG002|Maintenance Period|Lost to Follow-up|0|||
163096704|NCT01365455|589062759|FG003|Maintenance Period|Lost to Follow-up|0|||
163096705|NCT01365455|589062760|FG004|Maintenance Period|Lost to Follow-up|3|||
163096706|NCT01365455|589062756|FG000|Maintenance Period|Non-compliance with study treatment|0|||
163096707|NCT01365455|589062757|FG001|Maintenance Period|Non-compliance with study treatment|0|||
163096708|NCT01365455|589062758|FG002|Maintenance Period|Non-compliance with study treatment|0|||
163096709|NCT01365455|589062759|FG003|Maintenance Period|Non-compliance with study treatment|1|||
163096710|NCT01365455|589062760|FG004|Maintenance Period|Non-compliance with study treatment|0|||
163096711|NCT01365455|589062756|FG000|Maintenance Period|Physician Decision|0|||
163096712|NCT01365455|589062757|FG001|Maintenance Period|Physician Decision|1|||
163096713|NCT01365455|589062758|FG002|Maintenance Period|Physician Decision|0|||
163096714|NCT01365455|589062759|FG003|Maintenance Period|Physician Decision|0|||
163096715|NCT01365455|589062760|FG004|Maintenance Period|Physician Decision|1|||
163096716|NCT01365455|589062756|FG000|Maintenance Period|Pregnancy|0|||
163096717|NCT01365455|589062757|FG001|Maintenance Period|Pregnancy|4|||
163096718|NCT01365455|589062758|FG002|Maintenance Period|Pregnancy|0|||
163096719|NCT01365455|589062759|FG003|Maintenance Period|Pregnancy|0|||
163096720|NCT01365455|589062760|FG004|Maintenance Period|Pregnancy|2|||
163096721|NCT01365455|589062756|FG000|Maintenance Period|Protocol deviation|1|||
163096722|NCT01365455|589062757|FG001|Maintenance Period|Protocol deviation|1|||
163096723|NCT01365455|589062758|FG002|Maintenance Period|Protocol deviation|0|||
163096724|NCT01365455|589062759|FG003|Maintenance Period|Protocol deviation|0|||
163096725|NCT01365455|589062760|FG004|Maintenance Period|Protocol deviation|0|||
163096726|NCT01365455|589062756|FG000|Maintenance Period|Subject/guardian decision|4|||
163096727|NCT01365455|589062757|FG001|Maintenance Period|Subject/guardian decision|6|||
163096728|NCT01365455|589062758|FG002|Maintenance Period|Subject/guardian decision|2|||
163096729|NCT01365455|589062759|FG003|Maintenance Period|Subject/guardian decision|4|||
163220122|NCT02039674|589521412|FG006|Overall Study|Lost to Follow-up|0|||
163220123|NCT02039674|589521413|FG007|Overall Study|Lost to Follow-up|0|||
163220124|NCT02039674|589521414|FG008|Overall Study|Lost to Follow-up|0|||
163220125|NCT02039674|589521415|FG009|Overall Study|Lost to Follow-up|0|||
163220126|NCT02039674|589521416|FG010|Overall Study|Lost to Follow-up|0|||
163220127|NCT02039674|589521417|FG011|Overall Study|Lost to Follow-up|2|||
163220128|NCT02039674|589521418|FG012|Overall Study|Lost to Follow-up|2|||
163220129|NCT02039674|589521419|FG013|Overall Study|Lost to Follow-up|1|||
163220130|NCT02039674|589521406|FG000|Overall Study|Physician Decision|0|||
163220131|NCT02039674|589521407|FG001|Overall Study|Physician Decision|0|||
163220132|NCT02039674|589521408|FG002|Overall Study|Physician Decision|0|||
163220133|NCT02039674|589521409|FG003|Overall Study|Physician Decision|0|||
163220134|NCT02039674|589521410|FG004|Overall Study|Physician Decision|0|||
163220135|NCT02039674|589521411|FG005|Overall Study|Physician Decision|0|||
163220136|NCT02039674|589521412|FG006|Overall Study|Physician Decision|0|||
163220137|NCT02039674|589521413|FG007|Overall Study|Physician Decision|0|||
163220138|NCT02039674|589521414|FG008|Overall Study|Physician Decision|0|||
163220139|NCT02039674|589521415|FG009|Overall Study|Physician Decision|0|||
163220140|NCT02039674|589521416|FG010|Overall Study|Physician Decision|0|||
163220141|NCT02039674|589521417|FG011|Overall Study|Physician Decision|1|||
163220142|NCT02039674|589521418|FG012|Overall Study|Physician Decision|1|||
163220143|NCT02039674|589521419|FG013|Overall Study|Physician Decision|0|||
163220144|NCT02039674|589521406|FG000|Overall Study|Progressive Disease|8|||
163220145|NCT02039674|589521407|FG001|Overall Study|Progressive Disease|8|||
163220146|NCT02039674|589521408|FG002|Overall Study|Progressive Disease|6|||
163220147|NCT02039674|589521409|FG003|Overall Study|Progressive Disease|7|||
163339019|NCT01587703|589951091|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163220148|NCT02039674|589521410|FG004|Overall Study|Progressive Disease|9|||
163220149|NCT02039674|589521411|FG005|Overall Study|Progressive Disease|10|||
163220150|NCT02039674|589521412|FG006|Overall Study|Progressive Disease|1|||
163220151|NCT02039674|589521413|FG007|Overall Study|Progressive Disease|3|||
163220152|NCT02039674|589521414|FG008|Overall Study|Progressive Disease|6|||
163220153|NCT02039674|589521415|FG009|Overall Study|Progressive Disease|4|||
163339020|NCT01587703|589951092|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163339021|NCT01587703|589951093|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163096730|NCT01365455|589062760|FG004|Maintenance Period|Subject/guardian decision|1|||
163096731|NCT04267926|589064656|FG000|Overall Study|abnormal labs. No longer eligible|0|||
163220154|NCT02039674|589521416|FG010|Overall Study|Progressive Disease|0|||
163220155|NCT02039674|589521417|FG011|Overall Study|Progressive Disease|34|||
163220156|NCT02039674|589521418|FG012|Overall Study|Progressive Disease|34|||
163220157|NCT02039674|589521419|FG013|Overall Study|Progressive Disease|18|||
163220158|NCT02039674|589521406|FG000|Overall Study|Withdrawal by Subject|1|||
163220159|NCT02039674|589521407|FG001|Overall Study|Withdrawal by Subject|2|||
163220160|NCT02039674|589521408|FG002|Overall Study|Withdrawal by Subject|3|||
163220161|NCT02039674|589521409|FG003|Overall Study|Withdrawal by Subject|0|||
163096732|NCT04267926|589064657|FG001|Overall Study|abnormal labs. No longer eligible|0|||
163096733|NCT04267926|589064658|FG002|Overall Study|abnormal labs. No longer eligible|1|||
163096734|NCT04267926|589064656|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
163096735|NCT04267926|589064657|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
163096736|NCT04267926|589064658|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
163096737|NCT03145064|589064659|FG000|Overall Study|Death|24|||
163096738|NCT03145064|589064659|FG000|Overall Study|Lost to Follow-up|3|||
163096739|NCT03145064|589064659|FG000|Overall Study|Withdrawal by Subject|6|||
163096740|NCT03145064|589064659|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
163096741|NCT03145064|589064659|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
163096742|NCT00661830|589064660|FG000|Overall Study|Death|37|||
163096743|NCT00661830|589064661|FG001|Overall Study|Death|33|||
163096744|NCT00661830|589064660|FG000|Overall Study|Lost to Follow-up|1|||
163096745|NCT00661830|589064661|FG001|Overall Study|Lost to Follow-up|3|||
163096746|NCT00661830|589064660|FG000|Overall Study|Withdrawal by Subject|1|||
163096747|NCT00661830|589064661|FG001|Overall Study|Withdrawal by Subject|1|||
163096748|NCT00661830|589064660|FG000|Overall Study|Other reason|1|||
163096749|NCT00661830|589064661|FG001|Overall Study|Other reason|5|||
163096750|NCT01396187|589064662|FG000|Overall Study|Adverse Event|0|||
163096751|NCT01396187|589064663|FG001|Overall Study|Adverse Event|1|||
163096752|NCT01396187|589064664|FG002|Overall Study|Adverse Event|0|||
163096753|NCT01396187|589064665|FG003|Overall Study|Adverse Event|0|||
163096754|NCT01396187|589064666|FG004|Overall Study|Adverse Event|0|||
163096755|NCT01396187|589064662|FG000|Overall Study|Withdrawal by Subject|0|||
163096756|NCT01396187|589064663|FG001|Overall Study|Withdrawal by Subject|1|||
163096757|NCT01396187|589064664|FG002|Overall Study|Withdrawal by Subject|1|||
163096758|NCT01396187|589064665|FG003|Overall Study|Withdrawal by Subject|0|||
163096759|NCT01396187|589064666|FG004|Overall Study|Withdrawal by Subject|0|||
163096760|NCT01396187|589064662|FG000|Overall Study|Other|1|||
163096761|NCT01396187|589064663|FG001|Overall Study|Other|1|||
163096762|NCT01396187|589064664|FG002|Overall Study|Other|0|||
163096763|NCT01396187|589064665|FG003|Overall Study|Other|0|||
163096764|NCT01396187|589064666|FG004|Overall Study|Other|1|||
163096765|NCT01650831|589064667|FG000|Overall Study|Screen failure|1|||
163096766|NCT01897727|589064670|FG000|Overall Study|Exclusion: central sleep apnea|0|||
163096767|NCT01897727|589064671|FG001|Overall Study|Exclusion: central sleep apnea|1|||
163096768|NCT04245449|589064672|FG000|Overall Study|COVID shutdown|7|||
163096769|NCT01273038|589064673|FG000|Second Intervention (14 Days)|Adverse Event|0|||
163096770|NCT01273038|589064674|FG001|Second Intervention (14 Days)|Adverse Event|1|||
163096771|NCT01273038|589064673|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
163096772|NCT01273038|589064674|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
163096773|NCT02477527|589064675|FG000|Overall Study|Lost to Follow-up|2|||
163096774|NCT02477527|589064675|FG000|Overall Study|Withdrawal by Subject|1|||
163096775|NCT02477527|589064675|FG000|Overall Study|Screen Failure|3|||
163339022|NCT01587703|589951094|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163339023|NCT01587703|589951095|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163096776|NCT03692403|589064676|FG000|Overall Study|Withdrawal by Subject|1|||
163096777|NCT03692403|589064677|FG001|Overall Study|Withdrawal by Subject|0|||
163096778|NCT03692403|589064678|FG002|Overall Study|Withdrawal by Subject|1|||
163096779|NCT03692403|589064679|FG003|Overall Study|Withdrawal by Subject|0|||
163096780|NCT03692403|589064676|FG000|Overall Study|Adverse Event|0|||
163096781|NCT03692403|589064677|FG001|Overall Study|Adverse Event|0|||
163096782|NCT03692403|589064678|FG002|Overall Study|Adverse Event|0|||
163096783|NCT03692403|589064679|FG003|Overall Study|Adverse Event|1|||
163096784|NCT03692403|589064676|FG000|Overall Study|Pregnancy|0|||
163096785|NCT03692403|589064677|FG001|Overall Study|Pregnancy|1|||
163096786|NCT03692403|589064678|FG002|Overall Study|Pregnancy|0|||
163096787|NCT03692403|589064679|FG003|Overall Study|Pregnancy|0|||
163096788|NCT03692403|589064676|FG000|Overall Study|Other|0|||
163096789|NCT03692403|589064677|FG001|Overall Study|Other|0|||
163096790|NCT03692403|589064678|FG002|Overall Study|Other|1|||
163096791|NCT03692403|589064679|FG003|Overall Study|Other|0|||
163096792|NCT02479880|589064680|FG000|Overall Study|Study Terminated by Sponsor|13|||
163096793|NCT02479880|589064681|FG001|Overall Study|Study Terminated by Sponsor|12|||
163096794|NCT02479880|589064680|FG000|Overall Study|Pregnancy|0|||
163096795|NCT02479880|589064681|FG001|Overall Study|Pregnancy|1|||
163096796|NCT02840253|589064682|FG000|Overall Study|Unsuccessful block|4|||
163096797|NCT00856635|589064683|FG000|Overall Study|Lost to Follow-up|2|||
163096798|NCT00856635|589064684|FG001|Overall Study|Lost to Follow-up|5|||
163096799|NCT00856635|589064683|FG000|Overall Study|Pregnancy|1|||
163339024|NCT01587703|589951096|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163339025|NCT01587703|589951097|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163096800|NCT00856635|589064684|FG001|Overall Study|Pregnancy|0|||
163096801|NCT00856635|589064683|FG000|Overall Study|Withdrawal by Subject|3|||
163096802|NCT00856635|589064684|FG001|Overall Study|Withdrawal by Subject|1|||
163096803|NCT00856635|589064683|FG000|Overall Study|Serious Adverse Event|1|||
163096804|NCT00856635|589064684|FG001|Overall Study|Serious Adverse Event|0|||
163096805|NCT00856635|589064683|FG000|Overall Study|Other|1|||
163096806|NCT00856635|589064684|FG001|Overall Study|Other|0|||
163096807|NCT00856635|589064683|FG000|Overall Study|Discontinued at Randomization|2|||
163096808|NCT00856635|589064684|FG001|Overall Study|Discontinued at Randomization|2|||
163096809|NCT01349673|589064685|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
163096810|NCT01349673|589064685|FG000|Overall Study|No Longer Qualified For Study|1|||
163096811|NCT01349673|589064685|FG000|Overall Study|Site Closure|10|||
163096812|NCT01349673|589064685|FG000|Overall Study|Withdrawal by Subject|21|||
163096813|NCT01349673|589064685|FG000|Overall Study|Lost to Follow-up|6|||
163096814|NCT01349673|589064685|FG000|Overall Study|Adverse Event|17|||
163096815|NCT01349673|589064685|FG000|Overall Study|Study Terminated By Sponsor|50|||
163096816|NCT01349673|589064685|FG000|Overall Study|Lack of Efficacy|8|||
163096817|NCT00564733|589064686|FG000|Overall Study|Withdrawal by Subject|4|||
163096818|NCT00564733|589064686|FG000|Overall Study|Ineligible|5|||
163096819|NCT03198767|589064691|FG000|Overall Study|Protocol Violation|0|||
163096820|NCT03198767|589064692|FG001|Overall Study|Protocol Violation|0|||
163096821|NCT03198767|589064693|FG002|Overall Study|Protocol Violation|0|||
163096822|NCT03198767|589064694|FG003|Overall Study|Protocol Violation|6|||
163096823|NCT03198767|589064695|FG004|Overall Study|Protocol Violation|0|||
163096824|NCT03198767|589064696|FG005|Overall Study|Protocol Violation|0|||
163096825|NCT03198767|589064697|FG006|Overall Study|Protocol Violation|0|||
163096826|NCT03462758|589064698|FG000|Overall Study|Chose no or other method of contraception|20|||
163096827|NCT03462758|589064699|FG001|Overall Study|Chose no or other method of contraception|23|||
163096828|NCT03462758|589064698|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
163096829|NCT03462758|589064699|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
163096830|NCT03462758|589064698|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
163096831|NCT03462758|589064699|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
163096832|NCT03462758|589064698|FG000|Overall Study|Medical contraindication|2|||
163096833|NCT03462758|589064699|FG001|Overall Study|Medical contraindication|2|||
163096834|NCT03462758|589064698|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
163096835|NCT03462758|589064699|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
163096836|NCT02820844|589064700|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
163096837|NCT02820844|589064701|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
163096838|NCT02820844|589064702|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
163096839|NCT02820844|589064703|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
163096840|NCT02820844|589064704|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
163096841|NCT02820844|589064705|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
163096842|NCT02820844|589064700|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
163096843|NCT02820844|589064701|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
163096844|NCT02820844|589064702|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
163096845|NCT02820844|589064703|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
163096846|NCT02820844|589064704|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
163096847|NCT02820844|589064705|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
163096848|NCT02820844|589064700|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
163096849|NCT02820844|589064701|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
163096850|NCT02820844|589064702|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
163096851|NCT02820844|589064703|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
163096852|NCT02820844|589064704|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
163096853|NCT02820844|589064705|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
163096854|NCT02820844|589064700|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
163096855|NCT02820844|589064701|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
163096856|NCT02820844|589064702|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
163096857|NCT02820844|589064703|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
163096858|NCT02820844|589064704|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
163096859|NCT02820844|589064705|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
163096860|NCT02820844|589064700|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
163096861|NCT02820844|589064701|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
163096862|NCT02820844|589064702|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
163096863|NCT02820844|589064703|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
163096864|NCT02820844|589064704|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
163096865|NCT02820844|589064705|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
163096866|NCT02820844|589064700|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
163096867|NCT02820844|589064701|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
163096868|NCT02820844|589064702|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
163096869|NCT02820844|589064703|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
163096870|NCT02820844|589064704|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
163096871|NCT02820844|589064705|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
163096872|NCT02820844|589064700|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
163339026|NCT01587703|589951098|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163096873|NCT02820844|589064701|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
163096874|NCT02820844|589064702|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
163096875|NCT02820844|589064703|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
163096876|NCT02820844|589064704|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
163096877|NCT02820844|589064705|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
163096878|NCT02820844|589064700|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096879|NCT02820844|589064701|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096880|NCT02820844|589064702|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
163096881|NCT02820844|589064703|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
163096882|NCT02820844|589064704|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096883|NCT02820844|589064705|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096884|NCT02820844|589064700|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
163096885|NCT02820844|589064701|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
163096886|NCT02820844|589064702|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
163096887|NCT02820844|589064703|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
163096888|NCT02820844|589064704|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
163096889|NCT02820844|589064705|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
163096890|NCT02820844|589064700|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096891|NCT02820844|589064701|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096892|NCT02820844|589064702|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096893|NCT02820844|589064703|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096894|NCT02820844|589064704|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096895|NCT02820844|589064705|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
163096896|NCT00413660|589064707|FG000|Up To Week 12|Adverse Event|1|||
163096897|NCT00413660|589064708|FG001|Up To Week 12|Adverse Event|3|||
163096898|NCT00413660|589064709|FG002|Up To Week 12|Adverse Event|1|||
163096899|NCT00413660|589064710|FG003|Up To Week 12|Adverse Event|4|||
163096900|NCT00413660|589064711|FG004|Up To Week 12|Adverse Event|6|||
163096901|NCT00413660|589064712|FG005|Up To Week 12|Adverse Event|4|||
163096902|NCT00413660|589064713|FG006|Up To Week 12|Adverse Event|1|||
163096903|NCT00413660|589064714|FG007|Up To Week 12|Adverse Event|0|||
163096904|NCT00413660|589064715|FG008|Up To Week 12|Adverse Event|0|||
163096905|NCT00413660|589064716|FG009|Up To Week 12|Adverse Event|0|||
163096906|NCT00413660|589064717|FG010|Up To Week 12|Adverse Event|0|||
163096907|NCT00413660|589064707|FG000|Up To Week 12|Lack of Efficacy|2|||
163096908|NCT00413660|589064708|FG001|Up To Week 12|Lack of Efficacy|0|||
163096909|NCT00413660|589064709|FG002|Up To Week 12|Lack of Efficacy|0|||
163096910|NCT00413660|589064710|FG003|Up To Week 12|Lack of Efficacy|0|||
163096911|NCT00413660|589064711|FG004|Up To Week 12|Lack of Efficacy|0|||
163096912|NCT00413660|589064712|FG005|Up To Week 12|Lack of Efficacy|0|||
163096913|NCT00413660|589064713|FG006|Up To Week 12|Lack of Efficacy|5|||
163096914|NCT00413660|589064714|FG007|Up To Week 12|Lack of Efficacy|0|||
163096915|NCT00413660|589064715|FG008|Up To Week 12|Lack of Efficacy|0|||
163096916|NCT00413660|589064716|FG009|Up To Week 12|Lack of Efficacy|0|||
163096917|NCT00413660|589064717|FG010|Up To Week 12|Lack of Efficacy|0|||
163096918|NCT00413660|589064707|FG000|Up To Week 12|Lost to Follow-up|0|||
163096919|NCT00413660|589064708|FG001|Up To Week 12|Lost to Follow-up|1|||
163096920|NCT00413660|589064709|FG002|Up To Week 12|Lost to Follow-up|0|||
163096921|NCT00413660|589064710|FG003|Up To Week 12|Lost to Follow-up|0|||
163096922|NCT00413660|589064711|FG004|Up To Week 12|Lost to Follow-up|1|||
163096923|NCT00413660|589064712|FG005|Up To Week 12|Lost to Follow-up|0|||
163096924|NCT00413660|589064713|FG006|Up To Week 12|Lost to Follow-up|0|||
163096925|NCT00413660|589064714|FG007|Up To Week 12|Lost to Follow-up|0|||
163096926|NCT00413660|589064715|FG008|Up To Week 12|Lost to Follow-up|0|||
163096927|NCT00413660|589064716|FG009|Up To Week 12|Lost to Follow-up|0|||
163096928|NCT00413660|589064717|FG010|Up To Week 12|Lost to Follow-up|0|||
163096929|NCT00413660|589064707|FG000|Up To Week 12|Withdrawal by Subject|0|||
163096930|NCT00413660|589064708|FG001|Up To Week 12|Withdrawal by Subject|2|||
163096931|NCT00413660|589064709|FG002|Up To Week 12|Withdrawal by Subject|0|||
163096932|NCT00413660|589064710|FG003|Up To Week 12|Withdrawal by Subject|2|||
163096933|NCT00413660|589064711|FG004|Up To Week 12|Withdrawal by Subject|0|||
163339027|NCT01587703|589951080|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
163096934|NCT00413660|589064712|FG005|Up To Week 12|Withdrawal by Subject|2|||
163096935|NCT00413660|589064713|FG006|Up To Week 12|Withdrawal by Subject|2|||
163096936|NCT00413660|589064714|FG007|Up To Week 12|Withdrawal by Subject|0|||
163096937|NCT00413660|589064715|FG008|Up To Week 12|Withdrawal by Subject|0|||
163096938|NCT00413660|589064716|FG009|Up To Week 12|Withdrawal by Subject|0|||
163096939|NCT00413660|589064717|FG010|Up To Week 12|Withdrawal by Subject|0|||
163096940|NCT00413660|589064707|FG000|Up To Week 12|Randomized, Not Treated|1|||
163096941|NCT00413660|589064708|FG001|Up To Week 12|Randomized, Not Treated|0|||
163096942|NCT00413660|589064709|FG002|Up To Week 12|Randomized, Not Treated|0|||
163096943|NCT00413660|589064710|FG003|Up To Week 12|Randomized, Not Treated|1|||
163096944|NCT00413660|589064711|FG004|Up To Week 12|Randomized, Not Treated|0|||
163096945|NCT00413660|589064712|FG005|Up To Week 12|Randomized, Not Treated|0|||
163096946|NCT00413660|589064713|FG006|Up To Week 12|Randomized, Not Treated|0|||
163096947|NCT00413660|589064714|FG007|Up To Week 12|Randomized, Not Treated|0|||
163096948|NCT00413660|589064715|FG008|Up To Week 12|Randomized, Not Treated|0|||
163096949|NCT00413660|589064716|FG009|Up To Week 12|Randomized, Not Treated|0|||
163096950|NCT00413660|589064717|FG010|Up To Week 12|Randomized, Not Treated|0|||
163096951|NCT00413660|589064707|FG000|Up To Week 12|Other|3|||
163096952|NCT00413660|589064708|FG001|Up To Week 12|Other|1|||
163096953|NCT00413660|589064709|FG002|Up To Week 12|Other|6|||
163096954|NCT00413660|589064710|FG003|Up To Week 12|Other|1|||
163096955|NCT00413660|589064711|FG004|Up To Week 12|Other|2|||
163096956|NCT00413660|589064712|FG005|Up To Week 12|Other|4|||
163096957|NCT00413660|589064713|FG006|Up To Week 12|Other|3|||
163096958|NCT00413660|589064714|FG007|Up To Week 12|Other|0|||
163096959|NCT00413660|589064715|FG008|Up To Week 12|Other|0|||
163096960|NCT00413660|589064716|FG009|Up To Week 12|Other|0|||
163096961|NCT00413660|589064717|FG010|Up To Week 12|Other|0|||
163096962|NCT00413660|589064707|FG000|Post Week 12|Adverse Event|2|||
163096963|NCT00413660|589064708|FG001|Post Week 12|Adverse Event|0|||
163096964|NCT00413660|589064709|FG002|Post Week 12|Adverse Event|2|||
163096965|NCT00413660|589064710|FG003|Post Week 12|Adverse Event|1|||
163096966|NCT00413660|589064711|FG004|Post Week 12|Adverse Event|4|||
163096967|NCT00413660|589064712|FG005|Post Week 12|Adverse Event|2|||
163096968|NCT00413660|589064713|FG006|Post Week 12|Adverse Event|2|||
163096969|NCT00413660|589064714|FG007|Post Week 12|Adverse Event|0|||
163096970|NCT00413660|589064715|FG008|Post Week 12|Adverse Event|0|||
163096971|NCT00413660|589064716|FG009|Post Week 12|Adverse Event|0|||
163096972|NCT00413660|589064717|FG010|Post Week 12|Adverse Event|0|||
163096973|NCT00413660|589064707|FG000|Post Week 12|Lack of Efficacy|0|||
163096974|NCT00413660|589064708|FG001|Post Week 12|Lack of Efficacy|0|||
163096975|NCT00413660|589064709|FG002|Post Week 12|Lack of Efficacy|1|||
163096976|NCT00413660|589064710|FG003|Post Week 12|Lack of Efficacy|0|||
163096977|NCT00413660|589064711|FG004|Post Week 12|Lack of Efficacy|0|||
163096978|NCT00413660|589064712|FG005|Post Week 12|Lack of Efficacy|0|||
163096979|NCT00413660|589064713|FG006|Post Week 12|Lack of Efficacy|0|||
163096980|NCT00413660|589064714|FG007|Post Week 12|Lack of Efficacy|0|||
163096981|NCT00413660|589064715|FG008|Post Week 12|Lack of Efficacy|0|||
163096982|NCT00413660|589064716|FG009|Post Week 12|Lack of Efficacy|1|||
163096983|NCT00413660|589064717|FG010|Post Week 12|Lack of Efficacy|0|||
163096984|NCT00413660|589064707|FG000|Post Week 12|Lost to Follow-up|0|||
163096985|NCT00413660|589064708|FG001|Post Week 12|Lost to Follow-up|1|||
163096986|NCT00413660|589064709|FG002|Post Week 12|Lost to Follow-up|1|||
163096987|NCT00413660|589064710|FG003|Post Week 12|Lost to Follow-up|0|||
163096988|NCT00413660|589064711|FG004|Post Week 12|Lost to Follow-up|0|||
163096989|NCT00413660|589064712|FG005|Post Week 12|Lost to Follow-up|0|||
163096990|NCT00413660|589064713|FG006|Post Week 12|Lost to Follow-up|0|||
163096991|NCT00413660|589064714|FG007|Post Week 12|Lost to Follow-up|0|||
163096992|NCT00413660|589064715|FG008|Post Week 12|Lost to Follow-up|0|||
163096993|NCT00413660|589064716|FG009|Post Week 12|Lost to Follow-up|0|||
163096994|NCT00413660|589064717|FG010|Post Week 12|Lost to Follow-up|0|||
163096995|NCT00413660|589064707|FG000|Post Week 12|Withdrawal by Subject|0|||
163096996|NCT00413660|589064708|FG001|Post Week 12|Withdrawal by Subject|1|||
163096997|NCT00413660|589064709|FG002|Post Week 12|Withdrawal by Subject|1|||
163096998|NCT00413660|589064710|FG003|Post Week 12|Withdrawal by Subject|0|||
163096999|NCT00413660|589064711|FG004|Post Week 12|Withdrawal by Subject|1|||
163097000|NCT00413660|589064712|FG005|Post Week 12|Withdrawal by Subject|0|||
163407640|NCT02706873|590200871|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
163407641|NCT02706873|590200872|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
163407642|NCT02706873|590200873|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
163407643|NCT02706873|590200874|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
163097001|NCT00413660|589064713|FG006|Post Week 12|Withdrawal by Subject|0|||
163097002|NCT00413660|589064714|FG007|Post Week 12|Withdrawal by Subject|0|||
163097003|NCT00413660|589064715|FG008|Post Week 12|Withdrawal by Subject|0|||
163097004|NCT00413660|589064716|FG009|Post Week 12|Withdrawal by Subject|0|||
163097005|NCT00413660|589064717|FG010|Post Week 12|Withdrawal by Subject|1|||
163097006|NCT00413660|589064707|FG000|Post Week 12|Other|1|||
163097007|NCT00413660|589064708|FG001|Post Week 12|Other|2|||
163097008|NCT00413660|589064709|FG002|Post Week 12|Other|3|||
163097009|NCT00413660|589064710|FG003|Post Week 12|Other|0|||
163097010|NCT00413660|589064711|FG004|Post Week 12|Other|1|||
163097011|NCT00413660|589064712|FG005|Post Week 12|Other|1|||
163097012|NCT00413660|589064713|FG006|Post Week 12|Other|1|||
163097013|NCT00413660|589064714|FG007|Post Week 12|Other|0|||
163097014|NCT00413660|589064715|FG008|Post Week 12|Other|0|||
163097015|NCT00413660|589064716|FG009|Post Week 12|Other|0|||
163097016|NCT00413660|589064717|FG010|Post Week 12|Other|0|||
163097017|NCT02817594|589064721|FG000|Overall Study|Withdrawal by Subject|1|||
163097018|NCT02817594|589064721|FG000|Overall Study|Other|1|||
163097019|NCT02817594|589064721|FG000|Overall Study|Did Not Receive Treatment|1|||
163097020|NCT02010593|589064722|FG000|Overall Study|Lost to Follow-up|1|||
163097021|NCT02010593|589064723|FG001|Overall Study|Lost to Follow-up|0|||
163097022|NCT02010593|589064722|FG000|Overall Study|Physician Decision|1|||
163097023|NCT02010593|589064723|FG001|Overall Study|Physician Decision|0|||
163097024|NCT02010593|589064722|FG000|Overall Study|Unable to adhere to visit schedule|0|||
163097025|NCT02010593|589064723|FG001|Overall Study|Unable to adhere to visit schedule|2|||
163097026|NCT01135459|589064724|FG000|Overall Study|Adverse Event|8|||
163097027|NCT01135459|589064725|FG001|Overall Study|Adverse Event|10|||
163097028|NCT01135459|589064724|FG000|Overall Study|Lack of Efficacy|3|||
163097029|NCT01135459|589064725|FG001|Overall Study|Lack of Efficacy|1|||
163097030|NCT01135459|589064724|FG000|Overall Study|Withdrawal by Subject|2|||
163097031|NCT01135459|589064725|FG001|Overall Study|Withdrawal by Subject|3|||
163097032|NCT01135459|589064724|FG000|Overall Study|Protocol Violation|5|||
163097033|NCT01135459|589064725|FG001|Overall Study|Protocol Violation|3|||
163097034|NCT01135459|589064724|FG000|Overall Study|Lost to Follow-up|2|||
163097035|NCT01135459|589064725|FG001|Overall Study|Lost to Follow-up|1|||
163097036|NCT01135459|589064724|FG000|Overall Study|Non-compliance to study procedures|0|||
163097037|NCT01135459|589064725|FG001|Overall Study|Non-compliance to study procedures|1|||
163097038|NCT01135459|589064724|FG000|Overall Study|Other than specified|1|||
163097039|NCT01135459|589064725|FG001|Overall Study|Other than specified|1|||
163097040|NCT01803880|589064726|FG000|Overall Study|Adverse Event|1|||
163097041|NCT01803880|589064727|FG001|Overall Study|Adverse Event|0|||
163097042|NCT01803880|589064728|FG002|Overall Study|Adverse Event|0|||
163097043|NCT01803880|589064726|FG000|Overall Study|Withdrawal by Subject|1|||
163097044|NCT01803880|589064727|FG001|Overall Study|Withdrawal by Subject|1|||
163097045|NCT01803880|589064728|FG002|Overall Study|Withdrawal by Subject|4|||
163097046|NCT01803880|589064726|FG000|Overall Study|Physician Decision|0|||
163097047|NCT01803880|589064727|FG001|Overall Study|Physician Decision|0|||
163097048|NCT01803880|589064728|FG002|Overall Study|Physician Decision|1|||
163097049|NCT01803880|589064726|FG000|Overall Study|Unable to return for follow-up visits|0|||
163097050|NCT01803880|589064727|FG001|Overall Study|Unable to return for follow-up visits|1|||
163097051|NCT01803880|589064728|FG002|Overall Study|Unable to return for follow-up visits|2|||
163097052|NCT01803880|589064726|FG000|Overall Study|Lost to Follow-up|1|||
163097053|NCT01803880|589064727|FG001|Overall Study|Lost to Follow-up|2|||
163097054|NCT01803880|589064728|FG002|Overall Study|Lost to Follow-up|3|||
163097055|NCT01803880|589064726|FG000|Overall Study|Protocol Violation|1|||
163097056|NCT01803880|589064727|FG001|Overall Study|Protocol Violation|0|||
163097057|NCT01803880|589064728|FG002|Overall Study|Protocol Violation|0|||
163097058|NCT01803880|589064726|FG000|Overall Study|Early study termination|0|||
163097059|NCT01803880|589064727|FG001|Overall Study|Early study termination|6|||
163097060|NCT01803880|589064728|FG002|Overall Study|Early study termination|5|||
163097061|NCT01803880|589064726|FG000|Overall Study|Incomplete data entry by sites|2|||
163097062|NCT01803880|589064727|FG001|Overall Study|Incomplete data entry by sites|0|||
163097063|NCT01803880|589064728|FG002|Overall Study|Incomplete data entry by sites|0|||
163097064|NCT02651116|589064736|FG000|Overall Study|Adverse Event|0|||
163097065|NCT02651116|589064737|FG001|Overall Study|Adverse Event|1|||
163339028|NCT01587703|589951081|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
163339029|NCT01587703|589951082|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
163339030|NCT01587703|589951083|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
163339031|NCT01587703|589951084|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
163339032|NCT01587703|589951085|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
163339033|NCT01587703|589951086|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
163339034|NCT01587703|589951087|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
163339035|NCT01587703|589951088|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163339036|NCT01587703|589951089|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163339037|NCT01587703|589951090|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163339038|NCT01587703|589951091|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163339039|NCT01587703|589951092|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163339040|NCT01587703|589951093|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163339041|NCT01587703|589951094|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163339042|NCT01587703|589951095|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163339043|NCT01587703|589951096|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163097066|NCT02651116|589064736|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
163097067|NCT02651116|589064737|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
163097068|NCT02803203|589064738|FG000|Overall Study|Adverse Event|4|||
163097069|NCT02803203|589064738|FG000|Overall Study|Death|4|||
163339044|NCT01587703|589951097|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163097070|NCT02803203|589064738|FG000|Overall Study|Progressive disease|29|||
163097071|NCT02803203|589064738|FG000|Overall Study|Withdrawal by Subject|8|||
163097072|NCT02803203|589064738|FG000|Overall Study|Complete resection of target disease|2|||
163097073|NCT02803203|589064738|FG000|Overall Study|Switched to commercial Osi|1|||
163339045|NCT01587703|589951098|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163339046|NCT01587703|589951080|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163097074|NCT02803203|589064738|FG000|Overall Study|Participant moved away|1|||
163097075|NCT01887717|589064739|FG000|Overall Study|Withdrawal by Subject|1|||
163097076|NCT01887717|589064740|FG001|Overall Study|Withdrawal by Subject|7|||
163097077|NCT01887717|589064739|FG000|Overall Study|Physician Decision|0|||
163097078|NCT01887717|589064740|FG001|Overall Study|Physician Decision|2|||
163097079|NCT01887717|589064739|FG000|Overall Study|Administrative reasons|5|||
163097080|NCT01887717|589064740|FG001|Overall Study|Administrative reasons|2|||
163097081|NCT02041299|589064746|FG000|Overall Study|Adverse Event|9|||
163097082|NCT02041299|589064747|FG001|Overall Study|Adverse Event|3|||
163097083|NCT02041299|589064746|FG000|Overall Study|Lost to Follow-up|4|||
163097084|NCT02041299|589064747|FG001|Overall Study|Lost to Follow-up|1|||
163097085|NCT02041299|589064746|FG000|Overall Study|Physician Decision|1|||
163097086|NCT02041299|589064747|FG001|Overall Study|Physician Decision|1|||
163097087|NCT02041299|589064746|FG000|Overall Study|Withdrawal by Subject|13|||
163097088|NCT02041299|589064747|FG001|Overall Study|Withdrawal by Subject|7|||
163097089|NCT02041299|589064746|FG000|Overall Study|Protocol Violation|11|||
163097090|NCT02041299|589064747|FG001|Overall Study|Protocol Violation|4|||
163097091|NCT02041299|589064746|FG000|Overall Study|Termination of the study|7|||
163097092|NCT02041299|589064747|FG001|Overall Study|Termination of the study|3|||
163097093|NCT02041299|589064746|FG000|Overall Study|Required bone marrow transplant|0|||
163097094|NCT02041299|589064747|FG001|Overall Study|Required bone marrow transplant|1|||
163097095|NCT02041299|589064746|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
163097096|NCT02041299|589064747|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
163097097|NCT02389465|589064748|FG000|Overall Study|Lost to Follow-up|1|||
163097098|NCT02389465|589064749|FG001|Overall Study|Lost to Follow-up|3|||
163097099|NCT02389465|589064750|FG002|Overall Study|Lost to Follow-up|3|||
163097100|NCT02389465|589064751|FG003|Overall Study|Lost to Follow-up|0|||
163097101|NCT02389465|589064748|FG000|Overall Study|Physician Decision|0|||
163097102|NCT02389465|589064749|FG001|Overall Study|Physician Decision|0|||
163097103|NCT02389465|589064750|FG002|Overall Study|Physician Decision|0|||
163097104|NCT02389465|589064751|FG003|Overall Study|Physician Decision|1|||
163097105|NCT02389465|589064748|FG000|Overall Study|Withdrawal by Subject|0|||
163097106|NCT02389465|589064749|FG001|Overall Study|Withdrawal by Subject|1|||
163097107|NCT02389465|589064750|FG002|Overall Study|Withdrawal by Subject|2|||
163097108|NCT02389465|589064751|FG003|Overall Study|Withdrawal by Subject|2|||
163097109|NCT01925768|589064752|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
163097110|NCT01925768|589064753|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163097111|NCT01925768|589064752|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
163097112|NCT01925768|589064753|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
163097113|NCT01925768|589064752|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
163097114|NCT01925768|589064753|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
163097115|NCT01925768|589064752|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
163097116|NCT01925768|589064753|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
163097117|NCT01925768|589064752|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
163097118|NCT01925768|589064753|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
163097119|NCT01925768|589064752|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
163097120|NCT01925768|589064753|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
163097121|NCT01925768|589064752|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
163097122|NCT01925768|589064753|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
163097123|NCT01925768|589064752|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
163097124|NCT01925768|589064753|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
163097125|NCT01925768|589064752|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
163097126|NCT01925768|589064753|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
163097127|NCT01925768|589064752|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
163097128|NCT01925768|589064753|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
163097129|NCT01925768|589064752|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
163097130|NCT01925768|589064753|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
163097131|NCT00087698|589064756|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
163097132|NCT00087698|589064756|FG000|Overall Study|Death from Other Causes|3|||
163097133|NCT00087698|589064756|FG000|Overall Study|Adverse Event|4|||
163097134|NCT00087698|589064756|FG000|Overall Study|Withdrawal by Subject|4|||
163097135|NCT00087698|589064756|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
163097136|NCT00087698|589064756|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
163097137|NCT00087698|589064756|FG000|Overall Study|Clinical Relapse|1|||
163097138|NCT00087698|589064756|FG000|Overall Study|Death from Study Disease|2|||
163097139|NCT00087698|589064756|FG000|Overall Study|Death from Study Drug Toxicity|2|||
163097140|NCT00087698|589064756|FG000|Overall Study|Protocol Violation|1|||
163097141|NCT03542266|589064757|FG000|Treatment Phase|Withdrawal by Subject|1|||
163097142|NCT03542266|589064757|FG000|Treatment Phase|Adverse Event|1|||
163097143|NCT03542266|589064757|FG000|Treatment Phase|PD|1|||
163097144|NCT04721158|589064765|FG000|Overall Study|Lost to Follow-up|4|||
163097145|NCT04721158|589064765|FG000|Overall Study|Device did not connect|1|||
163097146|NCT00444925|589064767|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
163097147|NCT00444925|589064768|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
163097148|NCT00444925|589064769|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
163097149|NCT00444925|589064767|FG000|Double-blind Treatment Period|Death|2|||
163097150|NCT00444925|589064768|FG001|Double-blind Treatment Period|Death|0|||
163097151|NCT00444925|589064769|FG002|Double-blind Treatment Period|Death|0|||
163097152|NCT00444925|589064767|FG000|Double-blind Treatment Period|Adverse Event|6|||
163097153|NCT00444925|589064768|FG001|Double-blind Treatment Period|Adverse Event|28|||
163097154|NCT00444925|589064769|FG002|Double-blind Treatment Period|Adverse Event|44|||
163097155|NCT00444925|589064767|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
163097156|NCT00444925|589064768|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
163097157|NCT00444925|589064769|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
163097158|NCT00444925|589064767|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
163097159|NCT00444925|589064768|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
163097160|NCT00444925|589064769|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
163097161|NCT00444925|589064767|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
163097162|NCT00444925|589064768|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
163097163|NCT00444925|589064769|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
163097164|NCT00444925|589064767|FG000|Double-blind Treatment Period|Other|7|||
163097165|NCT00444925|589064768|FG001|Double-blind Treatment Period|Other|7|||
163097166|NCT00444925|589064769|FG002|Double-blind Treatment Period|Other|12|||
163097167|NCT00833027|589064770|FG000|Overall Study|Adverse Event|33|||
163097168|NCT00833027|589064770|FG000|Overall Study|Death|1|||
163097169|NCT00833027|589064770|FG000|Overall Study|Lack of Efficacy|12|||
163097170|NCT00833027|589064770|FG000|Overall Study|Lost to Follow-up|24|||
163097171|NCT00833027|589064770|FG000|Overall Study|Protocol Violation|115|||
163097172|NCT00833027|589064770|FG000|Overall Study|Withdrawal by Subject|16|||
163097173|NCT00833027|589064770|FG000|Overall Study|Missing|10|||
163097174|NCT03069716|589064774|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
163097175|NCT03069716|589064775|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
163097176|NCT03069716|589064776|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
163097177|NCT03069716|589064774|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
163097178|NCT03069716|589064775|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
163097179|NCT03069716|589064776|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
163097180|NCT03069716|589064774|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
163097181|NCT03069716|589064775|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
163097182|NCT03069716|589064776|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
163097183|NCT03069716|589064774|FG000|Randomized Treatment|Withdrawal by Subject|0|||
163097184|NCT03069716|589064775|FG001|Randomized Treatment|Withdrawal by Subject|2|||
163097185|NCT03069716|589064776|FG002|Randomized Treatment|Withdrawal by Subject|0|||
163097186|NCT00714948|589064777|FG000|Overall Study|Adverse Event|2|||
163097187|NCT01673126|589064778|FG000|Overall Study|change of diagnosis|4|||
163097188|NCT01673126|589064779|FG001|Overall Study|change of diagnosis|3|||
163097189|NCT00237042|589064782|FG000|Treatment|Became ineligible post-randomization|0|||
163097190|NCT00237042|589064783|FG001|Treatment|Became ineligible post-randomization|1|||
163097191|NCT00237042|589064784|FG002|Treatment|Became ineligible post-randomization|16|||
163097192|NCT00237042|589064782|FG000|Treatment|Moved out of state|1|||
163097193|NCT00237042|589064783|FG001|Treatment|Moved out of state|1|||
163097194|NCT00237042|589064784|FG002|Treatment|Moved out of state|1|||
163097195|NCT00237042|589064782|FG000|Treatment|Completed no treatment|5|||
163097196|NCT00237042|589064783|FG001|Treatment|Completed no treatment|5|||
163097197|NCT00237042|589064784|FG002|Treatment|Completed no treatment|21|||
163097198|NCT00237042|589064782|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
163097199|NCT00237042|589064783|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
163097200|NCT00237042|589064784|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
163097201|NCT00237042|589064782|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
163097202|NCT00237042|589064783|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
163097203|NCT00237042|589064784|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
163339047|NCT01587703|589951081|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163339048|NCT01587703|589951082|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163339049|NCT01587703|589951083|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163339050|NCT01587703|589951084|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163339051|NCT01587703|589951085|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163339052|NCT01587703|589951086|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163339053|NCT01587703|589951087|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163339054|NCT01587703|589951088|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
163339055|NCT01587703|589951089|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
163097204|NCT01913327|589064791|FG000|Overall Study|Withdrawal by Subject|0|||
163097205|NCT01913327|589064792|FG001|Overall Study|Withdrawal by Subject|1|||
163097206|NCT02151786|589064793|FG000|Overall Study|Unavailability of Case Report Form|26|||
163097207|NCT02151786|589064793|FG000|Overall Study|Outside the Contract Period|1|||
163097208|NCT02151786|589064793|FG000|Overall Study|Randomized, not Treated|1|||
163339056|NCT01587703|589951090|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
163339057|NCT01587703|589951091|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163339058|NCT01587703|589951092|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163097209|NCT02151786|589064793|FG000|Overall Study|Unavailability of Information|8|||
163097210|NCT02112656|589064794|FG000|Overall Study|Death|78|||
163097211|NCT02112656|589064795|FG001|Overall Study|Death|82|||
163097212|NCT02112656|589064794|FG000|Overall Study|Withdrawal by Subject|9|||
163097213|NCT02112656|589064795|FG001|Overall Study|Withdrawal by Subject|11|||
163097214|NCT02112656|589064794|FG000|Overall Study|Lost to Follow-up|2|||
163097215|NCT02112656|589064795|FG001|Overall Study|Lost to Follow-up|4|||
163097216|NCT02112656|589064794|FG000|Overall Study|Noncompliance|1|||
163097217|NCT02112656|589064795|FG001|Overall Study|Noncompliance|2|||
163097218|NCT01234480|589065999|FG000|Overall Study|Pregnancy|88|||
163097219|NCT01234480|589065999|FG000|Overall Study|>36/Normal History|50|||
163097220|NCT01234480|589065999|FG000|Overall Study|Age|3|||
163097221|NCT01234480|589065999|FG000|Overall Study|HPV Vaccine History|28|||
163097222|NCT01234480|589065999|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
163097223|NCT01234480|589065999|FG000|Overall Study|Hysterectomy|2|||
163097224|NCT01234480|589065999|FG000|Overall Study|Hysterectomy post enrollment|1|||
163097225|NCT01234480|589065999|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
163097226|NCT01234480|589065999|FG000|Overall Study|Informed Consent Form Violation|30|||
163097227|NCT01234480|589065999|FG000|Overall Study|Incorrect Visit|3|||
163097228|NCT01234480|589065999|FG000|Overall Study|No Florida Lab License|20|||
163097229|NCT01234480|589065999|FG000|Overall Study|Out of Window|42|||
163097230|NCT01234480|589065999|FG000|Overall Study|Sample Processing/Storage|92|||
163097231|NCT01234480|589065999|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
163097232|NCT01234480|589065999|FG000|Overall Study|Site/Subject non-compliance|44|||
163097233|NCT01234480|589065999|FG000|Overall Study|Missing Sample|9|||
163097234|NCT03370419|589066000|FG000|Overall Study|Lost to Follow-up|16|||
163097235|NCT02595879|589066006|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
163097236|NCT02595879|589066007|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
163097237|NCT01898286|589066008|FG000|Overall Study|Withdrawal by Subject|1|||
163097238|NCT01898286|589066008|FG000|Overall Study|Protocol Violation|1|||
163097239|NCT01898286|589066008|FG000|Overall Study|Lost to Follow-up|1|||
163097240|NCT02197572|589066009|FG000|Overall Study|Progressive Disease|28|||
163097241|NCT02197572|589066009|FG000|Overall Study|Withdrawal by Subject|9|||
163097242|NCT02197572|589066009|FG000|Overall Study|Adverse Event|3|||
163097243|NCT02197572|589066009|FG000|Overall Study|Reason Not Specified|4|||
163097244|NCT02383862|589066010|FG000|3 Month Follow up|Lost to Follow-up|23|||
163097245|NCT02383862|589066011|FG001|3 Month Follow up|Lost to Follow-up|21|||
163097246|NCT03801928|589066012|FG000|Overall Study|Adverse Event|1|||
163097247|NCT03801928|589066013|FG001|Overall Study|Adverse Event|0|||
163097248|NCT03801928|589066014|FG002|Overall Study|Adverse Event|1|||
163097249|NCT03801928|589066015|FG003|Overall Study|Adverse Event|2|||
163097250|NCT03801928|589066016|FG004|Overall Study|Adverse Event|0|||
163097251|NCT03801928|589066017|FG005|Overall Study|Adverse Event|2|||
163097252|NCT03801928|589066012|FG000|Overall Study|Lack of Efficacy|0|||
163097253|NCT03801928|589066013|FG001|Overall Study|Lack of Efficacy|0|||
163097254|NCT03801928|589066014|FG002|Overall Study|Lack of Efficacy|1|||
163097255|NCT03801928|589066015|FG003|Overall Study|Lack of Efficacy|0|||
163097256|NCT03801928|589066016|FG004|Overall Study|Lack of Efficacy|0|||
163097257|NCT03801928|589066017|FG005|Overall Study|Lack of Efficacy|0|||
163097258|NCT03801928|589066012|FG000|Overall Study|Lost to Follow-up|5|||
163097259|NCT03801928|589066013|FG001|Overall Study|Lost to Follow-up|1|||
163097260|NCT03801928|589066014|FG002|Overall Study|Lost to Follow-up|1|||
163097261|NCT03801928|589066015|FG003|Overall Study|Lost to Follow-up|4|||
163097262|NCT03801928|589066016|FG004|Overall Study|Lost to Follow-up|4|||
163097263|NCT03801928|589066017|FG005|Overall Study|Lost to Follow-up|2|||
163097264|NCT03801928|589066012|FG000|Overall Study|Withdrawal by Subject|0|||
163097265|NCT03801928|589066013|FG001|Overall Study|Withdrawal by Subject|0|||
163097266|NCT03801928|589066014|FG002|Overall Study|Withdrawal by Subject|2|||
163097267|NCT03801928|589066015|FG003|Overall Study|Withdrawal by Subject|1|||
163097268|NCT03801928|589066016|FG004|Overall Study|Withdrawal by Subject|0|||
163097269|NCT03801928|589066017|FG005|Overall Study|Withdrawal by Subject|0|||
163097270|NCT03801928|589066012|FG000|Overall Study|Other|0|||
163097271|NCT03801928|589066013|FG001|Overall Study|Other|2|||
163339059|NCT01587703|589951093|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163339060|NCT01587703|589951094|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163097272|NCT03801928|589066014|FG002|Overall Study|Other|0|||
163097273|NCT03801928|589066015|FG003|Overall Study|Other|1|||
163097274|NCT03801928|589066016|FG004|Overall Study|Other|0|||
163339061|NCT01587703|589951095|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163097275|NCT03801928|589066017|FG005|Overall Study|Other|1|||
163097276|NCT02763059|589066018|FG000|Overall Study|Lost to Follow-up|4|||
163097277|NCT02763059|589066019|FG001|Overall Study|Lost to Follow-up|1|||
163097278|NCT02763059|589066020|FG002|Overall Study|Lost to Follow-up|6|||
163097279|NCT02763059|589066018|FG000|Overall Study|Withdrawal by Subject|1|||
163097280|NCT02763059|589066019|FG001|Overall Study|Withdrawal by Subject|0|||
163097281|NCT02763059|589066020|FG002|Overall Study|Withdrawal by Subject|3|||
163097282|NCT03688919|589066021|FG000|Overall Study|Lost to Follow-up|2|||
163097283|NCT03688919|589066022|FG001|Overall Study|Lost to Follow-up|1|||
163097284|NCT03688919|589066021|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
163097285|NCT03688919|589066022|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
163097286|NCT04423939|589066027|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
163097287|NCT04423939|589066028|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
163097288|NCT04423939|589066027|FG000|Overall Study|Death|3|||
163097289|NCT04423939|589066028|FG001|Overall Study|Death|0|||
163097290|NCT04423939|589066027|FG000|Overall Study|Withdrawal by Subject|3|||
163097291|NCT04423939|589066028|FG001|Overall Study|Withdrawal by Subject|0|||
163097292|NCT04423939|589066027|FG000|Overall Study|Caregiver to patient who died|0|||
163097293|NCT04423939|589066028|FG001|Overall Study|Caregiver to patient who died|3|||
163097294|NCT04423939|589066027|FG000|Overall Study|Caregiver to patient who withdrew|0|||
163097295|NCT04423939|589066028|FG001|Overall Study|Caregiver to patient who withdrew|3|||
163097296|NCT01722994|589066032|FG000|Overall Study|Missing data|25|||
163097297|NCT01722994|589066033|FG001|Overall Study|Missing data|17|||
163097298|NCT01206140|589066037|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
163097299|NCT01206140|589066038|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
163097300|NCT00075764|589066039|FG000|Overall Study|Adverse Event|5|||
163097301|NCT00075764|589066040|FG001|Overall Study|Adverse Event|12|||
163097302|NCT00075764|589066039|FG000|Overall Study|Death|4|||
163097303|NCT00075764|589066040|FG001|Overall Study|Death|8|||
163097304|NCT00075764|589066039|FG000|Overall Study|Withdrawal by Subject|28|||
163097305|NCT00075764|589066040|FG001|Overall Study|Withdrawal by Subject|18|||
163097306|NCT00075764|589066039|FG000|Overall Study|Progression|269|||
163097307|NCT00075764|589066040|FG001|Overall Study|Progression|274|||
163097308|NCT00075764|589066039|FG000|Overall Study|Still on treatment|8|||
163097309|NCT00075764|589066040|FG001|Overall Study|Still on treatment|15|||
163097310|NCT00075764|589066039|FG000|Overall Study|Delinquent|4|||
163097311|NCT00075764|589066040|FG001|Overall Study|Delinquent|2|||
163097312|NCT00075764|589066039|FG000|Overall Study|Not protocol specified|27|||
163097313|NCT00075764|589066040|FG001|Overall Study|Not protocol specified|19|||
163097314|NCT00075764|589066039|FG000|Overall Study|Under review|0|||
163097315|NCT00075764|589066040|FG001|Overall Study|Under review|1|||
163097316|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
163097317|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
163097318|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
163097319|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
163097320|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
163097321|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
163097322|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
163097323|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
163097324|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
163097325|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
163097326|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
163220162|NCT02039674|589521410|FG004|Overall Study|Withdrawal by Subject|1|||
163220163|NCT02039674|589521411|FG005|Overall Study|Withdrawal by Subject|0|||
163220164|NCT02039674|589521412|FG006|Overall Study|Withdrawal by Subject|0|||
163220165|NCT02039674|589521413|FG007|Overall Study|Withdrawal by Subject|0|||
163220166|NCT02039674|589521414|FG008|Overall Study|Withdrawal by Subject|0|||
163220167|NCT02039674|589521415|FG009|Overall Study|Withdrawal by Subject|1|||
163220168|NCT02039674|589521416|FG010|Overall Study|Withdrawal by Subject|1|||
163220169|NCT02039674|589521417|FG011|Overall Study|Withdrawal by Subject|4|||
163220170|NCT02039674|589521418|FG012|Overall Study|Withdrawal by Subject|6|||
163220171|NCT02039674|589521419|FG013|Overall Study|Withdrawal by Subject|2|||
163220172|NCT02039674|589521406|FG000|Overall Study|Clinical Progression|0|||
163220173|NCT02039674|589521407|FG001|Overall Study|Clinical Progression|0|||
163220174|NCT02039674|589521408|FG002|Overall Study|Clinical Progression|0|||
163220175|NCT02039674|589521409|FG003|Overall Study|Clinical Progression|0|||
163220176|NCT02039674|589521410|FG004|Overall Study|Clinical Progression|0|||
163220177|NCT02039674|589521411|FG005|Overall Study|Clinical Progression|0|||
163220178|NCT02039674|589521412|FG006|Overall Study|Clinical Progression|1|||
163220179|NCT02039674|589521413|FG007|Overall Study|Clinical Progression|0|||
163220180|NCT02039674|589521414|FG008|Overall Study|Clinical Progression|0|||
163220181|NCT02039674|589521415|FG009|Overall Study|Clinical Progression|0|||
163220182|NCT02039674|589521416|FG010|Overall Study|Clinical Progression|0|||
163220183|NCT02039674|589521417|FG011|Overall Study|Clinical Progression|0|||
163220184|NCT02039674|589521418|FG012|Overall Study|Clinical Progression|1|||
163339062|NCT01587703|589951096|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163220185|NCT02039674|589521419|FG013|Overall Study|Clinical Progression|0|||
163220186|NCT02039674|589521406|FG000|Overall Study|Sponsor Decision|1|||
163220187|NCT02039674|589521407|FG001|Overall Study|Sponsor Decision|1|||
163220188|NCT02039674|589521408|FG002|Overall Study|Sponsor Decision|1|||
163220189|NCT02039674|589521409|FG003|Overall Study|Sponsor Decision|1|||
163220190|NCT02039674|589521410|FG004|Overall Study|Sponsor Decision|1|||
163097327|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
163097328|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
163097329|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
163097330|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
163097331|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
163097332|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
163097333|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
163097334|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
163097335|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
163097336|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
163097337|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
163097338|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
163097339|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
163097340|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Other|6|||
163097341|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Other|0|||
163097342|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Other|0|||
163097343|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
163097344|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
163097345|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
163097346|NCT05615220|589066047|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
163097347|NCT05615220|589066048|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
163097348|NCT05615220|589066049|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
163097349|NCT05615220|589066047|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
163097350|NCT05615220|589066048|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
163097351|NCT05615220|589066049|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
163097352|NCT05615220|589066047|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
163097353|NCT05615220|589066048|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
163097354|NCT05615220|589066049|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
163097355|NCT05615220|589066047|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
163097356|NCT05615220|589066048|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
163097357|NCT05615220|589066049|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
163097358|NCT05615220|589066047|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
163097359|NCT05615220|589066048|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
163097360|NCT05615220|589066049|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
163097361|NCT00533429|589066051|FG000|Overall Study|Adverse Event|3|||
163097362|NCT00533429|589066052|FG001|Overall Study|Adverse Event|1|||
163097363|NCT00533429|589066051|FG000|Overall Study|Death|1|||
163097364|NCT00533429|589066052|FG001|Overall Study|Death|0|||
163097365|NCT00533429|589066051|FG000|Overall Study|Withdrawal by Subject|2|||
163097366|NCT00533429|589066052|FG001|Overall Study|Withdrawal by Subject|0|||
163097367|NCT00533429|589066051|FG000|Overall Study|Progressive Disease|12|||
163097368|NCT00533429|589066052|FG001|Overall Study|Progressive Disease|13|||
163097369|NCT00533429|589066051|FG000|Overall Study|Symptomatic deterioration|1|||
163097370|NCT00533429|589066052|FG001|Overall Study|Symptomatic deterioration|2|||
163097371|NCT02655887|589066053|FG000|Overall Study|Lost to Follow-up|3|||
163097372|NCT02655887|589066053|FG000|Overall Study|Death|4|||
163097373|NCT02655887|589066053|FG000|Overall Study|Withdrawal by Subject|3|||
163097374|NCT02655887|589066053|FG000|Overall Study|Missed 12-month follow-up visit|4|||
163097375|NCT04245709|589066056|FG000|Overall Study|Adverse Event|13|||
163097376|NCT04245709|589066056|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
163097377|NCT04339413|589066060|FG000|Overall Study|Reason Not Specified|2|||
163097378|NCT04339413|589066061|FG001|Overall Study|Reason Not Specified|7|||
163097379|NCT04339413|589066060|FG000|Overall Study|Study Terminated by Sponsor|30|||
163097380|NCT04339413|589066061|FG001|Overall Study|Study Terminated by Sponsor|33|||
163097381|NCT04339413|589066060|FG000|Overall Study|Progressive Disease|9|||
163097382|NCT04339413|589066061|FG001|Overall Study|Progressive Disease|6|||
163097383|NCT04339413|589066060|FG000|Overall Study|Withdrawal by Subject|9|||
163097384|NCT04339413|589066061|FG001|Overall Study|Withdrawal by Subject|10|||
163097385|NCT04339413|589066060|FG000|Overall Study|Physician Decision|3|||
163097386|NCT04339413|589066061|FG001|Overall Study|Physician Decision|1|||
163097387|NCT04339413|589066060|FG000|Overall Study|Death|2|||
163097388|NCT04339413|589066061|FG001|Overall Study|Death|0|||
163339063|NCT01587703|589951097|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163339064|NCT01587703|589951098|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163339065|NCT01587703|589951080|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163097389|NCT04339413|589066060|FG000|Overall Study|Adverse Event|3|||
163097390|NCT04339413|589066061|FG001|Overall Study|Adverse Event|0|||
163097391|NCT01964378|589066065|FG000|Overall Study|Disc. due to death before first dosing|0|||
163339066|NCT01587703|589951081|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163097392|NCT01964378|589066066|FG001|Overall Study|Disc. due to death before first dosing|1|||
163097393|NCT01964378|589066065|FG000|Overall Study|Disc. due to AE before first dosing|1|||
163097394|NCT01964378|589066066|FG001|Overall Study|Disc. due to AE before first dosing|0|||
163097395|NCT01964378|589066065|FG000|Overall Study|Death|3|||
163097396|NCT01964378|589066066|FG001|Overall Study|Death|2|||
163097397|NCT01964378|589066065|FG000|Overall Study|Adverse Event|12|||
163097398|NCT01964378|589066066|FG001|Overall Study|Adverse Event|5|||
163097399|NCT01964378|589066065|FG000|Overall Study|Lack of Efficacy|0|||
163097400|NCT01964378|589066066|FG001|Overall Study|Lack of Efficacy|1|||
163097401|NCT01964378|589066065|FG000|Overall Study|Protocol Violation|0|||
163097402|NCT01964378|589066066|FG001|Overall Study|Protocol Violation|1|||
163097403|NCT01964378|589066065|FG000|Overall Study|Lost to Follow-up|0|||
163097404|NCT01964378|589066066|FG001|Overall Study|Lost to Follow-up|1|||
163097405|NCT01964378|589066065|FG000|Overall Study|Withdrawal by Subject|7|||
163097406|NCT01964378|589066066|FG001|Overall Study|Withdrawal by Subject|5|||
163097407|NCT01964378|589066065|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
163097408|NCT01964378|589066066|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
163097409|NCT01964378|589066065|FG000|Overall Study|Other|1|||
163097410|NCT01964378|589066066|FG001|Overall Study|Other|2|||
163097411|NCT00657267|589066074|FG000|Overall Study|Progressive disease|45|||
163097412|NCT00657267|589066074|FG000|Overall Study|Adverse Event|9|||
163097413|NCT00142792|589066077|FG000|Overall Study|Death|0|||
163097414|NCT00142792|589066078|FG001|Overall Study|Death|0|||
163097415|NCT00142792|589066079|FG002|Overall Study|Death|1|||
163097416|NCT00142792|589066077|FG000|Overall Study|Withdrawal by Subject|3|||
163097417|NCT00142792|589066078|FG001|Overall Study|Withdrawal by Subject|2|||
163097418|NCT00142792|589066079|FG002|Overall Study|Withdrawal by Subject|3|||
163097419|NCT00142792|589066077|FG000|Overall Study|Lost to Follow-up|8|||
163097420|NCT00142792|589066078|FG001|Overall Study|Lost to Follow-up|11|||
163097421|NCT00142792|589066079|FG002|Overall Study|Lost to Follow-up|7|||
163097422|NCT00142792|589066077|FG000|Overall Study|No category|1|||
163097423|NCT00142792|589066078|FG001|Overall Study|No category|2|||
163097424|NCT00142792|589066079|FG002|Overall Study|No category|1|||
163097425|NCT04872569|589066080|FG000|Overall Study|Withdrawal by Subject|2|||
163097426|NCT02382991|589066086|FG000|Overall Study|Adverse Event|1|||
163097427|NCT02382991|589066087|FG001|Overall Study|Adverse Event|2|||
163097428|NCT02382991|589066086|FG000|Overall Study|Lost to Follow-up|1|||
163097429|NCT02382991|589066087|FG001|Overall Study|Lost to Follow-up|0|||
163097430|NCT02382991|589066086|FG000|Overall Study|Withdrawal by Subject|0|||
163097431|NCT02382991|589066087|FG001|Overall Study|Withdrawal by Subject|1|||
163097432|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
163097433|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
163097434|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
163097435|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
163097436|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
163097437|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
163097438|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
163097439|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
163339067|NCT01587703|589951082|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163097440|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
163097441|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
163097442|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
163097443|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
163097444|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
163097445|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
163097446|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
163097447|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
163097448|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
163097449|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
163097450|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
163097451|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
163097452|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
163097453|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
163097454|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
163097455|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
163097456|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
163097457|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
163097458|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
163097459|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
163097460|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
163339068|NCT01587703|589951083|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163097461|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
163097462|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
163097463|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
163097464|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
163097465|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
163097466|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
163097467|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
163097468|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
163097469|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
163097470|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
163097471|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
163097472|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
163097473|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
163097474|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
163097475|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
163097476|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
163097477|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
163097478|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
163097479|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
163097480|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
163097481|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
163097482|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
163097483|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
163097484|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
163097485|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
163097486|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
163097487|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
163097488|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
163097489|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
163097490|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
163097491|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
163097492|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
163097493|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
163097494|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
163097495|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
163097496|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
163097497|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
163097498|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
163097499|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
163097500|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
163097501|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
163097502|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
163097503|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
163097504|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
163097505|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
163339069|NCT01587703|589951084|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163339070|NCT01587703|589951085|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163339071|NCT01587703|589951086|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163339072|NCT01587703|589951087|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163339073|NCT01587703|589951088|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
163339074|NCT01587703|589951089|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163339075|NCT01587703|589951090|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
163339076|NCT01587703|589951091|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163339077|NCT01587703|589951092|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163097506|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
163097507|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
163097508|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
163097509|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
163097510|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
163097511|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
163097512|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
163097513|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
163097514|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
163097515|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
163097516|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
163097517|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
163097518|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
163097519|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
163097520|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
163097521|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
163097522|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
163097523|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
163097524|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
163097525|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
163097526|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
163097527|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
163097528|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
163097529|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
163097530|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
163097531|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
163097532|NCT02891226|589066097|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
163097533|NCT02891226|589066098|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
163097534|NCT02891226|589066099|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
163097535|NCT02891226|589066100|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097536|NCT02891226|589066101|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097537|NCT02891226|589066102|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097538|NCT02891226|589066103|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097539|NCT02891226|589066104|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097540|NCT02891226|589066105|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097541|NCT02891226|589066106|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097542|NCT02891226|589066107|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097543|NCT02891226|589066108|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097544|NCT02891226|589066109|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097545|NCT02891226|589066110|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097546|NCT02891226|589066111|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097547|NCT02891226|589066112|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097548|NCT02891226|589066097|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
163097549|NCT02891226|589066098|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
163097550|NCT02891226|589066099|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097551|NCT02891226|589066100|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097552|NCT02891226|589066101|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097553|NCT02891226|589066102|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097554|NCT02891226|589066103|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097555|NCT02891226|589066104|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097556|NCT02891226|589066105|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097557|NCT02891226|589066106|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097558|NCT02891226|589066107|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097559|NCT02891226|589066108|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097560|NCT02891226|589066109|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097561|NCT02891226|589066110|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097562|NCT02891226|589066111|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097563|NCT02891226|589066112|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097564|NCT02891226|589066097|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097565|NCT02891226|589066098|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097566|NCT02891226|589066099|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097567|NCT02891226|589066100|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
163097568|NCT02891226|589066101|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097569|NCT02891226|589066102|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097570|NCT02891226|589066103|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097571|NCT02891226|589066104|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097572|NCT02891226|589066105|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097573|NCT02891226|589066106|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097574|NCT02891226|589066107|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097575|NCT02891226|589066108|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097576|NCT02891226|589066109|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163407644|NCT02706873|590200871|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
163097577|NCT02891226|589066110|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097578|NCT02891226|589066111|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097579|NCT02891226|589066112|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097580|NCT02891226|589066097|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097581|NCT02891226|589066098|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097582|NCT02891226|589066099|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
163097583|NCT02891226|589066100|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097584|NCT02891226|589066101|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097585|NCT02891226|589066102|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097586|NCT02891226|589066103|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097587|NCT02891226|589066104|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097588|NCT02891226|589066105|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097589|NCT02891226|589066106|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097590|NCT02891226|589066107|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097591|NCT02891226|589066108|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097592|NCT02891226|589066109|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097593|NCT02891226|589066110|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097594|NCT02891226|589066111|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097595|NCT02891226|589066112|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097596|NCT02891226|589066097|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097597|NCT02891226|589066098|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097598|NCT02891226|589066099|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097599|NCT02891226|589066100|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
163097600|NCT02891226|589066101|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097601|NCT02891226|589066102|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097602|NCT02891226|589066103|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097603|NCT02891226|589066104|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097604|NCT02891226|589066105|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097605|NCT02891226|589066106|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097606|NCT02891226|589066107|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097607|NCT02891226|589066108|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097608|NCT02891226|589066109|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097609|NCT02891226|589066110|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097610|NCT02891226|589066111|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097611|NCT02891226|589066112|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097612|NCT02891226|589066097|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097613|NCT02891226|589066098|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097614|NCT02891226|589066099|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097615|NCT02891226|589066100|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
163097616|NCT02891226|589066101|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097617|NCT02891226|589066102|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097618|NCT02891226|589066103|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097619|NCT02891226|589066104|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097620|NCT02891226|589066105|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097621|NCT02891226|589066106|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097622|NCT02891226|589066107|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097623|NCT02891226|589066108|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097624|NCT02891226|589066109|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097625|NCT02891226|589066110|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097626|NCT02891226|589066111|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097627|NCT02891226|589066112|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097628|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097629|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097630|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097631|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097632|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097633|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097634|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
163097635|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
163097636|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
163097637|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
163097638|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097639|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097640|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097641|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097642|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097643|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097644|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097645|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097646|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097647|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097648|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097649|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
163097650|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097651|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097652|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097653|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
163097654|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097655|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097656|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097657|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097658|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097659|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097660|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097661|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097662|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097663|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097664|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097665|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097666|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
163097667|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
163097668|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
163097669|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
163097670|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097671|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097672|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097673|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097674|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097675|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097676|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097677|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097678|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097679|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097680|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
163097681|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097682|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097683|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097684|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097685|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097686|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097687|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097688|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097689|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097690|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097691|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097692|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097693|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097694|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097695|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097696|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097697|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097698|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
163097699|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097700|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097701|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097702|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097703|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097704|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097705|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097706|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097707|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097708|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097709|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097710|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097711|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097712|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097713|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097714|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097715|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
163097716|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
163097717|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
163097718|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097719|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163339078|NCT01587703|589951093|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163097720|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097721|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097722|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097723|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097724|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097725|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097726|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097727|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097728|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097729|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097730|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097731|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
163097732|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097733|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097734|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097735|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097736|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097737|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097738|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097739|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097740|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097741|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097742|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097743|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097744|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097745|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097746|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097747|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097748|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
163097749|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097750|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097751|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097752|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097753|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097754|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097755|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097756|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097757|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097758|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097759|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097760|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097761|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097762|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097763|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097764|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097765|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
163097766|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097767|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097768|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097769|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097770|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097771|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097772|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097773|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097774|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097775|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097776|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097777|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163339079|NCT01587703|589951094|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163097778|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097779|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163339080|NCT01587703|589951095|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163097780|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097781|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
163097782|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097783|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097784|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097785|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097786|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097787|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097788|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097789|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097790|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097791|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097792|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097793|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097794|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097795|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097796|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097797|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097798|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
163097799|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097800|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097801|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097802|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097803|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097804|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097805|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097806|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097807|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097808|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097809|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097810|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097811|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097812|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097813|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097814|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
163097815|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097816|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097817|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097818|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097819|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097820|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097821|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097822|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097823|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097824|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097825|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097826|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097827|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097828|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097829|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097830|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
163097831|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097832|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097833|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097834|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097835|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097836|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097837|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097838|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097839|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097840|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097841|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097842|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097843|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097844|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097845|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097846|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
163097847|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097848|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097849|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097850|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097851|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097852|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097853|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097854|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097855|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097856|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097857|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097858|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097859|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097860|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097861|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097862|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
163097863|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097864|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097865|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097866|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097867|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097868|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097869|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097870|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097871|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097872|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097873|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097874|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097875|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097876|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097877|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097878|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
163097879|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097880|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097881|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097882|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097883|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097884|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097885|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097886|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097887|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097888|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097889|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097890|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097891|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097892|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097893|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097894|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
163097895|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097896|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097897|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097898|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097899|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097900|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097901|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097902|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097903|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097904|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097905|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097906|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097907|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097908|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097909|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097910|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
163097911|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097912|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097913|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097914|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097915|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097916|NCT02891226|589066097|FG000|Follow-up Period|Withdrawal by Subject|0|||
163097917|NCT02891226|589066098|FG001|Follow-up Period|Withdrawal by Subject|0|||
163097918|NCT02891226|589066099|FG002|Follow-up Period|Withdrawal by Subject|0|||
163097919|NCT02891226|589066100|FG003|Follow-up Period|Withdrawal by Subject|0|||
163097920|NCT02891226|589066101|FG004|Follow-up Period|Withdrawal by Subject|0|||
163097921|NCT02891226|589066102|FG005|Follow-up Period|Withdrawal by Subject|0|||
163097922|NCT02891226|589066103|FG006|Follow-up Period|Withdrawal by Subject|0|||
163097923|NCT02891226|589066104|FG007|Follow-up Period|Withdrawal by Subject|0|||
163097924|NCT02891226|589066105|FG008|Follow-up Period|Withdrawal by Subject|0|||
163097925|NCT02891226|589066106|FG009|Follow-up Period|Withdrawal by Subject|0|||
163097926|NCT02891226|589066107|FG010|Follow-up Period|Withdrawal by Subject|0|||
163097927|NCT02891226|589066108|FG011|Follow-up Period|Withdrawal by Subject|1|||
163097928|NCT02891226|589066109|FG012|Follow-up Period|Withdrawal by Subject|0|||
163097929|NCT02891226|589066110|FG013|Follow-up Period|Withdrawal by Subject|0|||
163097930|NCT02891226|589066111|FG014|Follow-up Period|Withdrawal by Subject|1|||
163097931|NCT02891226|589066112|FG015|Follow-up Period|Withdrawal by Subject|1|||
163097932|NCT01445847|589066115|FG000|Overall Study|Protocol Violation|13|||
163097933|NCT01445847|589066116|FG001|Overall Study|Protocol Violation|14|||
163097934|NCT01445847|589066115|FG000|Overall Study|Missed Data|1|||
163097935|NCT01445847|589066116|FG001|Overall Study|Missed Data|0|||
163097936|NCT04570384|589066117|FG000|Overall Study|Adverse Event|2|||
163097937|NCT04570384|589066118|FG001|Overall Study|Adverse Event|1|||
163097938|NCT04570384|589066117|FG000|Overall Study|Death|2|||
163097939|NCT04570384|589066118|FG001|Overall Study|Death|5|||
163097940|NCT04570384|589066117|FG000|Overall Study|Lost to Follow-up|1|||
163097941|NCT04570384|589066118|FG001|Overall Study|Lost to Follow-up|0|||
163097942|NCT04570384|589066117|FG000|Overall Study|Other|1|||
163097943|NCT04570384|589066118|FG001|Overall Study|Other|0|||
163097944|NCT04570384|589066117|FG000|Overall Study|Protocol Violation|0|||
163097945|NCT04570384|589066118|FG001|Overall Study|Protocol Violation|1|||
163097946|NCT04570384|589066117|FG000|Overall Study|Sponsor Decision|1|||
163097947|NCT04570384|589066118|FG001|Overall Study|Sponsor Decision|0|||
163097948|NCT04570384|589066117|FG000|Overall Study|Withdrawal by Subject|4|||
163097949|NCT04570384|589066118|FG001|Overall Study|Withdrawal by Subject|2|||
163097950|NCT03654274|589066119|FG000|Overall Study|Adverse Event|19|||
163097951|NCT03654274|589066120|FG001|Overall Study|Adverse Event|23|||
163097952|NCT03654274|589066121|FG002|Overall Study|Adverse Event|24|||
163097953|NCT03654274|589066119|FG000|Overall Study|Protocol Deviation|0|||
163097954|NCT03654274|589066120|FG001|Overall Study|Protocol Deviation|2|||
163097955|NCT03654274|589066121|FG002|Overall Study|Protocol Deviation|0|||
163097956|NCT03654274|589066119|FG000|Overall Study|Lost to Follow-up|8|||
163097957|NCT03654274|589066120|FG001|Overall Study|Lost to Follow-up|6|||
163097958|NCT03654274|589066121|FG002|Overall Study|Lost to Follow-up|5|||
163097959|NCT03654274|589066119|FG000|Overall Study|Withdrawal by Subject|46|||
163097960|NCT03654274|589066120|FG001|Overall Study|Withdrawal by Subject|25|||
163097961|NCT03654274|589066121|FG002|Overall Study|Withdrawal by Subject|33|||
163097962|NCT03654274|589066119|FG000|Overall Study|Lack of Efficacy|4|||
163097963|NCT03654274|589066120|FG001|Overall Study|Lack of Efficacy|5|||
163097964|NCT03654274|589066121|FG002|Overall Study|Lack of Efficacy|7|||
163097965|NCT03654274|589066119|FG000|Overall Study|Pregnancy|2|||
163097966|NCT03654274|589066120|FG001|Overall Study|Pregnancy|2|||
163097967|NCT03654274|589066121|FG002|Overall Study|Pregnancy|1|||
163097968|NCT03654274|589066119|FG000|Overall Study|Other|27|||
163097969|NCT03654274|589066120|FG001|Overall Study|Other|29|||
163097970|NCT03654274|589066121|FG002|Overall Study|Other|32|||
163097971|NCT03654274|589066119|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
163097972|NCT03654274|589066120|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
163097973|NCT03654274|589066121|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
163097974|NCT02454530|589066122|FG000|Overall Study|Other|8|||
163097975|NCT02454530|589066123|FG001|Overall Study|Other|13|||
163097976|NCT02454530|589066122|FG000|Overall Study|Missing information|56|||
163097977|NCT02454530|589066123|FG001|Overall Study|Missing information|69|||
163097978|NCT02454530|589066122|FG000|Overall Study|Death|2|||
163097979|NCT02454530|589066123|FG001|Overall Study|Death|41|||
163097980|NCT02454530|589066122|FG000|Overall Study|Lost to Follow-up|4|||
163097981|NCT02454530|589066123|FG001|Overall Study|Lost to Follow-up|4|||
163097982|NCT00326001|589066124|FG000|Overall Study|Adverse Event|4|||
163097983|NCT00326001|589066125|FG001|Overall Study|Adverse Event|5|||
163097984|NCT00326001|589066124|FG000|Overall Study|Physician Decision|3|||
163097985|NCT00326001|589066125|FG001|Overall Study|Physician Decision|3|||
163097986|NCT03265145|589066126|FG000|Overall Study|Protocol Violation|2|||
163097987|NCT03265145|589066127|FG001|Overall Study|Protocol Violation|0|||
163097988|NCT03265145|589066126|FG000|Overall Study|Adverse Event|1|||
163097989|NCT03265145|589066127|FG001|Overall Study|Adverse Event|0|||
163097990|NCT03265145|589066126|FG000|Overall Study|Withdrawal by Subject|23|||
163097991|NCT03265145|589066127|FG001|Overall Study|Withdrawal by Subject|19|||
163097992|NCT03265145|589066126|FG000|Overall Study|Death|12|||
163097993|NCT03265145|589066127|FG001|Overall Study|Death|12|||
163097994|NCT03265145|589066126|FG000|Overall Study|Lost to Follow-up|13|||
163097995|NCT03265145|589066127|FG001|Overall Study|Lost to Follow-up|9|||
163097996|NCT03265145|589066126|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
163097997|NCT03265145|589066127|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
163097998|NCT03265145|589066126|FG000|Overall Study|Switched back to previous medication|1|||
163097999|NCT03265145|589066127|FG001|Overall Study|Switched back to previous medication|0|||
163098000|NCT03265145|589066126|FG000|Overall Study|Did not want to take medication|1|||
163098001|NCT03265145|589066127|FG001|Overall Study|Did not want to take medication|0|||
163098002|NCT03265145|589066126|FG000|Overall Study|Subject could not afford medication|0|||
163098003|NCT03265145|589066127|FG001|Overall Study|Subject could not afford medication|1|||
163098004|NCT03265145|589066126|FG000|Overall Study|Site closed|2|||
163098005|NCT03265145|589066127|FG001|Overall Study|Site closed|3|||
163098006|NCT03265145|589066126|FG000|Overall Study|Incorrectly randomized|16|||
163098007|NCT03265145|589066127|FG001|Overall Study|Incorrectly randomized|6|||
163098008|NCT03265145|589066126|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
163098009|NCT03265145|589066127|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
163098010|NCT03265145|589066126|FG000|Overall Study|Physician Decision|0|||
163098011|NCT03265145|589066127|FG001|Overall Study|Physician Decision|3|||
163098012|NCT03265145|589066126|FG000|Overall Study|Subject transferred to another facility|0|||
163098013|NCT03265145|589066127|FG001|Overall Study|Subject transferred to another facility|1|||
163098014|NCT02137070|589066128|FG000|Overall Study|Adverse Event|12|||
163098015|NCT02137070|589066129|FG001|Overall Study|Adverse Event|3|||
163098016|NCT02137070|589066128|FG000|Overall Study|Death|2|||
163098017|NCT02137070|589066129|FG001|Overall Study|Death|0|||
163098018|NCT02137070|589066128|FG000|Overall Study|Lost to Follow-up|24|||
163098019|NCT02137070|589066129|FG001|Overall Study|Lost to Follow-up|9|||
163098020|NCT02137070|589066128|FG000|Overall Study|Physician Decision|0|||
163098021|NCT02137070|589066129|FG001|Overall Study|Physician Decision|1|||
163098022|NCT02137070|589066128|FG000|Overall Study|Protocol Violation|18|||
163098023|NCT02137070|589066129|FG001|Overall Study|Protocol Violation|4|||
163098024|NCT02137070|589066128|FG000|Overall Study|Withdrawal by Subject|18|||
163098025|NCT02137070|589066129|FG001|Overall Study|Withdrawal by Subject|1|||
163154808|NCT04123470|589281443|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
163154809|NCT04123470|589281442|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
163154810|NCT04123470|589281443|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
163154811|NCT04123470|589281442|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
163154812|NCT04123470|589281443|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
163154813|NCT03818256|589281444|FG000|Overall Study|Withdrawal by Subject|2|||
163154814|NCT03818256|589281445|FG001|Overall Study|Withdrawal by Subject|2|||
163154815|NCT03818256|589281444|FG000|Overall Study|Adverse Event|3|||
163154816|NCT03818256|589281445|FG001|Overall Study|Adverse Event|1|||
163154817|NCT03818256|589281444|FG000|Overall Study|Lost to Follow-up|0|||
163154818|NCT03818256|589281445|FG001|Overall Study|Lost to Follow-up|5|||
163154819|NCT03818256|589281444|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
163154820|NCT03818256|589281445|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
163154821|NCT03818256|589281444|FG000|Overall Study|Not reporting for scheduled visits|1|||
163154822|NCT03818256|589281445|FG001|Overall Study|Not reporting for scheduled visits|0|||
163154823|NCT03818256|589281444|FG000|Overall Study|Non-compliant with investigational product|1|||
163154824|NCT03818256|589281445|FG001|Overall Study|Non-compliant with investigational product|0|||
163154825|NCT02749422|589281446|FG000|Overall Study|Lost to Follow-up|0|||
163154826|NCT02749422|589281447|FG001|Overall Study|Lost to Follow-up|2|||
163154827|NCT02749422|589281446|FG000|Overall Study|Ineligible|0|||
163154828|NCT02749422|589281447|FG001|Overall Study|Ineligible|1|||
163154829|NCT00911170|589281448|FG000|Treatment Period|Randomized in error|1|||
163154830|NCT00911170|589281449|FG001|Treatment Period|Randomized in error|1|||
163154831|NCT00911170|589281448|FG000|Treatment Period|Ineligibility determined|1|||
163154832|NCT00911170|589281449|FG001|Treatment Period|Ineligibility determined|3|||
163154833|NCT00911170|589281448|FG000|Treatment Period|Protocol deviation|1|||
163154834|NCT00911170|589281449|FG001|Treatment Period|Protocol deviation|2|||
163154835|NCT00911170|589281448|FG000|Treatment Period|Adverse Event|9|||
163154836|NCT00911170|589281449|FG001|Treatment Period|Adverse Event|10|||
163339081|NCT01587703|589951096|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163154837|NCT00911170|589281448|FG000|Treatment Period|Withdrawal by Subject|4|||
163154838|NCT00911170|589281449|FG001|Treatment Period|Withdrawal by Subject|4|||
163154839|NCT00911170|589281448|FG000|Treatment Period|Disease progression|0|||
163339082|NCT01587703|589951097|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163339083|NCT01587703|589951098|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163339084|NCT01587703|589951080|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339085|NCT01587703|589951081|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339086|NCT01587703|589951082|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339087|NCT01587703|589951083|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339088|NCT01587703|589951084|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339089|NCT01587703|589951085|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339090|NCT01587703|589951086|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339091|NCT01587703|589951087|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339092|NCT01587703|589951088|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339093|NCT01587703|589951089|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
163339094|NCT01587703|589951090|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
163339095|NCT01587703|589951091|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339096|NCT01587703|589951092|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339097|NCT01587703|589951093|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339098|NCT01587703|589951094|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339099|NCT01587703|589951095|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339100|NCT01587703|589951096|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339101|NCT01587703|589951097|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339102|NCT01587703|589951098|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163339103|NCT01587703|589951080|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339104|NCT01587703|589951081|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339105|NCT01587703|589951082|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339106|NCT01587703|589951083|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339107|NCT01587703|589951084|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339108|NCT01587703|589951085|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339109|NCT01587703|589951086|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339110|NCT01587703|589951087|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339111|NCT01587703|589951088|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
163339112|NCT01587703|589951089|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339113|NCT01587703|589951090|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339114|NCT01587703|589951091|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339115|NCT01587703|589951092|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339116|NCT01587703|589951093|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339117|NCT01587703|589951094|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339118|NCT01587703|589951095|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339119|NCT01587703|589951096|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339120|NCT01587703|589951097|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339121|NCT01587703|589951098|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163339122|NCT01587703|589951080|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339123|NCT01587703|589951081|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339124|NCT01587703|589951082|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339125|NCT01587703|589951083|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339126|NCT01587703|589951084|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339127|NCT01587703|589951085|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339128|NCT01587703|589951086|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339129|NCT01587703|589951087|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339130|NCT01587703|589951088|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339131|NCT01587703|589951089|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339132|NCT01587703|589951090|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339133|NCT01587703|589951091|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339134|NCT01587703|589951092|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339135|NCT01587703|589951093|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339136|NCT01587703|589951094|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339137|NCT01587703|589951095|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339138|NCT01587703|589951096|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339139|NCT01587703|589951097|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163339140|NCT01587703|589951098|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
163339141|NCT01587703|589951080|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339142|NCT01587703|589951081|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339143|NCT01587703|589951082|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163407645|NCT02706873|590200872|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
163339144|NCT01587703|589951083|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339145|NCT01587703|589951084|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339146|NCT01587703|589951085|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339147|NCT01587703|589951086|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339148|NCT01587703|589951087|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339149|NCT01587703|589951088|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339150|NCT01587703|589951089|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339151|NCT01587703|589951090|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339152|NCT01587703|589951091|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339153|NCT01587703|589951092|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339154|NCT01587703|589951093|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339155|NCT01587703|589951094|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339156|NCT01587703|589951095|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339157|NCT01587703|589951096|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163339158|NCT01587703|589951097|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
163339159|NCT01587703|589951098|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
163339160|NCT01587703|589951080|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339161|NCT01587703|589951081|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339162|NCT01587703|589951082|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339163|NCT01587703|589951083|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339164|NCT01587703|589951084|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339165|NCT01587703|589951085|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339166|NCT01587703|589951086|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339167|NCT01587703|589951087|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163098026|NCT03640325|589067774|FG000|Overall Study|Withdrawal by Subject|4|||
163098027|NCT03640325|589067775|FG001|Overall Study|Withdrawal by Subject|1|||
163098028|NCT03640325|589067776|FG002|Overall Study|Withdrawal by Subject|0|||
163098029|NCT03640325|589067774|FG000|Overall Study|Lost to Follow-up|4|||
163098030|NCT03640325|589067775|FG001|Overall Study|Lost to Follow-up|5|||
163098031|NCT03640325|589067776|FG002|Overall Study|Lost to Follow-up|21|||
163098032|NCT03640325|589067774|FG000|Overall Study|Death|5|||
163098033|NCT03640325|589067775|FG001|Overall Study|Death|5|||
163098034|NCT03640325|589067776|FG002|Overall Study|Death|0|||
163098035|NCT01566149|589067779|FG000|Overall Study|Adverse Event|0|||
163098036|NCT01566149|589067780|FG001|Overall Study|Adverse Event|1|||
163098037|NCT01566149|589067779|FG000|Overall Study|Non-compliance with study medication|2|||
163098038|NCT01566149|589067780|FG001|Overall Study|Non-compliance with study medication|0|||
163098039|NCT01566149|589067779|FG000|Overall Study|Protocol Violation|0|||
163098040|NCT01566149|589067780|FG001|Overall Study|Protocol Violation|1|||
163098041|NCT01566149|589067779|FG000|Overall Study|Withdrawal by Subject|1|||
163098042|NCT01566149|589067780|FG001|Overall Study|Withdrawal by Subject|0|||
163098043|NCT03718325|589067785|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
163098044|NCT03718325|589067786|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
163098045|NCT03718325|589067787|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
163098046|NCT03718325|589067785|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
163098047|NCT03718325|589067786|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
163098048|NCT03718325|589067787|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
163098049|NCT03687957|589067788|FG000|Overall Study|Withdrawal by Subject|0|||
163098050|NCT03687957|589067789|FG001|Overall Study|Withdrawal by Subject|0|||
163098051|NCT03687957|589067790|FG002|Overall Study|Withdrawal by Subject|0|||
163098052|NCT03687957|589067791|FG003|Overall Study|Withdrawal by Subject|2|||
163098053|NCT03687957|589067792|FG004|Overall Study|Withdrawal by Subject|0|||
163098054|NCT03687957|589067793|FG005|Overall Study|Withdrawal by Subject|0|||
163098055|NCT03687957|589067794|FG006|Overall Study|Withdrawal by Subject|3|||
163098056|NCT03687957|589067795|FG007|Overall Study|Withdrawal by Subject|1|||
163098057|NCT03687957|589067796|FG008|Overall Study|Withdrawal by Subject|1|||
163098058|NCT03687957|589067797|FG009|Overall Study|Withdrawal by Subject|0|||
163098059|NCT03687957|589067788|FG000|Overall Study|Disease progression|0|||
163339168|NCT01587703|589951088|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339169|NCT01587703|589951089|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339170|NCT01587703|589951090|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339171|NCT01587703|589951091|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339172|NCT01587703|589951092|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339173|NCT01587703|589951093|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339174|NCT01587703|589951094|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339175|NCT01587703|589951095|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
163339176|NCT01587703|589951096|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163407646|NCT02706873|590200873|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
163098060|NCT03687957|589067789|FG001|Overall Study|Disease progression|1|||
163098061|NCT03687957|589067790|FG002|Overall Study|Disease progression|1|||
163098062|NCT03687957|589067791|FG003|Overall Study|Disease progression|2|||
163098063|NCT03687957|589067792|FG004|Overall Study|Disease progression|2|||
163098064|NCT03687957|589067793|FG005|Overall Study|Disease progression|0|||
163098065|NCT03687957|589067794|FG006|Overall Study|Disease progression|2|||
163098066|NCT03687957|589067795|FG007|Overall Study|Disease progression|1|||
163098067|NCT03687957|589067796|FG008|Overall Study|Disease progression|0|||
163098068|NCT03687957|589067797|FG009|Overall Study|Disease progression|0|||
163098069|NCT03687957|589067788|FG000|Overall Study|Physician Decision|0|||
163098070|NCT03687957|589067789|FG001|Overall Study|Physician Decision|0|||
163098071|NCT03687957|589067790|FG002|Overall Study|Physician Decision|0|||
163098072|NCT03687957|589067791|FG003|Overall Study|Physician Decision|2|||
163098073|NCT03687957|589067792|FG004|Overall Study|Physician Decision|1|||
163098074|NCT03687957|589067793|FG005|Overall Study|Physician Decision|0|||
163098075|NCT03687957|589067794|FG006|Overall Study|Physician Decision|1|||
163098076|NCT03687957|589067795|FG007|Overall Study|Physician Decision|0|||
163098077|NCT03687957|589067796|FG008|Overall Study|Physician Decision|0|||
163098078|NCT03687957|589067797|FG009|Overall Study|Physician Decision|0|||
163098079|NCT03687957|589067788|FG000|Overall Study|New malignancy|0|||
163098080|NCT03687957|589067789|FG001|Overall Study|New malignancy|0|||
163098081|NCT03687957|589067790|FG002|Overall Study|New malignancy|0|||
163098082|NCT03687957|589067791|FG003|Overall Study|New malignancy|0|||
163098083|NCT03687957|589067792|FG004|Overall Study|New malignancy|1|||
163098084|NCT03687957|589067793|FG005|Overall Study|New malignancy|0|||
163098085|NCT03687957|589067794|FG006|Overall Study|New malignancy|0|||
163098086|NCT03687957|589067795|FG007|Overall Study|New malignancy|0|||
163098087|NCT03687957|589067796|FG008|Overall Study|New malignancy|0|||
163098088|NCT03687957|589067797|FG009|Overall Study|New malignancy|0|||
163098089|NCT03687957|589067788|FG000|Overall Study|Adverse Event|0|||
163098090|NCT03687957|589067789|FG001|Overall Study|Adverse Event|0|||
163098091|NCT03687957|589067790|FG002|Overall Study|Adverse Event|0|||
163098092|NCT03687957|589067791|FG003|Overall Study|Adverse Event|0|||
163098093|NCT03687957|589067792|FG004|Overall Study|Adverse Event|0|||
163098094|NCT03687957|589067793|FG005|Overall Study|Adverse Event|2|||
163098095|NCT03687957|589067794|FG006|Overall Study|Adverse Event|0|||
163098096|NCT03687957|589067795|FG007|Overall Study|Adverse Event|3|||
163098097|NCT03687957|589067796|FG008|Overall Study|Adverse Event|0|||
163098098|NCT03687957|589067797|FG009|Overall Study|Adverse Event|0|||
163098099|NCT03687957|589067788|FG000|Overall Study|Patient went on hospice|0|||
163098100|NCT03687957|589067789|FG001|Overall Study|Patient went on hospice|0|||
163098101|NCT03687957|589067790|FG002|Overall Study|Patient went on hospice|0|||
163098102|NCT03687957|589067791|FG003|Overall Study|Patient went on hospice|0|||
163098103|NCT03687957|589067792|FG004|Overall Study|Patient went on hospice|0|||
163098104|NCT03687957|589067793|FG005|Overall Study|Patient went on hospice|0|||
163098105|NCT03687957|589067794|FG006|Overall Study|Patient went on hospice|1|||
163098106|NCT03687957|589067795|FG007|Overall Study|Patient went on hospice|0|||
163098107|NCT03687957|589067796|FG008|Overall Study|Patient went on hospice|0|||
163098108|NCT03687957|589067797|FG009|Overall Study|Patient went on hospice|0|||
163098109|NCT03687957|589067788|FG000|Overall Study|Death|0|||
163339177|NCT01587703|589951097|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339178|NCT01587703|589951098|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163339179|NCT01587703|589951080|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163098110|NCT03687957|589067789|FG001|Overall Study|Death|0|||
163098111|NCT03687957|589067790|FG002|Overall Study|Death|0|||
163098112|NCT03687957|589067791|FG003|Overall Study|Death|0|||
163098113|NCT03687957|589067792|FG004|Overall Study|Death|0|||
163098114|NCT03687957|589067793|FG005|Overall Study|Death|0|||
163098115|NCT03687957|589067794|FG006|Overall Study|Death|0|||
163339180|NCT01587703|589951081|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163339181|NCT01587703|589951082|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163098116|NCT03687957|589067795|FG007|Overall Study|Death|1|||
163098117|NCT03687957|589067796|FG008|Overall Study|Death|0|||
163098118|NCT03687957|589067797|FG009|Overall Study|Death|0|||
163098119|NCT01147965|589067803|FG000|Overall Study|Progressive Disease|3|||
163098120|NCT01147965|589067804|FG001|Overall Study|Progressive Disease|3|||
163098121|NCT01147965|589067805|FG002|Overall Study|Progressive Disease|5|||
163098122|NCT01147965|589067806|FG003|Overall Study|Progressive Disease|9|||
163098123|NCT01147965|589067807|FG004|Overall Study|Progressive Disease|5|||
163098124|NCT01147965|589067808|FG005|Overall Study|Progressive Disease|5|||
163098125|NCT01147965|589067803|FG000|Overall Study|Death|0|||
163098126|NCT01147965|589067804|FG001|Overall Study|Death|0|||
163098127|NCT01147965|589067805|FG002|Overall Study|Death|1|||
163098128|NCT01147965|589067806|FG003|Overall Study|Death|1|||
163098129|NCT01147965|589067807|FG004|Overall Study|Death|0|||
163098130|NCT01147965|589067808|FG005|Overall Study|Death|2|||
163098131|NCT01147965|589067803|FG000|Overall Study|Withdrawal by Subject|0|||
163098132|NCT01147965|589067804|FG001|Overall Study|Withdrawal by Subject|0|||
163098133|NCT01147965|589067805|FG002|Overall Study|Withdrawal by Subject|1|||
163098134|NCT01147965|589067806|FG003|Overall Study|Withdrawal by Subject|1|||
163098135|NCT01147965|589067807|FG004|Overall Study|Withdrawal by Subject|0|||
163098136|NCT01147965|589067808|FG005|Overall Study|Withdrawal by Subject|0|||
163098137|NCT01147965|589067803|FG000|Overall Study|Administration Of Alternative Therapy|0|||
163098138|NCT01147965|589067804|FG001|Overall Study|Administration Of Alternative Therapy|0|||
163098139|NCT01147965|589067805|FG002|Overall Study|Administration Of Alternative Therapy|0|||
163098140|NCT01147965|589067806|FG003|Overall Study|Administration Of Alternative Therapy|0|||
163098141|NCT01147965|589067807|FG004|Overall Study|Administration Of Alternative Therapy|0|||
163098142|NCT01147965|589067808|FG005|Overall Study|Administration Of Alternative Therapy|1|||
163098143|NCT01147965|589067803|FG000|Overall Study|Other|0|||
163098144|NCT01147965|589067804|FG001|Overall Study|Other|0|||
163098145|NCT01147965|589067805|FG002|Overall Study|Other|0|||
163098146|NCT01147965|589067806|FG003|Overall Study|Other|3|||
163098147|NCT01147965|589067807|FG004|Overall Study|Other|1|||
163098148|NCT01147965|589067808|FG005|Overall Study|Other|0|||
163098149|NCT00620373|589067809|FG000|Overall Study|Unverified cancer status|33|||
163098150|NCT01465386|589067814|FG000|Overall Study|Lack of Efficacy|3|||
163098151|NCT01465386|589067814|FG000|Overall Study|Adverse Event|1|||
163098152|NCT01279044|589067815|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
163098153|NCT01279044|589067816|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
163098154|NCT01279044|589067817|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
163098155|NCT01279044|589067815|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
163098156|NCT01279044|589067816|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
163098157|NCT01279044|589067817|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
163098158|NCT01279044|589067815|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
163098159|NCT01279044|589067816|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
163098160|NCT01279044|589067817|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
163098161|NCT01408277|589067820|FG000|Overall Study|Adverse Event|3|||
163098162|NCT01408277|589067821|FG001|Overall Study|Adverse Event|4|||
163098163|NCT01408277|589067820|FG000|Overall Study|Lost to Follow-up|1|||
163098164|NCT01408277|589067821|FG001|Overall Study|Lost to Follow-up|0|||
163098165|NCT01408277|589067820|FG000|Overall Study|Withdrawal by Subject|2|||
163098166|NCT01408277|589067821|FG001|Overall Study|Withdrawal by Subject|0|||
163098167|NCT01408277|589067820|FG000|Overall Study|Protocol Violation|2|||
163098168|NCT01408277|589067821|FG001|Overall Study|Protocol Violation|0|||
163098169|NCT02630693|589067828|FG000|Overall Study|No receive treatment|0|||
163098170|NCT02630693|589067829|FG001|Overall Study|No receive treatment|1|||
163098171|NCT01724216|589067830|FG000|Overall Study|Scan was not completed|1|||
163098172|NCT00175916|589067831|FG000|Overall Study|Death|19|||
163098173|NCT00175916|589067831|FG000|Overall Study|Adverse Event|81|||
163098174|NCT00175916|589067831|FG000|Overall Study|Lack of Efficacy|354|||
163098175|NCT00175916|589067831|FG000|Overall Study|Lost to Follow-up|17|||
163098176|NCT00175916|589067831|FG000|Overall Study|Subject Choice|98|||
163098177|NCT00175916|589067831|FG000|Overall Study|Lack of compliance|8|||
163098178|NCT00175916|589067831|FG000|Overall Study|Patient cannot record seizures|1|||
163098179|NCT00175916|589067831|FG000|Overall Study|Sponsor decision|17|||
163098180|NCT00175916|589067831|FG000|Overall Study|Vigabatrin intake|1|||
163098181|NCT00175916|589067831|FG000|Overall Study|Suicidal behaviour|1|||
163098182|NCT00175916|589067831|FG000|Overall Study|Withdrawal by Subject|1|||
163098183|NCT00175916|589067831|FG000|Overall Study|Seizure - free|4|||
163098184|NCT00175916|589067831|FG000|Overall Study|Administrative reason|1|||
163098185|NCT00175916|589067831|FG000|Overall Study|Pregnancy|1|||
163098186|NCT00175916|589067831|FG000|Overall Study|Patient's request|2|||
163098187|NCT00175916|589067831|FG000|Overall Study|Treating physiciant's choice|1|||
163098188|NCT00175916|589067831|FG000|Overall Study|Moved overseas|1|||
163098189|NCT00175916|589067831|FG000|Overall Study|Loss of job and economic burden|1|||
163098190|NCT00175916|589067831|FG000|Overall Study|Site was closed|9|||
163098191|NCT00175916|589067831|FG000|Overall Study|Patient went to prison|1|||
163098192|NCT01456130|589067833|FG000|Overall Study|Adverse Event|4|||
163098193|NCT01456130|589067833|FG000|Overall Study|Voluntary Withdrawal|1|||
163098194|NCT01456130|589067833|FG000|Overall Study|Lack of Efficacy|4|||
163098195|NCT01456130|589067833|FG000|Overall Study|Other|1|||
163098196|NCT03369665|589067838|FG000|Overall Study|Adverse Event|3|||
163098197|NCT03369665|589067838|FG000|Overall Study|Lost to Follow-up|7|||
163098198|NCT03369665|589067838|FG000|Overall Study|Withdrawal by Subject|15|||
163339182|NCT01587703|589951083|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163339183|NCT01587703|589951084|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163098199|NCT03369665|589067838|FG000|Overall Study|Progression Disease|2|||
163098200|NCT03369665|589067838|FG000|Overall Study|Not classified|3|||
163339184|NCT01587703|589951085|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163098201|NCT03230318|589067839|FG000|Overall Study|Radiographic disease progression|72|||
163098202|NCT03230318|589067840|FG001|Overall Study|Radiographic disease progression|19|||
163098203|NCT03230318|589067839|FG000|Overall Study|Clinical progression|17|||
163098204|NCT03230318|589067840|FG001|Overall Study|Clinical progression|7|||
163098205|NCT03230318|589067839|FG000|Overall Study|Adverse Event|5|||
163098206|NCT03230318|589067840|FG001|Overall Study|Adverse Event|3|||
163098207|NCT03230318|589067839|FG000|Overall Study|Physician Decision|2|||
163339185|NCT01587703|589951086|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163098208|NCT03230318|589067840|FG001|Overall Study|Physician Decision|3|||
163098209|NCT03230318|589067839|FG000|Overall Study|Death|3|||
163098210|NCT03230318|589067840|FG001|Overall Study|Death|2|||
163098211|NCT03230318|589067839|FG000|Overall Study|Lost to Follow-up|1|||
163098212|NCT03230318|589067840|FG001|Overall Study|Lost to Follow-up|0|||
163098213|NCT03230318|589067839|FG000|Overall Study|Withdrawal by Subject|1|||
163098214|NCT03230318|589067840|FG001|Overall Study|Withdrawal by Subject|3|||
163098215|NCT03230318|589067839|FG000|Overall Study|Other|3|||
163098216|NCT03230318|589067840|FG001|Overall Study|Other|7|||
163098217|NCT01057693|589067842|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
163098218|NCT01057693|589067843|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
163098219|NCT01057693|589067844|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
163098220|NCT01057693|589067842|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
163098221|NCT01057693|589067843|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
163098222|NCT01057693|589067844|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
163098223|NCT01057693|589067842|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
163098224|NCT01057693|589067843|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
163098225|NCT01057693|589067844|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
163098226|NCT01057693|589067842|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
163098227|NCT01057693|589067843|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
163098228|NCT01057693|589067844|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
163098229|NCT01057693|589067842|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
163098230|NCT01057693|589067843|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
163098231|NCT01057693|589067844|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
163098232|NCT01057693|589067842|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
163098233|NCT01057693|589067843|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
163098234|NCT01057693|589067844|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
163098235|NCT01057693|589067842|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
163098236|NCT01057693|589067843|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
163098237|NCT01057693|589067844|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
163098238|NCT01057693|589067842|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
163098239|NCT01057693|589067843|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
163098240|NCT01057693|589067844|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
163098241|NCT01057693|589067842|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
163098242|NCT01057693|589067843|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
163098243|NCT01057693|589067844|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
163098244|NCT01057693|589067842|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
163098245|NCT01057693|589067843|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
163098246|NCT01057693|589067844|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
163098247|NCT01057693|589067842|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
163098248|NCT01057693|589067843|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
163098249|NCT01057693|589067844|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
163098250|NCT01057693|589067842|FG000|Between Single-Blind and Double-Blind|Other|6|||
163098251|NCT01057693|589067843|FG001|Between Single-Blind and Double-Blind|Other|0|||
163098252|NCT01057693|589067844|FG002|Between Single-Blind and Double-Blind|Other|0|||
163098253|NCT01057693|589067842|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
163098254|NCT01057693|589067843|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
163098255|NCT01057693|589067844|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
163098256|NCT01057693|589067842|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
163098257|NCT01057693|589067843|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
163098258|NCT01057693|589067844|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
163098259|NCT01057693|589067842|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
163339186|NCT01587703|589951087|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163339187|NCT01587703|589951088|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163339188|NCT01587703|589951089|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163339189|NCT01587703|589951090|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163339190|NCT01587703|589951091|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
163339191|NCT01587703|589951092|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163339192|NCT01587703|589951093|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163339193|NCT01587703|589951094|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
163098260|NCT01057693|589067843|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
163098261|NCT01057693|589067844|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
163098262|NCT01057693|589067842|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
163098263|NCT01057693|589067843|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
163098264|NCT01057693|589067844|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
163098265|NCT01057693|589067842|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
163220191|NCT02039674|589521411|FG005|Overall Study|Sponsor Decision|0|||
163098266|NCT01057693|589067843|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
163339194|NCT01587703|589951095|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163339195|NCT01587703|589951096|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163339196|NCT01587703|589951097|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163339197|NCT01587703|589951098|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163339198|NCT01587703|589951080|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163339199|NCT01587703|589951081|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163339200|NCT01587703|589951082|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163098267|NCT01057693|589067844|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
163098268|NCT01057693|589067842|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
163098269|NCT01057693|589067843|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
163098270|NCT01057693|589067844|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
163339201|NCT01587703|589951083|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163339202|NCT01587703|589951084|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163339203|NCT01587703|589951085|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163339204|NCT01587703|589951086|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163339205|NCT01587703|589951087|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163339206|NCT01587703|589951088|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163339207|NCT01587703|589951089|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163339208|NCT01587703|589951090|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163339209|NCT01587703|589951091|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
163339210|NCT01587703|589951092|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
163339211|NCT01587703|589951093|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
163339212|NCT01587703|589951094|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
163339213|NCT01587703|589951095|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
163339214|NCT01587703|589951096|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
163339215|NCT01587703|589951097|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163339216|NCT01587703|589951098|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163339217|NCT01587703|589951080|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
163098271|NCT01057693|589067842|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
163098272|NCT01057693|589067843|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
163098273|NCT01057693|589067844|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
163098274|NCT02959463|589067845|FG000|Overall Study|Adverse Event|1|||
163098275|NCT02959463|589067846|FG001|Overall Study|Adverse Event|1|||
163098276|NCT02959463|589067845|FG000|Overall Study|Death|1|||
163098277|NCT02959463|589067846|FG001|Overall Study|Death|0|||
163098278|NCT02959463|589067845|FG000|Overall Study|Withdrawal by Subject|1|||
163098279|NCT02959463|589067846|FG001|Overall Study|Withdrawal by Subject|0|||
163098280|NCT02413996|589067847|FG000|Overall Study|not comfortable with the intervention|9|||
163098281|NCT02413996|589067848|FG001|Overall Study|not comfortable with the intervention|2|||
163098282|NCT00709319|589067849|FG000|Overall Study|Death|4|||
163098283|NCT00709319|589067849|FG000|Overall Study|Withdrawal by Subject|2|||
163098284|NCT00090779|589067850|FG000|Step 1|Withdrawal by Subject|4|||
163098285|NCT00090779|589067851|FG001|Step 1|Withdrawal by Subject|2|||
163098286|NCT00090779|589067850|FG000|Step 1|Lost to Follow-up|3|||
163098287|NCT00090779|589067851|FG001|Step 1|Lost to Follow-up|2|||
163098288|NCT00090779|589067850|FG000|Step 1|Death|0|||
163098289|NCT00090779|589067851|FG001|Step 1|Death|2|||
163098290|NCT00090779|589067850|FG000|Step 1|Physician Decision|1|||
163098291|NCT00090779|589067851|FG001|Step 1|Physician Decision|0|||
163098292|NCT00090779|589067850|FG000|Step 1|Pregnancy|1|||
163098293|NCT00090779|589067851|FG001|Step 1|Pregnancy|0|||
163098294|NCT00090779|589067850|FG000|Step 1|Non-compliance to study requirements|0|||
163098295|NCT00090779|589067851|FG001|Step 1|Non-compliance to study requirements|1|||
163098296|NCT00090779|589067850|FG000|Step 1|Subject relocated|2|||
163098297|NCT00090779|589067851|FG001|Step 1|Subject relocated|8|||
163098298|NCT00090779|589067850|FG000|Step 2|Off study per study closure|6|||
163098299|NCT00090779|589067851|FG001|Step 2|Off study per study closure|16|||
163098300|NCT00090779|589067850|FG000|Step 2|Subject relocated|0|||
163098301|NCT00090779|589067851|FG001|Step 2|Subject relocated|1|||
163098302|NCT00090779|589067850|FG000|Step 2|Non-compliance to study requirements|0|||
163339218|NCT01587703|589951081|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
163339219|NCT01587703|589951082|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
163339220|NCT01587703|589951083|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
163339221|NCT01587703|589951084|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
163339222|NCT01587703|589951085|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
163339223|NCT01587703|589951086|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
163339224|NCT01587703|589951087|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
163098303|NCT00090779|589067851|FG001|Step 2|Non-compliance to study requirements|1|||
163098304|NCT00090779|589067850|FG000|Step 3|Initiation of ART and off extended study|3|||
163098305|NCT00090779|589067851|FG001|Step 3|Initiation of ART and off extended study|2|||
163098306|NCT00090779|589067850|FG000|Step 3|Off extended study due to study closure|4|||
163098307|NCT00090779|589067851|FG001|Step 3|Off extended study due to study closure|3|||
163339225|NCT01587703|589951088|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
163339226|NCT01587703|589951089|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
163339227|NCT01587703|589951090|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
163339228|NCT01587703|589951091|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
163339229|NCT01587703|589951092|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
163339230|NCT01587703|589951093|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
163339231|NCT01587703|589951094|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
163339232|NCT01587703|589951095|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
163339233|NCT01587703|589951096|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
163339234|NCT01587703|589951097|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
163339235|NCT01587703|589951098|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
163339236|NCT01587703|589951080|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339237|NCT01587703|589951081|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339238|NCT01587703|589951082|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339239|NCT01587703|589951083|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339240|NCT01587703|589951084|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339241|NCT01587703|589951085|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339242|NCT01587703|589951086|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339243|NCT01587703|589951087|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339244|NCT01587703|589951088|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339245|NCT01587703|589951089|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339246|NCT01587703|589951090|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339247|NCT01587703|589951091|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
163339248|NCT01587703|589951092|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339249|NCT01587703|589951093|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339250|NCT01587703|589951094|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339251|NCT01587703|589951095|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339252|NCT01587703|589951096|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339253|NCT01587703|589951097|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339254|NCT01587703|589951098|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163339255|NCT01129011|589951099|FG000|Overall Study|Adverse Event|20|||
163339256|NCT01129011|589951100|FG001|Overall Study|Adverse Event|30|||
163339257|NCT01129011|589951099|FG000|Overall Study|Withdrawal by Subject|24|||
163339258|NCT01129011|589951100|FG001|Overall Study|Withdrawal by Subject|8|||
163339259|NCT01129011|589951099|FG000|Overall Study|Lost to Follow-up|6|||
163339260|NCT01129011|589951100|FG001|Overall Study|Lost to Follow-up|7|||
163339261|NCT01129011|589951099|FG000|Overall Study|Duodenal Ulcer|2|||
163339262|NCT01129011|589951100|FG001|Overall Study|Duodenal Ulcer|8|||
163339263|NCT01129011|589951099|FG000|Overall Study|misc|7|||
163339264|NCT01129011|589951100|FG001|Overall Study|misc|4|||
163339265|NCT00648895|589951106|FG000|Overall Study|Lack of Efficacy|0|||
163339266|NCT00648895|589951107|FG001|Overall Study|Lack of Efficacy|1|||
163339267|NCT04626128|589951109|FG000|Overall Study|Withdrawal by Subject|0|||
163339268|NCT04626128|589951110|FG001|Overall Study|Withdrawal by Subject|1|||
163339269|NCT04626128|589951111|FG002|Overall Study|Withdrawal by Subject|0|||
163339270|NCT04626128|589951112|FG003|Overall Study|Withdrawal by Subject|0|||
163098308|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
163098309|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
163098310|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
163098311|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
163098312|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
163339271|NCT03209492|589951113|FG000|Overall Study|Case Report Forms Uncollected|5|||
163339272|NCT01358175|589951114|FG000|Overall Study|Death|1|||
163339273|NCT01358175|589951115|FG001|Overall Study|Death|0|||
163339274|NCT01358175|589951116|FG002|Overall Study|Death|1|||
163339275|NCT01358175|589951114|FG000|Overall Study|Withdrawal by Subject|9|||
163339276|NCT01358175|589951115|FG001|Overall Study|Withdrawal by Subject|5|||
163339277|NCT01358175|589951116|FG002|Overall Study|Withdrawal by Subject|10|||
163098313|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
163098314|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
163098315|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
163339278|NCT01358175|589951114|FG000|Overall Study|Technical issues|0|||
163339279|NCT01358175|589951115|FG001|Overall Study|Technical issues|1|||
163339280|NCT01358175|589951116|FG002|Overall Study|Technical issues|0|||
163339281|NCT01358175|589951114|FG000|Overall Study|Pregnancy|0|||
163339282|NCT01358175|589951115|FG001|Overall Study|Pregnancy|1|||
163339283|NCT01358175|589951116|FG002|Overall Study|Pregnancy|0|||
163339284|NCT01358175|589951114|FG000|Overall Study|Physician Decision|1|||
163339285|NCT01358175|589951115|FG001|Overall Study|Physician Decision|0|||
163339286|NCT01358175|589951116|FG002|Overall Study|Physician Decision|0|||
163339287|NCT01358175|589951114|FG000|Overall Study|Non Compliance with Study Treatment|0|||
163339288|NCT01358175|589951115|FG001|Overall Study|Non Compliance with Study Treatment|1|||
163098316|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
163098317|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
163098318|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
163098319|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
163098320|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
163098321|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
163098322|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
163098323|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
163098324|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
163098325|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
163098326|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
163098327|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
163098328|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
163098329|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
163098330|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
163098331|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
163098332|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
163098333|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
163098334|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
163098335|NCT01672879|589067852|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
163098336|NCT01672879|589067853|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
163098337|NCT01672879|589067854|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
163098338|NCT01672879|589067852|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
163098339|NCT01672879|589067853|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
163098340|NCT01672879|589067854|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
163098341|NCT01672879|589067852|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
163098342|NCT01672879|589067853|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
163098343|NCT01672879|589067854|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
163098344|NCT01672879|589067852|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
163098345|NCT01672879|589067853|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
163098346|NCT01672879|589067854|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
163098347|NCT03951766|589067859|FG000|Treatment Phase|Lost to Follow-up|1|||
163098348|NCT03951766|589067859|FG000|Follow-up Phase|Lost to Follow-up|10|||
163098349|NCT00041470|589067860|FG000|Overall Study|Loss of Funding|38|||
163098350|NCT04158375|589067865|FG000|Overall Study|Withdrawal by Subject|0|||
163098351|NCT04158375|589067866|FG001|Overall Study|Withdrawal by Subject|3|||
163098352|NCT04158375|589067867|FG002|Overall Study|Withdrawal by Subject|0|||
163098353|NCT04847843|589067868|FG000|Overall Study|Scheduling Conflicts|6|||
163098354|NCT04847843|589067869|FG001|Overall Study|Scheduling Conflicts|9|||
163098355|NCT04847843|589067868|FG000|Overall Study|Withdrawal by Subject|1|||
163098356|NCT04847843|589067869|FG001|Overall Study|Withdrawal by Subject|0|||
163098357|NCT04847843|589067868|FG000|Overall Study|Lost to Follow-up|1|||
163098358|NCT04847843|589067869|FG001|Overall Study|Lost to Follow-up|1|||
163098359|NCT04847843|589067868|FG000|Overall Study|Pregnancy|0|||
163098360|NCT04847843|589067869|FG001|Overall Study|Pregnancy|2|||
163098361|NCT04847843|589067868|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
163098362|NCT04847843|589067869|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
163098363|NCT02734004|589067870|FG000|Overall Study|Death|36|||
163098364|NCT02734004|589067871|FG001|Overall Study|Death|24|||
163098365|NCT02734004|589067872|FG002|Overall Study|Death|26|||
163098366|NCT02734004|589067873|FG003|Overall Study|Death|35|||
163098367|NCT02734004|589067874|FG004|Overall Study|Death|13|||
163098368|NCT02734004|589067875|FG005|Overall Study|Death|17|||
163098369|NCT02734004|589067876|FG006|Overall Study|Death|20|||
163098370|NCT02734004|589067870|FG000|Overall Study|Lost to Follow-up|1|||
163098371|NCT02734004|589067871|FG001|Overall Study|Lost to Follow-up|1|||
163098372|NCT02734004|589067872|FG002|Overall Study|Lost to Follow-up|0|||
163098373|NCT02734004|589067873|FG003|Overall Study|Lost to Follow-up|0|||
163098374|NCT02734004|589067874|FG004|Overall Study|Lost to Follow-up|1|||
163098375|NCT02734004|589067875|FG005|Overall Study|Lost to Follow-up|0|||
163098376|NCT02734004|589067876|FG006|Overall Study|Lost to Follow-up|0|||
163098377|NCT02734004|589067870|FG000|Overall Study|Withdrawal by Subject|3|||
163098378|NCT02734004|589067871|FG001|Overall Study|Withdrawal by Subject|1|||
163098379|NCT02734004|589067872|FG002|Overall Study|Withdrawal by Subject|1|||
163098380|NCT02734004|589067873|FG003|Overall Study|Withdrawal by Subject|1|||
163098381|NCT02734004|589067874|FG004|Overall Study|Withdrawal by Subject|3|||
163098382|NCT02734004|589067875|FG005|Overall Study|Withdrawal by Subject|0|||
163098383|NCT02734004|589067876|FG006|Overall Study|Withdrawal by Subject|2|||
163098384|NCT02734004|589067870|FG000|Overall Study|Other|0|||
163098385|NCT02734004|589067871|FG001|Overall Study|Other|8|||
163098386|NCT02734004|589067872|FG002|Overall Study|Other|7|||
163098387|NCT02734004|589067873|FG003|Overall Study|Other|4|||
163098388|NCT02734004|589067874|FG004|Overall Study|Other|34|||
163098389|NCT02734004|589067875|FG005|Overall Study|Other|14|||
163098390|NCT02734004|589067876|FG006|Overall Study|Other|10|||
163098391|NCT01459666|589067878|FG000|Overall Study|PI left institution|5|||
163098392|NCT01459666|589067879|FG001|Overall Study|PI left institution|4|||
163098393|NCT01061385|589067880|FG000|Overall Study|Lost to Follow-up|1|||
163098394|NCT01061385|589067881|FG001|Overall Study|Lost to Follow-up|0|||
163098395|NCT01061385|589067880|FG000|Overall Study|subject decision not related to AE|0|||
163098396|NCT01061385|589067881|FG001|Overall Study|subject decision not related to AE|1|||
163098397|NCT02379052|589067894|FG000|Overall Study|Protocol Violation|0|||
163098398|NCT02379052|589067895|FG001|Overall Study|Protocol Violation|1|||
163098399|NCT02379052|589067894|FG000|Overall Study|Adverse Event|0|||
163098400|NCT02379052|589067895|FG001|Overall Study|Adverse Event|1|||
163098401|NCT02379052|589067894|FG000|Overall Study|Physician Decision|1|||
163098402|NCT02379052|589067895|FG001|Overall Study|Physician Decision|1|||
163098403|NCT02379052|589067894|FG000|Overall Study|Withdrawal by Subject|2|||
163098404|NCT02379052|589067895|FG001|Overall Study|Withdrawal by Subject|0|||
163098405|NCT02379052|589067894|FG000|Overall Study|Lost to Follow-up|2|||
163098406|NCT02379052|589067895|FG001|Overall Study|Lost to Follow-up|1|||
163098407|NCT02379052|589067894|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
163098408|NCT02379052|589067895|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
163098409|NCT02379052|589067894|FG000|Overall Study|Subject was Incarcerated|0|||
163098410|NCT02379052|589067895|FG001|Overall Study|Subject was Incarcerated|1|||
163098411|NCT00127855|589067896|FG000|Primary Vaccination Course|Adverse Event|0|||
163098412|NCT00127855|589067897|FG001|Primary Vaccination Course|Adverse Event|0|||
163098413|NCT00127855|589067898|FG002|Primary Vaccination Course|Adverse Event|1|||
163098414|NCT00127855|589067899|FG003|Primary Vaccination Course|Adverse Event|0|||
163098415|NCT00127855|589067900|FG004|Primary Vaccination Course|Adverse Event|0|||
163098416|NCT00127855|589067896|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
163098417|NCT00127855|589067897|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
163098418|NCT00127855|589067898|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
163098419|NCT00127855|589067899|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
163098420|NCT00127855|589067900|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
163098421|NCT00127855|589067896|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
163098422|NCT00127855|589067897|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
163098423|NCT00127855|589067898|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
163098424|NCT00127855|589067899|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
163098425|NCT00127855|589067900|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
163098426|NCT00127855|589067896|FG000|Primary Vaccination Course|Other|0|||
163098427|NCT00127855|589067897|FG001|Primary Vaccination Course|Other|0|||
163098428|NCT00127855|589067898|FG002|Primary Vaccination Course|Other|0|||
163098429|NCT00127855|589067899|FG003|Primary Vaccination Course|Other|0|||
163098430|NCT00127855|589067900|FG004|Primary Vaccination Course|Other|1|||
163098431|NCT02343302|589067901|FG000|Overall Study|Physician Decision|1|||
163098432|NCT02343302|589067902|FG001|Overall Study|Physician Decision|1|||
163098433|NCT01282866|589067905|FG000|Overall Study|Adverse Event|1|||
163098434|NCT04834726|589067906|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
163098435|NCT04834726|589067907|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
163098436|NCT04834726|589067908|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
163098437|NCT04834726|589067909|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
163098438|NCT04834726|589067910|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
163098439|NCT04834726|589067911|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
163098440|NCT04834726|589067912|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
163098441|NCT04834726|589067913|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
163098442|NCT04834726|589067914|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
163098443|NCT02948582|589067921|FG000|Washout Period 1|Adverse Event|0|||
163098444|NCT02948582|589067922|FG001|Washout Period 1|Adverse Event|2|||
163098445|NCT02948582|589067923|FG002|Washout Period 1|Adverse Event|0|||
163098446|NCT02948582|589067924|FG003|Washout Period 1|Adverse Event|0|||
163098447|NCT02948582|589067925|FG004|Washout Period 1|Adverse Event|0|||
163098448|NCT02948582|589067926|FG005|Washout Period 1|Adverse Event|0|||
163098449|NCT02948582|589067921|FG000|Washout Period 1|Protocol Violation|0|||
163098450|NCT02948582|589067922|FG001|Washout Period 1|Protocol Violation|0|||
163098451|NCT02948582|589067923|FG002|Washout Period 1|Protocol Violation|0|||
163098452|NCT02948582|589067924|FG003|Washout Period 1|Protocol Violation|0|||
163098453|NCT02948582|589067925|FG004|Washout Period 1|Protocol Violation|0|||
163098454|NCT02948582|589067926|FG005|Washout Period 1|Protocol Violation|1|||
163098455|NCT02948582|589067921|FG000|Washout Period 2|Adverse Event|0|||
163098456|NCT02948582|589067922|FG001|Washout Period 2|Adverse Event|1|||
163098457|NCT02948582|589067923|FG002|Washout Period 2|Adverse Event|0|||
163098458|NCT02948582|589067924|FG003|Washout Period 2|Adverse Event|0|||
163098459|NCT02948582|589067925|FG004|Washout Period 2|Adverse Event|0|||
163098460|NCT02948582|589067926|FG005|Washout Period 2|Adverse Event|0|||
163098461|NCT02948582|589067921|FG000|Washout Period 2|personal reasons|0|||
163407647|NCT02706873|590200874|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
163339289|NCT01358175|589951116|FG002|Overall Study|Non Compliance with Study Treatment|1|||
163339290|NCT01358175|589951114|FG000|Overall Study|Lost to Follow-up|1|||
163339291|NCT01358175|589951115|FG001|Overall Study|Lost to Follow-up|1|||
163339292|NCT01358175|589951116|FG002|Overall Study|Lost to Follow-up|3|||
163339293|NCT01358175|589951114|FG000|Overall Study|Lack of Efficacy|3|||
163339294|NCT01358175|589951115|FG001|Overall Study|Lack of Efficacy|8|||
163339295|NCT01358175|589951116|FG002|Overall Study|Lack of Efficacy|6|||
163339296|NCT01358175|589951114|FG000|Overall Study|Adverse Event|6|||
163339297|NCT01358175|589951115|FG001|Overall Study|Adverse Event|11|||
163339298|NCT01358175|589951116|FG002|Overall Study|Adverse Event|11|||
163339299|NCT04908488|589951117|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
163339300|NCT04908488|589951118|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
163339301|NCT04908488|589951117|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
163339302|NCT04908488|589951118|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
163339303|NCT01894620|589951123|FG000|Overall Study|Withdrawal by Subject|0|||
163339304|NCT01894620|589951124|FG001|Overall Study|Withdrawal by Subject|1|||
163339305|NCT01124916|589951125|FG000|Overall Study|Lost to Follow-up|3|||
163339306|NCT01124916|589951126|FG001|Overall Study|Lost to Follow-up|2|||
163339307|NCT00879710|589951127|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
163098462|NCT02948582|589067922|FG001|Washout Period 2|personal reasons|0|||
163098463|NCT02948582|589067923|FG002|Washout Period 2|personal reasons|0|||
163098464|NCT02948582|589067924|FG003|Washout Period 2|personal reasons|1|||
163098465|NCT02948582|589067925|FG004|Washout Period 2|personal reasons|0|||
163098466|NCT02948582|589067926|FG005|Washout Period 2|personal reasons|0|||
163098467|NCT02948582|589067921|FG000|Washout Period 4|Adverse Event|1|||
163098468|NCT02948582|589067922|FG001|Washout Period 4|Adverse Event|0|||
163098469|NCT02948582|589067923|FG002|Washout Period 4|Adverse Event|1|||
163098470|NCT02948582|589067924|FG003|Washout Period 4|Adverse Event|0|||
163098471|NCT02948582|589067925|FG004|Washout Period 4|Adverse Event|0|||
163098472|NCT02948582|589067926|FG005|Washout Period 4|Adverse Event|0|||
163098473|NCT03810014|589067932|FG000|Overall Study|Pregnancy|2|||
163098474|NCT03810014|589067933|FG001|Overall Study|Pregnancy|2|||
163098475|NCT03810014|589067934|FG002|Overall Study|Pregnancy|0|||
163098476|NCT03810014|589067935|FG003|Overall Study|Pregnancy|2|||
163098477|NCT03606486|589067936|FG000|Overall Study|Unable to collect sample|5|||
163098478|NCT00442416|589067946|FG000|Overall Study|Adverse Event|4|||
163098479|NCT00442416|589067947|FG001|Overall Study|Adverse Event|1|||
163098480|NCT00442416|589067946|FG000|Overall Study|Death|1|||
163098481|NCT00442416|589067947|FG001|Overall Study|Death|0|||
163098482|NCT00442416|589067946|FG000|Overall Study|Lack of Efficacy|2|||
163098483|NCT00442416|589067947|FG001|Overall Study|Lack of Efficacy|0|||
163098484|NCT00442416|589067946|FG000|Overall Study|Protocol Violation|2|||
163098485|NCT00442416|589067947|FG001|Overall Study|Protocol Violation|3|||
163098486|NCT00442416|589067946|FG000|Overall Study|Withdrew consent|1|||
163098487|NCT00442416|589067947|FG001|Overall Study|Withdrew consent|2|||
163098488|NCT00442416|589067946|FG000|Overall Study|Administrative/Other|27|||
163098489|NCT00442416|589067947|FG001|Overall Study|Administrative/Other|33|||
163339308|NCT00879710|589951128|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
163339309|NCT00879710|589951129|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
163339310|NCT00879710|589951130|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
163339311|NCT00879710|589951127|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
163098494|NCT01265992|589067954|FG000|Overall Study|Lost to Follow-up|1|||
163098495|NCT01265992|589067954|FG000|Overall Study|Withdrawal by Subject|1|||
163098496|NCT01265992|589067954|FG000|Overall Study|Adverse Event|1|||
163098497|NCT01265992|589067954|FG000|Overall Study|Administrative reasons|2|||
163098498|NCT01265992|589067954|FG000|Overall Study|Stopped treatment|3|||
163098499|NCT01265992|589067954|FG000|Overall Study|Did not receive treatment|1|||
163098500|NCT01102491|589067955|FG000|Overall Study|Protocol Violation|11|||
163098501|NCT01102491|589067956|FG001|Overall Study|Protocol Violation|12|||
163098502|NCT01444430|589067961|FG000|Overall Study|Withdrawal by Subject|53|||
163098503|NCT01444430|589067962|FG001|Overall Study|Withdrawal by Subject|72|||
163098504|NCT01444430|589067961|FG000|Overall Study|Death|6|||
163098505|NCT01444430|589067962|FG001|Overall Study|Death|8|||
163098506|NCT01444430|589067961|FG000|Overall Study|Lost to Follow-up|2|||
163098507|NCT01444430|589067962|FG001|Overall Study|Lost to Follow-up|0|||
163098508|NCT01444430|589067961|FG000|Overall Study|CRF termination module not completed.|0|||
163098509|NCT01444430|589067962|FG001|Overall Study|CRF termination module not completed.|1|||
163098510|NCT01142388|589069667|FG000|Overall Study|Lack of Efficacy|21|||
163098511|NCT01142388|589069668|FG001|Overall Study|Lack of Efficacy|31|||
163098512|NCT01142388|589069667|FG000|Overall Study|Adverse Event|9|||
163098513|NCT01142388|589069668|FG001|Overall Study|Adverse Event|5|||
163098514|NCT01142388|589069667|FG000|Overall Study|Death|3|||
163098515|NCT01142388|589069668|FG001|Overall Study|Death|2|||
163098516|NCT01142388|589069667|FG000|Overall Study|Withdrawal by Subject|5|||
163098517|NCT01142388|589069668|FG001|Overall Study|Withdrawal by Subject|3|||
163339312|NCT00879710|589951128|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
163339313|NCT00879710|589951129|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
163339314|NCT00879710|589951130|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
163339315|NCT00753896|589951131|FG000|Overall Study|Adverse Event|4|||
163098518|NCT01142388|589069667|FG000|Overall Study|Alternative therapy|1|||
163098519|NCT01142388|589069668|FG001|Overall Study|Alternative therapy|0|||
163098520|NCT01142388|589069667|FG000|Overall Study|Other complications|0|||
163098521|NCT01142388|589069668|FG001|Overall Study|Other complications|2|||
163098522|NCT01142388|589069667|FG000|Overall Study|Other|1|||
163098523|NCT01142388|589069668|FG001|Overall Study|Other|1|||
163098524|NCT01142388|589069667|FG000|Overall Study|Never started therapy|7|||
163098525|NCT01142388|589069668|FG001|Overall Study|Never started therapy|3|||
163098526|NCT05265728|589069674|FG000|Overall Study|Adverse Event|1|||
163098527|NCT05265728|589069674|FG000|Overall Study|Study Terminated by Sponsor|5|||
163098528|NCT05265728|589069674|FG000|Overall Study|Withdrawal by Subject|2|||
163098529|NCT03493451|589069675|FG000|Overall Study|Death|11|||
163098530|NCT03493451|589069676|FG001|Overall Study|Death|26|||
163098531|NCT03493451|589069677|FG002|Overall Study|Death|3|||
163098532|NCT03493451|589069675|FG000|Overall Study|Lost to Follow-up|1|||
163098533|NCT03493451|589069676|FG001|Overall Study|Lost to Follow-up|4|||
163098534|NCT03493451|589069677|FG002|Overall Study|Lost to Follow-up|1|||
163098535|NCT03493451|589069675|FG000|Overall Study|Withdrawal by Subject|1|||
163098536|NCT03493451|589069676|FG001|Overall Study|Withdrawal by Subject|1|||
163098537|NCT03493451|589069677|FG002|Overall Study|Withdrawal by Subject|2|||
163098538|NCT03493451|589069675|FG000|Overall Study|Progressive Disease|1|||
163098539|NCT03493451|589069676|FG001|Overall Study|Progressive Disease|0|||
163098540|NCT03493451|589069677|FG002|Overall Study|Progressive Disease|0|||
163098541|NCT03493451|589069675|FG000|Overall Study|Transferred to long term extension study|8|||
163098542|NCT03493451|589069676|FG001|Overall Study|Transferred to long term extension study|13|||
163098543|NCT03493451|589069677|FG002|Overall Study|Transferred to long term extension study|5|||
163098544|NCT01693250|589069678|FG000|Overall Study|Lost to Follow-up|2|||
163098545|NCT01693250|589069679|FG001|Overall Study|Lost to Follow-up|2|||
163098546|NCT02257242|589069680|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
163098547|NCT02257242|589069681|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098548|NCT02257242|589069682|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098549|NCT02257242|589069683|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098550|NCT02257242|589069684|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098551|NCT02257242|589069685|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098552|NCT02257242|589069686|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098553|NCT02257242|589069687|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098554|NCT02257242|589069688|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098555|NCT00600106|589069689|FG000|Overall Study|Withdrawal by Subject|1|||
163098556|NCT00600106|589069690|FG001|Overall Study|Withdrawal by Subject|1|||
163098557|NCT02213926|589069691|FG000|Overall Study|Death|59|||
163098558|NCT02213926|589069691|FG000|Overall Study|Withdrawal by Subject|10|||
163098559|NCT02213926|589069691|FG000|Overall Study|study terminated by sponsor|51|||
163098560|NCT02213926|589069691|FG000|Overall Study|Lost to Follow-up|3|||
163098561|NCT02213926|589069691|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
163098562|NCT03783962|589069694|FG000|Overall Study|Lost to Follow-up|3|||
163098563|NCT03783962|589069695|FG001|Overall Study|Lost to Follow-up|6|||
163098564|NCT03783962|589069694|FG000|Overall Study|Protocol Violation|0|||
163098565|NCT03783962|589069695|FG001|Overall Study|Protocol Violation|1|||
163098566|NCT02370368|589069696|FG000|Overall Study|Adverse Event|1|||
163098567|NCT02370368|589069697|FG001|Overall Study|Adverse Event|2|||
163098568|NCT02370368|589069696|FG000|Overall Study|Withdrawal by Subject|5|||
163098569|NCT02370368|589069697|FG001|Overall Study|Withdrawal by Subject|4|||
163098570|NCT01169337|589069698|FG000|Overall Study|Lack of Efficacy|5|||
163098571|NCT01169337|589069699|FG001|Overall Study|Lack of Efficacy|7|||
163098572|NCT01169337|589069700|FG002|Overall Study|Lack of Efficacy|0|||
163098573|NCT01169337|589069698|FG000|Overall Study|Adverse Event|12|||
163098574|NCT01169337|589069699|FG001|Overall Study|Adverse Event|18|||
163098575|NCT01169337|589069700|FG002|Overall Study|Adverse Event|0|||
163098576|NCT01169337|589069698|FG000|Overall Study|Death|2|||
163098577|NCT01169337|589069699|FG001|Overall Study|Death|0|||
163098578|NCT01169337|589069700|FG002|Overall Study|Death|0|||
163098579|NCT01169337|589069698|FG000|Overall Study|Withdrawal by Subject|11|||
163098580|NCT01169337|589069699|FG001|Overall Study|Withdrawal by Subject|11|||
163098581|NCT01169337|589069700|FG002|Overall Study|Withdrawal by Subject|6|||
163098582|NCT01169337|589069698|FG000|Overall Study|Noncompliance|2|||
163098583|NCT01169337|589069699|FG001|Overall Study|Noncompliance|0|||
163098584|NCT01169337|589069700|FG002|Overall Study|Noncompliance|0|||
163098585|NCT01169337|589069698|FG000|Overall Study|Other complicating disease|1|||
163098586|NCT01169337|589069699|FG001|Overall Study|Other complicating disease|1|||
163098587|NCT01169337|589069700|FG002|Overall Study|Other complicating disease|0|||
163098588|NCT01169337|589069698|FG000|Overall Study|Physician Decision|1|||
163098589|NCT01169337|589069699|FG001|Overall Study|Physician Decision|5|||
163098590|NCT01169337|589069700|FG002|Overall Study|Physician Decision|0|||
163098591|NCT01169337|589069698|FG000|Overall Study|Alternative therapy|0|||
163098592|NCT01169337|589069699|FG001|Overall Study|Alternative therapy|2|||
163098593|NCT01169337|589069700|FG002|Overall Study|Alternative therapy|0|||
163098594|NCT01169337|589069698|FG000|Overall Study|Changed hospital|0|||
163098595|NCT01169337|589069699|FG001|Overall Study|Changed hospital|1|||
163098596|NCT01169337|589069700|FG002|Overall Study|Changed hospital|0|||
163098597|NCT01169337|589069698|FG000|Overall Study|Never started treatment|0|||
163098598|NCT01169337|589069699|FG001|Overall Study|Never started treatment|2|||
163098599|NCT01169337|589069700|FG002|Overall Study|Never started treatment|0|||
163098600|NCT01169337|589069698|FG000|Overall Study|Reason not reported|1|||
163098601|NCT01169337|589069699|FG001|Overall Study|Reason not reported|0|||
163098602|NCT01169337|589069700|FG002|Overall Study|Reason not reported|0|||
163098603|NCT01169337|589069698|FG000|Overall Study|Continuing lenalidomide|9|||
163098604|NCT01169337|589069699|FG001|Overall Study|Continuing lenalidomide|43|||
163098605|NCT01169337|589069700|FG002|Overall Study|Continuing lenalidomide|0|||
163098606|NCT01643408|589069702|FG000|Overall Study|Adverse Event|12|||
163098607|NCT01643408|589069702|FG000|Overall Study|Other|2|||
163098608|NCT03726658|589069703|FG000|Overall Study|Lost to Follow-up|0|||
163098609|NCT03726658|589069704|FG001|Overall Study|Lost to Follow-up|0|||
163098610|NCT03726658|589069705|FG002|Overall Study|Lost to Follow-up|2|||
163098611|NCT03726658|589069706|FG003|Overall Study|Lost to Follow-up|0|||
163098612|NCT03726658|589069707|FG004|Overall Study|Lost to Follow-up|0|||
163098613|NCT03726658|589069708|FG005|Overall Study|Lost to Follow-up|1|||
163098614|NCT03726658|589069709|FG006|Overall Study|Lost to Follow-up|1|||
163098615|NCT03726658|589069703|FG000|Overall Study|Withdrawal by Subject|1|||
163098616|NCT03726658|589069704|FG001|Overall Study|Withdrawal by Subject|0|||
163098617|NCT03726658|589069705|FG002|Overall Study|Withdrawal by Subject|0|||
163098618|NCT03726658|589069706|FG003|Overall Study|Withdrawal by Subject|0|||
163098619|NCT03726658|589069707|FG004|Overall Study|Withdrawal by Subject|6|||
163098620|NCT03726658|589069708|FG005|Overall Study|Withdrawal by Subject|4|||
163098621|NCT03726658|589069709|FG006|Overall Study|Withdrawal by Subject|2|||
163098622|NCT03726658|589069703|FG000|Overall Study|Pregnancy|0|||
163098623|NCT03726658|589069704|FG001|Overall Study|Pregnancy|0|||
163098624|NCT03726658|589069705|FG002|Overall Study|Pregnancy|0|||
163098625|NCT03726658|589069706|FG003|Overall Study|Pregnancy|0|||
163098626|NCT03726658|589069707|FG004|Overall Study|Pregnancy|0|||
163098627|NCT03726658|589069708|FG005|Overall Study|Pregnancy|0|||
163098628|NCT03726658|589069709|FG006|Overall Study|Pregnancy|1|||
163098629|NCT03726658|589069703|FG000|Overall Study|Not Reported|0|||
163098630|NCT03726658|589069704|FG001|Overall Study|Not Reported|0|||
163098631|NCT03726658|589069705|FG002|Overall Study|Not Reported|0|||
163098632|NCT03726658|589069706|FG003|Overall Study|Not Reported|0|||
163098633|NCT03726658|589069707|FG004|Overall Study|Not Reported|0|||
163098634|NCT03726658|589069708|FG005|Overall Study|Not Reported|0|||
163098635|NCT03726658|589069709|FG006|Overall Study|Not Reported|1|||
163098636|NCT05710640|589069710|FG000|Overall Study|Physician Decision|0|||
163098637|NCT05710640|589069711|FG001|Overall Study|Physician Decision|1|||
163098638|NCT05710640|589069710|FG000|Overall Study|Withdrawal by Subject|1|||
163098639|NCT05710640|589069711|FG001|Overall Study|Withdrawal by Subject|0|||
163098640|NCT05710640|589069710|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
163098641|NCT05710640|589069711|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
163098642|NCT04188509|589069712|FG000|Overall Study|Adverse Event|2|||
163098643|NCT04188509|589069712|FG000|Overall Study|Lost to Follow-up|1|||
163098644|NCT04188509|589069712|FG000|Overall Study|Withdrawal of Consent|1|||
163098645|NCT04188509|589069712|FG000|Overall Study|Discretion of Investigator|1|||
163098646|NCT04188509|589069712|FG000|Overall Study|Noncompliance|3|||
163098647|NCT04188509|589069712|FG000|Overall Study|Sponsor Decision|127|||
163098648|NCT04188509|589069712|FG000|Overall Study|Other|2|||
163098649|NCT00049322|589069717|FG000|Overall Study|disease burden|0|||
163098650|NCT00049322|589069718|FG001|Overall Study|disease burden|3|||
163098651|NCT00049322|589069717|FG000|Overall Study|Adverse Event|1|||
163098652|NCT00049322|589069718|FG001|Overall Study|Adverse Event|0|||
163098653|NCT00049322|589069717|FG000|Overall Study|refused angio|0|||
163098654|NCT00049322|589069718|FG001|Overall Study|refused angio|3|||
163098655|NCT00703963|589069719|FG000|Overall Study|Withdrawal by Subject|7|||
163098656|NCT00703963|589069720|FG001|Overall Study|Withdrawal by Subject|13|||
163098657|NCT00703963|589069719|FG000|Overall Study|Physician Decision|0|||
163098658|NCT00703963|589069720|FG001|Overall Study|Physician Decision|1|||
163098659|NCT03994211|589069721|FG000|Core Phase|Adverse Event|0|||
163098660|NCT03994211|589069722|FG001|Core Phase|Adverse Event|1|||
163098661|NCT03994211|589069723|FG002|Core Phase|Adverse Event|0|||
163098662|NCT03994211|589069721|FG000|Extension Phase|Adverse Event|0|||
163098663|NCT03994211|589069722|FG001|Extension Phase|Adverse Event|0|||
163098664|NCT03994211|589069723|FG002|Extension Phase|Adverse Event|1|||
163098665|NCT03994211|589069721|FG000|Extension Phase|Physician Decision|0|||
163098666|NCT03994211|589069722|FG001|Extension Phase|Physician Decision|0|||
163098667|NCT03994211|589069723|FG002|Extension Phase|Physician Decision|1|||
163098668|NCT03994211|589069721|FG000|Extension Phase|Progressive Disease|0|||
163098669|NCT03994211|589069722|FG001|Extension Phase|Progressive Disease|0|||
163098670|NCT03994211|589069723|FG002|Extension Phase|Progressive Disease|20|||
163098671|NCT03994211|589069721|FG000|Extension Phase|Withdrawal by Subject|0|||
163098672|NCT03994211|589069722|FG001|Extension Phase|Withdrawal by Subject|0|||
163098673|NCT03994211|589069723|FG002|Extension Phase|Withdrawal by Subject|2|||
163098674|NCT00955474|589069727|FG000|Overall Study|Physician Decision|7|||
163098675|NCT00955474|589069728|FG001|Overall Study|Physician Decision|5|||
163098676|NCT02148263|589069730|FG000|Overall Study|Withdrawal by Subject|3|||
163098677|NCT02148263|589069731|FG001|Overall Study|Withdrawal by Subject|2|||
163098678|NCT03900728|589069732|FG000|Overall Study|No text responses|0|||
163098679|NCT03900728|589069733|FG001|Overall Study|No text responses|0|||
163098680|NCT03900728|589069734|FG002|Overall Study|No text responses|4|||
163098681|NCT01272037|589069743|FG000|Overall Study|Death|25|||
163098682|NCT01272037|589069744|FG001|Overall Study|Death|28|||
163098683|NCT01272037|589069743|FG000|Overall Study|Adverse Event|12|||
163098684|NCT01272037|589069744|FG001|Overall Study|Adverse Event|7|||
163098685|NCT01272037|589069743|FG000|Overall Study|Withdrawal by Subject|175|||
163098686|NCT01272037|589069744|FG001|Overall Study|Withdrawal by Subject|93|||
163098687|NCT01272037|589069743|FG000|Overall Study|Disease progression|70|||
163098688|NCT01272037|589069744|FG001|Overall Study|Disease progression|111|||
163098689|NCT01272037|589069743|FG000|Overall Study|Other reason|42|||
163098690|NCT01272037|589069744|FG001|Overall Study|Other reason|41|||
163098691|NCT01272037|589069743|FG000|Overall Study|Delinquent data|24|||
163098692|NCT01272037|589069744|FG001|Overall Study|Delinquent data|19|||
163098693|NCT01272037|589069743|FG000|Overall Study|Reason under review|33|||
163098694|NCT01272037|589069744|FG001|Overall Study|Reason under review|29|||
163098695|NCT01272037|589069743|FG000|Overall Study|On treatment|626|||
163098696|NCT01272037|589069744|FG001|Overall Study|On treatment|632|||
163098697|NCT01393899|589069745|FG000|Overall Study|Study terminated by sponsor|1|||
163098698|NCT01393899|589069746|FG001|Overall Study|Study terminated by sponsor|0|||
163098699|NCT01393899|589069747|FG002|Overall Study|Study terminated by sponsor|1|||
163098700|NCT01393899|589069745|FG000|Overall Study|Other|1|||
163098701|NCT01393899|589069746|FG001|Overall Study|Other|0|||
163098702|NCT01393899|589069747|FG002|Overall Study|Other|0|||
163098703|NCT01393899|589069745|FG000|Overall Study|Withdrawal by Subject|2|||
163098704|NCT01393899|589069746|FG001|Overall Study|Withdrawal by Subject|2|||
163098705|NCT01393899|589069747|FG002|Overall Study|Withdrawal by Subject|1|||
163098706|NCT01393899|589069745|FG000|Overall Study|Lost to Follow-up|0|||
163098707|NCT01393899|589069746|FG001|Overall Study|Lost to Follow-up|0|||
163098708|NCT01393899|589069747|FG002|Overall Study|Lost to Follow-up|1|||
163098709|NCT01393899|589069745|FG000|Overall Study|Does not meet entrance criteria|1|||
163098710|NCT01393899|589069746|FG001|Overall Study|Does not meet entrance criteria|0|||
163098711|NCT01393899|589069747|FG002|Overall Study|Does not meet entrance criteria|1|||
163098712|NCT01393899|589069745|FG000|Overall Study|Lack of Efficacy|26|||
163098713|NCT01393899|589069746|FG001|Overall Study|Lack of Efficacy|21|||
163098714|NCT01393899|589069747|FG002|Overall Study|Lack of Efficacy|16|||
163098715|NCT01393899|589069745|FG000|Overall Study|Adverse Event|1|||
163098716|NCT01393899|589069746|FG001|Overall Study|Adverse Event|5|||
163098717|NCT01393899|589069747|FG002|Overall Study|Adverse Event|3|||
163098718|NCT02503085|589069748|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
163098719|NCT02503085|589069749|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
163098720|NCT02503085|589069750|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
163339316|NCT00753896|589951131|FG000|Overall Study|Death|1|||
163339317|NCT00753896|589951131|FG000|Overall Study|Lost to Follow-up|2|||
163339318|NCT00753896|589951131|FG000|Overall Study|Protocol Violation|1|||
163339319|NCT00753896|589951131|FG000|Overall Study|Withdrawal by Subject|4|||
163339320|NCT00753896|589951131|FG000|Overall Study|Entry Criteria Not Met|4|||
163339321|NCT00952523|589951132|FG000|Overall Study|Withdrawal by Subject|7|||
163339322|NCT02707952|589951133|FG000|Overall Study|Adverse Event|1|||
163339323|NCT02707952|589951134|FG001|Overall Study|Adverse Event|0|||
163339324|NCT02707952|589951135|FG002|Overall Study|Adverse Event|0|||
163339325|NCT02707952|589951136|FG003|Overall Study|Adverse Event|0|||
163339326|NCT02707952|589951133|FG000|Overall Study|Lost to Follow-up|1|||
163339327|NCT02707952|589951134|FG001|Overall Study|Lost to Follow-up|0|||
163339328|NCT02707952|589951135|FG002|Overall Study|Lost to Follow-up|0|||
163339329|NCT02707952|589951136|FG003|Overall Study|Lost to Follow-up|0|||
163098721|NCT02503085|589069751|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
163098722|NCT01162473|589069755|FG000|Overall Study|Adverse Event|2|||
163098723|NCT01162473|589069756|FG001|Overall Study|Adverse Event|1|||
163098724|NCT01162473|589069755|FG000|Overall Study|Withdrawal by Subject|0|||
163098725|NCT01162473|589069756|FG001|Overall Study|Withdrawal by Subject|4|||
163098726|NCT01144416|589069757|FG000|Intervention Period|Adverse Event|5|||
163098727|NCT01144416|589069758|FG001|Intervention Period|Adverse Event|6|||
163098728|NCT01144416|589069757|FG000|Intervention Period|Insufficient ovarian response|11|||
163098729|NCT01144416|589069758|FG001|Intervention Period|Insufficient ovarian response|17|||
163098730|NCT01144416|589069757|FG000|Intervention Period|Risk of OHSS|0|||
163339330|NCT02707952|589951133|FG000|Overall Study|Withdrawal by Subject|0|||
163339331|NCT02707952|589951134|FG001|Overall Study|Withdrawal by Subject|1|||
163339332|NCT02707952|589951135|FG002|Overall Study|Withdrawal by Subject|2|||
163339333|NCT02707952|589951136|FG003|Overall Study|Withdrawal by Subject|0|||
163339334|NCT03072862|589951141|FG000|Overall Study|Withdrawal by Subject|4|||
163339335|NCT03072862|589951141|FG000|Overall Study|Lost to Follow-up|6|||
163339336|NCT03072862|589951141|FG000|Overall Study|Protocol Violation|4|||
163339337|NCT03072862|589951141|FG000|Overall Study|Physician Decision|2|||
163339338|NCT03072862|589951141|FG000|Overall Study|Death|1|||
163098731|NCT01144416|589069758|FG001|Intervention Period|Risk of OHSS|1|||
163098732|NCT01144416|589069757|FG000|Intervention Period|Too high ovarian response|4|||
163098733|NCT01144416|589069758|FG001|Intervention Period|Too high ovarian response|2|||
163098734|NCT01144416|589069757|FG000|Intervention Period|No/too few/bad oocytes|7|||
163098735|NCT01144416|589069758|FG001|Intervention Period|No/too few/bad oocytes|5|||
163098736|NCT01144416|589069757|FG000|Intervention Period|No or abnormal fertilization|25|||
163098737|NCT01144416|589069758|FG001|Intervention Period|No or abnormal fertilization|10|||
163098738|NCT01144416|589069757|FG000|Intervention Period|No/too few/bad quality embryos|3|||
163098739|NCT01144416|589069758|FG001|Intervention Period|No/too few/bad quality embryos|3|||
163098740|NCT01144416|589069757|FG000|Intervention Period|Other|7|||
163098741|NCT01144416|589069758|FG001|Intervention Period|Other|5|||
163098742|NCT02534883|589069760|FG000|Overall Study|Early Termination|8|||
163098743|NCT02534883|589069761|FG001|Overall Study|Early Termination|3|||
163098744|NCT03328832|589069762|FG000|Overall Study|Lost to Follow-up|0|||
163098745|NCT03328832|589069763|FG001|Overall Study|Lost to Follow-up|1|||
163098746|NCT00886769|589069764|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
163098747|NCT00886769|589069765|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
163098748|NCT00049257|589069766|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
163098749|NCT00049257|589069766|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
163098750|NCT00049257|589069766|FG000|Carboplatin, Paclitaxel|Death|2|||
163098751|NCT00049257|589069766|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
163098752|NCT00132301|589069767|FG000|Overall Study|Death|7|||
163098753|NCT00132301|589069768|FG001|Overall Study|Death|6|||
163098754|NCT00132301|589069767|FG000|Overall Study|Withdrawal by Subject|5|||
163098755|NCT00132301|589069768|FG001|Overall Study|Withdrawal by Subject|2|||
163098756|NCT00132301|589069767|FG000|Overall Study|Physician Decision|1|||
163098757|NCT00132301|589069768|FG001|Overall Study|Physician Decision|1|||
163098758|NCT00132301|589069767|FG000|Overall Study|Lost to Follow-up|5|||
163098759|NCT00132301|589069768|FG001|Overall Study|Lost to Follow-up|3|||
163098760|NCT00132301|589069767|FG000|Overall Study|Other|1|||
163098761|NCT00132301|589069768|FG001|Overall Study|Other|1|||
163098762|NCT00132301|589069767|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
163098763|NCT00132301|589069768|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
163098764|NCT01890265|589069771|FG000|Overall Study|Other (Unspecified reason)|0|||
163098765|NCT01890265|589069772|FG001|Overall Study|Other (Unspecified reason)|1|||
163098766|NCT01890265|589069773|FG002|Overall Study|Other (Unspecified reason)|0|||
163098767|NCT01890265|589069774|FG003|Overall Study|Other (Unspecified reason)|0|||
163098768|NCT01890265|589069775|FG004|Overall Study|Other (Unspecified reason)|0|||
163098769|NCT01890265|589069776|FG005|Overall Study|Other (Unspecified reason)|0|||
163098770|NCT01890265|589069771|FG000|Overall Study|Progressive disease|6|||
163098771|NCT01890265|589069772|FG001|Overall Study|Progressive disease|6|||
163098772|NCT01890265|589069773|FG002|Overall Study|Progressive disease|0|||
163098773|NCT01890265|589069774|FG003|Overall Study|Progressive disease|0|||
163098774|NCT01890265|589069775|FG004|Overall Study|Progressive disease|0|||
163098775|NCT01890265|589069776|FG005|Overall Study|Progressive disease|0|||
163098776|NCT01890265|589069771|FG000|Overall Study|Adverse Event|2|||
163098777|NCT01890265|589069772|FG001|Overall Study|Adverse Event|1|||
163098778|NCT01890265|589069773|FG002|Overall Study|Adverse Event|0|||
163098779|NCT01890265|589069774|FG003|Overall Study|Adverse Event|0|||
163098780|NCT01890265|589069775|FG004|Overall Study|Adverse Event|0|||
163098781|NCT01890265|589069776|FG005|Overall Study|Adverse Event|0|||
163098782|NCT01890265|589069771|FG000|Overall Study|Death|2|||
163098783|NCT01890265|589069772|FG001|Overall Study|Death|3|||
163098784|NCT01890265|589069773|FG002|Overall Study|Death|1|||
163098785|NCT01890265|589069774|FG003|Overall Study|Death|0|||
163098786|NCT01890265|589069775|FG004|Overall Study|Death|0|||
163098787|NCT01890265|589069776|FG005|Overall Study|Death|0|||
163098788|NCT01890265|589069771|FG000|Overall Study|Withdrawal by Subject|0|||
163098789|NCT01890265|589069772|FG001|Overall Study|Withdrawal by Subject|2|||
163098790|NCT01890265|589069773|FG002|Overall Study|Withdrawal by Subject|3|||
163098791|NCT01890265|589069774|FG003|Overall Study|Withdrawal by Subject|0|||
163098792|NCT01890265|589069775|FG004|Overall Study|Withdrawal by Subject|2|||
163098793|NCT01890265|589069776|FG005|Overall Study|Withdrawal by Subject|0|||
163098794|NCT03670355|589069782|FG000|Overall Study|Adverse Event|1|||
163098795|NCT03670355|589069783|FG001|Overall Study|Adverse Event|0|||
163098796|NCT03670355|589069782|FG000|Overall Study|Unable to comply with study procedures|0|||
163098797|NCT03670355|589069783|FG001|Overall Study|Unable to comply with study procedures|1|||
163098798|NCT03670355|589069782|FG000|Overall Study|Participant refused|0|||
163098799|NCT03670355|589069783|FG001|Overall Study|Participant refused|1|||
163098800|NCT03517436|589069784|FG000|Overall Study|Death|3|||
163339339|NCT03072862|589951141|FG000|Overall Study|Adverse Event|1|||
163339340|NCT02203513|589951142|FG000|Overall Study|Refused further treatment|2|||
163098801|NCT03517436|589069784|FG000|Overall Study|Withdrawal by Subject|4|||
163098802|NCT03517436|589069784|FG000|Overall Study|Did not receive study valve.|1|||
163098803|NCT04271540|589069785|FG000|Overall Study|Lost to Follow-up|1|||
163098804|NCT04271540|589069785|FG000|Overall Study|Screen Fail|5|||
163339341|NCT02203513|589951143|FG001|Overall Study|Refused further treatment|0|||
163339342|NCT02203513|589951144|FG002|Overall Study|Refused further treatment|1|||
163339343|NCT02203513|589951145|FG003|Overall Study|Refused further treatment|0|||
163098805|NCT04587869|589069788|FG000|Overall Study|Death|1|||
163098806|NCT04587869|589069789|FG001|Overall Study|Death|0|||
163098807|NCT04587869|589069788|FG000|Overall Study|Lost to Follow-up|27|||
163098808|NCT04587869|589069789|FG001|Overall Study|Lost to Follow-up|34|||
163098809|NCT04587869|589069788|FG000|Overall Study|Grant Termination|13|||
163098810|NCT04587869|589069789|FG001|Overall Study|Grant Termination|25|||
163098811|NCT04587869|589069788|FG000|Overall Study|too busy|2|||
163098812|NCT04587869|589069789|FG001|Overall Study|too busy|0|||
163098813|NCT04587869|589069788|FG000|Overall Study|Withdrawal by Subject|2|||
163098814|NCT04587869|589069789|FG001|Overall Study|Withdrawal by Subject|2|||
163098815|NCT04587869|589069788|FG000|Overall Study|Other|1|||
163098816|NCT04587869|589069789|FG001|Overall Study|Other|0|||
163098817|NCT02268383|589069792|FG000|Overall Study|Death|12|||
163098818|NCT02268383|589069792|FG000|Overall Study|Lost to Follow-up|2|||
163098819|NCT02268383|589069792|FG000|Overall Study|Withdrawal by Subject|9|||
163098820|NCT02268383|589069792|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
163098821|NCT02268383|589069792|FG000|Overall Study|Protocol deviation|3|||
163098822|NCT02268383|589069792|FG000|Overall Study|Sponsor decision|22|||
163098823|NCT02268383|589069792|FG000|Overall Study|Not reported|12|||
163098824|NCT00943761|589069793|FG000|Overall Study|Lost to Follow-up|2|||
163098825|NCT00943761|589069794|FG001|Overall Study|Lost to Follow-up|0|||
163098826|NCT00943761|589069793|FG000|Overall Study|Withdrawal by Subject|2|||
163098827|NCT00943761|589069794|FG001|Overall Study|Withdrawal by Subject|1|||
163098828|NCT02708680|589069797|FG000|Overall Study|Withdrawal by Subject|4|||
163098829|NCT02708680|589069798|FG001|Overall Study|Withdrawal by Subject|12|||
163098830|NCT02708680|589069799|FG002|Overall Study|Withdrawal by Subject|12|||
163098831|NCT02708680|589069797|FG000|Overall Study|Death|4|||
163098832|NCT02708680|589069798|FG001|Overall Study|Death|19|||
163098833|NCT02708680|589069799|FG002|Overall Study|Death|21|||
163098834|NCT02708680|589069797|FG000|Overall Study|Lost to Follow-up|0|||
163098835|NCT02708680|589069798|FG001|Overall Study|Lost to Follow-up|3|||
163098836|NCT02708680|589069799|FG002|Overall Study|Lost to Follow-up|3|||
163098837|NCT02708680|589069797|FG000|Overall Study|Study Terminated By Sponsor|0|||
163098838|NCT02708680|589069798|FG001|Overall Study|Study Terminated By Sponsor|5|||
163098839|NCT02708680|589069799|FG002|Overall Study|Study Terminated By Sponsor|4|||
163098840|NCT02708680|589069797|FG000|Overall Study|Other than Specified|0|||
163098841|NCT02708680|589069798|FG001|Overall Study|Other than Specified|0|||
163098842|NCT02708680|589069799|FG002|Overall Study|Other than Specified|1|||
163098843|NCT02708680|589069797|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
163098844|NCT02708680|589069798|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
163098845|NCT02708680|589069799|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
163098846|NCT01342926|589069800|FG000|Overall Study|Adverse Event|5|||
163098847|NCT01342926|589069801|FG001|Overall Study|Adverse Event|8|||
163098848|NCT01342926|589069802|FG002|Overall Study|Adverse Event|10|||
163098849|NCT01342926|589069803|FG003|Overall Study|Adverse Event|7|||
163098850|NCT01342926|589069800|FG000|Overall Study|Lost to Follow-up|0|||
163098851|NCT01342926|589069801|FG001|Overall Study|Lost to Follow-up|1|||
163098852|NCT01342926|589069802|FG002|Overall Study|Lost to Follow-up|1|||
163098853|NCT01342926|589069803|FG003|Overall Study|Lost to Follow-up|0|||
163098854|NCT01342926|589069800|FG000|Overall Study|Investigator Discretion|2|||
163098855|NCT01342926|589069801|FG001|Overall Study|Investigator Discretion|2|||
163098856|NCT01342926|589069802|FG002|Overall Study|Investigator Discretion|0|||
163098857|NCT01342926|589069803|FG003|Overall Study|Investigator Discretion|0|||
163098858|NCT01342926|589069800|FG000|Overall Study|Withdrawal by Subject|2|||
163098859|NCT01342926|589069801|FG001|Overall Study|Withdrawal by Subject|4|||
163098860|NCT01342926|589069802|FG002|Overall Study|Withdrawal by Subject|3|||
163098861|NCT01342926|589069803|FG003|Overall Study|Withdrawal by Subject|5|||
163098862|NCT04162470|589069804|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
163098863|NCT03382912|589069805|FG000|Overall Study|Physician Decision|0|||
163339344|NCT02203513|589951146|FG004|Overall Study|Refused further treatment|0|||
163339345|NCT02203513|589951142|FG000|Overall Study|Switched to alternative treatment|3|||
163098864|NCT03382912|589069806|FG001|Overall Study|Physician Decision|1|||
163098865|NCT03382912|589069805|FG000|Overall Study|Sponsor Decision|6|||
163339346|NCT02203513|589951143|FG001|Overall Study|Switched to alternative treatment|4|||
163098866|NCT03382912|589069806|FG001|Overall Study|Sponsor Decision|6|||
163098867|NCT03382912|589069805|FG000|Overall Study|Withdrawal by Subject|0|||
163098868|NCT03382912|589069806|FG001|Overall Study|Withdrawal by Subject|5|||
163098869|NCT01402869|589069811|FG000|Overall Study|Required Tooth Extraction|0|||
163098870|NCT01402869|589069812|FG001|Overall Study|Required Tooth Extraction|0|||
163098871|NCT01402869|589069813|FG002|Overall Study|Required Tooth Extraction|1|||
163098872|NCT00642707|589069814|FG000|Overall Study|Adverse Event|0|||
163098873|NCT00642707|589069815|FG001|Overall Study|Adverse Event|0|||
163098874|NCT00642707|589069816|FG002|Overall Study|Adverse Event|0|||
163098875|NCT00642707|589069817|FG003|Overall Study|Adverse Event|2|||
163098876|NCT00642707|589069814|FG000|Overall Study|Withdrawal by Subject|1|||
163098877|NCT00642707|589069815|FG001|Overall Study|Withdrawal by Subject|0|||
163098878|NCT00642707|589069816|FG002|Overall Study|Withdrawal by Subject|0|||
163098879|NCT00642707|589069817|FG003|Overall Study|Withdrawal by Subject|0|||
163098880|NCT02573948|589069818|FG000|Longitudinal Cohort|Death|9|||
163098881|NCT02573948|589069818|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
163098882|NCT02573948|589069818|FG000|Longitudinal Cohort|Incarcerated|25|||
163098883|NCT00707993|589069819|FG000|Overall Study|Adverse Event|16|||
163098884|NCT00707993|589069820|FG001|Overall Study|Adverse Event|20|||
163098885|NCT00707993|589069819|FG000|Overall Study|Protocol Violation|4|||
163098886|NCT00707993|589069820|FG001|Overall Study|Protocol Violation|7|||
163098887|NCT00707993|589069819|FG000|Overall Study|Lost to Follow-up|0|||
163098888|NCT00707993|589069820|FG001|Overall Study|Lost to Follow-up|4|||
163098889|NCT00707993|589069819|FG000|Overall Study|Withdrawal by Subject|12|||
163098890|NCT00707993|589069820|FG001|Overall Study|Withdrawal by Subject|16|||
163098891|NCT00707993|589069819|FG000|Overall Study|Hyperglycemic Rescue|55|||
163098892|NCT00707993|589069820|FG001|Overall Study|Hyperglycemic Rescue|47|||
163098893|NCT00707993|589069819|FG000|Overall Study|Other|2|||
163098894|NCT00707993|589069820|FG001|Overall Study|Other|0|||
163098895|NCT00436436|589069823|FG000|Overall Study|Progression|4|||
163098896|NCT00436436|589069823|FG000|Overall Study|Adverse Event|2|||
163098897|NCT00436436|589069823|FG000|Overall Study|Death|6|||
163098898|NCT01837680|589069824|FG000|Overall Study|Lost to Follow-up|2|||
163098899|NCT01837680|589069825|FG001|Overall Study|Lost to Follow-up|2|||
163098900|NCT01837680|589069824|FG000|Overall Study|lack of insurance|0|||
163098901|NCT01837680|589069825|FG001|Overall Study|lack of insurance|2|||
163098902|NCT01837680|589069824|FG000|Overall Study|allergic reaction|6|||
163098903|NCT01837680|589069825|FG001|Overall Study|allergic reaction|0|||
163098904|NCT01837680|589069824|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
163098905|NCT01837680|589069825|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
163098906|NCT05223673|589069826|FG000|Overall Study|Protocol Violation|1|||
163098907|NCT05223673|589069826|FG000|Overall Study|Study termination|6|||
163098908|NCT03941483|589069827|FG000|Overall Study|Miscellaneous|2|||
163098909|NCT03941483|589069828|FG001|Overall Study|Miscellaneous|3|||
163098910|NCT03941483|589069829|FG002|Overall Study|Miscellaneous|0|||
163098911|NCT03941483|589069827|FG000|Overall Study|Study Terminated by Sponsor|1|||
163098912|NCT03941483|589069828|FG001|Overall Study|Study Terminated by Sponsor|0|||
163098913|NCT03941483|589069829|FG002|Overall Study|Study Terminated by Sponsor|0|||
163098914|NCT03941483|589069827|FG000|Overall Study|Withdrawal by Subject|1|||
163098915|NCT03941483|589069828|FG001|Overall Study|Withdrawal by Subject|4|||
163098916|NCT03941483|589069829|FG002|Overall Study|Withdrawal by Subject|1|||
163098917|NCT03941483|589069827|FG000|Overall Study|Lost to Follow-up|2|||
163098918|NCT03941483|589069828|FG001|Overall Study|Lost to Follow-up|1|||
163098919|NCT03941483|589069829|FG002|Overall Study|Lost to Follow-up|8|||
163098920|NCT03941483|589069827|FG000|Overall Study|Death|3|||
163098921|NCT03941483|589069828|FG001|Overall Study|Death|2|||
163098922|NCT03941483|589069829|FG002|Overall Study|Death|6|||
163098923|NCT03154476|589069830|FG000|Overall Study|Lost to Follow-up|4|||
163098924|NCT03154476|589069831|FG001|Overall Study|Lost to Follow-up|4|||
163098925|NCT02685826|589069832|FG000|Overall Study|Adverse Event|2|||
163098926|NCT02685826|589069833|FG001|Overall Study|Adverse Event|0|||
163098927|NCT02685826|589069834|FG002|Overall Study|Adverse Event|1|||
163098928|NCT02685826|589069832|FG000|Overall Study|Progressive Disease|2|||
163098929|NCT02685826|589069833|FG001|Overall Study|Progressive Disease|1|||
163098930|NCT02685826|589069834|FG002|Overall Study|Progressive Disease|0|||
163098931|NCT02685826|589069832|FG000|Overall Study|Withdrawal by Subject|2|||
163098932|NCT02685826|589069833|FG001|Overall Study|Withdrawal by Subject|0|||
163098933|NCT02685826|589069834|FG002|Overall Study|Withdrawal by Subject|0|||
163098934|NCT02685826|589069832|FG000|Overall Study|Full Clinical Hold by FDA|19|||
163098935|NCT02685826|589069833|FG001|Overall Study|Full Clinical Hold by FDA|9|||
163098936|NCT02685826|589069834|FG002|Overall Study|Full Clinical Hold by FDA|20|||
163098937|NCT05823974|589071654|FG000|Overall Study|Lost to Follow-up|0|||
163098938|NCT05823974|589071655|FG001|Overall Study|Lost to Follow-up|3|||
163098939|NCT05823974|589071656|FG002|Overall Study|Lost to Follow-up|1|||
163098940|NCT05823974|589071657|FG003|Overall Study|Lost to Follow-up|0|||
163098941|NCT05823974|589071658|FG004|Overall Study|Lost to Follow-up|1|||
163098942|NCT05823974|589071659|FG005|Overall Study|Lost to Follow-up|0|||
163098943|NCT05823974|589071660|FG006|Overall Study|Lost to Follow-up|1|||
163339347|NCT02203513|589951144|FG002|Overall Study|Switched to alternative treatment|0|||
163098944|NCT05823974|589071661|FG007|Overall Study|Lost to Follow-up|0|||
163098945|NCT05823974|589071662|FG008|Overall Study|Lost to Follow-up|0|||
163098946|NCT05823974|589071663|FG009|Overall Study|Lost to Follow-up|1|||
163098947|NCT05823974|589071664|FG010|Overall Study|Lost to Follow-up|1|||
163098948|NCT05823974|589071665|FG011|Overall Study|Lost to Follow-up|0|||
163098949|NCT05823974|589071666|FG012|Overall Study|Lost to Follow-up|1|||
163098950|NCT05823974|589071667|FG013|Overall Study|Lost to Follow-up|2|||
163098951|NCT05823974|589071668|FG014|Overall Study|Lost to Follow-up|1|||
163098952|NCT05823974|589071669|FG015|Overall Study|Lost to Follow-up|1|||
163098953|NCT05823974|589071670|FG016|Overall Study|Lost to Follow-up|1|||
163098954|NCT05823974|589071671|FG017|Overall Study|Lost to Follow-up|0|||
163098955|NCT05823974|589071672|FG018|Overall Study|Lost to Follow-up|0|||
163098956|NCT05823974|589071673|FG019|Overall Study|Lost to Follow-up|2|||
163098957|NCT05823974|589071674|FG020|Overall Study|Lost to Follow-up|0|||
163098958|NCT05823974|589071654|FG000|Overall Study|Physician Decision|0|||
163098959|NCT05823974|589071655|FG001|Overall Study|Physician Decision|0|||
163098960|NCT05823974|589071656|FG002|Overall Study|Physician Decision|0|||
163098961|NCT05823974|589071657|FG003|Overall Study|Physician Decision|0|||
163098962|NCT05823974|589071658|FG004|Overall Study|Physician Decision|0|||
163098963|NCT05823974|589071659|FG005|Overall Study|Physician Decision|0|||
163098964|NCT05823974|589071660|FG006|Overall Study|Physician Decision|0|||
163098965|NCT05823974|589071661|FG007|Overall Study|Physician Decision|0|||
163098966|NCT05823974|589071662|FG008|Overall Study|Physician Decision|0|||
163098967|NCT05823974|589071663|FG009|Overall Study|Physician Decision|0|||
163098968|NCT05823974|589071664|FG010|Overall Study|Physician Decision|0|||
163098969|NCT05823974|589071665|FG011|Overall Study|Physician Decision|0|||
163098970|NCT05823974|589071666|FG012|Overall Study|Physician Decision|0|||
163098971|NCT05823974|589071667|FG013|Overall Study|Physician Decision|0|||
163098972|NCT05823974|589071668|FG014|Overall Study|Physician Decision|0|||
163098973|NCT05823974|589071669|FG015|Overall Study|Physician Decision|1|||
163098974|NCT05823974|589071670|FG016|Overall Study|Physician Decision|0|||
163098975|NCT05823974|589071671|FG017|Overall Study|Physician Decision|1|||
163098976|NCT05823974|589071672|FG018|Overall Study|Physician Decision|1|||
163098977|NCT05823974|589071673|FG019|Overall Study|Physician Decision|0|||
163098978|NCT05823974|589071674|FG020|Overall Study|Physician Decision|0|||
163098979|NCT05823974|589071654|FG000|Overall Study|Withdrawal by Subject|1|||
163098980|NCT05823974|589071655|FG001|Overall Study|Withdrawal by Subject|1|||
163098981|NCT05823974|589071656|FG002|Overall Study|Withdrawal by Subject|2|||
163098982|NCT05823974|589071657|FG003|Overall Study|Withdrawal by Subject|0|||
163098983|NCT05823974|589071658|FG004|Overall Study|Withdrawal by Subject|2|||
163098984|NCT05823974|589071659|FG005|Overall Study|Withdrawal by Subject|3|||
163098985|NCT05823974|589071660|FG006|Overall Study|Withdrawal by Subject|1|||
163098986|NCT05823974|589071661|FG007|Overall Study|Withdrawal by Subject|1|||
163098987|NCT05823974|589071662|FG008|Overall Study|Withdrawal by Subject|2|||
163098988|NCT05823974|589071663|FG009|Overall Study|Withdrawal by Subject|1|||
163098989|NCT05823974|589071664|FG010|Overall Study|Withdrawal by Subject|1|||
163098990|NCT05823974|589071665|FG011|Overall Study|Withdrawal by Subject|0|||
163098991|NCT05823974|589071666|FG012|Overall Study|Withdrawal by Subject|0|||
163098992|NCT05823974|589071667|FG013|Overall Study|Withdrawal by Subject|1|||
163098993|NCT05823974|589071668|FG014|Overall Study|Withdrawal by Subject|1|||
163098994|NCT05823974|589071669|FG015|Overall Study|Withdrawal by Subject|3|||
163098995|NCT05823974|589071670|FG016|Overall Study|Withdrawal by Subject|0|||
163098996|NCT05823974|589071671|FG017|Overall Study|Withdrawal by Subject|2|||
163098997|NCT05823974|589071672|FG018|Overall Study|Withdrawal by Subject|2|||
163098998|NCT05823974|589071673|FG019|Overall Study|Withdrawal by Subject|0|||
163098999|NCT05823974|589071674|FG020|Overall Study|Withdrawal by Subject|1|||
163099000|NCT05823974|589071654|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099001|NCT05823974|589071655|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099002|NCT05823974|589071656|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163099003|NCT05823974|589071657|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099004|NCT05823974|589071658|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099005|NCT05823974|589071659|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099006|NCT05823974|589071660|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099007|NCT05823974|589071661|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099008|NCT05823974|589071662|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099009|NCT05823974|589071663|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099010|NCT05823974|589071664|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099011|NCT05823974|589071665|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099012|NCT05823974|589071666|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099013|NCT05823974|589071667|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099014|NCT05823974|589071668|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163099015|NCT05823974|589071669|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099016|NCT05823974|589071670|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099017|NCT05823974|589071671|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099018|NCT05823974|589071672|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099019|NCT05823974|589071673|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099020|NCT05823974|589071674|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099021|NCT05823974|589071654|FG000|Overall Study|Other|0|||
163099022|NCT05823974|589071655|FG001|Overall Study|Other|1|||
163099023|NCT05823974|589071656|FG002|Overall Study|Other|1|||
163099024|NCT05823974|589071657|FG003|Overall Study|Other|1|||
163099025|NCT05823974|589071658|FG004|Overall Study|Other|0|||
163099026|NCT05823974|589071659|FG005|Overall Study|Other|1|||
163099027|NCT05823974|589071660|FG006|Overall Study|Other|1|||
163099028|NCT05823974|589071661|FG007|Overall Study|Other|1|||
163099029|NCT05823974|589071662|FG008|Overall Study|Other|1|||
163099030|NCT05823974|589071663|FG009|Overall Study|Other|0|||
163099031|NCT05823974|589071664|FG010|Overall Study|Other|0|||
163099032|NCT05823974|589071665|FG011|Overall Study|Other|0|||
163099033|NCT05823974|589071666|FG012|Overall Study|Other|2|||
163099034|NCT05823974|589071667|FG013|Overall Study|Other|1|||
163099035|NCT05823974|589071668|FG014|Overall Study|Other|0|||
163099036|NCT05823974|589071669|FG015|Overall Study|Other|1|||
163099037|NCT05823974|589071670|FG016|Overall Study|Other|0|||
163099038|NCT05823974|589071671|FG017|Overall Study|Other|0|||
163099039|NCT05823974|589071672|FG018|Overall Study|Other|0|||
163099040|NCT05823974|589071673|FG019|Overall Study|Other|0|||
163099041|NCT05823974|589071674|FG020|Overall Study|Other|0|||
163099042|NCT00316706|589071675|FG000|Overall Study|Lost to Follow-up|38|||
163099043|NCT00316706|589071676|FG001|Overall Study|Lost to Follow-up|48|||
163099044|NCT01133756|589071679|FG000|Overall Study|Adverse Event|1|||
163099045|NCT01133756|589071680|FG001|Overall Study|Adverse Event|2|||
163099046|NCT01133756|589071681|FG002|Overall Study|Adverse Event|1|||
163099047|NCT01133756|589071679|FG000|Overall Study|Investigator Decision|1|||
163099048|NCT01133756|589071680|FG001|Overall Study|Investigator Decision|0|||
163099049|NCT01133756|589071681|FG002|Overall Study|Investigator Decision|0|||
163099050|NCT01133756|589071679|FG000|Overall Study|Withdrawal by Subject|0|||
163099051|NCT01133756|589071680|FG001|Overall Study|Withdrawal by Subject|1|||
163099052|NCT01133756|589071681|FG002|Overall Study|Withdrawal by Subject|0|||
163099053|NCT01133756|589071679|FG000|Overall Study|Progression of Disease|0|||
163099054|NCT01133756|589071680|FG001|Overall Study|Progression of Disease|0|||
163099055|NCT01133756|589071681|FG002|Overall Study|Progression of Disease|1|||
163099056|NCT03941873|589071682|FG000|Overall Study|Death|0|||
163099057|NCT03941873|589071683|FG001|Overall Study|Death|12|||
163099058|NCT03941873|589071684|FG002|Overall Study|Death|2|||
163099059|NCT03941873|589071685|FG003|Overall Study|Death|53|||
163099060|NCT03941873|589071682|FG000|Overall Study|Withdrawal by Subject|1|||
163099061|NCT03941873|589071683|FG001|Overall Study|Withdrawal by Subject|1|||
163099062|NCT03941873|589071684|FG002|Overall Study|Withdrawal by Subject|0|||
163099063|NCT03941873|589071685|FG003|Overall Study|Withdrawal by Subject|5|||
163099064|NCT03941873|589071682|FG000|Overall Study|Lost to Follow-up|1|||
163099065|NCT03941873|589071683|FG001|Overall Study|Lost to Follow-up|2|||
163099066|NCT03941873|589071684|FG002|Overall Study|Lost to Follow-up|0|||
163099067|NCT03941873|589071685|FG003|Overall Study|Lost to Follow-up|0|||
163099068|NCT03941873|589071682|FG000|Overall Study|Sponsor Decision|0|||
163099069|NCT03941873|589071683|FG001|Overall Study|Sponsor Decision|6|||
163099070|NCT03941873|589071684|FG002|Overall Study|Sponsor Decision|0|||
163099071|NCT03941873|589071685|FG003|Overall Study|Sponsor Decision|15|||
163099072|NCT03276728|589071688|FG000|Overall Study|Lost to Follow-up|0|||
163099073|NCT03276728|589071689|FG001|Overall Study|Lost to Follow-up|0|||
163099074|NCT03276728|589071690|FG002|Overall Study|Lost to Follow-up|2|||
163099075|NCT03276728|589071691|FG003|Overall Study|Lost to Follow-up|2|||
163099076|NCT03276728|589071692|FG004|Overall Study|Lost to Follow-up|0|||
163099077|NCT03276728|589071693|FG005|Overall Study|Lost to Follow-up|0|||
163099078|NCT03276728|589071694|FG006|Overall Study|Lost to Follow-up|0|||
163099079|NCT03276728|589071695|FG007|Overall Study|Lost to Follow-up|0|||
163099080|NCT03276728|589071688|FG000|Overall Study|Withdrawal by Subject|0|||
163099081|NCT03276728|589071689|FG001|Overall Study|Withdrawal by Subject|0|||
163099082|NCT03276728|589071690|FG002|Overall Study|Withdrawal by Subject|0|||
163099083|NCT03276728|589071691|FG003|Overall Study|Withdrawal by Subject|3|||
163099084|NCT03276728|589071692|FG004|Overall Study|Withdrawal by Subject|0|||
163099085|NCT03276728|589071693|FG005|Overall Study|Withdrawal by Subject|0|||
163099086|NCT03276728|589071694|FG006|Overall Study|Withdrawal by Subject|0|||
163099087|NCT03276728|589071695|FG007|Overall Study|Withdrawal by Subject|0|||
163099088|NCT03276728|589071688|FG000|Overall Study|Decision by sponsor|0|||
163099089|NCT03276728|589071689|FG001|Overall Study|Decision by sponsor|0|||
163099090|NCT03276728|589071690|FG002|Overall Study|Decision by sponsor|0|||
163099091|NCT03276728|589071691|FG003|Overall Study|Decision by sponsor|0|||
163099092|NCT03276728|589071692|FG004|Overall Study|Decision by sponsor|1|||
163099093|NCT03276728|589071693|FG005|Overall Study|Decision by sponsor|0|||
163099094|NCT03276728|589071694|FG006|Overall Study|Decision by sponsor|2|||
163099095|NCT03276728|589071695|FG007|Overall Study|Decision by sponsor|1|||
163099096|NCT00617084|589071696|FG000|Overall Study|Withdrawal by Subject|5|||
163099097|NCT00617084|589071697|FG001|Overall Study|Withdrawal by Subject|7|||
163099098|NCT00617084|589071696|FG000|Overall Study|Missed 12 Months visit|16|||
163099099|NCT00617084|589071697|FG001|Overall Study|Missed 12 Months visit|19|||
163099100|NCT02222688|589071698|FG000|Overall Study|Withdrawal by Subject|0|||
163099101|NCT02222688|589071699|FG001|Overall Study|Withdrawal by Subject|0|||
163099102|NCT02222688|589071700|FG002|Overall Study|Withdrawal by Subject|0|||
163099103|NCT02222688|589071701|FG003|Overall Study|Withdrawal by Subject|2|||
163220192|NCT02039674|589521412|FG006|Overall Study|Sponsor Decision|0|||
163099104|NCT02222688|589071702|FG004|Overall Study|Withdrawal by Subject|1|||
163099105|NCT02222688|589071703|FG005|Overall Study|Withdrawal by Subject|0|||
163099106|NCT02222688|589071704|FG006|Overall Study|Withdrawal by Subject|1|||
163099107|NCT02222688|589071698|FG000|Overall Study|Disease progression|1|||
163099108|NCT02222688|589071699|FG001|Overall Study|Disease progression|0|||
163099109|NCT02222688|589071700|FG002|Overall Study|Disease progression|0|||
163099110|NCT02222688|589071701|FG003|Overall Study|Disease progression|0|||
163099111|NCT02222688|589071702|FG004|Overall Study|Disease progression|0|||
163099112|NCT02222688|589071703|FG005|Overall Study|Disease progression|0|||
163099113|NCT02222688|589071704|FG006|Overall Study|Disease progression|0|||
163099114|NCT03458325|589071717|FG000|Overall Study|Withdrawal by Subject|1|||
163099115|NCT01134614|589071718|FG000|Overall Study|Still on treatment as of March 2013|21|||
163099116|NCT01134614|589071719|FG001|Overall Study|Still on treatment as of March 2013|13|||
163099117|NCT01134614|589071718|FG000|Overall Study|Progressive disease|60|||
163099118|NCT01134614|589071719|FG001|Overall Study|Progressive disease|54|||
163099119|NCT01134614|589071718|FG000|Overall Study|Adverse Event|26|||
163099120|NCT01134614|589071719|FG001|Overall Study|Adverse Event|39|||
163099121|NCT01134614|589071718|FG000|Overall Study|Death|5|||
163099122|NCT01134614|589071719|FG001|Overall Study|Death|8|||
163099123|NCT01134614|589071718|FG000|Overall Study|Withdrawal by Subject|3|||
163099124|NCT01134614|589071719|FG001|Overall Study|Withdrawal by Subject|2|||
163099125|NCT01134614|589071718|FG000|Overall Study|Alternative therapy|2|||
163099126|NCT01134614|589071719|FG001|Overall Study|Alternative therapy|0|||
163099127|NCT01134614|589071718|FG000|Overall Study|Complicating disease|2|||
163099128|NCT01134614|589071719|FG001|Overall Study|Complicating disease|1|||
163099129|NCT01134614|589071718|FG000|Overall Study|Physician's decision|0|||
163099130|NCT01134614|589071719|FG001|Overall Study|Physician's decision|1|||
163099131|NCT01134614|589071718|FG000|Overall Study|Never started treatment|4|||
163099132|NCT01134614|589071719|FG001|Overall Study|Never started treatment|1|||
163099133|NCT01134614|589071718|FG000|Overall Study|Pt received tx not allowed on study|0|||
163099134|NCT01134614|589071719|FG001|Overall Study|Pt received tx not allowed on study|1|||
163099135|NCT01134614|589071718|FG000|Overall Study|Symptomatic deterioration|0|||
163099136|NCT01134614|589071719|FG001|Overall Study|Symptomatic deterioration|1|||
163099137|NCT01134614|589071718|FG000|Overall Study|Patient in hospice care|0|||
163099138|NCT01134614|589071719|FG001|Overall Study|Patient in hospice care|1|||
163099139|NCT01485796|589071721|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
163099140|NCT01485796|589071721|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
163099141|NCT01485796|589071721|FG000|Period 2: Epoch 2|Adverse Event|3|||
163099142|NCT01485796|589071721|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
163099143|NCT01485796|589071721|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
163099144|NCT01485796|589071721|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
163099145|NCT01485796|589071721|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
163099146|NCT01485796|589071721|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
163099147|NCT01766037|589071723|FG000|Overall Study|Adverse Event|1|||
163099148|NCT01766037|589071724|FG001|Overall Study|Adverse Event|0|||
163099149|NCT01766037|589071723|FG000|Overall Study|Lack of Efficacy|1|||
163099150|NCT01766037|589071724|FG001|Overall Study|Lack of Efficacy|0|||
163099151|NCT01766037|589071723|FG000|Overall Study|Lost to Follow-up|0|||
163099152|NCT01766037|589071724|FG001|Overall Study|Lost to Follow-up|10|||
163099153|NCT01766037|589071723|FG000|Overall Study|Physician Decision|0|||
163099154|NCT01766037|589071724|FG001|Overall Study|Physician Decision|1|||
163099155|NCT01766037|589071723|FG000|Overall Study|Withdrawal by Subject|18|||
163099156|NCT01766037|589071724|FG001|Overall Study|Withdrawal by Subject|16|||
163099157|NCT01766037|589071723|FG000|Overall Study|Moved from area|5|||
163099158|NCT01766037|589071724|FG001|Overall Study|Moved from area|0|||
163099159|NCT01766037|589071723|FG000|Overall Study|medical - unrelated|1|||
163099160|NCT01766037|589071724|FG001|Overall Study|medical - unrelated|2|||
163099161|NCT01766037|589071723|FG000|Overall Study|nausea / discomfort|3|||
163099162|NCT01766037|589071724|FG001|Overall Study|nausea / discomfort|0|||
163099163|NCT00292045|589071728|FG000|Core Study (Through Week 13)|Adverse Event|1|||
163099164|NCT00292045|589071728|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
163099165|NCT02236572|589071729|FG000|Overall Study|Withdrawal by Subject|1|||
163099166|NCT02236572|589071729|FG000|Overall Study|Protocol Violation|1|||
163099167|NCT02236572|589071729|FG000|Overall Study|Lost to Follow-up|1|||
163099168|NCT00606411|589071730|FG000|Overall Study|Adverse Event|1|||
163099169|NCT00606411|589071731|FG001|Overall Study|Adverse Event|2|||
163099170|NCT00606411|589071730|FG000|Overall Study|Lack of Adherence|1|||
163099171|NCT00606411|589071731|FG001|Overall Study|Lack of Adherence|1|||
163099172|NCT00606411|589071730|FG000|Overall Study|Lack of Efficacy|1|||
163099173|NCT00606411|589071731|FG001|Overall Study|Lack of Efficacy|1|||
163099174|NCT00606411|589071730|FG000|Overall Study|Withdrawal by Subject|2|||
163099175|NCT00606411|589071731|FG001|Overall Study|Withdrawal by Subject|0|||
163099176|NCT00606411|589071730|FG000|Overall Study|Lost to Follow-up|1|||
163099177|NCT00606411|589071731|FG001|Overall Study|Lost to Follow-up|2|||
163099178|NCT00606411|589071730|FG000|Overall Study|Move out of state|0|||
163099179|NCT00606411|589071731|FG001|Overall Study|Move out of state|1|||
163099180|NCT00412958|589071732|FG000|Overall Study|Withdrawal by Subject|3|||
163099181|NCT00412958|589071733|FG001|Overall Study|Withdrawal by Subject|0|||
163099182|NCT00412958|589071734|FG002|Overall Study|Withdrawal by Subject|0|||
163099183|NCT00412958|589071735|FG003|Overall Study|Withdrawal by Subject|1|||
163099184|NCT00412958|589071732|FG000|Overall Study|Adverse Event|0|||
163099185|NCT00412958|589071733|FG001|Overall Study|Adverse Event|1|||
163099186|NCT00412958|589071734|FG002|Overall Study|Adverse Event|0|||
163099187|NCT00412958|589071735|FG003|Overall Study|Adverse Event|0|||
163099188|NCT00412958|589071732|FG000|Overall Study|Lost to Follow-up|0|||
163099189|NCT00412958|589071733|FG001|Overall Study|Lost to Follow-up|1|||
163099190|NCT00412958|589071734|FG002|Overall Study|Lost to Follow-up|0|||
163099191|NCT00412958|589071735|FG003|Overall Study|Lost to Follow-up|0|||
163099192|NCT00412958|589071732|FG000|Overall Study|Death|0|||
163099193|NCT00412958|589071733|FG001|Overall Study|Death|1|||
163099194|NCT00412958|589071734|FG002|Overall Study|Death|0|||
163099195|NCT00412958|589071735|FG003|Overall Study|Death|0|||
163099196|NCT00412958|589071732|FG000|Overall Study|Transport issue|0|||
163099197|NCT00412958|589071733|FG001|Overall Study|Transport issue|1|||
163099198|NCT00412958|589071734|FG002|Overall Study|Transport issue|0|||
163099199|NCT00412958|589071735|FG003|Overall Study|Transport issue|0|||
163099200|NCT01318135|589071736|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
163099201|NCT01318135|589071737|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163099202|NCT01318135|589071738|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163099203|NCT01318135|589071739|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163099204|NCT01318135|589071740|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163099205|NCT01318135|589071741|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163099206|NCT01318135|589071742|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163099207|NCT01318135|589071743|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163099208|NCT01318135|589071736|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
163099209|NCT01318135|589071737|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
163099210|NCT01318135|589071738|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
163099211|NCT01318135|589071739|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
163099212|NCT01318135|589071740|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
163099213|NCT01318135|589071741|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
163099214|NCT01318135|589071742|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
163099215|NCT01318135|589071743|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
163099216|NCT01318135|589071736|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
163099217|NCT01318135|589071737|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
163099218|NCT01318135|589071738|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
163099219|NCT01318135|589071739|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
163099220|NCT01318135|589071740|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
163099221|NCT01318135|589071741|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
163099222|NCT01318135|589071742|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
163099223|NCT01318135|589071743|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
163099224|NCT01318135|589071736|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
163099225|NCT01318135|589071737|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
163099226|NCT01318135|589071738|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
163099227|NCT01318135|589071739|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
163099228|NCT01318135|589071740|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
163099229|NCT01318135|589071741|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
163099230|NCT01318135|589071742|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
163099231|NCT01318135|589071743|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
163099232|NCT01318135|589071736|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
163099233|NCT01318135|589071737|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
163099234|NCT01318135|589071738|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
163099235|NCT01318135|589071739|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163099236|NCT01318135|589071740|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
163099237|NCT01318135|589071741|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
163099238|NCT01318135|589071742|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
163099239|NCT01318135|589071743|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163099240|NCT01318135|589071736|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
163339348|NCT02203513|589951145|FG003|Overall Study|Switched to alternative treatment|0|||
163339349|NCT02203513|589951146|FG004|Overall Study|Switched to alternative treatment|4|||
163339350|NCT02203513|589951142|FG000|Overall Study|Did not receive investigational product (IP)|0|||
163339351|NCT02203513|589951143|FG001|Overall Study|Did not receive investigational product (IP)|1|||
163339352|NCT02203513|589951144|FG002|Overall Study|Did not receive investigational product (IP)|0|||
163099241|NCT01318135|589071737|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
163099242|NCT01318135|589071738|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
163099243|NCT01318135|589071739|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
163099244|NCT01318135|589071740|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
163099245|NCT01318135|589071741|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
163099246|NCT01318135|589071742|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
163099247|NCT01318135|589071743|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
163099248|NCT01318135|589071736|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
163099249|NCT01318135|589071737|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
163099250|NCT01318135|589071738|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
163099251|NCT01318135|589071739|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
163099252|NCT01318135|589071740|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
163099253|NCT01318135|589071741|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
163099254|NCT01318135|589071742|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
163099255|NCT01318135|589071743|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
163099256|NCT03465722|589071748|FG000|Overall Study|Withdrawal by Subject|21|||
163099257|NCT03465722|589071749|FG001|Overall Study|Withdrawal by Subject|14|||
163099258|NCT03465722|589071748|FG000|Overall Study|Death|89|||
163099259|NCT03465722|589071749|FG001|Overall Study|Death|87|||
163099260|NCT03465722|589071748|FG000|Overall Study|Lost to Follow-up|5|||
163099261|NCT03465722|589071749|FG001|Overall Study|Lost to Follow-up|3|||
163099262|NCT03465722|589071748|FG000|Overall Study|Administrative/Other|33|||
163099263|NCT03465722|589071749|FG001|Overall Study|Administrative/Other|32|||
163099264|NCT03465722|589071748|FG000|Overall Study|Not treated|1|||
163099265|NCT03465722|589071749|FG001|Overall Study|Not treated|2|||
163099266|NCT03465722|589071748|FG000|Overall Study|Sponsor decision|91|||
163099267|NCT03465722|589071749|FG001|Overall Study|Sponsor decision|98|||
163099268|NCT01541865|589071750|FG000|Overall Study|Lost to Follow-up|11|||
163099269|NCT01541865|589071750|FG000|Overall Study|Withdrawal by Subject|9|||
163099270|NCT01541865|589071750|FG000|Overall Study|Adverse Event|1|||
163099271|NCT01541865|589071750|FG000|Overall Study|Protocol Violation|1|||
163099272|NCT01140867|589071753|FG000|Overall Study|Adverse Event|22|||
163099273|NCT01140867|589071753|FG000|Overall Study|Lack of Efficacy|3|||
163099274|NCT01140867|589071753|FG000|Overall Study|Lost to Follow-up|2|||
163099275|NCT01140867|589071753|FG000|Overall Study|Withdrawal by Subject|1|||
163099276|NCT01140867|589071753|FG000|Overall Study|Protocol Violation|1|||
163099277|NCT01140867|589071753|FG000|Overall Study|Uncooperative patient|2|||
163099278|NCT01140867|589071753|FG000|Overall Study|Medication Noncompliance|2|||
163099279|NCT00503425|589071764|FG000|Overall Study|Participant files lost|6|||
163099280|NCT00503425|589071764|FG000|Overall Study|Adverse Event|5|||
163099281|NCT00503425|589071764|FG000|Overall Study|Lack of Efficacy|25|||
163099282|NCT00503425|589071764|FG000|Overall Study|Withdrawal by Subject|8|||
163099283|NCT00503425|589071764|FG000|Overall Study|Lost to Follow-up|3|||
163099284|NCT00503425|589071764|FG000|Overall Study|Death|3|||
163099285|NCT00503425|589071764|FG000|Overall Study|Missing Data/Unknown|4|||
163099286|NCT00881530|589071765|FG000|Overall Study|Adverse Event|5|||
163099287|NCT00881530|589071766|FG001|Overall Study|Adverse Event|1|||
163099288|NCT00881530|589071767|FG002|Overall Study|Adverse Event|1|||
163099289|NCT00881530|589071768|FG003|Overall Study|Adverse Event|4|||
163099290|NCT00881530|589071769|FG004|Overall Study|Adverse Event|10|||
163099291|NCT00881530|589071770|FG005|Overall Study|Adverse Event|2|||
163099292|NCT00881530|589071765|FG000|Overall Study|Lack of Efficacy|1|||
163099293|NCT00881530|589071766|FG001|Overall Study|Lack of Efficacy|0|||
163099294|NCT00881530|589071767|FG002|Overall Study|Lack of Efficacy|0|||
163099295|NCT00881530|589071768|FG003|Overall Study|Lack of Efficacy|0|||
163339353|NCT02203513|589951145|FG003|Overall Study|Did not receive investigational product (IP)|0|||
163339354|NCT02203513|589951146|FG004|Overall Study|Did not receive investigational product (IP)|0|||
163099296|NCT00881530|589071769|FG004|Overall Study|Lack of Efficacy|1|||
163099297|NCT00881530|589071770|FG005|Overall Study|Lack of Efficacy|1|||
163099298|NCT00881530|589071765|FG000|Overall Study|Not compliant with the protocol|0|||
163099299|NCT00881530|589071766|FG001|Overall Study|Not compliant with the protocol|0|||
163099300|NCT00881530|589071767|FG002|Overall Study|Not compliant with the protocol|0|||
163099301|NCT00881530|589071768|FG003|Overall Study|Not compliant with the protocol|0|||
163099302|NCT00881530|589071769|FG004|Overall Study|Not compliant with the protocol|2|||
163099303|NCT00881530|589071770|FG005|Overall Study|Not compliant with the protocol|0|||
163099304|NCT00881530|589071765|FG000|Overall Study|Lost to Follow-up|0|||
163099305|NCT00881530|589071766|FG001|Overall Study|Lost to Follow-up|1|||
163099306|NCT00881530|589071767|FG002|Overall Study|Lost to Follow-up|1|||
163099307|NCT00881530|589071768|FG003|Overall Study|Lost to Follow-up|3|||
163099308|NCT00881530|589071769|FG004|Overall Study|Lost to Follow-up|1|||
163099309|NCT00881530|589071770|FG005|Overall Study|Lost to Follow-up|0|||
163099310|NCT00881530|589071765|FG000|Overall Study|Refused to continue medication|7|||
163099311|NCT00881530|589071766|FG001|Overall Study|Refused to continue medication|2|||
163099312|NCT00881530|589071767|FG002|Overall Study|Refused to continue medication|1|||
163099313|NCT00881530|589071768|FG003|Overall Study|Refused to continue medication|2|||
163099314|NCT00881530|589071769|FG004|Overall Study|Refused to continue medication|0|||
163099315|NCT00881530|589071770|FG005|Overall Study|Refused to continue medication|0|||
163099316|NCT00881530|589071765|FG000|Overall Study|Other reason not defined above|1|||
163099317|NCT00881530|589071766|FG001|Overall Study|Other reason not defined above|1|||
163099318|NCT00881530|589071767|FG002|Overall Study|Other reason not defined above|2|||
163099319|NCT00881530|589071768|FG003|Overall Study|Other reason not defined above|0|||
163099320|NCT00881530|589071769|FG004|Overall Study|Other reason not defined above|0|||
163099321|NCT00881530|589071770|FG005|Overall Study|Other reason not defined above|2|||
163099322|NCT00003869|589071772|FG000|Overall Study|Adverse Event|14|||
163099323|NCT00003869|589071773|FG001|Overall Study|Adverse Event|3|||
163099324|NCT00003869|589071772|FG000|Overall Study|Withdrawal by Subject|21|||
163099325|NCT00003869|589071773|FG001|Overall Study|Withdrawal by Subject|3|||
163099326|NCT00003869|589071772|FG000|Overall Study|Death|1|||
163099327|NCT00003869|589071773|FG001|Overall Study|Death|2|||
163099328|NCT00003869|589071772|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
163099329|NCT00003869|589071773|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
163099330|NCT00763256|589071774|FG000|Overall Study|Didn't return for appointments|7|||
163099331|NCT00763256|589071775|FG001|Overall Study|Didn't return for appointments|10|||
163099332|NCT03364231|589071776|FG000|Overall Study|Adverse Event|1|||
163099333|NCT03364231|589071777|FG001|Overall Study|Adverse Event|4|||
163099334|NCT03364231|589071776|FG000|Overall Study|Death|1|||
163099335|NCT03364231|589071777|FG001|Overall Study|Death|0|||
163099336|NCT03364231|589071776|FG000|Overall Study|Investigator Decision|2|||
163099337|NCT03364231|589071777|FG001|Overall Study|Investigator Decision|2|||
163099338|NCT03364231|589071776|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
163099339|NCT03364231|589071777|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
163099340|NCT03364231|589071776|FG000|Overall Study|Withdrawal of Subject Consent|1|||
163099341|NCT03364231|589071777|FG001|Overall Study|Withdrawal of Subject Consent|0|||
163099342|NCT03364231|589071776|FG000|Overall Study|Reason Not Specified|1|||
163099343|NCT03364231|589071777|FG001|Overall Study|Reason Not Specified|0|||
163099344|NCT03364231|589071776|FG000|Overall Study|Disease Progression|0|||
163099345|NCT03364231|589071777|FG001|Overall Study|Disease Progression|6|||
163099346|NCT00124072|589071780|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
163099347|NCT00124072|589071781|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
163099348|NCT00124072|589071782|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
163099349|NCT00124072|589071783|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
163099350|NCT00124072|589071780|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
163099351|NCT00124072|589071781|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
163099352|NCT00124072|589071782|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
163099353|NCT00124072|589071783|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
163099354|NCT00124072|589071780|FG000|Overall Study|Death|499|||
163099355|NCT00124072|589071781|FG001|Overall Study|Death|484|||
163099356|NCT00124072|589071782|FG002|Overall Study|Death|471|||
163099357|NCT00124072|589071783|FG003|Overall Study|Death|480|||
163099358|NCT00414076|589071784|FG000|Overall Study|Progression|1|||
163099359|NCT00414076|589071785|FG001|Overall Study|Progression|2|||
163099360|NCT00414076|589071784|FG000|Overall Study|Withdrawal by Subject|1|||
163099361|NCT00414076|589071785|FG001|Overall Study|Withdrawal by Subject|3|||
163099362|NCT00414076|589071784|FG000|Overall Study|Adverse Event|1|||
163099363|NCT00414076|589071785|FG001|Overall Study|Adverse Event|0|||
163099364|NCT02720523|589071789|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
163099365|NCT02720523|589071790|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
163099366|NCT02720523|589071791|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
163099367|NCT02720523|589071792|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
163099368|NCT02720523|589071793|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
163099369|NCT02720523|589071794|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
163099370|NCT02720523|589071795|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
163099371|NCT02720523|589071789|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
163099372|NCT02720523|589071790|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
163099373|NCT02720523|589071791|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
163099374|NCT02720523|589071792|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
163099375|NCT02720523|589071793|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
163099376|NCT02720523|589071794|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
163099377|NCT02720523|589071795|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
163099378|NCT02720523|589071789|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
163099379|NCT02720523|589071790|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
163099380|NCT02720523|589071791|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
163407648|NCT02706873|590200871|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
163099381|NCT02720523|589071792|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
163099382|NCT02720523|589071793|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
163099383|NCT02720523|589071794|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
163099384|NCT02720523|589071795|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
163099385|NCT02720523|589071789|FG000|Period 1: Placebo-controlled Period|Other|0|||
163099386|NCT02720523|589071790|FG001|Period 1: Placebo-controlled Period|Other|0|||
163099387|NCT02720523|589071791|FG002|Period 1: Placebo-controlled Period|Other|1|||
163099388|NCT02720523|589071792|FG003|Period 1: Placebo-controlled Period|Other|1|||
163099389|NCT02720523|589071793|FG004|Period 1: Placebo-controlled Period|Other|0|||
163339355|NCT02203513|589951142|FG000|Overall Study|Death (unrelated to study therapy)|1|||
163339356|NCT02203513|589951143|FG001|Overall Study|Death (unrelated to study therapy)|3|||
163339357|NCT02203513|589951144|FG002|Overall Study|Death (unrelated to study therapy)|1|||
163339358|NCT02203513|589951145|FG003|Overall Study|Death (unrelated to study therapy)|0|||
163099390|NCT02720523|589071794|FG005|Period 1: Placebo-controlled Period|Other|0|||
163099391|NCT02720523|589071795|FG006|Period 1: Placebo-controlled Period|Other|0|||
163099392|NCT02720523|589071789|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
163099393|NCT02720523|589071790|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
163099394|NCT02720523|589071791|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
163099395|NCT02720523|589071792|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
163099396|NCT02720523|589071793|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
163099397|NCT02720523|589071794|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
163099398|NCT02720523|589071795|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
163099399|NCT02720523|589071789|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
163099400|NCT02720523|589071790|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
163099401|NCT02720523|589071791|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
163099402|NCT02720523|589071792|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
163099403|NCT02720523|589071793|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
163099404|NCT02720523|589071794|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
163099405|NCT02720523|589071795|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
163099406|NCT02720523|589071789|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
163099407|NCT02720523|589071790|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
163099408|NCT02720523|589071791|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
163099409|NCT02720523|589071792|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
163099410|NCT02720523|589071793|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
163099411|NCT02720523|589071794|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
163099412|NCT02720523|589071795|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
163099413|NCT02720523|589071789|FG000|Period 2: Long-term Extension Period|Other|0|||
163099414|NCT02720523|589071790|FG001|Period 2: Long-term Extension Period|Other|0|||
163099415|NCT02720523|589071791|FG002|Period 2: Long-term Extension Period|Other|0|||
163099416|NCT02720523|589071792|FG003|Period 2: Long-term Extension Period|Other|0|||
163099417|NCT02720523|589071793|FG004|Period 2: Long-term Extension Period|Other|2|||
163099418|NCT02720523|589071794|FG005|Period 2: Long-term Extension Period|Other|0|||
163099419|NCT02720523|589071795|FG006|Period 2: Long-term Extension Period|Other|3|||
163099420|NCT03146663|589071796|FG000|Overall Study|Did not receive study treatment|1|||
163099421|NCT03146663|589071797|FG001|Overall Study|Did not receive study treatment|1|||
163099422|NCT05526521|589071798|FG000|Overall Study|Withdrawal by Subject|0|||
163099423|NCT05526521|589071799|FG001|Overall Study|Withdrawal by Subject|1|||
163339359|NCT02203513|589951146|FG004|Overall Study|Death (unrelated to study therapy)|2|||
163339360|NCT02203513|589951142|FG000|Overall Study|Lost to Follow-up|0|||
163339361|NCT02203513|589951143|FG001|Overall Study|Lost to Follow-up|0|||
163339362|NCT02203513|589951144|FG002|Overall Study|Lost to Follow-up|1|||
163339363|NCT02203513|589951145|FG003|Overall Study|Lost to Follow-up|1|||
163339364|NCT02203513|589951146|FG004|Overall Study|Lost to Follow-up|0|||
163339365|NCT01441596|589951147|FG000|Overall Study|Other reason not defined below|0|||
163339366|NCT01441596|589951148|FG001|Overall Study|Other reason not defined below|2|||
163339367|NCT01441596|589951149|FG002|Overall Study|Other reason not defined below|1|||
163339368|NCT01441596|589951147|FG000|Overall Study|Withdrawal by Subject|4|||
163339369|NCT01441596|589951148|FG001|Overall Study|Withdrawal by Subject|0|||
163339370|NCT01441596|589951149|FG002|Overall Study|Withdrawal by Subject|2|||
163407649|NCT02706873|590200872|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
163099424|NCT05526521|589071800|FG002|Overall Study|Withdrawal by Subject|0|||
163099425|NCT05526521|589071801|FG003|Overall Study|Withdrawal by Subject|0|||
163099426|NCT03929913|589071802|FG000|Overall Study|Death|4|||
163099427|NCT03929913|589071802|FG000|Overall Study|Lost to Follow-up|1|||
163099428|NCT03929913|589071802|FG000|Overall Study|Failed Procedure|2|||
163099429|NCT03919929|589071805|FG000|Overall Study|Withdrawal by Subject|0|||
163099430|NCT03919929|589071806|FG001|Overall Study|Withdrawal by Subject|4|||
163099431|NCT03919929|589071805|FG000|Overall Study|Screen Failure|0|||
163099432|NCT03919929|589071806|FG001|Overall Study|Screen Failure|5|||
163339371|NCT01441596|589951147|FG000|Overall Study|Not treated|0|||
163339372|NCT01441596|589951148|FG001|Overall Study|Not treated|1|||
163339373|NCT01441596|589951149|FG002|Overall Study|Not treated|1|||
163339374|NCT03015220|589951152|FG000|Overall Study|Withdrawal by Subject|3|||
163339375|NCT03015220|589951153|FG001|Overall Study|Withdrawal by Subject|2|||
163339376|NCT03015220|589951154|FG002|Overall Study|Withdrawal by Subject|2|||
163099433|NCT01544348|589071807|FG000|Overall Study|Lost to Follow-up|1|||
163099434|NCT01544348|589071808|FG001|Overall Study|Lost to Follow-up|0|||
163099435|NCT01544348|589071809|FG002|Overall Study|Lost to Follow-up|0|||
163099436|NCT01544348|589071810|FG003|Overall Study|Lost to Follow-up|0|||
163099437|NCT01544348|589071811|FG004|Overall Study|Lost to Follow-up|0|||
163099438|NCT01544348|589071812|FG005|Overall Study|Lost to Follow-up|0|||
163099439|NCT01544348|589071813|FG006|Overall Study|Lost to Follow-up|1|||
163099440|NCT01544348|589071814|FG007|Overall Study|Lost to Follow-up|0|||
163099441|NCT01544348|589071807|FG000|Overall Study|Withdrawal by Subject|1|||
163099442|NCT01544348|589071808|FG001|Overall Study|Withdrawal by Subject|0|||
163099443|NCT01544348|589071809|FG002|Overall Study|Withdrawal by Subject|0|||
163099444|NCT01544348|589071810|FG003|Overall Study|Withdrawal by Subject|0|||
163099445|NCT01544348|589071811|FG004|Overall Study|Withdrawal by Subject|1|||
163099446|NCT01544348|589071812|FG005|Overall Study|Withdrawal by Subject|2|||
163099447|NCT01544348|589071813|FG006|Overall Study|Withdrawal by Subject|1|||
163099448|NCT01544348|589071814|FG007|Overall Study|Withdrawal by Subject|0|||
163099449|NCT01544348|589071807|FG000|Overall Study|Physician Decision|0|||
163099450|NCT01544348|589071808|FG001|Overall Study|Physician Decision|0|||
163099451|NCT01544348|589071809|FG002|Overall Study|Physician Decision|0|||
163099452|NCT01544348|589071810|FG003|Overall Study|Physician Decision|0|||
163099453|NCT01544348|589071811|FG004|Overall Study|Physician Decision|0|||
163099454|NCT01544348|589071812|FG005|Overall Study|Physician Decision|1|||
163099455|NCT01544348|589071813|FG006|Overall Study|Physician Decision|0|||
163099456|NCT01544348|589071814|FG007|Overall Study|Physician Decision|0|||
163099457|NCT03008070|589071823|FG000|Overall Study|Adverse Event|3|||
163099458|NCT03008070|589071824|FG001|Overall Study|Adverse Event|3|||
163099459|NCT03008070|589071825|FG002|Overall Study|Adverse Event|3|||
163099460|NCT03008070|589071823|FG000|Overall Study|Lost to Follow-up|1|||
163099461|NCT03008070|589071824|FG001|Overall Study|Lost to Follow-up|1|||
163099462|NCT03008070|589071825|FG002|Overall Study|Lost to Follow-up|0|||
163099463|NCT03008070|589071823|FG000|Overall Study|Non compliance|0|||
163099464|NCT03008070|589071824|FG001|Overall Study|Non compliance|1|||
163099465|NCT03008070|589071825|FG002|Overall Study|Non compliance|1|||
163099466|NCT03008070|589071823|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
163099467|NCT03008070|589071824|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
163099468|NCT03008070|589071825|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
163099469|NCT03008070|589071823|FG000|Overall Study|Withdrawal by Subject|2|||
163099470|NCT03008070|589071824|FG001|Overall Study|Withdrawal by Subject|0|||
163099471|NCT03008070|589071825|FG002|Overall Study|Withdrawal by Subject|1|||
163099472|NCT03008070|589071823|FG000|Overall Study|Use of prohibited drug|0|||
163099473|NCT03008070|589071824|FG001|Overall Study|Use of prohibited drug|0|||
163099474|NCT03008070|589071825|FG002|Overall Study|Use of prohibited drug|2|||
163099475|NCT05005273|589071826|FG000|Overall Study|Study Terminated|1|||
163099476|NCT05005273|589071827|FG001|Overall Study|Study Terminated|0|||
163099477|NCT04409834|589071828|FG000|Overall Study|Death|55|||
163099478|NCT04409834|589071829|FG001|Overall Study|Death|62|||
163099479|NCT03960684|589071831|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
163099480|NCT04266912|589071832|FG000|Overall Study|Withdrawal by Subject|1|||
163099481|NCT04266912|589071833|FG001|Overall Study|Withdrawal by Subject|0|||
163099482|NCT04266912|589071834|FG002|Overall Study|Withdrawal by Subject|0|||
163099483|NCT04266912|589071835|FG003|Overall Study|Withdrawal by Subject|0|||
163099484|NCT04266912|589071832|FG000|Overall Study|Progression|6|||
163099485|NCT04266912|589071833|FG001|Overall Study|Progression|6|||
163099486|NCT04266912|589071834|FG002|Overall Study|Progression|0|||
163099487|NCT04266912|589071835|FG003|Overall Study|Progression|10|||
163099488|NCT02574078|589073568|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099489|NCT02574078|589073569|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099490|NCT02574078|589073570|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099491|NCT02574078|589073571|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099492|NCT02574078|589073572|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099493|NCT02574078|589073573|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
163099494|NCT02574078|589073574|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
163099495|NCT02574078|589073575|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099496|NCT02574078|589073576|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
163099497|NCT02574078|589073577|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099498|NCT02574078|589073578|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099499|NCT02574078|589073579|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099500|NCT02574078|589073580|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099501|NCT02574078|589073568|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
163099502|NCT02574078|589073569|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
163099503|NCT02574078|589073570|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
163099504|NCT02574078|589073571|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
163099505|NCT02574078|589073572|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
163099506|NCT02574078|589073573|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
163099507|NCT02574078|589073574|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
163099508|NCT02574078|589073575|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
163099509|NCT02574078|589073576|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
163099510|NCT02574078|589073577|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
163099511|NCT02574078|589073578|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
163099512|NCT02574078|589073579|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
163099513|NCT02574078|589073580|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
163099514|NCT02574078|589073568|FG000|Pre-Treatment Period|Other reasons|0|||
163099515|NCT02574078|589073569|FG001|Pre-Treatment Period|Other reasons|0|||
163099516|NCT02574078|589073570|FG002|Pre-Treatment Period|Other reasons|0|||
163099517|NCT02574078|589073571|FG003|Pre-Treatment Period|Other reasons|0|||
163099518|NCT02574078|589073572|FG004|Pre-Treatment Period|Other reasons|0|||
163099519|NCT02574078|589073573|FG005|Pre-Treatment Period|Other reasons|0|||
163099520|NCT02574078|589073574|FG006|Pre-Treatment Period|Other reasons|2|||
163099521|NCT02574078|589073575|FG007|Pre-Treatment Period|Other reasons|0|||
163099522|NCT02574078|589073576|FG008|Pre-Treatment Period|Other reasons|0|||
163099523|NCT02574078|589073577|FG009|Pre-Treatment Period|Other reasons|0|||
163099524|NCT02574078|589073578|FG010|Pre-Treatment Period|Other reasons|2|||
163099525|NCT02574078|589073579|FG011|Pre-Treatment Period|Other reasons|0|||
163099526|NCT02574078|589073580|FG012|Pre-Treatment Period|Other reasons|0|||
163099527|NCT02574078|589073568|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
163099528|NCT02574078|589073569|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
163099529|NCT02574078|589073570|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
163099530|NCT02574078|589073571|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
163099531|NCT02574078|589073572|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
163099532|NCT02574078|589073573|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
163099533|NCT02574078|589073574|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
163099534|NCT02574078|589073575|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
163099535|NCT02574078|589073576|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
163099536|NCT02574078|589073577|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
163099537|NCT02574078|589073578|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
163099538|NCT02574078|589073579|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
163099539|NCT02574078|589073580|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
163099540|NCT02574078|589073568|FG000|Treatment Period|Disease progression|6|||
163099541|NCT02574078|589073569|FG001|Treatment Period|Disease progression|4|||
163099542|NCT02574078|589073570|FG002|Treatment Period|Disease progression|7|||
163099543|NCT02574078|589073571|FG003|Treatment Period|Disease progression|18|||
163099544|NCT02574078|589073572|FG004|Treatment Period|Disease progression|16|||
163099545|NCT02574078|589073573|FG005|Treatment Period|Disease progression|26|||
163099546|NCT02574078|589073574|FG006|Treatment Period|Disease progression|5|||
163099547|NCT02574078|589073575|FG007|Treatment Period|Disease progression|9|||
163099548|NCT02574078|589073576|FG008|Treatment Period|Disease progression|8|||
163099549|NCT02574078|589073577|FG009|Treatment Period|Disease progression|5|||
163099550|NCT02574078|589073578|FG010|Treatment Period|Disease progression|20|||
163099551|NCT02574078|589073579|FG011|Treatment Period|Disease progression|29|||
163099552|NCT02574078|589073580|FG012|Treatment Period|Disease progression|2|||
163099553|NCT02574078|589073568|FG000|Treatment Period|Study drug toxicity|1|||
163099554|NCT02574078|589073569|FG001|Treatment Period|Study drug toxicity|1|||
163099555|NCT02574078|589073570|FG002|Treatment Period|Study drug toxicity|0|||
163099556|NCT02574078|589073571|FG003|Treatment Period|Study drug toxicity|5|||
163099557|NCT02574078|589073572|FG004|Treatment Period|Study drug toxicity|3|||
163099558|NCT02574078|589073573|FG005|Treatment Period|Study drug toxicity|1|||
163099559|NCT02574078|589073574|FG006|Treatment Period|Study drug toxicity|2|||
163099560|NCT02574078|589073575|FG007|Treatment Period|Study drug toxicity|0|||
163099561|NCT02574078|589073576|FG008|Treatment Period|Study drug toxicity|2|||
163099562|NCT02574078|589073577|FG009|Treatment Period|Study drug toxicity|1|||
163099563|NCT02574078|589073578|FG010|Treatment Period|Study drug toxicity|16|||
163099564|NCT02574078|589073579|FG011|Treatment Period|Study drug toxicity|2|||
163099565|NCT02574078|589073580|FG012|Treatment Period|Study drug toxicity|4|||
163099566|NCT02574078|589073568|FG000|Treatment Period|Death|2|||
163099567|NCT02574078|589073569|FG001|Treatment Period|Death|0|||
163099568|NCT02574078|589073570|FG002|Treatment Period|Death|0|||
163099569|NCT02574078|589073571|FG003|Treatment Period|Death|0|||
163099570|NCT02574078|589073572|FG004|Treatment Period|Death|1|||
163099571|NCT02574078|589073573|FG005|Treatment Period|Death|1|||
163099572|NCT02574078|589073574|FG006|Treatment Period|Death|1|||
163099573|NCT02574078|589073575|FG007|Treatment Period|Death|1|||
163099574|NCT02574078|589073576|FG008|Treatment Period|Death|7|||
163099575|NCT02574078|589073577|FG009|Treatment Period|Death|1|||
163099576|NCT02574078|589073578|FG010|Treatment Period|Death|0|||
163099577|NCT02574078|589073579|FG011|Treatment Period|Death|2|||
163099578|NCT02574078|589073580|FG012|Treatment Period|Death|1|||
163339377|NCT03015220|589951155|FG003|Overall Study|Withdrawal by Subject|2|||
163339378|NCT03015220|589951152|FG000|Overall Study|Lost to Follow-up|0|||
163099579|NCT02574078|589073568|FG000|Treatment Period|Adverse event unrelated to drug|0|||
163099580|NCT02574078|589073569|FG001|Treatment Period|Adverse event unrelated to drug|0|||
163099581|NCT02574078|589073570|FG002|Treatment Period|Adverse event unrelated to drug|1|||
163099582|NCT02574078|589073571|FG003|Treatment Period|Adverse event unrelated to drug|0|||
163099583|NCT02574078|589073572|FG004|Treatment Period|Adverse event unrelated to drug|2|||
163339379|NCT03015220|589951153|FG001|Overall Study|Lost to Follow-up|0|||
163339380|NCT03015220|589951154|FG002|Overall Study|Lost to Follow-up|1|||
163339381|NCT03015220|589951155|FG003|Overall Study|Lost to Follow-up|0|||
163099584|NCT02574078|589073573|FG005|Treatment Period|Adverse event unrelated to drug|3|||
163099585|NCT02574078|589073574|FG006|Treatment Period|Adverse event unrelated to drug|0|||
163099586|NCT02574078|589073575|FG007|Treatment Period|Adverse event unrelated to drug|0|||
163099587|NCT02574078|589073576|FG008|Treatment Period|Adverse event unrelated to drug|1|||
163099588|NCT02574078|589073577|FG009|Treatment Period|Adverse event unrelated to drug|2|||
163099589|NCT02574078|589073578|FG010|Treatment Period|Adverse event unrelated to drug|4|||
163099590|NCT02574078|589073579|FG011|Treatment Period|Adverse event unrelated to drug|1|||
163099591|NCT02574078|589073580|FG012|Treatment Period|Adverse event unrelated to drug|0|||
163099592|NCT02574078|589073568|FG000|Treatment Period|Administrative reason by Sponsor|0|||
163099593|NCT02574078|589073569|FG001|Treatment Period|Administrative reason by Sponsor|1|||
163099594|NCT02574078|589073570|FG002|Treatment Period|Administrative reason by Sponsor|0|||
163099595|NCT02574078|589073571|FG003|Treatment Period|Administrative reason by Sponsor|0|||
163099596|NCT02574078|589073572|FG004|Treatment Period|Administrative reason by Sponsor|0|||
163099597|NCT02574078|589073573|FG005|Treatment Period|Administrative reason by Sponsor|0|||
163099598|NCT02574078|589073574|FG006|Treatment Period|Administrative reason by Sponsor|1|||
163099599|NCT02574078|589073575|FG007|Treatment Period|Administrative reason by Sponsor|0|||
163099600|NCT02574078|589073576|FG008|Treatment Period|Administrative reason by Sponsor|0|||
163099601|NCT02574078|589073577|FG009|Treatment Period|Administrative reason by Sponsor|0|||
163099602|NCT02574078|589073578|FG010|Treatment Period|Administrative reason by Sponsor|0|||
163099603|NCT02574078|589073579|FG011|Treatment Period|Administrative reason by Sponsor|0|||
163099604|NCT02574078|589073580|FG012|Treatment Period|Administrative reason by Sponsor|3|||
163099605|NCT02574078|589073568|FG000|Treatment Period|Other reasons|1|||
163099606|NCT02574078|589073569|FG001|Treatment Period|Other reasons|0|||
163099607|NCT02574078|589073570|FG002|Treatment Period|Other reasons|1|||
163099608|NCT02574078|589073571|FG003|Treatment Period|Other reasons|3|||
163099609|NCT02574078|589073572|FG004|Treatment Period|Other reasons|3|||
163099610|NCT02574078|589073573|FG005|Treatment Period|Other reasons|1|||
163099611|NCT02574078|589073574|FG006|Treatment Period|Other reasons|2|||
163099612|NCT02574078|589073575|FG007|Treatment Period|Other reasons|1|||
163099613|NCT02574078|589073576|FG008|Treatment Period|Other reasons|3|||
163099614|NCT02574078|589073577|FG009|Treatment Period|Other reasons|1|||
163099615|NCT02574078|589073578|FG010|Treatment Period|Other reasons|1|||
163099616|NCT02574078|589073579|FG011|Treatment Period|Other reasons|3|||
163099617|NCT02574078|589073580|FG012|Treatment Period|Other reasons|1|||
163099618|NCT02574078|589073568|FG000|Treatment Period|Participant request to stop drug|0|||
163099619|NCT02574078|589073569|FG001|Treatment Period|Participant request to stop drug|0|||
163099620|NCT02574078|589073570|FG002|Treatment Period|Participant request to stop drug|0|||
163099621|NCT02574078|589073571|FG003|Treatment Period|Participant request to stop drug|2|||
163099622|NCT02574078|589073572|FG004|Treatment Period|Participant request to stop drug|4|||
163099623|NCT02574078|589073573|FG005|Treatment Period|Participant request to stop drug|0|||
163099624|NCT02574078|589073574|FG006|Treatment Period|Participant request to stop drug|1|||
163099625|NCT02574078|589073575|FG007|Treatment Period|Participant request to stop drug|0|||
163099626|NCT02574078|589073576|FG008|Treatment Period|Participant request to stop drug|3|||
163099627|NCT02574078|589073577|FG009|Treatment Period|Participant request to stop drug|2|||
163099628|NCT02574078|589073578|FG010|Treatment Period|Participant request to stop drug|2|||
163099629|NCT02574078|589073579|FG011|Treatment Period|Participant request to stop drug|4|||
163099630|NCT02574078|589073580|FG012|Treatment Period|Participant request to stop drug|1|||
163099631|NCT02574078|589073568|FG000|Treatment Period|Participant withdrew consent|0|||
163099632|NCT02574078|589073569|FG001|Treatment Period|Participant withdrew consent|0|||
163099633|NCT02574078|589073570|FG002|Treatment Period|Participant withdrew consent|0|||
163099634|NCT02574078|589073571|FG003|Treatment Period|Participant withdrew consent|0|||
163099635|NCT02574078|589073572|FG004|Treatment Period|Participant withdrew consent|1|||
163099636|NCT02574078|589073573|FG005|Treatment Period|Participant withdrew consent|1|||
163099637|NCT02574078|589073574|FG006|Treatment Period|Participant withdrew consent|0|||
163099638|NCT02574078|589073575|FG007|Treatment Period|Participant withdrew consent|1|||
163099639|NCT02574078|589073576|FG008|Treatment Period|Participant withdrew consent|0|||
163099640|NCT02574078|589073577|FG009|Treatment Period|Participant withdrew consent|2|||
163099641|NCT02574078|589073578|FG010|Treatment Period|Participant withdrew consent|1|||
163099642|NCT02574078|589073579|FG011|Treatment Period|Participant withdrew consent|4|||
163099643|NCT02574078|589073580|FG012|Treatment Period|Participant withdrew consent|1|||
163099644|NCT02574078|589073568|FG000|Treatment Period|Participant no longer meets criteria|0|||
163099645|NCT02574078|589073569|FG001|Treatment Period|Participant no longer meets criteria|0|||
163099646|NCT02574078|589073570|FG002|Treatment Period|Participant no longer meets criteria|0|||
163099647|NCT02574078|589073571|FG003|Treatment Period|Participant no longer meets criteria|0|||
163099648|NCT02574078|589073572|FG004|Treatment Period|Participant no longer meets criteria|1|||
163099649|NCT02574078|589073573|FG005|Treatment Period|Participant no longer meets criteria|0|||
163099650|NCT02574078|589073574|FG006|Treatment Period|Participant no longer meets criteria|0|||
163099651|NCT02574078|589073575|FG007|Treatment Period|Participant no longer meets criteria|0|||
163099652|NCT02574078|589073576|FG008|Treatment Period|Participant no longer meets criteria|0|||
163099653|NCT02574078|589073577|FG009|Treatment Period|Participant no longer meets criteria|1|||
163099654|NCT02574078|589073578|FG010|Treatment Period|Participant no longer meets criteria|1|||
163099655|NCT02574078|589073579|FG011|Treatment Period|Participant no longer meets criteria|1|||
163099656|NCT02574078|589073580|FG012|Treatment Period|Participant no longer meets criteria|0|||
163099657|NCT02574078|589073568|FG000|Treatment Period|Lost to Follow-up|0|||
163099658|NCT02574078|589073569|FG001|Treatment Period|Lost to Follow-up|0|||
163099659|NCT02574078|589073570|FG002|Treatment Period|Lost to Follow-up|0|||
163099660|NCT02574078|589073571|FG003|Treatment Period|Lost to Follow-up|0|||
163099661|NCT02574078|589073572|FG004|Treatment Period|Lost to Follow-up|0|||
163099662|NCT02574078|589073573|FG005|Treatment Period|Lost to Follow-up|0|||
163099663|NCT02574078|589073574|FG006|Treatment Period|Lost to Follow-up|0|||
163099664|NCT02574078|589073575|FG007|Treatment Period|Lost to Follow-up|0|||
163099665|NCT02574078|589073576|FG008|Treatment Period|Lost to Follow-up|0|||
163099666|NCT02574078|589073577|FG009|Treatment Period|Lost to Follow-up|1|||
163099667|NCT02574078|589073578|FG010|Treatment Period|Lost to Follow-up|0|||
163099668|NCT02574078|589073579|FG011|Treatment Period|Lost to Follow-up|1|||
163099669|NCT02574078|589073580|FG012|Treatment Period|Lost to Follow-up|0|||
163099670|NCT02574078|589073568|FG000|Treatment Period|Maximum clinical benefit|0|||
163099671|NCT02574078|589073569|FG001|Treatment Period|Maximum clinical benefit|0|||
163099672|NCT02574078|589073570|FG002|Treatment Period|Maximum clinical benefit|0|||
163099673|NCT02574078|589073571|FG003|Treatment Period|Maximum clinical benefit|0|||
163099674|NCT02574078|589073572|FG004|Treatment Period|Maximum clinical benefit|0|||
163099675|NCT02574078|589073573|FG005|Treatment Period|Maximum clinical benefit|0|||
163099676|NCT02574078|589073574|FG006|Treatment Period|Maximum clinical benefit|0|||
163099677|NCT02574078|589073575|FG007|Treatment Period|Maximum clinical benefit|0|||
163099678|NCT02574078|589073576|FG008|Treatment Period|Maximum clinical benefit|0|||
163099679|NCT02574078|589073577|FG009|Treatment Period|Maximum clinical benefit|1|||
163099680|NCT02574078|589073578|FG010|Treatment Period|Maximum clinical benefit|0|||
163099681|NCT02574078|589073579|FG011|Treatment Period|Maximum clinical benefit|0|||
163099682|NCT02574078|589073580|FG012|Treatment Period|Maximum clinical benefit|0|||
163099683|NCT05935878|589073587|FG000|Overall Study|Death|1|||
163099684|NCT05935878|589073588|FG001|Overall Study|Death|2|||
163099685|NCT05935878|589073587|FG000|Overall Study|Withdrawal by Subject|5|||
163099686|NCT05935878|589073588|FG001|Overall Study|Withdrawal by Subject|5|||
163099687|NCT05935878|589073587|FG000|Overall Study|Revision of implant|1|||
163099688|NCT05935878|589073588|FG001|Overall Study|Revision of implant|1|||
163099689|NCT05935878|589073587|FG000|Overall Study|Mobile bearing dislocation|0|||
163099690|NCT05935878|589073588|FG001|Overall Study|Mobile bearing dislocation|1|||
163099691|NCT02297815|589073604|FG000|Overall Study|Lost to Follow-up|236|||
163099692|NCT02297815|589073605|FG001|Overall Study|Lost to Follow-up|140|||
163099693|NCT00662831|589073606|FG000|Overall Study|Death|4|||
163099694|NCT00662831|589073607|FG001|Overall Study|Death|1|||
163099695|NCT00662831|589073606|FG000|Overall Study|Lack of Efficacy|6|||
163099696|NCT00662831|589073607|FG001|Overall Study|Lack of Efficacy|6|||
163099697|NCT00662831|589073606|FG000|Overall Study|Lost to Follow-up|1|||
163099698|NCT00662831|589073607|FG001|Overall Study|Lost to Follow-up|0|||
163099699|NCT00662831|589073606|FG000|Overall Study|Withdrawal by Subject|2|||
163099700|NCT00662831|589073607|FG001|Overall Study|Withdrawal by Subject|1|||
163099701|NCT00662831|589073606|FG000|Overall Study|Other|62|||
163099702|NCT00662831|589073607|FG001|Overall Study|Other|31|||
163099703|NCT00662831|589073606|FG000|Overall Study|Protocol Violation|8|||
163099704|NCT00662831|589073607|FG001|Overall Study|Protocol Violation|4|||
163099705|NCT00662831|589073606|FG000|Overall Study|Adverse Event|23|||
163099706|NCT00662831|589073607|FG001|Overall Study|Adverse Event|16|||
163099707|NCT01734785|589073609|FG000|Open-Label Period|Adverse Event|0|||
163099708|NCT01734785|589073610|FG001|Open-Label Period|Adverse Event|0|||
163099709|NCT01734785|589073611|FG002|Open-Label Period|Adverse Event|0|||
163099710|NCT01734785|589073612|FG003|Open-Label Period|Adverse Event|9|||
163099711|NCT01734785|589073609|FG000|Open-Label Period|Lack of Efficacy|0|||
163099712|NCT01734785|589073610|FG001|Open-Label Period|Lack of Efficacy|0|||
163099713|NCT01734785|589073611|FG002|Open-Label Period|Lack of Efficacy|0|||
163099714|NCT01734785|589073612|FG003|Open-Label Period|Lack of Efficacy|1|||
163099715|NCT01734785|589073609|FG000|Open-Label Period|Protocol Violation|0|||
163099716|NCT01734785|589073610|FG001|Open-Label Period|Protocol Violation|0|||
163099717|NCT01734785|589073611|FG002|Open-Label Period|Protocol Violation|0|||
163099718|NCT01734785|589073612|FG003|Open-Label Period|Protocol Violation|13|||
163099719|NCT01734785|589073609|FG000|Open-Label Period|Lost to Follow-up|0|||
163099720|NCT01734785|589073610|FG001|Open-Label Period|Lost to Follow-up|0|||
163407650|NCT02706873|590200873|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
163099721|NCT01734785|589073611|FG002|Open-Label Period|Lost to Follow-up|0|||
163099722|NCT01734785|589073612|FG003|Open-Label Period|Lost to Follow-up|14|||
163099723|NCT01734785|589073609|FG000|Open-Label Period|Withdrawal by Subject|0|||
163099724|NCT01734785|589073610|FG001|Open-Label Period|Withdrawal by Subject|0|||
163099725|NCT01734785|589073611|FG002|Open-Label Period|Withdrawal by Subject|0|||
163099726|NCT01734785|589073612|FG003|Open-Label Period|Withdrawal by Subject|12|||
163099727|NCT01734785|589073609|FG000|Open-Label Period|Other Reasons|0|||
163099728|NCT01734785|589073610|FG001|Open-Label Period|Other Reasons|0|||
163407651|NCT02706873|590200874|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
163407652|NCT02706873|590200871|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
163099729|NCT01734785|589073611|FG002|Open-Label Period|Other Reasons|0|||
163099730|NCT01734785|589073612|FG003|Open-Label Period|Other Reasons|224|||
163099731|NCT01734785|589073609|FG000|Double-Blind Period|Adverse Event|0|||
163099732|NCT01734785|589073610|FG001|Double-Blind Period|Adverse Event|3|||
163099733|NCT01734785|589073611|FG002|Double-Blind Period|Adverse Event|2|||
163099734|NCT01734785|589073612|FG003|Double-Blind Period|Adverse Event|0|||
163099735|NCT01734785|589073609|FG000|Double-Blind Period|Lack of Efficacy|0|||
163099736|NCT01734785|589073610|FG001|Double-Blind Period|Lack of Efficacy|1|||
163099737|NCT01734785|589073611|FG002|Double-Blind Period|Lack of Efficacy|0|||
163099738|NCT01734785|589073612|FG003|Double-Blind Period|Lack of Efficacy|0|||
163099739|NCT01734785|589073609|FG000|Double-Blind Period|Protocol Violation|0|||
163099740|NCT01734785|589073610|FG001|Double-Blind Period|Protocol Violation|1|||
163099741|NCT01734785|589073611|FG002|Double-Blind Period|Protocol Violation|1|||
163099742|NCT01734785|589073612|FG003|Double-Blind Period|Protocol Violation|0|||
163099743|NCT01734785|589073609|FG000|Double-Blind Period|Lost to Follow-up|2|||
163099744|NCT01734785|589073610|FG001|Double-Blind Period|Lost to Follow-up|4|||
163099745|NCT01734785|589073611|FG002|Double-Blind Period|Lost to Follow-up|2|||
163099746|NCT01734785|589073612|FG003|Double-Blind Period|Lost to Follow-up|0|||
163099747|NCT01734785|589073609|FG000|Double-Blind Period|Withdrawal by Subject|2|||
163099748|NCT01734785|589073610|FG001|Double-Blind Period|Withdrawal by Subject|0|||
163099749|NCT01734785|589073611|FG002|Double-Blind Period|Withdrawal by Subject|0|||
163099750|NCT01734785|589073612|FG003|Double-Blind Period|Withdrawal by Subject|0|||
163099751|NCT01734785|589073609|FG000|Double-Blind Period|Not treated|1|||
163099752|NCT01734785|589073610|FG001|Double-Blind Period|Not treated|0|||
163099753|NCT01734785|589073611|FG002|Double-Blind Period|Not treated|0|||
163099754|NCT01734785|589073612|FG003|Double-Blind Period|Not treated|0|||
163099755|NCT02397915|589073613|FG000|Period 1|Protocol Violation|0|||
163099756|NCT02397915|589073614|FG001|Period 1|Protocol Violation|1|||
163099757|NCT02397915|589073615|FG002|Period 1|Protocol Violation|0|||
163099758|NCT02397915|589073616|FG003|Period 1|Protocol Violation|0|||
163099759|NCT02397915|589073613|FG000|Period 1|Physician Decision|1|||
163099760|NCT02397915|589073614|FG001|Period 1|Physician Decision|0|||
163099761|NCT02397915|589073615|FG002|Period 1|Physician Decision|0|||
163099762|NCT02397915|589073616|FG003|Period 1|Physician Decision|0|||
163099763|NCT00368745|589073617|FG000|Double-blind Treatment Period|Adverse Event|6|||
163099764|NCT00368745|589073618|FG001|Double-blind Treatment Period|Adverse Event|6|||
163099765|NCT00368745|589073617|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
163099766|NCT00368745|589073618|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
163099767|NCT00368745|589073617|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
163099768|NCT00368745|589073618|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
163099769|NCT00368745|589073617|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
163099770|NCT00368745|589073618|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
163099771|NCT00368745|589073617|FG000|Double-blind Treatment Period|Other|7|||
163099772|NCT00368745|589073618|FG001|Double-blind Treatment Period|Other|6|||
163099773|NCT00293813|589073622|FG000|Overall Study|Physician Decision|0|||
163099774|NCT00293813|589073623|FG001|Overall Study|Physician Decision|1|||
163099775|NCT00293813|589073624|FG002|Overall Study|Physician Decision|0|||
163099776|NCT00293813|589073622|FG000|Overall Study|Adverse Event|3|||
163099777|NCT00293813|589073623|FG001|Overall Study|Adverse Event|1|||
163099778|NCT00293813|589073624|FG002|Overall Study|Adverse Event|1|||
163099779|NCT00293813|589073622|FG000|Overall Study|Withdrawal by Subject|7|||
163099780|NCT00293813|589073623|FG001|Overall Study|Withdrawal by Subject|4|||
163099781|NCT00293813|589073624|FG002|Overall Study|Withdrawal by Subject|4|||
163099782|NCT00293813|589073622|FG000|Overall Study|Lost to Follow-up|3|||
163099783|NCT00293813|589073623|FG001|Overall Study|Lost to Follow-up|2|||
163099784|NCT00293813|589073624|FG002|Overall Study|Lost to Follow-up|3|||
163099785|NCT00293813|589073622|FG000|Overall Study|Noncompliance|0|||
163099786|NCT00293813|589073623|FG001|Overall Study|Noncompliance|1|||
163099787|NCT00293813|589073624|FG002|Overall Study|Noncompliance|0|||
163099788|NCT01188551|589073625|FG000|Overall Study|Pharmacy issues|1|||
163099789|NCT01188551|589073626|FG001|Overall Study|Pharmacy issues|0|||
163099790|NCT01188551|589073627|FG002|Overall Study|Pharmacy issues|0|||
163099791|NCT01188551|589073628|FG003|Overall Study|Pharmacy issues|0|||
163099792|NCT01306643|589073629|FG000|Overall Study|Adverse Event|5|||
163099793|NCT01306643|589073629|FG000|Overall Study|Disease Progression|7|||
163099794|NCT01306643|589073629|FG000|Overall Study|Other: Change in Eligibility Status|1|||
163099795|NCT01582009|589073631|FG000|Overall Study|Withdrawal by Subject|1|||
163099796|NCT01582009|589073631|FG000|Overall Study|Physician Decision|1|||
163099797|NCT00310375|589073632|FG000|Primary Reporting Phase|Adverse Event|28|||
163099798|NCT00310375|589073633|FG001|Primary Reporting Phase|Adverse Event|22|||
163099799|NCT00310375|589073634|FG002|Primary Reporting Phase|Adverse Event|0|||
163099800|NCT00310375|589073632|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
163099801|NCT00310375|589073633|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
163099802|NCT00310375|589073634|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
163099803|NCT00310375|589073632|FG000|Primary Reporting Phase|Pregnancy|2|||
163407653|NCT02706873|590200872|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
163099804|NCT00310375|589073633|FG001|Primary Reporting Phase|Pregnancy|2|||
163099805|NCT00310375|589073634|FG002|Primary Reporting Phase|Pregnancy|0|||
163099806|NCT00310375|589073632|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
163099807|NCT00310375|589073633|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
163099808|NCT00310375|589073634|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
163099809|NCT00310375|589073632|FG000|Primary Reporting Phase|Protocol Violation|8|||
163099810|NCT00310375|589073633|FG001|Primary Reporting Phase|Protocol Violation|5|||
163099811|NCT00310375|589073634|FG002|Primary Reporting Phase|Protocol Violation|0|||
163099812|NCT00310375|589073632|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
163099813|NCT00310375|589073633|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
163099814|NCT00310375|589073634|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
163099815|NCT00310375|589073632|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
163099816|NCT00310375|589073633|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
163099817|NCT00310375|589073634|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
163099818|NCT00310375|589073632|FG000|Primary Reporting Phase|Physician Decision|5|||
163099819|NCT00310375|589073633|FG001|Primary Reporting Phase|Physician Decision|3|||
163099820|NCT00310375|589073634|FG002|Primary Reporting Phase|Physician Decision|0|||
163099821|NCT00310375|589073632|FG000|Primary Reporting Phase|Request of the sponsor|2|||
163099822|NCT00310375|589073633|FG001|Primary Reporting Phase|Request of the sponsor|2|||
163099823|NCT00310375|589073634|FG002|Primary Reporting Phase|Request of the sponsor|0|||
163099824|NCT00310375|589073632|FG000|Primary Reporting Phase|Failed to return|1|||
163099825|NCT00310375|589073633|FG001|Primary Reporting Phase|Failed to return|3|||
163099826|NCT00310375|589073634|FG002|Primary Reporting Phase|Failed to return|0|||
163099827|NCT00310375|589073632|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
163099828|NCT00310375|589073633|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
163099829|NCT00310375|589073634|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
163099830|NCT00310375|589073632|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
163099831|NCT00310375|589073633|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
163099832|NCT00310375|589073634|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
163099833|NCT00310375|589073632|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
163099834|NCT00310375|589073633|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
163099835|NCT00310375|589073634|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
163099836|NCT00310375|589073632|FG000|Primary Reporting Phase|Site closure|3|||
163099837|NCT00310375|589073633|FG001|Primary Reporting Phase|Site closure|0|||
163099838|NCT00310375|589073634|FG002|Primary Reporting Phase|Site closure|0|||
163099839|NCT00310375|589073632|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
163099840|NCT00310375|589073633|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
163099841|NCT00310375|589073634|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
163099842|NCT00310375|589073632|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
163099843|NCT00310375|589073633|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
163099844|NCT00310375|589073634|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
163099845|NCT00310375|589073632|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
163099846|NCT00310375|589073633|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
163099847|NCT00310375|589073634|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
163099848|NCT00310375|589073632|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
163099849|NCT00310375|589073633|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
163099850|NCT00310375|589073634|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
163099851|NCT04024436|589073635|FG000|Overall Study|Death|10|||
163099852|NCT04024436|589073636|FG001|Overall Study|Death|14|||
163099853|NCT04024436|589073637|FG002|Overall Study|Death|2|||
163099854|NCT04024436|589073638|FG003|Overall Study|Death|7|||
163099855|NCT04024436|589073635|FG000|Overall Study|Loss to follow up|1|||
163099856|NCT04024436|589073636|FG001|Overall Study|Loss to follow up|0|||
163099857|NCT04024436|589073637|FG002|Overall Study|Loss to follow up|0|||
163099858|NCT04024436|589073638|FG003|Overall Study|Loss to follow up|1|||
163099859|NCT04024436|589073635|FG000|Overall Study|Withdrawal of consent|2|||
163099860|NCT04024436|589073636|FG001|Overall Study|Withdrawal of consent|0|||
163099861|NCT04024436|589073637|FG002|Overall Study|Withdrawal of consent|0|||
163099862|NCT04024436|589073638|FG003|Overall Study|Withdrawal of consent|1|||
163099863|NCT04024436|589073635|FG000|Overall Study|Study termination by sponsor|4|||
163099864|NCT04024436|589073636|FG001|Overall Study|Study termination by sponsor|6|||
163099865|NCT04024436|589073637|FG002|Overall Study|Study termination by sponsor|2|||
163099866|NCT04024436|589073638|FG003|Overall Study|Study termination by sponsor|11|||
163099867|NCT04024436|589073635|FG000|Overall Study|Reason Not Specified|0|||
163099868|NCT04024436|589073636|FG001|Overall Study|Reason Not Specified|1|||
163099869|NCT04024436|589073637|FG002|Overall Study|Reason Not Specified|0|||
163099870|NCT04024436|589073638|FG003|Overall Study|Reason Not Specified|2|||
163099871|NCT02553928|589073639|FG000|Overall Study|Adverse Event|2|||
163099872|NCT02553928|589073640|FG001|Overall Study|Adverse Event|1|||
163099873|NCT02553928|589073639|FG000|Overall Study|Lost to Follow-up|0|||
163099874|NCT02553928|589073640|FG001|Overall Study|Lost to Follow-up|1|||
163099875|NCT02553928|589073639|FG000|Overall Study|Administrative reason(s)|0|||
163099876|NCT02553928|589073640|FG001|Overall Study|Administrative reason(s)|1|||
163099877|NCT05507567|589073641|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
163099878|NCT05507567|589073642|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
163099879|NCT05507567|589073643|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
163099880|NCT05507567|589073641|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
163099881|NCT05507567|589073642|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
163099882|NCT05507567|589073643|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
163099883|NCT05507567|589073641|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
163099884|NCT05507567|589073642|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
163099885|NCT05507567|589073643|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
163099886|NCT05507567|589073641|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
163099887|NCT05507567|589073642|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
163099888|NCT05507567|589073643|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
163099889|NCT04830215|589073644|FG000|Overall Study|Adverse Event|6|||
163099890|NCT04830215|589073644|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
163099891|NCT04830215|589073644|FG000|Overall Study|Withdrawal by Subject|3|||
163099892|NCT04830215|589073644|FG000|Overall Study|Protocol Deviation|1|||
163099893|NCT00770562|589073647|FG000|Overall Study|Did not take treatment|1|||
163099894|NCT00770562|589073648|FG001|Overall Study|Did not take treatment|1|||
163099895|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
163099896|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
163099897|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099898|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099899|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099900|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099901|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099902|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099903|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099904|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099905|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
163099906|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
163099907|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099908|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099909|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099910|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099911|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099912|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099913|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099914|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099915|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
163099916|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099917|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099918|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099919|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099920|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099921|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099922|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099923|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099924|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099925|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
163099926|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
163099927|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099928|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099929|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099930|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099931|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099932|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099933|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099934|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099935|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099936|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
163099937|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099938|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099939|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099940|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099941|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099942|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099943|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099944|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099945|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
163099946|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
163099947|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099948|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099949|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099950|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099951|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099952|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099953|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099954|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099955|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
163099956|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
163099957|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099958|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099959|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099960|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099961|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099962|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099963|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099964|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099965|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
163099966|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
163099967|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099968|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099969|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099970|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099971|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099972|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099973|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099974|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099975|NCT01194219|589073649|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099976|NCT01194219|589073650|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099977|NCT01194219|589073651|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
163099978|NCT01194219|589073652|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
163099979|NCT01194219|589073653|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099980|NCT01194219|589073654|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099981|NCT01194219|589073655|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099982|NCT01194219|589073656|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099983|NCT01194219|589073657|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099984|NCT01194219|589073658|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099985|NCT01194219|589073649|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099986|NCT01194219|589073650|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099987|NCT01194219|589073651|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
163099988|NCT01194219|589073652|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
163099989|NCT01194219|589073653|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099990|NCT01194219|589073654|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099991|NCT01194219|589073655|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099992|NCT01194219|589073656|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099993|NCT01194219|589073657|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099994|NCT01194219|589073658|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099995|NCT01194219|589073649|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163099996|NCT01194219|589073650|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163099997|NCT01194219|589073651|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
163099998|NCT01194219|589073652|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
163099999|NCT01194219|589073653|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163100000|NCT01194219|589073654|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163100001|NCT01194219|589073655|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163100002|NCT01194219|589073656|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163100003|NCT01194219|589073657|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163100004|NCT01194219|589073658|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163100005|NCT01194219|589073649|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100006|NCT01194219|589073650|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100007|NCT01194219|589073651|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
163339382|NCT01670526|589951156|FG000|Overall Study|Withdrawal by Subject|3|||
163100008|NCT01194219|589073652|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
163100009|NCT01194219|589073653|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100010|NCT01194219|589073654|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100011|NCT01194219|589073655|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100012|NCT01194219|589073656|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100013|NCT01194219|589073657|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100014|NCT01194219|589073658|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100015|NCT01194219|589073649|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100016|NCT01194219|589073650|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100017|NCT01194219|589073651|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
163100018|NCT01194219|589073652|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100019|NCT01194219|589073653|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100020|NCT01194219|589073654|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100021|NCT01194219|589073655|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100022|NCT01194219|589073656|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100023|NCT01194219|589073657|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100024|NCT01194219|589073658|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100025|NCT01194219|589073649|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100026|NCT01194219|589073650|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100027|NCT01194219|589073651|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100028|NCT01194219|589073652|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
163100029|NCT01194219|589073653|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100030|NCT01194219|589073654|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100031|NCT01194219|589073655|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100032|NCT01194219|589073656|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100033|NCT01194219|589073657|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100034|NCT01194219|589073658|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100035|NCT01194219|589073649|FG000|Maintenance Phase Weeks16-32|Other|0|||
163100036|NCT01194219|589073650|FG001|Maintenance Phase Weeks16-32|Other|0|||
163100037|NCT01194219|589073651|FG002|Maintenance Phase Weeks16-32|Other|2|||
163100038|NCT01194219|589073652|FG003|Maintenance Phase Weeks16-32|Other|1|||
163100039|NCT01194219|589073653|FG004|Maintenance Phase Weeks16-32|Other|0|||
163100040|NCT01194219|589073654|FG005|Maintenance Phase Weeks16-32|Other|0|||
163100041|NCT01194219|589073655|FG006|Maintenance Phase Weeks16-32|Other|0|||
163100042|NCT01194219|589073656|FG007|Maintenance Phase Weeks16-32|Other|0|||
163100043|NCT01194219|589073657|FG008|Maintenance Phase Weeks16-32|Other|0|||
163100044|NCT01194219|589073658|FG009|Maintenance Phase Weeks16-32|Other|0|||
163100045|NCT01194219|589073649|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
163100046|NCT01194219|589073650|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
163100047|NCT01194219|589073651|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
163100048|NCT01194219|589073652|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
163100049|NCT01194219|589073653|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
163100050|NCT01194219|589073654|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
163100051|NCT01194219|589073655|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
163100052|NCT01194219|589073656|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
163100053|NCT01194219|589073657|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
163100054|NCT01194219|589073658|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
163100055|NCT01194219|589073649|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
163100056|NCT01194219|589073650|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
163100057|NCT01194219|589073651|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
163100058|NCT01194219|589073652|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
163100059|NCT01194219|589073653|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
163100060|NCT01194219|589073654|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
163100061|NCT01194219|589073655|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
163100062|NCT01194219|589073656|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
163100063|NCT01194219|589073657|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
163100064|NCT01194219|589073658|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
163100065|NCT01194219|589073649|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100066|NCT01194219|589073650|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100067|NCT01194219|589073651|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100068|NCT01194219|589073652|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100069|NCT01194219|589073653|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
163100070|NCT01194219|589073654|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100071|NCT01194219|589073655|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
163100072|NCT01194219|589073656|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100073|NCT01194219|589073657|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100074|NCT01194219|589073658|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100075|NCT01194219|589073649|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
163100076|NCT01194219|589073650|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
163100077|NCT01194219|589073651|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
163100078|NCT01194219|589073652|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
163100079|NCT01194219|589073653|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
163100080|NCT01194219|589073654|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
163100081|NCT01194219|589073655|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
163100082|NCT01194219|589073656|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
163100083|NCT01194219|589073657|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
163100084|NCT01194219|589073658|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
163100085|NCT01194219|589073649|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
163100086|NCT01194219|589073650|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
163100087|NCT01194219|589073651|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
163100088|NCT01194219|589073652|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
163100089|NCT01194219|589073653|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
163100090|NCT01194219|589073654|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
163100091|NCT01194219|589073655|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
163100092|NCT01194219|589073656|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
163100093|NCT01194219|589073657|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
163100094|NCT01194219|589073658|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
163100095|NCT01194219|589073649|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100096|NCT01194219|589073650|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100097|NCT01194219|589073651|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100098|NCT01194219|589073652|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100099|NCT01194219|589073653|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100100|NCT01194219|589073654|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100101|NCT01194219|589073655|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100102|NCT01194219|589073656|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
163100103|NCT01194219|589073657|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100104|NCT01194219|589073658|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100105|NCT01194219|589073649|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100106|NCT01194219|589073650|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100107|NCT01194219|589073651|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100108|NCT01194219|589073652|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100109|NCT01194219|589073653|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100110|NCT01194219|589073654|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100111|NCT01194219|589073655|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
163100112|NCT01194219|589073656|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100113|NCT01194219|589073657|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100114|NCT01194219|589073658|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100115|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100116|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100117|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100118|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100119|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100120|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100121|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100122|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100123|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
163100124|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
163100125|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100126|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100127|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100128|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100129|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100130|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100131|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100132|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100133|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
163100134|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
163100135|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
163339383|NCT01670526|589951157|FG001|Overall Study|Withdrawal by Subject|1|||
163339384|NCT01670526|589951156|FG000|Overall Study|Lost to Follow-up|9|||
163100136|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
163100137|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
163100138|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
163100139|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
163339385|NCT01670526|589951157|FG001|Overall Study|Lost to Follow-up|5|||
163339386|NCT03055988|589951158|FG000|Period 1|Adverse Event|0|||
163339387|NCT03055988|589951159|FG001|Period 1|Adverse Event|1|||
163100140|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
163100141|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
163100142|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
163100143|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
163100144|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
163100145|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100146|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100147|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100148|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100149|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100150|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100151|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100152|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100153|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
163100154|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
163100155|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
163100156|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
163100157|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
163100158|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
163100159|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
163100160|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
163100161|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
163100162|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
163100163|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
163100164|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
163100165|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100166|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100167|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100168|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100169|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100170|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100171|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100172|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100173|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
163100174|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
163100175|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100176|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100177|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100178|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100179|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100180|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100181|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100182|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100183|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
163100184|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100185|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100186|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100187|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100188|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100189|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100190|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100191|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100192|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100193|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
163100194|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
163100195|NCT05338710|589073659|FG000|Overall Study|Withdrawal by Subject|3|||
163100196|NCT01081951|589073660|FG000|Overall Study|Death|54|||
163100197|NCT01081951|589073661|FG001|Overall Study|Death|47|||
163100198|NCT01081951|589073660|FG000|Overall Study|Withdrawal by Subject|2|||
163100199|NCT01081951|589073661|FG001|Overall Study|Withdrawal by Subject|6|||
163100200|NCT01081951|589073660|FG000|Overall Study|Allocated treatment but did not take it|0|||
163100201|NCT01081951|589073661|FG001|Overall Study|Allocated treatment but did not take it|1|||
163100202|NCT01081951|589073660|FG000|Overall Study|Lost to Follow-up|0|||
163100203|NCT01081951|589073661|FG001|Overall Study|Lost to Follow-up|1|||
163100204|NCT05226598|589073664|FG000|Overall Study|Death|186|||
163339388|NCT03055988|589951158|FG000|Period 1|Lost to Follow-up|1|||
163339389|NCT03055988|589951159|FG001|Period 1|Lost to Follow-up|0|||
163100205|NCT05226598|589073665|FG001|Overall Study|Death|191|||
163100206|NCT05226598|589073664|FG000|Overall Study|Withdrawal by Subject|6|||
163100207|NCT05226598|589073665|FG001|Overall Study|Withdrawal by Subject|6|||
163100208|NCT05226598|589073664|FG000|Overall Study|Ongoing|174|||
163100209|NCT05226598|589073665|FG001|Overall Study|Ongoing|176|||
163100210|NCT04503551|589073666|FG000|Overall Study|Withdrawal by Subject|5|||
163100211|NCT04503551|589073667|FG001|Overall Study|Withdrawal by Subject|3|||
163100212|NCT04503551|589073666|FG000|Overall Study|Physician Decision|1|||
163100213|NCT04503551|589073667|FG001|Overall Study|Physician Decision|0|||
163100214|NCT04503551|589073666|FG000|Overall Study|Death|0|||
163100215|NCT04503551|589073667|FG001|Overall Study|Death|1|||
163100216|NCT04503551|589073666|FG000|Overall Study|Lost to Follow-up|1|||
163100217|NCT04503551|589073667|FG001|Overall Study|Lost to Follow-up|2|||
163100218|NCT04503551|589073666|FG000|Overall Study|Ongoing at Week 52|99|||
163100219|NCT04503551|589073667|FG001|Overall Study|Ongoing at Week 52|62|||
163100220|NCT02569476|589073668|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
163100221|NCT02569476|589073668|FG000|Overall Study|Death|33|||
163100222|NCT02569476|589073668|FG000|Overall Study|Withdrawal by Subject|9|||
163100223|NCT02569476|589073668|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
163100224|NCT02569476|589073668|FG000|Overall Study|Palliative care|1|||
163100225|NCT02569476|589073668|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
163100226|NCT02569476|589073668|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
163100227|NCT01152788|589073669|FG000|Overall Study|Withdrawal by Subject|0|||
163100228|NCT01152788|589073670|FG001|Overall Study|Withdrawal by Subject|3|||
163100229|NCT01152788|589073669|FG000|Overall Study|No treatment|0|||
163100230|NCT01152788|589073670|FG001|Overall Study|No treatment|1|||
163100231|NCT00778336|589073671|FG000|Index Procedure-Discharge|Death|6|||
163100232|NCT00778336|589073672|FG001|Index Procedure-Discharge|Death|3|||
163100233|NCT00778336|589073673|FG002|Index Procedure-Discharge|Death|2|||
163100234|NCT00778336|589073674|FG003|Index Procedure-Discharge|Death|0|||
163100235|NCT00778336|589073671|FG000|3 Month Follow Up|Lost to Follow-up|15|||
163100236|NCT00778336|589073672|FG001|3 Month Follow Up|Lost to Follow-up|20|||
163100237|NCT00778336|589073673|FG002|3 Month Follow Up|Lost to Follow-up|3|||
163100238|NCT00778336|589073674|FG003|3 Month Follow Up|Lost to Follow-up|0|||
163100239|NCT00778336|589073671|FG000|3 Month Follow Up|Death|8|||
163100240|NCT00778336|589073672|FG001|3 Month Follow Up|Death|3|||
163100241|NCT00778336|589073673|FG002|3 Month Follow Up|Death|2|||
163100242|NCT00778336|589073674|FG003|3 Month Follow Up|Death|0|||
163100243|NCT04585269|589073675|FG000|Intervention|Withdrawal by Subject|9|||
163100244|NCT04585269|589073676|FG001|Intervention|Withdrawal by Subject|0|||
163100245|NCT04585269|589073675|FG000|Intervention|Unable to schedule|15|||
163100246|NCT04585269|589073676|FG001|Intervention|Unable to schedule|0|||
163100247|NCT04585269|589073675|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
163100248|NCT04585269|589073676|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
163100249|NCT04585269|589073675|FG000|FU Time 2 (3 months)|Death|2|||
163100250|NCT04585269|589073676|FG001|FU Time 2 (3 months)|Death|2|||
163100251|NCT04585269|589073675|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
163100252|NCT04585269|589073676|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
163100253|NCT04585269|589073675|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
163100254|NCT04585269|589073676|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
163100255|NCT04585269|589073675|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
163100256|NCT04585269|589073676|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
163100257|NCT04585269|589073675|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
163100258|NCT04585269|589073676|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
163100259|NCT04585269|589073675|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
163100260|NCT04585269|589073676|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
163100261|NCT03666988|589073679|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
163100262|NCT03666988|589073680|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
163100263|NCT03666988|589073681|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
163100264|NCT03666988|589073682|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
163100265|NCT03666988|589073683|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
163100266|NCT03666988|589073684|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
163100267|NCT03666988|589073679|FG000|Part 1 (Up to 28 Months)|Other|0|||
163100268|NCT03666988|589073680|FG001|Part 1 (Up to 28 Months)|Other|1|||
163100269|NCT03666988|589073681|FG002|Part 1 (Up to 28 Months)|Other|1|||
163100270|NCT03666988|589073682|FG003|Part 1 (Up to 28 Months)|Other|0|||
163100271|NCT03666988|589073683|FG004|Part 1 (Up to 28 Months)|Other|0|||
163100272|NCT03666988|589073684|FG005|Part 1 (Up to 28 Months)|Other|0|||
163100273|NCT03666988|589073679|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
163100274|NCT03666988|589073680|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
163100275|NCT03666988|589073681|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
163100276|NCT03666988|589073682|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
163100277|NCT03666988|589073683|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
163100278|NCT03666988|589073684|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
163100279|NCT03666988|589073679|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
163100280|NCT03666988|589073680|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
163339390|NCT03055988|589951158|FG000|Period 1|Withdrawal by Subject|0|||
163100281|NCT03666988|589073681|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
163100282|NCT03666988|589073682|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
163100283|NCT03666988|589073683|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
163100284|NCT03666988|589073684|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
163100285|NCT03666988|589073679|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
163100286|NCT03666988|589073680|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
163100287|NCT03666988|589073681|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
163100288|NCT03666988|589073682|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
163100289|NCT03666988|589073683|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
163100290|NCT03666988|589073684|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
163100291|NCT02517398|589073685|FG000|Overall Study|Death|2|||
163100292|NCT02517398|589073686|FG001|Overall Study|Death|3|||
163100293|NCT02517398|589073687|FG002|Overall Study|Death|4|||
163100294|NCT02517398|589073688|FG003|Overall Study|Death|2|||
163100295|NCT02517398|589073689|FG004|Overall Study|Death|3|||
163100296|NCT02517398|589073690|FG005|Overall Study|Death|8|||
163100297|NCT02517398|589073691|FG006|Overall Study|Death|3|||
163100298|NCT02517398|589073692|FG007|Overall Study|Death|2|||
163100299|NCT02517398|589073693|FG008|Overall Study|Death|6|||
163100300|NCT02517398|589073694|FG009|Overall Study|Death|24|||
163100301|NCT02517398|589073695|FG010|Overall Study|Death|53|||
163100302|NCT02517398|589073696|FG011|Overall Study|Death|25|||
163100303|NCT02517398|589073697|FG012|Overall Study|Death|73|||
163100304|NCT02517398|589073698|FG013|Overall Study|Death|29|||
163100305|NCT02517398|589073699|FG014|Overall Study|Death|26|||
163100306|NCT02517398|589073700|FG015|Overall Study|Death|23|||
163100307|NCT02517398|589073701|FG016|Overall Study|Death|26|||
163100308|NCT02517398|589073702|FG017|Overall Study|Death|25|||
163100309|NCT02517398|589073703|FG018|Overall Study|Death|22|||
163100310|NCT02517398|589073704|FG019|Overall Study|Death|7|||
163100311|NCT02517398|589073705|FG020|Overall Study|Death|26|||
163100312|NCT02517398|589073706|FG021|Overall Study|Death|30|||
163100313|NCT02517398|589073707|FG022|Overall Study|Death|20|||
163100314|NCT02517398|589073685|FG000|Overall Study|Other|0|||
163100315|NCT02517398|589073686|FG001|Overall Study|Other|0|||
163100316|NCT02517398|589073687|FG002|Overall Study|Other|0|||
163100317|NCT02517398|589073688|FG003|Overall Study|Other|1|||
163100318|NCT02517398|589073689|FG004|Overall Study|Other|0|||
163100319|NCT02517398|589073690|FG005|Overall Study|Other|0|||
163100320|NCT02517398|589073691|FG006|Overall Study|Other|0|||
163100321|NCT02517398|589073692|FG007|Overall Study|Other|0|||
163100322|NCT02517398|589073693|FG008|Overall Study|Other|0|||
163100323|NCT02517398|589073694|FG009|Overall Study|Other|1|||
163100324|NCT02517398|589073695|FG010|Overall Study|Other|0|||
163100325|NCT02517398|589073696|FG011|Overall Study|Other|0|||
163100326|NCT02517398|589073697|FG012|Overall Study|Other|0|||
163100327|NCT02517398|589073698|FG013|Overall Study|Other|1|||
163100328|NCT02517398|589073699|FG014|Overall Study|Other|0|||
163100329|NCT02517398|589073700|FG015|Overall Study|Other|1|||
163100330|NCT02517398|589073701|FG016|Overall Study|Other|1|||
163100331|NCT02517398|589073702|FG017|Overall Study|Other|0|||
163100332|NCT02517398|589073703|FG018|Overall Study|Other|0|||
163100333|NCT02517398|589073704|FG019|Overall Study|Other|1|||
163100334|NCT02517398|589073705|FG020|Overall Study|Other|0|||
163100335|NCT02517398|589073706|FG021|Overall Study|Other|0|||
163100336|NCT02517398|589073707|FG022|Overall Study|Other|0|||
163100337|NCT02517398|589073685|FG000|Overall Study|Lost to Follow-up|0|||
163100338|NCT02517398|589073686|FG001|Overall Study|Lost to Follow-up|0|||
163100339|NCT02517398|589073687|FG002|Overall Study|Lost to Follow-up|0|||
163100340|NCT02517398|589073688|FG003|Overall Study|Lost to Follow-up|0|||
163100341|NCT02517398|589073689|FG004|Overall Study|Lost to Follow-up|0|||
163100342|NCT02517398|589073690|FG005|Overall Study|Lost to Follow-up|0|||
163100343|NCT02517398|589073691|FG006|Overall Study|Lost to Follow-up|0|||
163100344|NCT02517398|589073692|FG007|Overall Study|Lost to Follow-up|0|||
163100345|NCT02517398|589073693|FG008|Overall Study|Lost to Follow-up|0|||
163100346|NCT02517398|589073694|FG009|Overall Study|Lost to Follow-up|1|||
163100347|NCT02517398|589073695|FG010|Overall Study|Lost to Follow-up|0|||
163100348|NCT02517398|589073696|FG011|Overall Study|Lost to Follow-up|2|||
163100349|NCT02517398|589073697|FG012|Overall Study|Lost to Follow-up|2|||
163100350|NCT02517398|589073698|FG013|Overall Study|Lost to Follow-up|0|||
163100351|NCT02517398|589073699|FG014|Overall Study|Lost to Follow-up|1|||
163339391|NCT03055988|589951159|FG001|Period 1|Withdrawal by Subject|4|||
163100352|NCT02517398|589073700|FG015|Overall Study|Lost to Follow-up|1|||
163100353|NCT02517398|589073701|FG016|Overall Study|Lost to Follow-up|0|||
163100354|NCT02517398|589073702|FG017|Overall Study|Lost to Follow-up|3|||
163100355|NCT02517398|589073703|FG018|Overall Study|Lost to Follow-up|1|||
163100356|NCT02517398|589073704|FG019|Overall Study|Lost to Follow-up|0|||
163100357|NCT02517398|589073705|FG020|Overall Study|Lost to Follow-up|1|||
163100358|NCT02517398|589073706|FG021|Overall Study|Lost to Follow-up|0|||
163100359|NCT02517398|589073707|FG022|Overall Study|Lost to Follow-up|2|||
163100360|NCT02517398|589073685|FG000|Overall Study|Withdrew Consent|0|||
163100361|NCT02517398|589073686|FG001|Overall Study|Withdrew Consent|0|||
163100362|NCT02517398|589073687|FG002|Overall Study|Withdrew Consent|0|||
163100363|NCT02517398|589073688|FG003|Overall Study|Withdrew Consent|0|||
163100364|NCT02517398|589073689|FG004|Overall Study|Withdrew Consent|0|||
163100365|NCT02517398|589073690|FG005|Overall Study|Withdrew Consent|0|||
163100366|NCT02517398|589073691|FG006|Overall Study|Withdrew Consent|1|||
163100367|NCT02517398|589073692|FG007|Overall Study|Withdrew Consent|0|||
163100368|NCT02517398|589073693|FG008|Overall Study|Withdrew Consent|0|||
163100369|NCT02517398|589073694|FG009|Overall Study|Withdrew Consent|2|||
163100370|NCT02517398|589073695|FG010|Overall Study|Withdrew Consent|7|||
163100371|NCT02517398|589073696|FG011|Overall Study|Withdrew Consent|1|||
163100372|NCT02517398|589073697|FG012|Overall Study|Withdrew Consent|5|||
163100373|NCT02517398|589073698|FG013|Overall Study|Withdrew Consent|4|||
163100374|NCT02517398|589073699|FG014|Overall Study|Withdrew Consent|2|||
163100375|NCT02517398|589073700|FG015|Overall Study|Withdrew Consent|5|||
163100376|NCT02517398|589073701|FG016|Overall Study|Withdrew Consent|4|||
163100377|NCT02517398|589073702|FG017|Overall Study|Withdrew Consent|2|||
163100378|NCT02517398|589073703|FG018|Overall Study|Withdrew Consent|3|||
163100379|NCT02517398|589073704|FG019|Overall Study|Withdrew Consent|2|||
163100380|NCT02517398|589073705|FG020|Overall Study|Withdrew Consent|9|||
163100381|NCT02517398|589073706|FG021|Overall Study|Withdrew Consent|3|||
163100382|NCT02517398|589073707|FG022|Overall Study|Withdrew Consent|1|||
163100383|NCT05588440|589073714|FG000|Overall Study|Sponsor Decision|2|||
163100384|NCT05588440|589073715|FG001|Overall Study|Sponsor Decision|0|||
163100385|NCT05588440|589073716|FG002|Overall Study|Sponsor Decision|1|||
163100386|NCT05588440|589073714|FG000|Overall Study|Death|1|||
163100387|NCT05588440|589073715|FG001|Overall Study|Death|1|||
163100388|NCT05588440|589073716|FG002|Overall Study|Death|1|||
163100389|NCT05588440|589073714|FG000|Overall Study|Screen Fail|0|||
163100390|NCT05588440|589073715|FG001|Overall Study|Screen Fail|1|||
163100391|NCT05588440|589073716|FG002|Overall Study|Screen Fail|1|||
163100392|NCT05588440|589073714|FG000|Overall Study|Withdrawal by Subject|0|||
163100393|NCT05588440|589073715|FG001|Overall Study|Withdrawal by Subject|0|||
163100394|NCT05588440|589073716|FG002|Overall Study|Withdrawal by Subject|1|||
163100395|NCT03533660|589073717|FG000|Overall Study|Withdrawal by Subject|2|||
163100396|NCT03533660|589073718|FG001|Overall Study|Withdrawal by Subject|2|||
163100397|NCT03533660|589073717|FG000|Overall Study|Death|2|||
163100398|NCT03533660|589073718|FG001|Overall Study|Death|4|||
163100399|NCT03533660|589073717|FG000|Overall Study|Adverse Event|0|||
163100400|NCT03533660|589073718|FG001|Overall Study|Adverse Event|2|||
163100401|NCT01671956|589073719|FG000|Overall Study|Disease progression|0|||
163100402|NCT01671956|589073720|FG001|Overall Study|Disease progression|1|||
163100403|NCT01671956|589073719|FG000|Overall Study|Withdrawal by Subject|1|||
163100404|NCT01671956|589073720|FG001|Overall Study|Withdrawal by Subject|1|||
163100405|NCT01671956|589073719|FG000|Overall Study|Adverse Event|1|||
163100406|NCT01671956|589073720|FG001|Overall Study|Adverse Event|0|||
163100407|NCT03816176|589073728|FG000|Overall Study|Miscellaneous|5|||
163100408|NCT03816176|589073728|FG000|Overall Study|Lack of Efficacy|4|||
163100409|NCT03816176|589073728|FG000|Overall Study|Adverse Event|3|||
163100410|NCT03581292|589073729|FG000|Overall Study|Physician Decision|9|||
163100411|NCT03581292|589073730|FG001|Overall Study|Physician Decision|5|||
163100412|NCT03581292|589073729|FG000|Overall Study|Withdrawal by Subject|3|||
163100413|NCT03581292|589073730|FG001|Overall Study|Withdrawal by Subject|0|||
163100414|NCT03581292|589073729|FG000|Overall Study|Withdrawal before Therapy Start|1|||
163100415|NCT03581292|589073730|FG001|Overall Study|Withdrawal before Therapy Start|0|||
163100416|NCT05200572|589073731|FG000|Overall Study|Withdrawal by Subject|14|||
163100417|NCT02524145|589073735|FG000|Overall Study|Withdrawal by Subject|2|||
163100418|NCT02524145|589073736|FG001|Overall Study|Withdrawal by Subject|2|||
163100419|NCT02524145|589073737|FG002|Overall Study|Withdrawal by Subject|3|||
163100420|NCT07214935|589073740|FG000|Overall Study|Adverse Event|1|||
163100421|NCT07214935|589073741|FG001|Overall Study|Adverse Event|1|||
163100422|NCT07214935|589073742|FG002|Overall Study|Adverse Event|1|||
163100423|NCT07214935|589073743|FG003|Overall Study|Adverse Event|0|||
163100424|NCT07214935|589073740|FG000|Overall Study|Lost to Follow-up|0|||
163100425|NCT07214935|589073741|FG001|Overall Study|Lost to Follow-up|1|||
163100426|NCT07214935|589073742|FG002|Overall Study|Lost to Follow-up|0|||
163100427|NCT07214935|589073743|FG003|Overall Study|Lost to Follow-up|0|||
163100428|NCT07214935|589073740|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
163100429|NCT07214935|589073741|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
163100430|NCT07214935|589073742|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
163100431|NCT07214935|589073743|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
163100432|NCT07214935|589073740|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
163100433|NCT07214935|589073741|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
163100434|NCT07214935|589073742|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
163100435|NCT07214935|589073743|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
163100436|NCT02744612|589076018|FG000|Overall Study|Withdrawal by Subject|0|||
163100437|NCT02744612|589076019|FG001|Overall Study|Withdrawal by Subject|2|||
163100438|NCT00283803|589076020|FG000|Overall Study|Physician Decision|9|||
163100439|NCT00283803|589076020|FG000|Overall Study|Withdrawal by Subject|4|||
163100440|NCT01127607|589076021|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
163100441|NCT01127607|589076022|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
163100442|NCT01127607|589076021|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
163100443|NCT01127607|589076022|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
163100444|NCT03419897|589076023|FG000|Overall Study|Death|180|||
163100445|NCT03419897|589076023|FG000|Overall Study|Lost to Follow-up|1|||
163100446|NCT03419897|589076023|FG000|Overall Study|Withdrawal by Subject|6|||
163100447|NCT03419897|589076023|FG000|Overall Study|Sponsor Decision|61|||
163100448|NCT03419897|589076023|FG000|Overall Study|Physician Decision|1|||
163100449|NCT05730725|589076026|FG000|Overall Study|Withdrawal by Subject|3|||
163100450|NCT05730725|589076027|FG001|Overall Study|Withdrawal by Subject|0|||
163100451|NCT05730725|589076028|FG002|Overall Study|Withdrawal by Subject|0|||
163100452|NCT05730725|589076029|FG003|Overall Study|Withdrawal by Subject|1|||
163100453|NCT05730725|589076026|FG000|Overall Study|Not Reported|1|||
163100454|NCT05730725|589076027|FG001|Overall Study|Not Reported|1|||
163100455|NCT05730725|589076028|FG002|Overall Study|Not Reported|1|||
163100456|NCT05730725|589076029|FG003|Overall Study|Not Reported|1|||
163100457|NCT01945216|589076031|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
163100458|NCT01945216|589076031|FG000|Overall Study|Protocol Violation|42|||
163100459|NCT01945216|589076031|FG000|Overall Study|CRF not assured by investigators|5|||
163100460|NCT02982772|589076033|FG000|Intervention|Lost to Follow-up|19|||
163100461|NCT02982772|589076034|FG001|Intervention|Lost to Follow-up|13|||
163100462|NCT02982772|589076033|FG000|1M Follow-Up|Lost to Follow-up|21|||
163100463|NCT02982772|589076034|FG001|1M Follow-Up|Lost to Follow-up|18|||
163100464|NCT02982772|589076033|FG000|3M Follow-Up|Lost to Follow-up|17|||
163100465|NCT02982772|589076034|FG001|3M Follow-Up|Lost to Follow-up|11|||
163100466|NCT02982772|589076033|FG000|6M Follow-Up|Lost to Follow-up|11|||
163100467|NCT02982772|589076034|FG001|6M Follow-Up|Lost to Follow-up|9|||
163100468|NCT02982772|589076033|FG000|12M Follow-Up|Lost to Follow-up|11|||
163100469|NCT02982772|589076034|FG001|12M Follow-Up|Lost to Follow-up|5|||
163100470|NCT03107052|589076041|FG000|Overall Study|Adverse Event|6|||
163100471|NCT03107052|589076042|FG001|Overall Study|Adverse Event|1|||
163100472|NCT03107052|589076043|FG002|Overall Study|Adverse Event|2|||
163100473|NCT03107052|589076041|FG000|Overall Study|Withdrawal by Subject|9|||
163100474|NCT03107052|589076042|FG001|Overall Study|Withdrawal by Subject|5|||
163100475|NCT03107052|589076043|FG002|Overall Study|Withdrawal by Subject|8|||
163100476|NCT03107052|589076041|FG000|Overall Study|Protocol Violation|6|||
163100477|NCT03107052|589076042|FG001|Overall Study|Protocol Violation|0|||
163100478|NCT03107052|589076043|FG002|Overall Study|Protocol Violation|3|||
163100479|NCT03107052|589076041|FG000|Overall Study|Lost to Follow-up|4|||
163100480|NCT03107052|589076042|FG001|Overall Study|Lost to Follow-up|0|||
163100481|NCT03107052|589076043|FG002|Overall Study|Lost to Follow-up|1|||
163100482|NCT03107052|589076041|FG000|Overall Study|Lack of Efficacy|23|||
163100483|NCT03107052|589076042|FG001|Overall Study|Lack of Efficacy|7|||
163100484|NCT03107052|589076043|FG002|Overall Study|Lack of Efficacy|4|||
163100485|NCT03107052|589076041|FG000|Overall Study|Other than specified|4|||
163100486|NCT03107052|589076042|FG001|Overall Study|Other than specified|2|||
163100487|NCT03107052|589076043|FG002|Overall Study|Other than specified|0|||
163339392|NCT03055988|589951158|FG000|Period 2|Adverse Event|0|||
163339393|NCT03055988|589951159|FG001|Period 2|Adverse Event|1|||
163339394|NCT03055988|589951158|FG000|Period 2|Other than listed|1|||
163339395|NCT03055988|589951159|FG001|Period 2|Other than listed|1|||
163339396|NCT00392197|589951160|FG000|Overall Study|Adverse Event|4|||
163339397|NCT00392197|589951161|FG001|Overall Study|Adverse Event|12|||
163339398|NCT00392197|589951160|FG000|Overall Study|Lack of Efficacy|3|||
163339399|NCT00392197|589951161|FG001|Overall Study|Lack of Efficacy|4|||
163339400|NCT00392197|589951160|FG000|Overall Study|Lost to Follow-up|0|||
163339401|NCT00392197|589951161|FG001|Overall Study|Lost to Follow-up|1|||
163339402|NCT00392197|589951160|FG000|Overall Study|Physician Decision|3|||
163339403|NCT00392197|589951161|FG001|Overall Study|Physician Decision|2|||
163339404|NCT00392197|589951160|FG000|Overall Study|Protocol Violation|7|||
163339405|NCT00392197|589951161|FG001|Overall Study|Protocol Violation|5|||
163339406|NCT00392197|589951160|FG000|Overall Study|Withdrawal by Subject|4|||
163339407|NCT00392197|589951161|FG001|Overall Study|Withdrawal by Subject|6|||
163339408|NCT01528605|589951162|FG000|Overall Study|Lost to Follow-up|1|||
163339409|NCT01528605|589951163|FG001|Overall Study|Lost to Follow-up|0|||
163339410|NCT01528605|589951164|FG002|Overall Study|Lost to Follow-up|1|||
163100488|NCT03107052|589076041|FG000|Overall Study|Study terminated due to futility|67|||
163100489|NCT03107052|589076042|FG001|Overall Study|Study terminated due to futility|31|||
163339411|NCT01528605|589951165|FG003|Overall Study|Lost to Follow-up|1|||
163100490|NCT03107052|589076043|FG002|Overall Study|Study terminated due to futility|23|||
163100491|NCT00958360|589076044|FG000|Overall Study|Withdrawal by Subject|3|||
163100492|NCT00958360|589076045|FG001|Overall Study|Withdrawal by Subject|1|||
163100493|NCT00958360|589076044|FG000|Overall Study|Death|6|||
163100494|NCT00958360|589076045|FG001|Overall Study|Death|7|||
163100495|NCT00958360|589076044|FG000|Overall Study|Physician Decision|2|||
163339412|NCT01528605|589951166|FG004|Overall Study|Lost to Follow-up|0|||
163100496|NCT00958360|589076045|FG001|Overall Study|Physician Decision|1|||
163100497|NCT00958360|589076044|FG000|Overall Study|Lost to Follow-up|0|||
163100498|NCT00958360|589076045|FG001|Overall Study|Lost to Follow-up|1|||
163100499|NCT03015363|589076046|FG000|Overall Study|Physician Decision|14|||
163100500|NCT03015363|589076046|FG000|Overall Study|Withdrawal by Subject|3|||
163100501|NCT02263326|589076047|FG000|Overall Study|Lost to Follow-up|1|||
163100502|NCT02263326|589076048|FG001|Overall Study|Lost to Follow-up|1|||
163100503|NCT01061723|589076049|FG000|Overall Study|Adverse Event|0|||
163100504|NCT01061723|589076050|FG001|Overall Study|Adverse Event|2|||
163100505|NCT01061723|589076051|FG002|Overall Study|Adverse Event|5|||
163100506|NCT01061723|589076052|FG003|Overall Study|Adverse Event|5|||
163100507|NCT01061723|589076053|FG004|Overall Study|Adverse Event|2|||
163100508|NCT01061723|589076054|FG005|Overall Study|Adverse Event|6|||
163100509|NCT01061723|589076049|FG000|Overall Study|Lack of Efficacy|2|||
163100510|NCT01061723|589076050|FG001|Overall Study|Lack of Efficacy|3|||
163100511|NCT01061723|589076051|FG002|Overall Study|Lack of Efficacy|4|||
163100512|NCT01061723|589076052|FG003|Overall Study|Lack of Efficacy|2|||
163100513|NCT01061723|589076053|FG004|Overall Study|Lack of Efficacy|1|||
163100514|NCT01061723|589076054|FG005|Overall Study|Lack of Efficacy|1|||
163100515|NCT01061723|589076049|FG000|Overall Study|Randomized but not treated|0|||
163100516|NCT01061723|589076050|FG001|Overall Study|Randomized but not treated|0|||
163100517|NCT01061723|589076051|FG002|Overall Study|Randomized but not treated|0|||
163100518|NCT01061723|589076052|FG003|Overall Study|Randomized but not treated|0|||
163100519|NCT01061723|589076053|FG004|Overall Study|Randomized but not treated|0|||
163100520|NCT01061723|589076054|FG005|Overall Study|Randomized but not treated|1|||
163100521|NCT01061723|589076049|FG000|Overall Study|Other than specified above|2|||
163100522|NCT01061723|589076050|FG001|Overall Study|Other than specified above|1|||
163100523|NCT01061723|589076051|FG002|Overall Study|Other than specified above|1|||
163100524|NCT01061723|589076052|FG003|Overall Study|Other than specified above|1|||
163100525|NCT01061723|589076053|FG004|Overall Study|Other than specified above|0|||
163100526|NCT01061723|589076054|FG005|Overall Study|Other than specified above|1|||
163100527|NCT00500357|589076055|FG000|Overall Study|Death|1|||
163100528|NCT03292874|589076056|FG000|Overall Study|Due to pandemic|5|||
163100529|NCT02482298|589076057|FG000|Overall Study|Withdrawal by Subject|2|||
163100530|NCT02482298|589076058|FG001|Overall Study|Withdrawal by Subject|1|||
163100531|NCT02482298|589076059|FG002|Overall Study|Withdrawal by Subject|2|||
163100532|NCT02482298|589076057|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
163100533|NCT02482298|589076058|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
163100534|NCT02482298|589076059|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
163100535|NCT02482298|589076057|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
163100536|NCT02482298|589076058|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
163100537|NCT02482298|589076059|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
163100538|NCT02482298|589076057|FG000|Overall Study|Lost to Follow-up|0|||
163100539|NCT02482298|589076058|FG001|Overall Study|Lost to Follow-up|1|||
163100540|NCT02482298|589076059|FG002|Overall Study|Lost to Follow-up|0|||
163100541|NCT03592771|589076064|FG000|Overall Study|Adverse Event|2|||
163100542|NCT03592771|589076065|FG001|Overall Study|Adverse Event|0|||
163100543|NCT03592771|589076066|FG002|Overall Study|Adverse Event|1|||
163100544|NCT03592771|589076064|FG000|Overall Study|Death|0|||
163100545|NCT03592771|589076065|FG001|Overall Study|Death|1|||
163100546|NCT03592771|589076066|FG002|Overall Study|Death|1|||
163100547|NCT03592771|589076064|FG000|Overall Study|Lost to Follow-up|5|||
163100548|NCT03592771|589076065|FG001|Overall Study|Lost to Follow-up|11|||
163100549|NCT03592771|589076066|FG002|Overall Study|Lost to Follow-up|15|||
163100550|NCT03592771|589076064|FG000|Overall Study|Withdrawal by Subject|0|||
163100551|NCT03592771|589076065|FG001|Overall Study|Withdrawal by Subject|2|||
163100552|NCT03592771|589076066|FG002|Overall Study|Withdrawal by Subject|0|||
163100553|NCT01642901|589076067|FG000|12-month Follow-up|Withdrawal by Subject|1|||
163100554|NCT01642901|589076068|FG001|12-month Follow-up|Withdrawal by Subject|0|||
163100555|NCT05069597|589076071|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
163100556|NCT05069597|589076072|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
163100557|NCT03650413|589076073|FG000|Overall Study|Adverse Event|1|||
163100558|NCT03650413|589076073|FG000|Overall Study|Lack of Efficacy|17|||
163100559|NCT03650413|589076073|FG000|Overall Study|Other|9|||
163100560|NCT03650413|589076073|FG000|Overall Study|Physician Decision|2|||
163100561|NCT03650413|589076073|FG000|Overall Study|Study Terminated By Sponsor|16|||
163100562|NCT03650413|589076073|FG000|Overall Study|Withdrawal by Subject|16|||
163100563|NCT03332173|589076076|FG000|Overall Study|Death|7|||
163100564|NCT03332173|589076076|FG000|Overall Study|Withdrawal by Subject|6|||
163100565|NCT03332173|589076076|FG000|Overall Study|Lost to Follow-up|2|||
163339413|NCT01528605|589951167|FG005|Overall Study|Lost to Follow-up|0|||
163100566|NCT03332173|589076076|FG000|Overall Study|Transferred to long-term extension study|29|||
163100567|NCT00540592|589076077|FG000|Overall Study|Adverse Event|0|||
163100568|NCT00540592|589076078|FG001|Overall Study|Adverse Event|1|||
163100569|NCT00540592|589076079|FG002|Overall Study|Adverse Event|0|||
163100570|NCT00540592|589076080|FG003|Overall Study|Adverse Event|0|||
163339414|NCT01528605|589951162|FG000|Overall Study|Death|1|||
163339415|NCT01528605|589951163|FG001|Overall Study|Death|0|||
163100571|NCT00540592|589076081|FG004|Overall Study|Adverse Event|1|||
163100572|NCT00540592|589076082|FG005|Overall Study|Adverse Event|0|||
163100573|NCT00540592|589076083|FG006|Overall Study|Adverse Event|0|||
163100574|NCT00540592|589076084|FG007|Overall Study|Adverse Event|1|||
163100575|NCT00540592|589076085|FG008|Overall Study|Adverse Event|1|||
163100576|NCT00540592|589076086|FG009|Overall Study|Adverse Event|2|||
163100577|NCT00540592|589076077|FG000|Overall Study|Lost to Follow-up|2|||
163100578|NCT00540592|589076078|FG001|Overall Study|Lost to Follow-up|0|||
163100579|NCT00540592|589076079|FG002|Overall Study|Lost to Follow-up|0|||
163100580|NCT00540592|589076080|FG003|Overall Study|Lost to Follow-up|0|||
163100581|NCT00540592|589076081|FG004|Overall Study|Lost to Follow-up|0|||
163100582|NCT00540592|589076082|FG005|Overall Study|Lost to Follow-up|0|||
163100583|NCT00540592|589076083|FG006|Overall Study|Lost to Follow-up|0|||
163100584|NCT00540592|589076084|FG007|Overall Study|Lost to Follow-up|0|||
163100585|NCT00540592|589076085|FG008|Overall Study|Lost to Follow-up|0|||
163100586|NCT00540592|589076086|FG009|Overall Study|Lost to Follow-up|0|||
163100587|NCT00540592|589076077|FG000|Overall Study|Withdrawal by Subject|0|||
163100588|NCT00540592|589076078|FG001|Overall Study|Withdrawal by Subject|0|||
163100589|NCT00540592|589076079|FG002|Overall Study|Withdrawal by Subject|1|||
163100590|NCT00540592|589076080|FG003|Overall Study|Withdrawal by Subject|1|||
163100591|NCT00540592|589076081|FG004|Overall Study|Withdrawal by Subject|0|||
163100592|NCT00540592|589076082|FG005|Overall Study|Withdrawal by Subject|0|||
163100593|NCT00540592|589076083|FG006|Overall Study|Withdrawal by Subject|0|||
163100594|NCT00540592|589076084|FG007|Overall Study|Withdrawal by Subject|0|||
163100595|NCT00540592|589076085|FG008|Overall Study|Withdrawal by Subject|0|||
163100596|NCT00540592|589076086|FG009|Overall Study|Withdrawal by Subject|0|||
163100597|NCT00131352|589076087|FG000|Initial Treatment Period|Adverse Event|1|||
163100598|NCT00131352|589076088|FG001|Initial Treatment Period|Adverse Event|3|||
163100599|NCT00131352|589076087|FG000|Initial Treatment Period|Non-compliant|1|||
163100600|NCT00131352|589076088|FG001|Initial Treatment Period|Non-compliant|2|||
163100601|NCT00131352|589076087|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
163100602|NCT00131352|589076088|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
163100603|NCT00131352|589076087|FG000|Initial Treatment Period|Lack of Efficacy|6|||
163100604|NCT00131352|589076088|FG001|Initial Treatment Period|Lack of Efficacy|4|||
163100605|NCT00131352|589076087|FG000|Initial Treatment Period|Other|0|||
163100606|NCT00131352|589076088|FG001|Initial Treatment Period|Other|2|||
163100607|NCT00131352|589076087|FG000|Repeat Treatment Period|Adverse Event|1|||
163100608|NCT00131352|589076088|FG001|Repeat Treatment Period|Adverse Event|0|||
163100609|NCT00131352|589076087|FG000|Repeat Treatment Period|Other|1|||
163100610|NCT00131352|589076088|FG001|Repeat Treatment Period|Other|0|||
163100611|NCT04908683|589076089|FG000|Overall Study|Failure to meet continuation criteria|34|||
163100612|NCT04908683|589076090|FG001|Overall Study|Failure to meet continuation criteria|22|||
163100613|NCT04908683|589076089|FG000|Overall Study|Initiated prohibited medication|3|||
163100614|NCT04908683|589076090|FG001|Overall Study|Initiated prohibited medication|0|||
163100615|NCT04908683|589076089|FG000|Overall Study|Randomized by mistake|1|||
163100616|NCT04908683|589076090|FG001|Overall Study|Randomized by mistake|0|||
163100617|NCT04908683|589076089|FG000|Overall Study|Lost to Follow-up|679|||
163100618|NCT04908683|589076090|FG001|Overall Study|Lost to Follow-up|341|||
163100619|NCT04908683|589076089|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
163100620|NCT04908683|589076090|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
163100621|NCT04908683|589076089|FG000|Overall Study|Physician Decision|44|||
163100622|NCT04908683|589076090|FG001|Overall Study|Physician Decision|35|||
163100623|NCT04908683|589076089|FG000|Overall Study|Technical problems|12|||
163100624|NCT04908683|589076090|FG001|Overall Study|Technical problems|9|||
163100625|NCT04908683|589076089|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
163100626|NCT04908683|589076090|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
163100627|NCT04908683|589076089|FG000|Overall Study|Protocol Violation|2|||
163100628|NCT04908683|589076090|FG001|Overall Study|Protocol Violation|0|||
163100629|NCT04908683|589076089|FG000|Overall Study|Withdrawal by Subject|1188|||
163100630|NCT04908683|589076090|FG001|Overall Study|Withdrawal by Subject|570|||
163100631|NCT04908683|589076089|FG000|Overall Study|Site Closure by Sponsor|6|||
163100632|NCT04908683|589076090|FG001|Overall Study|Site Closure by Sponsor|3|||
163100633|NCT04908683|589076089|FG000|Overall Study|Adverse Event|21|||
163100634|NCT04908683|589076090|FG001|Overall Study|Adverse Event|11|||
163100635|NCT04908683|589076089|FG000|Overall Study|Death|101|||
163100636|NCT04908683|589076090|FG001|Overall Study|Death|61|||
163100637|NCT04908683|589076089|FG000|Overall Study|Sponsor's decision|14398|||
163100638|NCT04908683|589076090|FG001|Overall Study|Sponsor's decision|7205|||
163100639|NCT04908683|589076089|FG000|Overall Study|Other|92|||
163100640|NCT04908683|589076090|FG001|Overall Study|Other|50|||
163100641|NCT04908683|589076089|FG000|Overall Study|Randomized not vaccinated|108|||
163100642|NCT04908683|589076090|FG001|Overall Study|Randomized not vaccinated|52|||
163100643|NCT00910910|589076091|FG000|Overall Study|Adverse Event|63|||
163100644|NCT00910910|589076092|FG001|Overall Study|Adverse Event|35|||
163100645|NCT00910910|589076091|FG000|Overall Study|PD without histologic change|27|||
163100646|NCT00910910|589076092|FG001|Overall Study|PD without histologic change|23|||
163220193|NCT02039674|589521413|FG007|Overall Study|Sponsor Decision|0|||
163100647|NCT00910910|589076091|FG000|Overall Study|PD with histologic change|0|||
163100648|NCT00910910|589076092|FG001|Overall Study|PD with histologic change|2|||
163100649|NCT00910910|589076091|FG000|Overall Study|Withdrawal by Subject|7|||
163100650|NCT00910910|589076092|FG001|Overall Study|Withdrawal by Subject|5|||
163100651|NCT00910910|589076091|FG000|Overall Study|Lost to Follow-up|2|||
163100652|NCT00910910|589076092|FG001|Overall Study|Lost to Follow-up|2|||
163100653|NCT00910910|589076091|FG000|Overall Study|Death|9|||
163100654|NCT00910910|589076092|FG001|Overall Study|Death|3|||
163100655|NCT00910910|589076091|FG000|Overall Study|Protocol Violation|2|||
163100656|NCT00910910|589076092|FG001|Overall Study|Protocol Violation|2|||
163100657|NCT00910910|589076091|FG000|Overall Study|Completed 13 cycles of treatment|0|||
163100658|NCT00910910|589076092|FG001|Overall Study|Completed 13 cycles of treatment|118|||
163100659|NCT00910910|589076091|FG000|Overall Study|Other|114|||
163100660|NCT00910910|589076092|FG001|Overall Study|Other|32|||
163100661|NCT00910910|589076091|FG000|Overall Study|Untreated before cycle 1|1|||
163100662|NCT00910910|589076092|FG001|Overall Study|Untreated before cycle 1|2|||
163100663|NCT00383331|589076093|FG000|Overall Study|Protocol Violation|0|||
163100664|NCT00383331|589076094|FG001|Overall Study|Protocol Violation|1|||
163100665|NCT01973231|589076095|FG000|Overall Study|Protocol Violation|1|||
163100666|NCT01973231|589076096|FG001|Overall Study|Protocol Violation|1|||
163100667|NCT01973231|589076095|FG000|Overall Study|Lost to Follow-up|1|||
163100668|NCT01973231|589076096|FG001|Overall Study|Lost to Follow-up|1|||
163100669|NCT01973231|589076095|FG000|Overall Study|unclassified|2|||
163100670|NCT01973231|589076096|FG001|Overall Study|unclassified|1|||
163100671|NCT01973231|589076095|FG000|Overall Study|Withdrawal by Subject|7|||
163100672|NCT01973231|589076096|FG001|Overall Study|Withdrawal by Subject|9|||
163100673|NCT05384834|589076102|FG000|Overall Study|Lost to Follow-up|43|||
163100674|NCT05384834|589076102|FG000|Overall Study|Withdrawal by Subject|5|||
163100675|NCT01871545|589076103|FG000|Overall Study|Death|2|||
163100676|NCT01871545|589076104|FG001|Overall Study|Death|0|||
163100677|NCT01871545|589076103|FG000|Overall Study|Lack of Efficacy|11|||
163100678|NCT01871545|589076104|FG001|Overall Study|Lack of Efficacy|2|||
163100679|NCT01871545|589076103|FG000|Overall Study|Physician Decision|4|||
163100680|NCT01871545|589076104|FG001|Overall Study|Physician Decision|0|||
163100681|NCT01871545|589076103|FG000|Overall Study|Withdrawal by Subject|0|||
163100682|NCT01871545|589076104|FG001|Overall Study|Withdrawal by Subject|1|||
163100683|NCT01071954|589076105|FG000|Overall Study|Noncompliance|4|||
163100684|NCT01071954|589076105|FG000|Overall Study|Adverse Event|1|||
163100685|NCT01071954|589076105|FG000|Overall Study|Withdrawal by Subject|11|||
163100686|NCT01071954|589076105|FG000|Overall Study|Requirement for Alternative Therapy|5|||
163100687|NCT01071954|589076105|FG000|Overall Study|Administrative Decision|5|||
163100688|NCT01071954|589076105|FG000|Overall Study|Protocol Specified Criteria|1|||
163100689|NCT01926444|589076106|FG000|Overall Study|Colonoscopy not performed|0|||
163100690|NCT01926444|589076107|FG001|Overall Study|Colonoscopy not performed|0|||
163100691|NCT01926444|589076108|FG002|Overall Study|Colonoscopy not performed|4|||
163100692|NCT01926444|589076109|FG003|Overall Study|Colonoscopy not performed|2|||
163100693|NCT02243371|589076119|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
163100694|NCT02243371|589076120|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
163100695|NCT02243371|589076119|FG000|Overall Study|Death (unrelated)|2|||
163100696|NCT02243371|589076120|FG001|Overall Study|Death (unrelated)|4|||
163100697|NCT02243371|589076119|FG000|Overall Study|Adverse Event (unrelated)|0|||
163100698|NCT02243371|589076120|FG001|Overall Study|Adverse Event (unrelated)|1|||
163100699|NCT02243371|589076119|FG000|Overall Study|Lack of Clinical Benefit|0|||
163100700|NCT02243371|589076120|FG001|Overall Study|Lack of Clinical Benefit|1|||
163100701|NCT02243371|589076119|FG000|Overall Study|Withdrawal by Subject|0|||
163100702|NCT02243371|589076120|FG001|Overall Study|Withdrawal by Subject|2|||
163100703|NCT00271856|589076123|FG000|Overall Study|Withdrawal by Subject|1|||
163100704|NCT00271856|589076124|FG001|Overall Study|Withdrawal by Subject|7|||
163100705|NCT00271856|589076123|FG000|Overall Study|Lost to Follow-up|10|||
163100706|NCT00271856|589076124|FG001|Overall Study|Lost to Follow-up|11|||
163339416|NCT01528605|589951164|FG002|Overall Study|Death|0|||
163100707|NCT04599803|589076125|FG000|Overall Study|Withdrawal by Subject|5|||
163100708|NCT04599803|589076125|FG000|Overall Study|Lost to Follow-up|26|||
163100709|NCT02544750|589076126|FG000|Overall Study|Physician Decision|3|||
163100710|NCT02544750|589076127|FG001|Overall Study|Physician Decision|1|||
163100711|NCT02544750|589076126|FG000|Overall Study|Other reasons|69|||
163100712|NCT02544750|589076127|FG001|Overall Study|Other reasons|39|||
163100713|NCT02544750|589076126|FG000|Overall Study|Met withdrawal criteria|2|||
163100714|NCT02544750|589076127|FG001|Overall Study|Met withdrawal criteria|2|||
163100715|NCT02544750|589076126|FG000|Overall Study|Transition To Commercial Product|1|||
163100716|NCT02544750|589076127|FG001|Overall Study|Transition To Commercial Product|0|||
163100717|NCT02544750|589076126|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
163100718|NCT02544750|589076127|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
163100719|NCT02544750|589076126|FG000|Overall Study|Adverse Event|8|||
163100720|NCT02544750|589076127|FG001|Overall Study|Adverse Event|10|||
163100721|NCT02544750|589076126|FG000|Overall Study|Withdrawal by Subject|10|||
163100722|NCT02544750|589076127|FG001|Overall Study|Withdrawal by Subject|4|||
163339417|NCT01528605|589951165|FG003|Overall Study|Death|0|||
163100723|NCT02544750|589076126|FG000|Overall Study|Lost to Follow-up|1|||
163100724|NCT02544750|589076127|FG001|Overall Study|Lost to Follow-up|0|||
163100725|NCT03307785|589076130|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
163100726|NCT03307785|589076131|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100727|NCT03307785|589076132|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100728|NCT03307785|589076133|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100729|NCT03307785|589076134|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100730|NCT03307785|589076135|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100731|NCT03307785|589076136|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100732|NCT03307785|589076137|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100733|NCT03307785|589076138|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100734|NCT03307785|589076139|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100735|NCT03307785|589076140|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100736|NCT03307785|589076141|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100737|NCT03307785|589076142|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100738|NCT03307785|589076130|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
163100739|NCT03307785|589076131|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
163100740|NCT03307785|589076132|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100741|NCT03307785|589076133|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100742|NCT03307785|589076134|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100743|NCT03307785|589076135|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100744|NCT03307785|589076136|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100745|NCT03307785|589076137|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100746|NCT03307785|589076138|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100747|NCT03307785|589076139|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100748|NCT03307785|589076140|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100749|NCT03307785|589076141|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100750|NCT03307785|589076142|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100751|NCT03307785|589076130|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
163100752|NCT03307785|589076131|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
163100753|NCT03307785|589076132|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100754|NCT03307785|589076133|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100755|NCT03307785|589076134|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100756|NCT03307785|589076135|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100757|NCT03307785|589076136|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100758|NCT03307785|589076137|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100759|NCT03307785|589076138|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100760|NCT03307785|589076139|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100761|NCT03307785|589076140|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100762|NCT03307785|589076141|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100763|NCT03307785|589076142|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100764|NCT03307785|589076130|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
163100765|NCT03307785|589076131|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
163100766|NCT03307785|589076132|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100767|NCT03307785|589076133|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100768|NCT03307785|589076134|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100769|NCT03307785|589076135|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100770|NCT03307785|589076136|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100771|NCT03307785|589076137|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100772|NCT03307785|589076138|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100773|NCT03307785|589076139|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100774|NCT03307785|589076140|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100775|NCT03307785|589076141|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100776|NCT03307785|589076142|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100777|NCT03307785|589076130|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100778|NCT03307785|589076131|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100779|NCT03307785|589076132|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
163100780|NCT03307785|589076133|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100781|NCT03307785|589076134|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100782|NCT03307785|589076135|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100783|NCT03307785|589076136|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100784|NCT03307785|589076137|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100785|NCT03307785|589076138|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100786|NCT03307785|589076139|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100787|NCT03307785|589076140|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100788|NCT03307785|589076141|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100789|NCT03307785|589076142|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100790|NCT03307785|589076130|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100791|NCT03307785|589076131|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100792|NCT03307785|589076132|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
163100793|NCT03307785|589076133|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100794|NCT03307785|589076134|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100795|NCT03307785|589076135|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100796|NCT03307785|589076136|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100797|NCT03307785|589076137|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100798|NCT03307785|589076138|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100799|NCT03307785|589076139|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100800|NCT03307785|589076140|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100801|NCT03307785|589076141|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100802|NCT03307785|589076142|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100803|NCT03307785|589076130|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100804|NCT03307785|589076131|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100805|NCT03307785|589076132|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
163100806|NCT03307785|589076133|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100807|NCT03307785|589076134|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100808|NCT03307785|589076135|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100809|NCT03307785|589076136|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100810|NCT03307785|589076137|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100811|NCT03307785|589076138|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100812|NCT03307785|589076139|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100813|NCT03307785|589076140|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100814|NCT03307785|589076141|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100815|NCT03307785|589076142|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100816|NCT03307785|589076130|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100817|NCT03307785|589076131|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100818|NCT03307785|589076132|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
163100819|NCT03307785|589076133|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100820|NCT03307785|589076134|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100821|NCT03307785|589076135|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100822|NCT03307785|589076136|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100823|NCT03307785|589076137|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100824|NCT03307785|589076138|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100825|NCT03307785|589076139|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100826|NCT03307785|589076140|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100827|NCT03307785|589076141|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100828|NCT03307785|589076142|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100829|NCT03307785|589076130|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100830|NCT03307785|589076131|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100831|NCT03307785|589076132|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
163100832|NCT03307785|589076133|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100833|NCT03307785|589076134|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100834|NCT03307785|589076135|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100835|NCT03307785|589076136|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100836|NCT03307785|589076137|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100837|NCT03307785|589076138|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100838|NCT03307785|589076139|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100839|NCT03307785|589076140|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100840|NCT03307785|589076141|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100841|NCT03307785|589076142|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100842|NCT03307785|589076130|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100843|NCT03307785|589076131|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100844|NCT03307785|589076132|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100845|NCT03307785|589076133|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
163339418|NCT01528605|589951166|FG004|Overall Study|Death|0|||
163339419|NCT01528605|589951167|FG005|Overall Study|Death|0|||
163339420|NCT01681511|589951168|FG000|Overall Study|No Treatment Received|1|||
163100846|NCT03307785|589076134|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
163100847|NCT03307785|589076135|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163339421|NCT01681511|589951169|FG001|Overall Study|No Treatment Received|3|||
163100848|NCT03307785|589076136|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100849|NCT03307785|589076137|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100850|NCT03307785|589076138|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100851|NCT03307785|589076139|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100852|NCT03307785|589076140|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100853|NCT03307785|589076141|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100854|NCT03307785|589076142|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100855|NCT03307785|589076130|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100856|NCT03307785|589076131|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100857|NCT03307785|589076132|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100858|NCT03307785|589076133|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
163100859|NCT03307785|589076134|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
163100860|NCT03307785|589076135|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100861|NCT03307785|589076136|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100862|NCT03307785|589076137|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100863|NCT03307785|589076138|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100864|NCT03307785|589076139|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100865|NCT03307785|589076140|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100866|NCT03307785|589076141|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100867|NCT03307785|589076142|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100868|NCT03307785|589076130|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100869|NCT03307785|589076131|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100870|NCT03307785|589076132|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100871|NCT03307785|589076133|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
163100872|NCT03307785|589076134|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100873|NCT03307785|589076135|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100874|NCT03307785|589076136|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100875|NCT03307785|589076137|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100876|NCT03307785|589076138|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100877|NCT03307785|589076139|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100878|NCT03307785|589076140|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100879|NCT03307785|589076141|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100880|NCT03307785|589076142|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100881|NCT03307785|589076130|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100882|NCT03307785|589076131|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100883|NCT03307785|589076132|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100884|NCT03307785|589076133|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100885|NCT03307785|589076134|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
163100886|NCT03307785|589076135|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100887|NCT03307785|589076136|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100888|NCT03307785|589076137|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100889|NCT03307785|589076138|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100890|NCT03307785|589076139|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100891|NCT03307785|589076140|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100892|NCT03307785|589076141|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100893|NCT03307785|589076142|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100894|NCT03307785|589076130|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100895|NCT03307785|589076131|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100896|NCT03307785|589076132|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100897|NCT03307785|589076133|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100898|NCT03307785|589076134|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100899|NCT03307785|589076135|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
163100900|NCT03307785|589076136|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100901|NCT03307785|589076137|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100902|NCT03307785|589076138|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100903|NCT03307785|589076139|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100904|NCT03307785|589076140|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100905|NCT03307785|589076141|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100906|NCT03307785|589076142|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100907|NCT03307785|589076130|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100908|NCT03307785|589076131|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100909|NCT03307785|589076132|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100910|NCT03307785|589076133|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100911|NCT03307785|589076134|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100912|NCT03307785|589076135|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
163100913|NCT03307785|589076136|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100914|NCT03307785|589076137|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100915|NCT03307785|589076138|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100916|NCT03307785|589076139|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100917|NCT03307785|589076140|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100918|NCT03307785|589076141|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100919|NCT03307785|589076142|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100920|NCT03307785|589076130|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100921|NCT03307785|589076131|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100922|NCT03307785|589076132|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100923|NCT03307785|589076133|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100924|NCT03307785|589076134|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100925|NCT03307785|589076135|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
163100926|NCT03307785|589076136|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100927|NCT03307785|589076137|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100928|NCT03307785|589076138|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100929|NCT03307785|589076139|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100930|NCT03307785|589076140|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100931|NCT03307785|589076141|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100932|NCT03307785|589076142|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100933|NCT03307785|589076130|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100934|NCT03307785|589076131|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100935|NCT03307785|589076132|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100936|NCT03307785|589076133|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100937|NCT03307785|589076134|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100938|NCT03307785|589076135|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
163100939|NCT03307785|589076136|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100940|NCT03307785|589076137|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100941|NCT03307785|589076138|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100942|NCT03307785|589076139|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100943|NCT03307785|589076140|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100944|NCT03307785|589076141|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100945|NCT03307785|589076142|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100946|NCT03307785|589076130|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100947|NCT03307785|589076131|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100948|NCT03307785|589076132|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100949|NCT03307785|589076133|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100950|NCT03307785|589076134|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100951|NCT03307785|589076135|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
163100952|NCT03307785|589076136|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100953|NCT03307785|589076137|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100954|NCT03307785|589076138|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100955|NCT03307785|589076139|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100956|NCT03307785|589076140|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100957|NCT03307785|589076141|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100958|NCT03307785|589076142|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100959|NCT03307785|589076130|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100960|NCT03307785|589076131|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100961|NCT03307785|589076132|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100962|NCT03307785|589076133|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100963|NCT03307785|589076134|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100964|NCT03307785|589076135|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100965|NCT03307785|589076136|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
163100966|NCT03307785|589076137|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100967|NCT03307785|589076138|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100968|NCT03307785|589076139|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100969|NCT03307785|589076140|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100970|NCT03307785|589076141|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100971|NCT03307785|589076142|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100972|NCT03307785|589076130|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100973|NCT03307785|589076131|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100974|NCT03307785|589076132|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100975|NCT03307785|589076133|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100976|NCT03307785|589076134|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100977|NCT03307785|589076135|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100978|NCT03307785|589076136|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
163100979|NCT03307785|589076137|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100980|NCT03307785|589076138|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100981|NCT03307785|589076139|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100982|NCT03307785|589076140|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100983|NCT03307785|589076141|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100984|NCT03307785|589076142|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100985|NCT03307785|589076130|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100986|NCT03307785|589076131|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100987|NCT03307785|589076132|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100988|NCT03307785|589076133|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100989|NCT03307785|589076134|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100990|NCT03307785|589076135|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100991|NCT03307785|589076136|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100992|NCT03307785|589076137|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
163100993|NCT03307785|589076138|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100994|NCT03307785|589076139|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100995|NCT03307785|589076140|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100996|NCT03307785|589076141|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100997|NCT03307785|589076142|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100998|NCT03307785|589076130|FG000|PACT Phase: Up to 19 Months|Death|0|||
163100999|NCT03307785|589076131|FG001|PACT Phase: Up to 19 Months|Death|0|||
163101000|NCT03307785|589076132|FG002|PACT Phase: Up to 19 Months|Death|0|||
163101001|NCT03307785|589076133|FG003|PACT Phase: Up to 19 Months|Death|0|||
163101002|NCT03307785|589076134|FG004|PACT Phase: Up to 19 Months|Death|0|||
163101003|NCT03307785|589076135|FG005|PACT Phase: Up to 19 Months|Death|0|||
163101004|NCT03307785|589076136|FG006|PACT Phase: Up to 19 Months|Death|0|||
163101005|NCT03307785|589076137|FG007|PACT Phase: Up to 19 Months|Death|0|||
163101006|NCT03307785|589076138|FG008|PACT Phase: Up to 19 Months|Death|0|||
163101007|NCT03307785|589076139|FG009|PACT Phase: Up to 19 Months|Death|0|||
163101008|NCT03307785|589076140|FG010|PACT Phase: Up to 19 Months|Death|0|||
163101009|NCT03307785|589076141|FG011|PACT Phase: Up to 19 Months|Death|0|||
163101010|NCT03307785|589076142|FG012|PACT Phase: Up to 19 Months|Death|1|||
163101011|NCT01154452|589076147|FG000|Phase Ib|Not Treated|1|||
163101012|NCT01154452|589076148|FG001|Phase Ib|Not Treated|0|||
163101013|NCT01154452|589076149|FG002|Phase Ib|Not Treated|0|||
163101014|NCT01154452|589076150|FG003|Phase Ib|Not Treated|0|||
163101015|NCT01154452|589076147|FG000|Phase Ib|Adverse Event|2|||
163101016|NCT01154452|589076148|FG001|Phase Ib|Adverse Event|1|||
163101017|NCT01154452|589076149|FG002|Phase Ib|Adverse Event|0|||
163101018|NCT01154452|589076150|FG003|Phase Ib|Adverse Event|0|||
163101019|NCT01154452|589076147|FG000|Phase II|Withdrawal by Subject|0|||
163101020|NCT01154452|589076148|FG001|Phase II|Withdrawal by Subject|0|||
163101021|NCT01154452|589076149|FG002|Phase II|Withdrawal by Subject|1|||
163101022|NCT01154452|589076150|FG003|Phase II|Withdrawal by Subject|2|||
163101023|NCT01154452|589076147|FG000|Phase II|Adverse Event|0|||
163101024|NCT01154452|589076148|FG001|Phase II|Adverse Event|0|||
163101025|NCT01154452|589076149|FG002|Phase II|Adverse Event|4|||
163101026|NCT01154452|589076150|FG003|Phase II|Adverse Event|4|||
163101027|NCT01392573|589076151|FG000|Overall Study|Adverse Event|1|||
163101028|NCT01392573|589076152|FG001|Overall Study|Adverse Event|3|||
163101029|NCT01392573|589076151|FG000|Overall Study|Lack of Efficacy|1|||
163101030|NCT01392573|589076152|FG001|Overall Study|Lack of Efficacy|2|||
163101031|NCT01392573|589076151|FG000|Overall Study|Protocol Violation|0|||
163101032|NCT01392573|589076152|FG001|Overall Study|Protocol Violation|2|||
163101033|NCT01392573|589076151|FG000|Overall Study|Withdrawal Criteria|13|||
163101034|NCT01392573|589076152|FG001|Overall Study|Withdrawal Criteria|15|||
163101035|NCT01392573|589076151|FG000|Overall Study|Site closure|8|||
163101036|NCT01392573|589076152|FG001|Overall Study|Site closure|7|||
163339422|NCT01681511|589951168|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
163101037|NCT01392573|589076151|FG000|Overall Study|Unclassified|9|||
163101038|NCT01392573|589076152|FG001|Overall Study|Unclassified|6|||
163101039|NCT00325130|589076188|FG000|Overall Study|Lost to Follow-up|6|||
163101040|NCT00325130|589076189|FG001|Overall Study|Lost to Follow-up|14|||
163101041|NCT00325130|589076188|FG000|Overall Study|Withdrawal by Subject|12|||
163101042|NCT00325130|589076189|FG001|Overall Study|Withdrawal by Subject|14|||
163101043|NCT00325130|589076188|FG000|Overall Study|Protocol Deviation|0|||
163101044|NCT00325130|589076189|FG001|Overall Study|Protocol Deviation|1|||
163101045|NCT00325130|589076188|FG000|Overall Study|Moved|0|||
163339423|NCT01681511|589951169|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
163339424|NCT01681511|589951168|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
163101046|NCT00325130|589076189|FG001|Overall Study|Moved|1|||
163101047|NCT00325130|589076188|FG000|Overall Study|Patient Discontinued for Other|1|||
163101048|NCT00325130|589076189|FG001|Overall Study|Patient Discontinued for Other|0|||
163101049|NCT02220855|589077334|FG000|Overall Study|Adverse Event|8|||
163101050|NCT02220855|589077334|FG000|Overall Study|Disease Progression|5|||
163101051|NCT02220855|589077334|FG000|Overall Study|Withdrawal by Subject|1|||
163101052|NCT02974140|589077343|FG000|Overall Study|Adverse Event|2|||
163101053|NCT02974140|589077343|FG000|Overall Study|Lost to Follow-up|1|||
163101054|NCT02974140|589077343|FG000|Overall Study|Study Terminated by Sponsor|36|||
163101055|NCT01905943|589077344|FG000|Overall Study|Withdrawal of consent|90|||
163101056|NCT01905943|589077344|FG000|Overall Study|Lost to Follow-up|16|||
163101057|NCT01905943|589077344|FG000|Overall Study|Investigator discretion|7|||
163101058|NCT01905943|589077344|FG000|Overall Study|Death|186|||
163101059|NCT01905943|589077344|FG000|Overall Study|Adverse Event|3|||
163101060|NCT01905943|589077344|FG000|Overall Study|Other|12|||
163101061|NCT01238991|589077345|FG000|Overall Study|Adverse Event|1|||
163101062|NCT01238991|589077346|FG001|Overall Study|Adverse Event|0|||
163101063|NCT01238991|589077347|FG002|Overall Study|Adverse Event|3|||
163101064|NCT01238991|589077348|FG003|Overall Study|Adverse Event|1|||
163101065|NCT01238991|589077349|FG004|Overall Study|Adverse Event|1|||
163101066|NCT01238991|589077350|FG005|Overall Study|Adverse Event|0|||
163101067|NCT01238991|589077351|FG006|Overall Study|Adverse Event|1|||
163101068|NCT01238991|589077352|FG007|Overall Study|Adverse Event|1|||
163101069|NCT01238991|589077353|FG008|Overall Study|Adverse Event|0|||
163101070|NCT01238991|589077354|FG009|Overall Study|Adverse Event|0|||
163101071|NCT01238991|589077345|FG000|Overall Study|Death|0|||
163101072|NCT01238991|589077346|FG001|Overall Study|Death|0|||
163101073|NCT01238991|589077347|FG002|Overall Study|Death|0|||
163101074|NCT01238991|589077348|FG003|Overall Study|Death|1|||
163101075|NCT01238991|589077349|FG004|Overall Study|Death|0|||
163101076|NCT01238991|589077350|FG005|Overall Study|Death|0|||
163101077|NCT01238991|589077351|FG006|Overall Study|Death|0|||
163101078|NCT01238991|589077352|FG007|Overall Study|Death|0|||
163101079|NCT01238991|589077353|FG008|Overall Study|Death|0|||
163101080|NCT01238991|589077354|FG009|Overall Study|Death|0|||
163101081|NCT01238991|589077345|FG000|Overall Study|Lack of Efficacy|0|||
163101082|NCT01238991|589077346|FG001|Overall Study|Lack of Efficacy|0|||
163101083|NCT01238991|589077347|FG002|Overall Study|Lack of Efficacy|1|||
163101084|NCT01238991|589077348|FG003|Overall Study|Lack of Efficacy|0|||
163101085|NCT01238991|589077349|FG004|Overall Study|Lack of Efficacy|0|||
163101086|NCT01238991|589077350|FG005|Overall Study|Lack of Efficacy|0|||
163101087|NCT01238991|589077351|FG006|Overall Study|Lack of Efficacy|0|||
163101088|NCT01238991|589077352|FG007|Overall Study|Lack of Efficacy|0|||
163101089|NCT01238991|589077353|FG008|Overall Study|Lack of Efficacy|1|||
163101090|NCT01238991|589077354|FG009|Overall Study|Lack of Efficacy|0|||
163101091|NCT01238991|589077345|FG000|Overall Study|Withdrawal by Subject|0|||
163101092|NCT01238991|589077346|FG001|Overall Study|Withdrawal by Subject|0|||
163101093|NCT01238991|589077347|FG002|Overall Study|Withdrawal by Subject|1|||
163101094|NCT01238991|589077348|FG003|Overall Study|Withdrawal by Subject|0|||
163101095|NCT01238991|589077349|FG004|Overall Study|Withdrawal by Subject|0|||
163101096|NCT01238991|589077350|FG005|Overall Study|Withdrawal by Subject|0|||
163101097|NCT01238991|589077351|FG006|Overall Study|Withdrawal by Subject|0|||
163101098|NCT01238991|589077352|FG007|Overall Study|Withdrawal by Subject|0|||
163101099|NCT01238991|589077353|FG008|Overall Study|Withdrawal by Subject|0|||
163101100|NCT01238991|589077354|FG009|Overall Study|Withdrawal by Subject|0|||
163101101|NCT01238991|589077345|FG000|Overall Study|Study Terminated by Sponsor|0|||
163101102|NCT01238991|589077346|FG001|Overall Study|Study Terminated by Sponsor|0|||
163101103|NCT01238991|589077347|FG002|Overall Study|Study Terminated by Sponsor|0|||
163101104|NCT01238991|589077348|FG003|Overall Study|Study Terminated by Sponsor|0|||
163101105|NCT01238991|589077349|FG004|Overall Study|Study Terminated by Sponsor|1|||
163101106|NCT01238991|589077350|FG005|Overall Study|Study Terminated by Sponsor|0|||
163101107|NCT01238991|589077351|FG006|Overall Study|Study Terminated by Sponsor|7|||
163101108|NCT01238991|589077352|FG007|Overall Study|Study Terminated by Sponsor|4|||
163101109|NCT01238991|589077353|FG008|Overall Study|Study Terminated by Sponsor|2|||
163101110|NCT01238991|589077354|FG009|Overall Study|Study Terminated by Sponsor|2|||
163101111|NCT01238991|589077345|FG000|Overall Study|Caregiver's request|0|||
163101112|NCT01238991|589077346|FG001|Overall Study|Caregiver's request|0|||
163101113|NCT01238991|589077347|FG002|Overall Study|Caregiver's request|0|||
163101114|NCT01238991|589077348|FG003|Overall Study|Caregiver's request|0|||
163101115|NCT01238991|589077349|FG004|Overall Study|Caregiver's request|0|||
163101116|NCT01238991|589077350|FG005|Overall Study|Caregiver's request|0|||
163101117|NCT01238991|589077351|FG006|Overall Study|Caregiver's request|0|||
163101118|NCT01238991|589077352|FG007|Overall Study|Caregiver's request|0|||
163101119|NCT01238991|589077353|FG008|Overall Study|Caregiver's request|1|||
163101120|NCT01238991|589077354|FG009|Overall Study|Caregiver's request|0|||
163101121|NCT01238991|589077345|FG000|Overall Study|Admission to a nursing home|1|||
163101122|NCT01238991|589077346|FG001|Overall Study|Admission to a nursing home|0|||
163101123|NCT01238991|589077347|FG002|Overall Study|Admission to a nursing home|1|||
163101124|NCT01238991|589077348|FG003|Overall Study|Admission to a nursing home|0|||
163101125|NCT01238991|589077349|FG004|Overall Study|Admission to a nursing home|0|||
163101126|NCT01238991|589077350|FG005|Overall Study|Admission to a nursing home|0|||
163101127|NCT01238991|589077351|FG006|Overall Study|Admission to a nursing home|0|||
163101128|NCT01238991|589077352|FG007|Overall Study|Admission to a nursing home|0|||
163101129|NCT01238991|589077353|FG008|Overall Study|Admission to a nursing home|0|||
163101130|NCT01238991|589077354|FG009|Overall Study|Admission to a nursing home|0|||
163101131|NCT05959447|589077357|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
163101132|NCT05959447|589077358|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
163101133|NCT05959447|589077357|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
163101134|NCT05959447|589077358|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
163101135|NCT05959447|589077357|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
163101136|NCT05959447|589077358|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
163101137|NCT05959447|589077357|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
163101138|NCT05959447|589077358|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
163101139|NCT02522429|589077359|FG000|Overall Study|Lost to Follow-up|8|||
163101140|NCT02522429|589077359|FG000|Overall Study|Adverse Event|2|||
163101141|NCT02522429|589077359|FG000|Overall Study|Death|1|||
163101142|NCT02522429|589077359|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
163101143|NCT00294671|589077360|FG000|Overall Study|Lack of Efficacy|11|||
163101144|NCT00294671|589077361|FG001|Overall Study|Lack of Efficacy|23|||
163101145|NCT00294671|589077360|FG000|Overall Study|Liver transplant|7|||
163101146|NCT00294671|589077361|FG001|Overall Study|Liver transplant|9|||
163101147|NCT00294671|589077360|FG000|Overall Study|Drug related adverse event (AE)|4|||
163101148|NCT00294671|589077361|FG001|Overall Study|Drug related adverse event (AE)|2|||
163101149|NCT00294671|589077360|FG000|Overall Study|Non-drug related AE|3|||
163101150|NCT00294671|589077361|FG001|Overall Study|Non-drug related AE|2|||
163101151|NCT00294671|589077360|FG000|Overall Study|Lost to Follow-up|1|||
163101152|NCT00294671|589077361|FG001|Overall Study|Lost to Follow-up|3|||
163101153|NCT00294671|589077360|FG000|Overall Study|Non-compliance|1|||
163101154|NCT00294671|589077361|FG001|Overall Study|Non-compliance|0|||
163101155|NCT00294671|589077360|FG000|Overall Study|Death|0|||
163101156|NCT00294671|589077361|FG001|Overall Study|Death|1|||
163101157|NCT01961297|589077366|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
163101158|NCT01961297|589077367|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
163101159|NCT03053440|589077370|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
163101160|NCT03053440|589077371|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
163101161|NCT03053440|589077370|FG000|Overall Study|Death|18|||
163101162|NCT03053440|589077371|FG001|Overall Study|Death|14|||
163101163|NCT03053440|589077370|FG000|Overall Study|Withdrawal by Subject|9|||
163101164|NCT03053440|589077371|FG001|Overall Study|Withdrawal by Subject|8|||
163101165|NCT03053440|589077370|FG000|Overall Study|Lost to Follow-up|1|||
163101166|NCT03053440|589077371|FG001|Overall Study|Lost to Follow-up|0|||
163101167|NCT03053440|589077370|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
163101168|NCT03053440|589077371|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
163101169|NCT03053440|589077370|FG000|Overall Study|Physician Decision|2|||
163101170|NCT03053440|589077371|FG001|Overall Study|Physician Decision|1|||
163101171|NCT03053440|589077370|FG000|Overall Study|Participant Randomized but died before dosing|1|||
163101172|NCT03053440|589077371|FG001|Overall Study|Participant Randomized but died before dosing|0|||
163101173|NCT00391053|589077377|FG000|Overall Study|Serious Adverse Events|1|||
163101174|NCT00391053|589077378|FG001|Overall Study|Serious Adverse Events|0|||
163101175|NCT00391053|589077379|FG002|Overall Study|Serious Adverse Events|1|||
163101176|NCT00391053|589077380|FG003|Overall Study|Serious Adverse Events|4|||
163101177|NCT00391053|589077377|FG000|Overall Study|Protocol Violation|2|||
163101178|NCT00391053|589077378|FG001|Overall Study|Protocol Violation|0|||
163101179|NCT00391053|589077379|FG002|Overall Study|Protocol Violation|0|||
163101180|NCT00391053|589077380|FG003|Overall Study|Protocol Violation|0|||
163101181|NCT00391053|589077377|FG000|Overall Study|Lost to Follow-up|1|||
163101182|NCT00391053|589077378|FG001|Overall Study|Lost to Follow-up|0|||
163101183|NCT00391053|589077379|FG002|Overall Study|Lost to Follow-up|0|||
163101184|NCT00391053|589077380|FG003|Overall Study|Lost to Follow-up|5|||
163101185|NCT00391053|589077377|FG000|Overall Study|Withdrawal by Subject|5|||
163101186|NCT00391053|589077378|FG001|Overall Study|Withdrawal by Subject|1|||
163101187|NCT00391053|589077379|FG002|Overall Study|Withdrawal by Subject|1|||
163101188|NCT00391053|589077380|FG003|Overall Study|Withdrawal by Subject|1|||
163339425|NCT01681511|589951169|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
163339426|NCT01681511|589951168|FG000|Overall Study|No Daily Urine Sample Collected|0|||
163101189|NCT00473889|589077382|FG000|Overall Study|Did not receive study medication|1|||
163101190|NCT00473889|589077383|FG001|Overall Study|Did not receive study medication|4|||
163339427|NCT01681511|589951169|FG001|Overall Study|No Daily Urine Sample Collected|1|||
163101191|NCT00473889|589077382|FG000|Overall Study|Adverse Event|30|||
163101192|NCT00473889|589077383|FG001|Overall Study|Adverse Event|17|||
163101193|NCT00473889|589077382|FG000|Overall Study|Protocol Violation|4|||
163101194|NCT00473889|589077383|FG001|Overall Study|Protocol Violation|2|||
163101195|NCT00473889|589077382|FG000|Overall Study|Lack of Efficacy|28|||
163101196|NCT00473889|589077383|FG001|Overall Study|Lack of Efficacy|29|||
163339428|NCT01681511|589951168|FG000|Overall Study|No post-catheter sample collected|11|||
163339429|NCT01681511|589951169|FG001|Overall Study|No post-catheter sample collected|4|||
163339430|NCT01156675|589951170|FG000|Overall Study|Death|5|||
163339431|NCT01156675|589951171|FG001|Overall Study|Death|3|||
163339432|NCT01156675|589951172|FG002|Overall Study|Death|0|||
163339433|NCT01156675|589951170|FG000|Overall Study|No data|29|||
163101197|NCT00473889|589077382|FG000|Overall Study|Lost to Follow-up|2|||
163101198|NCT00473889|589077383|FG001|Overall Study|Lost to Follow-up|1|||
163101199|NCT00473889|589077382|FG000|Overall Study|Physician Decision|10|||
163101200|NCT00473889|589077383|FG001|Overall Study|Physician Decision|5|||
163101201|NCT00473889|589077382|FG000|Overall Study|Trial Terminated|3|||
163101202|NCT00473889|589077383|FG001|Overall Study|Trial Terminated|6|||
163101203|NCT00473889|589077382|FG000|Overall Study|Withdrawal by Subject|5|||
163101204|NCT00473889|589077383|FG001|Overall Study|Withdrawal by Subject|0|||
163101205|NCT02140970|589077384|FG000|Overall Study|Lost to Follow-up|1|||
163101206|NCT02140970|589077385|FG001|Overall Study|Lost to Follow-up|2|||
163101207|NCT02140970|589077384|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
163101208|NCT02140970|589077385|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
163101209|NCT02140970|589077384|FG000|Overall Study|Did not meet inclusion criteria|0|||
163101210|NCT02140970|589077385|FG001|Overall Study|Did not meet inclusion criteria|1|||
163339434|NCT01156675|589951171|FG001|Overall Study|No data|22|||
163339435|NCT01156675|589951172|FG002|Overall Study|No data|2|||
163339436|NCT01970527|589951173|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
163339437|NCT01970527|589951174|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
163339438|NCT01970527|589951173|FG000|Treatment|Disease progression|0|||
163339439|NCT01970527|589951174|FG001|Treatment|Disease progression|1|||
163339440|NCT01970527|589951173|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
163339441|NCT01970527|589951174|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
163101219|NCT00460655|589077391|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
163101220|NCT00460655|589077392|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163101221|NCT00460655|589077393|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163101222|NCT00460655|589077394|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163101223|NCT00460655|589077391|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
163101224|NCT00460655|589077392|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163101225|NCT00460655|589077393|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163101226|NCT00460655|589077394|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163101227|NCT00460655|589077391|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
163101228|NCT00460655|589077392|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
163101229|NCT00460655|589077393|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
163101230|NCT00460655|589077394|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
163101231|NCT00460655|589077391|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
163101232|NCT00460655|589077392|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
163101233|NCT00460655|589077393|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
163101234|NCT00460655|589077394|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
163101235|NCT00460655|589077391|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163101236|NCT00460655|589077392|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163101237|NCT00460655|589077393|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
163101238|NCT00460655|589077394|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
163101239|NCT00460655|589077391|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
163101240|NCT00460655|589077392|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
163101241|NCT00460655|589077393|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
163101242|NCT00460655|589077394|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
163101243|NCT03050450|589077395|FG000|Overall Study|Physician Decision|1|||
163101244|NCT03050450|589077396|FG001|Overall Study|Physician Decision|0|||
163101245|NCT03050450|589077397|FG002|Overall Study|Physician Decision|0|||
163101246|NCT03050450|589077398|FG003|Overall Study|Physician Decision|0|||
163101247|NCT03050450|589077399|FG004|Overall Study|Physician Decision|0|||
163101248|NCT00590122|589077400|FG000|Overall Study|swallowed oral dissolving dose|1|||
163101249|NCT00590122|589077401|FG001|Overall Study|swallowed oral dissolving dose|0|||
163101250|NCT00735553|589077405|FG000|Overall Study|Study prematurely terminated|77|||
163101251|NCT02705105|589077406|FG000|Treatment|Objective Disease Progression|1|||
163101252|NCT02705105|589077407|FG001|Treatment|Objective Disease Progression|50|||
163101253|NCT02705105|589077406|FG000|Treatment|Withdrawal by Subject|3|||
163101254|NCT02705105|589077407|FG001|Treatment|Withdrawal by Subject|5|||
163101255|NCT02705105|589077406|FG000|Treatment|Adverse Event|0|||
163339442|NCT01970527|589951173|FG000|Treatment|Death|0|||
163101256|NCT02705105|589077407|FG001|Treatment|Adverse Event|17|||
163101257|NCT02705105|589077406|FG000|Treatment|Clinical Disease Progression|0|||
163101258|NCT02705105|589077407|FG001|Treatment|Clinical Disease Progression|32|||
163101259|NCT02705105|589077406|FG000|Treatment|Physician Decision|0|||
163101260|NCT02705105|589077407|FG001|Treatment|Physician Decision|3|||
163101261|NCT02705105|589077406|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
163339443|NCT01970527|589951174|FG001|Treatment|Death|1|||
163339444|NCT01970527|589951173|FG000|Follow-up Clinic Visit|Disease progression|1|||
163101262|NCT02705105|589077407|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
163101263|NCT02705105|589077406|FG000|Follow-Up|Death|3|||
163101264|NCT02705105|589077407|FG001|Follow-Up|Death|68|||
163101265|NCT02705105|589077406|FG000|Follow-Up|Withdrawal by Subject|1|||
163101266|NCT02705105|589077407|FG001|Follow-Up|Withdrawal by Subject|14|||
163101267|NCT02705105|589077406|FG000|Follow-Up|Study Terminated|0|||
163101268|NCT02705105|589077407|FG001|Follow-Up|Study Terminated|26|||
163101269|NCT02705105|589077406|FG000|Follow-Up|Discontinued per Amendment 3|0|||
163101270|NCT02705105|589077407|FG001|Follow-Up|Discontinued per Amendment 3|2|||
163101271|NCT00711594|589077409|FG000|Overall Study|Progressive disease|2|||
163101272|NCT00711594|589077410|FG001|Overall Study|Progressive disease|2|||
163101273|NCT00711594|589077411|FG002|Overall Study|Progressive disease|6|||
163101274|NCT00711594|589077412|FG003|Overall Study|Progressive disease|44|||
163101275|NCT00711594|589077409|FG000|Overall Study|Other Adverse Event|1|||
163101276|NCT00711594|589077410|FG001|Overall Study|Other Adverse Event|0|||
163101277|NCT00711594|589077411|FG002|Overall Study|Other Adverse Event|0|||
163101278|NCT00711594|589077412|FG003|Overall Study|Other Adverse Event|16|||
163101279|NCT00711594|589077409|FG000|Overall Study|Withdrawal by Subject|0|||
163101280|NCT00711594|589077410|FG001|Overall Study|Withdrawal by Subject|1|||
163101281|NCT00711594|589077411|FG002|Overall Study|Withdrawal by Subject|0|||
163101282|NCT00711594|589077412|FG003|Overall Study|Withdrawal by Subject|2|||
163101283|NCT00211172|589077415|FG000|Overall Study|Died or lost health plan eligibility|39|||
163101284|NCT00211172|589077416|FG001|Overall Study|Died or lost health plan eligibility|32|||
163101285|NCT02253433|589077420|FG000|Overall Study|Unable to Contact|9|||
163101286|NCT02253433|589077421|FG001|Overall Study|Unable to Contact|16|||
163101287|NCT02253433|589077420|FG000|Overall Study|Death|1|||
163101288|NCT02253433|589077421|FG001|Overall Study|Death|1|||
163101289|NCT02253433|589077420|FG000|Overall Study|No Longer Interested|3|||
163101290|NCT02253433|589077421|FG001|Overall Study|No Longer Interested|15|||
163101291|NCT02253433|589077420|FG000|Overall Study|Out of Study Area|2|||
163101292|NCT02253433|589077421|FG001|Overall Study|Out of Study Area|7|||
163101293|NCT02253433|589077420|FG000|Overall Study|Uncomfortable with home visitors|0|||
163101294|NCT02253433|589077421|FG001|Overall Study|Uncomfortable with home visitors|3|||
163101295|NCT02253433|589077420|FG000|Overall Study|Unstable Housing/Homeless|0|||
163101296|NCT02253433|589077421|FG001|Overall Study|Unstable Housing/Homeless|7|||
163101297|NCT02253433|589077420|FG000|Overall Study|Too Busy|0|||
163101298|NCT02253433|589077421|FG001|Overall Study|Too Busy|4|||
163101299|NCT02253433|589077420|FG000|Overall Study|Medical or Other Concerns|1|||
163101300|NCT02253433|589077421|FG001|Overall Study|Medical or Other Concerns|2|||
163101301|NCT00040742|589077424|FG000|Overall Study|Death|0|||
163101302|NCT00040742|589077425|FG001|Overall Study|Death|0|||
163101303|NCT00040742|589077426|FG002|Overall Study|Death|1|||
163101304|NCT00040742|589077427|FG003|Overall Study|Death|0|||
163101305|NCT00040742|589077424|FG000|Overall Study|Adverse Event|15|||
163101306|NCT00040742|589077425|FG001|Overall Study|Adverse Event|16|||
163101307|NCT00040742|589077426|FG002|Overall Study|Adverse Event|21|||
163101308|NCT00040742|589077427|FG003|Overall Study|Adverse Event|9|||
163101309|NCT00040742|589077424|FG000|Overall Study|Withdrawal by Subject|7|||
163101310|NCT00040742|589077425|FG001|Overall Study|Withdrawal by Subject|15|||
163101311|NCT00040742|589077426|FG002|Overall Study|Withdrawal by Subject|10|||
163101312|NCT00040742|589077427|FG003|Overall Study|Withdrawal by Subject|13|||
163101313|NCT00040742|589077424|FG000|Overall Study|Chemotoxicity|4|||
163101314|NCT00040742|589077425|FG001|Overall Study|Chemotoxicity|3|||
163101315|NCT00040742|589077426|FG002|Overall Study|Chemotoxicity|5|||
163101316|NCT00040742|589077427|FG003|Overall Study|Chemotoxicity|2|||
163101317|NCT00040742|589077424|FG000|Overall Study|Incomplete Forms|6|||
163101318|NCT00040742|589077425|FG001|Overall Study|Incomplete Forms|10|||
163101319|NCT00040742|589077426|FG002|Overall Study|Incomplete Forms|4|||
163101320|NCT00040742|589077427|FG003|Overall Study|Incomplete Forms|5|||
163101321|NCT00040742|589077424|FG000|Overall Study|Other medical|7|||
163101322|NCT00040742|589077425|FG001|Overall Study|Other medical|5|||
163101323|NCT00040742|589077426|FG002|Overall Study|Other medical|5|||
163101324|NCT00040742|589077427|FG003|Overall Study|Other medical|5|||
163101325|NCT00624468|589077428|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
163101326|NCT00624468|589077429|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
163101327|NCT00624468|589077430|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
163101328|NCT00624468|589077431|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
163101329|NCT00624468|589077428|FG000|Double-blind Period|Withdrew Prematurely|1|||
163101330|NCT00624468|589077429|FG001|Double-blind Period|Withdrew Prematurely|1|||
163101331|NCT00624468|589077430|FG002|Double-blind Period|Withdrew Prematurely|0|||
163101332|NCT00624468|589077431|FG003|Double-blind Period|Withdrew Prematurely|0|||
163101333|NCT00624468|589077428|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
163101334|NCT00624468|589077429|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
163101335|NCT00624468|589077430|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
163101336|NCT00624468|589077431|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
163101337|NCT00624468|589077428|FG000|Safety Follow-up (SFU) Period|Other|0|||
163101338|NCT00624468|589077429|FG001|Safety Follow-up (SFU) Period|Other|0|||
163101339|NCT00624468|589077430|FG002|Safety Follow-up (SFU) Period|Other|1|||
163101340|NCT00624468|589077431|FG003|Safety Follow-up (SFU) Period|Other|1|||
163101341|NCT01523743|589077432|FG000|Period 1|Adverse Event|1|||
163101342|NCT01523743|589077433|FG001|Period 1|Adverse Event|0|||
163101343|NCT01523743|589077432|FG000|Period 1|Withdrawal by Subject|6|||
163101344|NCT01523743|589077433|FG001|Period 1|Withdrawal by Subject|2|||
163101345|NCT01523743|589077432|FG000|Period 1|Lost to Follow-up|1|||
163101346|NCT01523743|589077433|FG001|Period 1|Lost to Follow-up|0|||
163101347|NCT01523743|589077432|FG000|Period 1|Lack of Efficacy|1|||
163101348|NCT01523743|589077433|FG001|Period 1|Lack of Efficacy|0|||
163101349|NCT01523743|589077432|FG000|Period 1|Felt unable to empty bladder|1|||
163101350|NCT01523743|589077433|FG001|Period 1|Felt unable to empty bladder|0|||
163101351|NCT01523743|589077432|FG000|Period 2|Withdrawal by Subject|0|||
163101352|NCT01523743|589077433|FG001|Period 2|Withdrawal by Subject|2|||
163101353|NCT01523743|589077432|FG000|Period 2|Adverse Event|1|||
163101354|NCT01523743|589077433|FG001|Period 2|Adverse Event|0|||
163101355|NCT01434654|589077434|FG000|Overall Study|Withdrawal by Subject|1|||
163101356|NCT01434654|589077435|FG001|Overall Study|Withdrawal by Subject|0|||
163101357|NCT01434654|589077434|FG000|Overall Study|Lost to Follow-up|1|||
163101358|NCT01434654|589077435|FG001|Overall Study|Lost to Follow-up|0|||
163101359|NCT00363142|589077436|FG000|Overall Study|Adverse Event|2|||
163101360|NCT00363142|589077437|FG001|Overall Study|Adverse Event|0|||
163101361|NCT00363142|589077436|FG000|Overall Study|Lack of Efficacy|0|||
163101362|NCT00363142|589077437|FG001|Overall Study|Lack of Efficacy|1|||
163101363|NCT00363142|589077436|FG000|Overall Study|Lost to Follow-up|1|||
163101364|NCT00363142|589077437|FG001|Overall Study|Lost to Follow-up|0|||
163101365|NCT00363142|589077436|FG000|Overall Study|Non-compliance|1|||
163101366|NCT00363142|589077437|FG001|Overall Study|Non-compliance|1|||
163101367|NCT00363142|589077436|FG000|Overall Study|Withdrawal by Subject|3|||
163101368|NCT00363142|589077437|FG001|Overall Study|Withdrawal by Subject|1|||
163101369|NCT01340664|589077442|FG000|Overall Study|Adverse Event|0|||
163101370|NCT01340664|589077443|FG001|Overall Study|Adverse Event|1|||
163101371|NCT01340664|589077444|FG002|Overall Study|Adverse Event|7|||
163101372|NCT01340664|589077442|FG000|Overall Study|Lost to Follow-up|2|||
163101373|NCT01340664|589077443|FG001|Overall Study|Lost to Follow-up|0|||
163101374|NCT01340664|589077444|FG002|Overall Study|Lost to Follow-up|2|||
163101375|NCT01340664|589077442|FG000|Overall Study|Withdrawal by Subject|2|||
163101376|NCT01340664|589077443|FG001|Overall Study|Withdrawal by Subject|4|||
163101377|NCT01340664|589077444|FG002|Overall Study|Withdrawal by Subject|0|||
163101378|NCT01340664|589077442|FG000|Overall Study|Glycemic withdrawal criteria|2|||
163101379|NCT01340664|589077443|FG001|Overall Study|Glycemic withdrawal criteria|0|||
163101380|NCT01340664|589077444|FG002|Overall Study|Glycemic withdrawal criteria|0|||
163101381|NCT01340664|589077442|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
163101382|NCT01340664|589077443|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
163101383|NCT01340664|589077444|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
163101384|NCT01340664|589077442|FG000|Overall Study|Other|1|||
163101385|NCT01340664|589077443|FG001|Overall Study|Other|2|||
163101386|NCT01340664|589077444|FG002|Overall Study|Other|2|||
163101387|NCT01823198|589077446|FG000|Overall Study|Physician Decision|0|||
163101388|NCT01823198|589077447|FG001|Overall Study|Physician Decision|1|||
163101389|NCT01823198|589077448|FG002|Overall Study|Physician Decision|0|||
163101390|NCT01823198|589077449|FG003|Overall Study|Physician Decision|0|||
163101391|NCT01823198|589077450|FG004|Overall Study|Physician Decision|0|||
163101392|NCT01823198|589077451|FG005|Overall Study|Physician Decision|3|||
163101393|NCT01823198|589077452|FG006|Overall Study|Physician Decision|3|||
163101394|NCT02441101|589077453|FG000|Overall Study|Withdrawal by Subject|1|||
163101395|NCT02441101|589077454|FG001|Overall Study|Withdrawal by Subject|0|||
163101396|NCT02441101|589077453|FG000|Overall Study|Lost to Follow-up|1|||
163101397|NCT02441101|589077454|FG001|Overall Study|Lost to Follow-up|0|||
163101398|NCT02441101|589077453|FG000|Overall Study|PI relocated and study terminated|1|||
163101399|NCT02441101|589077454|FG001|Overall Study|PI relocated and study terminated|0|||
163101400|NCT02528942|589077455|FG000|Overall Study|Did not meet imaging criteria|9|||
163101401|NCT02528942|589077455|FG000|Overall Study|Lost to Follow-up|25|||
163101402|NCT03035864|589077456|FG000|Treatment Period|Adverse Event|1|||
163101403|NCT03035864|589077457|FG001|Treatment Period|Adverse Event|0|||
163101404|NCT03035864|589077456|FG000|Treatment Period|Other|3|||
163101405|NCT03035864|589077457|FG001|Treatment Period|Other|1|||
163101406|NCT03035864|589077456|FG000|Follow-up Period|Adverse Event|1|||
163101407|NCT03035864|589077457|FG001|Follow-up Period|Adverse Event|0|||
163101408|NCT03035864|589077456|FG000|Follow-up Period|Lost to Follow-up|6|||
163101409|NCT03035864|589077457|FG001|Follow-up Period|Lost to Follow-up|2|||
163101410|NCT03035864|589077456|FG000|Follow-up Period|Physician Decision|1|||
163101411|NCT03035864|589077457|FG001|Follow-up Period|Physician Decision|0|||
163101412|NCT03035864|589077456|FG000|Follow-up Period|Other|3|||
163101413|NCT03035864|589077457|FG001|Follow-up Period|Other|2|||
163101414|NCT00100802|589077460|FG000|Overall Study|Adverse Event|9|||
163101415|NCT00100802|589077460|FG000|Overall Study|Death|1|||
163101416|NCT00100802|589077460|FG000|Overall Study|Lack of Efficacy|47|||
163101417|NCT00100802|589077460|FG000|Overall Study|Physician Decision|5|||
163101418|NCT00100802|589077460|FG000|Overall Study|Protocol Violation|1|||
163101419|NCT00100802|589077460|FG000|Overall Study|Withdrawal by Subject|5|||
163101420|NCT00100802|589077460|FG000|Overall Study|Ineligible|12|||
163101421|NCT03744910|589079223|FG000|Overall Study|Withdrew Consent|1|||
163101422|NCT03744910|589079224|FG001|Overall Study|Withdrew Consent|8|||
163101423|NCT03744910|589079223|FG000|Overall Study|Physician Decision|5|||
163101424|NCT03744910|589079224|FG001|Overall Study|Physician Decision|4|||
163101425|NCT03744910|589079223|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
163101426|NCT03744910|589079224|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
163101427|NCT03744910|589079223|FG000|Overall Study|Lost to Follow-up|0|||
163101428|NCT03744910|589079224|FG001|Overall Study|Lost to Follow-up|1|||
163101429|NCT03744910|589079223|FG000|Overall Study|Other-unspecified|4|||
163101430|NCT03744910|589079224|FG001|Overall Study|Other-unspecified|1|||
163101431|NCT03430843|589079226|FG000|Overall Study|Death|233|||
163101432|NCT03430843|589079227|FG001|Overall Study|Death|233|||
163101433|NCT03430843|589079226|FG000|Overall Study|Sponsor Decision|17|||
163101434|NCT03430843|589079227|FG001|Overall Study|Sponsor Decision|6|||
163101435|NCT03430843|589079226|FG000|Overall Study|Withdrawal by Subject|5|||
163101436|NCT03430843|589079227|FG001|Overall Study|Withdrawal by Subject|14|||
163101437|NCT03430843|589079226|FG000|Overall Study|Lost to Follow-up|1|||
163101438|NCT03430843|589079227|FG001|Overall Study|Lost to Follow-up|3|||
163101439|NCT05360966|589079238|FG000|Overall Study|Adverse Event|5|||
163101440|NCT05360966|589079239|FG001|Overall Study|Adverse Event|5|||
163101441|NCT05360966|589079238|FG000|Overall Study|Withdrawal of Consent|5|||
163101442|NCT05360966|589079239|FG001|Overall Study|Withdrawal of Consent|3|||
163101443|NCT05360966|589079238|FG000|Overall Study|Noncompliance|2|||
163101444|NCT05360966|589079239|FG001|Overall Study|Noncompliance|1|||
163101445|NCT05360966|589079238|FG000|Overall Study|Lost to Follow-up|2|||
163101446|NCT05360966|589079239|FG001|Overall Study|Lost to Follow-up|3|||
163101447|NCT05360966|589079238|FG000|Overall Study|Protocol Deviation|2|||
163101448|NCT05360966|589079239|FG001|Overall Study|Protocol Deviation|1|||
163101449|NCT05360966|589079238|FG000|Overall Study|As specified in the Clinical Study Report|1|||
163101450|NCT05360966|589079239|FG001|Overall Study|As specified in the Clinical Study Report|3|||
163101451|NCT05396014|589079240|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
163101452|NCT05396014|589079241|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101453|NCT05396014|589079242|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101454|NCT05396014|589079243|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101455|NCT05396014|589079244|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101456|NCT05396014|589079245|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101457|NCT05396014|589079246|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101458|NCT05396014|589079247|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101459|NCT05396014|589079248|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101460|NCT05396014|589079249|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101461|NCT05396014|589079250|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101462|NCT05396014|589079251|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101463|NCT05396014|589079252|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101464|NCT05396014|589079253|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
163101465|NCT05396014|589079254|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101466|NCT05396014|589079255|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101467|NCT05396014|589079256|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101468|NCT05396014|589079257|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101469|NCT05396014|589079258|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101470|NCT05396014|589079259|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101471|NCT05396014|589079260|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101472|NCT05396014|589079261|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163220194|NCT02039674|589521414|FG008|Overall Study|Sponsor Decision|0|||
163220195|NCT02039674|589521415|FG009|Overall Study|Sponsor Decision|3|||
163220196|NCT02039674|589521416|FG010|Overall Study|Sponsor Decision|0|||
163220197|NCT02039674|589521417|FG011|Overall Study|Sponsor Decision|8|||
163220198|NCT02039674|589521418|FG012|Overall Study|Sponsor Decision|5|||
163220199|NCT02039674|589521419|FG013|Overall Study|Sponsor Decision|0|||
163220200|NCT02039674|589521406|FG000|Overall Study|Other|0|||
163220201|NCT02039674|589521407|FG001|Overall Study|Other|0|||
163220202|NCT02039674|589521408|FG002|Overall Study|Other|0|||
163220203|NCT02039674|589521409|FG003|Overall Study|Other|0|||
163220204|NCT02039674|589521410|FG004|Overall Study|Other|0|||
163220205|NCT02039674|589521411|FG005|Overall Study|Other|0|||
163101473|NCT05396014|589079262|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101474|NCT05396014|589079263|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101475|NCT05396014|589079264|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101476|NCT05396014|589079265|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101477|NCT05396014|589079266|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
163220206|NCT02039674|589521412|FG006|Overall Study|Other|0|||
163220207|NCT02039674|589521413|FG007|Overall Study|Other|0|||
163220208|NCT02039674|589521414|FG008|Overall Study|Other|0|||
163220209|NCT02039674|589521415|FG009|Overall Study|Other|0|||
163220210|NCT02039674|589521416|FG010|Overall Study|Other|0|||
163101478|NCT05396014|589079267|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101479|NCT05396014|589079268|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101480|NCT05396014|589079269|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101481|NCT05396014|589079270|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101482|NCT05396014|589079271|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101483|NCT05396014|589079272|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101484|NCT05396014|589079273|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101485|NCT05396014|589079274|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101486|NCT05396014|589079275|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101487|NCT05396014|589079276|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101488|NCT05396014|589079277|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101489|NCT05396014|589079278|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101490|NCT05396014|589079279|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
163101491|NCT05396014|589079280|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101492|NCT05396014|589079281|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101493|NCT05396014|589079282|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101494|NCT05396014|589079240|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
163101495|NCT05396014|589079241|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101496|NCT05396014|589079242|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101497|NCT05396014|589079243|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101498|NCT05396014|589079244|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101499|NCT05396014|589079245|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101500|NCT05396014|589079246|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101501|NCT05396014|589079247|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101502|NCT05396014|589079248|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101503|NCT05396014|589079249|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101504|NCT05396014|589079250|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101505|NCT05396014|589079251|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101506|NCT05396014|589079252|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101507|NCT05396014|589079253|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
163101508|NCT05396014|589079254|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101509|NCT05396014|589079255|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101510|NCT05396014|589079256|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101511|NCT05396014|589079257|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101512|NCT05396014|589079258|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101513|NCT05396014|589079259|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101514|NCT05396014|589079260|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101515|NCT05396014|589079261|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101516|NCT05396014|589079262|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101517|NCT05396014|589079263|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101518|NCT05396014|589079264|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101519|NCT05396014|589079265|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101520|NCT05396014|589079266|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
163101521|NCT05396014|589079267|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101522|NCT05396014|589079268|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101523|NCT05396014|589079269|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101524|NCT05396014|589079270|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101525|NCT05396014|589079271|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101526|NCT05396014|589079272|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101527|NCT05396014|589079273|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101528|NCT05396014|589079274|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101529|NCT05396014|589079275|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101530|NCT05396014|589079276|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101531|NCT05396014|589079277|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101532|NCT05396014|589079278|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101533|NCT05396014|589079279|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
163101534|NCT05396014|589079280|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101535|NCT05396014|589079281|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101536|NCT05396014|589079282|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101537|NCT05396014|589079240|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
163101538|NCT05396014|589079241|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101539|NCT05396014|589079242|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101540|NCT05396014|589079243|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101541|NCT05396014|589079244|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101542|NCT05396014|589079245|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101543|NCT05396014|589079246|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101544|NCT05396014|589079247|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101545|NCT05396014|589079248|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101546|NCT05396014|589079249|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101547|NCT05396014|589079250|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101548|NCT05396014|589079251|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101549|NCT05396014|589079252|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101550|NCT05396014|589079253|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
163101551|NCT05396014|589079254|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101552|NCT05396014|589079255|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101553|NCT05396014|589079256|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101554|NCT05396014|589079257|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101555|NCT05396014|589079258|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101556|NCT05396014|589079259|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101557|NCT05396014|589079260|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101558|NCT05396014|589079261|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101559|NCT05396014|589079262|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101560|NCT05396014|589079263|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101561|NCT05396014|589079264|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101562|NCT05396014|589079265|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101563|NCT05396014|589079266|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
163101564|NCT05396014|589079267|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101565|NCT05396014|589079268|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101566|NCT05396014|589079269|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101567|NCT05396014|589079270|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101568|NCT05396014|589079271|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101569|NCT05396014|589079272|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101570|NCT05396014|589079273|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101571|NCT05396014|589079274|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101572|NCT05396014|589079275|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101573|NCT05396014|589079276|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101574|NCT05396014|589079277|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101575|NCT05396014|589079278|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101576|NCT05396014|589079279|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
163101577|NCT05396014|589079280|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101578|NCT05396014|589079281|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101579|NCT05396014|589079282|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101580|NCT05396014|589079240|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101581|NCT05396014|589079241|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101582|NCT05396014|589079242|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101583|NCT05396014|589079243|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101584|NCT05396014|589079244|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101585|NCT05396014|589079245|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101586|NCT05396014|589079246|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101587|NCT05396014|589079247|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101588|NCT05396014|589079248|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101589|NCT05396014|589079249|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101590|NCT05396014|589079250|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101591|NCT05396014|589079251|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101592|NCT05396014|589079252|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101593|NCT05396014|589079253|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101594|NCT05396014|589079254|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101595|NCT05396014|589079255|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101596|NCT05396014|589079256|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101597|NCT05396014|589079257|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101598|NCT05396014|589079258|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101599|NCT05396014|589079259|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101600|NCT05396014|589079260|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101601|NCT05396014|589079261|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101602|NCT05396014|589079262|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101603|NCT05396014|589079263|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101604|NCT05396014|589079264|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101605|NCT05396014|589079265|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101606|NCT05396014|589079266|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
163101607|NCT05396014|589079267|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101608|NCT05396014|589079268|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101609|NCT05396014|589079269|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101610|NCT05396014|589079270|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101611|NCT05396014|589079271|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163339445|NCT01970527|589951174|FG001|Follow-up Clinic Visit|Disease progression|1|||
163339446|NCT01970527|589951173|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
163339447|NCT01970527|589951174|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
163101612|NCT05396014|589079272|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101613|NCT05396014|589079273|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101614|NCT05396014|589079274|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101615|NCT05396014|589079275|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101616|NCT05396014|589079276|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101617|NCT05396014|589079277|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101618|NCT05396014|589079278|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101619|NCT05396014|589079279|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
163101620|NCT05396014|589079280|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101621|NCT05396014|589079281|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101622|NCT05396014|589079282|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101623|NCT05396014|589079240|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101624|NCT05396014|589079241|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101625|NCT05396014|589079242|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101626|NCT05396014|589079243|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101627|NCT05396014|589079244|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101628|NCT05396014|589079245|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101629|NCT05396014|589079246|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101630|NCT05396014|589079247|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101631|NCT05396014|589079248|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101632|NCT05396014|589079249|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101633|NCT05396014|589079250|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101634|NCT05396014|589079251|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101635|NCT05396014|589079252|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101636|NCT05396014|589079253|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101637|NCT05396014|589079254|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101638|NCT05396014|589079255|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101639|NCT05396014|589079256|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101640|NCT05396014|589079257|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101641|NCT05396014|589079258|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101642|NCT05396014|589079259|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101643|NCT05396014|589079260|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101644|NCT05396014|589079261|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101645|NCT05396014|589079262|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101646|NCT05396014|589079263|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101647|NCT05396014|589079264|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101648|NCT05396014|589079265|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101649|NCT05396014|589079266|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
163101650|NCT05396014|589079267|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101651|NCT05396014|589079268|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101652|NCT05396014|589079269|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101653|NCT05396014|589079270|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101654|NCT05396014|589079271|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101655|NCT05396014|589079272|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101656|NCT05396014|589079273|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101657|NCT05396014|589079274|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101658|NCT05396014|589079275|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101659|NCT05396014|589079276|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101660|NCT05396014|589079277|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101661|NCT05396014|589079278|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101662|NCT05396014|589079279|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101663|NCT05396014|589079280|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101664|NCT05396014|589079281|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101665|NCT05396014|589079282|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101666|NCT05396014|589079240|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101667|NCT05396014|589079241|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101668|NCT05396014|589079242|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101669|NCT05396014|589079243|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163339448|NCT01970527|589951173|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
163101670|NCT05396014|589079244|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101671|NCT05396014|589079245|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163339449|NCT01970527|589951174|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
163339450|NCT00116649|589951190|FG000|Overall Study|Adverse Event|20|||
163101672|NCT05396014|589079246|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101673|NCT05396014|589079247|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101674|NCT05396014|589079248|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101675|NCT05396014|589079249|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101676|NCT05396014|589079250|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101677|NCT05396014|589079251|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101678|NCT05396014|589079252|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101679|NCT05396014|589079253|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
163101680|NCT05396014|589079254|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101681|NCT05396014|589079255|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101682|NCT05396014|589079256|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101683|NCT05396014|589079257|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101684|NCT05396014|589079258|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101685|NCT05396014|589079259|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101686|NCT05396014|589079260|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101687|NCT05396014|589079261|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101688|NCT05396014|589079262|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101689|NCT05396014|589079263|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101690|NCT05396014|589079264|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101691|NCT05396014|589079265|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101692|NCT05396014|589079266|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101693|NCT05396014|589079267|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101694|NCT05396014|589079268|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101695|NCT05396014|589079269|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101696|NCT05396014|589079270|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101697|NCT05396014|589079271|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101698|NCT05396014|589079272|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101699|NCT05396014|589079273|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101700|NCT05396014|589079274|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101701|NCT05396014|589079275|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101702|NCT05396014|589079276|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101703|NCT05396014|589079277|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101704|NCT05396014|589079278|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101705|NCT05396014|589079279|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101706|NCT05396014|589079280|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101707|NCT05396014|589079281|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101708|NCT05396014|589079282|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101709|NCT05396014|589079240|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
163101710|NCT05396014|589079241|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101711|NCT05396014|589079242|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101712|NCT05396014|589079243|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101713|NCT05396014|589079244|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101714|NCT05396014|589079245|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101715|NCT05396014|589079246|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101716|NCT05396014|589079247|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101717|NCT05396014|589079248|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101718|NCT05396014|589079249|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101719|NCT05396014|589079250|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101720|NCT05396014|589079251|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101721|NCT05396014|589079252|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101722|NCT05396014|589079253|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
163101723|NCT05396014|589079254|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101724|NCT05396014|589079255|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101725|NCT05396014|589079256|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101726|NCT05396014|589079257|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101727|NCT05396014|589079258|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101728|NCT05396014|589079259|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101729|NCT05396014|589079260|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101730|NCT05396014|589079261|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101731|NCT05396014|589079262|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101732|NCT05396014|589079263|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101733|NCT05396014|589079264|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163339451|NCT00116649|589951190|FG000|Overall Study|Lack of Efficacy|1|||
163339452|NCT00116649|589951190|FG000|Overall Study|Lost to Follow-up|32|||
163339453|NCT00116649|589951190|FG000|Overall Study|Withdrawal by Subject|68|||
163101734|NCT05396014|589079265|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101735|NCT05396014|589079266|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101736|NCT05396014|589079267|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101737|NCT05396014|589079268|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101738|NCT05396014|589079269|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101739|NCT05396014|589079270|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101740|NCT05396014|589079271|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101741|NCT05396014|589079272|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101742|NCT05396014|589079273|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101743|NCT05396014|589079274|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101744|NCT05396014|589079275|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101745|NCT05396014|589079276|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101746|NCT05396014|589079277|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101747|NCT05396014|589079278|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101748|NCT05396014|589079279|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
163101749|NCT05396014|589079280|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101750|NCT05396014|589079281|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101751|NCT05396014|589079282|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101752|NCT05396014|589079240|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
163101753|NCT05396014|589079241|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101754|NCT05396014|589079242|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101755|NCT05396014|589079243|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101756|NCT05396014|589079244|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101757|NCT05396014|589079245|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101758|NCT05396014|589079246|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101759|NCT05396014|589079247|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101760|NCT05396014|589079248|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101761|NCT05396014|589079249|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101762|NCT05396014|589079250|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101763|NCT05396014|589079251|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101764|NCT05396014|589079252|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101765|NCT05396014|589079253|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101766|NCT05396014|589079254|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101767|NCT05396014|589079255|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101768|NCT05396014|589079256|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101769|NCT05396014|589079257|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101770|NCT05396014|589079258|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101771|NCT05396014|589079259|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101772|NCT05396014|589079260|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101773|NCT05396014|589079261|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101774|NCT05396014|589079262|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101775|NCT05396014|589079263|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101776|NCT05396014|589079264|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101777|NCT05396014|589079265|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101778|NCT05396014|589079266|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
163101779|NCT05396014|589079267|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101780|NCT05396014|589079268|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101781|NCT05396014|589079269|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101782|NCT05396014|589079270|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101783|NCT05396014|589079271|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101784|NCT05396014|589079272|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101785|NCT05396014|589079273|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101786|NCT05396014|589079274|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101787|NCT05396014|589079275|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101788|NCT05396014|589079276|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101789|NCT05396014|589079277|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101790|NCT05396014|589079278|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101791|NCT05396014|589079279|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101792|NCT05396014|589079280|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101793|NCT05396014|589079281|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163339454|NCT00116649|589951190|FG000|Overall Study|Local Skin Reaction|9|||
163101794|NCT05396014|589079282|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163339455|NCT00116649|589951190|FG000|Overall Study|Various Reasons|18|||
163339456|NCT00116649|589951190|FG000|Overall Study|Protocol Specified|7|||
163101795|NCT05396014|589079240|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101796|NCT05396014|589079241|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101797|NCT05396014|589079242|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101798|NCT05396014|589079243|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101799|NCT05396014|589079244|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101800|NCT05396014|589079245|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101801|NCT05396014|589079246|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101802|NCT05396014|589079247|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101803|NCT05396014|589079248|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101804|NCT05396014|589079249|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101805|NCT05396014|589079250|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101806|NCT05396014|589079251|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101807|NCT05396014|589079252|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101808|NCT05396014|589079253|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
163101809|NCT05396014|589079254|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101810|NCT05396014|589079255|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101811|NCT05396014|589079256|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101812|NCT05396014|589079257|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101813|NCT05396014|589079258|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101814|NCT05396014|589079259|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101815|NCT05396014|589079260|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101816|NCT05396014|589079261|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101817|NCT05396014|589079262|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101818|NCT05396014|589079263|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101819|NCT05396014|589079264|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101820|NCT05396014|589079265|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101821|NCT05396014|589079266|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101822|NCT05396014|589079267|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101823|NCT05396014|589079268|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101824|NCT05396014|589079269|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101825|NCT05396014|589079270|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101826|NCT05396014|589079271|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101827|NCT05396014|589079272|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101828|NCT05396014|589079273|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101829|NCT05396014|589079274|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101830|NCT05396014|589079275|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101831|NCT05396014|589079276|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101832|NCT05396014|589079277|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101833|NCT05396014|589079278|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101834|NCT05396014|589079279|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101835|NCT05396014|589079280|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101836|NCT05396014|589079281|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101837|NCT05396014|589079282|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101838|NCT05396014|589079240|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101839|NCT05396014|589079241|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101840|NCT05396014|589079242|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101841|NCT05396014|589079243|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
163101842|NCT05396014|589079244|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101843|NCT05396014|589079245|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101844|NCT05396014|589079246|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101845|NCT05396014|589079247|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101846|NCT05396014|589079248|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
163101847|NCT05396014|589079249|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101848|NCT05396014|589079250|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101849|NCT05396014|589079251|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101850|NCT05396014|589079252|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101851|NCT05396014|589079253|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101852|NCT05396014|589079254|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101853|NCT05396014|589079255|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101854|NCT05396014|589079256|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101855|NCT05396014|589079257|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101856|NCT05396014|589079258|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101857|NCT05396014|589079259|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101858|NCT05396014|589079260|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101859|NCT05396014|589079261|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163220211|NCT02039674|589521417|FG011|Overall Study|Other|0|||
163220212|NCT02039674|589521418|FG012|Overall Study|Other|1|||
163220213|NCT02039674|589521419|FG013|Overall Study|Other|0|||
163220214|NCT01358357|589521420|FG000|Open Label Phase|Adverse Event|0|||
163220215|NCT01358357|589521421|FG001|Open Label Phase|Adverse Event|0|||
163220216|NCT01358357|589521422|FG002|Open Label Phase|Adverse Event|59|||
163220217|NCT01358357|589521420|FG000|Open Label Phase|Lack of Efficacy|0|||
163220218|NCT01358357|589521421|FG001|Open Label Phase|Lack of Efficacy|0|||
163220219|NCT01358357|589521422|FG002|Open Label Phase|Lack of Efficacy|107|||
163220220|NCT01358357|589521420|FG000|Open Label Phase|Lost to Follow-up|0|||
163220221|NCT01358357|589521421|FG001|Open Label Phase|Lost to Follow-up|0|||
163220222|NCT01358357|589521422|FG002|Open Label Phase|Lost to Follow-up|76|||
163220223|NCT01358357|589521420|FG000|Open Label Phase|Protocol Violation|0|||
163220224|NCT01358357|589521421|FG001|Open Label Phase|Protocol Violation|0|||
163220225|NCT01358357|589521422|FG002|Open Label Phase|Protocol Violation|45|||
163220226|NCT01358357|589521420|FG000|Open Label Phase|Withdrawal by Subject|0|||
163220227|NCT01358357|589521421|FG001|Open Label Phase|Withdrawal by Subject|0|||
163220228|NCT01358357|589521422|FG002|Open Label Phase|Withdrawal by Subject|112|||
163220229|NCT01358357|589521420|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
163220230|NCT01358357|589521421|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
163220231|NCT01358357|589521422|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
163220232|NCT01358357|589521420|FG000|Open Label Phase|Terminated at study completion|0|||
163220233|NCT01358357|589521421|FG001|Open Label Phase|Terminated at study completion|0|||
163220234|NCT01358357|589521422|FG002|Open Label Phase|Terminated at study completion|5|||
163220235|NCT01358357|589521420|FG000|Open Label Phase|Mood episode|0|||
163220236|NCT01358357|589521421|FG001|Open Label Phase|Mood episode|0|||
163220237|NCT01358357|589521422|FG002|Open Label Phase|Mood episode|42|||
163220238|NCT01358357|589521420|FG000|Double-Blind Phase|Adverse Event|8|||
163220239|NCT01358357|589521421|FG001|Double-Blind Phase|Adverse Event|5|||
163220240|NCT01358357|589521422|FG002|Double-Blind Phase|Adverse Event|0|||
163220241|NCT01358357|589521420|FG000|Double-Blind Phase|Lost to Follow-up|5|||
163220242|NCT01358357|589521421|FG001|Double-Blind Phase|Lost to Follow-up|7|||
163220243|NCT01358357|589521422|FG002|Double-Blind Phase|Lost to Follow-up|0|||
163220244|NCT01358357|589521420|FG000|Double-Blind Phase|Protocol Violation|1|||
163220245|NCT01358357|589521421|FG001|Double-Blind Phase|Protocol Violation|11|||
163220246|NCT01358357|589521422|FG002|Double-Blind Phase|Protocol Violation|0|||
163220247|NCT01358357|589521420|FG000|Double-Blind Phase|Protocol Violation|16|||
163220248|NCT01358357|589521421|FG001|Double-Blind Phase|Protocol Violation|12|||
163220249|NCT01358357|589521422|FG002|Double-Blind Phase|Protocol Violation|0|||
163220250|NCT01358357|589521420|FG000|Double-Blind Phase|Terminated at study completion|2|||
163220251|NCT01358357|589521421|FG001|Double-Blind Phase|Terminated at study completion|0|||
163220252|NCT01358357|589521422|FG002|Double-Blind Phase|Terminated at study completion|0|||
163220253|NCT01358357|589521420|FG000|Double-Blind Phase|Recurrence of mood event|48|||
163220254|NCT01358357|589521421|FG001|Double-Blind Phase|Recurrence of mood event|64|||
163220255|NCT01358357|589521422|FG002|Double-Blind Phase|Recurrence of mood event|0|||
163220256|NCT01358357|589521420|FG000|Double-Blind Phase|Administrative|0|||
163220257|NCT01358357|589521421|FG001|Double-Blind Phase|Administrative|1|||
163220258|NCT01358357|589521422|FG002|Double-Blind Phase|Administrative|0|||
163220259|NCT03774433|589521423|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
163220260|NCT00108160|589521428|FG000|Overall Study|Lost to Follow-up|25|||
163220261|NCT00108160|589521429|FG001|Overall Study|Lost to Follow-up|12|||
163220262|NCT00108160|589521428|FG000|Overall Study|Death|1|||
163220263|NCT00108160|589521429|FG001|Overall Study|Death|2|||
163220264|NCT00108160|589521428|FG000|Overall Study|Withdrawal by Subject|4|||
163220265|NCT00108160|589521429|FG001|Overall Study|Withdrawal by Subject|2|||
163220266|NCT00108160|589521428|FG000|Overall Study|Protocol Violation|9|||
163220267|NCT00108160|589521429|FG001|Overall Study|Protocol Violation|5|||
163220268|NCT02081079|589521430|FG000|Overall Study|Lack of Efficacy|3|||
163220269|NCT02081079|589521431|FG001|Overall Study|Lack of Efficacy|2|||
163220270|NCT02081079|589521430|FG000|Overall Study|Lost to Follow-up|1|||
163220271|NCT02081079|589521431|FG001|Overall Study|Lost to Follow-up|0|||
163220272|NCT00768144|589521432|FG000|Overall Study|Adverse Event|13|||
163220273|NCT00768144|589521432|FG000|Overall Study|Progressive Disease|21|||
163220274|NCT00768144|589521432|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
163220275|NCT00768144|589521432|FG000|Overall Study|Pt Withdrew Consent|1|||
163220276|NCT01712854|589521433|FG000|Overall Study|Physician Decision|1|||
163220277|NCT01150123|589521434|FG000|Overall Study|Withdrawal by Subject|1|||
163220278|NCT01150123|589521435|FG001|Overall Study|Withdrawal by Subject|1|||
163220279|NCT01150123|589521436|FG002|Overall Study|Withdrawal by Subject|2|||
163220280|NCT01150123|589521437|FG003|Overall Study|Withdrawal by Subject|1|||
163220281|NCT01150123|589521438|FG004|Overall Study|Withdrawal by Subject|1|||
163220282|NCT01150123|589521439|FG005|Overall Study|Withdrawal by Subject|1|||
163220283|NCT01150123|589521440|FG006|Overall Study|Withdrawal by Subject|0|||
163220284|NCT01150123|589521441|FG007|Overall Study|Withdrawal by Subject|3|||
163220285|NCT01150123|589521442|FG008|Overall Study|Withdrawal by Subject|2|||
163220286|NCT01150123|589521443|FG009|Overall Study|Withdrawal by Subject|0|||
163220287|NCT01150123|589521444|FG010|Overall Study|Withdrawal by Subject|1|||
163220288|NCT01150123|589521445|FG011|Overall Study|Withdrawal by Subject|0|||
163220289|NCT01150123|589521446|FG012|Overall Study|Withdrawal by Subject|1|||
163220290|NCT01150123|589521447|FG013|Overall Study|Withdrawal by Subject|0|||
163220291|NCT01150123|589521448|FG014|Overall Study|Withdrawal by Subject|0|||
163220292|NCT01150123|589521449|FG015|Overall Study|Withdrawal by Subject|1|||
163220293|NCT01150123|589521450|FG016|Overall Study|Withdrawal by Subject|0|||
163220294|NCT01150123|589521451|FG017|Overall Study|Withdrawal by Subject|1|||
163220295|NCT01150123|589521434|FG000|Overall Study|Lost to Follow-up|2|||
163220296|NCT01150123|589521435|FG001|Overall Study|Lost to Follow-up|1|||
163220297|NCT01150123|589521436|FG002|Overall Study|Lost to Follow-up|2|||
163220298|NCT01150123|589521437|FG003|Overall Study|Lost to Follow-up|2|||
163220299|NCT01150123|589521438|FG004|Overall Study|Lost to Follow-up|2|||
163220300|NCT01150123|589521439|FG005|Overall Study|Lost to Follow-up|5|||
163220301|NCT01150123|589521440|FG006|Overall Study|Lost to Follow-up|0|||
163220302|NCT01150123|589521441|FG007|Overall Study|Lost to Follow-up|0|||
163220303|NCT01150123|589521442|FG008|Overall Study|Lost to Follow-up|3|||
163220304|NCT01150123|589521443|FG009|Overall Study|Lost to Follow-up|1|||
163220305|NCT01150123|589521444|FG010|Overall Study|Lost to Follow-up|1|||
163220306|NCT01150123|589521445|FG011|Overall Study|Lost to Follow-up|1|||
163220307|NCT01150123|589521446|FG012|Overall Study|Lost to Follow-up|2|||
163220308|NCT01150123|589521447|FG013|Overall Study|Lost to Follow-up|0|||
163220309|NCT01150123|589521448|FG014|Overall Study|Lost to Follow-up|0|||
163220310|NCT01150123|589521449|FG015|Overall Study|Lost to Follow-up|0|||
163220311|NCT01150123|589521450|FG016|Overall Study|Lost to Follow-up|0|||
163220312|NCT01150123|589521451|FG017|Overall Study|Lost to Follow-up|0|||
163220313|NCT02171260|589521454|FG000|Overall Study|Death|0|||
163220314|NCT02171260|589521455|FG001|Overall Study|Death|0|||
163220315|NCT02171260|589521456|FG002|Overall Study|Death|0|||
163220316|NCT02171260|589521457|FG003|Overall Study|Death|1|||
163220317|NCT02171260|589521454|FG000|Overall Study|Physician Decision|1|||
163220318|NCT02171260|589521455|FG001|Overall Study|Physician Decision|0|||
163220319|NCT02171260|589521456|FG002|Overall Study|Physician Decision|1|||
163220320|NCT02171260|589521457|FG003|Overall Study|Physician Decision|0|||
163220321|NCT02171260|589521454|FG000|Overall Study|Withdrawal by Subject|1|||
163220322|NCT02171260|589521455|FG001|Overall Study|Withdrawal by Subject|0|||
163220323|NCT02171260|589521456|FG002|Overall Study|Withdrawal by Subject|0|||
163220324|NCT02171260|589521457|FG003|Overall Study|Withdrawal by Subject|0|||
163220325|NCT02171260|589521454|FG000|Overall Study|Evidence of progressive disease|4|||
163220326|NCT02171260|589521455|FG001|Overall Study|Evidence of progressive disease|6|||
163220327|NCT02171260|589521456|FG002|Overall Study|Evidence of progressive disease|4|||
163220328|NCT02171260|589521457|FG003|Overall Study|Evidence of progressive disease|4|||
163220329|NCT00322842|589521460|FG000|Overall Study|Withdrawal by Subject|0|||
163220330|NCT00322842|589521461|FG001|Overall Study|Withdrawal by Subject|1|||
163220331|NCT00322842|589521460|FG000|Overall Study|Lost to Follow-up|0|||
163220332|NCT00322842|589521461|FG001|Overall Study|Lost to Follow-up|1|||
163220333|NCT00322842|589521460|FG000|Overall Study|Refused transplant|1|||
163220334|NCT00322842|589521461|FG001|Overall Study|Refused transplant|0|||
163220335|NCT00322842|589521460|FG000|Overall Study|Death|1|||
163220336|NCT00322842|589521461|FG001|Overall Study|Death|0|||
163220337|NCT00323492|589521462|FG000|Study Phase 1|Adverse Event|2|||
163220338|NCT00323492|589521463|FG001|Study Phase 1|Adverse Event|0|||
163220339|NCT00323492|589521464|FG002|Study Phase 1|Adverse Event|0|||
163220340|NCT00323492|589521462|FG000|Study Phase 2|Adverse Event|1|||
163339457|NCT02161146|589951191|FG000|Overall Study|Adverse Event|1|||
163339458|NCT02161146|589951192|FG001|Overall Study|Adverse Event|1|||
163339459|NCT02161146|589951193|FG002|Overall Study|Adverse Event|0|||
163339460|NCT02161146|589951194|FG003|Overall Study|Adverse Event|1|||
163339461|NCT02161146|589951195|FG004|Overall Study|Adverse Event|0|||
163339462|NCT02161146|589951191|FG000|Overall Study|Lost to Follow-up|0|||
163407654|NCT02706873|590200873|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
163407655|NCT02706873|590200874|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
163407656|NCT02706873|590200871|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
163220341|NCT00323492|589521463|FG001|Study Phase 2|Adverse Event|0|||
163220342|NCT00323492|589521464|FG002|Study Phase 2|Adverse Event|0|||
163220343|NCT00323492|589521462|FG000|Study Phase 2|Physician Decision|1|||
163220344|NCT00323492|589521463|FG001|Study Phase 2|Physician Decision|0|||
163220345|NCT00323492|589521464|FG002|Study Phase 2|Physician Decision|0|||
163339463|NCT02161146|589951192|FG001|Overall Study|Lost to Follow-up|1|||
163339464|NCT02161146|589951193|FG002|Overall Study|Lost to Follow-up|0|||
163339465|NCT02161146|589951194|FG003|Overall Study|Lost to Follow-up|0|||
163407657|NCT02706873|590200872|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
163220346|NCT00323492|589521462|FG000|Study Phase 2|Lost to Follow-up|1|||
163220347|NCT00323492|589521463|FG001|Study Phase 2|Lost to Follow-up|0|||
163407658|NCT02706873|590200873|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
163220348|NCT00323492|589521464|FG002|Study Phase 2|Lost to Follow-up|0|||
163220349|NCT00323492|589521462|FG000|Study Phase 2|Withdrawal by Subject|0|||
163220350|NCT00323492|589521463|FG001|Study Phase 2|Withdrawal by Subject|1|||
163220351|NCT00323492|589521464|FG002|Study Phase 2|Withdrawal by Subject|0|||
163220352|NCT00323492|589521462|FG000|Study Phase 2|Noncompliance with study schedule|0|||
163407659|NCT02706873|590200874|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
163407660|NCT02706873|590200871|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
163407661|NCT02706873|590200872|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
163407662|NCT02706873|590200873|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
163407663|NCT02706873|590200874|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
163101860|NCT05396014|589079262|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101861|NCT05396014|589079263|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101862|NCT05396014|589079264|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101863|NCT05396014|589079265|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
163101864|NCT05396014|589079266|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101865|NCT05396014|589079267|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101866|NCT05396014|589079268|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101867|NCT05396014|589079269|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101868|NCT05396014|589079270|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101869|NCT05396014|589079271|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101870|NCT05396014|589079272|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101871|NCT05396014|589079273|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101872|NCT05396014|589079274|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101873|NCT05396014|589079275|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101874|NCT05396014|589079276|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101875|NCT05396014|589079277|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101876|NCT05396014|589079278|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101877|NCT05396014|589079279|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101878|NCT05396014|589079280|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
163101879|NCT05396014|589079281|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
163101880|NCT05396014|589079282|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101881|NCT05396014|589079240|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101882|NCT05396014|589079241|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101883|NCT05396014|589079242|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101884|NCT05396014|589079243|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101885|NCT05396014|589079244|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101886|NCT05396014|589079245|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101887|NCT05396014|589079246|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101888|NCT05396014|589079247|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101889|NCT05396014|589079248|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
163101890|NCT05396014|589079249|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101891|NCT05396014|589079250|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101892|NCT05396014|589079251|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101893|NCT05396014|589079252|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101894|NCT05396014|589079253|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101895|NCT05396014|589079254|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101896|NCT05396014|589079255|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101897|NCT05396014|589079256|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101898|NCT05396014|589079257|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101899|NCT05396014|589079258|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101900|NCT05396014|589079259|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101901|NCT05396014|589079260|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101902|NCT05396014|589079261|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101903|NCT05396014|589079262|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
163101904|NCT05396014|589079263|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101905|NCT05396014|589079264|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101906|NCT05396014|589079265|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101907|NCT05396014|589079266|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101908|NCT05396014|589079267|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101909|NCT05396014|589079268|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101910|NCT05396014|589079269|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101911|NCT05396014|589079270|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101912|NCT05396014|589079271|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101913|NCT05396014|589079272|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101914|NCT05396014|589079273|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101915|NCT05396014|589079274|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163220353|NCT00323492|589521463|FG001|Study Phase 2|Noncompliance with study schedule|0|||
163407664|NCT02706873|590200871|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
163101916|NCT05396014|589079275|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
163407665|NCT02706873|590200872|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
163101917|NCT05396014|589079276|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101918|NCT05396014|589079277|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101919|NCT05396014|589079278|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101920|NCT05396014|589079279|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101921|NCT05396014|589079280|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101922|NCT05396014|589079281|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
163101923|NCT05396014|589079282|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101924|NCT05396014|589079240|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101925|NCT05396014|589079241|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101926|NCT05396014|589079242|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101927|NCT05396014|589079243|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101928|NCT05396014|589079244|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101929|NCT05396014|589079245|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101930|NCT05396014|589079246|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101931|NCT05396014|589079247|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101932|NCT05396014|589079248|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101933|NCT05396014|589079249|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101934|NCT05396014|589079250|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101935|NCT05396014|589079251|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101936|NCT05396014|589079252|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101937|NCT05396014|589079253|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
163101938|NCT05396014|589079254|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101939|NCT05396014|589079255|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101940|NCT05396014|589079256|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101941|NCT05396014|589079257|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101942|NCT05396014|589079258|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101943|NCT05396014|589079259|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101944|NCT05396014|589079260|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101945|NCT05396014|589079261|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101946|NCT05396014|589079262|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101947|NCT05396014|589079263|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101948|NCT05396014|589079264|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101949|NCT05396014|589079265|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101950|NCT05396014|589079266|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
163101951|NCT05396014|589079267|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101952|NCT05396014|589079268|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101953|NCT05396014|589079269|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101954|NCT05396014|589079270|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101955|NCT05396014|589079271|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101956|NCT05396014|589079272|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101957|NCT05396014|589079273|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101958|NCT05396014|589079274|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
163101959|NCT05396014|589079275|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101960|NCT05396014|589079276|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101961|NCT05396014|589079277|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101962|NCT05396014|589079278|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101963|NCT05396014|589079279|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101964|NCT05396014|589079280|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101965|NCT05396014|589079281|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101966|NCT05396014|589079282|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
163101967|NCT05396014|589079240|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101968|NCT05396014|589079241|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101969|NCT05396014|589079242|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101970|NCT05396014|589079243|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101971|NCT05396014|589079244|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101972|NCT05396014|589079245|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101973|NCT05396014|589079246|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101974|NCT05396014|589079247|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101975|NCT05396014|589079248|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101976|NCT05396014|589079249|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101977|NCT05396014|589079250|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101978|NCT05396014|589079251|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101979|NCT05396014|589079252|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101980|NCT05396014|589079253|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101981|NCT05396014|589079254|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101982|NCT05396014|589079255|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163220354|NCT00323492|589521464|FG002|Study Phase 2|Noncompliance with study schedule|1|||
163101983|NCT05396014|589079256|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101984|NCT05396014|589079257|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101985|NCT05396014|589079258|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101986|NCT05396014|589079259|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101987|NCT05396014|589079260|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101988|NCT05396014|589079261|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101989|NCT05396014|589079262|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101990|NCT05396014|589079263|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101991|NCT05396014|589079264|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101992|NCT05396014|589079265|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101993|NCT05396014|589079266|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
163101994|NCT05396014|589079267|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101995|NCT05396014|589079268|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101996|NCT05396014|589079269|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101997|NCT05396014|589079270|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101998|NCT05396014|589079271|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101999|NCT05396014|589079272|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102000|NCT05396014|589079273|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102001|NCT05396014|589079274|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102002|NCT05396014|589079275|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102003|NCT05396014|589079276|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102004|NCT05396014|589079277|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102005|NCT05396014|589079278|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102006|NCT05396014|589079279|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102007|NCT05396014|589079280|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102008|NCT05396014|589079281|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102009|NCT05396014|589079282|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102010|NCT05258890|589079284|FG000|Overall Study|Patient withdrawal|6|||
163102011|NCT05258890|589079285|FG001|Overall Study|Patient withdrawal|7|||
163102012|NCT05258890|589079284|FG000|Overall Study|Patient lost to follow-up|10|||
163102013|NCT05258890|589079285|FG001|Overall Study|Patient lost to follow-up|3|||
163102014|NCT05258890|589079284|FG000|Overall Study|Social network member withdrawal|1|||
163102015|NCT05258890|589079285|FG001|Overall Study|Social network member withdrawal|0|||
163102016|NCT05258890|589079284|FG000|Overall Study|Social network member lost to follow-up|5|||
163102017|NCT05258890|589079285|FG001|Overall Study|Social network member lost to follow-up|0|||
163102018|NCT01893411|589079292|FG000|Overall Study|Protocol Violation|1|||
163102019|NCT01893411|589079293|FG001|Overall Study|Protocol Violation|0|||
163102020|NCT01893411|589079294|FG002|Overall Study|Protocol Violation|0|||
163102021|NCT01893411|589079292|FG000|Overall Study|Physician Decision|1|||
163102022|NCT01893411|589079293|FG001|Overall Study|Physician Decision|1|||
163102023|NCT01893411|589079294|FG002|Overall Study|Physician Decision|2|||
163102024|NCT01893411|589079292|FG000|Overall Study|Lack of Efficacy|2|||
163102025|NCT01893411|589079293|FG001|Overall Study|Lack of Efficacy|1|||
163102026|NCT01893411|589079294|FG002|Overall Study|Lack of Efficacy|0|||
163102027|NCT01893411|589079292|FG000|Overall Study|Other|3|||
163102028|NCT01893411|589079293|FG001|Overall Study|Other|1|||
163102029|NCT01893411|589079294|FG002|Overall Study|Other|3|||
163102030|NCT01893411|589079292|FG000|Overall Study|Adverse Event|1|||
163102031|NCT01893411|589079293|FG001|Overall Study|Adverse Event|0|||
163102032|NCT01893411|589079294|FG002|Overall Study|Adverse Event|0|||
163102033|NCT01893411|589079292|FG000|Overall Study|Withdrawal by Subject|7|||
163102034|NCT01893411|589079293|FG001|Overall Study|Withdrawal by Subject|4|||
163102035|NCT01893411|589079294|FG002|Overall Study|Withdrawal by Subject|3|||
163102036|NCT01893411|589079292|FG000|Overall Study|Lost to Follow-up|2|||
163102037|NCT01893411|589079293|FG001|Overall Study|Lost to Follow-up|0|||
163102038|NCT01893411|589079294|FG002|Overall Study|Lost to Follow-up|1|||
163102039|NCT00566982|589079295|FG000|Overall Study|Adverse Event|6|||
163102040|NCT00566982|589079296|FG001|Overall Study|Adverse Event|48|||
163102041|NCT00566982|589079295|FG000|Overall Study|Withdrawal by Subject|1|||
163102042|NCT00566982|589079296|FG001|Overall Study|Withdrawal by Subject|14|||
163102043|NCT00566982|589079295|FG000|Overall Study|Protocol Violation|1|||
163102044|NCT00566982|589079296|FG001|Overall Study|Protocol Violation|4|||
163102045|NCT00566982|589079295|FG000|Overall Study|Lost to Follow-up|0|||
163102046|NCT00566982|589079296|FG001|Overall Study|Lost to Follow-up|1|||
163102047|NCT00566982|589079295|FG000|Overall Study|Other-family problems & doctor's request|0|||
163102048|NCT00566982|589079296|FG001|Overall Study|Other-family problems & doctor's request|2|||
163339466|NCT02161146|589951195|FG004|Overall Study|Lost to Follow-up|0|||
163102049|NCT01947283|589079297|FG000|Overall Study|Death|1|||
163102050|NCT01947283|589079298|FG001|Overall Study|Death|1|||
163102051|NCT01947283|589079299|FG002|Overall Study|Death|1|||
163102052|NCT01947283|589079300|FG003|Overall Study|Death|0|||
163102053|NCT01947283|589079301|FG004|Overall Study|Death|0|||
163102054|NCT01947283|589079302|FG005|Overall Study|Death|0|||
163102055|NCT01947283|589079303|FG006|Overall Study|Death|0|||
163220355|NCT00323492|589521462|FG000|Study Phase 2|Protocol Violation|1|||
163220356|NCT00323492|589521463|FG001|Study Phase 2|Protocol Violation|0|||
163220357|NCT00323492|589521464|FG002|Study Phase 2|Protocol Violation|0|||
163102056|NCT01947283|589079297|FG000|Overall Study|Lost to Follow-up|4|||
163102057|NCT01947283|589079298|FG001|Overall Study|Lost to Follow-up|6|||
163102058|NCT01947283|589079299|FG002|Overall Study|Lost to Follow-up|5|||
163102059|NCT01947283|589079300|FG003|Overall Study|Lost to Follow-up|5|||
163102060|NCT01947283|589079301|FG004|Overall Study|Lost to Follow-up|0|||
163102061|NCT01947283|589079302|FG005|Overall Study|Lost to Follow-up|2|||
163102062|NCT01947283|589079303|FG006|Overall Study|Lost to Follow-up|5|||
163102063|NCT01947283|589079297|FG000|Overall Study|Withdrawal by Subject|10|||
163102064|NCT01947283|589079298|FG001|Overall Study|Withdrawal by Subject|8|||
163102065|NCT01947283|589079299|FG002|Overall Study|Withdrawal by Subject|4|||
163102066|NCT01947283|589079300|FG003|Overall Study|Withdrawal by Subject|1|||
163102067|NCT01947283|589079301|FG004|Overall Study|Withdrawal by Subject|0|||
163102068|NCT01947283|589079302|FG005|Overall Study|Withdrawal by Subject|0|||
163102069|NCT01947283|589079303|FG006|Overall Study|Withdrawal by Subject|2|||
163102070|NCT01947283|589079297|FG000|Overall Study|No Clinical Recording|12|||
163102071|NCT01947283|589079298|FG001|Overall Study|No Clinical Recording|6|||
163102072|NCT01947283|589079299|FG002|Overall Study|No Clinical Recording|8|||
163102073|NCT01947283|589079300|FG003|Overall Study|No Clinical Recording|10|||
163102074|NCT01947283|589079301|FG004|Overall Study|No Clinical Recording|0|||
163102075|NCT01947283|589079302|FG005|Overall Study|No Clinical Recording|0|||
163102076|NCT01947283|589079303|FG006|Overall Study|No Clinical Recording|0|||
163102077|NCT01947283|589079297|FG000|Overall Study|Non-coding Clinical Recording language|0|||
163102078|NCT01947283|589079298|FG001|Overall Study|Non-coding Clinical Recording language|0|||
163102079|NCT01947283|589079299|FG002|Overall Study|Non-coding Clinical Recording language|0|||
163102080|NCT01947283|589079300|FG003|Overall Study|Non-coding Clinical Recording language|1|||
163102081|NCT01947283|589079301|FG004|Overall Study|Non-coding Clinical Recording language|0|||
163102082|NCT01947283|589079302|FG005|Overall Study|Non-coding Clinical Recording language|0|||
163102083|NCT01947283|589079303|FG006|Overall Study|Non-coding Clinical Recording language|0|||
163102084|NCT01947283|589079297|FG000|Overall Study|Missing Follow-up Assessment|2|||
163102085|NCT01947283|589079298|FG001|Overall Study|Missing Follow-up Assessment|2|||
163102086|NCT01947283|589079299|FG002|Overall Study|Missing Follow-up Assessment|3|||
163102087|NCT01947283|589079300|FG003|Overall Study|Missing Follow-up Assessment|0|||
163102088|NCT01947283|589079301|FG004|Overall Study|Missing Follow-up Assessment|0|||
163102089|NCT01947283|589079302|FG005|Overall Study|Missing Follow-up Assessment|2|||
163102090|NCT01947283|589079303|FG006|Overall Study|Missing Follow-up Assessment|0|||
163102091|NCT01947283|589079297|FG000|Overall Study|No patients were enrolled in study|0|||
163102092|NCT01947283|589079298|FG001|Overall Study|No patients were enrolled in study|0|||
163102093|NCT01947283|589079299|FG002|Overall Study|No patients were enrolled in study|0|||
163102094|NCT01947283|589079300|FG003|Overall Study|No patients were enrolled in study|0|||
163102095|NCT01947283|589079301|FG004|Overall Study|No patients were enrolled in study|0|||
163102096|NCT01947283|589079302|FG005|Overall Study|No patients were enrolled in study|3|||
163102097|NCT01947283|589079303|FG006|Overall Study|No patients were enrolled in study|1|||
163102098|NCT01498692|589079304|FG000|Overall Study|Death|4|||
163220358|NCT03082599|589521465|FG000|Overall Study|Lost to Follow-up|1|||
163220359|NCT03082599|589521466|FG001|Overall Study|Lost to Follow-up|0|||
163220360|NCT02486042|589521467|FG000|Overall Study|Physician Decision|1|||
163220361|NCT02486042|589521468|FG001|Overall Study|Physician Decision|7|||
163220362|NCT02486042|589521467|FG000|Overall Study|Hospital transfer|2|||
163220363|NCT02486042|589521468|FG001|Overall Study|Hospital transfer|2|||
163220364|NCT02486042|589521467|FG000|Overall Study|Withdrawal by Subject|0|||
163220365|NCT02486042|589521468|FG001|Overall Study|Withdrawal by Subject|2|||
163220366|NCT01466387|589521469|FG000|Overall Study|Adverse Event|0|||
163220367|NCT01466387|589521470|FG001|Overall Study|Adverse Event|0|||
163220368|NCT01466387|589521471|FG002|Overall Study|Adverse Event|1|||
163339467|NCT02161146|589951191|FG000|Overall Study|Personal Reasons|0|||
163339468|NCT02161146|589951192|FG001|Overall Study|Personal Reasons|1|||
163339469|NCT02161146|589951193|FG002|Overall Study|Personal Reasons|0|||
163102099|NCT01498692|589079304|FG000|Overall Study|Withdrawal by Subject|1|||
163102100|NCT01498692|589079304|FG000|Overall Study|Missed 12-month visit|3|||
163220369|NCT01466387|589521472|FG003|Overall Study|Adverse Event|1|||
163220370|NCT01466387|589521473|FG004|Overall Study|Adverse Event|0|||
163339470|NCT02161146|589951194|FG003|Overall Study|Personal Reasons|2|||
163339471|NCT02161146|589951195|FG004|Overall Study|Personal Reasons|1|||
163339472|NCT02161146|589951191|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163102101|NCT04729972|589079305|FG000|Overall Study|Adverse Event|1|||
163102102|NCT05002985|589079306|FG000|Overall Study|Withdrawal by Subject|1|||
163102103|NCT03782259|589079307|FG000|Overall Study|Lost to Follow-up|1|||
163102104|NCT03782259|589079308|FG001|Overall Study|Lost to Follow-up|1|||
163102105|NCT03782259|589079307|FG000|Overall Study|Moved out of state|0|||
163102106|NCT03782259|589079308|FG001|Overall Study|Moved out of state|2|||
163220371|NCT01466387|589521474|FG005|Overall Study|Adverse Event|0|||
163220372|NCT01466387|589521469|FG000|Overall Study|Lost to Follow-up|0|||
163220373|NCT01466387|589521470|FG001|Overall Study|Lost to Follow-up|0|||
163339473|NCT02161146|589951192|FG001|Overall Study|Other Miscellaneous Reasons|1|||
163102107|NCT03782259|589079307|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
163102108|NCT03782259|589079308|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
163102109|NCT03782259|589079307|FG000|Overall Study|Subject discontinued intervention|1|||
163102110|NCT03782259|589079308|FG001|Overall Study|Subject discontinued intervention|0|||
163102111|NCT00603941|589079309|FG000|Overall Study|Disease progression|6|||
163102112|NCT00603941|589079310|FG001|Overall Study|Disease progression|7|||
163102113|NCT00603941|589079311|FG002|Overall Study|Disease progression|1|||
163102114|NCT00603941|589079309|FG000|Overall Study|Adverse Event|1|||
163102115|NCT00603941|589079310|FG001|Overall Study|Adverse Event|0|||
163102116|NCT00603941|589079311|FG002|Overall Study|Adverse Event|1|||
163102117|NCT00603941|589079309|FG000|Overall Study|Physician Decision|0|||
163102118|NCT00603941|589079310|FG001|Overall Study|Physician Decision|1|||
163102119|NCT00603941|589079311|FG002|Overall Study|Physician Decision|0|||
163102120|NCT00603941|589079309|FG000|Overall Study|Withdrawal by Subject|0|||
163102121|NCT00603941|589079310|FG001|Overall Study|Withdrawal by Subject|2|||
163102122|NCT00603941|589079311|FG002|Overall Study|Withdrawal by Subject|0|||
163102123|NCT02707965|589079312|FG000|Overall Study|Withdrawal by Subject|0|||
163102124|NCT02707965|589079313|FG001|Overall Study|Withdrawal by Subject|0|||
163102125|NCT02707965|589079314|FG002|Overall Study|Withdrawal by Subject|1|||
163102126|NCT02707965|589079315|FG003|Overall Study|Withdrawal by Subject|0|||
163102127|NCT02707965|589079316|FG004|Overall Study|Withdrawal by Subject|0|||
163102128|NCT02707965|589079317|FG005|Overall Study|Withdrawal by Subject|0|||
163102129|NCT02707965|589079318|FG006|Overall Study|Withdrawal by Subject|0|||
163102130|NCT02707965|589079319|FG007|Overall Study|Withdrawal by Subject|2|||
163102131|NCT02707965|589079320|FG008|Overall Study|Withdrawal by Subject|0|||
163220374|NCT01466387|589521471|FG002|Overall Study|Lost to Follow-up|0|||
163220375|NCT01466387|589521472|FG003|Overall Study|Lost to Follow-up|0|||
163220376|NCT01466387|589521473|FG004|Overall Study|Lost to Follow-up|0|||
163220377|NCT01466387|589521474|FG005|Overall Study|Lost to Follow-up|1|||
163220378|NCT01466387|589521469|FG000|Overall Study|Protocol Violation|1|||
163220379|NCT01466387|589521470|FG001|Overall Study|Protocol Violation|0|||
163220380|NCT01466387|589521471|FG002|Overall Study|Protocol Violation|0|||
163220381|NCT01466387|589521472|FG003|Overall Study|Protocol Violation|1|||
163220382|NCT01466387|589521473|FG004|Overall Study|Protocol Violation|0|||
163220383|NCT01466387|589521474|FG005|Overall Study|Protocol Violation|0|||
163220384|NCT00832585|589521485|FG000|Overall Study|Withdrawal by Subject|1|||
163220385|NCT00832585|589521485|FG000|Overall Study|Lost to Follow-up|1|||
163220386|NCT00673179|589521487|FG000|Overall Study|Toxicity/Complications|3|||
163220387|NCT00673179|589521488|FG001|Overall Study|Toxicity/Complications|0|||
163220388|NCT00352846|589521489|FG000|Overall Study|Disease progression|0|||
163220389|NCT00352846|589521490|FG001|Overall Study|Disease progression|2|||
163220390|NCT00352846|589521489|FG000|Overall Study|Withdrawal by Subject|3|||
163220391|NCT00352846|589521490|FG001|Overall Study|Withdrawal by Subject|8|||
163220392|NCT00352846|589521489|FG000|Overall Study|Ineligible|3|||
163220393|NCT00352846|589521490|FG001|Overall Study|Ineligible|2|||
163220394|NCT00352846|589521489|FG000|Overall Study|Non-compliance|2|||
163220395|NCT00352846|589521490|FG001|Overall Study|Non-compliance|0|||
163220396|NCT00352846|589521489|FG000|Overall Study|Death|0|||
163220397|NCT00352846|589521490|FG001|Overall Study|Death|1|||
163220398|NCT00281684|589521491|FG000|Overall Study|Lost to Follow-up|0|||
163220399|NCT00281684|589521492|FG001|Overall Study|Lost to Follow-up|0|||
163220400|NCT00281684|589521493|FG002|Overall Study|Lost to Follow-up|1|||
163220401|NCT00281684|589521494|FG003|Overall Study|Lost to Follow-up|0|||
163220402|NCT00281684|589521491|FG000|Overall Study|Withdrawal by Subject|1|||
163339474|NCT02161146|589951193|FG002|Overall Study|Other Miscellaneous Reasons|0|||
163339475|NCT02161146|589951194|FG003|Overall Study|Other Miscellaneous Reasons|0|||
163339476|NCT02161146|589951195|FG004|Overall Study|Other Miscellaneous Reasons|0|||
163102132|NCT02707965|589079321|FG009|Overall Study|Withdrawal by Subject|0|||
163102133|NCT02707965|589079322|FG010|Overall Study|Withdrawal by Subject|0|||
163102134|NCT02707965|589079323|FG011|Overall Study|Withdrawal by Subject|0|||
163102135|NCT02707965|589079324|FG012|Overall Study|Withdrawal by Subject|0|||
163102136|NCT02707965|589079325|FG013|Overall Study|Withdrawal by Subject|0|||
163102137|NCT02707965|589079326|FG014|Overall Study|Withdrawal by Subject|0|||
163102138|NCT02707965|589079327|FG015|Overall Study|Withdrawal by Subject|0|||
163102139|NCT02707965|589079312|FG000|Overall Study|PI decisions|0|||
163102140|NCT02707965|589079313|FG001|Overall Study|PI decisions|0|||
163102141|NCT02707965|589079314|FG002|Overall Study|PI decisions|0|||
163339477|NCT00845520|589951196|FG000|Overall Study|Death|1|||
163339478|NCT00845520|589951197|FG001|Overall Study|Death|2|||
163339479|NCT00845520|589951198|FG002|Overall Study|Death|0|||
163339480|NCT00845520|589951196|FG000|Overall Study|Lost to Follow-up|1|||
163102142|NCT02707965|589079315|FG003|Overall Study|PI decisions|0|||
163102143|NCT02707965|589079316|FG004|Overall Study|PI decisions|0|||
163220403|NCT00281684|589521492|FG001|Overall Study|Withdrawal by Subject|0|||
163102144|NCT02707965|589079317|FG005|Overall Study|PI decisions|0|||
163220404|NCT00281684|589521493|FG002|Overall Study|Withdrawal by Subject|0|||
163220405|NCT00281684|589521494|FG003|Overall Study|Withdrawal by Subject|0|||
163220406|NCT01531387|589521498|FG000|Overall Study|Early termination of study|11|||
163339481|NCT00845520|589951197|FG001|Overall Study|Lost to Follow-up|0|||
163339482|NCT00845520|589951198|FG002|Overall Study|Lost to Follow-up|0|||
163339483|NCT00845520|589951196|FG000|Overall Study|Adverse Event|0|||
163339484|NCT00845520|589951197|FG001|Overall Study|Adverse Event|0|||
163339485|NCT00845520|589951198|FG002|Overall Study|Adverse Event|1|||
163102145|NCT02707965|589079318|FG006|Overall Study|PI decisions|0|||
163102146|NCT02707965|589079319|FG007|Overall Study|PI decisions|0|||
163102147|NCT02707965|589079320|FG008|Overall Study|PI decisions|0|||
163102148|NCT02707965|589079321|FG009|Overall Study|PI decisions|0|||
163102149|NCT02707965|589079322|FG010|Overall Study|PI decisions|0|||
163102150|NCT02707965|589079323|FG011|Overall Study|PI decisions|0|||
163102151|NCT02707965|589079324|FG012|Overall Study|PI decisions|0|||
163102152|NCT02707965|589079325|FG013|Overall Study|PI decisions|0|||
163102153|NCT02707965|589079326|FG014|Overall Study|PI decisions|2|||
163102154|NCT02707965|589079327|FG015|Overall Study|PI decisions|0|||
163102155|NCT02707965|589079312|FG000|Overall Study|Protocol deviation|1|||
163102156|NCT02707965|589079313|FG001|Overall Study|Protocol deviation|1|||
163102157|NCT02707965|589079314|FG002|Overall Study|Protocol deviation|0|||
163102158|NCT02707965|589079315|FG003|Overall Study|Protocol deviation|0|||
163102159|NCT02707965|589079316|FG004|Overall Study|Protocol deviation|0|||
163102160|NCT02707965|589079317|FG005|Overall Study|Protocol deviation|0|||
163102161|NCT02707965|589079318|FG006|Overall Study|Protocol deviation|0|||
163102162|NCT02707965|589079319|FG007|Overall Study|Protocol deviation|1|||
163102163|NCT02707965|589079320|FG008|Overall Study|Protocol deviation|0|||
163102164|NCT02707965|589079321|FG009|Overall Study|Protocol deviation|0|||
163102165|NCT02707965|589079322|FG010|Overall Study|Protocol deviation|0|||
163102166|NCT02707965|589079323|FG011|Overall Study|Protocol deviation|0|||
163102167|NCT02707965|589079324|FG012|Overall Study|Protocol deviation|0|||
163102168|NCT02707965|589079325|FG013|Overall Study|Protocol deviation|0|||
163102169|NCT02707965|589079326|FG014|Overall Study|Protocol deviation|0|||
163102170|NCT02707965|589079327|FG015|Overall Study|Protocol deviation|0|||
163102171|NCT00249808|589079328|FG000|Overall Study|Other|27|||
163102172|NCT00249808|589079328|FG000|Overall Study|Protocol Violation|3|||
163102173|NCT00249808|589079328|FG000|Overall Study|Lost to Follow-up|8|||
163102174|NCT00249808|589079328|FG000|Overall Study|Adverse Event|81|||
163102175|NCT00249808|589079328|FG000|Overall Study|Lack of Efficacy|52|||
163102176|NCT00249808|589079328|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
163102177|NCT00485758|589079335|FG000|Overall Study|Adverse Event|102|||
163102178|NCT00485758|589079336|FG001|Overall Study|Adverse Event|31|||
163102179|NCT00485758|589079335|FG000|Overall Study|Death|0|||
163102180|NCT00485758|589079336|FG001|Overall Study|Death|1|||
163102181|NCT00485758|589079335|FG000|Overall Study|Lost to Follow-up|5|||
163102182|NCT00485758|589079336|FG001|Overall Study|Lost to Follow-up|1|||
163102183|NCT00485758|589079335|FG000|Overall Study|Physician Decision|3|||
163102184|NCT00485758|589079336|FG001|Overall Study|Physician Decision|3|||
163102185|NCT00485758|589079335|FG000|Overall Study|Protocol Violation|11|||
163102186|NCT00485758|589079336|FG001|Overall Study|Protocol Violation|2|||
163102187|NCT00485758|589079335|FG000|Overall Study|Withdrawal by Subject|32|||
163102188|NCT00485758|589079336|FG001|Overall Study|Withdrawal by Subject|27|||
163102189|NCT00485758|589079335|FG000|Overall Study|Study Terminated by Sponsor|3|||
163102190|NCT00485758|589079336|FG001|Overall Study|Study Terminated by Sponsor|0|||
163102191|NCT04556591|589079337|FG000|Overall Study|Lost to Follow-up|1|||
163102192|NCT04556591|589079338|FG001|Overall Study|Lost to Follow-up|0|||
163102193|NCT04556591|589079337|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
163102194|NCT04556591|589079338|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
163102195|NCT00135330|589079340|FG000|Overall Study|Adverse Event|2|||
163102196|NCT00135330|589079341|FG001|Overall Study|Adverse Event|5|||
163102197|NCT00135330|589079342|FG002|Overall Study|Adverse Event|1|||
163102198|NCT00135330|589079340|FG000|Overall Study|Lost to Follow-up|0|||
163102199|NCT00135330|589079341|FG001|Overall Study|Lost to Follow-up|2|||
163102200|NCT00135330|589079342|FG002|Overall Study|Lost to Follow-up|3|||
163102201|NCT00135330|589079340|FG000|Overall Study|Physician Decision|1|||
163102202|NCT00135330|589079341|FG001|Overall Study|Physician Decision|1|||
163102203|NCT00135330|589079342|FG002|Overall Study|Physician Decision|0|||
163102204|NCT00135330|589079340|FG000|Overall Study|Protocol Violation|4|||
163102205|NCT00135330|589079341|FG001|Overall Study|Protocol Violation|3|||
163102206|NCT00135330|589079342|FG002|Overall Study|Protocol Violation|3|||
163102207|NCT00135330|589079340|FG000|Overall Study|Patient Decision|5|||
163102208|NCT00135330|589079341|FG001|Overall Study|Patient Decision|1|||
163102209|NCT00135330|589079342|FG002|Overall Study|Patient Decision|4|||
163102210|NCT00135330|589079340|FG000|Overall Study|Sponsor Decision|0|||
163102211|NCT00135330|589079341|FG001|Overall Study|Sponsor Decision|1|||
163102212|NCT00135330|589079342|FG002|Overall Study|Sponsor Decision|0|||
163102213|NCT02229825|589079348|FG000|Overall Study|Personal Reasons|0|||
163102214|NCT02229825|589079349|FG001|Overall Study|Personal Reasons|1|||
163102215|NCT02229825|589079348|FG000|Overall Study|Refused continuing medication|7|||
163102216|NCT02229825|589079349|FG001|Overall Study|Refused continuing medication|6|||
163102217|NCT02229825|589079348|FG000|Overall Study|Lost to Follow-up|1|||
163339486|NCT02613403|589951199|FG000|Overall Study|Lost to Follow-up|0|||
163220407|NCT01531387|589521499|FG001|Overall Study|Early termination of study|11|||
163220408|NCT00578942|589521500|FG000|Overall Study|Lost to Follow-up|1|||
163220409|NCT01124643|589521503|FG000|Overall Study|Death|1|||
163220410|NCT04220411|589521504|FG000|Overall Study|Adverse Event|0|||
163220411|NCT04220411|589521505|FG001|Overall Study|Adverse Event|0|||
163220412|NCT04220411|589521506|FG002|Overall Study|Adverse Event|0|||
163220413|NCT04220411|589521507|FG003|Overall Study|Adverse Event|1|||
163220414|NCT00403273|589522833|FG000|Overall Study|Lost to Follow-up|3|||
163220415|NCT00403273|589522834|FG001|Overall Study|Lost to Follow-up|2|||
163220416|NCT00403273|589522833|FG000|Overall Study|Physician Decision|0|||
163220417|NCT00403273|589522834|FG001|Overall Study|Physician Decision|1|||
163220418|NCT00403273|589522833|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
163220419|NCT00403273|589522834|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
163220420|NCT00589108|589522839|FG000|Overall Study|Lost to Follow-up|1|||
163220421|NCT00589108|589522840|FG001|Overall Study|Lost to Follow-up|1|||
163220422|NCT00589108|589522841|FG002|Overall Study|Lost to Follow-up|1|||
163220423|NCT00589108|589522839|FG000|Overall Study|Death|3|||
163220424|NCT00589108|589522840|FG001|Overall Study|Death|3|||
163220425|NCT00589108|589522841|FG002|Overall Study|Death|4|||
163220426|NCT03256552|589522842|FG000|Overall Study|Protocol Violation|1|||
163220427|NCT03256552|589522842|FG000|Overall Study|Physician Decision|1|||
163220428|NCT03256552|589522842|FG000|Overall Study|Adverse Event|1|||
163220429|NCT03256552|589522842|FG000|Overall Study|Withdrawal by Subject|2|||
163220430|NCT01012622|589522843|FG000|Overall Study|Withdrawal by Subject|6|||
163220431|NCT01012622|589522843|FG000|Overall Study|Lost to Follow-up|5|||
163220432|NCT01012622|589522843|FG000|Overall Study|Adverse Event|7|||
163220433|NCT01012622|589522843|FG000|Overall Study|non-compliance with the drug|9|||
163220434|NCT01012622|589522843|FG000|Overall Study|Other|1|||
163220435|NCT01012622|589522843|FG000|Overall Study|screening failure|1|||
163220436|NCT01012622|589522843|FG000|Overall Study|withdrawal of consent by a parent|2|||
163220437|NCT01176292|589522844|FG000|Overall Study|Lost to Follow-up|2|||
163220438|NCT01176292|589522845|FG001|Overall Study|Lost to Follow-up|4|||
163339487|NCT02613403|589951200|FG001|Overall Study|Lost to Follow-up|1|||
163339488|NCT02613403|589951201|FG002|Overall Study|Lost to Follow-up|0|||
163102218|NCT02229825|589079349|FG001|Overall Study|Lost to Follow-up|2|||
163102219|NCT02229825|589079348|FG000|Overall Study|Protocol Violation|1|||
163102220|NCT02229825|589079349|FG001|Overall Study|Protocol Violation|1|||
163102221|NCT02229825|589079348|FG000|Overall Study|Lack of Efficacy|4|||
163102222|NCT02229825|589079349|FG001|Overall Study|Lack of Efficacy|10|||
163102223|NCT02229825|589079348|FG000|Overall Study|Adverse Event|11|||
163102224|NCT02229825|589079349|FG001|Overall Study|Adverse Event|9|||
163102225|NCT02229825|589079348|FG000|Overall Study|Not treated|0|||
163102226|NCT02229825|589079349|FG001|Overall Study|Not treated|1|||
163102227|NCT01309997|589079350|FG000|Overall Study|Adverse Event|1|||
163102228|NCT01309997|589079351|FG001|Overall Study|Adverse Event|0|||
163102229|NCT01309997|589079350|FG000|Overall Study|Death|1|||
163102230|NCT01309997|589079351|FG001|Overall Study|Death|3|||
163102231|NCT01309997|589079350|FG000|Overall Study|Lack of Efficacy|2|||
163102232|NCT01309997|589079351|FG001|Overall Study|Lack of Efficacy|2|||
163102233|NCT01309997|589079350|FG000|Overall Study|Withdrawal by Subject|1|||
163102234|NCT01309997|589079351|FG001|Overall Study|Withdrawal by Subject|1|||
163102235|NCT01532921|589079352|FG000|Overall Study|Death|3|||
163102236|NCT01532921|589079352|FG000|Overall Study|Withdrawal by Subject|2|||
163102237|NCT01532921|589079352|FG000|Overall Study|Lost to Follow-up|3|||
163102238|NCT01532921|589079352|FG000|Overall Study|Physician Decision|7|||
163102239|NCT01532921|589079352|FG000|Overall Study|Device was explanted during procedure|1|||
163102240|NCT02526212|589079353|FG000|Overall Study|Incarceration|1|||
163220439|NCT01176292|589522844|FG000|Overall Study|Adverse Event|1|||
163220440|NCT01176292|589522845|FG001|Overall Study|Adverse Event|1|||
163220441|NCT01176292|589522844|FG000|Overall Study|Physician Decision|0|||
163220442|NCT01176292|589522845|FG001|Overall Study|Physician Decision|2|||
163220443|NCT01176292|589522844|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
163220444|NCT01176292|589522845|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
163220445|NCT00380393|589522846|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
163339489|NCT02613403|589951202|FG003|Overall Study|Lost to Follow-up|0|||
163102241|NCT02526212|589079354|FG001|Overall Study|Incarceration|0|||
163102242|NCT02526212|589079353|FG000|Overall Study|Lost to Follow-up|1|||
163102243|NCT02526212|589079354|FG001|Overall Study|Lost to Follow-up|0|||
163220446|NCT00380393|589522847|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
163220447|NCT00380393|589522846|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
163220448|NCT00380393|589522847|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
163102244|NCT02526212|589079353|FG000|Overall Study|Death|0|||
163102245|NCT02526212|589079354|FG001|Overall Study|Death|1|||
163102246|NCT02443337|589079356|FG000|Overall Study|Adverse Event|0|||
163102247|NCT02443337|589079357|FG001|Overall Study|Adverse Event|1|||
163102248|NCT02443337|589079356|FG000|Overall Study|Clinical Progressive Disease|3|||
163220449|NCT00380393|589522846|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
163220450|NCT00380393|589522847|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
163339490|NCT02613403|589951203|FG004|Overall Study|Lost to Follow-up|0|||
163102249|NCT02443337|589079357|FG001|Overall Study|Clinical Progressive Disease|0|||
163102250|NCT02443337|589079356|FG000|Overall Study|Withdrawal by Subject|2|||
163102251|NCT02443337|589079357|FG001|Overall Study|Withdrawal by Subject|1|||
163102252|NCT02096952|589079364|FG000|Overall Study|Adverse Event|1|||
163102253|NCT03520920|589079365|FG000|Overall Study|Death|13|||
163102254|NCT03520920|589079366|FG001|Overall Study|Death|1|||
163102255|NCT03520920|589079367|FG002|Overall Study|Death|0|||
163102256|NCT03520920|589079365|FG000|Overall Study|Withdrawal by Subject|2|||
163102257|NCT03520920|589079366|FG001|Overall Study|Withdrawal by Subject|1|||
163102258|NCT03520920|589079367|FG002|Overall Study|Withdrawal by Subject|0|||
163102259|NCT03520920|589079365|FG000|Overall Study|Study Terminated by the Sponsor|5|||
163102260|NCT03520920|589079366|FG001|Overall Study|Study Terminated by the Sponsor|14|||
163102261|NCT03520920|589079367|FG002|Overall Study|Study Terminated by the Sponsor|5|||
163102262|NCT00372619|589079369|FG000|Overall Study|Ineligible|0|||
163102263|NCT00372619|589079370|FG001|Overall Study|Ineligible|0|||
163102264|NCT00372619|589079371|FG002|Overall Study|Ineligible|0|||
163102265|NCT00372619|589079372|FG003|Overall Study|Ineligible|0|||
163102266|NCT00372619|589079373|FG004|Overall Study|Ineligible|0|||
163102267|NCT00372619|589079374|FG005|Overall Study|Ineligible|2|||
163102268|NCT00372619|589079375|FG006|Overall Study|Ineligible|0|||
163102269|NCT00372619|589079369|FG000|Overall Study|Inevaluable|0|||
163102270|NCT00372619|589079370|FG001|Overall Study|Inevaluable|0|||
163102271|NCT00372619|589079371|FG002|Overall Study|Inevaluable|0|||
163102272|NCT00372619|589079372|FG003|Overall Study|Inevaluable|0|||
163102273|NCT00372619|589079373|FG004|Overall Study|Inevaluable|0|||
163102274|NCT00372619|589079374|FG005|Overall Study|Inevaluable|1|||
163102275|NCT00372619|589079375|FG006|Overall Study|Inevaluable|0|||
163102276|NCT05420961|589079385|FG000|Overall Study|Withdrawal by Subject|2|||
163102277|NCT05420961|589079386|FG001|Overall Study|Withdrawal by Subject|1|||
163102278|NCT05420961|589079387|FG002|Overall Study|Withdrawal by Subject|1|||
163102279|NCT05420961|589079388|FG003|Overall Study|Withdrawal by Subject|0|||
163102280|NCT05420961|589079389|FG004|Overall Study|Withdrawal by Subject|0|||
163102281|NCT05420961|589079385|FG000|Overall Study|Lost to Follow-up|0|||
163102282|NCT05420961|589079386|FG001|Overall Study|Lost to Follow-up|0|||
163102283|NCT05420961|589079387|FG002|Overall Study|Lost to Follow-up|1|||
163102284|NCT05420961|589079388|FG003|Overall Study|Lost to Follow-up|0|||
163102285|NCT05420961|589079389|FG004|Overall Study|Lost to Follow-up|0|||
163102286|NCT05420961|589079385|FG000|Overall Study|Randomized by mistake without study treatment|0|||
163102287|NCT05420961|589079386|FG001|Overall Study|Randomized by mistake without study treatment|0|||
163102288|NCT05420961|589079387|FG002|Overall Study|Randomized by mistake without study treatment|1|||
163102289|NCT05420961|589079388|FG003|Overall Study|Randomized by mistake without study treatment|0|||
163102290|NCT05420961|589079389|FG004|Overall Study|Randomized by mistake without study treatment|1|||
163102291|NCT04283656|589079390|FG000|Overall Study|Adverse Event|1|||
163102292|NCT04283656|589079391|FG001|Overall Study|Adverse Event|0|||
163102293|NCT04283656|589079390|FG000|Overall Study|Lost to Follow-up|0|||
163102294|NCT04283656|589079391|FG001|Overall Study|Lost to Follow-up|1|||
163102295|NCT00803361|589079392|FG000|Overall Study|Adverse Event|13|||
163102296|NCT00803361|589079393|FG001|Overall Study|Adverse Event|3|||
163102297|NCT00803361|589079392|FG000|Overall Study|Lack of Efficacy|4|||
163102298|NCT00803361|589079393|FG001|Overall Study|Lack of Efficacy|13|||
163102299|NCT00803361|589079392|FG000|Overall Study|Lost to Follow-up|1|||
163102300|NCT00803361|589079393|FG001|Overall Study|Lost to Follow-up|2|||
163102301|NCT00803361|589079392|FG000|Overall Study|Physician Decision|1|||
163102302|NCT00803361|589079393|FG001|Overall Study|Physician Decision|0|||
163102303|NCT00803361|589079392|FG000|Overall Study|Protocol Violation|2|||
163102304|NCT00803361|589079393|FG001|Overall Study|Protocol Violation|4|||
163102305|NCT00803361|589079392|FG000|Overall Study|Withdrawal by Subject|5|||
163102306|NCT00803361|589079393|FG001|Overall Study|Withdrawal by Subject|6|||
163102307|NCT04445519|589079394|FG000|Overall Study|Due to adaptive design|3|||
163102308|NCT04445519|589079395|FG001|Overall Study|Due to adaptive design|0|||
163102309|NCT04445519|589079396|FG002|Overall Study|Due to adaptive design|0|||
163102310|NCT04445519|589079394|FG000|Overall Study|Lost to Follow-up|0|||
163102311|NCT04445519|589079395|FG001|Overall Study|Lost to Follow-up|1|||
163102312|NCT04445519|589079396|FG002|Overall Study|Lost to Follow-up|4|||
163102313|NCT04445519|589079394|FG000|Overall Study|Sponsor or IRB Decision|0|||
163102314|NCT04445519|589079395|FG001|Overall Study|Sponsor or IRB Decision|1|||
163102315|NCT04445519|589079396|FG002|Overall Study|Sponsor or IRB Decision|2|||
163102316|NCT04445519|589079394|FG000|Overall Study|Withdrawal by Subject|0|||
163102317|NCT04445519|589079395|FG001|Overall Study|Withdrawal by Subject|3|||
163102318|NCT04445519|589079396|FG002|Overall Study|Withdrawal by Subject|3|||
163102319|NCT04445519|589079394|FG000|Overall Study|Adverse Event|0|||
163102320|NCT04445519|589079395|FG001|Overall Study|Adverse Event|8|||
163102321|NCT04445519|589079396|FG002|Overall Study|Adverse Event|6|||
163102322|NCT04445519|589079394|FG000|Overall Study|Other Reason|0|||
163102323|NCT04445519|589079395|FG001|Overall Study|Other Reason|1|||
163102324|NCT04445519|589079396|FG002|Overall Study|Other Reason|1|||
163102325|NCT04445519|589079394|FG000|Overall Study|Protocol Violation|0|||
163102326|NCT04445519|589079395|FG001|Overall Study|Protocol Violation|0|||
163102327|NCT04445519|589079396|FG002|Overall Study|Protocol Violation|1|||
163339491|NCT02613403|589951199|FG000|Overall Study|Withdrawal by Subject|2|||
163339492|NCT02613403|589951200|FG001|Overall Study|Withdrawal by Subject|0|||
163102328|NCT03782064|589079397|FG000|Overall Study|Lack of Efficacy|2|||
163102329|NCT03782064|589079397|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
163102330|NCT02446769|589079402|FG000|Screening Period|Screen Failure|11|||
163102331|NCT02446769|589079403|FG001|Screening Period|Screen Failure|0|||
163102332|NCT02446769|589079404|FG002|Screening Period|Screen Failure|0|||
163102333|NCT02446769|589079402|FG000|Study Period|Randomized in Error|0|||
163102334|NCT02446769|589079403|FG001|Study Period|Randomized in Error|2|||
163102335|NCT02446769|589079404|FG002|Study Period|Randomized in Error|0|||
163102336|NCT04482439|589079405|FG000|Overall Study|Lost to Follow-up|1|||
163102337|NCT04482439|589079405|FG000|Overall Study|Unrelated illness|1|||
163102338|NCT03072043|589079406|FG000|Overall Study|Death|0|||
163102339|NCT03072043|589079407|FG001|Overall Study|Death|0|||
163102340|NCT03072043|589079408|FG002|Overall Study|Death|3|||
163102341|NCT03072043|589079406|FG000|Overall Study|Adverse Event|0|||
163102342|NCT03072043|589079407|FG001|Overall Study|Adverse Event|0|||
163102343|NCT03072043|589079408|FG002|Overall Study|Adverse Event|2|||
163102344|NCT03072043|589079406|FG000|Overall Study|Withdrawal by Subject|0|||
163102345|NCT03072043|589079407|FG001|Overall Study|Withdrawal by Subject|0|||
163102346|NCT03072043|589079408|FG002|Overall Study|Withdrawal by Subject|4|||
163102347|NCT00645840|589079409|FG000|Overall Study|Protocol Violation|3|||
163102348|NCT02625220|589079410|FG000|Overall Study|Adverse Event|2|||
163102349|NCT02625220|589079410|FG000|Overall Study|Lost to Follow-up|2|||
163102350|NCT02625220|589079410|FG000|Overall Study|Protocol Violation|1|||
163102351|NCT02625220|589079410|FG000|Overall Study|Study discontinued at site|2|||
163102352|NCT04677543|589079411|FG000|Overall Study|Withdrawal by Subject|4|||
163102353|NCT04677543|589079412|FG001|Overall Study|Withdrawal by Subject|1|||
163102354|NCT04677543|589079411|FG000|Overall Study|Physician Decision|0|||
163102355|NCT04677543|589079412|FG001|Overall Study|Physician Decision|1|||
163102356|NCT04677543|589079411|FG000|Overall Study|Adverse Event|0|||
163102357|NCT04677543|589079412|FG001|Overall Study|Adverse Event|1|||
163102358|NCT00995436|589079413|FG000|Overall Study|Withdrawal by Subject|2|||
163102359|NCT00995436|589079414|FG001|Overall Study|Withdrawal by Subject|5|||
163102360|NCT00995436|589079415|FG002|Overall Study|Withdrawal by Subject|0|||
163102361|NCT02342288|589079417|FG000|Overall Study|no protocol anesthesiologist available|3|||
163102362|NCT02342288|589079418|FG001|Overall Study|no protocol anesthesiologist available|2|||
163102363|NCT02342288|589079417|FG000|Overall Study|anesthesia leak in system|1|||
163102364|NCT02342288|589079418|FG001|Overall Study|anesthesia leak in system|0|||
163102365|NCT02342288|589079417|FG000|Overall Study|Withdrawal by Subject|1|||
163102366|NCT02342288|589079418|FG001|Overall Study|Withdrawal by Subject|0|||
163102367|NCT02342288|589079417|FG000|Overall Study|coordinator contaminated with blood|0|||
163102368|NCT02342288|589079418|FG001|Overall Study|coordinator contaminated with blood|1|||
163102369|NCT02342288|589079417|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
163102370|NCT02342288|589079418|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
163102371|NCT02342288|589079417|FG000|Overall Study|coordinator not available|0|||
163102372|NCT02342288|589079418|FG001|Overall Study|coordinator not available|2|||
163102373|NCT00407602|589079420|FG000|Overall Study|Death - unrelated to device|1|||
163102374|NCT00407602|589079420|FG000|Overall Study|Device explanted|5|||
163102375|NCT00407602|589079420|FG000|Overall Study|Withdrawal by Subject|1|||
163102376|NCT00553436|589079421|FG000|Overall Study|Conversion to another procedure|1|||
163102377|NCT04188834|589079422|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
163102378|NCT02455336|589079423|FG000|Overall Study|Withdrawal by Subject|0|||
163102379|NCT02455336|589079424|FG001|Overall Study|Withdrawal by Subject|2|||
163102380|NCT02455336|589079423|FG000|Overall Study|Adverse Event|3|||
163102381|NCT02455336|589079424|FG001|Overall Study|Adverse Event|0|||
163102382|NCT02455336|589079423|FG000|Overall Study|Non-responder to treatment|2|||
163102383|NCT02455336|589079424|FG001|Overall Study|Non-responder to treatment|0|||
163102384|NCT00391430|589079425|FG000|Overall Study|Withdrawal by Subject|3|||
163102385|NCT00391430|589079426|FG001|Overall Study|Withdrawal by Subject|0|||
163102386|NCT00391430|589079427|FG002|Overall Study|Withdrawal by Subject|12|||
163339493|NCT02613403|589951201|FG002|Overall Study|Withdrawal by Subject|0|||
163339494|NCT02613403|589951202|FG003|Overall Study|Withdrawal by Subject|0|||
163339495|NCT02613403|589951203|FG004|Overall Study|Withdrawal by Subject|0|||
163339496|NCT00800176|589951207|FG000|Overall Study|Adverse Event|2|||
163339497|NCT00800176|589951208|FG001|Overall Study|Adverse Event|1|||
163102387|NCT00577707|589079430|FG000|Overall Study|Withdrawal by Subject|3|||
163339498|NCT00800176|589951209|FG002|Overall Study|Adverse Event|0|||
163339499|NCT00800176|589951210|FG003|Overall Study|Adverse Event|2|||
163339500|NCT00800176|589951211|FG004|Overall Study|Adverse Event|1|||
163339501|NCT00800176|589951212|FG005|Overall Study|Adverse Event|1|||
163102388|NCT03299244|589079431|FG000|Overall Study|Withdrawal by Subject|34|||
163102389|NCT03299244|589079432|FG001|Overall Study|Withdrawal by Subject|29|||
163102390|NCT03299244|589079431|FG000|Overall Study|Decision by Sponsor|4|||
163102391|NCT03299244|589079432|FG001|Overall Study|Decision by Sponsor|5|||
163339502|NCT00800176|589951207|FG000|Overall Study|Refused treatment|3|||
163102392|NCT03299244|589079431|FG000|Overall Study|Death|9|||
163102393|NCT03299244|589079432|FG001|Overall Study|Death|4|||
163102394|NCT03706430|589079443|FG000|Overall Study|No A-Line placed|5|||
163102395|NCT03706430|589079443|FG000|Overall Study|Subject had gel nail polish|1|||
163102396|NCT03706430|589079443|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
163102397|NCT03706430|589079443|FG000|Overall Study|Cancelled Case|6|||
163102398|NCT03706430|589079443|FG000|Overall Study|Physician Decision|2|||
163102399|NCT01928433|589079444|FG000|Overall Study|Adverse Event|5|||
163102400|NCT01928433|589079445|FG001|Overall Study|Adverse Event|2|||
163102401|NCT01928433|589079446|FG002|Overall Study|Adverse Event|5|||
163102402|NCT01928433|589079444|FG000|Overall Study|Protocol Violation|0|||
163102403|NCT01928433|589079445|FG001|Overall Study|Protocol Violation|0|||
163102404|NCT01928433|589079446|FG002|Overall Study|Protocol Violation|2|||
163102405|NCT01928433|589079444|FG000|Overall Study|Lack of Efficacy|5|||
163102406|NCT01928433|589079445|FG001|Overall Study|Lack of Efficacy|4|||
163102407|NCT01928433|589079446|FG002|Overall Study|Lack of Efficacy|4|||
163102408|NCT01928433|589079444|FG000|Overall Study|Withdrawal by Subject|0|||
163102409|NCT01928433|589079445|FG001|Overall Study|Withdrawal by Subject|4|||
163102410|NCT01928433|589079446|FG002|Overall Study|Withdrawal by Subject|0|||
163102411|NCT01928433|589079444|FG000|Overall Study|Negative screening urine culture|7|||
163102412|NCT01928433|589079445|FG001|Overall Study|Negative screening urine culture|6|||
163102413|NCT01928433|589079446|FG002|Overall Study|Negative screening urine culture|10|||
163102414|NCT01928433|589079444|FG000|Overall Study|Lost to Follow-up|0|||
163102415|NCT01928433|589079445|FG001|Overall Study|Lost to Follow-up|2|||
163102416|NCT01928433|589079446|FG002|Overall Study|Lost to Follow-up|3|||
163102417|NCT01928433|589079444|FG000|Overall Study|Other reasons|3|||
163102418|NCT01928433|589079445|FG001|Overall Study|Other reasons|3|||
163102419|NCT01928433|589079446|FG002|Overall Study|Other reasons|4|||
163102420|NCT00145626|589079447|FG000|Overall Study|Did not have NK infusions|2|||
163102421|NCT00145626|589079447|FG000|Overall Study|Turned 2 years old before treatment|1|||
163102422|NCT00145626|589079447|FG000|Overall Study|Death|1|||
163102423|NCT00145626|589079447|FG000|Overall Study|Withdrawal by Subject|1|||
163102424|NCT03381287|589079449|FG000|Overall Study|Withdrawal by Subject|0|||
163102425|NCT03381287|589079450|FG001|Overall Study|Withdrawal by Subject|1|||
163102426|NCT03381287|589079451|FG002|Overall Study|Withdrawal by Subject|0|||
163102427|NCT03381287|589079452|FG003|Overall Study|Withdrawal by Subject|0|||
163102428|NCT03381287|589079449|FG000|Overall Study|Adverse Event|0|||
163102429|NCT03381287|589079450|FG001|Overall Study|Adverse Event|0|||
163102430|NCT03381287|589079451|FG002|Overall Study|Adverse Event|0|||
163102431|NCT03381287|589079452|FG003|Overall Study|Adverse Event|1|||
163102432|NCT03381287|589079449|FG000|Overall Study|Physician Decision|0|||
163102433|NCT03381287|589079450|FG001|Overall Study|Physician Decision|0|||
163102434|NCT03381287|589079451|FG002|Overall Study|Physician Decision|0|||
163102435|NCT03381287|589079452|FG003|Overall Study|Physician Decision|1|||
163102436|NCT02709720|589079453|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
163102437|NCT02709720|589079453|FG000|Overall Study|Protocol Violation|1|||
163102438|NCT02709720|589079453|FG000|Overall Study|Not take study medication|1|||
163102439|NCT01198574|589079455|FG000|Overall Study|Resigned from schools|4|||
163102440|NCT01198574|589079456|FG001|Overall Study|Resigned from schools|1|||
163102441|NCT01198574|589079457|FG002|Overall Study|Resigned from schools|1|||
163102442|NCT01198574|589079458|FG003|Overall Study|Resigned from schools|4|||
163102443|NCT02712983|589081475|FG000|Treatment Phase|Adverse Event|3|||
163102444|NCT02712983|589081476|FG001|Treatment Phase|Adverse Event|1|||
163102445|NCT02712983|589081477|FG002|Treatment Phase|Adverse Event|1|||
163102446|NCT02712983|589081478|FG003|Treatment Phase|Adverse Event|4|||
163102447|NCT02712983|589081479|FG004|Treatment Phase|Adverse Event|3|||
163102448|NCT02712983|589081480|FG005|Treatment Phase|Adverse Event|0|||
163102449|NCT02712983|589081481|FG006|Treatment Phase|Adverse Event|6|||
163102450|NCT02712983|589081482|FG007|Treatment Phase|Adverse Event|6|||
163102451|NCT02712983|589081483|FG008|Treatment Phase|Adverse Event|1|||
163102452|NCT02712983|589081475|FG000|Treatment Phase|Protocol Deviation|0|||
163102453|NCT02712983|589081476|FG001|Treatment Phase|Protocol Deviation|0|||
163102454|NCT02712983|589081477|FG002|Treatment Phase|Protocol Deviation|0|||
163102455|NCT02712983|589081478|FG003|Treatment Phase|Protocol Deviation|2|||
163102456|NCT02712983|589081479|FG004|Treatment Phase|Protocol Deviation|0|||
163102457|NCT02712983|589081480|FG005|Treatment Phase|Protocol Deviation|0|||
163102458|NCT02712983|589081481|FG006|Treatment Phase|Protocol Deviation|1|||
163102459|NCT02712983|589081482|FG007|Treatment Phase|Protocol Deviation|0|||
163102460|NCT02712983|589081483|FG008|Treatment Phase|Protocol Deviation|0|||
163102461|NCT02712983|589081475|FG000|Treatment Phase|Technical Problems|0|||
163102462|NCT02712983|589081476|FG001|Treatment Phase|Technical Problems|0|||
163102463|NCT02712983|589081477|FG002|Treatment Phase|Technical Problems|0|||
163102464|NCT02712983|589081478|FG003|Treatment Phase|Technical Problems|0|||
163102465|NCT02712983|589081479|FG004|Treatment Phase|Technical Problems|0|||
163102466|NCT02712983|589081480|FG005|Treatment Phase|Technical Problems|0|||
163102467|NCT02712983|589081481|FG006|Treatment Phase|Technical Problems|1|||
163102468|NCT02712983|589081482|FG007|Treatment Phase|Technical Problems|0|||
163102469|NCT02712983|589081483|FG008|Treatment Phase|Technical Problems|0|||
163220451|NCT00380393|589522846|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
163220452|NCT00380393|589522847|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
163220453|NCT00380393|589522846|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
163220454|NCT00380393|589522847|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
163220455|NCT00380393|589522846|FG000|Month 14|Withdrawal by Subject|9|||
163220456|NCT00380393|589522847|FG001|Month 14|Withdrawal by Subject|7|||
163220457|NCT00380393|589522846|FG000|Month 14|Death|1|||
163220458|NCT00380393|589522847|FG001|Month 14|Death|0|||
163220459|NCT00380393|589522846|FG000|Month 14|Lost to Follow-up|0|||
163220460|NCT00380393|589522847|FG001|Month 14|Lost to Follow-up|1|||
163220461|NCT00380393|589522846|FG000|Month 14|Migrated/moved from study area|39|||
163220462|NCT00380393|589522847|FG001|Month 14|Migrated/moved from study area|42|||
163220463|NCT00380393|589522846|FG000|Month 14|Protocol Violation|2|||
163220464|NCT00380393|589522847|FG001|Month 14|Protocol Violation|0|||
163220465|NCT00380393|589522846|FG000|Month 14|Others|6|||
163220466|NCT00380393|589522847|FG001|Month 14|Others|6|||
163220467|NCT00278954|589522858|FG000|Overall Study|Adverse Event|3|||
163220468|NCT00278954|589522858|FG000|Overall Study|Lost to Follow-up|1|||
163220469|NCT00278954|589522858|FG000|Overall Study|Withdrawal by Subject|1|||
163220470|NCT00704535|589522860|FG000|Overall Study|Adverse Event|2|||
163220471|NCT00704535|589522860|FG000|Overall Study|Death|2|||
163220472|NCT00704535|589522860|FG000|Overall Study|Lost to Follow-up|8|||
163220473|NCT00704535|589522860|FG000|Overall Study|Protocol Violation|10|||
163220474|NCT00704535|589522860|FG000|Overall Study|Completed status not on Case Report Form|124|||
163220475|NCT01589445|589522863|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
163220476|NCT01589445|589522863|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
163220477|NCT01589445|589522863|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
163220478|NCT01589445|589522863|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
163220479|NCT01589445|589522863|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
163220480|NCT01589445|589522863|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
163220481|NCT01589445|589522863|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
163220482|NCT01589445|589522863|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
163220483|NCT01589445|589522863|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
163220484|NCT01589445|589522863|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
163220485|NCT00481195|589522875|FG000|Overall Study|Adverse Event|16|||
163220486|NCT00481195|589522876|FG001|Overall Study|Adverse Event|11|||
163220487|NCT00481195|589522875|FG000|Overall Study|Lack of Efficacy|1|||
163220488|NCT00481195|589522876|FG001|Overall Study|Lack of Efficacy|3|||
163220489|NCT00481195|589522875|FG000|Overall Study|Lost to Follow-up|4|||
163220490|NCT00481195|589522876|FG001|Overall Study|Lost to Follow-up|6|||
163220491|NCT00481195|589522875|FG000|Overall Study|Physician Decision|3|||
163220492|NCT00481195|589522876|FG001|Overall Study|Physician Decision|1|||
163220493|NCT00481195|589522875|FG000|Overall Study|Protocol Violation|10|||
163220494|NCT00481195|589522876|FG001|Overall Study|Protocol Violation|7|||
163220495|NCT00481195|589522875|FG000|Overall Study|Withdrawal by Subject|3|||
163220496|NCT00481195|589522876|FG001|Overall Study|Withdrawal by Subject|9|||
163407666|NCT02706873|590200873|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
163407667|NCT02706873|590200874|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
163220497|NCT00481195|589522875|FG000|Overall Study|Miscellaneous|2|||
163220498|NCT00481195|589522876|FG001|Overall Study|Miscellaneous|2|||
163220499|NCT02932904|589522877|FG000|Overall Study|Reason not Specified|1|||
163220500|NCT02932904|589522878|FG001|Overall Study|Reason not Specified|0|||
163220501|NCT02932904|589522879|FG002|Overall Study|Reason not Specified|2|||
163220502|NCT02932904|589522880|FG003|Overall Study|Reason not Specified|2|||
163220503|NCT02932904|589522877|FG000|Overall Study|Noncompliance with Study Drug|2|||
163220504|NCT02932904|589522878|FG001|Overall Study|Noncompliance with Study Drug|3|||
163220505|NCT02932904|589522879|FG002|Overall Study|Noncompliance with Study Drug|3|||
163220506|NCT02932904|589522880|FG003|Overall Study|Noncompliance with Study Drug|4|||
163220507|NCT02932904|589522877|FG000|Overall Study|Pregnancy|0|||
163220508|NCT02932904|589522878|FG001|Overall Study|Pregnancy|1|||
163220509|NCT02932904|589522879|FG002|Overall Study|Pregnancy|1|||
163407668|NCT02706873|590200871|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
163407669|NCT02706873|590200872|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
163220510|NCT02932904|589522880|FG003|Overall Study|Pregnancy|0|||
163220511|NCT02932904|589522877|FG000|Overall Study|Study Termination|0|||
163220512|NCT02932904|589522878|FG001|Overall Study|Study Termination|1|||
163220513|NCT02932904|589522879|FG002|Overall Study|Study Termination|0|||
163220514|NCT02932904|589522880|FG003|Overall Study|Study Termination|0|||
163220515|NCT02932904|589522877|FG000|Overall Study|Voluntary Withdrawal|2|||
163220516|NCT02932904|589522878|FG001|Overall Study|Voluntary Withdrawal|1|||
163220517|NCT02932904|589522879|FG002|Overall Study|Voluntary Withdrawal|4|||
163220518|NCT02932904|589522880|FG003|Overall Study|Voluntary Withdrawal|2|||
163220519|NCT02932904|589522877|FG000|Overall Study|Lost to Follow-up|5|||
163220520|NCT02932904|589522878|FG001|Overall Study|Lost to Follow-up|3|||
163220521|NCT02932904|589522879|FG002|Overall Study|Lost to Follow-up|6|||
163220522|NCT02932904|589522880|FG003|Overall Study|Lost to Follow-up|0|||
163220523|NCT02932904|589522877|FG000|Overall Study|Significant Protocol Deviation|2|||
163220524|NCT02932904|589522878|FG001|Overall Study|Significant Protocol Deviation|3|||
163220525|NCT02932904|589522879|FG002|Overall Study|Significant Protocol Deviation|6|||
163220526|NCT02932904|589522880|FG003|Overall Study|Significant Protocol Deviation|1|||
163220527|NCT02932904|589522877|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
163220528|NCT02932904|589522878|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
163220529|NCT02932904|589522879|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
163220530|NCT02932904|589522880|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
163220531|NCT02932904|589522877|FG000|Overall Study|Randomized But Not Treated|1|||
163220532|NCT02932904|589522878|FG001|Overall Study|Randomized But Not Treated|1|||
163220533|NCT02932904|589522879|FG002|Overall Study|Randomized But Not Treated|0|||
163220534|NCT02932904|589522880|FG003|Overall Study|Randomized But Not Treated|2|||
163220535|NCT01476696|589522885|FG000|Overall Study|Sponsor decision|2|||
163220536|NCT01476696|589522886|FG001|Overall Study|Sponsor decision|1|||
163220537|NCT01476696|589522887|FG002|Overall Study|Sponsor decision|0|||
163220538|NCT01476696|589522885|FG000|Overall Study|Withdrawal by Subject|1|||
163220539|NCT01476696|589522886|FG001|Overall Study|Withdrawal by Subject|0|||
163220540|NCT01476696|589522887|FG002|Overall Study|Withdrawal by Subject|0|||
163220541|NCT01498640|589522891|FG000|Overall Study|Lost to Follow-up|1|||
163220542|NCT01498640|589522891|FG000|Overall Study|Death|1|||
163220543|NCT01498640|589522891|FG000|Overall Study|Other|3|||
163220544|NCT02590939|589522892|FG000|Overall Study|Withdrawal by Subject|3|||
163220545|NCT02590939|589522893|FG001|Overall Study|Withdrawal by Subject|1|||
163220546|NCT02590939|589522892|FG000|Overall Study|Failed the nociceptive test|2|||
163220547|NCT02590939|589522893|FG001|Overall Study|Failed the nociceptive test|1|||
163220548|NCT02225743|589522894|FG000|Overall Study|Withdrawal by Subject|18|||
163220549|NCT01319877|589522899|FG000|Overall Study|Lost to Follow-up|100|||
163220550|NCT01319877|589522900|FG001|Overall Study|Lost to Follow-up|37|||
163220551|NCT01319877|589522899|FG000|Overall Study|Physician Decision|2|||
163220552|NCT01319877|589522900|FG001|Overall Study|Physician Decision|0|||
163220553|NCT01319877|589522899|FG000|Overall Study|Disease Progression|2|||
163220554|NCT01319877|589522900|FG001|Overall Study|Disease Progression|2|||
163102470|NCT02712983|589081475|FG000|Treatment Phase|Physician Decision|0|||
163102471|NCT02712983|589081476|FG001|Treatment Phase|Physician Decision|0|||
163102472|NCT02712983|589081477|FG002|Treatment Phase|Physician Decision|0|||
163102473|NCT02712983|589081478|FG003|Treatment Phase|Physician Decision|0|||
163102474|NCT02712983|589081479|FG004|Treatment Phase|Physician Decision|0|||
163102475|NCT02712983|589081480|FG005|Treatment Phase|Physician Decision|0|||
163102476|NCT02712983|589081481|FG006|Treatment Phase|Physician Decision|0|||
163102477|NCT02712983|589081482|FG007|Treatment Phase|Physician Decision|1|||
163102478|NCT02712983|589081483|FG008|Treatment Phase|Physician Decision|1|||
163102479|NCT02712983|589081475|FG000|Treatment Phase|Subject Decision|2|||
163102480|NCT02712983|589081476|FG001|Treatment Phase|Subject Decision|0|||
163102481|NCT02712983|589081477|FG002|Treatment Phase|Subject Decision|0|||
163102482|NCT02712983|589081478|FG003|Treatment Phase|Subject Decision|2|||
163102483|NCT02712983|589081479|FG004|Treatment Phase|Subject Decision|1|||
163102484|NCT02712983|589081480|FG005|Treatment Phase|Subject Decision|0|||
163102485|NCT02712983|589081481|FG006|Treatment Phase|Subject Decision|1|||
163102486|NCT02712983|589081482|FG007|Treatment Phase|Subject Decision|2|||
163102487|NCT02712983|589081483|FG008|Treatment Phase|Subject Decision|0|||
163102488|NCT02712983|589081475|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
163102489|NCT02712983|589081476|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
163102490|NCT02712983|589081477|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
163102491|NCT02712983|589081478|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
163102492|NCT02712983|589081479|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
163102493|NCT02712983|589081480|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
163102494|NCT02712983|589081481|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
163220555|NCT01319877|589522899|FG000|Overall Study|Withdrawal by Subject|0|||
163220556|NCT01319877|589522900|FG001|Overall Study|Withdrawal by Subject|1|||
163220557|NCT01319877|589522899|FG000|Overall Study|Reason Not Specified|4|||
163220558|NCT01319877|589522900|FG001|Overall Study|Reason Not Specified|5|||
163220559|NCT02347189|589522904|FG000|Overall Study|No implant attempted of study device|9|||
163220560|NCT02347189|589522904|FG000|Overall Study|No primary outcome data available|2|||
163220561|NCT02677987|589522905|FG000|Overall Study|Withdrawal by Subject|3|||
163220562|NCT02677987|589522906|FG001|Overall Study|Withdrawal by Subject|0|||
163220563|NCT02677987|589522905|FG000|Overall Study|Lost to Follow-up|1|||
163220564|NCT02677987|589522906|FG001|Overall Study|Lost to Follow-up|0|||
163220565|NCT03320564|589522907|FG000|Overall Study|Protocol Violation|1|||
163220566|NCT01527682|589522908|FG000|Overall Study|Protocol Violation|8|||
163220567|NCT04668950|589522909|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
163102495|NCT02712983|589081482|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
163102496|NCT02712983|589081483|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
163102497|NCT02712983|589081475|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
163102498|NCT02712983|589081476|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
163102499|NCT02712983|589081477|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
163339503|NCT00800176|589951208|FG001|Overall Study|Refused treatment|2|||
163102500|NCT02712983|589081478|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
163102501|NCT02712983|589081479|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
163102502|NCT02712983|589081480|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
163102503|NCT02712983|589081481|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
163102504|NCT02712983|589081482|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
163102505|NCT02712983|589081483|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
163102506|NCT02712983|589081475|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
163102507|NCT02712983|589081476|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
163102508|NCT02712983|589081477|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
163102509|NCT02712983|589081478|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
163102510|NCT02712983|589081479|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
163102511|NCT02712983|589081480|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
163102512|NCT02712983|589081481|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
163102513|NCT02712983|589081482|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
163102514|NCT02712983|589081483|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
163102515|NCT03280303|589081484|FG000|Overall Study|Death|505|||
163102516|NCT03280303|589081484|FG000|Overall Study|Study terminated by sponsor|383|||
163102517|NCT03280303|589081484|FG000|Overall Study|Other|148|||
163102518|NCT03280303|589081484|FG000|Overall Study|No longer willing to participate in study|101|||
163102519|NCT03280303|589081484|FG000|Overall Study|Lost to follow up|39|||
163102520|NCT03280303|589081484|FG000|Overall Study|Adverse Event|20|||
163102521|NCT00064259|589081485|FG000|Overall Study|Adverse Event|1|||
163102522|NCT00064259|589081486|FG001|Overall Study|Adverse Event|0|||
163102523|NCT00064259|589081487|FG002|Overall Study|Adverse Event|0|||
163102524|NCT00064259|589081488|FG003|Overall Study|Adverse Event|1|||
163102525|NCT01132651|589081491|FG000|Overall Study|Lost to Follow-up|1|||
163102526|NCT01132651|589081492|FG001|Overall Study|Lost to Follow-up|1|||
163102527|NCT00948857|589081493|FG000|Overall Study|Lost to Follow-up|1|||
163102528|NCT00948857|589081494|FG001|Overall Study|Lost to Follow-up|0|||
163102529|NCT04439539|589081495|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
163102530|NCT04439539|589081496|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
163102531|NCT04439539|589081497|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
163102532|NCT04439539|589081495|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
163102533|NCT04439539|589081496|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
163102534|NCT04439539|589081497|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
163102535|NCT04439539|589081495|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
163102536|NCT04439539|589081496|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
163102537|NCT04439539|589081497|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
163102538|NCT02013778|589081498|FG000|Overall Study|Death|4|||
163102539|NCT02013778|589081498|FG000|Overall Study|Withdrawal by Subject|1|||
163102540|NCT02013778|589081498|FG000|Overall Study|Physician Decision|1|||
163102541|NCT02013778|589081498|FG000|Overall Study|Adverse Event|1|||
163102542|NCT02719691|589081499|FG000|Overall Study|Physician Decision|0|||
163102543|NCT02719691|589081500|FG001|Overall Study|Physician Decision|0|||
163102544|NCT02719691|589081501|FG002|Overall Study|Physician Decision|1|||
163102545|NCT02719691|589081502|FG003|Overall Study|Physician Decision|0|||
163102546|NCT02719691|589081503|FG004|Overall Study|Physician Decision|0|||
163102547|NCT02719691|589081504|FG005|Overall Study|Physician Decision|0|||
163102548|NCT02719691|589081505|FG006|Overall Study|Physician Decision|0|||
163102549|NCT02719691|589081499|FG000|Overall Study|Withdrawal by Subject|0|||
163102550|NCT02719691|589081500|FG001|Overall Study|Withdrawal by Subject|0|||
163102551|NCT02719691|589081501|FG002|Overall Study|Withdrawal by Subject|0|||
163102552|NCT02719691|589081502|FG003|Overall Study|Withdrawal by Subject|0|||
163102553|NCT02719691|589081503|FG004|Overall Study|Withdrawal by Subject|0|||
163102554|NCT02719691|589081504|FG005|Overall Study|Withdrawal by Subject|1|||
163102555|NCT02719691|589081505|FG006|Overall Study|Withdrawal by Subject|0|||
163102556|NCT03308968|589081506|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
163102557|NCT03308968|589081507|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
163102558|NCT03308968|589081508|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
163102559|NCT03308968|589081506|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
163102560|NCT03308968|589081507|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
163102561|NCT03308968|589081508|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
163102562|NCT03308968|589081506|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
163102563|NCT03308968|589081507|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
163102564|NCT03308968|589081508|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
163102565|NCT03308968|589081506|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
163102566|NCT03308968|589081507|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
163102567|NCT03308968|589081508|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
163102568|NCT03308968|589081506|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
163102569|NCT03308968|589081507|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
163102570|NCT03308968|589081508|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
163102571|NCT03308968|589081506|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
163102572|NCT03308968|589081507|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
163102573|NCT03308968|589081508|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
163102574|NCT03308968|589081506|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
163102575|NCT03308968|589081507|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
163102576|NCT03308968|589081508|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
163102577|NCT03308968|589081506|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
163102578|NCT03308968|589081507|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
163102579|NCT03308968|589081508|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
163102580|NCT03308968|589081506|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
163102581|NCT03308968|589081507|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
163102582|NCT03308968|589081508|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
163102583|NCT03308968|589081506|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
163102584|NCT03308968|589081507|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
163102585|NCT03308968|589081508|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
163102586|NCT03308968|589081506|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
163102587|NCT03308968|589081507|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
163102588|NCT03308968|589081508|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
163102589|NCT03308968|589081506|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
163102590|NCT03308968|589081507|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
163339504|NCT00800176|589951209|FG002|Overall Study|Refused treatment|0|||
163339505|NCT00800176|589951210|FG003|Overall Study|Refused treatment|0|||
163339506|NCT00800176|589951211|FG004|Overall Study|Refused treatment|1|||
163339507|NCT00800176|589951212|FG005|Overall Study|Refused treatment|4|||
163339508|NCT00800176|589951207|FG000|Overall Study|Failure to return|3|||
163339509|NCT00800176|589951208|FG001|Overall Study|Failure to return|3|||
163339510|NCT00800176|589951209|FG002|Overall Study|Failure to return|0|||
163339511|NCT00800176|589951210|FG003|Overall Study|Failure to return|2|||
163339512|NCT00800176|589951211|FG004|Overall Study|Failure to return|0|||
163339513|NCT00800176|589951212|FG005|Overall Study|Failure to return|0|||
163339514|NCT00800176|589951207|FG000|Overall Study|Other|1|||
163339515|NCT00800176|589951208|FG001|Overall Study|Other|0|||
163339516|NCT00800176|589951209|FG002|Overall Study|Other|0|||
163339517|NCT00800176|589951210|FG003|Overall Study|Other|0|||
163339518|NCT00800176|589951211|FG004|Overall Study|Other|2|||
163407670|NCT02706873|590200873|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
163102591|NCT03308968|589081508|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
163102592|NCT03308968|589081506|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
163102593|NCT03308968|589081507|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
163102594|NCT03308968|589081508|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
163102595|NCT03308968|589081506|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
163102596|NCT03308968|589081507|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
163102597|NCT03308968|589081508|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
163102598|NCT01521923|589081514|FG000|Overall Study|AE, serious fatal|1|||
163102599|NCT01521923|589081515|FG001|Overall Study|AE, serious fatal|0|||
163102600|NCT01521923|589081516|FG002|Overall Study|AE, serious fatal|0|||
163102601|NCT01521923|589081517|FG003|Overall Study|AE, serious fatal|0|||
163102602|NCT01521923|589081514|FG000|Overall Study|SAE, non-fatal|0|||
163102603|NCT01521923|589081515|FG001|Overall Study|SAE, non-fatal|2|||
163102604|NCT01521923|589081516|FG002|Overall Study|SAE, non-fatal|2|||
163102605|NCT01521923|589081517|FG003|Overall Study|SAE, non-fatal|0|||
163102606|NCT01521923|589081514|FG000|Overall Study|AE, non-serious, non-fatal|1|||
163102607|NCT01521923|589081515|FG001|Overall Study|AE, non-serious, non-fatal|3|||
163102608|NCT01521923|589081516|FG002|Overall Study|AE, non-serious, non-fatal|6|||
163102609|NCT01521923|589081517|FG003|Overall Study|AE, non-serious, non-fatal|2|||
163102610|NCT01521923|589081514|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
163102611|NCT01521923|589081515|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
163102612|NCT01521923|589081516|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
163102613|NCT01521923|589081517|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
163102614|NCT01521923|589081514|FG000|Overall Study|Lack of Efficacy|1|||
163102615|NCT01521923|589081515|FG001|Overall Study|Lack of Efficacy|1|||
163339519|NCT00800176|589951212|FG005|Overall Study|Other|0|||
163407671|NCT02706873|590200874|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
163102616|NCT01521923|589081516|FG002|Overall Study|Lack of Efficacy|0|||
163102617|NCT01521923|589081517|FG003|Overall Study|Lack of Efficacy|0|||
163102618|NCT01521923|589081514|FG000|Overall Study|Protocol Violation|0|||
163339520|NCT02326220|589951215|FG000|Double-blind Treatment Period|Adverse Event|1|||
163102619|NCT01521923|589081515|FG001|Overall Study|Protocol Violation|0|||
163339521|NCT02326220|589951216|FG001|Double-blind Treatment Period|Adverse Event|2|||
163339522|NCT02326220|589951217|FG002|Double-blind Treatment Period|Adverse Event|0|||
163407672|NCT00618410|590200876|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
163102620|NCT01521923|589081516|FG002|Overall Study|Protocol Violation|1|||
163102621|NCT01521923|589081517|FG003|Overall Study|Protocol Violation|0|||
163102622|NCT01521923|589081514|FG000|Overall Study|Lost to Follow-up|1|||
163102623|NCT01521923|589081515|FG001|Overall Study|Lost to Follow-up|0|||
163102624|NCT01521923|589081516|FG002|Overall Study|Lost to Follow-up|2|||
163102625|NCT01521923|589081517|FG003|Overall Study|Lost to Follow-up|1|||
163102626|NCT01521923|589081514|FG000|Overall Study|Withdrawal by Subject|1|||
163102627|NCT01521923|589081515|FG001|Overall Study|Withdrawal by Subject|1|||
163102628|NCT01521923|589081516|FG002|Overall Study|Withdrawal by Subject|1|||
163102629|NCT01521923|589081517|FG003|Overall Study|Withdrawal by Subject|2|||
163102630|NCT01521923|589081514|FG000|Overall Study|Other|2|||
163102631|NCT01521923|589081515|FG001|Overall Study|Other|1|||
163102632|NCT01521923|589081516|FG002|Overall Study|Other|3|||
163102633|NCT01521923|589081517|FG003|Overall Study|Other|6|||
163102634|NCT01521923|589081514|FG000|Overall Study|AE, captured in Period 1|0|||
163102635|NCT01521923|589081515|FG001|Overall Study|AE, captured in Period 1|1|||
163102636|NCT01521923|589081516|FG002|Overall Study|AE, captured in Period 1|0|||
163102637|NCT01521923|589081517|FG003|Overall Study|AE, captured in Period 1|1|||
163102638|NCT03037476|589081518|FG000|Overall Study|Lost to Follow-up|63|||
163102639|NCT03037476|589081519|FG001|Overall Study|Lost to Follow-up|46|||
163102640|NCT02403817|589081520|FG000|Overall Study|Withdrawal by Subject|5|||
163102641|NCT02403817|589081521|FG001|Overall Study|Withdrawal by Subject|0|||
163102642|NCT01208324|589081527|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
163102643|NCT01208324|589081528|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
163102644|NCT01208324|589081529|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
163102645|NCT01208324|589081530|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
163102646|NCT00984165|589081531|FG000|Overall Study|Death on study|2|||
163102647|NCT00984165|589081532|FG001|Overall Study|Death on study|0|||
163102648|NCT00984165|589081533|FG002|Overall Study|Death on study|0|||
163102649|NCT00984165|589081534|FG003|Overall Study|Death on study|0|||
163102650|NCT00984165|589081531|FG000|Overall Study|Disease progression on study|5|||
163102651|NCT00984165|589081532|FG001|Overall Study|Disease progression on study|1|||
163102652|NCT00984165|589081533|FG002|Overall Study|Disease progression on study|0|||
163102653|NCT00984165|589081534|FG003|Overall Study|Disease progression on study|0|||
163102654|NCT00984165|589081531|FG000|Overall Study|Death of recipient|0|||
163102655|NCT00984165|589081532|FG001|Overall Study|Death of recipient|0|||
163102656|NCT00984165|589081533|FG002|Overall Study|Death of recipient|0|||
163102657|NCT00984165|589081534|FG003|Overall Study|Death of recipient|1|||
163102658|NCT00984165|589081531|FG000|Overall Study|New protocol|0|||
163102659|NCT00984165|589081532|FG001|Overall Study|New protocol|0|||
163102660|NCT00984165|589081533|FG002|Overall Study|New protocol|0|||
163102661|NCT00984165|589081534|FG003|Overall Study|New protocol|1|||
163102662|NCT00984165|589081531|FG000|Overall Study|P+/donor pair removed from protocol|0|||
163102663|NCT00984165|589081532|FG001|Overall Study|P+/donor pair removed from protocol|0|||
163102664|NCT00984165|589081533|FG002|Overall Study|P+/donor pair removed from protocol|0|||
163102665|NCT00984165|589081534|FG003|Overall Study|P+/donor pair removed from protocol|1|||
163102666|NCT00984165|589081531|FG000|Overall Study|removed with a pair recipient|0|||
163102667|NCT00984165|589081532|FG001|Overall Study|removed with a pair recipient|0|||
163102668|NCT00984165|589081533|FG002|Overall Study|removed with a pair recipient|0|||
163102669|NCT00984165|589081534|FG003|Overall Study|removed with a pair recipient|1|||
163102670|NCT04474197|589081535|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
163102671|NCT04474197|589081536|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
163102672|NCT04474197|589081537|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
163102673|NCT04474197|589081538|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
163102674|NCT00588237|589081541|FG000|Overall Study|Evaluable for toxicity only|3|||
163102675|NCT00588237|589081541|FG000|Overall Study|Patien not treated|1|||
163102676|NCT01390298|589081542|FG000|Overall Study|Death|1|||
163102677|NCT01390298|589081542|FG000|Overall Study|long term ICU admission|1|||
163102678|NCT01390298|589081542|FG000|Overall Study|Withdrawal by Subject|14|||
163102679|NCT01390298|589081542|FG000|Overall Study|Lost to Follow-up|7|||
163102680|NCT01390298|589081542|FG000|Overall Study|Surgery cancelled|1|||
163102681|NCT00066222|589081547|FG000|Overall Study|No protocol treatment received|1|||
163102682|NCT00635349|589081548|FG000|Overall Study|Other|8|||
163102683|NCT00635349|589081549|FG001|Overall Study|Other|6|||
163102684|NCT00635349|589081548|FG000|Overall Study|Protocol Violation|18|||
163102685|NCT00635349|589081549|FG001|Overall Study|Protocol Violation|22|||
163102686|NCT00635349|589081548|FG000|Overall Study|Withdrawal by Subject|3|||
163102687|NCT00635349|589081549|FG001|Overall Study|Withdrawal by Subject|8|||
163102688|NCT00635349|589081548|FG000|Overall Study|Lost to Follow-up|4|||
163102689|NCT00635349|589081549|FG001|Overall Study|Lost to Follow-up|3|||
163102690|NCT00635349|589081548|FG000|Overall Study|Adverse Event|11|||
163339523|NCT02326220|589951215|FG000|Double-blind Treatment Period|Protocol Violation|0|||
163102691|NCT00635349|589081549|FG001|Overall Study|Adverse Event|9|||
163102692|NCT01524224|589081553|FG000|Overall Study|Progressive Disease|1|||
163102693|NCT01524224|589081554|FG001|Overall Study|Progressive Disease|0|||
163102694|NCT01524224|589081555|FG002|Overall Study|Progressive Disease|2|||
163102695|NCT01524224|589081556|FG003|Overall Study|Progressive Disease|1|||
163102696|NCT01524224|589081557|FG004|Overall Study|Progressive Disease|2|||
163102697|NCT01524224|589081558|FG005|Overall Study|Progressive Disease|1|||
163102698|NCT01524224|589081559|FG006|Overall Study|Progressive Disease|1|||
163102699|NCT01524224|589081560|FG007|Overall Study|Progressive Disease|5|||
163102700|NCT01524224|589081553|FG000|Overall Study|Withdrawal by Subject|2|||
163102701|NCT01524224|589081554|FG001|Overall Study|Withdrawal by Subject|0|||
163102702|NCT01524224|589081555|FG002|Overall Study|Withdrawal by Subject|0|||
163102703|NCT01524224|589081556|FG003|Overall Study|Withdrawal by Subject|0|||
163102704|NCT01524224|589081557|FG004|Overall Study|Withdrawal by Subject|0|||
163102705|NCT01524224|589081558|FG005|Overall Study|Withdrawal by Subject|0|||
163102706|NCT01524224|589081559|FG006|Overall Study|Withdrawal by Subject|2|||
163102707|NCT01524224|589081560|FG007|Overall Study|Withdrawal by Subject|0|||
163102708|NCT01524224|589081553|FG000|Overall Study|Adverse Event|0|||
163102709|NCT01524224|589081554|FG001|Overall Study|Adverse Event|1|||
163102710|NCT01524224|589081555|FG002|Overall Study|Adverse Event|0|||
163102711|NCT01524224|589081556|FG003|Overall Study|Adverse Event|0|||
163102712|NCT01524224|589081557|FG004|Overall Study|Adverse Event|0|||
163102713|NCT01524224|589081558|FG005|Overall Study|Adverse Event|1|||
163102714|NCT01524224|589081559|FG006|Overall Study|Adverse Event|0|||
163102715|NCT01524224|589081560|FG007|Overall Study|Adverse Event|0|||
163102716|NCT01524224|589081553|FG000|Overall Study|Physician Decision|0|||
163102717|NCT01524224|589081554|FG001|Overall Study|Physician Decision|0|||
163102718|NCT01524224|589081555|FG002|Overall Study|Physician Decision|0|||
163102719|NCT01524224|589081556|FG003|Overall Study|Physician Decision|1|||
163102720|NCT01524224|589081557|FG004|Overall Study|Physician Decision|1|||
163102721|NCT01524224|589081558|FG005|Overall Study|Physician Decision|0|||
163102722|NCT01524224|589081559|FG006|Overall Study|Physician Decision|0|||
163102723|NCT01524224|589081560|FG007|Overall Study|Physician Decision|1|||
163102724|NCT01524224|589081553|FG000|Overall Study|Sponsor Decision|0|||
163102725|NCT01524224|589081554|FG001|Overall Study|Sponsor Decision|0|||
163102726|NCT01524224|589081555|FG002|Overall Study|Sponsor Decision|0|||
163102727|NCT01524224|589081556|FG003|Overall Study|Sponsor Decision|0|||
163102728|NCT01524224|589081557|FG004|Overall Study|Sponsor Decision|1|||
163102729|NCT01524224|589081558|FG005|Overall Study|Sponsor Decision|0|||
163102730|NCT01524224|589081559|FG006|Overall Study|Sponsor Decision|0|||
163102731|NCT01524224|589081560|FG007|Overall Study|Sponsor Decision|0|||
163102732|NCT01119066|589081567|FG000|Overall Study|Withdrawal by Subject|4|||
163102733|NCT01119066|589081568|FG001|Overall Study|Withdrawal by Subject|6|||
163102734|NCT01119066|589081569|FG002|Overall Study|Withdrawal by Subject|0|||
163102735|NCT01119066|589081570|FG003|Overall Study|Withdrawal by Subject|0|||
163102736|NCT01119066|589081567|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
163102737|NCT01119066|589081568|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
163102738|NCT01119066|589081569|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
163102739|NCT01119066|589081570|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
163102740|NCT01119066|589081567|FG000|Overall Study|Relapse identified before transplant|1|||
163102741|NCT01119066|589081568|FG001|Overall Study|Relapse identified before transplant|0|||
163102742|NCT01119066|589081569|FG002|Overall Study|Relapse identified before transplant|0|||
163102743|NCT01119066|589081570|FG003|Overall Study|Relapse identified before transplant|0|||
163102744|NCT01119066|589081567|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
163102745|NCT01119066|589081568|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
163102746|NCT01119066|589081569|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
163102747|NCT01119066|589081570|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
163102748|NCT01119066|589081567|FG000|Overall Study|Relapse identified before transplant|0|||
163102749|NCT01119066|589081568|FG001|Overall Study|Relapse identified before transplant|4|||
163102750|NCT01119066|589081569|FG002|Overall Study|Relapse identified before transplant|0|||
163102751|NCT01119066|589081570|FG003|Overall Study|Relapse identified before transplant|0|||
163102752|NCT00783835|589081571|FG000|Overall Study|Adverse Event|3|||
163102753|NCT00783835|589081571|FG000|Overall Study|Medical Criteria|1|||
163102754|NCT00783835|589081571|FG000|Overall Study|Withdrawal by Subject|2|||
163102755|NCT00783835|589081571|FG000|Overall Study|Lost to Follow-up|1|||
163102756|NCT00783835|589081571|FG000|Overall Study|Participant not Adherent|3|||
163102757|NCT00295646|589081572|FG000|Overall Study|Protocol Violation|18|||
163102758|NCT00295646|589081573|FG001|Overall Study|Protocol Violation|20|||
163102759|NCT00295646|589081574|FG002|Overall Study|Protocol Violation|20|||
163102760|NCT00295646|589081575|FG003|Overall Study|Protocol Violation|18|||
163102761|NCT00295646|589081572|FG000|Overall Study|Withdrawal by Subject|8|||
163102762|NCT00295646|589081573|FG001|Overall Study|Withdrawal by Subject|9|||
163102763|NCT00295646|589081574|FG002|Overall Study|Withdrawal by Subject|11|||
163102764|NCT00295646|589081575|FG003|Overall Study|Withdrawal by Subject|14|||
163102765|NCT00295646|589081572|FG000|Overall Study|Lost to Follow-up|0|||
163102766|NCT00295646|589081573|FG001|Overall Study|Lost to Follow-up|5|||
163102767|NCT00295646|589081574|FG002|Overall Study|Lost to Follow-up|1|||
163102768|NCT00295646|589081575|FG003|Overall Study|Lost to Follow-up|5|||
163102769|NCT00295646|589081572|FG000|Overall Study|Death|9|||
163102770|NCT00295646|589081573|FG001|Overall Study|Death|7|||
163102771|NCT00295646|589081574|FG002|Overall Study|Death|18|||
163102772|NCT00295646|589081575|FG003|Overall Study|Death|8|||
163102773|NCT01232127|589081577|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
163102774|NCT01232127|589081578|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
163102775|NCT01232127|589081579|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
163102776|NCT03162796|589081583|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
163102777|NCT03162796|589081584|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
163102778|NCT03162796|589081585|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
163102779|NCT03162796|589081583|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
163102780|NCT03162796|589081584|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
163102781|NCT03162796|589081585|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
163102782|NCT03162796|589081583|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
163102783|NCT03162796|589081584|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
163102784|NCT03162796|589081585|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
163102785|NCT03162796|589081583|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
163102786|NCT03162796|589081584|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
163102787|NCT03162796|589081585|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
163102788|NCT03162796|589081583|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
163102789|NCT03162796|589081584|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
163102790|NCT03162796|589081585|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
163102791|NCT03162796|589081583|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
163102792|NCT03162796|589081584|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
163102793|NCT03162796|589081585|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
163102794|NCT03162796|589081583|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
163102795|NCT03162796|589081584|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
163102796|NCT03162796|589081585|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
163102797|NCT03162796|589081583|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
163102798|NCT03162796|589081584|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
163102799|NCT03162796|589081585|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
163102800|NCT03162796|589081583|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
163102801|NCT03162796|589081584|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
163102802|NCT03162796|589081585|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
163102803|NCT03162796|589081583|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
163102804|NCT03162796|589081584|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
163102805|NCT03162796|589081585|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
163102806|NCT03162796|589081583|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
163102807|NCT03162796|589081584|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
163102808|NCT03162796|589081585|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
163102809|NCT02623205|589081586|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
163102810|NCT02623205|589081587|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
163102811|NCT02375373|589081591|FG000|Overall Study|Withdrawal by Subject|11|||
163102812|NCT02725476|589081592|FG000|Overall Study|Physician Decision|2|||
163102813|NCT02725476|589081593|FG001|Overall Study|Physician Decision|0|||
163102814|NCT02725476|589081592|FG000|Overall Study|Adverse Event|1|||
163102815|NCT02725476|589081593|FG001|Overall Study|Adverse Event|1|||
163102816|NCT00289289|589081595|FG000|Overall Study|Withdrawal by Subject|5|||
163102817|NCT00289289|589081596|FG001|Overall Study|Withdrawal by Subject|3|||
163102818|NCT00289289|589081597|FG002|Overall Study|Withdrawal by Subject|15|||
163102819|NCT00289289|589081595|FG000|Overall Study|Lost to Follow-up|1|||
163102820|NCT00289289|589081596|FG001|Overall Study|Lost to Follow-up|0|||
163102821|NCT00289289|589081597|FG002|Overall Study|Lost to Follow-up|1|||
163102822|NCT00289289|589081595|FG000|Overall Study|Death|4|||
163102823|NCT00289289|589081596|FG001|Overall Study|Death|2|||
163102824|NCT00289289|589081597|FG002|Overall Study|Death|5|||
163102825|NCT00289289|589081595|FG000|Overall Study|No implant attempted|0|||
163102826|NCT00289289|589081596|FG001|Overall Study|No implant attempted|0|||
163102827|NCT00289289|589081597|FG002|Overall Study|No implant attempted|1|||
163102828|NCT00289289|589081595|FG000|Overall Study|Physician Decision|1|||
163102829|NCT00289289|589081596|FG001|Overall Study|Physician Decision|0|||
163102830|NCT00289289|589081597|FG002|Overall Study|Physician Decision|6|||
163102831|NCT00289289|589081595|FG000|Overall Study|Non-study device implanted|2|||
163102832|NCT00289289|589081596|FG001|Overall Study|Non-study device implanted|1|||
163102833|NCT00289289|589081597|FG002|Overall Study|Non-study device implanted|3|||
163102834|NCT00289289|589081595|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
163102835|NCT00289289|589081596|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
163102836|NCT00289289|589081597|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
163102837|NCT00289289|589081595|FG000|Overall Study|Other Exit Reason|6|||
163102838|NCT00289289|589081596|FG001|Overall Study|Other Exit Reason|4|||
163102839|NCT00289289|589081597|FG002|Overall Study|Other Exit Reason|12|||
163102840|NCT01445613|589081598|FG000|30-day Follow-up|Withdrawal by Subject|6|||
163102841|NCT01445613|589081598|FG000|30-day Follow-up|Physician Decision|3|||
163102842|NCT01445613|589081598|FG000|30-day Follow-up|Missed visit|23|||
163102843|NCT01445613|589081598|FG000|30-day Follow-up|Death|3|||
163102844|NCT01445613|589081598|FG000|1-year Follow-up|Withdrawal by Subject|12|||
163102845|NCT01445613|589081598|FG000|1-year Follow-up|Missed visit|29|||
163102846|NCT01445613|589081598|FG000|1-year Follow-up|Lost to Follow-up|2|||
163102847|NCT01445613|589081598|FG000|1-year Follow-up|Death|30|||
163102848|NCT01445613|589081598|FG000|1-year Follow-up|Physician Decision|2|||
163102849|NCT01445613|589081598|FG000|1-year Follow-up|Received a non-study stent|2|||
163102850|NCT01169701|589081599|FG000|Overall Study|Lost to Follow-up|1|||
163102851|NCT01169701|589081600|FG001|Overall Study|Lost to Follow-up|1|||
163102852|NCT01169701|589081599|FG000|Overall Study|Withdrawal by Subject|1|||
163102853|NCT01169701|589081600|FG001|Overall Study|Withdrawal by Subject|3|||
163102854|NCT01169701|589081599|FG000|Overall Study|Adverse Event|1|||
163102855|NCT01169701|589081600|FG001|Overall Study|Adverse Event|2|||
163102856|NCT01169701|589081599|FG000|Overall Study|Exclusion criteria|2|||
163102857|NCT01169701|589081600|FG001|Overall Study|Exclusion criteria|0|||
163102858|NCT01169701|589081599|FG000|Overall Study|Death|0|||
163102859|NCT01169701|589081600|FG001|Overall Study|Death|1|||
163102860|NCT01169701|589081599|FG000|Overall Study|Administrative problems|0|||
163102861|NCT01169701|589081600|FG001|Overall Study|Administrative problems|1|||
163102862|NCT01169701|589081599|FG000|Overall Study|Serious adverse event|0|||
163102863|NCT01169701|589081600|FG001|Overall Study|Serious adverse event|1|||
163102864|NCT01169701|589081599|FG000|Overall Study|Sponsor decision|0|||
163102865|NCT01169701|589081600|FG001|Overall Study|Sponsor decision|1|||
163102866|NCT00980460|589081609|FG000|Overall Study|Death|0|||
163102867|NCT00980460|589081610|FG001|Overall Study|Death|0|||
163102868|NCT00980460|589081611|FG002|Overall Study|Death|1|||
163102869|NCT00980460|589081612|FG003|Overall Study|Death|2|||
163102870|NCT00980460|589081613|FG004|Overall Study|Death|1|||
163102871|NCT00980460|589081609|FG000|Overall Study|Lack of Efficacy|0|||
163102872|NCT00980460|589081610|FG001|Overall Study|Lack of Efficacy|0|||
163102873|NCT00980460|589081611|FG002|Overall Study|Lack of Efficacy|10|||
163102874|NCT00980460|589081612|FG003|Overall Study|Lack of Efficacy|6|||
163102875|NCT00980460|589081613|FG004|Overall Study|Lack of Efficacy|8|||
163102876|NCT00980460|589081609|FG000|Overall Study|Lost to Follow-up|0|||
163102877|NCT00980460|589081610|FG001|Overall Study|Lost to Follow-up|0|||
163102878|NCT00980460|589081611|FG002|Overall Study|Lost to Follow-up|0|||
163102879|NCT00980460|589081612|FG003|Overall Study|Lost to Follow-up|1|||
163102880|NCT00980460|589081613|FG004|Overall Study|Lost to Follow-up|0|||
163102881|NCT00980460|589081609|FG000|Overall Study|Physician Decision|0|||
163102882|NCT00980460|589081610|FG001|Overall Study|Physician Decision|0|||
163102883|NCT00980460|589081611|FG002|Overall Study|Physician Decision|11|||
163102884|NCT00980460|589081612|FG003|Overall Study|Physician Decision|5|||
163102885|NCT00980460|589081613|FG004|Overall Study|Physician Decision|3|||
163102886|NCT00980460|589081609|FG000|Overall Study|Withdrawal by Subject|0|||
163102887|NCT00980460|589081610|FG001|Overall Study|Withdrawal by Subject|0|||
163102888|NCT00980460|589081611|FG002|Overall Study|Withdrawal by Subject|1|||
163102889|NCT00980460|589081612|FG003|Overall Study|Withdrawal by Subject|0|||
163102890|NCT00980460|589081613|FG004|Overall Study|Withdrawal by Subject|0|||
163102891|NCT00980460|589081609|FG000|Overall Study|Ineligible|0|||
163102892|NCT00980460|589081610|FG001|Overall Study|Ineligible|2|||
163102893|NCT00980460|589081611|FG002|Overall Study|Ineligible|3|||
163102894|NCT00980460|589081612|FG003|Overall Study|Ineligible|1|||
163102895|NCT00980460|589081613|FG004|Overall Study|Ineligible|4|||
163102896|NCT00980460|589081609|FG000|Overall Study|Refusal of further therapy|0|||
163102897|NCT00980460|589081610|FG001|Overall Study|Refusal of further therapy|2|||
163102898|NCT00980460|589081611|FG002|Overall Study|Refusal of further therapy|3|||
163102899|NCT00980460|589081612|FG003|Overall Study|Refusal of further therapy|2|||
163102900|NCT00980460|589081613|FG004|Overall Study|Refusal of further therapy|0|||
163102901|NCT00980460|589081609|FG000|Overall Study|No therapy within 42 days of resection|0|||
163102902|NCT00980460|589081610|FG001|Overall Study|No therapy within 42 days of resection|0|||
163102903|NCT00980460|589081611|FG002|Overall Study|No therapy within 42 days of resection|3|||
163102904|NCT00980460|589081612|FG003|Overall Study|No therapy within 42 days of resection|1|||
163102905|NCT00980460|589081613|FG004|Overall Study|No therapy within 42 days of resection|0|||
163102906|NCT00980460|589081609|FG000|Overall Study|No transplant by protocol timepoints|0|||
163102907|NCT00980460|589081610|FG001|Overall Study|No transplant by protocol timepoints|0|||
163102908|NCT00980460|589081611|FG002|Overall Study|No transplant by protocol timepoints|3|||
163102909|NCT00980460|589081612|FG003|Overall Study|No transplant by protocol timepoints|0|||
163102910|NCT00980460|589081613|FG004|Overall Study|No transplant by protocol timepoints|0|||
163102911|NCT02842086|589081614|FG000|Overall Study|Randomized but Never Treated|6|||
163102912|NCT02842086|589081615|FG001|Overall Study|Randomized but Never Treated|6|||
163102913|NCT02842086|589081614|FG000|Overall Study|Still in Double-Blind Phase|7|||
163102914|NCT02842086|589081615|FG001|Overall Study|Still in Double-Blind Phase|3|||
163102915|NCT02842086|589081614|FG000|Overall Study|Adverse Event|18|||
163102916|NCT02842086|589081615|FG001|Overall Study|Adverse Event|20|||
163102917|NCT02842086|589081614|FG000|Overall Study|Death|3|||
163102918|NCT02842086|589081615|FG001|Overall Study|Death|3|||
163102919|NCT02842086|589081614|FG000|Overall Study|Investigator's Discretion|9|||
163102920|NCT02842086|589081615|FG001|Overall Study|Investigator's Discretion|13|||
163102921|NCT02842086|589081614|FG000|Overall Study|Non-Compliance with Study Drug|9|||
163102922|NCT02842086|589081615|FG001|Overall Study|Non-Compliance with Study Drug|8|||
163102923|NCT02842086|589081614|FG000|Overall Study|Protocol Violation|8|||
163102924|NCT02842086|589081615|FG001|Overall Study|Protocol Violation|4|||
163102925|NCT02842086|589081614|FG000|Overall Study|Withdrew Consent|205|||
163102926|NCT02842086|589081615|FG001|Overall Study|Withdrew Consent|194|||
163102927|NCT02842086|589081614|FG000|Overall Study|Lost to Follow-up|274|||
163102928|NCT02842086|589081615|FG001|Overall Study|Lost to Follow-up|236|||
163102929|NCT02842086|589081614|FG000|Overall Study|HIV-1 Infection|5|||
163102930|NCT02842086|589081615|FG001|Overall Study|HIV-1 Infection|6|||
163102931|NCT05696444|589081616|FG000|Treatment|Physician Decision|0|||
163102932|NCT05696444|589081617|FG001|Treatment|Physician Decision|1|||
163102933|NCT05696444|589081618|FG002|Treatment|Physician Decision|0|||
163102934|NCT05696444|589081616|FG000|30 Days|Death|1|||
163102935|NCT05696444|589081617|FG001|30 Days|Death|1|||
163102936|NCT05696444|589081618|FG002|30 Days|Death|0|||
163102937|NCT05696444|589081616|FG000|30 Days|Missed Visit|1|||
163102938|NCT05696444|589081617|FG001|30 Days|Missed Visit|1|||
163102939|NCT05696444|589081618|FG002|30 Days|Missed Visit|1|||
163102940|NCT00078806|589082985|FG000|Part 1A|Adverse Event|2|||
163102941|NCT00078806|589082986|FG001|Part 1A|Adverse Event|0|||
163102942|NCT00078806|589082987|FG002|Part 1A|Adverse Event|0|||
163102943|NCT00078806|589082988|FG003|Part 1A|Adverse Event|0|||
163102944|NCT00078806|589082985|FG000|Part 1A|Lack of Efficacy|7|||
163102945|NCT00078806|589082986|FG001|Part 1A|Lack of Efficacy|0|||
163102946|NCT00078806|589082987|FG002|Part 1A|Lack of Efficacy|0|||
163102947|NCT00078806|589082988|FG003|Part 1A|Lack of Efficacy|0|||
163102948|NCT00078806|589082985|FG000|Part 1A|Other|1|||
163102949|NCT00078806|589082986|FG001|Part 1A|Other|0|||
163102950|NCT00078806|589082987|FG002|Part 1A|Other|0|||
163102951|NCT00078806|589082988|FG003|Part 1A|Other|0|||
163102952|NCT00078806|589082985|FG000|Part 1B|Adverse Event|1|||
163102953|NCT00078806|589082986|FG001|Part 1B|Adverse Event|0|||
163102954|NCT00078806|589082987|FG002|Part 1B|Adverse Event|0|||
163102955|NCT00078806|589082988|FG003|Part 1B|Adverse Event|0|||
163102956|NCT00078806|589082985|FG000|Part 1B|Lack of Efficacy|7|||
163102957|NCT00078806|589082986|FG001|Part 1B|Lack of Efficacy|0|||
163102958|NCT00078806|589082987|FG002|Part 1B|Lack of Efficacy|0|||
163102959|NCT00078806|589082988|FG003|Part 1B|Lack of Efficacy|0|||
163102960|NCT00078806|589082985|FG000|Part 2|Adverse Event|0|||
163102961|NCT00078806|589082986|FG001|Part 2|Adverse Event|1|||
163102962|NCT00078806|589082987|FG002|Part 2|Adverse Event|0|||
163102963|NCT00078806|589082988|FG003|Part 2|Adverse Event|0|||
163102964|NCT00161616|589082989|FG000|Overall Study|Withdrawal by Subject|6|||
163102965|NCT00161616|589082990|FG001|Overall Study|Withdrawal by Subject|5|||
163102966|NCT00161616|589082989|FG000|Overall Study|Physician Decision|1|||
163102967|NCT00161616|589082990|FG001|Overall Study|Physician Decision|0|||
163102968|NCT00161616|589082989|FG000|Overall Study|Death|1|||
163102969|NCT00161616|589082990|FG001|Overall Study|Death|1|||
163102970|NCT00161616|589082989|FG000|Overall Study|Lost to Follow-up|17|||
163102971|NCT00161616|589082990|FG001|Overall Study|Lost to Follow-up|13|||
163102972|NCT00161616|589082989|FG000|Overall Study|Protocol deviation|1|||
163102973|NCT00161616|589082990|FG001|Overall Study|Protocol deviation|0|||
163102974|NCT00861757|589082993|FG000|Overall Study|Adverse Event|1|||
163102975|NCT00861757|589082994|FG001|Overall Study|Adverse Event|5|||
163102976|NCT00861757|589082995|FG002|Overall Study|Adverse Event|7|||
163102977|NCT00861757|589082996|FG003|Overall Study|Adverse Event|2|||
163102978|NCT00861757|589082993|FG000|Overall Study|Entry Criteria Not Met|1|||
163102979|NCT00861757|589082994|FG001|Overall Study|Entry Criteria Not Met|2|||
163102980|NCT00861757|589082995|FG002|Overall Study|Entry Criteria Not Met|1|||
163102981|NCT00861757|589082996|FG003|Overall Study|Entry Criteria Not Met|1|||
163339524|NCT02326220|589951216|FG001|Double-blind Treatment Period|Protocol Violation|1|||
163102982|NCT00861757|589082993|FG000|Overall Study|Lack of Efficacy|3|||
163102983|NCT00861757|589082994|FG001|Overall Study|Lack of Efficacy|1|||
163102984|NCT00861757|589082995|FG002|Overall Study|Lack of Efficacy|0|||
163102985|NCT00861757|589082996|FG003|Overall Study|Lack of Efficacy|1|||
163102986|NCT00861757|589082993|FG000|Overall Study|Lost to Follow-up|1|||
163102987|NCT00861757|589082994|FG001|Overall Study|Lost to Follow-up|0|||
163102988|NCT00861757|589082995|FG002|Overall Study|Lost to Follow-up|1|||
163220568|NCT04668950|589522910|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
163339525|NCT02326220|589951217|FG002|Double-blind Treatment Period|Protocol Violation|0|||
163102989|NCT00861757|589082996|FG003|Overall Study|Lost to Follow-up|1|||
163102990|NCT00861757|589082993|FG000|Overall Study|Physician Decision|0|||
163102991|NCT00861757|589082994|FG001|Overall Study|Physician Decision|0|||
163102992|NCT00861757|589082995|FG002|Overall Study|Physician Decision|0|||
163102993|NCT00861757|589082996|FG003|Overall Study|Physician Decision|1|||
163102994|NCT00861757|589082993|FG000|Overall Study|Protocol Violation|2|||
163102995|NCT00861757|589082994|FG001|Overall Study|Protocol Violation|2|||
163102996|NCT00861757|589082995|FG002|Overall Study|Protocol Violation|4|||
163102997|NCT00861757|589082996|FG003|Overall Study|Protocol Violation|1|||
163220569|NCT04668950|589522909|FG000|Overall Study|Could not confirm started study medication|15|||
163102998|NCT00861757|589082993|FG000|Overall Study|Withdrawal by Subject|1|||
163102999|NCT00861757|589082994|FG001|Overall Study|Withdrawal by Subject|5|||
163103000|NCT00861757|589082995|FG002|Overall Study|Withdrawal by Subject|5|||
163103001|NCT00861757|589082996|FG003|Overall Study|Withdrawal by Subject|2|||
163103002|NCT02141633|589082997|FG000|Overall Study|Physician Decision|1|||
163103003|NCT02141633|589082998|FG001|Overall Study|Physician Decision|0|||
163103004|NCT04908384|589082999|FG000|Overall Study|Lost to Follow-up|4|||
163103005|NCT04908384|589083000|FG001|Overall Study|Lost to Follow-up|4|||
163103006|NCT04908384|589083001|FG002|Overall Study|Lost to Follow-up|0|||
163103007|NCT04908384|589083002|FG003|Overall Study|Lost to Follow-up|0|||
163103008|NCT00833469|589083003|FG000|Overall Study|Withdrawal by Subject|1|||
163103009|NCT00833469|589083003|FG000|Overall Study|Lost to Follow-up|1|||
163103010|NCT02943070|589083004|FG000|Overall Study|Physician Decision|1|||
163103011|NCT02943070|589083004|FG000|Overall Study|Adverse Event|2|||
163103012|NCT02943070|589083004|FG000|Overall Study|Death|2|||
163103013|NCT02943070|589083004|FG000|Overall Study|Withdrawal by Subject|3|||
163103014|NCT02943070|589083004|FG000|Overall Study|Lost to Follow-up|4|||
163103015|NCT02943070|589083004|FG000|Overall Study|Retreatment or TURP|13|||
163103016|NCT02943070|589083004|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
163103017|NCT01701362|589083005|FG000|Overall Study|Adverse events not related to study drug|1|||
163103018|NCT01701362|589083006|FG001|Overall Study|Adverse events not related to study drug|6|||
163103019|NCT01701362|589083005|FG000|Overall Study|Adverse events related to study drug|12|||
163103020|NCT01701362|589083006|FG001|Overall Study|Adverse events related to study drug|10|||
163103021|NCT01701362|589083005|FG000|Overall Study|Protocol Violation|5|||
163103022|NCT01701362|589083006|FG001|Overall Study|Protocol Violation|3|||
163103023|NCT01701362|589083005|FG000|Overall Study|No longer willing to participate|8|||
163103024|NCT01701362|589083006|FG001|Overall Study|No longer willing to participate|14|||
163103025|NCT01701362|589083005|FG000|Overall Study|Lost to Follow-up|6|||
163103026|NCT01701362|589083006|FG001|Overall Study|Lost to Follow-up|9|||
163103027|NCT01701362|589083005|FG000|Overall Study|Insufficient clinical response|6|||
163103028|NCT01701362|589083006|FG001|Overall Study|Insufficient clinical response|6|||
163103029|NCT01701362|589083005|FG000|Overall Study|Death|0|||
163103030|NCT01701362|589083006|FG001|Overall Study|Death|1|||
163103031|NCT01701362|589083005|FG000|Overall Study|Randomized but not treated|1|||
163103032|NCT01701362|589083006|FG001|Overall Study|Randomized but not treated|2|||
163103033|NCT01701362|589083005|FG000|Overall Study|Reasons other than those mentioned above|3|||
163103034|NCT01701362|589083006|FG001|Overall Study|Reasons other than those mentioned above|5|||
163103035|NCT00570778|589083007|FG000|Overall Study|Protocol deviation|2|||
163103036|NCT00570778|589083008|FG001|Overall Study|Protocol deviation|1|||
163103037|NCT00570778|589083009|FG002|Overall Study|Protocol deviation|2|||
163103038|NCT00570778|589083010|FG003|Overall Study|Protocol deviation|2|||
163103039|NCT00570778|589083007|FG000|Overall Study|Adverse Event|0|||
163103040|NCT00570778|589083008|FG001|Overall Study|Adverse Event|1|||
163103041|NCT00570778|589083009|FG002|Overall Study|Adverse Event|4|||
163103042|NCT00570778|589083010|FG003|Overall Study|Adverse Event|1|||
163103043|NCT00570778|589083007|FG000|Overall Study|Subject withdrew consent|0|||
163103044|NCT00570778|589083008|FG001|Overall Study|Subject withdrew consent|1|||
163103045|NCT00570778|589083009|FG002|Overall Study|Subject withdrew consent|0|||
163103046|NCT00570778|589083010|FG003|Overall Study|Subject withdrew consent|1|||
163103047|NCT00570778|589083007|FG000|Overall Study|Abnormal test procedure|1|||
163103048|NCT00570778|589083008|FG001|Overall Study|Abnormal test procedure|0|||
163103049|NCT00570778|589083009|FG002|Overall Study|Abnormal test procedure|0|||
163103050|NCT00570778|589083010|FG003|Overall Study|Abnormal test procedure|0|||
163103051|NCT00570778|589083007|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163103052|NCT00570778|589083008|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163103053|NCT00570778|589083009|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
163220570|NCT04668950|589522910|FG001|Overall Study|Could not confirm started study medication|15|||
163220571|NCT04668950|589522909|FG000|Overall Study|Could not confirm baseline status|6|||
163220572|NCT04668950|589522910|FG001|Overall Study|Could not confirm baseline status|2|||
163103054|NCT00570778|589083010|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
163103055|NCT00570778|589083007|FG000|Overall Study|Lost to Follow-up|0|||
163103056|NCT00570778|589083008|FG001|Overall Study|Lost to Follow-up|0|||
163220573|NCT04668950|589522909|FG000|Overall Study|Drop out and did not start medication|15|||
163220574|NCT04668950|589522910|FG001|Overall Study|Drop out and did not start medication|17|||
163220575|NCT04668950|589522909|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
163103057|NCT00570778|589083009|FG002|Overall Study|Lost to Follow-up|1|||
163103058|NCT00570778|589083010|FG003|Overall Study|Lost to Follow-up|0|||
163103059|NCT00570778|589083007|FG000|Overall Study|Subject no longer requires study drug|0|||
163103060|NCT00570778|589083008|FG001|Overall Study|Subject no longer requires study drug|1|||
163103061|NCT00570778|589083009|FG002|Overall Study|Subject no longer requires study drug|0|||
163103062|NCT00570778|589083010|FG003|Overall Study|Subject no longer requires study drug|0|||
163103063|NCT00443872|589083013|FG000|Overall Study|Protocol Violation|7|||
163103064|NCT00443872|589083013|FG000|Overall Study|Lost to Follow-up|2|||
163407673|NCT00618410|590200877|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
163407674|NCT00464334|590200881|FG000|Overall Study|Adverse Event|0|||
163407675|NCT00464334|590200882|FG001|Overall Study|Adverse Event|0|||
163407676|NCT00464334|590200883|FG002|Overall Study|Adverse Event|0|||
163103065|NCT00443872|589083013|FG000|Overall Study|Adverse Event|8|||
163103066|NCT01014767|589083014|FG000|Overall Study|PI left institution, data unavailable|12|||
163103067|NCT01014767|589083015|FG001|Overall Study|PI left institution, data unavailable|1|||
163103068|NCT01014767|589083016|FG002|Overall Study|PI left institution, data unavailable|4|||
163103069|NCT01014767|589083017|FG003|Overall Study|PI left institution, data unavailable|1|||
163103070|NCT00700622|589083018|FG000|Overall Study|Adverse Event|4|||
163103071|NCT00700622|589083019|FG001|Overall Study|Adverse Event|0|||
163103072|NCT00700622|589083018|FG000|Overall Study|Lost to Follow-up|0|||
163103073|NCT00700622|589083019|FG001|Overall Study|Lost to Follow-up|1|||
163103074|NCT00700622|589083018|FG000|Overall Study|Physician Decision|2|||
163103075|NCT00700622|589083019|FG001|Overall Study|Physician Decision|1|||
163103076|NCT00700622|589083018|FG000|Overall Study|Protocol Violation|0|||
163103077|NCT00700622|589083019|FG001|Overall Study|Protocol Violation|1|||
163103078|NCT00700622|589083018|FG000|Overall Study|Withdrawal by Subject|4|||
163103079|NCT00700622|589083019|FG001|Overall Study|Withdrawal by Subject|1|||
163103080|NCT00700622|589083018|FG000|Overall Study|Other|3|||
163103081|NCT00700622|589083019|FG001|Overall Study|Other|1|||
163103082|NCT00282087|589083020|FG000|Overall Study|Death|1|||
163103083|NCT00405392|589083021|FG000|Overall Study|Adverse Event|15|||
163103084|NCT00405392|589083022|FG001|Overall Study|Adverse Event|14|||
163103085|NCT00405392|589083021|FG000|Overall Study|Did not meet Eligibility criteria|7|||
163103086|NCT00405392|589083022|FG001|Overall Study|Did not meet Eligibility criteria|2|||
163103087|NCT00405392|589083021|FG000|Overall Study|Withdrawal by Subject|4|||
163103088|NCT00405392|589083022|FG001|Overall Study|Withdrawal by Subject|3|||
163103089|NCT00405392|589083021|FG000|Overall Study|Lost to Follow-up|1|||
163103090|NCT00405392|589083022|FG001|Overall Study|Lost to Follow-up|2|||
163103091|NCT00405392|589083021|FG000|Overall Study|Data missing|2|||
163103092|NCT00405392|589083022|FG001|Overall Study|Data missing|0|||
163103093|NCT00405392|589083021|FG000|Overall Study|Non-compliance|0|||
163103094|NCT00405392|589083022|FG001|Overall Study|Non-compliance|1|||
163103095|NCT00405392|589083021|FG000|Overall Study|Other|1|||
163103096|NCT00405392|589083022|FG001|Overall Study|Other|5|||
163103097|NCT01703091|589083025|FG000|Overall Study|Adverse Event|5|||
163103098|NCT01703091|589083026|FG001|Overall Study|Adverse Event|3|||
163103099|NCT01703091|589083025|FG000|Overall Study|Physician Decision|2|||
163103100|NCT01703091|589083026|FG001|Overall Study|Physician Decision|1|||
163103101|NCT01703091|589083025|FG000|Overall Study|Withdrawal by Subject|1|||
163103102|NCT01703091|589083026|FG001|Overall Study|Withdrawal by Subject|0|||
163103103|NCT01703091|589083025|FG000|Overall Study|Sponsor Decision|1|||
163103104|NCT01703091|589083026|FG001|Overall Study|Sponsor Decision|0|||
163103105|NCT02550288|589083027|FG000|Overall Study|Adverse Event|0|||
163103106|NCT02550288|589083028|FG001|Overall Study|Adverse Event|1|||
163103107|NCT02550288|589083029|FG002|Overall Study|Adverse Event|0|||
163103108|NCT02550288|589083030|FG003|Overall Study|Adverse Event|0|||
163103109|NCT02550288|589083031|FG004|Overall Study|Adverse Event|0|||
163103110|NCT02550288|589083027|FG000|Overall Study|Physician Decision|0|||
163103111|NCT02550288|589083028|FG001|Overall Study|Physician Decision|0|||
163103112|NCT02550288|589083029|FG002|Overall Study|Physician Decision|0|||
163103113|NCT02550288|589083030|FG003|Overall Study|Physician Decision|1|||
163103114|NCT02550288|589083031|FG004|Overall Study|Physician Decision|0|||
163103115|NCT02550288|589083027|FG000|Overall Study|Protocol Violation|2|||
163407677|NCT00464334|590200884|FG003|Overall Study|Adverse Event|1|||
163103116|NCT02550288|589083028|FG001|Overall Study|Protocol Violation|2|||
163103117|NCT02550288|589083029|FG002|Overall Study|Protocol Violation|1|||
163103118|NCT02550288|589083030|FG003|Overall Study|Protocol Violation|0|||
163103119|NCT02550288|589083031|FG004|Overall Study|Protocol Violation|3|||
163103120|NCT02550288|589083027|FG000|Overall Study|Participant moved|0|||
163103121|NCT02550288|589083028|FG001|Overall Study|Participant moved|0|||
163103122|NCT02550288|589083029|FG002|Overall Study|Participant moved|0|||
163103123|NCT02550288|589083030|FG003|Overall Study|Participant moved|1|||
163103124|NCT02550288|589083031|FG004|Overall Study|Participant moved|0|||
163103125|NCT02550288|589083027|FG000|Overall Study|Withdrawal by Subject|0|||
163103126|NCT02550288|589083028|FG001|Overall Study|Withdrawal by Subject|0|||
163103127|NCT02550288|589083029|FG002|Overall Study|Withdrawal by Subject|0|||
163103128|NCT02550288|589083030|FG003|Overall Study|Withdrawal by Subject|1|||
163407678|NCT00464334|590200885|FG004|Overall Study|Adverse Event|1|||
163103129|NCT02550288|589083031|FG004|Overall Study|Withdrawal by Subject|0|||
163407679|NCT00464334|590200886|FG005|Overall Study|Adverse Event|1|||
163407680|NCT00464334|590200887|FG006|Overall Study|Adverse Event|0|||
163103130|NCT00988052|589083032|FG000|Overall Study|Missing|1|||
163103131|NCT00988052|589083033|FG001|Overall Study|Missing|0|||
163103132|NCT00988052|589083032|FG000|Overall Study|Teva requested subject withdrawal|3|||
163103133|NCT00988052|589083033|FG001|Overall Study|Teva requested subject withdrawal|1|||
163103134|NCT00988052|589083032|FG000|Overall Study|Death|1|||
163103135|NCT00988052|589083033|FG001|Overall Study|Death|3|||
163339526|NCT02326220|589951215|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
163339527|NCT02326220|589951216|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
163339528|NCT02326220|589951217|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
163339529|NCT02326220|589951215|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
163339530|NCT02326220|589951216|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
163339531|NCT02326220|589951217|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
163339532|NCT02326220|589951215|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
163103136|NCT00988052|589083032|FG000|Overall Study|Protocol Violation|6|||
163103137|NCT00988052|589083033|FG001|Overall Study|Protocol Violation|5|||
163103138|NCT00988052|589083032|FG000|Overall Study|Pregnancy|6|||
163103139|NCT00988052|589083033|FG001|Overall Study|Pregnancy|6|||
163103140|NCT00988052|589083032|FG000|Overall Study|Lack of Efficacy|8|||
163103141|NCT00988052|589083033|FG001|Overall Study|Lack of Efficacy|7|||
163103142|NCT00988052|589083032|FG000|Overall Study|Lost to Follow-up|6|||
163103143|NCT00988052|589083033|FG001|Overall Study|Lost to Follow-up|11|||
163103144|NCT00988052|589083032|FG000|Overall Study|Physician Decision|27|||
163103145|NCT00988052|589083033|FG001|Overall Study|Physician Decision|28|||
163103146|NCT00988052|589083032|FG000|Overall Study|Adverse Event|35|||
163103147|NCT00988052|589083033|FG001|Overall Study|Adverse Event|28|||
163103148|NCT00988052|589083032|FG000|Overall Study|Withdrawal by Subject|90|||
163103149|NCT00988052|589083033|FG001|Overall Study|Withdrawal by Subject|91|||
163103150|NCT00988052|589083032|FG000|Overall Study|Study terminated by sponsor|240|||
163103151|NCT00988052|589083033|FG001|Overall Study|Study terminated by sponsor|236|||
163103152|NCT00842153|589083034|FG000|Overall Study|Adverse Event|0|||
163103153|NCT00842153|589083035|FG001|Overall Study|Adverse Event|1|||
163103154|NCT00842153|589083034|FG000|Overall Study|Lost to Follow-up|1|||
163103155|NCT00842153|589083035|FG001|Overall Study|Lost to Follow-up|2|||
163103156|NCT05312697|589083037|FG000|Overall Study|Sponsor Terminated Trial|2|||
163103157|NCT02858440|589083038|FG000|Overall Study|Lost to Follow-up|3|||
163103158|NCT02858440|589083038|FG000|Overall Study|Protocol Violation|2|||
163103159|NCT02858440|589083038|FG000|Overall Study|Consent withdrawal|3|||
163103160|NCT02858440|589083038|FG000|Overall Study|Migrated/moved from study area|4|||
163103161|NCT00402324|589083039|FG000|Overall Study|Lost to Follow-up|11|||
163103162|NCT00402324|589083040|FG001|Overall Study|Lost to Follow-up|11|||
163103163|NCT00402324|589083039|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
163103164|NCT00402324|589083040|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
163103165|NCT00402324|589083039|FG000|Overall Study|Protocol Violation|8|||
163103166|NCT00402324|589083040|FG001|Overall Study|Protocol Violation|7|||
163103167|NCT00402324|589083039|FG000|Overall Study|Withdrawal by Subject|5|||
163103168|NCT00402324|589083040|FG001|Overall Study|Withdrawal by Subject|2|||
163103169|NCT00402324|589083039|FG000|Overall Study|Physician Decision|2|||
163103170|NCT00402324|589083040|FG001|Overall Study|Physician Decision|4|||
163103171|NCT00402324|589083039|FG000|Overall Study|Sponsor Decision|4|||
163103172|NCT00402324|589083040|FG001|Overall Study|Sponsor Decision|5|||
163103173|NCT00402324|589083039|FG000|Overall Study|Lack of Efficacy|1|||
163103174|NCT00402324|589083040|FG001|Overall Study|Lack of Efficacy|4|||
163103175|NCT00402324|589083039|FG000|Overall Study|Adverse Event|6|||
163103176|NCT00402324|589083040|FG001|Overall Study|Adverse Event|4|||
163103177|NCT00402324|589083039|FG000|Overall Study|Death|1|||
163103178|NCT00402324|589083040|FG001|Overall Study|Death|0|||
163103179|NCT01277822|589083041|FG000|Overall Study|Adverse Event|2|||
163103180|NCT01277822|589083042|FG001|Overall Study|Adverse Event|1|||
163103181|NCT01277822|589083041|FG000|Overall Study|Withdrawal by Subject|6|||
163103182|NCT01277822|589083042|FG001|Overall Study|Withdrawal by Subject|7|||
163103183|NCT01277822|589083041|FG000|Overall Study|Physician Decision|1|||
163103184|NCT01277822|589083042|FG001|Overall Study|Physician Decision|1|||
163103185|NCT01277822|589083041|FG000|Overall Study|Protocol Violation|1|||
163103186|NCT01277822|589083042|FG001|Overall Study|Protocol Violation|0|||
163103187|NCT01277822|589083041|FG000|Overall Study|Lost to Follow-up|2|||
163103188|NCT01277822|589083042|FG001|Overall Study|Lost to Follow-up|1|||
163103189|NCT01277822|589083041|FG000|Overall Study|Contraindicated medication used|2|||
163103190|NCT01277822|589083042|FG001|Overall Study|Contraindicated medication used|1|||
163103191|NCT01277822|589083041|FG000|Overall Study|Participant moved|1|||
163103192|NCT01277822|589083042|FG001|Overall Study|Participant moved|0|||
163339533|NCT02326220|589951216|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
163407681|NCT00464334|590200888|FG007|Overall Study|Adverse Event|0|||
163407682|NCT00464334|590200889|FG008|Overall Study|Adverse Event|2|||
163407683|NCT00464334|590200890|FG009|Overall Study|Adverse Event|1|||
163407684|NCT00464334|590200891|FG010|Overall Study|Adverse Event|2|||
163407685|NCT00464334|590200881|FG000|Overall Study|Lack of Efficacy|0|||
163103193|NCT00997984|589083043|FG000|Overall Study|Adverse Event|1|||
163103194|NCT00997984|589083044|FG001|Overall Study|Adverse Event|8|||
163103195|NCT00997984|589083045|FG002|Overall Study|Adverse Event|8|||
163103196|NCT00997984|589083043|FG000|Overall Study|Protocol Violation|1|||
163103197|NCT00997984|589083044|FG001|Overall Study|Protocol Violation|3|||
163103198|NCT00997984|589083045|FG002|Overall Study|Protocol Violation|0|||
163103199|NCT00997984|589083043|FG000|Overall Study|Withdrawal by Subject|6|||
163103200|NCT00997984|589083044|FG001|Overall Study|Withdrawal by Subject|9|||
163103201|NCT00997984|589083045|FG002|Overall Study|Withdrawal by Subject|5|||
163103202|NCT00997984|589083043|FG000|Overall Study|Lost to Follow-up|8|||
163103203|NCT00997984|589083044|FG001|Overall Study|Lost to Follow-up|5|||
163103204|NCT00997984|589083045|FG002|Overall Study|Lost to Follow-up|4|||
163103205|NCT00997984|589083043|FG000|Overall Study|Lack of Efficacy|20|||
163103206|NCT00997984|589083044|FG001|Overall Study|Lack of Efficacy|6|||
163103207|NCT00997984|589083045|FG002|Overall Study|Lack of Efficacy|3|||
163103208|NCT00997984|589083043|FG000|Overall Study|Met exclusion criteria|1|||
163103209|NCT00997984|589083044|FG001|Overall Study|Met exclusion criteria|0|||
163103210|NCT00997984|589083045|FG002|Overall Study|Met exclusion criteria|0|||
163103211|NCT00997984|589083043|FG000|Overall Study|non-compliance|0|||
163103212|NCT00997984|589083044|FG001|Overall Study|non-compliance|2|||
163103213|NCT00997984|589083045|FG002|Overall Study|non-compliance|3|||
163103214|NCT00997984|589083043|FG000|Overall Study|Wrong medication dispensed|0|||
163103215|NCT00997984|589083044|FG001|Overall Study|Wrong medication dispensed|1|||
163103216|NCT00997984|589083045|FG002|Overall Study|Wrong medication dispensed|0|||
163103217|NCT00997984|589083043|FG000|Overall Study|Suicidal ideation|0|||
163103218|NCT00997984|589083044|FG001|Overall Study|Suicidal ideation|0|||
163103219|NCT00997984|589083045|FG002|Overall Study|Suicidal ideation|1|||
163103220|NCT00997984|589083043|FG000|Overall Study|Work schedule|0|||
163103221|NCT00997984|589083044|FG001|Overall Study|Work schedule|0|||
163103222|NCT00997984|589083045|FG002|Overall Study|Work schedule|2|||
163103223|NCT01945996|589083047|FG000|Overall Study|Lost to Follow-up|3|||
163103224|NCT01945996|589083048|FG001|Overall Study|Lost to Follow-up|5|||
163103225|NCT04396795|589083050|FG000|Month 1|Lost to Follow-up|2|||
163103226|NCT04396795|589083051|FG001|Month 1|Lost to Follow-up|3|||
163103227|NCT04396795|589083050|FG000|Month 3|Lost to Follow-up|1|||
163103228|NCT04396795|589083051|FG001|Month 3|Lost to Follow-up|3|||
163103229|NCT04396795|589083050|FG000|Month 6|Lost to Follow-up|3|||
163103230|NCT04396795|589083051|FG001|Month 6|Lost to Follow-up|3|||
163103231|NCT02484443|589083052|FG000|Overall Study|Lack of Efficacy|28|||
163103232|NCT02484443|589083052|FG000|Overall Study|Physician Decision|2|||
163103233|NCT02484443|589083052|FG000|Overall Study|Ineligible|2|||
163103234|NCT01970241|589083053|FG000|Overall Study|Withdrawal by Subject|2|||
163103235|NCT01970241|589083054|FG001|Overall Study|Withdrawal by Subject|0|||
163103236|NCT01970241|589083053|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
163103237|NCT01970241|589083054|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
163103238|NCT02595866|589083055|FG000|Overall Study|Adverse Event|2|||
163103239|NCT02595866|589083056|FG001|Overall Study|Adverse Event|5|||
163103240|NCT02595866|589083055|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
163103241|NCT02595866|589083056|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
163103242|NCT02595866|589083055|FG000|Overall Study|Death|0|||
163103243|NCT02595866|589083056|FG001|Overall Study|Death|1|||
163103244|NCT02595866|589083055|FG000|Overall Study|Incarceration|1|||
163103245|NCT02595866|589083056|FG001|Overall Study|Incarceration|0|||
163103246|NCT02595866|589083055|FG000|Overall Study|Lack of Efficacy|17|||
163103247|NCT02595866|589083056|FG001|Overall Study|Lack of Efficacy|7|||
163103248|NCT02595866|589083055|FG000|Overall Study|Physician Decision|4|||
163103249|NCT02595866|589083056|FG001|Overall Study|Physician Decision|3|||
163103250|NCT02595866|589083055|FG000|Overall Study|Switched to Alternative Treatment|1|||
163103251|NCT02595866|589083056|FG001|Overall Study|Switched to Alternative Treatment|0|||
163103252|NCT02595866|589083055|FG000|Overall Study|Study Terminated|0|||
163103253|NCT02595866|589083056|FG001|Overall Study|Study Terminated|4|||
163103254|NCT02595866|589083055|FG000|Overall Study|Withdrawal by Subject|6|||
163103255|NCT02595866|589083056|FG001|Overall Study|Withdrawal by Subject|1|||
163103256|NCT01107392|589083057|FG000|Overall Study|Adverse Event|2|||
163103257|NCT01107392|589083058|FG001|Overall Study|Adverse Event|0|||
163103258|NCT01107392|589083057|FG000|Overall Study|Personal Reasons|2|||
163103259|NCT01107392|589083058|FG001|Overall Study|Personal Reasons|3|||
163103260|NCT01107392|589083057|FG000|Overall Study|Administrative decision|1|||
163103261|NCT01107392|589083058|FG001|Overall Study|Administrative decision|0|||
163103262|NCT02689206|589083062|FG000|Overall Study|Adverse Event|0|||
163103263|NCT02689206|589083063|FG001|Overall Study|Adverse Event|0|||
163103264|NCT02689206|589083064|FG002|Overall Study|Adverse Event|1|||
163103265|NCT02689206|589083065|FG003|Overall Study|Adverse Event|0|||
163103266|NCT02689206|589083066|FG004|Overall Study|Adverse Event|2|||
163103267|NCT02689206|589083062|FG000|Overall Study|Protocol Violation|1|||
163103268|NCT02689206|589083063|FG001|Overall Study|Protocol Violation|0|||
163103269|NCT02689206|589083064|FG002|Overall Study|Protocol Violation|0|||
163103270|NCT02689206|589083065|FG003|Overall Study|Protocol Violation|1|||
163220576|NCT04668950|589522910|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
163220577|NCT04668950|589522909|FG000|Overall Study|Other|2|||
163339534|NCT02326220|589951217|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
163339535|NCT02699099|589951218|FG000|Overall Study|Adverse Event|1|||
163220578|NCT04668950|589522910|FG001|Overall Study|Other|4|||
163103271|NCT02689206|589083066|FG004|Overall Study|Protocol Violation|2|||
163103272|NCT02689206|589083062|FG000|Overall Study|Other: Reached stopping criteria|0|||
163103273|NCT02689206|589083063|FG001|Overall Study|Other: Reached stopping criteria|1|||
163103274|NCT02689206|589083064|FG002|Overall Study|Other: Reached stopping criteria|2|||
163103275|NCT02689206|589083065|FG003|Overall Study|Other: Reached stopping criteria|3|||
163103276|NCT02689206|589083066|FG004|Overall Study|Other: Reached stopping criteria|4|||
163103277|NCT02689206|589083062|FG000|Overall Study|Physician Decision|1|||
163103278|NCT02689206|589083063|FG001|Overall Study|Physician Decision|0|||
163103279|NCT02689206|589083064|FG002|Overall Study|Physician Decision|0|||
163103280|NCT02689206|589083065|FG003|Overall Study|Physician Decision|0|||
163103281|NCT02689206|589083066|FG004|Overall Study|Physician Decision|0|||
163103282|NCT02689206|589083062|FG000|Overall Study|Withdrawal by Subject|1|||
163103283|NCT02689206|589083063|FG001|Overall Study|Withdrawal by Subject|0|||
163103284|NCT02689206|589083064|FG002|Overall Study|Withdrawal by Subject|1|||
163103285|NCT02689206|589083065|FG003|Overall Study|Withdrawal by Subject|0|||
163103286|NCT02689206|589083066|FG004|Overall Study|Withdrawal by Subject|0|||
163103287|NCT02520388|589083067|FG000|Overall Study|Physician Decision|1|||
163103288|NCT02520388|589083068|FG001|Overall Study|Physician Decision|0|||
163103289|NCT02520388|589083067|FG000|Overall Study|Subject or parent/guardian request|0|||
163103290|NCT02520388|589083068|FG001|Overall Study|Subject or parent/guardian request|6|||
163103291|NCT02520388|589083067|FG000|Overall Study|Adverse Event|1|||
163103292|NCT02520388|589083068|FG001|Overall Study|Adverse Event|4|||
163103293|NCT02520388|589083067|FG000|Overall Study|Lost to Follow-up|3|||
163103294|NCT02520388|589083068|FG001|Overall Study|Lost to Follow-up|2|||
163103295|NCT02520388|589083067|FG000|Overall Study|Other (reason not defined)|4|||
163103296|NCT02520388|589083068|FG001|Overall Study|Other (reason not defined)|4|||
163103297|NCT02131311|589083069|FG000|Overall Study|Adverse Event|2|||
163103298|NCT02131311|589083069|FG000|Overall Study|Protocol Violation|1|||
163103299|NCT02131311|589083069|FG000|Overall Study|Lost to Follow-up|1|||
163103300|NCT01479764|589083070|FG000|Randomized|Adverse Event|1|||
163103301|NCT01479764|589083071|FG001|Randomized|Adverse Event|1|||
163103302|NCT01479764|589083070|FG000|Randomized|Withdrawal by Subject|1|||
163103303|NCT01479764|589083071|FG001|Randomized|Withdrawal by Subject|0|||
163103304|NCT01479764|589083070|FG000|Treated|Lost to Follow-up|0|||
163103305|NCT01479764|589083071|FG001|Treated|Lost to Follow-up|2|||
163103306|NCT00255723|589083073|FG000|Overall Study|Adverse Event|1|||
163103307|NCT00255723|589083074|FG001|Overall Study|Adverse Event|1|||
163103308|NCT00255723|589083073|FG000|Overall Study|Death|0|||
163103309|NCT00255723|589083074|FG001|Overall Study|Death|1|||
163103310|NCT00255723|589083073|FG000|Overall Study|Response Data Not Available|1|||
163103311|NCT00255723|589083074|FG001|Overall Study|Response Data Not Available|0|||
163103312|NCT03711370|589083075|FG000|Overall Study|Lost to Follow-up|16|||
163103313|NCT03711370|589083076|FG001|Overall Study|Lost to Follow-up|10|||
163103314|NCT03711370|589083075|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
163103315|NCT03711370|589083076|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
163103316|NCT00431444|589083080|FG000|Overall Study|Protocol Violation|1|||
163103317|NCT00431444|589083081|FG001|Overall Study|Protocol Violation|4|||
163103318|NCT00431444|589083080|FG000|Overall Study|Adverse Event|2|||
163103319|NCT00431444|589083081|FG001|Overall Study|Adverse Event|1|||
163103320|NCT00431444|589083080|FG000|Overall Study|Withdrawal by Subject|1|||
163103321|NCT00431444|589083081|FG001|Overall Study|Withdrawal by Subject|1|||
163103322|NCT00431444|589083080|FG000|Overall Study|Lost to Follow-up|1|||
163103323|NCT00431444|589083081|FG001|Overall Study|Lost to Follow-up|0|||
163103324|NCT00431444|589083080|FG000|Overall Study|Administrative Problems|0|||
163339536|NCT02699099|589951219|FG001|Overall Study|Adverse Event|0|||
163339537|NCT02699099|589951220|FG002|Overall Study|Adverse Event|2|||
163339538|NCT02699099|589951218|FG000|Overall Study|Lost to Follow-up|0|||
163339539|NCT02699099|589951219|FG001|Overall Study|Lost to Follow-up|1|||
163339540|NCT02699099|589951220|FG002|Overall Study|Lost to Follow-up|0|||
163339541|NCT02699099|589951218|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
163339542|NCT02699099|589951219|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
163339543|NCT02699099|589951220|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
163103325|NCT00431444|589083081|FG001|Overall Study|Administrative Problems|1|||
163103326|NCT00130039|589083083|FG000|Overall Study|Withdrawal by Subject|15|||
163103327|NCT00130039|589083084|FG001|Overall Study|Withdrawal by Subject|11|||
163103328|NCT00130039|589083083|FG000|Overall Study|Lost to Follow-up|3|||
163103329|NCT00130039|589083084|FG001|Overall Study|Lost to Follow-up|1|||
163103330|NCT00130039|589083083|FG000|Overall Study|Adverse Event|4|||
163103331|NCT00130039|589083084|FG001|Overall Study|Adverse Event|2|||
163339544|NCT02659540|589951223|FG000|Overall Study|Adverse Event|3|||
163339545|NCT02659540|589951224|FG001|Overall Study|Adverse Event|2|||
163103332|NCT00130039|589083083|FG000|Overall Study|Physician Decision|3|||
163103333|NCT00130039|589083084|FG001|Overall Study|Physician Decision|0|||
163103334|NCT00130039|589083083|FG000|Overall Study|clinical events without follow up MRI|5|||
163103335|NCT00130039|589083084|FG001|Overall Study|clinical events without follow up MRI|4|||
163103336|NCT01740687|589083085|FG000|Overall Study|Lost to Follow-up|11|||
163103337|NCT01740687|589083085|FG000|Overall Study|Withdrawal by Subject|2|||
163103338|NCT01740687|589083085|FG000|Overall Study|other reason|22|||
163103339|NCT01740687|589083085|FG000|Overall Study|treatment not received|2|||
163103340|NCT00200967|589083087|FG000|First Treatment Period|Withdrawal by Subject|5|||
163220579|NCT03979638|589522911|FG000|Period 1|Physician Decision|1|||
163220580|NCT03979638|589522912|FG001|Period 1|Physician Decision|1|||
163103341|NCT00200967|589083088|FG001|First Treatment Period|Withdrawal by Subject|1|||
163103342|NCT00200967|589083087|FG000|First Treatment Period|Pregnancy|1|||
163103343|NCT00200967|589083088|FG001|First Treatment Period|Pregnancy|0|||
163103344|NCT00200967|589083087|FG000|Wash-out Period|Lost to Follow-up|0|||
163103345|NCT00200967|589083088|FG001|Wash-out Period|Lost to Follow-up|1|||
163103346|NCT00200967|589083087|FG000|Second Treatment Period|Withdrawal by Subject|1|||
163103347|NCT00200967|589083088|FG001|Second Treatment Period|Withdrawal by Subject|2|||
163103348|NCT00200967|589083087|FG000|Run-out Period|Lost to Follow-up|1|||
163103349|NCT00200967|589083088|FG001|Run-out Period|Lost to Follow-up|0|||
163103350|NCT00928187|589083089|FG000|Overall Study|Death|1|||
163103351|NCT00928187|589083090|FG001|Overall Study|Death|2|||
163103352|NCT00928187|589083091|FG002|Overall Study|Death|3|||
163103353|NCT00928187|589083089|FG000|Overall Study|Lost to Follow-up|1|||
163103354|NCT00928187|589083090|FG001|Overall Study|Lost to Follow-up|2|||
163103355|NCT00928187|589083091|FG002|Overall Study|Lost to Follow-up|1|||
163103356|NCT00928187|589083089|FG000|Overall Study|Withdrawal by Subject|0|||
163103357|NCT00928187|589083090|FG001|Overall Study|Withdrawal by Subject|1|||
163103358|NCT00928187|589083091|FG002|Overall Study|Withdrawal by Subject|1|||
163103359|NCT00928187|589083089|FG000|Overall Study|Protocol Violation|0|||
163103360|NCT00928187|589083090|FG001|Overall Study|Protocol Violation|1|||
163103361|NCT00928187|589083091|FG002|Overall Study|Protocol Violation|0|||
163103362|NCT03062280|589084509|FG000|Overall Study|Adverse Event|1|||
163103363|NCT03062280|589084509|FG000|Overall Study|Death|1|||
163103364|NCT03062280|589084509|FG000|Overall Study|Fertility Treatment|2|||
163103365|NCT03062280|589084509|FG000|Overall Study|Physician Decision|2|||
163103366|NCT03062280|589084509|FG000|Overall Study|Pregnancy|5|||
163103367|NCT03062280|589084509|FG000|Overall Study|Withdrawal by Subject|11|||
163103368|NCT00336284|589084510|FG000|Overall Study|Death|52|||
163103369|NCT00336284|589084511|FG001|Overall Study|Death|26|||
163103370|NCT00336284|589084510|FG000|Overall Study|Lost to Follow-up|82|||
163103371|NCT00336284|589084511|FG001|Overall Study|Lost to Follow-up|61|||
163103372|NCT00336284|589084510|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
163103373|NCT00336284|589084511|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
163103374|NCT04123093|589084512|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
163103375|NCT04123093|589084513|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
163103376|NCT04123093|589084512|FG000|Phase 2|Physician Decision|0|||
163103377|NCT04123093|589084513|FG001|Phase 2|Physician Decision|1|||
163103378|NCT04123093|589084512|FG000|Phase 2|Withdrawal by Subject|0|||
163103379|NCT04123093|589084513|FG001|Phase 2|Withdrawal by Subject|1|||
163103380|NCT03462641|589084517|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
163103381|NCT03462641|589084518|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
163103382|NCT03462641|589084517|FG000|Visit 2|Withdrawal by Subject|0|||
163103383|NCT03462641|589084518|FG001|Visit 2|Withdrawal by Subject|1|||
163103384|NCT00022763|589084529|FG000|Overall Study|Adverse Event|1|||
163103385|NCT00022763|589084530|FG001|Overall Study|Adverse Event|2|||
163103386|NCT00022763|589084529|FG000|Overall Study|Injection Site Reactions|0|||
163103387|NCT00022763|589084530|FG001|Overall Study|Injection Site Reactions|2|||
163103388|NCT00022763|589084529|FG000|Overall Study|Death|0|||
163103389|NCT00022763|589084530|FG001|Overall Study|Death|1|||
163103390|NCT00022763|589084529|FG000|Overall Study|Lost to Follow-up|0|||
163103391|NCT00022763|589084530|FG001|Overall Study|Lost to Follow-up|3|||
163103392|NCT00022763|589084529|FG000|Overall Study|Withdrawal by Subject|4|||
163103393|NCT00022763|589084530|FG001|Overall Study|Withdrawal by Subject|7|||
163103394|NCT00022763|589084529|FG000|Overall Study|Insufficient Therapy|1|||
163103395|NCT00022763|589084530|FG001|Overall Study|Insufficient Therapy|0|||
163103396|NCT00022763|589084529|FG000|Overall Study|Admin|3|||
163103397|NCT00022763|589084530|FG001|Overall Study|Admin|2|||
163103398|NCT03248531|589084531|FG000|Overall Study|Adverse Event|0|||
163103399|NCT03248531|589084532|FG001|Overall Study|Adverse Event|0|||
163103400|NCT03248531|589084533|FG002|Overall Study|Adverse Event|1|||
163103401|NCT03248531|589084531|FG000|Overall Study|Lost to Follow-up|1|||
163103402|NCT03248531|589084532|FG001|Overall Study|Lost to Follow-up|0|||
163407686|NCT00464334|590200882|FG001|Overall Study|Lack of Efficacy|1|||
163103403|NCT03248531|589084533|FG002|Overall Study|Lost to Follow-up|5|||
163103404|NCT03248531|589084531|FG000|Overall Study|Withdrawal by Subject|3|||
163103405|NCT03248531|589084532|FG001|Overall Study|Withdrawal by Subject|3|||
163103406|NCT03248531|589084533|FG002|Overall Study|Withdrawal by Subject|2|||
163103407|NCT03248531|589084531|FG000|Overall Study|Sponsor Request|0|||
163103408|NCT03248531|589084532|FG001|Overall Study|Sponsor Request|2|||
163103409|NCT03248531|589084533|FG002|Overall Study|Sponsor Request|0|||
163103410|NCT02923531|589084534|FG000|Overall Study|Adverse Event|4|||
163103411|NCT02923531|589084534|FG000|Overall Study|Clinical Deterioration|1|||
163103412|NCT02923531|589084534|FG000|Overall Study|Disease Progression|3|||
163103413|NCT02923531|589084534|FG000|Overall Study|Study Termination|1|||
163103414|NCT02201329|589084535|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
163103415|NCT02201329|589084535|FG000|Overall Study|Withdrawal by Subject|2|||
163103416|NCT02997865|589084536|FG000|Overall Study|Death|2|||
163103417|NCT02997865|589084537|FG001|Overall Study|Death|1|||
163407687|NCT00464334|590200883|FG002|Overall Study|Lack of Efficacy|0|||
163103418|NCT02997865|589084536|FG000|Overall Study|Lost to Follow-up|6|||
163103419|NCT02997865|589084537|FG001|Overall Study|Lost to Follow-up|3|||
163103420|NCT02997865|589084536|FG000|Overall Study|Withdrawal by Subject|5|||
163103421|NCT02997865|589084537|FG001|Overall Study|Withdrawal by Subject|0|||
163103422|NCT04660552|589084538|FG000|Overall Study|Withdrawal by Subject|3|||
163103423|NCT04660552|589084539|FG001|Overall Study|Withdrawal by Subject|1|||
163103424|NCT03012828|589084540|FG000|Overall Study|Lost to Follow-up|1|||
163103425|NCT03012828|589084541|FG001|Overall Study|Lost to Follow-up|0|||
163103426|NCT03012828|589084542|FG002|Overall Study|Lost to Follow-up|1|||
163103427|NCT03012828|589084543|FG003|Overall Study|Lost to Follow-up|0|||
163103428|NCT03012828|589084544|FG004|Overall Study|Lost to Follow-up|1|||
163103429|NCT03012828|589084545|FG005|Overall Study|Lost to Follow-up|0|||
163103430|NCT03012828|589084540|FG000|Overall Study|Withdrawal by Subject|0|||
163103431|NCT03012828|589084541|FG001|Overall Study|Withdrawal by Subject|0|||
163103432|NCT03012828|589084542|FG002|Overall Study|Withdrawal by Subject|1|||
163103433|NCT03012828|589084543|FG003|Overall Study|Withdrawal by Subject|0|||
163103434|NCT03012828|589084544|FG004|Overall Study|Withdrawal by Subject|0|||
163103435|NCT03012828|589084545|FG005|Overall Study|Withdrawal by Subject|1|||
163103436|NCT03012828|589084540|FG000|Overall Study|Non-compliance with protocol|0|||
163103437|NCT03012828|589084541|FG001|Overall Study|Non-compliance with protocol|0|||
163103438|NCT03012828|589084542|FG002|Overall Study|Non-compliance with protocol|0|||
163103439|NCT03012828|589084543|FG003|Overall Study|Non-compliance with protocol|0|||
163103440|NCT03012828|589084544|FG004|Overall Study|Non-compliance with protocol|1|||
163103441|NCT03012828|589084545|FG005|Overall Study|Non-compliance with protocol|0|||
163103442|NCT03012828|589084540|FG000|Overall Study|Delay to last visit would delay DBL|0|||
163103443|NCT03012828|589084541|FG001|Overall Study|Delay to last visit would delay DBL|0|||
163103444|NCT03012828|589084542|FG002|Overall Study|Delay to last visit would delay DBL|0|||
163103445|NCT03012828|589084543|FG003|Overall Study|Delay to last visit would delay DBL|0|||
163103446|NCT03012828|589084544|FG004|Overall Study|Delay to last visit would delay DBL|0|||
163103447|NCT03012828|589084545|FG005|Overall Study|Delay to last visit would delay DBL|1|||
163103448|NCT01509846|589084546|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
163103449|NCT01509846|589084547|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
163103450|NCT01509846|589084548|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
163103451|NCT01509846|589084549|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
163103452|NCT01509846|589084550|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
163103453|NCT01509846|589084546|FG000|Received Vaccination 2|Illness|0|||
163103454|NCT01509846|589084547|FG001|Received Vaccination 2|Illness|0|||
163103455|NCT01509846|589084548|FG002|Received Vaccination 2|Illness|0|||
163103456|NCT01509846|589084549|FG003|Received Vaccination 2|Illness|0|||
163103457|NCT01509846|589084550|FG004|Received Vaccination 2|Illness|1|||
163103458|NCT01509846|589084546|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
163103459|NCT01509846|589084547|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
163103460|NCT01509846|589084548|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
163103461|NCT01509846|589084549|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
163103462|NCT01509846|589084550|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
163103463|NCT01509846|589084546|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
163103464|NCT01509846|589084547|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
163103465|NCT01509846|589084548|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
163103466|NCT01509846|589084549|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
163103467|NCT01509846|589084550|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
163103468|NCT01509846|589084546|FG000|Received Vaccination 3|Pregnancy|0|||
163103469|NCT01509846|589084547|FG001|Received Vaccination 3|Pregnancy|0|||
163103470|NCT01509846|589084548|FG002|Received Vaccination 3|Pregnancy|0|||
163103471|NCT01509846|589084549|FG003|Received Vaccination 3|Pregnancy|1|||
163103472|NCT01509846|589084550|FG004|Received Vaccination 3|Pregnancy|0|||
163103473|NCT01509846|589084546|FG000|Received Vaccination 3|Lost to Follow-up|0|||
163103474|NCT01509846|589084547|FG001|Received Vaccination 3|Lost to Follow-up|0|||
163103475|NCT01509846|589084548|FG002|Received Vaccination 3|Lost to Follow-up|1|||
163103476|NCT01509846|589084549|FG003|Received Vaccination 3|Lost to Follow-up|0|||
163103477|NCT01509846|589084550|FG004|Received Vaccination 3|Lost to Follow-up|0|||
163103478|NCT01637584|589084552|FG000|Overall Study|Withdrawal by Subject|1|||
163103479|NCT01637584|589084553|FG001|Overall Study|Withdrawal by Subject|3|||
163220581|NCT03979638|589522911|FG000|Period 1|Withdrawal by Subject|4|||
163220582|NCT03979638|589522912|FG001|Period 1|Withdrawal by Subject|3|||
163407688|NCT00464334|590200884|FG003|Overall Study|Lack of Efficacy|0|||
163103480|NCT02366923|589084554|FG000|Overall Study|Withdrawal by Subject|1|||
163103481|NCT02366923|589084554|FG000|Overall Study|Positive Slit Lamp Findings|2|||
163220583|NCT03979638|589522911|FG000|Period 1|Study terminated by Sponsor|1|||
163103482|NCT02366923|589084554|FG000|Overall Study|High Astigmatism|3|||
163103483|NCT00992056|589084557|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
163103484|NCT00992056|589084558|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
163103485|NCT00992056|589084557|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
163103486|NCT00992056|589084558|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
163220584|NCT03979638|589522912|FG001|Period 1|Study terminated by Sponsor|3|||
163103487|NCT01001767|589084561|FG000|Overall Study|no baseline study performed|1|||
163103488|NCT01001767|589084562|FG001|Overall Study|no baseline study performed|0|||
163103489|NCT01001767|589084561|FG000|Overall Study|Protocol Violation|1|||
163103490|NCT01001767|589084562|FG001|Overall Study|Protocol Violation|0|||
163103491|NCT01001767|589084561|FG000|Overall Study|Lost to Follow-up|1|||
163103492|NCT01001767|589084562|FG001|Overall Study|Lost to Follow-up|0|||
163103493|NCT01001767|589084561|FG000|Overall Study|Physician Decision|1|||
163103494|NCT01001767|589084562|FG001|Overall Study|Physician Decision|0|||
163103495|NCT00851552|589084563|FG000|Overall Study|Death|2|||
163103496|NCT00851552|589084563|FG000|Overall Study|Adverse Event|1|||
163103497|NCT00851552|589084563|FG000|Overall Study|Disease Progression|4|||
163103498|NCT00177294|589084564|FG000|Overall Study|Withdrawal by Subject|7|||
163103499|NCT00177294|589084565|FG001|Overall Study|Withdrawal by Subject|5|||
163103500|NCT01437111|589084566|FG000|Overall Study|Adverse Event|2|||
163103501|NCT01437111|589084566|FG000|Overall Study|Withdrawal by Subject|4|||
163103502|NCT01437111|589084566|FG000|Overall Study|Not reported|5|||
163103503|NCT01437111|589084566|FG000|Overall Study|Physician Decision|1|||
163103504|NCT01437111|589084566|FG000|Overall Study|Lost to Follow-up|5|||
163103505|NCT01437111|589084566|FG000|Overall Study|Protocol Violation|1|||
163103506|NCT02473471|589084567|FG000|Overall Study|poor oral hygiene|2|||
163103507|NCT02473471|589084567|FG000|Overall Study|Lost to Follow-up|1|||
163103508|NCT03082677|589084568|FG000|Overall Study|Not Treated|2|||
163103509|NCT01667133|589084569|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
163103510|NCT01667133|589084570|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
163103511|NCT01667133|589084571|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
163103512|NCT01667133|589084572|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
163103513|NCT01667133|589084573|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
163103514|NCT01667133|589084574|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
163103515|NCT01667133|589084575|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
163103516|NCT01667133|589084576|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
163103517|NCT01667133|589084577|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
163103518|NCT01667133|589084578|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
163103519|NCT01667133|589084579|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
163103520|NCT01667133|589084580|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
163103521|NCT01667133|589084569|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103522|NCT01667133|589084570|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103523|NCT01667133|589084571|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
163103524|NCT01667133|589084572|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103525|NCT01667133|589084573|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103526|NCT01667133|589084574|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103527|NCT01667133|589084575|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103528|NCT01667133|589084576|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103529|NCT01667133|589084577|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103530|NCT01667133|589084578|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103531|NCT01667133|589084579|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103532|NCT01667133|589084580|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103533|NCT01667133|589084569|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
163103534|NCT01667133|589084570|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
163103535|NCT01667133|589084571|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
163103536|NCT01667133|589084572|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
163103537|NCT01667133|589084573|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
163103538|NCT01667133|589084574|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
163103539|NCT01667133|589084575|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
163103540|NCT01667133|589084576|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
163103541|NCT01667133|589084577|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
163103542|NCT01667133|589084578|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
163103543|NCT01667133|589084579|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
163103544|NCT01667133|589084580|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
163103545|NCT01667133|589084569|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103546|NCT01667133|589084570|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103547|NCT01667133|589084571|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103548|NCT01667133|589084572|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
163103549|NCT01667133|589084573|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103550|NCT01667133|589084574|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103551|NCT01667133|589084575|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103552|NCT01667133|589084576|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103553|NCT01667133|589084577|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103554|NCT01667133|589084578|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103555|NCT01667133|589084579|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103556|NCT01667133|589084580|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103557|NCT01667133|589084569|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
163103558|NCT01667133|589084570|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
163103559|NCT01667133|589084571|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
163103560|NCT01667133|589084572|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
163103561|NCT01667133|589084573|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
163103562|NCT01667133|589084574|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
163103563|NCT01667133|589084575|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
163103564|NCT01667133|589084576|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
163103565|NCT01667133|589084577|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
163103566|NCT01667133|589084578|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
163103567|NCT01667133|589084579|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
163103568|NCT01667133|589084580|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
163103569|NCT01667133|589084569|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103570|NCT01667133|589084570|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103571|NCT01667133|589084571|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103572|NCT01667133|589084572|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103573|NCT01667133|589084573|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103574|NCT01667133|589084574|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103575|NCT01667133|589084575|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103576|NCT01667133|589084576|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103577|NCT01667133|589084577|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103578|NCT01667133|589084578|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
163103579|NCT01667133|589084579|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103580|NCT01667133|589084580|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103581|NCT01667133|589084569|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
163103582|NCT01667133|589084570|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
163103583|NCT01667133|589084571|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
163103584|NCT01667133|589084572|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
163103585|NCT01667133|589084573|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
163103586|NCT01667133|589084574|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
163103587|NCT01667133|589084575|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
163103588|NCT01667133|589084576|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
163103589|NCT01667133|589084577|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
163103590|NCT01667133|589084578|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
163103591|NCT01667133|589084579|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
163103592|NCT01667133|589084580|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
163103593|NCT01667133|589084569|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103594|NCT01667133|589084570|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103595|NCT01667133|589084571|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103596|NCT01667133|589084572|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103597|NCT01667133|589084573|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103598|NCT01667133|589084574|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103599|NCT01667133|589084575|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103600|NCT01667133|589084576|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103601|NCT01667133|589084577|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103602|NCT01667133|589084578|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
163103603|NCT01667133|589084579|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103604|NCT01667133|589084580|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103605|NCT01667133|589084569|FG000|Phase 2: Dose-expansion|Death|0|||
163103606|NCT01667133|589084570|FG001|Phase 2: Dose-expansion|Death|0|||
163103607|NCT01667133|589084571|FG002|Phase 2: Dose-expansion|Death|0|||
163103608|NCT01667133|589084572|FG003|Phase 2: Dose-expansion|Death|0|||
163103609|NCT01667133|589084573|FG004|Phase 2: Dose-expansion|Death|0|||
163103610|NCT01667133|589084574|FG005|Phase 2: Dose-expansion|Death|0|||
163103611|NCT01667133|589084575|FG006|Phase 2: Dose-expansion|Death|0|||
163103612|NCT01667133|589084576|FG007|Phase 2: Dose-expansion|Death|0|||
163103613|NCT01667133|589084577|FG008|Phase 2: Dose-expansion|Death|0|||
163103614|NCT01667133|589084578|FG009|Phase 2: Dose-expansion|Death|1|||
163103615|NCT01667133|589084579|FG010|Phase 2: Dose-expansion|Death|0|||
163103616|NCT01667133|589084580|FG011|Phase 2: Dose-expansion|Death|0|||
163103617|NCT01667133|589084569|FG000|Phase 2: Dose-expansion|Other|0|||
163103618|NCT01667133|589084570|FG001|Phase 2: Dose-expansion|Other|0|||
163103619|NCT01667133|589084571|FG002|Phase 2: Dose-expansion|Other|0|||
163103620|NCT01667133|589084572|FG003|Phase 2: Dose-expansion|Other|0|||
163103621|NCT01667133|589084573|FG004|Phase 2: Dose-expansion|Other|0|||
163103622|NCT01667133|589084574|FG005|Phase 2: Dose-expansion|Other|0|||
163220585|NCT03979638|589522911|FG000|Period 1|Protocol Violation|1|||
163103623|NCT01667133|589084575|FG006|Phase 2: Dose-expansion|Other|0|||
163103624|NCT01667133|589084576|FG007|Phase 2: Dose-expansion|Other|0|||
163103625|NCT01667133|589084577|FG008|Phase 2: Dose-expansion|Other|0|||
163103626|NCT01667133|589084578|FG009|Phase 2: Dose-expansion|Other|0|||
163103627|NCT01667133|589084579|FG010|Phase 2: Dose-expansion|Other|0|||
163103628|NCT01667133|589084580|FG011|Phase 2: Dose-expansion|Other|1|||
163103629|NCT01916824|589084587|FG000|Overall Study|Lost to Follow-up|3|||
163103630|NCT01916824|589084588|FG001|Overall Study|Lost to Follow-up|6|||
163103631|NCT01916824|589084587|FG000|Overall Study|Physician Decision|2|||
163103632|NCT01916824|589084588|FG001|Overall Study|Physician Decision|0|||
163103633|NCT01916824|589084587|FG000|Overall Study|Withdrawal by Subject|2|||
163103634|NCT01916824|589084588|FG001|Overall Study|Withdrawal by Subject|3|||
163103635|NCT03835481|589084591|FG000|Double-blind Period|Other not stated below|0|||
163220586|NCT03979638|589522912|FG001|Period 1|Protocol Violation|0|||
163220587|NCT03979638|589522911|FG000|Period 2|Study terminated by Sponsor|1|||
163220588|NCT03979638|589522912|FG001|Period 2|Study terminated by Sponsor|1|||
163220589|NCT00600938|589522913|FG000|Core Study|Abnormal test procedure result(s)|3|||
163220590|NCT00600938|589522914|FG001|Core Study|Abnormal test procedure result(s)|2|||
163220591|NCT00600938|589522915|FG002|Core Study|Abnormal test procedure result(s)|0|||
163220592|NCT00600938|589522916|FG003|Core Study|Abnormal test procedure result(s)|0|||
163220593|NCT00600938|589522913|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
163103636|NCT03835481|589084592|FG001|Double-blind Period|Other not stated below|0|||
163103637|NCT03835481|589084593|FG002|Double-blind Period|Other not stated below|0|||
163103638|NCT03835481|589084594|FG003|Double-blind Period|Other not stated below|1|||
163103639|NCT03835481|589084595|FG004|Double-blind Period|Other not stated below|1|||
163103640|NCT03835481|589084591|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
163103641|NCT03835481|589084592|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
163103642|NCT03835481|589084593|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
163103643|NCT03835481|589084594|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
163103644|NCT03835481|589084595|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
163103645|NCT03835481|589084591|FG000|Double-blind Period|Withdrawal by Subject|0|||
163103646|NCT03835481|589084592|FG001|Double-blind Period|Withdrawal by Subject|0|||
163103647|NCT03835481|589084593|FG002|Double-blind Period|Withdrawal by Subject|1|||
163103648|NCT03835481|589084594|FG003|Double-blind Period|Withdrawal by Subject|0|||
163103649|NCT03835481|589084595|FG004|Double-blind Period|Withdrawal by Subject|5|||
163103650|NCT03835481|589084591|FG000|Double-blind Period|Lost to Follow-up|0|||
163103651|NCT03835481|589084592|FG001|Double-blind Period|Lost to Follow-up|0|||
163103652|NCT03835481|589084593|FG002|Double-blind Period|Lost to Follow-up|0|||
163103653|NCT03835481|589084594|FG003|Double-blind Period|Lost to Follow-up|1|||
163103654|NCT03835481|589084595|FG004|Double-blind Period|Lost to Follow-up|0|||
163103655|NCT03835481|589084591|FG000|Double-blind Period|Protocol Violation|0|||
163103656|NCT03835481|589084592|FG001|Double-blind Period|Protocol Violation|2|||
163103657|NCT03835481|589084593|FG002|Double-blind Period|Protocol Violation|0|||
163103658|NCT03835481|589084594|FG003|Double-blind Period|Protocol Violation|1|||
163103659|NCT03835481|589084595|FG004|Double-blind Period|Protocol Violation|0|||
163103660|NCT03835481|589084591|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
163103661|NCT03835481|589084592|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
163103662|NCT03835481|589084593|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
163103663|NCT03835481|589084594|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
163103664|NCT03835481|589084595|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
163103665|NCT03835481|589084591|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
163103666|NCT03835481|589084592|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
163103667|NCT03835481|589084593|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
163103668|NCT03835481|589084594|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
163103669|NCT03835481|589084595|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
163103670|NCT03835481|589084591|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
163103671|NCT03835481|589084592|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
163103672|NCT03835481|589084593|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
163103673|NCT03835481|589084594|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
163103674|NCT03835481|589084595|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
163103675|NCT03835481|589084591|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
163103676|NCT03835481|589084592|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
163103677|NCT03835481|589084593|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
163103678|NCT03835481|589084594|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
163103679|NCT03835481|589084595|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
163103680|NCT03835481|589084591|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
163103681|NCT03835481|589084592|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
163103682|NCT03835481|589084593|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
163103683|NCT03835481|589084594|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
163103684|NCT03835481|589084595|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
163103685|NCT03835481|589084591|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
163103686|NCT03835481|589084592|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
163103687|NCT03835481|589084593|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
163103688|NCT03835481|589084594|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
163103689|NCT03835481|589084595|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
163220594|NCT00600938|589522914|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
163103690|NCT00191945|589084596|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
163339546|NCT02659540|589951223|FG000|Overall Study|Death|1|||
163339547|NCT02659540|589951224|FG001|Overall Study|Death|0|||
163339548|NCT02659540|589951223|FG000|Overall Study|Progressive disease|2|||
163339549|NCT02659540|589951224|FG001|Overall Study|Progressive disease|6|||
163220595|NCT00600938|589522915|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
163407689|NCT00464334|590200885|FG004|Overall Study|Lack of Efficacy|0|||
163103691|NCT00191945|589084597|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
163103692|NCT00191945|589084596|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
163103693|NCT00191945|589084597|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
163103694|NCT00191945|589084596|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
163103695|NCT00191945|589084597|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
163103696|NCT00191945|589084596|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
163103697|NCT00191945|589084597|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
163103698|NCT02063984|589084598|FG000|Overall Study|Lost to Follow-up|6|||
163103699|NCT02063984|589084599|FG001|Overall Study|Lost to Follow-up|5|||
163103700|NCT01536561|589084603|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
163103701|NCT01536561|589084603|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
163103702|NCT01536561|589084603|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
163103703|NCT01536561|589084603|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
163103704|NCT01536561|589084603|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
163103705|NCT01536561|589084603|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
163103706|NCT01030952|589084604|FG000|Overall Study|Protocol Violation|0|||
163103707|NCT01030952|589084605|FG001|Overall Study|Protocol Violation|1|||
163103708|NCT01030952|589084604|FG000|Overall Study|Informed consent withdrawal|1|||
163103709|NCT01030952|589084605|FG001|Overall Study|Informed consent withdrawal|0|||
163103710|NCT01030952|589084604|FG000|Overall Study|Lost to Follow-up|0|||
163103711|NCT01030952|589084605|FG001|Overall Study|Lost to Follow-up|1|||
163103712|NCT01030952|589084604|FG000|Overall Study|Unexplained|1|||
163103713|NCT01030952|589084605|FG001|Overall Study|Unexplained|1|||
163103714|NCT01831466|589084611|FG000|Overall Study|Protocol Violation|1|||
163103715|NCT01831466|589084612|FG001|Overall Study|Protocol Violation|1|||
163103716|NCT01831466|589084613|FG002|Overall Study|Protocol Violation|2|||
163103717|NCT01831466|589084614|FG003|Overall Study|Protocol Violation|0|||
163103718|NCT01831466|589084615|FG004|Overall Study|Protocol Violation|0|||
163103719|NCT01831466|589084616|FG005|Overall Study|Protocol Violation|1|||
163103720|NCT01831466|589084617|FG006|Overall Study|Protocol Violation|0|||
163103721|NCT01831466|589084618|FG007|Overall Study|Protocol Violation|0|||
163103722|NCT01831466|589084619|FG008|Overall Study|Protocol Violation|0|||
163103723|NCT01831466|589084620|FG009|Overall Study|Protocol Violation|0|||
163103724|NCT01831466|589084621|FG010|Overall Study|Protocol Violation|0|||
163103725|NCT01831466|589084622|FG011|Overall Study|Protocol Violation|0|||
163103726|NCT01831466|589084611|FG000|Overall Study|Other|2|||
163103727|NCT01831466|589084612|FG001|Overall Study|Other|3|||
163103728|NCT01831466|589084613|FG002|Overall Study|Other|2|||
163103729|NCT01831466|589084614|FG003|Overall Study|Other|2|||
163103730|NCT01831466|589084615|FG004|Overall Study|Other|2|||
163103731|NCT01831466|589084616|FG005|Overall Study|Other|1|||
163103732|NCT01831466|589084617|FG006|Overall Study|Other|0|||
163103733|NCT01831466|589084618|FG007|Overall Study|Other|0|||
163103734|NCT01831466|589084619|FG008|Overall Study|Other|0|||
163103735|NCT01831466|589084620|FG009|Overall Study|Other|0|||
163103736|NCT01831466|589084621|FG010|Overall Study|Other|0|||
163103737|NCT01831466|589084622|FG011|Overall Study|Other|0|||
163103738|NCT01831466|589084611|FG000|Overall Study|Non-compliance with study treatment|2|||
163103739|NCT01831466|589084612|FG001|Overall Study|Non-compliance with study treatment|1|||
163103740|NCT01831466|589084613|FG002|Overall Study|Non-compliance with study treatment|1|||
163103741|NCT01831466|589084614|FG003|Overall Study|Non-compliance with study treatment|0|||
163103742|NCT01831466|589084615|FG004|Overall Study|Non-compliance with study treatment|0|||
163103743|NCT01831466|589084616|FG005|Overall Study|Non-compliance with study treatment|1|||
163103744|NCT01831466|589084617|FG006|Overall Study|Non-compliance with study treatment|0|||
163103745|NCT01831466|589084618|FG007|Overall Study|Non-compliance with study treatment|0|||
163103746|NCT01831466|589084619|FG008|Overall Study|Non-compliance with study treatment|0|||
163103747|NCT01831466|589084620|FG009|Overall Study|Non-compliance with study treatment|0|||
163103748|NCT01831466|589084621|FG010|Overall Study|Non-compliance with study treatment|0|||
163407690|NCT00464334|590200886|FG005|Overall Study|Lack of Efficacy|0|||
163103749|NCT01831466|589084622|FG011|Overall Study|Non-compliance with study treatment|0|||
163103750|NCT01831466|589084611|FG000|Overall Study|Death|0|||
163103751|NCT01831466|589084612|FG001|Overall Study|Death|1|||
163103752|NCT01831466|589084613|FG002|Overall Study|Death|0|||
163103753|NCT01831466|589084614|FG003|Overall Study|Death|0|||
163103754|NCT01831466|589084615|FG004|Overall Study|Death|0|||
163103755|NCT01831466|589084616|FG005|Overall Study|Death|0|||
163103756|NCT01831466|589084617|FG006|Overall Study|Death|0|||
163103757|NCT01831466|589084618|FG007|Overall Study|Death|0|||
163103758|NCT01831466|589084619|FG008|Overall Study|Death|0|||
163103759|NCT01831466|589084620|FG009|Overall Study|Death|0|||
163103760|NCT01831466|589084621|FG010|Overall Study|Death|0|||
163103761|NCT01831466|589084622|FG011|Overall Study|Death|0|||
163407691|NCT00464334|590200887|FG006|Overall Study|Lack of Efficacy|0|||
163103762|NCT01831466|589084611|FG000|Overall Study|Withdrawal by Subject|6|||
163103763|NCT01831466|589084612|FG001|Overall Study|Withdrawal by Subject|3|||
163407692|NCT00464334|590200888|FG007|Overall Study|Lack of Efficacy|0|||
163103764|NCT01831466|589084613|FG002|Overall Study|Withdrawal by Subject|3|||
163103765|NCT01831466|589084614|FG003|Overall Study|Withdrawal by Subject|3|||
163103766|NCT01831466|589084615|FG004|Overall Study|Withdrawal by Subject|3|||
163103767|NCT01831466|589084616|FG005|Overall Study|Withdrawal by Subject|5|||
163103768|NCT01831466|589084617|FG006|Overall Study|Withdrawal by Subject|0|||
163103769|NCT01831466|589084618|FG007|Overall Study|Withdrawal by Subject|0|||
163103770|NCT01831466|589084619|FG008|Overall Study|Withdrawal by Subject|0|||
163103771|NCT01831466|589084620|FG009|Overall Study|Withdrawal by Subject|1|||
163103772|NCT01831466|589084621|FG010|Overall Study|Withdrawal by Subject|0|||
163103773|NCT01831466|589084622|FG011|Overall Study|Withdrawal by Subject|1|||
163103774|NCT01831466|589084611|FG000|Overall Study|Lost to Follow-up|0|||
163103775|NCT01831466|589084612|FG001|Overall Study|Lost to Follow-up|1|||
163103776|NCT01831466|589084613|FG002|Overall Study|Lost to Follow-up|4|||
163103777|NCT01831466|589084614|FG003|Overall Study|Lost to Follow-up|2|||
163103778|NCT01831466|589084615|FG004|Overall Study|Lost to Follow-up|0|||
163103779|NCT01831466|589084616|FG005|Overall Study|Lost to Follow-up|3|||
163103780|NCT01831466|589084617|FG006|Overall Study|Lost to Follow-up|0|||
163103781|NCT01831466|589084618|FG007|Overall Study|Lost to Follow-up|0|||
163103782|NCT01831466|589084619|FG008|Overall Study|Lost to Follow-up|0|||
163103783|NCT01831466|589084620|FG009|Overall Study|Lost to Follow-up|1|||
163103784|NCT01831466|589084621|FG010|Overall Study|Lost to Follow-up|0|||
163103785|NCT01831466|589084622|FG011|Overall Study|Lost to Follow-up|1|||
163103786|NCT01831466|589084611|FG000|Overall Study|Lack of Efficacy|5|||
163103787|NCT01831466|589084612|FG001|Overall Study|Lack of Efficacy|8|||
163103788|NCT01831466|589084613|FG002|Overall Study|Lack of Efficacy|7|||
163103789|NCT01831466|589084614|FG003|Overall Study|Lack of Efficacy|6|||
163103790|NCT01831466|589084615|FG004|Overall Study|Lack of Efficacy|9|||
163103791|NCT01831466|589084616|FG005|Overall Study|Lack of Efficacy|8|||
163103792|NCT01831466|589084617|FG006|Overall Study|Lack of Efficacy|1|||
163103793|NCT01831466|589084618|FG007|Overall Study|Lack of Efficacy|1|||
163103794|NCT01831466|589084619|FG008|Overall Study|Lack of Efficacy|2|||
163103795|NCT01831466|589084620|FG009|Overall Study|Lack of Efficacy|2|||
163103796|NCT01831466|589084621|FG010|Overall Study|Lack of Efficacy|2|||
163103797|NCT01831466|589084622|FG011|Overall Study|Lack of Efficacy|0|||
163103798|NCT01831466|589084611|FG000|Overall Study|Adverse Event|0|||
163103799|NCT01831466|589084612|FG001|Overall Study|Adverse Event|0|||
163103800|NCT01831466|589084613|FG002|Overall Study|Adverse Event|4|||
163103801|NCT01831466|589084614|FG003|Overall Study|Adverse Event|6|||
163103802|NCT01831466|589084615|FG004|Overall Study|Adverse Event|3|||
163103803|NCT01831466|589084616|FG005|Overall Study|Adverse Event|7|||
163103804|NCT01831466|589084617|FG006|Overall Study|Adverse Event|0|||
163103805|NCT01831466|589084618|FG007|Overall Study|Adverse Event|1|||
163103806|NCT01831466|589084619|FG008|Overall Study|Adverse Event|1|||
163103807|NCT01831466|589084620|FG009|Overall Study|Adverse Event|1|||
163103808|NCT01831466|589084621|FG010|Overall Study|Adverse Event|0|||
163103809|NCT01831466|589084622|FG011|Overall Study|Adverse Event|2|||
163103810|NCT03497039|589084623|FG000|Overall Study|Withdrawal by Subject|1|||
163103811|NCT03497039|589084624|FG001|Overall Study|Withdrawal by Subject|0|||
163103812|NCT03497039|589084623|FG000|Overall Study|Protocol Violation|0|||
163103813|NCT03497039|589084624|FG001|Overall Study|Protocol Violation|1|||
163103814|NCT02131662|589084626|FG000|Overall Study|Protocol Violation|1|||
163103815|NCT02131662|589084627|FG001|Overall Study|Protocol Violation|0|||
163103816|NCT02131662|589084628|FG002|Overall Study|Protocol Violation|0|||
163103817|NCT02131662|589084629|FG003|Overall Study|Protocol Violation|0|||
163103818|NCT02131662|589084630|FG004|Overall Study|Protocol Violation|0|||
163103819|NCT02131662|589084626|FG000|Overall Study|Other|2|||
163103820|NCT02131662|589084627|FG001|Overall Study|Other|4|||
163103821|NCT02131662|589084628|FG002|Overall Study|Other|3|||
163103822|NCT02131662|589084629|FG003|Overall Study|Other|3|||
163103823|NCT02131662|589084630|FG004|Overall Study|Other|4|||
163103824|NCT02131662|589084626|FG000|Overall Study|Adverse Event|0|||
163103825|NCT02131662|589084627|FG001|Overall Study|Adverse Event|1|||
163103826|NCT02131662|589084628|FG002|Overall Study|Adverse Event|1|||
163103827|NCT02131662|589084629|FG003|Overall Study|Adverse Event|1|||
163103828|NCT02131662|589084630|FG004|Overall Study|Adverse Event|3|||
163103829|NCT02131662|589084626|FG000|Overall Study|Pregnancy|0|||
163103830|NCT02131662|589084627|FG001|Overall Study|Pregnancy|1|||
163103831|NCT02131662|589084628|FG002|Overall Study|Pregnancy|0|||
163103832|NCT02131662|589084629|FG003|Overall Study|Pregnancy|1|||
163103833|NCT02131662|589084630|FG004|Overall Study|Pregnancy|0|||
163103834|NCT02131662|589084626|FG000|Overall Study|Wish for pregnancy|0|||
163103835|NCT02131662|589084627|FG001|Overall Study|Wish for pregnancy|0|||
163103836|NCT02131662|589084628|FG002|Overall Study|Wish for pregnancy|0|||
163103837|NCT02131662|589084629|FG003|Overall Study|Wish for pregnancy|0|||
163103838|NCT02131662|589084630|FG004|Overall Study|Wish for pregnancy|1|||
163103839|NCT02131662|589084626|FG000|Overall Study|Lack of Efficacy|1|||
163103840|NCT02131662|589084627|FG001|Overall Study|Lack of Efficacy|0|||
163103841|NCT02131662|589084628|FG002|Overall Study|Lack of Efficacy|0|||
163103842|NCT02131662|589084629|FG003|Overall Study|Lack of Efficacy|0|||
163103843|NCT02131662|589084630|FG004|Overall Study|Lack of Efficacy|1|||
163103844|NCT02131662|589084626|FG000|Overall Study|Withdrawal by Subject|1|||
163220596|NCT00600938|589522916|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
163220597|NCT00600938|589522913|FG000|Core Study|Patient withdrew consent|7|||
163220598|NCT00600938|589522914|FG001|Core Study|Patient withdrew consent|12|||
163220599|NCT00600938|589522915|FG002|Core Study|Patient withdrew consent|0|||
163220600|NCT00600938|589522916|FG003|Core Study|Patient withdrew consent|0|||
163220601|NCT00600938|589522913|FG000|Core Study|Lost to Follow-up|3|||
163220602|NCT00600938|589522914|FG001|Core Study|Lost to Follow-up|2|||
163220603|NCT00600938|589522915|FG002|Core Study|Lost to Follow-up|0|||
163220604|NCT00600938|589522916|FG003|Core Study|Lost to Follow-up|0|||
163220605|NCT00600938|589522913|FG000|Core Study|Death|1|||
163220606|NCT00600938|589522914|FG001|Core Study|Death|1|||
163220607|NCT00600938|589522915|FG002|Core Study|Death|0|||
163220608|NCT00600938|589522916|FG003|Core Study|Death|0|||
163220609|NCT00600938|589522913|FG000|Core Study|Protocol Violation|1|||
163220610|NCT00600938|589522914|FG001|Core Study|Protocol Violation|2|||
163220611|NCT00600938|589522915|FG002|Core Study|Protocol Violation|0|||
163220612|NCT00600938|589522916|FG003|Core Study|Protocol Violation|0|||
163220613|NCT00600938|589522913|FG000|Extension Study|Adverse Event|1|||
163220614|NCT00600938|589522914|FG001|Extension Study|Adverse Event|0|||
163220615|NCT00600938|589522915|FG002|Extension Study|Adverse Event|2|||
163220616|NCT00600938|589522916|FG003|Extension Study|Adverse Event|0|||
163220617|NCT00600938|589522913|FG000|Extension Study|Abnormal test procedure results|0|||
163220618|NCT00600938|589522914|FG001|Extension Study|Abnormal test procedure results|1|||
163220619|NCT00600938|589522915|FG002|Extension Study|Abnormal test procedure results|1|||
163220620|NCT00600938|589522916|FG003|Extension Study|Abnormal test procedure results|1|||
163220621|NCT00600938|589522913|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
163220622|NCT00600938|589522914|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
163220623|NCT00600938|589522915|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
163220624|NCT00600938|589522916|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
163220625|NCT00600938|589522913|FG000|Extension Study|Withdrawal by Subject|2|||
163220626|NCT00600938|589522914|FG001|Extension Study|Withdrawal by Subject|2|||
163220627|NCT00600938|589522915|FG002|Extension Study|Withdrawal by Subject|3|||
163220628|NCT00600938|589522916|FG003|Extension Study|Withdrawal by Subject|0|||
163220629|NCT00600938|589522913|FG000|Extension Study|Lost to Follow-up|1|||
163220630|NCT00600938|589522914|FG001|Extension Study|Lost to Follow-up|1|||
163103845|NCT02131662|589084627|FG001|Overall Study|Withdrawal by Subject|5|||
163103846|NCT02131662|589084628|FG002|Overall Study|Withdrawal by Subject|1|||
163103847|NCT02131662|589084629|FG003|Overall Study|Withdrawal by Subject|5|||
163103848|NCT02131662|589084630|FG004|Overall Study|Withdrawal by Subject|6|||
163103849|NCT02131662|589084626|FG000|Overall Study|Lost to Follow-up|1|||
163103850|NCT02131662|589084627|FG001|Overall Study|Lost to Follow-up|3|||
163103851|NCT02131662|589084628|FG002|Overall Study|Lost to Follow-up|0|||
163103852|NCT02131662|589084629|FG003|Overall Study|Lost to Follow-up|9|||
163103853|NCT02131662|589084630|FG004|Overall Study|Lost to Follow-up|0|||
163103854|NCT02131662|589084626|FG000|Overall Study|Not treated|2|||
163103855|NCT02131662|589084627|FG001|Overall Study|Not treated|0|||
163103856|NCT02131662|589084628|FG002|Overall Study|Not treated|2|||
163103857|NCT02131662|589084629|FG003|Overall Study|Not treated|2|||
163103858|NCT02131662|589084630|FG004|Overall Study|Not treated|3|||
163103859|NCT03554018|589084631|FG000|Overall Study|Lost to Follow-up|3|||
163103860|NCT03554018|589084632|FG001|Overall Study|Lost to Follow-up|7|||
163103861|NCT01016132|589084638|FG000|Overall Study|Discomfort|1|||
163103862|NCT00556439|589084641|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
163220631|NCT00600938|589522915|FG002|Extension Study|Lost to Follow-up|2|||
163220632|NCT00600938|589522916|FG003|Extension Study|Lost to Follow-up|0|||
163220633|NCT00600938|589522913|FG000|Extension Study|Death|1|||
163220634|NCT00600938|589522914|FG001|Extension Study|Death|0|||
163220635|NCT00600938|589522915|FG002|Extension Study|Death|0|||
163103863|NCT00556439|589084642|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
163103864|NCT00556439|589084643|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
163220636|NCT00600938|589522916|FG003|Extension Study|Death|0|||
163220637|NCT02680639|589522917|FG000|Screening Period|Screen Failure|7|||
163220638|NCT02680639|589522918|FG001|Screening Period|Screen Failure|0|||
163220639|NCT02680639|589522919|FG002|Screening Period|Screen Failure|0|||
163103865|NCT00556439|589084644|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
163103866|NCT00556439|589084641|FG000|Study Entry to Week 12|Physician Decision|1|||
163103867|NCT00556439|589084642|FG001|Study Entry to Week 12|Physician Decision|0|||
163103868|NCT00556439|589084643|FG002|Study Entry to Week 12|Physician Decision|0|||
163103869|NCT00556439|589084644|FG003|Study Entry to Week 12|Physician Decision|0|||
163103870|NCT00556439|589084641|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
163220640|NCT02678676|589522920|FG000|Overall Study|Death|619|||
163220641|NCT02678676|589522921|FG001|Overall Study|Death|649|||
163220642|NCT02678676|589522920|FG000|Overall Study|Withdrawal by Subject|13|||
163220643|NCT02678676|589522921|FG001|Overall Study|Withdrawal by Subject|5|||
163220644|NCT02678676|589522920|FG000|Overall Study|Lost to Follow-up|171|||
163220645|NCT02678676|589522921|FG001|Overall Study|Lost to Follow-up|151|||
163220646|NCT02678676|589522920|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
163220647|NCT02678676|589522921|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
163220648|NCT03200899|589522922|FG000|Overall Study|Lost to Follow-up|10|||
163103871|NCT00556439|589084642|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
163103872|NCT00556439|589084643|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
163103873|NCT00556439|589084644|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
163103874|NCT00556439|589084641|FG000|Study Entry to Week 12|Recurrent infection|1|||
163103875|NCT00556439|589084642|FG001|Study Entry to Week 12|Recurrent infection|0|||
163103876|NCT00556439|589084643|FG002|Study Entry to Week 12|Recurrent infection|0|||
163103877|NCT00556439|589084644|FG003|Study Entry to Week 12|Recurrent infection|0|||
163103878|NCT00556439|589084641|FG000|Study Entry to Week 12|Malignancy|0|||
163103879|NCT00556439|589084642|FG001|Study Entry to Week 12|Malignancy|0|||
163103880|NCT00556439|589084643|FG002|Study Entry to Week 12|Malignancy|1|||
163103881|NCT00556439|589084644|FG003|Study Entry to Week 12|Malignancy|0|||
163103882|NCT00556439|589084641|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
163103883|NCT00556439|589084642|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
163103884|NCT00556439|589084643|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
163103885|NCT00556439|589084644|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
163103886|NCT00556439|589084641|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
163103887|NCT00556439|589084642|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
163103888|NCT00556439|589084643|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
163103889|NCT00556439|589084644|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
163103890|NCT00556439|589084641|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
163103891|NCT00556439|589084642|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
163103892|NCT00556439|589084643|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
163103893|NCT00556439|589084644|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
163103894|NCT00556439|589084641|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
163103895|NCT00556439|589084642|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
163103896|NCT00556439|589084643|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
163103897|NCT00556439|589084644|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
163103898|NCT02100423|589084646|FG000|Overall Study|Death|1|||
163103899|NCT02100423|589084646|FG000|Overall Study|Withdrawal by Subject|3|||
163103900|NCT02100423|589084646|FG000|Overall Study|Adverse Event|1|||
163103901|NCT02100423|589084646|FG000|Overall Study|Physician Decision|1|||
163103902|NCT00703846|589084647|FG000|Overall Study|Adverse Event|8|||
163103903|NCT00703846|589084647|FG000|Overall Study|Lost to Follow-up|55|||
163103904|NCT00703846|589084647|FG000|Overall Study|Lack of Efficacy|15|||
163103905|NCT00703846|589084647|FG000|Overall Study|Noncompliance with Study Treatment|2|||
163103906|NCT00703846|589084647|FG000|Overall Study|Withdrawal by Subject|40|||
163103907|NCT00703846|589084647|FG000|Overall Study|Death|1|||
163103908|NCT00703846|589084647|FG000|Overall Study|Other|14|||
163103909|NCT00703846|589084647|FG000|Overall Study|Did Not Receive Study Drug|2|||
163103910|NCT02195700|589084648|FG000|Overall Study|Protocol Violation|0|||
163103911|NCT02195700|589084649|FG001|Overall Study|Protocol Violation|2|||
163103912|NCT02195700|589084648|FG000|Overall Study|Noncompliance|1|||
163103913|NCT02195700|589084649|FG001|Overall Study|Noncompliance|0|||
163103914|NCT02195700|589084648|FG000|Overall Study|Adverse Event|1|||
163103915|NCT02195700|589084649|FG001|Overall Study|Adverse Event|2|||
163103916|NCT02195700|589084648|FG000|Overall Study|Withdrawal by Subject|3|||
163103917|NCT02195700|589084649|FG001|Overall Study|Withdrawal by Subject|2|||
163103918|NCT02195700|589084648|FG000|Overall Study|Lost to Follow-up|1|||
163103919|NCT02195700|589084649|FG001|Overall Study|Lost to Follow-up|1|||
163103920|NCT04601532|589084650|FG000|Overall Study|Lost to Follow-up|1|||
163103921|NCT04601532|589084651|FG001|Overall Study|Lost to Follow-up|2|||
163103922|NCT04601532|589084650|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
163103923|NCT04601532|589084651|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
163103924|NCT01352221|589084652|FG000|Double-blind Phase|Adverse Event|6|||
163103925|NCT01352221|589084653|FG001|Double-blind Phase|Adverse Event|4|||
163103926|NCT01352221|589084654|FG002|Double-blind Phase|Adverse Event|0|||
163103927|NCT01352221|589084655|FG003|Double-blind Phase|Adverse Event|0|||
163103928|NCT01352221|589084652|FG000|Double-blind Phase|Withdrawal by Subject|3|||
163103929|NCT01352221|589084653|FG001|Double-blind Phase|Withdrawal by Subject|5|||
163103930|NCT01352221|589084654|FG002|Double-blind Phase|Withdrawal by Subject|0|||
163103931|NCT01352221|589084655|FG003|Double-blind Phase|Withdrawal by Subject|0|||
163103932|NCT01352221|589084652|FG000|Double-blind Phase|Lost to Follow-up|0|||
163103933|NCT01352221|589084653|FG001|Double-blind Phase|Lost to Follow-up|1|||
163103934|NCT01352221|589084654|FG002|Double-blind Phase|Lost to Follow-up|0|||
163103935|NCT01352221|589084655|FG003|Double-blind Phase|Lost to Follow-up|0|||
163103936|NCT01352221|589084652|FG000|Double-blind Phase|Protocol Violation|0|||
163103937|NCT01352221|589084653|FG001|Double-blind Phase|Protocol Violation|1|||
163103938|NCT01352221|589084654|FG002|Double-blind Phase|Protocol Violation|0|||
163103939|NCT01352221|589084655|FG003|Double-blind Phase|Protocol Violation|0|||
163103940|NCT01352221|589084652|FG000|Open-label Phase|Physician Decision|0|||
163103941|NCT01352221|589084653|FG001|Open-label Phase|Physician Decision|0|||
163103942|NCT01352221|589084654|FG002|Open-label Phase|Physician Decision|2|||
163103943|NCT01352221|589084655|FG003|Open-label Phase|Physician Decision|1|||
163103944|NCT01352221|589084652|FG000|Open-label Phase|Pregnancy|0|||
163103945|NCT01352221|589084653|FG001|Open-label Phase|Pregnancy|0|||
163103946|NCT01352221|589084654|FG002|Open-label Phase|Pregnancy|1|||
163103947|NCT01352221|589084655|FG003|Open-label Phase|Pregnancy|0|||
163103948|NCT01352221|589084652|FG000|Open-label Phase|Adverse Event|0|||
163103949|NCT01352221|589084653|FG001|Open-label Phase|Adverse Event|0|||
163103950|NCT01352221|589084654|FG002|Open-label Phase|Adverse Event|8|||
163103951|NCT01352221|589084655|FG003|Open-label Phase|Adverse Event|4|||
163103952|NCT01352221|589084652|FG000|Open-label Phase|Withdrawal by Subject|0|||
163103953|NCT01352221|589084653|FG001|Open-label Phase|Withdrawal by Subject|0|||
163103954|NCT01352221|589084654|FG002|Open-label Phase|Withdrawal by Subject|1|||
163103955|NCT01352221|589084655|FG003|Open-label Phase|Withdrawal by Subject|6|||
163103956|NCT01352221|589084652|FG000|Open-label Phase|Worsening of IBD|0|||
163103957|NCT01352221|589084653|FG001|Open-label Phase|Worsening of IBD|0|||
163103958|NCT01352221|589084654|FG002|Open-label Phase|Worsening of IBD|1|||
163103959|NCT01352221|589084655|FG003|Open-label Phase|Worsening of IBD|0|||
163103960|NCT02949024|589084656|FG000|Overall Study|Withdrawal by Subject|0|||
163103961|NCT02949024|589084657|FG001|Overall Study|Withdrawal by Subject|1|||
163103962|NCT01340625|589086390|FG000|First Intervention|Adverse Event|1|||
163103963|NCT01340625|589086391|FG001|First Intervention|Adverse Event|0|||
163103964|NCT01340625|589086390|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
163103965|NCT01340625|589086391|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
163103966|NCT00854724|589086392|FG000|First Intervention|Withdrawal by Subject|1|||
163103967|NCT00854724|589086393|FG001|First Intervention|Withdrawal by Subject|1|||
163103968|NCT00854724|589086392|FG000|Washout|Protocol Violation|1|||
163103969|NCT00854724|589086393|FG001|Washout|Protocol Violation|0|||
163103970|NCT00854724|589086392|FG000|Washout|Withdrawal by Subject|0|||
163103971|NCT00854724|589086393|FG001|Washout|Withdrawal by Subject|1|||
163103972|NCT00854724|589086392|FG000|Second Intervention|Protocol Violation|1|||
163103973|NCT00854724|589086393|FG001|Second Intervention|Protocol Violation|0|||
163103974|NCT00854724|589086392|FG000|Second Intervention|Physician Decision|0|||
163103975|NCT00854724|589086393|FG001|Second Intervention|Physician Decision|1|||
163103976|NCT00576628|589086397|FG000|Overall Study|Adverse Event|11|||
163103977|NCT00576628|589086397|FG000|Overall Study|Death|2|||
163103978|NCT00576628|589086397|FG000|Overall Study|Failure to return|1|||
163103979|NCT00576628|589086397|FG000|Overall Study|Refused Treatment|8|||
163103980|NCT00576628|589086397|FG000|Overall Study|Pregnancy|1|||
163103981|NCT00576628|589086397|FG000|Overall Study|RBC transfusion|1|||
163103982|NCT00576628|589086397|FG000|Overall Study|Progression of Kidney Disease|1|||
163103983|NCT00576628|589086397|FG000|Overall Study|Progression of Renal Failure|1|||
163103984|NCT00576628|589086397|FG000|Overall Study|The patient move into other town|1|||
163103985|NCT00576628|589086397|FG000|Overall Study|Transplantation|1|||
163103986|NCT00576628|589086397|FG000|Overall Study|Dialysis|15|||
163103987|NCT03206970|589086398|FG000|Overall Study|Death|21|||
163103988|NCT03206970|589086398|FG000|Overall Study|Withdrawal by Subject|13|||
163103989|NCT03206970|589086398|FG000|Overall Study|Lost to Follow-up|3|||
163103990|NCT03206970|589086398|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
163103991|NCT03654040|589086405|FG000|Overall Study|Death|1|||
163103992|NCT03654040|589086406|FG001|Overall Study|Death|0|||
163103993|NCT03654040|589086405|FG000|Overall Study|Withdrawal by Subject|1|||
163103994|NCT03654040|589086406|FG001|Overall Study|Withdrawal by Subject|0|||
163103995|NCT03654040|589086405|FG000|Overall Study|Study terminated by sponsor|8|||
163103996|NCT03654040|589086406|FG001|Overall Study|Study terminated by sponsor|2|||
163103997|NCT03654040|589086405|FG000|Overall Study|Failure to initiate study therapy|2|||
163103998|NCT03654040|589086406|FG001|Overall Study|Failure to initiate study therapy|0|||
163103999|NCT03654040|589086405|FG000|Overall Study|Transplanted at another center|2|||
163104000|NCT03654040|589086406|FG001|Overall Study|Transplanted at another center|0|||
163104001|NCT03654040|589086405|FG000|Overall Study|Failure to meet eligibility criteria|14|||
163104002|NCT03654040|589086406|FG001|Overall Study|Failure to meet eligibility criteria|2|||
163104003|NCT03654040|589086405|FG000|Overall Study|No longer transplant candidate|1|||
163104004|NCT03654040|589086406|FG001|Overall Study|No longer transplant candidate|0|||
163104005|NCT03654040|589086405|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
163104006|NCT03654040|589086406|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
163104007|NCT03654040|589086405|FG000|Overall Study|Recipient ineligible|0|||
163104008|NCT03654040|589086406|FG001|Overall Study|Recipient ineligible|2|||
163104009|NCT03654040|589086405|FG000|Overall Study|Received deceased liver|0|||
163104010|NCT03654040|589086406|FG001|Overall Study|Received deceased liver|1|||
163104011|NCT01709110|589086411|FG000|Overall Study|Adverse Event|56|||
163104012|NCT01709110|589086412|FG001|Overall Study|Adverse Event|48|||
163104013|NCT01709110|589086411|FG000|Overall Study|Death|14|||
163104014|NCT01709110|589086412|FG001|Overall Study|Death|6|||
163104015|NCT01709110|589086411|FG000|Overall Study|Lost to Follow-up|7|||
163104016|NCT01709110|589086412|FG001|Overall Study|Lost to Follow-up|5|||
163104017|NCT01709110|589086411|FG000|Overall Study|Protocol Violation|4|||
163104018|NCT01709110|589086412|FG001|Overall Study|Protocol Violation|6|||
163104019|NCT01709110|589086411|FG000|Overall Study|Withdrawal by Subject|96|||
163220649|NCT03200899|589522923|FG001|Overall Study|Lost to Follow-up|23|||
163104020|NCT01709110|589086412|FG001|Overall Study|Withdrawal by Subject|89|||
163104021|NCT01709110|589086411|FG000|Overall Study|Physician Decision|4|||
163104022|NCT01709110|589086412|FG001|Overall Study|Physician Decision|10|||
163104023|NCT01709110|589086411|FG000|Overall Study|Sponsor Decision|2|||
163104024|NCT01709110|589086412|FG001|Overall Study|Sponsor Decision|2|||
163104025|NCT01709110|589086411|FG000|Overall Study|Lack of Efficacy|1|||
163104026|NCT01709110|589086412|FG001|Overall Study|Lack of Efficacy|1|||
163104027|NCT01709110|589086411|FG000|Overall Study|Caregiver Decision|1|||
163104028|NCT01709110|589086412|FG001|Overall Study|Caregiver Decision|1|||
163104029|NCT01951586|589086413|FG000|Overall Study|Death|61|||
163104030|NCT01951586|589086414|FG001|Overall Study|Death|120|||
163104031|NCT01951586|589086413|FG000|Overall Study|Withdrawal by Subject|8|||
163104032|NCT01951586|589086414|FG001|Overall Study|Withdrawal by Subject|17|||
163104033|NCT01951586|589086413|FG000|Overall Study|Lost to Follow-up|0|||
163104034|NCT01951586|589086414|FG001|Overall Study|Lost to Follow-up|1|||
163104035|NCT01951586|589086413|FG000|Overall Study|Sponsor Decision|9|||
163104036|NCT01951586|589086414|FG001|Overall Study|Sponsor Decision|10|||
163104037|NCT02789345|589086415|FG000|Overall Study|Adverse Event|0|||
163104038|NCT02789345|589086416|FG001|Overall Study|Adverse Event|0|||
163104039|NCT02789345|589086417|FG002|Overall Study|Adverse Event|1|||
163104040|NCT02789345|589086415|FG000|Overall Study|Death|0|||
163104041|NCT02789345|589086416|FG001|Overall Study|Death|0|||
163104042|NCT02789345|589086417|FG002|Overall Study|Death|1|||
163104043|NCT02789345|589086415|FG000|Overall Study|Physician Decision|2|||
163104044|NCT02789345|589086416|FG001|Overall Study|Physician Decision|0|||
163104045|NCT02789345|589086417|FG002|Overall Study|Physician Decision|1|||
163104046|NCT02789345|589086415|FG000|Overall Study|Progressive Disease|1|||
163104047|NCT02789345|589086416|FG001|Overall Study|Progressive Disease|3|||
163104048|NCT02789345|589086417|FG002|Overall Study|Progressive Disease|14|||
163104049|NCT03286543|589086423|FG000|Consented|Screen failure before randomization|2|||
163104050|NCT03286543|589086424|FG001|Consented|Screen failure before randomization|0|||
163104051|NCT03286543|589086425|FG002|Consented|Screen failure before randomization|0|||
163104052|NCT03286543|589086423|FG000|Consented|Screen failure before enrollment|4|||
163104053|NCT03286543|589086424|FG001|Consented|Screen failure before enrollment|0|||
163104054|NCT03286543|589086425|FG002|Consented|Screen failure before enrollment|0|||
163104055|NCT03286543|589086423|FG000|Consented|TKA cancelled after enrollment|1|||
163104056|NCT03286543|589086424|FG001|Consented|TKA cancelled after enrollment|0|||
163104057|NCT03286543|589086425|FG002|Consented|TKA cancelled after enrollment|0|||
163104058|NCT03286543|589086423|FG000|Consented|Withdrawn from study|12|||
163104059|NCT03286543|589086424|FG001|Consented|Withdrawn from study|0|||
163104060|NCT03286543|589086425|FG002|Consented|Withdrawn from study|0|||
163104061|NCT03286543|589086423|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
163104062|NCT03286543|589086424|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
163104063|NCT03286543|589086425|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
163104064|NCT03286543|589086423|FG000|Study Enrollment|Withdrawn from study|0|||
163104065|NCT03286543|589086424|FG001|Study Enrollment|Withdrawn from study|6|||
163104066|NCT03286543|589086425|FG002|Study Enrollment|Withdrawn from study|6|||
163104067|NCT02836717|589086429|FG000|Test Phase|Lack of Efficacy|14|||
163104068|NCT02836717|589086430|FG001|Test Phase|Lack of Efficacy|8|||
163104069|NCT02836717|589086431|FG002|Test Phase|Lack of Efficacy|0|||
163104070|NCT02836717|589086429|FG000|Study Phase|Adverse Event|2|||
163104071|NCT02836717|589086430|FG001|Study Phase|Adverse Event|0|||
163104072|NCT02836717|589086431|FG002|Study Phase|Adverse Event|0|||
163104073|NCT02836717|589086429|FG000|Study Phase|Lack of Efficacy|8|||
163104074|NCT02836717|589086430|FG001|Study Phase|Lack of Efficacy|6|||
163104075|NCT02836717|589086431|FG002|Study Phase|Lack of Efficacy|1|||
163104076|NCT02836717|589086429|FG000|Study Phase|Withdrawal by Subject|1|||
163104077|NCT02836717|589086430|FG001|Study Phase|Withdrawal by Subject|0|||
163104078|NCT02836717|589086431|FG002|Study Phase|Withdrawal by Subject|0|||
163104079|NCT02836717|589086429|FG000|Study Phase|Death|1|||
163104080|NCT02836717|589086430|FG001|Study Phase|Death|0|||
163104081|NCT02836717|589086431|FG002|Study Phase|Death|0|||
163104082|NCT02836717|589086429|FG000|Study Phase|abdominal surgeries|2|||
163104083|NCT02836717|589086430|FG001|Study Phase|abdominal surgeries|1|||
163104084|NCT02836717|589086431|FG002|Study Phase|abdominal surgeries|0|||
163104085|NCT00224120|589086432|FG000|Overall Study|Adverse Event|10|||
163104086|NCT00224120|589086433|FG001|Overall Study|Adverse Event|4|||
163104087|NCT00224120|589086432|FG000|Overall Study|Protocol Violation|1|||
163104088|NCT00224120|589086433|FG001|Overall Study|Protocol Violation|0|||
163104089|NCT00224120|589086432|FG000|Overall Study|Withdrawal by Subject|5|||
163104090|NCT00224120|589086433|FG001|Overall Study|Withdrawal by Subject|10|||
163104091|NCT00224120|589086432|FG000|Overall Study|Lack of Efficacy|0|||
163104092|NCT00224120|589086433|FG001|Overall Study|Lack of Efficacy|2|||
163104093|NCT00224120|589086432|FG000|Overall Study|Lost to Follow-up|2|||
163104094|NCT00224120|589086433|FG001|Overall Study|Lost to Follow-up|3|||
163104095|NCT00224120|589086432|FG000|Overall Study|Other|4|||
163104096|NCT00224120|589086433|FG001|Overall Study|Other|5|||
163104097|NCT00104416|589086434|FG000|Double-Blind Phase|Adverse Event|2|||
163104098|NCT00104416|589086435|FG001|Double-Blind Phase|Adverse Event|1|||
163104099|NCT00104416|589086436|FG002|Double-Blind Phase|Adverse Event|0|||
163407693|NCT00464334|590200889|FG008|Overall Study|Lack of Efficacy|0|||
163407694|NCT00464334|590200890|FG009|Overall Study|Lack of Efficacy|0|||
163407695|NCT00464334|590200891|FG010|Overall Study|Lack of Efficacy|0|||
163407696|NCT00464334|590200881|FG000|Overall Study|Lost to Follow-up|0|||
163407697|NCT00464334|590200882|FG001|Overall Study|Lost to Follow-up|0|||
163407698|NCT00464334|590200883|FG002|Overall Study|Lost to Follow-up|1|||
163407699|NCT00464334|590200884|FG003|Overall Study|Lost to Follow-up|0|||
163407700|NCT00464334|590200885|FG004|Overall Study|Lost to Follow-up|1|||
163104100|NCT00104416|589086437|FG003|Double-Blind Phase|Adverse Event|0|||
163104101|NCT00104416|589086438|FG004|Double-Blind Phase|Adverse Event|0|||
163104102|NCT00104416|589086434|FG000|Double-Blind Phase|Lost to Follow-up|0|||
163104103|NCT00104416|589086435|FG001|Double-Blind Phase|Lost to Follow-up|1|||
163104104|NCT00104416|589086436|FG002|Double-Blind Phase|Lost to Follow-up|0|||
163104105|NCT00104416|589086437|FG003|Double-Blind Phase|Lost to Follow-up|0|||
163104106|NCT00104416|589086438|FG004|Double-Blind Phase|Lost to Follow-up|0|||
163104107|NCT00104416|589086434|FG000|Double-Blind Phase|Protocol Violation|0|||
163104108|NCT00104416|589086435|FG001|Double-Blind Phase|Protocol Violation|1|||
163104109|NCT00104416|589086436|FG002|Double-Blind Phase|Protocol Violation|0|||
163104110|NCT00104416|589086437|FG003|Double-Blind Phase|Protocol Violation|0|||
163104111|NCT00104416|589086438|FG004|Double-Blind Phase|Protocol Violation|0|||
163104112|NCT00104416|589086434|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
163104113|NCT00104416|589086435|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
163104114|NCT00104416|589086436|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
163104115|NCT00104416|589086437|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
163104116|NCT00104416|589086438|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
163104117|NCT00104416|589086434|FG000|Double-Blind Phase|Pregnancy|1|||
163104118|NCT00104416|589086435|FG001|Double-Blind Phase|Pregnancy|0|||
163104119|NCT00104416|589086436|FG002|Double-Blind Phase|Pregnancy|0|||
163104120|NCT00104416|589086437|FG003|Double-Blind Phase|Pregnancy|0|||
163104121|NCT00104416|589086438|FG004|Double-Blind Phase|Pregnancy|0|||
163104122|NCT00104416|589086434|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
163104123|NCT00104416|589086435|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
163104124|NCT00104416|589086436|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
163104125|NCT00104416|589086437|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
163104126|NCT00104416|589086438|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
163104127|NCT00104416|589086434|FG000|Continuation Phase|Adverse Event|0|||
163104128|NCT00104416|589086435|FG001|Continuation Phase|Adverse Event|0|||
163104129|NCT00104416|589086436|FG002|Continuation Phase|Adverse Event|2|||
163104130|NCT00104416|589086437|FG003|Continuation Phase|Adverse Event|0|||
163104131|NCT00104416|589086438|FG004|Continuation Phase|Adverse Event|2|||
163104132|NCT00104416|589086434|FG000|Continuation Phase|Lost to Follow-up|0|||
163104133|NCT00104416|589086435|FG001|Continuation Phase|Lost to Follow-up|0|||
163104134|NCT00104416|589086436|FG002|Continuation Phase|Lost to Follow-up|1|||
163104135|NCT00104416|589086437|FG003|Continuation Phase|Lost to Follow-up|0|||
163104136|NCT00104416|589086438|FG004|Continuation Phase|Lost to Follow-up|1|||
163104137|NCT00104416|589086434|FG000|Continuation Phase|Withdrawal by Subject|0|||
163104138|NCT00104416|589086435|FG001|Continuation Phase|Withdrawal by Subject|0|||
163104139|NCT00104416|589086436|FG002|Continuation Phase|Withdrawal by Subject|2|||
163104140|NCT00104416|589086437|FG003|Continuation Phase|Withdrawal by Subject|1|||
163104141|NCT00104416|589086438|FG004|Continuation Phase|Withdrawal by Subject|1|||
163104142|NCT00104416|589086434|FG000|Continuation Phase|Pregnancy|0|||
163104143|NCT00104416|589086435|FG001|Continuation Phase|Pregnancy|0|||
163104144|NCT00104416|589086436|FG002|Continuation Phase|Pregnancy|1|||
163104145|NCT00104416|589086437|FG003|Continuation Phase|Pregnancy|1|||
163104146|NCT00104416|589086438|FG004|Continuation Phase|Pregnancy|0|||
163104147|NCT00104416|589086434|FG000|Continuation Phase|Non-compliance|0|||
163104148|NCT00104416|589086435|FG001|Continuation Phase|Non-compliance|0|||
163104149|NCT00104416|589086436|FG002|Continuation Phase|Non-compliance|0|||
163104150|NCT00104416|589086437|FG003|Continuation Phase|Non-compliance|0|||
163104151|NCT00104416|589086438|FG004|Continuation Phase|Non-compliance|1|||
163104152|NCT00438360|589086439|FG000|Overall Study|Adverse Event|6|||
163104153|NCT00438360|589086440|FG001|Overall Study|Adverse Event|1|||
163104154|NCT00438360|589086439|FG000|Overall Study|Lack of Efficacy|42|||
163104155|NCT00438360|589086440|FG001|Overall Study|Lack of Efficacy|27|||
163104156|NCT00438360|589086439|FG000|Overall Study|Other|24|||
163104157|NCT00438360|589086440|FG001|Overall Study|Other|15|||
163104158|NCT00070109|589086441|FG000|Overall Study|Death|1|||
163104159|NCT00070109|589086442|FG001|Overall Study|Death|1|||
163104160|NCT00070109|589086443|FG002|Overall Study|Death|0|||
163104161|NCT00070109|589086444|FG003|Overall Study|Death|0|||
163104162|NCT00070109|589086445|FG004|Overall Study|Death|1|||
163407701|NCT00464334|590200886|FG005|Overall Study|Lost to Follow-up|0|||
163104163|NCT00070109|589086441|FG000|Overall Study|Lack of Efficacy|6|||
163104164|NCT00070109|589086442|FG001|Overall Study|Lack of Efficacy|4|||
163220650|NCT01342510|589522938|FG000|Overall Study|Protocol Violation|12|||
163104165|NCT00070109|589086443|FG002|Overall Study|Lack of Efficacy|5|||
163104166|NCT00070109|589086444|FG003|Overall Study|Lack of Efficacy|15|||
163407702|NCT00464334|590200887|FG006|Overall Study|Lost to Follow-up|1|||
163407703|NCT00464334|590200888|FG007|Overall Study|Lost to Follow-up|0|||
163220651|NCT01342510|589522939|FG001|Overall Study|Protocol Violation|6|||
163220652|NCT01342510|589522940|FG002|Overall Study|Protocol Violation|13|||
163220653|NCT01342510|589522941|FG003|Overall Study|Protocol Violation|11|||
163220654|NCT01400516|589522943|FG000|Primary Trial|Withdrawal by Subject|0|||
163220655|NCT01400516|589522944|FG001|Primary Trial|Withdrawal by Subject|2|||
163220656|NCT00549562|589522945|FG000|Overall Study|Adverse Event|1|||
163220657|NCT00549562|589522945|FG000|Overall Study|Lack of Efficacy|1|||
163220658|NCT00323115|589522951|FG000|Vaccine Administration|Adverse Event|1|||
163220659|NCT00323115|589522951|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
163220660|NCT02496533|589522952|FG000|Overall Study|Lack of data on outcome|3|||
163220661|NCT02496533|589522953|FG001|Overall Study|Lack of data on outcome|0|||
163220662|NCT02496533|589522952|FG000|Overall Study|Patient did not complete all measures|0|||
163220663|NCT02496533|589522953|FG001|Overall Study|Patient did not complete all measures|4|||
163220664|NCT02496533|589522952|FG000|Overall Study|Late for radiologic testing|0|||
163220665|NCT02496533|589522953|FG001|Overall Study|Late for radiologic testing|2|||
163220666|NCT05756790|589522954|FG000|Overall Study|Withdrawal by Subject|1|||
163220667|NCT05756790|589522955|FG001|Overall Study|Withdrawal by Subject|1|||
163220668|NCT05756790|589522956|FG002|Overall Study|Withdrawal by Subject|1|||
163220669|NCT05756790|589522957|FG003|Overall Study|Withdrawal by Subject|1|||
163220670|NCT05756790|589522958|FG004|Overall Study|Withdrawal by Subject|0|||
163220671|NCT05756790|589522959|FG005|Overall Study|Withdrawal by Subject|0|||
163220672|NCT05756790|589522954|FG000|Overall Study|Protocol Violation|0|||
163220673|NCT05756790|589522955|FG001|Overall Study|Protocol Violation|0|||
163220674|NCT05756790|589522956|FG002|Overall Study|Protocol Violation|1|||
163220675|NCT05756790|589522957|FG003|Overall Study|Protocol Violation|1|||
163220676|NCT05756790|589522958|FG004|Overall Study|Protocol Violation|0|||
163220677|NCT05756790|589522959|FG005|Overall Study|Protocol Violation|0|||
163220678|NCT05756790|589522954|FG000|Overall Study|Ineligible|0|||
163220679|NCT05756790|589522955|FG001|Overall Study|Ineligible|0|||
163220680|NCT05756790|589522956|FG002|Overall Study|Ineligible|0|||
163220681|NCT05756790|589522957|FG003|Overall Study|Ineligible|0|||
163220682|NCT05756790|589522958|FG004|Overall Study|Ineligible|2|||
163220683|NCT05756790|589522959|FG005|Overall Study|Ineligible|2|||
163220684|NCT00502697|589524300|FG000|Overall Study|Withdrawal by Subject|3|||
163220685|NCT00502697|589524301|FG001|Overall Study|Withdrawal by Subject|1|||
163220686|NCT00502697|589524300|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
163220687|NCT00502697|589524301|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
163220688|NCT00502697|589524300|FG000|Overall Study|found not to meet eligibility criteria|3|||
163104167|NCT00070109|589086445|FG004|Overall Study|Lack of Efficacy|5|||
163104168|NCT00070109|589086441|FG000|Overall Study|Physician Decision|1|||
163104169|NCT00070109|589086442|FG001|Overall Study|Physician Decision|0|||
163104170|NCT00070109|589086443|FG002|Overall Study|Physician Decision|0|||
163104171|NCT00070109|589086444|FG003|Overall Study|Physician Decision|0|||
163104172|NCT00070109|589086445|FG004|Overall Study|Physician Decision|0|||
163104173|NCT00070109|589086441|FG000|Overall Study|Withdrawal by Subject|0|||
163104174|NCT00070109|589086442|FG001|Overall Study|Withdrawal by Subject|1|||
163104175|NCT00070109|589086443|FG002|Overall Study|Withdrawal by Subject|1|||
163104176|NCT00070109|589086444|FG003|Overall Study|Withdrawal by Subject|0|||
163104177|NCT00070109|589086445|FG004|Overall Study|Withdrawal by Subject|0|||
163104178|NCT00070109|589086441|FG000|Overall Study|Adverse Event|0|||
163104179|NCT00070109|589086442|FG001|Overall Study|Adverse Event|0|||
163104180|NCT00070109|589086443|FG002|Overall Study|Adverse Event|2|||
163104181|NCT00070109|589086444|FG003|Overall Study|Adverse Event|4|||
163104182|NCT00070109|589086445|FG004|Overall Study|Adverse Event|2|||
163104183|NCT00070109|589086441|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
163104184|NCT00070109|589086442|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
163104185|NCT00070109|589086443|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
163104186|NCT00070109|589086444|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
163104187|NCT00070109|589086445|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
163104188|NCT01164891|589086458|FG000|Overall Study|Disease Progression|5|||
163220689|NCT00502697|589524301|FG001|Overall Study|found not to meet eligibility criteria|4|||
163220690|NCT00502697|589524300|FG000|Overall Study|did not meet assignment criteria|4|||
163220691|NCT00502697|589524301|FG001|Overall Study|did not meet assignment criteria|2|||
163220692|NCT02268409|589524313|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
163220693|NCT02268409|589524313|FG000|Overall Study|Death|1|||
163104189|NCT01164891|589086458|FG000|Overall Study|Adverse Event|1|||
163220694|NCT02268409|589524313|FG000|Overall Study|Lost to Follow-up|1|||
163220695|NCT02268409|589524313|FG000|Overall Study|Protocol Violation|3|||
163220696|NCT02268409|589524313|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
163220697|NCT02268409|589524313|FG000|Overall Study|Withdrawal by Subject|5|||
163220698|NCT03026257|589524315|FG000|Overall Study|Adverse Event|3|||
163104190|NCT00441142|589086459|FG000|Overall Study|Adverse Event|2|||
163104191|NCT00441142|589086460|FG001|Overall Study|Adverse Event|3|||
163407704|NCT00464334|590200889|FG008|Overall Study|Lost to Follow-up|0|||
163104192|NCT00441142|589086461|FG002|Overall Study|Adverse Event|3|||
163104193|NCT00441142|589086462|FG003|Overall Study|Adverse Event|22|||
163220699|NCT03026257|589524316|FG001|Overall Study|Adverse Event|0|||
163220700|NCT03026257|589524317|FG002|Overall Study|Adverse Event|0|||
163220701|NCT03026257|589524318|FG003|Overall Study|Adverse Event|0|||
163220702|NCT03026257|589524319|FG004|Overall Study|Adverse Event|0|||
163220703|NCT03026257|589524320|FG005|Overall Study|Adverse Event|0|||
163220704|NCT03026257|589524315|FG000|Overall Study|Lost to Follow-up|1|||
163220705|NCT03026257|589524316|FG001|Overall Study|Lost to Follow-up|0|||
163220706|NCT03026257|589524317|FG002|Overall Study|Lost to Follow-up|0|||
163220707|NCT03026257|589524318|FG003|Overall Study|Lost to Follow-up|0|||
163220708|NCT03026257|589524319|FG004|Overall Study|Lost to Follow-up|0|||
163220709|NCT03026257|589524320|FG005|Overall Study|Lost to Follow-up|0|||
163220710|NCT03026257|589524315|FG000|Overall Study|Protocol Violation|1|||
163220711|NCT03026257|589524316|FG001|Overall Study|Protocol Violation|0|||
163220712|NCT03026257|589524317|FG002|Overall Study|Protocol Violation|0|||
163220713|NCT03026257|589524318|FG003|Overall Study|Protocol Violation|1|||
163220714|NCT03026257|589524319|FG004|Overall Study|Protocol Violation|1|||
163220715|NCT03026257|589524320|FG005|Overall Study|Protocol Violation|0|||
163220716|NCT03026257|589524315|FG000|Overall Study|Withdrawal by Subject|1|||
163220717|NCT03026257|589524316|FG001|Overall Study|Withdrawal by Subject|1|||
163220718|NCT03026257|589524317|FG002|Overall Study|Withdrawal by Subject|0|||
163220719|NCT03026257|589524318|FG003|Overall Study|Withdrawal by Subject|0|||
163220720|NCT03026257|589524319|FG004|Overall Study|Withdrawal by Subject|0|||
163220721|NCT03026257|589524320|FG005|Overall Study|Withdrawal by Subject|0|||
163220722|NCT02181556|589524321|FG000|Overall Study|Withdrawal by Subject|1|||
163220723|NCT00427635|589524322|FG000|Treatment Phase|Withdrawal by Subject|1|||
163220724|NCT00427635|589524323|FG001|Treatment Phase|Withdrawal by Subject|0|||
163220725|NCT00427635|589524322|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
163220726|NCT00427635|589524323|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
163220727|NCT00838201|589524326|FG000|Overall Study|Investigator decision, or other reasons|2|||
163220728|NCT00838201|589524327|FG001|Overall Study|Investigator decision, or other reasons|3|||
163220729|NCT00838201|589524326|FG000|Overall Study|Noncompliance|0|||
163220730|NCT00838201|589524327|FG001|Overall Study|Noncompliance|1|||
163220731|NCT00838201|589524326|FG000|Overall Study|Administrative decision|1|||
163220732|NCT00838201|589524327|FG001|Overall Study|Administrative decision|2|||
163220733|NCT00838201|589524326|FG000|Overall Study|Disease progression|3|||
163220734|NCT00838201|589524327|FG001|Overall Study|Disease progression|3|||
163220735|NCT00838201|589524326|FG000|Overall Study|Consent withdrawn|16|||
163220736|NCT00838201|589524327|FG001|Overall Study|Consent withdrawn|19|||
163220737|NCT00838201|589524326|FG000|Overall Study|Lost to Follow-up|4|||
163220738|NCT00838201|589524327|FG001|Overall Study|Lost to Follow-up|3|||
163220739|NCT00838201|589524326|FG000|Overall Study|Adverse Event|5|||
163220740|NCT00838201|589524327|FG001|Overall Study|Adverse Event|9|||
163220741|NCT00838201|589524326|FG000|Overall Study|Death|11|||
163104194|NCT00441142|589086459|FG000|Overall Study|Lack of Efficacy|3|||
163104195|NCT00441142|589086460|FG001|Overall Study|Lack of Efficacy|3|||
163104196|NCT00441142|589086461|FG002|Overall Study|Lack of Efficacy|17|||
163104197|NCT00441142|589086462|FG003|Overall Study|Lack of Efficacy|32|||
163104198|NCT00441142|589086459|FG000|Overall Study|Withdrawal by Subject|0|||
163104199|NCT00441142|589086460|FG001|Overall Study|Withdrawal by Subject|0|||
163104200|NCT00441142|589086461|FG002|Overall Study|Withdrawal by Subject|2|||
163104201|NCT00441142|589086462|FG003|Overall Study|Withdrawal by Subject|10|||
163104202|NCT00441142|589086459|FG000|Overall Study|Patient still receiving active study tx|1|||
163104203|NCT00441142|589086460|FG001|Overall Study|Patient still receiving active study tx|0|||
163104204|NCT00441142|589086461|FG002|Overall Study|Patient still receiving active study tx|0|||
163104205|NCT00441142|589086462|FG003|Overall Study|Patient still receiving active study tx|2|||
163104206|NCT00441142|589086459|FG000|Overall Study|Physician Decision|0|||
163104207|NCT00441142|589086460|FG001|Overall Study|Physician Decision|1|||
163104208|NCT00441142|589086461|FG002|Overall Study|Physician Decision|0|||
163104209|NCT00441142|589086462|FG003|Overall Study|Physician Decision|1|||
163104210|NCT00441142|589086459|FG000|Overall Study|Death|0|||
163220742|NCT00838201|589524327|FG001|Overall Study|Death|13|||
163220743|NCT00489853|589524328|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
163220744|NCT00489853|589524329|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
163220745|NCT00489853|589524330|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
163220746|NCT00489853|589524328|FG000|Wash-out Period 1|Adverse Event|0|||
163220747|NCT00489853|589524329|FG001|Wash-out Period 1|Adverse Event|1|||
163220748|NCT00489853|589524330|FG002|Wash-out Period 1|Adverse Event|1|||
163104211|NCT00441142|589086460|FG001|Overall Study|Death|0|||
163220749|NCT00489853|589524328|FG000|Wash-out Period 1|Protocol Violation|0|||
163220750|NCT00489853|589524329|FG001|Wash-out Period 1|Protocol Violation|1|||
163220751|NCT00489853|589524330|FG002|Wash-out Period 1|Protocol Violation|1|||
163220752|NCT00489853|589524328|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
163104212|NCT00441142|589086461|FG002|Overall Study|Death|0|||
163104213|NCT00441142|589086462|FG003|Overall Study|Death|1|||
163104214|NCT00338286|589086463|FG000|Overall Study|Withdrawal by Subject|50|||
163104215|NCT00338286|589086464|FG001|Overall Study|Withdrawal by Subject|54|||
163220753|NCT00489853|589524329|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
163104216|NCT00338286|589086463|FG000|Overall Study|Lost to Follow-up|80|||
163104217|NCT00338286|589086464|FG001|Overall Study|Lost to Follow-up|66|||
163104218|NCT00338286|589086463|FG000|Overall Study|Other|103|||
163104219|NCT00338286|589086464|FG001|Overall Study|Other|93|||
163104220|NCT01265563|589086465|FG000|Overall Study|Withdrawal by Subject|0|||
163104221|NCT01265563|589086466|FG001|Overall Study|Withdrawal by Subject|1|||
163104222|NCT01265563|589086467|FG002|Overall Study|Withdrawal by Subject|1|||
163104223|NCT01265563|589086468|FG003|Overall Study|Withdrawal by Subject|0|||
163104224|NCT01265563|589086469|FG004|Overall Study|Withdrawal by Subject|2|||
163104225|NCT04908865|589086473|FG000|Overall Study|Adverse Event|2|||
163104226|NCT04908865|589086473|FG000|Overall Study|Lack of Efficacy|5|||
163104227|NCT04908865|589086473|FG000|Overall Study|Lost to Follow-up|1|||
163104228|NCT05286658|589086474|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
163104229|NCT05286658|589086474|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
163104230|NCT01534351|589086477|FG000|Overall Study|Study Terminated Early|1|||
163104231|NCT01534351|589086478|FG001|Overall Study|Study Terminated Early|0|||
163104232|NCT01534351|589086479|FG002|Overall Study|Study Terminated Early|0|||
163104233|NCT00470262|589086480|FG000|Overall Study|Withdrawal by Subject|2|||
163104234|NCT00470262|589086481|FG001|Overall Study|Withdrawal by Subject|0|||
163104235|NCT03248167|589086482|FG000|Overall Study|Withdrawal by Subject|2|||
163104236|NCT03248167|589086483|FG001|Overall Study|Withdrawal by Subject|2|||
163104237|NCT03248167|589086482|FG000|Overall Study|Physician Decision|0|||
163104238|NCT03248167|589086483|FG001|Overall Study|Physician Decision|1|||
163104239|NCT03248167|589086482|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
163104240|NCT03248167|589086483|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
163104241|NCT03248167|589086482|FG000|Overall Study|Lost to Follow-up|1|||
163104242|NCT03248167|589086483|FG001|Overall Study|Lost to Follow-up|0|||
163104243|NCT02122146|589086484|FG000|Part 1: Dose Escalation|Death|0|||
163104244|NCT02122146|589086485|FG001|Part 1: Dose Escalation|Death|1|||
163104245|NCT02122146|589086486|FG002|Part 1: Dose Escalation|Death|1|||
163104246|NCT02122146|589086487|FG003|Part 1: Dose Escalation|Death|0|||
163104247|NCT02122146|589086488|FG004|Part 1: Dose Escalation|Death|0|||
163104248|NCT02122146|589086489|FG005|Part 1: Dose Escalation|Death|0|||
163104249|NCT02122146|589086490|FG006|Part 1: Dose Escalation|Death|0|||
163104250|NCT02122146|589086491|FG007|Part 1: Dose Escalation|Death|0|||
163104251|NCT02122146|589086484|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
163104252|NCT02122146|589086485|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
163104253|NCT02122146|589086486|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
163104254|NCT02122146|589086487|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
163104255|NCT02122146|589086488|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
163104256|NCT02122146|589086489|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
163104257|NCT02122146|589086490|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
163104258|NCT02122146|589086491|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
163104259|NCT02122146|589086484|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163104260|NCT02122146|589086485|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163104261|NCT02122146|589086486|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163104262|NCT02122146|589086487|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
163104263|NCT02122146|589086488|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163104264|NCT02122146|589086489|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163104265|NCT02122146|589086490|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163104266|NCT02122146|589086491|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163104267|NCT02122146|589086484|FG000|Part 1: Dose Escalation|Other|1|||
163104268|NCT02122146|589086485|FG001|Part 1: Dose Escalation|Other|0|||
163104269|NCT02122146|589086486|FG002|Part 1: Dose Escalation|Other|0|||
163104270|NCT02122146|589086487|FG003|Part 1: Dose Escalation|Other|0|||
163104271|NCT02122146|589086488|FG004|Part 1: Dose Escalation|Other|0|||
163104272|NCT02122146|589086489|FG005|Part 1: Dose Escalation|Other|1|||
163104273|NCT02122146|589086490|FG006|Part 1: Dose Escalation|Other|1|||
163104274|NCT02122146|589086491|FG007|Part 1: Dose Escalation|Other|2|||
163104275|NCT03472495|589086492|FG000|Overall Study|Treatment no longer indicated|1|||
163104276|NCT03472495|589086493|FG001|Overall Study|Treatment no longer indicated|2|||
163104277|NCT03472495|589086492|FG000|Overall Study|Physician Decision|0|||
163104278|NCT03472495|589086493|FG001|Overall Study|Physician Decision|2|||
163104279|NCT02584452|589086496|FG000|Overall Study|Physician Decision|1|||
163104280|NCT02584452|589086497|FG001|Overall Study|Physician Decision|1|||
163104281|NCT02584452|589086496|FG000|Overall Study|Lost to Follow-up|1|||
163104282|NCT02584452|589086497|FG001|Overall Study|Lost to Follow-up|1|||
163104283|NCT02998671|589086498|FG000|Period 1|Study Terminated By Sponsor|2|||
163104284|NCT02998671|589086499|FG001|Period 1|Study Terminated By Sponsor|1|||
163104285|NCT02998671|589086500|FG002|Period 1|Study Terminated By Sponsor|0|||
163104286|NCT02998671|589086501|FG003|Period 1|Study Terminated By Sponsor|0|||
163104287|NCT02998671|589086502|FG004|Period 1|Study Terminated By Sponsor|1|||
163104288|NCT02998671|589086498|FG000|Period 1|Withdrawal by Subject|1|||
163104289|NCT02998671|589086499|FG001|Period 1|Withdrawal by Subject|2|||
163104290|NCT02998671|589086500|FG002|Period 1|Withdrawal by Subject|0|||
163104291|NCT02998671|589086501|FG003|Period 1|Withdrawal by Subject|0|||
163104292|NCT02998671|589086502|FG004|Period 1|Withdrawal by Subject|2|||
163104293|NCT02998671|589086498|FG000|Period 1|Pregnancy|1|||
163104294|NCT02998671|589086499|FG001|Period 1|Pregnancy|0|||
163104295|NCT02998671|589086500|FG002|Period 1|Pregnancy|0|||
163104296|NCT02998671|589086501|FG003|Period 1|Pregnancy|0|||
163104297|NCT02998671|589086502|FG004|Period 1|Pregnancy|0|||
163104298|NCT02998671|589086498|FG000|Period 1|Adverse Event|0|||
163104299|NCT02998671|589086499|FG001|Period 1|Adverse Event|0|||
163104300|NCT02998671|589086500|FG002|Period 1|Adverse Event|0|||
163104301|NCT02998671|589086501|FG003|Period 1|Adverse Event|0|||
163104302|NCT02998671|589086502|FG004|Period 1|Adverse Event|1|||
163104303|NCT02998671|589086498|FG000|Period 2|Adverse Event|0|||
163104304|NCT02998671|589086499|FG001|Period 2|Adverse Event|1|||
163104305|NCT02998671|589086500|FG002|Period 2|Adverse Event|0|||
163104306|NCT02998671|589086501|FG003|Period 2|Adverse Event|0|||
163104307|NCT02998671|589086502|FG004|Period 2|Adverse Event|0|||
163104308|NCT02998671|589086498|FG000|Period 2|Study Terminated By Sponsor|3|||
163104309|NCT02998671|589086499|FG001|Period 2|Study Terminated By Sponsor|5|||
163104310|NCT02998671|589086500|FG002|Period 2|Study Terminated By Sponsor|1|||
163104311|NCT02998671|589086501|FG003|Period 2|Study Terminated By Sponsor|3|||
163104312|NCT02998671|589086502|FG004|Period 2|Study Terminated By Sponsor|0|||
163104313|NCT02998671|589086498|FG000|Period 2|Withdrawal by Subject|0|||
163104314|NCT02998671|589086499|FG001|Period 2|Withdrawal by Subject|1|||
163104315|NCT02998671|589086500|FG002|Period 2|Withdrawal by Subject|0|||
163104316|NCT02998671|589086501|FG003|Period 2|Withdrawal by Subject|0|||
163104317|NCT02998671|589086502|FG004|Period 2|Withdrawal by Subject|0|||
163104318|NCT02998671|589086498|FG000|Period 2|Lost to Follow-up|0|||
163104319|NCT02998671|589086499|FG001|Period 2|Lost to Follow-up|0|||
163104320|NCT02998671|589086500|FG002|Period 2|Lost to Follow-up|0|||
163104321|NCT02998671|589086501|FG003|Period 2|Lost to Follow-up|1|||
163104322|NCT02998671|589086502|FG004|Period 2|Lost to Follow-up|0|||
163104323|NCT01558596|589086504|FG000|Overall Study|Withdrawal by Subject|1|||
163104324|NCT01558596|589086505|FG001|Overall Study|Withdrawal by Subject|0|||
163104325|NCT01558596|589086504|FG000|Overall Study|surgery elsewhere or cancelled|1|||
163104326|NCT01558596|589086505|FG001|Overall Study|surgery elsewhere or cancelled|1|||
163104327|NCT01558596|589086504|FG000|Overall Study|Protocol Violation|1|||
163104328|NCT01558596|589086505|FG001|Overall Study|Protocol Violation|0|||
163104329|NCT04222699|589086513|FG000|Overall Study|Lost to Follow-up|2|||
163104330|NCT03583359|589086533|FG000|Overall Study|Withdrawal by Subject|15|||
163104331|NCT03583359|589086534|FG001|Overall Study|Withdrawal by Subject|6|||
163104332|NCT03583359|589086533|FG000|Overall Study|Lost to Follow-up|12|||
163104333|NCT03583359|589086534|FG001|Overall Study|Lost to Follow-up|3|||
163104334|NCT03583359|589086533|FG000|Overall Study|Adverse Event|0|||
163104335|NCT03583359|589086534|FG001|Overall Study|Adverse Event|1|||
163104336|NCT03583359|589086533|FG000|Overall Study|Protocol Violation|0|||
163104337|NCT03583359|589086534|FG001|Overall Study|Protocol Violation|1|||
163104338|NCT03583359|589086533|FG000|Overall Study|Other|2|||
163104339|NCT03583359|589086534|FG001|Overall Study|Other|1|||
163104340|NCT02567799|589086540|FG000|Concurrent Chemoradiotherapy|Death|1|||
163104341|NCT02567799|589086541|FG001|Concurrent Chemoradiotherapy|Death|0|||
163104342|NCT02567799|589086542|FG002|Concurrent Chemoradiotherapy|Death|0|||
163104343|NCT02567799|589086540|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
163104344|NCT02567799|589086541|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
163104345|NCT02567799|589086542|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
163104346|NCT02567799|589086540|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
163104347|NCT02567799|589086541|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
163104348|NCT02567799|589086542|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
163104349|NCT02567799|589086540|FG000|Follow-up|Death|1|||
163220754|NCT00489853|589524330|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
163220755|NCT00489853|589524328|FG000|Wash-out Period 2|Adverse Event|1|||
163104350|NCT02567799|589086541|FG001|Follow-up|Death|0|||
163104351|NCT02567799|589086542|FG002|Follow-up|Death|1|||
163104352|NCT02567799|589086540|FG000|Follow-up|Progressive Disease|1|||
163104353|NCT02567799|589086541|FG001|Follow-up|Progressive Disease|1|||
163104354|NCT02567799|589086542|FG002|Follow-up|Progressive Disease|3|||
163104355|NCT00790582|589086563|FG000|Overall Study|Death|14|||
163104356|NCT00790582|589086564|FG001|Overall Study|Death|32|||
163104357|NCT00790582|589086563|FG000|Overall Study|Physician Decision|7|||
163104358|NCT00790582|589086564|FG001|Overall Study|Physician Decision|1|||
163104359|NCT00790582|589086563|FG000|Overall Study|Lost to Follow-up|3|||
163104360|NCT00790582|589086564|FG001|Overall Study|Lost to Follow-up|3|||
163104361|NCT00790582|589086563|FG000|Overall Study|Withdrawal by Subject|7|||
163220756|NCT00489853|589524329|FG001|Wash-out Period 2|Adverse Event|1|||
163407705|NCT00464334|590200890|FG009|Overall Study|Lost to Follow-up|0|||
163104362|NCT00790582|589086564|FG001|Overall Study|Withdrawal by Subject|51|||
163104363|NCT00803595|589086565|FG000|Overall Study|Adverse Event|3|||
163104364|NCT00803595|589086566|FG001|Overall Study|Adverse Event|4|||
163104365|NCT00803595|589086567|FG002|Overall Study|Adverse Event|1|||
163104366|NCT00803595|589086565|FG000|Overall Study|Protocol Violation|7|||
163104367|NCT00803595|589086566|FG001|Overall Study|Protocol Violation|2|||
163220757|NCT00489853|589524330|FG002|Wash-out Period 2|Adverse Event|0|||
163104368|NCT00803595|589086567|FG002|Overall Study|Protocol Violation|12|||
163104369|NCT00803595|589086565|FG000|Overall Study|Withdrawal by Subject|5|||
163104370|NCT00803595|589086566|FG001|Overall Study|Withdrawal by Subject|2|||
163104371|NCT00803595|589086567|FG002|Overall Study|Withdrawal by Subject|3|||
163104372|NCT02566785|589086568|FG000|Overall Study|Lost to Follow-up|0|||
163104373|NCT02566785|589086569|FG001|Overall Study|Lost to Follow-up|2|||
163104374|NCT02566785|589086568|FG000|Overall Study|Worsening condition|1|||
163104375|NCT02566785|589086569|FG001|Overall Study|Worsening condition|1|||
163104376|NCT01597908|589086570|FG000|Randomized Phase|Death|217|||
163104377|NCT01597908|589086571|FG001|Randomized Phase|Death|238|||
163104378|NCT01597908|589086572|FG002|Randomized Phase|Death|0|||
163104379|NCT01597908|589086570|FG000|Randomized Phase|Sponsor Decision|93|||
163104380|NCT01597908|589086571|FG001|Randomized Phase|Sponsor Decision|39|||
163104381|NCT01597908|589086572|FG002|Randomized Phase|Sponsor Decision|0|||
163104382|NCT01597908|589086570|FG000|Randomized Phase|Lost to Follow-up|9|||
163104383|NCT01597908|589086571|FG001|Randomized Phase|Lost to Follow-up|16|||
163104384|NCT01597908|589086572|FG002|Randomized Phase|Lost to Follow-up|0|||
163104385|NCT01597908|589086570|FG000|Randomized Phase|Physician Decision|6|||
163104386|NCT01597908|589086571|FG001|Randomized Phase|Physician Decision|3|||
163104387|NCT01597908|589086572|FG002|Randomized Phase|Physician Decision|0|||
163104388|NCT01597908|589086570|FG000|Randomized Phase|Withdrawal by Subject|26|||
163104389|NCT01597908|589086571|FG001|Randomized Phase|Withdrawal by Subject|22|||
163104390|NCT01597908|589086572|FG002|Randomized Phase|Withdrawal by Subject|0|||
163104391|NCT01597908|589086570|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
163104392|NCT01597908|589086571|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
163104393|NCT01597908|589086572|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
163104394|NCT01597908|589086570|FG000|Crossover Phase|Death|0|||
163104395|NCT01597908|589086571|FG001|Crossover Phase|Death|0|||
163104396|NCT01597908|589086572|FG002|Crossover Phase|Death|11|||
163104397|NCT01597908|589086570|FG000|Crossover Phase|Withdrawal by Subject|0|||
163104398|NCT01597908|589086571|FG001|Crossover Phase|Withdrawal by Subject|0|||
163104399|NCT01597908|589086572|FG002|Crossover Phase|Withdrawal by Subject|3|||
163104400|NCT01597908|589086570|FG000|Crossover Phase|Sponsor Decision|0|||
163104401|NCT01597908|589086571|FG001|Crossover Phase|Sponsor Decision|0|||
163104402|NCT01597908|589086572|FG002|Crossover Phase|Sponsor Decision|20|||
163104403|NCT00451958|589086575|FG000|CS21A (NCT00451958)|Adverse Event|21|||
163104404|NCT00451958|589086576|FG001|CS21A (NCT00451958)|Adverse Event|34|||
163104405|NCT00451958|589086577|FG002|CS21A (NCT00451958)|Adverse Event|14|||
163104406|NCT00451958|589086578|FG003|CS21A (NCT00451958)|Adverse Event|17|||
163104407|NCT00451958|589086579|FG004|CS21A (NCT00451958)|Adverse Event|0|||
163104408|NCT00451958|589086575|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
163104409|NCT00451958|589086576|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
163104410|NCT00451958|589086577|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
163104411|NCT00451958|589086578|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
163104412|NCT00451958|589086579|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
163104413|NCT00451958|589086575|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
163104414|NCT00451958|589086576|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
163104415|NCT00451958|589086577|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
163104416|NCT00451958|589086578|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
163104417|NCT00451958|589086579|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
163104418|NCT00451958|589086575|FG000|CS21A (NCT00451958)|Physician Decision|2|||
163104419|NCT00451958|589086576|FG001|CS21A (NCT00451958)|Physician Decision|4|||
163104420|NCT00451958|589086577|FG002|CS21A (NCT00451958)|Physician Decision|4|||
163104421|NCT00451958|589086578|FG003|CS21A (NCT00451958)|Physician Decision|4|||
163104422|NCT00451958|589086579|FG004|CS21A (NCT00451958)|Physician Decision|0|||
163104423|NCT00451958|589086575|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
163104424|NCT00451958|589086576|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
163104425|NCT00451958|589086577|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
163104426|NCT00451958|589086578|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
163104427|NCT00451958|589086579|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
163104428|NCT00451958|589086575|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
163104429|NCT00451958|589086576|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
163104430|NCT00451958|589086577|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
163104431|NCT00451958|589086578|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
163104432|NCT00451958|589086579|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
163104433|NCT01027650|589086582|FG000|Overall Study|Personal Reasons|0|||
163220758|NCT00489853|589524328|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
163220759|NCT00489853|589524329|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
163104434|NCT01027650|589086583|FG001|Overall Study|Personal Reasons|0|||
163104435|NCT01027650|589086584|FG002|Overall Study|Personal Reasons|0|||
163104436|NCT01027650|589086585|FG003|Overall Study|Personal Reasons|0|||
163104437|NCT01027650|589086586|FG004|Overall Study|Personal Reasons|2|||
163104438|NCT01027650|589086587|FG005|Overall Study|Personal Reasons|1|||
163104439|NCT01027650|589086588|FG006|Overall Study|Personal Reasons|0|||
163104440|NCT01027650|589086589|FG007|Overall Study|Personal Reasons|0|||
163104441|NCT01027650|589086582|FG000|Overall Study|Lost to Follow-up|0|||
163104442|NCT01027650|589086583|FG001|Overall Study|Lost to Follow-up|0|||
163339550|NCT00824850|589951225|FG000|Overall Study|Withdrawal by Subject|0|||
163104443|NCT01027650|589086584|FG002|Overall Study|Lost to Follow-up|0|||
163104444|NCT01027650|589086585|FG003|Overall Study|Lost to Follow-up|0|||
163104445|NCT01027650|589086586|FG004|Overall Study|Lost to Follow-up|0|||
163104446|NCT01027650|589086587|FG005|Overall Study|Lost to Follow-up|0|||
163104447|NCT01027650|589086588|FG006|Overall Study|Lost to Follow-up|1|||
163104448|NCT01027650|589086589|FG007|Overall Study|Lost to Follow-up|0|||
163104449|NCT01027650|589086582|FG000|Overall Study|Lack of Efficacy|0|||
163104450|NCT01027650|589086583|FG001|Overall Study|Lack of Efficacy|0|||
163104451|NCT01027650|589086584|FG002|Overall Study|Lack of Efficacy|0|||
163104452|NCT01027650|589086585|FG003|Overall Study|Lack of Efficacy|0|||
163104453|NCT01027650|589086586|FG004|Overall Study|Lack of Efficacy|0|||
163104454|NCT01027650|589086587|FG005|Overall Study|Lack of Efficacy|1|||
163104455|NCT01027650|589086588|FG006|Overall Study|Lack of Efficacy|0|||
163104456|NCT01027650|589086589|FG007|Overall Study|Lack of Efficacy|0|||
163104457|NCT00670930|589086590|FG000|Overall Study|Adminstrative Problem|0|||
163104458|NCT00670930|589086591|FG001|Overall Study|Adminstrative Problem|1|||
163104459|NCT00670930|589086590|FG000|Overall Study|Lost to Follow-up|1|||
163104460|NCT00670930|589086591|FG001|Overall Study|Lost to Follow-up|0|||
163104461|NCT00782171|589088187|FG000|Overall Study|Lost to Follow-up|2|||
163104462|NCT00782171|589088188|FG001|Overall Study|Lost to Follow-up|2|||
163104463|NCT00782171|589088187|FG000|Overall Study|Withdrawal by Subject|2|||
163104464|NCT00782171|589088188|FG001|Overall Study|Withdrawal by Subject|1|||
163104465|NCT00782171|589088187|FG000|Overall Study|complications|3|||
163104466|NCT00782171|589088188|FG001|Overall Study|complications|1|||
163104467|NCT00782171|589088187|FG000|Overall Study|others|7|||
163104468|NCT00782171|589088188|FG001|Overall Study|others|9|||
163104469|NCT00782171|589088187|FG000|Overall Study|not eligible|8|||
163104470|NCT00782171|589088188|FG001|Overall Study|not eligible|6|||
163104471|NCT05897242|589088191|FG000|Overall Study|Lost to Follow-up|6|||
163104472|NCT05897242|589088192|FG001|Overall Study|Lost to Follow-up|1|||
163104473|NCT05897242|589088191|FG000|Overall Study|Incomplete|1|||
163104474|NCT05897242|589088192|FG001|Overall Study|Incomplete|0|||
163104475|NCT05897242|589088191|FG000|Overall Study|Withdrawal by Subject|1|||
163104476|NCT05897242|589088192|FG001|Overall Study|Withdrawal by Subject|0|||
163104477|NCT03522246|589088193|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
163104478|NCT03522246|589088194|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
163104479|NCT03522246|589088195|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
163104480|NCT03522246|589088196|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
163104481|NCT03522246|589088197|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
163104482|NCT00814580|589088198|FG000|Overall Study|Adverse Event|6|||
163104483|NCT00814580|589088199|FG001|Overall Study|Adverse Event|15|||
163104484|NCT00814580|589088198|FG000|Overall Study|Lack of Efficacy|18|||
163104485|NCT00814580|589088199|FG001|Overall Study|Lack of Efficacy|25|||
163104486|NCT00814580|589088198|FG000|Overall Study|Protocol Violation|2|||
163104487|NCT00814580|589088199|FG001|Overall Study|Protocol Violation|0|||
163104488|NCT00814580|589088198|FG000|Overall Study|Withdrawal by Subject|2|||
163104489|NCT00814580|589088199|FG001|Overall Study|Withdrawal by Subject|2|||
163104490|NCT00814580|589088198|FG000|Overall Study|Other|1|||
163104491|NCT00814580|589088199|FG001|Overall Study|Other|3|||
163104492|NCT00814580|589088198|FG000|Overall Study|Did Not Take Drug|2|||
163104493|NCT00814580|589088199|FG001|Overall Study|Did Not Take Drug|2|||
163104494|NCT02482428|589088200|FG000|Overall Study|Lost to Follow-up|4|||
163104495|NCT02482428|589088201|FG001|Overall Study|Lost to Follow-up|9|||
163104496|NCT02482428|589088202|FG002|Overall Study|Lost to Follow-up|1|||
163104497|NCT02482428|589088203|FG003|Overall Study|Lost to Follow-up|2|||
163104498|NCT02482428|589088204|FG004|Overall Study|Lost to Follow-up|4|||
163104499|NCT02482428|589088200|FG000|Overall Study|Physician Decision|0|||
163104500|NCT02482428|589088201|FG001|Overall Study|Physician Decision|0|||
163220760|NCT00489853|589524330|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
163220761|NCT00489853|589524328|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
163339551|NCT00824850|589951226|FG001|Overall Study|Withdrawal by Subject|1|||
163339552|NCT00882050|589951227|FG000|Overall Study|Physician Decision|1|||
163339553|NCT00882050|589951228|FG001|Overall Study|Physician Decision|0|||
163104501|NCT02482428|589088202|FG002|Overall Study|Physician Decision|0|||
163104502|NCT02482428|589088203|FG003|Overall Study|Physician Decision|0|||
163104503|NCT02482428|589088204|FG004|Overall Study|Physician Decision|1|||
163104504|NCT02482428|589088200|FG000|Overall Study|protocol deviation|1|||
163104505|NCT02482428|589088201|FG001|Overall Study|protocol deviation|1|||
163104506|NCT02482428|589088202|FG002|Overall Study|protocol deviation|0|||
163104507|NCT02482428|589088203|FG003|Overall Study|protocol deviation|0|||
163104508|NCT02482428|589088204|FG004|Overall Study|protocol deviation|0|||
163104509|NCT02482428|589088200|FG000|Overall Study|subject/guardian decision|4|||
163104510|NCT02482428|589088201|FG001|Overall Study|subject/guardian decision|2|||
163104511|NCT02482428|589088202|FG002|Overall Study|subject/guardian decision|0|||
163104512|NCT02482428|589088203|FG003|Overall Study|subject/guardian decision|0|||
163104513|NCT02482428|589088204|FG004|Overall Study|subject/guardian decision|2|||
163104514|NCT00809835|589088207|FG000|Overall Study|Lost to Follow-up|7|||
163104515|NCT00809835|589088208|FG001|Overall Study|Lost to Follow-up|6|||
163104516|NCT00809835|589088209|FG002|Overall Study|Lost to Follow-up|10|||
163104517|NCT00809835|589088210|FG003|Overall Study|Lost to Follow-up|2|||
163104518|NCT00809835|589088207|FG000|Overall Study|Withdrawal by Subject|1|||
163104519|NCT00809835|589088208|FG001|Overall Study|Withdrawal by Subject|1|||
163104520|NCT00809835|589088209|FG002|Overall Study|Withdrawal by Subject|1|||
163104521|NCT00809835|589088210|FG003|Overall Study|Withdrawal by Subject|0|||
163104522|NCT02547038|589088211|FG000|Overall Study|Lost to Follow-up|3|||
163104523|NCT02547038|589088212|FG001|Overall Study|Lost to Follow-up|2|||
163104524|NCT00516893|589088213|FG000|Overall Study|Lost to Follow-up|4|||
163104525|NCT00516893|589088213|FG000|Overall Study|Adverse Event|3|||
163104526|NCT00516893|589088213|FG000|Overall Study|Withdrawal by Subject|2|||
163104527|NCT00516893|589088213|FG000|Overall Study|Noncompliance|2|||
163104528|NCT00516893|589088213|FG000|Overall Study|Death|1|||
163104529|NCT00516893|589088213|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
163104530|NCT00516893|589088213|FG000|Overall Study|Relocated|1|||
163104531|NCT00516893|589088213|FG000|Overall Study|Pregnancy|1|||
163104532|NCT00516893|589088213|FG000|Overall Study|Received Medication From Another Study|1|||
163104533|NCT05160415|589088216|FG000|Overall Study|Withdrawal by Subject|3|||
163104534|NCT00933608|589088217|FG000|Overall Study|Adverse Event|4|||
163104535|NCT00933608|589088218|FG001|Overall Study|Adverse Event|2|||
163104536|NCT00933608|589088217|FG000|Overall Study|Physician Decision|1|||
163104537|NCT00933608|589088218|FG001|Overall Study|Physician Decision|0|||
163104538|NCT01519791|589088224|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
163104539|NCT01519791|589088225|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
163104540|NCT01519791|589088224|FG000|Overall Study|Protocol Violation|6|||
163104541|NCT01519791|589088225|FG001|Overall Study|Protocol Violation|19|||
163104542|NCT01519791|589088224|FG000|Overall Study|Other Reason|87|||
163104543|NCT01519791|589088225|FG001|Overall Study|Other Reason|222|||
163104544|NCT01519791|589088224|FG000|Overall Study|subjects randomized in error|2|||
163104545|NCT01519791|589088225|FG001|Overall Study|subjects randomized in error|0|||
163104546|NCT01519791|589088224|FG000|Overall Study|Lack of Efficacy|16|||
163104547|NCT01519791|589088225|FG001|Overall Study|Lack of Efficacy|20|||
163104548|NCT01519791|589088224|FG000|Overall Study|SAE, non-fatal|6|||
163104549|NCT01519791|589088225|FG001|Overall Study|SAE, non-fatal|22|||
163104550|NCT01519791|589088224|FG000|Overall Study|AE, serious fatal|0|||
163104551|NCT01519791|589088225|FG001|Overall Study|AE, serious fatal|1|||
163104552|NCT01519791|589088224|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
163104553|NCT01519791|589088225|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
163104554|NCT01519791|589088224|FG000|Overall Study|AE, non-serious non-fatal|12|||
163104555|NCT01519791|589088225|FG001|Overall Study|AE, non-serious non-fatal|31|||
163104556|NCT01519791|589088224|FG000|Overall Study|Withdrawal by Subject|15|||
163104557|NCT01519791|589088225|FG001|Overall Study|Withdrawal by Subject|37|||
163104558|NCT01519791|589088224|FG000|Overall Study|Lost to Follow-up|6|||
163104559|NCT01519791|589088225|FG001|Overall Study|Lost to Follow-up|14|||
163104560|NCT00623233|589088226|FG000|Overall Study|Adverse Event|10|||
163104561|NCT00623233|589088226|FG000|Overall Study|Physician Decision|10|||
163104562|NCT00623233|589088226|FG000|Overall Study|Lost to Follow-up|1|||
163104563|NCT00623233|589088226|FG000|Overall Study|Withdrawal by Subject|3|||
163104564|NCT00559845|589088227|FG000|Overall Study|Withdrew Consent|1|||
163104565|NCT00559845|589088227|FG000|Overall Study|Disease Progression|1|||
163104566|NCT00559845|589088227|FG000|Overall Study|Adverse Event|3|||
163104567|NCT00559845|589088227|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
163104568|NCT00559845|589088227|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
163104569|NCT00459875|589088228|FG000|Overall Study|Ineligible participant|1|||
163104570|NCT00459875|589088228|FG000|Overall Study|Adverse Event|2|||
163104571|NCT03645421|589088234|FG000|Overall Study|Adverse Event|0|||
163104572|NCT03645421|589088235|FG001|Overall Study|Adverse Event|0|||
163104573|NCT03645421|589088236|FG002|Overall Study|Adverse Event|4|||
163104574|NCT03645421|589088237|FG003|Overall Study|Adverse Event|1|||
163104575|NCT03645421|589088234|FG000|Overall Study|Withdrawal by patient|0|||
163104576|NCT03645421|589088235|FG001|Overall Study|Withdrawal by patient|0|||
163104577|NCT03645421|589088236|FG002|Overall Study|Withdrawal by patient|0|||
163104578|NCT03645421|589088237|FG003|Overall Study|Withdrawal by patient|3|||
163104579|NCT03645421|589088234|FG000|Overall Study|Study specific withdrawal criteria|0|||
163104580|NCT03645421|589088235|FG001|Overall Study|Study specific withdrawal criteria|0|||
163339554|NCT00882050|589951229|FG002|Overall Study|Physician Decision|0|||
163339555|NCT04820491|589951234|FG000|Overall Study|Withdrawal by Subject|1|||
163104581|NCT03645421|589088236|FG002|Overall Study|Study specific withdrawal criteria|1|||
163104582|NCT03645421|589088237|FG003|Overall Study|Study specific withdrawal criteria|0|||
163220762|NCT00489853|589524329|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
163339556|NCT04820491|589951235|FG001|Overall Study|Withdrawal by Subject|0|||
163104583|NCT02120781|589088238|FG000|Overall Study|Physician Decision|2|||
163339557|NCT00452452|589951236|FG000|Overall Study|Protocol Violation|0|||
163104584|NCT02120781|589088239|FG001|Overall Study|Physician Decision|0|||
163104585|NCT02120781|589088238|FG000|Overall Study|Completion not documented|2|||
163104586|NCT02120781|589088239|FG001|Overall Study|Completion not documented|1|||
163104587|NCT01977729|589088245|FG000|Overall Study|Study terminated|1|||
163220763|NCT00489853|589524330|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
163220764|NCT03265249|589524335|FG000|Overall Study|Withdrawal by Subject|0|||
163220765|NCT03265249|589524336|FG001|Overall Study|Withdrawal by Subject|1|||
163220766|NCT02520011|589524341|FG000|Overall Study|Adverse Event|0|||
163220767|NCT02520011|589524342|FG001|Overall Study|Adverse Event|1|||
163220768|NCT02520011|589524343|FG002|Overall Study|Adverse Event|2|||
163220769|NCT02520011|589524341|FG000|Overall Study|Death|0|||
163220770|NCT02520011|589524342|FG001|Overall Study|Death|8|||
163220771|NCT02520011|589524343|FG002|Overall Study|Death|1|||
163220772|NCT02520011|589524341|FG000|Overall Study|Lack of Efficacy|4|||
163220773|NCT02520011|589524342|FG001|Overall Study|Lack of Efficacy|26|||
163220774|NCT02520011|589524343|FG002|Overall Study|Lack of Efficacy|4|||
163220775|NCT02520011|589524341|FG000|Overall Study|Physician Decision|0|||
163220776|NCT02520011|589524342|FG001|Overall Study|Physician Decision|2|||
163220777|NCT02520011|589524343|FG002|Overall Study|Physician Decision|0|||
163220778|NCT02520011|589524341|FG000|Overall Study|Withdrawal by Subject|1|||
163220779|NCT02520011|589524342|FG001|Overall Study|Withdrawal by Subject|3|||
163220780|NCT02520011|589524343|FG002|Overall Study|Withdrawal by Subject|0|||
163220781|NCT02520011|589524341|FG000|Overall Study|Protocol Deviation|0|||
163220782|NCT02520011|589524342|FG001|Overall Study|Protocol Deviation|1|||
163220783|NCT02520011|589524343|FG002|Overall Study|Protocol Deviation|0|||
163220784|NCT02520011|589524341|FG000|Overall Study|Patient went to hospice|0|||
163220785|NCT02520011|589524342|FG001|Overall Study|Patient went to hospice|1|||
163220786|NCT02520011|589524343|FG002|Overall Study|Patient went to hospice|0|||
163220787|NCT02520011|589524341|FG000|Overall Study|Progressive disease following response|0|||
163220788|NCT02520011|589524342|FG001|Overall Study|Progressive disease following response|4|||
163220789|NCT02520011|589524343|FG002|Overall Study|Progressive disease following response|2|||
163220790|NCT00644969|589524344|FG000|Treatment Phase|Randomized, not treated|1|||
163220791|NCT00644969|589524345|FG001|Treatment Phase|Randomized, not treated|0|||
163220792|NCT00644969|589524344|FG000|Treatment Phase|Adverse Event|3|||
163220793|NCT00644969|589524345|FG001|Treatment Phase|Adverse Event|0|||
163220794|NCT00644969|589524344|FG000|Treatment Phase|Withdrawal by Subject|4|||
163220795|NCT00644969|589524345|FG001|Treatment Phase|Withdrawal by Subject|0|||
163220796|NCT00644969|589524344|FG000|Treatment Phase|Lost to Follow-up|2|||
163220797|NCT00644969|589524345|FG001|Treatment Phase|Lost to Follow-up|2|||
163220798|NCT00644969|589524344|FG000|Treatment Phase|Other|4|||
163220799|NCT00644969|589524345|FG001|Treatment Phase|Other|1|||
163220800|NCT00644969|589524344|FG000|Post Treatment Phase|Death|1|||
163220801|NCT00644969|589524345|FG001|Post Treatment Phase|Death|0|||
163220802|NCT00644969|589524344|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
163220803|NCT00644969|589524345|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
163220804|NCT00644969|589524344|FG000|Post Treatment Phase|Lost to Follow-up|4|||
163220805|NCT00644969|589524345|FG001|Post Treatment Phase|Lost to Follow-up|1|||
163220806|NCT00644969|589524344|FG000|Post Treatment Phase|Other|1|||
163220807|NCT00644969|589524345|FG001|Post Treatment Phase|Other|0|||
163220808|NCT01933048|589524346|FG000|Overall Study|Lost to Follow-up|15|||
163220809|NCT01933048|589524347|FG001|Overall Study|Lost to Follow-up|18|||
163220810|NCT01933048|589524346|FG000|Overall Study|personal reasons|1|||
163220811|NCT01933048|589524347|FG001|Overall Study|personal reasons|1|||
163220812|NCT01933048|589524346|FG000|Overall Study|Protocol Violation|7|||
163220813|NCT01933048|589524347|FG001|Overall Study|Protocol Violation|8|||
163220814|NCT01933048|589524346|FG000|Overall Study|Physician Decision|1|||
163220815|NCT01933048|589524347|FG001|Overall Study|Physician Decision|0|||
163220816|NCT01933048|589524346|FG000|Overall Study|unknown reasons|1|||
163220817|NCT01933048|589524347|FG001|Overall Study|unknown reasons|1|||
163220818|NCT02780804|589524348|FG000|Overall Study|Death|1|||
163220819|NCT02780804|589524349|FG001|Overall Study|Death|0|||
163220820|NCT02780804|589524350|FG002|Overall Study|Death|0|||
163220821|NCT02780804|589524348|FG000|Overall Study|Lack of Efficacy|5|||
163220822|NCT02780804|589524349|FG001|Overall Study|Lack of Efficacy|8|||
163220823|NCT02780804|589524350|FG002|Overall Study|Lack of Efficacy|4|||
163220824|NCT02780804|589524348|FG000|Overall Study|Physician Decision|0|||
163220825|NCT02780804|589524349|FG001|Overall Study|Physician Decision|0|||
163220826|NCT02780804|589524350|FG002|Overall Study|Physician Decision|2|||
163220827|NCT02780804|589524348|FG000|Overall Study|Withdrawal by Subject|0|||
163339558|NCT00452452|589951237|FG001|Overall Study|Protocol Violation|0|||
163220828|NCT02780804|589524349|FG001|Overall Study|Withdrawal by Subject|1|||
163220829|NCT02780804|589524350|FG002|Overall Study|Withdrawal by Subject|0|||
163220830|NCT02476968|589524351|FG000|Overall Study|Other|0|||
163220831|NCT02476968|589524352|FG001|Overall Study|Other|2|||
163220832|NCT02476968|589524353|FG002|Overall Study|Other|0|||
163220833|NCT02476968|589524351|FG000|Overall Study|Lost to Follow-up|10|||
163220834|NCT02476968|589524352|FG001|Overall Study|Lost to Follow-up|0|||
163220835|NCT02476968|589524353|FG002|Overall Study|Lost to Follow-up|1|||
163220836|NCT02476968|589524351|FG000|Overall Study|Death|48|||
163220837|NCT02476968|589524352|FG001|Overall Study|Death|8|||
163220838|NCT02476968|589524353|FG002|Overall Study|Death|1|||
163220839|NCT02476968|589524351|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163220840|NCT02476968|589524352|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
163104588|NCT05332392|589088246|FG000|Overall Study|Did not meet inclusion criteria|25|||
163104589|NCT05332392|589088246|FG000|Overall Study|Principal Investigator's decision|17|||
163104590|NCT05332392|589088246|FG000|Overall Study|Adverse Event|1|||
163104591|NCT05332392|589088246|FG000|Overall Study|Subject's decision|1|||
163104592|NCT01268046|589088247|FG000|Overall Study|Withdrawal by Subject|1|||
163104593|NCT01268046|589088248|FG001|Overall Study|Withdrawal by Subject|0|||
163104594|NCT01268046|589088249|FG002|Overall Study|Withdrawal by Subject|0|||
163104595|NCT01268046|589088250|FG003|Overall Study|Withdrawal by Subject|1|||
163104596|NCT01268046|589088247|FG000|Overall Study|Lost to Follow-up|0|||
163104597|NCT01268046|589088248|FG001|Overall Study|Lost to Follow-up|0|||
163104598|NCT01268046|589088249|FG002|Overall Study|Lost to Follow-up|1|||
163104599|NCT01268046|589088250|FG003|Overall Study|Lost to Follow-up|0|||
163104600|NCT03850093|589088251|FG000|Overall Study|Withdrawal by Subject|1|||
163104601|NCT03850093|589088252|FG001|Overall Study|Withdrawal by Subject|0|||
163104602|NCT03850093|589088253|FG002|Overall Study|Withdrawal by Subject|2|||
163104603|NCT03636893|589088254|FG000|Overall Study|Death|0|||
163104604|NCT03636893|589088255|FG001|Overall Study|Death|1|||
163104605|NCT03636893|589088254|FG000|Overall Study|Protocol Violation|0|||
163104606|NCT03636893|589088255|FG001|Overall Study|Protocol Violation|3|||
163104607|NCT03636893|589088254|FG000|Overall Study|Withdrawal by Subject|1|||
163104608|NCT03636893|589088255|FG001|Overall Study|Withdrawal by Subject|2|||
163104609|NCT03636893|589088254|FG000|Overall Study|Refusal to surgery|4|||
163104610|NCT03636893|589088255|FG001|Overall Study|Refusal to surgery|3|||
163104611|NCT03636893|589088254|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
163104612|NCT03636893|589088255|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
163104613|NCT03636893|589088254|FG000|Overall Study|Adverse Event|1|||
163104614|NCT03636893|589088255|FG001|Overall Study|Adverse Event|1|||
163104615|NCT02314156|589088256|FG000|Overall Study|Adverse Event|1|||
163104616|NCT02314156|589088257|FG001|Overall Study|Adverse Event|0|||
163104617|NCT02314156|589088256|FG000|Overall Study|Withdrawal by Subject|1|||
163104618|NCT02314156|589088257|FG001|Overall Study|Withdrawal by Subject|0|||
163104619|NCT00758069|589088262|FG000|Overall Study|Lack of Efficacy|0|||
163104620|NCT00758069|589088263|FG001|Overall Study|Lack of Efficacy|0|||
163104621|NCT00758069|589088264|FG002|Overall Study|Lack of Efficacy|1|||
163104622|NCT00758069|589088262|FG000|Overall Study|Incorrect Study Drug|1|||
163104623|NCT00758069|589088263|FG001|Overall Study|Incorrect Study Drug|0|||
163104624|NCT00758069|589088264|FG002|Overall Study|Incorrect Study Drug|0|||
163104625|NCT04560816|589088265|FG000|Overall Study|Withdrawal by Subject|1|||
163104626|NCT04560816|589088266|FG001|Overall Study|Withdrawal by Subject|1|||
163104627|NCT04560816|589088267|FG002|Overall Study|Withdrawal by Subject|1|||
163104628|NCT04560816|589088268|FG003|Overall Study|Withdrawal by Subject|0|||
163104629|NCT04560816|589088269|FG004|Overall Study|Withdrawal by Subject|3|||
163104630|NCT04560816|589088270|FG005|Overall Study|Withdrawal by Subject|0|||
163104631|NCT04560816|589088265|FG000|Overall Study|Lost to Follow-up|1|||
163104632|NCT04560816|589088266|FG001|Overall Study|Lost to Follow-up|0|||
163104633|NCT04560816|589088267|FG002|Overall Study|Lost to Follow-up|0|||
163104634|NCT04560816|589088268|FG003|Overall Study|Lost to Follow-up|0|||
163104635|NCT04560816|589088269|FG004|Overall Study|Lost to Follow-up|0|||
163104636|NCT04560816|589088270|FG005|Overall Study|Lost to Follow-up|0|||
163104637|NCT04560816|589088265|FG000|Overall Study|Protocol Violation|1|||
163104638|NCT04560816|589088266|FG001|Overall Study|Protocol Violation|0|||
163104639|NCT04560816|589088267|FG002|Overall Study|Protocol Violation|0|||
163104640|NCT04560816|589088268|FG003|Overall Study|Protocol Violation|0|||
163104641|NCT04560816|589088269|FG004|Overall Study|Protocol Violation|0|||
163104642|NCT04560816|589088270|FG005|Overall Study|Protocol Violation|0|||
163104643|NCT03226249|589088271|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
163104644|NCT03226249|589088271|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
163104645|NCT03226249|589088271|FG000|Survival Follow-up|Patients still in follow-up.|30|||
163104646|NCT02277691|589088272|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
163104647|NCT02277691|589088272|FG000|Overall Study|Voluntary Withdrawal|7|||
163104648|NCT02277691|589088272|FG000|Overall Study|Lack of Efficacy|5|||
163104649|NCT02277691|589088272|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
163104650|NCT02846389|589088275|FG000|Overall Study|Withdrawal by Subject|1|||
163104651|NCT02846389|589088276|FG001|Overall Study|Withdrawal by Subject|1|||
163104652|NCT01804049|589088279|FG000|Overall Study|Adverse Event|2|||
163104653|NCT01804049|589088280|FG001|Overall Study|Adverse Event|10|||
163104654|NCT01804049|589088279|FG000|Overall Study|Lost to Follow-up|2|||
163104655|NCT01804049|589088280|FG001|Overall Study|Lost to Follow-up|1|||
163104656|NCT01804049|589088279|FG000|Overall Study|Decreased interest/personal|4|||
163104657|NCT01804049|589088280|FG001|Overall Study|Decreased interest/personal|5|||
163104658|NCT01804049|589088279|FG000|Overall Study|Other health concerns|2|||
163104659|NCT01804049|589088280|FG001|Overall Study|Other health concerns|7|||
163104660|NCT01804049|589088279|FG000|Overall Study|Moved out of area|0|||
163104661|NCT01804049|589088280|FG001|Overall Study|Moved out of area|7|||
163339559|NCT00452452|589951238|FG002|Overall Study|Protocol Violation|1|||
163339560|NCT00452452|589951236|FG000|Overall Study|Withdrawal by Subject|1|||
163339561|NCT00452452|589951237|FG001|Overall Study|Withdrawal by Subject|0|||
163104662|NCT01804049|589088279|FG000|Overall Study|other MD recommended|1|||
163104663|NCT01804049|589088280|FG001|Overall Study|other MD recommended|1|||
163104664|NCT01804049|589088279|FG000|Overall Study|Enrollment in dual studies|0|||
163104665|NCT01804049|589088280|FG001|Overall Study|Enrollment in dual studies|1|||
163104666|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
163104667|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
163104668|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
163104669|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
163104670|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
163104671|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
163104672|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
163104673|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
163104674|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163104675|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163104676|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163104677|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163104678|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
163104679|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
163104680|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163104681|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163104682|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163104683|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163104684|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
163104685|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
163104686|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
163104687|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
163104688|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
163104689|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
163104690|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163104691|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
163104692|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163104693|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163104694|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163104695|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163104696|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
163104697|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
163104698|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
163104699|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
163104700|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
163104701|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
163104702|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
163104703|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
163104704|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
163104705|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
163104706|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
163104707|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
163104708|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
163104709|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
163104710|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
163104711|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
163104712|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
163104713|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
163104714|NCT03985943|589088281|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
163104715|NCT03985943|589088282|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
163104716|NCT03985943|589088283|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
163104717|NCT03985943|589088284|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
163104718|NCT03985943|589088285|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
163104719|NCT03985943|589088286|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
163104720|NCT03985943|589088281|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
163220841|NCT02476968|589524353|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
163220842|NCT02476968|589524351|FG000|Overall Study|Patient decision|37|||
163220843|NCT02476968|589524352|FG001|Overall Study|Patient decision|8|||
163220844|NCT02476968|589524353|FG002|Overall Study|Patient decision|0|||
163220845|NCT04171414|589524358|FG000|Overall Study|Death|1|||
163220846|NCT04171414|589524358|FG000|Overall Study|Withdrawal by Subject|1|||
163220847|NCT01714310|589524359|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
163220848|NCT01714310|589524360|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
163220849|NCT01714310|589524361|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
163220850|NCT01714310|589524359|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
163220851|NCT01714310|589524360|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
163220852|NCT01714310|589524361|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
163220853|NCT01714310|589524359|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
163220854|NCT01714310|589524360|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
163220855|NCT01714310|589524361|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
163220856|NCT01714310|589524359|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
163220857|NCT01714310|589524360|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
163220858|NCT01714310|589524361|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
163220859|NCT02487394|589524362|FG000|Phase 1|Withdrawal by Subject|0|||
163220860|NCT02487394|589524363|FG001|Phase 1|Withdrawal by Subject|1|||
163220861|NCT00218296|589524366|FG000|Overall Study|Lost to Follow-up|9|||
163220862|NCT00218296|589524367|FG001|Overall Study|Lost to Follow-up|7|||
163220863|NCT00218296|589524366|FG000|Overall Study|Withdrawal by Subject|36|||
163220864|NCT00218296|589524367|FG001|Overall Study|Withdrawal by Subject|47|||
163220865|NCT00218296|589524366|FG000|Overall Study|Randomized but did not enter treatment|66|||
163220866|NCT00218296|589524367|FG001|Overall Study|Randomized but did not enter treatment|67|||
163220867|NCT03161483|589524383|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
163220868|NCT03161483|589524384|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
163220869|NCT03161483|589524385|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
163220870|NCT03161483|589524386|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
163220871|NCT03161483|589524383|FG000|Treatment Period|Death|1|||
163104721|NCT03985943|589088282|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
163104722|NCT03985943|589088283|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
163104723|NCT03985943|589088284|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
163104724|NCT03985943|589088285|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
163104725|NCT03985943|589088286|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
163104726|NCT03985943|589088281|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
163104727|NCT03985943|589088282|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
163104728|NCT03985943|589088283|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
163104729|NCT03985943|589088284|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
163104730|NCT03985943|589088285|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
163104731|NCT03985943|589088286|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
163104732|NCT03985943|589088281|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163220872|NCT03161483|589524384|FG001|Treatment Period|Death|0|||
163220873|NCT03161483|589524385|FG002|Treatment Period|Death|0|||
163220874|NCT03161483|589524386|FG003|Treatment Period|Death|0|||
163220875|NCT03161483|589524383|FG000|Treatment Period|Adverse Event|5|||
163220876|NCT03161483|589524384|FG001|Treatment Period|Adverse Event|2|||
163220877|NCT03161483|589524385|FG002|Treatment Period|Adverse Event|1|||
163220878|NCT03161483|589524386|FG003|Treatment Period|Adverse Event|11|||
163220879|NCT03161483|589524383|FG000|Treatment Period|Pregnancy|1|||
163220880|NCT03161483|589524384|FG001|Treatment Period|Pregnancy|0|||
163220881|NCT03161483|589524385|FG002|Treatment Period|Pregnancy|0|||
163220882|NCT03161483|589524386|FG003|Treatment Period|Pregnancy|0|||
163220883|NCT03161483|589524383|FG000|Treatment Period|Lack of Efficacy|0|||
163220884|NCT03161483|589524384|FG001|Treatment Period|Lack of Efficacy|0|||
163220885|NCT03161483|589524385|FG002|Treatment Period|Lack of Efficacy|0|||
163220886|NCT03161483|589524386|FG003|Treatment Period|Lack of Efficacy|1|||
163220887|NCT03161483|589524383|FG000|Treatment Period|Withdrawal by Subject|2|||
163220888|NCT03161483|589524384|FG001|Treatment Period|Withdrawal by Subject|5|||
163220889|NCT03161483|589524385|FG002|Treatment Period|Withdrawal by Subject|2|||
163220890|NCT03161483|589524386|FG003|Treatment Period|Withdrawal by Subject|6|||
163220891|NCT03161483|589524383|FG000|Treatment Period|Lost to Follow-up|0|||
163339562|NCT00452452|589951238|FG002|Overall Study|Withdrawal by Subject|0|||
163104733|NCT03985943|589088282|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163104734|NCT03985943|589088283|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163104735|NCT03985943|589088284|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
163104736|NCT03985943|589088285|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
163220892|NCT03161483|589524384|FG001|Treatment Period|Lost to Follow-up|0|||
163220893|NCT03161483|589524385|FG002|Treatment Period|Lost to Follow-up|0|||
163220894|NCT03161483|589524386|FG003|Treatment Period|Lost to Follow-up|1|||
163339563|NCT00452452|589951236|FG000|Overall Study|Lost to Follow-up|1|||
163339564|NCT00452452|589951237|FG001|Overall Study|Lost to Follow-up|0|||
163104737|NCT03985943|589088286|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
163220895|NCT03161483|589524383|FG000|Treatment Period|Protocol Violation|0|||
163220896|NCT03161483|589524384|FG001|Treatment Period|Protocol Violation|0|||
163220897|NCT03161483|589524385|FG002|Treatment Period|Protocol Violation|0|||
163104738|NCT03985943|589088281|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
163104739|NCT03985943|589088282|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
163104740|NCT03985943|589088283|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
163104741|NCT03985943|589088284|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
163104742|NCT03985943|589088285|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
163104743|NCT03985943|589088286|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
163104744|NCT03985943|589088281|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
163104745|NCT03985943|589088282|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
163104746|NCT03985943|589088283|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
163104747|NCT03985943|589088284|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
163104748|NCT03985943|589088285|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
163104749|NCT03985943|589088286|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
163104750|NCT03985943|589088281|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
163104751|NCT03985943|589088282|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
163104752|NCT03985943|589088283|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
163104753|NCT03985943|589088284|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
163104754|NCT03985943|589088285|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
163104755|NCT03985943|589088286|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
163104756|NCT04075513|589088289|FG000|Overall Study|Withdrawal by Subject|2|||
163104757|NCT04075513|589088290|FG001|Overall Study|Withdrawal by Subject|2|||
163104758|NCT04075513|589088289|FG000|Overall Study|Lack of Efficacy|1|||
163104759|NCT04075513|589088290|FG001|Overall Study|Lack of Efficacy|0|||
163104760|NCT04075513|589088289|FG000|Overall Study|Lost to Follow-up|4|||
163104761|NCT04075513|589088290|FG001|Overall Study|Lost to Follow-up|2|||
163104762|NCT04075513|589088289|FG000|Overall Study|Switch to insulin pump|1|||
163104763|NCT04075513|589088290|FG001|Overall Study|Switch to insulin pump|0|||
163104764|NCT05730335|589088291|FG000|Overall Study|Lost to Follow-up|8|||
163104765|NCT05730335|589088291|FG000|Overall Study|Withdrawal by Subject|6|||
163104766|NCT03629223|589088292|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
163104767|NCT03629223|589088293|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
163104768|NCT03629223|589088294|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
163104769|NCT03629223|589088295|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
163104770|NCT03629223|589088296|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
163104771|NCT03629223|589088297|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
163104772|NCT03629223|589088292|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
163104773|NCT03629223|589088293|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
163104774|NCT03629223|589088294|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
163104775|NCT03629223|589088295|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
163104776|NCT03629223|589088296|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
163104777|NCT03629223|589088297|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
163104778|NCT03629223|589088292|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
163104779|NCT03629223|589088293|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
163104780|NCT03629223|589088294|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
163104781|NCT03629223|589088295|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
163104782|NCT03629223|589088296|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
163104783|NCT03629223|589088297|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
163104784|NCT03629223|589088292|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
163104785|NCT03629223|589088293|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
163104786|NCT03629223|589088294|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
163104787|NCT03629223|589088295|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
163104788|NCT03629223|589088296|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
163104789|NCT03629223|589088297|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
163104790|NCT03629223|589088292|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
163104791|NCT03629223|589088293|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
163104792|NCT03629223|589088294|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
163104793|NCT03629223|589088295|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
163104794|NCT03629223|589088296|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
163104795|NCT03629223|589088297|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
163104796|NCT01369199|589088300|FG000|Overall Study|Withdrawal by Subject|1|||
163104797|NCT01369199|589088300|FG000|Overall Study|Lost to Follow-up|2|||
163104798|NCT03902392|589088303|FG000|Overall Study|Lost to Follow-up|7|||
163104799|NCT03902392|589088304|FG001|Overall Study|Lost to Follow-up|7|||
163104800|NCT02038946|589088307|FG000|Overall Study|Death|5|||
163104801|NCT02038946|589088307|FG000|Overall Study|Withdrawal by Subject|3|||
163104802|NCT02038946|589088307|FG000|Overall Study|Lost to Follow-up|2|||
163104803|NCT02038946|589088307|FG000|Overall Study|Other reasons|2|||
163104804|NCT00771927|589088310|FG000|Overall Study|Adverse Event|100|||
163104805|NCT00771927|589088311|FG001|Overall Study|Adverse Event|105|||
163104806|NCT00771927|589088310|FG000|Overall Study|Lack of Efficacy|70|||
163407706|NCT00464334|590200891|FG010|Overall Study|Lost to Follow-up|2|||
163104807|NCT00771927|589088311|FG001|Overall Study|Lack of Efficacy|42|||
163104808|NCT00771927|589088310|FG000|Overall Study|Lost to Follow-up|46|||
163104809|NCT00771927|589088311|FG001|Overall Study|Lost to Follow-up|46|||
163104810|NCT00771927|589088310|FG000|Overall Study|Withdrawal by Subject|16|||
163104811|NCT00771927|589088311|FG001|Overall Study|Withdrawal by Subject|17|||
163104812|NCT00771927|589088310|FG000|Overall Study|Other reason|23|||
163104813|NCT00771927|589088311|FG001|Overall Study|Other reason|27|||
163104814|NCT02467192|589088315|FG000|Overall Study|Death|1|||
163104815|NCT02467192|589088315|FG000|Overall Study|revealed to have pneumonia before|2|||
163104816|NCT03213938|589088316|FG000|Overall Study|Lost to Follow-up|4|||
163104817|NCT03213938|589088317|FG001|Overall Study|Lost to Follow-up|3|||
163104818|NCT03213938|589088316|FG000|Overall Study|Lack of Efficacy|1|||
163104819|NCT03213938|589088317|FG001|Overall Study|Lack of Efficacy|0|||
163104820|NCT03213938|589088316|FG000|Overall Study|Decline to participate|5|||
163104821|NCT03213938|589088317|FG001|Overall Study|Decline to participate|4|||
163104822|NCT03213938|589088316|FG000|Overall Study|Without reason|4|||
163104823|NCT03213938|589088317|FG001|Overall Study|Without reason|5|||
163104824|NCT01814046|589088319|FG000|Drug Administration|Death due to complications of RSV|1|||
163104825|NCT01814046|589088320|FG001|Drug Administration|Death due to complications of RSV|0|||
163104826|NCT01814046|589088321|FG002|Drug Administration|Death due to complications of RSV|0|||
163104827|NCT00958347|589088322|FG000|Overall Study|Death|43|||
163104828|NCT00958347|589088322|FG000|Overall Study|Withdrawal by Subject|23|||
163104829|NCT00958347|589088322|FG000|Overall Study|Lost to Follow-up|15|||
163104830|NCT00958347|589088322|FG000|Overall Study|revision/removal|10|||
163104831|NCT00958347|589088322|FG000|Overall Study|study termination|135|||
163104832|NCT04552288|589088323|FG000|Overall Study|Death|3|||
163104833|NCT04552288|589088323|FG000|Overall Study|Lost to Follow-up|6|||
163104834|NCT04552288|589088323|FG000|Overall Study|Physician Decision|3|||
163104835|NCT04552288|589088323|FG000|Overall Study|Protocol Violation|9|||
163104836|NCT04552288|589088323|FG000|Overall Study|Withdrawal by Subject|6|||
163104837|NCT04552288|589088323|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
163104838|NCT00375505|589088324|FG000|Overall Study|Adverse Event|1|||
163104839|NCT00375505|589088325|FG001|Overall Study|Adverse Event|2|||
163104840|NCT00429182|589088326|FG000|Overall Study|Not evaluable, Disease Progression|2|||
163104841|NCT00429182|589088326|FG000|Overall Study|Not eligible|5|||
163104842|NCT03335150|589088329|FG000|Overall Study|Withdrawal by Subject|10|||
163104843|NCT03335150|589088330|FG001|Overall Study|Withdrawal by Subject|4|||
163104844|NCT03335150|589088329|FG000|Overall Study|Adverse Event|0|||
163104845|NCT03335150|589088330|FG001|Overall Study|Adverse Event|1|||
163104846|NCT02218697|589088335|FG000|Overall Study|Adverse Event|0|||
163104847|NCT02218697|589088336|FG001|Overall Study|Adverse Event|2|||
163104848|NCT02218697|589088335|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
163104849|NCT02218697|589088336|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
163104850|NCT02218697|589088335|FG000|Overall Study|Withdrawal by Subject|2|||
163104851|NCT02218697|589088336|FG001|Overall Study|Withdrawal by Subject|3|||
163104852|NCT02142803|589088339|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
163104853|NCT02142803|589088340|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
163104854|NCT02142803|589088341|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
163104855|NCT02142803|589088342|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
163104856|NCT05111002|589088345|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
163104857|NCT05111002|589088346|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
163104858|NCT05111002|589088345|FG000|Secondary Outcome|Lost to Follow-up|1|||
163104859|NCT05111002|589088346|FG001|Secondary Outcome|Lost to Follow-up|0|||
163104860|NCT04380753|589088347|FG000|Overall Study|Participants continuing study|4|||
163104861|NCT04380753|589088347|FG000|Overall Study|Death|2|||
163104862|NCT04776720|589088348|FG000|Overall Study|COVID Related|4|||
163104863|NCT04776720|589088349|FG001|Overall Study|COVID Related|2|||
163104864|NCT04776720|589088348|FG000|Overall Study|Adverse Event|2|||
163104865|NCT04776720|589088349|FG001|Overall Study|Adverse Event|0|||
163104866|NCT04776720|589088348|FG000|Overall Study|Serious Adverse Event|0|||
163104867|NCT04776720|589088349|FG001|Overall Study|Serious Adverse Event|1|||
163104868|NCT04776720|589088348|FG000|Overall Study|Too Busy|3|||
163104869|NCT04776720|589088349|FG001|Overall Study|Too Busy|1|||
163104870|NCT04776720|589088348|FG000|Overall Study|Lost to Follow-up|1|||
163104871|NCT04776720|589088349|FG001|Overall Study|Lost to Follow-up|2|||
163339565|NCT00452452|589951238|FG002|Overall Study|Lost to Follow-up|0|||
163104872|NCT04776720|589088348|FG000|Overall Study|Family|2|||
163104873|NCT04776720|589088349|FG001|Overall Study|Family|2|||
163104874|NCT04776720|589088348|FG000|Overall Study|No remote technology access|0|||
163104875|NCT04776720|589088349|FG001|Overall Study|No remote technology access|1|||
163104876|NCT04776720|589088348|FG000|Overall Study|Withdrawal by Subject|1|||
163104877|NCT04776720|589088349|FG001|Overall Study|Withdrawal by Subject|0|||
163104878|NCT04776720|589088348|FG000|Overall Study|Cannot tolerate intervention|1|||
163104879|NCT04776720|589088349|FG001|Overall Study|Cannot tolerate intervention|0|||
163104880|NCT04776720|589088348|FG000|Overall Study|Incomplete outcome data|6|||
163104881|NCT04776720|589088349|FG001|Overall Study|Incomplete outcome data|1|||
163220898|NCT03161483|589524386|FG003|Treatment Period|Protocol Violation|1|||
163220899|NCT03161483|589524383|FG000|Treatment Period|Other reasons|1|||
163220900|NCT03161483|589524384|FG001|Treatment Period|Other reasons|1|||
163220901|NCT03161483|589524385|FG002|Treatment Period|Other reasons|0|||
163220902|NCT03161483|589524386|FG003|Treatment Period|Other reasons|0|||
163220903|NCT00600756|589524389|FG000|Analysis After 6 Months|Adverse Event|43|||
163220904|NCT00600756|589524390|FG001|Analysis After 6 Months|Adverse Event|33|||
163220905|NCT00600756|589524389|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
163220906|NCT00600756|589524390|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
163220907|NCT00600756|589524389|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
163220908|NCT00600756|589524390|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
163220909|NCT00600756|589524389|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
163220910|NCT00600756|589524390|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
163220911|NCT00600756|589524389|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
163220912|NCT00600756|589524390|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
163220913|NCT00600756|589524389|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
163220914|NCT00600756|589524390|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
163220915|NCT00600756|589524389|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
163220916|NCT00600756|589524390|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
163220917|NCT00600756|589524389|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
163220918|NCT00600756|589524390|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
163220919|NCT00600756|589524389|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
163220920|NCT00600756|589524390|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
163220921|NCT00600756|589524389|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
163220922|NCT00600756|589524390|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
163220923|NCT00600756|589524389|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
163220924|NCT00600756|589524390|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
163220925|NCT00600756|589524389|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
163220926|NCT00600756|589524390|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
163220927|NCT00600756|589524389|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
163220928|NCT00600756|589524390|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
163220929|NCT00600756|589524389|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
163220930|NCT00600756|589524390|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
163220931|NCT04753164|589524391|FG000|Overall Study|Adverse Event|0|||
163220932|NCT04753164|589524392|FG001|Overall Study|Adverse Event|2|||
163220933|NCT04753164|589524391|FG000|Overall Study|Withdrawal by Subject|9|||
163220934|NCT04753164|589524392|FG001|Overall Study|Withdrawal by Subject|7|||
163339566|NCT03072238|589953025|FG000|Overall Study|Withdrawal by Subject|44|||
163339567|NCT03072238|589953026|FG001|Overall Study|Withdrawal by Subject|64|||
163339568|NCT03072238|589953025|FG000|Overall Study|Lost to Follow-up|14|||
163339569|NCT03072238|589953026|FG001|Overall Study|Lost to Follow-up|5|||
163339570|NCT03072238|589953025|FG000|Overall Study|Physician Decision|4|||
163339571|NCT03072238|589953026|FG001|Overall Study|Physician Decision|6|||
163339572|NCT03072238|589953025|FG000|Overall Study|Death|351|||
163339573|NCT03072238|589953026|FG001|Overall Study|Death|318|||
163339574|NCT03072238|589953025|FG000|Overall Study|Progressive Disease|3|||
163339575|NCT03072238|589953026|FG001|Overall Study|Progressive Disease|4|||
163339576|NCT03072238|589953025|FG000|Overall Study|Reason Not Specified|138|||
163339577|NCT03072238|589953026|FG001|Overall Study|Reason Not Specified|150|||
163339578|NCT00608959|589953029|FG000|Part 1|Did not meet eligibility criteria|1|||
163339579|NCT01005602|589953030|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
163339580|NCT01005602|589953031|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
163339581|NCT01919489|589953037|FG000|Overall Study|Rejected the need of injections|4|||
163339582|NCT01919489|589953038|FG001|Overall Study|Rejected the need of injections|7|||
163339583|NCT01919489|589953037|FG000|Overall Study|Adverse Event|10|||
163339584|NCT01919489|589953038|FG001|Overall Study|Adverse Event|0|||
163339585|NCT01919489|589953037|FG000|Overall Study|Hospital readmission|2|||
163339586|NCT01919489|589953038|FG001|Overall Study|Hospital readmission|9|||
163339587|NCT01919489|589953037|FG000|Overall Study|Death|2|||
163339588|NCT01919489|589953038|FG001|Overall Study|Death|1|||
163104882|NCT02311881|589088350|FG000|Overall Study|Did not meet the study criteria|2|||
163104883|NCT02311881|589088351|FG001|Overall Study|Did not meet the study criteria|2|||
163104884|NCT02311881|589088352|FG002|Overall Study|Did not meet the study criteria|0|||
163104885|NCT02311881|589088350|FG000|Overall Study|Adverse Event|7|||
163104886|NCT02311881|589088351|FG001|Overall Study|Adverse Event|15|||
163104887|NCT02311881|589088352|FG002|Overall Study|Adverse Event|8|||
163104888|NCT02311881|589088350|FG000|Overall Study|Lost to Follow-up|3|||
163104889|NCT02311881|589088351|FG001|Overall Study|Lost to Follow-up|3|||
163104890|NCT02311881|589088352|FG002|Overall Study|Lost to Follow-up|2|||
163104891|NCT02311881|589088350|FG000|Overall Study|Protocol Violation|1|||
163104892|NCT02311881|589088351|FG001|Overall Study|Protocol Violation|2|||
163220935|NCT04753164|589524391|FG000|Overall Study|Lost to Follow-up|6|||
163104893|NCT02311881|589088352|FG002|Overall Study|Protocol Violation|3|||
163104894|NCT02311881|589088350|FG000|Overall Study|Withdrawal of consent|14|||
163104895|NCT02311881|589088351|FG001|Overall Study|Withdrawal of consent|16|||
163104896|NCT02311881|589088352|FG002|Overall Study|Withdrawal of consent|17|||
163104897|NCT02311881|589088350|FG000|Overall Study|Other|0|||
163104898|NCT02311881|589088351|FG001|Overall Study|Other|0|||
163104899|NCT02311881|589088352|FG002|Overall Study|Other|1|||
163104900|NCT02311881|589088350|FG000|Overall Study|Lack of Efficacy|1|||
163104901|NCT02311881|589088351|FG001|Overall Study|Lack of Efficacy|2|||
163104902|NCT02311881|589088352|FG002|Overall Study|Lack of Efficacy|0|||
163104903|NCT02311881|589088350|FG000|Overall Study|Subject has border line pregnancy test|1|||
163104904|NCT02311881|589088351|FG001|Overall Study|Subject has border line pregnancy test|0|||
163104905|NCT02311881|589088352|FG002|Overall Study|Subject has border line pregnancy test|0|||
163104906|NCT02311881|589088350|FG000|Overall Study|Withdrawal by Subject|3|||
163104907|NCT02311881|589088351|FG001|Overall Study|Withdrawal by Subject|1|||
163104908|NCT02311881|589088352|FG002|Overall Study|Withdrawal by Subject|4|||
163104909|NCT02311881|589088350|FG000|Overall Study|Sponsor Decision|1|||
163104910|NCT02311881|589088351|FG001|Overall Study|Sponsor Decision|1|||
163104911|NCT02311881|589088352|FG002|Overall Study|Sponsor Decision|1|||
163104912|NCT02311881|589088350|FG000|Overall Study|Protocol Deviation|1|||
163104913|NCT02311881|589088351|FG001|Overall Study|Protocol Deviation|0|||
163104914|NCT02311881|589088352|FG002|Overall Study|Protocol Deviation|0|||
163104915|NCT02311881|589088350|FG000|Overall Study|Non-Compliance|1|||
163104916|NCT02311881|589088351|FG001|Overall Study|Non-Compliance|0|||
163104917|NCT02311881|589088352|FG002|Overall Study|Non-Compliance|2|||
163104918|NCT02311881|589088350|FG000|Overall Study|Physician Decision|0|||
163104919|NCT02311881|589088351|FG001|Overall Study|Physician Decision|0|||
163104920|NCT02311881|589088352|FG002|Overall Study|Physician Decision|1|||
163104921|NCT02311881|589088350|FG000|Overall Study|Medical Monitor Discretion|0|||
163104922|NCT02311881|589088351|FG001|Overall Study|Medical Monitor Discretion|0|||
163104923|NCT02311881|589088352|FG002|Overall Study|Medical Monitor Discretion|1|||
163220936|NCT04753164|589524392|FG001|Overall Study|Lost to Follow-up|6|||
163220937|NCT04753164|589524391|FG000|Overall Study|Other|12|||
163220938|NCT04753164|589524392|FG001|Overall Study|Other|5|||
163220939|NCT00694369|589524393|FG000|Overall Study|Adverse Event|0|||
163220940|NCT00694369|589524394|FG001|Overall Study|Adverse Event|1|||
163220941|NCT00694369|589524395|FG002|Overall Study|Adverse Event|0|||
163220942|NCT00694369|589524396|FG003|Overall Study|Adverse Event|1|||
163220943|NCT00694369|589524397|FG004|Overall Study|Adverse Event|3|||
163220944|NCT00694369|589524393|FG000|Overall Study|Lost to Follow-up|0|||
163220945|NCT00694369|589524394|FG001|Overall Study|Lost to Follow-up|0|||
163339589|NCT01919489|589953037|FG000|Overall Study|Lost to Follow-up|38|||
163339590|NCT01919489|589953038|FG001|Overall Study|Lost to Follow-up|27|||
163339591|NCT03884478|589953039|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
163339592|NCT03884478|589953040|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
163339593|NCT03884478|589953041|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
163339594|NCT03884478|589953039|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
163339595|NCT03884478|589953040|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
163339596|NCT03884478|589953041|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
163339597|NCT03884478|589953039|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
163339598|NCT03884478|589953040|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
163339599|NCT03884478|589953041|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
163339600|NCT03884478|589953039|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
163339601|NCT03884478|589953040|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
163339602|NCT03884478|589953041|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
163339603|NCT00828139|589953042|FG000|Overall Study|Adverse Event|8|||
163339604|NCT00828139|589953043|FG001|Overall Study|Adverse Event|1|||
163339605|NCT00828139|589953044|FG002|Overall Study|Adverse Event|10|||
163339606|NCT00828139|589953045|FG003|Overall Study|Adverse Event|5|||
163339607|NCT00828139|589953042|FG000|Overall Study|Death|2|||
163339608|NCT00828139|589953043|FG001|Overall Study|Death|1|||
163339609|NCT00828139|589953044|FG002|Overall Study|Death|0|||
163339610|NCT00828139|589953045|FG003|Overall Study|Death|2|||
163339611|NCT00828139|589953042|FG000|Overall Study|Refusal unrelated to toxicity|3|||
163339612|NCT00828139|589953043|FG001|Overall Study|Refusal unrelated to toxicity|4|||
163339613|NCT00828139|589953044|FG002|Overall Study|Refusal unrelated to toxicity|5|||
163104924|NCT02311881|589088350|FG000|Overall Study|Participant taking another medication|0|||
163104925|NCT02311881|589088351|FG001|Overall Study|Participant taking another medication|0|||
163104926|NCT02311881|589088352|FG002|Overall Study|Participant taking another medication|1|||
163104927|NCT02311881|589088350|FG000|Overall Study|Serious Adverse Event|0|||
163104928|NCT02311881|589088351|FG001|Overall Study|Serious Adverse Event|1|||
163104929|NCT02311881|589088352|FG002|Overall Study|Serious Adverse Event|0|||
163104930|NCT03306433|589088353|FG000|Overall Study|Lost to Follow-up|3|||
163220946|NCT00694369|589524395|FG002|Overall Study|Lost to Follow-up|1|||
163220947|NCT00694369|589524396|FG003|Overall Study|Lost to Follow-up|1|||
163220948|NCT00694369|589524397|FG004|Overall Study|Lost to Follow-up|0|||
163220949|NCT00694369|589524393|FG000|Overall Study|Physician Decision|0|||
163220950|NCT00694369|589524394|FG001|Overall Study|Physician Decision|0|||
163220951|NCT00694369|589524395|FG002|Overall Study|Physician Decision|0|||
163220952|NCT00694369|589524396|FG003|Overall Study|Physician Decision|0|||
163220953|NCT00694369|589524397|FG004|Overall Study|Physician Decision|1|||
163220954|NCT00694369|589524393|FG000|Overall Study|Protocol Violation|0|||
163220955|NCT00694369|589524394|FG001|Overall Study|Protocol Violation|1|||
163220956|NCT00694369|589524395|FG002|Overall Study|Protocol Violation|0|||
163220957|NCT00694369|589524396|FG003|Overall Study|Protocol Violation|0|||
163220958|NCT00694369|589524397|FG004|Overall Study|Protocol Violation|0|||
163220959|NCT00694369|589524393|FG000|Overall Study|Withdrawal by Subject|1|||
163220960|NCT00694369|589524394|FG001|Overall Study|Withdrawal by Subject|1|||
163220961|NCT00694369|589524395|FG002|Overall Study|Withdrawal by Subject|1|||
163220962|NCT00694369|589524396|FG003|Overall Study|Withdrawal by Subject|1|||
163220963|NCT00694369|589524397|FG004|Overall Study|Withdrawal by Subject|2|||
163220964|NCT00439556|589524398|FG000|Overall Study|Patient was taken off study for non-comp|0|||
163220965|NCT00439556|589524399|FG001|Overall Study|Patient was taken off study for non-comp|1|||
163220966|NCT00439556|589524400|FG002|Overall Study|Patient was taken off study for non-comp|0|||
163220967|NCT02871739|589524401|FG000|Overall Study|Lost to Follow-up|3|||
163220968|NCT02871739|589524402|FG001|Overall Study|Lost to Follow-up|2|||
163220969|NCT02871739|589524403|FG002|Overall Study|Lost to Follow-up|0|||
163220970|NCT02871739|589524404|FG003|Overall Study|Lost to Follow-up|2|||
163220971|NCT01324388|589524407|FG000|Part 1 of Study|Adverse Event|2|||
163220972|NCT01324388|589524408|FG001|Part 1 of Study|Adverse Event|0|||
163220973|NCT01324388|589524409|FG002|Part 1 of Study|Adverse Event|0|||
163220974|NCT01324388|589524410|FG003|Part 1 of Study|Adverse Event|0|||
163220975|NCT01324388|589524407|FG000|Part 1 of Study|Protocol Violation|1|||
163220976|NCT01324388|589524408|FG001|Part 1 of Study|Protocol Violation|2|||
163220977|NCT01324388|589524409|FG002|Part 1 of Study|Protocol Violation|0|||
163220978|NCT01324388|589524410|FG003|Part 1 of Study|Protocol Violation|0|||
163220979|NCT01324388|589524407|FG000|Part 1 of Study|Physician Decision|1|||
163220980|NCT01324388|589524408|FG001|Part 1 of Study|Physician Decision|0|||
163220981|NCT01324388|589524409|FG002|Part 1 of Study|Physician Decision|0|||
163220982|NCT01324388|589524410|FG003|Part 1 of Study|Physician Decision|0|||
163220983|NCT01324388|589524407|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
163220984|NCT01324388|589524408|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
163220985|NCT01324388|589524409|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
163220986|NCT01324388|589524410|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
163220987|NCT01324388|589524407|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
163220988|NCT01324388|589524408|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
163220989|NCT01324388|589524409|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
163220990|NCT01324388|589524410|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
163220991|NCT01405963|589524411|FG000|Overall Study|Moved Away|2|||
163220992|NCT01405963|589524412|FG001|Overall Study|Moved Away|0|||
163220993|NCT01405963|589524411|FG000|Overall Study|Adverse Event|0|||
163220994|NCT01405963|589524412|FG001|Overall Study|Adverse Event|1|||
163220995|NCT01405963|589524411|FG000|Overall Study|Lost to Follow-up|0|||
163220996|NCT01405963|589524412|FG001|Overall Study|Lost to Follow-up|1|||
163220997|NCT00850395|589524419|FG000|Overall Study|Death|1|||
163220998|NCT00850395|589524419|FG000|Overall Study|Adverse Event|1|||
163220999|NCT00850395|589524419|FG000|Overall Study|Insufficient clinical response|3|||
163221000|NCT00850395|589524419|FG000|Overall Study|Other|5|||
163221001|NCT01737047|589524420|FG000|Overall Study|Death|10|||
163221002|NCT01737047|589524421|FG001|Overall Study|Death|0|||
163221003|NCT01737047|589524422|FG002|Overall Study|Death|1|||
163221004|NCT01737047|589524420|FG000|Overall Study|Withdrawal by Subject|17|||
163221005|NCT01737047|589524421|FG001|Overall Study|Withdrawal by Subject|11|||
163221006|NCT01737047|589524422|FG002|Overall Study|Withdrawal by Subject|4|||
163221007|NCT02802592|589524423|FG000|Overall Study|Study terminated due to loss of funding|4|||
163221008|NCT04007523|589524424|FG000|Overall Study|Withdrawal by Subject|0|||
163221009|NCT04007523|589524425|FG001|Overall Study|Withdrawal by Subject|1|||
163221010|NCT04007523|589524426|FG002|Overall Study|Withdrawal by Subject|1|||
163339614|NCT00828139|589953045|FG003|Overall Study|Refusal unrelated to toxicity|3|||
163339615|NCT00828139|589953042|FG000|Overall Study|Disease Progression|24|||
163221011|NCT04007523|589524427|FG003|Overall Study|Withdrawal by Subject|0|||
163221012|NCT04007523|589524424|FG000|Overall Study|ICU Transfer|0|||
163221013|NCT04007523|589524425|FG001|Overall Study|ICU Transfer|1|||
163221014|NCT04007523|589524426|FG002|Overall Study|ICU Transfer|0|||
163221015|NCT04007523|589524427|FG003|Overall Study|ICU Transfer|0|||
163221016|NCT04007523|589524424|FG000|Overall Study|COVID hospital closure|0|||
163221017|NCT04007523|589524425|FG001|Overall Study|COVID hospital closure|0|||
163221018|NCT04007523|589524426|FG002|Overall Study|COVID hospital closure|1|||
163221019|NCT04007523|589524427|FG003|Overall Study|COVID hospital closure|2|||
163221020|NCT04007523|589524424|FG000|Overall Study|Surgery cancelled|0|||
163221021|NCT04007523|589524425|FG001|Overall Study|Surgery cancelled|0|||
163221022|NCT04007523|589524426|FG002|Overall Study|Surgery cancelled|1|||
163104931|NCT03306433|589088353|FG000|Overall Study|Patient did not have teeth extracted|1|||
163104932|NCT03306433|589088353|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
163104933|NCT01042158|589088354|FG000|Overall Study|Physician Decision|1|||
163104934|NCT01575808|589088355|FG000|Overall Study|Death|2|||
163104935|NCT01575808|589088356|FG001|Overall Study|Death|0|||
163104936|NCT01575808|589088355|FG000|Overall Study|Withdrawal by Subject|1|||
163104937|NCT01575808|589088356|FG001|Overall Study|Withdrawal by Subject|0|||
163104938|NCT00875485|589090257|FG000|Challenge Dose Epoch|Pregnancy|1|||
163104939|NCT00875485|589090258|FG001|Challenge Dose Epoch|Pregnancy|0|||
163104940|NCT01271010|589090259|FG000|Overall Study|Reason not specified|11|||
163104941|NCT01271010|589090259|FG000|Overall Study|Start of new CLL therapy|1|||
163104942|NCT01271010|589090259|FG000|Overall Study|Protocol Violation|1|||
163104943|NCT01271010|589090259|FG000|Overall Study|Death|2|||
163104944|NCT01271010|589090259|FG000|Overall Study|Progression and relapse of disease|1|||
163104945|NCT01271010|589090259|FG000|Overall Study|Withdrawal by Subject|18|||
163104946|NCT01271010|589090259|FG000|Overall Study|Disease progression|27|||
163104947|NCT01631747|589090260|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
163104948|NCT01631747|589090261|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
163104949|NCT01631747|589090260|FG000|Live Birth|Pregnancy Termination|1|||
163104950|NCT01631747|589090261|FG001|Live Birth|Pregnancy Termination|0|||
163104951|NCT01631747|589090260|FG000|Live Birth|MIscarriage|2|||
163104952|NCT01631747|589090261|FG001|Live Birth|MIscarriage|0|||
163104953|NCT01631747|589090260|FG000|Live Birth|Stillbirth|1|||
163104954|NCT01631747|589090261|FG001|Live Birth|Stillbirth|1|||
163104955|NCT01631747|589090260|FG000|One Year Infant Outcomes|Patient Refused|13|||
163104956|NCT01631747|589090261|FG001|One Year Infant Outcomes|Patient Refused|9|||
163104957|NCT02908685|589090262|FG000|Part 1 OLE|Withdrawal by Subject|0|||
163104958|NCT02908685|589090263|FG001|Part 1 OLE|Withdrawal by Subject|0|||
163104959|NCT02908685|589090264|FG002|Part 1 OLE|Withdrawal by Subject|0|||
163104960|NCT02908685|589090265|FG003|Part 1 OLE|Withdrawal by Subject|0|||
163104961|NCT02908685|589090266|FG004|Part 1 OLE|Withdrawal by Subject|0|||
163104962|NCT02908685|589090267|FG005|Part 1 OLE|Withdrawal by Subject|0|||
163104963|NCT02908685|589090268|FG006|Part 1 OLE|Withdrawal by Subject|0|||
163104964|NCT02908685|589090269|FG007|Part 1 OLE|Withdrawal by Subject|0|||
163104965|NCT02908685|589090270|FG008|Part 1 OLE|Withdrawal by Subject|0|||
163104966|NCT02908685|589090271|FG009|Part 1 OLE|Withdrawal by Subject|0|||
163104967|NCT02908685|589090272|FG010|Part 1 OLE|Withdrawal by Subject|2|||
163104968|NCT02908685|589090273|FG011|Part 1 OLE|Withdrawal by Subject|1|||
163104969|NCT02908685|589090274|FG012|Part 1 OLE|Withdrawal by Subject|0|||
163104970|NCT02908685|589090275|FG013|Part 1 OLE|Withdrawal by Subject|0|||
163104971|NCT02908685|589090262|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104972|NCT02908685|589090263|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104973|NCT02908685|589090264|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104974|NCT02908685|589090265|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104975|NCT02908685|589090266|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104976|NCT02908685|589090267|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104977|NCT02908685|589090268|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104978|NCT02908685|589090269|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104979|NCT02908685|589090270|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104980|NCT02908685|589090271|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104981|NCT02908685|589090272|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104982|NCT02908685|589090273|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104983|NCT02908685|589090274|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
163104984|NCT02908685|589090275|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
163104985|NCT02908685|589090262|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104986|NCT02908685|589090263|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104987|NCT02908685|589090264|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104988|NCT02908685|589090265|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104989|NCT02908685|589090266|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104990|NCT02908685|589090267|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104991|NCT02908685|589090268|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104992|NCT02908685|589090269|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104993|NCT02908685|589090270|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104994|NCT02908685|589090271|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104995|NCT02908685|589090272|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104996|NCT02908685|589090273|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104997|NCT02908685|589090274|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
163104998|NCT02908685|589090275|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104999|NCT02908685|589090262|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105000|NCT02908685|589090263|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105001|NCT02908685|589090264|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163221023|NCT04007523|589524427|FG003|Overall Study|Surgery cancelled|1|||
163221024|NCT01826487|589524428|FG000|Overall Study|Adverse Event|1|||
163221025|NCT01826487|589524429|FG001|Overall Study|Adverse Event|1|||
163221026|NCT01826487|589524428|FG000|Overall Study|Lost to Follow-up|1|||
163221027|NCT01826487|589524429|FG001|Overall Study|Lost to Follow-up|0|||
163221028|NCT01826487|589524428|FG000|Overall Study|Withdrawal by Subject|1|||
163221029|NCT01826487|589524429|FG001|Overall Study|Withdrawal by Subject|3|||
163221030|NCT01826487|589524428|FG000|Overall Study|Protocol Violation|1|||
163221031|NCT01826487|589524429|FG001|Overall Study|Protocol Violation|1|||
163221032|NCT01408030|589524430|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
163221033|NCT01408030|589524431|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
163105002|NCT02908685|589090265|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105003|NCT02908685|589090266|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105004|NCT02908685|589090267|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105005|NCT02908685|589090268|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105006|NCT02908685|589090269|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105007|NCT02908685|589090270|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105008|NCT02908685|589090271|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105009|NCT02908685|589090272|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105010|NCT02908685|589090273|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105011|NCT02908685|589090274|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
163105012|NCT02908685|589090275|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105013|NCT02908685|589090262|FG000|Part 2 OLE: > Month 24|Death|0|||
163105014|NCT02908685|589090263|FG001|Part 2 OLE: > Month 24|Death|0|||
163105015|NCT02908685|589090264|FG002|Part 2 OLE: > Month 24|Death|0|||
163105016|NCT02908685|589090265|FG003|Part 2 OLE: > Month 24|Death|0|||
163105017|NCT02908685|589090266|FG004|Part 2 OLE: > Month 24|Death|0|||
163105018|NCT02908685|589090267|FG005|Part 2 OLE: > Month 24|Death|0|||
163105019|NCT02908685|589090268|FG006|Part 2 OLE: > Month 24|Death|0|||
163105020|NCT02908685|589090269|FG007|Part 2 OLE: > Month 24|Death|0|||
163105021|NCT02908685|589090270|FG008|Part 2 OLE: > Month 24|Death|0|||
163105022|NCT02908685|589090271|FG009|Part 2 OLE: > Month 24|Death|0|||
163105023|NCT02908685|589090272|FG010|Part 2 OLE: > Month 24|Death|0|||
163105024|NCT02908685|589090273|FG011|Part 2 OLE: > Month 24|Death|0|||
163105025|NCT02908685|589090274|FG012|Part 2 OLE: > Month 24|Death|1|||
163105026|NCT02908685|589090275|FG013|Part 2 OLE: > Month 24|Death|0|||
163105027|NCT02908685|589090262|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
163105028|NCT02908685|589090263|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
163105029|NCT02908685|589090264|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
163105030|NCT02908685|589090265|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
163105031|NCT02908685|589090266|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
163105032|NCT02908685|589090267|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
163105033|NCT02908685|589090268|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
163105034|NCT02908685|589090269|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
163105035|NCT02908685|589090270|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
163105036|NCT02908685|589090271|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
163105037|NCT02908685|589090272|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
163105038|NCT02908685|589090273|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
163105039|NCT02908685|589090274|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
163105040|NCT02908685|589090275|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
163105041|NCT02908685|589090262|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105042|NCT02908685|589090263|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105043|NCT02908685|589090264|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105044|NCT02908685|589090265|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105045|NCT02908685|589090266|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163221034|NCT01408030|589524432|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
163221035|NCT01408030|589524433|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
163221036|NCT01408030|589524430|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
163221037|NCT01408030|589524431|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
163221038|NCT01408030|589524432|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
163221039|NCT01408030|589524433|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
163221040|NCT01408030|589524430|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
163105046|NCT02908685|589090267|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105047|NCT02908685|589090268|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105048|NCT02908685|589090269|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105049|NCT02908685|589090270|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105050|NCT02908685|589090271|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105051|NCT02908685|589090272|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105052|NCT02908685|589090273|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105053|NCT02908685|589090274|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
163221041|NCT01408030|589524431|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
163221042|NCT01408030|589524432|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
163221043|NCT01408030|589524433|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
163105054|NCT02908685|589090275|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
163105055|NCT01691014|589090276|FG000|Overall Study|Premature Termination|1|||
163105056|NCT01691014|589090277|FG001|Overall Study|Premature Termination|6|||
163105057|NCT01691014|589090278|FG002|Overall Study|Premature Termination|0|||
163105058|NCT01691014|589090279|FG003|Overall Study|Premature Termination|3|||
163105059|NCT01691014|589090276|FG000|Overall Study|Other|0|||
163105060|NCT01691014|589090277|FG001|Overall Study|Other|0|||
163105061|NCT01691014|589090278|FG002|Overall Study|Other|2|||
163105062|NCT01691014|589090279|FG003|Overall Study|Other|0|||
163105063|NCT01691014|589090276|FG000|Overall Study|Withdrawal by Subject|0|||
163105064|NCT01691014|589090277|FG001|Overall Study|Withdrawal by Subject|1|||
163105065|NCT01691014|589090278|FG002|Overall Study|Withdrawal by Subject|1|||
163105066|NCT01691014|589090279|FG003|Overall Study|Withdrawal by Subject|1|||
163105067|NCT01691014|589090276|FG000|Overall Study|Adverse Event|0|||
163105068|NCT01691014|589090277|FG001|Overall Study|Adverse Event|5|||
163105069|NCT01691014|589090278|FG002|Overall Study|Adverse Event|1|||
163105070|NCT01691014|589090279|FG003|Overall Study|Adverse Event|1|||
163105071|NCT01691014|589090276|FG000|Overall Study|Lack of Efficacy|2|||
163105072|NCT01691014|589090277|FG001|Overall Study|Lack of Efficacy|3|||
163105073|NCT01691014|589090278|FG002|Overall Study|Lack of Efficacy|7|||
163105074|NCT01691014|589090279|FG003|Overall Study|Lack of Efficacy|0|||
163105075|NCT04308239|589090280|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
163105076|NCT04308239|589090281|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
163105077|NCT04308239|589090280|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
163105078|NCT04308239|589090281|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
163105079|NCT04308239|589090280|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
163105080|NCT04308239|589090281|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
163105081|NCT04308239|589090280|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
163105082|NCT04308239|589090281|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
163105083|NCT05791565|589090284|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
163105084|NCT05791565|589090285|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
163105085|NCT00880269|589090286|FG000|Overall Study|Protocol Violation|1|||
163105086|NCT00880269|589090287|FG001|Overall Study|Protocol Violation|0|||
163105087|NCT00880269|589090286|FG000|Overall Study|Disease Progression|13|||
163105088|NCT00880269|589090287|FG001|Overall Study|Disease Progression|11|||
163105089|NCT00880269|589090286|FG000|Overall Study|New Cancer Therapy|1|||
163105090|NCT00880269|589090287|FG001|Overall Study|New Cancer Therapy|0|||
163105091|NCT00880269|589090286|FG000|Overall Study|Death|4|||
163105092|NCT00880269|589090287|FG001|Overall Study|Death|2|||
163105093|NCT00880269|589090286|FG000|Overall Study|Lost to Follow-up|0|||
163105094|NCT00880269|589090287|FG001|Overall Study|Lost to Follow-up|1|||
163105095|NCT00880269|589090286|FG000|Overall Study|Withdrawal by Subject|3|||
163105096|NCT00880269|589090287|FG001|Overall Study|Withdrawal by Subject|4|||
163105097|NCT00880269|589090286|FG000|Overall Study|Adverse Event|10|||
163105098|NCT00880269|589090287|FG001|Overall Study|Adverse Event|9|||
163105099|NCT02516982|589090288|FG000|Overall Study|Called in to antenatal appointment|32|||
163105100|NCT02516982|589090289|FG001|Overall Study|Called in to antenatal appointment|35|||
163105101|NCT02516982|589090290|FG002|Overall Study|Called in to antenatal appointment|0|||
163105102|NCT02516982|589090291|FG003|Overall Study|Called in to antenatal appointment|0|||
163105103|NCT02516982|589090288|FG000|Overall Study|Withdrawal by Subject|0|||
163105104|NCT02516982|589090289|FG001|Overall Study|Withdrawal by Subject|0|||
163105105|NCT02516982|589090290|FG002|Overall Study|Withdrawal by Subject|1|||
163105106|NCT02516982|589090291|FG003|Overall Study|Withdrawal by Subject|2|||
163105107|NCT02516982|589090288|FG000|Overall Study|Protocol Violation|0|||
163105108|NCT02516982|589090289|FG001|Overall Study|Protocol Violation|0|||
163105109|NCT02516982|589090290|FG002|Overall Study|Protocol Violation|1|||
163105110|NCT02516982|589090291|FG003|Overall Study|Protocol Violation|1|||
163105111|NCT02516982|589090288|FG000|Overall Study|Did not install the app|0|||
163105112|NCT02516982|589090289|FG001|Overall Study|Did not install the app|0|||
163105113|NCT02516982|589090290|FG002|Overall Study|Did not install the app|46|||
163105114|NCT02516982|589090291|FG003|Overall Study|Did not install the app|47|||
163105115|NCT03379259|589090293|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
163339616|NCT00828139|589953043|FG001|Overall Study|Disease Progression|33|||
163339617|NCT00828139|589953044|FG002|Overall Study|Disease Progression|35|||
163339618|NCT00828139|589953045|FG003|Overall Study|Disease Progression|39|||
163339619|NCT00828139|589953042|FG000|Overall Study|Other|4|||
163105116|NCT03379259|589090294|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
163105117|NCT03379259|589090295|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
163105118|NCT03379259|589090296|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
163105119|NCT03379259|589090297|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
163105120|NCT03379259|589090298|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
163105121|NCT03379259|589090293|FG000|Overall Study|Death|0|||
163105122|NCT03379259|589090294|FG001|Overall Study|Death|1|||
163105123|NCT03379259|589090295|FG002|Overall Study|Death|2|||
163339620|NCT00828139|589953043|FG001|Overall Study|Other|2|||
163221044|NCT01408030|589524430|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
163221045|NCT01408030|589524431|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
163221046|NCT01408030|589524432|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
163221047|NCT01408030|589524433|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
163221048|NCT01408030|589524430|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
163221049|NCT01408030|589524431|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
163221050|NCT01408030|589524432|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
163221051|NCT01408030|589524433|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
163221052|NCT01408030|589524430|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
163221053|NCT01408030|589524431|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
163221054|NCT01408030|589524432|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
163221055|NCT01408030|589524433|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
163221056|NCT01408030|589524430|FG000|Observation Phase (Off Drug)|Other|1|||
163221057|NCT01408030|589524431|FG001|Observation Phase (Off Drug)|Other|1|||
163221058|NCT01408030|589524432|FG002|Observation Phase (Off Drug)|Other|1|||
163221059|NCT01408030|589524433|FG003|Observation Phase (Off Drug)|Other|1|||
163221060|NCT03608774|589524435|FG000|Overall Study|Lost to Follow-up|5|||
163221061|NCT03608774|589524436|FG001|Overall Study|Lost to Follow-up|5|||
163221062|NCT03608774|589524435|FG000|Overall Study|Withdrawal by Subject|1|||
163221063|NCT03608774|589524436|FG001|Overall Study|Withdrawal by Subject|0|||
163221064|NCT03608774|589524435|FG000|Overall Study|Protocol Violation|1|||
163221065|NCT03608774|589524436|FG001|Overall Study|Protocol Violation|0|||
163221066|NCT03608774|589524435|FG000|Overall Study|Not eligible at enrollment|0|||
163221067|NCT03608774|589524436|FG001|Overall Study|Not eligible at enrollment|1|||
163221068|NCT03608774|589524435|FG000|Overall Study|Health related event|0|||
163221069|NCT03608774|589524436|FG001|Overall Study|Health related event|1|||
163221070|NCT01586819|589524437|FG000|Overall Study|Withdrawal by Subject|1|||
163221071|NCT01586819|589524438|FG001|Overall Study|Withdrawal by Subject|0|||
163221072|NCT01359254|589524439|FG000|Overall Study|Death|1|||
163221073|NCT01359254|589524440|FG001|Overall Study|Death|0|||
163221074|NCT04837131|589524441|FG000|Overall Study|Death|1|||
163221075|NCT04837131|589524441|FG000|Overall Study|Withdrawal by Subject|1|||
163221076|NCT04837131|589524441|FG000|Overall Study|Adverse Event|1|||
163221077|NCT04837131|589524441|FG000|Overall Study|Protocol Violation|1|||
163221078|NCT04439318|589524442|FG000|Overall Study|Ineligible|1|||
163221079|NCT04439318|589524442|FG000|Overall Study|Never Started Treatment|3|||
163221080|NCT04439318|589524442|FG000|Overall Study|Adverse Event|10|||
163221081|NCT04439318|589524442|FG000|Overall Study|Death|2|||
163221082|NCT04439318|589524442|FG000|Overall Study|Disease Progression|25|||
163221083|NCT04439318|589524442|FG000|Overall Study|Other Complicating Disease|2|||
163221084|NCT04439318|589524442|FG000|Overall Study|Withdrawal by Subject|4|||
163407707|NCT00464334|590200881|FG000|Overall Study|Progressive Disease|0|||
163407708|NCT00464334|590200882|FG001|Overall Study|Progressive Disease|0|||
163407709|NCT00464334|590200883|FG002|Overall Study|Progressive Disease|0|||
163407710|NCT00464334|590200884|FG003|Overall Study|Progressive Disease|0|||
163407711|NCT00464334|590200885|FG004|Overall Study|Progressive Disease|0|||
163407712|NCT00464334|590200886|FG005|Overall Study|Progressive Disease|1|||
163407713|NCT00464334|590200887|FG006|Overall Study|Progressive Disease|0|||
163407714|NCT00464334|590200888|FG007|Overall Study|Progressive Disease|0|||
163407715|NCT00464334|590200889|FG008|Overall Study|Progressive Disease|1|||
163407716|NCT00464334|590200890|FG009|Overall Study|Progressive Disease|0|||
163221085|NCT04439318|589524442|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
163221086|NCT04439318|589524442|FG000|Overall Study|Non-Compliance|1|||
163221087|NCT04439318|589524442|FG000|Overall Study|Still on Treatment|1|||
163221088|NCT03873987|589525885|FG000|Overall Study|Adverse Event|1|||
163221089|NCT03873987|589525886|FG001|Overall Study|Adverse Event|0|||
163221090|NCT03873987|589525885|FG000|Overall Study|staff was unable to start a new IV line|1|||
163221091|NCT03873987|589525886|FG001|Overall Study|staff was unable to start a new IV line|0|||
163221092|NCT03873987|589525885|FG000|Overall Study|Lost to Follow-up|0|||
163221093|NCT03873987|589525886|FG001|Overall Study|Lost to Follow-up|1|||
163221094|NCT01465022|589525887|FG000|Overall Study|Lost to Follow-up|15|||
163407717|NCT00464334|590200891|FG010|Overall Study|Progressive Disease|0|||
163407718|NCT00464334|590200881|FG000|Overall Study|Study Terminated by Sponsor|0|||
163407719|NCT00464334|590200882|FG001|Overall Study|Study Terminated by Sponsor|0|||
163407720|NCT00464334|590200883|FG002|Overall Study|Study Terminated by Sponsor|0|||
163407721|NCT00464334|590200884|FG003|Overall Study|Study Terminated by Sponsor|1|||
163407722|NCT00464334|590200885|FG004|Overall Study|Study Terminated by Sponsor|0|||
163407723|NCT00464334|590200886|FG005|Overall Study|Study Terminated by Sponsor|0|||
163221095|NCT01465022|589525888|FG001|Overall Study|Lost to Follow-up|14|||
163221096|NCT01465022|589525889|FG002|Overall Study|Lost to Follow-up|0|||
163221097|NCT01465022|589525887|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
163221098|NCT01465022|589525888|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
163221099|NCT01465022|589525889|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
163221100|NCT01465022|589525887|FG000|Overall Study|Not Randomized|0|||
163221101|NCT01465022|589525888|FG001|Overall Study|Not Randomized|0|||
163221102|NCT01465022|589525889|FG002|Overall Study|Not Randomized|70|||
163105124|NCT03379259|589090296|FG003|Overall Study|Death|1|||
163105125|NCT03379259|589090297|FG004|Overall Study|Death|4|||
163105126|NCT03379259|589090298|FG005|Overall Study|Death|2|||
163105127|NCT03379259|589090293|FG000|Overall Study|Withdrawal by Subject|0|||
163105128|NCT03379259|589090294|FG001|Overall Study|Withdrawal by Subject|0|||
163105129|NCT03379259|589090295|FG002|Overall Study|Withdrawal by Subject|1|||
163105130|NCT03379259|589090296|FG003|Overall Study|Withdrawal by Subject|0|||
163105131|NCT03379259|589090297|FG004|Overall Study|Withdrawal by Subject|2|||
163105132|NCT03379259|589090298|FG005|Overall Study|Withdrawal by Subject|0|||
163105133|NCT03379259|589090293|FG000|Overall Study|Study terminated by sponsor|0|||
163105134|NCT03379259|589090294|FG001|Overall Study|Study terminated by sponsor|0|||
163105135|NCT03379259|589090295|FG002|Overall Study|Study terminated by sponsor|0|||
163105136|NCT03379259|589090296|FG003|Overall Study|Study terminated by sponsor|1|||
163105137|NCT03379259|589090297|FG004|Overall Study|Study terminated by sponsor|1|||
163105138|NCT03379259|589090298|FG005|Overall Study|Study terminated by sponsor|4|||
163105139|NCT03379259|589090293|FG000|Overall Study|Disease progression|0|||
163105140|NCT03379259|589090294|FG001|Overall Study|Disease progression|0|||
163105141|NCT03379259|589090295|FG002|Overall Study|Disease progression|0|||
163105142|NCT03379259|589090296|FG003|Overall Study|Disease progression|1|||
163105143|NCT03379259|589090297|FG004|Overall Study|Disease progression|0|||
163105144|NCT03379259|589090298|FG005|Overall Study|Disease progression|1|||
163105145|NCT03379259|589090293|FG000|Overall Study|Lost to Follow-up|0|||
163105146|NCT03379259|589090294|FG001|Overall Study|Lost to Follow-up|0|||
163105147|NCT03379259|589090295|FG002|Overall Study|Lost to Follow-up|0|||
163105148|NCT03379259|589090296|FG003|Overall Study|Lost to Follow-up|0|||
163105149|NCT03379259|589090297|FG004|Overall Study|Lost to Follow-up|1|||
163105150|NCT03379259|589090298|FG005|Overall Study|Lost to Follow-up|0|||
163105151|NCT03379259|589090293|FG000|Overall Study|Deteriorating condition|0|||
163105152|NCT03379259|589090294|FG001|Overall Study|Deteriorating condition|0|||
163105153|NCT03379259|589090295|FG002|Overall Study|Deteriorating condition|0|||
163105154|NCT03379259|589090296|FG003|Overall Study|Deteriorating condition|0|||
163105155|NCT03379259|589090297|FG004|Overall Study|Deteriorating condition|1|||
163105156|NCT03379259|589090298|FG005|Overall Study|Deteriorating condition|0|||
163105157|NCT03195660|589090299|FG000|Overall Study|The study was terminated|2|||
163105158|NCT00375427|589090300|FG000|Overall Study|Adverse Event|21|||
163105159|NCT00375427|589090301|FG001|Overall Study|Adverse Event|27|||
163105160|NCT00375427|589090300|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163105161|NCT00375427|589090301|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163105162|NCT00375427|589090300|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163105163|NCT00375427|589090301|FG001|Overall Study|Abnormal laboratory value(s)|2|||
163105164|NCT00375427|589090300|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
163105165|NCT00375427|589090301|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
163105166|NCT00375427|589090300|FG000|Overall Study|Patient no longer requires study drug|3|||
163105167|NCT00375427|589090301|FG001|Overall Study|Patient no longer requires study drug|7|||
163105168|NCT00375427|589090300|FG000|Overall Study|Protocol Violation|10|||
163105169|NCT00375427|589090301|FG001|Overall Study|Protocol Violation|8|||
163105170|NCT00375427|589090300|FG000|Overall Study|Withdrawal by Subject|9|||
163105171|NCT00375427|589090301|FG001|Overall Study|Withdrawal by Subject|13|||
163105172|NCT00375427|589090300|FG000|Overall Study|Lost to Follow-up|1|||
163105173|NCT00375427|589090301|FG001|Overall Study|Lost to Follow-up|1|||
163105174|NCT00375427|589090300|FG000|Overall Study|Administrative reasons|0|||
163105175|NCT00375427|589090301|FG001|Overall Study|Administrative reasons|1|||
163105176|NCT00375427|589090300|FG000|Overall Study|Death|11|||
163105177|NCT00375427|589090301|FG001|Overall Study|Death|10|||
163105178|NCT03818607|589090307|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
163105179|NCT03818607|589090308|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
163105180|NCT03818607|589090307|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
163105181|NCT03818607|589090308|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
163105182|NCT03818607|589090307|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
163105183|NCT03818607|589090308|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
163339621|NCT00828139|589953044|FG002|Overall Study|Other|5|||
163339622|NCT00828139|589953045|FG003|Overall Study|Other|2|||
163339623|NCT04271254|589953046|FG000|Overall Study|Withdrawal by Subject|3|||
163105184|NCT01147250|589090312|FG000|Overall Study|Lost to Follow-up|14|||
163339624|NCT04751929|589953047|FG000|Overall Study|Withdrawal by Subject|2|||
163105185|NCT01147250|589090313|FG001|Overall Study|Lost to Follow-up|11|||
163105186|NCT01147250|589090312|FG000|Overall Study|Withdrawal by Subject|83|||
163105187|NCT01147250|589090313|FG001|Overall Study|Withdrawal by Subject|88|||
163339625|NCT04751929|589953048|FG001|Overall Study|Withdrawal by Subject|0|||
163105188|NCT01147250|589090312|FG000|Overall Study|Site termination by sponsor|13|||
163105189|NCT01147250|589090313|FG001|Overall Study|Site termination by sponsor|5|||
163105190|NCT01147250|589090312|FG000|Overall Study|Other than specified|0|||
163105191|NCT01147250|589090313|FG001|Overall Study|Other than specified|1|||
163105192|NCT02249091|589090315|FG000|Overall Study|Lack of Efficacy|8|||
163105193|NCT02249091|589090316|FG001|Overall Study|Lack of Efficacy|3|||
163339626|NCT04751929|589953049|FG002|Overall Study|Withdrawal by Subject|0|||
163221103|NCT00004888|589525890|FG000|Overall Study|Adverse Event|5|||
163221104|NCT00004888|589525891|FG001|Overall Study|Adverse Event|10|||
163221105|NCT00004888|589525890|FG000|Overall Study|Withdrawal by Subject|0|||
163221106|NCT00004888|589525891|FG001|Overall Study|Withdrawal by Subject|3|||
163221107|NCT00004888|589525890|FG000|Overall Study|Physician Decision|1|||
163221108|NCT00004888|589525891|FG001|Overall Study|Physician Decision|1|||
163221109|NCT00004888|589525890|FG000|Overall Study|Progressive Disease|4|||
163221110|NCT00004888|589525891|FG001|Overall Study|Progressive Disease|9|||
163221111|NCT00004888|589525890|FG000|Overall Study|Death without progressive disease|0|||
163221112|NCT00004888|589525891|FG001|Overall Study|Death without progressive disease|1|||
163221113|NCT00004888|589525890|FG000|Overall Study|Toxic death|1|||
163221114|NCT00004888|589525891|FG001|Overall Study|Toxic death|0|||
163221115|NCT00136084|589525892|FG000|Overall Study|Death|12|||
163221116|NCT00136084|589525893|FG001|Overall Study|Death|5|||
163221117|NCT00136084|589525892|FG000|Overall Study|Unacceptable toxicity|8|||
163221118|NCT00136084|589525893|FG001|Overall Study|Unacceptable toxicity|11|||
163221119|NCT00136084|589525892|FG000|Overall Study|Relapse|20|||
163221120|NCT00136084|589525893|FG001|Overall Study|Relapse|23|||
163221121|NCT00136084|589525892|FG000|Overall Study|Lost to Follow-up|2|||
163221122|NCT00136084|589525893|FG001|Overall Study|Lost to Follow-up|0|||
163221123|NCT00136084|589525892|FG000|Overall Study|No Response|1|||
163221124|NCT00136084|589525893|FG001|Overall Study|No Response|2|||
163221125|NCT00136084|589525892|FG000|Overall Study|Withdrawal by Subject|5|||
163221126|NCT00136084|589525893|FG001|Overall Study|Withdrawal by Subject|1|||
163221127|NCT02579265|589525894|FG000|Overall Study|Weaned off earlier than 28 days|44|||
163221128|NCT02579265|589525895|FG001|Overall Study|Weaned off earlier than 28 days|43|||
163221129|NCT02579265|589525894|FG000|Overall Study|Adverse Event|2|||
163221130|NCT02579265|589525895|FG001|Overall Study|Adverse Event|0|||
163221131|NCT02579265|589525894|FG000|Overall Study|Any other reason not specified|0|||
163221132|NCT02579265|589525895|FG001|Overall Study|Any other reason not specified|2|||
163221133|NCT02579265|589525894|FG000|Overall Study|Withdrawal by Subject|2|||
163221134|NCT02579265|589525895|FG001|Overall Study|Withdrawal by Subject|0|||
163221135|NCT02579265|589525894|FG000|Overall Study|Physician Decision|1|||
163221136|NCT02579265|589525895|FG001|Overall Study|Physician Decision|0|||
163221137|NCT02579265|589525894|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
163221138|NCT02579265|589525895|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
163221139|NCT02174848|589525896|FG000|Overall Study|Adverse Event|2|||
163221140|NCT02174848|589525897|FG001|Overall Study|Adverse Event|1|||
163221141|NCT02174848|589525896|FG000|Overall Study|Withdrawal by Subject|3|||
163221142|NCT02174848|589525897|FG001|Overall Study|Withdrawal by Subject|3|||
163221143|NCT02174848|589525896|FG000|Overall Study|Lost to Follow-up|0|||
163407724|NCT00464334|590200887|FG006|Overall Study|Study Terminated by Sponsor|0|||
163105194|NCT02249091|589090315|FG000|Overall Study|Physician Decision|4|||
163105195|NCT02249091|589090316|FG001|Overall Study|Physician Decision|1|||
163105196|NCT02249091|589090315|FG000|Overall Study|Withdrawal by Subject|2|||
163105197|NCT02249091|589090316|FG001|Overall Study|Withdrawal by Subject|2|||
163105198|NCT02249091|589090315|FG000|Overall Study|Death|3|||
163105199|NCT02249091|589090316|FG001|Overall Study|Death|4|||
163105200|NCT02249091|589090315|FG000|Overall Study|Adverse Event|1|||
163105201|NCT02249091|589090316|FG001|Overall Study|Adverse Event|0|||
163105202|NCT02249091|589090315|FG000|Overall Study|Stable disease with following SCT|0|||
163105203|NCT02249091|589090316|FG001|Overall Study|Stable disease with following SCT|1|||
163105204|NCT02249091|589090315|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
163105205|NCT02249091|589090316|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
163105206|NCT02249091|589090315|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
163105207|NCT02249091|589090316|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
163105208|NCT02249091|589090315|FG000|Overall Study|Refractory AML|1|||
163105209|NCT02249091|589090316|FG001|Overall Study|Refractory AML|1|||
163105210|NCT00716482|589090320|FG000|Overall Study|Lost to Follow-up|6|||
163105211|NCT00716482|589090320|FG000|Overall Study|Inadequate acquisition or analysis|50|||
163105212|NCT00716482|589090320|FG000|Overall Study|no pathology obtained|10|||
163105213|NCT00716482|589090320|FG000|Overall Study|technical/machine error|28|||
163105214|NCT00716482|589090320|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
163105215|NCT03249909|589090321|FG000|Overall Study|Withdrawal by Subject|3|||
163105216|NCT03249909|589090322|FG001|Overall Study|Withdrawal by Subject|0|||
163105217|NCT03249909|589090323|FG002|Overall Study|Withdrawal by Subject|0|||
163105218|NCT03249909|589090321|FG000|Overall Study|Adverse Event|3|||
163105219|NCT03249909|589090322|FG001|Overall Study|Adverse Event|0|||
163105220|NCT03249909|589090323|FG002|Overall Study|Adverse Event|0|||
163221144|NCT02174848|589525897|FG001|Overall Study|Lost to Follow-up|1|||
163221145|NCT02174848|589525896|FG000|Overall Study|Worsening of disease|1|||
163221146|NCT02174848|589525897|FG001|Overall Study|Worsening of disease|1|||
163221147|NCT02174848|589525896|FG000|Overall Study|Unable to comply with study requirements|1|||
163221148|NCT02174848|589525897|FG001|Overall Study|Unable to comply with study requirements|0|||
163221149|NCT00997503|589525903|FG000|Overall Study|Death|53|||
163221150|NCT00997503|589525903|FG000|Overall Study|Withdrawal by Subject|76|||
163105221|NCT03249909|589090321|FG000|Overall Study|Lost to Follow-up|0|||
163105222|NCT03249909|589090322|FG001|Overall Study|Lost to Follow-up|1|||
163105223|NCT03249909|589090323|FG002|Overall Study|Lost to Follow-up|0|||
163105224|NCT03517371|589090324|FG000|Overall Study|Adverse Event|8|||
163105225|NCT03517371|589090325|FG001|Overall Study|Adverse Event|9|||
163105226|NCT03517371|589090324|FG000|Overall Study|Lost to Follow-up|1|||
163105227|NCT03517371|589090325|FG001|Overall Study|Lost to Follow-up|2|||
163105228|NCT03517371|589090324|FG000|Overall Study|Withdrawal by Subject|4|||
163105229|NCT03517371|589090325|FG001|Overall Study|Withdrawal by Subject|4|||
163105230|NCT03517371|589090324|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
163105231|NCT03517371|589090325|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
163105232|NCT03517371|589090324|FG000|Overall Study|COVID restrictions|2|||
163105233|NCT03517371|589090325|FG001|Overall Study|COVID restrictions|0|||
163105234|NCT03517371|589090324|FG000|Overall Study|Receiving DBS Surgery|0|||
163105235|NCT03517371|589090325|FG001|Overall Study|Receiving DBS Surgery|1|||
163105236|NCT05411822|589090326|FG000|Overall Study|Withdrawal by Subject|2|||
163105237|NCT05411822|589090327|FG001|Overall Study|Withdrawal by Subject|1|||
163105238|NCT01345929|589090328|FG000|Overall Study|Withdrawal by Subject|9|||
163105239|NCT01345929|589090329|FG001|Overall Study|Withdrawal by Subject|8|||
163105240|NCT01345929|589090328|FG000|Overall Study|Lost to Follow-up|9|||
163105241|NCT01345929|589090329|FG001|Overall Study|Lost to Follow-up|9|||
163105242|NCT01345929|589090328|FG000|Overall Study|Adverse Event|0|||
163105243|NCT01345929|589090329|FG001|Overall Study|Adverse Event|1|||
163105244|NCT01345929|589090328|FG000|Overall Study|Didn't meet eligibility criteria|2|||
163105245|NCT01345929|589090329|FG001|Overall Study|Didn't meet eligibility criteria|0|||
163105246|NCT01345929|589090328|FG000|Overall Study|40,000 CFU/ML|1|||
163105247|NCT01345929|589090329|FG001|Overall Study|40,000 CFU/ML|0|||
163105248|NCT01345929|589090328|FG000|Overall Study|Patient withdrawal|0|||
163105249|NCT01345929|589090329|FG001|Overall Study|Patient withdrawal|1|||
163105250|NCT02819297|589090330|FG000|Overall Study|Withdrawal by Subject|25|||
163105251|NCT02819297|589090331|FG001|Overall Study|Withdrawal by Subject|13|||
163105252|NCT02819297|589090330|FG000|Overall Study|Lost to Follow-up|12|||
163105253|NCT02819297|589090331|FG001|Overall Study|Lost to Follow-up|14|||
163105254|NCT02819297|589090330|FG000|Overall Study|Adverse Event|12|||
163105255|NCT02819297|589090331|FG001|Overall Study|Adverse Event|10|||
163105256|NCT02819297|589090330|FG000|Overall Study|Physician Decision|5|||
163105257|NCT02819297|589090331|FG001|Overall Study|Physician Decision|5|||
163105258|NCT02819297|589090330|FG000|Overall Study|Lack of Efficacy|5|||
163105259|NCT02819297|589090331|FG001|Overall Study|Lack of Efficacy|8|||
163105260|NCT02819297|589090330|FG000|Overall Study|Protocol Violation|1|||
163105261|NCT02819297|589090331|FG001|Overall Study|Protocol Violation|2|||
163105262|NCT01670279|589090332|FG000|Overall Study|Adverse Event|0|||
163105263|NCT01670279|589090333|FG001|Overall Study|Adverse Event|1|||
163105264|NCT01670279|589090334|FG002|Overall Study|Adverse Event|0|||
163105265|NCT01670279|589090335|FG003|Overall Study|Adverse Event|0|||
163105266|NCT01670279|589090332|FG000|Overall Study|Physician Decision|0|||
163105267|NCT01670279|589090333|FG001|Overall Study|Physician Decision|1|||
163105268|NCT01670279|589090334|FG002|Overall Study|Physician Decision|0|||
163105269|NCT01670279|589090335|FG003|Overall Study|Physician Decision|0|||
163105270|NCT01670279|589090332|FG000|Overall Study|Participant met withdrawal criteria|0|||
163105271|NCT01670279|589090333|FG001|Overall Study|Participant met withdrawal criteria|0|||
163105272|NCT01670279|589090334|FG002|Overall Study|Participant met withdrawal criteria|0|||
163105273|NCT01670279|589090335|FG003|Overall Study|Participant met withdrawal criteria|1|||
163105274|NCT02318368|589090336|FG000|Overall Study|Withdrawal by Subject|2|||
163105275|NCT02318368|589090337|FG001|Overall Study|Withdrawal by Subject|0|||
163105276|NCT02318368|589090336|FG000|Overall Study|Study terminated by the sponsor|5|||
163105277|NCT02318368|589090337|FG001|Overall Study|Study terminated by the sponsor|2|||
163105278|NCT02318368|589090336|FG000|Overall Study|Death|0|||
163105279|NCT02318368|589090337|FG001|Overall Study|Death|1|||
163105280|NCT01901614|589090338|FG000|Overall Study|Adverse Event|0|||
163105281|NCT01901614|589090339|FG001|Overall Study|Adverse Event|1|||
163105282|NCT01901614|589090338|FG000|Overall Study|Lost to Follow-up|1|||
163105283|NCT01901614|589090339|FG001|Overall Study|Lost to Follow-up|0|||
163105284|NCT01901614|589090338|FG000|Overall Study|Screen Fail|1|||
163105285|NCT01901614|589090339|FG001|Overall Study|Screen Fail|0|||
163105286|NCT02702609|589090340|FG000|Overall Study|Lost to Follow-up|8|||
163105287|NCT02702609|589090341|FG001|Overall Study|Lost to Follow-up|4|||
163105288|NCT02702609|589090340|FG000|Overall Study|Physician Decision|1|||
163105289|NCT02702609|589090341|FG001|Overall Study|Physician Decision|0|||
163105290|NCT02674464|589090342|FG000|Overall Study|Death|10|||
163105291|NCT02674464|589090343|FG001|Overall Study|Death|21|||
163105292|NCT02674464|589090342|FG000|Overall Study|Withdrawal by Subject|24|||
163105293|NCT02674464|589090343|FG001|Overall Study|Withdrawal by Subject|44|||
163105294|NCT02674464|589090342|FG000|Overall Study|Lost to Follow-up|97|||
163105295|NCT02674464|589090343|FG001|Overall Study|Lost to Follow-up|92|||
163105296|NCT02674464|589090342|FG000|Overall Study|Outside survey window|6|||
163105297|NCT02674464|589090343|FG001|Overall Study|Outside survey window|3|||
163105298|NCT04153981|589090344|FG000|Overall Study|Death|1|||
163105299|NCT04153981|589090344|FG000|Overall Study|Withdrawal by Subject|24|||
163105300|NCT04153981|589090344|FG000|Overall Study|Lost to Follow-up|1|||
163105301|NCT04153981|589090344|FG000|Overall Study|Physician Decision|1|||
163105302|NCT04153981|589090344|FG000|Overall Study|Due to Unavailable Glucometer|1|||
163105303|NCT04153981|589090344|FG000|Overall Study|Covid 19|52|||
163105304|NCT04153981|589090344|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
163105305|NCT04153981|589090344|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
163105306|NCT01555073|589090345|FG000|Overall Study|Lost to Follow-up|1|||
163105307|NCT01555073|589090346|FG001|Overall Study|Lost to Follow-up|2|||
163105308|NCT01555073|589090347|FG002|Overall Study|Lost to Follow-up|0|||
163105309|NCT01555073|589090348|FG003|Overall Study|Lost to Follow-up|5|||
163105310|NCT01262638|589090349|FG000|Overall Study|Adverse Event|3|||
163105311|NCT01262638|589090350|FG001|Overall Study|Adverse Event|4|||
163105312|NCT01262638|589090351|FG002|Overall Study|Adverse Event|3|||
163105313|NCT01262638|589090352|FG003|Overall Study|Adverse Event|4|||
163105314|NCT01262638|589090349|FG000|Overall Study|Protocol Violation|1|||
163105315|NCT01262638|589090350|FG001|Overall Study|Protocol Violation|0|||
163105316|NCT01262638|589090351|FG002|Overall Study|Protocol Violation|0|||
163105317|NCT01262638|589090352|FG003|Overall Study|Protocol Violation|1|||
163105318|NCT01262638|589090349|FG000|Overall Study|Withdrawal by Subject|2|||
163105319|NCT01262638|589090350|FG001|Overall Study|Withdrawal by Subject|1|||
163105320|NCT01262638|589090351|FG002|Overall Study|Withdrawal by Subject|0|||
163105321|NCT01262638|589090352|FG003|Overall Study|Withdrawal by Subject|1|||
163105322|NCT01262638|589090349|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
163105323|NCT01262638|589090350|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
163105324|NCT01262638|589090351|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
163105325|NCT01262638|589090352|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
163105326|NCT01262638|589090349|FG000|Overall Study|Lost to Follow-up|1|||
163105327|NCT01262638|589090350|FG001|Overall Study|Lost to Follow-up|1|||
163105328|NCT01262638|589090351|FG002|Overall Study|Lost to Follow-up|1|||
163105329|NCT01262638|589090352|FG003|Overall Study|Lost to Follow-up|1|||
163105330|NCT01262638|589090349|FG000|Overall Study|Participant Went Out of Town|0|||
163105331|NCT01262638|589090350|FG001|Overall Study|Participant Went Out of Town|0|||
163105332|NCT01262638|589090351|FG002|Overall Study|Participant Went Out of Town|1|||
163105333|NCT01262638|589090352|FG003|Overall Study|Participant Went Out of Town|0|||
163105334|NCT01071252|589090353|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
163105335|NCT01071252|589090354|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
163105336|NCT01071252|589090355|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
163105337|NCT01071252|589090356|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
163105338|NCT01071252|589090357|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
163105339|NCT01071252|589090353|FG000|Overall Study|Withdrawal by Subject|8|||
163105340|NCT01071252|589090354|FG001|Overall Study|Withdrawal by Subject|2|||
163105341|NCT01071252|589090355|FG002|Overall Study|Withdrawal by Subject|1|||
163105342|NCT01071252|589090356|FG003|Overall Study|Withdrawal by Subject|2|||
163105343|NCT01071252|589090357|FG004|Overall Study|Withdrawal by Subject|3|||
163105344|NCT01071252|589090353|FG000|Overall Study|administrative problems|1|||
163105345|NCT01071252|589090354|FG001|Overall Study|administrative problems|1|||
163105346|NCT01071252|589090355|FG002|Overall Study|administrative problems|0|||
163105347|NCT01071252|589090356|FG003|Overall Study|administrative problems|2|||
163105348|NCT01071252|589090357|FG004|Overall Study|administrative problems|1|||
163105349|NCT01071252|589090353|FG000|Overall Study|Lost to Follow-up|1|||
163105350|NCT01071252|589090354|FG001|Overall Study|Lost to Follow-up|0|||
163105351|NCT01071252|589090355|FG002|Overall Study|Lost to Follow-up|1|||
163105352|NCT01071252|589090356|FG003|Overall Study|Lost to Follow-up|2|||
163105353|NCT01071252|589090357|FG004|Overall Study|Lost to Follow-up|0|||
163105354|NCT01071252|589090353|FG000|Overall Study|Adverse Event|1|||
163105355|NCT01071252|589090354|FG001|Overall Study|Adverse Event|1|||
163105356|NCT01071252|589090355|FG002|Overall Study|Adverse Event|0|||
163105357|NCT01071252|589090356|FG003|Overall Study|Adverse Event|1|||
163105358|NCT01071252|589090357|FG004|Overall Study|Adverse Event|0|||
163105359|NCT01071252|589090353|FG000|Overall Study|Death|0|||
163105360|NCT01071252|589090354|FG001|Overall Study|Death|0|||
163105361|NCT01071252|589090355|FG002|Overall Study|Death|0|||
163105362|NCT01071252|589090356|FG003|Overall Study|Death|0|||
163105363|NCT01071252|589090357|FG004|Overall Study|Death|1|||
163105364|NCT01066104|589090358|FG000|Overall Study|Adverse Event|1|||
163105365|NCT01066104|589090359|FG001|Overall Study|Adverse Event|1|||
163105366|NCT01066104|589090358|FG000|Overall Study|Protocol Violation|1|||
163105367|NCT01066104|589090359|FG001|Overall Study|Protocol Violation|0|||
163105368|NCT00260832|589090362|FG000|Overall Study|Adverse Event|26|||
163105369|NCT00260832|589090363|FG001|Overall Study|Adverse Event|19|||
163105370|NCT00260832|589090362|FG000|Overall Study|Progression|116|||
163105371|NCT00260832|589090363|FG001|Overall Study|Progression|96|||
163105372|NCT00260832|589090362|FG000|Overall Study|Withdrawal by Subject|15|||
163105373|NCT00260832|589090363|FG001|Overall Study|Withdrawal by Subject|17|||
163105374|NCT00260832|589090362|FG000|Overall Study|Physician Decision|15|||
163105375|NCT00260832|589090363|FG001|Overall Study|Physician Decision|9|||
163105376|NCT00260832|589090362|FG000|Overall Study|Death|43|||
163105377|NCT00260832|589090363|FG001|Overall Study|Death|62|||
163105378|NCT00260832|589090362|FG000|Overall Study|Other|10|||
163105379|NCT00260832|589090363|FG001|Overall Study|Other|7|||
163105380|NCT00260832|589090362|FG000|Overall Study|Protocol Violation|3|||
163105381|NCT00260832|589090363|FG001|Overall Study|Protocol Violation|1|||
163105382|NCT01104545|589090364|FG000|Overall Study|Adverse Event|0|||
163105383|NCT01104545|589090365|FG001|Overall Study|Adverse Event|1|||
163105384|NCT01104545|589090366|FG002|Overall Study|Adverse Event|2|||
163105385|NCT00564902|589090367|FG000|Overall Study|Withdrawal by Subject|0|||
163105386|NCT00564902|589090368|FG001|Overall Study|Withdrawal by Subject|3|||
163105387|NCT00564902|589090369|FG002|Overall Study|Withdrawal by Subject|4|||
163105388|NCT00564902|589090367|FG000|Overall Study|Death|1|||
163105389|NCT00564902|589090368|FG001|Overall Study|Death|1|||
163105390|NCT00564902|589090369|FG002|Overall Study|Death|0|||
163105391|NCT04532294|589090372|FG000|Overall Study|Withdrawal by Subject|0|||
163105392|NCT04532294|589090373|FG001|Overall Study|Withdrawal by Subject|0|||
163105393|NCT04532294|589090374|FG002|Overall Study|Withdrawal by Subject|1|||
163105394|NCT04532294|589090372|FG000|Overall Study|Participants Not Dosed|0|||
163105395|NCT04532294|589090373|FG001|Overall Study|Participants Not Dosed|0|||
163105396|NCT04532294|589090374|FG002|Overall Study|Participants Not Dosed|2|||
163105397|NCT03089047|589090375|FG000|Overall Study|Lost to Follow-up|1|||
163105398|NCT03089047|589090376|FG001|Overall Study|Lost to Follow-up|0|||
163105399|NCT02146131|589090377|FG000|Overall Study|Physician Decision|61|||
163105400|NCT02146131|589090378|FG001|Overall Study|Physician Decision|56|||
163105401|NCT02097719|589090379|FG000|Overall Study|Subject Withdrew Consent|1|||
163105402|NCT02097719|589090380|FG001|Overall Study|Subject Withdrew Consent|0|||
163105403|NCT02097719|589090379|FG000|Overall Study|Lost to Follow-up|0|||
163105404|NCT02097719|589090380|FG001|Overall Study|Lost to Follow-up|1|||
163105405|NCT02097719|589090379|FG000|Overall Study|Adverse Event|2|||
163105406|NCT02097719|589090380|FG001|Overall Study|Adverse Event|0|||
163105407|NCT00809926|589090382|FG000|Overall Study|Adverse Event|18|||
163105408|NCT00809926|589090383|FG001|Overall Study|Adverse Event|10|||
163105409|NCT00809926|589090382|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
163105410|NCT00809926|589090383|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
163105411|NCT00809926|589090382|FG000|Overall Study|Patient withdrew consent|8|||
163105412|NCT00809926|589090383|FG001|Overall Study|Patient withdrew consent|6|||
163105413|NCT00809926|589090382|FG000|Overall Study|Lost to Follow-up|2|||
163105414|NCT00809926|589090383|FG001|Overall Study|Lost to Follow-up|1|||
163105415|NCT00809926|589090382|FG000|Overall Study|Administrative Problems|0|||
163105416|NCT00809926|589090383|FG001|Overall Study|Administrative Problems|1|||
163105417|NCT00809926|589090382|FG000|Overall Study|Protocol deviation|0|||
163105418|NCT00809926|589090383|FG001|Overall Study|Protocol deviation|2|||
163105419|NCT01108731|589090390|FG000|Overall Study|Withdrawal by Subject|1|||
163105420|NCT01108731|589090391|FG001|Overall Study|Withdrawal by Subject|1|||
163105421|NCT01108731|589090390|FG000|Overall Study|Adverse Event|3|||
163105422|NCT01108731|589090391|FG001|Overall Study|Adverse Event|3|||
163105423|NCT05356910|589090392|FG000|Overall Study|Lost to Follow-up|10|||
163105424|NCT05356910|589090393|FG001|Overall Study|Lost to Follow-up|19|||
163105425|NCT05356910|589090394|FG002|Overall Study|Lost to Follow-up|0|||
163105426|NCT05356910|589090395|FG003|Overall Study|Lost to Follow-up|0|||
163105427|NCT05356910|589090392|FG000|Overall Study|Withdrawal by Subject|4|||
163105428|NCT05356910|589090393|FG001|Overall Study|Withdrawal by Subject|2|||
163105429|NCT05356910|589090394|FG002|Overall Study|Withdrawal by Subject|0|||
163105430|NCT05356910|589090395|FG003|Overall Study|Withdrawal by Subject|0|||
163105431|NCT02712996|589090399|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
163105432|NCT02712996|589090400|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
163105433|NCT01451749|589090403|FG000|Overall Study|Protocol Violation|14|||
163105434|NCT01451749|589090404|FG001|Overall Study|Protocol Violation|7|||
163339627|NCT04751929|589953050|FG003|Overall Study|Withdrawal by Subject|0|||
163339628|NCT04751929|589953047|FG000|Overall Study|Rising PSA|0|||
163339629|NCT04751929|589953048|FG001|Overall Study|Rising PSA|1|||
163105435|NCT01451749|589090403|FG000|Overall Study|Lost to Follow-up|15|||
163105436|NCT01451749|589090404|FG001|Overall Study|Lost to Follow-up|5|||
163105437|NCT01451749|589090403|FG000|Overall Study|Meet the exclusion criteria,and|1|||
163105438|NCT01451749|589090404|FG001|Overall Study|Meet the exclusion criteria,and|1|||
163105439|NCT01451749|589090403|FG000|Overall Study|Adverse Event|2|||
163105440|NCT01451749|589090404|FG001|Overall Study|Adverse Event|0|||
163105441|NCT01451749|589090403|FG000|Overall Study|Withdrawal by Subject|0|||
163105442|NCT01451749|589090404|FG001|Overall Study|Withdrawal by Subject|1|||
163105443|NCT00972517|589090405|FG000|Overall Study|Adverse Event|0|||
163105444|NCT00972517|589090406|FG001|Overall Study|Adverse Event|0|||
163105445|NCT00972517|589090407|FG002|Overall Study|Adverse Event|0|||
163105446|NCT00972517|589090408|FG003|Overall Study|Adverse Event|1|||
163105447|NCT00972517|589090409|FG004|Overall Study|Adverse Event|0|||
163105448|NCT00972517|589090410|FG005|Overall Study|Adverse Event|0|||
163105449|NCT00972517|589090405|FG000|Overall Study|Withdrawal by Subject|0|||
163105450|NCT00972517|589090406|FG001|Overall Study|Withdrawal by Subject|1|||
163105451|NCT00972517|589090407|FG002|Overall Study|Withdrawal by Subject|0|||
163339630|NCT04751929|589953049|FG002|Overall Study|Rising PSA|0|||
163105452|NCT00972517|589090408|FG003|Overall Study|Withdrawal by Subject|2|||
163105453|NCT00972517|589090409|FG004|Overall Study|Withdrawal by Subject|1|||
163105454|NCT00972517|589090410|FG005|Overall Study|Withdrawal by Subject|0|||
163105455|NCT00819156|589090411|FG000|Overall Study|Adverse Event|1|||
163105456|NCT00819156|589090412|FG001|Overall Study|Adverse Event|4|||
163105457|NCT00819156|589090413|FG002|Overall Study|Adverse Event|2|||
163105458|NCT00819156|589090414|FG003|Overall Study|Adverse Event|1|||
163105459|NCT00819156|589090415|FG004|Overall Study|Adverse Event|2|||
163105460|NCT00819156|589090416|FG005|Overall Study|Adverse Event|3|||
163105461|NCT00819156|589090411|FG000|Overall Study|Withdrawal by Subject|0|||
163105462|NCT00819156|589090412|FG001|Overall Study|Withdrawal by Subject|3|||
163105463|NCT00819156|589090413|FG002|Overall Study|Withdrawal by Subject|2|||
163105464|NCT00819156|589090414|FG003|Overall Study|Withdrawal by Subject|0|||
163105465|NCT00819156|589090415|FG004|Overall Study|Withdrawal by Subject|1|||
163105466|NCT00819156|589090416|FG005|Overall Study|Withdrawal by Subject|0|||
163105467|NCT00819156|589090411|FG000|Overall Study|Protocol Violation|1|||
163105468|NCT00819156|589090412|FG001|Overall Study|Protocol Violation|0|||
163105469|NCT00819156|589090413|FG002|Overall Study|Protocol Violation|1|||
163105470|NCT00819156|589090414|FG003|Overall Study|Protocol Violation|0|||
163105471|NCT00819156|589090415|FG004|Overall Study|Protocol Violation|0|||
163105472|NCT00819156|589090416|FG005|Overall Study|Protocol Violation|1|||
163105473|NCT00819156|589090411|FG000|Overall Study|Lost to Follow-up|0|||
163105474|NCT00819156|589090412|FG001|Overall Study|Lost to Follow-up|1|||
163105475|NCT00819156|589090413|FG002|Overall Study|Lost to Follow-up|0|||
163105476|NCT00819156|589090414|FG003|Overall Study|Lost to Follow-up|0|||
163105477|NCT00819156|589090415|FG004|Overall Study|Lost to Follow-up|0|||
163105478|NCT00819156|589090416|FG005|Overall Study|Lost to Follow-up|2|||
163105479|NCT00819156|589090411|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
163105480|NCT00819156|589090412|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
163105481|NCT00819156|589090413|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
163105482|NCT00819156|589090414|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
163105483|NCT00819156|589090415|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
163105484|NCT00819156|589090416|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
163105485|NCT00819156|589090411|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
163105486|NCT00819156|589090412|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
163105487|NCT00819156|589090413|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
163105488|NCT00819156|589090414|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
163105489|NCT00819156|589090415|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
163105490|NCT00819156|589090416|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
163105491|NCT00819156|589090411|FG000|Overall Study|Prostate-specific antigen progression|0|||
163105492|NCT00819156|589090412|FG001|Overall Study|Prostate-specific antigen progression|0|||
163105493|NCT00819156|589090413|FG002|Overall Study|Prostate-specific antigen progression|0|||
163105494|NCT00819156|589090414|FG003|Overall Study|Prostate-specific antigen progression|0|||
163105495|NCT00819156|589090415|FG004|Overall Study|Prostate-specific antigen progression|1|||
163105496|NCT00819156|589090416|FG005|Overall Study|Prostate-specific antigen progression|0|||
163105497|NCT00984594|589090417|FG000|Overall Study|Lost to Follow-up|1|||
163105498|NCT00984594|589090418|FG001|Overall Study|Lost to Follow-up|0|||
163105499|NCT00984594|589090417|FG000|Overall Study|Withdrawal by Subject|0|||
163105500|NCT00984594|589090418|FG001|Overall Study|Withdrawal by Subject|1|||
163105501|NCT01063062|589090419|FG000|Overall Study|Patient withdrew consent|0|||
163105502|NCT01063062|589090420|FG001|Overall Study|Patient withdrew consent|1|||
163105503|NCT01063062|589090419|FG000|Overall Study|Adverse Event|2|||
163105504|NCT01063062|589090420|FG001|Overall Study|Adverse Event|4|||
163105505|NCT01063062|589090419|FG000|Overall Study|Protocol Violation|5|||
163105506|NCT01063062|589090420|FG001|Overall Study|Protocol Violation|4|||
163105507|NCT01063062|589090419|FG000|Overall Study|Investigator's request|1|||
163105508|NCT01063062|589090420|FG001|Overall Study|Investigator's request|0|||
163105509|NCT01063062|589090419|FG000|Overall Study|Lost to Follow-up|0|||
163105510|NCT01063062|589090420|FG001|Overall Study|Lost to Follow-up|2|||
163105511|NCT01063062|589090419|FG000|Overall Study|Miscellaneous reason|0|||
163105512|NCT01063062|589090420|FG001|Overall Study|Miscellaneous reason|1|||
163105513|NCT00281099|589090423|FG000|Overall Study|Death|46|||
163105514|NCT00281099|589090424|FG001|Overall Study|Death|57|||
163105515|NCT00281099|589090423|FG000|Overall Study|Lost to Follow-up|10|||
163105516|NCT00281099|589090424|FG001|Overall Study|Lost to Follow-up|19|||
163105517|NCT00281099|589090423|FG000|Overall Study|Withdrawal by Subject|65|||
163105518|NCT00281099|589090424|FG001|Overall Study|Withdrawal by Subject|70|||
163105519|NCT00281099|589090423|FG000|Overall Study|Physician Decision|79|||
163105520|NCT00281099|589090424|FG001|Overall Study|Physician Decision|72|||
163105521|NCT00281099|589090423|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
163105522|NCT00281099|589090424|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
163105523|NCT02175277|589090425|FG000|Overall Study|Protocol-specified Criteria|1|||
163105524|NCT01082081|589090426|FG000|Overall Study|Lost to Follow-up|0|||
163105525|NCT01082081|589090427|FG001|Overall Study|Lost to Follow-up|0|||
163105526|NCT01082081|589090428|FG002|Overall Study|Lost to Follow-up|1|||
163105527|NCT01082081|589090426|FG000|Overall Study|Withdrawal by Subject|0|||
163105528|NCT01082081|589090427|FG001|Overall Study|Withdrawal by Subject|0|||
163105529|NCT01082081|589090428|FG002|Overall Study|Withdrawal by Subject|1|||
163105530|NCT01082081|589090426|FG000|Overall Study|Other Reason|0|||
163105531|NCT01082081|589090427|FG001|Overall Study|Other Reason|1|||
163105532|NCT01082081|589090428|FG002|Overall Study|Other Reason|0|||
163105533|NCT03159468|589090429|FG000|Overall Study|Withdrawal by Subject|0|||
163105534|NCT03159468|589090430|FG001|Overall Study|Withdrawal by Subject|0|||
163105535|NCT03159468|589090431|FG002|Overall Study|Withdrawal by Subject|3|||
163105536|NCT03159468|589090432|FG003|Overall Study|Withdrawal by Subject|0|||
163105537|NCT03159468|589090433|FG004|Overall Study|Withdrawal by Subject|0|||
163105538|NCT03159468|589090434|FG005|Overall Study|Withdrawal by Subject|0|||
163105539|NCT02954406|589091982|FG000|Overall Study|Adverse Event|0|||
163105540|NCT02954406|589091983|FG001|Overall Study|Adverse Event|1|||
163105541|NCT02954406|589091984|FG002|Overall Study|Adverse Event|0|||
163105542|NCT02954406|589091985|FG003|Overall Study|Adverse Event|0|||
163105543|NCT02954406|589091986|FG004|Overall Study|Adverse Event|1|||
163105544|NCT02954406|589091987|FG005|Overall Study|Adverse Event|0|||
163105545|NCT02954406|589091988|FG006|Overall Study|Adverse Event|0|||
163105546|NCT02954406|589091989|FG007|Overall Study|Adverse Event|0|||
163105547|NCT02954406|589091990|FG008|Overall Study|Adverse Event|1|||
163105548|NCT02954406|589091991|FG009|Overall Study|Adverse Event|1|||
163105549|NCT02954406|589091992|FG010|Overall Study|Adverse Event|0|||
163105550|NCT02954406|589091982|FG000|Overall Study|Progressive Disease|3|||
163105551|NCT02954406|589091983|FG001|Overall Study|Progressive Disease|4|||
163105552|NCT02954406|589091984|FG002|Overall Study|Progressive Disease|3|||
163105553|NCT02954406|589091985|FG003|Overall Study|Progressive Disease|4|||
163105554|NCT02954406|589091986|FG004|Overall Study|Progressive Disease|3|||
163105555|NCT02954406|589091987|FG005|Overall Study|Progressive Disease|3|||
163105556|NCT02954406|589091988|FG006|Overall Study|Progressive Disease|2|||
163105557|NCT02954406|589091989|FG007|Overall Study|Progressive Disease|2|||
163105558|NCT02954406|589091990|FG008|Overall Study|Progressive Disease|1|||
163105559|NCT02954406|589091991|FG009|Overall Study|Progressive Disease|1|||
163105560|NCT02954406|589091992|FG010|Overall Study|Progressive Disease|0|||
163105561|NCT02954406|589091982|FG000|Overall Study|Symptomatic Deterioration|0|||
163105562|NCT02954406|589091983|FG001|Overall Study|Symptomatic Deterioration|1|||
163105563|NCT02954406|589091984|FG002|Overall Study|Symptomatic Deterioration|0|||
163105564|NCT02954406|589091985|FG003|Overall Study|Symptomatic Deterioration|0|||
163105565|NCT02954406|589091986|FG004|Overall Study|Symptomatic Deterioration|0|||
163105566|NCT02954406|589091987|FG005|Overall Study|Symptomatic Deterioration|0|||
163105567|NCT02954406|589091988|FG006|Overall Study|Symptomatic Deterioration|0|||
163105568|NCT02954406|589091989|FG007|Overall Study|Symptomatic Deterioration|0|||
163105569|NCT02954406|589091990|FG008|Overall Study|Symptomatic Deterioration|0|||
163105570|NCT02954406|589091991|FG009|Overall Study|Symptomatic Deterioration|0|||
163105571|NCT02954406|589091992|FG010|Overall Study|Symptomatic Deterioration|0|||
163105572|NCT02954406|589091982|FG000|Overall Study|Death|0|||
163105573|NCT02954406|589091983|FG001|Overall Study|Death|0|||
163105574|NCT02954406|589091984|FG002|Overall Study|Death|0|||
163105575|NCT02954406|589091985|FG003|Overall Study|Death|0|||
163105576|NCT02954406|589091986|FG004|Overall Study|Death|1|||
163105577|NCT02954406|589091987|FG005|Overall Study|Death|0|||
163105578|NCT02954406|589091988|FG006|Overall Study|Death|0|||
163105579|NCT02954406|589091989|FG007|Overall Study|Death|0|||
163105580|NCT02954406|589091990|FG008|Overall Study|Death|1|||
163105581|NCT02954406|589091991|FG009|Overall Study|Death|1|||
163105582|NCT02954406|589091992|FG010|Overall Study|Death|0|||
163105583|NCT02954406|589091982|FG000|Overall Study|Reason Not Specified|0|||
163105584|NCT02954406|589091983|FG001|Overall Study|Reason Not Specified|0|||
163105585|NCT02954406|589091984|FG002|Overall Study|Reason Not Specified|3|||
163105586|NCT02954406|589091985|FG003|Overall Study|Reason Not Specified|2|||
163105587|NCT02954406|589091986|FG004|Overall Study|Reason Not Specified|2|||
163105588|NCT02954406|589091987|FG005|Overall Study|Reason Not Specified|0|||
163105589|NCT02954406|589091988|FG006|Overall Study|Reason Not Specified|1|||
163105590|NCT02954406|589091989|FG007|Overall Study|Reason Not Specified|0|||
163105591|NCT02954406|589091990|FG008|Overall Study|Reason Not Specified|1|||
163105592|NCT02954406|589091991|FG009|Overall Study|Reason Not Specified|0|||
163105593|NCT02954406|589091992|FG010|Overall Study|Reason Not Specified|0|||
163105594|NCT05924165|589091997|FG000|Overall Study|Physician Decision|2|||
163105595|NCT05924165|589091998|FG001|Overall Study|Physician Decision|3|||
163105596|NCT01681186|589091999|FG000|Washout Period From Second Intervention|Adverse Event|0|||
163105597|NCT01681186|589092000|FG001|Washout Period From Second Intervention|Adverse Event|0|||
163105598|NCT01681186|589092001|FG002|Washout Period From Second Intervention|Adverse Event|0|||
163105599|NCT01681186|589092002|FG003|Washout Period From Second Intervention|Adverse Event|0|||
163105600|NCT01681186|589092003|FG004|Washout Period From Second Intervention|Adverse Event|0|||
163105601|NCT01681186|589092004|FG005|Washout Period From Second Intervention|Adverse Event|0|||
163105602|NCT01681186|589092005|FG006|Washout Period From Second Intervention|Adverse Event|1|||
163105603|NCT01681186|589092006|FG007|Washout Period From Second Intervention|Adverse Event|0|||
163221151|NCT00997503|589525903|FG000|Overall Study|Lost to Follow-up|33|||
163221152|NCT00997503|589525903|FG000|Overall Study|Adverse Event|3|||
163105604|NCT01681186|589091999|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
163105605|NCT01681186|589092000|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
163105606|NCT01681186|589092001|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
163105607|NCT01681186|589092002|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
163105608|NCT01681186|589092003|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
163105609|NCT01681186|589092004|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
163105610|NCT01681186|589092005|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
163105611|NCT01681186|589092006|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
163105612|NCT01681186|589091999|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
163105613|NCT01681186|589092000|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
163105614|NCT01681186|589092001|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
163105615|NCT01681186|589092002|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
163105616|NCT01681186|589092003|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
163105617|NCT01681186|589092004|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
163105618|NCT01681186|589092005|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
163105619|NCT01681186|589092006|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
163105620|NCT01681186|589091999|FG000|Fourth Intervention|Protocol Violation|0|||
163105621|NCT01681186|589092000|FG001|Fourth Intervention|Protocol Violation|0|||
163105622|NCT01681186|589092001|FG002|Fourth Intervention|Protocol Violation|0|||
163105623|NCT01681186|589092002|FG003|Fourth Intervention|Protocol Violation|0|||
163105624|NCT01681186|589092003|FG004|Fourth Intervention|Protocol Violation|0|||
163105625|NCT01681186|589092004|FG005|Fourth Intervention|Protocol Violation|0|||
163105626|NCT01681186|589092005|FG006|Fourth Intervention|Protocol Violation|0|||
163105627|NCT01681186|589092006|FG007|Fourth Intervention|Protocol Violation|1|||
163105628|NCT00606034|589092011|FG000|Overall Study|incarceration|1|||
163105629|NCT01734395|589092012|FG000|Overall Study|Other|65|||
163105630|NCT01734395|589092012|FG000|Overall Study|Lost to Follow-up|287|||
163105631|NCT01734395|589092012|FG000|Overall Study|Lack of Efficacy|5|||
163105632|NCT01734395|589092012|FG000|Overall Study|Adverse Event|40|||
163105633|NCT01734395|589092012|FG000|Overall Study|Withdrawal by Subject|10|||
163105634|NCT01734395|589092012|FG000|Overall Study|Missing the reasons for not completed|3|||
163105635|NCT00765037|589092013|FG000|Overall Study|Lost to Follow-up|5|||
163105636|NCT00765037|589092013|FG000|Overall Study|Adverse Event|1|||
163105637|NCT02125838|589092016|FG000|Overall Study|Lost to Follow-up|4|||
163105638|NCT02125838|589092017|FG001|Overall Study|Lost to Follow-up|4|||
163105639|NCT02565147|589092018|FG000|Overall Study|Withdrawal by Subject|5|||
163105640|NCT02565147|589092019|FG001|Overall Study|Withdrawal by Subject|1|||
163105641|NCT02565147|589092018|FG000|Overall Study|Lost to Follow-up|0|||
163105642|NCT02565147|589092019|FG001|Overall Study|Lost to Follow-up|1|||
163105643|NCT02565147|589092018|FG000|Overall Study|Death|1|||
163105644|NCT02565147|589092019|FG001|Overall Study|Death|1|||
163105645|NCT00787839|589092020|FG000|Overall Study|Failure to have the OGTT was most common|404|||
163105646|NCT00244725|589092028|FG000|Overall Study|Lost to Follow-up|3|||
163105647|NCT00244725|589092029|FG001|Overall Study|Lost to Follow-up|4|||
163105648|NCT00244725|589092030|FG002|Overall Study|Lost to Follow-up|9|||
163105649|NCT00244725|589092031|FG003|Overall Study|Lost to Follow-up|2|||
163105650|NCT00244725|589092028|FG000|Overall Study|Withdrawal by Subject|9|||
163105651|NCT00244725|589092029|FG001|Overall Study|Withdrawal by Subject|7|||
163105652|NCT00244725|589092030|FG002|Overall Study|Withdrawal by Subject|7|||
163105653|NCT00244725|589092031|FG003|Overall Study|Withdrawal by Subject|8|||
163105654|NCT00244725|589092028|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
163105655|NCT00244725|589092029|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
163105656|NCT00244725|589092030|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
163105657|NCT00244725|589092031|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
163105658|NCT00244725|589092028|FG000|Overall Study|Physician Decision|3|||
163105659|NCT00244725|589092029|FG001|Overall Study|Physician Decision|0|||
163105660|NCT00244725|589092030|FG002|Overall Study|Physician Decision|1|||
163105661|NCT00244725|589092031|FG003|Overall Study|Physician Decision|2|||
163105662|NCT00244725|589092028|FG000|Overall Study|Adverse Events|3|||
163105663|NCT00244725|589092029|FG001|Overall Study|Adverse Events|1|||
163105664|NCT00244725|589092030|FG002|Overall Study|Adverse Events|4|||
163105665|NCT00244725|589092031|FG003|Overall Study|Adverse Events|4|||
163105666|NCT00244725|589092028|FG000|Overall Study|Withdrwal by participant|1|||
163105667|NCT00244725|589092029|FG001|Overall Study|Withdrwal by participant|0|||
163105668|NCT00244725|589092030|FG002|Overall Study|Withdrwal by participant|0|||
163105669|NCT00244725|589092031|FG003|Overall Study|Withdrwal by participant|1|||
163105670|NCT00244725|589092028|FG000|Overall Study|Liver function test abnormality|2|||
163105671|NCT00244725|589092029|FG001|Overall Study|Liver function test abnormality|0|||
163105672|NCT00244725|589092030|FG002|Overall Study|Liver function test abnormality|0|||
163105673|NCT00244725|589092031|FG003|Overall Study|Liver function test abnormality|1|||
163105674|NCT00244725|589092028|FG000|Overall Study|Sponsor withdrew the participant|1|||
163105675|NCT00244725|589092029|FG001|Overall Study|Sponsor withdrew the participant|0|||
163105676|NCT00244725|589092030|FG002|Overall Study|Sponsor withdrew the participant|0|||
163105677|NCT00244725|589092031|FG003|Overall Study|Sponsor withdrew the participant|1|||
163105678|NCT00244725|589092028|FG000|Overall Study|Mediciation Error|0|||
163105679|NCT00244725|589092029|FG001|Overall Study|Mediciation Error|1|||
163105680|NCT00244725|589092030|FG002|Overall Study|Mediciation Error|0|||
163105681|NCT00244725|589092031|FG003|Overall Study|Mediciation Error|0|||
163105682|NCT00244725|589092028|FG000|Overall Study|Rehab Refused to allow participantion|0|||
163105683|NCT00244725|589092029|FG001|Overall Study|Rehab Refused to allow participantion|1|||
163105684|NCT00244725|589092030|FG002|Overall Study|Rehab Refused to allow participantion|0|||
163105685|NCT00244725|589092031|FG003|Overall Study|Rehab Refused to allow participantion|0|||
163105686|NCT00244725|589092028|FG000|Overall Study|Headache|0|||
163105687|NCT00244725|589092029|FG001|Overall Study|Headache|1|||
163105688|NCT00244725|589092030|FG002|Overall Study|Headache|0|||
163105689|NCT00244725|589092031|FG003|Overall Study|Headache|0|||
163105690|NCT00244725|589092028|FG000|Overall Study|Received prohibited medication|0|||
163105691|NCT00244725|589092029|FG001|Overall Study|Received prohibited medication|1|||
163105692|NCT00244725|589092030|FG002|Overall Study|Received prohibited medication|0|||
163105693|NCT00244725|589092031|FG003|Overall Study|Received prohibited medication|1|||
163105694|NCT00244725|589092028|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
163105695|NCT00244725|589092029|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
163105696|NCT00244725|589092030|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
163105697|NCT00244725|589092031|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
163105698|NCT00244725|589092028|FG000|Overall Study|Administrative reason|0|||
163105699|NCT00244725|589092029|FG001|Overall Study|Administrative reason|0|||
163105700|NCT00244725|589092030|FG002|Overall Study|Administrative reason|1|||
163105701|NCT00244725|589092031|FG003|Overall Study|Administrative reason|0|||
163105702|NCT00244725|589092028|FG000|Overall Study|Vomit|0|||
163105703|NCT00244725|589092029|FG001|Overall Study|Vomit|0|||
163105704|NCT00244725|589092030|FG002|Overall Study|Vomit|1|||
163105705|NCT00244725|589092031|FG003|Overall Study|Vomit|0|||
163105706|NCT00244725|589092028|FG000|Overall Study|Failed to follow-up|0|||
163105707|NCT00244725|589092029|FG001|Overall Study|Failed to follow-up|0|||
163105708|NCT00244725|589092030|FG002|Overall Study|Failed to follow-up|1|||
163105709|NCT00244725|589092031|FG003|Overall Study|Failed to follow-up|1|||
163105710|NCT04004221|589092036|FG000|Overall Study|Death|89|||
163105711|NCT04004221|589092036|FG000|Overall Study|Withdrawal by Subject|5|||
163105712|NCT04004221|589092036|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
163105713|NCT04004221|589092036|FG000|Overall Study|Sponsor Decision|9|||
163105714|NCT04004221|589092036|FG000|Overall Study|Participant refused to enter LTE|1|||
163105715|NCT03423238|589092037|FG000|Overall Study|Lost to Follow-up|1|||
163105716|NCT03423238|589092038|FG001|Overall Study|Lost to Follow-up|0|||
163105717|NCT03423238|589092037|FG000|Overall Study|Withdrawal by Subject|1|||
163105718|NCT03423238|589092038|FG001|Overall Study|Withdrawal by Subject|0|||
163105719|NCT00506454|589092040|FG000|Overall Study|Withdrawal by Subject|1|||
163105720|NCT00506454|589092041|FG001|Overall Study|Withdrawal by Subject|1|||
163105721|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
163105722|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
163105723|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
163105724|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163105725|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163105726|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163105727|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163105728|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
163105729|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163105730|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163105731|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163105732|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163105733|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163105734|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163105735|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
163105736|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
163105737|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
163105738|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163105739|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163105740|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163105741|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163105742|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
163105743|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
163105744|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163105745|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163105746|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163221153|NCT00997503|589525903|FG000|Overall Study|Physician Decision|10|||
163221154|NCT00997503|589525903|FG000|Overall Study|Missed 12-month follow-up|85|||
163221155|NCT00997503|589525903|FG000|Overall Study|Other reason|13|||
163221156|NCT01641367|589525912|FG000|Cohorts|Death|18|||
163221157|NCT01641367|589525913|FG001|Cohorts|Death|1|||
163221158|NCT01641367|589525914|FG002|Cohorts|Death|2|||
163221159|NCT01641367|589525915|FG003|Cohorts|Death|0|||
163221160|NCT01641367|589525916|FG004|Cohorts|Death|1|||
163221161|NCT01641367|589525917|FG005|Cohorts|Death|1|||
163221162|NCT01641367|589525918|FG006|Cohorts|Death|0|||
163221163|NCT01641367|589525919|FG007|Cohorts|Death|0|||
163221164|NCT01641367|589525912|FG000|Cohorts|Lost to Follow-up|16|||
163221165|NCT01641367|589525913|FG001|Cohorts|Lost to Follow-up|0|||
163221166|NCT01641367|589525914|FG002|Cohorts|Lost to Follow-up|2|||
163221167|NCT01641367|589525915|FG003|Cohorts|Lost to Follow-up|0|||
163221168|NCT01641367|589525916|FG004|Cohorts|Lost to Follow-up|2|||
163221169|NCT01641367|589525917|FG005|Cohorts|Lost to Follow-up|0|||
163221170|NCT01641367|589525918|FG006|Cohorts|Lost to Follow-up|0|||
163221171|NCT01641367|589525919|FG007|Cohorts|Lost to Follow-up|0|||
163221172|NCT01641367|589525912|FG000|Randomized Adherence Intervention|Death|0|||
163221173|NCT01641367|589525913|FG001|Randomized Adherence Intervention|Death|0|||
163221174|NCT01641367|589525914|FG002|Randomized Adherence Intervention|Death|0|||
163221175|NCT01641367|589525915|FG003|Randomized Adherence Intervention|Death|0|||
163221176|NCT01641367|589525916|FG004|Randomized Adherence Intervention|Death|0|||
163221177|NCT01641367|589525917|FG005|Randomized Adherence Intervention|Death|0|||
163221178|NCT01641367|589525918|FG006|Randomized Adherence Intervention|Death|11|||
163221179|NCT01641367|589525919|FG007|Randomized Adherence Intervention|Death|12|||
163221180|NCT01641367|589525912|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
163221181|NCT01641367|589525913|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
163221182|NCT01641367|589525914|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
163221183|NCT01641367|589525915|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
163221184|NCT01641367|589525916|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
163221185|NCT01641367|589525917|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
163221186|NCT01641367|589525918|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
163221187|NCT01641367|589525919|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
163221188|NCT04064294|589525925|FG000|Overall Study|Adverse Event|1|||
163221189|NCT04064294|589525926|FG001|Overall Study|Adverse Event|0|||
163221190|NCT04064294|589525927|FG002|Overall Study|Adverse Event|0|||
163221191|NCT01289847|589525929|FG000|Overall Study|Patient could not comply with visits|1|||
163221192|NCT00006478|589525930|FG000|Overall Study|Vaccine could not be produced|1|||
163221193|NCT00006478|589525930|FG000|Overall Study|Physician Decision|6|||
163221194|NCT00409617|589525940|FG000|Overall Study|Adverse Event|57|||
163221195|NCT00409617|589525940|FG000|Overall Study|Lack of Efficacy|54|||
163221196|NCT00409617|589525940|FG000|Overall Study|Lost to Follow-up|2|||
163221197|NCT00409617|589525940|FG000|Overall Study|Protocol Violation|24|||
163221198|NCT00409617|589525940|FG000|Overall Study|Withdrawal by Subject|8|||
163221199|NCT00409617|589525940|FG000|Overall Study|Administrative reasons|1|||
163221200|NCT00409617|589525940|FG000|Overall Study|Not described|14|||
163221201|NCT02159521|589525941|FG000|Overall Study|Enrolled but not treated|3|||
163221202|NCT02159521|589525941|FG000|Overall Study|Withdrawal by Subject|7|||
163221203|NCT02159521|589525941|FG000|Overall Study|Lost to Follow-up|6|||
163221204|NCT02159521|589525941|FG000|Overall Study|Death|1|||
163221205|NCT02159521|589525941|FG000|Overall Study|Other than specified|1|||
163221206|NCT00907374|589525944|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
163221207|NCT00907374|589525945|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
163221208|NCT03818516|589525946|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
163221209|NCT01524692|589525950|FG000|Overall Study|Withdrawal by Subject|3|||
163221210|NCT01709695|589525951|FG000|Overall Study|Withdrawal by Subject|1|||
163105747|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163105748|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163105749|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
163105750|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
163105751|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
163105752|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
163105753|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
163221211|NCT01709695|589525952|FG001|Overall Study|Withdrawal by Subject|1|||
163221212|NCT03065244|589525955|FG000|Overall Study|Lost to Follow-up|1|||
163221213|NCT03065244|589525956|FG001|Overall Study|Lost to Follow-up|1|||
163221214|NCT03065244|589525955|FG000|Overall Study|Diagnosed with a different disease|1|||
163221215|NCT03065244|589525956|FG001|Overall Study|Diagnosed with a different disease|1|||
163221216|NCT03065244|589525955|FG000|Overall Study|Protocol Violation|0|||
163221217|NCT03065244|589525956|FG001|Overall Study|Protocol Violation|1|||
163221218|NCT03065244|589525955|FG000|Overall Study|Withdrawal by Subject|1|||
163221219|NCT03065244|589525956|FG001|Overall Study|Withdrawal by Subject|1|||
163221220|NCT01894152|589525957|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
163221221|NCT02965703|589525962|FG000|Overall Study|Withdrawal by Subject|6|||
163221222|NCT02965703|589525963|FG001|Overall Study|Withdrawal by Subject|3|||
163221223|NCT02965703|589525964|FG002|Overall Study|Withdrawal by Subject|1|||
163221224|NCT02965703|589525962|FG000|Overall Study|Protocol Violation|1|||
163221225|NCT02965703|589525963|FG001|Overall Study|Protocol Violation|0|||
163221226|NCT02965703|589525964|FG002|Overall Study|Protocol Violation|0|||
163221227|NCT02965703|589525962|FG000|Overall Study|Adverse Event|1|||
163221228|NCT02965703|589525963|FG001|Overall Study|Adverse Event|1|||
163221229|NCT02965703|589525964|FG002|Overall Study|Adverse Event|0|||
163221230|NCT02965703|589525962|FG000|Overall Study|Lost to Follow-up|2|||
163221231|NCT02965703|589525963|FG001|Overall Study|Lost to Follow-up|1|||
163221232|NCT02965703|589525964|FG002|Overall Study|Lost to Follow-up|1|||
163221233|NCT03560531|589525969|FG000|Overall Study|Death|4|||
163221234|NCT03560531|589525970|FG001|Overall Study|Death|1|||
163221235|NCT03560531|589525971|FG002|Overall Study|Death|1|||
163221236|NCT03560531|589525972|FG003|Overall Study|Death|2|||
163221237|NCT03560531|589525973|FG004|Overall Study|Death|6|||
163221238|NCT03560531|589525974|FG005|Overall Study|Death|1|||
163221239|NCT03560531|589525975|FG006|Overall Study|Death|4|||
163221240|NCT03560531|589525976|FG007|Overall Study|Death|8|||
163221241|NCT03560531|589525977|FG008|Overall Study|Death|1|||
163221242|NCT03560531|589525978|FG009|Overall Study|Death|3|||
163221243|NCT03560531|589525979|FG010|Overall Study|Death|2|||
163221244|NCT03560531|589525980|FG011|Overall Study|Death|0|||
163221245|NCT03560531|589525981|FG012|Overall Study|Death|4|||
163221246|NCT03560531|589525982|FG013|Overall Study|Death|1|||
163221247|NCT03560531|589525969|FG000|Overall Study|Lost to Follow-up|1|||
163221248|NCT03560531|589525970|FG001|Overall Study|Lost to Follow-up|1|||
163221249|NCT03560531|589525971|FG002|Overall Study|Lost to Follow-up|0|||
163221250|NCT03560531|589525972|FG003|Overall Study|Lost to Follow-up|0|||
163221251|NCT03560531|589525973|FG004|Overall Study|Lost to Follow-up|0|||
163221252|NCT03560531|589525974|FG005|Overall Study|Lost to Follow-up|0|||
163221253|NCT03560531|589525975|FG006|Overall Study|Lost to Follow-up|1|||
163221254|NCT03560531|589525976|FG007|Overall Study|Lost to Follow-up|0|||
163221255|NCT03560531|589525977|FG008|Overall Study|Lost to Follow-up|0|||
163221256|NCT03560531|589525978|FG009|Overall Study|Lost to Follow-up|0|||
163221257|NCT03560531|589525979|FG010|Overall Study|Lost to Follow-up|0|||
163221258|NCT03560531|589525980|FG011|Overall Study|Lost to Follow-up|0|||
163221259|NCT03560531|589525981|FG012|Overall Study|Lost to Follow-up|0|||
163221260|NCT03560531|589525982|FG013|Overall Study|Lost to Follow-up|0|||
163221261|NCT03560531|589525969|FG000|Overall Study|Withdrawal by Subject|1|||
163221262|NCT03560531|589525970|FG001|Overall Study|Withdrawal by Subject|0|||
163221263|NCT03560531|589525971|FG002|Overall Study|Withdrawal by Subject|0|||
163221264|NCT03560531|589525972|FG003|Overall Study|Withdrawal by Subject|0|||
163221265|NCT03560531|589525973|FG004|Overall Study|Withdrawal by Subject|0|||
163221266|NCT03560531|589525974|FG005|Overall Study|Withdrawal by Subject|0|||
163221267|NCT03560531|589525975|FG006|Overall Study|Withdrawal by Subject|0|||
163221268|NCT03560531|589525976|FG007|Overall Study|Withdrawal by Subject|3|||
163221269|NCT03560531|589525977|FG008|Overall Study|Withdrawal by Subject|2|||
163221270|NCT03560531|589525978|FG009|Overall Study|Withdrawal by Subject|0|||
163221271|NCT03560531|589525979|FG010|Overall Study|Withdrawal by Subject|0|||
163221272|NCT03560531|589525980|FG011|Overall Study|Withdrawal by Subject|0|||
163221273|NCT03560531|589525981|FG012|Overall Study|Withdrawal by Subject|2|||
163221274|NCT03560531|589525982|FG013|Overall Study|Withdrawal by Subject|0|||
163221275|NCT03560531|589525969|FG000|Overall Study|Study end per-protocol|1|||
163221276|NCT03560531|589525970|FG001|Overall Study|Study end per-protocol|1|||
163221277|NCT03560531|589525971|FG002|Overall Study|Study end per-protocol|2|||
163221278|NCT03560531|589525972|FG003|Overall Study|Study end per-protocol|0|||
163221279|NCT03560531|589525973|FG004|Overall Study|Study end per-protocol|1|||
163221280|NCT03560531|589525974|FG005|Overall Study|Study end per-protocol|0|||
163221281|NCT03560531|589525975|FG006|Overall Study|Study end per-protocol|0|||
163339631|NCT04751929|589953050|FG003|Overall Study|Rising PSA|0|||
163339632|NCT04751929|589953047|FG000|Overall Study|Adverse Event|1|||
163339633|NCT04751929|589953048|FG001|Overall Study|Adverse Event|2|||
163339634|NCT04751929|589953049|FG002|Overall Study|Adverse Event|0|||
163339635|NCT04751929|589953050|FG003|Overall Study|Adverse Event|0|||
163339636|NCT04751929|589953047|FG000|Overall Study|Progressive Disease|3|||
163221282|NCT03560531|589525976|FG007|Overall Study|Study end per-protocol|0|||
163221283|NCT03560531|589525977|FG008|Overall Study|Study end per-protocol|0|||
163221284|NCT03560531|589525978|FG009|Overall Study|Study end per-protocol|0|||
163221285|NCT03560531|589525979|FG010|Overall Study|Study end per-protocol|0|||
163221286|NCT03560531|589525980|FG011|Overall Study|Study end per-protocol|0|||
163221287|NCT03560531|589525981|FG012|Overall Study|Study end per-protocol|0|||
163221288|NCT03560531|589525982|FG013|Overall Study|Study end per-protocol|0|||
163221289|NCT03560531|589525969|FG000|Overall Study|Early study termination by sponsor|9|||
163221290|NCT03560531|589525970|FG001|Overall Study|Early study termination by sponsor|0|||
163221291|NCT03560531|589525971|FG002|Overall Study|Early study termination by sponsor|0|||
163221292|NCT03560531|589525972|FG003|Overall Study|Early study termination by sponsor|4|||
163221293|NCT03560531|589525973|FG004|Overall Study|Early study termination by sponsor|8|||
163339637|NCT04751929|589953048|FG001|Overall Study|Progressive Disease|4|||
163105754|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
163105755|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
163105756|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163105757|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
163105758|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163105759|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163105760|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163105761|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163105762|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163105763|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
163105764|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
163105765|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
163105766|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163105767|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163105768|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163105769|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163105770|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
163105771|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
163105772|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
163105773|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
163105774|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
163105775|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
163105776|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
163105777|NCT03745638|589092042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163105778|NCT03745638|589092043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163105779|NCT03745638|589092044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163105780|NCT03745638|589092045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163105781|NCT03745638|589092046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163105782|NCT03745638|589092047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
163105783|NCT03745638|589092048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
163105784|NCT03745638|589092042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163105785|NCT03745638|589092043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163105786|NCT03745638|589092044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163105787|NCT03745638|589092045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
163105788|NCT03745638|589092046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163105789|NCT03745638|589092047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
163105790|NCT03745638|589092048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
163105791|NCT03745638|589092042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163105792|NCT03745638|589092043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163105793|NCT03745638|589092044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163105794|NCT03745638|589092045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
163105795|NCT03745638|589092046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
163105796|NCT03745638|589092047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
163105797|NCT03745638|589092048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
163105798|NCT03745638|589092042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163105799|NCT03745638|589092043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163105800|NCT03745638|589092044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163105801|NCT03745638|589092045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163105802|NCT03745638|589092046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
163105803|NCT03745638|589092047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
163105804|NCT03745638|589092048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163105805|NCT03745638|589092042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163105806|NCT03745638|589092043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163105807|NCT03745638|589092044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163105808|NCT03745638|589092045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163105809|NCT03745638|589092046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163105810|NCT03745638|589092047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
163105811|NCT03745638|589092048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163105812|NCT03745638|589092042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163105813|NCT03745638|589092043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163105814|NCT03745638|589092044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163105815|NCT03745638|589092045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
163105816|NCT03745638|589092046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
163105817|NCT03745638|589092047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
163105818|NCT03745638|589092048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
163105819|NCT03745638|589092042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
163105820|NCT03745638|589092043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
163105821|NCT03745638|589092044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
163105822|NCT03745638|589092045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
163105823|NCT03745638|589092046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
163105824|NCT03745638|589092047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
163105825|NCT03745638|589092048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
163105826|NCT00976716|589092049|FG000|Overall Study|Adverse Event|1|||
163105827|NCT02993822|589092057|FG000|Overall Study|Lack of Efficacy|1|||
163105828|NCT02993822|589092058|FG001|Overall Study|Lack of Efficacy|1|||
163221294|NCT03560531|589525974|FG005|Overall Study|Early study termination by sponsor|2|||
163221295|NCT03560531|589525975|FG006|Overall Study|Early study termination by sponsor|5|||
163221296|NCT03560531|589525976|FG007|Overall Study|Early study termination by sponsor|64|||
163221297|NCT03560531|589525977|FG008|Overall Study|Early study termination by sponsor|7|||
163221298|NCT03560531|589525978|FG009|Overall Study|Early study termination by sponsor|2|||
163221299|NCT03560531|589525979|FG010|Overall Study|Early study termination by sponsor|16|||
163221300|NCT03560531|589525980|FG011|Overall Study|Early study termination by sponsor|2|||
163221301|NCT03560531|589525981|FG012|Overall Study|Early study termination by sponsor|6|||
163221302|NCT03560531|589525982|FG013|Overall Study|Early study termination by sponsor|2|||
163221303|NCT02968979|589525983|FG000|Overall Study|Protocol Violation|7|||
163221304|NCT02968979|589525983|FG000|Overall Study|Withdrawal by Subject|1|||
163221305|NCT01471379|589525984|FG000|Overall Study|Adverse Event|1|||
163221306|NCT01471379|589525985|FG001|Overall Study|Adverse Event|0|||
163221307|NCT01471379|589525986|FG002|Overall Study|Adverse Event|0|||
163221308|NCT01471379|589525984|FG000|Overall Study|Study terminated|0|||
163221309|NCT01471379|589525985|FG001|Overall Study|Study terminated|1|||
163221310|NCT01471379|589525986|FG002|Overall Study|Study terminated|0|||
163221311|NCT00788827|589525987|FG000|Overall Study|Lack of Efficacy|2|||
163221312|NCT02818777|589525999|FG000|Overall Study|Adverse Event|3|||
163221313|NCT02028988|589526000|FG000|Overall Study|Withdrawal by Subject|2|||
163221314|NCT00747435|589526003|FG000|Overall Study|Lost to Follow-up|2|||
163221315|NCT00747435|589526003|FG000|Overall Study|Withdrawal by Subject|3|||
163221316|NCT00747435|589526003|FG000|Overall Study|Still undergoing follow up|1|||
163221317|NCT01324349|589526004|FG000|Overall Study|Death|1|||
163221318|NCT01324349|589526005|FG001|Overall Study|Death|1|||
163221319|NCT01324349|589526004|FG000|Overall Study|Withdrawal by Subject|0|||
163221320|NCT01324349|589526005|FG001|Overall Study|Withdrawal by Subject|1|||
163221321|NCT00851799|589526006|FG000|Overall Study|Death|1|||
163221322|NCT00851799|589526007|FG001|Overall Study|Death|0|||
163221323|NCT00851799|589526008|FG002|Overall Study|Death|1|||
163221324|NCT00851799|589526006|FG000|Overall Study|Lost to Follow-up|5|||
163221325|NCT00851799|589526007|FG001|Overall Study|Lost to Follow-up|3|||
163221326|NCT00851799|589526008|FG002|Overall Study|Lost to Follow-up|10|||
163221327|NCT00851799|589526006|FG000|Overall Study|Not able to get to clinic|8|||
163221328|NCT00851799|589526007|FG001|Overall Study|Not able to get to clinic|5|||
163221329|NCT00851799|589526008|FG002|Overall Study|Not able to get to clinic|9|||
163221330|NCT00851799|589526006|FG000|Overall Study|Not willing to adhere to requirements|1|||
163221331|NCT00851799|589526007|FG001|Overall Study|Not willing to adhere to requirements|2|||
163221332|NCT00851799|589526008|FG002|Overall Study|Not willing to adhere to requirements|2|||
163221333|NCT00851799|589526006|FG000|Overall Study|Withdrew consent prior study completion|1|||
163221334|NCT00851799|589526007|FG001|Overall Study|Withdrew consent prior study completion|2|||
163221335|NCT00851799|589526008|FG002|Overall Study|Withdrew consent prior study completion|1|||
163221336|NCT00851799|589526006|FG000|Overall Study|Severe Debilitation|0|||
163221337|NCT00851799|589526007|FG001|Overall Study|Severe Debilitation|1|||
163221338|NCT00851799|589526008|FG002|Overall Study|Severe Debilitation|0|||
163407725|NCT00464334|590200888|FG007|Overall Study|Study Terminated by Sponsor|0|||
163407726|NCT00464334|590200889|FG008|Overall Study|Study Terminated by Sponsor|0|||
163407727|NCT00464334|590200890|FG009|Overall Study|Study Terminated by Sponsor|0|||
163105829|NCT02993822|589092059|FG002|Overall Study|Lack of Efficacy|0|||
163105830|NCT02993822|589092060|FG003|Overall Study|Lack of Efficacy|0|||
163221339|NCT00851799|589526006|FG000|Overall Study|Completed protocol due to pregnancy|0|||
163221340|NCT00851799|589526007|FG001|Overall Study|Completed protocol due to pregnancy|0|||
163221341|NCT00851799|589526008|FG002|Overall Study|Completed protocol due to pregnancy|1|||
163221342|NCT02276612|589526011|FG000|Overall Study|Death|1|||
163221343|NCT02276612|589526012|FG001|Overall Study|Death|0|||
163407728|NCT00464334|590200891|FG010|Overall Study|Study Terminated by Sponsor|0|||
163407729|NCT00464334|590200881|FG000|Overall Study|Withdrawal by Subject|1|||
163221344|NCT02276612|589526011|FG000|Overall Study|Pregnancy|1|||
163221345|NCT02276612|589526012|FG001|Overall Study|Pregnancy|0|||
163221346|NCT02276612|589526011|FG000|Overall Study|Withdrew Consent|1|||
163221347|NCT02276612|589526012|FG001|Overall Study|Withdrew Consent|0|||
163221348|NCT02276612|589526011|FG000|Overall Study|Lost to Follow-up|1|||
163221349|NCT02276612|589526012|FG001|Overall Study|Lost to Follow-up|0|||
163221350|NCT04365556|589526013|FG000|Overall Study|No longer eligible due to treatment plan|1|||
163221351|NCT04365556|589526014|FG001|Overall Study|No longer eligible due to treatment plan|0|||
163221352|NCT04365556|589526013|FG000|Overall Study|Lost to Follow-up|3|||
163221353|NCT04365556|589526014|FG001|Overall Study|Lost to Follow-up|2|||
163221354|NCT04920123|589528028|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
163221355|NCT04920123|589528029|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
163221356|NCT04920123|589528030|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
163221357|NCT00826267|589528031|FG000|Overall Study|Other Adverse Event|1|||
163221358|NCT00826267|589528032|FG001|Overall Study|Other Adverse Event|0|||
163221359|NCT00826267|589528033|FG002|Overall Study|Other Adverse Event|0|||
163221360|NCT02586493|589528046|FG000|Overall Study|Adverse Event|4|||
163221361|NCT02586493|589528046|FG000|Overall Study|Protocol Violation|6|||
163221362|NCT02586493|589528046|FG000|Overall Study|Lost to Follow-up|1|||
163221363|NCT02586493|589528046|FG000|Overall Study|Withdrawal by Subject|1|||
163221364|NCT01604343|589528054|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
163221365|NCT01604343|589528055|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
163221366|NCT01604343|589528056|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
163221367|NCT01604343|589528057|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
163221368|NCT01604343|589528058|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
163221369|NCT01604343|589528054|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
163221370|NCT01604343|589528055|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
163221371|NCT01604343|589528056|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
163221372|NCT01604343|589528057|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
163221373|NCT01604343|589528058|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
163221374|NCT01604343|589528054|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
163221375|NCT01604343|589528055|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
163221376|NCT01604343|589528056|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
163221377|NCT01604343|589528057|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
163221378|NCT01604343|589528058|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
163221379|NCT01604343|589528054|FG000|Prior to W52 Administration(Through W52)|Death|5|||
163221380|NCT01604343|589528055|FG001|Prior to W52 Administration(Through W52)|Death|0|||
163221381|NCT01604343|589528056|FG002|Prior to W52 Administration(Through W52)|Death|2|||
163221382|NCT01604343|589528057|FG003|Prior to W52 Administration(Through W52)|Death|0|||
163221383|NCT01604343|589528058|FG004|Prior to W52 Administration(Through W52)|Death|4|||
163221384|NCT01604343|589528054|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
163221385|NCT01604343|589528055|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
163221386|NCT01604343|589528056|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
163221387|NCT01604343|589528057|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
163221388|NCT01604343|589528058|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
163221389|NCT01604343|589528054|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
163221390|NCT01604343|589528055|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
163221391|NCT01604343|589528056|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
163221392|NCT01604343|589528057|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
163221393|NCT01604343|589528058|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
163221394|NCT01604343|589528054|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
163221395|NCT01604343|589528055|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
163221396|NCT01604343|589528056|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
163339638|NCT04751929|589953049|FG002|Overall Study|Progressive Disease|4|||
163339639|NCT04751929|589953050|FG003|Overall Study|Progressive Disease|0|||
163339640|NCT04751929|589953047|FG000|Overall Study|Death|1|||
163339641|NCT04751929|589953048|FG001|Overall Study|Death|1|||
163339642|NCT04751929|589953049|FG002|Overall Study|Death|0|||
163339643|NCT04751929|589953050|FG003|Overall Study|Death|0|||
163339644|NCT00473512|589953055|FG000|Period 1 (Phase 1)|Adverse Event|0|||
163339645|NCT00473512|589953056|FG001|Period 1 (Phase 1)|Adverse Event|0|||
163339646|NCT00473512|589953057|FG002|Period 1 (Phase 1)|Adverse Event|0|||
163339647|NCT00473512|589953058|FG003|Period 1 (Phase 1)|Adverse Event|5|||
163339648|NCT00473512|589953059|FG004|Period 1 (Phase 1)|Adverse Event|0|||
163339649|NCT00473512|589953055|FG000|Period 1 (Phase 1)|Death|0|||
163339650|NCT00473512|589953056|FG001|Period 1 (Phase 1)|Death|0|||
163339651|NCT00473512|589953057|FG002|Period 1 (Phase 1)|Death|0|||
163339652|NCT00473512|589953058|FG003|Period 1 (Phase 1)|Death|1|||
163339653|NCT00473512|589953059|FG004|Period 1 (Phase 1)|Death|0|||
163339654|NCT00473512|589953055|FG000|Period 1 (Phase 1)|Disease Progression|1|||
163221397|NCT01604343|589528057|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
163339655|NCT00473512|589953056|FG001|Period 1 (Phase 1)|Disease Progression|1|||
163339656|NCT00473512|589953057|FG002|Period 1 (Phase 1)|Disease Progression|0|||
163221398|NCT01604343|589528058|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
163339657|NCT00473512|589953058|FG003|Period 1 (Phase 1)|Disease Progression|10|||
163339658|NCT00473512|589953059|FG004|Period 1 (Phase 1)|Disease Progression|1|||
163339659|NCT00473512|589953055|FG000|Period 1 (Phase 1)|Other|0|||
163105831|NCT02993822|589092057|FG000|Overall Study|Protocol Violation|1|||
163105832|NCT02993822|589092058|FG001|Overall Study|Protocol Violation|0|||
163105833|NCT02993822|589092059|FG002|Overall Study|Protocol Violation|0|||
163105834|NCT02993822|589092060|FG003|Overall Study|Protocol Violation|0|||
163105835|NCT02993822|589092057|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
163105836|NCT02993822|589092058|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
163105837|NCT02993822|589092059|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
163105838|NCT02993822|589092060|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
163105839|NCT02993822|589092057|FG000|Overall Study|Adverse Event|3|||
163105840|NCT02993822|589092058|FG001|Overall Study|Adverse Event|1|||
163105841|NCT02993822|589092059|FG002|Overall Study|Adverse Event|7|||
163105842|NCT02993822|589092060|FG003|Overall Study|Adverse Event|0|||
163105843|NCT02993822|589092057|FG000|Overall Study|Withdrawal by Subject|4|||
163105844|NCT02993822|589092058|FG001|Overall Study|Withdrawal by Subject|2|||
163105845|NCT02993822|589092059|FG002|Overall Study|Withdrawal by Subject|2|||
163105846|NCT02993822|589092060|FG003|Overall Study|Withdrawal by Subject|3|||
163105847|NCT02993822|589092057|FG000|Overall Study|Lost to Follow-up|1|||
163105848|NCT02993822|589092058|FG001|Overall Study|Lost to Follow-up|0|||
163105849|NCT02993822|589092059|FG002|Overall Study|Lost to Follow-up|1|||
163105850|NCT02993822|589092060|FG003|Overall Study|Lost to Follow-up|0|||
163105851|NCT01221753|589092064|FG000|Overall Study|Adverse Event|1|||
163105852|NCT01939977|589092068|FG000|Overall Study|Adverse Event|4|||
163105853|NCT01939977|589092069|FG001|Overall Study|Adverse Event|3|||
163105854|NCT01939977|589092068|FG000|Overall Study|Lack of Efficacy|3|||
163105855|NCT01939977|589092069|FG001|Overall Study|Lack of Efficacy|0|||
163105856|NCT01939977|589092068|FG000|Overall Study|Physician Decision|1|||
163105857|NCT01939977|589092069|FG001|Overall Study|Physician Decision|1|||
163105858|NCT01939977|589092068|FG000|Overall Study|Withdrawal by Subject|0|||
163105859|NCT01939977|589092069|FG001|Overall Study|Withdrawal by Subject|2|||
163105860|NCT01939977|589092068|FG000|Overall Study|Did not meet inclusion criteria|1|||
163105861|NCT01939977|589092069|FG001|Overall Study|Did not meet inclusion criteria|0|||
163105862|NCT01939977|589092068|FG000|Overall Study|Did not receive study medication|0|||
163105863|NCT01939977|589092069|FG001|Overall Study|Did not receive study medication|1|||
163105864|NCT01603043|589092073|FG000|Overall Study|Study Futility|7|||
163105865|NCT01603043|589092074|FG001|Overall Study|Study Futility|3|||
163105866|NCT01917929|589092075|FG000|Overall Study|Death|8|||
163105867|NCT01917929|589092075|FG000|Overall Study|Lost to Follow-up|19|||
163105868|NCT01917929|589092075|FG000|Overall Study|Withdrawal by Subject|33|||
163105869|NCT01917929|589092075|FG000|Overall Study|Adverse Event|6|||
163105870|NCT01917929|589092075|FG000|Overall Study|Investigative Site Terminated|35|||
163105871|NCT01917929|589092075|FG000|Overall Study|Censored because study device not implanted|6|||
163105872|NCT01917929|589092075|FG000|Overall Study|Censored because surgery not performed|3|||
163105873|NCT01917929|589092075|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
163105874|NCT01917929|589092075|FG000|Overall Study|Sponsor terminated study|175|||
163105875|NCT01696981|589092076|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
163105876|NCT01696981|589092077|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
163105877|NCT01696981|589092076|FG000|Overall Study|Died Before Randomization|3|||
163105878|NCT01696981|589092077|FG001|Overall Study|Died Before Randomization|8|||
163105879|NCT01696981|589092076|FG000|Overall Study|Died Before ASU (Control)|278|||
163105880|NCT01696981|589092077|FG001|Overall Study|Died Before ASU (Control)|0|||
163105881|NCT01696981|589092076|FG000|Overall Study|Refused ASU (Control)|920|||
163105882|NCT01696981|589092077|FG001|Overall Study|Refused ASU (Control)|0|||
163105883|NCT01696981|589092076|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
163105884|NCT01696981|589092077|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
163105885|NCT03599518|589092078|FG000|Overall Study|Clinical progression|0|||
163105886|NCT03599518|589092079|FG001|Overall Study|Clinical progression|0|||
163105887|NCT03599518|589092080|FG002|Overall Study|Clinical progression|0|||
163105888|NCT03599518|589092081|FG003|Overall Study|Clinical progression|0|||
163105889|NCT03599518|589092082|FG004|Overall Study|Clinical progression|1|||
163105890|NCT03599518|589092078|FG000|Overall Study|Adverse Event|0|||
163105891|NCT03599518|589092079|FG001|Overall Study|Adverse Event|0|||
163105892|NCT03599518|589092080|FG002|Overall Study|Adverse Event|0|||
163105893|NCT03599518|589092081|FG003|Overall Study|Adverse Event|0|||
163105894|NCT03599518|589092082|FG004|Overall Study|Adverse Event|1|||
163105895|NCT03599518|589092078|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
163105896|NCT03599518|589092079|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
163105897|NCT03599518|589092080|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
163105898|NCT03599518|589092081|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
163105899|NCT03599518|589092082|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
163105900|NCT03599518|589092078|FG000|Overall Study|Participant withdrawal from study treatment|0|||
163105901|NCT03599518|589092079|FG001|Overall Study|Participant withdrawal from study treatment|0|||
163105902|NCT03599518|589092080|FG002|Overall Study|Participant withdrawal from study treatment|1|||
163105903|NCT03599518|589092081|FG003|Overall Study|Participant withdrawal from study treatment|0|||
163105904|NCT03599518|589092082|FG004|Overall Study|Participant withdrawal from study treatment|0|||
163105905|NCT02798315|589092085|FG000|Overall Study|Failure to return|1|||
163105906|NCT00005947|589092086|FG000|Overall Study|Death|54|||
163105907|NCT00005947|589092087|FG001|Overall Study|Death|40|||
163105908|NCT00005947|589092086|FG000|Overall Study|Patient Refused to Continue|2|||
163105909|NCT00005947|589092087|FG001|Overall Study|Patient Refused to Continue|1|||
163105910|NCT00005947|589092086|FG000|Overall Study|Site Closure|1|||
163105911|NCT00005947|589092087|FG001|Overall Study|Site Closure|0|||
163105912|NCT00465972|589092088|FG000|Overall Study|Withdrawal by Subject|2|||
163105913|NCT00465972|589092089|FG001|Overall Study|Withdrawal by Subject|1|||
163105914|NCT03292640|589092090|FG000|Overall Study|Withdrawal by Subject|17|||
163105915|NCT03292640|589092091|FG001|Overall Study|Withdrawal by Subject|16|||
163105916|NCT03292640|589092090|FG000|Overall Study|Adverse Event|20|||
163105917|NCT03292640|589092091|FG001|Overall Study|Adverse Event|2|||
163105918|NCT03292640|589092090|FG000|Overall Study|Lost to Follow-up|24|||
163105919|NCT03292640|589092091|FG001|Overall Study|Lost to Follow-up|24|||
163105920|NCT00851890|589092096|FG000|Overall Study|Lost to Follow-up|0|||
163105921|NCT00851890|589092097|FG001|Overall Study|Lost to Follow-up|1|||
163105922|NCT00851890|589092098|FG002|Overall Study|Lost to Follow-up|0|||
163105923|NCT00851890|589092099|FG003|Overall Study|Lost to Follow-up|1|||
163105924|NCT03135431|589092100|FG000|Overall Study|Study Surgeon not available|2|||
163105925|NCT03135431|589092101|FG001|Overall Study|Study Surgeon not available|0|||
163105926|NCT02015481|589092102|FG000|Overall Study|Death|1|||
163105927|NCT03122145|589092104|FG000|Overall Study|Concurrent respiratory disease|3|||
163105928|NCT03122145|589092105|FG001|Overall Study|Concurrent respiratory disease|0|||
163105929|NCT00079391|589092106|FG000|Overall Study|Withdrawal by Subject|1|||
163105930|NCT00837161|589092107|FG000|Overall Study|refused hysterectomy|2|||
163105931|NCT03206918|589092108|FG000|Overall Study|Death|11|||
163105932|NCT03206918|589092108|FG000|Overall Study|Withdrawal by Subject|5|||
163105933|NCT03206918|589092108|FG000|Overall Study|Study terminated by sponsor|12|||
163105934|NCT03206918|589092108|FG000|Overall Study|Lost to Follow-up|3|||
163105935|NCT03206918|589092108|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
163105936|NCT02701764|589092109|FG000|Overall Study|Lost to Follow-up|0|||
163105937|NCT02701764|589092110|FG001|Overall Study|Lost to Follow-up|1|||
163105938|NCT06899737|589092116|FG000|Overall Study|Lost to Follow-up|19|||
163105939|NCT06899737|589092117|FG001|Overall Study|Lost to Follow-up|7|||
163105940|NCT01170273|589092118|FG000|Overall Study|Lost to Follow-up|6|||
163105941|NCT01170273|589092119|FG001|Overall Study|Lost to Follow-up|8|||
163105942|NCT01170273|589092118|FG000|Overall Study|Protocol Violation|1|||
163105943|NCT01170273|589092119|FG001|Overall Study|Protocol Violation|0|||
163105944|NCT01170273|589092118|FG000|Overall Study|Death|1|||
163105945|NCT01170273|589092119|FG001|Overall Study|Death|0|||
163105946|NCT01170273|589092118|FG000|Overall Study|Adverse Event|0|||
163105947|NCT01170273|589092119|FG001|Overall Study|Adverse Event|1|||
163105948|NCT00375674|589092120|FG000|Overall Study|Other|26|||
163105949|NCT00375674|589092121|FG001|Overall Study|Other|18|||
163105950|NCT00375674|589092120|FG000|Overall Study|Death|67|||
163105951|NCT00375674|589092121|FG001|Overall Study|Death|76|||
163105952|NCT00375674|589092120|FG000|Overall Study|Participants refused further follow-up|31|||
163105953|NCT00375674|589092121|FG001|Overall Study|Participants refused further follow-up|30|||
163105954|NCT00375674|589092120|FG000|Overall Study|Lost to Follow-up|17|||
163105955|NCT00375674|589092121|FG001|Overall Study|Lost to Follow-up|15|||
163105956|NCT00375674|589092120|FG000|Overall Study|Enrolled but not treated|3|||
163105957|NCT00375674|589092121|FG001|Overall Study|Enrolled but not treated|2|||
163105958|NCT00912782|589092122|FG000|Overall Study|Death|2|||
163105959|NCT00912782|589092123|FG001|Overall Study|Death|1|||
163105960|NCT00912782|589092122|FG000|Overall Study|Lost to Follow-up|0|||
163105961|NCT00912782|589092123|FG001|Overall Study|Lost to Follow-up|1|||
163105962|NCT00912782|589092122|FG000|Overall Study|Did not receive vascular access type|1|||
163105963|NCT00912782|589092123|FG001|Overall Study|Did not receive vascular access type|2|||
163105964|NCT00912782|589092122|FG000|Overall Study|Relocated before study completion|0|||
163105965|NCT00912782|589092123|FG001|Overall Study|Relocated before study completion|1|||
163105966|NCT00301262|589093954|FG000|Double Blind Phase (DB)|Adverse Event|1|||
163105967|NCT00301262|589093955|FG001|Double Blind Phase (DB)|Adverse Event|0|||
163105968|NCT00301262|589093954|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
163105969|NCT00301262|589093955|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
163105970|NCT00301262|589093954|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
163105971|NCT00301262|589093955|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
163105972|NCT00301262|589093954|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
163105973|NCT00301262|589093955|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
163105974|NCT00301262|589093954|FG000|Double Blind Phase (DB)|Other|1|||
163105975|NCT00301262|589093955|FG001|Double Blind Phase (DB)|Other|4|||
163105976|NCT00301262|589093954|FG000|Open Label Phase (OL)|Adverse Event|1|||
163105977|NCT00301262|589093955|FG001|Open Label Phase (OL)|Adverse Event|0|||
163105978|NCT00301262|589093954|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
163105979|NCT00301262|589093955|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
163105980|NCT00301262|589093954|FG000|Open Label Phase (OL)|Other|2|||
163105981|NCT00301262|589093955|FG001|Open Label Phase (OL)|Other|0|||
163105982|NCT03530995|589093962|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
163105983|NCT03530995|589093963|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
163105984|NCT03530995|589093962|FG000|Part 1 Period 3|Protocol Violation|1|||
163105985|NCT03530995|589093963|FG001|Part 1 Period 3|Protocol Violation|0|||
163105986|NCT03530995|589093962|FG000|Part 1 Period 4|Physician Decision|1|||
163105987|NCT03530995|589093963|FG001|Part 1 Period 4|Physician Decision|0|||
163105988|NCT03530995|589093962|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
163105989|NCT03530995|589093963|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
163105990|NCT01443364|589093965|FG000|Overall Study|Lack of Efficacy|14|||
163105991|NCT01443364|589093965|FG000|Overall Study|Lost to Follow-up|3|||
163105992|NCT01443364|589093965|FG000|Overall Study|Withdrawal by Subject|5|||
163105993|NCT01443364|589093965|FG000|Overall Study|Other Reason|4|||
163105994|NCT01443364|589093965|FG000|Overall Study|SAE, non-fatal|6|||
163105995|NCT01443364|589093965|FG000|Overall Study|AE, non-serious non-fatal|8|||
163105996|NCT01443364|589093965|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
163105997|NCT02650804|589093966|FG000|Overall Study|Adverse Event|3|||
163105998|NCT02650804|589093967|FG001|Overall Study|Adverse Event|2|||
163105999|NCT02650804|589093966|FG000|Overall Study|Death|1|||
163106000|NCT02650804|589093967|FG001|Overall Study|Death|2|||
163106001|NCT02650804|589093966|FG000|Overall Study|Progressive Disease|7|||
163106002|NCT02650804|589093967|FG001|Overall Study|Progressive Disease|10|||
163106003|NCT02650804|589093966|FG000|Overall Study|Physician Decision|0|||
163106004|NCT02650804|589093967|FG001|Overall Study|Physician Decision|2|||
163106005|NCT02650804|589093966|FG000|Overall Study|Withdrawal by Subject|1|||
163106006|NCT02650804|589093967|FG001|Overall Study|Withdrawal by Subject|4|||
163106007|NCT02650804|589093966|FG000|Overall Study|Symptomatic deterioration|5|||
163106008|NCT02650804|589093967|FG001|Overall Study|Symptomatic deterioration|7|||
163106009|NCT02650804|589093966|FG000|Overall Study|Protocol Violation|0|||
163106010|NCT02650804|589093967|FG001|Overall Study|Protocol Violation|1|||
163106011|NCT01986231|589093972|FG000|Overall Study|Adverse Event|1|||
163106012|NCT02150057|589093973|FG000|Overall Study|Lost to Follow-up|6|||
163106013|NCT02150057|589093974|FG001|Overall Study|Lost to Follow-up|4|||
163106014|NCT02388165|589093975|FG000|Overall Study|Study terminated by sponsor|5|||
163106015|NCT02388165|589093976|FG001|Overall Study|Study terminated by sponsor|5|||
163106016|NCT02388165|589093975|FG000|Overall Study|Other|11|||
163106017|NCT02388165|589093976|FG001|Overall Study|Other|13|||
163106018|NCT02388165|589093975|FG000|Overall Study|No longer meet eligibility criteria|40|||
163106019|NCT02388165|589093976|FG001|Overall Study|No longer meet eligibility criteria|43|||
163106020|NCT02388165|589093975|FG000|Overall Study|Withdrawal of consent|31|||
163106021|NCT02388165|589093976|FG001|Overall Study|Withdrawal of consent|32|||
163106022|NCT02388165|589093975|FG000|Overall Study|Lost to Follow-up|19|||
163106023|NCT02388165|589093976|FG001|Overall Study|Lost to Follow-up|20|||
163106024|NCT02388165|589093975|FG000|Overall Study|Death|13|||
163106025|NCT02388165|589093976|FG001|Overall Study|Death|10|||
163106026|NCT02388165|589093975|FG000|Overall Study|Adverse Event|3|||
163106027|NCT02388165|589093976|FG001|Overall Study|Adverse Event|5|||
163106028|NCT02388165|589093975|FG000|Overall Study|Did not meet entrance criteria|5|||
163106029|NCT02388165|589093976|FG001|Overall Study|Did not meet entrance criteria|2|||
163106030|NCT04551963|589093980|FG000|Overall Study|Physician Decision|1|||
163106031|NCT04551963|589093981|FG001|Overall Study|Physician Decision|1|||
163106032|NCT04551963|589093980|FG000|Overall Study|Death|1|||
163106033|NCT04551963|589093981|FG001|Overall Study|Death|0|||
163106034|NCT02974855|589093982|FG000|Overall Study|Adverse Event|0|||
163106035|NCT02974855|589093983|FG001|Overall Study|Adverse Event|1|||
163106036|NCT02974855|589093984|FG002|Overall Study|Adverse Event|0|||
163106037|NCT02974855|589093985|FG003|Overall Study|Adverse Event|1|||
163106038|NCT01474772|589093986|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
163106039|NCT01474772|589093987|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
163106040|NCT01474772|589093986|FG000|Period 1|AE not Related to Study Drug|1|||
163106041|NCT01474772|589093987|FG001|Period 1|AE not Related to Study Drug|0|||
163106042|NCT01474772|589093986|FG000|Period 1|Withdrawal by Subject|3|||
163106043|NCT01474772|589093987|FG001|Period 1|Withdrawal by Subject|1|||
163106044|NCT01474772|589093986|FG000|Period 1|Lost to Follow-up|1|||
163106045|NCT01474772|589093987|FG001|Period 1|Lost to Follow-up|0|||
163106046|NCT01474772|589093986|FG000|Period 1|Reason not Specified|1|||
163106047|NCT01474772|589093987|FG001|Period 1|Reason not Specified|1|||
163221399|NCT01604343|589528054|FG000|Prior to W52 Administration(Through W52)|Other|15|||
163221400|NCT01604343|589528055|FG001|Prior to W52 Administration(Through W52)|Other|0|||
163106048|NCT01474772|589093986|FG000|Washout|AE not Related to Study Drug|2|||
163106049|NCT01474772|589093987|FG001|Washout|AE not Related to Study Drug|0|||
163106050|NCT01474772|589093986|FG000|Washout|Withdrawal by Subject|1|||
163106051|NCT01474772|589093987|FG001|Washout|Withdrawal by Subject|0|||
163106052|NCT01474772|589093986|FG000|Washout|Lost to Follow-up|0|||
163106053|NCT01474772|589093987|FG001|Washout|Lost to Follow-up|1|||
163106054|NCT01474772|589093986|FG000|Washout|Reason not Specified|0|||
163106055|NCT01474772|589093987|FG001|Washout|Reason not Specified|1|||
163106056|NCT01474772|589093986|FG000|Period 2|Death|0|||
163106057|NCT01474772|589093987|FG001|Period 2|Death|1|||
163106058|NCT01474772|589093986|FG000|Period 2|AE Related to Study Drug|0|||
163106059|NCT01474772|589093987|FG001|Period 2|AE Related to Study Drug|1|||
163221401|NCT01604343|589528056|FG002|Prior to W52 Administration(Through W52)|Other|10|||
163221402|NCT01604343|589528057|FG003|Prior to W52 Administration(Through W52)|Other|0|||
163221403|NCT01604343|589528058|FG004|Prior to W52 Administration(Through W52)|Other|6|||
163221404|NCT01604343|589528054|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
163221405|NCT01604343|589528055|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
163221406|NCT01604343|589528056|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
163221407|NCT01604343|589528057|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
163221408|NCT01604343|589528058|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
163221409|NCT01604343|589528054|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
163221410|NCT01604343|589528055|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
163221411|NCT01604343|589528056|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
163221412|NCT01604343|589528057|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
163221413|NCT01604343|589528058|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
163221414|NCT01604343|589528054|FG000|Week 52 to Week 104|Adverse Event|0|||
163221415|NCT01604343|589528055|FG001|Week 52 to Week 104|Adverse Event|12|||
163221416|NCT01604343|589528056|FG002|Week 52 to Week 104|Adverse Event|26|||
163221417|NCT01604343|589528057|FG003|Week 52 to Week 104|Adverse Event|21|||
163221418|NCT01604343|589528058|FG004|Week 52 to Week 104|Adverse Event|27|||
163221419|NCT01604343|589528054|FG000|Week 52 to Week 104|Death|0|||
163221420|NCT01604343|589528055|FG001|Week 52 to Week 104|Death|4|||
163221421|NCT01604343|589528056|FG002|Week 52 to Week 104|Death|2|||
163221422|NCT01604343|589528057|FG003|Week 52 to Week 104|Death|5|||
163221423|NCT01604343|589528058|FG004|Week 52 to Week 104|Death|0|||
163221424|NCT01604343|589528054|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
163221425|NCT01604343|589528055|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
163221426|NCT01604343|589528056|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
163221427|NCT01604343|589528057|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
163221428|NCT01604343|589528058|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
163221429|NCT01604343|589528054|FG000|Week 52 to Week 104|Physician Decision|0|||
163221430|NCT01604343|589528055|FG001|Week 52 to Week 104|Physician Decision|1|||
163221431|NCT01604343|589528056|FG002|Week 52 to Week 104|Physician Decision|0|||
163221432|NCT01604343|589528057|FG003|Week 52 to Week 104|Physician Decision|0|||
163221433|NCT01604343|589528058|FG004|Week 52 to Week 104|Physician Decision|2|||
163221434|NCT01604343|589528054|FG000|Week 52 to Week 104|Pregnancy|0|||
163221435|NCT01604343|589528055|FG001|Week 52 to Week 104|Pregnancy|0|||
163221436|NCT01604343|589528056|FG002|Week 52 to Week 104|Pregnancy|1|||
163221437|NCT01604343|589528057|FG003|Week 52 to Week 104|Pregnancy|2|||
163221438|NCT01604343|589528058|FG004|Week 52 to Week 104|Pregnancy|1|||
163221439|NCT01604343|589528054|FG000|Week 52 to Week 104|Other|0|||
163221440|NCT01604343|589528055|FG001|Week 52 to Week 104|Other|11|||
163221441|NCT01604343|589528056|FG002|Week 52 to Week 104|Other|11|||
163221442|NCT01604343|589528057|FG003|Week 52 to Week 104|Other|6|||
163221443|NCT01604343|589528058|FG004|Week 52 to Week 104|Other|3|||
163221444|NCT01604343|589528054|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
163221445|NCT01604343|589528055|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
163221446|NCT01604343|589528056|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
163221447|NCT01604343|589528057|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
163221448|NCT01604343|589528058|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
163221449|NCT01604343|589528054|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
163221450|NCT01604343|589528055|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
163221451|NCT01604343|589528056|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
163221452|NCT01604343|589528057|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
163221453|NCT01604343|589528058|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
163221454|NCT01604343|589528054|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
163221455|NCT01604343|589528055|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
163221456|NCT01604343|589528056|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
163221457|NCT01604343|589528057|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
163221458|NCT01604343|589528058|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
163221459|NCT00436748|589528059|FG000|Overall Study|Ineligibility Determined|1|||
163221460|NCT00436748|589528060|FG001|Overall Study|Ineligibility Determined|1|||
163339660|NCT00473512|589953056|FG001|Period 1 (Phase 1)|Other|0|||
163339661|NCT00473512|589953057|FG002|Period 1 (Phase 1)|Other|0|||
163339662|NCT00473512|589953058|FG003|Period 1 (Phase 1)|Other|1|||
163339663|NCT00473512|589953059|FG004|Period 1 (Phase 1)|Other|0|||
163221461|NCT00436748|589528059|FG000|Overall Study|Adverse Event|0|||
163221462|NCT00436748|589528060|FG001|Overall Study|Adverse Event|2|||
163221463|NCT00436748|589528059|FG000|Overall Study|Consent Withdrawn|1|||
163339664|NCT00473512|589953055|FG000|Period 2 (Phase 2)|Adverse Event|0|||
163221464|NCT00436748|589528060|FG001|Overall Study|Consent Withdrawn|4|||
163221465|NCT00436748|589528059|FG000|Overall Study|Administrative Decision|1|||
163221466|NCT00436748|589528060|FG001|Overall Study|Administrative Decision|0|||
163221467|NCT00436748|589528059|FG000|Overall Study|Lost to Follow-up|0|||
163221468|NCT00436748|589528060|FG001|Overall Study|Lost to Follow-up|1|||
163221469|NCT00436748|589528059|FG000|Overall Study|Protocol-specified Criteria|5|||
163221470|NCT00436748|589528060|FG001|Overall Study|Protocol-specified Criteria|4|||
163221471|NCT00436748|589528059|FG000|Overall Study|Other|3|||
163106060|NCT01474772|589093986|FG000|Period 2|AE not Related to Study Drug|4|||
163106061|NCT01474772|589093987|FG001|Period 2|AE not Related to Study Drug|1|||
163106062|NCT01474772|589093986|FG000|Period 2|Lack of Efficacy|1|||
163106063|NCT01474772|589093987|FG001|Period 2|Lack of Efficacy|0|||
163106064|NCT01474772|589093986|FG000|Period 2|Withdrawal by Subject|3|||
163106065|NCT01474772|589093987|FG001|Period 2|Withdrawal by Subject|4|||
163106066|NCT01474772|589093986|FG000|Period 2|Lost to Follow-up|1|||
163106067|NCT01474772|589093987|FG001|Period 2|Lost to Follow-up|1|||
163106068|NCT01474772|589093986|FG000|Period 2|Reason not Specified|0|||
163106069|NCT01474772|589093987|FG001|Period 2|Reason not Specified|2|||
163106070|NCT01474772|589093986|FG000|Follow-up|AE not Related to Study Drug|0|||
163106071|NCT01474772|589093987|FG001|Follow-up|AE not Related to Study Drug|1|||
163106072|NCT00633074|589093988|FG000|Overall Study|Adverse Event|1|||
163106073|NCT00633074|589093989|FG001|Overall Study|Adverse Event|0|||
163106074|NCT00365105|589093990|FG000|Overall Study|Protocol Violation|5|||
163106075|NCT00365105|589093991|FG001|Overall Study|Protocol Violation|8|||
163106076|NCT00748618|589093992|FG000|Overall Study|Adverse Event|1|||
163106077|NCT00748618|589093993|FG001|Overall Study|Adverse Event|0|||
163106078|NCT06004895|589093994|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
163106079|NCT06004895|589093994|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
163106080|NCT00466947|589093995|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
163106081|NCT00466947|589093996|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
163106082|NCT00466947|589093995|FG000|Study End Analysis Period|Adverse Event|35|||
163106083|NCT00466947|589093996|FG001|Study End Analysis Period|Adverse Event|43|||
163106084|NCT00466947|589093995|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
163106085|NCT00466947|589093996|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
163106086|NCT00466947|589093995|FG000|Study End Analysis Period|Physician Decision|29|||
163106087|NCT00466947|589093996|FG001|Study End Analysis Period|Physician Decision|29|||
163106088|NCT00466947|589093995|FG000|Study End Analysis Period|Protocol Violation|9|||
163106089|NCT00466947|589093996|FG001|Study End Analysis Period|Protocol Violation|17|||
163106090|NCT00466947|589093995|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
163106091|NCT00466947|589093996|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
163106092|NCT00466947|589093995|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
163106093|NCT00466947|589093996|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
163106094|NCT00466947|589093995|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
163106095|NCT00466947|589093996|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
163106096|NCT00466947|589093995|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
163106097|NCT00466947|589093996|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
163106098|NCT00878254|589093997|FG000|Overall Study|Physician Decision|1|||
163106099|NCT00878254|589093997|FG000|Overall Study|Death|1|||
163106100|NCT00878254|589093997|FG000|Overall Study|Withdrawal by Subject|1|||
163106101|NCT01995526|589093998|FG000|Overall Study|Physician Decision|1|||
163106102|NCT03367403|589094003|FG000|Overall Study|Adverse Event|20|||
163106103|NCT03367403|589094004|FG001|Overall Study|Adverse Event|6|||
163106104|NCT03367403|589094005|FG002|Overall Study|Adverse Event|2|||
163106105|NCT03367403|589094003|FG000|Overall Study|Withdrawal by Subject|12|||
163106106|NCT03367403|589094004|FG001|Overall Study|Withdrawal by Subject|13|||
163106107|NCT03367403|589094005|FG002|Overall Study|Withdrawal by Subject|1|||
163106108|NCT03367403|589094003|FG000|Overall Study|Death|1|||
163106109|NCT03367403|589094004|FG001|Overall Study|Death|2|||
163106110|NCT03367403|589094005|FG002|Overall Study|Death|0|||
163106111|NCT03367403|589094003|FG000|Overall Study|Physician Decision|0|||
163106112|NCT03367403|589094004|FG001|Overall Study|Physician Decision|1|||
163106113|NCT03367403|589094005|FG002|Overall Study|Physician Decision|0|||
163106114|NCT03367403|589094003|FG000|Overall Study|Protocol Violation|1|||
163106115|NCT03367403|589094004|FG001|Overall Study|Protocol Violation|1|||
163106116|NCT03367403|589094005|FG002|Overall Study|Protocol Violation|0|||
163106117|NCT03367403|589094003|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
163106118|NCT03367403|589094004|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
163106119|NCT03367403|589094005|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
163106120|NCT03367403|589094003|FG000|Overall Study|COVID-19|3|||
163221472|NCT00436748|589528060|FG001|Overall Study|Other|0|||
163221473|NCT00850200|589528061|FG000|Overall Study|Physician Decision|2|||
163106121|NCT03367403|589094004|FG001|Overall Study|COVID-19|6|||
163106122|NCT03367403|589094005|FG002|Overall Study|COVID-19|0|||
163106123|NCT03367403|589094003|FG000|Overall Study|Abuse of Alcohol Intake|0|||
163221474|NCT00850200|589528061|FG000|Overall Study|Did not recieve treatment|2|||
163106124|NCT03367403|589094004|FG001|Overall Study|Abuse of Alcohol Intake|1|||
163106125|NCT03367403|589094005|FG002|Overall Study|Abuse of Alcohol Intake|0|||
163106126|NCT03367403|589094003|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
163106127|NCT03367403|589094004|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
163221475|NCT00850200|589528061|FG000|Overall Study|Withdrawal by Subject|1|||
163221476|NCT02711800|589528062|FG000|Overall Study|Lost to Follow-up|1|||
163106128|NCT03367403|589094005|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
163106129|NCT02321319|589094010|FG000|Overall Study|Product discontinued|5|||
163106130|NCT03497975|589094013|FG000|Overall Study|Withdrew Consent|34|||
163106131|NCT03497975|589094014|FG001|Overall Study|Withdrew Consent|35|||
163106132|NCT03497975|589094013|FG000|Overall Study|Lost to Follow-up|7|||
163106133|NCT03497975|589094014|FG001|Overall Study|Lost to Follow-up|7|||
163106134|NCT03497975|589094013|FG000|Overall Study|Physician Decision|4|||
163106135|NCT03497975|589094014|FG001|Overall Study|Physician Decision|5|||
163106136|NCT03497975|589094013|FG000|Overall Study|Discontinued|42|||
163106137|NCT03497975|589094014|FG001|Overall Study|Discontinued|39|||
163106138|NCT03497975|589094013|FG000|Overall Study|Reason Not Specified|15|||
163106139|NCT03497975|589094014|FG001|Overall Study|Reason Not Specified|14|||
163106140|NCT02141399|589094015|FG000|Overall Study|Adverse Event|158|||
163106141|NCT02141399|589094015|FG000|Overall Study|Lack of Efficacy|62|||
163106142|NCT02141399|589094015|FG000|Overall Study|Lost to Follow-up|151|||
163106143|NCT02141399|589094015|FG000|Overall Study|Non-compliance with study drug|18|||
163106144|NCT02141399|589094015|FG000|Overall Study|Other|45|||
163106145|NCT02141399|589094015|FG000|Overall Study|Physician Decision|17|||
163106146|NCT02141399|589094015|FG000|Overall Study|Pregnancy|3|||
163106147|NCT02141399|589094015|FG000|Overall Study|Protocol Violation|38|||
163106148|NCT02141399|589094015|FG000|Overall Study|Withdrawal by Subject|238|||
163106149|NCT02141399|589094015|FG000|Overall Study|Failure to meet eligibility criteria|14|||
163106150|NCT00935493|589094021|FG000|Overall Study|Lost to Follow-up|1|||
163106151|NCT00935493|589094022|FG001|Overall Study|Lost to Follow-up|1|||
163106152|NCT00935493|589094023|FG002|Overall Study|Lost to Follow-up|1|||
163106153|NCT00935493|589094021|FG000|Overall Study|Treatment Discontinued|0|||
163106154|NCT00935493|589094022|FG001|Overall Study|Treatment Discontinued|1|||
163106155|NCT00935493|589094023|FG002|Overall Study|Treatment Discontinued|0|||
163106156|NCT03799952|589094029|FG000|Overall Study|Program was too easy, discontinued|1|||
163106157|NCT03799952|589094030|FG001|Overall Study|Program was too easy, discontinued|0|||
163106158|NCT03799952|589094029|FG000|Overall Study|Lost to Follow-up|0|||
163106159|NCT03799952|589094030|FG001|Overall Study|Lost to Follow-up|2|||
163106160|NCT00902850|589094031|FG000|Overall Study|Physician Decision|2|||
163106161|NCT00902850|589094032|FG001|Overall Study|Physician Decision|2|||
163106162|NCT02016716|589094043|FG000|Overall Study|Withdrawal by Subject|5|||
163106163|NCT02016716|589094044|FG001|Overall Study|Withdrawal by Subject|5|||
163106164|NCT02016716|589094045|FG002|Overall Study|Withdrawal by Subject|5|||
163106165|NCT02016716|589094043|FG000|Overall Study|Protocol-specified Criteria|0|||
163106166|NCT02016716|589094044|FG001|Overall Study|Protocol-specified Criteria|1|||
163106167|NCT02016716|589094045|FG002|Overall Study|Protocol-specified Criteria|0|||
163106168|NCT02016716|589094043|FG000|Overall Study|Lost to Follow-up|1|||
163106169|NCT02016716|589094044|FG001|Overall Study|Lost to Follow-up|2|||
163106170|NCT02016716|589094045|FG002|Overall Study|Lost to Follow-up|1|||
163106171|NCT02931838|589094046|FG000|Overall Study|Reason not provided by investigator|1|||
163106172|NCT02931838|589094047|FG001|Overall Study|Reason not provided by investigator|0|||
163106173|NCT02931838|589094048|FG002|Overall Study|Reason not provided by investigator|1|||
163106174|NCT02931838|589094049|FG003|Overall Study|Reason not provided by investigator|0|||
163106175|NCT02931838|589094050|FG004|Overall Study|Reason not provided by investigator|0|||
163106176|NCT02931838|589094051|FG005|Overall Study|Reason not provided by investigator|0|||
163106177|NCT02931838|589094046|FG000|Overall Study|Poor/non-compliance|0|||
163106178|NCT02931838|589094047|FG001|Overall Study|Poor/non-compliance|0|||
163106179|NCT02931838|589094048|FG002|Overall Study|Poor/non-compliance|1|||
163106180|NCT02931838|589094049|FG003|Overall Study|Poor/non-compliance|0|||
163106181|NCT02931838|589094050|FG004|Overall Study|Poor/non-compliance|0|||
163106182|NCT02931838|589094051|FG005|Overall Study|Poor/non-compliance|0|||
163106183|NCT02931838|589094046|FG000|Overall Study|Lack of Efficacy|5|||
163106184|NCT02931838|589094047|FG001|Overall Study|Lack of Efficacy|4|||
163106185|NCT02931838|589094048|FG002|Overall Study|Lack of Efficacy|0|||
163106186|NCT02931838|589094049|FG003|Overall Study|Lack of Efficacy|0|||
163106187|NCT02931838|589094050|FG004|Overall Study|Lack of Efficacy|0|||
163106188|NCT02931838|589094051|FG005|Overall Study|Lack of Efficacy|1|||
163106189|NCT02931838|589094046|FG000|Overall Study|Lost to Follow-up|1|||
163106190|NCT02931838|589094047|FG001|Overall Study|Lost to Follow-up|0|||
163106191|NCT02931838|589094048|FG002|Overall Study|Lost to Follow-up|1|||
163106192|NCT02931838|589094049|FG003|Overall Study|Lost to Follow-up|1|||
163106193|NCT02931838|589094050|FG004|Overall Study|Lost to Follow-up|2|||
163106194|NCT02931838|589094051|FG005|Overall Study|Lost to Follow-up|0|||
163106195|NCT02931838|589094046|FG000|Overall Study|Subject request to discontinue treatment|4|||
163106196|NCT02931838|589094047|FG001|Overall Study|Subject request to discontinue treatment|3|||
163106197|NCT02931838|589094048|FG002|Overall Study|Subject request to discontinue treatment|3|||
163106198|NCT02931838|589094049|FG003|Overall Study|Subject request to discontinue treatment|0|||
163221477|NCT02711800|589528062|FG000|Overall Study|Withdrawal by Subject|1|||
163339665|NCT00473512|589953056|FG001|Period 2 (Phase 2)|Adverse Event|0|||
163106199|NCT02931838|589094050|FG004|Overall Study|Subject request to discontinue treatment|1|||
163106200|NCT02931838|589094051|FG005|Overall Study|Subject request to discontinue treatment|0|||
163106201|NCT02931838|589094046|FG000|Overall Study|Withdrawal by Subject|1|||
163106202|NCT02931838|589094047|FG001|Overall Study|Withdrawal by Subject|2|||
163339666|NCT00473512|589953057|FG002|Period 2 (Phase 2)|Adverse Event|0|||
163339667|NCT00473512|589953058|FG003|Period 2 (Phase 2)|Adverse Event|1|||
163106203|NCT02931838|589094048|FG002|Overall Study|Withdrawal by Subject|0|||
163106204|NCT02931838|589094049|FG003|Overall Study|Withdrawal by Subject|1|||
163106205|NCT02931838|589094050|FG004|Overall Study|Withdrawal by Subject|0|||
163106206|NCT02931838|589094051|FG005|Overall Study|Withdrawal by Subject|0|||
163106207|NCT02931838|589094046|FG000|Overall Study|Adverse Event|2|||
163106208|NCT02931838|589094047|FG001|Overall Study|Adverse Event|1|||
163106209|NCT02931838|589094048|FG002|Overall Study|Adverse Event|2|||
163106210|NCT02931838|589094049|FG003|Overall Study|Adverse Event|1|||
163106211|NCT02931838|589094050|FG004|Overall Study|Adverse Event|3|||
163106212|NCT02931838|589094051|FG005|Overall Study|Adverse Event|1|||
163106213|NCT00104728|589094052|FG000|Overall Study|screen failures|19|||
163106214|NCT01963767|589094053|FG000|Overall Study|Withdrawal by Subject|4|||
163106215|NCT01963767|589094054|FG001|Overall Study|Withdrawal by Subject|2|||
163106216|NCT01963767|589094053|FG000|Overall Study|Adverse Event|2|||
163106217|NCT01963767|589094054|FG001|Overall Study|Adverse Event|0|||
163106218|NCT01659996|589094055|FG000|Overall Study|Protocol Violation|3|||
163106219|NCT01659996|589094056|FG001|Overall Study|Protocol Violation|3|||
163106220|NCT01659996|589094057|FG002|Overall Study|Protocol Violation|3|||
163106221|NCT01659996|589094055|FG000|Overall Study|Lost to Follow-up|1|||
163106222|NCT01659996|589094056|FG001|Overall Study|Lost to Follow-up|3|||
163106223|NCT01659996|589094057|FG002|Overall Study|Lost to Follow-up|2|||
163106224|NCT01659996|589094055|FG000|Overall Study|Adverse Event|0|||
163106225|NCT01659996|589094056|FG001|Overall Study|Adverse Event|0|||
163106226|NCT01659996|589094057|FG002|Overall Study|Adverse Event|1|||
163106227|NCT01659996|589094055|FG000|Overall Study|Withdrawal by Subject|4|||
163106228|NCT01659996|589094056|FG001|Overall Study|Withdrawal by Subject|1|||
163106229|NCT01659996|589094057|FG002|Overall Study|Withdrawal by Subject|5|||
163106230|NCT02709577|589094058|FG000|Overall Study|non-accommodating anatomy|0|||
163106231|NCT02709577|589094059|FG001|Overall Study|non-accommodating anatomy|1|||
163106232|NCT02709577|589094060|FG002|Overall Study|non-accommodating anatomy|0|||
163106233|NCT02709577|589094061|FG003|Overall Study|non-accommodating anatomy|0|||
163106234|NCT02709577|589094058|FG000|Overall Study|procedural complication|0|||
163106235|NCT02709577|589094059|FG001|Overall Study|procedural complication|1|||
163106236|NCT02709577|589094060|FG002|Overall Study|procedural complication|0|||
163106237|NCT02709577|589094061|FG003|Overall Study|procedural complication|0|||
163106238|NCT02709577|589094058|FG000|Overall Study|Withdrawal by Subject|2|||
163106239|NCT02709577|589094059|FG001|Overall Study|Withdrawal by Subject|3|||
163106240|NCT02709577|589094060|FG002|Overall Study|Withdrawal by Subject|2|||
163106241|NCT02709577|589094061|FG003|Overall Study|Withdrawal by Subject|0|||
163106242|NCT03823287|589094062|FG000|Overall Study|Withdrawal by Subject|25|||
163106243|NCT03823287|589094063|FG001|Overall Study|Withdrawal by Subject|17|||
163106244|NCT03823287|589094062|FG000|Overall Study|Death|13|||
163106245|NCT03823287|589094063|FG001|Overall Study|Death|7|||
163106246|NCT03823287|589094062|FG000|Overall Study|Lost to Follow-up|7|||
163106247|NCT03823287|589094063|FG001|Overall Study|Lost to Follow-up|8|||
163106248|NCT03823287|589094062|FG000|Overall Study|Adverse Event|6|||
163106249|NCT03823287|589094063|FG001|Overall Study|Adverse Event|8|||
163106250|NCT03823287|589094062|FG000|Overall Study|Physician Decision|5|||
163106251|NCT03823287|589094063|FG001|Overall Study|Physician Decision|2|||
163106252|NCT03823287|589094062|FG000|Overall Study|Lack of Efficacy|2|||
163106253|NCT03823287|589094063|FG001|Overall Study|Lack of Efficacy|0|||
163106254|NCT03823287|589094062|FG000|Overall Study|Other|2|||
163106255|NCT03823287|589094063|FG001|Overall Study|Other|4|||
163106256|NCT01059864|589094066|FG000|Open-Label Run-In Phase|Adverse Event|7|||
163106257|NCT01059864|589094067|FG001|Open-Label Run-In Phase|Adverse Event|0|||
163106258|NCT01059864|589094068|FG002|Open-Label Run-In Phase|Adverse Event|0|||
163106259|NCT01059864|589094066|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
163106260|NCT01059864|589094067|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
163106261|NCT01059864|589094068|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
163106262|NCT01059864|589094066|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
163106263|NCT01059864|589094067|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
163106264|NCT01059864|589094068|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
163106265|NCT01059864|589094066|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
163106266|NCT01059864|589094067|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
163221478|NCT05442554|589528065|FG000|Overall Study|Adverse Event|1|||
163339668|NCT00473512|589953059|FG004|Period 2 (Phase 2)|Adverse Event|0|||
163106267|NCT01059864|589094068|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
163339669|NCT00473512|589953055|FG000|Period 2 (Phase 2)|Death|0|||
163339670|NCT00473512|589953056|FG001|Period 2 (Phase 2)|Death|0|||
163106268|NCT01059864|589094066|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
163106269|NCT01059864|589094067|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
163106270|NCT01059864|589094068|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
163106271|NCT01059864|589094066|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
163221479|NCT01990495|589528077|FG000|Overall Study|Physician Decision|5|||
163339671|NCT00473512|589953057|FG002|Period 2 (Phase 2)|Death|0|||
163106272|NCT01059864|589094067|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
163106273|NCT01059864|589094068|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
163106274|NCT03108521|589094069|FG000|Overall Study|Lost to Follow-up|3|||
163106275|NCT03108521|589094070|FG001|Overall Study|Lost to Follow-up|0|||
163106276|NCT03108521|589094069|FG000|Overall Study|Lack of Efficacy|2|||
163106277|NCT03108521|589094070|FG001|Overall Study|Lack of Efficacy|0|||
163106278|NCT03108521|589094069|FG000|Overall Study|Physician Decision|4|||
163106279|NCT03108521|589094070|FG001|Overall Study|Physician Decision|0|||
163106280|NCT03108521|589094069|FG000|Overall Study|Adverse Event|3|||
163106281|NCT03108521|589094070|FG001|Overall Study|Adverse Event|0|||
163106282|NCT03281629|589094076|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
163106283|NCT03281629|589094077|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
163106284|NCT03281629|589094076|FG000|Overall Study|Death|0|||
163106285|NCT03281629|589094077|FG001|Overall Study|Death|1|||
163106286|NCT03281629|589094076|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
163106287|NCT03281629|589094077|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
163106288|NCT01456195|589095860|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
163106289|NCT01456195|589095861|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
163106290|NCT01456195|589095862|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
163106291|NCT01456195|589095860|FG000|Overall Study|Lost to Follow-up|3|||
163106292|NCT01456195|589095861|FG001|Overall Study|Lost to Follow-up|1|||
163106293|NCT01456195|589095862|FG002|Overall Study|Lost to Follow-up|3|||
163106294|NCT01456195|589095860|FG000|Overall Study|Voluntary Withdrawal|5|||
163106295|NCT01456195|589095861|FG001|Overall Study|Voluntary Withdrawal|3|||
163106296|NCT01456195|589095862|FG002|Overall Study|Voluntary Withdrawal|7|||
163106297|NCT01456195|589095860|FG000|Overall Study|Lack of Efficacy|0|||
163106298|NCT01456195|589095861|FG001|Overall Study|Lack of Efficacy|1|||
163106299|NCT01456195|589095862|FG002|Overall Study|Lack of Efficacy|0|||
163106300|NCT01456195|589095860|FG000|Overall Study|Other Reasons|2|||
163106301|NCT01456195|589095861|FG001|Overall Study|Other Reasons|1|||
163106302|NCT01456195|589095862|FG002|Overall Study|Other Reasons|3|||
163106303|NCT02109432|589095863|FG000|Overall Study|Withdrawal by Subject|1|||
163106304|NCT03372551|589095870|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
163106305|NCT03372551|589095871|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
163106306|NCT04683029|589095881|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
163106307|NCT04683029|589095882|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
163106308|NCT04683029|589095883|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
163106309|NCT04683029|589095884|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
163106310|NCT04683029|589095881|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
163106311|NCT04683029|589095882|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
163106312|NCT04683029|589095883|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
163106313|NCT04683029|589095884|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
163106314|NCT04683029|589095881|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
163106315|NCT04683029|589095882|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
163106316|NCT04683029|589095883|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
163106317|NCT04683029|589095884|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
163106318|NCT04299308|589095885|FG000|Overall Study|Withdrawal by Subject|1|||
163106319|NCT04299308|589095886|FG001|Overall Study|Withdrawal by Subject|0|||
163106320|NCT04299308|589095885|FG000|Overall Study|issue with PET image (1)|1|||
163106321|NCT04299308|589095886|FG001|Overall Study|issue with PET image (1)|0|||
163106322|NCT02920528|589095889|FG000|Overall Study|Incomplete Data|1|||
163106323|NCT02920528|589095890|FG001|Overall Study|Incomplete Data|1|||
163106324|NCT02920528|589095891|FG002|Overall Study|Incomplete Data|1|||
163106325|NCT02920528|589095889|FG000|Overall Study|Adverse Event|0|||
163106326|NCT02920528|589095890|FG001|Overall Study|Adverse Event|0|||
163106327|NCT02920528|589095891|FG002|Overall Study|Adverse Event|3|||
163106328|NCT02920528|589095889|FG000|Overall Study|Did not meet inclusion criteria|2|||
163106329|NCT02920528|589095890|FG001|Overall Study|Did not meet inclusion criteria|0|||
163106330|NCT02920528|589095891|FG002|Overall Study|Did not meet inclusion criteria|1|||
163106331|NCT03596047|589095893|FG000|Overall Study|Withdrawal by Subject|7|||
163106332|NCT03596047|589095894|FG001|Overall Study|Withdrawal by Subject|4|||
163106333|NCT03596047|589095893|FG000|Overall Study|Lost to Follow-up|0|||
163106334|NCT03596047|589095894|FG001|Overall Study|Lost to Follow-up|2|||
163106335|NCT00066703|589095895|FG000|Overall Study|Adverse Event|80|||
163106336|NCT00066703|589095896|FG001|Overall Study|Adverse Event|111|||
163106337|NCT00066703|589095895|FG000|Overall Study|Death|3|||
163106338|NCT00066703|589095896|FG001|Overall Study|Death|0|||
163106339|NCT00066703|589095895|FG000|Overall Study|Lack of Efficacy|114|||
163106340|NCT00066703|589095896|FG001|Overall Study|Lack of Efficacy|69|||
163106341|NCT00066703|589095895|FG000|Overall Study|Lost to Follow-up|31|||
163106342|NCT00066703|589095896|FG001|Overall Study|Lost to Follow-up|28|||
163106343|NCT00066703|589095895|FG000|Overall Study|Withdrawal by Subject|38|||
163106344|NCT00066703|589095896|FG001|Overall Study|Withdrawal by Subject|63|||
163106345|NCT00066703|589095895|FG000|Overall Study|Treatment ongoing|346|||
163106346|NCT00066703|589095896|FG001|Overall Study|Treatment ongoing|311|||
163106347|NCT01696968|589095897|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
163106348|NCT01696968|589095898|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
163106349|NCT01696968|589095897|FG000|Overall Study|Died Before Randomization|3|||
163106350|NCT01696968|589095898|FG001|Overall Study|Died Before Randomization|8|||
163106351|NCT01696968|589095897|FG000|Overall Study|Died Before ASU (Control)|278|||
163106352|NCT01696968|589095898|FG001|Overall Study|Died Before ASU (Control)|0|||
163106353|NCT01696968|589095897|FG000|Overall Study|Refused ASU (Control)|920|||
163106354|NCT01696968|589095898|FG001|Overall Study|Refused ASU (Control)|0|||
163106355|NCT01696968|589095897|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
163106356|NCT01696968|589095898|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
163106357|NCT00734604|589095899|FG000|Overall Study|Adverse Event|0|||
163106358|NCT00734604|589095900|FG001|Overall Study|Adverse Event|2|||
163106359|NCT00734604|589095901|FG002|Overall Study|Adverse Event|0|||
163106360|NCT00734604|589095902|FG003|Overall Study|Adverse Event|2|||
163106361|NCT00734604|589095903|FG004|Overall Study|Adverse Event|1|||
163106362|NCT00734604|589095904|FG005|Overall Study|Adverse Event|1|||
163106363|NCT00734604|589095899|FG000|Overall Study|Serious Adverse Event|1|||
163106364|NCT00734604|589095900|FG001|Overall Study|Serious Adverse Event|0|||
163106365|NCT00734604|589095901|FG002|Overall Study|Serious Adverse Event|1|||
163106366|NCT00734604|589095902|FG003|Overall Study|Serious Adverse Event|2|||
163106367|NCT00734604|589095903|FG004|Overall Study|Serious Adverse Event|0|||
163106368|NCT00734604|589095904|FG005|Overall Study|Serious Adverse Event|1|||
163106369|NCT00734604|589095899|FG000|Overall Study|Lost to Follow-up|1|||
163106370|NCT00734604|589095900|FG001|Overall Study|Lost to Follow-up|2|||
163106371|NCT00734604|589095901|FG002|Overall Study|Lost to Follow-up|2|||
163106372|NCT00734604|589095902|FG003|Overall Study|Lost to Follow-up|4|||
163106373|NCT00734604|589095903|FG004|Overall Study|Lost to Follow-up|2|||
163106374|NCT00734604|589095904|FG005|Overall Study|Lost to Follow-up|3|||
163106375|NCT00734604|589095899|FG000|Overall Study|Physician Decision|0|||
163106376|NCT00734604|589095900|FG001|Overall Study|Physician Decision|1|||
163106377|NCT00734604|589095901|FG002|Overall Study|Physician Decision|1|||
163106378|NCT00734604|589095902|FG003|Overall Study|Physician Decision|0|||
163106379|NCT00734604|589095903|FG004|Overall Study|Physician Decision|0|||
163106380|NCT00734604|589095904|FG005|Overall Study|Physician Decision|0|||
163106381|NCT00734604|589095899|FG000|Overall Study|Protocol Violation|0|||
163106382|NCT00734604|589095900|FG001|Overall Study|Protocol Violation|2|||
163106383|NCT00734604|589095901|FG002|Overall Study|Protocol Violation|0|||
163106384|NCT00734604|589095902|FG003|Overall Study|Protocol Violation|0|||
163106385|NCT00734604|589095903|FG004|Overall Study|Protocol Violation|1|||
163106386|NCT00734604|589095904|FG005|Overall Study|Protocol Violation|0|||
163106387|NCT00734604|589095899|FG000|Overall Study|Sponsor Decision|1|||
163106388|NCT00734604|589095900|FG001|Overall Study|Sponsor Decision|2|||
163106389|NCT00734604|589095901|FG002|Overall Study|Sponsor Decision|1|||
163106390|NCT00734604|589095902|FG003|Overall Study|Sponsor Decision|0|||
163106391|NCT00734604|589095903|FG004|Overall Study|Sponsor Decision|2|||
163106392|NCT00734604|589095904|FG005|Overall Study|Sponsor Decision|0|||
163106393|NCT00734604|589095899|FG000|Overall Study|Withdrawal by Subject|0|||
163106394|NCT00734604|589095900|FG001|Overall Study|Withdrawal by Subject|2|||
163106395|NCT00734604|589095901|FG002|Overall Study|Withdrawal by Subject|0|||
163106396|NCT00734604|589095902|FG003|Overall Study|Withdrawal by Subject|1|||
163106397|NCT00734604|589095903|FG004|Overall Study|Withdrawal by Subject|2|||
163106398|NCT00734604|589095904|FG005|Overall Study|Withdrawal by Subject|1|||
163106399|NCT00734604|589095899|FG000|Overall Study|Lack of Efficacy|0|||
163106400|NCT00734604|589095900|FG001|Overall Study|Lack of Efficacy|1|||
163106401|NCT00734604|589095901|FG002|Overall Study|Lack of Efficacy|1|||
163106402|NCT00734604|589095902|FG003|Overall Study|Lack of Efficacy|0|||
163106403|NCT00734604|589095903|FG004|Overall Study|Lack of Efficacy|0|||
163106404|NCT00734604|589095904|FG005|Overall Study|Lack of Efficacy|0|||
163106405|NCT02199314|589095905|FG000|Overall Study|Withdrawal by Subject|6|||
163106406|NCT02199314|589095905|FG000|Overall Study|Physician Decision|10|||
163106407|NCT04848220|589095906|FG000|Overall Study|Unable to proceed to study procedure|0|||
163106408|NCT04848220|589095907|FG001|Overall Study|Unable to proceed to study procedure|1|||
163106409|NCT04848220|589095908|FG002|Overall Study|Unable to proceed to study procedure|0|||
163106410|NCT04848220|589095906|FG000|Overall Study|Fractional flow not significant|0|||
163106411|NCT04848220|589095907|FG001|Overall Study|Fractional flow not significant|1|||
163106412|NCT04848220|589095908|FG002|Overall Study|Fractional flow not significant|0|||
163106413|NCT02557100|589095913|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
163106414|NCT02557100|589095914|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
163106415|NCT02557100|589095915|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
163106416|NCT02557100|589095913|FG000|Single Blind Treatment Period|Death|0|||
163106417|NCT02557100|589095914|FG001|Single Blind Treatment Period|Death|1|||
163106418|NCT02557100|589095915|FG002|Single Blind Treatment Period|Death|0|||
163106419|NCT02557100|589095913|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
163106420|NCT02557100|589095914|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
163106421|NCT02557100|589095915|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
163106422|NCT02557100|589095913|FG000|Single Blind Treatment Period|Adverse Event|0|||
163221480|NCT01990495|589528078|FG001|Overall Study|Physician Decision|4|||
163221481|NCT00097721|589528079|FG000|Overall Study|Adverse Event|8|||
163221482|NCT00097721|589528080|FG001|Overall Study|Adverse Event|1|||
163106423|NCT02557100|589095914|FG001|Single Blind Treatment Period|Adverse Event|1|||
163106424|NCT02557100|589095915|FG002|Single Blind Treatment Period|Adverse Event|0|||
163221483|NCT00097721|589528079|FG000|Overall Study|Withdrawal by Subject|6|||
163221484|NCT00097721|589528080|FG001|Overall Study|Withdrawal by Subject|1|||
163221485|NCT00097721|589528079|FG000|Overall Study|Progressive Disease|55|||
163221486|NCT00097721|589528080|FG001|Overall Study|Progressive Disease|27|||
163221487|NCT00097721|589528079|FG000|Overall Study|Physician Decision|1|||
163221488|NCT00097721|589528080|FG001|Overall Study|Physician Decision|3|||
163221489|NCT00097721|589528079|FG000|Overall Study|Reason not given|1|||
163221490|NCT00097721|589528080|FG001|Overall Study|Reason not given|1|||
163221491|NCT00449956|589528081|FG000|Overall Study|Adverse Event|7|||
163221492|NCT00449956|589528082|FG001|Overall Study|Adverse Event|1|||
163221493|NCT00449956|589528083|FG002|Overall Study|Adverse Event|6|||
163221494|NCT00449956|589528081|FG000|Overall Study|Lack of Efficacy|0|||
163221495|NCT00449956|589528082|FG001|Overall Study|Lack of Efficacy|0|||
163221496|NCT00449956|589528083|FG002|Overall Study|Lack of Efficacy|1|||
163221497|NCT00449956|589528081|FG000|Overall Study|Protocol Violation|1|||
163221498|NCT00449956|589528082|FG001|Overall Study|Protocol Violation|1|||
163221499|NCT00449956|589528083|FG002|Overall Study|Protocol Violation|1|||
163221500|NCT00449956|589528081|FG000|Overall Study|Withdrawal by Subject|0|||
163221501|NCT00449956|589528082|FG001|Overall Study|Withdrawal by Subject|1|||
163221502|NCT00449956|589528083|FG002|Overall Study|Withdrawal by Subject|0|||
163221503|NCT00449956|589528081|FG000|Overall Study|Physician Decision|2|||
163221504|NCT00449956|589528082|FG001|Overall Study|Physician Decision|1|||
163221505|NCT00449956|589528083|FG002|Overall Study|Physician Decision|1|||
163221506|NCT02972632|589528093|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
163221507|NCT02972632|589528093|FG000|Overall Study|Lost to Follow-up|4|||
163407730|NCT00464334|590200882|FG001|Overall Study|Withdrawal by Subject|7|||
163407731|NCT00464334|590200883|FG002|Overall Study|Withdrawal by Subject|4|||
163407732|NCT00464334|590200884|FG003|Overall Study|Withdrawal by Subject|2|||
163407733|NCT00464334|590200885|FG004|Overall Study|Withdrawal by Subject|2|||
163407734|NCT00464334|590200886|FG005|Overall Study|Withdrawal by Subject|2|||
163407735|NCT00464334|590200887|FG006|Overall Study|Withdrawal by Subject|2|||
163407736|NCT00464334|590200888|FG007|Overall Study|Withdrawal by Subject|1|||
163407737|NCT00464334|590200889|FG008|Overall Study|Withdrawal by Subject|3|||
163106425|NCT02557100|589095913|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
163106426|NCT02557100|589095914|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
163106427|NCT02557100|589095915|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
163106428|NCT02557100|589095913|FG000|Cumulative Abatacept Period|Other Reasons|0|||
163106429|NCT02557100|589095914|FG001|Cumulative Abatacept Period|Other Reasons|0|||
163106430|NCT02557100|589095915|FG002|Cumulative Abatacept Period|Other Reasons|1|||
163106431|NCT02557100|589095913|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
163106432|NCT02557100|589095914|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
163106433|NCT02557100|589095915|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
163106434|NCT02557100|589095913|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
163106435|NCT02557100|589095914|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
163106436|NCT02557100|589095915|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
163106437|NCT02513485|589095919|FG000|Overall Study|Adverse Event|1|||
163106438|NCT02513485|589095920|FG001|Overall Study|Adverse Event|0|||
163106439|NCT01406938|589095936|FG000|Induction Period|Subject/guardian decision|6|||
163106440|NCT01406938|589095937|FG001|Induction Period|Subject/guardian decision|8|||
163407738|NCT00464334|590200890|FG009|Overall Study|Withdrawal by Subject|0|||
163407739|NCT00464334|590200891|FG010|Overall Study|Withdrawal by Subject|0|||
163407740|NCT00797732|590200892|FG000|Overall Study|Withdrawal by Subject|3|||
163407741|NCT00797732|590200893|FG001|Overall Study|Withdrawal by Subject|3|||
163407742|NCT00797732|590200894|FG002|Overall Study|Withdrawal by Subject|0|||
163407743|NCT00797732|590200892|FG000|Overall Study|Lost to Follow-up|1|||
163407744|NCT00797732|590200893|FG001|Overall Study|Lost to Follow-up|0|||
163407745|NCT00797732|590200894|FG002|Overall Study|Lost to Follow-up|0|||
163106441|NCT01406938|589095938|FG002|Induction Period|Subject/guardian decision|0|||
163106442|NCT01406938|589095939|FG003|Induction Period|Subject/guardian decision|0|||
163106443|NCT01406938|589095940|FG004|Induction Period|Subject/guardian decision|0|||
163106444|NCT01406938|589095941|FG005|Induction Period|Subject/guardian decision|0|||
163221508|NCT02972632|589528093|FG000|Overall Study|Voluntary Withdrawal|10|||
163221509|NCT02126969|589528094|FG000|Overall Study|Withdrawal by Subject|1|||
163221510|NCT02126969|589528095|FG001|Overall Study|Withdrawal by Subject|2|||
163221511|NCT00354172|589528096|FG000|Overall Study|Did not receive transplant|1|||
163221512|NCT01828034|589528097|FG000|Overall Study|Withdrawal by Subject|0|||
163221513|NCT01828034|589528098|FG001|Overall Study|Withdrawal by Subject|0|||
163221514|NCT01828034|589528099|FG002|Overall Study|Withdrawal by Subject|0|||
163221515|NCT01828034|589528100|FG003|Overall Study|Withdrawal by Subject|1|||
163221516|NCT02023151|589528101|FG000|Overall Study|Lost to Follow-up|4|||
163407746|NCT00797732|590200892|FG000|Overall Study|Death|1|||
163407747|NCT00797732|590200893|FG001|Overall Study|Death|0|||
163407748|NCT00797732|590200894|FG002|Overall Study|Death|0|||
163407749|NCT00797732|590200892|FG000|Overall Study|Not meet inclusion criteria|0|||
163407750|NCT00797732|590200893|FG001|Overall Study|Not meet inclusion criteria|0|||
163407751|NCT00797732|590200894|FG002|Overall Study|Not meet inclusion criteria|7|||
163407752|NCT00797732|590200892|FG000|Overall Study|Excluded due to time constraints|0|||
163407753|NCT00797732|590200893|FG001|Overall Study|Excluded due to time constraints|0|||
163407754|NCT00797732|590200894|FG002|Overall Study|Excluded due to time constraints|24|||
163407755|NCT00797732|590200892|FG000|Overall Study|Refused to Participate|0|||
163407756|NCT00797732|590200893|FG001|Overall Study|Refused to Participate|0|||
163407757|NCT00797732|590200894|FG002|Overall Study|Refused to Participate|123|||
163407758|NCT03948178|590200895|FG000|Overall Study|Protocol Violation|1|||
163221517|NCT03450707|589528102|FG000|Overall Study|Outside enrollment window|4|||
163221518|NCT03450707|589528103|FG001|Overall Study|Outside enrollment window|1|||
163221519|NCT03450707|589528102|FG000|Overall Study|Death|1|||
163221520|NCT03450707|589528103|FG001|Overall Study|Death|0|||
163221521|NCT03450707|589528102|FG000|Overall Study|Indication for thiamine|1|||
163221522|NCT03450707|589528103|FG001|Overall Study|Indication for thiamine|1|||
163221523|NCT03450707|589528102|FG000|Overall Study|Evidence of traumatic brain injury|1|||
163221524|NCT03450707|589528103|FG001|Overall Study|Evidence of traumatic brain injury|0|||
163221525|NCT03450707|589528102|FG000|Overall Study|Following commands|0|||
163221526|NCT03450707|589528103|FG001|Overall Study|Following commands|3|||
163221527|NCT03450707|589528102|FG000|Overall Study|Lactate < 3.5|0|||
163221528|NCT03450707|589528103|FG001|Overall Study|Lactate < 3.5|2|||
163221529|NCT03450707|589528102|FG000|Overall Study|Rearrest with ECMO|0|||
163221530|NCT03450707|589528103|FG001|Overall Study|Rearrest with ECMO|1|||
163221531|NCT03450707|589528102|FG000|Overall Study|Indication for thiamine + head CT results|0|||
163221532|NCT03450707|589528103|FG001|Overall Study|Indication for thiamine + head CT results|1|||
163221533|NCT03450707|589528102|FG000|Overall Study|Family/patient goals of care|0|||
163221534|NCT03450707|589528103|FG001|Overall Study|Family/patient goals of care|1|||
163221535|NCT02871375|589528104|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
163221536|NCT02871375|589528105|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
163221537|NCT01988571|589528108|FG000|Overall Study|Death|3|||
163221538|NCT01988571|589528109|FG001|Overall Study|Death|1|||
163221539|NCT01988571|589528108|FG000|Overall Study|Physician Decision|2|||
163221540|NCT01988571|589528109|FG001|Overall Study|Physician Decision|1|||
163221541|NCT01988571|589528108|FG000|Overall Study|Lost to Follow-up|3|||
163221542|NCT01988571|589528109|FG001|Overall Study|Lost to Follow-up|0|||
163221543|NCT01988571|589528108|FG000|Overall Study|Withdrawal by Subject|31|||
163221544|NCT01988571|589528109|FG001|Overall Study|Withdrawal by Subject|33|||
163221545|NCT00004412|589528110|FG000|Randomized Period|Moved to Crossover Period|3|||
163221546|NCT00004412|589528111|FG001|Randomized Period|Moved to Crossover Period|0|||
163221547|NCT00004412|589528112|FG002|Randomized Period|Moved to Crossover Period|0|||
163221548|NCT00337103|589528113|FG000|Overall Study|Progressive Disease|414|||
163221549|NCT00337103|589528114|FG001|Overall Study|Progressive Disease|410|||
163221550|NCT00337103|589528113|FG000|Overall Study|Adverse Event|45|||
163221551|NCT00337103|589528114|FG001|Overall Study|Adverse Event|59|||
163221552|NCT00337103|589528113|FG000|Overall Study|Subject Choice|34|||
163221553|NCT00337103|589528114|FG001|Overall Study|Subject Choice|27|||
163221554|NCT00337103|589528113|FG000|Overall Study|Clinical Progression|27|||
163221555|NCT00337103|589528114|FG001|Overall Study|Clinical Progression|24|||
163221556|NCT00337103|589528113|FG000|Overall Study|Physician Decision|15|||
163221557|NCT00337103|589528114|FG001|Overall Study|Physician Decision|14|||
163221558|NCT00337103|589528113|FG000|Overall Study|Withdrawal by Subject|8|||
163221559|NCT00337103|589528114|FG001|Overall Study|Withdrawal by Subject|5|||
163221560|NCT00337103|589528113|FG000|Overall Study|Other|5|||
163221561|NCT00337103|589528114|FG001|Overall Study|Other|6|||
163221562|NCT00337103|589528113|FG000|Overall Study|Entry Criteria Not Met|4|||
163221563|NCT00337103|589528114|FG001|Overall Study|Entry Criteria Not Met|1|||
163221564|NCT00337103|589528113|FG000|Overall Study|Lost to Follow-up|1|||
163407759|NCT03948178|590200895|FG000|Overall Study|Lost to Follow-up|2|||
163407760|NCT03948178|590200895|FG000|Overall Study|Withdrawal by Subject|2|||
163407761|NCT03948178|590200895|FG000|Overall Study|Reason not known|2|||
163221565|NCT00337103|589528114|FG001|Overall Study|Lost to Follow-up|2|||
163221566|NCT00337103|589528113|FG000|Overall Study|Death|1|||
163221567|NCT00337103|589528114|FG001|Overall Study|Death|0|||
163221568|NCT03387813|589528115|FG000|Overall Study|Death|40|||
163221569|NCT03387813|589528116|FG001|Overall Study|Death|37|||
163221570|NCT03387813|589528117|FG002|Overall Study|Death|190|||
163221571|NCT03387813|589528115|FG000|Overall Study|Withdrawal by Subject|9|||
163221572|NCT03387813|589528116|FG001|Overall Study|Withdrawal by Subject|19|||
163221573|NCT03387813|589528117|FG002|Overall Study|Withdrawal by Subject|32|||
163221574|NCT03387813|589528115|FG000|Overall Study|Lost to Follow-up|3|||
163221575|NCT03387813|589528116|FG001|Overall Study|Lost to Follow-up|9|||
163407762|NCT03948178|590200895|FG000|Overall Study|Personal reason|14|||
163221576|NCT03387813|589528117|FG002|Overall Study|Lost to Follow-up|15|||
163221577|NCT03387813|589528115|FG000|Overall Study|Non-Compliance|6|||
163106445|NCT01406938|589095936|FG000|Induction Period|Protocol deviation|1|||
163106446|NCT01406938|589095937|FG001|Induction Period|Protocol deviation|0|||
163106447|NCT01406938|589095938|FG002|Induction Period|Protocol deviation|0|||
163106448|NCT01406938|589095939|FG003|Induction Period|Protocol deviation|0|||
163106449|NCT01406938|589095940|FG004|Induction Period|Protocol deviation|0|||
163106450|NCT01406938|589095941|FG005|Induction Period|Protocol deviation|0|||
163106451|NCT01406938|589095936|FG000|Induction Period|Adverse Event|8|||
163106452|NCT01406938|589095937|FG001|Induction Period|Adverse Event|9|||
163106453|NCT01406938|589095938|FG002|Induction Period|Adverse Event|0|||
163106454|NCT01406938|589095939|FG003|Induction Period|Adverse Event|0|||
163106455|NCT01406938|589095940|FG004|Induction Period|Adverse Event|0|||
163106456|NCT01406938|589095941|FG005|Induction Period|Adverse Event|0|||
163106457|NCT01406938|589095936|FG000|Induction Period|Lack of Efficacy|1|||
163106458|NCT01406938|589095937|FG001|Induction Period|Lack of Efficacy|0|||
163106459|NCT01406938|589095938|FG002|Induction Period|Lack of Efficacy|0|||
163106460|NCT01406938|589095939|FG003|Induction Period|Lack of Efficacy|0|||
163106461|NCT01406938|589095940|FG004|Induction Period|Lack of Efficacy|0|||
163106462|NCT01406938|589095941|FG005|Induction Period|Lack of Efficacy|0|||
163106463|NCT01406938|589095936|FG000|Induction Period|Lost to Follow-up|2|||
163106464|NCT01406938|589095937|FG001|Induction Period|Lost to Follow-up|3|||
163106465|NCT01406938|589095938|FG002|Induction Period|Lost to Follow-up|0|||
163106466|NCT01406938|589095939|FG003|Induction Period|Lost to Follow-up|0|||
163106467|NCT01406938|589095940|FG004|Induction Period|Lost to Follow-up|0|||
163106468|NCT01406938|589095941|FG005|Induction Period|Lost to Follow-up|0|||
163106469|NCT01406938|589095936|FG000|Maintenance Period|Adverse Event|0|||
163106470|NCT01406938|589095937|FG001|Maintenance Period|Adverse Event|0|||
163106471|NCT01406938|589095938|FG002|Maintenance Period|Adverse Event|2|||
163106472|NCT01406938|589095939|FG003|Maintenance Period|Adverse Event|8|||
163106473|NCT01406938|589095940|FG004|Maintenance Period|Adverse Event|4|||
163106474|NCT01406938|589095941|FG005|Maintenance Period|Adverse Event|2|||
163106475|NCT01406938|589095936|FG000|Maintenance Period|Death|0|||
163106476|NCT01406938|589095937|FG001|Maintenance Period|Death|0|||
163106477|NCT01406938|589095938|FG002|Maintenance Period|Death|0|||
163106478|NCT01406938|589095939|FG003|Maintenance Period|Death|0|||
163106479|NCT01406938|589095940|FG004|Maintenance Period|Death|1|||
163106480|NCT01406938|589095941|FG005|Maintenance Period|Death|0|||
163106481|NCT01406938|589095936|FG000|Maintenance Period|Subject/guardian decision|0|||
163106482|NCT01406938|589095937|FG001|Maintenance Period|Subject/guardian decision|0|||
163106483|NCT01406938|589095938|FG002|Maintenance Period|Subject/guardian decision|11|||
163106484|NCT01406938|589095939|FG003|Maintenance Period|Subject/guardian decision|7|||
163106485|NCT01406938|589095940|FG004|Maintenance Period|Subject/guardian decision|10|||
163106486|NCT01406938|589095941|FG005|Maintenance Period|Subject/guardian decision|7|||
163106487|NCT01406938|589095936|FG000|Maintenance Period|Protocol Violation|0|||
163106488|NCT01406938|589095937|FG001|Maintenance Period|Protocol Violation|0|||
163106489|NCT01406938|589095938|FG002|Maintenance Period|Protocol Violation|2|||
163106490|NCT01406938|589095939|FG003|Maintenance Period|Protocol Violation|2|||
163106491|NCT01406938|589095940|FG004|Maintenance Period|Protocol Violation|2|||
163106492|NCT01406938|589095941|FG005|Maintenance Period|Protocol Violation|2|||
163106493|NCT01406938|589095936|FG000|Maintenance Period|Pregnancy|0|||
163106494|NCT01406938|589095937|FG001|Maintenance Period|Pregnancy|0|||
163106495|NCT01406938|589095938|FG002|Maintenance Period|Pregnancy|0|||
163106496|NCT01406938|589095939|FG003|Maintenance Period|Pregnancy|0|||
163106497|NCT01406938|589095940|FG004|Maintenance Period|Pregnancy|1|||
163106498|NCT01406938|589095941|FG005|Maintenance Period|Pregnancy|0|||
163106499|NCT01406938|589095936|FG000|Maintenance Period|Lost to Follow-up|0|||
163106500|NCT01406938|589095937|FG001|Maintenance Period|Lost to Follow-up|0|||
163106501|NCT01406938|589095938|FG002|Maintenance Period|Lost to Follow-up|0|||
163106502|NCT01406938|589095939|FG003|Maintenance Period|Lost to Follow-up|0|||
163106503|NCT01406938|589095940|FG004|Maintenance Period|Lost to Follow-up|4|||
163106504|NCT01406938|589095941|FG005|Maintenance Period|Lost to Follow-up|0|||
163106505|NCT01406938|589095936|FG000|Maintenance Period|Lack of Efficacy|0|||
163106506|NCT01406938|589095937|FG001|Maintenance Period|Lack of Efficacy|0|||
163106507|NCT01406938|589095938|FG002|Maintenance Period|Lack of Efficacy|2|||
163106508|NCT01406938|589095939|FG003|Maintenance Period|Lack of Efficacy|1|||
163106509|NCT01406938|589095940|FG004|Maintenance Period|Lack of Efficacy|3|||
163106510|NCT01406938|589095941|FG005|Maintenance Period|Lack of Efficacy|5|||
163106511|NCT01406938|589095936|FG000|Follow up|Lack of Efficacy|3|||
163106512|NCT01406938|589095937|FG001|Follow up|Lack of Efficacy|2|||
163106513|NCT01406938|589095938|FG002|Follow up|Lack of Efficacy|1|||
163106514|NCT01406938|589095939|FG003|Follow up|Lack of Efficacy|0|||
163106515|NCT01406938|589095940|FG004|Follow up|Lack of Efficacy|0|||
163106516|NCT01406938|589095941|FG005|Follow up|Lack of Efficacy|0|||
163106517|NCT01406938|589095936|FG000|Follow up|Patient/guardian decision|4|||
163106518|NCT01406938|589095937|FG001|Follow up|Patient/guardian decision|2|||
163106519|NCT01406938|589095938|FG002|Follow up|Patient/guardian decision|4|||
163106520|NCT01406938|589095939|FG003|Follow up|Patient/guardian decision|2|||
163106521|NCT01406938|589095940|FG004|Follow up|Patient/guardian decision|4|||
163106522|NCT01406938|589095941|FG005|Follow up|Patient/guardian decision|1|||
163221578|NCT03387813|589528116|FG001|Overall Study|Non-Compliance|6|||
163221579|NCT03387813|589528117|FG002|Overall Study|Non-Compliance|31|||
163221580|NCT03387813|589528115|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
163221581|NCT03387813|589528116|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
163221582|NCT03387813|589528117|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
163221583|NCT00149747|589528132|FG000|Overall Study|Death|1|||
163221584|NCT00149747|589528133|FG001|Overall Study|Death|0|||
163221585|NCT00149747|589528132|FG000|Overall Study|Withdrawal by Subject|3|||
163221586|NCT00149747|589528133|FG001|Overall Study|Withdrawal by Subject|3|||
163221587|NCT03373383|589528134|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
163221588|NCT03373383|589528135|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
163221589|NCT03373383|589528136|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
163221590|NCT03373383|589528137|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
163221591|NCT03373383|589528138|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
163221592|NCT03373383|589528134|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
163221593|NCT03373383|589528135|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
163106523|NCT01406938|589095936|FG000|Follow up|Protocol Violation|0|||
163106524|NCT01406938|589095937|FG001|Follow up|Protocol Violation|0|||
163106525|NCT01406938|589095938|FG002|Follow up|Protocol Violation|1|||
163106526|NCT01406938|589095939|FG003|Follow up|Protocol Violation|0|||
163106527|NCT01406938|589095940|FG004|Follow up|Protocol Violation|0|||
163106528|NCT01406938|589095941|FG005|Follow up|Protocol Violation|0|||
163106529|NCT01406938|589095936|FG000|Follow up|Physician Decision|0|||
163106530|NCT01406938|589095937|FG001|Follow up|Physician Decision|0|||
163106531|NCT01406938|589095938|FG002|Follow up|Physician Decision|2|||
163106532|NCT01406938|589095939|FG003|Follow up|Physician Decision|0|||
163106533|NCT01406938|589095940|FG004|Follow up|Physician Decision|3|||
163106534|NCT01406938|589095941|FG005|Follow up|Physician Decision|1|||
163106535|NCT01406938|589095936|FG000|Follow up|Lost to Follow-up|1|||
163106536|NCT01406938|589095937|FG001|Follow up|Lost to Follow-up|1|||
163106537|NCT01406938|589095938|FG002|Follow up|Lost to Follow-up|0|||
163106538|NCT01406938|589095939|FG003|Follow up|Lost to Follow-up|1|||
163106539|NCT01406938|589095940|FG004|Follow up|Lost to Follow-up|2|||
163106540|NCT01406938|589095941|FG005|Follow up|Lost to Follow-up|1|||
163106541|NCT01576146|589095944|FG000|Extension Period 1|Adverse Event|2|||
163106542|NCT01576146|589095944|FG000|Extension Period 1|Death|2|||
163106543|NCT01576146|589095944|FG000|Extension Period 1|Physician Decision|2|||
163106544|NCT01576146|589095944|FG000|Extension Period 1|Withdrawal by Subject|1|||
163106545|NCT01576146|589095944|FG000|Extension Period 1|Lost to Follow-up|1|||
163106546|NCT01576146|589095944|FG000|Extension Period 1|Parathyroidectomy|1|||
163106547|NCT01576146|589095944|FG000|Extension Period 1|Renal Transplant|1|||
163106548|NCT01576146|589095944|FG000|Extension Period 2|Sponsor Decision|13|||
163106549|NCT01576146|589095944|FG000|Extension Period 2|Death|1|||
163106550|NCT01576146|589095944|FG000|Extension Period 2|Adverse Event|1|||
163106551|NCT01576146|589095944|FG000|Extension Period 2|Renal Transplant|1|||
163106552|NCT01576146|589095944|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
163106553|NCT03654404|589095946|FG000|Overall Study|Death|1|||
163106554|NCT03654404|589095946|FG000|Overall Study|Lost to Follow-up|2|||
163106555|NCT03654404|589095946|FG000|Overall Study|Withdrawal by Subject|5|||
163106556|NCT00654745|589095947|FG000|Overall Study|Adverse Event|12|||
163106557|NCT00654745|589095947|FG000|Overall Study|Lost to Follow-up|7|||
163106558|NCT00654745|589095947|FG000|Overall Study|Protocol Violation|11|||
163106559|NCT00654745|589095947|FG000|Overall Study|Withdrawal by Subject|10|||
163106560|NCT00654745|589095947|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
163106561|NCT00194077|589095950|FG000|Overall Study|Lack of Efficacy|22|||
163106562|NCT00194077|589095951|FG001|Overall Study|Lack of Efficacy|29|||
163106563|NCT00194077|589095950|FG000|Overall Study|Study nonadherence|1|||
163106564|NCT00194077|589095951|FG001|Overall Study|Study nonadherence|0|||
163106565|NCT00194077|589095950|FG000|Overall Study|Withdrawal by Subject|1|||
163106566|NCT00194077|589095951|FG001|Overall Study|Withdrawal by Subject|1|||
163221594|NCT03373383|589528136|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
163407763|NCT03948178|590200895|FG000|Overall Study|Disease progression|30|||
163407764|NCT03948178|590200895|FG000|Overall Study|Adverse Event|12|||
163106567|NCT03470194|589095952|FG000|Overall Study|Lost to Follow-up|11|||
163221595|NCT03373383|589528137|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
163221596|NCT03373383|589528138|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
163407765|NCT03948178|590200895|FG000|Overall Study|Sponsor terminated study|164|||
163407766|NCT01087905|590200907|FG000|Overall Study|Lost to Follow-up|24|||
163106568|NCT03470194|589095953|FG001|Overall Study|Lost to Follow-up|17|||
163106569|NCT01822899|589095954|FG000|Overall Study|Adverse Event|6|||
163106570|NCT01822899|589095955|FG001|Overall Study|Adverse Event|5|||
163106571|NCT01822899|589095954|FG000|Overall Study|Lack of Efficacy|6|||
163106572|NCT01822899|589095955|FG001|Overall Study|Lack of Efficacy|3|||
163106573|NCT01822899|589095954|FG000|Overall Study|Protocol Violation|6|||
163106574|NCT01822899|589095955|FG001|Overall Study|Protocol Violation|3|||
163106575|NCT01822899|589095954|FG000|Overall Study|Lost to Follow-up|1|||
163106576|NCT01822899|589095955|FG001|Overall Study|Lost to Follow-up|0|||
163339672|NCT00473512|589953058|FG003|Period 2 (Phase 2)|Death|1|||
163106577|NCT01822899|589095954|FG000|Overall Study|Withdrawal by Subject|5|||
163106578|NCT01822899|589095955|FG001|Overall Study|Withdrawal by Subject|7|||
163106579|NCT00759876|589095957|FG000|Overall Study|Sponsor terminated study early|36|||
163106580|NCT01450696|589095958|FG000|Overall Study|Never Treated|1|||
163106581|NCT01450696|589095959|FG001|Overall Study|Never Treated|1|||
163106582|NCT01450696|589095958|FG000|Overall Study|Death|77|||
163106583|NCT01450696|589095959|FG001|Overall Study|Death|84|||
163106584|NCT01450696|589095958|FG000|Overall Study|Lost to Follow-up|3|||
163106585|NCT01450696|589095959|FG001|Overall Study|Lost to Follow-up|3|||
163106586|NCT01450696|589095958|FG000|Overall Study|Non-Compliance|1|||
163106587|NCT01450696|589095959|FG001|Overall Study|Non-Compliance|0|||
163106588|NCT01450696|589095958|FG000|Overall Study|Withdrawal by Subject|13|||
163106589|NCT01450696|589095959|FG001|Overall Study|Withdrawal by Subject|2|||
163106590|NCT01450696|589095958|FG000|Overall Study|Study Terminated by Sponsor|53|||
163106591|NCT01450696|589095959|FG001|Overall Study|Study Terminated by Sponsor|58|||
163106592|NCT02570152|589095960|FG000|Overall Study|Protocol Violation|2|||
163106593|NCT02570152|589095960|FG000|Overall Study|Migrated/moved from study area|13|||
163106594|NCT02684617|589095961|FG000|Overall Study|Adverse Event|1|||
163106595|NCT02684617|589095962|FG001|Overall Study|Adverse Event|0|||
163106596|NCT02684617|589095963|FG002|Overall Study|Adverse Event|1|||
163106597|NCT02684617|589095961|FG000|Overall Study|Death|8|||
163106598|NCT02684617|589095962|FG001|Overall Study|Death|16|||
163106599|NCT02684617|589095963|FG002|Overall Study|Death|28|||
163106600|NCT02684617|589095961|FG000|Overall Study|Withdrawal by Subject|2|||
163106601|NCT02684617|589095962|FG001|Overall Study|Withdrawal by Subject|0|||
163106602|NCT02684617|589095963|FG002|Overall Study|Withdrawal by Subject|4|||
163106603|NCT02684617|589095961|FG000|Overall Study|Screen Failure|1|||
163106604|NCT02684617|589095962|FG001|Overall Study|Screen Failure|0|||
163106605|NCT02684617|589095963|FG002|Overall Study|Screen Failure|2|||
163106606|NCT02684617|589095961|FG000|Overall Study|Study Terminated by Sponsor|6|||
163106607|NCT02684617|589095962|FG001|Overall Study|Study Terminated by Sponsor|1|||
163106608|NCT02684617|589095963|FG002|Overall Study|Study Terminated by Sponsor|5|||
163106609|NCT00853242|589095964|FG000|Overall Study|Adverse Event|0|||
163106610|NCT00853242|589095965|FG001|Overall Study|Adverse Event|1|||
163106611|NCT00853242|589095966|FG002|Overall Study|Adverse Event|1|||
163106612|NCT00853242|589095967|FG003|Overall Study|Adverse Event|0|||
163106613|NCT00853242|589095968|FG004|Overall Study|Adverse Event|3|||
163106614|NCT00853242|589095969|FG005|Overall Study|Adverse Event|1|||
163106615|NCT00853242|589095970|FG006|Overall Study|Adverse Event|1|||
163106616|NCT00853242|589095964|FG000|Overall Study|Noncompliant|0|||
163106617|NCT00853242|589095965|FG001|Overall Study|Noncompliant|0|||
163106618|NCT00853242|589095966|FG002|Overall Study|Noncompliant|0|||
163106619|NCT00853242|589095967|FG003|Overall Study|Noncompliant|0|||
163106620|NCT00853242|589095968|FG004|Overall Study|Noncompliant|1|||
163106621|NCT00853242|589095969|FG005|Overall Study|Noncompliant|0|||
163106622|NCT00853242|589095970|FG006|Overall Study|Noncompliant|0|||
163106623|NCT00853242|589095964|FG000|Overall Study|Withdrawal by Subject|1|||
163106624|NCT00853242|589095965|FG001|Overall Study|Withdrawal by Subject|2|||
163106625|NCT00853242|589095966|FG002|Overall Study|Withdrawal by Subject|0|||
163106626|NCT00853242|589095967|FG003|Overall Study|Withdrawal by Subject|4|||
163106627|NCT00853242|589095968|FG004|Overall Study|Withdrawal by Subject|0|||
163106628|NCT00853242|589095969|FG005|Overall Study|Withdrawal by Subject|0|||
163106629|NCT00853242|589095970|FG006|Overall Study|Withdrawal by Subject|2|||
163106630|NCT00853242|589095964|FG000|Overall Study|Other|2|||
163106631|NCT00853242|589095965|FG001|Overall Study|Other|0|||
163106632|NCT00853242|589095966|FG002|Overall Study|Other|2|||
163106633|NCT00853242|589095967|FG003|Overall Study|Other|0|||
163106634|NCT00853242|589095968|FG004|Overall Study|Other|0|||
163106635|NCT00853242|589095969|FG005|Overall Study|Other|1|||
163106636|NCT00853242|589095970|FG006|Overall Study|Other|2|||
163106637|NCT02516098|589095978|FG000|Period 1|Protocol Violation|1|||
163106638|NCT02516098|589095979|FG001|Period 1|Protocol Violation|0|||
163106639|NCT02516098|589095978|FG000|Washout After Period 1|Adverse Event|0|||
163106640|NCT02516098|589095979|FG001|Washout After Period 1|Adverse Event|1|||
163106641|NCT02516098|589095978|FG000|Period 2|Withdrawal by Subject|0|||
163106642|NCT02516098|589095979|FG001|Period 2|Withdrawal by Subject|1|||
163106643|NCT01092780|589095980|FG000|Washout Period 1|Adverse Event|0|||
163106644|NCT01092780|589095981|FG001|Washout Period 1|Adverse Event|1|||
163106645|NCT01092780|589095982|FG002|Washout Period 1|Adverse Event|0|||
163106646|NCT01092780|589095983|FG003|Washout Period 1|Adverse Event|0|||
163339673|NCT00473512|589953059|FG004|Period 2 (Phase 2)|Death|1|||
163106647|NCT01092780|589095980|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
163106648|NCT01092780|589095981|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
163106649|NCT01092780|589095982|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
163106650|NCT01092780|589095983|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
163106651|NCT01092780|589095980|FG000|Washout Period 2|Adverse Event|0|||
163106652|NCT01092780|589095981|FG001|Washout Period 2|Adverse Event|1|||
163106653|NCT01092780|589095982|FG002|Washout Period 2|Adverse Event|1|||
163106654|NCT01092780|589095983|FG003|Washout Period 2|Adverse Event|0|||
163106655|NCT01257230|589095984|FG000|Overall Study|Not Treated|0|||
163106656|NCT01257230|589095985|FG001|Overall Study|Not Treated|0|||
163106657|NCT01257230|589095986|FG002|Overall Study|Not Treated|1|||
163106658|NCT01257230|589095984|FG000|Overall Study|Adverse Event|2|||
163106659|NCT01257230|589095985|FG001|Overall Study|Adverse Event|0|||
163106660|NCT01257230|589095986|FG002|Overall Study|Adverse Event|0|||
163106661|NCT01257230|589095984|FG000|Overall Study|Lack of Efficacy|0|||
163106662|NCT01257230|589095985|FG001|Overall Study|Lack of Efficacy|1|||
163106663|NCT01257230|589095986|FG002|Overall Study|Lack of Efficacy|0|||
163106664|NCT01257230|589095984|FG000|Overall Study|Protocol Violation|3|||
163106665|NCT01257230|589095985|FG001|Overall Study|Protocol Violation|0|||
163106666|NCT01257230|589095986|FG002|Overall Study|Protocol Violation|1|||
163106667|NCT01257230|589095984|FG000|Overall Study|Withdrawal by Subject|0|||
163106668|NCT01257230|589095985|FG001|Overall Study|Withdrawal by Subject|4|||
163106669|NCT01257230|589095986|FG002|Overall Study|Withdrawal by Subject|1|||
163106670|NCT01257230|589095984|FG000|Overall Study|Other reason not defined above|1|||
163106671|NCT01257230|589095985|FG001|Overall Study|Other reason not defined above|5|||
163106672|NCT01257230|589095986|FG002|Overall Study|Other reason not defined above|3|||
163106673|NCT01205061|589095989|FG000|Overall Study|Adverse Event|4|||
163106674|NCT01205061|589095989|FG000|Overall Study|Withdrawal by Subject|11|||
163106675|NCT01205061|589095989|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
163106676|NCT01205061|589095989|FG000|Overall Study|Lost to Follow-up|9|||
163106677|NCT01205061|589095989|FG000|Overall Study|Other|1|||
163106678|NCT04026009|589095990|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163106679|NCT04026009|589095991|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
163106680|NCT04026009|589095992|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
163106681|NCT04026009|589095993|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
163106682|NCT04026009|589095994|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
163106683|NCT04026009|589095990|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
163106684|NCT04026009|589095991|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
163106685|NCT04026009|589095992|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
163106686|NCT04026009|589095993|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
163106687|NCT04026009|589095994|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
163106688|NCT01988662|589095995|FG000|Overall Study|Subject/guardian decision|1|||
163106689|NCT01988662|589095996|FG001|Overall Study|Subject/guardian decision|1|||
163106690|NCT01988662|589095995|FG000|Overall Study|Adverse Event|3|||
163106691|NCT01988662|589095996|FG001|Overall Study|Adverse Event|1|||
163106692|NCT00615719|589095997|FG000|Overall Study|Physician Decision|5|||
163106693|NCT02300558|589095998|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
163106694|NCT02300558|589095998|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
163106695|NCT02300558|589095998|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
163106696|NCT02300558|589095998|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
163106697|NCT01471028|589095999|FG000|VTI-208|Adverse Event|39|||
163106698|NCT01471028|589096000|FG001|VTI-208|Adverse Event|41|||
163106699|NCT01471028|589095999|FG000|VTI-208|Withdrawal by Subject|0|||
163106700|NCT01471028|589096000|FG001|VTI-208|Withdrawal by Subject|2|||
163106701|NCT01471028|589095999|FG000|VTI-208|Lost to Follow-up|1|||
163106702|NCT01471028|589096000|FG001|VTI-208|Lost to Follow-up|1|||
163106703|NCT01471028|589095999|FG000|VTI-208E|Death|7|||
163106704|NCT01471028|589096000|FG001|VTI-208E|Death|10|||
163106705|NCT01471028|589095999|FG000|VTI-208E|Withdrawal by Subject|1|||
163106706|NCT01471028|589096000|FG001|VTI-208E|Withdrawal by Subject|0|||
163106707|NCT01471028|589095999|FG000|VTI-208E|Lost to Follow-up|0|||
163106708|NCT01471028|589096000|FG001|VTI-208E|Lost to Follow-up|2|||
163106709|NCT02957747|589096001|FG000|Overall Study|Withdrawal by Subject|0|||
163106710|NCT02957747|589096002|FG001|Overall Study|Withdrawal by Subject|3|||
163106711|NCT02957747|589096001|FG000|Overall Study|Lost to Follow-up|10|||
163106712|NCT02957747|589096002|FG001|Overall Study|Lost to Follow-up|5|||
163106713|NCT01355679|589096007|FG000|Overall Study|benign tumor types found at biopsy|2|||
163106714|NCT02027311|589096008|FG000|Overall Study|Protocol Violation|3|||
163339674|NCT00473512|589953055|FG000|Period 2 (Phase 2)|Disease Progression|0|||
163106715|NCT02027311|589096009|FG001|Overall Study|Protocol Violation|2|||
163106716|NCT00964002|589096010|FG000|Overall Study|Protocol Violation|8|||
163221597|NCT03373383|589528134|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
163221598|NCT03373383|589528135|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
163339675|NCT00473512|589953056|FG001|Period 2 (Phase 2)|Disease Progression|2|||
163339676|NCT00473512|589953057|FG002|Period 2 (Phase 2)|Disease Progression|2|||
163221599|NCT03373383|589528136|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
163339677|NCT00473512|589953058|FG003|Period 2 (Phase 2)|Disease Progression|17|||
163106717|NCT03768089|589096011|FG000|Part A|Lost to Follow-up|0|||
163106718|NCT03768089|589096012|FG001|Part A|Lost to Follow-up|0|||
163106719|NCT03768089|589096013|FG002|Part A|Lost to Follow-up|0|||
163106720|NCT03768089|589096014|FG003|Part A|Lost to Follow-up|0|||
163106721|NCT03768089|589096015|FG004|Part A|Lost to Follow-up|1|||
163106722|NCT03768089|589096016|FG005|Part A|Lost to Follow-up|0|||
163106723|NCT03768089|589096017|FG006|Part A|Lost to Follow-up|0|||
163106724|NCT03768089|589096018|FG007|Part A|Lost to Follow-up|0|||
163339678|NCT00473512|589953059|FG004|Period 2 (Phase 2)|Disease Progression|1|||
163339679|NCT00473512|589953055|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
163339680|NCT00473512|589953056|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
163339681|NCT00473512|589953057|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
163106725|NCT03768089|589096019|FG008|Part A|Lost to Follow-up|0|||
163106726|NCT03768089|589096020|FG009|Part A|Lost to Follow-up|0|||
163106727|NCT03768089|589096021|FG010|Part A|Lost to Follow-up|0|||
163106728|NCT03768089|589096022|FG011|Part A|Lost to Follow-up|0|||
163106729|NCT03768089|589096023|FG012|Part A|Lost to Follow-up|0|||
163106730|NCT03768089|589096024|FG013|Part A|Lost to Follow-up|0|||
163106731|NCT03768089|589096025|FG014|Part A|Lost to Follow-up|0|||
163106732|NCT03768089|589096026|FG015|Part A|Lost to Follow-up|0|||
163106733|NCT03768089|589096027|FG016|Part A|Lost to Follow-up|0|||
163106734|NCT03768089|589096028|FG017|Part A|Lost to Follow-up|0|||
163106735|NCT03768089|589096011|FG000|Part C|Randomized, Never Dosed|0|||
163106736|NCT03768089|589096012|FG001|Part C|Randomized, Never Dosed|0|||
163106737|NCT03768089|589096013|FG002|Part C|Randomized, Never Dosed|0|||
163106738|NCT03768089|589096014|FG003|Part C|Randomized, Never Dosed|0|||
163106739|NCT03768089|589096015|FG004|Part C|Randomized, Never Dosed|0|||
163106740|NCT03768089|589096016|FG005|Part C|Randomized, Never Dosed|0|||
163106741|NCT03768089|589096017|FG006|Part C|Randomized, Never Dosed|0|||
163106742|NCT03768089|589096018|FG007|Part C|Randomized, Never Dosed|0|||
163106743|NCT03768089|589096019|FG008|Part C|Randomized, Never Dosed|0|||
163106744|NCT03768089|589096020|FG009|Part C|Randomized, Never Dosed|0|||
163106745|NCT03768089|589096021|FG010|Part C|Randomized, Never Dosed|0|||
163106746|NCT03768089|589096022|FG011|Part C|Randomized, Never Dosed|0|||
163106747|NCT03768089|589096023|FG012|Part C|Randomized, Never Dosed|0|||
163106748|NCT03768089|589096024|FG013|Part C|Randomized, Never Dosed|0|||
163106749|NCT03768089|589096025|FG014|Part C|Randomized, Never Dosed|1|||
163106750|NCT03768089|589096026|FG015|Part C|Randomized, Never Dosed|0|||
163106751|NCT03768089|589096027|FG016|Part C|Randomized, Never Dosed|0|||
163106752|NCT03768089|589096028|FG017|Part C|Randomized, Never Dosed|0|||
163106753|NCT02091362|589096033|FG000|Period 1|Protocol Violation|1|||
163106754|NCT02091362|589096034|FG001|Period 1|Protocol Violation|0|||
163106755|NCT02091362|589096033|FG000|Period 1|Withdrawal by Subject|2|||
163106756|NCT02091362|589096034|FG001|Period 1|Withdrawal by Subject|3|||
163106757|NCT02091362|589096033|FG000|Period 1|Lost to Follow-up|0|||
163106758|NCT02091362|589096034|FG001|Period 1|Lost to Follow-up|1|||
163106759|NCT02091362|589096033|FG000|Period 1|Adverse Event|2|||
163106760|NCT02091362|589096034|FG001|Period 1|Adverse Event|0|||
163106761|NCT02091362|589096033|FG000|Wash-out|Lost to Follow-up|1|||
163106762|NCT02091362|589096034|FG001|Wash-out|Lost to Follow-up|1|||
163106763|NCT02091362|589096033|FG000|Wash-out|Withdrawal by Subject|0|||
163106764|NCT02091362|589096034|FG001|Wash-out|Withdrawal by Subject|2|||
163106765|NCT02091362|589096033|FG000|Period 2|Adverse Event|1|||
163106766|NCT02091362|589096034|FG001|Period 2|Adverse Event|0|||
163106767|NCT02091362|589096033|FG000|Period 2|Lost to Follow-up|0|||
163106768|NCT02091362|589096034|FG001|Period 2|Lost to Follow-up|1|||
163106769|NCT02091362|589096033|FG000|Period 2|Withdrawal by Subject|1|||
163106770|NCT02091362|589096034|FG001|Period 2|Withdrawal by Subject|1|||
163106771|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
163106772|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
163106773|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
163106774|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
163106775|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Death|58|||
163106776|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Death|65|||
163106777|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Adverse Event|28|||
163106778|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Adverse Event|40|||
163106779|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Disease Progression|22|||
163106780|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Disease Progression|35|||
163106781|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Other|25|||
163106782|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Other|33|||
163106783|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
163106784|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
163106785|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Noncompliance|8|||
163106786|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Noncompliance|8|||
163106787|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
163106788|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
163106789|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
163106790|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
163106791|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
163106792|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
163339682|NCT00473512|589953058|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
163106793|NCT00286091|589096035|FG000|Open-label Treatment Phase|Physician Decision|24|||
163106794|NCT00286091|589096036|FG001|Open-label Treatment Phase|Physician Decision|21|||
163106795|NCT00286091|589096035|FG000|Open-label Treatment Phase|Adverse Event|5|||
163106796|NCT00286091|589096036|FG001|Open-label Treatment Phase|Adverse Event|16|||
163106797|NCT00286091|589096035|FG000|Open-label Treatment Phase|Other|11|||
163106798|NCT00286091|589096036|FG001|Open-label Treatment Phase|Other|11|||
163106799|NCT00286091|589096035|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
163106800|NCT00286091|589096036|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
163106801|NCT00286091|589096035|FG000|Open-label Treatment Phase|Death|10|||
163106802|NCT00286091|589096036|FG001|Open-label Treatment Phase|Death|7|||
163106803|NCT00286091|589096035|FG000|Open-label Treatment Phase|Disease Progression|9|||
163106804|NCT00286091|589096036|FG001|Open-label Treatment Phase|Disease Progression|3|||
163106805|NCT00286091|589096035|FG000|Open-label Treatment Phase|Noncompliance|3|||
163106806|NCT00286091|589096036|FG001|Open-label Treatment Phase|Noncompliance|1|||
163106807|NCT00286091|589096035|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
163106808|NCT00286091|589096036|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
163106809|NCT00286091|589096035|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
163106810|NCT00286091|589096036|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
163106811|NCT00286091|589096035|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
163106812|NCT00286091|589096036|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
163106813|NCT02936869|589096037|FG000|Overall Study|Lost to Follow-up|1|||
163106814|NCT02936869|589096038|FG001|Overall Study|Lost to Follow-up|3|||
163106815|NCT02936869|589096037|FG000|Overall Study|Death|0|||
163106816|NCT02936869|589096038|FG001|Overall Study|Death|1|||
163106817|NCT02936869|589096037|FG000|Overall Study|Legal Case|0|||
163106818|NCT02936869|589096038|FG001|Overall Study|Legal Case|1|||
163106819|NCT02936869|589096037|FG000|Overall Study|Protocol Violation|1|||
163106820|NCT02936869|589096038|FG001|Overall Study|Protocol Violation|0|||
163106821|NCT00335738|589096039|FG000|Overall Study|Physician Decision|6|||
163106822|NCT00335738|589096040|FG001|Overall Study|Physician Decision|0|||
163106823|NCT00335738|589096039|FG000|Overall Study|Withdrawal by Subject|2|||
163106824|NCT00335738|589096040|FG001|Overall Study|Withdrawal by Subject|0|||
163106825|NCT00335738|589096039|FG000|Overall Study|Ineligible|3|||
163106826|NCT00335738|589096040|FG001|Overall Study|Ineligible|4|||
163106827|NCT05141175|589096043|FG000|Overall Study|Withdrawal by Subject|1|||
163106828|NCT02036580|589096044|FG000|Overall Study|Withdrawal by Subject|0|||
163106829|NCT02036580|589096045|FG001|Overall Study|Withdrawal by Subject|1|||
163106830|NCT02036580|589096046|FG002|Overall Study|Withdrawal by Subject|0|||
163106831|NCT02036580|589096044|FG000|Overall Study|Adverse Event|1|||
163106832|NCT02036580|589096045|FG001|Overall Study|Adverse Event|0|||
163106833|NCT02036580|589096046|FG002|Overall Study|Adverse Event|0|||
163106834|NCT04470050|589096053|FG000|Double-blind Treatment Phase|Adverse Event|0|||
163106835|NCT04470050|589096054|FG001|Double-blind Treatment Phase|Adverse Event|0|||
163106836|NCT04470050|589096055|FG002|Double-blind Treatment Phase|Adverse Event|0|||
163106837|NCT04470050|589096056|FG003|Double-blind Treatment Phase|Adverse Event|1|||
163106838|NCT04470050|589096057|FG004|Double-blind Treatment Phase|Adverse Event|0|||
163106839|NCT04470050|589096058|FG005|Double-blind Treatment Phase|Adverse Event|0|||
163106840|NCT04470050|589096059|FG006|Double-blind Treatment Phase|Adverse Event|0|||
163106841|NCT04470050|589096053|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
163106842|NCT04470050|589096054|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
163106843|NCT04470050|589096055|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
163106844|NCT04470050|589096056|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
163106845|NCT04470050|589096057|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
163106846|NCT04470050|589096058|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
163106847|NCT04470050|589096059|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
163106848|NCT04470050|589096053|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
163106849|NCT04470050|589096054|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
163106850|NCT04470050|589096055|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
163106851|NCT04470050|589096056|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
163106852|NCT04470050|589096057|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
163106853|NCT04470050|589096058|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
163106854|NCT04470050|589096059|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
163106855|NCT03098433|589096060|FG000|Overall Study|Withdrawal by Subject|10|||
163106856|NCT01813058|589096061|FG000|Overall Study|Withdrawal by Subject|5|||
163106857|NCT01813058|589096062|FG001|Overall Study|Withdrawal by Subject|4|||
163106858|NCT03585764|589096063|FG000|Overall Study|Death|3|||
163106859|NCT03585764|589096064|FG001|Overall Study|Death|2|||
163106860|NCT03585764|589096065|FG002|Overall Study|Death|3|||
163106861|NCT03585764|589096066|FG003|Overall Study|Death|0|||
163106862|NCT03585764|589096063|FG000|Overall Study|Lost to Follow-up|0|||
163106863|NCT03585764|589096064|FG001|Overall Study|Lost to Follow-up|1|||
163106864|NCT03585764|589096065|FG002|Overall Study|Lost to Follow-up|0|||
163106865|NCT03585764|589096066|FG003|Overall Study|Lost to Follow-up|0|||
163106866|NCT03585764|589096063|FG000|Overall Study|Physician Decision|0|||
163106867|NCT03585764|589096064|FG001|Overall Study|Physician Decision|0|||
163106868|NCT03585764|589096065|FG002|Overall Study|Physician Decision|2|||
163106869|NCT03585764|589096066|FG003|Overall Study|Physician Decision|0|||
163106870|NCT01581021|589096068|FG000|Overall Study|Lost to Follow-up|4|||
163106871|NCT01581021|589096069|FG001|Overall Study|Lost to Follow-up|6|||
163407767|NCT01087905|590200908|FG001|Overall Study|Lost to Follow-up|28|||
163106872|NCT01581021|589096068|FG000|Overall Study|More than 2 hooks in thoracic|3|||
163106873|NCT01581021|589096069|FG001|Overall Study|More than 2 hooks in thoracic|0|||
163106874|NCT01581021|589096068|FG000|Overall Study|Neuromuscular|2|||
163106875|NCT01581021|589096069|FG001|Overall Study|Neuromuscular|1|||
163106876|NCT01581021|589096068|FG000|Overall Study|Not Randomized|1|||
163106877|NCT01581021|589096069|FG001|Overall Study|Not Randomized|2|||
163106878|NCT01581021|589096068|FG000|Overall Study|Lenke 6 Classification|0|||
163106879|NCT01581021|589096069|FG001|Overall Study|Lenke 6 Classification|1|||
163106880|NCT01581021|589096068|FG000|Overall Study|Lack of Efficacy|0|||
163106881|NCT01581021|589096069|FG001|Overall Study|Lack of Efficacy|1|||
163106882|NCT03604172|589096070|FG000|Overall Study|Lost to Follow-up|1|||
163106883|NCT03604172|589096071|FG001|Overall Study|Lost to Follow-up|2|||
163106884|NCT00054327|589096072|FG000|Overall Study|Engraftment failure|1|||
163106885|NCT00054327|589096073|FG001|Overall Study|Engraftment failure|0|||
163106886|NCT00054327|589096074|FG002|Overall Study|Engraftment failure|0|||
163106887|NCT00054327|589096075|FG003|Overall Study|Engraftment failure|0|||
163106888|NCT00054327|589096076|FG004|Overall Study|Engraftment failure|0|||
163106889|NCT00054327|589096077|FG005|Overall Study|Engraftment failure|0|||
163106890|NCT03028129|589096080|FG000|Overall Study|Adverse Event|13|||
163106891|NCT03028129|589096081|FG001|Overall Study|Adverse Event|2|||
163106892|NCT03028129|589096080|FG000|Overall Study|Lost to Follow-up|50|||
163106893|NCT03028129|589096081|FG001|Overall Study|Lost to Follow-up|38|||
163106894|NCT03028129|589096080|FG000|Overall Study|Physician Decision|0|||
163106895|NCT03028129|589096081|FG001|Overall Study|Physician Decision|1|||
163106896|NCT03028129|589096080|FG000|Overall Study|Protocol Violation|1|||
163106897|NCT03028129|589096081|FG001|Overall Study|Protocol Violation|1|||
163106898|NCT03028129|589096080|FG000|Overall Study|Withdrawal by Subject|62|||
163106899|NCT03028129|589096081|FG001|Overall Study|Withdrawal by Subject|45|||
163106900|NCT00923351|589096082|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
163106901|NCT00923351|589096083|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
163106902|NCT00923351|589096084|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
163106903|NCT02597452|589096086|FG000|Overall Study|testing incomplete|30|||
163106904|NCT01579565|589098100|FG000|Randomized|Adverse Event|1|||
163106905|NCT01579565|589098101|FG001|Randomized|Adverse Event|3|||
163106906|NCT01579565|589098100|FG000|Randomized|Withdrawal by Subject|3|||
163106907|NCT01579565|589098101|FG001|Randomized|Withdrawal by Subject|0|||
163106908|NCT01579565|589098100|FG000|Randomized|inadequate preoperative pupil dilation|0|||
163106909|NCT01579565|589098101|FG001|Randomized|inadequate preoperative pupil dilation|1|||
163106910|NCT01579565|589098100|FG000|Randomized|prohibited preoperative eating|1|||
163106911|NCT01579565|589098101|FG001|Randomized|prohibited preoperative eating|0|||
163106912|NCT01579565|589098100|FG000|Randomized|prohibited preoperative medication|0|||
163106913|NCT01579565|589098101|FG001|Randomized|prohibited preoperative medication|1|||
163106914|NCT01579565|589098100|FG000|Treated|Physician Decision|0|||
163106915|NCT01579565|589098101|FG001|Treated|Physician Decision|1|||
163106916|NCT01579565|589098100|FG000|Treated|Lost to Follow-up|2|||
163106917|NCT01579565|589098101|FG001|Treated|Lost to Follow-up|1|||
163106918|NCT01579565|589098100|FG000|Treated|declined to return for final visit|0|||
163407768|NCT01087905|590200909|FG002|Overall Study|Lost to Follow-up|18|||
163407769|NCT01087905|590200910|FG003|Overall Study|Lost to Follow-up|31|||
163407770|NCT01087905|590200911|FG004|Overall Study|Lost to Follow-up|27|||
163407771|NCT01087905|590200912|FG005|Overall Study|Lost to Follow-up|25|||
163407772|NCT01087905|590200913|FG006|Overall Study|Lost to Follow-up|20|||
163407773|NCT01087905|590200914|FG007|Overall Study|Lost to Follow-up|24|||
163407774|NCT01087905|590200907|FG000|Overall Study|Withdrawal by Subject|5|||
163407775|NCT01087905|590200908|FG001|Overall Study|Withdrawal by Subject|4|||
163407776|NCT01087905|590200909|FG002|Overall Study|Withdrawal by Subject|4|||
163407777|NCT01087905|590200910|FG003|Overall Study|Withdrawal by Subject|5|||
163407778|NCT01087905|590200911|FG004|Overall Study|Withdrawal by Subject|4|||
163407779|NCT01087905|590200912|FG005|Overall Study|Withdrawal by Subject|3|||
163407780|NCT01087905|590200913|FG006|Overall Study|Withdrawal by Subject|3|||
163407781|NCT01087905|590200914|FG007|Overall Study|Withdrawal by Subject|5|||
163407782|NCT02873936|590200915|FG000|Overall Study|Withdrew Consent|4|||
163407783|NCT02873936|590200916|FG001|Overall Study|Withdrew Consent|11|||
163106919|NCT01579565|589098101|FG001|Treated|declined to return for final visit|1|||
163106920|NCT01380535|589098102|FG000|Overall Study|Adverse Event|3|||
163106921|NCT01380535|589098103|FG001|Overall Study|Adverse Event|3|||
163407784|NCT02873936|590200917|FG002|Overall Study|Withdrew Consent|20|||
163106922|NCT01380535|589098102|FG000|Overall Study|Death|3|||
163407785|NCT02873936|590200915|FG000|Overall Study|Investigator's Discretion|3|||
163407786|NCT02873936|590200916|FG001|Overall Study|Investigator's Discretion|5|||
163407787|NCT02873936|590200917|FG002|Overall Study|Investigator's Discretion|4|||
163407788|NCT02873936|590200915|FG000|Overall Study|Adverse Event|3|||
163106923|NCT01380535|589098103|FG001|Overall Study|Death|0|||
163106924|NCT01380535|589098102|FG000|Overall Study|Study site closed|0|||
163106925|NCT01380535|589098103|FG001|Overall Study|Study site closed|5|||
163106926|NCT01380535|589098102|FG000|Overall Study|Withdrawal by Subject|1|||
163106927|NCT01380535|589098103|FG001|Overall Study|Withdrawal by Subject|2|||
163106928|NCT01380535|589098102|FG000|Overall Study|Protocol Violation|0|||
163106929|NCT01380535|589098103|FG001|Overall Study|Protocol Violation|2|||
163106930|NCT01380535|589098102|FG000|Overall Study|Lack of Efficacy|0|||
163106931|NCT01380535|589098103|FG001|Overall Study|Lack of Efficacy|3|||
163106932|NCT00489424|589098109|FG000|Overall Study|Adverse Event|3|||
163106933|NCT00489424|589098110|FG001|Overall Study|Adverse Event|3|||
163106934|NCT00489424|589098111|FG002|Overall Study|Adverse Event|4|||
163106935|NCT00489424|589098109|FG000|Overall Study|Lack of Efficacy|1|||
163106936|NCT00489424|589098110|FG001|Overall Study|Lack of Efficacy|0|||
163106937|NCT00489424|589098111|FG002|Overall Study|Lack of Efficacy|0|||
163106938|NCT00489424|589098109|FG000|Overall Study|Administrative problems|0|||
163106939|NCT00489424|589098110|FG001|Overall Study|Administrative problems|2|||
163106940|NCT00489424|589098111|FG002|Overall Study|Administrative problems|1|||
163106941|NCT00394251|589098112|FG000|Overall Study|Adverse Event|7|||
163106942|NCT00394251|589098113|FG001|Overall Study|Adverse Event|5|||
163106943|NCT00394251|589098112|FG000|Overall Study|Unacceptable Toxicity|20|||
163106944|NCT00394251|589098113|FG001|Overall Study|Unacceptable Toxicity|18|||
163106945|NCT00394251|589098112|FG000|Overall Study|Physician Decision|1|||
163106946|NCT00394251|589098113|FG001|Overall Study|Physician Decision|1|||
163106947|NCT00394251|589098112|FG000|Overall Study|Protocol Violation|0|||
163106948|NCT00394251|589098113|FG001|Overall Study|Protocol Violation|1|||
163106949|NCT00394251|589098112|FG000|Overall Study|Withdrawal by Subject|7|||
163106950|NCT00394251|589098113|FG001|Overall Study|Withdrawal by Subject|11|||
163106951|NCT00394251|589098112|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
163106952|NCT00394251|589098113|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
163106953|NCT01436656|589098114|FG000|Dose Escalation|Death|1|||
163106954|NCT01436656|589098115|FG001|Dose Escalation|Death|3|||
163106955|NCT01436656|589098116|FG002|Dose Escalation|Death|1|||
163106956|NCT01436656|589098117|FG003|Dose Escalation|Death|0|||
163106957|NCT01436656|589098118|FG004|Dose Escalation|Death|2|||
163106958|NCT01436656|589098119|FG005|Dose Escalation|Death|1|||
163106959|NCT01436656|589098120|FG006|Dose Escalation|Death|1|||
163106960|NCT01436656|589098121|FG007|Dose Escalation|Death|1|||
163106961|NCT01436656|589098122|FG008|Dose Escalation|Death|1|||
163106962|NCT01436656|589098123|FG009|Dose Escalation|Death|0|||
163106963|NCT01436656|589098124|FG010|Dose Escalation|Death|0|||
163106964|NCT01436656|589098125|FG011|Dose Escalation|Death|0|||
163106965|NCT01436656|589098126|FG012|Dose Escalation|Death|0|||
163106966|NCT01436656|589098127|FG013|Dose Escalation|Death|0|||
163106967|NCT01436656|589098128|FG014|Dose Escalation|Death|0|||
163106968|NCT01436656|589098129|FG015|Dose Escalation|Death|0|||
163106969|NCT01436656|589098130|FG016|Dose Escalation|Death|0|||
163106970|NCT01436656|589098131|FG017|Dose Escalation|Death|0|||
163106971|NCT01436656|589098114|FG000|Dose Escalation|Protocol Violation|0|||
163106972|NCT01436656|589098115|FG001|Dose Escalation|Protocol Violation|0|||
163106973|NCT01436656|589098116|FG002|Dose Escalation|Protocol Violation|0|||
163106974|NCT01436656|589098117|FG003|Dose Escalation|Protocol Violation|0|||
163106975|NCT01436656|589098118|FG004|Dose Escalation|Protocol Violation|0|||
163106976|NCT01436656|589098119|FG005|Dose Escalation|Protocol Violation|1|||
163106977|NCT01436656|589098120|FG006|Dose Escalation|Protocol Violation|0|||
163106978|NCT01436656|589098121|FG007|Dose Escalation|Protocol Violation|0|||
163106979|NCT01436656|589098122|FG008|Dose Escalation|Protocol Violation|0|||
163106980|NCT01436656|589098123|FG009|Dose Escalation|Protocol Violation|0|||
163106981|NCT01436656|589098124|FG010|Dose Escalation|Protocol Violation|0|||
163106982|NCT01436656|589098125|FG011|Dose Escalation|Protocol Violation|0|||
163106983|NCT01436656|589098126|FG012|Dose Escalation|Protocol Violation|0|||
163106984|NCT01436656|589098127|FG013|Dose Escalation|Protocol Violation|0|||
163106985|NCT01436656|589098128|FG014|Dose Escalation|Protocol Violation|0|||
163106986|NCT01436656|589098129|FG015|Dose Escalation|Protocol Violation|0|||
163106987|NCT01436656|589098130|FG016|Dose Escalation|Protocol Violation|0|||
163106988|NCT01436656|589098131|FG017|Dose Escalation|Protocol Violation|0|||
163221600|NCT03373383|589528137|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
163221601|NCT03373383|589528138|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
163106989|NCT01436656|589098114|FG000|Dose Escalation|Withdrawal by Subject|0|||
163106990|NCT01436656|589098115|FG001|Dose Escalation|Withdrawal by Subject|0|||
163106991|NCT01436656|589098116|FG002|Dose Escalation|Withdrawal by Subject|0|||
163106992|NCT01436656|589098117|FG003|Dose Escalation|Withdrawal by Subject|0|||
163106993|NCT01436656|589098118|FG004|Dose Escalation|Withdrawal by Subject|1|||
163106994|NCT01436656|589098119|FG005|Dose Escalation|Withdrawal by Subject|0|||
163106995|NCT01436656|589098120|FG006|Dose Escalation|Withdrawal by Subject|0|||
163106996|NCT01436656|589098121|FG007|Dose Escalation|Withdrawal by Subject|2|||
163106997|NCT01436656|589098122|FG008|Dose Escalation|Withdrawal by Subject|0|||
163106998|NCT01436656|589098123|FG009|Dose Escalation|Withdrawal by Subject|1|||
163407789|NCT02873936|590200916|FG001|Overall Study|Adverse Event|5|||
163106999|NCT01436656|589098124|FG010|Dose Escalation|Withdrawal by Subject|1|||
163107000|NCT01436656|589098125|FG011|Dose Escalation|Withdrawal by Subject|0|||
163107001|NCT01436656|589098126|FG012|Dose Escalation|Withdrawal by Subject|0|||
163107002|NCT01436656|589098127|FG013|Dose Escalation|Withdrawal by Subject|0|||
163107003|NCT01436656|589098128|FG014|Dose Escalation|Withdrawal by Subject|0|||
163107004|NCT01436656|589098129|FG015|Dose Escalation|Withdrawal by Subject|0|||
163107005|NCT01436656|589098130|FG016|Dose Escalation|Withdrawal by Subject|0|||
163107006|NCT01436656|589098131|FG017|Dose Escalation|Withdrawal by Subject|0|||
163107007|NCT01436656|589098114|FG000|Dose Escalation|Administrative problems|0|||
163107008|NCT01436656|589098115|FG001|Dose Escalation|Administrative problems|1|||
163107009|NCT01436656|589098116|FG002|Dose Escalation|Administrative problems|0|||
163107010|NCT01436656|589098117|FG003|Dose Escalation|Administrative problems|0|||
163107011|NCT01436656|589098118|FG004|Dose Escalation|Administrative problems|0|||
163107012|NCT01436656|589098119|FG005|Dose Escalation|Administrative problems|0|||
163107013|NCT01436656|589098120|FG006|Dose Escalation|Administrative problems|0|||
163107014|NCT01436656|589098121|FG007|Dose Escalation|Administrative problems|0|||
163107015|NCT01436656|589098122|FG008|Dose Escalation|Administrative problems|0|||
163107016|NCT01436656|589098123|FG009|Dose Escalation|Administrative problems|0|||
163107017|NCT01436656|589098124|FG010|Dose Escalation|Administrative problems|0|||
163107018|NCT01436656|589098125|FG011|Dose Escalation|Administrative problems|0|||
163107019|NCT01436656|589098126|FG012|Dose Escalation|Administrative problems|0|||
163107020|NCT01436656|589098127|FG013|Dose Escalation|Administrative problems|0|||
163107021|NCT01436656|589098128|FG014|Dose Escalation|Administrative problems|0|||
163107022|NCT01436656|589098129|FG015|Dose Escalation|Administrative problems|0|||
163107023|NCT01436656|589098130|FG016|Dose Escalation|Administrative problems|0|||
163107024|NCT01436656|589098131|FG017|Dose Escalation|Administrative problems|0|||
163107025|NCT01436656|589098114|FG000|Dose Escalation|Lost to Follow-up|1|||
163107026|NCT01436656|589098115|FG001|Dose Escalation|Lost to Follow-up|0|||
163107027|NCT01436656|589098116|FG002|Dose Escalation|Lost to Follow-up|0|||
163107028|NCT01436656|589098117|FG003|Dose Escalation|Lost to Follow-up|0|||
163107029|NCT01436656|589098118|FG004|Dose Escalation|Lost to Follow-up|1|||
163107030|NCT01436656|589098119|FG005|Dose Escalation|Lost to Follow-up|0|||
163107031|NCT01436656|589098120|FG006|Dose Escalation|Lost to Follow-up|0|||
163107032|NCT01436656|589098121|FG007|Dose Escalation|Lost to Follow-up|0|||
163107033|NCT01436656|589098122|FG008|Dose Escalation|Lost to Follow-up|0|||
163107034|NCT01436656|589098123|FG009|Dose Escalation|Lost to Follow-up|0|||
163107035|NCT01436656|589098124|FG010|Dose Escalation|Lost to Follow-up|0|||
163107036|NCT01436656|589098125|FG011|Dose Escalation|Lost to Follow-up|0|||
163107037|NCT01436656|589098126|FG012|Dose Escalation|Lost to Follow-up|0|||
163107038|NCT01436656|589098127|FG013|Dose Escalation|Lost to Follow-up|0|||
163107039|NCT01436656|589098128|FG014|Dose Escalation|Lost to Follow-up|0|||
163107040|NCT01436656|589098129|FG015|Dose Escalation|Lost to Follow-up|0|||
163107041|NCT01436656|589098130|FG016|Dose Escalation|Lost to Follow-up|0|||
163107042|NCT01436656|589098131|FG017|Dose Escalation|Lost to Follow-up|0|||
163107043|NCT01436656|589098114|FG000|Dose Escalation|New anti-cancer therapy|1|||
163107044|NCT01436656|589098115|FG001|Dose Escalation|New anti-cancer therapy|0|||
163107045|NCT01436656|589098116|FG002|Dose Escalation|New anti-cancer therapy|0|||
163107046|NCT01436656|589098117|FG003|Dose Escalation|New anti-cancer therapy|0|||
163107047|NCT01436656|589098118|FG004|Dose Escalation|New anti-cancer therapy|0|||
163107048|NCT01436656|589098119|FG005|Dose Escalation|New anti-cancer therapy|0|||
163107049|NCT01436656|589098120|FG006|Dose Escalation|New anti-cancer therapy|0|||
163107050|NCT01436656|589098121|FG007|Dose Escalation|New anti-cancer therapy|0|||
163107051|NCT01436656|589098122|FG008|Dose Escalation|New anti-cancer therapy|1|||
163107052|NCT01436656|589098123|FG009|Dose Escalation|New anti-cancer therapy|1|||
163107053|NCT01436656|589098124|FG010|Dose Escalation|New anti-cancer therapy|0|||
163107054|NCT01436656|589098125|FG011|Dose Escalation|New anti-cancer therapy|0|||
163107055|NCT01436656|589098126|FG012|Dose Escalation|New anti-cancer therapy|0|||
163107056|NCT01436656|589098127|FG013|Dose Escalation|New anti-cancer therapy|0|||
163107057|NCT01436656|589098128|FG014|Dose Escalation|New anti-cancer therapy|0|||
163107058|NCT01436656|589098129|FG015|Dose Escalation|New anti-cancer therapy|0|||
163107059|NCT01436656|589098130|FG016|Dose Escalation|New anti-cancer therapy|0|||
163107060|NCT01436656|589098131|FG017|Dose Escalation|New anti-cancer therapy|0|||
163107061|NCT01436656|589098114|FG000|Dose Expansion|Adverse Event|0|||
163107062|NCT01436656|589098115|FG001|Dose Expansion|Adverse Event|0|||
163107063|NCT01436656|589098116|FG002|Dose Expansion|Adverse Event|0|||
163107064|NCT01436656|589098117|FG003|Dose Expansion|Adverse Event|0|||
163107065|NCT01436656|589098118|FG004|Dose Expansion|Adverse Event|0|||
163107066|NCT01436656|589098119|FG005|Dose Expansion|Adverse Event|0|||
163107067|NCT01436656|589098120|FG006|Dose Expansion|Adverse Event|0|||
163107068|NCT01436656|589098121|FG007|Dose Expansion|Adverse Event|0|||
163107069|NCT01436656|589098122|FG008|Dose Expansion|Adverse Event|0|||
163107070|NCT01436656|589098123|FG009|Dose Expansion|Adverse Event|0|||
163107071|NCT01436656|589098124|FG010|Dose Expansion|Adverse Event|0|||
163107072|NCT01436656|589098125|FG011|Dose Expansion|Adverse Event|1|||
163107073|NCT01436656|589098126|FG012|Dose Expansion|Adverse Event|0|||
163107074|NCT01436656|589098127|FG013|Dose Expansion|Adverse Event|0|||
163107075|NCT01436656|589098128|FG014|Dose Expansion|Adverse Event|0|||
163107076|NCT01436656|589098129|FG015|Dose Expansion|Adverse Event|0|||
163107077|NCT01436656|589098130|FG016|Dose Expansion|Adverse Event|0|||
163107078|NCT01436656|589098131|FG017|Dose Expansion|Adverse Event|0|||
163107079|NCT01436656|589098114|FG000|Dose Expansion|Withdrawal by Subject|0|||
163107080|NCT01436656|589098115|FG001|Dose Expansion|Withdrawal by Subject|0|||
163107081|NCT01436656|589098116|FG002|Dose Expansion|Withdrawal by Subject|0|||
163407790|NCT02873936|590200917|FG002|Overall Study|Adverse Event|3|||
163107082|NCT01436656|589098117|FG003|Dose Expansion|Withdrawal by Subject|0|||
163107083|NCT01436656|589098118|FG004|Dose Expansion|Withdrawal by Subject|0|||
163107084|NCT01436656|589098119|FG005|Dose Expansion|Withdrawal by Subject|0|||
163107085|NCT01436656|589098120|FG006|Dose Expansion|Withdrawal by Subject|0|||
163107086|NCT01436656|589098121|FG007|Dose Expansion|Withdrawal by Subject|0|||
163107087|NCT01436656|589098122|FG008|Dose Expansion|Withdrawal by Subject|0|||
163107088|NCT01436656|589098123|FG009|Dose Expansion|Withdrawal by Subject|0|||
163107089|NCT01436656|589098124|FG010|Dose Expansion|Withdrawal by Subject|0|||
163107090|NCT01436656|589098125|FG011|Dose Expansion|Withdrawal by Subject|1|||
163107091|NCT01436656|589098126|FG012|Dose Expansion|Withdrawal by Subject|3|||
163107092|NCT01436656|589098127|FG013|Dose Expansion|Withdrawal by Subject|1|||
163107093|NCT01436656|589098128|FG014|Dose Expansion|Withdrawal by Subject|2|||
163107094|NCT01436656|589098129|FG015|Dose Expansion|Withdrawal by Subject|0|||
163107095|NCT01436656|589098130|FG016|Dose Expansion|Withdrawal by Subject|1|||
163107096|NCT01436656|589098131|FG017|Dose Expansion|Withdrawal by Subject|1|||
163107097|NCT01436656|589098114|FG000|Dose Expansion|Death|0|||
163107098|NCT01436656|589098115|FG001|Dose Expansion|Death|0|||
163107099|NCT01436656|589098116|FG002|Dose Expansion|Death|0|||
163107100|NCT01436656|589098117|FG003|Dose Expansion|Death|0|||
163107101|NCT01436656|589098118|FG004|Dose Expansion|Death|0|||
163107102|NCT01436656|589098119|FG005|Dose Expansion|Death|0|||
163107103|NCT01436656|589098120|FG006|Dose Expansion|Death|0|||
163107104|NCT01436656|589098121|FG007|Dose Expansion|Death|0|||
163107105|NCT01436656|589098122|FG008|Dose Expansion|Death|0|||
163107106|NCT01436656|589098123|FG009|Dose Expansion|Death|0|||
163107107|NCT01436656|589098124|FG010|Dose Expansion|Death|0|||
163107108|NCT01436656|589098125|FG011|Dose Expansion|Death|0|||
163107109|NCT01436656|589098126|FG012|Dose Expansion|Death|1|||
163107110|NCT01436656|589098127|FG013|Dose Expansion|Death|0|||
163107111|NCT01436656|589098128|FG014|Dose Expansion|Death|3|||
163107112|NCT01436656|589098129|FG015|Dose Expansion|Death|0|||
163107113|NCT01436656|589098130|FG016|Dose Expansion|Death|3|||
163107114|NCT01436656|589098131|FG017|Dose Expansion|Death|3|||
163107115|NCT01436656|589098114|FG000|Dose Expansion|Lost to Follow-up|0|||
163107116|NCT01436656|589098115|FG001|Dose Expansion|Lost to Follow-up|0|||
163107117|NCT01436656|589098116|FG002|Dose Expansion|Lost to Follow-up|0|||
163107118|NCT01436656|589098117|FG003|Dose Expansion|Lost to Follow-up|0|||
163107119|NCT01436656|589098118|FG004|Dose Expansion|Lost to Follow-up|0|||
163107120|NCT01436656|589098119|FG005|Dose Expansion|Lost to Follow-up|0|||
163107121|NCT01436656|589098120|FG006|Dose Expansion|Lost to Follow-up|0|||
163107122|NCT01436656|589098121|FG007|Dose Expansion|Lost to Follow-up|0|||
163107123|NCT01436656|589098122|FG008|Dose Expansion|Lost to Follow-up|0|||
163107124|NCT01436656|589098123|FG009|Dose Expansion|Lost to Follow-up|0|||
163107125|NCT01436656|589098124|FG010|Dose Expansion|Lost to Follow-up|0|||
163107126|NCT01436656|589098125|FG011|Dose Expansion|Lost to Follow-up|0|||
163107127|NCT01436656|589098126|FG012|Dose Expansion|Lost to Follow-up|0|||
163107128|NCT01436656|589098127|FG013|Dose Expansion|Lost to Follow-up|0|||
163107129|NCT01436656|589098128|FG014|Dose Expansion|Lost to Follow-up|0|||
163107130|NCT01436656|589098129|FG015|Dose Expansion|Lost to Follow-up|0|||
163107131|NCT01436656|589098130|FG016|Dose Expansion|Lost to Follow-up|0|||
163107132|NCT01436656|589098131|FG017|Dose Expansion|Lost to Follow-up|3|||
163107133|NCT01436656|589098114|FG000|Dose Expansion|Disease progression|0|||
163107134|NCT01436656|589098115|FG001|Dose Expansion|Disease progression|0|||
163107135|NCT01436656|589098116|FG002|Dose Expansion|Disease progression|0|||
163107136|NCT01436656|589098117|FG003|Dose Expansion|Disease progression|0|||
163107137|NCT01436656|589098118|FG004|Dose Expansion|Disease progression|0|||
163107138|NCT01436656|589098119|FG005|Dose Expansion|Disease progression|0|||
163107139|NCT01436656|589098120|FG006|Dose Expansion|Disease progression|0|||
163107140|NCT01436656|589098121|FG007|Dose Expansion|Disease progression|0|||
163107141|NCT01436656|589098122|FG008|Dose Expansion|Disease progression|0|||
163107142|NCT01436656|589098123|FG009|Dose Expansion|Disease progression|0|||
163107143|NCT01436656|589098124|FG010|Dose Expansion|Disease progression|0|||
163107144|NCT01436656|589098125|FG011|Dose Expansion|Disease progression|3|||
163107145|NCT01436656|589098126|FG012|Dose Expansion|Disease progression|1|||
163107146|NCT01436656|589098127|FG013|Dose Expansion|Disease progression|0|||
163107147|NCT01436656|589098128|FG014|Dose Expansion|Disease progression|1|||
163107148|NCT01436656|589098129|FG015|Dose Expansion|Disease progression|0|||
163107149|NCT01436656|589098130|FG016|Dose Expansion|Disease progression|0|||
163107150|NCT01436656|589098131|FG017|Dose Expansion|Disease progression|1|||
163107151|NCT01436656|589098114|FG000|Dose Expansion|New cancer therapy|0|||
163107152|NCT01436656|589098115|FG001|Dose Expansion|New cancer therapy|0|||
163107153|NCT01436656|589098116|FG002|Dose Expansion|New cancer therapy|0|||
163107154|NCT01436656|589098117|FG003|Dose Expansion|New cancer therapy|0|||
163107155|NCT01436656|589098118|FG004|Dose Expansion|New cancer therapy|0|||
163107156|NCT01436656|589098119|FG005|Dose Expansion|New cancer therapy|0|||
163107157|NCT01436656|589098120|FG006|Dose Expansion|New cancer therapy|0|||
163107158|NCT01436656|589098121|FG007|Dose Expansion|New cancer therapy|0|||
163107159|NCT01436656|589098122|FG008|Dose Expansion|New cancer therapy|0|||
163107160|NCT01436656|589098123|FG009|Dose Expansion|New cancer therapy|0|||
163107161|NCT01436656|589098124|FG010|Dose Expansion|New cancer therapy|0|||
163107162|NCT01436656|589098125|FG011|Dose Expansion|New cancer therapy|1|||
163107163|NCT01436656|589098126|FG012|Dose Expansion|New cancer therapy|1|||
163107164|NCT01436656|589098127|FG013|Dose Expansion|New cancer therapy|0|||
163107165|NCT01436656|589098128|FG014|Dose Expansion|New cancer therapy|2|||
163107166|NCT01436656|589098129|FG015|Dose Expansion|New cancer therapy|0|||
163107167|NCT01436656|589098130|FG016|Dose Expansion|New cancer therapy|0|||
163107168|NCT01436656|589098131|FG017|Dose Expansion|New cancer therapy|0|||
163107169|NCT01667224|589098133|FG000|Overall Study|Withdrawal by Subject|3|||
163107170|NCT01667224|589098134|FG001|Overall Study|Withdrawal by Subject|1|||
163107171|NCT01667224|589098133|FG000|Overall Study|Protocol Violation|1|||
163107172|NCT01667224|589098134|FG001|Overall Study|Protocol Violation|1|||
163107173|NCT00962741|589098135|FG000|Overall Study|Failed to return|3|||
163107174|NCT00962741|589098135|FG000|Overall Study|Lost to Follow-up|2|||
163107175|NCT00962741|589098135|FG000|Overall Study|Withdrawal by Subject|1|||
163107176|NCT00962741|589098135|FG000|Overall Study|Lack of Efficacy|1|||
163107177|NCT00962741|589098135|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
163107178|NCT03350035|589098136|FG000|Overall Study|Lack of Efficacy|2|||
163107179|NCT03350035|589098137|FG001|Overall Study|Lack of Efficacy|0|||
163107180|NCT03350035|589098138|FG002|Overall Study|Lack of Efficacy|0|||
163107181|NCT03350035|589098136|FG000|Overall Study|Subject discharged to hospice|0|||
163107182|NCT03350035|589098137|FG001|Overall Study|Subject discharged to hospice|0|||
163107183|NCT03350035|589098138|FG002|Overall Study|Subject discharged to hospice|1|||
163107184|NCT01811485|589098139|FG000|Overall Study|Adverse Event|1|||
163107185|NCT01811485|589098140|FG001|Overall Study|Adverse Event|3|||
163107186|NCT01811485|589098141|FG002|Overall Study|Adverse Event|2|||
163107187|NCT01811485|589098139|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163107188|NCT01811485|589098140|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163107189|NCT01811485|589098141|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
163107190|NCT01811485|589098139|FG000|Overall Study|Administrative problems|1|||
163107191|NCT01811485|589098140|FG001|Overall Study|Administrative problems|0|||
163107192|NCT01811485|589098141|FG002|Overall Study|Administrative problems|0|||
163107193|NCT01811485|589098139|FG000|Overall Study|Protocol Deviation|0|||
163107194|NCT01811485|589098140|FG001|Overall Study|Protocol Deviation|1|||
163107195|NCT01811485|589098141|FG002|Overall Study|Protocol Deviation|0|||
163107196|NCT01545934|589098142|FG000|Overall Study|Withdrawal by Subject|4|||
163107197|NCT01545934|589098143|FG001|Overall Study|Withdrawal by Subject|3|||
163107198|NCT01545934|589098142|FG000|Overall Study|Lost to Follow-up|1|||
163107199|NCT01545934|589098143|FG001|Overall Study|Lost to Follow-up|0|||
163107200|NCT01843673|589098148|FG000|Overall Study|Lack of Efficacy|2|||
163107201|NCT01843673|589098148|FG000|Overall Study|Withdrawal by Subject|4|||
163107202|NCT00695955|589098155|FG000|Cohort 1|Adverse Event|26|||
163107203|NCT00695955|589098155|FG000|Cohort 1|Protocol Violation|2|||
163107204|NCT00695955|589098155|FG000|Cohort 1|Lost to Follow-up|30|||
163107205|NCT00695955|589098155|FG000|Cohort 1|Withdrawal by Subject|25|||
163107206|NCT00695955|589098155|FG000|Cohort 1|Lack of Efficacy|3|||
163107207|NCT00695955|589098155|FG000|Cohort 1|Other|16|||
163107208|NCT00695955|589098155|FG000|Cohort 2|Adverse Event|24|||
163107209|NCT00695955|589098155|FG000|Cohort 2|Protocol Violation|5|||
163107210|NCT00695955|589098155|FG000|Cohort 2|Lost to Follow-up|38|||
163107211|NCT00695955|589098155|FG000|Cohort 2|Withdrawal by Subject|28|||
163221602|NCT03373383|589528134|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
163221603|NCT03373383|589528135|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
163221604|NCT03373383|589528136|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
163221605|NCT03373383|589528137|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
163221606|NCT03373383|589528138|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
163221607|NCT03373383|589528134|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
163407791|NCT02873936|590200915|FG000|Overall Study|Protocol Violation|0|||
163107212|NCT00695955|589098155|FG000|Cohort 2|Lack of Efficacy|4|||
163107213|NCT00695955|589098155|FG000|Cohort 2|Other|5|||
163107214|NCT01177553|589098156|FG000|Overall Study|babies not yet 6 months of age|1|||
163107215|NCT01177553|589098157|FG001|Overall Study|babies not yet 6 months of age|0|||
163107216|NCT00888329|589098159|FG000|Overall Study|Physician Decision|6|||
163107217|NCT00888329|589098160|FG001|Overall Study|Physician Decision|9|||
163107218|NCT04826094|589098161|FG000|Overall Study|Lost to Follow-up|2|||
163107219|NCT04826094|589098162|FG001|Overall Study|Lost to Follow-up|1|||
163107220|NCT04826094|589098163|FG002|Overall Study|Lost to Follow-up|0|||
163107221|NCT04826094|589098164|FG003|Overall Study|Lost to Follow-up|0|||
163107222|NCT04826094|589098165|FG004|Overall Study|Lost to Follow-up|1|||
163407792|NCT02873936|590200916|FG001|Overall Study|Protocol Violation|1|||
163407793|NCT02873936|590200917|FG002|Overall Study|Protocol Violation|3|||
163107223|NCT04826094|589098166|FG005|Overall Study|Lost to Follow-up|3|||
163107224|NCT04826094|589098167|FG006|Overall Study|Lost to Follow-up|1|||
163107225|NCT04826094|589098168|FG007|Overall Study|Lost to Follow-up|1|||
163107226|NCT04826094|589098161|FG000|Overall Study|Participant withdrew consent|1|||
163107227|NCT04826094|589098162|FG001|Overall Study|Participant withdrew consent|0|||
163107228|NCT04826094|589098163|FG002|Overall Study|Participant withdrew consent|0|||
163107229|NCT04826094|589098164|FG003|Overall Study|Participant withdrew consent|1|||
163107230|NCT04826094|589098165|FG004|Overall Study|Participant withdrew consent|1|||
163107231|NCT04826094|589098166|FG005|Overall Study|Participant withdrew consent|1|||
163107232|NCT04826094|589098167|FG006|Overall Study|Participant withdrew consent|0|||
163107233|NCT04826094|589098168|FG007|Overall Study|Participant withdrew consent|1|||
163107234|NCT04826094|589098161|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
163107235|NCT04826094|589098162|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
163107236|NCT04826094|589098163|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
163107237|NCT04826094|589098164|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
163107238|NCT04826094|589098165|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
163107239|NCT04826094|589098166|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
163107240|NCT04826094|589098167|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
163107241|NCT04826094|589098168|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
163107242|NCT04826094|589098161|FG000|Overall Study|Withdrawn by Investigator|0|||
163107243|NCT04826094|589098162|FG001|Overall Study|Withdrawn by Investigator|0|||
163107244|NCT04826094|589098163|FG002|Overall Study|Withdrawn by Investigator|0|||
163107245|NCT04826094|589098164|FG003|Overall Study|Withdrawn by Investigator|0|||
163107246|NCT04826094|589098165|FG004|Overall Study|Withdrawn by Investigator|0|||
163107247|NCT04826094|589098166|FG005|Overall Study|Withdrawn by Investigator|1|||
163107248|NCT04826094|589098167|FG006|Overall Study|Withdrawn by Investigator|0|||
163107249|NCT04826094|589098168|FG007|Overall Study|Withdrawn by Investigator|1|||
163107250|NCT04826094|589098161|FG000|Overall Study|Other: Moved from area|1|||
163107251|NCT04826094|589098162|FG001|Overall Study|Other: Moved from area|1|||
163107252|NCT04826094|589098163|FG002|Overall Study|Other: Moved from area|1|||
163107253|NCT04826094|589098164|FG003|Overall Study|Other: Moved from area|0|||
163107254|NCT04826094|589098165|FG004|Overall Study|Other: Moved from area|0|||
163107255|NCT04826094|589098166|FG005|Overall Study|Other: Moved from area|0|||
163107256|NCT04826094|589098167|FG006|Overall Study|Other: Moved from area|0|||
163339683|NCT00473512|589953059|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
163339684|NCT00473512|589953055|FG000|Period 2 (Phase 2)|Other|1|||
163339685|NCT00473512|589953056|FG001|Period 2 (Phase 2)|Other|0|||
163339686|NCT00473512|589953057|FG002|Period 2 (Phase 2)|Other|0|||
163339687|NCT00473512|589953058|FG003|Period 2 (Phase 2)|Other|3|||
163107257|NCT04826094|589098168|FG007|Overall Study|Other: Moved from area|0|||
163107258|NCT04826094|589098161|FG000|Overall Study|Other: Declined|0|||
163107259|NCT04826094|589098162|FG001|Overall Study|Other: Declined|0|||
163107260|NCT04826094|589098163|FG002|Overall Study|Other: Declined|0|||
163107261|NCT04826094|589098164|FG003|Overall Study|Other: Declined|0|||
163107262|NCT04826094|589098165|FG004|Overall Study|Other: Declined|1|||
163107263|NCT04826094|589098166|FG005|Overall Study|Other: Declined|0|||
163107264|NCT04826094|589098167|FG006|Overall Study|Other: Declined|0|||
163107265|NCT04826094|589098168|FG007|Overall Study|Other: Declined|0|||
163107266|NCT04826094|589098161|FG000|Overall Study|Other: Vaccine not administered|0|||
163107267|NCT04826094|589098162|FG001|Overall Study|Other: Vaccine not administered|0|||
163107268|NCT04826094|589098163|FG002|Overall Study|Other: Vaccine not administered|1|||
163107269|NCT04826094|589098164|FG003|Overall Study|Other: Vaccine not administered|0|||
163107270|NCT04826094|589098165|FG004|Overall Study|Other: Vaccine not administered|0|||
163107271|NCT04826094|589098166|FG005|Overall Study|Other: Vaccine not administered|1|||
163339688|NCT00473512|589953059|FG004|Period 2 (Phase 2)|Other|0|||
163339689|NCT03557307|589953064|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
163339690|NCT03557307|589953064|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
163339691|NCT03557307|589953064|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
163339692|NCT03557307|589953064|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
163339693|NCT03557307|589953064|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
163339694|NCT03557307|589953064|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
163339695|NCT03557307|589953064|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
163339696|NCT03557307|589953064|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
163339697|NCT03557307|589953064|FG000|Period 2: Maintenance Phase|Death|3|||
163339698|NCT03557307|589953064|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
163339699|NCT03557307|589953064|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
163339700|NCT03557307|589953064|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
163339701|NCT03557307|589953064|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
163339702|NCT03557307|589953064|FG000|Period 2: Maintenance Phase|other|3|||
163339703|NCT03745651|589953065|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
163107272|NCT04826094|589098167|FG006|Overall Study|Other: Vaccine not administered|1|||
163107273|NCT04826094|589098168|FG007|Overall Study|Other: Vaccine not administered|3|||
163107274|NCT03928418|589098172|FG000|Overall Study|Lost to Follow-up|5|||
163107275|NCT03928418|589098173|FG001|Overall Study|Lost to Follow-up|3|||
163107276|NCT03928418|589098174|FG002|Overall Study|Lost to Follow-up|5|||
163107277|NCT03928418|589098172|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
163107278|NCT03928418|589098173|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
163107279|NCT03928418|589098174|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
163339704|NCT03745651|589953066|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
163407794|NCT02873936|590200915|FG000|Overall Study|Lost to Follow-up|1|||
163339705|NCT03745651|589953067|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163339706|NCT03745651|589953068|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163407795|NCT02873936|590200916|FG001|Overall Study|Lost to Follow-up|1|||
163107280|NCT05319600|589098175|FG000|Overall Study|Withdrawal by Subject|1|||
163107281|NCT05319600|589098176|FG001|Overall Study|Withdrawal by Subject|0|||
163107282|NCT05319600|589098175|FG000|Overall Study|Lost to Follow-up|0|||
163107283|NCT05319600|589098176|FG001|Overall Study|Lost to Follow-up|4|||
163107284|NCT00904670|589098177|FG000|Open Label Phase|Withdrawal by Subject|2|||
163107285|NCT00904670|589098178|FG001|Open Label Phase|Withdrawal by Subject|0|||
163107286|NCT00904670|589098177|FG000|Open Label Phase|Adverse Event|2|||
163107287|NCT00904670|589098178|FG001|Open Label Phase|Adverse Event|0|||
163107288|NCT00904670|589098177|FG000|Open Label Phase|Lack of Efficacy|1|||
163107289|NCT00904670|589098178|FG001|Open Label Phase|Lack of Efficacy|0|||
163107290|NCT00904670|589098177|FG000|Open Label Phase|Lost to Follow-up|1|||
163107291|NCT00904670|589098178|FG001|Open Label Phase|Lost to Follow-up|0|||
163107292|NCT00690430|589098184|FG000|Core Phase|Abnormal Laboratory value|0|||
163107293|NCT00690430|589098185|FG001|Core Phase|Abnormal Laboratory value|1|||
163107294|NCT00690430|589098186|FG002|Core Phase|Abnormal Laboratory value|0|||
163107295|NCT00690430|589098184|FG000|Core Phase|Adverse Event|5|||
163107296|NCT00690430|589098185|FG001|Core Phase|Adverse Event|1|||
163107297|NCT00690430|589098186|FG002|Core Phase|Adverse Event|0|||
163107298|NCT00690430|589098184|FG000|Core Phase|Death|0|||
163107299|NCT00690430|589098185|FG001|Core Phase|Death|2|||
163107300|NCT00690430|589098186|FG002|Core Phase|Death|0|||
163107301|NCT00690430|589098184|FG000|Core Phase|Protocol Violation|1|||
163107302|NCT00690430|589098185|FG001|Core Phase|Protocol Violation|0|||
163107303|NCT00690430|589098186|FG002|Core Phase|Protocol Violation|0|||
163107304|NCT00690430|589098184|FG000|Core Phase|Withdrawal by Subject|3|||
163107305|NCT00690430|589098185|FG001|Core Phase|Withdrawal by Subject|3|||
163107306|NCT00690430|589098186|FG002|Core Phase|Withdrawal by Subject|0|||
163107307|NCT00690430|589098184|FG000|Core Phase|Subject no longer requires study drug|1|||
163107308|NCT00690430|589098185|FG001|Core Phase|Subject no longer requires study drug|0|||
163107309|NCT00690430|589098186|FG002|Core Phase|Subject no longer requires study drug|0|||
163107310|NCT00690430|589098184|FG000|Core Phase|Lack of Efficacy|8|||
163107311|NCT00690430|589098185|FG001|Core Phase|Lack of Efficacy|10|||
163107312|NCT00690430|589098186|FG002|Core Phase|Lack of Efficacy|0|||
163107313|NCT00690430|589098184|FG000|Core Phase|Administrative Problems|0|||
163107314|NCT00690430|589098185|FG001|Core Phase|Administrative Problems|1|||
163107315|NCT00690430|589098186|FG002|Core Phase|Administrative Problems|0|||
163107316|NCT00690430|589098184|FG000|Core Phase|Early Termination|0|||
163107317|NCT00690430|589098185|FG001|Core Phase|Early Termination|5|||
163107318|NCT00690430|589098186|FG002|Core Phase|Early Termination|0|||
163107319|NCT00690430|589098184|FG000|Extension Phase|Lack of Efficacy|3|||
163107320|NCT00690430|589098185|FG001|Extension Phase|Lack of Efficacy|1|||
163107321|NCT00690430|589098186|FG002|Extension Phase|Lack of Efficacy|4|||
163107322|NCT00690430|589098184|FG000|Extension Phase|Abnormal Lab Values|1|||
163107323|NCT00690430|589098185|FG001|Extension Phase|Abnormal Lab Values|0|||
163107324|NCT00690430|589098186|FG002|Extension Phase|Abnormal Lab Values|0|||
163107325|NCT00690430|589098184|FG000|Extension Phase|Abnormal test procedure results|1|||
163107326|NCT00690430|589098185|FG001|Extension Phase|Abnormal test procedure results|0|||
163107327|NCT00690430|589098186|FG002|Extension Phase|Abnormal test procedure results|0|||
163107328|NCT00690430|589098184|FG000|Extension Phase|Administrative Problems|0|||
163107329|NCT00690430|589098185|FG001|Extension Phase|Administrative Problems|1|||
163107330|NCT00690430|589098186|FG002|Extension Phase|Administrative Problems|1|||
163107331|NCT00690430|589098184|FG000|Extension Phase|Adverse Event|2|||
163107332|NCT00690430|589098185|FG001|Extension Phase|Adverse Event|1|||
163107333|NCT00690430|589098186|FG002|Extension Phase|Adverse Event|2|||
163107334|NCT00690430|589098184|FG000|Extension Phase|Death|1|||
163107335|NCT00690430|589098185|FG001|Extension Phase|Death|1|||
163107336|NCT00690430|589098186|FG002|Extension Phase|Death|1|||
163107337|NCT00690430|589098184|FG000|Extension Phase|Withdrawal by Subject|0|||
163107338|NCT00690430|589098185|FG001|Extension Phase|Withdrawal by Subject|0|||
163107339|NCT00690430|589098186|FG002|Extension Phase|Withdrawal by Subject|2|||
163107340|NCT00690430|589098184|FG000|Extension Phase|Early Termination|10|||
163107341|NCT00690430|589098185|FG001|Extension Phase|Early Termination|1|||
163107342|NCT00690430|589098186|FG002|Extension Phase|Early Termination|3|||
163107343|NCT02120300|589098187|FG000|Overall Study|Enrolled but Never Treated|2|||
163107344|NCT02120300|589098188|FG001|Overall Study|Enrolled but Never Treated|0|||
163107345|NCT02120300|589098189|FG002|Overall Study|Enrolled but Never Treated|0|||
163107346|NCT02120300|589098190|FG003|Overall Study|Enrolled but Never Treated|0|||
163107347|NCT02120300|589098187|FG000|Overall Study|Lack of Efficacy|0|||
163107348|NCT02120300|589098188|FG001|Overall Study|Lack of Efficacy|0|||
163107349|NCT02120300|589098189|FG002|Overall Study|Lack of Efficacy|0|||
163107350|NCT02120300|589098190|FG003|Overall Study|Lack of Efficacy|1|||
163107351|NCT02120300|589098187|FG000|Overall Study|Lost to Follow-up|1|||
163107352|NCT02120300|589098188|FG001|Overall Study|Lost to Follow-up|0|||
163107353|NCT02120300|589098189|FG002|Overall Study|Lost to Follow-up|0|||
163107354|NCT02120300|589098190|FG003|Overall Study|Lost to Follow-up|0|||
163107355|NCT01721486|589098193|FG000|Overall Study|Protocol Violation|1|||
163107356|NCT01721486|589098194|FG001|Overall Study|Protocol Violation|0|||
163107357|NCT01721486|589098193|FG000|Overall Study|Physician Decision|0|||
163107358|NCT01721486|589098194|FG001|Overall Study|Physician Decision|1|||
163107359|NCT00182078|589098201|FG000|Overall Study|Withdrawal by Subject|1|||
163107360|NCT00182078|589098202|FG001|Overall Study|Withdrawal by Subject|0|||
163107361|NCT01076205|589098203|FG000|Overall Study|Adverse Drug Reaction|299|||
163107362|NCT01076205|589098203|FG000|Overall Study|Lack of Effectiveness|1423|||
163107363|NCT01076205|589098203|FG000|Overall Study|Other Reason|1075|||
163107364|NCT01076205|589098203|FG000|Overall Study|Unknown Reason|71|||
163107365|NCT01076205|589098203|FG000|Overall Study|Lost to Follow-up|3151|||
163107366|NCT00361231|589098204|FG000|Overall Study|Physician Decision|3|||
163107367|NCT00361231|589098204|FG000|Overall Study|Symptomatic deterioration|5|||
163107368|NCT00361231|589098204|FG000|Overall Study|Radiographic disease progression|16|||
163107369|NCT00361231|589098204|FG000|Overall Study|Withdrawal by Subject|4|||
163107370|NCT00361231|589098204|FG000|Overall Study|Adverse Event|6|||
163107371|NCT01732510|589098205|FG000|Overall Study|Adverse Event|0|||
163107372|NCT01732510|589098206|FG001|Overall Study|Adverse Event|1|||
163107373|NCT01732510|589098207|FG002|Overall Study|Adverse Event|1|||
163107374|NCT01732510|589098208|FG003|Overall Study|Adverse Event|0|||
163107375|NCT01732510|589098209|FG004|Overall Study|Adverse Event|0|||
163107376|NCT01732510|589098210|FG005|Overall Study|Adverse Event|0|||
163107377|NCT01732510|589098211|FG006|Overall Study|Adverse Event|1|||
163107378|NCT01732510|589098205|FG000|Overall Study|Protocol Violation|0|||
163107379|NCT01732510|589098206|FG001|Overall Study|Protocol Violation|0|||
163107380|NCT01732510|589098207|FG002|Overall Study|Protocol Violation|0|||
163107381|NCT01732510|589098208|FG003|Overall Study|Protocol Violation|1|||
163107382|NCT01732510|589098209|FG004|Overall Study|Protocol Violation|0|||
163107383|NCT01732510|589098210|FG005|Overall Study|Protocol Violation|0|||
163107384|NCT01732510|589098211|FG006|Overall Study|Protocol Violation|0|||
163107385|NCT01732510|589098205|FG000|Overall Study|Withdrawal by Subject|1|||
163107386|NCT01732510|589098206|FG001|Overall Study|Withdrawal by Subject|3|||
163107387|NCT01732510|589098207|FG002|Overall Study|Withdrawal by Subject|2|||
163107388|NCT01732510|589098208|FG003|Overall Study|Withdrawal by Subject|1|||
163107389|NCT01732510|589098209|FG004|Overall Study|Withdrawal by Subject|5|||
163107390|NCT01732510|589098210|FG005|Overall Study|Withdrawal by Subject|0|||
163107391|NCT01732510|589098211|FG006|Overall Study|Withdrawal by Subject|1|||
163107392|NCT01732510|589098205|FG000|Overall Study|Lost to Follow-up|0|||
163107393|NCT01732510|589098206|FG001|Overall Study|Lost to Follow-up|0|||
163107394|NCT01732510|589098207|FG002|Overall Study|Lost to Follow-up|1|||
163107395|NCT01732510|589098208|FG003|Overall Study|Lost to Follow-up|1|||
163107396|NCT01732510|589098209|FG004|Overall Study|Lost to Follow-up|0|||
163107397|NCT01732510|589098210|FG005|Overall Study|Lost to Follow-up|1|||
163107398|NCT01732510|589098211|FG006|Overall Study|Lost to Follow-up|0|||
163107399|NCT01732510|589098205|FG000|Overall Study|Physician Decision|0|||
163107400|NCT01732510|589098206|FG001|Overall Study|Physician Decision|1|||
163107401|NCT01732510|589098207|FG002|Overall Study|Physician Decision|0|||
163107402|NCT01732510|589098208|FG003|Overall Study|Physician Decision|0|||
163107403|NCT01732510|589098209|FG004|Overall Study|Physician Decision|0|||
163107404|NCT01732510|589098210|FG005|Overall Study|Physician Decision|0|||
163107405|NCT01732510|589098211|FG006|Overall Study|Physician Decision|0|||
163107406|NCT01732510|589098205|FG000|Overall Study|Pregnancy|0|||
163107407|NCT01732510|589098206|FG001|Overall Study|Pregnancy|0|||
163107408|NCT01732510|589098207|FG002|Overall Study|Pregnancy|0|||
163107409|NCT01732510|589098208|FG003|Overall Study|Pregnancy|1|||
163107410|NCT01732510|589098209|FG004|Overall Study|Pregnancy|0|||
163107411|NCT01732510|589098210|FG005|Overall Study|Pregnancy|0|||
163107412|NCT01732510|589098211|FG006|Overall Study|Pregnancy|0|||
163107413|NCT01732510|589098205|FG000|Overall Study|Study Terminated By Sponsor|0|||
163339707|NCT03745651|589953069|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163107414|NCT01732510|589098206|FG001|Overall Study|Study Terminated By Sponsor|0|||
163107415|NCT01732510|589098207|FG002|Overall Study|Study Terminated By Sponsor|0|||
163107416|NCT01732510|589098208|FG003|Overall Study|Study Terminated By Sponsor|1|||
163107417|NCT01732510|589098209|FG004|Overall Study|Study Terminated By Sponsor|0|||
163107418|NCT01732510|589098210|FG005|Overall Study|Study Terminated By Sponsor|12|||
163107419|NCT01732510|589098211|FG006|Overall Study|Study Terminated By Sponsor|6|||
163107420|NCT00313144|589098212|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
163107421|NCT00313144|589098212|FG000|Overall Study|Death|7|||
163107422|NCT00313144|589098212|FG000|Overall Study|Lost to Follow-up|5|||
163107423|NCT00313144|589098212|FG000|Overall Study|Withdrawal by Subject|4|||
163107424|NCT00313144|589098212|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
163107425|NCT00313144|589098212|FG000|Overall Study|Physician Decision|4|||
163107426|NCT00313144|589098212|FG000|Overall Study|Adverse event - transient|5|||
163107427|NCT00313144|589098212|FG000|Overall Study|Liver transplant|1|||
163107428|NCT00313144|589098212|FG000|Overall Study|Insurance (homecare provider) change|1|||
163107429|NCT00313144|589098212|FG000|Overall Study|Change to different product|1|||
163107430|NCT00313144|589098212|FG000|Overall Study|Due to termination of the study|66|||
163339708|NCT03745651|589953070|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163107431|NCT03403361|589098213|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
163107432|NCT02487654|589098215|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
163107433|NCT02487654|589098216|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
163107434|NCT02487654|589098215|FG000|Overall Study|Withdrawal by Subject|3|||
163107435|NCT02487654|589098216|FG001|Overall Study|Withdrawal by Subject|7|||
163107436|NCT02443116|589098219|FG000|Part 1|Adverse Event|2|||
163107437|NCT02443116|589098220|FG001|Part 1|Adverse Event|3|||
163107438|NCT02443116|589098221|FG002|Part 1|Adverse Event|0|||
163107439|NCT02443116|589098222|FG003|Part 1|Adverse Event|0|||
163107440|NCT02443116|589098223|FG004|Part 1|Adverse Event|0|||
163107441|NCT02443116|589098224|FG005|Part 1|Adverse Event|0|||
163107442|NCT02443116|589098225|FG006|Part 1|Adverse Event|0|||
163107443|NCT02443116|589098226|FG007|Part 1|Adverse Event|0|||
163107444|NCT02443116|589098227|FG008|Part 1|Adverse Event|0|||
163107445|NCT02443116|589098219|FG000|Part 1|Withdrew informed consent|0|||
163107446|NCT02443116|589098220|FG001|Part 1|Withdrew informed consent|1|||
163107447|NCT02443116|589098221|FG002|Part 1|Withdrew informed consent|0|||
163107448|NCT02443116|589098222|FG003|Part 1|Withdrew informed consent|0|||
163107449|NCT02443116|589098223|FG004|Part 1|Withdrew informed consent|0|||
163107450|NCT02443116|589098224|FG005|Part 1|Withdrew informed consent|0|||
163107451|NCT02443116|589098225|FG006|Part 1|Withdrew informed consent|0|||
163107452|NCT02443116|589098226|FG007|Part 1|Withdrew informed consent|0|||
163107453|NCT02443116|589098227|FG008|Part 1|Withdrew informed consent|0|||
163107454|NCT02443116|589098219|FG000|Part 1|Lost to Follow-up|0|||
163107455|NCT02443116|589098220|FG001|Part 1|Lost to Follow-up|0|||
163107456|NCT02443116|589098221|FG002|Part 1|Lost to Follow-up|2|||
163107457|NCT02443116|589098222|FG003|Part 1|Lost to Follow-up|0|||
163107458|NCT02443116|589098223|FG004|Part 1|Lost to Follow-up|0|||
163107459|NCT02443116|589098224|FG005|Part 1|Lost to Follow-up|0|||
163107460|NCT02443116|589098225|FG006|Part 1|Lost to Follow-up|0|||
163107461|NCT02443116|589098226|FG007|Part 1|Lost to Follow-up|0|||
163107462|NCT02443116|589098227|FG008|Part 1|Lost to Follow-up|0|||
163107463|NCT02443116|589098219|FG000|Part 1|Participant moved out of state|0|||
163107464|NCT02443116|589098220|FG001|Part 1|Participant moved out of state|0|||
163107465|NCT02443116|589098221|FG002|Part 1|Participant moved out of state|1|||
163107466|NCT02443116|589098222|FG003|Part 1|Participant moved out of state|0|||
163107467|NCT02443116|589098223|FG004|Part 1|Participant moved out of state|0|||
163107468|NCT02443116|589098224|FG005|Part 1|Participant moved out of state|0|||
163107469|NCT02443116|589098225|FG006|Part 1|Participant moved out of state|0|||
163107470|NCT02443116|589098226|FG007|Part 1|Participant moved out of state|0|||
163107471|NCT02443116|589098227|FG008|Part 1|Participant moved out of state|0|||
163107472|NCT02443116|589098219|FG000|Part 1|Participant enrolled in another clinical trial|0|||
163107473|NCT02443116|589098220|FG001|Part 1|Participant enrolled in another clinical trial|0|||
163107474|NCT02443116|589098221|FG002|Part 1|Participant enrolled in another clinical trial|1|||
163107475|NCT02443116|589098222|FG003|Part 1|Participant enrolled in another clinical trial|0|||
163107476|NCT02443116|589098223|FG004|Part 1|Participant enrolled in another clinical trial|0|||
163107477|NCT02443116|589098224|FG005|Part 1|Participant enrolled in another clinical trial|0|||
163107478|NCT02443116|589098225|FG006|Part 1|Participant enrolled in another clinical trial|0|||
163107479|NCT02443116|589098226|FG007|Part 1|Participant enrolled in another clinical trial|0|||
163107480|NCT02443116|589098227|FG008|Part 1|Participant enrolled in another clinical trial|0|||
163107481|NCT02443116|589098219|FG000|Part 2|Adverse Event|0|||
163107482|NCT02443116|589098220|FG001|Part 2|Adverse Event|0|||
163107483|NCT02443116|589098221|FG002|Part 2|Adverse Event|0|||
163107484|NCT02443116|589098222|FG003|Part 2|Adverse Event|0|||
163107485|NCT02443116|589098223|FG004|Part 2|Adverse Event|1|||
163107486|NCT02443116|589098224|FG005|Part 2|Adverse Event|1|||
163107487|NCT02443116|589098225|FG006|Part 2|Adverse Event|2|||
163107488|NCT02443116|589098226|FG007|Part 2|Adverse Event|0|||
163107489|NCT02443116|589098227|FG008|Part 2|Adverse Event|0|||
163107490|NCT02443116|589098219|FG000|Part 2|Withdrew informed consent|0|||
163339709|NCT03745651|589953071|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163339710|NCT03745651|589953065|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
163339711|NCT03745651|589953066|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
163339712|NCT03745651|589953067|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
163339713|NCT03745651|589953068|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163107491|NCT02443116|589098220|FG001|Part 2|Withdrew informed consent|0|||
163107492|NCT02443116|589098221|FG002|Part 2|Withdrew informed consent|0|||
163107493|NCT02443116|589098222|FG003|Part 2|Withdrew informed consent|0|||
163107494|NCT02443116|589098223|FG004|Part 2|Withdrew informed consent|0|||
163107495|NCT02443116|589098224|FG005|Part 2|Withdrew informed consent|1|||
163107496|NCT02443116|589098225|FG006|Part 2|Withdrew informed consent|1|||
163107497|NCT02443116|589098226|FG007|Part 2|Withdrew informed consent|0|||
163107498|NCT02443116|589098227|FG008|Part 2|Withdrew informed consent|0|||
163107499|NCT02443116|589098219|FG000|Part 2|Inability to comply with protocol|0|||
163107500|NCT02443116|589098220|FG001|Part 2|Inability to comply with protocol|0|||
163107501|NCT02443116|589098221|FG002|Part 2|Inability to comply with protocol|0|||
163107502|NCT02443116|589098222|FG003|Part 2|Inability to comply with protocol|1|||
163107503|NCT02443116|589098223|FG004|Part 2|Inability to comply with protocol|0|||
163107504|NCT02443116|589098224|FG005|Part 2|Inability to comply with protocol|0|||
163107505|NCT02443116|589098225|FG006|Part 2|Inability to comply with protocol|0|||
163107506|NCT02443116|589098226|FG007|Part 2|Inability to comply with protocol|0|||
163107507|NCT02443116|589098227|FG008|Part 2|Inability to comply with protocol|0|||
163107508|NCT02443116|589098219|FG000|Part 2|Lost to Follow-up|0|||
163107509|NCT02443116|589098220|FG001|Part 2|Lost to Follow-up|0|||
163107510|NCT02443116|589098221|FG002|Part 2|Lost to Follow-up|0|||
163107511|NCT02443116|589098222|FG003|Part 2|Lost to Follow-up|1|||
163107512|NCT02443116|589098223|FG004|Part 2|Lost to Follow-up|0|||
163107513|NCT02443116|589098224|FG005|Part 2|Lost to Follow-up|0|||
163107514|NCT02443116|589098225|FG006|Part 2|Lost to Follow-up|0|||
163107515|NCT02443116|589098226|FG007|Part 2|Lost to Follow-up|0|||
163107516|NCT02443116|589098227|FG008|Part 2|Lost to Follow-up|0|||
163107517|NCT02443116|589098219|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107518|NCT02443116|589098220|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107519|NCT02443116|589098221|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107520|NCT02443116|589098222|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107521|NCT02443116|589098223|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107522|NCT02443116|589098224|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
163107523|NCT02443116|589098225|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107524|NCT02443116|589098226|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107525|NCT02443116|589098227|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107526|NCT02443116|589098219|FG000|Part 3|Adverse Event|0|||
163107527|NCT02443116|589098220|FG001|Part 3|Adverse Event|0|||
163107528|NCT02443116|589098221|FG002|Part 3|Adverse Event|0|||
163107529|NCT02443116|589098222|FG003|Part 3|Adverse Event|0|||
163107530|NCT02443116|589098223|FG004|Part 3|Adverse Event|0|||
163107531|NCT02443116|589098224|FG005|Part 3|Adverse Event|0|||
163107532|NCT02443116|589098225|FG006|Part 3|Adverse Event|0|||
163107533|NCT02443116|589098226|FG007|Part 3|Adverse Event|0|||
163107534|NCT02443116|589098227|FG008|Part 3|Adverse Event|1|||
163107535|NCT02443116|589098219|FG000|Part 3|Withdrew informed consent|0|||
163107536|NCT02443116|589098220|FG001|Part 3|Withdrew informed consent|0|||
163107537|NCT02443116|589098221|FG002|Part 3|Withdrew informed consent|0|||
163107538|NCT02443116|589098222|FG003|Part 3|Withdrew informed consent|0|||
163107539|NCT02443116|589098223|FG004|Part 3|Withdrew informed consent|0|||
163107540|NCT02443116|589098224|FG005|Part 3|Withdrew informed consent|0|||
163107541|NCT02443116|589098225|FG006|Part 3|Withdrew informed consent|0|||
163107542|NCT02443116|589098226|FG007|Part 3|Withdrew informed consent|3|||
163107543|NCT02443116|589098227|FG008|Part 3|Withdrew informed consent|2|||
163107544|NCT02443116|589098219|FG000|Part 3|Lost to Follow-up|0|||
163107545|NCT02443116|589098220|FG001|Part 3|Lost to Follow-up|0|||
163107546|NCT02443116|589098221|FG002|Part 3|Lost to Follow-up|0|||
163107547|NCT02443116|589098222|FG003|Part 3|Lost to Follow-up|0|||
163107548|NCT02443116|589098223|FG004|Part 3|Lost to Follow-up|0|||
163107549|NCT02443116|589098224|FG005|Part 3|Lost to Follow-up|0|||
163107550|NCT02443116|589098225|FG006|Part 3|Lost to Follow-up|0|||
163107551|NCT02443116|589098226|FG007|Part 3|Lost to Follow-up|1|||
163107552|NCT02443116|589098227|FG008|Part 3|Lost to Follow-up|2|||
163107553|NCT01932372|589098228|FG000|Overall Study|Not meeting eligibility criteria|33|||
163107554|NCT01932372|589098229|FG001|Overall Study|Not meeting eligibility criteria|179|||
163107555|NCT03594747|589098234|FG000|Overall Study|Death|78|||
163107556|NCT03594747|589098235|FG001|Overall Study|Death|86|||
163107557|NCT03594747|589098236|FG002|Overall Study|Death|87|||
163107558|NCT03594747|589098234|FG000|Overall Study|Withdrawal by Subject|5|||
163107559|NCT03594747|589098235|FG001|Overall Study|Withdrawal by Subject|2|||
163107560|NCT03594747|589098236|FG002|Overall Study|Withdrawal by Subject|11|||
163107561|NCT03594747|589098234|FG000|Overall Study|Lost to Follow-up|4|||
163107562|NCT03594747|589098235|FG001|Overall Study|Lost to Follow-up|1|||
163107563|NCT03594747|589098236|FG002|Overall Study|Lost to Follow-up|1|||
163107564|NCT03594747|589098234|FG000|Overall Study|Physician Decision|0|||
163107565|NCT03594747|589098235|FG001|Overall Study|Physician Decision|1|||
163107566|NCT03594747|589098236|FG002|Overall Study|Physician Decision|0|||
163107567|NCT03594747|589098234|FG000|Overall Study|Sponsor decision|23|||
163107568|NCT03594747|589098235|FG001|Overall Study|Sponsor decision|17|||
163107569|NCT03594747|589098236|FG002|Overall Study|Sponsor decision|16|||
163107570|NCT03594747|589098234|FG000|Overall Study|Did not meet inclusion criteria|0|||
163107571|NCT03594747|589098235|FG001|Overall Study|Did not meet inclusion criteria|0|||
163107572|NCT03594747|589098236|FG002|Overall Study|Did not meet inclusion criteria|1|||
163107573|NCT03594747|589098234|FG000|Overall Study|Transfer to long term extension study|10|||
163107574|NCT03594747|589098235|FG001|Overall Study|Transfer to long term extension study|12|||
163107575|NCT03594747|589098236|FG002|Overall Study|Transfer to long term extension study|5|||
163107576|NCT04382586|589098237|FG000|Overall Study|Death|3|||
163107577|NCT04382586|589098238|FG001|Overall Study|Death|4|||
163107578|NCT04382586|589098237|FG000|Overall Study|Lost to Follow-up|11|||
163107579|NCT04382586|589098238|FG001|Overall Study|Lost to Follow-up|8|||
163107580|NCT04382586|589098237|FG000|Overall Study|Withdrawal by Subject|3|||
163107581|NCT04382586|589098238|FG001|Overall Study|Withdrawal by Subject|1|||
163107582|NCT04382586|589098237|FG000|Overall Study|Physician Decision|0|||
163107583|NCT04382586|589098238|FG001|Overall Study|Physician Decision|3|||
163107584|NCT02265536|589098246|FG000|Overall Study|Adverse Event|1|||
163107585|NCT02265536|589098247|FG001|Overall Study|Adverse Event|0|||
163107586|NCT02265536|589098248|FG002|Overall Study|Adverse Event|0|||
163107587|NCT02265536|589098249|FG003|Overall Study|Adverse Event|0|||
163107588|NCT02265536|589098250|FG004|Overall Study|Adverse Event|1|||
163107589|NCT02265536|589098251|FG005|Overall Study|Adverse Event|0|||
163107590|NCT02265536|589098246|FG000|Overall Study|Physician Decision|0|||
163107591|NCT02265536|589098247|FG001|Overall Study|Physician Decision|0|||
163107592|NCT02265536|589098248|FG002|Overall Study|Physician Decision|0|||
163107593|NCT02265536|589098249|FG003|Overall Study|Physician Decision|0|||
163107594|NCT02265536|589098250|FG004|Overall Study|Physician Decision|2|||
163107595|NCT02265536|589098251|FG005|Overall Study|Physician Decision|0|||
163107596|NCT02265536|589098246|FG000|Overall Study|Withdrawal by Subject|0|||
163107597|NCT02265536|589098247|FG001|Overall Study|Withdrawal by Subject|3|||
163107598|NCT02265536|589098248|FG002|Overall Study|Withdrawal by Subject|0|||
163107599|NCT02265536|589098249|FG003|Overall Study|Withdrawal by Subject|0|||
163107600|NCT02265536|589098250|FG004|Overall Study|Withdrawal by Subject|0|||
163107601|NCT02265536|589098251|FG005|Overall Study|Withdrawal by Subject|0|||
163107602|NCT00349349|589098254|FG000|Overall Study|Adverse Event|5|||
163107603|NCT00349349|589098255|FG001|Overall Study|Adverse Event|6|||
163107604|NCT00349349|589098256|FG002|Overall Study|Adverse Event|2|||
163107605|NCT00349349|589098254|FG000|Overall Study|Withdrawal by Subject|5|||
163107606|NCT00349349|589098255|FG001|Overall Study|Withdrawal by Subject|2|||
163107607|NCT00349349|589098256|FG002|Overall Study|Withdrawal by Subject|1|||
163107608|NCT00349349|589098254|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
163107609|NCT00349349|589098255|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
163107610|NCT00349349|589098256|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
163107611|NCT00349349|589098254|FG000|Overall Study|Death|13|||
163107612|NCT00349349|589098255|FG001|Overall Study|Death|10|||
163107613|NCT00349349|589098256|FG002|Overall Study|Death|1|||
163107614|NCT00349349|589098254|FG000|Overall Study|Other Treatment Selected|2|||
163107615|NCT00349349|589098255|FG001|Overall Study|Other Treatment Selected|0|||
163107616|NCT00349349|589098256|FG002|Overall Study|Other Treatment Selected|0|||
163107617|NCT00349349|589098254|FG000|Overall Study|Participant Reduced General Condition|0|||
163107618|NCT00349349|589098255|FG001|Overall Study|Participant Reduced General Condition|1|||
163107619|NCT00349349|589098256|FG002|Overall Study|Participant Reduced General Condition|0|||
163107620|NCT00349349|589098254|FG000|Overall Study|Physician Decision|1|||
163107621|NCT00349349|589098255|FG001|Overall Study|Physician Decision|2|||
163107622|NCT00349349|589098256|FG002|Overall Study|Physician Decision|1|||
163107623|NCT00349349|589098254|FG000|Overall Study|No Response|0|||
163107624|NCT00349349|589098255|FG001|Overall Study|No Response|3|||
163107625|NCT00349349|589098256|FG002|Overall Study|No Response|0|||
163107626|NCT00349349|589098254|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
163107627|NCT00349349|589098255|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
163107628|NCT00349349|589098256|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
163107629|NCT02907216|589098257|FG000|Overall Study|No benefit to be obtained by continuing|0|||
163107630|NCT02907216|589098258|FG001|Overall Study|No benefit to be obtained by continuing|1|||
163107631|NCT02907216|589098257|FG000|Overall Study|Withdrawal by Subject|1|||
163107632|NCT02907216|589098258|FG001|Overall Study|Withdrawal by Subject|0|||
163107633|NCT02485639|589098261|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
163107634|NCT02485639|589098261|FG000|Overall Study|Early termination|4|||
163107635|NCT02485639|589098261|FG000|Overall Study|Withdrawal by Subject|4|||
163107636|NCT03763656|589098262|FG000|Overall Study|Physician Decision|1|||
163107637|NCT03763656|589098262|FG000|Overall Study|Protocol Violation|1|||
163107638|NCT03763656|589098262|FG000|Overall Study|Withdrawal by Subject|7|||
163107639|NCT03479541|589098263|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
163107640|NCT03479541|589098264|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
163107641|NCT03479541|589098265|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
163107642|NCT03479541|589098266|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
163107643|NCT03479541|589098263|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
163107644|NCT03479541|589098264|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
163339714|NCT03745651|589953069|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163107645|NCT03479541|589098265|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
163107646|NCT03479541|589098266|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
163107647|NCT03479541|589098263|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
163107648|NCT03479541|589098264|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
163107649|NCT03479541|589098265|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
163107650|NCT03479541|589098266|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
163107651|NCT03479541|589098263|FG000|Home Monitoring|Lost to Follow-up|0|||
163107652|NCT03479541|589098264|FG001|Home Monitoring|Lost to Follow-up|0|||
163339715|NCT03745651|589953070|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163339716|NCT03745651|589953071|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163339717|NCT03745651|589953065|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
163339718|NCT03745651|589953066|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163339719|NCT03745651|589953067|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
163107653|NCT03479541|589098265|FG002|Home Monitoring|Lost to Follow-up|8|||
163107654|NCT03479541|589098266|FG003|Home Monitoring|Lost to Follow-up|12|||
163107655|NCT03479541|589098263|FG000|Home Monitoring|Withdrawal by Subject|0|||
163107656|NCT03479541|589098264|FG001|Home Monitoring|Withdrawal by Subject|0|||
163107657|NCT03479541|589098265|FG002|Home Monitoring|Withdrawal by Subject|17|||
163107658|NCT03479541|589098266|FG003|Home Monitoring|Withdrawal by Subject|30|||
163107659|NCT03479541|589098263|FG000|Home Monitoring|Early Termination - PI Decision|0|||
163107660|NCT03479541|589098264|FG001|Home Monitoring|Early Termination - PI Decision|0|||
163107661|NCT03479541|589098265|FG002|Home Monitoring|Early Termination - PI Decision|4|||
163107662|NCT03479541|589098266|FG003|Home Monitoring|Early Termination - PI Decision|6|||
163107663|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
163107664|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
163107665|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
163107666|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
163107667|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
163107668|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
163107669|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
163107670|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
163107671|NCT01673854|589098268|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
163107672|NCT01673854|589098268|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
163107673|NCT01673854|589098268|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
163107674|NCT01673854|589098268|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
163107675|NCT00334737|589098269|FG000|Hospital Phase|Death|1|||
163107676|NCT00334737|589098270|FG001|Hospital Phase|Death|2|||
163107677|NCT00334737|589098271|FG002|Hospital Phase|Death|3|||
163107678|NCT00334737|589098269|FG000|Hospital Phase|Withdrawal by Subject|0|||
163107679|NCT00334737|589098270|FG001|Hospital Phase|Withdrawal by Subject|0|||
163107680|NCT00334737|589098271|FG002|Hospital Phase|Withdrawal by Subject|1|||
163107681|NCT00334737|589098269|FG000|Hospital Phase|Did not receive study drug|1|||
163107682|NCT00334737|589098270|FG001|Hospital Phase|Did not receive study drug|0|||
163107683|NCT00334737|589098271|FG002|Hospital Phase|Did not receive study drug|0|||
163107684|NCT00334737|589098269|FG000|Follow up Phase|Lost to Follow-up|5|||
163107685|NCT00334737|589098270|FG001|Follow up Phase|Lost to Follow-up|3|||
163107686|NCT00334737|589098271|FG002|Follow up Phase|Lost to Follow-up|6|||
163107687|NCT02316353|589098272|FG000|Overall Study|Pregnancy|1|||
163107688|NCT02316353|589098273|FG001|Overall Study|Pregnancy|3|||
163107689|NCT02316353|589098272|FG000|Overall Study|Adverse Event|1|||
163107690|NCT02316353|589098273|FG001|Overall Study|Adverse Event|3|||
163107691|NCT02316353|589098272|FG000|Overall Study|Withdrawal by Subject|6|||
163107692|NCT02316353|589098273|FG001|Overall Study|Withdrawal by Subject|2|||
163107693|NCT02640625|589099923|FG000|Overall Study|Adverse Event|1|||
163107694|NCT02013206|589099924|FG000|Overall Study|Progressive disease (PD)|14|||
163107695|NCT02013206|589099925|FG001|Overall Study|Progressive disease (PD)|17|||
163107696|NCT02013206|589099924|FG000|Overall Study|Symptomatic deterioration|3|||
163107697|NCT02013206|589099925|FG001|Overall Study|Symptomatic deterioration|1|||
163107698|NCT02013206|589099924|FG000|Overall Study|Adverse Event|1|||
163107699|NCT02013206|589099925|FG001|Overall Study|Adverse Event|0|||
163107700|NCT02013206|589099924|FG000|Overall Study|Patient refusal|2|||
163107701|NCT02013206|589099925|FG001|Overall Study|Patient refusal|0|||
163107702|NCT02013206|589099924|FG000|Overall Study|Patient non-compliance|1|||
163107703|NCT02013206|589099925|FG001|Overall Study|Patient non-compliance|0|||
163107704|NCT02013206|589099924|FG000|Overall Study|Death|1|||
163107705|NCT02013206|589099925|FG001|Overall Study|Death|2|||
163221608|NCT03373383|589528135|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
163339720|NCT03745651|589953068|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163339721|NCT03745651|589953069|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163407796|NCT02873936|590200917|FG002|Overall Study|Lost to Follow-up|1|||
163407797|NCT02873936|590200915|FG000|Overall Study|Non-compliance With Study Drug|1|||
163107706|NCT02013206|589099924|FG000|Overall Study|Other reasons off treatment|5|||
163107707|NCT02013206|589099925|FG001|Overall Study|Other reasons off treatment|2|||
163107708|NCT05425732|589099926|FG000|Overall Study|Death|4|||
163107709|NCT05425732|589099927|FG001|Overall Study|Death|2|||
163107710|NCT05425732|589099928|FG002|Overall Study|Death|0|||
163107711|NCT05425732|589099929|FG003|Overall Study|Death|0|||
163107712|NCT05425732|589099926|FG000|Overall Study|Lost to Follow-up|10|||
163107713|NCT05425732|589099927|FG001|Overall Study|Lost to Follow-up|15|||
163107714|NCT05425732|589099928|FG002|Overall Study|Lost to Follow-up|5|||
163107715|NCT05425732|589099929|FG003|Overall Study|Lost to Follow-up|3|||
163407798|NCT02873936|590200916|FG001|Overall Study|Non-compliance With Study Drug|0|||
163407799|NCT02873936|590200917|FG002|Overall Study|Non-compliance With Study Drug|1|||
163407800|NCT02873936|590200915|FG000|Overall Study|Randomized but not Dosed|1|||
163107716|NCT05425732|589099926|FG000|Overall Study|Physician Decision|0|||
163107717|NCT05425732|589099927|FG001|Overall Study|Physician Decision|2|||
163107718|NCT05425732|589099928|FG002|Overall Study|Physician Decision|0|||
163107719|NCT05425732|589099929|FG003|Overall Study|Physician Decision|0|||
163107720|NCT05425732|589099926|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
163107721|NCT05425732|589099927|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
163107722|NCT05425732|589099928|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163107723|NCT05425732|589099929|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163107724|NCT05425732|589099926|FG000|Overall Study|Withdrawal by Subject|4|||
163107725|NCT05425732|589099927|FG001|Overall Study|Withdrawal by Subject|8|||
163107726|NCT05425732|589099928|FG002|Overall Study|Withdrawal by Subject|1|||
163107727|NCT05425732|589099929|FG003|Overall Study|Withdrawal by Subject|1|||
163107728|NCT05425732|589099926|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
163107729|NCT05425732|589099927|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
163107730|NCT05425732|589099928|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
163107731|NCT05425732|589099929|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
163107732|NCT02582814|589099930|FG000|Overall Study|Study-specific withdrawal criteria|1|||
163107733|NCT02582814|589099931|FG001|Overall Study|Study-specific withdrawal criteria|0|||
163107734|NCT02582814|589099930|FG000|Overall Study|Withdrawal by Subject|4|||
163107735|NCT02582814|589099931|FG001|Overall Study|Withdrawal by Subject|3|||
163107736|NCT02582814|589099930|FG000|Overall Study|Adverse Event|4|||
163107737|NCT02582814|589099931|FG001|Overall Study|Adverse Event|4|||
163107738|NCT01558115|589099935|FG000|Overall Study|Withdrawal by Subject|3|||
163107739|NCT01558115|589099935|FG000|Overall Study|Study closed due to poor enrollment|4|||
163107740|NCT01696994|589099936|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
163107741|NCT01696994|589099937|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
163107742|NCT01696994|589099936|FG000|Overall Study|Died Before Randomization|1|||
163107743|NCT01696994|589099937|FG001|Overall Study|Died Before Randomization|2|||
163107744|NCT01696994|589099936|FG000|Overall Study|Died Before ASU (Control)|73|||
163107745|NCT01696994|589099937|FG001|Overall Study|Died Before ASU (Control)|0|||
163107746|NCT01696994|589099936|FG000|Overall Study|No Ovaries at Baseline|4807|||
163107747|NCT01696994|589099937|FG001|Overall Study|No Ovaries at Baseline|4851|||
163107748|NCT01696994|589099936|FG000|Overall Study|Refused ASU (Control)|311|||
163107749|NCT01696994|589099937|FG001|Overall Study|Refused ASU (Control)|0|||
163107750|NCT01696994|589099936|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
163107751|NCT01696994|589099937|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
163107752|NCT04644276|589099938|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
163107753|NCT04644276|589099939|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
163107754|NCT04644276|589099940|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
163107755|NCT00705250|589099941|FG000|Overall Study|Withdrawal by Subject|1|||
163107756|NCT00705250|589099941|FG000|Overall Study|Patient died in car accident|1|||
163107757|NCT00316225|589099942|FG000|Overall Study|Adverse Event|2|||
163107758|NCT00316225|589099942|FG000|Overall Study|Physician Decision|3|||
163107759|NCT00316225|589099942|FG000|Overall Study|Progressive Disease|15|||
163107760|NCT00316225|589099942|FG000|Overall Study|Withdrawal by Subject|3|||
163107761|NCT00316225|589099942|FG000|Overall Study|Death|2|||
163107762|NCT01814878|589099943|FG000|Overall Study|Adverse Event|16|||
163107763|NCT01814878|589099944|FG001|Overall Study|Adverse Event|5|||
163107764|NCT01814878|589099943|FG000|Overall Study|Withdrawal by Subject|20|||
163107765|NCT01814878|589099944|FG001|Overall Study|Withdrawal by Subject|16|||
163107766|NCT01814878|589099943|FG000|Overall Study|Protocol Violation|5|||
163107767|NCT01814878|589099944|FG001|Overall Study|Protocol Violation|5|||
163107768|NCT01814878|589099943|FG000|Overall Study|Physician Decision|3|||
163107769|NCT01814878|589099944|FG001|Overall Study|Physician Decision|1|||
163107770|NCT01814878|589099943|FG000|Overall Study|Screening failure (drop-out)|0|||
163107771|NCT01814878|589099944|FG001|Overall Study|Screening failure (drop-out)|3|||
163107772|NCT01814878|589099943|FG000|Overall Study|Other|2|||
163107773|NCT01814878|589099944|FG001|Overall Study|Other|0|||
163221609|NCT03373383|589528136|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
163221610|NCT03373383|589528137|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
163221611|NCT03373383|589528138|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
163407801|NCT02873936|590200916|FG001|Overall Study|Randomized but not Dosed|0|||
163107774|NCT01200407|589099947|FG000|Overall Study|Lost to Follow-up|56|||
163107775|NCT01200407|589099947|FG000|Overall Study|Adverse Event|3|||
163107776|NCT01200407|589099947|FG000|Overall Study|Withdrawal by Subject|4|||
163107777|NCT01200407|589099947|FG000|Overall Study|Other|19|||
163107778|NCT00425698|589099948|FG000|Overall Study|Adverse Event|3|||
163107779|NCT00425698|589099949|FG001|Overall Study|Adverse Event|1|||
163107780|NCT00425698|589099948|FG000|Overall Study|Withdrawal by Subject|0|||
163107781|NCT00425698|589099949|FG001|Overall Study|Withdrawal by Subject|1|||
163107782|NCT01126268|589099953|FG000|Overall Study|Adverse Event|1|||
163107783|NCT03831191|589099957|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
163107784|NCT03831191|589099958|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
163107785|NCT03831191|589099959|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
163107786|NCT03831191|589099960|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
163107787|NCT03831191|589099961|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
163107788|NCT03831191|589099962|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
163107789|NCT03831191|589099963|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
163107790|NCT03831191|589099964|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
163107791|NCT03831191|589099965|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
163107792|NCT03831191|589099966|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
163107793|NCT03831191|589099967|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
163107794|NCT03831191|589099968|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
163107795|NCT03831191|589099969|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
163107796|NCT03831191|589099970|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
163107797|NCT03831191|589099971|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
163107798|NCT03831191|589099957|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
163107799|NCT03831191|589099958|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
163107800|NCT03831191|589099959|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107801|NCT03831191|589099960|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107802|NCT03831191|589099961|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107803|NCT03831191|589099962|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107804|NCT03831191|589099963|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107805|NCT03831191|589099964|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107806|NCT03831191|589099965|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107807|NCT03831191|589099966|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107808|NCT03831191|589099967|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107809|NCT03831191|589099968|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107810|NCT03831191|589099969|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107811|NCT03831191|589099970|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107812|NCT03831191|589099971|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107813|NCT03831191|589099957|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
163107814|NCT03831191|589099958|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
163107815|NCT03831191|589099959|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
163107816|NCT03831191|589099960|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
163107817|NCT03831191|589099961|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
163107818|NCT03831191|589099962|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
163107819|NCT03831191|589099963|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
163107820|NCT03831191|589099964|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
163107821|NCT03831191|589099965|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
163107822|NCT03831191|589099966|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
163107823|NCT03831191|589099967|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
163107824|NCT03831191|589099968|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
163107825|NCT03831191|589099969|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
163107826|NCT03831191|589099970|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
163107827|NCT03831191|589099971|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
163107828|NCT03831191|589099957|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
163107829|NCT03831191|589099958|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
163107830|NCT03831191|589099959|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
163107831|NCT03831191|589099960|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
163107832|NCT03831191|589099961|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
163107833|NCT03831191|589099962|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
163107834|NCT03831191|589099963|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
163107835|NCT03831191|589099964|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
163107836|NCT03831191|589099965|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
163107837|NCT03831191|589099966|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
163107838|NCT03831191|589099967|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
163107839|NCT03831191|589099968|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
163107840|NCT03831191|589099969|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
163107841|NCT03831191|589099970|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
163107842|NCT03831191|589099971|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
163107843|NCT03831191|589099957|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
163107844|NCT03831191|589099958|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
163107845|NCT03831191|589099959|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
163107846|NCT03831191|589099960|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
163107847|NCT03831191|589099961|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107848|NCT03831191|589099962|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107849|NCT03831191|589099963|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107850|NCT03831191|589099964|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107851|NCT03831191|589099965|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107852|NCT03831191|589099966|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163221612|NCT03373383|589528134|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
163221613|NCT03373383|589528135|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
163221614|NCT03373383|589528136|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
163221615|NCT03373383|589528137|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
163221616|NCT03373383|589528138|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
163221617|NCT03373383|589528134|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
163221618|NCT03373383|589528135|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
163221619|NCT03373383|589528136|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
163221620|NCT03373383|589528137|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
163221621|NCT03373383|589528138|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
163221622|NCT03373383|589528134|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
163221623|NCT03373383|589528135|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
163221624|NCT03373383|589528136|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
163221625|NCT03373383|589528137|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
163221626|NCT03373383|589528138|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
163221627|NCT03373383|589528134|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
163221628|NCT03373383|589528135|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
163221629|NCT03373383|589528136|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
163221630|NCT03373383|589528137|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
163221631|NCT03373383|589528138|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
163221632|NCT02689258|589528139|FG000|Overall Study|Subject Non-Compliance|0|||
163221633|NCT02689258|589528140|FG001|Overall Study|Subject Non-Compliance|1|||
163221634|NCT02689258|589528141|FG002|Overall Study|Subject Non-Compliance|0|||
163221635|NCT02689258|589528142|FG003|Overall Study|Subject Non-Compliance|0|||
163221636|NCT02689258|589528143|FG004|Overall Study|Subject Non-Compliance|0|||
163221637|NCT02689258|589528144|FG005|Overall Study|Subject Non-Compliance|0|||
163221638|NCT02689258|589528145|FG006|Overall Study|Subject Non-Compliance|0|||
163221639|NCT02689258|589528146|FG007|Overall Study|Subject Non-Compliance|0|||
163107853|NCT03831191|589099967|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107854|NCT03831191|589099968|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107855|NCT03831191|589099969|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107856|NCT03831191|589099970|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107857|NCT03831191|589099971|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107858|NCT03831191|589099957|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
163107859|NCT03831191|589099958|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
163107860|NCT03831191|589099959|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
163107861|NCT03831191|589099960|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
163107862|NCT03831191|589099961|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107863|NCT03831191|589099962|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107864|NCT03831191|589099963|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107865|NCT03831191|589099964|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107866|NCT03831191|589099965|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107867|NCT03831191|589099966|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107868|NCT03831191|589099967|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107869|NCT03831191|589099968|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107870|NCT03831191|589099969|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107871|NCT03831191|589099970|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107872|NCT03831191|589099971|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163221640|NCT02689258|589528147|FG008|Overall Study|Subject Non-Compliance|0|||
163221641|NCT02689258|589528148|FG009|Overall Study|Subject Non-Compliance|0|||
163221642|NCT02689258|589528149|FG010|Overall Study|Subject Non-Compliance|0|||
163221643|NCT02689258|589528150|FG011|Overall Study|Subject Non-Compliance|0|||
163221644|NCT02689258|589528139|FG000|Overall Study|Subject Refusal to Continue|0|||
163221645|NCT02689258|589528140|FG001|Overall Study|Subject Refusal to Continue|1|||
163221646|NCT02689258|589528141|FG002|Overall Study|Subject Refusal to Continue|0|||
163339722|NCT03745651|589953070|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163339723|NCT03745651|589953071|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163339724|NCT03745651|589953065|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163339725|NCT03745651|589953066|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
163339726|NCT03745651|589953067|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163339727|NCT03745651|589953068|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163339728|NCT03745651|589953069|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163339729|NCT03745651|589953070|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163339730|NCT03745651|589953071|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163339731|NCT03745651|589953065|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
163107873|NCT03831191|589099957|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107874|NCT03831191|589099958|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107875|NCT03831191|589099959|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107876|NCT03831191|589099960|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
163107877|NCT03831191|589099961|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107878|NCT03831191|589099962|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107879|NCT03831191|589099963|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107880|NCT03831191|589099964|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107881|NCT03831191|589099965|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107882|NCT03831191|589099966|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107883|NCT03831191|589099967|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107884|NCT03831191|589099968|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107885|NCT03831191|589099969|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107886|NCT03831191|589099970|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107887|NCT03831191|589099971|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107888|NCT03831191|589099957|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
163107889|NCT03831191|589099958|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
163107890|NCT03831191|589099959|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
163107891|NCT03831191|589099960|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
163107892|NCT03831191|589099961|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
163107893|NCT03831191|589099962|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
163107894|NCT03831191|589099963|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
163107895|NCT03831191|589099964|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
163107896|NCT03831191|589099965|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
163107897|NCT03831191|589099966|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
163107898|NCT03831191|589099967|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
163107899|NCT03831191|589099968|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
163107900|NCT03831191|589099969|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
163107901|NCT03831191|589099970|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
163107902|NCT03831191|589099971|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
163107903|NCT03831191|589099957|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107904|NCT03831191|589099958|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107905|NCT03831191|589099959|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107906|NCT03831191|589099960|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107907|NCT03831191|589099961|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107908|NCT03831191|589099962|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107909|NCT03831191|589099963|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107910|NCT03831191|589099964|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107911|NCT03831191|589099965|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107912|NCT03831191|589099966|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107913|NCT03831191|589099967|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107914|NCT03831191|589099968|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107915|NCT03831191|589099969|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107916|NCT03831191|589099970|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107917|NCT03831191|589099971|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
163107918|NCT03831191|589099957|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107919|NCT03831191|589099958|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107920|NCT03831191|589099959|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107921|NCT03831191|589099960|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107922|NCT03831191|589099961|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107923|NCT03831191|589099962|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107924|NCT03831191|589099963|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107925|NCT03831191|589099964|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107926|NCT03831191|589099965|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107927|NCT03831191|589099966|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107928|NCT03831191|589099967|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107929|NCT03831191|589099968|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107930|NCT03831191|589099969|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107931|NCT03831191|589099970|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107932|NCT03831191|589099971|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
163107933|NCT01626118|589099972|FG000|Overall Study|Lack of Efficacy|1|||
163107934|NCT01626118|589099973|FG001|Overall Study|Lack of Efficacy|0|||
163107935|NCT01626118|589099974|FG002|Overall Study|Lack of Efficacy|1|||
163107936|NCT01626118|589099975|FG003|Overall Study|Lack of Efficacy|3|||
163107937|NCT01626118|589099972|FG000|Overall Study|Lost to Follow-up|1|||
163107938|NCT01626118|589099973|FG001|Overall Study|Lost to Follow-up|0|||
163107939|NCT01626118|589099974|FG002|Overall Study|Lost to Follow-up|0|||
163107940|NCT01626118|589099975|FG003|Overall Study|Lost to Follow-up|0|||
163107941|NCT01626118|589099972|FG000|Overall Study|Adverse Event|0|||
163107942|NCT01626118|589099973|FG001|Overall Study|Adverse Event|1|||
163107943|NCT01626118|589099974|FG002|Overall Study|Adverse Event|1|||
163107944|NCT01626118|589099975|FG003|Overall Study|Adverse Event|0|||
163107945|NCT01626118|589099972|FG000|Overall Study|Investigator Decision|0|||
163107946|NCT01626118|589099973|FG001|Overall Study|Investigator Decision|1|||
163107947|NCT01626118|589099974|FG002|Overall Study|Investigator Decision|0|||
163107948|NCT01626118|589099975|FG003|Overall Study|Investigator Decision|0|||
163107949|NCT00002540|589099976|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
163107950|NCT00002540|589099977|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
163107951|NCT00002540|589099976|FG000|Overall Study|Died Before Randomization|2|||
163107952|NCT00002540|589099977|FG001|Overall Study|Died Before Randomization|6|||
163107953|NCT00002540|589099976|FG000|Overall Study|Died Before ASU (Control)|202|||
163107954|NCT00002540|589099977|FG001|Overall Study|Died Before ASU (Control)|0|||
163107955|NCT00002540|589099976|FG000|Overall Study|Refused ASU (Control)|597|||
163107956|NCT00002540|589099977|FG001|Overall Study|Refused ASU (Control)|0|||
163107957|NCT00002540|589099976|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
163107958|NCT00002540|589099977|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
163107959|NCT02151903|589099978|FG000|Overall Study|Withdrawal by Subject|1|||
163107960|NCT02151903|589099979|FG001|Overall Study|Withdrawal by Subject|0|||
163107961|NCT02151903|589099978|FG000|Overall Study|Progressive disease|2|||
163107962|NCT02151903|589099979|FG001|Overall Study|Progressive disease|1|||
163107963|NCT01864148|589099980|FG000|Overall Study|Other|2|||
163107964|NCT01864148|589099981|FG001|Overall Study|Other|1|||
163107965|NCT01864148|589099982|FG002|Overall Study|Other|1|||
163107966|NCT01864148|589099983|FG003|Overall Study|Other|3|||
163107967|NCT01864148|589099984|FG004|Overall Study|Other|1|||
163107968|NCT01864148|589099980|FG000|Overall Study|Death|0|||
163107969|NCT01864148|589099981|FG001|Overall Study|Death|0|||
163107970|NCT01864148|589099982|FG002|Overall Study|Death|0|||
163107971|NCT01864148|589099983|FG003|Overall Study|Death|1|||
163107972|NCT01864148|589099984|FG004|Overall Study|Death|0|||
163107973|NCT01864148|589099980|FG000|Overall Study|Investigator Decision|5|||
163107974|NCT01864148|589099981|FG001|Overall Study|Investigator Decision|0|||
163107975|NCT01864148|589099982|FG002|Overall Study|Investigator Decision|0|||
163107976|NCT01864148|589099983|FG003|Overall Study|Investigator Decision|4|||
163107977|NCT01864148|589099984|FG004|Overall Study|Investigator Decision|6|||
163107978|NCT01864148|589099980|FG000|Overall Study|Withdrawal by Subject|9|||
163107979|NCT01864148|589099981|FG001|Overall Study|Withdrawal by Subject|2|||
163107980|NCT01864148|589099982|FG002|Overall Study|Withdrawal by Subject|6|||
163107981|NCT01864148|589099983|FG003|Overall Study|Withdrawal by Subject|8|||
163107982|NCT01864148|589099984|FG004|Overall Study|Withdrawal by Subject|8|||
163107983|NCT01864148|589099980|FG000|Overall Study|Lost to Follow-up|0|||
163107984|NCT01864148|589099981|FG001|Overall Study|Lost to Follow-up|0|||
163107985|NCT01864148|589099982|FG002|Overall Study|Lost to Follow-up|0|||
163107986|NCT01864148|589099983|FG003|Overall Study|Lost to Follow-up|2|||
163107987|NCT01864148|589099984|FG004|Overall Study|Lost to Follow-up|1|||
163107988|NCT01864148|589099980|FG000|Overall Study|Adverse Event|4|||
163107989|NCT01864148|589099981|FG001|Overall Study|Adverse Event|2|||
163107990|NCT01864148|589099982|FG002|Overall Study|Adverse Event|4|||
163107991|NCT01864148|589099983|FG003|Overall Study|Adverse Event|7|||
163107992|NCT01864148|589099984|FG004|Overall Study|Adverse Event|7|||
163107993|NCT01864148|589099980|FG000|Overall Study|Not Dosed|0|||
163107994|NCT01864148|589099981|FG001|Overall Study|Not Dosed|0|||
163107995|NCT01864148|589099982|FG002|Overall Study|Not Dosed|0|||
163107996|NCT01864148|589099983|FG003|Overall Study|Not Dosed|1|||
163107997|NCT01864148|589099984|FG004|Overall Study|Not Dosed|0|||
163107998|NCT00778375|589099985|FG000|Overall Study|Ineligible|3|||
163107999|NCT03490292|589099986|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
163108000|NCT03490292|589099987|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
163108001|NCT03490292|589099986|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
163108002|NCT03490292|589099987|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
163108003|NCT03490292|589099986|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
163108004|NCT03490292|589099987|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
163108005|NCT03490292|589099986|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
163221647|NCT02689258|589528142|FG003|Overall Study|Subject Refusal to Continue|0|||
163221648|NCT02689258|589528143|FG004|Overall Study|Subject Refusal to Continue|0|||
163221649|NCT02689258|589528144|FG005|Overall Study|Subject Refusal to Continue|0|||
163108006|NCT03490292|589099987|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
163108007|NCT03490292|589099986|FG000|1 Year Follow Up Post Last Dose|Death|1|||
163108008|NCT03490292|589099987|FG001|1 Year Follow Up Post Last Dose|Death|1|||
163108009|NCT01421303|589099988|FG000|Overall Study|Lost to Follow-up|13|||
163108010|NCT01421303|589099988|FG000|Overall Study|Non compliance with study procedure|1|||
163108011|NCT01421303|589099988|FG000|Overall Study|Other|7|||
163108012|NCT01421303|589099988|FG000|Overall Study|Withdrawal by Subject|1|||
163108013|NCT00582712|589099997|FG000|Overall Study|Adverse Event|1|||
163108014|NCT00582712|589099997|FG000|Overall Study|Lack of Efficacy|1|||
163108015|NCT00582712|589099997|FG000|Overall Study|Withdrawal by Subject|1|||
163108016|NCT00582712|589099997|FG000|Overall Study|Complicating disease requiring treatment|1|||
163108017|NCT03640507|589100001|FG000|Overall Study|Withdrawal by Subject|0|||
163108018|NCT03640507|589100002|FG001|Overall Study|Withdrawal by Subject|0|||
163108019|NCT03640507|589100003|FG002|Overall Study|Withdrawal by Subject|1|||
163108020|NCT03525600|589100004|FG000|Overall Study|Adverse Event|9|||
163108021|NCT03525600|589100005|FG001|Overall Study|Adverse Event|6|||
163108022|NCT03525600|589100006|FG002|Overall Study|Adverse Event|5|||
163108023|NCT03525600|589100007|FG003|Overall Study|Adverse Event|3|||
163108024|NCT03525600|589100004|FG000|Overall Study|Lost to Follow-up|2|||
163108025|NCT03525600|589100005|FG001|Overall Study|Lost to Follow-up|4|||
163108026|NCT03525600|589100006|FG002|Overall Study|Lost to Follow-up|4|||
163108027|NCT03525600|589100007|FG003|Overall Study|Lost to Follow-up|0|||
163108028|NCT03525600|589100004|FG000|Overall Study|Physician Decision|1|||
163108029|NCT03525600|589100005|FG001|Overall Study|Physician Decision|0|||
163108030|NCT03525600|589100006|FG002|Overall Study|Physician Decision|2|||
163108031|NCT03525600|589100007|FG003|Overall Study|Physician Decision|0|||
163108032|NCT03525600|589100004|FG000|Overall Study|Consent withdrawal|36|||
163108033|NCT03525600|589100005|FG001|Overall Study|Consent withdrawal|20|||
163108034|NCT03525600|589100006|FG002|Overall Study|Consent withdrawal|6|||
163108035|NCT03525600|589100007|FG003|Overall Study|Consent withdrawal|13|||
163108036|NCT03525600|589100004|FG000|Overall Study|Death|7|||
163108037|NCT03525600|589100005|FG001|Overall Study|Death|6|||
163108038|NCT03525600|589100006|FG002|Overall Study|Death|4|||
163108039|NCT03525600|589100007|FG003|Overall Study|Death|3|||
163108040|NCT03525600|589100004|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
163108041|NCT03525600|589100005|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
163108042|NCT03525600|589100006|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
163108043|NCT03525600|589100007|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
163108044|NCT03525600|589100004|FG000|Overall Study|Other|0|||
163108045|NCT03525600|589100005|FG001|Overall Study|Other|1|||
163108046|NCT03525600|589100006|FG002|Overall Study|Other|0|||
163108047|NCT03525600|589100007|FG003|Overall Study|Other|0|||
163108048|NCT02676895|589100008|FG000|Overall Study|Administrative reason|1|||
163108049|NCT02676895|589100009|FG001|Overall Study|Administrative reason|0|||
163108050|NCT02676895|589100010|FG002|Overall Study|Administrative reason|0|||
163108051|NCT02676895|589100008|FG000|Overall Study|Protocol Violation|1|||
163108052|NCT02676895|589100009|FG001|Overall Study|Protocol Violation|0|||
163108053|NCT02676895|589100010|FG002|Overall Study|Protocol Violation|0|||
163108054|NCT02676895|589100008|FG000|Overall Study|Adverse Event|0|||
163108055|NCT02676895|589100009|FG001|Overall Study|Adverse Event|3|||
163108056|NCT02676895|589100010|FG002|Overall Study|Adverse Event|1|||
163108057|NCT02676895|589100008|FG000|Overall Study|Lost to Follow-up|0|||
163108058|NCT02676895|589100009|FG001|Overall Study|Lost to Follow-up|0|||
163108059|NCT02676895|589100010|FG002|Overall Study|Lost to Follow-up|1|||
163108060|NCT02676895|589100008|FG000|Overall Study|Withdrawal by Subject|0|||
163108061|NCT02676895|589100009|FG001|Overall Study|Withdrawal by Subject|0|||
163108062|NCT02676895|589100010|FG002|Overall Study|Withdrawal by Subject|1|||
163108063|NCT01270880|589100014|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
163108064|NCT00613327|589100015|FG000|Overall Study|Adverse Event|38|||
163108065|NCT00613327|589100015|FG000|Overall Study|Lost to Follow-up|8|||
163108066|NCT00613327|589100015|FG000|Overall Study|Withdrawal by Subject|6|||
163108067|NCT00613327|589100015|FG000|Overall Study|Protocol Violation|2|||
163108068|NCT00613327|589100015|FG000|Overall Study|Other|47|||
163108069|NCT00344318|589100016|FG000|Overall Study|Adverse Event|0|||
163108070|NCT00344318|589100017|FG001|Overall Study|Adverse Event|3|||
163108071|NCT00344318|589100018|FG002|Overall Study|Adverse Event|0|||
163108072|NCT00344318|589100019|FG003|Overall Study|Adverse Event|1|||
163108073|NCT00344318|589100016|FG000|Overall Study|Withdrawal by Subject|2|||
163108074|NCT00344318|589100017|FG001|Overall Study|Withdrawal by Subject|2|||
163108075|NCT00344318|589100018|FG002|Overall Study|Withdrawal by Subject|0|||
163108076|NCT00344318|589100019|FG003|Overall Study|Withdrawal by Subject|2|||
163108077|NCT00344318|589100016|FG000|Overall Study|Lost to Follow-up|2|||
163108078|NCT00344318|589100017|FG001|Overall Study|Lost to Follow-up|0|||
163108079|NCT00344318|589100018|FG002|Overall Study|Lost to Follow-up|1|||
163221650|NCT02689258|589528145|FG006|Overall Study|Subject Refusal to Continue|0|||
163339732|NCT03745651|589953066|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
163339733|NCT03745651|589953067|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
163339734|NCT03745651|589953068|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163339735|NCT03745651|589953069|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163339736|NCT03745651|589953070|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163108080|NCT00344318|589100019|FG003|Overall Study|Lost to Follow-up|0|||
163108081|NCT00395486|589100025|FG000|Overall Study|Adverse Event|1|||
163108082|NCT00395486|589100026|FG001|Overall Study|Adverse Event|2|||
163108083|NCT00395486|589100025|FG000|Overall Study|Withdrawal by Subject|5|||
163108084|NCT00395486|589100026|FG001|Overall Study|Withdrawal by Subject|2|||
163108085|NCT00395486|589100025|FG000|Overall Study|Lost to Follow-up|0|||
163108086|NCT00395486|589100026|FG001|Overall Study|Lost to Follow-up|1|||
163108087|NCT00290771|589100033|FG000|Overall Study|Disease progression|95|||
163108088|NCT00290771|589100034|FG001|Overall Study|Disease progression|73|||
163108089|NCT00290771|589100033|FG000|Overall Study|Death|11|||
163221651|NCT02689258|589528146|FG007|Overall Study|Subject Refusal to Continue|0|||
163221652|NCT02689258|589528147|FG008|Overall Study|Subject Refusal to Continue|1|||
163221653|NCT02689258|589528148|FG009|Overall Study|Subject Refusal to Continue|0|||
163221654|NCT02689258|589528149|FG010|Overall Study|Subject Refusal to Continue|0|||
163221655|NCT02689258|589528150|FG011|Overall Study|Subject Refusal to Continue|1|||
163108090|NCT00290771|589100034|FG001|Overall Study|Death|10|||
163108091|NCT00290771|589100033|FG000|Overall Study|Adverse Event|12|||
163108092|NCT00290771|589100034|FG001|Overall Study|Adverse Event|6|||
163221656|NCT02689258|589528139|FG000|Overall Study|Other|0|||
163221657|NCT02689258|589528140|FG001|Overall Study|Other|2|||
163221658|NCT02689258|589528141|FG002|Overall Study|Other|0|||
163221659|NCT02689258|589528142|FG003|Overall Study|Other|0|||
163221660|NCT02689258|589528143|FG004|Overall Study|Other|1|||
163221661|NCT02689258|589528144|FG005|Overall Study|Other|0|||
163221662|NCT02689258|589528145|FG006|Overall Study|Other|0|||
163221663|NCT02689258|589528146|FG007|Overall Study|Other|0|||
163221664|NCT02689258|589528147|FG008|Overall Study|Other|1|||
163221665|NCT02689258|589528148|FG009|Overall Study|Other|0|||
163221666|NCT02689258|589528149|FG010|Overall Study|Other|0|||
163221667|NCT02689258|589528150|FG011|Overall Study|Other|0|||
163221668|NCT00594464|589528152|FG000|Overall Study|Withdrawal by Subject|1|||
163221669|NCT00594464|589528152|FG000|Overall Study|Delay in operation|2|||
163221670|NCT00785486|589528153|FG000|Midazolam Alone|Withdrawal by Subject|1|||
163221671|NCT02907359|589528160|FG000|Overall Study|Death|234|||
163221672|NCT02907359|589528161|FG001|Overall Study|Death|117|||
163221673|NCT02907359|589528160|FG000|Overall Study|Withdrawal by Subject|6|||
163221674|NCT02907359|589528161|FG001|Overall Study|Withdrawal by Subject|11|||
163221675|NCT02907359|589528160|FG000|Overall Study|Lost to Follow-up|1|||
163221676|NCT02907359|589528161|FG001|Overall Study|Lost to Follow-up|0|||
163221677|NCT03131440|589528162|FG000|Overall Study|Withdrawal by Subject|1|||
163221678|NCT03131440|589528163|FG001|Overall Study|Withdrawal by Subject|3|||
163221679|NCT03131440|589528164|FG002|Overall Study|Withdrawal by Subject|0|||
163221680|NCT03131440|589528165|FG003|Overall Study|Withdrawal by Subject|0|||
163221681|NCT03131440|589528166|FG004|Overall Study|Withdrawal by Subject|1|||
163221682|NCT03131440|589528167|FG005|Overall Study|Withdrawal by Subject|0|||
163221683|NCT03131440|589528168|FG006|Overall Study|Withdrawal by Subject|0|||
163221684|NCT03131440|589528169|FG007|Overall Study|Withdrawal by Subject|1|||
163221685|NCT03131440|589528170|FG008|Overall Study|Withdrawal by Subject|1|||
163221686|NCT03131440|589528171|FG009|Overall Study|Withdrawal by Subject|1|||
163221687|NCT03131440|589528172|FG010|Overall Study|Withdrawal by Subject|0|||
163221688|NCT03131440|589528173|FG011|Overall Study|Withdrawal by Subject|1|||
163108093|NCT00290771|589100033|FG000|Overall Study|Withdrawal by Subject|5|||
163108094|NCT00290771|589100034|FG001|Overall Study|Withdrawal by Subject|6|||
163108095|NCT00290771|589100033|FG000|Overall Study|Administrative problems|2|||
163108096|NCT00290771|589100034|FG001|Overall Study|Administrative problems|1|||
163108097|NCT00290771|589100033|FG000|Overall Study|Protocol Violation|2|||
163108098|NCT00290771|589100034|FG001|Overall Study|Protocol Violation|0|||
163108099|NCT00290771|589100033|FG000|Overall Study|Lost to Follow-up|0|||
163108100|NCT00290771|589100034|FG001|Overall Study|Lost to Follow-up|1|||
163221689|NCT03131440|589528174|FG012|Overall Study|Withdrawal by Subject|1|||
163221690|NCT03131440|589528175|FG013|Overall Study|Withdrawal by Subject|0|||
163221691|NCT03131440|589528176|FG014|Overall Study|Withdrawal by Subject|1|||
163221692|NCT03131440|589528177|FG015|Overall Study|Withdrawal by Subject|0|||
163221693|NCT03131440|589528178|FG016|Overall Study|Withdrawal by Subject|0|||
163221694|NCT03131440|589528179|FG017|Overall Study|Withdrawal by Subject|0|||
163221695|NCT03131440|589528180|FG018|Overall Study|Withdrawal by Subject|1|||
163221696|NCT03131440|589528181|FG019|Overall Study|Withdrawal by Subject|0|||
163339737|NCT03745651|589953071|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163339738|NCT03745651|589953065|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
163339739|NCT03745651|589953066|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
163108101|NCT04154293|589100037|FG000|Overall Study|Withdrawal by Subject|2|||
163221697|NCT03131440|589528182|FG020|Overall Study|Withdrawal by Subject|1|||
163221698|NCT03131440|589528183|FG021|Overall Study|Withdrawal by Subject|1|||
163221699|NCT03131440|589528184|FG022|Overall Study|Withdrawal by Subject|1|||
163221700|NCT03131440|589528185|FG023|Overall Study|Withdrawal by Subject|0|||
163221701|NCT03131440|589528186|FG024|Overall Study|Withdrawal by Subject|0|||
163221702|NCT03131440|589528187|FG025|Overall Study|Withdrawal by Subject|0|||
163221703|NCT03131440|589528188|FG026|Overall Study|Withdrawal by Subject|0|||
163221704|NCT03131440|589528189|FG027|Overall Study|Withdrawal by Subject|0|||
163221705|NCT03131440|589528190|FG028|Overall Study|Withdrawal by Subject|0|||
163221706|NCT03131440|589528191|FG029|Overall Study|Withdrawal by Subject|0|||
163221707|NCT03131440|589528192|FG030|Overall Study|Withdrawal by Subject|1|||
163221708|NCT03131440|589528193|FG031|Overall Study|Withdrawal by Subject|0|||
163221709|NCT03131440|589528162|FG000|Overall Study|Lost to Follow-up|0|||
163221710|NCT03131440|589528163|FG001|Overall Study|Lost to Follow-up|0|||
163221711|NCT03131440|589528164|FG002|Overall Study|Lost to Follow-up|0|||
163108102|NCT04154293|589100038|FG001|Overall Study|Withdrawal by Subject|3|||
163221712|NCT03131440|589528165|FG003|Overall Study|Lost to Follow-up|0|||
163108103|NCT04154293|589100039|FG002|Overall Study|Withdrawal by Subject|1|||
163108104|NCT04154293|589100037|FG000|Overall Study|Physician Decision|0|||
163108105|NCT04154293|589100038|FG001|Overall Study|Physician Decision|0|||
163108106|NCT04154293|589100039|FG002|Overall Study|Physician Decision|1|||
163108107|NCT04731298|589100040|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
163108108|NCT04731298|589100041|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
163108109|NCT01208961|589100042|FG000|High-Fat Period III|Protocol Violation|1|||
163108110|NCT01208961|589100043|FG001|High-Fat Period III|Protocol Violation|0|||
163108111|NCT01262560|589100044|FG000|Overall Study|Protocol Violation|0|||
163108112|NCT01262560|589100045|FG001|Overall Study|Protocol Violation|1|||
163108113|NCT01262560|589100046|FG002|Overall Study|Protocol Violation|2|||
163108114|NCT00350870|589100049|FG000|Overall Study|Withdrawal by Subject|21|||
163108115|NCT00350870|589100050|FG001|Overall Study|Withdrawal by Subject|17|||
163108116|NCT00350870|589100051|FG002|Overall Study|Withdrawal by Subject|15|||
163108117|NCT00350870|589100052|FG003|Overall Study|Withdrawal by Subject|14|||
163108118|NCT00350870|589100049|FG000|Overall Study|Physician Decision|1|||
163108119|NCT00350870|589100050|FG001|Overall Study|Physician Decision|0|||
163108120|NCT00350870|589100051|FG002|Overall Study|Physician Decision|1|||
163108121|NCT00350870|589100052|FG003|Overall Study|Physician Decision|1|||
163108122|NCT02095873|589100055|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
163108123|NCT02095873|589100056|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
163108124|NCT02095873|589100055|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
163108125|NCT02095873|589100056|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
163108126|NCT02095873|589100055|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
163108127|NCT02095873|589100056|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
163108128|NCT02791516|589100061|FG000|Overall Study|Withdrawal by Subject|1|||
163108129|NCT02791516|589100062|FG001|Overall Study|Withdrawal by Subject|1|||
163108130|NCT02524275|589100063|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
163108131|NCT01439971|589100064|FG000|Overall Study|Required number in cohort dosed|0|||
163108132|NCT01439971|589100065|FG001|Overall Study|Required number in cohort dosed|1|||
163108133|NCT01439971|589100066|FG002|Overall Study|Required number in cohort dosed|2|||
163108134|NCT01439971|589100067|FG003|Overall Study|Required number in cohort dosed|0|||
163108135|NCT01439971|589100068|FG004|Overall Study|Required number in cohort dosed|1|||
163108136|NCT02628600|589100069|FG000|Overall Study|Death|2|||
163108137|NCT02628600|589100070|FG001|Overall Study|Death|1|||
163108138|NCT02628600|589100069|FG000|Overall Study|Adverse Event|3|||
163108139|NCT02628600|589100070|FG001|Overall Study|Adverse Event|20|||
163108140|NCT02628600|589100069|FG000|Overall Study|Protocol Violation|0|||
163108141|NCT02628600|589100070|FG001|Overall Study|Protocol Violation|1|||
163108142|NCT02628600|589100069|FG000|Overall Study|Lack of Efficacy|2|||
163108143|NCT02628600|589100070|FG001|Overall Study|Lack of Efficacy|0|||
163108144|NCT02628600|589100069|FG000|Overall Study|Withdrawal by Subject|13|||
163108145|NCT02628600|589100070|FG001|Overall Study|Withdrawal by Subject|8|||
163108146|NCT02628600|589100069|FG000|Overall Study|Lost to Follow-up|1|||
163108147|NCT02628600|589100070|FG001|Overall Study|Lost to Follow-up|0|||
163108148|NCT02628600|589100069|FG000|Overall Study|Physician Decision|2|||
163108149|NCT02628600|589100070|FG001|Overall Study|Physician Decision|2|||
163108150|NCT02628600|589100069|FG000|Overall Study|Other not specified|1|||
163108151|NCT02628600|589100070|FG001|Overall Study|Other not specified|0|||
163108152|NCT03110029|589100075|FG000|Overall Study|Withdrawal by Subject|1|||
163108153|NCT03110029|589100076|FG001|Overall Study|Withdrawal by Subject|1|||
163108154|NCT00511433|589102931|FG000|Overall Study|Adverse Event|5|||
163108155|NCT00511433|589102932|FG001|Overall Study|Adverse Event|0|||
163108156|NCT00511433|589102931|FG000|Overall Study|Other Reason|1|||
163108157|NCT00511433|589102932|FG001|Overall Study|Other Reason|1|||
163108158|NCT00197145|589102933|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
163108159|NCT00197145|589102934|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
163108160|NCT00197145|589102933|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
163108161|NCT00197145|589102934|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
163108162|NCT00197145|589102933|FG000|Period 1: Randomized Treatment Phase|Other|2|||
163108163|NCT00197145|589102934|FG001|Period 1: Randomized Treatment Phase|Other|2|||
163108164|NCT00197145|589102933|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
163108165|NCT00197145|589102934|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
163108166|NCT00197145|589102933|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
163108167|NCT00197145|589102934|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
163108168|NCT00197145|589102933|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
163108169|NCT00197145|589102934|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
163108170|NCT00197145|589102933|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
163108171|NCT00197145|589102934|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
163108172|NCT00197145|589102933|FG000|Period 2 : Open Label Phase|Other|1|||
163108173|NCT00197145|589102934|FG001|Period 2 : Open Label Phase|Other|0|||
163108174|NCT00790868|589102935|FG000|Overall Study|Withdrawal by Subject|4|||
163108175|NCT00790868|589102936|FG001|Overall Study|Withdrawal by Subject|5|||
163108176|NCT00790868|589102935|FG000|Overall Study|Lost to Follow-up|2|||
163108177|NCT00790868|589102936|FG001|Overall Study|Lost to Follow-up|12|||
163108178|NCT02867813|589102937|FG000|Overall Study|Withdrawal by Subject|57|||
163108179|NCT02867813|589102938|FG001|Overall Study|Withdrawal by Subject|56|||
163108180|NCT02867813|589102937|FG000|Overall Study|Decision by Sponsor|7|||
163108181|NCT02867813|589102938|FG001|Overall Study|Decision by Sponsor|7|||
163108182|NCT02867813|589102937|FG000|Overall Study|Lost to Follow-up|91|||
163108183|NCT02867813|589102938|FG001|Overall Study|Lost to Follow-up|78|||
163108184|NCT02867813|589102937|FG000|Overall Study|Missing|2|||
163108185|NCT02867813|589102938|FG001|Overall Study|Missing|1|||
163108186|NCT02867813|589102937|FG000|Overall Study|Death|294|||
163108187|NCT02867813|589102938|FG001|Overall Study|Death|268|||
163108188|NCT01952665|589102942|FG000|Overall Study|Physician Decision|3|||
163108189|NCT01952665|589102943|FG001|Overall Study|Physician Decision|2|||
163108190|NCT01952665|589102942|FG000|Overall Study|Lost to Follow-up|1|||
163108191|NCT01952665|589102943|FG001|Overall Study|Lost to Follow-up|2|||
163108192|NCT01952665|589102942|FG000|Overall Study|Adverse Event|2|||
163108193|NCT01952665|589102943|FG001|Overall Study|Adverse Event|1|||
163108194|NCT01952665|589102942|FG000|Overall Study|Protocol Violation|0|||
163108195|NCT01952665|589102943|FG001|Overall Study|Protocol Violation|1|||
163108196|NCT02578680|589102944|FG000|Overall Study|Death|329|||
163108197|NCT02578680|589102945|FG001|Overall Study|Death|181|||
163108198|NCT02578680|589102944|FG000|Overall Study|Lost to Follow-up|3|||
163108199|NCT02578680|589102945|FG001|Overall Study|Lost to Follow-up|1|||
163108200|NCT02578680|589102944|FG000|Overall Study|Physician Decision|0|||
163108201|NCT02578680|589102945|FG001|Overall Study|Physician Decision|1|||
163108202|NCT02578680|589102944|FG000|Overall Study|Protocol Violation|1|||
163108203|NCT02578680|589102945|FG001|Overall Study|Protocol Violation|1|||
163108204|NCT02578680|589102944|FG000|Overall Study|Sponsor Decision|64|||
163108205|NCT02578680|589102945|FG001|Overall Study|Sponsor Decision|13|||
163108206|NCT02578680|589102944|FG000|Overall Study|Withdrawal by Subject|13|||
163108207|NCT02578680|589102945|FG001|Overall Study|Withdrawal by Subject|9|||
163108208|NCT02596958|589102947|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
163108209|NCT02596958|589102947|FG000|Overall Study|Cancer Progression|441|||
163108210|NCT02596958|589102947|FG000|Overall Study|Death From Cancer|112|||
163108211|NCT02596958|589102947|FG000|Overall Study|Death From Other Cause|33|||
163108212|NCT02596958|589102947|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
163108213|NCT02596958|589102947|FG000|Overall Study|Administrative Reasons/Other|231|||
163108214|NCT02596958|589102947|FG000|Overall Study|Lost to Follow-up|33|||
163108215|NCT02596958|589102947|FG000|Overall Study|Missing|32|||
163108216|NCT02596958|589102947|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
163108217|NCT01559259|589102948|FG000|Overall Study|Withdrawal by Subject|0|||
163108218|NCT01559259|589102949|FG001|Overall Study|Withdrawal by Subject|0|||
163108219|NCT01559259|589102950|FG002|Overall Study|Withdrawal by Subject|0|||
163108220|NCT01559259|589102951|FG003|Overall Study|Withdrawal by Subject|1|||
163108221|NCT01559259|589102952|FG004|Overall Study|Withdrawal by Subject|0|||
163108222|NCT01559259|589102948|FG000|Overall Study|Adverse Event|0|||
163108223|NCT01559259|589102949|FG001|Overall Study|Adverse Event|1|||
163108224|NCT01559259|589102950|FG002|Overall Study|Adverse Event|1|||
163108225|NCT01559259|589102951|FG003|Overall Study|Adverse Event|0|||
163108226|NCT01559259|589102952|FG004|Overall Study|Adverse Event|0|||
163108227|NCT01995669|589102953|FG000|Overall Study|Progression|2|||
163108228|NCT01995669|589102954|FG001|Overall Study|Progression|1|||
163108229|NCT01995669|589102955|FG002|Overall Study|Progression|1|||
163108230|NCT01995669|589102956|FG003|Overall Study|Progression|13|||
163108231|NCT01995669|589102953|FG000|Overall Study|Adverse Event|0|||
163108232|NCT01995669|589102954|FG001|Overall Study|Adverse Event|0|||
163108233|NCT01995669|589102955|FG002|Overall Study|Adverse Event|0|||
163108234|NCT01995669|589102956|FG003|Overall Study|Adverse Event|3|||
163108235|NCT01995669|589102953|FG000|Overall Study|Death|0|||
163108236|NCT01995669|589102954|FG001|Overall Study|Death|0|||
163108237|NCT01995669|589102955|FG002|Overall Study|Death|0|||
163108238|NCT01995669|589102956|FG003|Overall Study|Death|6|||
163108239|NCT01995669|589102953|FG000|Overall Study|Withdrawal by Subject|0|||
163108240|NCT01995669|589102954|FG001|Overall Study|Withdrawal by Subject|0|||
163108241|NCT01995669|589102955|FG002|Overall Study|Withdrawal by Subject|0|||
163108242|NCT01995669|589102956|FG003|Overall Study|Withdrawal by Subject|6|||
163108243|NCT01995669|589102953|FG000|Overall Study|Insurance Expired|0|||
163108244|NCT01995669|589102954|FG001|Overall Study|Insurance Expired|0|||
163108245|NCT01995669|589102955|FG002|Overall Study|Insurance Expired|0|||
163108246|NCT01995669|589102956|FG003|Overall Study|Insurance Expired|1|||
163108247|NCT03727646|589102957|FG000|Overall Study|Adverse Event|1|||
163108248|NCT03727646|589102958|FG001|Overall Study|Adverse Event|0|||
163108249|NCT05659719|589102959|FG000|Overall Study|At sponsor's request|0|||
163221713|NCT03131440|589528166|FG004|Overall Study|Lost to Follow-up|0|||
163108250|NCT05659719|589102960|FG001|Overall Study|At sponsor's request|0|||
163108251|NCT05659719|589102961|FG002|Overall Study|At sponsor's request|0|||
163108252|NCT05659719|589102962|FG003|Overall Study|At sponsor's request|95|||
163108253|NCT05659719|589102959|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
163108254|NCT05659719|589102960|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
163108255|NCT05659719|589102961|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
163108256|NCT05659719|589102962|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
163108257|NCT05659719|589102959|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
163108258|NCT05659719|589102960|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
163108259|NCT05659719|589102961|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
163108260|NCT05659719|589102962|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
163108261|NCT05659719|589102959|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
163108262|NCT05659719|589102960|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
163108263|NCT05659719|589102961|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
163108264|NCT05659719|589102962|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
163108265|NCT05659719|589102959|FG000|Overall Study|Lost to Follow-up|0|||
163108266|NCT05659719|589102960|FG001|Overall Study|Lost to Follow-up|0|||
163108267|NCT05659719|589102961|FG002|Overall Study|Lost to Follow-up|0|||
163108268|NCT05659719|589102962|FG003|Overall Study|Lost to Follow-up|2|||
163108269|NCT05659719|589102959|FG000|Overall Study|Moved to another observational study|0|||
163108270|NCT05659719|589102960|FG001|Overall Study|Moved to another observational study|0|||
163108271|NCT05659719|589102961|FG002|Overall Study|Moved to another observational study|0|||
163108272|NCT05659719|589102962|FG003|Overall Study|Moved to another observational study|1|||
163108273|NCT05659719|589102959|FG000|Overall Study|The child was enrolled in an interventional study|0|||
163108274|NCT05659719|589102960|FG001|Overall Study|The child was enrolled in an interventional study|0|||
163108275|NCT05659719|589102961|FG002|Overall Study|The child was enrolled in an interventional study|0|||
163108276|NCT05659719|589102962|FG003|Overall Study|The child was enrolled in an interventional study|55|||
163108277|NCT05659719|589102959|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
163108278|NCT05659719|589102960|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
163108279|NCT05659719|589102961|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
163108280|NCT05659719|589102962|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
163108281|NCT05659719|589102959|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
163108282|NCT05659719|589102960|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
163108283|NCT05659719|589102961|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
163108284|NCT05659719|589102962|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
163108285|NCT02290691|589102966|FG000|Overall Study|Noncompliance|0|||
163108286|NCT02290691|589102967|FG001|Overall Study|Noncompliance|1|||
163108287|NCT02290691|589102966|FG000|Overall Study|Withdrawal by Subject|1|||
163108288|NCT02290691|589102967|FG001|Overall Study|Withdrawal by Subject|1|||
163108289|NCT02290691|589102966|FG000|Overall Study|Lost to Follow-up|7|||
163108290|NCT02290691|589102967|FG001|Overall Study|Lost to Follow-up|7|||
163108291|NCT00306293|589102969|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
163108292|NCT00306293|589102970|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
163108293|NCT00306293|589102969|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
163108294|NCT00306293|589102970|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
163108295|NCT00306293|589102969|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
163108296|NCT00306293|589102970|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
163108297|NCT00306293|589102969|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
163108298|NCT00306293|589102970|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
163108299|NCT00306293|589102969|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
163108300|NCT00306293|589102970|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
163108301|NCT00306293|589102969|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
163108302|NCT00306293|589102970|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
163108303|NCT00306293|589102969|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
163108304|NCT00306293|589102970|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
163108305|NCT00306293|589102969|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
163108306|NCT00306293|589102970|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
163108307|NCT00185380|589102973|FG000|Overall Study|Adverse Event|41|||
163108308|NCT00185380|589102974|FG001|Overall Study|Adverse Event|43|||
163108309|NCT00185380|589102975|FG002|Overall Study|Adverse Event|48|||
163108310|NCT00185380|589102973|FG000|Overall Study|Lost to Follow-up|0|||
163108311|NCT00185380|589102974|FG001|Overall Study|Lost to Follow-up|4|||
163108312|NCT00185380|589102975|FG002|Overall Study|Lost to Follow-up|3|||
163108313|NCT00185380|589102973|FG000|Overall Study|Pregnancy|1|||
163108314|NCT00185380|589102974|FG001|Overall Study|Pregnancy|4|||
163108315|NCT00185380|589102975|FG002|Overall Study|Pregnancy|0|||
163108316|NCT00185380|589102973|FG000|Overall Study|Protocol Violation|2|||
163108317|NCT00185380|589102974|FG001|Overall Study|Protocol Violation|2|||
163339740|NCT03745651|589953067|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
163108318|NCT00185380|589102975|FG002|Overall Study|Protocol Violation|1|||
163108319|NCT00185380|589102973|FG000|Overall Study|Withdrawal by Subject|1|||
163108320|NCT00185380|589102974|FG001|Overall Study|Withdrawal by Subject|2|||
163108321|NCT00185380|589102975|FG002|Overall Study|Withdrawal by Subject|0|||
163108322|NCT00185380|589102973|FG000|Overall Study|Failed insertion|1|||
163108323|NCT00185380|589102974|FG001|Overall Study|Failed insertion|1|||
163108324|NCT00185380|589102975|FG002|Overall Study|Failed insertion|2|||
163108325|NCT00185380|589102973|FG000|Overall Study|Planned pregnancy|9|||
163108326|NCT00185380|589102974|FG001|Overall Study|Planned pregnancy|12|||
163108327|NCT00185380|589102975|FG002|Overall Study|Planned pregnancy|12|||
163108328|NCT00185380|589102973|FG000|Overall Study|No need for contraception|3|||
163108329|NCT00185380|589102974|FG001|Overall Study|No need for contraception|3|||
163108330|NCT00185380|589102975|FG002|Overall Study|No need for contraception|3|||
163108331|NCT00185380|589102973|FG000|Overall Study|Could not attend visits|2|||
163108332|NCT00185380|589102974|FG001|Overall Study|Could not attend visits|0|||
163108333|NCT00185380|589102975|FG002|Overall Study|Could not attend visits|4|||
163108334|NCT00185380|589102973|FG000|Overall Study|personal reason|6|||
163108335|NCT00185380|589102974|FG001|Overall Study|personal reason|1|||
163108336|NCT00185380|589102975|FG002|Overall Study|personal reason|1|||
163108337|NCT00218634|589102976|FG000|Overall Study|Lost to Follow-up|8|||
163108338|NCT00218634|589102977|FG001|Overall Study|Lost to Follow-up|15|||
163108339|NCT02589665|589102978|FG000|Induction Period|Did not receive drug|0|||
163108340|NCT02589665|589102979|FG001|Induction Period|Did not receive drug|0|||
163108341|NCT02589665|589102980|FG002|Induction Period|Did not receive drug|0|||
163108342|NCT02589665|589102981|FG003|Induction Period|Did not receive drug|1|||
163108343|NCT02589665|589102982|FG004|Induction Period|Did not receive drug|0|||
163108344|NCT02589665|589102983|FG005|Induction Period|Did not receive drug|0|||
163108345|NCT02589665|589102984|FG006|Induction Period|Did not receive drug|0|||
163108346|NCT02589665|589102985|FG007|Induction Period|Did not receive drug|0|||
163108347|NCT02589665|589102986|FG008|Induction Period|Did not receive drug|0|||
163108348|NCT02589665|589102987|FG009|Induction Period|Did not receive drug|0|||
163108349|NCT02589665|589102978|FG000|Induction Period|Adverse Event|3|||
163108350|NCT02589665|589102979|FG001|Induction Period|Adverse Event|0|||
163108351|NCT02589665|589102980|FG002|Induction Period|Adverse Event|2|||
163108352|NCT02589665|589102981|FG003|Induction Period|Adverse Event|2|||
163108353|NCT02589665|589102982|FG004|Induction Period|Adverse Event|0|||
163108354|NCT02589665|589102983|FG005|Induction Period|Adverse Event|0|||
163108355|NCT02589665|589102984|FG006|Induction Period|Adverse Event|0|||
163108356|NCT02589665|589102985|FG007|Induction Period|Adverse Event|0|||
163108357|NCT02589665|589102986|FG008|Induction Period|Adverse Event|0|||
163108358|NCT02589665|589102987|FG009|Induction Period|Adverse Event|0|||
163108359|NCT02589665|589102978|FG000|Induction Period|Withdrawal by Subject|0|||
163108360|NCT02589665|589102979|FG001|Induction Period|Withdrawal by Subject|1|||
163108361|NCT02589665|589102980|FG002|Induction Period|Withdrawal by Subject|0|||
163108362|NCT02589665|589102981|FG003|Induction Period|Withdrawal by Subject|1|||
163108363|NCT02589665|589102982|FG004|Induction Period|Withdrawal by Subject|0|||
163339741|NCT03745651|589953068|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
163339742|NCT03745651|589953069|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
163339743|NCT03745651|589953070|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
163339744|NCT03745651|589953071|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
163339745|NCT03745651|589953065|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163339746|NCT03745651|589953066|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163339747|NCT03745651|589953067|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163407802|NCT02873936|590200917|FG002|Overall Study|Randomized but not Dosed|0|||
163108364|NCT02589665|589102983|FG005|Induction Period|Withdrawal by Subject|0|||
163108365|NCT02589665|589102984|FG006|Induction Period|Withdrawal by Subject|0|||
163108366|NCT02589665|589102985|FG007|Induction Period|Withdrawal by Subject|0|||
163108367|NCT02589665|589102986|FG008|Induction Period|Withdrawal by Subject|0|||
163108368|NCT02589665|589102987|FG009|Induction Period|Withdrawal by Subject|0|||
163108369|NCT02589665|589102978|FG000|Induction Period|Protocol Violation|0|||
163108370|NCT02589665|589102979|FG001|Induction Period|Protocol Violation|1|||
163108371|NCT02589665|589102980|FG002|Induction Period|Protocol Violation|0|||
163221714|NCT03131440|589528167|FG005|Overall Study|Lost to Follow-up|1|||
163221715|NCT03131440|589528168|FG006|Overall Study|Lost to Follow-up|0|||
163221716|NCT03131440|589528169|FG007|Overall Study|Lost to Follow-up|0|||
163221717|NCT03131440|589528170|FG008|Overall Study|Lost to Follow-up|0|||
163221718|NCT03131440|589528171|FG009|Overall Study|Lost to Follow-up|0|||
163221719|NCT03131440|589528172|FG010|Overall Study|Lost to Follow-up|0|||
163221720|NCT03131440|589528173|FG011|Overall Study|Lost to Follow-up|0|||
163221721|NCT03131440|589528174|FG012|Overall Study|Lost to Follow-up|0|||
163221722|NCT03131440|589528175|FG013|Overall Study|Lost to Follow-up|0|||
163221723|NCT03131440|589528176|FG014|Overall Study|Lost to Follow-up|0|||
163221724|NCT03131440|589528177|FG015|Overall Study|Lost to Follow-up|0|||
163108372|NCT02589665|589102981|FG003|Induction Period|Protocol Violation|0|||
163108373|NCT02589665|589102982|FG004|Induction Period|Protocol Violation|0|||
163221725|NCT03131440|589528178|FG016|Overall Study|Lost to Follow-up|0|||
163108374|NCT02589665|589102983|FG005|Induction Period|Protocol Violation|0|||
163108375|NCT02589665|589102984|FG006|Induction Period|Protocol Violation|0|||
163108376|NCT02589665|589102985|FG007|Induction Period|Protocol Violation|0|||
163108377|NCT02589665|589102986|FG008|Induction Period|Protocol Violation|0|||
163108378|NCT02589665|589102987|FG009|Induction Period|Protocol Violation|0|||
163108379|NCT02589665|589102978|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108380|NCT02589665|589102979|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108381|NCT02589665|589102980|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108382|NCT02589665|589102981|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108383|NCT02589665|589102982|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
163108384|NCT02589665|589102983|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
163108385|NCT02589665|589102984|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
163108386|NCT02589665|589102985|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108387|NCT02589665|589102986|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108388|NCT02589665|589102987|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108389|NCT02589665|589102978|FG000|Maintenance Period|Withdrawal by Subject|0|||
163108390|NCT02589665|589102979|FG001|Maintenance Period|Withdrawal by Subject|0|||
163108391|NCT02589665|589102980|FG002|Maintenance Period|Withdrawal by Subject|0|||
163108392|NCT02589665|589102981|FG003|Maintenance Period|Withdrawal by Subject|0|||
163108393|NCT02589665|589102982|FG004|Maintenance Period|Withdrawal by Subject|4|||
163108394|NCT02589665|589102983|FG005|Maintenance Period|Withdrawal by Subject|2|||
163108395|NCT02589665|589102984|FG006|Maintenance Period|Withdrawal by Subject|4|||
163108396|NCT02589665|589102985|FG007|Maintenance Period|Withdrawal by Subject|0|||
163108397|NCT02589665|589102986|FG008|Maintenance Period|Withdrawal by Subject|0|||
163108398|NCT02589665|589102987|FG009|Maintenance Period|Withdrawal by Subject|0|||
163108399|NCT02589665|589102978|FG000|Maintenance Period|Lack of Efficacy|0|||
163108400|NCT02589665|589102979|FG001|Maintenance Period|Lack of Efficacy|0|||
163108401|NCT02589665|589102980|FG002|Maintenance Period|Lack of Efficacy|0|||
163108402|NCT02589665|589102981|FG003|Maintenance Period|Lack of Efficacy|0|||
163108403|NCT02589665|589102982|FG004|Maintenance Period|Lack of Efficacy|2|||
163108404|NCT02589665|589102983|FG005|Maintenance Period|Lack of Efficacy|1|||
163108405|NCT02589665|589102984|FG006|Maintenance Period|Lack of Efficacy|0|||
163108406|NCT02589665|589102985|FG007|Maintenance Period|Lack of Efficacy|0|||
163108407|NCT02589665|589102986|FG008|Maintenance Period|Lack of Efficacy|0|||
163108408|NCT02589665|589102987|FG009|Maintenance Period|Lack of Efficacy|0|||
163108409|NCT02589665|589102978|FG000|Maintenance Period|Adverse Event|0|||
163108410|NCT02589665|589102979|FG001|Maintenance Period|Adverse Event|0|||
163108411|NCT02589665|589102980|FG002|Maintenance Period|Adverse Event|0|||
163108412|NCT02589665|589102981|FG003|Maintenance Period|Adverse Event|0|||
163108413|NCT02589665|589102982|FG004|Maintenance Period|Adverse Event|0|||
163108414|NCT02589665|589102983|FG005|Maintenance Period|Adverse Event|0|||
163108415|NCT02589665|589102984|FG006|Maintenance Period|Adverse Event|2|||
163108416|NCT02589665|589102985|FG007|Maintenance Period|Adverse Event|0|||
163108417|NCT02589665|589102986|FG008|Maintenance Period|Adverse Event|0|||
163108418|NCT02589665|589102987|FG009|Maintenance Period|Adverse Event|0|||
163108419|NCT02589665|589102978|FG000|Maintenance Period|Lost to Follow-up|0|||
163108420|NCT02589665|589102979|FG001|Maintenance Period|Lost to Follow-up|0|||
163108421|NCT02589665|589102980|FG002|Maintenance Period|Lost to Follow-up|0|||
163108422|NCT02589665|589102981|FG003|Maintenance Period|Lost to Follow-up|0|||
163108423|NCT02589665|589102982|FG004|Maintenance Period|Lost to Follow-up|0|||
163108424|NCT02589665|589102983|FG005|Maintenance Period|Lost to Follow-up|1|||
163108425|NCT02589665|589102984|FG006|Maintenance Period|Lost to Follow-up|0|||
163108426|NCT02589665|589102985|FG007|Maintenance Period|Lost to Follow-up|0|||
163108427|NCT02589665|589102986|FG008|Maintenance Period|Lost to Follow-up|0|||
163221726|NCT03131440|589528179|FG017|Overall Study|Lost to Follow-up|0|||
163221727|NCT03131440|589528180|FG018|Overall Study|Lost to Follow-up|0|||
163221728|NCT03131440|589528181|FG019|Overall Study|Lost to Follow-up|2|||
163108428|NCT02589665|589102987|FG009|Maintenance Period|Lost to Follow-up|0|||
163221729|NCT03131440|589528182|FG020|Overall Study|Lost to Follow-up|1|||
163221730|NCT03131440|589528183|FG021|Overall Study|Lost to Follow-up|0|||
163221731|NCT03131440|589528184|FG022|Overall Study|Lost to Follow-up|1|||
163221732|NCT03131440|589528185|FG023|Overall Study|Lost to Follow-up|0|||
163221733|NCT03131440|589528186|FG024|Overall Study|Lost to Follow-up|1|||
163339748|NCT03745651|589953068|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163339749|NCT03745651|589953069|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163339750|NCT03745651|589953070|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
163339751|NCT03745651|589953071|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163339752|NCT03745651|589953065|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163108429|NCT02589665|589102978|FG000|Maintenance Period|Physician Decision|0|||
163108430|NCT02589665|589102979|FG001|Maintenance Period|Physician Decision|0|||
163108431|NCT02589665|589102980|FG002|Maintenance Period|Physician Decision|0|||
163221734|NCT03131440|589528187|FG025|Overall Study|Lost to Follow-up|0|||
163221735|NCT03131440|589528188|FG026|Overall Study|Lost to Follow-up|0|||
163108432|NCT02589665|589102981|FG003|Maintenance Period|Physician Decision|0|||
163108433|NCT02589665|589102982|FG004|Maintenance Period|Physician Decision|0|||
163108434|NCT02589665|589102983|FG005|Maintenance Period|Physician Decision|1|||
163108435|NCT02589665|589102984|FG006|Maintenance Period|Physician Decision|0|||
163108436|NCT02589665|589102985|FG007|Maintenance Period|Physician Decision|0|||
163108437|NCT02589665|589102986|FG008|Maintenance Period|Physician Decision|0|||
163108438|NCT02589665|589102987|FG009|Maintenance Period|Physician Decision|0|||
163108439|NCT02589665|589102978|FG000|Maintenance Period|Reason Not Collected|0|||
163108440|NCT02589665|589102979|FG001|Maintenance Period|Reason Not Collected|0|||
163108441|NCT02589665|589102980|FG002|Maintenance Period|Reason Not Collected|0|||
163108442|NCT02589665|589102981|FG003|Maintenance Period|Reason Not Collected|0|||
163108443|NCT02589665|589102982|FG004|Maintenance Period|Reason Not Collected|0|||
163108444|NCT02589665|589102983|FG005|Maintenance Period|Reason Not Collected|1|||
163108445|NCT02589665|589102984|FG006|Maintenance Period|Reason Not Collected|1|||
163108446|NCT02589665|589102985|FG007|Maintenance Period|Reason Not Collected|0|||
163108447|NCT02589665|589102986|FG008|Maintenance Period|Reason Not Collected|0|||
163108448|NCT02589665|589102987|FG009|Maintenance Period|Reason Not Collected|0|||
163108449|NCT02589665|589102978|FG000|Induction Extension Period|Adverse Event|0|||
163108450|NCT02589665|589102979|FG001|Induction Extension Period|Adverse Event|0|||
163108451|NCT02589665|589102980|FG002|Induction Extension Period|Adverse Event|0|||
163108452|NCT02589665|589102981|FG003|Induction Extension Period|Adverse Event|0|||
163108453|NCT02589665|589102982|FG004|Induction Extension Period|Adverse Event|0|||
163108454|NCT02589665|589102983|FG005|Induction Extension Period|Adverse Event|0|||
163108455|NCT02589665|589102984|FG006|Induction Extension Period|Adverse Event|0|||
163108456|NCT02589665|589102985|FG007|Induction Extension Period|Adverse Event|0|||
163108457|NCT02589665|589102986|FG008|Induction Extension Period|Adverse Event|4|||
163108458|NCT02589665|589102987|FG009|Induction Extension Period|Adverse Event|0|||
163108459|NCT02589665|589102978|FG000|Induction Extension Period|Lack of Efficacy|0|||
163108460|NCT02589665|589102979|FG001|Induction Extension Period|Lack of Efficacy|0|||
163108461|NCT02589665|589102980|FG002|Induction Extension Period|Lack of Efficacy|0|||
163108462|NCT02589665|589102981|FG003|Induction Extension Period|Lack of Efficacy|0|||
163108463|NCT02589665|589102982|FG004|Induction Extension Period|Lack of Efficacy|0|||
163108464|NCT02589665|589102983|FG005|Induction Extension Period|Lack of Efficacy|0|||
163108465|NCT02589665|589102984|FG006|Induction Extension Period|Lack of Efficacy|0|||
163108466|NCT02589665|589102985|FG007|Induction Extension Period|Lack of Efficacy|0|||
163108467|NCT02589665|589102986|FG008|Induction Extension Period|Lack of Efficacy|3|||
163108468|NCT02589665|589102987|FG009|Induction Extension Period|Lack of Efficacy|0|||
163108469|NCT02589665|589102978|FG000|Induction Extension Period|Withdrawal by Subject|0|||
163108470|NCT02589665|589102979|FG001|Induction Extension Period|Withdrawal by Subject|0|||
163108471|NCT02589665|589102980|FG002|Induction Extension Period|Withdrawal by Subject|0|||
163108472|NCT02589665|589102981|FG003|Induction Extension Period|Withdrawal by Subject|0|||
163108473|NCT02589665|589102982|FG004|Induction Extension Period|Withdrawal by Subject|0|||
163108474|NCT02589665|589102983|FG005|Induction Extension Period|Withdrawal by Subject|0|||
163108475|NCT02589665|589102984|FG006|Induction Extension Period|Withdrawal by Subject|0|||
163108476|NCT02589665|589102985|FG007|Induction Extension Period|Withdrawal by Subject|2|||
163108477|NCT02589665|589102986|FG008|Induction Extension Period|Withdrawal by Subject|3|||
163108478|NCT02589665|589102987|FG009|Induction Extension Period|Withdrawal by Subject|0|||
163108479|NCT02589665|589102978|FG000|Induction Extension Period|Physician Decision|0|||
163108480|NCT02589665|589102979|FG001|Induction Extension Period|Physician Decision|0|||
163108481|NCT02589665|589102980|FG002|Induction Extension Period|Physician Decision|0|||
163108482|NCT02589665|589102981|FG003|Induction Extension Period|Physician Decision|0|||
163108483|NCT02589665|589102982|FG004|Induction Extension Period|Physician Decision|0|||
163108484|NCT02589665|589102983|FG005|Induction Extension Period|Physician Decision|0|||
163108485|NCT02589665|589102984|FG006|Induction Extension Period|Physician Decision|0|||
163108486|NCT02589665|589102985|FG007|Induction Extension Period|Physician Decision|0|||
163108487|NCT02589665|589102986|FG008|Induction Extension Period|Physician Decision|1|||
163108488|NCT02589665|589102987|FG009|Induction Extension Period|Physician Decision|0|||
163108489|NCT02589665|589102978|FG000|Induction Extension Period|Reason Not Collected|0|||
163108490|NCT02589665|589102979|FG001|Induction Extension Period|Reason Not Collected|0|||
163221736|NCT03131440|589528189|FG027|Overall Study|Lost to Follow-up|2|||
163221737|NCT03131440|589528190|FG028|Overall Study|Lost to Follow-up|0|||
163221738|NCT03131440|589528191|FG029|Overall Study|Lost to Follow-up|2|||
163221739|NCT03131440|589528192|FG030|Overall Study|Lost to Follow-up|0|||
163221740|NCT03131440|589528193|FG031|Overall Study|Lost to Follow-up|0|||
163221741|NCT03131440|589528162|FG000|Overall Study|Death|0|||
163108491|NCT02589665|589102980|FG002|Induction Extension Period|Reason Not Collected|0|||
163108492|NCT02589665|589102981|FG003|Induction Extension Period|Reason Not Collected|0|||
163108493|NCT02589665|589102982|FG004|Induction Extension Period|Reason Not Collected|0|||
163108494|NCT02589665|589102983|FG005|Induction Extension Period|Reason Not Collected|0|||
163108495|NCT02589665|589102984|FG006|Induction Extension Period|Reason Not Collected|0|||
163108496|NCT02589665|589102985|FG007|Induction Extension Period|Reason Not Collected|0|||
163108497|NCT02589665|589102986|FG008|Induction Extension Period|Reason Not Collected|1|||
163221742|NCT03131440|589528163|FG001|Overall Study|Death|0|||
163108498|NCT02589665|589102987|FG009|Induction Extension Period|Reason Not Collected|0|||
163108499|NCT02589665|589102978|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108500|NCT02589665|589102979|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108501|NCT02589665|589102980|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108502|NCT02589665|589102981|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108503|NCT02589665|589102982|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108504|NCT02589665|589102983|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108505|NCT02589665|589102984|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108506|NCT02589665|589102985|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108507|NCT02589665|589102986|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108508|NCT02589665|589102987|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
163108509|NCT02589665|589102978|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
163108510|NCT02589665|589102979|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
163108511|NCT02589665|589102980|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
163108512|NCT02589665|589102981|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
163108513|NCT02589665|589102982|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
163108514|NCT02589665|589102983|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
163108515|NCT02589665|589102984|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
163108516|NCT02589665|589102985|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
163108517|NCT02589665|589102986|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
163108518|NCT02589665|589102987|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
163108519|NCT02589665|589102978|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
163108520|NCT02589665|589102979|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
163108521|NCT02589665|589102980|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
163108522|NCT02589665|589102981|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
163108523|NCT02589665|589102982|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
163108524|NCT02589665|589102983|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
163108525|NCT02589665|589102984|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
163108526|NCT02589665|589102985|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
163108527|NCT02589665|589102986|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
163108528|NCT02589665|589102987|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
163108529|NCT02589665|589102978|FG000|Maintenance Extension Period|Adverse Event|0|||
163108530|NCT02589665|589102979|FG001|Maintenance Extension Period|Adverse Event|0|||
163108531|NCT02589665|589102980|FG002|Maintenance Extension Period|Adverse Event|0|||
163108532|NCT02589665|589102981|FG003|Maintenance Extension Period|Adverse Event|0|||
163108533|NCT02589665|589102982|FG004|Maintenance Extension Period|Adverse Event|0|||
163108534|NCT02589665|589102983|FG005|Maintenance Extension Period|Adverse Event|0|||
163108535|NCT02589665|589102984|FG006|Maintenance Extension Period|Adverse Event|0|||
163108536|NCT02589665|589102985|FG007|Maintenance Extension Period|Adverse Event|0|||
163108537|NCT02589665|589102986|FG008|Maintenance Extension Period|Adverse Event|0|||
163108538|NCT02589665|589102987|FG009|Maintenance Extension Period|Adverse Event|2|||
163108539|NCT02589665|589102978|FG000|Maintenance Extension Period|Non-responder|0|||
163108540|NCT02589665|589102979|FG001|Maintenance Extension Period|Non-responder|0|||
163108541|NCT02589665|589102980|FG002|Maintenance Extension Period|Non-responder|0|||
163108542|NCT02589665|589102981|FG003|Maintenance Extension Period|Non-responder|0|||
163108543|NCT02589665|589102982|FG004|Maintenance Extension Period|Non-responder|0|||
163108544|NCT02589665|589102983|FG005|Maintenance Extension Period|Non-responder|0|||
163108545|NCT02589665|589102984|FG006|Maintenance Extension Period|Non-responder|0|||
163108546|NCT02589665|589102985|FG007|Maintenance Extension Period|Non-responder|0|||
163108547|NCT02589665|589102986|FG008|Maintenance Extension Period|Non-responder|0|||
163108548|NCT02589665|589102987|FG009|Maintenance Extension Period|Non-responder|1|||
163108549|NCT00978380|589102990|FG000|Overall Study|Protocol Violation|2|||
163108550|NCT00978380|589102990|FG000|Overall Study|Withdrawal criteria|9|||
163108551|NCT00978380|589102990|FG000|Overall Study|Unclassified|8|||
163108552|NCT00176488|589102991|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
163108553|NCT00327015|589102992|FG000|Overall Study|Lack of Efficacy|18|||
163407803|NCT02054897|590200918|FG000|Overall Study|Withdrawal by Subject|2|||
163407804|NCT02054897|590200919|FG001|Overall Study|Withdrawal by Subject|0|||
163108554|NCT00327015|589102993|FG001|Overall Study|Lack of Efficacy|18|||
163108555|NCT00327015|589102994|FG002|Overall Study|Lack of Efficacy|35|||
163108556|NCT00327015|589102995|FG003|Overall Study|Lack of Efficacy|29|||
163108557|NCT00327015|589102992|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
163407805|NCT02054897|590200920|FG002|Overall Study|Withdrawal by Subject|2|||
163407806|NCT02054897|590200918|FG000|Overall Study|Missing follow-up information|3|||
163108558|NCT00327015|589102993|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
163108559|NCT00327015|589102994|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
163108560|NCT00327015|589102995|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
163108561|NCT00327015|589102992|FG000|Overall Study|Lost to Follow-up|22|||
163108562|NCT00327015|589102993|FG001|Overall Study|Lost to Follow-up|23|||
163108563|NCT00327015|589102994|FG002|Overall Study|Lost to Follow-up|29|||
163108564|NCT00327015|589102995|FG003|Overall Study|Lost to Follow-up|22|||
163108565|NCT00327015|589102992|FG000|Overall Study|Adverse Event|14|||
163108566|NCT00327015|589102993|FG001|Overall Study|Adverse Event|10|||
163108567|NCT00327015|589102994|FG002|Overall Study|Adverse Event|14|||
163108568|NCT00327015|589102995|FG003|Overall Study|Adverse Event|14|||
163108569|NCT00327015|589102992|FG000|Overall Study|Subject no longer meets study criteria|4|||
163108570|NCT00327015|589102993|FG001|Overall Study|Subject no longer meets study criteria|2|||
163108571|NCT00327015|589102994|FG002|Overall Study|Subject no longer meets study criteria|8|||
163339753|NCT03745651|589953066|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163339754|NCT03745651|589953067|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163108572|NCT00327015|589102995|FG003|Overall Study|Subject no longer meets study criteria|7|||
163108573|NCT00327015|589102992|FG000|Overall Study|Poor/Noncompliance|11|||
163108574|NCT00327015|589102993|FG001|Overall Study|Poor/Noncompliance|8|||
163108575|NCT00327015|589102994|FG002|Overall Study|Poor/Noncompliance|4|||
163108576|NCT00327015|589102995|FG003|Overall Study|Poor/Noncompliance|5|||
163108577|NCT00327015|589102992|FG000|Overall Study|Physician Decision|0|||
163108578|NCT00327015|589102993|FG001|Overall Study|Physician Decision|1|||
163108579|NCT00327015|589102994|FG002|Overall Study|Physician Decision|3|||
163108580|NCT00327015|589102995|FG003|Overall Study|Physician Decision|2|||
163108581|NCT00327015|589102992|FG000|Overall Study|Death|1|||
163108582|NCT00327015|589102993|FG001|Overall Study|Death|2|||
163108583|NCT00327015|589102994|FG002|Overall Study|Death|2|||
163108584|NCT00327015|589102995|FG003|Overall Study|Death|3|||
163108585|NCT00327015|589102992|FG000|Overall Study|Pregnancy|0|||
163108586|NCT00327015|589102993|FG001|Overall Study|Pregnancy|2|||
163108587|NCT00327015|589102994|FG002|Overall Study|Pregnancy|1|||
163108588|NCT00327015|589102995|FG003|Overall Study|Pregnancy|1|||
163108589|NCT00327015|589102992|FG000|Overall Study|Administrative Reason by Sponsor|1|||
163108590|NCT00327015|589102993|FG001|Overall Study|Administrative Reason by Sponsor|2|||
163108591|NCT00327015|589102994|FG002|Overall Study|Administrative Reason by Sponsor|2|||
163108592|NCT00327015|589102995|FG003|Overall Study|Administrative Reason by Sponsor|1|||
163339755|NCT03745651|589953068|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
163108593|NCT02242435|589102996|FG000|Overall Study|Lost to Follow-up|3|||
163108594|NCT02242435|589102997|FG001|Overall Study|Lost to Follow-up|4|||
163108595|NCT02242435|589102996|FG000|Overall Study|Adverse Event|3|||
163108596|NCT02242435|589102997|FG001|Overall Study|Adverse Event|2|||
163108597|NCT02242435|589102996|FG000|Overall Study|Withdrawal by Subject|13|||
163108598|NCT02242435|589102997|FG001|Overall Study|Withdrawal by Subject|8|||
163108599|NCT02242435|589102996|FG000|Overall Study|Death|0|||
163108600|NCT02242435|589102997|FG001|Overall Study|Death|1|||
163108601|NCT02242435|589102996|FG000|Overall Study|Protocol Violation|1|||
163108602|NCT02242435|589102997|FG001|Overall Study|Protocol Violation|0|||
163108603|NCT02242435|589102996|FG000|Overall Study|Physician Decision|0|||
163108604|NCT02242435|589102997|FG001|Overall Study|Physician Decision|1|||
163108605|NCT00510718|589103006|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
163108606|NCT00510718|589103007|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
163108607|NCT00510718|589103006|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
163108608|NCT00510718|589103007|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
163108609|NCT00510718|589103006|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
163108610|NCT00510718|589103007|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
163108611|NCT00510718|589103006|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
163108612|NCT00510718|589103007|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
163339756|NCT03745651|589953069|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163339757|NCT03745651|589953070|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
163339758|NCT03745651|589953071|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
163339759|NCT03745651|589953065|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163108613|NCT00510718|589103006|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
163108614|NCT00510718|589103007|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
163339760|NCT03745651|589953066|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163339761|NCT03745651|589953067|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163407807|NCT02054897|590200919|FG001|Overall Study|Missing follow-up information|5|||
163108615|NCT00510718|589103006|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
163407808|NCT02054897|590200920|FG002|Overall Study|Missing follow-up information|3|||
163407809|NCT02054897|590200918|FG000|Overall Study|Lost to Follow-up|4|||
163108616|NCT00510718|589103007|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
163108617|NCT01089413|589103010|FG000|Overall Study|Lost to Follow-up|1|||
163108618|NCT01089413|589103010|FG000|Overall Study|Progressive Disease|93|||
163108619|NCT01089413|589103010|FG000|Overall Study|Participant Withdrew Consent|1|||
163108620|NCT01089413|589103010|FG000|Overall Study|Unacceptable Toxicity|12|||
163108621|NCT01089413|589103010|FG000|Overall Study|Death|10|||
163108622|NCT01089413|589103010|FG000|Overall Study|Metastasectomy|13|||
163108623|NCT01089413|589103010|FG000|Overall Study|Other|71|||
163108624|NCT01610557|589103015|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
163221743|NCT03131440|589528164|FG002|Overall Study|Death|0|||
163108625|NCT01610557|589103016|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
163108626|NCT01610557|589103017|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
163108627|NCT01610557|589103018|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
163108628|NCT01610557|589103019|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
163108629|NCT01610557|589103015|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
163108630|NCT01610557|589103016|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
163108631|NCT01610557|589103017|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
163108632|NCT01610557|589103018|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
163108633|NCT01610557|589103019|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
163108634|NCT02003638|589103022|FG000|Overall Study|Withdrawal by Subject|1|||
163108635|NCT02003638|589103023|FG001|Overall Study|Withdrawal by Subject|0|||
163108636|NCT04115748|589103024|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
163108637|NCT04115748|589103025|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
163108638|NCT04115748|589103026|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
163108639|NCT04115748|589103027|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
163108640|NCT04115748|589103028|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
163108641|NCT04115748|589103029|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
163108642|NCT04115748|589103030|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
163108643|NCT04115748|589103031|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
163108644|NCT04115748|589103032|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
163108645|NCT04115748|589103033|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
163108646|NCT04115748|589103024|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108647|NCT04115748|589103025|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108648|NCT04115748|589103026|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108649|NCT04115748|589103027|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
163108650|NCT04115748|589103028|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108651|NCT04115748|589103029|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108652|NCT04115748|589103030|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108653|NCT04115748|589103031|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108654|NCT04115748|589103032|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108655|NCT04115748|589103033|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108656|NCT04115748|589103024|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
163108657|NCT04115748|589103025|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
163108658|NCT04115748|589103026|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
163108659|NCT04115748|589103027|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
163108660|NCT04115748|589103028|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
163108661|NCT04115748|589103029|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
163108662|NCT04115748|589103030|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
163108663|NCT04115748|589103031|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
163108664|NCT04115748|589103032|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
163108665|NCT04115748|589103033|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
163108666|NCT04115748|589103024|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108667|NCT04115748|589103025|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108668|NCT04115748|589103026|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108669|NCT04115748|589103027|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108670|NCT04115748|589103028|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108671|NCT04115748|589103029|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108672|NCT04115748|589103030|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108673|NCT04115748|589103031|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108674|NCT04115748|589103032|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
163108675|NCT04115748|589103033|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108676|NCT02752633|589103034|FG000|Overall Study|Withdrawal by Subject|1|||
163108677|NCT00152477|589103036|FG000|Chemotherapy Period|Adverse Event|9|||
163108678|NCT00152477|589103037|FG001|Chemotherapy Period|Adverse Event|4|||
163108679|NCT00152477|589103038|FG002|Chemotherapy Period|Adverse Event|5|||
163108680|NCT00152477|589103036|FG000|Chemotherapy Period|Death|1|||
163108681|NCT00152477|589103037|FG001|Chemotherapy Period|Death|3|||
163108682|NCT00152477|589103038|FG002|Chemotherapy Period|Death|3|||
163108683|NCT00152477|589103036|FG000|Chemotherapy Period|Lack of Efficacy|4|||
163108684|NCT00152477|589103037|FG001|Chemotherapy Period|Lack of Efficacy|5|||
163108685|NCT00152477|589103038|FG002|Chemotherapy Period|Lack of Efficacy|6|||
163108686|NCT00152477|589103036|FG000|Chemotherapy Period|Lost to Follow-up|1|||
163108687|NCT00152477|589103037|FG001|Chemotherapy Period|Lost to Follow-up|0|||
163108688|NCT00152477|589103038|FG002|Chemotherapy Period|Lost to Follow-up|1|||
163108689|NCT00152477|589103036|FG000|Chemotherapy Period|Protocol Violation|1|||
163108690|NCT00152477|589103037|FG001|Chemotherapy Period|Protocol Violation|1|||
163108691|NCT00152477|589103038|FG002|Chemotherapy Period|Protocol Violation|0|||
163108692|NCT00152477|589103036|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
163108693|NCT00152477|589103037|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
163221744|NCT03131440|589528165|FG003|Overall Study|Death|0|||
163221745|NCT03131440|589528166|FG004|Overall Study|Death|0|||
163221746|NCT03131440|589528167|FG005|Overall Study|Death|0|||
163221747|NCT03131440|589528168|FG006|Overall Study|Death|0|||
163221748|NCT03131440|589528169|FG007|Overall Study|Death|0|||
163221749|NCT03131440|589528170|FG008|Overall Study|Death|0|||
163221750|NCT03131440|589528171|FG009|Overall Study|Death|0|||
163221751|NCT03131440|589528172|FG010|Overall Study|Death|0|||
163221752|NCT03131440|589528173|FG011|Overall Study|Death|0|||
163221753|NCT03131440|589528174|FG012|Overall Study|Death|0|||
163221754|NCT03131440|589528175|FG013|Overall Study|Death|0|||
163221755|NCT03131440|589528176|FG014|Overall Study|Death|0|||
163221756|NCT03131440|589528177|FG015|Overall Study|Death|0|||
163221757|NCT03131440|589528178|FG016|Overall Study|Death|0|||
163221758|NCT03131440|589528179|FG017|Overall Study|Death|0|||
163221759|NCT03131440|589528180|FG018|Overall Study|Death|0|||
163221760|NCT03131440|589528181|FG019|Overall Study|Death|0|||
163221761|NCT03131440|589528182|FG020|Overall Study|Death|0|||
163221762|NCT03131440|589528183|FG021|Overall Study|Death|0|||
163221763|NCT03131440|589528184|FG022|Overall Study|Death|0|||
163221764|NCT03131440|589528185|FG023|Overall Study|Death|0|||
163221765|NCT03131440|589528186|FG024|Overall Study|Death|0|||
163221766|NCT03131440|589528187|FG025|Overall Study|Death|1|||
163221767|NCT03131440|589528188|FG026|Overall Study|Death|0|||
163221768|NCT03131440|589528189|FG027|Overall Study|Death|0|||
163221769|NCT03131440|589528190|FG028|Overall Study|Death|0|||
163221770|NCT03131440|589528191|FG029|Overall Study|Death|0|||
163221771|NCT03131440|589528192|FG030|Overall Study|Death|0|||
163221772|NCT03131440|589528193|FG031|Overall Study|Death|0|||
163221773|NCT00746941|589528196|FG000|Overall Study|Death|2|||
163221774|NCT00746941|589528197|FG001|Overall Study|Death|0|||
163221775|NCT00746941|589528198|FG002|Overall Study|Death|0|||
163221776|NCT00746941|589528199|FG003|Overall Study|Death|6|||
163221777|NCT00746941|589528196|FG000|Overall Study|Physician Decision|0|||
163221778|NCT00746941|589528197|FG001|Overall Study|Physician Decision|0|||
163221779|NCT00746941|589528198|FG002|Overall Study|Physician Decision|2|||
163221780|NCT00746941|589528199|FG003|Overall Study|Physician Decision|0|||
163221781|NCT00746941|589528196|FG000|Overall Study|Withdrawal by Subject|3|||
163221782|NCT00746941|589528197|FG001|Overall Study|Withdrawal by Subject|0|||
163221783|NCT00746941|589528198|FG002|Overall Study|Withdrawal by Subject|0|||
163221784|NCT00746941|589528199|FG003|Overall Study|Withdrawal by Subject|2|||
163221785|NCT00746941|589528196|FG000|Overall Study|Other, reason not provided|2|||
163221786|NCT00746941|589528197|FG001|Overall Study|Other, reason not provided|4|||
163221787|NCT00746941|589528198|FG002|Overall Study|Other, reason not provided|0|||
163221788|NCT00746941|589528199|FG003|Overall Study|Other, reason not provided|4|||
163221789|NCT00746941|589528196|FG000|Overall Study|Adverse Event|0|||
163221790|NCT00746941|589528197|FG001|Overall Study|Adverse Event|0|||
163221791|NCT00746941|589528198|FG002|Overall Study|Adverse Event|0|||
163221792|NCT00746941|589528199|FG003|Overall Study|Adverse Event|1|||
163221793|NCT03742141|589528206|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
163221794|NCT01354496|589528212|FG000|Period 1|Adverse Event|0|||
163221795|NCT01354496|589528213|FG001|Period 1|Adverse Event|0|||
163221796|NCT01354496|589528214|FG002|Period 1|Adverse Event|1|||
163221797|NCT01354496|589528215|FG003|Period 1|Adverse Event|0|||
163221798|NCT01354496|589528216|FG004|Period 1|Adverse Event|0|||
163221799|NCT01354496|589528217|FG005|Period 1|Adverse Event|0|||
163221800|NCT01354496|589528212|FG000|Period 1|Physician Decision|0|||
163221801|NCT01354496|589528213|FG001|Period 1|Physician Decision|0|||
163221802|NCT01354496|589528214|FG002|Period 1|Physician Decision|1|||
163221803|NCT01354496|589528215|FG003|Period 1|Physician Decision|0|||
163221804|NCT01354496|589528216|FG004|Period 1|Physician Decision|0|||
163221805|NCT01354496|589528217|FG005|Period 1|Physician Decision|0|||
163221806|NCT01354496|589528212|FG000|Period 2|Adverse Event|0|||
163221807|NCT01354496|589528213|FG001|Period 2|Adverse Event|0|||
163221808|NCT01354496|589528214|FG002|Period 2|Adverse Event|0|||
163221809|NCT01354496|589528215|FG003|Period 2|Adverse Event|1|||
163221810|NCT01354496|589528216|FG004|Period 2|Adverse Event|0|||
163221811|NCT01354496|589528217|FG005|Period 2|Adverse Event|0|||
163221812|NCT01354496|589528212|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
163221813|NCT01354496|589528213|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
163221814|NCT01354496|589528214|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
163221815|NCT01354496|589528215|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
163221816|NCT01354496|589528216|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
163221817|NCT01354496|589528217|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
163221818|NCT00500292|589528221|FG000|Overall Study|Adverse Event|3|||
163221819|NCT00500292|589528222|FG001|Overall Study|Adverse Event|6|||
163221820|NCT00500292|589528223|FG002|Overall Study|Adverse Event|4|||
163221821|NCT00500292|589528221|FG000|Overall Study|Condition under investigation worsened|21|||
163221822|NCT00500292|589528222|FG001|Overall Study|Condition under investigation worsened|23|||
163221823|NCT00500292|589528223|FG002|Overall Study|Condition under investigation worsened|19|||
163221824|NCT00500292|589528221|FG000|Overall Study|Withdrawal by Subject|0|||
163221825|NCT00500292|589528222|FG001|Overall Study|Withdrawal by Subject|1|||
163221826|NCT00500292|589528223|FG002|Overall Study|Withdrawal by Subject|0|||
163221827|NCT00500292|589528221|FG000|Overall Study|Other|1|||
163221828|NCT00500292|589528222|FG001|Overall Study|Other|1|||
163221829|NCT00500292|589528223|FG002|Overall Study|Other|4|||
163221830|NCT03717480|589528224|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
163221831|NCT02741700|589528225|FG000|Overall Study|Lost to Follow-up|17|||
163221832|NCT02741700|589528226|FG001|Overall Study|Lost to Follow-up|8|||
163221833|NCT02741700|589528225|FG000|Overall Study|Withdrawal by Subject|2|||
163221834|NCT02741700|589528226|FG001|Overall Study|Withdrawal by Subject|5|||
163221835|NCT02741700|589528225|FG000|Overall Study|Physician Decision|3|||
163221836|NCT02741700|589528226|FG001|Overall Study|Physician Decision|0|||
163221837|NCT02741700|589528225|FG000|Overall Study|Moved out of State|0|||
163221838|NCT02741700|589528226|FG001|Overall Study|Moved out of State|1|||
163221839|NCT02741700|589528225|FG000|Overall Study|Death|4|||
163221840|NCT02741700|589528226|FG001|Overall Study|Death|5|||
163221841|NCT01774786|589528228|FG000|Overall Study|Death|300|||
163221842|NCT01774786|589528229|FG001|Overall Study|Death|319|||
163221843|NCT01774786|589528228|FG000|Overall Study|Lost to Follow-up|6|||
163221844|NCT01774786|589528229|FG001|Overall Study|Lost to Follow-up|7|||
163221845|NCT01774786|589528228|FG000|Overall Study|Withdrawal by Subject|18|||
163221846|NCT01774786|589528229|FG001|Overall Study|Withdrawal by Subject|14|||
163221847|NCT01774786|589528228|FG000|Overall Study|Physician Decision|2|||
163221848|NCT01774786|589528229|FG001|Overall Study|Physician Decision|0|||
163221849|NCT01774786|589528228|FG000|Overall Study|Non-compliance|0|||
163221850|NCT01774786|589528229|FG001|Overall Study|Non-compliance|1|||
163221851|NCT01774786|589528228|FG000|Overall Study|Reason Not Specified|2|||
163221852|NCT01774786|589528229|FG001|Overall Study|Reason Not Specified|5|||
163221853|NCT00075582|589528230|FG000|Overall Study|Adverse Event|3|||
163221854|NCT00075582|589528231|FG001|Overall Study|Adverse Event|1|||
163221855|NCT00075582|589528230|FG000|Overall Study|Lack of Efficacy|4|||
163221856|NCT00075582|589528231|FG001|Overall Study|Lack of Efficacy|8|||
163221857|NCT00075582|589528230|FG000|Overall Study|Physician Decision|5|||
163221858|NCT00075582|589528231|FG001|Overall Study|Physician Decision|8|||
163221859|NCT00075582|589528230|FG000|Overall Study|Withdrawal by Subject|2|||
163221860|NCT00075582|589528231|FG001|Overall Study|Withdrawal by Subject|2|||
163221861|NCT00075582|589528230|FG000|Overall Study|Ineligible for study|36|||
163221862|NCT00075582|589528231|FG001|Overall Study|Ineligible for study|16|||
163221863|NCT04544293|589528232|FG000|Double-blind|Adverse Event|2|||
163221864|NCT04544293|589528233|FG001|Double-blind|Adverse Event|1|||
163221865|NCT04544293|589528232|FG000|Double-blind|Pregnancy|0|||
163221866|NCT04544293|589528233|FG001|Double-blind|Pregnancy|1|||
163221867|NCT04544293|589528232|FG000|Double-blind|Lost to Follow-up|0|||
163221868|NCT04544293|589528233|FG001|Double-blind|Lost to Follow-up|1|||
163221869|NCT04544293|589528232|FG000|Open-Label Extension|Study ongoing|79|||
163221870|NCT04544293|589528233|FG001|Open-Label Extension|Study ongoing|81|||
163221871|NCT05045144|589528234|FG000|Overall Study|Lost to Follow-up|3|||
163221872|NCT05045144|589528235|FG001|Overall Study|Lost to Follow-up|2|||
163221873|NCT05045144|589528236|FG002|Overall Study|Lost to Follow-up|3|||
163221874|NCT05045144|589528237|FG003|Overall Study|Lost to Follow-up|5|||
163221875|NCT05045144|589528238|FG004|Overall Study|Lost to Follow-up|13|||
163221876|NCT05045144|589528234|FG000|Overall Study|Withdrawal by Subject|0|||
163221877|NCT05045144|589528235|FG001|Overall Study|Withdrawal by Subject|1|||
163221878|NCT05045144|589528236|FG002|Overall Study|Withdrawal by Subject|0|||
163221879|NCT05045144|589528237|FG003|Overall Study|Withdrawal by Subject|0|||
163221880|NCT05045144|589528238|FG004|Overall Study|Withdrawal by Subject|0|||
163221881|NCT05045144|589528234|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163221882|NCT05045144|589528235|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163221883|NCT05045144|589528236|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163221884|NCT05045144|589528237|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163221885|NCT05045144|589528238|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163221886|NCT02385084|589528239|FG000|Period 2|Protocol Violation|0|||
163339762|NCT03745651|589953068|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
163221887|NCT02385084|589528240|FG001|Period 2|Protocol Violation|0|||
163221888|NCT02385084|589528241|FG002|Period 2|Protocol Violation|1|||
163221889|NCT02385084|589528242|FG003|Period 2|Protocol Violation|0|||
163221890|NCT02385084|589528243|FG004|Period 2|Protocol Violation|0|||
163221891|NCT02385084|589528244|FG005|Period 2|Protocol Violation|0|||
163221892|NCT00744627|589528245|FG000|Overall Study|Adverse Event|6|||
163221893|NCT00744627|589528246|FG001|Overall Study|Adverse Event|9|||
163221894|NCT00744627|589528245|FG000|Overall Study|Lack of Efficacy|7|||
163221895|NCT00744627|589528246|FG001|Overall Study|Lack of Efficacy|3|||
163339763|NCT03745651|589953069|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
163221896|NCT00744627|589528245|FG000|Overall Study|Noncompliance|0|||
163221897|NCT00744627|589528246|FG001|Overall Study|Noncompliance|1|||
163221898|NCT00744627|589528245|FG000|Overall Study|Protocol Deviations|0|||
163221899|NCT00744627|589528246|FG001|Overall Study|Protocol Deviations|2|||
163221900|NCT00744627|589528245|FG000|Overall Study|Voluntary Withdrawal|9|||
163221901|NCT00744627|589528246|FG001|Overall Study|Voluntary Withdrawal|6|||
163108694|NCT00152477|589103038|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
163108695|NCT00152477|589103036|FG000|Chemotherapy Period|Progression of Disease|6|||
163108696|NCT00152477|589103037|FG001|Chemotherapy Period|Progression of Disease|8|||
163108697|NCT00152477|589103038|FG002|Chemotherapy Period|Progression of Disease|4|||
163108698|NCT00152477|589103036|FG000|Chemotherapy Period|Investigator decision|0|||
163108699|NCT00152477|589103037|FG001|Chemotherapy Period|Investigator decision|0|||
163108700|NCT00152477|589103038|FG002|Chemotherapy Period|Investigator decision|1|||
163108701|NCT00152477|589103036|FG000|Chemotherapy Period|Patient condition worsened|1|||
163108702|NCT00152477|589103037|FG001|Chemotherapy Period|Patient condition worsened|0|||
163108703|NCT00152477|589103038|FG002|Chemotherapy Period|Patient condition worsened|0|||
163108704|NCT00152477|589103036|FG000|Monotherapy Period|Adverse Event|1|||
163108705|NCT00152477|589103037|FG001|Monotherapy Period|Adverse Event|0|||
163108706|NCT00152477|589103038|FG002|Monotherapy Period|Adverse Event|5|||
163108707|NCT00152477|589103036|FG000|Monotherapy Period|Death|2|||
163108708|NCT00152477|589103037|FG001|Monotherapy Period|Death|0|||
163108709|NCT00152477|589103038|FG002|Monotherapy Period|Death|1|||
163108710|NCT00152477|589103036|FG000|Monotherapy Period|Lack of Efficacy|7|||
163108711|NCT00152477|589103037|FG001|Monotherapy Period|Lack of Efficacy|16|||
163108712|NCT00152477|589103038|FG002|Monotherapy Period|Lack of Efficacy|10|||
163108713|NCT00152477|589103036|FG000|Monotherapy Period|Protocol Violation|0|||
163108714|NCT00152477|589103037|FG001|Monotherapy Period|Protocol Violation|1|||
163108715|NCT00152477|589103038|FG002|Monotherapy Period|Protocol Violation|0|||
163108716|NCT00152477|589103036|FG000|Monotherapy Period|Withdrawal by Subject|0|||
163108717|NCT00152477|589103037|FG001|Monotherapy Period|Withdrawal by Subject|0|||
163108718|NCT00152477|589103038|FG002|Monotherapy Period|Withdrawal by Subject|4|||
163108719|NCT00152477|589103036|FG000|Monotherapy Period|Progression of Disease|5|||
163108720|NCT00152477|589103037|FG001|Monotherapy Period|Progression of Disease|11|||
163108721|NCT00152477|589103038|FG002|Monotherapy Period|Progression of Disease|12|||
163108722|NCT00152477|589103036|FG000|Monotherapy Period|Patient decision|0|||
163108723|NCT00152477|589103037|FG001|Monotherapy Period|Patient decision|1|||
163108724|NCT00152477|589103038|FG002|Monotherapy Period|Patient decision|1|||
163108725|NCT00152477|589103036|FG000|Monotherapy Period|Study personel decision|0|||
163108726|NCT00152477|589103037|FG001|Monotherapy Period|Study personel decision|0|||
163108727|NCT00152477|589103038|FG002|Monotherapy Period|Study personel decision|1|||
163108728|NCT00730041|589103041|FG000|Overall Study|Lost to Follow-up|0|||
163108729|NCT00730041|589103042|FG001|Overall Study|Lost to Follow-up|2|||
163108730|NCT00433966|589103045|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
163108731|NCT00433966|589103046|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
163108732|NCT00433966|589103047|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
163108733|NCT00433966|589103048|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
163108734|NCT00433966|589103045|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
163108735|NCT00433966|589103046|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
163108736|NCT00433966|589103047|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
163108737|NCT00433966|589103048|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
163108738|NCT00433966|589103045|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
163108739|NCT00433966|589103046|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
163108740|NCT00433966|589103047|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
163108741|NCT00433966|589103048|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
163108742|NCT00433966|589103045|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
163108743|NCT00433966|589103046|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
163108744|NCT00433966|589103047|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
163108745|NCT00433966|589103048|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
163108746|NCT00433966|589103045|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
163108747|NCT00433966|589103046|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
163108748|NCT00433966|589103047|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
163108749|NCT00433966|589103048|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
163221902|NCT00744627|589528245|FG000|Overall Study|Lost to Follow-up|2|||
163221903|NCT00744627|589528246|FG001|Overall Study|Lost to Follow-up|1|||
163339764|NCT03745651|589953070|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
163339765|NCT03745651|589953071|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
163339766|NCT03745651|589953065|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163339767|NCT03745651|589953066|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163339768|NCT03745651|589953067|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163339769|NCT03745651|589953068|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
163108750|NCT01296711|589103049|FG000|Overall Study|Adverse Event|3|||
163108751|NCT01296711|589103050|FG001|Overall Study|Adverse Event|1|||
163108752|NCT01296711|589103051|FG002|Overall Study|Adverse Event|4|||
163108753|NCT01296711|589103052|FG003|Overall Study|Adverse Event|3|||
163108754|NCT01296711|589103053|FG004|Overall Study|Adverse Event|1|||
163221904|NCT00744627|589528245|FG000|Overall Study|Other|1|||
163339770|NCT03745651|589953069|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163108755|NCT01296711|589103054|FG005|Overall Study|Adverse Event|6|||
163108756|NCT01296711|589103055|FG006|Overall Study|Adverse Event|11|||
163108757|NCT01296711|589103056|FG007|Overall Study|Adverse Event|3|||
163108758|NCT01296711|589103049|FG000|Overall Study|Lack of Efficacy|1|||
163108759|NCT01296711|589103050|FG001|Overall Study|Lack of Efficacy|4|||
163108760|NCT01296711|589103051|FG002|Overall Study|Lack of Efficacy|1|||
163108761|NCT01296711|589103052|FG003|Overall Study|Lack of Efficacy|1|||
163108762|NCT01296711|589103053|FG004|Overall Study|Lack of Efficacy|1|||
163108763|NCT01296711|589103054|FG005|Overall Study|Lack of Efficacy|0|||
163108764|NCT01296711|589103055|FG006|Overall Study|Lack of Efficacy|2|||
163108765|NCT01296711|589103056|FG007|Overall Study|Lack of Efficacy|3|||
163108766|NCT01296711|589103049|FG000|Overall Study|Lost to Follow-up|0|||
163108767|NCT01296711|589103050|FG001|Overall Study|Lost to Follow-up|0|||
163108768|NCT01296711|589103051|FG002|Overall Study|Lost to Follow-up|1|||
163108769|NCT01296711|589103052|FG003|Overall Study|Lost to Follow-up|1|||
163108770|NCT01296711|589103053|FG004|Overall Study|Lost to Follow-up|2|||
163108771|NCT01296711|589103054|FG005|Overall Study|Lost to Follow-up|0|||
163108772|NCT01296711|589103055|FG006|Overall Study|Lost to Follow-up|4|||
163108773|NCT01296711|589103056|FG007|Overall Study|Lost to Follow-up|2|||
163108774|NCT01296711|589103049|FG000|Overall Study|Protocol Violation|0|||
163108775|NCT01296711|589103050|FG001|Overall Study|Protocol Violation|0|||
163108776|NCT01296711|589103051|FG002|Overall Study|Protocol Violation|0|||
163108777|NCT01296711|589103052|FG003|Overall Study|Protocol Violation|1|||
163108778|NCT01296711|589103053|FG004|Overall Study|Protocol Violation|1|||
163108779|NCT01296711|589103054|FG005|Overall Study|Protocol Violation|0|||
163108780|NCT01296711|589103055|FG006|Overall Study|Protocol Violation|0|||
163108781|NCT01296711|589103056|FG007|Overall Study|Protocol Violation|0|||
163108782|NCT01296711|589103049|FG000|Overall Study|Withdrawal by Subject|4|||
163108783|NCT01296711|589103050|FG001|Overall Study|Withdrawal by Subject|2|||
163108784|NCT01296711|589103051|FG002|Overall Study|Withdrawal by Subject|2|||
163108785|NCT01296711|589103052|FG003|Overall Study|Withdrawal by Subject|1|||
163108786|NCT01296711|589103053|FG004|Overall Study|Withdrawal by Subject|1|||
163108787|NCT01296711|589103054|FG005|Overall Study|Withdrawal by Subject|1|||
163108788|NCT01296711|589103055|FG006|Overall Study|Withdrawal by Subject|2|||
163108789|NCT01296711|589103056|FG007|Overall Study|Withdrawal by Subject|1|||
163108790|NCT01296711|589103049|FG000|Overall Study|Study termination|8|||
163108791|NCT01296711|589103050|FG001|Overall Study|Study termination|1|||
163108792|NCT01296711|589103051|FG002|Overall Study|Study termination|5|||
163108793|NCT01296711|589103052|FG003|Overall Study|Study termination|4|||
163108794|NCT01296711|589103053|FG004|Overall Study|Study termination|4|||
163108795|NCT01296711|589103054|FG005|Overall Study|Study termination|4|||
163108796|NCT01296711|589103055|FG006|Overall Study|Study termination|8|||
163108797|NCT01296711|589103056|FG007|Overall Study|Study termination|10|||
163108798|NCT01296711|589103049|FG000|Overall Study|Continued elevated liver enzymes|0|||
163108799|NCT01296711|589103050|FG001|Overall Study|Continued elevated liver enzymes|0|||
163108800|NCT01296711|589103051|FG002|Overall Study|Continued elevated liver enzymes|0|||
163108801|NCT01296711|589103052|FG003|Overall Study|Continued elevated liver enzymes|1|||
163108802|NCT01296711|589103053|FG004|Overall Study|Continued elevated liver enzymes|0|||
163108803|NCT01296711|589103054|FG005|Overall Study|Continued elevated liver enzymes|0|||
163108804|NCT01296711|589103055|FG006|Overall Study|Continued elevated liver enzymes|0|||
163108805|NCT01296711|589103056|FG007|Overall Study|Continued elevated liver enzymes|0|||
163221905|NCT00744627|589528246|FG001|Overall Study|Other|0|||
163221906|NCT02268786|589528247|FG000|Overall Study|No Euploid Embryos available|42|||
163108806|NCT01296711|589103049|FG000|Overall Study|Methotrexate discontinued|0|||
163108807|NCT01296711|589103050|FG001|Overall Study|Methotrexate discontinued|0|||
163108808|NCT01296711|589103051|FG002|Overall Study|Methotrexate discontinued|0|||
163108809|NCT01296711|589103052|FG003|Overall Study|Methotrexate discontinued|1|||
163108810|NCT01296711|589103053|FG004|Overall Study|Methotrexate discontinued|0|||
163108811|NCT01296711|589103054|FG005|Overall Study|Methotrexate discontinued|0|||
163108812|NCT01296711|589103055|FG006|Overall Study|Methotrexate discontinued|0|||
163108813|NCT01296711|589103056|FG007|Overall Study|Methotrexate discontinued|0|||
163108814|NCT01296711|589103049|FG000|Overall Study|Investigator discretion|0|||
163108815|NCT01296711|589103050|FG001|Overall Study|Investigator discretion|0|||
163108816|NCT01296711|589103051|FG002|Overall Study|Investigator discretion|0|||
163221907|NCT02268786|589528248|FG001|Overall Study|No Euploid Embryos available|0|||
163108817|NCT01296711|589103052|FG003|Overall Study|Investigator discretion|0|||
163108818|NCT01296711|589103053|FG004|Overall Study|Investigator discretion|0|||
163108819|NCT01296711|589103054|FG005|Overall Study|Investigator discretion|0|||
163108820|NCT01296711|589103055|FG006|Overall Study|Investigator discretion|1|||
163108821|NCT01296711|589103056|FG007|Overall Study|Investigator discretion|0|||
163108822|NCT01296711|589103049|FG000|Overall Study|Other|0|||
163108823|NCT01296711|589103050|FG001|Overall Study|Other|0|||
163108824|NCT01296711|589103051|FG002|Overall Study|Other|0|||
163108825|NCT01296711|589103052|FG003|Overall Study|Other|0|||
163108826|NCT01296711|589103053|FG004|Overall Study|Other|0|||
163108827|NCT01296711|589103054|FG005|Overall Study|Other|0|||
163108828|NCT01296711|589103055|FG006|Overall Study|Other|1|||
163108829|NCT01296711|589103056|FG007|Overall Study|Other|0|||
163407810|NCT02054897|590200919|FG001|Overall Study|Lost to Follow-up|2|||
163407811|NCT02054897|590200920|FG002|Overall Study|Lost to Follow-up|7|||
163108830|NCT01296711|589103049|FG000|Overall Study|Required restricted steroid injections|0|||
163108831|NCT01296711|589103050|FG001|Overall Study|Required restricted steroid injections|0|||
163108832|NCT01296711|589103051|FG002|Overall Study|Required restricted steroid injections|0|||
163108833|NCT01296711|589103052|FG003|Overall Study|Required restricted steroid injections|0|||
163108834|NCT01296711|589103053|FG004|Overall Study|Required restricted steroid injections|0|||
163108835|NCT01296711|589103054|FG005|Overall Study|Required restricted steroid injections|0|||
163108836|NCT01296711|589103055|FG006|Overall Study|Required restricted steroid injections|1|||
163108837|NCT01296711|589103056|FG007|Overall Study|Required restricted steroid injections|0|||
163108838|NCT01296711|589103049|FG000|Overall Study|Ongoing missed appointments|0|||
163108839|NCT01296711|589103050|FG001|Overall Study|Ongoing missed appointments|0|||
163108840|NCT01296711|589103051|FG002|Overall Study|Ongoing missed appointments|0|||
163108841|NCT01296711|589103052|FG003|Overall Study|Ongoing missed appointments|0|||
163108842|NCT01296711|589103053|FG004|Overall Study|Ongoing missed appointments|0|||
163108843|NCT01296711|589103054|FG005|Overall Study|Ongoing missed appointments|0|||
163108844|NCT01296711|589103055|FG006|Overall Study|Ongoing missed appointments|1|||
163108845|NCT01296711|589103056|FG007|Overall Study|Ongoing missed appointments|0|||
163108846|NCT01296711|589103049|FG000|Overall Study|Failure to comply with visits|0|||
163108847|NCT01296711|589103050|FG001|Overall Study|Failure to comply with visits|0|||
163108848|NCT01296711|589103051|FG002|Overall Study|Failure to comply with visits|0|||
163108849|NCT01296711|589103052|FG003|Overall Study|Failure to comply with visits|0|||
163108850|NCT01296711|589103053|FG004|Overall Study|Failure to comply with visits|0|||
163108851|NCT01296711|589103054|FG005|Overall Study|Failure to comply with visits|0|||
163108852|NCT01296711|589103055|FG006|Overall Study|Failure to comply with visits|0|||
163108853|NCT01296711|589103056|FG007|Overall Study|Failure to comply with visits|1|||
163108854|NCT01296711|589103049|FG000|Overall Study|Patient decision due to transport|0|||
163108855|NCT01296711|589103050|FG001|Overall Study|Patient decision due to transport|0|||
163108856|NCT01296711|589103051|FG002|Overall Study|Patient decision due to transport|0|||
163108857|NCT01296711|589103052|FG003|Overall Study|Patient decision due to transport|0|||
163108858|NCT01296711|589103053|FG004|Overall Study|Patient decision due to transport|0|||
163108859|NCT01296711|589103054|FG005|Overall Study|Patient decision due to transport|0|||
163108860|NCT01296711|589103055|FG006|Overall Study|Patient decision due to transport|0|||
163108861|NCT01296711|589103056|FG007|Overall Study|Patient decision due to transport|1|||
163108862|NCT01328535|589103057|FG000|Overall Study|Ineligible|1|||
163108863|NCT01035463|589103058|FG000|Overall Study|Adverse Event|0|||
163108864|NCT01035463|589103059|FG001|Overall Study|Adverse Event|0|||
163108865|NCT01035463|589103060|FG002|Overall Study|Adverse Event|4|||
163108866|NCT01035463|589103061|FG003|Overall Study|Adverse Event|1|||
163108867|NCT01035463|589103062|FG004|Overall Study|Adverse Event|5|||
163108868|NCT01035463|589103063|FG005|Overall Study|Adverse Event|7|||
163108869|NCT01035463|589103058|FG000|Overall Study|Withdrawal by Subject|0|||
163108870|NCT01035463|589103059|FG001|Overall Study|Withdrawal by Subject|2|||
163108871|NCT01035463|589103060|FG002|Overall Study|Withdrawal by Subject|1|||
163108872|NCT01035463|589103061|FG003|Overall Study|Withdrawal by Subject|0|||
163108873|NCT01035463|589103062|FG004|Overall Study|Withdrawal by Subject|1|||
163108874|NCT01035463|589103063|FG005|Overall Study|Withdrawal by Subject|4|||
163108875|NCT01035463|589103058|FG000|Overall Study|Disease progression|0|||
163108876|NCT01035463|589103059|FG001|Overall Study|Disease progression|0|||
163108877|NCT01035463|589103060|FG002|Overall Study|Disease progression|0|||
163108878|NCT01035463|589103061|FG003|Overall Study|Disease progression|0|||
163108879|NCT01035463|589103062|FG004|Overall Study|Disease progression|0|||
163108880|NCT01035463|589103063|FG005|Overall Study|Disease progression|3|||
163108881|NCT01035463|589103058|FG000|Overall Study|Other Malignancy|0|||
163108882|NCT01035463|589103059|FG001|Overall Study|Other Malignancy|0|||
163108883|NCT01035463|589103060|FG002|Overall Study|Other Malignancy|0|||
163108884|NCT01035463|589103061|FG003|Overall Study|Other Malignancy|0|||
163108885|NCT01035463|589103062|FG004|Overall Study|Other Malignancy|0|||
163108886|NCT01035463|589103063|FG005|Overall Study|Other Malignancy|2|||
163108887|NCT01035463|589103058|FG000|Overall Study|Other|0|||
163108888|NCT01035463|589103059|FG001|Overall Study|Other|0|||
163108889|NCT01035463|589103060|FG002|Overall Study|Other|0|||
163407812|NCT02054897|590200918|FG000|Overall Study|Randomized but not exposed|1|||
163221908|NCT02268786|589528247|FG000|Overall Study|Withdrawal by Subject|7|||
163221909|NCT02268786|589528248|FG001|Overall Study|Withdrawal by Subject|14|||
163407813|NCT02054897|590200919|FG001|Overall Study|Randomized but not exposed|0|||
163108890|NCT01035463|589103061|FG003|Overall Study|Other|1|||
163108891|NCT01035463|589103062|FG004|Overall Study|Other|0|||
163108892|NCT01035463|589103063|FG005|Overall Study|Other|2|||
163108893|NCT03425006|589103066|FG000|Overall Study|Withdrawal by Subject|1|||
163108894|NCT03425006|589103066|FG000|Overall Study|Physician Decision|1|||
163108895|NCT03425006|589103066|FG000|Overall Study|Death|1|||
163108896|NCT03748706|589103070|FG000|Overall Study|Lost to Follow-up|1|||
163108897|NCT03070171|589103073|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
163108898|NCT03070171|589103074|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
163108899|NCT03070171|589103073|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
163108900|NCT03070171|589103074|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
163108901|NCT00610857|589103080|FG000|Overall Study|Not evaluable for response|2|||
163108902|NCT03655054|589103083|FG000|Overall Study|Lost to Follow-up|1|||
163108903|NCT03931382|589103084|FG000|Overall Study|Equipment malfunction|2|||
163108904|NCT03931382|589103085|FG001|Overall Study|Equipment malfunction|0|||
163108905|NCT03931382|589103086|FG002|Overall Study|Equipment malfunction|2|||
163108906|NCT03931382|589103084|FG000|Overall Study|Withdrawal by Subject|0|||
163108907|NCT03931382|589103085|FG001|Overall Study|Withdrawal by Subject|1|||
163108908|NCT03931382|589103086|FG002|Overall Study|Withdrawal by Subject|0|||
163108909|NCT01500252|589103089|FG000|Overall Study|Death|4|||
163108910|NCT01500252|589103090|FG001|Overall Study|Death|2|||
163108911|NCT01500252|589103089|FG000|Overall Study|Lost to Follow-up|5|||
163108912|NCT01500252|589103090|FG001|Overall Study|Lost to Follow-up|4|||
163108913|NCT06003777|589103091|FG000|Period 1|Adverse Event|0|||
163108914|NCT06003777|589103092|FG001|Period 1|Adverse Event|0|||
163108915|NCT06003777|589103093|FG002|Period 1|Adverse Event|1|||
163108916|NCT06003777|589103094|FG003|Period 1|Adverse Event|0|||
163108917|NCT06003777|589103095|FG004|Period 1|Adverse Event|0|||
163108918|NCT06003777|589103096|FG005|Period 1|Adverse Event|0|||
163108919|NCT06003777|589103097|FG006|Period 1|Adverse Event|0|||
163108920|NCT06003777|589103098|FG007|Period 1|Adverse Event|0|||
163108921|NCT06003777|589103099|FG008|Period 1|Adverse Event|0|||
163108922|NCT06003777|589103100|FG009|Period 1|Adverse Event|0|||
163108923|NCT06003777|589103101|FG010|Period 1|Adverse Event|0|||
163108924|NCT06003777|589103102|FG011|Period 1|Adverse Event|0|||
163108925|NCT06003777|589103091|FG000|Period 1|Withdrawal by Subject|0|||
163108926|NCT06003777|589103092|FG001|Period 1|Withdrawal by Subject|0|||
163108927|NCT06003777|589103093|FG002|Period 1|Withdrawal by Subject|0|||
163108928|NCT06003777|589103094|FG003|Period 1|Withdrawal by Subject|0|||
163108929|NCT06003777|589103095|FG004|Period 1|Withdrawal by Subject|1|||
163108930|NCT06003777|589103096|FG005|Period 1|Withdrawal by Subject|0|||
163108931|NCT06003777|589103097|FG006|Period 1|Withdrawal by Subject|0|||
163108932|NCT06003777|589103098|FG007|Period 1|Withdrawal by Subject|0|||
163108933|NCT06003777|589103099|FG008|Period 1|Withdrawal by Subject|0|||
163108934|NCT06003777|589103100|FG009|Period 1|Withdrawal by Subject|0|||
163108935|NCT06003777|589103101|FG010|Period 1|Withdrawal by Subject|0|||
163108936|NCT06003777|589103102|FG011|Period 1|Withdrawal by Subject|0|||
163108937|NCT06003777|589103091|FG000|Period 2|Withdrawal by Subject|0|||
163108938|NCT06003777|589103092|FG001|Period 2|Withdrawal by Subject|0|||
163108939|NCT06003777|589103093|FG002|Period 2|Withdrawal by Subject|0|||
163108940|NCT06003777|589103094|FG003|Period 2|Withdrawal by Subject|0|||
163108941|NCT06003777|589103095|FG004|Period 2|Withdrawal by Subject|0|||
163108942|NCT06003777|589103096|FG005|Period 2|Withdrawal by Subject|0|||
163108943|NCT06003777|589103097|FG006|Period 2|Withdrawal by Subject|0|||
163108944|NCT06003777|589103098|FG007|Period 2|Withdrawal by Subject|0|||
163108945|NCT06003777|589103099|FG008|Period 2|Withdrawal by Subject|1|||
163108946|NCT06003777|589103100|FG009|Period 2|Withdrawal by Subject|0|||
163108947|NCT06003777|589103101|FG010|Period 2|Withdrawal by Subject|0|||
163108948|NCT06003777|589103102|FG011|Period 2|Withdrawal by Subject|0|||
163108949|NCT06003777|589103091|FG000|Period 3|Adverse Event|0|||
163108950|NCT06003777|589103092|FG001|Period 3|Adverse Event|0|||
163108951|NCT06003777|589103093|FG002|Period 3|Adverse Event|0|||
163108952|NCT06003777|589103094|FG003|Period 3|Adverse Event|0|||
163108953|NCT06003777|589103095|FG004|Period 3|Adverse Event|0|||
163108954|NCT06003777|589103096|FG005|Period 3|Adverse Event|0|||
163108955|NCT06003777|589103097|FG006|Period 3|Adverse Event|1|||
163108956|NCT06003777|589103098|FG007|Period 3|Adverse Event|0|||
163108957|NCT06003777|589103099|FG008|Period 3|Adverse Event|0|||
163108958|NCT06003777|589103100|FG009|Period 3|Adverse Event|0|||
163108959|NCT06003777|589103101|FG010|Period 3|Adverse Event|0|||
163108960|NCT06003777|589103102|FG011|Period 3|Adverse Event|0|||
163108961|NCT06003777|589103091|FG000|Period 4|No longer met eligibility criteria|0|||
163108962|NCT06003777|589103092|FG001|Period 4|No longer met eligibility criteria|0|||
163108963|NCT06003777|589103093|FG002|Period 4|No longer met eligibility criteria|1|||
163108964|NCT06003777|589103094|FG003|Period 4|No longer met eligibility criteria|0|||
163108965|NCT06003777|589103095|FG004|Period 4|No longer met eligibility criteria|0|||
163108966|NCT06003777|589103096|FG005|Period 4|No longer met eligibility criteria|0|||
163108967|NCT06003777|589103097|FG006|Period 4|No longer met eligibility criteria|0|||
163108968|NCT06003777|589103098|FG007|Period 4|No longer met eligibility criteria|0|||
163108969|NCT06003777|589103099|FG008|Period 4|No longer met eligibility criteria|0|||
163108970|NCT06003777|589103100|FG009|Period 4|No longer met eligibility criteria|0|||
163108971|NCT06003777|589103101|FG010|Period 4|No longer met eligibility criteria|0|||
163108972|NCT06003777|589103102|FG011|Period 4|No longer met eligibility criteria|0|||
163108973|NCT06003777|589103091|FG000|Period 4|Withdrawal by Subject|0|||
163108974|NCT06003777|589103092|FG001|Period 4|Withdrawal by Subject|1|||
163108975|NCT06003777|589103093|FG002|Period 4|Withdrawal by Subject|0|||
163108976|NCT06003777|589103094|FG003|Period 4|Withdrawal by Subject|0|||
163108977|NCT06003777|589103095|FG004|Period 4|Withdrawal by Subject|0|||
163108978|NCT06003777|589103096|FG005|Period 4|Withdrawal by Subject|0|||
163221910|NCT02268786|589528247|FG000|Overall Study|Thaw Failure|6|||
163221911|NCT02268786|589528248|FG001|Overall Study|Thaw Failure|4|||
163221912|NCT02268786|589528247|FG000|Overall Study|Protocol Violation|1|||
163221913|NCT02268786|589528248|FG001|Overall Study|Protocol Violation|0|||
163221914|NCT04809220|589528251|FG000|Overall Study|Adverse Event|4|||
163221915|NCT04809220|589528252|FG001|Overall Study|Adverse Event|0|||
163221916|NCT04809220|589528251|FG000|Overall Study|Death|1|||
163221917|NCT04809220|589528252|FG001|Overall Study|Death|0|||
163221918|NCT04809220|589528251|FG000|Overall Study|Lost to Follow-up|3|||
163221919|NCT04809220|589528252|FG001|Overall Study|Lost to Follow-up|0|||
163221920|NCT04809220|589528251|FG000|Overall Study|Physician Decision|0|||
163221921|NCT04809220|589528252|FG001|Overall Study|Physician Decision|1|||
163221922|NCT04809220|589528251|FG000|Overall Study|Withdrawal by Subject|9|||
163221923|NCT04809220|589528252|FG001|Overall Study|Withdrawal by Subject|5|||
163221924|NCT04809220|589528251|FG000|Overall Study|Due to long-term overseas business trips|1|||
163221925|NCT04809220|589528252|FG001|Overall Study|Due to long-term overseas business trips|0|||
163221926|NCT01062555|589528257|FG000|Phase 1|Death|10|||
163221927|NCT01062555|589528258|FG001|Phase 1|Death|17|||
163221928|NCT01062555|589528259|FG002|Phase 1|Death|0|||
163221929|NCT01062555|589528260|FG003|Phase 1|Death|0|||
163221930|NCT01062555|589528257|FG000|Phase 1|Graft Failure|12|||
163221931|NCT01062555|589528258|FG001|Phase 1|Graft Failure|8|||
163221932|NCT01062555|589528259|FG002|Phase 1|Graft Failure|0|||
163221933|NCT01062555|589528260|FG003|Phase 1|Graft Failure|0|||
163221934|NCT01062555|589528257|FG000|Phase 1|Withdrawal by Subject|1|||
163221935|NCT01062555|589528258|FG001|Phase 1|Withdrawal by Subject|1|||
163221936|NCT01062555|589528259|FG002|Phase 1|Withdrawal by Subject|0|||
163221937|NCT01062555|589528260|FG003|Phase 1|Withdrawal by Subject|0|||
163221938|NCT01062555|589528257|FG000|Phase 2|Death|0|||
163221939|NCT01062555|589528258|FG001|Phase 2|Death|0|||
163221940|NCT01062555|589528259|FG002|Phase 2|Death|8|||
163221941|NCT01062555|589528260|FG003|Phase 2|Death|3|||
163221942|NCT01062555|589528257|FG000|Phase 2|Graft failure|0|||
163221943|NCT01062555|589528258|FG001|Phase 2|Graft failure|0|||
163108979|NCT06003777|589103097|FG006|Period 4|Withdrawal by Subject|0|||
163108980|NCT06003777|589103098|FG007|Period 4|Withdrawal by Subject|0|||
163108981|NCT06003777|589103099|FG008|Period 4|Withdrawal by Subject|0|||
163108982|NCT06003777|589103100|FG009|Period 4|Withdrawal by Subject|0|||
163108983|NCT06003777|589103101|FG010|Period 4|Withdrawal by Subject|0|||
163108984|NCT06003777|589103102|FG011|Period 4|Withdrawal by Subject|0|||
163108985|NCT01106651|589103103|FG000|Overall Study|Adverse Event|17|||
163108986|NCT01106651|589103104|FG001|Overall Study|Adverse Event|9|||
163108987|NCT01106651|589103105|FG002|Overall Study|Adverse Event|23|||
163108988|NCT01106651|589103103|FG000|Overall Study|Lost to Follow-up|8|||
163108989|NCT01106651|589103104|FG001|Overall Study|Lost to Follow-up|2|||
163108990|NCT01106651|589103105|FG002|Overall Study|Lost to Follow-up|6|||
163108991|NCT01106651|589103103|FG000|Overall Study|Physician Decision|4|||
163108992|NCT01106651|589103104|FG001|Overall Study|Physician Decision|3|||
163108993|NCT01106651|589103105|FG002|Overall Study|Physician Decision|1|||
163108994|NCT01106651|589103103|FG000|Overall Study|Protocol Violation|1|||
163108995|NCT01106651|589103104|FG001|Overall Study|Protocol Violation|2|||
163108996|NCT01106651|589103105|FG002|Overall Study|Protocol Violation|1|||
163108997|NCT01106651|589103103|FG000|Overall Study|Withdrawal by Subject|14|||
163108998|NCT01106651|589103104|FG001|Overall Study|Withdrawal by Subject|7|||
163108999|NCT01106651|589103105|FG002|Overall Study|Withdrawal by Subject|4|||
163109000|NCT01106651|589103103|FG000|Overall Study|Noncompliance with study drug|1|||
163109001|NCT01106651|589103104|FG001|Overall Study|Noncompliance with study drug|0|||
163221944|NCT01062555|589528259|FG002|Phase 2|Graft failure|7|||
163221945|NCT01062555|589528260|FG003|Phase 2|Graft failure|4|||
163221946|NCT01062555|589528257|FG000|Phase 2|Withdrawal by Subject|0|||
163221947|NCT01062555|589528258|FG001|Phase 2|Withdrawal by Subject|0|||
163221948|NCT01062555|589528259|FG002|Phase 2|Withdrawal by Subject|0|||
163339771|NCT03745651|589953070|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
163109002|NCT01106651|589103105|FG002|Overall Study|Noncompliance with study drug|2|||
163109003|NCT01106651|589103103|FG000|Overall Study|Other|34|||
163109004|NCT01106651|589103104|FG001|Overall Study|Other|31|||
163109005|NCT01106651|589103105|FG002|Overall Study|Other|21|||
163109006|NCT01106651|589103103|FG000|Overall Study|Death|0|||
163109007|NCT01106651|589103104|FG001|Overall Study|Death|3|||
163109008|NCT01106651|589103105|FG002|Overall Study|Death|0|||
163221949|NCT01062555|589528260|FG003|Phase 2|Withdrawal by Subject|7|||
163221950|NCT01062555|589528257|FG000|Phase 2|Protocol Violation|0|||
163221951|NCT01062555|589528258|FG001|Phase 2|Protocol Violation|0|||
163221952|NCT01062555|589528259|FG002|Phase 2|Protocol Violation|0|||
163109009|NCT02466425|589103106|FG000|Overall Study|Adverse Event|3|||
163109010|NCT02466425|589103107|FG001|Overall Study|Adverse Event|11|||
163109011|NCT02466425|589103106|FG000|Overall Study|Lack of Efficacy|4|||
163109012|NCT02466425|589103107|FG001|Overall Study|Lack of Efficacy|1|||
163109013|NCT02466425|589103106|FG000|Overall Study|Lost to Follow-up|3|||
163221953|NCT01062555|589528260|FG003|Phase 2|Protocol Violation|3|||
163221954|NCT01062555|589528257|FG000|Phase 2|Physician Decision|0|||
163221955|NCT01062555|589528258|FG001|Phase 2|Physician Decision|0|||
163109014|NCT02466425|589103107|FG001|Overall Study|Lost to Follow-up|0|||
163109015|NCT02466425|589103106|FG000|Overall Study|Protocol Violation|1|||
163109016|NCT02466425|589103107|FG001|Overall Study|Protocol Violation|0|||
163109017|NCT02466425|589103106|FG000|Overall Study|Withdrawal by Subject|0|||
163109018|NCT02466425|589103107|FG001|Overall Study|Withdrawal by Subject|1|||
163109019|NCT02466425|589103106|FG000|Overall Study|Other|1|||
163109020|NCT02466425|589103107|FG001|Overall Study|Other|3|||
163109021|NCT02466425|589103106|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
163109022|NCT02466425|589103107|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163109023|NCT00712725|589103110|FG000|Overall Study|Adverse Event|1|||
163109024|NCT00712725|589103111|FG001|Overall Study|Adverse Event|0|||
163109025|NCT00712725|589103112|FG002|Overall Study|Adverse Event|0|||
163109026|NCT00712725|589103113|FG003|Overall Study|Adverse Event|1|||
163109027|NCT00712725|589103114|FG004|Overall Study|Adverse Event|0|||
163109028|NCT00712725|589103115|FG005|Overall Study|Adverse Event|0|||
163109029|NCT00712725|589103116|FG006|Overall Study|Adverse Event|0|||
163109030|NCT00712725|589103117|FG007|Overall Study|Adverse Event|0|||
163109031|NCT00712725|589103110|FG000|Overall Study|Lost to Follow-up|3|||
163109032|NCT00712725|589103111|FG001|Overall Study|Lost to Follow-up|2|||
163109033|NCT00712725|589103112|FG002|Overall Study|Lost to Follow-up|1|||
163109034|NCT00712725|589103113|FG003|Overall Study|Lost to Follow-up|1|||
163109035|NCT00712725|589103114|FG004|Overall Study|Lost to Follow-up|2|||
163109036|NCT00712725|589103115|FG005|Overall Study|Lost to Follow-up|2|||
163109037|NCT00712725|589103116|FG006|Overall Study|Lost to Follow-up|3|||
163109038|NCT00712725|589103117|FG007|Overall Study|Lost to Follow-up|1|||
163109039|NCT00712725|589103110|FG000|Overall Study|Physician Decision|2|||
163109040|NCT00712725|589103111|FG001|Overall Study|Physician Decision|0|||
163109041|NCT00712725|589103112|FG002|Overall Study|Physician Decision|0|||
163109042|NCT00712725|589103113|FG003|Overall Study|Physician Decision|0|||
163109043|NCT00712725|589103114|FG004|Overall Study|Physician Decision|1|||
163109044|NCT00712725|589103115|FG005|Overall Study|Physician Decision|0|||
163109045|NCT00712725|589103116|FG006|Overall Study|Physician Decision|2|||
163109046|NCT00712725|589103117|FG007|Overall Study|Physician Decision|0|||
163109047|NCT00712725|589103110|FG000|Overall Study|Pregnancy|0|||
163109048|NCT00712725|589103111|FG001|Overall Study|Pregnancy|1|||
163109049|NCT00712725|589103112|FG002|Overall Study|Pregnancy|0|||
163109050|NCT00712725|589103113|FG003|Overall Study|Pregnancy|0|||
163109051|NCT00712725|589103114|FG004|Overall Study|Pregnancy|1|||
163109052|NCT00712725|589103115|FG005|Overall Study|Pregnancy|0|||
163109053|NCT00712725|589103116|FG006|Overall Study|Pregnancy|2|||
163109054|NCT00712725|589103117|FG007|Overall Study|Pregnancy|0|||
163109055|NCT00712725|589103110|FG000|Overall Study|Protocol Violation|2|||
163109056|NCT00712725|589103111|FG001|Overall Study|Protocol Violation|0|||
163109057|NCT00712725|589103112|FG002|Overall Study|Protocol Violation|1|||
163109058|NCT00712725|589103113|FG003|Overall Study|Protocol Violation|3|||
163109059|NCT00712725|589103114|FG004|Overall Study|Protocol Violation|2|||
163109060|NCT00712725|589103115|FG005|Overall Study|Protocol Violation|0|||
163109061|NCT00712725|589103116|FG006|Overall Study|Protocol Violation|1|||
163109062|NCT00712725|589103117|FG007|Overall Study|Protocol Violation|1|||
163109063|NCT00712725|589103110|FG000|Overall Study|Withdrawal by Subject|2|||
163109064|NCT00712725|589103111|FG001|Overall Study|Withdrawal by Subject|1|||
163109065|NCT00712725|589103112|FG002|Overall Study|Withdrawal by Subject|1|||
163109066|NCT00712725|589103113|FG003|Overall Study|Withdrawal by Subject|2|||
163109067|NCT00712725|589103114|FG004|Overall Study|Withdrawal by Subject|1|||
163109068|NCT00712725|589103115|FG005|Overall Study|Withdrawal by Subject|1|||
163109069|NCT00712725|589103116|FG006|Overall Study|Withdrawal by Subject|1|||
163109070|NCT00712725|589103117|FG007|Overall Study|Withdrawal by Subject|2|||
163109071|NCT00712725|589103110|FG000|Overall Study|Lack of Qualifying Event|16|||
163109072|NCT00712725|589103111|FG001|Overall Study|Lack of Qualifying Event|2|||
163109073|NCT00712725|589103112|FG002|Overall Study|Lack of Qualifying Event|6|||
163109074|NCT00712725|589103113|FG003|Overall Study|Lack of Qualifying Event|8|||
163109075|NCT00712725|589103114|FG004|Overall Study|Lack of Qualifying Event|11|||
163109076|NCT00712725|589103115|FG005|Overall Study|Lack of Qualifying Event|13|||
163109077|NCT00712725|589103116|FG006|Overall Study|Lack of Qualifying Event|11|||
163109078|NCT00712725|589103117|FG007|Overall Study|Lack of Qualifying Event|6|||
163109079|NCT00712725|589103110|FG000|Overall Study|Protocol Specified Criteria|3|||
163109080|NCT00712725|589103111|FG001|Overall Study|Protocol Specified Criteria|0|||
163109081|NCT00712725|589103112|FG002|Overall Study|Protocol Specified Criteria|1|||
163109082|NCT00712725|589103113|FG003|Overall Study|Protocol Specified Criteria|2|||
163109083|NCT00712725|589103114|FG004|Overall Study|Protocol Specified Criteria|1|||
163109084|NCT00712725|589103115|FG005|Overall Study|Protocol Specified Criteria|0|||
163109085|NCT00712725|589103116|FG006|Overall Study|Protocol Specified Criteria|2|||
163109086|NCT00712725|589103117|FG007|Overall Study|Protocol Specified Criteria|1|||
163109087|NCT01901289|589103118|FG000|Overall Study|Death|32|||
163109088|NCT01901289|589103118|FG000|Overall Study|Lost to Follow-up|16|||
163109089|NCT01901289|589103118|FG000|Overall Study|Withdrawal by Subject|35|||
163109090|NCT01901289|589103118|FG000|Overall Study|Other type of endpoint met|2|||
163109091|NCT00889603|589103119|FG000|Overall Study|Adverse Event|7|||
163109092|NCT00889603|589103119|FG000|Overall Study|Death|3|||
163109093|NCT00889603|589103119|FG000|Overall Study|Lost to Follow-up|19|||
163109094|NCT00889603|589103119|FG000|Overall Study|No longer willing to participant in stud|4|||
163109095|NCT00889603|589103119|FG000|Overall Study|Other|4|||
163109096|NCT00700882|589103123|FG000|Overall Study|Never received treatment|6|||
163109097|NCT00700882|589103123|FG000|Overall Study|Ineligible|2|||
163109098|NCT00700882|589103123|FG000|Overall Study|No KIT mutation|51|||
163109099|NCT01606176|589103124|FG000|Overall Study|Adverse Event|2|||
163109100|NCT01606176|589103125|FG001|Overall Study|Adverse Event|3|||
163109101|NCT01606176|589103124|FG000|Overall Study|Disease progression|1|||
163109102|NCT01606176|589103125|FG001|Overall Study|Disease progression|0|||
163109103|NCT01606176|589103124|FG000|Overall Study|Withdrawal by Subject|1|||
163109104|NCT01606176|589103125|FG001|Overall Study|Withdrawal by Subject|0|||
163109105|NCT01832493|589103126|FG000|Overall Study|Physician Decision|2|||
163109106|NCT01832493|589103126|FG000|Overall Study|Protocol Violation|4|||
163109107|NCT01832493|589103126|FG000|Overall Study|Unable to place LV lead|2|||
163109108|NCT01814397|589103129|FG000|Overall Study|Adverse Event|7|||
163109109|NCT01814397|589103129|FG000|Overall Study|Withdrawal by Subject|7|||
163109110|NCT02247011|589103133|FG000|Overall Study|Poor quality of radiological results|125|||
163109111|NCT01818258|589103135|FG000|Overall Study|Death|3|||
163109112|NCT01818258|589103136|FG001|Overall Study|Death|0|||
163109113|NCT01818258|589103135|FG000|Overall Study|Withdrawal by Subject|0|||
163109114|NCT01818258|589103136|FG001|Overall Study|Withdrawal by Subject|1|||
163109115|NCT01818258|589103135|FG000|Overall Study|Lost to Follow-up|0|||
163109116|NCT01818258|589103136|FG001|Overall Study|Lost to Follow-up|1|||
163109117|NCT01818258|589103135|FG000|Overall Study|Unable to Travel to Clinic|0|||
163109118|NCT01818258|589103136|FG001|Overall Study|Unable to Travel to Clinic|1|||
163109119|NCT02839720|589103137|FG000|Overall Study|Adverse Event|2|||
163109120|NCT02839720|589103137|FG000|Overall Study|Non-compliance|2|||
163109121|NCT02839720|589103137|FG000|Overall Study|Intercurrent Illness|1|||
163109122|NCT02839720|589103137|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
163109123|NCT00349921|589103138|FG000|First Spinal Injection|Physician Decision|1|||
163109124|NCT00349921|589103139|FG001|First Spinal Injection|Physician Decision|0|||
163109125|NCT00349921|589103140|FG002|First Spinal Injection|Physician Decision|0|||
163109126|NCT00349921|589103141|FG003|First Spinal Injection|Physician Decision|0|||
163109127|NCT00349921|589103138|FG000|First Spinal Injection|Adverse Event|0|||
163109128|NCT00349921|589103139|FG001|First Spinal Injection|Adverse Event|0|||
163109129|NCT00349921|589103140|FG002|First Spinal Injection|Adverse Event|1|||
163109130|NCT00349921|589103141|FG003|First Spinal Injection|Adverse Event|0|||
163109131|NCT00792740|589103147|FG000|Overall Study|Disease Worsening|3|||
163109132|NCT00792740|589103148|FG001|Overall Study|Disease Worsening|2|||
163109133|NCT00792740|589103147|FG000|Overall Study|Personal Reason|1|||
163109134|NCT00792740|589103148|FG001|Overall Study|Personal Reason|0|||
163109135|NCT00792740|589103147|FG000|Overall Study|Adverse Event|1|||
163109136|NCT00792740|589103148|FG001|Overall Study|Adverse Event|3|||
163109137|NCT00792740|589103147|FG000|Overall Study|Patient's withdrawal of consent|0|||
163109138|NCT00792740|589103148|FG001|Overall Study|Patient's withdrawal of consent|1|||
163109139|NCT00792740|589103147|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
163109140|NCT00792740|589103148|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
163109141|NCT00792740|589103147|FG000|Overall Study|Other reasons|0|||
163109142|NCT00792740|589103148|FG001|Overall Study|Other reasons|1|||
163109143|NCT00107900|589103149|FG000|Overall Study|Adverse Event|3|||
163109144|NCT00107900|589103150|FG001|Overall Study|Adverse Event|2|||
163109145|NCT00107900|589103151|FG002|Overall Study|Adverse Event|10|||
163109146|NCT00107900|589103152|FG003|Overall Study|Adverse Event|3|||
163109147|NCT00107900|589103153|FG004|Overall Study|Adverse Event|5|||
163109148|NCT00107900|589103154|FG005|Overall Study|Adverse Event|3|||
163109149|NCT00107900|589103149|FG000|Overall Study|Death|0|||
163109150|NCT00107900|589103150|FG001|Overall Study|Death|0|||
163109151|NCT00107900|589103151|FG002|Overall Study|Death|0|||
163339772|NCT03745651|589953071|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
163339773|NCT03745651|589953065|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
163339774|NCT03745651|589953066|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
163109152|NCT00107900|589103152|FG003|Overall Study|Death|0|||
163109153|NCT00107900|589103153|FG004|Overall Study|Death|1|||
163339775|NCT03745651|589953067|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
163109154|NCT00107900|589103154|FG005|Overall Study|Death|0|||
163109155|NCT00107900|589103149|FG000|Overall Study|Lost to Follow-up|4|||
163109156|NCT00107900|589103150|FG001|Overall Study|Lost to Follow-up|1|||
163109157|NCT00107900|589103151|FG002|Overall Study|Lost to Follow-up|3|||
163109158|NCT00107900|589103152|FG003|Overall Study|Lost to Follow-up|2|||
163109159|NCT00107900|589103153|FG004|Overall Study|Lost to Follow-up|5|||
163109160|NCT00107900|589103154|FG005|Overall Study|Lost to Follow-up|5|||
163109161|NCT00107900|589103149|FG000|Overall Study|Protocol Violation|1|||
163109162|NCT00107900|589103150|FG001|Overall Study|Protocol Violation|0|||
163109163|NCT00107900|589103151|FG002|Overall Study|Protocol Violation|5|||
163109164|NCT00107900|589103152|FG003|Overall Study|Protocol Violation|5|||
163109165|NCT00107900|589103153|FG004|Overall Study|Protocol Violation|7|||
163109166|NCT00107900|589103154|FG005|Overall Study|Protocol Violation|0|||
163109167|NCT00107900|589103149|FG000|Overall Study|Withdrawal by Subject|1|||
163109168|NCT00107900|589103150|FG001|Overall Study|Withdrawal by Subject|0|||
163109169|NCT00107900|589103151|FG002|Overall Study|Withdrawal by Subject|5|||
163109170|NCT00107900|589103152|FG003|Overall Study|Withdrawal by Subject|0|||
163109171|NCT00107900|589103153|FG004|Overall Study|Withdrawal by Subject|1|||
163109172|NCT00107900|589103154|FG005|Overall Study|Withdrawal by Subject|1|||
163109173|NCT00107900|589103149|FG000|Overall Study|Administrative Reasons|1|||
163109174|NCT00107900|589103150|FG001|Overall Study|Administrative Reasons|0|||
163109175|NCT00107900|589103151|FG002|Overall Study|Administrative Reasons|2|||
163109176|NCT00107900|589103152|FG003|Overall Study|Administrative Reasons|2|||
163109177|NCT00107900|589103153|FG004|Overall Study|Administrative Reasons|2|||
163109178|NCT00107900|589103154|FG005|Overall Study|Administrative Reasons|0|||
163109179|NCT03724981|589106433|FG000|First Device|Protocol Violation|1|||
163109180|NCT03724981|589106434|FG001|First Device|Protocol Violation|1|||
163109181|NCT01740089|589106436|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
163109182|NCT01740089|589106437|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
163109183|NCT01740089|589106438|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
163109184|NCT01740089|589106436|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
163109185|NCT01740089|589106437|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
163109186|NCT01740089|589106438|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
163109187|NCT01740089|589106436|FG000|After 12 Weeks|Lack of Efficacy|3|||
163109188|NCT01740089|589106437|FG001|After 12 Weeks|Lack of Efficacy|1|||
163109189|NCT01740089|589106438|FG002|After 12 Weeks|Lack of Efficacy|4|||
163109190|NCT01740089|589106436|FG000|After 12 Weeks|Adverse Event|2|||
163109191|NCT01740089|589106437|FG001|After 12 Weeks|Adverse Event|0|||
163109192|NCT01740089|589106438|FG002|After 12 Weeks|Adverse Event|5|||
163109193|NCT01740089|589106436|FG000|After 12 Weeks|Protocol Violation|1|||
163109194|NCT01740089|589106437|FG001|After 12 Weeks|Protocol Violation|1|||
163109195|NCT01740089|589106438|FG002|After 12 Weeks|Protocol Violation|1|||
163109196|NCT01740089|589106436|FG000|After 12 Weeks|Withdrawal by Subject|1|||
163109197|NCT01740089|589106437|FG001|After 12 Weeks|Withdrawal by Subject|1|||
163109198|NCT01740089|589106438|FG002|After 12 Weeks|Withdrawal by Subject|1|||
163109199|NCT02791191|589106441|FG000|Overall Study|Adverse Event|2|||
163109200|NCT02791191|589106442|FG001|Overall Study|Adverse Event|4|||
163109201|NCT02791191|589106443|FG002|Overall Study|Adverse Event|5|||
163109202|NCT02791191|589106441|FG000|Overall Study|Lack of Efficacy|0|||
163109203|NCT02791191|589106442|FG001|Overall Study|Lack of Efficacy|1|||
163109204|NCT02791191|589106443|FG002|Overall Study|Lack of Efficacy|0|||
163109205|NCT02791191|589106441|FG000|Overall Study|Study Drug Non-Compliance|0|||
163109206|NCT02791191|589106442|FG001|Overall Study|Study Drug Non-Compliance|2|||
163109207|NCT02791191|589106443|FG002|Overall Study|Study Drug Non-Compliance|0|||
163109208|NCT02791191|589106441|FG000|Overall Study|Site Closed by Sponsor|1|||
163109209|NCT02791191|589106442|FG001|Overall Study|Site Closed by Sponsor|1|||
163109210|NCT02791191|589106443|FG002|Overall Study|Site Closed by Sponsor|3|||
163109211|NCT02791191|589106441|FG000|Overall Study|Progressive Disease|1|||
163109212|NCT02791191|589106442|FG001|Overall Study|Progressive Disease|0|||
163109213|NCT02791191|589106443|FG002|Overall Study|Progressive Disease|0|||
163109214|NCT02791191|589106441|FG000|Overall Study|Study Terminated by Sponsor|29|||
163109215|NCT02791191|589106442|FG001|Overall Study|Study Terminated by Sponsor|101|||
163109216|NCT02791191|589106443|FG002|Overall Study|Study Terminated by Sponsor|109|||
163109217|NCT02791191|589106441|FG000|Overall Study|Withdrawal by Subject|3|||
163109218|NCT02791191|589106442|FG001|Overall Study|Withdrawal by Subject|1|||
163109219|NCT02791191|589106443|FG002|Overall Study|Withdrawal by Subject|3|||
163109220|NCT02791191|589106441|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
163109221|NCT02791191|589106442|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
163109222|NCT02791191|589106443|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
163109223|NCT02370537|589106444|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
163109224|NCT02370537|589106445|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
163109225|NCT02370537|589106446|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
163109226|NCT02370537|589106444|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
163339776|NCT03745651|589953068|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
163339777|NCT03745651|589953069|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
163339778|NCT03745651|589953070|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
163339779|NCT03745651|589953071|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
163339780|NCT03745651|589953065|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163109227|NCT02370537|589106445|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
163109228|NCT02370537|589106446|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
163109229|NCT02370537|589106444|FG000|Part B|Not randomised to receive treatment|1|||
163339781|NCT03745651|589953066|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163109230|NCT02370537|589106445|FG001|Part B|Not randomised to receive treatment|2|||
163109231|NCT02370537|589106446|FG002|Part B|Not randomised to receive treatment|259|||
163109232|NCT02370537|589106444|FG000|Part B|Withdrawal by Subject|0|||
163109233|NCT02370537|589106445|FG001|Part B|Withdrawal by Subject|1|||
163109234|NCT02370537|589106446|FG002|Part B|Withdrawal by Subject|0|||
163109235|NCT03100539|589106455|FG000|Overall Study|Lost to Follow-up|60|||
163109236|NCT03100539|589106456|FG001|Overall Study|Lost to Follow-up|54|||
163221956|NCT01062555|589528259|FG002|Phase 2|Physician Decision|0|||
163221957|NCT01062555|589528260|FG003|Phase 2|Physician Decision|17|||
163109237|NCT03100539|589106457|FG002|Overall Study|Lost to Follow-up|17|||
163109238|NCT03100539|589106455|FG000|Overall Study|Uncollected|8|||
163109239|NCT03100539|589106456|FG001|Overall Study|Uncollected|8|||
163109240|NCT03100539|589106457|FG002|Overall Study|Uncollected|0|||
163109241|NCT03100539|589106455|FG000|Overall Study|Ally Health|0|||
163109242|NCT03100539|589106456|FG001|Overall Study|Ally Health|0|||
163221958|NCT00729183|589528261|FG000|Overall Study|Adverse Event|11|||
163221959|NCT00729183|589528262|FG001|Overall Study|Adverse Event|5|||
163221960|NCT00729183|589528261|FG000|Overall Study|Lack of Efficacy|0|||
163221961|NCT00729183|589528262|FG001|Overall Study|Lack of Efficacy|1|||
163221962|NCT00729183|589528261|FG000|Overall Study|Lost to Follow-up|3|||
163221963|NCT00729183|589528262|FG001|Overall Study|Lost to Follow-up|1|||
163221964|NCT00729183|589528261|FG000|Overall Study|Physician Decision|1|||
163221965|NCT00729183|589528262|FG001|Overall Study|Physician Decision|1|||
163221966|NCT00729183|589528261|FG000|Overall Study|Protocol Violation|1|||
163221967|NCT00729183|589528262|FG001|Overall Study|Protocol Violation|0|||
163221968|NCT00729183|589528261|FG000|Overall Study|Withdrawal by Subject|9|||
163221969|NCT00729183|589528262|FG001|Overall Study|Withdrawal by Subject|7|||
163221970|NCT03299842|589529732|FG000|Overall Study|Caregiver withdrew consent|2|||
163221971|NCT03299842|589529732|FG000|Overall Study|Child would not keep the watch on|3|||
163221972|NCT04380857|589529733|FG000|Overall Study|Lost to Follow-up|3|||
163221973|NCT04380857|589529734|FG001|Overall Study|Lost to Follow-up|3|||
163221974|NCT02558790|589529735|FG000|Overall Study|Lost to Follow-up|2|||
163221975|NCT02558790|589529735|FG000|Overall Study|Physician Decision|1|||
163221976|NCT02558790|589529735|FG000|Overall Study|Withdrawal by Subject|1|||
163221977|NCT02558790|589529735|FG000|Overall Study|Screen Fail|3|||
163221978|NCT05083442|589529736|FG000|Overall Study|Lost to Follow-up|1|||
163221979|NCT05083442|589529737|FG001|Overall Study|Lost to Follow-up|0|||
163221980|NCT05083442|589529736|FG000|Overall Study|Lack of Efficacy|0|||
163221981|NCT05083442|589529737|FG001|Overall Study|Lack of Efficacy|1|||
163221982|NCT05083442|589529736|FG000|Overall Study|Withdrawal by Subject|1|||
163221983|NCT05083442|589529737|FG001|Overall Study|Withdrawal by Subject|3|||
163221984|NCT05083442|589529736|FG000|Overall Study|scheduling difficulties|1|||
163221985|NCT05083442|589529737|FG001|Overall Study|scheduling difficulties|2|||
163221986|NCT04865354|589529745|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
163221987|NCT04865354|589529746|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
163221988|NCT04865354|589529745|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
163221989|NCT04865354|589529746|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
163221990|NCT04865354|589529745|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
163221991|NCT04865354|589529746|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
163221992|NCT02945410|589529747|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
163221993|NCT02945410|589529748|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
163221994|NCT02945410|589529749|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
163221995|NCT02945410|589529750|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
163221996|NCT02945410|589529751|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
163221997|NCT02945410|589529752|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
163221998|NCT02945410|589529747|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
163221999|NCT02945410|589529748|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
163222000|NCT02945410|589529749|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
163222001|NCT02945410|589529750|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
163339782|NCT03745651|589953067|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163339783|NCT03745651|589953068|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163109243|NCT03100539|589106457|FG002|Overall Study|Ally Health|3|||
163109244|NCT03100539|589106455|FG000|Overall Study|Disinterest|0|||
163339784|NCT03745651|589953069|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163339785|NCT03745651|589953070|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
163339786|NCT03745651|589953071|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163109245|NCT03100539|589106456|FG001|Overall Study|Disinterest|0|||
163109246|NCT03100539|589106457|FG002|Overall Study|Disinterest|22|||
163222002|NCT02945410|589529751|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
163222003|NCT02945410|589529752|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
163222004|NCT02945410|589529747|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
163222005|NCT02945410|589529748|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
163339787|NCT03745651|589953065|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163109247|NCT03100539|589106455|FG000|Overall Study|Veteran Health|0|||
163222006|NCT02945410|589529749|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
163222007|NCT02945410|589529750|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
163222008|NCT02945410|589529751|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
163222009|NCT02945410|589529752|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
163222010|NCT00110812|589529753|FG000|Main Study|Death|0|||
163222011|NCT00110812|589529754|FG001|Main Study|Death|0|||
163222012|NCT00110812|589529755|FG002|Main Study|Death|2|||
163109248|NCT03100539|589106456|FG001|Overall Study|Veteran Health|0|||
163109249|NCT03100539|589106457|FG002|Overall Study|Veteran Health|8|||
163222013|NCT00110812|589529753|FG000|Main Study|Withdrawal by Subject|0|||
163222014|NCT00110812|589529754|FG001|Main Study|Withdrawal by Subject|0|||
163222015|NCT00110812|589529755|FG002|Main Study|Withdrawal by Subject|1|||
163222016|NCT00110812|589529753|FG000|Main Study|Lost to Follow-up|8|||
163222017|NCT00110812|589529754|FG001|Main Study|Lost to Follow-up|11|||
163222018|NCT00110812|589529755|FG002|Main Study|Lost to Follow-up|10|||
163222019|NCT00110812|589529753|FG000|Extended Follow-up|Death|1|||
163222020|NCT00110812|589529754|FG001|Extended Follow-up|Death|0|||
163222021|NCT00110812|589529755|FG002|Extended Follow-up|Death|3|||
163222022|NCT00110812|589529753|FG000|Extended Follow-up|Withdrawal by Subject|0|||
163222023|NCT00110812|589529754|FG001|Extended Follow-up|Withdrawal by Subject|1|||
163222024|NCT00110812|589529755|FG002|Extended Follow-up|Withdrawal by Subject|0|||
163222025|NCT00110812|589529753|FG000|Extended Follow-up|Lost to Follow-up|1|||
163222026|NCT00110812|589529754|FG001|Extended Follow-up|Lost to Follow-up|3|||
163222027|NCT00110812|589529755|FG002|Extended Follow-up|Lost to Follow-up|1|||
163222028|NCT04200248|589529756|FG000|Overall Study|Personal reasons|0|||
163222029|NCT04200248|589529757|FG001|Overall Study|Personal reasons|0|||
163222030|NCT04200248|589529758|FG002|Overall Study|Personal reasons|1|||
163222031|NCT04200248|589529756|FG000|Overall Study|Discontinued prior to treatment|3|||
163222032|NCT04200248|589529757|FG001|Overall Study|Discontinued prior to treatment|3|||
163222033|NCT04200248|589529758|FG002|Overall Study|Discontinued prior to treatment|2|||
163222034|NCT01454726|589529759|FG000|Overall Study|Withdrawal by Subject|0|||
163222035|NCT01454726|589529760|FG001|Overall Study|Withdrawal by Subject|1|||
163222036|NCT01886833|589529761|FG000|Overall Study|IgA not available from both periods|204|||
163222037|NCT04476030|589529762|FG000|Overall Study|Withdrawal by Subject|20|||
163222038|NCT04476030|589529763|FG001|Overall Study|Withdrawal by Subject|16|||
163222039|NCT04476030|589529762|FG000|Overall Study|Adverse Event|10|||
163222040|NCT04476030|589529763|FG001|Overall Study|Adverse Event|11|||
163222041|NCT04476030|589529762|FG000|Overall Study|Lost to Follow-up|7|||
163222042|NCT04476030|589529763|FG001|Overall Study|Lost to Follow-up|4|||
163222043|NCT04476030|589529762|FG000|Overall Study|Physician Decision|1|||
163222044|NCT04476030|589529763|FG001|Overall Study|Physician Decision|1|||
163222045|NCT04476030|589529762|FG000|Overall Study|Protocol Deviation|2|||
163222046|NCT04476030|589529763|FG001|Overall Study|Protocol Deviation|0|||
163222047|NCT04476030|589529762|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
163222048|NCT04476030|589529763|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
163222049|NCT04476030|589529762|FG000|Overall Study|Randomized but not Dosed|2|||
163222050|NCT04476030|589529763|FG001|Overall Study|Randomized but not Dosed|8|||
163222051|NCT02342704|589529764|FG000|Overall Study|Physician Decision|0|||
163222052|NCT02342704|589529765|FG001|Overall Study|Physician Decision|3|||
163222053|NCT02342704|589529764|FG000|Overall Study|Sponsor Termination|49|||
163222054|NCT02342704|589529765|FG001|Overall Study|Sponsor Termination|43|||
163222055|NCT02342704|589529764|FG000|Overall Study|Other|0|||
163222056|NCT02342704|589529765|FG001|Overall Study|Other|1|||
163222057|NCT02342704|589529764|FG000|Overall Study|Withdrawal by Subject|1|||
163222058|NCT02342704|589529765|FG001|Overall Study|Withdrawal by Subject|0|||
163222059|NCT02342704|589529764|FG000|Overall Study|Lost to Follow-up|2|||
163222060|NCT02342704|589529765|FG001|Overall Study|Lost to Follow-up|1|||
163222061|NCT02342704|589529764|FG000|Overall Study|Adverse Event|1|||
163222062|NCT02342704|589529765|FG001|Overall Study|Adverse Event|3|||
163222063|NCT00302003|589529766|FG000|Overall Study|Lack of Efficacy|62|||
163109250|NCT03100539|589106455|FG000|Overall Study|Moved|0|||
163109251|NCT03100539|589106456|FG001|Overall Study|Moved|0|||
163109252|NCT03100539|589106457|FG002|Overall Study|Moved|1|||
163109253|NCT03100539|589106455|FG000|Overall Study|Scheduling Conflicts|0|||
163109254|NCT03100539|589106456|FG001|Overall Study|Scheduling Conflicts|0|||
163109255|NCT03100539|589106457|FG002|Overall Study|Scheduling Conflicts|12|||
163109256|NCT04753658|589106467|FG000|Overall Study|Progressive disease|7|||
163109257|NCT04753658|589106467|FG000|Overall Study|Other|7|||
163109258|NCT04753658|589106467|FG000|Overall Study|Adverse Event|1|||
163109259|NCT01892436|589106468|FG000|Overall Study|Withdrawal by Subject|8|||
163109260|NCT01892436|589106469|FG001|Overall Study|Withdrawal by Subject|15|||
163109261|NCT01892436|589106470|FG002|Overall Study|Withdrawal by Subject|4|||
163109262|NCT01892436|589106471|FG003|Overall Study|Withdrawal by Subject|4|||
163109263|NCT01892436|589106468|FG000|Overall Study|Death|1|||
163109264|NCT01892436|589106469|FG001|Overall Study|Death|1|||
163222064|NCT00302003|589529766|FG000|Overall Study|Lost to Follow-up|1|||
163222065|NCT00302003|589529766|FG000|Overall Study|Physician Decision|2|||
163222066|NCT00302003|589529766|FG000|Overall Study|Withdrawal by Subject|5|||
163222067|NCT00302003|589529766|FG000|Overall Study|Ineligible|9|||
163222068|NCT00302003|589529766|FG000|Overall Study|Protocol Violation|1|||
163222069|NCT02042924|589529767|FG000|Overall Study|Early Death|1|||
163222070|NCT04033003|589529768|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
163222071|NCT04033003|589529769|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
163109265|NCT01892436|589106470|FG002|Overall Study|Death|0|||
163109266|NCT01892436|589106471|FG003|Overall Study|Death|0|||
163109267|NCT01892436|589106468|FG000|Overall Study|Physician Decision|2|||
163109268|NCT01892436|589106469|FG001|Overall Study|Physician Decision|1|||
163109269|NCT01892436|589106470|FG002|Overall Study|Physician Decision|0|||
163109270|NCT01892436|589106471|FG003|Overall Study|Physician Decision|1|||
163109271|NCT01892436|589106468|FG000|Overall Study|Pregnancy|0|||
163109272|NCT01892436|589106469|FG001|Overall Study|Pregnancy|2|||
163109273|NCT01892436|589106470|FG002|Overall Study|Pregnancy|1|||
163109274|NCT01892436|589106471|FG003|Overall Study|Pregnancy|0|||
163109275|NCT01892436|589106468|FG000|Overall Study|Technical problems|2|||
163109276|NCT01892436|589106469|FG001|Overall Study|Technical problems|1|||
163109277|NCT01892436|589106470|FG002|Overall Study|Technical problems|1|||
163109278|NCT01892436|589106471|FG003|Overall Study|Technical problems|1|||
163109279|NCT01892436|589106468|FG000|Overall Study|Lack of Efficacy|1|||
163109280|NCT01892436|589106469|FG001|Overall Study|Lack of Efficacy|2|||
163109281|NCT01892436|589106470|FG002|Overall Study|Lack of Efficacy|2|||
163109282|NCT01892436|589106471|FG003|Overall Study|Lack of Efficacy|2|||
163109283|NCT01892436|589106468|FG000|Overall Study|Lost to Follow-up|1|||
163109284|NCT01892436|589106469|FG001|Overall Study|Lost to Follow-up|1|||
163109285|NCT01892436|589106470|FG002|Overall Study|Lost to Follow-up|1|||
163109286|NCT01892436|589106471|FG003|Overall Study|Lost to Follow-up|3|||
163109287|NCT01892436|589106468|FG000|Overall Study|non-compliance with treatment|1|||
163109288|NCT01892436|589106469|FG001|Overall Study|non-compliance with treatment|0|||
163109289|NCT01892436|589106470|FG002|Overall Study|non-compliance with treatment|0|||
163109290|NCT01892436|589106471|FG003|Overall Study|non-compliance with treatment|0|||
163109291|NCT01892436|589106468|FG000|Overall Study|Adverse Event|7|||
163109292|NCT01892436|589106469|FG001|Overall Study|Adverse Event|6|||
163109293|NCT01892436|589106470|FG002|Overall Study|Adverse Event|2|||
163109294|NCT01892436|589106471|FG003|Overall Study|Adverse Event|3|||
163109295|NCT02923830|589106475|FG000|Overall Study|Physician Decision|13|||
163109296|NCT02923830|589106476|FG001|Overall Study|Physician Decision|15|||
163109297|NCT00837265|589106477|FG000|Pilot Phase|Withdrawal by Subject|0|||
163109298|NCT00837265|589106478|FG001|Pilot Phase|Withdrawal by Subject|2|||
163109299|NCT00837265|589106479|FG002|Pilot Phase|Withdrawal by Subject|3|||
163109300|NCT00837265|589106480|FG003|Pilot Phase|Withdrawal by Subject|2|||
163109301|NCT00837265|589106481|FG004|Pilot Phase|Withdrawal by Subject|0|||
163109302|NCT00837265|589106482|FG005|Pilot Phase|Withdrawal by Subject|0|||
163109303|NCT00837265|589106483|FG006|Pilot Phase|Withdrawal by Subject|0|||
163109304|NCT00837265|589106477|FG000|Pilot Phase|Decision of the investigator|2|||
163109305|NCT00837265|589106478|FG001|Pilot Phase|Decision of the investigator|1|||
163109306|NCT00837265|589106479|FG002|Pilot Phase|Decision of the investigator|0|||
163109307|NCT00837265|589106480|FG003|Pilot Phase|Decision of the investigator|0|||
163109308|NCT00837265|589106481|FG004|Pilot Phase|Decision of the investigator|0|||
163109309|NCT00837265|589106482|FG005|Pilot Phase|Decision of the investigator|0|||
163109310|NCT00837265|589106483|FG006|Pilot Phase|Decision of the investigator|0|||
163109311|NCT00837265|589106477|FG000|Pilot Phase|Adverse Event|1|||
163109312|NCT00837265|589106478|FG001|Pilot Phase|Adverse Event|0|||
163109313|NCT00837265|589106479|FG002|Pilot Phase|Adverse Event|0|||
163109314|NCT00837265|589106480|FG003|Pilot Phase|Adverse Event|0|||
163109315|NCT00837265|589106481|FG004|Pilot Phase|Adverse Event|0|||
163109316|NCT00837265|589106482|FG005|Pilot Phase|Adverse Event|0|||
163109317|NCT00837265|589106483|FG006|Pilot Phase|Adverse Event|0|||
163109318|NCT00837265|589106477|FG000|Pilot Phase|Disease progression|0|||
163109319|NCT00837265|589106478|FG001|Pilot Phase|Disease progression|0|||
163109320|NCT00837265|589106479|FG002|Pilot Phase|Disease progression|0|||
163109321|NCT00837265|589106480|FG003|Pilot Phase|Disease progression|1|||
163109322|NCT00837265|589106481|FG004|Pilot Phase|Disease progression|0|||
163109323|NCT00837265|589106482|FG005|Pilot Phase|Disease progression|0|||
163109324|NCT00837265|589106483|FG006|Pilot Phase|Disease progression|0|||
163109325|NCT00837265|589106477|FG000|Pilot Phase|Participant left the city|0|||
163109326|NCT00837265|589106478|FG001|Pilot Phase|Participant left the city|0|||
163109327|NCT00837265|589106479|FG002|Pilot Phase|Participant left the city|0|||
163109328|NCT00837265|589106480|FG003|Pilot Phase|Participant left the city|1|||
163109329|NCT00837265|589106481|FG004|Pilot Phase|Participant left the city|0|||
163109330|NCT00837265|589106482|FG005|Pilot Phase|Participant left the city|0|||
163109331|NCT00837265|589106483|FG006|Pilot Phase|Participant left the city|0|||
163109332|NCT00837265|589106477|FG000|Main Phase|Withdrawal by Subject|0|||
163109333|NCT00837265|589106478|FG001|Main Phase|Withdrawal by Subject|0|||
163109334|NCT00837265|589106479|FG002|Main Phase|Withdrawal by Subject|0|||
163109335|NCT00837265|589106480|FG003|Main Phase|Withdrawal by Subject|0|||
163109336|NCT00837265|589106481|FG004|Main Phase|Withdrawal by Subject|4|||
163109337|NCT00837265|589106482|FG005|Main Phase|Withdrawal by Subject|2|||
163109338|NCT00837265|589106483|FG006|Main Phase|Withdrawal by Subject|1|||
163109339|NCT00837265|589106477|FG000|Main Phase|Decision of the investigator|0|||
163109340|NCT00837265|589106478|FG001|Main Phase|Decision of the investigator|0|||
163109341|NCT00837265|589106479|FG002|Main Phase|Decision of the investigator|0|||
163109342|NCT00837265|589106480|FG003|Main Phase|Decision of the investigator|0|||
163109343|NCT00837265|589106481|FG004|Main Phase|Decision of the investigator|0|||
163109344|NCT00837265|589106482|FG005|Main Phase|Decision of the investigator|2|||
163109345|NCT00837265|589106483|FG006|Main Phase|Decision of the investigator|1|||
163109346|NCT00837265|589106477|FG000|Main Phase|Adverse Event|0|||
163109347|NCT00837265|589106478|FG001|Main Phase|Adverse Event|0|||
163109348|NCT00837265|589106479|FG002|Main Phase|Adverse Event|0|||
163339788|NCT03745651|589953066|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163339789|NCT03745651|589953067|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163339790|NCT03745651|589953068|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
163339791|NCT03745651|589953069|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
163339792|NCT03745651|589953070|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
163339793|NCT03745651|589953071|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
163339794|NCT03745651|589953065|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
163339795|NCT03745651|589953066|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
163339796|NCT03745651|589953067|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
163407814|NCT02054897|590200920|FG002|Overall Study|Randomized but not exposed|0|||
163109349|NCT00837265|589106480|FG003|Main Phase|Adverse Event|0|||
163109350|NCT00837265|589106481|FG004|Main Phase|Adverse Event|0|||
163109351|NCT00837265|589106482|FG005|Main Phase|Adverse Event|1|||
163109352|NCT00837265|589106483|FG006|Main Phase|Adverse Event|0|||
163109353|NCT00837265|589106477|FG000|Main Phase|Death|0|||
163109354|NCT00837265|589106478|FG001|Main Phase|Death|0|||
163109355|NCT00837265|589106479|FG002|Main Phase|Death|0|||
163109356|NCT00837265|589106480|FG003|Main Phase|Death|0|||
163109357|NCT00837265|589106481|FG004|Main Phase|Death|2|||
163109358|NCT00837265|589106482|FG005|Main Phase|Death|0|||
163109359|NCT00837265|589106483|FG006|Main Phase|Death|1|||
163109360|NCT00837265|589106477|FG000|Main Phase|Lost to Follow-up|0|||
163109361|NCT00837265|589106478|FG001|Main Phase|Lost to Follow-up|0|||
163109362|NCT00837265|589106479|FG002|Main Phase|Lost to Follow-up|0|||
163109363|NCT00837265|589106480|FG003|Main Phase|Lost to Follow-up|0|||
163109364|NCT00837265|589106481|FG004|Main Phase|Lost to Follow-up|1|||
163109365|NCT00837265|589106482|FG005|Main Phase|Lost to Follow-up|0|||
163109366|NCT00837265|589106483|FG006|Main Phase|Lost to Follow-up|0|||
163109367|NCT00837265|589106477|FG000|Main Phase|Principal investigator resignation|0|||
163109368|NCT00837265|589106478|FG001|Main Phase|Principal investigator resignation|0|||
163109369|NCT00837265|589106479|FG002|Main Phase|Principal investigator resignation|0|||
163109370|NCT00837265|589106480|FG003|Main Phase|Principal investigator resignation|0|||
163109371|NCT00837265|589106481|FG004|Main Phase|Principal investigator resignation|2|||
163109372|NCT00837265|589106482|FG005|Main Phase|Principal investigator resignation|0|||
163109373|NCT00837265|589106483|FG006|Main Phase|Principal investigator resignation|0|||
163109374|NCT00837265|589106477|FG000|Main Phase|Participant's personal reason|0|||
163109375|NCT00837265|589106478|FG001|Main Phase|Participant's personal reason|0|||
163109376|NCT00837265|589106479|FG002|Main Phase|Participant's personal reason|0|||
163109377|NCT00837265|589106480|FG003|Main Phase|Participant's personal reason|0|||
163109378|NCT00837265|589106481|FG004|Main Phase|Participant's personal reason|1|||
163109379|NCT00837265|589106482|FG005|Main Phase|Participant's personal reason|0|||
163109380|NCT00837265|589106483|FG006|Main Phase|Participant's personal reason|0|||
163109381|NCT00733291|589106485|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
163109382|NCT00733291|589106486|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
163109383|NCT00733291|589106487|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
163109384|NCT00733291|589106488|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
163109385|NCT01751906|589106495|FG000|Overall Study|Lost to Follow-up|151|||
163109386|NCT01751906|589106496|FG001|Overall Study|Lost to Follow-up|68|||
163109387|NCT01751906|589106495|FG000|Overall Study|Withdrawal by Subject|22|||
163109388|NCT01751906|589106496|FG001|Overall Study|Withdrawal by Subject|18|||
163109389|NCT01751906|589106495|FG000|Overall Study|Physician Decision|5|||
163109390|NCT01751906|589106496|FG001|Overall Study|Physician Decision|2|||
163109391|NCT01751906|589106495|FG000|Overall Study|Death|84|||
163109392|NCT01751906|589106496|FG001|Overall Study|Death|43|||
163339797|NCT03745651|589953068|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
163339798|NCT03745651|589953069|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
163339799|NCT03745651|589953070|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
163407815|NCT02069899|590200921|FG000|Overall Study|Adverse Event|6|||
163109393|NCT01751906|589106495|FG000|Overall Study|Denied on premises for follow-up by law|1|||
163109394|NCT01751906|589106496|FG001|Overall Study|Denied on premises for follow-up by law|0|||
163109395|NCT01110330|589106501|FG000|Overall Study|Adverse Event|0|||
163109396|NCT01110330|589106502|FG001|Overall Study|Adverse Event|4|||
163109397|NCT01110330|589106503|FG002|Overall Study|Adverse Event|3|||
163109398|NCT01110330|589106501|FG000|Overall Study|Lack of Efficacy|3|||
163109399|NCT01110330|589106502|FG001|Overall Study|Lack of Efficacy|1|||
163109400|NCT01110330|589106503|FG002|Overall Study|Lack of Efficacy|1|||
163109401|NCT01110330|589106501|FG000|Overall Study|Lost to Follow-up|9|||
163109402|NCT01110330|589106502|FG001|Overall Study|Lost to Follow-up|10|||
163109403|NCT01110330|589106503|FG002|Overall Study|Lost to Follow-up|15|||
163109404|NCT01110330|589106501|FG000|Overall Study|Physician Decision|0|||
163109405|NCT01110330|589106502|FG001|Overall Study|Physician Decision|1|||
163109406|NCT01110330|589106503|FG002|Overall Study|Physician Decision|0|||
163109407|NCT01110330|589106501|FG000|Overall Study|Protocol Violation|2|||
163109408|NCT01110330|589106502|FG001|Overall Study|Protocol Violation|0|||
163109409|NCT01110330|589106503|FG002|Overall Study|Protocol Violation|4|||
163109410|NCT01110330|589106501|FG000|Overall Study|Withdrawal by Subject|0|||
163109411|NCT01110330|589106502|FG001|Overall Study|Withdrawal by Subject|6|||
163109412|NCT01110330|589106503|FG002|Overall Study|Withdrawal by Subject|2|||
163109413|NCT01110330|589106501|FG000|Overall Study|Other|1|||
163109414|NCT01110330|589106502|FG001|Overall Study|Other|1|||
163109415|NCT01110330|589106503|FG002|Overall Study|Other|1|||
163109416|NCT02759107|589106504|FG000|Overall Study|Adverse Event|0|||
163109417|NCT02759107|589106505|FG001|Overall Study|Adverse Event|0|||
163109418|NCT02759107|589106506|FG002|Overall Study|Adverse Event|0|||
163109419|NCT02759107|589106507|FG003|Overall Study|Adverse Event|0|||
163109420|NCT02759107|589106508|FG004|Overall Study|Adverse Event|0|||
163109421|NCT02759107|589106509|FG005|Overall Study|Adverse Event|0|||
163109422|NCT02759107|589106510|FG006|Overall Study|Adverse Event|0|||
163109423|NCT02759107|589106511|FG007|Overall Study|Adverse Event|0|||
163109424|NCT02759107|589106512|FG008|Overall Study|Adverse Event|0|||
163109425|NCT02759107|589106513|FG009|Overall Study|Adverse Event|0|||
163109426|NCT02759107|589106514|FG010|Overall Study|Adverse Event|0|||
163109427|NCT02759107|589106515|FG011|Overall Study|Adverse Event|0|||
163109428|NCT02759107|589106516|FG012|Overall Study|Adverse Event|2|||
163109429|NCT02759107|589106517|FG013|Overall Study|Adverse Event|0|||
163109430|NCT02759107|589106518|FG014|Overall Study|Adverse Event|0|||
163109431|NCT02759107|589106519|FG015|Overall Study|Adverse Event|1|||
163109432|NCT02759107|589106520|FG016|Overall Study|Adverse Event|0|||
163109433|NCT02759107|589106521|FG017|Overall Study|Adverse Event|2|||
163109434|NCT02759107|589106504|FG000|Overall Study|Scheduling Conflict|0|||
163109435|NCT02759107|589106505|FG001|Overall Study|Scheduling Conflict|0|||
163109436|NCT02759107|589106506|FG002|Overall Study|Scheduling Conflict|0|||
163109437|NCT02759107|589106507|FG003|Overall Study|Scheduling Conflict|0|||
163109438|NCT02759107|589106508|FG004|Overall Study|Scheduling Conflict|0|||
163109439|NCT02759107|589106509|FG005|Overall Study|Scheduling Conflict|0|||
163109440|NCT02759107|589106510|FG006|Overall Study|Scheduling Conflict|0|||
163109441|NCT02759107|589106511|FG007|Overall Study|Scheduling Conflict|0|||
163109442|NCT02759107|589106512|FG008|Overall Study|Scheduling Conflict|0|||
163109443|NCT02759107|589106513|FG009|Overall Study|Scheduling Conflict|1|||
163109444|NCT02759107|589106514|FG010|Overall Study|Scheduling Conflict|0|||
163109445|NCT02759107|589106515|FG011|Overall Study|Scheduling Conflict|0|||
163109446|NCT02759107|589106516|FG012|Overall Study|Scheduling Conflict|0|||
163109447|NCT02759107|589106517|FG013|Overall Study|Scheduling Conflict|0|||
163109448|NCT02759107|589106518|FG014|Overall Study|Scheduling Conflict|0|||
163109449|NCT02759107|589106519|FG015|Overall Study|Scheduling Conflict|0|||
163109450|NCT02759107|589106520|FG016|Overall Study|Scheduling Conflict|0|||
163109451|NCT02759107|589106521|FG017|Overall Study|Scheduling Conflict|0|||
163109452|NCT00420004|589106527|FG000|Overall Study|Adverse Event|4|||
163109453|NCT00420004|589106528|FG001|Overall Study|Adverse Event|1|||
163109454|NCT00420004|589106529|FG002|Overall Study|Adverse Event|1|||
163109455|NCT00420004|589106527|FG000|Overall Study|Lack of Efficacy|5|||
163109456|NCT00420004|589106528|FG001|Overall Study|Lack of Efficacy|4|||
163109457|NCT00420004|589106529|FG002|Overall Study|Lack of Efficacy|1|||
163109458|NCT00420004|589106527|FG000|Overall Study|Lost to Follow-up|31|||
163109459|NCT00420004|589106528|FG001|Overall Study|Lost to Follow-up|12|||
163109460|NCT00420004|589106529|FG002|Overall Study|Lost to Follow-up|10|||
163339800|NCT03745651|589953071|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
163339801|NCT04175834|589953072|FG000|Overall Study|Withdrawal by Subject|1|||
163339802|NCT04175834|589953073|FG001|Overall Study|Withdrawal by Subject|0|||
163339803|NCT00946088|589953074|FG000|Overall Study|Withdrawal by Subject|0|||
163339804|NCT00946088|589953075|FG001|Overall Study|Withdrawal by Subject|1|||
163339805|NCT01322347|589953079|FG000|Overall Study|Adverse Event|7|||
163339806|NCT01322347|589953080|FG001|Overall Study|Adverse Event|2|||
163109461|NCT00420004|589106527|FG000|Overall Study|Entry Criteria Not Met|0|||
163109462|NCT00420004|589106528|FG001|Overall Study|Entry Criteria Not Met|1|||
163109463|NCT00420004|589106529|FG002|Overall Study|Entry Criteria Not Met|0|||
163109464|NCT00420004|589106527|FG000|Overall Study|Physician Decision|14|||
163109465|NCT00420004|589106528|FG001|Overall Study|Physician Decision|4|||
163109466|NCT00420004|589106529|FG002|Overall Study|Physician Decision|2|||
163109467|NCT00420004|589106527|FG000|Overall Study|Protocol Violation|5|||
163109468|NCT00420004|589106528|FG001|Overall Study|Protocol Violation|4|||
163109469|NCT00420004|589106529|FG002|Overall Study|Protocol Violation|3|||
163109470|NCT00420004|589106527|FG000|Overall Study|Withdrawal by Subject|67|||
163109471|NCT00420004|589106528|FG001|Overall Study|Withdrawal by Subject|42|||
163109472|NCT00420004|589106529|FG002|Overall Study|Withdrawal by Subject|14|||
163109473|NCT00420004|589106527|FG000|Overall Study|Sponsor Decision|3|||
163109474|NCT00420004|589106528|FG001|Overall Study|Sponsor Decision|3|||
163109475|NCT00420004|589106529|FG002|Overall Study|Sponsor Decision|1|||
163109476|NCT00591149|589106530|FG000|Overall Study|Adverse Event|4|||
163109477|NCT00591149|589106530|FG000|Overall Study|Withdrawal by Subject|1|||
163109478|NCT03002818|589106531|FG000|Overall Study|Decision of the investigator|1|||
163109479|NCT01606787|589106533|FG000|Overall Study|Withdrawal by Subject|4|||
163339807|NCT01322347|589953079|FG000|Overall Study|Death|5|||
163109480|NCT01606787|589106534|FG001|Overall Study|Withdrawal by Subject|5|||
163339808|NCT01322347|589953080|FG001|Overall Study|Death|3|||
163222072|NCT04033003|589529768|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
163222073|NCT04033003|589529769|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
163407816|NCT02069899|590200922|FG001|Overall Study|Adverse Event|0|||
163407817|NCT02069899|590200923|FG002|Overall Study|Adverse Event|1|||
163407818|NCT02069899|590200921|FG000|Overall Study|Withdrawal by Participant|2|||
163407819|NCT02069899|590200922|FG001|Overall Study|Withdrawal by Participant|0|||
163407820|NCT02069899|590200923|FG002|Overall Study|Withdrawal by Participant|0|||
163407821|NCT02069899|590200921|FG000|Overall Study|Lost to Follow-up|1|||
163407822|NCT02069899|590200922|FG001|Overall Study|Lost to Follow-up|0|||
163407823|NCT02069899|590200923|FG002|Overall Study|Lost to Follow-up|1|||
163407824|NCT02069899|590200921|FG000|Overall Study|Other|4|||
163407825|NCT02069899|590200922|FG001|Overall Study|Other|0|||
163407826|NCT02069899|590200923|FG002|Overall Study|Other|0|||
163407827|NCT02069899|590200921|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
163407828|NCT02069899|590200922|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
163407829|NCT02069899|590200923|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
163407830|NCT02069899|590200921|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
163407831|NCT02069899|590200922|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
163407832|NCT02069899|590200923|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
163407833|NCT01119248|590200924|FG000|Overall Study|Physician Decision|5|||
163109481|NCT01606787|589106533|FG000|Overall Study|Surgery canceled|0|||
163407834|NCT01273883|590200926|FG000|First Intervention|Adverse Event|2|||
163407835|NCT01273883|590200927|FG001|First Intervention|Adverse Event|1|||
163407836|NCT01273883|590200926|FG000|Second Intervention|Lost to Follow-up|1|||
163407837|NCT01273883|590200927|FG001|Second Intervention|Lost to Follow-up|1|||
163407838|NCT01273883|590200926|FG000|Second Intervention|Lack of Efficacy|1|||
163407839|NCT01273883|590200927|FG001|Second Intervention|Lack of Efficacy|0|||
163407840|NCT01553136|590200928|FG000|Overall Study|Adverse Event|3|||
163407841|NCT01553136|590200929|FG001|Overall Study|Adverse Event|2|||
163407842|NCT01553136|590200928|FG000|Overall Study|Withdrawal by Subject|2|||
163407843|NCT01553136|590200929|FG001|Overall Study|Withdrawal by Subject|3|||
163407844|NCT01553136|590200928|FG000|Overall Study|Lost to Follow-up|4|||
163109482|NCT01606787|589106534|FG001|Overall Study|Surgery canceled|2|||
163109483|NCT00713349|589106541|FG000|Overall Study|Protocol Violation|1|||
163109484|NCT03299881|589106542|FG000|Overall Study|Study Termination|17|||
163109485|NCT03299881|589106543|FG001|Overall Study|Study Termination|13|||
163109486|NCT01289353|589106544|FG000|Overall Study|Lost to Follow-up|2|||
163109487|NCT00473668|589106547|FG000|Overall Study|Withdrawal by Subject|0|||
163109488|NCT00473668|589106548|FG001|Overall Study|Withdrawal by Subject|2|||
163109489|NCT00473668|589106549|FG002|Overall Study|Withdrawal by Subject|0|||
163109490|NCT00473668|589106547|FG000|Overall Study|Migrated/moved from study area|3|||
163109491|NCT00473668|589106548|FG001|Overall Study|Migrated/moved from study area|2|||
163109492|NCT00473668|589106549|FG002|Overall Study|Migrated/moved from study area|0|||
163109493|NCT00473668|589106547|FG000|Overall Study|Lost to Follow-up|0|||
163109494|NCT00473668|589106548|FG001|Overall Study|Lost to Follow-up|4|||
163109495|NCT00473668|589106549|FG002|Overall Study|Lost to Follow-up|6|||
163109496|NCT00473668|589106547|FG000|Overall Study|Other|2|||
163109497|NCT00473668|589106548|FG001|Overall Study|Other|3|||
163109498|NCT00473668|589106549|FG002|Overall Study|Other|4|||
163109499|NCT02226562|589106550|FG000|Overall Study|Lost to Follow-up|0|||
163109500|NCT02226562|589106551|FG001|Overall Study|Lost to Follow-up|1|||
163109501|NCT04569136|589106552|FG000|Overall Study|Lost to Follow-up|2|||
163109502|NCT04569136|589106553|FG001|Overall Study|Lost to Follow-up|0|||
163109503|NCT04569136|589106554|FG002|Overall Study|Lost to Follow-up|1|||
163109504|NCT01466660|589106560|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
163109505|NCT01466660|589106561|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
163109506|NCT01466660|589106560|FG000|Overall Study|Worsening of underlying cancer disease|5|||
163109507|NCT01466660|589106561|FG001|Overall Study|Worsening of underlying cancer disease|2|||
163222074|NCT04033003|589529768|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
163407845|NCT01553136|590200929|FG001|Overall Study|Lost to Follow-up|10|||
163407846|NCT01553136|590200928|FG000|Overall Study|Physician Decision|2|||
163407847|NCT01553136|590200929|FG001|Overall Study|Physician Decision|3|||
163407848|NCT01553136|590200928|FG000|Overall Study|Scheduling Difficulties|5|||
163109508|NCT01466660|589106560|FG000|Overall Study|Other adverse event|19|||
163109509|NCT01466660|589106561|FG001|Overall Study|Other adverse event|18|||
163109510|NCT01466660|589106560|FG000|Overall Study|Protocol Violation|2|||
163109511|NCT01466660|589106561|FG001|Overall Study|Protocol Violation|1|||
163109512|NCT01466660|589106560|FG000|Overall Study|Refused continuation of trial medication|4|||
163109513|NCT01466660|589106561|FG001|Overall Study|Refused continuation of trial medication|3|||
163109514|NCT01466660|589106560|FG000|Overall Study|Other reason not defined above|10|||
163109515|NCT01466660|589106561|FG001|Overall Study|Other reason not defined above|8|||
163109516|NCT03576066|589106562|FG000|Overall Study|Noncompliance with study drug|0|||
163109517|NCT03576066|589106563|FG001|Overall Study|Noncompliance with study drug|1|||
163109518|NCT00129701|589106564|FG000|Overall Study|Withdrawal by Subject|33|||
163109519|NCT02750345|589106565|FG000|Intervention 1|Adverse Event|0|||
163109520|NCT02750345|589106566|FG001|Intervention 1|Adverse Event|0|||
163109521|NCT02750345|589106567|FG002|Intervention 1|Adverse Event|0|||
163109522|NCT02750345|589106568|FG003|Intervention 1|Adverse Event|0|||
163109523|NCT02750345|589106569|FG004|Intervention 1|Adverse Event|1|||
163109524|NCT02750345|589106570|FG005|Intervention 1|Adverse Event|0|||
163109525|NCT00006164|589106571|FG000|Overall Study|Withdrew or lost to follow-up|70|||
163109526|NCT00006164|589106572|FG001|Overall Study|Withdrew or lost to follow-up|81|||
163109527|NCT00223808|589106573|FG000|Overall Study|<5 hrs therapy before discharge|3|||
163109528|NCT00223808|589106574|FG001|Overall Study|<5 hrs therapy before discharge|5|||
163109529|NCT00223808|589106575|FG002|Overall Study|<5 hrs therapy before discharge|5|||
163109530|NCT00191724|589106578|FG000|Overall Study|Adverse Event|0|||
163109531|NCT00191724|589106579|FG001|Overall Study|Adverse Event|0|||
163109532|NCT00191724|589106580|FG002|Overall Study|Adverse Event|1|||
163109533|NCT00191724|589106581|FG003|Overall Study|Adverse Event|0|||
163109534|NCT00191724|589106582|FG004|Overall Study|Adverse Event|0|||
163109535|NCT00191724|589106578|FG000|Overall Study|Lost to Follow-up|1|||
163109536|NCT00191724|589106579|FG001|Overall Study|Lost to Follow-up|1|||
163109537|NCT00191724|589106580|FG002|Overall Study|Lost to Follow-up|0|||
163109538|NCT00191724|589106581|FG003|Overall Study|Lost to Follow-up|2|||
163109539|NCT00191724|589106582|FG004|Overall Study|Lost to Follow-up|3|||
163109540|NCT00191724|589106578|FG000|Overall Study|Withdrawal by Subject|0|||
163109541|NCT00191724|589106579|FG001|Overall Study|Withdrawal by Subject|0|||
163109542|NCT00191724|589106580|FG002|Overall Study|Withdrawal by Subject|0|||
163109543|NCT00191724|589106581|FG003|Overall Study|Withdrawal by Subject|1|||
163109544|NCT00191724|589106582|FG004|Overall Study|Withdrawal by Subject|0|||
163109545|NCT00608023|589106583|FG000|Overall Study|Withdrawal by Subject|8|||
163109546|NCT00608023|589106584|FG001|Overall Study|Withdrawal by Subject|10|||
163109547|NCT00608023|589106585|FG002|Overall Study|Withdrawal by Subject|7|||
163109548|NCT00608023|589106583|FG000|Overall Study|Adverse Event|1|||
163109549|NCT00608023|589106584|FG001|Overall Study|Adverse Event|4|||
163109550|NCT00608023|589106585|FG002|Overall Study|Adverse Event|5|||
163109551|NCT00608023|589106583|FG000|Overall Study|Lost to Follow-up|2|||
163109552|NCT00608023|589106584|FG001|Overall Study|Lost to Follow-up|2|||
163109553|NCT00608023|589106585|FG002|Overall Study|Lost to Follow-up|1|||
163109554|NCT00608023|589106583|FG000|Overall Study|Protocol Violation|1|||
163109555|NCT00608023|589106584|FG001|Overall Study|Protocol Violation|3|||
163109556|NCT00608023|589106585|FG002|Overall Study|Protocol Violation|1|||
163109557|NCT00608023|589106583|FG000|Overall Study|Unknown reason|0|||
163109558|NCT00608023|589106584|FG001|Overall Study|Unknown reason|3|||
163109559|NCT00608023|589106585|FG002|Overall Study|Unknown reason|0|||
163109560|NCT01231321|589106588|FG000|Overall Study|Adverse Event|3|||
163109561|NCT01231321|589106588|FG000|Overall Study|Lack of Efficacy|2|||
163109562|NCT00489736|589106589|FG000|Overall Study|Lack of Efficacy|53|||
163109563|NCT00489736|589106590|FG001|Overall Study|Lack of Efficacy|14|||
163109564|NCT00489736|589106589|FG000|Overall Study|Adverse Event|32|||
163109565|NCT00489736|589106590|FG001|Overall Study|Adverse Event|45|||
163109566|NCT00489736|589106589|FG000|Overall Study|Poor compliance|6|||
163109567|NCT00489736|589106590|FG001|Overall Study|Poor compliance|2|||
163109568|NCT00489736|589106589|FG000|Overall Study|Not coded/ Not pre-specified|5|||
163109569|NCT00489736|589106590|FG001|Overall Study|Not coded/ Not pre-specified|8|||
163109570|NCT04021524|589106591|FG000|Overall Study|Change in surgical intervention|0|||
163109571|NCT04021524|589106592|FG001|Overall Study|Change in surgical intervention|1|||
163109572|NCT06422364|589106593|FG000|Overall Study|Withdrawn due to study closure|0|||
163109573|NCT06422364|589106594|FG001|Overall Study|Withdrawn due to study closure|2|||
163109574|NCT05260073|589106596|FG000|Overall Study|Physician Decision|1|||
163109575|NCT05260073|589106596|FG000|Overall Study|Withdrawal by Subject|6|||
163109576|NCT05260073|589106596|FG000|Overall Study|Lost to Follow-up|14|||
163222075|NCT04033003|589529769|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
163109577|NCT03458910|589106597|FG000|Overall Study|Withdrawal by Subject|7|||
163109578|NCT03458910|589106598|FG001|Overall Study|Withdrawal by Subject|8|||
163109579|NCT03458910|589106599|FG002|Overall Study|Withdrawal by Subject|6|||
163109580|NCT03458910|589106600|FG003|Overall Study|Withdrawal by Subject|4|||
163109581|NCT03458910|589106597|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
163109582|NCT03458910|589106598|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
163109583|NCT03458910|589106599|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
163109584|NCT03458910|589106600|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
163109585|NCT05275010|589106601|FG000|Overall Study|Reason Not Specified|4|||
163109586|NCT05275010|589106602|FG001|Overall Study|Reason Not Specified|1|||
163109587|NCT05275010|589106601|FG000|Overall Study|Withdrawal by Subject|1|||
163109588|NCT05275010|589106602|FG001|Overall Study|Withdrawal by Subject|0|||
163109589|NCT05275010|589106601|FG000|Overall Study|Lost to Follow-up|0|||
163109590|NCT05275010|589106602|FG001|Overall Study|Lost to Follow-up|1|||
163109591|NCT04484649|589106603|FG000|Overall Study|Lost to Follow-up|2|||
163109592|NCT04484649|589106604|FG001|Overall Study|Lost to Follow-up|1|||
163109593|NCT04484649|589106603|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
163109594|NCT04484649|589106604|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
163109595|NCT00245050|589106609|FG000|Overall Study|Adverse Event|3|||
163109596|NCT00245050|589106610|FG001|Overall Study|Adverse Event|2|||
163109597|NCT03275246|589106613|FG000|Overall Study|Protocol Violation|5|||
163109598|NCT03275246|589106613|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
163109599|NCT02301546|589106614|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
163109600|NCT02301546|589106615|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
163109601|NCT02301546|589106614|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
163109602|NCT02301546|589106615|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
163109603|NCT02301546|589106614|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
163109604|NCT02301546|589106615|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
163109605|NCT02301546|589106614|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
163109606|NCT02301546|589106615|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
163109607|NCT02301546|589106614|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
163109608|NCT02301546|589106615|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
163109609|NCT02301546|589106614|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
163109610|NCT02301546|589106615|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
163109611|NCT02301546|589106614|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
163109612|NCT02301546|589106615|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
163109613|NCT05059301|589106616|FG000|Overall Study|Adverse Event|0|||
163109614|NCT05059301|589106617|FG001|Overall Study|Adverse Event|2|||
163109615|NCT05059301|589106618|FG002|Overall Study|Adverse Event|2|||
163109616|NCT05059301|589106616|FG000|Overall Study|Lost to Follow-up|2|||
163109617|NCT05059301|589106617|FG001|Overall Study|Lost to Follow-up|3|||
163109618|NCT05059301|589106618|FG002|Overall Study|Lost to Follow-up|3|||
163109619|NCT04952597|589106620|FG000|Overall Study|Death|12|||
163109620|NCT04952597|589106621|FG001|Overall Study|Death|13|||
163109621|NCT04952597|589106622|FG002|Overall Study|Death|14|||
163109622|NCT04952597|589106620|FG000|Overall Study|Withdrawal by Subject|1|||
163109623|NCT04952597|589106621|FG001|Overall Study|Withdrawal by Subject|0|||
163109624|NCT04952597|589106622|FG002|Overall Study|Withdrawal by Subject|3|||
163109625|NCT04952597|589106620|FG000|Overall Study|Lost to Follow-up|0|||
163109626|NCT04952597|589106621|FG001|Overall Study|Lost to Follow-up|1|||
163109627|NCT04952597|589106622|FG002|Overall Study|Lost to Follow-up|1|||
163109628|NCT04238481|589106638|FG000|Overall Study|Miscellaneous|0|||
163109629|NCT04238481|589106639|FG001|Overall Study|Miscellaneous|1|||
163109630|NCT04238481|589106640|FG002|Overall Study|Miscellaneous|0|||
163109631|NCT04238481|589106641|FG003|Overall Study|Miscellaneous|0|||
163109632|NCT02152371|589106642|FG000|Overall Study|Adverse Event|6|||
163109633|NCT02152371|589106643|FG001|Overall Study|Adverse Event|2|||
163109634|NCT02152371|589106642|FG000|Overall Study|Withdrawal by Subject|3|||
163109635|NCT02152371|589106643|FG001|Overall Study|Withdrawal by Subject|7|||
163109636|NCT02152371|589106642|FG000|Overall Study|Protocol Violation|2|||
163109637|NCT02152371|589106643|FG001|Overall Study|Protocol Violation|3|||
163109638|NCT02152371|589106642|FG000|Overall Study|Lost to Follow-up|1|||
163109639|NCT02152371|589106643|FG001|Overall Study|Lost to Follow-up|0|||
163109640|NCT02152371|589106642|FG000|Overall Study|Lack of Efficacy|0|||
163109641|NCT02152371|589106643|FG001|Overall Study|Lack of Efficacy|1|||
163109642|NCT02152371|589106642|FG000|Overall Study|Physician Decision|0|||
163109643|NCT02152371|589106643|FG001|Overall Study|Physician Decision|2|||
163109644|NCT02152371|589106642|FG000|Overall Study|Reason Not Given|0|||
163109645|NCT02152371|589106643|FG001|Overall Study|Reason Not Given|1|||
163109646|NCT00656058|589106645|FG000|Overall Study|Withdrawal by Subject|2|||
163109647|NCT00656058|589106645|FG000|Overall Study|Withdrawal by Subject|4|||
163109648|NCT03194568|589106646|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
163109649|NCT05285644|589106647|FG000|Overall Study|Adverse Event|3|||
163109650|NCT05285644|589106648|FG001|Overall Study|Adverse Event|3|||
163109651|NCT05285644|589106647|FG000|Overall Study|Withdrawal of Consent|2|||
163109652|NCT05285644|589106648|FG001|Overall Study|Withdrawal of Consent|5|||
163109653|NCT05285644|589106647|FG000|Overall Study|Noncompliance|0|||
163109654|NCT05285644|589106648|FG001|Overall Study|Noncompliance|4|||
163109655|NCT05285644|589106647|FG000|Overall Study|Lost to Follow-up|4|||
163109656|NCT05285644|589106648|FG001|Overall Study|Lost to Follow-up|6|||
163109657|NCT05285644|589106647|FG000|Overall Study|Disallowed Concurrent Medication|1|||
163109658|NCT05285644|589106648|FG001|Overall Study|Disallowed Concurrent Medication|1|||
163109659|NCT05285644|589106647|FG000|Overall Study|Investigator Decision|2|||
163109660|NCT05285644|589106648|FG001|Overall Study|Investigator Decision|0|||
163109661|NCT05285644|589106647|FG000|Overall Study|Protocol Deviation|1|||
163109662|NCT05285644|589106648|FG001|Overall Study|Protocol Deviation|0|||
163109663|NCT05285644|589106647|FG000|Overall Study|As specified in the Clinical Study Report|7|||
163109664|NCT05285644|589106648|FG001|Overall Study|As specified in the Clinical Study Report|3|||
163109665|NCT01448824|589108330|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
163109666|NCT01448824|589108331|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
163339809|NCT01322347|589953079|FG000|Overall Study|Physician Decision|2|||
163407849|NCT01553136|590200929|FG001|Overall Study|Scheduling Difficulties|4|||
163407850|NCT00333359|590200930|FG000|Overall Study|Adverse Event|29|||
163407851|NCT00333359|590200931|FG001|Overall Study|Adverse Event|35|||
163407852|NCT00333359|590200930|FG000|Overall Study|Withdrawal by Subject|19|||
163407853|NCT00333359|590200931|FG001|Overall Study|Withdrawal by Subject|37|||
163407854|NCT00333359|590200930|FG000|Overall Study|Physician Decision|2|||
163407855|NCT00333359|590200931|FG001|Overall Study|Physician Decision|2|||
163407856|NCT00333359|590200930|FG000|Overall Study|Protocol Non-compliance|2|||
163407857|NCT00333359|590200931|FG001|Overall Study|Protocol Non-compliance|8|||
163407858|NCT00333359|590200930|FG000|Overall Study|Lost to Follow-up|15|||
163407859|NCT00333359|590200931|FG001|Overall Study|Lost to Follow-up|25|||
163407860|NCT00333359|590200930|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
163407861|NCT00333359|590200931|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
163407862|NCT00333359|590200930|FG000|Overall Study|Treatment Failure|3|||
163407863|NCT00333359|590200931|FG001|Overall Study|Treatment Failure|8|||
163407864|NCT00333359|590200930|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
163407865|NCT00333359|590200931|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
163407866|NCT01452152|590200934|FG000|Overall Study|Study termination by sponsor|5|||
163407867|NCT01452152|590200935|FG001|Overall Study|Study termination by sponsor|0|||
163407868|NCT01452152|590200936|FG002|Overall Study|Study termination by sponsor|4|||
163407869|NCT03315871|590200938|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
163109667|NCT01448824|589108332|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
163109668|NCT01448824|589108333|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
163109669|NCT01448824|589108334|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
163109670|NCT01448824|589108335|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
163109671|NCT01448824|589108336|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
163109672|NCT01448824|589108337|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
163109673|NCT01448824|589108330|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
163109674|NCT01448824|589108331|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
163109675|NCT01448824|589108332|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
163109676|NCT01448824|589108333|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
163109677|NCT01448824|589108334|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
163109678|NCT01448824|589108335|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
163109679|NCT01448824|589108336|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
163109680|NCT01448824|589108337|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
163109681|NCT01448824|589108330|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
163109682|NCT01448824|589108331|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
163109683|NCT01448824|589108332|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
163109684|NCT01448824|589108333|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
163109685|NCT01448824|589108334|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
163109686|NCT01448824|589108335|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
163109687|NCT01448824|589108336|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
163109688|NCT01448824|589108337|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
163109689|NCT01448824|589108330|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
163109690|NCT01448824|589108331|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
163109691|NCT01448824|589108332|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
163109692|NCT01448824|589108333|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
163222076|NCT04033003|589529768|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
163109693|NCT01448824|589108334|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
163109694|NCT01448824|589108335|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
163339810|NCT01322347|589953080|FG001|Overall Study|Physician Decision|1|||
163339811|NCT01322347|589953079|FG000|Overall Study|Protocol Violation|5|||
163339812|NCT01322347|589953080|FG001|Overall Study|Protocol Violation|2|||
163339813|NCT01322347|589953079|FG000|Overall Study|Withdrawal by Subject|1|||
163339814|NCT01322347|589953080|FG001|Overall Study|Withdrawal by Subject|4|||
163339815|NCT01322347|589953079|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
163339816|NCT01322347|589953080|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
163339817|NCT01322347|589953079|FG000|Overall Study|blood transfusion|5|||
163339818|NCT01322347|589953080|FG001|Overall Study|blood transfusion|5|||
163339819|NCT01322347|589953079|FG000|Overall Study|sponsor decision|1|||
163339820|NCT01322347|589953080|FG001|Overall Study|sponsor decision|3|||
163339821|NCT01322347|589953079|FG000|Overall Study|ineligible|6|||
163339822|NCT01322347|589953080|FG001|Overall Study|ineligible|3|||
163339823|NCT01322347|589953079|FG000|Overall Study|kidney transplant|3|||
163339824|NCT01322347|589953080|FG001|Overall Study|kidney transplant|1|||
163339825|NCT01322347|589953079|FG000|Overall Study|study drug withheld > 12 wks|0|||
163339826|NCT01322347|589953080|FG001|Overall Study|study drug withheld > 12 wks|1|||
163339827|NCT01322347|589953079|FG000|Overall Study|moved/changed dialysis|2|||
163339828|NCT01322347|589953080|FG001|Overall Study|moved/changed dialysis|4|||
163339829|NCT01193283|589953081|FG000|Overall Study|Death|1|||
163109695|NCT01448824|589108336|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
163109696|NCT01448824|589108337|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
163109697|NCT01448824|589108330|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163109698|NCT01448824|589108331|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163109699|NCT01448824|589108332|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163109700|NCT01448824|589108333|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163109701|NCT01448824|589108334|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163109702|NCT01448824|589108335|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163109703|NCT01448824|589108336|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163109704|NCT01448824|589108337|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
163109705|NCT01448824|589108330|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
163109706|NCT01448824|589108331|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
163109707|NCT01448824|589108332|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
163109708|NCT01448824|589108333|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
163109709|NCT01448824|589108334|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
163109710|NCT01448824|589108335|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
163109711|NCT01448824|589108336|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
163109712|NCT01448824|589108337|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
163109713|NCT01448824|589108330|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
163109714|NCT01448824|589108331|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
163109715|NCT01448824|589108332|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
163109716|NCT01448824|589108333|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
163109717|NCT01448824|589108334|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
163109718|NCT01448824|589108335|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
163109719|NCT01448824|589108336|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
163109720|NCT01448824|589108337|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
163109721|NCT01448824|589108330|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
163109722|NCT01448824|589108331|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
163109723|NCT01448824|589108332|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
163109724|NCT01448824|589108333|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
163109725|NCT01448824|589108334|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
163109726|NCT01448824|589108335|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
163109727|NCT01448824|589108336|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
163109728|NCT01448824|589108337|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
163109729|NCT01537081|589108340|FG000|Overall Study|Adverse Event|5|||
163109730|NCT01537081|589108341|FG001|Overall Study|Adverse Event|2|||
163109731|NCT01537081|589108342|FG002|Overall Study|Adverse Event|2|||
163109732|NCT01537081|589108340|FG000|Overall Study|Lack of Efficacy|2|||
163109733|NCT01537081|589108341|FG001|Overall Study|Lack of Efficacy|1|||
163109734|NCT01537081|589108342|FG002|Overall Study|Lack of Efficacy|0|||
163109735|NCT01537081|589108340|FG000|Overall Study|Lost to Follow-up|17|||
163109736|NCT01537081|589108341|FG001|Overall Study|Lost to Follow-up|15|||
163109737|NCT01537081|589108342|FG002|Overall Study|Lost to Follow-up|9|||
163109738|NCT01537081|589108340|FG000|Overall Study|Protocol Violation|3|||
163109739|NCT01537081|589108341|FG001|Overall Study|Protocol Violation|2|||
163109740|NCT01537081|589108342|FG002|Overall Study|Protocol Violation|2|||
163109741|NCT01537081|589108340|FG000|Overall Study|Withdrawal by Subject|6|||
163109742|NCT01537081|589108341|FG001|Overall Study|Withdrawal by Subject|11|||
163109743|NCT01537081|589108342|FG002|Overall Study|Withdrawal by Subject|3|||
163109744|NCT01537081|589108340|FG000|Overall Study|Physician Decision|5|||
163109745|NCT01537081|589108341|FG001|Overall Study|Physician Decision|6|||
163109746|NCT01537081|589108342|FG002|Overall Study|Physician Decision|0|||
163109747|NCT01537081|589108340|FG000|Overall Study|Sponsor decision|0|||
163109748|NCT01537081|589108341|FG001|Overall Study|Sponsor decision|1|||
163222077|NCT04033003|589529769|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
163222078|NCT04033003|589529768|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
163339830|NCT04239911|589953082|FG000|Overall Study|Lost to Follow-up|2|||
163109749|NCT01537081|589108342|FG002|Overall Study|Sponsor decision|0|||
163109750|NCT01537081|589108340|FG000|Overall Study|Assigned but never dosed|1|||
163222079|NCT04033003|589529769|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
163222080|NCT04033003|589529768|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
163222081|NCT04033003|589529769|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
163339831|NCT04239911|589953083|FG001|Overall Study|Lost to Follow-up|1|||
163109751|NCT01537081|589108341|FG001|Overall Study|Assigned but never dosed|0|||
163109752|NCT01537081|589108342|FG002|Overall Study|Assigned but never dosed|0|||
163109753|NCT01463111|589108343|FG000|Overall Study|Withdrawal by Subject|2|||
163109754|NCT01463111|589108343|FG000|Overall Study|Lost to Follow-up|5|||
163109755|NCT01463111|589108343|FG000|Overall Study|Physician Decision|2|||
163109756|NCT00882583|589108344|FG000|Overall Study|Physician Decision|1|||
163109757|NCT00882583|589108345|FG001|Overall Study|Physician Decision|0|||
163222082|NCT04033003|589529768|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
163109758|NCT00882583|589108344|FG000|Overall Study|Adverse Event|0|||
163109759|NCT00882583|589108345|FG001|Overall Study|Adverse Event|1|||
163109760|NCT00983515|589108346|FG000|Ritonavir Alone|liver panel out of range|6|||
163109761|NCT00983515|589108346|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
163109762|NCT02526524|589108349|FG000|Overall Study|Withdrawal by Subject|3|||
163109763|NCT02526524|589108350|FG001|Overall Study|Withdrawal by Subject|3|||
163109764|NCT02526524|589108351|FG002|Overall Study|Withdrawal by Subject|6|||
163109765|NCT02526524|589108352|FG003|Overall Study|Withdrawal by Subject|1|||
163109766|NCT02526524|589108353|FG004|Overall Study|Withdrawal by Subject|9|||
163109767|NCT02526524|589108354|FG005|Overall Study|Withdrawal by Subject|5|||
163109768|NCT02526524|589108349|FG000|Overall Study|Adverse Event|3|||
163109769|NCT02526524|589108350|FG001|Overall Study|Adverse Event|2|||
163109770|NCT02526524|589108351|FG002|Overall Study|Adverse Event|4|||
163109771|NCT02526524|589108352|FG003|Overall Study|Adverse Event|2|||
163109772|NCT02526524|589108353|FG004|Overall Study|Adverse Event|6|||
163109773|NCT02526524|589108354|FG005|Overall Study|Adverse Event|8|||
163109774|NCT02526524|589108349|FG000|Overall Study|Lost to Follow-up|2|||
163109775|NCT02526524|589108350|FG001|Overall Study|Lost to Follow-up|3|||
163109776|NCT02526524|589108351|FG002|Overall Study|Lost to Follow-up|8|||
163109777|NCT02526524|589108352|FG003|Overall Study|Lost to Follow-up|1|||
163109778|NCT02526524|589108353|FG004|Overall Study|Lost to Follow-up|2|||
163109779|NCT02526524|589108354|FG005|Overall Study|Lost to Follow-up|5|||
163109780|NCT02526524|589108349|FG000|Overall Study|Protocol Violation|3|||
163109781|NCT02526524|589108350|FG001|Overall Study|Protocol Violation|1|||
163109782|NCT02526524|589108351|FG002|Overall Study|Protocol Violation|5|||
163109783|NCT02526524|589108352|FG003|Overall Study|Protocol Violation|3|||
163109784|NCT02526524|589108353|FG004|Overall Study|Protocol Violation|4|||
163109785|NCT02526524|589108354|FG005|Overall Study|Protocol Violation|3|||
163109786|NCT02526524|589108349|FG000|Overall Study|Loss of Glucose Control|0|||
163109787|NCT02526524|589108350|FG001|Overall Study|Loss of Glucose Control|0|||
163109788|NCT02526524|589108351|FG002|Overall Study|Loss of Glucose Control|3|||
163109789|NCT02526524|589108352|FG003|Overall Study|Loss of Glucose Control|0|||
163109790|NCT02526524|589108353|FG004|Overall Study|Loss of Glucose Control|2|||
163109791|NCT02526524|589108354|FG005|Overall Study|Loss of Glucose Control|0|||
163109792|NCT02526524|589108349|FG000|Overall Study|Physician Decision|0|||
163109793|NCT02526524|589108350|FG001|Overall Study|Physician Decision|0|||
163109794|NCT02526524|589108351|FG002|Overall Study|Physician Decision|0|||
163109795|NCT02526524|589108352|FG003|Overall Study|Physician Decision|0|||
163109796|NCT02526524|589108353|FG004|Overall Study|Physician Decision|1|||
163109797|NCT02526524|589108354|FG005|Overall Study|Physician Decision|0|||
163109798|NCT02526524|589108349|FG000|Overall Study|Sponsor Decision|1|||
163109799|NCT02526524|589108350|FG001|Overall Study|Sponsor Decision|0|||
163109800|NCT02526524|589108351|FG002|Overall Study|Sponsor Decision|0|||
163109801|NCT02526524|589108352|FG003|Overall Study|Sponsor Decision|0|||
163109802|NCT02526524|589108353|FG004|Overall Study|Sponsor Decision|0|||
163109803|NCT02526524|589108354|FG005|Overall Study|Sponsor Decision|0|||
163109804|NCT03764631|589108361|FG000|Overall Study|Personal Reasons|3|||
163109805|NCT03764631|589108362|FG001|Overall Study|Personal Reasons|2|||
163109806|NCT03764631|589108361|FG000|Overall Study|Switching Therapy|3|||
163109807|NCT03764631|589108362|FG001|Overall Study|Switching Therapy|3|||
163109808|NCT03764631|589108361|FG000|Overall Study|Adverse Event|0|||
163109809|NCT03764631|589108362|FG001|Overall Study|Adverse Event|1|||
163109810|NCT03764631|589108361|FG000|Overall Study|Lost to Follow-up|33|||
163109811|NCT03764631|589108362|FG001|Overall Study|Lost to Follow-up|41|||
163109812|NCT03764631|589108361|FG000|Overall Study|No data as study site was closed|2|||
163109813|NCT03764631|589108362|FG001|Overall Study|No data as study site was closed|6|||
163109814|NCT01549886|589108363|FG000|Overall Study|Sponsor's decision|2|||
163109815|NCT01549886|589108364|FG001|Overall Study|Sponsor's decision|3|||
163109816|NCT02039219|589108365|FG000|Treatment|Withdrawal by Subject|1|||
163109817|NCT02039219|589108366|FG001|Treatment|Withdrawal by Subject|0|||
163109818|NCT02039219|589108365|FG000|Treatment|Adverse Event|0|||
163109819|NCT02039219|589108366|FG001|Treatment|Adverse Event|1|||
163109820|NCT02039219|589108365|FG000|Treatment|Physician Decision|1|||
163109821|NCT02039219|589108366|FG001|Treatment|Physician Decision|0|||
163109822|NCT02039219|589108365|FG000|Treatment|Lost to Follow-up|0|||
163109823|NCT02039219|589108366|FG001|Treatment|Lost to Follow-up|1|||
163109824|NCT02039219|589108365|FG000|Treatment|Protocol Violation|1|||
163109825|NCT02039219|589108366|FG001|Treatment|Protocol Violation|0|||
163109826|NCT02039219|589108365|FG000|Treatment|Death|1|||
163109827|NCT02039219|589108366|FG001|Treatment|Death|0|||
163109828|NCT02039219|589108365|FG000|Follow up|Adverse Event|0|||
163109829|NCT02039219|589108366|FG001|Follow up|Adverse Event|1|||
163109830|NCT01681069|589108377|FG000|Overall Study|Withdrawal by Subject|4|||
163109831|NCT01681069|589108378|FG001|Overall Study|Withdrawal by Subject|5|||
163109832|NCT01681069|589108377|FG000|Overall Study|Protocol Violation|1|||
163109833|NCT01681069|589108378|FG001|Overall Study|Protocol Violation|1|||
163109834|NCT01681069|589108377|FG000|Overall Study|Adverse Event|0|||
163109835|NCT01681069|589108378|FG001|Overall Study|Adverse Event|1|||
163109836|NCT01463696|589108379|FG000|Overall Study|Adverse Event|0|||
163109837|NCT01463696|589108380|FG001|Overall Study|Adverse Event|1|||
163109838|NCT01463696|589108381|FG002|Overall Study|Adverse Event|0|||
163109839|NCT01463696|589108382|FG003|Overall Study|Adverse Event|2|||
163109840|NCT01463696|589108383|FG004|Overall Study|Adverse Event|0|||
163109841|NCT01463696|589108384|FG005|Overall Study|Adverse Event|1|||
163109842|NCT01463696|589108385|FG006|Overall Study|Adverse Event|3|||
163109843|NCT01463696|589108386|FG007|Overall Study|Adverse Event|2|||
163109844|NCT01463696|589108379|FG000|Overall Study|Lost to Follow-up|0|||
163109845|NCT01463696|589108380|FG001|Overall Study|Lost to Follow-up|0|||
163109846|NCT01463696|589108381|FG002|Overall Study|Lost to Follow-up|1|||
163109847|NCT01463696|589108382|FG003|Overall Study|Lost to Follow-up|0|||
163109848|NCT01463696|589108383|FG004|Overall Study|Lost to Follow-up|0|||
163109849|NCT01463696|589108384|FG005|Overall Study|Lost to Follow-up|0|||
163109850|NCT01463696|589108385|FG006|Overall Study|Lost to Follow-up|0|||
163109851|NCT01463696|589108386|FG007|Overall Study|Lost to Follow-up|0|||
163109852|NCT01463696|589108379|FG000|Overall Study|Progressive Disease|0|||
163109853|NCT01463696|589108380|FG001|Overall Study|Progressive Disease|1|||
163109854|NCT01463696|589108381|FG002|Overall Study|Progressive Disease|0|||
163109855|NCT01463696|589108382|FG003|Overall Study|Progressive Disease|1|||
163109856|NCT01463696|589108383|FG004|Overall Study|Progressive Disease|0|||
163109857|NCT01463696|589108384|FG005|Overall Study|Progressive Disease|1|||
163109858|NCT01463696|589108385|FG006|Overall Study|Progressive Disease|4|||
163109859|NCT01463696|589108386|FG007|Overall Study|Progressive Disease|2|||
163109860|NCT01463696|589108379|FG000|Overall Study|Withdrawal by Subject|0|||
163109861|NCT01463696|589108380|FG001|Overall Study|Withdrawal by Subject|0|||
163109862|NCT01463696|589108381|FG002|Overall Study|Withdrawal by Subject|0|||
163109863|NCT01463696|589108382|FG003|Overall Study|Withdrawal by Subject|1|||
163109864|NCT01463696|589108383|FG004|Overall Study|Withdrawal by Subject|1|||
163109865|NCT01463696|589108384|FG005|Overall Study|Withdrawal by Subject|1|||
163109866|NCT01463696|589108385|FG006|Overall Study|Withdrawal by Subject|2|||
163109867|NCT01463696|589108386|FG007|Overall Study|Withdrawal by Subject|0|||
163109868|NCT01463696|589108379|FG000|Overall Study|Not Treated|0|||
163109869|NCT01463696|589108380|FG001|Overall Study|Not Treated|0|||
163109870|NCT01463696|589108381|FG002|Overall Study|Not Treated|0|||
163109871|NCT01463696|589108382|FG003|Overall Study|Not Treated|0|||
163109872|NCT01463696|589108383|FG004|Overall Study|Not Treated|0|||
163109873|NCT01463696|589108384|FG005|Overall Study|Not Treated|0|||
163109874|NCT01463696|589108385|FG006|Overall Study|Not Treated|1|||
163109875|NCT01463696|589108386|FG007|Overall Study|Not Treated|0|||
163109876|NCT03883165|589108388|FG000|Overall Study|Withdrawal by Subject|4|||
163109877|NCT03883165|589108389|FG001|Overall Study|Withdrawal by Subject|3|||
163222083|NCT04033003|589529769|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
163222084|NCT04033003|589529768|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
163222085|NCT04033003|589529769|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
163222086|NCT04033003|589529768|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
163222087|NCT04033003|589529769|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
163222088|NCT04033003|589529768|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
163222089|NCT04033003|589529769|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
163222090|NCT04033003|589529768|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
163222091|NCT04033003|589529769|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
163222092|NCT04033003|589529768|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
163222093|NCT04033003|589529769|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
163222094|NCT04033003|589529768|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
163222095|NCT04033003|589529769|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
163222096|NCT02919670|589529770|FG000|Overall Study|Only 17 participants met compliance|43|||
163222097|NCT02919670|589529771|FG001|Overall Study|Only 17 participants met compliance|39|||
163222098|NCT02256891|589529772|FG000|Overall Study|Death|0|||
163222099|NCT02256891|589529773|FG001|Overall Study|Death|2|||
163222100|NCT02256891|589529772|FG000|Overall Study|Lost to Follow-up|0|||
163222101|NCT02256891|589529773|FG001|Overall Study|Lost to Follow-up|3|||
163109878|NCT00967694|589108390|FG000|Overall Study|Withdrawal by Subject|6|||
163109879|NCT05526781|589108392|FG000|Overall Study|Lost to Follow-up|1|||
163109880|NCT03905265|589108393|FG000|Overall Study|Withdrawal by Subject|1|||
163109881|NCT03905265|589108394|FG001|Overall Study|Withdrawal by Subject|1|||
163109882|NCT03905265|589108395|FG002|Overall Study|Withdrawal by Subject|0|||
163222102|NCT02256891|589529772|FG000|Overall Study|Physician Decision|7|||
163109883|NCT03905265|589108396|FG003|Overall Study|Withdrawal by Subject|0|||
163109884|NCT03632993|589108399|FG000|Overall Study|Withdrawal by Subject|1|||
163109885|NCT03632993|589108400|FG001|Overall Study|Withdrawal by Subject|0|||
163222103|NCT02256891|589529773|FG001|Overall Study|Physician Decision|3|||
163109886|NCT03632993|589108401|FG002|Overall Study|Withdrawal by Subject|0|||
163109887|NCT03632993|589108402|FG003|Overall Study|Withdrawal by Subject|0|||
163109888|NCT03632993|589108403|FG004|Overall Study|Withdrawal by Subject|0|||
163109889|NCT03632993|589108404|FG005|Overall Study|Withdrawal by Subject|0|||
163109890|NCT03632993|589108405|FG006|Overall Study|Withdrawal by Subject|0|||
163109891|NCT03632993|589108406|FG007|Overall Study|Withdrawal by Subject|0|||
163109892|NCT03632993|589108407|FG008|Overall Study|Withdrawal by Subject|0|||
163109893|NCT03632993|589108408|FG009|Overall Study|Withdrawal by Subject|1|||
163222104|NCT02256891|589529772|FG000|Overall Study|Screen Fail|5|||
163109894|NCT03632993|589108399|FG000|Overall Study|Protocol Non-compliance|0|||
163109895|NCT03632993|589108400|FG001|Overall Study|Protocol Non-compliance|1|||
163109896|NCT03632993|589108401|FG002|Overall Study|Protocol Non-compliance|0|||
163109897|NCT03632993|589108402|FG003|Overall Study|Protocol Non-compliance|0|||
163109898|NCT03632993|589108403|FG004|Overall Study|Protocol Non-compliance|0|||
163109899|NCT03632993|589108404|FG005|Overall Study|Protocol Non-compliance|0|||
163109900|NCT03632993|589108405|FG006|Overall Study|Protocol Non-compliance|0|||
163109901|NCT03632993|589108406|FG007|Overall Study|Protocol Non-compliance|0|||
163109902|NCT03632993|589108407|FG008|Overall Study|Protocol Non-compliance|0|||
163109903|NCT03632993|589108408|FG009|Overall Study|Protocol Non-compliance|0|||
163109904|NCT03632993|589108399|FG000|Overall Study|Lost to Follow-up|0|||
163109905|NCT03632993|589108400|FG001|Overall Study|Lost to Follow-up|0|||
163109906|NCT03632993|589108401|FG002|Overall Study|Lost to Follow-up|0|||
163109907|NCT03632993|589108402|FG003|Overall Study|Lost to Follow-up|0|||
163109908|NCT03632993|589108403|FG004|Overall Study|Lost to Follow-up|0|||
163109909|NCT03632993|589108404|FG005|Overall Study|Lost to Follow-up|1|||
163109910|NCT03632993|589108405|FG006|Overall Study|Lost to Follow-up|0|||
163109911|NCT03632993|589108406|FG007|Overall Study|Lost to Follow-up|1|||
163109912|NCT03632993|589108407|FG008|Overall Study|Lost to Follow-up|0|||
163109913|NCT03632993|589108408|FG009|Overall Study|Lost to Follow-up|0|||
163109914|NCT03632993|589108399|FG000|Overall Study|Adverse Event|0|||
163109915|NCT03632993|589108400|FG001|Overall Study|Adverse Event|0|||
163109916|NCT03632993|589108401|FG002|Overall Study|Adverse Event|0|||
163109917|NCT03632993|589108402|FG003|Overall Study|Adverse Event|0|||
163109918|NCT03632993|589108403|FG004|Overall Study|Adverse Event|0|||
163109919|NCT03632993|589108404|FG005|Overall Study|Adverse Event|1|||
163109920|NCT03632993|589108405|FG006|Overall Study|Adverse Event|0|||
163109921|NCT03632993|589108406|FG007|Overall Study|Adverse Event|1|||
163109922|NCT03632993|589108407|FG008|Overall Study|Adverse Event|0|||
163109923|NCT03632993|589108408|FG009|Overall Study|Adverse Event|0|||
163109924|NCT01005316|589108409|FG000|Overall Study|Adverse Event|0|||
163109925|NCT01005316|589108410|FG001|Overall Study|Adverse Event|0|||
163109926|NCT01005316|589108411|FG002|Overall Study|Adverse Event|0|||
163109927|NCT01005316|589108412|FG003|Overall Study|Adverse Event|1|||
163109928|NCT01005316|589108409|FG000|Overall Study|Death|20|||
163109929|NCT01005316|589108410|FG001|Overall Study|Death|5|||
163109930|NCT01005316|589108411|FG002|Overall Study|Death|1|||
163109931|NCT01005316|589108412|FG003|Overall Study|Death|15|||
163109932|NCT01005316|589108409|FG000|Overall Study|Study Termination|5|||
163109933|NCT01005316|589108410|FG001|Overall Study|Study Termination|63|||
163109934|NCT01005316|589108411|FG002|Overall Study|Study Termination|9|||
163109935|NCT01005316|589108412|FG003|Overall Study|Study Termination|85|||
163109936|NCT01005316|589108409|FG000|Overall Study|Lost to Follow-up|1|||
163109937|NCT01005316|589108410|FG001|Overall Study|Lost to Follow-up|3|||
163109938|NCT01005316|589108411|FG002|Overall Study|Lost to Follow-up|0|||
163109939|NCT01005316|589108412|FG003|Overall Study|Lost to Follow-up|2|||
163109940|NCT01005316|589108409|FG000|Overall Study|Physician Decision|6|||
163109941|NCT01005316|589108410|FG001|Overall Study|Physician Decision|0|||
163109942|NCT01005316|589108411|FG002|Overall Study|Physician Decision|0|||
163109943|NCT01005316|589108412|FG003|Overall Study|Physician Decision|0|||
163109944|NCT01005316|589108409|FG000|Overall Study|Sponsor Decision|6|||
163109945|NCT01005316|589108410|FG001|Overall Study|Sponsor Decision|3|||
163109946|NCT01005316|589108411|FG002|Overall Study|Sponsor Decision|0|||
163109947|NCT01005316|589108412|FG003|Overall Study|Sponsor Decision|0|||
163109948|NCT01005316|589108409|FG000|Overall Study|Withdrawal by Subject|1|||
163109949|NCT01005316|589108410|FG001|Overall Study|Withdrawal by Subject|1|||
163109950|NCT01005316|589108411|FG002|Overall Study|Withdrawal by Subject|0|||
163109951|NCT01005316|589108412|FG003|Overall Study|Withdrawal by Subject|2|||
163109952|NCT01005316|589108409|FG000|Overall Study|Consented to Another Study|2|||
163109953|NCT01005316|589108410|FG001|Overall Study|Consented to Another Study|0|||
163222105|NCT02256891|589529773|FG001|Overall Study|Screen Fail|4|||
163339832|NCT02137785|589953084|FG000|Overall Study|Lost to Follow-up|1|||
163109954|NCT01005316|589108411|FG002|Overall Study|Consented to Another Study|0|||
163109955|NCT01005316|589108412|FG003|Overall Study|Consented to Another Study|0|||
163109956|NCT01005316|589108409|FG000|Overall Study|Delisted|8|||
163109957|NCT01005316|589108410|FG001|Overall Study|Delisted|0|||
163109958|NCT01005316|589108411|FG002|Overall Study|Delisted|0|||
163222106|NCT02256891|589529772|FG000|Overall Study|Equipment Malfunction|0|||
163339833|NCT02137785|589953085|FG001|Overall Study|Lost to Follow-up|0|||
163339834|NCT02137785|589953084|FG000|Overall Study|Withdrawal by Subject|1|||
163109959|NCT01005316|589108412|FG003|Overall Study|Delisted|0|||
163109960|NCT01005316|589108409|FG000|Overall Study|Transferred Care|1|||
163109961|NCT01005316|589108410|FG001|Overall Study|Transferred Care|0|||
163109962|NCT01005316|589108411|FG002|Overall Study|Transferred Care|1|||
163109963|NCT01005316|589108412|FG003|Overall Study|Transferred Care|3|||
163109964|NCT01005316|589108409|FG000|Overall Study|Retransplanted|0|||
163109965|NCT01005316|589108410|FG001|Overall Study|Retransplanted|1|||
163109966|NCT01005316|589108411|FG002|Overall Study|Retransplanted|0|||
163109967|NCT01005316|589108412|FG003|Overall Study|Retransplanted|0|||
163109968|NCT00632827|589108413|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
163109969|NCT00632827|589108413|FG000|Overall Study|Death|2|||
163109970|NCT00632827|589108413|FG000|Overall Study|Adverse Event|5|||
163109971|NCT00632827|589108413|FG000|Overall Study|Lost to Follow-up|1|||
163109972|NCT00368836|589108414|FG000|Phase II|Screen Failure|1|||
163109973|NCT00368836|589108414|FG000|Phase II|Withdrawal by Subject|1|||
163109974|NCT00368836|589108414|FG000|Phase II|unable to collect blood and/or breath|17|||
163109975|NCT00368836|589108414|FG000|Phase II|Protocol Violation|2|||
163109976|NCT03272828|589108417|FG000|Overall Study|Lost to Follow-up|7|||
163109977|NCT03272828|589108418|FG001|Overall Study|Lost to Follow-up|7|||
163109978|NCT03272828|589108417|FG000|Overall Study|Withdrawal by Subject|2|||
163109979|NCT03272828|589108418|FG001|Overall Study|Withdrawal by Subject|0|||
163109980|NCT03272828|589108417|FG000|Overall Study|Deceased|1|||
163109981|NCT03272828|589108418|FG001|Overall Study|Deceased|1|||
163109982|NCT03272828|589108417|FG000|Overall Study|Failed implant|1|||
163109983|NCT03272828|589108418|FG001|Overall Study|Failed implant|2|||
163109984|NCT03888235|589108422|FG000|Overall Study|Lost to Follow-up|1|||
163109985|NCT03888235|589108423|FG001|Overall Study|Lost to Follow-up|1|||
163109986|NCT03888235|589108424|FG002|Overall Study|Lost to Follow-up|0|||
163109987|NCT01054560|589108425|FG000|Overall Study|Death|10|||
163109988|NCT01054560|589108426|FG001|Overall Study|Death|21|||
163109989|NCT01054560|589108425|FG000|Overall Study|Lost to Follow-up|2|||
163109990|NCT01054560|589108426|FG001|Overall Study|Lost to Follow-up|5|||
163109991|NCT01054560|589108425|FG000|Overall Study|Withdrawal by Subject|0|||
163109992|NCT01054560|589108426|FG001|Overall Study|Withdrawal by Subject|2|||
163109993|NCT01054560|589108425|FG000|Overall Study|Physician Decision|1|||
163109994|NCT01054560|589108426|FG001|Overall Study|Physician Decision|0|||
163339835|NCT02137785|589953085|FG001|Overall Study|Withdrawal by Subject|4|||
163339836|NCT02137785|589953084|FG000|Overall Study|subject moved out of state|1|||
163339837|NCT02137785|589953085|FG001|Overall Study|subject moved out of state|0|||
163339838|NCT03345407|589953087|FG000|Overall Study|Withdrawal by Subject|11|||
163339839|NCT03345407|589953088|FG001|Overall Study|Withdrawal by Subject|1|||
163339840|NCT03345407|589953089|FG002|Overall Study|Withdrawal by Subject|5|||
163339841|NCT03345407|589953090|FG003|Overall Study|Withdrawal by Subject|6|||
163339842|NCT03345407|589953091|FG004|Overall Study|Withdrawal by Subject|3|||
163339843|NCT03345407|589953092|FG005|Overall Study|Withdrawal by Subject|6|||
163339844|NCT03345407|589953093|FG006|Overall Study|Withdrawal by Subject|16|||
163339845|NCT03345407|589953087|FG000|Overall Study|Physician Decision|3|||
163339846|NCT03345407|589953088|FG001|Overall Study|Physician Decision|1|||
163339847|NCT03345407|589953089|FG002|Overall Study|Physician Decision|0|||
163339848|NCT03345407|589953090|FG003|Overall Study|Physician Decision|0|||
163339849|NCT03345407|589953091|FG004|Overall Study|Physician Decision|1|||
163339850|NCT03345407|589953092|FG005|Overall Study|Physician Decision|2|||
163339851|NCT03345407|589953093|FG006|Overall Study|Physician Decision|3|||
163339852|NCT03345407|589953087|FG000|Overall Study|Lost to Follow-up|2|||
163339853|NCT03345407|589953088|FG001|Overall Study|Lost to Follow-up|0|||
163339854|NCT03345407|589953089|FG002|Overall Study|Lost to Follow-up|1|||
163339855|NCT03345407|589953090|FG003|Overall Study|Lost to Follow-up|0|||
163339856|NCT03345407|589953091|FG004|Overall Study|Lost to Follow-up|1|||
163339857|NCT03345407|589953092|FG005|Overall Study|Lost to Follow-up|2|||
163339858|NCT03345407|589953093|FG006|Overall Study|Lost to Follow-up|3|||
163339859|NCT03345407|589953087|FG000|Overall Study|Protocol-defined stopping criteria|9|||
163339860|NCT03345407|589953088|FG001|Overall Study|Protocol-defined stopping criteria|0|||
163339861|NCT03345407|589953089|FG002|Overall Study|Protocol-defined stopping criteria|0|||
163339862|NCT03345407|589953090|FG003|Overall Study|Protocol-defined stopping criteria|0|||
163339863|NCT03345407|589953091|FG004|Overall Study|Protocol-defined stopping criteria|2|||
163339864|NCT03345407|589953092|FG005|Overall Study|Protocol-defined stopping criteria|1|||
163339865|NCT03345407|589953093|FG006|Overall Study|Protocol-defined stopping criteria|1|||
163109995|NCT00244933|589108434|FG000|Overall Study|Not response evaluable|2|||
163109996|NCT03703817|589108435|FG000|Overall Study|Not meeting eligibility criteria|7|||
163109997|NCT03703817|589108436|FG001|Overall Study|Not meeting eligibility criteria|4|||
163109998|NCT05129449|589108439|FG000|Overall Study|Protocol Violation|1|||
163109999|NCT02901054|589108443|FG000|Overall Study|Physician Decision|1|||
163110000|NCT02901054|589108443|FG000|Overall Study|Withdrawal by Subject|3|||
163110001|NCT00616018|589108447|FG000|Overall Study|Protocol Violation|3|||
163339866|NCT03345407|589953087|FG000|Overall Study|Protocol Violation|2|||
163339867|NCT03345407|589953088|FG001|Overall Study|Protocol Violation|0|||
163339868|NCT03345407|589953089|FG002|Overall Study|Protocol Violation|0|||
163339869|NCT03345407|589953090|FG003|Overall Study|Protocol Violation|0|||
163110002|NCT05145322|589108448|FG000|Overall Study|Lost to Follow-up|4|||
163110003|NCT05145322|589108449|FG001|Overall Study|Lost to Follow-up|5|||
163110004|NCT06359028|589108450|FG000|Overall Study|Adverse Event|1|||
163110005|NCT06359028|589108451|FG001|Overall Study|Adverse Event|0|||
163339870|NCT03345407|589953091|FG004|Overall Study|Protocol Violation|1|||
163339871|NCT03345407|589953092|FG005|Overall Study|Protocol Violation|0|||
163110006|NCT06359028|589108450|FG000|Overall Study|Withdrawal by Subject|1|||
163110007|NCT06359028|589108451|FG001|Overall Study|Withdrawal by Subject|0|||
163339872|NCT03345407|589953093|FG006|Overall Study|Protocol Violation|3|||
163110008|NCT04700540|589108452|FG000|Overall Study|Withdrawal by Subject|12|||
163339873|NCT03345407|589953087|FG000|Overall Study|Lack of Efficacy|1|||
163339874|NCT03345407|589953088|FG001|Overall Study|Lack of Efficacy|1|||
163110009|NCT04700540|589108453|FG001|Overall Study|Withdrawal by Subject|8|||
163110010|NCT04700540|589108452|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
163110011|NCT04700540|589108453|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
163110012|NCT05248997|589108454|FG000|Overall Study|Lost to Follow-up|1|||
163110013|NCT05248997|589108455|FG001|Overall Study|Lost to Follow-up|1|||
163110014|NCT05248997|589108454|FG000|Overall Study|Randomized but not treated|32|||
163110015|NCT05248997|589108455|FG001|Overall Study|Randomized but not treated|25|||
163110016|NCT03515551|589108456|FG000|Overall Study|Death|4|||
163110017|NCT03515551|589108457|FG001|Overall Study|Death|1|||
163110018|NCT03515551|589108458|FG002|Overall Study|Death|2|||
163110019|NCT03515551|589108459|FG003|Overall Study|Death|2|||
163110020|NCT03515551|589108460|FG004|Overall Study|Death|2|||
163110021|NCT03515551|589108461|FG005|Overall Study|Death|4|||
163110022|NCT03515551|589108462|FG006|Overall Study|Death|1|||
163110023|NCT03515551|589108456|FG000|Overall Study|Lost to Follow-up|0|||
163110024|NCT03515551|589108457|FG001|Overall Study|Lost to Follow-up|0|||
163110025|NCT03515551|589108458|FG002|Overall Study|Lost to Follow-up|1|||
163110026|NCT03515551|589108459|FG003|Overall Study|Lost to Follow-up|0|||
163110027|NCT03515551|589108460|FG004|Overall Study|Lost to Follow-up|0|||
163110028|NCT03515551|589108461|FG005|Overall Study|Lost to Follow-up|0|||
163110029|NCT03515551|589108462|FG006|Overall Study|Lost to Follow-up|0|||
163110030|NCT03515551|589108456|FG000|Overall Study|Withdrawal by Subject|0|||
163110031|NCT03515551|589108457|FG001|Overall Study|Withdrawal by Subject|1|||
163110032|NCT03515551|589108458|FG002|Overall Study|Withdrawal by Subject|0|||
163110033|NCT03515551|589108459|FG003|Overall Study|Withdrawal by Subject|0|||
163110034|NCT03515551|589108460|FG004|Overall Study|Withdrawal by Subject|0|||
163110035|NCT03515551|589108461|FG005|Overall Study|Withdrawal by Subject|0|||
163110036|NCT03515551|589108462|FG006|Overall Study|Withdrawal by Subject|1|||
163110037|NCT03515551|589108456|FG000|Overall Study|Study ended by sponsor|0|||
163110038|NCT03515551|589108457|FG001|Overall Study|Study ended by sponsor|0|||
163110039|NCT03515551|589108458|FG002|Overall Study|Study ended by sponsor|2|||
163110040|NCT03515551|589108459|FG003|Overall Study|Study ended by sponsor|1|||
163110041|NCT03515551|589108460|FG004|Overall Study|Study ended by sponsor|3|||
163110042|NCT03515551|589108461|FG005|Overall Study|Study ended by sponsor|0|||
163110043|NCT03515551|589108462|FG006|Overall Study|Study ended by sponsor|3|||
163110044|NCT03515551|589108456|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
163110045|NCT03515551|589108457|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
163110046|NCT03515551|589108458|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
163110047|NCT03515551|589108459|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
163110048|NCT03515551|589108460|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
163110049|NCT03515551|589108461|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
163110050|NCT03515551|589108462|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
163110051|NCT00673231|589108463|FG000|Overall Study|Withdrawal by Subject|14|||
163110052|NCT00673231|589108464|FG001|Overall Study|Withdrawal by Subject|10|||
163110053|NCT00673231|589108465|FG002|Overall Study|Withdrawal by Subject|8|||
163110054|NCT00673231|589108466|FG003|Overall Study|Withdrawal by Subject|6|||
163110055|NCT00673231|589108463|FG000|Overall Study|Adverse Event|6|||
163110056|NCT00673231|589108464|FG001|Overall Study|Adverse Event|5|||
163110057|NCT00673231|589108465|FG002|Overall Study|Adverse Event|9|||
163110058|NCT00673231|589108466|FG003|Overall Study|Adverse Event|6|||
163110059|NCT00673231|589108463|FG000|Overall Study|Lost to Follow-up|1|||
163110060|NCT00673231|589108464|FG001|Overall Study|Lost to Follow-up|2|||
163339875|NCT03345407|589953089|FG002|Overall Study|Lack of Efficacy|1|||
163339876|NCT03345407|589953090|FG003|Overall Study|Lack of Efficacy|1|||
163110061|NCT00673231|589108465|FG002|Overall Study|Lost to Follow-up|1|||
163110062|NCT00673231|589108466|FG003|Overall Study|Lost to Follow-up|2|||
163110063|NCT00673231|589108463|FG000|Overall Study|Death|0|||
163110064|NCT00673231|589108464|FG001|Overall Study|Death|0|||
163110065|NCT00673231|589108465|FG002|Overall Study|Death|1|||
163110066|NCT00673231|589108466|FG003|Overall Study|Death|0|||
163110067|NCT00673231|589108463|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
163110068|NCT00673231|589108464|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
163110069|NCT00673231|589108465|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
163110070|NCT00673231|589108466|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
163110071|NCT02952313|589108467|FG000|Primary Endpoint|Lost to Follow-up|4|||
163110072|NCT02952313|589108467|FG000|Primary Endpoint|Withdrawal by Subject|1|||
163110073|NCT02952313|589108467|FG000|Primary Endpoint|Lack of Efficacy|1|||
163110074|NCT02952313|589108467|FG000|Primary Endpoint|Missed visit|1|||
163110075|NCT02952313|589108467|FG000|Long-term Follow-up|Lost to Follow-up|12|||
163110076|NCT02952313|589108467|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
163110077|NCT02952313|589108467|FG000|Long-term Follow-up|Lack of Efficacy|6|||
163110078|NCT02952313|589108467|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
163110079|NCT02952313|589108467|FG000|Long-term Follow-up|Physician Decision|1|||
163110080|NCT02952313|589108467|FG000|Long-term Follow-up|Death|1|||
163339877|NCT03345407|589953091|FG004|Overall Study|Lack of Efficacy|1|||
163407870|NCT03315871|590200939|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
163407871|NCT03315871|590200940|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
163407872|NCT03315871|590200938|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
163407873|NCT03315871|590200939|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
163407874|NCT03315871|590200940|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
163407875|NCT03315871|590200938|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
163407876|NCT03315871|590200939|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
163407877|NCT03315871|590200940|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
163407878|NCT03315871|590200938|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
163407879|NCT03315871|590200939|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
163407880|NCT03315871|590200940|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
163407881|NCT03315871|590200938|FG000|PROSTVAC + CV301|Progressive disease|0|||
163110081|NCT00920387|589108470|FG000|Stage 1|Adverse Event|1|||
163110082|NCT00920387|589108471|FG001|Stage 1|Adverse Event|0|||
163110083|NCT00920387|589108472|FG002|Stage 1|Adverse Event|0|||
163110084|NCT04470908|589108473|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
163110085|NCT02470585|589108477|FG000|Overall Study|Death|224|||
163110086|NCT02470585|589108478|FG001|Overall Study|Death|227|||
163110087|NCT02470585|589108479|FG002|Overall Study|Death|199|||
163110088|NCT02470585|589108477|FG000|Overall Study|Withdrew consent|21|||
163110089|NCT02470585|589108478|FG001|Overall Study|Withdrew consent|22|||
163110090|NCT02470585|589108479|FG002|Overall Study|Withdrew consent|31|||
163110091|NCT02470585|589108477|FG000|Overall Study|Lost to Follow-up|8|||
163110092|NCT02470585|589108478|FG001|Overall Study|Lost to Follow-up|15|||
163110093|NCT02470585|589108479|FG002|Overall Study|Lost to Follow-up|13|||
163110094|NCT02470585|589108477|FG000|Overall Study|Sponsor discontinued study|117|||
163110095|NCT02470585|589108478|FG001|Overall Study|Sponsor discontinued study|110|||
163110096|NCT02470585|589108479|FG002|Overall Study|Sponsor discontinued study|122|||
163110097|NCT02470585|589108477|FG000|Overall Study|Other, not specified|5|||
163110098|NCT02470585|589108478|FG001|Overall Study|Other, not specified|7|||
163110099|NCT02470585|589108479|FG002|Overall Study|Other, not specified|14|||
163110100|NCT02470585|589108477|FG000|Overall Study|Missing due to site non-compliance|0|||
163110101|NCT02470585|589108478|FG001|Overall Study|Missing due to site non-compliance|2|||
163110102|NCT02470585|589108479|FG002|Overall Study|Missing due to site non-compliance|3|||
163110103|NCT03028415|589108480|FG000|Overall Study|Lost to Follow-up|6|||
163110104|NCT03028415|589108481|FG001|Overall Study|Lost to Follow-up|3|||
163110105|NCT03028415|589108480|FG000|Overall Study|Withdrawal by Subject|1|||
163110106|NCT03028415|589108481|FG001|Overall Study|Withdrawal by Subject|0|||
163110107|NCT03028415|589108480|FG000|Overall Study|Discontinued due to COVID-19|1|||
163110108|NCT03028415|589108481|FG001|Overall Study|Discontinued due to COVID-19|0|||
163110109|NCT05005013|589108484|FG000|Overall Study|Withdrawal by Subject|5|||
163110110|NCT05005013|589108485|FG001|Overall Study|Withdrawal by Subject|1|||
163110111|NCT05005013|589108484|FG000|Overall Study|Lost to Follow-up|3|||
163110112|NCT05005013|589108485|FG001|Overall Study|Lost to Follow-up|1|||
163110113|NCT05005013|589108484|FG000|Overall Study|Ineligibility|1|||
163110114|NCT05005013|589108485|FG001|Overall Study|Ineligibility|1|||
163110115|NCT04283994|589108488|FG000|Overall Study|Death|11|||
163110116|NCT04283994|589108489|FG001|Overall Study|Death|20|||
163110117|NCT04283994|589108490|FG002|Overall Study|Death|11|||
163110118|NCT04283994|589108491|FG003|Overall Study|Death|0|||
163110119|NCT04283994|589108492|FG004|Overall Study|Death|0|||
163110120|NCT04283994|589108493|FG005|Overall Study|Death|0|||
163110121|NCT04283994|589108494|FG006|Overall Study|Death|0|||
163110122|NCT04283994|589108488|FG000|Overall Study|Withdrawal by Subject|16|||
163110123|NCT04283994|589108489|FG001|Overall Study|Withdrawal by Subject|4|||
163110124|NCT04283994|589108490|FG002|Overall Study|Withdrawal by Subject|6|||
163110125|NCT04283994|589108491|FG003|Overall Study|Withdrawal by Subject|1|||
163407882|NCT03315871|590200939|FG001|PROSTVAC + CV301|Progressive disease|0|||
163407883|NCT03315871|590200940|FG002|PROSTVAC + CV301|Progressive disease|1|||
163407884|NCT03315871|590200938|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
163110126|NCT04283994|589108492|FG004|Overall Study|Withdrawal by Subject|0|||
163110127|NCT04283994|589108493|FG005|Overall Study|Withdrawal by Subject|1|||
163110128|NCT04283994|589108494|FG006|Overall Study|Withdrawal by Subject|0|||
163110129|NCT03315793|589108495|FG000|Overall Study|Adverse Event|4|||
163110130|NCT03315793|589108496|FG001|Overall Study|Adverse Event|2|||
163110131|NCT03315793|589108495|FG000|Overall Study|Protocol Deviation|1|||
163110132|NCT03315793|589108496|FG001|Overall Study|Protocol Deviation|0|||
163110133|NCT03315793|589108495|FG000|Overall Study|Difficult for regular visit|0|||
163110134|NCT03315793|589108496|FG001|Overall Study|Difficult for regular visit|1|||
163110135|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Adverse Event|76|||
163110136|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Adverse Event|0|||
163110137|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Adverse Event|0|||
163110138|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Death|3|||
163110139|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Death|0|||
163110140|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Death|0|||
163110141|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
163222107|NCT02256891|589529773|FG001|Overall Study|Equipment Malfunction|1|||
163222108|NCT01675882|589529776|FG000|Overall Study|Adverse Event|0|||
163222109|NCT01675882|589529777|FG001|Overall Study|Adverse Event|2|||
163222110|NCT01675882|589529778|FG002|Overall Study|Adverse Event|1|||
163222111|NCT01675882|589529779|FG003|Overall Study|Adverse Event|0|||
163222112|NCT01675882|589529776|FG000|Overall Study|Participant unwilling to continue|2|||
163222113|NCT01675882|589529777|FG001|Overall Study|Participant unwilling to continue|4|||
163222114|NCT01675882|589529778|FG002|Overall Study|Participant unwilling to continue|2|||
163222115|NCT01675882|589529779|FG003|Overall Study|Participant unwilling to continue|1|||
163222116|NCT01675882|589529776|FG000|Overall Study|Lost to Follow-up|0|||
163222117|NCT01675882|589529777|FG001|Overall Study|Lost to Follow-up|1|||
163222118|NCT01675882|589529778|FG002|Overall Study|Lost to Follow-up|0|||
163222119|NCT01675882|589529779|FG003|Overall Study|Lost to Follow-up|0|||
163222120|NCT01675882|589529776|FG000|Overall Study|Non-compliance|0|||
163222121|NCT01675882|589529777|FG001|Overall Study|Non-compliance|0|||
163222122|NCT01675882|589529778|FG002|Overall Study|Non-compliance|0|||
163222123|NCT01675882|589529779|FG003|Overall Study|Non-compliance|1|||
163222124|NCT01446965|589529782|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
163222125|NCT01446965|589529783|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
163222126|NCT01446965|589529782|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
163222127|NCT01446965|589529783|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
163222128|NCT02016482|589529793|FG000|Period A|Adverse Event|3|||
163222129|NCT02016482|589529794|FG001|Period A|Adverse Event|5|||
163222130|NCT02016482|589529793|FG000|Period A|Withdrawal by Subject|3|||
163222131|NCT02016482|589529794|FG001|Period A|Withdrawal by Subject|4|||
163222132|NCT02016482|589529793|FG000|Period A|Lost to Follow-up|3|||
163222133|NCT02016482|589529794|FG001|Period A|Lost to Follow-up|3|||
163222134|NCT02016482|589529793|FG000|Period A|Lack of Efficacy|2|||
163222135|NCT02016482|589529794|FG001|Period A|Lack of Efficacy|1|||
163222136|NCT02016482|589529793|FG000|Period A|Other|3|||
163222137|NCT02016482|589529794|FG001|Period A|Other|0|||
163222138|NCT02016482|589529793|FG000|Period A|Protocol Violation|0|||
163222139|NCT02016482|589529794|FG001|Period A|Protocol Violation|1|||
163222140|NCT02016482|589529793|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
163222141|NCT02016482|589529794|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
163222142|NCT02016482|589529793|FG000|Period B|Withdrawal by Subject|1|||
163222143|NCT02016482|589529794|FG001|Period B|Withdrawal by Subject|1|||
163222144|NCT02016482|589529793|FG000|Period B|Lost to Follow-up|2|||
163222145|NCT02016482|589529794|FG001|Period B|Lost to Follow-up|0|||
163222146|NCT02016482|589529793|FG000|Period B|Lack of Efficacy|6|||
163222147|NCT02016482|589529794|FG001|Period B|Lack of Efficacy|4|||
163222148|NCT02016482|589529793|FG000|Period B|Other|4|||
163222149|NCT02016482|589529794|FG001|Period B|Other|0|||
163222150|NCT02016482|589529793|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
163222151|NCT02016482|589529794|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
163339878|NCT03345407|589953092|FG005|Overall Study|Lack of Efficacy|0|||
163339879|NCT03345407|589953093|FG006|Overall Study|Lack of Efficacy|3|||
163339880|NCT03345407|589953087|FG000|Overall Study|Adverse Event|4|||
163339881|NCT03345407|589953088|FG001|Overall Study|Adverse Event|0|||
163339882|NCT03345407|589953089|FG002|Overall Study|Adverse Event|5|||
163339883|NCT03345407|589953090|FG003|Overall Study|Adverse Event|4|||
163339884|NCT03345407|589953091|FG004|Overall Study|Adverse Event|6|||
163339885|NCT03345407|589953092|FG005|Overall Study|Adverse Event|5|||
163339886|NCT03345407|589953093|FG006|Overall Study|Adverse Event|16|||
163339887|NCT01584648|589953094|FG000|Overall Study|Death|136|||
163339888|NCT01584648|589953095|FG001|Overall Study|Death|146|||
163339889|NCT01584648|589953094|FG000|Overall Study|Lost to Follow-up|9|||
163339890|NCT01584648|589953095|FG001|Overall Study|Lost to Follow-up|9|||
163407885|NCT03315871|590200939|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
163222152|NCT00606892|589529795|FG000|First Intervention|Protocol Violation|1|||
163222153|NCT00606892|589529796|FG001|First Intervention|Protocol Violation|4|||
163222154|NCT00855309|589529798|FG000|Overall Study|patient never recieved drug|1|||
163222155|NCT00855309|589529799|FG001|Overall Study|patient never recieved drug|0|||
163339891|NCT01584648|589953094|FG000|Overall Study|Investigator discretion|3|||
163339892|NCT01584648|589953095|FG001|Overall Study|Investigator discretion|2|||
163339893|NCT01584648|589953094|FG000|Overall Study|Withdrew consent|13|||
163407886|NCT03315871|590200940|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
163339894|NCT01584648|589953095|FG001|Overall Study|Withdrew consent|4|||
163339895|NCT01584648|589953094|FG000|Overall Study|Study closed/terminated|50|||
163407887|NCT00328627|590203961|FG000|Overall Study|Hyperglycemic Rescue|41|||
163222156|NCT00829296|589529800|FG000|Overall Study|Adverse Event|5|||
163222157|NCT00829296|589529801|FG001|Overall Study|Adverse Event|4|||
163222158|NCT04960228|589529807|FG000|Overall Study|Withdrawal by Subject|216|||
163222159|NCT04960228|589529808|FG001|Overall Study|Withdrawal by Subject|35|||
163222160|NCT04960228|589529807|FG000|Overall Study|Failed attention check|69|||
163222161|NCT04960228|589529808|FG001|Overall Study|Failed attention check|148|||
163222162|NCT04960228|589529807|FG000|Overall Study|Flagged for response quality by Dynata|3|||
163339896|NCT01584648|589953095|FG001|Overall Study|Study closed/terminated|23|||
163222163|NCT04960228|589529808|FG001|Overall Study|Flagged for response quality by Dynata|3|||
163222164|NCT02547129|589529809|FG000|Overall Study|Difficulty with ongoing infection|1|||
163222165|NCT02547129|589529810|FG001|Overall Study|Difficulty with ongoing infection|0|||
163222166|NCT00794196|589529811|FG000|Overall Study|Lost to Follow-up|5|||
163222167|NCT00794196|589529812|FG001|Overall Study|Lost to Follow-up|23|||
163222168|NCT01640366|589529813|FG000|Overall Study|Withdrawal by Subject|1|||
163222169|NCT01640366|589529813|FG000|Overall Study|Protocol Violation|16|||
163222170|NCT01640366|589529813|FG000|Overall Study|Lost to Follow-up|5|||
163222171|NCT01200797|589529816|FG000|Overall Study|symptomatic deterioration|2|||
163222172|NCT01200797|589529816|FG000|Overall Study|Adverse Event|4|||
163222173|NCT01200797|589529816|FG000|Overall Study|Disease Progression|13|||
163222174|NCT03745144|589529819|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
163222175|NCT03745144|589529820|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
163222176|NCT03745144|589529821|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
163222177|NCT03745144|589529819|FG000|Period 1|Other|0|||
163222178|NCT03745144|589529820|FG001|Period 1|Other|0|||
163222179|NCT03745144|589529821|FG002|Period 1|Other|1|||
163222180|NCT00642668|589529826|FG000|Overall Study|Lost to Follow-up|1|||
163222181|NCT00642668|589529826|FG000|Overall Study|Adverse Event|2|||
163222182|NCT00642668|589529826|FG000|Overall Study|Death|2|||
163110142|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
163110143|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
163110144|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Physician Decision|9|||
163110145|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Physician Decision|0|||
163222183|NCT00642668|589529826|FG000|Overall Study|Insufficient Therapeutic Response|1|||
163222184|NCT00642668|589529826|FG000|Overall Study|Failure to Return|1|||
163222185|NCT00642668|589529826|FG000|Overall Study|Dialysis Initiation|5|||
163110146|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Physician Decision|0|||
163110147|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
163110148|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
163110149|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
163110150|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Disease progression|45|||
163110151|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Disease progression|0|||
163110152|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Disease progression|0|||
163110153|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
163110154|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
163110155|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
163110156|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
163110157|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
163110158|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
163110159|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
163110160|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
163110161|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
163110162|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
163110163|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
163110164|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
163110165|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
163110166|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
163110167|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
163110168|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
163110169|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
163110170|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
163222186|NCT00642668|589529826|FG000|Overall Study|Blood Transfusion|2|||
163222187|NCT00896337|589529827|FG000|Overall Study|Death|7|||
163222188|NCT00896337|589529827|FG000|Overall Study|Withdrawal by Subject|7|||
163222189|NCT00896337|589529827|FG000|Overall Study|Lost to Follow-up|11|||
163222190|NCT01070316|589529829|FG000|Extension Phase|Lack of Efficacy|3|||
163222191|NCT01070316|589529829|FG000|Extension Phase|Withdrawal by Subject|1|||
163222192|NCT01113879|589529834|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
163339897|NCT01584648|589953094|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
163339898|NCT01584648|589953095|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
163339899|NCT03693989|589953098|FG000|Overall Study|Protocol Violation|3|||
163339900|NCT03693989|589953099|FG001|Overall Study|Protocol Violation|4|||
163339901|NCT01190436|589953100|FG000|Overall Study|Lost to Follow-up|35|||
163339902|NCT01190436|589953100|FG000|Overall Study|Other|4|||
163339903|NCT03146845|589953101|FG000|Overall Study|Reference ulcer healed|1|||
163339904|NCT03146845|589953102|FG001|Overall Study|Reference ulcer healed|0|||
163222193|NCT01113879|589529835|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
163222194|NCT04151290|589529836|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
163222195|NCT00082433|589529840|FG000|Overall Study|Adverse Event|12|||
163222196|NCT00082433|589529841|FG001|Overall Study|Adverse Event|17|||
163222197|NCT00082433|589529840|FG000|Overall Study|Death|8|||
163110171|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
163110172|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
163110173|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
163110174|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
163110175|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
163110176|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
163110177|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
163110178|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
163110179|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
163110180|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Promotor request|1|||
163110181|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Promotor request|0|||
163110182|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Promotor request|0|||
163110183|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
163110184|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
163110185|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
163110186|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
163110187|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
163110188|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
163110189|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Death|3|||
163110190|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Death|0|||
163110191|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Death|0|||
163110192|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
163110193|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
163110194|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
163110195|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
163110196|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
163110197|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
163110198|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Diseases progression|91|||
163110199|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Diseases progression|0|||
163110200|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Diseases progression|0|||
163110201|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Adverse Event|70|||
163110202|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Adverse Event|0|||
163110203|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Adverse Event|0|||
163110204|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Physician Decision|9|||
163110205|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Physician Decision|0|||
163110206|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Physician Decision|0|||
163110207|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
163110208|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
163110209|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
163110210|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
163110211|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
163110212|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
163110213|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
163110214|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
163110215|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
163110216|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Not compliant|1|||
163110217|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Not compliant|0|||
163110218|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Not compliant|0|||
163110219|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
163110220|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
163110221|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
163110222|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Adverse Event|0|||
163110223|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Adverse Event|2|||
163110224|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Adverse Event|0|||
163110225|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Death|0|||
163110226|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Death|10|||
163110227|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Death|8|||
163110228|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Physician Decision|0|||
163110229|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Physician Decision|0|||
163110230|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Physician Decision|4|||
163110231|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
163407888|NCT00328627|590203962|FG001|Overall Study|Hyperglycemic Rescue|18|||
163407889|NCT00328627|590203963|FG002|Overall Study|Hyperglycemic Rescue|16|||
163110232|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
163110233|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
163110234|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Moved to another town|0|||
163110235|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Moved to another town|1|||
163110236|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Moved to another town|0|||
163222198|NCT00082433|589529841|FG001|Overall Study|Death|18|||
163222199|NCT00082433|589529840|FG000|Overall Study|Disease Progression/Relapse|270|||
163222200|NCT00082433|589529841|FG001|Overall Study|Disease Progression/Relapse|388|||
163222201|NCT00082433|589529840|FG000|Overall Study|Physician Decision|50|||
163222202|NCT00082433|589529841|FG001|Overall Study|Physician Decision|61|||
163222203|NCT00082433|589529840|FG000|Overall Study|Lost to Follow-up|1|||
163222204|NCT00082433|589529841|FG001|Overall Study|Lost to Follow-up|2|||
163222205|NCT00082433|589529840|FG000|Overall Study|Study Drug Toxicity|179|||
163222206|NCT00082433|589529841|FG001|Overall Study|Study Drug Toxicity|66|||
163222207|NCT00082433|589529840|FG000|Overall Study|Withdrawal by Subject|55|||
163222208|NCT00082433|589529841|FG001|Overall Study|Withdrawal by Subject|30|||
163222209|NCT00082433|589529840|FG000|Overall Study|Still On Treatment|2|||
163222210|NCT00082433|589529841|FG001|Overall Study|Still On Treatment|1|||
163222211|NCT00082433|589529840|FG000|Overall Study|Not Treated|12|||
163222212|NCT00082433|589529841|FG001|Overall Study|Not Treated|11|||
163222213|NCT00082433|589529840|FG000|Overall Study|Ineligible|2|||
163222214|NCT00082433|589529841|FG001|Overall Study|Ineligible|1|||
163222215|NCT00082433|589529840|FG000|Overall Study|Noncompliance|2|||
163222216|NCT00082433|589529841|FG001|Overall Study|Noncompliance|1|||
163222217|NCT00082433|589529840|FG000|Overall Study|New primary cancer|1|||
163222218|NCT00082433|589529841|FG001|Overall Study|New primary cancer|0|||
163110237|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Disease progression|0|||
163110238|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Disease progression|0|||
163110239|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Disease progression|3|||
163110240|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
163110241|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
163110242|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
163110243|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
163110244|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
163110245|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
163110246|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
163110247|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
163110248|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
163110249|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
163110250|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
163110251|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
163110252|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
163110253|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
163110254|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
163110255|NCT00539513|589110126|FG000|Overall Study|Withdrawal by Subject|2|||
163110256|NCT00539513|589110127|FG001|Overall Study|Withdrawal by Subject|1|||
163110257|NCT00539513|589110126|FG000|Overall Study|Lost to Follow-up|0|||
163110258|NCT00539513|589110127|FG001|Overall Study|Lost to Follow-up|1|||
163110259|NCT01801436|589110134|FG000|Overall Study|Withdrawal by Subject|3|||
163110260|NCT01801436|589110134|FG000|Overall Study|Adverse Event|2|||
163110261|NCT01801436|589110134|FG000|Overall Study|Progressive disease|4|||
163110262|NCT04085458|589110137|FG000|Overall Study|Other|1|||
163110263|NCT04085458|589110137|FG000|Overall Study|Withdrawal by Subject|2|||
163110264|NCT04085458|589110137|FG000|Overall Study|Adverse Event|2|||
163110265|NCT02447250|589110138|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
163110266|NCT02447250|589110138|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
163110267|NCT02447250|589110138|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
163110268|NCT01921218|589110139|FG000|Overall Study|Death|2|||
163110269|NCT01921218|589110140|FG001|Overall Study|Death|1|||
163110270|NCT01921218|589110139|FG000|Overall Study|Withdrawal by Subject|0|||
163110271|NCT01921218|589110140|FG001|Overall Study|Withdrawal by Subject|2|||
163110272|NCT01921218|589110139|FG000|Overall Study|Kidney transplant|1|||
163110273|NCT01921218|589110140|FG001|Overall Study|Kidney transplant|1|||
163222219|NCT00082433|589529840|FG000|Overall Study|Impending surgery|0|||
163222220|NCT00082433|589529841|FG001|Overall Study|Impending surgery|1|||
163222221|NCT01796197|589529844|FG000|Overall Study|Lost to Follow-up|1|||
163222222|NCT01796197|589529844|FG000|Overall Study|Lack of Efficacy|1|||
163222223|NCT04097821|589529845|FG000|Overall Study|Subject Decision|0|||
163222224|NCT04097821|589529846|FG001|Overall Study|Subject Decision|0|||
163222225|NCT04097821|589529847|FG002|Overall Study|Subject Decision|0|||
163110274|NCT03389555|589110141|FG000|Overall Study|Protocol Violation|1|||
163222226|NCT04097821|589529848|FG003|Overall Study|Subject Decision|1|||
163222227|NCT04097821|589529849|FG004|Overall Study|Subject Decision|2|||
163222228|NCT04097821|589529850|FG005|Overall Study|Subject Decision|2|||
163222229|NCT04097821|589529851|FG006|Overall Study|Subject Decision|0|||
163222230|NCT04097821|589529852|FG007|Overall Study|Subject Decision|1|||
163110275|NCT03389555|589110142|FG001|Overall Study|Protocol Violation|3|||
163110276|NCT03389555|589110141|FG000|Overall Study|Death|1|||
163110277|NCT03389555|589110142|FG001|Overall Study|Death|0|||
163110278|NCT01885208|589110143|FG000|Overall Study|Unclassified|32|||
163110279|NCT01885208|589110144|FG001|Overall Study|Unclassified|38|||
163222231|NCT04097821|589529845|FG000|Overall Study|Death|0|||
163110280|NCT00920218|589110149|FG000|Overall Study|Serious Adverse Event|2|||
163110281|NCT00920218|589110150|FG001|Overall Study|Serious Adverse Event|0|||
163110282|NCT00920218|589110151|FG002|Overall Study|Serious Adverse Event|2|||
163110283|NCT00920218|589110152|FG003|Overall Study|Serious Adverse Event|1|||
163110284|NCT00920218|589110149|FG000|Overall Study|Withdrawal by Subject|0|||
163110285|NCT00920218|589110150|FG001|Overall Study|Withdrawal by Subject|3|||
163110286|NCT00920218|589110151|FG002|Overall Study|Withdrawal by Subject|2|||
163110287|NCT00920218|589110152|FG003|Overall Study|Withdrawal by Subject|0|||
163110288|NCT00920218|589110149|FG000|Overall Study|Migrated/moved from study area|0|||
163110289|NCT00920218|589110150|FG001|Overall Study|Migrated/moved from study area|0|||
163110290|NCT00920218|589110151|FG002|Overall Study|Migrated/moved from study area|1|||
163110291|NCT00920218|589110152|FG003|Overall Study|Migrated/moved from study area|0|||
163110292|NCT00920218|589110149|FG000|Overall Study|Lost to Follow-up|0|||
163110293|NCT00920218|589110150|FG001|Overall Study|Lost to Follow-up|1|||
163110294|NCT00920218|589110151|FG002|Overall Study|Lost to Follow-up|0|||
163110295|NCT00920218|589110152|FG003|Overall Study|Lost to Follow-up|3|||
163110296|NCT00920218|589110149|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
163110297|NCT00920218|589110150|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
163110298|NCT00920218|589110151|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
163110299|NCT00920218|589110152|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
163110300|NCT00920218|589110149|FG000|Overall Study|Other|0|||
163110301|NCT00920218|589110150|FG001|Overall Study|Other|0|||
163110302|NCT00920218|589110151|FG002|Overall Study|Other|1|||
163110303|NCT00920218|589110152|FG003|Overall Study|Other|0|||
163110304|NCT00923975|589110153|FG000|Overall Study|Did not meet inclusion criteria|1|||
163110305|NCT00960011|589110156|FG000|Overall Study|Death|5|||
163110306|NCT00960011|589110157|FG001|Overall Study|Death|0|||
163110307|NCT00960011|589110156|FG000|Overall Study|Lost to Follow-up|6|||
163110308|NCT00960011|589110157|FG001|Overall Study|Lost to Follow-up|2|||
163110309|NCT04417218|589110161|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
163110310|NCT04417218|589110162|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
163110311|NCT00873041|589110163|FG000|Core Study|Adverse Event|2|||
163110312|NCT00873041|589110164|FG001|Core Study|Adverse Event|3|||
163110313|NCT00873041|589110165|FG002|Core Study|Adverse Event|1|||
163110314|NCT00873041|589110163|FG000|Core Study|Withdrawal by Subject|1|||
163110315|NCT00873041|589110164|FG001|Core Study|Withdrawal by Subject|2|||
163110316|NCT00873041|589110165|FG002|Core Study|Withdrawal by Subject|2|||
163110317|NCT00873041|589110163|FG000|Core Study|Lost to Follow-up|3|||
163110318|NCT00873041|589110164|FG001|Core Study|Lost to Follow-up|1|||
163110319|NCT00873041|589110165|FG002|Core Study|Lost to Follow-up|0|||
163110320|NCT00873041|589110163|FG000|Core Study|Abnormal laboratory value|0|||
163110321|NCT00873041|589110164|FG001|Core Study|Abnormal laboratory value|0|||
163110322|NCT00873041|589110165|FG002|Core Study|Abnormal laboratory value|1|||
163110323|NCT00873041|589110163|FG000|Core Study|Protocol deviation|1|||
163110324|NCT00873041|589110164|FG001|Core Study|Protocol deviation|0|||
163110325|NCT00873041|589110165|FG002|Core Study|Protocol deviation|1|||
163110326|NCT00873041|589110163|FG000|Extension Study|Adverse Event|1|||
163110327|NCT00873041|589110164|FG001|Extension Study|Adverse Event|0|||
163110328|NCT00873041|589110165|FG002|Extension Study|Adverse Event|1|||
163110329|NCT00873041|589110163|FG000|Extension Study|Administrative reasons|0|||
163110330|NCT00873041|589110164|FG001|Extension Study|Administrative reasons|0|||
163110331|NCT00873041|589110165|FG002|Extension Study|Administrative reasons|1|||
163110332|NCT02449889|589110168|FG000|Overall Study|Adverse Event|1|||
163110333|NCT02449889|589110169|FG001|Overall Study|Adverse Event|2|||
163110334|NCT02449889|589110170|FG002|Overall Study|Adverse Event|0|||
163110335|NCT02449889|589110168|FG000|Overall Study|Protocol Violation|0|||
163110336|NCT02449889|589110169|FG001|Overall Study|Protocol Violation|4|||
163110337|NCT02449889|589110170|FG002|Overall Study|Protocol Violation|1|||
163110338|NCT00758264|589110171|FG000|Active Phase|Withdrawal by Subject|0|||
163110339|NCT00758264|589110172|FG001|Active Phase|Withdrawal by Subject|0|||
163110340|NCT00758264|589110173|FG002|Active Phase|Withdrawal by Subject|1|||
163110341|NCT00758264|589110171|FG000|Active Phase|Lost to Follow-up|1|||
163110342|NCT00758264|589110172|FG001|Active Phase|Lost to Follow-up|0|||
163110343|NCT00758264|589110173|FG002|Active Phase|Lost to Follow-up|0|||
163110344|NCT00758264|589110171|FG000|Active Phase|Other|0|||
163110345|NCT00758264|589110172|FG001|Active Phase|Other|0|||
163110346|NCT00758264|589110173|FG002|Active Phase|Other|4|||
163110347|NCT01082874|589110179|FG000|Overall Study|Lost to Follow-up|10|||
163110348|NCT01082874|589110180|FG001|Overall Study|Lost to Follow-up|10|||
163110349|NCT01082874|589110181|FG002|Overall Study|Lost to Follow-up|6|||
163110350|NCT01082874|589110182|FG003|Overall Study|Lost to Follow-up|10|||
163110351|NCT01082874|589110179|FG000|Overall Study|Withdrawal by Subject|1|||
163110352|NCT01082874|589110180|FG001|Overall Study|Withdrawal by Subject|2|||
163110353|NCT01082874|589110181|FG002|Overall Study|Withdrawal by Subject|5|||
163110354|NCT01082874|589110182|FG003|Overall Study|Withdrawal by Subject|3|||
163110355|NCT03176472|589110189|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
163110356|NCT03176472|589110190|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
163110357|NCT03176472|589110189|FG000|Double Blind Treatment Period|Adverse Event|0|||
163110358|NCT03176472|589110190|FG001|Double Blind Treatment Period|Adverse Event|5|||
163110359|NCT03176472|589110189|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
163110360|NCT03176472|589110190|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
163110361|NCT03176472|589110189|FG000|Double Blind Treatment Period|Physician Decision|0|||
163110362|NCT03176472|589110190|FG001|Double Blind Treatment Period|Physician Decision|1|||
163110363|NCT03176472|589110189|FG000|Double Blind Treatment Period|Protocol Violation|1|||
163110364|NCT03176472|589110190|FG001|Double Blind Treatment Period|Protocol Violation|0|||
163110365|NCT03176472|589110189|FG000|Double Blind Treatment Period|Not Provided|1|||
163110366|NCT03176472|589110190|FG001|Double Blind Treatment Period|Not Provided|0|||
163110367|NCT03176472|589110189|FG000|Open Label Extension|Withdrawal by Subject|3|||
163110368|NCT03176472|589110190|FG001|Open Label Extension|Withdrawal by Subject|4|||
163110369|NCT03176472|589110189|FG000|Open Label Extension|Adverse Event|2|||
163110370|NCT03176472|589110190|FG001|Open Label Extension|Adverse Event|4|||
163110371|NCT03176472|589110189|FG000|Open Label Extension|Lost to Follow-up|1|||
163110372|NCT03176472|589110190|FG001|Open Label Extension|Lost to Follow-up|2|||
163110373|NCT03176472|589110189|FG000|Open Label Extension|Protocol Violation|0|||
163110374|NCT03176472|589110190|FG001|Open Label Extension|Protocol Violation|1|||
163110375|NCT03176472|589110189|FG000|Open Label Extension|Not Provided|2|||
163110376|NCT03176472|589110190|FG001|Open Label Extension|Not Provided|1|||
163110377|NCT01846663|589110191|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
163110378|NCT01846663|589110192|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
163110379|NCT01846663|589110191|FG000|Overall Study|Withdrawal by Subject|1|||
163110380|NCT01846663|589110192|FG001|Overall Study|Withdrawal by Subject|0|||
163110381|NCT01846663|589110191|FG000|Overall Study|Adverse Event|1|||
163110382|NCT01846663|589110192|FG001|Overall Study|Adverse Event|2|||
163110383|NCT04295681|589110206|FG000|Overall Study|Eligibility error|1|||
163110384|NCT04295681|589110207|FG001|Overall Study|Eligibility error|3|||
163110385|NCT02210689|589110214|FG000|Overall Study|Withdrawal by Subject|7|||
163110386|NCT02210689|589110215|FG001|Overall Study|Withdrawal by Subject|4|||
163110387|NCT02210689|589110216|FG002|Overall Study|Withdrawal by Subject|2|||
163110388|NCT02210689|589110214|FG000|Overall Study|Adverse Event|0|||
163110389|NCT02210689|589110215|FG001|Overall Study|Adverse Event|1|||
163110390|NCT02210689|589110216|FG002|Overall Study|Adverse Event|0|||
163110391|NCT02210689|589110214|FG000|Overall Study|Protocol Violation|1|||
163110392|NCT02210689|589110215|FG001|Overall Study|Protocol Violation|0|||
163110393|NCT02210689|589110216|FG002|Overall Study|Protocol Violation|0|||
163110394|NCT02210689|589110214|FG000|Overall Study|Lost to Follow-up|11|||
163110395|NCT02210689|589110215|FG001|Overall Study|Lost to Follow-up|9|||
163110396|NCT02210689|589110216|FG002|Overall Study|Lost to Follow-up|5|||
163110397|NCT02210689|589110214|FG000|Overall Study|Pregnancy|0|||
163110398|NCT02210689|589110215|FG001|Overall Study|Pregnancy|1|||
163110399|NCT02210689|589110216|FG002|Overall Study|Pregnancy|0|||
163110400|NCT02210689|589110214|FG000|Overall Study|Lack of Efficacy|0|||
163110401|NCT02210689|589110215|FG001|Overall Study|Lack of Efficacy|1|||
163110402|NCT02210689|589110216|FG002|Overall Study|Lack of Efficacy|5|||
163110403|NCT02210689|589110214|FG000|Overall Study|Prohibited medication|2|||
163110404|NCT02210689|589110215|FG001|Overall Study|Prohibited medication|8|||
163110405|NCT02210689|589110216|FG002|Overall Study|Prohibited medication|1|||
163110406|NCT02210689|589110214|FG000|Overall Study|Negative Nugent score at baseline|6|||
163110407|NCT02210689|589110215|FG001|Overall Study|Negative Nugent score at baseline|2|||
163110408|NCT02210689|589110216|FG002|Overall Study|Negative Nugent score at baseline|2|||
163110409|NCT02210689|589110214|FG000|Overall Study|Other|25|||
163110410|NCT02210689|589110215|FG001|Overall Study|Other|21|||
163110411|NCT02210689|589110216|FG002|Overall Study|Other|8|||
163110412|NCT00675441|589110217|FG000|Overall Study|Withdrawal by Subject|2|||
163110413|NCT00675441|589110217|FG000|Overall Study|Death|1|||
163110414|NCT01923363|589110218|FG000|Overall Study|Protocol Violation|1|||
163110415|NCT00866047|589110220|FG000|Treatment Period|Progressive disease|13|||
163110416|NCT00866047|589110220|FG000|Treatment Period|Adverse Event|16|||
163110417|NCT00866047|589110220|FG000|Treatment Period|Physician Decision|14|||
163110418|NCT00866047|589110220|FG000|Treatment Period|Withdrawal by Subject|5|||
163110419|NCT00866047|589110220|FG000|Follow-up Period|Lost to Follow-up|5|||
163110420|NCT02928029|589110221|FG000|Overall Study|Withdrawal by Subject|0|||
163110421|NCT02928029|589110222|FG001|Overall Study|Withdrawal by Subject|1|||
163110422|NCT02928029|589110221|FG000|Overall Study|Radiological progression|1|||
163110423|NCT02928029|589110222|FG001|Overall Study|Radiological progression|0|||
163110424|NCT02928029|589110221|FG000|Overall Study|Clinical progression|1|||
163110425|NCT02928029|589110222|FG001|Overall Study|Clinical progression|2|||
163110426|NCT02928029|589110221|FG000|Overall Study|AE not related to clinical progression|1|||
163110427|NCT02928029|589110222|FG001|Overall Study|AE not related to clinical progression|1|||
163110428|NCT05427539|589110224|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
163110429|NCT05427539|589110225|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
163110430|NCT05427539|589110224|FG000|Period 1|Withdrawal by Subject|1|||
163110431|NCT05427539|589110225|FG001|Period 1|Withdrawal by Subject|0|||
163110432|NCT03718884|589110226|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
163110433|NCT03718884|589110227|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
163339905|NCT03146845|589953101|FG000|Overall Study|Physician Decision|1|||
163110434|NCT03718884|589110226|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
163110435|NCT03718884|589110227|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
163110436|NCT02099344|589110228|FG000|Overall Study|Physician Decision|1|||
163110437|NCT02099344|589110229|FG001|Overall Study|Physician Decision|0|||
163110438|NCT00404755|589110234|FG000|Phase I (Bupropion)|Adverse Event|3|||
163110439|NCT00404755|589110234|FG000|Phase I (Bupropion)|Other|1|||
163110440|NCT00404755|589110234|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
163110441|NCT04376684|589110237|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
163110442|NCT04376684|589110238|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
163110443|NCT04376684|589110239|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
163110444|NCT04376684|589110240|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
163110445|NCT04376684|589110237|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
163110446|NCT04376684|589110238|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
163110447|NCT04376684|589110239|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
163110448|NCT04376684|589110240|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
163110449|NCT04376684|589110237|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
163110450|NCT04376684|589110238|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
163110451|NCT04376684|589110239|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
163110452|NCT04376684|589110240|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
163110453|NCT04376684|589110237|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
163110454|NCT04376684|589110238|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
163110455|NCT04376684|589110239|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
163110456|NCT04376684|589110240|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
163110457|NCT04376684|589110237|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
163110458|NCT04376684|589110238|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
163110459|NCT04376684|589110239|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
163110460|NCT04376684|589110240|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
163110461|NCT04376684|589110237|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
163110462|NCT04376684|589110238|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
163110463|NCT04376684|589110239|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
163110464|NCT04376684|589110240|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
163110465|NCT04376684|589110237|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
163110466|NCT04376684|589110238|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
163110467|NCT04376684|589110239|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
163110468|NCT04376684|589110240|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
163110469|NCT01666119|589110241|FG000|Overall Study|Adverse Event|6|||
163110470|NCT01666119|589110241|FG000|Overall Study|Withdrawal by Subject|16|||
163110471|NCT01666119|589110241|FG000|Overall Study|Lost to Follow-up|7|||
163110472|NCT01666119|589110241|FG000|Overall Study|non compliance with study medication, pa|18|||
163110473|NCT01666119|589110241|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
163110474|NCT02602275|589110254|FG000|Day 1|Physician Decision|0|||
163110475|NCT02602275|589110255|FG001|Day 1|Physician Decision|1|||
163110476|NCT02241733|589110257|FG000|Overall Study|Lost to Follow-up|9|||
163110477|NCT02241733|589110258|FG001|Overall Study|Lost to Follow-up|4|||
163110478|NCT02241733|589110257|FG000|Overall Study|Physician Decision|6|||
163110479|NCT02241733|589110258|FG001|Overall Study|Physician Decision|2|||
163110480|NCT02241733|589110257|FG000|Overall Study|Withdrawal by Subject|0|||
163110481|NCT02241733|589110258|FG001|Overall Study|Withdrawal by Subject|2|||
163110482|NCT02241733|589110257|FG000|Overall Study|Death|0|||
163110483|NCT02241733|589110258|FG001|Overall Study|Death|2|||
163110484|NCT01866111|589110263|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
163110485|NCT01866111|589110264|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
163110486|NCT01866111|589110265|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
163110487|NCT01866111|589110266|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
163110488|NCT01866111|589110263|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
163110489|NCT01866111|589110264|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
163110490|NCT01866111|589110265|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
163110491|NCT01866111|589110266|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
163110492|NCT01866111|589110263|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
163339906|NCT03146845|589953102|FG001|Overall Study|Physician Decision|0|||
163110493|NCT01866111|589110264|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
163110494|NCT01866111|589110265|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
163110495|NCT01866111|589110266|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
163110496|NCT01866111|589110263|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
163110497|NCT01866111|589110264|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
163110498|NCT01866111|589110265|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
163110499|NCT01866111|589110266|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
163339907|NCT03146845|589953101|FG000|Overall Study|Adverse Event|1|||
163339908|NCT03146845|589953102|FG001|Overall Study|Adverse Event|0|||
163110500|NCT01866111|589110263|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
163110501|NCT01866111|589110264|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
163222232|NCT04097821|589529846|FG001|Overall Study|Death|0|||
163110502|NCT01866111|589110265|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
163110503|NCT01866111|589110266|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
163110504|NCT01866111|589110263|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
163110505|NCT01866111|589110264|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
163110506|NCT01866111|589110265|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
163110507|NCT01866111|589110266|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
163110508|NCT01866111|589110263|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
163110509|NCT01866111|589110264|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
163110510|NCT01866111|589110265|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
163110511|NCT01866111|589110266|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
163110512|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
163110513|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
163110514|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
163110515|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
163110516|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
163110517|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
163110518|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
163110519|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
163110520|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
163110521|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
163110522|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
163110523|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
163110524|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
163110525|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
163110526|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
163110527|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
163110528|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Death|1|||
163110529|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Death|1|||
163110530|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Death|3|||
163110531|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Death|2|||
163110532|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
163110533|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
163110534|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
163110535|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
163110536|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
163110537|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
163110538|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
163110539|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
163110540|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
163110541|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
163110542|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
163110543|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
163110544|NCT00516906|589110269|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
163110545|NCT00516906|589110270|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
163110546|NCT01974206|589110271|FG000|Overall Study|Did Not Take Study Drug|0|||
163110547|NCT01974206|589110272|FG001|Overall Study|Did Not Take Study Drug|1|||
163110548|NCT01974206|589110271|FG000|Overall Study|Physician Decision|1|||
163110549|NCT01974206|589110272|FG001|Overall Study|Physician Decision|0|||
163110550|NCT01974206|589110271|FG000|Overall Study|Withdrawal by Subject|3|||
163110551|NCT01974206|589110272|FG001|Overall Study|Withdrawal by Subject|0|||
163110552|NCT01974206|589110271|FG000|Overall Study|Lost to Follow-up|1|||
163110553|NCT01974206|589110272|FG001|Overall Study|Lost to Follow-up|0|||
163110554|NCT01974206|589110271|FG000|Overall Study|Death|1|||
163110555|NCT01974206|589110272|FG001|Overall Study|Death|0|||
163110556|NCT04113018|589110273|FG000|Overall Study|Death|2|||
163110557|NCT04113018|589110273|FG000|Overall Study|Lost to Follow-up|1|||
163110558|NCT04113018|589110273|FG000|Overall Study|Still On Study (on study treatment)|24|||
163110559|NCT04113018|589110273|FG000|Overall Study|Still On Study (in follow up)|12|||
163110560|NCT03802630|589110274|FG000|Overall Study|Study terminated by sponsor|130|||
163222233|NCT04097821|589529847|FG002|Overall Study|Death|3|||
163222234|NCT04097821|589529848|FG003|Overall Study|Death|1|||
163110561|NCT03802630|589110275|FG001|Overall Study|Study terminated by sponsor|134|||
163110562|NCT03802630|589110274|FG000|Overall Study|Subject decision|16|||
163110563|NCT03802630|589110275|FG001|Overall Study|Subject decision|9|||
163110564|NCT03802630|589110274|FG000|Overall Study|Adverse Event|3|||
163110565|NCT03802630|589110275|FG001|Overall Study|Adverse Event|1|||
163110566|NCT03802630|589110274|FG000|Overall Study|Lost to Follow-up|2|||
163110567|NCT03802630|589110275|FG001|Overall Study|Lost to Follow-up|2|||
163407890|NCT00328627|590203964|FG003|Overall Study|Hyperglycemic Rescue|13|||
163110568|NCT03802630|589110274|FG000|Overall Study|Physician Decision|2|||
163110569|NCT03802630|589110275|FG001|Overall Study|Physician Decision|0|||
163110570|NCT03802630|589110274|FG000|Overall Study|Death|0|||
163110571|NCT03802630|589110275|FG001|Overall Study|Death|2|||
163110572|NCT00157196|589110276|FG000|Overall Study|Ongoing at data cut-off|9|||
163110573|NCT06099223|589110277|FG000|Overall Study|Preoperative surveys missed|0|||
163110574|NCT06099223|589110278|FG001|Overall Study|Preoperative surveys missed|1|||
163110575|NCT00583752|589110279|FG000|Overall Study|Lost to Follow-up|5|||
163110576|NCT00583752|589110280|FG001|Overall Study|Lost to Follow-up|5|||
163110577|NCT00526656|589110281|FG000|Overall Study|Death|1|||
163110578|NCT00526656|589110281|FG000|Overall Study|Refused surgery|1|||
163110579|NCT04091581|589110282|FG000|Overall Study|Lost to Follow-up|0|||
163110580|NCT04091581|589110283|FG001|Overall Study|Lost to Follow-up|1|||
163110581|NCT01795495|589110284|FG000|Overall Study|Protocol Violation|1|||
163110582|NCT01795495|589110285|FG001|Overall Study|Protocol Violation|0|||
163110583|NCT01795495|589110286|FG002|Overall Study|Protocol Violation|1|||
163110584|NCT01795495|589110284|FG000|Overall Study|Physician Decision|0|||
163110585|NCT01795495|589110285|FG001|Overall Study|Physician Decision|0|||
163110586|NCT01795495|589110286|FG002|Overall Study|Physician Decision|1|||
163110587|NCT01331837|589110287|FG000|Overall Study|Death|30|||
163110588|NCT01331837|589110288|FG001|Overall Study|Death|34|||
163110589|NCT01331837|589110287|FG000|Overall Study|Lost to Follow-up|3|||
163110590|NCT01331837|589110288|FG001|Overall Study|Lost to Follow-up|1|||
163110591|NCT01331837|589110287|FG000|Overall Study|Info not recorded|10|||
163110592|NCT01331837|589110288|FG001|Overall Study|Info not recorded|16|||
163110593|NCT01331837|589110287|FG000|Overall Study|Withdrawal by Subject|13|||
163110594|NCT01331837|589110288|FG001|Overall Study|Withdrawal by Subject|16|||
163110595|NCT00711113|589112196|FG000|Overall Study|Lost to Follow-up|9|||
163110596|NCT00711113|589112196|FG000|Overall Study|Implant lost|2|||
163110597|NCT02456636|589112197|FG000|Overall Study|Death|0|||
163110598|NCT02456636|589112198|FG001|Overall Study|Death|3|||
163110599|NCT02456636|589112199|FG002|Overall Study|Death|0|||
163110600|NCT02456636|589112197|FG000|Overall Study|Pregnancy|1|||
163110601|NCT02456636|589112198|FG001|Overall Study|Pregnancy|3|||
163110602|NCT02456636|589112199|FG002|Overall Study|Pregnancy|5|||
163110603|NCT02456636|589112197|FG000|Overall Study|Physician Decision|4|||
163110604|NCT02456636|589112198|FG001|Overall Study|Physician Decision|5|||
163110605|NCT02456636|589112199|FG002|Overall Study|Physician Decision|4|||
163110606|NCT02456636|589112197|FG000|Overall Study|Withdrawal by Subject|13|||
163110607|NCT02456636|589112198|FG001|Overall Study|Withdrawal by Subject|14|||
163110608|NCT02456636|589112199|FG002|Overall Study|Withdrawal by Subject|16|||
163110609|NCT02456636|589112197|FG000|Overall Study|Lost to Follow-up|50|||
163110610|NCT02456636|589112198|FG001|Overall Study|Lost to Follow-up|44|||
163110611|NCT02456636|589112199|FG002|Overall Study|Lost to Follow-up|50|||
163110612|NCT05312632|589112202|FG000|Overall Study|Adverse Event|12|||
163110613|NCT05312632|589112202|FG000|Overall Study|Withdrawal by Subject|10|||
163110614|NCT05312632|589112202|FG000|Overall Study|Lack of Efficacy|4|||
163110615|NCT05312632|589112202|FG000|Overall Study|Non-compliance with study procedures|9|||
163110616|NCT05312632|589112202|FG000|Overall Study|Other|4|||
163110617|NCT02379221|589112203|FG000|Overall Study|Lost to Follow-up|1|||
163110618|NCT00519376|589112204|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110619|NCT00519376|589112205|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110620|NCT00519376|589112206|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110621|NCT00519376|589112207|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110622|NCT00519376|589112208|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110623|NCT00519376|589112209|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110624|NCT00519376|589112210|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110625|NCT00519376|589112211|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110626|NCT00519376|589112212|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110627|NCT00519376|589112213|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110628|NCT00519376|589112214|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110629|NCT00519376|589112215|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110630|NCT00519376|589112216|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
163110631|NCT00519376|589112217|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110632|NCT00519376|589112218|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110633|NCT00519376|589112219|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110634|NCT00519376|589112204|FG000|Treatment Period 4|Lost to Follow-up|0|||
163110635|NCT00519376|589112205|FG001|Treatment Period 4|Lost to Follow-up|0|||
163110636|NCT00519376|589112206|FG002|Treatment Period 4|Lost to Follow-up|1|||
163110637|NCT00519376|589112207|FG003|Treatment Period 4|Lost to Follow-up|0|||
163110638|NCT00519376|589112208|FG004|Treatment Period 4|Lost to Follow-up|0|||
163110639|NCT00519376|589112209|FG005|Treatment Period 4|Lost to Follow-up|0|||
163110640|NCT00519376|589112210|FG006|Treatment Period 4|Lost to Follow-up|0|||
163222235|NCT04097821|589529849|FG004|Overall Study|Death|0|||
163222236|NCT04097821|589529850|FG005|Overall Study|Death|0|||
163222237|NCT04097821|589529851|FG006|Overall Study|Death|0|||
163222238|NCT04097821|589529852|FG007|Overall Study|Death|0|||
163222239|NCT04097821|589529845|FG000|Overall Study|Physician Decision|1|||
163222240|NCT04097821|589529846|FG001|Overall Study|Physician Decision|2|||
163222241|NCT04097821|589529847|FG002|Overall Study|Physician Decision|0|||
163222242|NCT04097821|589529848|FG003|Overall Study|Physician Decision|0|||
163222243|NCT04097821|589529849|FG004|Overall Study|Physician Decision|0|||
163222244|NCT04097821|589529850|FG005|Overall Study|Physician Decision|0|||
163222245|NCT04097821|589529851|FG006|Overall Study|Physician Decision|0|||
163222246|NCT04097821|589529852|FG007|Overall Study|Physician Decision|0|||
163222247|NCT04097821|589529845|FG000|Overall Study|Adverse Event|0|||
163222248|NCT04097821|589529846|FG001|Overall Study|Adverse Event|0|||
163222249|NCT04097821|589529847|FG002|Overall Study|Adverse Event|1|||
163222250|NCT04097821|589529848|FG003|Overall Study|Adverse Event|1|||
163222251|NCT04097821|589529849|FG004|Overall Study|Adverse Event|0|||
163222252|NCT04097821|589529850|FG005|Overall Study|Adverse Event|0|||
163222253|NCT04097821|589529851|FG006|Overall Study|Adverse Event|0|||
163222254|NCT04097821|589529852|FG007|Overall Study|Adverse Event|0|||
163222255|NCT04097821|589529845|FG000|Overall Study|New Therapy For Study Indication|0|||
163222256|NCT04097821|589529846|FG001|Overall Study|New Therapy For Study Indication|0|||
163222257|NCT04097821|589529847|FG002|Overall Study|New Therapy For Study Indication|0|||
163222258|NCT04097821|589529848|FG003|Overall Study|New Therapy For Study Indication|0|||
163222259|NCT04097821|589529849|FG004|Overall Study|New Therapy For Study Indication|0|||
163222260|NCT04097821|589529850|FG005|Overall Study|New Therapy For Study Indication|0|||
163222261|NCT04097821|589529851|FG006|Overall Study|New Therapy For Study Indication|1|||
163222262|NCT04097821|589529852|FG007|Overall Study|New Therapy For Study Indication|0|||
163222263|NCT00244712|589529856|FG000|Overall Study|Adverse Event|20|||
163222264|NCT00244712|589529857|FG001|Overall Study|Adverse Event|21|||
163222265|NCT00244712|589529856|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
163222266|NCT00244712|589529857|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
163222267|NCT00244712|589529856|FG000|Overall Study|Lack of Compliance|10|||
163222268|NCT00244712|589529857|FG001|Overall Study|Lack of Compliance|11|||
163222269|NCT00244712|589529856|FG000|Overall Study|Lost to Follow-up|45|||
163222270|NCT00244712|589529857|FG001|Overall Study|Lost to Follow-up|52|||
163222271|NCT00244712|589529856|FG000|Overall Study|Withdrawal by Subject|13|||
163222272|NCT00244712|589529857|FG001|Overall Study|Withdrawal by Subject|23|||
163222273|NCT00244712|589529856|FG000|Overall Study|Protocol Violation, disease progression|13|||
163222274|NCT00244712|589529857|FG001|Overall Study|Protocol Violation, disease progression|11|||
163222275|NCT01077804|589529860|FG000|Overall Study|Unreachable|102|||
163222276|NCT01077804|589529860|FG000|Overall Study|Refused to continue|79|||
163222277|NCT01077804|589529860|FG000|Overall Study|Other|18|||
163222278|NCT02776917|589529861|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
163222279|NCT00560950|589529864|FG000|Overall Study|Lost to Follow-up|1|||
163222280|NCT00560950|589529865|FG001|Overall Study|Lost to Follow-up|0|||
163222281|NCT02970968|589531436|FG000|Overall Study|Withdrawal by Subject|3|||
163222282|NCT02970968|589531437|FG001|Overall Study|Withdrawal by Subject|3|||
163222283|NCT02970968|589531436|FG000|Overall Study|Adverse Event|1|||
163222284|NCT02970968|589531437|FG001|Overall Study|Adverse Event|2|||
163339909|NCT03146845|589953101|FG000|Overall Study|Withdrawal by Subject|2|||
163339910|NCT03146845|589953102|FG001|Overall Study|Withdrawal by Subject|0|||
163339911|NCT03146845|589953101|FG000|Overall Study|Noncompliance|0|||
163339912|NCT03146845|589953102|FG001|Overall Study|Noncompliance|1|||
163339913|NCT03146845|589953101|FG000|Overall Study|Protocol Violation|0|||
163339914|NCT03146845|589953102|FG001|Overall Study|Protocol Violation|2|||
163339915|NCT03146845|589953101|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
163339916|NCT03146845|589953102|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
163339917|NCT01052272|589953106|FG000|Overall Study|Death|0|||
163339918|NCT01052272|589953107|FG001|Overall Study|Death|0|||
163339919|NCT01052272|589953108|FG002|Overall Study|Death|1|||
163222285|NCT02970968|589531436|FG000|Overall Study|Lost to Follow-up|1|||
163339920|NCT01052272|589953109|FG003|Overall Study|Death|1|||
163222286|NCT02970968|589531437|FG001|Overall Study|Lost to Follow-up|1|||
163222287|NCT02970968|589531436|FG000|Overall Study|Non-Compliance|0|||
163222288|NCT02970968|589531437|FG001|Overall Study|Non-Compliance|1|||
163222289|NCT03003520|589531438|FG000|Overall Study|Adverse Event|9|||
163222290|NCT03003520|589531439|FG001|Overall Study|Adverse Event|0|||
163222291|NCT03003520|589531438|FG000|Overall Study|Death|1|||
163339921|NCT01052272|589953106|FG000|Overall Study|Physician Decision|0|||
163339922|NCT01052272|589953107|FG001|Overall Study|Physician Decision|1|||
163339923|NCT01052272|589953108|FG002|Overall Study|Physician Decision|0|||
163222292|NCT03003520|589531439|FG001|Overall Study|Death|0|||
163222293|NCT03003520|589531438|FG000|Overall Study|Other reasons|4|||
163222294|NCT03003520|589531439|FG001|Overall Study|Other reasons|0|||
163222295|NCT03003520|589531438|FG000|Overall Study|Withdrawal by Subject|6|||
163222296|NCT03003520|589531439|FG001|Overall Study|Withdrawal by Subject|0|||
163222297|NCT03003520|589531438|FG000|Overall Study|Progressive disease|9|||
163222298|NCT03003520|589531439|FG001|Overall Study|Progressive disease|1|||
163110641|NCT00519376|589112211|FG007|Treatment Period 4|Lost to Follow-up|0|||
163110642|NCT00519376|589112212|FG008|Treatment Period 4|Lost to Follow-up|0|||
163110643|NCT00519376|589112213|FG009|Treatment Period 4|Lost to Follow-up|0|||
163110644|NCT00519376|589112214|FG010|Treatment Period 4|Lost to Follow-up|0|||
163110645|NCT00519376|589112215|FG011|Treatment Period 4|Lost to Follow-up|0|||
163110646|NCT00519376|589112216|FG012|Treatment Period 4|Lost to Follow-up|0|||
163110647|NCT00519376|589112217|FG013|Treatment Period 4|Lost to Follow-up|0|||
163110648|NCT00519376|589112218|FG014|Treatment Period 4|Lost to Follow-up|0|||
163110649|NCT00519376|589112219|FG015|Treatment Period 4|Lost to Follow-up|0|||
163110650|NCT03812185|589112223|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
163110651|NCT02743949|589112231|FG000|Overall Study|Adverse Event|0|||
163110652|NCT02743949|589112232|FG001|Overall Study|Adverse Event|0|||
163110653|NCT02743949|589112233|FG002|Overall Study|Adverse Event|2|||
163110654|NCT02743949|589112231|FG000|Overall Study|Significant Protocol Deviation|2|||
163110655|NCT02743949|589112232|FG001|Overall Study|Significant Protocol Deviation|0|||
163110656|NCT02743949|589112233|FG002|Overall Study|Significant Protocol Deviation|1|||
163110657|NCT02743949|589112231|FG000|Overall Study|Voluntary Withdrawal|2|||
163110658|NCT02743949|589112232|FG001|Overall Study|Voluntary Withdrawal|1|||
163110659|NCT02743949|589112233|FG002|Overall Study|Voluntary Withdrawal|0|||
163110660|NCT01498575|589112234|FG000|Overall Sample|Withdrawal by Subject|60|||
163110661|NCT01498575|589112235|FG001|Overall Sample|Withdrawal by Subject|14|||
163110662|NCT01498575|589112234|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
163110663|NCT01498575|589112235|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
163110664|NCT01498575|589112234|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
163110665|NCT01498575|589112235|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
163110666|NCT00090142|589112239|FG000|Treatment Period I|Lost to Follow-up|1|||
163110667|NCT00090142|589112240|FG001|Treatment Period I|Lost to Follow-up|2|||
163110668|NCT00090142|589112239|FG000|Treatment Period I|Protocol Violation|2|||
163110669|NCT00090142|589112240|FG001|Treatment Period I|Protocol Violation|0|||
163110670|NCT00090142|589112239|FG000|Treatment Period I|Withdrawal by Subject|2|||
163110671|NCT00090142|589112240|FG001|Treatment Period I|Withdrawal by Subject|0|||
163110672|NCT00090142|589112239|FG000|Treatment Period I|Other|0|||
163110673|NCT00090142|589112240|FG001|Treatment Period I|Other|1|||
163110674|NCT00090142|589112239|FG000|Treatment Period II|Other|1|||
163110675|NCT00090142|589112240|FG001|Treatment Period II|Other|0|||
163110676|NCT01126437|589112241|FG000|Overall Study|Not treated|11|||
163110677|NCT01126437|589112242|FG001|Overall Study|Not treated|18|||
163110678|NCT01126437|589112243|FG002|Overall Study|Not treated|19|||
163110679|NCT01126437|589112241|FG000|Overall Study|Sites with data irregularities/fraud|6|||
163110680|NCT01126437|589112242|FG001|Overall Study|Sites with data irregularities/fraud|6|||
163110681|NCT01126437|589112243|FG002|Overall Study|Sites with data irregularities/fraud|7|||
163110682|NCT01126437|589112241|FG000|Overall Study|Adverse Event|602|||
163110683|NCT01126437|589112242|FG001|Overall Study|Adverse Event|606|||
163110684|NCT01126437|589112243|FG002|Overall Study|Adverse Event|635|||
163110685|NCT01126437|589112241|FG000|Overall Study|Lack of Efficacy|65|||
163110686|NCT01126437|589112242|FG001|Overall Study|Lack of Efficacy|60|||
163110687|NCT01126437|589112243|FG002|Overall Study|Lack of Efficacy|59|||
163110688|NCT01126437|589112241|FG000|Overall Study|Protocol Violation|64|||
163110689|NCT01126437|589112242|FG001|Overall Study|Protocol Violation|66|||
163110690|NCT01126437|589112243|FG002|Overall Study|Protocol Violation|41|||
163110691|NCT01126437|589112241|FG000|Overall Study|Lost to Follow-up|52|||
163110692|NCT01126437|589112242|FG001|Overall Study|Lost to Follow-up|63|||
163110693|NCT01126437|589112243|FG002|Overall Study|Lost to Follow-up|55|||
163110694|NCT01126437|589112241|FG000|Overall Study|Withdrawal by Subject|331|||
163110695|NCT01126437|589112242|FG001|Overall Study|Withdrawal by Subject|335|||
163110696|NCT01126437|589112243|FG002|Overall Study|Withdrawal by Subject|319|||
163110697|NCT01126437|589112241|FG000|Overall Study|Other reason not specified|210|||
163110698|NCT01126437|589112242|FG001|Overall Study|Other reason not specified|176|||
163110699|NCT01126437|589112243|FG002|Overall Study|Other reason not specified|178|||
163110700|NCT00006046|589112249|FG000|Overall Study|Adverse Event|3|||
163110701|NCT00006046|589112250|FG001|Overall Study|Adverse Event|0|||
163110702|NCT00006046|589112251|FG002|Overall Study|Adverse Event|0|||
163110703|NCT00006046|589112252|FG003|Overall Study|Adverse Event|0|||
163110704|NCT00006046|589112253|FG004|Overall Study|Adverse Event|0|||
163110705|NCT00006046|589112249|FG000|Overall Study|Disease Progression|2|||
163110706|NCT00006046|589112250|FG001|Overall Study|Disease Progression|0|||
163110707|NCT00006046|589112251|FG002|Overall Study|Disease Progression|0|||
163110708|NCT00006046|589112252|FG003|Overall Study|Disease Progression|0|||
163110709|NCT00006046|589112253|FG004|Overall Study|Disease Progression|0|||
163110710|NCT00596154|589112254|FG000|Overall Study|Not Evaluable|2|||
163110711|NCT00642369|589112264|FG000|Overall Study|Adverse Event|2|||
163110712|NCT00642369|589112265|FG001|Overall Study|Adverse Event|3|||
163110713|NCT00642369|589112264|FG000|Overall Study|Withdrawal by Subject|1|||
163110714|NCT00642369|589112265|FG001|Overall Study|Withdrawal by Subject|0|||
163110715|NCT00642369|589112264|FG000|Overall Study|misdiagnosis|0|||
163407891|NCT00328627|590203965|FG004|Overall Study|Hyperglycemic Rescue|6|||
163110716|NCT00642369|589112265|FG001|Overall Study|misdiagnosis|1|||
163110717|NCT00642369|589112264|FG000|Overall Study|Lack of Efficacy|2|||
163110718|NCT00642369|589112265|FG001|Overall Study|Lack of Efficacy|2|||
163110719|NCT00996281|589112273|FG000|Overall Study|Adverse Event|75|||
163110720|NCT00996281|589112274|FG001|Overall Study|Adverse Event|37|||
163110721|NCT00996281|589112273|FG000|Overall Study|Major Protocol Deviation|6|||
163110722|NCT00996281|589112274|FG001|Overall Study|Major Protocol Deviation|7|||
163110723|NCT00996281|589112273|FG000|Overall Study|Lost to Follow-up|14|||
163110724|NCT00996281|589112274|FG001|Overall Study|Lost to Follow-up|16|||
163110725|NCT00996281|589112273|FG000|Overall Study|Withdrawal by Subject|31|||
163110726|NCT00996281|589112274|FG001|Overall Study|Withdrawal by Subject|20|||
163110727|NCT00996281|589112273|FG000|Overall Study|Lack of Efficacy|0|||
163110728|NCT00996281|589112274|FG001|Overall Study|Lack of Efficacy|2|||
163110729|NCT00996281|589112273|FG000|Overall Study|Other|5|||
163110730|NCT00996281|589112274|FG001|Overall Study|Other|7|||
163110731|NCT05593913|589112277|FG000|Overall Study|Insufficient image quality|39|||
163110732|NCT01453205|589112278|FG000|Overall Study|Lost to Follow-up|3|||
163110733|NCT01453205|589112279|FG001|Overall Study|Lost to Follow-up|0|||
163110734|NCT01453205|589112280|FG002|Overall Study|Lost to Follow-up|1|||
163110735|NCT01453205|589112278|FG000|Overall Study|Withdrawal by Subject|8|||
163110736|NCT01453205|589112279|FG001|Overall Study|Withdrawal by Subject|3|||
163110737|NCT01453205|589112280|FG002|Overall Study|Withdrawal by Subject|0|||
163110738|NCT01453205|589112278|FG000|Overall Study|Death|24|||
163110739|NCT01453205|589112279|FG001|Overall Study|Death|22|||
163110740|NCT01453205|589112280|FG002|Overall Study|Death|18|||
163110741|NCT01453205|589112278|FG000|Overall Study|Other|45|||
163110742|NCT01453205|589112279|FG001|Overall Study|Other|27|||
163110743|NCT01453205|589112280|FG002|Overall Study|Other|35|||
163110744|NCT04934800|589112283|FG000|Overall Study|Other|1|||
163110745|NCT04934800|589112283|FG000|Overall Study|Withdrawal by Subject|5|||
163110746|NCT04934800|589112283|FG000|Overall Study|Lack of Efficacy|1|||
163110747|NCT04934800|589112283|FG000|Overall Study|Adverse Event|9|||
163110748|NCT04934800|589112283|FG000|Overall Study|Lost to Follow-up|5|||
163110749|NCT04934800|589112283|FG000|Overall Study|Enrolled but not treated|1|||
163110750|NCT05596734|589112284|FG000|Substudy A|Withdrawal by Subject|1|||
163110751|NCT05596734|589112285|FG001|Substudy A|Withdrawal by Subject|0|||
163110752|NCT05596734|589112286|FG002|Substudy A|Withdrawal by Subject|0|||
163110753|NCT05596734|589112287|FG003|Substudy A|Withdrawal by Subject|0|||
163110754|NCT05596734|589112288|FG004|Substudy A|Withdrawal by Subject|0|||
163339924|NCT01052272|589953109|FG003|Overall Study|Physician Decision|0|||
163339925|NCT01052272|589953106|FG000|Overall Study|patient refuses follow-up|5|||
163339926|NCT01052272|589953107|FG001|Overall Study|patient refuses follow-up|4|||
163339927|NCT01052272|589953108|FG002|Overall Study|patient refuses follow-up|2|||
163339928|NCT01052272|589953109|FG003|Overall Study|patient refuses follow-up|4|||
163339929|NCT01052272|589953106|FG000|Overall Study|Withdrawal by Subject|0|||
163110755|NCT05596734|589112289|FG005|Substudy A|Withdrawal by Subject|0|||
163110756|NCT05596734|589112290|FG006|Substudy A|Withdrawal by Subject|1|||
163110757|NCT05596734|589112291|FG007|Substudy A|Withdrawal by Subject|0|||
163110758|NCT05596734|589112292|FG008|Substudy A|Withdrawal by Subject|0|||
163110759|NCT05596734|589112293|FG009|Substudy A|Withdrawal by Subject|0|||
163110760|NCT05596734|589112294|FG010|Substudy A|Withdrawal by Subject|0|||
163110761|NCT05596734|589112295|FG011|Substudy A|Withdrawal by Subject|0|||
163110762|NCT05596734|589112296|FG012|Substudy A|Withdrawal by Subject|0|||
163110763|NCT05596734|589112297|FG013|Substudy A|Withdrawal by Subject|0|||
163110764|NCT05596734|589112298|FG014|Substudy A|Withdrawal by Subject|0|||
163110765|NCT05596734|589112299|FG015|Substudy A|Withdrawal by Subject|0|||
163110766|NCT05596734|589112300|FG016|Substudy A|Withdrawal by Subject|0|||
163110767|NCT05596734|589112301|FG017|Substudy A|Withdrawal by Subject|0|||
163110768|NCT05596734|589112302|FG018|Substudy A|Withdrawal by Subject|0|||
163110769|NCT05596734|589112303|FG019|Substudy A|Withdrawal by Subject|0|||
163110770|NCT05596734|589112304|FG020|Substudy A|Withdrawal by Subject|0|||
163110771|NCT05596734|589112305|FG021|Substudy A|Withdrawal by Subject|0|||
163110772|NCT05596734|589112306|FG022|Substudy A|Withdrawal by Subject|0|||
163110773|NCT05596734|589112307|FG023|Substudy A|Withdrawal by Subject|0|||
163110774|NCT05596734|589112284|FG000|Substudy A|Lost to Follow-up|1|||
163110775|NCT05596734|589112285|FG001|Substudy A|Lost to Follow-up|0|||
163110776|NCT05596734|589112286|FG002|Substudy A|Lost to Follow-up|1|||
163110777|NCT05596734|589112287|FG003|Substudy A|Lost to Follow-up|0|||
163110778|NCT05596734|589112288|FG004|Substudy A|Lost to Follow-up|0|||
163339930|NCT01052272|589953107|FG001|Overall Study|Withdrawal by Subject|2|||
163110779|NCT05596734|589112289|FG005|Substudy A|Lost to Follow-up|0|||
163110780|NCT05596734|589112290|FG006|Substudy A|Lost to Follow-up|0|||
163110781|NCT05596734|589112291|FG007|Substudy A|Lost to Follow-up|0|||
163110782|NCT05596734|589112292|FG008|Substudy A|Lost to Follow-up|0|||
163110783|NCT05596734|589112293|FG009|Substudy A|Lost to Follow-up|0|||
163110784|NCT05596734|589112294|FG010|Substudy A|Lost to Follow-up|0|||
163110785|NCT05596734|589112295|FG011|Substudy A|Lost to Follow-up|0|||
163110786|NCT05596734|589112296|FG012|Substudy A|Lost to Follow-up|0|||
163110787|NCT05596734|589112297|FG013|Substudy A|Lost to Follow-up|0|||
163110788|NCT05596734|589112298|FG014|Substudy A|Lost to Follow-up|0|||
163110789|NCT05596734|589112299|FG015|Substudy A|Lost to Follow-up|0|||
163110790|NCT05596734|589112300|FG016|Substudy A|Lost to Follow-up|0|||
163110791|NCT05596734|589112301|FG017|Substudy A|Lost to Follow-up|0|||
163110792|NCT05596734|589112302|FG018|Substudy A|Lost to Follow-up|0|||
163110793|NCT05596734|589112303|FG019|Substudy A|Lost to Follow-up|0|||
163110794|NCT05596734|589112304|FG020|Substudy A|Lost to Follow-up|0|||
163110795|NCT05596734|589112305|FG021|Substudy A|Lost to Follow-up|0|||
163110796|NCT05596734|589112306|FG022|Substudy A|Lost to Follow-up|0|||
163110797|NCT05596734|589112307|FG023|Substudy A|Lost to Follow-up|0|||
163110798|NCT05596734|589112284|FG000|Substudy B|Withdrawal by Subject|0|||
163110799|NCT05596734|589112285|FG001|Substudy B|Withdrawal by Subject|0|||
163110800|NCT05596734|589112286|FG002|Substudy B|Withdrawal by Subject|0|||
163110801|NCT05596734|589112287|FG003|Substudy B|Withdrawal by Subject|0|||
163110802|NCT05596734|589112288|FG004|Substudy B|Withdrawal by Subject|0|||
163110803|NCT05596734|589112289|FG005|Substudy B|Withdrawal by Subject|0|||
163110804|NCT05596734|589112290|FG006|Substudy B|Withdrawal by Subject|0|||
163110805|NCT05596734|589112291|FG007|Substudy B|Withdrawal by Subject|0|||
163110806|NCT05596734|589112292|FG008|Substudy B|Withdrawal by Subject|0|||
163110807|NCT05596734|589112293|FG009|Substudy B|Withdrawal by Subject|0|||
163110808|NCT05596734|589112294|FG010|Substudy B|Withdrawal by Subject|0|||
163110809|NCT05596734|589112295|FG011|Substudy B|Withdrawal by Subject|0|||
163110810|NCT05596734|589112296|FG012|Substudy B|Withdrawal by Subject|1|||
163110811|NCT05596734|589112297|FG013|Substudy B|Withdrawal by Subject|0|||
163110812|NCT05596734|589112298|FG014|Substudy B|Withdrawal by Subject|1|||
163110813|NCT05596734|589112299|FG015|Substudy B|Withdrawal by Subject|2|||
163110814|NCT05596734|589112300|FG016|Substudy B|Withdrawal by Subject|2|||
163110815|NCT05596734|589112301|FG017|Substudy B|Withdrawal by Subject|1|||
163110816|NCT05596734|589112302|FG018|Substudy B|Withdrawal by Subject|2|||
163110817|NCT05596734|589112303|FG019|Substudy B|Withdrawal by Subject|0|||
163110818|NCT05596734|589112304|FG020|Substudy B|Withdrawal by Subject|0|||
163110819|NCT05596734|589112305|FG021|Substudy B|Withdrawal by Subject|0|||
163110820|NCT05596734|589112306|FG022|Substudy B|Withdrawal by Subject|0|||
163110821|NCT05596734|589112307|FG023|Substudy B|Withdrawal by Subject|1|||
163110822|NCT05596734|589112284|FG000|Substudy B|Physician Decision|0|||
163110823|NCT05596734|589112285|FG001|Substudy B|Physician Decision|0|||
163110824|NCT05596734|589112286|FG002|Substudy B|Physician Decision|0|||
163110825|NCT05596734|589112287|FG003|Substudy B|Physician Decision|0|||
163110826|NCT05596734|589112288|FG004|Substudy B|Physician Decision|0|||
163110827|NCT05596734|589112289|FG005|Substudy B|Physician Decision|0|||
163110828|NCT05596734|589112290|FG006|Substudy B|Physician Decision|0|||
163110829|NCT05596734|589112291|FG007|Substudy B|Physician Decision|0|||
163110830|NCT05596734|589112292|FG008|Substudy B|Physician Decision|0|||
163110831|NCT05596734|589112293|FG009|Substudy B|Physician Decision|0|||
163110832|NCT05596734|589112294|FG010|Substudy B|Physician Decision|0|||
163110833|NCT05596734|589112295|FG011|Substudy B|Physician Decision|0|||
163110834|NCT05596734|589112296|FG012|Substudy B|Physician Decision|0|||
163110835|NCT05596734|589112297|FG013|Substudy B|Physician Decision|0|||
163110836|NCT05596734|589112298|FG014|Substudy B|Physician Decision|0|||
163110837|NCT05596734|589112299|FG015|Substudy B|Physician Decision|1|||
163110838|NCT05596734|589112300|FG016|Substudy B|Physician Decision|0|||
163110839|NCT05596734|589112301|FG017|Substudy B|Physician Decision|0|||
163110840|NCT05596734|589112302|FG018|Substudy B|Physician Decision|0|||
163110841|NCT05596734|589112303|FG019|Substudy B|Physician Decision|0|||
163110842|NCT05596734|589112304|FG020|Substudy B|Physician Decision|0|||
163110843|NCT05596734|589112305|FG021|Substudy B|Physician Decision|0|||
163110844|NCT05596734|589112306|FG022|Substudy B|Physician Decision|0|||
163110845|NCT05596734|589112307|FG023|Substudy B|Physician Decision|0|||
163110846|NCT05596734|589112284|FG000|Substudy B|Lost to Follow-up|0|||
163110847|NCT05596734|589112285|FG001|Substudy B|Lost to Follow-up|0|||
163110848|NCT05596734|589112286|FG002|Substudy B|Lost to Follow-up|0|||
163110849|NCT05596734|589112287|FG003|Substudy B|Lost to Follow-up|0|||
163110850|NCT05596734|589112288|FG004|Substudy B|Lost to Follow-up|0|||
163110851|NCT05596734|589112289|FG005|Substudy B|Lost to Follow-up|0|||
163339931|NCT01052272|589953108|FG002|Overall Study|Withdrawal by Subject|3|||
163339932|NCT01052272|589953109|FG003|Overall Study|Withdrawal by Subject|2|||
163339933|NCT01052272|589953106|FG000|Overall Study|placed in long-term care|0|||
163110852|NCT05596734|589112290|FG006|Substudy B|Lost to Follow-up|0|||
163110853|NCT05596734|589112291|FG007|Substudy B|Lost to Follow-up|0|||
163110854|NCT05596734|589112292|FG008|Substudy B|Lost to Follow-up|0|||
163110855|NCT05596734|589112293|FG009|Substudy B|Lost to Follow-up|0|||
163110856|NCT05596734|589112294|FG010|Substudy B|Lost to Follow-up|0|||
163110857|NCT05596734|589112295|FG011|Substudy B|Lost to Follow-up|0|||
163110858|NCT05596734|589112296|FG012|Substudy B|Lost to Follow-up|1|||
163110859|NCT05596734|589112297|FG013|Substudy B|Lost to Follow-up|0|||
163110860|NCT05596734|589112298|FG014|Substudy B|Lost to Follow-up|1|||
163110861|NCT05596734|589112299|FG015|Substudy B|Lost to Follow-up|1|||
163110862|NCT05596734|589112300|FG016|Substudy B|Lost to Follow-up|0|||
163110863|NCT05596734|589112301|FG017|Substudy B|Lost to Follow-up|0|||
163110864|NCT05596734|589112302|FG018|Substudy B|Lost to Follow-up|0|||
163110865|NCT05596734|589112303|FG019|Substudy B|Lost to Follow-up|0|||
163110866|NCT05596734|589112304|FG020|Substudy B|Lost to Follow-up|0|||
163110867|NCT05596734|589112305|FG021|Substudy B|Lost to Follow-up|0|||
163110868|NCT05596734|589112306|FG022|Substudy B|Lost to Follow-up|0|||
163110869|NCT05596734|589112307|FG023|Substudy B|Lost to Follow-up|0|||
163110870|NCT02059499|589112313|FG000|Upto Week 20|Lost to Follow-up|2|||
163110871|NCT02059499|589112314|FG001|Upto Week 20|Lost to Follow-up|6|||
163110872|NCT02059499|589112315|FG002|Upto Week 20|Lost to Follow-up|0|||
163110873|NCT02059499|589112313|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
163110874|NCT02059499|589112314|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
163110875|NCT02059499|589112315|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
163110876|NCT02059499|589112313|FG000|Upto Week 20|Withdrawal by Subject|1|||
163110877|NCT02059499|589112314|FG001|Upto Week 20|Withdrawal by Subject|1|||
163110878|NCT02059499|589112315|FG002|Upto Week 20|Withdrawal by Subject|0|||
163110879|NCT02059499|589112313|FG000|Upto Week 20|No treatment per protocol criteria|0|||
163110880|NCT02059499|589112314|FG001|Upto Week 20|No treatment per protocol criteria|0|||
163110881|NCT02059499|589112315|FG002|Upto Week 20|No treatment per protocol criteria|5|||
163110882|NCT02059499|589112313|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
163110883|NCT02059499|589112314|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
163110884|NCT02059499|589112315|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
163110885|NCT02059499|589112313|FG000|Post-week 20|Lost to Follow-up|0|||
163110886|NCT02059499|589112314|FG001|Post-week 20|Lost to Follow-up|2|||
163110887|NCT02059499|589112315|FG002|Post-week 20|Lost to Follow-up|0|||
163110888|NCT02059499|589112313|FG000|Post-week 20|Withdrawal by Subject|0|||
163110889|NCT02059499|589112314|FG001|Post-week 20|Withdrawal by Subject|1|||
163110890|NCT02059499|589112315|FG002|Post-week 20|Withdrawal by Subject|0|||
163110891|NCT02059499|589112313|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
163110892|NCT02059499|589112314|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
163110893|NCT02059499|589112315|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
163110894|NCT04210245|589112316|FG000|Overall Study|Adverse Event|0|||
163110895|NCT04210245|589112317|FG001|Overall Study|Adverse Event|3|||
163110896|NCT04210245|589112318|FG002|Overall Study|Adverse Event|6|||
163110897|NCT04210245|589112319|FG003|Overall Study|Adverse Event|0|||
163110898|NCT04210245|589112316|FG000|Overall Study|Withdrawal by Subject|0|||
163110899|NCT04210245|589112317|FG001|Overall Study|Withdrawal by Subject|1|||
163110900|NCT04210245|589112318|FG002|Overall Study|Withdrawal by Subject|4|||
163110901|NCT04210245|589112319|FG003|Overall Study|Withdrawal by Subject|4|||
163110902|NCT04210245|589112316|FG000|Overall Study|Lost to Follow-up|0|||
163110903|NCT04210245|589112317|FG001|Overall Study|Lost to Follow-up|1|||
163110904|NCT04210245|589112318|FG002|Overall Study|Lost to Follow-up|1|||
163110905|NCT04210245|589112319|FG003|Overall Study|Lost to Follow-up|1|||
163110906|NCT04210245|589112316|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
163110907|NCT04210245|589112317|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
163110908|NCT04210245|589112318|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
163110909|NCT04210245|589112319|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
163110910|NCT03989349|589112324|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
163110911|NCT03989349|589112325|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163110912|NCT03989349|589112326|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163110913|NCT03989349|589112327|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163110914|NCT03989349|589112328|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163110915|NCT03989349|589112329|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163110916|NCT03989349|589112324|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
163110917|NCT03989349|589112325|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
163110918|NCT03989349|589112326|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163110919|NCT03989349|589112327|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163222299|NCT01332149|589531440|FG000|Overall Study|Adverse Event|11|||
163110920|NCT03989349|589112328|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163110921|NCT03989349|589112329|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163110922|NCT03989349|589112324|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
163110923|NCT03989349|589112325|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
163110924|NCT03989349|589112326|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
163110925|NCT03989349|589112327|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
163110926|NCT03989349|589112328|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
163110927|NCT03989349|589112329|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
163110928|NCT03989349|589112324|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
163222300|NCT01332149|589531441|FG001|Overall Study|Adverse Event|9|||
163222301|NCT01332149|589531440|FG000|Overall Study|Other unspecified|5|||
163110929|NCT03989349|589112325|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
163110930|NCT03989349|589112326|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163110931|NCT03989349|589112327|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163222302|NCT01332149|589531441|FG001|Overall Study|Other unspecified|7|||
163339934|NCT01052272|589953107|FG001|Overall Study|placed in long-term care|0|||
163339935|NCT01052272|589953108|FG002|Overall Study|placed in long-term care|1|||
163110932|NCT03989349|589112328|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163110933|NCT03989349|589112329|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163110934|NCT03989349|589112324|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
163110935|NCT03989349|589112325|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
163110936|NCT03989349|589112326|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
163110937|NCT03989349|589112327|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
163110938|NCT03989349|589112328|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
163110939|NCT03989349|589112329|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
163110940|NCT03989349|589112324|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
163110941|NCT03989349|589112325|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
163110942|NCT03989349|589112326|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
163110943|NCT03989349|589112327|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
163110944|NCT03989349|589112328|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
163110945|NCT03989349|589112329|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
163110946|NCT03989349|589112324|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
163110947|NCT03989349|589112325|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
163110948|NCT03989349|589112326|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
163110949|NCT03989349|589112327|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
163110950|NCT03989349|589112328|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
163110951|NCT03989349|589112329|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
163110952|NCT03989349|589112324|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
163110953|NCT03989349|589112325|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
163110954|NCT03989349|589112326|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
163110955|NCT03989349|589112327|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
163110956|NCT03989349|589112328|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
163110957|NCT03989349|589112329|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
163110958|NCT03989349|589112324|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
163110959|NCT03989349|589112325|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
163110960|NCT03989349|589112326|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
163110961|NCT03989349|589112327|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
163110962|NCT03989349|589112328|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
163110963|NCT03989349|589112329|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
163110964|NCT03989349|589112324|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
163110965|NCT03989349|589112325|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
163110966|NCT03989349|589112326|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
163110967|NCT03989349|589112327|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
163110968|NCT03989349|589112328|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
163110969|NCT03989349|589112329|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
163110970|NCT03989349|589112324|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163110971|NCT03989349|589112325|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163110972|NCT03989349|589112326|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
163110973|NCT03989349|589112327|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163110974|NCT03989349|589112328|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
163110975|NCT03989349|589112329|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163110976|NCT03989349|589112324|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
163110977|NCT03989349|589112325|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
163110978|NCT03989349|589112326|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
163110979|NCT03989349|589112327|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
163110980|NCT03989349|589112328|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
163110981|NCT03989349|589112329|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
163110982|NCT03989349|589112324|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
163222303|NCT01332149|589531440|FG000|Overall Study|Protocol Violation|1|||
163339936|NCT01052272|589953109|FG003|Overall Study|placed in long-term care|0|||
163339937|NCT01052272|589953106|FG000|Overall Study|decline in health|0|||
163339938|NCT01052272|589953107|FG001|Overall Study|decline in health|0|||
163339939|NCT01052272|589953108|FG002|Overall Study|decline in health|1|||
163339940|NCT01052272|589953109|FG003|Overall Study|decline in health|0|||
163339941|NCT00113529|589953110|FG000|Overall Study|Adverse Event|4|||
163339942|NCT00113529|589953110|FG000|Overall Study|Lack of Efficacy|20|||
163339943|NCT00113529|589953110|FG000|Overall Study|Decision of sponsor|6|||
163339944|NCT00113529|589953110|FG000|Overall Study|Withdrawal by Subject|4|||
163339945|NCT00841321|589953113|FG000|Overall Study|Lost to Follow-up|1|||
163339946|NCT00841321|589953114|FG001|Overall Study|Lost to Follow-up|1|||
163110983|NCT03989349|589112325|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
163110984|NCT03989349|589112326|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
163110985|NCT03989349|589112327|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
163110986|NCT03989349|589112328|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
163110987|NCT03989349|589112329|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
163110988|NCT03989349|589112324|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
163110989|NCT03989349|589112325|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
163110990|NCT03989349|589112326|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
163110991|NCT03989349|589112327|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
163110992|NCT03989349|589112328|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
163110993|NCT03989349|589112329|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
163110994|NCT02684058|589112330|FG000|Treatment Period|Progressive disease|4|||
163110995|NCT02684058|589112331|FG001|Treatment Period|Progressive disease|10|||
163110996|NCT02684058|589112332|FG002|Treatment Period|Progressive disease|19|||
163110997|NCT02684058|589112330|FG000|Treatment Period|Adverse Event|3|||
163110998|NCT02684058|589112331|FG001|Treatment Period|Adverse Event|8|||
163110999|NCT02684058|589112332|FG002|Treatment Period|Adverse Event|1|||
163111000|NCT02684058|589112330|FG000|Treatment Period|Physician Decision|5|||
163111001|NCT02684058|589112331|FG001|Treatment Period|Physician Decision|1|||
163111002|NCT02684058|589112332|FG002|Treatment Period|Physician Decision|2|||
163111003|NCT02684058|589112330|FG000|Treatment Period|New therapy for study indication|1|||
163111004|NCT02684058|589112331|FG001|Treatment Period|New therapy for study indication|0|||
163111005|NCT02684058|589112332|FG002|Treatment Period|New therapy for study indication|0|||
163111006|NCT02684058|589112330|FG000|Treatment Period|Protocol deviation|0|||
163111007|NCT02684058|589112331|FG001|Treatment Period|Protocol deviation|1|||
163111008|NCT02684058|589112332|FG002|Treatment Period|Protocol deviation|0|||
163111009|NCT02684058|589112330|FG000|Treatment Period|Subject/guardian decision|4|||
163111010|NCT02684058|589112331|FG001|Treatment Period|Subject/guardian decision|3|||
163111011|NCT02684058|589112332|FG002|Treatment Period|Subject/guardian decision|0|||
163111012|NCT02684058|589112330|FG000|Treatment Period|Death|0|||
163111013|NCT02684058|589112331|FG001|Treatment Period|Death|0|||
163111014|NCT02684058|589112332|FG002|Treatment Period|Death|2|||
163111015|NCT02684058|589112330|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
163111016|NCT02684058|589112331|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
163111017|NCT02684058|589112332|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
163111018|NCT02684058|589112330|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
163111019|NCT02684058|589112331|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
163111020|NCT02684058|589112332|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
163111021|NCT02684058|589112330|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
163222304|NCT01332149|589531441|FG001|Overall Study|Protocol Violation|3|||
163222305|NCT01332149|589531440|FG000|Overall Study|Withdrawal by Subject|4|||
163222306|NCT01332149|589531441|FG001|Overall Study|Withdrawal by Subject|5|||
163222307|NCT01332149|589531440|FG000|Overall Study|Lost to Follow-up|1|||
163222308|NCT01332149|589531441|FG001|Overall Study|Lost to Follow-up|1|||
163222309|NCT01332149|589531440|FG000|Overall Study|Insufficient clinical response|4|||
163222310|NCT01332149|589531441|FG001|Overall Study|Insufficient clinical response|7|||
163222311|NCT01332149|589531440|FG000|Overall Study|Did not meet entrance criteria|3|||
163222312|NCT01332149|589531441|FG001|Overall Study|Did not meet entrance criteria|4|||
163222313|NCT01332149|589531440|FG000|Overall Study|Randomized but not treated|1|||
163222314|NCT01332149|589531441|FG001|Overall Study|Randomized but not treated|2|||
163222315|NCT04982029|589531442|FG000|Overall Study|Lost to Follow-up|2|||
163222316|NCT04982029|589531443|FG001|Overall Study|Lost to Follow-up|3|||
163222317|NCT03264404|589531444|FG000|Overall Study|Death|2|||
163222318|NCT03264404|589531444|FG000|Overall Study|Physician Decision|1|||
163222319|NCT03264404|589531444|FG000|Overall Study|Disease Progression|28|||
163222320|NCT03264404|589531444|FG000|Overall Study|Adverse Event|1|||
163222321|NCT03264404|589531444|FG000|Overall Study|Off study prior to treatment|2|||
163222322|NCT02565381|589531445|FG000|Overall Study|Lost to Follow-up|1|||
163111022|NCT02684058|589112331|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
163111023|NCT02684058|589112332|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
163222323|NCT02565381|589531446|FG001|Overall Study|Lost to Follow-up|0|||
163222324|NCT02565381|589531447|FG002|Overall Study|Lost to Follow-up|1|||
163222325|NCT04615949|589531450|FG000|Overall Study|Withdrawal by Subject|2|||
163222326|NCT04615949|589531451|FG001|Overall Study|Withdrawal by Subject|4|||
163222327|NCT04615949|589531450|FG000|Overall Study|Lost to Follow-up|2|||
163222328|NCT04615949|589531451|FG001|Overall Study|Lost to Follow-up|2|||
163222329|NCT04615949|589531450|FG000|Overall Study|Death|0|||
163222330|NCT04615949|589531451|FG001|Overall Study|Death|2|||
163222331|NCT03036566|589531452|FG000|Overall Study|Lost to Follow-up|3|||
163222332|NCT05458856|589531453|FG000|Overall Study|Withdrawal by Subject|5|||
163339947|NCT00841321|589953113|FG000|Overall Study|Adverse Event|0|||
163339948|NCT00841321|589953114|FG001|Overall Study|Adverse Event|2|||
163339949|NCT02632747|589953115|FG000|Wash-out Period|Adverse Event|1|||
163111024|NCT02684058|589112330|FG000|Post-treatment Efficacy Follow-up|Death|0|||
163111025|NCT02684058|589112331|FG001|Post-treatment Efficacy Follow-up|Death|0|||
163111026|NCT02684058|589112332|FG002|Post-treatment Efficacy Follow-up|Death|3|||
163111027|NCT02684058|589112330|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
163111028|NCT02684058|589112331|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
163111029|NCT02684058|589112332|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
163111030|NCT02684058|589112330|FG000|Post-treatment Survival Follow-up|Death|0|||
163111031|NCT02684058|589112331|FG001|Post-treatment Survival Follow-up|Death|0|||
163111032|NCT02684058|589112332|FG002|Post-treatment Survival Follow-up|Death|7|||
163111033|NCT02684058|589112330|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
163111034|NCT02684058|589112331|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
163111035|NCT02684058|589112332|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
163111036|NCT02684058|589112330|FG000|Crossover Treatment Period|Progressive disease|0|||
163111037|NCT02684058|589112331|FG001|Crossover Treatment Period|Progressive disease|1|||
163111038|NCT02684058|589112332|FG002|Crossover Treatment Period|Progressive disease|0|||
163111039|NCT01802580|589112333|FG000|Overall Study|Physician Decision|1|||
163111040|NCT01802580|589112334|FG001|Overall Study|Physician Decision|0|||
163111041|NCT01802580|589112333|FG000|Overall Study|Protocol Violation|2|||
163111042|NCT01802580|589112334|FG001|Overall Study|Protocol Violation|0|||
163111043|NCT01802580|589112333|FG000|Overall Study|Withdrawal by Subject|5|||
163111044|NCT01802580|589112334|FG001|Overall Study|Withdrawal by Subject|6|||
163111045|NCT01802580|589112333|FG000|Overall Study|Other|1|||
163111046|NCT01802580|589112334|FG001|Overall Study|Other|3|||
163111047|NCT01802580|589112333|FG000|Overall Study|Lack of Efficacy|0|||
163111048|NCT01802580|589112334|FG001|Overall Study|Lack of Efficacy|2|||
163111049|NCT03255967|589112335|FG000|Overall Study|Adverse Event|26|||
163111050|NCT03255967|589112336|FG001|Overall Study|Adverse Event|30|||
163111051|NCT03255967|589112335|FG000|Overall Study|Withdrawal by Subject|6|||
163111052|NCT03255967|589112336|FG001|Overall Study|Withdrawal by Subject|6|||
163111053|NCT03255967|589112335|FG000|Overall Study|Schedule conflict|6|||
163111054|NCT03255967|589112336|FG001|Overall Study|Schedule conflict|4|||
163111055|NCT03255967|589112335|FG000|Overall Study|POA did not sign consent form|2|||
163111056|NCT03255967|589112336|FG001|Overall Study|POA did not sign consent form|0|||
163111057|NCT01252186|589112337|FG000|Overall Study|Adverse Event|9|||
163111058|NCT01252186|589112338|FG001|Overall Study|Adverse Event|6|||
163111059|NCT01252186|589112339|FG002|Overall Study|Adverse Event|8|||
163111060|NCT01252186|589112337|FG000|Overall Study|Withdrawal by Subject|2|||
163111061|NCT01252186|589112338|FG001|Overall Study|Withdrawal by Subject|5|||
163111062|NCT01252186|589112339|FG002|Overall Study|Withdrawal by Subject|2|||
163111063|NCT01252186|589112337|FG000|Overall Study|Physician Decision|0|||
163111064|NCT01252186|589112338|FG001|Overall Study|Physician Decision|0|||
163111065|NCT01252186|589112339|FG002|Overall Study|Physician Decision|1|||
163111066|NCT01252186|589112337|FG000|Overall Study|Non-compliance|0|||
163111067|NCT01252186|589112338|FG001|Overall Study|Non-compliance|3|||
163111068|NCT01252186|589112339|FG002|Overall Study|Non-compliance|4|||
163111069|NCT01252186|589112337|FG000|Overall Study|Protocol Violation|0|||
163111070|NCT01252186|589112338|FG001|Overall Study|Protocol Violation|0|||
163111071|NCT01252186|589112339|FG002|Overall Study|Protocol Violation|1|||
163111072|NCT01252186|589112337|FG000|Overall Study|Pregnancy|2|||
163111073|NCT01252186|589112338|FG001|Overall Study|Pregnancy|2|||
163111074|NCT01252186|589112339|FG002|Overall Study|Pregnancy|0|||
163111075|NCT01252186|589112337|FG000|Overall Study|Sponsor Request|2|||
163111076|NCT01252186|589112338|FG001|Overall Study|Sponsor Request|1|||
163111077|NCT01252186|589112339|FG002|Overall Study|Sponsor Request|0|||
163111078|NCT01252186|589112337|FG000|Overall Study|Lost to Follow-up|10|||
163111079|NCT01252186|589112338|FG001|Overall Study|Lost to Follow-up|10|||
163111080|NCT01252186|589112339|FG002|Overall Study|Lost to Follow-up|11|||
163111081|NCT01252186|589112337|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
163111082|NCT01252186|589112338|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
163111083|NCT01252186|589112339|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
163111084|NCT01327053|589112348|FG000|Overall Study|Adverse Event|23|||
163111085|NCT01327053|589112349|FG001|Overall Study|Adverse Event|57|||
163111086|NCT01327053|589112348|FG000|Overall Study|Patient/guardian decision|11|||
163111087|NCT01327053|589112349|FG001|Overall Study|Patient/guardian decision|35|||
163111088|NCT01327053|589112348|FG000|Overall Study|Physician Decision|10|||
163111089|NCT01327053|589112349|FG001|Overall Study|Physician Decision|14|||
163111090|NCT01327053|589112348|FG000|Overall Study|Death|1|||
163111091|NCT01327053|589112349|FG001|Overall Study|Death|5|||
163111092|NCT01327053|589112348|FG000|Overall Study|Lost to Follow-up|2|||
163111093|NCT01327053|589112349|FG001|Overall Study|Lost to Follow-up|4|||
163111094|NCT01327053|589112348|FG000|Overall Study|Non-compliance with study treatment|0|||
163111095|NCT01327053|589112349|FG001|Overall Study|Non-compliance with study treatment|5|||
163111096|NCT01327053|589112348|FG000|Overall Study|Study terminated by Sponsor|1|||
163111097|NCT01327053|589112349|FG001|Overall Study|Study terminated by Sponsor|3|||
163111098|NCT01327053|589112348|FG000|Overall Study|Progressive disease|31|||
163111099|NCT01327053|589112349|FG001|Overall Study|Progressive disease|26|||
163111100|NCT01327053|589112348|FG000|Overall Study|Protocol Violation|0|||
163222333|NCT05458856|589531453|FG000|Overall Study|Death|4|||
163222334|NCT05458856|589531453|FG000|Overall Study|Protocol Deviation|3|||
163222335|NCT05458856|589531453|FG000|Overall Study|Physician Decision|1|||
163222336|NCT00071812|589531457|FG000|24-Week Double-Blind Period|Adverse Event|2|||
163222337|NCT00071812|589531458|FG001|24-Week Double-Blind Period|Adverse Event|3|||
163222338|NCT00071812|589531459|FG002|24-Week Double-Blind Period|Adverse Event|4|||
163222339|NCT00071812|589531460|FG003|24-Week Double-Blind Period|Adverse Event|4|||
163222340|NCT00071812|589531457|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
163222341|NCT00071812|589531458|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
163222342|NCT00071812|589531459|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
163222343|NCT00071812|589531460|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
163222344|NCT00071812|589531457|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
163222345|NCT00071812|589531458|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
163222346|NCT00071812|589531459|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
163222347|NCT00071812|589531460|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
163222348|NCT00071812|589531457|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
163222349|NCT00071812|589531458|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
163222350|NCT00071812|589531459|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
163222351|NCT00071812|589531460|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
163222352|NCT00071812|589531457|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
163222353|NCT00071812|589531458|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
163222354|NCT00071812|589531459|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
163222355|NCT00071812|589531460|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
163222356|NCT00071812|589531457|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
163222357|NCT00071812|589531458|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
163222358|NCT00071812|589531459|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
163222359|NCT00071812|589531460|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
163222360|NCT00071812|589531457|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
163222361|NCT00071812|589531458|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
163222362|NCT00071812|589531459|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
163222363|NCT00071812|589531460|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
163222364|NCT00071812|589531457|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
163222365|NCT00071812|589531458|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
163222366|NCT00071812|589531459|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
163222367|NCT00071812|589531460|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
163222368|NCT00071812|589531457|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
163222369|NCT00071812|589531458|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
163222370|NCT00071812|589531459|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
163222371|NCT00071812|589531460|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
163222372|NCT00071812|589531457|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
163222373|NCT00071812|589531458|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
163222374|NCT00071812|589531459|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
163222375|NCT00071812|589531460|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
163222376|NCT01940120|589531463|FG000|Overall Study|Death|40|||
163222377|NCT01940120|589531463|FG000|Overall Study|Withdrawal by Subject|8|||
163222378|NCT03711162|589531465|FG000|Overall Study|Adverse Event|5|||
163222379|NCT03711162|589531466|FG001|Overall Study|Adverse Event|2|||
163222380|NCT03711162|589531467|FG002|Overall Study|Adverse Event|4|||
163222381|NCT03711162|589531465|FG000|Overall Study|Death|11|||
163222382|NCT03711162|589531466|FG001|Overall Study|Death|7|||
163222383|NCT03711162|589531467|FG002|Overall Study|Death|8|||
163222384|NCT03711162|589531465|FG000|Overall Study|Lost to Follow-up|1|||
163222385|NCT03711162|589531466|FG001|Overall Study|Lost to Follow-up|0|||
163222386|NCT03711162|589531467|FG002|Overall Study|Lost to Follow-up|1|||
163222387|NCT03711162|589531465|FG000|Overall Study|Study Terminated by Sponsor|139|||
163222388|NCT03711162|589531466|FG001|Overall Study|Study Terminated by Sponsor|152|||
163222389|NCT03711162|589531467|FG002|Overall Study|Study Terminated by Sponsor|146|||
163222390|NCT03711162|589531465|FG000|Overall Study|Withdrawal by Subject|17|||
163222391|NCT03711162|589531466|FG001|Overall Study|Withdrawal by Subject|10|||
163222392|NCT03711162|589531467|FG002|Overall Study|Withdrawal by Subject|10|||
163222393|NCT03711162|589531465|FG000|Overall Study|Miscellaneous|1|||
163222394|NCT03711162|589531466|FG001|Overall Study|Miscellaneous|2|||
163222395|NCT03711162|589531467|FG002|Overall Study|Miscellaneous|2|||
163222396|NCT03711162|589531465|FG000|Overall Study|Not Treated|1|||
163222397|NCT03711162|589531466|FG001|Overall Study|Not Treated|0|||
163222398|NCT03711162|589531467|FG002|Overall Study|Not Treated|1|||
163222399|NCT03711162|589531465|FG000|Overall Study|Physician Decision|0|||
163222400|NCT03711162|589531466|FG001|Overall Study|Physician Decision|2|||
163222401|NCT03711162|589531467|FG002|Overall Study|Physician Decision|0|||
163222402|NCT03711162|589531465|FG000|Overall Study|Lack of Efficacy|0|||
163222403|NCT03711162|589531466|FG001|Overall Study|Lack of Efficacy|0|||
163222404|NCT03711162|589531467|FG002|Overall Study|Lack of Efficacy|2|||
163222405|NCT03711162|589531465|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
163111101|NCT01327053|589112349|FG001|Overall Study|Protocol Violation|1|||
163111102|NCT01327053|589112348|FG000|Overall Study|Untreated|0|||
163111103|NCT01327053|589112349|FG001|Overall Study|Untreated|1|||
163111104|NCT00778258|589112350|FG000|Overall Study|Adverse Event|1|||
163111105|NCT00778258|589112351|FG001|Overall Study|Adverse Event|0|||
163111106|NCT00778258|589112352|FG002|Overall Study|Adverse Event|0|||
163111107|NCT00778258|589112353|FG003|Overall Study|Adverse Event|0|||
163111108|NCT00778258|589112354|FG004|Overall Study|Adverse Event|0|||
163111109|NCT00778258|589112355|FG005|Overall Study|Adverse Event|1|||
163111110|NCT00778258|589112356|FG006|Overall Study|Adverse Event|0|||
163111111|NCT00778258|589112357|FG007|Overall Study|Adverse Event|0|||
163111112|NCT00778258|589112358|FG008|Overall Study|Adverse Event|0|||
163111113|NCT00778258|589112350|FG000|Overall Study|Lost to Follow-up|0|||
163111114|NCT00778258|589112351|FG001|Overall Study|Lost to Follow-up|0|||
163111115|NCT00778258|589112352|FG002|Overall Study|Lost to Follow-up|2|||
163111116|NCT00778258|589112353|FG003|Overall Study|Lost to Follow-up|0|||
163111117|NCT00778258|589112354|FG004|Overall Study|Lost to Follow-up|0|||
163111118|NCT00778258|589112355|FG005|Overall Study|Lost to Follow-up|3|||
163111119|NCT00778258|589112356|FG006|Overall Study|Lost to Follow-up|2|||
163111120|NCT00778258|589112357|FG007|Overall Study|Lost to Follow-up|2|||
163111121|NCT00778258|589112358|FG008|Overall Study|Lost to Follow-up|0|||
163111122|NCT00778258|589112350|FG000|Overall Study|Withdrawal by Subject|6|||
163111123|NCT00778258|589112351|FG001|Overall Study|Withdrawal by Subject|2|||
163111124|NCT00778258|589112352|FG002|Overall Study|Withdrawal by Subject|8|||
163111125|NCT00778258|589112353|FG003|Overall Study|Withdrawal by Subject|2|||
163111126|NCT00778258|589112354|FG004|Overall Study|Withdrawal by Subject|0|||
163111127|NCT00778258|589112355|FG005|Overall Study|Withdrawal by Subject|6|||
163111128|NCT00778258|589112356|FG006|Overall Study|Withdrawal by Subject|12|||
163111129|NCT00778258|589112357|FG007|Overall Study|Withdrawal by Subject|12|||
163111130|NCT00778258|589112358|FG008|Overall Study|Withdrawal by Subject|4|||
163111131|NCT00778258|589112350|FG000|Overall Study|New Contraindication|0|||
163111132|NCT00778258|589112351|FG001|Overall Study|New Contraindication|0|||
163111133|NCT00778258|589112352|FG002|Overall Study|New Contraindication|0|||
163111134|NCT00778258|589112353|FG003|Overall Study|New Contraindication|0|||
163111135|NCT00778258|589112354|FG004|Overall Study|New Contraindication|0|||
163111136|NCT00778258|589112355|FG005|Overall Study|New Contraindication|0|||
163111137|NCT00778258|589112356|FG006|Overall Study|New Contraindication|0|||
163111138|NCT00778258|589112357|FG007|Overall Study|New Contraindication|1|||
163111139|NCT00778258|589112358|FG008|Overall Study|New Contraindication|0|||
163111140|NCT00778258|589112350|FG000|Overall Study|Non-compliance|0|||
163111141|NCT00778258|589112351|FG001|Overall Study|Non-compliance|0|||
163111142|NCT00778258|589112352|FG002|Overall Study|Non-compliance|0|||
163111143|NCT00778258|589112353|FG003|Overall Study|Non-compliance|1|||
163111144|NCT00778258|589112354|FG004|Overall Study|Non-compliance|0|||
163111145|NCT00778258|589112355|FG005|Overall Study|Non-compliance|0|||
163111146|NCT00778258|589112356|FG006|Overall Study|Non-compliance|0|||
163111147|NCT00778258|589112357|FG007|Overall Study|Non-compliance|0|||
163111148|NCT00778258|589112358|FG008|Overall Study|Non-compliance|0|||
163111149|NCT00778258|589112350|FG000|Overall Study|Other|0|||
163111150|NCT00778258|589112351|FG001|Overall Study|Other|0|||
163111151|NCT00778258|589112352|FG002|Overall Study|Other|0|||
163111152|NCT00778258|589112353|FG003|Overall Study|Other|0|||
163111153|NCT00778258|589112354|FG004|Overall Study|Other|0|||
163111154|NCT00778258|589112355|FG005|Overall Study|Other|0|||
163111155|NCT00778258|589112356|FG006|Overall Study|Other|1|||
163111156|NCT00778258|589112357|FG007|Overall Study|Other|0|||
163111157|NCT00778258|589112358|FG008|Overall Study|Other|0|||
163111158|NCT01221623|589112359|FG000|Overall Study|Withdrawal by Subject|19|||
163111159|NCT01221623|589112360|FG001|Overall Study|Withdrawal by Subject|8|||
163111160|NCT01221623|589112359|FG000|Overall Study|Lost to Follow-up|7|||
163111161|NCT01221623|589112360|FG001|Overall Study|Lost to Follow-up|1|||
163339950|NCT02632747|589953116|FG001|Wash-out Period|Adverse Event|0|||
163339951|NCT01107912|589953117|FG000|Period 1|Adverse Event|0|||
163339952|NCT01107912|589953118|FG001|Period 1|Adverse Event|0|||
163339953|NCT01107912|589953119|FG002|Period 1|Adverse Event|0|||
163111162|NCT01221623|589112359|FG000|Overall Study|Adverse Event|6|||
163111163|NCT01221623|589112360|FG001|Overall Study|Adverse Event|3|||
163111164|NCT01221623|589112359|FG000|Overall Study|Death|1|||
163111165|NCT01221623|589112360|FG001|Overall Study|Death|0|||
163111166|NCT01221623|589112359|FG000|Overall Study|Other|5|||
163111167|NCT01221623|589112360|FG001|Overall Study|Other|2|||
163111168|NCT00661726|589112361|FG000|Overall Study|Adverse Event|1|||
163111169|NCT02644096|589112362|FG000|Overall Study|Withdrawal by Subject|28|||
163111170|NCT02644096|589112363|FG001|Overall Study|Withdrawal by Subject|25|||
163111171|NCT02147197|589112364|FG000|Overall Study|Adverse Event|1|||
163111172|NCT02147197|589112365|FG001|Overall Study|Adverse Event|0|||
163111173|NCT02147197|589112366|FG002|Overall Study|Adverse Event|0|||
163111174|NCT02147197|589112364|FG000|Overall Study|Withdrawal of Consent|4|||
163111175|NCT02147197|589112365|FG001|Overall Study|Withdrawal of Consent|3|||
163111176|NCT02147197|589112366|FG002|Overall Study|Withdrawal of Consent|2|||
163339954|NCT01107912|589953120|FG003|Period 1|Adverse Event|0|||
163111177|NCT02147197|589112364|FG000|Overall Study|Lost to Follow-up|2|||
163111178|NCT02147197|589112365|FG001|Overall Study|Lost to Follow-up|3|||
163111179|NCT02147197|589112366|FG002|Overall Study|Lost to Follow-up|1|||
163111180|NCT02147197|589112364|FG000|Overall Study|Protocol Violation|1|||
163111181|NCT02147197|589112365|FG001|Overall Study|Protocol Violation|0|||
163111182|NCT02147197|589112366|FG002|Overall Study|Protocol Violation|3|||
163111183|NCT02147197|589112364|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163111184|NCT02147197|589112365|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163111185|NCT02147197|589112366|FG002|Overall Study|Other Miscellaneous Reasons|3|||
163111186|NCT00830375|589112367|FG000|Overall Study|Lost to Follow-up|1|||
163111187|NCT01700959|589112368|FG000|Overall Study|Adverse Event|0|||
163111188|NCT01700959|589112369|FG001|Overall Study|Adverse Event|1|||
163111189|NCT01700959|589112370|FG002|Overall Study|Adverse Event|1|||
163111190|NCT01700959|589112371|FG003|Overall Study|Adverse Event|2|||
163111191|NCT01700959|589112372|FG004|Overall Study|Adverse Event|0|||
163111192|NCT01700959|589112373|FG005|Overall Study|Adverse Event|2|||
163111193|NCT01700959|589112368|FG000|Overall Study|Withdrawal by Subject|15|||
163111194|NCT01700959|589112369|FG001|Overall Study|Withdrawal by Subject|9|||
163111195|NCT01700959|589112370|FG002|Overall Study|Withdrawal by Subject|12|||
163111196|NCT01700959|589112371|FG003|Overall Study|Withdrawal by Subject|11|||
163111197|NCT01700959|589112372|FG004|Overall Study|Withdrawal by Subject|8|||
163111198|NCT01700959|589112373|FG005|Overall Study|Withdrawal by Subject|12|||
163111199|NCT01700959|589112368|FG000|Overall Study|Ineligible|2|||
163111200|NCT01700959|589112369|FG001|Overall Study|Ineligible|1|||
163111201|NCT01700959|589112370|FG002|Overall Study|Ineligible|2|||
163111202|NCT01700959|589112371|FG003|Overall Study|Ineligible|0|||
163111203|NCT01700959|589112372|FG004|Overall Study|Ineligible|0|||
163111204|NCT01700959|589112373|FG005|Overall Study|Ineligible|1|||
163111205|NCT01700959|589112368|FG000|Overall Study|Noncompliant|9|||
163111206|NCT01700959|589112369|FG001|Overall Study|Noncompliant|9|||
163111207|NCT01700959|589112370|FG002|Overall Study|Noncompliant|17|||
163111208|NCT01700959|589112371|FG003|Overall Study|Noncompliant|18|||
163111209|NCT01700959|589112372|FG004|Overall Study|Noncompliant|15|||
163111210|NCT01700959|589112373|FG005|Overall Study|Noncompliant|9|||
163111211|NCT01700959|589112368|FG000|Overall Study|Side effects|1|||
163111212|NCT01700959|589112369|FG001|Overall Study|Side effects|4|||
163111213|NCT01700959|589112370|FG002|Overall Study|Side effects|8|||
163111214|NCT01700959|589112371|FG003|Overall Study|Side effects|4|||
163111215|NCT01700959|589112372|FG004|Overall Study|Side effects|4|||
163111216|NCT01700959|589112373|FG005|Overall Study|Side effects|1|||
163111217|NCT00322452|589112374|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163111218|NCT00322452|589112375|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163111219|NCT00322452|589112374|FG000|Overall Study|Lost to Follow-up|5|||
163111220|NCT00322452|589112375|FG001|Overall Study|Lost to Follow-up|2|||
163111221|NCT00322452|589112374|FG000|Overall Study|Withdrawal by Subject|19|||
163111222|NCT00322452|589112375|FG001|Overall Study|Withdrawal by Subject|46|||
163111223|NCT00322452|589112374|FG000|Overall Study|Death|223|||
163111224|NCT00322452|589112375|FG001|Overall Study|Death|227|||
163222406|NCT03711162|589531466|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
163222407|NCT03711162|589531467|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
163222408|NCT01275066|589531470|FG000|Overall Study|Withdrawal by Subject|0|||
163111225|NCT02438384|589112376|FG000|Overall Study|Lost to Follow-up|8|||
163111226|NCT02438384|589112377|FG001|Overall Study|Lost to Follow-up|6|||
163111227|NCT02438384|589112378|FG002|Overall Study|Lost to Follow-up|4|||
163111228|NCT02650128|589112379|FG000|Overall Study|Death|2|||
163111229|NCT01263015|589114040|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
163111230|NCT01263015|589114041|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
163111231|NCT01263015|589114040|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
163111232|NCT01263015|589114041|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
163111233|NCT01263015|589114040|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
163111234|NCT01263015|589114041|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
163111235|NCT01263015|589114040|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
163111236|NCT01263015|589114041|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
163111237|NCT01263015|589114040|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
163111238|NCT01263015|589114041|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
163111239|NCT01263015|589114040|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
163222409|NCT01275066|589531471|FG001|Overall Study|Withdrawal by Subject|0|||
163222410|NCT01275066|589531472|FG002|Overall Study|Withdrawal by Subject|1|||
163222411|NCT01275066|589531470|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
163111240|NCT01263015|589114041|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
163111241|NCT01263015|589114040|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
163111242|NCT01263015|589114041|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
163111243|NCT01263015|589114040|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
163111244|NCT01263015|589114041|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
163111245|NCT01263015|589114040|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
163111246|NCT01263015|589114041|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
163111247|NCT01263015|589114040|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
163111248|NCT01263015|589114041|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
163111249|NCT01263015|589114040|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
163111250|NCT01263015|589114041|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
163111251|NCT01263015|589114040|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
163111252|NCT01263015|589114041|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
163111253|NCT05599451|589114042|FG000|Overall Study|Not randomized|11|||
163111254|NCT05599451|589114043|FG001|Overall Study|Not randomized|0|||
163111255|NCT05599451|589114044|FG002|Overall Study|Not randomized|0|||
163111256|NCT05599451|589114045|FG003|Overall Study|Not randomized|0|||
163111257|NCT05599451|589114046|FG004|Overall Study|Not randomized|0|||
163111258|NCT05599451|589114042|FG000|Overall Study|Physician Decision|0|||
163111259|NCT05599451|589114043|FG001|Overall Study|Physician Decision|0|||
163111260|NCT05599451|589114044|FG002|Overall Study|Physician Decision|0|||
163111261|NCT05599451|589114045|FG003|Overall Study|Physician Decision|1|||
163111262|NCT05599451|589114046|FG004|Overall Study|Physician Decision|0|||
163111263|NCT02723006|589114047|FG000|Overall Study|Withdrawal by Subject|0|||
163111264|NCT02723006|589114048|FG001|Overall Study|Withdrawal by Subject|1|||
163111265|NCT02723006|589114049|FG002|Overall Study|Withdrawal by Subject|1|||
163111266|NCT02723006|589114047|FG000|Overall Study|Study Terminated by Sponsor|1|||
163111267|NCT02723006|589114048|FG001|Overall Study|Study Terminated by Sponsor|6|||
163111268|NCT02723006|589114049|FG002|Overall Study|Study Terminated by Sponsor|6|||
163111269|NCT00303446|589114050|FG000|Overall Study|Withdrawal by Subject|2|||
163111270|NCT00303446|589114051|FG001|Overall Study|Withdrawal by Subject|2|||
163111271|NCT00303446|589114050|FG000|Overall Study|Death|0|||
163111272|NCT00303446|589114051|FG001|Overall Study|Death|1|||
163111273|NCT00303446|589114050|FG000|Overall Study|Physician Decision|0|||
163111274|NCT00303446|589114051|FG001|Overall Study|Physician Decision|1|||
163111275|NCT03116828|589114053|FG000|Overall Study|Adverse Event|1|||
163111276|NCT03116828|589114054|FG001|Overall Study|Adverse Event|10|||
163111277|NCT03116828|589114053|FG000|Overall Study|Withdrawal by Subject|4|||
163111278|NCT03116828|589114054|FG001|Overall Study|Withdrawal by Subject|8|||
163111279|NCT03116828|589114053|FG000|Overall Study|OTHER|3|||
163111280|NCT03116828|589114054|FG001|Overall Study|OTHER|3|||
163111281|NCT05243745|589114057|FG000|Overall Study|Withdrawal by Subject|0|||
163111282|NCT05243745|589114058|FG001|Overall Study|Withdrawal by Subject|0|||
163111283|NCT05243745|589114059|FG002|Overall Study|Withdrawal by Subject|0|||
163111284|NCT05243745|589114060|FG003|Overall Study|Withdrawal by Subject|1|||
163111285|NCT05243745|589114057|FG000|Overall Study|Unable to Attend Visit 6|0|||
163111286|NCT05243745|589114058|FG001|Overall Study|Unable to Attend Visit 6|0|||
163111287|NCT05243745|589114059|FG002|Overall Study|Unable to Attend Visit 6|1|||
163111288|NCT05243745|589114060|FG003|Overall Study|Unable to Attend Visit 6|0|||
163111289|NCT02998203|589114061|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
163111290|NCT02998203|589114062|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
163111291|NCT02998203|589114061|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
163111292|NCT02998203|589114062|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
163111293|NCT04187144|589114075|FG000|Overall Study|Lost to Follow-up|12|||
163111294|NCT04187144|589114076|FG001|Overall Study|Lost to Follow-up|11|||
163111295|NCT04187144|589114075|FG000|Overall Study|Withdrawal by Subject|20|||
163111296|NCT04187144|589114076|FG001|Overall Study|Withdrawal by Subject|18|||
163111297|NCT04187144|589114075|FG000|Overall Study|Adverse Event|19|||
163111298|NCT04187144|589114076|FG001|Overall Study|Adverse Event|4|||
163111299|NCT04187144|589114075|FG000|Overall Study|Physician Decision|5|||
163222412|NCT01275066|589531471|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
163339955|NCT01107912|589953121|FG004|Period 1|Adverse Event|2|||
163339956|NCT01107912|589953122|FG005|Period 1|Adverse Event|0|||
163111300|NCT04187144|589114076|FG001|Overall Study|Physician Decision|3|||
163111301|NCT04187144|589114075|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
163111302|NCT04187144|589114076|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
163111303|NCT04187144|589114075|FG000|Overall Study|Protocol Deviation|1|||
163111304|NCT04187144|589114076|FG001|Overall Study|Protocol Deviation|4|||
163111305|NCT03842969|589114077|FG000|Overall Study|Participant declined follow-up visit|0|||
163111306|NCT03842969|589114078|FG001|Overall Study|Participant declined follow-up visit|1|||
163111307|NCT03842969|589114079|FG002|Overall Study|Participant declined follow-up visit|0|||
163111308|NCT03842969|589114077|FG000|Overall Study|Sponsor's decision|12|||
163111309|NCT03842969|589114078|FG001|Overall Study|Sponsor's decision|99|||
163111310|NCT03842969|589114079|FG002|Overall Study|Sponsor's decision|61|||
163111311|NCT03842969|589114077|FG000|Overall Study|Pregnancy|0|||
163222413|NCT01275066|589531472|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
163111312|NCT03842969|589114078|FG001|Overall Study|Pregnancy|0|||
163111313|NCT03842969|589114079|FG002|Overall Study|Pregnancy|1|||
163222414|NCT03240133|589531473|FG000|Overall Study|Withdrawal by Subject|0|||
163111314|NCT03842969|589114077|FG000|Overall Study|Death|1|||
163111315|NCT03842969|589114078|FG001|Overall Study|Death|0|||
163111316|NCT03842969|589114079|FG002|Overall Study|Death|1|||
163111317|NCT03842969|589114077|FG000|Overall Study|Withdrawal by Subject|3|||
163222415|NCT03240133|589531474|FG001|Overall Study|Withdrawal by Subject|1|||
163222416|NCT03240133|589531475|FG002|Overall Study|Withdrawal by Subject|0|||
163222417|NCT03240133|589531473|FG000|Overall Study|Adverse Event|1|||
163222418|NCT03240133|589531474|FG001|Overall Study|Adverse Event|1|||
163222419|NCT03240133|589531475|FG002|Overall Study|Adverse Event|0|||
163222420|NCT03240133|589531473|FG000|Overall Study|Rash|1|||
163222421|NCT03240133|589531474|FG001|Overall Study|Rash|0|||
163222422|NCT03240133|589531475|FG002|Overall Study|Rash|0|||
163222423|NCT03240133|589531473|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
163222424|NCT03240133|589531474|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
163222425|NCT03240133|589531475|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
163222426|NCT03240133|589531473|FG000|Overall Study|Intercurrent illness.|0|||
163222427|NCT03240133|589531474|FG001|Overall Study|Intercurrent illness.|1|||
163111318|NCT03842969|589114078|FG001|Overall Study|Withdrawal by Subject|30|||
163111319|NCT03842969|589114079|FG002|Overall Study|Withdrawal by Subject|18|||
163111320|NCT03842969|589114077|FG000|Overall Study|Protocol Violation|1|||
163111321|NCT03842969|589114078|FG001|Overall Study|Protocol Violation|1|||
163111322|NCT03842969|589114079|FG002|Overall Study|Protocol Violation|0|||
163111323|NCT03842969|589114077|FG000|Overall Study|Physician Decision|0|||
163111324|NCT03842969|589114078|FG001|Overall Study|Physician Decision|3|||
163111325|NCT03842969|589114079|FG002|Overall Study|Physician Decision|0|||
163111326|NCT03842969|589114077|FG000|Overall Study|Lost to Follow-up|0|||
163111327|NCT03842969|589114078|FG001|Overall Study|Lost to Follow-up|2|||
163111328|NCT03842969|589114079|FG002|Overall Study|Lost to Follow-up|0|||
163111329|NCT03842969|589114077|FG000|Overall Study|Adverse Event|0|||
163111330|NCT03842969|589114078|FG001|Overall Study|Adverse Event|2|||
163111331|NCT03842969|589114079|FG002|Overall Study|Adverse Event|0|||
163111332|NCT01044745|589114080|FG000|Overall Study|Ineiligible|2|||
163111333|NCT01159171|589114083|FG000|Overall Study|Adverse Event|11|||
163111334|NCT01159171|589114083|FG000|Overall Study|Progression of Disease|28|||
163111335|NCT01159171|589114083|FG000|Overall Study|Protocol Violation|1|||
163111336|NCT01159171|589114083|FG000|Overall Study|Need for Surgery|5|||
163111337|NCT01159171|589114083|FG000|Overall Study|Medical Decision|4|||
163111338|NCT01159171|589114083|FG000|Overall Study|Death|1|||
163111339|NCT01962987|589114084|FG000|Overall Study|Adverse Event|4|||
163111340|NCT01962987|589114085|FG001|Overall Study|Adverse Event|4|||
163111341|NCT01962987|589114086|FG002|Overall Study|Adverse Event|0|||
163111342|NCT01962987|589114084|FG000|Overall Study|Lost to Follow-up|0|||
163111343|NCT01962987|589114085|FG001|Overall Study|Lost to Follow-up|0|||
163111344|NCT01962987|589114086|FG002|Overall Study|Lost to Follow-up|1|||
163111345|NCT01962987|589114084|FG000|Overall Study|Non compliance with dosing requirements|4|||
163111346|NCT01962987|589114085|FG001|Overall Study|Non compliance with dosing requirements|2|||
163111347|NCT01962987|589114086|FG002|Overall Study|Non compliance with dosing requirements|0|||
163111348|NCT01962987|589114084|FG000|Overall Study|Miscellaneous|1|||
163111349|NCT01962987|589114085|FG001|Overall Study|Miscellaneous|9|||
163111350|NCT01962987|589114086|FG002|Overall Study|Miscellaneous|2|||
163111351|NCT01962987|589114084|FG000|Overall Study|Restricted medication|5|||
163111352|NCT01962987|589114085|FG001|Overall Study|Restricted medication|1|||
163111353|NCT01962987|589114086|FG002|Overall Study|Restricted medication|1|||
163111354|NCT01962987|589114084|FG000|Overall Study|Serious Adverse Event|1|||
163111355|NCT01962987|589114085|FG001|Overall Study|Serious Adverse Event|0|||
163111356|NCT01962987|589114086|FG002|Overall Study|Serious Adverse Event|0|||
163111357|NCT01962987|589114084|FG000|Overall Study|Withdrawal by Subject|11|||
163111358|NCT01962987|589114085|FG001|Overall Study|Withdrawal by Subject|10|||
163111359|NCT01962987|589114086|FG002|Overall Study|Withdrawal by Subject|6|||
163222428|NCT03240133|589531475|FG002|Overall Study|Intercurrent illness.|0|||
163339957|NCT01107912|589953117|FG000|Period 1|Physician Decision|0|||
163222429|NCT03240133|589531473|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
163222430|NCT03240133|589531474|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
163222431|NCT03240133|589531475|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
163222432|NCT00749463|589531476|FG000|Overall Study|Adverse Event|0|||
163222433|NCT00749463|589531477|FG001|Overall Study|Adverse Event|4|||
163339958|NCT01107912|589953118|FG001|Period 1|Physician Decision|0|||
163339959|NCT01107912|589953119|FG002|Period 1|Physician Decision|0|||
163339960|NCT01107912|589953120|FG003|Period 1|Physician Decision|0|||
163111360|NCT01962987|589114084|FG000|Overall Study|Randomized in Error|4|||
163111361|NCT01962987|589114085|FG001|Overall Study|Randomized in Error|2|||
163111362|NCT01962987|589114086|FG002|Overall Study|Randomized in Error|2|||
163111363|NCT02264665|589114087|FG000|Overall Study|Other|0|||
163222434|NCT00749463|589531478|FG002|Overall Study|Adverse Event|1|||
163222435|NCT00749463|589531476|FG000|Overall Study|Withdrawal by Subject|1|||
163339961|NCT01107912|589953121|FG004|Period 1|Physician Decision|1|||
163111364|NCT02264665|589114088|FG001|Overall Study|Other|0|||
163111365|NCT02264665|589114089|FG002|Overall Study|Other|3|||
163111366|NCT02264665|589114090|FG003|Overall Study|Other|0|||
163111367|NCT02264665|589114091|FG004|Overall Study|Other|0|||
163111368|NCT02264665|589114092|FG005|Overall Study|Other|0|||
163111369|NCT02264665|589114093|FG006|Overall Study|Other|0|||
163222436|NCT00749463|589531477|FG001|Overall Study|Withdrawal by Subject|0|||
163222437|NCT00749463|589531478|FG002|Overall Study|Withdrawal by Subject|0|||
163222438|NCT00116831|589531479|FG000|Overall Study|Adverse Event|14|||
163222439|NCT00116831|589531480|FG001|Overall Study|Adverse Event|16|||
163222440|NCT00116831|589531479|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
163222441|NCT00116831|589531480|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
163222442|NCT00116831|589531479|FG000|Overall Study|Lost to Follow-up|8|||
163222443|NCT00116831|589531480|FG001|Overall Study|Lost to Follow-up|6|||
163222444|NCT00116831|589531479|FG000|Overall Study|Protocol Violation|3|||
163222445|NCT00116831|589531480|FG001|Overall Study|Protocol Violation|6|||
163222446|NCT00116831|589531479|FG000|Overall Study|Hypoglycaemic events|1|||
163222447|NCT00116831|589531480|FG001|Overall Study|Hypoglycaemic events|0|||
163222448|NCT00116831|589531479|FG000|Overall Study|Low haemoglobin on screening|1|||
163222449|NCT00116831|589531480|FG001|Overall Study|Low haemoglobin on screening|0|||
163222450|NCT00116831|589531479|FG000|Overall Study|Withdrawn investigational product|1|||
163222451|NCT00116831|589531480|FG001|Overall Study|Withdrawn investigational product|0|||
163222452|NCT00116831|589531479|FG000|Overall Study|Withdrawal by Subject|32|||
163222453|NCT00116831|589531480|FG001|Overall Study|Withdrawal by Subject|32|||
163222454|NCT00116831|589531479|FG000|Overall Study|Insufficient therapeutic effect|0|||
163222455|NCT00116831|589531480|FG001|Overall Study|Insufficient therapeutic effect|1|||
163222456|NCT00116831|589531479|FG000|Overall Study|Missing data for participant|1|||
163222457|NCT00116831|589531480|FG001|Overall Study|Missing data for participant|0|||
163222458|NCT04904185|589531481|FG000|Overall Study|Expansion failure|1|||
163222459|NCT04904185|589531482|FG001|Overall Study|Expansion failure|0|||
163222460|NCT04904185|589531481|FG000|Overall Study|Late response on prior treatment|1|||
163222461|NCT04904185|589531482|FG001|Overall Study|Late response on prior treatment|0|||
163222462|NCT01344369|589531485|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
163222463|NCT01344369|589531486|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
163222464|NCT01344369|589531485|FG000|Washout of 28 Days|Physician Decision|0|||
163222465|NCT01344369|589531486|FG001|Washout of 28 Days|Physician Decision|1|||
163222466|NCT01344369|589531485|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
163222467|NCT01344369|589531486|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
163222468|NCT00333229|589531493|FG000|Overall Study|Lack of Efficacy|0|||
163222469|NCT00333229|589531494|FG001|Overall Study|Lack of Efficacy|1|||
163222470|NCT00735371|589531501|FG000|Overall Study|Adverse Event|3|||
163222471|NCT00735371|589531502|FG001|Overall Study|Adverse Event|3|||
163222472|NCT00735371|589531503|FG002|Overall Study|Adverse Event|4|||
163222473|NCT00735371|589531504|FG003|Overall Study|Adverse Event|1|||
163222474|NCT00735371|589531501|FG000|Overall Study|Protocol Violation|2|||
163222475|NCT00735371|589531502|FG001|Overall Study|Protocol Violation|2|||
163222476|NCT00735371|589531503|FG002|Overall Study|Protocol Violation|0|||
163222477|NCT00735371|589531504|FG003|Overall Study|Protocol Violation|3|||
163222478|NCT00735371|589531501|FG000|Overall Study|Withdrawal by Subject|0|||
163111370|NCT02264665|589114087|FG000|Overall Study|Death|9|||
163111371|NCT02264665|589114088|FG001|Overall Study|Death|8|||
163111372|NCT02264665|589114089|FG002|Overall Study|Death|13|||
163111373|NCT02264665|589114090|FG003|Overall Study|Death|5|||
163111374|NCT02264665|589114091|FG004|Overall Study|Death|0|||
163111375|NCT02264665|589114092|FG005|Overall Study|Death|0|||
163111376|NCT02264665|589114093|FG006|Overall Study|Death|1|||
163111377|NCT02264665|589114087|FG000|Overall Study|Lost to Follow-up|1|||
163111378|NCT02264665|589114088|FG001|Overall Study|Lost to Follow-up|0|||
163111379|NCT02264665|589114089|FG002|Overall Study|Lost to Follow-up|2|||
163111380|NCT02264665|589114090|FG003|Overall Study|Lost to Follow-up|1|||
163111381|NCT02264665|589114091|FG004|Overall Study|Lost to Follow-up|0|||
163111382|NCT02264665|589114092|FG005|Overall Study|Lost to Follow-up|0|||
163222479|NCT00735371|589531502|FG001|Overall Study|Withdrawal by Subject|2|||
163222480|NCT00735371|589531503|FG002|Overall Study|Withdrawal by Subject|2|||
163222481|NCT00735371|589531504|FG003|Overall Study|Withdrawal by Subject|0|||
163222482|NCT00735371|589531501|FG000|Overall Study|Lost to Follow-up|1|||
163111383|NCT02264665|589114093|FG006|Overall Study|Lost to Follow-up|0|||
163111384|NCT02264665|589114087|FG000|Overall Study|Participant decision|0|||
163222483|NCT00735371|589531502|FG001|Overall Study|Lost to Follow-up|1|||
163222484|NCT00735371|589531503|FG002|Overall Study|Lost to Follow-up|3|||
163222485|NCT00735371|589531504|FG003|Overall Study|Lost to Follow-up|1|||
163222486|NCT00735371|589531501|FG000|Overall Study|Lack of Efficacy|4|||
163222487|NCT00735371|589531502|FG001|Overall Study|Lack of Efficacy|2|||
163222488|NCT00735371|589531503|FG002|Overall Study|Lack of Efficacy|0|||
163222489|NCT00735371|589531504|FG003|Overall Study|Lack of Efficacy|4|||
163222490|NCT00735371|589531501|FG000|Overall Study|Sponsor Decision|3|||
163222491|NCT00735371|589531502|FG001|Overall Study|Sponsor Decision|1|||
163339962|NCT01107912|589953122|FG005|Period 1|Physician Decision|0|||
163339963|NCT01107912|589953117|FG000|Period 1|Withdrawal by Subject|1|||
163222492|NCT00735371|589531503|FG002|Overall Study|Sponsor Decision|0|||
163339964|NCT01107912|589953118|FG001|Period 1|Withdrawal by Subject|0|||
163111385|NCT02264665|589114088|FG001|Overall Study|Participant decision|0|||
163111386|NCT02264665|589114089|FG002|Overall Study|Participant decision|0|||
163111387|NCT02264665|589114090|FG003|Overall Study|Participant decision|1|||
163111388|NCT02264665|589114091|FG004|Overall Study|Participant decision|0|||
163111389|NCT02264665|589114092|FG005|Overall Study|Participant decision|0|||
163111390|NCT02264665|589114093|FG006|Overall Study|Participant decision|0|||
163111391|NCT02264665|589114087|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
163111392|NCT02264665|589114088|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
163111393|NCT02264665|589114089|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
163111394|NCT02264665|589114090|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
163111395|NCT02264665|589114091|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
163111396|NCT02264665|589114092|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
163111397|NCT02264665|589114093|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
163111398|NCT02264665|589114087|FG000|Overall Study|Data Missing|0|||
163111399|NCT02264665|589114088|FG001|Overall Study|Data Missing|0|||
163111400|NCT02264665|589114089|FG002|Overall Study|Data Missing|1|||
163111401|NCT02264665|589114090|FG003|Overall Study|Data Missing|0|||
163111402|NCT02264665|589114091|FG004|Overall Study|Data Missing|0|||
163111403|NCT02264665|589114092|FG005|Overall Study|Data Missing|0|||
163111404|NCT02264665|589114093|FG006|Overall Study|Data Missing|0|||
163111405|NCT00789581|589114094|FG000|AC Therapy|Adverse Event|2|||
163111406|NCT00789581|589114095|FG001|AC Therapy|Adverse Event|3|||
163111407|NCT00789581|589114094|FG000|AC Therapy|Withdrawal by Subject|4|||
163111408|NCT00789581|589114095|FG001|AC Therapy|Withdrawal by Subject|7|||
163111409|NCT00789581|589114094|FG000|AC Therapy|Disease recurrence|3|||
163111410|NCT00789581|589114095|FG001|AC Therapy|Disease recurrence|1|||
163111411|NCT00789581|589114094|FG000|AC Therapy|Intercurrent Illness|1|||
163111412|NCT00789581|589114095|FG001|AC Therapy|Intercurrent Illness|0|||
163111413|NCT00789581|589114094|FG000|AC Therapy|Never Treated|1|||
163111414|NCT00789581|589114095|FG001|AC Therapy|Never Treated|4|||
163111415|NCT00789581|589114094|FG000|AC Therapy|Other|0|||
163111416|NCT00789581|589114095|FG001|AC Therapy|Other|2|||
163111417|NCT00789581|589114094|FG000|Adjuvant Therapy|Never treated|2|||
163111418|NCT00789581|589114095|FG001|Adjuvant Therapy|Never treated|2|||
163111419|NCT00789581|589114094|FG000|Adjuvant Therapy|Adverse Event|20|||
163111420|NCT00789581|589114095|FG001|Adjuvant Therapy|Adverse Event|44|||
163111421|NCT00789581|589114094|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
163111422|NCT00789581|589114095|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
163111423|NCT00789581|589114094|FG000|Adjuvant Therapy|Disease recurrence|2|||
163111424|NCT00789581|589114095|FG001|Adjuvant Therapy|Disease recurrence|1|||
163111425|NCT00789581|589114094|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
163111426|NCT00789581|589114095|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
163111427|NCT00789581|589114094|FG000|Adjuvant Therapy|Protocol Violation|1|||
163111428|NCT00789581|589114095|FG001|Adjuvant Therapy|Protocol Violation|1|||
163111429|NCT00789581|589114094|FG000|Adjuvant Therapy|Other|0|||
163111430|NCT00789581|589114095|FG001|Adjuvant Therapy|Other|1|||
163111431|NCT01468207|589114096|FG000|Treatment Period 1|Adverse Event|1|||
163111432|NCT01468207|589114097|FG001|Treatment Period 1|Adverse Event|0|||
163111433|NCT01468207|589114098|FG002|Treatment Period 1|Adverse Event|0|||
163111434|NCT01468207|589114099|FG003|Treatment Period 1|Adverse Event|0|||
163111435|NCT01468207|589114100|FG004|Treatment Period 1|Adverse Event|0|||
163111436|NCT01468207|589114101|FG005|Treatment Period 1|Adverse Event|0|||
163111437|NCT01468207|589114096|FG000|Treatment Period 1|Protocol Violation|1|||
163111438|NCT01468207|589114097|FG001|Treatment Period 1|Protocol Violation|1|||
163111439|NCT01468207|589114098|FG002|Treatment Period 1|Protocol Violation|0|||
163111440|NCT01468207|589114099|FG003|Treatment Period 1|Protocol Violation|0|||
163111441|NCT01468207|589114100|FG004|Treatment Period 1|Protocol Violation|0|||
163111442|NCT01468207|589114101|FG005|Treatment Period 1|Protocol Violation|0|||
163111443|NCT01468207|589114096|FG000|Treatment Period 1|Withdrawal by Subject|5|||
163222493|NCT00735371|589531504|FG003|Overall Study|Sponsor Decision|1|||
163222494|NCT00735371|589531501|FG000|Overall Study|Protocol Violation|0|||
163222495|NCT00735371|589531502|FG001|Overall Study|Protocol Violation|1|||
163222496|NCT00735371|589531503|FG002|Overall Study|Protocol Violation|2|||
163222497|NCT00735371|589531504|FG003|Overall Study|Protocol Violation|0|||
163222498|NCT00735371|589531501|FG000|Overall Study|Prior Vyvanse Exposure|1|||
163222499|NCT00735371|589531502|FG001|Overall Study|Prior Vyvanse Exposure|1|||
163222500|NCT00735371|589531503|FG002|Overall Study|Prior Vyvanse Exposure|0|||
163111444|NCT01468207|589114097|FG001|Treatment Period 1|Withdrawal by Subject|4|||
163111445|NCT01468207|589114098|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163111446|NCT01468207|589114099|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163111447|NCT01468207|589114100|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163111448|NCT01468207|589114101|FG005|Treatment Period 1|Withdrawal by Subject|0|||
163111449|NCT01468207|589114096|FG000|Treatment Period 1|Lost to Follow-up|2|||
163111450|NCT01468207|589114097|FG001|Treatment Period 1|Lost to Follow-up|1|||
163111451|NCT01468207|589114098|FG002|Treatment Period 1|Lost to Follow-up|0|||
163111452|NCT01468207|589114099|FG003|Treatment Period 1|Lost to Follow-up|0|||
163111453|NCT01468207|589114100|FG004|Treatment Period 1|Lost to Follow-up|0|||
163111454|NCT01468207|589114101|FG005|Treatment Period 1|Lost to Follow-up|0|||
163111455|NCT01468207|589114096|FG000|Treatment Period 1|Other|0|||
163111456|NCT01468207|589114097|FG001|Treatment Period 1|Other|2|||
163111457|NCT01468207|589114098|FG002|Treatment Period 1|Other|0|||
163111458|NCT01468207|589114099|FG003|Treatment Period 1|Other|0|||
163111459|NCT01468207|589114100|FG004|Treatment Period 1|Other|0|||
163111460|NCT01468207|589114101|FG005|Treatment Period 1|Other|0|||
163111461|NCT01468207|589114096|FG000|Treatment Period 2|Adverse Event|0|||
163111462|NCT01468207|589114097|FG001|Treatment Period 2|Adverse Event|0|||
163111463|NCT01468207|589114098|FG002|Treatment Period 2|Adverse Event|6|||
163111464|NCT01468207|589114099|FG003|Treatment Period 2|Adverse Event|1|||
163111465|NCT01468207|589114100|FG004|Treatment Period 2|Adverse Event|2|||
163111466|NCT01468207|589114101|FG005|Treatment Period 2|Adverse Event|1|||
163111467|NCT01468207|589114096|FG000|Treatment Period 2|Lack of Efficacy|0|||
163111468|NCT01468207|589114097|FG001|Treatment Period 2|Lack of Efficacy|0|||
163111469|NCT01468207|589114098|FG002|Treatment Period 2|Lack of Efficacy|1|||
163111470|NCT01468207|589114099|FG003|Treatment Period 2|Lack of Efficacy|1|||
163111471|NCT01468207|589114100|FG004|Treatment Period 2|Lack of Efficacy|0|||
163111472|NCT01468207|589114101|FG005|Treatment Period 2|Lack of Efficacy|2|||
163111473|NCT01468207|589114096|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163111474|NCT01468207|589114097|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163111475|NCT01468207|589114098|FG002|Treatment Period 2|Withdrawal by Subject|5|||
163111476|NCT01468207|589114099|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163111477|NCT01468207|589114100|FG004|Treatment Period 2|Withdrawal by Subject|0|||
163111478|NCT01468207|589114101|FG005|Treatment Period 2|Withdrawal by Subject|2|||
163111479|NCT01468207|589114096|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
163111480|NCT01468207|589114097|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
163111481|NCT01468207|589114098|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
163111482|NCT01468207|589114099|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
163111483|NCT01468207|589114100|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
163111484|NCT01468207|589114101|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
163111485|NCT01468207|589114096|FG000|Treatment Period 2|Lost to Follow-up|0|||
163111486|NCT01468207|589114097|FG001|Treatment Period 2|Lost to Follow-up|0|||
163111487|NCT01468207|589114098|FG002|Treatment Period 2|Lost to Follow-up|5|||
163111488|NCT01468207|589114099|FG003|Treatment Period 2|Lost to Follow-up|1|||
163111489|NCT01468207|589114100|FG004|Treatment Period 2|Lost to Follow-up|0|||
163111490|NCT01468207|589114101|FG005|Treatment Period 2|Lost to Follow-up|0|||
163111491|NCT01468207|589114096|FG000|Treatment Period 2|Other|0|||
163111492|NCT01468207|589114097|FG001|Treatment Period 2|Other|0|||
163111493|NCT01468207|589114098|FG002|Treatment Period 2|Other|5|||
163111494|NCT01468207|589114099|FG003|Treatment Period 2|Other|1|||
163111495|NCT01468207|589114100|FG004|Treatment Period 2|Other|1|||
163111496|NCT01468207|589114101|FG005|Treatment Period 2|Other|2|||
163111497|NCT00470093|589114102|FG000|Overall Study|Adverse Event|2|||
163111498|NCT01328041|589114103|FG000|Overall Study|Adverse Event|7|||
163111499|NCT01328041|589114103|FG000|Overall Study|Lack of Efficacy|27|||
163111500|NCT01328041|589114103|FG000|Overall Study|Protocol Violation|7|||
163111501|NCT01328041|589114103|FG000|Overall Study|Lost to Follow-up|7|||
163111502|NCT01328041|589114103|FG000|Overall Study|Physician Decision|2|||
163111503|NCT01328041|589114103|FG000|Overall Study|Withdrawal by Subject|7|||
163111504|NCT00664560|589114104|FG000|Overall Study|Adverse Event|19|||
163111505|NCT00664560|589114105|FG001|Overall Study|Adverse Event|16|||
163111506|NCT00664560|589114106|FG002|Overall Study|Adverse Event|7|||
163111507|NCT00664560|589114104|FG000|Overall Study|Withdrawal by Subject|9|||
163111508|NCT00664560|589114105|FG001|Overall Study|Withdrawal by Subject|13|||
163111509|NCT00664560|589114106|FG002|Overall Study|Withdrawal by Subject|7|||
163111510|NCT00664560|589114104|FG000|Overall Study|Lost to Follow-up|0|||
163111511|NCT00664560|589114105|FG001|Overall Study|Lost to Follow-up|2|||
163111512|NCT00664560|589114106|FG002|Overall Study|Lost to Follow-up|0|||
163111513|NCT00664560|589114104|FG000|Overall Study|Other|11|||
163111514|NCT00664560|589114105|FG001|Overall Study|Other|4|||
163111515|NCT00664560|589114106|FG002|Overall Study|Other|5|||
163111516|NCT03392883|589114107|FG000|Overall Study|Lost to Follow-up|122|||
163111517|NCT03392883|589114108|FG001|Overall Study|Lost to Follow-up|13|||
163111518|NCT03392883|589114109|FG002|Overall Study|Lost to Follow-up|9|||
163111519|NCT03392883|589114107|FG000|Overall Study|Death|4|||
163111520|NCT03392883|589114108|FG001|Overall Study|Death|0|||
163111521|NCT03392883|589114109|FG002|Overall Study|Death|0|||
163111522|NCT03392883|589114107|FG000|Overall Study|Lack of Efficacy|29|||
163111523|NCT03392883|589114108|FG001|Overall Study|Lack of Efficacy|0|||
163111524|NCT03392883|589114109|FG002|Overall Study|Lack of Efficacy|0|||
163111525|NCT03392883|589114107|FG000|Overall Study|Withdrawal by Subject|180|||
163111526|NCT03392883|589114108|FG001|Overall Study|Withdrawal by Subject|0|||
163111527|NCT03392883|589114109|FG002|Overall Study|Withdrawal by Subject|0|||
163111528|NCT03392883|589114107|FG000|Overall Study|Adverse Event|1|||
163111529|NCT03392883|589114108|FG001|Overall Study|Adverse Event|0|||
163111530|NCT03392883|589114109|FG002|Overall Study|Adverse Event|0|||
163111531|NCT02688088|589114111|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
163111532|NCT02688088|589114112|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
163111533|NCT02688088|589114113|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
163111534|NCT02688088|589114114|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
163222501|NCT00735371|589531504|FG003|Overall Study|Prior Vyvanse Exposure|0|||
163222502|NCT00735371|589531501|FG000|Overall Study|Exclusion criteria|1|||
163222503|NCT00735371|589531502|FG001|Overall Study|Exclusion criteria|0|||
163222504|NCT00735371|589531503|FG002|Overall Study|Exclusion criteria|0|||
163222505|NCT00735371|589531504|FG003|Overall Study|Exclusion criteria|0|||
163222506|NCT01533246|589531505|FG000|Overall Study|Adverse Event|1|||
163222507|NCT01533246|589531505|FG000|Overall Study|Withdrawal by Subject|1|||
163222508|NCT01987427|589531511|FG000|Overall Study|Adverse Event|4|||
163222509|NCT01987427|589531512|FG001|Overall Study|Adverse Event|2|||
163222510|NCT01987427|589531513|FG002|Overall Study|Adverse Event|8|||
163222511|NCT01987427|589531511|FG000|Overall Study|Lost to Follow-up|6|||
163222512|NCT01987427|589531512|FG001|Overall Study|Lost to Follow-up|6|||
163222513|NCT01987427|589531513|FG002|Overall Study|Lost to Follow-up|9|||
163222514|NCT01987427|589531511|FG000|Overall Study|Withdrawal by Subject|2|||
163222515|NCT01987427|589531512|FG001|Overall Study|Withdrawal by Subject|1|||
163222516|NCT01987427|589531513|FG002|Overall Study|Withdrawal by Subject|3|||
163222517|NCT01987427|589531511|FG000|Overall Study|Lack of Efficacy|1|||
163222518|NCT01987427|589531512|FG001|Overall Study|Lack of Efficacy|0|||
163222519|NCT01987427|589531513|FG002|Overall Study|Lack of Efficacy|0|||
163222520|NCT01987427|589531511|FG000|Overall Study|Other|1|||
163222521|NCT01987427|589531512|FG001|Overall Study|Other|1|||
163222522|NCT01987427|589531513|FG002|Overall Study|Other|0|||
163222523|NCT02129803|589531521|FG000|Overall Study|Protocol Violation|4|||
163222524|NCT02129803|589531522|FG001|Overall Study|Protocol Violation|0|||
163222525|NCT02129803|589531521|FG000|Overall Study|Physician Decision|0|||
163222526|NCT02129803|589531522|FG001|Overall Study|Physician Decision|1|||
163222527|NCT02129803|589531521|FG000|Overall Study|Difficulty sleeping|1|||
163222528|NCT02129803|589531522|FG001|Overall Study|Difficulty sleeping|0|||
163222529|NCT02129803|589531521|FG000|Overall Study|Morning headache|0|||
163222530|NCT02129803|589531522|FG001|Overall Study|Morning headache|1|||
163222531|NCT02129803|589531521|FG000|Overall Study|Withdrawal by Subject|1|||
163222532|NCT02129803|589531522|FG001|Overall Study|Withdrawal by Subject|1|||
163222533|NCT02319031|589531523|FG000|Treatment Period|Death|1|||
163222534|NCT02319031|589531524|FG001|Treatment Period|Death|0|||
163222535|NCT01465464|589531535|FG000|Overall Study|Adverse Event|96|||
163222536|NCT01465464|589531536|FG001|Overall Study|Adverse Event|49|||
163222537|NCT01465464|589531535|FG000|Overall Study|Lack of Efficacy|139|||
163222538|NCT01465464|589531536|FG001|Overall Study|Lack of Efficacy|190|||
163222539|NCT01465464|589531535|FG000|Overall Study|Physician Decision|13|||
163222540|NCT01465464|589531536|FG001|Overall Study|Physician Decision|5|||
163222541|NCT01465464|589531535|FG000|Overall Study|Protocol Violation|1|||
163222542|NCT01465464|589531536|FG001|Overall Study|Protocol Violation|1|||
163222543|NCT01465464|589531535|FG000|Overall Study|Withdrawal by Subject|46|||
163222544|NCT01465464|589531536|FG001|Overall Study|Withdrawal by Subject|30|||
163222545|NCT01465464|589531535|FG000|Overall Study|Other|9|||
163222546|NCT01465464|589531536|FG001|Overall Study|Other|3|||
163222547|NCT01465464|589531535|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
163222548|NCT01465464|589531536|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
163222549|NCT01183975|589531539|FG000|Overall Study|Lost to Follow-up|73|||
163222550|NCT02739269|589531547|FG000|Overall Study|Protocol Violation|5|||
163222551|NCT02739269|589531548|FG001|Overall Study|Protocol Violation|0|||
163222552|NCT02739269|589531547|FG000|Overall Study|Cycle cancellation|2|||
163222553|NCT02739269|589531548|FG001|Overall Study|Cycle cancellation|2|||
163222554|NCT02739269|589531547|FG000|Overall Study|Withdrawal by Subject|0|||
163222555|NCT02739269|589531548|FG001|Overall Study|Withdrawal by Subject|2|||
163222556|NCT02244580|589531549|FG000|Overall Study|No cancer tissues available|241|||
163222557|NCT02136576|589531551|FG000|Overall Study|Lost to Follow-up|2|||
163222558|NCT02136576|589531552|FG001|Overall Study|Lost to Follow-up|0|||
163222559|NCT02136576|589531553|FG002|Overall Study|Lost to Follow-up|0|||
163222560|NCT01708174|589531554|FG000|Treatment Period|Withdrawal by Subject|1|||
163222561|NCT01708174|589531555|FG001|Treatment Period|Withdrawal by Subject|0|||
163222562|NCT01708174|589531556|FG002|Treatment Period|Withdrawal by Subject|0|||
163222563|NCT01708174|589531554|FG000|Treatment Period|Progressive disease|0|||
163222564|NCT01708174|589531555|FG001|Treatment Period|Progressive disease|1|||
163222565|NCT01708174|589531556|FG002|Treatment Period|Progressive disease|0|||
163222566|NCT01708174|589531554|FG000|Treatment Period|Death|0|||
163222567|NCT01708174|589531555|FG001|Treatment Period|Death|0|||
163222568|NCT01708174|589531556|FG002|Treatment Period|Death|1|||
163222569|NCT01708174|589531554|FG000|Treatment Period|Adverse Event|0|||
163222570|NCT01708174|589531555|FG001|Treatment Period|Adverse Event|1|||
163222571|NCT01708174|589531556|FG002|Treatment Period|Adverse Event|0|||
163222572|NCT00923559|589531557|FG000|Overall Study|Lost to Follow-up|2|||
163222573|NCT00923559|589531558|FG001|Overall Study|Lost to Follow-up|3|||
163222574|NCT02268812|589531559|FG000|Overall Study|Adverse Event|8|||
163222575|NCT02268812|589531560|FG001|Overall Study|Adverse Event|26|||
163222576|NCT02268812|589531561|FG002|Overall Study|Adverse Event|7|||
163222577|NCT02268812|589531562|FG003|Overall Study|Adverse Event|10|||
163222578|NCT02268812|589531559|FG000|Overall Study|Protocol deviation|0|||
163222579|NCT02268812|589531560|FG001|Overall Study|Protocol deviation|0|||
163222580|NCT02268812|589531561|FG002|Overall Study|Protocol deviation|1|||
163339965|NCT01107912|589953119|FG002|Period 1|Withdrawal by Subject|0|||
163111535|NCT02688088|589114115|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
163111536|NCT02688088|589114111|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
163111537|NCT02688088|589114112|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
163111538|NCT02688088|589114113|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
163111539|NCT02688088|589114114|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
163111540|NCT02688088|589114115|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
163111541|NCT02688088|589114111|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
163111542|NCT02688088|589114112|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
163111543|NCT02688088|589114113|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
163111544|NCT02688088|589114114|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
163111545|NCT02688088|589114115|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
163111546|NCT02688088|589114111|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
163111547|NCT02688088|589114112|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
163111548|NCT02688088|589114113|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
163111549|NCT02688088|589114114|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
163111550|NCT02688088|589114115|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
163111551|NCT02688088|589114111|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
163111552|NCT02688088|589114112|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
163111553|NCT02688088|589114113|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
163111554|NCT02688088|589114114|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
163111555|NCT02688088|589114115|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
163111556|NCT02688088|589114111|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
163111557|NCT02688088|589114112|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
163111558|NCT02688088|589114113|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
163111559|NCT02688088|589114114|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
163111560|NCT02688088|589114115|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
163111561|NCT02688088|589114111|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
163111562|NCT02688088|589114112|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
163111563|NCT02688088|589114113|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
163111564|NCT02688088|589114114|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
163111565|NCT02688088|589114115|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
163111566|NCT02688088|589114111|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
163111567|NCT02688088|589114112|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
163111568|NCT02688088|589114113|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
163111569|NCT02688088|589114114|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
163111570|NCT02688088|589114115|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
163111571|NCT02688088|589114111|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
163111572|NCT02688088|589114112|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
163111573|NCT02688088|589114113|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
163111574|NCT02688088|589114114|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
163111575|NCT02688088|589114115|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
163111576|NCT00313313|589114119|FG000|Overall Study|Lack of Efficacy|14|||
163111577|NCT00313313|589114120|FG001|Overall Study|Lack of Efficacy|9|||
163111578|NCT00313313|589114121|FG002|Overall Study|Lack of Efficacy|20|||
163111579|NCT00313313|589114119|FG000|Overall Study|Withdrawal of consent by subject|18|||
163111580|NCT00313313|589114120|FG001|Overall Study|Withdrawal of consent by subject|17|||
163111581|NCT00313313|589114121|FG002|Overall Study|Withdrawal of consent by subject|31|||
163111582|NCT00313313|589114119|FG000|Overall Study|Lost to Follow-up|10|||
163111583|NCT00313313|589114120|FG001|Overall Study|Lost to Follow-up|7|||
163111584|NCT00313313|589114121|FG002|Overall Study|Lost to Follow-up|9|||
163111585|NCT00313313|589114119|FG000|Overall Study|Adverse Event|15|||
163111586|NCT00313313|589114120|FG001|Overall Study|Adverse Event|16|||
163111587|NCT00313313|589114121|FG002|Overall Study|Adverse Event|12|||
163111588|NCT00313313|589114119|FG000|Overall Study|Physician Decision|2|||
163111589|NCT00313313|589114120|FG001|Overall Study|Physician Decision|6|||
163111590|NCT00313313|589114121|FG002|Overall Study|Physician Decision|4|||
163111591|NCT00313313|589114119|FG000|Overall Study|Poor/Noncompliance|3|||
163111592|NCT00313313|589114120|FG001|Overall Study|Poor/Noncompliance|6|||
163111593|NCT00313313|589114121|FG002|Overall Study|Poor/Noncompliance|2|||
163111594|NCT00313313|589114119|FG000|Overall Study|Pregnancy|1|||
163111595|NCT00313313|589114120|FG001|Overall Study|Pregnancy|2|||
163111596|NCT00313313|589114121|FG002|Overall Study|Pregnancy|0|||
163111597|NCT00313313|589114119|FG000|Overall Study|Death|0|||
163111598|NCT00313313|589114120|FG001|Overall Study|Death|0|||
163111599|NCT00313313|589114121|FG002|Overall Study|Death|2|||
163111600|NCT00313313|589114119|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
163111601|NCT00313313|589114120|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
163111602|NCT00313313|589114121|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
163111603|NCT01973387|589114122|FG000|Overall Study|Adverse Event|14|||
163407892|NCT00328627|590203966|FG005|Overall Study|Hyperglycemic Rescue|5|||
163407893|NCT00328627|590203967|FG006|Overall Study|Hyperglycemic Rescue|19|||
163407894|NCT00328627|590203968|FG007|Overall Study|Hyperglycemic Rescue|6|||
163407895|NCT00328627|590203969|FG008|Overall Study|Hyperglycemic Rescue|6|||
163111604|NCT01973387|589114123|FG001|Overall Study|Adverse Event|4|||
163111605|NCT01973387|589114122|FG000|Overall Study|Withdrawal by Subject|7|||
163111606|NCT01973387|589114123|FG001|Overall Study|Withdrawal by Subject|4|||
163111607|NCT01973387|589114122|FG000|Overall Study|Study terminated by sponsor|63|||
163111608|NCT01973387|589114123|FG001|Overall Study|Study terminated by sponsor|0|||
163111609|NCT01973387|589114122|FG000|Overall Study|Progressive disease or relapse|16|||
163111610|NCT01973387|589114123|FG001|Overall Study|Progressive disease or relapse|5|||
163111611|NCT01973387|589114122|FG000|Overall Study|Death|4|||
163111612|NCT01973387|589114123|FG001|Overall Study|Death|3|||
163111613|NCT01973387|589114122|FG000|Overall Study|Randomized, not treated|2|||
163111614|NCT01973387|589114123|FG001|Overall Study|Randomized, not treated|2|||
163111615|NCT01345591|589114124|FG000|Overall Study|Lost to Follow-up|1|||
163111616|NCT03305419|589114127|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163111617|NCT03305419|589114128|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
163111618|NCT03305419|589114129|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163111619|NCT03305419|589114130|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163111620|NCT03305419|589114131|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163111621|NCT03305419|589114132|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163111622|NCT03305419|589114133|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163111623|NCT03305419|589114134|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163111624|NCT03305419|589114127|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
163111625|NCT03305419|589114128|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
163111626|NCT03305419|589114129|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
163111627|NCT03305419|589114130|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
163111628|NCT03305419|589114131|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
163111629|NCT03305419|589114132|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
163111630|NCT03305419|589114133|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
163111631|NCT03305419|589114134|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
163111632|NCT03305419|589114127|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
163111633|NCT03305419|589114128|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
163111634|NCT03305419|589114129|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
163111635|NCT03305419|589114130|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
163111636|NCT03305419|589114131|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
163111637|NCT03305419|589114132|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
163111638|NCT03305419|589114133|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
163111639|NCT03305419|589114134|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
163111640|NCT03305419|589114127|FG000|Part B (14 Days)|Adverse Event|0|||
163111641|NCT03305419|589114128|FG001|Part B (14 Days)|Adverse Event|0|||
163111642|NCT03305419|589114129|FG002|Part B (14 Days)|Adverse Event|0|||
163111643|NCT03305419|589114130|FG003|Part B (14 Days)|Adverse Event|0|||
163111644|NCT03305419|589114131|FG004|Part B (14 Days)|Adverse Event|1|||
163111645|NCT03305419|589114132|FG005|Part B (14 Days)|Adverse Event|2|||
163111646|NCT03305419|589114133|FG006|Part B (14 Days)|Adverse Event|4|||
163111647|NCT03305419|589114134|FG007|Part B (14 Days)|Adverse Event|0|||
163111648|NCT03305419|589114127|FG000|Part B (14 Days)|Physician Decision|0|||
163111649|NCT03305419|589114128|FG001|Part B (14 Days)|Physician Decision|0|||
163222581|NCT02268812|589531562|FG003|Overall Study|Protocol deviation|0|||
163222582|NCT02268812|589531559|FG000|Overall Study|Withdrawal by Subject|0|||
163222583|NCT02268812|589531560|FG001|Overall Study|Withdrawal by Subject|1|||
163222584|NCT02268812|589531561|FG002|Overall Study|Withdrawal by Subject|0|||
163222585|NCT02268812|589531562|FG003|Overall Study|Withdrawal by Subject|0|||
163222586|NCT02268812|589531559|FG000|Overall Study|Physician Decision|3|||
163222587|NCT02268812|589531560|FG001|Overall Study|Physician Decision|1|||
163222588|NCT02268812|589531561|FG002|Overall Study|Physician Decision|0|||
163222589|NCT02268812|589531562|FG003|Overall Study|Physician Decision|1|||
163222590|NCT02268812|589531559|FG000|Overall Study|Other|5|||
163222591|NCT02268812|589531560|FG001|Overall Study|Other|4|||
163222592|NCT02268812|589531561|FG002|Overall Study|Other|1|||
163222593|NCT02268812|589531562|FG003|Overall Study|Other|3|||
163222594|NCT01951157|589531564|FG000|Overall Study|Progressive Disease|12|||
163407896|NCT00328627|590203970|FG009|Overall Study|Hyperglycemic Rescue|11|||
163407897|NCT00328627|590203971|FG010|Overall Study|Hyperglycemic Rescue|3|||
163111650|NCT03305419|589114129|FG002|Part B (14 Days)|Physician Decision|0|||
163111651|NCT03305419|589114130|FG003|Part B (14 Days)|Physician Decision|0|||
163111652|NCT03305419|589114131|FG004|Part B (14 Days)|Physician Decision|2|||
163111653|NCT03305419|589114132|FG005|Part B (14 Days)|Physician Decision|8|||
163111654|NCT03305419|589114133|FG006|Part B (14 Days)|Physician Decision|1|||
163111655|NCT03305419|589114134|FG007|Part B (14 Days)|Physician Decision|0|||
163222595|NCT01951157|589531565|FG001|Overall Study|Progressive Disease|13|||
163111656|NCT00223977|589114138|FG000|Overall Study|Adverse Event|7|||
163111657|NCT00223977|589114139|FG001|Overall Study|Adverse Event|10|||
163111658|NCT00223977|589114140|FG002|Overall Study|Adverse Event|0|||
163111659|NCT00223977|589114138|FG000|Overall Study|Protocol Violation|0|||
163111660|NCT00223977|589114139|FG001|Overall Study|Protocol Violation|0|||
163111661|NCT00223977|589114140|FG002|Overall Study|Protocol Violation|1|||
163111662|NCT00223977|589114138|FG000|Overall Study|Withdrawal by Subject|1|||
163111663|NCT00223977|589114139|FG001|Overall Study|Withdrawal by Subject|1|||
163111664|NCT00223977|589114140|FG002|Overall Study|Withdrawal by Subject|2|||
163111665|NCT00223977|589114138|FG000|Overall Study|Other|1|||
163111666|NCT00223977|589114139|FG001|Overall Study|Other|0|||
163111667|NCT00223977|589114140|FG002|Overall Study|Other|0|||
163111668|NCT02359045|589114141|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
163111669|NCT02359045|589114142|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163111670|NCT02359045|589114141|FG000|Overall Study|Lost to Follow-up|1|||
163111671|NCT02359045|589114142|FG001|Overall Study|Lost to Follow-up|1|||
163111672|NCT02359045|589114141|FG000|Overall Study|Adverse Event|0|||
163111673|NCT02359045|589114142|FG001|Overall Study|Adverse Event|1|||
163111674|NCT02118766|589114148|FG000|Overall Study|Adverse Event|7|||
163111675|NCT02118766|589114149|FG001|Overall Study|Adverse Event|2|||
163111676|NCT02118766|589114148|FG000|Overall Study|Withdrawal by Subject|3|||
163111677|NCT02118766|589114149|FG001|Overall Study|Withdrawal by Subject|6|||
163111678|NCT02118766|589114148|FG000|Overall Study|Lost to Follow-up|5|||
163111679|NCT02118766|589114149|FG001|Overall Study|Lost to Follow-up|4|||
163111680|NCT02118766|589114148|FG000|Overall Study|Withdrawal by parent/guardian|12|||
163111681|NCT02118766|589114149|FG001|Overall Study|Withdrawal by parent/guardian|18|||
163111682|NCT02118766|589114148|FG000|Overall Study|Other|3|||
163111683|NCT02118766|589114149|FG001|Overall Study|Other|1|||
163111684|NCT02248649|589114152|FG000|Overall Study|Death|7|||
163111685|NCT02248649|589114153|FG001|Overall Study|Death|11|||
163111686|NCT02248649|589114152|FG000|Overall Study|Lost to Follow-up|14|||
163111687|NCT02248649|589114153|FG001|Overall Study|Lost to Follow-up|10|||
163111688|NCT04621240|589114155|FG000|Overall Study|Withdrawal by Subject|36|||
163111689|NCT00780143|589114156|FG000|Overall Study|Progressive disease|1|||
163111690|NCT00780143|589114156|FG000|Overall Study|Toxicity|1|||
163111691|NCT00780143|589114156|FG000|Overall Study|Adverse Event|1|||
163111692|NCT01457014|589114161|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
163111693|NCT01457014|589114162|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
163111694|NCT01457014|589114163|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
163111695|NCT01457014|589114164|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
163111696|NCT01457014|589114161|FG000|First Night|Withdrawal by Subject|3|||
163111697|NCT01457014|589114162|FG001|First Night|Withdrawal by Subject|0|||
163111698|NCT01457014|589114163|FG002|First Night|Withdrawal by Subject|0|||
163111699|NCT01457014|589114164|FG003|First Night|Withdrawal by Subject|0|||
163111700|NCT02461290|589114165|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
163111701|NCT02461290|589114165|FG000|Overall Study|Lost to Follow-up|3|||
163111702|NCT03319953|589114166|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
163111703|NCT03319953|589114167|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
163111704|NCT03319953|589114168|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
163111705|NCT03319953|589114169|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
163111706|NCT03319953|589114166|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
163111707|NCT03319953|589114167|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
163111708|NCT03319953|589114168|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
163111709|NCT03319953|589114169|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
163111710|NCT04027049|589114173|FG000|Overall Study|Withdrawn by family|1|||
163111711|NCT04027049|589114174|FG001|Overall Study|Withdrawn by family|0|||
163111712|NCT04027049|589114173|FG000|Overall Study|Participant safety|1|||
163111713|NCT04027049|589114174|FG001|Overall Study|Participant safety|0|||
163111714|NCT02226198|589115530|FG000|Lead-in Phase|Protocol Violation|1|||
163111715|NCT02226198|589115531|FG001|Lead-in Phase|Protocol Violation|0|||
163111716|NCT02226198|589115532|FG002|Lead-in Phase|Protocol Violation|0|||
163111717|NCT02226198|589115530|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
163111718|NCT02226198|589115531|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
163111719|NCT02226198|589115532|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
163111720|NCT01440517|589115536|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
163111721|NCT01288612|589115537|FG000|Overall Study|Unable to contact|11|||
163111722|NCT01288612|589115538|FG001|Overall Study|Unable to contact|16|||
163111723|NCT01288612|589115539|FG002|Overall Study|Unable to contact|20|||
163111724|NCT01288612|589115537|FG000|Overall Study|Declined|78|||
163111725|NCT01288612|589115538|FG001|Overall Study|Declined|63|||
163111726|NCT01288612|589115539|FG002|Overall Study|Declined|62|||
163222596|NCT01951157|589531566|FG002|Overall Study|Progressive Disease|10|||
163111727|NCT01288612|589115537|FG000|Overall Study|Unable to intubate|0|||
163111728|NCT01288612|589115538|FG001|Overall Study|Unable to intubate|3|||
163111729|NCT01288612|589115539|FG002|Overall Study|Unable to intubate|0|||
163111730|NCT00871923|589115540|FG000|Overall Study|Death|1|||
163111731|NCT00871923|589115540|FG000|Overall Study|Withdrawal by Subject|1|||
163111732|NCT00496483|589115546|FG000|Overall Study|Not dosed|9|||
163111733|NCT00496483|589115546|FG000|Overall Study|Adverse Event|2|||
163111734|NCT00496483|589115546|FG000|Overall Study|Lack of Efficacy|1|||
163111735|NCT04258995|589115548|FG000|Overall Study|Lost to Follow-up|1|||
163111736|NCT04258995|589115549|FG001|Overall Study|Lost to Follow-up|1|||
163111737|NCT03285958|589115551|FG000|Overall Study|Lost to Follow-up|1|||
163111738|NCT03285958|589115552|FG001|Overall Study|Lost to Follow-up|1|||
163111739|NCT03285958|589115551|FG000|Overall Study|Withdrawal by Subject|1|||
163111740|NCT03285958|589115552|FG001|Overall Study|Withdrawal by Subject|0|||
163111741|NCT03285958|589115551|FG000|Overall Study|Not able to attend required orientation|3|||
163111742|NCT03285958|589115552|FG001|Overall Study|Not able to attend required orientation|0|||
163111743|NCT00316693|589115555|FG000|Overall Study|Adverse Event|6|||
163111744|NCT00316693|589115556|FG001|Overall Study|Adverse Event|1|||
163111745|NCT00316693|589115555|FG000|Overall Study|Protocol Violation|1|||
163111746|NCT00316693|589115556|FG001|Overall Study|Protocol Violation|0|||
163111747|NCT00316693|589115555|FG000|Overall Study|Withdrawal by Subject|6|||
163111748|NCT00316693|589115556|FG001|Overall Study|Withdrawal by Subject|6|||
163111749|NCT00316693|589115555|FG000|Overall Study|Lost to Follow-up|26|||
163111750|NCT00316693|589115556|FG001|Overall Study|Lost to Follow-up|34|||
163111751|NCT00316693|589115555|FG000|Overall Study|Other|38|||
163111752|NCT00316693|589115556|FG001|Overall Study|Other|44|||
163111753|NCT01967823|589115557|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
163111754|NCT00413894|589115562|FG000|Overall Study|Withdrawal by Subject|10|||
163111755|NCT00413894|589115562|FG000|Overall Study|Administrative Reasons|1|||
163111756|NCT00413894|589115562|FG000|Overall Study|Hb <10 grams/deciliter|12|||
163111757|NCT00413894|589115562|FG000|Overall Study|Adverse Event|28|||
163111758|NCT00413894|589115562|FG000|Overall Study|Protocol Violation|11|||
163111759|NCT00413894|589115562|FG000|Overall Study|Other|18|||
163111760|NCT04225676|589115563|FG000|Overall Study|Physician Decision|1|||
163111761|NCT04225676|589115563|FG000|Overall Study|Lack of Efficacy|1|||
163111762|NCT04225676|589115563|FG000|Overall Study|Study terminated by sponsor|3|||
163111763|NCT05289271|589115566|FG000|Overall Study|Mistakenly allocated, untreated|1|||
163111764|NCT05289271|589115567|FG001|Overall Study|Mistakenly allocated, untreated|0|||
163111765|NCT02019108|589115568|FG000|Overall Study|Lost to Follow-up|5|||
163111766|NCT02019108|589115569|FG001|Overall Study|Lost to Follow-up|7|||
163111767|NCT00908115|589115580|FG000|Overall Study|Other|14|||
163111768|NCT02442310|589115590|FG000|Overall Study|Adverse Event|2|||
163111769|NCT02442310|589115590|FG000|Overall Study|Withdrawal by Subject|1|||
163111770|NCT02851797|589115591|FG000|Overall Study|Withdrawal by Subject|4|||
163111771|NCT02851797|589115592|FG001|Overall Study|Withdrawal by Subject|2|||
163111772|NCT02851797|589115591|FG000|Overall Study|Adverse Event|3|||
163111773|NCT02851797|589115592|FG001|Overall Study|Adverse Event|0|||
163111774|NCT03077438|589115593|FG000|Overall Study|Protocol Violation|3|||
163111775|NCT03077438|589115594|FG001|Overall Study|Protocol Violation|5|||
163111776|NCT03077438|589115593|FG000|Overall Study|Withdrawal by Subject|3|||
163111777|NCT03077438|589115594|FG001|Overall Study|Withdrawal by Subject|6|||
163111778|NCT03077438|589115593|FG000|Overall Study|Lost to Follow-up|6|||
163111779|NCT03077438|589115594|FG001|Overall Study|Lost to Follow-up|3|||
163111780|NCT03466099|589115596|FG000|Overall Study|Adverse Event|1|||
163111781|NCT03466099|589115597|FG001|Overall Study|Adverse Event|1|||
163111782|NCT03466099|589115598|FG002|Overall Study|Adverse Event|1|||
163111783|NCT03466099|589115596|FG000|Overall Study|Withdrawal by Subject|2|||
163111784|NCT03466099|589115597|FG001|Overall Study|Withdrawal by Subject|3|||
163111785|NCT03466099|589115598|FG002|Overall Study|Withdrawal by Subject|1|||
163111786|NCT03466099|589115596|FG000|Overall Study|Use of rescue medication|8|||
163111787|NCT03466099|589115597|FG001|Overall Study|Use of rescue medication|9|||
163111788|NCT03466099|589115598|FG002|Overall Study|Use of rescue medication|13|||
163111789|NCT03466099|589115596|FG000|Overall Study|Rescued without meeting criteria|4|||
163111790|NCT03466099|589115597|FG001|Overall Study|Rescued without meeting criteria|1|||
163111791|NCT03466099|589115598|FG002|Overall Study|Rescued without meeting criteria|1|||
163111792|NCT03466099|589115596|FG000|Overall Study|Subject compliance|2|||
163111793|NCT03466099|589115597|FG001|Overall Study|Subject compliance|0|||
163111794|NCT03466099|589115598|FG002|Overall Study|Subject compliance|0|||
163111795|NCT03466099|589115596|FG000|Overall Study|Worsening disease|0|||
163339966|NCT01107912|589953120|FG003|Period 1|Withdrawal by Subject|0|||
163339967|NCT01107912|589953121|FG004|Period 1|Withdrawal by Subject|0|||
163339968|NCT01107912|589953122|FG005|Period 1|Withdrawal by Subject|0|||
163339969|NCT01107912|589953117|FG000|Period 2|Physician Decision|0|||
163339970|NCT01107912|589953118|FG001|Period 2|Physician Decision|0|||
163111796|NCT03466099|589115597|FG001|Overall Study|Worsening disease|0|||
163111797|NCT03466099|589115598|FG002|Overall Study|Worsening disease|1|||
163111798|NCT03622112|589115599|FG000|Overall Study|Withdrawal by Subject|6|||
163111799|NCT03622112|589115600|FG001|Overall Study|Withdrawal by Subject|2|||
163111800|NCT03622112|589115601|FG002|Overall Study|Withdrawal by Subject|4|||
163111801|NCT03622112|589115602|FG003|Overall Study|Withdrawal by Subject|2|||
163111802|NCT03622112|589115603|FG004|Overall Study|Withdrawal by Subject|1|||
163111803|NCT03622112|589115604|FG005|Overall Study|Withdrawal by Subject|2|||
163111804|NCT03622112|589115605|FG006|Overall Study|Withdrawal by Subject|2|||
163111805|NCT03622112|589115599|FG000|Overall Study|Death|0|||
163111806|NCT03622112|589115600|FG001|Overall Study|Death|0|||
163111807|NCT03622112|589115601|FG002|Overall Study|Death|0|||
163111808|NCT03622112|589115602|FG003|Overall Study|Death|1|||
163111809|NCT03622112|589115603|FG004|Overall Study|Death|0|||
163111810|NCT03622112|589115604|FG005|Overall Study|Death|0|||
163111811|NCT03622112|589115605|FG006|Overall Study|Death|0|||
163111812|NCT03622112|589115599|FG000|Overall Study|Lost to Follow-up|1|||
163111813|NCT03622112|589115600|FG001|Overall Study|Lost to Follow-up|1|||
163111814|NCT03622112|589115601|FG002|Overall Study|Lost to Follow-up|0|||
163111815|NCT03622112|589115602|FG003|Overall Study|Lost to Follow-up|0|||
163111816|NCT03622112|589115603|FG004|Overall Study|Lost to Follow-up|0|||
163111817|NCT03622112|589115604|FG005|Overall Study|Lost to Follow-up|0|||
163111818|NCT03622112|589115605|FG006|Overall Study|Lost to Follow-up|0|||
163111819|NCT03622112|589115599|FG000|Overall Study|Study-specific withdrawal criteria|10|||
163111820|NCT03622112|589115600|FG001|Overall Study|Study-specific withdrawal criteria|8|||
163111821|NCT03622112|589115601|FG002|Overall Study|Study-specific withdrawal criteria|7|||
163111822|NCT03622112|589115602|FG003|Overall Study|Study-specific withdrawal criteria|6|||
163111823|NCT03622112|589115603|FG004|Overall Study|Study-specific withdrawal criteria|4|||
163111824|NCT03622112|589115604|FG005|Overall Study|Study-specific withdrawal criteria|18|||
163111825|NCT03622112|589115605|FG006|Overall Study|Study-specific withdrawal criteria|4|||
163111826|NCT03622112|589115599|FG000|Overall Study|Protocol Violation|2|||
163111827|NCT03622112|589115600|FG001|Overall Study|Protocol Violation|0|||
163111828|NCT03622112|589115601|FG002|Overall Study|Protocol Violation|1|||
163111829|NCT03622112|589115602|FG003|Overall Study|Protocol Violation|1|||
163111830|NCT03622112|589115603|FG004|Overall Study|Protocol Violation|0|||
163111831|NCT03622112|589115604|FG005|Overall Study|Protocol Violation|0|||
163111832|NCT03622112|589115605|FG006|Overall Study|Protocol Violation|0|||
163111833|NCT03622112|589115599|FG000|Overall Study|Adverse Event|6|||
163111834|NCT03622112|589115600|FG001|Overall Study|Adverse Event|8|||
163111835|NCT03622112|589115601|FG002|Overall Study|Adverse Event|4|||
163111836|NCT03622112|589115602|FG003|Overall Study|Adverse Event|11|||
163111837|NCT03622112|589115603|FG004|Overall Study|Adverse Event|4|||
163111838|NCT03622112|589115604|FG005|Overall Study|Adverse Event|20|||
163111839|NCT03622112|589115605|FG006|Overall Study|Adverse Event|2|||
163111840|NCT03622112|589115599|FG000|Overall Study|Reason not specified|0|||
163111841|NCT03622112|589115600|FG001|Overall Study|Reason not specified|1|||
163111842|NCT03622112|589115601|FG002|Overall Study|Reason not specified|0|||
163111843|NCT03622112|589115602|FG003|Overall Study|Reason not specified|1|||
163111844|NCT03622112|589115603|FG004|Overall Study|Reason not specified|1|||
163111845|NCT03622112|589115604|FG005|Overall Study|Reason not specified|2|||
163111846|NCT03622112|589115605|FG006|Overall Study|Reason not specified|1|||
163111847|NCT01165320|589115606|FG000|Overall Study|Clinical adverse experience|2|||
163111848|NCT01165320|589115607|FG001|Overall Study|Clinical adverse experience|1|||
163111849|NCT01165320|589115608|FG002|Overall Study|Clinical adverse experience|0|||
163111850|NCT01165320|589115606|FG000|Overall Study|Laboratory adverse experience|1|||
163111851|NCT01165320|589115607|FG001|Overall Study|Laboratory adverse experience|0|||
163111852|NCT01165320|589115608|FG002|Overall Study|Laboratory adverse experience|0|||
163111853|NCT01165320|589115606|FG000|Overall Study|Lack of Efficacy|0|||
163111854|NCT01165320|589115607|FG001|Overall Study|Lack of Efficacy|2|||
163111855|NCT01165320|589115608|FG002|Overall Study|Lack of Efficacy|0|||
163111856|NCT01165320|589115606|FG000|Overall Study|Reason unknown|0|||
163111857|NCT01165320|589115607|FG001|Overall Study|Reason unknown|1|||
163111858|NCT01165320|589115608|FG002|Overall Study|Reason unknown|0|||
163111859|NCT02075047|589115614|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
163111860|NCT02075047|589115615|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
163111861|NCT02075047|589115614|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
163111862|NCT02075047|589115615|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
163111863|NCT02075047|589115614|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
163111864|NCT02075047|589115615|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
163111865|NCT02075047|589115614|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
163111866|NCT02075047|589115615|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
163111867|NCT02075047|589115614|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
163111868|NCT02075047|589115615|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
163111869|NCT02075047|589115614|FG000|Treatment Phase (4 Weeks)|Other|1|||
163111870|NCT02075047|589115615|FG001|Treatment Phase (4 Weeks)|Other|1|||
163111871|NCT02075047|589115614|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
163111872|NCT02075047|589115615|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
163222597|NCT01951157|589531564|FG000|Overall Study|Treatment-unrelated AE|1|||
163111873|NCT02075047|589115614|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
163111874|NCT02075047|589115615|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
163222598|NCT01951157|589531565|FG001|Overall Study|Treatment-unrelated AE|0|||
163111875|NCT02075047|589115614|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
163111876|NCT02075047|589115615|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
163111877|NCT02075047|589115614|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
163111878|NCT02075047|589115615|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
163111879|NCT02075047|589115614|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
163111880|NCT02075047|589115615|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
163111881|NCT02075047|589115614|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
163111882|NCT02075047|589115615|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
163111883|NCT02075047|589115614|FG000|Follow up Phase (5 Weeks)|Other|1|||
163111884|NCT02075047|589115615|FG001|Follow up Phase (5 Weeks)|Other|2|||
163111885|NCT02075047|589115614|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
163111886|NCT02075047|589115615|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
163111887|NCT01155466|589115616|FG000|Overall Study|Adverse Event|13|||
163111888|NCT01155466|589115617|FG001|Overall Study|Adverse Event|15|||
163111889|NCT01155466|589115618|FG002|Overall Study|Adverse Event|6|||
163111890|NCT01155466|589115619|FG003|Overall Study|Adverse Event|17|||
163111891|NCT01155466|589115620|FG004|Overall Study|Adverse Event|18|||
163111892|NCT01155466|589115616|FG000|Overall Study|Lost to Follow-up|0|||
163111893|NCT01155466|589115617|FG001|Overall Study|Lost to Follow-up|0|||
163111894|NCT01155466|589115618|FG002|Overall Study|Lost to Follow-up|0|||
163111895|NCT01155466|589115619|FG003|Overall Study|Lost to Follow-up|0|||
163111896|NCT01155466|589115620|FG004|Overall Study|Lost to Follow-up|2|||
163111897|NCT01155466|589115616|FG000|Overall Study|Withdrawal by Subject|7|||
163111898|NCT01155466|589115617|FG001|Overall Study|Withdrawal by Subject|5|||
163111899|NCT01155466|589115618|FG002|Overall Study|Withdrawal by Subject|9|||
163111900|NCT01155466|589115619|FG003|Overall Study|Withdrawal by Subject|4|||
163111901|NCT01155466|589115620|FG004|Overall Study|Withdrawal by Subject|4|||
163111902|NCT01155466|589115616|FG000|Overall Study|Protocol Violation|0|||
163111903|NCT01155466|589115617|FG001|Overall Study|Protocol Violation|0|||
163111904|NCT01155466|589115618|FG002|Overall Study|Protocol Violation|2|||
163111905|NCT01155466|589115619|FG003|Overall Study|Protocol Violation|0|||
163111906|NCT01155466|589115620|FG004|Overall Study|Protocol Violation|1|||
163111907|NCT01155466|589115616|FG000|Overall Study|Administrative|0|||
163111908|NCT01155466|589115617|FG001|Overall Study|Administrative|3|||
163111909|NCT01155466|589115618|FG002|Overall Study|Administrative|0|||
163111910|NCT01155466|589115619|FG003|Overall Study|Administrative|0|||
163111911|NCT01155466|589115620|FG004|Overall Study|Administrative|0|||
163111912|NCT01155466|589115616|FG000|Overall Study|Randomized not treated|2|||
163111913|NCT01155466|589115617|FG001|Overall Study|Randomized not treated|2|||
163111914|NCT01155466|589115618|FG002|Overall Study|Randomized not treated|3|||
163111915|NCT01155466|589115619|FG003|Overall Study|Randomized not treated|0|||
163111916|NCT01155466|589115620|FG004|Overall Study|Randomized not treated|2|||
163111917|NCT00075946|589115621|FG000|Overall Study|Path ineligible: undetermined histology|0|||
163111918|NCT00075946|589115622|FG001|Overall Study|Path ineligible: undetermined histology|0|||
163111919|NCT00075946|589115623|FG002|Overall Study|Path ineligible: undetermined histology|0|||
163111920|NCT00075946|589115624|FG003|Overall Study|Path ineligible: undetermined histology|0|||
163111921|NCT00075946|589115625|FG004|Overall Study|Path ineligible: undetermined histology|6|||
163111922|NCT00075946|589115621|FG000|Overall Study|Did not achieve response after induction|0|||
163111923|NCT00075946|589115622|FG001|Overall Study|Did not achieve response after induction|0|||
163111924|NCT00075946|589115623|FG002|Overall Study|Did not achieve response after induction|0|||
163111925|NCT00075946|589115624|FG003|Overall Study|Did not achieve response after induction|0|||
163111926|NCT00075946|589115625|FG004|Overall Study|Did not achieve response after induction|182|||
163111927|NCT00075946|589115621|FG000|Overall Study|Incorrectly randomized (no response)|5|||
163111928|NCT00075946|589115622|FG001|Overall Study|Incorrectly randomized (no response)|5|||
163111929|NCT00075946|589115623|FG002|Overall Study|Incorrectly randomized (no response)|5|||
163111930|NCT00075946|589115624|FG003|Overall Study|Incorrectly randomized (no response)|1|||
163111931|NCT00075946|589115625|FG004|Overall Study|Incorrectly randomized (no response)|0|||
163111932|NCT00075946|589115621|FG000|Overall Study|Adverse Event|2|||
163111933|NCT00075946|589115622|FG001|Overall Study|Adverse Event|10|||
163111934|NCT00075946|589115623|FG002|Overall Study|Adverse Event|0|||
163111935|NCT00075946|589115624|FG003|Overall Study|Adverse Event|2|||
163111936|NCT00075946|589115625|FG004|Overall Study|Adverse Event|0|||
163111937|NCT00075946|589115621|FG000|Overall Study|Death|0|||
163111938|NCT00075946|589115622|FG001|Overall Study|Death|1|||
163111939|NCT00075946|589115623|FG002|Overall Study|Death|0|||
163111940|NCT00075946|589115624|FG003|Overall Study|Death|0|||
163111941|NCT00075946|589115625|FG004|Overall Study|Death|0|||
163111942|NCT00075946|589115621|FG000|Overall Study|Withdrawal by Subject|23|||
163111943|NCT00075946|589115622|FG001|Overall Study|Withdrawal by Subject|58|||
163111944|NCT00075946|589115623|FG002|Overall Study|Withdrawal by Subject|4|||
163111945|NCT00075946|589115624|FG003|Overall Study|Withdrawal by Subject|9|||
163111946|NCT00075946|589115625|FG004|Overall Study|Withdrawal by Subject|0|||
163111947|NCT00075946|589115621|FG000|Overall Study|Alternative therapy|16|||
163111948|NCT00075946|589115622|FG001|Overall Study|Alternative therapy|2|||
163111949|NCT00075946|589115623|FG002|Overall Study|Alternative therapy|5|||
163111950|NCT00075946|589115624|FG003|Overall Study|Alternative therapy|0|||
163111951|NCT00075946|589115625|FG004|Overall Study|Alternative therapy|0|||
163111952|NCT00075946|589115621|FG000|Overall Study|Other complicating disease|7|||
163111953|NCT00075946|589115622|FG001|Overall Study|Other complicating disease|13|||
163111954|NCT00075946|589115623|FG002|Overall Study|Other complicating disease|1|||
163111955|NCT00075946|589115624|FG003|Overall Study|Other complicating disease|4|||
163111956|NCT00075946|589115625|FG004|Overall Study|Other complicating disease|0|||
163111957|NCT00075946|589115621|FG000|Overall Study|No response to retreatment|23|||
163111958|NCT00075946|589115622|FG001|Overall Study|No response to retreatment|0|||
163111959|NCT00075946|589115623|FG002|Overall Study|No response to retreatment|2|||
163111960|NCT00075946|589115624|FG003|Overall Study|No response to retreatment|0|||
163111961|NCT00075946|589115625|FG004|Overall Study|No response to retreatment|0|||
163111962|NCT00075946|589115621|FG000|Overall Study|Time to progression less than 6 months|15|||
163111963|NCT00075946|589115622|FG001|Overall Study|Time to progression less than 6 months|30|||
163111964|NCT00075946|589115623|FG002|Overall Study|Time to progression less than 6 months|8|||
163111965|NCT00075946|589115624|FG003|Overall Study|Time to progression less than 6 months|3|||
163111966|NCT00075946|589115625|FG004|Overall Study|Time to progression less than 6 months|0|||
163111967|NCT00075946|589115621|FG000|Overall Study|Other|57|||
163111968|NCT00075946|589115622|FG001|Overall Study|Other|32|||
163111969|NCT00075946|589115623|FG002|Overall Study|Other|3|||
163111970|NCT00075946|589115624|FG003|Overall Study|Other|11|||
163111971|NCT00075946|589115625|FG004|Overall Study|Other|0|||
163111972|NCT04154605|589115630|FG000|Overall Study|Procedure Canceled|1|||
163111973|NCT04154605|589115631|FG001|Overall Study|Procedure Canceled|1|||
163111974|NCT04154605|589115630|FG000|Overall Study|Missed follow up|1|||
163111975|NCT04154605|589115631|FG001|Overall Study|Missed follow up|1|||
163111976|NCT04154605|589115630|FG000|Overall Study|Withdrawal by Subject|1|||
163111977|NCT04154605|589115631|FG001|Overall Study|Withdrawal by Subject|0|||
163111978|NCT01229254|589115632|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
163111979|NCT01229254|589115633|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
163111980|NCT01229254|589115634|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
163111981|NCT01229254|589115632|FG000|Overall Study|Adverse Event|4|||
163111982|NCT01229254|589115633|FG001|Overall Study|Adverse Event|5|||
163111983|NCT01229254|589115634|FG002|Overall Study|Adverse Event|3|||
163111984|NCT01229254|589115632|FG000|Overall Study|Lost to Follow-up|3|||
163111985|NCT01229254|589115633|FG001|Overall Study|Lost to Follow-up|0|||
163111986|NCT01229254|589115634|FG002|Overall Study|Lost to Follow-up|1|||
163111987|NCT01229254|589115632|FG000|Overall Study|Physician Decision|0|||
163111988|NCT01229254|589115633|FG001|Overall Study|Physician Decision|3|||
163111989|NCT01229254|589115634|FG002|Overall Study|Physician Decision|0|||
163111990|NCT01229254|589115632|FG000|Overall Study|Protocol Violation|4|||
163111991|NCT01229254|589115633|FG001|Overall Study|Protocol Violation|6|||
163111992|NCT01229254|589115634|FG002|Overall Study|Protocol Violation|5|||
163111993|NCT01229254|589115632|FG000|Overall Study|Withdrawal by Subject|1|||
163111994|NCT01229254|589115633|FG001|Overall Study|Withdrawal by Subject|0|||
163111995|NCT01229254|589115634|FG002|Overall Study|Withdrawal by Subject|1|||
163111996|NCT01229254|589115632|FG000|Overall Study|Non-compliance with Study Drug|0|||
163111997|NCT01229254|589115633|FG001|Overall Study|Non-compliance with Study Drug|1|||
163111998|NCT01229254|589115634|FG002|Overall Study|Non-compliance with Study Drug|1|||
163111999|NCT02231892|589115635|FG000|Overall Study|Lost to Follow-up|1|||
163112000|NCT02231892|589115636|FG001|Overall Study|Lost to Follow-up|0|||
163112001|NCT02231892|589115637|FG002|Overall Study|Lost to Follow-up|3|||
163112002|NCT02231892|589115635|FG000|Overall Study|Withdrawal by Subject|4|||
163112003|NCT02231892|589115636|FG001|Overall Study|Withdrawal by Subject|3|||
163112004|NCT02231892|589115637|FG002|Overall Study|Withdrawal by Subject|15|||
163112005|NCT02231892|589115635|FG000|Overall Study|Physician Decision|0|||
163112006|NCT02231892|589115636|FG001|Overall Study|Physician Decision|2|||
163112007|NCT02231892|589115637|FG002|Overall Study|Physician Decision|4|||
163112008|NCT02231892|589115635|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
163112009|NCT02231892|589115636|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
163112010|NCT02231892|589115637|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
163112011|NCT02231892|589115635|FG000|Overall Study|Participant motor threshold was >83%|0|||
163112012|NCT02231892|589115636|FG001|Overall Study|Participant motor threshold was >83%|0|||
163112013|NCT02231892|589115637|FG002|Overall Study|Participant motor threshold was >83%|9|||
163112014|NCT02231892|589115635|FG000|Overall Study|Could not find motor threshold|2|||
163112015|NCT02231892|589115636|FG001|Overall Study|Could not find motor threshold|0|||
163112016|NCT02231892|589115637|FG002|Overall Study|Could not find motor threshold|1|||
163112017|NCT02231892|589115635|FG000|Overall Study|Could not find reliable motor hotspot|0|||
163112018|NCT02231892|589115636|FG001|Overall Study|Could not find reliable motor hotspot|0|||
163112019|NCT02231892|589115637|FG002|Overall Study|Could not find reliable motor hotspot|1|||
163112020|NCT00515294|589115645|FG000|Overall Study|Lost to Follow-up|3|||
163112021|NCT00515294|589115646|FG001|Overall Study|Lost to Follow-up|2|||
163112022|NCT00515294|589115647|FG002|Overall Study|Lost to Follow-up|3|||
163112023|NCT00515294|589115648|FG003|Overall Study|Lost to Follow-up|1|||
163112024|NCT00515294|589115645|FG000|Overall Study|Driver simulator problems|1|||
163112025|NCT00515294|589115646|FG001|Overall Study|Driver simulator problems|1|||
163112026|NCT00515294|589115647|FG002|Overall Study|Driver simulator problems|1|||
163112027|NCT00515294|589115648|FG003|Overall Study|Driver simulator problems|3|||
163112028|NCT00515294|589115645|FG000|Overall Study|Caffeine amount inaccurate|5|||
163112029|NCT00515294|589115646|FG001|Overall Study|Caffeine amount inaccurate|0|||
163112030|NCT00515294|589115647|FG002|Overall Study|Caffeine amount inaccurate|7|||
163112031|NCT00515294|589115648|FG003|Overall Study|Caffeine amount inaccurate|0|||
163112032|NCT01534260|589115653|FG000|Overall Study|Adverse Event|1|||
163112033|NCT01534260|589115654|FG001|Overall Study|Adverse Event|8|||
163112034|NCT01534260|589115653|FG000|Overall Study|Death|2|||
163112035|NCT01534260|589115654|FG001|Overall Study|Death|0|||
163112036|NCT01534260|589115653|FG000|Overall Study|Lack of Efficacy|1|||
163112037|NCT01534260|589115654|FG001|Overall Study|Lack of Efficacy|1|||
163112038|NCT01534260|589115653|FG000|Overall Study|Withdrawal by Subject|1|||
163112039|NCT01534260|589115654|FG001|Overall Study|Withdrawal by Subject|3|||
163112040|NCT01534260|589115653|FG000|Overall Study|Disease Progression|8|||
163112041|NCT01534260|589115654|FG001|Overall Study|Disease Progression|6|||
163112042|NCT01534260|589115653|FG000|Overall Study|Physician Decision|3|||
163112043|NCT01534260|589115654|FG001|Overall Study|Physician Decision|1|||
163112044|NCT01534260|589115653|FG000|Overall Study|No treatment, per protocol|0|||
163112045|NCT01534260|589115654|FG001|Overall Study|No treatment, per protocol|1|||
163112046|NCT01342965|589115658|FG000|Overall Study|Death|58|||
163112047|NCT01342965|589115659|FG001|Overall Study|Death|57|||
163112048|NCT01342965|589115658|FG000|Overall Study|Lost to Follow-up|5|||
163112049|NCT01342965|589115659|FG001|Overall Study|Lost to Follow-up|3|||
163112050|NCT01342965|589115658|FG000|Overall Study|Other Reasons- Unspecified|44|||
163112051|NCT01342965|589115659|FG001|Overall Study|Other Reasons- Unspecified|38|||
163112052|NCT01342965|589115658|FG000|Overall Study|Withdrawal by Subject|2|||
163112053|NCT01342965|589115659|FG001|Overall Study|Withdrawal by Subject|9|||
163112054|NCT00856206|589115660|FG000|Overall Study|Protocol Violation|6|||
163112055|NCT00856206|589115661|FG001|Overall Study|Protocol Violation|18|||
163112056|NCT00856206|589115660|FG000|Overall Study|Adverse Event|10|||
163112057|NCT00856206|589115661|FG001|Overall Study|Adverse Event|46|||
163112058|NCT00856206|589115660|FG000|Overall Study|Lack of Efficacy|1|||
163112059|NCT00856206|589115661|FG001|Overall Study|Lack of Efficacy|2|||
163112060|NCT00856206|589115660|FG000|Overall Study|Withdrawal by Subject|15|||
163112061|NCT00856206|589115661|FG001|Overall Study|Withdrawal by Subject|36|||
163112062|NCT00856206|589115660|FG000|Overall Study|Lost to Follow-up|13|||
163112063|NCT00856206|589115661|FG001|Overall Study|Lost to Follow-up|39|||
163112064|NCT00856206|589115660|FG000|Overall Study|Death|2|||
163112065|NCT00856206|589115661|FG001|Overall Study|Death|2|||
163112066|NCT00856206|589115660|FG000|Overall Study|Decision by the Sponsor|4|||
163112067|NCT00856206|589115661|FG001|Overall Study|Decision by the Sponsor|8|||
163112068|NCT00856206|589115660|FG000|Overall Study|Other than specified above|3|||
163112069|NCT00856206|589115661|FG001|Overall Study|Other than specified above|10|||
163112070|NCT00503581|589115666|FG000|Overall Study|Study closed|3|||
163112071|NCT00503581|589115667|FG001|Overall Study|Study closed|4|||
163112072|NCT00503581|589115668|FG002|Overall Study|Study closed|2|||
163112073|NCT02780856|589115669|FG000|Overall Study|Lost to Follow-up|1|||
163112074|NCT01301066|589115673|FG000|Overall Study|Lost to Follow-up|5|||
163112075|NCT01301066|589115674|FG001|Overall Study|Lost to Follow-up|11|||
163112076|NCT01301066|589115673|FG000|Overall Study|Protocol Violation|8|||
163407898|NCT00328627|590203972|FG011|Overall Study|Hyperglycemic Rescue|2|||
163407899|NCT00328627|590203961|FG000|Overall Study|Adverse Event|3|||
163112077|NCT01301066|589115674|FG001|Overall Study|Protocol Violation|7|||
163112078|NCT01301066|589115673|FG000|Overall Study|Withdrawal by Subject|4|||
163112079|NCT01301066|589115674|FG001|Overall Study|Withdrawal by Subject|9|||
163112080|NCT01301066|589115673|FG000|Overall Study|Adverse Event|6|||
163112081|NCT01301066|589115674|FG001|Overall Study|Adverse Event|6|||
163112082|NCT01301066|589115673|FG000|Overall Study|Sponsor Decision|2|||
163112083|NCT01301066|589115674|FG001|Overall Study|Sponsor Decision|1|||
163112084|NCT01301066|589115673|FG000|Overall Study|Physician Decision|0|||
163112085|NCT01301066|589115674|FG001|Overall Study|Physician Decision|1|||
163112086|NCT01301066|589115673|FG000|Overall Study|Other|2|||
163112087|NCT01301066|589115674|FG001|Overall Study|Other|0|||
163112088|NCT04003207|589115677|FG000|Overall Study|Protocol Violation|1|||
163112089|NCT01145352|589117704|FG000|Overall Study|Found to have been registered twice|6|||
163112090|NCT01145352|589117704|FG000|Overall Study|Treated before marketing approval|4|||
163112091|NCT01145352|589117704|FG000|Overall Study|Syringe formulation was used|1|||
163112092|NCT01739933|589117707|FG000|Overall Study|Death|89|||
163112093|NCT01739933|589117708|FG001|Overall Study|Death|86|||
163112094|NCT01739933|589117707|FG000|Overall Study|Withdrawal by Subject|10|||
163112095|NCT01739933|589117708|FG001|Overall Study|Withdrawal by Subject|8|||
163112096|NCT01739933|589117707|FG000|Overall Study|Lost to Follow-up|3|||
163112097|NCT01739933|589117708|FG001|Overall Study|Lost to Follow-up|10|||
163112098|NCT01739933|589117707|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
163112099|NCT01739933|589117708|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
163112100|NCT03356977|589117709|FG000|Overall Study|Lost to Follow-up|3|||
163112101|NCT03356977|589117709|FG000|Overall Study|Withdrawal by parent/guardian|2|||
163407900|NCT00328627|590203962|FG001|Overall Study|Adverse Event|1|||
163112102|NCT01728077|589117710|FG000|Overall Study|Lack of Efficacy|3|||
163112103|NCT01728077|589117711|FG001|Overall Study|Lack of Efficacy|1|||
163407901|NCT00328627|590203963|FG002|Overall Study|Adverse Event|2|||
163112104|NCT01728077|589117710|FG000|Overall Study|Lost to Follow-up|1|||
163112105|NCT01728077|589117711|FG001|Overall Study|Lost to Follow-up|0|||
163339971|NCT01107912|589953119|FG002|Period 2|Physician Decision|1|||
163339972|NCT01107912|589953120|FG003|Period 2|Physician Decision|0|||
163339973|NCT01107912|589953121|FG004|Period 2|Physician Decision|0|||
163339974|NCT01107912|589953122|FG005|Period 2|Physician Decision|0|||
163112106|NCT01728077|589117710|FG000|Overall Study|Subject choice|2|||
163112107|NCT01728077|589117711|FG001|Overall Study|Subject choice|3|||
163112108|NCT01728077|589117710|FG000|Overall Study|Death|0|||
163112109|NCT01728077|589117711|FG001|Overall Study|Death|1|||
163112110|NCT01728077|589117710|FG000|Overall Study|Patient moving|1|||
163112111|NCT01728077|589117711|FG001|Overall Study|Patient moving|0|||
163112112|NCT01728077|589117710|FG000|Overall Study|Non compliance|1|||
163112113|NCT01728077|589117711|FG001|Overall Study|Non compliance|0|||
163112114|NCT00378599|589117714|FG000|Overall Study|Adverse Event|38|||
163112115|NCT00378599|589117714|FG000|Overall Study|Protocol Violation|2|||
163112116|NCT00378599|589117714|FG000|Overall Study|Treatment failure|7|||
163112117|NCT00378599|589117714|FG000|Overall Study|Withdrawal by Subject|5|||
163112118|NCT03224507|589117715|FG000|Overall Study|Death|3|||
163112119|NCT03224507|589117716|FG001|Overall Study|Death|0|||
163112120|NCT03224507|589117715|FG000|Overall Study|Lack of Efficacy|6|||
163112121|NCT03224507|589117716|FG001|Overall Study|Lack of Efficacy|0|||
163112122|NCT03224507|589117715|FG000|Overall Study|Withdrawal by Subject|6|||
163112123|NCT03224507|589117716|FG001|Overall Study|Withdrawal by Subject|0|||
163112124|NCT01032291|589117717|FG000|Safety Lead-in|Adverse Event|1|||
163112125|NCT01032291|589117718|FG001|Safety Lead-in|Adverse Event|0|||
163112126|NCT01032291|589117719|FG002|Safety Lead-in|Adverse Event|0|||
163112127|NCT01032291|589117717|FG000|Safety Lead-in|Death|1|||
163112128|NCT01032291|589117718|FG001|Safety Lead-in|Death|0|||
163112129|NCT01032291|589117719|FG002|Safety Lead-in|Death|0|||
163112130|NCT01032291|589117717|FG000|Proof of Concept|Adverse Event|0|||
163112131|NCT01032291|589117718|FG001|Proof of Concept|Adverse Event|5|||
163112132|NCT01032291|589117719|FG002|Proof of Concept|Adverse Event|1|||
163112133|NCT01032291|589117717|FG000|Proof of Concept|Death|0|||
163112134|NCT01032291|589117718|FG001|Proof of Concept|Death|1|||
163112135|NCT01032291|589117719|FG002|Proof of Concept|Death|2|||
163112136|NCT01032291|589117717|FG000|Proof of Concept|Lack of Efficacy|0|||
163112137|NCT01032291|589117718|FG001|Proof of Concept|Lack of Efficacy|1|||
163112138|NCT01032291|589117719|FG002|Proof of Concept|Lack of Efficacy|0|||
163112139|NCT01032291|589117717|FG000|Proof of Concept|Never Received Study Drug|0|||
163112140|NCT01032291|589117718|FG001|Proof of Concept|Never Received Study Drug|1|||
163112141|NCT01032291|589117719|FG002|Proof of Concept|Never Received Study Drug|0|||
163112142|NCT00347438|589117720|FG000|Overall Study|Withdrawal by Subject|1|||
163112143|NCT00347438|589117720|FG000|Overall Study|Physician Decision|1|||
163112144|NCT01529515|589117723|FG000|TRANSITION PHASE|Adverse Event|16|||
163112145|NCT01529515|589117724|FG001|TRANSITION PHASE|Adverse Event|0|||
163112146|NCT01529515|589117725|FG002|TRANSITION PHASE|Adverse Event|0|||
163112147|NCT01529515|589117726|FG003|TRANSITION PHASE|Adverse Event|0|||
163112148|NCT01529515|589117723|FG000|TRANSITION PHASE|Death|1|||
163112149|NCT01529515|589117724|FG001|TRANSITION PHASE|Death|0|||
163112150|NCT01529515|589117725|FG002|TRANSITION PHASE|Death|0|||
163339975|NCT01107912|589953117|FG000|Period 3|Adverse Event|0|||
163339976|NCT01107912|589953118|FG001|Period 3|Adverse Event|1|||
163339977|NCT01107912|589953119|FG002|Period 3|Adverse Event|1|||
163339978|NCT01107912|589953120|FG003|Period 3|Adverse Event|0|||
163339979|NCT01107912|589953121|FG004|Period 3|Adverse Event|0|||
163112151|NCT01529515|589117726|FG003|TRANSITION PHASE|Death|0|||
163112152|NCT01529515|589117723|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
163112153|NCT01529515|589117724|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
163112154|NCT01529515|589117725|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
163112155|NCT01529515|589117726|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
163112156|NCT01529515|589117723|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
163112157|NCT01529515|589117724|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
163112158|NCT01529515|589117725|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
163112159|NCT01529515|589117726|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
163112160|NCT01529515|589117723|FG000|TRANSITION PHASE|Protocol Violation|4|||
163112161|NCT01529515|589117724|FG001|TRANSITION PHASE|Protocol Violation|0|||
163112162|NCT01529515|589117725|FG002|TRANSITION PHASE|Protocol Violation|0|||
163112163|NCT01529515|589117726|FG003|TRANSITION PHASE|Protocol Violation|0|||
163112164|NCT01529515|589117723|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
163112165|NCT01529515|589117724|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
163112166|NCT01529515|589117725|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
163112167|NCT01529515|589117726|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
163112168|NCT01529515|589117723|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
163112169|NCT01529515|589117724|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
163339980|NCT01107912|589953122|FG005|Period 3|Adverse Event|0|||
163112170|NCT01529515|589117725|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
163112171|NCT01529515|589117726|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
163112172|NCT01529515|589117723|FG000|TRANSITION PHASE|Other|9|||
163112173|NCT01529515|589117724|FG001|TRANSITION PHASE|Other|0|||
163112174|NCT01529515|589117725|FG002|TRANSITION PHASE|Other|0|||
163112175|NCT01529515|589117726|FG003|TRANSITION PHASE|Other|0|||
163112176|NCT01529515|589117723|FG000|MAINTENANCE PHASE|Adverse Event|0|||
163112177|NCT01529515|589117724|FG001|MAINTENANCE PHASE|Adverse Event|10|||
163112178|NCT01529515|589117725|FG002|MAINTENANCE PHASE|Adverse Event|0|||
163112179|NCT01529515|589117726|FG003|MAINTENANCE PHASE|Adverse Event|0|||
163112180|NCT01529515|589117723|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
163112181|NCT01529515|589117724|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
163112182|NCT01529515|589117725|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
163112183|NCT01529515|589117726|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
163112184|NCT01529515|589117723|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
163112185|NCT01529515|589117724|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
163112186|NCT01529515|589117725|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
163112187|NCT01529515|589117726|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
163112188|NCT01529515|589117723|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
163112189|NCT01529515|589117724|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
163112190|NCT01529515|589117725|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
163112191|NCT01529515|589117726|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
163112192|NCT01529515|589117723|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
163112193|NCT01529515|589117724|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
163112194|NCT01529515|589117725|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
163112195|NCT01529515|589117726|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
163112196|NCT01529515|589117723|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
163112197|NCT01529515|589117724|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
163112198|NCT01529515|589117725|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
163112199|NCT01529515|589117726|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
163112200|NCT01529515|589117723|FG000|MAINTENANCE PHASE|Other|0|||
163112201|NCT01529515|589117724|FG001|MAINTENANCE PHASE|Other|10|||
163112202|NCT01529515|589117725|FG002|MAINTENANCE PHASE|Other|0|||
163112203|NCT01529515|589117726|FG003|MAINTENANCE PHASE|Other|0|||
163112204|NCT01529515|589117723|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
163112205|NCT01529515|589117724|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
163112206|NCT01529515|589117725|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
163112207|NCT01529515|589117726|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
163112208|NCT01529515|589117723|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
163112209|NCT01529515|589117724|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
163112210|NCT01529515|589117725|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
163112211|NCT01529515|589117726|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
163112212|NCT01529515|589117723|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
163112213|NCT01529515|589117724|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
163112214|NCT01529515|589117725|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
163112215|NCT01529515|589117726|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
163112216|NCT01529515|589117723|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
163112217|NCT01529515|589117724|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
163112218|NCT01529515|589117725|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
163112219|NCT01529515|589117726|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
163112220|NCT01529515|589117723|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
163112221|NCT01529515|589117724|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
163112222|NCT01529515|589117725|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
163112223|NCT01529515|589117726|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
163112224|NCT01529515|589117723|FG000|DOUBLE BLIND PHASE|Other|0|||
163112225|NCT01529515|589117724|FG001|DOUBLE BLIND PHASE|Other|0|||
163112226|NCT01529515|589117725|FG002|DOUBLE BLIND PHASE|Other|9|||
163112227|NCT01529515|589117726|FG003|DOUBLE BLIND PHASE|Other|2|||
163112228|NCT00322023|589117728|FG000|Overall Study|various|0|||
163112229|NCT00322023|589117729|FG001|Overall Study|various|2|||
163112230|NCT00322023|589117730|FG002|Overall Study|various|6|||
163112231|NCT03327220|589117731|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
163112232|NCT03327220|589117732|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
163112233|NCT03327220|589117731|FG000|Overall Study|Investigator Decision|2|||
163112234|NCT03327220|589117732|FG001|Overall Study|Investigator Decision|0|||
163112235|NCT03327220|589117731|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
163112236|NCT03327220|589117732|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
163112237|NCT03327220|589117731|FG000|Overall Study|Fungal infection|1|||
163112238|NCT03327220|589117732|FG001|Overall Study|Fungal infection|0|||
163112239|NCT03327220|589117731|FG000|Overall Study|Discharged to Rehabilitation|0|||
163112240|NCT03327220|589117732|FG001|Overall Study|Discharged to Rehabilitation|1|||
163112241|NCT03327220|589117731|FG000|Overall Study|Missing|1|||
163112242|NCT03327220|589117732|FG001|Overall Study|Missing|0|||
163112243|NCT03920293|589117733|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
163339981|NCT01107912|589953117|FG000|Period 3|Withdrawal by Subject|0|||
163112244|NCT03920293|589117734|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
163112245|NCT03920293|589117733|FG000|Randomized-Controlled Period|Physician Decision|1|||
163112246|NCT03920293|589117734|FG001|Randomized-Controlled Period|Physician Decision|2|||
163112247|NCT03920293|589117733|FG000|Randomized-Controlled Period|Adverse Event|0|||
163112248|NCT03920293|589117734|FG001|Randomized-Controlled Period|Adverse Event|2|||
163112249|NCT03920293|589117733|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
163112250|NCT03920293|589117734|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
163112251|NCT03920293|589117733|FG000|Randomized-Controlled Period|Death|2|||
163112252|NCT03920293|589117734|FG001|Randomized-Controlled Period|Death|0|||
163112253|NCT03920293|589117733|FG000|Randomized-Controlled Period|Protocol Violation|1|||
163112254|NCT03920293|589117734|FG001|Randomized-Controlled Period|Protocol Violation|0|||
163112255|NCT03920293|589117733|FG000|Randomized-Controlled Period|Noncompliance|1|||
163112256|NCT03920293|589117734|FG001|Randomized-Controlled Period|Noncompliance|0|||
163112257|NCT03920293|589117733|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
163112258|NCT03920293|589117734|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
163112259|NCT03920293|589117733|FG000|Open- Label Extension Period|Death|3|||
163112260|NCT03920293|589117734|FG001|Open- Label Extension Period|Death|3|||
163112261|NCT03920293|589117733|FG000|Open- Label Extension Period|Physician Decision|5|||
163112262|NCT03920293|589117734|FG001|Open- Label Extension Period|Physician Decision|3|||
163112263|NCT03920293|589117733|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
163112264|NCT03920293|589117734|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
163112265|NCT00523705|589117735|FG000|Overall Study|No time for study.|0|||
163112266|NCT00523705|589117736|FG001|Overall Study|No time for study.|1|||
163112267|NCT00693017|589117737|FG000|Overall Study|Sponsor Decision|2|||
163112268|NCT00693017|589117738|FG001|Overall Study|Sponsor Decision|1|||
163112269|NCT00693017|589117737|FG000|Overall Study|Death|0|||
163112270|NCT00693017|589117738|FG001|Overall Study|Death|1|||
163112271|NCT01691885|589117742|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
163112272|NCT01691885|589117743|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
163112273|NCT01691885|589117742|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
163112274|NCT01691885|589117743|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
163112275|NCT03555981|589117744|FG000|Overall Study|Lost to Follow-up|0|||
163112276|NCT03555981|589117745|FG001|Overall Study|Lost to Follow-up|2|||
163112277|NCT00688324|589117747|FG000|Overall Study|Withdrawal by Subject|2|||
163112278|NCT00688324|589117747|FG000|Overall Study|Physician Decision|5|||
163112279|NCT00688324|589117747|FG000|Overall Study|Lost to Follow-up|1|||
163112280|NCT01972308|589117748|FG000|Overall Study|Withdrawal by Subject|0|||
163112281|NCT01972308|589117749|FG001|Overall Study|Withdrawal by Subject|1|||
163112282|NCT01972308|589117748|FG000|Overall Study|Lost to Follow-up|4|||
163112283|NCT01972308|589117749|FG001|Overall Study|Lost to Follow-up|6|||
163112284|NCT01972308|589117748|FG000|Overall Study|Death|4|||
163112285|NCT01972308|589117749|FG001|Overall Study|Death|1|||
163112286|NCT00585546|589117751|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
163112287|NCT00585546|589117751|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
163112288|NCT01562314|589117752|FG000|Overall Study|Adverse Event|10|||
163112289|NCT01562314|589117753|FG001|Overall Study|Adverse Event|5|||
163112290|NCT01562314|589117752|FG000|Overall Study|Met Withdrawal Criteria|3|||
163112291|NCT01562314|589117753|FG001|Overall Study|Met Withdrawal Criteria|2|||
163112292|NCT01562314|589117752|FG000|Overall Study|Withdrawal by Subject|0|||
163112293|NCT01562314|589117753|FG001|Overall Study|Withdrawal by Subject|1|||
163112294|NCT00813865|589117760|FG000|Overall Study|Failure to Respond|3|||
163112295|NCT00813865|589117760|FG000|Overall Study|Lost to Follow-up|3|||
163112296|NCT00813865|589117760|FG000|Overall Study|Withdrawal by Subject|1|||
163112297|NCT01190475|589117762|FG000|Overall Study|Withdrawal by Subject|0|||
163112298|NCT01190475|589117763|FG001|Overall Study|Withdrawal by Subject|0|||
163112299|NCT01190475|589117764|FG002|Overall Study|Withdrawal by Subject|1|||
163112300|NCT00543803|589117767|FG000|Overall Study|Adverse Event|14|||
163112301|NCT00543803|589117767|FG000|Overall Study|Lack of Efficacy|22|||
163112302|NCT00543803|589117767|FG000|Overall Study|Lost to Follow-up|20|||
163112303|NCT00543803|589117767|FG000|Overall Study|Other|86|||
163222599|NCT01951157|589531566|FG002|Overall Study|Treatment-unrelated AE|3|||
163339982|NCT01107912|589953118|FG001|Period 3|Withdrawal by Subject|0|||
163112304|NCT00624585|589117768|FG000|Overall Study|Death|3|||
163112305|NCT00624585|589117768|FG000|Overall Study|Disease Progression|6|||
163112306|NCT00624585|589117768|FG000|Overall Study|Adverse Event|3|||
163112307|NCT04154345|589117772|FG000|Overall Study|Covid-19 pandemic|4|||
163112308|NCT03505788|589117773|FG000|Overall Study|Lost to Follow-up|2|||
163112309|NCT03505788|589117774|FG001|Overall Study|Lost to Follow-up|1|||
163112310|NCT03505788|589117773|FG000|Overall Study|Withdrawal by Subject|1|||
163112311|NCT03505788|589117774|FG001|Overall Study|Withdrawal by Subject|3|||
163112312|NCT03505788|589117773|FG000|Overall Study|Physician Decision|0|||
163112313|NCT03505788|589117774|FG001|Overall Study|Physician Decision|1|||
163112314|NCT01535599|589117776|FG000|Overall Study|Adverse Event|6|||
163112315|NCT01535599|589117777|FG001|Overall Study|Adverse Event|15|||
163112316|NCT01535599|589117776|FG000|Overall Study|Lost to Follow-up|3|||
163112317|NCT01535599|589117777|FG001|Overall Study|Lost to Follow-up|4|||
163112318|NCT01535599|589117776|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
163112319|NCT01535599|589117777|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
163112320|NCT01535599|589117776|FG000|Overall Study|Treatment Failure|33|||
163112321|NCT01535599|589117777|FG001|Overall Study|Treatment Failure|66|||
163112322|NCT01535599|589117776|FG000|Overall Study|BL Culture + for Group A Strep|0|||
163112323|NCT01535599|589117777|FG001|Overall Study|BL Culture + for Group A Strep|1|||
163112324|NCT01535599|589117776|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
163112325|NCT01535599|589117777|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
163112326|NCT01535599|589117776|FG000|Overall Study|Randomized in Error|2|||
163112327|NCT01535599|589117777|FG001|Overall Study|Randomized in Error|4|||
163112328|NCT01535599|589117776|FG000|Overall Study|Did not use product|1|||
163112329|NCT01535599|589117777|FG001|Overall Study|Did not use product|0|||
163112330|NCT01535599|589117776|FG000|Overall Study|Other|1|||
163112331|NCT01535599|589117777|FG001|Overall Study|Other|0|||
163112332|NCT01535599|589117776|FG000|Overall Study|Stopped medication|0|||
163112333|NCT01535599|589117777|FG001|Overall Study|Stopped medication|1|||
163112334|NCT01535599|589117776|FG000|Overall Study|Noncompliance|0|||
163112335|NCT01535599|589117777|FG001|Overall Study|Noncompliance|1|||
163112336|NCT00676520|589117778|FG000|Overall Study|Withdrawal by Subject|163|||
163112337|NCT00676520|589117778|FG000|Overall Study|Lost to Follow-up|162|||
163112338|NCT00676520|589117778|FG000|Overall Study|Death|159|||
163112339|NCT00676520|589117778|FG000|Overall Study|Physician Decision|20|||
163112340|NCT00676520|589117778|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
163112341|NCT00676520|589117778|FG000|Overall Study|Other Reason|18|||
163112342|NCT00590824|589117790|FG000|Overall Study|Disease could not be resected|0|||
163112343|NCT00590824|589117791|FG001|Overall Study|Disease could not be resected|2|||
163112344|NCT00590824|589117792|FG002|Overall Study|Disease could not be resected|1|||
163112345|NCT00590824|589117793|FG003|Overall Study|Disease could not be resected|0|||
163112346|NCT00590824|589117790|FG000|Overall Study|Adverse Event|0|||
163112347|NCT00590824|589117791|FG001|Overall Study|Adverse Event|0|||
163112348|NCT00590824|589117792|FG002|Overall Study|Adverse Event|0|||
163112349|NCT00590824|589117793|FG003|Overall Study|Adverse Event|1|||
163112350|NCT00744978|589117796|FG000|Period 1|Lost to Follow-up|1|||
163112351|NCT00744978|589117797|FG001|Period 1|Lost to Follow-up|0|||
163112352|NCT00744978|589117796|FG000|Period 1|Withdrawal by Subject|0|||
163112353|NCT00744978|589117797|FG001|Period 1|Withdrawal by Subject|2|||
163112354|NCT00744978|589117796|FG000|Period 1|Other|0|||
163112355|NCT00744978|589117797|FG001|Period 1|Other|2|||
163112356|NCT00744978|589117796|FG000|Period 1|Adverse Event|4|||
163112357|NCT00744978|589117797|FG001|Period 1|Adverse Event|0|||
163112358|NCT00744978|589117796|FG000|Period 1|Randomized but not Treated|1|||
163112359|NCT00744978|589117797|FG001|Period 1|Randomized but not Treated|1|||
163112360|NCT00744978|589117796|FG000|Period 2|Adverse Event|0|||
163112361|NCT00744978|589117797|FG001|Period 2|Adverse Event|1|||
163112362|NCT03773133|589117798|FG000|Overall Study|Screen Failure|8|||
163112363|NCT03770728|589117799|FG000|Overall Study|Adverse Event|1|||
163112364|NCT03770728|589117800|FG001|Overall Study|Adverse Event|0|||
163112365|NCT03770728|589117801|FG002|Overall Study|Adverse Event|1|||
163112366|NCT03770728|589117802|FG003|Overall Study|Adverse Event|0|||
163112367|NCT03770728|589117799|FG000|Overall Study|Poor compliance to protocol|0|||
163112368|NCT03770728|589117800|FG001|Overall Study|Poor compliance to protocol|0|||
163112369|NCT03770728|589117801|FG002|Overall Study|Poor compliance to protocol|1|||
163112370|NCT03770728|589117802|FG003|Overall Study|Poor compliance to protocol|0|||
163112371|NCT03770728|589117799|FG000|Overall Study|Withdrawal by Subject|13|||
163112372|NCT03770728|589117800|FG001|Overall Study|Withdrawal by Subject|8|||
163112373|NCT03770728|589117801|FG002|Overall Study|Withdrawal by Subject|9|||
163112374|NCT03770728|589117802|FG003|Overall Study|Withdrawal by Subject|13|||
163112375|NCT03770728|589117799|FG000|Overall Study|Other than specified|24|||
163112376|NCT03770728|589117800|FG001|Overall Study|Other than specified|23|||
163222600|NCT01951157|589531564|FG000|Overall Study|Study Termination|0|||
163222601|NCT01951157|589531565|FG001|Overall Study|Study Termination|0|||
163222602|NCT01951157|589531566|FG002|Overall Study|Study Termination|1|||
163407902|NCT00328627|590203964|FG003|Overall Study|Adverse Event|3|||
163112377|NCT03770728|589117801|FG002|Overall Study|Other than specified|21|||
163112378|NCT03770728|589117802|FG003|Overall Study|Other than specified|22|||
163112379|NCT02778555|589117803|FG000|Overall Study|Withdrawal by Subject|55|||
163112380|NCT02778555|589117804|FG001|Overall Study|Withdrawal by Subject|32|||
163112381|NCT02778555|589117805|FG002|Overall Study|Withdrawal by Subject|107|||
163112382|NCT02379988|589117806|FG000|Overall Study|Not eligible|1|||
163112383|NCT01895543|589117811|FG000|Overall Study|Withdrawal by Subject|43|||
163112384|NCT01895543|589117811|FG000|Overall Study|Lost to Follow-up|25|||
163112385|NCT01895543|589117811|FG000|Overall Study|Adverse Event|28|||
163112386|NCT01895543|589117811|FG000|Overall Study|Subject's substantial non-compliance|6|||
163222603|NCT01951157|589531564|FG000|Overall Study|Physician Decision|5|||
163112387|NCT01895543|589117811|FG000|Overall Study|Protocol Violation|1|||
163112388|NCT01895543|589117811|FG000|Overall Study|Physician Decision|2|||
163112389|NCT01895543|589117811|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
163112390|NCT04262882|589117812|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
163112391|NCT04262882|589117813|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
163112392|NCT04262882|589117812|FG000|Overall Study|Lost to Follow-up|1|||
163112393|NCT04262882|589117813|FG001|Overall Study|Lost to Follow-up|0|||
163112394|NCT00468676|589117818|FG000|Overall Study|Lost to Follow-up|14|||
163112395|NCT00468676|589117819|FG001|Overall Study|Lost to Follow-up|11|||
163112396|NCT00468676|589117818|FG000|Overall Study|Death|2|||
163112397|NCT00468676|589117819|FG001|Overall Study|Death|1|||
163112398|NCT02979093|589117822|FG000|First Scan Session|Scanning data problems|1|||
163112399|NCT02979093|589117823|FG001|First Scan Session|Scanning data problems|2|||
163112400|NCT02979093|589117824|FG002|First Scan Session|Scanning data problems|2|||
163112401|NCT02979093|589117825|FG003|First Scan Session|Scanning data problems|0|||
163112402|NCT02979093|589117822|FG000|Second Scan Session|Scanning data problems|3|||
163112403|NCT02979093|589117823|FG001|Second Scan Session|Scanning data problems|0|||
163112404|NCT02979093|589117824|FG002|Second Scan Session|Scanning data problems|1|||
163112405|NCT02979093|589117825|FG003|Second Scan Session|Scanning data problems|3|||
163112406|NCT00522418|589117826|FG000|Overall Study|Local IRB Consent Violation|5|||
163112407|NCT00522418|589117827|FG001|Overall Study|Local IRB Consent Violation|5|||
163112408|NCT00522418|589117826|FG000|Overall Study|Early Study Termination|46|||
163112409|NCT00522418|589117827|FG001|Overall Study|Early Study Termination|47|||
163112410|NCT00522418|589117826|FG000|Overall Study|Noncompliance|2|||
163112411|NCT00522418|589117827|FG001|Overall Study|Noncompliance|2|||
163112412|NCT00522418|589117826|FG000|Overall Study|Reason Not Specified|3|||
163112413|NCT00522418|589117827|FG001|Overall Study|Reason Not Specified|1|||
163112414|NCT00522418|589117826|FG000|Overall Study|Consent Withdraw|1|||
163112415|NCT00522418|589117827|FG001|Overall Study|Consent Withdraw|2|||
163112416|NCT00522418|589117826|FG000|Overall Study|Lack of Efficacy|0|||
163112417|NCT00522418|589117827|FG001|Overall Study|Lack of Efficacy|1|||
163112418|NCT02438683|589117831|FG000|Overall Study|Adverse Event|1|||
163112419|NCT02438683|589117832|FG001|Overall Study|Adverse Event|0|||
163112420|NCT02438683|589117833|FG002|Overall Study|Adverse Event|0|||
163112421|NCT02438683|589117834|FG003|Overall Study|Adverse Event|0|||
163112422|NCT02438683|589117835|FG004|Overall Study|Adverse Event|0|||
163112423|NCT02438683|589117836|FG005|Overall Study|Adverse Event|0|||
163112424|NCT00721578|589117837|FG000|Overall Study|Death|1|||
163112425|NCT00721578|589117838|FG001|Overall Study|Death|1|||
163112426|NCT00721578|589117837|FG000|Overall Study|Withdrawal by Subject|1|||
163112427|NCT00721578|589117838|FG001|Overall Study|Withdrawal by Subject|1|||
163112428|NCT02256384|589117852|FG000|Overall Study|Withdrawal by Subject|12|||
163112429|NCT02256384|589117852|FG000|Overall Study|Equipment not capturing data|2|||
163112430|NCT05032690|589117859|FG000|Period 1|Adverse Event|0|||
163112431|NCT05032690|589117860|FG001|Period 1|Adverse Event|1|||
163112432|NCT05032690|589117861|FG002|Period 1|Adverse Event|0|||
163112433|NCT05032690|589117862|FG003|Period 1|Adverse Event|0|||
163112434|NCT05032690|589117859|FG000|Period 1|Withdrawal by Subject|1|||
163112435|NCT05032690|589117860|FG001|Period 1|Withdrawal by Subject|0|||
163112436|NCT05032690|589117861|FG002|Period 1|Withdrawal by Subject|0|||
163112437|NCT05032690|589117862|FG003|Period 1|Withdrawal by Subject|0|||
163112438|NCT05032690|589117859|FG000|Period 1|No longer meets eligibility criteria|0|||
163112439|NCT05032690|589117860|FG001|Period 1|No longer meets eligibility criteria|1|||
163112440|NCT05032690|589117861|FG002|Period 1|No longer meets eligibility criteria|0|||
163112441|NCT05032690|589117862|FG003|Period 1|No longer meets eligibility criteria|0|||
163112442|NCT05032690|589117859|FG000|Period 2|Adverse Event|1|||
163112443|NCT05032690|589117860|FG001|Period 2|Adverse Event|0|||
163112444|NCT05032690|589117861|FG002|Period 2|Adverse Event|0|||
163112445|NCT05032690|589117862|FG003|Period 2|Adverse Event|0|||
163112446|NCT05032690|589117859|FG000|Period 2|Withdrawal by Subject|0|||
163112447|NCT05032690|589117860|FG001|Period 2|Withdrawal by Subject|1|||
163112448|NCT05032690|589117861|FG002|Period 2|Withdrawal by Subject|0|||
163112449|NCT05032690|589117862|FG003|Period 2|Withdrawal by Subject|0|||
163112450|NCT05032690|589117859|FG000|Period 2|No longer meets eligibility criteria|0|||
163112451|NCT05032690|589117860|FG001|Period 2|No longer meets eligibility criteria|1|||
163112452|NCT05032690|589117861|FG002|Period 2|No longer meets eligibility criteria|0|||
163112453|NCT05032690|589117862|FG003|Period 2|No longer meets eligibility criteria|0|||
163112454|NCT05032690|589117859|FG000|Period 3|Adverse Event|0|||
163112455|NCT05032690|589117860|FG001|Period 3|Adverse Event|1|||
163112456|NCT05032690|589117861|FG002|Period 3|Adverse Event|0|||
163112457|NCT05032690|589117862|FG003|Period 3|Adverse Event|0|||
163112458|NCT00487942|589117863|FG000|Overall Study|Adverse Event|1|||
163112459|NCT00487942|589117864|FG001|Overall Study|Adverse Event|1|||
163112460|NCT00487942|589117865|FG002|Overall Study|Adverse Event|1|||
163112461|NCT00487942|589117866|FG003|Overall Study|Adverse Event|1|||
163112462|NCT00487942|589117863|FG000|Overall Study|Lost to Follow-up|1|||
163112463|NCT00487942|589117864|FG001|Overall Study|Lost to Follow-up|0|||
163112464|NCT00487942|589117865|FG002|Overall Study|Lost to Follow-up|0|||
163339983|NCT01107912|589953119|FG002|Period 3|Withdrawal by Subject|0|||
163339984|NCT01107912|589953120|FG003|Period 3|Withdrawal by Subject|1|||
163112465|NCT00487942|589117866|FG003|Overall Study|Lost to Follow-up|1|||
163112466|NCT00487942|589117863|FG000|Overall Study|Protocol Violation|1|||
163112467|NCT00487942|589117864|FG001|Overall Study|Protocol Violation|1|||
163112468|NCT00487942|589117865|FG002|Overall Study|Protocol Violation|0|||
163112469|NCT00487942|589117866|FG003|Overall Study|Protocol Violation|0|||
163112470|NCT00487942|589117863|FG000|Overall Study|Withdrawal by Subject|0|||
163339985|NCT01107912|589953121|FG004|Period 3|Withdrawal by Subject|0|||
163112471|NCT00487942|589117864|FG001|Overall Study|Withdrawal by Subject|1|||
163112472|NCT00487942|589117865|FG002|Overall Study|Withdrawal by Subject|2|||
163112473|NCT00487942|589117866|FG003|Overall Study|Withdrawal by Subject|0|||
163112474|NCT00211757|589117867|FG000|Overall Study|Withdrawal by Subject|1|||
163112475|NCT00211757|589117868|FG001|Overall Study|Withdrawal by Subject|1|||
163112476|NCT00211757|589117867|FG000|Overall Study|Lack of Efficacy|0|||
163112477|NCT00211757|589117868|FG001|Overall Study|Lack of Efficacy|1|||
163112478|NCT05151445|589117869|FG000|Overall Study|Withdrawal by Subject|3|||
163112479|NCT02298179|589117870|FG000|Overall Study|Lost to Follow-up|0|||
163112480|NCT02298179|589117871|FG001|Overall Study|Lost to Follow-up|0|||
163112481|NCT02298179|589117872|FG002|Overall Study|Lost to Follow-up|1|||
163112482|NCT02298179|589117873|FG003|Overall Study|Lost to Follow-up|0|||
163112483|NCT02298179|589117874|FG004|Overall Study|Lost to Follow-up|0|||
163112484|NCT02298179|589117875|FG005|Overall Study|Lost to Follow-up|0|||
163112485|NCT02298179|589117876|FG006|Overall Study|Lost to Follow-up|0|||
163112486|NCT02298179|589117877|FG007|Overall Study|Lost to Follow-up|1|||
163112487|NCT02298179|589117878|FG008|Overall Study|Lost to Follow-up|0|||
163112488|NCT02298179|589117879|FG009|Overall Study|Lost to Follow-up|0|||
163112489|NCT02298179|589117880|FG010|Overall Study|Lost to Follow-up|0|||
163112490|NCT02298179|589117881|FG011|Overall Study|Lost to Follow-up|0|||
163112491|NCT00082368|589117882|FG000|Overall Study|Not treated-pt had poor IV access|1|||
163112492|NCT02825420|589117884|FG000|Overall Study|Death|30|||
163112493|NCT02825420|589117885|FG001|Overall Study|Death|12|||
163112494|NCT02825420|589117884|FG000|Overall Study|Progressive disease|6|||
163112495|NCT02825420|589117885|FG001|Overall Study|Progressive disease|1|||
163112496|NCT02825420|589117884|FG000|Overall Study|Lost to Follow-up|2|||
163112497|NCT02825420|589117885|FG001|Overall Study|Lost to Follow-up|2|||
163112498|NCT02825420|589117884|FG000|Overall Study|Withdrawal by Subject|1|||
163112499|NCT02825420|589117885|FG001|Overall Study|Withdrawal by Subject|1|||
163112500|NCT02825420|589117884|FG000|Overall Study|Protocol amendment not signed|1|||
163112501|NCT02825420|589117885|FG001|Overall Study|Protocol amendment not signed|1|||
163112502|NCT02825420|589117884|FG000|Overall Study|Physician Decision|1|||
163112503|NCT02825420|589117885|FG001|Overall Study|Physician Decision|0|||
163112504|NCT02825420|589117884|FG000|Overall Study|Did not receive PLD|2|||
163112505|NCT02825420|589117885|FG001|Overall Study|Did not receive PLD|0|||
163112506|NCT00642174|589119868|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
163112507|NCT00642174|589119869|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
163112508|NCT00896363|589119870|FG000|Overall Study|Adverse Event|3|||
163112509|NCT00896363|589119871|FG001|Overall Study|Adverse Event|4|||
163112510|NCT00896363|589119872|FG002|Overall Study|Adverse Event|2|||
163112511|NCT00896363|589119870|FG000|Overall Study|Lack of Efficacy|0|||
163112512|NCT00896363|589119871|FG001|Overall Study|Lack of Efficacy|2|||
163112513|NCT00896363|589119872|FG002|Overall Study|Lack of Efficacy|1|||
163112514|NCT00896363|589119870|FG000|Overall Study|Withdrawal by Subject|3|||
163112515|NCT00896363|589119871|FG001|Overall Study|Withdrawal by Subject|5|||
163112516|NCT00896363|589119872|FG002|Overall Study|Withdrawal by Subject|5|||
163112517|NCT01730339|589119873|FG000|Overall Study|Withdrawal by Subject|3|||
163112518|NCT01730339|589119874|FG001|Overall Study|Withdrawal by Subject|2|||
163112519|NCT01730339|589119873|FG000|Overall Study|Lost to Follow-up|1|||
163112520|NCT01730339|589119874|FG001|Overall Study|Lost to Follow-up|1|||
163112521|NCT01730339|589119873|FG000|Overall Study|Un-specified|1|||
163112522|NCT01730339|589119874|FG001|Overall Study|Un-specified|0|||
163112523|NCT00847665|589119877|FG000|Overall Study|Withdrawal by Subject|1|||
163112524|NCT00847665|589119878|FG001|Overall Study|Withdrawal by Subject|0|||
163112525|NCT04035564|589119879|FG000|Overall Study|Protocol Violation|1|||
163112526|NCT04035564|589119880|FG001|Overall Study|Protocol Violation|2|||
163112527|NCT04035564|589119879|FG000|Overall Study|No laboratory available|2|||
163112528|NCT04035564|589119880|FG001|Overall Study|No laboratory available|2|||
163112529|NCT04035564|589119879|FG000|Overall Study|Guardian declined consent|1|||
163112530|NCT04035564|589119880|FG001|Overall Study|Guardian declined consent|2|||
163112531|NCT03333252|589119885|FG000|Overall Study|Adverse Event|10|||
163112532|NCT03333252|589119886|FG001|Overall Study|Adverse Event|6|||
163112533|NCT03333252|589119887|FG002|Overall Study|Adverse Event|5|||
163112534|NCT03333252|589119888|FG003|Overall Study|Adverse Event|2|||
163112535|NCT03333252|589119885|FG000|Overall Study|Death|1|||
163112536|NCT03333252|589119886|FG001|Overall Study|Death|3|||
163112537|NCT03333252|589119887|FG002|Overall Study|Death|0|||
163112538|NCT03333252|589119888|FG003|Overall Study|Death|0|||
163112539|NCT03333252|589119885|FG000|Overall Study|Lack of Efficacy|8|||
163112540|NCT03333252|589119886|FG001|Overall Study|Lack of Efficacy|4|||
163112541|NCT03333252|589119887|FG002|Overall Study|Lack of Efficacy|0|||
163112542|NCT03333252|589119888|FG003|Overall Study|Lack of Efficacy|7|||
163112543|NCT03333252|589119885|FG000|Overall Study|Lost to Follow-up|0|||
163112544|NCT03333252|589119886|FG001|Overall Study|Lost to Follow-up|5|||
163112545|NCT03333252|589119887|FG002|Overall Study|Lost to Follow-up|9|||
163112546|NCT03333252|589119888|FG003|Overall Study|Lost to Follow-up|3|||
163112547|NCT03333252|589119885|FG000|Overall Study|Withdrawal by Subject|14|||
163112548|NCT03333252|589119886|FG001|Overall Study|Withdrawal by Subject|24|||
163112549|NCT03333252|589119887|FG002|Overall Study|Withdrawal by Subject|11|||
163112550|NCT03333252|589119888|FG003|Overall Study|Withdrawal by Subject|17|||
163112551|NCT00939029|589119889|FG000|Overall Study|Withdrawal by Subject|3|||
163112552|NCT00939029|589119890|FG001|Overall Study|Withdrawal by Subject|7|||
163112553|NCT00939029|589119889|FG000|Overall Study|Lost to Follow-up|3|||
163112554|NCT00939029|589119890|FG001|Overall Study|Lost to Follow-up|4|||
163112555|NCT00939029|589119889|FG000|Overall Study|Adverse Event|0|||
163112556|NCT00939029|589119890|FG001|Overall Study|Adverse Event|1|||
163112557|NCT04686084|589119891|FG000|Overall Study|Lost to Follow-up|1|||
163112558|NCT01779856|589119892|FG000|Overall Study|Withdrawal by Subject|15|||
163112559|NCT01779856|589119892|FG000|Overall Study|Death|3|||
163112560|NCT01779856|589119892|FG000|Overall Study|Physician Decision|1|||
163112561|NCT01779856|589119892|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
163112562|NCT01779856|589119892|FG000|Overall Study|Delays in scheduling implant|1|||
163112563|NCT01779856|589119892|FG000|Overall Study|Subject ineligible for Implant|2|||
163112564|NCT01425359|589119897|FG000|Overall Study|Randomized but Not Treated|2|||
163112565|NCT01425359|589119898|FG001|Overall Study|Randomized but Not Treated|3|||
163112566|NCT01425359|589119897|FG000|Overall Study|Adverse Event|9|||
163112567|NCT01425359|589119898|FG001|Overall Study|Adverse Event|8|||
163112568|NCT01425359|589119897|FG000|Overall Study|Revascularization|0|||
163112569|NCT01425359|589119898|FG001|Overall Study|Revascularization|1|||
163112570|NCT01425359|589119897|FG000|Overall Study|Death|0|||
163112571|NCT01425359|589119898|FG001|Overall Study|Death|1|||
163112572|NCT01425359|589119897|FG000|Overall Study|Unsatisfactory Response|1|||
163112573|NCT01425359|589119898|FG001|Overall Study|Unsatisfactory Response|0|||
163112574|NCT01425359|589119897|FG000|Overall Study|Protocol Violation|1|||
163112575|NCT01425359|589119898|FG001|Overall Study|Protocol Violation|2|||
163112576|NCT01425359|589119897|FG000|Overall Study|Subject Withdrew Consent|1|||
163112577|NCT01425359|589119898|FG001|Overall Study|Subject Withdrew Consent|2|||
163112578|NCT01425359|589119897|FG000|Overall Study|Investigator's Discretion|2|||
163112579|NCT01425359|589119898|FG001|Overall Study|Investigator's Discretion|0|||
163112580|NCT01425359|589119897|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
163112581|NCT01425359|589119898|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
163112582|NCT03960580|589119899|FG000|Overall Study|Adverse Event|2|||
163112583|NCT03960580|589119900|FG001|Overall Study|Adverse Event|1|||
163112584|NCT03960580|589119901|FG002|Overall Study|Adverse Event|1|||
163112585|NCT03960580|589119899|FG000|Overall Study|Lost to Follow-up|1|||
163112586|NCT03960580|589119900|FG001|Overall Study|Lost to Follow-up|0|||
163112587|NCT03960580|589119901|FG002|Overall Study|Lost to Follow-up|0|||
163112588|NCT03960580|589119899|FG000|Overall Study|Lack of Efficacy|2|||
163112589|NCT03960580|589119900|FG001|Overall Study|Lack of Efficacy|1|||
163112590|NCT03960580|589119901|FG002|Overall Study|Lack of Efficacy|0|||
163112591|NCT03960580|589119899|FG000|Overall Study|Protocol Violation|0|||
163112592|NCT03960580|589119900|FG001|Overall Study|Protocol Violation|0|||
163112593|NCT03960580|589119901|FG002|Overall Study|Protocol Violation|1|||
163112594|NCT03960580|589119899|FG000|Overall Study|Withdrawal by Subject|1|||
163112595|NCT03960580|589119900|FG001|Overall Study|Withdrawal by Subject|1|||
163112596|NCT03960580|589119901|FG002|Overall Study|Withdrawal by Subject|1|||
163112597|NCT03960580|589119899|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
163112598|NCT03960580|589119900|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
163112599|NCT03960580|589119901|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
163112600|NCT02135029|589119909|FG000|Overall Study|Adverse Event|2|||
163112601|NCT02135029|589119910|FG001|Overall Study|Adverse Event|2|||
163112602|NCT02135029|589119911|FG002|Overall Study|Adverse Event|2|||
163112603|NCT02135029|589119909|FG000|Overall Study|Lost to Follow-up|0|||
163112604|NCT02135029|589119910|FG001|Overall Study|Lost to Follow-up|1|||
163112605|NCT02135029|589119911|FG002|Overall Study|Lost to Follow-up|0|||
163112606|NCT02135029|589119909|FG000|Overall Study|Withdrawal by Subject|2|||
163112607|NCT02135029|589119910|FG001|Overall Study|Withdrawal by Subject|0|||
163112608|NCT02135029|589119911|FG002|Overall Study|Withdrawal by Subject|1|||
163112609|NCT02135029|589119909|FG000|Overall Study|Other|0|||
163112610|NCT02135029|589119910|FG001|Overall Study|Other|1|||
163222604|NCT01951157|589531565|FG001|Overall Study|Physician Decision|3|||
163222605|NCT01951157|589531566|FG002|Overall Study|Physician Decision|2|||
163407903|NCT00328627|590203965|FG004|Overall Study|Adverse Event|1|||
163407904|NCT00328627|590203966|FG005|Overall Study|Adverse Event|2|||
163112611|NCT02135029|589119911|FG002|Overall Study|Other|0|||
163112612|NCT02135029|589119909|FG000|Overall Study|Death|0|||
163112613|NCT02135029|589119910|FG001|Overall Study|Death|1|||
163222606|NCT01951157|589531564|FG000|Overall Study|Non-treatmentrelated death|2|||
163112614|NCT02135029|589119911|FG002|Overall Study|Death|0|||
163112615|NCT00385944|589119917|FG000|1st Maintenance Dose Period|Physician Decision|1|||
163112616|NCT00385944|589119918|FG001|1st Maintenance Dose Period|Physician Decision|0|||
163112617|NCT00385944|589119919|FG002|1st Maintenance Dose Period|Physician Decision|0|||
163112618|NCT00385944|589119917|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
163112619|NCT00385944|589119918|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
163112620|NCT00385944|589119919|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
163112621|NCT00385944|589119917|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
163112622|NCT00385944|589119918|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
163112623|NCT00385944|589119919|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
163112624|NCT00385944|589119917|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
163112625|NCT00385944|589119918|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
163112626|NCT00385944|589119919|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
163112627|NCT03832322|589119921|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
163112628|NCT03832322|589119922|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
163112629|NCT01694121|589119924|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
163112630|NCT01694121|589119925|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
163112631|NCT00521599|589119926|FG000|Overall Study|Adverse Event|5|||
163112632|NCT00521599|589119927|FG001|Overall Study|Adverse Event|7|||
163112633|NCT00521599|589119928|FG002|Overall Study|Adverse Event|6|||
163112634|NCT00521599|589119926|FG000|Overall Study|Treatment Failure|8|||
163112635|NCT00521599|589119927|FG001|Overall Study|Treatment Failure|9|||
163112636|NCT00521599|589119928|FG002|Overall Study|Treatment Failure|22|||
163112637|NCT00521599|589119926|FG000|Overall Study|Lost to Follow-up|2|||
163112638|NCT00521599|589119927|FG001|Overall Study|Lost to Follow-up|1|||
163112639|NCT00521599|589119928|FG002|Overall Study|Lost to Follow-up|2|||
163112640|NCT00521599|589119926|FG000|Overall Study|Withdrawal by Subject|3|||
163112641|NCT00521599|589119927|FG001|Overall Study|Withdrawal by Subject|5|||
163112642|NCT00521599|589119928|FG002|Overall Study|Withdrawal by Subject|1|||
163112643|NCT00521599|589119926|FG000|Overall Study|Withdrawal by subject treatment related|3|||
163112644|NCT00521599|589119927|FG001|Overall Study|Withdrawal by subject treatment related|1|||
163112645|NCT00521599|589119928|FG002|Overall Study|Withdrawal by subject treatment related|2|||
163112646|NCT00521599|589119926|FG000|Overall Study|Protocol Violation|2|||
163112647|NCT00521599|589119927|FG001|Overall Study|Protocol Violation|4|||
163112648|NCT00521599|589119928|FG002|Overall Study|Protocol Violation|2|||
163112649|NCT00521599|589119926|FG000|Overall Study|Did not meet protocol eligibility|2|||
163112650|NCT00521599|589119927|FG001|Overall Study|Did not meet protocol eligibility|2|||
163112651|NCT00521599|589119928|FG002|Overall Study|Did not meet protocol eligibility|1|||
163112652|NCT01778049|589119932|FG000|Open Label Treatment Period|Adverse Event|5|||
163112653|NCT01778049|589119933|FG001|Open Label Treatment Period|Adverse Event|15|||
163112654|NCT01778049|589119934|FG002|Open Label Treatment Period|Adverse Event|0|||
163112655|NCT01778049|589119935|FG003|Open Label Treatment Period|Adverse Event|0|||
163112656|NCT01778049|589119936|FG004|Open Label Treatment Period|Adverse Event|0|||
163112657|NCT01778049|589119937|FG005|Open Label Treatment Period|Adverse Event|0|||
163112658|NCT01778049|589119932|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
163112659|NCT01778049|589119933|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
163112660|NCT01778049|589119934|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
163112661|NCT01778049|589119935|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
163112662|NCT01778049|589119936|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
163112663|NCT01778049|589119937|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
163112664|NCT01778049|589119932|FG000|Open Label Treatment Period|Protocol Violation|5|||
163112665|NCT01778049|589119933|FG001|Open Label Treatment Period|Protocol Violation|5|||
163112666|NCT01778049|589119934|FG002|Open Label Treatment Period|Protocol Violation|0|||
163112667|NCT01778049|589119935|FG003|Open Label Treatment Period|Protocol Violation|0|||
163112668|NCT01778049|589119936|FG004|Open Label Treatment Period|Protocol Violation|0|||
163112669|NCT01778049|589119937|FG005|Open Label Treatment Period|Protocol Violation|0|||
163112670|NCT01778049|589119932|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
163112671|NCT01778049|589119933|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
163112672|NCT01778049|589119934|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
163112673|NCT01778049|589119935|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
163112674|NCT01778049|589119936|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
163112675|NCT01778049|589119937|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
163112676|NCT01778049|589119932|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
163112677|NCT01778049|589119933|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
163112678|NCT01778049|589119934|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
163112679|NCT01778049|589119935|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
163112680|NCT01778049|589119936|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
163222607|NCT01951157|589531565|FG001|Overall Study|Non-treatmentrelated death|2|||
163222608|NCT01951157|589531566|FG002|Overall Study|Non-treatmentrelated death|2|||
163222609|NCT01951157|589531564|FG000|Overall Study|No treated|0|||
163222610|NCT01951157|589531565|FG001|Overall Study|No treated|1|||
163222611|NCT01951157|589531566|FG002|Overall Study|No treated|0|||
163339986|NCT01107912|589953122|FG005|Period 3|Withdrawal by Subject|0|||
163112681|NCT01778049|589119937|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
163112682|NCT01778049|589119932|FG000|Open Label Treatment Period|Not treated|2|||
163112683|NCT01778049|589119933|FG001|Open Label Treatment Period|Not treated|1|||
163112684|NCT01778049|589119934|FG002|Open Label Treatment Period|Not treated|0|||
163112685|NCT01778049|589119935|FG003|Open Label Treatment Period|Not treated|0|||
163222612|NCT01951157|589531564|FG000|Overall Study|Treatment-related AE|2|||
163112686|NCT01778049|589119936|FG004|Open Label Treatment Period|Not treated|0|||
163222613|NCT01951157|589531565|FG001|Overall Study|Treatment-related AE|0|||
163112687|NCT01778049|589119937|FG005|Open Label Treatment Period|Not treated|0|||
163112688|NCT01778049|589119932|FG000|Open Label Treatment Period|Other reason not defined above|77|||
163112689|NCT01778049|589119933|FG001|Open Label Treatment Period|Other reason not defined above|94|||
163112690|NCT01778049|589119934|FG002|Open Label Treatment Period|Other reason not defined above|0|||
163112691|NCT01778049|589119935|FG003|Open Label Treatment Period|Other reason not defined above|0|||
163112692|NCT01778049|589119936|FG004|Open Label Treatment Period|Other reason not defined above|0|||
163112693|NCT01778049|589119937|FG005|Open Label Treatment Period|Other reason not defined above|0|||
163112694|NCT01778049|589119932|FG000|Double Blind Treatment Period|Adverse Event|0|||
163112695|NCT01778049|589119933|FG001|Double Blind Treatment Period|Adverse Event|0|||
163112696|NCT01778049|589119934|FG002|Double Blind Treatment Period|Adverse Event|4|||
163112697|NCT01778049|589119935|FG003|Double Blind Treatment Period|Adverse Event|5|||
163112698|NCT01778049|589119936|FG004|Double Blind Treatment Period|Adverse Event|3|||
163112699|NCT01778049|589119937|FG005|Double Blind Treatment Period|Adverse Event|2|||
163112700|NCT01778049|589119932|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
163112701|NCT01778049|589119933|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
163112702|NCT01778049|589119934|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
163112703|NCT01778049|589119935|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
163112704|NCT01778049|589119936|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
163112705|NCT01778049|589119937|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
163112706|NCT01778049|589119932|FG000|Double Blind Treatment Period|Protocol Violation|0|||
163112707|NCT01778049|589119933|FG001|Double Blind Treatment Period|Protocol Violation|0|||
163112708|NCT01778049|589119934|FG002|Double Blind Treatment Period|Protocol Violation|2|||
163112709|NCT01778049|589119935|FG003|Double Blind Treatment Period|Protocol Violation|0|||
163112710|NCT01778049|589119936|FG004|Double Blind Treatment Period|Protocol Violation|0|||
163112711|NCT01778049|589119937|FG005|Double Blind Treatment Period|Protocol Violation|0|||
163112712|NCT01778049|589119932|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
163112713|NCT01778049|589119933|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
163112714|NCT01778049|589119934|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
163112715|NCT01778049|589119935|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
163112716|NCT01778049|589119936|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
163112717|NCT01778049|589119937|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
163112718|NCT01778049|589119932|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
163112719|NCT01778049|589119933|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
163112720|NCT01778049|589119934|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
163112721|NCT01778049|589119935|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
163112722|NCT01778049|589119936|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
163112723|NCT01778049|589119937|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
163112724|NCT01778049|589119932|FG000|Double Blind Treatment Period|Not treated|0|||
163112725|NCT01778049|589119933|FG001|Double Blind Treatment Period|Not treated|0|||
163112726|NCT01778049|589119934|FG002|Double Blind Treatment Period|Not treated|0|||
163112727|NCT01778049|589119935|FG003|Double Blind Treatment Period|Not treated|2|||
163112728|NCT01778049|589119936|FG004|Double Blind Treatment Period|Not treated|2|||
163112729|NCT01778049|589119937|FG005|Double Blind Treatment Period|Not treated|0|||
163112730|NCT01778049|589119932|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
163112731|NCT01778049|589119933|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
163112732|NCT01778049|589119934|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
163112733|NCT01778049|589119935|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
163112734|NCT01778049|589119936|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
163112735|NCT01778049|589119937|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
163112736|NCT02186652|589119938|FG000|Overall Study|Lost to Follow-up|2|||
163112737|NCT02186652|589119939|FG001|Overall Study|Lost to Follow-up|0|||
163112738|NCT00503776|589119943|FG000|Overall Study|Withdrawal by Subject|1|||
163112739|NCT00503776|589119944|FG001|Overall Study|Withdrawal by Subject|0|||
163112740|NCT00503776|589119945|FG002|Overall Study|Withdrawal by Subject|1|||
163112741|NCT00503776|589119946|FG003|Overall Study|Withdrawal by Subject|1|||
163112742|NCT00503776|589119943|FG000|Overall Study|Physician Decision|0|||
163112743|NCT00503776|589119944|FG001|Overall Study|Physician Decision|0|||
163112744|NCT00503776|589119945|FG002|Overall Study|Physician Decision|1|||
163112745|NCT00503776|589119946|FG003|Overall Study|Physician Decision|1|||
163112746|NCT00107315|589119947|FG000|Overall Study|Disease Progression|9|||
163112747|NCT00107315|589119947|FG000|Overall Study|Adverse Event|4|||
163112748|NCT00107315|589119947|FG000|Overall Study|Withdrawal by Subject|2|||
163112749|NCT02509039|589119952|FG000|Overall Study|Adverse Event|0|||
163112750|NCT02509039|589119953|FG001|Overall Study|Adverse Event|1|||
163112751|NCT02509039|589119954|FG002|Overall Study|Adverse Event|1|||
163112752|NCT02509039|589119955|FG003|Overall Study|Adverse Event|1|||
163112753|NCT02509039|589119952|FG000|Overall Study|Withdrawal by Subject|0|||
163112754|NCT02509039|589119953|FG001|Overall Study|Withdrawal by Subject|0|||
163112755|NCT02509039|589119954|FG002|Overall Study|Withdrawal by Subject|1|||
163222614|NCT01951157|589531566|FG002|Overall Study|Treatment-related AE|4|||
163222615|NCT01951157|589531564|FG000|Overall Study|Consent withdrawn by subject|0|||
163112756|NCT02509039|589119955|FG003|Overall Study|Withdrawal by Subject|0|||
163112757|NCT02509039|589119952|FG000|Overall Study|Progressive disease|2|||
163112758|NCT02509039|589119953|FG001|Overall Study|Progressive disease|2|||
163112759|NCT02509039|589119954|FG002|Overall Study|Progressive disease|1|||
163112760|NCT02509039|589119955|FG003|Overall Study|Progressive disease|5|||
163112761|NCT02509039|589119952|FG000|Overall Study|Study terminated by Sponsor|1|||
163112762|NCT02509039|589119953|FG001|Overall Study|Study terminated by Sponsor|0|||
163112763|NCT02509039|589119954|FG002|Overall Study|Study terminated by Sponsor|0|||
163112764|NCT02509039|589119955|FG003|Overall Study|Study terminated by Sponsor|0|||
163112765|NCT03359785|589119956|FG000|Overall Study|Protocol Violation|0|||
163112766|NCT03359785|589119957|FG001|Overall Study|Protocol Violation|1|||
163112767|NCT03359785|589119958|FG002|Overall Study|Protocol Violation|0|||
163112768|NCT03359785|589119959|FG003|Overall Study|Protocol Violation|0|||
163112769|NCT03359785|589119956|FG000|Overall Study|Early study termination due to study pause|0|||
163112770|NCT03359785|589119957|FG001|Overall Study|Early study termination due to study pause|0|||
163112771|NCT03359785|589119958|FG002|Overall Study|Early study termination due to study pause|2|||
163112772|NCT03359785|589119959|FG003|Overall Study|Early study termination due to study pause|0|||
163112773|NCT03359785|589119956|FG000|Overall Study|Withdrawal by Subject|2|||
163112774|NCT03359785|589119957|FG001|Overall Study|Withdrawal by Subject|2|||
163112775|NCT03359785|589119958|FG002|Overall Study|Withdrawal by Subject|0|||
163112776|NCT03359785|589119959|FG003|Overall Study|Withdrawal by Subject|0|||
163112777|NCT03276026|589119963|FG000|Overall Study|Protocol Violation|1|||
163112778|NCT03276026|589119964|FG001|Overall Study|Protocol Violation|0|||
163112779|NCT03650803|589119965|FG000|Overall Study|Lost to Follow-up|6|||
163112780|NCT00367744|589119966|FG000|Overall Study|Lost to Follow-up|4|||
163112781|NCT00367744|589119967|FG001|Overall Study|Lost to Follow-up|5|||
163112782|NCT03664674|589119969|FG000|Overall Study|Adverse Event|1|||
163112783|NCT03664674|589119970|FG001|Overall Study|Adverse Event|1|||
163112784|NCT03664674|589119969|FG000|Overall Study|Physician Decision|0|||
163112785|NCT03664674|589119970|FG001|Overall Study|Physician Decision|1|||
163112786|NCT03664674|589119969|FG000|Overall Study|Withdrawal by Subject|2|||
163112787|NCT03664674|589119970|FG001|Overall Study|Withdrawal by Subject|0|||
163112788|NCT04584346|589119976|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
163112789|NCT04584346|589119977|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
163112790|NCT03894969|589119986|FG000|Overall Study|Adverse Event|0|||
163112791|NCT03894969|589119987|FG001|Overall Study|Adverse Event|2|||
163112792|NCT03894969|589119988|FG002|Overall Study|Adverse Event|0|||
163112793|NCT03894969|589119989|FG003|Overall Study|Adverse Event|1|||
163112794|NCT03894969|589119990|FG004|Overall Study|Adverse Event|2|||
163112795|NCT03894969|589119986|FG000|Overall Study|Lost to Follow-up|3|||
163112796|NCT03894969|589119987|FG001|Overall Study|Lost to Follow-up|1|||
163112797|NCT03894969|589119988|FG002|Overall Study|Lost to Follow-up|1|||
163112798|NCT03894969|589119989|FG003|Overall Study|Lost to Follow-up|0|||
163112799|NCT03894969|589119990|FG004|Overall Study|Lost to Follow-up|0|||
163112800|NCT03894969|589119986|FG000|Overall Study|Withdrawal by Subject|2|||
163112801|NCT03894969|589119987|FG001|Overall Study|Withdrawal by Subject|1|||
163112802|NCT03894969|589119988|FG002|Overall Study|Withdrawal by Subject|3|||
163112803|NCT03894969|589119989|FG003|Overall Study|Withdrawal by Subject|4|||
163112804|NCT03894969|589119990|FG004|Overall Study|Withdrawal by Subject|8|||
163112805|NCT03894969|589119986|FG000|Overall Study|Other|0|||
163112806|NCT03894969|589119987|FG001|Overall Study|Other|0|||
163112807|NCT03894969|589119988|FG002|Overall Study|Other|0|||
163112808|NCT03894969|589119989|FG003|Overall Study|Other|0|||
163112809|NCT03894969|589119990|FG004|Overall Study|Other|3|||
163112810|NCT03894969|589119986|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
163112811|NCT03894969|589119987|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
163112812|NCT03894969|589119988|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
163112813|NCT03894969|589119989|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
163112814|NCT03894969|589119990|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
163112815|NCT03894969|589119986|FG000|Overall Study|Solicited Adverse Event|0|||
163112816|NCT03894969|589119987|FG001|Overall Study|Solicited Adverse Event|1|||
163112817|NCT03894969|589119988|FG002|Overall Study|Solicited Adverse Event|0|||
163112818|NCT03894969|589119989|FG003|Overall Study|Solicited Adverse Event|0|||
163112819|NCT03894969|589119990|FG004|Overall Study|Solicited Adverse Event|0|||
163112820|NCT06107803|589119991|FG000|Overall Study|Adverse Event|1|||
163112821|NCT06107803|589119991|FG000|Overall Study|Withdrawal by Subject|2|||
163112822|NCT06107803|589119991|FG000|Overall Study|Protocol Violation|1|||
163112823|NCT03099174|589119992|FG000|Overall Study|Withdrawal by Subject|0|||
163112824|NCT03099174|589119993|FG001|Overall Study|Withdrawal by Subject|0|||
163112825|NCT03099174|589119994|FG002|Overall Study|Withdrawal by Subject|1|||
163112826|NCT03099174|589119995|FG003|Overall Study|Withdrawal by Subject|0|||
163112827|NCT03099174|589119996|FG004|Overall Study|Withdrawal by Subject|2|||
163112828|NCT03099174|589119997|FG005|Overall Study|Withdrawal by Subject|2|||
163112829|NCT03099174|589119998|FG006|Overall Study|Withdrawal by Subject|1|||
163112830|NCT03099174|589119999|FG007|Overall Study|Withdrawal by Subject|4|||
163112831|NCT03099174|589119992|FG000|Overall Study|Adverse Event|0|||
163112832|NCT03099174|589119993|FG001|Overall Study|Adverse Event|1|||
163339987|NCT00595959|589953123|FG000|Overall Study|Withdrawal by Subject|1|||
163339988|NCT00595959|589953123|FG000|Overall Study|Lost to Follow-up|1|||
163339989|NCT00886834|589953124|FG000|Overall Study|Protocol Violation|0|||
163339990|NCT00886834|589953125|FG001|Overall Study|Protocol Violation|3|||
163339991|NCT03875729|589953126|FG000|Overall Study|Adverse Event|0|||
163339992|NCT03875729|589953127|FG001|Overall Study|Adverse Event|5|||
163112833|NCT03099174|589119994|FG002|Overall Study|Adverse Event|1|||
163112834|NCT03099174|589119995|FG003|Overall Study|Adverse Event|2|||
163112835|NCT03099174|589119996|FG004|Overall Study|Adverse Event|5|||
163112836|NCT03099174|589119997|FG005|Overall Study|Adverse Event|3|||
163112837|NCT03099174|589119998|FG006|Overall Study|Adverse Event|6|||
163112838|NCT03099174|589119999|FG007|Overall Study|Adverse Event|4|||
163112839|NCT03099174|589119992|FG000|Overall Study|Other than listed|6|||
163112840|NCT03099174|589119993|FG001|Overall Study|Other than listed|6|||
163112841|NCT03099174|589119994|FG002|Overall Study|Other than listed|5|||
163112842|NCT03099174|589119995|FG003|Overall Study|Other than listed|6|||
163112843|NCT03099174|589119996|FG004|Overall Study|Other than listed|19|||
163112844|NCT03099174|589119997|FG005|Overall Study|Other than listed|10|||
163112845|NCT03099174|589119998|FG006|Overall Study|Other than listed|26|||
163112846|NCT03099174|589119999|FG007|Overall Study|Other than listed|23|||
163112847|NCT04173260|589120000|FG000|Overall Study|Early termination|4|||
163112848|NCT04730635|589120001|FG000|Overall Study|Lost to Follow-up|1|||
163112849|NCT04730635|589120002|FG001|Overall Study|Lost to Follow-up|0|||
163112850|NCT04730635|589120001|FG000|Overall Study|Withdrawal by Subject|0|||
163112851|NCT04730635|589120002|FG001|Overall Study|Withdrawal by Subject|1|||
163112852|NCT03070223|589120005|FG000|Overall Study|Lost to Follow-up|34|||
163112853|NCT03070223|589120006|FG001|Overall Study|Lost to Follow-up|27|||
163112854|NCT03070223|589120005|FG000|Overall Study|Withdrawal by Subject|12|||
163112855|NCT03070223|589120006|FG001|Overall Study|Withdrawal by Subject|22|||
163112856|NCT03070223|589120005|FG000|Overall Study|Protocol Violation|0|||
163112857|NCT03070223|589120006|FG001|Overall Study|Protocol Violation|1|||
163112858|NCT02308163|589120007|FG000|Overall Study|Not fulfill eligible criteria|1|||
163112859|NCT02308163|589120008|FG001|Overall Study|Not fulfill eligible criteria|2|||
163112860|NCT02308163|589120009|FG002|Overall Study|Not fulfill eligible criteria|0|||
163112861|NCT02308163|589120010|FG003|Overall Study|Not fulfill eligible criteria|1|||
163112862|NCT02308163|589120011|FG004|Overall Study|Not fulfill eligible criteria|1|||
163112863|NCT02308163|589120007|FG000|Overall Study|Adverse Event|9|||
163112864|NCT02308163|589120008|FG001|Overall Study|Adverse Event|5|||
163112865|NCT02308163|589120009|FG002|Overall Study|Adverse Event|2|||
163112866|NCT02308163|589120010|FG003|Overall Study|Adverse Event|2|||
163112867|NCT02308163|589120011|FG004|Overall Study|Adverse Event|11|||
163112868|NCT02308163|589120007|FG000|Overall Study|Lack of Efficacy|11|||
163112869|NCT02308163|589120008|FG001|Overall Study|Lack of Efficacy|3|||
163112870|NCT02308163|589120009|FG002|Overall Study|Lack of Efficacy|8|||
163112871|NCT02308163|589120010|FG003|Overall Study|Lack of Efficacy|4|||
163112872|NCT02308163|589120011|FG004|Overall Study|Lack of Efficacy|6|||
163112873|NCT02308163|589120007|FG000|Overall Study|Withdrawal of consent|2|||
163112874|NCT02308163|589120008|FG001|Overall Study|Withdrawal of consent|3|||
163112875|NCT02308163|589120009|FG002|Overall Study|Withdrawal of consent|0|||
163112876|NCT02308163|589120010|FG003|Overall Study|Withdrawal of consent|2|||
163112877|NCT02308163|589120011|FG004|Overall Study|Withdrawal of consent|6|||
163112878|NCT02308163|589120007|FG000|Overall Study|Protocol Violation|3|||
163112879|NCT02308163|589120008|FG001|Overall Study|Protocol Violation|3|||
163112880|NCT02308163|589120009|FG002|Overall Study|Protocol Violation|3|||
163112881|NCT02308163|589120010|FG003|Overall Study|Protocol Violation|2|||
163112882|NCT02308163|589120011|FG004|Overall Study|Protocol Violation|5|||
163112883|NCT02308163|589120007|FG000|Overall Study|Lab data met discontinuation criteria|3|||
163112884|NCT02308163|589120008|FG001|Overall Study|Lab data met discontinuation criteria|0|||
163112885|NCT02308163|589120009|FG002|Overall Study|Lab data met discontinuation criteria|0|||
163339993|NCT03875729|589953126|FG000|Overall Study|Withdrawal by Subject|8|||
163339994|NCT03875729|589953127|FG001|Overall Study|Withdrawal by Subject|11|||
163112886|NCT02308163|589120010|FG003|Overall Study|Lab data met discontinuation criteria|2|||
163112887|NCT02308163|589120011|FG004|Overall Study|Lab data met discontinuation criteria|0|||
163112888|NCT02308163|589120007|FG000|Overall Study|Miscellaneous|2|||
163112889|NCT02308163|589120008|FG001|Overall Study|Miscellaneous|2|||
163112890|NCT02308163|589120009|FG002|Overall Study|Miscellaneous|1|||
163112891|NCT02308163|589120010|FG003|Overall Study|Miscellaneous|0|||
163112892|NCT02308163|589120011|FG004|Overall Study|Miscellaneous|5|||
163112893|NCT03219034|589120017|FG000|Overall Study|Lost to Follow-up|9|||
163112894|NCT03219034|589120018|FG001|Overall Study|Lost to Follow-up|13|||
163112895|NCT03219034|589120017|FG000|Overall Study|Additional dental work needed|1|||
163112896|NCT03219034|589120018|FG001|Overall Study|Additional dental work needed|0|||
163112897|NCT03219034|589120017|FG000|Overall Study|UPPP Surgery|1|||
163112898|NCT03219034|589120018|FG001|Overall Study|UPPP Surgery|0|||
163112899|NCT03219034|589120017|FG000|Overall Study|Dental sensitivity|0|||
163339995|NCT03875729|589953126|FG000|Overall Study|Pregnancy|0|||
163339996|NCT03875729|589953127|FG001|Overall Study|Pregnancy|1|||
163339997|NCT03875729|589953126|FG000|Overall Study|Lost to Follow-up|0|||
163112900|NCT03219034|589120018|FG001|Overall Study|Dental sensitivity|1|||
163112901|NCT03219034|589120017|FG000|Overall Study|Death in family|0|||
163112902|NCT03219034|589120018|FG001|Overall Study|Death in family|1|||
163112903|NCT00118846|589120019|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
163112904|NCT00118846|589120020|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
163112905|NCT00118846|589120019|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
163112906|NCT00118846|589120020|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
163112907|NCT00118846|589120019|FG000|Overall Study|Physician Decision|1|||
163112908|NCT00118846|589120020|FG001|Overall Study|Physician Decision|0|||
163112909|NCT00118846|589120019|FG000|Overall Study|Medical condition|2|||
163112910|NCT00118846|589120020|FG001|Overall Study|Medical condition|2|||
163112911|NCT00118846|589120019|FG000|Overall Study|Lost to Follow-up|0|||
163112912|NCT00118846|589120020|FG001|Overall Study|Lost to Follow-up|2|||
163112913|NCT00118846|589120019|FG000|Overall Study|Personal reason|4|||
163112914|NCT00118846|589120020|FG001|Overall Study|Personal reason|5|||
163112915|NCT00443053|589120022|FG000|Overall Study|Adverse Event|2|||
163112916|NCT00443053|589120023|FG001|Overall Study|Adverse Event|1|||
163112917|NCT00443053|589120022|FG000|Overall Study|Withdrawal by Subject|9|||
163112918|NCT00443053|589120023|FG001|Overall Study|Withdrawal by Subject|18|||
163112919|NCT00443053|589120022|FG000|Overall Study|Lost to Follow-up|4|||
163112920|NCT00443053|589120023|FG001|Overall Study|Lost to Follow-up|5|||
163112921|NCT00443053|589120022|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
163112922|NCT00443053|589120023|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
163112923|NCT00443053|589120022|FG000|Overall Study|Noncompliance|2|||
163112924|NCT00443053|589120023|FG001|Overall Study|Noncompliance|1|||
163112925|NCT00443053|589120022|FG000|Overall Study|Other|3|||
163112926|NCT00443053|589120023|FG001|Overall Study|Other|4|||
163112927|NCT00443053|589120022|FG000|Overall Study|Physician Decision|0|||
163112928|NCT00443053|589120023|FG001|Overall Study|Physician Decision|4|||
163112929|NCT00541866|589120024|FG000|Overall Study|Adverse Event|3|||
163112930|NCT00541866|589120025|FG001|Overall Study|Adverse Event|0|||
163112931|NCT00541866|589120026|FG002|Overall Study|Adverse Event|0|||
163112932|NCT00541866|589120027|FG003|Overall Study|Adverse Event|0|||
163112933|NCT00541866|589120028|FG004|Overall Study|Adverse Event|0|||
163112934|NCT00541866|589120024|FG000|Overall Study|Death|1|||
163112935|NCT00541866|589120025|FG001|Overall Study|Death|0|||
163112936|NCT00541866|589120026|FG002|Overall Study|Death|0|||
163112937|NCT00541866|589120027|FG003|Overall Study|Death|0|||
163112938|NCT00541866|589120028|FG004|Overall Study|Death|0|||
163112939|NCT00541866|589120024|FG000|Overall Study|Lack of Efficacy|19|||
163112940|NCT00541866|589120025|FG001|Overall Study|Lack of Efficacy|15|||
163112941|NCT00541866|589120026|FG002|Overall Study|Lack of Efficacy|10|||
163112942|NCT00541866|589120027|FG003|Overall Study|Lack of Efficacy|12|||
163112943|NCT00541866|589120028|FG004|Overall Study|Lack of Efficacy|14|||
163112944|NCT00541866|589120024|FG000|Overall Study|Not Reported or Other|11|||
163112945|NCT00541866|589120025|FG001|Overall Study|Not Reported or Other|3|||
163112946|NCT00541866|589120026|FG002|Overall Study|Not Reported or Other|3|||
163112947|NCT00541866|589120027|FG003|Overall Study|Not Reported or Other|3|||
163112948|NCT00541866|589120028|FG004|Overall Study|Not Reported or Other|1|||
163112949|NCT00541866|589120024|FG000|Overall Study|Physician Decision|0|||
163112950|NCT00541866|589120025|FG001|Overall Study|Physician Decision|0|||
163112951|NCT00541866|589120026|FG002|Overall Study|Physician Decision|2|||
163112952|NCT00541866|589120027|FG003|Overall Study|Physician Decision|1|||
163112953|NCT00541866|589120028|FG004|Overall Study|Physician Decision|0|||
163112954|NCT00578877|589120032|FG000|Overall Study|Lost to Follow-up|8|||
163112955|NCT00578877|589120033|FG001|Overall Study|Lost to Follow-up|10|||
163112956|NCT00578877|589120032|FG000|Overall Study|early discontinue|61|||
163112957|NCT00578877|589120033|FG001|Overall Study|early discontinue|101|||
163112958|NCT00578877|589120032|FG000|Overall Study|did not provide follow-up data|12|||
163112959|NCT00578877|589120033|FG001|Overall Study|did not provide follow-up data|17|||
163112960|NCT03245736|589122016|FG000|Overall Study|Adverse Event|1|||
163112961|NCT03245736|589122016|FG000|Overall Study|Progressive Disease|4|||
163112962|NCT02251717|589122024|FG000|Overall Study|Adverse Event|0|||
163112963|NCT02251717|589122025|FG001|Overall Study|Adverse Event|1|||
163112964|NCT02251717|589122024|FG000|Overall Study|Withdrew Consent|1|||
163112965|NCT02251717|589122025|FG001|Overall Study|Withdrew Consent|0|||
163112966|NCT04098367|589122026|FG000|Overall Study|Adverse Event|0|||
163112967|NCT04098367|589122027|FG001|Overall Study|Adverse Event|0|||
163112968|NCT04098367|589122028|FG002|Overall Study|Adverse Event|1|||
163112969|NCT04098367|589122026|FG000|Overall Study|Lost to Follow-up|1|||
163112970|NCT04098367|589122027|FG001|Overall Study|Lost to Follow-up|5|||
163112971|NCT04098367|589122028|FG002|Overall Study|Lost to Follow-up|2|||
163112972|NCT04098367|589122026|FG000|Overall Study|Withdrawal by Subject|0|||
163112973|NCT04098367|589122027|FG001|Overall Study|Withdrawal by Subject|0|||
163112974|NCT04098367|589122028|FG002|Overall Study|Withdrawal by Subject|1|||
163112975|NCT04098367|589122026|FG000|Overall Study|Sick . Could not attend visit|1|||
163112976|NCT04098367|589122027|FG001|Overall Study|Sick . Could not attend visit|0|||
163112977|NCT04098367|589122028|FG002|Overall Study|Sick . Could not attend visit|0|||
163112978|NCT00445939|589122032|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
163112979|NCT00445939|589122033|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
163112980|NCT00445939|589122034|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
163112981|NCT00445939|589122035|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
163112982|NCT00445939|589122032|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
163112983|NCT00445939|589122033|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
163112984|NCT00445939|589122034|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
163112985|NCT00445939|589122035|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
163112986|NCT00416715|589122036|FG000|Overall Study|Not evaluable for joint aches|7|||
163112987|NCT00416715|589122036|FG000|Overall Study|Vitamin D levels not evaluable|8|||
163112988|NCT01007435|589122049|FG000|Overall Study|Adverse Event|16|||
163112989|NCT01007435|589122050|FG001|Overall Study|Adverse Event|25|||
163112990|NCT01007435|589122051|FG002|Overall Study|Adverse Event|47|||
163112991|NCT01007435|589122052|FG003|Overall Study|Adverse Event|31|||
163112992|NCT01007435|589122049|FG000|Overall Study|Death|2|||
163112993|NCT01007435|589122050|FG001|Overall Study|Death|4|||
163112994|NCT01007435|589122051|FG002|Overall Study|Death|2|||
163112995|NCT01007435|589122052|FG003|Overall Study|Death|1|||
163112996|NCT01007435|589122049|FG000|Overall Study|Insufficient Therapeutic Response|21|||
163112997|NCT01007435|589122050|FG001|Overall Study|Insufficient Therapeutic Response|7|||
163112998|NCT01007435|589122051|FG002|Overall Study|Insufficient Therapeutic Response|2|||
163112999|NCT01007435|589122052|FG003|Overall Study|Insufficient Therapeutic Response|9|||
163113000|NCT01007435|589122049|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
163113001|NCT01007435|589122050|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
163113002|NCT01007435|589122051|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
163113003|NCT01007435|589122052|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
163113004|NCT01007435|589122049|FG000|Overall Study|Other Protocol Violation|2|||
163113005|NCT01007435|589122050|FG001|Overall Study|Other Protocol Violation|0|||
163113006|NCT01007435|589122051|FG002|Overall Study|Other Protocol Violation|1|||
163113007|NCT01007435|589122052|FG003|Overall Study|Other Protocol Violation|0|||
163113008|NCT01007435|589122049|FG000|Overall Study|Refused Treatment|13|||
163113009|NCT01007435|589122050|FG001|Overall Study|Refused Treatment|13|||
163113010|NCT01007435|589122051|FG002|Overall Study|Refused Treatment|5|||
163113011|NCT01007435|589122052|FG003|Overall Study|Refused Treatment|8|||
163113012|NCT01007435|589122049|FG000|Overall Study|Failure to Return|5|||
163113013|NCT01007435|589122050|FG001|Overall Study|Failure to Return|4|||
163113014|NCT01007435|589122051|FG002|Overall Study|Failure to Return|3|||
163113015|NCT01007435|589122052|FG003|Overall Study|Failure to Return|6|||
163113016|NCT01007435|589122049|FG000|Overall Study|Reason not Specified|1|||
163113017|NCT01007435|589122050|FG001|Overall Study|Reason not Specified|1|||
163113018|NCT01007435|589122051|FG002|Overall Study|Reason not Specified|2|||
163113019|NCT01007435|589122052|FG003|Overall Study|Reason not Specified|1|||
163113020|NCT02576535|589122053|FG000|Overall Study|Withdrawal by Subject|2|||
163113021|NCT02545517|589122054|FG000|Overall Study|Death|2|||
163113022|NCT02545517|589122055|FG001|Overall Study|Death|2|||
163113023|NCT02545517|589122056|FG002|Overall Study|Death|1|||
163113024|NCT02545517|589122054|FG000|Overall Study|Lost to Follow-up|14|||
163113025|NCT02545517|589122055|FG001|Overall Study|Lost to Follow-up|13|||
163113026|NCT02545517|589122056|FG002|Overall Study|Lost to Follow-up|17|||
163113027|NCT02545517|589122054|FG000|Overall Study|Protocol Violation|0|||
163113028|NCT02545517|589122055|FG001|Overall Study|Protocol Violation|1|||
163113029|NCT02545517|589122056|FG002|Overall Study|Protocol Violation|1|||
163113030|NCT02545517|589122054|FG000|Overall Study|Withdrawal by Subject|5|||
163113031|NCT02545517|589122055|FG001|Overall Study|Withdrawal by Subject|8|||
163113032|NCT02545517|589122056|FG002|Overall Study|Withdrawal by Subject|9|||
163113033|NCT02545517|589122054|FG000|Overall Study|Administrative reason|5|||
163113034|NCT02545517|589122055|FG001|Overall Study|Administrative reason|6|||
163113035|NCT02545517|589122056|FG002|Overall Study|Administrative reason|10|||
163113036|NCT02545517|589122054|FG000|Overall Study|Other|2|||
163113037|NCT02545517|589122055|FG001|Overall Study|Other|4|||
163113038|NCT02545517|589122056|FG002|Overall Study|Other|3|||
163113039|NCT03334851|589122057|FG000|Overall Study|Other|0|||
163113040|NCT03334851|589122058|FG001|Overall Study|Other|0|||
163113041|NCT03334851|589122059|FG002|Overall Study|Other|0|||
163113042|NCT03334851|589122060|FG003|Overall Study|Other|0|||
163113043|NCT03334851|589122061|FG004|Overall Study|Other|0|||
163113044|NCT03334851|589122062|FG005|Overall Study|Other|0|||
163113045|NCT03334851|589122063|FG006|Overall Study|Other|0|||
163113046|NCT03334851|589122064|FG007|Overall Study|Other|1|||
163113047|NCT03334851|589122065|FG008|Overall Study|Other|0|||
163113048|NCT03334851|589122066|FG009|Overall Study|Other|0|||
163113049|NCT03334851|589122067|FG010|Overall Study|Other|0|||
163113050|NCT03334851|589122068|FG011|Overall Study|Other|0|||
163113051|NCT03334851|589122069|FG012|Overall Study|Other|0|||
163113052|NCT03334851|589122057|FG000|Overall Study|Adverse Event|0|||
163113053|NCT03334851|589122058|FG001|Overall Study|Adverse Event|0|||
163113054|NCT03334851|589122059|FG002|Overall Study|Adverse Event|0|||
163113055|NCT03334851|589122060|FG003|Overall Study|Adverse Event|0|||
163113056|NCT03334851|589122061|FG004|Overall Study|Adverse Event|0|||
163113057|NCT03334851|589122062|FG005|Overall Study|Adverse Event|0|||
163113058|NCT03334851|589122063|FG006|Overall Study|Adverse Event|0|||
163113059|NCT03334851|589122064|FG007|Overall Study|Adverse Event|1|||
163113060|NCT03334851|589122065|FG008|Overall Study|Adverse Event|0|||
163113061|NCT03334851|589122066|FG009|Overall Study|Adverse Event|0|||
163113062|NCT03334851|589122067|FG010|Overall Study|Adverse Event|0|||
163113063|NCT03334851|589122068|FG011|Overall Study|Adverse Event|0|||
163113064|NCT03334851|589122069|FG012|Overall Study|Adverse Event|0|||
163113065|NCT03334851|589122057|FG000|Overall Study|Withdrawal by Subject|0|||
163113066|NCT03334851|589122058|FG001|Overall Study|Withdrawal by Subject|0|||
163113067|NCT03334851|589122059|FG002|Overall Study|Withdrawal by Subject|0|||
163113068|NCT03334851|589122060|FG003|Overall Study|Withdrawal by Subject|0|||
163113069|NCT03334851|589122061|FG004|Overall Study|Withdrawal by Subject|0|||
163113070|NCT03334851|589122062|FG005|Overall Study|Withdrawal by Subject|0|||
163113071|NCT03334851|589122063|FG006|Overall Study|Withdrawal by Subject|0|||
163113072|NCT03334851|589122064|FG007|Overall Study|Withdrawal by Subject|0|||
163113073|NCT03334851|589122065|FG008|Overall Study|Withdrawal by Subject|0|||
163113074|NCT03334851|589122066|FG009|Overall Study|Withdrawal by Subject|0|||
163113075|NCT03334851|589122067|FG010|Overall Study|Withdrawal by Subject|1|||
163113076|NCT03334851|589122068|FG011|Overall Study|Withdrawal by Subject|0|||
163113077|NCT03334851|589122069|FG012|Overall Study|Withdrawal by Subject|1|||
163113078|NCT03334851|589122057|FG000|Overall Study|Lost to Follow-up|0|||
163113079|NCT03334851|589122058|FG001|Overall Study|Lost to Follow-up|0|||
163113080|NCT03334851|589122059|FG002|Overall Study|Lost to Follow-up|0|||
163113081|NCT03334851|589122060|FG003|Overall Study|Lost to Follow-up|0|||
163113082|NCT03334851|589122061|FG004|Overall Study|Lost to Follow-up|0|||
163113083|NCT03334851|589122062|FG005|Overall Study|Lost to Follow-up|0|||
163113084|NCT03334851|589122063|FG006|Overall Study|Lost to Follow-up|0|||
163113085|NCT03334851|589122064|FG007|Overall Study|Lost to Follow-up|0|||
163113086|NCT03334851|589122065|FG008|Overall Study|Lost to Follow-up|0|||
163113087|NCT03334851|589122066|FG009|Overall Study|Lost to Follow-up|0|||
163113088|NCT03334851|589122067|FG010|Overall Study|Lost to Follow-up|2|||
163113089|NCT03334851|589122068|FG011|Overall Study|Lost to Follow-up|1|||
163113090|NCT03334851|589122069|FG012|Overall Study|Lost to Follow-up|0|||
163113091|NCT03575065|589122070|FG000|Overall Study|Death|31|||
163113092|NCT03575065|589122071|FG001|Overall Study|Death|12|||
163113093|NCT03575065|589122070|FG000|Overall Study|Sponsor's Decision|28|||
163113094|NCT03575065|589122071|FG001|Overall Study|Sponsor's Decision|13|||
163113095|NCT03575065|589122070|FG000|Overall Study|Withdrawal by Subject|2|||
163113096|NCT03575065|589122071|FG001|Overall Study|Withdrawal by Subject|1|||
163113097|NCT03575065|589122070|FG000|Overall Study|Lost to Follow-up|1|||
163113098|NCT03575065|589122071|FG001|Overall Study|Lost to Follow-up|0|||
163113099|NCT02323126|589122072|FG000|Overall Study|Patient / guardian decision|0|||
163113100|NCT02323126|589122073|FG001|Overall Study|Patient / guardian decision|1|||
163113101|NCT02323126|589122074|FG002|Overall Study|Patient / guardian decision|2|||
163113102|NCT02323126|589122072|FG000|Overall Study|Progressive disease|14|||
163113103|NCT02323126|589122073|FG001|Overall Study|Progressive disease|8|||
163113104|NCT02323126|589122074|FG002|Overall Study|Progressive disease|14|||
163113105|NCT02323126|589122072|FG000|Overall Study|Physician Decision|0|||
163113106|NCT02323126|589122073|FG001|Overall Study|Physician Decision|1|||
163113107|NCT02323126|589122074|FG002|Overall Study|Physician Decision|3|||
163113108|NCT02323126|589122072|FG000|Overall Study|Death|1|||
163113109|NCT02323126|589122073|FG001|Overall Study|Death|1|||
163113110|NCT02323126|589122074|FG002|Overall Study|Death|4|||
163113111|NCT02323126|589122072|FG000|Overall Study|Adverse Event|3|||
163113112|NCT02323126|589122073|FG001|Overall Study|Adverse Event|5|||
163113113|NCT02323126|589122074|FG002|Overall Study|Adverse Event|7|||
163113114|NCT00396136|589122078|FG000|Overall Study|Death|43|||
163113115|NCT00396136|589122078|FG000|Overall Study|Withdrawal by Subject|59|||
163113116|NCT00396136|589122078|FG000|Overall Study|Lost to Follow-up|15|||
163113117|NCT00396136|589122078|FG000|Overall Study|Study device explanted|8|||
163113118|NCT04043234|589122079|FG000|Overall Study|Lost to Follow-up|1|||
163113119|NCT04043234|589122079|FG000|Overall Study|Withdrawal by Subject|1|||
163113120|NCT03172325|589122080|FG000|Overall Study|Adverse Event|2|||
163113121|NCT03172325|589122081|FG001|Overall Study|Adverse Event|3|||
163113122|NCT03172325|589122080|FG000|Overall Study|Positive PPD|1|||
163113123|NCT03172325|589122081|FG001|Overall Study|Positive PPD|0|||
163113124|NCT03172325|589122080|FG000|Overall Study|Poor Compliance|1|||
163113125|NCT03172325|589122081|FG001|Overall Study|Poor Compliance|1|||
163113126|NCT00496197|589122082|FG000|Overall Study|Discontinued study due to death|43|||
163113127|NCT00496197|589122082|FG000|Overall Study|Adverse Event|13|||
163113128|NCT00496197|589122082|FG000|Overall Study|Does not meet entrance criteria|5|||
163113129|NCT00496197|589122082|FG000|Overall Study|Insufficient clinical response|3|||
163113130|NCT00496197|589122082|FG000|Overall Study|Insufficient bacteriological response|10|||
163113131|NCT00496197|589122082|FG000|Overall Study|Lost to Follow-up|11|||
163113132|NCT00496197|589122082|FG000|Overall Study|Withdrawal by Subject|11|||
163113133|NCT00496197|589122082|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
163113134|NCT00496197|589122082|FG000|Overall Study|Other|14|||
163113135|NCT00496197|589122082|FG000|Overall Study|Protocol Violation|8|||
163113136|NCT00149994|589122083|FG000|Overall Study|Administrative problems:|1|||
163113137|NCT00149994|589122084|FG001|Overall Study|Administrative problems:|0|||
163113138|NCT00149994|589122083|FG000|Overall Study|Protocol Violation|0|||
163113139|NCT00149994|589122084|FG001|Overall Study|Protocol Violation|1|||
163113140|NCT01610713|589122085|FG000|Overall Study|Adverse Event|3|||
163113141|NCT01610713|589122086|FG001|Overall Study|Adverse Event|0|||
163113142|NCT01610713|589122085|FG000|Overall Study|Lack of Efficacy|1|||
163113143|NCT01610713|589122086|FG001|Overall Study|Lack of Efficacy|0|||
163113144|NCT01610713|589122085|FG000|Overall Study|low mood and poor motivation|1|||
163113145|NCT01610713|589122086|FG001|Overall Study|low mood and poor motivation|0|||
163113146|NCT01610713|589122085|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
163113147|NCT01610713|589122086|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
163113148|NCT01610713|589122085|FG000|Overall Study|Lost to Follow-up|0|||
163113149|NCT01610713|589122086|FG001|Overall Study|Lost to Follow-up|1|||
163113150|NCT03943550|589122091|FG000|Overall Study|Adverse Event|0|||
163113151|NCT03943550|589122092|FG001|Overall Study|Adverse Event|0|||
163113152|NCT03943550|589122093|FG002|Overall Study|Adverse Event|1|||
163113153|NCT03943550|589122091|FG000|Overall Study|Lost to Follow-up|0|||
163113154|NCT03943550|589122092|FG001|Overall Study|Lost to Follow-up|0|||
163113155|NCT03943550|589122093|FG002|Overall Study|Lost to Follow-up|1|||
163113156|NCT03943550|589122091|FG000|Overall Study|Progressive Disease|0|||
163113157|NCT03943550|589122092|FG001|Overall Study|Progressive Disease|0|||
163113158|NCT03943550|589122093|FG002|Overall Study|Progressive Disease|2|||
163113159|NCT03943550|589122091|FG000|Overall Study|Participant Moved Out of the Country|0|||
163113160|NCT03943550|589122092|FG001|Overall Study|Participant Moved Out of the Country|1|||
163113161|NCT03943550|589122093|FG002|Overall Study|Participant Moved Out of the Country|0|||
163113162|NCT00543296|589122094|FG000|Overall Study|Physician Decision|7|||
163113163|NCT00934947|589122095|FG000|Overall Study|Adverse Event|0|||
163113164|NCT00934947|589122096|FG001|Overall Study|Adverse Event|2|||
163113165|NCT00252694|589122102|FG000|Overall Study|Withdrawal by Subject|83|||
163113166|NCT00252694|589122103|FG001|Overall Study|Withdrawal by Subject|91|||
163113167|NCT00252694|589122102|FG000|Overall Study|Death|36|||
163113168|NCT00252694|589122103|FG001|Overall Study|Death|34|||
163113169|NCT00252694|589122102|FG000|Overall Study|Mostly Lost to Follow Up|8|||
163113170|NCT00252694|589122103|FG001|Overall Study|Mostly Lost to Follow Up|13|||
163113171|NCT00252694|589122102|FG000|Overall Study|Patient Moving|17|||
163113172|NCT00252694|589122103|FG001|Overall Study|Patient Moving|16|||
163113173|NCT00096226|589122105|FG000|Overall Study|Ineligible|2|||
163113174|NCT00096226|589122105|FG000|Overall Study|Protocol treatment not started|1|||
163113175|NCT02378298|589122108|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
163113176|NCT02378298|589122109|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
163113177|NCT02378298|589122110|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
163113178|NCT02378298|589122108|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
163113179|NCT02378298|589122109|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
163113180|NCT02378298|589122110|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
163113181|NCT02378298|589122108|FG000|Surveillance (19-68 Weeks)|Death|1|||
163113182|NCT02378298|589122109|FG001|Surveillance (19-68 Weeks)|Death|0|||
163113183|NCT02378298|589122110|FG002|Surveillance (19-68 Weeks)|Death|0|||
163113184|NCT03006458|589122112|FG000|First Intervention|Unsatisfied Vision|0|||
163113185|NCT03006458|589122113|FG001|First Intervention|Unsatisfied Vision|3|||
163113186|NCT01468233|589122116|FG000|Treatment Period 1|Adverse Event|5|||
163113187|NCT01468233|589122117|FG001|Treatment Period 1|Adverse Event|3|||
163113188|NCT01468233|589122118|FG002|Treatment Period 1|Adverse Event|0|||
163113189|NCT01468233|589122119|FG003|Treatment Period 1|Adverse Event|0|||
163113190|NCT01468233|589122120|FG004|Treatment Period 1|Adverse Event|0|||
163113191|NCT01468233|589122121|FG005|Treatment Period 1|Adverse Event|0|||
163113192|NCT01468233|589122116|FG000|Treatment Period 1|Withdrawal by Subject|3|||
163113193|NCT01468233|589122117|FG001|Treatment Period 1|Withdrawal by Subject|4|||
163113194|NCT01468233|589122118|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163113195|NCT01468233|589122119|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163113196|NCT01468233|589122120|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163222616|NCT01951157|589531565|FG001|Overall Study|Consent withdrawn by subject|1|||
163113197|NCT01468233|589122121|FG005|Treatment Period 1|Withdrawal by Subject|0|||
163113198|NCT01468233|589122116|FG000|Treatment Period 1|Lost to Follow-up|3|||
163113199|NCT01468233|589122117|FG001|Treatment Period 1|Lost to Follow-up|0|||
163222617|NCT01951157|589531566|FG002|Overall Study|Consent withdrawn by subject|3|||
163222618|NCT01951157|589531564|FG000|Overall Study|Treatment-related death|0|||
163222619|NCT01951157|589531565|FG001|Overall Study|Treatment-related death|2|||
163222620|NCT01951157|589531566|FG002|Overall Study|Treatment-related death|0|||
163339998|NCT03875729|589953127|FG001|Overall Study|Lost to Follow-up|5|||
163113200|NCT01468233|589122118|FG002|Treatment Period 1|Lost to Follow-up|0|||
163113201|NCT01468233|589122119|FG003|Treatment Period 1|Lost to Follow-up|0|||
163113202|NCT01468233|589122120|FG004|Treatment Period 1|Lost to Follow-up|0|||
163113203|NCT01468233|589122121|FG005|Treatment Period 1|Lost to Follow-up|0|||
163113204|NCT01468233|589122116|FG000|Treatment Period 1|Other|1|||
163113205|NCT01468233|589122117|FG001|Treatment Period 1|Other|1|||
163113206|NCT01468233|589122118|FG002|Treatment Period 1|Other|0|||
163113207|NCT01468233|589122119|FG003|Treatment Period 1|Other|0|||
163113208|NCT01468233|589122120|FG004|Treatment Period 1|Other|0|||
163113209|NCT01468233|589122121|FG005|Treatment Period 1|Other|0|||
163113210|NCT01468233|589122116|FG000|Treatment Period 2|Adverse Event|0|||
163113211|NCT01468233|589122117|FG001|Treatment Period 2|Adverse Event|0|||
163113212|NCT01468233|589122118|FG002|Treatment Period 2|Adverse Event|3|||
163113213|NCT01468233|589122119|FG003|Treatment Period 2|Adverse Event|0|||
163113214|NCT01468233|589122120|FG004|Treatment Period 2|Adverse Event|2|||
163113215|NCT01468233|589122121|FG005|Treatment Period 2|Adverse Event|1|||
163113216|NCT01468233|589122116|FG000|Treatment Period 2|Lack of Efficacy|0|||
163113217|NCT01468233|589122117|FG001|Treatment Period 2|Lack of Efficacy|0|||
163113218|NCT01468233|589122118|FG002|Treatment Period 2|Lack of Efficacy|9|||
163113219|NCT01468233|589122119|FG003|Treatment Period 2|Lack of Efficacy|2|||
163113220|NCT01468233|589122120|FG004|Treatment Period 2|Lack of Efficacy|0|||
163113221|NCT01468233|589122121|FG005|Treatment Period 2|Lack of Efficacy|1|||
163113222|NCT01468233|589122116|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163113223|NCT01468233|589122117|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163113224|NCT01468233|589122118|FG002|Treatment Period 2|Withdrawal by Subject|9|||
163113225|NCT01468233|589122119|FG003|Treatment Period 2|Withdrawal by Subject|1|||
163113226|NCT01468233|589122120|FG004|Treatment Period 2|Withdrawal by Subject|1|||
163113227|NCT01468233|589122121|FG005|Treatment Period 2|Withdrawal by Subject|1|||
163113228|NCT01468233|589122116|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
163113229|NCT01468233|589122117|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
163113230|NCT01468233|589122118|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
163113231|NCT01468233|589122119|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
163113232|NCT01468233|589122120|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
163113233|NCT01468233|589122121|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
163113234|NCT01468233|589122116|FG000|Treatment Period 2|Lost to Follow-up|0|||
163113235|NCT01468233|589122117|FG001|Treatment Period 2|Lost to Follow-up|0|||
163113236|NCT01468233|589122118|FG002|Treatment Period 2|Lost to Follow-up|3|||
163113237|NCT01468233|589122119|FG003|Treatment Period 2|Lost to Follow-up|0|||
163113238|NCT01468233|589122120|FG004|Treatment Period 2|Lost to Follow-up|2|||
163113239|NCT01468233|589122121|FG005|Treatment Period 2|Lost to Follow-up|0|||
163113240|NCT01468233|589122116|FG000|Treatment Period 2|Other|0|||
163113241|NCT01468233|589122117|FG001|Treatment Period 2|Other|0|||
163113242|NCT01468233|589122118|FG002|Treatment Period 2|Other|3|||
163113243|NCT01468233|589122119|FG003|Treatment Period 2|Other|0|||
163113244|NCT01468233|589122120|FG004|Treatment Period 2|Other|1|||
163113245|NCT01468233|589122121|FG005|Treatment Period 2|Other|0|||
163113246|NCT01574157|589122122|FG000|Overall Study|Withdrawal by Subject|4|||
163113247|NCT01574157|589122123|FG001|Overall Study|Withdrawal by Subject|5|||
163113248|NCT01574157|589122122|FG000|Overall Study|Lost to Follow-up|0|||
163113249|NCT01574157|589122123|FG001|Overall Study|Lost to Follow-up|3|||
163113250|NCT01944098|589122124|FG000|Overall Study|Physician Decision|1|||
163113251|NCT01944098|589122125|FG001|Overall Study|Physician Decision|0|||
163113252|NCT02136680|589122127|FG000|Overall Study|No Longer Interested|1|||
163113253|NCT02136680|589122128|FG001|Overall Study|No Longer Interested|1|||
163113254|NCT02136680|589122127|FG000|Overall Study|No longer receiving care at clinic|3|||
163113255|NCT02136680|589122128|FG001|Overall Study|No longer receiving care at clinic|5|||
163113256|NCT02136680|589122127|FG000|Overall Study|Moved away|5|||
163113257|NCT02136680|589122128|FG001|Overall Study|Moved away|4|||
163113258|NCT02136680|589122127|FG000|Overall Study|Unable to schedule|17|||
163113259|NCT02136680|589122128|FG001|Overall Study|Unable to schedule|16|||
163113260|NCT02136680|589122127|FG000|Overall Study|Study ended before interview due|6|||
163113261|NCT02136680|589122128|FG001|Overall Study|Study ended before interview due|3|||
163113262|NCT01632241|589122129|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
163113263|NCT01632241|589122130|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
163339999|NCT03875729|589953126|FG000|Overall Study|Personal reasons|2|||
163340000|NCT03875729|589953127|FG001|Overall Study|Personal reasons|0|||
163340001|NCT01280656|589953128|FG000|Overall Study|Adverse Event|1|||
163340002|NCT01280656|589953129|FG001|Overall Study|Adverse Event|14|||
163113264|NCT01632241|589122129|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
163113265|NCT01632241|589122130|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
163340003|NCT01280656|589953130|FG002|Overall Study|Adverse Event|13|||
163113266|NCT01632241|589122129|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
163113267|NCT01632241|589122130|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
163113268|NCT01632241|589122129|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
163113269|NCT01632241|589122130|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
163113270|NCT01632241|589122129|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
163113271|NCT01632241|589122130|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
163340004|NCT01280656|589953128|FG000|Overall Study|Lack of Efficacy|1|||
163113272|NCT01632241|589122129|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
163113273|NCT01632241|589122130|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
163113274|NCT01632241|589122129|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
163113275|NCT01632241|589122130|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
163113276|NCT01632241|589122129|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
163113277|NCT01632241|589122130|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
163113278|NCT01632241|589122129|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
163113279|NCT01632241|589122130|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
163113280|NCT01632241|589122129|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
163113281|NCT01632241|589122130|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
163113282|NCT01632241|589122129|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
163113283|NCT01632241|589122130|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
163113284|NCT01632241|589122129|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
163113285|NCT01632241|589122130|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
163113286|NCT01632241|589122129|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
163113287|NCT01632241|589122130|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
163113288|NCT01632241|589122129|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
163113289|NCT01632241|589122130|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
163113290|NCT01202188|589122131|FG000|Overall Study|Protocol deviation|14|||
163113291|NCT01202188|589122132|FG001|Overall Study|Protocol deviation|8|||
163113292|NCT01202188|589122133|FG002|Overall Study|Protocol deviation|12|||
163113293|NCT01202188|589122134|FG003|Overall Study|Protocol deviation|10|||
163113294|NCT01202188|589122135|FG004|Overall Study|Protocol deviation|11|||
163113295|NCT01202188|589122131|FG000|Overall Study|Subject withdrew consent|12|||
163113296|NCT01202188|589122132|FG001|Overall Study|Subject withdrew consent|13|||
163113297|NCT01202188|589122133|FG002|Overall Study|Subject withdrew consent|22|||
163113298|NCT01202188|589122134|FG003|Overall Study|Subject withdrew consent|11|||
163113299|NCT01202188|589122135|FG004|Overall Study|Subject withdrew consent|13|||
163113300|NCT01202188|589122131|FG000|Overall Study|Adverse Event|5|||
163113301|NCT01202188|589122132|FG001|Overall Study|Adverse Event|23|||
163113302|NCT01202188|589122133|FG002|Overall Study|Adverse Event|13|||
163113303|NCT01202188|589122134|FG003|Overall Study|Adverse Event|10|||
163113304|NCT01202188|589122135|FG004|Overall Study|Adverse Event|10|||
163113305|NCT01202188|589122131|FG000|Overall Study|Administrative problems|3|||
163113306|NCT01202188|589122132|FG001|Overall Study|Administrative problems|2|||
163113307|NCT01202188|589122133|FG002|Overall Study|Administrative problems|1|||
163113308|NCT01202188|589122134|FG003|Overall Study|Administrative problems|1|||
163113309|NCT01202188|589122135|FG004|Overall Study|Administrative problems|2|||
163113310|NCT01202188|589122131|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163113311|NCT01202188|589122132|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
163113312|NCT01202188|589122133|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
163113313|NCT01202188|589122134|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
163113314|NCT01202188|589122135|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
163113315|NCT01202188|589122131|FG000|Overall Study|Lost to Follow-up|1|||
163113316|NCT01202188|589122132|FG001|Overall Study|Lost to Follow-up|1|||
163113317|NCT01202188|589122133|FG002|Overall Study|Lost to Follow-up|0|||
163113318|NCT01202188|589122134|FG003|Overall Study|Lost to Follow-up|4|||
163113319|NCT01202188|589122135|FG004|Overall Study|Lost to Follow-up|1|||
163113320|NCT01202188|589122131|FG000|Overall Study|Death|1|||
163113321|NCT01202188|589122132|FG001|Overall Study|Death|1|||
163113322|NCT01202188|589122133|FG002|Overall Study|Death|1|||
163113323|NCT01202188|589122134|FG003|Overall Study|Death|1|||
163113324|NCT01202188|589122135|FG004|Overall Study|Death|0|||
163113325|NCT01202188|589122131|FG000|Overall Study|Abnormal test procedure result (s)|0|||
163113326|NCT01202188|589122132|FG001|Overall Study|Abnormal test procedure result (s)|0|||
163113327|NCT01202188|589122133|FG002|Overall Study|Abnormal test procedure result (s)|2|||
163113328|NCT01202188|589122134|FG003|Overall Study|Abnormal test procedure result (s)|0|||
163113329|NCT01202188|589122135|FG004|Overall Study|Abnormal test procedure result (s)|0|||
163113330|NCT01330628|589122143|FG000|Overall Study|Death|2|||
163113331|NCT01330628|589122144|FG001|Overall Study|Death|3|||
163113332|NCT01330628|589122143|FG000|Overall Study|Lost to Follow-up|5|||
163113333|NCT01330628|589122144|FG001|Overall Study|Lost to Follow-up|6|||
163113334|NCT01330628|589122143|FG000|Overall Study|Adverse Event|44|||
163113335|NCT01330628|589122144|FG001|Overall Study|Adverse Event|25|||
163113336|NCT01330628|589122143|FG000|Overall Study|Withdrawn|18|||
163113337|NCT01330628|589122144|FG001|Overall Study|Withdrawn|6|||
163113338|NCT01330628|589122143|FG000|Overall Study|Didn't receive study treatment|1|||
163113339|NCT01330628|589122144|FG001|Overall Study|Didn't receive study treatment|0|||
163113340|NCT03761394|589122145|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
163113341|NCT03761394|589122146|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
163113342|NCT03761394|589122147|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
163340005|NCT01280656|589953129|FG001|Overall Study|Lack of Efficacy|22|||
163340006|NCT01280656|589953130|FG002|Overall Study|Lack of Efficacy|38|||
163113343|NCT03761394|589122148|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
163113344|NCT03761394|589122145|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
163113345|NCT03761394|589122146|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
163113346|NCT03761394|589122147|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
163113347|NCT03761394|589122148|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
163113348|NCT03761394|589122145|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
163113349|NCT03761394|589122146|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
163113350|NCT03761394|589122147|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
163113351|NCT03761394|589122148|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
163113352|NCT03761394|589122145|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
163113353|NCT03761394|589122146|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
163113354|NCT03761394|589122147|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
163113355|NCT03761394|589122148|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
163113356|NCT01080768|589122158|FG000|Overall Study|Protocol Deviation|2|||
163113357|NCT01080768|589122159|FG001|Overall Study|Protocol Deviation|1|||
163113358|NCT00580034|589122170|FG000|Overall Study|Toxicity|10|||
163113359|NCT00580034|589122171|FG001|Overall Study|Toxicity|0|||
163113360|NCT01939002|589122172|FG000|Overall Study|Adverse Event|13|||
163113361|NCT01939002|589122173|FG001|Overall Study|Adverse Event|13|||
163113362|NCT01939002|589122172|FG000|Overall Study|Withdrawal by Subject|5|||
163113363|NCT01939002|589122173|FG001|Overall Study|Withdrawal by Subject|3|||
163113364|NCT01939002|589122172|FG000|Overall Study|Other|1|||
163113365|NCT01939002|589122173|FG001|Overall Study|Other|2|||
163113366|NCT00098748|589122177|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
163113367|NCT00098748|589122178|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
163113368|NCT00098748|589122179|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
163113369|NCT00098748|589122177|FG000|Received Study Treatment|Death|2|||
163113370|NCT00098748|589122178|FG001|Received Study Treatment|Death|1|||
163113371|NCT00098748|589122179|FG002|Received Study Treatment|Death|2|||
163113372|NCT00098748|589122177|FG000|Received Study Treatment|Adverse Event|1|||
163113373|NCT00098748|589122178|FG001|Received Study Treatment|Adverse Event|2|||
163113374|NCT00098748|589122179|FG002|Received Study Treatment|Adverse Event|5|||
163113375|NCT00098748|589122177|FG000|Received Study Treatment|Lack of Efficacy|40|||
163113376|NCT00098748|589122178|FG001|Received Study Treatment|Lack of Efficacy|27|||
163113377|NCT00098748|589122179|FG002|Received Study Treatment|Lack of Efficacy|27|||
163113378|NCT00098748|589122177|FG000|Received Study Treatment|Other|2|||
163113379|NCT00098748|589122178|FG001|Received Study Treatment|Other|2|||
163113380|NCT00098748|589122179|FG002|Received Study Treatment|Other|6|||
163113381|NCT00098748|589122177|FG000|Received Study Treatment|Subject defaulted|3|||
163113382|NCT00098748|589122178|FG001|Received Study Treatment|Subject defaulted|4|||
163113383|NCT00098748|589122179|FG002|Received Study Treatment|Subject defaulted|4|||
163113384|NCT00098748|589122177|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
163113385|NCT00098748|589122178|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
163113386|NCT00098748|589122179|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
163113387|NCT00098748|589122177|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
163113388|NCT00098748|589122178|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
163113389|NCT00098748|589122179|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
163113390|NCT00098748|589122177|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
163113391|NCT00098748|589122178|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
163113392|NCT00098748|589122179|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
163113393|NCT00098748|589122177|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
163113394|NCT00098748|589122178|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
163113395|NCT00098748|589122179|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
163113396|NCT00098748|589122177|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
163113397|NCT00098748|589122178|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
163113398|NCT00098748|589122179|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
163113399|NCT03095027|589124297|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
163113400|NCT03095027|589124298|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
163113401|NCT02982018|589124299|FG000|Overall Study|Incorrect Lens Dispensed|1|||
163113402|NCT02982018|589124300|FG001|Overall Study|Incorrect Lens Dispensed|0|||
163113403|NCT02982018|589124299|FG000|Overall Study|Protocol Violation|1|||
163113404|NCT02982018|589124300|FG001|Overall Study|Protocol Violation|1|||
163113405|NCT02982018|589124299|FG000|Overall Study|Adverse Event|1|||
163113406|NCT02982018|589124300|FG001|Overall Study|Adverse Event|1|||
163113407|NCT02982018|589124299|FG000|Overall Study|Lens Discomfort|2|||
163113408|NCT02982018|589124300|FG001|Overall Study|Lens Discomfort|0|||
163113409|NCT02982018|589124299|FG000|Overall Study|Withdrawal by Subject|0|||
163113410|NCT02982018|589124300|FG001|Overall Study|Withdrawal by Subject|1|||
163113411|NCT01942161|589124301|FG000|Overall Study|Adverse Event|1|||
163113412|NCT01942161|589124302|FG001|Overall Study|Adverse Event|2|||
163113413|NCT01942161|589124303|FG002|Overall Study|Adverse Event|5|||
163113414|NCT01942161|589124301|FG000|Overall Study|Physician Decision|3|||
163113415|NCT01942161|589124302|FG001|Overall Study|Physician Decision|1|||
163113416|NCT01942161|589124303|FG002|Overall Study|Physician Decision|0|||
163113417|NCT01942161|589124301|FG000|Overall Study|Protocol Violation|1|||
163113418|NCT01942161|589124302|FG001|Overall Study|Protocol Violation|0|||
163113419|NCT01942161|589124303|FG002|Overall Study|Protocol Violation|0|||
163113420|NCT01942161|589124301|FG000|Overall Study|Withdrawal by Subject|3|||
163113421|NCT01942161|589124302|FG001|Overall Study|Withdrawal by Subject|3|||
163113422|NCT01942161|589124303|FG002|Overall Study|Withdrawal by Subject|1|||
163113423|NCT01257568|589124306|FG000|Overall Study|Lost to Follow-up|2|||
163113424|NCT01257568|589124306|FG000|Overall Study|Withdrawal by Subject|6|||
163113425|NCT01257568|589124306|FG000|Overall Study|Terminated|1|||
163113426|NCT01257568|589124306|FG000|Overall Study|Component Revision|24|||
163113427|NCT00132691|589124308|FG000|Overall Study|Lost to Follow-up|5|||
163113428|NCT00132691|589124309|FG001|Overall Study|Lost to Follow-up|8|||
163113429|NCT00132691|589124308|FG000|Overall Study|Missed 2-year visit|4|||
163113430|NCT00132691|589124309|FG001|Overall Study|Missed 2-year visit|4|||
163113431|NCT00132691|589124308|FG000|Overall Study|Death|2|||
163113432|NCT00132691|589124309|FG001|Overall Study|Death|0|||
163113433|NCT00798317|589124310|FG000|Overall Study|Physician Decision|0|||
163113434|NCT00798317|589124311|FG001|Overall Study|Physician Decision|1|||
163113435|NCT00798317|589124310|FG000|Overall Study|Withdrawal by Subject|5|||
163113436|NCT00798317|589124311|FG001|Overall Study|Withdrawal by Subject|4|||
163113437|NCT00798317|589124310|FG000|Overall Study|Lost to Follow-up|2|||
163113438|NCT00798317|589124311|FG001|Overall Study|Lost to Follow-up|2|||
163113439|NCT00798317|589124310|FG000|Overall Study|Adverse Event|2|||
163113440|NCT00798317|589124311|FG001|Overall Study|Adverse Event|0|||
163113441|NCT00798317|589124310|FG000|Overall Study|Death|1|||
163113442|NCT00798317|589124311|FG001|Overall Study|Death|0|||
163113443|NCT00919867|589124312|FG000|First Intervention|Withdrawal by Subject|0|||
163113444|NCT00919867|589124313|FG001|First Intervention|Withdrawal by Subject|0|||
163113445|NCT00919867|589124314|FG002|First Intervention|Withdrawal by Subject|1|||
163113446|NCT00919867|589124315|FG003|First Intervention|Withdrawal by Subject|0|||
163113447|NCT00919867|589124316|FG004|First Intervention|Withdrawal by Subject|0|||
163113448|NCT00919867|589124317|FG005|First Intervention|Withdrawal by Subject|0|||
163113449|NCT00919867|589124312|FG000|First Intervention|Physician Decision|0|||
163113450|NCT00919867|589124313|FG001|First Intervention|Physician Decision|0|||
163113451|NCT00919867|589124314|FG002|First Intervention|Physician Decision|0|||
163113452|NCT00919867|589124315|FG003|First Intervention|Physician Decision|0|||
163113453|NCT00919867|589124316|FG004|First Intervention|Physician Decision|0|||
163113454|NCT00919867|589124317|FG005|First Intervention|Physician Decision|1|||
163113455|NCT03361189|589124325|FG000|Overall Study|Received heart transplant|1|||
163113456|NCT03361189|589124326|FG001|Overall Study|Received heart transplant|0|||
163113457|NCT03361189|589124325|FG000|Overall Study|Pacemake replacement|0|||
163113458|NCT03361189|589124326|FG001|Overall Study|Pacemake replacement|1|||
163113459|NCT03344549|589124327|FG000|Overall Study|Withdrawal by Subject|3|||
163113460|NCT03344549|589124328|FG001|Overall Study|Withdrawal by Subject|2|||
163113461|NCT03344549|589124327|FG000|Overall Study|Dialysis|2|||
163113462|NCT03344549|589124328|FG001|Overall Study|Dialysis|0|||
163113463|NCT03344549|589124327|FG000|Overall Study|Cancer|1|||
163113464|NCT03344549|589124328|FG001|Overall Study|Cancer|0|||
163113465|NCT03344549|589124327|FG000|Overall Study|Lack of electronic device|1|||
163113466|NCT03344549|589124328|FG001|Overall Study|Lack of electronic device|0|||
163113467|NCT03344549|589124327|FG000|Overall Study|Transportation difficulty|0|||
163113468|NCT03344549|589124328|FG001|Overall Study|Transportation difficulty|13|||
163113469|NCT01685801|589124334|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
163113470|NCT01685801|589124335|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
163113471|NCT01685801|589124336|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
163113472|NCT01685801|589124337|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
163113473|NCT01685801|589124334|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
163113474|NCT01685801|589124335|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
163113475|NCT01685801|589124336|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
163113476|NCT01685801|589124337|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
163113477|NCT00113399|589124338|FG000|Overall Study|Death|1|||
163113478|NCT00113399|589124339|FG001|Overall Study|Death|1|||
163113479|NCT00113399|589124338|FG000|Overall Study|Withdrawal by Subject|1|||
163113480|NCT00113399|589124339|FG001|Overall Study|Withdrawal by Subject|2|||
163113481|NCT00113399|589124338|FG000|Overall Study|Complete Response|0|||
163113482|NCT00113399|589124339|FG001|Overall Study|Complete Response|1|||
163113483|NCT00113399|589124338|FG000|Overall Study|Other|0|||
163113484|NCT00113399|589124339|FG001|Overall Study|Other|1|||
163113485|NCT03350256|589124340|FG000|Overall Study|Inclusion/exclusion violation|4|||
163113486|NCT03350256|589124340|FG000|Overall Study|Recommended for other therapies|2|||
163113487|NCT03350256|589124340|FG000|Overall Study|Protocol Violation|3|||
163113488|NCT03350256|589124340|FG000|Overall Study|Non compliance|2|||
163113489|NCT03350256|589124340|FG000|Overall Study|Denial by insurance|1|||
163113490|NCT03350256|589124340|FG000|Overall Study|Adverse Event|2|||
163113491|NCT03350256|589124340|FG000|Overall Study|Trial failure|12|||
163113492|NCT03350256|589124340|FG000|Overall Study|Did not proceed to permanent implant|3|||
163113493|NCT03350256|589124340|FG000|Overall Study|Withdrawal by Subject|3|||
163113494|NCT03350256|589124340|FG000|Overall Study|Subject moving out of state|1|||
163113495|NCT03350256|589124340|FG000|Overall Study|Lost to Follow-up|1|||
163113496|NCT03350256|589124340|FG000|Overall Study|Lack of Efficacy|2|||
163113497|NCT00666588|589124341|FG000|Overall Study|ineligible|2|||
163113498|NCT00666588|589124342|FG001|Overall Study|ineligible|0|||
163113499|NCT00666588|589124343|FG002|Overall Study|ineligible|0|||
163113500|NCT00666588|589124344|FG003|Overall Study|ineligible|2|||
163113501|NCT00666588|589124341|FG000|Overall Study|inevaluable|2|||
163113502|NCT00666588|589124342|FG001|Overall Study|inevaluable|0|||
163113503|NCT00666588|589124343|FG002|Overall Study|inevaluable|0|||
163113504|NCT00666588|589124344|FG003|Overall Study|inevaluable|0|||
163113505|NCT01187446|589124347|FG000|Overall Study|Patient started non-protocol therapy|0|||
163113506|NCT01187446|589124348|FG001|Overall Study|Patient started non-protocol therapy|1|||
163113507|NCT00823212|589124350|FG000|Overall Study|Death|8|||
163113508|NCT00823212|589124351|FG001|Overall Study|Death|10|||
163113509|NCT00823212|589124350|FG000|Overall Study|Withdrawal by Subject|6|||
163113510|NCT00823212|589124351|FG001|Overall Study|Withdrawal by Subject|1|||
163113511|NCT00823212|589124350|FG000|Overall Study|Incarcerated|0|||
163113512|NCT00823212|589124351|FG001|Overall Study|Incarcerated|1|||
163113513|NCT00823212|589124350|FG000|Overall Study|Missed 12-month visit|21|||
163113514|NCT00823212|589124351|FG001|Overall Study|Missed 12-month visit|21|||
163113515|NCT00791479|589124356|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
163113516|NCT00791479|589124357|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
163113517|NCT00791479|589124358|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
163113518|NCT00791479|589124359|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
163113519|NCT00791479|589124360|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
163113520|NCT00791479|589124361|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
163113521|NCT00791479|589124356|FG000|Overall Study|Adverse Event|0|||
163113522|NCT00791479|589124357|FG001|Overall Study|Adverse Event|1|||
163113523|NCT00791479|589124358|FG002|Overall Study|Adverse Event|0|||
163113524|NCT00791479|589124359|FG003|Overall Study|Adverse Event|2|||
163113525|NCT00791479|589124360|FG004|Overall Study|Adverse Event|0|||
163113526|NCT00791479|589124361|FG005|Overall Study|Adverse Event|1|||
163113527|NCT00791479|589124356|FG000|Overall Study|Lost to Follow-up|0|||
163113528|NCT00791479|589124357|FG001|Overall Study|Lost to Follow-up|1|||
163113529|NCT00791479|589124358|FG002|Overall Study|Lost to Follow-up|0|||
163113530|NCT00791479|589124359|FG003|Overall Study|Lost to Follow-up|0|||
163113531|NCT00791479|589124360|FG004|Overall Study|Lost to Follow-up|0|||
163113532|NCT00791479|589124361|FG005|Overall Study|Lost to Follow-up|1|||
163113533|NCT00791479|589124356|FG000|Overall Study|Protocol Violation|2|||
163113534|NCT00791479|589124357|FG001|Overall Study|Protocol Violation|1|||
163113535|NCT00791479|589124358|FG002|Overall Study|Protocol Violation|0|||
163113536|NCT00791479|589124359|FG003|Overall Study|Protocol Violation|1|||
163113537|NCT00791479|589124360|FG004|Overall Study|Protocol Violation|0|||
163113538|NCT00791479|589124361|FG005|Overall Study|Protocol Violation|0|||
163113539|NCT00791479|589124356|FG000|Overall Study|Withdrawal by Subject|0|||
163113540|NCT00791479|589124357|FG001|Overall Study|Withdrawal by Subject|0|||
163113541|NCT00791479|589124358|FG002|Overall Study|Withdrawal by Subject|0|||
163113542|NCT00791479|589124359|FG003|Overall Study|Withdrawal by Subject|1|||
163113543|NCT00791479|589124360|FG004|Overall Study|Withdrawal by Subject|0|||
163113544|NCT00791479|589124361|FG005|Overall Study|Withdrawal by Subject|1|||
163113545|NCT03405935|589124364|FG000|Overall Study|Adverse Event|3|||
163113546|NCT03405935|589124364|FG000|Overall Study|Death|2|||
163113547|NCT03405935|589124364|FG000|Overall Study|Withdrawal by Subject|1|||
163113548|NCT03405935|589124364|FG000|Overall Study|Lost to Follow-up|2|||
163113549|NCT04979897|589124365|FG000|Overall Study|Death|1|||
163113550|NCT04979897|589124366|FG001|Overall Study|Death|8|||
163113551|NCT04979897|589124365|FG000|Overall Study|Lost to Follow-up|111|||
163113552|NCT04979897|589124366|FG001|Overall Study|Lost to Follow-up|56|||
163113553|NCT04979897|589124365|FG000|Overall Study|Withdrawal by Subject|7|||
163113554|NCT04979897|589124366|FG001|Overall Study|Withdrawal by Subject|2|||
163113555|NCT01774097|589124367|FG000|Overall Study|Withdrawal by Subject|1|||
163113556|NCT01774097|589124368|FG001|Overall Study|Withdrawal by Subject|1|||
163113557|NCT01774097|589124367|FG000|Overall Study|Adverse Event|1|||
163113558|NCT01774097|589124368|FG001|Overall Study|Adverse Event|1|||
163222621|NCT04964128|589531569|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
163222622|NCT04964128|589531569|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
163222623|NCT00994240|589531571|FG000|Overall Study|Lost to Follow-up|3|||
163113559|NCT04659174|589124374|FG000|Overall Study|Sponsor decision to discontinue study|0|||
163113560|NCT04659174|589124375|FG001|Overall Study|Sponsor decision to discontinue study|2|||
163222624|NCT00994240|589531572|FG001|Overall Study|Lost to Follow-up|2|||
163113561|NCT04659174|589124374|FG000|Overall Study|Lost to Follow-up|9|||
163113562|NCT04659174|589124375|FG001|Overall Study|Lost to Follow-up|11|||
163113563|NCT04659174|589124374|FG000|Overall Study|Adverse Event|8|||
163222625|NCT00994240|589531571|FG000|Overall Study|Withdrawal by Subject|1|||
163113564|NCT04659174|589124375|FG001|Overall Study|Adverse Event|5|||
163113565|NCT04659174|589124374|FG000|Overall Study|Withdrawal by Subject|17|||
163222626|NCT00994240|589531572|FG001|Overall Study|Withdrawal by Subject|0|||
163407905|NCT00328627|590203967|FG006|Overall Study|Adverse Event|1|||
163113566|NCT04659174|589124375|FG001|Overall Study|Withdrawal by Subject|33|||
163222627|NCT00994240|589531571|FG000|Overall Study|study termination|2|||
163222628|NCT00994240|589531572|FG001|Overall Study|study termination|3|||
163113567|NCT04659174|589124374|FG000|Overall Study|Progressive disease|0|||
163113568|NCT04659174|589124375|FG001|Overall Study|Progressive disease|2|||
163113569|NCT04659174|589124374|FG000|Overall Study|Other reasons|0|||
163113570|NCT04659174|589124375|FG001|Overall Study|Other reasons|2|||
163113571|NCT04659174|589124374|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
163113572|NCT04659174|589124375|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
163113573|NCT04659174|589124374|FG000|Overall Study|Alcohol or illegal drug use|0|||
163113574|NCT04659174|589124375|FG001|Overall Study|Alcohol or illegal drug use|3|||
163113575|NCT04659174|589124374|FG000|Overall Study|Violation of entry criteria|1|||
163113576|NCT04659174|589124375|FG001|Overall Study|Violation of entry criteria|0|||
163113577|NCT04659174|589124374|FG000|Overall Study|Death|0|||
163113578|NCT04659174|589124375|FG001|Overall Study|Death|1|||
163113579|NCT02781792|589124376|FG000|Overall Study|Adverse Event|1|||
163113580|NCT02781792|589124377|FG001|Overall Study|Adverse Event|2|||
163113581|NCT02781792|589124376|FG000|Overall Study|Withdrawal by Subject|3|||
163113582|NCT02781792|589124377|FG001|Overall Study|Withdrawal by Subject|1|||
163113583|NCT02781792|589124376|FG000|Overall Study|Lack of Efficacy|1|||
163113584|NCT02781792|589124377|FG001|Overall Study|Lack of Efficacy|1|||
163113585|NCT02781792|589124376|FG000|Overall Study|Hospice|0|||
163113586|NCT02781792|589124377|FG001|Overall Study|Hospice|1|||
163113587|NCT03447314|589124382|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
163113588|NCT03447314|589124383|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
163113589|NCT03447314|589124384|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
163113590|NCT03447314|589124385|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
163113591|NCT03447314|589124386|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
163113592|NCT03447314|589124387|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
163113593|NCT03447314|589124388|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
163113594|NCT03447314|589124389|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113595|NCT03447314|589124390|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113596|NCT03447314|589124391|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113597|NCT03447314|589124392|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
163113598|NCT03447314|589124393|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
163113599|NCT03447314|589124394|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113600|NCT03447314|589124395|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113601|NCT03447314|589124396|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113602|NCT03447314|589124397|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113603|NCT03447314|589124398|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113604|NCT03447314|589124399|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113605|NCT03447314|589124382|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
163113606|NCT03447314|589124383|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113607|NCT03447314|589124384|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
163113608|NCT03447314|589124385|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113609|NCT03447314|589124386|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113610|NCT03447314|589124387|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
163113611|NCT03447314|589124388|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
163113612|NCT03447314|589124389|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113613|NCT03447314|589124390|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113614|NCT03447314|589124391|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113615|NCT03447314|589124392|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113616|NCT03447314|589124393|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113617|NCT03447314|589124394|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113618|NCT03447314|589124395|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113619|NCT03447314|589124396|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113620|NCT03447314|589124397|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113621|NCT03447314|589124398|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113622|NCT03447314|589124399|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113623|NCT03447314|589124382|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113624|NCT03447314|589124383|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113625|NCT03447314|589124384|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
163113626|NCT03447314|589124385|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113627|NCT03447314|589124386|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113628|NCT03447314|589124387|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113629|NCT03447314|589124388|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113630|NCT03447314|589124389|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113631|NCT03447314|589124390|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113632|NCT03447314|589124391|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113633|NCT03447314|589124392|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113634|NCT03447314|589124393|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163222629|NCT01177540|589531573|FG000|Overall Study|Adverse Event|1|||
163113635|NCT03447314|589124394|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113636|NCT03447314|589124395|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113637|NCT03447314|589124396|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113638|NCT03447314|589124397|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113639|NCT03447314|589124398|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113640|NCT03447314|589124399|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113641|NCT03447314|589124382|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113642|NCT03447314|589124383|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113643|NCT03447314|589124384|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
163113644|NCT03447314|589124385|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113645|NCT03447314|589124386|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113646|NCT03447314|589124387|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113647|NCT03447314|589124388|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113648|NCT03447314|589124389|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113649|NCT03447314|589124390|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113650|NCT03447314|589124391|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113651|NCT03447314|589124392|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113652|NCT03447314|589124393|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113653|NCT03447314|589124394|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113654|NCT03447314|589124395|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113655|NCT03447314|589124396|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113656|NCT03447314|589124397|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113657|NCT03447314|589124398|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113658|NCT03447314|589124399|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113659|NCT03447314|589124382|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113660|NCT03447314|589124383|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113661|NCT03447314|589124384|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113662|NCT03447314|589124385|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113663|NCT03447314|589124386|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113664|NCT03447314|589124387|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113665|NCT03447314|589124388|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113666|NCT03447314|589124389|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113667|NCT03447314|589124390|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113668|NCT03447314|589124391|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113669|NCT03447314|589124392|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
163113670|NCT03447314|589124393|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113671|NCT03447314|589124394|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113672|NCT03447314|589124395|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113673|NCT03447314|589124396|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113674|NCT03447314|589124397|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113675|NCT03447314|589124398|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113676|NCT03447314|589124399|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113677|NCT03447314|589124382|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113678|NCT03447314|589124383|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113679|NCT03447314|589124384|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113680|NCT03447314|589124385|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
163113681|NCT03447314|589124386|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113682|NCT03447314|589124387|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
163113683|NCT03447314|589124388|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163340007|NCT01280656|589953128|FG000|Overall Study|Treatment shortening (RGT)|0|||
163340008|NCT01280656|589953129|FG001|Overall Study|Treatment shortening (RGT)|4|||
163340009|NCT01280656|589953130|FG002|Overall Study|Treatment shortening (RGT)|5|||
163340010|NCT01280656|589953128|FG000|Overall Study|Other|1|||
163340011|NCT01280656|589953129|FG001|Overall Study|Other|7|||
163340012|NCT01280656|589953130|FG002|Overall Study|Other|7|||
163340013|NCT04085614|589953131|FG000|Overall Study|Protocol Violation|9|||
163340014|NCT04085614|589953132|FG001|Overall Study|Protocol Violation|6|||
163340015|NCT01029925|589953133|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
163340016|NCT01029925|589953133|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
163340017|NCT01029925|589953133|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
163113684|NCT03447314|589124389|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113685|NCT03447314|589124390|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113686|NCT03447314|589124391|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113687|NCT03447314|589124392|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113688|NCT03447314|589124393|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113689|NCT03447314|589124394|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113690|NCT03447314|589124395|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113691|NCT03447314|589124396|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113692|NCT03447314|589124397|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113693|NCT03447314|589124398|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113694|NCT03447314|589124399|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113695|NCT01920568|589124401|FG000|Overall Study|Adverse Event|27|||
163113696|NCT01920568|589124402|FG001|Overall Study|Adverse Event|8|||
163113697|NCT01920568|589124401|FG000|Overall Study|Protocol Violation|5|||
163113698|NCT01920568|589124402|FG001|Overall Study|Protocol Violation|3|||
163113699|NCT01920568|589124401|FG000|Overall Study|Lost to Follow-up|2|||
163113700|NCT01920568|589124402|FG001|Overall Study|Lost to Follow-up|2|||
163113701|NCT01920568|589124401|FG000|Overall Study|Physician Decision|13|||
163113702|NCT01920568|589124402|FG001|Overall Study|Physician Decision|4|||
163113703|NCT01920568|589124401|FG000|Overall Study|Withdrawal by Subject|79|||
163113704|NCT01920568|589124402|FG001|Overall Study|Withdrawal by Subject|55|||
163113705|NCT01920568|589124401|FG000|Overall Study|Death due to disease progression|25|||
163113706|NCT01920568|589124402|FG001|Overall Study|Death due to disease progression|12|||
163113707|NCT04049266|589124406|FG000|Overall Study|Adverse Event|16|||
163113708|NCT04049266|589124407|FG001|Overall Study|Adverse Event|9|||
163113709|NCT04049266|589124406|FG000|Overall Study|Non-compliance with study drug|0|||
163113710|NCT04049266|589124407|FG001|Overall Study|Non-compliance with study drug|3|||
163113711|NCT04049266|589124406|FG000|Overall Study|Withdrawal by Subject|6|||
163113712|NCT04049266|589124407|FG001|Overall Study|Withdrawal by Subject|10|||
163113713|NCT04049266|589124406|FG000|Overall Study|Lost to Follow-up|2|||
163113714|NCT04049266|589124407|FG001|Overall Study|Lost to Follow-up|2|||
163113715|NCT04049266|589124406|FG000|Overall Study|Progressive disease|11|||
163113716|NCT04049266|589124407|FG001|Overall Study|Progressive disease|2|||
163113717|NCT04049266|589124406|FG000|Overall Study|Physician Decision|1|||
163113718|NCT04049266|589124407|FG001|Overall Study|Physician Decision|0|||
163113719|NCT04049266|589124406|FG000|Overall Study|Patient moved out of state|1|||
163113720|NCT04049266|589124407|FG001|Overall Study|Patient moved out of state|0|||
163113721|NCT01703208|589124408|FG000|Overall Study|Death|61|||
163113722|NCT01703208|589124409|FG001|Overall Study|Death|48|||
163113723|NCT01703208|589124408|FG000|Overall Study|Lack of Efficacy|1|||
163113724|NCT01703208|589124409|FG001|Overall Study|Lack of Efficacy|2|||
163113725|NCT01703208|589124408|FG000|Overall Study|Lost to Follow-up|68|||
163113726|NCT01703208|589124409|FG001|Overall Study|Lost to Follow-up|62|||
163113727|NCT01703208|589124408|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163113728|NCT01703208|589124409|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163113729|NCT01703208|589124408|FG000|Overall Study|Excluded Medication|1|||
163113730|NCT01703208|589124409|FG001|Overall Study|Excluded Medication|2|||
163113731|NCT01703208|589124408|FG000|Overall Study|Site Discontinued Study Participation|23|||
163113732|NCT01703208|589124409|FG001|Overall Study|Site Discontinued Study Participation|27|||
163113733|NCT01703208|589124408|FG000|Overall Study|Physician Decision|11|||
163113734|NCT01703208|589124409|FG001|Overall Study|Physician Decision|13|||
163113735|NCT01703208|589124408|FG000|Overall Study|Progressive disease|2|||
163113736|NCT01703208|589124409|FG001|Overall Study|Progressive disease|2|||
163113737|NCT01703208|589124408|FG000|Overall Study|Protocol Violation|1|||
163113738|NCT01703208|589124409|FG001|Overall Study|Protocol Violation|1|||
163113739|NCT01703208|589124408|FG000|Overall Study|Study Terminated by Sponsor|1710|||
163113740|NCT01703208|589124409|FG001|Overall Study|Study Terminated by Sponsor|1716|||
163113741|NCT01703208|589124408|FG000|Overall Study|Withdrawal by Subject|205|||
163113742|NCT01703208|589124409|FG001|Overall Study|Withdrawal by Subject|209|||
163113743|NCT01703208|589124408|FG000|Overall Study|Adverse Event|14|||
163113744|NCT01703208|589124409|FG001|Overall Study|Adverse Event|19|||
163113745|NCT01703208|589124408|FG000|Overall Study|Technical Problems|0|||
163113746|NCT01703208|589124409|FG001|Overall Study|Technical Problems|1|||
163113747|NCT01703208|589124408|FG000|Overall Study|Protocol Deviation|2|||
163113748|NCT01703208|589124409|FG001|Overall Study|Protocol Deviation|0|||
163113749|NCT04600076|589124413|FG000|Overall Study|Lost to Follow-up|3|||
163113750|NCT01639339|589124414|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
163113751|NCT01639339|589124415|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
163113752|NCT01639339|589124414|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
163113753|NCT01639339|589124415|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
163113754|NCT01639339|589124414|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
163222630|NCT01177540|589531574|FG001|Overall Study|Adverse Event|0|||
163113755|NCT01639339|589124415|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
163113756|NCT01639339|589124414|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
163113757|NCT01639339|589124415|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
163113758|NCT01639339|589124414|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
163113759|NCT01639339|589124415|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
163113760|NCT01639339|589124414|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
163113761|NCT01639339|589124415|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
163113762|NCT01639339|589124414|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
163113763|NCT01639339|589124415|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
163113764|NCT01639339|589124414|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
163113765|NCT01639339|589124415|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
163113766|NCT01639339|589124414|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
163113767|NCT01639339|589124415|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
163113768|NCT01639339|589124414|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
163113769|NCT01639339|589124415|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
163113770|NCT02891681|589124416|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
163113771|NCT02891681|589124417|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
163113772|NCT02891681|589124418|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
163113773|NCT02891681|589124416|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
163113774|NCT02891681|589124417|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
163113775|NCT02891681|589124418|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
163113776|NCT02891681|589124416|FG000|Overall Study|Taken off study after first imaging appointment|1|||
163113777|NCT02891681|589124417|FG001|Overall Study|Taken off study after first imaging appointment|0|||
163113778|NCT02891681|589124418|FG002|Overall Study|Taken off study after first imaging appointment|0|||
163113779|NCT01170598|589124419|FG000|Overall Study|Withdrawal by Subject|1|||
163113780|NCT01170598|589124419|FG000|Overall Study|Death|3|||
163113781|NCT01170598|589124419|FG000|Overall Study|Lost to Follow-up|1|||
163113782|NCT01170598|589124419|FG000|Overall Study|Refused|1|||
163113783|NCT01271712|589124420|FG000|Double Blind Treatment|Death|2|||
163113784|NCT01271712|589124421|FG001|Double Blind Treatment|Death|0|||
163113785|NCT01271712|589124420|FG000|Double Blind Treatment|Lack of Efficacy|1|||
163113786|NCT01271712|589124421|FG001|Double Blind Treatment|Lack of Efficacy|0|||
163113787|NCT01271712|589124420|FG000|Double Blind Treatment|Adverse Event|9|||
163113788|NCT01271712|589124421|FG001|Double Blind Treatment|Adverse Event|4|||
163113789|NCT01271712|589124420|FG000|Double Blind Treatment|Progressive disease|23|||
163113790|NCT01271712|589124421|FG001|Double Blind Treatment|Progressive disease|3|||
163113791|NCT01271712|589124420|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
163113792|NCT01271712|589124421|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
163113793|NCT01271712|589124420|FG000|Double Blind Treatment|Non compliance with study drug|2|||
163113794|NCT01271712|589124421|FG001|Double Blind Treatment|Non compliance with study drug|0|||
163113795|NCT01271712|589124420|FG000|Double Blind Treatment|receive no study drug|1|||
163113796|NCT01271712|589124421|FG001|Double Blind Treatment|receive no study drug|0|||
163113797|NCT01271712|589124420|FG000|Open Label Treatment|Death|6|||
163113798|NCT01271712|589124421|FG001|Open Label Treatment|Death|5|||
163113799|NCT01271712|589124420|FG000|Open Label Treatment|Withdrawal by Subject|6|||
163113800|NCT01271712|589124421|FG001|Open Label Treatment|Withdrawal by Subject|11|||
163113801|NCT01271712|589124420|FG000|Open Label Treatment|Physician Decision|2|||
163113802|NCT01271712|589124421|FG001|Open Label Treatment|Physician Decision|0|||
163113803|NCT01271712|589124420|FG000|Open Label Treatment|Adverse Event|14|||
163113804|NCT01271712|589124421|FG001|Open Label Treatment|Adverse Event|8|||
163113805|NCT01271712|589124420|FG000|Open Label Treatment|Progressive disease|59|||
163113806|NCT01271712|589124421|FG001|Open Label Treatment|Progressive disease|32|||
163113807|NCT01271712|589124420|FG000|Open Label Treatment|transferred to rollover study|1|||
163113808|NCT01271712|589124421|FG001|Open Label Treatment|transferred to rollover study|0|||
163113809|NCT01271712|589124420|FG000|Open Label Treatment|Non-compliance with study drug|1|||
163113810|NCT01271712|589124421|FG001|Open Label Treatment|Non-compliance with study drug|0|||
163113811|NCT01271712|589124420|FG000|Open Label Treatment|Protocol Violation|0|||
163113812|NCT01271712|589124421|FG001|Open Label Treatment|Protocol Violation|1|||
163113813|NCT01271712|589124420|FG000|Open Label Treatment|Switching to other therapy|2|||
163113814|NCT01271712|589124421|FG001|Open Label Treatment|Switching to other therapy|1|||
163113815|NCT01271712|589124420|FG000|Safety Follow-up|Death|11|||
163113816|NCT01271712|589124421|FG001|Safety Follow-up|Death|7|||
163113817|NCT01271712|589124420|FG000|Safety Follow-up|Withdrawal by Subject|4|||
163113818|NCT01271712|589124421|FG001|Safety Follow-up|Withdrawal by Subject|2|||
163113819|NCT01271712|589124420|FG000|Safety Follow-up|Protocol Violation|1|||
163113820|NCT01271712|589124421|FG001|Safety Follow-up|Protocol Violation|1|||
163113821|NCT01271712|589124420|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
163113822|NCT01271712|589124421|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
163113823|NCT01271712|589124420|FG000|Safety Follow-up|No follow-up|1|||
163113824|NCT01271712|589124421|FG001|Safety Follow-up|No follow-up|1|||
163113825|NCT01271712|589124420|FG000|Safety Follow-up|Progressive disease|1|||
163113826|NCT01271712|589124421|FG001|Safety Follow-up|Progressive disease|0|||
163113827|NCT01271712|589124420|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
163113828|NCT01271712|589124421|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
163113829|NCT02685748|589124424|FG000|Overall Study|Withdrawal by Subject|3|||
163113830|NCT02685748|589124425|FG001|Overall Study|Withdrawal by Subject|2|||
163113831|NCT04669262|589124435|FG000|Overall Study|Withdrawal by Subject|0|||
163113832|NCT04669262|589124436|FG001|Overall Study|Withdrawal by Subject|0|||
163113833|NCT04669262|589124437|FG002|Overall Study|Withdrawal by Subject|0|||
163113834|NCT04669262|589124438|FG003|Overall Study|Withdrawal by Subject|1|||
163113835|NCT04669262|589124435|FG000|Overall Study|Randomized but Not Treated|0|||
163113836|NCT04669262|589124436|FG001|Overall Study|Randomized but Not Treated|1|||
163113837|NCT04669262|589124437|FG002|Overall Study|Randomized but Not Treated|0|||
163113838|NCT04669262|589124438|FG003|Overall Study|Randomized but Not Treated|0|||
163113839|NCT01638013|589124439|FG000|Overall Study|Adverse Event|36|||
163113840|NCT01638013|589124440|FG001|Overall Study|Adverse Event|29|||
163113841|NCT01638013|589124441|FG002|Overall Study|Adverse Event|48|||
163113842|NCT01638013|589124439|FG000|Overall Study|Lack of Efficacy|39|||
163113843|NCT01638013|589124440|FG001|Overall Study|Lack of Efficacy|11|||
163113844|NCT01638013|589124441|FG002|Overall Study|Lack of Efficacy|14|||
163113845|NCT01638013|589124439|FG000|Overall Study|Protocol Violation|10|||
163113846|NCT01638013|589124440|FG001|Overall Study|Protocol Violation|7|||
163113847|NCT01638013|589124441|FG002|Overall Study|Protocol Violation|11|||
163113848|NCT01638013|589124439|FG000|Overall Study|Met discontinuation criteria|4|||
163113849|NCT01638013|589124440|FG001|Overall Study|Met discontinuation criteria|0|||
163113850|NCT01638013|589124441|FG002|Overall Study|Met discontinuation criteria|7|||
163113851|NCT01638013|589124439|FG000|Overall Study|Subject Lost to Follow up|1|||
163113852|NCT01638013|589124440|FG001|Overall Study|Subject Lost to Follow up|0|||
163113853|NCT01638013|589124441|FG002|Overall Study|Subject Lost to Follow up|1|||
163113854|NCT01638013|589124439|FG000|Overall Study|Miscellaneous|25|||
163113855|NCT01638013|589124440|FG001|Overall Study|Miscellaneous|19|||
163113856|NCT01638013|589124441|FG002|Overall Study|Miscellaneous|23|||
163113857|NCT01638013|589124439|FG000|Overall Study|Withdrawal of Consent|16|||
163113858|NCT01638013|589124440|FG001|Overall Study|Withdrawal of Consent|12|||
163113859|NCT01638013|589124441|FG002|Overall Study|Withdrawal of Consent|16|||
163113860|NCT01638013|589124439|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
163113861|NCT01638013|589124440|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
163113862|NCT01638013|589124441|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
163113863|NCT01846299|589124444|FG000|Overall Study|Physician Decision|4|||
163113864|NCT01846299|589124445|FG001|Overall Study|Physician Decision|2|||
163113865|NCT01846299|589124444|FG000|Overall Study|Protocol deviation|1|||
163113866|NCT01846299|589124445|FG001|Overall Study|Protocol deviation|0|||
163113867|NCT01846299|589124444|FG000|Overall Study|Death|1|||
163113868|NCT01846299|589124445|FG001|Overall Study|Death|2|||
163113869|NCT01846299|589124444|FG000|Overall Study|Lost to Follow-up|3|||
163113870|NCT01846299|589124445|FG001|Overall Study|Lost to Follow-up|0|||
163113871|NCT01846299|589124444|FG000|Overall Study|Withdrawal by Subject|1|||
163113872|NCT01846299|589124445|FG001|Overall Study|Withdrawal by Subject|6|||
163113873|NCT01846299|589124444|FG000|Overall Study|Adverse Event|2|||
163113874|NCT01846299|589124445|FG001|Overall Study|Adverse Event|0|||
163113875|NCT03559517|589124446|FG000|Overall Study|Withdrawal by Subject|1|||
163222631|NCT00748215|589531585|FG000|Overall Study|Withdrawal by Subject|7|||
163222632|NCT00748215|589531586|FG001|Overall Study|Withdrawal by Subject|7|||
163222633|NCT00748215|589531585|FG000|Overall Study|Treatment change|2|||
163222634|NCT00748215|589531586|FG001|Overall Study|Treatment change|1|||
163222635|NCT00748215|589531585|FG000|Overall Study|Change in patient condition|0|||
163222636|NCT00748215|589531586|FG001|Overall Study|Change in patient condition|3|||
163222637|NCT00748215|589531585|FG000|Overall Study|Non-compliant|0|||
163222638|NCT00748215|589531586|FG001|Overall Study|Non-compliant|2|||
163222639|NCT00748215|589531585|FG000|Overall Study|Adverse Event|0|||
163222640|NCT00748215|589531586|FG001|Overall Study|Adverse Event|5|||
163340018|NCT05265247|589953134|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
163340019|NCT05265247|589953135|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
163340020|NCT05265247|589953134|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
163340021|NCT05265247|589953135|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
163340022|NCT05265247|589953134|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
163340023|NCT05265247|589953135|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
163113876|NCT03559517|589124447|FG001|Overall Study|Withdrawal by Subject|0|||
163113877|NCT03559517|589124448|FG002|Overall Study|Withdrawal by Subject|0|||
163113878|NCT01960998|589124449|FG000|Overall Study|Lost to Follow-up|3|||
163113879|NCT01960998|589124450|FG001|Overall Study|Lost to Follow-up|7|||
163113880|NCT01960998|589124449|FG000|Overall Study|Death|0|||
163113881|NCT01960998|589124450|FG001|Overall Study|Death|1|||
163113882|NCT01960998|589124449|FG000|Overall Study|Withdrawal by Subject|8|||
163113883|NCT01960998|589124450|FG001|Overall Study|Withdrawal by Subject|2|||
163113884|NCT01960998|589124449|FG000|Overall Study|lost computer access|0|||
163113885|NCT01960998|589124450|FG001|Overall Study|lost computer access|1|||
163222641|NCT02013167|589531587|FG000|Overall Study|Withdrawal by Subject|15|||
163340024|NCT00476957|589953136|FG000|Overall Study|Lost to Follow-up|176|||
163340025|NCT00476957|589953137|FG001|Overall Study|Lost to Follow-up|193|||
163340026|NCT02516202|589953138|FG000|Overall Study|Withdrawal by Subject|1|||
163340027|NCT02516202|589953139|FG001|Overall Study|Withdrawal by Subject|0|||
163340028|NCT02516202|589953140|FG002|Overall Study|Withdrawal by Subject|1|||
163340029|NCT02516202|589953138|FG000|Overall Study|Lost to Follow-up|1|||
163340030|NCT02516202|589953139|FG001|Overall Study|Lost to Follow-up|1|||
163113886|NCT01774253|589124454|FG000|Overall Study|Lack of Efficacy|4|||
163113887|NCT01774253|589124454|FG000|Overall Study|Physician Decision|2|||
163113888|NCT01774253|589124454|FG000|Overall Study|Withdrawal by Subject|2|||
163113889|NCT01774253|589124454|FG000|Overall Study|Death|1|||
163113890|NCT00772369|589124455|FG000|Overall Study|Did not return record release form|1|||
163113891|NCT03510468|589124456|FG000|Overall Study|Lost to Follow-up|1|||
163113892|NCT03510468|589124456|FG000|Overall Study|Adverse Event|5|||
163113893|NCT03510468|589124456|FG000|Overall Study|Physician Decision|1|||
163113894|NCT03510468|589124456|FG000|Overall Study|non-compliant with treatment|2|||
163113895|NCT03510468|589124456|FG000|Overall Study|Missed visit|1|||
163113896|NCT00840060|589125752|FG000|Overall Study|Withdrawal by Subject|1|||
163113897|NCT00840060|589125753|FG001|Overall Study|Withdrawal by Subject|0|||
163113898|NCT00840060|589125752|FG000|Overall Study|Change in emotional/behavioral status|0|||
163113899|NCT00840060|589125753|FG001|Overall Study|Change in emotional/behavioral status|1|||
163113900|NCT01103063|589125754|FG000|Overall Study|Adverse Event|3|||
163113901|NCT01103063|589125755|FG001|Overall Study|Adverse Event|1|||
163113902|NCT01103063|589125754|FG000|Overall Study|Lost to Follow-up|68|||
163113903|NCT01103063|589125755|FG001|Overall Study|Lost to Follow-up|51|||
163113904|NCT01103063|589125754|FG000|Overall Study|Withdrawal by Subject|60|||
163113905|NCT01103063|589125755|FG001|Overall Study|Withdrawal by Subject|15|||
163113906|NCT01103063|589125754|FG000|Overall Study|Other|16|||
163113907|NCT01103063|589125755|FG001|Overall Study|Other|11|||
163113908|NCT01103063|589125754|FG000|Overall Study|Protocol Violation|1|||
163113909|NCT01103063|589125755|FG001|Overall Study|Protocol Violation|0|||
163113910|NCT01103063|589125754|FG000|Overall Study|Study terminated by Sponsor|326|||
163113911|NCT01103063|589125755|FG001|Overall Study|Study terminated by Sponsor|342|||
163113912|NCT01103063|589125754|FG000|Overall Study|Death|3|||
163113913|NCT01103063|589125755|FG001|Overall Study|Death|1|||
163113914|NCT03899064|589125758|FG000|Overall Study|Lost to Follow-up|1|||
163113915|NCT03899064|589125758|FG000|Overall Study|Protocol Violation|2|||
163113916|NCT03899064|589125758|FG000|Overall Study|Withdrawal by Subject|2|||
163113917|NCT03899064|589125758|FG000|Overall Study|Other|2|||
163113918|NCT03283098|589125759|FG000|Overall Study|Withdrawal by Subject|0|||
163113919|NCT03283098|589125760|FG001|Overall Study|Withdrawal by Subject|1|||
163113920|NCT01069861|589125763|FG000|Overall Study|Death|1|||
163113921|NCT01069861|589125763|FG000|Overall Study|Adverse Event|1|||
163113922|NCT01069861|589125763|FG000|Overall Study|Did not meet entrance criteria|1|||
163113923|NCT00354107|589125764|FG000|Overall Study|Adverse Event|2|||
163113924|NCT00354107|589125764|FG000|Overall Study|Physician Decision|2|||
163113925|NCT00354107|589125764|FG000|Overall Study|Withdrawal by Subject|1|||
163113926|NCT03136497|589125775|FG000|Overall Study|Screen Failure|1|||
163113927|NCT03136497|589125776|FG001|Overall Study|Screen Failure|0|||
163113928|NCT03136497|589125777|FG002|Overall Study|Screen Failure|0|||
163113929|NCT00557310|589125779|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
163113930|NCT00557310|589125779|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
163113931|NCT00557310|589125779|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
163113932|NCT00557310|589125779|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
163113933|NCT00557310|589125779|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
163113934|NCT00557310|589125779|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
163113935|NCT02351349|589125780|FG000|Overall Study|Withdrawal by Subject|2|||
163113936|NCT02351349|589125781|FG001|Overall Study|Withdrawal by Subject|3|||
163113937|NCT02649218|589125782|FG000|Overall Study|Adverse Event|8|||
163113938|NCT02649218|589125782|FG000|Overall Study|Lack of Efficacy|8|||
163113939|NCT02649218|589125782|FG000|Overall Study|Pregnancy|3|||
163113940|NCT02649218|589125782|FG000|Overall Study|Protocol Violation|3|||
163113941|NCT02649218|589125782|FG000|Overall Study|Physician Decision|1|||
163113942|NCT02649218|589125782|FG000|Overall Study|Withdrawal by Subject|2|||
163113943|NCT01224821|589125783|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
163113944|NCT01224821|589125783|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
163113945|NCT01224821|589125783|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
163113946|NCT01224821|589125783|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
163113947|NCT01224821|589125783|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
163113948|NCT01224821|589125783|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
163113949|NCT01224821|589125783|FG000|Long-Term Follow-Up|Death|2|||
163113950|NCT01224821|589125783|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
163113951|NCT02174523|589125784|FG000|Overall Study|Withdrawal by Subject|1|||
163113952|NCT02174523|589125785|FG001|Overall Study|Withdrawal by Subject|0|||
163113953|NCT00794365|589125786|FG000|Overall Study|Lost to Follow-up|38|||
163340031|NCT02516202|589953140|FG002|Overall Study|Lost to Follow-up|1|||
163113954|NCT00794365|589125786|FG000|Overall Study|Other|17|||
163113955|NCT00794365|589125786|FG000|Overall Study|Poor Compliance|11|||
163113956|NCT00794365|589125786|FG000|Overall Study|Adverse Event|10|||
163113957|NCT00794365|589125786|FG000|Overall Study|Lack of Efficacy|3|||
163113958|NCT02701777|589125789|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
163113959|NCT02701777|589125790|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
163113960|NCT02701777|589125791|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
163113961|NCT02701777|589125792|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
163113962|NCT02701777|589125789|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
163113963|NCT02701777|589125790|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
163113964|NCT02701777|589125791|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
163113965|NCT02701777|589125792|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
163113966|NCT03549871|589125795|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
163113967|NCT03549871|589125796|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
163113968|NCT03549871|589125795|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
163113969|NCT03549871|589125796|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
163113970|NCT03549871|589125795|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
163113971|NCT03549871|589125796|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
163113972|NCT03549871|589125795|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
163113973|NCT03549871|589125796|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
163113974|NCT03549871|589125795|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
163113975|NCT03549871|589125796|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
163113976|NCT03549871|589125795|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
163113977|NCT03549871|589125796|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
163113978|NCT03549871|589125795|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
163113979|NCT03549871|589125796|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
163113980|NCT03549871|589125795|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
163113981|NCT03549871|589125796|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
163113982|NCT03549871|589125795|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
163113983|NCT03549871|589125796|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
163113984|NCT03549871|589125795|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
163113985|NCT03549871|589125796|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
163113986|NCT03549871|589125795|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
163113987|NCT03549871|589125796|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
163113988|NCT01904149|589125797|FG000|Overall Study|Adverse Event|3|||
163113989|NCT01904149|589125798|FG001|Overall Study|Adverse Event|4|||
163113990|NCT01904149|589125799|FG002|Overall Study|Adverse Event|0|||
163113991|NCT01904149|589125800|FG003|Overall Study|Adverse Event|1|||
163113992|NCT01904149|589125801|FG004|Overall Study|Adverse Event|1|||
163113993|NCT01904149|589125802|FG005|Overall Study|Adverse Event|2|||
163113994|NCT01904149|589125797|FG000|Overall Study|Lack of Efficacy|0|||
163113995|NCT01904149|589125798|FG001|Overall Study|Lack of Efficacy|3|||
163113996|NCT01904149|589125799|FG002|Overall Study|Lack of Efficacy|1|||
163113997|NCT01904149|589125800|FG003|Overall Study|Lack of Efficacy|3|||
163113998|NCT01904149|589125801|FG004|Overall Study|Lack of Efficacy|3|||
163113999|NCT01904149|589125802|FG005|Overall Study|Lack of Efficacy|1|||
163114000|NCT01904149|589125797|FG000|Overall Study|Withdrawal by Subject|1|||
163114001|NCT01904149|589125798|FG001|Overall Study|Withdrawal by Subject|3|||
163114002|NCT01904149|589125799|FG002|Overall Study|Withdrawal by Subject|1|||
163114003|NCT01904149|589125800|FG003|Overall Study|Withdrawal by Subject|0|||
163114004|NCT01904149|589125801|FG004|Overall Study|Withdrawal by Subject|1|||
163114005|NCT01904149|589125802|FG005|Overall Study|Withdrawal by Subject|0|||
163114006|NCT01904149|589125797|FG000|Overall Study|Protocol Violation|0|||
163114007|NCT01904149|589125798|FG001|Overall Study|Protocol Violation|1|||
163340032|NCT02516202|589953138|FG000|Overall Study|Stopped Follow-up|0|||
163340033|NCT02516202|589953139|FG001|Overall Study|Stopped Follow-up|0|||
163340034|NCT02516202|589953140|FG002|Overall Study|Stopped Follow-up|1|||
163340035|NCT01000649|589953143|FG000|Overall Study|Adverse Event|5|||
163340036|NCT01000649|589953144|FG001|Overall Study|Adverse Event|1|||
163340037|NCT01000649|589953145|FG002|Overall Study|Adverse Event|2|||
163340038|NCT01000649|589953146|FG003|Overall Study|Adverse Event|4|||
163340039|NCT01000649|589953143|FG000|Overall Study|Lost to Follow-up|0|||
163340040|NCT01000649|589953144|FG001|Overall Study|Lost to Follow-up|2|||
163340041|NCT01000649|589953145|FG002|Overall Study|Lost to Follow-up|0|||
163340042|NCT01000649|589953146|FG003|Overall Study|Lost to Follow-up|2|||
163114008|NCT01904149|589125799|FG002|Overall Study|Protocol Violation|0|||
163114009|NCT01904149|589125800|FG003|Overall Study|Protocol Violation|0|||
163340043|NCT01916109|589953147|FG000|Overall Study|Withdrawal by Subject|1|||
163340044|NCT00103857|589953148|FG000|54-Week Base Study|Adverse Event|12|||
163340045|NCT00103857|589953149|FG001|54-Week Base Study|Adverse Event|9|||
163114010|NCT01904149|589125801|FG004|Overall Study|Protocol Violation|0|||
163114011|NCT01904149|589125802|FG005|Overall Study|Protocol Violation|0|||
163114012|NCT01904149|589125797|FG000|Overall Study|non compliance with study drug|1|||
163114013|NCT01904149|589125798|FG001|Overall Study|non compliance with study drug|0|||
163114014|NCT01904149|589125799|FG002|Overall Study|non compliance with study drug|0|||
163114015|NCT01904149|589125800|FG003|Overall Study|non compliance with study drug|0|||
163114016|NCT01904149|589125801|FG004|Overall Study|non compliance with study drug|0|||
163114017|NCT01904149|589125802|FG005|Overall Study|non compliance with study drug|0|||
163114018|NCT01357161|589125803|FG000|Part 1 (Open Label Run-in)|Death|5|||
163114019|NCT01357161|589125804|FG001|Part 1 (Open Label Run-in)|Death|0|||
163114020|NCT01357161|589125805|FG002|Part 1 (Open Label Run-in)|Death|0|||
163114021|NCT01357161|589125803|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
163114022|NCT01357161|589125804|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
163114023|NCT01357161|589125805|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
163114024|NCT01357161|589125803|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
163114025|NCT01357161|589125804|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
163114026|NCT01357161|589125805|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
163114027|NCT01357161|589125803|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
163114028|NCT01357161|589125804|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
163114029|NCT01357161|589125805|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
163114030|NCT01357161|589125803|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
163114031|NCT01357161|589125804|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
163114032|NCT01357161|589125805|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
163114033|NCT01357161|589125803|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
163114034|NCT01357161|589125804|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
163114035|NCT01357161|589125805|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
163114036|NCT01357161|589125803|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
163114037|NCT01357161|589125804|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
163114038|NCT01357161|589125805|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
163114039|NCT01357161|589125803|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
163114040|NCT01357161|589125804|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
163114041|NCT01357161|589125805|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
163114042|NCT01357161|589125803|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
163114043|NCT01357161|589125804|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
163114044|NCT01357161|589125805|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
163114045|NCT01357161|589125803|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
163114046|NCT01357161|589125804|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
163114047|NCT01357161|589125805|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
163114048|NCT01357161|589125803|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
163114049|NCT01357161|589125804|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
163114050|NCT01357161|589125805|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
163114051|NCT01824823|589125806|FG000|Overall Study|Lack of Efficacy|1|||
163114052|NCT01824823|589125807|FG001|Overall Study|Lack of Efficacy|1|||
163114053|NCT01824823|589125806|FG000|Overall Study|Off-treatment reason not submitted|1|||
163114054|NCT01824823|589125807|FG001|Overall Study|Off-treatment reason not submitted|0|||
163114055|NCT03349645|589125808|FG000|Overall Study|Sponsor Terminated Study|75|||
163114056|NCT03349645|589125808|FG000|Overall Study|Withdrawal by Subject|4|||
163114057|NCT03349645|589125808|FG000|Overall Study|Protocol Violation|1|||
163114058|NCT03349645|589125808|FG000|Overall Study|Other|2|||
163114059|NCT02910401|589125809|FG000|Overall Study|Study closure Study closure|0|||
163114060|NCT02910401|589125810|FG001|Overall Study|Study closure Study closure|0|||
163114061|NCT02910401|589125811|FG002|Overall Study|Study closure Study closure|2|||
163114062|NCT02910401|589125809|FG000|Overall Study|Physician Decision|1|||
163114063|NCT02910401|589125810|FG001|Overall Study|Physician Decision|0|||
163114064|NCT02910401|589125811|FG002|Overall Study|Physician Decision|0|||
163114065|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
163114066|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
163114067|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Death|0|||
163114068|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Death|0|||
163114069|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
163114070|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
163114071|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
163114072|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
163114073|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
163114074|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
163114075|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
163114076|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
163340046|NCT00103857|589953150|FG002|54-Week Base Study|Adverse Event|11|||
163340047|NCT00103857|589953151|FG003|54-Week Base Study|Adverse Event|6|||
163222642|NCT02013167|589531588|FG001|Overall Study|Withdrawal by Subject|14|||
163222643|NCT02013167|589531587|FG000|Overall Study|Sponsor Decision|1|||
163114077|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
163114078|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
163114079|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
163114080|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
163114081|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
163114082|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
163114083|NCT00433160|589125813|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
163114084|NCT00433160|589125814|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
163114085|NCT00433160|589125813|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
163114086|NCT00433160|589125814|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
163114087|NCT00433160|589125813|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
163114088|NCT00433160|589125814|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
163114089|NCT00433160|589125813|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
163114090|NCT00433160|589125814|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
163114091|NCT00433160|589125813|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
163114092|NCT00433160|589125814|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
163114093|NCT00433160|589125813|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
163114094|NCT00433160|589125814|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
163114095|NCT00433160|589125813|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
163114096|NCT00433160|589125814|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
163114097|NCT02240368|589125815|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
163114098|NCT02240368|589125816|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
163114099|NCT02240368|589125817|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
163114100|NCT02240368|589125815|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
163114101|NCT02240368|589125816|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
163114102|NCT02240368|589125817|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
163114103|NCT03372460|589125821|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
163114104|NCT03372460|589125822|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
163114105|NCT00871117|589125830|FG000|Overall Study|Lost to Follow-up|5|||
163114106|NCT00871117|589125831|FG001|Overall Study|Lost to Follow-up|6|||
163114107|NCT00871117|589125830|FG000|Overall Study|Other|0|||
163114108|NCT00871117|589125831|FG001|Overall Study|Other|4|||
163114109|NCT00916058|589125832|FG000|Phase 1|Screen Failure|0|||
163114110|NCT00916058|589125833|FG001|Phase 1|Screen Failure|0|||
163114111|NCT00916058|589125834|FG002|Phase 1|Screen Failure|0|||
163114112|NCT00916058|589125835|FG003|Phase 1|Screen Failure|0|||
163114113|NCT00916058|589125836|FG004|Phase 1|Screen Failure|0|||
163114114|NCT00916058|589125837|FG005|Phase 1|Screen Failure|1|||
163114115|NCT00916058|589125838|FG006|Phase 1|Screen Failure|0|||
163114116|NCT00916058|589125832|FG000|Phase 2|Screen Failure|0|||
163114117|NCT00916058|589125833|FG001|Phase 2|Screen Failure|0|||
163114118|NCT00916058|589125834|FG002|Phase 2|Screen Failure|0|||
163114119|NCT00916058|589125835|FG003|Phase 2|Screen Failure|0|||
163114120|NCT00916058|589125836|FG004|Phase 2|Screen Failure|0|||
163114121|NCT00916058|589125837|FG005|Phase 2|Screen Failure|0|||
163114122|NCT00916058|589125838|FG006|Phase 2|Screen Failure|3|||
163114123|NCT03222973|589125839|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
163114124|NCT03222973|589125840|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
163222644|NCT02013167|589531588|FG001|Overall Study|Sponsor Decision|3|||
163114125|NCT03222973|589125841|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
163114126|NCT03222973|589125842|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
163114127|NCT03222973|589125839|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
163114128|NCT03222973|589125840|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
163114129|NCT03222973|589125841|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
163222645|NCT02013167|589531587|FG000|Overall Study|Lost to Follow-up|0|||
163222646|NCT02013167|589531588|FG001|Overall Study|Lost to Follow-up|1|||
163222647|NCT02013167|589531587|FG000|Overall Study|Death|85|||
163340048|NCT00103857|589953152|FG004|54-Week Base Study|Adverse Event|5|||
163340049|NCT00103857|589953153|FG005|54-Week Base Study|Adverse Event|11|||
163340050|NCT00103857|589953154|FG006|54-Week Base Study|Adverse Event|3|||
163340051|NCT00103857|589953148|FG000|54-Week Base Study|Death|0|||
163340052|NCT00103857|589953149|FG001|54-Week Base Study|Death|0|||
163114130|NCT03222973|589125842|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
163114131|NCT03222973|589125839|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
163222648|NCT02013167|589531588|FG001|Overall Study|Death|160|||
163222649|NCT02620046|589531593|FG000|Overall Study|Adverse Event|22|||
163340053|NCT00103857|589953150|FG002|54-Week Base Study|Death|0|||
163340054|NCT00103857|589953151|FG003|54-Week Base Study|Death|0|||
163340055|NCT00103857|589953152|FG004|54-Week Base Study|Death|1|||
163114132|NCT03222973|589125840|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
163114133|NCT03222973|589125841|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
163114134|NCT03222973|589125842|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
163114135|NCT03222973|589125839|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
163340056|NCT00103857|589953153|FG005|54-Week Base Study|Death|1|||
163340057|NCT00103857|589953154|FG006|54-Week Base Study|Death|0|||
163222650|NCT02620046|589531594|FG001|Overall Study|Adverse Event|42|||
163222651|NCT02620046|589531593|FG000|Overall Study|Lost to Follow-up|4|||
163222652|NCT02620046|589531594|FG001|Overall Study|Lost to Follow-up|10|||
163222653|NCT02620046|589531593|FG000|Overall Study|Withdrawal by Subject|36|||
163222654|NCT02620046|589531594|FG001|Overall Study|Withdrawal by Subject|66|||
163222655|NCT02620046|589531593|FG000|Overall Study|Site Termination|3|||
163222656|NCT02620046|589531594|FG001|Overall Study|Site Termination|3|||
163222657|NCT02620046|589531593|FG000|Overall Study|Pregnancy|3|||
163222658|NCT02620046|589531594|FG001|Overall Study|Pregnancy|7|||
163222659|NCT02620046|589531593|FG000|Overall Study|Lack of Efficacy|81|||
163222660|NCT02620046|589531594|FG001|Overall Study|Lack of Efficacy|146|||
163222661|NCT02620046|589531593|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
163222662|NCT02620046|589531594|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
163222663|NCT02620046|589531593|FG000|Overall Study|Reason Not Specified|13|||
163222664|NCT02620046|589531594|FG001|Overall Study|Reason Not Specified|21|||
163222665|NCT02620046|589531593|FG000|Overall Study|Significant Protocol Deviation|0|||
163222666|NCT02620046|589531594|FG001|Overall Study|Significant Protocol Deviation|1|||
163222667|NCT00574405|589533300|FG000|Overall Study|Withdrawal by Subject|3|||
163222668|NCT00574405|589533301|FG001|Overall Study|Withdrawal by Subject|2|||
163222669|NCT01336738|589533302|FG000|Overall Study|Adverse Event|0|||
163222670|NCT01336738|589533303|FG001|Overall Study|Adverse Event|3|||
163114136|NCT03222973|589125840|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
163114137|NCT03222973|589125841|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
163114138|NCT03222973|589125842|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
163114139|NCT03222973|589125839|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
163114140|NCT03222973|589125840|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
163114141|NCT03222973|589125841|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
163114142|NCT03222973|589125842|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
163114143|NCT03222973|589125839|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
163114144|NCT03222973|589125840|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
163114145|NCT03222973|589125841|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
163114146|NCT03222973|589125842|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
163114147|NCT03222973|589125839|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
163114148|NCT03222973|589125840|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
163114149|NCT03222973|589125841|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
163114150|NCT03222973|589125842|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
163114151|NCT03222973|589125839|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
163114152|NCT03222973|589125840|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
163114153|NCT03222973|589125841|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
163114154|NCT03222973|589125842|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
163114155|NCT03222973|589125839|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
163114156|NCT03222973|589125840|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
163114157|NCT03222973|589125841|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
163114158|NCT03222973|589125842|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
163114159|NCT03222973|589125839|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
163114160|NCT03222973|589125840|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
163114161|NCT03222973|589125841|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
163114162|NCT03222973|589125842|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
163114163|NCT03222973|589125839|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
163114164|NCT03222973|589125840|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
163114165|NCT03222973|589125841|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
163114166|NCT03222973|589125842|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
163114167|NCT03222973|589125839|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
163114168|NCT03222973|589125840|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
163114169|NCT03222973|589125841|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
163114170|NCT03222973|589125842|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
163114171|NCT02080481|589125843|FG000|Overall Study|Never received a block.|1|||
163114172|NCT02080481|589125844|FG001|Overall Study|Never received a block.|0|||
163114173|NCT02439450|589125846|FG000|Overall Study|Adverse Event|4|||
163114174|NCT02439450|589125847|FG001|Overall Study|Adverse Event|1|||
163114175|NCT02439450|589125848|FG002|Overall Study|Adverse Event|0|||
163114176|NCT02439450|589125849|FG003|Overall Study|Adverse Event|0|||
163114177|NCT02439450|589125846|FG000|Overall Study|Withdrawal by Subject|1|||
163114178|NCT02439450|589125847|FG001|Overall Study|Withdrawal by Subject|2|||
163114179|NCT02439450|589125848|FG002|Overall Study|Withdrawal by Subject|0|||
163340058|NCT00103857|589953148|FG000|54-Week Base Study|Lack of Efficacy|11|||
163340059|NCT00103857|589953149|FG001|54-Week Base Study|Lack of Efficacy|14|||
163340060|NCT00103857|589953150|FG002|54-Week Base Study|Lack of Efficacy|8|||
163114180|NCT02439450|589125849|FG003|Overall Study|Withdrawal by Subject|0|||
163222671|NCT01336738|589533304|FG002|Overall Study|Adverse Event|2|||
163340061|NCT00103857|589953151|FG003|54-Week Base Study|Lack of Efficacy|4|||
163222672|NCT01336738|589533305|FG003|Overall Study|Adverse Event|1|||
163114181|NCT02439450|589125846|FG000|Overall Study|Death|3|||
163222673|NCT01336738|589533306|FG004|Overall Study|Adverse Event|3|||
163222674|NCT01336738|589533302|FG000|Overall Study|Lost to Follow-up|2|||
163407906|NCT00328627|590203968|FG007|Overall Study|Adverse Event|2|||
163114182|NCT02439450|589125847|FG001|Overall Study|Death|0|||
163114183|NCT02439450|589125848|FG002|Overall Study|Death|0|||
163114184|NCT02439450|589125849|FG003|Overall Study|Death|1|||
163114185|NCT02439450|589125846|FG000|Overall Study|Progressive Disease|18|||
163114186|NCT02439450|589125847|FG001|Overall Study|Progressive Disease|41|||
163114187|NCT02439450|589125848|FG002|Overall Study|Progressive Disease|2|||
163114188|NCT02439450|589125849|FG003|Overall Study|Progressive Disease|3|||
163114189|NCT03730961|589125854|FG000|Overall Study|Adverse Event|0|||
163114190|NCT03730961|589125855|FG001|Overall Study|Adverse Event|1|||
163114191|NCT04508751|589125860|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
163114192|NCT04508751|589125861|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
163114193|NCT04508751|589125862|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
163114194|NCT01444027|589125873|FG000|Overall Study|Withdrawal by Subject|4|||
163114195|NCT01444027|589125874|FG001|Overall Study|Withdrawal by Subject|10|||
163114196|NCT01444027|589125875|FG002|Overall Study|Withdrawal by Subject|24|||
163114197|NCT01444027|589125873|FG000|Overall Study|Lost to Follow-up|26|||
163114198|NCT01444027|589125874|FG001|Overall Study|Lost to Follow-up|20|||
163114199|NCT01444027|589125875|FG002|Overall Study|Lost to Follow-up|14|||
163114200|NCT03551665|589125877|FG000|Overall Study|Lost to Follow-up|11|||
163114201|NCT03551665|589125878|FG001|Overall Study|Lost to Follow-up|2|||
163114202|NCT03966885|589127428|FG000|Overall Study|Death|1|||
163114203|NCT03966885|589127429|FG001|Overall Study|Death|0|||
163114204|NCT03966885|589127428|FG000|Overall Study|Lost to Follow-up|1|||
163114205|NCT03966885|589127429|FG001|Overall Study|Lost to Follow-up|2|||
163114206|NCT03966885|589127428|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
163114207|NCT03966885|589127429|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
163114208|NCT03966885|589127428|FG000|Overall Study|Moved from study area.|0|||
163114209|NCT03966885|589127429|FG001|Overall Study|Moved from study area.|2|||
163114210|NCT01514240|589127430|FG000|Overall Study|Adverse Event|4|||
163114211|NCT01514240|589127431|FG001|Overall Study|Adverse Event|4|||
163114212|NCT01514240|589127430|FG000|Overall Study|Subject Decision|2|||
163114213|NCT01514240|589127431|FG001|Overall Study|Subject Decision|7|||
163114214|NCT00509093|589127432|FG000|Overall Study|Adverse Event|10|||
163114215|NCT00509093|589127432|FG000|Overall Study|Disease Progression|9|||
163114216|NCT00509093|589127432|FG000|Overall Study|Transformed into MDS|1|||
163114217|NCT00509093|589127432|FG000|Overall Study|Withdrawal by Subject|3|||
163114218|NCT00509093|589127432|FG000|Overall Study|Physician Decision|1|||
163114219|NCT05013424|589127433|FG000|Overall Study|Lost to Follow-up|1|||
163114220|NCT05013424|589127434|FG001|Overall Study|Lost to Follow-up|1|||
163114221|NCT05013424|589127435|FG002|Overall Study|Lost to Follow-up|1|||
163114222|NCT05013424|589127433|FG000|Overall Study|Withdrawal by Subject|0|||
163114223|NCT05013424|589127434|FG001|Overall Study|Withdrawal by Subject|1|||
163114224|NCT05013424|589127435|FG002|Overall Study|Withdrawal by Subject|0|||
163114225|NCT04143217|589127442|FG000|Overall Study|Withdrawal by Subject|42|||
163114226|NCT04143217|589127442|FG000|Overall Study|Adverse Event|29|||
163114227|NCT04143217|589127442|FG000|Overall Study|Lost to Follow-up|29|||
163114228|NCT04143217|589127442|FG000|Overall Study|Lack of Efficacy|15|||
163114229|NCT04143217|589127442|FG000|Overall Study|Physician Decision|1|||
163114230|NCT04143217|589127442|FG000|Overall Study|Non-Compliance With Study Drug|6|||
163114231|NCT04143217|589127442|FG000|Overall Study|Other, Multiple Categories|11|||
163114232|NCT03538444|589127456|FG000|Overall Study|opioid withdrawal|1|||
163114233|NCT03538444|589127457|FG001|Overall Study|opioid withdrawal|0|||
163114234|NCT01451931|589127458|FG000|Overall Study|Lost to Follow-up|17|||
163114235|NCT01451931|589127459|FG001|Overall Study|Lost to Follow-up|36|||
163114236|NCT01451931|589127460|FG002|Overall Study|Lost to Follow-up|21|||
163114237|NCT01451931|589127458|FG000|Overall Study|Withdrawal by Subject|16|||
163114238|NCT01451931|589127459|FG001|Overall Study|Withdrawal by Subject|22|||
163114239|NCT01451931|589127460|FG002|Overall Study|Withdrawal by Subject|22|||
163114240|NCT03640052|589127466|FG000|Overall Study|Lost to Follow-up|0|||
163114241|NCT03640052|589127467|FG001|Overall Study|Lost to Follow-up|1|||
163114242|NCT03640052|589127468|FG002|Overall Study|Lost to Follow-up|0|||
163114243|NCT03640052|589127469|FG003|Overall Study|Lost to Follow-up|0|||
163114244|NCT03640052|589127470|FG004|Overall Study|Lost to Follow-up|0|||
163407907|NCT00328627|590203969|FG008|Overall Study|Adverse Event|0|||
163407908|NCT00328627|590203970|FG009|Overall Study|Adverse Event|7|||
163407909|NCT00328627|590203971|FG010|Overall Study|Adverse Event|5|||
163114245|NCT04422561|589127471|FG000|Overall Study|Lost to Follow-up|25|||
163114246|NCT04422561|589127472|FG001|Overall Study|Lost to Follow-up|11|||
163114247|NCT05479097|589127478|FG000|Overall Study|Withdrawal by Subject|2|||
163114248|NCT04126564|589127479|FG000|Overall Study|Withdrawal by Subject|0|||
163114249|NCT04126564|589127480|FG001|Overall Study|Withdrawal by Subject|2|||
163114250|NCT04126564|589127479|FG000|Overall Study|Lost to Follow-up|0|||
163114251|NCT04126564|589127480|FG001|Overall Study|Lost to Follow-up|1|||
163114252|NCT00230282|589127484|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
163114253|NCT00230282|589127484|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
163114254|NCT00230282|589127484|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
163114255|NCT00230282|589127484|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
163222675|NCT01336738|589533303|FG001|Overall Study|Lost to Follow-up|1|||
163222676|NCT01336738|589533304|FG002|Overall Study|Lost to Follow-up|2|||
163222677|NCT01336738|589533305|FG003|Overall Study|Lost to Follow-up|2|||
163222678|NCT01336738|589533306|FG004|Overall Study|Lost to Follow-up|2|||
163222679|NCT01336738|589533302|FG000|Overall Study|Did not meet entrance criteria|0|||
163222680|NCT01336738|589533303|FG001|Overall Study|Did not meet entrance criteria|1|||
163222681|NCT01336738|589533304|FG002|Overall Study|Did not meet entrance criteria|0|||
163222682|NCT01336738|589533305|FG003|Overall Study|Did not meet entrance criteria|0|||
163222683|NCT01336738|589533306|FG004|Overall Study|Did not meet entrance criteria|0|||
163222684|NCT01336738|589533302|FG000|Overall Study|Protocol Violation|0|||
163222685|NCT01336738|589533303|FG001|Overall Study|Protocol Violation|1|||
163222686|NCT01336738|589533304|FG002|Overall Study|Protocol Violation|0|||
163222687|NCT01336738|589533305|FG003|Overall Study|Protocol Violation|0|||
163222688|NCT01336738|589533306|FG004|Overall Study|Protocol Violation|0|||
163222689|NCT01336738|589533302|FG000|Overall Study|Withdrawal by Subject|2|||
163222690|NCT01336738|589533303|FG001|Overall Study|Withdrawal by Subject|0|||
163222691|NCT01336738|589533304|FG002|Overall Study|Withdrawal by Subject|2|||
163222692|NCT01336738|589533305|FG003|Overall Study|Withdrawal by Subject|1|||
163222693|NCT01336738|589533306|FG004|Overall Study|Withdrawal by Subject|1|||
163222694|NCT01336738|589533302|FG000|Overall Study|Other|3|||
163222695|NCT01336738|589533303|FG001|Overall Study|Other|3|||
163222696|NCT01336738|589533304|FG002|Overall Study|Other|2|||
163222697|NCT01336738|589533305|FG003|Overall Study|Other|3|||
163222698|NCT01336738|589533306|FG004|Overall Study|Other|4|||
163222699|NCT01083433|589533307|FG000|Overall Study|Lost to Follow-up|2|||
163222700|NCT01083433|589533308|FG001|Overall Study|Lost to Follow-up|1|||
163222701|NCT01083433|589533309|FG002|Overall Study|Lost to Follow-up|1|||
163222702|NCT01083433|589533307|FG000|Overall Study|Withdrawal by Subject|0|||
163222703|NCT01083433|589533308|FG001|Overall Study|Withdrawal by Subject|5|||
163222704|NCT01083433|589533309|FG002|Overall Study|Withdrawal by Subject|3|||
163222705|NCT01083433|589533307|FG000|Overall Study|Pregnancy|0|||
163222706|NCT01083433|589533308|FG001|Overall Study|Pregnancy|0|||
163222707|NCT01083433|589533309|FG002|Overall Study|Pregnancy|1|||
163222708|NCT01852292|589533311|FG000|Overall Study|Untreated - did not receive study drug|3|||
163222709|NCT01852292|589533312|FG001|Overall Study|Untreated - did not receive study drug|1|||
163222710|NCT01852292|589533311|FG000|Overall Study|Death|9|||
163222711|NCT01852292|589533312|FG001|Overall Study|Death|8|||
163222712|NCT01852292|589533311|FG000|Overall Study|Patient/guardian decision|8|||
163222713|NCT01852292|589533312|FG001|Overall Study|Patient/guardian decision|4|||
163222714|NCT01852292|589533311|FG000|Overall Study|Adverse Event|8|||
163222715|NCT01852292|589533312|FG001|Overall Study|Adverse Event|11|||
163222716|NCT01852292|589533311|FG000|Overall Study|Physician Decision|6|||
163222717|NCT01852292|589533312|FG001|Overall Study|Physician Decision|2|||
163222718|NCT01852292|589533311|FG000|Overall Study|Protocol Violation|2|||
163222719|NCT01852292|589533312|FG001|Overall Study|Protocol Violation|0|||
163222720|NCT01852292|589533311|FG000|Overall Study|Non-compliance with study treatment|1|||
163222721|NCT01852292|589533312|FG001|Overall Study|Non-compliance with study treatment|0|||
163222722|NCT01852292|589533311|FG000|Overall Study|Study terminated by Sponsor|0|||
163222723|NCT01852292|589533312|FG001|Overall Study|Study terminated by Sponsor|1|||
163222724|NCT01852292|589533311|FG000|Overall Study|Progressive disease|42|||
163340062|NCT00103857|589953152|FG004|54-Week Base Study|Lack of Efficacy|3|||
163340063|NCT00103857|589953153|FG005|54-Week Base Study|Lack of Efficacy|14|||
163340064|NCT00103857|589953154|FG006|54-Week Base Study|Lack of Efficacy|19|||
163340065|NCT00103857|589953148|FG000|54-Week Base Study|Lost to Follow-up|5|||
163340066|NCT00103857|589953149|FG001|54-Week Base Study|Lost to Follow-up|4|||
163340067|NCT00103857|589953150|FG002|54-Week Base Study|Lost to Follow-up|7|||
163340068|NCT00103857|589953151|FG003|54-Week Base Study|Lost to Follow-up|5|||
163340069|NCT00103857|589953152|FG004|54-Week Base Study|Lost to Follow-up|10|||
163340070|NCT00103857|589953153|FG005|54-Week Base Study|Lost to Follow-up|9|||
163340071|NCT00103857|589953154|FG006|54-Week Base Study|Lost to Follow-up|3|||
163340072|NCT00103857|589953148|FG000|54-Week Base Study|Physician Decision|1|||
163340073|NCT00103857|589953149|FG001|54-Week Base Study|Physician Decision|1|||
163222725|NCT01852292|589533312|FG001|Overall Study|Progressive disease|52|||
163222726|NCT01914666|589533315|FG000|Treatment Period|Lack of Efficacy|0|||
163222727|NCT01914666|589533316|FG001|Treatment Period|Lack of Efficacy|0|||
163222728|NCT01914666|589533317|FG002|Treatment Period|Lack of Efficacy|2|||
163222729|NCT01914666|589533315|FG000|Treatment Period|Adverse Event|10|||
163222730|NCT01914666|589533316|FG001|Treatment Period|Adverse Event|4|||
163222731|NCT01914666|589533317|FG002|Treatment Period|Adverse Event|2|||
163222732|NCT01914666|589533315|FG000|Treatment Period|Withdrawal by Subject|3|||
163222733|NCT01914666|589533316|FG001|Treatment Period|Withdrawal by Subject|2|||
163340074|NCT00103857|589953150|FG002|54-Week Base Study|Physician Decision|0|||
163222734|NCT01914666|589533317|FG002|Treatment Period|Withdrawal by Subject|2|||
163222735|NCT01914666|589533315|FG000|Treatment Period|Physician Decision|0|||
163222736|NCT01914666|589533316|FG001|Treatment Period|Physician Decision|0|||
163222737|NCT01914666|589533317|FG002|Treatment Period|Physician Decision|2|||
163222738|NCT02388737|589533319|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
163340075|NCT00103857|589953151|FG003|54-Week Base Study|Physician Decision|0|||
163114256|NCT03941964|589127489|FG000|Overall Study|Adverse Event|1|||
163114257|NCT03941964|589127490|FG001|Overall Study|Adverse Event|8|||
163114258|NCT03941964|589127489|FG000|Overall Study|Progressive disease|7|||
163114259|NCT03941964|589127490|FG001|Overall Study|Progressive disease|3|||
163114260|NCT03941964|589127489|FG000|Overall Study|Lack of Efficacy|0|||
163114261|NCT03941964|589127490|FG001|Overall Study|Lack of Efficacy|1|||
163114262|NCT03941964|589127489|FG000|Overall Study|Death|3|||
163114263|NCT03941964|589127490|FG001|Overall Study|Death|1|||
163114264|NCT03941964|589127489|FG000|Overall Study|Withdrew consent|1|||
163114265|NCT03941964|589127490|FG001|Overall Study|Withdrew consent|3|||
163114266|NCT03941964|589127489|FG000|Overall Study|Physician Decision|9|||
163114267|NCT03941964|589127490|FG001|Overall Study|Physician Decision|2|||
163114268|NCT03941964|589127489|FG000|Overall Study|Other, not specified|2|||
163114269|NCT03941964|589127490|FG001|Overall Study|Other, not specified|1|||
163114270|NCT00457821|589127494|FG000|Part 2|Withdrawal by Subject|0|||
163114271|NCT00457821|589127495|FG001|Part 2|Withdrawal by Subject|0|||
163114272|NCT00457821|589127496|FG002|Part 2|Withdrawal by Subject|0|||
163114273|NCT00457821|589127497|FG003|Part 2|Withdrawal by Subject|0|||
163114274|NCT00457821|589127498|FG004|Part 2|Withdrawal by Subject|0|||
163114275|NCT00457821|589127499|FG005|Part 2|Withdrawal by Subject|0|||
163114276|NCT00457821|589127500|FG006|Part 2|Withdrawal by Subject|0|||
163114277|NCT00457821|589127501|FG007|Part 2|Withdrawal by Subject|1|||
163114278|NCT00790647|589127506|FG000|Overall Study|Adverse Event|1|||
163114279|NCT02437409|589127511|FG000|Overall Study|Withdrawal by Subject|3|||
163114280|NCT02437409|589127511|FG000|Overall Study|Screening failure|12|||
163114281|NCT00027378|589127512|FG000|Overall Study|Physician Decision|0|||
163114282|NCT00027378|589127513|FG001|Overall Study|Physician Decision|3|||
163114283|NCT01369680|589127515|FG000|Overall Study|Lost to Follow-up|0|||
163114284|NCT01369680|589127516|FG001|Overall Study|Lost to Follow-up|0|||
163114285|NCT01369680|589127517|FG002|Overall Study|Lost to Follow-up|1|||
163114286|NCT01369680|589127518|FG003|Overall Study|Lost to Follow-up|2|||
163114287|NCT00737568|589127521|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
163114288|NCT00737568|589127522|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
163114289|NCT00737568|589127521|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
163114290|NCT00737568|589127522|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
163114291|NCT00737568|589127521|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
163114292|NCT00737568|589127522|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
163114293|NCT00737568|589127521|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
163114294|NCT00737568|589127522|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
163114295|NCT00737568|589127521|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
163114296|NCT00737568|589127522|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
163114297|NCT00737568|589127521|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
163114298|NCT00737568|589127522|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
163114299|NCT00737568|589127521|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
163114300|NCT00737568|589127522|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
163114301|NCT00737568|589127521|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
163114302|NCT00737568|589127522|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
163114303|NCT00737568|589127521|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
163114304|NCT00737568|589127522|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
163114305|NCT01133626|589127523|FG000|Overall Study|Adverse Event|0|||
163114306|NCT01133626|589127524|FG001|Overall Study|Adverse Event|1|||
163114307|NCT01133626|589127525|FG002|Overall Study|Adverse Event|0|||
163114308|NCT01133626|589127523|FG000|Overall Study|Withdrawal by Subject|1|||
163114309|NCT01133626|589127524|FG001|Overall Study|Withdrawal by Subject|2|||
163114310|NCT01133626|589127525|FG002|Overall Study|Withdrawal by Subject|2|||
163114311|NCT01133626|589127523|FG000|Overall Study|Other|0|||
163114312|NCT01133626|589127524|FG001|Overall Study|Other|2|||
163114313|NCT01133626|589127525|FG002|Overall Study|Other|0|||
163114314|NCT00951080|589127526|FG000|Overall Study|Adverse Event|3|||
163114315|NCT00951080|589127527|FG001|Overall Study|Adverse Event|3|||
163114316|NCT00951080|589127526|FG000|Overall Study|Lost to Follow-up|0|||
163114317|NCT00951080|589127527|FG001|Overall Study|Lost to Follow-up|1|||
163114318|NCT00951080|589127526|FG000|Overall Study|Physician Decision|4|||
163114319|NCT00951080|589127527|FG001|Overall Study|Physician Decision|1|||
163114320|NCT00951080|589127526|FG000|Overall Study|Other|19|||
163114321|NCT00951080|589127527|FG001|Overall Study|Other|22|||
163114322|NCT01713283|589127531|FG000|Overall Study|Lack of Efficacy|10|||
163114323|NCT01713283|589127532|FG001|Overall Study|Lack of Efficacy|2|||
163114324|NCT01713283|589127531|FG000|Overall Study|Lost to Follow-up|1|||
163114325|NCT01713283|589127532|FG001|Overall Study|Lost to Follow-up|1|||
163407910|NCT00328627|590203972|FG011|Overall Study|Adverse Event|4|||
163114326|NCT02585830|589127533|FG000|Overall Study|Withdrawal by Subject|3|||
163114327|NCT00835640|589127534|FG000|Second Intervention|Protocol Violation|1|||
163114328|NCT00835640|589127535|FG001|Second Intervention|Protocol Violation|0|||
163114329|NCT00350272|589127536|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
163114330|NCT00350272|589127537|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
163114331|NCT00350272|589127536|FG000|Blinded 12-Week Treatment|Death|1|||
163114332|NCT00350272|589127537|FG001|Blinded 12-Week Treatment|Death|0|||
163114333|NCT00350272|589127536|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
163114334|NCT00350272|589127537|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
163114335|NCT00350272|589127536|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
163114336|NCT00350272|589127537|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
163114337|NCT00350272|589127536|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
163114338|NCT00350272|589127537|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
163114339|NCT00350272|589127536|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
163114340|NCT00350272|589127537|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
163114341|NCT00350272|589127536|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
163114342|NCT00350272|589127537|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
163114343|NCT00350272|589127536|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
163114344|NCT00350272|589127537|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
163114345|NCT00350272|589127536|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
163114346|NCT00350272|589127537|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
163114347|NCT00350272|589127536|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
163114348|NCT00350272|589127537|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
163114349|NCT00350272|589127536|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
163114350|NCT00350272|589127537|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
163114351|NCT00812006|589127538|FG000|Overall Study|Lost to Follow-up|0|||
163114352|NCT00812006|589127539|FG001|Overall Study|Lost to Follow-up|0|||
163114353|NCT00812006|589127540|FG002|Overall Study|Lost to Follow-up|2|||
163114354|NCT00812006|589127538|FG000|Overall Study|Physician Decision|0|||
163114355|NCT00812006|589127539|FG001|Overall Study|Physician Decision|0|||
163114356|NCT00812006|589127540|FG002|Overall Study|Physician Decision|1|||
163114357|NCT00812006|589127538|FG000|Overall Study|Withdrawal by Subject|2|||
163114358|NCT00812006|589127539|FG001|Overall Study|Withdrawal by Subject|1|||
163114359|NCT00812006|589127540|FG002|Overall Study|Withdrawal by Subject|1|||
163114360|NCT00812006|589127538|FG000|Overall Study|Lack of Qualifying Event|4|||
163114361|NCT00812006|589127539|FG001|Overall Study|Lack of Qualifying Event|2|||
163114362|NCT00812006|589127540|FG002|Overall Study|Lack of Qualifying Event|2|||
163114363|NCT00068250|589127541|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
163114364|NCT00068250|589127542|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
163114365|NCT00068250|589127543|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
163114366|NCT00068250|589127544|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
163114367|NCT00235391|589127546|FG000|Overall Study|Adverse Event|4|||
163114368|NCT00235391|589127547|FG001|Overall Study|Adverse Event|5|||
163114369|NCT00235391|589127548|FG002|Overall Study|Adverse Event|10|||
163114370|NCT00235391|589127549|FG003|Overall Study|Adverse Event|72|||
163114371|NCT00235391|589127550|FG004|Overall Study|Adverse Event|5|||
163114372|NCT00235391|589127551|FG005|Overall Study|Adverse Event|2|||
163114373|NCT00235391|589127546|FG000|Overall Study|Abnormal laboratory value(s)|3|||
163114374|NCT00235391|589127547|FG001|Overall Study|Abnormal laboratory value(s)|5|||
163114375|NCT00235391|589127548|FG002|Overall Study|Abnormal laboratory value(s)|4|||
163114376|NCT00235391|589127549|FG003|Overall Study|Abnormal laboratory value(s)|27|||
163114377|NCT00235391|589127550|FG004|Overall Study|Abnormal laboratory value(s)|1|||
163114378|NCT00235391|589127551|FG005|Overall Study|Abnormal laboratory value(s)|2|||
163114379|NCT00235391|589127546|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163114380|NCT00235391|589127547|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163114381|NCT00235391|589127548|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
163114382|NCT00235391|589127549|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
163114383|NCT00235391|589127550|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
163114384|NCT00235391|589127551|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
163114385|NCT00235391|589127546|FG000|Overall Study|Condition no longer requires treatment|3|||
163114386|NCT00235391|589127547|FG001|Overall Study|Condition no longer requires treatment|0|||
163114387|NCT00235391|589127548|FG002|Overall Study|Condition no longer requires treatment|0|||
163340076|NCT00103857|589953152|FG004|54-Week Base Study|Physician Decision|1|||
163340077|NCT00103857|589953153|FG005|54-Week Base Study|Physician Decision|0|||
163340078|NCT00103857|589953154|FG006|54-Week Base Study|Physician Decision|0|||
163340079|NCT00103857|589953148|FG000|54-Week Base Study|Pregnancy|1|||
163340080|NCT00103857|589953149|FG001|54-Week Base Study|Pregnancy|0|||
163114388|NCT00235391|589127549|FG003|Overall Study|Condition no longer requires treatment|11|||
163114389|NCT00235391|589127550|FG004|Overall Study|Condition no longer requires treatment|1|||
163114390|NCT00235391|589127551|FG005|Overall Study|Condition no longer requires treatment|0|||
163114391|NCT00235391|589127546|FG000|Overall Study|Protocol deviation|0|||
163114392|NCT00235391|589127547|FG001|Overall Study|Protocol deviation|0|||
163114393|NCT00235391|589127548|FG002|Overall Study|Protocol deviation|1|||
163114394|NCT00235391|589127549|FG003|Overall Study|Protocol deviation|11|||
163114395|NCT00235391|589127550|FG004|Overall Study|Protocol deviation|0|||
163114396|NCT00235391|589127551|FG005|Overall Study|Protocol deviation|0|||
163114397|NCT00235391|589127546|FG000|Overall Study|Withdrawal by Subject|2|||
163114398|NCT00235391|589127547|FG001|Overall Study|Withdrawal by Subject|3|||
163340081|NCT00103857|589953150|FG002|54-Week Base Study|Pregnancy|0|||
163114399|NCT00235391|589127548|FG002|Overall Study|Withdrawal by Subject|3|||
163114400|NCT00235391|589127549|FG003|Overall Study|Withdrawal by Subject|61|||
163114401|NCT00235391|589127550|FG004|Overall Study|Withdrawal by Subject|5|||
163114402|NCT00235391|589127551|FG005|Overall Study|Withdrawal by Subject|0|||
163114403|NCT00235391|589127546|FG000|Overall Study|Lost to Follow-up|0|||
163114404|NCT00235391|589127547|FG001|Overall Study|Lost to Follow-up|3|||
163114405|NCT00235391|589127548|FG002|Overall Study|Lost to Follow-up|3|||
163114406|NCT00235391|589127549|FG003|Overall Study|Lost to Follow-up|16|||
163114407|NCT00235391|589127550|FG004|Overall Study|Lost to Follow-up|0|||
163114408|NCT00235391|589127551|FG005|Overall Study|Lost to Follow-up|0|||
163114409|NCT00235391|589127546|FG000|Overall Study|Administrative problems|0|||
163114410|NCT00235391|589127547|FG001|Overall Study|Administrative problems|0|||
163114411|NCT00235391|589127548|FG002|Overall Study|Administrative problems|0|||
163114412|NCT00235391|589127549|FG003|Overall Study|Administrative problems|1|||
163114413|NCT00235391|589127550|FG004|Overall Study|Administrative problems|0|||
163114414|NCT00235391|589127551|FG005|Overall Study|Administrative problems|0|||
163114415|NCT00235391|589127546|FG000|Overall Study|Death|0|||
163114416|NCT00235391|589127547|FG001|Overall Study|Death|0|||
163114417|NCT00235391|589127548|FG002|Overall Study|Death|1|||
163114418|NCT00235391|589127549|FG003|Overall Study|Death|4|||
163114419|NCT00235391|589127550|FG004|Overall Study|Death|0|||
163114420|NCT00235391|589127551|FG005|Overall Study|Death|0|||
163114421|NCT02927925|589127554|FG000|Overall Study|Death|16|||
163114422|NCT02927925|589127554|FG000|Overall Study|Physician Decision|1|||
163114423|NCT02927925|589127554|FG000|Overall Study|Withdrawal by Subject|11|||
163114424|NCT02927925|589127554|FG000|Overall Study|Other|3|||
163114425|NCT02927925|589127554|FG000|Overall Study|Disease progression at clinical cutoff|1|||
163114426|NCT00075725|589127557|FG000|Overall Study|Adverse Event|6|||
163114427|NCT00075725|589127558|FG001|Overall Study|Adverse Event|6|||
163114428|NCT00075725|589127559|FG002|Overall Study|Adverse Event|20|||
163114429|NCT00075725|589127560|FG003|Overall Study|Adverse Event|8|||
163114430|NCT00075725|589127561|FG004|Overall Study|Adverse Event|4|||
163114431|NCT00075725|589127562|FG005|Overall Study|Adverse Event|38|||
163114432|NCT00075725|589127563|FG006|Overall Study|Adverse Event|3|||
163114433|NCT00075725|589127564|FG007|Overall Study|Adverse Event|51|||
163114434|NCT00075725|589127565|FG008|Overall Study|Adverse Event|15|||
163114435|NCT00075725|589127566|FG009|Overall Study|Adverse Event|4|||
163114436|NCT00075725|589127567|FG010|Overall Study|Adverse Event|2|||
163114437|NCT00075725|589127568|FG011|Overall Study|Adverse Event|2|||
163114438|NCT00075725|589127557|FG000|Overall Study|Death|3|||
163114439|NCT00075725|589127558|FG001|Overall Study|Death|5|||
163114440|NCT00075725|589127559|FG002|Overall Study|Death|10|||
163114441|NCT00075725|589127560|FG003|Overall Study|Death|2|||
163114442|NCT00075725|589127561|FG004|Overall Study|Death|3|||
163114443|NCT00075725|589127562|FG005|Overall Study|Death|25|||
163114444|NCT00075725|589127563|FG006|Overall Study|Death|4|||
163114445|NCT00075725|589127564|FG007|Overall Study|Death|22|||
163114446|NCT00075725|589127565|FG008|Overall Study|Death|14|||
163114447|NCT00075725|589127566|FG009|Overall Study|Death|4|||
163114448|NCT00075725|589127567|FG010|Overall Study|Death|3|||
163114449|NCT00075725|589127568|FG011|Overall Study|Death|0|||
163114450|NCT00075725|589127557|FG000|Overall Study|Lost to Follow-up|1|||
163114451|NCT00075725|589127558|FG001|Overall Study|Lost to Follow-up|1|||
163114452|NCT00075725|589127559|FG002|Overall Study|Lost to Follow-up|4|||
163114453|NCT00075725|589127560|FG003|Overall Study|Lost to Follow-up|1|||
163114454|NCT00075725|589127561|FG004|Overall Study|Lost to Follow-up|0|||
163114455|NCT00075725|589127562|FG005|Overall Study|Lost to Follow-up|13|||
163114456|NCT00075725|589127563|FG006|Overall Study|Lost to Follow-up|2|||
163114457|NCT00075725|589127564|FG007|Overall Study|Lost to Follow-up|4|||
163114458|NCT00075725|589127565|FG008|Overall Study|Lost to Follow-up|1|||
163114459|NCT00075725|589127566|FG009|Overall Study|Lost to Follow-up|0|||
163114460|NCT00075725|589127567|FG010|Overall Study|Lost to Follow-up|0|||
163114461|NCT00075725|589127568|FG011|Overall Study|Lost to Follow-up|0|||
163114462|NCT00075725|589127557|FG000|Overall Study|Physician Decision|2|||
163114463|NCT00075725|589127558|FG001|Overall Study|Physician Decision|6|||
163114464|NCT00075725|589127559|FG002|Overall Study|Physician Decision|5|||
163114465|NCT00075725|589127560|FG003|Overall Study|Physician Decision|8|||
163114466|NCT00075725|589127561|FG004|Overall Study|Physician Decision|4|||
163114467|NCT00075725|589127562|FG005|Overall Study|Physician Decision|19|||
163114468|NCT00075725|589127563|FG006|Overall Study|Physician Decision|3|||
163114469|NCT00075725|589127564|FG007|Overall Study|Physician Decision|17|||
163114470|NCT00075725|589127565|FG008|Overall Study|Physician Decision|5|||
163222739|NCT02388737|589533320|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
163114471|NCT00075725|589127566|FG009|Overall Study|Physician Decision|0|||
163114472|NCT00075725|589127567|FG010|Overall Study|Physician Decision|1|||
163114473|NCT00075725|589127568|FG011|Overall Study|Physician Decision|0|||
163114474|NCT00075725|589127557|FG000|Overall Study|Pregnancy|0|||
163114475|NCT00075725|589127558|FG001|Overall Study|Pregnancy|0|||
163114476|NCT00075725|589127559|FG002|Overall Study|Pregnancy|0|||
163114477|NCT00075725|589127560|FG003|Overall Study|Pregnancy|0|||
163114478|NCT00075725|589127561|FG004|Overall Study|Pregnancy|0|||
163114479|NCT00075725|589127562|FG005|Overall Study|Pregnancy|1|||
163114480|NCT00075725|589127563|FG006|Overall Study|Pregnancy|0|||
163114481|NCT00075725|589127564|FG007|Overall Study|Pregnancy|1|||
163114482|NCT00075725|589127565|FG008|Overall Study|Pregnancy|0|||
163114483|NCT00075725|589127566|FG009|Overall Study|Pregnancy|0|||
163340082|NCT00103857|589953151|FG003|54-Week Base Study|Pregnancy|0|||
163340083|NCT00103857|589953152|FG004|54-Week Base Study|Pregnancy|1|||
163340084|NCT00103857|589953153|FG005|54-Week Base Study|Pregnancy|0|||
163340085|NCT00103857|589953154|FG006|54-Week Base Study|Pregnancy|1|||
163114484|NCT00075725|589127567|FG010|Overall Study|Pregnancy|0|||
163114485|NCT00075725|589127568|FG011|Overall Study|Pregnancy|0|||
163114486|NCT00075725|589127557|FG000|Overall Study|Protocol Violation|1|||
163114487|NCT00075725|589127558|FG001|Overall Study|Protocol Violation|1|||
163114488|NCT00075725|589127559|FG002|Overall Study|Protocol Violation|0|||
163114489|NCT00075725|589127560|FG003|Overall Study|Protocol Violation|3|||
163114490|NCT00075725|589127561|FG004|Overall Study|Protocol Violation|3|||
163114491|NCT00075725|589127562|FG005|Overall Study|Protocol Violation|2|||
163114492|NCT00075725|589127563|FG006|Overall Study|Protocol Violation|1|||
163114493|NCT00075725|589127564|FG007|Overall Study|Protocol Violation|2|||
163114494|NCT00075725|589127565|FG008|Overall Study|Protocol Violation|3|||
163114495|NCT00075725|589127566|FG009|Overall Study|Protocol Violation|0|||
163114496|NCT00075725|589127567|FG010|Overall Study|Protocol Violation|0|||
163114497|NCT00075725|589127568|FG011|Overall Study|Protocol Violation|1|||
163114498|NCT00075725|589127557|FG000|Overall Study|Withdrawal by Subject|12|||
163114499|NCT00075725|589127558|FG001|Overall Study|Withdrawal by Subject|3|||
163114500|NCT00075725|589127559|FG002|Overall Study|Withdrawal by Subject|6|||
163114501|NCT00075725|589127560|FG003|Overall Study|Withdrawal by Subject|10|||
163114502|NCT00075725|589127561|FG004|Overall Study|Withdrawal by Subject|6|||
163114503|NCT00075725|589127562|FG005|Overall Study|Withdrawal by Subject|27|||
163114504|NCT00075725|589127563|FG006|Overall Study|Withdrawal by Subject|7|||
163114505|NCT00075725|589127564|FG007|Overall Study|Withdrawal by Subject|31|||
163114506|NCT00075725|589127565|FG008|Overall Study|Withdrawal by Subject|10|||
163114507|NCT00075725|589127566|FG009|Overall Study|Withdrawal by Subject|2|||
163114508|NCT00075725|589127567|FG010|Overall Study|Withdrawal by Subject|0|||
163114509|NCT00075725|589127568|FG011|Overall Study|Withdrawal by Subject|0|||
163114510|NCT00075725|589127557|FG000|Overall Study|Disease Progression, all other reasons|17|||
163222740|NCT02388737|589533321|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
163222741|NCT02388737|589533319|FG000|Overall Study|Major Protocol Deviation|18|||
163222742|NCT02388737|589533320|FG001|Overall Study|Major Protocol Deviation|25|||
163222743|NCT02388737|589533321|FG002|Overall Study|Major Protocol Deviation|22|||
163222744|NCT02388737|589533319|FG000|Overall Study|Lost to Follow-up|5|||
163222745|NCT02388737|589533320|FG001|Overall Study|Lost to Follow-up|1|||
163222746|NCT02388737|589533321|FG002|Overall Study|Lost to Follow-up|4|||
163222747|NCT02388737|589533319|FG000|Overall Study|Voluntary Withdrawal|10|||
163222748|NCT02388737|589533320|FG001|Overall Study|Voluntary Withdrawal|18|||
163222749|NCT02388737|589533321|FG002|Overall Study|Voluntary Withdrawal|17|||
163222750|NCT02388737|589533319|FG000|Overall Study|Lack of Efficacy|3|||
163222751|NCT02388737|589533320|FG001|Overall Study|Lack of Efficacy|0|||
163222752|NCT02388737|589533321|FG002|Overall Study|Lack of Efficacy|3|||
163222753|NCT02388737|589533319|FG000|Overall Study|Reason Not Specified|5|||
163222754|NCT02388737|589533320|FG001|Overall Study|Reason Not Specified|5|||
163222755|NCT02388737|589533321|FG002|Overall Study|Reason Not Specified|4|||
163222756|NCT03252522|589533322|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
163222757|NCT03252522|589533323|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
163222758|NCT03252522|589533324|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
163222759|NCT03252522|589533322|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
163340086|NCT00103857|589953148|FG000|54-Week Base Study|Protocol Violation|6|||
163340087|NCT00103857|589953149|FG001|54-Week Base Study|Protocol Violation|4|||
163340088|NCT00103857|589953150|FG002|54-Week Base Study|Protocol Violation|2|||
163340089|NCT00103857|589953151|FG003|54-Week Base Study|Protocol Violation|4|||
163340090|NCT00103857|589953152|FG004|54-Week Base Study|Protocol Violation|0|||
163222760|NCT03252522|589533323|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
163222761|NCT03252522|589533324|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
163222762|NCT03252522|589533322|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
163222763|NCT03252522|589533323|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
163222764|NCT03252522|589533324|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
163340091|NCT00103857|589953153|FG005|54-Week Base Study|Protocol Violation|3|||
163340092|NCT00103857|589953154|FG006|54-Week Base Study|Protocol Violation|3|||
163340093|NCT00103857|589953148|FG000|54-Week Base Study|Withdrawal by Subject|17|||
163340094|NCT00103857|589953149|FG001|54-Week Base Study|Withdrawal by Subject|16|||
163340095|NCT00103857|589953150|FG002|54-Week Base Study|Withdrawal by Subject|16|||
163114511|NCT00075725|589127558|FG001|Overall Study|Disease Progression, all other reasons|5|||
163114512|NCT00075725|589127559|FG002|Overall Study|Disease Progression, all other reasons|33|||
163114513|NCT00075725|589127560|FG003|Overall Study|Disease Progression, all other reasons|6|||
163114514|NCT00075725|589127561|FG004|Overall Study|Disease Progression, all other reasons|21|||
163114515|NCT00075725|589127562|FG005|Overall Study|Disease Progression, all other reasons|59|||
163340096|NCT00103857|589953151|FG003|54-Week Base Study|Withdrawal by Subject|15|||
163340097|NCT00103857|589953152|FG004|54-Week Base Study|Withdrawal by Subject|10|||
163340098|NCT00103857|589953153|FG005|54-Week Base Study|Withdrawal by Subject|15|||
163340099|NCT00103857|589953154|FG006|54-Week Base Study|Withdrawal by Subject|4|||
163114516|NCT00075725|589127563|FG006|Overall Study|Disease Progression, all other reasons|20|||
163114517|NCT00075725|589127564|FG007|Overall Study|Disease Progression, all other reasons|46|||
163114518|NCT00075725|589127565|FG008|Overall Study|Disease Progression, all other reasons|21|||
163114519|NCT00075725|589127566|FG009|Overall Study|Disease Progression, all other reasons|4|||
163114520|NCT00075725|589127567|FG010|Overall Study|Disease Progression, all other reasons|0|||
163114521|NCT00075725|589127568|FG011|Overall Study|Disease Progression, all other reasons|5|||
163114522|NCT00075725|589127557|FG000|Overall Study|Patient off treatment|0|||
163114523|NCT00075725|589127558|FG001|Overall Study|Patient off treatment|0|||
163114524|NCT00075725|589127559|FG002|Overall Study|Patient off treatment|1|||
163114525|NCT00075725|589127560|FG003|Overall Study|Patient off treatment|2|||
163114526|NCT00075725|589127561|FG004|Overall Study|Patient off treatment|1|||
163114527|NCT00075725|589127562|FG005|Overall Study|Patient off treatment|0|||
163114528|NCT00075725|589127563|FG006|Overall Study|Patient off treatment|0|||
163114529|NCT00075725|589127564|FG007|Overall Study|Patient off treatment|2|||
163114530|NCT00075725|589127565|FG008|Overall Study|Patient off treatment|1|||
163114531|NCT00075725|589127566|FG009|Overall Study|Patient off treatment|0|||
163114532|NCT00075725|589127567|FG010|Overall Study|Patient off treatment|0|||
163114533|NCT00075725|589127568|FG011|Overall Study|Patient off treatment|0|||
163114534|NCT00075725|589127557|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
163114535|NCT00075725|589127558|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
163114536|NCT00075725|589127559|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
163114537|NCT00075725|589127560|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
163114538|NCT00075725|589127561|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
163114539|NCT00075725|589127562|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
163114540|NCT00075725|589127563|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
163114541|NCT00075725|589127564|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
163114542|NCT00075725|589127565|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
163114543|NCT00075725|589127566|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
163114544|NCT00075725|589127567|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
163114545|NCT00075725|589127568|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
163114546|NCT00075725|589127557|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
163114547|NCT00075725|589127558|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
163114548|NCT00075725|589127559|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
163114549|NCT00075725|589127560|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
163114550|NCT00075725|589127561|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
163114551|NCT00075725|589127562|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
163114552|NCT00075725|589127563|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
163114553|NCT00075725|589127564|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
163114554|NCT00075725|589127565|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
163114555|NCT00075725|589127566|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
163114556|NCT00075725|589127567|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
163114557|NCT00075725|589127568|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
163114558|NCT00075725|589127557|FG000|Overall Study|Pt non compliant with therapy|2|||
163114559|NCT00075725|589127558|FG001|Overall Study|Pt non compliant with therapy|1|||
163114560|NCT00075725|589127559|FG002|Overall Study|Pt non compliant with therapy|1|||
163114561|NCT00075725|589127560|FG003|Overall Study|Pt non compliant with therapy|0|||
163114562|NCT00075725|589127561|FG004|Overall Study|Pt non compliant with therapy|2|||
163114563|NCT00075725|589127562|FG005|Overall Study|Pt non compliant with therapy|14|||
163114564|NCT00075725|589127563|FG006|Overall Study|Pt non compliant with therapy|2|||
163114565|NCT00075725|589127564|FG007|Overall Study|Pt non compliant with therapy|5|||
163114566|NCT00075725|589127565|FG008|Overall Study|Pt non compliant with therapy|3|||
163114567|NCT00075725|589127566|FG009|Overall Study|Pt non compliant with therapy|0|||
163114568|NCT00075725|589127567|FG010|Overall Study|Pt non compliant with therapy|0|||
163114569|NCT00075725|589127568|FG011|Overall Study|Pt non compliant with therapy|0|||
163114570|NCT00075725|589127557|FG000|Overall Study|Pt age out of range for treatment|0|||
163114571|NCT00075725|589127558|FG001|Overall Study|Pt age out of range for treatment|1|||
163114572|NCT00075725|589127559|FG002|Overall Study|Pt age out of range for treatment|0|||
163114573|NCT00075725|589127560|FG003|Overall Study|Pt age out of range for treatment|0|||
163340100|NCT00103857|589953148|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
163340101|NCT00103857|589953149|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
163340102|NCT00103857|589953150|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
163340103|NCT00103857|589953151|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
163114574|NCT00075725|589127561|FG004|Overall Study|Pt age out of range for treatment|0|||
163114575|NCT00075725|589127562|FG005|Overall Study|Pt age out of range for treatment|1|||
163114576|NCT00075725|589127563|FG006|Overall Study|Pt age out of range for treatment|0|||
163340104|NCT00103857|589953152|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
163114577|NCT00075725|589127564|FG007|Overall Study|Pt age out of range for treatment|1|||
163114578|NCT00075725|589127565|FG008|Overall Study|Pt age out of range for treatment|0|||
163114579|NCT00075725|589127566|FG009|Overall Study|Pt age out of range for treatment|0|||
163114580|NCT00075725|589127567|FG010|Overall Study|Pt age out of range for treatment|0|||
163114581|NCT00075725|589127568|FG011|Overall Study|Pt age out of range for treatment|0|||
163114582|NCT00075725|589127557|FG000|Overall Study|Insurance issues|0|||
163114583|NCT00075725|589127558|FG001|Overall Study|Insurance issues|1|||
163114584|NCT00075725|589127559|FG002|Overall Study|Insurance issues|0|||
163114585|NCT00075725|589127560|FG003|Overall Study|Insurance issues|1|||
163114586|NCT00075725|589127561|FG004|Overall Study|Insurance issues|1|||
163114587|NCT00075725|589127562|FG005|Overall Study|Insurance issues|1|||
163114588|NCT00075725|589127563|FG006|Overall Study|Insurance issues|0|||
163114589|NCT00075725|589127564|FG007|Overall Study|Insurance issues|1|||
163114590|NCT00075725|589127565|FG008|Overall Study|Insurance issues|0|||
163114591|NCT00075725|589127566|FG009|Overall Study|Insurance issues|0|||
163114592|NCT00075725|589127567|FG010|Overall Study|Insurance issues|0|||
163114593|NCT00075725|589127568|FG011|Overall Study|Insurance issues|0|||
163114594|NCT00075725|589127557|FG000|Overall Study|MRD positive after extended ind|0|||
163114595|NCT00075725|589127558|FG001|Overall Study|MRD positive after extended ind|1|||
163114596|NCT00075725|589127559|FG002|Overall Study|MRD positive after extended ind|1|||
163114597|NCT00075725|589127560|FG003|Overall Study|MRD positive after extended ind|0|||
163114598|NCT00075725|589127561|FG004|Overall Study|MRD positive after extended ind|1|||
163114599|NCT00075725|589127562|FG005|Overall Study|MRD positive after extended ind|2|||
163114600|NCT00075725|589127563|FG006|Overall Study|MRD positive after extended ind|0|||
163114601|NCT00075725|589127564|FG007|Overall Study|MRD positive after extended ind|1|||
163114602|NCT00075725|589127565|FG008|Overall Study|MRD positive after extended ind|0|||
163114603|NCT00075725|589127566|FG009|Overall Study|MRD positive after extended ind|0|||
163114604|NCT00075725|589127567|FG010|Overall Study|MRD positive after extended ind|0|||
163114605|NCT00075725|589127568|FG011|Overall Study|MRD positive after extended ind|0|||
163114606|NCT00075725|589127557|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
163114607|NCT00075725|589127558|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
163114608|NCT00075725|589127559|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
163114609|NCT00075725|589127560|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
163114610|NCT00075725|589127561|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
163114611|NCT00075725|589127562|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
163114612|NCT00075725|589127563|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
163114613|NCT00075725|589127564|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
163114614|NCT00075725|589127565|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
163114615|NCT00075725|589127566|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
163114616|NCT00075725|589127567|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
163114617|NCT00075725|589127568|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
163114618|NCT00075725|589127557|FG000|Overall Study|Inevaluable|1|||
163114619|NCT00075725|589127558|FG001|Overall Study|Inevaluable|1|||
163114620|NCT00075725|589127559|FG002|Overall Study|Inevaluable|4|||
163114621|NCT00075725|589127560|FG003|Overall Study|Inevaluable|2|||
163114622|NCT00075725|589127561|FG004|Overall Study|Inevaluable|2|||
163114623|NCT00075725|589127562|FG005|Overall Study|Inevaluable|9|||
163114624|NCT00075725|589127563|FG006|Overall Study|Inevaluable|1|||
163114625|NCT00075725|589127564|FG007|Overall Study|Inevaluable|11|||
163114626|NCT00075725|589127565|FG008|Overall Study|Inevaluable|2|||
163114627|NCT00075725|589127566|FG009|Overall Study|Inevaluable|0|||
163114628|NCT00075725|589127567|FG010|Overall Study|Inevaluable|1|||
163114629|NCT00075725|589127568|FG011|Overall Study|Inevaluable|0|||
163114630|NCT00075725|589127557|FG000|Overall Study|Other|4|||
163114631|NCT00075725|589127558|FG001|Overall Study|Other|2|||
163114632|NCT00075725|589127559|FG002|Overall Study|Other|1|||
163114633|NCT00075725|589127560|FG003|Overall Study|Other|1|||
163114634|NCT00075725|589127561|FG004|Overall Study|Other|1|||
163114635|NCT00075725|589127562|FG005|Overall Study|Other|4|||
163114636|NCT00075725|589127563|FG006|Overall Study|Other|2|||
163114637|NCT00075725|589127564|FG007|Overall Study|Other|9|||
163114638|NCT00075725|589127565|FG008|Overall Study|Other|2|||
163114639|NCT00075725|589127566|FG009|Overall Study|Other|1|||
163114640|NCT00075725|589127567|FG010|Overall Study|Other|0|||
163114641|NCT00075725|589127568|FG011|Overall Study|Other|3|||
163114642|NCT00075725|589127557|FG000|Overall Study|Pt trying to find a BM donor|0|||
163114643|NCT00075725|589127558|FG001|Overall Study|Pt trying to find a BM donor|1|||
163114644|NCT00075725|589127559|FG002|Overall Study|Pt trying to find a BM donor|0|||
163114645|NCT00075725|589127560|FG003|Overall Study|Pt trying to find a BM donor|0|||
163114646|NCT00075725|589127561|FG004|Overall Study|Pt trying to find a BM donor|0|||
163114647|NCT00075725|589127562|FG005|Overall Study|Pt trying to find a BM donor|0|||
163114648|NCT00075725|589127563|FG006|Overall Study|Pt trying to find a BM donor|0|||
163114649|NCT00075725|589127564|FG007|Overall Study|Pt trying to find a BM donor|0|||
163114650|NCT00075725|589127565|FG008|Overall Study|Pt trying to find a BM donor|0|||
163114651|NCT00075725|589127566|FG009|Overall Study|Pt trying to find a BM donor|0|||
163114652|NCT00075725|589127567|FG010|Overall Study|Pt trying to find a BM donor|0|||
163222765|NCT03252522|589533322|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
163222766|NCT03252522|589533323|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
163222767|NCT03252522|589533324|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
163222768|NCT03252522|589533322|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
163222769|NCT03252522|589533323|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
163222770|NCT03252522|589533324|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
163222771|NCT03252522|589533322|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
163222772|NCT03252522|589533323|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
163222773|NCT03252522|589533324|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
163222774|NCT03252522|589533322|FG000|Phase 2: Open Label|Adverse Event|0|||
163222775|NCT03252522|589533323|FG001|Phase 2: Open Label|Adverse Event|0|||
163222776|NCT03252522|589533324|FG002|Phase 2: Open Label|Adverse Event|2|||
163222777|NCT03252522|589533322|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
163222778|NCT03252522|589533323|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
163222779|NCT03252522|589533324|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
163222780|NCT04152447|589533326|FG000|Overall Study|Lost to Follow-up|1|||
163222781|NCT04152447|589533327|FG001|Overall Study|Lost to Follow-up|0|||
163222782|NCT04152447|589533326|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
163222783|NCT04152447|589533327|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
163222784|NCT04152447|589533326|FG000|Overall Study|Withdrawal by Subject|0|||
163222785|NCT04152447|589533327|FG001|Overall Study|Withdrawal by Subject|1|||
163222786|NCT04152447|589533326|FG000|Overall Study|Found ineligible after enrolling|1|||
163222787|NCT04152447|589533327|FG001|Overall Study|Found ineligible after enrolling|1|||
163222788|NCT04152447|589533326|FG000|Overall Study|Did not receive VR headset in time.|0|||
163222789|NCT04152447|589533327|FG001|Overall Study|Did not receive VR headset in time.|2|||
163222790|NCT03240575|589533328|FG000|Overall Study|Adverse Event|0|||
163222791|NCT03240575|589533329|FG001|Overall Study|Adverse Event|2|||
163222792|NCT03240575|589533330|FG002|Overall Study|Adverse Event|0|||
163222793|NCT03240575|589533331|FG003|Overall Study|Adverse Event|1|||
163222794|NCT03240575|589533328|FG000|Overall Study|Withdrawal by Subject|2|||
163222795|NCT03240575|589533329|FG001|Overall Study|Withdrawal by Subject|11|||
163222796|NCT03240575|589533330|FG002|Overall Study|Withdrawal by Subject|0|||
163222797|NCT03240575|589533331|FG003|Overall Study|Withdrawal by Subject|1|||
163222798|NCT03240575|589533328|FG000|Overall Study|Other|0|||
163222799|NCT03240575|589533329|FG001|Overall Study|Other|1|||
163114653|NCT00075725|589127568|FG011|Overall Study|Pt trying to find a BM donor|0|||
163114654|NCT00075725|589127557|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
163114655|NCT00075725|589127558|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
163114656|NCT00075725|589127559|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
163114657|NCT00075725|589127560|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
163114658|NCT00075725|589127561|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
163114659|NCT00075725|589127562|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
163114660|NCT00075725|589127563|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
163114661|NCT00075725|589127564|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
163114662|NCT00075725|589127565|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
163114663|NCT00075725|589127566|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
163114664|NCT00075725|589127567|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
163114665|NCT00075725|589127568|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
163114666|NCT00075725|589127557|FG000|Overall Study|Unsuccessful institutional transfer|0|||
163114667|NCT00075725|589127558|FG001|Overall Study|Unsuccessful institutional transfer|0|||
163114668|NCT00075725|589127559|FG002|Overall Study|Unsuccessful institutional transfer|2|||
163114669|NCT00075725|589127560|FG003|Overall Study|Unsuccessful institutional transfer|0|||
163222800|NCT03240575|589533330|FG002|Overall Study|Other|0|||
163222801|NCT03240575|589533331|FG003|Overall Study|Other|0|||
163222802|NCT04482179|589533332|FG000|Overall Study|Death|1|||
163222803|NCT04482179|589533333|FG001|Overall Study|Death|0|||
163222804|NCT04482179|589533332|FG000|Overall Study|Withdrawal by Subject|1|||
163222805|NCT04482179|589533333|FG001|Overall Study|Withdrawal by Subject|0|||
163222806|NCT03034954|589533336|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
163222807|NCT03034954|589533337|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
163114670|NCT00075725|589127561|FG004|Overall Study|Unsuccessful institutional transfer|0|||
163114671|NCT00075725|589127562|FG005|Overall Study|Unsuccessful institutional transfer|0|||
163222808|NCT03568942|589533340|FG000|Overall Study|Family emergency|1|||
163222809|NCT03568942|589533340|FG000|Overall Study|Lost to Follow-up|1|||
163222810|NCT04145895|589533344|FG000|Overall Study|Physician Decision|2|||
163222811|NCT04145895|589533345|FG001|Overall Study|Physician Decision|0|||
163222812|NCT04145895|589533344|FG000|Overall Study|Withdrawal by Subject|0|||
163222813|NCT04145895|589533345|FG001|Overall Study|Withdrawal by Subject|2|||
163222814|NCT00913744|589533346|FG000|Overall Study|Adverse Event|2|||
163222815|NCT00913744|589533347|FG001|Overall Study|Adverse Event|0|||
163222816|NCT00913744|589533346|FG000|Overall Study|Withdrawal by Subject|2|||
163222817|NCT00913744|589533347|FG001|Overall Study|Withdrawal by Subject|1|||
163222818|NCT00913744|589533346|FG000|Overall Study|Death|1|||
163114672|NCT00075725|589127563|FG006|Overall Study|Unsuccessful institutional transfer|0|||
163114673|NCT00075725|589127564|FG007|Overall Study|Unsuccessful institutional transfer|0|||
163114674|NCT00075725|589127565|FG008|Overall Study|Unsuccessful institutional transfer|0|||
163114675|NCT00075725|589127566|FG009|Overall Study|Unsuccessful institutional transfer|1|||
163114676|NCT00075725|589127567|FG010|Overall Study|Unsuccessful institutional transfer|0|||
163114677|NCT00075725|589127568|FG011|Overall Study|Unsuccessful institutional transfer|0|||
163114678|NCT00075725|589127557|FG000|Overall Study|specimen(s) not submitted|0|||
163114679|NCT00075725|589127558|FG001|Overall Study|specimen(s) not submitted|0|||
163114680|NCT00075725|589127559|FG002|Overall Study|specimen(s) not submitted|2|||
163114681|NCT00075725|589127560|FG003|Overall Study|specimen(s) not submitted|0|||
163114682|NCT00075725|589127561|FG004|Overall Study|specimen(s) not submitted|0|||
163114683|NCT00075725|589127562|FG005|Overall Study|specimen(s) not submitted|0|||
163114684|NCT00075725|589127563|FG006|Overall Study|specimen(s) not submitted|0|||
163114685|NCT00075725|589127564|FG007|Overall Study|specimen(s) not submitted|0|||
163114686|NCT00075725|589127565|FG008|Overall Study|specimen(s) not submitted|0|||
163114687|NCT00075725|589127566|FG009|Overall Study|specimen(s) not submitted|0|||
163114688|NCT00075725|589127567|FG010|Overall Study|specimen(s) not submitted|0|||
163114689|NCT00075725|589127568|FG011|Overall Study|specimen(s) not submitted|0|||
163114690|NCT00075725|589127557|FG000|Overall Study|Pt went to transplant|0|||
163114691|NCT00075725|589127558|FG001|Overall Study|Pt went to transplant|0|||
163114692|NCT00075725|589127559|FG002|Overall Study|Pt went to transplant|0|||
163114693|NCT00075725|589127560|FG003|Overall Study|Pt went to transplant|1|||
163114694|NCT00075725|589127561|FG004|Overall Study|Pt went to transplant|0|||
163114695|NCT00075725|589127562|FG005|Overall Study|Pt went to transplant|1|||
163114696|NCT00075725|589127563|FG006|Overall Study|Pt went to transplant|0|||
163114697|NCT00075725|589127564|FG007|Overall Study|Pt went to transplant|0|||
163114698|NCT00075725|589127565|FG008|Overall Study|Pt went to transplant|0|||
163114699|NCT00075725|589127566|FG009|Overall Study|Pt went to transplant|0|||
163114700|NCT00075725|589127567|FG010|Overall Study|Pt went to transplant|0|||
163114701|NCT00075725|589127568|FG011|Overall Study|Pt went to transplant|0|||
163114702|NCT00075725|589127557|FG000|Overall Study|Pt received additional steroids|0|||
163114703|NCT00075725|589127558|FG001|Overall Study|Pt received additional steroids|0|||
163114704|NCT00075725|589127559|FG002|Overall Study|Pt received additional steroids|0|||
163114705|NCT00075725|589127560|FG003|Overall Study|Pt received additional steroids|1|||
163114706|NCT00075725|589127561|FG004|Overall Study|Pt received additional steroids|0|||
163114707|NCT00075725|589127562|FG005|Overall Study|Pt received additional steroids|0|||
163114708|NCT00075725|589127563|FG006|Overall Study|Pt received additional steroids|0|||
163114709|NCT00075725|589127564|FG007|Overall Study|Pt received additional steroids|0|||
163114710|NCT00075725|589127565|FG008|Overall Study|Pt received additional steroids|0|||
163114711|NCT00075725|589127566|FG009|Overall Study|Pt received additional steroids|0|||
163114712|NCT00075725|589127567|FG010|Overall Study|Pt received additional steroids|0|||
163114713|NCT00075725|589127568|FG011|Overall Study|Pt received additional steroids|0|||
163114714|NCT00075725|589127557|FG000|Overall Study|Pt relocated|0|||
163114715|NCT00075725|589127558|FG001|Overall Study|Pt relocated|0|||
163114716|NCT00075725|589127559|FG002|Overall Study|Pt relocated|0|||
163114717|NCT00075725|589127560|FG003|Overall Study|Pt relocated|2|||
163114718|NCT00075725|589127561|FG004|Overall Study|Pt relocated|0|||
163114719|NCT00075725|589127562|FG005|Overall Study|Pt relocated|1|||
163114720|NCT00075725|589127563|FG006|Overall Study|Pt relocated|1|||
163114721|NCT00075725|589127564|FG007|Overall Study|Pt relocated|2|||
163114722|NCT00075725|589127565|FG008|Overall Study|Pt relocated|1|||
163114723|NCT00075725|589127566|FG009|Overall Study|Pt relocated|0|||
163114724|NCT00075725|589127567|FG010|Overall Study|Pt relocated|0|||
163114725|NCT00075725|589127568|FG011|Overall Study|Pt relocated|0|||
163114726|NCT00075725|589127557|FG000|Overall Study|Institution Terminated|0|||
163114727|NCT00075725|589127558|FG001|Overall Study|Institution Terminated|0|||
163114728|NCT00075725|589127559|FG002|Overall Study|Institution Terminated|0|||
163114729|NCT00075725|589127560|FG003|Overall Study|Institution Terminated|0|||
163114730|NCT00075725|589127561|FG004|Overall Study|Institution Terminated|1|||
163114731|NCT00075725|589127562|FG005|Overall Study|Institution Terminated|0|||
163114732|NCT00075725|589127563|FG006|Overall Study|Institution Terminated|0|||
163114733|NCT00075725|589127564|FG007|Overall Study|Institution Terminated|3|||
163114734|NCT00075725|589127565|FG008|Overall Study|Institution Terminated|0|||
163114735|NCT00075725|589127566|FG009|Overall Study|Institution Terminated|0|||
163222819|NCT00913744|589533347|FG001|Overall Study|Death|0|||
163340105|NCT00103857|589953153|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
163114736|NCT00075725|589127567|FG010|Overall Study|Institution Terminated|0|||
163114737|NCT00075725|589127568|FG011|Overall Study|Institution Terminated|0|||
163114738|NCT00075725|589127557|FG000|Overall Study|Study Closure|1|||
163114739|NCT00075725|589127558|FG001|Overall Study|Study Closure|0|||
163114740|NCT00075725|589127559|FG002|Overall Study|Study Closure|0|||
163114741|NCT00075725|589127560|FG003|Overall Study|Study Closure|0|||
163114742|NCT00075725|589127561|FG004|Overall Study|Study Closure|1|||
163340106|NCT00103857|589953154|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
163114743|NCT00075725|589127562|FG005|Overall Study|Study Closure|3|||
163114744|NCT00075725|589127563|FG006|Overall Study|Study Closure|0|||
163114745|NCT00075725|589127564|FG007|Overall Study|Study Closure|1|||
163114746|NCT00075725|589127565|FG008|Overall Study|Study Closure|0|||
163114747|NCT00075725|589127566|FG009|Overall Study|Study Closure|0|||
163114748|NCT00075725|589127567|FG010|Overall Study|Study Closure|0|||
163114749|NCT00075725|589127568|FG011|Overall Study|Study Closure|0|||
163114750|NCT00075725|589127557|FG000|Overall Study|Other complications|0|||
163114751|NCT00075725|589127558|FG001|Overall Study|Other complications|0|||
163114752|NCT00075725|589127559|FG002|Overall Study|Other complications|0|||
163114753|NCT00075725|589127560|FG003|Overall Study|Other complications|0|||
163114754|NCT00075725|589127561|FG004|Overall Study|Other complications|0|||
163114755|NCT00075725|589127562|FG005|Overall Study|Other complications|1|||
163114756|NCT00075725|589127563|FG006|Overall Study|Other complications|0|||
163114757|NCT00075725|589127564|FG007|Overall Study|Other complications|0|||
163114758|NCT00075725|589127565|FG008|Overall Study|Other complications|0|||
163114759|NCT00075725|589127566|FG009|Overall Study|Other complications|0|||
163114760|NCT00075725|589127567|FG010|Overall Study|Other complications|0|||
163114761|NCT00075725|589127568|FG011|Overall Study|Other complications|0|||
163114762|NCT00075725|589127557|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
163114763|NCT00075725|589127558|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
163114764|NCT00075725|589127559|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
163114765|NCT00075725|589127560|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
163114766|NCT00075725|589127561|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
163114767|NCT00075725|589127562|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
163114768|NCT00075725|589127563|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
163114769|NCT00075725|589127564|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
163114770|NCT00075725|589127565|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
163114771|NCT00075725|589127566|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
163114772|NCT00075725|589127567|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
163114773|NCT00075725|589127568|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
163114774|NCT00075725|589127557|FG000|Overall Study|Pt incarcerated|0|||
163114775|NCT00075725|589127558|FG001|Overall Study|Pt incarcerated|0|||
163114776|NCT00075725|589127559|FG002|Overall Study|Pt incarcerated|0|||
163114777|NCT00075725|589127560|FG003|Overall Study|Pt incarcerated|0|||
163114778|NCT00075725|589127561|FG004|Overall Study|Pt incarcerated|0|||
163114779|NCT00075725|589127562|FG005|Overall Study|Pt incarcerated|0|||
163114780|NCT00075725|589127563|FG006|Overall Study|Pt incarcerated|0|||
163114781|NCT00075725|589127564|FG007|Overall Study|Pt incarcerated|1|||
163114782|NCT00075725|589127565|FG008|Overall Study|Pt incarcerated|0|||
163114783|NCT00075725|589127566|FG009|Overall Study|Pt incarcerated|0|||
163114784|NCT00075725|589127567|FG010|Overall Study|Pt incarcerated|0|||
163114785|NCT00075725|589127568|FG011|Overall Study|Pt incarcerated|0|||
163114786|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Death|1|||
163114787|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Death|1|||
163114788|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Death|0|||
163114789|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Death|0|||
163114790|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Death|1|||
163114791|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Death|0|||
163114792|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Death|0|||
163114793|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Death|0|||
163114794|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Death|0|||
163114795|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Death|0|||
163114796|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
163114797|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
163114798|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
163114799|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
163114800|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
163114801|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
163114802|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
163114803|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
163114804|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
163114805|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
163114806|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114807|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114808|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114809|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114810|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
163114811|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114812|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114813|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114814|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114815|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114816|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
163114817|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114818|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163222820|NCT00805935|589533348|FG000|Overall Study|Stimulation Failure|1|||
163222821|NCT00805935|589533349|FG001|Overall Study|Stimulation Failure|5|||
163222822|NCT00805935|589533350|FG002|Overall Study|Stimulation Failure|2|||
163222823|NCT00805935|589533351|FG003|Overall Study|Stimulation Failure|2|||
163222824|NCT00805935|589533348|FG000|Overall Study|Cycle cancelled|0|||
163222825|NCT00805935|589533349|FG001|Overall Study|Cycle cancelled|0|||
163222826|NCT00805935|589533350|FG002|Overall Study|Cycle cancelled|2|||
163222827|NCT00805935|589533351|FG003|Overall Study|Cycle cancelled|0|||
163222828|NCT00805935|589533348|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
163222829|NCT00805935|589533349|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
163222830|NCT00805935|589533350|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
163222831|NCT00805935|589533351|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
163222832|NCT00805935|589533348|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
163222833|NCT00805935|589533349|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
163222834|NCT00805935|589533350|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
163222835|NCT00805935|589533351|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
163222836|NCT00805935|589533348|FG000|Overall Study|Lost to Follow-up|1|||
163222837|NCT00805935|589533349|FG001|Overall Study|Lost to Follow-up|0|||
163222838|NCT00805935|589533350|FG002|Overall Study|Lost to Follow-up|0|||
163222839|NCT00805935|589533351|FG003|Overall Study|Lost to Follow-up|0|||
163340107|NCT00103857|589953148|FG000|54-Week Base Study|patient moved|0|||
163340108|NCT00103857|589953149|FG001|54-Week Base Study|patient moved|1|||
163340109|NCT00103857|589953150|FG002|54-Week Base Study|patient moved|1|||
163340110|NCT00103857|589953151|FG003|54-Week Base Study|patient moved|2|||
163340111|NCT00103857|589953152|FG004|54-Week Base Study|patient moved|3|||
163340112|NCT00103857|589953153|FG005|54-Week Base Study|patient moved|1|||
163407911|NCT00328627|590203961|FG000|Overall Study|Protocol Violation|2|||
163114819|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114820|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114821|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114822|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114823|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114824|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114825|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114826|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
163114827|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
163114828|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
163114829|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
163114830|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
163114831|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
163114832|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
163114833|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
163114834|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
163114835|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
163114836|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
163114837|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114838|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114839|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
163114840|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114841|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114842|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114843|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114844|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114845|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114846|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
163114847|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
163114848|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
163114849|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
163114850|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
163114851|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
163114852|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
163114853|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
163114854|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
163222840|NCT00805935|589533348|FG000|Overall Study|No positive serum pregnancy|8|||
163222841|NCT00805935|589533349|FG001|Overall Study|No positive serum pregnancy|7|||
163340113|NCT00103857|589953154|FG006|54-Week Base Study|patient moved|0|||
163407912|NCT00328627|590203962|FG001|Overall Study|Protocol Violation|2|||
163222842|NCT00805935|589533350|FG002|Overall Study|No positive serum pregnancy|6|||
163222843|NCT00805935|589533351|FG003|Overall Study|No positive serum pregnancy|5|||
163340114|NCT00103857|589953148|FG000|54-Week Base Study|non-compliance with study procedures|1|||
163340115|NCT00103857|589953149|FG001|54-Week Base Study|non-compliance with study procedures|2|||
163407913|NCT00328627|590203963|FG002|Overall Study|Protocol Violation|2|||
163222844|NCT00805935|589533348|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
163222845|NCT00805935|589533349|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
163222846|NCT00805935|589533350|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
163222847|NCT00805935|589533351|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
163222848|NCT00805935|589533348|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
163222849|NCT00805935|589533349|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
163222850|NCT00805935|589533350|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
163222851|NCT00805935|589533351|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
163222852|NCT00805935|589533348|FG000|Overall Study|Biochemical pregnancy|0|||
163222853|NCT00805935|589533349|FG001|Overall Study|Biochemical pregnancy|1|||
163222854|NCT00805935|589533350|FG002|Overall Study|Biochemical pregnancy|0|||
163222855|NCT00805935|589533351|FG003|Overall Study|Biochemical pregnancy|0|||
163222856|NCT00805935|589533348|FG000|Overall Study|Chemical pregnancy|0|||
163222857|NCT00805935|589533349|FG001|Overall Study|Chemical pregnancy|5|||
163222858|NCT00805935|589533350|FG002|Overall Study|Chemical pregnancy|3|||
163222859|NCT00805935|589533351|FG003|Overall Study|Chemical pregnancy|2|||
163222860|NCT00805935|589533348|FG000|Overall Study|Ectopic pregnancy|0|||
163222861|NCT00805935|589533349|FG001|Overall Study|Ectopic pregnancy|0|||
163222862|NCT00805935|589533350|FG002|Overall Study|Ectopic pregnancy|1|||
163222863|NCT00805935|589533351|FG003|Overall Study|Ectopic pregnancy|0|||
163222864|NCT00805935|589533348|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
163222865|NCT00805935|589533349|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
163222866|NCT00805935|589533350|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
163222867|NCT00805935|589533351|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
163222868|NCT01539226|589533352|FG000|Overall Study|Withdrawal by Subject|24|||
163222869|NCT01539226|589533353|FG001|Overall Study|Withdrawal by Subject|54|||
163222870|NCT01539226|589533352|FG000|Overall Study|Lost to Follow-up|20|||
163222871|NCT01539226|589533353|FG001|Overall Study|Lost to Follow-up|54|||
163222872|NCT01539226|589533352|FG000|Overall Study|Death|1|||
163222873|NCT01539226|589533353|FG001|Overall Study|Death|2|||
163222874|NCT01539226|589533352|FG000|Overall Study|Adverse Event|2|||
163222875|NCT01539226|589533353|FG001|Overall Study|Adverse Event|0|||
163222876|NCT01539226|589533352|FG000|Overall Study|Pregnancy|13|||
163222877|NCT01539226|589533353|FG001|Overall Study|Pregnancy|29|||
163222878|NCT01539226|589533352|FG000|Overall Study|inappropriate enrollment|0|||
163222879|NCT01539226|589533353|FG001|Overall Study|inappropriate enrollment|1|||
163222880|NCT01539226|589533352|FG000|Overall Study|Multiple Reasons|3|||
163222881|NCT01539226|589533353|FG001|Overall Study|Multiple Reasons|1|||
163222882|NCT01539226|589533352|FG000|Overall Study|not HIV seroconversion-related|93|||
163222883|NCT01539226|589533353|FG001|Overall Study|not HIV seroconversion-related|176|||
163222884|NCT01539226|589533352|FG000|Overall Study|HIV seroconversion-related|55|||
163222885|NCT01539226|589533353|FG001|Overall Study|HIV seroconversion-related|80|||
163222886|NCT01539226|589533352|FG000|Overall Study|Non-compliance|6|||
163222887|NCT01539226|589533353|FG001|Overall Study|Non-compliance|8|||
163222888|NCT00283439|589533354|FG000|Overall Study|Adverse Event|0|||
163222889|NCT00283439|589533355|FG001|Overall Study|Adverse Event|0|||
163222890|NCT00283439|589533356|FG002|Overall Study|Adverse Event|0|||
163222891|NCT00283439|589533357|FG003|Overall Study|Adverse Event|1|||
163222892|NCT00283439|589533354|FG000|Overall Study|Death|0|||
163222893|NCT00283439|589533355|FG001|Overall Study|Death|0|||
163222894|NCT00283439|589533356|FG002|Overall Study|Death|1|||
163340116|NCT00103857|589953150|FG002|54-Week Base Study|non-compliance with study procedures|0|||
163340117|NCT00103857|589953151|FG003|54-Week Base Study|non-compliance with study procedures|0|||
163340118|NCT00103857|589953152|FG004|54-Week Base Study|non-compliance with study procedures|0|||
163340119|NCT00103857|589953153|FG005|54-Week Base Study|non-compliance with study procedures|2|||
163340120|NCT00103857|589953154|FG006|54-Week Base Study|non-compliance with study procedures|0|||
163340121|NCT00103857|589953148|FG000|54-Week Base Study|patient incarcerated|0|||
163340122|NCT00103857|589953149|FG001|54-Week Base Study|patient incarcerated|0|||
163340123|NCT00103857|589953150|FG002|54-Week Base Study|patient incarcerated|0|||
163340124|NCT00103857|589953151|FG003|54-Week Base Study|patient incarcerated|0|||
163340125|NCT00103857|589953152|FG004|54-Week Base Study|patient incarcerated|1|||
163340126|NCT00103857|589953153|FG005|54-Week Base Study|patient incarcerated|1|||
163340127|NCT00103857|589953154|FG006|54-Week Base Study|patient incarcerated|0|||
163340128|NCT00103857|589953148|FG000|54-Week Base Study|laboratory reporting error|0|||
163340129|NCT00103857|589953149|FG001|54-Week Base Study|laboratory reporting error|0|||
163340130|NCT00103857|589953150|FG002|54-Week Base Study|laboratory reporting error|0|||
163340131|NCT00103857|589953151|FG003|54-Week Base Study|laboratory reporting error|0|||
163340132|NCT00103857|589953152|FG004|54-Week Base Study|laboratory reporting error|1|||
163340133|NCT00103857|589953153|FG005|54-Week Base Study|laboratory reporting error|0|||
163340134|NCT00103857|589953154|FG006|54-Week Base Study|laboratory reporting error|0|||
163340135|NCT00103857|589953148|FG000|54-Week Base Study|site error|0|||
163340136|NCT00103857|589953149|FG001|54-Week Base Study|site error|0|||
163340137|NCT00103857|589953150|FG002|54-Week Base Study|site error|0|||
163222895|NCT00283439|589533357|FG003|Overall Study|Death|0|||
163222896|NCT00283439|589533354|FG000|Overall Study|Disease progression|0|||
163222897|NCT00283439|589533355|FG001|Overall Study|Disease progression|1|||
163114855|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
163114856|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
163114857|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
163114858|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
163114859|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163114860|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
163114861|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163114862|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163114863|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163114864|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163114865|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163114866|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
163114867|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
163114868|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
163114869|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
163114870|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
163114871|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
163114872|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
163114873|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
163114874|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
163114875|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
163114876|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
163114877|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
163114878|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163114879|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
163114880|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
163114881|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163114882|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163114883|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163114884|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163114885|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163114886|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114887|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114888|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
163114889|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114890|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
163114891|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114892|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114893|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114894|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114895|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114896|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
163114897|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
163114898|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
163114899|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
163114900|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
163114901|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
163114902|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
163114903|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
163114904|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
163114905|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
163114906|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114907|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114908|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114909|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
163114910|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
163114911|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114912|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114913|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114914|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114915|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114916|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
163114917|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163114918|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
163114919|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
163114920|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
163114921|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163114922|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163114923|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163114924|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163114925|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163114926|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
163114927|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114928|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114929|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114930|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
163114931|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114932|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114933|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114934|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114935|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114936|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114937|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114938|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114939|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114940|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
163114941|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114942|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114943|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114944|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114945|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114946|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
163114947|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
163114948|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
163114949|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
163114950|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
163114951|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
163114952|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
163114953|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
163222898|NCT00283439|589533356|FG002|Overall Study|Disease progression|0|||
163222899|NCT00283439|589533357|FG003|Overall Study|Disease progression|0|||
163222900|NCT00283439|589533354|FG000|Overall Study|Requirement for alternative therapy|1|||
163222901|NCT00283439|589533355|FG001|Overall Study|Requirement for alternative therapy|2|||
163222902|NCT00283439|589533356|FG002|Overall Study|Requirement for alternative therapy|5|||
163340138|NCT00103857|589953151|FG003|54-Week Base Study|site error|0|||
163340139|NCT00103857|589953152|FG004|54-Week Base Study|site error|0|||
163340140|NCT00103857|589953153|FG005|54-Week Base Study|site error|1|||
163340141|NCT00103857|589953154|FG006|54-Week Base Study|site error|0|||
163407914|NCT00328627|590203964|FG003|Overall Study|Protocol Violation|8|||
163222903|NCT00283439|589533357|FG003|Overall Study|Requirement for alternative therapy|2|||
163222904|NCT00283439|589533354|FG000|Overall Study|Stem cell transplant|6|||
163222905|NCT00283439|589533355|FG001|Overall Study|Stem cell transplant|6|||
163222906|NCT00283439|589533356|FG002|Overall Study|Stem cell transplant|4|||
163222907|NCT00283439|589533357|FG003|Overall Study|Stem cell transplant|3|||
163222908|NCT00283439|589533354|FG000|Overall Study|Treatment discontinued|0|||
163222909|NCT00283439|589533355|FG001|Overall Study|Treatment discontinued|2|||
163222910|NCT00283439|589533356|FG002|Overall Study|Treatment discontinued|1|||
163222911|NCT00283439|589533357|FG003|Overall Study|Treatment discontinued|3|||
163222912|NCT00283439|589533354|FG000|Overall Study|Other|1|||
163222913|NCT00283439|589533355|FG001|Overall Study|Other|0|||
163222914|NCT00283439|589533356|FG002|Overall Study|Other|0|||
163114954|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
163114955|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
163114956|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
163114957|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114958|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114959|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114960|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
163114961|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114962|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114963|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114964|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114965|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114966|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
163114967|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
163114968|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
163114969|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
163114970|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
163114971|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
163114972|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
163114973|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
163114974|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
163114975|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
163114976|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Other|5|||
163114977|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Other|1|||
163114978|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Other|0|||
163114979|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Other|3|||
163114980|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Other|0|||
163114981|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Other|0|||
163114982|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Other|0|||
163114983|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Other|0|||
163114984|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Other|0|||
163114985|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Other|0|||
163114986|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114987|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114988|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114989|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114990|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
163114991|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114992|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114993|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114994|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114995|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114996|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Death|0|||
163114997|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Death|0|||
163114998|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Death|0|||
163114999|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Death|0|||
163115000|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Death|0|||
163115001|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Death|1|||
163115002|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Death|0|||
163115003|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Death|1|||
163115004|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Death|1|||
163115005|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Death|1|||
163115006|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115007|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115008|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115009|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115010|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115011|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
163115012|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163222915|NCT00283439|589533357|FG003|Overall Study|Other|0|||
163115013|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115014|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115015|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115016|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115017|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115018|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115019|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115020|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115021|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115022|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115023|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115024|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
163115025|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115026|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
163115027|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
163115028|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
163115029|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
163115030|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
163115031|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
163115032|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
163115033|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
163115034|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
163115035|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
163115036|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163115037|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163115038|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163115039|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163115040|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163115041|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
163115042|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163115043|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
163115044|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
163115045|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
163115046|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163115047|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163115048|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163115049|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163115050|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163115051|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
163115052|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163115053|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
163115054|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
163115055|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163115056|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
163115057|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
163115058|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
163115059|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
163115060|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
163115061|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
163115062|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
163115063|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
163115064|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
163115065|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
163115066|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163115067|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163115068|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163340142|NCT00103857|589953148|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
163115069|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163115070|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163115071|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163115072|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163115073|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163115074|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
163115075|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
163115076|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115077|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115078|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115079|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115080|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115081|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115082|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115083|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
163115084|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115085|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115086|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115087|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115088|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115089|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115090|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115091|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115092|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115093|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
163115094|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115095|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115096|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115097|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115098|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115099|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115100|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115101|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115102|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115103|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
163115104|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
163115105|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115106|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115107|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115108|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115109|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115110|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115111|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
163115112|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115113|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115114|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
163115115|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115116|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115117|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115118|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115119|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115120|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115121|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163407915|NCT00328627|590203965|FG004|Overall Study|Protocol Violation|5|||
163407916|NCT00328627|590203966|FG005|Overall Study|Protocol Violation|5|||
163407917|NCT00328627|590203967|FG006|Overall Study|Protocol Violation|6|||
163115122|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115123|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115124|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115125|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
163115126|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115127|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115128|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115129|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115130|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115131|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115132|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115133|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115134|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
163115135|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
163115136|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115137|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115138|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115139|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115140|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115141|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115142|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115143|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
163115144|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
163115145|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115146|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Other|0|||
163115147|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Other|0|||
163115148|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Other|0|||
163115149|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Other|0|||
163115150|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Other|0|||
163115151|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Other|0|||
163115152|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Other|0|||
163115153|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Other|1|||
163115154|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Other|0|||
163115155|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Other|0|||
163115156|NCT04677660|589127579|FG000|Overall Study|Lost to Follow-up|0|||
163115157|NCT04677660|589127580|FG001|Overall Study|Lost to Follow-up|2|||
163115158|NCT04677660|589127579|FG000|Overall Study|Withdrawal by Subject|0|||
163115159|NCT04677660|589127580|FG001|Overall Study|Withdrawal by Subject|1|||
163115160|NCT04677660|589127579|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
163115161|NCT04677660|589127580|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
163115162|NCT03242772|589127581|FG000|Overall Study|Lost to Follow-up|2|||
163115163|NCT03242772|589127582|FG001|Overall Study|Lost to Follow-up|0|||
163115164|NCT03242772|589127581|FG000|Overall Study|Physician Decision|0|||
163115165|NCT03242772|589127582|FG001|Overall Study|Physician Decision|1|||
163115166|NCT03242772|589127581|FG000|Overall Study|Withdrawal by Subject|1|||
163115167|NCT03242772|589127582|FG001|Overall Study|Withdrawal by Subject|0|||
163115168|NCT02499900|589127583|FG000|Core Study Period|Other|1|||
163115169|NCT02499900|589127584|FG001|Core Study Period|Other|4|||
163115170|NCT02499900|589127583|FG000|Core Study Period|Lost to Follow-up|1|||
163115171|NCT02499900|589127584|FG001|Core Study Period|Lost to Follow-up|2|||
163115172|NCT02499900|589127583|FG000|Core Study Period|Per sponsor request|0|||
163115173|NCT02499900|589127584|FG001|Core Study Period|Per sponsor request|1|||
163340143|NCT00103857|589953149|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
163340144|NCT00103857|589953150|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
163340145|NCT00103857|589953151|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
163340146|NCT00103857|589953152|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
163340147|NCT00103857|589953153|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
163340148|NCT00103857|589953154|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
163340149|NCT00103857|589953148|FG000|50-Week Extension Study|Adverse Event|2|||
163340150|NCT00103857|589953149|FG001|50-Week Extension Study|Adverse Event|3|||
163340151|NCT00103857|589953150|FG002|50-Week Extension Study|Adverse Event|2|||
163115174|NCT02499900|589127583|FG000|Core Study Period|Pregnancy|1|||
163115175|NCT02499900|589127584|FG001|Core Study Period|Pregnancy|0|||
163115176|NCT02499900|589127583|FG000|Core Study Period|Protocol Violation|3|||
163115177|NCT02499900|589127584|FG001|Core Study Period|Protocol Violation|0|||
163115178|NCT02499900|589127583|FG000|Core Study Period|Withdrawal by Subject|11|||
163115179|NCT02499900|589127584|FG001|Core Study Period|Withdrawal by Subject|10|||
163115180|NCT02499900|589127583|FG000|Core Study Period|Adverse Event|18|||
163115181|NCT02499900|589127584|FG001|Core Study Period|Adverse Event|14|||
163115182|NCT02499900|589127583|FG000|Core Study Period|Death|0|||
163115183|NCT02499900|589127584|FG001|Core Study Period|Death|1|||
163115184|NCT02499900|589127583|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
163407918|NCT00328627|590203968|FG007|Overall Study|Protocol Violation|2|||
163407919|NCT00328627|590203969|FG008|Overall Study|Protocol Violation|1|||
163407920|NCT00328627|590203970|FG009|Overall Study|Protocol Violation|4|||
163407921|NCT00328627|590203971|FG010|Overall Study|Protocol Violation|6|||
163407922|NCT00328627|590203972|FG011|Overall Study|Protocol Violation|2|||
163407923|NCT00328627|590203961|FG000|Overall Study|Lost to Follow-up|4|||
163407924|NCT00328627|590203962|FG001|Overall Study|Lost to Follow-up|2|||
163407925|NCT00328627|590203963|FG002|Overall Study|Lost to Follow-up|2|||
163407926|NCT00328627|590203964|FG003|Overall Study|Lost to Follow-up|4|||
163407927|NCT00328627|590203965|FG004|Overall Study|Lost to Follow-up|0|||
163407928|NCT00328627|590203966|FG005|Overall Study|Lost to Follow-up|2|||
163407929|NCT00328627|590203967|FG006|Overall Study|Lost to Follow-up|3|||
163407930|NCT00328627|590203968|FG007|Overall Study|Lost to Follow-up|0|||
163407931|NCT00328627|590203969|FG008|Overall Study|Lost to Follow-up|3|||
163115185|NCT02499900|589127584|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
163115186|NCT02499900|589127583|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
163115187|NCT02499900|589127584|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
163115188|NCT02499900|589127583|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
163115189|NCT02499900|589127584|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
163115190|NCT02499900|589127583|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
163115191|NCT02499900|589127584|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
163115192|NCT02499900|589127583|FG000|Extension Study Period|Adverse Event|2|||
163115193|NCT02499900|589127584|FG001|Extension Study Period|Adverse Event|4|||
163115194|NCT02499900|589127583|FG000|Extension Study Period|Withdrawal by Subject|5|||
163115195|NCT02499900|589127584|FG001|Extension Study Period|Withdrawal by Subject|2|||
163115196|NCT02499900|589127583|FG000|Extension Study Period|Physician Decision|2|||
163115197|NCT02499900|589127584|FG001|Extension Study Period|Physician Decision|5|||
163115198|NCT02499900|589127583|FG000|Extension Study Period|Pregnancy|1|||
163115199|NCT02499900|589127584|FG001|Extension Study Period|Pregnancy|2|||
163115200|NCT02499900|589127583|FG000|Extension Study Period|Lost to Follow-up|2|||
163115201|NCT02499900|589127584|FG001|Extension Study Period|Lost to Follow-up|5|||
163115202|NCT02499900|589127583|FG000|Extension Study Period|Other|0|||
163115203|NCT02499900|589127584|FG001|Extension Study Period|Other|2|||
163115204|NCT01560637|589127585|FG000|Overall Study|Adverse Event|63|||
163115205|NCT01560637|589127585|FG000|Overall Study|Death|69|||
163115206|NCT01560637|589127585|FG000|Overall Study|Lost to Follow-up|8|||
163115207|NCT01560637|589127585|FG000|Overall Study|Protocol Violation|8|||
163115208|NCT01560637|589127585|FG000|Overall Study|Withdrawal by Subject|24|||
163115209|NCT01560637|589127585|FG000|Overall Study|Progressive Disease|20|||
163115210|NCT01560637|589127585|FG000|Overall Study|Other Reason Not Specified|6|||
163115211|NCT01089023|589127590|FG000|Overall Study|Lost to Follow-up|3|||
163115212|NCT01089023|589127590|FG000|Overall Study|Adverse Event|1|||
163115213|NCT01089023|589127590|FG000|Overall Study|Withdrawal by Subject|1|||
163115214|NCT01089023|589127590|FG000|Overall Study|Protocol Violation|1|||
163115215|NCT01089023|589127590|FG000|Overall Study|Lack of Efficacy|1|||
163115216|NCT02434354|589127591|FG000|Overall Study|screen fail|3|||
163115217|NCT01185964|589127595|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
163115218|NCT01185964|589127596|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
163115219|NCT01185964|589127597|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
163115220|NCT01185964|589127598|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
163115221|NCT01185964|589127595|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
163115222|NCT01185964|589127596|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
163115223|NCT01185964|589127597|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
163115224|NCT01185964|589127598|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
163115225|NCT01185964|589127595|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
163115226|NCT01185964|589127596|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
163115227|NCT01185964|589127597|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
163115228|NCT01185964|589127598|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
163115229|NCT01185964|589127595|FG000|Phase 1b and Phase 2|Adverse Event|1|||
163115230|NCT01185964|589127596|FG001|Phase 1b and Phase 2|Adverse Event|0|||
163115231|NCT01185964|589127597|FG002|Phase 1b and Phase 2|Adverse Event|2|||
163115232|NCT01185964|589127598|FG003|Phase 1b and Phase 2|Adverse Event|0|||
163115233|NCT01185964|589127595|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
163115234|NCT01185964|589127596|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
163115235|NCT01185964|589127597|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
163115236|NCT01185964|589127598|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
163115237|NCT01185964|589127595|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
163115238|NCT01185964|589127596|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
163407932|NCT00328627|590203970|FG009|Overall Study|Lost to Follow-up|2|||
163407933|NCT00328627|590203971|FG010|Overall Study|Lost to Follow-up|0|||
163407934|NCT00328627|590203972|FG011|Overall Study|Lost to Follow-up|1|||
163407935|NCT00328627|590203961|FG000|Overall Study|Withdrawal by Subject|5|||
163407936|NCT00328627|590203962|FG001|Overall Study|Withdrawal by Subject|4|||
163115239|NCT01185964|589127597|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
163115240|NCT01185964|589127598|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
163115241|NCT01185964|589127595|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
163115242|NCT01185964|589127596|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
163115243|NCT01185964|589127597|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
163115244|NCT01185964|589127598|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
163115245|NCT01185964|589127595|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
163115246|NCT01185964|589127596|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
163115247|NCT01185964|589127597|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
163115248|NCT01185964|589127598|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
163115249|NCT04962230|589127612|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
163115250|NCT04962230|589127612|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
163115251|NCT03576755|589127613|FG000|Overall Study|Withdrawal by Subject|1|||
163115252|NCT03576755|589127614|FG001|Overall Study|Withdrawal by Subject|0|||
163115253|NCT03576755|589127615|FG002|Overall Study|Withdrawal by Subject|0|||
163115254|NCT03576755|589127616|FG003|Overall Study|Withdrawal by Subject|0|||
163115255|NCT01646645|589127617|FG000|Overall Study|No Treated|1|||
163115256|NCT01646645|589127617|FG000|Overall Study|Inevaluable Donor|29|||
163115257|NCT00717522|589127618|FG000|Overall Study|Disease Progression|5|||
163115258|NCT00717522|589127618|FG000|Overall Study|Adverse Event|1|||
163115259|NCT00717522|589127618|FG000|Overall Study|Death|1|||
163115260|NCT01799239|589127619|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
163115261|NCT01799239|589127620|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
163115262|NCT01799239|589127619|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
163115263|NCT01799239|589127620|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
163115264|NCT01799239|589127619|FG000|Period 1 (7 Days)|Protocol Violation|0|||
163115265|NCT01799239|589127620|FG001|Period 1 (7 Days)|Protocol Violation|1|||
163115266|NCT01799239|589127619|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
163115267|NCT01799239|589127620|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
163115268|NCT01799239|589127619|FG000|Period 2 (7 Days)|Protocol Violation|1|||
163115269|NCT01799239|589127620|FG001|Period 2 (7 Days)|Protocol Violation|0|||
163115270|NCT04209114|589127621|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
163115271|NCT04209114|589127622|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
163115272|NCT04209114|589127623|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
163115273|NCT04209114|589127621|FG000|Pre-Treatment Phase|Other reasons|0|||
163115274|NCT04209114|589127622|FG001|Pre-Treatment Phase|Other reasons|0|||
163115275|NCT04209114|589127623|FG002|Pre-Treatment Phase|Other reasons|1|||
163115276|NCT04209114|589127621|FG000|Pre-Treatment Phase|Death|0|||
163115277|NCT04209114|589127622|FG001|Pre-Treatment Phase|Death|0|||
163115278|NCT04209114|589127623|FG002|Pre-Treatment Phase|Death|1|||
163115279|NCT04209114|589127621|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
163115280|NCT04209114|589127622|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
163115281|NCT04209114|589127623|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
163115282|NCT04209114|589127621|FG000|Treatment Phase|Other reasons|5|||
163115283|NCT04209114|589127622|FG001|Treatment Phase|Other reasons|3|||
163115284|NCT04209114|589127623|FG002|Treatment Phase|Other reasons|0|||
163115285|NCT04209114|589127621|FG000|Treatment Phase|Lost to Follow-up|1|||
163115286|NCT04209114|589127622|FG001|Treatment Phase|Lost to Follow-up|0|||
163115287|NCT04209114|589127623|FG002|Treatment Phase|Lost to Follow-up|0|||
163115288|NCT04209114|589127621|FG000|Treatment Phase|Participant withdrew consent|1|||
163115289|NCT04209114|589127622|FG001|Treatment Phase|Participant withdrew consent|0|||
163115290|NCT04209114|589127623|FG002|Treatment Phase|Participant withdrew consent|0|||
163115291|NCT04209114|589127621|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
163115292|NCT04209114|589127622|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
163115293|NCT04209114|589127623|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
163115294|NCT04209114|589127621|FG000|Treatment Phase|Death|4|||
163115295|NCT04209114|589127622|FG001|Treatment Phase|Death|1|||
163115296|NCT04209114|589127623|FG002|Treatment Phase|Death|0|||
163115297|NCT04209114|589127621|FG000|Treatment Phase|Study drug toxicity|4|||
163115298|NCT04209114|589127622|FG001|Treatment Phase|Study drug toxicity|6|||
163115299|NCT04209114|589127623|FG002|Treatment Phase|Study drug toxicity|0|||
163115300|NCT04209114|589127621|FG000|Treatment Phase|Disease progression|6|||
163115301|NCT04209114|589127622|FG001|Treatment Phase|Disease progression|9|||
163115302|NCT04209114|589127623|FG002|Treatment Phase|Disease progression|0|||
163115303|NCT02210832|589129461|FG000|Overall Study|Pregnancy termination .|3|||
163115304|NCT02210832|589129462|FG001|Overall Study|Pregnancy termination .|4|||
163115305|NCT02210832|589129463|FG002|Overall Study|Pregnancy termination .|1|||
163115306|NCT02210832|589129461|FG000|Overall Study|Lost to Follow-up|26|||
163115307|NCT02210832|589129462|FG001|Overall Study|Lost to Follow-up|32|||
163115308|NCT02210832|589129463|FG002|Overall Study|Lost to Follow-up|17|||
163115309|NCT00471887|589129466|FG000|Overall Study|Adverse Event|9|||
163115310|NCT03710876|589129471|FG000|Overall Study|Death|0|||
163115311|NCT03710876|589129472|FG001|Overall Study|Death|2|||
163115312|NCT03710876|589129471|FG000|Overall Study|Withdrawal by Subject|0|||
163222916|NCT01218516|589533358|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
163222917|NCT01218516|589533359|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
163222918|NCT01218516|589533360|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
163222919|NCT01218516|589533361|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
163222920|NCT01218516|589533358|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
163222921|NCT01218516|589533359|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
163222922|NCT01218516|589533360|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
163222923|NCT01218516|589533361|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
163222924|NCT01218516|589533358|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
163222925|NCT01218516|589533359|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
163222926|NCT01218516|589533360|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
163222927|NCT01218516|589533361|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
163222928|NCT01218516|589533358|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
163222929|NCT01218516|589533359|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
163222930|NCT01218516|589533360|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
163222931|NCT01218516|589533361|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
163222932|NCT01218516|589533358|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
163222933|NCT01218516|589533359|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
163222934|NCT01218516|589533360|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
163222935|NCT01218516|589533361|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
163222936|NCT01218516|589533358|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
163222937|NCT01218516|589533359|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
163222938|NCT01218516|589533360|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
163222939|NCT01218516|589533361|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
163222940|NCT01218516|589533358|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
163222941|NCT01218516|589533359|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
163222942|NCT01218516|589533360|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
163222943|NCT01218516|589533361|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
163222944|NCT01218516|589533358|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
163222945|NCT01218516|589533359|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
163222946|NCT01218516|589533360|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
163222947|NCT01218516|589533361|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
163222948|NCT01218516|589533358|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
163222949|NCT01218516|589533359|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
163222950|NCT01218516|589533360|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
163222951|NCT01218516|589533361|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
163222952|NCT01218516|589533358|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
163222953|NCT01218516|589533359|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
163222954|NCT01218516|589533360|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
163222955|NCT01218516|589533361|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
163222956|NCT01218516|589533358|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
163222957|NCT01218516|589533359|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
163222958|NCT01218516|589533360|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
163222959|NCT01218516|589533361|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
163222960|NCT01218516|589533358|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
163222961|NCT01218516|589533359|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
163222962|NCT01218516|589533360|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
163222963|NCT01218516|589533361|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
163222964|NCT01632891|589533362|FG000|Overall Study|Lost to Follow-up|0|||
163222965|NCT01632891|589533363|FG001|Overall Study|Lost to Follow-up|1|||
163222966|NCT01632891|589533362|FG000|Overall Study|Withdrawal by Subject|1|||
163407937|NCT00328627|590203963|FG002|Overall Study|Withdrawal by Subject|5|||
163407938|NCT00328627|590203964|FG003|Overall Study|Withdrawal by Subject|6|||
163115313|NCT03710876|589129472|FG001|Overall Study|Withdrawal by Subject|2|||
163115314|NCT01278407|589129473|FG000|Confirmatory Phase|Adverse Event|5|||
163115315|NCT01278407|589129474|FG001|Confirmatory Phase|Adverse Event|10|||
163115316|NCT01278407|589129475|FG002|Confirmatory Phase|Adverse Event|1|||
163115317|NCT01278407|589129476|FG003|Confirmatory Phase|Adverse Event|0|||
163115318|NCT01278407|589129477|FG004|Confirmatory Phase|Adverse Event|0|||
163115319|NCT01278407|589129473|FG000|Confirmatory Phase|Participant's Choice|3|||
163115320|NCT01278407|589129474|FG001|Confirmatory Phase|Participant's Choice|5|||
163115321|NCT01278407|589129475|FG002|Confirmatory Phase|Participant's Choice|3|||
163115322|NCT01278407|589129476|FG003|Confirmatory Phase|Participant's Choice|0|||
163115323|NCT01278407|589129477|FG004|Confirmatory Phase|Participant's Choice|0|||
163115324|NCT01278407|589129473|FG000|Confirmatory Phase|Other|1|||
163115325|NCT01278407|589129474|FG001|Confirmatory Phase|Other|1|||
163115326|NCT01278407|589129475|FG002|Confirmatory Phase|Other|2|||
163115327|NCT01278407|589129476|FG003|Confirmatory Phase|Other|0|||
163115328|NCT01278407|589129477|FG004|Confirmatory Phase|Other|0|||
163115329|NCT01278407|589129473|FG000|Extension Phase|Adverse Event|0|||
163115330|NCT01278407|589129474|FG001|Extension Phase|Adverse Event|0|||
163115331|NCT01278407|589129475|FG002|Extension Phase|Adverse Event|0|||
163115332|NCT01278407|589129476|FG003|Extension Phase|Adverse Event|7|||
163115333|NCT01278407|589129477|FG004|Extension Phase|Adverse Event|16|||
163115334|NCT01278407|589129473|FG000|Extension Phase|Participant's Choice|0|||
163115335|NCT01278407|589129474|FG001|Extension Phase|Participant's Choice|0|||
163115336|NCT01278407|589129475|FG002|Extension Phase|Participant's Choice|0|||
163115337|NCT01278407|589129476|FG003|Extension Phase|Participant's Choice|4|||
163115338|NCT01278407|589129477|FG004|Extension Phase|Participant's Choice|11|||
163115339|NCT01278407|589129473|FG000|Extension Phase|Other|0|||
163115340|NCT01278407|589129474|FG001|Extension Phase|Other|0|||
163115341|NCT01278407|589129475|FG002|Extension Phase|Other|0|||
163115342|NCT01278407|589129476|FG003|Extension Phase|Other|1|||
163115343|NCT01278407|589129477|FG004|Extension Phase|Other|3|||
163115344|NCT02534935|589129479|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
163115345|NCT02534935|589129480|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
163115346|NCT02534935|589129481|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
163115347|NCT02534935|589129479|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
163115348|NCT02534935|589129480|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
163115349|NCT02534935|589129481|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
163115350|NCT02534935|589129479|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
163115351|NCT02534935|589129480|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
163115352|NCT02534935|589129481|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
163115353|NCT02534935|589129479|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
163115354|NCT02534935|589129480|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
163115355|NCT02534935|589129481|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
163115356|NCT02534935|589129479|FG000|Stage 1: 24 Months|Adverse Event|0|||
163115357|NCT02534935|589129480|FG001|Stage 1: 24 Months|Adverse Event|2|||
163115358|NCT02534935|589129481|FG002|Stage 1: 24 Months|Adverse Event|0|||
163115359|NCT02534935|589129479|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
163115360|NCT02534935|589129480|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
163115361|NCT02534935|589129481|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
163115362|NCT02534935|589129479|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
163115363|NCT02534935|589129480|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
163115364|NCT02534935|589129481|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
163115365|NCT01460719|589129482|FG000|Overall Study|Adverse Event|1|||
163115366|NCT01460719|589129482|FG000|Overall Study|Withdrawal by Subject|1|||
163115367|NCT03602885|589129488|FG000|Overall Study|Lost to Follow-up|3|||
163115368|NCT03602885|589129489|FG001|Overall Study|Lost to Follow-up|0|||
163115369|NCT01007123|589129494|FG000|Overall Study|Adverse Event|3|||
163115370|NCT01007123|589129495|FG001|Overall Study|Adverse Event|4|||
163115371|NCT01007123|589129496|FG002|Overall Study|Adverse Event|7|||
163115372|NCT01007123|589129497|FG003|Overall Study|Adverse Event|1|||
163115373|NCT01007123|589129494|FG000|Overall Study|Lack of Efficacy|1|||
163115374|NCT01007123|589129495|FG001|Overall Study|Lack of Efficacy|0|||
163115375|NCT01007123|589129496|FG002|Overall Study|Lack of Efficacy|1|||
163115376|NCT01007123|589129497|FG003|Overall Study|Lack of Efficacy|4|||
163115377|NCT01007123|589129494|FG000|Overall Study|Protocol Violation|1|||
163115378|NCT01007123|589129495|FG001|Overall Study|Protocol Violation|1|||
163115379|NCT01007123|589129496|FG002|Overall Study|Protocol Violation|2|||
163115380|NCT01007123|589129497|FG003|Overall Study|Protocol Violation|1|||
163115381|NCT01007123|589129494|FG000|Overall Study|Withdrawal by Subject|1|||
163115382|NCT01007123|589129495|FG001|Overall Study|Withdrawal by Subject|0|||
163115383|NCT01007123|589129496|FG002|Overall Study|Withdrawal by Subject|1|||
163115384|NCT01007123|589129497|FG003|Overall Study|Withdrawal by Subject|0|||
163115385|NCT01007123|589129494|FG000|Overall Study|Lost to Follow-up|0|||
163115386|NCT01007123|589129495|FG001|Overall Study|Lost to Follow-up|1|||
163115387|NCT01007123|589129496|FG002|Overall Study|Lost to Follow-up|0|||
163115388|NCT01007123|589129497|FG003|Overall Study|Lost to Follow-up|0|||
163115389|NCT02838901|589129498|FG000|Overall Study|Withdrawal by Subject|1|||
163115390|NCT02838901|589129499|FG001|Overall Study|Withdrawal by Subject|1|||
163115391|NCT02838901|589129498|FG000|Overall Study|Lost to Follow-up|1|||
163115392|NCT02838901|589129499|FG001|Overall Study|Lost to Follow-up|1|||
163115393|NCT04431713|589129500|FG000|Overall Study|Withdrawal by Subject|2|||
163115394|NCT04431713|589129501|FG001|Overall Study|Withdrawal by Subject|0|||
163115395|NCT04431713|589129500|FG000|Overall Study|Death|2|||
163115396|NCT04431713|589129501|FG001|Overall Study|Death|2|||
163115397|NCT02285114|589129503|FG000|Main Phase|Investigator's Discretion|0|||
163115398|NCT02285114|589129504|FG001|Main Phase|Investigator's Discretion|2|||
163115399|NCT02285114|589129505|FG002|Main Phase|Investigator's Discretion|0|||
163115400|NCT02285114|589129506|FG003|Main Phase|Investigator's Discretion|0|||
163115401|NCT02285114|589129507|FG004|Main Phase|Investigator's Discretion|0|||
163115402|NCT02285114|589129508|FG005|Main Phase|Investigator's Discretion|0|||
163115403|NCT02285114|589129503|FG000|Main Phase|Enrolled but Never Treated|1|||
163115404|NCT02285114|589129504|FG001|Main Phase|Enrolled but Never Treated|0|||
163115405|NCT02285114|589129505|FG002|Main Phase|Enrolled but Never Treated|0|||
163115406|NCT02285114|589129506|FG003|Main Phase|Enrolled but Never Treated|0|||
163115407|NCT02285114|589129507|FG004|Main Phase|Enrolled but Never Treated|0|||
163115408|NCT02285114|589129508|FG005|Main Phase|Enrolled but Never Treated|0|||
163115409|NCT02285114|589129503|FG000|Main Phase|Withdrew Consent|0|||
163115410|NCT02285114|589129504|FG001|Main Phase|Withdrew Consent|0|||
163115411|NCT02285114|589129505|FG002|Main Phase|Withdrew Consent|1|||
163115412|NCT02285114|589129506|FG003|Main Phase|Withdrew Consent|0|||
163115413|NCT02285114|589129507|FG004|Main Phase|Withdrew Consent|0|||
163115414|NCT02285114|589129508|FG005|Main Phase|Withdrew Consent|0|||
163115415|NCT02285114|589129503|FG000|Extension Phase|Investigator's Discretion|0|||
163115416|NCT02285114|589129504|FG001|Extension Phase|Investigator's Discretion|0|||
163115417|NCT02285114|589129505|FG002|Extension Phase|Investigator's Discretion|0|||
163115418|NCT02285114|589129506|FG003|Extension Phase|Investigator's Discretion|14|||
163115419|NCT02285114|589129507|FG004|Extension Phase|Investigator's Discretion|1|||
163115420|NCT02285114|589129508|FG005|Extension Phase|Investigator's Discretion|0|||
163115421|NCT02285114|589129503|FG000|Extension Phase|Lost to Follow-up|0|||
163115422|NCT02285114|589129504|FG001|Extension Phase|Lost to Follow-up|0|||
163115423|NCT02285114|589129505|FG002|Extension Phase|Lost to Follow-up|0|||
163115424|NCT02285114|589129506|FG003|Extension Phase|Lost to Follow-up|1|||
163115425|NCT02285114|589129507|FG004|Extension Phase|Lost to Follow-up|1|||
163115426|NCT02285114|589129508|FG005|Extension Phase|Lost to Follow-up|0|||
163115427|NCT02285114|589129503|FG000|Extension Phase|Non-compliance with Study Drug|0|||
163115428|NCT02285114|589129504|FG001|Extension Phase|Non-compliance with Study Drug|0|||
163115429|NCT02285114|589129505|FG002|Extension Phase|Non-compliance with Study Drug|0|||
163115430|NCT02285114|589129506|FG003|Extension Phase|Non-compliance with Study Drug|2|||
163115431|NCT02285114|589129507|FG004|Extension Phase|Non-compliance with Study Drug|0|||
163115432|NCT02285114|589129508|FG005|Extension Phase|Non-compliance with Study Drug|0|||
163115433|NCT02285114|589129503|FG000|Extension Phase|Pregnancy|0|||
163115434|NCT02285114|589129504|FG001|Extension Phase|Pregnancy|0|||
163115435|NCT02285114|589129505|FG002|Extension Phase|Pregnancy|0|||
163115436|NCT02285114|589129506|FG003|Extension Phase|Pregnancy|1|||
163115437|NCT02285114|589129507|FG004|Extension Phase|Pregnancy|0|||
163115438|NCT02285114|589129508|FG005|Extension Phase|Pregnancy|0|||
163115439|NCT00320255|589129509|FG000|Overall Study|Lack of Efficacy|1|||
163115440|NCT00320255|589129510|FG001|Overall Study|Lack of Efficacy|0|||
163115441|NCT00320255|589129511|FG002|Overall Study|Lack of Efficacy|0|||
163115442|NCT00320255|589129512|FG003|Overall Study|Lack of Efficacy|0|||
163115443|NCT00320255|589129513|FG004|Overall Study|Lack of Efficacy|0|||
163115444|NCT00320255|589129514|FG005|Overall Study|Lack of Efficacy|0|||
163115445|NCT00320255|589129509|FG000|Overall Study|Adverse Event|5|||
163115446|NCT00320255|589129510|FG001|Overall Study|Adverse Event|2|||
163115447|NCT00320255|589129511|FG002|Overall Study|Adverse Event|3|||
163115448|NCT00320255|589129512|FG003|Overall Study|Adverse Event|2|||
163115449|NCT00320255|589129513|FG004|Overall Study|Adverse Event|0|||
163115450|NCT00320255|589129514|FG005|Overall Study|Adverse Event|0|||
163115451|NCT00320255|589129509|FG000|Overall Study|Withdrawal by Subject|1|||
163115452|NCT00320255|589129510|FG001|Overall Study|Withdrawal by Subject|2|||
163115453|NCT00320255|589129511|FG002|Overall Study|Withdrawal by Subject|2|||
163115454|NCT00320255|589129512|FG003|Overall Study|Withdrawal by Subject|4|||
163115455|NCT00320255|589129513|FG004|Overall Study|Withdrawal by Subject|0|||
163115456|NCT00320255|589129514|FG005|Overall Study|Withdrawal by Subject|0|||
163115457|NCT00320255|589129509|FG000|Overall Study|Poor compliance/noncompliance|1|||
163115458|NCT00320255|589129510|FG001|Overall Study|Poor compliance/noncompliance|1|||
163115459|NCT00320255|589129511|FG002|Overall Study|Poor compliance/noncompliance|0|||
163115460|NCT00320255|589129512|FG003|Overall Study|Poor compliance/noncompliance|1|||
163115461|NCT00320255|589129513|FG004|Overall Study|Poor compliance/noncompliance|0|||
163115462|NCT00320255|589129514|FG005|Overall Study|Poor compliance/noncompliance|0|||
163115463|NCT00320255|589129509|FG000|Overall Study|No longer meets study criteria|0|||
163115464|NCT00320255|589129510|FG001|Overall Study|No longer meets study criteria|0|||
163115465|NCT00320255|589129511|FG002|Overall Study|No longer meets study criteria|0|||
163115466|NCT00320255|589129512|FG003|Overall Study|No longer meets study criteria|1|||
163115467|NCT00320255|589129513|FG004|Overall Study|No longer meets study criteria|0|||
163115468|NCT00320255|589129514|FG005|Overall Study|No longer meets study criteria|0|||
163115469|NCT00320255|589129509|FG000|Overall Study|Other|3|||
163115470|NCT00320255|589129510|FG001|Overall Study|Other|2|||
163115471|NCT00320255|589129511|FG002|Overall Study|Other|1|||
163115472|NCT00320255|589129512|FG003|Overall Study|Other|0|||
163115473|NCT00320255|589129513|FG004|Overall Study|Other|0|||
163115474|NCT00320255|589129514|FG005|Overall Study|Other|0|||
163115475|NCT00683917|589129517|FG000|Overall Study|Study prematurely terminated|10|||
163115476|NCT03022097|589129523|FG000|Overall Study|Adverse Event|3|||
163115477|NCT03022097|589129524|FG001|Overall Study|Adverse Event|4|||
163115478|NCT03022097|589129525|FG002|Overall Study|Adverse Event|1|||
163115479|NCT03022097|589129526|FG003|Overall Study|Adverse Event|3|||
163115480|NCT03022097|589129523|FG000|Overall Study|Progressive Disease|2|||
163115481|NCT03022097|589129524|FG001|Overall Study|Progressive Disease|0|||
163115482|NCT03022097|589129525|FG002|Overall Study|Progressive Disease|5|||
163115483|NCT03022097|589129526|FG003|Overall Study|Progressive Disease|2|||
163115484|NCT03022097|589129523|FG000|Overall Study|Lack of Efficacy|0|||
163115485|NCT03022097|589129524|FG001|Overall Study|Lack of Efficacy|0|||
163115486|NCT03022097|589129525|FG002|Overall Study|Lack of Efficacy|3|||
163115487|NCT03022097|589129526|FG003|Overall Study|Lack of Efficacy|3|||
163115488|NCT03022097|589129523|FG000|Overall Study|Protocol Violation|1|||
163115489|NCT03022097|589129524|FG001|Overall Study|Protocol Violation|0|||
163115490|NCT03022097|589129525|FG002|Overall Study|Protocol Violation|1|||
163115491|NCT03022097|589129526|FG003|Overall Study|Protocol Violation|0|||
163115492|NCT03022097|589129523|FG000|Overall Study|Withdrawal by Subject|11|||
163115493|NCT03022097|589129524|FG001|Overall Study|Withdrawal by Subject|13|||
163115494|NCT03022097|589129525|FG002|Overall Study|Withdrawal by Subject|15|||
163115495|NCT03022097|589129526|FG003|Overall Study|Withdrawal by Subject|21|||
163115496|NCT03022097|589129523|FG000|Overall Study|Lost to Follow-up|0|||
163115497|NCT03022097|589129524|FG001|Overall Study|Lost to Follow-up|0|||
163115498|NCT03022097|589129525|FG002|Overall Study|Lost to Follow-up|1|||
163115499|NCT03022097|589129526|FG003|Overall Study|Lost to Follow-up|1|||
163115500|NCT03022097|589129523|FG000|Overall Study|Other|4|||
163115501|NCT03022097|589129524|FG001|Overall Study|Other|1|||
163115502|NCT03022097|589129525|FG002|Overall Study|Other|6|||
163115503|NCT03022097|589129526|FG003|Overall Study|Other|4|||
163115504|NCT03022097|589129523|FG000|Overall Study|Due to COVID-19 pandemic|0|||
163115505|NCT03022097|589129524|FG001|Overall Study|Due to COVID-19 pandemic|1|||
163115506|NCT03022097|589129525|FG002|Overall Study|Due to COVID-19 pandemic|0|||
163115507|NCT03022097|589129526|FG003|Overall Study|Due to COVID-19 pandemic|0|||
163115508|NCT00623545|589129527|FG000|Overall Study|Adverse Event|6|||
163115509|NCT00623545|589129527|FG000|Overall Study|Withdrawal by Subject|4|||
163115510|NCT00445848|589129528|FG000|Overall Study|Adverse Event|14|||
163115511|NCT00445848|589129528|FG000|Overall Study|Withdrawal by Subject|4|||
163115512|NCT00445848|589129528|FG000|Overall Study|Progression|62|||
163115513|NCT00445848|589129528|FG000|Overall Study|Other-Not protocol specified|5|||
163115514|NCT05605691|589129529|FG000|Overall Study|Lost to Follow-up|1|||
163115515|NCT00855933|589129531|FG000|Overall Study|Withdrawal by Subject|0|||
163115516|NCT00855933|589129532|FG001|Overall Study|Withdrawal by Subject|1|||
163115517|NCT05463744|589129533|FG000|Treatment Period|Withdrawal by Subject|19|||
163115518|NCT05463744|589129534|FG001|Treatment Period|Withdrawal by Subject|16|||
163115519|NCT05463744|589129533|FG000|Treatment Period|Adverse Event|4|||
163115520|NCT05463744|589129534|FG001|Treatment Period|Adverse Event|4|||
163115521|NCT05463744|589129533|FG000|Treatment Period|Pregnancy|0|||
163115522|NCT05463744|589129534|FG001|Treatment Period|Pregnancy|3|||
163115523|NCT05463744|589129533|FG000|Treatment Period|Lost to Follow-up|1|||
163115524|NCT05463744|589129534|FG001|Treatment Period|Lost to Follow-up|3|||
163115525|NCT05463744|589129533|FG000|Treatment Period|Inadvertent enrollment|2|||
163115526|NCT05463744|589129534|FG001|Treatment Period|Inadvertent enrollment|1|||
163115527|NCT05463744|589129533|FG000|Treatment Period|Death|0|||
163115528|NCT05463744|589129534|FG001|Treatment Period|Death|1|||
163115529|NCT05463744|589129533|FG000|Treatment Period|Non-compliance with Study Drug|1|||
163115530|NCT05463744|589129534|FG001|Treatment Period|Non-compliance with Study Drug|0|||
163115531|NCT05463744|589129533|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
163115532|NCT05463744|589129534|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
163115533|NCT05463744|589129533|FG000|Treatment Period|Physician Decision|0|||
163115534|NCT05463744|589129534|FG001|Treatment Period|Physician Decision|1|||
163115535|NCT05463744|589129533|FG000|Follow-Up Period|Withdrawal by Subject|3|||
163115536|NCT05463744|589129534|FG001|Follow-Up Period|Withdrawal by Subject|1|||
163115537|NCT05463744|589129533|FG000|Follow-Up Period|Lost to Follow-up|1|||
163115538|NCT05463744|589129534|FG001|Follow-Up Period|Lost to Follow-up|1|||
163115539|NCT02851407|589129535|FG000|Overall Study|Withdrawal by parent/guardian|2|||
163115540|NCT02851407|589129536|FG001|Overall Study|Withdrawal by parent/guardian|7|||
163115541|NCT02851407|589129535|FG000|Overall Study|Protocol deviation|0|||
163115542|NCT02851407|589129536|FG001|Overall Study|Protocol deviation|1|||
163115543|NCT02851407|589129535|FG000|Overall Study|Transferred to another hospital to continue|1|||
163115544|NCT02851407|589129536|FG001|Overall Study|Transferred to another hospital to continue|0|||
163115545|NCT02851407|589129535|FG000|Overall Study|Other Death|30|||
163115546|NCT02851407|589129536|FG001|Overall Study|Other Death|20|||
163115547|NCT02851407|589129535|FG000|Overall Study|Adverse event, serious fatal|6|||
163115548|NCT02851407|589129536|FG001|Overall Study|Adverse event, serious fatal|8|||
163115549|NCT02851407|589129535|FG000|Overall Study|Consent withdrawn by participant|5|||
163115550|NCT02851407|589129536|FG001|Overall Study|Consent withdrawn by participant|3|||
163115551|NCT02851407|589129535|FG000|Overall Study|Screen failure|2|||
163115552|NCT02851407|589129536|FG001|Overall Study|Screen failure|1|||
163115553|NCT02851407|589129535|FG000|Overall Study|Disease relapse|9|||
163115554|NCT02851407|589129536|FG001|Overall Study|Disease relapse|6|||
163115555|NCT02851407|589129535|FG000|Overall Study|Physician Decision|7|||
163115556|NCT02851407|589129536|FG001|Overall Study|Physician Decision|6|||
163115557|NCT02851407|589129535|FG000|Overall Study|Transferred to hospital closer to home|0|||
163115558|NCT02851407|589129536|FG001|Overall Study|Transferred to hospital closer to home|1|||
163115559|NCT02851407|589129535|FG000|Overall Study|Enrolled in an investigational study|0|||
163115560|NCT02851407|589129536|FG001|Overall Study|Enrolled in an investigational study|1|||
163115561|NCT02851407|589129535|FG000|Overall Study|Early recovery|1|||
163115562|NCT02851407|589129536|FG001|Overall Study|Early recovery|0|||
163115563|NCT02851407|589129535|FG000|Overall Study|Adverse event, non-fatal|7|||
163115564|NCT02851407|589129536|FG001|Overall Study|Adverse event, non-fatal|5|||
163115565|NCT02851407|589129535|FG000|Overall Study|Lost to Follow-up|0|||
163115566|NCT02851407|589129536|FG001|Overall Study|Lost to Follow-up|2|||
163115567|NCT03385265|589129540|FG000|Overall Study|Withdrawal by Subject|5|||
163115568|NCT03385265|589129541|FG001|Overall Study|Withdrawal by Subject|2|||
163115569|NCT03385265|589129542|FG002|Overall Study|Withdrawal by Subject|5|||
163115570|NCT03385265|589129543|FG003|Overall Study|Withdrawal by Subject|2|||
163115571|NCT04465877|589129547|FG000|Overall Study|Noncompliant with study requirements|0|||
163115572|NCT04465877|589129548|FG001|Overall Study|Noncompliant with study requirements|0|||
163115573|NCT04465877|589129549|FG002|Overall Study|Noncompliant with study requirements|1|||
163115574|NCT04465877|589129550|FG003|Overall Study|Noncompliant with study requirements|0|||
163115575|NCT03440918|589129551|FG000|Overall Study|Protocol Violation|0|||
163115576|NCT03440918|589129552|FG001|Overall Study|Protocol Violation|16|||
163115577|NCT04346108|589129553|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
163115578|NCT04346108|589129554|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
163115579|NCT04346108|589129555|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
163115580|NCT04346108|589129553|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
163115581|NCT04346108|589129554|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
163115582|NCT04346108|589129555|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
163115583|NCT01598753|589129556|FG000|Overall Study|Adverse Event|1|||
163115584|NCT01598753|589129557|FG001|Overall Study|Adverse Event|9|||
163115585|NCT01598753|589129558|FG002|Overall Study|Adverse Event|1|||
163115586|NCT01598753|589129559|FG003|Overall Study|Adverse Event|7|||
163115587|NCT01598753|589129556|FG000|Overall Study|Lost to Follow-up|4|||
163115588|NCT01598753|589129557|FG001|Overall Study|Lost to Follow-up|3|||
163115589|NCT01598753|589129558|FG002|Overall Study|Lost to Follow-up|7|||
163115590|NCT01598753|589129559|FG003|Overall Study|Lost to Follow-up|5|||
163115591|NCT01598753|589129556|FG000|Overall Study|Physician Decision|0|||
163115592|NCT01598753|589129557|FG001|Overall Study|Physician Decision|1|||
163115593|NCT01598753|589129558|FG002|Overall Study|Physician Decision|0|||
163115594|NCT01598753|589129559|FG003|Overall Study|Physician Decision|2|||
163115595|NCT01598753|589129556|FG000|Overall Study|Withdrawal by Subject|7|||
163115596|NCT01598753|589129557|FG001|Overall Study|Withdrawal by Subject|2|||
163115597|NCT01598753|589129558|FG002|Overall Study|Withdrawal by Subject|0|||
163115598|NCT01598753|589129559|FG003|Overall Study|Withdrawal by Subject|1|||
163115599|NCT02275117|589129560|FG000|Overall Study|Adverse Event|0|||
163115600|NCT02275117|589129561|FG001|Overall Study|Adverse Event|0|||
163115601|NCT02275117|589129562|FG002|Overall Study|Adverse Event|0|||
163115602|NCT02275117|589129563|FG003|Overall Study|Adverse Event|0|||
163115603|NCT02275117|589129564|FG004|Overall Study|Adverse Event|1|||
163115604|NCT02275117|589129560|FG000|Overall Study|Lack of Efficacy|6|||
163115605|NCT02275117|589129561|FG001|Overall Study|Lack of Efficacy|7|||
163115606|NCT02275117|589129562|FG002|Overall Study|Lack of Efficacy|5|||
163115607|NCT02275117|589129563|FG003|Overall Study|Lack of Efficacy|2|||
163115608|NCT02275117|589129564|FG004|Overall Study|Lack of Efficacy|10|||
163115609|NCT02275117|589129560|FG000|Overall Study|Lost to Follow-up|11|||
163115610|NCT02275117|589129561|FG001|Overall Study|Lost to Follow-up|16|||
163115611|NCT02275117|589129562|FG002|Overall Study|Lost to Follow-up|15|||
163115612|NCT02275117|589129563|FG003|Overall Study|Lost to Follow-up|16|||
163115613|NCT02275117|589129564|FG004|Overall Study|Lost to Follow-up|8|||
163115614|NCT02275117|589129560|FG000|Overall Study|Physician Decision|0|||
163407939|NCT00328627|590203965|FG004|Overall Study|Withdrawal by Subject|2|||
163115615|NCT02275117|589129561|FG001|Overall Study|Physician Decision|1|||
163115616|NCT02275117|589129562|FG002|Overall Study|Physician Decision|1|||
163115617|NCT02275117|589129563|FG003|Overall Study|Physician Decision|0|||
163115618|NCT02275117|589129564|FG004|Overall Study|Physician Decision|1|||
163115619|NCT02275117|589129560|FG000|Overall Study|Protocol Violation|1|||
163115620|NCT02275117|589129561|FG001|Overall Study|Protocol Violation|0|||
163115621|NCT02275117|589129562|FG002|Overall Study|Protocol Violation|1|||
163115622|NCT02275117|589129563|FG003|Overall Study|Protocol Violation|1|||
163115623|NCT02275117|589129564|FG004|Overall Study|Protocol Violation|0|||
163115624|NCT02275117|589129560|FG000|Overall Study|Withdrawal by Subject|6|||
163222967|NCT01632891|589533363|FG001|Overall Study|Withdrawal by Subject|0|||
163115625|NCT02275117|589129561|FG001|Overall Study|Withdrawal by Subject|4|||
163115626|NCT02275117|589129562|FG002|Overall Study|Withdrawal by Subject|7|||
163115627|NCT02275117|589129563|FG003|Overall Study|Withdrawal by Subject|3|||
163407940|NCT00328627|590203966|FG005|Overall Study|Withdrawal by Subject|5|||
163115628|NCT02275117|589129564|FG004|Overall Study|Withdrawal by Subject|3|||
163115629|NCT02275117|589129560|FG000|Overall Study|Terminated by Sponsor|4|||
163115630|NCT02275117|589129561|FG001|Overall Study|Terminated by Sponsor|4|||
163115631|NCT02275117|589129562|FG002|Overall Study|Terminated by Sponsor|4|||
163115632|NCT02275117|589129563|FG003|Overall Study|Terminated by Sponsor|6|||
163115633|NCT02275117|589129564|FG004|Overall Study|Terminated by Sponsor|4|||
163115634|NCT02275117|589129560|FG000|Overall Study|Worsening of Study Indication|0|||
163115635|NCT02275117|589129561|FG001|Overall Study|Worsening of Study Indication|1|||
163115636|NCT02275117|589129562|FG002|Overall Study|Worsening of Study Indication|2|||
163115637|NCT02275117|589129563|FG003|Overall Study|Worsening of Study Indication|0|||
163115638|NCT02275117|589129564|FG004|Overall Study|Worsening of Study Indication|0|||
163115639|NCT02275117|589129560|FG000|Overall Study|Study Burden|5|||
163115640|NCT02275117|589129561|FG001|Overall Study|Study Burden|4|||
163115641|NCT02275117|589129562|FG002|Overall Study|Study Burden|7|||
163115642|NCT02275117|589129563|FG003|Overall Study|Study Burden|5|||
163115643|NCT02275117|589129564|FG004|Overall Study|Study Burden|7|||
163115644|NCT02275117|589129560|FG000|Overall Study|Other|1|||
163115645|NCT02275117|589129561|FG001|Overall Study|Other|0|||
163115646|NCT02275117|589129562|FG002|Overall Study|Other|0|||
163115647|NCT02275117|589129563|FG003|Overall Study|Other|0|||
163115648|NCT02275117|589129564|FG004|Overall Study|Other|2|||
163115649|NCT01081301|589129568|FG000|Overall Study|Bereaved|3|||
163115650|NCT01081301|589129568|FG000|Overall Study|Too busy|5|||
163115651|NCT01081301|589129568|FG000|Overall Study|Patient too ill|2|||
163115652|NCT01081301|589129568|FG000|Overall Study|Lost to Follow-up|4|||
163115653|NCT01338610|589129569|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
163115654|NCT01338610|589129570|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
163115655|NCT01338610|589129571|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
163115656|NCT01338610|589129569|FG000|Overall Study|Protocol Violation|1|||
163115657|NCT01338610|589129570|FG001|Overall Study|Protocol Violation|0|||
163115658|NCT01338610|589129571|FG002|Overall Study|Protocol Violation|1|||
163115659|NCT01338610|589129569|FG000|Overall Study|Adverse Event|3|||
163115660|NCT01338610|589129570|FG001|Overall Study|Adverse Event|0|||
163115661|NCT01338610|589129571|FG002|Overall Study|Adverse Event|0|||
163115662|NCT02046226|589129572|FG000|Overall Study|Lost to Follow-up|7|||
163115663|NCT01095653|589129573|FG000|Overall Study|Lack of Efficacy|3|||
163115664|NCT01095653|589129574|FG001|Overall Study|Lack of Efficacy|0|||
163115665|NCT01095653|589129575|FG002|Overall Study|Lack of Efficacy|0|||
163115666|NCT01095653|589129573|FG000|Overall Study|Adverse Event|1|||
163115667|NCT01095653|589129574|FG001|Overall Study|Adverse Event|4|||
163115668|NCT01095653|589129575|FG002|Overall Study|Adverse Event|4|||
163115669|NCT01095653|589129573|FG000|Overall Study|Lost to Follow-up|1|||
163115670|NCT01095653|589129574|FG001|Overall Study|Lost to Follow-up|0|||
163115671|NCT01095653|589129575|FG002|Overall Study|Lost to Follow-up|4|||
163115672|NCT01095653|589129573|FG000|Overall Study|Withdrawal by Subject|4|||
163115673|NCT01095653|589129574|FG001|Overall Study|Withdrawal by Subject|5|||
163115674|NCT01095653|589129575|FG002|Overall Study|Withdrawal by Subject|3|||
163115675|NCT01095653|589129573|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
163115676|NCT01095653|589129574|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
163115677|NCT01095653|589129575|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
163115678|NCT02692040|589129576|FG000|Overall Study|Protocol Violation|0|||
163115679|NCT02692040|589129577|FG001|Overall Study|Protocol Violation|0|||
163115680|NCT02692040|589129578|FG002|Overall Study|Protocol Violation|0|||
163115681|NCT02692040|589129579|FG003|Overall Study|Protocol Violation|0|||
163115682|NCT02692040|589129580|FG004|Overall Study|Protocol Violation|0|||
163115683|NCT02692040|589129581|FG005|Overall Study|Protocol Violation|0|||
163115684|NCT02692040|589129582|FG006|Overall Study|Protocol Violation|0|||
163115685|NCT02692040|589129583|FG007|Overall Study|Protocol Violation|0|||
163115686|NCT02692040|589129584|FG008|Overall Study|Protocol Violation|0|||
163115687|NCT02692040|589129585|FG009|Overall Study|Protocol Violation|0|||
163115688|NCT02692040|589129586|FG010|Overall Study|Protocol Violation|0|||
163115689|NCT02692040|589129587|FG011|Overall Study|Protocol Violation|0|||
163115690|NCT02692040|589129588|FG012|Overall Study|Protocol Violation|1|||
163115691|NCT02692040|589129589|FG013|Overall Study|Protocol Violation|0|||
163115692|NCT02692040|589129590|FG014|Overall Study|Protocol Violation|0|||
163115693|NCT02692040|589129591|FG015|Overall Study|Protocol Violation|0|||
163115694|NCT02692040|589129592|FG016|Overall Study|Protocol Violation|0|||
163115695|NCT02692040|589129576|FG000|Overall Study|Adverse Event|0|||
163115696|NCT02692040|589129577|FG001|Overall Study|Adverse Event|0|||
163115697|NCT02692040|589129578|FG002|Overall Study|Adverse Event|0|||
163115698|NCT02692040|589129579|FG003|Overall Study|Adverse Event|0|||
163115699|NCT02692040|589129580|FG004|Overall Study|Adverse Event|0|||
163115700|NCT02692040|589129581|FG005|Overall Study|Adverse Event|0|||
163115701|NCT02692040|589129582|FG006|Overall Study|Adverse Event|0|||
163115702|NCT02692040|589129583|FG007|Overall Study|Adverse Event|0|||
163115703|NCT02692040|589129584|FG008|Overall Study|Adverse Event|0|||
163115704|NCT02692040|589129585|FG009|Overall Study|Adverse Event|0|||
163115705|NCT02692040|589129586|FG010|Overall Study|Adverse Event|0|||
163115706|NCT02692040|589129587|FG011|Overall Study|Adverse Event|0|||
163115707|NCT02692040|589129588|FG012|Overall Study|Adverse Event|0|||
163407941|NCT00328627|590203967|FG006|Overall Study|Withdrawal by Subject|4|||
163115708|NCT02692040|589129589|FG013|Overall Study|Adverse Event|3|||
163115709|NCT02692040|589129590|FG014|Overall Study|Adverse Event|1|||
163115710|NCT02692040|589129591|FG015|Overall Study|Adverse Event|1|||
163115711|NCT02692040|589129592|FG016|Overall Study|Adverse Event|0|||
163115712|NCT00171925|589129596|FG000|Overall Study|Adverse Event|10|||
163115713|NCT00171925|589129597|FG001|Overall Study|Adverse Event|6|||
163115714|NCT00171925|589129596|FG000|Overall Study|Protocol Violation|1|||
163115715|NCT00171925|589129597|FG001|Overall Study|Protocol Violation|1|||
163115716|NCT00171925|589129596|FG000|Overall Study|Withdrawal by Subject|6|||
163115717|NCT00171925|589129597|FG001|Overall Study|Withdrawal by Subject|9|||
163115718|NCT00171925|589129596|FG000|Overall Study|Lost to Follow-up|2|||
163115719|NCT00171925|589129597|FG001|Overall Study|Lost to Follow-up|2|||
163115720|NCT00171925|589129596|FG000|Overall Study|Administrative problems|10|||
163115721|NCT00171925|589129597|FG001|Overall Study|Administrative problems|11|||
163115722|NCT00171925|589129596|FG000|Overall Study|Death|1|||
163115723|NCT00171925|589129597|FG001|Overall Study|Death|2|||
163115724|NCT02836873|589129600|FG000|Overall Study|Protocol Violation|0|||
163115725|NCT02836873|589129601|FG001|Overall Study|Protocol Violation|1|||
163115726|NCT02836873|589129600|FG000|Overall Study|Adverse Event|1|||
163115727|NCT02836873|589129601|FG001|Overall Study|Adverse Event|4|||
163115728|NCT02836873|589129600|FG000|Overall Study|Withdrawal by Subject|2|||
163115729|NCT02836873|589129601|FG001|Overall Study|Withdrawal by Subject|2|||
163115730|NCT02836873|589129600|FG000|Overall Study|Lost to Follow-up|1|||
163115731|NCT02836873|589129601|FG001|Overall Study|Lost to Follow-up|3|||
163115732|NCT02836873|589129600|FG000|Overall Study|Physician Decision|0|||
163115733|NCT02836873|589129601|FG001|Overall Study|Physician Decision|1|||
163115734|NCT02836873|589129600|FG000|Overall Study|Other|1|||
163115735|NCT02836873|589129601|FG001|Overall Study|Other|0|||
163115736|NCT00853125|589129610|FG000|Overall Study|Study participant's donor was CMV +|1|||
163115737|NCT02914548|589129611|FG000|Overall Study|Adverse Event|15|||
163115738|NCT02914548|589129612|FG001|Overall Study|Adverse Event|7|||
163115739|NCT02914548|589129613|FG002|Overall Study|Adverse Event|15|||
163115740|NCT02914548|589129611|FG000|Overall Study|Physician Decision|2|||
163115741|NCT02914548|589129612|FG001|Overall Study|Physician Decision|2|||
163115742|NCT02914548|589129613|FG002|Overall Study|Physician Decision|0|||
163115743|NCT02914548|589129611|FG000|Overall Study|Protocol Violation|1|||
163115744|NCT02914548|589129612|FG001|Overall Study|Protocol Violation|0|||
163115745|NCT02914548|589129613|FG002|Overall Study|Protocol Violation|0|||
163115746|NCT02914548|589129611|FG000|Overall Study|Withdrawal by Subject|3|||
163115747|NCT02914548|589129612|FG001|Overall Study|Withdrawal by Subject|4|||
163115748|NCT02914548|589129613|FG002|Overall Study|Withdrawal by Subject|4|||
163115749|NCT02914548|589129611|FG000|Overall Study|>40% of body surface area|0|||
163115750|NCT02914548|589129612|FG001|Overall Study|>40% of body surface area|1|||
163115751|NCT02914548|589129613|FG002|Overall Study|>40% of body surface area|1|||
163115752|NCT03746600|589129618|FG000|Overall Study|Withdrawal by Subject|3|||
163115753|NCT03746600|589129619|FG001|Overall Study|Withdrawal by Subject|3|||
163115754|NCT03746600|589129618|FG000|Overall Study|dismissed from study|1|||
163115755|NCT03746600|589129619|FG001|Overall Study|dismissed from study|0|||
163115756|NCT03746600|589129618|FG000|Overall Study|Lost to Follow-up|1|||
163115757|NCT03746600|589129619|FG001|Overall Study|Lost to Follow-up|0|||
163115758|NCT02374814|589129627|FG000|Overall Study|Lost to Follow-up|1|||
163115759|NCT02374814|589129628|FG001|Overall Study|Lost to Follow-up|1|||
163115760|NCT02374814|589129629|FG002|Overall Study|Lost to Follow-up|0|||
163115761|NCT02374814|589129630|FG003|Overall Study|Lost to Follow-up|1|||
163115762|NCT02374814|589129631|FG004|Overall Study|Lost to Follow-up|0|||
163115763|NCT02374814|589129632|FG005|Overall Study|Lost to Follow-up|0|||
163115764|NCT02374814|589129627|FG000|Overall Study|Withdrawal by Subject|0|||
163115765|NCT02374814|589129628|FG001|Overall Study|Withdrawal by Subject|0|||
163115766|NCT02374814|589129629|FG002|Overall Study|Withdrawal by Subject|1|||
163115767|NCT02374814|589129630|FG003|Overall Study|Withdrawal by Subject|1|||
163115768|NCT02374814|589129631|FG004|Overall Study|Withdrawal by Subject|0|||
163115769|NCT02374814|589129632|FG005|Overall Study|Withdrawal by Subject|0|||
163115770|NCT00884039|589129633|FG000|Overall Study|Withdrawal by Subject|0|||
163115771|NCT00884039|589129634|FG001|Overall Study|Withdrawal by Subject|1|||
163115772|NCT00884039|589129633|FG000|Overall Study|Lack of Efficacy|2|||
163115773|NCT00884039|589129634|FG001|Overall Study|Lack of Efficacy|0|||
163115774|NCT05291936|589129635|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
163115775|NCT05291936|589129636|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
163115776|NCT05291936|589129635|FG000|Period 1|Withdrew Consent during study|1|||
163115777|NCT05291936|589129636|FG001|Period 1|Withdrew Consent during study|0|||
163115778|NCT05291936|589129635|FG000|Period 2|Adverse Event|0|||
163115779|NCT05291936|589129636|FG001|Period 2|Adverse Event|1|||
163115780|NCT05291936|589129635|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
163115781|NCT05291936|589129636|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
163115782|NCT01300819|589129637|FG000|Overall Study|Adverse Event|9|||
163115783|NCT01300819|589129638|FG001|Overall Study|Adverse Event|27|||
163115784|NCT01300819|589129637|FG000|Overall Study|Lack of Efficacy|2|||
163222968|NCT00240071|589533364|FG000|Overall Study|Withdrawal by Subject|3|||
163222969|NCT04627064|589533372|FG000|Overall Study|Progressive disease|8|||
163115785|NCT01300819|589129638|FG001|Overall Study|Lack of Efficacy|1|||
163115786|NCT01300819|589129637|FG000|Overall Study|Withdrawal by Subject|10|||
163115787|NCT01300819|589129638|FG001|Overall Study|Withdrawal by Subject|12|||
163115788|NCT01300819|589129637|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
163115789|NCT01300819|589129638|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
163115790|NCT01300819|589129637|FG000|Overall Study|Refusal to down titrate study drug|0|||
163115791|NCT01300819|589129638|FG001|Overall Study|Refusal to down titrate study drug|1|||
163115792|NCT01300819|589129637|FG000|Overall Study|Administrative reason|0|||
163115793|NCT01300819|589129638|FG001|Overall Study|Administrative reason|1|||
163115794|NCT01300819|589129637|FG000|Overall Study|Safety follow up not done by mistake|0|||
163115795|NCT01300819|589129638|FG001|Overall Study|Safety follow up not done by mistake|1|||
163115796|NCT01300819|589129637|FG000|Overall Study|Follow up call was not done|1|||
163115797|NCT01300819|589129638|FG001|Overall Study|Follow up call was not done|0|||
163115798|NCT02032407|589132318|FG000|Overall Study|Lost to Follow-up|2|||
163115799|NCT02032407|589132318|FG000|Overall Study|Pregnancy|1|||
163115800|NCT02032407|589132318|FG000|Overall Study|Other Miscellaneous Reasons|2|||
163115801|NCT00428220|589132319|FG000|Overall Study|Participant died|8|||
163115802|NCT00428220|589132319|FG000|Overall Study|Global deterioration of health status|7|||
163115803|NCT00428220|589132319|FG000|Overall Study|Lost to Follow-up|4|||
163115804|NCT00428220|589132319|FG000|Overall Study|Objective progression or relapse|123|||
163115805|NCT00428220|589132319|FG000|Overall Study|Participant refused continued treatment|7|||
163115806|NCT00428220|589132319|FG000|Overall Study|Adverse Event|51|||
163115807|NCT00428220|589132319|FG000|Overall Study|Other|23|||
163115808|NCT00549900|589132320|FG000|Overall Study|Adverse Event|1|||
163115809|NCT01176565|589132327|FG000|Overall Study|Lost to Follow-up|12|||
163115810|NCT01176565|589132328|FG001|Overall Study|Lost to Follow-up|16|||
163115811|NCT01176565|589132327|FG000|Overall Study|Withdrawal by Subject|7|||
163115812|NCT01176565|589132328|FG001|Overall Study|Withdrawal by Subject|1|||
163115813|NCT01176565|589132327|FG000|Overall Study|Not Analyzed (any other reason)|1|||
163115814|NCT01176565|589132328|FG001|Overall Study|Not Analyzed (any other reason)|2|||
163115815|NCT02754141|589132329|FG000|Overall Study|Disease progression|11|||
163115816|NCT02754141|589132330|FG001|Overall Study|Disease progression|7|||
163115817|NCT02754141|589132331|FG002|Overall Study|Disease progression|8|||
163115818|NCT02754141|589132332|FG003|Overall Study|Disease progression|5|||
163115819|NCT02754141|589132333|FG004|Overall Study|Disease progression|7|||
163115820|NCT02754141|589132334|FG005|Overall Study|Disease progression|7|||
163115821|NCT02754141|589132335|FG006|Overall Study|Disease progression|7|||
163115822|NCT02754141|589132336|FG007|Overall Study|Disease progression|6|||
163115823|NCT02754141|589132337|FG008|Overall Study|Disease progression|11|||
163115824|NCT02754141|589132338|FG009|Overall Study|Disease progression|16|||
163115825|NCT02754141|589132339|FG010|Overall Study|Disease progression|18|||
163115826|NCT02754141|589132340|FG011|Overall Study|Disease progression|13|||
163115827|NCT02754141|589132341|FG012|Overall Study|Disease progression|10|||
163115828|NCT02754141|589132342|FG013|Overall Study|Disease progression|12|||
163115829|NCT02754141|589132343|FG014|Overall Study|Disease progression|12|||
163115830|NCT02754141|589132344|FG015|Overall Study|Disease progression|14|||
163115831|NCT02754141|589132345|FG016|Overall Study|Disease progression|0|||
163115832|NCT02754141|589132346|FG017|Overall Study|Disease progression|1|||
163115833|NCT02754141|589132329|FG000|Overall Study|Study drug toxicity|1|||
163115834|NCT02754141|589132330|FG001|Overall Study|Study drug toxicity|1|||
163115835|NCT02754141|589132331|FG002|Overall Study|Study drug toxicity|0|||
163115836|NCT02754141|589132332|FG003|Overall Study|Study drug toxicity|0|||
163115837|NCT02754141|589132333|FG004|Overall Study|Study drug toxicity|0|||
163115838|NCT02754141|589132334|FG005|Overall Study|Study drug toxicity|0|||
163115839|NCT02754141|589132335|FG006|Overall Study|Study drug toxicity|0|||
163115840|NCT02754141|589132336|FG007|Overall Study|Study drug toxicity|0|||
163115841|NCT02754141|589132337|FG008|Overall Study|Study drug toxicity|0|||
163115842|NCT02754141|589132338|FG009|Overall Study|Study drug toxicity|0|||
163115843|NCT02754141|589132339|FG010|Overall Study|Study drug toxicity|2|||
163115844|NCT02754141|589132340|FG011|Overall Study|Study drug toxicity|1|||
163222970|NCT04627064|589533373|FG001|Overall Study|Progressive disease|0|||
163340152|NCT00103857|589953151|FG003|50-Week Extension Study|Adverse Event|0|||
163340153|NCT00103857|589953152|FG004|50-Week Extension Study|Adverse Event|1|||
163115845|NCT02754141|589132341|FG012|Overall Study|Study drug toxicity|1|||
163115846|NCT02754141|589132342|FG013|Overall Study|Study drug toxicity|0|||
163115847|NCT02754141|589132343|FG014|Overall Study|Study drug toxicity|0|||
163340154|NCT00103857|589953153|FG005|50-Week Extension Study|Adverse Event|1|||
163115848|NCT02754141|589132344|FG015|Overall Study|Study drug toxicity|0|||
163115849|NCT02754141|589132345|FG016|Overall Study|Study drug toxicity|0|||
163115850|NCT02754141|589132346|FG017|Overall Study|Study drug toxicity|0|||
163115851|NCT02754141|589132329|FG000|Overall Study|AE unrelated to study drug|1|||
163222971|NCT04627064|589533372|FG000|Overall Study|Withdrawal by Subject|2|||
163115852|NCT02754141|589132330|FG001|Overall Study|AE unrelated to study drug|1|||
163115853|NCT02754141|589132331|FG002|Overall Study|AE unrelated to study drug|0|||
163222972|NCT04627064|589533373|FG001|Overall Study|Withdrawal by Subject|0|||
163340155|NCT00103857|589953154|FG006|50-Week Extension Study|Adverse Event|0|||
163115854|NCT02754141|589132332|FG003|Overall Study|AE unrelated to study drug|1|||
163115855|NCT02754141|589132333|FG004|Overall Study|AE unrelated to study drug|3|||
163115856|NCT02754141|589132334|FG005|Overall Study|AE unrelated to study drug|2|||
163115857|NCT02754141|589132335|FG006|Overall Study|AE unrelated to study drug|1|||
163115858|NCT02754141|589132336|FG007|Overall Study|AE unrelated to study drug|0|||
163115859|NCT02754141|589132337|FG008|Overall Study|AE unrelated to study drug|0|||
163115860|NCT02754141|589132338|FG009|Overall Study|AE unrelated to study drug|0|||
163115861|NCT02754141|589132339|FG010|Overall Study|AE unrelated to study drug|0|||
163115862|NCT02754141|589132340|FG011|Overall Study|AE unrelated to study drug|0|||
163115863|NCT02754141|589132341|FG012|Overall Study|AE unrelated to study drug|0|||
163115864|NCT02754141|589132342|FG013|Overall Study|AE unrelated to study drug|0|||
163115865|NCT02754141|589132343|FG014|Overall Study|AE unrelated to study drug|0|||
163115866|NCT02754141|589132344|FG015|Overall Study|AE unrelated to study drug|0|||
163115867|NCT02754141|589132345|FG016|Overall Study|AE unrelated to study drug|0|||
163115868|NCT02754141|589132346|FG017|Overall Study|AE unrelated to study drug|0|||
163115869|NCT02754141|589132329|FG000|Overall Study|Request to discontinue|0|||
163115870|NCT02754141|589132330|FG001|Overall Study|Request to discontinue|0|||
163115871|NCT02754141|589132331|FG002|Overall Study|Request to discontinue|0|||
163115872|NCT02754141|589132332|FG003|Overall Study|Request to discontinue|0|||
163115873|NCT02754141|589132333|FG004|Overall Study|Request to discontinue|0|||
163115874|NCT02754141|589132334|FG005|Overall Study|Request to discontinue|0|||
163115875|NCT02754141|589132335|FG006|Overall Study|Request to discontinue|0|||
163115876|NCT02754141|589132336|FG007|Overall Study|Request to discontinue|0|||
163115877|NCT02754141|589132337|FG008|Overall Study|Request to discontinue|1|||
163115878|NCT02754141|589132338|FG009|Overall Study|Request to discontinue|0|||
163115879|NCT02754141|589132339|FG010|Overall Study|Request to discontinue|0|||
163115880|NCT02754141|589132340|FG011|Overall Study|Request to discontinue|0|||
163115881|NCT02754141|589132341|FG012|Overall Study|Request to discontinue|0|||
163115882|NCT02754141|589132342|FG013|Overall Study|Request to discontinue|1|||
163115883|NCT02754141|589132343|FG014|Overall Study|Request to discontinue|1|||
163115884|NCT02754141|589132344|FG015|Overall Study|Request to discontinue|0|||
163115885|NCT02754141|589132345|FG016|Overall Study|Request to discontinue|0|||
163115886|NCT02754141|589132346|FG017|Overall Study|Request to discontinue|0|||
163115887|NCT02754141|589132329|FG000|Overall Study|Withdrew consent|0|||
163115888|NCT02754141|589132330|FG001|Overall Study|Withdrew consent|0|||
163115889|NCT02754141|589132331|FG002|Overall Study|Withdrew consent|0|||
163115890|NCT02754141|589132332|FG003|Overall Study|Withdrew consent|0|||
163115891|NCT02754141|589132333|FG004|Overall Study|Withdrew consent|0|||
163115892|NCT02754141|589132334|FG005|Overall Study|Withdrew consent|0|||
163115893|NCT02754141|589132335|FG006|Overall Study|Withdrew consent|0|||
163115894|NCT02754141|589132336|FG007|Overall Study|Withdrew consent|0|||
163115895|NCT02754141|589132337|FG008|Overall Study|Withdrew consent|0|||
163115896|NCT02754141|589132338|FG009|Overall Study|Withdrew consent|1|||
163115897|NCT02754141|589132339|FG010|Overall Study|Withdrew consent|0|||
163115898|NCT02754141|589132340|FG011|Overall Study|Withdrew consent|0|||
163115899|NCT02754141|589132341|FG012|Overall Study|Withdrew consent|0|||
163115900|NCT02754141|589132342|FG013|Overall Study|Withdrew consent|0|||
163115901|NCT02754141|589132343|FG014|Overall Study|Withdrew consent|0|||
163115902|NCT02754141|589132344|FG015|Overall Study|Withdrew consent|0|||
163115903|NCT02754141|589132345|FG016|Overall Study|Withdrew consent|0|||
163115904|NCT02754141|589132346|FG017|Overall Study|Withdrew consent|0|||
163115905|NCT02754141|589132329|FG000|Overall Study|Maximum clinical benefit|0|||
163115906|NCT02754141|589132330|FG001|Overall Study|Maximum clinical benefit|0|||
163115907|NCT02754141|589132331|FG002|Overall Study|Maximum clinical benefit|0|||
163115908|NCT02754141|589132332|FG003|Overall Study|Maximum clinical benefit|1|||
163115909|NCT02754141|589132333|FG004|Overall Study|Maximum clinical benefit|0|||
163115910|NCT02754141|589132334|FG005|Overall Study|Maximum clinical benefit|0|||
163115911|NCT02754141|589132335|FG006|Overall Study|Maximum clinical benefit|0|||
163115912|NCT02754141|589132336|FG007|Overall Study|Maximum clinical benefit|0|||
163340156|NCT00103857|589953148|FG000|50-Week Extension Study|Death|0|||
163340157|NCT00103857|589953149|FG001|50-Week Extension Study|Death|0|||
163340158|NCT00103857|589953150|FG002|50-Week Extension Study|Death|0|||
163340159|NCT00103857|589953151|FG003|50-Week Extension Study|Death|1|||
163340160|NCT00103857|589953152|FG004|50-Week Extension Study|Death|0|||
163340161|NCT00103857|589953153|FG005|50-Week Extension Study|Death|1|||
163407942|NCT00328627|590203968|FG007|Overall Study|Withdrawal by Subject|4|||
163115913|NCT02754141|589132337|FG008|Overall Study|Maximum clinical benefit|0|||
163115914|NCT02754141|589132338|FG009|Overall Study|Maximum clinical benefit|0|||
163115915|NCT02754141|589132339|FG010|Overall Study|Maximum clinical benefit|0|||
163115916|NCT02754141|589132340|FG011|Overall Study|Maximum clinical benefit|0|||
163115917|NCT02754141|589132341|FG012|Overall Study|Maximum clinical benefit|0|||
163115918|NCT02754141|589132342|FG013|Overall Study|Maximum clinical benefit|0|||
163115919|NCT02754141|589132343|FG014|Overall Study|Maximum clinical benefit|0|||
163115920|NCT02754141|589132344|FG015|Overall Study|Maximum clinical benefit|0|||
163115921|NCT02754141|589132345|FG016|Overall Study|Maximum clinical benefit|0|||
163340162|NCT00103857|589953154|FG006|50-Week Extension Study|Death|0|||
163340163|NCT00103857|589953148|FG000|50-Week Extension Study|Lack of Efficacy|26|||
163222973|NCT04627064|589533372|FG000|Overall Study|Physician Decision|1|||
163222974|NCT04627064|589533373|FG001|Overall Study|Physician Decision|0|||
163222975|NCT02086110|589533377|FG000|Overall Study|Withdrawal by Subject|1|||
163222976|NCT02086110|589533378|FG001|Overall Study|Withdrawal by Subject|1|||
163222977|NCT01869192|589533379|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
163222978|NCT01869192|589533380|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
163222979|NCT01869192|589533379|FG000|Postoperative Chemotherapy|Physician Decision|0|||
163222980|NCT01869192|589533380|FG001|Postoperative Chemotherapy|Physician Decision|2|||
163222981|NCT02286193|589533383|FG000|Overall Study|Referred: CRS unable to make contact|62|||
163222982|NCT02286193|589533383|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
163222983|NCT02286193|589533383|FG000|Overall Study|Referred: Declined service|38|||
163222984|NCT00423891|589533384|FG000|Enrolled|Withdrawal by Subject|0|||
163222985|NCT00423891|589533385|FG001|Enrolled|Withdrawal by Subject|0|||
163222986|NCT00423891|589533386|FG002|Enrolled|Withdrawal by Subject|1|||
163222987|NCT00423891|589533384|FG000|Enrolled|Lost to Follow-up|0|||
163222988|NCT00423891|589533385|FG001|Enrolled|Lost to Follow-up|0|||
163222989|NCT00423891|589533386|FG002|Enrolled|Lost to Follow-up|1|||
163222990|NCT00423891|589533384|FG000|Enrolled|No longer met criteria|11|||
163222991|NCT00423891|589533385|FG001|Enrolled|No longer met criteria|2|||
163222992|NCT00423891|589533386|FG002|Enrolled|No longer met criteria|1|||
163222993|NCT00423891|589533384|FG000|Treatment|Withdrawal by Subject|1|||
163222994|NCT00423891|589533385|FG001|Treatment|Withdrawal by Subject|0|||
163222995|NCT00423891|589533386|FG002|Treatment|Withdrawal by Subject|0|||
163222996|NCT00423891|589533384|FG000|Treatment|Lost to Follow-up|1|||
163222997|NCT00423891|589533385|FG001|Treatment|Lost to Follow-up|0|||
163222998|NCT00423891|589533386|FG002|Treatment|Lost to Follow-up|0|||
163222999|NCT00423891|589533384|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
163223000|NCT00423891|589533385|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
163223001|NCT00423891|589533386|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
163223002|NCT00423891|589533384|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
163223003|NCT00423891|589533385|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
163223004|NCT00423891|589533386|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
163223005|NCT04225923|589533408|FG000|Overall Study|Protocol Violation|1|||
163223006|NCT04225923|589533409|FG001|Overall Study|Protocol Violation|0|||
163223007|NCT04225923|589533410|FG002|Overall Study|Protocol Violation|1|||
163223008|NCT04225923|589533408|FG000|Overall Study|Withdrawal by Subject|4|||
163223009|NCT04225923|589533409|FG001|Overall Study|Withdrawal by Subject|1|||
163223010|NCT04225923|589533410|FG002|Overall Study|Withdrawal by Subject|3|||
163223011|NCT04225923|589533408|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
163223012|NCT04225923|589533409|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
163223013|NCT04225923|589533410|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
163223014|NCT01364428|589533416|FG000|Overall Study|Adverse Event|1|||
163223015|NCT01364428|589533417|FG001|Overall Study|Adverse Event|2|||
163223016|NCT01364428|589533416|FG000|Overall Study|Protocol Violation|2|||
163223017|NCT01364428|589533417|FG001|Overall Study|Protocol Violation|0|||
163223018|NCT01364428|589533416|FG000|Overall Study|Withdrawal Criteria|14|||
163223019|NCT01364428|589533417|FG001|Overall Study|Withdrawal Criteria|10|||
163115922|NCT02754141|589132346|FG017|Overall Study|Maximum clinical benefit|0|||
163115923|NCT02754141|589132329|FG000|Overall Study|No longer meets study criteria|0|||
163115924|NCT02754141|589132330|FG001|Overall Study|No longer meets study criteria|0|||
163115925|NCT02754141|589132331|FG002|Overall Study|No longer meets study criteria|0|||
163115926|NCT02754141|589132332|FG003|Overall Study|No longer meets study criteria|1|||
163115927|NCT02754141|589132333|FG004|Overall Study|No longer meets study criteria|0|||
163115928|NCT02754141|589132334|FG005|Overall Study|No longer meets study criteria|0|||
163115929|NCT02754141|589132335|FG006|Overall Study|No longer meets study criteria|0|||
163223020|NCT01364428|589533416|FG000|Overall Study|Other|3|||
163223021|NCT01364428|589533417|FG001|Overall Study|Other|3|||
163223022|NCT01585766|589533418|FG000|Overall Study|Withdrawal by Subject|0|||
163223023|NCT01585766|589533419|FG001|Overall Study|Withdrawal by Subject|1|||
163223024|NCT01585766|589533420|FG002|Overall Study|Withdrawal by Subject|1|||
163223025|NCT01585766|589533421|FG003|Overall Study|Withdrawal by Subject|0|||
163223026|NCT01585766|589533422|FG004|Overall Study|Withdrawal by Subject|0|||
163115930|NCT02754141|589132336|FG007|Overall Study|No longer meets study criteria|0|||
163115931|NCT02754141|589132337|FG008|Overall Study|No longer meets study criteria|0|||
163115932|NCT02754141|589132338|FG009|Overall Study|No longer meets study criteria|0|||
163115933|NCT02754141|589132339|FG010|Overall Study|No longer meets study criteria|0|||
163115934|NCT02754141|589132340|FG011|Overall Study|No longer meets study criteria|0|||
163223027|NCT01585766|589533423|FG005|Overall Study|Withdrawal by Subject|0|||
163223028|NCT01585766|589533418|FG000|Overall Study|Death|0|||
163223029|NCT01585766|589533419|FG001|Overall Study|Death|1|||
163223030|NCT01585766|589533420|FG002|Overall Study|Death|0|||
163223031|NCT01585766|589533421|FG003|Overall Study|Death|0|||
163223032|NCT01585766|589533422|FG004|Overall Study|Death|0|||
163223033|NCT01585766|589533423|FG005|Overall Study|Death|0|||
163223034|NCT01585766|589533418|FG000|Overall Study|Physician Decision|0|||
163115935|NCT02754141|589132341|FG012|Overall Study|No longer meets study criteria|0|||
163223035|NCT01585766|589533419|FG001|Overall Study|Physician Decision|0|||
163223036|NCT01585766|589533420|FG002|Overall Study|Physician Decision|1|||
163223037|NCT01585766|589533421|FG003|Overall Study|Physician Decision|0|||
163223038|NCT01585766|589533422|FG004|Overall Study|Physician Decision|0|||
163223039|NCT01585766|589533423|FG005|Overall Study|Physician Decision|0|||
163223040|NCT01073865|589533424|FG000|Overall Study|Reasons other than below|19|||
163223041|NCT01073865|589533425|FG001|Overall Study|Reasons other than below|31|||
163223042|NCT01073865|589533424|FG000|Overall Study|Lost to Follow-up|1|||
163223043|NCT01073865|589533425|FG001|Overall Study|Lost to Follow-up|1|||
163223044|NCT01073865|589533424|FG000|Overall Study|Death|3|||
163223045|NCT01073865|589533425|FG001|Overall Study|Death|2|||
163223046|NCT01073865|589533424|FG000|Overall Study|Withdrawal by Subject|5|||
163223047|NCT01073865|589533425|FG001|Overall Study|Withdrawal by Subject|5|||
163223048|NCT00696137|589533429|FG000|Overall Study|Withdrawal by Subject|2|||
163223049|NCT04371380|589533430|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
163223050|NCT04371380|589533431|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
163223051|NCT04371380|589533432|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
163223052|NCT02376166|589533433|FG000|Overall Study|Adverse Event|1|||
163223053|NCT02376166|589533433|FG000|Overall Study|Discontinued metformin early|2|||
163223054|NCT01228747|589533436|FG000|Overall Study|Adverse Event|8|||
163223055|NCT01228747|589533437|FG001|Overall Study|Adverse Event|4|||
163115936|NCT02754141|589132342|FG013|Overall Study|No longer meets study criteria|0|||
163115937|NCT02754141|589132343|FG014|Overall Study|No longer meets study criteria|0|||
163115938|NCT02754141|589132344|FG015|Overall Study|No longer meets study criteria|0|||
163115939|NCT02754141|589132345|FG016|Overall Study|No longer meets study criteria|0|||
163115940|NCT02754141|589132346|FG017|Overall Study|No longer meets study criteria|0|||
163115941|NCT02754141|589132329|FG000|Overall Study|Other reasons|0|||
163115942|NCT02754141|589132330|FG001|Overall Study|Other reasons|0|||
163115943|NCT02754141|589132331|FG002|Overall Study|Other reasons|0|||
163115944|NCT02754141|589132332|FG003|Overall Study|Other reasons|0|||
163115945|NCT02754141|589132333|FG004|Overall Study|Other reasons|0|||
163115946|NCT02754141|589132334|FG005|Overall Study|Other reasons|0|||
163115947|NCT02754141|589132335|FG006|Overall Study|Other reasons|0|||
163115948|NCT02754141|589132336|FG007|Overall Study|Other reasons|1|||
163115949|NCT02754141|589132337|FG008|Overall Study|Other reasons|0|||
163115950|NCT02754141|589132338|FG009|Overall Study|Other reasons|0|||
163115951|NCT02754141|589132339|FG010|Overall Study|Other reasons|0|||
163115952|NCT02754141|589132340|FG011|Overall Study|Other reasons|0|||
163115953|NCT02754141|589132341|FG012|Overall Study|Other reasons|2|||
163115954|NCT02754141|589132342|FG013|Overall Study|Other reasons|0|||
163115955|NCT02754141|589132343|FG014|Overall Study|Other reasons|0|||
163115956|NCT02754141|589132344|FG015|Overall Study|Other reasons|0|||
163115957|NCT02754141|589132345|FG016|Overall Study|Other reasons|0|||
163115958|NCT02754141|589132346|FG017|Overall Study|Other reasons|0|||
163115959|NCT02754141|589132329|FG000|Overall Study|Completed treatment as per protocol|0|||
163115960|NCT02754141|589132330|FG001|Overall Study|Completed treatment as per protocol|1|||
163115961|NCT02754141|589132331|FG002|Overall Study|Completed treatment as per protocol|0|||
163115962|NCT02754141|589132332|FG003|Overall Study|Completed treatment as per protocol|0|||
163115963|NCT02754141|589132333|FG004|Overall Study|Completed treatment as per protocol|0|||
163115964|NCT02754141|589132334|FG005|Overall Study|Completed treatment as per protocol|0|||
163115965|NCT02754141|589132335|FG006|Overall Study|Completed treatment as per protocol|0|||
163115966|NCT02754141|589132336|FG007|Overall Study|Completed treatment as per protocol|0|||
163115967|NCT02754141|589132337|FG008|Overall Study|Completed treatment as per protocol|0|||
163115968|NCT02754141|589132338|FG009|Overall Study|Completed treatment as per protocol|0|||
163115969|NCT02754141|589132339|FG010|Overall Study|Completed treatment as per protocol|0|||
163115970|NCT02754141|589132340|FG011|Overall Study|Completed treatment as per protocol|0|||
163115971|NCT02754141|589132341|FG012|Overall Study|Completed treatment as per protocol|1|||
163115972|NCT02754141|589132342|FG013|Overall Study|Completed treatment as per protocol|0|||
163115973|NCT02754141|589132343|FG014|Overall Study|Completed treatment as per protocol|0|||
163115974|NCT02754141|589132344|FG015|Overall Study|Completed treatment as per protocol|0|||
163115975|NCT02754141|589132345|FG016|Overall Study|Completed treatment as per protocol|0|||
163115976|NCT02754141|589132346|FG017|Overall Study|Completed treatment as per protocol|0|||
163115977|NCT02754141|589132329|FG000|Overall Study|Not completing monotherapy|0|||
163115978|NCT02754141|589132330|FG001|Overall Study|Not completing monotherapy|0|||
163115979|NCT02754141|589132331|FG002|Overall Study|Not completing monotherapy|0|||
163115980|NCT02754141|589132332|FG003|Overall Study|Not completing monotherapy|0|||
163115981|NCT02754141|589132333|FG004|Overall Study|Not completing monotherapy|0|||
163115982|NCT02754141|589132334|FG005|Overall Study|Not completing monotherapy|0|||
163115983|NCT02754141|589132335|FG006|Overall Study|Not completing monotherapy|0|||
163115984|NCT02754141|589132336|FG007|Overall Study|Not completing monotherapy|0|||
163223056|NCT01228747|589533436|FG000|Overall Study|Lack of Efficacy|40|||
163115985|NCT02754141|589132337|FG008|Overall Study|Not completing monotherapy|0|||
163223057|NCT01228747|589533437|FG001|Overall Study|Lack of Efficacy|27|||
163223058|NCT01228747|589533436|FG000|Overall Study|Protocol Violation|6|||
163223059|NCT01228747|589533437|FG001|Overall Study|Protocol Violation|5|||
163115986|NCT02754141|589132338|FG009|Overall Study|Not completing monotherapy|0|||
163115987|NCT02754141|589132339|FG010|Overall Study|Not completing monotherapy|0|||
163115988|NCT02754141|589132340|FG011|Overall Study|Not completing monotherapy|0|||
163115989|NCT02754141|589132341|FG012|Overall Study|Not completing monotherapy|0|||
163115990|NCT02754141|589132342|FG013|Overall Study|Not completing monotherapy|1|||
163115991|NCT02754141|589132343|FG014|Overall Study|Not completing monotherapy|0|||
163115992|NCT02754141|589132344|FG015|Overall Study|Not completing monotherapy|0|||
163115993|NCT02754141|589132345|FG016|Overall Study|Not completing monotherapy|0|||
163115994|NCT02754141|589132346|FG017|Overall Study|Not completing monotherapy|0|||
163115995|NCT02680041|589132347|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
163115996|NCT02680041|589132347|FG000|Overall Study|Lost to Follow-up|2|||
163115997|NCT02324205|589132348|FG000|Overall Study|Withdrawal by Subject|37|||
163115998|NCT04239222|589132349|FG000|Baseline|Withdrawal by Subject|0|||
163115999|NCT04239222|589132350|FG001|Baseline|Withdrawal by Subject|0|||
163116000|NCT04239222|589132351|FG002|Baseline|Withdrawal by Subject|1|||
163116001|NCT04239222|589132352|FG003|Baseline|Withdrawal by Subject|1|||
163116002|NCT04239222|589132349|FG000|First Foot Assignment|Withdrawal by Subject|0|||
163116003|NCT04239222|589132350|FG001|First Foot Assignment|Withdrawal by Subject|0|||
163116004|NCT04239222|589132351|FG002|First Foot Assignment|Withdrawal by Subject|1|||
163116005|NCT04239222|589132352|FG003|First Foot Assignment|Withdrawal by Subject|0|||
163116006|NCT04239222|589132349|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
163116007|NCT04239222|589132350|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
163116008|NCT04239222|589132351|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
163116009|NCT04239222|589132352|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
163116010|NCT00937404|589132355|FG000|Overall Study|Protocol Violation|1|||
163116011|NCT00937404|589132355|FG000|Overall Study|Withdrawal by Subject|1|||
163116012|NCT00090233|589132356|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
163116013|NCT00090233|589132357|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
163116014|NCT00090233|589132356|FG000|Overall Study|Adverse Event|214|||
163116015|NCT00090233|589132357|FG001|Overall Study|Adverse Event|198|||
163116016|NCT00090233|589132356|FG000|Overall Study|Lost to Follow-up|68|||
163116017|NCT00090233|589132357|FG001|Overall Study|Lost to Follow-up|95|||
163116018|NCT00090233|589132356|FG000|Overall Study|Protocol Violation|960|||
163116019|NCT00090233|589132357|FG001|Overall Study|Protocol Violation|1022|||
163116020|NCT00090233|589132356|FG000|Overall Study|Withdrawal by Subject|182|||
163116021|NCT00090233|589132357|FG001|Overall Study|Withdrawal by Subject|211|||
163116022|NCT00090233|589132356|FG000|Overall Study|Moved|203|||
163116023|NCT00090233|589132357|FG001|Overall Study|Moved|189|||
163116024|NCT00090233|589132356|FG000|Overall Study|Other|1211|||
163116025|NCT00090233|589132357|FG001|Overall Study|Other|1160|||
163116026|NCT00090233|589132356|FG000|Overall Study|Data not available at data cut-off point|1552|||
163116027|NCT00090233|589132357|FG001|Overall Study|Data not available at data cut-off point|1563|||
163116028|NCT04863248|589132358|FG000|Overall Study|Sponsor Terminated|4|||
163116029|NCT04863248|589132359|FG001|Overall Study|Sponsor Terminated|1|||
163116030|NCT04863248|589132358|FG000|Overall Study|Death|0|||
163116031|NCT04863248|589132359|FG001|Overall Study|Death|1|||
163116032|NCT04863248|589132358|FG000|Overall Study|Withdrawal by Subject|0|||
163116033|NCT04863248|589132359|FG001|Overall Study|Withdrawal by Subject|1|||
163116034|NCT01779869|589132360|FG000|Overall Study|Physician Decision|2|||
163116035|NCT02536300|589132361|FG000|Overall Study|Investigator's Discretion|17|||
163116036|NCT02536300|589132362|FG001|Overall Study|Investigator's Discretion|11|||
163116037|NCT02536300|589132363|FG002|Overall Study|Investigator's Discretion|2|||
163116038|NCT02536300|589132361|FG000|Overall Study|Progressive Disease|11|||
163116039|NCT02536300|589132362|FG001|Overall Study|Progressive Disease|7|||
163116040|NCT02536300|589132363|FG002|Overall Study|Progressive Disease|6|||
163116041|NCT02536300|589132361|FG000|Overall Study|Study Terminated by Sponsor|6|||
163116042|NCT02536300|589132362|FG001|Overall Study|Study Terminated by Sponsor|4|||
163116043|NCT02536300|589132363|FG002|Overall Study|Study Terminated by Sponsor|7|||
163116044|NCT02536300|589132361|FG000|Overall Study|Death|7|||
163116045|NCT02536300|589132362|FG001|Overall Study|Death|0|||
163116046|NCT02536300|589132363|FG002|Overall Study|Death|5|||
163116047|NCT02536300|589132361|FG000|Overall Study|Withdrew Consent|4|||
163116048|NCT02536300|589132362|FG001|Overall Study|Withdrew Consent|2|||
163116049|NCT02536300|589132363|FG002|Overall Study|Withdrew Consent|0|||
163116050|NCT02536300|589132361|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
163116051|NCT02536300|589132362|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
163116052|NCT02536300|589132363|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
163116053|NCT02536300|589132361|FG000|Overall Study|Enrolled but Never Treated|0|||
163116054|NCT02536300|589132362|FG001|Overall Study|Enrolled but Never Treated|0|||
163116055|NCT02536300|589132363|FG002|Overall Study|Enrolled but Never Treated|1|||
163116056|NCT02536300|589132361|FG000|Overall Study|Non-compliance With Study Drug|1|||
163116057|NCT02536300|589132362|FG001|Overall Study|Non-compliance With Study Drug|0|||
163116058|NCT02536300|589132363|FG002|Overall Study|Non-compliance With Study Drug|0|||
163116059|NCT02536300|589132361|FG000|Overall Study|Protocol Violation|0|||
163116060|NCT02536300|589132362|FG001|Overall Study|Protocol Violation|1|||
163223060|NCT01228747|589533436|FG000|Overall Study|Lost to Follow-up|4|||
163223061|NCT01228747|589533437|FG001|Overall Study|Lost to Follow-up|3|||
163223062|NCT01228747|589533436|FG000|Overall Study|Withdrawal by Subject|5|||
163223063|NCT01228747|589533437|FG001|Overall Study|Withdrawal by Subject|1|||
163223064|NCT01228747|589533436|FG000|Overall Study|Other Reason|2|||
163223065|NCT01228747|589533437|FG001|Overall Study|Other Reason|5|||
163223066|NCT02197806|589533441|FG000|Overall Study|Adverse Event|0|||
163223067|NCT02197806|589533442|FG001|Overall Study|Adverse Event|1|||
163223068|NCT02197806|589533443|FG002|Overall Study|Adverse Event|0|||
163223069|NCT02197806|589533444|FG003|Overall Study|Adverse Event|1|||
163223070|NCT00680901|589533445|FG000|Overall Study|Ongoing: On Study Treatment|1|||
163223071|NCT00680901|589533446|FG001|Overall Study|Ongoing: On Study Treatment|0|||
163223072|NCT00680901|589533445|FG000|Overall Study|Ongoing: In Follow Up|1|||
163223073|NCT00680901|589533446|FG001|Overall Study|Ongoing: In Follow Up|0|||
163223074|NCT00680901|589533445|FG000|Overall Study|Adverse Event|1|||
163223075|NCT00680901|589533446|FG001|Overall Study|Adverse Event|1|||
163223076|NCT00680901|589533445|FG000|Overall Study|Lost to Follow-up|3|||
163223077|NCT00680901|589533446|FG001|Overall Study|Lost to Follow-up|5|||
163223078|NCT00680901|589533445|FG000|Overall Study|Subject decided to withdraw from the study|4|||
163223079|NCT00680901|589533446|FG001|Overall Study|Subject decided to withdraw from the study|15|||
163223080|NCT00680901|589533445|FG000|Overall Study|Sponsor decision|1|||
163223081|NCT00680901|589533446|FG001|Overall Study|Sponsor decision|0|||
163223082|NCT00680901|589533445|FG000|Overall Study|Physician Decision|0|||
163223083|NCT00680901|589533446|FG001|Overall Study|Physician Decision|2|||
163223084|NCT00680901|589533445|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
163223085|NCT00680901|589533446|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
163223086|NCT00680901|589533445|FG000|Overall Study|Other protocol defined stopping criteria|17|||
163223087|NCT00680901|589533446|FG001|Overall Study|Other protocol defined stopping criteria|17|||
163223088|NCT04251221|589533449|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
163223089|NCT04251221|589533450|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
163223090|NCT02120794|589533453|FG000|Overall Study|Withdrawal by Subject|43|||
163223091|NCT02120794|589533453|FG000|Overall Study|Adverse Event|10|||
163223092|NCT02120794|589533453|FG000|Overall Study|Physician Decision|4|||
163223093|NCT02120794|589533453|FG000|Overall Study|Due to insurance coverage|1|||
163223094|NCT01148511|589533454|FG000|Exposed to Study Drug|Protocol Violation|2|||
163223095|NCT01148511|589533455|FG001|Exposed to Study Drug|Protocol Violation|0|||
163223096|NCT01148511|589533456|FG002|Exposed to Study Drug|Protocol Violation|0|||
163223097|NCT01148511|589533454|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
163223098|NCT01148511|589533455|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
163223099|NCT01148511|589533456|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
163223100|NCT01148511|589533454|FG000|Randomized|Adverse Event|0|||
163340164|NCT00103857|589953149|FG001|50-Week Extension Study|Lack of Efficacy|15|||
163340165|NCT00103857|589953150|FG002|50-Week Extension Study|Lack of Efficacy|13|||
163340166|NCT00103857|589953151|FG003|50-Week Extension Study|Lack of Efficacy|16|||
163116061|NCT02536300|589132363|FG002|Overall Study|Protocol Violation|0|||
163116062|NCT01691105|589132371|FG000|1 Month Follow-up|Lost to Follow-up|41|||
163116063|NCT01691105|589132372|FG001|1 Month Follow-up|Lost to Follow-up|38|||
163116064|NCT01691105|589132371|FG000|1 Month Follow-up|Death|2|||
163116065|NCT01691105|589132372|FG001|1 Month Follow-up|Death|3|||
163116066|NCT01691105|589132371|FG000|6 Month Follow-up|Lost to Follow-up|39|||
163116067|NCT01691105|589132372|FG001|6 Month Follow-up|Lost to Follow-up|58|||
163116068|NCT01691105|589132371|FG000|6 Month Follow-up|Death|13|||
163116069|NCT01691105|589132372|FG001|6 Month Follow-up|Death|13|||
163116070|NCT01691105|589132371|FG000|12 Month Follow-up|Lost to Follow-up|50|||
163116071|NCT01691105|589132372|FG001|12 Month Follow-up|Lost to Follow-up|71|||
163116072|NCT01691105|589132371|FG000|12 Month Follow-up|Death|22|||
163116073|NCT01691105|589132372|FG001|12 Month Follow-up|Death|30|||
163116074|NCT01691105|589132371|FG000|12 Month Biochemical Verification|Death|22|||
163223101|NCT01148511|589533455|FG001|Randomized|Adverse Event|1|||
163223102|NCT01148511|589533456|FG002|Randomized|Adverse Event|0|||
163223103|NCT01148511|589533454|FG000|Randomized|Protocol Violation|0|||
163223104|NCT01148511|589533455|FG001|Randomized|Protocol Violation|2|||
163223105|NCT01148511|589533456|FG002|Randomized|Protocol Violation|1|||
163340167|NCT00103857|589953152|FG004|50-Week Extension Study|Lack of Efficacy|8|||
163223106|NCT01148511|589533454|FG000|Randomized|Lost to Follow-up|0|||
163223107|NCT01148511|589533455|FG001|Randomized|Lost to Follow-up|1|||
163223108|NCT01148511|589533456|FG002|Randomized|Lost to Follow-up|1|||
163223109|NCT01148511|589533454|FG000|Randomized|Consent withdrawal|0|||
163340168|NCT00103857|589953153|FG005|50-Week Extension Study|Lack of Efficacy|8|||
163116075|NCT01691105|589132372|FG001|12 Month Biochemical Verification|Death|30|||
163223110|NCT01148511|589533455|FG001|Randomized|Consent withdrawal|5|||
163223111|NCT01148511|589533456|FG002|Randomized|Consent withdrawal|3|||
163223112|NCT01148511|589533454|FG000|Randomized|Other|0|||
163223113|NCT01148511|589533455|FG001|Randomized|Other|1|||
163223114|NCT01148511|589533456|FG002|Randomized|Other|1|||
163223115|NCT00969553|589533465|FG000|Overall Study|Progressive disease (PD)|2|||
163116076|NCT01691105|589132371|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
163223116|NCT00969553|589533466|FG001|Overall Study|Progressive disease (PD)|2|||
163223117|NCT00969553|589533467|FG002|Overall Study|Progressive disease (PD)|6|||
163223118|NCT00969553|589533468|FG003|Overall Study|Progressive disease (PD)|9|||
163223119|NCT00969553|589533469|FG004|Overall Study|Progressive disease (PD)|2|||
163223120|NCT00969553|589533470|FG005|Overall Study|Progressive disease (PD)|4|||
163223121|NCT00969553|589533471|FG006|Overall Study|Progressive disease (PD)|2|||
163223122|NCT00969553|589533472|FG007|Overall Study|Progressive disease (PD)|12|||
163223123|NCT00969553|589533473|FG008|Overall Study|Progressive disease (PD)|3|||
163223124|NCT00969553|589533465|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
163223125|NCT00969553|589533466|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
163223126|NCT00969553|589533467|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
163223127|NCT00969553|589533468|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
163223128|NCT00969553|589533469|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
163223129|NCT00969553|589533470|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
163223130|NCT00969553|589533471|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
163223131|NCT00969553|589533472|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
163223132|NCT00969553|589533473|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
163223133|NCT00969553|589533465|FG000|Overall Study|Other Adverse Event|0|||
163223134|NCT00969553|589533466|FG001|Overall Study|Other Adverse Event|0|||
163223135|NCT00969553|589533467|FG002|Overall Study|Other Adverse Event|0|||
163223136|NCT00969553|589533468|FG003|Overall Study|Other Adverse Event|1|||
163223137|NCT00969553|589533469|FG004|Overall Study|Other Adverse Event|0|||
163223138|NCT00969553|589533470|FG005|Overall Study|Other Adverse Event|0|||
163223139|NCT00969553|589533471|FG006|Overall Study|Other Adverse Event|1|||
163223140|NCT00969553|589533472|FG007|Overall Study|Other Adverse Event|0|||
163223141|NCT00969553|589533473|FG008|Overall Study|Other Adverse Event|0|||
163223142|NCT00969553|589533465|FG000|Overall Study|Refused cont. medication|1|||
163223143|NCT00969553|589533466|FG001|Overall Study|Refused cont. medication|1|||
163223144|NCT00969553|589533467|FG002|Overall Study|Refused cont. medication|0|||
163223145|NCT00969553|589533468|FG003|Overall Study|Refused cont. medication|2|||
163223146|NCT00969553|589533469|FG004|Overall Study|Refused cont. medication|0|||
163223147|NCT00969553|589533470|FG005|Overall Study|Refused cont. medication|0|||
163223148|NCT00969553|589533471|FG006|Overall Study|Refused cont. medication|0|||
163223149|NCT00969553|589533472|FG007|Overall Study|Refused cont. medication|1|||
163223150|NCT00969553|589533473|FG008|Overall Study|Refused cont. medication|0|||
163223151|NCT00969553|589533465|FG000|Overall Study|Not specified above|0|||
163223152|NCT00969553|589533466|FG001|Overall Study|Not specified above|0|||
163223153|NCT00969553|589533467|FG002|Overall Study|Not specified above|0|||
163223154|NCT00969553|589533468|FG003|Overall Study|Not specified above|4|||
163223155|NCT00969553|589533469|FG004|Overall Study|Not specified above|0|||
163223156|NCT00969553|589533470|FG005|Overall Study|Not specified above|0|||
163223157|NCT00969553|589533471|FG006|Overall Study|Not specified above|1|||
163223158|NCT00969553|589533472|FG007|Overall Study|Not specified above|1|||
163340169|NCT00103857|589953154|FG006|50-Week Extension Study|Lack of Efficacy|0|||
163116077|NCT01691105|589132372|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
163116078|NCT01691105|589132371|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
163116079|NCT01691105|589132372|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
163116080|NCT00957944|589132373|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
163116081|NCT00957944|589132374|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
163116082|NCT01482169|589132376|FG000|Overall Study|Physician Decision|2|||
163116083|NCT01777542|589132379|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
163116084|NCT01777542|589132380|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
163116085|NCT01030874|589132383|FG000|Overall Study|Withdrawal by Subject|1|||
163116086|NCT01030874|589132384|FG001|Overall Study|Withdrawal by Subject|0|||
163116087|NCT01030874|589132383|FG000|Overall Study|Discharged in first 2 weeks|17|||
163116088|NCT01030874|589132384|FG001|Overall Study|Discharged in first 2 weeks|16|||
163116089|NCT00869050|589132390|FG000|Overall Study|Screen Failure|3|||
163116090|NCT03298984|589132396|FG000|Overall Study|Physician Decision|1|||
163116091|NCT03298984|589132397|FG001|Overall Study|Physician Decision|0|||
163116092|NCT03298984|589132398|FG002|Overall Study|Physician Decision|0|||
163116093|NCT03298984|589132399|FG003|Overall Study|Physician Decision|6|||
163116094|NCT03298984|589132396|FG000|Overall Study|Lack of Efficacy|0|||
163116095|NCT03298984|589132397|FG001|Overall Study|Lack of Efficacy|1|||
163116096|NCT03298984|589132398|FG002|Overall Study|Lack of Efficacy|1|||
163223159|NCT00969553|589533473|FG008|Overall Study|Not specified above|0|||
163223160|NCT04243538|589533474|FG000|Overall Study|Withdrawal by Subject|0|||
163223161|NCT04243538|589533475|FG001|Overall Study|Withdrawal by Subject|2|||
163223162|NCT04243538|589533474|FG000|Overall Study|Lost to Follow-up|0|||
163223163|NCT04243538|589533475|FG001|Overall Study|Lost to Follow-up|3|||
163223164|NCT04536727|589533476|FG000|Overall Study|Lost to Follow-up|1|||
163223165|NCT04536727|589533477|FG001|Overall Study|Lost to Follow-up|1|||
163223166|NCT04536727|589533476|FG000|Overall Study|Death|0|||
163223167|NCT04536727|589533477|FG001|Overall Study|Death|1|||
163223168|NCT00500370|589533478|FG000|Overall Study|Adverse Event|9|||
163223169|NCT00500370|589533479|FG001|Overall Study|Adverse Event|3|||
163223170|NCT00500370|589533478|FG000|Overall Study|Lost to Follow-up|10|||
163116097|NCT03298984|589132399|FG003|Overall Study|Lack of Efficacy|4|||
163116098|NCT03298984|589132396|FG000|Overall Study|Relapsed disease (following remission)|0|||
163116099|NCT03298984|589132397|FG001|Overall Study|Relapsed disease (following remission)|0|||
163116100|NCT03298984|589132398|FG002|Overall Study|Relapsed disease (following remission)|1|||
163116101|NCT03298984|589132399|FG003|Overall Study|Relapsed disease (following remission)|1|||
163116102|NCT03298984|589132396|FG000|Overall Study|Adverse Event|0|||
163116103|NCT03298984|589132397|FG001|Overall Study|Adverse Event|0|||
163116104|NCT03298984|589132398|FG002|Overall Study|Adverse Event|0|||
163116105|NCT03298984|589132399|FG003|Overall Study|Adverse Event|1|||
163116106|NCT03298984|589132396|FG000|Overall Study|Death|0|||
163116107|NCT03298984|589132397|FG001|Overall Study|Death|0|||
163116108|NCT03298984|589132398|FG002|Overall Study|Death|0|||
163116109|NCT03298984|589132399|FG003|Overall Study|Death|2|||
163116110|NCT03298984|589132396|FG000|Overall Study|Insurance Company Decision|0|||
163116111|NCT03298984|589132397|FG001|Overall Study|Insurance Company Decision|0|||
163116112|NCT03298984|589132398|FG002|Overall Study|Insurance Company Decision|0|||
163116113|NCT03298984|589132399|FG003|Overall Study|Insurance Company Decision|1|||
163116114|NCT01571284|589132400|FG000|Overall Study|Participant's decision|84|||
163116115|NCT01571284|589132400|FG000|Overall Study|Lost to Follow-up|3|||
163116116|NCT01571284|589132400|FG000|Overall Study|Enrolled but not treated|2|||
163116117|NCT01571284|589132400|FG000|Overall Study|Other than specified above|80|||
163116118|NCT03883113|589132419|FG000|Overall Study|Physician Decision|4|||
163116119|NCT03883113|589132420|FG001|Overall Study|Physician Decision|2|||
163116120|NCT03883113|589132419|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
163116121|NCT03883113|589132420|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
163116122|NCT03883113|589132419|FG000|Overall Study|Pregnancy|1|||
163116123|NCT03883113|589132420|FG001|Overall Study|Pregnancy|0|||
163116124|NCT03883113|589132419|FG000|Overall Study|Adverse Event|0|||
163116125|NCT03883113|589132420|FG001|Overall Study|Adverse Event|1|||
163116126|NCT03883113|589132419|FG000|Overall Study|Withdrawal by Subject|1|||
163116127|NCT03883113|589132420|FG001|Overall Study|Withdrawal by Subject|2|||
163116128|NCT03883113|589132419|FG000|Overall Study|Lost to Follow-up|1|||
163116129|NCT03883113|589132420|FG001|Overall Study|Lost to Follow-up|0|||
163116130|NCT02323204|589132426|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
163116131|NCT02323204|589132427|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
163116132|NCT02323204|589132428|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
163116133|NCT02323204|589132429|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
163116134|NCT02323204|589132426|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
163116135|NCT02323204|589132427|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
163116136|NCT02323204|589132428|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
163116137|NCT02323204|589132429|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
163116138|NCT02323204|589132426|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
163116139|NCT02323204|589132427|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
163116140|NCT02323204|589132428|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
163116141|NCT02323204|589132429|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
163116142|NCT02323204|589132426|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
163116143|NCT02323204|589132427|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
163116144|NCT02323204|589132428|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
163116145|NCT02323204|589132429|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
163116146|NCT02323204|589132426|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
163116147|NCT02323204|589132427|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
163116148|NCT02323204|589132428|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
163116149|NCT02323204|589132429|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
163116150|NCT02323204|589132426|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
163116151|NCT02323204|589132427|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
163116152|NCT02323204|589132428|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
163116153|NCT02323204|589132429|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
163116154|NCT02323204|589132426|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
163116155|NCT02323204|589132427|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
163116156|NCT02323204|589132428|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
163116157|NCT02323204|589132429|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
163116158|NCT02323204|589132426|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
163116159|NCT02323204|589132427|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
163116160|NCT02323204|589132428|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
163116161|NCT02323204|589132429|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
163116162|NCT02323204|589132426|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
163116163|NCT02323204|589132427|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
163116164|NCT02323204|589132428|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
163223171|NCT00500370|589533479|FG001|Overall Study|Lost to Follow-up|10|||
163407943|NCT00328627|590203969|FG008|Overall Study|Withdrawal by Subject|4|||
163407944|NCT00328627|590203970|FG009|Overall Study|Withdrawal by Subject|5|||
163116165|NCT02323204|589132429|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
163116166|NCT02014480|589132430|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
163116167|NCT02014480|589132431|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
163116168|NCT02014480|589132432|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
163116169|NCT02014480|589132433|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
163116170|NCT02014480|589132434|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
163116171|NCT02014480|589132435|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
163116172|NCT02014480|589132430|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163116173|NCT02014480|589132431|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163116174|NCT02014480|589132432|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163116175|NCT02014480|589132433|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
163116176|NCT02014480|589132434|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163116177|NCT02014480|589132435|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163116178|NCT02014480|589132430|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163116179|NCT02014480|589132431|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163116180|NCT02014480|589132432|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
163116181|NCT02014480|589132433|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163116182|NCT02014480|589132434|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163116183|NCT02014480|589132435|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163116184|NCT02014480|589132430|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
163116185|NCT02014480|589132431|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
163116186|NCT02014480|589132432|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
163116187|NCT02014480|589132433|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
163116188|NCT02014480|589132434|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163116189|NCT02014480|589132435|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163116190|NCT02014480|589132430|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163116191|NCT02014480|589132431|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
163116192|NCT02014480|589132432|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163116193|NCT02014480|589132433|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163116194|NCT02014480|589132434|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163116195|NCT02014480|589132435|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163116196|NCT02014480|589132430|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
163116197|NCT02014480|589132431|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
163116198|NCT02014480|589132432|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
163116199|NCT02014480|589132433|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
163116200|NCT02014480|589132434|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
163116201|NCT02014480|589132435|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
163116202|NCT02014480|589132430|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163116203|NCT02014480|589132431|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163116204|NCT02014480|589132432|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163116205|NCT02014480|589132433|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163116206|NCT02014480|589132434|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163116207|NCT02014480|589132435|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
163116208|NCT00724854|589132436|FG000|Overall Study|Lack of Efficacy|187|||
163116209|NCT00724854|589132437|FG001|Overall Study|Lack of Efficacy|13|||
163116210|NCT00724854|589132436|FG000|Overall Study|Lost to Follow-up|87|||
163116211|NCT00724854|589132437|FG001|Overall Study|Lost to Follow-up|10|||
163116212|NCT00724854|589132436|FG000|Overall Study|Adverse Event|62|||
163116213|NCT00724854|589132437|FG001|Overall Study|Adverse Event|4|||
163116214|NCT00724854|589132436|FG000|Overall Study|Other|42|||
163116215|NCT00724854|589132437|FG001|Overall Study|Other|3|||
163223172|NCT00500370|589533478|FG000|Overall Study|Protocol Violation|2|||
163223173|NCT00500370|589533479|FG001|Overall Study|Protocol Violation|4|||
163223174|NCT00500370|589533478|FG000|Overall Study|Sponsor Decision|2|||
163223175|NCT00500370|589533479|FG001|Overall Study|Sponsor Decision|0|||
163223176|NCT00500370|589533478|FG000|Overall Study|Subject Decision|10|||
163223177|NCT00500370|589533479|FG001|Overall Study|Subject Decision|17|||
163223178|NCT05308901|589535200|FG000|Overall Study|Death|6|||
163223179|NCT02586012|589535201|FG000|Overall Study|Withdrawal by Subject|1|||
163223180|NCT02586012|589535202|FG001|Overall Study|Withdrawal by Subject|1|||
163223181|NCT02586012|589535203|FG002|Overall Study|Withdrawal by Subject|0|||
163223182|NCT02586012|589535204|FG003|Overall Study|Withdrawal by Subject|1|||
163223183|NCT02586012|589535205|FG004|Overall Study|Withdrawal by Subject|0|||
163116216|NCT00724854|589132436|FG000|Overall Study|Death|11|||
163116217|NCT00724854|589132437|FG001|Overall Study|Death|0|||
163116218|NCT00724854|589132436|FG000|Overall Study|Change of treatment|7|||
163116219|NCT00724854|589132437|FG001|Overall Study|Change of treatment|0|||
163116220|NCT00724854|589132436|FG000|Overall Study|Withdrawal by Subject|5|||
163116221|NCT00724854|589132437|FG001|Overall Study|Withdrawal by Subject|0|||
163116222|NCT00724854|589132436|FG000|Overall Study|Adverse event + lack of efficacy|2|||
163223184|NCT02586012|589535206|FG005|Overall Study|Withdrawal by Subject|2|||
163223185|NCT02586012|589535201|FG000|Overall Study|Protocol Violation|0|||
163223186|NCT02586012|589535202|FG001|Overall Study|Protocol Violation|0|||
163116223|NCT00724854|589132437|FG001|Overall Study|Adverse event + lack of efficacy|1|||
163116224|NCT01865812|589132438|FG000|Primary Treatment Phase|Adverse Event|2|||
163116225|NCT01865812|589132439|FG001|Primary Treatment Phase|Adverse Event|0|||
163116226|NCT01865812|589132438|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
163116227|NCT01865812|589132439|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
163116228|NCT01865812|589132438|FG000|Long-term Safety Extension Phase|Pruritus|0|||
163116229|NCT01865812|589132439|FG001|Long-term Safety Extension Phase|Pruritus|3|||
163116230|NCT01865812|589132438|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
163116231|NCT01865812|589132439|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
163116232|NCT01865812|589132438|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
163116233|NCT01865812|589132439|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
163116234|NCT01819129|589132440|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
163116235|NCT01819129|589132441|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
163116236|NCT01819129|589132440|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
163116237|NCT01819129|589132441|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
163116238|NCT01819129|589132440|FG000|Overall Study|Other, Subject moved out of the country|0|||
163116239|NCT01819129|589132441|FG001|Overall Study|Other, Subject moved out of the country|1|||
163116240|NCT01819129|589132440|FG000|Overall Study|Withdrawal by Subject|15|||
163116241|NCT01819129|589132441|FG001|Overall Study|Withdrawal by Subject|15|||
163116242|NCT01819129|589132440|FG000|Overall Study|Lost to Follow-up|5|||
163116243|NCT01819129|589132441|FG001|Overall Study|Lost to Follow-up|2|||
163116244|NCT01819129|589132440|FG000|Overall Study|Lack of Efficacy|0|||
163116245|NCT01819129|589132441|FG001|Overall Study|Lack of Efficacy|1|||
163116246|NCT01819129|589132440|FG000|Overall Study|Adverse Event|1|||
163116247|NCT01819129|589132441|FG001|Overall Study|Adverse Event|4|||
163116248|NCT01819129|589132440|FG000|Overall Study|Death|1|||
163116249|NCT01819129|589132441|FG001|Overall Study|Death|1|||
163116250|NCT01819129|589132440|FG000|Overall Study|Withdrawal Criteria|20|||
163116251|NCT01819129|589132441|FG001|Overall Study|Withdrawal Criteria|15|||
163116252|NCT02752958|589132442|FG000|Overall Study|Adverse Event|3|||
163116253|NCT02752958|589132442|FG000|Overall Study|Lost to Follow-up|1|||
163116254|NCT02752958|589132442|FG000|Overall Study|Protocol Violation|1|||
163116255|NCT02752958|589132442|FG000|Overall Study|Withdrawal by Subject|2|||
163116256|NCT02752958|589132442|FG000|Overall Study|Other (Reason not specified)|2|||
163116257|NCT00054691|589132446|FG000|Overall Study|Unmeasurable Disease|2|||
163116258|NCT00054691|589132446|FG000|Overall Study|Noncompliant|1|||
163116259|NCT03023826|589132448|FG000|Period 1|Withdrawal by Subject|0|||
163116260|NCT03023826|589132449|FG001|Period 1|Withdrawal by Subject|0|||
163116261|NCT03023826|589132450|FG002|Period 1|Withdrawal by Subject|0|||
163116262|NCT03023826|589132451|FG003|Period 1|Withdrawal by Subject|0|||
163116263|NCT03023826|589132452|FG004|Period 1|Withdrawal by Subject|1|||
163116264|NCT03023826|589132453|FG005|Period 1|Withdrawal by Subject|0|||
163116265|NCT00977938|589132454|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
163116266|NCT00977938|589132455|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
163116267|NCT00977938|589132456|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
163116268|NCT00977938|589132457|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
163116269|NCT00977938|589132454|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
163116270|NCT00977938|589132455|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
163116271|NCT00977938|589132456|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
163116272|NCT00977938|589132457|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
163116273|NCT00977938|589132454|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
163116274|NCT00977938|589132455|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
163116275|NCT00977938|589132456|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
163116276|NCT00977938|589132457|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
163116277|NCT00977938|589132454|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
163116278|NCT00977938|589132455|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
163116279|NCT00977938|589132456|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
163116280|NCT00977938|589132457|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
163116281|NCT00977938|589132454|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
163116282|NCT00977938|589132455|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
163116283|NCT00977938|589132456|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
163116284|NCT00977938|589132457|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
163116285|NCT00977938|589132454|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
163116286|NCT00977938|589132455|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
163116287|NCT00977938|589132456|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
163116288|NCT00977938|589132457|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
163407945|NCT00328627|590203971|FG010|Overall Study|Withdrawal by Subject|2|||
163116289|NCT02142283|589132459|FG000|Overall Study|Death|20|||
163116290|NCT02142283|589132460|FG001|Overall Study|Death|18|||
163116291|NCT02142283|589132459|FG000|Overall Study|Withdrawal by Subject|1|||
163116292|NCT02142283|589132460|FG001|Overall Study|Withdrawal by Subject|3|||
163223187|NCT02586012|589535203|FG002|Overall Study|Protocol Violation|0|||
163223188|NCT02586012|589535204|FG003|Overall Study|Protocol Violation|0|||
163223189|NCT02586012|589535205|FG004|Overall Study|Protocol Violation|0|||
163223190|NCT02586012|589535206|FG005|Overall Study|Protocol Violation|1|||
163223191|NCT02586012|589535201|FG000|Overall Study|study terminated|0|||
163223192|NCT02586012|589535202|FG001|Overall Study|study terminated|2|||
163223193|NCT02586012|589535203|FG002|Overall Study|study terminated|1|||
163223194|NCT02586012|589535204|FG003|Overall Study|study terminated|1|||
163223195|NCT02586012|589535205|FG004|Overall Study|study terminated|1|||
163223196|NCT02586012|589535206|FG005|Overall Study|study terminated|0|||
163223197|NCT01816139|589535207|FG000|Overall Study|Adverse Event|6|||
163223198|NCT01816139|589535208|FG001|Overall Study|Adverse Event|8|||
163223199|NCT01816139|589535207|FG000|Overall Study|Lack of Efficacy|1|||
163223200|NCT01816139|589535208|FG001|Overall Study|Lack of Efficacy|2|||
163223201|NCT01816139|589535207|FG000|Overall Study|Lost to Follow-up|5|||
163223202|NCT01816139|589535208|FG001|Overall Study|Lost to Follow-up|3|||
163223203|NCT01816139|589535207|FG000|Overall Study|Withdrew Consent|6|||
163223204|NCT01816139|589535208|FG001|Overall Study|Withdrew Consent|4|||
163223205|NCT01816139|589535207|FG000|Overall Study|Protocol Violation|6|||
163223206|NCT01816139|589535208|FG001|Overall Study|Protocol Violation|3|||
163223207|NCT01816139|589535207|FG000|Overall Study|Reason not Specified|4|||
163223208|NCT01816139|589535208|FG001|Overall Study|Reason not Specified|2|||
163116293|NCT02460783|589132461|FG000|Overall Study|Withdrawal by Subject|1|||
163223209|NCT01572038|589535209|FG000|Overall Study|Death|648|||
163223210|NCT01572038|589535209|FG000|Overall Study|Withdrawal by Subject|204|||
163116294|NCT02460783|589132462|FG001|Overall Study|Withdrawal by Subject|3|||
163116295|NCT02460783|589132461|FG000|Overall Study|Lost to Follow-up|1|||
163116296|NCT02460783|589132462|FG001|Overall Study|Lost to Follow-up|1|||
163116297|NCT00747344|589132463|FG000|Controlled Period|Adverse Event|3|||
163116298|NCT00747344|589132464|FG001|Controlled Period|Adverse Event|0|||
163116299|NCT00747344|589132465|FG002|Controlled Period|Adverse Event|0|||
163116300|NCT00747344|589132466|FG003|Controlled Period|Adverse Event|0|||
163116301|NCT00747344|589132463|FG000|Controlled Period|Lack of Efficacy|2|||
163116302|NCT00747344|589132464|FG001|Controlled Period|Lack of Efficacy|1|||
163116303|NCT00747344|589132465|FG002|Controlled Period|Lack of Efficacy|0|||
163116304|NCT00747344|589132466|FG003|Controlled Period|Lack of Efficacy|0|||
163116305|NCT00747344|589132463|FG000|Controlled Period|Other|0|||
163116306|NCT00747344|589132464|FG001|Controlled Period|Other|3|||
163116307|NCT00747344|589132465|FG002|Controlled Period|Other|0|||
163116308|NCT00747344|589132466|FG003|Controlled Period|Other|0|||
163116309|NCT00747344|589132463|FG000|After Controlled Period|Adverse Event|0|||
163116310|NCT00747344|589132464|FG001|After Controlled Period|Adverse Event|0|||
163116311|NCT00747344|589132465|FG002|After Controlled Period|Adverse Event|0|||
163116312|NCT00747344|589132466|FG003|After Controlled Period|Adverse Event|1|||
163116313|NCT01484834|589132467|FG000|Overall Study|Lost to Follow-up|5|||
163116314|NCT01484834|589132468|FG001|Overall Study|Lost to Follow-up|8|||
163116315|NCT01484834|589132469|FG002|Overall Study|Lost to Follow-up|1|||
163116316|NCT01484834|589132470|FG003|Overall Study|Lost to Follow-up|4|||
163116317|NCT01371643|589132471|FG000|Overall Study|Withdrawal by Subject|3|||
163116318|NCT01371643|589132472|FG001|Overall Study|Withdrawal by Subject|0|||
163116319|NCT02182440|589132482|FG000|Overall Study|Adverse Event|0|||
163116320|NCT02182440|589132483|FG001|Overall Study|Adverse Event|1|||
163116321|NCT02182440|589132484|FG002|Overall Study|Adverse Event|0|||
163116322|NCT02182440|589132485|FG003|Overall Study|Adverse Event|0|||
163116323|NCT02182440|589132482|FG000|Overall Study|Death|31|||
163116324|NCT02182440|589132483|FG001|Overall Study|Death|8|||
163116325|NCT02182440|589132484|FG002|Overall Study|Death|5|||
163116326|NCT02182440|589132485|FG003|Overall Study|Death|16|||
163116327|NCT02182440|589132482|FG000|Overall Study|Protocol Violation|0|||
163223211|NCT01572038|589535209|FG000|Overall Study|Lost to Follow-up|81|||
163223212|NCT01572038|589535209|FG000|Overall Study|Physician Decision|20|||
163223213|NCT01572038|589535209|FG000|Overall Study|Patient Decision|14|||
163223214|NCT01572038|589535209|FG000|Overall Study|Progressive Disease|8|||
163223215|NCT01572038|589535209|FG000|Overall Study|Site Closed Before Completing Form|6|||
163407946|NCT00328627|590203972|FG011|Overall Study|Withdrawal by Subject|7|||
163407947|NCT00328627|590203961|FG000|Overall Study|Pregnancy|0|||
163223216|NCT01572038|589535209|FG000|Overall Study|Enrolled into Another Trial|3|||
163407948|NCT00328627|590203962|FG001|Overall Study|Pregnancy|1|||
163223217|NCT01572038|589535209|FG000|Overall Study|Participated in Another Trial|3|||
163223218|NCT01572038|589535209|FG000|Overall Study|Termination by Sponsor|2|||
163223219|NCT01572038|589535209|FG000|Overall Study|Patient Deterioration|1|||
163407949|NCT00328627|590203963|FG002|Overall Study|Pregnancy|0|||
163116328|NCT02182440|589132483|FG001|Overall Study|Protocol Violation|1|||
163116329|NCT02182440|589132484|FG002|Overall Study|Protocol Violation|0|||
163116330|NCT02182440|589132485|FG003|Overall Study|Protocol Violation|0|||
163116331|NCT02182440|589132482|FG000|Overall Study|Physician Decision|1|||
163116332|NCT02182440|589132483|FG001|Overall Study|Physician Decision|0|||
163116333|NCT02182440|589132484|FG002|Overall Study|Physician Decision|0|||
163116334|NCT02182440|589132485|FG003|Overall Study|Physician Decision|0|||
163223220|NCT01572038|589535209|FG000|Overall Study|Sponsor Decision|1|||
163116335|NCT02182440|589132482|FG000|Overall Study|Withdrawal by Subject|1|||
163116336|NCT02182440|589132483|FG001|Overall Study|Withdrawal by Subject|1|||
163116337|NCT02182440|589132484|FG002|Overall Study|Withdrawal by Subject|3|||
163116338|NCT02182440|589132485|FG003|Overall Study|Withdrawal by Subject|4|||
163116339|NCT02182440|589132482|FG000|Overall Study|different, e.g adm other hospital|12|||
163116340|NCT02182440|589132483|FG001|Overall Study|different, e.g adm other hospital|3|||
163116341|NCT02182440|589132484|FG002|Overall Study|different, e.g adm other hospital|3|||
163116342|NCT02182440|589132485|FG003|Overall Study|different, e.g adm other hospital|10|||
163116343|NCT00072293|589132486|FG000|Overall Study|Lost to Follow-up|1|||
163116344|NCT00072293|589132487|FG001|Overall Study|Lost to Follow-up|1|||
163116345|NCT00072293|589132486|FG000|Overall Study|Withdrawal by Subject|0|||
163116346|NCT00072293|589132487|FG001|Overall Study|Withdrawal by Subject|1|||
163116347|NCT03754582|589132488|FG000|Treatment Phase|Adverse Event|0|||
163116348|NCT03754582|589132489|FG001|Treatment Phase|Adverse Event|1|||
163116349|NCT03754582|589132490|FG002|Treatment Phase|Adverse Event|0|||
163116350|NCT03754582|589132488|FG000|Follow-up Phase|Other|0|||
163116351|NCT03754582|589132489|FG001|Follow-up Phase|Other|0|||
163116352|NCT03754582|589132490|FG002|Follow-up Phase|Other|1|||
163116353|NCT01561755|589132493|FG000|Overall Study|Lost to Follow-up|0|||
163116354|NCT01561755|589132494|FG001|Overall Study|Lost to Follow-up|1|||
163116355|NCT01166958|589132495|FG000|Overall Study|Withdrawal by Subject|1|||
163116356|NCT01166958|589132496|FG001|Overall Study|Withdrawal by Subject|0|||
163116357|NCT01605227|589132497|FG000|Overall Study|Did not receive study treatment|2|||
163116358|NCT01605227|589132498|FG001|Overall Study|Did not receive study treatment|3|||
163116359|NCT01605227|589132497|FG000|Overall Study|Adverse Event|228|||
163116360|NCT01605227|589132498|FG001|Overall Study|Adverse Event|42|||
163116361|NCT01605227|589132497|FG000|Overall Study|Progressive Disease|132|||
163116362|NCT01605227|589132498|FG001|Overall Study|Progressive Disease|128|||
163116363|NCT01605227|589132497|FG000|Overall Study|Clinical Deterioration|227|||
163116364|NCT01605227|589132498|FG001|Overall Study|Clinical Deterioration|133|||
163116365|NCT01605227|589132497|FG000|Overall Study|Lost to Follow-up|1|||
163116366|NCT01605227|589132498|FG001|Overall Study|Lost to Follow-up|0|||
163116367|NCT01605227|589132497|FG000|Overall Study|Protocol Violation|1|||
163116368|NCT01605227|589132498|FG001|Overall Study|Protocol Violation|0|||
163116369|NCT01605227|589132497|FG000|Overall Study|Physician Decision|9|||
163116370|NCT01605227|589132498|FG001|Overall Study|Physician Decision|7|||
163116371|NCT01605227|589132497|FG000|Overall Study|Withdrawal by Subject|18|||
163116372|NCT01605227|589132498|FG001|Overall Study|Withdrawal by Subject|14|||
163116373|NCT01605227|589132497|FG000|Overall Study|Sponsor Decision|2|||
163116374|NCT01605227|589132498|FG001|Overall Study|Sponsor Decision|0|||
163116375|NCT01605227|589132497|FG000|Overall Study|Started New Therapy|1|||
163116376|NCT01605227|589132498|FG001|Overall Study|Started New Therapy|0|||
163116377|NCT01605227|589132497|FG000|Overall Study|Subject Decision|0|||
163116378|NCT01605227|589132498|FG001|Overall Study|Subject Decision|1|||
163116379|NCT01605227|589132497|FG000|Overall Study|Dose Held >6 weeks|0|||
163116380|NCT01605227|589132498|FG001|Overall Study|Dose Held >6 weeks|1|||
163116381|NCT01286987|589132499|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
163116382|NCT01286987|589132500|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
163116383|NCT01286987|589132501|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
163116384|NCT01286987|589132502|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
163116385|NCT01286987|589132503|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
163116386|NCT01286987|589132504|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
163116387|NCT01286987|589132505|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
163116388|NCT01286987|589132506|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
163116389|NCT01286987|589132507|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
163116390|NCT01286987|589132508|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
163116391|NCT01286987|589132509|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
163116392|NCT01286987|589132510|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
163116393|NCT01286987|589132511|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
163116394|NCT01286987|589132512|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
163116395|NCT01286987|589132513|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
163116396|NCT01286987|589132499|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
163116397|NCT01286987|589132500|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
163116398|NCT01286987|589132501|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
163116399|NCT01286987|589132502|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
163116400|NCT01286987|589132503|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
163116401|NCT01286987|589132504|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
163116402|NCT01286987|589132505|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
163116403|NCT01286987|589132506|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
163116404|NCT01286987|589132507|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
163116405|NCT01286987|589132508|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
163116406|NCT01286987|589132509|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
163116407|NCT01286987|589132510|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
163116408|NCT01286987|589132511|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
163116409|NCT01286987|589132512|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
163116410|NCT01286987|589132513|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
163116411|NCT01286987|589132499|FG000|Part 1: Dose Escalation|Physician Decision|0|||
163116412|NCT01286987|589132500|FG001|Part 1: Dose Escalation|Physician Decision|0|||
163116413|NCT01286987|589132501|FG002|Part 1: Dose Escalation|Physician Decision|0|||
163116414|NCT01286987|589132502|FG003|Part 1: Dose Escalation|Physician Decision|0|||
163116415|NCT01286987|589132503|FG004|Part 1: Dose Escalation|Physician Decision|1|||
163116416|NCT01286987|589132504|FG005|Part 1: Dose Escalation|Physician Decision|0|||
163116417|NCT01286987|589132505|FG006|Part 1: Dose Escalation|Physician Decision|0|||
163116418|NCT01286987|589132506|FG007|Part 1: Dose Escalation|Physician Decision|0|||
163116419|NCT01286987|589132507|FG008|Part 1: Dose Escalation|Physician Decision|0|||
163116420|NCT01286987|589132508|FG009|Part 1: Dose Escalation|Physician Decision|0|||
163116421|NCT01286987|589132509|FG010|Part 1: Dose Escalation|Physician Decision|0|||
163116422|NCT01286987|589132510|FG011|Part 1: Dose Escalation|Physician Decision|0|||
163116423|NCT01286987|589132511|FG012|Part 1: Dose Escalation|Physician Decision|0|||
163116424|NCT01286987|589132512|FG013|Part 1: Dose Escalation|Physician Decision|0|||
163116425|NCT01286987|589132513|FG014|Part 1: Dose Escalation|Physician Decision|0|||
163116426|NCT01286987|589132499|FG000|Part 2: Dose Expansion|Death|0|||
163116427|NCT01286987|589132500|FG001|Part 2: Dose Expansion|Death|0|||
163116428|NCT01286987|589132501|FG002|Part 2: Dose Expansion|Death|0|||
163116429|NCT01286987|589132502|FG003|Part 2: Dose Expansion|Death|0|||
163116430|NCT01286987|589132503|FG004|Part 2: Dose Expansion|Death|0|||
163116431|NCT01286987|589132504|FG005|Part 2: Dose Expansion|Death|0|||
163116432|NCT01286987|589132505|FG006|Part 2: Dose Expansion|Death|0|||
163116433|NCT01286987|589132506|FG007|Part 2: Dose Expansion|Death|0|||
163116434|NCT01286987|589132507|FG008|Part 2: Dose Expansion|Death|0|||
163116435|NCT01286987|589132508|FG009|Part 2: Dose Expansion|Death|0|||
163116436|NCT01286987|589132509|FG010|Part 2: Dose Expansion|Death|0|||
163116437|NCT01286987|589132510|FG011|Part 2: Dose Expansion|Death|0|||
163116438|NCT01286987|589132511|FG012|Part 2: Dose Expansion|Death|1|||
163116439|NCT01286987|589132512|FG013|Part 2: Dose Expansion|Death|1|||
163116440|NCT01286987|589132513|FG014|Part 2: Dose Expansion|Death|0|||
163116441|NCT01286987|589132499|FG000|Part 2: Dose Expansion|Physician Decision|0|||
163116442|NCT01286987|589132500|FG001|Part 2: Dose Expansion|Physician Decision|0|||
163116443|NCT01286987|589132501|FG002|Part 2: Dose Expansion|Physician Decision|0|||
163116444|NCT01286987|589132502|FG003|Part 2: Dose Expansion|Physician Decision|0|||
163116445|NCT01286987|589132503|FG004|Part 2: Dose Expansion|Physician Decision|0|||
163116446|NCT01286987|589132504|FG005|Part 2: Dose Expansion|Physician Decision|0|||
163116447|NCT01286987|589132505|FG006|Part 2: Dose Expansion|Physician Decision|0|||
163116448|NCT01286987|589132506|FG007|Part 2: Dose Expansion|Physician Decision|0|||
163116449|NCT01286987|589132507|FG008|Part 2: Dose Expansion|Physician Decision|0|||
163116450|NCT01286987|589132508|FG009|Part 2: Dose Expansion|Physician Decision|0|||
163116451|NCT01286987|589132509|FG010|Part 2: Dose Expansion|Physician Decision|1|||
163116452|NCT01286987|589132510|FG011|Part 2: Dose Expansion|Physician Decision|1|||
163116453|NCT01286987|589132511|FG012|Part 2: Dose Expansion|Physician Decision|0|||
163116454|NCT01286987|589132512|FG013|Part 2: Dose Expansion|Physician Decision|1|||
163116455|NCT01286987|589132513|FG014|Part 2: Dose Expansion|Physician Decision|0|||
163116456|NCT01286987|589132499|FG000|Part 2: Dose Expansion|Other|0|||
163116457|NCT01286987|589132500|FG001|Part 2: Dose Expansion|Other|0|||
163116458|NCT01286987|589132501|FG002|Part 2: Dose Expansion|Other|0|||
163116459|NCT01286987|589132502|FG003|Part 2: Dose Expansion|Other|0|||
163116460|NCT01286987|589132503|FG004|Part 2: Dose Expansion|Other|0|||
163116461|NCT01286987|589132504|FG005|Part 2: Dose Expansion|Other|0|||
163116462|NCT01286987|589132505|FG006|Part 2: Dose Expansion|Other|0|||
163116463|NCT01286987|589132506|FG007|Part 2: Dose Expansion|Other|0|||
163116464|NCT01286987|589132507|FG008|Part 2: Dose Expansion|Other|0|||
163116465|NCT01286987|589132508|FG009|Part 2: Dose Expansion|Other|0|||
163116466|NCT01286987|589132509|FG010|Part 2: Dose Expansion|Other|0|||
163116467|NCT01286987|589132510|FG011|Part 2: Dose Expansion|Other|0|||
163116468|NCT01286987|589132511|FG012|Part 2: Dose Expansion|Other|0|||
163116469|NCT01286987|589132512|FG013|Part 2: Dose Expansion|Other|1|||
163116470|NCT01286987|589132513|FG014|Part 2: Dose Expansion|Other|0|||
163116471|NCT01286987|589132499|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
163116472|NCT01286987|589132500|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
163116473|NCT01286987|589132501|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
163116474|NCT01286987|589132502|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
163116475|NCT01286987|589132503|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
163116476|NCT01286987|589132504|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
163116477|NCT01286987|589132505|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
163223221|NCT02554656|589535210|FG000|Overall Study|Protocol Violation|3|||
163223222|NCT01888497|589535211|FG000|Washout Period 1|Withdrawal by Subject|0|||
163116478|NCT01286987|589132506|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
163116479|NCT01286987|589132507|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
163116480|NCT01286987|589132508|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
163116481|NCT01286987|589132509|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
163116482|NCT01286987|589132510|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
163223223|NCT01888497|589535212|FG001|Washout Period 1|Withdrawal by Subject|0|||
163223224|NCT01888497|589535213|FG002|Washout Period 1|Withdrawal by Subject|1|||
163223225|NCT01888497|589535214|FG003|Washout Period 1|Withdrawal by Subject|1|||
163223226|NCT01888497|589535211|FG000|Washout Period 2|Adverse Event|0|||
163223227|NCT01888497|589535212|FG001|Washout Period 2|Adverse Event|0|||
163223228|NCT01888497|589535213|FG002|Washout Period 2|Adverse Event|0|||
163223229|NCT01888497|589535214|FG003|Washout Period 2|Adverse Event|1|||
163223230|NCT01888497|589535211|FG000|Washout Period 2|Withdrawal by Subject|0|||
163223231|NCT01888497|589535212|FG001|Washout Period 2|Withdrawal by Subject|0|||
163223232|NCT01888497|589535213|FG002|Washout Period 2|Withdrawal by Subject|0|||
163223233|NCT01888497|589535214|FG003|Washout Period 2|Withdrawal by Subject|1|||
163223234|NCT01140477|589535217|FG000|Overall Study|Lost to Follow-up|4|||
163223235|NCT01140477|589535218|FG001|Overall Study|Lost to Follow-up|0|||
163223236|NCT01140477|589535217|FG000|Overall Study|Withdrawal by Subject|1|||
163223237|NCT01140477|589535218|FG001|Overall Study|Withdrawal by Subject|4|||
163223238|NCT01140477|589535217|FG000|Overall Study|Surgical complication preventing implant|2|||
163223239|NCT01140477|589535218|FG001|Overall Study|Surgical complication preventing implant|0|||
163223240|NCT01140477|589535217|FG000|Overall Study|Death|1|||
163223241|NCT01140477|589535218|FG001|Overall Study|Death|1|||
163223242|NCT01140477|589535217|FG000|Overall Study|Subject explanted|0|||
163223243|NCT01140477|589535218|FG001|Overall Study|Subject explanted|1|||
163223244|NCT04127786|589535223|FG000|Primary Series|Adverse Event|1|||
163223245|NCT04127786|589535224|FG001|Primary Series|Adverse Event|0|||
163223246|NCT04127786|589535225|FG002|Primary Series|Adverse Event|0|||
163223247|NCT04127786|589535226|FG003|Primary Series|Adverse Event|1|||
163223248|NCT04127786|589535227|FG004|Primary Series|Adverse Event|0|||
163223249|NCT04127786|589535228|FG005|Primary Series|Adverse Event|1|||
163223250|NCT04127786|589535223|FG000|Primary Series|Protocol Violation|5|||
163223251|NCT04127786|589535224|FG001|Primary Series|Protocol Violation|3|||
163223252|NCT04127786|589535225|FG002|Primary Series|Protocol Violation|4|||
163223253|NCT04127786|589535226|FG003|Primary Series|Protocol Violation|3|||
163223254|NCT04127786|589535227|FG004|Primary Series|Protocol Violation|2|||
163223255|NCT04127786|589535228|FG005|Primary Series|Protocol Violation|0|||
163223256|NCT04127786|589535223|FG000|Primary Series|Withdrawal by Subject|0|||
163223257|NCT04127786|589535224|FG001|Primary Series|Withdrawal by Subject|0|||
163223258|NCT04127786|589535225|FG002|Primary Series|Withdrawal by Subject|0|||
163223259|NCT04127786|589535226|FG003|Primary Series|Withdrawal by Subject|1|||
163223260|NCT04127786|589535227|FG004|Primary Series|Withdrawal by Subject|0|||
163223261|NCT04127786|589535228|FG005|Primary Series|Withdrawal by Subject|0|||
163223262|NCT04127786|589535223|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
163223263|NCT04127786|589535224|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
163223264|NCT04127786|589535225|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
163223265|NCT04127786|589535226|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
163223266|NCT04127786|589535227|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
163223267|NCT04127786|589535228|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
163223268|NCT04127786|589535223|FG000|Booster Phase|Withdrawal by Subject|2|||
163223269|NCT04127786|589535224|FG001|Booster Phase|Withdrawal by Subject|0|||
163223270|NCT04127786|589535225|FG002|Booster Phase|Withdrawal by Subject|0|||
163223271|NCT04127786|589535226|FG003|Booster Phase|Withdrawal by Subject|0|||
163340170|NCT00103857|589953148|FG000|50-Week Extension Study|Lost to Follow-up|4|||
163340171|NCT00103857|589953149|FG001|50-Week Extension Study|Lost to Follow-up|0|||
163340172|NCT00103857|589953150|FG002|50-Week Extension Study|Lost to Follow-up|1|||
163340173|NCT00103857|589953151|FG003|50-Week Extension Study|Lost to Follow-up|4|||
163340174|NCT00103857|589953152|FG004|50-Week Extension Study|Lost to Follow-up|3|||
163116483|NCT01286987|589132511|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
163116484|NCT01286987|589132512|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
163116485|NCT01286987|589132513|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
163116486|NCT01286987|589132499|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
163116487|NCT01286987|589132500|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
163116488|NCT01286987|589132501|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
163116489|NCT01286987|589132502|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
163116490|NCT01286987|589132503|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
163223272|NCT04127786|589535227|FG004|Booster Phase|Withdrawal by Subject|0|||
163340175|NCT00103857|589953153|FG005|50-Week Extension Study|Lost to Follow-up|3|||
163340176|NCT00103857|589953154|FG006|50-Week Extension Study|Lost to Follow-up|0|||
163116491|NCT01286987|589132504|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
163223273|NCT04127786|589535228|FG005|Booster Phase|Withdrawal by Subject|0|||
163223274|NCT01904604|589535229|FG000|Overall Study|Withdrew before receiving dosing|0|||
163223275|NCT01904604|589535230|FG001|Overall Study|Withdrew before receiving dosing|1|||
163223276|NCT01904604|589535231|FG002|Overall Study|Withdrew before receiving dosing|0|||
163223277|NCT01904604|589535229|FG000|Overall Study|Non-compliance|1|||
163223278|NCT01904604|589535230|FG001|Overall Study|Non-compliance|0|||
163223279|NCT01904604|589535231|FG002|Overall Study|Non-compliance|0|||
163223280|NCT01904604|589535229|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
163340177|NCT00103857|589953148|FG000|50-Week Extension Study|Physician Decision|0|||
163340178|NCT00103857|589953149|FG001|50-Week Extension Study|Physician Decision|1|||
163340179|NCT00103857|589953150|FG002|50-Week Extension Study|Physician Decision|1|||
163340180|NCT00103857|589953151|FG003|50-Week Extension Study|Physician Decision|0|||
163340181|NCT00103857|589953152|FG004|50-Week Extension Study|Physician Decision|0|||
163340182|NCT00103857|589953153|FG005|50-Week Extension Study|Physician Decision|0|||
163340183|NCT00103857|589953154|FG006|50-Week Extension Study|Physician Decision|0|||
163340184|NCT00103857|589953148|FG000|50-Week Extension Study|Pregnancy|0|||
163340185|NCT00103857|589953149|FG001|50-Week Extension Study|Pregnancy|0|||
163340186|NCT00103857|589953150|FG002|50-Week Extension Study|Pregnancy|1|||
163116492|NCT01286987|589132505|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
163116493|NCT01286987|589132506|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
163116494|NCT01286987|589132507|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
163116495|NCT01286987|589132508|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
163116496|NCT01286987|589132509|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
163116497|NCT01286987|589132510|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
163116498|NCT01286987|589132511|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
163116499|NCT01286987|589132512|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
163116500|NCT01286987|589132513|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
163116501|NCT01286987|589132499|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116502|NCT01286987|589132500|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116503|NCT01286987|589132501|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116504|NCT01286987|589132502|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116505|NCT01286987|589132503|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116506|NCT01286987|589132504|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116507|NCT01286987|589132505|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116508|NCT01286987|589132506|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116509|NCT01286987|589132507|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116510|NCT01286987|589132508|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116511|NCT01286987|589132509|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
163116512|NCT01286987|589132510|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116513|NCT01286987|589132511|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116514|NCT01286987|589132512|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116515|NCT01286987|589132513|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116516|NCT00624819|589132514|FG000|Follow-up Period: Year 4|Parents decision|0|||
163116517|NCT00624819|589132515|FG001|Follow-up Period: Year 4|Parents decision|0|||
163116518|NCT00624819|589132516|FG002|Follow-up Period: Year 4|Parents decision|1|||
163116519|NCT00624819|589132517|FG003|Follow-up Period: Year 4|Parents decision|0|||
163116520|NCT00624819|589132514|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
163116521|NCT00624819|589132515|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
163116522|NCT00624819|589132516|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
163116523|NCT00624819|589132517|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
163116524|NCT02847858|589132518|FG000|Overall Study|Lost to Follow-up|401|||
163116525|NCT02847858|589132519|FG001|Overall Study|Lost to Follow-up|269|||
163116526|NCT02826421|589132522|FG000|Overall Study|Adverse Event|1|||
163116527|NCT02826421|589132523|FG001|Overall Study|Adverse Event|0|||
163116528|NCT02826421|589132524|FG002|Overall Study|Adverse Event|0|||
163116529|NCT02826421|589132525|FG003|Overall Study|Adverse Event|1|||
163116530|NCT02826421|589132522|FG000|Overall Study|Withdrawal by Subject|1|||
163116531|NCT02826421|589132523|FG001|Overall Study|Withdrawal by Subject|3|||
163116532|NCT02826421|589132524|FG002|Overall Study|Withdrawal by Subject|1|||
163116533|NCT02826421|589132525|FG003|Overall Study|Withdrawal by Subject|1|||
163116534|NCT02826421|589132522|FG000|Overall Study|Reason not given|1|||
163116535|NCT02826421|589132523|FG001|Overall Study|Reason not given|0|||
163116536|NCT02826421|589132524|FG002|Overall Study|Reason not given|1|||
163116537|NCT02826421|589132525|FG003|Overall Study|Reason not given|0|||
163116538|NCT02210221|589132528|FG000|Overall Study|Lack of Efficacy|7|||
163116539|NCT02210221|589132528|FG000|Overall Study|Withdrawal by Subject|43|||
163116540|NCT00405964|589132533|FG000|Overall Study|Treatment Failure|17|||
163116541|NCT00405964|589132534|FG001|Overall Study|Treatment Failure|45|||
163116542|NCT00405964|589132533|FG000|Overall Study|Adverse Event|7|||
163116543|NCT00405964|589132534|FG001|Overall Study|Adverse Event|16|||
163116544|NCT00405964|589132533|FG000|Overall Study|Lost to Follow-up|5|||
163116545|NCT00405964|589132534|FG001|Overall Study|Lost to Follow-up|5|||
163116546|NCT00405964|589132533|FG000|Overall Study|Withdrawal by Subject|19|||
163116547|NCT00405964|589132534|FG001|Overall Study|Withdrawal by Subject|23|||
163116548|NCT00405964|589132533|FG000|Overall Study|Protocol Violation|11|||
163116549|NCT00405964|589132534|FG001|Overall Study|Protocol Violation|6|||
163116550|NCT03271047|589132535|FG000|Phase 1b: Dose Finding Period|Death|8|||
163116551|NCT03271047|589132536|FG001|Phase 1b: Dose Finding Period|Death|8|||
163116552|NCT03271047|589132537|FG002|Phase 1b: Dose Finding Period|Death|0|||
163116553|NCT03271047|589132538|FG003|Phase 1b: Dose Finding Period|Death|0|||
163116554|NCT03271047|589132535|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
163223281|NCT01904604|589535230|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
163407950|NCT00328627|590203964|FG003|Overall Study|Pregnancy|0|||
163340187|NCT00103857|589953151|FG003|50-Week Extension Study|Pregnancy|0|||
163340188|NCT00103857|589953152|FG004|50-Week Extension Study|Pregnancy|1|||
163340189|NCT00103857|589953153|FG005|50-Week Extension Study|Pregnancy|0|||
163340190|NCT00103857|589953154|FG006|50-Week Extension Study|Pregnancy|0|||
163340191|NCT00103857|589953148|FG000|50-Week Extension Study|Protocol Violation|1|||
163340192|NCT00103857|589953149|FG001|50-Week Extension Study|Protocol Violation|1|||
163116555|NCT03271047|589132536|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
163116556|NCT03271047|589132537|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
163116557|NCT03271047|589132538|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
163116558|NCT03271047|589132535|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
163116559|NCT03271047|589132536|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
163116560|NCT03271047|589132537|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
163116561|NCT03271047|589132538|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
163116562|NCT03271047|589132535|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
163116563|NCT03271047|589132536|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
163116564|NCT03271047|589132537|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
163116565|NCT03271047|589132538|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
163116566|NCT03271047|589132535|FG000|Randomized Phase 2 Period|Other|0|||
163116567|NCT03271047|589132536|FG001|Randomized Phase 2 Period|Other|0|||
163116568|NCT03271047|589132537|FG002|Randomized Phase 2 Period|Other|0|||
163116569|NCT03271047|589132538|FG003|Randomized Phase 2 Period|Other|1|||
163116570|NCT03271047|589132535|FG000|Randomized Phase 2 Period|Death|0|||
163116571|NCT03271047|589132536|FG001|Randomized Phase 2 Period|Death|0|||
163116572|NCT03271047|589132537|FG002|Randomized Phase 2 Period|Death|20|||
163116573|NCT03271047|589132538|FG003|Randomized Phase 2 Period|Death|21|||
163116574|NCT03271047|589132535|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
163116575|NCT03271047|589132536|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
163116576|NCT03271047|589132537|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
163116577|NCT03271047|589132538|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
163116578|NCT03271047|589132535|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
163116579|NCT03271047|589132536|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
163116580|NCT03271047|589132537|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
163116581|NCT03271047|589132538|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
163116582|NCT03271047|589132535|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
163116583|NCT03271047|589132536|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
163116584|NCT03271047|589132537|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
163116585|NCT03271047|589132538|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
163116586|NCT00711802|589132539|FG000|Overall Study|Not treated (no further detail)|2|||
163116587|NCT00711802|589132540|FG001|Overall Study|Not treated (no further detail)|1|||
163116588|NCT00711802|589132541|FG002|Overall Study|Not treated (no further detail)|2|||
163116589|NCT00711802|589132542|FG003|Overall Study|Not treated (no further detail)|0|||
163116590|NCT00711802|589132543|FG004|Overall Study|Not treated (no further detail)|2|||
163116591|NCT00711802|589132544|FG005|Overall Study|Not treated (no further detail)|0|||
163116592|NCT00711802|589132545|FG006|Overall Study|Not treated (no further detail)|0|||
163116593|NCT00711802|589132546|FG007|Overall Study|Not treated (no further detail)|0|||
163116594|NCT00711802|589132539|FG000|Overall Study|Adverse Event|0|||
163116595|NCT00711802|589132540|FG001|Overall Study|Adverse Event|0|||
163116596|NCT00711802|589132541|FG002|Overall Study|Adverse Event|0|||
163116597|NCT00711802|589132542|FG003|Overall Study|Adverse Event|0|||
163116598|NCT00711802|589132543|FG004|Overall Study|Adverse Event|1|||
163116599|NCT00711802|589132544|FG005|Overall Study|Adverse Event|1|||
163116600|NCT00711802|589132545|FG006|Overall Study|Adverse Event|0|||
163116601|NCT00711802|589132546|FG007|Overall Study|Adverse Event|0|||
163116602|NCT00711802|589132539|FG000|Overall Study|Microbiological failure|0|||
163116603|NCT00711802|589132540|FG001|Overall Study|Microbiological failure|1|||
163116604|NCT00711802|589132541|FG002|Overall Study|Microbiological failure|0|||
163116605|NCT00711802|589132542|FG003|Overall Study|Microbiological failure|0|||
163116606|NCT00711802|589132543|FG004|Overall Study|Microbiological failure|0|||
163116607|NCT00711802|589132544|FG005|Overall Study|Microbiological failure|1|||
163116608|NCT00711802|589132545|FG006|Overall Study|Microbiological failure|0|||
163116609|NCT00711802|589132546|FG007|Overall Study|Microbiological failure|0|||
163116610|NCT00711802|589132539|FG000|Overall Study|Protocol Violation|0|||
163116611|NCT00711802|589132540|FG001|Overall Study|Protocol Violation|0|||
163116612|NCT00711802|589132541|FG002|Overall Study|Protocol Violation|0|||
163116613|NCT00711802|589132542|FG003|Overall Study|Protocol Violation|1|||
163116614|NCT00711802|589132543|FG004|Overall Study|Protocol Violation|0|||
163340193|NCT00103857|589953150|FG002|50-Week Extension Study|Protocol Violation|1|||
163340194|NCT00103857|589953151|FG003|50-Week Extension Study|Protocol Violation|2|||
163340195|NCT00103857|589953152|FG004|50-Week Extension Study|Protocol Violation|0|||
163340196|NCT00103857|589953153|FG005|50-Week Extension Study|Protocol Violation|1|||
163340197|NCT00103857|589953154|FG006|50-Week Extension Study|Protocol Violation|0|||
163340198|NCT00103857|589953148|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
163340199|NCT00103857|589953149|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
163223282|NCT01904604|589535231|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
163223283|NCT01904604|589535229|FG000|Overall Study|Patch site reactions|1|||
163223284|NCT01904604|589535230|FG001|Overall Study|Patch site reactions|1|||
163223285|NCT01904604|589535231|FG002|Overall Study|Patch site reactions|0|||
163223286|NCT01904604|589535229|FG000|Overall Study|Increased syncope|0|||
163223287|NCT01904604|589535230|FG001|Overall Study|Increased syncope|1|||
163223288|NCT01904604|589535231|FG002|Overall Study|Increased syncope|0|||
163223289|NCT01904604|589535229|FG000|Overall Study|Unrelated illness|0|||
163223290|NCT01904604|589535230|FG001|Overall Study|Unrelated illness|1|||
163223291|NCT01904604|589535231|FG002|Overall Study|Unrelated illness|0|||
163223292|NCT01904604|589535229|FG000|Overall Study|Passed Week 52 OFC|1|||
163223293|NCT01904604|589535230|FG001|Overall Study|Passed Week 52 OFC|0|||
163223294|NCT01904604|589535231|FG002|Overall Study|Passed Week 52 OFC|0|||
163223295|NCT01904604|589535229|FG000|Overall Study|Withdrawal by Subject|1|||
163223296|NCT01904604|589535230|FG001|Overall Study|Withdrawal by Subject|2|||
163223297|NCT01904604|589535231|FG002|Overall Study|Withdrawal by Subject|0|||
163223298|NCT01904604|589535229|FG000|Overall Study|Participant Relocated|1|||
163223299|NCT01904604|589535230|FG001|Overall Study|Participant Relocated|1|||
163223300|NCT01904604|589535231|FG002|Overall Study|Participant Relocated|1|||
163223301|NCT01904604|589535229|FG000|Overall Study|Lost to Follow-up|0|||
163223302|NCT01904604|589535230|FG001|Overall Study|Lost to Follow-up|0|||
163223303|NCT01904604|589535231|FG002|Overall Study|Lost to Follow-up|1|||
163223304|NCT02821962|589535237|FG000|Overall Study|Lost to Follow-up|2|||
163223305|NCT02821962|589535238|FG001|Overall Study|Lost to Follow-up|0|||
163223306|NCT04206293|589535251|FG000|Overall Study|Consent withdrawal|1|||
163223307|NCT03325166|589535253|FG000|Overall Study|Adverse Event|1|||
163223308|NCT00782210|589535255|FG000|Overall Study|Adverse Event|21|||
163223309|NCT00782210|589535256|FG001|Overall Study|Adverse Event|17|||
163223310|NCT00782210|589535257|FG002|Overall Study|Adverse Event|16|||
163223311|NCT00782210|589535255|FG000|Overall Study|Lost to Follow-up|2|||
163223312|NCT00782210|589535256|FG001|Overall Study|Lost to Follow-up|1|||
163223313|NCT00782210|589535257|FG002|Overall Study|Lost to Follow-up|2|||
163223314|NCT00782210|589535255|FG000|Overall Study|Withdrawal by Subject|11|||
163223315|NCT00782210|589535256|FG001|Overall Study|Withdrawal by Subject|8|||
163223316|NCT00782210|589535257|FG002|Overall Study|Withdrawal by Subject|11|||
163223317|NCT00782210|589535255|FG000|Overall Study|Non compliance with protocol|0|||
163223318|NCT00782210|589535256|FG001|Overall Study|Non compliance with protocol|3|||
163223319|NCT00782210|589535257|FG002|Overall Study|Non compliance with protocol|2|||
163223320|NCT00782210|589535255|FG000|Overall Study|Lack of Efficacy|13|||
163223321|NCT00782210|589535256|FG001|Overall Study|Lack of Efficacy|4|||
163223322|NCT00782210|589535257|FG002|Overall Study|Lack of Efficacy|1|||
163223323|NCT00782210|589535255|FG000|Overall Study|Other reason not described above|3|||
163223324|NCT00782210|589535256|FG001|Overall Study|Other reason not described above|2|||
163223325|NCT00782210|589535257|FG002|Overall Study|Other reason not described above|3|||
163223326|NCT01610791|589535262|FG000|Overall Study|Lost to Follow-up|7|||
163223327|NCT01610791|589535262|FG000|Overall Study|Adverse Event|6|||
163340200|NCT00103857|589953150|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
163340201|NCT00103857|589953151|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
163340202|NCT00103857|589953152|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
163340203|NCT00103857|589953153|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
163223328|NCT01610791|589535262|FG000|Overall Study|Physician Decision|1|||
163223329|NCT01610791|589535262|FG000|Overall Study|Adverse event and Investigator decision|1|||
163223330|NCT01610791|589535262|FG000|Overall Study|Death|1|||
163223331|NCT01610791|589535262|FG000|Overall Study|Not determined|5|||
163223332|NCT05923229|589535263|FG000|Overall Study|Withdrawal by Subject|3|||
163223333|NCT05923229|589535264|FG001|Overall Study|Withdrawal by Subject|0|||
163223334|NCT05923229|589535263|FG000|Overall Study|Health related|2|||
163223335|NCT05923229|589535264|FG001|Overall Study|Health related|1|||
163223336|NCT04304001|589535265|FG000|Overall Study|Lost to Follow-up|13|||
163340204|NCT00103857|589953154|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
163340205|NCT00103857|589953148|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
163340206|NCT00103857|589953149|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
163340207|NCT00103857|589953150|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
163340208|NCT00103857|589953151|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
163340209|NCT00103857|589953152|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
163340210|NCT00103857|589953153|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
163223337|NCT04304001|589535266|FG001|Overall Study|Lost to Follow-up|9|||
163223338|NCT04164901|589535267|FG000|Overall Study|Withdrawal by Subject|4|||
163223339|NCT04164901|589535268|FG001|Overall Study|Withdrawal by Subject|4|||
163223340|NCT02465528|589535269|FG000|Overall Study|Progressive disease|0|||
163223341|NCT02465528|589535270|FG001|Overall Study|Progressive disease|2|||
163223342|NCT02465528|589535271|FG002|Overall Study|Progressive disease|9|||
163223343|NCT02465528|589535272|FG003|Overall Study|Progressive disease|4|||
163223344|NCT02465528|589535269|FG000|Overall Study|Study terminated by sponsor|1|||
163223345|NCT02465528|589535270|FG001|Overall Study|Study terminated by sponsor|2|||
163223346|NCT02465528|589535271|FG002|Overall Study|Study terminated by sponsor|0|||
163340211|NCT00103857|589953154|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
163116615|NCT00711802|589132544|FG005|Overall Study|Protocol Violation|0|||
163116616|NCT00711802|589132545|FG006|Overall Study|Protocol Violation|0|||
163116617|NCT00711802|589132546|FG007|Overall Study|Protocol Violation|0|||
163116618|NCT00711802|589132539|FG000|Overall Study|Physician Decision|0|||
163116619|NCT00711802|589132540|FG001|Overall Study|Physician Decision|2|||
163116620|NCT00711802|589132541|FG002|Overall Study|Physician Decision|0|||
163116621|NCT00711802|589132542|FG003|Overall Study|Physician Decision|0|||
163116622|NCT00711802|589132543|FG004|Overall Study|Physician Decision|0|||
163116623|NCT00711802|589132544|FG005|Overall Study|Physician Decision|0|||
163116624|NCT00711802|589132545|FG006|Overall Study|Physician Decision|0|||
163116625|NCT00711802|589132546|FG007|Overall Study|Physician Decision|0|||
163116626|NCT00711802|589132539|FG000|Overall Study|Withdrawal by Subject|0|||
163116627|NCT00711802|589132540|FG001|Overall Study|Withdrawal by Subject|1|||
163116628|NCT00711802|589132541|FG002|Overall Study|Withdrawal by Subject|0|||
163116629|NCT00711802|589132542|FG003|Overall Study|Withdrawal by Subject|1|||
163116630|NCT00711802|589132543|FG004|Overall Study|Withdrawal by Subject|0|||
163116631|NCT00711802|589132544|FG005|Overall Study|Withdrawal by Subject|0|||
163116632|NCT00711802|589132545|FG006|Overall Study|Withdrawal by Subject|0|||
163116633|NCT00711802|589132546|FG007|Overall Study|Withdrawal by Subject|0|||
163116634|NCT00711802|589132539|FG000|Overall Study|Lost to Follow-up|0|||
163116635|NCT00711802|589132540|FG001|Overall Study|Lost to Follow-up|0|||
163116636|NCT00711802|589132541|FG002|Overall Study|Lost to Follow-up|3|||
163116637|NCT00711802|589132542|FG003|Overall Study|Lost to Follow-up|1|||
163116638|NCT00711802|589132543|FG004|Overall Study|Lost to Follow-up|10|||
163116639|NCT00711802|589132544|FG005|Overall Study|Lost to Follow-up|6|||
163116640|NCT00711802|589132545|FG006|Overall Study|Lost to Follow-up|4|||
163116641|NCT00711802|589132546|FG007|Overall Study|Lost to Follow-up|2|||
163116642|NCT00711802|589132539|FG000|Overall Study|Reason not reported|0|||
163116643|NCT00711802|589132540|FG001|Overall Study|Reason not reported|1|||
163116644|NCT00711802|589132541|FG002|Overall Study|Reason not reported|1|||
163116645|NCT00711802|589132542|FG003|Overall Study|Reason not reported|0|||
163116646|NCT00711802|589132543|FG004|Overall Study|Reason not reported|1|||
163116647|NCT00711802|589132544|FG005|Overall Study|Reason not reported|0|||
163116648|NCT00711802|589132545|FG006|Overall Study|Reason not reported|1|||
163116649|NCT00711802|589132546|FG007|Overall Study|Reason not reported|0|||
163116650|NCT00391391|589132547|FG000|Overall Study|Adverse Event|0|||
163116651|NCT00391391|589132548|FG001|Overall Study|Adverse Event|0|||
163116652|NCT00391391|589132549|FG002|Overall Study|Adverse Event|0|||
163116653|NCT00391391|589132550|FG003|Overall Study|Adverse Event|1|||
163116654|NCT00391391|589132547|FG000|Overall Study|Lost to Follow-up|1|||
163116655|NCT00391391|589132548|FG001|Overall Study|Lost to Follow-up|3|||
163116656|NCT00391391|589132549|FG002|Overall Study|Lost to Follow-up|7|||
163116657|NCT00391391|589132550|FG003|Overall Study|Lost to Follow-up|4|||
163116658|NCT00391391|589132547|FG000|Overall Study|Protocol Violation|2|||
163116659|NCT00391391|589132548|FG001|Overall Study|Protocol Violation|3|||
163116660|NCT00391391|589132549|FG002|Overall Study|Protocol Violation|6|||
163116661|NCT00391391|589132550|FG003|Overall Study|Protocol Violation|7|||
163116662|NCT00391391|589132547|FG000|Overall Study|Withdrawal by Subject|6|||
163116663|NCT00391391|589132548|FG001|Overall Study|Withdrawal by Subject|4|||
163116664|NCT00391391|589132549|FG002|Overall Study|Withdrawal by Subject|10|||
163116665|NCT00391391|589132550|FG003|Overall Study|Withdrawal by Subject|7|||
163116666|NCT02649855|589132551|FG000|Overall Study|Refused further treatment|2|||
163116667|NCT02649855|589132552|FG001|Overall Study|Refused further treatment|1|||
163116668|NCT02649855|589132553|FG002|Overall Study|Refused further treatment|1|||
163116669|NCT02649855|589132551|FG000|Overall Study|Withdrew consent|0|||
163116670|NCT02649855|589132552|FG001|Overall Study|Withdrew consent|1|||
163116671|NCT02649855|589132553|FG002|Overall Study|Withdrew consent|0|||
163116672|NCT02649855|589132551|FG000|Overall Study|Switched to alternative treatment|0|||
163116673|NCT02649855|589132552|FG001|Overall Study|Switched to alternative treatment|1|||
163116674|NCT02649855|589132553|FG002|Overall Study|Switched to alternative treatment|1|||
163116675|NCT02649855|589132551|FG000|Overall Study|Principal investigator discretion|0|||
163116676|NCT02649855|589132552|FG001|Overall Study|Principal investigator discretion|1|||
163116677|NCT02649855|589132553|FG002|Overall Study|Principal investigator discretion|1|||
163116678|NCT02649855|589132551|FG000|Overall Study|No treatment, per protocol|1|||
163116679|NCT02649855|589132552|FG001|Overall Study|No treatment, per protocol|0|||
163116680|NCT02649855|589132553|FG002|Overall Study|No treatment, per protocol|0|||
163116681|NCT02649855|589132551|FG000|Overall Study|Initiate new treatment|1|||
163116682|NCT02649855|589132552|FG001|Overall Study|Initiate new treatment|0|||
163116683|NCT02649855|589132553|FG002|Overall Study|Initiate new treatment|0|||
163116684|NCT01344538|589133925|FG000|Overall Study|Adverse Event|1|||
163340212|NCT00103857|589953148|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
163407951|NCT00328627|590203965|FG004|Overall Study|Pregnancy|0|||
163116685|NCT01344538|589133926|FG001|Overall Study|Adverse Event|1|||
163116686|NCT01344538|589133925|FG000|Overall Study|Lost to Follow-up|1|||
163116687|NCT01344538|589133926|FG001|Overall Study|Lost to Follow-up|0|||
163116688|NCT01655381|589133927|FG000|Overall Study|Investigator Decision|1|||
163116689|NCT01655381|589133927|FG000|Overall Study|Moved to Another City|1|||
163116690|NCT01655381|589133927|FG000|Overall Study|Insufficient Treatment Response|1|||
163116691|NCT04195438|589133928|FG000|Overall Study|Withdrawal by Subject|1|||
163116692|NCT00613925|589133929|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
163116693|NCT00613925|589133930|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
163116694|NCT01156389|589133931|FG000|Overall Study|Elevated liver enzymes|4|||
163116695|NCT01156389|589133932|FG001|Overall Study|Elevated liver enzymes|0|||
163116696|NCT01156389|589133931|FG000|Overall Study|Vomiting|0|||
163116697|NCT01156389|589133932|FG001|Overall Study|Vomiting|1|||
163116698|NCT00350623|589133935|FG000|Overall Study|Lost to Follow-up|8|||
163116699|NCT00350623|589133936|FG001|Overall Study|Lost to Follow-up|3|||
163116700|NCT00350623|589133937|FG002|Overall Study|Lost to Follow-up|4|||
163116701|NCT00350623|589133935|FG000|Overall Study|Withdrawal by Subject|0|||
163116702|NCT00350623|589133936|FG001|Overall Study|Withdrawal by Subject|1|||
163116703|NCT00350623|589133937|FG002|Overall Study|Withdrawal by Subject|1|||
163116704|NCT00350623|589133935|FG000|Overall Study|patient traveling outside the country|0|||
163116705|NCT00350623|589133936|FG001|Overall Study|patient traveling outside the country|0|||
163116706|NCT00350623|589133937|FG002|Overall Study|patient traveling outside the country|1|||
163116707|NCT02279719|589133950|FG000|Overall Study|Patients randomized but never treated|0|||
163116708|NCT02279719|589133951|FG001|Overall Study|Patients randomized but never treated|0|||
163116709|NCT02279719|589133952|FG002|Overall Study|Patients randomized but never treated|0|||
163116710|NCT02279719|589133953|FG003|Overall Study|Patients randomized but never treated|0|||
163116711|NCT02279719|589133954|FG004|Overall Study|Patients randomized but never treated|3|||
163116712|NCT02279719|589133955|FG005|Overall Study|Patients randomized but never treated|0|||
163116713|NCT02279719|589133956|FG006|Overall Study|Patients randomized but never treated|3|||
163116714|NCT04706273|589133957|FG000|Overall Study|Withdrawal by Subject|27|||
163116715|NCT04706273|589133957|FG000|Overall Study|Physician Decision|1|||
163116716|NCT04706273|589133957|FG000|Overall Study|Lost to Follow-up|42|||
163116717|NCT04706273|589133957|FG000|Overall Study|Death|85|||
163116718|NCT04706273|589133957|FG000|Overall Study|Amputation that removes study device|2|||
163116719|NCT04706273|589133957|FG000|Overall Study|Surgical bypass|3|||
163116720|NCT04706273|589133957|FG000|Overall Study|Changing hospital|23|||
163116721|NCT04706273|589133957|FG000|Overall Study|Unable to attend hospital|2|||
163116722|NCT03541187|589133958|FG000|Overall Study|Lost to Follow-up|2|||
163116723|NCT03541187|589133959|FG001|Overall Study|Lost to Follow-up|6|||
163116724|NCT03541187|589133958|FG000|Overall Study|Pregnancy|0|||
163116725|NCT03541187|589133959|FG001|Overall Study|Pregnancy|1|||
163116726|NCT03541187|589133958|FG000|Overall Study|Withdrawal by Subject|6|||
163116727|NCT03541187|589133959|FG001|Overall Study|Withdrawal by Subject|2|||
163116728|NCT03541187|589133958|FG000|Overall Study|Moved out of town|1|||
163116729|NCT03541187|589133959|FG001|Overall Study|Moved out of town|0|||
163116730|NCT03541187|589133958|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
163116731|NCT03541187|589133959|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
163116732|NCT03541187|589133958|FG000|Overall Study|Did not meet randomization criteria|1|||
163116733|NCT03541187|589133959|FG001|Overall Study|Did not meet randomization criteria|1|||
163116734|NCT03541187|589133958|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
163116735|NCT03541187|589133959|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
163116736|NCT03541187|589133958|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
163116737|NCT03541187|589133959|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
163116738|NCT03199053|589133965|FG000|ST Period|Withdrawal by Subject|2|||
163116739|NCT03199053|589133966|FG001|ST Period|Withdrawal by Subject|4|||
163116740|NCT03199053|589133967|FG002|ST Period|Withdrawal by Subject|6|||
163116741|NCT03199053|589133965|FG000|ST Period|Withdrawal by parent/guardian|1|||
163116742|NCT03199053|589133966|FG001|ST Period|Withdrawal by parent/guardian|1|||
163116743|NCT03199053|589133967|FG002|ST Period|Withdrawal by parent/guardian|1|||
163116744|NCT03199053|589133965|FG000|ST Period|Lost to Follow-up|2|||
163116745|NCT03199053|589133966|FG001|ST Period|Lost to Follow-up|0|||
163116746|NCT03199053|589133967|FG002|ST Period|Lost to Follow-up|1|||
163116747|NCT03199053|589133965|FG000|LT Period|Withdrawal by Subject|1|||
163116748|NCT03199053|589133966|FG001|LT Period|Withdrawal by Subject|3|||
163116749|NCT03199053|589133967|FG002|LT Period|Withdrawal by Subject|3|||
163116750|NCT03199053|589133965|FG000|LT Period|Withdrawal by parent/guardian|0|||
163116751|NCT03199053|589133966|FG001|LT Period|Withdrawal by parent/guardian|0|||
163116752|NCT03199053|589133967|FG002|LT Period|Withdrawal by parent/guardian|1|||
163116753|NCT03199053|589133965|FG000|LT Period|Lost to Follow-up|0|||
163116754|NCT03199053|589133966|FG001|LT Period|Lost to Follow-up|1|||
163116755|NCT03199053|589133967|FG002|LT Period|Lost to Follow-up|1|||
163116756|NCT03199053|589133965|FG000|LT Period|Miscellaneous|0|||
163116757|NCT03199053|589133966|FG001|LT Period|Miscellaneous|0|||
163116758|NCT03199053|589133967|FG002|LT Period|Miscellaneous|2|||
163116759|NCT03199053|589133965|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
163116760|NCT03199053|589133966|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
163116761|NCT03199053|589133967|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
163116762|NCT03199053|589133965|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
163340213|NCT00103857|589953149|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
163340214|NCT00103857|589953150|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
163340215|NCT00103857|589953151|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
163340216|NCT00103857|589953152|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
163116763|NCT03199053|589133966|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
163116764|NCT03199053|589133967|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
163116765|NCT03199053|589133965|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
163116766|NCT03199053|589133966|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
163116767|NCT03199053|589133967|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
163116768|NCT03199053|589133965|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
163116769|NCT03199053|589133966|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
163116770|NCT03199053|589133967|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
163116771|NCT03263923|589133969|FG000|Overall Study|Withdrawal by Subject|10|||
163116772|NCT03263923|589133970|FG001|Overall Study|Withdrawal by Subject|8|||
163116773|NCT03263923|589133969|FG000|Overall Study|Lost to Follow-up|15|||
163116774|NCT03263923|589133970|FG001|Overall Study|Lost to Follow-up|13|||
163116775|NCT01323270|589133971|FG000|Overall Study|Withdrawal by Subject|19|||
163116776|NCT01323270|589133972|FG001|Overall Study|Withdrawal by Subject|10|||
163116777|NCT01323270|589133971|FG000|Overall Study|Protocol Violation|9|||
163116778|NCT01323270|589133972|FG001|Overall Study|Protocol Violation|7|||
163116779|NCT01323270|589133971|FG000|Overall Study|Lost to Follow-up|4|||
163116780|NCT01323270|589133972|FG001|Overall Study|Lost to Follow-up|6|||
163116781|NCT01323270|589133971|FG000|Overall Study|Adverse Event|8|||
163116782|NCT01323270|589133972|FG001|Overall Study|Adverse Event|0|||
163116783|NCT01323270|589133971|FG000|Overall Study|Other|0|||
163116784|NCT01323270|589133972|FG001|Overall Study|Other|3|||
163116785|NCT01323270|589133971|FG000|Overall Study|Physician Decision|0|||
163116786|NCT01323270|589133972|FG001|Overall Study|Physician Decision|2|||
163116787|NCT01323270|589133971|FG000|Overall Study|Not eligible|1|||
163116788|NCT01323270|589133972|FG001|Overall Study|Not eligible|1|||
163116789|NCT01323270|589133971|FG000|Overall Study|Death|1|||
163116790|NCT01323270|589133972|FG001|Overall Study|Death|0|||
163116791|NCT01323270|589133971|FG000|Overall Study|Randomized, but not vaccinated|1|||
163116792|NCT01323270|589133972|FG001|Overall Study|Randomized, but not vaccinated|0|||
163116793|NCT02229214|589133981|FG000|Overall Study|Adverse Event|2|||
163116794|NCT02229214|589133982|FG001|Overall Study|Adverse Event|0|||
163116795|NCT02229214|589133981|FG000|Overall Study|Withdrawal by Subject|4|||
163116796|NCT02229214|589133982|FG001|Overall Study|Withdrawal by Subject|0|||
163116797|NCT00246025|589133983|FG000|Overall Study|Adverse Event|7|||
163116798|NCT00246025|589133984|FG001|Overall Study|Adverse Event|9|||
163116799|NCT00246025|589133985|FG002|Overall Study|Adverse Event|9|||
163116800|NCT00246025|589133986|FG003|Overall Study|Adverse Event|10|||
163116801|NCT00246025|589133983|FG000|Overall Study|Withdrawal by Subject|3|||
163116802|NCT00246025|589133984|FG001|Overall Study|Withdrawal by Subject|0|||
163116803|NCT00246025|589133985|FG002|Overall Study|Withdrawal by Subject|1|||
163116804|NCT00246025|589133986|FG003|Overall Study|Withdrawal by Subject|2|||
163116805|NCT00246025|589133983|FG000|Overall Study|unsuitable medical history was found|0|||
163116806|NCT00246025|589133984|FG001|Overall Study|unsuitable medical history was found|0|||
163116807|NCT00246025|589133985|FG002|Overall Study|unsuitable medical history was found|0|||
163116808|NCT00246025|589133986|FG003|Overall Study|unsuitable medical history was found|1|||
163116809|NCT03305081|589133989|FG000|Overall Study|Lost to Follow-up|10|||
163116810|NCT03305081|589133990|FG001|Overall Study|Lost to Follow-up|15|||
163116811|NCT01218100|589133991|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
163116812|NCT01218100|589133992|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
163116813|NCT01218100|589133993|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
163116814|NCT01218100|589133994|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
163116815|NCT01218100|589133991|FG000|Overall Study|Adverse Event|4|||
163116816|NCT01218100|589133992|FG001|Overall Study|Adverse Event|6|||
163116817|NCT01218100|589133993|FG002|Overall Study|Adverse Event|6|||
163116818|NCT01218100|589133994|FG003|Overall Study|Adverse Event|7|||
163340217|NCT00103857|589953153|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
163340218|NCT00103857|589953154|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
163407952|NCT00328627|590203966|FG005|Overall Study|Pregnancy|0|||
163116819|NCT01218100|589133991|FG000|Overall Study|Lack of Efficacy|9|||
163116820|NCT01218100|589133992|FG001|Overall Study|Lack of Efficacy|6|||
163116821|NCT01218100|589133993|FG002|Overall Study|Lack of Efficacy|5|||
163116822|NCT01218100|589133994|FG003|Overall Study|Lack of Efficacy|12|||
163116823|NCT01218100|589133991|FG000|Overall Study|Protocol Violation|0|||
163116824|NCT01218100|589133992|FG001|Overall Study|Protocol Violation|0|||
163116825|NCT01218100|589133993|FG002|Overall Study|Protocol Violation|1|||
163116826|NCT01218100|589133994|FG003|Overall Study|Protocol Violation|1|||
163116827|NCT01218100|589133991|FG000|Overall Study|Withdrawal by Subject|5|||
163116828|NCT01218100|589133992|FG001|Overall Study|Withdrawal by Subject|2|||
163116829|NCT01218100|589133993|FG002|Overall Study|Withdrawal by Subject|6|||
163116830|NCT01218100|589133994|FG003|Overall Study|Withdrawal by Subject|7|||
163116831|NCT01218100|589133991|FG000|Overall Study|Lost to Follow-up|3|||
163116832|NCT01218100|589133992|FG001|Overall Study|Lost to Follow-up|8|||
163116833|NCT01218100|589133993|FG002|Overall Study|Lost to Follow-up|2|||
163116834|NCT01218100|589133994|FG003|Overall Study|Lost to Follow-up|1|||
163116835|NCT01218100|589133991|FG000|Overall Study|Other Reason|2|||
163116836|NCT01218100|589133992|FG001|Overall Study|Other Reason|2|||
163116837|NCT01218100|589133993|FG002|Overall Study|Other Reason|6|||
163116838|NCT01218100|589133994|FG003|Overall Study|Other Reason|4|||
163116839|NCT02437305|589133995|FG000|Overall Study|Lost to Follow-up|18|||
163116840|NCT02437305|589133996|FG001|Overall Study|Lost to Follow-up|12|||
163116841|NCT01118520|589133997|FG000|Overall Study|AAA repair|9|||
163116842|NCT01118520|589133998|FG001|Overall Study|AAA repair|7|||
163116843|NCT01118520|589133999|FG002|Overall Study|AAA repair|9|||
163116844|NCT01118520|589133997|FG000|Overall Study|Adverse Event|3|||
163116845|NCT01118520|589133998|FG001|Overall Study|Adverse Event|3|||
163116846|NCT01118520|589133999|FG002|Overall Study|Adverse Event|3|||
163116847|NCT01118520|589133997|FG000|Overall Study|Withdrawal by Subject|8|||
163116848|NCT01118520|589133998|FG001|Overall Study|Withdrawal by Subject|13|||
163116849|NCT01118520|589133999|FG002|Overall Study|Withdrawal by Subject|8|||
163116850|NCT01170065|589134000|FG000|Overall Study|Adverse Event|17|||
163116851|NCT01170065|589134001|FG001|Overall Study|Adverse Event|50|||
163116852|NCT01170065|589134002|FG002|Overall Study|Adverse Event|10|||
163116853|NCT01170065|589134000|FG000|Overall Study|Lost to Follow-up|1|||
163116854|NCT01170065|589134001|FG001|Overall Study|Lost to Follow-up|4|||
163116855|NCT01170065|589134002|FG002|Overall Study|Lost to Follow-up|1|||
163116856|NCT01170065|589134000|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
163116857|NCT01170065|589134001|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
163116858|NCT01170065|589134002|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
163116859|NCT01170065|589134000|FG000|Overall Study|Reason other than specified|3|||
163116860|NCT01170065|589134001|FG001|Overall Study|Reason other than specified|8|||
163116861|NCT01170065|589134002|FG002|Overall Study|Reason other than specified|3|||
163116862|NCT01170065|589134000|FG000|Overall Study|Ongoing after planned observation time|5|||
163116863|NCT01170065|589134001|FG001|Overall Study|Ongoing after planned observation time|26|||
163116864|NCT01170065|589134002|FG002|Overall Study|Ongoing after planned observation time|10|||
163116865|NCT03220581|589134003|FG000|Overall Study|Withdrawal by Subject|0|||
163116866|NCT03220581|589134004|FG001|Overall Study|Withdrawal by Subject|1|||
163223347|NCT02465528|589535272|FG003|Overall Study|Study terminated by sponsor|0|||
163223348|NCT02465528|589535269|FG000|Overall Study|Withdrawal by Subject|0|||
163223349|NCT02465528|589535270|FG001|Overall Study|Withdrawal by Subject|0|||
163223350|NCT02465528|589535271|FG002|Overall Study|Withdrawal by Subject|2|||
163223351|NCT02465528|589535272|FG003|Overall Study|Withdrawal by Subject|0|||
163223352|NCT02465528|589535269|FG000|Overall Study|Adverse Event|0|||
163223353|NCT02465528|589535270|FG001|Overall Study|Adverse Event|0|||
163223354|NCT02465528|589535271|FG002|Overall Study|Adverse Event|0|||
163223355|NCT02465528|589535272|FG003|Overall Study|Adverse Event|1|||
163223356|NCT02465528|589535269|FG000|Overall Study|Physician Decision|0|||
163223357|NCT02465528|589535270|FG001|Overall Study|Physician Decision|0|||
163223358|NCT02465528|589535271|FG002|Overall Study|Physician Decision|1|||
163223359|NCT02465528|589535272|FG003|Overall Study|Physician Decision|0|||
163223360|NCT05358821|589535273|FG000|Overall Study|Withdrawal by Subject|0|||
163223361|NCT05358821|589535274|FG001|Overall Study|Withdrawal by Subject|1|||
163223362|NCT05358821|589535275|FG002|Overall Study|Withdrawal by Subject|0|||
163223363|NCT05358821|589535273|FG000|Overall Study|Withdrawal of Consent|0|||
163223364|NCT05358821|589535274|FG001|Overall Study|Withdrawal of Consent|0|||
163223365|NCT05358821|589535275|FG002|Overall Study|Withdrawal of Consent|1|||
163223366|NCT04098458|589535282|FG000|Overall Study|Death|1|||
163223367|NCT04098458|589535282|FG000|Overall Study|did not meet study inclusion criteria|3|||
163223368|NCT02272413|589535287|FG000|Randomized Through Treatment Start|Not treated|3|||
163223369|NCT02272413|589535288|FG001|Randomized Through Treatment Start|Not treated|5|||
163223370|NCT02272413|589535287|FG000|Pre-switch Period|Adverse Event|38|||
163223371|NCT02272413|589535288|FG001|Pre-switch Period|Adverse Event|37|||
163223372|NCT02272413|589535287|FG000|Pre-switch Period|Death|26|||
163223373|NCT02272413|589535288|FG001|Pre-switch Period|Death|26|||
163223374|NCT02272413|589535287|FG000|Pre-switch Period|Withdrawal by Subject|27|||
163223375|NCT02272413|589535288|FG001|Pre-switch Period|Withdrawal by Subject|15|||
163223376|NCT02272413|589535287|FG000|Pre-switch Period|Physician Decision|6|||
163223377|NCT02272413|589535288|FG001|Pre-switch Period|Physician Decision|18|||
163223378|NCT02272413|589535287|FG000|Pre-switch Period|Progressive disease|185|||
163223379|NCT02272413|589535288|FG001|Pre-switch Period|Progressive disease|173|||
163223380|NCT02272413|589535287|FG000|Pre-switch Period|Lost to Follow-up|0|||
163223381|NCT02272413|589535288|FG001|Pre-switch Period|Lost to Follow-up|2|||
163116867|NCT03220581|589134003|FG000|Overall Study|Lost to Follow-up|3|||
163116868|NCT03220581|589134004|FG001|Overall Study|Lost to Follow-up|6|||
163116869|NCT01071200|589134005|FG000|Overall Study|Lack of ovarian response|1|||
163116870|NCT01071200|589134006|FG001|Overall Study|Lack of ovarian response|1|||
163116871|NCT01071200|589134005|FG000|Overall Study|No fertilization|4|||
163116872|NCT01071200|589134006|FG001|Overall Study|No fertilization|0|||
163223382|NCT02272413|589535287|FG000|Pre-switch Period|Protocol Violation|1|||
163340219|NCT00103857|589953148|FG000|50-Week Extension Study|patient moved|0|||
163340220|NCT00103857|589953149|FG001|50-Week Extension Study|patient moved|0|||
163340221|NCT00103857|589953150|FG002|50-Week Extension Study|patient moved|1|||
163340222|NCT00103857|589953151|FG003|50-Week Extension Study|patient moved|2|||
163340223|NCT00103857|589953152|FG004|50-Week Extension Study|patient moved|0|||
163340224|NCT00103857|589953153|FG005|50-Week Extension Study|patient moved|0|||
163340225|NCT00103857|589953154|FG006|50-Week Extension Study|patient moved|0|||
163116873|NCT01071200|589134005|FG000|Overall Study|No oocytes retrieved|1|||
163116874|NCT01071200|589134006|FG001|Overall Study|No oocytes retrieved|1|||
163223383|NCT02272413|589535288|FG001|Pre-switch Period|Protocol Violation|0|||
163223384|NCT02272413|589535287|FG000|Pre-switch Period|Other than listed|10|||
163223385|NCT02272413|589535288|FG001|Pre-switch Period|Other than listed|11|||
163223386|NCT02272413|589535287|FG000|Post-switch Period|Adverse Event|4|||
163223387|NCT02272413|589535288|FG001|Post-switch Period|Adverse Event|4|||
163223388|NCT02272413|589535287|FG000|Post-switch Period|Death|3|||
163223389|NCT02272413|589535288|FG001|Post-switch Period|Death|2|||
163223390|NCT02272413|589535287|FG000|Post-switch Period|Withdrawal by Subject|1|||
163223391|NCT02272413|589535288|FG001|Post-switch Period|Withdrawal by Subject|2|||
163223392|NCT02272413|589535287|FG000|Post-switch Period|Physician Decision|1|||
163223393|NCT02272413|589535288|FG001|Post-switch Period|Physician Decision|1|||
163223394|NCT02272413|589535287|FG000|Post-switch Period|Progressive disease|21|||
163223395|NCT02272413|589535288|FG001|Post-switch Period|Progressive disease|21|||
163223396|NCT02272413|589535287|FG000|Post-switch Period|Study terminated by sponsor|8|||
163223397|NCT02272413|589535288|FG001|Post-switch Period|Study terminated by sponsor|11|||
163223398|NCT02272413|589535287|FG000|Post-switch Period|Other than listed|4|||
163116875|NCT01071200|589134005|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
163116876|NCT01071200|589134006|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
163116877|NCT01071200|589134005|FG000|Overall Study|No viable embryos|0|||
163116878|NCT01071200|589134006|FG001|Overall Study|No viable embryos|1|||
163116879|NCT01920893|589134009|FG000|Overall Study|Adverse Event|5|||
163116880|NCT01920893|589134010|FG001|Overall Study|Adverse Event|2|||
163116881|NCT01920893|589134009|FG000|Overall Study|Lack of Efficacy|2|||
163116882|NCT01920893|589134010|FG001|Overall Study|Lack of Efficacy|0|||
163116883|NCT01396265|589134011|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
163116884|NCT01767493|589134012|FG000|Overall Study|screen failures|3|||
163116885|NCT02446418|589134013|FG000|Overall Study|Adverse Event|4|||
163116886|NCT02446418|589134014|FG001|Overall Study|Adverse Event|8|||
163116887|NCT02446418|589134013|FG000|Overall Study|Physician Decision|5|||
163116888|NCT02446418|589134014|FG001|Overall Study|Physician Decision|1|||
163116889|NCT02446418|589134013|FG000|Overall Study|Withdrawal by Subject|3|||
163116890|NCT02446418|589134014|FG001|Overall Study|Withdrawal by Subject|3|||
163116891|NCT02446418|589134013|FG000|Overall Study|Lost to Follow-up|2|||
163116892|NCT02446418|589134014|FG001|Overall Study|Lost to Follow-up|2|||
163116893|NCT02446418|589134013|FG000|Overall Study|Protocol Violation|1|||
163116894|NCT02446418|589134014|FG001|Overall Study|Protocol Violation|2|||
163116895|NCT02446418|589134013|FG000|Overall Study|Lack of Efficacy|2|||
163116896|NCT02446418|589134014|FG001|Overall Study|Lack of Efficacy|0|||
163116897|NCT02446418|589134013|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
163116898|NCT02446418|589134014|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
163116899|NCT03093974|589134017|FG000|Overall Study|Withdrawal by Subject|32|||
163116900|NCT03093974|589134018|FG001|Overall Study|Withdrawal by Subject|27|||
163116901|NCT03093974|589134017|FG000|Overall Study|Adverse Event|17|||
163116902|NCT03093974|589134018|FG001|Overall Study|Adverse Event|24|||
163116903|NCT03093974|589134017|FG000|Overall Study|Death|0|||
163116904|NCT03093974|589134018|FG001|Overall Study|Death|1|||
163116905|NCT03093974|589134017|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163116906|NCT03093974|589134018|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163116907|NCT03093974|589134017|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
163223399|NCT02272413|589535288|FG001|Post-switch Period|Other than listed|5|||
163223400|NCT04327999|589535289|FG000|Overall Study|Protocol Violation|1|||
163223401|NCT02872116|589535290|FG000|Pre-Treatment|Disease Progression|0|||
163223402|NCT02872116|589535291|FG001|Pre-Treatment|Disease Progression|1|||
163223403|NCT02872116|589535292|FG002|Pre-Treatment|Disease Progression|0|||
163340226|NCT00103857|589953148|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
163116908|NCT03093974|589134018|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
163116909|NCT03093974|589134017|FG000|Overall Study|Lost to Follow-up|0|||
163116910|NCT03093974|589134018|FG001|Overall Study|Lost to Follow-up|1|||
163116911|NCT03093974|589134017|FG000|Overall Study|Other|1|||
163116912|NCT03093974|589134018|FG001|Overall Study|Other|2|||
163223404|NCT02872116|589535290|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
163340227|NCT00103857|589953149|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
163340228|NCT00103857|589953150|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
163116913|NCT01009346|589134023|FG000|Overall Study|Adverse Event|4|||
163116914|NCT00033540|589134024|FG000|Overall Study|Adverse Event|14|||
163116915|NCT00033540|589134024|FG000|Overall Study|Death|1|||
163116916|NCT00033540|589134024|FG000|Overall Study|Progression|26|||
163116917|NCT00033540|589134024|FG000|Overall Study|Withdrawal by Subject|6|||
163223405|NCT02872116|589535291|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
163223406|NCT02872116|589535292|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
163223407|NCT02872116|589535290|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
163223408|NCT02872116|589535291|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
163223409|NCT02872116|589535292|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
163223410|NCT02872116|589535290|FG000|Pre-Treatment|Participant withdrew consent|2|||
163223411|NCT02872116|589535291|FG001|Pre-Treatment|Participant withdrew consent|20|||
163223412|NCT02872116|589535292|FG002|Pre-Treatment|Participant withdrew consent|3|||
163223413|NCT02872116|589535290|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
163223414|NCT02872116|589535291|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
163223415|NCT02872116|589535292|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
163223416|NCT02872116|589535290|FG000|Pre-Treatment|Other reasons|1|||
163223417|NCT02872116|589535291|FG001|Pre-Treatment|Other reasons|2|||
163223418|NCT02872116|589535292|FG002|Pre-Treatment|Other reasons|2|||
163223419|NCT02872116|589535290|FG000|Treatment|Death|121|||
163223420|NCT02872116|589535291|FG001|Treatment|Death|94|||
163223421|NCT02872116|589535292|FG002|Treatment|Death|68|||
163223422|NCT02872116|589535290|FG000|Treatment|Lost to Follow-up|5|||
163223423|NCT02872116|589535291|FG001|Treatment|Lost to Follow-up|7|||
163223424|NCT02872116|589535292|FG002|Treatment|Lost to Follow-up|3|||
163223425|NCT02872116|589535290|FG000|Treatment|Participant withdrew consent|20|||
163223426|NCT02872116|589535291|FG001|Treatment|Participant withdrew consent|40|||
163223427|NCT02872116|589535292|FG002|Treatment|Participant withdrew consent|8|||
163223428|NCT02872116|589535290|FG000|Treatment|Other reasons|13|||
163223429|NCT02872116|589535291|FG001|Treatment|Other reasons|12|||
163223430|NCT02872116|589535292|FG002|Treatment|Other reasons|5|||
163223431|NCT03792672|589535297|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
163223432|NCT03792672|589535298|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
163223433|NCT03792672|589535299|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
163223434|NCT03792672|589535300|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
163223435|NCT03792672|589535301|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
163223436|NCT03792672|589535302|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
163223437|NCT03792672|589535297|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
163223438|NCT03792672|589535298|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
163223439|NCT03792672|589535299|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
163223440|NCT03792672|589535300|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
163223441|NCT03792672|589535301|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
163223442|NCT03792672|589535302|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
163223443|NCT03792672|589535297|FG000|Treatment Period 4 (2 Days)|Other|1|||
163223444|NCT03792672|589535298|FG001|Treatment Period 4 (2 Days)|Other|0|||
163223445|NCT03792672|589535299|FG002|Treatment Period 4 (2 Days)|Other|0|||
163223446|NCT03792672|589535300|FG003|Treatment Period 4 (2 Days)|Other|0|||
163223447|NCT03792672|589535301|FG004|Treatment Period 4 (2 Days)|Other|0|||
163223448|NCT03792672|589535302|FG005|Treatment Period 4 (2 Days)|Other|0|||
163223449|NCT00453999|589535303|FG000|Overall Study|Adverse Event|1|||
163223450|NCT00453999|589535304|FG001|Overall Study|Adverse Event|2|||
163223451|NCT00453999|589535305|FG002|Overall Study|Adverse Event|1|||
163223452|NCT00453999|589535303|FG000|Overall Study|Lost to Follow-up|0|||
163116918|NCT00033540|589134024|FG000|Overall Study|Other|5|||
163116919|NCT00033540|589134024|FG000|Overall Study|Ineligible|3|||
163116920|NCT00033540|589134024|FG000|Overall Study|Never received treatment|2|||
163116921|NCT01253265|589134027|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
163116922|NCT01253265|589134028|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
163116923|NCT01253265|589134029|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
163116924|NCT01253265|589134030|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
163116925|NCT01253265|589134031|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
163116926|NCT01253265|589134027|FG000|Overall Study|Withdrawal by Subject|0|||
163116927|NCT01253265|589134028|FG001|Overall Study|Withdrawal by Subject|0|||
163116928|NCT01253265|589134029|FG002|Overall Study|Withdrawal by Subject|0|||
163223453|NCT00453999|589535304|FG001|Overall Study|Lost to Follow-up|1|||
163116929|NCT01253265|589134030|FG003|Overall Study|Withdrawal by Subject|0|||
163116930|NCT01253265|589134031|FG004|Overall Study|Withdrawal by Subject|1|||
163223454|NCT00453999|589535305|FG002|Overall Study|Lost to Follow-up|1|||
163223455|NCT00453999|589535303|FG000|Overall Study|Withdrawal by Subject|2|||
163223456|NCT00453999|589535304|FG001|Overall Study|Withdrawal by Subject|1|||
163223457|NCT00453999|589535305|FG002|Overall Study|Withdrawal by Subject|1|||
163223458|NCT00453999|589535303|FG000|Overall Study|Subject Request|2|||
163223459|NCT00453999|589535304|FG001|Overall Study|Subject Request|1|||
163223460|NCT00453999|589535305|FG002|Overall Study|Subject Request|0|||
163223461|NCT04238728|589535308|FG000|Overall Study|Withdrawal by Subject|1|||
163340229|NCT00103857|589953151|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
163223462|NCT04238728|589535308|FG000|Overall Study|Lost to Follow-up|2|||
163340230|NCT00103857|589953152|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
163407953|NCT00328627|590203967|FG006|Overall Study|Pregnancy|0|||
163116931|NCT00066469|589134034|FG000|Overall Study|Death|3|||
163223463|NCT01907828|589535310|FG000|Overall Study|Exclusion criteria not met|0|||
163223464|NCT01907828|589535311|FG001|Overall Study|Exclusion criteria not met|1|||
163223465|NCT01907828|589535310|FG000|Overall Study|Withdrawal by Subject|3|||
163223466|NCT01907828|589535311|FG001|Overall Study|Withdrawal by Subject|4|||
163223467|NCT01907828|589535310|FG000|Overall Study|Lost to Follow-up|3|||
163223468|NCT01907828|589535311|FG001|Overall Study|Lost to Follow-up|0|||
163223469|NCT01907828|589535310|FG000|Overall Study|Participant refused 24-month follow-up|1|||
163223470|NCT01907828|589535311|FG001|Overall Study|Participant refused 24-month follow-up|0|||
163223471|NCT01907828|589535310|FG000|Overall Study|Participant met exclusion criteria|0|||
163223472|NCT01907828|589535311|FG001|Overall Study|Participant met exclusion criteria|1|||
163223473|NCT03925324|589535312|FG000|Overall Study|Death|1|||
163223474|NCT03925324|589535313|FG001|Overall Study|Death|1|||
163223475|NCT04414553|589535314|FG000|Overall Study|Lost to Follow-up|20|||
163223476|NCT03554291|589535324|FG000|Overall Study|Death|2|||
163223477|NCT03554291|589535325|FG001|Overall Study|Death|1|||
163223478|NCT03554291|589535324|FG000|Overall Study|Lost to Follow-up|1|||
163223479|NCT03554291|589535325|FG001|Overall Study|Lost to Follow-up|0|||
163223480|NCT03554291|589535324|FG000|Overall Study|Withdrawal by Subject|1|||
163223481|NCT03554291|589535325|FG001|Overall Study|Withdrawal by Subject|0|||
163223482|NCT03554291|589535324|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
163223483|NCT03554291|589535325|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
163223484|NCT00537381|589535326|FG000|Overall Study|Adverse Event|13|||
163223485|NCT00537381|589535327|FG001|Overall Study|Adverse Event|9|||
163223486|NCT00537381|589535326|FG000|Overall Study|Death|3|||
163223487|NCT00537381|589535327|FG001|Overall Study|Death|3|||
163223488|NCT00537381|589535326|FG000|Overall Study|Withdrawal by Subject|5|||
163223489|NCT00537381|589535327|FG001|Overall Study|Withdrawal by Subject|14|||
163223490|NCT00537381|589535326|FG000|Overall Study|Physician Decision|7|||
163223491|NCT00537381|589535327|FG001|Overall Study|Physician Decision|6|||
163223492|NCT00537381|589535326|FG000|Overall Study|Disease Progression|9|||
163223493|NCT00537381|589535327|FG001|Overall Study|Disease Progression|18|||
163223494|NCT00537381|589535326|FG000|Overall Study|Sponsor decision|14|||
163223495|NCT00537381|589535327|FG001|Overall Study|Sponsor decision|9|||
163223496|NCT00537381|589535326|FG000|Overall Study|Other|5|||
163223497|NCT00537381|589535327|FG001|Overall Study|Other|3|||
163223498|NCT04258605|589535336|FG000|Overall Study|Death|1|||
163223499|NCT04258605|589535337|FG001|Overall Study|Death|0|||
163223500|NCT04258605|589535336|FG000|Overall Study|Early study termination|21|||
163223501|NCT04258605|589535337|FG001|Overall Study|Early study termination|2|||
163223502|NCT02910167|589535338|FG000|Overall Study|Adverse Event|1|||
163223503|NCT02910167|589535338|FG000|Overall Study|Lost to Follow-up|18|||
163223504|NCT00842348|589535346|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
163223505|NCT00842348|589535347|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
163223506|NCT00842348|589535346|FG000|Study 729|Disease progression/death|19|||
163223507|NCT00842348|589535347|FG001|Study 729|Disease progression/death|30|||
163223508|NCT00842348|589535346|FG000|Study 729|Adverse Event|1|||
163223509|NCT00842348|589535347|FG001|Study 729|Adverse Event|1|||
163223510|NCT00842348|589535346|FG000|Study 729|Protocol Violation|1|||
163223511|NCT00842348|589535347|FG001|Study 729|Protocol Violation|1|||
163223512|NCT00842348|589535346|FG000|Study 729|Withdrawal by Subject|2|||
163223513|NCT00842348|589535347|FG001|Study 729|Withdrawal by Subject|4|||
163223514|NCT00842348|589535346|FG000|Study 729|Due to Sponsor stopping the study|1|||
163223515|NCT00842348|589535347|FG001|Study 729|Due to Sponsor stopping the study|1|||
163223516|NCT00842348|589535346|FG000|Study 729|Due to non-availability of IP|0|||
163223517|NCT00842348|589535347|FG001|Study 729|Due to non-availability of IP|1|||
163223518|NCT00842348|589535346|FG000|Study 729|Sponsor's decision|1|||
163223519|NCT00842348|589535347|FG001|Study 729|Sponsor's decision|0|||
163223520|NCT00842348|589535346|FG000|Study 729|Surgical resection|1|||
163223521|NCT00842348|589535347|FG001|Study 729|Surgical resection|0|||
163223522|NCT00026793|589535352|FG000|Overall Study|Death on study due to underlying disease|4|||
163223523|NCT00026793|589535352|FG000|Overall Study|Physician Decision|2|||
163223524|NCT00026793|589535352|FG000|Overall Study|Off study|2|||
163223525|NCT01449526|589535353|FG000|Overall Study|Lost to Follow-up|1|||
163223526|NCT01449526|589535354|FG001|Overall Study|Lost to Follow-up|2|||
163223527|NCT01449526|589535353|FG000|Overall Study|Withdrawal by Subject|1|||
163223528|NCT01449526|589535354|FG001|Overall Study|Withdrawal by Subject|1|||
163223529|NCT01449526|589535353|FG000|Overall Study|Symptoms/complaints|0|||
163223530|NCT01449526|589535354|FG001|Overall Study|Symptoms/complaints|1|||
163223531|NCT01449526|589535353|FG000|Overall Study|Lack of Motivation|0|||
163223532|NCT01449526|589535354|FG001|Overall Study|Lack of Motivation|1|||
163223533|NCT01449526|589535353|FG000|Overall Study|Cannot maintain visits|0|||
163223534|NCT01449526|589535354|FG001|Overall Study|Cannot maintain visits|1|||
163223535|NCT01132495|589535355|FG000|Overall Study|Various reasons|40|||
163223536|NCT01132495|589535356|FG001|Overall Study|Various reasons|38|||
163223537|NCT01132495|589535357|FG002|Overall Study|Various reasons|20|||
163223538|NCT01132495|589535358|FG003|Overall Study|Various reasons|12|||
163223539|NCT03913091|589535359|FG000|Overall Study|Lost to Follow-up|18|||
163223540|NCT03913091|589535360|FG001|Overall Study|Lost to Follow-up|11|||
163223541|NCT03913091|589535359|FG000|Overall Study|Required additional meds/surgery|1|||
163223542|NCT03913091|589535360|FG001|Overall Study|Required additional meds/surgery|2|||
163223543|NCT03913091|589535359|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
163223544|NCT03913091|589535360|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
163223545|NCT00655564|589535361|FG000|Overall Study|Adverse Event|1|||
163223546|NCT00655564|589535361|FG000|Overall Study|Lost to Follow-up|1|||
163223547|NCT00655564|589535361|FG000|Overall Study|Desired Alternate Therapy|1|||
163223548|NCT04013191|589537683|FG000|Overall Study|Adverse Event|1|||
163223549|NCT04013191|589537684|FG001|Overall Study|Adverse Event|0|||
163223550|NCT04144166|589537685|FG000|Overall Study|Discharged before study start|1|||
163223551|NCT04144166|589537685|FG000|Overall Study|Pregnancy|1|||
163223552|NCT04144166|589537685|FG000|Overall Study|Nail polish could not be removed from finger|1|||
163223553|NCT01236755|589537687|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
163223554|NCT01236755|589537687|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
163223555|NCT01236755|589537687|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
163223556|NCT01236755|589537687|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
163223557|NCT01481116|589537688|FG000|Overall Study|Adverse Event|26|||
163223558|NCT01481116|589537689|FG001|Overall Study|Adverse Event|26|||
163223559|NCT01481116|589537690|FG002|Overall Study|Adverse Event|42|||
163223560|NCT01481116|589537688|FG000|Overall Study|Major Protocol Deviation|3|||
163223561|NCT01481116|589537689|FG001|Overall Study|Major Protocol Deviation|7|||
163223562|NCT01481116|589537690|FG002|Overall Study|Major Protocol Deviation|1|||
163223563|NCT01481116|589537688|FG000|Overall Study|Lost to Follow-up|8|||
163223564|NCT01481116|589537689|FG001|Overall Study|Lost to Follow-up|12|||
163223565|NCT01481116|589537690|FG002|Overall Study|Lost to Follow-up|11|||
163223566|NCT01481116|589537688|FG000|Overall Study|Withdrawal by Subject|37|||
163223567|NCT01481116|589537689|FG001|Overall Study|Withdrawal by Subject|33|||
163223568|NCT01481116|589537690|FG002|Overall Study|Withdrawal by Subject|37|||
163223569|NCT01481116|589537688|FG000|Overall Study|Study Termination|730|||
163223570|NCT01481116|589537689|FG001|Overall Study|Study Termination|729|||
163223571|NCT01481116|589537690|FG002|Overall Study|Study Termination|713|||
163223572|NCT01481116|589537688|FG000|Overall Study|Pregnancy|0|||
163223573|NCT01481116|589537689|FG001|Overall Study|Pregnancy|0|||
163223574|NCT01481116|589537690|FG002|Overall Study|Pregnancy|1|||
163223575|NCT01481116|589537688|FG000|Overall Study|Lack of Efficacy|3|||
163223576|NCT01481116|589537689|FG001|Overall Study|Lack of Efficacy|3|||
163223577|NCT01481116|589537690|FG002|Overall Study|Lack of Efficacy|1|||
163223578|NCT01481116|589537688|FG000|Overall Study|Contraindications|1|||
163223579|NCT01481116|589537689|FG001|Overall Study|Contraindications|1|||
163223580|NCT01481116|589537690|FG002|Overall Study|Contraindications|0|||
163223581|NCT01481116|589537688|FG000|Overall Study|Other|1|||
163223582|NCT01481116|589537689|FG001|Overall Study|Other|1|||
163223583|NCT01481116|589537690|FG002|Overall Study|Other|0|||
163223584|NCT01481116|589537688|FG000|Overall Study|Participant Started Taking Glipizide|1|||
163223585|NCT01481116|589537689|FG001|Overall Study|Participant Started Taking Glipizide|0|||
163223586|NCT01481116|589537690|FG002|Overall Study|Participant Started Taking Glipizide|0|||
163223587|NCT01481116|589537688|FG000|Overall Study|Participant Moved Out of Area|2|||
163116932|NCT00066469|589134034|FG000|Overall Study|Lack of Efficacy|9|||
163116933|NCT00066469|589134034|FG000|Overall Study|Lost to Follow-up|1|||
163116934|NCT00066469|589134034|FG000|Overall Study|Physician Decision|1|||
163116935|NCT00066469|589134034|FG000|Overall Study|Withdrawal by Subject|1|||
163116936|NCT00066469|589134034|FG000|Overall Study|ineligible|1|||
163116937|NCT00882908|589134037|FG000|Overall Study|Adverse Event|0|||
163116938|NCT00882908|589134038|FG001|Overall Study|Adverse Event|0|||
163116939|NCT00882908|589134039|FG002|Overall Study|Adverse Event|1|||
163116940|NCT00882908|589134040|FG003|Overall Study|Adverse Event|0|||
163223588|NCT01481116|589537689|FG001|Overall Study|Participant Moved Out of Area|0|||
163223589|NCT01481116|589537690|FG002|Overall Study|Participant Moved Out of Area|1|||
163223590|NCT01481116|589537688|FG000|Overall Study|Participant Moved Out of Country|1|||
163223591|NCT01481116|589537689|FG001|Overall Study|Participant Moved Out of Country|0|||
163223592|NCT01481116|589537690|FG002|Overall Study|Participant Moved Out of Country|1|||
163223593|NCT01481116|589537688|FG000|Overall Study|Investigator Decision|3|||
163223594|NCT01481116|589537689|FG001|Overall Study|Investigator Decision|2|||
163223595|NCT01481116|589537690|FG002|Overall Study|Investigator Decision|1|||
163223596|NCT01481116|589537688|FG000|Overall Study|Sponsor Decision|0|||
163223597|NCT01481116|589537689|FG001|Overall Study|Sponsor Decision|1|||
163223598|NCT01481116|589537690|FG002|Overall Study|Sponsor Decision|3|||
163116941|NCT00882908|589134041|FG004|Overall Study|Adverse Event|1|||
163116942|NCT00882908|589134037|FG000|Overall Study|Lost to Follow-up|3|||
163116943|NCT00882908|589134038|FG001|Overall Study|Lost to Follow-up|5|||
163223599|NCT01481116|589537688|FG000|Overall Study|Non-Compliant With Study Drug|0|||
163223600|NCT01481116|589537689|FG001|Overall Study|Non-Compliant With Study Drug|1|||
163223601|NCT01481116|589537690|FG002|Overall Study|Non-Compliant With Study Drug|1|||
163116944|NCT00882908|589134039|FG002|Overall Study|Lost to Follow-up|3|||
163223602|NCT01481116|589537688|FG000|Overall Study|Investigator's Discretion|2|||
163116945|NCT00882908|589134040|FG003|Overall Study|Lost to Follow-up|1|||
163116946|NCT00882908|589134041|FG004|Overall Study|Lost to Follow-up|2|||
163116947|NCT00882908|589134037|FG000|Overall Study|Protocol Violation|0|||
163116948|NCT00882908|589134038|FG001|Overall Study|Protocol Violation|1|||
163116949|NCT00882908|589134039|FG002|Overall Study|Protocol Violation|0|||
163116950|NCT00882908|589134040|FG003|Overall Study|Protocol Violation|0|||
163116951|NCT00882908|589134041|FG004|Overall Study|Protocol Violation|0|||
163116952|NCT00882908|589134037|FG000|Overall Study|Withdrawal by Subject|0|||
163116953|NCT00882908|589134038|FG001|Overall Study|Withdrawal by Subject|0|||
163116954|NCT00882908|589134039|FG002|Overall Study|Withdrawal by Subject|3|||
163116955|NCT00882908|589134040|FG003|Overall Study|Withdrawal by Subject|5|||
163116956|NCT00882908|589134041|FG004|Overall Study|Withdrawal by Subject|2|||
163116957|NCT00882908|589134037|FG000|Overall Study|Subject reached a virologic endpoint|0|||
163116958|NCT00882908|589134038|FG001|Overall Study|Subject reached a virologic endpoint|0|||
163116959|NCT00882908|589134039|FG002|Overall Study|Subject reached a virologic endpoint|0|||
163116960|NCT00882908|589134040|FG003|Overall Study|Subject reached a virologic endpoint|0|||
163116961|NCT00882908|589134041|FG004|Overall Study|Subject reached a virologic endpoint|1|||
163116962|NCT00882908|589134037|FG000|Overall Study|Study terminated in error|0|||
163116963|NCT00882908|589134038|FG001|Overall Study|Study terminated in error|0|||
163116964|NCT00882908|589134039|FG002|Overall Study|Study terminated in error|0|||
163116965|NCT00882908|589134040|FG003|Overall Study|Study terminated in error|1|||
163116966|NCT00882908|589134041|FG004|Overall Study|Study terminated in error|0|||
163116967|NCT03283150|589134042|FG000|Overall Study|Withdrawal by Subject|6|||
163116968|NCT03283150|589134043|FG001|Overall Study|Withdrawal by Subject|0|||
163116969|NCT03283150|589134044|FG002|Overall Study|Withdrawal by Subject|0|||
163116970|NCT00581828|589134045|FG000|Overall Study|Protocol Violation|1|||
163116971|NCT02981407|589134046|FG000|Overall Study|Withdrawal by Subject|2|||
163116972|NCT02981407|589134047|FG001|Overall Study|Withdrawal by Subject|0|||
163116973|NCT02410824|589134050|FG000|First Intervention (One Week)|Headache|0|||
163116974|NCT02410824|589134051|FG001|First Intervention (One Week)|Headache|1|||
163116975|NCT00392808|589134052|FG000|Overall Study|Lost to Follow-up|3|||
163116976|NCT00392808|589134053|FG001|Overall Study|Lost to Follow-up|2|||
163116977|NCT00392808|589134054|FG002|Overall Study|Lost to Follow-up|1|||
163116978|NCT00392808|589134055|FG003|Overall Study|Lost to Follow-up|2|||
163116979|NCT00392808|589134052|FG000|Overall Study|Unable to withdraw blood|3|||
163116980|NCT00392808|589134053|FG001|Overall Study|Unable to withdraw blood|1|||
163116981|NCT00392808|589134054|FG002|Overall Study|Unable to withdraw blood|1|||
163116982|NCT00392808|589134055|FG003|Overall Study|Unable to withdraw blood|2|||
163116983|NCT02084238|589134056|FG000|Overall Study|Lost to Follow-up|2|||
163116984|NCT02436408|589134057|FG000|Overall Study|Death|1|||
163116985|NCT02818036|589134058|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
163116986|NCT02818036|589134059|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
163116987|NCT02818036|589134058|FG000|Overall Study|Withdrawal by Subject|1|||
163116988|NCT02818036|589134059|FG001|Overall Study|Withdrawal by Subject|0|||
163116989|NCT01038713|589134060|FG000|Overall Study|Patient to hospice|1|||
163116990|NCT01038713|589134061|FG001|Overall Study|Patient to hospice|1|||
163116991|NCT01038713|589134062|FG002|Overall Study|Patient to hospice|1|||
163116992|NCT01038713|589134060|FG000|Overall Study|Lost to Follow-up|3|||
163116993|NCT01038713|589134061|FG001|Overall Study|Lost to Follow-up|0|||
163116994|NCT01038713|589134062|FG002|Overall Study|Lost to Follow-up|0|||
163116995|NCT01038713|589134060|FG000|Overall Study|Neuroendocrine Tumor|0|||
163116996|NCT01038713|589134061|FG001|Overall Study|Neuroendocrine Tumor|1|||
163116997|NCT01038713|589134062|FG002|Overall Study|Neuroendocrine Tumor|0|||
163116998|NCT01038713|589134060|FG000|Overall Study|died from PEP|0|||
163116999|NCT01038713|589134061|FG001|Overall Study|died from PEP|1|||
163117000|NCT01038713|589134062|FG002|Overall Study|died from PEP|0|||
163117001|NCT01038713|589134060|FG000|Overall Study|Autoimmune Pancreatitis|1|||
163117002|NCT01038713|589134061|FG001|Overall Study|Autoimmune Pancreatitis|0|||
163117003|NCT01038713|589134062|FG002|Overall Study|Autoimmune Pancreatitis|0|||
163117004|NCT01154283|589134063|FG000|0-6 Weeks|Withdrawal by Subject|7|||
163117005|NCT01154283|589134064|FG001|0-6 Weeks|Withdrawal by Subject|2|||
163117006|NCT01154283|589134063|FG000|0-6 Weeks|Death|0|||
163117007|NCT01154283|589134064|FG001|0-6 Weeks|Death|1|||
163117008|NCT01154283|589134063|FG000|7-12 Weeks|Death|1|||
163117009|NCT01154283|589134064|FG001|7-12 Weeks|Death|0|||
163117010|NCT01154283|589134063|FG000|7-12 Weeks|Withdrawal by Subject|0|||
163117011|NCT01154283|589134064|FG001|7-12 Weeks|Withdrawal by Subject|1|||
163117012|NCT03777917|589134065|FG000|Overall Study|Withdrawal by Subject|1|||
163117013|NCT03777917|589134066|FG001|Overall Study|Withdrawal by Subject|0|||
163117014|NCT03777917|589134065|FG000|Overall Study|Physician Decision|1|||
163117015|NCT03777917|589134066|FG001|Overall Study|Physician Decision|0|||
163117016|NCT03777917|589134065|FG000|Overall Study|Lost to Follow-up|6|||
163117017|NCT03777917|589134066|FG001|Overall Study|Lost to Follow-up|2|||
163117018|NCT03777917|589134065|FG000|Overall Study|Other|1|||
163117019|NCT03777917|589134066|FG001|Overall Study|Other|0|||
163117020|NCT00320372|589134067|FG000|Overall Study|Physician Decision|4|||
163117021|NCT00320372|589134068|FG001|Overall Study|Physician Decision|7|||
163117022|NCT00320372|589134067|FG000|Overall Study|Death|7|||
163117023|NCT00320372|589134068|FG001|Overall Study|Death|8|||
163223603|NCT01481116|589537689|FG001|Overall Study|Investigator's Discretion|0|||
163223604|NCT01481116|589537690|FG002|Overall Study|Investigator's Discretion|0|||
163223605|NCT01481116|589537688|FG000|Overall Study|Death|2|||
163223606|NCT01481116|589537689|FG001|Overall Study|Death|1|||
163223607|NCT01481116|589537690|FG002|Overall Study|Death|0|||
163223608|NCT01481116|589537688|FG000|Overall Study|Hypoglycemic Event|4|||
163223609|NCT01481116|589537689|FG001|Overall Study|Hypoglycemic Event|0|||
163223610|NCT01481116|589537690|FG002|Overall Study|Hypoglycemic Event|0|||
163223611|NCT03848845|589537691|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
163223612|NCT03848845|589537692|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
163223613|NCT03848845|589537693|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
163223614|NCT03848845|589537694|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
163223615|NCT03848845|589537691|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
163223616|NCT03848845|589537692|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
163223617|NCT03848845|589537693|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
163223618|NCT03848845|589537694|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
163223619|NCT03848845|589537691|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
163223620|NCT03848845|589537692|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
163117024|NCT00320372|589134067|FG000|Overall Study|Withdrawal by Subject|55|||
163117025|NCT00320372|589134068|FG001|Overall Study|Withdrawal by Subject|37|||
163117026|NCT00320372|589134067|FG000|Overall Study|Non-Compliance|40|||
163117027|NCT00320372|589134068|FG001|Overall Study|Non-Compliance|39|||
163117028|NCT00320372|589134067|FG000|Overall Study|Did not Meet (I/E)|3|||
163117029|NCT00320372|589134068|FG001|Overall Study|Did not Meet (I/E)|1|||
163117030|NCT00320372|589134067|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
163117031|NCT00320372|589134068|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
163117032|NCT04063787|589134069|FG000|Overall Study|Inadequate Doppler data|4|||
163117033|NCT04063787|589134069|FG000|Overall Study|Lost to Follow-up|2|||
163117034|NCT04063787|589134069|FG000|Overall Study|Death|3|||
163117035|NCT01416441|589134070|FG000|Overall Study|Lost to Follow-up|5|||
163117036|NCT01416441|589134070|FG000|Overall Study|Adverse Event|6|||
163117037|NCT01416441|589134070|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
163117038|NCT01416441|589134070|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
163117039|NCT01416441|589134070|FG000|Overall Study|Investigator Withdrew Subject|2|||
163117040|NCT01416441|589134070|FG000|Overall Study|Subject Withdrew Consent|12|||
163117041|NCT01416441|589134070|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
163117042|NCT02191605|589135448|FG000|Overall Study|Lost to Follow-up|9|||
163117043|NCT02191605|589135449|FG001|Overall Study|Lost to Follow-up|4|||
163117044|NCT02191605|589135450|FG002|Overall Study|Lost to Follow-up|7|||
163117045|NCT02191605|589135451|FG003|Overall Study|Lost to Follow-up|3|||
163117046|NCT02191605|589135452|FG004|Overall Study|Lost to Follow-up|4|||
163117047|NCT03131596|589135457|FG000|Overall Study|Protocol Violation|3|||
163117048|NCT03131596|589135458|FG001|Overall Study|Protocol Violation|3|||
163117049|NCT03131596|589135457|FG000|Overall Study|Lost to Follow-up|3|||
163117050|NCT03131596|589135458|FG001|Overall Study|Lost to Follow-up|0|||
163117051|NCT00734071|589135459|FG000|Overall Study|Adverse Event|4|||
163117052|NCT00734071|589135460|FG001|Overall Study|Adverse Event|3|||
163117053|NCT00734071|589135459|FG000|Overall Study|Lack of Efficacy|3|||
163117054|NCT00734071|589135460|FG001|Overall Study|Lack of Efficacy|1|||
163117055|NCT00734071|589135459|FG000|Overall Study|Noncompliance|2|||
163117056|NCT00734071|589135460|FG001|Overall Study|Noncompliance|2|||
163117057|NCT00734071|589135459|FG000|Overall Study|Protocol Deviations|3|||
163117058|NCT00734071|589135460|FG001|Overall Study|Protocol Deviations|4|||
163117059|NCT00734071|589135459|FG000|Overall Study|Voluntary Withdrawal|9|||
163117060|NCT00734071|589135460|FG001|Overall Study|Voluntary Withdrawal|7|||
163117061|NCT00734071|589135459|FG000|Overall Study|Lost to Follow-up|16|||
163117062|NCT00734071|589135460|FG001|Overall Study|Lost to Follow-up|8|||
163117063|NCT00734071|589135459|FG000|Overall Study|Other|1|||
163117064|NCT00734071|589135460|FG001|Overall Study|Other|2|||
163117065|NCT03654885|589135461|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
163117066|NCT03654885|589135462|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
163117067|NCT03654885|589135461|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
163117068|NCT03654885|589135462|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
163117069|NCT03654885|589135461|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
163117070|NCT03654885|589135462|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
163117071|NCT03654885|589135461|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
163117072|NCT03654885|589135462|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
163223621|NCT03848845|589537693|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
163223622|NCT03848845|589537694|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
163223623|NCT03848845|589537691|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
163223624|NCT03848845|589537692|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
163117073|NCT03654885|589135461|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
163223625|NCT03848845|589537693|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
163223626|NCT03848845|589537694|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
163223627|NCT02433834|589537696|FG000|Overall Study|Protocol-specified criteria|7|||
163223628|NCT02433834|589537696|FG000|Overall Study|Protocol Violation|3|||
163223629|NCT02433834|589537696|FG000|Overall Study|Lost to Follow-up|6|||
163223630|NCT02433834|589537696|FG000|Overall Study|Withdrawal by Subject|14|||
163223631|NCT02433834|589537696|FG000|Overall Study|Adverse Event|6|||
163223632|NCT02433834|589537696|FG000|Overall Study|Physician Decision|1|||
163223633|NCT00934544|589537697|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
163223634|NCT00934544|589537698|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
163223635|NCT00934544|589537699|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
163223636|NCT00934544|589537697|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
163223637|NCT00934544|589537698|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
163223638|NCT00934544|589537699|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
163223639|NCT00934544|589537697|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
163223640|NCT00934544|589537698|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
163223641|NCT00934544|589537699|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
163223642|NCT00934544|589537697|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
163223643|NCT00934544|589537698|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
163223644|NCT00934544|589537699|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
163223645|NCT00934544|589537697|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
163223646|NCT00934544|589537698|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
163223647|NCT00934544|589537699|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
163223648|NCT00934544|589537697|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
163223649|NCT00934544|589537698|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
163223650|NCT00934544|589537699|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
163223651|NCT00934544|589537697|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
163223652|NCT00934544|589537698|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
163223653|NCT00934544|589537699|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
163223654|NCT00934544|589537697|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
163223655|NCT00934544|589537698|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
163223656|NCT00934544|589537699|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
163223657|NCT00934544|589537697|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
163223658|NCT00934544|589537698|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
163223659|NCT00934544|589537699|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
163223660|NCT00934544|589537697|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
163223661|NCT00934544|589537698|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
163223662|NCT00934544|589537699|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
163223663|NCT00934544|589537697|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
163223664|NCT00934544|589537698|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
163223665|NCT00934544|589537699|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
163223666|NCT00934544|589537697|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
163223667|NCT00934544|589537698|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
163223668|NCT00934544|589537699|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
163223669|NCT00934544|589537697|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
163223670|NCT00934544|589537698|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
163223671|NCT00934544|589537699|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
163223672|NCT00934544|589537697|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
163223673|NCT00934544|589537698|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
163223674|NCT00934544|589537699|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
163223675|NCT00934544|589537697|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
163407954|NCT00328627|590203968|FG007|Overall Study|Pregnancy|0|||
163407955|NCT00328627|590203969|FG008|Overall Study|Pregnancy|0|||
163223676|NCT00934544|589537698|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
163223677|NCT00934544|589537699|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
163223678|NCT00934544|589537697|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
163223679|NCT00934544|589537698|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
163223680|NCT00934544|589537699|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
163223681|NCT02643251|589537700|FG000|Overall Study|Adverse Event|3|||
163223682|NCT02643251|589537701|FG001|Overall Study|Adverse Event|1|||
163223683|NCT02643251|589537700|FG000|Overall Study|Withdrawal by Subject|2|||
163223684|NCT02643251|589537701|FG001|Overall Study|Withdrawal by Subject|0|||
163223685|NCT02643251|589537700|FG000|Overall Study|Lost to Follow-up|4|||
163223686|NCT02643251|589537701|FG001|Overall Study|Lost to Follow-up|1|||
163407956|NCT00328627|590203970|FG009|Overall Study|Pregnancy|0|||
163407957|NCT00328627|590203971|FG010|Overall Study|Pregnancy|0|||
163223687|NCT02643251|589537700|FG000|Overall Study|Protocol Violation|1|||
163223688|NCT02643251|589537701|FG001|Overall Study|Protocol Violation|0|||
163223689|NCT02643251|589537700|FG000|Overall Study|PI Decision to terminate patient|1|||
163223690|NCT02643251|589537701|FG001|Overall Study|PI Decision to terminate patient|0|||
163223691|NCT00348556|589537702|FG000|Overall Study|Adverse Event|1|||
163223692|NCT00192075|589537703|FG000|Overall Study|Disease Progression|23|||
163223693|NCT00192075|589537704|FG001|Overall Study|Disease Progression|6|||
163223694|NCT00192075|589537703|FG000|Overall Study|Adverse Event|1|||
163223695|NCT00192075|589537704|FG001|Overall Study|Adverse Event|3|||
163223696|NCT00192075|589537703|FG000|Overall Study|Death|0|||
163223697|NCT00192075|589537704|FG001|Overall Study|Death|1|||
163223698|NCT00192075|589537703|FG000|Overall Study|Lack of Efficacy|0|||
163223699|NCT00192075|589537704|FG001|Overall Study|Lack of Efficacy|0|||
163223700|NCT00192075|589537703|FG000|Overall Study|Physician Decision|3|||
163223701|NCT00192075|589537704|FG001|Overall Study|Physician Decision|0|||
163223702|NCT00192075|589537703|FG000|Overall Study|Withdrawal by Subject|5|||
163223703|NCT00192075|589537704|FG001|Overall Study|Withdrawal by Subject|5|||
163223704|NCT00192075|589537703|FG000|Overall Study|Patient Non-Compliance|0|||
163223705|NCT00192075|589537704|FG001|Overall Study|Patient Non-Compliance|1|||
163223706|NCT00192075|589537703|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
163223707|NCT00192075|589537704|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
163223708|NCT00192075|589537703|FG000|Overall Study|Other|5|||
163223709|NCT00192075|589537704|FG001|Overall Study|Other|2|||
163223710|NCT00779675|589537705|FG000|Treatment Period|Adverse Event|87|||
163223711|NCT00779675|589537705|FG000|Treatment Period|Treatment Failure|80|||
163223712|NCT00779675|589537705|FG000|Treatment Period|Transferred to Another Study|38|||
163223713|NCT00779675|589537705|FG000|Treatment Period|Lost to Follow-up|23|||
163223714|NCT00779675|589537705|FG000|Treatment Period|Withdrawal by Subject|46|||
163223715|NCT00779675|589537705|FG000|Treatment Period|Protocol Violation|54|||
163223716|NCT00779675|589537705|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
163223717|NCT00779675|589537705|FG000|Treatment Period|Administrative|3|||
163223718|NCT00779675|589537705|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
163223719|NCT00779675|589537705|FG000|Extended Treatment Period|Protocol Violation|13|||
163223720|NCT00779675|589537705|FG000|Extended Treatment Period|Adverse Event|6|||
163223721|NCT00779675|589537705|FG000|Extended Treatment Period|Treatment Failure|11|||
163223722|NCT00779675|589537705|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
163223723|NCT00779675|589537705|FG000|Extended Treatment Period|Lost to Follow-up|6|||
163223724|NCT01944059|589537706|FG000|Overall Study|Lost to Follow-up|1|||
163223725|NCT01944059|589537706|FG000|Overall Study|Physician Decision|3|||
163223726|NCT01944059|589537706|FG000|Overall Study|Withdrawal by Subject|1|||
163223727|NCT01944059|589537706|FG000|Overall Study|Adverse Event|2|||
163223728|NCT00430092|589537713|FG000|Overall Study|Adverse Event|0|||
163223729|NCT00430092|589537714|FG001|Overall Study|Adverse Event|0|||
163223730|NCT00430092|589537715|FG002|Overall Study|Adverse Event|1|||
163223731|NCT00430092|589537713|FG000|Overall Study|Lack of Efficacy|5|||
163223732|NCT00430092|589537714|FG001|Overall Study|Lack of Efficacy|2|||
163223733|NCT00430092|589537715|FG002|Overall Study|Lack of Efficacy|54|||
163223734|NCT00430092|589537713|FG000|Overall Study|Lost to Follow-up|1|||
163223735|NCT00430092|589537714|FG001|Overall Study|Lost to Follow-up|0|||
163223736|NCT00430092|589537715|FG002|Overall Study|Lost to Follow-up|0|||
163223737|NCT00430092|589537713|FG000|Overall Study|Protocol Violation|0|||
163223738|NCT00430092|589537714|FG001|Overall Study|Protocol Violation|1|||
163223739|NCT00430092|589537715|FG002|Overall Study|Protocol Violation|1|||
163223740|NCT00430092|589537713|FG000|Overall Study|Withdrawal by Subject|0|||
163223741|NCT00430092|589537714|FG001|Overall Study|Withdrawal by Subject|1|||
163223742|NCT00430092|589537715|FG002|Overall Study|Withdrawal by Subject|1|||
163223743|NCT01956110|589537716|FG000|Overall Study|Protocol Violation|25|||
163223744|NCT01956110|589537717|FG001|Overall Study|Protocol Violation|11|||
163223745|NCT01956110|589537716|FG000|Overall Study|Adverse Event|9|||
163223746|NCT01956110|589537717|FG001|Overall Study|Adverse Event|10|||
163223747|NCT01956110|589537716|FG000|Overall Study|Personal reasons|1|||
163223748|NCT01956110|589537717|FG001|Overall Study|Personal reasons|1|||
163223749|NCT02118428|589537722|FG000|Overall Study|Physician Decision|0|||
163223750|NCT02118428|589537723|FG001|Overall Study|Physician Decision|1|||
163223751|NCT02118428|589537724|FG002|Overall Study|Physician Decision|0|||
163407958|NCT00328627|590203972|FG011|Overall Study|Pregnancy|0|||
163223752|NCT02118428|589537722|FG000|Overall Study|Withdrawal by Subject|2|||
163223753|NCT02118428|589537723|FG001|Overall Study|Withdrawal by Subject|2|||
163223754|NCT02118428|589537724|FG002|Overall Study|Withdrawal by Subject|0|||
163223755|NCT02118428|589537722|FG000|Overall Study|Death|7|||
163223756|NCT02118428|589537723|FG001|Overall Study|Death|5|||
163407959|NCT00328627|590203961|FG000|Overall Study|Physician Decision|4|||
163223757|NCT02118428|589537724|FG002|Overall Study|Death|0|||
163223758|NCT02118428|589537722|FG000|Overall Study|Lost to Follow-up|3|||
163223759|NCT02118428|589537723|FG001|Overall Study|Lost to Follow-up|1|||
163223760|NCT02118428|589537724|FG002|Overall Study|Lost to Follow-up|0|||
163223761|NCT02118428|589537722|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
163223762|NCT02118428|589537723|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
163117074|NCT03654885|589135462|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
163117075|NCT03654885|589135461|FG000|Overall Study|Adverse Event in Study Eye|3|||
163117076|NCT03654885|589135462|FG001|Overall Study|Adverse Event in Study Eye|0|||
163117077|NCT03654885|589135461|FG000|Overall Study|Consent Withdrawn|1|||
163117078|NCT03654885|589135462|FG001|Overall Study|Consent Withdrawn|0|||
163117079|NCT03654885|589135461|FG000|Overall Study|Death|3|||
163117080|NCT03654885|589135462|FG001|Overall Study|Death|1|||
163117081|NCT03654885|589135461|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
163117082|NCT03654885|589135462|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
163117083|NCT03654885|589135461|FG000|Overall Study|Lost to Follow-up|3|||
163117084|NCT03654885|589135462|FG001|Overall Study|Lost to Follow-up|3|||
163117085|NCT05275582|589135463|FG000|Overall Study|Lost to Follow-up|1|||
163117086|NCT05275582|589135464|FG001|Overall Study|Lost to Follow-up|0|||
163117087|NCT05275582|589135463|FG000|Overall Study|Withdrawal by Subject|0|||
163117088|NCT05275582|589135464|FG001|Overall Study|Withdrawal by Subject|2|||
163117089|NCT05275582|589135463|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
163117090|NCT05275582|589135464|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
163117091|NCT05275582|589135463|FG000|Overall Study|Death|1|||
163117092|NCT05275582|589135464|FG001|Overall Study|Death|0|||
163117093|NCT05275582|589135463|FG000|Overall Study|Protocol Violation|1|||
163117094|NCT05275582|589135464|FG001|Overall Study|Protocol Violation|0|||
163117095|NCT05320393|589135465|FG000|Overall Study|Withdrawal by Subject|1|||
163117096|NCT05320393|589135466|FG001|Overall Study|Withdrawal by Subject|0|||
163117097|NCT05320393|589135467|FG002|Overall Study|Withdrawal by Subject|2|||
163117098|NCT05320393|589135465|FG000|Overall Study|Lost to Follow-up|1|||
163117099|NCT05320393|589135466|FG001|Overall Study|Lost to Follow-up|2|||
163117100|NCT05320393|589135467|FG002|Overall Study|Lost to Follow-up|1|||
163117101|NCT05320393|589135465|FG000|Overall Study|Moved; too much driving|0|||
163117102|NCT05320393|589135466|FG001|Overall Study|Moved; too much driving|0|||
163117103|NCT05320393|589135467|FG002|Overall Study|Moved; too much driving|2|||
163117104|NCT05320393|589135465|FG000|Overall Study|Did not receive treatment|0|||
163117105|NCT05320393|589135466|FG001|Overall Study|Did not receive treatment|0|||
163117106|NCT05320393|589135467|FG002|Overall Study|Did not receive treatment|1|||
163117107|NCT04411420|589135468|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
163117108|NCT04411420|589135469|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
163117109|NCT04411420|589135468|FG000|Survey Subset|Lost to Follow-up|134|||
163117110|NCT04411420|589135469|FG001|Survey Subset|Lost to Follow-up|120|||
163117111|NCT03187834|589135470|FG000|Overall Study|Lost to Follow-up|0|||
163117112|NCT03187834|589135471|FG001|Overall Study|Lost to Follow-up|1|||
163117113|NCT03187834|589135472|FG002|Overall Study|Lost to Follow-up|2|||
163117114|NCT03187834|589135473|FG003|Overall Study|Lost to Follow-up|2|||
163117115|NCT03187834|589135470|FG000|Overall Study|Had invalid anthropometric measurements|5|||
163117116|NCT03187834|589135471|FG001|Overall Study|Had invalid anthropometric measurements|3|||
163117117|NCT03187834|589135472|FG002|Overall Study|Had invalid anthropometric measurements|4|||
163117118|NCT03187834|589135473|FG003|Overall Study|Had invalid anthropometric measurements|2|||
163117119|NCT03559699|589135474|FG000|Overall Study|Withdrawal by Subject|6|||
163117120|NCT03559699|589135474|FG000|Overall Study|Lost to Follow-up|1|||
163117121|NCT00031460|589135475|FG000|Overall Study|Lost to Follow-up|0|||
163117122|NCT00031460|589135476|FG001|Overall Study|Lost to Follow-up|1|||
163117123|NCT00031460|589135475|FG000|Overall Study|Withdrawal by Subject|1|||
163117124|NCT00031460|589135476|FG001|Overall Study|Withdrawal by Subject|1|||
163117125|NCT00031460|589135475|FG000|Overall Study|Non-Compliant|1|||
163117126|NCT00031460|589135476|FG001|Overall Study|Non-Compliant|1|||
163117127|NCT00031460|589135475|FG000|Overall Study|Death|0|||
163117128|NCT00031460|589135476|FG001|Overall Study|Death|1|||
163117129|NCT00031460|589135475|FG000|Overall Study|Reactivation of Disease|5|||
163117130|NCT00031460|589135476|FG001|Overall Study|Reactivation of Disease|9|||
163117131|NCT00031460|589135475|FG000|Overall Study|Disruption of blinded drug supply|2|||
163340231|NCT00103857|589953153|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
163340232|NCT00103857|589953154|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
163340233|NCT00103857|589953148|FG000|50-Week Extension Study|reason unspecified|0|||
163117132|NCT00031460|589135476|FG001|Overall Study|Disruption of blinded drug supply|0|||
163117133|NCT00031460|589135475|FG000|Overall Study|Confirmed unevaluable|0|||
163117134|NCT00031460|589135476|FG001|Overall Study|Confirmed unevaluable|1|||
163117135|NCT01930890|589135478|FG000|Overall Study|Study Termination|14|||
163117136|NCT01930890|589135479|FG001|Overall Study|Study Termination|28|||
163117137|NCT01930890|589135480|FG002|Overall Study|Study Termination|13|||
163117138|NCT01930890|589135481|FG003|Overall Study|Study Termination|25|||
163117139|NCT01930890|589135478|FG000|Overall Study|Death|0|||
163117140|NCT01930890|589135479|FG001|Overall Study|Death|0|||
163117141|NCT01930890|589135480|FG002|Overall Study|Death|0|||
163340234|NCT00103857|589953149|FG001|50-Week Extension Study|reason unspecified|0|||
163340235|NCT00103857|589953150|FG002|50-Week Extension Study|reason unspecified|0|||
163223763|NCT02118428|589537724|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
163223764|NCT01633944|589537727|FG000|Open-label Titration Phase|Adverse Event|109|||
163223765|NCT01633944|589537728|FG001|Open-label Titration Phase|Adverse Event|0|||
163117142|NCT01930890|589135481|FG003|Overall Study|Death|1|||
163117143|NCT01930890|589135478|FG000|Overall Study|Investigator Decision|0|||
163117144|NCT01930890|589135479|FG001|Overall Study|Investigator Decision|1|||
163117145|NCT01930890|589135480|FG002|Overall Study|Investigator Decision|0|||
163117146|NCT01930890|589135481|FG003|Overall Study|Investigator Decision|0|||
163117147|NCT01930890|589135478|FG000|Overall Study|Consent Withdrawn|0|||
163117148|NCT01930890|589135479|FG001|Overall Study|Consent Withdrawn|3|||
163117149|NCT01930890|589135480|FG002|Overall Study|Consent Withdrawn|0|||
163117150|NCT01930890|589135481|FG003|Overall Study|Consent Withdrawn|1|||
163117151|NCT01930890|589135478|FG000|Overall Study|Adverse Event|0|||
163117152|NCT01930890|589135479|FG001|Overall Study|Adverse Event|1|||
163117153|NCT01930890|589135480|FG002|Overall Study|Adverse Event|0|||
163117154|NCT01930890|589135481|FG003|Overall Study|Adverse Event|0|||
163117155|NCT01703117|589135490|FG000|Overall Study|Adverse Event|4|||
163117156|NCT01703117|589135491|FG001|Overall Study|Adverse Event|3|||
163117157|NCT01703117|589135490|FG000|Overall Study|Withdrawal by Subject|0|||
163117158|NCT01703117|589135491|FG001|Overall Study|Withdrawal by Subject|1|||
163117159|NCT00330928|589135496|FG000|Overall Study|Lost to Follow-up|6|||
163117160|NCT00330928|589135496|FG000|Overall Study|Physician Decision|9|||
163117161|NCT00330928|589135496|FG000|Overall Study|Death|1|||
163117162|NCT00330928|589135496|FG000|Overall Study|IVUS could not be performed.|1|||
163117163|NCT03028480|589135499|FG000|Overall Study|No revisit after the first prescription date|2|||
163117164|NCT03028480|589135499|FG000|Overall Study|Did not use the drug|1|||
163117165|NCT03028480|589135499|FG000|Overall Study|Violation of the enrollment deadline|10|||
163117166|NCT03028480|589135499|FG000|Overall Study|Case report forms were not collected|21|||
163117167|NCT00759356|589135504|FG000|Overall Study|Adverse Event|0|||
163117168|NCT00759356|589135505|FG001|Overall Study|Adverse Event|1|||
163117169|NCT00759356|589135504|FG000|Overall Study|Withdrawal by Subject|0|||
163117170|NCT00759356|589135505|FG001|Overall Study|Withdrawal by Subject|2|||
163117171|NCT00759356|589135504|FG000|Overall Study|Subject was unable to return|1|||
163117172|NCT00759356|589135505|FG001|Overall Study|Subject was unable to return|0|||
163117173|NCT02403635|589135510|FG000|Overall Study|Not eligible|9|||
163117174|NCT00585221|589135514|FG000|Overall Study|Protocol Violation|8|||
163117175|NCT02509052|589135515|FG000|Overall Study|Non compliance|0|||
163117176|NCT02509052|589135516|FG001|Overall Study|Non compliance|0|||
163117177|NCT02509052|589135517|FG002|Overall Study|Non compliance|1|||
163117178|NCT03554772|589135520|FG000|Overall Study|Lost to Follow-up|0|||
163117179|NCT03554772|589135521|FG001|Overall Study|Lost to Follow-up|0|||
163117180|NCT03554772|589135522|FG002|Overall Study|Lost to Follow-up|0|||
163117181|NCT03554772|589135523|FG003|Overall Study|Lost to Follow-up|2|||
163117182|NCT00241631|589135530|FG000|Run in (2 Weeks)|Physician Decision|3|||
163117183|NCT00241631|589135531|FG001|Run in (2 Weeks)|Physician Decision|3|||
163117184|NCT00241631|589135530|FG000|Phase 1 (4 Weeks)|sore throat|1|||
163117185|NCT00241631|589135531|FG001|Phase 1 (4 Weeks)|sore throat|0|||
163117186|NCT00241631|589135530|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
163117187|NCT00241631|589135531|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
163117188|NCT00241631|589135530|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
163117189|NCT00241631|589135531|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
163117190|NCT00241631|589135530|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
163117191|NCT00241631|589135531|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
163117192|NCT03444766|589135533|FG000|Overall Study|Other Reasons|2|||
163117193|NCT03444766|589135533|FG000|Overall Study|Participant Withdrew Consent|5|||
163117194|NCT03444766|589135533|FG000|Overall Study|Lost to Follow-up|2|||
163117195|NCT03444766|589135533|FG000|Overall Study|Death|2|||
163117196|NCT03444766|589135533|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
163117197|NCT03444766|589135533|FG000|Overall Study|Disease Progression|49|||
163117198|NCT03421743|589135536|FG000|Overall Study|Lack of Efficacy|1|||
163117199|NCT03421743|589135537|FG001|Overall Study|Lack of Efficacy|0|||
163117200|NCT03421743|589135536|FG000|Overall Study|Adverse Event|2|||
163117201|NCT03421743|589135537|FG001|Overall Study|Adverse Event|1|||
163117202|NCT03421743|589135536|FG000|Overall Study|Withdrawal by Subject|0|||
163117203|NCT03421743|589135537|FG001|Overall Study|Withdrawal by Subject|1|||
163117204|NCT00435162|589135538|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
163117205|NCT00435162|589135539|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
163223766|NCT01633944|589537729|FG002|Open-label Titration Phase|Adverse Event|0|||
163223767|NCT01633944|589537727|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
163223768|NCT01633944|589537728|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
163223769|NCT01633944|589537729|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
163223770|NCT01633944|589537727|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
163117206|NCT00435162|589135540|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
163117207|NCT00435162|589135541|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
163117208|NCT00435162|589135542|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
163117209|NCT00435162|589135543|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
163117210|NCT00694096|589135544|FG000|Overall Study|Withdrawal by Subject|5|||
163117211|NCT02680574|589135550|FG000|Overall Study|Death|137|||
163223771|NCT01633944|589537728|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
163223772|NCT01633944|589537729|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
163340236|NCT00103857|589953151|FG003|50-Week Extension Study|reason unspecified|0|||
163340237|NCT00103857|589953152|FG004|50-Week Extension Study|reason unspecified|1|||
163340238|NCT00103857|589953153|FG005|50-Week Extension Study|reason unspecified|0|||
163340239|NCT00103857|589953154|FG006|50-Week Extension Study|reason unspecified|0|||
163117212|NCT02680574|589135551|FG001|Overall Study|Death|137|||
163117213|NCT02680574|589135550|FG000|Overall Study|Withdrawal by Subject|17|||
163117214|NCT02680574|589135551|FG001|Overall Study|Withdrawal by Subject|9|||
163117215|NCT02680574|589135550|FG000|Overall Study|Lost to Follow-up|4|||
163117216|NCT02680574|589135551|FG001|Overall Study|Lost to Follow-up|6|||
163117217|NCT02078102|589135555|FG000|Overall Study|Adverse Event|1|||
163117218|NCT02078102|589135556|FG001|Overall Study|Adverse Event|0|||
163117219|NCT02078102|589135555|FG000|Overall Study|Withdrawal by Subject|1|||
163117220|NCT02078102|589135556|FG001|Overall Study|Withdrawal by Subject|0|||
163117221|NCT02078102|589135555|FG000|Overall Study|Physician Decision|0|||
163117222|NCT02078102|589135556|FG001|Overall Study|Physician Decision|1|||
163117223|NCT02185014|589135559|FG000|Overall Study|Adverse Event|18|||
163117224|NCT02185014|589135559|FG000|Overall Study|Withdrew Consent|8|||
163117225|NCT02185014|589135559|FG000|Overall Study|Lost to Follow-up|4|||
163117226|NCT02185014|589135559|FG000|Overall Study|Lack of Efficacy|14|||
163117227|NCT02185014|589135559|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
163117228|NCT02185014|589135559|FG000|Overall Study|Subject Noncompliance|1|||
163117229|NCT02185014|589135559|FG000|Overall Study|Other|4|||
163117230|NCT02141490|589135562|FG000|Overall Study|Screening failures|4|||
163117231|NCT02141490|589135563|FG001|Overall Study|Screening failures|0|||
163117232|NCT02141490|589135564|FG002|Overall Study|Screening failures|0|||
163117233|NCT01813721|589135565|FG000|Overall Study|Ineligibility determined|63|||
163117234|NCT01813721|589135565|FG000|Overall Study|Withdrawal by Subject|1|||
163117235|NCT02387164|589135566|FG000|Overall Study|Lost to Follow-up|2|||
163117236|NCT02387164|589135567|FG001|Overall Study|Lost to Follow-up|0|||
163117237|NCT02387164|589135566|FG000|Overall Study|Diagnosed|1|||
163117238|NCT02387164|589135567|FG001|Overall Study|Diagnosed|2|||
163117239|NCT02133664|589135570|FG000|Overall Study|Lost to Follow-up|2|||
163117240|NCT02133664|589135571|FG001|Overall Study|Lost to Follow-up|1|||
163117241|NCT02133664|589135570|FG000|Overall Study|Adverse Event|3|||
163117242|NCT02133664|589135571|FG001|Overall Study|Adverse Event|6|||
163117243|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
163117244|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
163117245|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
163117246|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
163117247|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
163117248|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
163117249|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
163117250|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
163117251|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
163117252|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
163117253|NCT03906656|589135572|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
163117254|NCT03906656|589135573|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
163117255|NCT03906656|589135572|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
163117256|NCT03906656|589135573|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
163117257|NCT03906656|589135572|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
163117258|NCT03906656|589135573|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
163117259|NCT03906656|589135572|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
163117260|NCT03906656|589135573|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
163117261|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
163117262|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
163117263|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
163340240|NCT01287832|589953157|FG000|Overall Study|Adverse Event|1|||
163340241|NCT01287832|589953158|FG001|Overall Study|Adverse Event|0|||
163340242|NCT01287832|589953157|FG000|Overall Study|Death|0|||
163117264|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
163117265|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
163117266|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
163117267|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
163117268|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
163117269|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
163117270|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
163117271|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
163117272|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
163117273|NCT03906656|589135572|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
163117274|NCT03906656|589135573|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
163340243|NCT01287832|589953158|FG001|Overall Study|Death|1|||
163340244|NCT03065400|589953161|FG000|Overall Study|Adverse Event|1|||
163340245|NCT03065400|589953161|FG000|Overall Study|Physician Decision|3|||
163340246|NCT03065400|589953161|FG000|Overall Study|Withdrawal by Subject|1|||
163340247|NCT03065400|589953161|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
163340248|NCT00632736|589953162|FG000|Overall Study|Adverse Event|104|||
163340249|NCT00632736|589953162|FG000|Overall Study|Lost to Follow-up|15|||
163340250|NCT00632736|589953162|FG000|Overall Study|Protocol Violation|14|||
163340251|NCT00632736|589953162|FG000|Overall Study|Withdrawal by Subject|99|||
163340252|NCT00632736|589953162|FG000|Overall Study|Lack of Efficacy|5|||
163340253|NCT00632736|589953162|FG000|Overall Study|Sponsor terminated study|5|||
163340254|NCT00632736|589953162|FG000|Overall Study|Non-compliance|10|||
163117275|NCT03906656|589135572|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
163117276|NCT03906656|589135573|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
163117277|NCT03906656|589135572|FG000|Home Use 2 (3 Months)|Death|2|||
163117278|NCT03906656|589135573|FG001|Home Use 2 (3 Months)|Death|0|||
163117279|NCT03906656|589135572|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
163117280|NCT03906656|589135573|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
163117281|NCT03906656|589135572|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
163117282|NCT03906656|589135573|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
163117283|NCT01036529|589135574|FG000|Overall Study|Adverse Event|0|||
163117284|NCT01036529|589135575|FG001|Overall Study|Adverse Event|1|||
163117285|NCT01036529|589135574|FG000|Overall Study|Lost to Follow-up|0|||
163117286|NCT01036529|589135575|FG001|Overall Study|Lost to Follow-up|1|||
163117287|NCT01036529|589135574|FG000|Overall Study|Physician Decision|1|||
163117288|NCT01036529|589135575|FG001|Overall Study|Physician Decision|0|||
163117289|NCT01036529|589135574|FG000|Overall Study|Withdrawal by Subject|1|||
163117290|NCT01036529|589135575|FG001|Overall Study|Withdrawal by Subject|1|||
163117291|NCT01036529|589135574|FG000|Overall Study|Sponsor study termination|11|||
163117292|NCT01036529|589135575|FG001|Overall Study|Sponsor study termination|12|||
163117293|NCT00343915|589135577|FG000|Primary Study|Withdrawal by Subject|1|||
163117294|NCT00343915|589135578|FG001|Primary Study|Withdrawal by Subject|0|||
163117295|NCT00343915|589135577|FG000|Primary Study|Lost to Follow-up|2|||
163117296|NCT00343915|589135578|FG001|Primary Study|Lost to Follow-up|3|||
163117297|NCT00343915|589135577|FG000|Primary Study|Other|1|||
163117298|NCT00343915|589135578|FG001|Primary Study|Other|0|||
163117299|NCT02525939|589135579|FG000|Overall Study|Lost to Follow-up|27|||
163117300|NCT02525939|589135580|FG001|Overall Study|Lost to Follow-up|24|||
163117301|NCT02525939|589135579|FG000|Overall Study|Physician Decision|0|||
163117302|NCT02525939|589135580|FG001|Overall Study|Physician Decision|1|||
163117303|NCT02525939|589135579|FG000|Overall Study|Withdrawal by Subject|24|||
163117304|NCT02525939|589135580|FG001|Overall Study|Withdrawal by Subject|39|||
163117305|NCT02525939|589135579|FG000|Overall Study|Death|180|||
163117306|NCT02525939|589135580|FG001|Overall Study|Death|179|||
163117307|NCT00536874|589135581|FG000|Overall Study|Adverse Event|1|||
163117308|NCT00536874|589135581|FG000|Overall Study|Death|2|||
163117309|NCT00536874|589135581|FG000|Overall Study|Withdrawal by Subject|1|||
163117310|NCT01853072|589135582|FG000|Overall Study|Adverse event prior to treatment|0|||
163117311|NCT01853072|589135583|FG001|Overall Study|Adverse event prior to treatment|1|||
163117312|NCT01853072|589135582|FG000|Overall Study|Adverse Event|0|||
163117313|NCT01853072|589135583|FG001|Overall Study|Adverse Event|3|||
163117314|NCT01853072|589135582|FG000|Overall Study|Death|1|||
163117315|NCT01853072|589135583|FG001|Overall Study|Death|4|||
163117316|NCT01853072|589135582|FG000|Overall Study|Lost to Follow-up|0|||
163117317|NCT01853072|589135583|FG001|Overall Study|Lost to Follow-up|3|||
163117318|NCT01853072|589135582|FG000|Overall Study|Non-compliance with study drug|0|||
163340255|NCT00632736|589953162|FG000|Overall Study|Other|16|||
163340256|NCT03347396|589953163|FG000|Part A (26 Weeks)|Adverse Event|1|||
163340257|NCT03347396|589953164|FG001|Part A (26 Weeks)|Adverse Event|0|||
163340258|NCT03347396|589953163|FG000|Part A (26 Weeks)|Death|0|||
163340259|NCT03347396|589953164|FG001|Part A (26 Weeks)|Death|1|||
163340260|NCT03347396|589953163|FG000|Part B (149 Weeks)|Adverse Event|1|||
163340261|NCT03347396|589953164|FG001|Part B (149 Weeks)|Adverse Event|1|||
163340262|NCT03347396|589953163|FG000|Part B (149 Weeks)|Death|1|||
163117319|NCT01853072|589135583|FG001|Overall Study|Non-compliance with study drug|1|||
163117320|NCT01853072|589135582|FG000|Overall Study|Physician Decision|1|||
163340263|NCT03347396|589953164|FG001|Part B (149 Weeks)|Death|0|||
163340264|NCT02312258|589953165|FG000|Overall Study|Lost to Follow-up|8|||
163340265|NCT02312258|589953166|FG001|Overall Study|Lost to Follow-up|8|||
163117321|NCT01853072|589135583|FG001|Overall Study|Physician Decision|1|||
163117322|NCT01853072|589135582|FG000|Overall Study|Withdrawal by Subject|1|||
163117323|NCT01853072|589135583|FG001|Overall Study|Withdrawal by Subject|2|||
163117324|NCT01853072|589135582|FG000|Overall Study|Reason not specified|9|||
163117325|NCT01853072|589135583|FG001|Overall Study|Reason not specified|6|||
163117326|NCT01287221|589135584|FG000|Overall Study|Lack of Perceived Benefit|1|||
163117327|NCT01287221|589135585|FG001|Overall Study|Lack of Perceived Benefit|1|||
163117328|NCT01287221|589135584|FG000|Overall Study|Adverse Event|3|||
163340266|NCT02312258|589953165|FG000|Overall Study|Withdrawal by Patient|49|||
163407960|NCT00328627|590203962|FG001|Overall Study|Physician Decision|3|||
163223773|NCT01633944|589537727|FG000|Open-label Titration Phase|Protocol Violation|24|||
163223774|NCT01633944|589537728|FG001|Open-label Titration Phase|Protocol Violation|0|||
163223775|NCT01633944|589537729|FG002|Open-label Titration Phase|Protocol Violation|0|||
163223776|NCT01633944|589537727|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
163223777|NCT01633944|589537728|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
163223778|NCT01633944|589537729|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
163223779|NCT01633944|589537727|FG000|Open-label Titration Phase|Other|68|||
163223780|NCT01633944|589537728|FG001|Open-label Titration Phase|Other|0|||
163223781|NCT01633944|589537729|FG002|Open-label Titration Phase|Other|0|||
163223782|NCT01633944|589537727|FG000|Double-blind Treatment Phase|Adverse Event|0|||
163223783|NCT01633944|589537728|FG001|Double-blind Treatment Phase|Adverse Event|13|||
163223784|NCT01633944|589537729|FG002|Double-blind Treatment Phase|Adverse Event|7|||
163223785|NCT01633944|589537727|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
163223786|NCT01633944|589537728|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
163223787|NCT01633944|589537729|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
163223788|NCT01633944|589537727|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
163223789|NCT01633944|589537728|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
163223790|NCT01633944|589537729|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
163223791|NCT01633944|589537727|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
163223792|NCT01633944|589537728|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
163223793|NCT01633944|589537729|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
163223794|NCT01633944|589537727|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
163223795|NCT01633944|589537728|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
163223796|NCT01633944|589537729|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
163223797|NCT01633944|589537727|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
163223798|NCT01633944|589537728|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
163223799|NCT01633944|589537729|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
163223800|NCT01633944|589537727|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
163223801|NCT01633944|589537728|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
163223802|NCT01633944|589537729|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
163223803|NCT01633944|589537727|FG000|Double-blind Treatment Phase|Other|0|||
163340267|NCT02312258|589953166|FG001|Overall Study|Withdrawal by Patient|76|||
163340268|NCT02312258|589953165|FG000|Overall Study|Reason not Specified|107|||
163223804|NCT01633944|589537728|FG001|Double-blind Treatment Phase|Other|7|||
163223805|NCT01633944|589537729|FG002|Double-blind Treatment Phase|Other|0|||
163223806|NCT00463060|589537730|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
163223807|NCT00463060|589537730|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
163223808|NCT00701129|589537731|FG000|Overall Study|Death|2|||
163223809|NCT01400841|589537732|FG000|Initial Study Phase (6 Months)|Death|1|||
163223810|NCT01400841|589537732|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
163223811|NCT00910715|589537733|FG000|Overall Study|Lost to Follow-up|22|||
163223812|NCT00910715|589537734|FG001|Overall Study|Lost to Follow-up|26|||
163223813|NCT00910715|589537735|FG002|Overall Study|Lost to Follow-up|0|||
163223814|NCT00706966|589537736|FG000|Overall Study|Adverse Event|1|||
163223815|NCT02884089|589537737|FG000|Period 1|Dosing error|2|||
163223816|NCT02884089|589537738|FG001|Period 1|Dosing error|2|||
163223817|NCT02884089|589537739|FG002|Period 1|Dosing error|0|||
163223818|NCT02884089|589537740|FG003|Period 1|Dosing error|0|||
163223819|NCT02884089|589537737|FG000|Washout Period 1|Lost to Follow-up|0|||
163223820|NCT02884089|589537738|FG001|Washout Period 1|Lost to Follow-up|1|||
163223821|NCT02884089|589537739|FG002|Washout Period 1|Lost to Follow-up|0|||
163340269|NCT02312258|589953166|FG001|Overall Study|Reason not Specified|159|||
163340270|NCT02312258|589953165|FG000|Overall Study|Missing|2|||
163340271|NCT02312258|589953166|FG001|Overall Study|Missing|1|||
163340272|NCT02312258|589953165|FG000|Overall Study|Death|115|||
163340273|NCT02312258|589953166|FG001|Overall Study|Death|181|||
163340274|NCT00946998|589954764|FG000|Overall Study|Exited prior to first outcome assessment|5|||
163223822|NCT02884089|589537740|FG003|Washout Period 1|Lost to Follow-up|1|||
163223823|NCT02884089|589537737|FG000|Washout Period 1|Withdrawal by Subject|0|||
163223824|NCT02884089|589537738|FG001|Washout Period 1|Withdrawal by Subject|1|||
163223825|NCT02884089|589537739|FG002|Washout Period 1|Withdrawal by Subject|0|||
163223826|NCT02884089|589537740|FG003|Washout Period 1|Withdrawal by Subject|0|||
163223827|NCT02884089|589537737|FG000|Period 2|Adverse Event|1|||
163223828|NCT02884089|589537738|FG001|Period 2|Adverse Event|0|||
163223829|NCT02884089|589537739|FG002|Period 2|Adverse Event|0|||
163223830|NCT02884089|589537740|FG003|Period 2|Adverse Event|0|||
163223831|NCT02884089|589537737|FG000|Period 3|Withdrawal by Subject|0|||
163223832|NCT02884089|589537738|FG001|Period 3|Withdrawal by Subject|0|||
163223833|NCT02884089|589537739|FG002|Period 3|Withdrawal by Subject|1|||
163223834|NCT02884089|589537740|FG003|Period 3|Withdrawal by Subject|0|||
163223835|NCT02884089|589537737|FG000|Washout Period 3|Withdrawal by Subject|0|||
163223836|NCT02884089|589537738|FG001|Washout Period 3|Withdrawal by Subject|0|||
163223837|NCT02884089|589537739|FG002|Washout Period 3|Withdrawal by Subject|1|||
163340275|NCT00946998|589954765|FG001|Overall Study|Exited prior to first outcome assessment|3|||
163407961|NCT00328627|590203963|FG002|Overall Study|Physician Decision|1|||
163407962|NCT00328627|590203964|FG003|Overall Study|Physician Decision|2|||
163407963|NCT00328627|590203965|FG004|Overall Study|Physician Decision|1|||
163407964|NCT00328627|590203966|FG005|Overall Study|Physician Decision|1|||
163117329|NCT01287221|589135585|FG001|Overall Study|Adverse Event|3|||
163117330|NCT01287221|589135584|FG000|Overall Study|Withdrawal by Subject|0|||
163117331|NCT01287221|589135585|FG001|Overall Study|Withdrawal by Subject|1|||
163117332|NCT00930969|589135586|FG000|Overall Study|Death|5|||
163117333|NCT00930969|589135586|FG000|Overall Study|Lost to Follow-up|1|||
163117334|NCT00930969|589135586|FG000|Overall Study|Physician Decision|13|||
163117335|NCT00930969|589135586|FG000|Overall Study|Withdrawal by Subject|19|||
163117336|NCT03515941|589135587|FG000|Overall Study|Adverse Event|1|||
163117337|NCT03515941|589135588|FG001|Overall Study|Adverse Event|0|||
163117338|NCT03959982|589138032|FG000|Overall Study|Withdrawal by Subject|1|||
163117339|NCT03959982|589138033|FG001|Overall Study|Withdrawal by Subject|0|||
163117340|NCT03959982|589138032|FG000|Overall Study|Physician Decision|2|||
163117341|NCT03959982|589138033|FG001|Overall Study|Physician Decision|0|||
163117342|NCT03959982|589138032|FG000|Overall Study|Lost to Follow-up|1|||
163117343|NCT03959982|589138033|FG001|Overall Study|Lost to Follow-up|0|||
163117344|NCT04030247|589138034|FG000|Overall Study|Withdrawal by Subject|4|||
163117345|NCT04030247|589138034|FG000|Overall Study|Lost to Follow-up|13|||
163117346|NCT01309269|589138037|FG000|Overall Study|Adverse Event|56|||
163117347|NCT01309269|589138037|FG000|Overall Study|Withdrawal by Subject|25|||
163117348|NCT01309269|589138037|FG000|Overall Study|Lack of Acceptance|15|||
163117349|NCT01309269|589138037|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
163117350|NCT01309269|589138037|FG000|Overall Study|Kidney Transplant|25|||
163117351|NCT01309269|589138037|FG000|Overall Study|Administrative Problems|141|||
163117352|NCT01309269|589138037|FG000|Overall Study|Other|256|||
163117353|NCT01309269|589138037|FG000|Overall Study|Other|1|||
163117354|NCT01309269|589138037|FG000|Overall Study|Study Completion Data Not Recorded|95|||
163117355|NCT01309269|589138037|FG000|Overall Study|Enrolled but not Treated|107|||
163117356|NCT03647267|589138054|FG000|Overall Study|Lost to Follow-up|1|||
163117357|NCT03647267|589138055|FG001|Overall Study|Lost to Follow-up|0|||
163117358|NCT05079477|589138056|FG000|Overall Study|Lost to Follow-up|2|||
163117359|NCT05079477|589138057|FG001|Overall Study|Lost to Follow-up|0|||
163117360|NCT05079477|589138056|FG000|Overall Study|Withdrawal by Subject|1|||
163117361|NCT05079477|589138057|FG001|Overall Study|Withdrawal by Subject|0|||
163117362|NCT05079477|589138056|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
163117363|NCT05079477|589138057|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
163117364|NCT05079477|589138056|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
163117365|NCT05079477|589138057|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
163117366|NCT00240110|589138061|FG000|Overall Study|Lost to Follow-up|6|||
163117367|NCT00240110|589138062|FG001|Overall Study|Lost to Follow-up|7|||
163117368|NCT02080260|589138064|FG000|Overall Study|Death|18|||
163117369|NCT02080260|589138064|FG000|Overall Study|Withdrawal by Subject|1|||
163117370|NCT05438602|589138065|FG000|Treatment (15 Days)|Adverse Event|2|||
163117371|NCT05438602|589138066|FG001|Treatment (15 Days)|Adverse Event|1|||
163117372|NCT05438602|589138067|FG002|Treatment (15 Days)|Adverse Event|3|||
163117373|NCT05438602|589138065|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
163117374|NCT05438602|589138066|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
163117375|NCT05438602|589138067|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
163117376|NCT05438602|589138065|FG000|Treatment (15 Days)|Other|0|||
163117377|NCT05438602|589138066|FG001|Treatment (15 Days)|Other|0|||
163117378|NCT05438602|589138067|FG002|Treatment (15 Days)|Other|1|||
163117379|NCT05438602|589138065|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
163117380|NCT05438602|589138066|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
163117381|NCT05438602|589138067|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
163117382|NCT05438602|589138065|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
163117383|NCT05438602|589138066|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
163117384|NCT05438602|589138067|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
163117385|NCT05438602|589138065|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
163117386|NCT05438602|589138066|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
163117387|NCT05438602|589138067|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
163117388|NCT05438602|589138065|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
163117389|NCT05438602|589138066|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
163117390|NCT05438602|589138067|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
163117391|NCT05438602|589138065|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
163117392|NCT05438602|589138066|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
163407965|NCT00328627|590203967|FG006|Overall Study|Physician Decision|1|||
163117393|NCT05438602|589138067|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
163117394|NCT05438602|589138065|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
163117395|NCT05438602|589138066|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
163117396|NCT05438602|589138067|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
163117397|NCT05438602|589138065|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
163223838|NCT02884089|589537740|FG003|Washout Period 3|Withdrawal by Subject|0|||
163223839|NCT02884089|589537737|FG000|Washout Period 3|Lost to Follow-up|0|||
163223840|NCT02884089|589537738|FG001|Washout Period 3|Lost to Follow-up|0|||
163223841|NCT02884089|589537739|FG002|Washout Period 3|Lost to Follow-up|0|||
163223842|NCT02884089|589537740|FG003|Washout Period 3|Lost to Follow-up|1|||
163223843|NCT02884089|589537737|FG000|Period 4|Withdrawal by Subject|0|||
163223844|NCT02884089|589537738|FG001|Period 4|Withdrawal by Subject|1|||
163223845|NCT02884089|589537739|FG002|Period 4|Withdrawal by Subject|0|||
163223846|NCT02884089|589537740|FG003|Period 4|Withdrawal by Subject|0|||
163223847|NCT02884089|589537737|FG000|Period 4|Lost to Follow-up|1|||
163223848|NCT02884089|589537738|FG001|Period 4|Lost to Follow-up|0|||
163223849|NCT02884089|589537739|FG002|Period 4|Lost to Follow-up|0|||
163223850|NCT02884089|589537740|FG003|Period 4|Lost to Follow-up|0|||
163223851|NCT02884089|589537737|FG000|Follow-up Visit|Withdrawal by Subject|1|||
163223852|NCT02884089|589537738|FG001|Follow-up Visit|Withdrawal by Subject|0|||
163223853|NCT02884089|589537739|FG002|Follow-up Visit|Withdrawal by Subject|0|||
163223854|NCT02884089|589537740|FG003|Follow-up Visit|Withdrawal by Subject|1|||
163223855|NCT01631474|589537741|FG000|Overall Study|Lost to Follow-up|8|||
163223856|NCT01631474|589537742|FG001|Overall Study|Lost to Follow-up|5|||
163340276|NCT01945593|589954766|FG000|Overall Study|Adverse Event|0|||
163340277|NCT01945593|589954767|FG001|Overall Study|Adverse Event|0|||
163340278|NCT01945593|589954768|FG002|Overall Study|Adverse Event|0|||
163340279|NCT01945593|589954769|FG003|Overall Study|Adverse Event|5|||
163340280|NCT01945593|589954766|FG000|Overall Study|Physician Decision|0|||
163340281|NCT01945593|589954767|FG001|Overall Study|Physician Decision|0|||
163340282|NCT01945593|589954768|FG002|Overall Study|Physician Decision|1|||
163340283|NCT01945593|589954769|FG003|Overall Study|Physician Decision|1|||
163117398|NCT05438602|589138066|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
163117399|NCT05438602|589138067|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
163117400|NCT02091284|589138068|FG000|Overall Study|Withdrawal by Subject|2|||
163117401|NCT02091284|589138069|FG001|Overall Study|Withdrawal by Subject|1|||
163117402|NCT02091284|589138068|FG000|Overall Study|unreliable data|1|||
163117403|NCT02091284|589138069|FG001|Overall Study|unreliable data|0|||
163117404|NCT02853435|589138070|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
163117405|NCT02853435|589138071|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
163117406|NCT02853435|589138072|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
163117407|NCT02853435|589138073|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
163117408|NCT02853435|589138074|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
163117409|NCT02853435|589138075|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
163117410|NCT03747120|589138078|FG000|Overall Study|treatment related toxicity|3|||
163117411|NCT03747120|589138079|FG001|Overall Study|treatment related toxicity|0|||
163117412|NCT03747120|589138080|FG002|Overall Study|treatment related toxicity|0|||
163117413|NCT03747120|589138078|FG000|Overall Study|Withdrawal by Subject|0|||
163117414|NCT03747120|589138079|FG001|Overall Study|Withdrawal by Subject|1|||
163117415|NCT03747120|589138080|FG002|Overall Study|Withdrawal by Subject|2|||
163117416|NCT02317809|589138102|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
163117417|NCT02317809|589138103|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
163117418|NCT02317809|589138102|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
163117419|NCT02317809|589138103|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
163117420|NCT00096174|589138104|FG000|Overall Study|Lack of Efficacy|9|||
163117421|NCT00096174|589138104|FG000|Overall Study|Adverse Event|15|||
163117422|NCT00096174|589138104|FG000|Overall Study|Death|6|||
163117423|NCT00096174|589138104|FG000|Overall Study|Withdrawal by Subject|15|||
163117424|NCT00096174|589138104|FG000|Overall Study|Not started protocol therapy|3|||
163117425|NCT00096174|589138104|FG000|Overall Study|Ineligible|6|||
163117426|NCT00096174|589138104|FG000|Overall Study|other reason|8|||
163117427|NCT00953524|589138105|FG000|Overall Study|Adverse Event|2|||
163117428|NCT00953524|589138106|FG001|Overall Study|Adverse Event|0|||
163117429|NCT00953524|589138107|FG002|Overall Study|Adverse Event|1|||
163117430|NCT00953524|589138108|FG003|Overall Study|Adverse Event|2|||
163117431|NCT00953524|589138105|FG000|Overall Study|Protocol Violation|18|||
163117432|NCT00953524|589138106|FG001|Overall Study|Protocol Violation|10|||
163117433|NCT00953524|589138107|FG002|Overall Study|Protocol Violation|11|||
163117434|NCT00953524|589138108|FG003|Overall Study|Protocol Violation|6|||
163117435|NCT00953524|589138105|FG000|Overall Study|Lost to Follow-up|0|||
163117436|NCT00953524|589138106|FG001|Overall Study|Lost to Follow-up|1|||
163117437|NCT00953524|589138107|FG002|Overall Study|Lost to Follow-up|1|||
163117438|NCT00953524|589138108|FG003|Overall Study|Lost to Follow-up|0|||
163117439|NCT00953524|589138105|FG000|Overall Study|Withdrawal by Subject|2|||
163117440|NCT00953524|589138106|FG001|Overall Study|Withdrawal by Subject|4|||
163223857|NCT01631474|589537743|FG002|Overall Study|Lost to Follow-up|7|||
163117441|NCT00953524|589138107|FG002|Overall Study|Withdrawal by Subject|1|||
163117442|NCT00953524|589138108|FG003|Overall Study|Withdrawal by Subject|0|||
163117443|NCT03362931|589138110|FG000|Overall Study|Adverse Event|1|||
163223858|NCT01631474|589537744|FG003|Overall Study|Lost to Follow-up|5|||
163340284|NCT01945593|589954766|FG000|Overall Study|Withdrawal by Subject|0|||
163223859|NCT01631474|589537745|FG004|Overall Study|Lost to Follow-up|5|||
163223860|NCT01631474|589537741|FG000|Overall Study|Withdrawal by Subject|4|||
163223861|NCT01631474|589537742|FG001|Overall Study|Withdrawal by Subject|4|||
163223862|NCT01631474|589537743|FG002|Overall Study|Withdrawal by Subject|2|||
163223863|NCT01631474|589537744|FG003|Overall Study|Withdrawal by Subject|6|||
163223864|NCT01631474|589537745|FG004|Overall Study|Withdrawal by Subject|5|||
163223865|NCT01631474|589537741|FG000|Overall Study|Lack of Efficacy|2|||
163223866|NCT01631474|589537742|FG001|Overall Study|Lack of Efficacy|2|||
163223867|NCT01631474|589537743|FG002|Overall Study|Lack of Efficacy|0|||
163223868|NCT01631474|589537744|FG003|Overall Study|Lack of Efficacy|0|||
163223869|NCT01631474|589537745|FG004|Overall Study|Lack of Efficacy|2|||
163223870|NCT01631474|589537741|FG000|Overall Study|Noncompliance with Study Drug|0|||
163223871|NCT01631474|589537742|FG001|Overall Study|Noncompliance with Study Drug|0|||
163223872|NCT01631474|589537743|FG002|Overall Study|Noncompliance with Study Drug|0|||
163223873|NCT01631474|589537744|FG003|Overall Study|Noncompliance with Study Drug|0|||
163223874|NCT01631474|589537745|FG004|Overall Study|Noncompliance with Study Drug|1|||
163223875|NCT01631474|589537741|FG000|Overall Study|Adverse Event|0|||
163223876|NCT01631474|589537742|FG001|Overall Study|Adverse Event|1|||
163223877|NCT01631474|589537743|FG002|Overall Study|Adverse Event|0|||
163223878|NCT01631474|589537744|FG003|Overall Study|Adverse Event|0|||
163223879|NCT01631474|589537745|FG004|Overall Study|Adverse Event|0|||
163223880|NCT01467076|589537746|FG000|Overall Study|Lost to Follow-up|1|||
163223881|NCT01467076|589537747|FG001|Overall Study|Lost to Follow-up|0|||
163223882|NCT01467076|589537748|FG002|Overall Study|Lost to Follow-up|0|||
163223883|NCT03354429|589537749|FG000|Overall Study|Withdrawal by Subject|8|||
163223884|NCT03354429|589537750|FG001|Overall Study|Withdrawal by Subject|7|||
163223885|NCT03354429|589537749|FG000|Overall Study|Lost to Follow-up|1|||
163223886|NCT03354429|589537750|FG001|Overall Study|Lost to Follow-up|0|||
163223887|NCT00654381|589537756|FG000|1st Stage|Adverse Event|3|||
163223888|NCT00654381|589537757|FG001|1st Stage|Adverse Event|3|||
163223889|NCT00654381|589537758|FG002|1st Stage|Adverse Event|3|||
163223890|NCT00654381|589537759|FG003|1st Stage|Adverse Event|3|||
163223891|NCT00654381|589537760|FG004|1st Stage|Adverse Event|2|||
163223892|NCT00654381|589537761|FG005|1st Stage|Adverse Event|1|||
163223893|NCT00654381|589537756|FG000|1st Stage|Withdrawal by Subject|0|||
163223894|NCT00654381|589537757|FG001|1st Stage|Withdrawal by Subject|0|||
163223895|NCT00654381|589537758|FG002|1st Stage|Withdrawal by Subject|0|||
163223896|NCT00654381|589537759|FG003|1st Stage|Withdrawal by Subject|1|||
163223897|NCT00654381|589537760|FG004|1st Stage|Withdrawal by Subject|0|||
163223898|NCT00654381|589537761|FG005|1st Stage|Withdrawal by Subject|1|||
163223899|NCT00654381|589537756|FG000|1st Stage|Investigator's decision|0|||
163223900|NCT00654381|589537757|FG001|1st Stage|Investigator's decision|0|||
163223901|NCT00654381|589537758|FG002|1st Stage|Investigator's decision|0|||
163223902|NCT00654381|589537759|FG003|1st Stage|Investigator's decision|1|||
163223903|NCT00654381|589537760|FG004|1st Stage|Investigator's decision|0|||
163223904|NCT00654381|589537761|FG005|1st Stage|Investigator's decision|0|||
163223905|NCT00654381|589537756|FG000|2nd Stage|Adverse Event|2|||
163223906|NCT00654381|589537757|FG001|2nd Stage|Adverse Event|0|||
163223907|NCT00654381|589537758|FG002|2nd Stage|Adverse Event|2|||
163223908|NCT00654381|589537759|FG003|2nd Stage|Adverse Event|3|||
163223909|NCT00654381|589537760|FG004|2nd Stage|Adverse Event|7|||
163223910|NCT00654381|589537761|FG005|2nd Stage|Adverse Event|2|||
163223911|NCT00654381|589537756|FG000|2nd Stage|Withdrawal by Subject|0|||
163223912|NCT00654381|589537757|FG001|2nd Stage|Withdrawal by Subject|0|||
163223913|NCT00654381|589537758|FG002|2nd Stage|Withdrawal by Subject|0|||
163223914|NCT00654381|589537759|FG003|2nd Stage|Withdrawal by Subject|0|||
163223915|NCT00654381|589537760|FG004|2nd Stage|Withdrawal by Subject|1|||
163223916|NCT00654381|589537761|FG005|2nd Stage|Withdrawal by Subject|1|||
163223917|NCT00654381|589537756|FG000|2nd Stage|Investigator's decision|0|||
163340285|NCT01945593|589954767|FG001|Overall Study|Withdrawal by Subject|2|||
163340286|NCT01945593|589954768|FG002|Overall Study|Withdrawal by Subject|0|||
163340287|NCT01945593|589954769|FG003|Overall Study|Withdrawal by Subject|4|||
163223918|NCT00654381|589537757|FG001|2nd Stage|Investigator's decision|0|||
163223919|NCT00654381|589537758|FG002|2nd Stage|Investigator's decision|1|||
163223920|NCT00654381|589537759|FG003|2nd Stage|Investigator's decision|1|||
163223921|NCT00654381|589537760|FG004|2nd Stage|Investigator's decision|0|||
163223922|NCT00654381|589537761|FG005|2nd Stage|Investigator's decision|0|||
163223923|NCT00654381|589537756|FG000|Extension Stage|Adverse Event|1|||
163223924|NCT00654381|589537757|FG001|Extension Stage|Adverse Event|2|||
163223925|NCT00654381|589537758|FG002|Extension Stage|Adverse Event|9|||
163223926|NCT00654381|589537759|FG003|Extension Stage|Adverse Event|7|||
163223927|NCT00654381|589537760|FG004|Extension Stage|Adverse Event|1|||
163223928|NCT00654381|589537761|FG005|Extension Stage|Adverse Event|1|||
163340288|NCT01945593|589954766|FG000|Overall Study|Protocol Violation|0|||
163340289|NCT01945593|589954767|FG001|Overall Study|Protocol Violation|2|||
163223929|NCT00654381|589537756|FG000|Extension Stage|Protocol Violation|0|||
163223930|NCT00654381|589537757|FG001|Extension Stage|Protocol Violation|0|||
163223931|NCT00654381|589537758|FG002|Extension Stage|Protocol Violation|0|||
163223932|NCT00654381|589537759|FG003|Extension Stage|Protocol Violation|1|||
163223933|NCT00654381|589537760|FG004|Extension Stage|Protocol Violation|0|||
163340290|NCT01945593|589954768|FG002|Overall Study|Protocol Violation|1|||
163340291|NCT01945593|589954769|FG003|Overall Study|Protocol Violation|3|||
163340292|NCT01945593|589954766|FG000|Overall Study|Death|0|||
163340293|NCT01945593|589954767|FG001|Overall Study|Death|0|||
163340294|NCT01945593|589954768|FG002|Overall Study|Death|1|||
163340295|NCT01945593|589954769|FG003|Overall Study|Death|0|||
163340296|NCT01945593|589954766|FG000|Overall Study|Other: Terminated|0|||
163340297|NCT01945593|589954767|FG001|Overall Study|Other: Terminated|0|||
163117444|NCT03362931|589138110|FG000|Overall Study|Death|2|||
163117445|NCT01998893|589138111|FG000|Overall Study|Adverse Event|2|||
163117446|NCT01998893|589138111|FG000|Overall Study|Death|1|||
163117447|NCT01998893|589138111|FG000|Overall Study|Lost to Follow-up|8|||
163117448|NCT01998893|589138111|FG000|Overall Study|Physician Decision|2|||
163117449|NCT01998893|589138111|FG000|Overall Study|Protocol Violation|2|||
163117450|NCT01998893|589138111|FG000|Overall Study|Withdrawal by Subject|1|||
163117451|NCT01998893|589138111|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
163117452|NCT03276052|589138112|FG000|Overall Study|Withdrawal by Subject|5|||
163117453|NCT03276052|589138112|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
163117454|NCT01994863|589138117|FG000|Period 1|Adverse Event|4|||
163117455|NCT01994863|589138118|FG001|Period 1|Adverse Event|0|||
163117456|NCT01994863|589138117|FG000|Period 1|Withdrawal by Subject|1|||
163117457|NCT01994863|589138118|FG001|Period 1|Withdrawal by Subject|0|||
163117458|NCT01994863|589138117|FG000|Period 1|Trial stopped by sponsor|1|||
163117459|NCT01994863|589138118|FG001|Period 1|Trial stopped by sponsor|3|||
163117460|NCT01994863|589138117|FG000|Period 1|Lack of Efficacy|1|||
163117461|NCT01994863|589138118|FG001|Period 1|Lack of Efficacy|0|||
163117462|NCT01994863|589138117|FG000|Period 2|Adverse Event|0|||
163117463|NCT01994863|589138118|FG001|Period 2|Adverse Event|1|||
163117464|NCT01994863|589138117|FG000|Period 2|Lack of Efficacy|0|||
163117465|NCT01994863|589138118|FG001|Period 2|Lack of Efficacy|2|||
163117466|NCT01994863|589138117|FG000|Period 2|Withdrawal by Subject|1|||
163117467|NCT01994863|589138118|FG001|Period 2|Withdrawal by Subject|1|||
163117468|NCT05136898|589138119|FG000|Overall Study|Adverse Event|2|||
163117469|NCT03784846|589138122|FG000|Pre-COVID Study|Lost to Follow-up|3|||
163117470|NCT03784846|589138123|FG001|Pre-COVID Study|Lost to Follow-up|3|||
163117471|NCT03784846|589138124|FG002|Pre-COVID Study|Lost to Follow-up|2|||
163117472|NCT03784846|589138122|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
163117473|NCT03784846|589138123|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
163117474|NCT03784846|589138124|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
163117475|NCT03784846|589138122|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
163117476|NCT03784846|589138123|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
163117477|NCT03784846|589138124|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
163117478|NCT03784846|589138122|FG000|Post-COVID Study|Lost to Follow-up|3|||
163117479|NCT03784846|589138123|FG001|Post-COVID Study|Lost to Follow-up|5|||
163117480|NCT03784846|589138124|FG002|Post-COVID Study|Lost to Follow-up|1|||
163117481|NCT03784846|589138122|FG000|Post-COVID Study|Withdrawal by Subject|1|||
163117482|NCT03784846|589138123|FG001|Post-COVID Study|Withdrawal by Subject|2|||
163117483|NCT03784846|589138124|FG002|Post-COVID Study|Withdrawal by Subject|0|||
163117484|NCT03054350|589138125|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
163117485|NCT03054350|589138126|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
163117486|NCT03054350|589138127|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
163117487|NCT03054350|589138128|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
163117488|NCT03054350|589138129|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
163117489|NCT03054350|589138130|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
163117490|NCT03054350|589138125|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
163117491|NCT03054350|589138126|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
163117492|NCT03054350|589138127|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
163117493|NCT03054350|589138128|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
163117494|NCT03054350|589138129|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
163117495|NCT03054350|589138130|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
163117496|NCT03054350|589138125|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
163117497|NCT03054350|589138126|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
163117498|NCT03054350|589138127|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
163117499|NCT03054350|589138128|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
163117500|NCT03054350|589138129|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
163117501|NCT03054350|589138130|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
163117502|NCT03054350|589138125|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
163117503|NCT03054350|589138126|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
163117504|NCT03054350|589138127|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
163117505|NCT03054350|589138128|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
163117506|NCT03054350|589138129|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
163340298|NCT01945593|589954768|FG002|Overall Study|Other: Terminated|0|||
163340299|NCT01945593|589954769|FG003|Overall Study|Other: Terminated|1|||
163340300|NCT01945593|589954766|FG000|Overall Study|Other: Surgical Procedure|0|||
163340301|NCT01945593|589954767|FG001|Overall Study|Other: Surgical Procedure|2|||
163340302|NCT01945593|589954768|FG002|Overall Study|Other: Surgical Procedure|0|||
163340303|NCT01945593|589954769|FG003|Overall Study|Other: Surgical Procedure|6|||
163340304|NCT01945593|589954766|FG000|Overall Study|Other: Screen Failure|0|||
163223934|NCT00654381|589537761|FG005|Extension Stage|Protocol Violation|0|||
163223935|NCT00654381|589537756|FG000|Extension Stage|Lack of Efficacy|0|||
163223936|NCT00654381|589537757|FG001|Extension Stage|Lack of Efficacy|0|||
163223937|NCT00654381|589537758|FG002|Extension Stage|Lack of Efficacy|1|||
163223938|NCT00654381|589537759|FG003|Extension Stage|Lack of Efficacy|0|||
163223939|NCT00654381|589537760|FG004|Extension Stage|Lack of Efficacy|0|||
163223940|NCT00654381|589537761|FG005|Extension Stage|Lack of Efficacy|0|||
163223941|NCT00654381|589537756|FG000|Extension Stage|Withdrawal by Subject|0|||
163223942|NCT00654381|589537757|FG001|Extension Stage|Withdrawal by Subject|0|||
163223943|NCT00654381|589537758|FG002|Extension Stage|Withdrawal by Subject|1|||
163223944|NCT00654381|589537759|FG003|Extension Stage|Withdrawal by Subject|1|||
163223945|NCT00654381|589537760|FG004|Extension Stage|Withdrawal by Subject|1|||
163223946|NCT00654381|589537761|FG005|Extension Stage|Withdrawal by Subject|1|||
163223947|NCT00654381|589537756|FG000|Extension Stage|Closure of the trial site|0|||
163223948|NCT00654381|589537757|FG001|Extension Stage|Closure of the trial site|0|||
163223949|NCT00654381|589537758|FG002|Extension Stage|Closure of the trial site|0|||
163223950|NCT00654381|589537759|FG003|Extension Stage|Closure of the trial site|0|||
163223951|NCT00654381|589537760|FG004|Extension Stage|Closure of the trial site|1|||
163223952|NCT00654381|589537761|FG005|Extension Stage|Closure of the trial site|1|||
163340305|NCT01945593|589954767|FG001|Overall Study|Other: Screen Failure|2|||
163340306|NCT01945593|589954768|FG002|Overall Study|Other: Screen Failure|0|||
163340307|NCT01945593|589954769|FG003|Overall Study|Other: Screen Failure|0|||
163340308|NCT00228813|589954770|FG000|Overall Study|Death|4|||
163117507|NCT03054350|589138130|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
163117508|NCT00931723|589138131|FG000|Overall Study|Withdrawal by Subject|11|||
163117509|NCT00931723|589138132|FG001|Overall Study|Withdrawal by Subject|13|||
163117510|NCT00931723|589138131|FG000|Overall Study|Adverse Event|6|||
163117511|NCT00931723|589138132|FG001|Overall Study|Adverse Event|13|||
163117512|NCT00931723|589138131|FG000|Overall Study|Lithium found in blood|0|||
163117513|NCT00931723|589138132|FG001|Overall Study|Lithium found in blood|1|||
163117514|NCT00931723|589138131|FG000|Overall Study|Condition under investigation worsened|1|||
163117515|NCT00931723|589138132|FG001|Overall Study|Condition under investigation worsened|2|||
163117516|NCT00931723|589138131|FG000|Overall Study|Lost to Follow-up|1|||
163117517|NCT00931723|589138132|FG001|Overall Study|Lost to Follow-up|2|||
163117518|NCT00931723|589138131|FG000|Overall Study|Study-specific discontinuation criteria|1|||
163117519|NCT00931723|589138132|FG001|Overall Study|Study-specific discontinuation criteria|1|||
163117520|NCT00931723|589138131|FG000|Overall Study|Severe non-compliance to protocol|2|||
163117521|NCT00931723|589138132|FG001|Overall Study|Severe non-compliance to protocol|0|||
163117522|NCT00931723|589138131|FG000|Overall Study|Safety reasons|0|||
163117523|NCT00931723|589138132|FG001|Overall Study|Safety reasons|1|||
163117524|NCT00931723|589138131|FG000|Overall Study|Took prohibited concomitant medication|0|||
163117525|NCT00931723|589138132|FG001|Overall Study|Took prohibited concomitant medication|1|||
163117526|NCT00931723|589138131|FG000|Overall Study|Lack or insufficient theraputic response|2|||
163117527|NCT00931723|589138132|FG001|Overall Study|Lack or insufficient theraputic response|5|||
163117528|NCT00931723|589138131|FG000|Overall Study|Sponsor decision|1|||
163117529|NCT00931723|589138132|FG001|Overall Study|Sponsor decision|0|||
163117530|NCT00931723|589138131|FG000|Overall Study|Late hospital discharge|1|||
163117531|NCT00931723|589138132|FG001|Overall Study|Late hospital discharge|0|||
163117532|NCT01643850|589138133|FG000|Overall Study|Withdrawal by Subject|0|||
163117533|NCT01643850|589138134|FG001|Overall Study|Withdrawal by Subject|0|||
163117534|NCT01643850|589138135|FG002|Overall Study|Withdrawal by Subject|0|||
163117535|NCT01643850|589138136|FG003|Overall Study|Withdrawal by Subject|0|||
163117536|NCT01643850|589138137|FG004|Overall Study|Withdrawal by Subject|1|||
163117537|NCT01643850|589138138|FG005|Overall Study|Withdrawal by Subject|0|||
163117538|NCT01643850|589138139|FG006|Overall Study|Withdrawal by Subject|0|||
163117539|NCT01643850|589138140|FG007|Overall Study|Withdrawal by Subject|0|||
163340309|NCT01131325|589954775|FG000|Overall Study|Adverse Event|1|||
163340310|NCT01131325|589954775|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
163117540|NCT01643850|589138141|FG008|Overall Study|Withdrawal by Subject|0|||
163117541|NCT01643850|589138133|FG000|Overall Study|Lost to Follow-up|0|||
163117542|NCT01643850|589138134|FG001|Overall Study|Lost to Follow-up|0|||
163223953|NCT05040152|589537767|FG000|Overall Study|Withdrawal by Subject|5|||
163117543|NCT01643850|589138135|FG002|Overall Study|Lost to Follow-up|0|||
163117544|NCT01643850|589138136|FG003|Overall Study|Lost to Follow-up|0|||
163223954|NCT05040152|589537768|FG001|Overall Study|Withdrawal by Subject|0|||
163340311|NCT03761849|589954776|FG000|Overall Study|transferred to OpenLabelExtension|35|||
163223955|NCT05040152|589537767|FG000|Overall Study|Lost to Follow-up|0|||
163223956|NCT05040152|589537768|FG001|Overall Study|Lost to Follow-up|2|||
163223957|NCT00006489|589537770|FG000|Overall Study|Adverse Event|3|||
163340312|NCT03761849|589954777|FG001|Overall Study|transferred to OpenLabelExtension|34|||
163340313|NCT03761849|589954778|FG002|Overall Study|transferred to OpenLabelExtension|36|||
163340314|NCT03761849|589954779|FG003|Overall Study|transferred to OpenLabelExtension|0|||
163340315|NCT03761849|589954780|FG004|Overall Study|transferred to OpenLabelExtension|0|||
163340316|NCT03761849|589954781|FG005|Overall Study|transferred to OpenLabelExtension|0|||
163340317|NCT03761849|589954776|FG000|Overall Study|Adverse Event|1|||
163340318|NCT03761849|589954777|FG001|Overall Study|Adverse Event|0|||
163340319|NCT03761849|589954778|FG002|Overall Study|Adverse Event|0|||
163340320|NCT03761849|589954779|FG003|Overall Study|Adverse Event|0|||
163340321|NCT03761849|589954780|FG004|Overall Study|Adverse Event|2|||
163340322|NCT03761849|589954781|FG005|Overall Study|Adverse Event|3|||
163340323|NCT03761849|589954776|FG000|Overall Study|Withdrawal by Subject|0|||
163340324|NCT03761849|589954777|FG001|Overall Study|Withdrawal by Subject|0|||
163340325|NCT03761849|589954778|FG002|Overall Study|Withdrawal by Subject|0|||
163340326|NCT03761849|589954779|FG003|Overall Study|Withdrawal by Subject|41|||
163340327|NCT03761849|589954780|FG004|Overall Study|Withdrawal by Subject|43|||
163340328|NCT03761849|589954781|FG005|Overall Study|Withdrawal by Subject|35|||
163340329|NCT03761849|589954776|FG000|Overall Study|Lost to Follow-up|0|||
163340330|NCT03761849|589954777|FG001|Overall Study|Lost to Follow-up|1|||
163340331|NCT03761849|589954778|FG002|Overall Study|Lost to Follow-up|0|||
163340332|NCT03761849|589954779|FG003|Overall Study|Lost to Follow-up|2|||
163340333|NCT03761849|589954780|FG004|Overall Study|Lost to Follow-up|4|||
163340334|NCT03761849|589954781|FG005|Overall Study|Lost to Follow-up|5|||
163340335|NCT03761849|589954776|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
163340336|NCT03761849|589954777|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
163340337|NCT03761849|589954778|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
163340338|NCT03761849|589954779|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
163340339|NCT03761849|589954780|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
163340340|NCT03761849|589954781|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
163340341|NCT03761849|589954776|FG000|Overall Study|Physician Decision|0|||
163340342|NCT03761849|589954777|FG001|Overall Study|Physician Decision|0|||
163340343|NCT03761849|589954778|FG002|Overall Study|Physician Decision|0|||
163340344|NCT03761849|589954779|FG003|Overall Study|Physician Decision|1|||
163340345|NCT03761849|589954780|FG004|Overall Study|Physician Decision|4|||
163340346|NCT03761849|589954781|FG005|Overall Study|Physician Decision|4|||
163340347|NCT03761849|589954776|FG000|Overall Study|Death|0|||
163340348|NCT03761849|589954777|FG001|Overall Study|Death|0|||
163340349|NCT03761849|589954778|FG002|Overall Study|Death|0|||
163340350|NCT03761849|589954779|FG003|Overall Study|Death|1|||
163340351|NCT03761849|589954780|FG004|Overall Study|Death|1|||
163340352|NCT03761849|589954781|FG005|Overall Study|Death|3|||
163340353|NCT03761849|589954776|FG000|Overall Study|Protocol Violation|0|||
163340354|NCT03761849|589954777|FG001|Overall Study|Protocol Violation|0|||
163340355|NCT03761849|589954778|FG002|Overall Study|Protocol Violation|0|||
163340356|NCT03761849|589954779|FG003|Overall Study|Protocol Violation|2|||
163340357|NCT03761849|589954780|FG004|Overall Study|Protocol Violation|2|||
163340358|NCT03761849|589954781|FG005|Overall Study|Protocol Violation|1|||
163340359|NCT03761849|589954776|FG000|Overall Study|Participant could not come to site|0|||
163340360|NCT03761849|589954777|FG001|Overall Study|Participant could not come to site|0|||
163117545|NCT01643850|589138137|FG004|Overall Study|Lost to Follow-up|0|||
163117546|NCT01643850|589138138|FG005|Overall Study|Lost to Follow-up|0|||
163117547|NCT01643850|589138139|FG006|Overall Study|Lost to Follow-up|1|||
163117548|NCT01643850|589138140|FG007|Overall Study|Lost to Follow-up|0|||
163117549|NCT01643850|589138141|FG008|Overall Study|Lost to Follow-up|1|||
163117550|NCT01643850|589138133|FG000|Overall Study|Adverse Event|0|||
163117551|NCT01643850|589138134|FG001|Overall Study|Adverse Event|0|||
163117552|NCT01643850|589138135|FG002|Overall Study|Adverse Event|0|||
163117553|NCT01643850|589138136|FG003|Overall Study|Adverse Event|0|||
163117554|NCT01643850|589138137|FG004|Overall Study|Adverse Event|1|||
163117555|NCT01643850|589138138|FG005|Overall Study|Adverse Event|0|||
163117556|NCT01643850|589138139|FG006|Overall Study|Adverse Event|0|||
163117557|NCT01643850|589138140|FG007|Overall Study|Adverse Event|0|||
163117558|NCT01643850|589138141|FG008|Overall Study|Adverse Event|0|||
163340361|NCT03761849|589954778|FG002|Overall Study|Participant could not come to site|0|||
163340362|NCT03761849|589954779|FG003|Overall Study|Participant could not come to site|0|||
163340363|NCT03761849|589954780|FG004|Overall Study|Participant could not come to site|1|||
163340364|NCT03761849|589954781|FG005|Overall Study|Participant could not come to site|0|||
163340365|NCT03761849|589954776|FG000|Overall Study|SF- safety Finding|0|||
163340366|NCT03761849|589954777|FG001|Overall Study|SF- safety Finding|0|||
163340367|NCT03761849|589954778|FG002|Overall Study|SF- safety Finding|0|||
163117559|NCT01643850|589138133|FG000|Overall Study|Administrative Problems|0|||
163117560|NCT01643850|589138134|FG001|Overall Study|Administrative Problems|0|||
163117561|NCT01643850|589138135|FG002|Overall Study|Administrative Problems|1|||
163340368|NCT03761849|589954779|FG003|Overall Study|SF- safety Finding|0|||
163340369|NCT03761849|589954780|FG004|Overall Study|SF- safety Finding|0|||
163340370|NCT03761849|589954781|FG005|Overall Study|SF- safety Finding|1|||
163340371|NCT03761849|589954776|FG000|Overall Study|Patient did not attend visit|0|||
163340372|NCT03761849|589954777|FG001|Overall Study|Patient did not attend visit|0|||
163223958|NCT00006489|589537771|FG001|Overall Study|Adverse Event|2|||
163223959|NCT00006489|589537772|FG002|Overall Study|Adverse Event|4|||
163223960|NCT00006489|589537773|FG003|Overall Study|Adverse Event|3|||
163223961|NCT00006489|589537770|FG000|Overall Study|Withdrawal by Subject|10|||
163223962|NCT00006489|589537771|FG001|Overall Study|Withdrawal by Subject|9|||
163223963|NCT00006489|589537772|FG002|Overall Study|Withdrawal by Subject|9|||
163223964|NCT00006489|589537773|FG003|Overall Study|Withdrawal by Subject|6|||
163223965|NCT00006489|589537770|FG000|Overall Study|Scheduling Conflict|0|||
163223966|NCT00006489|589537771|FG001|Overall Study|Scheduling Conflict|3|||
163223967|NCT00006489|589537772|FG002|Overall Study|Scheduling Conflict|2|||
163223968|NCT00006489|589537773|FG003|Overall Study|Scheduling Conflict|1|||
163223969|NCT00006489|589537770|FG000|Overall Study|Death|0|||
163223970|NCT00006489|589537771|FG001|Overall Study|Death|0|||
163223971|NCT00006489|589537772|FG002|Overall Study|Death|0|||
163223972|NCT00006489|589537773|FG003|Overall Study|Death|1|||
163223973|NCT00578175|589537774|FG000|Overall Study|Adverse Event|0|||
163223974|NCT00578175|589537775|FG001|Overall Study|Adverse Event|1|||
163223975|NCT00578175|589537776|FG002|Overall Study|Adverse Event|1|||
163223976|NCT00578175|589537774|FG000|Overall Study|Other reasons|70|||
163223977|NCT00578175|589537775|FG001|Overall Study|Other reasons|42|||
163223978|NCT00578175|589537776|FG002|Overall Study|Other reasons|23|||
163223979|NCT03029624|589537782|FG000|Overall Study|Adverse Event|1|||
163223980|NCT03029624|589537782|FG000|Overall Study|Withdrawal by Subject|1|||
163223981|NCT03029624|589537782|FG000|Overall Study|Lack of Efficacy|1|||
163223982|NCT03029624|589537782|FG000|Overall Study|MRI need|2|||
163223983|NCT00974571|589537784|FG000|Overall Study|Adverse Event|31|||
163223984|NCT00974571|589537785|FG001|Overall Study|Adverse Event|4|||
163223985|NCT00974571|589537786|FG002|Overall Study|Adverse Event|27|||
163223986|NCT00974571|589537784|FG000|Overall Study|Lack of Efficacy|3|||
163223987|NCT00974571|589537785|FG001|Overall Study|Lack of Efficacy|2|||
163223988|NCT00974571|589537786|FG002|Overall Study|Lack of Efficacy|9|||
163223989|NCT00974571|589537784|FG000|Overall Study|Lost to Follow-up|2|||
163223990|NCT00974571|589537785|FG001|Overall Study|Lost to Follow-up|1|||
163223991|NCT00974571|589537786|FG002|Overall Study|Lost to Follow-up|2|||
163223992|NCT00974571|589537784|FG000|Overall Study|Protocol Violation|13|||
163223993|NCT00974571|589537785|FG001|Overall Study|Protocol Violation|4|||
163223994|NCT00974571|589537786|FG002|Overall Study|Protocol Violation|18|||
163223995|NCT00974571|589537784|FG000|Overall Study|Withdrawal by Subject|14|||
163223996|NCT00974571|589537785|FG001|Overall Study|Withdrawal by Subject|5|||
163223997|NCT00974571|589537786|FG002|Overall Study|Withdrawal by Subject|16|||
163223998|NCT00974571|589537784|FG000|Overall Study|Patient Moved|1|||
163223999|NCT00974571|589537785|FG001|Overall Study|Patient Moved|0|||
163224000|NCT00974571|589537786|FG002|Overall Study|Patient Moved|1|||
163224001|NCT00974571|589537784|FG000|Overall Study|Other|4|||
163224002|NCT00974571|589537785|FG001|Overall Study|Other|0|||
163224003|NCT00974571|589537786|FG002|Overall Study|Other|10|||
163224004|NCT01371656|589537787|FG000|Overall Study|Death|7|||
163224005|NCT01371656|589537788|FG001|Overall Study|Death|4|||
163224006|NCT01371656|589537787|FG000|Overall Study|Physician Decision|46|||
163224007|NCT01371656|589537788|FG001|Overall Study|Physician Decision|7|||
163224008|NCT01371656|589537787|FG000|Overall Study|Withdrawal by Subject|7|||
163224009|NCT01371656|589537788|FG001|Overall Study|Withdrawal by Subject|0|||
163224010|NCT01371656|589537787|FG000|Overall Study|Ineligible|4|||
163224011|NCT01371656|589537788|FG001|Overall Study|Ineligible|3|||
163340373|NCT03761849|589954778|FG002|Overall Study|Patient did not attend visit|0|||
163340374|NCT03761849|589954779|FG003|Overall Study|Patient did not attend visit|0|||
163340375|NCT03761849|589954780|FG004|Overall Study|Patient did not attend visit|0|||
163340376|NCT03761849|589954781|FG005|Overall Study|Patient did not attend visit|1|||
163340377|NCT02213094|589954784|FG000|Overall Study|Adverse Event|1|||
163340378|NCT02213094|589954785|FG001|Overall Study|Adverse Event|0|||
163340379|NCT02163499|589954786|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
163340380|NCT02163499|589954786|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
163340381|NCT02163499|589954786|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
163224012|NCT04334460|589537801|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
163224013|NCT04334460|589537802|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
163224014|NCT04334460|589537801|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
163224015|NCT04334460|589537802|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
163224016|NCT03778931|589537803|FG000|Overall Study|Withdrawal by Subject|12|||
163224017|NCT03778931|589537804|FG001|Overall Study|Withdrawal by Subject|25|||
163224018|NCT03778931|589537803|FG000|Overall Study|Physician Decision|1|||
163224019|NCT03778931|589537804|FG001|Overall Study|Physician Decision|3|||
163224020|NCT03778931|589537803|FG000|Overall Study|Participant Noncompliance|1|||
163224021|NCT03778931|589537804|FG001|Overall Study|Participant Noncompliance|1|||
163224022|NCT03778931|589537803|FG000|Overall Study|Lost to Follow-up|4|||
163224023|NCT03778931|589537804|FG001|Overall Study|Lost to Follow-up|1|||
163224024|NCT03778931|589537803|FG000|Overall Study|Death|69|||
163224025|NCT03778931|589537804|FG001|Overall Study|Death|79|||
163117562|NCT01643850|589138136|FG003|Overall Study|Administrative Problems|0|||
163117563|NCT01643850|589138137|FG004|Overall Study|Administrative Problems|1|||
163117564|NCT01643850|589138138|FG005|Overall Study|Administrative Problems|0|||
163117565|NCT01643850|589138139|FG006|Overall Study|Administrative Problems|0|||
163117566|NCT01643850|589138140|FG007|Overall Study|Administrative Problems|0|||
163117567|NCT01643850|589138141|FG008|Overall Study|Administrative Problems|0|||
163117568|NCT01133405|589138142|FG000|Period 1|Withdrawal by Subject|0|||
163117569|NCT01133405|589138143|FG001|Period 1|Withdrawal by Subject|1|||
163117570|NCT01133405|589138144|FG002|Period 1|Withdrawal by Subject|0|||
163117571|NCT01133405|589138145|FG003|Period 1|Withdrawal by Subject|1|||
163117572|NCT01133405|589138146|FG004|Period 1|Withdrawal by Subject|0|||
163117573|NCT01133405|589138147|FG005|Period 1|Withdrawal by Subject|1|||
163117574|NCT01133405|589138148|FG006|Period 1|Withdrawal by Subject|0|||
163117575|NCT01133405|589138149|FG007|Period 1|Withdrawal by Subject|0|||
163117576|NCT01133405|589138150|FG008|Period 1|Withdrawal by Subject|0|||
163117577|NCT01133405|589138151|FG009|Period 1|Withdrawal by Subject|0|||
163117578|NCT01133405|589138142|FG000|Period 1|Physician Decision|0|||
163117579|NCT01133405|589138143|FG001|Period 1|Physician Decision|0|||
163117580|NCT01133405|589138144|FG002|Period 1|Physician Decision|0|||
163117581|NCT01133405|589138145|FG003|Period 1|Physician Decision|1|||
163117582|NCT01133405|589138146|FG004|Period 1|Physician Decision|0|||
163117583|NCT01133405|589138147|FG005|Period 1|Physician Decision|0|||
163117584|NCT01133405|589138148|FG006|Period 1|Physician Decision|0|||
163117585|NCT01133405|589138149|FG007|Period 1|Physician Decision|0|||
163117586|NCT01133405|589138150|FG008|Period 1|Physician Decision|0|||
163117587|NCT01133405|589138151|FG009|Period 1|Physician Decision|0|||
163117588|NCT01133405|589138142|FG000|Period 1|Discontinued after randomization|1|||
163117589|NCT01133405|589138143|FG001|Period 1|Discontinued after randomization|0|||
163117590|NCT01133405|589138144|FG002|Period 1|Discontinued after randomization|0|||
163117591|NCT01133405|589138145|FG003|Period 1|Discontinued after randomization|0|||
163117592|NCT01133405|589138146|FG004|Period 1|Discontinued after randomization|0|||
163117593|NCT01133405|589138147|FG005|Period 1|Discontinued after randomization|0|||
163117594|NCT01133405|589138148|FG006|Period 1|Discontinued after randomization|1|||
163117595|NCT01133405|589138149|FG007|Period 1|Discontinued after randomization|0|||
163117596|NCT01133405|589138150|FG008|Period 1|Discontinued after randomization|0|||
163117597|NCT01133405|589138151|FG009|Period 1|Discontinued after randomization|0|||
163117598|NCT01133405|589138142|FG000|Period 1|Received drug only in period 2|0|||
163117599|NCT01133405|589138143|FG001|Period 1|Received drug only in period 2|1|||
163117600|NCT01133405|589138144|FG002|Period 1|Received drug only in period 2|0|||
163117601|NCT01133405|589138145|FG003|Period 1|Received drug only in period 2|2|||
163117602|NCT01133405|589138146|FG004|Period 1|Received drug only in period 2|0|||
163117603|NCT01133405|589138147|FG005|Period 1|Received drug only in period 2|1|||
163117604|NCT01133405|589138148|FG006|Period 1|Received drug only in period 2|0|||
163117605|NCT01133405|589138149|FG007|Period 1|Received drug only in period 2|0|||
163117606|NCT01133405|589138150|FG008|Period 1|Received drug only in period 2|0|||
163117607|NCT01133405|589138151|FG009|Period 1|Received drug only in period 2|0|||
163117608|NCT01133405|589138142|FG000|Period 1|Received drug only in period 3|0|||
163117609|NCT01133405|589138143|FG001|Period 1|Received drug only in period 3|1|||
163117610|NCT01133405|589138144|FG002|Period 1|Received drug only in period 3|1|||
163117611|NCT01133405|589138145|FG003|Period 1|Received drug only in period 3|0|||
163117612|NCT01133405|589138146|FG004|Period 1|Received drug only in period 3|0|||
163117613|NCT01133405|589138147|FG005|Period 1|Received drug only in period 3|0|||
163117614|NCT01133405|589138148|FG006|Period 1|Received drug only in period 3|0|||
163117615|NCT01133405|589138149|FG007|Period 1|Received drug only in period 3|0|||
163117616|NCT01133405|589138150|FG008|Period 1|Received drug only in period 3|0|||
163117617|NCT01133405|589138151|FG009|Period 1|Received drug only in period 3|0|||
163117618|NCT01133405|589138142|FG000|Period 2|Adverse Event|0|||
163117619|NCT01133405|589138143|FG001|Period 2|Adverse Event|0|||
163117620|NCT01133405|589138144|FG002|Period 2|Adverse Event|1|||
163117621|NCT01133405|589138145|FG003|Period 2|Adverse Event|0|||
163117622|NCT01133405|589138146|FG004|Period 2|Adverse Event|0|||
163340382|NCT02163499|589954786|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
163117623|NCT01133405|589138147|FG005|Period 2|Adverse Event|0|||
163117624|NCT01133405|589138148|FG006|Period 2|Adverse Event|0|||
163340383|NCT02163499|589954786|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
163340384|NCT02163499|589954786|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
163407966|NCT00328627|590203968|FG007|Overall Study|Physician Decision|0|||
163117625|NCT01133405|589138149|FG007|Period 2|Adverse Event|0|||
163117626|NCT01133405|589138150|FG008|Period 2|Adverse Event|0|||
163117627|NCT01133405|589138151|FG009|Period 2|Adverse Event|0|||
163117628|NCT01133405|589138142|FG000|Period 2|Withdrawal by Subject|0|||
163117629|NCT01133405|589138143|FG001|Period 2|Withdrawal by Subject|0|||
163117630|NCT01133405|589138144|FG002|Period 2|Withdrawal by Subject|0|||
163117631|NCT01133405|589138145|FG003|Period 2|Withdrawal by Subject|1|||
163117632|NCT01133405|589138146|FG004|Period 2|Withdrawal by Subject|0|||
163117633|NCT01133405|589138147|FG005|Period 2|Withdrawal by Subject|1|||
163117634|NCT01133405|589138148|FG006|Period 2|Withdrawal by Subject|0|||
163117635|NCT01133405|589138149|FG007|Period 2|Withdrawal by Subject|0|||
163117636|NCT01133405|589138150|FG008|Period 2|Withdrawal by Subject|0|||
163117637|NCT01133405|589138151|FG009|Period 2|Withdrawal by Subject|0|||
163117638|NCT01133405|589138142|FG000|Period 2|Entry Criteria Not Met|0|||
163117639|NCT01133405|589138143|FG001|Period 2|Entry Criteria Not Met|1|||
163117640|NCT01133405|589138144|FG002|Period 2|Entry Criteria Not Met|0|||
163117641|NCT01133405|589138145|FG003|Period 2|Entry Criteria Not Met|0|||
163117642|NCT01133405|589138146|FG004|Period 2|Entry Criteria Not Met|0|||
163117643|NCT01133405|589138147|FG005|Period 2|Entry Criteria Not Met|0|||
163117644|NCT01133405|589138148|FG006|Period 2|Entry Criteria Not Met|0|||
163117645|NCT01133405|589138149|FG007|Period 2|Entry Criteria Not Met|0|||
163117646|NCT01133405|589138150|FG008|Period 2|Entry Criteria Not Met|0|||
163117647|NCT01133405|589138151|FG009|Period 2|Entry Criteria Not Met|0|||
163117648|NCT01133405|589138142|FG000|Period 2|Physician Decision|0|||
163117649|NCT01133405|589138143|FG001|Period 2|Physician Decision|0|||
163117650|NCT01133405|589138144|FG002|Period 2|Physician Decision|0|||
163117651|NCT01133405|589138145|FG003|Period 2|Physician Decision|0|||
163117652|NCT01133405|589138146|FG004|Period 2|Physician Decision|0|||
163117653|NCT01133405|589138147|FG005|Period 2|Physician Decision|1|||
163117654|NCT01133405|589138148|FG006|Period 2|Physician Decision|0|||
163117655|NCT01133405|589138149|FG007|Period 2|Physician Decision|0|||
163117656|NCT01133405|589138150|FG008|Period 2|Physician Decision|0|||
163117657|NCT01133405|589138151|FG009|Period 2|Physician Decision|0|||
163117658|NCT00867087|589138154|FG000|Overall Study|Other|1|||
163117659|NCT00867087|589138154|FG000|Overall Study|Withdrawal by Subject|4|||
163117660|NCT00867087|589138154|FG000|Overall Study|Death|37|||
163117661|NCT03300024|589138155|FG000|Overall Study|Physician Decision|4|||
163117662|NCT03300024|589138156|FG001|Overall Study|Physician Decision|6|||
163117663|NCT01238835|589138157|FG000|Overall Study|Death|124|||
163117664|NCT01238835|589138157|FG000|Overall Study|Withdrawal by Subject|9|||
163117665|NCT01238835|589138157|FG000|Overall Study|Lost to Follow-up|1|||
163117666|NCT01238835|589138157|FG000|Overall Study|Site early discontinuation|2|||
163117667|NCT02088073|589138158|FG000|Acute Phase|Withdrawal by Subject|5|||
163117668|NCT02088073|589138159|FG001|Acute Phase|Withdrawal by Subject|0|||
163117669|NCT02088073|589138160|FG002|Acute Phase|Withdrawal by Subject|0|||
163117670|NCT02088073|589138161|FG003|Acute Phase|Withdrawal by Subject|0|||
163117671|NCT02088073|589138162|FG004|Acute Phase|Withdrawal by Subject|0|||
163117672|NCT02088073|589138158|FG000|Acute Phase|Hyperkalemia|2|||
163117673|NCT02088073|589138159|FG001|Acute Phase|Hyperkalemia|0|||
163117674|NCT02088073|589138160|FG002|Acute Phase|Hyperkalemia|0|||
163117675|NCT02088073|589138161|FG003|Acute Phase|Hyperkalemia|0|||
163117676|NCT02088073|589138162|FG004|Acute Phase|Hyperkalemia|0|||
163117677|NCT02088073|589138158|FG000|Maintanance Phase|Withdrawal by Subject|0|||
163117678|NCT02088073|589138159|FG001|Maintanance Phase|Withdrawal by Subject|2|||
163117679|NCT02088073|589138160|FG002|Maintanance Phase|Withdrawal by Subject|0|||
163117680|NCT02088073|589138161|FG003|Maintanance Phase|Withdrawal by Subject|0|||
163117681|NCT02088073|589138162|FG004|Maintanance Phase|Withdrawal by Subject|0|||
163117682|NCT02088073|589138158|FG000|Maintanance Phase|Adverse Event|0|||
163117683|NCT02088073|589138159|FG001|Maintanance Phase|Adverse Event|0|||
163117684|NCT02088073|589138160|FG002|Maintanance Phase|Adverse Event|3|||
163117685|NCT02088073|589138161|FG003|Maintanance Phase|Adverse Event|0|||
163117686|NCT02088073|589138162|FG004|Maintanance Phase|Adverse Event|1|||
163117687|NCT02088073|589138158|FG000|Maintanance Phase|Physician Decision|0|||
163117688|NCT02088073|589138159|FG001|Maintanance Phase|Physician Decision|0|||
163117689|NCT02088073|589138160|FG002|Maintanance Phase|Physician Decision|0|||
163117690|NCT02088073|589138161|FG003|Maintanance Phase|Physician Decision|0|||
163117691|NCT02088073|589138162|FG004|Maintanance Phase|Physician Decision|1|||
163117692|NCT02088073|589138158|FG000|Maintanance Phase|Sponsor's decision|0|||
163117693|NCT02088073|589138159|FG001|Maintanance Phase|Sponsor's decision|2|||
163117694|NCT02088073|589138160|FG002|Maintanance Phase|Sponsor's decision|0|||
163117695|NCT02088073|589138161|FG003|Maintanance Phase|Sponsor's decision|2|||
163117696|NCT02088073|589138162|FG004|Maintanance Phase|Sponsor's decision|1|||
163117697|NCT02088073|589138158|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
163117698|NCT02088073|589138159|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
163117699|NCT02088073|589138160|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
163117700|NCT02088073|589138161|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
163117701|NCT02088073|589138162|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
163117702|NCT02088073|589138158|FG000|Maintanance Phase|Miscellaneous|0|||
163117703|NCT02088073|589138159|FG001|Maintanance Phase|Miscellaneous|2|||
163117704|NCT02088073|589138160|FG002|Maintanance Phase|Miscellaneous|1|||
163117705|NCT02088073|589138161|FG003|Maintanance Phase|Miscellaneous|2|||
163117706|NCT02088073|589138162|FG004|Maintanance Phase|Miscellaneous|1|||
163117707|NCT02088073|589138158|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
163117708|NCT02088073|589138159|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
163117709|NCT02088073|589138160|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
163117710|NCT02088073|589138161|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
163117711|NCT02088073|589138162|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
163117712|NCT02088073|589138158|FG000|Maintanance Phase|Subject compliance|0|||
163117713|NCT02088073|589138159|FG001|Maintanance Phase|Subject compliance|1|||
163117714|NCT02088073|589138160|FG002|Maintanance Phase|Subject compliance|0|||
163117715|NCT02088073|589138161|FG003|Maintanance Phase|Subject compliance|0|||
163224026|NCT00775437|589537809|FG000|Overall Study|Loss of efficacy|2|||
163224027|NCT00775437|589537809|FG000|Overall Study|Withdrawal by Subject|3|||
163224028|NCT00775437|589537809|FG000|Overall Study|Lost to Follow-up|1|||
163224029|NCT04180020|589537812|FG000|Overall Study|missed visit|18|||
163224030|NCT04180020|589537813|FG001|Overall Study|missed visit|16|||
163224031|NCT04180020|589537812|FG000|Overall Study|Death|2|||
163224032|NCT04180020|589537813|FG001|Overall Study|Death|3|||
163224033|NCT04180020|589537812|FG000|Overall Study|Withdrawal by Subject|1|||
163224034|NCT04180020|589537813|FG001|Overall Study|Withdrawal by Subject|5|||
163224035|NCT04180020|589537812|FG000|Overall Study|incarcerated|1|||
163224036|NCT04180020|589537813|FG001|Overall Study|incarcerated|1|||
163224037|NCT04180020|589537812|FG000|Overall Study|Physician Decision|0|||
163224038|NCT04180020|589537813|FG001|Overall Study|Physician Decision|2|||
163224039|NCT03216850|589537818|FG000|Overall Study|Pre-analytical error|6|||
163224040|NCT02357940|589537821|FG000|Overall Study|Adverse Event|0|||
163224041|NCT02357940|589537822|FG001|Overall Study|Adverse Event|1|||
163224042|NCT02357940|589537821|FG000|Overall Study|Investigator's judgement|0|||
163224043|NCT02357940|589537822|FG001|Overall Study|Investigator's judgement|1|||
163224044|NCT02442778|589537823|FG000|Overall Study|Adverse Event|2|||
163224045|NCT02442778|589537824|FG001|Overall Study|Adverse Event|6|||
163224046|NCT02442778|589537825|FG002|Overall Study|Adverse Event|6|||
163224047|NCT02442778|589537823|FG000|Overall Study|Death|0|||
163224048|NCT02442778|589537824|FG001|Overall Study|Death|2|||
163224049|NCT02442778|589537825|FG002|Overall Study|Death|0|||
163224050|NCT02442778|589537823|FG000|Overall Study|Lack of Efficacy|1|||
163224051|NCT02442778|589537824|FG001|Overall Study|Lack of Efficacy|0|||
163224052|NCT02442778|589537825|FG002|Overall Study|Lack of Efficacy|0|||
163224053|NCT02442778|589537823|FG000|Overall Study|Lost to Follow-up|1|||
163224054|NCT02442778|589537824|FG001|Overall Study|Lost to Follow-up|1|||
163340385|NCT02163499|589954786|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
163117716|NCT02088073|589138162|FG004|Maintanance Phase|Subject compliance|0|||
163117717|NCT02419131|589138163|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
163117718|NCT02419131|589138164|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
163117719|NCT02419131|589138165|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
163117720|NCT02419131|589138163|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
163117721|NCT02419131|589138164|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
163117722|NCT02419131|589138165|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
163117723|NCT02969590|589138171|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
163117724|NCT02969590|589138172|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
163117725|NCT02969590|589138173|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
163117726|NCT00681564|589138175|FG000|Overall Study|Lost to Follow-up|6|||
163117727|NCT00681564|589138176|FG001|Overall Study|Lost to Follow-up|6|||
163117728|NCT00681564|589138175|FG000|Overall Study|Withdrawal by Subject|0|||
163117729|NCT00681564|589138176|FG001|Overall Study|Withdrawal by Subject|1|||
163117730|NCT00681564|589138175|FG000|Overall Study|Death|0|||
163117731|NCT00681564|589138176|FG001|Overall Study|Death|1|||
163117732|NCT02370641|589138177|FG000|Overall Study|dropped study|4|||
163117733|NCT02370641|589138178|FG001|Overall Study|dropped study|2|||
163117734|NCT01719003|589138180|FG000|Overall Study|Non compliant with protocol|1|||
163117735|NCT01719003|589138181|FG001|Overall Study|Non compliant with protocol|1|||
163117736|NCT01719003|589138182|FG002|Overall Study|Non compliant with protocol|0|||
163117737|NCT01719003|589138183|FG003|Overall Study|Non compliant with protocol|1|||
163117738|NCT01719003|589138184|FG004|Overall Study|Non compliant with protocol|2|||
163117739|NCT01719003|589138185|FG005|Overall Study|Non compliant with protocol|1|||
163117740|NCT01719003|589138186|FG006|Overall Study|Non compliant with protocol|2|||
163117741|NCT01719003|589138187|FG007|Overall Study|Non compliant with protocol|3|||
163117742|NCT01719003|589138188|FG008|Overall Study|Non compliant with protocol|0|||
163117743|NCT01719003|589138180|FG000|Overall Study|Adverse Event|6|||
163117744|NCT01719003|589138181|FG001|Overall Study|Adverse Event|5|||
163117745|NCT01719003|589138182|FG002|Overall Study|Adverse Event|4|||
163117746|NCT01719003|589138183|FG003|Overall Study|Adverse Event|3|||
163117747|NCT01719003|589138184|FG004|Overall Study|Adverse Event|4|||
163117748|NCT01719003|589138185|FG005|Overall Study|Adverse Event|3|||
163117749|NCT01719003|589138186|FG006|Overall Study|Adverse Event|6|||
163117750|NCT01719003|589138187|FG007|Overall Study|Adverse Event|5|||
163117751|NCT01719003|589138188|FG008|Overall Study|Adverse Event|0|||
163117752|NCT01719003|589138180|FG000|Overall Study|Lost to Follow-up|0|||
163117753|NCT01719003|589138181|FG001|Overall Study|Lost to Follow-up|6|||
163117754|NCT01719003|589138182|FG002|Overall Study|Lost to Follow-up|7|||
163117755|NCT01719003|589138183|FG003|Overall Study|Lost to Follow-up|2|||
163117756|NCT01719003|589138184|FG004|Overall Study|Lost to Follow-up|3|||
163117757|NCT01719003|589138185|FG005|Overall Study|Lost to Follow-up|4|||
163224055|NCT02442778|589537825|FG002|Overall Study|Lost to Follow-up|1|||
163224056|NCT02442778|589537823|FG000|Overall Study|Non-compliance with study drug|2|||
163224057|NCT02442778|589537824|FG001|Overall Study|Non-compliance with study drug|0|||
163224058|NCT02442778|589537825|FG002|Overall Study|Non-compliance with study drug|1|||
163224059|NCT02442778|589537823|FG000|Overall Study|Physician Decision|1|||
163117758|NCT01719003|589138186|FG006|Overall Study|Lost to Follow-up|3|||
163117759|NCT01719003|589138187|FG007|Overall Study|Lost to Follow-up|2|||
163117760|NCT01719003|589138188|FG008|Overall Study|Lost to Follow-up|2|||
163117761|NCT01719003|589138180|FG000|Overall Study|Refusal to continue, not due to AE|2|||
163340386|NCT02163499|589954786|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
163340387|NCT02163499|589954786|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
163340388|NCT02163499|589954786|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
163340389|NCT02163499|589954786|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
163340390|NCT02163499|589954786|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
163340391|NCT02163499|589954786|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
163340392|NCT02163499|589954786|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
163340393|NCT02163499|589954786|FG000|Extended Dosing Phase: ZS|Death|8|||
163340394|NCT02163499|589954786|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
163340395|NCT02163499|589954786|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
163340396|NCT02163499|589954786|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
163340397|NCT00555620|589954790|FG000|Overall Study|Death|0|||
163340398|NCT00555620|589954791|FG001|Overall Study|Death|1|||
163340399|NCT00555620|589954792|FG002|Overall Study|Death|0|||
163340400|NCT00555620|589954793|FG003|Overall Study|Death|0|||
163340401|NCT00555620|589954794|FG004|Overall Study|Death|0|||
163340402|NCT00555620|589954795|FG005|Overall Study|Death|1|||
163340403|NCT00555620|589954790|FG000|Overall Study|Study terminated by sponsor|0|||
163340404|NCT00555620|589954791|FG001|Overall Study|Study terminated by sponsor|0|||
163340405|NCT00555620|589954792|FG002|Overall Study|Study terminated by sponsor|1|||
163340406|NCT00555620|589954793|FG003|Overall Study|Study terminated by sponsor|0|||
163340407|NCT00555620|589954794|FG004|Overall Study|Study terminated by sponsor|0|||
163340408|NCT00555620|589954795|FG005|Overall Study|Study terminated by sponsor|0|||
163340409|NCT00555620|589954790|FG000|Overall Study|Adverse Event|0|||
163340410|NCT00555620|589954791|FG001|Overall Study|Adverse Event|0|||
163340411|NCT00555620|589954792|FG002|Overall Study|Adverse Event|1|||
163340412|NCT00555620|589954793|FG003|Overall Study|Adverse Event|5|||
163340413|NCT00555620|589954794|FG004|Overall Study|Adverse Event|0|||
163340414|NCT00555620|589954795|FG005|Overall Study|Adverse Event|1|||
163340415|NCT00555620|589954790|FG000|Overall Study|Objective progression or relapse|6|||
163340416|NCT00555620|589954791|FG001|Overall Study|Objective progression or relapse|5|||
163340417|NCT00555620|589954792|FG002|Overall Study|Objective progression or relapse|12|||
163340418|NCT00555620|589954793|FG003|Overall Study|Objective progression or relapse|17|||
163117762|NCT01719003|589138181|FG001|Overall Study|Refusal to continue, not due to AE|5|||
163117763|NCT01719003|589138182|FG002|Overall Study|Refusal to continue, not due to AE|4|||
163117764|NCT01719003|589138183|FG003|Overall Study|Refusal to continue, not due to AE|4|||
163117765|NCT01719003|589138184|FG004|Overall Study|Refusal to continue, not due to AE|4|||
163117766|NCT01719003|589138185|FG005|Overall Study|Refusal to continue, not due to AE|3|||
163117767|NCT01719003|589138186|FG006|Overall Study|Refusal to continue, not due to AE|8|||
163117768|NCT01719003|589138187|FG007|Overall Study|Refusal to continue, not due to AE|7|||
163117769|NCT01719003|589138188|FG008|Overall Study|Refusal to continue, not due to AE|1|||
163117770|NCT01719003|589138180|FG000|Overall Study|Reason other than those specified|0|||
163117771|NCT01719003|589138181|FG001|Overall Study|Reason other than those specified|0|||
163117772|NCT01719003|589138182|FG002|Overall Study|Reason other than those specified|2|||
163117773|NCT01719003|589138183|FG003|Overall Study|Reason other than those specified|3|||
163117774|NCT01719003|589138184|FG004|Overall Study|Reason other than those specified|4|||
163117775|NCT01719003|589138185|FG005|Overall Study|Reason other than those specified|1|||
163117776|NCT01719003|589138186|FG006|Overall Study|Reason other than those specified|0|||
163117777|NCT01719003|589138187|FG007|Overall Study|Reason other than those specified|3|||
163117778|NCT01719003|589138188|FG008|Overall Study|Reason other than those specified|1|||
163117779|NCT01719003|589138180|FG000|Overall Study|Lack of Efficacy|0|||
163117780|NCT01719003|589138181|FG001|Overall Study|Lack of Efficacy|0|||
163117781|NCT01719003|589138182|FG002|Overall Study|Lack of Efficacy|0|||
163117782|NCT01719003|589138183|FG003|Overall Study|Lack of Efficacy|0|||
163117783|NCT01719003|589138184|FG004|Overall Study|Lack of Efficacy|0|||
163117784|NCT01719003|589138185|FG005|Overall Study|Lack of Efficacy|0|||
163117785|NCT01719003|589138186|FG006|Overall Study|Lack of Efficacy|1|||
163117786|NCT01719003|589138187|FG007|Overall Study|Lack of Efficacy|0|||
163117787|NCT01719003|589138188|FG008|Overall Study|Lack of Efficacy|0|||
163117788|NCT02370095|589138189|FG000|Overall Study|Withdrawal by Subject|0|||
163117789|NCT02370095|589138190|FG001|Overall Study|Withdrawal by Subject|1|||
163117790|NCT00700102|589138191|FG000|Overall Study|Died|394|||
163117791|NCT00700102|589138192|FG001|Overall Study|Died|385|||
163117792|NCT00700102|589138191|FG000|Overall Study|Lost to Follow-up|8|||
163117793|NCT00700102|589138192|FG001|Overall Study|Lost to Follow-up|10|||
163117794|NCT01667562|589138193|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
163407967|NCT00328627|590203969|FG008|Overall Study|Physician Decision|3|||
163117795|NCT01667562|589138194|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
163117796|NCT01667562|589138193|FG000|Erlotinib Phase|Lost to Follow-up|0|||
163117797|NCT01667562|589138194|FG001|Erlotinib Phase|Lost to Follow-up|1|||
163117798|NCT01667562|589138193|FG000|Erlotinib Phase|Adverse Event|0|||
163117799|NCT01667562|589138194|FG001|Erlotinib Phase|Adverse Event|1|||
163117800|NCT01667562|589138193|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
163117801|NCT01667562|589138194|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
163117802|NCT02130986|589138195|FG000|Overall Study|Withdrawal by Subject|4|||
163117803|NCT02130986|589138196|FG001|Overall Study|Withdrawal by Subject|4|||
163117804|NCT02130986|589138195|FG000|Overall Study|Lost to Follow-up|151|||
163117805|NCT02130986|589138196|FG001|Overall Study|Lost to Follow-up|160|||
163117806|NCT01129882|589138197|FG000|Overall Study|Adverse Event|39|||
163117807|NCT01129882|589138197|FG000|Overall Study|Death|6|||
163117808|NCT01129882|589138197|FG000|Overall Study|Lack of Efficacy|5|||
163117809|NCT01129882|589138197|FG000|Overall Study|Lost to Follow-up|13|||
163117810|NCT01129882|589138197|FG000|Overall Study|Physician Decision|27|||
163117811|NCT01129882|589138197|FG000|Overall Study|Protocol Deviation|3|||
163117812|NCT01129882|589138197|FG000|Overall Study|Withdrawal Criteria Met|19|||
163117813|NCT01129882|589138197|FG000|Overall Study|Trial Termination by Sponsor|6|||
163117814|NCT01129882|589138197|FG000|Overall Study|Withdrawal by Subject|160|||
163117815|NCT01028716|589138198|FG000|Overall Study|Physician Decision|1|||
163117816|NCT00762996|589138199|FG000|Period One|Protocol Violation|0|||
163117817|NCT00762996|589138200|FG001|Period One|Protocol Violation|0|||
163117818|NCT00762996|589138201|FG002|Period One|Protocol Violation|1|||
163117819|NCT00762996|589138202|FG003|Period One|Protocol Violation|0|||
163117820|NCT00762996|589138199|FG000|Period One|ineligible|0|||
163117821|NCT00762996|589138200|FG001|Period One|ineligible|0|||
163117822|NCT00762996|589138201|FG002|Period One|ineligible|1|||
163117823|NCT00762996|589138202|FG003|Period One|ineligible|1|||
163117824|NCT00762996|589138199|FG000|Period One|Adverse Event|0|||
163117825|NCT00762996|589138200|FG001|Period One|Adverse Event|0|||
163117826|NCT00762996|589138201|FG002|Period One|Adverse Event|1|||
163117827|NCT00762996|589138202|FG003|Period One|Adverse Event|0|||
163117828|NCT00762996|589138199|FG000|Period One|Withdrawal by Subject|0|||
163117829|NCT00762996|589138200|FG001|Period One|Withdrawal by Subject|0|||
163117830|NCT00762996|589138201|FG002|Period One|Withdrawal by Subject|1|||
163117831|NCT00762996|589138202|FG003|Period One|Withdrawal by Subject|0|||
163117832|NCT00657150|589138204|FG000|Overall Study|Adverse Event|19|||
163117833|NCT00657150|589138205|FG001|Overall Study|Adverse Event|10|||
163117834|NCT00657150|589138204|FG000|Overall Study|Non-compliant with protocol|5|||
163117835|NCT00657150|589138205|FG001|Overall Study|Non-compliant with protocol|9|||
163117836|NCT00657150|589138204|FG000|Overall Study|Lost to Follow-up|2|||
163117837|NCT00657150|589138205|FG001|Overall Study|Lost to Follow-up|0|||
163117838|NCT00657150|589138204|FG000|Overall Study|Withdrawal by Subject|51|||
163117839|NCT00657150|589138205|FG001|Overall Study|Withdrawal by Subject|36|||
163117840|NCT00657150|589138204|FG000|Overall Study|Other|38|||
163117841|NCT00657150|589138205|FG001|Overall Study|Other|38|||
163117842|NCT00657150|589138204|FG000|Treatment|Adverse Event|60|||
163117843|NCT00657150|589138205|FG001|Treatment|Adverse Event|53|||
163117844|NCT00657150|589138204|FG000|Treatment|Non-compliant with protocol|10|||
163117845|NCT00657150|589138205|FG001|Treatment|Non-compliant with protocol|9|||
163117846|NCT00657150|589138204|FG000|Treatment|Lost to Follow-up|1|||
163117847|NCT00657150|589138205|FG001|Treatment|Lost to Follow-up|0|||
163117848|NCT00657150|589138204|FG000|Treatment|Withdrawal by Subject|23|||
163117849|NCT00657150|589138205|FG001|Treatment|Withdrawal by Subject|20|||
163117850|NCT00657150|589138204|FG000|Treatment|Other|13|||
163117851|NCT00657150|589138205|FG001|Treatment|Other|15|||
163117852|NCT01319721|589138213|FG000|Overall Study|Lost to Follow-up|1|||
163117853|NCT01319721|589138214|FG001|Overall Study|Lost to Follow-up|6|||
163117854|NCT02653495|589138215|FG000|Overall Study|Lost to Follow-up|2|||
163117855|NCT02653495|589138216|FG001|Overall Study|Lost to Follow-up|0|||
163117856|NCT02653495|589138215|FG000|Overall Study|Screening Failure|10|||
163117857|NCT02653495|589138216|FG001|Overall Study|Screening Failure|0|||
163340419|NCT00555620|589954794|FG004|Overall Study|Objective progression or relapse|3|||
163340420|NCT00555620|589954795|FG005|Overall Study|Objective progression or relapse|16|||
163340421|NCT00555620|589954790|FG000|Overall Study|Participant refused treatment|0|||
163340422|NCT00555620|589954791|FG001|Overall Study|Participant refused treatment|1|||
163117858|NCT00468845|589138217|FG000|Overall Study|Adverse Event|9|||
163117859|NCT00468845|589138218|FG001|Overall Study|Adverse Event|14|||
163117860|NCT00468845|589138219|FG002|Overall Study|Adverse Event|11|||
163117861|NCT00468845|589138217|FG000|Overall Study|Lost to Follow-up|2|||
163117862|NCT00468845|589138218|FG001|Overall Study|Lost to Follow-up|1|||
163117863|NCT00468845|589138219|FG002|Overall Study|Lost to Follow-up|2|||
163117864|NCT00468845|589138217|FG000|Overall Study|Other|4|||
163117865|NCT00468845|589138218|FG001|Overall Study|Other|9|||
163117866|NCT00468845|589138219|FG002|Overall Study|Other|5|||
163117867|NCT00468845|589138217|FG000|Overall Study|No longer willing to participate|5|||
163117868|NCT00468845|589138218|FG001|Overall Study|No longer willing to participate|6|||
163117869|NCT00468845|589138219|FG002|Overall Study|No longer willing to participate|10|||
163117870|NCT00468845|589138217|FG000|Overall Study|Randomized, not treated|1|||
163117871|NCT00468845|589138218|FG001|Overall Study|Randomized, not treated|4|||
163117872|NCT00468845|589138219|FG002|Overall Study|Randomized, not treated|2|||
163117873|NCT02761694|589138220|FG000|Overall Study|Lack of Efficacy|0|||
163117874|NCT02761694|589138221|FG001|Overall Study|Lack of Efficacy|0|||
163117875|NCT02761694|589138222|FG002|Overall Study|Lack of Efficacy|0|||
163117876|NCT02761694|589138223|FG003|Overall Study|Lack of Efficacy|0|||
163117877|NCT02761694|589138224|FG004|Overall Study|Lack of Efficacy|0|||
163117878|NCT02761694|589138225|FG005|Overall Study|Lack of Efficacy|0|||
163117879|NCT02761694|589138226|FG006|Overall Study|Lack of Efficacy|6|||
163117880|NCT02761694|589138227|FG007|Overall Study|Lack of Efficacy|0|||
163117881|NCT02761694|589138228|FG008|Overall Study|Lack of Efficacy|0|||
163117882|NCT02761694|589138229|FG009|Overall Study|Lack of Efficacy|1|||
163117883|NCT02761694|589138230|FG010|Overall Study|Lack of Efficacy|1|||
163117884|NCT02761694|589138231|FG011|Overall Study|Lack of Efficacy|4|||
163117885|NCT02761694|589138220|FG000|Overall Study|Death|0|||
163117886|NCT02761694|589138221|FG001|Overall Study|Death|0|||
163117887|NCT02761694|589138222|FG002|Overall Study|Death|0|||
163117888|NCT02761694|589138223|FG003|Overall Study|Death|0|||
163117889|NCT02761694|589138224|FG004|Overall Study|Death|0|||
163117890|NCT02761694|589138225|FG005|Overall Study|Death|0|||
163117891|NCT02761694|589138226|FG006|Overall Study|Death|2|||
163117892|NCT02761694|589138227|FG007|Overall Study|Death|0|||
163117893|NCT02761694|589138228|FG008|Overall Study|Death|2|||
163117894|NCT02761694|589138229|FG009|Overall Study|Death|2|||
163117895|NCT02761694|589138230|FG010|Overall Study|Death|1|||
163117896|NCT02761694|589138231|FG011|Overall Study|Death|0|||
163340423|NCT00555620|589954792|FG002|Overall Study|Participant refused treatment|1|||
163340424|NCT00555620|589954793|FG003|Overall Study|Participant refused treatment|0|||
163117897|NCT02761694|589138220|FG000|Overall Study|Physician Decision|0|||
163117898|NCT02761694|589138221|FG001|Overall Study|Physician Decision|0|||
163117899|NCT02761694|589138222|FG002|Overall Study|Physician Decision|0|||
163117900|NCT02761694|589138223|FG003|Overall Study|Physician Decision|0|||
163117901|NCT02761694|589138224|FG004|Overall Study|Physician Decision|0|||
163117902|NCT02761694|589138225|FG005|Overall Study|Physician Decision|0|||
163117903|NCT02761694|589138226|FG006|Overall Study|Physician Decision|1|||
163117904|NCT02761694|589138227|FG007|Overall Study|Physician Decision|0|||
163117905|NCT02761694|589138228|FG008|Overall Study|Physician Decision|0|||
163117906|NCT02761694|589138229|FG009|Overall Study|Physician Decision|0|||
163117907|NCT02761694|589138230|FG010|Overall Study|Physician Decision|0|||
163117908|NCT02761694|589138231|FG011|Overall Study|Physician Decision|0|||
163117909|NCT02761694|589138220|FG000|Overall Study|Withdrawal by Subject|0|||
163117910|NCT02761694|589138221|FG001|Overall Study|Withdrawal by Subject|0|||
163117911|NCT02761694|589138222|FG002|Overall Study|Withdrawal by Subject|0|||
163117912|NCT02761694|589138223|FG003|Overall Study|Withdrawal by Subject|1|||
163117913|NCT02761694|589138224|FG004|Overall Study|Withdrawal by Subject|0|||
163117914|NCT02761694|589138225|FG005|Overall Study|Withdrawal by Subject|0|||
163117915|NCT02761694|589138226|FG006|Overall Study|Withdrawal by Subject|4|||
163117916|NCT02761694|589138227|FG007|Overall Study|Withdrawal by Subject|0|||
163117917|NCT02761694|589138228|FG008|Overall Study|Withdrawal by Subject|2|||
163117918|NCT02761694|589138229|FG009|Overall Study|Withdrawal by Subject|1|||
163117919|NCT02761694|589138230|FG010|Overall Study|Withdrawal by Subject|0|||
163117920|NCT02761694|589138231|FG011|Overall Study|Withdrawal by Subject|0|||
163117921|NCT02761694|589138220|FG000|Overall Study|Lost to Follow-up|0|||
163117922|NCT02761694|589138221|FG001|Overall Study|Lost to Follow-up|0|||
163117923|NCT02761694|589138222|FG002|Overall Study|Lost to Follow-up|0|||
163117924|NCT02761694|589138223|FG003|Overall Study|Lost to Follow-up|0|||
163117925|NCT02761694|589138224|FG004|Overall Study|Lost to Follow-up|0|||
163117926|NCT02761694|589138225|FG005|Overall Study|Lost to Follow-up|0|||
163117927|NCT02761694|589138226|FG006|Overall Study|Lost to Follow-up|1|||
163117928|NCT02761694|589138227|FG007|Overall Study|Lost to Follow-up|0|||
163117929|NCT02761694|589138228|FG008|Overall Study|Lost to Follow-up|0|||
163117930|NCT02761694|589138229|FG009|Overall Study|Lost to Follow-up|0|||
163117931|NCT02761694|589138230|FG010|Overall Study|Lost to Follow-up|0|||
163117932|NCT02761694|589138231|FG011|Overall Study|Lost to Follow-up|1|||
163117933|NCT02761694|589138220|FG000|Overall Study|Adverse Event|0|||
163117934|NCT02761694|589138221|FG001|Overall Study|Adverse Event|0|||
163117935|NCT02761694|589138222|FG002|Overall Study|Adverse Event|0|||
163117936|NCT02761694|589138223|FG003|Overall Study|Adverse Event|0|||
163117937|NCT02761694|589138224|FG004|Overall Study|Adverse Event|0|||
163407968|NCT00328627|590203970|FG009|Overall Study|Physician Decision|2|||
163117938|NCT02761694|589138225|FG005|Overall Study|Adverse Event|0|||
163117939|NCT02761694|589138226|FG006|Overall Study|Adverse Event|1|||
163117940|NCT02761694|589138227|FG007|Overall Study|Adverse Event|0|||
163117941|NCT02761694|589138228|FG008|Overall Study|Adverse Event|1|||
163117942|NCT02761694|589138229|FG009|Overall Study|Adverse Event|0|||
163117943|NCT02761694|589138230|FG010|Overall Study|Adverse Event|0|||
163117944|NCT02761694|589138231|FG011|Overall Study|Adverse Event|1|||
163117945|NCT02761694|589138220|FG000|Overall Study|Other|4|||
163117946|NCT02761694|589138221|FG001|Overall Study|Other|4|||
163117947|NCT02761694|589138222|FG002|Overall Study|Other|1|||
163117948|NCT02761694|589138223|FG003|Overall Study|Other|2|||
163117949|NCT02761694|589138224|FG004|Overall Study|Other|3|||
163117950|NCT02761694|589138225|FG005|Overall Study|Other|3|||
163117951|NCT02761694|589138226|FG006|Overall Study|Other|18|||
163117952|NCT02761694|589138227|FG007|Overall Study|Other|8|||
163117953|NCT02761694|589138228|FG008|Overall Study|Other|0|||
163117954|NCT02761694|589138229|FG009|Overall Study|Other|1|||
163340425|NCT00555620|589954794|FG004|Overall Study|Participant refused treatment|0|||
163340426|NCT00555620|589954795|FG005|Overall Study|Participant refused treatment|1|||
163340427|NCT00555620|589954790|FG000|Overall Study|Other|0|||
163340428|NCT00555620|589954791|FG001|Overall Study|Other|0|||
163340429|NCT00555620|589954792|FG002|Overall Study|Other|0|||
163340430|NCT00555620|589954793|FG003|Overall Study|Other|1|||
163340431|NCT00555620|589954794|FG004|Overall Study|Other|0|||
163340432|NCT00555620|589954795|FG005|Overall Study|Other|3|||
163340433|NCT00476151|589954796|FG000|Overall Study|Adverse Event|0|||
163340434|NCT00476151|589954797|FG001|Overall Study|Adverse Event|2|||
163340435|NCT00476151|589954796|FG000|Overall Study|Protocol Violation|1|||
163340436|NCT00476151|589954797|FG001|Overall Study|Protocol Violation|3|||
163340437|NCT00476151|589954796|FG000|Overall Study|Withdrawal by Subject|2|||
163340438|NCT00476151|589954797|FG001|Overall Study|Withdrawal by Subject|0|||
163340439|NCT00476151|589954796|FG000|Overall Study|Physician Decision|0|||
163340440|NCT00476151|589954797|FG001|Overall Study|Physician Decision|2|||
163340441|NCT02068352|589954798|FG000|Overall Study|Lost to Follow-up|0|||
163340442|NCT02068352|589954799|FG001|Overall Study|Lost to Follow-up|2|||
163340443|NCT02068352|589954800|FG002|Overall Study|Lost to Follow-up|0|||
163340444|NCT02068352|589954798|FG000|Overall Study|Adverse Event|4|||
163340445|NCT02068352|589954799|FG001|Overall Study|Adverse Event|2|||
163340446|NCT02068352|589954800|FG002|Overall Study|Adverse Event|7|||
163340447|NCT02068352|589954798|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
163340448|NCT02068352|589954799|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
163340449|NCT02068352|589954800|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
163340450|NCT02068352|589954798|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
163340451|NCT02068352|589954799|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
163340452|NCT02068352|589954800|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
163340453|NCT02068352|589954798|FG000|Overall Study|Protocol Deviation|0|||
163340454|NCT02068352|589954799|FG001|Overall Study|Protocol Deviation|0|||
163340455|NCT02068352|589954800|FG002|Overall Study|Protocol Deviation|1|||
163340456|NCT01767376|589954805|FG000|Overall Study|Lost to Follow-up|3|||
163340457|NCT01767376|589954806|FG001|Overall Study|Lost to Follow-up|2|||
163340458|NCT01767376|589954807|FG002|Overall Study|Lost to Follow-up|0|||
163340459|NCT01767376|589954805|FG000|Overall Study|Withdrawal by Subject|1|||
163340460|NCT01767376|589954806|FG001|Overall Study|Withdrawal by Subject|1|||
163340461|NCT01767376|589954807|FG002|Overall Study|Withdrawal by Subject|0|||
163340462|NCT04883541|589954808|FG000|Overall Study|Not attending regular yoga class|16|||
163340463|NCT04883541|589954809|FG001|Overall Study|Not attending regular yoga class|0|||
163340464|NCT04883541|589954808|FG000|Overall Study|Not attending the pregnancy school|0|||
163340465|NCT04883541|589954809|FG001|Overall Study|Not attending the pregnancy school|9|||
163340466|NCT01369147|589954810|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
163340467|NCT01369147|589954811|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
163117955|NCT02761694|589138230|FG010|Overall Study|Other|1|||
163117956|NCT02761694|589138231|FG011|Overall Study|Other|0|||
163117957|NCT02395055|589138235|FG000|Overall Study|Withdrawal by Subject|7|||
163117958|NCT02395055|589138236|FG001|Overall Study|Withdrawal by Subject|3|||
163117959|NCT00787930|589138237|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
163340468|NCT01369147|589954812|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
163340469|NCT03456856|589954813|FG000|Overall Study|Lost to Follow-up|2|||
163340470|NCT03456856|589954813|FG000|Overall Study|Withdrawal by Subject|1|||
163340471|NCT02542696|589954815|FG000|Overall Study|Adverse Event|167|||
163340472|NCT02542696|589954815|FG000|Overall Study|Lack of Efficacy|26|||
163340473|NCT02542696|589954815|FG000|Overall Study|Lost to Follow-up|6|||
163340474|NCT02542696|589954815|FG000|Overall Study|Withdrawal by Subject|104|||
163340475|NCT02542696|589954815|FG000|Overall Study|Protocol Violation|5|||
163340476|NCT02542696|589954815|FG000|Overall Study|Death|8|||
163340477|NCT02542696|589954815|FG000|Overall Study|DECREASED OFF TIME|1|||
163340478|NCT02542696|589954815|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
163340479|NCT02542696|589954815|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
163340480|NCT02542696|589954815|FG000|Overall Study|MEDICAL HISTORY|1|||
163340481|NCT02542696|589954815|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
163340482|NCT02542696|589954815|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
163340483|NCT02542696|589954815|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
163340484|NCT02542696|589954815|FG000|Overall Study|SPONSOR DECISION|3|||
163340485|NCT02542696|589954815|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
163340486|NCT02542696|589954815|FG000|Overall Study|SUBJECT DECISION|2|||
163340487|NCT03262389|589954816|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
163340488|NCT03262389|589954816|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
163340489|NCT03262389|589954816|FG000|Overall Study|opted out of PET/MR|1|||
163340490|NCT02256553|589954818|FG000|Period I|Adverse Event|5|||
163340491|NCT02256553|589954818|FG000|Period I|Protocol Violation|1|||
163340492|NCT02256553|589954818|FG000|Period II|Adverse Event|1|||
163340493|NCT02256553|589954818|FG000|Period II|Subject Moved|1|||
163117960|NCT01896271|589138238|FG000|Overall Study|Physician Decision|10|||
163117961|NCT03002623|589138242|FG000|Overall Study|Lost to Follow-up|1|||
163117962|NCT03002623|589138243|FG001|Overall Study|Lost to Follow-up|0|||
163117963|NCT03002623|589138242|FG000|Overall Study|Physician Decision|1|||
163117964|NCT03002623|589138243|FG001|Overall Study|Physician Decision|1|||
163117965|NCT03762616|589138246|FG000|Overall Study|Protocol Violation|2|||
163117966|NCT00758589|589140414|FG000|Overall Study|Adverse Event|3|||
163117967|NCT00758589|589140415|FG001|Overall Study|Adverse Event|2|||
163117968|NCT00758589|589140416|FG002|Overall Study|Adverse Event|5|||
163117969|NCT00758589|589140417|FG003|Overall Study|Adverse Event|4|||
163117970|NCT00758589|589140414|FG000|Overall Study|Withdrawal by Subject|0|||
163117971|NCT00758589|589140415|FG001|Overall Study|Withdrawal by Subject|1|||
163117972|NCT00758589|589140416|FG002|Overall Study|Withdrawal by Subject|1|||
163117973|NCT00758589|589140417|FG003|Overall Study|Withdrawal by Subject|1|||
163117974|NCT00758589|589140414|FG000|Overall Study|Palm stopped to work|0|||
163117975|NCT00758589|589140415|FG001|Overall Study|Palm stopped to work|0|||
163117976|NCT00758589|589140416|FG002|Overall Study|Palm stopped to work|0|||
163117977|NCT00758589|589140417|FG003|Overall Study|Palm stopped to work|1|||
163117978|NCT00583791|589140419|FG000|Overall Study|Other|67|||
163117979|NCT00583791|589140419|FG000|Overall Study|Death|6|||
163117980|NCT00203021|589140420|FG000|Overall Study|Death|4|||
163117981|NCT00203021|589140421|FG001|Overall Study|Death|1|||
163117982|NCT00203021|589140420|FG000|Overall Study|Adverse Event|10|||
163117983|NCT00203021|589140421|FG001|Overall Study|Adverse Event|5|||
163117984|NCT00203021|589140420|FG000|Overall Study|Withdrawal by Subject|45|||
163117985|NCT00203021|589140421|FG001|Overall Study|Withdrawal by Subject|48|||
163117986|NCT00203021|589140420|FG000|Overall Study|Lost to Follow-up|9|||
163117987|NCT00203021|589140421|FG001|Overall Study|Lost to Follow-up|7|||
163117988|NCT00203021|589140420|FG000|Overall Study|Other than specified|11|||
163117989|NCT00203021|589140421|FG001|Overall Study|Other than specified|16|||
163117990|NCT03204890|589140426|FG000|Overall Study|Withdrawal by Subject|1|||
163117991|NCT04524455|589140437|FG000|Overall Study|Death|3|||
163117992|NCT04524455|589140438|FG001|Overall Study|Death|3|||
163117993|NCT04524455|589140437|FG000|Overall Study|Decision by Sponsor|0|||
163117994|NCT04524455|589140438|FG001|Overall Study|Decision by Sponsor|2|||
163117995|NCT04524455|589140437|FG000|Overall Study|Withdrawal of Consent From Study|1|||
163117996|NCT04524455|589140438|FG001|Overall Study|Withdrawal of Consent From Study|0|||
163117997|NCT04524455|589140437|FG000|Overall Study|Lost to Follow-up|0|||
163117998|NCT04524455|589140438|FG001|Overall Study|Lost to Follow-up|1|||
163117999|NCT01688739|589140439|FG000|Overall Study|Administrative Decision|1|||
163118000|NCT01688739|589140440|FG001|Overall Study|Administrative Decision|0|||
163118001|NCT01688739|589140441|FG002|Overall Study|Administrative Decision|0|||
163118002|NCT01688739|589140442|FG003|Overall Study|Administrative Decision|0|||
163118003|NCT01688739|589140443|FG004|Overall Study|Administrative Decision|0|||
163118004|NCT01688739|589140444|FG005|Overall Study|Administrative Decision|0|||
163118005|NCT01688739|589140445|FG006|Overall Study|Administrative Decision|0|||
163118006|NCT01688739|589140446|FG007|Overall Study|Administrative Decision|0|||
163118007|NCT01688739|589140447|FG008|Overall Study|Administrative Decision|0|||
163118008|NCT01688739|589140448|FG009|Overall Study|Administrative Decision|0|||
163118009|NCT00490776|589140451|FG000|Overall Study|Withdrawal by Subject|1|||
163118010|NCT00490776|589140451|FG000|Overall Study|Administrative Problems|1|||
163118011|NCT00490776|589140451|FG000|Overall Study|Death|1|||
163118012|NCT00490776|589140451|FG000|Overall Study|New Cancer Therapy|1|||
163118013|NCT00490776|589140451|FG000|Overall Study|Disease Progression|5|||
163118014|NCT03383783|589140452|FG000|Overall Study|Withdrawal by Subject|2|||
163118015|NCT01340937|589140454|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
163118016|NCT01340937|589140455|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
163118017|NCT01340937|589140456|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
163118018|NCT01340937|589140457|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
163118019|NCT01340937|589140454|FG000|Period 1: Infant Series|Adverse Event|0|||
163118020|NCT01340937|589140455|FG001|Period 1: Infant Series|Adverse Event|1|||
163118021|NCT01340937|589140456|FG002|Period 1: Infant Series|Adverse Event|4|||
163118022|NCT01340937|589140457|FG003|Period 1: Infant Series|Adverse Event|0|||
163118023|NCT01340937|589140454|FG000|Period 1: Infant Series|Death|2|||
163118024|NCT01340937|589140455|FG001|Period 1: Infant Series|Death|0|||
163118025|NCT01340937|589140456|FG002|Period 1: Infant Series|Death|2|||
163118026|NCT01340937|589140457|FG003|Period 1: Infant Series|Death|0|||
163118027|NCT01340937|589140454|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
163118028|NCT01340937|589140455|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
163118029|NCT01340937|589140456|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
163118030|NCT01340937|589140457|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
163118031|NCT01340937|589140454|FG000|Period 1: Infant Series|Physician Decision|2|||
163118032|NCT01340937|589140455|FG001|Period 1: Infant Series|Physician Decision|3|||
163118033|NCT01340937|589140456|FG002|Period 1: Infant Series|Physician Decision|1|||
163118034|NCT01340937|589140457|FG003|Period 1: Infant Series|Physician Decision|0|||
163118035|NCT01340937|589140454|FG000|Period 1: Infant Series|Protocol Violation|1|||
163118036|NCT01340937|589140455|FG001|Period 1: Infant Series|Protocol Violation|4|||
163118037|NCT01340937|589140456|FG002|Period 1: Infant Series|Protocol Violation|4|||
163118038|NCT01340937|589140457|FG003|Period 1: Infant Series|Protocol Violation|3|||
163118039|NCT01340937|589140454|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
163118040|NCT01340937|589140455|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
163118041|NCT01340937|589140456|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
163118042|NCT01340937|589140457|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
163118043|NCT01340937|589140454|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
163118044|NCT01340937|589140455|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
163118045|NCT01340937|589140456|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
163118046|NCT01340937|589140457|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
163118047|NCT01340937|589140454|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
163118048|NCT01340937|589140455|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
163118049|NCT01340937|589140456|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
163118050|NCT01340937|589140457|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
163118051|NCT01340937|589140454|FG000|Period 2: Interim Period|Adverse Event|1|||
163118052|NCT01340937|589140455|FG001|Period 2: Interim Period|Adverse Event|0|||
163118053|NCT01340937|589140456|FG002|Period 2: Interim Period|Adverse Event|1|||
163118054|NCT01340937|589140457|FG003|Period 2: Interim Period|Adverse Event|0|||
163118055|NCT01340937|589140454|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
163118056|NCT01340937|589140455|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
163118057|NCT01340937|589140456|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
163118058|NCT01340937|589140457|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
163118059|NCT01340937|589140454|FG000|Period 2: Interim Period|Physician Decision|0|||
163118060|NCT01340937|589140455|FG001|Period 2: Interim Period|Physician Decision|1|||
163118061|NCT01340937|589140456|FG002|Period 2: Interim Period|Physician Decision|1|||
163118062|NCT01340937|589140457|FG003|Period 2: Interim Period|Physician Decision|0|||
163118063|NCT01340937|589140454|FG000|Period 2: Interim Period|Protocol Violation|5|||
163118064|NCT01340937|589140455|FG001|Period 2: Interim Period|Protocol Violation|3|||
163118065|NCT01340937|589140456|FG002|Period 2: Interim Period|Protocol Violation|6|||
163118066|NCT01340937|589140457|FG003|Period 2: Interim Period|Protocol Violation|3|||
163118067|NCT01340937|589140454|FG000|Period 2: Interim Period|Technical problems|4|||
163118068|NCT01340937|589140455|FG001|Period 2: Interim Period|Technical problems|4|||
163118069|NCT01340937|589140456|FG002|Period 2: Interim Period|Technical problems|6|||
163118070|NCT01340937|589140457|FG003|Period 2: Interim Period|Technical problems|3|||
163118071|NCT01340937|589140454|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
163118072|NCT01340937|589140455|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
163118073|NCT01340937|589140456|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
163118074|NCT01340937|589140457|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
163118075|NCT01340937|589140454|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
163118076|NCT01340937|589140455|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
163118077|NCT01340937|589140456|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
163118078|NCT01340937|589140457|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
163118079|NCT01340937|589140454|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
163118080|NCT01340937|589140455|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
163118081|NCT01340937|589140456|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
163118082|NCT01340937|589140457|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
163118083|NCT01340937|589140454|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
163118084|NCT01340937|589140455|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
163118085|NCT01340937|589140456|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
163118086|NCT01340937|589140457|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
163118087|NCT00046930|589140458|FG000|Overall Study|Ineligible|12|||
163118088|NCT00046930|589140459|FG001|Overall Study|Ineligible|4|||
163118089|NCT00440310|589140460|FG000|Overall Study|Lost to Follow-up|4|||
163118090|NCT00440310|589140461|FG001|Overall Study|Lost to Follow-up|5|||
163118091|NCT00440310|589140460|FG000|Overall Study|Protocol Violation|0|||
163118092|NCT00440310|589140461|FG001|Overall Study|Protocol Violation|1|||
163118093|NCT00440310|589140460|FG000|Overall Study|Withdrawal by Subject|15|||
163118094|NCT00440310|589140461|FG001|Overall Study|Withdrawal by Subject|14|||
163118095|NCT00440310|589140460|FG000|Overall Study|No Reply at EOS|7|||
163118096|NCT00440310|589140461|FG001|Overall Study|No Reply at EOS|7|||
163340494|NCT02256553|589954818|FG000|Period III|Adverse Event|3|||
163340495|NCT04421456|589954827|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
163340496|NCT04421456|589954828|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
163340497|NCT04421456|589954829|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
163118097|NCT00440310|589140460|FG000|Overall Study|Other|1|||
163118098|NCT00440310|589140461|FG001|Overall Study|Other|0|||
163118099|NCT00440310|589140460|FG000|Overall Study|Status Unknown|1|||
163118100|NCT00440310|589140461|FG001|Overall Study|Status Unknown|3|||
163118101|NCT02119156|589140464|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
163118102|NCT02119156|589140465|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
163118103|NCT02119156|589140466|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
163118104|NCT02119156|589140464|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
163118105|NCT02119156|589140465|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
163118106|NCT02119156|589140466|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
163118107|NCT02119156|589140464|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
163118108|NCT02119156|589140465|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
163118109|NCT02119156|589140466|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
163118110|NCT02119156|589140464|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
163118111|NCT02119156|589140465|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
163118112|NCT02119156|589140466|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
163118113|NCT02119156|589140464|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
163118114|NCT02119156|589140465|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
163118115|NCT02119156|589140466|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
163118116|NCT01657760|589140467|FG000|Overall Study|Withdrawal by Subject|0|||
163118117|NCT01657760|589140468|FG001|Overall Study|Withdrawal by Subject|0|||
163118118|NCT01657760|589140469|FG002|Overall Study|Withdrawal by Subject|0|||
163118119|NCT01657760|589140470|FG003|Overall Study|Withdrawal by Subject|1|||
163118120|NCT01657760|589140467|FG000|Overall Study|Physician Decision|1|||
163118121|NCT01657760|589140468|FG001|Overall Study|Physician Decision|1|||
163118122|NCT01657760|589140469|FG002|Overall Study|Physician Decision|1|||
163118123|NCT01657760|589140470|FG003|Overall Study|Physician Decision|2|||
163118124|NCT02469415|589140471|FG000|Overall Study|Withdrawal by Subject|1|||
163118125|NCT02469415|589140471|FG000|Overall Study|Investigational agent placed on hold|2|||
163118126|NCT00940485|589140476|FG000|Overall Study|HBeAb positive at Baseline|3|||
163118127|NCT00940485|589140477|FG001|Overall Study|HBeAb positive at Baseline|2|||
163118128|NCT00940485|589140476|FG000|Overall Study|Lost to Follow-up|2|||
163118129|NCT00940485|589140477|FG001|Overall Study|Lost to Follow-up|3|||
163118130|NCT00940485|589140476|FG000|Overall Study|Adverse Event|8|||
163118131|NCT00940485|589140477|FG001|Overall Study|Adverse Event|0|||
163118132|NCT00940485|589140476|FG000|Overall Study|Withdrawal by Subject|1|||
163118133|NCT00940485|589140477|FG001|Overall Study|Withdrawal by Subject|1|||
163118134|NCT00940485|589140476|FG000|Overall Study|Others|1|||
163118135|NCT00940485|589140477|FG001|Overall Study|Others|1|||
163118136|NCT01113580|589140478|FG000|Overall Study|Protocol Violation|1|||
163118137|NCT01113580|589140479|FG001|Overall Study|Protocol Violation|0|||
163118138|NCT04599166|589140485|FG000|Overall Study|Technological failure connecting to study app|80|||
163118139|NCT01974752|589140486|FG000|Overall Study|Death|33|||
163118140|NCT01974752|589140487|FG001|Overall Study|Death|11|||
163118141|NCT01974752|589140486|FG000|Overall Study|Lost to Follow-up|2|||
163118142|NCT01974752|589140487|FG001|Overall Study|Lost to Follow-up|0|||
163118143|NCT01974752|589140486|FG000|Overall Study|Withdrawal by Subject|2|||
163118144|NCT01974752|589140487|FG001|Overall Study|Withdrawal by Subject|3|||
163118145|NCT01974752|589140486|FG000|Overall Study|Other Eligibility Criteria|0|||
163118146|NCT01974752|589140487|FG001|Overall Study|Other Eligibility Criteria|1|||
163118147|NCT02233738|589140488|FG000|Overall Study|Lost to Follow-up|5|||
163118148|NCT02233738|589140489|FG001|Overall Study|Lost to Follow-up|12|||
163118149|NCT02233738|589140488|FG000|Overall Study|Death|0|||
163118150|NCT02233738|589140489|FG001|Overall Study|Death|1|||
163118151|NCT02233738|589140488|FG000|Overall Study|Withdrawal by Subject|0|||
163118152|NCT02233738|589140489|FG001|Overall Study|Withdrawal by Subject|1|||
163118153|NCT02233738|589140488|FG000|Overall Study|Did not return after Baseline|3|||
163118154|NCT02233738|589140489|FG001|Overall Study|Did not return after Baseline|2|||
163118155|NCT02435680|589140490|FG000|Overall Study|Physician Decision|3|||
163118156|NCT02435680|589140491|FG001|Overall Study|Physician Decision|0|||
163118157|NCT02435680|589140492|FG002|Overall Study|Physician Decision|0|||
163118158|NCT02435680|589140490|FG000|Overall Study|subject / guardian decision|0|||
163118159|NCT02435680|589140491|FG001|Overall Study|subject / guardian decision|3|||
163118160|NCT02435680|589140492|FG002|Overall Study|subject / guardian decision|2|||
163118161|NCT02435680|589140490|FG000|Overall Study|Adverse Event|8|||
163118162|NCT02435680|589140491|FG001|Overall Study|Adverse Event|3|||
163118163|NCT02435680|589140492|FG002|Overall Study|Adverse Event|2|||
163118164|NCT02435680|589140490|FG000|Overall Study|progressive disease|10|||
163118165|NCT02435680|589140491|FG001|Overall Study|progressive disease|7|||
163118166|NCT02435680|589140492|FG002|Overall Study|progressive disease|11|||
163118167|NCT02435680|589140490|FG000|Overall Study|not treated|0|||
163118168|NCT02435680|589140491|FG001|Overall Study|not treated|0|||
163118169|NCT02435680|589140492|FG002|Overall Study|not treated|1|||
163118170|NCT00294645|589140493|FG000|Overall Study|Death|10|||
163118171|NCT00294645|589140494|FG001|Overall Study|Death|18|||
163118172|NCT00294645|589140493|FG000|Overall Study|Lost to Follow-up|1|||
163118173|NCT00294645|589140494|FG001|Overall Study|Lost to Follow-up|10|||
163118174|NCT00294645|589140493|FG000|Overall Study|Withdrawal by Subject|18|||
163118175|NCT00294645|589140494|FG001|Overall Study|Withdrawal by Subject|34|||
163118176|NCT00294645|589140493|FG000|Overall Study|Physician Decision|15|||
163118177|NCT00294645|589140494|FG001|Overall Study|Physician Decision|20|||
163118178|NCT00294645|589140493|FG000|Overall Study|Other|4|||
163118179|NCT00294645|589140494|FG001|Overall Study|Other|10|||
163118180|NCT00554619|589140497|FG000|Overall Study|Adverse Event|1|||
163118181|NCT00554619|589140497|FG000|Overall Study|Physician Decision|1|||
163118182|NCT00554619|589140497|FG000|Overall Study|Liver Function Test Abnormality|1|||
163118183|NCT00907803|589140499|FG000|Overall Study|Withdrawal of consent - long commute|1|||
163118184|NCT00907803|589140500|FG001|Overall Study|Withdrawal of consent - long commute|0|||
163118185|NCT00907803|589140501|FG002|Overall Study|Withdrawal of consent - long commute|0|||
163118186|NCT00907803|589140499|FG000|Overall Study|Adverse Event|2|||
163118187|NCT00907803|589140500|FG001|Overall Study|Adverse Event|0|||
163118188|NCT00907803|589140501|FG002|Overall Study|Adverse Event|0|||
163118189|NCT00907803|589140499|FG000|Overall Study|Withdrawal by Subject|0|||
163118190|NCT00907803|589140500|FG001|Overall Study|Withdrawal by Subject|1|||
163118191|NCT00907803|589140501|FG002|Overall Study|Withdrawal by Subject|0|||
163118192|NCT00907803|589140499|FG000|Overall Study|Lost to Follow-up|0|||
163118193|NCT00907803|589140500|FG001|Overall Study|Lost to Follow-up|1|||
163118194|NCT00907803|589140501|FG002|Overall Study|Lost to Follow-up|0|||
163118195|NCT00907803|589140499|FG000|Overall Study|Protocol Violation|0|||
163118196|NCT00907803|589140500|FG001|Overall Study|Protocol Violation|1|||
163118197|NCT00907803|589140501|FG002|Overall Study|Protocol Violation|0|||
163118198|NCT04612842|589140506|FG000|Overall Study|Lost to Follow-up|20|||
163118199|NCT04612842|589140507|FG001|Overall Study|Lost to Follow-up|11|||
163118200|NCT04612842|589140506|FG000|Overall Study|Withdrawal by Subject|26|||
163118201|NCT04612842|589140507|FG001|Overall Study|Withdrawal by Subject|15|||
163118202|NCT04612842|589140506|FG000|Overall Study|Death|2|||
163118203|NCT04612842|589140507|FG001|Overall Study|Death|2|||
163118204|NCT05426031|589140508|FG000|Overall Study|Circulatory Arrest|3|||
163118205|NCT05426031|589140509|FG001|Overall Study|Circulatory Arrest|2|||
163118206|NCT03060512|589140510|FG000|Overall Study|Adverse Event|4|||
163118207|NCT03060512|589140511|FG001|Overall Study|Adverse Event|6|||
163118208|NCT03060512|589140510|FG000|Overall Study|Lost to Follow-up|1|||
163118209|NCT03060512|589140511|FG001|Overall Study|Lost to Follow-up|1|||
163118210|NCT03060512|589140510|FG000|Overall Study|Withdrawal by Subject|1|||
163118211|NCT03060512|589140511|FG001|Overall Study|Withdrawal by Subject|0|||
163118212|NCT03060512|589140510|FG000|Overall Study|Non-compliance with study medication|1|||
163118213|NCT03060512|589140511|FG001|Overall Study|Non-compliance with study medication|2|||
163118214|NCT00089986|589140512|FG000|Overall Study|Adverse Event|6|||
163118215|NCT00089986|589140513|FG001|Overall Study|Adverse Event|9|||
163118216|NCT00089986|589140514|FG002|Overall Study|Adverse Event|6|||
163118217|NCT00089986|589140512|FG000|Overall Study|Lost to Follow-up|3|||
163118218|NCT00089986|589140513|FG001|Overall Study|Lost to Follow-up|1|||
163118219|NCT00089986|589140514|FG002|Overall Study|Lost to Follow-up|1|||
163118220|NCT00089986|589140512|FG000|Overall Study|Protocol Violation|0|||
163118221|NCT00089986|589140513|FG001|Overall Study|Protocol Violation|1|||
163118222|NCT00089986|589140514|FG002|Overall Study|Protocol Violation|0|||
163118223|NCT00089986|589140512|FG000|Overall Study|Patient transferred to another hospital|2|||
163118224|NCT00089986|589140513|FG001|Overall Study|Patient transferred to another hospital|1|||
163118225|NCT00089986|589140514|FG002|Overall Study|Patient transferred to another hospital|0|||
163118226|NCT00089986|589140512|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
163118227|NCT00089986|589140513|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
163118228|NCT00089986|589140514|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
163118229|NCT00089986|589140512|FG000|Overall Study|Hemohlobin stopping rule|0|||
163118230|NCT00089986|589140513|FG001|Overall Study|Hemohlobin stopping rule|1|||
163118231|NCT00089986|589140514|FG002|Overall Study|Hemohlobin stopping rule|0|||
163118232|NCT00089986|589140512|FG000|Overall Study|Investigator decision to withdrew|0|||
163118233|NCT00089986|589140513|FG001|Overall Study|Investigator decision to withdrew|1|||
163118234|NCT00089986|589140514|FG002|Overall Study|Investigator decision to withdrew|0|||
163118235|NCT00089986|589140512|FG000|Overall Study|Enrollment in another study|0|||
163118236|NCT00089986|589140513|FG001|Overall Study|Enrollment in another study|1|||
163118237|NCT00089986|589140514|FG002|Overall Study|Enrollment in another study|0|||
163118238|NCT00089986|589140512|FG000|Overall Study|Family decision|0|||
163340498|NCT04421456|589954827|FG000|Randomized Treatment Period|Adverse Event|0|||
163340499|NCT04421456|589954828|FG001|Randomized Treatment Period|Adverse Event|1|||
163340500|NCT04421456|589954829|FG002|Randomized Treatment Period|Adverse Event|0|||
163340501|NCT04421456|589954827|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
163118239|NCT00089986|589140513|FG001|Overall Study|Family decision|1|||
163118240|NCT00089986|589140514|FG002|Overall Study|Family decision|0|||
163118241|NCT00089986|589140512|FG000|Overall Study|Do not resuscitate (DNR)|0|||
163118242|NCT00089986|589140513|FG001|Overall Study|Do not resuscitate (DNR)|0|||
163118243|NCT00089986|589140514|FG002|Overall Study|Do not resuscitate (DNR)|1|||
163118244|NCT00089986|589140512|FG000|Overall Study|Withdrawal by Subject|3|||
163118245|NCT00089986|589140513|FG001|Overall Study|Withdrawal by Subject|6|||
163118246|NCT00089986|589140514|FG002|Overall Study|Withdrawal by Subject|2|||
163118247|NCT04065074|589140518|FG000|Overall Study|Adverse Event|1|||
163118248|NCT04065074|589140518|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
163118249|NCT02334683|589140519|FG000|First 12 Week Period|Lost to Follow-up|1|||
163118250|NCT02334683|589140520|FG001|First 12 Week Period|Lost to Follow-up|0|||
163118251|NCT02334683|589140519|FG000|Second 12 Week Period|Adverse Event|0|||
163224060|NCT02442778|589537824|FG001|Overall Study|Physician Decision|1|||
163118252|NCT02334683|589140520|FG001|Second 12 Week Period|Adverse Event|1|||
163118253|NCT01062841|589140521|FG000|Overall Study|Indwelling Device Removed|41|||
163118254|NCT01062841|589140522|FG001|Overall Study|Indwelling Device Removed|48|||
163118255|NCT01062841|589140521|FG000|Overall Study|Death|3|||
163118256|NCT01062841|589140522|FG001|Overall Study|Death|5|||
163118257|NCT01062841|589140521|FG000|Overall Study|Withdrawal by Subject|2|||
163118258|NCT01062841|589140522|FG001|Overall Study|Withdrawal by Subject|0|||
163118259|NCT01062841|589140521|FG000|Overall Study|Withdrawal by Study|3|||
163118260|NCT01062841|589140522|FG001|Overall Study|Withdrawal by Study|0|||
163118261|NCT03958656|589140523|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
163118262|NCT03958656|589140524|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
163118263|NCT03958656|589140525|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
163118264|NCT03958656|589140526|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
163118265|NCT03958656|589140523|FG000|Overall Study|No longer meets eligibility criteria|0|||
163118266|NCT03958656|589140524|FG001|Overall Study|No longer meets eligibility criteria|0|||
163118267|NCT03958656|589140525|FG002|Overall Study|No longer meets eligibility criteria|1|||
163118268|NCT03958656|589140526|FG003|Overall Study|No longer meets eligibility criteria|0|||
163118269|NCT03958656|589140523|FG000|Overall Study|Started anti-cancer treatment|0|||
163118270|NCT03958656|589140524|FG001|Overall Study|Started anti-cancer treatment|0|||
163118271|NCT03958656|589140525|FG002|Overall Study|Started anti-cancer treatment|1|||
163118272|NCT03958656|589140526|FG003|Overall Study|Started anti-cancer treatment|0|||
163118273|NCT03831880|589140527|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
163118274|NCT03831880|589140528|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
163118275|NCT03831880|589140527|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
163118276|NCT03831880|589140528|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
163118277|NCT03158012|589140531|FG000|Overall Study|Withdrawal by Subject|0|||
163118278|NCT03158012|589140532|FG001|Overall Study|Withdrawal by Subject|1|||
163118279|NCT02788201|589140533|FG000|Overall Study|Death|1|||
163118280|NCT02788201|589140534|FG001|Overall Study|Death|1|||
163118281|NCT02788201|589140535|FG002|Overall Study|Death|1|||
163118282|NCT02788201|589140536|FG003|Overall Study|Death|1|||
163118283|NCT02788201|589140537|FG004|Overall Study|Death|0|||
163118284|NCT02788201|589140538|FG005|Overall Study|Death|1|||
163118285|NCT02788201|589140533|FG000|Overall Study|Ineligible|0|||
163118286|NCT02788201|589140534|FG001|Overall Study|Ineligible|0|||
163118287|NCT02788201|589140535|FG002|Overall Study|Ineligible|0|||
163118288|NCT02788201|589140536|FG003|Overall Study|Ineligible|0|||
163118289|NCT02788201|589140537|FG004|Overall Study|Ineligible|0|||
163118290|NCT02788201|589140538|FG005|Overall Study|Ineligible|1|||
163118291|NCT02788201|589140533|FG000|Overall Study|Withdrawal by Subject|0|||
163118292|NCT02788201|589140534|FG001|Overall Study|Withdrawal by Subject|0|||
163118293|NCT02788201|589140535|FG002|Overall Study|Withdrawal by Subject|0|||
163118294|NCT02788201|589140536|FG003|Overall Study|Withdrawal by Subject|0|||
163118295|NCT02788201|589140537|FG004|Overall Study|Withdrawal by Subject|0|||
163118296|NCT02788201|589140538|FG005|Overall Study|Withdrawal by Subject|1|||
163118297|NCT01414205|589140539|FG000|Overall Study|Death|5|||
163118298|NCT01414205|589140540|FG001|Overall Study|Death|1|||
163118299|NCT01414205|589140539|FG000|Overall Study|Lost to Follow-up|1|||
163118300|NCT01414205|589140540|FG001|Overall Study|Lost to Follow-up|4|||
163118301|NCT01414205|589140539|FG000|Overall Study|Physician Decision|0|||
163118302|NCT01414205|589140540|FG001|Overall Study|Physician Decision|1|||
163118303|NCT01414205|589140539|FG000|Overall Study|Randomized but not Treated|1|||
163118304|NCT01414205|589140540|FG001|Overall Study|Randomized but not Treated|1|||
163118305|NCT01166373|589140541|FG000|Overall Study|Lost to Follow-up|3|||
163118306|NCT01166373|589140542|FG001|Overall Study|Lost to Follow-up|2|||
163118307|NCT01166373|589140543|FG002|Overall Study|Lost to Follow-up|2|||
163118308|NCT01166373|589140544|FG003|Overall Study|Lost to Follow-up|2|||
163118309|NCT01166373|589140541|FG000|Overall Study|Withdrawal by Subject|1|||
163118310|NCT01166373|589140542|FG001|Overall Study|Withdrawal by Subject|2|||
163118311|NCT01166373|589140543|FG002|Overall Study|Withdrawal by Subject|2|||
163118312|NCT01166373|589140544|FG003|Overall Study|Withdrawal by Subject|3|||
163118313|NCT01166373|589140541|FG000|Overall Study|Physician Decision|1|||
163118314|NCT01166373|589140542|FG001|Overall Study|Physician Decision|0|||
163118315|NCT01166373|589140543|FG002|Overall Study|Physician Decision|0|||
163118316|NCT01166373|589140544|FG003|Overall Study|Physician Decision|0|||
163340502|NCT04421456|589954828|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
163340503|NCT04421456|589954829|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
163340504|NCT04421456|589954827|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
163340505|NCT04421456|589954828|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
163118317|NCT02498067|589140545|FG000|Overall Study|Lost to Follow-up|22|||
163118318|NCT02498067|589140545|FG000|Overall Study|Did not meet inclusion criteria|11|||
163118319|NCT01874275|589140546|FG000|Overall Study|Lost to Follow-up|1|||
163118320|NCT01874275|589140547|FG001|Overall Study|Lost to Follow-up|0|||
163118321|NCT02214225|589140552|FG000|Overall Study|Lost to Follow-up|46|||
163118322|NCT02214225|589140553|FG001|Overall Study|Lost to Follow-up|18|||
163118323|NCT02214225|589140554|FG002|Overall Study|Lost to Follow-up|18|||
163118324|NCT02214225|589140552|FG000|Overall Study|Withdrawal by Subject|2|||
163118325|NCT02214225|589140553|FG001|Overall Study|Withdrawal by Subject|0|||
163118326|NCT02214225|589140554|FG002|Overall Study|Withdrawal by Subject|2|||
163118327|NCT02214225|589140552|FG000|Overall Study|Death|5|||
163118328|NCT02214225|589140553|FG001|Overall Study|Death|0|||
163118329|NCT02214225|589140554|FG002|Overall Study|Death|1|||
163118330|NCT02214225|589140552|FG000|Overall Study|randomized in error, not vaccinated|2|||
163118331|NCT02214225|589140553|FG001|Overall Study|randomized in error, not vaccinated|1|||
163118332|NCT02214225|589140554|FG002|Overall Study|randomized in error, not vaccinated|1|||
163118333|NCT03987932|589140555|FG000|Overall Study|Lost to Follow-up|2|||
163118334|NCT03987932|589140556|FG001|Overall Study|Lost to Follow-up|1|||
163118335|NCT03987932|589140557|FG002|Overall Study|Lost to Follow-up|1|||
163118336|NCT03987932|589140555|FG000|Overall Study|Non-study related elective surgery|0|||
163118337|NCT03987932|589140556|FG001|Overall Study|Non-study related elective surgery|0|||
163118338|NCT03987932|589140557|FG002|Overall Study|Non-study related elective surgery|1|||
163118339|NCT01669421|589140558|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
163118340|NCT01669421|589140558|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
163118341|NCT02813668|589140564|FG000|Overall Study|Death|4|||
163118342|NCT02813668|589140564|FG000|Overall Study|Lost to Follow-up|509|||
163118343|NCT02813668|589140564|FG000|Overall Study|Withdrawal by Subject|148|||
163118344|NCT02813668|589140564|FG000|Overall Study|No longer at worksite|85|||
163118345|NCT02813668|589140564|FG000|Overall Study|Medical reasons not related to the study|4|||
163118346|NCT02961790|589140565|FG000|Overall Study|Canceled|4|||
163118347|NCT02961790|589140566|FG001|Overall Study|Canceled|5|||
163118348|NCT02961790|589140567|FG002|Overall Study|Canceled|1|||
163118349|NCT02961790|589140568|FG003|Overall Study|Canceled|4|||
163118350|NCT02961790|589140565|FG000|Overall Study|without baseline data|4|||
163118351|NCT02961790|589140566|FG001|Overall Study|without baseline data|0|||
163118352|NCT02961790|589140567|FG002|Overall Study|without baseline data|1|||
163118353|NCT02961790|589140568|FG003|Overall Study|without baseline data|0|||
163118354|NCT02961790|589140565|FG000|Overall Study|without post baseline data|7|||
163118355|NCT02961790|589140566|FG001|Overall Study|without post baseline data|6|||
163118356|NCT02961790|589140567|FG002|Overall Study|without post baseline data|4|||
163118357|NCT02961790|589140568|FG003|Overall Study|without post baseline data|1|||
163118358|NCT02594098|589140571|FG000|Overall Study|Lack of Efficacy|17|||
163118359|NCT02594098|589140572|FG001|Overall Study|Lack of Efficacy|6|||
163118360|NCT02594098|589140571|FG000|Overall Study|Withdrawal by Subject|1|||
163118361|NCT02594098|589140572|FG001|Overall Study|Withdrawal by Subject|3|||
163118362|NCT02594098|589140571|FG000|Overall Study|Terminated participation|6|||
163118363|NCT02594098|589140572|FG001|Overall Study|Terminated participation|2|||
163118364|NCT02594098|589140571|FG000|Overall Study|Seek alternative treatment|2|||
163118365|NCT02594098|589140572|FG001|Overall Study|Seek alternative treatment|1|||
163118366|NCT02594098|589140571|FG000|Overall Study|Other|0|||
163118367|NCT02594098|589140572|FG001|Overall Study|Other|1|||
163118368|NCT01866423|589140573|FG000|Overall Study|Lack of Efficacy|3|||
163118369|NCT01866423|589140573|FG000|Overall Study|Sponsor Decision|1|||
163118370|NCT00526110|589140580|FG000|Overall Study|Adverse Event|2|||
163118371|NCT00526110|589140581|FG001|Overall Study|Adverse Event|9|||
163118372|NCT00526110|589140580|FG000|Overall Study|Disease Progression|0|||
163118373|NCT00526110|589140581|FG001|Overall Study|Disease Progression|19|||
163118374|NCT00526110|589140580|FG000|Overall Study|Maximal Response|0|||
163118375|NCT00526110|589140581|FG001|Overall Study|Maximal Response|6|||
163118376|NCT00526110|589140580|FG000|Overall Study|Withdrawal by Subject|0|||
163118377|NCT00526110|589140581|FG001|Overall Study|Withdrawal by Subject|2|||
163118378|NCT00526110|589140580|FG000|Overall Study|Poor Tolerance|0|||
163118379|NCT00526110|589140581|FG001|Overall Study|Poor Tolerance|5|||
163118380|NCT01400243|589140582|FG000|Overall Study|Protocol Violation|8|||
163118381|NCT01400243|589140583|FG001|Overall Study|Protocol Violation|11|||
163118382|NCT00953680|589140584|FG000|Period 1|Withdrawal by Subject|0|||
163118383|NCT00953680|589140585|FG001|Period 1|Withdrawal by Subject|1|||
163118384|NCT00570037|589142551|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
163118385|NCT00570037|589142552|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
163118386|NCT03946124|589142553|FG000|Overall Study|Withdrawal by Subject|19|||
163118387|NCT02118597|589142555|FG000|Overall Study|Sponsor terminated the study|14|||
163118388|NCT02118597|589142555|FG000|Overall Study|Serious Adverse Event|1|||
163118389|NCT02118597|589142555|FG000|Overall Study|Investigator's decision|1|||
163118390|NCT01891344|589142556|FG000|Overall Study|Ongoing|6|||
163118391|NCT01891344|589142557|FG001|Overall Study|Ongoing|2|||
163118392|NCT01891344|589142558|FG002|Overall Study|Ongoing|0|||
163118393|NCT01891344|589142559|FG003|Overall Study|Ongoing|1|||
163118394|NCT01891344|589142560|FG004|Overall Study|Ongoing|4|||
163118395|NCT01891344|589142561|FG005|Overall Study|Ongoing|1|||
163118396|NCT01891344|589142562|FG006|Overall Study|Ongoing|0|||
163118397|NCT01891344|589142563|FG007|Overall Study|Ongoing|0|||
163340506|NCT04421456|589954829|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
163118398|NCT01852825|589142564|FG000|Overall Study|Withdrawal by Subject|2|||
163118399|NCT01852825|589142565|FG001|Overall Study|Withdrawal by Subject|0|||
163118400|NCT01852825|589142566|FG002|Overall Study|Withdrawal by Subject|0|||
163118401|NCT01665430|589142567|FG000|Overall Study|Adverse Event|1|||
163118402|NCT01665430|589142567|FG000|Overall Study|Withdrawal by Subject|6|||
163118403|NCT01665430|589142567|FG000|Overall Study|Other Unspecified|2|||
163118404|NCT02310230|589142568|FG000|Overall Study|Physician Decision|1|||
163118405|NCT02310230|589142569|FG001|Overall Study|Physician Decision|3|||
163118406|NCT02310230|589142568|FG000|Overall Study|monitor baseline taken after induction|2|||
163118407|NCT02310230|589142569|FG001|Overall Study|monitor baseline taken after induction|7|||
163118408|NCT02310230|589142568|FG000|Overall Study|Poor signal quality|5|||
163118409|NCT02310230|589142569|FG001|Overall Study|Poor signal quality|8|||
163118410|NCT02310230|589142568|FG000|Overall Study|Case cancelled|1|||
163118411|NCT02310230|589142569|FG001|Overall Study|Case cancelled|0|||
163118412|NCT03593681|589142570|FG000|Overall Study|Inadequate sample collected|12|||
163118413|NCT03593681|589142570|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
163118414|NCT03593681|589142570|FG000|Overall Study|Protocol Violation|3|||
163118415|NCT03593681|589142570|FG000|Overall Study|Withdrawal by Subject|3|||
163118416|NCT03593681|589142570|FG000|Overall Study|Procedure not attempted|3|||
163118417|NCT03593681|589142570|FG000|Overall Study|Adverse Event|2|||
163118418|NCT03593681|589142570|FG000|Overall Study|Physician Decision|1|||
163118419|NCT01149486|589142573|FG000|First Intervention|Adverse Event|0|||
163118420|NCT01149486|589142574|FG001|First Intervention|Adverse Event|1|||
163118421|NCT04662073|589142575|FG000|Overall Study|Withdrawal by Subject|1|||
163118422|NCT04662073|589142576|FG001|Overall Study|Withdrawal by Subject|0|||
163118423|NCT00598078|589142579|FG000|Period 2 (Day 2)|Adverse Event|1|||
163118424|NCT00598078|589142580|FG001|Period 2 (Day 2)|Adverse Event|0|||
163118425|NCT03366103|589142584|FG000|Overall Study|Disease Progression|3|||
163118426|NCT03366103|589142585|FG001|Overall Study|Disease Progression|1|||
163118427|NCT03366103|589142586|FG002|Overall Study|Disease Progression|0|||
163118428|NCT03366103|589142584|FG000|Overall Study|Adverse Event|0|||
163118429|NCT03366103|589142585|FG001|Overall Study|Adverse Event|1|||
163118430|NCT03366103|589142586|FG002|Overall Study|Adverse Event|0|||
163118431|NCT00541099|589142587|FG000|Overall Study|Ineligible|3|||
163118432|NCT05590000|589142594|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
163118433|NCT01174004|589142595|FG000|Overall Study|Adverse Event|2|||
163118434|NCT01174004|589142596|FG001|Overall Study|Adverse Event|10|||
163118435|NCT01174004|589142595|FG000|Overall Study|Withdrawal by Subject|2|||
163118436|NCT01174004|589142596|FG001|Overall Study|Withdrawal by Subject|3|||
163118437|NCT01174004|589142595|FG000|Overall Study|At Discretion of Sponsor|2|||
163118438|NCT01174004|589142596|FG001|Overall Study|At Discretion of Sponsor|2|||
163118439|NCT01174004|589142595|FG000|Overall Study|Protocol Violation|0|||
163118440|NCT01174004|589142596|FG001|Overall Study|Protocol Violation|1|||
163118441|NCT01174004|589142595|FG000|Overall Study|Physician Decision|1|||
163118442|NCT01174004|589142596|FG001|Overall Study|Physician Decision|0|||
163118443|NCT02689076|589142597|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
163118444|NCT02689076|589142598|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
163118445|NCT02689076|589142599|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
163118446|NCT02689076|589142597|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
163118447|NCT02689076|589142598|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
163118448|NCT02689076|589142599|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
163118449|NCT02689076|589142597|FG000|Overall Study|Did not have an HIE match|2|||
163118450|NCT02689076|589142598|FG001|Overall Study|Did not have an HIE match|0|||
163118451|NCT02689076|589142599|FG002|Overall Study|Did not have an HIE match|0|||
163118452|NCT02689076|589142597|FG000|Overall Study|Death during non-VA encounter|2|||
163118453|NCT02689076|589142598|FG001|Overall Study|Death during non-VA encounter|5|||
163118454|NCT02689076|589142599|FG002|Overall Study|Death during non-VA encounter|0|||
163118455|NCT02689076|589142597|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
163118456|NCT02689076|589142598|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
163118457|NCT02689076|589142599|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
163118458|NCT02689076|589142597|FG000|Overall Study|Participant no longer active in VA system|1|||
163118459|NCT02689076|589142598|FG001|Overall Study|Participant no longer active in VA system|0|||
163118460|NCT02689076|589142599|FG002|Overall Study|Participant no longer active in VA system|0|||
163118461|NCT02689076|589142597|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
163118462|NCT02689076|589142598|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
163118463|NCT02689076|589142599|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
163118464|NCT00933244|589142600|FG000|Overall Study|Withdrawal by Subject|5|||
163118465|NCT00933244|589142601|FG001|Overall Study|Withdrawal by Subject|1|||
163118466|NCT00933244|589142602|FG002|Overall Study|Withdrawal by Subject|3|||
163118467|NCT00434759|589142605|FG000|Overall Study|Lack of Efficacy|5|||
163118468|NCT00434759|589142606|FG001|Overall Study|Lack of Efficacy|4|||
163118469|NCT00434759|589142605|FG000|Overall Study|Withdrawal by Subject|17|||
163118470|NCT00434759|589142606|FG001|Overall Study|Withdrawal by Subject|1|||
163118471|NCT00434759|589142605|FG000|Overall Study|family affairs|2|||
163118472|NCT00434759|589142606|FG001|Overall Study|family affairs|0|||
163118473|NCT01143896|589142613|FG000|Overall Study|Did not complete Baseline Interview|5|||
163118474|NCT01143896|589142614|FG001|Overall Study|Did not complete Baseline Interview|4|||
163118475|NCT01143896|589142613|FG000|Overall Study|Lost to Follow-up|18|||
163118476|NCT01143896|589142614|FG001|Overall Study|Lost to Follow-up|13|||
163118477|NCT01143896|589142613|FG000|Overall Study|Withdrawal by Subject|13|||
163118478|NCT01143896|589142614|FG001|Overall Study|Withdrawal by Subject|5|||
163118479|NCT01143896|589142613|FG000|Overall Study|Death|6|||
163118480|NCT01143896|589142614|FG001|Overall Study|Death|3|||
163118481|NCT01318070|589142615|FG000|Overall Study|Adverse Event|1|||
163118482|NCT01318070|589142616|FG001|Overall Study|Adverse Event|1|||
163118483|NCT01318070|589142617|FG002|Overall Study|Adverse Event|5|||
163118484|NCT01318070|589142615|FG000|Overall Study|Withdrawal by Subject|0|||
163118485|NCT01318070|589142616|FG001|Overall Study|Withdrawal by Subject|1|||
163118486|NCT01318070|589142617|FG002|Overall Study|Withdrawal by Subject|1|||
163118487|NCT01318070|589142615|FG000|Overall Study|Lack of Efficacy|0|||
163118488|NCT01318070|589142616|FG001|Overall Study|Lack of Efficacy|0|||
163118489|NCT01318070|589142617|FG002|Overall Study|Lack of Efficacy|1|||
163118490|NCT01318070|589142615|FG000|Overall Study|Principal Investigator Discretion|1|||
163118491|NCT01318070|589142616|FG001|Overall Study|Principal Investigator Discretion|0|||
163118492|NCT01318070|589142617|FG002|Overall Study|Principal Investigator Discretion|0|||
163118493|NCT00693472|589142620|FG000|Part 1|Adverse Event|1|||
163118494|NCT00693472|589142621|FG001|Part 1|Adverse Event|1|||
163118495|NCT00693472|589142622|FG002|Part 1|Adverse Event|0|||
163118496|NCT00693472|589142623|FG003|Part 1|Adverse Event|0|||
163118497|NCT00693472|589142620|FG000|Part 1|Lost to Follow-up|0|||
163118498|NCT00693472|589142621|FG001|Part 1|Lost to Follow-up|1|||
163118499|NCT00693472|589142622|FG002|Part 1|Lost to Follow-up|0|||
163118500|NCT00693472|589142623|FG003|Part 1|Lost to Follow-up|0|||
163118501|NCT00693472|589142620|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
163118502|NCT00693472|589142621|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
163118503|NCT00693472|589142622|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
163118504|NCT00693472|589142623|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
163118505|NCT00693472|589142620|FG000|Part 2|Adverse Event|0|||
163118506|NCT00693472|589142621|FG001|Part 2|Adverse Event|0|||
163118507|NCT00693472|589142622|FG002|Part 2|Adverse Event|1|||
163118508|NCT00693472|589142623|FG003|Part 2|Adverse Event|0|||
163118509|NCT00693472|589142620|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
163118510|NCT00693472|589142621|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
163118511|NCT00693472|589142622|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
163118512|NCT00693472|589142623|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
163118513|NCT00042432|589142624|FG000|Overall Study|Adverse Event|4|||
163118514|NCT00042432|589142625|FG001|Overall Study|Adverse Event|1|||
163118515|NCT00042432|589142624|FG000|Overall Study|Withdrawal by Subject|1|||
163118516|NCT00042432|589142625|FG001|Overall Study|Withdrawal by Subject|3|||
163118517|NCT00042432|589142624|FG000|Overall Study|Death|0|||
163118518|NCT00042432|589142625|FG001|Overall Study|Death|2|||
163118519|NCT00042432|589142624|FG000|Overall Study|Ineligibility determined|1|||
163118520|NCT00042432|589142625|FG001|Overall Study|Ineligibility determined|0|||
163118521|NCT00042432|589142624|FG000|Overall Study|Initiation of maintenance dialysis|1|||
163118522|NCT00042432|589142625|FG001|Overall Study|Initiation of maintenance dialysis|1|||
163118523|NCT00042432|589142624|FG000|Overall Study|Other|2|||
163118524|NCT00042432|589142625|FG001|Overall Study|Other|0|||
163118525|NCT00849875|589142627|FG000|Overall Study|Death|28|||
163118526|NCT00849875|589142627|FG000|Overall Study|Ongoing (unknown completion status)|11|||
163118527|NCT00849875|589142627|FG000|Overall Study|Others|6|||
163118528|NCT00849875|589142627|FG000|Overall Study|Lost to Follow-up|2|||
163118529|NCT02966795|589142629|FG000|Overall Study|Patient Left the Country|0|||
163118530|NCT02966795|589142630|FG001|Overall Study|Patient Left the Country|1|||
163118531|NCT00432744|589142631|FG000|Months 0-6|Withdrawal by Subject|4|||
163340507|NCT04421456|589954827|FG000|Randomized Treatment Period|Participant non-compliance|1|||
163118532|NCT00432744|589142632|FG001|Months 0-6|Withdrawal by Subject|4|||
163118533|NCT00432744|589142631|FG000|Months 0-6|Too disabled to score|1|||
163118534|NCT00432744|589142632|FG001|Months 0-6|Too disabled to score|0|||
163118535|NCT00432744|589142631|FG000|Months 7 - 12|Withdrawal by Subject|1|||
163118536|NCT00432744|589142632|FG001|Months 7 - 12|Withdrawal by Subject|0|||
163118537|NCT00432744|589142631|FG000|Months 7 - 12|Too disabled to score|0|||
163118538|NCT00432744|589142632|FG001|Months 7 - 12|Too disabled to score|1|||
163118539|NCT00461305|589142635|FG000|Treatment|Adverse Event|26|||
163118540|NCT00461305|589142636|FG001|Treatment|Adverse Event|3|||
163118541|NCT00461305|589142635|FG000|Treatment|Lost to Follow-up|4|||
163118542|NCT00461305|589142636|FG001|Treatment|Lost to Follow-up|2|||
163118543|NCT00461305|589142635|FG000|Treatment|Protocol Violation|13|||
163118544|NCT00461305|589142636|FG001|Treatment|Protocol Violation|2|||
163118545|NCT00461305|589142635|FG000|Treatment|Withdrawal by Subject|48|||
163118546|NCT00461305|589142636|FG001|Treatment|Withdrawal by Subject|2|||
163118547|NCT00461305|589142635|FG000|Treatment|Never dispensed|5|||
163118548|NCT00461305|589142636|FG001|Treatment|Never dispensed|0|||
163118549|NCT00461305|589142635|FG000|Treatment|Study drug not taken|1|||
163118550|NCT00461305|589142636|FG001|Treatment|Study drug not taken|0|||
163118551|NCT00461305|589142635|FG000|Treatment|Partially missing diary|2|||
163340508|NCT04421456|589954828|FG001|Randomized Treatment Period|Participant non-compliance|1|||
163340509|NCT04421456|589954829|FG002|Randomized Treatment Period|Participant non-compliance|2|||
163340510|NCT04421456|589954827|FG000|Randomized Treatment Period|Other|0|||
163340511|NCT04421456|589954828|FG001|Randomized Treatment Period|Other|1|||
163340512|NCT04421456|589954829|FG002|Randomized Treatment Period|Other|3|||
163340513|NCT00379210|589954830|FG000|Overall Study|Withdrawal by Subject|10|||
163340514|NCT00379210|589954831|FG001|Overall Study|Withdrawal by Subject|7|||
163340515|NCT03651271|589954832|FG000|Overall Study|Death|4|||
163340516|NCT03651271|589954833|FG001|Overall Study|Death|37|||
163340517|NCT03651271|589954834|FG002|Overall Study|Death|0|||
163340518|NCT03651271|589954835|FG003|Overall Study|Death|2|||
163340519|NCT03651271|589954836|FG004|Overall Study|Death|6|||
163340520|NCT03651271|589954832|FG000|Overall Study|Lost to Follow-up|1|||
163340521|NCT03651271|589954833|FG001|Overall Study|Lost to Follow-up|5|||
163340522|NCT03651271|589954834|FG002|Overall Study|Lost to Follow-up|0|||
163340523|NCT03651271|589954835|FG003|Overall Study|Lost to Follow-up|1|||
163340524|NCT03651271|589954836|FG004|Overall Study|Lost to Follow-up|0|||
163340525|NCT03651271|589954832|FG000|Overall Study|Physician Decision|0|||
163340526|NCT03651271|589954833|FG001|Overall Study|Physician Decision|2|||
163340527|NCT03651271|589954834|FG002|Overall Study|Physician Decision|0|||
163340528|NCT03651271|589954835|FG003|Overall Study|Physician Decision|0|||
163340529|NCT03651271|589954836|FG004|Overall Study|Physician Decision|0|||
163340530|NCT03651271|589954832|FG000|Overall Study|Withdrawal by Subject|1|||
163340531|NCT03651271|589954833|FG001|Overall Study|Withdrawal by Subject|15|||
163340532|NCT03651271|589954834|FG002|Overall Study|Withdrawal by Subject|0|||
163340533|NCT03651271|589954835|FG003|Overall Study|Withdrawal by Subject|0|||
163340534|NCT03651271|589954836|FG004|Overall Study|Withdrawal by Subject|1|||
163340535|NCT03651271|589954832|FG000|Overall Study|Patient medically unable to continue|0|||
163340536|NCT03651271|589954833|FG001|Overall Study|Patient medically unable to continue|0|||
163340537|NCT03651271|589954834|FG002|Overall Study|Patient medically unable to continue|0|||
163340538|NCT03651271|589954835|FG003|Overall Study|Patient medically unable to continue|1|||
163340539|NCT03651271|589954836|FG004|Overall Study|Patient medically unable to continue|0|||
163340540|NCT00821093|589954837|FG000|Overall Study|Adverse Event|20|||
163340541|NCT00821093|589954838|FG001|Overall Study|Adverse Event|12|||
163340542|NCT00821093|589954837|FG000|Overall Study|Withdrawal by Subject|9|||
163340543|NCT00821093|589954838|FG001|Overall Study|Withdrawal by Subject|13|||
163340544|NCT00821093|589954837|FG000|Overall Study|Lost to Follow-up|9|||
163340545|NCT00821093|589954838|FG001|Overall Study|Lost to Follow-up|3|||
163340546|NCT00821093|589954837|FG000|Overall Study|Protocol deviation|3|||
163340547|NCT00821093|589954838|FG001|Overall Study|Protocol deviation|6|||
163340548|NCT00821093|589954837|FG000|Overall Study|Abnormal laboratory value(s)|2|||
163340549|NCT00821093|589954838|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163340550|NCT00821093|589954837|FG000|Overall Study|Lack of Efficacy|2|||
163340551|NCT00821093|589954838|FG001|Overall Study|Lack of Efficacy|2|||
163340552|NCT00821093|589954837|FG000|Overall Study|Death|2|||
163340553|NCT00821093|589954838|FG001|Overall Study|Death|1|||
163340554|NCT00821093|589954837|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163340555|NCT00821093|589954838|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163340556|NCT00821093|589954837|FG000|Overall Study|Administrative problems|1|||
163340557|NCT00821093|589954838|FG001|Overall Study|Administrative problems|2|||
163340558|NCT05104242|589954839|FG000|Overall Study|Withdrawal by Subject|1|||
163340559|NCT05104242|589954840|FG001|Overall Study|Withdrawal by Subject|5|||
163340560|NCT05104242|589954839|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
163340561|NCT05104242|589954840|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
163340562|NCT02469155|589954845|FG000|Overall Study|Adverse Event|6|||
163407969|NCT00328627|590203971|FG010|Overall Study|Physician Decision|1|||
163118552|NCT00461305|589142636|FG001|Treatment|Partially missing diary|0|||
163407970|NCT00328627|590203972|FG011|Overall Study|Physician Decision|0|||
163407971|NCT00328627|590203961|FG000|Overall Study|Other|0|||
163407972|NCT00328627|590203962|FG001|Overall Study|Other|0|||
163407973|NCT00328627|590203963|FG002|Overall Study|Other|0|||
163118553|NCT00461305|589142635|FG000|Treatment|Other (missing drug etc)|2|||
163118554|NCT00461305|589142636|FG001|Treatment|Other (missing drug etc)|0|||
163118555|NCT00461305|589142635|FG000|Continued Treatment|Adverse Event|26|||
163118556|NCT00461305|589142636|FG001|Continued Treatment|Adverse Event|0|||
163340563|NCT02469155|589954846|FG001|Overall Study|Adverse Event|0|||
163340564|NCT02469155|589954847|FG002|Overall Study|Adverse Event|1|||
163340565|NCT02469155|589954848|FG003|Overall Study|Adverse Event|10|||
163340566|NCT02469155|589954845|FG000|Overall Study|Lack of Efficacy|13|||
163340567|NCT02469155|589954846|FG001|Overall Study|Lack of Efficacy|10|||
163340568|NCT02469155|589954847|FG002|Overall Study|Lack of Efficacy|10|||
163340569|NCT02469155|589954848|FG003|Overall Study|Lack of Efficacy|8|||
163407974|NCT00328627|590203964|FG003|Overall Study|Other|1|||
163407975|NCT00328627|590203965|FG004|Overall Study|Other|0|||
163407976|NCT00328627|590203966|FG005|Overall Study|Other|0|||
163407977|NCT00328627|590203967|FG006|Overall Study|Other|1|||
163407978|NCT00328627|590203968|FG007|Overall Study|Other|0|||
163407979|NCT00328627|590203969|FG008|Overall Study|Other|0|||
163407980|NCT00328627|590203970|FG009|Overall Study|Other|1|||
163407981|NCT00328627|590203971|FG010|Overall Study|Other|1|||
163407982|NCT00328627|590203972|FG011|Overall Study|Other|0|||
163407983|NCT00513409|590203974|FG000|Overall Study|Adverse Event|0|||
163407984|NCT00513409|590203975|FG001|Overall Study|Adverse Event|1|||
163407985|NCT00513409|590203974|FG000|Overall Study|Withdrawal by Subject|0|||
163407986|NCT00513409|590203975|FG001|Overall Study|Withdrawal by Subject|2|||
163407987|NCT00513409|590203974|FG000|Overall Study|Lost to Follow-up|0|||
163407988|NCT00513409|590203975|FG001|Overall Study|Lost to Follow-up|1|||
163407989|NCT00513409|590203974|FG000|Overall Study|Physician Decision|1|||
163407990|NCT00513409|590203975|FG001|Overall Study|Physician Decision|0|||
163407991|NCT00513409|590203974|FG000|Overall Study|Visit 3 not done|1|||
163407992|NCT00513409|590203975|FG001|Overall Study|Visit 3 not done|2|||
163407993|NCT00691483|590203976|FG000|Overall Study|Adverse Event|14|||
163407994|NCT00691483|590203977|FG001|Overall Study|Adverse Event|6|||
163407995|NCT00691483|590203976|FG000|Overall Study|Lost to Follow-up|17|||
163407996|NCT00691483|590203977|FG001|Overall Study|Lost to Follow-up|10|||
163407997|NCT00691483|590203976|FG000|Overall Study|Withdrawal by Subject|24|||
163407998|NCT00691483|590203977|FG001|Overall Study|Withdrawal by Subject|7|||
163407999|NCT00691483|590203976|FG000|Overall Study|Other known cause|6|||
163408000|NCT00691483|590203977|FG001|Overall Study|Other known cause|1|||
163408001|NCT00691483|590203976|FG000|Overall Study|Randomized by not treated|7|||
163408002|NCT00691483|590203977|FG001|Overall Study|Randomized by not treated|1|||
163408003|NCT04623242|590203978|FG000|Overall Study|Withdrawal by Subject|7|||
163408004|NCT04623242|590203979|FG001|Overall Study|Withdrawal by Subject|12|||
163408005|NCT04623242|590203980|FG002|Overall Study|Withdrawal by Subject|5|||
163408006|NCT04623242|590203981|FG003|Overall Study|Withdrawal by Subject|7|||
163408007|NCT04623242|590203982|FG004|Overall Study|Withdrawal by Subject|0|||
163408008|NCT04623242|590203978|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
163408009|NCT04623242|590203979|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
163408010|NCT04623242|590203980|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
163408011|NCT04623242|590203981|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
163408012|NCT04623242|590203982|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
163408013|NCT04623242|590203978|FG000|Overall Study|Subject unblinded to mutation status|0|||
163408014|NCT04623242|590203979|FG001|Overall Study|Subject unblinded to mutation status|0|||
163408015|NCT04623242|590203980|FG002|Overall Study|Subject unblinded to mutation status|0|||
163408016|NCT04623242|590203981|FG003|Overall Study|Subject unblinded to mutation status|13|||
163408017|NCT04623242|590203982|FG004|Overall Study|Subject unblinded to mutation status|0|||
163408018|NCT02921971|590203985|FG000|Overall Study|Adverse Event|1|||
163408019|NCT02921971|590203986|FG001|Overall Study|Adverse Event|2|||
163408020|NCT02921971|590203985|FG000|Overall Study|Lack of Efficacy|3|||
163408021|NCT02921971|590203986|FG001|Overall Study|Lack of Efficacy|1|||
163408022|NCT02921971|590203985|FG000|Overall Study|Other than specified above|2|||
163408023|NCT02921971|590203986|FG001|Overall Study|Other than specified above|1|||
163408024|NCT02105454|590203987|FG000|Overall Study|Withdrawal by Subject|1|||
163408025|NCT02721355|590203990|FG000|Overall Study|Lost to Follow-up|6|||
163408026|NCT02721355|590203991|FG001|Overall Study|Lost to Follow-up|1|||
163408027|NCT00356278|590203992|FG000|Overall Study|Withdrawal by Subject|25|||
163408028|NCT00356278|590203993|FG001|Overall Study|Withdrawal by Subject|15|||
163408029|NCT00356278|590203994|FG002|Overall Study|Withdrawal by Subject|19|||
163408030|NCT01268293|590204002|FG000|Overall Study|Disease progression|7|||
163408031|NCT01268293|590204002|FG000|Overall Study|Adverse Event|1|||
163408032|NCT01268293|590204002|FG000|Overall Study|Subject choice|1|||
163408033|NCT02597855|590204003|FG000|Overall Study|Lost to Follow-up|2|||
163408034|NCT02597855|590204004|FG001|Overall Study|Lost to Follow-up|1|||
163408035|NCT01777152|590204010|FG000|Overall Study|Withdrawal by Subject|22|||
163408036|NCT01777152|590204011|FG001|Overall Study|Withdrawal by Subject|16|||
163408037|NCT01777152|590204010|FG000|Overall Study|Lost to Follow-up|3|||
163408038|NCT01777152|590204011|FG001|Overall Study|Lost to Follow-up|5|||
163408039|NCT01777152|590204010|FG000|Overall Study|Death|68|||
163408040|NCT01777152|590204011|FG001|Overall Study|Death|89|||
163408041|NCT01777152|590204010|FG000|Overall Study|Not eligible, no study drug received|1|||
163408042|NCT01777152|590204011|FG001|Overall Study|Not eligible, no study drug received|0|||
163408043|NCT01777152|590204010|FG000|Overall Study|Change of diagnosis|1|||
163408044|NCT01777152|590204011|FG001|Overall Study|Change of diagnosis|0|||
163408045|NCT03446885|590204012|FG000|Overall Study|Lost to Follow-up|1|||
163408046|NCT03446885|590204013|FG001|Overall Study|Lost to Follow-up|0|||
163408047|NCT03446885|590204012|FG000|Overall Study|Did not complete entire visit|1|||
163408048|NCT03446885|590204013|FG001|Overall Study|Did not complete entire visit|0|||
163408049|NCT01903837|590204018|FG000|Part A|Withdrawal by Subject|4|||
163408050|NCT01903837|590204019|FG001|Part A|Withdrawal by Subject|9|||
163408051|NCT01903837|590204020|FG002|Part A|Withdrawal by Subject|8|||
163340570|NCT02469155|589954845|FG000|Overall Study|Death|0|||
163340571|NCT02469155|589954846|FG001|Overall Study|Death|0|||
163340572|NCT02469155|589954847|FG002|Overall Study|Death|0|||
163340573|NCT02469155|589954848|FG003|Overall Study|Death|1|||
163118557|NCT00461305|589142635|FG000|Continued Treatment|Lost to Follow-up|4|||
163118558|NCT00461305|589142636|FG001|Continued Treatment|Lost to Follow-up|0|||
163118559|NCT00461305|589142635|FG000|Continued Treatment|Protocol Violation|13|||
163118560|NCT00461305|589142636|FG001|Continued Treatment|Protocol Violation|0|||
163118561|NCT00461305|589142635|FG000|Continued Treatment|Withdrawal by Subject|48|||
163118562|NCT00461305|589142636|FG001|Continued Treatment|Withdrawal by Subject|0|||
163118563|NCT00461305|589142635|FG000|Continued Treatment|Partially missing diary|2|||
163118564|NCT00461305|589142636|FG001|Continued Treatment|Partially missing diary|0|||
163118565|NCT00461305|589142635|FG000|Continued Treatment|Other (missing drug etc)|2|||
163118566|NCT00461305|589142636|FG001|Continued Treatment|Other (missing drug etc)|0|||
163118567|NCT02513823|589142637|FG000|Overall Study|Lost to Follow-up|4|||
163118568|NCT02513823|589142637|FG000|Overall Study|Physician Decision|1|||
163118569|NCT02743780|589142638|FG000|Part 3 (7 Days)|Adverse Event|0|||
163118570|NCT02743780|589142639|FG001|Part 3 (7 Days)|Adverse Event|0|||
163118571|NCT02743780|589142640|FG002|Part 3 (7 Days)|Adverse Event|1|||
163118572|NCT02743780|589142641|FG003|Part 3 (7 Days)|Adverse Event|0|||
163118573|NCT02743780|589142642|FG004|Part 3 (7 Days)|Adverse Event|0|||
163118574|NCT01294462|589142643|FG000|Overall Study|Lost to Follow-up|1|||
163118575|NCT01294462|589142644|FG001|Overall Study|Lost to Follow-up|0|||
163118576|NCT01294462|589142643|FG000|Overall Study|Withdrawal by Subject|65|||
163118577|NCT01294462|589142644|FG001|Overall Study|Withdrawal by Subject|63|||
163118578|NCT04342689|589142648|FG000|Overall Study|Withdrawal by Subject|32|||
163118579|NCT04342689|589142649|FG001|Overall Study|Withdrawal by Subject|33|||
163118580|NCT04342689|589142648|FG000|Overall Study|Lost to Follow-up|10|||
163118581|NCT04342689|589142649|FG001|Overall Study|Lost to Follow-up|12|||
163118582|NCT01460407|589142650|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
163118583|NCT01460407|589142651|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
163118584|NCT00844805|589142653|FG000|Treatment Phase|Adverse Event|5|||
163118585|NCT00844805|589142654|FG001|Treatment Phase|Adverse Event|1|||
163118586|NCT00844805|589142655|FG002|Treatment Phase|Adverse Event|0|||
163118587|NCT00844805|589142656|FG003|Treatment Phase|Adverse Event|0|||
163118588|NCT00844805|589142653|FG000|Treatment Phase|Withdrawal by Subject|3|||
163118589|NCT00844805|589142654|FG001|Treatment Phase|Withdrawal by Subject|4|||
163118590|NCT00844805|589142655|FG002|Treatment Phase|Withdrawal by Subject|0|||
163118591|NCT00844805|589142656|FG003|Treatment Phase|Withdrawal by Subject|0|||
163118592|NCT00844805|589142653|FG000|Treatment Phase|Noncompliance With Protocol|1|||
163118593|NCT00844805|589142654|FG001|Treatment Phase|Noncompliance With Protocol|0|||
163118594|NCT00844805|589142655|FG002|Treatment Phase|Noncompliance With Protocol|0|||
163118595|NCT00844805|589142656|FG003|Treatment Phase|Noncompliance With Protocol|0|||
163118596|NCT00844805|589142653|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
163118597|NCT00844805|589142654|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
163118598|NCT00844805|589142655|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
163118599|NCT00844805|589142656|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
163118600|NCT00844805|589142653|FG000|Follow-Up Phase|Adverse Event|0|||
163118601|NCT00844805|589142654|FG001|Follow-Up Phase|Adverse Event|0|||
163118602|NCT00844805|589142655|FG002|Follow-Up Phase|Adverse Event|1|||
163118603|NCT00844805|589142656|FG003|Follow-Up Phase|Adverse Event|0|||
163118604|NCT00844805|589142653|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
163118605|NCT00844805|589142654|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
163118606|NCT00844805|589142655|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
163118607|NCT00844805|589142656|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
163118608|NCT00844805|589142653|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
163118609|NCT00844805|589142654|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
163118610|NCT00844805|589142655|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
163118611|NCT00844805|589142656|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
163118612|NCT00844805|589142653|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
163118613|NCT00844805|589142654|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
163118614|NCT00844805|589142655|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
163118615|NCT00844805|589142656|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
163118616|NCT00844805|589142653|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
163118617|NCT00844805|589142654|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
163118618|NCT00844805|589142655|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
163118619|NCT00844805|589142656|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
163118620|NCT00259298|589142660|FG000|Overall Study|Withdrawal by Subject|1|||
163118621|NCT00259298|589142660|FG000|Overall Study|Physician Decision|2|||
163118622|NCT01011933|589142661|FG000|Overall Study|Wrong cell type|1|||
163118623|NCT01011933|589142661|FG000|Overall Study|Improper pre-protocol Rx|1|||
163118624|NCT01011933|589142661|FG000|Overall Study|Inadequate pathology|1|||
163118625|NCT01011933|589142661|FG000|Overall Study|Never treated|1|||
163118626|NCT00475865|589142663|FG000|Overall Study|Adverse Event|0|||
163340574|NCT02469155|589954845|FG000|Overall Study|Lost to Follow-up|5|||
163340575|NCT02469155|589954846|FG001|Overall Study|Lost to Follow-up|2|||
163340576|NCT02469155|589954847|FG002|Overall Study|Lost to Follow-up|7|||
163340577|NCT02469155|589954848|FG003|Overall Study|Lost to Follow-up|2|||
163340578|NCT02469155|589954845|FG000|Overall Study|Physician Decision|0|||
163340579|NCT02469155|589954846|FG001|Overall Study|Physician Decision|0|||
163340580|NCT02469155|589954847|FG002|Overall Study|Physician Decision|1|||
163340581|NCT02469155|589954848|FG003|Overall Study|Physician Decision|0|||
163118627|NCT00475865|589142664|FG001|Overall Study|Adverse Event|3|||
163118628|NCT00475865|589142665|FG002|Overall Study|Adverse Event|4|||
163118629|NCT00475865|589142663|FG000|Overall Study|Lack of Efficacy|1|||
163118630|NCT00475865|589142664|FG001|Overall Study|Lack of Efficacy|0|||
163118631|NCT00475865|589142665|FG002|Overall Study|Lack of Efficacy|0|||
163118632|NCT00475865|589142663|FG000|Overall Study|Progressive disease|0|||
163118633|NCT00475865|589142664|FG001|Overall Study|Progressive disease|1|||
163118634|NCT00475865|589142665|FG002|Overall Study|Progressive disease|2|||
163118635|NCT00475865|589142663|FG000|Overall Study|Participant did not wish to continue|1|||
163118636|NCT00475865|589142664|FG001|Overall Study|Participant did not wish to continue|0|||
163118637|NCT00475865|589142665|FG002|Overall Study|Participant did not wish to continue|0|||
163118638|NCT00475865|589142663|FG000|Overall Study|Other than above|0|||
163118639|NCT00475865|589142664|FG001|Overall Study|Other than above|1|||
163118640|NCT00475865|589142665|FG002|Overall Study|Other than above|0|||
163118641|NCT02726880|589142666|FG000|Overall Study|Withdrawal by Subject|2|||
163118642|NCT02726880|589142667|FG001|Overall Study|Withdrawal by Subject|0|||
163118643|NCT02726880|589142666|FG000|Overall Study|Lost to Follow-up|1|||
163118644|NCT02726880|589142667|FG001|Overall Study|Lost to Follow-up|3|||
163118645|NCT04316741|589142668|FG000|Baseline Enrollment|Lost to Follow-up|1|||
163118646|NCT04316741|589142669|FG001|Baseline Enrollment|Lost to Follow-up|1|||
163118647|NCT04316741|589142668|FG000|Immediate Post-Test|Lost to Follow-up|5|||
163118648|NCT04316741|589142669|FG001|Immediate Post-Test|Lost to Follow-up|1|||
163118649|NCT04316741|589142668|FG000|1-month Post-test|Lost to Follow-up|7|||
163118650|NCT04316741|589142669|FG001|1-month Post-test|Lost to Follow-up|2|||
163118651|NCT04316741|589142668|FG000|3-month Follow-up|Lost to Follow-up|10|||
163118652|NCT04316741|589142669|FG001|3-month Follow-up|Lost to Follow-up|2|||
163118653|NCT00787202|589142670|FG000|Overall Study|Adverse Event|3|||
163118654|NCT00787202|589142671|FG001|Overall Study|Adverse Event|2|||
163118655|NCT00787202|589142672|FG002|Overall Study|Adverse Event|0|||
163118656|NCT00787202|589142673|FG003|Overall Study|Adverse Event|0|||
163118657|NCT00787202|589142674|FG004|Overall Study|Adverse Event|2|||
163118658|NCT00787202|589142670|FG000|Overall Study|Lack of Efficacy|5|||
163118659|NCT00787202|589142671|FG001|Overall Study|Lack of Efficacy|6|||
163118660|NCT00787202|589142672|FG002|Overall Study|Lack of Efficacy|5|||
163118661|NCT00787202|589142673|FG003|Overall Study|Lack of Efficacy|2|||
163118662|NCT00787202|589142674|FG004|Overall Study|Lack of Efficacy|1|||
163118663|NCT00787202|589142670|FG000|Overall Study|Lost to Follow-up|1|||
163118664|NCT00787202|589142671|FG001|Overall Study|Lost to Follow-up|0|||
163118665|NCT00787202|589142672|FG002|Overall Study|Lost to Follow-up|0|||
163118666|NCT00787202|589142673|FG003|Overall Study|Lost to Follow-up|0|||
163118667|NCT00787202|589142674|FG004|Overall Study|Lost to Follow-up|0|||
163118668|NCT00787202|589142670|FG000|Overall Study|Withdrawal by Subject|2|||
163118669|NCT00787202|589142671|FG001|Overall Study|Withdrawal by Subject|2|||
163118670|NCT00787202|589142672|FG002|Overall Study|Withdrawal by Subject|2|||
163118671|NCT00787202|589142673|FG003|Overall Study|Withdrawal by Subject|0|||
163118672|NCT00787202|589142674|FG004|Overall Study|Withdrawal by Subject|0|||
163118673|NCT00787202|589142670|FG000|Overall Study|Protocol Violation|2|||
163118674|NCT00787202|589142671|FG001|Overall Study|Protocol Violation|1|||
163118675|NCT00787202|589142672|FG002|Overall Study|Protocol Violation|0|||
163118676|NCT00787202|589142673|FG003|Overall Study|Protocol Violation|0|||
163118677|NCT00787202|589142674|FG004|Overall Study|Protocol Violation|1|||
163118678|NCT00787202|589142670|FG000|Overall Study|Randomized, not treated|1|||
163118679|NCT00787202|589142671|FG001|Overall Study|Randomized, not treated|0|||
163118680|NCT00787202|589142672|FG002|Overall Study|Randomized, not treated|0|||
163118681|NCT00787202|589142673|FG003|Overall Study|Randomized, not treated|0|||
163118682|NCT00787202|589142674|FG004|Overall Study|Randomized, not treated|0|||
163118683|NCT01510145|589142675|FG000|Overall Study|Adverse Event|6|||
163118684|NCT01510145|589142675|FG000|Overall Study|Lost to Follow-up|5|||
163340582|NCT02469155|589954845|FG000|Overall Study|Withdrawal by Subject|34|||
163118685|NCT01510145|589142675|FG000|Overall Study|Withdrawal by Subject|6|||
163118686|NCT01510145|589142675|FG000|Overall Study|Relative reported subject withdrew|1|||
163118687|NCT01442064|589142676|FG000|Overall Study|Adverse Event|2|||
163118688|NCT01442064|589142677|FG001|Overall Study|Adverse Event|2|||
163340583|NCT02469155|589954846|FG001|Overall Study|Withdrawal by Subject|30|||
163118689|NCT01442064|589142678|FG002|Overall Study|Adverse Event|2|||
163118690|NCT01442064|589142679|FG003|Overall Study|Adverse Event|1|||
163118691|NCT01442064|589142680|FG004|Overall Study|Adverse Event|2|||
163118692|NCT01442064|589142681|FG005|Overall Study|Adverse Event|0|||
163118693|NCT01442064|589142676|FG000|Overall Study|Death|0|||
163118694|NCT01442064|589142677|FG001|Overall Study|Death|1|||
163118695|NCT01442064|589142678|FG002|Overall Study|Death|3|||
163118696|NCT01442064|589142679|FG003|Overall Study|Death|3|||
163118697|NCT01442064|589142680|FG004|Overall Study|Death|1|||
163340584|NCT02469155|589954847|FG002|Overall Study|Withdrawal by Subject|20|||
163340585|NCT02469155|589954848|FG003|Overall Study|Withdrawal by Subject|37|||
163340586|NCT02469155|589954845|FG000|Overall Study|Other|3|||
163340587|NCT02469155|589954846|FG001|Overall Study|Other|3|||
163340588|NCT02469155|589954847|FG002|Overall Study|Other|2|||
163340589|NCT02469155|589954848|FG003|Overall Study|Other|10|||
163340590|NCT02469155|589954845|FG000|Overall Study|Protocol Violation|0|||
163340591|NCT02469155|589954846|FG001|Overall Study|Protocol Violation|1|||
163340592|NCT02469155|589954847|FG002|Overall Study|Protocol Violation|0|||
163340593|NCT02469155|589954848|FG003|Overall Study|Protocol Violation|1|||
163340594|NCT02991118|589954849|FG000|Overall Study|Death|3|||
163340595|NCT02991118|589954850|FG001|Overall Study|Death|8|||
163340596|NCT02991118|589954849|FG000|Overall Study|Protocol Violation|0|||
163340597|NCT02991118|589954850|FG001|Overall Study|Protocol Violation|3|||
163340598|NCT02991118|589954849|FG000|Overall Study|Physician Decision|0|||
163340599|NCT02991118|589954850|FG001|Overall Study|Physician Decision|1|||
163340600|NCT02991118|589954849|FG000|Overall Study|Moved out of the country|0|||
163340601|NCT02991118|589954850|FG001|Overall Study|Moved out of the country|1|||
163340602|NCT02991118|589954849|FG000|Overall Study|Adverse Event|2|||
163340603|NCT02991118|589954850|FG001|Overall Study|Adverse Event|2|||
163340604|NCT02991118|589954849|FG000|Overall Study|Withdrawal by Subject|1|||
163340605|NCT02991118|589954850|FG001|Overall Study|Withdrawal by Subject|7|||
163340606|NCT02991118|589954849|FG000|Overall Study|Could not attend study visits|0|||
163340607|NCT02991118|589954850|FG001|Overall Study|Could not attend study visits|1|||
163340608|NCT02991118|589954849|FG000|Overall Study|Lost to Follow-up|1|||
163340609|NCT02991118|589954850|FG001|Overall Study|Lost to Follow-up|9|||
163340610|NCT02764320|589954858|FG000|Overall Study|Withdrawal by Subject|35|||
163340611|NCT02764320|589954859|FG001|Overall Study|Withdrawal by Subject|38|||
163340612|NCT02764320|589954858|FG000|Overall Study|Protocol Violation|11|||
163340613|NCT02764320|589954859|FG001|Overall Study|Protocol Violation|6|||
163340614|NCT02764320|589954858|FG000|Overall Study|Adverse Event|2|||
163340615|NCT02764320|589954859|FG001|Overall Study|Adverse Event|0|||
163340616|NCT02764320|589954858|FG000|Overall Study|Health Issues unable to continue|2|||
163340617|NCT02764320|589954859|FG001|Overall Study|Health Issues unable to continue|0|||
163340618|NCT02764320|589954858|FG000|Overall Study|Did not meet inclusion criteria|1|||
163340619|NCT02764320|589954859|FG001|Overall Study|Did not meet inclusion criteria|0|||
163340620|NCT02764320|589954858|FG000|Overall Study|Subject moved|0|||
163340621|NCT02764320|589954859|FG001|Overall Study|Subject moved|2|||
163340622|NCT02764320|589954858|FG000|Overall Study|Overused medication unavailable|0|||
163340623|NCT02764320|589954859|FG001|Overall Study|Overused medication unavailable|1|||
163340624|NCT02764320|589954858|FG000|Overall Study|Seeking care outside site|0|||
163340625|NCT02764320|589954859|FG001|Overall Study|Seeking care outside site|1|||
163340626|NCT02764320|589954858|FG000|Overall Study|Technology barriers|0|||
163340627|NCT02764320|589954859|FG001|Overall Study|Technology barriers|1|||
163340628|NCT04765046|589954860|FG000|Overall Study|Screen Failure|2|||
163340629|NCT04765046|589954860|FG000|Overall Study|Withdrawal by Subject|4|||
163340630|NCT04765046|589954860|FG000|Overall Study|Physician Decision|4|||
163340631|NCT04765046|589954860|FG000|Overall Study|Surgery Cancelled|8|||
163340632|NCT03150589|589954862|FG000|Overall Study|Withdrawal by Subject|16|||
163340633|NCT03150589|589954863|FG001|Overall Study|Withdrawal by Subject|9|||
163340634|NCT03150589|589954862|FG000|Overall Study|Adverse Event|7|||
163340635|NCT03150589|589954863|FG001|Overall Study|Adverse Event|6|||
163118698|NCT01442064|589142681|FG005|Overall Study|Death|3|||
163340636|NCT03150589|589954862|FG000|Overall Study|Protocol Violation|4|||
163340637|NCT03150589|589954863|FG001|Overall Study|Protocol Violation|3|||
163340638|NCT03150589|589954862|FG000|Overall Study|Lost to Follow-up|3|||
163340639|NCT03150589|589954863|FG001|Overall Study|Lost to Follow-up|3|||
163340640|NCT03150589|589954862|FG000|Overall Study|Death|2|||
163340641|NCT03150589|589954863|FG001|Overall Study|Death|3|||
163340642|NCT03150589|589954862|FG000|Overall Study|IP non-compliance and other reasons|12|||
163340643|NCT03150589|589954863|FG001|Overall Study|IP non-compliance and other reasons|3|||
163340644|NCT01405508|589954864|FG000|Overall Study|AE, non-serious non-fatal|1|||
163340645|NCT01405508|589954865|FG001|Overall Study|AE, non-serious non-fatal|1|||
163340646|NCT01405508|589954866|FG002|Overall Study|AE, non-serious non-fatal|0|||
163340647|NCT01405508|589954867|FG003|Overall Study|AE, non-serious non-fatal|0|||
163340648|NCT03529942|589954868|FG000|Overall Study|Withdrawal by Subject|13|||
163340649|NCT03529942|589954868|FG000|Overall Study|Physician Decision|1|||
163118699|NCT01442064|589142676|FG000|Overall Study|Lost to Follow-up|5|||
163340650|NCT03529942|589954868|FG000|Overall Study|Lost to Follow-up|7|||
163340651|NCT03529942|589954868|FG000|Overall Study|Needle inserted but no drug administered|1|||
163340652|NCT03529942|589954868|FG000|Overall Study|Personal reasons|1|||
163340653|NCT00409747|589954879|FG000|Overall Study|Withdrawal by Subject|1|||
163340654|NCT01989156|589954882|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
163340655|NCT01989156|589954883|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
163340656|NCT01989156|589954884|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
163340657|NCT01989156|589954882|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
163340658|NCT01989156|589954883|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
163118700|NCT01442064|589142677|FG001|Overall Study|Lost to Follow-up|5|||
163118701|NCT01442064|589142678|FG002|Overall Study|Lost to Follow-up|1|||
163118702|NCT01442064|589142679|FG003|Overall Study|Lost to Follow-up|1|||
163118703|NCT01442064|589142680|FG004|Overall Study|Lost to Follow-up|3|||
163118704|NCT01442064|589142681|FG005|Overall Study|Lost to Follow-up|3|||
163118705|NCT01442064|589142676|FG000|Overall Study|Physician Decision|1|||
163118706|NCT01442064|589142677|FG001|Overall Study|Physician Decision|1|||
163118707|NCT01442064|589142678|FG002|Overall Study|Physician Decision|2|||
163118708|NCT01442064|589142679|FG003|Overall Study|Physician Decision|3|||
163118709|NCT01442064|589142680|FG004|Overall Study|Physician Decision|3|||
163118710|NCT01442064|589142681|FG005|Overall Study|Physician Decision|1|||
163118711|NCT01442064|589142676|FG000|Overall Study|Withdrawal by Subject|6|||
163118712|NCT01442064|589142677|FG001|Overall Study|Withdrawal by Subject|3|||
163118713|NCT01442064|589142678|FG002|Overall Study|Withdrawal by Subject|2|||
163118714|NCT01442064|589142679|FG003|Overall Study|Withdrawal by Subject|2|||
163118715|NCT01442064|589142680|FG004|Overall Study|Withdrawal by Subject|2|||
163118716|NCT01442064|589142681|FG005|Overall Study|Withdrawal by Subject|1|||
163118717|NCT01442064|589142676|FG000|Overall Study|Sponsor decision|82|||
163118718|NCT01442064|589142677|FG001|Overall Study|Sponsor decision|88|||
163118719|NCT01442064|589142678|FG002|Overall Study|Sponsor decision|92|||
163224061|NCT02442778|589537825|FG002|Overall Study|Physician Decision|1|||
163224062|NCT02442778|589537823|FG000|Overall Study|Protocol Deviation|3|||
163224063|NCT02442778|589537824|FG001|Overall Study|Protocol Deviation|0|||
163224064|NCT02442778|589537825|FG002|Overall Study|Protocol Deviation|1|||
163224065|NCT02442778|589537823|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
163224066|NCT02442778|589537824|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
163224067|NCT02442778|589537825|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
163224068|NCT02442778|589537823|FG000|Overall Study|Withdrawal by Subject|4|||
163224069|NCT02442778|589537824|FG001|Overall Study|Withdrawal by Subject|4|||
163224070|NCT02442778|589537825|FG002|Overall Study|Withdrawal by Subject|3|||
163224071|NCT02442778|589537823|FG000|Overall Study|Reason not specified|1|||
163224072|NCT02442778|589537824|FG001|Overall Study|Reason not specified|4|||
163224073|NCT02442778|589537825|FG002|Overall Study|Reason not specified|0|||
163224074|NCT02641379|589537828|FG000|Overall Study|Exclusion criterion during screening|1|||
163224075|NCT02641379|589537829|FG001|Overall Study|Exclusion criterion during screening|0|||
163224076|NCT02641379|589537830|FG002|Overall Study|Exclusion criterion during screening|0|||
163224077|NCT02641379|589537831|FG003|Overall Study|Exclusion criterion during screening|1|||
163224078|NCT02641379|589537832|FG004|Overall Study|Exclusion criterion during screening|2|||
163224079|NCT02641379|589537833|FG005|Overall Study|Exclusion criterion during screening|0|||
163224080|NCT02641379|589537834|FG006|Overall Study|Exclusion criterion during screening|0|||
163224081|NCT02641379|589537835|FG007|Overall Study|Exclusion criterion during screening|0|||
163224082|NCT02641379|589537836|FG008|Overall Study|Exclusion criterion during screening|0|||
163224083|NCT02641379|589537837|FG009|Overall Study|Exclusion criterion during screening|0|||
163224084|NCT02641379|589537838|FG010|Overall Study|Exclusion criterion during screening|0|||
163224085|NCT02641379|589537828|FG000|Overall Study|Withdrawal of informed consent|0|||
163224086|NCT02641379|589537829|FG001|Overall Study|Withdrawal of informed consent|1|||
163224087|NCT02641379|589537830|FG002|Overall Study|Withdrawal of informed consent|0|||
163224088|NCT02641379|589537831|FG003|Overall Study|Withdrawal of informed consent|0|||
163224089|NCT02641379|589537832|FG004|Overall Study|Withdrawal of informed consent|0|||
163224090|NCT02641379|589537833|FG005|Overall Study|Withdrawal of informed consent|0|||
163224091|NCT02641379|589537834|FG006|Overall Study|Withdrawal of informed consent|0|||
163224092|NCT02641379|589537835|FG007|Overall Study|Withdrawal of informed consent|1|||
163224093|NCT02641379|589537836|FG008|Overall Study|Withdrawal of informed consent|0|||
163224094|NCT02641379|589537837|FG009|Overall Study|Withdrawal of informed consent|0|||
163224095|NCT02641379|589537838|FG010|Overall Study|Withdrawal of informed consent|0|||
163224096|NCT02641379|589537828|FG000|Overall Study|Adverse Event|7|||
163224097|NCT02641379|589537829|FG001|Overall Study|Adverse Event|8|||
163224098|NCT02641379|589537830|FG002|Overall Study|Adverse Event|2|||
163224099|NCT02641379|589537831|FG003|Overall Study|Adverse Event|2|||
163224100|NCT02641379|589537832|FG004|Overall Study|Adverse Event|5|||
163224101|NCT02641379|589537833|FG005|Overall Study|Adverse Event|1|||
163224102|NCT02641379|589537834|FG006|Overall Study|Adverse Event|5|||
163224103|NCT02641379|589537835|FG007|Overall Study|Adverse Event|0|||
163224104|NCT02641379|589537836|FG008|Overall Study|Adverse Event|1|||
163224105|NCT02641379|589537837|FG009|Overall Study|Adverse Event|1|||
163224106|NCT02641379|589537838|FG010|Overall Study|Adverse Event|5|||
163224107|NCT02641379|589537828|FG000|Overall Study|Lack of Efficacy|0|||
163224108|NCT02641379|589537829|FG001|Overall Study|Lack of Efficacy|0|||
163224109|NCT02641379|589537830|FG002|Overall Study|Lack of Efficacy|2|||
163224110|NCT02641379|589537831|FG003|Overall Study|Lack of Efficacy|0|||
163224111|NCT02641379|589537832|FG004|Overall Study|Lack of Efficacy|0|||
163224112|NCT02641379|589537833|FG005|Overall Study|Lack of Efficacy|2|||
163340659|NCT01989156|589954884|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
163118720|NCT01442064|589142679|FG003|Overall Study|Sponsor decision|88|||
163118721|NCT01442064|589142680|FG004|Overall Study|Sponsor decision|95|||
163224113|NCT02641379|589537834|FG006|Overall Study|Lack of Efficacy|0|||
163224114|NCT02641379|589537835|FG007|Overall Study|Lack of Efficacy|5|||
163224115|NCT02641379|589537836|FG008|Overall Study|Lack of Efficacy|0|||
163224116|NCT02641379|589537837|FG009|Overall Study|Lack of Efficacy|0|||
163224117|NCT02641379|589537838|FG010|Overall Study|Lack of Efficacy|0|||
163224118|NCT02641379|589537828|FG000|Overall Study|Participant unable to attend study visit|4|||
163224119|NCT02641379|589537829|FG001|Overall Study|Participant unable to attend study visit|10|||
163224120|NCT02641379|589537830|FG002|Overall Study|Participant unable to attend study visit|1|||
163224121|NCT02641379|589537831|FG003|Overall Study|Participant unable to attend study visit|2|||
163224122|NCT02641379|589537832|FG004|Overall Study|Participant unable to attend study visit|5|||
163224123|NCT02641379|589537833|FG005|Overall Study|Participant unable to attend study visit|1|||
163224124|NCT02641379|589537834|FG006|Overall Study|Participant unable to attend study visit|1|||
163224125|NCT02641379|589537835|FG007|Overall Study|Participant unable to attend study visit|1|||
163224126|NCT02641379|589537836|FG008|Overall Study|Participant unable to attend study visit|0|||
163224127|NCT02641379|589537837|FG009|Overall Study|Participant unable to attend study visit|2|||
163224128|NCT02641379|589537838|FG010|Overall Study|Participant unable to attend study visit|0|||
163224129|NCT02641379|589537828|FG000|Overall Study|Participant's compliance|0|||
163224130|NCT02641379|589537829|FG001|Overall Study|Participant's compliance|1|||
163224131|NCT02641379|589537830|FG002|Overall Study|Participant's compliance|0|||
163224132|NCT02641379|589537831|FG003|Overall Study|Participant's compliance|1|||
163224133|NCT02641379|589537832|FG004|Overall Study|Participant's compliance|0|||
163224134|NCT02641379|589537833|FG005|Overall Study|Participant's compliance|2|||
163224135|NCT02641379|589537834|FG006|Overall Study|Participant's compliance|0|||
163224136|NCT02641379|589537835|FG007|Overall Study|Participant's compliance|0|||
163224137|NCT02641379|589537836|FG008|Overall Study|Participant's compliance|1|||
163224138|NCT02641379|589537837|FG009|Overall Study|Participant's compliance|1|||
163224139|NCT02641379|589537838|FG010|Overall Study|Participant's compliance|1|||
163224140|NCT02641379|589537828|FG000|Overall Study|Participant cannot be reached|4|||
163224141|NCT02641379|589537829|FG001|Overall Study|Participant cannot be reached|4|||
163224142|NCT02641379|589537830|FG002|Overall Study|Participant cannot be reached|0|||
163224143|NCT02641379|589537831|FG003|Overall Study|Participant cannot be reached|8|||
163224144|NCT02641379|589537832|FG004|Overall Study|Participant cannot be reached|2|||
163224145|NCT02641379|589537833|FG005|Overall Study|Participant cannot be reached|1|||
163224146|NCT02641379|589537834|FG006|Overall Study|Participant cannot be reached|0|||
163224147|NCT02641379|589537835|FG007|Overall Study|Participant cannot be reached|1|||
163224148|NCT02641379|589537836|FG008|Overall Study|Participant cannot be reached|0|||
163224149|NCT02641379|589537837|FG009|Overall Study|Participant cannot be reached|2|||
163224150|NCT02641379|589537838|FG010|Overall Study|Participant cannot be reached|1|||
163224151|NCT02641379|589537828|FG000|Overall Study|PCR positive at Week 24|15|||
163224152|NCT02641379|589537829|FG001|Overall Study|PCR positive at Week 24|21|||
163224153|NCT02641379|589537830|FG002|Overall Study|PCR positive at Week 24|62|||
163224154|NCT02641379|589537831|FG003|Overall Study|PCR positive at Week 24|0|||
163224155|NCT02641379|589537832|FG004|Overall Study|PCR positive at Week 24|0|||
163224156|NCT02641379|589537833|FG005|Overall Study|PCR positive at Week 24|6|||
163224157|NCT02641379|589537834|FG006|Overall Study|PCR positive at Week 24|3|||
163224158|NCT02641379|589537835|FG007|Overall Study|PCR positive at Week 24|8|||
163224159|NCT02641379|589537836|FG008|Overall Study|PCR positive at Week 24|0|||
163224160|NCT02641379|589537837|FG009|Overall Study|PCR positive at Week 24|1|||
163224161|NCT02641379|589537838|FG010|Overall Study|PCR positive at Week 24|0|||
163224162|NCT02641379|589537828|FG000|Overall Study|PCR positive at follow up 2|1|||
163224163|NCT02641379|589537829|FG001|Overall Study|PCR positive at follow up 2|0|||
163224164|NCT02641379|589537830|FG002|Overall Study|PCR positive at follow up 2|0|||
163224165|NCT02641379|589537831|FG003|Overall Study|PCR positive at follow up 2|0|||
163224166|NCT02641379|589537832|FG004|Overall Study|PCR positive at follow up 2|0|||
163224167|NCT02641379|589537833|FG005|Overall Study|PCR positive at follow up 2|0|||
163224168|NCT02641379|589537834|FG006|Overall Study|PCR positive at follow up 2|0|||
163224169|NCT02641379|589537835|FG007|Overall Study|PCR positive at follow up 2|0|||
163224170|NCT02641379|589537836|FG008|Overall Study|PCR positive at follow up 2|0|||
163224171|NCT02641379|589537837|FG009|Overall Study|PCR positive at follow up 2|0|||
163224172|NCT02641379|589537838|FG010|Overall Study|PCR positive at follow up 2|0|||
163224173|NCT02641379|589537828|FG000|Overall Study|Participant showed relapse|1|||
163224174|NCT02641379|589537829|FG001|Overall Study|Participant showed relapse|0|||
163224175|NCT02641379|589537830|FG002|Overall Study|Participant showed relapse|0|||
163224176|NCT02641379|589537831|FG003|Overall Study|Participant showed relapse|0|||
163224177|NCT02641379|589537832|FG004|Overall Study|Participant showed relapse|0|||
163224178|NCT02641379|589537833|FG005|Overall Study|Participant showed relapse|0|||
163224179|NCT02641379|589537834|FG006|Overall Study|Participant showed relapse|1|||
163224180|NCT02641379|589537835|FG007|Overall Study|Participant showed relapse|0|||
163224181|NCT02641379|589537836|FG008|Overall Study|Participant showed relapse|0|||
163224182|NCT02641379|589537837|FG009|Overall Study|Participant showed relapse|0|||
163224183|NCT02641379|589537838|FG010|Overall Study|Participant showed relapse|0|||
163224184|NCT02641379|589537828|FG000|Overall Study|Participant stopped study/treatment|1|||
163224185|NCT02641379|589537829|FG001|Overall Study|Participant stopped study/treatment|3|||
163118722|NCT01442064|589142681|FG005|Overall Study|Sponsor decision|87|||
163118723|NCT01442064|589142676|FG000|Overall Study|Subject non-compliance|0|||
163118724|NCT01442064|589142677|FG001|Overall Study|Subject non-compliance|0|||
163118725|NCT01442064|589142678|FG002|Overall Study|Subject non-compliance|0|||
163118726|NCT01442064|589142679|FG003|Overall Study|Subject non-compliance|0|||
163118727|NCT01442064|589142680|FG004|Overall Study|Subject non-compliance|0|||
163118728|NCT01442064|589142681|FG005|Overall Study|Subject non-compliance|2|||
163118729|NCT01442064|589142676|FG000|Overall Study|Condition mandated other intervention|1|||
163118730|NCT01442064|589142677|FG001|Overall Study|Condition mandated other intervention|1|||
163118731|NCT01442064|589142678|FG002|Overall Study|Condition mandated other intervention|2|||
163118732|NCT01442064|589142679|FG003|Overall Study|Condition mandated other intervention|0|||
163118733|NCT01442064|589142680|FG004|Overall Study|Condition mandated other intervention|0|||
163118734|NCT01442064|589142681|FG005|Overall Study|Condition mandated other intervention|2|||
163118735|NCT01360398|589142682|FG000|Overall Study|Withdrawal by Subject|14|||
163118736|NCT01360398|589142682|FG000|Overall Study|Other|7|||
163118737|NCT01360398|589142682|FG000|Overall Study|Migrated/moved from study area|1|||
163118738|NCT02153346|589142683|FG000|Overall Study|Lost to Follow-up|11|||
163118739|NCT01710527|589142684|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
163118740|NCT01710527|589142685|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
163118741|NCT01822535|589142686|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
163118742|NCT01822535|589142687|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
163118743|NCT01822535|589142686|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
163118744|NCT01822535|589142687|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
163118745|NCT01822535|589142686|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
163118746|NCT01822535|589142687|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
163118747|NCT02278614|589142690|FG000|Overall Study|Withdrawal by Subject|3|||
163118748|NCT02278614|589142691|FG001|Overall Study|Withdrawal by Subject|5|||
163118749|NCT02278614|589142690|FG000|Overall Study|Adverse Event|1|||
163118750|NCT02278614|589142691|FG001|Overall Study|Adverse Event|0|||
163118751|NCT02278614|589142690|FG000|Overall Study|left eye was not eligible|1|||
163118752|NCT02278614|589142691|FG001|Overall Study|left eye was not eligible|0|||
163118753|NCT02279498|589142692|FG000|Overall Study|Adverse Event|3|||
163118754|NCT02279498|589142693|FG001|Overall Study|Adverse Event|0|||
163118755|NCT02279498|589142692|FG000|Overall Study|Lack of Efficacy|4|||
163118756|NCT02279498|589142693|FG001|Overall Study|Lack of Efficacy|0|||
163118757|NCT02279498|589142692|FG000|Overall Study|Lost to Follow-up|0|||
163118758|NCT02279498|589142693|FG001|Overall Study|Lost to Follow-up|1|||
163118759|NCT02279498|589142692|FG000|Overall Study|Withdrawal by Subject|9|||
163118760|NCT02279498|589142693|FG001|Overall Study|Withdrawal by Subject|2|||
163118761|NCT02279498|589142692|FG000|Overall Study|Undefined|2|||
163118762|NCT02279498|589142693|FG001|Overall Study|Undefined|1|||
163118763|NCT00737711|589142696|FG000|Overall Study|Adverse Event|2|||
163118764|NCT00737711|589142696|FG000|Overall Study|Death|8|||
163118765|NCT00737711|589142696|FG000|Overall Study|Failure to return|4|||
163118766|NCT00737711|589142696|FG000|Overall Study|Protocol Violation|1|||
163118767|NCT00737711|589142696|FG000|Overall Study|Withdrawal by Subject|5|||
163118768|NCT00737711|589142696|FG000|Overall Study|Blood transfusion|6|||
163118769|NCT00737711|589142696|FG000|Overall Study|Other|5|||
163118770|NCT02739321|589142697|FG000|Overall Study|Lack of Efficacy|1|||
163118771|NCT02739321|589142698|FG001|Overall Study|Lack of Efficacy|1|||
163118772|NCT02739321|589142697|FG000|Overall Study|Lost to Follow-up|1|||
163118773|NCT02739321|589142698|FG001|Overall Study|Lost to Follow-up|1|||
163118774|NCT02739321|589142697|FG000|Overall Study|Withdrawal by Subject|1|||
163118775|NCT02739321|589142698|FG001|Overall Study|Withdrawal by Subject|2|||
163118776|NCT02558400|589142699|FG000|Overall Study|Adverse Event|47|||
163118777|NCT02558400|589142700|FG001|Overall Study|Adverse Event|53|||
163118778|NCT02558400|589142701|FG002|Overall Study|Adverse Event|4|||
163118779|NCT02558400|589142699|FG000|Overall Study|Withdrawal by Subject|13|||
163118780|NCT02558400|589142700|FG001|Overall Study|Withdrawal by Subject|9|||
163118781|NCT02558400|589142701|FG002|Overall Study|Withdrawal by Subject|8|||
163118782|NCT02558400|589142699|FG000|Overall Study|Non-Compliant|0|||
163118783|NCT02558400|589142700|FG001|Overall Study|Non-Compliant|1|||
163224186|NCT02641379|589537830|FG002|Overall Study|Participant stopped study/treatment|1|||
163118784|NCT02558400|589142701|FG002|Overall Study|Non-Compliant|3|||
163118785|NCT02558400|589142699|FG000|Overall Study|Lost to Follow-up|5|||
163118786|NCT02558400|589142700|FG001|Overall Study|Lost to Follow-up|5|||
163118787|NCT02558400|589142701|FG002|Overall Study|Lost to Follow-up|4|||
163118788|NCT02558400|589142699|FG000|Overall Study|Lack of Efficacy|0|||
163118789|NCT02558400|589142700|FG001|Overall Study|Lack of Efficacy|13|||
163118790|NCT02558400|589142701|FG002|Overall Study|Lack of Efficacy|1|||
163118791|NCT02558400|589142699|FG000|Overall Study|Disallowed Concurrent Medication|6|||
163118792|NCT02558400|589142700|FG001|Overall Study|Disallowed Concurrent Medication|7|||
163118793|NCT02558400|589142701|FG002|Overall Study|Disallowed Concurrent Medication|5|||
163118794|NCT02558400|589142699|FG000|Overall Study|Physician Decision|2|||
163224187|NCT02641379|589537831|FG003|Overall Study|Participant stopped study/treatment|0|||
163224188|NCT02641379|589537832|FG004|Overall Study|Participant stopped study/treatment|0|||
163118795|NCT02558400|589142700|FG001|Overall Study|Physician Decision|2|||
163118796|NCT02558400|589142701|FG002|Overall Study|Physician Decision|0|||
163118797|NCT02558400|589142699|FG000|Overall Study|Protocol Violation|6|||
163118798|NCT02558400|589142700|FG001|Overall Study|Protocol Violation|3|||
163118799|NCT02558400|589142701|FG002|Overall Study|Protocol Violation|8|||
163118800|NCT02558400|589142699|FG000|Overall Study|Death|0|||
163118801|NCT02558400|589142700|FG001|Overall Study|Death|1|||
163118802|NCT02558400|589142701|FG002|Overall Study|Death|0|||
163118803|NCT02558400|589142699|FG000|Overall Study|Ineligible for the study|0|||
163118804|NCT02558400|589142700|FG001|Overall Study|Ineligible for the study|2|||
163118805|NCT02558400|589142701|FG002|Overall Study|Ineligible for the study|0|||
163118806|NCT02230683|589142705|FG000|Overall Study|Adverse Event|1|||
163118807|NCT00624780|589142706|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
163118808|NCT00624780|589142707|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
163118809|NCT00624780|589142708|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
163118810|NCT00624780|589142709|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
163118811|NCT00624780|589142710|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
163118812|NCT00624780|589142711|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
163118813|NCT00624780|589142706|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
163118814|NCT00624780|589142707|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
163118815|NCT00624780|589142708|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
163118816|NCT00624780|589142709|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
163118817|NCT00624780|589142710|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
163118818|NCT00624780|589142711|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
163118819|NCT00624780|589142706|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
163118820|NCT00624780|589142707|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
163118821|NCT00624780|589142708|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
163118822|NCT00624780|589142709|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
163118823|NCT00624780|589142710|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
163118824|NCT00624780|589142711|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
163118825|NCT00624780|589142706|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
163118826|NCT00624780|589142707|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
163118827|NCT00624780|589142708|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
163118828|NCT00624780|589142709|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
163118829|NCT00624780|589142710|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
163118830|NCT00624780|589142711|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
163118831|NCT00624780|589142706|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
163118832|NCT00624780|589142707|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
163118833|NCT00624780|589142708|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
163118834|NCT00624780|589142709|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
163118835|NCT00624780|589142710|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
163118836|NCT00624780|589142711|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
163118837|NCT00624780|589142706|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
163118838|NCT00624780|589142707|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
163118839|NCT00624780|589142708|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
163118840|NCT00624780|589142709|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
163118841|NCT00624780|589142710|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
163118842|NCT00624780|589142711|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
163118843|NCT00624780|589142706|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
163118844|NCT00624780|589142707|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
163118845|NCT00624780|589142708|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
163118846|NCT00624780|589142709|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
163118847|NCT00624780|589142710|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
163118848|NCT00624780|589142711|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
163118849|NCT00624780|589142706|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
163118850|NCT00624780|589142707|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
163118851|NCT00624780|589142708|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
163118852|NCT00624780|589142709|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
163118853|NCT00624780|589142710|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
163118854|NCT00624780|589142711|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
163118855|NCT00624780|589142706|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
163118856|NCT00624780|589142707|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
163118857|NCT00624780|589142708|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
163118858|NCT00624780|589142709|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
163118859|NCT00624780|589142710|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
163118860|NCT00624780|589142711|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
163118861|NCT00624780|589142706|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
163118862|NCT00624780|589142707|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
163408052|NCT01903837|590204021|FG003|Part A|Withdrawal by Subject|5|||
163340660|NCT01989156|589954882|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
163340661|NCT01989156|589954883|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
163340662|NCT01989156|589954884|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
163340663|NCT01989156|589954882|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
163340664|NCT01989156|589954883|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
163340665|NCT01989156|589954884|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
163340666|NCT01989156|589954882|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
163340667|NCT01989156|589954883|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
163340668|NCT01989156|589954884|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
163340669|NCT01989156|589954882|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
163340670|NCT01989156|589954883|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
163340671|NCT01989156|589954884|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
163340672|NCT01989156|589954882|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
163340673|NCT01989156|589954883|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
163340674|NCT01989156|589954884|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
163340675|NCT01989156|589954882|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
163340676|NCT01989156|589954883|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
163340677|NCT01989156|589954884|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
163340678|NCT03839355|589954885|FG000|Overall Study|Withdrawal by Subject|1|||
163118863|NCT00624780|589142708|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
163118864|NCT00624780|589142709|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
163118865|NCT00624780|589142710|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
163118866|NCT00624780|589142711|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
163118867|NCT00624780|589142706|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
163118868|NCT00624780|589142707|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
163340679|NCT03839355|589954886|FG001|Overall Study|Withdrawal by Subject|0|||
163118869|NCT00624780|589142708|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
163118870|NCT00624780|589142709|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
163118871|NCT00624780|589142710|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
163118872|NCT00624780|589142711|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
163118873|NCT00624780|589142706|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
163118874|NCT00624780|589142707|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
163118875|NCT00624780|589142708|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
163118876|NCT00624780|589142709|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
163118877|NCT00624780|589142710|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
163118878|NCT00624780|589142711|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
163118879|NCT00624780|589142706|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
163118880|NCT00624780|589142707|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
163118881|NCT00624780|589142708|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
163118882|NCT00624780|589142709|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
163118883|NCT00624780|589142710|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
163118884|NCT00624780|589142711|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
163118885|NCT00624780|589142706|FG000|Follow-up (Week 26)|Death|0|||
163118886|NCT00624780|589142707|FG001|Follow-up (Week 26)|Death|0|||
163118887|NCT00624780|589142708|FG002|Follow-up (Week 26)|Death|1|||
163118888|NCT00624780|589142709|FG003|Follow-up (Week 26)|Death|0|||
163118889|NCT00624780|589142710|FG004|Follow-up (Week 26)|Death|0|||
163118890|NCT00624780|589142711|FG005|Follow-up (Week 26)|Death|0|||
163118891|NCT00624780|589142706|FG000|Follow-up (Week 26)|Adverse Event|0|||
163118892|NCT00624780|589142707|FG001|Follow-up (Week 26)|Adverse Event|0|||
163118893|NCT00624780|589142708|FG002|Follow-up (Week 26)|Adverse Event|0|||
163118894|NCT00624780|589142709|FG003|Follow-up (Week 26)|Adverse Event|0|||
163118895|NCT00624780|589142710|FG004|Follow-up (Week 26)|Adverse Event|1|||
163118896|NCT00624780|589142711|FG005|Follow-up (Week 26)|Adverse Event|0|||
163118897|NCT00624780|589142706|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
163118898|NCT00624780|589142707|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
163118899|NCT00624780|589142708|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
163118900|NCT00624780|589142709|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
163118901|NCT00624780|589142710|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
163118902|NCT00624780|589142711|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
163118903|NCT00624780|589142706|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
163118904|NCT00624780|589142707|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
163118905|NCT00624780|589142708|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
163224189|NCT02641379|589537833|FG005|Overall Study|Participant stopped study/treatment|1|||
163340680|NCT01794689|589954889|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
163118906|NCT00624780|589142709|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
163118907|NCT00624780|589142710|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
163118908|NCT00624780|589142711|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
163118909|NCT00624780|589142706|FG000|Follow-up (Week 26)|Other|1|||
163118910|NCT00624780|589142707|FG001|Follow-up (Week 26)|Other|1|||
163118911|NCT00624780|589142708|FG002|Follow-up (Week 26)|Other|0|||
163224190|NCT02641379|589537834|FG006|Overall Study|Participant stopped study/treatment|2|||
163118912|NCT00624780|589142709|FG003|Follow-up (Week 26)|Other|0|||
163118913|NCT00624780|589142710|FG004|Follow-up (Week 26)|Other|0|||
163118914|NCT00624780|589142711|FG005|Follow-up (Week 26)|Other|0|||
163118915|NCT04068519|589142713|FG000|Dose Verification|Death|15|||
163118916|NCT04068519|589142713|FG000|Dose Verification|Withdrawal by Subject|1|||
163118917|NCT04068519|589142713|FG000|Pharmacokinetic Sub-study|Death|35|||
163118918|NCT04068519|589142713|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
163118919|NCT04068519|589142713|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
163118920|NCT04068519|589142713|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
163118921|NCT04068519|589142713|FG000|Indication Expansion|Death|152|||
163118922|NCT04068519|589142713|FG000|Indication Expansion|Withdrawal by Subject|10|||
163118923|NCT04068519|589142713|FG000|Indication Expansion|Lost to Follow-up|7|||
163118924|NCT00969761|589142714|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
163118925|NCT00969761|589142715|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118926|NCT00969761|589142716|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118927|NCT00969761|589142717|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
163118928|NCT00969761|589142718|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118929|NCT00969761|589142719|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118930|NCT00969761|589142720|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118931|NCT00969761|589142721|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118932|NCT00969761|589142722|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
163118933|NCT00969761|589142723|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
163118934|NCT00969761|589142724|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118935|NCT00969761|589142725|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118936|NCT00969761|589142714|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118937|NCT00969761|589142715|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118938|NCT00969761|589142716|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
163118939|NCT00969761|589142717|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118940|NCT00969761|589142718|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118941|NCT00969761|589142719|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118942|NCT00969761|589142720|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118943|NCT00969761|589142721|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118944|NCT00969761|589142722|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118945|NCT00969761|589142723|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118946|NCT00969761|589142724|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118947|NCT00969761|589142725|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118948|NCT00969761|589142714|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118949|NCT00969761|589142715|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118950|NCT00969761|589142716|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
163118951|NCT00969761|589142717|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118952|NCT00969761|589142718|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118953|NCT00969761|589142719|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118954|NCT00969761|589142720|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118955|NCT00969761|589142721|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118956|NCT00969761|589142722|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118957|NCT00969761|589142723|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118958|NCT00969761|589142724|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118959|NCT00969761|589142725|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118960|NCT00969761|589142714|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118961|NCT00969761|589142715|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118962|NCT00969761|589142716|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118963|NCT00969761|589142717|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118964|NCT00969761|589142718|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118965|NCT00969761|589142719|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118966|NCT00969761|589142720|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118967|NCT00969761|589142721|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118968|NCT00969761|589142722|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
163118969|NCT00969761|589142723|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118970|NCT00969761|589142724|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163224191|NCT02641379|589537835|FG007|Overall Study|Participant stopped study/treatment|0|||
163224192|NCT02641379|589537836|FG008|Overall Study|Participant stopped study/treatment|1|||
163224193|NCT02641379|589537837|FG009|Overall Study|Participant stopped study/treatment|0|||
163408053|NCT01903837|590204018|FG000|Part A|Adverse Event|3|||
163224194|NCT02641379|589537838|FG010|Overall Study|Participant stopped study/treatment|0|||
163340681|NCT01794689|589954890|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
163340682|NCT01794689|589954891|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
163340683|NCT01794689|589954892|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
163340684|NCT01794689|589954889|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
163340685|NCT01794689|589954890|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
163340686|NCT01794689|589954891|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
163340687|NCT01794689|589954892|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
163340688|NCT01794689|589954889|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
163340689|NCT01794689|589954890|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
163340690|NCT01794689|589954891|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
163340691|NCT01794689|589954892|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
163340692|NCT01794689|589954889|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
163340693|NCT01794689|589954890|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
163340694|NCT01794689|589954891|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
163340695|NCT01794689|589954892|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
163340696|NCT01697956|589954893|FG000|Overall Study|Protocol Violation|1|||
163340697|NCT01697956|589954894|FG001|Overall Study|Protocol Violation|1|||
163340698|NCT03060525|589954895|FG000|Overall Study|moved out of state|1|||
163340699|NCT03060525|589954896|FG001|Overall Study|moved out of state|1|||
163340700|NCT03060525|589954897|FG002|Overall Study|moved out of state|1|||
163340701|NCT03060525|589954898|FG003|Overall Study|moved out of state|1|||
163118971|NCT00969761|589142725|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118972|NCT00969761|589142714|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
163118973|NCT00969761|589142715|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
163118974|NCT00969761|589142716|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
163118975|NCT00969761|589142717|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
163118976|NCT00969761|589142718|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
163118977|NCT00969761|589142719|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
163118978|NCT00969761|589142720|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
163118979|NCT00969761|589142721|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
163118980|NCT00969761|589142722|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
163118981|NCT00969761|589142723|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
163118982|NCT00969761|589142724|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
163118983|NCT00969761|589142725|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
163118984|NCT00969761|589142714|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118985|NCT00969761|589142715|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118986|NCT00969761|589142716|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118987|NCT00969761|589142717|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
163118988|NCT00969761|589142718|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
163118989|NCT00969761|589142719|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118990|NCT00969761|589142720|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118991|NCT00969761|589142721|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118992|NCT00969761|589142722|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
163118993|NCT00969761|589142723|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118994|NCT00969761|589142724|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118995|NCT00969761|589142725|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118996|NCT03081858|589144675|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
163118997|NCT03081858|589144676|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
163118998|NCT03081858|589144677|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
163118999|NCT03081858|589144678|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
163119000|NCT02936284|589144685|FG000|Overall Study|Withdrawal by Subject|3|||
163119001|NCT02936284|589144686|FG001|Overall Study|Withdrawal by Subject|1|||
163119002|NCT02936284|589144685|FG000|Overall Study|Lost to Follow-up|7|||
163119003|NCT02936284|589144686|FG001|Overall Study|Lost to Follow-up|8|||
163119004|NCT01610596|589144687|FG000|Overall Study|Lost to Follow-up|0|||
163119005|NCT01610596|589144688|FG001|Overall Study|Lost to Follow-up|1|||
163119006|NCT00799591|589144691|FG000|Overall Study|De-escalation of doses|20|||
163119007|NCT00799591|589144691|FG000|Overall Study|Death|14|||
163119008|NCT00799591|589144691|FG000|Overall Study|Technical failure|12|||
163119009|NCT00799591|589144691|FG000|Overall Study|Resistant germ|11|||
163119010|NCT00799591|589144691|FG000|Overall Study|New infection|4|||
163119011|NCT00799591|589144691|FG000|Overall Study|Resistance germ and technical failure|2|||
163119012|NCT00799591|589144691|FG000|Overall Study|Persistance of fever undetermined origin|1|||
163119013|NCT00799591|589144691|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
163119014|NCT00799591|589144691|FG000|Overall Study|Infectious origin not probable|1|||
163119015|NCT02098369|589144692|FG000|Overall Study|Withdrawal by Subject|1|||
163340702|NCT03060525|589954895|FG000|Overall Study|unable to meet time commitment required of study|2|||
163340703|NCT03060525|589954896|FG001|Overall Study|unable to meet time commitment required of study|3|||
163408054|NCT01903837|590204019|FG001|Part A|Adverse Event|6|||
163119016|NCT02098369|589144693|FG001|Overall Study|Withdrawal by Subject|5|||
163119017|NCT02098369|589144694|FG002|Overall Study|Withdrawal by Subject|0|||
163119018|NCT02098369|589144692|FG000|Overall Study|Lost to Follow-up|5|||
163119019|NCT02098369|589144693|FG001|Overall Study|Lost to Follow-up|1|||
163119020|NCT02098369|589144694|FG002|Overall Study|Lost to Follow-up|3|||
163119021|NCT02098369|589144692|FG000|Overall Study|Death|1|||
163119022|NCT02098369|589144693|FG001|Overall Study|Death|1|||
163119023|NCT02098369|589144694|FG002|Overall Study|Death|1|||
163119024|NCT02098369|589144692|FG000|Overall Study|Other|0|||
163119025|NCT02098369|589144693|FG001|Overall Study|Other|2|||
163119026|NCT02098369|589144694|FG002|Overall Study|Other|1|||
163224195|NCT02641379|589537828|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
163224196|NCT02641379|589537829|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
163224197|NCT02641379|589537830|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
163224198|NCT02641379|589537831|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
163224199|NCT02641379|589537832|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
163224200|NCT02641379|589537833|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
163224201|NCT02641379|589537834|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
163224202|NCT02641379|589537835|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
163224203|NCT02641379|589537836|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
163224204|NCT02641379|589537837|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
163224205|NCT02641379|589537838|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
163224206|NCT02641379|589537828|FG000|Overall Study|Financial problems|0|||
163224207|NCT02641379|589537829|FG001|Overall Study|Financial problems|1|||
163224208|NCT02641379|589537830|FG002|Overall Study|Financial problems|0|||
163224209|NCT02641379|589537831|FG003|Overall Study|Financial problems|0|||
163224210|NCT02641379|589537832|FG004|Overall Study|Financial problems|0|||
163224211|NCT02641379|589537833|FG005|Overall Study|Financial problems|0|||
163224212|NCT02641379|589537834|FG006|Overall Study|Financial problems|0|||
163224213|NCT02641379|589537835|FG007|Overall Study|Financial problems|0|||
163224214|NCT02641379|589537836|FG008|Overall Study|Financial problems|0|||
163224215|NCT02641379|589537837|FG009|Overall Study|Financial problems|0|||
163224216|NCT02641379|589537838|FG010|Overall Study|Financial problems|0|||
163224217|NCT02641379|589537828|FG000|Overall Study|PCR positive at Week 68|0|||
163224218|NCT02641379|589537829|FG001|Overall Study|PCR positive at Week 68|1|||
163224219|NCT02641379|589537830|FG002|Overall Study|PCR positive at Week 68|0|||
163224220|NCT02641379|589537831|FG003|Overall Study|PCR positive at Week 68|0|||
163224221|NCT02641379|589537832|FG004|Overall Study|PCR positive at Week 68|0|||
163224222|NCT02641379|589537833|FG005|Overall Study|PCR positive at Week 68|0|||
163224223|NCT02641379|589537834|FG006|Overall Study|PCR positive at Week 68|0|||
163224224|NCT02641379|589537835|FG007|Overall Study|PCR positive at Week 68|0|||
163224225|NCT02641379|589537836|FG008|Overall Study|PCR positive at Week 68|0|||
163224226|NCT02641379|589537837|FG009|Overall Study|PCR positive at Week 68|0|||
163224227|NCT02641379|589537838|FG010|Overall Study|PCR positive at Week 68|0|||
163224228|NCT02641379|589537828|FG000|Overall Study|PCR positive at Week 48|0|||
163224229|NCT02641379|589537829|FG001|Overall Study|PCR positive at Week 48|1|||
163224230|NCT02641379|589537830|FG002|Overall Study|PCR positive at Week 48|0|||
163224231|NCT02641379|589537831|FG003|Overall Study|PCR positive at Week 48|0|||
163224232|NCT02641379|589537832|FG004|Overall Study|PCR positive at Week 48|0|||
163224233|NCT02641379|589537833|FG005|Overall Study|PCR positive at Week 48|0|||
163224234|NCT02641379|589537834|FG006|Overall Study|PCR positive at Week 48|0|||
163224235|NCT02641379|589537835|FG007|Overall Study|PCR positive at Week 48|0|||
163224236|NCT02641379|589537836|FG008|Overall Study|PCR positive at Week 48|0|||
163224237|NCT02641379|589537837|FG009|Overall Study|PCR positive at Week 48|0|||
163224238|NCT02641379|589537838|FG010|Overall Study|PCR positive at Week 48|0|||
163224239|NCT02641379|589537828|FG000|Overall Study|PCR not performed at Week 12|0|||
163224240|NCT02641379|589537829|FG001|Overall Study|PCR not performed at Week 12|0|||
163224241|NCT02641379|589537830|FG002|Overall Study|PCR not performed at Week 12|1|||
163224242|NCT02641379|589537831|FG003|Overall Study|PCR not performed at Week 12|0|||
163224243|NCT02641379|589537832|FG004|Overall Study|PCR not performed at Week 12|0|||
163224244|NCT02641379|589537833|FG005|Overall Study|PCR not performed at Week 12|0|||
163224245|NCT02641379|589537834|FG006|Overall Study|PCR not performed at Week 12|0|||
163224246|NCT02641379|589537835|FG007|Overall Study|PCR not performed at Week 12|0|||
163224247|NCT02641379|589537836|FG008|Overall Study|PCR not performed at Week 12|0|||
163224248|NCT02641379|589537837|FG009|Overall Study|PCR not performed at Week 12|0|||
163224249|NCT02641379|589537838|FG010|Overall Study|PCR not performed at Week 12|0|||
163224250|NCT02641379|589537828|FG000|Overall Study|No PCR at baseline|0|||
163224251|NCT02641379|589537829|FG001|Overall Study|No PCR at baseline|0|||
163224252|NCT02641379|589537830|FG002|Overall Study|No PCR at baseline|1|||
163224253|NCT02641379|589537831|FG003|Overall Study|No PCR at baseline|0|||
163224254|NCT02641379|589537832|FG004|Overall Study|No PCR at baseline|0|||
163119027|NCT00413920|589144704|FG000|Overall Study|Adverse Event|9|||
163119028|NCT00413920|589144705|FG001|Overall Study|Adverse Event|11|||
163119029|NCT00413920|589144704|FG000|Overall Study|Lack of Efficacy|11|||
163119030|NCT00413920|589144705|FG001|Overall Study|Lack of Efficacy|9|||
163340704|NCT03060525|589954897|FG002|Overall Study|unable to meet time commitment required of study|3|||
163340705|NCT03060525|589954898|FG003|Overall Study|unable to meet time commitment required of study|1|||
163340706|NCT03060525|589954895|FG000|Overall Study|no longer interested in doing intervention|0|||
163340707|NCT03060525|589954896|FG001|Overall Study|no longer interested in doing intervention|0|||
163340708|NCT03060525|589954897|FG002|Overall Study|no longer interested in doing intervention|0|||
163340709|NCT03060525|589954898|FG003|Overall Study|no longer interested in doing intervention|1|||
163340710|NCT01964547|589954899|FG000|Overall Study|Adverse Event|8|||
163119031|NCT00413920|589144704|FG000|Overall Study|Death|3|||
163119032|NCT00413920|589144705|FG001|Overall Study|Death|5|||
163119033|NCT00413920|589144704|FG000|Overall Study|Graft Loss|5|||
163119034|NCT00413920|589144705|FG001|Overall Study|Graft Loss|3|||
163119035|NCT01765426|589144707|FG000|Overall Study|Lost to Follow-up|0|||
163119036|NCT01765426|589144708|FG001|Overall Study|Lost to Follow-up|1|||
163119037|NCT01765426|589144709|FG002|Overall Study|Lost to Follow-up|0|||
163119038|NCT01765426|589144710|FG003|Overall Study|Lost to Follow-up|0|||
163119039|NCT00545532|589144711|FG000|Overall Study|Withdrawal by Subject|1|||
163119040|NCT00545532|589144712|FG001|Overall Study|Withdrawal by Subject|3|||
163119041|NCT00545532|589144711|FG000|Overall Study|Lost to Follow-up|5|||
163119042|NCT00545532|589144712|FG001|Overall Study|Lost to Follow-up|6|||
163119043|NCT00545532|589144711|FG000|Overall Study|Death|0|||
163119044|NCT00545532|589144712|FG001|Overall Study|Death|1|||
163119045|NCT01479595|589144713|FG000|Overall Study|Protocol deviation|0|||
163119046|NCT01479595|589144714|FG001|Overall Study|Protocol deviation|1|||
163119047|NCT01479595|589144713|FG000|Overall Study|Adverse Event|2|||
163119048|NCT01479595|589144714|FG001|Overall Study|Adverse Event|1|||
163119049|NCT02120365|589144715|FG000|Overall Study|Withdrawal by Subject|0|||
163119050|NCT02120365|589144716|FG001|Overall Study|Withdrawal by Subject|0|||
163119051|NCT02120365|589144717|FG002|Overall Study|Withdrawal by Subject|2|||
163119052|NCT02120365|589144718|FG003|Overall Study|Withdrawal by Subject|4|||
163119053|NCT02120365|589144719|FG004|Overall Study|Withdrawal by Subject|0|||
163119054|NCT02120365|589144720|FG005|Overall Study|Withdrawal by Subject|2|||
163119055|NCT01344629|589144723|FG000|Crossover Period 2|Withdrawal by Subject|0|||
163119056|NCT01344629|589144724|FG001|Crossover Period 2|Withdrawal by Subject|1|||
163119057|NCT00900146|589144725|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
163119058|NCT00900146|589144726|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
163119059|NCT00900146|589144727|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
163119060|NCT00900146|589144728|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
163119061|NCT00900146|589144729|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
163119062|NCT00900146|589144725|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
163119063|NCT00900146|589144726|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
163119064|NCT00900146|589144727|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
163119065|NCT00900146|589144728|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
163119066|NCT00900146|589144729|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
163119067|NCT00900146|589144725|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
163119068|NCT00900146|589144726|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
163119069|NCT00900146|589144727|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
163119070|NCT00900146|589144728|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
163119071|NCT00900146|589144729|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
163119072|NCT00900146|589144725|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
163119073|NCT00900146|589144726|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
163119074|NCT00900146|589144727|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
163119075|NCT00900146|589144728|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
163119076|NCT00900146|589144729|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
163119077|NCT00900146|589144725|FG000|Intermediate: Period III|Lost to Follow-up|2|||
163119078|NCT00900146|589144726|FG001|Intermediate: Period III|Lost to Follow-up|0|||
163119079|NCT00900146|589144727|FG002|Intermediate: Period III|Lost to Follow-up|0|||
163119080|NCT00900146|589144728|FG003|Intermediate: Period III|Lost to Follow-up|0|||
163119081|NCT00900146|589144729|FG004|Intermediate: Period III|Lost to Follow-up|1|||
163119082|NCT00900146|589144725|FG000|Intermediate: Period III|Administrative problems|85|||
163119083|NCT00900146|589144726|FG001|Intermediate: Period III|Administrative problems|92|||
163119084|NCT00900146|589144727|FG002|Intermediate: Period III|Administrative problems|84|||
163119085|NCT00900146|589144728|FG003|Intermediate: Period III|Administrative problems|90|||
163119086|NCT00900146|589144729|FG004|Intermediate: Period III|Administrative problems|163|||
163119087|NCT02305849|589144730|FG000|Overall Study|Adverse Event|10|||
163119088|NCT02305849|589144731|FG001|Overall Study|Adverse Event|12|||
163119089|NCT02305849|589144732|FG002|Overall Study|Adverse Event|7|||
163119090|NCT02305849|589144733|FG003|Overall Study|Adverse Event|3|||
163119091|NCT02305849|589144730|FG000|Overall Study|Lack of Efficacy|10|||
163119092|NCT02305849|589144731|FG001|Overall Study|Lack of Efficacy|6|||
163119093|NCT02305849|589144732|FG002|Overall Study|Lack of Efficacy|3|||
163119094|NCT02305849|589144733|FG003|Overall Study|Lack of Efficacy|9|||
163224255|NCT02641379|589537833|FG005|Overall Study|No PCR at baseline|0|||
163224256|NCT02641379|589537834|FG006|Overall Study|No PCR at baseline|0|||
163119095|NCT02305849|589144730|FG000|Overall Study|Withdrawal by Subject|2|||
163224257|NCT02641379|589537835|FG007|Overall Study|No PCR at baseline|0|||
163224258|NCT02641379|589537836|FG008|Overall Study|No PCR at baseline|0|||
163224259|NCT02641379|589537837|FG009|Overall Study|No PCR at baseline|0|||
163224260|NCT02641379|589537838|FG010|Overall Study|No PCR at baseline|0|||
163224261|NCT02641379|589537828|FG000|Overall Study|PCR positive at Week 28|0|||
163224262|NCT02641379|589537829|FG001|Overall Study|PCR positive at Week 28|0|||
163224263|NCT02641379|589537830|FG002|Overall Study|PCR positive at Week 28|1|||
163224264|NCT02641379|589537831|FG003|Overall Study|PCR positive at Week 28|0|||
163224265|NCT02641379|589537832|FG004|Overall Study|PCR positive at Week 28|0|||
163224266|NCT02641379|589537833|FG005|Overall Study|PCR positive at Week 28|0|||
163224267|NCT02641379|589537834|FG006|Overall Study|PCR positive at Week 28|0|||
163119096|NCT02305849|589144731|FG001|Overall Study|Withdrawal by Subject|2|||
163119097|NCT02305849|589144732|FG002|Overall Study|Withdrawal by Subject|1|||
163119098|NCT02305849|589144733|FG003|Overall Study|Withdrawal by Subject|4|||
163119099|NCT02305849|589144730|FG000|Overall Study|Lost to Follow-up|0|||
163119100|NCT02305849|589144731|FG001|Overall Study|Lost to Follow-up|2|||
163119101|NCT02305849|589144732|FG002|Overall Study|Lost to Follow-up|0|||
163119102|NCT02305849|589144733|FG003|Overall Study|Lost to Follow-up|0|||
163119103|NCT02305849|589144730|FG000|Overall Study|Protocol Violation|3|||
163119104|NCT02305849|589144731|FG001|Overall Study|Protocol Violation|2|||
163119105|NCT02305849|589144732|FG002|Overall Study|Protocol Violation|1|||
163119106|NCT02305849|589144733|FG003|Overall Study|Protocol Violation|1|||
163119107|NCT02305849|589144730|FG000|Overall Study|Lab data met discontinuation criteria|0|||
163119108|NCT02305849|589144731|FG001|Overall Study|Lab data met discontinuation criteria|1|||
163119109|NCT02305849|589144732|FG002|Overall Study|Lab data met discontinuation criteria|2|||
163119110|NCT02305849|589144733|FG003|Overall Study|Lab data met discontinuation criteria|1|||
163119111|NCT02305849|589144730|FG000|Overall Study|Miscellaneous|1|||
163119112|NCT02305849|589144731|FG001|Overall Study|Miscellaneous|2|||
163119113|NCT02305849|589144732|FG002|Overall Study|Miscellaneous|4|||
163119114|NCT02305849|589144733|FG003|Overall Study|Miscellaneous|1|||
163119115|NCT02305849|589144730|FG000|Overall Study|Not fulfill eligibility criteria|1|||
163119116|NCT02305849|589144731|FG001|Overall Study|Not fulfill eligibility criteria|1|||
163119117|NCT02305849|589144732|FG002|Overall Study|Not fulfill eligibility criteria|0|||
163119118|NCT02305849|589144733|FG003|Overall Study|Not fulfill eligibility criteria|0|||
163119119|NCT00355342|589144734|FG000|Overall Study|Adverse Event|13|||
163119120|NCT00355342|589144735|FG001|Overall Study|Adverse Event|15|||
163119121|NCT00355342|589144734|FG000|Overall Study|Lost to Follow-up|4|||
163119122|NCT00355342|589144735|FG001|Overall Study|Lost to Follow-up|2|||
163119123|NCT00355342|589144734|FG000|Overall Study|Withdrawal by Subject|14|||
163119124|NCT00355342|589144735|FG001|Overall Study|Withdrawal by Subject|11|||
163119125|NCT00355342|589144734|FG000|Overall Study|Sponsor terminated study|2|||
163119126|NCT00355342|589144735|FG001|Overall Study|Sponsor terminated study|2|||
163119127|NCT00355342|589144734|FG000|Overall Study|Overcompliant-PI discretion|1|||
163119128|NCT00355342|589144735|FG001|Overall Study|Overcompliant-PI discretion|0|||
163119129|NCT00355342|589144734|FG000|Overall Study|Use of prohibited medication|1|||
163119130|NCT00355342|589144735|FG001|Overall Study|Use of prohibited medication|0|||
163119131|NCT00355342|589144734|FG000|Overall Study|COPD exacerbation|1|||
163119132|NCT00355342|589144735|FG001|Overall Study|COPD exacerbation|1|||
163119133|NCT00355342|589144734|FG000|Overall Study|Dispensed wrong study drug kit|1|||
163119134|NCT00355342|589144735|FG001|Overall Study|Dispensed wrong study drug kit|0|||
163119135|NCT00355342|589144734|FG000|Overall Study|Non-compliance with Dexa scans|1|||
163119136|NCT00355342|589144735|FG001|Overall Study|Non-compliance with Dexa scans|0|||
163119137|NCT00355342|589144734|FG000|Overall Study|Withdrawal by participant and physician|1|||
163119138|NCT00355342|589144735|FG001|Overall Study|Withdrawal by participant and physician|0|||
163119139|NCT00355342|589144734|FG000|Overall Study|Participant relocated|0|||
163119140|NCT00355342|589144735|FG001|Overall Study|Participant relocated|1|||
163119141|NCT00355342|589144734|FG000|Overall Study|Participant discontinued study drug|0|||
163119142|NCT00355342|589144735|FG001|Overall Study|Participant discontinued study drug|1|||
163119143|NCT00355342|589144734|FG000|Overall Study|Study management|0|||
163119144|NCT00355342|589144735|FG001|Overall Study|Study management|1|||
163119145|NCT00355342|589144734|FG000|Overall Study|Protocol Violation|0|||
163119146|NCT00355342|589144735|FG001|Overall Study|Protocol Violation|1|||
163119147|NCT00355342|589144734|FG000|Overall Study|Use of protocol excluded medication|0|||
163224268|NCT02641379|589537835|FG007|Overall Study|PCR positive at Week 28|0|||
163224269|NCT02641379|589537836|FG008|Overall Study|PCR positive at Week 28|0|||
163224270|NCT02641379|589537837|FG009|Overall Study|PCR positive at Week 28|0|||
163224271|NCT02641379|589537838|FG010|Overall Study|PCR positive at Week 28|0|||
163224272|NCT02641379|589537828|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
163119148|NCT00355342|589144735|FG001|Overall Study|Use of protocol excluded medication|1|||
163119149|NCT00495521|589144737|FG000|Overall Study|Physician Decision|0|||
163119150|NCT00495521|589144738|FG001|Overall Study|Physician Decision|1|||
163119151|NCT02782325|589144739|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
163119152|NCT02782325|589144740|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
163119153|NCT02782325|589144741|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
163224273|NCT02641379|589537829|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
163224274|NCT02641379|589537830|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
163224275|NCT02641379|589537831|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
163224276|NCT02641379|589537832|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
163224277|NCT02641379|589537833|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
163224278|NCT02641379|589537834|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
163224279|NCT02641379|589537835|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
163224280|NCT02641379|589537836|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
163224281|NCT02641379|589537837|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
163224282|NCT02641379|589537838|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
163224283|NCT02641379|589537828|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
163224284|NCT02641379|589537829|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
163224285|NCT02641379|589537830|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
163224286|NCT02641379|589537831|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
163224287|NCT02641379|589537832|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
163224288|NCT02641379|589537833|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
163224289|NCT02641379|589537834|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
163224290|NCT02641379|589537835|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
163224291|NCT02641379|589537836|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
163224292|NCT02641379|589537837|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
163224293|NCT02641379|589537838|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
163224294|NCT02641379|589537828|FG000|Overall Study|Baseline viral load unavailable|0|||
163224295|NCT02641379|589537829|FG001|Overall Study|Baseline viral load unavailable|0|||
163224296|NCT02641379|589537830|FG002|Overall Study|Baseline viral load unavailable|0|||
163224297|NCT02641379|589537831|FG003|Overall Study|Baseline viral load unavailable|1|||
163224298|NCT02641379|589537832|FG004|Overall Study|Baseline viral load unavailable|0|||
163224299|NCT02641379|589537833|FG005|Overall Study|Baseline viral load unavailable|0|||
163224300|NCT02641379|589537834|FG006|Overall Study|Baseline viral load unavailable|0|||
163224301|NCT02641379|589537835|FG007|Overall Study|Baseline viral load unavailable|0|||
163224302|NCT02641379|589537836|FG008|Overall Study|Baseline viral load unavailable|0|||
163224303|NCT02641379|589537837|FG009|Overall Study|Baseline viral load unavailable|0|||
163224304|NCT02641379|589537838|FG010|Overall Study|Baseline viral load unavailable|0|||
163224305|NCT02641379|589537828|FG000|Overall Study|Blood could not be drawn|0|||
163224306|NCT02641379|589537829|FG001|Overall Study|Blood could not be drawn|0|||
163224307|NCT02641379|589537830|FG002|Overall Study|Blood could not be drawn|0|||
163224308|NCT02641379|589537831|FG003|Overall Study|Blood could not be drawn|0|||
163224309|NCT02641379|589537832|FG004|Overall Study|Blood could not be drawn|1|||
163224310|NCT02641379|589537833|FG005|Overall Study|Blood could not be drawn|0|||
163224311|NCT02641379|589537834|FG006|Overall Study|Blood could not be drawn|0|||
163224312|NCT02641379|589537835|FG007|Overall Study|Blood could not be drawn|0|||
163224313|NCT02641379|589537836|FG008|Overall Study|Blood could not be drawn|0|||
163224314|NCT02641379|589537837|FG009|Overall Study|Blood could not be drawn|0|||
163224315|NCT02641379|589537838|FG010|Overall Study|Blood could not be drawn|0|||
163224316|NCT02641379|589537828|FG000|Overall Study|Protocol Violation|0|||
163224317|NCT02641379|589537829|FG001|Overall Study|Protocol Violation|0|||
163224318|NCT02641379|589537830|FG002|Overall Study|Protocol Violation|0|||
163224319|NCT02641379|589537831|FG003|Overall Study|Protocol Violation|0|||
163224320|NCT02641379|589537832|FG004|Overall Study|Protocol Violation|2|||
163224321|NCT02641379|589537833|FG005|Overall Study|Protocol Violation|0|||
163224322|NCT02641379|589537834|FG006|Overall Study|Protocol Violation|0|||
163224323|NCT02641379|589537835|FG007|Overall Study|Protocol Violation|0|||
163224324|NCT02641379|589537836|FG008|Overall Study|Protocol Violation|1|||
163224325|NCT02641379|589537837|FG009|Overall Study|Protocol Violation|0|||
163224326|NCT02641379|589537838|FG010|Overall Study|Protocol Violation|0|||
163224327|NCT02641379|589537828|FG000|Overall Study|Participation in sili rescue study|0|||
163224328|NCT02641379|589537829|FG001|Overall Study|Participation in sili rescue study|0|||
163224329|NCT02641379|589537830|FG002|Overall Study|Participation in sili rescue study|0|||
163224330|NCT02641379|589537831|FG003|Overall Study|Participation in sili rescue study|0|||
163224331|NCT02641379|589537832|FG004|Overall Study|Participation in sili rescue study|0|||
163224332|NCT02641379|589537833|FG005|Overall Study|Participation in sili rescue study|1|||
163224333|NCT02641379|589537834|FG006|Overall Study|Participation in sili rescue study|0|||
163224334|NCT02641379|589537835|FG007|Overall Study|Participation in sili rescue study|0|||
163340711|NCT01964547|589954900|FG001|Overall Study|Adverse Event|2|||
163340712|NCT01964547|589954899|FG000|Overall Study|Withdrawal by Subject|4|||
163340713|NCT01964547|589954900|FG001|Overall Study|Withdrawal by Subject|7|||
163340714|NCT01964547|589954899|FG000|Overall Study|Lost to Follow-up|0|||
163340715|NCT01964547|589954900|FG001|Overall Study|Lost to Follow-up|1|||
163340716|NCT01964547|589954899|FG000|Overall Study|Withdrawal by Investigator|0|||
163224335|NCT02641379|589537836|FG008|Overall Study|Participation in sili rescue study|0|||
163340717|NCT01964547|589954900|FG001|Overall Study|Withdrawal by Investigator|1|||
163340718|NCT01115309|589954901|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
163340719|NCT01115309|589954901|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
163224336|NCT02641379|589537837|FG009|Overall Study|Participation in sili rescue study|0|||
163119154|NCT02782325|589144739|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
163119155|NCT02782325|589144740|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
163119156|NCT02782325|589144741|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
163119157|NCT01527383|589144744|FG000|Overall Study|Adverse Event|5|||
163119158|NCT01527383|589144745|FG001|Overall Study|Adverse Event|0|||
163119159|NCT01527383|589144744|FG000|Overall Study|Lost to Follow-up|3|||
163119160|NCT01527383|589144745|FG001|Overall Study|Lost to Follow-up|0|||
163119161|NCT01527383|589144744|FG000|Overall Study|Physician Decision|2|||
163119162|NCT01527383|589144745|FG001|Overall Study|Physician Decision|0|||
163119163|NCT01527383|589144744|FG000|Overall Study|Pregnancy|1|||
163119164|NCT01527383|589144745|FG001|Overall Study|Pregnancy|0|||
163119165|NCT01527383|589144744|FG000|Overall Study|Protocol Violation|1|||
163119166|NCT01527383|589144745|FG001|Overall Study|Protocol Violation|0|||
163119167|NCT01527383|589144744|FG000|Overall Study|Screen failure|1|||
163119168|NCT01527383|589144745|FG001|Overall Study|Screen failure|0|||
163119169|NCT01527383|589144744|FG000|Overall Study|Participant moved|0|||
163119170|NCT01527383|589144745|FG001|Overall Study|Participant moved|1|||
163119171|NCT01527383|589144744|FG000|Overall Study|Withdrawal by Subject|2|||
163119172|NCT01527383|589144745|FG001|Overall Study|Withdrawal by Subject|3|||
163119173|NCT00554099|589144749|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
163119174|NCT00554099|589144750|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
163119175|NCT00554099|589144751|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
163119176|NCT00554099|589144749|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
163119177|NCT00554099|589144750|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
163119178|NCT00554099|589144751|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
163119179|NCT00554099|589144749|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
163119180|NCT00554099|589144750|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163119181|NCT00554099|589144751|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
163119182|NCT00554099|589144749|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
163119183|NCT00554099|589144750|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
163119184|NCT00554099|589144751|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
163119185|NCT00554099|589144749|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
163119186|NCT00554099|589144750|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
163119187|NCT00554099|589144751|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
163119188|NCT00554099|589144749|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
163119189|NCT00554099|589144750|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
163119190|NCT00554099|589144751|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
163119191|NCT00554099|589144749|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
163119192|NCT00554099|589144750|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
163119193|NCT00554099|589144751|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
163119194|NCT00554099|589144749|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
163119195|NCT00554099|589144750|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
163119196|NCT00554099|589144751|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
163119197|NCT00554099|589144749|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
163119198|NCT00554099|589144750|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
163119199|NCT00554099|589144751|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
163119200|NCT04957758|589144756|FG000|Overall Study|Adverse Event|1|||
163119201|NCT04957758|589144757|FG001|Overall Study|Adverse Event|0|||
163119202|NCT04957758|589144756|FG000|Overall Study|Lost to Follow-up|0|||
163119203|NCT04957758|589144757|FG001|Overall Study|Lost to Follow-up|2|||
163119204|NCT04957758|589144756|FG000|Overall Study|Withdrawal by Subject|4|||
163119205|NCT04957758|589144757|FG001|Overall Study|Withdrawal by Subject|2|||
163119206|NCT04957758|589144756|FG000|Overall Study|Protocol Violation|0|||
163119207|NCT04957758|589144757|FG001|Overall Study|Protocol Violation|1|||
163119208|NCT03353922|589144758|FG000|Overall Study|Withdrawal by Subject|1|||
163119209|NCT03353922|589144759|FG001|Overall Study|Withdrawal by Subject|0|||
163119210|NCT03353922|589144760|FG002|Overall Study|Withdrawal by Subject|1|||
163119211|NCT03353922|589144761|FG003|Overall Study|Withdrawal by Subject|1|||
163119212|NCT03353922|589144762|FG004|Overall Study|Withdrawal by Subject|0|||
163119213|NCT03353922|589144763|FG005|Overall Study|Withdrawal by Subject|0|||
163119214|NCT03353922|589144758|FG000|Overall Study|Adverse Event|0|||
163119215|NCT03353922|589144759|FG001|Overall Study|Adverse Event|1|||
163119216|NCT03353922|589144760|FG002|Overall Study|Adverse Event|0|||
163119217|NCT03353922|589144761|FG003|Overall Study|Adverse Event|0|||
163119218|NCT03353922|589144762|FG004|Overall Study|Adverse Event|0|||
163119219|NCT03353922|589144763|FG005|Overall Study|Adverse Event|0|||
163119220|NCT03688555|589144764|FG000|Treatment Period|Adverse Event|0|||
163119221|NCT03688555|589144765|FG001|Treatment Period|Adverse Event|0|||
163119222|NCT03688555|589144766|FG002|Treatment Period|Adverse Event|1|||
163119223|NCT00886119|589144767|FG000|Period 1|Did not meet inclusion criteria|1|||
163119224|NCT00886119|589144768|FG001|Period 1|Did not meet inclusion criteria|0|||
163119225|NCT00394901|589144769|FG000|Baseline Phase|Protocol Violation|0|||
163340720|NCT01115309|589954901|FG000|Long-term Follow-up|Lost to Follow-up|6|||
163119226|NCT00394901|589144770|FG001|Baseline Phase|Protocol Violation|0|||
163119227|NCT00394901|589144771|FG002|Baseline Phase|Protocol Violation|1|||
163224337|NCT02641379|589537838|FG010|Overall Study|Participation in sili rescue study|0|||
163224338|NCT02641379|589537828|FG000|Overall Study|Lost to Follow-up|0|||
163224339|NCT02641379|589537829|FG001|Overall Study|Lost to Follow-up|0|||
163224340|NCT02641379|589537830|FG002|Overall Study|Lost to Follow-up|0|||
163224341|NCT02641379|589537831|FG003|Overall Study|Lost to Follow-up|0|||
163224342|NCT02641379|589537832|FG004|Overall Study|Lost to Follow-up|0|||
163224343|NCT02641379|589537833|FG005|Overall Study|Lost to Follow-up|0|||
163224344|NCT02641379|589537834|FG006|Overall Study|Lost to Follow-up|0|||
163224345|NCT02641379|589537835|FG007|Overall Study|Lost to Follow-up|0|||
163224346|NCT02641379|589537836|FG008|Overall Study|Lost to Follow-up|1|||
163224347|NCT02641379|589537837|FG009|Overall Study|Lost to Follow-up|0|||
163224348|NCT02641379|589537838|FG010|Overall Study|Lost to Follow-up|0|||
163224349|NCT02641379|589537828|FG000|Overall Study|Source data not found|0|||
163119228|NCT00394901|589144772|FG003|Baseline Phase|Protocol Violation|0|||
163119229|NCT00394901|589144769|FG000|Double-blind Phase|Adverse Event|5|||
163119230|NCT00394901|589144770|FG001|Double-blind Phase|Adverse Event|7|||
163119231|NCT00394901|589144771|FG002|Double-blind Phase|Adverse Event|16|||
163119232|NCT00394901|589144772|FG003|Double-blind Phase|Adverse Event|20|||
163119233|NCT00394901|589144769|FG000|Double-blind Phase|Lack of Efficacy|6|||
163119234|NCT00394901|589144770|FG001|Double-blind Phase|Lack of Efficacy|4|||
163119235|NCT00394901|589144771|FG002|Double-blind Phase|Lack of Efficacy|1|||
163119236|NCT00394901|589144772|FG003|Double-blind Phase|Lack of Efficacy|3|||
163119237|NCT00394901|589144769|FG000|Double-blind Phase|Withdrawal by Subject|2|||
163119238|NCT00394901|589144770|FG001|Double-blind Phase|Withdrawal by Subject|0|||
163119239|NCT00394901|589144771|FG002|Double-blind Phase|Withdrawal by Subject|0|||
163119240|NCT00394901|589144772|FG003|Double-blind Phase|Withdrawal by Subject|0|||
163119241|NCT00394901|589144769|FG000|Double-blind Phase|Lost to Follow-up|0|||
163119242|NCT00394901|589144770|FG001|Double-blind Phase|Lost to Follow-up|0|||
163119243|NCT00394901|589144771|FG002|Double-blind Phase|Lost to Follow-up|0|||
163119244|NCT00394901|589144772|FG003|Double-blind Phase|Lost to Follow-up|1|||
163119245|NCT00394901|589144769|FG000|Double-blind Phase|Protocol Violation|0|||
163119246|NCT00394901|589144770|FG001|Double-blind Phase|Protocol Violation|0|||
163119247|NCT00394901|589144771|FG002|Double-blind Phase|Protocol Violation|0|||
163119248|NCT00394901|589144772|FG003|Double-blind Phase|Protocol Violation|1|||
163119249|NCT00394901|589144769|FG000|Double-blind Phase|Death|1|||
163119250|NCT00394901|589144770|FG001|Double-blind Phase|Death|0|||
163119251|NCT00394901|589144771|FG002|Double-blind Phase|Death|0|||
163119252|NCT00394901|589144772|FG003|Double-blind Phase|Death|0|||
163119253|NCT00394901|589144769|FG000|Double-blind Phase|Subject's Personal Reason|1|||
163119254|NCT00394901|589144770|FG001|Double-blind Phase|Subject's Personal Reason|0|||
163119255|NCT00394901|589144771|FG002|Double-blind Phase|Subject's Personal Reason|0|||
163119256|NCT00394901|589144772|FG003|Double-blind Phase|Subject's Personal Reason|1|||
163119257|NCT00394901|589144769|FG000|Double-blind Phase|Lack of Compliance|0|||
163119258|NCT00394901|589144770|FG001|Double-blind Phase|Lack of Compliance|3|||
163119259|NCT00394901|589144771|FG002|Double-blind Phase|Lack of Compliance|0|||
163119260|NCT00394901|589144772|FG003|Double-blind Phase|Lack of Compliance|0|||
163119261|NCT00394901|589144769|FG000|Double-blind Phase|Entry into another study was found|0|||
163119262|NCT00394901|589144770|FG001|Double-blind Phase|Entry into another study was found|0|||
163119263|NCT00394901|589144771|FG002|Double-blind Phase|Entry into another study was found|1|||
163119264|NCT00394901|589144772|FG003|Double-blind Phase|Entry into another study was found|0|||
163119265|NCT00394901|589144769|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
163119266|NCT00394901|589144770|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
163119267|NCT00394901|589144771|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
163119268|NCT00394901|589144772|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
163119269|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
163224350|NCT02641379|589537829|FG001|Overall Study|Source data not found|0|||
163224351|NCT02641379|589537830|FG002|Overall Study|Source data not found|0|||
163224352|NCT02641379|589537831|FG003|Overall Study|Source data not found|0|||
163224353|NCT02641379|589537832|FG004|Overall Study|Source data not found|0|||
163224354|NCT02641379|589537833|FG005|Overall Study|Source data not found|1|||
163224355|NCT02641379|589537834|FG006|Overall Study|Source data not found|0|||
163224356|NCT02641379|589537835|FG007|Overall Study|Source data not found|0|||
163224357|NCT02641379|589537836|FG008|Overall Study|Source data not found|0|||
163224358|NCT02641379|589537837|FG009|Overall Study|Source data not found|0|||
163224359|NCT02641379|589537838|FG010|Overall Study|Source data not found|0|||
163224360|NCT02641379|589537828|FG000|Overall Study|Participant showed weight reduction|0|||
163119270|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
163119271|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
163119272|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
163224361|NCT02641379|589537829|FG001|Overall Study|Participant showed weight reduction|0|||
163119273|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
163119274|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
163224362|NCT02641379|589537830|FG002|Overall Study|Participant showed weight reduction|0|||
163224363|NCT02641379|589537831|FG003|Overall Study|Participant showed weight reduction|0|||
163119275|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
163119276|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
163119277|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
163119278|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
163119279|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
163119280|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
163119281|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
163119282|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
163119283|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
163119284|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
163119285|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
163119286|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
163119287|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
163119288|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
163119289|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
163119290|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
163119291|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
163119292|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
163119293|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
163119294|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
163119295|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
163119296|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
163119297|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
163119298|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
163119299|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
163119300|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
163119301|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
163119302|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
163119303|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
163119304|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
163119305|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
163119306|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
163119307|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
163119308|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
163119309|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
163119310|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
163119311|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
163119312|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
163119313|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
163119314|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
163119315|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
163119316|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
163119317|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
163119318|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
163119319|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
163119320|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
163119321|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
163119322|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
163119323|NCT02008357|589144776|FG000|Open-label Extension Period|Adverse Event|8|||
163119324|NCT02008357|589144777|FG001|Open-label Extension Period|Adverse Event|7|||
163119325|NCT02008357|589144776|FG000|Open-label Extension Period|Death|7|||
163119326|NCT02008357|589144777|FG001|Open-label Extension Period|Death|4|||
163224364|NCT02641379|589537832|FG004|Overall Study|Participant showed weight reduction|0|||
163340721|NCT04447287|589954902|FG000|Period 1: Run-in Period|Adverse Event|3|||
163340722|NCT04447287|589954903|FG001|Period 1: Run-in Period|Adverse Event|0|||
163340723|NCT04447287|589954904|FG002|Period 1: Run-in Period|Adverse Event|0|||
163340724|NCT04447287|589954902|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
163340725|NCT04447287|589954903|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
163340726|NCT04447287|589954904|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
163384897|NCT00427895|590119256|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
163119327|NCT02008357|589144776|FG000|Open-label Extension Period|Lack of Efficacy|9|||
163119328|NCT02008357|589144777|FG001|Open-label Extension Period|Lack of Efficacy|5|||
163119329|NCT02008357|589144776|FG000|Open-label Extension Period|Lost to Follow-up|2|||
163119330|NCT02008357|589144777|FG001|Open-label Extension Period|Lost to Follow-up|2|||
163119331|NCT02008357|589144776|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
163119332|NCT02008357|589144777|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
163119333|NCT02008357|589144776|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
163119334|NCT02008357|589144777|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
163119335|NCT02008357|589144776|FG000|Open-label Extension Period|Safety Risk|2|||
163119336|NCT02008357|589144777|FG001|Open-label Extension Period|Safety Risk|1|||
163119337|NCT02008357|589144776|FG000|Open-label Extension Period|Non-Compliance|0|||
163119338|NCT02008357|589144777|FG001|Open-label Extension Period|Non-Compliance|1|||
163119339|NCT02008357|589144776|FG000|Open-label Extension Period|Investigator Recommendation|0|||
163119340|NCT02008357|589144777|FG001|Open-label Extension Period|Investigator Recommendation|1|||
163119341|NCT02008357|589144776|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
163119342|NCT02008357|589144777|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
163119343|NCT02008357|589144776|FG000|Open-label Extension Period|Coordinating Center Request|2|||
163119344|NCT02008357|589144777|FG001|Open-label Extension Period|Coordinating Center Request|4|||
163119345|NCT02008357|589144776|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
163119346|NCT02008357|589144777|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
163119347|NCT02008357|589144776|FG000|Open-label Extension Period|Study Ended|20|||
163119348|NCT02008357|589144777|FG001|Open-label Extension Period|Study Ended|25|||
163119349|NCT02008357|589144776|FG000|Open-label Extension Period|Personal Reasons|0|||
163119350|NCT02008357|589144777|FG001|Open-label Extension Period|Personal Reasons|1|||
163119351|NCT02008357|589144776|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
163119352|NCT02008357|589144777|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
163119353|NCT02008357|589144776|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
163119354|NCT02008357|589144777|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
163119355|NCT02008357|589144776|FG000|Open-label Extension Period|Other|2|||
163119356|NCT02008357|589144777|FG001|Open-label Extension Period|Other|0|||
163119357|NCT04941807|589144779|FG000|Overall Study|Lost to Follow-up|1|||
163119358|NCT04941807|589144780|FG001|Overall Study|Lost to Follow-up|1|||
163119359|NCT03553498|589144781|FG000|Overall Study|Missing primary outcome|1|||
163119360|NCT03553498|589144782|FG001|Overall Study|Missing primary outcome|2|||
163119361|NCT01498185|589144783|FG000|Overall Study|Adverse Event|0|||
163119362|NCT01498185|589144784|FG001|Overall Study|Adverse Event|0|||
163119363|NCT01498185|589144785|FG002|Overall Study|Adverse Event|0|||
163119364|NCT01498185|589144786|FG003|Overall Study|Adverse Event|1|||
163119365|NCT01498185|589144787|FG004|Overall Study|Adverse Event|0|||
163119366|NCT01498185|589144783|FG000|Overall Study|Withdrawal by Subject|1|||
163119367|NCT01498185|589144784|FG001|Overall Study|Withdrawal by Subject|1|||
163119368|NCT01498185|589144785|FG002|Overall Study|Withdrawal by Subject|0|||
163119369|NCT01498185|589144786|FG003|Overall Study|Withdrawal by Subject|2|||
163119370|NCT01498185|589144787|FG004|Overall Study|Withdrawal by Subject|1|||
163119371|NCT01498185|589144783|FG000|Overall Study|No longer met criteria, etc|0|||
163119372|NCT01498185|589144784|FG001|Overall Study|No longer met criteria, etc|0|||
163119373|NCT01498185|589144785|FG002|Overall Study|No longer met criteria, etc|0|||
163119374|NCT01498185|589144786|FG003|Overall Study|No longer met criteria, etc|0|||
163119375|NCT01498185|589144787|FG004|Overall Study|No longer met criteria, etc|2|||
163119376|NCT01453946|589144789|FG000|Overall Study|Did not receive drug for the taper phase|1|||
163119377|NCT01453946|589144789|FG000|Overall Study|Protocol Violation|2|||
163119378|NCT01453946|589144789|FG000|Overall Study|Lack of Efficacy|3|||
163119379|NCT01453946|589144789|FG000|Overall Study|Adverse Event|3|||
163119380|NCT00846040|589144790|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
163119381|NCT00846040|589144791|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
163119382|NCT00846040|589144792|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
163119383|NCT00846040|589144790|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
163119384|NCT00846040|589144791|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
163119385|NCT00846040|589144792|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
163119386|NCT03352453|589144794|FG000|Overall Study|Miscellaneous Reasons|1|||
163224365|NCT02641379|589537833|FG005|Overall Study|Participant showed weight reduction|0|||
163224366|NCT02641379|589537834|FG006|Overall Study|Participant showed weight reduction|0|||
163224367|NCT02641379|589537835|FG007|Overall Study|Participant showed weight reduction|1|||
163224368|NCT02641379|589537836|FG008|Overall Study|Participant showed weight reduction|0|||
163119387|NCT03352453|589144795|FG001|Overall Study|Miscellaneous Reasons|2|||
163119388|NCT03352453|589144794|FG000|Overall Study|Lack of Efficacy|1|||
163119389|NCT03352453|589144795|FG001|Overall Study|Lack of Efficacy|0|||
163119390|NCT03352453|589144794|FG000|Overall Study|Withdrawal by Subject|8|||
163119391|NCT03352453|589144795|FG001|Overall Study|Withdrawal by Subject|14|||
163119392|NCT03352453|589144794|FG000|Overall Study|Study Terminated by Sponsor|2|||
163119393|NCT03352453|589144795|FG001|Overall Study|Study Terminated by Sponsor|1|||
163119394|NCT03352453|589144794|FG000|Overall Study|Protocol Deviation|1|||
163340727|NCT04447287|589954902|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
163340728|NCT04447287|589954903|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
163340729|NCT04447287|589954904|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
163340730|NCT05700851|589954905|FG000|Overall Study|Received a kidney transplant|1|||
163340731|NCT05700851|589954905|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
163340732|NCT05700851|589954905|FG000|Overall Study|Withdrawal by Subject|1|||
163119395|NCT03352453|589144795|FG001|Overall Study|Protocol Deviation|0|||
163119396|NCT03352453|589144794|FG000|Overall Study|Lost to Follow-up|7|||
163119397|NCT03352453|589144795|FG001|Overall Study|Lost to Follow-up|6|||
163119398|NCT03352453|589144794|FG000|Overall Study|Adverse Event|2|||
163119399|NCT03352453|589144795|FG001|Overall Study|Adverse Event|9|||
163119400|NCT02827500|589144800|FG000|Overall Study|Death|7|||
163119401|NCT02827500|589144801|FG001|Overall Study|Death|3|||
163119402|NCT02827500|589144800|FG000|Overall Study|Lost to Follow-up|1|||
163119403|NCT02827500|589144801|FG001|Overall Study|Lost to Follow-up|1|||
163119404|NCT02827500|589144800|FG000|Overall Study|Withdrawal by Subject|3|||
163119405|NCT02827500|589144801|FG001|Overall Study|Withdrawal by Subject|1|||
163119406|NCT02827500|589144800|FG000|Overall Study|Missing primary endpoint data|3|||
163119407|NCT02827500|589144801|FG001|Overall Study|Missing primary endpoint data|1|||
163119408|NCT02827500|589144800|FG000|Overall Study|Other|5|||
163119409|NCT02827500|589144801|FG001|Overall Study|Other|1|||
163119410|NCT03158272|589144804|FG000|Overall Study|Disease progression|3|||
163119411|NCT03158272|589144805|FG001|Overall Study|Disease progression|3|||
163119412|NCT03158272|589144806|FG002|Overall Study|Disease progression|4|||
163119413|NCT03158272|589144807|FG003|Overall Study|Disease progression|6|||
163119414|NCT03158272|589144804|FG000|Overall Study|Death|0|||
163119415|NCT03158272|589144805|FG001|Overall Study|Death|0|||
163119416|NCT03158272|589144806|FG002|Overall Study|Death|1|||
163119417|NCT03158272|589144807|FG003|Overall Study|Death|0|||
163119418|NCT03158272|589144804|FG000|Overall Study|Other reasons|0|||
163119419|NCT03158272|589144805|FG001|Overall Study|Other reasons|0|||
163119420|NCT03158272|589144806|FG002|Overall Study|Other reasons|1|||
163119421|NCT03158272|589144807|FG003|Overall Study|Other reasons|0|||
163119422|NCT03158272|589144804|FG000|Overall Study|Adverse event unrelated to the drug|0|||
163119423|NCT03158272|589144805|FG001|Overall Study|Adverse event unrelated to the drug|1|||
163119424|NCT03158272|589144806|FG002|Overall Study|Adverse event unrelated to the drug|0|||
163119425|NCT03158272|589144807|FG003|Overall Study|Adverse event unrelated to the drug|0|||
163119426|NCT00514020|589144808|FG000|Overall Study|Adverse Event|6|||
163119427|NCT00514020|589144808|FG000|Overall Study|Withdrawal by Subject|3|||
163119428|NCT00514020|589144808|FG000|Overall Study|Physician Decision|1|||
163119429|NCT00514020|589144808|FG000|Overall Study|disease progression|9|||
163119430|NCT00514020|589144808|FG000|Overall Study|other complicating disease|2|||
163119431|NCT00514020|589144808|FG000|Overall Study|patient went to radiation treatment|1|||
163119432|NCT00514020|589144808|FG000|Overall Study|"patients moved to the no tx group"|6|||
163119433|NCT01688921|589144809|FG000|Overall Study|Lost to Follow-up|7|||
163119434|NCT01688921|589144810|FG001|Overall Study|Lost to Follow-up|13|||
163119435|NCT01688921|589144809|FG000|Overall Study|Physician Decision|6|||
163119436|NCT01688921|589144810|FG001|Overall Study|Physician Decision|1|||
163119437|NCT01688921|589144809|FG000|Overall Study|Protocol Violation|0|||
163119438|NCT01688921|589144810|FG001|Overall Study|Protocol Violation|1|||
163119439|NCT01688921|589144809|FG000|Overall Study|informed consent|3|||
163119440|NCT01688921|589144810|FG001|Overall Study|informed consent|0|||
163119441|NCT03697993|589144816|FG000|Overall Study|Became Ineligible after Enrollment|1|||
163119442|NCT03697993|589144817|FG001|Overall Study|Became Ineligible after Enrollment|3|||
163119443|NCT03697993|589144816|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
163119444|NCT03697993|589144817|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
163119445|NCT03697993|589144816|FG000|Overall Study|Lost to Follow-up|3|||
163119446|NCT03697993|589144817|FG001|Overall Study|Lost to Follow-up|0|||
163119447|NCT03697993|589144816|FG000|Overall Study|Physician Decision|4|||
163119448|NCT03697993|589144817|FG001|Overall Study|Physician Decision|0|||
163340733|NCT02147093|589954906|FG000|Period 1|Lost to Follow-up|0|||
163340734|NCT02147093|589954907|FG001|Period 1|Lost to Follow-up|1|||
163119449|NCT03697993|589144816|FG000|Overall Study|Initial Urine Culture Negative|0|||
163119450|NCT03697993|589144817|FG001|Overall Study|Initial Urine Culture Negative|1|||
163119451|NCT04384107|589144818|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
163119452|NCT04384107|589144819|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
163119453|NCT04384107|589144818|FG000|Overall Study|Lost to Follow-up|1|||
163119454|NCT04384107|589144819|FG001|Overall Study|Lost to Follow-up|0|||
163119455|NCT01048866|589144824|FG000|Overall Study|Adverse Event|1|||
163119456|NCT01048866|589144825|FG001|Overall Study|Adverse Event|0|||
163119457|NCT01048866|589144824|FG000|Overall Study|Protocol Violation|1|||
163119458|NCT01048866|589144825|FG001|Overall Study|Protocol Violation|0|||
163119459|NCT01048866|589144824|FG000|Overall Study|Physician Decision|1|||
163119460|NCT01048866|589144825|FG001|Overall Study|Physician Decision|0|||
163119461|NCT01048866|589144824|FG000|Overall Study|Withdrawal by Subject|0|||
163119462|NCT01048866|589144825|FG001|Overall Study|Withdrawal by Subject|2|||
163119463|NCT01048866|589144824|FG000|Overall Study|Lost to Follow-up|0|||
163119464|NCT01048866|589144825|FG001|Overall Study|Lost to Follow-up|2|||
163119465|NCT01048866|589144824|FG000|Overall Study|Other|1|||
163119466|NCT01048866|589144825|FG001|Overall Study|Other|1|||
163119467|NCT03582813|589144826|FG000|Overall Study|Lost to Follow-up|18|||
163119468|NCT03582813|589144827|FG001|Overall Study|Lost to Follow-up|21|||
163119469|NCT03582813|589144826|FG000|Overall Study|Withdrawal by Subject|1|||
163119470|NCT03582813|589144827|FG001|Overall Study|Withdrawal by Subject|0|||
163119471|NCT02525094|589144832|FG000|Overall Study|Lost to Follow-up|2|||
163119472|NCT02525094|589144833|FG001|Overall Study|Lost to Follow-up|1|||
163119473|NCT02525094|589144832|FG000|Overall Study|Withdrawal by Subject|5|||
163119474|NCT02525094|589144833|FG001|Overall Study|Withdrawal by Subject|6|||
163119475|NCT02525094|589144832|FG000|Overall Study|Not Treated|1|||
163119476|NCT02525094|589144833|FG001|Overall Study|Not Treated|1|||
163119477|NCT01591863|589144834|FG000|Overall Study|Adverse Event|3|||
163119478|NCT01591863|589144834|FG000|Overall Study|Withdrawal by Subject|1|||
163119479|NCT01591863|589144834|FG000|Overall Study|recurrence|9|||
163119480|NCT01591863|589144834|FG000|Overall Study|Lack of Efficacy|1|||
163119481|NCT01751776|589144837|FG000|Overall Study|Adverse Event|0|||
163119482|NCT01751776|589144838|FG001|Overall Study|Adverse Event|0|||
163119483|NCT01751776|589144839|FG002|Overall Study|Adverse Event|0|||
163119484|NCT01751776|589144840|FG003|Overall Study|Adverse Event|0|||
163119485|NCT01751776|589144841|FG004|Overall Study|Adverse Event|0|||
163119486|NCT01751776|589144842|FG005|Overall Study|Adverse Event|0|||
163119487|NCT01751776|589144843|FG006|Overall Study|Adverse Event|4|||
163119488|NCT01751776|589144844|FG007|Overall Study|Adverse Event|2|||
163119489|NCT01751776|589144837|FG000|Overall Study|Consent withdrawn|0|||
163119490|NCT01751776|589144838|FG001|Overall Study|Consent withdrawn|0|||
163119491|NCT01751776|589144839|FG002|Overall Study|Consent withdrawn|0|||
163119492|NCT01751776|589144840|FG003|Overall Study|Consent withdrawn|0|||
163119493|NCT01751776|589144841|FG004|Overall Study|Consent withdrawn|0|||
163119494|NCT01751776|589144842|FG005|Overall Study|Consent withdrawn|0|||
163119495|NCT01751776|589144843|FG006|Overall Study|Consent withdrawn|0|||
163119496|NCT01751776|589144844|FG007|Overall Study|Consent withdrawn|1|||
163119497|NCT01751776|589144837|FG000|Overall Study|Other reason not specified above|0|||
163119498|NCT01751776|589144838|FG001|Overall Study|Other reason not specified above|0|||
163119499|NCT01751776|589144839|FG002|Overall Study|Other reason not specified above|0|||
163119500|NCT01751776|589144840|FG003|Overall Study|Other reason not specified above|0|||
163119501|NCT01751776|589144841|FG004|Overall Study|Other reason not specified above|0|||
163119502|NCT01751776|589144842|FG005|Overall Study|Other reason not specified above|0|||
163119503|NCT01751776|589144843|FG006|Overall Study|Other reason not specified above|0|||
163119504|NCT01751776|589144844|FG007|Overall Study|Other reason not specified above|1|||
163119505|NCT00160654|589144845|FG000|Overall Study|Adverse Event|14|||
163119506|NCT00160654|589144845|FG000|Overall Study|Lack of Efficacy|4|||
163119507|NCT00160654|589144845|FG000|Overall Study|Lost to Follow-up|2|||
163119508|NCT00160654|589144845|FG000|Overall Study|Intake of expired drug|7|||
163119509|NCT00160654|589144845|FG000|Overall Study|Psychological trauma|1|||
163119510|NCT00160654|589144845|FG000|Overall Study|Sponsor decision|1|||
163119511|NCT00160654|589144845|FG000|Overall Study|Patient met exclusion criteria|1|||
163119512|NCT00160654|589144845|FG000|Overall Study|Patient decision|1|||
163119513|NCT00160654|589144845|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
163119514|NCT00160654|589144845|FG000|Overall Study|Met exclusion criteria|1|||
163119515|NCT00831701|589144846|FG000|Overall Study|Withdrawal by Subject|2|||
163119516|NCT00831701|589144847|FG001|Overall Study|Withdrawal by Subject|0|||
163119517|NCT00831701|589144846|FG000|Overall Study|Stone expulsion before first medication|2|||
163119518|NCT00831701|589144847|FG001|Overall Study|Stone expulsion before first medication|2|||
163119519|NCT00831701|589144846|FG000|Overall Study|Lost to Follow-up|1|||
163119520|NCT00831701|589144847|FG001|Overall Study|Lost to Follow-up|3|||
163119521|NCT02366767|589144848|FG000|Overall Study|left for home after 1 day at camp|1|||
163119522|NCT02366767|589144849|FG001|Overall Study|left for home after 1 day at camp|0|||
163119523|NCT00664326|589146375|FG000|Overall Study|Adverse Event|14|||
163119524|NCT00664326|589146375|FG000|Overall Study|Noncompliance with study medication|3|||
163119525|NCT00664326|589146375|FG000|Overall Study|Withdrawal by Subject|1|||
163119526|NCT00664326|589146375|FG000|Overall Study|Physician Decision|1|||
163119527|NCT00664326|589146375|FG000|Overall Study|Other Reasons|3|||
163119528|NCT00664326|589146375|FG000|Overall Study|Death|2|||
163119529|NCT00664326|589146375|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
163119530|NCT01161537|589146377|FG000|Part B|Withdrawal by Subject|2|||
163119531|NCT00004445|589146378|FG000|Overall Study|Physician Decision|2|||
163119532|NCT00004445|589146378|FG000|Overall Study|Withdrawal by Subject|1|||
163119533|NCT00076336|589146379|FG000|Overall Study|Death|13|||
163224369|NCT02641379|589537837|FG009|Overall Study|Participant showed weight reduction|0|||
163119534|NCT00076336|589146380|FG001|Overall Study|Death|17|||
163119535|NCT00076336|589146379|FG000|Overall Study|Adverse Event|4|||
163119536|NCT00076336|589146380|FG001|Overall Study|Adverse Event|4|||
163119537|NCT00076336|589146379|FG000|Overall Study|Lost to Follow-up|4|||
163119538|NCT00076336|589146380|FG001|Overall Study|Lost to Follow-up|4|||
163119539|NCT00076336|589146379|FG000|Overall Study|Non-Compliance|2|||
163119540|NCT00076336|589146380|FG001|Overall Study|Non-Compliance|0|||
163119541|NCT00076336|589146379|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
163119542|NCT00076336|589146380|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
163119543|NCT00076336|589146379|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
163119544|NCT00076336|589146380|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
163119545|NCT00076336|589146379|FG000|Overall Study|Liver Transplantation|3|||
163119546|NCT00076336|589146380|FG001|Overall Study|Liver Transplantation|3|||
163119547|NCT00076336|589146379|FG000|Overall Study|Virologic Breakthrough|14|||
163119548|NCT00076336|589146380|FG001|Overall Study|Virologic Breakthrough|16|||
163119549|NCT00076336|589146379|FG000|Overall Study|Treatment failure|4|||
163119550|NCT00076336|589146380|FG001|Overall Study|Treatment failure|5|||
163119551|NCT01519674|589146382|FG000|Overall Study|Adverse Event|3|||
163119552|NCT01519674|589146383|FG001|Overall Study|Adverse Event|3|||
163119553|NCT01519674|589146384|FG002|Overall Study|Adverse Event|0|||
163119554|NCT01519674|589146382|FG000|Overall Study|Lack of Efficacy|1|||
163119555|NCT01519674|589146383|FG001|Overall Study|Lack of Efficacy|1|||
163119556|NCT01519674|589146384|FG002|Overall Study|Lack of Efficacy|1|||
163119557|NCT01519674|589146382|FG000|Overall Study|Protocol Violation|0|||
163119558|NCT01519674|589146383|FG001|Overall Study|Protocol Violation|3|||
163119559|NCT01519674|589146384|FG002|Overall Study|Protocol Violation|1|||
163119560|NCT01519674|589146382|FG000|Overall Study|Withdrawal Criteria|7|||
163119561|NCT01519674|589146383|FG001|Overall Study|Withdrawal Criteria|2|||
163119562|NCT01519674|589146384|FG002|Overall Study|Withdrawal Criteria|7|||
163119563|NCT01519674|589146382|FG000|Overall Study|Unsclassified|10|||
163119564|NCT01519674|589146383|FG001|Overall Study|Unsclassified|4|||
163119565|NCT01519674|589146384|FG002|Overall Study|Unsclassified|3|||
163119566|NCT02046174|589146388|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
163119567|NCT02046174|589146389|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
163119568|NCT00186537|589146391|FG000|Overall Study|Withdrawal by Subject|4|||
163119569|NCT00186537|589146392|FG001|Overall Study|Withdrawal by Subject|0|||
163119570|NCT00186537|589146393|FG002|Overall Study|Withdrawal by Subject|3|||
163119571|NCT00186537|589146391|FG000|Overall Study|ALT > 1.5 x ULN|3|||
163119572|NCT00186537|589146392|FG001|Overall Study|ALT > 1.5 x ULN|0|||
163119573|NCT00186537|589146393|FG002|Overall Study|ALT > 1.5 x ULN|0|||
163119574|NCT01146288|589146397|FG000|First Intervention(1 Day)|Adverse Event|0|||
163119575|NCT01146288|589146398|FG001|First Intervention(1 Day)|Adverse Event|1|||
163119576|NCT03630302|589146399|FG000|Surgery|hardware issue prevented LFP recordings|1|||
163119577|NCT03630302|589146399|FG000|3 Month Visit|Adverse Event|2|||
163119578|NCT03630302|589146399|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
163119579|NCT01135914|589146400|FG000|Overall Study|Withdrawal by Subject|1|||
163119580|NCT01135914|589146401|FG001|Overall Study|Withdrawal by Subject|3|||
163119581|NCT01135914|589146402|FG002|Overall Study|Withdrawal by Subject|6|||
163119582|NCT01135914|589146400|FG000|Overall Study|Lost to Follow-up|1|||
163119583|NCT01135914|589146401|FG001|Overall Study|Lost to Follow-up|0|||
163119584|NCT01135914|589146402|FG002|Overall Study|Lost to Follow-up|1|||
163119585|NCT01135914|589146400|FG000|Overall Study|Protocol Violation|0|||
163119586|NCT01135914|589146401|FG001|Overall Study|Protocol Violation|0|||
163119587|NCT01135914|589146402|FG002|Overall Study|Protocol Violation|3|||
163119588|NCT01135914|589146400|FG000|Overall Study|Lack of Efficacy|2|||
163119589|NCT01135914|589146401|FG001|Overall Study|Lack of Efficacy|1|||
163119590|NCT01135914|589146402|FG002|Overall Study|Lack of Efficacy|10|||
163119591|NCT01135914|589146400|FG000|Overall Study|Adverse Event|0|||
163119592|NCT01135914|589146401|FG001|Overall Study|Adverse Event|1|||
163119593|NCT01135914|589146402|FG002|Overall Study|Adverse Event|2|||
163119594|NCT00931801|589146405|FG000|Overall Study|Adverse Event|0|||
163119595|NCT00931801|589146406|FG001|Overall Study|Adverse Event|0|||
163119596|NCT00931801|589146407|FG002|Overall Study|Adverse Event|1|||
163119597|NCT00931801|589146405|FG000|Overall Study|Lost to Follow-up|0|||
163119598|NCT00931801|589146406|FG001|Overall Study|Lost to Follow-up|1|||
163119599|NCT00931801|589146407|FG002|Overall Study|Lost to Follow-up|0|||
163119600|NCT00931801|589146405|FG000|Overall Study|Withdrawal by Subject|1|||
163224370|NCT02641379|589537838|FG010|Overall Study|Participant showed weight reduction|0|||
163224371|NCT02641379|589537828|FG000|Overall Study|Non-response Week 12|0|||
163224372|NCT02641379|589537829|FG001|Overall Study|Non-response Week 12|0|||
163224373|NCT02641379|589537830|FG002|Overall Study|Non-response Week 12|0|||
163119601|NCT00931801|589146406|FG001|Overall Study|Withdrawal by Subject|0|||
163119602|NCT00931801|589146407|FG002|Overall Study|Withdrawal by Subject|0|||
163119603|NCT00931801|589146405|FG000|Overall Study|Confirmed Virologic Failure|0|||
163119604|NCT00931801|589146406|FG001|Overall Study|Confirmed Virologic Failure|0|||
163119605|NCT00931801|589146407|FG002|Overall Study|Confirmed Virologic Failure|3|||
163119606|NCT00746733|589146408|FG000|Second Intervention|Adverse Event|1|||
163119607|NCT00746733|589146409|FG001|Second Intervention|Adverse Event|0|||
163119608|NCT00746733|589146408|FG000|Third Intervention|Withdrawal by Subject|1|||
163119609|NCT00746733|589146409|FG001|Third Intervention|Withdrawal by Subject|1|||
163119610|NCT00610441|589146410|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
163224374|NCT02641379|589537831|FG003|Overall Study|Non-response Week 12|0|||
163119611|NCT00610441|589146411|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
163119612|NCT00610441|589146412|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
163119613|NCT00610441|589146413|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
163119614|NCT00610441|589146410|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
163119615|NCT00610441|589146411|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
163119616|NCT00610441|589146412|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
163119617|NCT00610441|589146413|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
163119618|NCT00610441|589146410|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
163119619|NCT00610441|589146411|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
163119620|NCT00610441|589146412|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
163119621|NCT00610441|589146413|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
163119622|NCT00610441|589146410|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
163119623|NCT00610441|589146411|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
163119624|NCT00610441|589146412|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
163119625|NCT00610441|589146413|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
163119626|NCT00610441|589146410|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
163119627|NCT00610441|589146411|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
163119628|NCT00610441|589146412|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
163119629|NCT00610441|589146413|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
163119630|NCT00610441|589146410|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
163119631|NCT00610441|589146411|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
163119632|NCT00610441|589146412|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
163119633|NCT00610441|589146413|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
163119634|NCT00610441|589146410|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
163119635|NCT00610441|589146411|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
163119636|NCT00610441|589146412|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
163119637|NCT00610441|589146413|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
163119638|NCT00610441|589146410|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
163119639|NCT00610441|589146411|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
163119640|NCT00610441|589146412|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
163119641|NCT00610441|589146413|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
163119642|NCT00610441|589146410|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
163119643|NCT00610441|589146411|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
163119644|NCT00610441|589146412|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
163119645|NCT00610441|589146413|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
163119646|NCT00334282|589146414|FG000|Overall Study|Lost to Follow-up|11|||
163119647|NCT00334282|589146415|FG001|Overall Study|Lost to Follow-up|5|||
163119648|NCT00334282|589146414|FG000|Overall Study|Withdrawal by Subject|17|||
163119649|NCT00334282|589146415|FG001|Overall Study|Withdrawal by Subject|3|||
163119650|NCT00334282|589146414|FG000|Overall Study|Death|194|||
163119651|NCT00334282|589146415|FG001|Overall Study|Death|100|||
163119652|NCT00837876|589146420|FG000|Overall Study|Death|2|||
163119653|NCT00837876|589146420|FG000|Overall Study|Adverse Event|7|||
163119654|NCT00837876|589146420|FG000|Overall Study|Physician Decision|1|||
163119655|NCT00837876|589146420|FG000|Overall Study|Withdrawal by Subject|3|||
163119656|NCT00837876|589146420|FG000|Overall Study|disease progression|24|||
163119657|NCT00276094|589146422|FG000|Overall Study|Adverse Event|15|||
163119658|NCT00276094|589146423|FG001|Overall Study|Adverse Event|13|||
163119659|NCT00276094|589146424|FG002|Overall Study|Adverse Event|11|||
163119660|NCT00276094|589146422|FG000|Overall Study|Withdrawal by Subject|14|||
163119661|NCT00276094|589146423|FG001|Overall Study|Withdrawal by Subject|14|||
163119662|NCT00276094|589146424|FG002|Overall Study|Withdrawal by Subject|12|||
163119663|NCT00276094|589146422|FG000|Overall Study|Protocol Violation|16|||
163119664|NCT00276094|589146423|FG001|Overall Study|Protocol Violation|7|||
163119665|NCT00276094|589146424|FG002|Overall Study|Protocol Violation|10|||
163119666|NCT00276094|589146422|FG000|Overall Study|Lost to Follow-up|8|||
163119667|NCT00276094|589146423|FG001|Overall Study|Lost to Follow-up|6|||
163119668|NCT00276094|589146424|FG002|Overall Study|Lost to Follow-up|4|||
163119669|NCT00276094|589146422|FG000|Overall Study|Other-Subject moved out of country|1|||
163119670|NCT00276094|589146423|FG001|Overall Study|Other-Subject moved out of country|0|||
163119671|NCT00276094|589146424|FG002|Overall Study|Other-Subject moved out of country|0|||
163119672|NCT00276094|589146422|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
163119673|NCT00276094|589146423|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
163119674|NCT00276094|589146424|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
163119675|NCT00276094|589146422|FG000|Overall Study|Other-Lack of efficacy|1|||
163119676|NCT00276094|589146423|FG001|Overall Study|Other-Lack of efficacy|0|||
163119677|NCT00276094|589146424|FG002|Overall Study|Other-Lack of efficacy|0|||
163119678|NCT00276094|589146422|FG000|Overall Study|Other-Refused follow-up visit|1|||
163119679|NCT00276094|589146423|FG001|Overall Study|Other-Refused follow-up visit|0|||
163119680|NCT00276094|589146424|FG002|Overall Study|Other-Refused follow-up visit|0|||
163119681|NCT00276094|589146422|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
163119682|NCT00276094|589146423|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
163119683|NCT00276094|589146424|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
163224375|NCT02641379|589537832|FG004|Overall Study|Non-response Week 12|0|||
163224376|NCT02641379|589537833|FG005|Overall Study|Non-response Week 12|0|||
163224377|NCT02641379|589537834|FG006|Overall Study|Non-response Week 12|0|||
163224378|NCT02641379|589537835|FG007|Overall Study|Non-response Week 12|1|||
163224379|NCT02641379|589537836|FG008|Overall Study|Non-response Week 12|0|||
163224380|NCT02641379|589537837|FG009|Overall Study|Non-response Week 12|0|||
163224381|NCT02641379|589537838|FG010|Overall Study|Non-response Week 12|0|||
163224382|NCT02641379|589537828|FG000|Overall Study|No 2 Log drop at Week 12|0|||
163224383|NCT02641379|589537829|FG001|Overall Study|No 2 Log drop at Week 12|0|||
163224384|NCT02641379|589537830|FG002|Overall Study|No 2 Log drop at Week 12|0|||
163224385|NCT02641379|589537831|FG003|Overall Study|No 2 Log drop at Week 12|0|||
163224386|NCT02641379|589537832|FG004|Overall Study|No 2 Log drop at Week 12|0|||
163224387|NCT02641379|589537833|FG005|Overall Study|No 2 Log drop at Week 12|0|||
163224388|NCT02641379|589537834|FG006|Overall Study|No 2 Log drop at Week 12|0|||
163224389|NCT02641379|589537835|FG007|Overall Study|No 2 Log drop at Week 12|0|||
163224390|NCT02641379|589537836|FG008|Overall Study|No 2 Log drop at Week 12|0|||
163224391|NCT02641379|589537837|FG009|Overall Study|No 2 Log drop at Week 12|0|||
163224392|NCT02641379|589537838|FG010|Overall Study|No 2 Log drop at Week 12|1|||
163224393|NCT02641379|589537828|FG000|Overall Study|Negative PCR result|0|||
163224394|NCT02641379|589537829|FG001|Overall Study|Negative PCR result|0|||
163224395|NCT02641379|589537830|FG002|Overall Study|Negative PCR result|0|||
163224396|NCT02641379|589537831|FG003|Overall Study|Negative PCR result|0|||
163224397|NCT02641379|589537832|FG004|Overall Study|Negative PCR result|0|||
163224398|NCT02641379|589537833|FG005|Overall Study|Negative PCR result|0|||
163224399|NCT02641379|589537834|FG006|Overall Study|Negative PCR result|0|||
163224400|NCT02641379|589537835|FG007|Overall Study|Negative PCR result|0|||
163224401|NCT02641379|589537836|FG008|Overall Study|Negative PCR result|0|||
163224402|NCT02641379|589537837|FG009|Overall Study|Negative PCR result|1|||
163224403|NCT02641379|589537838|FG010|Overall Study|Negative PCR result|0|||
163224404|NCT02641379|589537828|FG000|Overall Study|Participant's PCR high|0|||
163224405|NCT02641379|589537829|FG001|Overall Study|Participant's PCR high|0|||
163224406|NCT02641379|589537830|FG002|Overall Study|Participant's PCR high|0|||
163224407|NCT02641379|589537831|FG003|Overall Study|Participant's PCR high|0|||
163224408|NCT02641379|589537832|FG004|Overall Study|Participant's PCR high|0|||
163224409|NCT02641379|589537833|FG005|Overall Study|Participant's PCR high|0|||
163224410|NCT02641379|589537834|FG006|Overall Study|Participant's PCR high|0|||
163224411|NCT02641379|589537835|FG007|Overall Study|Participant's PCR high|1|||
163224412|NCT02641379|589537836|FG008|Overall Study|Participant's PCR high|0|||
163224413|NCT02641379|589537837|FG009|Overall Study|Participant's PCR high|0|||
163224414|NCT02641379|589537838|FG010|Overall Study|Participant's PCR high|0|||
163224415|NCT02641379|589537828|FG000|Overall Study|Participant treated after Week 24|0|||
163224416|NCT02641379|589537829|FG001|Overall Study|Participant treated after Week 24|0|||
163224417|NCT02641379|589537830|FG002|Overall Study|Participant treated after Week 24|0|||
163224418|NCT02641379|589537831|FG003|Overall Study|Participant treated after Week 24|0|||
163224419|NCT02641379|589537832|FG004|Overall Study|Participant treated after Week 24|0|||
163224420|NCT02641379|589537833|FG005|Overall Study|Participant treated after Week 24|0|||
163224421|NCT02641379|589537834|FG006|Overall Study|Participant treated after Week 24|0|||
163224422|NCT02641379|589537835|FG007|Overall Study|Participant treated after Week 24|0|||
163224423|NCT02641379|589537836|FG008|Overall Study|Participant treated after Week 24|1|||
163224424|NCT02641379|589537837|FG009|Overall Study|Participant treated after Week 24|0|||
163224425|NCT02641379|589537838|FG010|Overall Study|Participant treated after Week 24|0|||
163224426|NCT02641379|589537828|FG000|Overall Study|Missing PCR result at Week 8|0|||
163224427|NCT02641379|589537829|FG001|Overall Study|Missing PCR result at Week 8|0|||
163224428|NCT02641379|589537830|FG002|Overall Study|Missing PCR result at Week 8|0|||
163224429|NCT02641379|589537831|FG003|Overall Study|Missing PCR result at Week 8|0|||
163224430|NCT02641379|589537832|FG004|Overall Study|Missing PCR result at Week 8|0|||
163224431|NCT02641379|589537833|FG005|Overall Study|Missing PCR result at Week 8|0|||
163224432|NCT02641379|589537834|FG006|Overall Study|Missing PCR result at Week 8|0|||
163224433|NCT02641379|589537835|FG007|Overall Study|Missing PCR result at Week 8|0|||
163224434|NCT02641379|589537836|FG008|Overall Study|Missing PCR result at Week 8|0|||
163224435|NCT02641379|589537837|FG009|Overall Study|Missing PCR result at Week 8|1|||
163224436|NCT02641379|589537838|FG010|Overall Study|Missing PCR result at Week 8|0|||
163340735|NCT02147093|589954906|FG000|Period 2|Protocol Violation|2|||
163340736|NCT02147093|589954907|FG001|Period 2|Protocol Violation|0|||
163340737|NCT03246724|589954908|FG000|Overall Study|Withdrawal by Subject|5|||
163224437|NCT02641379|589537828|FG000|Overall Study|PCR positive|0|||
163224438|NCT02641379|589537829|FG001|Overall Study|PCR positive|0|||
163224439|NCT02641379|589537830|FG002|Overall Study|PCR positive|0|||
163224440|NCT02641379|589537831|FG003|Overall Study|PCR positive|0|||
163224441|NCT02641379|589537832|FG004|Overall Study|PCR positive|0|||
163224442|NCT02641379|589537833|FG005|Overall Study|PCR positive|0|||
163224443|NCT02641379|589537834|FG006|Overall Study|PCR positive|1|||
163224444|NCT02641379|589537835|FG007|Overall Study|PCR positive|0|||
163224445|NCT02641379|589537836|FG008|Overall Study|PCR positive|0|||
163224446|NCT02641379|589537837|FG009|Overall Study|PCR positive|0|||
163224447|NCT02641379|589537838|FG010|Overall Study|PCR positive|0|||
163224448|NCT01165138|589537839|FG000|Overall Study|Adverse Event|0|||
163224449|NCT01165138|589537840|FG001|Overall Study|Adverse Event|1|||
163224450|NCT01165138|589537841|FG002|Overall Study|Adverse Event|0|||
163224451|NCT01165138|589537842|FG003|Overall Study|Adverse Event|2|||
163224452|NCT01165138|589537839|FG000|Overall Study|Lack of Efficacy|0|||
163224453|NCT01165138|589537840|FG001|Overall Study|Lack of Efficacy|32|||
163224454|NCT01165138|589537841|FG002|Overall Study|Lack of Efficacy|6|||
163224455|NCT01165138|589537842|FG003|Overall Study|Lack of Efficacy|7|||
163224456|NCT01165138|589537839|FG000|Overall Study|Protocol Violation|0|||
163408055|NCT01903837|590204020|FG002|Part A|Adverse Event|9|||
163408056|NCT01903837|590204021|FG003|Part A|Adverse Event|6|||
163408057|NCT01903837|590204018|FG000|Part A|Lost to Follow-up|9|||
163119684|NCT00276094|589146422|FG000|Overall Study|Other-Relocation|0|||
163119685|NCT00276094|589146423|FG001|Overall Study|Other-Relocation|1|||
163119686|NCT00276094|589146424|FG002|Overall Study|Other-Relocation|0|||
163119687|NCT00276094|589146422|FG000|Overall Study|Other-Study medication lost|0|||
163224457|NCT01165138|589537840|FG001|Overall Study|Protocol Violation|7|||
163224458|NCT01165138|589537841|FG002|Overall Study|Protocol Violation|0|||
163224459|NCT01165138|589537842|FG003|Overall Study|Protocol Violation|2|||
163224460|NCT01165138|589537839|FG000|Overall Study|Lost to Follow-up|0|||
163224461|NCT01165138|589537840|FG001|Overall Study|Lost to Follow-up|0|||
163224462|NCT01165138|589537841|FG002|Overall Study|Lost to Follow-up|1|||
163224463|NCT01165138|589537842|FG003|Overall Study|Lost to Follow-up|2|||
163224464|NCT01165138|589537839|FG000|Overall Study|Physician Decision|0|||
163224465|NCT01165138|589537840|FG001|Overall Study|Physician Decision|6|||
163119688|NCT00276094|589146423|FG001|Overall Study|Other-Study medication lost|0|||
163119689|NCT00276094|589146424|FG002|Overall Study|Other-Study medication lost|1|||
163119690|NCT00787137|589146425|FG000|Overall Study|Study Termination|0|||
163119691|NCT00787137|589146426|FG001|Overall Study|Study Termination|0|||
163119692|NCT00787137|589146427|FG002|Overall Study|Study Termination|1|||
163119693|NCT02075632|589146431|FG000|Overall Study|Adverse Event|1|||
163119694|NCT02075632|589146432|FG001|Overall Study|Adverse Event|1|||
163119695|NCT02075632|589146431|FG000|Overall Study|Lost to Follow-up|0|||
163119696|NCT02075632|589146432|FG001|Overall Study|Lost to Follow-up|3|||
163119697|NCT02075632|589146431|FG000|Overall Study|Withdrawal by Subject|0|||
163119698|NCT02075632|589146432|FG001|Overall Study|Withdrawal by Subject|1|||
163119699|NCT03464422|589146433|FG000|Overall Study|Lost to Follow-up|2|||
163119700|NCT03464422|589146433|FG000|Overall Study|Withdrawal by Subject|2|||
163119701|NCT01628367|589146437|FG000|Overall Study|Adverse Event|1|||
163119702|NCT01628367|589146438|FG001|Overall Study|Adverse Event|0|||
163119703|NCT00740714|589146439|FG000|Overall Study|Withdrawal by Subject|17|||
163119704|NCT00740714|589146440|FG001|Overall Study|Withdrawal by Subject|19|||
163119705|NCT00740714|589146441|FG002|Overall Study|Withdrawal by Subject|29|||
163119706|NCT01352741|589146452|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
163119707|NCT01352741|589146453|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
163119708|NCT01352741|589146452|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
163119709|NCT01352741|589146453|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
163119710|NCT01352741|589146452|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
163119711|NCT01352741|589146453|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
163119712|NCT01352741|589146452|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
163119713|NCT01352741|589146453|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
163119714|NCT01352741|589146452|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
163119715|NCT01352741|589146453|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
163119716|NCT01352741|589146452|FG000|Open-label Tapentadol Titration Period|Other|4|||
163119717|NCT01352741|589146453|FG001|Open-label Tapentadol Titration Period|Other|0|||
163119718|NCT01352741|589146452|FG000|Double-blind Comparative Period|Protocol Violation|2|||
163224466|NCT01165138|589537841|FG002|Overall Study|Physician Decision|7|||
163224467|NCT01165138|589537842|FG003|Overall Study|Physician Decision|6|||
163224468|NCT01165138|589537839|FG000|Overall Study|Withdrawal by Subject|0|||
163224469|NCT01165138|589537840|FG001|Overall Study|Withdrawal by Subject|6|||
163224470|NCT01165138|589537841|FG002|Overall Study|Withdrawal by Subject|6|||
163224471|NCT01165138|589537842|FG003|Overall Study|Withdrawal by Subject|3|||
163224472|NCT01644175|589537845|FG000|Overall Study|Randomized But Not Treated|0|||
163224473|NCT01644175|589537846|FG001|Overall Study|Randomized But Not Treated|2|||
163224474|NCT01644175|589537845|FG000|Overall Study|Adverse Event|8|||
163224475|NCT01644175|589537846|FG001|Overall Study|Adverse Event|13|||
163224476|NCT01644175|589537845|FG000|Overall Study|Death|1|||
163224477|NCT01644175|589537846|FG001|Overall Study|Death|2|||
163224478|NCT01644175|589537845|FG000|Overall Study|Poor compliance to protocol|9|||
163119719|NCT01352741|589146453|FG001|Double-blind Comparative Period|Protocol Violation|0|||
163119720|NCT01352741|589146452|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
163119721|NCT01352741|589146453|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
163224479|NCT01644175|589537846|FG001|Overall Study|Poor compliance to protocol|10|||
163224480|NCT01644175|589537845|FG000|Overall Study|Physician Decision|1|||
163224481|NCT01644175|589537846|FG001|Overall Study|Physician Decision|2|||
163224482|NCT01644175|589537845|FG000|Overall Study|Participant Moved|1|||
163224483|NCT01644175|589537846|FG001|Overall Study|Participant Moved|2|||
163224484|NCT01644175|589537845|FG000|Overall Study|Consent withdrawn by participant|3|||
163119722|NCT01352741|589146452|FG000|Double-blind Comparative Period|Adverse Event|16|||
163224485|NCT01644175|589537846|FG001|Overall Study|Consent withdrawn by participant|4|||
163224486|NCT01644175|589537845|FG000|Overall Study|Related to Autoinjector Administration|2|||
163224487|NCT01644175|589537846|FG001|Overall Study|Related to Autoinjector Administration|1|||
163224488|NCT01644175|589537845|FG000|Overall Study|Last visit outside protocol visit window|4|||
163224489|NCT01644175|589537846|FG001|Overall Study|Last visit outside protocol visit window|11|||
163224490|NCT01644175|589537845|FG000|Overall Study|Selection criteria finally not met|0|||
163224491|NCT01644175|589537846|FG001|Overall Study|Selection criteria finally not met|1|||
163224492|NCT01644175|589537845|FG000|Overall Study|Site closure|2|||
163224493|NCT01644175|589537846|FG001|Overall Study|Site closure|2|||
163224494|NCT01644175|589537845|FG000|Overall Study|Lost to Follow-up|1|||
163224495|NCT01644175|589537846|FG001|Overall Study|Lost to Follow-up|0|||
163224496|NCT01644175|589537845|FG000|Overall Study|Other than specified above|0|||
163224497|NCT01644175|589537846|FG001|Overall Study|Other than specified above|3|||
163224498|NCT01398956|589537850|FG000|Overall Study|Withdrawal by Subject|4|||
163224499|NCT01398956|589537850|FG000|Overall Study|AE, non-serious non-fatal|4|||
163224500|NCT01398956|589537850|FG000|Overall Study|Withdrawal Criteria No.3|1|||
163119723|NCT01352741|589146453|FG001|Double-blind Comparative Period|Adverse Event|17|||
163119724|NCT01352741|589146452|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
163119725|NCT01352741|589146453|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
163119726|NCT01352741|589146452|FG000|Double-blind Comparative Period|Death|0|||
163119727|NCT01352741|589146453|FG001|Double-blind Comparative Period|Death|1|||
163119728|NCT01352741|589146452|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
163119729|NCT01352741|589146453|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
163119730|NCT01352741|589146452|FG000|Double-blind Comparative Period|Other|1|||
163119731|NCT01352741|589146453|FG001|Double-blind Comparative Period|Other|2|||
163119732|NCT01352741|589146452|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
163119733|NCT01352741|589146453|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
163119734|NCT01352741|589146452|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
163119735|NCT01352741|589146453|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
163119736|NCT01352741|589146452|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
163119737|NCT01352741|589146453|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
163119738|NCT01352741|589146452|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
163119739|NCT01352741|589146453|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
163119740|NCT04070326|589146455|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
163119741|NCT04070326|589146456|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
163119742|NCT00645528|589146457|FG000|Overall Study|Did not show up for Visit 2|7|||
163119743|NCT01367704|589146460|FG000|Overall Study|Lost to Follow-up|47|||
163119744|NCT01367704|589146461|FG001|Overall Study|Lost to Follow-up|161|||
163119745|NCT03461406|589146463|FG000|Overall Study|Death|1|||
163119746|NCT03461406|589146464|FG001|Overall Study|Death|2|||
163119747|NCT03461406|589146463|FG000|Overall Study|Consent Withdrawn by Participant|0|||
163119748|NCT03461406|589146464|FG001|Overall Study|Consent Withdrawn by Participant|1|||
163119749|NCT03461406|589146463|FG000|Overall Study|Screen Failure|3|||
163119750|NCT03461406|589146464|FG001|Overall Study|Screen Failure|1|||
163119751|NCT03461406|589146463|FG000|Overall Study|Reason not Specified|1|||
163119752|NCT03461406|589146464|FG001|Overall Study|Reason not Specified|3|||
163224501|NCT01398956|589537850|FG000|Overall Study|Subject moved a long distance|1|||
163224502|NCT00856908|589537854|FG000|Overall Study|Lost to Follow-up|1|||
163224503|NCT00856908|589537855|FG001|Overall Study|Lost to Follow-up|0|||
163224504|NCT01063595|589537856|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
163224505|NCT01063595|589537857|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
163224506|NCT01063595|589537856|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
163224507|NCT01063595|589537857|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
163224508|NCT01063595|589537856|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
163224509|NCT01063595|589537857|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
163224510|NCT01063595|589537856|FG000|First Intervention|Adverse Event|1|||
163224511|NCT01063595|589537857|FG001|First Intervention|Adverse Event|4|||
163224512|NCT01063595|589537856|FG000|First Intervention|Withdrawal by Subject|1|||
163224513|NCT01063595|589537857|FG001|First Intervention|Withdrawal by Subject|0|||
163119753|NCT03461406|589146463|FG000|Overall Study|Lost to Follow-up|3|||
163119754|NCT03461406|589146464|FG001|Overall Study|Lost to Follow-up|0|||
163119755|NCT01886690|589146465|FG000|Overall Study|Protocol Violation|0|||
163119756|NCT01886690|589146466|FG001|Overall Study|Protocol Violation|1|||
163119757|NCT01886690|589146465|FG000|Overall Study|Personal Reasons|0|||
163119758|NCT01886690|589146466|FG001|Overall Study|Personal Reasons|1|||
163119759|NCT03077698|589146467|FG000|Progestin Monotherapy|Stable Disease|8|||
163224514|NCT01063595|589537856|FG000|First Intervention|Reason not Specified|0|||
163224515|NCT01063595|589537857|FG001|First Intervention|Reason not Specified|1|||
163224516|NCT01623596|589537861|FG000|Overall Study|Abnormal laboratory values|2|||
163119760|NCT03077698|589146468|FG001|Progestin Monotherapy|Stable Disease|0|||
163119761|NCT03077698|589146467|FG000|Progestin Monotherapy|Adverse Event|1|||
163119762|NCT03077698|589146468|FG001|Progestin Monotherapy|Adverse Event|0|||
163119763|NCT03077698|589146467|FG000|Progestin Monotherapy|Death|1|||
163119764|NCT03077698|589146468|FG001|Progestin Monotherapy|Death|0|||
163119765|NCT03077698|589146467|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
163119766|NCT03077698|589146468|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
163119767|NCT03077698|589146467|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
163119768|NCT03077698|589146468|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
163340738|NCT03246724|589954909|FG001|Overall Study|Withdrawal by Subject|2|||
163340739|NCT03246724|589954910|FG002|Overall Study|Withdrawal by Subject|4|||
163119769|NCT03077698|589146467|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
163119770|NCT03077698|589146468|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
163119771|NCT03077698|589146467|FG000|Safety Follow Up|Withdrawal by Subject|2|||
163119772|NCT03077698|589146468|FG001|Safety Follow Up|Withdrawal by Subject|1|||
163119773|NCT03077698|589146467|FG000|Safety Follow Up|Transfer of care to hospice|1|||
163119774|NCT03077698|589146468|FG001|Safety Follow Up|Transfer of care to hospice|0|||
163119775|NCT01439074|589146469|FG000|Overall Study|Lost to Follow-up|3|||
163119776|NCT01439074|589146470|FG001|Overall Study|Lost to Follow-up|4|||
163119777|NCT01439074|589146469|FG000|Overall Study|Subject shedding|1|||
163119778|NCT01439074|589146470|FG001|Overall Study|Subject shedding|0|||
163119779|NCT01439074|589146469|FG000|Overall Study|Withdrawal by Subject|1|||
163119780|NCT01439074|589146470|FG001|Overall Study|Withdrawal by Subject|5|||
163119781|NCT01439074|589146469|FG000|Overall Study|Other|4|||
163119782|NCT01439074|589146470|FG001|Overall Study|Other|4|||
163119783|NCT01140568|589146471|FG000|Overall Study|disease progression|31|||
163119784|NCT01140568|589146471|FG000|Overall Study|Withdrawal by Subject|1|||
163119785|NCT01140568|589146471|FG000|Overall Study|Screen Fail|4|||
163119786|NCT03618628|589146472|FG000|Overall Study|Death|1|||
163119787|NCT03618628|589146472|FG000|Overall Study|Lost to Follow-up|1|||
163119788|NCT01969500|589146473|FG000|Overall Study|Death|0|||
163119789|NCT01969500|589146474|FG001|Overall Study|Death|1|||
163119790|NCT01969500|589146473|FG000|Overall Study|extended hospitalization|1|||
163119791|NCT01969500|589146474|FG001|Overall Study|extended hospitalization|1|||
163119792|NCT02193087|589146475|FG000|Overall Study|Adverse Event|2|||
163119793|NCT02193087|589146476|FG001|Overall Study|Adverse Event|0|||
163119794|NCT02193087|589146477|FG002|Overall Study|Adverse Event|0|||
163119795|NCT02193087|589146478|FG003|Overall Study|Adverse Event|11|||
163119796|NCT02193087|589146475|FG000|Overall Study|Lost to Follow-up|14|||
163119797|NCT02193087|589146476|FG001|Overall Study|Lost to Follow-up|6|||
163119798|NCT02193087|589146477|FG002|Overall Study|Lost to Follow-up|4|||
163119799|NCT02193087|589146478|FG003|Overall Study|Lost to Follow-up|37|||
163119800|NCT02193087|589146475|FG000|Overall Study|Protocol Violation|2|||
163119801|NCT02193087|589146476|FG001|Overall Study|Protocol Violation|0|||
163119802|NCT02193087|589146477|FG002|Overall Study|Protocol Violation|1|||
163119803|NCT02193087|589146478|FG003|Overall Study|Protocol Violation|2|||
163119804|NCT02193087|589146475|FG000|Overall Study|Withdrawal by Subject|10|||
163119805|NCT02193087|589146476|FG001|Overall Study|Withdrawal by Subject|3|||
163119806|NCT02193087|589146477|FG002|Overall Study|Withdrawal by Subject|1|||
163119807|NCT02193087|589146478|FG003|Overall Study|Withdrawal by Subject|19|||
163119808|NCT02193087|589146475|FG000|Overall Study|Other Reason Not Specified|7|||
163119809|NCT02193087|589146476|FG001|Overall Study|Other Reason Not Specified|2|||
163119810|NCT02193087|589146477|FG002|Overall Study|Other Reason Not Specified|1|||
163119811|NCT02193087|589146478|FG003|Overall Study|Other Reason Not Specified|9|||
163119812|NCT02193087|589146475|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
163119813|NCT02193087|589146476|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
163119814|NCT02193087|589146477|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
163119815|NCT02193087|589146478|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
163119816|NCT04096820|589146479|FG000|Overall Study|Did not return for intervention|2|||
163119817|NCT04096820|589146479|FG000|Overall Study|Death|1|||
163119818|NCT02463032|589146480|FG000|Overall Study|Lack of Efficacy|61|||
163340740|NCT03246724|589954911|FG003|Overall Study|Withdrawal by Subject|2|||
163340741|NCT03246724|589954908|FG000|Overall Study|Ineligible on day of surgery|7|||
163340742|NCT03246724|589954909|FG001|Overall Study|Ineligible on day of surgery|2|||
163119819|NCT02463032|589146481|FG001|Overall Study|Lack of Efficacy|50|||
163119820|NCT02463032|589146480|FG000|Overall Study|Death|8|||
163119821|NCT02463032|589146481|FG001|Overall Study|Death|8|||
163119822|NCT02463032|589146480|FG000|Overall Study|Adverse Event|2|||
163119823|NCT02463032|589146481|FG001|Overall Study|Adverse Event|6|||
163119824|NCT00612508|589146482|FG000|Overall Study|Withdrawal by Subject|3|||
163119825|NCT00612508|589146483|FG001|Overall Study|Withdrawal by Subject|4|||
163119826|NCT02312219|589146484|FG000|Overall Study|Withdrawal by Subject|1|||
163119827|NCT02312219|589146485|FG001|Overall Study|Withdrawal by Subject|2|||
163119828|NCT02312219|589146484|FG000|Overall Study|could not schedule imaging in time|0|||
163119829|NCT02312219|589146485|FG001|Overall Study|could not schedule imaging in time|2|||
163119830|NCT02312219|589146484|FG000|Overall Study|Other|0|||
163408058|NCT01903837|590204019|FG001|Part A|Lost to Follow-up|7|||
163340743|NCT03246724|589954910|FG002|Overall Study|Ineligible on day of surgery|0|||
163340744|NCT03246724|589954911|FG003|Overall Study|Ineligible on day of surgery|3|||
163340745|NCT03246724|589954908|FG000|Overall Study|Study completed before surgical date|2|||
163340746|NCT03246724|589954909|FG001|Overall Study|Study completed before surgical date|1|||
163340747|NCT03246724|589954910|FG002|Overall Study|Study completed before surgical date|8|||
163119831|NCT02312219|589146485|FG001|Overall Study|Other|1|||
163119832|NCT02312219|589146484|FG000|Overall Study|Not randomized. Ineligible|0|||
163340748|NCT03246724|589954911|FG003|Overall Study|Study completed before surgical date|1|||
163340749|NCT03246724|589954908|FG000|Overall Study|Transferred to other arm|0|||
163119833|NCT02312219|589146485|FG001|Overall Study|Not randomized. Ineligible|1|||
163119834|NCT01100567|589146486|FG000|Overall Study|Withdrawal by Subject|5|||
163119835|NCT01100567|589146487|FG001|Overall Study|Withdrawal by Subject|8|||
163119836|NCT01100567|589146486|FG000|Overall Study|Early Hospital Discharge|6|||
163119837|NCT01100567|589146487|FG001|Overall Study|Early Hospital Discharge|4|||
163119838|NCT01100567|589146486|FG000|Overall Study|Lost to Follow-up|1|||
163119839|NCT01100567|589146487|FG001|Overall Study|Lost to Follow-up|2|||
163119840|NCT01100567|589146486|FG000|Overall Study|Physician Decision|0|||
163119841|NCT01100567|589146487|FG001|Overall Study|Physician Decision|1|||
163119842|NCT01100567|589146486|FG000|Overall Study|Deemed ineligible after consent|0|||
163119843|NCT01100567|589146487|FG001|Overall Study|Deemed ineligible after consent|1|||
163119844|NCT02741570|589146488|FG000|Pre-Treatment Period|Other reasons|0|||
163119845|NCT02741570|589146489|FG001|Pre-Treatment Period|Other reasons|3|||
163119846|NCT02741570|589146488|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
163119847|NCT02741570|589146489|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
163119848|NCT02741570|589146488|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
163119849|NCT02741570|589146489|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
163119850|NCT02741570|589146488|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
163119851|NCT02741570|589146489|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
163119852|NCT02741570|589146488|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
163119853|NCT02741570|589146489|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
163119854|NCT02741570|589146488|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
163119855|NCT02741570|589146489|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
163119856|NCT02741570|589146488|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
163119857|NCT02741570|589146489|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
163119858|NCT02741570|589146488|FG000|Pre-Treatment Period|Death|0|||
163119859|NCT02741570|589146489|FG001|Pre-Treatment Period|Death|1|||
163119860|NCT02741570|589146488|FG000|Pre-Treatment Period|Disease progression|0|||
163119861|NCT02741570|589146489|FG001|Pre-Treatment Period|Disease progression|1|||
163119862|NCT02741570|589146488|FG000|Treatment Period|Other reasons|47|||
163119863|NCT02741570|589146489|FG001|Treatment Period|Other reasons|12|||
163119864|NCT02741570|589146488|FG000|Treatment Period|Poor/non-compliance|0|||
163119865|NCT02741570|589146489|FG001|Treatment Period|Poor/non-compliance|2|||
163119866|NCT02741570|589146488|FG000|Treatment Period|Maximum clinical benefit|4|||
163119867|NCT02741570|589146489|FG001|Treatment Period|Maximum clinical benefit|6|||
163119868|NCT02741570|589146488|FG000|Treatment Period|Lost to Follow-up|1|||
163119869|NCT02741570|589146489|FG001|Treatment Period|Lost to Follow-up|3|||
163119870|NCT02741570|589146488|FG000|Treatment Period|Participant withdrew consent|9|||
163119871|NCT02741570|589146489|FG001|Treatment Period|Participant withdrew consent|13|||
163119872|NCT02741570|589146488|FG000|Treatment Period|Participant request to discontinue treatment|8|||
163119873|NCT02741570|589146489|FG001|Treatment Period|Participant request to discontinue treatment|23|||
163119874|NCT02741570|589146488|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
163119875|NCT02741570|589146489|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
163119876|NCT02741570|589146488|FG000|Treatment Period|Death|9|||
163119877|NCT02741570|589146489|FG001|Treatment Period|Death|7|||
163119878|NCT02741570|589146488|FG000|Treatment Period|Study drug toxicity|55|||
163119879|NCT02741570|589146489|FG001|Treatment Period|Study drug toxicity|47|||
163119880|NCT02741570|589146488|FG000|Treatment Period|Disease progression|294|||
163119881|NCT02741570|589146489|FG001|Treatment Period|Disease progression|301|||
163119882|NCT02741570|589146488|FG000|Treatment Period|Administrative reason by sponsor|0|||
163340750|NCT03246724|589954909|FG001|Overall Study|Transferred to other arm|0|||
163340751|NCT03246724|589954910|FG002|Overall Study|Transferred to other arm|1|||
163340752|NCT03246724|589954911|FG003|Overall Study|Transferred to other arm|0|||
163340753|NCT03246724|589954908|FG000|Overall Study|Unable to obtain medication timely|0|||
163340754|NCT03246724|589954909|FG001|Overall Study|Unable to obtain medication timely|2|||
163340755|NCT03246724|589954910|FG002|Overall Study|Unable to obtain medication timely|2|||
163340756|NCT03246724|589954911|FG003|Overall Study|Unable to obtain medication timely|1|||
163119883|NCT02741570|589146489|FG001|Treatment Period|Administrative reason by sponsor|1|||
163119884|NCT00946322|589146492|FG000|Pre-treatment|participant failure to follow up|1|||
163119885|NCT00946322|589146492|FG000|Post-treatment|participant failure to follow up|2|||
163119886|NCT01241760|589146494|FG000|Overall Study|Adverse Event|1|||
163224517|NCT01623596|589537862|FG001|Overall Study|Abnormal laboratory values|0|||
163340757|NCT03246724|589954908|FG000|Overall Study|Re-consented to participate|0|||
163408059|NCT01903837|590204020|FG002|Part A|Lost to Follow-up|7|||
163408060|NCT01903837|590204021|FG003|Part A|Lost to Follow-up|2|||
163119887|NCT01241760|589146495|FG001|Overall Study|Adverse Event|0|||
163119888|NCT01241760|589146494|FG000|Overall Study|Lost to Follow-up|18|||
163119889|NCT01241760|589146495|FG001|Overall Study|Lost to Follow-up|22|||
163119890|NCT01241760|589146494|FG000|Overall Study|Withdrawal by Subject|13|||
163119891|NCT01241760|589146495|FG001|Overall Study|Withdrawal by Subject|13|||
163119892|NCT01241760|589146494|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
163119893|NCT01241760|589146495|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
163119894|NCT01241760|589146494|FG000|Overall Study|Other|1|||
163119895|NCT01241760|589146495|FG001|Overall Study|Other|1|||
163119896|NCT01636713|589146497|FG000|Overall Study|Adverse Event|16|||
163119897|NCT01636713|589146498|FG001|Overall Study|Adverse Event|16|||
163119898|NCT01636713|589146499|FG002|Overall Study|Adverse Event|7|||
163119899|NCT01636713|589146497|FG000|Overall Study|Lack of Efficacy|6|||
163119900|NCT01636713|589146498|FG001|Overall Study|Lack of Efficacy|6|||
163119901|NCT01636713|589146499|FG002|Overall Study|Lack of Efficacy|2|||
163119902|NCT01636713|589146497|FG000|Overall Study|Protocol Violation|3|||
163119903|NCT01636713|589146498|FG001|Overall Study|Protocol Violation|0|||
163119904|NCT01636713|589146499|FG002|Overall Study|Protocol Violation|1|||
163119905|NCT01636713|589146497|FG000|Overall Study|Lost to Follow-up|0|||
163119906|NCT01636713|589146498|FG001|Overall Study|Lost to Follow-up|0|||
163119907|NCT01636713|589146499|FG002|Overall Study|Lost to Follow-up|1|||
163119908|NCT01636713|589146497|FG000|Overall Study|Withdrawal by Subject|5|||
163119909|NCT01636713|589146498|FG001|Overall Study|Withdrawal by Subject|4|||
163119910|NCT01636713|589146499|FG002|Overall Study|Withdrawal by Subject|8|||
163119911|NCT01636713|589146497|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
163119912|NCT01636713|589146498|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
163119913|NCT01636713|589146499|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
163224518|NCT01623596|589537861|FG000|Overall Study|Administrative problems|9|||
163224519|NCT01623596|589537862|FG001|Overall Study|Administrative problems|13|||
163224520|NCT01623596|589537861|FG000|Overall Study|Adverse Event|20|||
163224521|NCT01623596|589537862|FG001|Overall Study|Adverse Event|29|||
163224522|NCT01623596|589537861|FG000|Overall Study|Death|0|||
163224523|NCT01623596|589537862|FG001|Overall Study|Death|2|||
163224524|NCT01623596|589537861|FG000|Overall Study|Lost to Follow-up|12|||
163224525|NCT01623596|589537862|FG001|Overall Study|Lost to Follow-up|16|||
163224526|NCT01623596|589537861|FG000|Overall Study|Withdrawal by Subject|13|||
163224527|NCT01623596|589537862|FG001|Overall Study|Withdrawal by Subject|31|||
163224528|NCT01623596|589537861|FG000|Overall Study|Patient no longer requires study drug|1|||
163224529|NCT01623596|589537862|FG001|Overall Study|Patient no longer requires study drug|0|||
163224530|NCT01623596|589537861|FG000|Overall Study|Protocol Violation|0|||
163224531|NCT01623596|589537862|FG001|Overall Study|Protocol Violation|6|||
163224532|NCT01623596|589537861|FG000|Overall Study|Lack of Efficacy|5|||
163224533|NCT01623596|589537862|FG001|Overall Study|Lack of Efficacy|3|||
163224534|NCT04059146|589537863|FG000|Overall Study|Withdrawal by Subject|0|||
163224535|NCT04059146|589537864|FG001|Overall Study|Withdrawal by Subject|1|||
163224536|NCT00451035|589537865|FG000|Overall Study|Disease progression|11|||
163224537|NCT00451035|589537865|FG000|Overall Study|Death|3|||
163224538|NCT00451035|589537865|FG000|Overall Study|New anti-neoplastic therapy|3|||
163224539|NCT01712256|589537868|FG000|Overall Study|Lost to Follow-up|1|||
163224540|NCT00962104|589537871|FG000|Overall Study|Adverse Event|10|||
163224541|NCT00962104|589537872|FG001|Overall Study|Adverse Event|3|||
163224542|NCT00962104|589537871|FG000|Overall Study|Entry Criteria Not Met|1|||
163224543|NCT00962104|589537872|FG001|Overall Study|Entry Criteria Not Met|2|||
163224544|NCT00962104|589537871|FG000|Overall Study|Lack of Efficacy|0|||
163224545|NCT00962104|589537872|FG001|Overall Study|Lack of Efficacy|1|||
163224546|NCT00962104|589537871|FG000|Overall Study|Lost to Follow-up|10|||
163224547|NCT00962104|589537872|FG001|Overall Study|Lost to Follow-up|4|||
163224548|NCT00962104|589537871|FG000|Overall Study|Physician Decision|1|||
163224549|NCT00962104|589537872|FG001|Overall Study|Physician Decision|0|||
163224550|NCT00962104|589537871|FG000|Overall Study|Protocol Violation|6|||
163224551|NCT00962104|589537872|FG001|Overall Study|Protocol Violation|8|||
163224552|NCT00962104|589537871|FG000|Overall Study|Sponsor Decision|0|||
163224553|NCT00962104|589537872|FG001|Overall Study|Sponsor Decision|1|||
163224554|NCT00962104|589537871|FG000|Overall Study|Withdrawal by Subject|10|||
163408061|NCT01903837|590204018|FG000|Part A|Non-compliance with study drug|1|||
163119914|NCT00276614|589146502|FG000|Overall Study|Progression of disease under study|3|||
163119915|NCT02117349|589146505|FG000|Overall Study|Withdrawal by Subject|1|||
163119916|NCT02117349|589146506|FG001|Overall Study|Withdrawal by Subject|0|||
163224555|NCT00962104|589537872|FG001|Overall Study|Withdrawal by Subject|6|||
163224556|NCT00962104|589537871|FG000|Overall Study|Other|2|||
163119917|NCT02117349|589146505|FG000|Overall Study|Lost to Follow-up|1|||
163119918|NCT02117349|589146506|FG001|Overall Study|Lost to Follow-up|1|||
163119919|NCT02117349|589146505|FG000|Overall Study|Death|1|||
163119920|NCT02117349|589146506|FG001|Overall Study|Death|0|||
163224557|NCT00962104|589537872|FG001|Overall Study|Other|0|||
163224558|NCT03274986|589537873|FG000|Overall Study|Withdrawal by Subject|0|||
163408062|NCT01903837|590204019|FG001|Part A|Non-compliance with study drug|4|||
163340758|NCT03246724|589954909|FG001|Overall Study|Re-consented to participate|0|||
163340759|NCT03246724|589954910|FG002|Overall Study|Re-consented to participate|0|||
163340760|NCT03246724|589954911|FG003|Overall Study|Re-consented to participate|1|||
163340761|NCT00655824|589954912|FG000|Overall Study|Adverse Event|3|||
163340762|NCT00655824|589954912|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
163340763|NCT00655824|589954912|FG000|Overall Study|Protocol Violation|1|||
163340764|NCT00655824|589954912|FG000|Overall Study|Withdrawal by Subject|4|||
163340765|NCT00655824|589954912|FG000|Overall Study|Deterioration of Trial Disease|2|||
163340766|NCT02978716|589954913|FG000|Overall Study|Death|25|||
163340767|NCT02978716|589954914|FG001|Overall Study|Death|13|||
163340768|NCT02978716|589954915|FG002|Overall Study|Death|20|||
163340769|NCT02978716|589954913|FG000|Overall Study|Lost to Follow-up|0|||
163340770|NCT02978716|589954914|FG001|Overall Study|Lost to Follow-up|0|||
163340771|NCT02978716|589954915|FG002|Overall Study|Lost to Follow-up|1|||
163340772|NCT02978716|589954913|FG000|Overall Study|Withdrawal by Subject|6|||
163340773|NCT02978716|589954914|FG001|Overall Study|Withdrawal by Subject|4|||
163340774|NCT02978716|589954915|FG002|Overall Study|Withdrawal by Subject|5|||
163340775|NCT02978716|589954913|FG000|Overall Study|Sponsor terminated|2|||
163340776|NCT02978716|589954914|FG001|Overall Study|Sponsor terminated|13|||
163340777|NCT02978716|589954915|FG002|Overall Study|Sponsor terminated|9|||
163340778|NCT02978716|589954913|FG000|Overall Study|Other|1|||
163340779|NCT02978716|589954914|FG001|Overall Study|Other|3|||
163340780|NCT02978716|589954915|FG002|Overall Study|Other|0|||
163340781|NCT00589628|589954916|FG000|Overall Study|Lost to Follow-up|0|||
163340782|NCT00589628|589954917|FG001|Overall Study|Lost to Follow-up|1|||
163340783|NCT00538629|589956843|FG000|Overall Study|At subject's request|1|||
163340784|NCT00538629|589956843|FG000|Overall Study|Adverse Event|2|||
163340785|NCT00538629|589956843|FG000|Overall Study|Lack of Efficacy|12|||
163340786|NCT00538629|589956843|FG000|Overall Study|Lost to Follow-up|6|||
163340787|NCT00538629|589956843|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
163340788|NCT04454125|589956844|FG000|Overall Study|Lost to Follow-up|0|||
163340789|NCT04454125|589956845|FG001|Overall Study|Lost to Follow-up|1|||
163340790|NCT01922102|589956846|FG000|Overall Study|Withdrawal by Subject|7|||
163340791|NCT01922102|589956847|FG001|Overall Study|Withdrawal by Subject|3|||
163340792|NCT01922102|589956848|FG002|Overall Study|Withdrawal by Subject|7|||
163340793|NCT01922102|589956846|FG000|Overall Study|Physician Decision|0|||
163340794|NCT01922102|589956847|FG001|Overall Study|Physician Decision|2|||
163340795|NCT01922102|589956848|FG002|Overall Study|Physician Decision|1|||
163340796|NCT01922102|589956846|FG000|Overall Study|Adverse Event|1|||
163340797|NCT01922102|589956847|FG001|Overall Study|Adverse Event|2|||
163340798|NCT01922102|589956848|FG002|Overall Study|Adverse Event|0|||
163340799|NCT01922102|589956846|FG000|Overall Study|Lost to Follow-up|1|||
163119921|NCT02242981|589146509|FG000|Overall Study|Withdrawal by Subject|1|||
163119922|NCT03474081|589146512|FG000|Overall Study|Adverse Event|6|||
163119923|NCT03474081|589146513|FG001|Overall Study|Adverse Event|3|||
163119924|NCT03474081|589146512|FG000|Overall Study|Lost to Follow-up|2|||
163119925|NCT03474081|589146513|FG001|Overall Study|Lost to Follow-up|1|||
163119926|NCT03474081|589146512|FG000|Overall Study|Physician Decision|3|||
163119927|NCT03474081|589146513|FG001|Overall Study|Physician Decision|2|||
163119928|NCT03474081|589146512|FG000|Overall Study|Withdrawal by Subject|5|||
163119929|NCT03474081|589146513|FG001|Overall Study|Withdrawal by Subject|7|||
163119930|NCT03474081|589146512|FG000|Overall Study|Investigator site closed|1|||
163119931|NCT03474081|589146513|FG001|Overall Study|Investigator site closed|0|||
163224559|NCT03274986|589537874|FG001|Overall Study|Withdrawal by Subject|1|||
163340800|NCT01922102|589956847|FG001|Overall Study|Lost to Follow-up|0|||
163340801|NCT01922102|589956848|FG002|Overall Study|Lost to Follow-up|0|||
163340802|NCT01922102|589956846|FG000|Overall Study|Administrative problems|0|||
163340803|NCT01922102|589956847|FG001|Overall Study|Administrative problems|2|||
163340804|NCT01922102|589956848|FG002|Overall Study|Administrative problems|0|||
163119932|NCT01977690|589146514|FG000|Overall Study|Withdrawal by Subject|0|||
163224560|NCT03274986|589537873|FG000|Overall Study|Lost to Follow-up|0|||
163224561|NCT03274986|589537874|FG001|Overall Study|Lost to Follow-up|1|||
163340805|NCT05203822|589956849|FG000|Overall Study|Adverse Event|1|||
163340806|NCT05203822|589956849|FG000|Overall Study|Withdrawal by Subject|1|||
163340807|NCT01816165|589956856|FG000|Overall Study|Adverse Event|1|||
163340808|NCT01816165|589956857|FG001|Overall Study|Adverse Event|0|||
163340809|NCT01816165|589956858|FG002|Overall Study|Adverse Event|0|||
163340810|NCT01816165|589956859|FG003|Overall Study|Adverse Event|0|||
163340811|NCT00447499|589956860|FG000|Overall Study|Adverse Event|1|||
163340812|NCT00447499|589956860|FG000|Overall Study|Patient Decision|4|||
163224562|NCT00603746|589537875|FG000|Overall Study|Adverse Event|2|||
163340813|NCT00447499|589956860|FG000|Overall Study|Sponsor Decision|1|||
163340814|NCT00447499|589956860|FG000|Overall Study|Physician Decision|1|||
163340815|NCT02092909|589956862|FG000|Overall Study|Adverse Event|0|||
163119933|NCT01977690|589146515|FG001|Overall Study|Withdrawal by Subject|4|||
163119934|NCT01711866|589146521|FG000|Overall Study|Noncompliant|3|||
163119935|NCT01711866|589146521|FG000|Overall Study|Withdrawal by Subject|3|||
163340816|NCT02092909|589956863|FG001|Overall Study|Adverse Event|0|||
163340817|NCT02092909|589956864|FG002|Overall Study|Adverse Event|4|||
163340818|NCT02092909|589956865|FG003|Overall Study|Adverse Event|2|||
163340819|NCT02092909|589956862|FG000|Overall Study|Lack of Efficacy|0|||
163340820|NCT02092909|589956863|FG001|Overall Study|Lack of Efficacy|2|||
163340821|NCT02092909|589956864|FG002|Overall Study|Lack of Efficacy|1|||
163340822|NCT02092909|589956865|FG003|Overall Study|Lack of Efficacy|0|||
163340823|NCT02092909|589956862|FG000|Overall Study|Withdrawal by Subject|0|||
163340824|NCT02092909|589956863|FG001|Overall Study|Withdrawal by Subject|0|||
163340825|NCT02092909|589956864|FG002|Overall Study|Withdrawal by Subject|2|||
163340826|NCT02092909|589956865|FG003|Overall Study|Withdrawal by Subject|1|||
163340827|NCT02092909|589956862|FG000|Overall Study|Study terminated by Sponsor|0|||
163340828|NCT02092909|589956863|FG001|Overall Study|Study terminated by Sponsor|0|||
163340829|NCT02092909|589956864|FG002|Overall Study|Study terminated by Sponsor|0|||
163340830|NCT02092909|589956865|FG003|Overall Study|Study terminated by Sponsor|2|||
163340831|NCT02092909|589956862|FG000|Overall Study|Miscellaneous|1|||
163340832|NCT02092909|589956863|FG001|Overall Study|Miscellaneous|1|||
163340833|NCT02092909|589956864|FG002|Overall Study|Miscellaneous|2|||
163340834|NCT02092909|589956865|FG003|Overall Study|Miscellaneous|1|||
163340835|NCT00096278|589956866|FG000|Overall Study|No follow-up data|15|||
163340836|NCT00096278|589956867|FG001|Overall Study|No follow-up data|18|||
163340837|NCT00096278|589956866|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
163340838|NCT00096278|589956867|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
163340839|NCT02865083|589956868|FG000|Overall Study|Early Termination|3|||
163119936|NCT01711866|589146521|FG000|Overall Study|Adverse Event|2|||
163119937|NCT00459537|589146522|FG000|Overall Study|Adverse Event|1|||
163119938|NCT00459537|589146523|FG001|Overall Study|Adverse Event|6|||
163119939|NCT00459537|589146522|FG000|Overall Study|Lack of Efficacy|10|||
163119940|NCT00459537|589146523|FG001|Overall Study|Lack of Efficacy|11|||
163119941|NCT00459537|589146522|FG000|Overall Study|Withdrawal by Subject|20|||
163119942|NCT00459537|589146523|FG001|Overall Study|Withdrawal by Subject|26|||
163119943|NCT00459537|589146522|FG000|Overall Study|Lost to Follow-up|27|||
163119944|NCT00459537|589146523|FG001|Overall Study|Lost to Follow-up|30|||
163119945|NCT00459537|589146522|FG000|Overall Study|Administrative problems|3|||
163119946|NCT00459537|589146523|FG001|Overall Study|Administrative problems|0|||
163119947|NCT00459537|589146522|FG000|Overall Study|Protocol Violation|4|||
163119948|NCT00459537|589146523|FG001|Overall Study|Protocol Violation|3|||
163119949|NCT00459537|589146522|FG000|Overall Study|Missing|1|||
163119950|NCT00459537|589146523|FG001|Overall Study|Missing|0|||
163119951|NCT00546260|589146524|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
163119952|NCT00546260|589146525|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
163119953|NCT03172130|589148279|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
163119954|NCT03172130|589148280|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
163119955|NCT00262847|589148291|FG000|Overall Study|Disease Progression|309|||
163119956|NCT00262847|589148292|FG001|Overall Study|Disease Progression|274|||
163119957|NCT00262847|589148293|FG002|Overall Study|Disease Progression|195|||
163119958|NCT00262847|589148291|FG000|Overall Study|Patient Refusal|41|||
163119959|NCT00262847|589148292|FG001|Overall Study|Patient Refusal|52|||
163119960|NCT00262847|589148293|FG002|Overall Study|Patient Refusal|47|||
163119961|NCT00262847|589148291|FG000|Overall Study|Adverse Event|74|||
163119962|NCT00262847|589148292|FG001|Overall Study|Adverse Event|88|||
163119963|NCT00262847|589148293|FG002|Overall Study|Adverse Event|108|||
163119964|NCT00262847|589148291|FG000|Overall Study|Death|8|||
163119965|NCT00262847|589148292|FG001|Overall Study|Death|8|||
163119966|NCT00262847|589148293|FG002|Overall Study|Death|11|||
163119967|NCT00262847|589148291|FG000|Overall Study|Concomitant disease|3|||
163119968|NCT00262847|589148292|FG001|Overall Study|Concomitant disease|2|||
163119969|NCT00262847|589148293|FG002|Overall Study|Concomitant disease|4|||
163119970|NCT00262847|589148291|FG000|Overall Study|Other Reasons|79|||
163119971|NCT00262847|589148292|FG001|Overall Study|Other Reasons|88|||
163119972|NCT00262847|589148293|FG002|Overall Study|Other Reasons|27|||
163119973|NCT00262847|589148291|FG000|Overall Study|Did not receive study treatment|4|||
163119974|NCT00262847|589148292|FG001|Overall Study|Did not receive study treatment|1|||
163119975|NCT00262847|589148293|FG002|Overall Study|Did not receive study treatment|4|||
163119976|NCT00387647|589148294|FG000|Overall Study|Death|18|||
163119977|NCT01825941|589148295|FG000|Overall Study|Lost to Follow-up|4|||
163119978|NCT01825941|589148296|FG001|Overall Study|Lost to Follow-up|1|||
163119979|NCT00528996|589148297|FG000|Overall Study|Other reasons than listing|6|||
163119980|NCT00528996|589148298|FG001|Overall Study|Other reasons than listing|7|||
163119981|NCT00528996|589148299|FG002|Overall Study|Other reasons than listing|14|||
163119982|NCT00528996|589148300|FG003|Overall Study|Other reasons than listing|11|||
163119983|NCT00528996|589148301|FG004|Overall Study|Other reasons than listing|5|||
163119984|NCT00528996|589148297|FG000|Overall Study|Refused continue medication|16|||
163119985|NCT00528996|589148298|FG001|Overall Study|Refused continue medication|0|||
163119986|NCT00528996|589148299|FG002|Overall Study|Refused continue medication|3|||
163119987|NCT00528996|589148300|FG003|Overall Study|Refused continue medication|3|||
163119988|NCT00528996|589148301|FG004|Overall Study|Refused continue medication|6|||
163119989|NCT00528996|589148297|FG000|Overall Study|Lost to Follow-up|2|||
163119990|NCT00528996|589148298|FG001|Overall Study|Lost to Follow-up|0|||
163119991|NCT00528996|589148299|FG002|Overall Study|Lost to Follow-up|4|||
163119992|NCT00528996|589148300|FG003|Overall Study|Lost to Follow-up|1|||
163119993|NCT00528996|589148301|FG004|Overall Study|Lost to Follow-up|3|||
163119994|NCT00528996|589148297|FG000|Overall Study|Protocol Violation|1|||
163119995|NCT00528996|589148298|FG001|Overall Study|Protocol Violation|2|||
163119996|NCT00528996|589148299|FG002|Overall Study|Protocol Violation|3|||
163119997|NCT00528996|589148300|FG003|Overall Study|Protocol Violation|3|||
163119998|NCT00528996|589148301|FG004|Overall Study|Protocol Violation|2|||
163119999|NCT00528996|589148297|FG000|Overall Study|Lack of Efficacy|7|||
163120000|NCT00528996|589148298|FG001|Overall Study|Lack of Efficacy|2|||
163120001|NCT00528996|589148299|FG002|Overall Study|Lack of Efficacy|1|||
163120002|NCT00528996|589148300|FG003|Overall Study|Lack of Efficacy|3|||
163120003|NCT00528996|589148301|FG004|Overall Study|Lack of Efficacy|3|||
163120004|NCT00528996|589148297|FG000|Overall Study|Adverse Event|32|||
163120005|NCT00528996|589148298|FG001|Overall Study|Adverse Event|13|||
163120006|NCT00528996|589148299|FG002|Overall Study|Adverse Event|18|||
163120007|NCT00528996|589148300|FG003|Overall Study|Adverse Event|29|||
163120008|NCT00528996|589148301|FG004|Overall Study|Adverse Event|18|||
163120009|NCT02831933|589148302|FG000|Overall Study|Physician Decision|11|||
163120010|NCT03495102|589148303|FG000|Overall Study|Adverse Event|5|||
163120011|NCT03495102|589148304|FG001|Overall Study|Adverse Event|7|||
163120012|NCT03495102|589148305|FG002|Overall Study|Adverse Event|10|||
163120013|NCT03495102|589148303|FG000|Overall Study|Death|3|||
163120014|NCT03495102|589148304|FG001|Overall Study|Death|4|||
163120015|NCT03495102|589148305|FG002|Overall Study|Death|4|||
163120016|NCT03495102|589148303|FG000|Overall Study|Lost to Follow-up|15|||
163120017|NCT03495102|589148304|FG001|Overall Study|Lost to Follow-up|16|||
163120018|NCT03495102|589148305|FG002|Overall Study|Lost to Follow-up|17|||
163120019|NCT03495102|589148303|FG000|Overall Study|Physician Decision|2|||
163120020|NCT03495102|589148304|FG001|Overall Study|Physician Decision|0|||
163120021|NCT03495102|589148305|FG002|Overall Study|Physician Decision|2|||
163120022|NCT03495102|589148303|FG000|Overall Study|Withdrawal by Subject|25|||
163120023|NCT03495102|589148304|FG001|Overall Study|Withdrawal by Subject|36|||
163120024|NCT03495102|589148305|FG002|Overall Study|Withdrawal by Subject|18|||
163120025|NCT03495102|589148303|FG000|Overall Study|Protocol Violation|1|||
163120026|NCT03495102|589148304|FG001|Overall Study|Protocol Violation|1|||
163120027|NCT03495102|589148305|FG002|Overall Study|Protocol Violation|0|||
163120028|NCT03495102|589148303|FG000|Overall Study|Site Closure|3|||
163120029|NCT03495102|589148304|FG001|Overall Study|Site Closure|1|||
163120030|NCT03495102|589148305|FG002|Overall Study|Site Closure|2|||
163120031|NCT03495102|589148303|FG000|Overall Study|Non-compliance|1|||
163120032|NCT03495102|589148304|FG001|Overall Study|Non-compliance|0|||
163120033|NCT03495102|589148305|FG002|Overall Study|Non-compliance|0|||
163120034|NCT03495102|589148303|FG000|Overall Study|Participant Duplicated at Another Site|0|||
163120035|NCT03495102|589148304|FG001|Overall Study|Participant Duplicated at Another Site|0|||
163120036|NCT03495102|589148305|FG002|Overall Study|Participant Duplicated at Another Site|1|||
163120037|NCT03495102|589148303|FG000|Overall Study|Primary Care Physician Recommendation|0|||
163120038|NCT03495102|589148304|FG001|Overall Study|Primary Care Physician Recommendation|1|||
163120039|NCT03495102|589148305|FG002|Overall Study|Primary Care Physician Recommendation|0|||
163120040|NCT03495102|589148303|FG000|Overall Study|Relocated to Another Country|0|||
163120041|NCT03495102|589148304|FG001|Overall Study|Relocated to Another Country|1|||
163120042|NCT03495102|589148305|FG002|Overall Study|Relocated to Another Country|0|||
163120043|NCT03495102|589148303|FG000|Overall Study|Participant was in Rehabilitation|1|||
163120044|NCT03495102|589148304|FG001|Overall Study|Participant was in Rehabilitation|0|||
163120045|NCT03495102|589148305|FG002|Overall Study|Participant was in Rehabilitation|0|||
163120046|NCT00358436|589148312|FG000|Overall Study|Adverse Event|29|||
163120047|NCT00358436|589148313|FG001|Overall Study|Adverse Event|13|||
163120048|NCT00358436|589148312|FG000|Overall Study|Lack of Efficacy|34|||
163120049|NCT00358436|589148313|FG001|Overall Study|Lack of Efficacy|36|||
163120050|NCT00358436|589148312|FG000|Overall Study|Lost to Follow-up|11|||
163120051|NCT00358436|589148313|FG001|Overall Study|Lost to Follow-up|6|||
163120052|NCT00358436|589148312|FG000|Overall Study|Protocol Violation|8|||
163120053|NCT00358436|589148313|FG001|Overall Study|Protocol Violation|3|||
163120054|NCT00358436|589148312|FG000|Overall Study|Withdrawal by Subject|40|||
163120055|NCT00358436|589148313|FG001|Overall Study|Withdrawal by Subject|17|||
163120056|NCT00358436|589148312|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
163120057|NCT00358436|589148313|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
163120058|NCT00358436|589148312|FG000|Overall Study|COPD exacerbation|22|||
163120059|NCT00358436|589148313|FG001|Overall Study|COPD exacerbation|10|||
163120060|NCT00358436|589148312|FG000|Overall Study|Other|6|||
163120061|NCT00358436|589148313|FG001|Overall Study|Other|1|||
163120062|NCT05065190|589148315|FG000|Overall Study|Other than listed|2|||
163120063|NCT05065190|589148316|FG001|Overall Study|Other than listed|12|||
163120064|NCT05065190|589148315|FG000|Overall Study|Lack of Efficacy|4|||
163224563|NCT00603746|589537876|FG001|Overall Study|Adverse Event|3|||
163224564|NCT00603746|589537877|FG002|Overall Study|Adverse Event|0|||
163224565|NCT00603746|589537878|FG003|Overall Study|Adverse Event|1|||
163224566|NCT00603746|589537879|FG004|Overall Study|Adverse Event|0|||
163224567|NCT00603746|589537880|FG005|Overall Study|Adverse Event|4|||
163224568|NCT00603746|589537875|FG000|Overall Study|Lack of Efficacy|34|||
163224569|NCT00603746|589537876|FG001|Overall Study|Lack of Efficacy|11|||
163224570|NCT00603746|589537877|FG002|Overall Study|Lack of Efficacy|6|||
163224571|NCT00603746|589537878|FG003|Overall Study|Lack of Efficacy|11|||
163224572|NCT00603746|589537879|FG004|Overall Study|Lack of Efficacy|12|||
163224573|NCT00603746|589537880|FG005|Overall Study|Lack of Efficacy|8|||
163224574|NCT00603746|589537875|FG000|Overall Study|Protocol Violation|0|||
163224575|NCT00603746|589537876|FG001|Overall Study|Protocol Violation|3|||
163224576|NCT00603746|589537877|FG002|Overall Study|Protocol Violation|1|||
163224577|NCT00603746|589537878|FG003|Overall Study|Protocol Violation|0|||
163224578|NCT00603746|589537879|FG004|Overall Study|Protocol Violation|1|||
163224579|NCT00603746|589537880|FG005|Overall Study|Protocol Violation|0|||
163224580|NCT00603746|589537875|FG000|Overall Study|Lost to Follow-up|0|||
163224581|NCT00603746|589537876|FG001|Overall Study|Lost to Follow-up|1|||
163224582|NCT00603746|589537877|FG002|Overall Study|Lost to Follow-up|1|||
163224583|NCT00603746|589537878|FG003|Overall Study|Lost to Follow-up|0|||
163224584|NCT00603746|589537879|FG004|Overall Study|Lost to Follow-up|0|||
163224585|NCT00603746|589537880|FG005|Overall Study|Lost to Follow-up|0|||
163224586|NCT00603746|589537875|FG000|Overall Study|Physician Decision|1|||
163224587|NCT00603746|589537876|FG001|Overall Study|Physician Decision|0|||
163224588|NCT00603746|589537877|FG002|Overall Study|Physician Decision|0|||
163224589|NCT00603746|589537878|FG003|Overall Study|Physician Decision|0|||
163224590|NCT00603746|589537879|FG004|Overall Study|Physician Decision|1|||
163224591|NCT00603746|589537880|FG005|Overall Study|Physician Decision|0|||
163224592|NCT00603746|589537875|FG000|Overall Study|Withdrawal by Subject|1|||
163224593|NCT00603746|589537876|FG001|Overall Study|Withdrawal by Subject|0|||
163224594|NCT00603746|589537877|FG002|Overall Study|Withdrawal by Subject|0|||
163224595|NCT00603746|589537878|FG003|Overall Study|Withdrawal by Subject|1|||
163224596|NCT00603746|589537879|FG004|Overall Study|Withdrawal by Subject|3|||
163224597|NCT00603746|589537880|FG005|Overall Study|Withdrawal by Subject|1|||
163224598|NCT01524627|589537882|FG000|Overall Study|Physician Decision|0|||
163224599|NCT01524627|589537883|FG001|Overall Study|Physician Decision|1|||
163224600|NCT01524627|589537882|FG000|Overall Study|Lost to Follow-up|1|||
163224601|NCT01524627|589537883|FG001|Overall Study|Lost to Follow-up|1|||
163224602|NCT05627518|589537884|FG000|Treatment Period 1|Adverse Event|0|||
163224603|NCT05627518|589537885|FG001|Treatment Period 1|Adverse Event|0|||
163224604|NCT05627518|589537886|FG002|Treatment Period 1|Adverse Event|1|||
163224605|NCT05627518|589537887|FG003|Treatment Period 1|Adverse Event|0|||
163224606|NCT05627518|589537888|FG004|Treatment Period 1|Adverse Event|0|||
163224607|NCT05627518|589537889|FG005|Treatment Period 1|Adverse Event|0|||
163224608|NCT05627518|589537890|FG006|Treatment Period 1|Adverse Event|0|||
163224609|NCT05627518|589537891|FG007|Treatment Period 1|Adverse Event|1|||
163224610|NCT05627518|589537884|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163224611|NCT05627518|589537885|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163224612|NCT05627518|589537886|FG002|Treatment Period 1|Withdrawal by Subject|1|||
163224613|NCT05627518|589537887|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163224614|NCT05627518|589537888|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163224615|NCT05627518|589537889|FG005|Treatment Period 1|Withdrawal by Subject|1|||
163224616|NCT05627518|589537890|FG006|Treatment Period 1|Withdrawal by Subject|0|||
163224617|NCT05627518|589537891|FG007|Treatment Period 1|Withdrawal by Subject|0|||
163224618|NCT05627518|589537884|FG000|Treatment Period 1|Protocol Violation|0|||
163224619|NCT05627518|589537885|FG001|Treatment Period 1|Protocol Violation|0|||
163224620|NCT05627518|589537886|FG002|Treatment Period 1|Protocol Violation|0|||
163224621|NCT05627518|589537887|FG003|Treatment Period 1|Protocol Violation|0|||
163224622|NCT05627518|589537888|FG004|Treatment Period 1|Protocol Violation|0|||
163224623|NCT05627518|589537889|FG005|Treatment Period 1|Protocol Violation|0|||
163224624|NCT05627518|589537890|FG006|Treatment Period 1|Protocol Violation|6|||
163224625|NCT05627518|589537891|FG007|Treatment Period 1|Protocol Violation|6|||
163224626|NCT05627518|589537884|FG000|Treatment Period 2|Adverse Event|1|||
163224627|NCT05627518|589537885|FG001|Treatment Period 2|Adverse Event|0|||
163224628|NCT05627518|589537886|FG002|Treatment Period 2|Adverse Event|0|||
163224629|NCT05627518|589537887|FG003|Treatment Period 2|Adverse Event|0|||
163224630|NCT05627518|589537888|FG004|Treatment Period 2|Adverse Event|0|||
163224631|NCT05627518|589537889|FG005|Treatment Period 2|Adverse Event|0|||
163224632|NCT05627518|589537890|FG006|Treatment Period 2|Adverse Event|0|||
163224633|NCT05627518|589537891|FG007|Treatment Period 2|Adverse Event|0|||
163224634|NCT05627518|589537884|FG000|Treatment Period 2|Withdrawal by Subject|1|||
163224635|NCT05627518|589537885|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163224636|NCT05627518|589537886|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163224637|NCT05627518|589537887|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163224638|NCT05627518|589537888|FG004|Treatment Period 2|Withdrawal by Subject|0|||
163224639|NCT05627518|589537889|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163224640|NCT05627518|589537890|FG006|Treatment Period 2|Withdrawal by Subject|0|||
163224641|NCT05627518|589537891|FG007|Treatment Period 2|Withdrawal by Subject|0|||
163120065|NCT05065190|589148316|FG001|Overall Study|Lack of Efficacy|0|||
163120066|NCT05065190|589148315|FG000|Overall Study|Adverse Event|1|||
163120067|NCT05065190|589148316|FG001|Overall Study|Adverse Event|10|||
163120068|NCT03938324|589148324|FG000|Overall Study|Lost to Follow-up|42|||
163120069|NCT03938324|589148325|FG001|Overall Study|Lost to Follow-up|21|||
163120070|NCT03938324|589148324|FG000|Overall Study|Withdrawal by Subject|6|||
163120071|NCT03938324|589148325|FG001|Overall Study|Withdrawal by Subject|1|||
163120072|NCT02769962|589148326|FG000|Overall Study|Physician Decision|0|||
163120073|NCT02769962|589148327|FG001|Overall Study|Physician Decision|0|||
163120074|NCT02769962|589148328|FG002|Overall Study|Physician Decision|0|||
163120075|NCT02769962|589148329|FG003|Overall Study|Physician Decision|0|||
163120076|NCT02769962|589148330|FG004|Overall Study|Physician Decision|0|||
163120077|NCT02769962|589148331|FG005|Overall Study|Physician Decision|1|||
163120078|NCT02769962|589148332|FG006|Overall Study|Physician Decision|0|||
163120079|NCT02769962|589148333|FG007|Overall Study|Physician Decision|1|||
163120080|NCT02769962|589148326|FG000|Overall Study|Refused further treatment|0|||
163120081|NCT02769962|589148327|FG001|Overall Study|Refused further treatment|0|||
163120082|NCT02769962|589148328|FG002|Overall Study|Refused further treatment|0|||
163120083|NCT02769962|589148329|FG003|Overall Study|Refused further treatment|0|||
163120084|NCT02769962|589148330|FG004|Overall Study|Refused further treatment|0|||
163120085|NCT02769962|589148331|FG005|Overall Study|Refused further treatment|1|||
163120086|NCT02769962|589148332|FG006|Overall Study|Refused further treatment|1|||
163120087|NCT02769962|589148333|FG007|Overall Study|Refused further treatment|0|||
163120088|NCT05565937|589148334|FG000|Overall Study|Adverse Event|0|||
163120089|NCT05565937|589148335|FG001|Overall Study|Adverse Event|1|||
163120090|NCT05565937|589148334|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
163120091|NCT05565937|589148335|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
163120092|NCT05565937|589148334|FG000|Overall Study|Lost to Follow-up|2|||
163120093|NCT05565937|589148335|FG001|Overall Study|Lost to Follow-up|0|||
163120094|NCT05565937|589148334|FG000|Overall Study|Pregnancy|0|||
163120095|NCT05565937|589148335|FG001|Overall Study|Pregnancy|2|||
163120096|NCT05565937|589148334|FG000|Overall Study|Anisometropia|0|||
163120097|NCT05565937|589148335|FG001|Overall Study|Anisometropia|1|||
163120098|NCT04544683|589148336|FG000|Overall Study|Lost to Follow-up|2|||
163120099|NCT04544683|589148336|FG000|Overall Study|Underwent cervical spine surgery|6|||
163120100|NCT00151372|589148337|FG000|Overall Study|Death|12|||
163120101|NCT00151372|589148338|FG001|Overall Study|Death|11|||
163120102|NCT00151372|589148337|FG000|Overall Study|Lost to Follow-up|5|||
163120103|NCT00151372|589148338|FG001|Overall Study|Lost to Follow-up|5|||
163120104|NCT00151372|589148337|FG000|Overall Study|Too sick medically to continue|5|||
163120105|NCT00151372|589148338|FG001|Overall Study|Too sick medically to continue|6|||
163120106|NCT00151372|589148337|FG000|Overall Study|Withdrawal by Subject|7|||
163120107|NCT00151372|589148338|FG001|Overall Study|Withdrawal by Subject|7|||
163120108|NCT05160766|589148339|FG000|Overall Study|Adverse Event|0|||
163120109|NCT05160766|589148340|FG001|Overall Study|Adverse Event|1|||
163120110|NCT05160766|589148341|FG002|Overall Study|Adverse Event|0|||
163120111|NCT05160766|589148342|FG003|Overall Study|Adverse Event|0|||
163120112|NCT05160766|589148339|FG000|Overall Study|COVID-19 infection|0|||
163120113|NCT05160766|589148340|FG001|Overall Study|COVID-19 infection|1|||
163120114|NCT05160766|589148341|FG002|Overall Study|COVID-19 infection|0|||
163120115|NCT05160766|589148342|FG003|Overall Study|COVID-19 infection|0|||
163120116|NCT05160766|589148339|FG000|Overall Study|travel time|1|||
163120117|NCT05160766|589148340|FG001|Overall Study|travel time|0|||
163120118|NCT05160766|589148341|FG002|Overall Study|travel time|0|||
163120119|NCT05160766|589148342|FG003|Overall Study|travel time|1|||
163120120|NCT05160766|589148339|FG000|Overall Study|Withdrawal by Subject|3|||
163120121|NCT05160766|589148340|FG001|Overall Study|Withdrawal by Subject|5|||
163120122|NCT05160766|589148341|FG002|Overall Study|Withdrawal by Subject|4|||
163120123|NCT05160766|589148342|FG003|Overall Study|Withdrawal by Subject|2|||
163120124|NCT05160766|589148339|FG000|Overall Study|Death|0|||
163120125|NCT05160766|589148340|FG001|Overall Study|Death|0|||
163120126|NCT05160766|589148341|FG002|Overall Study|Death|2|||
163120127|NCT05160766|589148342|FG003|Overall Study|Death|5|||
163120128|NCT05160766|589148339|FG000|Overall Study|Lost to Follow-up|0|||
163120129|NCT05160766|589148340|FG001|Overall Study|Lost to Follow-up|0|||
163120130|NCT05160766|589148341|FG002|Overall Study|Lost to Follow-up|1|||
163120131|NCT05160766|589148342|FG003|Overall Study|Lost to Follow-up|2|||
163120132|NCT05160766|589148339|FG000|Overall Study|No show|0|||
163120133|NCT05160766|589148340|FG001|Overall Study|No show|0|||
163120134|NCT05160766|589148341|FG002|Overall Study|No show|1|||
163120135|NCT05160766|589148342|FG003|Overall Study|No show|1|||
163120136|NCT05160766|589148339|FG000|Overall Study|Physician Decision|0|||
163120137|NCT05160766|589148340|FG001|Overall Study|Physician Decision|0|||
163120138|NCT05160766|589148341|FG002|Overall Study|Physician Decision|0|||
163120139|NCT05160766|589148342|FG003|Overall Study|Physician Decision|1|||
163120140|NCT05160766|589148339|FG000|Overall Study|Protocol Violation|0|||
163120141|NCT05160766|589148340|FG001|Overall Study|Protocol Violation|0|||
163120142|NCT05160766|589148341|FG002|Overall Study|Protocol Violation|1|||
163120143|NCT05160766|589148342|FG003|Overall Study|Protocol Violation|0|||
163120144|NCT01282294|589148343|FG000|Overall Study|Lost to Follow-up|14|||
163340840|NCT02865083|589956869|FG001|Overall Study|Early Termination|1|||
163340841|NCT02105688|589956870|FG000|Part A: Double-Blind|Adverse Event|1|||
163340842|NCT02105688|589956871|FG001|Part A: Double-Blind|Adverse Event|0|||
163340843|NCT02105688|589956870|FG000|Part A: Double-Blind|Death|0|||
163340844|NCT02105688|589956871|FG001|Part A: Double-Blind|Death|1|||
163340845|NCT02105688|589956870|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
163340846|NCT02105688|589956871|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
163340847|NCT02105688|589956870|FG000|Part A: Double-Blind|Physician Decision|0|||
163340848|NCT02105688|589956871|FG001|Part A: Double-Blind|Physician Decision|1|||
163340849|NCT02105688|589956870|FG000|Part A: Double-Blind|Status Unknown|0|||
163340850|NCT02105688|589956871|FG001|Part A: Double-Blind|Status Unknown|2|||
163120145|NCT01282294|589148343|FG000|Overall Study|Screening failure|1|||
163120146|NCT01282294|589148343|FG000|Overall Study|Adverse Event|1|||
163120147|NCT01282294|589148343|FG000|Overall Study|Patient non-compliance|2|||
163120148|NCT01282294|589148343|FG000|Overall Study|Physician Decision|1|||
163120149|NCT02408523|589148344|FG000|Overall Study|Adverse Event|4|||
163120150|NCT02408523|589148345|FG001|Overall Study|Adverse Event|10|||
163120151|NCT02408523|589148344|FG000|Overall Study|Lack of Efficacy|0|||
163120152|NCT02408523|589148345|FG001|Overall Study|Lack of Efficacy|1|||
163120153|NCT02408523|589148344|FG000|Overall Study|Protocol Violation|1|||
163340851|NCT02105688|589956870|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
163340852|NCT02105688|589956871|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
163120154|NCT02408523|589148345|FG001|Overall Study|Protocol Violation|2|||
163120155|NCT02408523|589148344|FG000|Overall Study|Lost to Follow-up|2|||
163120156|NCT02408523|589148345|FG001|Overall Study|Lost to Follow-up|3|||
163120157|NCT02408523|589148344|FG000|Overall Study|Withdrawal by Subject|3|||
163120158|NCT02408523|589148345|FG001|Overall Study|Withdrawal by Subject|1|||
163120159|NCT02408523|589148344|FG000|Overall Study|Sponsor request|1|||
163120160|NCT02408523|589148345|FG001|Overall Study|Sponsor request|0|||
163120161|NCT02408523|589148344|FG000|Overall Study|Did not satisfy extension conditions|0|||
163120162|NCT02408523|589148345|FG001|Overall Study|Did not satisfy extension conditions|1|||
163120163|NCT02943915|589148346|FG000|Overall Study|Withdrawal by Subject|2|||
163120164|NCT02943915|589148347|FG001|Overall Study|Withdrawal by Subject|1|||
163120165|NCT02943915|589148348|FG002|Overall Study|Withdrawal by Subject|0|||
163120166|NCT02943915|589148349|FG003|Overall Study|Withdrawal by Subject|0|||
163120167|NCT02943915|589148346|FG000|Overall Study|Lost to Follow-up|3|||
163120168|NCT02943915|589148347|FG001|Overall Study|Lost to Follow-up|1|||
163120169|NCT02943915|589148348|FG002|Overall Study|Lost to Follow-up|0|||
163120170|NCT02943915|589148349|FG003|Overall Study|Lost to Follow-up|0|||
163120171|NCT02943915|589148346|FG000|Overall Study|excluded|0|||
163120172|NCT02943915|589148347|FG001|Overall Study|excluded|1|||
163120173|NCT02943915|589148348|FG002|Overall Study|excluded|0|||
163120174|NCT02943915|589148349|FG003|Overall Study|excluded|0|||
163120175|NCT03769311|589148351|FG000|Overall Study|Withdrawal by Subject|1|||
163120176|NCT00996801|589148352|FG000|Overall Study|Adverse Event|6|||
163120177|NCT00996801|589148353|FG001|Overall Study|Adverse Event|4|||
163120178|NCT00996801|589148354|FG002|Overall Study|Adverse Event|12|||
163120179|NCT00996801|589148355|FG003|Overall Study|Adverse Event|17|||
163120180|NCT00996801|589148356|FG004|Overall Study|Adverse Event|31|||
163120181|NCT00996801|589148357|FG005|Overall Study|Adverse Event|3|||
163120182|NCT00996801|589148352|FG000|Overall Study|Lack of Efficacy|3|||
163120183|NCT00996801|589148353|FG001|Overall Study|Lack of Efficacy|0|||
163120184|NCT00996801|589148354|FG002|Overall Study|Lack of Efficacy|1|||
163120185|NCT00996801|589148355|FG003|Overall Study|Lack of Efficacy|3|||
163120186|NCT00996801|589148356|FG004|Overall Study|Lack of Efficacy|0|||
163408063|NCT01903837|590204020|FG002|Part A|Non-compliance with study drug|4|||
163408064|NCT01903837|590204021|FG003|Part A|Non-compliance with study drug|0|||
163120187|NCT00996801|589148357|FG005|Overall Study|Lack of Efficacy|1|||
163120188|NCT00996801|589148352|FG000|Overall Study|Lost to Follow-up|0|||
163120189|NCT00996801|589148353|FG001|Overall Study|Lost to Follow-up|0|||
163120190|NCT00996801|589148354|FG002|Overall Study|Lost to Follow-up|0|||
163120191|NCT00996801|589148355|FG003|Overall Study|Lost to Follow-up|3|||
163120192|NCT00996801|589148356|FG004|Overall Study|Lost to Follow-up|3|||
163120193|NCT00996801|589148357|FG005|Overall Study|Lost to Follow-up|2|||
163120194|NCT00996801|589148352|FG000|Overall Study|Physician Decision|0|||
163120195|NCT00996801|589148353|FG001|Overall Study|Physician Decision|0|||
163120196|NCT00996801|589148354|FG002|Overall Study|Physician Decision|0|||
163120197|NCT00996801|589148355|FG003|Overall Study|Physician Decision|1|||
163120198|NCT00996801|589148356|FG004|Overall Study|Physician Decision|0|||
163120199|NCT00996801|589148357|FG005|Overall Study|Physician Decision|0|||
163120200|NCT00996801|589148352|FG000|Overall Study|Progressive Disease|0|||
163120201|NCT00996801|589148353|FG001|Overall Study|Progressive Disease|1|||
163120202|NCT00996801|589148354|FG002|Overall Study|Progressive Disease|0|||
163120203|NCT00996801|589148355|FG003|Overall Study|Progressive Disease|0|||
163120204|NCT00996801|589148356|FG004|Overall Study|Progressive Disease|0|||
163340853|NCT02105688|589956870|FG000|Part B: Observational Follow-up|Death|2|||
163120205|NCT00996801|589148357|FG005|Overall Study|Progressive Disease|0|||
163340854|NCT02105688|589956871|FG001|Part B: Observational Follow-up|Death|1|||
163340855|NCT02105688|589956870|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
163224642|NCT01581593|589539973|FG000|Overall Study|Withdrawal by Subject|1|||
163224643|NCT01101841|589539974|FG000|Overall Study|Adverse Event|15|||
163224644|NCT01101841|589539975|FG001|Overall Study|Adverse Event|15|||
163224645|NCT01101841|589539974|FG000|Overall Study|Lost to Follow-up|9|||
163224646|NCT01101841|589539975|FG001|Overall Study|Lost to Follow-up|3|||
163224647|NCT01101841|589539974|FG000|Overall Study|Withdrawal by Subject|21|||
163224648|NCT01101841|589539975|FG001|Overall Study|Withdrawal by Subject|40|||
163224649|NCT01101841|589539974|FG000|Overall Study|Protocol Violation|1|||
163224650|NCT01101841|589539975|FG001|Overall Study|Protocol Violation|1|||
163408065|NCT01903837|590204018|FG000|Part A|Physician Decision|1|||
163408066|NCT01903837|590204019|FG001|Part A|Physician Decision|1|||
163408067|NCT01903837|590204020|FG002|Part A|Physician Decision|0|||
163408068|NCT01903837|590204021|FG003|Part A|Physician Decision|0|||
163408069|NCT01903837|590204018|FG000|Part A|Protocol Violation|1|||
163408070|NCT01903837|590204019|FG001|Part A|Protocol Violation|1|||
163408071|NCT01903837|590204020|FG002|Part A|Protocol Violation|0|||
163408072|NCT01903837|590204021|FG003|Part A|Protocol Violation|0|||
163408073|NCT01903837|590204018|FG000|Part B|Lost to Follow-up|0|||
163408074|NCT01903837|590204019|FG001|Part B|Lost to Follow-up|3|||
163408075|NCT01903837|590204020|FG002|Part B|Lost to Follow-up|3|||
163408076|NCT01903837|590204021|FG003|Part B|Lost to Follow-up|4|||
163408077|NCT01903837|590204018|FG000|Part B|Withdrawal by Subject|1|||
163408078|NCT01903837|590204019|FG001|Part B|Withdrawal by Subject|2|||
163408079|NCT01903837|590204020|FG002|Part B|Withdrawal by Subject|0|||
163408080|NCT01903837|590204021|FG003|Part B|Withdrawal by Subject|3|||
163408081|NCT01903837|590204018|FG000|Part B|Adverse Event|3|||
163408082|NCT01903837|590204019|FG001|Part B|Adverse Event|0|||
163408083|NCT01903837|590204020|FG002|Part B|Adverse Event|2|||
163408084|NCT01903837|590204021|FG003|Part B|Adverse Event|0|||
163408085|NCT01903837|590204018|FG000|Part B|Non-compliance with study drug|2|||
163408086|NCT01903837|590204019|FG001|Part B|Non-compliance with study drug|0|||
163408087|NCT01903837|590204020|FG002|Part B|Non-compliance with study drug|0|||
163408088|NCT01903837|590204021|FG003|Part B|Non-compliance with study drug|1|||
163408089|NCT01903837|590204018|FG000|Part B|Incarceration|2|||
163408090|NCT01903837|590204019|FG001|Part B|Incarceration|0|||
163120206|NCT00996801|589148352|FG000|Overall Study|Protocol Violation|3|||
163120207|NCT00996801|589148353|FG001|Overall Study|Protocol Violation|4|||
163120208|NCT00996801|589148354|FG002|Overall Study|Protocol Violation|1|||
163120209|NCT00996801|589148355|FG003|Overall Study|Protocol Violation|2|||
163120210|NCT00996801|589148356|FG004|Overall Study|Protocol Violation|3|||
163120211|NCT00996801|589148357|FG005|Overall Study|Protocol Violation|4|||
163120212|NCT00996801|589148352|FG000|Overall Study|Study Terminated by Sponsor|0|||
163120213|NCT00996801|589148353|FG001|Overall Study|Study Terminated by Sponsor|1|||
163120214|NCT00996801|589148354|FG002|Overall Study|Study Terminated by Sponsor|0|||
163120215|NCT00996801|589148355|FG003|Overall Study|Study Terminated by Sponsor|0|||
163120216|NCT00996801|589148356|FG004|Overall Study|Study Terminated by Sponsor|46|||
163120217|NCT00996801|589148357|FG005|Overall Study|Study Terminated by Sponsor|0|||
163120218|NCT00996801|589148352|FG000|Overall Study|Withdrawal by Subject|8|||
163120219|NCT00996801|589148353|FG001|Overall Study|Withdrawal by Subject|6|||
163120220|NCT00996801|589148354|FG002|Overall Study|Withdrawal by Subject|9|||
163120221|NCT00996801|589148355|FG003|Overall Study|Withdrawal by Subject|5|||
163120222|NCT00996801|589148356|FG004|Overall Study|Withdrawal by Subject|5|||
163120223|NCT00996801|589148357|FG005|Overall Study|Withdrawal by Subject|9|||
163120224|NCT00289198|589148358|FG000|Overall Study|Adverse Event|0|||
163120225|NCT00289198|589148359|FG001|Overall Study|Adverse Event|2|||
163120226|NCT00289198|589148358|FG000|Overall Study|Protocol Violation|2|||
163120227|NCT00289198|589148359|FG001|Overall Study|Protocol Violation|1|||
163120228|NCT00289198|589148358|FG000|Overall Study|Withdrawal by Subject|4|||
163120229|NCT00289198|589148359|FG001|Overall Study|Withdrawal by Subject|1|||
163120230|NCT00289198|589148358|FG000|Overall Study|Lack of Efficacy|2|||
163224651|NCT01101841|589539974|FG000|Overall Study|Physician Decision|0|||
163224652|NCT01101841|589539975|FG001|Overall Study|Physician Decision|2|||
163224653|NCT01101841|589539974|FG000|Overall Study|Lack of Efficacy|0|||
163408091|NCT01903837|590204020|FG002|Part B|Incarceration|0|||
163408092|NCT01903837|590204021|FG003|Part B|Incarceration|1|||
163408093|NCT01903837|590204018|FG000|Part B|Physician Decision|1|||
163408094|NCT01903837|590204019|FG001|Part B|Physician Decision|0|||
163408095|NCT01903837|590204020|FG002|Part B|Physician Decision|0|||
163408096|NCT01903837|590204021|FG003|Part B|Physician Decision|2|||
163120231|NCT00289198|589148359|FG001|Overall Study|Lack of Efficacy|0|||
163120232|NCT00289198|589148358|FG000|Overall Study|Other: Low compliance|0|||
163120233|NCT00289198|589148359|FG001|Overall Study|Other: Low compliance|1|||
163224654|NCT01101841|589539975|FG001|Overall Study|Lack of Efficacy|2|||
163224655|NCT01101841|589539974|FG000|Overall Study|Other|0|||
163224656|NCT01101841|589539975|FG001|Overall Study|Other|1|||
163408097|NCT01903837|590204018|FG000|Part B|Lack of Efficacy|0|||
163408098|NCT01903837|590204019|FG001|Part B|Lack of Efficacy|1|||
163408099|NCT01903837|590204020|FG002|Part B|Lack of Efficacy|0|||
163408100|NCT01903837|590204021|FG003|Part B|Lack of Efficacy|0|||
163408101|NCT00705939|590204023|FG000|Overall Study|Protocol Violation|0|||
163408102|NCT00705939|590204024|FG001|Overall Study|Protocol Violation|0|||
163408103|NCT00705939|590204025|FG002|Overall Study|Protocol Violation|1|||
163340856|NCT02105688|589956871|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
163340857|NCT02105688|589956870|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
163340858|NCT02105688|589956871|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
163340859|NCT02105688|589956870|FG000|Part B: Observational Follow-up|Physician Decision|3|||
163340860|NCT02105688|589956871|FG001|Part B: Observational Follow-up|Physician Decision|1|||
163340861|NCT03541369|589956878|FG000|Overall Study|Death|0|||
163340862|NCT03541369|589956879|FG001|Overall Study|Death|0|||
163340863|NCT03541369|589956880|FG002|Overall Study|Death|0|||
163340864|NCT03541369|589956881|FG003|Overall Study|Death|0|||
163340865|NCT03541369|589956882|FG004|Overall Study|Death|1|||
163340866|NCT03541369|589956883|FG005|Overall Study|Death|1|||
163340867|NCT03541369|589956884|FG006|Overall Study|Death|0|||
163340868|NCT03541369|589956885|FG007|Overall Study|Death|2|||
163340869|NCT03541369|589956886|FG008|Overall Study|Death|1|||
163340870|NCT03541369|589956887|FG009|Overall Study|Death|2|||
163120234|NCT00289198|589148358|FG000|Overall Study|Other: Physician's decision|0|||
163120235|NCT00289198|589148359|FG001|Overall Study|Other: Physician's decision|1|||
163120236|NCT00289198|589148358|FG000|Overall Study|Other: Unable to attend on schedule|2|||
163120237|NCT00289198|589148359|FG001|Overall Study|Other: Unable to attend on schedule|1|||
163120238|NCT00289198|589148358|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
163120239|NCT00289198|589148359|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
163120240|NCT00289198|589148358|FG000|Overall Study|Other: Impossible to come on visit|0|||
163120241|NCT00289198|589148359|FG001|Overall Study|Other: Impossible to come on visit|1|||
163120242|NCT02559414|589148367|FG000|Overall Study|Lost to Follow-up|0|||
163120243|NCT02559414|589148368|FG001|Overall Study|Lost to Follow-up|1|||
163120244|NCT02559414|589148369|FG002|Overall Study|Lost to Follow-up|0|||
163120245|NCT02559414|589148367|FG000|Overall Study|Withdrawal by Subject|1|||
163120246|NCT02559414|589148368|FG001|Overall Study|Withdrawal by Subject|0|||
163120247|NCT02559414|589148369|FG002|Overall Study|Withdrawal by Subject|1|||
163120248|NCT02559414|589148367|FG000|Overall Study|Other|0|||
163120249|NCT02559414|589148368|FG001|Overall Study|Other|1|||
163120250|NCT02559414|589148369|FG002|Overall Study|Other|1|||
163120251|NCT03369431|589148370|FG000|Overall Study|Lost to Follow-up|1|||
163120252|NCT03369431|589148371|FG001|Overall Study|Lost to Follow-up|3|||
163120253|NCT03369431|589148370|FG000|Overall Study|Withdrawal by Subject|2|||
163120254|NCT03369431|589148371|FG001|Overall Study|Withdrawal by Subject|3|||
163120255|NCT03369431|589148370|FG000|Overall Study|Protocol Violation|1|||
163120256|NCT03369431|589148371|FG001|Overall Study|Protocol Violation|1|||
163120257|NCT01062061|589148372|FG000|Overall Study|Enrolled more than once|2|||
163120258|NCT01062061|589148372|FG000|Overall Study|Investigated before study start|13|||
163120259|NCT01062061|589148372|FG000|Overall Study|Outside chief indications|10|||
163120260|NCT01062061|589148372|FG000|Overall Study|Failed to meet inclusion criteria|2|||
163120261|NCT00524589|589148373|FG000|Overall Study|Withdrawal by Subject|2|||
163120262|NCT00524589|589148373|FG000|Overall Study|Disease Progression|16|||
163120263|NCT01266317|589148376|FG000|Overall Study|Withdrawal by Subject|2|||
163120264|NCT02753127|589148379|FG000|Overall Study|Lost to Follow-up|13|||
163120265|NCT02753127|589148380|FG001|Overall Study|Lost to Follow-up|11|||
163120266|NCT02753127|589148379|FG000|Overall Study|Withdrawal by Subject|37|||
163120267|NCT02753127|589148380|FG001|Overall Study|Withdrawal by Subject|47|||
163120268|NCT02753127|589148379|FG000|Overall Study|Other|3|||
163120269|NCT02753127|589148380|FG001|Overall Study|Other|8|||
163120270|NCT02753127|589148379|FG000|Overall Study|Hospice|0|||
163120271|NCT02753127|589148380|FG001|Overall Study|Hospice|2|||
163120272|NCT00098722|589148381|FG000|Double Blind Phase|Adverse Event|7|||
163120273|NCT00098722|589148382|FG001|Double Blind Phase|Adverse Event|7|||
163120274|NCT00098722|589148383|FG002|Double Blind Phase|Adverse Event|3|||
163120275|NCT00098722|589148384|FG003|Double Blind Phase|Adverse Event|0|||
163120276|NCT00098722|589148385|FG004|Double Blind Phase|Adverse Event|0|||
163120277|NCT00098722|589148386|FG005|Double Blind Phase|Adverse Event|0|||
163340871|NCT03541369|589956888|FG010|Overall Study|Death|1|||
163340872|NCT03541369|589956889|FG011|Overall Study|Death|0|||
163340873|NCT03541369|589956890|FG012|Overall Study|Death|2|||
163340874|NCT03541369|589956891|FG013|Overall Study|Death|1|||
163340875|NCT03541369|589956892|FG014|Overall Study|Death|1|||
163340876|NCT03541369|589956893|FG015|Overall Study|Death|1|||
163120278|NCT00098722|589148387|FG006|Double Blind Phase|Adverse Event|0|||
163120279|NCT00098722|589148381|FG000|Double Blind Phase|Death|2|||
163120280|NCT00098722|589148382|FG001|Double Blind Phase|Death|5|||
163120281|NCT00098722|589148383|FG002|Double Blind Phase|Death|0|||
163120282|NCT00098722|589148384|FG003|Double Blind Phase|Death|0|||
163120283|NCT00098722|589148385|FG004|Double Blind Phase|Death|0|||
163120284|NCT00098722|589148386|FG005|Double Blind Phase|Death|0|||
163120285|NCT00098722|589148387|FG006|Double Blind Phase|Death|0|||
163120286|NCT00098722|589148381|FG000|Double Blind Phase|Lack of Efficacy|21|||
163120287|NCT00098722|589148382|FG001|Double Blind Phase|Lack of Efficacy|23|||
163120288|NCT00098722|589148383|FG002|Double Blind Phase|Lack of Efficacy|15|||
163340877|NCT03541369|589956894|FG016|Overall Study|Death|0|||
163340878|NCT03541369|589956895|FG017|Overall Study|Death|1|||
163340879|NCT03541369|589956878|FG000|Overall Study|Decision by sponsor|0|||
163340880|NCT03541369|589956879|FG001|Overall Study|Decision by sponsor|0|||
163120289|NCT00098722|589148384|FG003|Double Blind Phase|Lack of Efficacy|0|||
163120290|NCT00098722|589148385|FG004|Double Blind Phase|Lack of Efficacy|0|||
163120291|NCT00098722|589148386|FG005|Double Blind Phase|Lack of Efficacy|0|||
163120292|NCT00098722|589148387|FG006|Double Blind Phase|Lack of Efficacy|0|||
163120293|NCT00098722|589148381|FG000|Double Blind Phase|Participant defaulted|16|||
163120294|NCT00098722|589148382|FG001|Double Blind Phase|Participant defaulted|11|||
163120295|NCT00098722|589148383|FG002|Double Blind Phase|Participant defaulted|9|||
163120296|NCT00098722|589148384|FG003|Double Blind Phase|Participant defaulted|0|||
163120297|NCT00098722|589148385|FG004|Double Blind Phase|Participant defaulted|0|||
163120298|NCT00098722|589148386|FG005|Double Blind Phase|Participant defaulted|0|||
163120299|NCT00098722|589148387|FG006|Double Blind Phase|Participant defaulted|0|||
163120300|NCT00098722|589148381|FG000|Double Blind Phase|Pregnancy|1|||
163120301|NCT00098722|589148382|FG001|Double Blind Phase|Pregnancy|0|||
163120302|NCT00098722|589148383|FG002|Double Blind Phase|Pregnancy|0|||
163120303|NCT00098722|589148384|FG003|Double Blind Phase|Pregnancy|0|||
163120304|NCT00098722|589148385|FG004|Double Blind Phase|Pregnancy|0|||
163120305|NCT00098722|589148386|FG005|Double Blind Phase|Pregnancy|0|||
163120306|NCT00098722|589148387|FG006|Double Blind Phase|Pregnancy|0|||
163120307|NCT00098722|589148381|FG000|Double Blind Phase|Randomized, not treated|4|||
163120308|NCT00098722|589148382|FG001|Double Blind Phase|Randomized, not treated|3|||
163120309|NCT00098722|589148383|FG002|Double Blind Phase|Randomized, not treated|3|||
163120310|NCT00098722|589148384|FG003|Double Blind Phase|Randomized, not treated|0|||
163120311|NCT00098722|589148385|FG004|Double Blind Phase|Randomized, not treated|0|||
163120312|NCT00098722|589148386|FG005|Double Blind Phase|Randomized, not treated|0|||
163120313|NCT00098722|589148387|FG006|Double Blind Phase|Randomized, not treated|0|||
163120314|NCT00098722|589148381|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
163120315|NCT00098722|589148382|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
163120316|NCT00098722|589148383|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
163120317|NCT00098722|589148384|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
163120318|NCT00098722|589148385|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
163120319|NCT00098722|589148386|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
163120320|NCT00098722|589148387|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
163120321|NCT00098722|589148381|FG000|Double Blind Phase|Other|7|||
163120322|NCT00098722|589148382|FG001|Double Blind Phase|Other|8|||
163120323|NCT00098722|589148383|FG002|Double Blind Phase|Other|7|||
163120324|NCT00098722|589148384|FG003|Double Blind Phase|Other|0|||
163120325|NCT00098722|589148385|FG004|Double Blind Phase|Other|0|||
163120326|NCT00098722|589148386|FG005|Double Blind Phase|Other|0|||
163120327|NCT00098722|589148387|FG006|Double Blind Phase|Other|0|||
163120328|NCT00098722|589148381|FG000|Open Label Phase|Adverse Event|0|||
163120329|NCT00098722|589148382|FG001|Open Label Phase|Adverse Event|0|||
163120330|NCT00098722|589148383|FG002|Open Label Phase|Adverse Event|0|||
163120331|NCT00098722|589148384|FG003|Open Label Phase|Adverse Event|5|||
163120332|NCT00098722|589148385|FG004|Open Label Phase|Adverse Event|0|||
163120333|NCT00098722|589148386|FG005|Open Label Phase|Adverse Event|0|||
163120334|NCT00098722|589148387|FG006|Open Label Phase|Adverse Event|0|||
163120335|NCT00098722|589148381|FG000|Open Label Phase|Death|0|||
163120336|NCT00098722|589148382|FG001|Open Label Phase|Death|0|||
163340881|NCT03541369|589956880|FG002|Overall Study|Decision by sponsor|0|||
163120337|NCT00098722|589148383|FG002|Open Label Phase|Death|0|||
163120338|NCT00098722|589148384|FG003|Open Label Phase|Death|2|||
163120339|NCT00098722|589148385|FG004|Open Label Phase|Death|0|||
163120340|NCT00098722|589148386|FG005|Open Label Phase|Death|0|||
163120341|NCT00098722|589148387|FG006|Open Label Phase|Death|0|||
163120342|NCT00098722|589148381|FG000|Open Label Phase|Lack of Efficacy|0|||
163120343|NCT00098722|589148382|FG001|Open Label Phase|Lack of Efficacy|0|||
163120344|NCT00098722|589148383|FG002|Open Label Phase|Lack of Efficacy|0|||
163120345|NCT00098722|589148384|FG003|Open Label Phase|Lack of Efficacy|8|||
163120346|NCT00098722|589148385|FG004|Open Label Phase|Lack of Efficacy|0|||
163120347|NCT00098722|589148386|FG005|Open Label Phase|Lack of Efficacy|0|||
163120348|NCT00098722|589148387|FG006|Open Label Phase|Lack of Efficacy|0|||
163120349|NCT00098722|589148381|FG000|Open Label Phase|Pregnancy|0|||
163120350|NCT00098722|589148382|FG001|Open Label Phase|Pregnancy|0|||
163120351|NCT00098722|589148383|FG002|Open Label Phase|Pregnancy|0|||
163120352|NCT00098722|589148384|FG003|Open Label Phase|Pregnancy|1|||
163120353|NCT00098722|589148385|FG004|Open Label Phase|Pregnancy|0|||
163120354|NCT00098722|589148386|FG005|Open Label Phase|Pregnancy|0|||
163120355|NCT00098722|589148387|FG006|Open Label Phase|Pregnancy|0|||
163120356|NCT00098722|589148381|FG000|Open Label Phase|Participant defaulted|0|||
163120357|NCT00098722|589148382|FG001|Open Label Phase|Participant defaulted|0|||
163120358|NCT00098722|589148383|FG002|Open Label Phase|Participant defaulted|0|||
163120359|NCT00098722|589148384|FG003|Open Label Phase|Participant defaulted|18|||
163120360|NCT00098722|589148385|FG004|Open Label Phase|Participant defaulted|0|||
163120361|NCT00098722|589148386|FG005|Open Label Phase|Participant defaulted|0|||
163120362|NCT00098722|589148387|FG006|Open Label Phase|Participant defaulted|0|||
163120363|NCT00098722|589148381|FG000|Open Label Phase|Ongoing at cut-off date|0|||
163120364|NCT00098722|589148382|FG001|Open Label Phase|Ongoing at cut-off date|0|||
163340882|NCT03541369|589956881|FG003|Overall Study|Decision by sponsor|1|||
163120365|NCT00098722|589148383|FG002|Open Label Phase|Ongoing at cut-off date|0|||
163120366|NCT00098722|589148384|FG003|Open Label Phase|Ongoing at cut-off date|220|||
163120367|NCT00098722|589148385|FG004|Open Label Phase|Ongoing at cut-off date|50|||
163120368|NCT00098722|589148386|FG005|Open Label Phase|Ongoing at cut-off date|0|||
163120369|NCT00098722|589148387|FG006|Open Label Phase|Ongoing at cut-off date|0|||
163120370|NCT00098722|589148381|FG000|Open Label Phase|Other|0|||
163120371|NCT00098722|589148382|FG001|Open Label Phase|Other|0|||
163120372|NCT00098722|589148383|FG002|Open Label Phase|Other|0|||
163120373|NCT00098722|589148384|FG003|Open Label Phase|Other|18|||
163120374|NCT00098722|589148385|FG004|Open Label Phase|Other|0|||
163120375|NCT00098722|589148386|FG005|Open Label Phase|Other|0|||
163120376|NCT00098722|589148387|FG006|Open Label Phase|Other|0|||
163120377|NCT00098722|589148381|FG000|Observation Phase|Death|0|||
163120378|NCT00098722|589148382|FG001|Observation Phase|Death|0|||
163120379|NCT00098722|589148383|FG002|Observation Phase|Death|0|||
163120380|NCT00098722|589148384|FG003|Observation Phase|Death|0|||
163120381|NCT00098722|589148385|FG004|Observation Phase|Death|0|||
163120382|NCT00098722|589148386|FG005|Observation Phase|Death|5|||
163120383|NCT00098722|589148387|FG006|Observation Phase|Death|3|||
163120384|NCT00098722|589148381|FG000|Observation Phase|Lack of Efficacy|0|||
163120385|NCT00098722|589148382|FG001|Observation Phase|Lack of Efficacy|0|||
163120386|NCT00098722|589148383|FG002|Observation Phase|Lack of Efficacy|0|||
163120387|NCT00098722|589148384|FG003|Observation Phase|Lack of Efficacy|0|||
163120388|NCT00098722|589148385|FG004|Observation Phase|Lack of Efficacy|0|||
163120389|NCT00098722|589148386|FG005|Observation Phase|Lack of Efficacy|2|||
163120390|NCT00098722|589148387|FG006|Observation Phase|Lack of Efficacy|0|||
163120391|NCT00098722|589148381|FG000|Observation Phase|Participant defaulted|0|||
163120392|NCT00098722|589148382|FG001|Observation Phase|Participant defaulted|0|||
163120393|NCT00098722|589148383|FG002|Observation Phase|Participant defaulted|0|||
163120394|NCT00098722|589148384|FG003|Observation Phase|Participant defaulted|0|||
163120395|NCT00098722|589148385|FG004|Observation Phase|Participant defaulted|0|||
163120396|NCT00098722|589148386|FG005|Observation Phase|Participant defaulted|17|||
163120397|NCT00098722|589148387|FG006|Observation Phase|Participant defaulted|4|||
163120398|NCT00098722|589148381|FG000|Observation Phase|Other|0|||
163120399|NCT00098722|589148382|FG001|Observation Phase|Other|0|||
163120400|NCT00098722|589148383|FG002|Observation Phase|Other|0|||
163120401|NCT00098722|589148384|FG003|Observation Phase|Other|0|||
163120402|NCT00098722|589148385|FG004|Observation Phase|Other|0|||
163120403|NCT00098722|589148386|FG005|Observation Phase|Other|21|||
163120404|NCT00098722|589148387|FG006|Observation Phase|Other|10|||
163120405|NCT02046070|589148396|FG000|Overall Study|Progressive Disease|18|||
163120406|NCT02046070|589148397|FG001|Overall Study|Progressive Disease|11|||
163120407|NCT02046070|589148398|FG002|Overall Study|Progressive Disease|40|||
163120408|NCT02046070|589148396|FG000|Overall Study|Adverse Event|8|||
163120409|NCT02046070|589148397|FG001|Overall Study|Adverse Event|10|||
163120410|NCT02046070|589148398|FG002|Overall Study|Adverse Event|17|||
163120411|NCT02046070|589148396|FG000|Overall Study|Withdrawal by Subject|1|||
163120412|NCT02046070|589148397|FG001|Overall Study|Withdrawal by Subject|2|||
163120413|NCT02046070|589148398|FG002|Overall Study|Withdrawal by Subject|6|||
163120414|NCT02046070|589148396|FG000|Overall Study|Study Terminated by Sponsor|1|||
163120415|NCT02046070|589148397|FG001|Overall Study|Study Terminated by Sponsor|1|||
163120416|NCT02046070|589148398|FG002|Overall Study|Study Terminated by Sponsor|1|||
163120417|NCT02046070|589148396|FG000|Overall Study|Reason not Specified|4|||
163120418|NCT02046070|589148397|FG001|Overall Study|Reason not Specified|4|||
163120419|NCT02046070|589148398|FG002|Overall Study|Reason not Specified|6|||
163120420|NCT04619004|589148401|FG000|Overall Study|Death|114|||
163120421|NCT04619004|589148402|FG001|Overall Study|Death|28|||
163120422|NCT04619004|589148401|FG000|Overall Study|Lost to Follow-up|1|||
163120423|NCT04619004|589148402|FG001|Overall Study|Lost to Follow-up|1|||
163120424|NCT04619004|589148401|FG000|Overall Study|Withdrawal by Subject|24|||
163120425|NCT04619004|589148402|FG001|Overall Study|Withdrawal by Subject|7|||
163120426|NCT04619004|589148401|FG000|Overall Study|Other - Not specified|0|||
163120427|NCT04619004|589148402|FG001|Overall Study|Other - Not specified|1|||
163120428|NCT05601102|589148406|FG000|Overall Study|Death|1|||
163120429|NCT05601102|589148407|FG001|Overall Study|Death|2|||
163120430|NCT05601102|589148406|FG000|Overall Study|Withdrawal by Subject|1|||
163120431|NCT05601102|589148407|FG001|Overall Study|Withdrawal by Subject|1|||
163120432|NCT05601102|589148406|FG000|Overall Study|Lost to Follow-up|0|||
163120433|NCT05601102|589148407|FG001|Overall Study|Lost to Follow-up|2|||
163120434|NCT04284813|589148412|FG000|Overall Study|Withdrawal by Subject|1|||
163120435|NCT01145053|589148418|FG000|Overall Study|Adverse Event|22|||
163120436|NCT01145053|589148418|FG000|Overall Study|Lost to Follow-up|28|||
163120437|NCT01145053|589148418|FG000|Overall Study|Withdrawal by Subject|25|||
163120438|NCT01145053|589148418|FG000|Overall Study|Other|18|||
163120439|NCT00293709|589148419|FG000|Overall Study|Other|47|||
163120440|NCT02785458|589148420|FG000|1 Month|Withdrawal by Subject|2|||
163120441|NCT02785458|589148421|FG001|1 Month|Withdrawal by Subject|1|||
163120442|NCT02785458|589148420|FG000|1 Month|Lost to Follow-up|38|||
163120443|NCT02785458|589148421|FG001|1 Month|Lost to Follow-up|31|||
163120444|NCT02785458|589148420|FG000|1 Month|Deemed Ineligible|1|||
163120445|NCT02785458|589148421|FG001|1 Month|Deemed Ineligible|0|||
163120446|NCT02785458|589148420|FG000|1 Month|Completed Evaluation by Baseline|42|||
163120447|NCT02785458|589148421|FG001|1 Month|Completed Evaluation by Baseline|39|||
163120448|NCT02785458|589148420|FG000|1 Month|Partial Interview|0|||
163120449|NCT02785458|589148421|FG001|1 Month|Partial Interview|4|||
163120450|NCT02785458|589148420|FG000|3 Months|Withdrawal by Subject|3|||
163120451|NCT02785458|589148421|FG001|3 Months|Withdrawal by Subject|1|||
163120452|NCT02785458|589148420|FG000|3 Months|Lost to Follow-up|25|||
163120453|NCT02785458|589148421|FG001|3 Months|Lost to Follow-up|21|||
163120454|NCT02785458|589148420|FG000|3 Months|Completed Evaluation at 1 Month|100|||
163120455|NCT02785458|589148421|FG001|3 Months|Completed Evaluation at 1 Month|89|||
163120456|NCT01146652|589148422|FG000|Overall Study|Adverse Event|506|||
163120457|NCT01146652|589148423|FG001|Overall Study|Adverse Event|15|||
163120458|NCT01146652|589148422|FG000|Overall Study|Lack of Efficacy|91|||
163120459|NCT01146652|589148423|FG001|Overall Study|Lack of Efficacy|7|||
163120460|NCT01146652|589148422|FG000|Overall Study|Poor compliance to protocol|38|||
163120461|NCT01146652|589148423|FG001|Overall Study|Poor compliance to protocol|1|||
163120462|NCT01146652|589148422|FG000|Overall Study|Other unspecified reasons|314|||
163120463|NCT01146652|589148423|FG001|Overall Study|Other unspecified reasons|22|||
163120464|NCT01146652|589148422|FG000|Overall Study|Enrolled but not treated|2|||
163120465|NCT01146652|589148423|FG001|Overall Study|Enrolled but not treated|0|||
163224657|NCT01101841|589539974|FG000|Overall Study|Suicidality Tracking Scale|3|||
163224658|NCT01101841|589539975|FG001|Overall Study|Suicidality Tracking Scale|1|||
163224659|NCT01101841|589539974|FG000|Overall Study|Eligibility Criteria|1|||
163224660|NCT01101841|589539975|FG001|Overall Study|Eligibility Criteria|2|||
163224661|NCT00588445|589539978|FG000|Overall Study|Protocol Violation|1|||
163224662|NCT00588445|589539978|FG000|Overall Study|Withdrawal by Subject|3|||
163224663|NCT00588445|589539978|FG000|Overall Study|Disease Progression|1|||
163224664|NCT00588445|589539978|FG000|Overall Study|Not Treated|10|||
163224665|NCT00358527|589539979|FG000|Overall Study|Adverse Event|4|||
163224666|NCT00358527|589539980|FG001|Overall Study|Adverse Event|0|||
163224667|NCT00358527|589539979|FG000|Overall Study|Withdrawal by Subject|1|||
163224668|NCT00358527|589539980|FG001|Overall Study|Withdrawal by Subject|1|||
163224669|NCT00358527|589539979|FG000|Overall Study|Non-compliance with protocol|6|||
163224670|NCT00358527|589539980|FG001|Overall Study|Non-compliance with protocol|1|||
163224671|NCT00358527|589539979|FG000|Overall Study|Administrative|2|||
163224672|NCT00358527|589539980|FG001|Overall Study|Administrative|1|||
163224673|NCT00145509|589539983|FG000|Overall Study|Adverse Event|10|||
163224674|NCT00145509|589539984|FG001|Overall Study|Adverse Event|3|||
163224675|NCT00145509|589539983|FG000|Overall Study|Lack of Efficacy|3|||
163224676|NCT00145509|589539984|FG001|Overall Study|Lack of Efficacy|1|||
163224677|NCT00145509|589539983|FG000|Overall Study|Lost to Follow-up|5|||
163224678|NCT00145509|589539984|FG001|Overall Study|Lost to Follow-up|9|||
163224679|NCT00145509|589539983|FG000|Overall Study|Withdrew Consent|2|||
163224680|NCT00145509|589539984|FG001|Overall Study|Withdrew Consent|7|||
163224681|NCT00145509|589539983|FG000|Overall Study|Reason not provided|2|||
163224682|NCT00145509|589539984|FG001|Overall Study|Reason not provided|1|||
163224683|NCT00697346|589539989|FG000|Overall Study|Adverse Event|4|||
163224684|NCT00697346|589539990|FG001|Overall Study|Adverse Event|5|||
163224685|NCT00697346|589539991|FG002|Overall Study|Adverse Event|0|||
163224686|NCT00697346|589539989|FG000|Overall Study|Progressive Disease|19|||
163224687|NCT00697346|589539990|FG001|Overall Study|Progressive Disease|18|||
163224688|NCT00697346|589539991|FG002|Overall Study|Progressive Disease|0|||
163224689|NCT00697346|589539989|FG000|Overall Study|Symptomatic Deterioration|0|||
163224690|NCT00697346|589539990|FG001|Overall Study|Symptomatic Deterioration|1|||
163224691|NCT00697346|589539991|FG002|Overall Study|Symptomatic Deterioration|0|||
163224692|NCT00697346|589539989|FG000|Overall Study|Withdrawal by Subject|2|||
163120466|NCT02590562|589148431|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
163120467|NCT01457950|589148432|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
163120468|NCT01457950|589148433|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
163120469|NCT01457950|589148434|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
163120470|NCT01457950|589148435|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
163120471|NCT01457950|589148432|FG000|Double-Blind Phase|Protocol Violation|2|||
163120472|NCT01457950|589148433|FG001|Double-Blind Phase|Protocol Violation|1|||
163120473|NCT01457950|589148434|FG002|Double-Blind Phase|Protocol Violation|0|||
163120474|NCT01457950|589148435|FG003|Double-Blind Phase|Protocol Violation|0|||
163120475|NCT01457950|589148432|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
163120476|NCT01457950|589148433|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
163120477|NCT01457950|589148434|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
163224693|NCT00697346|589539990|FG001|Overall Study|Withdrawal by Subject|2|||
163224694|NCT00697346|589539991|FG002|Overall Study|Withdrawal by Subject|0|||
163224695|NCT00697346|589539989|FG000|Overall Study|Reason not Specified|3|||
163224696|NCT00697346|589539990|FG001|Overall Study|Reason not Specified|0|||
163224697|NCT00697346|589539991|FG002|Overall Study|Reason not Specified|1|||
163224698|NCT03569371|589539992|FG000|Overall Study|Lack of Efficacy|1|||
163224699|NCT03569371|589539992|FG000|Overall Study|Lost to Follow-up|1|||
163224700|NCT03569371|589539992|FG000|Overall Study|Adverse Event|1|||
163224701|NCT03643562|589539995|FG000|Overall Study|Adverse Event|1|||
163340883|NCT03541369|589956882|FG004|Overall Study|Decision by sponsor|0|||
163340884|NCT03541369|589956883|FG005|Overall Study|Decision by sponsor|2|||
163340885|NCT03541369|589956884|FG006|Overall Study|Decision by sponsor|0|||
163340886|NCT03541369|589956885|FG007|Overall Study|Decision by sponsor|1|||
163340887|NCT03541369|589956886|FG008|Overall Study|Decision by sponsor|2|||
163340888|NCT03541369|589956887|FG009|Overall Study|Decision by sponsor|0|||
163340889|NCT03541369|589956888|FG010|Overall Study|Decision by sponsor|0|||
163120478|NCT01457950|589148435|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
163120479|NCT01457950|589148432|FG000|Open-Label Phase|Adverse Event|0|||
163120480|NCT01457950|589148433|FG001|Open-Label Phase|Adverse Event|0|||
163120481|NCT01457950|589148434|FG002|Open-Label Phase|Adverse Event|0|||
163120482|NCT01457950|589148435|FG003|Open-Label Phase|Adverse Event|1|||
163120483|NCT01457950|589148432|FG000|Open-Label Phase|Protocol Violation|0|||
163120484|NCT01457950|589148433|FG001|Open-Label Phase|Protocol Violation|0|||
163120485|NCT01457950|589148434|FG002|Open-Label Phase|Protocol Violation|0|||
163120486|NCT01457950|589148435|FG003|Open-Label Phase|Protocol Violation|1|||
163120487|NCT01457950|589148432|FG000|Open-Label Phase|Withdrawal by Subject|0|||
163120488|NCT01457950|589148433|FG001|Open-Label Phase|Withdrawal by Subject|0|||
163120489|NCT01457950|589148434|FG002|Open-Label Phase|Withdrawal by Subject|2|||
163120490|NCT01457950|589148435|FG003|Open-Label Phase|Withdrawal by Subject|0|||
163120491|NCT03351114|589148438|FG000|Overall Study|Withdrawal by Subject|1|||
163120492|NCT00989235|589148442|FG000|Overall Study|Death|0|||
163120493|NCT00989235|589148443|FG001|Overall Study|Death|1|||
163120494|NCT00989235|589148442|FG000|Overall Study|Adverse Event|0|||
163120495|NCT00989235|589148443|FG001|Overall Study|Adverse Event|1|||
163120496|NCT00989235|589148442|FG000|Overall Study|Lack of Efficacy|1|||
163120497|NCT00989235|589148443|FG001|Overall Study|Lack of Efficacy|0|||
163120498|NCT00989235|589148442|FG000|Overall Study|Withdrawal of Consent|1|||
163120499|NCT00989235|589148443|FG001|Overall Study|Withdrawal of Consent|1|||
163120500|NCT00989235|589148442|FG000|Overall Study|Desire to Become Pregnant|1|||
163120501|NCT00989235|589148443|FG001|Overall Study|Desire to Become Pregnant|0|||
163120502|NCT00989235|589148442|FG000|Overall Study|Randomized by Mistake|0|||
163120503|NCT00989235|589148443|FG001|Overall Study|Randomized by Mistake|2|||
163120504|NCT00989235|589148442|FG000|Overall Study|Lost to Follow-up|0|||
163120505|NCT00989235|589148443|FG001|Overall Study|Lost to Follow-up|1|||
163120506|NCT03249935|589148444|FG000|Overall Study|Discharged from facility early|36|||
163120507|NCT03249935|589148444|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
163120508|NCT03249935|589148444|FG000|Overall Study|Protocol Violation|5|||
163120509|NCT03780959|589148450|FG000|Part 1|Adverse Event|1|||
163120510|NCT03780959|589148451|FG001|Part 1|Adverse Event|0|||
163120511|NCT03780959|589148452|FG002|Part 1|Adverse Event|0|||
163120512|NCT03780959|589148450|FG000|Part 1|Withdrawal by Subject|1|||
163120513|NCT03780959|589148451|FG001|Part 1|Withdrawal by Subject|0|||
163120514|NCT03780959|589148452|FG002|Part 1|Withdrawal by Subject|0|||
163120515|NCT03780959|589148450|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
163120516|NCT03780959|589148451|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
163120517|NCT03780959|589148452|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
163120518|NCT03780959|589148450|FG000|Part 1|Response Status|2|||
163120519|NCT03780959|589148451|FG001|Part 1|Response Status|0|||
163120520|NCT03780959|589148452|FG002|Part 1|Response Status|0|||
163120521|NCT03780959|589148450|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
163120522|NCT03780959|589148451|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
163120523|NCT03780959|589148452|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
163120524|NCT03780959|589148450|FG000|Part 2|Response Status|0|||
163340890|NCT03541369|589956889|FG011|Overall Study|Decision by sponsor|0|||
163340891|NCT03541369|589956890|FG012|Overall Study|Decision by sponsor|2|||
163120525|NCT03780959|589148451|FG001|Part 2|Response Status|18|||
163120526|NCT03780959|589148452|FG002|Part 2|Response Status|6|||
163120527|NCT04732949|589150270|FG000|Overall Study|Withdrawal by Subject|23|||
163120528|NCT04732949|589150271|FG001|Overall Study|Withdrawal by Subject|27|||
163120529|NCT04732949|589150270|FG000|Overall Study|Protocol Violation|0|||
163120530|NCT04732949|589150271|FG001|Overall Study|Protocol Violation|1|||
163120531|NCT04732949|589150270|FG000|Overall Study|Non-compliance|0|||
163120532|NCT04732949|589150271|FG001|Overall Study|Non-compliance|2|||
163120533|NCT04732949|589150270|FG000|Overall Study|Physician Decision|2|||
163120534|NCT04732949|589150271|FG001|Overall Study|Physician Decision|1|||
163120535|NCT04732949|589150270|FG000|Overall Study|Serious adverse event (Fatal)|16|||
163224702|NCT03643562|589539996|FG001|Overall Study|Adverse Event|0|||
163340892|NCT03541369|589956891|FG013|Overall Study|Decision by sponsor|2|||
163340893|NCT03541369|589956892|FG014|Overall Study|Decision by sponsor|0|||
163120536|NCT04732949|589150271|FG001|Overall Study|Serious adverse event (Fatal)|18|||
163120537|NCT04732949|589150270|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
163120538|NCT04732949|589150271|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
163340894|NCT03541369|589956893|FG015|Overall Study|Decision by sponsor|1|||
163340895|NCT03541369|589956894|FG016|Overall Study|Decision by sponsor|1|||
163340896|NCT03541369|589956895|FG017|Overall Study|Decision by sponsor|1|||
163340897|NCT03541369|589956878|FG000|Overall Study|Withdrawal by Subject|0|||
163120539|NCT04732949|589150270|FG000|Overall Study|Non-serious adverse event|1|||
163340898|NCT03541369|589956879|FG001|Overall Study|Withdrawal by Subject|0|||
163224703|NCT03643562|589539995|FG000|Overall Study|Lack of Efficacy|0|||
163224704|NCT03643562|589539996|FG001|Overall Study|Lack of Efficacy|1|||
163224705|NCT03643562|589539995|FG000|Overall Study|Physician Decision|0|||
163224706|NCT03643562|589539996|FG001|Overall Study|Physician Decision|1|||
163224707|NCT03643562|589539995|FG000|Overall Study|Study Terminated by Sponsor|2|||
163224708|NCT03643562|589539996|FG001|Overall Study|Study Terminated by Sponsor|10|||
163224709|NCT03643562|589539995|FG000|Overall Study|Withdrawal by Subject|2|||
163224710|NCT03643562|589539996|FG001|Overall Study|Withdrawal by Subject|2|||
163224711|NCT03643562|589539995|FG000|Overall Study|Other than specified|3|||
163224712|NCT03643562|589539996|FG001|Overall Study|Other than specified|2|||
163224713|NCT01982253|589539997|FG000|Overall Study|Withdrawal by Subject|1|||
163224714|NCT01982253|589539998|FG001|Overall Study|Withdrawal by Subject|0|||
163224715|NCT01982253|589539999|FG002|Overall Study|Withdrawal by Subject|0|||
163224716|NCT01982253|589539997|FG000|Overall Study|Study terminated by sponsor|1|||
163224717|NCT01982253|589539998|FG001|Overall Study|Study terminated by sponsor|4|||
163224718|NCT01982253|589539999|FG002|Overall Study|Study terminated by sponsor|4|||
163224719|NCT02223767|589540003|FG000|Overall Study|Withdrawal by Subject|4|||
163224720|NCT02223767|589540004|FG001|Overall Study|Withdrawal by Subject|4|||
163224721|NCT02789176|589540005|FG000|Overall Study|Death|0|||
163224722|NCT02789176|589540006|FG001|Overall Study|Death|0|||
163224723|NCT02789176|589540007|FG002|Overall Study|Death|3|||
163224724|NCT02789176|589540008|FG003|Overall Study|Death|0|||
163224725|NCT02789176|589540005|FG000|Overall Study|Withdrawal by Subject|0|||
163224726|NCT02789176|589540006|FG001|Overall Study|Withdrawal by Subject|0|||
163224727|NCT02789176|589540007|FG002|Overall Study|Withdrawal by Subject|1|||
163224728|NCT02789176|589540008|FG003|Overall Study|Withdrawal by Subject|0|||
163224729|NCT02789176|589540005|FG000|Overall Study|Lost to Follow-up|8|||
163224730|NCT02789176|589540006|FG001|Overall Study|Lost to Follow-up|2|||
163224731|NCT02789176|589540007|FG002|Overall Study|Lost to Follow-up|6|||
163224732|NCT02789176|589540008|FG003|Overall Study|Lost to Follow-up|1|||
163224733|NCT00770120|589540014|FG000|Overall Study|Progression|31|||
163224734|NCT00770120|589540014|FG000|Overall Study|Adverse Event|11|||
163224735|NCT00770120|589540014|FG000|Overall Study|Not Protocol Specified|11|||
163224736|NCT00770120|589540014|FG000|Overall Study|Death|3|||
163224737|NCT00770120|589540014|FG000|Overall Study|Withdrawal by Subject|2|||
163224738|NCT00770120|589540014|FG000|Overall Study|Ineligible|1|||
163224739|NCT00770120|589540014|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
163224740|NCT00770120|589540014|FG000|Overall Study|Reason under Review|1|||
163224741|NCT02412631|589540015|FG000|Overall Study|Adverse Event|1|||
163224742|NCT02412631|589540016|FG001|Overall Study|Adverse Event|2|||
163224743|NCT02412631|589540015|FG000|Overall Study|Lost to Follow-up|5|||
163224744|NCT02412631|589540016|FG001|Overall Study|Lost to Follow-up|9|||
163224745|NCT02412631|589540015|FG000|Overall Study|Withdrawal by Subject|9|||
163224746|NCT02412631|589540016|FG001|Overall Study|Withdrawal by Subject|3|||
163224747|NCT02412631|589540015|FG000|Overall Study|Early stop by FDA|5|||
163224748|NCT02412631|589540016|FG001|Overall Study|Early stop by FDA|2|||
163224749|NCT02412631|589540015|FG000|Overall Study|Unspecified reason|6|||
163224750|NCT02412631|589540016|FG001|Overall Study|Unspecified reason|8|||
163224751|NCT03100825|589540021|FG000|Overall Study|Participant/Guardian Decision|7|||
163224752|NCT03100825|589540021|FG000|Overall Study|Physician Decision|1|||
163224753|NCT00994448|589540022|FG000|Overall Study|Adverse Event|1|||
163224754|NCT00994448|589540023|FG001|Overall Study|Adverse Event|0|||
163224755|NCT00994448|589540022|FG000|Overall Study|Lost to Follow-up|5|||
163224756|NCT00994448|589540023|FG001|Overall Study|Lost to Follow-up|1|||
163224757|NCT00994448|589540022|FG000|Overall Study|Withdrawal by Subject|1|||
163224758|NCT00994448|589540023|FG001|Overall Study|Withdrawal by Subject|1|||
163224759|NCT00994448|589540022|FG000|Overall Study|Physician Decision|1|||
163224760|NCT00994448|589540023|FG001|Overall Study|Physician Decision|0|||
163224761|NCT05288556|589540025|FG000|Overall Study|Protocol Violation|1|||
163120540|NCT04732949|589150271|FG001|Overall Study|Non-serious adverse event|3|||
163120541|NCT04732949|589150270|FG000|Overall Study|Lost to Follow-up|26|||
163120542|NCT04732949|589150271|FG001|Overall Study|Lost to Follow-up|27|||
163120543|NCT04732949|589150270|FG000|Overall Study|Other|6|||
163120544|NCT04732949|589150271|FG001|Overall Study|Other|3|||
163120545|NCT01023672|589150272|FG000|Overall Study|Worsening disease|2|||
163120546|NCT01023672|589150272|FG000|Overall Study|Death|1|||
163120547|NCT01286077|589150273|FG000|Overall Study|Adverse Event|2|||
163120548|NCT01286077|589150274|FG001|Overall Study|Adverse Event|0|||
163120549|NCT01286077|589150273|FG000|Overall Study|Death|1|||
163120550|NCT01286077|589150274|FG001|Overall Study|Death|0|||
163224762|NCT05288556|589540025|FG000|Overall Study|Withdrawal by Subject|1|||
163224763|NCT02704364|589540026|FG000|Overall Study|Adverse Event|1|||
163224764|NCT02704364|589540027|FG001|Overall Study|Adverse Event|1|||
163224765|NCT02704364|589540028|FG002|Overall Study|Adverse Event|0|||
163224766|NCT02704364|589540026|FG000|Overall Study|Noncompliance with study drug|1|||
163224767|NCT02704364|589540027|FG001|Overall Study|Noncompliance with study drug|1|||
163224768|NCT02704364|589540028|FG002|Overall Study|Noncompliance with study drug|0|||
163224769|NCT02704364|589540026|FG000|Overall Study|Other|0|||
163224770|NCT02704364|589540027|FG001|Overall Study|Other|1|||
163120551|NCT01286077|589150273|FG000|Overall Study|Protocol Violation|1|||
163120552|NCT01286077|589150274|FG001|Overall Study|Protocol Violation|1|||
163120553|NCT01286077|589150273|FG000|Overall Study|Withdrawal by Subject|0|||
163120554|NCT01286077|589150274|FG001|Overall Study|Withdrawal by Subject|2|||
163120555|NCT01286077|589150273|FG000|Overall Study|Intercurrent illness|1|||
163120556|NCT01286077|589150274|FG001|Overall Study|Intercurrent illness|0|||
163120557|NCT01286077|589150273|FG000|Overall Study|Non-compliance|1|||
163120558|NCT01286077|589150274|FG001|Overall Study|Non-compliance|0|||
163120559|NCT01286077|589150273|FG000|Overall Study|The subject starts with alternative MMY|0|||
163120560|NCT01286077|589150274|FG001|Overall Study|The subject starts with alternative MMY|3|||
163120561|NCT01286077|589150273|FG000|Overall Study|Patient's decision to stop treatment|3|||
163120562|NCT01286077|589150274|FG001|Overall Study|Patient's decision to stop treatment|0|||
163120563|NCT01286077|589150273|FG000|Overall Study|Progression of disease|0|||
163120564|NCT01286077|589150274|FG001|Overall Study|Progression of disease|1|||
163120565|NCT01286077|589150273|FG000|Overall Study|refill medication not received in time|1|||
163120566|NCT01286077|589150274|FG001|Overall Study|refill medication not received in time|0|||
163120567|NCT02654236|589150275|FG000|Overall Study|Withdrawal by Subject|0|||
163120568|NCT02654236|589150276|FG001|Overall Study|Withdrawal by Subject|0|||
163120569|NCT02654236|589150277|FG002|Overall Study|Withdrawal by Subject|2|||
163120570|NCT01549873|589150278|FG000|Overall Study|Physician Decision|0|||
163120571|NCT01549873|589150279|FG001|Overall Study|Physician Decision|1|||
163120572|NCT02905006|589150280|FG000|Overall Study|Adverse Event|1|||
163120573|NCT02905006|589150281|FG001|Overall Study|Adverse Event|1|||
163120574|NCT02905006|589150282|FG002|Overall Study|Adverse Event|1|||
163120575|NCT02905006|589150283|FG003|Overall Study|Adverse Event|1|||
163120576|NCT02905006|589150284|FG004|Overall Study|Adverse Event|0|||
163120577|NCT02905006|589150285|FG005|Overall Study|Adverse Event|1|||
163120578|NCT02905006|589150280|FG000|Overall Study|Lack of Efficacy|1|||
163120579|NCT02905006|589150281|FG001|Overall Study|Lack of Efficacy|0|||
163120580|NCT02905006|589150282|FG002|Overall Study|Lack of Efficacy|0|||
163120581|NCT02905006|589150283|FG003|Overall Study|Lack of Efficacy|0|||
163120582|NCT02905006|589150284|FG004|Overall Study|Lack of Efficacy|0|||
163120583|NCT02905006|589150285|FG005|Overall Study|Lack of Efficacy|0|||
163120584|NCT02905006|589150280|FG000|Overall Study|Protocol Violation|2|||
163120585|NCT02905006|589150281|FG001|Overall Study|Protocol Violation|0|||
163120586|NCT02905006|589150282|FG002|Overall Study|Protocol Violation|0|||
163120587|NCT02905006|589150283|FG003|Overall Study|Protocol Violation|0|||
163120588|NCT02905006|589150284|FG004|Overall Study|Protocol Violation|0|||
163120589|NCT02905006|589150285|FG005|Overall Study|Protocol Violation|0|||
163120590|NCT02905006|589150280|FG000|Overall Study|Lost to Follow-up|0|||
163120591|NCT02905006|589150281|FG001|Overall Study|Lost to Follow-up|0|||
163120592|NCT02905006|589150282|FG002|Overall Study|Lost to Follow-up|0|||
163120593|NCT02905006|589150283|FG003|Overall Study|Lost to Follow-up|1|||
163120594|NCT02905006|589150284|FG004|Overall Study|Lost to Follow-up|1|||
163120595|NCT02905006|589150285|FG005|Overall Study|Lost to Follow-up|0|||
163120596|NCT02905006|589150280|FG000|Overall Study|Withdrawal by Subject|0|||
163120597|NCT02905006|589150281|FG001|Overall Study|Withdrawal by Subject|0|||
163120598|NCT02905006|589150282|FG002|Overall Study|Withdrawal by Subject|1|||
163120599|NCT02905006|589150283|FG003|Overall Study|Withdrawal by Subject|1|||
163120600|NCT02905006|589150284|FG004|Overall Study|Withdrawal by Subject|0|||
163120601|NCT02905006|589150285|FG005|Overall Study|Withdrawal by Subject|1|||
163120602|NCT02905006|589150280|FG000|Overall Study|Screening exclusion criteria met|1|||
163120603|NCT02905006|589150281|FG001|Overall Study|Screening exclusion criteria met|0|||
163120604|NCT02905006|589150282|FG002|Overall Study|Screening exclusion criteria met|0|||
163120605|NCT02905006|589150283|FG003|Overall Study|Screening exclusion criteria met|0|||
163120606|NCT02905006|589150284|FG004|Overall Study|Screening exclusion criteria met|0|||
163120607|NCT02905006|589150285|FG005|Overall Study|Screening exclusion criteria met|0|||
163120608|NCT02905006|589150280|FG000|Overall Study|Lab withdrawal criterion met|0|||
163120609|NCT02905006|589150281|FG001|Overall Study|Lab withdrawal criterion met|1|||
163120610|NCT02905006|589150282|FG002|Overall Study|Lab withdrawal criterion met|2|||
163120611|NCT02905006|589150283|FG003|Overall Study|Lab withdrawal criterion met|2|||
163120612|NCT02905006|589150284|FG004|Overall Study|Lab withdrawal criterion met|2|||
163120613|NCT02905006|589150285|FG005|Overall Study|Lab withdrawal criterion met|1|||
163120614|NCT02905006|589150280|FG000|Overall Study|Positive for Tuberculosis|0|||
163120615|NCT02905006|589150281|FG001|Overall Study|Positive for Tuberculosis|1|||
163120616|NCT02905006|589150282|FG002|Overall Study|Positive for Tuberculosis|0|||
163120617|NCT02905006|589150283|FG003|Overall Study|Positive for Tuberculosis|0|||
163120618|NCT02905006|589150284|FG004|Overall Study|Positive for Tuberculosis|0|||
163120619|NCT02905006|589150285|FG005|Overall Study|Positive for Tuberculosis|0|||
163120620|NCT02905006|589150280|FG000|Overall Study|Subject positive for Hep B|0|||
163120621|NCT02905006|589150281|FG001|Overall Study|Subject positive for Hep B|0|||
163120622|NCT02905006|589150282|FG002|Overall Study|Subject positive for Hep B|1|||
163120623|NCT02905006|589150283|FG003|Overall Study|Subject positive for Hep B|0|||
163120624|NCT02905006|589150284|FG004|Overall Study|Subject positive for Hep B|0|||
163120625|NCT02905006|589150285|FG005|Overall Study|Subject positive for Hep B|0|||
163120626|NCT02905006|589150280|FG000|Overall Study|Patient moved abroad|0|||
163120627|NCT02905006|589150281|FG001|Overall Study|Patient moved abroad|0|||
163120628|NCT02905006|589150282|FG002|Overall Study|Patient moved abroad|0|||
163120629|NCT02905006|589150283|FG003|Overall Study|Patient moved abroad|1|||
163120630|NCT02905006|589150284|FG004|Overall Study|Patient moved abroad|0|||
163120631|NCT02905006|589150285|FG005|Overall Study|Patient moved abroad|0|||
163120632|NCT02905006|589150280|FG000|Overall Study|Patient randomized by mistake|0|||
163120633|NCT02905006|589150281|FG001|Overall Study|Patient randomized by mistake|0|||
163120634|NCT02905006|589150282|FG002|Overall Study|Patient randomized by mistake|0|||
163120635|NCT02905006|589150283|FG003|Overall Study|Patient randomized by mistake|0|||
163120636|NCT02905006|589150284|FG004|Overall Study|Patient randomized by mistake|0|||
163120637|NCT02905006|589150285|FG005|Overall Study|Patient randomized by mistake|1|||
163120638|NCT03627065|589150288|FG000|Overall Study|Study Terminated by sponsor|1|||
163120639|NCT03627065|589150288|FG000|Overall Study|Withdrawal by Subject|2|||
163120640|NCT02797184|589150289|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
163120641|NCT02797184|589150290|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
163120642|NCT06250738|589150291|FG000|Overall Study|Lost to Follow-up|1|||
163120643|NCT04912895|589150292|FG000|Overall Study|Unable to provide specimen|2|||
163120644|NCT04912895|589150293|FG001|Overall Study|Unable to provide specimen|0|||
163120645|NCT04912895|589150294|FG002|Overall Study|Unable to provide specimen|0|||
163120646|NCT03294135|589150295|FG000|Overall Study|Serious Adverse Event|1|||
163120647|NCT03294135|589150296|FG001|Overall Study|Serious Adverse Event|0|||
163120648|NCT03294135|589150297|FG002|Overall Study|Serious Adverse Event|0|||
163120649|NCT03294135|589150295|FG000|Overall Study|Lost to Follow-up|1|||
163120650|NCT03294135|589150296|FG001|Overall Study|Lost to Follow-up|0|||
163120651|NCT03294135|589150297|FG002|Overall Study|Lost to Follow-up|1|||
163120652|NCT03294135|589150295|FG000|Overall Study|Withdrawal by Subject|0|||
163120653|NCT03294135|589150296|FG001|Overall Study|Withdrawal by Subject|0|||
163120654|NCT03294135|589150297|FG002|Overall Study|Withdrawal by Subject|1|||
163120655|NCT03294135|589150295|FG000|Overall Study|Other|2|||
163120656|NCT03294135|589150296|FG001|Overall Study|Other|0|||
163120657|NCT03294135|589150297|FG002|Overall Study|Other|0|||
163120658|NCT02763254|589150298|FG000|Overall Study|Adverse Event|1|||
163120659|NCT03684304|589150299|FG000|Overall Study|Lost to Follow-up|19|||
163120660|NCT03684304|589150300|FG001|Overall Study|Lost to Follow-up|17|||
163120661|NCT00824005|589150301|FG000|Overall Study|Death|0|||
163120662|NCT00824005|589150302|FG001|Overall Study|Death|1|||
163120663|NCT00824005|589150301|FG000|Overall Study|Lost to Follow-up|0|||
163120664|NCT00824005|589150302|FG001|Overall Study|Lost to Follow-up|1|||
163120665|NCT01510184|589150303|FG000|Overall Study|Sponsor discretion|28|||
163120666|NCT01510184|589150304|FG001|Overall Study|Sponsor discretion|28|||
163120667|NCT01510184|589150303|FG000|Overall Study|Death|1|||
163120668|NCT01510184|589150304|FG001|Overall Study|Death|2|||
163120669|NCT01510184|589150303|FG000|Overall Study|Withdrawal by Subject|1|||
163120670|NCT01510184|589150304|FG001|Overall Study|Withdrawal by Subject|4|||
163120671|NCT01510184|589150303|FG000|Overall Study|Other|0|||
163120672|NCT01510184|589150304|FG001|Overall Study|Other|1|||
163120673|NCT01143051|589150305|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
163120674|NCT01143051|589150306|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
163120675|NCT01143051|589150307|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
163120676|NCT01143051|589150308|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
163120677|NCT01143051|589150309|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
163120678|NCT01143051|589150310|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
163120679|NCT01143051|589150305|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
163120680|NCT01143051|589150306|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
163120681|NCT01143051|589150307|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
163120682|NCT01143051|589150308|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
163120683|NCT01143051|589150309|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
163120684|NCT01143051|589150310|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
163120685|NCT03458702|589150311|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
163120686|NCT03458702|589150312|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
163120687|NCT03458702|589150311|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
163120688|NCT03458702|589150312|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
163120689|NCT01390779|589150313|FG000|Overall Study|Physician Decision|1|||
163120690|NCT01697462|589150314|FG000|Overall Study|Disease Progression|1|||
163120691|NCT01697462|589150314|FG000|Overall Study|Adverse Event|6|||
163120692|NCT01697462|589150314|FG000|Overall Study|Lost to Follow-up|21|||
163120693|NCT01697462|589150314|FG000|Overall Study|Withdrawal by Subject|12|||
163120694|NCT01697462|589150314|FG000|Overall Study|Investigator Decision|21|||
163120695|NCT01697462|589150314|FG000|Overall Study|Death|1|||
163120696|NCT01697462|589150314|FG000|Overall Study|Other|10|||
163120697|NCT01697462|589150314|FG000|Overall Study|Missing|5|||
163120698|NCT02255565|589150321|FG000|Overall Study|Withdrawal by Subject|0|||
163120699|NCT02255565|589150322|FG001|Overall Study|Withdrawal by Subject|1|||
163120700|NCT02255565|589150323|FG002|Overall Study|Withdrawal by Subject|0|||
163120701|NCT01635764|589150324|FG000|Overall Study|Adverse Event|46|||
163120702|NCT01635764|589150324|FG000|Overall Study|Lack of Efficacy|76|||
163120703|NCT01635764|589150324|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
163120704|NCT01635764|589150324|FG000|Overall Study|Protocol Deviation|1|||
163120705|NCT01635764|589150324|FG000|Overall Study|Withdrew Consent|67|||
163120706|NCT01635764|589150324|FG000|Overall Study|Lost to Follow-up|53|||
163120707|NCT01635764|589150324|FG000|Overall Study|Other|28|||
163120708|NCT01816906|589150328|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
163120709|NCT01816906|589150329|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
163120710|NCT01816906|589150328|FG000|Six Months|Lost to Follow-up|14|||
163120711|NCT01816906|589150329|FG001|Six Months|Lost to Follow-up|16|||
163120712|NCT01816906|589150328|FG000|12 Months|Adverse Event|2|||
163120713|NCT01816906|589150329|FG001|12 Months|Adverse Event|2|||
163120714|NCT01816906|589150328|FG000|12 Months|Death|0|||
163120715|NCT01816906|589150329|FG001|12 Months|Death|2|||
163120716|NCT01816906|589150328|FG000|12 Months|Lost to Follow-up|2|||
163120717|NCT01816906|589150329|FG001|12 Months|Lost to Follow-up|1|||
163120718|NCT04375397|589150330|FG000|Overall Study|Death|1|||
163120719|NCT04375397|589150331|FG001|Overall Study|Death|1|||
163120720|NCT04375397|589150330|FG000|Overall Study|Withdrew consent|2|||
163120721|NCT04375397|589150331|FG001|Overall Study|Withdrew consent|0|||
163120722|NCT04375397|589150330|FG000|Overall Study|Lost to Follow-up|6|||
163120723|NCT04375397|589150331|FG001|Overall Study|Lost to Follow-up|4|||
163120724|NCT04375397|589150330|FG000|Overall Study|Other, not specified|0|||
163120725|NCT04375397|589150331|FG001|Overall Study|Other, not specified|1|||
163120726|NCT00086502|589150332|FG000|Overall Study|Adverse Event|11|||
163120727|NCT00086502|589150333|FG001|Overall Study|Adverse Event|2|||
163120728|NCT00086502|589150332|FG000|Overall Study|Lack of Efficacy|0|||
163120729|NCT00086502|589150333|FG001|Overall Study|Lack of Efficacy|2|||
163120730|NCT00086502|589150332|FG000|Overall Study|Lost to Follow-up|3|||
163120731|NCT00086502|589150333|FG001|Overall Study|Lost to Follow-up|1|||
163120732|NCT00086502|589150332|FG000|Overall Study|Physician Decision|1|||
163120733|NCT00086502|589150333|FG001|Overall Study|Physician Decision|1|||
163120734|NCT00086502|589150332|FG000|Overall Study|Pregnancy|0|||
163120735|NCT00086502|589150333|FG001|Overall Study|Pregnancy|1|||
163120736|NCT00086502|589150332|FG000|Overall Study|Protocol Violation|3|||
163120737|NCT00086502|589150333|FG001|Overall Study|Protocol Violation|3|||
163120738|NCT00086502|589150332|FG000|Overall Study|Withdrawal by Subject|5|||
163120739|NCT00086502|589150333|FG001|Overall Study|Withdrawal by Subject|6|||
163120740|NCT00086502|589150332|FG000|Overall Study|Patient Moved|1|||
163120741|NCT00086502|589150333|FG001|Overall Study|Patient Moved|1|||
163120742|NCT00086502|589150332|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
163120743|NCT00086502|589150333|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
163120744|NCT00086502|589150332|FG000|Overall Study|Patient Accidentally Unblinded|1|||
163120745|NCT00086502|589150333|FG001|Overall Study|Patient Accidentally Unblinded|0|||
163120746|NCT01304329|589150334|FG000|Third Intervention (3 Days)|Adverse Event|0|||
163120747|NCT01304329|589150335|FG001|Third Intervention (3 Days)|Adverse Event|1|||
163120748|NCT01304329|589150336|FG002|Third Intervention (3 Days)|Adverse Event|0|||
163120749|NCT01304329|589150337|FG003|Third Intervention (3 Days)|Adverse Event|0|||
163120750|NCT01304329|589150338|FG004|Third Intervention (3 Days)|Adverse Event|0|||
163120751|NCT01304329|589150339|FG005|Third Intervention (3 Days)|Adverse Event|0|||
163120752|NCT05545644|589150341|FG000|Overall Study|Lost to Follow-up|4|||
163120753|NCT05545644|589150342|FG001|Overall Study|Lost to Follow-up|3|||
163120754|NCT01945775|589150349|FG000|Overall Study|Death|214|||
163120755|NCT01945775|589150350|FG001|Overall Study|Death|98|||
163120756|NCT01945775|589150349|FG000|Overall Study|Lost to Follow-up|12|||
163120757|NCT01945775|589150350|FG001|Overall Study|Lost to Follow-up|7|||
163120758|NCT01945775|589150349|FG000|Overall Study|Withdrawal by Subject|11|||
163120759|NCT01945775|589150350|FG001|Overall Study|Withdrawal by Subject|21|||
163120760|NCT01945775|589150349|FG000|Overall Study|Other|50|||
163120761|NCT01945775|589150350|FG001|Overall Study|Other|18|||
163120762|NCT02876328|589150351|FG000|Overall Study|Death|2|||
163120763|NCT02876328|589150352|FG001|Overall Study|Death|1|||
163120764|NCT02876328|589150353|FG002|Overall Study|Death|3|||
163120765|NCT02876328|589150354|FG003|Overall Study|Death|0|||
163120766|NCT02876328|589150355|FG004|Overall Study|Death|0|||
163120767|NCT02876328|589150356|FG005|Overall Study|Death|0|||
163120768|NCT02876328|589150357|FG006|Overall Study|Death|1|||
163120769|NCT02876328|589150358|FG007|Overall Study|Death|3|||
163120770|NCT02876328|589150359|FG008|Overall Study|Death|0|||
163120771|NCT02876328|589150360|FG009|Overall Study|Death|1|||
163120772|NCT02876328|589150361|FG010|Overall Study|Death|1|||
163120773|NCT02876328|589150362|FG011|Overall Study|Death|0|||
163120774|NCT02876328|589150363|FG012|Overall Study|Death|0|||
163120775|NCT02876328|589150364|FG013|Overall Study|Death|0|||
163120776|NCT02876328|589150365|FG014|Overall Study|Death|0|||
163120777|NCT02876328|589150366|FG015|Overall Study|Death|0|||
163120778|NCT02876328|589150367|FG016|Overall Study|Death|1|||
163120779|NCT02876328|589150368|FG017|Overall Study|Death|1|||
163120780|NCT02876328|589150369|FG018|Overall Study|Death|0|||
163120781|NCT02876328|589150370|FG019|Overall Study|Death|0|||
163120782|NCT02876328|589150371|FG020|Overall Study|Death|0|||
163120783|NCT02876328|589150372|FG021|Overall Study|Death|1|||
163224771|NCT02704364|589540028|FG002|Overall Study|Other|1|||
163224772|NCT01232296|589540029|FG000|Overall Study|Adverse Event|24|||
163224773|NCT01232296|589540030|FG001|Overall Study|Adverse Event|12|||
163224774|NCT01232296|589540029|FG000|Overall Study|Physician Decision|1|||
163224775|NCT01232296|589540030|FG001|Overall Study|Physician Decision|1|||
163224776|NCT01232296|589540029|FG000|Overall Study|Progressive disease|43|||
163224777|NCT01232296|589540030|FG001|Overall Study|Progressive disease|61|||
163224778|NCT01232296|589540029|FG000|Overall Study|Study terminated by sponsor|0|||
163224779|NCT01232296|589540030|FG001|Overall Study|Study terminated by sponsor|1|||
163224780|NCT01232296|589540029|FG000|Overall Study|Technical problems|3|||
163224781|NCT01232296|589540030|FG001|Overall Study|Technical problems|0|||
163224782|NCT01232296|589540029|FG000|Overall Study|Subject/guardian decision|10|||
163224783|NCT01232296|589540030|FG001|Overall Study|Subject/guardian decision|2|||
163224784|NCT01232296|589540029|FG000|Overall Study|Death|1|||
163224785|NCT01232296|589540030|FG001|Overall Study|Death|6|||
163224786|NCT01461096|589540032|FG000|Overall Study|Death|3|||
163224787|NCT01461096|589540033|FG001|Overall Study|Death|6|||
163224788|NCT01461096|589540032|FG000|Overall Study|Severe debilitation, unable to continue|1|||
163224789|NCT01461096|589540033|FG001|Overall Study|Severe debilitation, unable to continue|1|||
163224790|NCT01461096|589540032|FG000|Overall Study|Subj not able to get to clinic|15|||
163224791|NCT01461096|589540033|FG001|Overall Study|Subj not able to get to clinic|13|||
163224792|NCT01461096|589540032|FG000|Overall Study|Site is closing|27|||
163224793|NCT01461096|589540033|FG001|Overall Study|Site is closing|30|||
163224794|NCT01461096|589540032|FG000|Overall Study|Withdrawal by Subject|5|||
163224795|NCT01461096|589540033|FG001|Overall Study|Withdrawal by Subject|3|||
163224796|NCT01461096|589540032|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
163408104|NCT00705939|590204023|FG000|Overall Study|Withdrawal by Subject|0|||
163120784|NCT02876328|589150373|FG022|Overall Study|Death|0|||
163120785|NCT02876328|589150374|FG023|Overall Study|Death|0|||
163120786|NCT02876328|589150351|FG000|Overall Study|Withdrawal by Subject|0|||
163120787|NCT02876328|589150352|FG001|Overall Study|Withdrawal by Subject|2|||
163120788|NCT02876328|589150353|FG002|Overall Study|Withdrawal by Subject|3|||
163120789|NCT02876328|589150354|FG003|Overall Study|Withdrawal by Subject|3|||
163120790|NCT02876328|589150355|FG004|Overall Study|Withdrawal by Subject|0|||
163120791|NCT02876328|589150356|FG005|Overall Study|Withdrawal by Subject|1|||
163120792|NCT02876328|589150357|FG006|Overall Study|Withdrawal by Subject|0|||
163120793|NCT02876328|589150358|FG007|Overall Study|Withdrawal by Subject|1|||
163120794|NCT02876328|589150359|FG008|Overall Study|Withdrawal by Subject|1|||
163120795|NCT02876328|589150360|FG009|Overall Study|Withdrawal by Subject|2|||
163120796|NCT02876328|589150361|FG010|Overall Study|Withdrawal by Subject|0|||
163120797|NCT02876328|589150362|FG011|Overall Study|Withdrawal by Subject|0|||
163120798|NCT02876328|589150363|FG012|Overall Study|Withdrawal by Subject|0|||
163120799|NCT02876328|589150364|FG013|Overall Study|Withdrawal by Subject|0|||
163120800|NCT02876328|589150365|FG014|Overall Study|Withdrawal by Subject|0|||
163120801|NCT02876328|589150366|FG015|Overall Study|Withdrawal by Subject|0|||
163120802|NCT02876328|589150367|FG016|Overall Study|Withdrawal by Subject|1|||
163120803|NCT02876328|589150368|FG017|Overall Study|Withdrawal by Subject|3|||
163120804|NCT02876328|589150369|FG018|Overall Study|Withdrawal by Subject|0|||
163120805|NCT02876328|589150370|FG019|Overall Study|Withdrawal by Subject|0|||
163120806|NCT02876328|589150371|FG020|Overall Study|Withdrawal by Subject|1|||
163120807|NCT02876328|589150372|FG021|Overall Study|Withdrawal by Subject|0|||
163120808|NCT02876328|589150373|FG022|Overall Study|Withdrawal by Subject|0|||
163120809|NCT02876328|589150374|FG023|Overall Study|Withdrawal by Subject|0|||
163120810|NCT02876328|589150351|FG000|Overall Study|Missed 12 Month Visit|15|||
163120811|NCT02876328|589150352|FG001|Overall Study|Missed 12 Month Visit|10|||
163120812|NCT02876328|589150353|FG002|Overall Study|Missed 12 Month Visit|11|||
163120813|NCT02876328|589150354|FG003|Overall Study|Missed 12 Month Visit|6|||
163120814|NCT02876328|589150355|FG004|Overall Study|Missed 12 Month Visit|10|||
163120815|NCT02876328|589150356|FG005|Overall Study|Missed 12 Month Visit|14|||
163120816|NCT02876328|589150357|FG006|Overall Study|Missed 12 Month Visit|3|||
163120817|NCT02876328|589150358|FG007|Overall Study|Missed 12 Month Visit|8|||
163120818|NCT02876328|589150359|FG008|Overall Study|Missed 12 Month Visit|9|||
163120819|NCT02876328|589150360|FG009|Overall Study|Missed 12 Month Visit|5|||
163120820|NCT02876328|589150361|FG010|Overall Study|Missed 12 Month Visit|4|||
163224797|NCT01461096|589540033|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
163224798|NCT01461096|589540032|FG000|Overall Study|Lost to Follow-up|8|||
163224799|NCT01461096|589540033|FG001|Overall Study|Lost to Follow-up|4|||
163408105|NCT00705939|590204024|FG001|Overall Study|Withdrawal by Subject|1|||
163120821|NCT02876328|589150362|FG011|Overall Study|Missed 12 Month Visit|1|||
163120822|NCT02876328|589150363|FG012|Overall Study|Missed 12 Month Visit|5|||
163120823|NCT02876328|589150364|FG013|Overall Study|Missed 12 Month Visit|4|||
163224800|NCT04889625|589540035|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
163224801|NCT04889625|589540036|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
163120824|NCT02876328|589150365|FG014|Overall Study|Missed 12 Month Visit|4|||
163224802|NCT04889625|589540035|FG000|Period 1|Subject out of window|0|||
163224803|NCT04889625|589540036|FG001|Period 1|Subject out of window|1|||
163120825|NCT02876328|589150366|FG015|Overall Study|Missed 12 Month Visit|4|||
163120826|NCT02876328|589150367|FG016|Overall Study|Missed 12 Month Visit|3|||
163120827|NCT02876328|589150368|FG017|Overall Study|Missed 12 Month Visit|6|||
163120828|NCT02876328|589150369|FG018|Overall Study|Missed 12 Month Visit|2|||
163120829|NCT02876328|589150370|FG019|Overall Study|Missed 12 Month Visit|2|||
163120830|NCT02876328|589150371|FG020|Overall Study|Missed 12 Month Visit|11|||
163120831|NCT02876328|589150372|FG021|Overall Study|Missed 12 Month Visit|7|||
163120832|NCT02876328|589150373|FG022|Overall Study|Missed 12 Month Visit|1|||
163120833|NCT02876328|589150374|FG023|Overall Study|Missed 12 Month Visit|0|||
163120834|NCT01995552|589150375|FG000|Overall Study|Protocol Violation|1|||
163120835|NCT01995552|589150375|FG000|Overall Study|Lack of Efficacy|15|||
163120836|NCT01995552|589150375|FG000|Overall Study|Death|1|||
163120837|NCT02068118|589150377|FG000|18-month Comparative Study Period|Death|90|||
163120838|NCT02068118|589150378|FG001|18-month Comparative Study Period|Death|97|||
163120839|NCT02068118|589150377|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
163120840|NCT02068118|589150378|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
163120841|NCT02068118|589150377|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
163120842|NCT02068118|589150378|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
163120843|NCT02068118|589150377|FG000|18-month Comparative Study Period|Heart transplant|9|||
163120844|NCT02068118|589150378|FG001|18-month Comparative Study Period|Heart transplant|15|||
163120845|NCT02068118|589150377|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
163120846|NCT02068118|589150378|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
163120847|NCT02068118|589150377|FG000|18-month Comparative Study Period|Hemiplegia|0|||
163120848|NCT02068118|589150378|FG001|18-month Comparative Study Period|Hemiplegia|1|||
163120849|NCT02068118|589150377|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
163120850|NCT02068118|589150378|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
163120851|NCT02068118|589150377|FG000|18-month Comparative Study Period|Move|0|||
163120852|NCT02068118|589150378|FG001|18-month Comparative Study Period|Move|1|||
163120853|NCT02068118|589150377|FG000|18-month Comparative Study Period|Hearing loss|0|||
163120854|NCT02068118|589150378|FG001|18-month Comparative Study Period|Hearing loss|1|||
163120855|NCT02068118|589150377|FG000|Extension Period|Death|0|||
163120856|NCT02068118|589150378|FG001|Extension Period|Death|2|||
163120857|NCT02068118|589150377|FG000|Extension Period|Withdrawal by Subject|1|||
163120858|NCT02068118|589150378|FG001|Extension Period|Withdrawal by Subject|0|||
163120859|NCT02068118|589150377|FG000|Extension Period|Heart transplant|1|||
163120860|NCT02068118|589150378|FG001|Extension Period|Heart transplant|0|||
163120861|NCT02068118|589150377|FG000|Extension Period|Wrong device use|0|||
163120862|NCT02068118|589150378|FG001|Extension Period|Wrong device use|1|||
163120863|NCT00353873|589150381|FG000|Overall Study|Protocol Violation|1|||
163120864|NCT00353873|589150382|FG001|Overall Study|Protocol Violation|2|||
163120865|NCT00353873|589150381|FG000|Overall Study|Exacerbation|1|||
163120866|NCT00353873|589150382|FG001|Overall Study|Exacerbation|0|||
163120867|NCT00353873|589150381|FG000|Overall Study|Adverse Event|1|||
163120868|NCT00353873|589150382|FG001|Overall Study|Adverse Event|0|||
163120869|NCT00353873|589150381|FG000|Overall Study|Physician Decision|2|||
163120870|NCT00353873|589150382|FG001|Overall Study|Physician Decision|0|||
163120871|NCT00353873|589150381|FG000|Overall Study|Withdrawal by Subject|1|||
163120872|NCT00353873|589150382|FG001|Overall Study|Withdrawal by Subject|1|||
163120873|NCT01420627|589150383|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
163120874|NCT00453973|589150384|FG000|Overall Study|Adverse Event|4|||
163120875|NCT00453973|589150385|FG001|Overall Study|Adverse Event|9|||
163120876|NCT00453973|589150384|FG000|Overall Study|Withdrawal by Subject|7|||
163120877|NCT00453973|589150385|FG001|Overall Study|Withdrawal by Subject|6|||
163120878|NCT00453973|589150384|FG000|Overall Study|PI Decision|0|||
163120879|NCT00453973|589150385|FG001|Overall Study|PI Decision|2|||
163120880|NCT00453973|589150384|FG000|Overall Study|Relocation|1|||
163120881|NCT00453973|589150385|FG001|Overall Study|Relocation|0|||
163120882|NCT00453973|589150384|FG000|Overall Study|Renal transplant|1|||
163120883|NCT00453973|589150385|FG001|Overall Study|Renal transplant|1|||
163120884|NCT00453973|589150384|FG000|Overall Study|Site closed by sponsor|3|||
163120885|NCT00453973|589150385|FG001|Overall Study|Site closed by sponsor|0|||
163120886|NCT00453973|589150384|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
163120887|NCT00453973|589150385|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
163120888|NCT03743064|589150386|FG000|Overall Study|Adverse Event|7|||
163120889|NCT03743064|589150387|FG001|Overall Study|Adverse Event|9|||
163120890|NCT03743064|589150386|FG000|Overall Study|Death|25|||
163120891|NCT03743064|589150387|FG001|Overall Study|Death|28|||
163120892|NCT03743064|589150386|FG000|Overall Study|Lost to Follow-up|3|||
163120893|NCT03743064|589150387|FG001|Overall Study|Lost to Follow-up|6|||
163120894|NCT03743064|589150386|FG000|Overall Study|Withdrawal by Subject|28|||
163120895|NCT03743064|589150387|FG001|Overall Study|Withdrawal by Subject|25|||
163120896|NCT03743064|589150386|FG000|Overall Study|Physician Decision|2|||
163120897|NCT03743064|589150387|FG001|Overall Study|Physician Decision|4|||
163120898|NCT03743064|589150386|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
163120899|NCT03743064|589150387|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
163120900|NCT02759315|589150392|FG000|Overall Study|Adverse Event|0|||
163120901|NCT02759315|589150393|FG001|Overall Study|Adverse Event|0|||
163120902|NCT02759315|589150394|FG002|Overall Study|Adverse Event|0|||
163120903|NCT02759315|589150395|FG003|Overall Study|Adverse Event|1|||
163120904|NCT02759315|589150396|FG004|Overall Study|Adverse Event|0|||
163120905|NCT02759315|589150392|FG000|Overall Study|Death|0|||
163120906|NCT02759315|589150393|FG001|Overall Study|Death|0|||
163120907|NCT02759315|589150394|FG002|Overall Study|Death|1|||
163120908|NCT02759315|589150395|FG003|Overall Study|Death|0|||
163120909|NCT02759315|589150396|FG004|Overall Study|Death|0|||
163120910|NCT02759315|589150392|FG000|Overall Study|Lost to Follow-up|2|||
163120911|NCT02759315|589150393|FG001|Overall Study|Lost to Follow-up|0|||
163120912|NCT02759315|589150394|FG002|Overall Study|Lost to Follow-up|4|||
163340899|NCT03541369|589956880|FG002|Overall Study|Withdrawal by Subject|0|||
163120913|NCT02759315|589150395|FG003|Overall Study|Lost to Follow-up|0|||
163120914|NCT02759315|589150396|FG004|Overall Study|Lost to Follow-up|0|||
163120915|NCT02759315|589150392|FG000|Overall Study|Protocol Violation|0|||
163120916|NCT02759315|589150393|FG001|Overall Study|Protocol Violation|1|||
163120917|NCT02759315|589150394|FG002|Overall Study|Protocol Violation|0|||
163120918|NCT02759315|589150395|FG003|Overall Study|Protocol Violation|0|||
163120919|NCT02759315|589150396|FG004|Overall Study|Protocol Violation|0|||
163120920|NCT02759315|589150392|FG000|Overall Study|Study terminated prior to completion|2|||
163120921|NCT02759315|589150393|FG001|Overall Study|Study terminated prior to completion|0|||
163120922|NCT02759315|589150394|FG002|Overall Study|Study terminated prior to completion|5|||
163120923|NCT02759315|589150395|FG003|Overall Study|Study terminated prior to completion|0|||
163120924|NCT02759315|589150396|FG004|Overall Study|Study terminated prior to completion|1|||
163120925|NCT00870194|589150397|FG000|Overall Study|Adverse Event|10|||
163120926|NCT00870194|589150398|FG001|Overall Study|Adverse Event|5|||
163120927|NCT00870194|589150397|FG000|Overall Study|Lack of Efficacy|0|||
163120928|NCT00870194|589150398|FG001|Overall Study|Lack of Efficacy|1|||
163120929|NCT00870194|589150397|FG000|Overall Study|Lost to Follow-up|2|||
163120930|NCT00870194|589150398|FG001|Overall Study|Lost to Follow-up|0|||
163120931|NCT00870194|589150397|FG000|Overall Study|Physician Decision|3|||
163120932|NCT00870194|589150398|FG001|Overall Study|Physician Decision|1|||
163120933|NCT00870194|589150397|FG000|Overall Study|Protocol Violation|3|||
163120934|NCT00870194|589150398|FG001|Overall Study|Protocol Violation|3|||
163120935|NCT00870194|589150397|FG000|Overall Study|Entry Criteria Not Met|1|||
163120936|NCT00870194|589150398|FG001|Overall Study|Entry Criteria Not Met|2|||
163120937|NCT00870194|589150397|FG000|Overall Study|Subject Decision|7|||
163120938|NCT00870194|589150398|FG001|Overall Study|Subject Decision|2|||
163120939|NCT00582738|589150400|FG000|Overall Study|Administrative Problems|7|||
163120940|NCT00582738|589150401|FG001|Overall Study|Administrative Problems|8|||
163120941|NCT00582738|589150400|FG000|Overall Study|Adverse Event|0|||
163120942|NCT00582738|589150401|FG001|Overall Study|Adverse Event|5|||
163120943|NCT00582738|589150400|FG000|Overall Study|Graft Lost|0|||
163120944|NCT00582738|589150401|FG001|Overall Study|Graft Lost|1|||
163120945|NCT00582738|589150400|FG000|Overall Study|Other|1|||
163120946|NCT00582738|589150401|FG001|Overall Study|Other|0|||
163120947|NCT00582738|589150400|FG000|Overall Study|Protocol Violation|1|||
163120948|NCT00582738|589150401|FG001|Overall Study|Protocol Violation|1|||
163120949|NCT00582738|589150400|FG000|Overall Study|Withdrawal by Subject|0|||
163120950|NCT00582738|589150401|FG001|Overall Study|Withdrawal by Subject|3|||
163120951|NCT01490294|589150403|FG000|Overall Study|Prematurely discontinuation|4|||
163120952|NCT01490294|589150404|FG001|Overall Study|Prematurely discontinuation|0|||
163120953|NCT01490294|589150405|FG002|Overall Study|Prematurely discontinuation|1|||
163120954|NCT01490294|589150406|FG003|Overall Study|Prematurely discontinuation|1|||
163224804|NCT04889625|589540035|FG000|Period 1|Wrong add power dispensed|0|||
163340900|NCT03541369|589956881|FG003|Overall Study|Withdrawal by Subject|0|||
163120955|NCT01490294|589150403|FG000|Overall Study|Adverse Event|1|||
163120956|NCT01490294|589150404|FG001|Overall Study|Adverse Event|0|||
163120957|NCT01490294|589150405|FG002|Overall Study|Adverse Event|0|||
163120958|NCT01490294|589150406|FG003|Overall Study|Adverse Event|0|||
163120959|NCT02210091|589150412|FG000|Overall Study|Physician Decision|0|||
163120960|NCT02210091|589150413|FG001|Overall Study|Physician Decision|1|||
163120961|NCT02210091|589150412|FG000|Overall Study|Withdrawal by Sponsor|0|||
163120962|NCT02210091|589150413|FG001|Overall Study|Withdrawal by Sponsor|1|||
163120963|NCT01831817|589150414|FG000|Overall Study|Lost to Follow-up|1|||
163120964|NCT01831817|589150415|FG001|Overall Study|Lost to Follow-up|0|||
163120965|NCT01831817|589150416|FG002|Overall Study|Lost to Follow-up|0|||
163120966|NCT01831817|589150417|FG003|Overall Study|Lost to Follow-up|0|||
163120967|NCT01831817|589150414|FG000|Overall Study|Withdrawl of Consent|3|||
163120968|NCT01831817|589150415|FG001|Overall Study|Withdrawl of Consent|0|||
163120969|NCT01831817|589150416|FG002|Overall Study|Withdrawl of Consent|0|||
163120970|NCT01831817|589150417|FG003|Overall Study|Withdrawl of Consent|0|||
163120971|NCT00958217|589150418|FG000|Overall Study|Death|2|||
163340901|NCT03541369|589956882|FG004|Overall Study|Withdrawal by Subject|0|||
163120972|NCT00958217|589150419|FG001|Overall Study|Death|1|||
163120973|NCT00958217|589150418|FG000|Overall Study|Withdrawal by Subject|4|||
163120974|NCT00958217|589150419|FG001|Overall Study|Withdrawal by Subject|3|||
163120975|NCT00958217|589150418|FG000|Overall Study|Lost to Follow-up|17|||
163120976|NCT00958217|589150419|FG001|Overall Study|Lost to Follow-up|19|||
163120977|NCT00958217|589150418|FG000|Overall Study|Moved out of area|1|||
163120978|NCT00958217|589150419|FG001|Overall Study|Moved out of area|1|||
163120979|NCT00958217|589150418|FG000|Overall Study|Inpatient hospitalization|0|||
163120980|NCT00958217|589150419|FG001|Overall Study|Inpatient hospitalization|1|||
163120981|NCT00456599|589150421|FG000|Overall Study|Non-compliance|1|||
163120982|NCT00456599|589150421|FG000|Overall Study|Withdrawal by Subject|2|||
163120983|NCT00260065|589150422|FG000|Overall Study|Progressive Disease|22|||
163120984|NCT00260065|589150422|FG000|Overall Study|Adverse Event|17|||
163120985|NCT00260065|589150422|FG000|Overall Study|Death|13|||
163120986|NCT00260065|589150422|FG000|Overall Study|Withdrawal by Subject|13|||
163120987|NCT00260065|589150422|FG000|Overall Study|Physician Decision|19|||
163120988|NCT00260065|589150422|FG000|Overall Study|Not otherwise specified|8|||
163120989|NCT00260065|589150422|FG000|Overall Study|Medication Noncompliance|1|||
163120990|NCT02198235|589150423|FG000|Overall Study|Lost to Follow-up|3|||
163120991|NCT02198235|589150424|FG001|Overall Study|Lost to Follow-up|2|||
163120992|NCT02198235|589150425|FG002|Overall Study|Lost to Follow-up|2|||
163120993|NCT02440789|589150428|FG000|Overall Study|Withdrawal by Subject|3|||
163120994|NCT02440789|589150428|FG000|Overall Study|Not willing to adhere to reqs|1|||
163120995|NCT01999218|589150430|FG000|Overall Study|Hyperglycemia|18|||
163120996|NCT01999218|589150431|FG001|Overall Study|Hyperglycemia|17|||
163120997|NCT01999218|589150432|FG002|Overall Study|Hyperglycemia|17|||
163120998|NCT01999218|589150430|FG000|Overall Study|Lack of Efficacy|1|||
163120999|NCT01999218|589150431|FG001|Overall Study|Lack of Efficacy|0|||
163121000|NCT01999218|589150432|FG002|Overall Study|Lack of Efficacy|1|||
163121001|NCT01999218|589150430|FG000|Overall Study|Lost to Follow-up|22|||
163121002|NCT01999218|589150431|FG001|Overall Study|Lost to Follow-up|17|||
163121003|NCT01999218|589150432|FG002|Overall Study|Lost to Follow-up|18|||
163121004|NCT01999218|589150430|FG000|Overall Study|Non-Compliance With Study Drug|6|||
163121005|NCT01999218|589150431|FG001|Overall Study|Non-Compliance With Study Drug|4|||
163121006|NCT01999218|589150432|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163121007|NCT01999218|589150430|FG000|Overall Study|Physician Decision|1|||
163121008|NCT01999218|589150431|FG001|Overall Study|Physician Decision|4|||
163121009|NCT01999218|589150432|FG002|Overall Study|Physician Decision|6|||
163121010|NCT01999218|589150430|FG000|Overall Study|Protocol Violation|4|||
163121011|NCT01999218|589150431|FG001|Overall Study|Protocol Violation|5|||
163121012|NCT01999218|589150432|FG002|Overall Study|Protocol Violation|4|||
163121013|NCT01999218|589150430|FG000|Overall Study|Screen failure|0|||
163121014|NCT01999218|589150431|FG001|Overall Study|Screen failure|1|||
163121015|NCT01999218|589150432|FG002|Overall Study|Screen failure|0|||
163121016|NCT01999218|589150430|FG000|Overall Study|Study Terminated By Sponsor|7|||
163121017|NCT01999218|589150431|FG001|Overall Study|Study Terminated By Sponsor|5|||
163121018|NCT01999218|589150432|FG002|Overall Study|Study Terminated By Sponsor|12|||
163121019|NCT01999218|589150430|FG000|Overall Study|Participant moves|2|||
163121020|NCT01999218|589150431|FG001|Overall Study|Participant moves|5|||
163121021|NCT01999218|589150432|FG002|Overall Study|Participant moves|3|||
163121022|NCT01999218|589150430|FG000|Overall Study|Withdrawal by Subject|28|||
163340902|NCT03541369|589956883|FG005|Overall Study|Withdrawal by Subject|0|||
163340903|NCT03541369|589956884|FG006|Overall Study|Withdrawal by Subject|1|||
163340904|NCT03541369|589956885|FG007|Overall Study|Withdrawal by Subject|0|||
163340905|NCT03541369|589956886|FG008|Overall Study|Withdrawal by Subject|0|||
163340906|NCT03541369|589956887|FG009|Overall Study|Withdrawal by Subject|0|||
163340907|NCT03541369|589956888|FG010|Overall Study|Withdrawal by Subject|0|||
163340908|NCT03541369|589956889|FG011|Overall Study|Withdrawal by Subject|1|||
163340909|NCT03541369|589956890|FG012|Overall Study|Withdrawal by Subject|0|||
163340910|NCT03541369|589956891|FG013|Overall Study|Withdrawal by Subject|0|||
163340911|NCT03541369|589956892|FG014|Overall Study|Withdrawal by Subject|3|||
163121023|NCT01999218|589150431|FG001|Overall Study|Withdrawal by Subject|29|||
163121024|NCT01999218|589150432|FG002|Overall Study|Withdrawal by Subject|34|||
163121025|NCT01999218|589150430|FG000|Overall Study|Creatinine/eGFR|0|||
163121026|NCT01999218|589150431|FG001|Overall Study|Creatinine/eGFR|0|||
163121027|NCT01999218|589150432|FG002|Overall Study|Creatinine/eGFR|1|||
163121028|NCT01999218|589150430|FG000|Overall Study|Death|7|||
163121029|NCT01999218|589150431|FG001|Overall Study|Death|1|||
163121030|NCT01999218|589150432|FG002|Overall Study|Death|2|||
163121031|NCT01999218|589150430|FG000|Overall Study|Excluded Medication|1|||
163121032|NCT01999218|589150431|FG001|Overall Study|Excluded Medication|1|||
163121033|NCT01999218|589150432|FG002|Overall Study|Excluded Medication|2|||
163121034|NCT01999218|589150430|FG000|Overall Study|Adverse Event|9|||
163121035|NCT01999218|589150431|FG001|Overall Study|Adverse Event|7|||
163121036|NCT01999218|589150432|FG002|Overall Study|Adverse Event|7|||
163121037|NCT01999218|589150430|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
163121038|NCT01999218|589150431|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
163340912|NCT03541369|589956893|FG015|Overall Study|Withdrawal by Subject|0|||
163340913|NCT03541369|589956894|FG016|Overall Study|Withdrawal by Subject|4|||
163121039|NCT01999218|589150432|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
163121040|NCT01073930|589152476|FG000|Overall Study|Withdrawal by Subject|3|||
163121041|NCT01073930|589152477|FG001|Overall Study|Withdrawal by Subject|2|||
163121042|NCT01073930|589152476|FG000|Overall Study|Lost to Follow-up|0|||
163121043|NCT01073930|589152477|FG001|Overall Study|Lost to Follow-up|1|||
163121044|NCT01073930|589152476|FG000|Overall Study|Adverse Event|0|||
163121045|NCT01073930|589152477|FG001|Overall Study|Adverse Event|1|||
163121046|NCT01073930|589152476|FG000|Overall Study|Noncompliance with study drug|0|||
163121047|NCT01073930|589152477|FG001|Overall Study|Noncompliance with study drug|1|||
163121048|NCT01073930|589152476|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
163121049|NCT01073930|589152477|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
163121050|NCT00541346|589152478|FG000|Follow-up|Adverse Event|1|||
163121051|NCT02008773|589152479|FG000|Overall Study|Adverse Event|3|||
163121052|NCT02008773|589152480|FG001|Overall Study|Adverse Event|3|||
163121053|NCT02008773|589152481|FG002|Overall Study|Adverse Event|1|||
163121054|NCT02008773|589152482|FG003|Overall Study|Adverse Event|2|||
163121055|NCT02008773|589152479|FG000|Overall Study|Medication Non-compliance|2|||
163121056|NCT02008773|589152480|FG001|Overall Study|Medication Non-compliance|1|||
163121057|NCT02008773|589152481|FG002|Overall Study|Medication Non-compliance|3|||
163121058|NCT02008773|589152482|FG003|Overall Study|Medication Non-compliance|2|||
163121059|NCT02008773|589152479|FG000|Overall Study|Withdrawal by Subject|8|||
163121060|NCT02008773|589152480|FG001|Overall Study|Withdrawal by Subject|4|||
163121061|NCT02008773|589152481|FG002|Overall Study|Withdrawal by Subject|7|||
163121062|NCT02008773|589152482|FG003|Overall Study|Withdrawal by Subject|6|||
163121063|NCT02008773|589152479|FG000|Overall Study|Lost to Follow-up|0|||
163121064|NCT02008773|589152480|FG001|Overall Study|Lost to Follow-up|1|||
163121065|NCT02008773|589152481|FG002|Overall Study|Lost to Follow-up|3|||
163121066|NCT02008773|589152482|FG003|Overall Study|Lost to Follow-up|2|||
163121067|NCT04435600|589152485|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121068|NCT04435600|589152486|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121069|NCT04435600|589152487|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
163121070|NCT04435600|589152488|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121071|NCT04435600|589152489|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121072|NCT04435600|589152490|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121073|NCT04435600|589152491|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163224805|NCT04889625|589540036|FG001|Period 1|Wrong add power dispensed|1|||
163224806|NCT04889625|589540035|FG000|Period 1|Discontinued due to fitting guide error|1|||
163224807|NCT04889625|589540036|FG001|Period 1|Discontinued due to fitting guide error|1|||
163224808|NCT04889625|589540035|FG000|Period 2|Test article no longer available|1|||
163224809|NCT04889625|589540036|FG001|Period 2|Test article no longer available|0|||
163224810|NCT04889625|589540035|FG000|Period 2|Incorrect lens dispensed|1|||
163224811|NCT04889625|589540036|FG001|Period 2|Incorrect lens dispensed|0|||
163224812|NCT04889625|589540035|FG000|Period 2|Wrong add power dispensed|0|||
163224813|NCT04889625|589540036|FG001|Period 2|Wrong add power dispensed|1|||
163224814|NCT00404352|589540037|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
163224815|NCT00404352|589540038|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
163224816|NCT00404352|589540039|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
163224817|NCT00404352|589540040|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
163224818|NCT00404352|589540041|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
163224819|NCT00404352|589540042|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
163224820|NCT00404352|589540043|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
163224821|NCT00404352|589540044|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
163224822|NCT00404352|589540045|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
163224823|NCT00404352|589540037|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
163224824|NCT00404352|589540038|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
163224825|NCT00404352|589540039|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
163224826|NCT00404352|589540040|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
163224827|NCT00404352|589540041|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
163224828|NCT00404352|589540042|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
163224829|NCT00404352|589540043|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
163224830|NCT00404352|589540044|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
163224831|NCT00404352|589540045|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
163224832|NCT00404352|589540037|FG000|Double Blind (up to 24 Month)|Death|0|||
163121074|NCT04435600|589152492|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121075|NCT04435600|589152493|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121076|NCT04435600|589152494|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121077|NCT04435600|589152485|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121078|NCT04435600|589152486|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121079|NCT04435600|589152487|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121080|NCT04435600|589152488|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121081|NCT04435600|589152489|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121082|NCT04435600|589152490|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121083|NCT04435600|589152491|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121084|NCT04435600|589152492|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163224833|NCT00404352|589540038|FG001|Double Blind (up to 24 Month)|Death|0|||
163121085|NCT04435600|589152493|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121086|NCT04435600|589152494|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
163121087|NCT04435600|589152485|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121088|NCT04435600|589152486|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121089|NCT04435600|589152487|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121090|NCT04435600|589152488|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121091|NCT04435600|589152489|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121092|NCT04435600|589152490|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121093|NCT04435600|589152491|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121094|NCT04435600|589152492|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121095|NCT04435600|589152493|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121096|NCT04435600|589152494|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
163121097|NCT04435600|589152485|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121098|NCT04435600|589152486|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121099|NCT04435600|589152487|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
163224834|NCT00404352|589540039|FG002|Double Blind (up to 24 Month)|Death|1|||
163224835|NCT00404352|589540040|FG003|Double Blind (up to 24 Month)|Death|0|||
163224836|NCT00404352|589540041|FG004|Double Blind (up to 24 Month)|Death|0|||
163224837|NCT00404352|589540042|FG005|Double Blind (up to 24 Month)|Death|0|||
163224838|NCT00404352|589540043|FG006|Double Blind (up to 24 Month)|Death|0|||
163224839|NCT00404352|589540044|FG007|Double Blind (up to 24 Month)|Death|0|||
163224840|NCT00404352|589540045|FG008|Double Blind (up to 24 Month)|Death|0|||
163224841|NCT00404352|589540037|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
163224842|NCT00404352|589540038|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
163224843|NCT00404352|589540039|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
163121100|NCT04435600|589152488|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121101|NCT04435600|589152489|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121102|NCT04435600|589152490|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121103|NCT04435600|589152491|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121104|NCT04435600|589152492|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121105|NCT04435600|589152493|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121106|NCT04435600|589152494|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
163121107|NCT05149313|589152500|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
163121108|NCT05149313|589152501|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
163121109|NCT05149313|589152502|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
163121110|NCT05149313|589152503|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
163121111|NCT05149313|589152500|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
163121112|NCT05149313|589152501|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
163121113|NCT05149313|589152502|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
163121114|NCT05149313|589152503|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
163121115|NCT05149313|589152500|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
163121116|NCT05149313|589152501|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
163121117|NCT05149313|589152502|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
163121118|NCT05149313|589152503|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
163121119|NCT05149313|589152500|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
163121120|NCT05149313|589152501|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
163121121|NCT05149313|589152502|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
163121122|NCT05149313|589152503|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
163121123|NCT05149313|589152500|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
163121124|NCT05149313|589152501|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
163121125|NCT05149313|589152502|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
163121126|NCT05149313|589152503|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
163121127|NCT05149313|589152500|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
163121128|NCT05149313|589152501|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
163121129|NCT05149313|589152502|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
163121130|NCT05149313|589152503|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
163121131|NCT05149313|589152500|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
163224844|NCT00404352|589540040|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
163224845|NCT00404352|589540041|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
163224846|NCT00404352|589540042|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
163224847|NCT00404352|589540043|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
163224848|NCT00404352|589540044|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
163224849|NCT00404352|589540045|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
163340914|NCT03541369|589956895|FG017|Overall Study|Withdrawal by Subject|2|||
163224850|NCT00404352|589540037|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
163224851|NCT00404352|589540038|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
163340915|NCT03541369|589956878|FG000|Overall Study|Lost to Follow-up|0|||
163340916|NCT03541369|589956879|FG001|Overall Study|Lost to Follow-up|0|||
163121132|NCT05149313|589152501|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
163121133|NCT05149313|589152502|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
163121134|NCT05149313|589152503|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
163121135|NCT05149313|589152500|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163121136|NCT05149313|589152501|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163121137|NCT05149313|589152502|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
163121138|NCT05149313|589152503|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
163121139|NCT05149313|589152500|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
163121140|NCT05149313|589152501|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
163121141|NCT05149313|589152502|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
163121142|NCT05149313|589152503|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
163121143|NCT05149313|589152500|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163121144|NCT05149313|589152501|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163121145|NCT05149313|589152502|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
163121146|NCT05149313|589152503|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163121147|NCT05149313|589152500|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
163121148|NCT05149313|589152501|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
163121149|NCT05149313|589152502|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
163121150|NCT05149313|589152503|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
163121151|NCT03826342|589152513|FG000|Overall Study|Withdrawal by Subject|8|||
163121152|NCT03826342|589152514|FG001|Overall Study|Withdrawal by Subject|1|||
163121153|NCT03826342|589152513|FG000|Overall Study|Lost to Follow-up|7|||
163121154|NCT03826342|589152514|FG001|Overall Study|Lost to Follow-up|7|||
163121155|NCT03826342|589152513|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
163121156|NCT03826342|589152514|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
163121157|NCT02212678|589152517|FG000|Overall Study|Adverse Event|1|||
163121158|NCT04030962|589152519|FG000|Stage 2|Adverse Event|0|||
163121159|NCT04030962|589152520|FG001|Stage 2|Adverse Event|0|||
163121160|NCT04030962|589152521|FG002|Stage 2|Adverse Event|0|||
163121161|NCT04030962|589152522|FG003|Stage 2|Adverse Event|0|||
163121162|NCT04030962|589152523|FG004|Stage 2|Adverse Event|0|||
163121163|NCT04030962|589152524|FG005|Stage 2|Adverse Event|0|||
163121164|NCT04030962|589152525|FG006|Stage 2|Adverse Event|0|||
163121165|NCT04030962|589152526|FG007|Stage 2|Adverse Event|0|||
163121166|NCT04030962|589152527|FG008|Stage 2|Adverse Event|1|||
163121167|NCT04030962|589152528|FG009|Stage 2|Adverse Event|0|||
163121168|NCT04030962|589152529|FG010|Stage 2|Adverse Event|1|||
163121169|NCT04030962|589152530|FG011|Stage 2|Adverse Event|1|||
163121170|NCT04030962|589152531|FG012|Stage 2|Adverse Event|1|||
163121171|NCT04030962|589152519|FG000|Stage 2|Withdrawal by Subject|0|||
163121172|NCT04030962|589152520|FG001|Stage 2|Withdrawal by Subject|0|||
163121173|NCT04030962|589152521|FG002|Stage 2|Withdrawal by Subject|0|||
163121174|NCT04030962|589152522|FG003|Stage 2|Withdrawal by Subject|0|||
163121175|NCT04030962|589152523|FG004|Stage 2|Withdrawal by Subject|0|||
163121176|NCT04030962|589152524|FG005|Stage 2|Withdrawal by Subject|0|||
163121177|NCT04030962|589152525|FG006|Stage 2|Withdrawal by Subject|0|||
163121178|NCT04030962|589152526|FG007|Stage 2|Withdrawal by Subject|0|||
163121179|NCT04030962|589152527|FG008|Stage 2|Withdrawal by Subject|1|||
163121180|NCT04030962|589152528|FG009|Stage 2|Withdrawal by Subject|0|||
163121181|NCT04030962|589152529|FG010|Stage 2|Withdrawal by Subject|0|||
163121182|NCT04030962|589152530|FG011|Stage 2|Withdrawal by Subject|2|||
163121183|NCT04030962|589152531|FG012|Stage 2|Withdrawal by Subject|1|||
163121184|NCT04030962|589152519|FG000|Stage 2|Lost to Follow-up|0|||
163121185|NCT04030962|589152520|FG001|Stage 2|Lost to Follow-up|0|||
163121186|NCT04030962|589152521|FG002|Stage 2|Lost to Follow-up|0|||
163121187|NCT04030962|589152522|FG003|Stage 2|Lost to Follow-up|0|||
163121188|NCT04030962|589152523|FG004|Stage 2|Lost to Follow-up|0|||
163121189|NCT04030962|589152524|FG005|Stage 2|Lost to Follow-up|0|||
163121190|NCT04030962|589152525|FG006|Stage 2|Lost to Follow-up|0|||
163121191|NCT04030962|589152526|FG007|Stage 2|Lost to Follow-up|0|||
163121192|NCT04030962|589152527|FG008|Stage 2|Lost to Follow-up|1|||
163121193|NCT04030962|589152528|FG009|Stage 2|Lost to Follow-up|0|||
163121194|NCT04030962|589152529|FG010|Stage 2|Lost to Follow-up|0|||
163121195|NCT04030962|589152530|FG011|Stage 2|Lost to Follow-up|0|||
163121196|NCT04030962|589152531|FG012|Stage 2|Lost to Follow-up|0|||
163121197|NCT04030962|589152519|FG000|Stage 2|Technical Problems|0|||
163121198|NCT04030962|589152520|FG001|Stage 2|Technical Problems|0|||
163121199|NCT04030962|589152521|FG002|Stage 2|Technical Problems|0|||
163121200|NCT04030962|589152522|FG003|Stage 2|Technical Problems|0|||
163121201|NCT04030962|589152523|FG004|Stage 2|Technical Problems|0|||
163121202|NCT04030962|589152524|FG005|Stage 2|Technical Problems|0|||
163121203|NCT04030962|589152525|FG006|Stage 2|Technical Problems|0|||
163121204|NCT04030962|589152526|FG007|Stage 2|Technical Problems|0|||
163121205|NCT04030962|589152527|FG008|Stage 2|Technical Problems|0|||
163121206|NCT04030962|589152528|FG009|Stage 2|Technical Problems|0|||
163121207|NCT04030962|589152529|FG010|Stage 2|Technical Problems|0|||
163121208|NCT04030962|589152530|FG011|Stage 2|Technical Problems|1|||
163121209|NCT04030962|589152531|FG012|Stage 2|Technical Problems|0|||
163121210|NCT05288166|589152534|FG000|Overall Study|Adverse Event|1|||
163121211|NCT05288166|589152535|FG001|Overall Study|Adverse Event|0|||
163121212|NCT05288166|589152534|FG000|Overall Study|Lost to Follow-up|2|||
163121213|NCT05288166|589152535|FG001|Overall Study|Lost to Follow-up|0|||
163121214|NCT05288166|589152534|FG000|Overall Study|Physician Decision|0|||
163121215|NCT05288166|589152535|FG001|Overall Study|Physician Decision|2|||
163121216|NCT05288166|589152534|FG000|Overall Study|Screen Failure|1|||
163121217|NCT05288166|589152535|FG001|Overall Study|Screen Failure|1|||
163121218|NCT05288166|589152534|FG000|Overall Study|Withdrawal by Subject|4|||
163121219|NCT05288166|589152535|FG001|Overall Study|Withdrawal by Subject|2|||
163121220|NCT05288166|589152534|FG000|Overall Study|On Study Treatment|408|||
163121221|NCT05288166|589152535|FG001|Overall Study|On Study Treatment|418|||
163121222|NCT01114360|589152536|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
163121223|NCT01114360|589152537|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
163121224|NCT03007745|589152538|FG000|Overall Study|Sleep test negative for OSA|53|||
163121225|NCT03007745|589152539|FG001|Overall Study|Sleep test negative for OSA|49|||
163121226|NCT03007745|589152538|FG000|Overall Study|Physician Decision|6|||
163121227|NCT03007745|589152539|FG001|Overall Study|Physician Decision|9|||
163121228|NCT03007745|589152538|FG000|Overall Study|Withdrawal by Subject|38|||
163121229|NCT03007745|589152539|FG001|Overall Study|Withdrawal by Subject|16|||
163121230|NCT03007745|589152538|FG000|Overall Study|Lost to Follow-up|19|||
163121231|NCT03007745|589152539|FG001|Overall Study|Lost to Follow-up|25|||
163121232|NCT03007745|589152538|FG000|Overall Study|Unable to login to website|17|||
163121233|NCT03007745|589152539|FG001|Overall Study|Unable to login to website|4|||
163121234|NCT02981524|589152542|FG000|Overall Study|Progressive Disease|14|||
163121235|NCT02981524|589152542|FG000|Overall Study|Death (unrelated)|1|||
163121236|NCT02981524|589152542|FG000|Overall Study|Treatment Related Toxicity|1|||
163121237|NCT02981524|589152542|FG000|Overall Study|Withdrawal by Subject|1|||
163121238|NCT00431951|589152544|FG000|Overall Study|Inability to follow study procedures|1|||
163121239|NCT00431951|589152545|FG001|Overall Study|Inability to follow study procedures|0|||
163121240|NCT00431951|589152546|FG002|Overall Study|Inability to follow study procedures|1|||
163121241|NCT00431951|589152547|FG003|Overall Study|Inability to follow study procedures|2|||
163121242|NCT00431951|589152544|FG000|Overall Study|Lost to Follow-up|0|||
163121243|NCT00431951|589152545|FG001|Overall Study|Lost to Follow-up|1|||
163121244|NCT00431951|589152546|FG002|Overall Study|Lost to Follow-up|0|||
163121245|NCT00431951|589152547|FG003|Overall Study|Lost to Follow-up|0|||
163121246|NCT00431951|589152544|FG000|Overall Study|Withdrawal by Subject|0|||
163121247|NCT00431951|589152545|FG001|Overall Study|Withdrawal by Subject|1|||
163121248|NCT00431951|589152546|FG002|Overall Study|Withdrawal by Subject|0|||
163121249|NCT00431951|589152547|FG003|Overall Study|Withdrawal by Subject|0|||
163121250|NCT00431951|589152544|FG000|Overall Study|Adverse Event|0|||
163121251|NCT00431951|589152545|FG001|Overall Study|Adverse Event|0|||
163121252|NCT00431951|589152546|FG002|Overall Study|Adverse Event|1|||
163121253|NCT00431951|589152547|FG003|Overall Study|Adverse Event|0|||
163121254|NCT02677844|589152548|FG000|Period 3|Withdrawal by Subject|0|||
163121255|NCT02677844|589152549|FG001|Period 3|Withdrawal by Subject|0|||
163121256|NCT02677844|589152550|FG002|Period 3|Withdrawal by Subject|0|||
163121257|NCT02677844|589152551|FG003|Period 3|Withdrawal by Subject|1|||
163121258|NCT02677844|589152552|FG004|Period 3|Withdrawal by Subject|0|||
163121259|NCT02677844|589152553|FG005|Period 3|Withdrawal by Subject|0|||
163121260|NCT02677844|589152554|FG006|Period 3|Withdrawal by Subject|0|||
163121261|NCT00765882|589152555|FG000|Overall Study|Adverse Event|10|||
163121262|NCT00765882|589152556|FG001|Overall Study|Adverse Event|21|||
163121263|NCT00765882|589152557|FG002|Overall Study|Adverse Event|20|||
163121264|NCT00765882|589152555|FG000|Overall Study|Lack of Efficacy|4|||
163121265|NCT00765882|589152556|FG001|Overall Study|Lack of Efficacy|0|||
163121266|NCT00765882|589152557|FG002|Overall Study|Lack of Efficacy|1|||
163121267|NCT00765882|589152555|FG000|Overall Study|Protocol Violation|4|||
163121268|NCT00765882|589152556|FG001|Overall Study|Protocol Violation|3|||
163121269|NCT00765882|589152557|FG002|Overall Study|Protocol Violation|1|||
163121270|NCT00765882|589152555|FG000|Overall Study|Withdrawal by Subject|2|||
163121271|NCT00765882|589152556|FG001|Overall Study|Withdrawal by Subject|6|||
163121272|NCT00765882|589152557|FG002|Overall Study|Withdrawal by Subject|6|||
163121273|NCT00765882|589152555|FG000|Overall Study|Lost to Follow-up|1|||
163121274|NCT00765882|589152556|FG001|Overall Study|Lost to Follow-up|9|||
163121275|NCT00765882|589152557|FG002|Overall Study|Lost to Follow-up|6|||
163121276|NCT00765882|589152555|FG000|Overall Study|Other Reason|3|||
163121277|NCT00765882|589152556|FG001|Overall Study|Other Reason|1|||
163121278|NCT00765882|589152557|FG002|Overall Study|Other Reason|2|||
163121279|NCT02231762|589152560|FG000|Combination Phase|Adverse Event|10|||
163121280|NCT02231762|589152561|FG001|Combination Phase|Adverse Event|0|||
163121281|NCT02231762|589152562|FG002|Combination Phase|Adverse Event|0|||
163121282|NCT02231762|589152563|FG003|Combination Phase|Adverse Event|0|||
163121283|NCT02231762|589152560|FG000|Combination Phase|Withdrawal by Subject|2|||
163121284|NCT02231762|589152561|FG001|Combination Phase|Withdrawal by Subject|0|||
163121285|NCT02231762|589152562|FG002|Combination Phase|Withdrawal by Subject|0|||
163121286|NCT02231762|589152563|FG003|Combination Phase|Withdrawal by Subject|0|||
163340917|NCT03541369|589956880|FG002|Overall Study|Lost to Follow-up|0|||
163340918|NCT03541369|589956881|FG003|Overall Study|Lost to Follow-up|0|||
163340919|NCT03541369|589956882|FG004|Overall Study|Lost to Follow-up|1|||
163121287|NCT02231762|589152560|FG000|Combination Phase|Disease Progression|6|||
163121288|NCT02231762|589152561|FG001|Combination Phase|Disease Progression|0|||
163121289|NCT02231762|589152562|FG002|Combination Phase|Disease Progression|0|||
163121290|NCT02231762|589152563|FG003|Combination Phase|Disease Progression|0|||
163121291|NCT02231762|589152560|FG000|Combination Phase|Did not meet inclusion criteria|1|||
163121292|NCT02231762|589152561|FG001|Combination Phase|Did not meet inclusion criteria|0|||
163121293|NCT02231762|589152562|FG002|Combination Phase|Did not meet inclusion criteria|0|||
163121294|NCT02231762|589152563|FG003|Combination Phase|Did not meet inclusion criteria|0|||
163121295|NCT02231762|589152560|FG000|Combination Phase|Protocol Violation|1|||
163121296|NCT02231762|589152561|FG001|Combination Phase|Protocol Violation|0|||
163121297|NCT02231762|589152562|FG002|Combination Phase|Protocol Violation|0|||
163121298|NCT02231762|589152563|FG003|Combination Phase|Protocol Violation|0|||
163121299|NCT02231762|589152560|FG000|Maintenance Phase|Disease progression|0|||
163121300|NCT02231762|589152561|FG001|Maintenance Phase|Disease progression|3|||
163121301|NCT02231762|589152562|FG002|Maintenance Phase|Disease progression|4|||
163121302|NCT02231762|589152563|FG003|Maintenance Phase|Disease progression|3|||
163121303|NCT02231762|589152560|FG000|Maintenance Phase|Adverse Event|0|||
163121304|NCT02231762|589152561|FG001|Maintenance Phase|Adverse Event|0|||
163121305|NCT02231762|589152562|FG002|Maintenance Phase|Adverse Event|1|||
163121306|NCT02231762|589152563|FG003|Maintenance Phase|Adverse Event|2|||
163121307|NCT03455829|589152564|FG000|Overall Study|Death|2|||
163121308|NCT03455829|589152565|FG001|Overall Study|Death|3|||
163121309|NCT03455829|589152566|FG002|Overall Study|Death|2|||
163121310|NCT03455829|589152567|FG003|Overall Study|Death|4|||
163121311|NCT03455829|589152568|FG004|Overall Study|Death|2|||
163121312|NCT03455829|589152564|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
163121313|NCT03455829|589152565|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
163121314|NCT03455829|589152566|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
163121315|NCT03455829|589152567|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
163121316|NCT03455829|589152568|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
163121317|NCT03455829|589152564|FG000|Overall Study|Disease progression|0|||
163121318|NCT03455829|589152565|FG001|Overall Study|Disease progression|0|||
163121319|NCT03455829|589152566|FG002|Overall Study|Disease progression|0|||
163121320|NCT03455829|589152567|FG003|Overall Study|Disease progression|1|||
163121321|NCT03455829|589152568|FG004|Overall Study|Disease progression|1|||
163121322|NCT00168103|589152573|FG000|Overall Study|Withdrawal by Subject|1|||
163121323|NCT00168103|589152574|FG001|Overall Study|Withdrawal by Subject|2|||
163121324|NCT00168103|589152575|FG002|Overall Study|Withdrawal by Subject|1|||
163121325|NCT00168103|589152576|FG003|Overall Study|Withdrawal by Subject|0|||
163121326|NCT00168103|589152573|FG000|Overall Study|Lost to Follow-up|1|||
163121327|NCT00168103|589152574|FG001|Overall Study|Lost to Follow-up|3|||
163121328|NCT00168103|589152575|FG002|Overall Study|Lost to Follow-up|0|||
163121329|NCT00168103|589152576|FG003|Overall Study|Lost to Follow-up|0|||
163121330|NCT03532932|589152579|FG000|Overall Study|Protocol Deviation|33|||
163121331|NCT03532932|589152580|FG001|Overall Study|Protocol Deviation|31|||
163121332|NCT03532932|589152579|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
163121333|NCT03532932|589152580|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
163121334|NCT03532932|589152579|FG000|Overall Study|Withdrawal by Subject|2|||
163121335|NCT03532932|589152580|FG001|Overall Study|Withdrawal by Subject|0|||
163121336|NCT03532932|589152579|FG000|Overall Study|Lost to Follow-up|15|||
163121337|NCT03532932|589152580|FG001|Overall Study|Lost to Follow-up|9|||
163121338|NCT03532932|589152579|FG000|Overall Study|Adverse Event|4|||
163121339|NCT03532932|589152580|FG001|Overall Study|Adverse Event|3|||
163121340|NCT03532932|589152579|FG000|Overall Study|Death|0|||
163121341|NCT03532932|589152580|FG001|Overall Study|Death|2|||
163121342|NCT03532932|589152579|FG000|Overall Study|Other|11|||
163121343|NCT03532932|589152580|FG001|Overall Study|Other|16|||
163121344|NCT02699450|589152582|FG000|Overall Study|Death|2|||
163121345|NCT02699450|589152583|FG001|Overall Study|Death|1|||
163121346|NCT02699450|589152584|FG002|Overall Study|Death|2|||
163121347|NCT02699450|589152582|FG000|Overall Study|Met Criteria for Study Exit|0|||
163121348|NCT02699450|589152583|FG001|Overall Study|Met Criteria for Study Exit|0|||
163121349|NCT02699450|589152584|FG002|Overall Study|Met Criteria for Study Exit|1|||
163121350|NCT02699450|589152582|FG000|Overall Study|Protocol Violation|4|||
163121351|NCT02699450|589152583|FG001|Overall Study|Protocol Violation|3|||
163121352|NCT02699450|589152584|FG002|Overall Study|Protocol Violation|5|||
163340920|NCT03541369|589956883|FG005|Overall Study|Lost to Follow-up|0|||
163121353|NCT02699450|589152582|FG000|Overall Study|Lost to Follow-up|3|||
163121354|NCT02699450|589152583|FG001|Overall Study|Lost to Follow-up|0|||
163121355|NCT02699450|589152584|FG002|Overall Study|Lost to Follow-up|5|||
163121356|NCT02699450|589152582|FG000|Overall Study|Physician Decision|2|||
163121357|NCT02699450|589152583|FG001|Overall Study|Physician Decision|0|||
163340921|NCT03541369|589956884|FG006|Overall Study|Lost to Follow-up|0|||
163340922|NCT03541369|589956885|FG007|Overall Study|Lost to Follow-up|0|||
163340923|NCT03541369|589956886|FG008|Overall Study|Lost to Follow-up|1|||
163121358|NCT02699450|589152584|FG002|Overall Study|Physician Decision|0|||
163121359|NCT02699450|589152582|FG000|Overall Study|Withdrawal by Subject|3|||
163121360|NCT02699450|589152583|FG001|Overall Study|Withdrawal by Subject|1|||
163121361|NCT02699450|589152584|FG002|Overall Study|Withdrawal by Subject|2|||
163121362|NCT02699450|589152582|FG000|Overall Study|Adverse Event|1|||
163121363|NCT02699450|589152583|FG001|Overall Study|Adverse Event|0|||
163121364|NCT02699450|589152584|FG002|Overall Study|Adverse Event|0|||
163121365|NCT00810901|589152585|FG000|Overall Study|Lost to Follow-up|88|||
163121366|NCT00810901|589152586|FG001|Overall Study|Lost to Follow-up|58|||
163121367|NCT03689712|589152587|FG000|Overall Study|Adverse Event|1|||
163121368|NCT03689712|589152588|FG001|Overall Study|Adverse Event|0|||
163121369|NCT03689712|589152587|FG000|Overall Study|Death|20|||
163121370|NCT03689712|589152588|FG001|Overall Study|Death|10|||
163121371|NCT03689712|589152587|FG000|Overall Study|Lost to Follow-up|6|||
163121372|NCT03689712|589152588|FG001|Overall Study|Lost to Follow-up|6|||
163121373|NCT03689712|589152587|FG000|Overall Study|Other|1|||
163121374|NCT03689712|589152588|FG001|Overall Study|Other|0|||
163121375|NCT03689712|589152587|FG000|Overall Study|Patient Non-Compliance|0|||
163121376|NCT03689712|589152588|FG001|Overall Study|Patient Non-Compliance|1|||
163121377|NCT03689712|589152587|FG000|Overall Study|Withdrawal by Subject|20|||
163121378|NCT03689712|589152588|FG001|Overall Study|Withdrawal by Subject|4|||
163121379|NCT03689712|589152587|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
163121380|NCT03689712|589152588|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
163121381|NCT03689712|589152587|FG000|Overall Study|Randomized but not Treated|13|||
163121382|NCT03689712|589152588|FG001|Overall Study|Randomized but not Treated|7|||
163121383|NCT03689712|589152587|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
163121384|NCT03689712|589152588|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
163121385|NCT00689793|589152589|FG000|Overall Study|Lost to Follow-up|4|||
163121386|NCT00689793|589152590|FG001|Overall Study|Lost to Follow-up|5|||
163121387|NCT01133275|589152600|FG000|Overall Study|Withdrawal by Subject|1|||
163121388|NCT01133275|589152600|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
163121389|NCT02266875|589152605|FG000|Overall Study|Withdrawal by Subject|9|||
163121390|NCT02266875|589152606|FG001|Overall Study|Withdrawal by Subject|0|||
163121391|NCT02266875|589152605|FG000|Overall Study|Lost to Follow-up|2|||
163121392|NCT02266875|589152606|FG001|Overall Study|Lost to Follow-up|0|||
163121393|NCT02956850|589152607|FG000|Overall Study|Withdrawal by Subject|0|||
163121394|NCT02956850|589152608|FG001|Overall Study|Withdrawal by Subject|0|||
163121395|NCT02956850|589152609|FG002|Overall Study|Withdrawal by Subject|0|||
163121396|NCT02956850|589152610|FG003|Overall Study|Withdrawal by Subject|0|||
163121397|NCT02956850|589152611|FG004|Overall Study|Withdrawal by Subject|0|||
163121398|NCT02956850|589152612|FG005|Overall Study|Withdrawal by Subject|0|||
163121399|NCT02956850|589152613|FG006|Overall Study|Withdrawal by Subject|0|||
163121400|NCT02956850|589152614|FG007|Overall Study|Withdrawal by Subject|0|||
163121401|NCT02956850|589152615|FG008|Overall Study|Withdrawal by Subject|0|||
163121402|NCT02956850|589152616|FG009|Overall Study|Withdrawal by Subject|0|||
163121403|NCT02956850|589152617|FG010|Overall Study|Withdrawal by Subject|0|||
163121404|NCT02956850|589152618|FG011|Overall Study|Withdrawal by Subject|0|||
163121405|NCT02956850|589152619|FG012|Overall Study|Withdrawal by Subject|0|||
163121406|NCT02956850|589152620|FG013|Overall Study|Withdrawal by Subject|0|||
163121407|NCT02956850|589152621|FG014|Overall Study|Withdrawal by Subject|0|||
163121408|NCT02956850|589152622|FG015|Overall Study|Withdrawal by Subject|0|||
163121409|NCT02956850|589152623|FG016|Overall Study|Withdrawal by Subject|0|||
163121410|NCT02956850|589152624|FG017|Overall Study|Withdrawal by Subject|1|||
163121411|NCT01920152|589152625|FG000|Overall Study|Withdrawal by Subject|1|||
163121412|NCT01920152|589152626|FG001|Overall Study|Withdrawal by Subject|2|||
163121413|NCT00708734|589152627|FG000|Overall Study|scheduling conflict|2|||
163121414|NCT00708734|589152627|FG000|Overall Study|moved|1|||
163121415|NCT00708734|589152627|FG000|Overall Study|leg injury|1|||
163121416|NCT00708734|589152627|FG000|Overall Study|knee replacement|1|||
163340924|NCT03541369|589956887|FG009|Overall Study|Lost to Follow-up|0|||
163340925|NCT03541369|589956888|FG010|Overall Study|Lost to Follow-up|0|||
163340926|NCT03541369|589956889|FG011|Overall Study|Lost to Follow-up|0|||
163340927|NCT03541369|589956890|FG012|Overall Study|Lost to Follow-up|1|||
163340928|NCT03541369|589956891|FG013|Overall Study|Lost to Follow-up|0|||
163121417|NCT00708734|589152627|FG000|Overall Study|vertigo|1|||
163121418|NCT00708734|589152627|FG000|Overall Study|leg fracture|1|||
163121419|NCT03412604|589152629|FG000|Overall Study|Withdrawal by Subject|1|||
163121420|NCT02634606|589152630|FG000|Overall Study|unable to obtain the drug at start|13|||
163121421|NCT00993499|589152640|FG000|Run-in Period (8 Days)|Adverse Event|0|||
163121422|NCT00993499|589152641|FG001|Run-in Period (8 Days)|Adverse Event|1|||
163121423|NCT00993499|589152642|FG002|Run-in Period (8 Days)|Adverse Event|0|||
163121424|NCT00993499|589152643|FG003|Run-in Period (8 Days)|Adverse Event|0|||
163121425|NCT00993499|589152644|FG004|Run-in Period (8 Days)|Adverse Event|0|||
163121426|NCT00993499|589152645|FG005|Run-in Period (8 Days)|Adverse Event|0|||
163121427|NCT00993499|589152640|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
163340929|NCT03541369|589956892|FG014|Overall Study|Lost to Follow-up|0|||
163340930|NCT03541369|589956893|FG015|Overall Study|Lost to Follow-up|0|||
163340931|NCT03541369|589956894|FG016|Overall Study|Lost to Follow-up|0|||
163121428|NCT00993499|589152641|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
163121429|NCT00993499|589152642|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
163121430|NCT00993499|589152643|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
163121431|NCT00993499|589152644|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
163121432|NCT00993499|589152645|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
163121433|NCT00993499|589152640|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
163121434|NCT00993499|589152641|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
163121435|NCT00993499|589152642|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
163121436|NCT00993499|589152643|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
163121437|NCT00993499|589152644|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
163121438|NCT00993499|589152645|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
163121439|NCT00993499|589152640|FG000|Run-in Period (8 Days)|Progressive disease|0|||
163121440|NCT00993499|589152641|FG001|Run-in Period (8 Days)|Progressive disease|1|||
163121441|NCT00993499|589152642|FG002|Run-in Period (8 Days)|Progressive disease|1|||
163121442|NCT00993499|589152643|FG003|Run-in Period (8 Days)|Progressive disease|0|||
163121443|NCT00993499|589152644|FG004|Run-in Period (8 Days)|Progressive disease|0|||
163121444|NCT00993499|589152645|FG005|Run-in Period (8 Days)|Progressive disease|0|||
163121445|NCT00993499|589152640|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
163121446|NCT00993499|589152641|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
163121447|NCT00993499|589152642|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
163121448|NCT00993499|589152643|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
163121449|NCT00993499|589152644|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
163121450|NCT00993499|589152645|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
163121451|NCT00993499|589152640|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
163121452|NCT00993499|589152641|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
163121453|NCT00993499|589152642|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
163121454|NCT00993499|589152643|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
163121455|NCT00993499|589152644|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
163121456|NCT00993499|589152645|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
163121457|NCT00993499|589152640|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
163121458|NCT00993499|589152641|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
163121459|NCT00993499|589152642|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
163121460|NCT00993499|589152643|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
163121461|NCT00993499|589152644|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
163121462|NCT00993499|589152645|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
163121463|NCT00993499|589152640|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
163121464|NCT00993499|589152641|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
163121465|NCT00993499|589152642|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
163121466|NCT00993499|589152643|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
163121467|NCT00993499|589152644|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
163121468|NCT00993499|589152645|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
163121469|NCT00993499|589152640|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
163121470|NCT00993499|589152641|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
163121471|NCT00993499|589152642|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
163121472|NCT00993499|589152643|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
163121473|NCT00993499|589152644|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
163121474|NCT00993499|589152645|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
163121475|NCT00993499|589152640|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
163121476|NCT00993499|589152641|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
163121477|NCT00993499|589152642|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
163121478|NCT00993499|589152643|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
163224852|NCT00404352|589540039|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
163340932|NCT03541369|589956895|FG017|Overall Study|Lost to Follow-up|0|||
163340933|NCT01856569|589956896|FG000|Overall Study|Other|1|||
163340934|NCT01856569|589956896|FG000|Overall Study|Changed Site/Structure|1|||
163121479|NCT00993499|589152644|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
163121480|NCT00993499|589152645|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
163121481|NCT00993499|589152640|FG000|Discontinued After Starting Course 3|DLT|1|||
163121482|NCT00993499|589152641|FG001|Discontinued After Starting Course 3|DLT|0|||
163224853|NCT00404352|589540040|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
163340935|NCT01856569|589956896|FG000|Overall Study|Lost to Follow-up|3|||
163340936|NCT01856569|589956896|FG000|Overall Study|Did not met inclusion criteria|8|||
163340937|NCT00696241|589956897|FG000|Overall Study|Adverse Event|11|||
163340938|NCT00696241|589956898|FG001|Overall Study|Adverse Event|3|||
163121483|NCT00993499|589152642|FG002|Discontinued After Starting Course 3|DLT|2|||
163121484|NCT00993499|589152643|FG003|Discontinued After Starting Course 3|DLT|1|||
163121485|NCT00993499|589152644|FG004|Discontinued After Starting Course 3|DLT|0|||
163340939|NCT00696241|589956899|FG002|Overall Study|Adverse Event|6|||
163340940|NCT00696241|589956900|FG003|Overall Study|Adverse Event|4|||
163340941|NCT00696241|589956901|FG004|Overall Study|Adverse Event|5|||
163340942|NCT00696241|589956897|FG000|Overall Study|Protocol Violation|1|||
163340943|NCT00696241|589956898|FG001|Overall Study|Protocol Violation|1|||
163340944|NCT00696241|589956899|FG002|Overall Study|Protocol Violation|2|||
163340945|NCT00696241|589956900|FG003|Overall Study|Protocol Violation|0|||
163340946|NCT00696241|589956901|FG004|Overall Study|Protocol Violation|3|||
163340947|NCT00696241|589956897|FG000|Overall Study|Lost to Follow-up|1|||
163340948|NCT00696241|589956898|FG001|Overall Study|Lost to Follow-up|4|||
163340949|NCT00696241|589956899|FG002|Overall Study|Lost to Follow-up|1|||
163340950|NCT00696241|589956900|FG003|Overall Study|Lost to Follow-up|2|||
163340951|NCT00696241|589956901|FG004|Overall Study|Lost to Follow-up|0|||
163340952|NCT00696241|589956897|FG000|Overall Study|Withdrawal by Subject|4|||
163340953|NCT00696241|589956898|FG001|Overall Study|Withdrawal by Subject|8|||
163340954|NCT00696241|589956899|FG002|Overall Study|Withdrawal by Subject|6|||
163340955|NCT00696241|589956900|FG003|Overall Study|Withdrawal by Subject|1|||
163340956|NCT00696241|589956901|FG004|Overall Study|Withdrawal by Subject|0|||
163340957|NCT00696241|589956897|FG000|Overall Study|Lack of Efficacy|1|||
163340958|NCT00696241|589956898|FG001|Overall Study|Lack of Efficacy|5|||
163340959|NCT00696241|589956899|FG002|Overall Study|Lack of Efficacy|4|||
163340960|NCT00696241|589956900|FG003|Overall Study|Lack of Efficacy|5|||
163340961|NCT00696241|589956901|FG004|Overall Study|Lack of Efficacy|3|||
163340962|NCT00696241|589956897|FG000|Overall Study|Other|6|||
163340963|NCT00696241|589956898|FG001|Overall Study|Other|1|||
163340964|NCT00696241|589956899|FG002|Overall Study|Other|5|||
163340965|NCT00696241|589956900|FG003|Overall Study|Other|2|||
163340966|NCT00696241|589956901|FG004|Overall Study|Other|1|||
163340967|NCT01613599|589956902|FG000|Overall Study|Death|9|||
163340968|NCT01613599|589956902|FG000|Overall Study|Lost to Follow-up|5|||
163340969|NCT01613599|589956902|FG000|Overall Study|Withdrawal by Subject|8|||
163340970|NCT01613599|589956902|FG000|Overall Study|Reason not specified|3|||
163340971|NCT04749797|589956907|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
163340972|NCT04749797|589956908|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
163340973|NCT04749797|589956909|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
163340974|NCT02513667|589956910|FG000|Overall Study|Withdrawal by Subject|0|||
163340975|NCT02513667|589956911|FG001|Overall Study|Withdrawal by Subject|1|||
163340976|NCT00871715|589956922|FG000|Overall Study|Withdrawal by Subject|6|||
163340977|NCT00871715|589956923|FG001|Overall Study|Withdrawal by Subject|10|||
163340978|NCT00871715|589956924|FG002|Overall Study|Withdrawal by Subject|15|||
163340979|NCT00871715|589956922|FG000|Overall Study|Physician Decision|6|||
163340980|NCT00871715|589956923|FG001|Overall Study|Physician Decision|0|||
163340981|NCT00871715|589956924|FG002|Overall Study|Physician Decision|2|||
163340982|NCT00871715|589956922|FG000|Overall Study|Lost to Follow-up|3|||
163340983|NCT00871715|589956923|FG001|Overall Study|Lost to Follow-up|6|||
163340984|NCT00871715|589956924|FG002|Overall Study|Lost to Follow-up|9|||
163340985|NCT02291549|589956925|FG000|Overall Study|Lost to Follow-up|1|||
163340986|NCT02291549|589956926|FG001|Overall Study|Lost to Follow-up|0|||
163340987|NCT02291549|589956925|FG000|Overall Study|Withdrawal by Subject|0|||
163340988|NCT02291549|589956926|FG001|Overall Study|Withdrawal by Subject|1|||
163340989|NCT00537914|589956927|FG000|Overall Study|Death|1|||
163340990|NCT00537914|589956927|FG000|Overall Study|Adverse Event|7|||
163340991|NCT00537914|589956927|FG000|Overall Study|Treatment failure|10|||
163340992|NCT00537914|589956927|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
163340993|NCT00537914|589956927|FG000|Overall Study|Lost to Follow-up|19|||
163340994|NCT00537914|589956927|FG000|Overall Study|Withdrawal of informed consent|59|||
163340995|NCT02189759|589956943|FG000|Overall Study|Lost to Follow-up|0|||
163340996|NCT02189759|589956944|FG001|Overall Study|Lost to Follow-up|0|||
163340997|NCT02189759|589956945|FG002|Overall Study|Lost to Follow-up|2|||
163340998|NCT02189759|589956946|FG003|Overall Study|Lost to Follow-up|5|||
163340999|NCT03032198|589956947|FG000|Overall Study|Screen Fail|1|||
163341000|NCT02470806|589956948|FG000|Overall Study|Lost to Follow-up|1|||
163341001|NCT02470806|589956949|FG001|Overall Study|Lost to Follow-up|1|||
163408106|NCT00705939|590204025|FG002|Overall Study|Withdrawal by Subject|3|||
163408107|NCT00705939|590204023|FG000|Overall Study|Physician Decision|0|||
163408108|NCT00705939|590204024|FG001|Overall Study|Physician Decision|1|||
163341002|NCT02470806|589956948|FG000|Overall Study|Adverse Event|5|||
163341003|NCT02470806|589956949|FG001|Overall Study|Adverse Event|2|||
163341004|NCT02470806|589956948|FG000|Overall Study|Protocol Violation|4|||
163341005|NCT02470806|589956949|FG001|Overall Study|Protocol Violation|11|||
163341006|NCT02470806|589956948|FG000|Overall Study|Physician Decision|0|||
163341007|NCT02470806|589956949|FG001|Overall Study|Physician Decision|3|||
163341008|NCT02470806|589956948|FG000|Overall Study|Withdrawal by Subject|3|||
163341009|NCT02470806|589956949|FG001|Overall Study|Withdrawal by Subject|10|||
163341010|NCT02470806|589956948|FG000|Overall Study|Lack of Efficacy|5|||
163408109|NCT00705939|590204025|FG002|Overall Study|Physician Decision|0|||
163341011|NCT02470806|589956949|FG001|Overall Study|Lack of Efficacy|15|||
163121486|NCT00993499|589152645|FG005|Discontinued After Starting Course 3|DLT|0|||
163121487|NCT00993499|589152640|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
163341012|NCT01147471|589956950|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
163341013|NCT01147471|589956951|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
163341014|NCT01147471|589956950|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
163341015|NCT01147471|589956951|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
163341016|NCT01147471|589956950|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
163341017|NCT01147471|589956951|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
163341018|NCT01147471|589956950|FG000|3 Month Follow Up|Lost to Follow-up|1|||
163341019|NCT01147471|589956951|FG001|3 Month Follow Up|Lost to Follow-up|1|||
163341020|NCT01147471|589956950|FG000|3 Month Follow Up|Physician Decision|0|||
163341021|NCT01147471|589956951|FG001|3 Month Follow Up|Physician Decision|1|||
163341022|NCT01147471|589956950|FG000|6 Month Follow Up|Lost to Follow-up|4|||
163341023|NCT01147471|589956951|FG001|6 Month Follow Up|Lost to Follow-up|2|||
163341024|NCT00866619|589956952|FG000|Overall Study|Adverse Event|112|||
163341025|NCT00866619|589956953|FG001|Overall Study|Adverse Event|106|||
163341026|NCT00866619|589956954|FG002|Overall Study|Adverse Event|47|||
163341027|NCT00866619|589956955|FG003|Overall Study|Adverse Event|44|||
163341028|NCT00866619|589956952|FG000|Overall Study|Protocol Violation|2|||
163341029|NCT00866619|589956953|FG001|Overall Study|Protocol Violation|39|||
163341030|NCT00866619|589956954|FG002|Overall Study|Protocol Violation|2|||
163341031|NCT00866619|589956955|FG003|Overall Study|Protocol Violation|17|||
163341032|NCT00866619|589956952|FG000|Overall Study|Withdrawal by Subject|587|||
163341033|NCT00866619|589956953|FG001|Overall Study|Withdrawal by Subject|295|||
163341034|NCT00866619|589956954|FG002|Overall Study|Withdrawal by Subject|272|||
163341035|NCT00866619|589956955|FG003|Overall Study|Withdrawal by Subject|144|||
163341036|NCT00866619|589956952|FG000|Overall Study|Lost to Follow-up|1145|||
163341037|NCT00866619|589956953|FG001|Overall Study|Lost to Follow-up|830|||
163341038|NCT00866619|589956954|FG002|Overall Study|Lost to Follow-up|568|||
163341039|NCT00866619|589956955|FG003|Overall Study|Lost to Follow-up|425|||
163341040|NCT01307800|589956962|FG000|Overall Study|Adverse Event|9|||
163341041|NCT01307800|589956963|FG001|Overall Study|Adverse Event|8|||
163341042|NCT01307800|589956964|FG002|Overall Study|Adverse Event|10|||
163341043|NCT01307800|589956965|FG003|Overall Study|Adverse Event|14|||
163341044|NCT01307800|589956962|FG000|Overall Study|Entry Criteria Not Met|0|||
163341045|NCT01307800|589956963|FG001|Overall Study|Entry Criteria Not Met|0|||
163341046|NCT01307800|589956964|FG002|Overall Study|Entry Criteria Not Met|0|||
163341047|NCT01307800|589956965|FG003|Overall Study|Entry Criteria Not Met|2|||
163341048|NCT01307800|589956962|FG000|Overall Study|Lost to Follow-up|5|||
163341049|NCT01307800|589956963|FG001|Overall Study|Lost to Follow-up|6|||
163341050|NCT01307800|589956964|FG002|Overall Study|Lost to Follow-up|2|||
163341051|NCT01307800|589956965|FG003|Overall Study|Lost to Follow-up|8|||
163341052|NCT01307800|589956962|FG000|Overall Study|Perceived Lack of Efficacy|24|||
163341053|NCT01307800|589956963|FG001|Overall Study|Perceived Lack of Efficacy|23|||
163341054|NCT01307800|589956964|FG002|Overall Study|Perceived Lack of Efficacy|20|||
163341055|NCT01307800|589956965|FG003|Overall Study|Perceived Lack of Efficacy|33|||
163341056|NCT01307800|589956962|FG000|Overall Study|Protocol Violation|0|||
163341057|NCT01307800|589956963|FG001|Overall Study|Protocol Violation|3|||
163341058|NCT01307800|589956964|FG002|Overall Study|Protocol Violation|4|||
163341059|NCT01307800|589956965|FG003|Overall Study|Protocol Violation|5|||
163341060|NCT01307800|589956962|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
163341061|NCT01307800|589956963|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
163341062|NCT01307800|589956964|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
163341063|NCT01307800|589956965|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
163341064|NCT01307800|589956962|FG000|Overall Study|Sponsor Decision|6|||
163341065|NCT01307800|589956963|FG001|Overall Study|Sponsor Decision|9|||
163341066|NCT01307800|589956964|FG002|Overall Study|Sponsor Decision|12|||
163341067|NCT01307800|589956965|FG003|Overall Study|Sponsor Decision|28|||
163341068|NCT01307800|589956962|FG000|Overall Study|Withdrawal by Subject|10|||
163121488|NCT00993499|589152641|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
163121489|NCT00993499|589152642|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
163121490|NCT00993499|589152643|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
163121491|NCT00993499|589152644|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
163121492|NCT00993499|589152645|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
163121493|NCT01287195|589152646|FG000|Overall Study|Withdrawal by Subject|2|||
163121494|NCT00283868|589152653|FG000|Overall Study|Lost to Follow-up|7|||
163121495|NCT00283868|589152654|FG001|Overall Study|Lost to Follow-up|8|||
163121496|NCT01515475|589152655|FG000|Overall Study|Lost to Follow-up|20|||
163224854|NCT00404352|589540041|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
163341069|NCT01307800|589956963|FG001|Overall Study|Withdrawal by Subject|11|||
163341070|NCT01307800|589956964|FG002|Overall Study|Withdrawal by Subject|8|||
163341071|NCT01307800|589956965|FG003|Overall Study|Withdrawal by Subject|15|||
163341072|NCT01307800|589956962|FG000|Overall Study|Participant Moved|0|||
163341073|NCT01307800|589956963|FG001|Overall Study|Participant Moved|2|||
163341074|NCT01307800|589956964|FG002|Overall Study|Participant Moved|1|||
163341075|NCT01307800|589956965|FG003|Overall Study|Participant Moved|3|||
163341076|NCT02892019|589956966|FG000|Overall Study|randomized but not treated|0|||
163341077|NCT02892019|589956967|FG001|Overall Study|randomized but not treated|1|||
163341078|NCT02892019|589956966|FG000|Overall Study|Withdrawal by Subject|0|||
163341079|NCT02892019|589956967|FG001|Overall Study|Withdrawal by Subject|1|||
163341080|NCT02892019|589956966|FG000|Overall Study|Adverse Event|1|||
163341081|NCT02892019|589956967|FG001|Overall Study|Adverse Event|1|||
163341082|NCT00689351|589956968|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
163341083|NCT00689351|589956969|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
163341084|NCT00689351|589956968|FG000|Infant Series of Dosing|Adverse Event|1|||
163341085|NCT00689351|589956969|FG001|Infant Series of Dosing|Adverse Event|0|||
163341086|NCT00689351|589956968|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
163341087|NCT00689351|589956969|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
163341088|NCT00689351|589956968|FG000|After Infant Series|Parent/legal guardian request|1|||
163341089|NCT00689351|589956969|FG001|After Infant Series|Parent/legal guardian request|0|||
163341090|NCT01766206|589956970|FG000|Overall Study|Withdrawal by Subject|22|||
163341091|NCT01766206|589956970|FG000|Overall Study|Lost to Follow-up|10|||
163341092|NCT01766206|589956970|FG000|Overall Study|Inappropriate enrollment|18|||
163341093|NCT01766206|589956970|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
163341094|NCT01662505|589956971|FG000|Overall Study|Progressive disease|6|||
163341095|NCT01662505|589956972|FG001|Overall Study|Progressive disease|1|||
163341096|NCT01662505|589956973|FG002|Overall Study|Progressive disease|5|||
163341097|NCT01662505|589956971|FG000|Overall Study|Refused cont. medication|0|||
163341098|NCT01662505|589956972|FG001|Overall Study|Refused cont. medication|0|||
163341099|NCT01662505|589956973|FG002|Overall Study|Refused cont. medication|1|||
163341100|NCT01662505|589956971|FG000|Overall Study|Not specified above|1|||
163341101|NCT01662505|589956972|FG001|Overall Study|Not specified above|3|||
163341102|NCT01662505|589956973|FG002|Overall Study|Not specified above|2|||
163341103|NCT01313663|589956974|FG000|Overall Study|Study Closed/Terminated|2|||
163341104|NCT01313663|589956975|FG001|Overall Study|Study Closed/Terminated|4|||
163341105|NCT01313663|589956974|FG000|Overall Study|Lost to Follow-up|0|||
163341106|NCT01313663|589956975|FG001|Overall Study|Lost to Follow-up|1|||
163341107|NCT01313663|589956974|FG000|Overall Study|Physician Decision|0|||
163341108|NCT01313663|589956975|FG001|Overall Study|Physician Decision|2|||
163341109|NCT01313663|589956974|FG000|Overall Study|Withdrawal by Subject|2|||
163341110|NCT01313663|589956975|FG001|Overall Study|Withdrawal by Subject|1|||
163341111|NCT01229176|589956976|FG000|Overall Study|Withdrawal by Subject|0|||
163341112|NCT01229176|589956977|FG001|Overall Study|Withdrawal by Subject|0|||
163341113|NCT01229176|589956978|FG002|Overall Study|Withdrawal by Subject|0|||
163341114|NCT01229176|589956979|FG003|Overall Study|Withdrawal by Subject|1|||
163341115|NCT01229176|589956980|FG004|Overall Study|Withdrawal by Subject|1|||
163341116|NCT01229176|589956981|FG005|Overall Study|Withdrawal by Subject|1|||
163341117|NCT01229176|589956982|FG006|Overall Study|Withdrawal by Subject|0|||
163341118|NCT01229176|589956983|FG007|Overall Study|Withdrawal by Subject|1|||
163341119|NCT01229176|589956976|FG000|Overall Study|Lost to Follow-up|0|||
163341120|NCT01229176|589956977|FG001|Overall Study|Lost to Follow-up|3|||
163341121|NCT01229176|589956978|FG002|Overall Study|Lost to Follow-up|0|||
163341122|NCT01229176|589956979|FG003|Overall Study|Lost to Follow-up|0|||
163341123|NCT01229176|589956980|FG004|Overall Study|Lost to Follow-up|1|||
163341124|NCT01229176|589956981|FG005|Overall Study|Lost to Follow-up|1|||
163341125|NCT01229176|589956982|FG006|Overall Study|Lost to Follow-up|0|||
163341126|NCT01229176|589956983|FG007|Overall Study|Lost to Follow-up|2|||
163341127|NCT03890484|589956989|FG000|Overall Study|Lost to Follow-up|1|||
163341128|NCT03890484|589956990|FG001|Overall Study|Lost to Follow-up|1|||
163341129|NCT00518206|589956991|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
163341130|NCT00518206|589956992|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
163341131|NCT00518206|589956991|FG000|Overall Study|Withdrawal by Subject|2|||
163341132|NCT00518206|589956992|FG001|Overall Study|Withdrawal by Subject|0|||
163341133|NCT00518206|589956991|FG000|Overall Study|Drug Supply Issue|1|||
163341134|NCT00518206|589956992|FG001|Overall Study|Drug Supply Issue|0|||
163341135|NCT00518206|589956991|FG000|Overall Study|Reason Unknown|1|||
163341136|NCT00518206|589956992|FG001|Overall Study|Reason Unknown|0|||
163341137|NCT00518206|589956991|FG000|Overall Study|Completion Status Unknown|1|||
163341138|NCT00518206|589956992|FG001|Overall Study|Completion Status Unknown|0|||
163341139|NCT03075878|589956993|FG000|Overall Study|Physician Decision|1|||
163341140|NCT02188459|589956994|FG000|Overall Study|Lost to Follow-up|3|||
163341141|NCT02188459|589956995|FG001|Overall Study|Lost to Follow-up|4|||
163341142|NCT02188459|589956994|FG000|Overall Study|Early Termination|0|||
163341143|NCT02188459|589956995|FG001|Overall Study|Early Termination|3|||
163341144|NCT02367794|589957000|FG000|Overall Study|Death|252|||
163341145|NCT02367794|589957001|FG001|Overall Study|Death|245|||
163341146|NCT02367794|589957002|FG002|Overall Study|Death|243|||
163341147|NCT02367794|589957000|FG000|Overall Study|Lost to Follow-up|1|||
163341148|NCT02367794|589957001|FG001|Overall Study|Lost to Follow-up|2|||
163341149|NCT02367794|589957002|FG002|Overall Study|Lost to Follow-up|2|||
163408110|NCT05098041|590204026|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
163408111|NCT01297270|590204027|FG000|Overall Study|Adverse Event|19|||
163341150|NCT02367794|589957000|FG000|Overall Study|Physician Decision|0|||
163341151|NCT02367794|589957001|FG001|Overall Study|Physician Decision|5|||
163341152|NCT02367794|589957002|FG002|Overall Study|Physician Decision|3|||
163341153|NCT02367794|589957000|FG000|Overall Study|Protocol Violation|1|||
163341154|NCT02367794|589957001|FG001|Overall Study|Protocol Violation|0|||
163341155|NCT02367794|589957002|FG002|Overall Study|Protocol Violation|1|||
163341156|NCT02367794|589957000|FG000|Overall Study|Withdrawal by Subject|25|||
163341157|NCT02367794|589957001|FG001|Overall Study|Withdrawal by Subject|12|||
163341158|NCT02367794|589957002|FG002|Overall Study|Withdrawal by Subject|20|||
163341159|NCT02367794|589957000|FG000|Overall Study|Brain metastasis|1|||
163341160|NCT02367794|589957001|FG001|Overall Study|Brain metastasis|0|||
163341161|NCT02367794|589957002|FG002|Overall Study|Brain metastasis|0|||
163341162|NCT02367794|589957000|FG000|Overall Study|Randomized in error|0|||
163341163|NCT02367794|589957001|FG001|Overall Study|Randomized in error|0|||
163341164|NCT02367794|589957002|FG002|Overall Study|Randomized in error|1|||
163341165|NCT02367794|589957000|FG000|Overall Study|Patient unable to receive carboplatin|0|||
163341166|NCT02367794|589957001|FG001|Overall Study|Patient unable to receive carboplatin|0|||
163341167|NCT02367794|589957002|FG002|Overall Study|Patient unable to receive carboplatin|1|||
163341168|NCT02367794|589957000|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
163341169|NCT02367794|589957001|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
163341170|NCT02367794|589957002|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
163341171|NCT02367794|589957000|FG000|Overall Study|Adverse Event|0|||
163341172|NCT02367794|589957001|FG001|Overall Study|Adverse Event|0|||
163341173|NCT02367794|589957002|FG002|Overall Study|Adverse Event|2|||
163341174|NCT02367794|589957000|FG000|Overall Study|Study Terminated By Sponsor|0|||
163341175|NCT02367794|589957001|FG001|Overall Study|Study Terminated By Sponsor|1|||
163341176|NCT02367794|589957002|FG002|Overall Study|Study Terminated By Sponsor|1|||
163341177|NCT02367794|589957000|FG000|Overall Study|Moved to Roll-Over Study|0|||
163341178|NCT02367794|589957001|FG001|Overall Study|Moved to Roll-Over Study|15|||
163341179|NCT02367794|589957002|FG002|Overall Study|Moved to Roll-Over Study|13|||
163341180|NCT02367794|589957000|FG000|Overall Study|Sponsor Request|60|||
163341181|NCT02367794|589957001|FG001|Overall Study|Sponsor Request|57|||
163341182|NCT02367794|589957002|FG002|Overall Study|Sponsor Request|45|||
163341183|NCT02367794|589957000|FG000|Overall Study|Moved into PTAP Study|0|||
163341184|NCT02367794|589957001|FG001|Overall Study|Moved into PTAP Study|2|||
163341185|NCT02367794|589957002|FG002|Overall Study|Moved into PTAP Study|3|||
163341186|NCT02367794|589957000|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
163341187|NCT02367794|589957001|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
163341188|NCT02367794|589957002|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
163341189|NCT02367794|589957000|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
163341190|NCT02367794|589957001|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
163341191|NCT02367794|589957002|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
163341192|NCT02367794|589957000|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
163341193|NCT02367794|589957001|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
163341194|NCT02367794|589957002|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
163341195|NCT02367794|589957000|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
163341196|NCT02367794|589957001|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
163341197|NCT02367794|589957002|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
163341198|NCT02612285|589957003|FG000|Overall Study|Withdrawal by Subject|1|||
163341199|NCT02010684|589957004|FG000|Overall Study|Lost to Follow-up|8|||
163341200|NCT02010684|589957005|FG001|Overall Study|Lost to Follow-up|18|||
163341201|NCT02010684|589957004|FG000|Overall Study|Withdrawal by Subject|4|||
163341202|NCT02010684|589957005|FG001|Overall Study|Withdrawal by Subject|5|||
163341203|NCT01986348|589957006|FG000|Overall Study|Death|8|||
163341204|NCT01986348|589957007|FG001|Overall Study|Death|22|||
163341205|NCT01986348|589957008|FG002|Overall Study|Death|10|||
163341206|NCT01986348|589957009|FG003|Overall Study|Death|21|||
163341207|NCT01986348|589957006|FG000|Overall Study|Lost to Follow-up|0|||
163341208|NCT01986348|589957007|FG001|Overall Study|Lost to Follow-up|0|||
163341209|NCT01986348|589957008|FG002|Overall Study|Lost to Follow-up|0|||
163341210|NCT01986348|589957009|FG003|Overall Study|Lost to Follow-up|2|||
163341211|NCT01986348|589957006|FG000|Overall Study|Physician Decision|0|||
163341212|NCT01986348|589957007|FG001|Overall Study|Physician Decision|0|||
163341213|NCT01986348|589957008|FG002|Overall Study|Physician Decision|0|||
163341214|NCT01986348|589957009|FG003|Overall Study|Physician Decision|1|||
163341215|NCT01986348|589957006|FG000|Overall Study|Progressive Disease|0|||
163341216|NCT01986348|589957007|FG001|Overall Study|Progressive Disease|0|||
163341217|NCT01986348|589957008|FG002|Overall Study|Progressive Disease|2|||
163341218|NCT01986348|589957009|FG003|Overall Study|Progressive Disease|0|||
163341219|NCT01986348|589957006|FG000|Overall Study|Withdrawal by Participant|0|||
163341220|NCT01986348|589957007|FG001|Overall Study|Withdrawal by Participant|1|||
163224855|NCT00404352|589540042|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
163341221|NCT01986348|589957008|FG002|Overall Study|Withdrawal by Participant|2|||
163341222|NCT01986348|589957009|FG003|Overall Study|Withdrawal by Participant|1|||
163341223|NCT01986348|589957006|FG000|Overall Study|Study Terminated by Sponsor|0|||
163121497|NCT01515475|589152656|FG001|Overall Study|Lost to Follow-up|15|||
163121498|NCT01515475|589152657|FG002|Overall Study|Lost to Follow-up|12|||
163121499|NCT01515475|589152658|FG003|Overall Study|Lost to Follow-up|12|||
163121500|NCT01996592|589152661|FG000|Overall Study|no response to text/no diary entry|32|||
163121501|NCT01996592|589152661|FG000|Overall Study|change in surgical date|4|||
163121502|NCT01996592|589152661|FG000|Overall Study|Withdrawal by Subject|5|||
163121503|NCT01996592|589152661|FG000|Overall Study|change in mode of delivery|4|||
163121504|NCT01406015|589152662|FG000|Overall Study|Withdrawal by Subject|3|||
163121505|NCT01406015|589152663|FG001|Overall Study|Withdrawal by Subject|3|||
163121506|NCT00707746|589152664|FG000|Treatment Period|Adverse Event|2|||
163121507|NCT00707746|589152665|FG001|Treatment Period|Adverse Event|4|||
163224856|NCT00404352|589540043|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
163224857|NCT00404352|589540044|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
163224858|NCT00404352|589540045|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
163224859|NCT00404352|589540037|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
163224860|NCT00404352|589540038|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
163224861|NCT00404352|589540039|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
163224862|NCT00404352|589540040|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
163224863|NCT00404352|589540041|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
163224864|NCT00404352|589540042|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
163224865|NCT00404352|589540043|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
163224866|NCT00404352|589540044|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
163224867|NCT00404352|589540045|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
163224868|NCT00404352|589540037|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
163224869|NCT00404352|589540038|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
163224870|NCT00404352|589540039|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
163224871|NCT00404352|589540040|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
163224872|NCT00404352|589540041|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
163224873|NCT00404352|589540042|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
163224874|NCT00404352|589540043|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
163224875|NCT00404352|589540044|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
163224876|NCT00404352|589540045|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
163224877|NCT00404352|589540037|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
163224878|NCT00404352|589540038|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
163224879|NCT00404352|589540039|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
163224880|NCT00404352|589540040|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
163224881|NCT00404352|589540041|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
163224882|NCT00404352|589540042|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
163224883|NCT00404352|589540043|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
163224884|NCT00404352|589540044|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
163224885|NCT00404352|589540045|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
163224886|NCT00404352|589540037|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
163224887|NCT00404352|589540038|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
163224888|NCT00404352|589540039|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
163224889|NCT00404352|589540040|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
163224890|NCT00404352|589540041|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
163224891|NCT00404352|589540042|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
163224892|NCT00404352|589540043|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
163224893|NCT00404352|589540044|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
163224894|NCT00404352|589540045|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
163224895|NCT00404352|589540037|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
163224896|NCT00404352|589540038|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
163224897|NCT00404352|589540039|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
163224898|NCT00404352|589540040|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
163224899|NCT00404352|589540041|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
163224900|NCT00404352|589540042|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
163224901|NCT00404352|589540043|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
163224902|NCT00404352|589540044|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
163224903|NCT00404352|589540045|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
163121508|NCT00707746|589152664|FG000|Treatment Period|Ineligibility|0|||
163121509|NCT00707746|589152665|FG001|Treatment Period|Ineligibility|1|||
163224904|NCT00404352|589540037|FG000|Double Blind (up to 24 Month)|Other|0|||
163224905|NCT00404352|589540038|FG001|Double Blind (up to 24 Month)|Other|1|||
163224906|NCT00404352|589540039|FG002|Double Blind (up to 24 Month)|Other|0|||
163224907|NCT00404352|589540040|FG003|Double Blind (up to 24 Month)|Other|0|||
163224908|NCT00404352|589540041|FG004|Double Blind (up to 24 Month)|Other|0|||
163224909|NCT00404352|589540042|FG005|Double Blind (up to 24 Month)|Other|0|||
163224910|NCT00404352|589540043|FG006|Double Blind (up to 24 Month)|Other|0|||
163224911|NCT00404352|589540044|FG007|Double Blind (up to 24 Month)|Other|0|||
163121510|NCT02573246|589152670|FG000|Overall Study|Lost to Follow-up|2|||
163224912|NCT00404352|589540045|FG008|Double Blind (up to 24 Month)|Other|0|||
163224913|NCT00404352|589540037|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
163224914|NCT00404352|589540038|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
163224915|NCT00404352|589540039|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
163224916|NCT00404352|589540040|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
163224917|NCT00404352|589540041|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
163224918|NCT00404352|589540042|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
163224919|NCT00404352|589540043|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
163224920|NCT00404352|589540044|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
163224921|NCT00404352|589540045|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
163224922|NCT00404352|589540037|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
163224923|NCT00404352|589540038|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
163224924|NCT00404352|589540039|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
163224925|NCT00404352|589540040|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
163224926|NCT00404352|589540041|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
163224927|NCT00404352|589540042|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
163224928|NCT00404352|589540043|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
163224929|NCT00404352|589540044|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
163224930|NCT00404352|589540045|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
163224931|NCT00404352|589540037|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
163224932|NCT00404352|589540038|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
163224933|NCT00404352|589540039|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
163224934|NCT00404352|589540040|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
163224935|NCT00404352|589540041|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
163224936|NCT00404352|589540042|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
163224937|NCT00404352|589540043|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
163224938|NCT00404352|589540044|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
163224939|NCT00404352|589540045|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
163224940|NCT00404352|589540037|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
163224941|NCT00404352|589540038|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
163224942|NCT00404352|589540039|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
163224943|NCT00404352|589540040|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
163224944|NCT00404352|589540041|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
163224945|NCT00404352|589540042|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
163224946|NCT00404352|589540043|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
163224947|NCT00404352|589540044|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
163224948|NCT00404352|589540045|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
163224949|NCT00404352|589540037|FG000|Open Label (up to 24 Month)|Disease progression|0|||
163224950|NCT00404352|589540038|FG001|Open Label (up to 24 Month)|Disease progression|0|||
163224951|NCT00404352|589540039|FG002|Open Label (up to 24 Month)|Disease progression|0|||
163224952|NCT00404352|589540040|FG003|Open Label (up to 24 Month)|Disease progression|1|||
163224953|NCT00404352|589540041|FG004|Open Label (up to 24 Month)|Disease progression|0|||
163224954|NCT00404352|589540042|FG005|Open Label (up to 24 Month)|Disease progression|0|||
163224955|NCT00404352|589540043|FG006|Open Label (up to 24 Month)|Disease progression|0|||
163341224|NCT01986348|589957007|FG001|Overall Study|Study Terminated by Sponsor|0|||
163341225|NCT01986348|589957008|FG002|Overall Study|Study Terminated by Sponsor|0|||
163341226|NCT01986348|589957009|FG003|Overall Study|Study Terminated by Sponsor|3|||
163341227|NCT01986348|589957006|FG000|Overall Study|Other-unspecified|0|||
163341228|NCT01986348|589957007|FG001|Overall Study|Other-unspecified|1|||
163341229|NCT01986348|589957008|FG002|Overall Study|Other-unspecified|0|||
163341230|NCT01986348|589957009|FG003|Overall Study|Other-unspecified|2|||
163341231|NCT00805441|589957010|FG000|Overall Study|Adverse Event|5|||
163341232|NCT00805441|589957011|FG001|Overall Study|Adverse Event|2|||
163341233|NCT00805441|589957010|FG000|Overall Study|Lack of Efficacy|0|||
163341234|NCT00805441|589957011|FG001|Overall Study|Lack of Efficacy|2|||
163341235|NCT00805441|589957010|FG000|Overall Study|Protocol Violation|4|||
163341236|NCT00805441|589957011|FG001|Overall Study|Protocol Violation|8|||
163341237|NCT00805441|589957010|FG000|Overall Study|Lost to Follow-up|10|||
163224956|NCT00404352|589540044|FG007|Open Label (up to 24 Month)|Disease progression|0|||
163341238|NCT00805441|589957011|FG001|Overall Study|Lost to Follow-up|13|||
163341239|NCT00805441|589957010|FG000|Overall Study|Withdrawal by Subject|15|||
163341240|NCT00805441|589957011|FG001|Overall Study|Withdrawal by Subject|9|||
163341241|NCT00805441|589957010|FG000|Overall Study|Physician Decision|0|||
163341242|NCT00805441|589957011|FG001|Overall Study|Physician Decision|1|||
163341243|NCT00805441|589957010|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
163341244|NCT00805441|589957011|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
163224957|NCT00404352|589540045|FG008|Open Label (up to 24 Month)|Disease progression|0|||
163224958|NCT00404352|589540037|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
163224959|NCT00404352|589540038|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
163224960|NCT00404352|589540039|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
163341245|NCT05379400|589958140|FG000|Overall Study|Lost to Follow-up|1|||
163341246|NCT05379400|589958141|FG001|Overall Study|Lost to Follow-up|1|||
163341247|NCT05356130|589958142|FG000|Overall Study|Withdrawal by Subject|0|||
163341248|NCT05356130|589958143|FG001|Overall Study|Withdrawal by Subject|0|||
163408112|NCT01297270|590204028|FG001|Overall Study|Adverse Event|32|||
163408113|NCT01297270|590204029|FG002|Overall Study|Adverse Event|5|||
163408114|NCT01297270|590204027|FG000|Overall Study|Lack of Efficacy|15|||
163408115|NCT01297270|590204028|FG001|Overall Study|Lack of Efficacy|17|||
163408116|NCT01297270|590204029|FG002|Overall Study|Lack of Efficacy|15|||
163408117|NCT01297270|590204027|FG000|Overall Study|Lost to Follow-up|1|||
163408118|NCT01297270|590204028|FG001|Overall Study|Lost to Follow-up|2|||
163408119|NCT01297270|590204029|FG002|Overall Study|Lost to Follow-up|1|||
163408120|NCT01297270|590204027|FG000|Overall Study|Protocol Violation|0|||
163408121|NCT01297270|590204028|FG001|Overall Study|Protocol Violation|2|||
163408122|NCT01297270|590204029|FG002|Overall Study|Protocol Violation|0|||
163408123|NCT01297270|590204027|FG000|Overall Study|Withdrawal by Subject|7|||
163408124|NCT01297270|590204028|FG001|Overall Study|Withdrawal by Subject|15|||
163408125|NCT01297270|590204029|FG002|Overall Study|Withdrawal by Subject|7|||
163408126|NCT01297270|590204027|FG000|Overall Study|Other reason not defined above|3|||
163408127|NCT01297270|590204028|FG001|Overall Study|Other reason not defined above|3|||
163408128|NCT01297270|590204029|FG002|Overall Study|Other reason not defined above|1|||
163408129|NCT01297270|590204027|FG000|Overall Study|Not treated|0|||
163408130|NCT01297270|590204028|FG001|Overall Study|Not treated|1|||
163408131|NCT01297270|590204029|FG002|Overall Study|Not treated|0|||
163408132|NCT02432235|590204032|FG000|Overall Study|Death|1|||
163408133|NCT02432235|590204033|FG001|Overall Study|Death|1|||
163408134|NCT02432235|590204034|FG002|Overall Study|Death|2|||
163121511|NCT02573246|589152671|FG001|Overall Study|Lost to Follow-up|0|||
163121512|NCT02573246|589152672|FG002|Overall Study|Lost to Follow-up|0|||
163121513|NCT02573246|589152673|FG003|Overall Study|Lost to Follow-up|0|||
163121514|NCT02573246|589152674|FG004|Overall Study|Lost to Follow-up|1|||
163121515|NCT02573246|589152670|FG000|Overall Study|Withdrawal by Subject|0|||
163121516|NCT02573246|589152671|FG001|Overall Study|Withdrawal by Subject|0|||
163121517|NCT02573246|589152672|FG002|Overall Study|Withdrawal by Subject|0|||
163121518|NCT02573246|589152673|FG003|Overall Study|Withdrawal by Subject|0|||
163121519|NCT02573246|589152674|FG004|Overall Study|Withdrawal by Subject|1|||
163121520|NCT02573246|589152670|FG000|Overall Study|Physician Decision|1|||
163121521|NCT02573246|589152671|FG001|Overall Study|Physician Decision|1|||
163121522|NCT02573246|589152672|FG002|Overall Study|Physician Decision|3|||
163121523|NCT02573246|589152673|FG003|Overall Study|Physician Decision|2|||
163121524|NCT02573246|589152674|FG004|Overall Study|Physician Decision|2|||
163121525|NCT01219933|589152675|FG000|Overall Study|Adverse Event|8|||
163121526|NCT01219933|589152675|FG000|Overall Study|No LDA reached|5|||
163121527|NCT01219933|589152675|FG000|Overall Study|No LDA maintained|7|||
163121528|NCT01219933|589152675|FG000|Overall Study|Lost to Follow-up|3|||
163121529|NCT01219933|589152675|FG000|Overall Study|GC free|1|||
163121530|NCT01219933|589152675|FG000|Overall Study|Withdrawal by Subject|5|||
163121531|NCT01219933|589152675|FG000|Overall Study|Protocol Violation|8|||
163121532|NCT01219933|589152675|FG000|Overall Study|Lack of Efficacy|1|||
163121533|NCT01902888|589152676|FG000|Overall Study|Study Terminated|3|||
163121534|NCT02256267|589152677|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
163121535|NCT02256267|589152677|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
163121536|NCT01685983|589152678|FG000|Overall Study|Adverse Event|7|||
163121537|NCT01685983|589152678|FG000|Overall Study|Death|1|||
163121538|NCT01685983|589152678|FG000|Overall Study|Withdrawal by Subject|19|||
163121539|NCT01685983|589152678|FG000|Overall Study|Protocol Violation|2|||
163121540|NCT01685983|589152678|FG000|Overall Study|Physician Decision|13|||
163121541|NCT01685983|589152678|FG000|Overall Study|Other|7|||
163121542|NCT01685983|589152678|FG000|Overall Study|Progressive Disease|32|||
163121543|NCT01685983|589152678|FG000|Overall Study|Noncompliance with Study Drug|1|||
163121544|NCT03149003|589152679|FG000|Overall Study|Randomized but not treated|0|||
163121545|NCT03149003|589152680|FG001|Overall Study|Randomized but not treated|1|||
163121546|NCT03149003|589152681|FG002|Overall Study|Randomized but not treated|18|||
163121547|NCT01443130|589152682|FG000|Overall Study|Lost to Follow-up|44|||
163121548|NCT01443130|589152683|FG001|Overall Study|Lost to Follow-up|42|||
163121549|NCT01443130|589152684|FG002|Overall Study|Lost to Follow-up|50|||
163121550|NCT01443130|589152685|FG003|Overall Study|Lost to Follow-up|23|||
163121551|NCT01443130|589152686|FG004|Overall Study|Lost to Follow-up|25|||
163121552|NCT01443130|589152687|FG005|Overall Study|Lost to Follow-up|21|||
163121553|NCT01443130|589152682|FG000|Overall Study|Death|0|||
163121554|NCT01443130|589152683|FG001|Overall Study|Death|1|||
163408135|NCT02432235|590204035|FG003|Overall Study|Death|2|||
163408136|NCT02432235|590204036|FG004|Overall Study|Death|1|||
163408137|NCT02432235|590204037|FG005|Overall Study|Death|3|||
163408138|NCT02432235|590204038|FG006|Overall Study|Death|11|||
163408139|NCT02432235|590204039|FG007|Overall Study|Death|15|||
163121555|NCT01443130|589152684|FG002|Overall Study|Death|0|||
163121556|NCT01443130|589152685|FG003|Overall Study|Death|7|||
163121557|NCT01443130|589152686|FG004|Overall Study|Death|10|||
163121558|NCT01443130|589152687|FG005|Overall Study|Death|8|||
163121559|NCT01443130|589152682|FG000|Overall Study|Adverse Event|2|||
163121560|NCT01443130|589152683|FG001|Overall Study|Adverse Event|1|||
163121561|NCT01443130|589152684|FG002|Overall Study|Adverse Event|1|||
163408140|NCT02432235|590204040|FG008|Overall Study|Death|15|||
163408141|NCT02432235|590204041|FG009|Overall Study|Death|3|||
163224961|NCT00404352|589540040|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
163224962|NCT00404352|589540041|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
163224963|NCT00404352|589540042|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
163224964|NCT00404352|589540043|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
163224965|NCT00404352|589540044|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
163224966|NCT00404352|589540045|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
163224967|NCT00404352|589540037|FG000|Open Label Extension (up to 36 Months)|Other|0|||
163224968|NCT00404352|589540038|FG001|Open Label Extension (up to 36 Months)|Other|0|||
163224969|NCT00404352|589540039|FG002|Open Label Extension (up to 36 Months)|Other|0|||
163224970|NCT00404352|589540040|FG003|Open Label Extension (up to 36 Months)|Other|0|||
163224971|NCT00404352|589540041|FG004|Open Label Extension (up to 36 Months)|Other|0|||
163224972|NCT00404352|589540042|FG005|Open Label Extension (up to 36 Months)|Other|0|||
163224973|NCT00404352|589540043|FG006|Open Label Extension (up to 36 Months)|Other|0|||
163224974|NCT00404352|589540044|FG007|Open Label Extension (up to 36 Months)|Other|0|||
163224975|NCT00404352|589540045|FG008|Open Label Extension (up to 36 Months)|Other|2|||
163224976|NCT01479621|589540048|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
163341249|NCT05356130|589958144|FG002|Overall Study|Withdrawal by Subject|3|||
163341250|NCT04820023|589958147|FG000|Overall Study|Death|0|||
163121562|NCT01443130|589152685|FG003|Overall Study|Adverse Event|0|||
163121563|NCT01443130|589152686|FG004|Overall Study|Adverse Event|0|||
163121564|NCT01443130|589152687|FG005|Overall Study|Adverse Event|0|||
163121565|NCT01443130|589152682|FG000|Overall Study|Protocol Violation|2|||
163121566|NCT01443130|589152683|FG001|Overall Study|Protocol Violation|1|||
163121567|NCT01443130|589152684|FG002|Overall Study|Protocol Violation|3|||
163121568|NCT01443130|589152685|FG003|Overall Study|Protocol Violation|2|||
163121569|NCT01443130|589152686|FG004|Overall Study|Protocol Violation|2|||
163121570|NCT01443130|589152687|FG005|Overall Study|Protocol Violation|3|||
163121571|NCT01443130|589152682|FG000|Overall Study|Withdrawal by Subject|15|||
163121572|NCT01443130|589152683|FG001|Overall Study|Withdrawal by Subject|14|||
163121573|NCT01443130|589152684|FG002|Overall Study|Withdrawal by Subject|12|||
163121574|NCT01443130|589152685|FG003|Overall Study|Withdrawal by Subject|7|||
163121575|NCT01443130|589152686|FG004|Overall Study|Withdrawal by Subject|7|||
163121576|NCT01443130|589152687|FG005|Overall Study|Withdrawal by Subject|2|||
163121577|NCT01443130|589152682|FG000|Overall Study|Death of Subject's Infant|5|||
163121578|NCT01443130|589152683|FG001|Overall Study|Death of Subject's Infant|10|||
163121579|NCT01443130|589152684|FG002|Overall Study|Death of Subject's Infant|11|||
163121580|NCT01443130|589152685|FG003|Overall Study|Death of Subject's Infant|0|||
163121581|NCT01443130|589152686|FG004|Overall Study|Death of Subject's Infant|0|||
163121582|NCT01443130|589152687|FG005|Overall Study|Death of Subject's Infant|0|||
163121583|NCT01266590|589153743|FG000|Overall Study|Adverse Event|3|||
163121584|NCT01266590|589153743|FG000|Overall Study|Lost to Follow-up|1|||
163121585|NCT01266590|589153743|FG000|Overall Study|Withdrawal by Subject|1|||
163121586|NCT01266590|589153743|FG000|Overall Study|Physician Decision|1|||
163121587|NCT01806064|589153746|FG000|Overall Study|Randomized Not Enrolled|0|||
163121588|NCT01806064|589153747|FG001|Overall Study|Randomized Not Enrolled|0|||
163121589|NCT01806064|589153748|FG002|Overall Study|Randomized Not Enrolled|0|||
163121590|NCT01806064|589153749|FG003|Overall Study|Randomized Not Enrolled|1|||
163121591|NCT01806064|589153750|FG004|Overall Study|Randomized Not Enrolled|2|||
163121592|NCT02804750|589153754|FG000|Period 1|Adverse Event|0|||
163121593|NCT02804750|589153755|FG001|Period 1|Adverse Event|2|||
163121594|NCT02804750|589153754|FG000|Period 1|Withdrawal by Subject|0|||
163121595|NCT02804750|589153755|FG001|Period 1|Withdrawal by Subject|1|||
163121596|NCT02804750|589153754|FG000|Period 2|Adverse Event|1|||
163121597|NCT02804750|589153755|FG001|Period 2|Adverse Event|0|||
163224977|NCT01479621|589540049|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163224978|NCT01479621|589540050|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163224979|NCT01479621|589540051|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163224980|NCT01479621|589540052|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163224981|NCT01479621|589540053|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163224982|NCT01479621|589540054|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163224983|NCT01479621|589540048|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
163224984|NCT01479621|589540049|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163341251|NCT04820023|589958148|FG001|Overall Study|Death|0|||
163341252|NCT04820023|589958149|FG002|Overall Study|Death|0|||
163341253|NCT04820023|589958150|FG003|Overall Study|Death|0|||
163341254|NCT04820023|589958151|FG004|Overall Study|Death|0|||
163341255|NCT04820023|589958152|FG005|Overall Study|Death|0|||
163121598|NCT02804750|589153754|FG000|Period 3|Adverse Event|0|||
163121599|NCT02804750|589153755|FG001|Period 3|Adverse Event|2|||
163121600|NCT02804750|589153754|FG000|Period 4|Adverse Event|0|||
163121601|NCT02804750|589153755|FG001|Period 4|Adverse Event|5|||
163121602|NCT02337634|589153763|FG000|Overall Study|Protocol Violation|3|||
163121603|NCT02337634|589153764|FG001|Overall Study|Protocol Violation|1|||
163121604|NCT02337634|589153763|FG000|Overall Study|Lost to Follow-up|1|||
163121605|NCT02337634|589153764|FG001|Overall Study|Lost to Follow-up|0|||
163121606|NCT02428205|589153766|FG000|Overall Study|Lack of Efficacy|1|||
163121607|NCT02428205|589153767|FG001|Overall Study|Lack of Efficacy|0|||
163121608|NCT02428205|589153766|FG000|Overall Study|Lost to Follow-up|1|||
163121609|NCT02428205|589153767|FG001|Overall Study|Lost to Follow-up|1|||
163121610|NCT02428205|589153766|FG000|Overall Study|Worse behavior|0|||
163121611|NCT02428205|589153767|FG001|Overall Study|Worse behavior|1|||
163121612|NCT02888743|589153768|FG000|Overall Study|Withdrawal by Subject|1|||
163121613|NCT02888743|589153769|FG001|Overall Study|Withdrawal by Subject|2|||
163121614|NCT02888743|589153770|FG002|Overall Study|Withdrawal by Subject|2|||
163121615|NCT02888743|589153771|FG003|Overall Study|Withdrawal by Subject|0|||
163121616|NCT02888743|589153772|FG004|Overall Study|Withdrawal by Subject|1|||
163121617|NCT02888743|589153768|FG000|Overall Study|Disease progression before treatment|2|||
163121618|NCT02888743|589153769|FG001|Overall Study|Disease progression before treatment|0|||
163121619|NCT02888743|589153770|FG002|Overall Study|Disease progression before treatment|2|||
163121620|NCT02888743|589153771|FG003|Overall Study|Disease progression before treatment|0|||
163121621|NCT02888743|589153772|FG004|Overall Study|Disease progression before treatment|0|||
163121622|NCT02888743|589153768|FG000|Overall Study|Patient ineligible|1|||
163121623|NCT02888743|589153769|FG001|Overall Study|Patient ineligible|2|||
163121624|NCT02888743|589153770|FG002|Overall Study|Patient ineligible|0|||
163121625|NCT02888743|589153771|FG003|Overall Study|Patient ineligible|0|||
163121626|NCT02888743|589153772|FG004|Overall Study|Patient ineligible|0|||
163121627|NCT00527319|589153773|FG000|Overall Study|Withdrawal by Subject|5|||
163121628|NCT00527319|589153774|FG001|Overall Study|Withdrawal by Subject|0|||
163121629|NCT00527319|589153775|FG002|Overall Study|Withdrawal by Subject|1|||
163121630|NCT00527319|589153773|FG000|Overall Study|Lost to Follow-up|1|||
163121631|NCT00527319|589153774|FG001|Overall Study|Lost to Follow-up|0|||
163121632|NCT00527319|589153775|FG002|Overall Study|Lost to Follow-up|0|||
163121633|NCT00527319|589153773|FG000|Overall Study|Death|0|||
163121634|NCT00527319|589153774|FG001|Overall Study|Death|3|||
163121635|NCT00527319|589153775|FG002|Overall Study|Death|1|||
163121636|NCT00527319|589153773|FG000|Overall Study|Intercurrent Medical Illness|0|||
163121637|NCT00527319|589153774|FG001|Overall Study|Intercurrent Medical Illness|1|||
163121638|NCT00527319|589153775|FG002|Overall Study|Intercurrent Medical Illness|3|||
163121639|NCT00527319|589153773|FG000|Overall Study|Adverse Event|0|||
163121640|NCT00527319|589153774|FG001|Overall Study|Adverse Event|0|||
163121641|NCT00527319|589153775|FG002|Overall Study|Adverse Event|1|||
163121642|NCT03344172|589153778|FG000|Overall Study|Received <1 dose of treatment|1|||
163121643|NCT03344172|589153779|FG001|Overall Study|Received <1 dose of treatment|0|||
163341256|NCT04820023|589958153|FG006|Overall Study|Death|1|||
163341257|NCT04820023|589958154|FG007|Overall Study|Death|0|||
163341258|NCT04820023|589958155|FG008|Overall Study|Death|1|||
163341259|NCT04820023|589958147|FG000|Overall Study|Withdrawal by Subject|1|||
163341260|NCT04820023|589958148|FG001|Overall Study|Withdrawal by Subject|2|||
163341261|NCT04820023|589958149|FG002|Overall Study|Withdrawal by Subject|2|||
163121644|NCT03106415|589153780|FG000|Phase 1|Withdrawal by Subject|1|||
163121645|NCT03106415|589153781|FG001|Phase 1|Withdrawal by Subject|0|||
163121646|NCT03106415|589153782|FG002|Phase 1|Withdrawal by Subject|0|||
163121647|NCT03106415|589153780|FG000|Phase 1|Adverse Event|1|||
163121648|NCT03106415|589153781|FG001|Phase 1|Adverse Event|1|||
163121649|NCT03106415|589153782|FG002|Phase 1|Adverse Event|0|||
163121650|NCT03106415|589153780|FG000|Phase 1|Protocol Violation|0|||
163121651|NCT03106415|589153781|FG001|Phase 1|Protocol Violation|1|||
163121652|NCT03106415|589153782|FG002|Phase 1|Protocol Violation|0|||
163121653|NCT01804582|589153783|FG000|Overall Study|Lost to Follow-up|47|||
163121654|NCT01804582|589153784|FG001|Overall Study|Lost to Follow-up|56|||
163121655|NCT01804582|589153783|FG000|Overall Study|Physician Decision|2|||
163121656|NCT01804582|589153784|FG001|Overall Study|Physician Decision|0|||
163121657|NCT00520013|589153787|FG000|Overall Study|Withdrawal by Subject|0|||
163121658|NCT00520013|589153788|FG001|Overall Study|Withdrawal by Subject|0|||
163121659|NCT00520013|589153789|FG002|Overall Study|Withdrawal by Subject|1|||
163121660|NCT00520013|589153787|FG000|Overall Study|Adverse Event|2|||
163121661|NCT00520013|589153788|FG001|Overall Study|Adverse Event|10|||
163341262|NCT04820023|589958150|FG003|Overall Study|Withdrawal by Subject|1|||
163341263|NCT04820023|589958151|FG004|Overall Study|Withdrawal by Subject|4|||
163341264|NCT04820023|589958152|FG005|Overall Study|Withdrawal by Subject|3|||
163121662|NCT00520013|589153789|FG002|Overall Study|Adverse Event|7|||
163121663|NCT00520013|589153787|FG000|Overall Study|Progressive Disease|7|||
163341265|NCT04820023|589958153|FG006|Overall Study|Withdrawal by Subject|3|||
163341266|NCT04820023|589958154|FG007|Overall Study|Withdrawal by Subject|6|||
163121664|NCT00520013|589153788|FG001|Overall Study|Progressive Disease|3|||
163121665|NCT00520013|589153789|FG002|Overall Study|Progressive Disease|0|||
163121666|NCT00520013|589153787|FG000|Overall Study|Clinical Progression|3|||
163121667|NCT00520013|589153788|FG001|Overall Study|Clinical Progression|1|||
163121668|NCT00520013|589153789|FG002|Overall Study|Clinical Progression|0|||
163121669|NCT00520013|589153787|FG000|Overall Study|Death|0|||
163121670|NCT00520013|589153788|FG001|Overall Study|Death|1|||
163121671|NCT00520013|589153789|FG002|Overall Study|Death|0|||
163224985|NCT01479621|589540050|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163224986|NCT01479621|589540051|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163224987|NCT01479621|589540052|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163224988|NCT01479621|589540053|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163224989|NCT01479621|589540054|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163224990|NCT01479621|589540048|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
163121672|NCT00520013|589153787|FG000|Overall Study|Physician Decision|0|||
163121673|NCT00520013|589153788|FG001|Overall Study|Physician Decision|0|||
163121674|NCT00520013|589153789|FG002|Overall Study|Physician Decision|3|||
163121675|NCT00159913|589153790|FG000|Overall Study|Adverse Event|1|||
163121676|NCT00159913|589153791|FG001|Overall Study|Adverse Event|0|||
163121677|NCT00159913|589153792|FG002|Overall Study|Adverse Event|1|||
163121678|NCT00159913|589153793|FG003|Overall Study|Adverse Event|0|||
163121679|NCT00159913|589153790|FG000|Overall Study|Withdrawal by Subject|0|||
163121680|NCT00159913|589153791|FG001|Overall Study|Withdrawal by Subject|0|||
163121681|NCT00159913|589153792|FG002|Overall Study|Withdrawal by Subject|0|||
163121682|NCT00159913|589153793|FG003|Overall Study|Withdrawal by Subject|1|||
163121683|NCT00159913|589153790|FG000|Overall Study|Lost to Follow-up|0|||
163121684|NCT00159913|589153791|FG001|Overall Study|Lost to Follow-up|0|||
163121685|NCT00159913|589153792|FG002|Overall Study|Lost to Follow-up|0|||
163121686|NCT00159913|589153793|FG003|Overall Study|Lost to Follow-up|1|||
163121687|NCT00159913|589153790|FG000|Overall Study|Protocol Violation|1|||
163121688|NCT00159913|589153791|FG001|Overall Study|Protocol Violation|0|||
163121689|NCT00159913|589153792|FG002|Overall Study|Protocol Violation|1|||
163121690|NCT00159913|589153793|FG003|Overall Study|Protocol Violation|0|||
163121691|NCT00385723|589153794|FG000|Overall Study|Lost to Follow-up|1|||
163121692|NCT00385723|589153795|FG001|Overall Study|Lost to Follow-up|1|||
163121693|NCT00385723|589153796|FG002|Overall Study|Lost to Follow-up|0|||
163121694|NCT00385723|589153794|FG000|Overall Study|Withdrawal by Subject|1|||
163121695|NCT00385723|589153795|FG001|Overall Study|Withdrawal by Subject|0|||
163121696|NCT00385723|589153796|FG002|Overall Study|Withdrawal by Subject|2|||
163121697|NCT00413010|589153798|FG000|Overall Study|Adverse Event|8|||
163121698|NCT00413010|589153799|FG001|Overall Study|Adverse Event|4|||
163121699|NCT00413010|589153798|FG000|Overall Study|Laboratory abnormality|0|||
163121700|NCT00413010|589153799|FG001|Overall Study|Laboratory abnormality|2|||
163121701|NCT00413010|589153798|FG000|Overall Study|Lack of Efficacy|0|||
163121702|NCT00413010|589153799|FG001|Overall Study|Lack of Efficacy|3|||
163121703|NCT00413010|589153798|FG000|Overall Study|Lost to Follow-up|3|||
163121704|NCT00413010|589153799|FG001|Overall Study|Lost to Follow-up|0|||
163121705|NCT00413010|589153798|FG000|Overall Study|Withdrawal by Subject|7|||
163121706|NCT00413010|589153799|FG001|Overall Study|Withdrawal by Subject|2|||
163121707|NCT00413010|589153798|FG000|Overall Study|Due to termination of the study|54|||
163121708|NCT00413010|589153799|FG001|Overall Study|Due to termination of the study|52|||
163121709|NCT05432167|589153802|FG000|Overall Study|Adverse Event|0|||
163121710|NCT05432167|589153803|FG001|Overall Study|Adverse Event|2|||
163121711|NCT05432167|589153804|FG002|Overall Study|Adverse Event|1|||
163121712|NCT05432167|589153802|FG000|Overall Study|Lost to Follow-up|3|||
163121713|NCT05432167|589153803|FG001|Overall Study|Lost to Follow-up|3|||
163121714|NCT05432167|589153804|FG002|Overall Study|Lost to Follow-up|2|||
163121715|NCT05432167|589153802|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
163121716|NCT05432167|589153803|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
163121717|NCT05432167|589153804|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
163121718|NCT05432167|589153802|FG000|Overall Study|Physician Decision|1|||
163121719|NCT05432167|589153803|FG001|Overall Study|Physician Decision|0|||
163121720|NCT05432167|589153804|FG002|Overall Study|Physician Decision|0|||
163121721|NCT05432167|589153802|FG000|Overall Study|Withdrawal by Subject|7|||
163224991|NCT01479621|589540049|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163224992|NCT01479621|589540050|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163121722|NCT05432167|589153803|FG001|Overall Study|Withdrawal by Subject|4|||
163121723|NCT05432167|589153804|FG002|Overall Study|Withdrawal by Subject|11|||
163121724|NCT05432167|589153802|FG000|Overall Study|Other|0|||
163121725|NCT05432167|589153803|FG001|Overall Study|Other|0|||
163121726|NCT05432167|589153804|FG002|Overall Study|Other|1|||
163121727|NCT02758301|589153813|FG000|Overall Study|Death|12|||
163121728|NCT02758301|589153814|FG001|Overall Study|Death|0|||
163121729|NCT02758301|589153813|FG000|Overall Study|Physician Decision|10|||
163341267|NCT04820023|589958155|FG008|Overall Study|Withdrawal by Subject|5|||
163121730|NCT02758301|589153814|FG001|Overall Study|Physician Decision|1|||
163121731|NCT02758301|589153813|FG000|Overall Study|Withdrawal by Subject|5|||
163121732|NCT02758301|589153814|FG001|Overall Study|Withdrawal by Subject|6|||
163121733|NCT02758301|589153813|FG000|Overall Study|Lost to Follow-up|7|||
163224993|NCT01479621|589540051|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163341268|NCT04820023|589958147|FG000|Overall Study|Progressive Disease|3|||
163341269|NCT04820023|589958148|FG001|Overall Study|Progressive Disease|0|||
163121734|NCT02758301|589153814|FG001|Overall Study|Lost to Follow-up|0|||
163121735|NCT02758301|589153813|FG000|Overall Study|Protocol Violation|0|||
163121736|NCT02758301|589153814|FG001|Overall Study|Protocol Violation|1|||
163121737|NCT00364533|589153815|FG000|Overall Study|Adverse Event|8|||
163121738|NCT00364533|589153816|FG001|Overall Study|Adverse Event|7|||
163121739|NCT00364533|589153817|FG002|Overall Study|Adverse Event|15|||
163121740|NCT00364533|589153818|FG003|Overall Study|Adverse Event|5|||
163121741|NCT00364533|589153819|FG004|Overall Study|Adverse Event|2|||
163121742|NCT00364533|589153815|FG000|Overall Study|Withdrawal by Subject|4|||
163121743|NCT00364533|589153816|FG001|Overall Study|Withdrawal by Subject|8|||
163121744|NCT00364533|589153817|FG002|Overall Study|Withdrawal by Subject|6|||
163121745|NCT00364533|589153818|FG003|Overall Study|Withdrawal by Subject|6|||
163121746|NCT00364533|589153819|FG004|Overall Study|Withdrawal by Subject|6|||
163121747|NCT00364533|589153815|FG000|Overall Study|Lack of Efficacy|22|||
163121748|NCT00364533|589153816|FG001|Overall Study|Lack of Efficacy|22|||
163121749|NCT00364533|589153817|FG002|Overall Study|Lack of Efficacy|21|||
163121750|NCT00364533|589153818|FG003|Overall Study|Lack of Efficacy|17|||
163121751|NCT00364533|589153819|FG004|Overall Study|Lack of Efficacy|42|||
163121752|NCT00364533|589153815|FG000|Overall Study|Subject discharged from hospital|4|||
163121753|NCT00364533|589153816|FG001|Overall Study|Subject discharged from hospital|1|||
163121754|NCT00364533|589153817|FG002|Overall Study|Subject discharged from hospital|2|||
163121755|NCT00364533|589153818|FG003|Overall Study|Subject discharged from hospital|3|||
163121756|NCT00364533|589153819|FG004|Overall Study|Subject discharged from hospital|1|||
163121757|NCT00364533|589153815|FG000|Overall Study|Variations in drug compliance|2|||
163121758|NCT00364533|589153816|FG001|Overall Study|Variations in drug compliance|1|||
163121759|NCT00364533|589153817|FG002|Overall Study|Variations in drug compliance|1|||
163121760|NCT00364533|589153818|FG003|Overall Study|Variations in drug compliance|0|||
163121761|NCT00364533|589153819|FG004|Overall Study|Variations in drug compliance|0|||
163121762|NCT00364533|589153815|FG000|Overall Study|Non-compliance|1|||
163121763|NCT00364533|589153816|FG001|Overall Study|Non-compliance|0|||
163121764|NCT00364533|589153817|FG002|Overall Study|Non-compliance|0|||
163121765|NCT00364533|589153818|FG003|Overall Study|Non-compliance|0|||
163121766|NCT00364533|589153819|FG004|Overall Study|Non-compliance|0|||
163121767|NCT00364533|589153815|FG000|Overall Study|Protocol Violation|1|||
163121768|NCT00364533|589153816|FG001|Overall Study|Protocol Violation|1|||
163121769|NCT00364533|589153817|FG002|Overall Study|Protocol Violation|0|||
163121770|NCT00364533|589153818|FG003|Overall Study|Protocol Violation|0|||
163121771|NCT00364533|589153819|FG004|Overall Study|Protocol Violation|0|||
163121772|NCT01167907|589153821|FG000|Overall Study|Protocol Violation|1|||
163121773|NCT01167907|589153822|FG001|Overall Study|Protocol Violation|0|||
163121774|NCT01167907|589153821|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
163121775|NCT01167907|589153822|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
163121776|NCT01814670|589153829|FG000|Overall Study|Protocol Violation|12|||
163121777|NCT00973102|589153830|FG000|Overall Study|Protocol Violation|1|||
163121778|NCT00973102|589153831|FG001|Overall Study|Protocol Violation|0|||
163121779|NCT00973102|589153830|FG000|Overall Study|Prisoner|0|||
163121780|NCT00973102|589153831|FG001|Overall Study|Prisoner|1|||
163121781|NCT01066780|589153832|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
163121782|NCT01066780|589153833|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
163121783|NCT02360293|589153834|FG000|Overall Study|Lost to Follow-up|73|||
163121784|NCT02360293|589153835|FG001|Overall Study|Lost to Follow-up|95|||
163121785|NCT02360293|589153834|FG000|Overall Study|Withdrawal by Subject|2|||
163121786|NCT02360293|589153835|FG001|Overall Study|Withdrawal by Subject|1|||
163121787|NCT02360293|589153834|FG000|Overall Study|Excluded|1|||
163121788|NCT02360293|589153835|FG001|Overall Study|Excluded|0|||
163121789|NCT02226549|589153836|FG000|Overall Study|Randomized but Never Treated|1|||
163121790|NCT02226549|589153837|FG001|Overall Study|Randomized but Never Treated|0|||
163121791|NCT02226549|589153836|FG000|Overall Study|Lost to Follow-up|0|||
163121792|NCT02226549|589153837|FG001|Overall Study|Lost to Follow-up|1|||
163121793|NCT03099148|589153838|FG000|Wash-out|scheduling conflict|0|||
163121794|NCT03099148|589153839|FG001|Wash-out|scheduling conflict|1|||
163121795|NCT03099148|589153840|FG002|Wash-out|scheduling conflict|0|||
163121796|NCT03099148|589153841|FG003|Wash-out|scheduling conflict|0|||
163224994|NCT01479621|589540052|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163121797|NCT03099148|589153838|FG000|Wash-out|Adverse Event|0|||
163121798|NCT03099148|589153839|FG001|Wash-out|Adverse Event|1|||
163121799|NCT03099148|589153840|FG002|Wash-out|Adverse Event|0|||
163121800|NCT03099148|589153841|FG003|Wash-out|Adverse Event|0|||
163121801|NCT01269385|589153842|FG000|Overall Study|Adverse Event|1|||
163121802|NCT01269385|589153843|FG001|Overall Study|Adverse Event|1|||
163121803|NCT01269385|589153844|FG002|Overall Study|Adverse Event|0|||
163121804|NCT01269385|589153845|FG003|Overall Study|Adverse Event|0|||
163121805|NCT00687609|589153850|FG000|Overall Study|Physician Decision|1|||
163121806|NCT00687609|589153850|FG000|Overall Study|Withdrawal by Subject|2|||
163121807|NCT02713529|589153851|FG000|Overall Study|Withdrawal by Subject|3|||
163121808|NCT02713529|589153852|FG001|Overall Study|Withdrawal by Subject|1|||
163121809|NCT02713529|589153853|FG002|Overall Study|Withdrawal by Subject|4|||
163121810|NCT02713529|589153854|FG003|Overall Study|Withdrawal by Subject|2|||
163121811|NCT02713529|589153855|FG004|Overall Study|Withdrawal by Subject|0|||
163224995|NCT01479621|589540053|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163121812|NCT02713529|589153856|FG005|Overall Study|Withdrawal by Subject|1|||
163121813|NCT02713529|589153857|FG006|Overall Study|Withdrawal by Subject|1|||
163121814|NCT02713529|589153851|FG000|Overall Study|Lost to Follow-up|1|||
163121815|NCT02713529|589153852|FG001|Overall Study|Lost to Follow-up|0|||
163121816|NCT02713529|589153853|FG002|Overall Study|Lost to Follow-up|1|||
163121817|NCT02713529|589153854|FG003|Overall Study|Lost to Follow-up|0|||
163121818|NCT02713529|589153855|FG004|Overall Study|Lost to Follow-up|0|||
163224996|NCT01479621|589540054|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163224997|NCT01479621|589540048|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
163224998|NCT01479621|589540049|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163224999|NCT01479621|589540050|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163121819|NCT02713529|589153856|FG005|Overall Study|Lost to Follow-up|0|||
163121820|NCT02713529|589153857|FG006|Overall Study|Lost to Follow-up|0|||
163121821|NCT02713529|589153851|FG000|Overall Study|Death|3|||
163121822|NCT02713529|589153852|FG001|Overall Study|Death|3|||
163121823|NCT02713529|589153853|FG002|Overall Study|Death|26|||
163121824|NCT02713529|589153854|FG003|Overall Study|Death|27|||
163121825|NCT02713529|589153855|FG004|Overall Study|Death|3|||
163121826|NCT02713529|589153856|FG005|Overall Study|Death|13|||
163121827|NCT02713529|589153857|FG006|Overall Study|Death|3|||
163121828|NCT01739803|589153859|FG000|Overall Study|Lost to Follow-up|9|||
163121829|NCT01739803|589153860|FG001|Overall Study|Lost to Follow-up|6|||
163121830|NCT03759041|589153865|FG000|Overall Study|Withdrawal by Subject|4|||
163121831|NCT03759041|589153866|FG001|Overall Study|Withdrawal by Subject|10|||
163121832|NCT03759041|589153867|FG002|Overall Study|Withdrawal by Subject|10|||
163121833|NCT03759041|589153865|FG000|Overall Study|Adverse Event|1|||
163121834|NCT03759041|589153866|FG001|Overall Study|Adverse Event|3|||
163121835|NCT03759041|589153867|FG002|Overall Study|Adverse Event|4|||
163121836|NCT03759041|589153865|FG000|Overall Study|Lack of Efficacy|0|||
163121837|NCT03759041|589153866|FG001|Overall Study|Lack of Efficacy|0|||
163121838|NCT03759041|589153867|FG002|Overall Study|Lack of Efficacy|1|||
163121839|NCT03759041|589153865|FG000|Overall Study|Study Terminated by Sponsor|15|||
163121840|NCT03759041|589153866|FG001|Overall Study|Study Terminated by Sponsor|16|||
163121841|NCT03759041|589153867|FG002|Overall Study|Study Terminated by Sponsor|10|||
163121842|NCT03759041|589153865|FG000|Overall Study|Other reason for discontinuation|0|||
163121843|NCT03759041|589153866|FG001|Overall Study|Other reason for discontinuation|2|||
163121844|NCT03759041|589153867|FG002|Overall Study|Other reason for discontinuation|1|||
163121845|NCT03759041|589153865|FG000|Overall Study|Lost to Follow-up|7|||
163121846|NCT03759041|589153866|FG001|Overall Study|Lost to Follow-up|2|||
163121847|NCT03759041|589153867|FG002|Overall Study|Lost to Follow-up|2|||
163121848|NCT03759041|589153865|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
163121849|NCT03759041|589153866|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
163121850|NCT03759041|589153867|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
163121851|NCT02449018|589153868|FG000|Overall Study|Abnormal laboratory value|0|||
163121852|NCT02449018|589153869|FG001|Overall Study|Abnormal laboratory value|1|||
163121853|NCT02449018|589153868|FG000|Overall Study|Administrative problems|1|||
163121854|NCT02449018|589153869|FG001|Overall Study|Administrative problems|0|||
163121855|NCT02449018|589153868|FG000|Overall Study|Adverse Event|5|||
163121856|NCT02449018|589153869|FG001|Overall Study|Adverse Event|1|||
163121857|NCT02449018|589153868|FG000|Overall Study|Protocol deviation|4|||
163121858|NCT02449018|589153869|FG001|Overall Study|Protocol deviation|0|||
163121859|NCT02449018|589153868|FG000|Overall Study|Patient decision|2|||
163121860|NCT02449018|589153869|FG001|Overall Study|Patient decision|0|||
163225000|NCT01479621|589540051|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163225001|NCT01479621|589540052|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163225002|NCT01479621|589540053|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163225003|NCT01479621|589540054|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163225004|NCT01479621|589540048|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
163225005|NCT01479621|589540049|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163225006|NCT01479621|589540050|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163408142|NCT02432235|590204042|FG010|Overall Study|Death|1|||
163408143|NCT02432235|590204043|FG011|Overall Study|Death|0|||
163408144|NCT02432235|590204032|FG000|Overall Study|Withdrawal by Subject|0|||
163121861|NCT00525824|589153875|FG000|Overall Study|Adverse Event|7|||
163121862|NCT00525824|589153876|FG001|Overall Study|Adverse Event|11|||
163121863|NCT00525824|589153877|FG002|Overall Study|Adverse Event|6|||
163121864|NCT00525824|589153878|FG003|Overall Study|Adverse Event|7|||
163121865|NCT00525824|589153875|FG000|Overall Study|Withdrawal by Subject|5|||
163121866|NCT00525824|589153876|FG001|Overall Study|Withdrawal by Subject|9|||
163121867|NCT00525824|589153877|FG002|Overall Study|Withdrawal by Subject|3|||
163225007|NCT01479621|589540051|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163121868|NCT00525824|589153878|FG003|Overall Study|Withdrawal by Subject|4|||
163121869|NCT00525824|589153875|FG000|Overall Study|Lost to Follow-up|4|||
163408145|NCT02432235|590204033|FG001|Overall Study|Withdrawal by Subject|1|||
163408146|NCT02432235|590204034|FG002|Overall Study|Withdrawal by Subject|0|||
163341270|NCT04820023|589958149|FG002|Overall Study|Progressive Disease|2|||
163341271|NCT04820023|589958150|FG003|Overall Study|Progressive Disease|2|||
163341272|NCT04820023|589958151|FG004|Overall Study|Progressive Disease|2|||
163121870|NCT00525824|589153876|FG001|Overall Study|Lost to Follow-up|2|||
163341273|NCT04820023|589958152|FG005|Overall Study|Progressive Disease|0|||
163341274|NCT04820023|589958153|FG006|Overall Study|Progressive Disease|1|||
163341275|NCT04820023|589958154|FG007|Overall Study|Progressive Disease|1|||
163341276|NCT04820023|589958155|FG008|Overall Study|Progressive Disease|0|||
163341277|NCT04820023|589958147|FG000|Overall Study|New anti-cancer therapy|0|||
163341278|NCT04820023|589958148|FG001|Overall Study|New anti-cancer therapy|0|||
163341279|NCT04820023|589958149|FG002|Overall Study|New anti-cancer therapy|0|||
163341280|NCT04820023|589958150|FG003|Overall Study|New anti-cancer therapy|0|||
163341281|NCT04820023|589958151|FG004|Overall Study|New anti-cancer therapy|2|||
163341282|NCT04820023|589958152|FG005|Overall Study|New anti-cancer therapy|0|||
163341283|NCT04820023|589958153|FG006|Overall Study|New anti-cancer therapy|0|||
163341284|NCT04820023|589958154|FG007|Overall Study|New anti-cancer therapy|0|||
163341285|NCT04820023|589958155|FG008|Overall Study|New anti-cancer therapy|0|||
163341286|NCT04820023|589958147|FG000|Overall Study|Other|0|||
163341287|NCT04820023|589958148|FG001|Overall Study|Other|1|||
163341288|NCT04820023|589958149|FG002|Overall Study|Other|0|||
163341289|NCT04820023|589958150|FG003|Overall Study|Other|0|||
163341290|NCT04820023|589958151|FG004|Overall Study|Other|0|||
163341291|NCT04820023|589958152|FG005|Overall Study|Other|0|||
163341292|NCT04820023|589958153|FG006|Overall Study|Other|0|||
163341293|NCT04820023|589958154|FG007|Overall Study|Other|2|||
163341294|NCT04820023|589958155|FG008|Overall Study|Other|0|||
163341295|NCT01020487|589958156|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
163341296|NCT01020487|589958157|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
163341297|NCT01020487|589958158|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
163341298|NCT01020487|589958156|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
163341299|NCT01020487|589958157|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
163341300|NCT01020487|589958158|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
163341301|NCT01020487|589958156|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
163341302|NCT01020487|589958157|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
163341303|NCT01020487|589958158|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
163341304|NCT01020487|589958156|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
163341305|NCT01020487|589958157|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
163341306|NCT01020487|589958158|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
163341307|NCT01020487|589958156|FG000|Part 2 Open-label Period|Adverse Event|0|||
163121871|NCT00525824|589153877|FG002|Overall Study|Lost to Follow-up|4|||
163121872|NCT00525824|589153878|FG003|Overall Study|Lost to Follow-up|0|||
163121873|NCT00525824|589153875|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
163121874|NCT00525824|589153876|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
163121875|NCT00525824|589153877|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
163121876|NCT00525824|589153878|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
163121877|NCT00525824|589153875|FG000|Overall Study|Severe non-compliance|0|||
163121878|NCT00525824|589153876|FG001|Overall Study|Severe non-compliance|1|||
163121879|NCT00525824|589153877|FG002|Overall Study|Severe non-compliance|1|||
163121880|NCT00525824|589153878|FG003|Overall Study|Severe non-compliance|1|||
163121881|NCT00525824|589153875|FG000|Overall Study|Safety reasons|1|||
163121882|NCT00525824|589153876|FG001|Overall Study|Safety reasons|0|||
163121883|NCT00525824|589153877|FG002|Overall Study|Safety reasons|1|||
163121884|NCT00525824|589153878|FG003|Overall Study|Safety reasons|0|||
163121885|NCT00525824|589153875|FG000|Overall Study|Other|1|||
163341308|NCT01020487|589958157|FG001|Part 2 Open-label Period|Adverse Event|4|||
163341309|NCT01020487|589958158|FG002|Part 2 Open-label Period|Adverse Event|1|||
163341310|NCT02109172|589958169|FG000|Overall Study|Withdrawal by Subject|1|||
163341311|NCT02109172|589958170|FG001|Overall Study|Withdrawal by Subject|0|||
163341312|NCT02109172|589958171|FG002|Overall Study|Withdrawal by Subject|0|||
163341313|NCT02109172|589958172|FG003|Overall Study|Withdrawal by Subject|1|||
163341314|NCT02109172|589958173|FG004|Overall Study|Withdrawal by Subject|0|||
163341315|NCT02109172|589958174|FG005|Overall Study|Withdrawal by Subject|0|||
163341316|NCT02109172|589958169|FG000|Overall Study|Adverse Event|0|||
163341317|NCT02109172|589958170|FG001|Overall Study|Adverse Event|0|||
163408147|NCT02432235|590204035|FG003|Overall Study|Withdrawal by Subject|0|||
163408148|NCT02432235|590204036|FG004|Overall Study|Withdrawal by Subject|0|||
163121886|NCT00525824|589153876|FG001|Overall Study|Other|3|||
163121887|NCT00525824|589153877|FG002|Overall Study|Other|3|||
163341318|NCT02109172|589958171|FG002|Overall Study|Adverse Event|1|||
163341319|NCT02109172|589958172|FG003|Overall Study|Adverse Event|0|||
163341320|NCT02109172|589958173|FG004|Overall Study|Adverse Event|0|||
163341321|NCT02109172|589958174|FG005|Overall Study|Adverse Event|1|||
163341322|NCT02109172|589958169|FG000|Overall Study|Death|0|||
163341323|NCT02109172|589958170|FG001|Overall Study|Death|0|||
163341324|NCT02109172|589958171|FG002|Overall Study|Death|0|||
163121888|NCT00525824|589153878|FG003|Overall Study|Other|1|||
163225008|NCT01479621|589540052|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163225009|NCT01479621|589540053|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163225010|NCT01479621|589540054|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163225011|NCT01479621|589540048|FG000|Treatment Period|Adverse Event|0|||
163121889|NCT05011513|589155563|FG000|Overall Study|Death|0|||
163121890|NCT05011513|589155564|FG001|Overall Study|Death|1|||
163225012|NCT01479621|589540049|FG001|Treatment Period|Adverse Event|0|||
163225013|NCT01479621|589540050|FG002|Treatment Period|Adverse Event|0|||
163225014|NCT01479621|589540051|FG003|Treatment Period|Adverse Event|0|||
163225015|NCT01479621|589540052|FG004|Treatment Period|Adverse Event|1|||
163225016|NCT01479621|589540053|FG005|Treatment Period|Adverse Event|2|||
163225017|NCT01479621|589540054|FG006|Treatment Period|Adverse Event|2|||
163225018|NCT01479621|589540048|FG000|Treatment Period|Withdrawal by Subject|0|||
163225019|NCT01479621|589540049|FG001|Treatment Period|Withdrawal by Subject|4|||
163225020|NCT01479621|589540050|FG002|Treatment Period|Withdrawal by Subject|2|||
163225021|NCT01479621|589540051|FG003|Treatment Period|Withdrawal by Subject|2|||
163225022|NCT01479621|589540052|FG004|Treatment Period|Withdrawal by Subject|5|||
163225023|NCT01479621|589540053|FG005|Treatment Period|Withdrawal by Subject|5|||
163225024|NCT01479621|589540054|FG006|Treatment Period|Withdrawal by Subject|1|||
163225025|NCT01479621|589540048|FG000|Treatment Period|Physician Decision|0|||
163225026|NCT01479621|589540049|FG001|Treatment Period|Physician Decision|0|||
163225027|NCT01479621|589540050|FG002|Treatment Period|Physician Decision|0|||
163225028|NCT01479621|589540051|FG003|Treatment Period|Physician Decision|0|||
163225029|NCT01479621|589540052|FG004|Treatment Period|Physician Decision|1|||
163225030|NCT01479621|589540053|FG005|Treatment Period|Physician Decision|1|||
163225031|NCT01479621|589540054|FG006|Treatment Period|Physician Decision|0|||
163225032|NCT01479621|589540048|FG000|Treatment Period|Non-compliance to study drug|0|||
163121891|NCT05011513|589155563|FG000|Overall Study|Lost to Follow-up|4|||
163121892|NCT05011513|589155564|FG001|Overall Study|Lost to Follow-up|0|||
163121893|NCT05011513|589155563|FG000|Overall Study|Withdrawal by Subject|18|||
163121894|NCT05011513|589155564|FG001|Overall Study|Withdrawal by Subject|17|||
163121895|NCT05011513|589155563|FG000|Overall Study|Other|4|||
163121896|NCT05011513|589155564|FG001|Overall Study|Other|2|||
163121897|NCT03667690|589155565|FG000|Overall Study|Adverse Event|0|||
163121898|NCT03667690|589155566|FG001|Overall Study|Adverse Event|3|||
163121899|NCT03667690|589155565|FG000|Overall Study|Death|22|||
163121900|NCT03667690|589155566|FG001|Overall Study|Death|21|||
163121901|NCT03667690|589155565|FG000|Overall Study|Lost to Follow-up|4|||
163121902|NCT03667690|589155566|FG001|Overall Study|Lost to Follow-up|5|||
163121903|NCT03667690|589155565|FG000|Overall Study|Withdrawal by Subject|7|||
163121904|NCT03667690|589155566|FG001|Overall Study|Withdrawal by Subject|8|||
163121905|NCT03667690|589155565|FG000|Overall Study|Subject could not return for additional investigational product|1|||
163121906|NCT03667690|589155566|FG001|Overall Study|Subject could not return for additional investigational product|0|||
163121907|NCT03667690|589155565|FG000|Overall Study|Subject discharged to hospice care|2|||
163121908|NCT03667690|589155566|FG001|Overall Study|Subject discharged to hospice care|0|||
163121909|NCT03667690|589155565|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
163121910|NCT03667690|589155566|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
163121911|NCT03667690|589155565|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
163121912|NCT03667690|589155566|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
163121913|NCT03667690|589155565|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
163121914|NCT03667690|589155566|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
163121915|NCT03667690|589155565|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
163121916|NCT03667690|589155566|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
163121917|NCT03667690|589155565|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
163121918|NCT03667690|589155566|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
163121919|NCT01192568|589155575|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
163121920|NCT01192568|589155576|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
163121921|NCT01192568|589155577|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
163121922|NCT01192568|589155578|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
163121923|NCT01192568|589155575|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
163121924|NCT01192568|589155576|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
163121925|NCT01192568|589155577|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
163225033|NCT01479621|589540049|FG001|Treatment Period|Non-compliance to study drug|1|||
163341325|NCT02109172|589958172|FG003|Overall Study|Death|0|||
163121926|NCT01192568|589155578|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
163225034|NCT01479621|589540050|FG002|Treatment Period|Non-compliance to study drug|0|||
163225035|NCT01479621|589540051|FG003|Treatment Period|Non-compliance to study drug|0|||
163225036|NCT01479621|589540052|FG004|Treatment Period|Non-compliance to study drug|0|||
163225037|NCT01479621|589540053|FG005|Treatment Period|Non-compliance to study drug|0|||
163225038|NCT01479621|589540054|FG006|Treatment Period|Non-compliance to study drug|1|||
163341326|NCT02109172|589958173|FG004|Overall Study|Death|1|||
163121927|NCT02593825|589155579|FG000|Intervention|Lost to Follow-up|10|||
163121928|NCT02593825|589155580|FG001|Intervention|Lost to Follow-up|12|||
163121929|NCT06359080|589155581|FG000|Overall Study|Withdrawal by Subject|3|||
163121930|NCT00511134|589155584|FG000|Overall Study|Withdrawal by Subject|0|||
163121931|NCT00511134|589155585|FG001|Overall Study|Withdrawal by Subject|2|||
163121932|NCT01949090|589155588|FG000|Overall Study|Serious Adverse Event|0|||
163121933|NCT01949090|589155589|FG001|Overall Study|Serious Adverse Event|1|||
163121934|NCT01949090|589155590|FG002|Overall Study|Serious Adverse Event|2|||
163121935|NCT01949090|589155591|FG003|Overall Study|Serious Adverse Event|0|||
163121936|NCT01949090|589155592|FG004|Overall Study|Serious Adverse Event|1|||
163121937|NCT01949090|589155588|FG000|Overall Study|Withdrawal by Subject|2|||
163121938|NCT01949090|589155589|FG001|Overall Study|Withdrawal by Subject|0|||
163121939|NCT01949090|589155590|FG002|Overall Study|Withdrawal by Subject|0|||
163121940|NCT01949090|589155591|FG003|Overall Study|Withdrawal by Subject|0|||
163121941|NCT01949090|589155592|FG004|Overall Study|Withdrawal by Subject|1|||
163121942|NCT01949090|589155588|FG000|Overall Study|Protocol non-compliance|0|||
163121943|NCT01949090|589155589|FG001|Overall Study|Protocol non-compliance|0|||
163121944|NCT01949090|589155590|FG002|Overall Study|Protocol non-compliance|0|||
163121945|NCT01949090|589155591|FG003|Overall Study|Protocol non-compliance|0|||
163121946|NCT01949090|589155592|FG004|Overall Study|Protocol non-compliance|1|||
163121947|NCT01949090|589155588|FG000|Overall Study|Lost to Follow-up|2|||
163121948|NCT01949090|589155589|FG001|Overall Study|Lost to Follow-up|1|||
163121949|NCT01949090|589155590|FG002|Overall Study|Lost to Follow-up|0|||
163121950|NCT01949090|589155591|FG003|Overall Study|Lost to Follow-up|1|||
163121951|NCT01949090|589155592|FG004|Overall Study|Lost to Follow-up|1|||
163121952|NCT02783170|589155593|FG000|Overall Study|Randomized but not Vaccinated|1|||
163121953|NCT02783170|589155594|FG001|Overall Study|Randomized but not Vaccinated|0|||
163121954|NCT03323736|589155595|FG000|Overall Study|Screen Failure|14|||
163121955|NCT03323736|589155596|FG001|Overall Study|Screen Failure|9|||
163121956|NCT03323736|589155597|FG002|Overall Study|Screen Failure|1|||
163121957|NCT03323736|589155595|FG000|Overall Study|Withdrawal Before Treatment|3|||
163121958|NCT03323736|589155596|FG001|Overall Study|Withdrawal Before Treatment|1|||
163121959|NCT03323736|589155597|FG002|Overall Study|Withdrawal Before Treatment|1|||
163121960|NCT03323736|589155595|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
163121961|NCT03323736|589155596|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
163121962|NCT03323736|589155597|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
163121963|NCT00701805|589155604|FG000|Overall Study|Withdrawal by Subject|3|||
163121964|NCT00701805|589155605|FG001|Overall Study|Withdrawal by Subject|1|||
163121965|NCT00701805|589155606|FG002|Overall Study|Withdrawal by Subject|4|||
163121966|NCT00701805|589155607|FG003|Overall Study|Withdrawal by Subject|3|||
163121967|NCT00701805|589155604|FG000|Overall Study|Adverse Event|0|||
163121968|NCT00701805|589155605|FG001|Overall Study|Adverse Event|1|||
163121969|NCT00701805|589155606|FG002|Overall Study|Adverse Event|1|||
163121970|NCT00701805|589155607|FG003|Overall Study|Adverse Event|0|||
163121971|NCT00701805|589155604|FG000|Overall Study|Missed 7 consecutive doses|0|||
163121972|NCT00701805|589155605|FG001|Overall Study|Missed 7 consecutive doses|1|||
163341327|NCT02109172|589958174|FG005|Overall Study|Death|0|||
163341328|NCT01279447|589958175|FG000|Overall Study|Lost to Follow-up|3|||
163341329|NCT01279447|589958176|FG001|Overall Study|Lost to Follow-up|1|||
163341330|NCT03360071|589958177|FG000|Overall Study|Lost to Follow-up|1|||
163341331|NCT03360071|589958178|FG001|Overall Study|Lost to Follow-up|0|||
163341332|NCT03184519|589958187|FG000|Overall Study|Lost to Follow-up|6|||
163341333|NCT03184519|589958187|FG000|Overall Study|Physician Decision|21|||
163341334|NCT02823574|589958191|FG000|Randomization|Disease Progression|0|||
163341335|NCT02823574|589958192|FG001|Randomization|Disease Progression|0|||
163341336|NCT02823574|589958193|FG002|Randomization|Disease Progression|1|||
163341337|NCT02823574|589958194|FG003|Randomization|Disease Progression|0|||
163341338|NCT02823574|589958191|FG000|Randomization|AE unrelated to Study Drug|1|||
163341339|NCT02823574|589958192|FG001|Randomization|AE unrelated to Study Drug|0|||
163341340|NCT02823574|589958193|FG002|Randomization|AE unrelated to Study Drug|0|||
163341341|NCT02823574|589958194|FG003|Randomization|AE unrelated to Study Drug|0|||
163121973|NCT00701805|589155606|FG002|Overall Study|Missed 7 consecutive doses|0|||
163341342|NCT02823574|589958191|FG000|Treatment Period|Poor/Non Compliance|1|||
163121974|NCT00701805|589155607|FG003|Overall Study|Missed 7 consecutive doses|0|||
163121975|NCT00701805|589155604|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
163121976|NCT00701805|589155605|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
163121977|NCT00701805|589155606|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
163121978|NCT00701805|589155607|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
163121979|NCT00701805|589155604|FG000|Overall Study|Physician decision, change of therapy|0|||
163121980|NCT00701805|589155605|FG001|Overall Study|Physician decision, change of therapy|0|||
163121981|NCT00701805|589155606|FG002|Overall Study|Physician decision, change of therapy|0|||
163341343|NCT02823574|589958192|FG001|Treatment Period|Poor/Non Compliance|0|||
163341344|NCT02823574|589958193|FG002|Treatment Period|Poor/Non Compliance|0|||
163341345|NCT02823574|589958194|FG003|Treatment Period|Poor/Non Compliance|1|||
163341346|NCT02823574|589958191|FG000|Treatment Period|Maximum Clinical Benefit|8|||
163341347|NCT02823574|589958192|FG001|Treatment Period|Maximum Clinical Benefit|4|||
163121982|NCT00701805|589155607|FG003|Overall Study|Physician decision, change of therapy|1|||
163121983|NCT00701805|589155604|FG000|Overall Study|Difficult to travel to dialysis site|0|||
163121984|NCT00701805|589155605|FG001|Overall Study|Difficult to travel to dialysis site|0|||
163121985|NCT00701805|589155606|FG002|Overall Study|Difficult to travel to dialysis site|1|||
163121986|NCT00701805|589155607|FG003|Overall Study|Difficult to travel to dialysis site|0|||
163121987|NCT00701805|589155604|FG000|Overall Study|Resumption criteria were not met|0|||
163121988|NCT00701805|589155605|FG001|Overall Study|Resumption criteria were not met|1|||
163121989|NCT00701805|589155606|FG002|Overall Study|Resumption criteria were not met|0|||
163121990|NCT00701805|589155607|FG003|Overall Study|Resumption criteria were not met|0|||
163121991|NCT05063539|589155608|FG000|Overall Study|Adverse Event|1|||
163121992|NCT05063539|589155609|FG001|Overall Study|Adverse Event|2|||
163121993|NCT05063539|589155610|FG002|Overall Study|Adverse Event|1|||
163121994|NCT05063539|589155608|FG000|Overall Study|Death|0|||
163121995|NCT05063539|589155609|FG001|Overall Study|Death|1|||
163121996|NCT05063539|589155610|FG002|Overall Study|Death|1|||
163121997|NCT05063539|589155608|FG000|Overall Study|Lost to Follow-up|0|||
163121998|NCT05063539|589155609|FG001|Overall Study|Lost to Follow-up|1|||
163121999|NCT05063539|589155610|FG002|Overall Study|Lost to Follow-up|0|||
163122000|NCT05063539|589155608|FG000|Overall Study|Physician Decision|4|||
163122001|NCT05063539|589155609|FG001|Overall Study|Physician Decision|3|||
163122002|NCT05063539|589155610|FG002|Overall Study|Physician Decision|1|||
163122003|NCT05063539|589155608|FG000|Overall Study|Progressive Disease|0|||
163122004|NCT05063539|589155609|FG001|Overall Study|Progressive Disease|2|||
163122005|NCT05063539|589155610|FG002|Overall Study|Progressive Disease|0|||
163122006|NCT05063539|589155608|FG000|Overall Study|Withdrawal by Subject|17|||
163122007|NCT05063539|589155609|FG001|Overall Study|Withdrawal by Subject|26|||
163122008|NCT05063539|589155610|FG002|Overall Study|Withdrawal by Subject|14|||
163122009|NCT05063539|589155608|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
163122010|NCT05063539|589155609|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
163122011|NCT05063539|589155610|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
163122012|NCT05063539|589155608|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
163122013|NCT05063539|589155609|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
163122014|NCT05063539|589155610|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
163122015|NCT05063539|589155608|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
163122016|NCT05063539|589155609|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
163122017|NCT05063539|589155610|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
163122018|NCT05063539|589155608|FG000|Overall Study|Discontinued due to Common Close Design|0|||
163122019|NCT05063539|589155609|FG001|Overall Study|Discontinued due to Common Close Design|1|||
163122020|NCT05063539|589155610|FG002|Overall Study|Discontinued due to Common Close Design|0|||
163122021|NCT05063539|589155608|FG000|Overall Study|Participant not co-operative|0|||
163122022|NCT05063539|589155609|FG001|Overall Study|Participant not co-operative|1|||
163122023|NCT05063539|589155610|FG002|Overall Study|Participant not co-operative|0|||
163122024|NCT05063539|589155608|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
163122025|NCT05063539|589155609|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
163122026|NCT05063539|589155610|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
163122027|NCT05063539|589155608|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
163122028|NCT05063539|589155609|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
163122029|NCT05063539|589155610|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
163122030|NCT04256512|589155611|FG000|Overall Study|Withdrawal by Subject|1|||
163122031|NCT04692077|589155614|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
163122032|NCT01751139|589155615|FG000|Overall Study|Other|135|||
163122033|NCT01751139|589155615|FG000|Overall Study|Sponsor study termination|1609|||
163122034|NCT01751139|589155615|FG000|Overall Study|Lost to Follow-up|240|||
163122035|NCT01751139|589155615|FG000|Overall Study|Withdrawal by Subject|251|||
163122036|NCT01751139|589155615|FG000|Overall Study|Adverse Event|1|||
163122037|NCT01751139|589155615|FG000|Overall Study|Death|31|||
163122038|NCT04271475|589155618|FG000|DB Period: Day 1 up to EODBT|Death|1|||
163122039|NCT04271475|589155619|FG001|DB Period: Day 1 up to EODBT|Death|0|||
163122040|NCT04271475|589155620|FG002|DB Period: Day 1 up to EODBT|Death|0|||
163122041|NCT04271475|589155621|FG003|DB Period: Day 1 up to EODBT|Death|0|||
163122042|NCT04271475|589155618|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
163122043|NCT04271475|589155619|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
163122044|NCT04271475|589155620|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
163122045|NCT04271475|589155621|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
163122046|NCT04271475|589155618|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
163341348|NCT02823574|589958193|FG002|Treatment Period|Maximum Clinical Benefit|7|||
163341349|NCT02823574|589958194|FG003|Treatment Period|Maximum Clinical Benefit|1|||
163122047|NCT04271475|589155619|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
163341350|NCT02823574|589958191|FG000|Treatment Period|Lost to Follow-up|1|||
163341351|NCT02823574|589958192|FG001|Treatment Period|Lost to Follow-up|1|||
163341352|NCT02823574|589958193|FG002|Treatment Period|Lost to Follow-up|0|||
163341353|NCT02823574|589958194|FG003|Treatment Period|Lost to Follow-up|0|||
163122048|NCT04271475|589155620|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
163122049|NCT04271475|589155621|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
163122050|NCT04271475|589155618|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
163122051|NCT04271475|589155619|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
163122052|NCT04271475|589155620|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
163122053|NCT04271475|589155621|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
163122054|NCT04271475|589155618|FG000|DB Period: Day 1 up to EODBT|Other|8|||
163122055|NCT04271475|589155619|FG001|DB Period: Day 1 up to EODBT|Other|5|||
163122056|NCT04271475|589155620|FG002|DB Period: Day 1 up to EODBT|Other|0|||
163122057|NCT04271475|589155621|FG003|DB Period: Day 1 up to EODBT|Other|0|||
163122058|NCT04271475|589155618|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
163122059|NCT04271475|589155619|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
163122060|NCT04271475|589155620|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
163122061|NCT04271475|589155621|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
163122062|NCT04271475|589155618|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
163122063|NCT04271475|589155619|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
163122064|NCT04271475|589155620|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
163122065|NCT04271475|589155621|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
163122066|NCT01818284|589155624|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
163122067|NCT01818284|589155625|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
163122068|NCT01818284|589155624|FG000|Overall Study|Death|0|||
163122069|NCT01818284|589155625|FG001|Overall Study|Death|2|||
163122070|NCT01300351|589155627|FG000|Overall Study|Did not receive treatment|2|||
163122071|NCT01300351|589155628|FG001|Overall Study|Did not receive treatment|0|||
163122072|NCT01300351|589155627|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
163122073|NCT01300351|589155628|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
163122074|NCT01300351|589155627|FG000|Overall Study|Lost to Follow-up|0|||
163122075|NCT01300351|589155628|FG001|Overall Study|Lost to Follow-up|1|||
163122076|NCT01300351|589155627|FG000|Overall Study|Adverse Event|0|||
163122077|NCT01300351|589155628|FG001|Overall Study|Adverse Event|4|||
163122078|NCT01300351|589155627|FG000|Overall Study|Withdrawal by Subject|7|||
163122079|NCT01300351|589155628|FG001|Overall Study|Withdrawal by Subject|10|||
163122080|NCT05824936|589155633|FG000|Overall Study|Lost to Follow-up|1|||
163122081|NCT00673881|589155634|FG000|Overall Study|Withdrawal by Subject|1|||
163122082|NCT00096018|589155635|FG000|Overall Study|Became Ineligible (not treated)|0|||
163122083|NCT00096018|589155636|FG001|Overall Study|Became Ineligible (not treated)|3|||
163122084|NCT00096018|589155635|FG000|Overall Study|Miscellaneous (not treated)|0|||
163122085|NCT00096018|589155636|FG001|Overall Study|Miscellaneous (not treated)|2|||
163122086|NCT00096018|589155635|FG000|Overall Study|Adverse Event|0|||
163122087|NCT00096018|589155636|FG001|Overall Study|Adverse Event|5|||
163122088|NCT00096018|589155635|FG000|Overall Study|Death|0|||
163122089|NCT00096018|589155636|FG001|Overall Study|Death|1|||
163122090|NCT00096018|589155635|FG000|Overall Study|Withdrawal by Subject|0|||
163122091|NCT00096018|589155636|FG001|Overall Study|Withdrawal by Subject|2|||
163122092|NCT00096018|589155635|FG000|Overall Study|Miscellaneous|2|||
163122093|NCT00096018|589155636|FG001|Overall Study|Miscellaneous|1|||
163225039|NCT01479621|589540048|FG000|Treatment Period|Protocol Violation|0|||
163341354|NCT02823574|589958191|FG000|Treatment Period|Participant withdrew consent|4|||
163341355|NCT02823574|589958192|FG001|Treatment Period|Participant withdrew consent|0|||
163341356|NCT02823574|589958193|FG002|Treatment Period|Participant withdrew consent|0|||
163341357|NCT02823574|589958194|FG003|Treatment Period|Participant withdrew consent|1|||
163341358|NCT02823574|589958191|FG000|Treatment Period|Participant request to discontinue|5|||
163341359|NCT02823574|589958192|FG001|Treatment Period|Participant request to discontinue|0|||
163341360|NCT02823574|589958193|FG002|Treatment Period|Participant request to discontinue|3|||
163341361|NCT02823574|589958194|FG003|Treatment Period|Participant request to discontinue|2|||
163341362|NCT02823574|589958191|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
163341363|NCT02823574|589958192|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
163341364|NCT02823574|589958193|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
163341365|NCT02823574|589958194|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
163341366|NCT02823574|589958191|FG000|Treatment Period|Study Drug Toxicity|11|||
163341367|NCT02823574|589958192|FG001|Treatment Period|Study Drug Toxicity|2|||
163122094|NCT00483041|589155637|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
163122095|NCT00483041|589155638|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
163122096|NCT02258529|589155639|FG000|Overall Study|Study Terminated by Sponsor|9|||
163225040|NCT01479621|589540049|FG001|Treatment Period|Protocol Violation|9|||
163341368|NCT02823574|589958193|FG002|Treatment Period|Study Drug Toxicity|14|||
163341369|NCT02823574|589958194|FG003|Treatment Period|Study Drug Toxicity|4|||
163341370|NCT02823574|589958191|FG000|Treatment Period|Disease Progression|113|||
163341371|NCT02823574|589958192|FG001|Treatment Period|Disease Progression|64|||
163341372|NCT02823574|589958193|FG002|Treatment Period|Disease Progression|82|||
163341373|NCT02823574|589958194|FG003|Treatment Period|Disease Progression|43|||
163341374|NCT02823574|589958191|FG000|Treatment Period|Other reasons|5|||
163341375|NCT02823574|589958192|FG001|Treatment Period|Other reasons|9|||
163341376|NCT02823574|589958193|FG002|Treatment Period|Other reasons|3|||
163341377|NCT02823574|589958194|FG003|Treatment Period|Other reasons|6|||
163341378|NCT02823574|589958191|FG000|Treatment Period|Participant no longer meets study criteria|0|||
163122097|NCT02258529|589155639|FG000|Overall Study|Adverse Event|1|||
163122098|NCT00875056|589155642|FG000|Overall Study|Adverse Event|6|||
163122099|NCT00875056|589155643|FG001|Overall Study|Adverse Event|1|||
163122100|NCT00875056|589155644|FG002|Overall Study|Adverse Event|2|||
163122101|NCT00875056|589155642|FG000|Overall Study|Progressive Disease|14|||
163122102|NCT00875056|589155643|FG001|Overall Study|Progressive Disease|8|||
163122103|NCT00875056|589155644|FG002|Overall Study|Progressive Disease|3|||
163122104|NCT00875056|589155642|FG000|Overall Study|Withdrawal by Subject|3|||
163122105|NCT00875056|589155643|FG001|Overall Study|Withdrawal by Subject|0|||
163122106|NCT00875056|589155644|FG002|Overall Study|Withdrawal by Subject|1|||
163122107|NCT01842581|589155652|FG000|Overall Study|Adverse Event|6|||
163122108|NCT01842581|589155653|FG001|Overall Study|Adverse Event|4|||
163122109|NCT01842581|589155652|FG000|Overall Study|HE breakthrough|26|||
163122110|NCT01842581|589155653|FG001|Overall Study|HE breakthrough|13|||
163122111|NCT01842581|589155652|FG000|Overall Study|Liver transplant|2|||
163122112|NCT01842581|589155653|FG001|Overall Study|Liver transplant|0|||
163122113|NCT01842581|589155652|FG000|Overall Study|Lost to Follow-up|2|||
163122114|NCT01842581|589155653|FG001|Overall Study|Lost to Follow-up|5|||
163122115|NCT01842581|589155652|FG000|Overall Study|Withdrawal by Subject|5|||
163122116|NCT01842581|589155653|FG001|Overall Study|Withdrawal by Subject|7|||
163122117|NCT01842581|589155652|FG000|Overall Study|Other than specified|3|||
163122118|NCT01842581|589155653|FG001|Overall Study|Other than specified|1|||
163122119|NCT00286221|589155654|FG000|Overall Study|Protocol Violation|2|||
163122120|NCT00286221|589155655|FG001|Overall Study|Protocol Violation|1|||
163122121|NCT00286221|589155656|FG002|Overall Study|Protocol Violation|6|||
163122122|NCT00286221|589155657|FG003|Overall Study|Protocol Violation|4|||
163122123|NCT00286221|589155654|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
163122124|NCT00286221|589155655|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
163122125|NCT00286221|589155656|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
163122126|NCT00286221|589155657|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
163122127|NCT00286221|589155654|FG000|Overall Study|Inability to trigger PCA|2|||
163122128|NCT00286221|589155655|FG001|Overall Study|Inability to trigger PCA|0|||
163122129|NCT00286221|589155656|FG002|Overall Study|Inability to trigger PCA|0|||
163122130|NCT00286221|589155657|FG003|Overall Study|Inability to trigger PCA|0|||
163122131|NCT00286221|589155654|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
163122132|NCT00286221|589155655|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
163122133|NCT00286221|589155656|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
163122134|NCT00286221|589155657|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
163122135|NCT02553538|589155660|FG000|Overall Study|Could Not Reach by Telephone|133|||
163122136|NCT02553538|589155661|FG001|Overall Study|Could Not Reach by Telephone|0|||
163122137|NCT02553538|589155660|FG000|Overall Study|Died or Left Network|54|||
163122138|NCT02553538|589155661|FG001|Overall Study|Died or Left Network|56|||
163122139|NCT02648217|589155662|FG000|Overall Study|Adverse Event|0|||
163341379|NCT02823574|589958192|FG001|Treatment Period|Participant no longer meets study criteria|0|||
163341380|NCT02823574|589958193|FG002|Treatment Period|Participant no longer meets study criteria|1|||
163341381|NCT02823574|589958194|FG003|Treatment Period|Participant no longer meets study criteria|0|||
163341382|NCT02823574|589958191|FG000|Treatment Period|Death|0|||
163341383|NCT02823574|589958192|FG001|Treatment Period|Death|0|||
163341384|NCT02823574|589958193|FG002|Treatment Period|Death|3|||
163341385|NCT02823574|589958194|FG003|Treatment Period|Death|1|||
163122140|NCT02648217|589155663|FG001|Overall Study|Adverse Event|1|||
163122141|NCT02648217|589155662|FG000|Overall Study|Lost to Follow-up|1|||
163122142|NCT02648217|589155663|FG001|Overall Study|Lost to Follow-up|1|||
163122143|NCT02648217|589155662|FG000|Overall Study|Withdrawal by Subject|4|||
163122144|NCT02648217|589155663|FG001|Overall Study|Withdrawal by Subject|3|||
163122145|NCT02648217|589155662|FG000|Overall Study|Unclassified|5|||
163122146|NCT02648217|589155663|FG001|Overall Study|Unclassified|0|||
163122147|NCT00357656|589155664|FG000|Overall Study|Other, No surgery performed|0|||
163122148|NCT00357656|589155665|FG001|Overall Study|Other, No surgery performed|3|||
163122149|NCT00815191|589155671|FG000|Overall Study|Protocol Violation|1|||
163122150|NCT00815191|589155672|FG001|Overall Study|Protocol Violation|1|||
163122151|NCT02900170|589155673|FG000|Overall Study|Lost to Follow-up|8|||
163122152|NCT01873729|589155674|FG000|Overall Study|Withdrawal by Subject|1|||
163122153|NCT01741532|589155675|FG000|Overall Study|Adverse Event|4|||
163122154|NCT01741532|589155676|FG001|Overall Study|Adverse Event|0|||
163122155|NCT01741532|589155675|FG000|Overall Study|Withdrawal by Subject|1|||
163341386|NCT00590759|589958195|FG000|Overall Study|Death|52|||
163341387|NCT00590759|589958195|FG000|Overall Study|Lost to Follow-up|28|||
163341388|NCT00901459|589958200|FG000|Overall Study|Withdrawal by Subject|6|||
163341389|NCT02959866|589958204|FG000|Overall Study|Withdrawal by Subject|1|||
163122156|NCT01741532|589155676|FG001|Overall Study|Withdrawal by Subject|1|||
163122157|NCT01741532|589155675|FG000|Overall Study|Protocol Violation|0|||
163122158|NCT01741532|589155676|FG001|Overall Study|Protocol Violation|1|||
163122159|NCT01741532|589155675|FG000|Overall Study|Worsening of the disease|3|||
163122160|NCT01741532|589155676|FG001|Overall Study|Worsening of the disease|1|||
163122161|NCT01741532|589155675|FG000|Overall Study|Sponsor decision|1|||
163122162|NCT01741532|589155676|FG001|Overall Study|Sponsor decision|0|||
163122163|NCT01741532|589155675|FG000|Overall Study|Medical event|1|||
163122164|NCT01741532|589155676|FG001|Overall Study|Medical event|0|||
163122165|NCT00613080|589155677|FG000|Overall Study|Ineligible / no protocol treatment|11|||
163122166|NCT02012686|589155679|FG000|Overall Study|muscle contraction|0|||
163122167|NCT02012686|589155680|FG001|Overall Study|muscle contraction|1|||
163122168|NCT02012686|589155679|FG000|Overall Study|electrocardiography monitoring noise|0|||
163122169|NCT02012686|589155680|FG001|Overall Study|electrocardiography monitoring noise|1|||
163122170|NCT01703065|589155681|FG000|Overall Study|Lack of Efficacy|1|||
163122171|NCT01703065|589155682|FG001|Overall Study|Lack of Efficacy|0|||
163122172|NCT02124772|589155683|FG000|Overall Study|Lack of Efficacy|2|||
163122173|NCT02124772|589155684|FG001|Overall Study|Lack of Efficacy|0|||
163122174|NCT02124772|589155685|FG002|Overall Study|Lack of Efficacy|0|||
163122175|NCT02124772|589155686|FG003|Overall Study|Lack of Efficacy|1|||
163122176|NCT02124772|589155687|FG004|Overall Study|Lack of Efficacy|2|||
163122177|NCT02124772|589155688|FG005|Overall Study|Lack of Efficacy|3|||
163122178|NCT02124772|589155689|FG006|Overall Study|Lack of Efficacy|0|||
163122179|NCT02124772|589155690|FG007|Overall Study|Lack of Efficacy|2|||
163122180|NCT02124772|589155691|FG008|Overall Study|Lack of Efficacy|0|||
163122181|NCT02124772|589155692|FG009|Overall Study|Lack of Efficacy|1|||
163122182|NCT02124772|589155693|FG010|Overall Study|Lack of Efficacy|0|||
163122183|NCT02124772|589155694|FG011|Overall Study|Lack of Efficacy|0|||
163122184|NCT02124772|589155695|FG012|Overall Study|Lack of Efficacy|1|||
163122185|NCT02124772|589155683|FG000|Overall Study|Adverse Event|1|||
163122186|NCT02124772|589155684|FG001|Overall Study|Adverse Event|4|||
163122187|NCT02124772|589155685|FG002|Overall Study|Adverse Event|1|||
163122188|NCT02124772|589155686|FG003|Overall Study|Adverse Event|5|||
163122189|NCT02124772|589155687|FG004|Overall Study|Adverse Event|2|||
163122190|NCT02124772|589155688|FG005|Overall Study|Adverse Event|1|||
163122191|NCT02124772|589155689|FG006|Overall Study|Adverse Event|1|||
163122192|NCT02124772|589155690|FG007|Overall Study|Adverse Event|5|||
163122193|NCT02124772|589155691|FG008|Overall Study|Adverse Event|0|||
163122194|NCT02124772|589155692|FG009|Overall Study|Adverse Event|3|||
163122195|NCT02124772|589155693|FG010|Overall Study|Adverse Event|1|||
163122196|NCT02124772|589155694|FG011|Overall Study|Adverse Event|3|||
163122197|NCT02124772|589155695|FG012|Overall Study|Adverse Event|1|||
163122198|NCT02124772|589155683|FG000|Overall Study|Withdrawal consent|0|||
163122199|NCT02124772|589155684|FG001|Overall Study|Withdrawal consent|1|||
163122200|NCT02124772|589155685|FG002|Overall Study|Withdrawal consent|1|||
163122201|NCT02124772|589155686|FG003|Overall Study|Withdrawal consent|1|||
163122202|NCT02124772|589155687|FG004|Overall Study|Withdrawal consent|0|||
163122203|NCT02124772|589155688|FG005|Overall Study|Withdrawal consent|1|||
163122204|NCT02124772|589155689|FG006|Overall Study|Withdrawal consent|1|||
163122205|NCT02124772|589155690|FG007|Overall Study|Withdrawal consent|0|||
163122206|NCT02124772|589155691|FG008|Overall Study|Withdrawal consent|0|||
163122207|NCT02124772|589155692|FG009|Overall Study|Withdrawal consent|1|||
163122208|NCT02124772|589155693|FG010|Overall Study|Withdrawal consent|0|||
163341390|NCT00910871|589958213|FG000|Overall Study|Adverse Event|5|||
163341391|NCT00910871|589958213|FG000|Overall Study|Death|12|||
163341392|NCT00910871|589958213|FG000|Overall Study|Lost to Follow-up|8|||
163341393|NCT00910871|589958213|FG000|Overall Study|Protocol Violation|11|||
163341394|NCT00910871|589958213|FG000|Overall Study|Withdrawal by Subject|12|||
163341395|NCT00910871|589958213|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
163408149|NCT02432235|590204037|FG005|Overall Study|Withdrawal by Subject|2|||
163122209|NCT02124772|589155694|FG011|Overall Study|Withdrawal consent|1|||
163122210|NCT02124772|589155695|FG012|Overall Study|Withdrawal consent|0|||
163122211|NCT02124772|589155683|FG000|Overall Study|Investigator discretion|0|||
163122212|NCT02124772|589155684|FG001|Overall Study|Investigator discretion|2|||
163122213|NCT02124772|589155685|FG002|Overall Study|Investigator discretion|2|||
163122214|NCT02124772|589155686|FG003|Overall Study|Investigator discretion|1|||
163122215|NCT02124772|589155687|FG004|Overall Study|Investigator discretion|1|||
163122216|NCT02124772|589155688|FG005|Overall Study|Investigator discretion|0|||
163122217|NCT02124772|589155689|FG006|Overall Study|Investigator discretion|1|||
163122218|NCT02124772|589155690|FG007|Overall Study|Investigator discretion|0|||
163122219|NCT02124772|589155691|FG008|Overall Study|Investigator discretion|0|||
163122220|NCT02124772|589155692|FG009|Overall Study|Investigator discretion|1|||
163122221|NCT02124772|589155693|FG010|Overall Study|Investigator discretion|0|||
163122222|NCT02124772|589155694|FG011|Overall Study|Investigator discretion|1|||
163122223|NCT02124772|589155695|FG012|Overall Study|Investigator discretion|0|||
163122224|NCT02124772|589155683|FG000|Overall Study|Progressive disease|0|||
163122225|NCT02124772|589155684|FG001|Overall Study|Progressive disease|0|||
163341396|NCT00910871|589958213|FG000|Overall Study|Undefined|1|||
163122226|NCT02124772|589155685|FG002|Overall Study|Progressive disease|0|||
163122227|NCT02124772|589155686|FG003|Overall Study|Progressive disease|0|||
163122228|NCT02124772|589155687|FG004|Overall Study|Progressive disease|0|||
163122229|NCT02124772|589155688|FG005|Overall Study|Progressive disease|0|||
163122230|NCT02124772|589155689|FG006|Overall Study|Progressive disease|1|||
163122231|NCT02124772|589155690|FG007|Overall Study|Progressive disease|1|||
163122232|NCT02124772|589155691|FG008|Overall Study|Progressive disease|0|||
163122233|NCT02124772|589155692|FG009|Overall Study|Progressive disease|0|||
163122234|NCT02124772|589155693|FG010|Overall Study|Progressive disease|0|||
163122235|NCT02124772|589155694|FG011|Overall Study|Progressive disease|0|||
163122236|NCT02124772|589155695|FG012|Overall Study|Progressive disease|0|||
163122237|NCT02124772|589155683|FG000|Overall Study|Other|0|||
163122238|NCT02124772|589155684|FG001|Overall Study|Other|7|||
163122239|NCT02124772|589155685|FG002|Overall Study|Other|2|||
163122240|NCT02124772|589155686|FG003|Overall Study|Other|5|||
163122241|NCT02124772|589155687|FG004|Overall Study|Other|4|||
163122242|NCT02124772|589155688|FG005|Overall Study|Other|3|||
163122243|NCT02124772|589155689|FG006|Overall Study|Other|4|||
163122244|NCT02124772|589155690|FG007|Overall Study|Other|1|||
163122245|NCT02124772|589155691|FG008|Overall Study|Other|1|||
163122246|NCT02124772|589155692|FG009|Overall Study|Other|1|||
163122247|NCT02124772|589155693|FG010|Overall Study|Other|1|||
163122248|NCT02124772|589155694|FG011|Overall Study|Other|1|||
163122249|NCT02124772|589155695|FG012|Overall Study|Other|0|||
163122250|NCT01827332|589155696|FG000|Overall Study|Lost to Follow-up|2|||
163122251|NCT01827332|589155697|FG001|Overall Study|Lost to Follow-up|1|||
163122252|NCT01522404|589155698|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
163122253|NCT01522404|589155699|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
163122254|NCT01522404|589155698|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
163122255|NCT01522404|589155699|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
163122256|NCT01522404|589155698|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
163122257|NCT01522404|589155699|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
163122258|NCT02698371|589155700|FG000|All Participants Flow|Lost to Follow-up|3|||
163122259|NCT02698371|589155700|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
163122260|NCT02698371|589155700|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
163122261|NCT02698371|589155700|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
163122262|NCT02698371|589155700|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
163122263|NCT02698371|589155700|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
163122264|NCT02698371|589155700|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
163122265|NCT01440881|589155701|FG000|Overall Study|Death|0|||
163122266|NCT01440881|589155702|FG001|Overall Study|Death|1|||
163122267|NCT02644356|589155704|FG000|Overall Study|Withdrawal by Subject|2|||
163122268|NCT02290938|589155705|FG000|Overall Study|Lost to Follow-up|14|||
163122269|NCT02290938|589155706|FG001|Overall Study|Lost to Follow-up|43|||
163122270|NCT00897390|589155707|FG000|Overall Study|Adverse Event|2|||
163122271|NCT00897390|589155707|FG000|Overall Study|No Longer Met Study Criteria|1|||
163122272|NCT00897390|589155707|FG000|Overall Study|Personal Reasons|1|||
163122273|NCT00897390|589155707|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
163122274|NCT04500769|589156658|FG000|Overall Study|Withdrawal by Subject|5|||
163122275|NCT01511562|589156659|FG000|Induction|Adverse Event|2|||
163122276|NCT01511562|589156660|FG001|Induction|Adverse Event|0|||
163122277|NCT01511562|589156659|FG000|Induction|Disease Progression|3|||
163122278|NCT01511562|589156660|FG001|Induction|Disease Progression|7|||
163122279|NCT01511562|589156659|FG000|Induction|Death|1|||
163122280|NCT01511562|589156660|FG001|Induction|Death|3|||
163122281|NCT01511562|589156659|FG000|Induction|Withdrawal by Subject|0|||
163122282|NCT01511562|589156660|FG001|Induction|Withdrawal by Subject|4|||
163122283|NCT01511562|589156659|FG000|Induction|Other|3|||
163122284|NCT01511562|589156660|FG001|Induction|Other|0|||
163122285|NCT01511562|589156659|FG000|Consolidation|Withdrawal by Subject|1|||
163122286|NCT01511562|589156660|FG001|Consolidation|Withdrawal by Subject|0|||
163122287|NCT01511562|589156659|FG000|Consolidation|Other|1|||
163122288|NCT01511562|589156660|FG001|Consolidation|Other|0|||
163122289|NCT04736199|589156661|FG000|Overall Study|Adverse Event|28|||
163122290|NCT04736199|589156662|FG001|Overall Study|Adverse Event|22|||
163122291|NCT04736199|589156661|FG000|Overall Study|Death|9|||
163122292|NCT04736199|589156662|FG001|Overall Study|Death|3|||
163122293|NCT04736199|589156661|FG000|Overall Study|Lost to Follow-up|4|||
163122294|NCT04736199|589156662|FG001|Overall Study|Lost to Follow-up|1|||
163122295|NCT04736199|589156661|FG000|Overall Study|Physician Decision|5|||
163122296|NCT04736199|589156662|FG001|Overall Study|Physician Decision|9|||
163122297|NCT04736199|589156661|FG000|Overall Study|Withdrawal by Subject|21|||
163122298|NCT04736199|589156662|FG001|Overall Study|Withdrawal by Subject|9|||
163122299|NCT04736199|589156661|FG000|Overall Study|Progressive disease|120|||
163122300|NCT04736199|589156662|FG001|Overall Study|Progressive disease|101|||
163122301|NCT04736199|589156661|FG000|Overall Study|Subject decision|13|||
163122302|NCT04736199|589156662|FG001|Overall Study|Subject decision|13|||
163122303|NCT04736199|589156661|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
163122304|NCT04736199|589156662|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
163225041|NCT01479621|589540050|FG002|Treatment Period|Protocol Violation|6|||
163225042|NCT01479621|589540051|FG003|Treatment Period|Protocol Violation|5|||
163225043|NCT01479621|589540052|FG004|Treatment Period|Protocol Violation|2|||
163225044|NCT01479621|589540053|FG005|Treatment Period|Protocol Violation|10|||
163225045|NCT01479621|589540054|FG006|Treatment Period|Protocol Violation|6|||
163225046|NCT01479621|589540048|FG000|Treatment Period|Pregnancy|0|||
163225047|NCT01479621|589540049|FG001|Treatment Period|Pregnancy|0|||
163225048|NCT01479621|589540050|FG002|Treatment Period|Pregnancy|2|||
163225049|NCT01479621|589540051|FG003|Treatment Period|Pregnancy|0|||
163225050|NCT01479621|589540052|FG004|Treatment Period|Pregnancy|0|||
163225051|NCT01479621|589540053|FG005|Treatment Period|Pregnancy|0|||
163225052|NCT01479621|589540054|FG006|Treatment Period|Pregnancy|0|||
163225053|NCT01479621|589540048|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
163225054|NCT01479621|589540049|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
163225055|NCT01479621|589540050|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
163225056|NCT01479621|589540051|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
163225057|NCT01479621|589540052|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
163225058|NCT01479621|589540053|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
163225059|NCT01479621|589540054|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
163225060|NCT01479621|589540048|FG000|Treatment Period|Lost to Follow-up|0|||
163225061|NCT01479621|589540049|FG001|Treatment Period|Lost to Follow-up|0|||
163225062|NCT01479621|589540050|FG002|Treatment Period|Lost to Follow-up|1|||
163225063|NCT01479621|589540051|FG003|Treatment Period|Lost to Follow-up|0|||
163225064|NCT01479621|589540052|FG004|Treatment Period|Lost to Follow-up|2|||
163225065|NCT01479621|589540053|FG005|Treatment Period|Lost to Follow-up|2|||
163225066|NCT01479621|589540054|FG006|Treatment Period|Lost to Follow-up|1|||
163225067|NCT01479621|589540048|FG000|Treatment Period|Met stopping criteria|0|||
163225068|NCT01479621|589540049|FG001|Treatment Period|Met stopping criteria|8|||
163225069|NCT01479621|589540050|FG002|Treatment Period|Met stopping criteria|7|||
163225070|NCT01479621|589540051|FG003|Treatment Period|Met stopping criteria|4|||
163225071|NCT01479621|589540052|FG004|Treatment Period|Met stopping criteria|9|||
163225072|NCT01479621|589540053|FG005|Treatment Period|Met stopping criteria|20|||
163225073|NCT01479621|589540054|FG006|Treatment Period|Met stopping criteria|6|||
163225074|NCT02308735|589540057|FG000|Overall Study|Physician Decision|2|||
163225075|NCT02308735|589540058|FG001|Overall Study|Physician Decision|0|||
163225076|NCT02308735|589540059|FG002|Overall Study|Physician Decision|0|||
163225077|NCT02308735|589540060|FG003|Overall Study|Physician Decision|2|||
163225078|NCT01417481|589540064|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
163225079|NCT01417481|589540065|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
163225080|NCT00582933|589540068|FG000|Overall Study|Physician Decision|3|||
163225081|NCT01736696|589540077|FG000|Overall Study|Withdrawal by Subject|0|||
163225082|NCT01736696|589540078|FG001|Overall Study|Withdrawal by Subject|0|||
163225083|NCT01736696|589540079|FG002|Overall Study|Withdrawal by Subject|1|||
163225084|NCT01736696|589540080|FG003|Overall Study|Withdrawal by Subject|0|||
163225085|NCT01736696|589540081|FG004|Overall Study|Withdrawal by Subject|0|||
163225086|NCT01736696|589540082|FG005|Overall Study|Withdrawal by Subject|0|||
163225087|NCT01736696|589540083|FG006|Overall Study|Withdrawal by Subject|0|||
163225088|NCT01116232|589540084|FG000|Overall Study|Progressive diease|4|||
163225089|NCT00405548|589540085|FG000|Overall Study|Cognitive Memory problems on study day|1|||
163225090|NCT00405548|589540086|FG001|Overall Study|Cognitive Memory problems on study day|0|||
163225091|NCT00405548|589540085|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
163408150|NCT02432235|590204038|FG006|Overall Study|Withdrawal by Subject|5|||
163122305|NCT04736199|589156661|FG000|Overall Study|Additional primary malignancy|1|||
163122306|NCT04736199|589156662|FG001|Overall Study|Additional primary malignancy|0|||
163122307|NCT04736199|589156661|FG000|Overall Study|Non-compliance with study drug|0|||
163122308|NCT04736199|589156662|FG001|Overall Study|Non-compliance with study drug|1|||
163122309|NCT04736199|589156661|FG000|Overall Study|Other reason|0|||
163122310|NCT04736199|589156662|FG001|Overall Study|Other reason|1|||
163122311|NCT04736199|589156661|FG000|Overall Study|Ongoing with study drug|240|||
163122312|NCT04736199|589156662|FG001|Overall Study|Ongoing with study drug|63|||
163122313|NCT04736199|589156661|FG000|Overall Study|Study drug never administered|3|||
163122314|NCT04736199|589156662|FG001|Overall Study|Study drug never administered|0|||
163122315|NCT04744831|589156663|FG000|Overall Study|Adverse Event|6|||
163122316|NCT04744831|589156664|FG001|Overall Study|Adverse Event|4|||
163122317|NCT04744831|589156663|FG000|Overall Study|Clinical Progression|5|||
163122318|NCT04744831|589156664|FG001|Overall Study|Clinical Progression|5|||
163225092|NCT00405548|589540086|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
163225093|NCT00405548|589540085|FG000|Overall Study|Unable to self-administer shots|1|||
163225094|NCT00405548|589540086|FG001|Overall Study|Unable to self-administer shots|0|||
163225095|NCT00405548|589540085|FG000|Overall Study|Venous access failed during study day|1|||
163225096|NCT00405548|589540086|FG001|Overall Study|Venous access failed during study day|0|||
163225097|NCT00405548|589540085|FG000|Overall Study|Withdrawal by Subject|1|||
163225098|NCT00405548|589540086|FG001|Overall Study|Withdrawal by Subject|0|||
163408151|NCT02432235|590204039|FG007|Overall Study|Withdrawal by Subject|3|||
163341397|NCT00850993|589958214|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
163341398|NCT00850993|589958215|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
163341399|NCT00850993|589958216|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
163341400|NCT00850993|589958217|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
163122319|NCT04744831|589156663|FG000|Overall Study|Death|2|||
163122320|NCT04744831|589156664|FG001|Overall Study|Death|1|||
163122321|NCT04744831|589156663|FG000|Overall Study|Other|5|||
163122322|NCT04744831|589156664|FG001|Overall Study|Other|1|||
163122323|NCT04744831|589156663|FG000|Overall Study|Progressive Disease|63|||
163122324|NCT04744831|589156664|FG001|Overall Study|Progressive Disease|29|||
163122325|NCT04744831|589156663|FG000|Overall Study|Withdrawal by Subject|1|||
163122326|NCT04744831|589156664|FG001|Overall Study|Withdrawal by Subject|0|||
163122327|NCT02805725|589156665|FG000|Phase I (Dose escalation part)|Clinical progression|0|||
163122328|NCT02805725|589156666|FG001|Phase I (Dose escalation part)|Clinical progression|0|||
163122329|NCT02805725|589156667|FG002|Phase I (Dose escalation part)|Clinical progression|1|||
163122330|NCT02805725|589156668|FG003|Phase I (Dose escalation part)|Clinical progression|0|||
163122331|NCT02805725|589156669|FG004|Phase I (Dose escalation part)|Clinical progression|0|||
163122332|NCT02805725|589156665|FG000|Phase I (Dose escalation part)|Adverse Event|0|||
163122333|NCT02805725|589156666|FG001|Phase I (Dose escalation part)|Adverse Event|0|||
163122334|NCT02805725|589156667|FG002|Phase I (Dose escalation part)|Adverse Event|1|||
163122335|NCT02805725|589156668|FG003|Phase I (Dose escalation part)|Adverse Event|2|||
163122336|NCT02805725|589156669|FG004|Phase I (Dose escalation part)|Adverse Event|0|||
163122337|NCT02805725|589156665|FG000|Phase II|Protocol Violation|0|||
163122338|NCT02805725|589156666|FG001|Phase II|Protocol Violation|0|||
163122339|NCT02805725|589156667|FG002|Phase II|Protocol Violation|0|||
163122340|NCT02805725|589156668|FG003|Phase II|Protocol Violation|0|||
163122341|NCT02805725|589156669|FG004|Phase II|Protocol Violation|6|||
163122342|NCT06024096|589156675|FG000|Overall Study|Lost to Follow-up|2|||
163122343|NCT06024096|589156676|FG001|Overall Study|Lost to Follow-up|5|||
163122344|NCT06024096|589156675|FG000|Overall Study|Physician Decision|0|||
163122345|NCT06024096|589156676|FG001|Overall Study|Physician Decision|1|||
163122346|NCT06024096|589156675|FG000|Overall Study|Withdrawal by Subject|2|||
163122347|NCT06024096|589156676|FG001|Overall Study|Withdrawal by Subject|3|||
163122348|NCT05818137|589156677|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
163122349|NCT05818137|589156677|FG000|Extension Treatment Period|Ongoing participants|44|||
163122350|NCT04938037|589156678|FG000|Overall Study|Lost to Follow-up|4|||
163122351|NCT04938037|589156679|FG001|Overall Study|Lost to Follow-up|3|||
163122352|NCT05925374|589156680|FG000|Overall Study|Lost to Follow-up|13|||
163122353|NCT03320330|589156683|FG000|Overall Study|Lack of Efficacy|5|||
163122354|NCT03320330|589156684|FG001|Overall Study|Lack of Efficacy|5|||
163122355|NCT03320330|589156685|FG002|Overall Study|Lack of Efficacy|14|||
163122356|NCT03320330|589156683|FG000|Overall Study|Physician Decision|1|||
163122357|NCT03320330|589156684|FG001|Overall Study|Physician Decision|0|||
163122358|NCT03320330|589156685|FG002|Overall Study|Physician Decision|0|||
163122359|NCT05206370|589156686|FG000|Overall Study|Adverse Event|3|||
163122360|NCT05206370|589156687|FG001|Overall Study|Adverse Event|4|||
163122361|NCT05206370|589156688|FG002|Overall Study|Adverse Event|5|||
163122362|NCT05206370|589156686|FG000|Overall Study|Withdrawal by Subject|27|||
163122363|NCT05206370|589156687|FG001|Overall Study|Withdrawal by Subject|30|||
163122364|NCT05206370|589156688|FG002|Overall Study|Withdrawal by Subject|24|||
163122365|NCT05206370|589156686|FG000|Overall Study|Physician Decision|1|||
163122366|NCT05206370|589156687|FG001|Overall Study|Physician Decision|3|||
163122367|NCT05206370|589156688|FG002|Overall Study|Physician Decision|2|||
163122368|NCT05206370|589156686|FG000|Overall Study|Death|0|||
163122369|NCT05206370|589156687|FG001|Overall Study|Death|1|||
163122370|NCT05206370|589156688|FG002|Overall Study|Death|3|||
163122371|NCT05206370|589156686|FG000|Overall Study|Lost to Follow-up|23|||
163122372|NCT05206370|589156687|FG001|Overall Study|Lost to Follow-up|16|||
163122373|NCT05206370|589156688|FG002|Overall Study|Lost to Follow-up|14|||
163122374|NCT05206370|589156686|FG000|Overall Study|Other, Nor Specified|2|||
163122375|NCT05206370|589156687|FG001|Overall Study|Other, Nor Specified|2|||
163122376|NCT05206370|589156688|FG002|Overall Study|Other, Nor Specified|4|||
163122377|NCT04998851|589156689|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
163122378|NCT04998851|589156690|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
163341401|NCT00636168|589958223|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
163341402|NCT00636168|589958224|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
163122379|NCT04998851|589156689|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
163122380|NCT04998851|589156690|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
163122381|NCT06038123|589156695|FG000|Overall Study|Withdrawal by Subject|1|||
163122382|NCT06038123|589156695|FG000|Overall Study|not return due to femur fracture|1|||
163122383|NCT05218499|589156696|FG000|Overall Study|Not treated|1|||
163122384|NCT05218499|589156697|FG001|Overall Study|Not treated|1|||
163122385|NCT05218499|589156698|FG002|Overall Study|Not treated|8|||
163122386|NCT05218499|589156696|FG000|Overall Study|Death|2|||
163122387|NCT05218499|589156697|FG001|Overall Study|Death|0|||
163122388|NCT05218499|589156698|FG002|Overall Study|Death|0|||
163122389|NCT05218499|589156696|FG000|Overall Study|Other than listed|3|||
163122390|NCT05218499|589156697|FG001|Overall Study|Other than listed|7|||
163122391|NCT05218499|589156698|FG002|Overall Study|Other than listed|10|||
163122392|NCT05218499|589156696|FG000|Overall Study|Protocol deviation|5|||
163122393|NCT05218499|589156697|FG001|Overall Study|Protocol deviation|6|||
163122394|NCT05218499|589156698|FG002|Overall Study|Protocol deviation|4|||
163122395|NCT05218499|589156696|FG000|Overall Study|Technical problems|0|||
163122396|NCT05218499|589156697|FG001|Overall Study|Technical problems|1|||
163122397|NCT05218499|589156698|FG002|Overall Study|Technical problems|0|||
163122398|NCT05218499|589156696|FG000|Overall Study|Burden of trial procedures|0|||
163122399|NCT05218499|589156697|FG001|Overall Study|Burden of trial procedures|1|||
163122400|NCT05218499|589156698|FG002|Overall Study|Burden of trial procedures|2|||
163122401|NCT05218499|589156696|FG000|Overall Study|Clinical disease progression|6|||
163122402|NCT05218499|589156697|FG001|Overall Study|Clinical disease progression|6|||
163122403|NCT05218499|589156698|FG002|Overall Study|Clinical disease progression|11|||
163122404|NCT05218499|589156696|FG000|Overall Study|Objective disease progression|44|||
163122405|NCT05218499|589156697|FG001|Overall Study|Objective disease progression|61|||
163122406|NCT05218499|589156698|FG002|Overall Study|Objective disease progression|42|||
163122407|NCT05218499|589156696|FG000|Overall Study|Adverse Event|11|||
163122408|NCT05218499|589156697|FG001|Overall Study|Adverse Event|36|||
163122409|NCT05218499|589156698|FG002|Overall Study|Adverse Event|9|||
163122410|NCT05218499|589156696|FG000|Overall Study|On treatment at time of snapshot|18|||
163122411|NCT05218499|589156697|FG001|Overall Study|On treatment at time of snapshot|29|||
163122412|NCT05218499|589156698|FG002|Overall Study|On treatment at time of snapshot|0|||
163122413|NCT03199469|589156699|FG000|Overall Study|Randomized, not treated|0|||
163122414|NCT03199469|589156700|FG001|Overall Study|Randomized, not treated|3|||
163122415|NCT03199469|589156699|FG000|Overall Study|Withdrawal by Subject|1|||
163122416|NCT03199469|589156700|FG001|Overall Study|Withdrawal by Subject|0|||
163122417|NCT03199469|589156699|FG000|Overall Study|Death|1|||
163122418|NCT03199469|589156700|FG001|Overall Study|Death|3|||
163122419|NCT03199469|589156699|FG000|Overall Study|Ongoing|5|||
163122420|NCT03199469|589156700|FG001|Overall Study|Ongoing|14|||
163122421|NCT05431387|589156710|FG000|Overall Study|Adverse Event|1|||
163122422|NCT05431387|589156711|FG001|Overall Study|Adverse Event|0|||
163122423|NCT05431387|589156710|FG000|Overall Study|Withdrawal by Subject|4|||
163122424|NCT05431387|589156711|FG001|Overall Study|Withdrawal by Subject|4|||
163122425|NCT05431387|589156710|FG000|Overall Study|Physician Decision|0|||
163122426|NCT05431387|589156711|FG001|Overall Study|Physician Decision|1|||
163122427|NCT05431387|589156710|FG000|Overall Study|Lost to Follow-up|5|||
163122428|NCT05431387|589156711|FG001|Overall Study|Lost to Follow-up|9|||
163122429|NCT05431387|589156710|FG000|Overall Study|Other, Not Specified|1|||
163122430|NCT05431387|589156711|FG001|Overall Study|Other, Not Specified|4|||
163122431|NCT03199391|589156712|FG000|Overall Study|Death|1|||
163122432|NCT03199391|589156712|FG000|Overall Study|Lost to Follow-up|3|||
163122433|NCT03199391|589156712|FG000|Overall Study|Adverse Event|2|||
163122434|NCT03199391|589156712|FG000|Overall Study|Withdrawal by Subject|10|||
163122435|NCT01867086|589156713|FG000|Overall Study|Disease Progression|1|||
163122436|NCT04257929|589156714|FG000|Overall Study|Adverse Event|1|||
163122437|NCT04257929|589156715|FG001|Overall Study|Adverse Event|0|||
163122438|NCT04257929|589156716|FG002|Overall Study|Adverse Event|1|||
163122439|NCT04257929|589156714|FG000|Overall Study|Withdrawal by Subject|1|||
163122440|NCT04257929|589156715|FG001|Overall Study|Withdrawal by Subject|0|||
163122441|NCT04257929|589156716|FG002|Overall Study|Withdrawal by Subject|0|||
163122442|NCT04257929|589156714|FG000|Overall Study|COVID-19|0|||
163122443|NCT04257929|589156715|FG001|Overall Study|COVID-19|1|||
163122444|NCT04257929|589156716|FG002|Overall Study|COVID-19|1|||
163122445|NCT04257929|589156714|FG000|Overall Study|Lost to Follow-up|0|||
163122446|NCT04257929|589156715|FG001|Overall Study|Lost to Follow-up|0|||
163122447|NCT04257929|589156716|FG002|Overall Study|Lost to Follow-up|1|||
163122448|NCT06036914|589156717|FG000|Overall Study|Withdrawal by Subject|1|||
163122449|NCT06036914|589156718|FG001|Overall Study|Withdrawal by Subject|0|||
163408152|NCT02432235|590204040|FG008|Overall Study|Withdrawal by Subject|1|||
163408153|NCT02432235|590204041|FG009|Overall Study|Withdrawal by Subject|0|||
163408154|NCT02432235|590204042|FG010|Overall Study|Withdrawal by Subject|0|||
163122450|NCT04697381|589156719|FG000|Extension Period|Adverse Event|0|||
163122451|NCT04697381|589156720|FG001|Extension Period|Adverse Event|0|||
163122452|NCT04697381|589156721|FG002|Extension Period|Adverse Event|3|||
163122453|NCT04697381|589156719|FG000|Extension Period|Physician Decision|0|||
163122454|NCT04697381|589156720|FG001|Extension Period|Physician Decision|0|||
163122455|NCT04697381|589156721|FG002|Extension Period|Physician Decision|2|||
163122456|NCT04697381|589156719|FG000|Extension Period|Other|0|||
163122457|NCT04697381|589156720|FG001|Extension Period|Other|0|||
163122458|NCT04697381|589156721|FG002|Extension Period|Other|1|||
163122459|NCT04088331|589156724|FG000|Overall Study|Lost to Follow-up|3|||
163122460|NCT04088331|589156724|FG000|Overall Study|Withdrawal by Subject|7|||
163122461|NCT04088331|589156724|FG000|Overall Study|Adverse Event|4|||
163122462|NCT03500172|589156728|FG000|Period 1: Baseline Randomization|Death|0|||
163122463|NCT03500172|589156729|FG001|Period 1: Baseline Randomization|Death|0|||
163122464|NCT03500172|589156730|FG002|Period 1: Baseline Randomization|Death|0|||
163122465|NCT03500172|589156731|FG003|Period 1: Baseline Randomization|Death|0|||
163122466|NCT03500172|589156732|FG004|Period 1: Baseline Randomization|Death|0|||
163122467|NCT03500172|589156733|FG005|Period 1: Baseline Randomization|Death|0|||
163122468|NCT03500172|589156734|FG006|Period 1: Baseline Randomization|Death|0|||
163122469|NCT03500172|589156735|FG007|Period 1: Baseline Randomization|Death|0|||
163122470|NCT03500172|589156736|FG008|Period 1: Baseline Randomization|Death|0|||
163122471|NCT03500172|589156737|FG009|Period 1: Baseline Randomization|Death|2|||
163122472|NCT03500172|589156738|FG010|Period 1: Baseline Randomization|Death|0|||
163122473|NCT03500172|589156728|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
163122474|NCT03500172|589156729|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
163122475|NCT03500172|589156730|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
163122476|NCT03500172|589156731|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
163122477|NCT03500172|589156732|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
163122478|NCT03500172|589156733|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
163122479|NCT03500172|589156734|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
163122480|NCT03500172|589156735|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
163122481|NCT03500172|589156736|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
163122482|NCT03500172|589156737|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
163122483|NCT03500172|589156738|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
163122484|NCT03500172|589156728|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
163122485|NCT03500172|589156729|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
163122486|NCT03500172|589156730|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
163122487|NCT03500172|589156731|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
163122488|NCT03500172|589156732|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
163122489|NCT03500172|589156733|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
163122490|NCT03500172|589156734|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
163122491|NCT03500172|589156735|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
163122492|NCT03500172|589156736|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
163122493|NCT03500172|589156737|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
163122494|NCT03500172|589156738|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
163122495|NCT03500172|589156728|FG000|Period 2: Re-Randomization|Death|0|||
163122496|NCT03500172|589156729|FG001|Period 2: Re-Randomization|Death|0|||
163122497|NCT03500172|589156730|FG002|Period 2: Re-Randomization|Death|0|||
163122498|NCT03500172|589156731|FG003|Period 2: Re-Randomization|Death|4|||
163122499|NCT03500172|589156732|FG004|Period 2: Re-Randomization|Death|2|||
163122500|NCT03500172|589156733|FG005|Period 2: Re-Randomization|Death|0|||
163122501|NCT03500172|589156734|FG006|Period 2: Re-Randomization|Death|5|||
163122502|NCT03500172|589156735|FG007|Period 2: Re-Randomization|Death|2|||
163122503|NCT03500172|589156736|FG008|Period 2: Re-Randomization|Death|0|||
163122504|NCT03500172|589156737|FG009|Period 2: Re-Randomization|Death|0|||
163122505|NCT03500172|589156738|FG010|Period 2: Re-Randomization|Death|0|||
163122506|NCT03298451|589156745|FG000|Overall Study|Death|275|||
163122507|NCT03298451|589156746|FG001|Overall Study|Death|260|||
163122508|NCT03298451|589156747|FG002|Overall Study|Death|122|||
163122509|NCT03298451|589156748|FG003|Overall Study|Death|280|||
163122510|NCT03298451|589156745|FG000|Overall Study|Lost to Follow-up|1|||
163122511|NCT03298451|589156746|FG001|Overall Study|Lost to Follow-up|1|||
163122512|NCT03298451|589156747|FG002|Overall Study|Lost to Follow-up|0|||
163122513|NCT03298451|589156748|FG003|Overall Study|Lost to Follow-up|7|||
163122514|NCT03298451|589156745|FG000|Overall Study|Withdrawal by Subject|9|||
163122515|NCT03298451|589156746|FG001|Overall Study|Withdrawal by Subject|7|||
163122516|NCT03298451|589156747|FG002|Overall Study|Withdrawal by Subject|1|||
163122517|NCT03298451|589156748|FG003|Overall Study|Withdrawal by Subject|20|||
163122518|NCT01299571|589156756|FG000|Overall Study|Protocol Violation|107|||
163122519|NCT02486718|589157292|FG000|Enrollment Phase|Death|19|||
163122520|NCT02486718|589157293|FG001|Enrollment Phase|Death|0|||
163122521|NCT02486718|589157294|FG002|Enrollment Phase|Death|0|||
163122522|NCT02486718|589157292|FG000|Enrollment Phase|Symptomatic deterioration|1|||
163122523|NCT02486718|589157293|FG001|Enrollment Phase|Symptomatic deterioration|0|||
163225099|NCT02036502|589540087|FG000|Part 1:Dose Determination/Escalation|Death|3|||
163122524|NCT02486718|589157294|FG002|Enrollment Phase|Symptomatic deterioration|0|||
163122525|NCT02486718|589157292|FG000|Enrollment Phase|Withdrawal by Subject|86|||
163122526|NCT02486718|589157293|FG001|Enrollment Phase|Withdrawal by Subject|0|||
163122527|NCT02486718|589157294|FG002|Enrollment Phase|Withdrawal by Subject|0|||
163122528|NCT02486718|589157292|FG000|Enrollment Phase|Protocol Violation|18|||
163122529|NCT02486718|589157293|FG001|Enrollment Phase|Protocol Violation|0|||
163122530|NCT02486718|589157294|FG002|Enrollment Phase|Protocol Violation|0|||
163122531|NCT02486718|589157292|FG000|Enrollment Phase|Physician Decision|18|||
163122532|NCT02486718|589157293|FG001|Enrollment Phase|Physician Decision|0|||
163122533|NCT02486718|589157294|FG002|Enrollment Phase|Physician Decision|0|||
163122534|NCT02486718|589157292|FG000|Enrollment Phase|Reason not provided|41|||
163122535|NCT02486718|589157293|FG001|Enrollment Phase|Reason not provided|0|||
163122536|NCT02486718|589157294|FG002|Enrollment Phase|Reason not provided|0|||
163122537|NCT02486718|589157292|FG000|Enrollment Phase|Disease relapse|54|||
163122538|NCT02486718|589157293|FG001|Enrollment Phase|Disease relapse|0|||
163122539|NCT02486718|589157294|FG002|Enrollment Phase|Disease relapse|0|||
163122540|NCT02486718|589157292|FG000|Enrollment Phase|Lost to Follow-up|4|||
163122541|NCT02486718|589157293|FG001|Enrollment Phase|Lost to Follow-up|0|||
163122542|NCT02486718|589157294|FG002|Enrollment Phase|Lost to Follow-up|0|||
163122543|NCT02486718|589157292|FG000|Enrollment Phase|Adverse Event|34|||
163122544|NCT02486718|589157293|FG001|Enrollment Phase|Adverse Event|0|||
163122545|NCT02486718|589157294|FG002|Enrollment Phase|Adverse Event|0|||
163122546|NCT02486718|589157292|FG000|Randomized Phase|Withdrawal by Subject|0|||
163122547|NCT02486718|589157293|FG001|Randomized Phase|Withdrawal by Subject|44|||
163122548|NCT02486718|589157294|FG002|Randomized Phase|Withdrawal by Subject|47|||
163122549|NCT02486718|589157292|FG000|Randomized Phase|Protocol Violation|0|||
163122550|NCT02486718|589157293|FG001|Randomized Phase|Protocol Violation|2|||
163122551|NCT02486718|589157294|FG002|Randomized Phase|Protocol Violation|0|||
163122552|NCT02486718|589157292|FG000|Randomized Phase|Physician Decision|0|||
163122553|NCT02486718|589157293|FG001|Randomized Phase|Physician Decision|0|||
163122554|NCT02486718|589157294|FG002|Randomized Phase|Physician Decision|3|||
163122555|NCT02486718|589157292|FG000|Randomized Phase|Lost to Follow-up|0|||
163122556|NCT02486718|589157293|FG001|Randomized Phase|Lost to Follow-up|5|||
163122557|NCT02486718|589157294|FG002|Randomized Phase|Lost to Follow-up|11|||
163122558|NCT02486718|589157292|FG000|Randomized Phase|Disease Relapse|0|||
163122559|NCT02486718|589157293|FG001|Randomized Phase|Disease Relapse|1|||
163122560|NCT02486718|589157294|FG002|Randomized Phase|Disease Relapse|0|||
163122561|NCT02486718|589157292|FG000|Randomized Phase|Death|0|||
163122562|NCT02486718|589157293|FG001|Randomized Phase|Death|154|||
163122563|NCT02486718|589157294|FG002|Randomized Phase|Death|155|||
163122564|NCT02486718|589157292|FG000|Randomized Phase|Ongoing|0|||
163122565|NCT02486718|589157293|FG001|Randomized Phase|Ongoing|301|||
163122566|NCT02486718|589157294|FG002|Randomized Phase|Ongoing|282|||
163122567|NCT05702918|589157295|FG000|Overall Study|Withdrawal by Subject|0|||
163122568|NCT05702918|589157296|FG001|Overall Study|Withdrawal by Subject|2|||
163122569|NCT05702918|589157295|FG000|Overall Study|Lost to Follow-up|0|||
163122570|NCT05702918|589157296|FG001|Overall Study|Lost to Follow-up|2|||
163122571|NCT05702918|589157295|FG000|Overall Study|Unrelated injury|2|||
163122572|NCT05702918|589157296|FG001|Overall Study|Unrelated injury|0|||
163122573|NCT03171545|589157303|FG000|Baseline|Withdrawal by Subject|0|||
163122574|NCT03171545|589157304|FG001|Baseline|Withdrawal by Subject|0|||
163122575|NCT03171545|589157305|FG002|Baseline|Withdrawal by Subject|1|||
163122576|NCT03171545|589157306|FG003|Baseline|Withdrawal by Subject|2|||
163122577|NCT03171545|589157303|FG000|Baseline|Transferred out of clinic|4|||
163122578|NCT03171545|589157304|FG001|Baseline|Transferred out of clinic|0|||
163122579|NCT03171545|589157305|FG002|Baseline|Transferred out of clinic|2|||
163122580|NCT03171545|589157306|FG003|Baseline|Transferred out of clinic|0|||
163122581|NCT03171545|589157303|FG000|Baseline|Death|1|||
163122582|NCT03171545|589157304|FG001|Baseline|Death|2|||
163122583|NCT03171545|589157305|FG002|Baseline|Death|1|||
163122584|NCT03171545|589157306|FG003|Baseline|Death|5|||
163122585|NCT03171545|589157303|FG000|Baseline|Recovered renal function|0|||
163122586|NCT03171545|589157304|FG001|Baseline|Recovered renal function|0|||
163122587|NCT03171545|589157305|FG002|Baseline|Recovered renal function|1|||
163122588|NCT03171545|589157306|FG003|Baseline|Recovered renal function|0|||
163122589|NCT03171545|589157303|FG000|Baseline|Received transplant|0|||
163122590|NCT03171545|589157304|FG001|Baseline|Received transplant|0|||
163122591|NCT03171545|589157305|FG002|Baseline|Received transplant|1|||
163122592|NCT03171545|589157306|FG003|Baseline|Received transplant|0|||
163122593|NCT03171545|589157303|FG000|Baseline|No longer receiving in-center hemodialysis|0|||
163122594|NCT03171545|589157304|FG001|Baseline|No longer receiving in-center hemodialysis|2|||
163122595|NCT03171545|589157305|FG002|Baseline|No longer receiving in-center hemodialysis|3|||
163122596|NCT03171545|589157306|FG003|Baseline|No longer receiving in-center hemodialysis|0|||
163122597|NCT03171545|589157303|FG000|Intervention|Withdrawal by Subject|2|||
163122598|NCT03171545|589157304|FG001|Intervention|Withdrawal by Subject|0|||
163122599|NCT03171545|589157305|FG002|Intervention|Withdrawal by Subject|0|||
163122600|NCT03171545|589157306|FG003|Intervention|Withdrawal by Subject|4|||
163122601|NCT03171545|589157303|FG000|Intervention|Transferred out of clinic|12|||
163122602|NCT03171545|589157304|FG001|Intervention|Transferred out of clinic|9|||
163122603|NCT03171545|589157305|FG002|Intervention|Transferred out of clinic|17|||
163122604|NCT03171545|589157306|FG003|Intervention|Transferred out of clinic|9|||
163122605|NCT03171545|589157303|FG000|Intervention|Death|26|||
163122606|NCT03171545|589157304|FG001|Intervention|Death|16|||
163122607|NCT03171545|589157305|FG002|Intervention|Death|29|||
163122608|NCT03171545|589157306|FG003|Intervention|Death|14|||
163122609|NCT03171545|589157303|FG000|Intervention|Received transplant|7|||
163122610|NCT03171545|589157304|FG001|Intervention|Received transplant|5|||
163122611|NCT03171545|589157305|FG002|Intervention|Received transplant|3|||
163122612|NCT03171545|589157306|FG003|Intervention|Received transplant|6|||
163122613|NCT03171545|589157303|FG000|Intervention|No longer receiving in-center hemodialysis|7|||
163122614|NCT03171545|589157304|FG001|Intervention|No longer receiving in-center hemodialysis|4|||
163122615|NCT03171545|589157305|FG002|Intervention|No longer receiving in-center hemodialysis|4|||
163122616|NCT03171545|589157306|FG003|Intervention|No longer receiving in-center hemodialysis|6|||
163122617|NCT03171545|589157303|FG000|Intervention|Lost to Follow-up|0|||
163122618|NCT03171545|589157304|FG001|Intervention|Lost to Follow-up|1|||
163122619|NCT03171545|589157305|FG002|Intervention|Lost to Follow-up|0|||
163122620|NCT03171545|589157306|FG003|Intervention|Lost to Follow-up|0|||
163122621|NCT03171545|589157303|FG000|Follow up|Withdrawal by Subject|1|||
163122622|NCT03171545|589157304|FG001|Follow up|Withdrawal by Subject|1|||
163122623|NCT03171545|589157305|FG002|Follow up|Withdrawal by Subject|0|||
163122624|NCT03171545|589157306|FG003|Follow up|Withdrawal by Subject|0|||
163122625|NCT03171545|589157303|FG000|Follow up|Transferred out of clinic|4|||
163122626|NCT03171545|589157304|FG001|Follow up|Transferred out of clinic|4|||
163122627|NCT03171545|589157305|FG002|Follow up|Transferred out of clinic|12|||
163122628|NCT03171545|589157306|FG003|Follow up|Transferred out of clinic|7|||
163122629|NCT03171545|589157303|FG000|Follow up|Death|18|||
163122630|NCT03171545|589157304|FG001|Follow up|Death|12|||
163122631|NCT03171545|589157305|FG002|Follow up|Death|5|||
163122632|NCT03171545|589157306|FG003|Follow up|Death|8|||
163122633|NCT03171545|589157303|FG000|Follow up|Received transplant|4|||
163122634|NCT03171545|589157304|FG001|Follow up|Received transplant|1|||
163122635|NCT03171545|589157305|FG002|Follow up|Received transplant|0|||
163122636|NCT03171545|589157306|FG003|Follow up|Received transplant|1|||
163122637|NCT03171545|589157303|FG000|Follow up|No longer receiving in-center hemodialysis|4|||
163122638|NCT03171545|589157304|FG001|Follow up|No longer receiving in-center hemodialysis|2|||
163122639|NCT03171545|589157305|FG002|Follow up|No longer receiving in-center hemodialysis|1|||
163122640|NCT03171545|589157306|FG003|Follow up|No longer receiving in-center hemodialysis|0|||
163122641|NCT03171545|589157303|FG000|Follow up|Lost to Follow-up|1|||
163122642|NCT03171545|589157304|FG001|Follow up|Lost to Follow-up|2|||
163122643|NCT03171545|589157305|FG002|Follow up|Lost to Follow-up|3|||
163122644|NCT03171545|589157306|FG003|Follow up|Lost to Follow-up|1|||
163122645|NCT04409457|589157307|FG000|Screening Prior to Randomization|Screening fail prior to randomization|16|||
163122646|NCT04409457|589157308|FG001|Screening Prior to Randomization|Screening fail prior to randomization|13|||
163122647|NCT04409457|589157309|FG002|Screening Prior to Randomization|Screening fail prior to randomization|0|||
163122648|NCT04409457|589157310|FG003|Screening Prior to Randomization|Screening fail prior to randomization|0|||
163122649|NCT04409457|589157311|FG004|Screening Prior to Randomization|Screening fail prior to randomization|0|||
163122650|NCT04409457|589157312|FG005|Screening Prior to Randomization|Screening fail prior to randomization|0|||
163122651|NCT04409457|589157307|FG000|Screening Prior to Randomization|Withdrawal by Subject|2|||
163122652|NCT04409457|589157308|FG001|Screening Prior to Randomization|Withdrawal by Subject|1|||
163122653|NCT04409457|589157309|FG002|Screening Prior to Randomization|Withdrawal by Subject|0|||
163122654|NCT04409457|589157310|FG003|Screening Prior to Randomization|Withdrawal by Subject|0|||
163122655|NCT04409457|589157311|FG004|Screening Prior to Randomization|Withdrawal by Subject|0|||
163122656|NCT04409457|589157312|FG005|Screening Prior to Randomization|Withdrawal by Subject|0|||
163122657|NCT04409457|589157307|FG000|Randomization|Withdrawal by Subject|0|||
163122658|NCT04409457|589157308|FG001|Randomization|Withdrawal by Subject|0|||
163122659|NCT04409457|589157309|FG002|Randomization|Withdrawal by Subject|0|||
163122660|NCT04409457|589157310|FG003|Randomization|Withdrawal by Subject|0|||
163122661|NCT04409457|589157311|FG004|Randomization|Withdrawal by Subject|1|||
163122662|NCT04409457|589157312|FG005|Randomization|Withdrawal by Subject|0|||
163122663|NCT04409457|589157307|FG000|Randomization|Incidental MRI finding at scan 1|0|||
163122664|NCT04409457|589157308|FG001|Randomization|Incidental MRI finding at scan 1|0|||
163122665|NCT04409457|589157309|FG002|Randomization|Incidental MRI finding at scan 1|0|||
163122666|NCT04409457|589157310|FG003|Randomization|Incidental MRI finding at scan 1|1|||
163122667|NCT04409457|589157311|FG004|Randomization|Incidental MRI finding at scan 1|0|||
163122668|NCT04409457|589157312|FG005|Randomization|Incidental MRI finding at scan 1|1|||
163122669|NCT04409457|589157307|FG000|Randomization|Technical/equipment error at scan 1|0|||
163122670|NCT04409457|589157308|FG001|Randomization|Technical/equipment error at scan 1|0|||
163122671|NCT04409457|589157309|FG002|Randomization|Technical/equipment error at scan 1|0|||
163341403|NCT00636168|589958223|FG000|Randomized to Study Drug|Adverse Event|1|||
163341404|NCT00636168|589958224|FG001|Randomized to Study Drug|Adverse Event|0|||
163122672|NCT04409457|589157310|FG003|Randomization|Technical/equipment error at scan 1|0|||
163122673|NCT04409457|589157311|FG004|Randomization|Technical/equipment error at scan 1|0|||
163122674|NCT04409457|589157312|FG005|Randomization|Technical/equipment error at scan 1|1|||
163122675|NCT04865770|589157313|FG000|Overall Study|Withdrawal by Subject|3|||
163122676|NCT04865770|589157314|FG001|Overall Study|Withdrawal by Subject|0|||
163122677|NCT04865770|589157313|FG000|Overall Study|Physician Decision|9|||
163122678|NCT04865770|589157314|FG001|Overall Study|Physician Decision|0|||
163122679|NCT04865770|589157313|FG000|Overall Study|Death|1|||
163122680|NCT04865770|589157314|FG001|Overall Study|Death|1|||
163122681|NCT04522973|589157318|FG000|Overall Study|Lost to Follow-up|4|||
163122682|NCT04522973|589157318|FG000|Overall Study|Could not adhere to study schedule|1|||
163122683|NCT04007796|589157319|FG000|Overall Study|Exclusion criterion met during the trial|1|||
163122684|NCT04007796|589157320|FG001|Overall Study|Exclusion criterion met during the trial|1|||
163122685|NCT04007796|589157319|FG000|Overall Study|Withdrawal by Subject|1|||
163122686|NCT04007796|589157320|FG001|Overall Study|Withdrawal by Subject|0|||
163122687|NCT03573401|589157321|FG000|Overall Study|Withdrawal by Subject|2|||
163122688|NCT03573401|589157322|FG001|Overall Study|Withdrawal by Subject|0|||
163122689|NCT03573401|589157321|FG000|Overall Study|Subject non-compliance with study schedule|1|||
163122690|NCT03573401|589157322|FG001|Overall Study|Subject non-compliance with study schedule|0|||
163122691|NCT03573401|589157321|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
163122692|NCT03573401|589157322|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
163122693|NCT03573401|589157321|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
163122694|NCT03573401|589157322|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
163122695|NCT05579249|589157323|FG000|Overall Study|Withdrawal by Subject|1|||
163122696|NCT05579249|589157324|FG001|Overall Study|Withdrawal by Subject|3|||
163122697|NCT05579249|589157323|FG000|Overall Study|Lost to Follow-up|33|||
163122698|NCT05579249|589157324|FG001|Overall Study|Lost to Follow-up|52|||
163122699|NCT05579249|589157323|FG000|Overall Study|Physician Decision|2|||
163122700|NCT05579249|589157324|FG001|Overall Study|Physician Decision|2|||
163122701|NCT05579249|589157323|FG000|Overall Study|Death|0|||
163122702|NCT05579249|589157324|FG001|Overall Study|Death|2|||
163122703|NCT05028517|589157325|FG000|Overall Study|Lost to Follow-up|13|||
163122704|NCT05028517|589157326|FG001|Overall Study|Lost to Follow-up|20|||
163122705|NCT05028517|589157327|FG002|Overall Study|Lost to Follow-up|12|||
163122706|NCT05028517|589157325|FG000|Overall Study|Withdrawal by Subject|0|||
163122707|NCT05028517|589157326|FG001|Overall Study|Withdrawal by Subject|0|||
163122708|NCT05028517|589157327|FG002|Overall Study|Withdrawal by Subject|1|||
163122709|NCT04514341|589157328|FG000|Step 2 (Months 19-21)|In a 3-month delay period|0|||
163122710|NCT04514341|589157329|FG001|Step 2 (Months 19-21)|In a 3-month delay period|15725|||
163122711|NCT04514341|589157328|FG000|Step 4 (Months 31-33)|In a 3-month delay period|0|||
163122712|NCT04514341|589157329|FG001|Step 4 (Months 31-33)|In a 3-month delay period|15037|||
163122713|NCT01216683|589158226|FG000|Induction|Never started treatment|0|||
163122714|NCT01216683|589158227|FG001|Induction|Never started treatment|6|||
163122715|NCT01216683|589158228|FG002|Induction|Never started treatment|3|||
163122716|NCT01216683|589158226|FG000|Induction|Lack of Efficacy|4|||
163122717|NCT01216683|589158227|FG001|Induction|Lack of Efficacy|3|||
163122718|NCT01216683|589158228|FG002|Induction|Lack of Efficacy|7|||
163122719|NCT01216683|589158226|FG000|Induction|Adverse Event|0|||
163122720|NCT01216683|589158227|FG001|Induction|Adverse Event|5|||
163122721|NCT01216683|589158228|FG002|Induction|Adverse Event|5|||
163122722|NCT01216683|589158226|FG000|Induction|Death|0|||
163122723|NCT01216683|589158227|FG001|Induction|Death|0|||
163122724|NCT01216683|589158228|FG002|Induction|Death|2|||
163122725|NCT01216683|589158226|FG000|Induction|Withdrawal by Subject|0|||
163122726|NCT01216683|589158227|FG001|Induction|Withdrawal by Subject|4|||
163122727|NCT01216683|589158228|FG002|Induction|Withdrawal by Subject|2|||
163122728|NCT01216683|589158226|FG000|Induction|Other disease|0|||
163122729|NCT01216683|589158227|FG001|Induction|Other disease|1|||
163122730|NCT01216683|589158228|FG002|Induction|Other disease|2|||
163122731|NCT01216683|589158226|FG000|Continuation|Lack of Efficacy|3|||
163122732|NCT01216683|589158227|FG001|Continuation|Lack of Efficacy|2|||
163122733|NCT01216683|589158228|FG002|Continuation|Lack of Efficacy|7|||
163122734|NCT01216683|589158226|FG000|Continuation|Adverse Event|5|||
163122735|NCT01216683|589158227|FG001|Continuation|Adverse Event|3|||
163122736|NCT01216683|589158228|FG002|Continuation|Adverse Event|16|||
163122737|NCT01216683|589158226|FG000|Continuation|Death|1|||
163122738|NCT01216683|589158227|FG001|Continuation|Death|0|||
163122739|NCT01216683|589158228|FG002|Continuation|Death|2|||
163122740|NCT01216683|589158226|FG000|Continuation|Withdrawal by Subject|4|||
163122741|NCT01216683|589158227|FG001|Continuation|Withdrawal by Subject|5|||
163122742|NCT01216683|589158228|FG002|Continuation|Withdrawal by Subject|9|||
163122743|NCT01216683|589158226|FG000|Continuation|Other diseases|0|||
163122744|NCT01216683|589158227|FG001|Continuation|Other diseases|2|||
163122745|NCT01216683|589158228|FG002|Continuation|Other diseases|1|||
163122746|NCT01216683|589158226|FG000|Continuation|Physician Decision|1|||
163122747|NCT01216683|589158227|FG001|Continuation|Physician Decision|0|||
163122748|NCT01216683|589158228|FG002|Continuation|Physician Decision|1|||
163122749|NCT01216683|589158226|FG000|Continuation|Non-compliance|1|||
163122750|NCT01216683|589158227|FG001|Continuation|Non-compliance|0|||
163122751|NCT01216683|589158228|FG002|Continuation|Non-compliance|1|||
163122752|NCT01216683|589158226|FG000|Continuation|Insurance change|0|||
163122753|NCT01216683|589158227|FG001|Continuation|Insurance change|1|||
163122754|NCT01216683|589158228|FG002|Continuation|Insurance change|0|||
163122755|NCT01216683|589158226|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
163122756|NCT01216683|589158227|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
163122757|NCT01216683|589158228|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
163122758|NCT01216683|589158226|FG000|Continuation|Not reported|0|||
163122759|NCT01216683|589158227|FG001|Continuation|Not reported|0|||
163122760|NCT01216683|589158228|FG002|Continuation|Not reported|1|||
163122761|NCT01216683|589158226|FG000|Continuation|Never started treatment|0|||
163122762|NCT01216683|589158227|FG001|Continuation|Never started treatment|1|||
163122763|NCT01216683|589158228|FG002|Continuation|Never started treatment|5|||
163122764|NCT01350115|589158229|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
163122765|NCT01350115|589158230|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
163122766|NCT01350115|589158229|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
163122767|NCT01350115|589158230|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
163122768|NCT01350115|589158229|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
163122769|NCT01350115|589158230|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
163122770|NCT04327024|589158231|FG000|Overall Study|Death|1|||
163122771|NCT04327024|589158232|FG001|Overall Study|Death|2|||
163122772|NCT04327024|589158233|FG002|Overall Study|Death|1|||
163122773|NCT04327024|589158231|FG000|Overall Study|Non-compliance with study drug|0|||
163122774|NCT04327024|589158232|FG001|Overall Study|Non-compliance with study drug|1|||
163122775|NCT04327024|589158233|FG002|Overall Study|Non-compliance with study drug|0|||
163122776|NCT04327024|589158231|FG000|Overall Study|Withdrawal by Subject|1|||
163122777|NCT04327024|589158232|FG001|Overall Study|Withdrawal by Subject|1|||
163122778|NCT04327024|589158233|FG002|Overall Study|Withdrawal by Subject|2|||
163122779|NCT03968159|589158235|FG000|Overall Study|Adverse Event|4|||
163122780|NCT03968159|589158236|FG001|Overall Study|Adverse Event|4|||
163122781|NCT03968159|589158235|FG000|Overall Study|Lost to Follow-up|1|||
163122782|NCT03968159|589158236|FG001|Overall Study|Lost to Follow-up|1|||
163122783|NCT03968159|589158235|FG000|Overall Study|Use of prohibited medication|0|||
163122784|NCT03968159|589158236|FG001|Overall Study|Use of prohibited medication|1|||
163122785|NCT03968159|589158235|FG000|Overall Study|Protocol Violation|2|||
163122786|NCT03968159|589158236|FG001|Overall Study|Protocol Violation|2|||
163122787|NCT03968159|589158235|FG000|Overall Study|Withdrawal by Subject|4|||
163122788|NCT03968159|589158236|FG001|Overall Study|Withdrawal by Subject|6|||
163122789|NCT03968159|589158235|FG000|Overall Study|Lack of Efficacy|0|||
163122790|NCT03968159|589158236|FG001|Overall Study|Lack of Efficacy|1|||
163122791|NCT03968159|589158235|FG000|Overall Study|Not further specified|2|||
163122792|NCT03968159|589158236|FG001|Overall Study|Not further specified|0|||
163122793|NCT00864851|589158237|FG000|Overall Study|Withdrawal by Subject|0|||
163122794|NCT00864851|589158238|FG001|Overall Study|Withdrawal by Subject|1|||
163122795|NCT00864851|589158239|FG002|Overall Study|Withdrawal by Subject|0|||
163122796|NCT00864851|589158237|FG000|Overall Study|Physician Decision|1|||
163122797|NCT00864851|589158238|FG001|Overall Study|Physician Decision|0|||
163122798|NCT00864851|589158239|FG002|Overall Study|Physician Decision|0|||
163122799|NCT00864851|589158237|FG000|Overall Study|Death|1|||
163122800|NCT00864851|589158238|FG001|Overall Study|Death|0|||
163122801|NCT00864851|589158239|FG002|Overall Study|Death|0|||
163122802|NCT00864851|589158237|FG000|Overall Study|Patient uncooperative|1|||
163122803|NCT00864851|589158238|FG001|Overall Study|Patient uncooperative|0|||
163122804|NCT00864851|589158239|FG002|Overall Study|Patient uncooperative|0|||
163122805|NCT00443781|589158240|FG000|Overall Study|Lost to Follow-up|10|||
163122806|NCT00443781|589158240|FG000|Overall Study|Physician Decision|2|||
163122807|NCT00443781|589158240|FG000|Overall Study|Protocol Violation|1|||
163122808|NCT00443781|589158240|FG000|Overall Study|Withdrawal by Subject|6|||
163122809|NCT00443781|589158240|FG000|Overall Study|Unable to comply with study follow up|2|||
163122810|NCT00443781|589158240|FG000|Overall Study|Investigator terminated participation|1|||
163122811|NCT00443781|589158240|FG000|Overall Study|Insurance not covered|2|||
163122812|NCT00443781|589158240|FG000|Overall Study|PD/FAD not done|1|||
163122813|NCT00430937|589158241|FG000|Overall Study|Adverse Event|3|||
163122814|NCT00430937|589158242|FG001|Overall Study|Adverse Event|8|||
163122815|NCT00430937|589158241|FG000|Overall Study|Death|0|||
163122816|NCT00430937|589158242|FG001|Overall Study|Death|1|||
163122817|NCT00430937|589158241|FG000|Overall Study|Lost to Follow-up|6|||
163122818|NCT00430937|589158242|FG001|Overall Study|Lost to Follow-up|6|||
163122819|NCT00430937|589158241|FG000|Overall Study|Withdrawal by Subject|5|||
163122820|NCT00430937|589158242|FG001|Overall Study|Withdrawal by Subject|2|||
163122821|NCT00430937|589158241|FG000|Overall Study|Protocol Violation|3|||
163122822|NCT00430937|589158242|FG001|Overall Study|Protocol Violation|2|||
163122823|NCT00430937|589158241|FG000|Overall Study|Lack of Efficacy|6|||
163122824|NCT00430937|589158242|FG001|Overall Study|Lack of Efficacy|5|||
163122825|NCT00430937|589158241|FG000|Overall Study|Inappropriate enrollment|2|||
163122826|NCT00430937|589158242|FG001|Overall Study|Inappropriate enrollment|1|||
163122827|NCT00430937|589158241|FG000|Overall Study|Administrative reasons|1|||
163122828|NCT00430937|589158242|FG001|Overall Study|Administrative reasons|0|||
163122829|NCT00430937|589158241|FG000|Overall Study|Protocol discontinuation criteria met|1|||
163122830|NCT00430937|589158242|FG001|Overall Study|Protocol discontinuation criteria met|2|||
163122831|NCT00430937|589158241|FG000|Overall Study|Unable to classify|0|||
163122832|NCT00430937|589158242|FG001|Overall Study|Unable to classify|1|||
163122833|NCT01533922|589158243|FG000|Overall Study|Adverse Event|5|||
163122834|NCT01533922|589158244|FG001|Overall Study|Adverse Event|8|||
163122835|NCT01533922|589158245|FG002|Overall Study|Adverse Event|6|||
163122836|NCT01533922|589158246|FG003|Overall Study|Adverse Event|3|||
163122837|NCT01533922|589158247|FG004|Overall Study|Adverse Event|4|||
163122838|NCT01533922|589158243|FG000|Overall Study|Lack of Efficacy|0|||
163122839|NCT01533922|589158244|FG001|Overall Study|Lack of Efficacy|0|||
163122840|NCT01533922|589158245|FG002|Overall Study|Lack of Efficacy|1|||
163122841|NCT01533922|589158246|FG003|Overall Study|Lack of Efficacy|0|||
163122842|NCT01533922|589158247|FG004|Overall Study|Lack of Efficacy|0|||
163122843|NCT01533922|589158243|FG000|Overall Study|Protocol Violation|0|||
163122844|NCT01533922|589158244|FG001|Overall Study|Protocol Violation|3|||
163122845|NCT01533922|589158245|FG002|Overall Study|Protocol Violation|0|||
163122846|NCT01533922|589158246|FG003|Overall Study|Protocol Violation|0|||
163122847|NCT01533922|589158247|FG004|Overall Study|Protocol Violation|1|||
163122848|NCT01533922|589158243|FG000|Overall Study|Withdrawal by Subject|3|||
163122849|NCT01533922|589158244|FG001|Overall Study|Withdrawal by Subject|1|||
163122850|NCT01533922|589158245|FG002|Overall Study|Withdrawal by Subject|2|||
163122851|NCT01533922|589158246|FG003|Overall Study|Withdrawal by Subject|2|||
163122852|NCT01533922|589158247|FG004|Overall Study|Withdrawal by Subject|1|||
163122853|NCT01533922|589158243|FG000|Overall Study|Other reason not defined above|2|||
163122854|NCT01533922|589158244|FG001|Overall Study|Other reason not defined above|0|||
163122855|NCT01533922|589158245|FG002|Overall Study|Other reason not defined above|1|||
163122856|NCT01533922|589158246|FG003|Overall Study|Other reason not defined above|0|||
163122857|NCT01533922|589158247|FG004|Overall Study|Other reason not defined above|0|||
163122858|NCT00895661|589158250|FG000|Overall Study|Death|1|||
163122859|NCT00895661|589158250|FG000|Overall Study|reason unknown|2|||
163122860|NCT02006069|589158251|FG000|Overall Study|MPP other programming|239|||
163122861|NCT02006069|589158252|FG001|Overall Study|MPP other programming|0|||
163122862|NCT02006069|589158251|FG000|Overall Study|RV only pacing|0|||
163122863|NCT02006069|589158252|FG001|Overall Study|RV only pacing|3|||
163122864|NCT02989805|589158255|FG000|Overall Study|invalid consent|6|||
163122865|NCT02989805|589158256|FG001|Overall Study|invalid consent|4|||
163122866|NCT02776033|589158257|FG000|Overall Study|Withdrawal by Subject|0|||
163122867|NCT02776033|589158258|FG001|Overall Study|Withdrawal by Subject|0|||
163122868|NCT02776033|589158259|FG002|Overall Study|Withdrawal by Subject|2|||
163122869|NCT02776033|589158257|FG000|Overall Study|Physician Decision|2|||
163122870|NCT02776033|589158258|FG001|Overall Study|Physician Decision|0|||
163122871|NCT02776033|589158259|FG002|Overall Study|Physician Decision|0|||
163122872|NCT02776033|589158257|FG000|Overall Study|Lost to Follow-up|1|||
163122873|NCT02776033|589158258|FG001|Overall Study|Lost to Follow-up|0|||
163122874|NCT02776033|589158259|FG002|Overall Study|Lost to Follow-up|0|||
163122875|NCT02776033|589158257|FG000|Overall Study|Adverse Event|1|||
163122876|NCT02776033|589158258|FG001|Overall Study|Adverse Event|2|||
163122877|NCT02776033|589158259|FG002|Overall Study|Adverse Event|0|||
163122878|NCT00685373|589158260|FG000|Overall Study|Adverse Event|3|||
163122879|NCT00685373|589158260|FG000|Overall Study|Withdrawal by Subject|5|||
163122880|NCT00685373|589158260|FG000|Overall Study|Lack of Efficacy|3|||
163122881|NCT00685373|589158260|FG000|Overall Study|Condition no longer requires study drug|1|||
163122882|NCT00685373|589158260|FG000|Overall Study|Lost to Follow-up|2|||
163122883|NCT00685373|589158260|FG000|Overall Study|Protocol Violation|1|||
163122884|NCT01302054|589158261|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
163122885|NCT01302054|589158262|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
163122886|NCT01302054|589158263|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
163122887|NCT01302054|589158261|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
163122888|NCT01302054|589158262|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
163122889|NCT01302054|589158263|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
163122890|NCT01302054|589158261|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
163122891|NCT01302054|589158262|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
163122892|NCT01302054|589158263|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
163122893|NCT01302054|589158261|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
163122894|NCT01302054|589158262|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
163122895|NCT01302054|589158263|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
163122896|NCT01302054|589158261|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
163122897|NCT01302054|589158262|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
163122898|NCT01302054|589158263|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
163122899|NCT01302054|589158261|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
163122900|NCT01302054|589158262|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
163122901|NCT01302054|589158263|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
163122902|NCT01302054|589158261|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
163122903|NCT01302054|589158262|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
163122904|NCT01302054|589158263|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
163122905|NCT01302054|589158261|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
163122906|NCT01302054|589158262|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
163122907|NCT01302054|589158263|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
163122908|NCT01302054|589158261|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
163122909|NCT01302054|589158262|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
163122910|NCT01302054|589158263|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
163122911|NCT01302054|589158261|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
163122912|NCT01302054|589158262|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
163122913|NCT01302054|589158263|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
163122914|NCT01302054|589158261|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
163122915|NCT01302054|589158262|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
163122916|NCT01302054|589158263|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
163122917|NCT01302054|589158261|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
163122918|NCT01302054|589158262|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
163122919|NCT01302054|589158263|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
163122920|NCT01302054|589158261|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
163122921|NCT01302054|589158262|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
163122922|NCT01302054|589158263|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
163122923|NCT01302054|589158261|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
163122924|NCT01302054|589158262|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
163122925|NCT01302054|589158263|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
163122926|NCT01302054|589158261|FG000|Double-Blind Treatment Phase|Other|0|||
163122927|NCT01302054|589158262|FG001|Double-Blind Treatment Phase|Other|4|||
163122928|NCT01302054|589158263|FG002|Double-Blind Treatment Phase|Other|9|||
163122929|NCT02639338|589158264|FG000|Overall Study|Lost to Follow-up|2|||
163122930|NCT02639338|589158265|FG001|Overall Study|Lost to Follow-up|2|||
163122931|NCT02639338|589158264|FG000|Overall Study|Withdrew Consent|1|||
163122932|NCT02639338|589158265|FG001|Overall Study|Withdrew Consent|2|||
163122933|NCT02639338|589158264|FG000|Overall Study|Death|1|||
163122934|NCT02639338|589158265|FG001|Overall Study|Death|0|||
163122935|NCT02639338|589158264|FG000|Overall Study|Randomized but Not Treated|0|||
163122936|NCT02639338|589158265|FG001|Overall Study|Randomized but Not Treated|1|||
163122937|NCT02725593|589158271|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
163122938|NCT02725593|589158272|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
163122939|NCT02725593|589158271|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
163122940|NCT02725593|589158272|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
163122941|NCT02725593|589158271|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
163122942|NCT02725593|589158272|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
163122943|NCT02725593|589158271|FG000|Long Term Extension|Withdrawal by Subject|1|||
163122944|NCT02725593|589158272|FG001|Long Term Extension|Withdrawal by Subject|3|||
163122945|NCT03689244|589158273|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
163122946|NCT03689244|589158274|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
163122947|NCT03689244|589158275|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
163122948|NCT03689244|589158276|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
163122949|NCT03689244|589158273|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
163122950|NCT03689244|589158274|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
163122951|NCT03689244|589158275|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
163122952|NCT03689244|589158276|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
163122953|NCT03689244|589158273|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
163122954|NCT03689244|589158274|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
163122955|NCT03689244|589158275|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
163122956|NCT03689244|589158276|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
163122957|NCT03689244|589158273|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
163122958|NCT03689244|589158274|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
163122959|NCT03689244|589158275|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
163122960|NCT03689244|589158276|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
163122961|NCT03689244|589158273|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
163122962|NCT03689244|589158274|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
163122963|NCT03689244|589158275|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
163122964|NCT03689244|589158276|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
163122965|NCT03689244|589158273|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
163122966|NCT03689244|589158274|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
163122967|NCT03689244|589158275|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
163122968|NCT03689244|589158276|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
163122969|NCT03689244|589158273|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
163122970|NCT03689244|589158274|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
163122971|NCT03689244|589158275|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
163122972|NCT03689244|589158276|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
163122973|NCT03689244|589158273|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
163122974|NCT03689244|589158274|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
163122975|NCT03689244|589158275|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
163122976|NCT03689244|589158276|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
163341405|NCT00636168|589958223|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
163122977|NCT00444067|589158281|FG000|Overall Study|Lost to Follow-up|0|||
163225100|NCT02036502|589540088|FG001|Part 1:Dose Determination/Escalation|Death|2|||
163341406|NCT00636168|589958224|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
163122978|NCT00444067|589158282|FG001|Overall Study|Lost to Follow-up|1|||
163122979|NCT00267150|589158285|FG000|Overall Study|Adverse Event|1|||
163122980|NCT00969436|589158290|FG000|Overall Study|Protocol Violation|1|||
163122981|NCT00969436|589158291|FG001|Overall Study|Protocol Violation|3|||
163122982|NCT00969436|589158292|FG002|Overall Study|Protocol Violation|0|||
163122983|NCT00969436|589158290|FG000|Overall Study|Migrated/moved from study area|12|||
163122984|NCT00969436|589158291|FG001|Overall Study|Migrated/moved from study area|10|||
163122985|NCT00969436|589158292|FG002|Overall Study|Migrated/moved from study area|2|||
163122986|NCT00969436|589158290|FG000|Overall Study|Father - serious health problem|0|||
163122987|NCT00969436|589158291|FG001|Overall Study|Father - serious health problem|0|||
163122988|NCT00969436|589158292|FG002|Overall Study|Father - serious health problem|1|||
163122989|NCT00969436|589158290|FG000|Overall Study|Parents personal problem|0|||
163122990|NCT00969436|589158291|FG001|Overall Study|Parents personal problem|0|||
163122991|NCT00969436|589158292|FG002|Overall Study|Parents personal problem|1|||
163122992|NCT00969436|589158290|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
163122993|NCT00969436|589158291|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
163122994|NCT00969436|589158292|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
163122995|NCT00969436|589158290|FG000|Overall Study|Withdrawal by Subject|3|||
163122996|NCT00969436|589158291|FG001|Overall Study|Withdrawal by Subject|0|||
163122997|NCT00969436|589158292|FG002|Overall Study|Withdrawal by Subject|2|||
163122998|NCT00969436|589158290|FG000|Overall Study|Lost to Follow-up|8|||
163122999|NCT00969436|589158291|FG001|Overall Study|Lost to Follow-up|8|||
163123000|NCT00969436|589158292|FG002|Overall Study|Lost to Follow-up|5|||
163123001|NCT00351273|589158293|FG000|Overall Study|Lost to Follow-up|1|||
163123002|NCT00351273|589158294|FG001|Overall Study|Lost to Follow-up|2|||
163123003|NCT00351273|589158295|FG002|Overall Study|Lost to Follow-up|5|||
163123004|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
163123005|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
163123006|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
163123007|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
163123008|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
163123009|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
163123010|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
163123011|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
163123012|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
163123013|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
163123014|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
163123015|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
163123016|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
163123017|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
163123018|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
163123019|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
163123020|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
163123021|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
163123022|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
163123023|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
163123024|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
163123025|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
163123026|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
163123027|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
163123028|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
163123029|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
163123030|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
163123031|NCT01672866|589158296|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
163123032|NCT01672866|589158297|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
163123033|NCT01672866|589158298|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
163123034|NCT01672866|589158296|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
163123035|NCT01672866|589158297|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
163123036|NCT01672866|589158298|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
163123037|NCT01672866|589158296|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
163225101|NCT02036502|589540089|FG002|Part 1:Dose Determination/Escalation|Death|0|||
163225102|NCT02036502|589540090|FG003|Part 1:Dose Determination/Escalation|Death|0|||
163123038|NCT01672866|589158297|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
163123039|NCT01672866|589158298|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
163123040|NCT01672866|589158296|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
163123041|NCT01672866|589158297|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
163123042|NCT01672866|589158298|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
163123043|NCT02544373|589158305|FG000|Overall Study|Lost to Follow-up|5|||
163123044|NCT02544373|589158306|FG001|Overall Study|Lost to Follow-up|3|||
163225103|NCT02036502|589540091|FG004|Part 1:Dose Determination/Escalation|Death|0|||
163123045|NCT02544373|589158305|FG000|Overall Study|Withdrawal by Subject|8|||
163123046|NCT02544373|589158306|FG001|Overall Study|Withdrawal by Subject|2|||
163123047|NCT04208087|589158308|FG000|Overall Study|Adverse Event|1|||
163123048|NCT04208087|589158309|FG001|Overall Study|Adverse Event|0|||
163123049|NCT04208087|589158310|FG002|Overall Study|Adverse Event|0|||
163123050|NCT04208087|589158311|FG003|Overall Study|Adverse Event|0|||
163123051|NCT04208087|589158312|FG004|Overall Study|Adverse Event|0|||
163123052|NCT04208087|589158308|FG000|Overall Study|Withdrawal by Subject|0|||
163123053|NCT04208087|589158309|FG001|Overall Study|Withdrawal by Subject|0|||
163123054|NCT04208087|589158310|FG002|Overall Study|Withdrawal by Subject|1|||
163123055|NCT04208087|589158311|FG003|Overall Study|Withdrawal by Subject|0|||
163123056|NCT04208087|589158312|FG004|Overall Study|Withdrawal by Subject|0|||
163123057|NCT04208087|589158308|FG000|Overall Study|Other|0|||
163123058|NCT04208087|589158309|FG001|Overall Study|Other|0|||
163123059|NCT04208087|589158310|FG002|Overall Study|Other|0|||
163123060|NCT04208087|589158311|FG003|Overall Study|Other|0|||
163123061|NCT04208087|589158312|FG004|Overall Study|Other|1|||
163123062|NCT01198509|589158313|FG000|Overall Study|Withdrawal by Subject|1|||
163123063|NCT01198509|589158314|FG001|Overall Study|Withdrawal by Subject|0|||
163123064|NCT01198509|589158315|FG002|Overall Study|Withdrawal by Subject|0|||
163123065|NCT01198509|589158316|FG003|Overall Study|Withdrawal by Subject|0|||
163123066|NCT01198509|589158317|FG004|Overall Study|Withdrawal by Subject|0|||
163123067|NCT01198509|589158318|FG005|Overall Study|Withdrawal by Subject|0|||
163123068|NCT02621073|589158328|FG000|Overall Study|Lost to Follow-up|0|||
163123069|NCT02621073|589158329|FG001|Overall Study|Lost to Follow-up|1|||
163123070|NCT02621073|589158328|FG000|Overall Study|Physician Decision|3|||
163123071|NCT02621073|589158329|FG001|Overall Study|Physician Decision|2|||
163123072|NCT01595581|589158330|FG000|Overall Study|Withdrawal by Subject|1|||
163123073|NCT01595581|589158331|FG001|Overall Study|Withdrawal by Subject|0|||
163123074|NCT01969721|589158332|FG000|Overall Study|Adverse Event|3|||
163123075|NCT01969721|589158333|FG001|Overall Study|Adverse Event|8|||
163123076|NCT01969721|589158334|FG002|Overall Study|Adverse Event|3|||
163123077|NCT01969721|589158335|FG003|Overall Study|Adverse Event|2|||
163123078|NCT01969721|589158332|FG000|Overall Study|Lack of Efficacy|0|||
163123079|NCT01969721|589158333|FG001|Overall Study|Lack of Efficacy|0|||
163123080|NCT01969721|589158334|FG002|Overall Study|Lack of Efficacy|1|||
163123081|NCT01969721|589158335|FG003|Overall Study|Lack of Efficacy|0|||
163123082|NCT01969721|589158332|FG000|Overall Study|Non compliant with protocol|1|||
163123083|NCT01969721|589158333|FG001|Overall Study|Non compliant with protocol|1|||
163123084|NCT01969721|589158334|FG002|Overall Study|Non compliant with protocol|0|||
163123085|NCT01969721|589158335|FG003|Overall Study|Non compliant with protocol|2|||
163123086|NCT01969721|589158332|FG000|Overall Study|Other not defined above|0|||
163123087|NCT01969721|589158333|FG001|Overall Study|Other not defined above|2|||
163123088|NCT01969721|589158334|FG002|Overall Study|Other not defined above|0|||
163123089|NCT01969721|589158335|FG003|Overall Study|Other not defined above|0|||
163123090|NCT01969721|589158332|FG000|Overall Study|Discontinued during washout periods.|0|||
163123091|NCT01969721|589158333|FG001|Overall Study|Discontinued during washout periods.|1|||
163123092|NCT01969721|589158334|FG002|Overall Study|Discontinued during washout periods.|1|||
163123093|NCT01969721|589158335|FG003|Overall Study|Discontinued during washout periods.|2|||
163123094|NCT02920957|589158339|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
163123095|NCT02920957|589158340|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
163123096|NCT02920957|589158339|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
163123097|NCT02920957|589158340|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
163123098|NCT02920957|589158339|FG000|First Intervention : 1 Month|Adverse Event|1|||
163123099|NCT02920957|589158340|FG001|First Intervention : 1 Month|Adverse Event|0|||
163123100|NCT02920957|589158339|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
163123101|NCT02920957|589158340|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
163123102|NCT01789606|589158341|FG000|Overall Study|Participant not Purchased the Product|0|||
163123103|NCT01789606|589158342|FG001|Overall Study|Participant not Purchased the Product|20|||
163123104|NCT01789606|589158341|FG000|Overall Study|Withdrawal by Subject|0|||
163123105|NCT01789606|589158342|FG001|Overall Study|Withdrawal by Subject|1|||
163123106|NCT01789606|589158341|FG000|Overall Study|Ineligible|6|||
163341407|NCT00636168|589958223|FG000|Treated With Study Drug|Recurrence of disease|135|||
163341408|NCT00636168|589958224|FG001|Treated With Study Drug|Recurrence of disease|282|||
163123107|NCT01789606|589158342|FG001|Overall Study|Ineligible|2|||
163123108|NCT01789606|589158341|FG000|Overall Study|Administrative Reasons|17|||
163123109|NCT01789606|589158342|FG001|Overall Study|Administrative Reasons|6|||
163123110|NCT01789606|589158341|FG000|Overall Study|No Study Medication Taken|0|||
163123111|NCT01789606|589158342|FG001|Overall Study|No Study Medication Taken|1|||
163123112|NCT01789606|589158341|FG000|Overall Study|Protocol Violation|0|||
163123113|NCT01789606|589158342|FG001|Overall Study|Protocol Violation|55|||
163123114|NCT01789606|589158341|FG000|Overall Study|Adverse Event|0|||
163123115|NCT01789606|589158342|FG001|Overall Study|Adverse Event|3|||
163341409|NCT00636168|589958223|FG000|Treated With Study Drug|Adverse Event|250|||
163123116|NCT01789606|589158341|FG000|Overall Study|Lost to Follow-up|0|||
163341410|NCT00636168|589958224|FG001|Treated With Study Drug|Adverse Event|22|||
163225104|NCT02036502|589540092|FG005|Part 1:Dose Determination/Escalation|Death|0|||
163225105|NCT02036502|589540093|FG006|Part 1:Dose Determination/Escalation|Death|0|||
163225106|NCT02036502|589540094|FG007|Part 1:Dose Determination/Escalation|Death|0|||
163225107|NCT02036502|589540087|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
163225108|NCT02036502|589540088|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
163225109|NCT02036502|589540089|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
163225110|NCT02036502|589540090|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
163225111|NCT02036502|589540091|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
163225112|NCT02036502|589540092|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
163225113|NCT02036502|589540093|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
163225114|NCT02036502|589540094|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
163225115|NCT02036502|589540087|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
163225116|NCT02036502|589540088|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
163225117|NCT02036502|589540089|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
163225118|NCT02036502|589540090|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
163225119|NCT02036502|589540091|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
163225120|NCT02036502|589540092|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
163225121|NCT02036502|589540093|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
163225122|NCT02036502|589540094|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
163225123|NCT02036502|589540087|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
163225124|NCT02036502|589540088|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
163225125|NCT02036502|589540089|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
163225126|NCT02036502|589540090|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
163225127|NCT02036502|589540091|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
163225128|NCT02036502|589540092|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
163225129|NCT02036502|589540093|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
163225130|NCT02036502|589540094|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
163225131|NCT02036502|589540087|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
163225132|NCT02036502|589540088|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
163225133|NCT02036502|589540089|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
163225134|NCT02036502|589540090|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
163225135|NCT02036502|589540091|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
163225136|NCT02036502|589540092|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
163225137|NCT02036502|589540093|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
163225138|NCT02036502|589540094|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
163225139|NCT02036502|589540087|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
163225140|NCT02036502|589540088|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
163225141|NCT02036502|589540089|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
163225142|NCT02036502|589540090|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
163225143|NCT02036502|589540091|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
163225144|NCT02036502|589540092|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
163225145|NCT02036502|589540093|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
163225146|NCT02036502|589540094|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
163225147|NCT02036502|589540087|FG000|Part 2:Dose Confirmation|Death|0|||
163225148|NCT02036502|589540088|FG001|Part 2:Dose Confirmation|Death|0|||
163225149|NCT02036502|589540089|FG002|Part 2:Dose Confirmation|Death|1|||
163225150|NCT02036502|589540090|FG003|Part 2:Dose Confirmation|Death|0|||
163225151|NCT02036502|589540091|FG004|Part 2:Dose Confirmation|Death|0|||
163225152|NCT02036502|589540092|FG005|Part 2:Dose Confirmation|Death|0|||
163225153|NCT02036502|589540093|FG006|Part 2:Dose Confirmation|Death|0|||
163225154|NCT02036502|589540094|FG007|Part 2:Dose Confirmation|Death|0|||
163225155|NCT02036502|589540087|FG000|Part 2:Dose Confirmation|Not treated|0|||
163225156|NCT02036502|589540088|FG001|Part 2:Dose Confirmation|Not treated|0|||
163225157|NCT02036502|589540089|FG002|Part 2:Dose Confirmation|Not treated|0|||
163225158|NCT02036502|589540090|FG003|Part 2:Dose Confirmation|Not treated|1|||
163225159|NCT02036502|589540091|FG004|Part 2:Dose Confirmation|Not treated|0|||
163225160|NCT02036502|589540092|FG005|Part 2:Dose Confirmation|Not treated|0|||
163225161|NCT02036502|589540093|FG006|Part 2:Dose Confirmation|Not treated|0|||
163225162|NCT02036502|589540094|FG007|Part 2:Dose Confirmation|Not treated|0|||
163225163|NCT02036502|589540087|FG000|Part 3:Dose Expansion|Adverse Event|0|||
163225164|NCT02036502|589540088|FG001|Part 3:Dose Expansion|Adverse Event|0|||
163225165|NCT02036502|589540089|FG002|Part 3:Dose Expansion|Adverse Event|0|||
163225166|NCT02036502|589540090|FG003|Part 3:Dose Expansion|Adverse Event|0|||
163225167|NCT02036502|589540091|FG004|Part 3:Dose Expansion|Adverse Event|0|||
163225168|NCT02036502|589540092|FG005|Part 3:Dose Expansion|Adverse Event|4|||
163225169|NCT02036502|589540093|FG006|Part 3:Dose Expansion|Adverse Event|0|||
163225170|NCT02036502|589540094|FG007|Part 3:Dose Expansion|Adverse Event|2|||
163225171|NCT02036502|589540087|FG000|Part 3:Dose Expansion|Death|0|||
163225172|NCT02036502|589540088|FG001|Part 3:Dose Expansion|Death|0|||
163225173|NCT02036502|589540089|FG002|Part 3:Dose Expansion|Death|0|||
163123117|NCT01789606|589158342|FG001|Overall Study|Lost to Follow-up|14|||
163123118|NCT01789606|589158341|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
163123119|NCT01789606|589158342|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
163123120|NCT03180307|589158345|FG000|Overall Study|Lost to Follow-up|2|||
163123121|NCT03180307|589158346|FG001|Overall Study|Lost to Follow-up|0|||
163123122|NCT03180307|589158345|FG000|Overall Study|Death|1|||
163123123|NCT03180307|589158346|FG001|Overall Study|Death|0|||
163123124|NCT03180307|589158345|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
163123125|NCT03180307|589158346|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
163123126|NCT03159104|589158347|FG000|Overall Study|Violation of inclusion criteria|1|||
163123127|NCT03159104|589158348|FG001|Overall Study|Violation of inclusion criteria|2|||
163123128|NCT01563172|589158352|FG000|Overall Study|Adverse Event|5|||
163123129|NCT01563172|589158352|FG000|Overall Study|Lost to Follow-up|2|||
163123130|NCT01563172|589158352|FG000|Overall Study|Other (Protocol deviation)|5|||
163123131|NCT01563172|589158352|FG000|Overall Study|Other (Not specified)|1|||
163123132|NCT00837759|589160236|FG000|Overall Study|Protocol Violation|3|||
163123133|NCT00837759|589160236|FG000|Overall Study|Lost to Follow-up|1|||
163123134|NCT01597635|589160237|FG000|Part A|Adverse Event|3|||
163123135|NCT01597635|589160238|FG001|Part A|Adverse Event|0|||
163123136|NCT01597635|589160239|FG002|Part A|Adverse Event|0|||
163123137|NCT01597635|589160237|FG000|Part B|Adverse Event|0|||
163123138|NCT01597635|589160238|FG001|Part B|Adverse Event|0|||
163123139|NCT01597635|589160239|FG002|Part B|Adverse Event|1|||
163123140|NCT01597635|589160237|FG000|Part B|Protocol Violation|0|||
163123141|NCT01597635|589160238|FG001|Part B|Protocol Violation|1|||
163123142|NCT01597635|589160239|FG002|Part B|Protocol Violation|0|||
163123143|NCT01597635|589160237|FG000|Part B|Protocol-defined stopping criteria|0|||
163123144|NCT01597635|589160238|FG001|Part B|Protocol-defined stopping criteria|4|||
163123145|NCT01597635|589160239|FG002|Part B|Protocol-defined stopping criteria|3|||
163123146|NCT01597635|589160237|FG000|Part B|Withdrawal by Subject|0|||
163123147|NCT01597635|589160238|FG001|Part B|Withdrawal by Subject|1|||
163123148|NCT01597635|589160239|FG002|Part B|Withdrawal by Subject|0|||
163123149|NCT01267175|589160241|FG000|Overall Study|Withdrawal by Subject|1|||
163123150|NCT01267175|589160241|FG000|Overall Study|Lost to Follow-up|1|||
163123151|NCT02066129|589160242|FG000|Overall Study|Lost to Follow-up|13|||
163123152|NCT02066129|589160243|FG001|Overall Study|Lost to Follow-up|12|||
163123153|NCT02066129|589160242|FG000|Overall Study|Withdrawal by Subject|7|||
163123154|NCT02066129|589160243|FG001|Overall Study|Withdrawal by Subject|10|||
163123155|NCT02066129|589160242|FG000|Overall Study|Lack of Efficacy|8|||
163123156|NCT02066129|589160243|FG001|Overall Study|Lack of Efficacy|10|||
163123157|NCT02066129|589160242|FG000|Overall Study|Physician Decision|1|||
163123158|NCT02066129|589160243|FG001|Overall Study|Physician Decision|1|||
163123159|NCT02616393|589160244|FG000|Overall Study|Death|5|||
163123160|NCT02616393|589160245|FG001|Overall Study|Death|12|||
163123161|NCT02616393|589160246|FG002|Overall Study|Death|1|||
163123162|NCT02616393|589160244|FG000|Overall Study|Termination by Sponsor|4|||
163123163|NCT02616393|589160245|FG001|Overall Study|Termination by Sponsor|5|||
163123164|NCT02616393|589160246|FG002|Overall Study|Termination by Sponsor|2|||
163123165|NCT02616393|589160244|FG000|Overall Study|Other|3|||
163123166|NCT02616393|589160245|FG001|Overall Study|Other|0|||
163123167|NCT02616393|589160246|FG002|Overall Study|Other|0|||
163123168|NCT02616393|589160244|FG000|Overall Study|Withdrawal by Subject|1|||
163123169|NCT02616393|589160245|FG001|Overall Study|Withdrawal by Subject|1|||
163123170|NCT02616393|589160246|FG002|Overall Study|Withdrawal by Subject|0|||
163341411|NCT00636168|589958223|FG000|Treated With Study Drug|Participant withdrew consent|16|||
163123171|NCT02616393|589160244|FG000|Overall Study|Lost to Follow-up|0|||
163123172|NCT02616393|589160245|FG001|Overall Study|Lost to Follow-up|2|||
163123173|NCT02616393|589160246|FG002|Overall Study|Lost to Follow-up|0|||
163123174|NCT02642965|589160247|FG000|Overall Study|Lack of Efficacy|4|||
163123175|NCT02642965|589160247|FG000|Overall Study|Physician Decision|9|||
163123176|NCT02713867|589160254|FG000|Randomization|Other Reason|2|||
163123177|NCT02713867|589160255|FG001|Randomization|Other Reason|1|||
163123178|NCT02713867|589160254|FG000|Randomization|Participant Withdrew consent|0|||
163341412|NCT00636168|589958224|FG001|Treated With Study Drug|Participant withdrew consent|21|||
163123179|NCT02713867|589160255|FG001|Randomization|Participant Withdrew consent|2|||
163123180|NCT02713867|589160254|FG000|Treatment Period|Other Reasons|22|||
163123181|NCT02713867|589160255|FG001|Treatment Period|Other Reasons|28|||
163123182|NCT02713867|589160254|FG000|Treatment Period|Administrative reason by sponsor|21|||
163123183|NCT02713867|589160255|FG001|Treatment Period|Administrative reason by sponsor|16|||
163123184|NCT02713867|589160254|FG000|Treatment Period|No longer meets study criteria|2|||
163123185|NCT02713867|589160255|FG001|Treatment Period|No longer meets study criteria|1|||
163123186|NCT02713867|589160254|FG000|Treatment Period|Poor/Non Compliance|1|||
163123187|NCT02713867|589160255|FG001|Treatment Period|Poor/Non Compliance|0|||
163123188|NCT02713867|589160254|FG000|Treatment Period|Maximum Clinical Benefit|5|||
163123189|NCT02713867|589160255|FG001|Treatment Period|Maximum Clinical Benefit|6|||
163123190|NCT02713867|589160254|FG000|Treatment Period|Withdrew consent|3|||
163123191|NCT02713867|589160255|FG001|Treatment Period|Withdrew consent|6|||
163123192|NCT02713867|589160254|FG000|Treatment Period|Requested to Discontinue|8|||
163225174|NCT02036502|589540090|FG003|Part 3:Dose Expansion|Death|0|||
163225175|NCT02036502|589540091|FG004|Part 3:Dose Expansion|Death|0|||
163225176|NCT02036502|589540092|FG005|Part 3:Dose Expansion|Death|24|||
163225177|NCT02036502|589540093|FG006|Part 3:Dose Expansion|Death|0|||
163225178|NCT02036502|589540094|FG007|Part 3:Dose Expansion|Death|3|||
163225179|NCT02036502|589540087|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
163225180|NCT02036502|589540088|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
163225181|NCT02036502|589540089|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
163225182|NCT02036502|589540090|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
163225183|NCT02036502|589540091|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
163225184|NCT02036502|589540092|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
163225185|NCT02036502|589540093|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
163225186|NCT02036502|589540094|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
163225187|NCT02036502|589540087|FG000|Part 3:Dose Expansion|Physician Decision|0|||
163225188|NCT02036502|589540088|FG001|Part 3:Dose Expansion|Physician Decision|0|||
163225189|NCT02036502|589540089|FG002|Part 3:Dose Expansion|Physician Decision|0|||
163225190|NCT02036502|589540090|FG003|Part 3:Dose Expansion|Physician Decision|0|||
163225191|NCT02036502|589540091|FG004|Part 3:Dose Expansion|Physician Decision|0|||
163225192|NCT02036502|589540092|FG005|Part 3:Dose Expansion|Physician Decision|1|||
163225193|NCT02036502|589540093|FG006|Part 3:Dose Expansion|Physician Decision|0|||
163225194|NCT02036502|589540094|FG007|Part 3:Dose Expansion|Physician Decision|0|||
163225195|NCT02036502|589540087|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
163225196|NCT02036502|589540088|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
163225197|NCT02036502|589540089|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
163225198|NCT02036502|589540090|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
163225199|NCT02036502|589540091|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
163225200|NCT02036502|589540092|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
163225201|NCT02036502|589540093|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
163225202|NCT02036502|589540094|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
163225203|NCT02036502|589540087|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
163225204|NCT02036502|589540088|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
163225205|NCT02036502|589540089|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
163225206|NCT02036502|589540090|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
163225207|NCT02036502|589540091|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
163225208|NCT02036502|589540092|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
163225209|NCT02036502|589540093|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
163225210|NCT02036502|589540094|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
163225211|NCT02036502|589540087|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
163225212|NCT02036502|589540088|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
163225213|NCT02036502|589540089|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
163225214|NCT02036502|589540090|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
163225215|NCT02036502|589540091|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
163225216|NCT02036502|589540092|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
163225217|NCT02036502|589540093|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
163225218|NCT02036502|589540094|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
163225219|NCT02036502|589540087|FG000|Part 3:Dose Expansion|Not Treated|0|||
163225220|NCT02036502|589540088|FG001|Part 3:Dose Expansion|Not Treated|0|||
163225221|NCT02036502|589540089|FG002|Part 3:Dose Expansion|Not Treated|0|||
163225222|NCT02036502|589540090|FG003|Part 3:Dose Expansion|Not Treated|0|||
163225223|NCT02036502|589540091|FG004|Part 3:Dose Expansion|Not Treated|0|||
163225224|NCT02036502|589540092|FG005|Part 3:Dose Expansion|Not Treated|2|||
163225225|NCT02036502|589540093|FG006|Part 3:Dose Expansion|Not Treated|0|||
163225226|NCT02036502|589540094|FG007|Part 3:Dose Expansion|Not Treated|0|||
163225227|NCT00811577|589540100|FG000|Overall Study|Lost to Follow-up|7|||
163225228|NCT00811577|589540101|FG001|Overall Study|Lost to Follow-up|1|||
163225229|NCT00811577|589540100|FG000|Overall Study|Withdrawal by Subject|3|||
163225230|NCT00811577|589540101|FG001|Overall Study|Withdrawal by Subject|0|||
163225231|NCT04011410|589540102|FG000|Overall Study|Withdrawal by Subject|1|||
163225232|NCT01068509|589540103|FG000|Overall Study|Death|0|||
163225233|NCT01068509|589540104|FG001|Overall Study|Death|0|||
163225234|NCT01068509|589540105|FG002|Overall Study|Death|1|||
163225235|NCT01068509|589540103|FG000|Overall Study|Disease Progression|5|||
163225236|NCT01068509|589540104|FG001|Overall Study|Disease Progression|20|||
163225237|NCT01068509|589540105|FG002|Overall Study|Disease Progression|18|||
163225238|NCT01068509|589540103|FG000|Overall Study|Lost to Follow-up|1|||
163225239|NCT01068509|589540104|FG001|Overall Study|Lost to Follow-up|0|||
163225240|NCT01068509|589540105|FG002|Overall Study|Lost to Follow-up|0|||
163225241|NCT01068509|589540103|FG000|Overall Study|Withdrew Consent|0|||
163225242|NCT01068509|589540104|FG001|Overall Study|Withdrew Consent|1|||
163225243|NCT01068509|589540105|FG002|Overall Study|Withdrew Consent|2|||
163225244|NCT01068509|589540103|FG000|Overall Study|Reason Not Specified|0|||
163225245|NCT01068509|589540104|FG001|Overall Study|Reason Not Specified|1|||
163225246|NCT01068509|589540105|FG002|Overall Study|Reason Not Specified|0|||
163225247|NCT01455012|589540106|FG000|Overall Study|Adverse Event|0|||
163225248|NCT01455012|589540107|FG001|Overall Study|Adverse Event|2|||
163225249|NCT01455012|589540106|FG000|Overall Study|Lack of Efficacy|6|||
163123193|NCT02713867|589160255|FG001|Treatment Period|Requested to Discontinue|8|||
163123194|NCT02713867|589160254|FG000|Treatment Period|AE unrelated to Study Drug|11|||
163123195|NCT02713867|589160255|FG001|Treatment Period|AE unrelated to Study Drug|10|||
163123196|NCT02713867|589160254|FG000|Treatment Period|Death|7|||
163123197|NCT02713867|589160255|FG001|Treatment Period|Death|3|||
163123198|NCT02713867|589160254|FG000|Treatment Period|Study Drug Toxicity|16|||
163123199|NCT02713867|589160255|FG001|Treatment Period|Study Drug Toxicity|19|||
163123200|NCT02713867|589160254|FG000|Treatment Period|Disease Progression|82|||
163123201|NCT02713867|589160255|FG001|Treatment Period|Disease Progression|83|||
163123202|NCT00857948|589160256|FG000|Overall Study|Withdrawal by Subject|2|||
163123203|NCT00857948|589160257|FG001|Overall Study|Withdrawal by Subject|0|||
163123204|NCT00857948|589160258|FG002|Overall Study|Withdrawal by Subject|0|||
163123205|NCT00857948|589160259|FG003|Overall Study|Withdrawal by Subject|0|||
163123206|NCT00857948|589160256|FG000|Overall Study|Protocol Violation|1|||
163123207|NCT00857948|589160257|FG001|Overall Study|Protocol Violation|0|||
163123208|NCT00857948|589160258|FG002|Overall Study|Protocol Violation|1|||
163123209|NCT00857948|589160259|FG003|Overall Study|Protocol Violation|0|||
163123210|NCT04135859|589160265|FG000|Overall Study|Withdrawal by Subject|1|||
163123211|NCT04135859|589160266|FG001|Overall Study|Withdrawal by Subject|0|||
163123212|NCT04135859|589160265|FG000|Overall Study|Withdrawal due to screening failure|1|||
163123213|NCT04135859|589160266|FG001|Overall Study|Withdrawal due to screening failure|2|||
163123214|NCT04135859|589160265|FG000|Overall Study|Did not complete stress test|3|||
163123215|NCT04135859|589160266|FG001|Overall Study|Did not complete stress test|3|||
163123216|NCT04135859|589160265|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
163123217|NCT04135859|589160266|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
163123218|NCT00493636|589160267|FG000|Overall Study|Withdrawal by Subject|1|||
163123219|NCT00493636|589160268|FG001|Overall Study|Withdrawal by Subject|0|||
163123220|NCT00493636|589160267|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
163123221|NCT00493636|589160268|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
163123222|NCT00493636|589160267|FG000|Overall Study|Mis-randomization|1|||
163123223|NCT00493636|589160268|FG001|Overall Study|Mis-randomization|1|||
163123224|NCT01600053|589160271|FG000|Overall Study|Adverse Event|2|||
163123225|NCT01600053|589160271|FG000|Overall Study|trial will not meet the interim endpoint|9|||
163123226|NCT03230292|589160274|FG000|Overall Study|Adverse Event|1|||
163123227|NCT03230292|589160274|FG000|Overall Study|Protocol Violation|1|||
163123228|NCT03230292|589160274|FG000|Overall Study|Lost to Follow-up|1|||
163123229|NCT03230292|589160274|FG000|Overall Study|Withdrawal by Subject|3|||
163123230|NCT04047420|589160277|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
163123231|NCT04047420|589160277|FG000|Washout Period|Refused Participation|2|||
163123232|NCT02855944|589160278|FG000|Period 1: Treatment|Ongoing|14|||
163123233|NCT02855944|589160279|FG001|Period 1: Treatment|Ongoing|0|||
163123234|NCT02855944|589160278|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
163123235|NCT02855944|589160279|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
163123236|NCT02855944|589160278|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
163123237|NCT02855944|589160279|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
163123238|NCT03757130|589160280|FG000|Overall Study|Lost to Follow-up|0|||
163123239|NCT03757130|589160281|FG001|Overall Study|Lost to Follow-up|0|||
163123240|NCT03757130|589160282|FG002|Overall Study|Lost to Follow-up|0|||
163123241|NCT03757130|589160283|FG003|Overall Study|Lost to Follow-up|1|||
163123242|NCT03757130|589160284|FG004|Overall Study|Lost to Follow-up|0|||
163123243|NCT03757130|589160285|FG005|Overall Study|Lost to Follow-up|0|||
163123244|NCT03757130|589160286|FG006|Overall Study|Lost to Follow-up|0|||
163123245|NCT03757130|589160287|FG007|Overall Study|Lost to Follow-up|1|||
163123246|NCT03757130|589160280|FG000|Overall Study|Withdrawal by Subject|0|||
163123247|NCT03757130|589160281|FG001|Overall Study|Withdrawal by Subject|0|||
163123248|NCT03757130|589160282|FG002|Overall Study|Withdrawal by Subject|0|||
163123249|NCT03757130|589160283|FG003|Overall Study|Withdrawal by Subject|0|||
163123250|NCT03757130|589160284|FG004|Overall Study|Withdrawal by Subject|0|||
163123251|NCT03757130|589160285|FG005|Overall Study|Withdrawal by Subject|0|||
163123252|NCT03757130|589160286|FG006|Overall Study|Withdrawal by Subject|1|||
163225250|NCT01455012|589540107|FG001|Overall Study|Lack of Efficacy|1|||
163225251|NCT01455012|589540106|FG000|Overall Study|Withdrawal by Subject|3|||
163225252|NCT01455012|589540107|FG001|Overall Study|Withdrawal by Subject|1|||
163225253|NCT01455012|589540106|FG000|Overall Study|Unknown reason|2|||
163225254|NCT01455012|589540107|FG001|Overall Study|Unknown reason|0|||
163225255|NCT01418937|589540110|FG000|Overall Study|Lost to Follow-up|5|||
163123253|NCT03757130|589160287|FG007|Overall Study|Withdrawal by Subject|0|||
163123254|NCT01639755|589160288|FG000|Overall Study|Study Ongoing|15|||
163123255|NCT01639755|589160288|FG000|Overall Study|Patient had device explantation|4|||
163123256|NCT00966719|589160289|FG000|Overall Study|Lost to Follow-up|6|||
163123257|NCT00966719|589160290|FG001|Overall Study|Lost to Follow-up|11|||
163123258|NCT01439126|589160291|FG000|Overall Study|Adverse Event|2|||
163123259|NCT01439126|589160292|FG001|Overall Study|Adverse Event|0|||
163123260|NCT01439126|589160291|FG000|Overall Study|Withdrawal by Subject|5|||
163225256|NCT01418937|589540110|FG000|Overall Study|Protocol Violation|1|||
163225257|NCT01418937|589540110|FG000|Overall Study|Pregnancy|1|||
163123261|NCT01439126|589160292|FG001|Overall Study|Withdrawal by Subject|21|||
163123262|NCT01439126|589160291|FG000|Overall Study|Protocol Violation|6|||
163123263|NCT01439126|589160292|FG001|Overall Study|Protocol Violation|4|||
163123264|NCT01439126|589160291|FG000|Overall Study|Lost to Follow-up|6|||
163123265|NCT01439126|589160292|FG001|Overall Study|Lost to Follow-up|3|||
163123266|NCT01439126|589160291|FG000|Overall Study|Other-Use of prohibited treatment|0|||
163123267|NCT01439126|589160292|FG001|Overall Study|Other-Use of prohibited treatment|2|||
163123268|NCT01439126|589160291|FG000|Overall Study|Other-Miscellaneous|12|||
163123269|NCT01439126|589160292|FG001|Overall Study|Other-Miscellaneous|12|||
163123270|NCT03242018|589160294|FG000|Overall Study|Adverse Event|7|||
163123271|NCT03242018|589160295|FG001|Overall Study|Adverse Event|7|||
163123272|NCT03242018|589160296|FG002|Overall Study|Adverse Event|6|||
163123273|NCT03242018|589160294|FG000|Overall Study|Lost to Follow-up|2|||
163123274|NCT03242018|589160295|FG001|Overall Study|Lost to Follow-up|2|||
163123275|NCT03242018|589160296|FG002|Overall Study|Lost to Follow-up|2|||
163123276|NCT03242018|589160294|FG000|Overall Study|At the Participant's Own Request|5|||
163123277|NCT03242018|589160295|FG001|Overall Study|At the Participant's Own Request|1|||
163123278|NCT03242018|589160296|FG002|Overall Study|At the Participant's Own Request|4|||
163123279|NCT03242018|589160294|FG000|Overall Study|Reason Not Specified|3|||
163123280|NCT03242018|589160295|FG001|Overall Study|Reason Not Specified|4|||
163123281|NCT03242018|589160296|FG002|Overall Study|Reason Not Specified|1|||
163123282|NCT03242018|589160294|FG000|Overall Study|Study Terminated by Sponsor|1|||
163123283|NCT03242018|589160295|FG001|Overall Study|Study Terminated by Sponsor|0|||
163123284|NCT03242018|589160296|FG002|Overall Study|Study Terminated by Sponsor|1|||
163123285|NCT00160199|589160299|FG000|Overall Study|Adverse Event|5|||
163123286|NCT00160199|589160300|FG001|Overall Study|Adverse Event|14|||
163123287|NCT00160199|589160299|FG000|Overall Study|Lack of Efficacy|0|||
163123288|NCT00160199|589160300|FG001|Overall Study|Lack of Efficacy|1|||
163123289|NCT00160199|589160299|FG000|Overall Study|Lost to Follow-up|7|||
163123290|NCT00160199|589160300|FG001|Overall Study|Lost to Follow-up|7|||
163123291|NCT00160199|589160299|FG000|Overall Study|Withdrawal by Subject|4|||
163123292|NCT00160199|589160300|FG001|Overall Study|Withdrawal by Subject|6|||
163123293|NCT00160199|589160299|FG000|Overall Study|Administrative|0|||
163123294|NCT00160199|589160300|FG001|Overall Study|Administrative|1|||
163123295|NCT00160199|589160299|FG000|Overall Study|Protocol Violation|8|||
163123296|NCT00160199|589160300|FG001|Overall Study|Protocol Violation|8|||
163123297|NCT02365285|589160301|FG000|Overall Study|Physician Decision|0|||
163123298|NCT02365285|589160302|FG001|Overall Study|Physician Decision|1|||
163123299|NCT02365285|589160303|FG002|Overall Study|Physician Decision|1|||
163123300|NCT02365285|589160304|FG003|Overall Study|Physician Decision|0|||
163123301|NCT02365285|589160301|FG000|Overall Study|Adverse Event|0|||
163123302|NCT02365285|589160302|FG001|Overall Study|Adverse Event|0|||
163123303|NCT02365285|589160303|FG002|Overall Study|Adverse Event|0|||
163123304|NCT02365285|589160304|FG003|Overall Study|Adverse Event|2|||
163123305|NCT03262116|589160305|FG000|Overall Study|Physician Decision|0|||
163123306|NCT03262116|589160306|FG001|Overall Study|Physician Decision|2|||
163123307|NCT03262116|589160307|FG002|Overall Study|Physician Decision|1|||
163123308|NCT03262116|589160308|FG003|Overall Study|Physician Decision|1|||
163123309|NCT03262116|589160309|FG004|Overall Study|Physician Decision|1|||
163123310|NCT03262116|589160310|FG005|Overall Study|Physician Decision|2|||
163123311|NCT02635347|589160313|FG000|Overall Study|Failed screening|20|||
163123312|NCT02635347|589160314|FG001|Overall Study|Failed screening|7|||
163123313|NCT00635089|589160319|FG000|Overall Study|Adverse Event|7|||
163123314|NCT00635089|589160319|FG000|Overall Study|Lack of Efficacy|28|||
163123315|NCT00635089|589160319|FG000|Overall Study|Protocol Deviation|4|||
163123316|NCT00635089|589160319|FG000|Overall Study|Lost to Follow-up|8|||
163123317|NCT00635089|589160319|FG000|Overall Study|Other|31|||
163123318|NCT01617447|589160320|FG000|Overall Study|Adverse Event|0|||
163123319|NCT01617447|589160321|FG001|Overall Study|Adverse Event|1|||
163123320|NCT01617447|589160320|FG000|Overall Study|Physician Decision|0|||
163123321|NCT01617447|589160321|FG001|Overall Study|Physician Decision|2|||
163123322|NCT01283542|589160323|FG000|Main Phase|Acute or progressive vision loss|1|||
163123323|NCT01283542|589160323|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
163123324|NCT01283542|589160323|FG000|Main Phase|abnormal laboratory values|5|||
163123325|NCT01283542|589160323|FG000|Extension Phase|Physician Decision|1|||
163123326|NCT01283542|589160323|FG000|Extension Phase|Adverse Event|1|||
163123327|NCT01283542|589160323|FG000|Extension Phase|Administrative problems|1|||
163123328|NCT05059977|589160324|FG000|Overall Study|Withdrawal by Subject|0|||
163123329|NCT05059977|589160325|FG001|Overall Study|Withdrawal by Subject|0|||
163123330|NCT05059977|589160326|FG002|Overall Study|Withdrawal by Subject|1|||
163123331|NCT00576472|589160327|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123332|NCT00576472|589160328|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123333|NCT00576472|589160329|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123334|NCT00576472|589160330|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
163123335|NCT00576472|589160331|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123336|NCT00576472|589160332|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123337|NCT00576472|589160333|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123338|NCT00576472|589160334|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123339|NCT00576472|589160335|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123340|NCT00576472|589160336|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123341|NCT00576472|589160337|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123342|NCT00576472|589160338|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123343|NCT00576472|589160339|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123344|NCT00576472|589160340|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123345|NCT00576472|589160341|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123346|NCT00576472|589160327|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
163123347|NCT00576472|589160328|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
163123348|NCT00576472|589160329|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
163123349|NCT00576472|589160330|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
163123350|NCT00576472|589160331|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
163123351|NCT00576472|589160332|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
163123352|NCT00576472|589160333|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
163123353|NCT00576472|589160334|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
163123354|NCT00576472|589160335|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
163123355|NCT00576472|589160336|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
163123356|NCT00576472|589160337|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
163123357|NCT00576472|589160338|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
163123358|NCT00576472|589160339|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
163123359|NCT00576472|589160340|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
163123360|NCT00576472|589160341|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
163123361|NCT00576472|589160327|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123362|NCT00576472|589160328|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123363|NCT00576472|589160329|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123364|NCT00576472|589160330|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
163123365|NCT00576472|589160331|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123366|NCT00576472|589160332|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123367|NCT00576472|589160333|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123368|NCT00576472|589160334|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123369|NCT00576472|589160335|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123370|NCT00576472|589160336|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123371|NCT00576472|589160337|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123372|NCT00576472|589160338|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123373|NCT00576472|589160339|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123374|NCT00576472|589160340|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123375|NCT00576472|589160341|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123376|NCT00576472|589160327|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
163123377|NCT00576472|589160328|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
163123378|NCT00576472|589160329|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
163123379|NCT00576472|589160330|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
163123380|NCT00576472|589160331|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
163123381|NCT00576472|589160332|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
163123382|NCT00576472|589160333|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
163123383|NCT00576472|589160334|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
163123384|NCT00576472|589160335|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
163123385|NCT00576472|589160336|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
163123386|NCT00576472|589160337|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
163123387|NCT00576472|589160338|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
163123388|NCT00576472|589160339|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
163123389|NCT00576472|589160340|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
163123390|NCT00576472|589160341|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
163123391|NCT00576472|589160327|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123392|NCT00576472|589160328|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123393|NCT00576472|589160329|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123394|NCT00576472|589160330|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
163123395|NCT00576472|589160331|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123396|NCT00576472|589160332|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123397|NCT00576472|589160333|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123398|NCT00576472|589160334|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123399|NCT00576472|589160335|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123400|NCT00576472|589160336|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123401|NCT00576472|589160337|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123402|NCT00576472|589160338|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123403|NCT00576472|589160339|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123404|NCT00576472|589160340|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123405|NCT00576472|589160341|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123406|NCT00576472|589160327|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123407|NCT00576472|589160328|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123408|NCT00576472|589160329|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123409|NCT00576472|589160330|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123410|NCT00576472|589160331|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123411|NCT00576472|589160332|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123412|NCT00576472|589160333|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
163123413|NCT00576472|589160334|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123414|NCT00576472|589160335|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123415|NCT00576472|589160336|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123416|NCT00576472|589160337|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123417|NCT00576472|589160338|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123418|NCT00576472|589160339|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123419|NCT00576472|589160340|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123420|NCT00576472|589160341|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123421|NCT00576472|589160327|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
163123422|NCT00576472|589160328|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
163123423|NCT00576472|589160329|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
163123424|NCT00576472|589160330|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
163123425|NCT00576472|589160331|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
163123426|NCT00576472|589160332|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
163123427|NCT00576472|589160333|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
163123428|NCT00576472|589160334|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
163123429|NCT00576472|589160335|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
163123430|NCT00576472|589160336|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
163123431|NCT00576472|589160337|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
163123432|NCT00576472|589160338|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
163123433|NCT00576472|589160339|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
163123434|NCT00576472|589160340|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
163123435|NCT00576472|589160341|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
163123436|NCT00576472|589160327|FG000|MPH Cross Over Phase|Physician Decision|0|||
163123437|NCT00576472|589160328|FG001|MPH Cross Over Phase|Physician Decision|0|||
163123438|NCT00576472|589160329|FG002|MPH Cross Over Phase|Physician Decision|0|||
163123439|NCT00576472|589160330|FG003|MPH Cross Over Phase|Physician Decision|0|||
163123440|NCT00576472|589160331|FG004|MPH Cross Over Phase|Physician Decision|0|||
163123441|NCT00576472|589160332|FG005|MPH Cross Over Phase|Physician Decision|0|||
163123442|NCT00576472|589160333|FG006|MPH Cross Over Phase|Physician Decision|4|||
163123443|NCT00576472|589160334|FG007|MPH Cross Over Phase|Physician Decision|0|||
163123444|NCT00576472|589160335|FG008|MPH Cross Over Phase|Physician Decision|0|||
163123445|NCT00576472|589160336|FG009|MPH Cross Over Phase|Physician Decision|0|||
163123446|NCT00576472|589160337|FG010|MPH Cross Over Phase|Physician Decision|0|||
163123447|NCT00576472|589160338|FG011|MPH Cross Over Phase|Physician Decision|0|||
163123448|NCT00576472|589160339|FG012|MPH Cross Over Phase|Physician Decision|0|||
163123449|NCT00576472|589160340|FG013|MPH Cross Over Phase|Physician Decision|0|||
163123450|NCT00576472|589160341|FG014|MPH Cross Over Phase|Physician Decision|0|||
163123451|NCT00576472|589160327|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123452|NCT00576472|589160328|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123453|NCT00576472|589160329|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123454|NCT00576472|589160330|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123455|NCT00576472|589160331|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123456|NCT00576472|589160332|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123457|NCT00576472|589160333|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123458|NCT00576472|589160334|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123459|NCT00576472|589160335|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
163123460|NCT00576472|589160336|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123461|NCT00576472|589160337|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
163123462|NCT00576472|589160338|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
163123463|NCT00576472|589160339|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123464|NCT00576472|589160340|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123465|NCT00576472|589160341|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123466|NCT00576472|589160327|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123467|NCT00576472|589160328|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123468|NCT00576472|589160329|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123469|NCT00576472|589160330|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123470|NCT00576472|589160331|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123471|NCT00576472|589160332|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123472|NCT00576472|589160333|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123473|NCT00576472|589160334|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163225258|NCT01418937|589540110|FG000|Overall Study|Withdrawal by Subject|1|||
163225259|NCT03323658|589540131|FG000|Overall Study|Adverse Event|0|||
163225260|NCT03323658|589540132|FG001|Overall Study|Adverse Event|1|||
163225261|NCT03323658|589540133|FG002|Overall Study|Adverse Event|0|||
163123474|NCT00576472|589160335|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123475|NCT00576472|589160336|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123476|NCT00576472|589160337|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123477|NCT00576472|589160338|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123478|NCT00576472|589160339|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123479|NCT00576472|589160340|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
163123480|NCT00576472|589160341|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123481|NCT00576472|589160327|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
163123482|NCT00576472|589160328|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
163123483|NCT00576472|589160329|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
163123484|NCT00576472|589160330|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
163123485|NCT00576472|589160331|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
163123486|NCT00576472|589160332|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
163123487|NCT00576472|589160333|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
163123488|NCT00576472|589160334|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
163123489|NCT00576472|589160335|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
163123490|NCT00576472|589160336|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
163123491|NCT00576472|589160337|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
163123492|NCT00576472|589160338|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
163123493|NCT00576472|589160339|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
163123494|NCT00576472|589160340|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
163123495|NCT00576472|589160341|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
163123496|NCT00576472|589160327|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
163123497|NCT00576472|589160328|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
163123498|NCT00576472|589160329|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
163123499|NCT00576472|589160330|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
163123500|NCT00576472|589160331|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
163123501|NCT00576472|589160332|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
163123502|NCT00576472|589160333|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
163123503|NCT00576472|589160334|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
163123504|NCT00576472|589160335|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
163123505|NCT00576472|589160336|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
163123506|NCT00576472|589160337|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
163123507|NCT00576472|589160338|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
163123508|NCT00576472|589160339|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
163123509|NCT00576472|589160340|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
163123510|NCT00576472|589160341|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
163123511|NCT00576472|589160327|FG000|MPH Home Maintenance Phase|Side effects|0|||
163123512|NCT00576472|589160328|FG001|MPH Home Maintenance Phase|Side effects|0|||
163123513|NCT00576472|589160329|FG002|MPH Home Maintenance Phase|Side effects|0|||
163123514|NCT00576472|589160330|FG003|MPH Home Maintenance Phase|Side effects|0|||
163123515|NCT00576472|589160331|FG004|MPH Home Maintenance Phase|Side effects|0|||
163123516|NCT00576472|589160332|FG005|MPH Home Maintenance Phase|Side effects|0|||
163123517|NCT00576472|589160333|FG006|MPH Home Maintenance Phase|Side effects|0|||
163123518|NCT00576472|589160334|FG007|MPH Home Maintenance Phase|Side effects|0|||
163123519|NCT00576472|589160335|FG008|MPH Home Maintenance Phase|Side effects|0|||
163123520|NCT00576472|589160336|FG009|MPH Home Maintenance Phase|Side effects|0|||
163123521|NCT00576472|589160337|FG010|MPH Home Maintenance Phase|Side effects|0|||
163123522|NCT00576472|589160338|FG011|MPH Home Maintenance Phase|Side effects|0|||
163123523|NCT00576472|589160339|FG012|MPH Home Maintenance Phase|Side effects|0|||
163123524|NCT00576472|589160340|FG013|MPH Home Maintenance Phase|Side effects|0|||
163123525|NCT00576472|589160341|FG014|MPH Home Maintenance Phase|Side effects|8|||
163123526|NCT00576472|589160327|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123527|NCT00576472|589160328|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123528|NCT00576472|589160329|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123529|NCT00576472|589160330|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123530|NCT00576472|589160331|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123531|NCT00576472|589160332|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123532|NCT00576472|589160333|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123533|NCT00576472|589160334|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123534|NCT00576472|589160335|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123535|NCT00576472|589160336|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123536|NCT00576472|589160337|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123537|NCT00576472|589160338|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123538|NCT00576472|589160339|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123539|NCT00576472|589160340|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123540|NCT00576472|589160341|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
163123541|NCT00576472|589160327|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
163123542|NCT00576472|589160328|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
163225262|NCT00615056|589540134|FG000|Overall Study|Death|31|||
163123543|NCT00576472|589160329|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
163123544|NCT00576472|589160330|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
163123545|NCT00576472|589160331|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
163123546|NCT00576472|589160332|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
163123547|NCT00576472|589160333|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
163123548|NCT00576472|589160334|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
163123549|NCT00576472|589160335|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
163123550|NCT00576472|589160336|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
163123551|NCT00576472|589160337|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
163123552|NCT00576472|589160338|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
163123553|NCT00576472|589160339|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
163123554|NCT00576472|589160340|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
163123555|NCT00576472|589160341|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
163123556|NCT00576472|589160327|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123557|NCT00576472|589160328|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123558|NCT00576472|589160329|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123559|NCT00576472|589160330|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123560|NCT00576472|589160331|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123561|NCT00576472|589160332|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123562|NCT00576472|589160333|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123563|NCT00576472|589160334|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123564|NCT00576472|589160335|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123565|NCT00576472|589160336|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163341413|NCT00636168|589958223|FG000|Treated With Study Drug|Poor/non-compliance|1|||
163341414|NCT00636168|589958224|FG001|Treated With Study Drug|Poor/non-compliance|3|||
163341415|NCT00636168|589958223|FG000|Treated With Study Drug|Death|3|||
163341416|NCT00636168|589958224|FG001|Treated With Study Drug|Death|0|||
163341417|NCT00636168|589958223|FG000|Treated With Study Drug|Pregnancy|1|||
163341418|NCT00636168|589958224|FG001|Treated With Study Drug|Pregnancy|0|||
163341419|NCT00636168|589958223|FG000|Treated With Study Drug|No longer meets study criteria|1|||
163341420|NCT00636168|589958224|FG001|Treated With Study Drug|No longer meets study criteria|0|||
163341421|NCT00636168|589958223|FG000|Treated With Study Drug|Other reason|1|||
163341422|NCT00636168|589958224|FG001|Treated With Study Drug|Other reason|3|||
163341423|NCT00636168|589958223|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
163341424|NCT00636168|589958224|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
163341425|NCT00636168|589958223|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
163341426|NCT00636168|589958224|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
163341427|NCT00636168|589958223|FG000|Long Term Follow-Up|Death|8|||
163341428|NCT00636168|589958224|FG001|Long Term Follow-Up|Death|9|||
163341429|NCT04501614|589958228|FG000|Overall Study|Study Terminated by Sponsor|6|||
163341430|NCT04501614|589958229|FG001|Overall Study|Study Terminated by Sponsor|3|||
163341431|NCT04501614|589958228|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
163408155|NCT02432235|590204043|FG011|Overall Study|Withdrawal by Subject|0|||
163408156|NCT02432235|590204032|FG000|Overall Study|Lost to Follow-up|0|||
163123566|NCT00576472|589160337|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123567|NCT00576472|589160338|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123568|NCT00576472|589160339|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123569|NCT00576472|589160340|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123570|NCT00576472|589160341|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
163123571|NCT04405245|589160342|FG000|Overall Study|Adverse Event|0|||
163123572|NCT04405245|589160343|FG001|Overall Study|Adverse Event|1|||
163123573|NCT04405245|589160344|FG002|Overall Study|Adverse Event|0|||
163123574|NCT03443427|589160346|FG000|Overall Study|Adverse Event|2|||
163341432|NCT04501614|589958229|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
163408157|NCT02432235|590204033|FG001|Overall Study|Lost to Follow-up|0|||
163408158|NCT02432235|590204034|FG002|Overall Study|Lost to Follow-up|0|||
163408159|NCT02432235|590204035|FG003|Overall Study|Lost to Follow-up|0|||
163408160|NCT02432235|590204036|FG004|Overall Study|Lost to Follow-up|0|||
163123575|NCT03443427|589160347|FG001|Overall Study|Adverse Event|3|||
163123576|NCT03443427|589160346|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
163123577|NCT03443427|589160347|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
163123578|NCT03443427|589160346|FG000|Overall Study|Other|4|||
163123579|NCT03443427|589160347|FG001|Overall Study|Other|6|||
163341433|NCT02555397|589958233|FG000|Overall Study|Withdrawal by Subject|1|||
163341434|NCT02555397|589958234|FG001|Overall Study|Withdrawal by Subject|0|||
163341435|NCT02555397|589958235|FG002|Overall Study|Withdrawal by Subject|0|||
163408161|NCT02432235|590204037|FG005|Overall Study|Lost to Follow-up|1|||
163123580|NCT02576860|589160350|FG000|Overall Study|Adverse Event|6|||
163123581|NCT02576860|589160351|FG001|Overall Study|Adverse Event|6|||
163123582|NCT02576860|589160350|FG000|Overall Study|Lost to Follow-up|5|||
163341436|NCT02555397|589958236|FG003|Overall Study|Withdrawal by Subject|0|||
163341437|NCT02555397|589958237|FG004|Overall Study|Withdrawal by Subject|0|||
163341438|NCT04529941|589958240|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
163408162|NCT02432235|590204038|FG006|Overall Study|Lost to Follow-up|0|||
163123583|NCT02576860|589160351|FG001|Overall Study|Lost to Follow-up|7|||
163123584|NCT02576860|589160350|FG000|Overall Study|Physician Decision|0|||
163123585|NCT02576860|589160351|FG001|Overall Study|Physician Decision|1|||
163123586|NCT02576860|589160350|FG000|Overall Study|Protocol Violation|0|||
163123587|NCT02576860|589160351|FG001|Overall Study|Protocol Violation|2|||
163123588|NCT02576860|589160350|FG000|Overall Study|Withdrawal by Subject|13|||
163123589|NCT02576860|589160351|FG001|Overall Study|Withdrawal by Subject|8|||
163123590|NCT02576860|589160350|FG000|Overall Study|Disallowed medication|1|||
163123591|NCT02576860|589160351|FG001|Overall Study|Disallowed medication|0|||
163123592|NCT00780273|589160352|FG000|Overall Study|Death|1|||
163123593|NCT00780273|589160352|FG000|Overall Study|Lost to Follow-up|1|||
163123594|NCT02391961|589160353|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
163123595|NCT02391961|589160354|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
163123596|NCT02391961|589160353|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
163123597|NCT02391961|589160354|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
163123598|NCT02391961|589160353|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
163123599|NCT02391961|589160354|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
163123600|NCT00477269|589160355|FG000|Core Study|Adverse Event|6|||
163123601|NCT00477269|589160356|FG001|Core Study|Adverse Event|4|||
163123602|NCT00477269|589160357|FG002|Core Study|Adverse Event|0|||
163123603|NCT00477269|589160355|FG000|Core Study|Death|3|||
163123604|NCT00477269|589160356|FG001|Core Study|Death|3|||
163123605|NCT00477269|589160357|FG002|Core Study|Death|0|||
163123606|NCT00477269|589160355|FG000|Core Study|Withdrawn Consent|0|||
163123607|NCT00477269|589160356|FG001|Core Study|Withdrawn Consent|1|||
163123608|NCT00477269|589160357|FG002|Core Study|Withdrawn Consent|0|||
163123609|NCT00477269|589160355|FG000|Open Label Extension|Adverse Event|0|||
163123610|NCT00477269|589160356|FG001|Open Label Extension|Adverse Event|0|||
163123611|NCT00477269|589160357|FG002|Open Label Extension|Adverse Event|4|||
163123612|NCT00477269|589160355|FG000|Open Label Extension|Abnormal laboratory values|0|||
163225263|NCT00615056|589540135|FG001|Overall Study|Death|31|||
163225264|NCT00615056|589540136|FG002|Overall Study|Death|21|||
163225265|NCT00615056|589540137|FG003|Overall Study|Death|23|||
163225266|NCT00615056|589540134|FG000|Overall Study|Lost to Follow-up|1|||
163225267|NCT00615056|589540135|FG001|Overall Study|Lost to Follow-up|2|||
163225268|NCT00615056|589540136|FG002|Overall Study|Lost to Follow-up|4|||
163341439|NCT04529941|589958241|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
163341440|NCT01005914|589958243|FG000|Overall Study|Adverse Event|4|||
163341441|NCT01005914|589958243|FG000|Overall Study|Death|4|||
163341442|NCT01005914|589958243|FG000|Overall Study|Lack of Efficacy|1|||
163341443|NCT01005914|589958243|FG000|Overall Study|Withdrawal by Subject|1|||
163341444|NCT02066389|589958244|FG000|Overall Study|Adverse Event|1|||
163341445|NCT02066389|589958245|FG001|Overall Study|Adverse Event|1|||
163341446|NCT02066389|589958246|FG002|Overall Study|Adverse Event|1|||
163341447|NCT02066389|589958247|FG003|Overall Study|Adverse Event|1|||
163341448|NCT02066389|589958248|FG004|Overall Study|Adverse Event|5|||
163341449|NCT02066389|589958249|FG005|Overall Study|Adverse Event|1|||
163341450|NCT02066389|589958244|FG000|Overall Study|Withdrawal by Subject|4|||
163341451|NCT02066389|589958245|FG001|Overall Study|Withdrawal by Subject|0|||
163341452|NCT02066389|589958246|FG002|Overall Study|Withdrawal by Subject|5|||
163341453|NCT02066389|589958247|FG003|Overall Study|Withdrawal by Subject|1|||
163341454|NCT02066389|589958248|FG004|Overall Study|Withdrawal by Subject|1|||
163341455|NCT02066389|589958249|FG005|Overall Study|Withdrawal by Subject|2|||
163341456|NCT02066389|589958244|FG000|Overall Study|Lost to Follow-up|0|||
163341457|NCT02066389|589958245|FG001|Overall Study|Lost to Follow-up|0|||
163341458|NCT02066389|589958246|FG002|Overall Study|Lost to Follow-up|0|||
163341459|NCT02066389|589958247|FG003|Overall Study|Lost to Follow-up|1|||
163341460|NCT02066389|589958248|FG004|Overall Study|Lost to Follow-up|1|||
163341461|NCT02066389|589958249|FG005|Overall Study|Lost to Follow-up|1|||
163341462|NCT02066389|589958244|FG000|Overall Study|Randomized in Error|0|||
163341463|NCT02066389|589958245|FG001|Overall Study|Randomized in Error|0|||
163341464|NCT02066389|589958246|FG002|Overall Study|Randomized in Error|0|||
163341465|NCT02066389|589958247|FG003|Overall Study|Randomized in Error|0|||
163341466|NCT02066389|589958248|FG004|Overall Study|Randomized in Error|0|||
163341467|NCT02066389|589958249|FG005|Overall Study|Randomized in Error|1|||
163341468|NCT00736502|589958250|FG000|Overall Study|Adverse Event|22|||
163341469|NCT00736502|589958250|FG000|Overall Study|Lack of Efficacy|16|||
163341470|NCT00736502|589958250|FG000|Overall Study|Lost to Follow-up|27|||
163123613|NCT00477269|589160356|FG001|Open Label Extension|Abnormal laboratory values|0|||
163225269|NCT00615056|589540137|FG003|Overall Study|Lost to Follow-up|5|||
163225270|NCT00615056|589540134|FG000|Overall Study|Other|13|||
163341471|NCT02935894|589958255|FG000|Overall Study|Subject dismissed|1|||
163341472|NCT00853957|589958258|FG000|Overall Study|Adverse Event|9|||
163341473|NCT00853957|589958259|FG001|Overall Study|Adverse Event|3|||
163341474|NCT00853957|589958258|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163341475|NCT00853957|589958259|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163341476|NCT00853957|589958258|FG000|Overall Study|Subject withdrew consent|4|||
163341477|NCT00853957|589958259|FG001|Overall Study|Subject withdrew consent|5|||
163341478|NCT00853957|589958258|FG000|Overall Study|Lost to Follow-up|1|||
163123614|NCT00477269|589160357|FG002|Open Label Extension|Abnormal laboratory values|1|||
163123615|NCT00477269|589160355|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
163123616|NCT00477269|589160356|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
163123617|NCT00477269|589160357|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
163123618|NCT00477269|589160355|FG000|Open Label Extension|Adminiatrative problems|0|||
163123619|NCT00477269|589160356|FG001|Open Label Extension|Adminiatrative problems|0|||
163123620|NCT00477269|589160357|FG002|Open Label Extension|Adminiatrative problems|2|||
163123621|NCT00477269|589160355|FG000|Open Label Extension|Death|0|||
163123622|NCT00477269|589160356|FG001|Open Label Extension|Death|0|||
163123623|NCT00477269|589160357|FG002|Open Label Extension|Death|4|||
163123624|NCT01565564|589160370|FG000|Overall Study|Lost to Follow-up|5|||
163123625|NCT01565564|589160371|FG001|Overall Study|Lost to Follow-up|1|||
163123626|NCT00249613|589160372|FG000|12 Month Follow-up|Death|1|||
163123627|NCT00249613|589160373|FG001|12 Month Follow-up|Death|1|||
163123628|NCT00249613|589160372|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
163123629|NCT00249613|589160373|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
163123630|NCT00249613|589160372|FG000|12 Month Follow-up|Lost to Follow-up|10|||
163123631|NCT00249613|589160373|FG001|12 Month Follow-up|Lost to Follow-up|8|||
163123632|NCT00806442|589160396|FG000|Overall Study|Lost to Follow-up|3|||
163123633|NCT00806442|589160397|FG001|Overall Study|Lost to Follow-up|2|||
163123634|NCT00806442|589160396|FG000|Overall Study|Withdrawal by Subject|1|||
163123635|NCT00806442|589160397|FG001|Overall Study|Withdrawal by Subject|5|||
163123636|NCT00654004|589160401|FG000|Overall Study|Lost to Follow-up|1|||
163123637|NCT00654004|589160402|FG001|Overall Study|Lost to Follow-up|0|||
163123638|NCT02528357|589160411|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123639|NCT02528357|589160412|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
163123640|NCT02528357|589160413|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123641|NCT02528357|589160414|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123642|NCT02528357|589160415|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123643|NCT02528357|589160416|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123644|NCT02528357|589160417|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123645|NCT02528357|589160418|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123646|NCT02528357|589160419|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123647|NCT02528357|589160420|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123648|NCT02528357|589160421|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123649|NCT02528357|589160422|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123650|NCT02528357|589160423|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123651|NCT02528357|589160424|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123652|NCT02528357|589160425|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123653|NCT02528357|589160426|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123654|NCT02528357|589160427|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123655|NCT02528357|589160428|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123656|NCT02528357|589160429|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123657|NCT02528357|589160411|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123658|NCT02528357|589160412|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123659|NCT02528357|589160413|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123660|NCT02528357|589160414|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
163123661|NCT02528357|589160415|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123662|NCT02528357|589160416|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
163123663|NCT02528357|589160417|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123664|NCT02528357|589160418|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
163123665|NCT02528357|589160419|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123666|NCT02528357|589160420|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123667|NCT02528357|589160421|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123668|NCT02528357|589160422|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123669|NCT02528357|589160423|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123670|NCT02528357|589160424|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123671|NCT02528357|589160425|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123672|NCT02528357|589160426|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123673|NCT02528357|589160427|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163225271|NCT00615056|589540135|FG001|Overall Study|Other|15|||
163225272|NCT00615056|589540136|FG002|Overall Study|Other|10|||
163225273|NCT00615056|589540137|FG003|Overall Study|Other|7|||
163225274|NCT00615056|589540134|FG000|Overall Study|Objective progression or relapse|0|||
163225275|NCT00615056|589540135|FG001|Overall Study|Objective progression or relapse|2|||
163225276|NCT00615056|589540136|FG002|Overall Study|Objective progression or relapse|0|||
163225277|NCT00615056|589540137|FG003|Overall Study|Objective progression or relapse|0|||
163225278|NCT00615056|589540134|FG000|Overall Study|Withdrawal by Subject|0|||
163341479|NCT00853957|589958259|FG001|Overall Study|Lost to Follow-up|6|||
163341480|NCT00853957|589958258|FG000|Overall Study|Protocol deviation|0|||
163341481|NCT00853957|589958259|FG001|Overall Study|Protocol deviation|3|||
163341482|NCT01884571|589958260|FG000|Overall Study|Adverse Event|1|||
163123674|NCT02528357|589160428|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123675|NCT02528357|589160429|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123676|NCT02528357|589160411|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123677|NCT02528357|589160412|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123678|NCT02528357|589160413|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
163123679|NCT02528357|589160414|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123680|NCT02528357|589160415|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
163123681|NCT02528357|589160416|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123682|NCT02528357|589160417|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
163123683|NCT02528357|589160418|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
163123684|NCT02528357|589160419|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123685|NCT02528357|589160420|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123686|NCT02528357|589160421|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123687|NCT02528357|589160422|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123688|NCT02528357|589160423|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123689|NCT02528357|589160424|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123690|NCT02528357|589160425|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123691|NCT02528357|589160426|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123692|NCT02528357|589160427|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123693|NCT02528357|589160428|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123694|NCT02528357|589160429|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123695|NCT02528357|589160411|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123696|NCT02528357|589160412|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123697|NCT02528357|589160413|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123698|NCT02528357|589160414|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123699|NCT02528357|589160415|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
163123700|NCT02528357|589160416|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123701|NCT02528357|589160417|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123702|NCT02528357|589160418|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123703|NCT02528357|589160419|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123704|NCT02528357|589160420|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123705|NCT02528357|589160421|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123706|NCT02528357|589160422|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123707|NCT02528357|589160423|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123708|NCT02528357|589160424|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123709|NCT02528357|589160425|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123710|NCT02528357|589160426|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123711|NCT02528357|589160427|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123712|NCT02528357|589160428|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123713|NCT02528357|589160429|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123714|NCT02528357|589160411|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123715|NCT02528357|589160412|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123716|NCT02528357|589160413|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123717|NCT02528357|589160414|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123718|NCT02528357|589160415|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123719|NCT02528357|589160416|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123720|NCT02528357|589160417|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123721|NCT02528357|589160418|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123722|NCT02528357|589160419|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123723|NCT02528357|589160420|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123724|NCT02528357|589160421|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123725|NCT02528357|589160422|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123726|NCT02528357|589160423|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163341483|NCT01884571|589958260|FG000|Overall Study|Death|2|||
163123727|NCT02528357|589160424|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
163123728|NCT02528357|589160425|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
163123729|NCT02528357|589160426|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123730|NCT02528357|589160427|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123731|NCT02528357|589160428|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123732|NCT02528357|589160429|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123733|NCT02528357|589160411|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123734|NCT02528357|589160412|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123735|NCT02528357|589160413|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123736|NCT02528357|589160414|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123737|NCT02528357|589160415|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123738|NCT02528357|589160416|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123739|NCT02528357|589160417|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123740|NCT02528357|589160418|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123741|NCT02528357|589160419|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123742|NCT02528357|589160420|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123743|NCT02528357|589160421|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123744|NCT02528357|589160422|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123745|NCT02528357|589160423|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123746|NCT02528357|589160424|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
163123747|NCT02528357|589160425|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123748|NCT02528357|589160426|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123749|NCT02528357|589160427|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123750|NCT02528357|589160428|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123751|NCT02528357|589160429|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123752|NCT02528357|589160411|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123753|NCT02528357|589160412|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123754|NCT02528357|589160413|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123755|NCT02528357|589160414|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123756|NCT02528357|589160415|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123757|NCT02528357|589160416|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123758|NCT02528357|589160417|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123759|NCT02528357|589160418|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123760|NCT02528357|589160419|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123761|NCT02528357|589160420|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123762|NCT02528357|589160421|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
163123763|NCT02528357|589160422|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123764|NCT02528357|589160423|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
163123765|NCT02528357|589160424|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
163123766|NCT02528357|589160425|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
163123767|NCT02528357|589160426|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123768|NCT02528357|589160427|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123769|NCT02528357|589160428|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123770|NCT02528357|589160429|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123771|NCT02528357|589160411|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123772|NCT02528357|589160412|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123773|NCT02528357|589160413|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123774|NCT02528357|589160414|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123775|NCT02528357|589160415|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123776|NCT02528357|589160416|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123777|NCT02528357|589160417|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123778|NCT02528357|589160418|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123779|NCT02528357|589160419|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
163123780|NCT02528357|589160420|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
163123781|NCT02528357|589160421|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123782|NCT02528357|589160422|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
163123783|NCT02528357|589160423|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
163123784|NCT02528357|589160424|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
163123785|NCT02528357|589160425|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
163123786|NCT02528357|589160426|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123787|NCT02528357|589160427|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123788|NCT02528357|589160428|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123789|NCT02528357|589160429|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123790|NCT02528357|589160411|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123791|NCT02528357|589160412|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123792|NCT02528357|589160413|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123793|NCT02528357|589160414|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123794|NCT02528357|589160415|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123795|NCT02528357|589160416|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123796|NCT02528357|589160417|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123797|NCT02528357|589160418|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123798|NCT02528357|589160419|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123799|NCT02528357|589160420|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123800|NCT02528357|589160421|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123801|NCT02528357|589160422|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123802|NCT02528357|589160423|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123803|NCT02528357|589160424|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123804|NCT02528357|589160425|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123805|NCT02528357|589160426|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123806|NCT02528357|589160427|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
163123807|NCT02528357|589160428|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123808|NCT02528357|589160429|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123809|NCT02528357|589160411|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123810|NCT02528357|589160412|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123811|NCT02528357|589160413|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123812|NCT02528357|589160414|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123813|NCT02528357|589160415|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123814|NCT02528357|589160416|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123815|NCT02528357|589160417|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123816|NCT02528357|589160418|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123817|NCT02528357|589160419|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123818|NCT02528357|589160420|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123819|NCT02528357|589160421|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123820|NCT02528357|589160422|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123821|NCT02528357|589160423|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123822|NCT02528357|589160424|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123823|NCT02528357|589160425|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123824|NCT02528357|589160426|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123825|NCT02528357|589160427|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
163123826|NCT02528357|589160428|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
163123827|NCT02528357|589160429|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
163123828|NCT01455220|589160431|FG000|Overall Study|screen fail|30|||
163123829|NCT00495755|589160432|FG000|Overall Study|Adverse Event|3|||
163123830|NCT00720343|589162039|FG000|Overall Study|Lost to Follow-up|1|||
163123831|NCT00720343|589162040|FG001|Overall Study|Lost to Follow-up|0|||
163123832|NCT00720343|589162039|FG000|Overall Study|Protocol Violation|0|||
163123833|NCT00720343|589162040|FG001|Overall Study|Protocol Violation|2|||
163123834|NCT03459365|589162043|FG000|Overall Study|Withdrawal by Subject|6|||
163123835|NCT03459365|589162043|FG000|Overall Study|Protocol Violation|8|||
163123836|NCT00344500|589162045|FG000|Overall Study|Adverse Event|6|||
163123837|NCT00344500|589162046|FG001|Overall Study|Adverse Event|2|||
163123838|NCT00344500|589162047|FG002|Overall Study|Adverse Event|0|||
163123839|NCT00344500|589162045|FG000|Overall Study|Lost to Follow-up|5|||
163123840|NCT00344500|589162046|FG001|Overall Study|Lost to Follow-up|13|||
163123841|NCT00344500|589162047|FG002|Overall Study|Lost to Follow-up|1|||
163123842|NCT00344500|589162045|FG000|Overall Study|Withdrawal by Subject|7|||
163123843|NCT00344500|589162046|FG001|Overall Study|Withdrawal by Subject|10|||
163123844|NCT00344500|589162047|FG002|Overall Study|Withdrawal by Subject|0|||
163341484|NCT01884571|589958260|FG000|Overall Study|Withdrawal by Subject|2|||
163341485|NCT01884571|589958260|FG000|Overall Study|Disease progression|3|||
163341486|NCT01186809|589958263|FG000|Overall Study|Death|30|||
163341487|NCT04895085|589958264|FG000|Overall Study|Death|1|||
163341488|NCT04895085|589958264|FG000|Overall Study|Withdrawal by Subject|1|||
163341489|NCT04895085|589958264|FG000|Overall Study|No longer eligible: Moved from area|1|||
163341490|NCT01159600|589958270|FG000|Overall Study|Not treated|0|||
163341491|NCT01159600|589958271|FG001|Overall Study|Not treated|0|||
163341492|NCT01159600|589958272|FG002|Overall Study|Not treated|1|||
163341493|NCT01159600|589958273|FG003|Overall Study|Not treated|0|||
163341494|NCT01159600|589958274|FG004|Overall Study|Not treated|0|||
163341495|NCT01159600|589958275|FG005|Overall Study|Not treated|1|||
163341496|NCT01159600|589958276|FG006|Overall Study|Not treated|2|||
163341497|NCT01159600|589958277|FG007|Overall Study|Not treated|2|||
163341498|NCT01159600|589958270|FG000|Overall Study|Adverse Event|7|||
163341499|NCT01159600|589958271|FG001|Overall Study|Adverse Event|2|||
163341500|NCT01159600|589958272|FG002|Overall Study|Adverse Event|5|||
163341501|NCT01159600|589958273|FG003|Overall Study|Adverse Event|1|||
163341502|NCT01159600|589958274|FG004|Overall Study|Adverse Event|8|||
163341503|NCT01159600|589958275|FG005|Overall Study|Adverse Event|6|||
163341504|NCT01159600|589958276|FG006|Overall Study|Adverse Event|7|||
163341505|NCT01159600|589958277|FG007|Overall Study|Adverse Event|5|||
163341506|NCT01159600|589958270|FG000|Overall Study|Lack of Efficacy|0|||
163341507|NCT01159600|589958271|FG001|Overall Study|Lack of Efficacy|0|||
163123845|NCT00344500|589162045|FG000|Overall Study|Protocol Violation|4|||
163123846|NCT00344500|589162046|FG001|Overall Study|Protocol Violation|7|||
163123847|NCT00344500|589162047|FG002|Overall Study|Protocol Violation|1|||
163123848|NCT00344500|589162045|FG000|Overall Study|Not Noted|1|||
163123849|NCT00344500|589162046|FG001|Overall Study|Not Noted|3|||
163123850|NCT00344500|589162047|FG002|Overall Study|Not Noted|0|||
163123851|NCT00599755|589162048|FG000|Overall Study|Adverse Event|11|||
163123852|NCT00599755|589162048|FG000|Overall Study|Withdrawal by Subject|2|||
163123853|NCT00599755|589162048|FG000|Overall Study|Progression of Disease|3|||
163123854|NCT00599755|589162048|FG000|Overall Study|Other Reason|2|||
163123855|NCT00599755|589162048|FG000|Overall Study|No data available|1|||
163123856|NCT04037254|589162049|FG000|Overall Study|Protocol Violation|1|||
163123857|NCT04037254|589162050|FG001|Overall Study|Protocol Violation|0|||
163123858|NCT04037254|589162051|FG002|Overall Study|Protocol Violation|0|||
163123859|NCT04037254|589162052|FG003|Overall Study|Protocol Violation|0|||
163123860|NCT04037254|589162053|FG004|Overall Study|Protocol Violation|0|||
163123861|NCT04037254|589162049|FG000|Overall Study|Withdrawal by Subject|0|||
163123862|NCT04037254|589162050|FG001|Overall Study|Withdrawal by Subject|0|||
163123863|NCT04037254|589162051|FG002|Overall Study|Withdrawal by Subject|1|||
163123864|NCT04037254|589162052|FG003|Overall Study|Withdrawal by Subject|0|||
163123865|NCT04037254|589162053|FG004|Overall Study|Withdrawal by Subject|0|||
163123866|NCT04037254|589162049|FG000|Overall Study|Delayed or incomplete treatment|0|||
163123867|NCT04037254|589162050|FG001|Overall Study|Delayed or incomplete treatment|2|||
163123868|NCT04037254|589162051|FG002|Overall Study|Delayed or incomplete treatment|1|||
163123869|NCT04037254|589162052|FG003|Overall Study|Delayed or incomplete treatment|0|||
163123870|NCT04037254|589162053|FG004|Overall Study|Delayed or incomplete treatment|0|||
163123871|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
163123872|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
163123873|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
163123874|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
163123875|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
163123876|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
163123877|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
163123878|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
163123879|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
163123880|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
163341508|NCT01159600|589958272|FG002|Overall Study|Lack of Efficacy|0|||
163341509|NCT01159600|589958273|FG003|Overall Study|Lack of Efficacy|0|||
163341510|NCT01159600|589958274|FG004|Overall Study|Lack of Efficacy|2|||
163123881|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
163123882|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
163123883|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
163123884|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
163123885|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
163123886|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
163341511|NCT01159600|589958275|FG005|Overall Study|Lack of Efficacy|0|||
163341512|NCT01159600|589958276|FG006|Overall Study|Lack of Efficacy|0|||
163341513|NCT01159600|589958277|FG007|Overall Study|Lack of Efficacy|1|||
163341514|NCT01159600|589958270|FG000|Overall Study|Non compliant with protocol|2|||
163341515|NCT01159600|589958271|FG001|Overall Study|Non compliant with protocol|1|||
163341516|NCT01159600|589958272|FG002|Overall Study|Non compliant with protocol|0|||
163341517|NCT01159600|589958273|FG003|Overall Study|Non compliant with protocol|0|||
163341518|NCT01159600|589958274|FG004|Overall Study|Non compliant with protocol|2|||
163225279|NCT00615056|589540135|FG001|Overall Study|Withdrawal by Subject|1|||
163225280|NCT00615056|589540136|FG002|Overall Study|Withdrawal by Subject|1|||
163225281|NCT00615056|589540137|FG003|Overall Study|Withdrawal by Subject|0|||
163225282|NCT00615056|589540134|FG000|Overall Study|Discontinued by Sponsor|1|||
163225283|NCT00615056|589540135|FG001|Overall Study|Discontinued by Sponsor|0|||
163225284|NCT00615056|589540136|FG002|Overall Study|Discontinued by Sponsor|0|||
163225285|NCT00615056|589540137|FG003|Overall Study|Discontinued by Sponsor|0|||
163225286|NCT00615056|589540134|FG000|Overall Study|Randomized but not treated|3|||
163225287|NCT00615056|589540135|FG001|Overall Study|Randomized but not treated|0|||
163225288|NCT00615056|589540136|FG002|Overall Study|Randomized but not treated|0|||
163225289|NCT00615056|589540137|FG003|Overall Study|Randomized but not treated|0|||
163225290|NCT00717769|589540138|FG000|Overall Study|Adverse Event|9|||
163225291|NCT00717769|589540139|FG001|Overall Study|Adverse Event|6|||
163225292|NCT00717769|589540140|FG002|Overall Study|Adverse Event|1|||
163225293|NCT00717769|589540138|FG000|Overall Study|Lack of compliance|0|||
163225294|NCT00717769|589540139|FG001|Overall Study|Lack of compliance|2|||
163225295|NCT00717769|589540140|FG002|Overall Study|Lack of compliance|0|||
163225296|NCT00717769|589540138|FG000|Overall Study|Lost to Follow-up|3|||
163225297|NCT00717769|589540139|FG001|Overall Study|Lost to Follow-up|4|||
163225298|NCT00717769|589540140|FG002|Overall Study|Lost to Follow-up|0|||
163225299|NCT00717769|589540138|FG000|Overall Study|Lack of Efficacy|1|||
163225300|NCT00717769|589540139|FG001|Overall Study|Lack of Efficacy|2|||
163225301|NCT00717769|589540140|FG002|Overall Study|Lack of Efficacy|0|||
163225302|NCT00717769|589540138|FG000|Overall Study|Protocol Violation|0|||
163225303|NCT00717769|589540139|FG001|Overall Study|Protocol Violation|2|||
163225304|NCT00717769|589540140|FG002|Overall Study|Protocol Violation|0|||
163225305|NCT00717769|589540138|FG000|Overall Study|Sponsor decision|1|||
163225306|NCT00717769|589540139|FG001|Overall Study|Sponsor decision|0|||
163225307|NCT00717769|589540140|FG002|Overall Study|Sponsor decision|10|||
163225308|NCT00717769|589540138|FG000|Overall Study|Withdrew consent|2|||
163225309|NCT00717769|589540139|FG001|Overall Study|Withdrew consent|2|||
163225310|NCT00717769|589540140|FG002|Overall Study|Withdrew consent|0|||
163225311|NCT01380184|589540143|FG000|Part 1 (19 Days)|Adverse Event|1|||
163225312|NCT01380184|589540143|FG000|Part 2|Adverse Event|5|||
163225313|NCT01380184|589540143|FG000|Part 2|Disease Progression|8|||
163225314|NCT01380184|589540143|FG000|Part 2|Lost to Follow-up|1|||
163225315|NCT04327986|589540146|FG000|Overall Study|Physician Decision|2|||
163225316|NCT04327986|589540147|FG001|Overall Study|Physician Decision|0|||
163225317|NCT04327986|589540148|FG002|Overall Study|Physician Decision|0|||
163225318|NCT04327986|589540146|FG000|Overall Study|Death|1|||
163225319|NCT04327986|589540147|FG001|Overall Study|Death|0|||
163225320|NCT04327986|589540148|FG002|Overall Study|Death|0|||
163225321|NCT03350503|589540151|FG000|Overall Study|Adverse Event|5|||
163225322|NCT03350503|589540151|FG000|Overall Study|Withdrawal by Subject|5|||
163225323|NCT03350503|589540151|FG000|Overall Study|Continuation impossible due to move|4|||
163225324|NCT03350503|589540151|FG000|Overall Study|Physician Decision|3|||
163225325|NCT03829046|589540154|FG000|Overall Study|Withdrawal by Subject|1|||
163225326|NCT03829046|589540155|FG001|Overall Study|Withdrawal by Subject|0|||
163225327|NCT00262067|589540156|FG000|Overall Study|Death|190|||
163225328|NCT00262067|589540157|FG001|Overall Study|Death|89|||
163225329|NCT00262067|589540158|FG002|Overall Study|Death|186|||
163225330|NCT00262067|589540159|FG003|Overall Study|Death|99|||
163225331|NCT00262067|589540156|FG000|Overall Study|Lost to Follow-up|5|||
163341519|NCT01159600|589958275|FG005|Overall Study|Non compliant with protocol|0|||
163341520|NCT01159600|589958276|FG006|Overall Study|Non compliant with protocol|2|||
163341521|NCT01159600|589958277|FG007|Overall Study|Non compliant with protocol|0|||
163225332|NCT00262067|589540157|FG001|Overall Study|Lost to Follow-up|4|||
163225333|NCT00262067|589540158|FG002|Overall Study|Lost to Follow-up|7|||
163225334|NCT00262067|589540159|FG003|Overall Study|Lost to Follow-up|5|||
163225335|NCT00262067|589540156|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
163225336|NCT00262067|589540157|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
163225337|NCT00262067|589540158|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
163225338|NCT00262067|589540159|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
163225339|NCT00262067|589540156|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
163225340|NCT00262067|589540157|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
163225341|NCT00262067|589540158|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
163341522|NCT01159600|589958270|FG000|Overall Study|Lost to Follow-up|2|||
163225342|NCT00262067|589540159|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
163225343|NCT04804813|589540162|FG000|Overall Study|Protocol Violation|2|||
163225344|NCT04804813|589540163|FG001|Overall Study|Protocol Violation|0|||
163225345|NCT04804813|589540162|FG000|Overall Study|Withdrawal by Subject|1|||
163225346|NCT04804813|589540163|FG001|Overall Study|Withdrawal by Subject|0|||
163225347|NCT00653224|589541986|FG000|Overall Study|Adverse Event|2|||
163225348|NCT00653224|589541987|FG001|Overall Study|Adverse Event|1|||
163225349|NCT00653224|589541986|FG000|Overall Study|Lack of Efficacy|1|||
163225350|NCT00653224|589541987|FG001|Overall Study|Lack of Efficacy|2|||
163225351|NCT00653224|589541986|FG000|Overall Study|Loss of efficacy|1|||
163341523|NCT01159600|589958271|FG001|Overall Study|Lost to Follow-up|3|||
163341524|NCT01159600|589958272|FG002|Overall Study|Lost to Follow-up|4|||
163123887|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
163123888|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
163123889|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
163123890|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
163123891|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
163123892|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
163123893|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
163123894|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
163123895|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
163123896|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
163123897|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
163123898|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
163123899|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
163123900|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
163123901|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
163123902|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
163123903|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
163123904|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
163123905|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
163123906|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
163123907|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
163123908|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
163123909|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
163123910|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
163123911|NCT02198794|589162054|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
163123912|NCT02198794|589162055|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
163123913|NCT02198794|589162056|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
163123914|NCT02198794|589162057|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
163123915|NCT02198794|589162054|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
163123916|NCT02198794|589162055|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
163123917|NCT02198794|589162056|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
163123918|NCT02198794|589162057|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
163123919|NCT02198794|589162054|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
163123920|NCT02198794|589162055|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
163123921|NCT02198794|589162056|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
163123922|NCT02198794|589162057|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
163123923|NCT02198794|589162054|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
163123924|NCT02198794|589162055|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
163123925|NCT02198794|589162056|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
163123926|NCT02198794|589162057|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
163123927|NCT02198794|589162054|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
163123928|NCT02198794|589162055|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
163123929|NCT02198794|589162056|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
163123930|NCT02198794|589162057|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
163123931|NCT01306656|589162058|FG000|Overall Study|Lost to Follow-up|1|||
163123932|NCT01306656|589162059|FG001|Overall Study|Lost to Follow-up|0|||
163123933|NCT01918332|589162063|FG000|Overall Study|Adverse Event|0|||
163123934|NCT01918332|589162064|FG001|Overall Study|Adverse Event|0|||
163123935|NCT01918332|589162065|FG002|Overall Study|Adverse Event|0|||
163123936|NCT01918332|589162066|FG003|Overall Study|Adverse Event|1|||
163123937|NCT01918332|589162063|FG000|Overall Study|Withdrawal by Subject|2|||
163123938|NCT01918332|589162064|FG001|Overall Study|Withdrawal by Subject|3|||
163123939|NCT01918332|589162065|FG002|Overall Study|Withdrawal by Subject|2|||
163123940|NCT01918332|589162066|FG003|Overall Study|Withdrawal by Subject|3|||
163123941|NCT01918332|589162063|FG000|Overall Study|Protocol Violation|6|||
163123942|NCT01918332|589162064|FG001|Overall Study|Protocol Violation|2|||
163123943|NCT01918332|589162065|FG002|Overall Study|Protocol Violation|6|||
163123944|NCT01918332|589162066|FG003|Overall Study|Protocol Violation|3|||
163123945|NCT01918332|589162063|FG000|Overall Study|lipid result by central lab did not meet|0|||
163123946|NCT01918332|589162064|FG001|Overall Study|lipid result by central lab did not meet|0|||
163123947|NCT01918332|589162065|FG002|Overall Study|lipid result by central lab did not meet|1|||
163341525|NCT01159600|589958273|FG003|Overall Study|Lost to Follow-up|3|||
163341526|NCT01159600|589958274|FG004|Overall Study|Lost to Follow-up|3|||
163123948|NCT01918332|589162066|FG003|Overall Study|lipid result by central lab did not meet|0|||
163123949|NCT02252965|589162069|FG000|Overall Study|Adverse Event|9|||
163123950|NCT02252965|589162070|FG001|Overall Study|Adverse Event|14|||
163123951|NCT02252965|589162069|FG000|Overall Study|Lost to Follow-up|16|||
163341527|NCT01159600|589958275|FG005|Overall Study|Lost to Follow-up|0|||
163341528|NCT01159600|589958276|FG006|Overall Study|Lost to Follow-up|3|||
163123952|NCT02252965|589162070|FG001|Overall Study|Lost to Follow-up|8|||
163123953|NCT02252965|589162069|FG000|Overall Study|Protocol Violation|4|||
163123954|NCT02252965|589162070|FG001|Overall Study|Protocol Violation|5|||
163123955|NCT02252965|589162069|FG000|Overall Study|Lack of Efficacy|0|||
163123956|NCT02252965|589162070|FG001|Overall Study|Lack of Efficacy|2|||
163123957|NCT02252965|589162069|FG000|Overall Study|Withdrawal by Subject|7|||
163123958|NCT02252965|589162070|FG001|Overall Study|Withdrawal by Subject|9|||
163123959|NCT02252965|589162069|FG000|Overall Study|Other|4|||
163123960|NCT02252965|589162070|FG001|Overall Study|Other|5|||
163123961|NCT04736628|589162075|FG000|Overall Study|Not treated|0|||
163123962|NCT04736628|589162076|FG001|Overall Study|Not treated|0|||
163123963|NCT04736628|589162077|FG002|Overall Study|Not treated|0|||
163123964|NCT04736628|589162078|FG003|Overall Study|Not treated|2|||
163123965|NCT04736628|589162075|FG000|Overall Study|Other reason than listed|1|||
163123966|NCT04736628|589162076|FG001|Overall Study|Other reason than listed|2|||
163123967|NCT04736628|589162077|FG002|Overall Study|Other reason than listed|2|||
163123968|NCT04736628|589162078|FG003|Overall Study|Other reason than listed|3|||
163123969|NCT04736628|589162075|FG000|Overall Study|Protocol deviation|0|||
163123970|NCT04736628|589162076|FG001|Overall Study|Protocol deviation|0|||
163123971|NCT04736628|589162077|FG002|Overall Study|Protocol deviation|0|||
163123972|NCT04736628|589162078|FG003|Overall Study|Protocol deviation|1|||
163123973|NCT04736628|589162075|FG000|Overall Study|Burden of study procedures|1|||
163123974|NCT04736628|589162076|FG001|Overall Study|Burden of study procedures|0|||
163123975|NCT04736628|589162077|FG002|Overall Study|Burden of study procedures|0|||
163123976|NCT04736628|589162078|FG003|Overall Study|Burden of study procedures|1|||
163123977|NCT04736628|589162075|FG000|Overall Study|Change of residence|0|||
163123978|NCT04736628|589162076|FG001|Overall Study|Change of residence|1|||
163123979|NCT04736628|589162077|FG002|Overall Study|Change of residence|0|||
163123980|NCT04736628|589162078|FG003|Overall Study|Change of residence|0|||
163123981|NCT04736628|589162075|FG000|Overall Study|Perceived lack of efficacy|1|||
163123982|NCT04736628|589162076|FG001|Overall Study|Perceived lack of efficacy|0|||
163123983|NCT04736628|589162077|FG002|Overall Study|Perceived lack of efficacy|0|||
163123984|NCT04736628|589162078|FG003|Overall Study|Perceived lack of efficacy|1|||
163123985|NCT04736628|589162075|FG000|Overall Study|Adverse Event|3|||
163123986|NCT04736628|589162076|FG001|Overall Study|Adverse Event|2|||
163123987|NCT04736628|589162077|FG002|Overall Study|Adverse Event|4|||
163123988|NCT04736628|589162078|FG003|Overall Study|Adverse Event|3|||
163123989|NCT04279613|589162079|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
163123990|NCT04279613|589162080|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
163123991|NCT04279613|589162081|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
163123992|NCT04279613|589162082|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
163123993|NCT04279613|589162083|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
163123994|NCT04279613|589162079|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
163123995|NCT04279613|589162080|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
163123996|NCT04279613|589162081|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
163123997|NCT04279613|589162082|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
163123998|NCT04279613|589162083|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
163123999|NCT04279613|589162079|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
163124000|NCT04279613|589162080|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
163124001|NCT04279613|589162081|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
163124002|NCT04279613|589162082|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
163124003|NCT04279613|589162083|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
163225352|NCT00653224|589541987|FG001|Overall Study|Loss of efficacy|0|||
163225353|NCT00653224|589541986|FG000|Overall Study|Lost to Follow-up|1|||
163225354|NCT00653224|589541987|FG001|Overall Study|Lost to Follow-up|0|||
163225355|NCT00653224|589541986|FG000|Overall Study|Other|2|||
163225356|NCT00653224|589541987|FG001|Overall Study|Other|4|||
163225357|NCT03756558|589541988|FG000|Overall Study|Death|1|||
163225358|NCT03756558|589541988|FG000|Overall Study|Lost to Follow-up|2|||
163225359|NCT03756558|589541988|FG000|Overall Study|Withdrawal by Subject|2|||
163225360|NCT02896400|589541989|FG000|1 Month Follow-up|Lost to Follow-up|7|||
163225361|NCT02896400|589541990|FG001|1 Month Follow-up|Lost to Follow-up|7|||
163225362|NCT02896400|589541991|FG002|1 Month Follow-up|Lost to Follow-up|5|||
163225363|NCT02896400|589541992|FG003|1 Month Follow-up|Lost to Follow-up|8|||
163225364|NCT02896400|589541993|FG004|1 Month Follow-up|Lost to Follow-up|9|||
163225365|NCT02896400|589541994|FG005|1 Month Follow-up|Lost to Follow-up|6|||
163225366|NCT02896400|589541995|FG006|1 Month Follow-up|Lost to Follow-up|5|||
163225367|NCT02896400|589541996|FG007|1 Month Follow-up|Lost to Follow-up|6|||
163124004|NCT04279613|589162079|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
163124005|NCT04279613|589162080|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
163124006|NCT04279613|589162081|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
163225368|NCT02896400|589541997|FG008|1 Month Follow-up|Lost to Follow-up|4|||
163225369|NCT02896400|589541998|FG009|1 Month Follow-up|Lost to Follow-up|7|||
163124007|NCT04279613|589162082|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
163124008|NCT04279613|589162083|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
163124009|NCT04279613|589162079|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
163124010|NCT04279613|589162080|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
163341529|NCT01159600|589958277|FG007|Overall Study|Lost to Follow-up|2|||
163341530|NCT01159600|589958270|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
163341531|NCT01159600|589958271|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
163341532|NCT01159600|589958272|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
163341533|NCT01159600|589958273|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
163341534|NCT01159600|589958274|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
163341535|NCT01159600|589958275|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
163341536|NCT01159600|589958276|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
163341537|NCT01159600|589958277|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
163341538|NCT01159600|589958270|FG000|Overall Study|Other reason not defined above|3|||
163341539|NCT01159600|589958271|FG001|Overall Study|Other reason not defined above|0|||
163341540|NCT01159600|589958272|FG002|Overall Study|Other reason not defined above|4|||
163341541|NCT01159600|589958273|FG003|Overall Study|Other reason not defined above|2|||
163341542|NCT01159600|589958274|FG004|Overall Study|Other reason not defined above|5|||
163341543|NCT01159600|589958275|FG005|Overall Study|Other reason not defined above|7|||
163341544|NCT01159600|589958276|FG006|Overall Study|Other reason not defined above|3|||
163341545|NCT01159600|589958277|FG007|Overall Study|Other reason not defined above|3|||
163341546|NCT04919499|589958278|FG000|Overall Study|Adverse Event|0|||
163341547|NCT04919499|589958279|FG001|Overall Study|Adverse Event|0|||
163341548|NCT04919499|589958280|FG002|Overall Study|Adverse Event|0|||
163341549|NCT04919499|589958281|FG003|Overall Study|Adverse Event|0|||
163341550|NCT04919499|589958282|FG004|Overall Study|Adverse Event|2|||
163341551|NCT04919499|589958278|FG000|Overall Study|Not treated|0|||
163341552|NCT04919499|589958279|FG001|Overall Study|Not treated|0|||
163341553|NCT04919499|589958280|FG002|Overall Study|Not treated|0|||
163341554|NCT04919499|589958281|FG003|Overall Study|Not treated|1|||
163341555|NCT04919499|589958282|FG004|Overall Study|Not treated|0|||
163341556|NCT04851587|589959548|FG000|Overall Study|Lost to Follow-up|18|||
163341557|NCT05878990|589959549|FG000|Overall Study|Lost to Follow-up|7|||
163341558|NCT05878990|589959549|FG000|Overall Study|Withdrawal by Subject|1|||
163341559|NCT03605745|589959550|FG000|Overall Study|Study was terminated for business reasons|47|||
163341560|NCT01074229|589959551|FG000|Overall Study|Lost to Follow-up|1|||
163341561|NCT01074229|589959552|FG001|Overall Study|Lost to Follow-up|0|||
163341562|NCT01074229|589959553|FG002|Overall Study|Lost to Follow-up|0|||
163341563|NCT01074229|589959551|FG000|Overall Study|Change to open surgical procedure|1|||
163341564|NCT01074229|589959552|FG001|Overall Study|Change to open surgical procedure|3|||
163341565|NCT01074229|589959553|FG002|Overall Study|Change to open surgical procedure|4|||
163341566|NCT00584909|589959554|FG000|Overall Study|Adverse Event|4|||
163341567|NCT03436797|589959555|FG000|Main Study|Withdrawal by Subject|2|||
163341568|NCT03436797|589959555|FG000|Main Study|Adverse Event|4|||
163341569|NCT03436797|589959555|FG000|Main Study|Lost to Follow-up|1|||
163341570|NCT03436797|589959555|FG000|Main Study|Death|1|||
163341571|NCT03436797|589959555|FG000|Main Study|Non-Specific|2|||
163341572|NCT03436797|589959555|FG000|Extended Dosing|Patient decision|1|||
163341573|NCT01951105|589959558|FG000|Overall Study|Adverse Event|0|||
163124011|NCT04279613|589162081|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
163124012|NCT04279613|589162082|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
163124013|NCT04279613|589162083|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
163124014|NCT02478164|589162084|FG000|Overall Study|Lack of Efficacy|13|||
163124015|NCT02478164|589162084|FG000|Overall Study|Adverse Event|1|||
163124016|NCT02478164|589162084|FG000|Overall Study|Withdrawal by Subject|1|||
163124017|NCT04051827|589162085|FG000|Overall Study|Death|1|||
163124018|NCT04051827|589162085|FG000|Overall Study|Withdrawal by Subject|4|||
163124019|NCT04051827|589162085|FG000|Overall Study|Progressive disease|16|||
163124020|NCT04051827|589162085|FG000|Overall Study|Physician Decision|1|||
163124021|NCT04051827|589162085|FG000|Overall Study|Other|4|||
163124022|NCT05779007|589162086|FG000|Overall Study|not meeting eligibility criteria|3517|||
163124023|NCT05779007|589162087|FG001|Overall Study|not meeting eligibility criteria|2009|||
163124024|NCT01424566|589162088|FG000|Single-blind Treatment|Adverse Event|71|||
163124025|NCT01424566|589162089|FG001|Single-blind Treatment|Adverse Event|0|||
163225370|NCT02896400|589541999|FG010|1 Month Follow-up|Lost to Follow-up|5|||
163341574|NCT01951105|589959559|FG001|Overall Study|Adverse Event|5|||
163124026|NCT01424566|589162090|FG002|Single-blind Treatment|Adverse Event|0|||
163124027|NCT01424566|589162088|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
163124028|NCT01424566|589162089|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
163225371|NCT02896400|589542000|FG011|1 Month Follow-up|Lost to Follow-up|5|||
163225372|NCT02896400|589542001|FG012|1 Month Follow-up|Lost to Follow-up|3|||
163225373|NCT02896400|589542002|FG013|1 Month Follow-up|Lost to Follow-up|4|||
163341575|NCT01951105|589959560|FG002|Overall Study|Adverse Event|0|||
163341576|NCT01951105|589959558|FG000|Overall Study|Lost to Follow-up|0|||
163341577|NCT01951105|589959559|FG001|Overall Study|Lost to Follow-up|1|||
163341578|NCT01951105|589959560|FG002|Overall Study|Lost to Follow-up|0|||
163341579|NCT01951105|589959558|FG000|Overall Study|Protocol Violation|1|||
163341580|NCT01951105|589959559|FG001|Overall Study|Protocol Violation|1|||
163341581|NCT01951105|589959560|FG002|Overall Study|Protocol Violation|1|||
163341582|NCT01951105|589959558|FG000|Overall Study|Withdrawal by Subject|0|||
163124029|NCT01424566|589162090|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
163341583|NCT01951105|589959559|FG001|Overall Study|Withdrawal by Subject|3|||
163341584|NCT01951105|589959560|FG002|Overall Study|Withdrawal by Subject|1|||
163341585|NCT02727998|589959561|FG000|Overall Study|Lost to Follow-up|3|||
163341586|NCT02727998|589959562|FG001|Overall Study|Lost to Follow-up|3|||
163124030|NCT01424566|589162088|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
163124031|NCT01424566|589162089|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
163124032|NCT01424566|589162090|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
163124033|NCT01424566|589162088|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
163124034|NCT01424566|589162089|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
163124035|NCT01424566|589162090|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
163124036|NCT01424566|589162088|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
163124037|NCT01424566|589162089|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
163124038|NCT01424566|589162090|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
163124039|NCT01424566|589162088|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
163124040|NCT01424566|589162089|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
163124041|NCT01424566|589162090|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
163124042|NCT01424566|589162088|FG000|Double-blind Treatment|Adverse Event|0|||
163124043|NCT01424566|589162089|FG001|Double-blind Treatment|Adverse Event|21|||
163124044|NCT01424566|589162090|FG002|Double-blind Treatment|Adverse Event|13|||
163124045|NCT01424566|589162088|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
163124046|NCT01424566|589162089|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
163124047|NCT01424566|589162090|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
163124048|NCT01424566|589162088|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
163124049|NCT01424566|589162089|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
163124050|NCT01424566|589162090|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
163124051|NCT01424566|589162088|FG000|Double-blind Treatment|Lack of Efficacy|0|||
163124052|NCT01424566|589162089|FG001|Double-blind Treatment|Lack of Efficacy|1|||
163124053|NCT01424566|589162090|FG002|Double-blind Treatment|Lack of Efficacy|1|||
163124054|NCT00680368|589162093|FG000|Overall Study|not supervised, not eligible|15|||
163124055|NCT03779503|589162094|FG000|First Intervention|Adverse Event|0|||
163124056|NCT03779503|589162095|FG001|First Intervention|Adverse Event|1|||
163124057|NCT03779503|589162094|FG000|First Intervention|Withdrawal by Subject|1|||
163124058|NCT03779503|589162095|FG001|First Intervention|Withdrawal by Subject|0|||
163124059|NCT02771626|589162099|FG000|Overall Study|Adverse Event|1|||
163124060|NCT02771626|589162100|FG001|Overall Study|Adverse Event|5|||
163124061|NCT02771626|589162101|FG002|Overall Study|Adverse Event|3|||
163124062|NCT02771626|589162102|FG003|Overall Study|Adverse Event|0|||
163124063|NCT02771626|589162103|FG004|Overall Study|Adverse Event|1|||
163124064|NCT02771626|589162104|FG005|Overall Study|Adverse Event|1|||
163124065|NCT02771626|589162099|FG000|Overall Study|Radiologic Disease Progression|6|||
163124066|NCT02771626|589162100|FG001|Overall Study|Radiologic Disease Progression|13|||
163124067|NCT02771626|589162101|FG002|Overall Study|Radiologic Disease Progression|10|||
163124068|NCT02771626|589162102|FG003|Overall Study|Radiologic Disease Progression|7|||
163124069|NCT02771626|589162103|FG004|Overall Study|Radiologic Disease Progression|28|||
163124070|NCT02771626|589162104|FG005|Overall Study|Radiologic Disease Progression|15|||
163124071|NCT02771626|589162099|FG000|Overall Study|Symptomatic Deterioration|0|||
163124072|NCT02771626|589162100|FG001|Overall Study|Symptomatic Deterioration|4|||
163124073|NCT02771626|589162101|FG002|Overall Study|Symptomatic Deterioration|2|||
163124074|NCT02771626|589162102|FG003|Overall Study|Symptomatic Deterioration|0|||
163124075|NCT02771626|589162103|FG004|Overall Study|Symptomatic Deterioration|5|||
163124076|NCT02771626|589162104|FG005|Overall Study|Symptomatic Deterioration|2|||
163124077|NCT02771626|589162099|FG000|Overall Study|Participant Request|0|||
163124078|NCT02771626|589162100|FG001|Overall Study|Participant Request|1|||
163124079|NCT02771626|589162101|FG002|Overall Study|Participant Request|0|||
163124080|NCT02771626|589162102|FG003|Overall Study|Participant Request|2|||
163124081|NCT02771626|589162103|FG004|Overall Study|Participant Request|0|||
163124082|NCT02771626|589162104|FG005|Overall Study|Participant Request|1|||
163124083|NCT02771626|589162099|FG000|Overall Study|Investigator Decision|0|||
163124084|NCT02771626|589162100|FG001|Overall Study|Investigator Decision|1|||
163124085|NCT02771626|589162101|FG002|Overall Study|Investigator Decision|0|||
163341587|NCT02727998|589959561|FG000|Overall Study|Withdrawal by Subject|0|||
163341588|NCT02727998|589959562|FG001|Overall Study|Withdrawal by Subject|1|||
163124086|NCT02771626|589162102|FG003|Overall Study|Investigator Decision|0|||
163124087|NCT02771626|589162103|FG004|Overall Study|Investigator Decision|1|||
163124088|NCT02771626|589162104|FG005|Overall Study|Investigator Decision|0|||
163124089|NCT02771626|589162099|FG000|Overall Study|Study Termination by Sponsor|0|||
163124090|NCT02771626|589162100|FG001|Overall Study|Study Termination by Sponsor|2|||
163124091|NCT02771626|589162101|FG002|Overall Study|Study Termination by Sponsor|1|||
163124092|NCT02771626|589162102|FG003|Overall Study|Study Termination by Sponsor|0|||
163124093|NCT02771626|589162103|FG004|Overall Study|Study Termination by Sponsor|1|||
163124094|NCT02771626|589162104|FG005|Overall Study|Study Termination by Sponsor|0|||
163341589|NCT05072795|589959565|FG000|Overall Study|Lost to Follow-up|5|||
163341590|NCT00422162|589959568|FG000|Overall Study|Adverse Event|11|||
163124095|NCT02771626|589162099|FG000|Overall Study|Informed Consent Withdrawn|0|||
163124096|NCT02771626|589162100|FG001|Overall Study|Informed Consent Withdrawn|0|||
163124097|NCT02771626|589162101|FG002|Overall Study|Informed Consent Withdrawn|1|||
163124098|NCT02771626|589162102|FG003|Overall Study|Informed Consent Withdrawn|0|||
163124099|NCT02771626|589162103|FG004|Overall Study|Informed Consent Withdrawn|1|||
163124100|NCT02771626|589162104|FG005|Overall Study|Informed Consent Withdrawn|1|||
163124101|NCT02771626|589162099|FG000|Overall Study|Other, Not Specified|1|||
163124102|NCT02771626|589162100|FG001|Overall Study|Other, Not Specified|0|||
163124103|NCT02771626|589162101|FG002|Overall Study|Other, Not Specified|0|||
163124104|NCT02771626|589162102|FG003|Overall Study|Other, Not Specified|0|||
163124105|NCT02771626|589162103|FG004|Overall Study|Other, Not Specified|0|||
163124106|NCT02771626|589162104|FG005|Overall Study|Other, Not Specified|1|||
163124107|NCT02690649|589162105|FG000|Overall Study|Withdrawal by Subject|1|||
163124108|NCT02690649|589162106|FG001|Overall Study|Withdrawal by Subject|1|||
163124109|NCT02690649|589162105|FG000|Overall Study|Protocol Violation|0|||
163124110|NCT02690649|589162106|FG001|Overall Study|Protocol Violation|3|||
163124111|NCT02392403|589162107|FG000|Overall Study|Adverse Event|1|||
163124112|NCT02392403|589162107|FG000|Overall Study|Death|1|||
163124113|NCT02392403|589162107|FG000|Overall Study|Withdrawal by Subject|1|||
163124114|NCT00316888|589162113|FG000|Overall Study|Adverse Event|4|||
163124115|NCT00316888|589162114|FG001|Overall Study|Adverse Event|5|||
163124116|NCT00316888|589162113|FG000|Overall Study|Withdrawal by Subject|2|||
163124117|NCT00316888|589162114|FG001|Overall Study|Withdrawal by Subject|2|||
163124118|NCT00316888|589162113|FG000|Overall Study|Not start protocol therapy|0|||
163124119|NCT00316888|589162114|FG001|Overall Study|Not start protocol therapy|1|||
163124120|NCT00657371|589162115|FG000|Overall Study|Poor bowel preparation|15|||
163124121|NCT00657371|589162115|FG000|Overall Study|Unable to intubate the cecum|5|||
163124122|NCT00657371|589162115|FG000|Overall Study|Protocol Violation|2|||
163124123|NCT00657371|589162115|FG000|Overall Study|Device- related reasons|13|||
163124124|NCT00657371|589162115|FG000|Overall Study|Pre-existing medical condition|4|||
163124125|NCT00652899|589162116|FG000|Overall Study|Death|1|||
163124126|NCT00652899|589162116|FG000|Overall Study|Treating physician decision|1|||
163124127|NCT02715726|589162117|FG000|Overall Study|Adverse Event|2|||
163124128|NCT02715726|589162118|FG001|Overall Study|Adverse Event|6|||
163124129|NCT02715726|589162117|FG000|Overall Study|Protocol Violation|1|||
163124130|NCT02715726|589162118|FG001|Overall Study|Protocol Violation|0|||
163124131|NCT02715726|589162117|FG000|Overall Study|Death|2|||
163124132|NCT02715726|589162118|FG001|Overall Study|Death|1|||
163124133|NCT02715726|589162117|FG000|Overall Study|Participant moved|1|||
163124134|NCT02715726|589162118|FG001|Overall Study|Participant moved|3|||
163124135|NCT02715726|589162117|FG000|Overall Study|Other than specified above|11|||
163124136|NCT02715726|589162118|FG001|Overall Study|Other than specified above|15|||
163124137|NCT02715726|589162117|FG000|Overall Study|Randomized but not treated|1|||
163124138|NCT02715726|589162118|FG001|Overall Study|Randomized but not treated|2|||
163124139|NCT02445573|589162119|FG000|Overall Study|Withdrawal by Subject|1|||
163124140|NCT02445573|589162120|FG001|Overall Study|Withdrawal by Subject|1|||
163124141|NCT02445573|589162119|FG000|Overall Study|Lost to Follow-up|0|||
163124142|NCT02445573|589162120|FG001|Overall Study|Lost to Follow-up|1|||
163124143|NCT01565941|589162121|FG000|Overall Study|Withdrawn by parent/guardian|3|||
163124144|NCT01565941|589162122|FG001|Overall Study|Withdrawn by parent/guardian|2|||
163124145|NCT01565941|589162121|FG000|Overall Study|Randomized; did not receive intevention|8|||
163124146|NCT01565941|589162122|FG001|Overall Study|Randomized; did not receive intevention|2|||
163124147|NCT03629912|589162130|FG000|Overall Study|Lost to Follow-up|19|||
163124148|NCT03629912|589162131|FG001|Overall Study|Lost to Follow-up|7|||
163124149|NCT03629912|589162132|FG002|Overall Study|Lost to Follow-up|5|||
163124150|NCT03629912|589162133|FG003|Overall Study|Lost to Follow-up|1|||
163124151|NCT03629912|589162130|FG000|Overall Study|Withdrawal by Subject|6|||
163124152|NCT03629912|589162131|FG001|Overall Study|Withdrawal by Subject|0|||
163124153|NCT03629912|589162132|FG002|Overall Study|Withdrawal by Subject|1|||
163124154|NCT03629912|589162133|FG003|Overall Study|Withdrawal by Subject|2|||
163124155|NCT03629912|589162130|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
163124156|NCT03629912|589162131|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
163225374|NCT02896400|589542003|FG014|1 Month Follow-up|Lost to Follow-up|1|||
163341591|NCT00422162|589959569|FG001|Overall Study|Adverse Event|9|||
163124157|NCT03629912|589162132|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
163124158|NCT03629912|589162133|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
163124159|NCT03629912|589162130|FG000|Overall Study|Death|1|||
163124160|NCT03629912|589162131|FG001|Overall Study|Death|0|||
163124161|NCT03629912|589162132|FG002|Overall Study|Death|0|||
163124162|NCT03629912|589162133|FG003|Overall Study|Death|0|||
163124163|NCT02608450|589162134|FG000|Overall Study|Lost to Follow-up|39|||
163124164|NCT02608450|589162135|FG001|Overall Study|Lost to Follow-up|32|||
163124165|NCT02608450|589162134|FG000|Overall Study|Withdrawal by Subject|21|||
163124166|NCT02608450|589162135|FG001|Overall Study|Withdrawal by Subject|15|||
163124167|NCT02608450|589162134|FG000|Overall Study|Adverse Event|3|||
163124168|NCT02608450|589162135|FG001|Overall Study|Adverse Event|6|||
163124169|NCT02608450|589162134|FG000|Overall Study|Withdrawal by parent|2|||
163341592|NCT00422162|589959568|FG000|Overall Study|Lack of Efficacy|4|||
163124170|NCT02608450|589162135|FG001|Overall Study|Withdrawal by parent|3|||
163124171|NCT02608450|589162134|FG000|Overall Study|Lack of Efficacy|0|||
163124172|NCT02608450|589162135|FG001|Overall Study|Lack of Efficacy|3|||
163124173|NCT02608450|589162134|FG000|Overall Study|Noncompliance with study drug|0|||
163124174|NCT02608450|589162135|FG001|Overall Study|Noncompliance with study drug|2|||
163124175|NCT02608450|589162134|FG000|Overall Study|Physician Decision|0|||
163124176|NCT02608450|589162135|FG001|Overall Study|Physician Decision|1|||
163124177|NCT02608450|589162134|FG000|Overall Study|Pregnancy|0|||
163124178|NCT02608450|589162135|FG001|Overall Study|Pregnancy|1|||
163124179|NCT02608450|589162134|FG000|Overall Study|Progressive disease|1|||
163124180|NCT02608450|589162135|FG001|Overall Study|Progressive disease|0|||
163124181|NCT02608450|589162134|FG000|Overall Study|Multiple reasons|0|||
163124182|NCT02608450|589162135|FG001|Overall Study|Multiple reasons|2|||
163124183|NCT02565810|589162136|FG000|Overall Study|Withdrawal by Subject|1|||
163124184|NCT02636946|589162139|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
163124185|NCT02636946|589162140|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
163124186|NCT02636946|589162139|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
163124187|NCT02636946|589162140|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
163124188|NCT02636946|589162139|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
163124189|NCT02636946|589162140|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
163124190|NCT02636946|589162139|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
163124191|NCT02636946|589162140|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
163124192|NCT02636946|589162139|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
163124193|NCT02636946|589162140|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
163124194|NCT02636946|589162139|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
163124195|NCT02636946|589162140|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
163124196|NCT03089944|589162141|FG000|Overall Study|Lost to Follow-up|8|||
163124197|NCT03089944|589162141|FG000|Overall Study|Withdrew Consent|2|||
163124198|NCT03089944|589162141|FG000|Overall Study|Adverse Event|1|||
163124199|NCT03089944|589162141|FG000|Overall Study|Other|1|||
163124200|NCT02308488|589162142|FG000|Overall Study|Withdrawal by Subject|2|||
163124201|NCT01541917|589162143|FG000|Overall Study|Lost to Follow-up|2|||
163124202|NCT01541917|589162144|FG001|Overall Study|Lost to Follow-up|2|||
163124203|NCT01541917|589162143|FG000|Overall Study|Withdrawal by Subject|13|||
163124204|NCT01541917|589162144|FG001|Overall Study|Withdrawal by Subject|7|||
163124205|NCT00121641|589162149|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
163124206|NCT00121641|589162150|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
163124207|NCT00121641|589162151|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
163124208|NCT00121641|589162152|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
163124209|NCT00121641|589162153|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
163124210|NCT00121641|589162149|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
163124211|NCT00121641|589162150|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
163124212|NCT00121641|589162151|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
163124213|NCT00121641|589162152|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
163124214|NCT00121641|589162153|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
163124215|NCT00121641|589162149|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
163124216|NCT00121641|589162150|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
163124217|NCT00121641|589162151|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
163124218|NCT00121641|589162152|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
163124219|NCT00121641|589162153|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
163124220|NCT00121641|589162149|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
163124221|NCT00121641|589162150|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
163124222|NCT00121641|589162151|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
163124223|NCT00121641|589162152|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
163124224|NCT00121641|589162153|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
163124225|NCT00121641|589162149|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
163124226|NCT00121641|589162150|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
163124227|NCT00121641|589162151|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
163124228|NCT00121641|589162152|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
163341593|NCT00422162|589959569|FG001|Overall Study|Lack of Efficacy|10|||
163341594|NCT00422162|589959568|FG000|Overall Study|Withdrawal by Subject|7|||
163341595|NCT00422162|589959569|FG001|Overall Study|Withdrawal by Subject|6|||
163341596|NCT00422162|589959568|FG000|Overall Study|Lost to Follow-up|1|||
163124229|NCT00121641|589162153|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
163124230|NCT00121641|589162149|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
163124231|NCT00121641|589162150|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
163124232|NCT00121641|589162151|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
163124233|NCT00121641|589162152|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
163341597|NCT00422162|589959569|FG001|Overall Study|Lost to Follow-up|2|||
163408163|NCT02432235|590204039|FG007|Overall Study|Lost to Follow-up|0|||
163341598|NCT00422162|589959568|FG000|Overall Study|Non-Compliant with Protocol|1|||
163341599|NCT00422162|589959569|FG001|Overall Study|Non-Compliant with Protocol|1|||
163341600|NCT00422162|589959568|FG000|Overall Study|Other|0|||
163124234|NCT00121641|589162153|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
163124235|NCT00121641|589162149|FG000|24-week Short-term Treatment Period|Other Reason|1|||
163124236|NCT00121641|589162150|FG001|24-week Short-term Treatment Period|Other Reason|0|||
163124237|NCT00121641|589162151|FG002|24-week Short-term Treatment Period|Other Reason|0|||
163124238|NCT00121641|589162152|FG003|24-week Short-term Treatment Period|Other Reason|0|||
163124239|NCT00121641|589162153|FG004|24-week Short-term Treatment Period|Other Reason|0|||
163124240|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
163124241|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
163124242|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
163124243|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
163124244|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
163124245|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
163124246|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
163124247|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
163124248|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
163124249|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
163124250|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
163124251|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
163124252|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
163124253|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
163124254|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
163124255|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
163124256|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
163124257|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
163124258|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
163124259|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
163124260|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
163124261|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
163124262|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
163124263|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
163124264|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
163124265|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
163124266|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
163124267|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
163124268|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
163124269|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
163124270|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
163124271|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
163124272|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
163124273|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
163124274|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
163124275|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
163124276|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
163124277|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
163124278|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
163124279|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
163124280|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Death|0|||
163124281|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Death|0|||
163124282|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Death|0|||
163124283|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Death|1|||
163124284|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Death|0|||
163124285|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Missing|0|||
163124286|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Missing|0|||
163124287|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Missing|1|||
163124288|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Missing|0|||
163124289|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Missing|0|||
163124290|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
163124291|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
163124292|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
163124293|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
163124294|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
163341601|NCT00422162|589959569|FG001|Overall Study|Other|1|||
163124295|NCT01792518|589162154|FG000|Overall Study|Adverse Event|3|||
163124296|NCT01792518|589162155|FG001|Overall Study|Adverse Event|4|||
163124297|NCT01792518|589162154|FG000|Overall Study|Protocol Violation|0|||
163124298|NCT01792518|589162155|FG001|Overall Study|Protocol Violation|1|||
163124299|NCT01792518|589162154|FG000|Overall Study|Lost to Follow-up|3|||
163124300|NCT01792518|589162155|FG001|Overall Study|Lost to Follow-up|1|||
163124301|NCT01792518|589162154|FG000|Overall Study|Withdrawal by Subject|2|||
163124302|NCT01792518|589162155|FG001|Overall Study|Withdrawal by Subject|0|||
163124303|NCT01792518|589162154|FG000|Overall Study|Other Reason|0|||
163124304|NCT01792518|589162155|FG001|Overall Study|Other Reason|1|||
163124305|NCT03263780|589162156|FG000|Overall Study|Withdrawal by Subject|3|||
163124306|NCT03263780|589162156|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
163124307|NCT01504204|589162157|FG000|Overall Study|Lost to Follow-up|1|||
163124308|NCT01504204|589162158|FG001|Overall Study|Lost to Follow-up|1|||
163124309|NCT02241187|589162161|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
163124310|NCT02966015|589162162|FG000|Inclusion Visit|did not answer questionnaire|8|||
163124311|NCT02966015|589162163|FG001|Inclusion Visit|did not answer questionnaire|3|||
163124312|NCT02356887|589162164|FG000|Overall Study|poor compliance|2|||
163124313|NCT00558272|589162169|FG000|Overall Study|Adverse Event|10|||
163124314|NCT00558272|589162170|FG001|Overall Study|Adverse Event|0|||
163124315|NCT00558272|589162169|FG000|Overall Study|Death|1|||
163124316|NCT00558272|589162170|FG001|Overall Study|Death|0|||
163124317|NCT00558272|589162169|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
163124318|NCT00558272|589162170|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
163124319|NCT00558272|589162169|FG000|Overall Study|AZ study team decision|0|||
163124320|NCT00558272|589162170|FG001|Overall Study|AZ study team decision|1|||
163124321|NCT00558272|589162169|FG000|Overall Study|Incorrectly enrolled|1|||
163124322|NCT00558272|589162170|FG001|Overall Study|Incorrectly enrolled|0|||
163124323|NCT00558272|589162169|FG000|Overall Study|Withdrawal by Subject|0|||
163124324|NCT00558272|589162170|FG001|Overall Study|Withdrawal by Subject|1|||
163124325|NCT03442296|589162175|FG000|3 Month Follow-up|Death|3|||
163124326|NCT03442296|589162176|FG001|3 Month Follow-up|Death|1|||
163124327|NCT03442296|589162175|FG000|3 Month Follow-up|Lost to Follow-up|1|||
163124328|NCT03442296|589162176|FG001|3 Month Follow-up|Lost to Follow-up|1|||
163124329|NCT03442296|589162175|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
163124330|NCT03442296|589162176|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
163124331|NCT03442296|589162175|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
163124332|NCT03442296|589162176|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
163124333|NCT03442296|589162175|FG000|12 Month Follow-up|Incomplete measurement|1|||
163124334|NCT03442296|589162176|FG001|12 Month Follow-up|Incomplete measurement|1|||
163124335|NCT00447122|589162177|FG000|Overall Study|worsening medical condition -came off|0|||
163124336|NCT00447122|589162178|FG001|Overall Study|worsening medical condition -came off|1|||
163124337|NCT00447122|589162179|FG002|Overall Study|worsening medical condition -came off|0|||
163124338|NCT00447122|589162180|FG003|Overall Study|worsening medical condition -came off|0|||
163124339|NCT02409342|589162181|FG000|Overall Study|Death|211|||
163124340|NCT02409342|589162182|FG001|Overall Study|Death|201|||
163124341|NCT02409342|589162181|FG000|Overall Study|Withdrawal by Subject|24|||
163124342|NCT02409342|589162182|FG001|Overall Study|Withdrawal by Subject|17|||
163124343|NCT02409342|589162181|FG000|Overall Study|Study Terminated By Sponsor|48|||
163124344|NCT02409342|589162182|FG001|Overall Study|Study Terminated By Sponsor|59|||
163124345|NCT02409342|589162181|FG000|Overall Study|Lost to Follow-up|3|||
163341602|NCT00422162|589959568|FG000|Overall Study|Didn't Receive Treatment|0|||
163341603|NCT00422162|589959569|FG001|Overall Study|Didn't Receive Treatment|1|||
163341604|NCT05274906|589959570|FG000|Overall Study|Withdrawal by Subject|2|||
163341605|NCT05274906|589959571|FG001|Overall Study|Withdrawal by Subject|1|||
163124346|NCT02409342|589162182|FG001|Overall Study|Lost to Follow-up|5|||
163124347|NCT02409342|589162181|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
163124348|NCT02409342|589162182|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
163124349|NCT02409342|589162181|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
163124350|NCT02409342|589162182|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
163124351|NCT02409342|589162181|FG000|Overall Study|Sponsor Decision|1|||
163124352|NCT02409342|589162182|FG001|Overall Study|Sponsor Decision|0|||
163124353|NCT00279812|589162183|FG000|Overall Study|Protocol Violation|1|||
163124354|NCT00279812|589162184|FG001|Overall Study|Protocol Violation|1|||
163124355|NCT00279812|589162185|FG002|Overall Study|Protocol Violation|0|||
163124356|NCT00279812|589162186|FG003|Overall Study|Protocol Violation|0|||
163124357|NCT00279812|589162187|FG004|Overall Study|Protocol Violation|1|||
163124358|NCT00279812|589162188|FG005|Overall Study|Protocol Violation|0|||
163124359|NCT00279812|589162183|FG000|Overall Study|Withdrawal by Subject|0|||
163124360|NCT00279812|589162184|FG001|Overall Study|Withdrawal by Subject|4|||
163124361|NCT00279812|589162185|FG002|Overall Study|Withdrawal by Subject|2|||
163124362|NCT00279812|589162186|FG003|Overall Study|Withdrawal by Subject|0|||
163124363|NCT00279812|589162187|FG004|Overall Study|Withdrawal by Subject|0|||
163124364|NCT00279812|589162188|FG005|Overall Study|Withdrawal by Subject|0|||
163124365|NCT00279812|589162183|FG000|Overall Study|Adverse Event|0|||
163341606|NCT01622088|589959575|FG000|Overall Study|Adverse Event|20|||
163341607|NCT01622088|589959575|FG000|Overall Study|Lost to Follow-up|1|||
163341608|NCT01622088|589959575|FG000|Overall Study|Withdrawal by Subject|20|||
163341609|NCT01622088|589959575|FG000|Overall Study|Investigator Decision|1|||
163341610|NCT01622088|589959575|FG000|Overall Study|Death|53|||
163341611|NCT01622088|589959575|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
163341612|NCT02971683|589959576|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
163341613|NCT02971683|589959577|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
163124366|NCT00279812|589162184|FG001|Overall Study|Adverse Event|1|||
163124367|NCT00279812|589162185|FG002|Overall Study|Adverse Event|1|||
163124368|NCT00279812|589162186|FG003|Overall Study|Adverse Event|0|||
163124369|NCT00279812|589162187|FG004|Overall Study|Adverse Event|2|||
163124370|NCT00279812|589162188|FG005|Overall Study|Adverse Event|1|||
163124371|NCT04046250|589162196|FG000|Overall Study|Death|0|||
163124372|NCT04046250|589162197|FG001|Overall Study|Death|1|||
163124373|NCT04046250|589162196|FG000|Overall Study|Withdrawal by Subject|3|||
163124374|NCT04046250|589162197|FG001|Overall Study|Withdrawal by Subject|3|||
163124375|NCT03834220|589162202|FG000|Overall Study|Adverse Event|1|||
163124376|NCT03834220|589162203|FG001|Overall Study|Adverse Event|0|||
163124377|NCT03834220|589162204|FG002|Overall Study|Adverse Event|0|||
163124378|NCT03834220|589162202|FG000|Overall Study|Death|8|||
163124379|NCT03834220|589162203|FG001|Overall Study|Death|1|||
163124380|NCT03834220|589162204|FG002|Overall Study|Death|17|||
163124381|NCT03834220|589162202|FG000|Overall Study|Reason not Specified|9|||
163124382|NCT03834220|589162203|FG001|Overall Study|Reason not Specified|0|||
163124383|NCT03834220|589162204|FG002|Overall Study|Reason not Specified|6|||
163124384|NCT03834220|589162202|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
163124385|NCT03834220|589162203|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
163124386|NCT03834220|589162204|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
163124387|NCT03834220|589162202|FG000|Overall Study|Withdrawal of Consent|2|||
163124388|NCT03834220|589162203|FG001|Overall Study|Withdrawal of Consent|2|||
163124389|NCT03834220|589162204|FG002|Overall Study|Withdrawal of Consent|2|||
163124390|NCT00527332|589162206|FG000|Overall Study|Protocol Violation|4|||
163124391|NCT00527332|589162207|FG001|Overall Study|Protocol Violation|8|||
163124392|NCT00527332|589162206|FG000|Overall Study|Withdrew consent|5|||
163124393|NCT00527332|589162207|FG001|Overall Study|Withdrew consent|1|||
163124394|NCT03684694|589162210|FG000|Phase 1|Withdrawal by Subject|1|||
163124395|NCT03684694|589162211|FG001|Phase 1|Withdrawal by Subject|0|||
163124396|NCT03684694|589162212|FG002|Phase 1|Withdrawal by Subject|0|||
163124397|NCT03684694|589162213|FG003|Phase 1|Withdrawal by Subject|0|||
163124398|NCT03684694|589162214|FG004|Phase 1|Withdrawal by Subject|0|||
163124399|NCT03684694|589162215|FG005|Phase 1|Withdrawal by Subject|0|||
163124400|NCT03684694|589162210|FG000|Phase 1|Investigator/Sponsor Decision|12|||
163124401|NCT03684694|589162211|FG001|Phase 1|Investigator/Sponsor Decision|2|||
163124402|NCT03684694|589162212|FG002|Phase 1|Investigator/Sponsor Decision|1|||
163124403|NCT03684694|589162213|FG003|Phase 1|Investigator/Sponsor Decision|0|||
163124404|NCT03684694|589162214|FG004|Phase 1|Investigator/Sponsor Decision|0|||
163124405|NCT03684694|589162215|FG005|Phase 1|Investigator/Sponsor Decision|0|||
163124406|NCT03684694|589162210|FG000|Phase 1|Death|24|||
163124407|NCT03684694|589162211|FG001|Phase 1|Death|0|||
163124408|NCT03684694|589162212|FG002|Phase 1|Death|3|||
163124409|NCT03684694|589162213|FG003|Phase 1|Death|0|||
163124410|NCT03684694|589162214|FG004|Phase 1|Death|0|||
163124411|NCT03684694|589162215|FG005|Phase 1|Death|0|||
163124412|NCT03684694|589162210|FG000|Phase 1|Lost to Follow-up|0|||
163124413|NCT03684694|589162211|FG001|Phase 1|Lost to Follow-up|0|||
163225375|NCT02896400|589542004|FG015|1 Month Follow-up|Lost to Follow-up|2|||
163124414|NCT03684694|589162212|FG002|Phase 1|Lost to Follow-up|1|||
163124415|NCT03684694|589162213|FG003|Phase 1|Lost to Follow-up|0|||
163124416|NCT03684694|589162214|FG004|Phase 1|Lost to Follow-up|0|||
163124417|NCT03684694|589162215|FG005|Phase 1|Lost to Follow-up|0|||
163124418|NCT03684694|589162210|FG000|Phase 1|Miscellaneous|0|||
163124419|NCT03684694|589162211|FG001|Phase 1|Miscellaneous|1|||
163124420|NCT03684694|589162212|FG002|Phase 1|Miscellaneous|0|||
163124421|NCT03684694|589162213|FG003|Phase 1|Miscellaneous|0|||
163124422|NCT03684694|589162214|FG004|Phase 1|Miscellaneous|0|||
163124423|NCT03684694|589162215|FG005|Phase 1|Miscellaneous|0|||
163124424|NCT03684694|589162210|FG000|Phase 2|Withdrawal by Subject|0|||
163124425|NCT03684694|589162211|FG001|Phase 2|Withdrawal by Subject|0|||
163124426|NCT03684694|589162212|FG002|Phase 2|Withdrawal by Subject|0|||
163124427|NCT03684694|589162213|FG003|Phase 2|Withdrawal by Subject|0|||
163124428|NCT03684694|589162214|FG004|Phase 2|Withdrawal by Subject|0|||
163124429|NCT03684694|589162215|FG005|Phase 2|Withdrawal by Subject|1|||
163124430|NCT03684694|589162210|FG000|Phase 2|Investigator/Sponsor Decision|0|||
163124431|NCT03684694|589162211|FG001|Phase 2|Investigator/Sponsor Decision|0|||
163124432|NCT03684694|589162212|FG002|Phase 2|Investigator/Sponsor Decision|0|||
163124433|NCT03684694|589162213|FG003|Phase 2|Investigator/Sponsor Decision|17|||
163124434|NCT03684694|589162214|FG004|Phase 2|Investigator/Sponsor Decision|16|||
163124435|NCT03684694|589162215|FG005|Phase 2|Investigator/Sponsor Decision|6|||
163341614|NCT02971683|589959576|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
163124436|NCT03684694|589162210|FG000|Phase 2|Death|0|||
163124437|NCT03684694|589162211|FG001|Phase 2|Death|0|||
163124438|NCT03684694|589162212|FG002|Phase 2|Death|0|||
163124439|NCT03684694|589162213|FG003|Phase 2|Death|28|||
163124440|NCT03684694|589162214|FG004|Phase 2|Death|14|||
163124441|NCT03684694|589162215|FG005|Phase 2|Death|3|||
163124442|NCT03684694|589162210|FG000|Phase 2|Lost to Follow-up|0|||
163124443|NCT03684694|589162211|FG001|Phase 2|Lost to Follow-up|0|||
163124444|NCT03684694|589162212|FG002|Phase 2|Lost to Follow-up|0|||
163124445|NCT03684694|589162213|FG003|Phase 2|Lost to Follow-up|1|||
163124446|NCT03684694|589162214|FG004|Phase 2|Lost to Follow-up|0|||
163124447|NCT03684694|589162215|FG005|Phase 2|Lost to Follow-up|0|||
163124448|NCT03684694|589162210|FG000|Phase 2|Miscellaneous|0|||
163124449|NCT03684694|589162211|FG001|Phase 2|Miscellaneous|0|||
163124450|NCT03684694|589162212|FG002|Phase 2|Miscellaneous|0|||
163124451|NCT03684694|589162213|FG003|Phase 2|Miscellaneous|3|||
163124452|NCT03684694|589162214|FG004|Phase 2|Miscellaneous|0|||
163124453|NCT03684694|589162215|FG005|Phase 2|Miscellaneous|0|||
163124454|NCT02720692|589163932|FG000|Overall Study|Withdrawal by Subject|3|||
163124455|NCT02720692|589163933|FG001|Overall Study|Withdrawal by Subject|0|||
163124456|NCT02720692|589163932|FG000|Overall Study|Physician Decision|1|||
163124457|NCT02720692|589163933|FG001|Overall Study|Physician Decision|0|||
163124458|NCT02720692|589163932|FG000|Overall Study|Lost to Follow-up|8|||
163124459|NCT02720692|589163933|FG001|Overall Study|Lost to Follow-up|3|||
163124460|NCT02720692|589163932|FG000|Overall Study|Subject unable to return for visit|1|||
163124461|NCT02720692|589163933|FG001|Overall Study|Subject unable to return for visit|0|||
163124462|NCT01206582|589163934|FG000|Overall Study|Withdrew prior to study|1|||
163124463|NCT01206582|589163935|FG001|Overall Study|Withdrew prior to study|0|||
163124464|NCT01206582|589163934|FG000|Overall Study|Discontinued intervention before week 8|1|||
163124465|NCT01206582|589163935|FG001|Overall Study|Discontinued intervention before week 8|2|||
163124466|NCT00528801|589163936|FG000|Overall Study|Withdrawal by Subject|1|||
163124467|NCT00528801|589163937|FG001|Overall Study|Withdrawal by Subject|1|||
163124468|NCT00528801|589163936|FG000|Overall Study|Protocol Violation|11|||
163124469|NCT00528801|589163937|FG001|Overall Study|Protocol Violation|5|||
163124470|NCT00528801|589163936|FG000|Overall Study|Lost to Follow-up|15|||
163124471|NCT00528801|589163937|FG001|Overall Study|Lost to Follow-up|4|||
163124472|NCT00528801|589163936|FG000|Overall Study|Administrative Reasons|0|||
163124473|NCT00528801|589163937|FG001|Overall Study|Administrative Reasons|1|||
163124474|NCT02207491|589163938|FG000|Overall Study|Adverse Event|20|||
163124475|NCT02207491|589163939|FG001|Overall Study|Adverse Event|4|||
163124476|NCT02207491|589163938|FG000|Overall Study|Withdrawal by Subject|3|||
163124477|NCT02207491|589163939|FG001|Overall Study|Withdrawal by Subject|2|||
163124478|NCT02207491|589163938|FG000|Overall Study|Non-compliant|0|||
163124479|NCT02207491|589163939|FG001|Overall Study|Non-compliant|1|||
163124480|NCT02207491|589163938|FG000|Overall Study|Lost to Follow-up|0|||
163124481|NCT02207491|589163939|FG001|Overall Study|Lost to Follow-up|1|||
163124482|NCT02207491|589163938|FG000|Overall Study|Lack of Efficacy|3|||
163124483|NCT02207491|589163939|FG001|Overall Study|Lack of Efficacy|0|||
163124484|NCT02207491|589163938|FG000|Overall Study|Physician Decision|2|||
163124485|NCT02207491|589163939|FG001|Overall Study|Physician Decision|0|||
163124486|NCT02207491|589163938|FG000|Overall Study|Protocol Violation|3|||
163124487|NCT02207491|589163939|FG001|Overall Study|Protocol Violation|5|||
163124488|NCT00477152|589163942|FG000|Overall Study|Parent withdrew consent|2|||
163124489|NCT00477152|589163942|FG000|Overall Study|Adverse Event|1|||
163124490|NCT03221842|589163943|FG000|Period 1 (Open-label)|Adverse Event|4|||
163124491|NCT03221842|589163944|FG001|Period 1 (Open-label)|Adverse Event|0|||
163124492|NCT03221842|589163943|FG000|Period 1 (Open-label)|Physician Decision|2|||
163124493|NCT03221842|589163944|FG001|Period 1 (Open-label)|Physician Decision|0|||
163124494|NCT03221842|589163943|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
163124495|NCT03221842|589163944|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
163124496|NCT03221842|589163943|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
163124497|NCT03221842|589163944|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
163124498|NCT03221842|589163943|FG000|Period 1 (Open-label)|Other|2|||
163225376|NCT02896400|589541989|FG000|1 Month Follow-up|Death|0|||
163225377|NCT02896400|589541990|FG001|1 Month Follow-up|Death|0|||
163408164|NCT02432235|590204040|FG008|Overall Study|Lost to Follow-up|1|||
163225378|NCT02896400|589541991|FG002|1 Month Follow-up|Death|0|||
163124499|NCT03221842|589163944|FG001|Period 1 (Open-label)|Other|0|||
163124500|NCT03221842|589163943|FG000|Period 2 (Randomized, Blinded)|Death|0|||
163124501|NCT03221842|589163944|FG001|Period 2 (Randomized, Blinded)|Death|1|||
163124502|NCT03221842|589163943|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
163124503|NCT03221842|589163944|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
163124504|NCT02504580|589163945|FG000|Overall Study|Other|1|||
163124505|NCT02504580|589163946|FG001|Overall Study|Other|0|||
163124506|NCT02504580|589163947|FG002|Overall Study|Other|0|||
163124507|NCT02504580|589163948|FG003|Overall Study|Other|2|||
163124508|NCT02504580|589163949|FG004|Overall Study|Other|1|||
163124509|NCT02504580|589163950|FG005|Overall Study|Other|1|||
163124510|NCT02504580|589163951|FG006|Overall Study|Other|1|||
163124511|NCT02504580|589163952|FG007|Overall Study|Other|2|||
163124512|NCT02504580|589163953|FG008|Overall Study|Other|0|||
163341615|NCT02971683|589959577|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
163341616|NCT02971683|589959576|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
163341617|NCT02971683|589959577|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
163341618|NCT02971683|589959576|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
163341619|NCT02971683|589959577|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
163341620|NCT02971683|589959576|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
163341621|NCT02971683|589959577|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
163341622|NCT02971683|589959576|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
163341623|NCT02971683|589959577|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
163341624|NCT02971683|589959576|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
163341625|NCT02971683|589959577|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
163341626|NCT02971683|589959576|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
163341627|NCT02971683|589959577|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
163341628|NCT02971683|589959576|FG000|Open-Label|Lost to Follow-up|1|||
163341629|NCT02971683|589959577|FG001|Open-Label|Lost to Follow-up|0|||
163341630|NCT02971683|589959576|FG000|Open-Label|Participants withdrew consent|0|||
163341631|NCT02971683|589959577|FG001|Open-Label|Participants withdrew consent|2|||
163341632|NCT02971683|589959576|FG000|Open-Label|Participant request to discontinue study treatment|1|||
163341633|NCT02971683|589959577|FG001|Open-Label|Participant request to discontinue study treatment|0|||
163341634|NCT02971683|589959576|FG000|Open-Label|Lack of Efficacy|2|||
163341635|NCT02971683|589959577|FG001|Open-Label|Lack of Efficacy|0|||
163341636|NCT02971683|589959576|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
163341637|NCT02971683|589959577|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
163341638|NCT02971683|589959576|FG000|Long-Term Open Label|Participant withdrew consent|1|||
163341639|NCT02971683|589959577|FG001|Long-Term Open Label|Participant withdrew consent|0|||
163341640|NCT02971683|589959576|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
163341641|NCT02971683|589959577|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
163341642|NCT02971683|589959576|FG000|Long-Term Open Label|Adverse Event|1|||
163341643|NCT02971683|589959577|FG001|Long-Term Open Label|Adverse Event|2|||
163124513|NCT02504580|589163954|FG009|Overall Study|Other|0|||
163124514|NCT02504580|589163955|FG010|Overall Study|Other|0|||
163124515|NCT02504580|589163956|FG011|Overall Study|Other|2|||
163124516|NCT02504580|589163945|FG000|Overall Study|Subject refusal to continue|0|||
163124517|NCT02504580|589163946|FG001|Overall Study|Subject refusal to continue|1|||
163124518|NCT02504580|589163947|FG002|Overall Study|Subject refusal to continue|0|||
163124519|NCT02504580|589163948|FG003|Overall Study|Subject refusal to continue|0|||
163124520|NCT02504580|589163949|FG004|Overall Study|Subject refusal to continue|0|||
163124521|NCT02504580|589163950|FG005|Overall Study|Subject refusal to continue|0|||
163124522|NCT02504580|589163951|FG006|Overall Study|Subject refusal to continue|0|||
163124523|NCT02504580|589163952|FG007|Overall Study|Subject refusal to continue|0|||
163124524|NCT02504580|589163953|FG008|Overall Study|Subject refusal to continue|0|||
163124525|NCT02504580|589163954|FG009|Overall Study|Subject refusal to continue|0|||
163124526|NCT02504580|589163955|FG010|Overall Study|Subject refusal to continue|0|||
163124527|NCT02504580|589163956|FG011|Overall Study|Subject refusal to continue|0|||
163124528|NCT01939366|589163957|FG000|Overall Study|Adverse Event|8|||
163124529|NCT01939366|589163958|FG001|Overall Study|Adverse Event|17|||
163124530|NCT01939366|589163959|FG002|Overall Study|Adverse Event|30|||
163124531|NCT01939366|589163960|FG003|Overall Study|Adverse Event|8|||
163124532|NCT01939366|589163961|FG004|Overall Study|Adverse Event|5|||
163124533|NCT01939366|589163957|FG000|Overall Study|Lack of Efficacy|2|||
163124534|NCT01939366|589163958|FG001|Overall Study|Lack of Efficacy|1|||
163124535|NCT01939366|589163959|FG002|Overall Study|Lack of Efficacy|1|||
163124536|NCT01939366|589163960|FG003|Overall Study|Lack of Efficacy|1|||
163124537|NCT01939366|589163961|FG004|Overall Study|Lack of Efficacy|3|||
163124538|NCT01939366|589163957|FG000|Overall Study|Lost to Follow-up|1|||
163124539|NCT01939366|589163958|FG001|Overall Study|Lost to Follow-up|1|||
163124540|NCT01939366|589163959|FG002|Overall Study|Lost to Follow-up|0|||
163124541|NCT01939366|589163960|FG003|Overall Study|Lost to Follow-up|0|||
163124542|NCT01939366|589163961|FG004|Overall Study|Lost to Follow-up|0|||
163124543|NCT01939366|589163957|FG000|Overall Study|Withdrawal by Subject|1|||
163124544|NCT01939366|589163958|FG001|Overall Study|Withdrawal by Subject|0|||
163124545|NCT01939366|589163959|FG002|Overall Study|Withdrawal by Subject|2|||
163124546|NCT01939366|589163960|FG003|Overall Study|Withdrawal by Subject|2|||
163124547|NCT01939366|589163961|FG004|Overall Study|Withdrawal by Subject|3|||
163124548|NCT01939366|589163957|FG000|Overall Study|Inclusion criteria not met|0|||
163124549|NCT01939366|589163958|FG001|Overall Study|Inclusion criteria not met|1|||
163124550|NCT01939366|589163959|FG002|Overall Study|Inclusion criteria not met|1|||
163124551|NCT01939366|589163960|FG003|Overall Study|Inclusion criteria not met|0|||
163124552|NCT01939366|589163961|FG004|Overall Study|Inclusion criteria not met|1|||
163124553|NCT01939366|589163957|FG000|Overall Study|Other|0|||
163124554|NCT01939366|589163958|FG001|Overall Study|Other|0|||
163341644|NCT02971683|589959576|FG000|Long-Term Open Label|Lack of Efficacy|1|||
163341645|NCT02971683|589959577|FG001|Long-Term Open Label|Lack of Efficacy|1|||
163341646|NCT01240785|589959580|FG000|Overall Study|Lost to Follow-up|1|||
163124555|NCT01939366|589163959|FG002|Overall Study|Other|2|||
163124556|NCT01939366|589163960|FG003|Overall Study|Other|2|||
163124557|NCT01939366|589163961|FG004|Overall Study|Other|1|||
163124558|NCT01939366|589163957|FG000|Overall Study|Protocol Violation|0|||
163124559|NCT01939366|589163958|FG001|Overall Study|Protocol Violation|0|||
163124560|NCT01939366|589163959|FG002|Overall Study|Protocol Violation|0|||
163124561|NCT01939366|589163960|FG003|Overall Study|Protocol Violation|1|||
163124562|NCT01939366|589163961|FG004|Overall Study|Protocol Violation|0|||
163124563|NCT01939366|589163957|FG000|Overall Study|Sponsor decision|0|||
163124564|NCT01939366|589163958|FG001|Overall Study|Sponsor decision|0|||
163124565|NCT01939366|589163959|FG002|Overall Study|Sponsor decision|0|||
163124566|NCT01939366|589163960|FG003|Overall Study|Sponsor decision|0|||
163124567|NCT01939366|589163961|FG004|Overall Study|Sponsor decision|2|||
163124568|NCT01939366|589163957|FG000|Overall Study|GCP non-compliance at site|2|||
163124569|NCT01939366|589163958|FG001|Overall Study|GCP non-compliance at site|3|||
163124570|NCT01939366|589163959|FG002|Overall Study|GCP non-compliance at site|2|||
163124571|NCT01939366|589163960|FG003|Overall Study|GCP non-compliance at site|3|||
163124572|NCT01939366|589163961|FG004|Overall Study|GCP non-compliance at site|3|||
163124573|NCT00231413|589163964|FG000|Overall Study|Non-serious AE|0|||
163124574|NCT00231413|589163965|FG001|Overall Study|Non-serious AE|0|||
163124575|NCT00231413|589163966|FG002|Overall Study|Non-serious AE|1|||
163124576|NCT00231413|589163967|FG003|Overall Study|Non-serious AE|0|||
163124577|NCT00231413|589163968|FG004|Overall Study|Non-serious AE|0|||
163124578|NCT00231413|589163969|FG005|Overall Study|Non-serious AE|0|||
163124579|NCT00231413|589163970|FG006|Overall Study|Non-serious AE|1|||
163124580|NCT00231413|589163964|FG000|Overall Study|Withdrawal by Subject|3|||
163124581|NCT00231413|589163965|FG001|Overall Study|Withdrawal by Subject|1|||
163124582|NCT00231413|589163966|FG002|Overall Study|Withdrawal by Subject|4|||
163124583|NCT00231413|589163967|FG003|Overall Study|Withdrawal by Subject|2|||
163124584|NCT00231413|589163968|FG004|Overall Study|Withdrawal by Subject|2|||
163124585|NCT00231413|589163969|FG005|Overall Study|Withdrawal by Subject|0|||
163124586|NCT00231413|589163970|FG006|Overall Study|Withdrawal by Subject|3|||
163124587|NCT00231413|589163964|FG000|Overall Study|Migrated/moved from study area|0|||
163124588|NCT00231413|589163965|FG001|Overall Study|Migrated/moved from study area|0|||
163225379|NCT02896400|589541992|FG003|1 Month Follow-up|Death|0|||
163225380|NCT02896400|589541993|FG004|1 Month Follow-up|Death|0|||
163225381|NCT02896400|589541994|FG005|1 Month Follow-up|Death|0|||
163225382|NCT02896400|589541995|FG006|1 Month Follow-up|Death|0|||
163225383|NCT02896400|589541996|FG007|1 Month Follow-up|Death|0|||
163225384|NCT02896400|589541997|FG008|1 Month Follow-up|Death|0|||
163225385|NCT02896400|589541998|FG009|1 Month Follow-up|Death|0|||
163225386|NCT02896400|589541999|FG010|1 Month Follow-up|Death|0|||
163225387|NCT02896400|589542000|FG011|1 Month Follow-up|Death|0|||
163225388|NCT02896400|589542001|FG012|1 Month Follow-up|Death|0|||
163225389|NCT02896400|589542002|FG013|1 Month Follow-up|Death|0|||
163225390|NCT02896400|589542003|FG014|1 Month Follow-up|Death|0|||
163225391|NCT02896400|589542004|FG015|1 Month Follow-up|Death|1|||
163225392|NCT02896400|589541989|FG000|3 Month Follow-up|Lost to Follow-up|6|||
163225393|NCT02896400|589541990|FG001|3 Month Follow-up|Lost to Follow-up|3|||
163225394|NCT02896400|589541991|FG002|3 Month Follow-up|Lost to Follow-up|6|||
163225395|NCT02896400|589541992|FG003|3 Month Follow-up|Lost to Follow-up|11|||
163225396|NCT02896400|589541993|FG004|3 Month Follow-up|Lost to Follow-up|12|||
163225397|NCT02896400|589541994|FG005|3 Month Follow-up|Lost to Follow-up|6|||
163225398|NCT02896400|589541995|FG006|3 Month Follow-up|Lost to Follow-up|4|||
163225399|NCT02896400|589541996|FG007|3 Month Follow-up|Lost to Follow-up|3|||
163225400|NCT02896400|589541997|FG008|3 Month Follow-up|Lost to Follow-up|6|||
163225401|NCT02896400|589541998|FG009|3 Month Follow-up|Lost to Follow-up|5|||
163225402|NCT02896400|589541999|FG010|3 Month Follow-up|Lost to Follow-up|6|||
163225403|NCT02896400|589542000|FG011|3 Month Follow-up|Lost to Follow-up|6|||
163225404|NCT02896400|589542001|FG012|3 Month Follow-up|Lost to Follow-up|3|||
163225405|NCT02896400|589542002|FG013|3 Month Follow-up|Lost to Follow-up|5|||
163225406|NCT02896400|589542003|FG014|3 Month Follow-up|Lost to Follow-up|3|||
163341647|NCT01240785|589959581|FG001|Overall Study|Lost to Follow-up|0|||
163341648|NCT01240785|589959580|FG000|Overall Study|Protocol Violation|0|||
163225407|NCT02896400|589542004|FG015|3 Month Follow-up|Lost to Follow-up|2|||
163225408|NCT02896400|589541989|FG000|3 Month Follow-up|Death|0|||
163225409|NCT02896400|589541990|FG001|3 Month Follow-up|Death|0|||
163225410|NCT02896400|589541991|FG002|3 Month Follow-up|Death|0|||
163225411|NCT02896400|589541992|FG003|3 Month Follow-up|Death|0|||
163341649|NCT01240785|589959581|FG001|Overall Study|Protocol Violation|3|||
163124589|NCT00231413|589163966|FG002|Overall Study|Migrated/moved from study area|1|||
163124590|NCT00231413|589163967|FG003|Overall Study|Migrated/moved from study area|0|||
163124591|NCT00231413|589163968|FG004|Overall Study|Migrated/moved from study area|0|||
163124592|NCT00231413|589163969|FG005|Overall Study|Migrated/moved from study area|1|||
163124593|NCT00231413|589163970|FG006|Overall Study|Migrated/moved from study area|0|||
163124594|NCT00231413|589163964|FG000|Overall Study|Lost to Follow-up|4|||
163124595|NCT00231413|589163965|FG001|Overall Study|Lost to Follow-up|4|||
163124596|NCT00231413|589163966|FG002|Overall Study|Lost to Follow-up|1|||
163225412|NCT02896400|589541993|FG004|3 Month Follow-up|Death|0|||
163341650|NCT00237809|589959582|FG000|Overall Study|Lost to Follow-up|11|||
163124597|NCT00231413|589163967|FG003|Overall Study|Lost to Follow-up|1|||
163341651|NCT00237809|589959583|FG001|Overall Study|Lost to Follow-up|10|||
163341652|NCT00237809|589959584|FG002|Overall Study|Lost to Follow-up|9|||
163341653|NCT00237809|589959585|FG003|Overall Study|Lost to Follow-up|9|||
163341654|NCT02006641|589959586|FG000|Overall Study|Withdrawal before treatment|2|||
163341655|NCT02006641|589959587|FG001|Overall Study|Withdrawal before treatment|5|||
163341656|NCT02006641|589959588|FG002|Overall Study|Withdrawal before treatment|3|||
163341657|NCT02006641|589959586|FG000|Overall Study|Adverse Event|15|||
163341658|NCT02006641|589959587|FG001|Overall Study|Adverse Event|11|||
163341659|NCT02006641|589959588|FG002|Overall Study|Adverse Event|15|||
163341660|NCT02006641|589959586|FG000|Overall Study|Protocol Violation|0|||
163341661|NCT02006641|589959587|FG001|Overall Study|Protocol Violation|2|||
163341662|NCT02006641|589959588|FG002|Overall Study|Protocol Violation|2|||
163341663|NCT02006641|589959586|FG000|Overall Study|Lost to Follow-up|0|||
163341664|NCT02006641|589959587|FG001|Overall Study|Lost to Follow-up|1|||
163124598|NCT00231413|589163968|FG004|Overall Study|Lost to Follow-up|1|||
163124599|NCT00231413|589163969|FG005|Overall Study|Lost to Follow-up|4|||
163124600|NCT00231413|589163970|FG006|Overall Study|Lost to Follow-up|0|||
163124601|NCT00231413|589163964|FG000|Overall Study|Pregnancy|1|||
163124602|NCT00231413|589163965|FG001|Overall Study|Pregnancy|0|||
163124603|NCT00231413|589163966|FG002|Overall Study|Pregnancy|0|||
163124604|NCT00231413|589163967|FG003|Overall Study|Pregnancy|0|||
163124605|NCT00231413|589163968|FG004|Overall Study|Pregnancy|0|||
163124606|NCT00231413|589163969|FG005|Overall Study|Pregnancy|0|||
163124607|NCT00231413|589163970|FG006|Overall Study|Pregnancy|0|||
163124608|NCT03242252|589163975|FG000|Overall Study|At the Participant's own Request|18|||
163124609|NCT03242252|589163976|FG001|Overall Study|At the Participant's own Request|10|||
163124610|NCT03242252|589163977|FG002|Overall Study|At the Participant's own Request|15|||
163124611|NCT03242252|589163975|FG000|Overall Study|Adverse Event|8|||
163124612|NCT03242252|589163976|FG001|Overall Study|Adverse Event|6|||
163124613|NCT03242252|589163977|FG002|Overall Study|Adverse Event|9|||
163124614|NCT03242252|589163975|FG000|Overall Study|Poor Compliance to Protocol|0|||
163124615|NCT03242252|589163976|FG001|Overall Study|Poor Compliance to Protocol|2|||
163124616|NCT03242252|589163977|FG002|Overall Study|Poor Compliance to Protocol|3|||
163124617|NCT03242252|589163975|FG000|Overall Study|Study Terminated by Sponsor|1|||
163124618|NCT03242252|589163976|FG001|Overall Study|Study Terminated by Sponsor|0|||
163124619|NCT03242252|589163977|FG002|Overall Study|Study Terminated by Sponsor|0|||
163124620|NCT03242252|589163975|FG000|Overall Study|Reason not Specified|4|||
163124621|NCT03242252|589163976|FG001|Overall Study|Reason not Specified|4|||
163124622|NCT03242252|589163977|FG002|Overall Study|Reason not Specified|1|||
163124623|NCT03242252|589163975|FG000|Overall Study|Lost to Follow-up|5|||
163124624|NCT03242252|589163976|FG001|Overall Study|Lost to Follow-up|1|||
163124625|NCT03242252|589163977|FG002|Overall Study|Lost to Follow-up|4|||
163124626|NCT01659255|589163978|FG000|Overall Study|Adverse Event|0|||
163124627|NCT01659255|589163979|FG001|Overall Study|Adverse Event|0|||
163124628|NCT01659255|589163980|FG002|Overall Study|Adverse Event|0|||
163124629|NCT01659255|589163981|FG003|Overall Study|Adverse Event|0|||
163124630|NCT01659255|589163982|FG004|Overall Study|Adverse Event|0|||
163124631|NCT01659255|589163983|FG005|Overall Study|Adverse Event|1|||
163124632|NCT01659255|589163984|FG006|Overall Study|Adverse Event|1|||
163124633|NCT01659255|589163985|FG007|Overall Study|Adverse Event|0|||
163124634|NCT01659255|589163986|FG008|Overall Study|Adverse Event|0|||
163124635|NCT01659255|589163987|FG009|Overall Study|Adverse Event|1|||
163124636|NCT01659255|589163988|FG010|Overall Study|Adverse Event|0|||
163124637|NCT01659255|589163989|FG011|Overall Study|Adverse Event|1|||
163124638|NCT01659255|589163990|FG012|Overall Study|Adverse Event|0|||
163124639|NCT01659255|589163991|FG013|Overall Study|Adverse Event|2|||
163124640|NCT01659255|589163992|FG014|Overall Study|Adverse Event|0|||
163124641|NCT01659255|589163993|FG015|Overall Study|Adverse Event|1|||
163124642|NCT01659255|589163994|FG016|Overall Study|Adverse Event|0|||
163225413|NCT02896400|589541994|FG005|3 Month Follow-up|Death|0|||
163341665|NCT02006641|589959588|FG002|Overall Study|Lost to Follow-up|0|||
163124643|NCT01659255|589163978|FG000|Overall Study|Death|0|||
163124644|NCT01659255|589163979|FG001|Overall Study|Death|1|||
163124645|NCT01659255|589163980|FG002|Overall Study|Death|0|||
163124646|NCT01659255|589163981|FG003|Overall Study|Death|0|||
163124647|NCT01659255|589163982|FG004|Overall Study|Death|0|||
163124648|NCT01659255|589163983|FG005|Overall Study|Death|0|||
163124649|NCT01659255|589163984|FG006|Overall Study|Death|0|||
163124650|NCT01659255|589163985|FG007|Overall Study|Death|1|||
163124651|NCT01659255|589163986|FG008|Overall Study|Death|1|||
163124652|NCT01659255|589163987|FG009|Overall Study|Death|0|||
163124653|NCT01659255|589163988|FG010|Overall Study|Death|0|||
163124654|NCT01659255|589163989|FG011|Overall Study|Death|0|||
163124655|NCT01659255|589163990|FG012|Overall Study|Death|1|||
163124656|NCT01659255|589163991|FG013|Overall Study|Death|1|||
163124657|NCT01659255|589163992|FG014|Overall Study|Death|2|||
163341666|NCT02006641|589959586|FG000|Overall Study|Withdrawal by Subject|7|||
163341667|NCT02006641|589959587|FG001|Overall Study|Withdrawal by Subject|12|||
163341668|NCT02006641|589959588|FG002|Overall Study|Withdrawal by Subject|11|||
163341669|NCT02006641|589959586|FG000|Overall Study|Other reason: patient didn't show up|1|||
163341670|NCT02006641|589959587|FG001|Overall Study|Other reason: patient didn't show up|0|||
163341671|NCT02006641|589959588|FG002|Overall Study|Other reason: patient didn't show up|0|||
163341672|NCT02006641|589959586|FG000|Overall Study|Other reason:patient didn't want to come|0|||
163341673|NCT02006641|589959587|FG001|Overall Study|Other reason:patient didn't want to come|0|||
163341674|NCT02006641|589959588|FG002|Overall Study|Other reason:patient didn't want to come|1|||
163341675|NCT02006641|589959586|FG000|Overall Study|Other reason: patient has moved|1|||
163341676|NCT02006641|589959587|FG001|Overall Study|Other reason: patient has moved|0|||
163341677|NCT02006641|589959588|FG002|Overall Study|Other reason: patient has moved|1|||
163341678|NCT02006641|589959586|FG000|Overall Study|Other reason: caregiver in hospital|0|||
163341679|NCT02006641|589959587|FG001|Overall Study|Other reason: caregiver in hospital|1|||
163341680|NCT02006641|589959588|FG002|Overall Study|Other reason: caregiver in hospital|0|||
163341681|NCT02006641|589959586|FG000|Overall Study|Other reason: patient's wife has died|0|||
163341682|NCT02006641|589959587|FG001|Overall Study|Other reason: patient's wife has died|0|||
163341683|NCT02006641|589959588|FG002|Overall Study|Other reason: patient's wife has died|1|||
163341684|NCT02006641|589959586|FG000|Overall Study|Other reason: hospitalisation|0|||
163341685|NCT02006641|589959587|FG001|Overall Study|Other reason: hospitalisation|1|||
163341686|NCT02006641|589959588|FG002|Overall Study|Other reason: hospitalisation|0|||
163341687|NCT02006641|589959586|FG000|Overall Study|Other reason: caregiver impossibility|0|||
163341688|NCT02006641|589959587|FG001|Overall Study|Other reason: caregiver impossibility|0|||
163341689|NCT02006641|589959588|FG002|Overall Study|Other reason: caregiver impossibility|1|||
163341690|NCT02006641|589959586|FG000|Overall Study|Other reason: protocol non-compliance|0|||
163341691|NCT02006641|589959587|FG001|Overall Study|Other reason: protocol non-compliance|0|||
163341692|NCT02006641|589959588|FG002|Overall Study|Other reason: protocol non-compliance|1|||
163341693|NCT02132195|589959592|FG000|Initial Assignment|Relapsed|14|||
163341694|NCT02132195|589959593|FG001|Initial Assignment|Relapsed|0|||
163341695|NCT02132195|589959594|FG002|Initial Assignment|Relapsed|0|||
163341696|NCT02132195|589959592|FG000|Rescue Therapy|Relapsed|0|||
163341697|NCT02132195|589959593|FG001|Rescue Therapy|Relapsed|0|||
163341698|NCT02132195|589959594|FG002|Rescue Therapy|Relapsed|7|||
163341699|NCT02132195|589959592|FG000|Rescue Therapy|Physician Decision|0|||
163341700|NCT02132195|589959593|FG001|Rescue Therapy|Physician Decision|0|||
163341701|NCT02132195|589959594|FG002|Rescue Therapy|Physician Decision|1|||
163341702|NCT02132195|589959592|FG000|Rescue Therapy|Withdrawal by Subject|0|||
163341703|NCT02132195|589959593|FG001|Rescue Therapy|Withdrawal by Subject|0|||
163341704|NCT02132195|589959594|FG002|Rescue Therapy|Withdrawal by Subject|1|||
163341705|NCT02132195|589959592|FG000|Rescue Therapy|Adverse Event|0|||
163341706|NCT02132195|589959593|FG001|Rescue Therapy|Adverse Event|0|||
163341707|NCT02132195|589959594|FG002|Rescue Therapy|Adverse Event|2|||
163341708|NCT00321555|589959597|FG000|Overall Study|Developed antibodies|1|||
163341709|NCT00321555|589959597|FG000|Overall Study|Switched to alternative treatment|3|||
163124658|NCT01659255|589163993|FG015|Overall Study|Death|1|||
163124659|NCT01659255|589163994|FG016|Overall Study|Death|0|||
163124660|NCT01659255|589163978|FG000|Overall Study|Progressive Disease|2|||
163124661|NCT01659255|589163979|FG001|Overall Study|Progressive Disease|0|||
163124662|NCT01659255|589163980|FG002|Overall Study|Progressive Disease|0|||
163124663|NCT01659255|589163981|FG003|Overall Study|Progressive Disease|0|||
163124664|NCT01659255|589163982|FG004|Overall Study|Progressive Disease|0|||
163124665|NCT01659255|589163983|FG005|Overall Study|Progressive Disease|0|||
163124666|NCT01659255|589163984|FG006|Overall Study|Progressive Disease|0|||
163124667|NCT01659255|589163985|FG007|Overall Study|Progressive Disease|1|||
163124668|NCT01659255|589163986|FG008|Overall Study|Progressive Disease|0|||
163124669|NCT01659255|589163987|FG009|Overall Study|Progressive Disease|2|||
163124670|NCT01659255|589163988|FG010|Overall Study|Progressive Disease|2|||
163124671|NCT01659255|589163989|FG011|Overall Study|Progressive Disease|3|||
163124672|NCT01659255|589163990|FG012|Overall Study|Progressive Disease|5|||
163124673|NCT01659255|589163991|FG013|Overall Study|Progressive Disease|13|||
163124674|NCT01659255|589163992|FG014|Overall Study|Progressive Disease|6|||
163124675|NCT01659255|589163993|FG015|Overall Study|Progressive Disease|2|||
163124676|NCT01659255|589163994|FG016|Overall Study|Progressive Disease|3|||
163124677|NCT01659255|589163978|FG000|Overall Study|Withdrew Consent|0|||
163124678|NCT01659255|589163979|FG001|Overall Study|Withdrew Consent|0|||
163124679|NCT01659255|589163980|FG002|Overall Study|Withdrew Consent|0|||
163124680|NCT01659255|589163981|FG003|Overall Study|Withdrew Consent|0|||
163124681|NCT01659255|589163982|FG004|Overall Study|Withdrew Consent|0|||
163124682|NCT01659255|589163983|FG005|Overall Study|Withdrew Consent|0|||
163225414|NCT02896400|589541995|FG006|3 Month Follow-up|Death|0|||
163341710|NCT00321555|589959597|FG000|Overall Study|Physician Decision|1|||
163341711|NCT00321555|589959597|FG000|Overall Study|Disease progression on study|1|||
163341712|NCT01468597|589959600|FG000|Overall Study|Found ineligible|17|||
163341713|NCT01468597|589959600|FG000|Overall Study|concomitant valves|12|||
163341714|NCT01468597|589959600|FG000|Overall Study|off-pump CABG|1|||
163341715|NCT01468597|589959600|FG000|Overall Study|no platelet function data|5|||
163341716|NCT00912964|589959601|FG000|Overall Study|Eligibility criterion not met|1|||
163341717|NCT00912964|589959602|FG001|Overall Study|Eligibility criterion not met|1|||
163341718|NCT00912964|589959603|FG002|Overall Study|Eligibility criterion not met|0|||
163341719|NCT00912964|589959601|FG000|Overall Study|Adverse Event|15|||
163124683|NCT01659255|589163984|FG006|Overall Study|Withdrew Consent|0|||
163124684|NCT01659255|589163985|FG007|Overall Study|Withdrew Consent|0|||
163124685|NCT01659255|589163986|FG008|Overall Study|Withdrew Consent|0|||
163124686|NCT01659255|589163987|FG009|Overall Study|Withdrew Consent|0|||
163124687|NCT01659255|589163988|FG010|Overall Study|Withdrew Consent|1|||
163124688|NCT01659255|589163989|FG011|Overall Study|Withdrew Consent|0|||
163124689|NCT01659255|589163990|FG012|Overall Study|Withdrew Consent|0|||
163124690|NCT01659255|589163991|FG013|Overall Study|Withdrew Consent|1|||
163124691|NCT01659255|589163992|FG014|Overall Study|Withdrew Consent|0|||
163124692|NCT01659255|589163993|FG015|Overall Study|Withdrew Consent|0|||
163124693|NCT01659255|589163994|FG016|Overall Study|Withdrew Consent|0|||
163124694|NCT01659255|589163978|FG000|Overall Study|Investigator Decision|0|||
163124695|NCT01659255|589163979|FG001|Overall Study|Investigator Decision|0|||
163124696|NCT01659255|589163980|FG002|Overall Study|Investigator Decision|0|||
163341720|NCT00912964|589959602|FG001|Overall Study|Adverse Event|18|||
163341721|NCT00912964|589959603|FG002|Overall Study|Adverse Event|12|||
163341722|NCT00912964|589959601|FG000|Overall Study|Lack of Efficacy|11|||
163341723|NCT00912964|589959602|FG001|Overall Study|Lack of Efficacy|4|||
163341724|NCT00912964|589959603|FG002|Overall Study|Lack of Efficacy|3|||
163341725|NCT00912964|589959601|FG000|Overall Study|Withdrawal by Subject|20|||
163341726|NCT00912964|589959602|FG001|Overall Study|Withdrawal by Subject|12|||
163341727|NCT00912964|589959603|FG002|Overall Study|Withdrawal by Subject|18|||
163341728|NCT00912964|589959601|FG000|Overall Study|Lost to Follow-up|4|||
163341729|NCT00912964|589959602|FG001|Overall Study|Lost to Follow-up|3|||
163341730|NCT00912964|589959603|FG002|Overall Study|Lost to Follow-up|3|||
163341731|NCT00912964|589959601|FG000|Overall Study|Protocol Violation|5|||
163341732|NCT00912964|589959602|FG001|Overall Study|Protocol Violation|3|||
163341733|NCT00912964|589959603|FG002|Overall Study|Protocol Violation|8|||
163341734|NCT00912964|589959601|FG000|Overall Study|Taking exclusionary medications|7|||
163341735|NCT00912964|589959602|FG001|Overall Study|Taking exclusionary medications|4|||
163341736|NCT00912964|589959603|FG002|Overall Study|Taking exclusionary medications|8|||
163341737|NCT00912964|589959601|FG000|Overall Study|Medical History|1|||
163341738|NCT00912964|589959602|FG001|Overall Study|Medical History|0|||
163341739|NCT00912964|589959603|FG002|Overall Study|Medical History|0|||
163341740|NCT00912964|589959601|FG000|Overall Study|Non-compliance with study procedures|2|||
163341741|NCT00912964|589959602|FG001|Overall Study|Non-compliance with study procedures|0|||
163341742|NCT00912964|589959603|FG002|Overall Study|Non-compliance with study procedures|0|||
163341743|NCT00912964|589959601|FG000|Overall Study|Violation of exclusion criterion|0|||
163341744|NCT00912964|589959602|FG001|Overall Study|Violation of exclusion criterion|0|||
163341745|NCT00912964|589959603|FG002|Overall Study|Violation of exclusion criterion|2|||
163341746|NCT00912964|589959601|FG000|Overall Study|Randomized but never received study drug|0|||
163341747|NCT00912964|589959602|FG001|Overall Study|Randomized but never received study drug|1|||
163341748|NCT00912964|589959603|FG002|Overall Study|Randomized but never received study drug|0|||
163341749|NCT02561195|589959605|FG000|Vaccination 1 to 3|Adverse Event|4|||
163341750|NCT02561195|589959606|FG001|Vaccination 1 to 3|Adverse Event|5|||
163124697|NCT01659255|589163981|FG003|Overall Study|Investigator Decision|0|||
163124698|NCT01659255|589163982|FG004|Overall Study|Investigator Decision|0|||
163124699|NCT01659255|589163983|FG005|Overall Study|Investigator Decision|0|||
163124700|NCT01659255|589163984|FG006|Overall Study|Investigator Decision|0|||
163124701|NCT01659255|589163985|FG007|Overall Study|Investigator Decision|0|||
163124702|NCT01659255|589163986|FG008|Overall Study|Investigator Decision|0|||
163124703|NCT01659255|589163987|FG009|Overall Study|Investigator Decision|0|||
163124704|NCT01659255|589163988|FG010|Overall Study|Investigator Decision|0|||
163124705|NCT01659255|589163989|FG011|Overall Study|Investigator Decision|0|||
163124706|NCT01659255|589163990|FG012|Overall Study|Investigator Decision|1|||
163124707|NCT01659255|589163991|FG013|Overall Study|Investigator Decision|1|||
163124708|NCT01659255|589163992|FG014|Overall Study|Investigator Decision|0|||
163124709|NCT01659255|589163993|FG015|Overall Study|Investigator Decision|0|||
163124710|NCT01659255|589163994|FG016|Overall Study|Investigator Decision|0|||
163124711|NCT01659255|589163978|FG000|Overall Study|Sponsor's Decision|0|||
163124712|NCT01659255|589163979|FG001|Overall Study|Sponsor's Decision|0|||
163124713|NCT01659255|589163980|FG002|Overall Study|Sponsor's Decision|0|||
163124714|NCT01659255|589163981|FG003|Overall Study|Sponsor's Decision|0|||
163124715|NCT01659255|589163982|FG004|Overall Study|Sponsor's Decision|0|||
163124716|NCT01659255|589163983|FG005|Overall Study|Sponsor's Decision|0|||
163341751|NCT02561195|589959607|FG002|Vaccination 1 to 3|Adverse Event|0|||
163341752|NCT02561195|589959608|FG003|Vaccination 1 to 3|Adverse Event|3|||
163341753|NCT02561195|589959609|FG004|Vaccination 1 to 3|Adverse Event|4|||
163341754|NCT02561195|589959610|FG005|Vaccination 1 to 3|Adverse Event|0|||
163341755|NCT02561195|589959611|FG006|Vaccination 1 to 3|Adverse Event|0|||
163341756|NCT02561195|589959612|FG007|Vaccination 1 to 3|Adverse Event|0|||
163341757|NCT02561195|589959613|FG008|Vaccination 1 to 3|Adverse Event|0|||
163341758|NCT02561195|589959614|FG009|Vaccination 1 to 3|Adverse Event|0|||
163341759|NCT02561195|589959615|FG010|Vaccination 1 to 3|Adverse Event|0|||
163341760|NCT02561195|589959616|FG011|Vaccination 1 to 3|Adverse Event|0|||
163341761|NCT02561195|589959617|FG012|Vaccination 1 to 3|Adverse Event|0|||
163341762|NCT02561195|589959618|FG013|Vaccination 1 to 3|Adverse Event|0|||
163124717|NCT01659255|589163984|FG006|Overall Study|Sponsor's Decision|1|||
163124718|NCT01659255|589163985|FG007|Overall Study|Sponsor's Decision|0|||
163124719|NCT01659255|589163986|FG008|Overall Study|Sponsor's Decision|0|||
163124720|NCT01659255|589163987|FG009|Overall Study|Sponsor's Decision|0|||
163124721|NCT01659255|589163988|FG010|Overall Study|Sponsor's Decision|0|||
163124722|NCT01659255|589163989|FG011|Overall Study|Sponsor's Decision|0|||
163124723|NCT01659255|589163990|FG012|Overall Study|Sponsor's Decision|0|||
163124724|NCT01659255|589163991|FG013|Overall Study|Sponsor's Decision|0|||
163124725|NCT01659255|589163992|FG014|Overall Study|Sponsor's Decision|0|||
163124726|NCT01659255|589163993|FG015|Overall Study|Sponsor's Decision|0|||
163124727|NCT01659255|589163994|FG016|Overall Study|Sponsor's Decision|0|||
163124728|NCT01659255|589163978|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124729|NCT01659255|589163979|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124730|NCT01659255|589163980|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124731|NCT01659255|589163981|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124732|NCT01659255|589163982|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124733|NCT01659255|589163983|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124734|NCT01659255|589163984|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124735|NCT01659255|589163985|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124736|NCT01659255|589163986|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124737|NCT01659255|589163987|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124738|NCT01659255|589163988|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124739|NCT01659255|589163989|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124740|NCT01659255|589163990|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124741|NCT01659255|589163991|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124742|NCT01659255|589163992|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124743|NCT01659255|589163993|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
163124744|NCT01659255|589163994|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124745|NCT01659255|589163978|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
163124746|NCT01659255|589163979|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
163124747|NCT01659255|589163980|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
163124748|NCT01659255|589163981|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
163124749|NCT01659255|589163982|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
163124750|NCT01659255|589163983|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
163124751|NCT01659255|589163984|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
163124752|NCT01659255|589163985|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
163124753|NCT01659255|589163986|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
163124754|NCT01659255|589163987|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
163124755|NCT01659255|589163988|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
163124756|NCT01659255|589163989|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
163124757|NCT01659255|589163990|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
163124758|NCT01659255|589163991|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
163124759|NCT01659255|589163992|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
163124760|NCT01659255|589163993|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
163124761|NCT01659255|589163994|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
163124762|NCT04094584|589163997|FG000|Overall Study|No interest in study|88|||
163124763|NCT04094584|589163997|FG000|Overall Study|Unwilling to undergo screening tests|36|||
163124764|NCT04094584|589163997|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
163124765|NCT04094584|589163997|FG000|Overall Study|Opioid use|7|||
163124766|NCT04094584|589163997|FG000|Overall Study|Need for major surgery in study period|4|||
163124767|NCT04094584|589163997|FG000|Overall Study|eligible but declined enrollment|4|||
163124768|NCT04094584|589163997|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
163124769|NCT04094584|589163997|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
163124770|NCT04094584|589163997|FG000|Overall Study|Lost to Follow-up|3|||
163124771|NCT04094584|589163997|FG000|Overall Study|Withdrawal by Subject|2|||
163124772|NCT02276547|589163998|FG000|Overall Study|Death|2|||
163124773|NCT02276547|589163998|FG000|Overall Study|Explant|2|||
163124774|NCT00106691|589163999|FG000|Overall Study|Adverse Event|60|||
163124775|NCT00106691|589164000|FG001|Overall Study|Adverse Event|64|||
163124776|NCT00106691|589163999|FG000|Overall Study|Lost to Follow-up|23|||
163124777|NCT00106691|589164000|FG001|Overall Study|Lost to Follow-up|18|||
163225415|NCT02896400|589541996|FG007|3 Month Follow-up|Death|0|||
163225416|NCT02896400|589541997|FG008|3 Month Follow-up|Death|0|||
163225417|NCT02896400|589541998|FG009|3 Month Follow-up|Death|0|||
163225418|NCT02896400|589541999|FG010|3 Month Follow-up|Death|0|||
163225419|NCT02896400|589542000|FG011|3 Month Follow-up|Death|0|||
163225420|NCT02896400|589542001|FG012|3 Month Follow-up|Death|0|||
163225421|NCT02896400|589542002|FG013|3 Month Follow-up|Death|1|||
163225422|NCT02896400|589542003|FG014|3 Month Follow-up|Death|1|||
163225423|NCT02896400|589542004|FG015|3 Month Follow-up|Death|0|||
163225424|NCT02896400|589541989|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
163341763|NCT02561195|589959605|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
163341764|NCT02561195|589959606|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
163124778|NCT00106691|589163999|FG000|Overall Study|Physician Decision|18|||
163124779|NCT00106691|589164000|FG001|Overall Study|Physician Decision|21|||
163124780|NCT00106691|589163999|FG000|Overall Study|Protocol Violation|13|||
163124781|NCT00106691|589164000|FG001|Overall Study|Protocol Violation|18|||
163124782|NCT00106691|589163999|FG000|Overall Study|Withdrawal by Subject|75|||
163124783|NCT00106691|589164000|FG001|Overall Study|Withdrawal by Subject|70|||
163124784|NCT00106691|589163999|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
163124785|NCT00106691|589164000|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
163124786|NCT00106691|589163999|FG000|Overall Study|QTc>480|3|||
163124787|NCT00106691|589164000|FG001|Overall Study|QTc>480|1|||
163124788|NCT00106691|589163999|FG000|Overall Study|mililtary deployment|2|||
163124789|NCT00106691|589164000|FG001|Overall Study|mililtary deployment|0|||
163124790|NCT00106691|589163999|FG000|Overall Study|Study Site Closing/PI Moved|1|||
163124791|NCT00106691|589164000|FG001|Overall Study|Study Site Closing/PI Moved|2|||
163124792|NCT00106691|589163999|FG000|Overall Study|Cardiologist recommendation|1|||
163124793|NCT00106691|589164000|FG001|Overall Study|Cardiologist recommendation|0|||
163124794|NCT00106691|589163999|FG000|Overall Study|Pt. moved to another state|1|||
163124795|NCT00106691|589164000|FG001|Overall Study|Pt. moved to another state|0|||
163124796|NCT00106691|589163999|FG000|Overall Study|Taking exclusionary avodart|1|||
163124797|NCT00106691|589164000|FG001|Overall Study|Taking exclusionary avodart|0|||
163124798|NCT00106691|589163999|FG000|Overall Study|Not able to discontinue plavix|0|||
163124799|NCT00106691|589164000|FG001|Overall Study|Not able to discontinue plavix|1|||
163124800|NCT00530920|589164001|FG000|Overall Study|Randomized but not treated|0|||
163124801|NCT00530920|589164002|FG001|Overall Study|Randomized but not treated|2|||
163124802|NCT00530920|589164003|FG002|Overall Study|Randomized but not treated|0|||
163124803|NCT00530920|589164001|FG000|Overall Study|Adverse Event|0|||
163124804|NCT00530920|589164002|FG001|Overall Study|Adverse Event|0|||
163124805|NCT00530920|589164003|FG002|Overall Study|Adverse Event|3|||
163124806|NCT00530920|589164001|FG000|Overall Study|Withdrawal by Subject|0|||
163124807|NCT00530920|589164002|FG001|Overall Study|Withdrawal by Subject|0|||
163124808|NCT00530920|589164003|FG002|Overall Study|Withdrawal by Subject|1|||
163124809|NCT00907296|589164004|FG000|Overall Study|Ineligibility Determined|1|||
163124810|NCT00907296|589164005|FG001|Overall Study|Ineligibility Determined|0|||
163124811|NCT00907296|589164006|FG002|Overall Study|Ineligibility Determined|0|||
163124812|NCT00907296|589164007|FG003|Overall Study|Ineligibility Determined|1|||
163124813|NCT00907296|589164008|FG004|Overall Study|Ineligibility Determined|0|||
163124814|NCT00907296|589164009|FG005|Overall Study|Ineligibility Determined|0|||
163124815|NCT00907296|589164010|FG006|Overall Study|Ineligibility Determined|0|||
163124816|NCT00907296|589164011|FG007|Overall Study|Ineligibility Determined|1|||
163124817|NCT00907296|589164012|FG008|Overall Study|Ineligibility Determined|0|||
163124818|NCT00907296|589164013|FG009|Overall Study|Ineligibility Determined|0|||
163124819|NCT00907296|589164004|FG000|Overall Study|Protocol Deviation|0|||
163124820|NCT00907296|589164005|FG001|Overall Study|Protocol Deviation|1|||
163124821|NCT00907296|589164006|FG002|Overall Study|Protocol Deviation|0|||
163124822|NCT00907296|589164007|FG003|Overall Study|Protocol Deviation|0|||
163124823|NCT00907296|589164008|FG004|Overall Study|Protocol Deviation|0|||
163124824|NCT00907296|589164009|FG005|Overall Study|Protocol Deviation|0|||
163124825|NCT00907296|589164010|FG006|Overall Study|Protocol Deviation|0|||
163124826|NCT00907296|589164011|FG007|Overall Study|Protocol Deviation|0|||
163124827|NCT00907296|589164012|FG008|Overall Study|Protocol Deviation|0|||
163124828|NCT00907296|589164013|FG009|Overall Study|Protocol Deviation|0|||
163124829|NCT00907296|589164004|FG000|Overall Study|Noncompliance|1|||
163124830|NCT00907296|589164005|FG001|Overall Study|Noncompliance|1|||
163124831|NCT00907296|589164006|FG002|Overall Study|Noncompliance|1|||
163124832|NCT00907296|589164007|FG003|Overall Study|Noncompliance|0|||
163124833|NCT00907296|589164008|FG004|Overall Study|Noncompliance|0|||
163124834|NCT00907296|589164009|FG005|Overall Study|Noncompliance|1|||
163124835|NCT00907296|589164010|FG006|Overall Study|Noncompliance|0|||
163124836|NCT00907296|589164011|FG007|Overall Study|Noncompliance|2|||
163225425|NCT02896400|589541990|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
163124837|NCT00907296|589164012|FG008|Overall Study|Noncompliance|0|||
163124838|NCT00907296|589164013|FG009|Overall Study|Noncompliance|0|||
163124839|NCT00907296|589164004|FG000|Overall Study|Adverse Event|2|||
163225426|NCT02896400|589541991|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
163225427|NCT02896400|589541992|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
163124840|NCT00907296|589164005|FG001|Overall Study|Adverse Event|0|||
163124841|NCT00907296|589164006|FG002|Overall Study|Adverse Event|0|||
163124842|NCT00907296|589164007|FG003|Overall Study|Adverse Event|0|||
163124843|NCT00907296|589164008|FG004|Overall Study|Adverse Event|0|||
163124844|NCT00907296|589164009|FG005|Overall Study|Adverse Event|0|||
163124845|NCT00907296|589164010|FG006|Overall Study|Adverse Event|1|||
163124846|NCT00907296|589164011|FG007|Overall Study|Adverse Event|0|||
163124847|NCT00907296|589164012|FG008|Overall Study|Adverse Event|0|||
163124848|NCT00907296|589164013|FG009|Overall Study|Adverse Event|1|||
163124849|NCT00907296|589164004|FG000|Overall Study|Withdrawal by Subject|7|||
163124850|NCT00907296|589164005|FG001|Overall Study|Withdrawal by Subject|2|||
163124851|NCT00907296|589164006|FG002|Overall Study|Withdrawal by Subject|1|||
163341765|NCT02561195|589959607|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
163341766|NCT02561195|589959608|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
163341767|NCT02561195|589959609|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
163341768|NCT02561195|589959610|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
163341769|NCT02561195|589959611|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
163124852|NCT00907296|589164007|FG003|Overall Study|Withdrawal by Subject|1|||
163124853|NCT00907296|589164008|FG004|Overall Study|Withdrawal by Subject|1|||
163124854|NCT00907296|589164009|FG005|Overall Study|Withdrawal by Subject|5|||
163124855|NCT00907296|589164010|FG006|Overall Study|Withdrawal by Subject|3|||
163124856|NCT00907296|589164011|FG007|Overall Study|Withdrawal by Subject|2|||
163124857|NCT00907296|589164012|FG008|Overall Study|Withdrawal by Subject|4|||
163124858|NCT00907296|589164013|FG009|Overall Study|Withdrawal by Subject|2|||
163124859|NCT00907296|589164004|FG000|Overall Study|Lost to Follow-up|9|||
163124860|NCT00907296|589164005|FG001|Overall Study|Lost to Follow-up|1|||
163124861|NCT00907296|589164006|FG002|Overall Study|Lost to Follow-up|0|||
163124862|NCT00907296|589164007|FG003|Overall Study|Lost to Follow-up|2|||
163124863|NCT00907296|589164008|FG004|Overall Study|Lost to Follow-up|0|||
163124864|NCT00907296|589164009|FG005|Overall Study|Lost to Follow-up|3|||
163124865|NCT00907296|589164010|FG006|Overall Study|Lost to Follow-up|2|||
163124866|NCT00907296|589164011|FG007|Overall Study|Lost to Follow-up|2|||
163124867|NCT00907296|589164012|FG008|Overall Study|Lost to Follow-up|0|||
163124868|NCT00907296|589164013|FG009|Overall Study|Lost to Follow-up|4|||
163124869|NCT01177969|589164023|FG000|Overall Study|Protocol Violation|2|||
163124870|NCT01177969|589164024|FG001|Overall Study|Protocol Violation|1|||
163124871|NCT01177969|589164023|FG000|Overall Study|Withdrawal by Subject|1|||
163124872|NCT01177969|589164024|FG001|Overall Study|Withdrawal by Subject|2|||
163124873|NCT01353911|589164031|FG000|Overall Study|Lost to Follow-up|2|||
163124874|NCT01353911|589164032|FG001|Overall Study|Lost to Follow-up|6|||
163124875|NCT01353911|589164033|FG002|Overall Study|Lost to Follow-up|4|||
163124876|NCT01353911|589164034|FG003|Overall Study|Lost to Follow-up|0|||
163124877|NCT01353911|589164035|FG004|Overall Study|Lost to Follow-up|4|||
163124878|NCT01353911|589164036|FG005|Overall Study|Lost to Follow-up|4|||
163124879|NCT01353911|589164037|FG006|Overall Study|Lost to Follow-up|3|||
163124880|NCT01353911|589164038|FG007|Overall Study|Lost to Follow-up|6|||
163124881|NCT01353911|589164031|FG000|Overall Study|Withdrawal by Subject|2|||
163124882|NCT01353911|589164032|FG001|Overall Study|Withdrawal by Subject|3|||
163124883|NCT01353911|589164033|FG002|Overall Study|Withdrawal by Subject|4|||
163124884|NCT01353911|589164034|FG003|Overall Study|Withdrawal by Subject|2|||
163124885|NCT01353911|589164035|FG004|Overall Study|Withdrawal by Subject|2|||
163124886|NCT01353911|589164036|FG005|Overall Study|Withdrawal by Subject|3|||
163124887|NCT01353911|589164037|FG006|Overall Study|Withdrawal by Subject|3|||
163124888|NCT01353911|589164038|FG007|Overall Study|Withdrawal by Subject|9|||
163124889|NCT01353911|589164031|FG000|Overall Study|Status Not Recorded|4|||
163124890|NCT01353911|589164032|FG001|Overall Study|Status Not Recorded|0|||
163124891|NCT01353911|589164033|FG002|Overall Study|Status Not Recorded|1|||
163124892|NCT01353911|589164034|FG003|Overall Study|Status Not Recorded|0|||
163124893|NCT01353911|589164035|FG004|Overall Study|Status Not Recorded|0|||
163124894|NCT01353911|589164036|FG005|Overall Study|Status Not Recorded|0|||
163124895|NCT01353911|589164037|FG006|Overall Study|Status Not Recorded|0|||
163124896|NCT01353911|589164038|FG007|Overall Study|Status Not Recorded|0|||
163124897|NCT02049138|589164043|FG000|Overall Study|Adverse Event|46|||
163124898|NCT02049138|589164044|FG001|Overall Study|Adverse Event|25|||
163124899|NCT02049138|589164045|FG002|Overall Study|Adverse Event|1|||
163124900|NCT02049138|589164043|FG000|Overall Study|Withdrawal by Subject|57|||
163124901|NCT02049138|589164044|FG001|Overall Study|Withdrawal by Subject|21|||
163124902|NCT02049138|589164045|FG002|Overall Study|Withdrawal by Subject|5|||
163341770|NCT02561195|589959612|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
163341771|NCT02561195|589959613|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
163341772|NCT02561195|589959614|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
163124903|NCT02049138|589164043|FG000|Overall Study|Lost to Follow-up|18|||
163124904|NCT02049138|589164044|FG001|Overall Study|Lost to Follow-up|5|||
163124905|NCT02049138|589164045|FG002|Overall Study|Lost to Follow-up|1|||
163124906|NCT02049138|589164043|FG000|Overall Study|Lack of Efficacy|10|||
163124907|NCT02049138|589164044|FG001|Overall Study|Lack of Efficacy|26|||
163124908|NCT02049138|589164045|FG002|Overall Study|Lack of Efficacy|1|||
163124909|NCT02049138|589164043|FG000|Overall Study|Non-Compliance|15|||
163124910|NCT02049138|589164044|FG001|Overall Study|Non-Compliance|6|||
163124911|NCT02049138|589164045|FG002|Overall Study|Non-Compliance|0|||
163124912|NCT02049138|589164043|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
163124913|NCT02049138|589164044|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
163124914|NCT02049138|589164045|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
163124915|NCT02049138|589164043|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
163341773|NCT02561195|589959615|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
163341774|NCT02561195|589959616|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
163408165|NCT02432235|590204041|FG009|Overall Study|Lost to Follow-up|0|||
163408166|NCT02432235|590204042|FG010|Overall Study|Lost to Follow-up|0|||
163408167|NCT02432235|590204043|FG011|Overall Study|Lost to Follow-up|0|||
163124916|NCT02049138|589164044|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
163124917|NCT02049138|589164045|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
163124918|NCT02049138|589164043|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
163124919|NCT02049138|589164044|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
163124920|NCT02049138|589164045|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
163124921|NCT02049138|589164043|FG000|Overall Study|Other|15|||
163124922|NCT02049138|589164044|FG001|Overall Study|Other|13|||
163124923|NCT02049138|589164045|FG002|Overall Study|Other|0|||
163124924|NCT02049138|589164043|FG000|Overall Study|Missing|0|||
163124925|NCT02049138|589164044|FG001|Overall Study|Missing|1|||
163124926|NCT02049138|589164045|FG002|Overall Study|Missing|0|||
163124927|NCT03995355|589164046|FG000|Overall Study|Adverse Event|1|||
163124928|NCT03995355|589164047|FG001|Overall Study|Adverse Event|0|||
163124929|NCT03995355|589164046|FG000|Overall Study|Withdrawal by Subject|1|||
163124930|NCT03995355|589164047|FG001|Overall Study|Withdrawal by Subject|0|||
163124931|NCT03995355|589164046|FG000|Overall Study|Scheduling Issues|0|||
163124932|NCT03995355|589164047|FG001|Overall Study|Scheduling Issues|1|||
163124933|NCT00094107|589164048|FG000|Overall Study|Lack of Efficacy|23|||
163124934|NCT00094107|589164048|FG000|Overall Study|Death|5|||
163124935|NCT00094107|589164048|FG000|Overall Study|Adverse Event|3|||
163124936|NCT00094107|589164048|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
163124937|NCT00587847|589164050|FG000|Overall Study|Lack of Efficacy|5|||
163124938|NCT00587847|589164050|FG000|Overall Study|Adverse Event|2|||
163124939|NCT00343382|589164051|FG000|Overall Study|Adverse Event|2|||
163124940|NCT00343382|589164052|FG001|Overall Study|Adverse Event|10|||
163124941|NCT00343382|589164053|FG002|Overall Study|Adverse Event|7|||
163124942|NCT00343382|589164051|FG000|Overall Study|Withdrawal by Subject|1|||
163124943|NCT00343382|589164052|FG001|Overall Study|Withdrawal by Subject|2|||
163124944|NCT00343382|589164053|FG002|Overall Study|Withdrawal by Subject|6|||
163124945|NCT00343382|589164051|FG000|Overall Study|Other Reason Not Specified|1|||
163124946|NCT00343382|589164052|FG001|Overall Study|Other Reason Not Specified|2|||
163124947|NCT00343382|589164053|FG002|Overall Study|Other Reason Not Specified|4|||
163124948|NCT00199888|589164060|FG000|Overall Study|Lost to Follow-up|1|||
163124949|NCT05219669|589164065|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
163124950|NCT05219669|589164066|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
163124951|NCT05219669|589164067|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
163124952|NCT05219669|589164068|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
163124953|NCT05219669|589164069|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
163124954|NCT05219669|589164070|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
163124955|NCT02177838|589164072|FG000|Overall Study|Withdrawal by Subject|1|||
163124956|NCT02177838|589164072|FG000|Overall Study|Physician Decision|1|||
163124957|NCT02177838|589164072|FG000|Overall Study|Death|1|||
163124958|NCT02404649|589164074|FG000|Overall Study|Adverse Event|1|||
163124959|NCT02404649|589164075|FG001|Overall Study|Adverse Event|2|||
163124960|NCT02299076|589164079|FG000|Overall Study|Fraudulent Entries|20|||
163124961|NCT02299076|589164080|FG001|Overall Study|Fraudulent Entries|14|||
163124962|NCT00162266|589164081|FG000|Double-Blind Period|Adverse Event|5|||
163124963|NCT00162266|589164082|FG001|Double-Blind Period|Adverse Event|9|||
163124964|NCT00162266|589164083|FG002|Double-Blind Period|Adverse Event|11|||
163124965|NCT00162266|589164084|FG003|Double-Blind Period|Adverse Event|0|||
163124966|NCT00162266|589164081|FG000|Double-Blind Period|Death|0|||
163124967|NCT00162266|589164082|FG001|Double-Blind Period|Death|1|||
163124968|NCT00162266|589164083|FG002|Double-Blind Period|Death|0|||
163124969|NCT00162266|589164084|FG003|Double-Blind Period|Death|0|||
163124970|NCT00162266|589164081|FG000|Double-Blind Period|Lost to Follow-up|1|||
163124971|NCT00162266|589164082|FG001|Double-Blind Period|Lost to Follow-up|2|||
163124972|NCT00162266|589164083|FG002|Double-Blind Period|Lost to Follow-up|0|||
163124973|NCT00162266|589164084|FG003|Double-Blind Period|Lost to Follow-up|0|||
163124974|NCT00162266|589164081|FG000|Double-Blind Period|Other Reason|1|||
163124975|NCT00162266|589164082|FG001|Double-Blind Period|Other Reason|0|||
163124976|NCT00162266|589164083|FG002|Double-Blind Period|Other Reason|1|||
163124977|NCT00162266|589164084|FG003|Double-Blind Period|Other Reason|0|||
163124978|NCT00162266|589164081|FG000|Double-Blind Period|Lack of Efficacy|13|||
163124979|NCT00162266|589164082|FG001|Double-Blind Period|Lack of Efficacy|17|||
163124980|NCT00162266|589164083|FG002|Double-Blind Period|Lack of Efficacy|30|||
163124981|NCT00162266|589164084|FG003|Double-Blind Period|Lack of Efficacy|0|||
163124982|NCT00162266|589164081|FG000|Double-Blind Period|Withdrawal by Subject|5|||
163124983|NCT00162266|589164082|FG001|Double-Blind Period|Withdrawal by Subject|2|||
163124984|NCT00162266|589164083|FG002|Double-Blind Period|Withdrawal by Subject|6|||
163124985|NCT00162266|589164084|FG003|Double-Blind Period|Withdrawal by Subject|0|||
163124986|NCT00162266|589164081|FG000|Open-Label Period|Death|0|||
163124987|NCT00162266|589164082|FG001|Open-Label Period|Death|0|||
163124988|NCT00162266|589164083|FG002|Open-Label Period|Death|0|||
163124989|NCT00162266|589164084|FG003|Open-Label Period|Death|7|||
163124990|NCT00162266|589164081|FG000|Open-Label Period|Adverse Event|0|||
163124991|NCT00162266|589164082|FG001|Open-Label Period|Adverse Event|0|||
163124992|NCT00162266|589164083|FG002|Open-Label Period|Adverse Event|0|||
163225428|NCT02896400|589541993|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
163225429|NCT02896400|589541994|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
163225430|NCT02896400|589541995|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
163225431|NCT02896400|589541996|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
163225432|NCT02896400|589541997|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
163225433|NCT02896400|589541998|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
163225434|NCT02896400|589541999|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
163225435|NCT02896400|589542000|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
163225436|NCT02896400|589542001|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
163225437|NCT02896400|589542002|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
163225438|NCT02896400|589542003|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
163225439|NCT02896400|589542004|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
163225440|NCT02896400|589541989|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
163225441|NCT02896400|589541990|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
163225442|NCT02896400|589541991|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
163225443|NCT02896400|589541992|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
163225444|NCT02896400|589541993|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
163225445|NCT02896400|589541994|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
163225446|NCT02896400|589541995|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
163225447|NCT02896400|589541996|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
163225448|NCT02896400|589541997|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
163124993|NCT00162266|589164084|FG003|Open-Label Period|Adverse Event|46|||
163124994|NCT00162266|589164081|FG000|Open-Label Period|Lack of Efficacy|0|||
163124995|NCT00162266|589164082|FG001|Open-Label Period|Lack of Efficacy|0|||
163124996|NCT00162266|589164083|FG002|Open-Label Period|Lack of Efficacy|0|||
163124997|NCT00162266|589164084|FG003|Open-Label Period|Lack of Efficacy|26|||
163124998|NCT00162266|589164081|FG000|Open-Label Period|Lost to Follow-up|0|||
163124999|NCT00162266|589164082|FG001|Open-Label Period|Lost to Follow-up|0|||
163125000|NCT00162266|589164083|FG002|Open-Label Period|Lost to Follow-up|0|||
163125001|NCT00162266|589164084|FG003|Open-Label Period|Lost to Follow-up|3|||
163125002|NCT00162266|589164081|FG000|Open-Label Period|Withdrawal by Subject|0|||
163125003|NCT00162266|589164082|FG001|Open-Label Period|Withdrawal by Subject|0|||
163125004|NCT00162266|589164083|FG002|Open-Label Period|Withdrawal by Subject|0|||
163125005|NCT00162266|589164084|FG003|Open-Label Period|Withdrawal by Subject|31|||
163125006|NCT00162266|589164081|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
163125007|NCT00162266|589164082|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
163125008|NCT00162266|589164083|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
163125009|NCT00162266|589164084|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
163125010|NCT00162266|589164081|FG000|Open-Label Period|Other Reasons|0|||
163125011|NCT00162266|589164082|FG001|Open-Label Period|Other Reasons|0|||
163125012|NCT00162266|589164083|FG002|Open-Label Period|Other Reasons|0|||
163125013|NCT00162266|589164084|FG003|Open-Label Period|Other Reasons|15|||
163125014|NCT00330668|589164085|FG000|BID Dosing Period|Adverse Event|1|||
163125015|NCT00330668|589164085|FG000|BID Dosing Period|Lost to Follow-up|7|||
163125016|NCT00330668|589164085|FG000|BID Dosing Period|Non-Compliance|5|||
163125017|NCT00330668|589164085|FG000|BID Dosing Period|Withdrawal by Subject|19|||
163125018|NCT00330668|589164085|FG000|BID Dosing Period|Sponsor's decision|1|||
163125019|NCT00330668|589164085|FG000|BID Dosing Period|Other|3|||
163125020|NCT00330668|589164085|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
163125021|NCT00330668|589164085|FG000|QD Dosing Period|Other|1|||
163125022|NCT00330668|589164085|FG000|QD Dosing Period|Withdrawal by Subject|1|||
163125023|NCT00330668|589164085|FG000|QD Dosing Period|Lost to Follow-up|2|||
163125024|NCT01839656|589164086|FG000|Overall Study|Withdrawal by Subject|1|||
163125025|NCT01839656|589164087|FG001|Overall Study|Withdrawal by Subject|1|||
163125026|NCT01839656|589164086|FG000|Overall Study|Adverse event, serious fatal|1|||
163125027|NCT01839656|589164087|FG001|Overall Study|Adverse event, serious fatal|4|||
163125028|NCT01839656|589164086|FG000|Overall Study|Early study closure|0|||
163125029|NCT01839656|589164087|FG001|Overall Study|Early study closure|11|||
163125030|NCT01839656|589164086|FG000|Overall Study|Adverse Event|1|||
163125031|NCT01839656|589164087|FG001|Overall Study|Adverse Event|0|||
163125032|NCT00499746|589164093|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
163125033|NCT00499746|589164093|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
163125034|NCT00499746|589164093|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
163125035|NCT00499746|589164093|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
163125036|NCT01012323|589164094|FG000|Overall Study|Investigator Judgment|1|||
163125037|NCT02273960|589164095|FG000|Short Term Period|Lost to Follow-up|1|||
163125038|NCT02273960|589164096|FG001|Short Term Period|Lost to Follow-up|0|||
163125039|NCT02273960|589164097|FG002|Short Term Period|Lost to Follow-up|0|||
163341775|NCT02561195|589959617|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
163341776|NCT02561195|589959618|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
163341777|NCT02561195|589959605|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163341778|NCT02561195|589959606|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
163341779|NCT02561195|589959607|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163341780|NCT02561195|589959608|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
163341781|NCT02561195|589959609|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
163341782|NCT02561195|589959610|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
163341783|NCT02561195|589959611|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163341784|NCT02561195|589959612|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163341785|NCT02561195|589959613|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163125040|NCT02273960|589164098|FG003|Short Term Period|Lost to Follow-up|0|||
163125041|NCT02273960|589164095|FG000|Short Term Period|Lack of Efficacy|0|||
163125042|NCT02273960|589164096|FG001|Short Term Period|Lack of Efficacy|0|||
163125043|NCT02273960|589164097|FG002|Short Term Period|Lack of Efficacy|0|||
163125044|NCT02273960|589164098|FG003|Short Term Period|Lack of Efficacy|1|||
163125045|NCT02273960|589164095|FG000|Short Term Period|ST complete, not entering LTE|4|||
163125046|NCT02273960|589164096|FG001|Short Term Period|ST complete, not entering LTE|6|||
163125047|NCT02273960|589164097|FG002|Short Term Period|ST complete, not entering LTE|4|||
163125048|NCT02273960|589164098|FG003|Short Term Period|ST complete, not entering LTE|5|||
163125049|NCT02273960|589164095|FG000|Long Term Extension|Death|0|||
163125050|NCT02273960|589164096|FG001|Long Term Extension|Death|0|||
163125051|NCT02273960|589164097|FG002|Long Term Extension|Death|0|||
163125052|NCT02273960|589164098|FG003|Long Term Extension|Death|1|||
163125053|NCT00737633|589164105|FG000|Overall Study|Study terminated by sponsor|44|||
163125054|NCT00737633|589164106|FG001|Overall Study|Study terminated by sponsor|55|||
163125055|NCT00737633|589164105|FG000|Overall Study|Lost to Follow-up|0|||
163125056|NCT00737633|589164106|FG001|Overall Study|Lost to Follow-up|1|||
163125057|NCT00737633|589164105|FG000|Overall Study|protocol non-compliance|0|||
163125058|NCT00737633|589164106|FG001|Overall Study|protocol non-compliance|1|||
163125059|NCT01105377|589164112|FG000|Overall Study|Withdrawal by Subject|0|||
163125060|NCT01105377|589164113|FG001|Overall Study|Withdrawal by Subject|1|||
163125061|NCT02100475|589166368|FG000|Overall Study|Unclassified|1|||
163125062|NCT02100475|589166369|FG001|Overall Study|Unclassified|2|||
163125063|NCT02100475|589166368|FG000|Overall Study|Withdrawal criteria|1|||
163125064|NCT02100475|589166369|FG001|Overall Study|Withdrawal criteria|0|||
163125065|NCT03268941|589166370|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
163125066|NCT03268941|589166371|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
163125067|NCT03268941|589166372|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
163125068|NCT03268941|589166373|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
163125069|NCT03268941|589166374|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
163125070|NCT03268941|589166375|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
163125071|NCT03268941|589166376|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
163125072|NCT03268941|589166370|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
163125073|NCT03268941|589166371|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
163125074|NCT03268941|589166372|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
163125075|NCT03268941|589166373|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
163125076|NCT03268941|589166374|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
163125077|NCT03268941|589166375|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
163125078|NCT03268941|589166376|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
163125079|NCT03268941|589166370|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
163125080|NCT03268941|589166371|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
163125081|NCT03268941|589166372|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
163125082|NCT03268941|589166373|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
163125083|NCT03268941|589166374|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
163125084|NCT03268941|589166375|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
163125085|NCT03268941|589166376|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
163125086|NCT03268941|589166370|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
163125087|NCT03268941|589166371|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
163125088|NCT03268941|589166372|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
163125089|NCT03268941|589166373|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
163125090|NCT03268941|589166374|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
163125091|NCT03268941|589166375|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
163341786|NCT02561195|589959614|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163125092|NCT03268941|589166376|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
163125093|NCT03268941|589166370|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
163125094|NCT03268941|589166371|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
163125095|NCT03268941|589166372|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
163125096|NCT03268941|589166373|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
163125097|NCT03268941|589166374|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
163125098|NCT03268941|589166375|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
163125099|NCT03268941|589166376|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
163341787|NCT02561195|589959615|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163125100|NCT03878758|589166381|FG000|Overall Study|Withdrawal by Subject|1|||
163125101|NCT03878758|589166381|FG000|Overall Study|Protocol defined|2|||
163125102|NCT03878758|589166381|FG000|Overall Study|Improper consent documentation|1|||
163125103|NCT01769196|589166382|FG000|Overall Study|Adverse Event|24|||
163125104|NCT01769196|589166383|FG001|Overall Study|Adverse Event|20|||
163125105|NCT01769196|589166382|FG000|Overall Study|Death|21|||
163125106|NCT01769196|589166383|FG001|Overall Study|Death|26|||
163125107|NCT01769196|589166382|FG000|Overall Study|Investigator Discretion|7|||
163125108|NCT01769196|589166383|FG001|Overall Study|Investigator Discretion|3|||
163125109|NCT01769196|589166382|FG000|Overall Study|Lack of Efficacy|3|||
163125110|NCT01769196|589166383|FG001|Overall Study|Lack of Efficacy|2|||
163125111|NCT01769196|589166382|FG000|Overall Study|Progressive disease|11|||
163125112|NCT01769196|589166383|FG001|Overall Study|Progressive disease|6|||
163125113|NCT01769196|589166382|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
163125114|NCT01769196|589166383|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
163125115|NCT01769196|589166382|FG000|Overall Study|Protocol Violation|0|||
163125116|NCT01769196|589166383|FG001|Overall Study|Protocol Violation|3|||
163125117|NCT01769196|589166382|FG000|Overall Study|Study terminated by sponsor|160|||
163125118|NCT01769196|589166383|FG001|Overall Study|Study terminated by sponsor|161|||
163125119|NCT01769196|589166382|FG000|Overall Study|Participant never dosed with study drug|1|||
163125120|NCT01769196|589166383|FG001|Overall Study|Participant never dosed with study drug|0|||
163125121|NCT01769196|589166382|FG000|Overall Study|Withdrew consent|36|||
163125122|NCT01769196|589166383|FG001|Overall Study|Withdrew consent|40|||
163125123|NCT00765063|589166384|FG000|Overall Study|Lack of Efficacy|5|||
163125124|NCT00765063|589166384|FG000|Overall Study|Withdrawal by Subject|1|||
163125125|NCT00765063|589166384|FG000|Overall Study|Other|16|||
163125126|NCT00765063|589166384|FG000|Overall Study|Protocol Violation|6|||
163125127|NCT00765063|589166384|FG000|Overall Study|Adverse Event|4|||
163125128|NCT03614325|589166385|FG000|Overall Study|Withdrawal by Subject|0|||
163125129|NCT03614325|589166386|FG001|Overall Study|Withdrawal by Subject|2|||
163125130|NCT03614325|589166385|FG000|Overall Study|Surgery Cancelled|2|||
163125131|NCT03614325|589166386|FG001|Overall Study|Surgery Cancelled|1|||
163125132|NCT03614325|589166385|FG000|Overall Study|Lost to Follow-up|2|||
163125133|NCT03614325|589166386|FG001|Overall Study|Lost to Follow-up|1|||
163125134|NCT03614325|589166385|FG000|Overall Study|Surgery never scheduled|1|||
163125135|NCT03614325|589166386|FG001|Overall Study|Surgery never scheduled|0|||
163125136|NCT00321464|589166387|FG000|Overall Study|Death|169|||
163125137|NCT00321464|589166388|FG001|Overall Study|Death|174|||
163125138|NCT00321464|589166387|FG000|Overall Study|Disease progression|124|||
163125139|NCT00321464|589166388|FG001|Overall Study|Disease progression|124|||
163125140|NCT00321464|589166387|FG000|Overall Study|Withdrawal by Subject|117|||
163125141|NCT00321464|589166388|FG001|Overall Study|Withdrawal by Subject|118|||
163125142|NCT00321464|589166387|FG000|Overall Study|Participant request|57|||
163125143|NCT00321464|589166388|FG001|Overall Study|Participant request|61|||
163125144|NCT00321464|589166387|FG000|Overall Study|Adverse Event|43|||
163125145|NCT00321464|589166388|FG001|Overall Study|Adverse Event|28|||
163125146|NCT00321464|589166387|FG000|Overall Study|Physician Decision|15|||
163125147|NCT00321464|589166388|FG001|Overall Study|Physician Decision|14|||
163125148|NCT00321464|589166387|FG000|Overall Study|Noncompliance|4|||
163125149|NCT00321464|589166388|FG001|Overall Study|Noncompliance|10|||
163125150|NCT00321464|589166387|FG000|Overall Study|Lost to Follow-up|7|||
163125151|NCT00321464|589166388|FG001|Overall Study|Lost to Follow-up|8|||
163125152|NCT00321464|589166387|FG000|Overall Study|Protocol deviation|0|||
163125153|NCT00321464|589166388|FG001|Overall Study|Protocol deviation|2|||
163125154|NCT00321464|589166387|FG000|Overall Study|Ineligibility determined|2|||
163125155|NCT00321464|589166388|FG001|Overall Study|Ineligibility determined|1|||
163125156|NCT00321464|589166387|FG000|Overall Study|Other|21|||
163125157|NCT00321464|589166388|FG001|Overall Study|Other|18|||
163125158|NCT01673620|589166394|FG000|Overall Study|Adverse Event|1|||
163125159|NCT01673620|589166395|FG001|Overall Study|Adverse Event|0|||
163125160|NCT00652951|589166396|FG000|Booster Phase|Adverse event, non-fatal|0|||
163125161|NCT00652951|589166397|FG001|Booster Phase|Adverse event, non-fatal|1|||
163125162|NCT00652951|589166398|FG002|Booster Phase|Adverse event, non-fatal|0|||
163225449|NCT02896400|589541998|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
163408168|NCT02432235|590204032|FG000|Overall Study|Miscellaneous|0|||
163125163|NCT00652951|589166396|FG000|Booster Phase|Other|1|||
163125164|NCT00652951|589166397|FG001|Booster Phase|Other|0|||
163125165|NCT00652951|589166398|FG002|Booster Phase|Other|0|||
163125166|NCT01022424|589166399|FG000|Overall Study|Adverse Event|1|||
163125167|NCT01022424|589166399|FG000|Overall Study|Physician Decision|1|||
163125168|NCT01022424|589166399|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
163125169|NCT02100969|589166400|FG000|Overall Study|Did not pass screening phase|1|||
163125170|NCT00372697|589166401|FG000|Overall Study|Protocol Violation|1|||
163125171|NCT00372697|589166402|FG001|Overall Study|Protocol Violation|1|||
163125172|NCT00527982|589166404|FG000|Overall Study|Physician Decision|1|||
163125173|NCT00527982|589166405|FG001|Overall Study|Physician Decision|0|||
163125174|NCT00007020|589166408|FG000|Overall Study|Death|16|||
163125175|NCT00007020|589166408|FG000|Overall Study|Lost to Follow-up|13|||
163408169|NCT02432235|590204033|FG001|Overall Study|Miscellaneous|0|||
163225450|NCT02896400|589541999|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
163225451|NCT02896400|589542000|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
163225452|NCT02896400|589542001|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
163225453|NCT02896400|589542002|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
163225454|NCT02896400|589542003|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
163225455|NCT02896400|589542004|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
163225456|NCT02984020|589542005|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
163225457|NCT02984020|589542005|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
163225458|NCT02984020|589542005|FG000|Overall Study|Other significant protocol violation|2|||
163225459|NCT01700179|589542006|FG000|Overall Study|Physician Decision|2|||
163225460|NCT01207778|589542007|FG000|Overall Study|Lost to Follow-up|0|||
163225461|NCT01207778|589542008|FG001|Overall Study|Lost to Follow-up|3|||
163225462|NCT01207778|589542009|FG002|Overall Study|Lost to Follow-up|3|||
163225463|NCT05168475|589542012|FG000|Period 1|Protocol Violation|1|||
163225464|NCT05168475|589542012|FG000|Period 1|IMP shortage|2|||
163225465|NCT05168475|589542012|FG000|Period 1|Not randomised|2|||
163225466|NCT05168475|589542012|FG000|Period 2|IMP shortage|1|||
163225467|NCT00646204|589542013|FG000|Overall Study|Adverse Event|3|||
163225468|NCT00646204|589542014|FG001|Overall Study|Adverse Event|0|||
163225469|NCT00646204|589542013|FG000|Overall Study|Withdrawal by Subject|1|||
163225470|NCT00646204|589542014|FG001|Overall Study|Withdrawal by Subject|0|||
163225471|NCT00503841|589542021|FG000|Overall Study|All screen failures|44|||
163225472|NCT01302964|589542022|FG000|Overall Study|Adverse Event|1|||
163225473|NCT01302964|589542023|FG001|Overall Study|Adverse Event|0|||
163225474|NCT01945489|589542024|FG000|Cycle 1|Adverse Event|2|||
163225475|NCT01945489|589542025|FG001|Cycle 1|Adverse Event|0|||
163225476|NCT01945489|589542024|FG000|Cycle 1|Lost to Follow-up|4|||
163225477|NCT01945489|589542025|FG001|Cycle 1|Lost to Follow-up|0|||
163225478|NCT01945489|589542024|FG000|Cycle 1|Personal Reasons|4|||
163225479|NCT01945489|589542025|FG001|Cycle 1|Personal Reasons|2|||
163225480|NCT01945489|589542024|FG000|Cycle 1|Protocol Violation|0|||
163225481|NCT01945489|589542025|FG001|Cycle 1|Protocol Violation|1|||
163225482|NCT01945489|589542024|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
163225483|NCT01945489|589542025|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
163225484|NCT01945489|589542024|FG000|Cycle 2|Adverse Event|1|||
163225485|NCT01945489|589542025|FG001|Cycle 2|Adverse Event|0|||
163225486|NCT01945489|589542024|FG000|Cycle 2|Lost to Follow-up|0|||
163225487|NCT01945489|589542025|FG001|Cycle 2|Lost to Follow-up|1|||
163225488|NCT00394212|589542028|FG000|Overall Study|Lost to Follow-up|3|||
163225489|NCT00394212|589542029|FG001|Overall Study|Lost to Follow-up|0|||
163225490|NCT00394212|589542028|FG000|Overall Study|Withdrawal by Subject|4|||
163225491|NCT00394212|589542029|FG001|Overall Study|Withdrawal by Subject|1|||
163225492|NCT02347527|589542031|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
163225493|NCT02347527|589542032|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
163225494|NCT02347527|589542033|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
163225495|NCT02347527|589542034|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
163225496|NCT02347527|589542031|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
163225497|NCT02347527|589542032|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
163225498|NCT02347527|589542033|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
163225499|NCT02347527|589542034|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
163225500|NCT02347527|589542031|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
163225501|NCT02347527|589542032|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
163225502|NCT02347527|589542033|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
163225503|NCT02347527|589542034|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
163225504|NCT02347527|589542031|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
163225505|NCT02347527|589542032|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
163225506|NCT02347527|589542033|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
163225507|NCT02347527|589542034|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
163225508|NCT02347527|589542031|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
163225509|NCT02347527|589542032|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
163341788|NCT02561195|589959616|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163341789|NCT02561195|589959617|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163341790|NCT02561195|589959618|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163225510|NCT02347527|589542033|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
163225511|NCT02347527|589542034|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
163225512|NCT00596011|589542035|FG000|Overall Study|Withdrawal by Subject|2|||
163225513|NCT00596011|589542036|FG001|Overall Study|Withdrawal by Subject|3|||
163225514|NCT00596011|589542035|FG000|Overall Study|Adverse Event|11|||
163408170|NCT02432235|590204034|FG002|Overall Study|Miscellaneous|0|||
163125176|NCT00007020|589166408|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
163125177|NCT00007020|589166408|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
163125178|NCT00007020|589166408|FG000|Overall Study|Pt cared for by outside physician|4|||
163125179|NCT00007020|589166408|FG000|Overall Study|No evidence of treatment|6|||
163125180|NCT02708485|589166409|FG000|Overall Study|Withdrawal by Subject|3|||
163125181|NCT02708485|589166410|FG001|Overall Study|Withdrawal by Subject|2|||
163125182|NCT01100528|589166411|FG000|Overall Study|Death|1|||
163125183|NCT01100528|589166411|FG000|Overall Study|Withdrawal by Subject|2|||
163125184|NCT02066415|589166412|FG000|Overall Study|Decision by Sponsor|5|||
163125185|NCT02066415|589166413|FG001|Overall Study|Decision by Sponsor|4|||
163125186|NCT02066415|589166414|FG002|Overall Study|Decision by Sponsor|2|||
163125187|NCT02066415|589166412|FG000|Overall Study|Withdrawal by Subject|9|||
163125188|NCT02066415|589166413|FG001|Overall Study|Withdrawal by Subject|1|||
163125189|NCT02066415|589166414|FG002|Overall Study|Withdrawal by Subject|4|||
163125190|NCT02066415|589166412|FG000|Overall Study|Lost to Follow-up|7|||
163125191|NCT02066415|589166413|FG001|Overall Study|Lost to Follow-up|2|||
163125192|NCT02066415|589166414|FG002|Overall Study|Lost to Follow-up|2|||
163125193|NCT01116427|589166415|FG000|Core Phase|Adverse Event|0|||
163125194|NCT01116427|589166416|FG001|Core Phase|Adverse Event|1|||
163125195|NCT01116427|589166415|FG000|Core Phase|Lost to Follow-up|1|||
163125196|NCT01116427|589166416|FG001|Core Phase|Lost to Follow-up|0|||
163125197|NCT01116427|589166415|FG000|Core Phase|Withdrawal by Subject|3|||
163125198|NCT01116427|589166416|FG001|Core Phase|Withdrawal by Subject|0|||
163125199|NCT01116427|589166415|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
163125200|NCT01116427|589166416|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
163125201|NCT01116427|589166415|FG000|Extension Phase|Adverse Event|1|||
163125202|NCT01116427|589166416|FG001|Extension Phase|Adverse Event|1|||
163125203|NCT01116427|589166415|FG000|Extension Phase|Lost to Follow-up|2|||
163125204|NCT01116427|589166416|FG001|Extension Phase|Lost to Follow-up|0|||
163125205|NCT01116427|589166415|FG000|Extension Phase|Withdrawal by Subject|5|||
163125206|NCT01116427|589166416|FG001|Extension Phase|Withdrawal by Subject|1|||
163125207|NCT01116427|589166415|FG000|Extension Phase|Not using appropriate birth control|1|||
163125208|NCT01116427|589166416|FG001|Extension Phase|Not using appropriate birth control|0|||
163125209|NCT02211313|589166417|FG000|Overall Study|Treatment Failure|5|||
163125210|NCT02211313|589166418|FG001|Overall Study|Treatment Failure|2|||
163125211|NCT02211313|589166417|FG000|Overall Study|No Follow up Questionnaires|1|||
163125212|NCT02211313|589166418|FG001|Overall Study|No Follow up Questionnaires|1|||
163125213|NCT01423916|589166419|FG000|Overall Study|Adverse Event|5|||
163125214|NCT01423916|589166420|FG001|Overall Study|Adverse Event|9|||
163125215|NCT01423916|589166421|FG002|Overall Study|Adverse Event|2|||
163125216|NCT01423916|589166419|FG000|Overall Study|Met Withdrawal Criteria|1|||
163125217|NCT01423916|589166420|FG001|Overall Study|Met Withdrawal Criteria|1|||
163125218|NCT01423916|589166421|FG002|Overall Study|Met Withdrawal Criteria|1|||
163125219|NCT01423916|589166419|FG000|Overall Study|Physician Decision|1|||
163125220|NCT01423916|589166420|FG001|Overall Study|Physician Decision|0|||
163125221|NCT01423916|589166421|FG002|Overall Study|Physician Decision|1|||
163125222|NCT01423916|589166419|FG000|Overall Study|Withdrawal by Subject|3|||
163125223|NCT01423916|589166420|FG001|Overall Study|Withdrawal by Subject|10|||
163125224|NCT01423916|589166421|FG002|Overall Study|Withdrawal by Subject|3|||
163125225|NCT01423916|589166419|FG000|Overall Study|Protocol Deviation|1|||
163125226|NCT01423916|589166420|FG001|Overall Study|Protocol Deviation|0|||
163125227|NCT01423916|589166421|FG002|Overall Study|Protocol Deviation|0|||
163125228|NCT03316950|589166422|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
163125229|NCT03316950|589166423|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
163125230|NCT03316950|589166424|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
163125231|NCT03316950|589166425|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
163125232|NCT03316950|589166422|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
163125233|NCT03316950|589166423|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
163125234|NCT03316950|589166424|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
163125235|NCT03316950|589166425|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
163125236|NCT03316950|589166422|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
163125237|NCT03316950|589166423|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
163125238|NCT03316950|589166424|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
163125239|NCT03316950|589166425|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
163125240|NCT01754194|589166426|FG000|Overall Study|Lost to Follow-up|39|||
163125241|NCT01754194|589166427|FG001|Overall Study|Lost to Follow-up|14|||
163125242|NCT01754194|589166426|FG000|Overall Study|Withdrawal by Subject|4|||
163125243|NCT01754194|589166427|FG001|Overall Study|Withdrawal by Subject|5|||
163125244|NCT01754194|589166426|FG000|Overall Study|Other|9|||
163125245|NCT01754194|589166427|FG001|Overall Study|Other|8|||
163125246|NCT00791557|589166428|FG000|Overall Study|Adverse Event|1|||
163125247|NCT01079936|589166429|FG000|Phase I: MTD|First Remission Status|2|||
163125248|NCT01079936|589166430|FG001|Phase I: MTD|First Remission Status|0|||
163125249|NCT01079936|589166431|FG002|Phase I: MTD|First Remission Status|0|||
163125250|NCT01079936|589166432|FG003|Phase I: MTD|First Remission Status|0|||
163125251|NCT01079936|589166433|FG004|Phase I: MTD|First Remission Status|0|||
163125252|NCT01079936|589166429|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
163125253|NCT01079936|589166430|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
163125254|NCT01079936|589166431|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
163125255|NCT01079936|589166432|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
163125256|NCT01079936|589166433|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
163125257|NCT01079936|589166429|FG000|Phase II|Adverse Event|0|||
163125258|NCT01079936|589166430|FG001|Phase II|Adverse Event|0|||
163125259|NCT01079936|589166431|FG002|Phase II|Adverse Event|1|||
163125260|NCT01079936|589166432|FG003|Phase II|Adverse Event|0|||
163125261|NCT01079936|589166433|FG004|Phase II|Adverse Event|0|||
163125262|NCT01079936|589166429|FG000|Phase II|Insurance Issue|0|||
163125263|NCT01079936|589166430|FG001|Phase II|Insurance Issue|0|||
163125264|NCT01079936|589166431|FG002|Phase II|Insurance Issue|0|||
163125265|NCT01079936|589166432|FG003|Phase II|Insurance Issue|0|||
163125266|NCT01079936|589166433|FG004|Phase II|Insurance Issue|1|||
163125267|NCT02322190|589166434|FG000|Overall Study|Death on study|1|||
163125268|NCT02322190|589166435|FG001|Overall Study|Death on study|0|||
163125269|NCT03344640|589166436|FG000|Overall Study|Adverse Event|1|||
163125270|NCT03344640|589166437|FG001|Overall Study|Adverse Event|0|||
163125271|NCT03344640|589166436|FG000|Overall Study|Physician Decision|1|||
163125272|NCT03344640|589166437|FG001|Overall Study|Physician Decision|1|||
163125273|NCT03344640|589166436|FG000|Overall Study|Withdrawal by Subject|1|||
163125274|NCT03344640|589166437|FG001|Overall Study|Withdrawal by Subject|2|||
163125275|NCT03344640|589166436|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
163125276|NCT03344640|589166437|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
163125277|NCT02809053|589166438|FG000|Overall Study|Death|0|||
163125278|NCT02809053|589166439|FG001|Overall Study|Death|1|||
163125279|NCT02809053|589166438|FG000|Overall Study|Lost to Follow-up|3|||
163125280|NCT02809053|589166439|FG001|Overall Study|Lost to Follow-up|1|||
163125281|NCT02809053|589166438|FG000|Overall Study|Withdrawal by Subject|2|||
163125282|NCT02809053|589166439|FG001|Overall Study|Withdrawal by Subject|3|||
163125283|NCT02809053|589166438|FG000|Overall Study|Disease Progression|2|||
163125284|NCT02809053|589166439|FG001|Overall Study|Disease Progression|1|||
163125285|NCT01147900|589166440|FG000|At Year 10|Lost to Follow-up|0|||
163125286|NCT01147900|589166441|FG001|At Year 10|Lost to Follow-up|1|||
163125287|NCT01147900|589166442|FG002|At Year 10|Lost to Follow-up|0|||
163125288|NCT00025155|589166443|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
163125289|NCT00025155|589166443|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
163125290|NCT05086510|589166444|FG000|Overall Study|Lost to Follow-up|0|||
163125291|NCT05086510|589166445|FG001|Overall Study|Lost to Follow-up|2|||
163125292|NCT05086510|589166444|FG000|Overall Study|Death|0|||
163125293|NCT05086510|589166445|FG001|Overall Study|Death|2|||
163125294|NCT03022981|589166446|FG000|Overall Study|Adverse Event|0|||
163125295|NCT03022981|589166447|FG001|Overall Study|Adverse Event|1|||
163125296|NCT03022981|589166448|FG002|Overall Study|Adverse Event|0|||
163125297|NCT03022981|589166446|FG000|Overall Study|Investigator's Discretion|0|||
163125298|NCT03022981|589166447|FG001|Overall Study|Investigator's Discretion|1|||
163125299|NCT03022981|589166448|FG002|Overall Study|Investigator's Discretion|2|||
163125300|NCT03022981|589166446|FG000|Overall Study|Lost to Follow-up|6|||
163125301|NCT03022981|589166447|FG001|Overall Study|Lost to Follow-up|2|||
163125302|NCT03022981|589166448|FG002|Overall Study|Lost to Follow-up|1|||
163125303|NCT03022981|589166446|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163125304|NCT03022981|589166447|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163125305|NCT03022981|589166448|FG002|Overall Study|Non-Compliance With Study Drug|2|||
163125306|NCT03022981|589166446|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
163125307|NCT03022981|589166447|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
163125308|NCT03022981|589166448|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
163125309|NCT00884832|589166450|FG000|Overall Study|Withdrawal by Subject|0|||
163125310|NCT00884832|589166451|FG001|Overall Study|Withdrawal by Subject|1|||
163125311|NCT02337725|589166452|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
163125312|NCT02337725|589166453|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
163125313|NCT02337725|589166452|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
163125314|NCT02337725|589166453|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
163125315|NCT02337725|589166452|FG000|Overall Study|Major Protocol Deviation|0|||
163125316|NCT02337725|589166453|FG001|Overall Study|Major Protocol Deviation|1|||
163125317|NCT02337725|589166452|FG000|Overall Study|Voluntary Withdrawal|14|||
163125318|NCT02337725|589166453|FG001|Overall Study|Voluntary Withdrawal|3|||
163125319|NCT02337725|589166452|FG000|Overall Study|Lack of Efficacy|4|||
163125320|NCT02337725|589166453|FG001|Overall Study|Lack of Efficacy|0|||
163125321|NCT00500760|589166455|FG000|Overall Study|Death|32|||
163125322|NCT00500760|589166456|FG001|Overall Study|Death|15|||
163125323|NCT00500760|589166455|FG000|Overall Study|Withdrawal by Subject|5|||
163125324|NCT00500760|589166456|FG001|Overall Study|Withdrawal by Subject|7|||
163125325|NCT00500760|589166455|FG000|Overall Study|Administrative decision|2|||
163125326|NCT00500760|589166456|FG001|Overall Study|Administrative decision|0|||
163125327|NCT00500760|589166455|FG000|Overall Study|Lost to Follow-up|3|||
163125328|NCT00500760|589166456|FG001|Overall Study|Lost to Follow-up|0|||
163125329|NCT00500760|589166455|FG000|Overall Study|Other|1|||
163125330|NCT00500760|589166456|FG001|Overall Study|Other|2|||
163125331|NCT01264770|589166457|FG000|Overall Study|Not reported|0|||
163125332|NCT01264770|589166458|FG001|Overall Study|Not reported|0|||
163125333|NCT01264770|589166459|FG002|Overall Study|Not reported|1|||
163125334|NCT01264770|589166460|FG003|Overall Study|Not reported|0|||
163125335|NCT01264770|589166461|FG004|Overall Study|Not reported|0|||
163125336|NCT01264770|589166462|FG005|Overall Study|Not reported|0|||
163125337|NCT01264770|589166457|FG000|Overall Study|e.g., change in circumstances|8|||
163125338|NCT01264770|589166458|FG001|Overall Study|e.g., change in circumstances|3|||
163125339|NCT01264770|589166459|FG002|Overall Study|e.g., change in circumstances|3|||
163125340|NCT01264770|589166460|FG003|Overall Study|e.g., change in circumstances|3|||
163125341|NCT01264770|589166461|FG004|Overall Study|e.g., change in circumstances|4|||
163125342|NCT01264770|589166462|FG005|Overall Study|e.g., change in circumstances|4|||
163125343|NCT01264770|589166457|FG000|Overall Study|Severe non-compliance to protocol|0|||
163125344|NCT01264770|589166458|FG001|Overall Study|Severe non-compliance to protocol|0|||
163125345|NCT01264770|589166459|FG002|Overall Study|Severe non-compliance to protocol|1|||
163125346|NCT01264770|589166460|FG003|Overall Study|Severe non-compliance to protocol|1|||
163125347|NCT01264770|589166461|FG004|Overall Study|Severe non-compliance to protocol|0|||
163125348|NCT01264770|589166462|FG005|Overall Study|Severe non-compliance to protocol|0|||
163125349|NCT01264770|589166457|FG000|Overall Study|Lack of therapeutic response|1|||
163125350|NCT01264770|589166458|FG001|Overall Study|Lack of therapeutic response|0|||
163125351|NCT01264770|589166459|FG002|Overall Study|Lack of therapeutic response|2|||
163125352|NCT01264770|589166460|FG003|Overall Study|Lack of therapeutic response|1|||
163125353|NCT01264770|589166461|FG004|Overall Study|Lack of therapeutic response|1|||
163125354|NCT01264770|589166462|FG005|Overall Study|Lack of therapeutic response|0|||
163125355|NCT01264770|589166457|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
163225515|NCT00596011|589542036|FG001|Overall Study|Adverse Event|7|||
163225516|NCT01466270|589542041|FG000|Overall Study|Withdrawal by Subject|4|||
163225517|NCT01466270|589542042|FG001|Overall Study|Withdrawal by Subject|1|||
163225518|NCT01466270|589542041|FG000|Overall Study|Physician Decision|1|||
163225519|NCT01466270|589542042|FG001|Overall Study|Physician Decision|0|||
163225520|NCT01466270|589542041|FG000|Overall Study|Lost to Follow-up|1|||
163225521|NCT01466270|589542042|FG001|Overall Study|Lost to Follow-up|3|||
163225522|NCT01466270|589542041|FG000|Overall Study|Progression|1|||
163225523|NCT01466270|589542042|FG001|Overall Study|Progression|0|||
163225524|NCT01466270|589542041|FG000|Overall Study|Toxicity|4|||
163225525|NCT01466270|589542042|FG001|Overall Study|Toxicity|1|||
163225526|NCT01466270|589542041|FG000|Overall Study|Multiple|1|||
163225527|NCT01466270|589542042|FG001|Overall Study|Multiple|1|||
163225528|NCT00749775|589542051|FG000|Overall Study|Protocol Violation|24|||
163225529|NCT00749775|589542051|FG000|Overall Study|Lost to Follow-up|36|||
163225530|NCT00749775|589542051|FG000|Overall Study|No visit after first day of treatment|44|||
163225531|NCT00749775|589542051|FG000|Overall Study|No drug administration|3|||
163225532|NCT03364049|589542059|FG000|Overall Study|Death|6|||
163225533|NCT03364049|589542060|FG001|Overall Study|Death|4|||
163225534|NCT03364049|589542061|FG002|Overall Study|Death|5|||
163225535|NCT03364049|589542062|FG003|Overall Study|Death|14|||
163225536|NCT03364049|589542059|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
163225537|NCT03364049|589542060|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
163225538|NCT03364049|589542061|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
163225539|NCT03364049|589542062|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
163225540|NCT03364049|589542059|FG000|Overall Study|Withdrawal by Subject|0|||
163225541|NCT03364049|589542060|FG001|Overall Study|Withdrawal by Subject|1|||
163225542|NCT03364049|589542061|FG002|Overall Study|Withdrawal by Subject|1|||
163225543|NCT03364049|589542062|FG003|Overall Study|Withdrawal by Subject|1|||
163225544|NCT01340976|589542063|FG000|Overall Study|Physician Decision|2|||
163225545|NCT01340976|589542064|FG001|Overall Study|Physician Decision|0|||
163225546|NCT01340976|589542065|FG002|Overall Study|Physician Decision|1|||
163225547|NCT01340976|589542066|FG003|Overall Study|Physician Decision|1|||
163225548|NCT01340976|589542067|FG004|Overall Study|Physician Decision|1|||
163225549|NCT01340976|589542068|FG005|Overall Study|Physician Decision|0|||
163225550|NCT01340976|589542063|FG000|Overall Study|Death|0|||
163225551|NCT01340976|589542064|FG001|Overall Study|Death|1|||
163225552|NCT01340976|589542065|FG002|Overall Study|Death|0|||
163225553|NCT01340976|589542066|FG003|Overall Study|Death|0|||
163225554|NCT01340976|589542067|FG004|Overall Study|Death|0|||
163225555|NCT01340976|589542068|FG005|Overall Study|Death|0|||
163225556|NCT01340976|589542063|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
163225557|NCT01340976|589542064|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
163225558|NCT01340976|589542065|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
163225559|NCT01340976|589542066|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
163225560|NCT01340976|589542067|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
163225561|NCT01340976|589542068|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
163125356|NCT01264770|589166458|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
163125357|NCT01264770|589166459|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
163125358|NCT01264770|589166460|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
163125359|NCT01264770|589166461|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
163125360|NCT01264770|589166462|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
163125361|NCT01264770|589166457|FG000|Overall Study|Lost to Follow-up|0|||
163125362|NCT01264770|589166458|FG001|Overall Study|Lost to Follow-up|0|||
163125363|NCT01264770|589166459|FG002|Overall Study|Lost to Follow-up|1|||
163125364|NCT01264770|589166460|FG003|Overall Study|Lost to Follow-up|1|||
163125365|NCT01264770|589166461|FG004|Overall Study|Lost to Follow-up|0|||
163125366|NCT01264770|589166462|FG005|Overall Study|Lost to Follow-up|0|||
163125367|NCT01264770|589166457|FG000|Overall Study|Adverse Event|7|||
163125368|NCT01264770|589166458|FG001|Overall Study|Adverse Event|7|||
163125369|NCT01264770|589166459|FG002|Overall Study|Adverse Event|8|||
163125370|NCT01264770|589166460|FG003|Overall Study|Adverse Event|0|||
163125371|NCT01264770|589166461|FG004|Overall Study|Adverse Event|2|||
163125372|NCT01264770|589166462|FG005|Overall Study|Adverse Event|1|||
163125373|NCT00129961|589166463|FG000|Overall Study|Adverse Event|1|||
163125374|NCT00129961|589166464|FG001|Overall Study|Adverse Event|0|||
163125375|NCT00129961|589166463|FG000|Overall Study|Death|1|||
163125376|NCT00129961|589166464|FG001|Overall Study|Death|1|||
163125377|NCT00129961|589166463|FG000|Overall Study|Withdrawal by Sponsor|14|||
163125378|NCT00129961|589166464|FG001|Overall Study|Withdrawal by Sponsor|20|||
163125379|NCT00129961|589166463|FG000|Overall Study|Physician Decision|1|||
163125380|NCT00129961|589166464|FG001|Overall Study|Physician Decision|0|||
163125381|NCT00129961|589166463|FG000|Overall Study|Withdrawal by Subject|2|||
163125382|NCT00129961|589166464|FG001|Overall Study|Withdrawal by Subject|1|||
163125383|NCT00129961|589166463|FG000|Overall Study|Missing Record|0|||
163125384|NCT00129961|589166464|FG001|Overall Study|Missing Record|1|||
163125385|NCT00084487|589166465|FG000|Overall Study|Death|1|||
163125386|NCT03691779|589166468|FG000|Part B (24 Weeks)|Adverse Event|0|||
163125387|NCT03691779|589166469|FG001|Part B (24 Weeks)|Adverse Event|1|||
163125388|NCT03691779|589166468|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
163125389|NCT03691779|589166469|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
163125390|NCT04881747|589166470|FG000|Period 2 Washout|Adverse Event|1|||
163125391|NCT04881747|589166471|FG001|Period 2 Washout|Adverse Event|0|||
163125392|NCT04881747|589166472|FG002|Period 2 Washout|Adverse Event|0|||
163125393|NCT04881747|589166473|FG003|Period 2 Washout|Adverse Event|0|||
163125394|NCT04881747|589166474|FG004|Period 2 Washout|Adverse Event|1|||
163125395|NCT04881747|589166475|FG005|Period 2 Washout|Adverse Event|0|||
163125396|NCT04881747|589166470|FG000|Period 2 Washout|Withdrawal by Subject|1|||
163125397|NCT04881747|589166471|FG001|Period 2 Washout|Withdrawal by Subject|0|||
163125398|NCT04881747|589166472|FG002|Period 2 Washout|Withdrawal by Subject|0|||
163125399|NCT04881747|589166473|FG003|Period 2 Washout|Withdrawal by Subject|1|||
163125400|NCT04881747|589166474|FG004|Period 2 Washout|Withdrawal by Subject|0|||
163125401|NCT04881747|589166475|FG005|Period 2 Washout|Withdrawal by Subject|0|||
163125402|NCT03869333|589166481|FG000|Overall Study|Lost to Follow-up|1|||
163125403|NCT03869333|589166482|FG001|Overall Study|Lost to Follow-up|0|||
163125404|NCT03869333|589166483|FG002|Overall Study|Lost to Follow-up|0|||
163125405|NCT03869333|589166484|FG003|Overall Study|Lost to Follow-up|0|||
163125406|NCT03869333|589166481|FG000|Overall Study|Pregnancy|1|||
163125407|NCT03869333|589166482|FG001|Overall Study|Pregnancy|0|||
163125408|NCT03869333|589166483|FG002|Overall Study|Pregnancy|0|||
163125409|NCT03869333|589166484|FG003|Overall Study|Pregnancy|0|||
163125410|NCT03869333|589166481|FG000|Overall Study|Physician Decision|0|||
163125411|NCT03869333|589166482|FG001|Overall Study|Physician Decision|1|||
163125412|NCT03869333|589166483|FG002|Overall Study|Physician Decision|0|||
163125413|NCT03869333|589166484|FG003|Overall Study|Physician Decision|0|||
163125414|NCT01927055|589166485|FG000|Open-label|Adverse Event|6|||
163125415|NCT01927055|589166486|FG001|Open-label|Adverse Event|0|||
163125416|NCT01927055|589166487|FG002|Open-label|Adverse Event|0|||
163125417|NCT01927055|589166485|FG000|Open-label|Withdrawal by Subject|1|||
163125418|NCT01927055|589166486|FG001|Open-label|Withdrawal by Subject|0|||
163225562|NCT01340976|589542063|FG000|Overall Study|Withdrawal by Subject|0|||
163225563|NCT01340976|589542064|FG001|Overall Study|Withdrawal by Subject|0|||
163225564|NCT01340976|589542065|FG002|Overall Study|Withdrawal by Subject|0|||
163225565|NCT01340976|589542066|FG003|Overall Study|Withdrawal by Subject|1|||
163225566|NCT01340976|589542067|FG004|Overall Study|Withdrawal by Subject|1|||
163225567|NCT01340976|589542068|FG005|Overall Study|Withdrawal by Subject|0|||
163125419|NCT01927055|589166487|FG002|Open-label|Withdrawal by Subject|0|||
163125420|NCT01927055|589166485|FG000|Open-label|Study Stopped|4|||
163125421|NCT01927055|589166486|FG001|Open-label|Study Stopped|0|||
163125422|NCT01927055|589166487|FG002|Open-label|Study Stopped|0|||
163125423|NCT01927055|589166485|FG000|Open-label|Supine Hypertension|4|||
163125424|NCT01927055|589166486|FG001|Open-label|Supine Hypertension|0|||
163125425|NCT01927055|589166487|FG002|Open-label|Supine Hypertension|0|||
163125426|NCT01927055|589166485|FG000|Open-label|Difficulty attending study visits|1|||
163125427|NCT01927055|589166486|FG001|Open-label|Difficulty attending study visits|0|||
163225568|NCT01340976|589542063|FG000|Overall Study|Other anemia treatment|1|||
163341791|NCT02561195|589959605|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
163341792|NCT02561195|589959606|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
163341793|NCT02561195|589959607|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
163341794|NCT02561195|589959608|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
163341795|NCT02561195|589959609|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
163341796|NCT02561195|589959610|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
163408171|NCT02432235|590204035|FG003|Overall Study|Miscellaneous|0|||
163408172|NCT02432235|590204036|FG004|Overall Study|Miscellaneous|1|||
163408173|NCT02432235|590204037|FG005|Overall Study|Miscellaneous|6|||
163125428|NCT01927055|589166487|FG002|Open-label|Difficulty attending study visits|0|||
163125429|NCT01927055|589166485|FG000|Double-Blind|Adverse Event|0|||
163125430|NCT01927055|589166486|FG001|Double-Blind|Adverse Event|1|||
163125431|NCT01927055|589166487|FG002|Double-Blind|Adverse Event|1|||
163125432|NCT01927055|589166485|FG000|Double-Blind|Protocol Violation|0|||
163125433|NCT01927055|589166486|FG001|Double-Blind|Protocol Violation|0|||
163125434|NCT01927055|589166487|FG002|Double-Blind|Protocol Violation|1|||
163125435|NCT01927055|589166485|FG000|Double-Blind|Withdrawal by Subject|0|||
163125436|NCT01927055|589166486|FG001|Double-Blind|Withdrawal by Subject|2|||
163125437|NCT01927055|589166487|FG002|Double-Blind|Withdrawal by Subject|3|||
163125438|NCT01927055|589166485|FG000|Double-Blind|Study Stopped|0|||
163125439|NCT01927055|589166486|FG001|Double-Blind|Study Stopped|7|||
163125440|NCT01927055|589166487|FG002|Double-Blind|Study Stopped|7|||
163125441|NCT01927055|589166485|FG000|Double-Blind|Supine Hypertension|0|||
163125442|NCT01927055|589166486|FG001|Double-Blind|Supine Hypertension|0|||
163125443|NCT01927055|589166487|FG002|Double-Blind|Supine Hypertension|1|||
163125444|NCT01927055|589166485|FG000|Double-Blind|Extended Vacation|0|||
163125445|NCT01927055|589166486|FG001|Double-Blind|Extended Vacation|1|||
163125446|NCT01927055|589166487|FG002|Double-Blind|Extended Vacation|0|||
163125447|NCT02598128|589166488|FG000|Period A: Days -7 to -1|Adverse Event|1|||
163125448|NCT02598128|589166489|FG001|Period A: Days -7 to -1|Adverse Event|0|||
163125449|NCT02598128|589166490|FG002|Period A: Days -7 to -1|Adverse Event|0|||
163125450|NCT02598128|589166491|FG003|Period A: Days -7 to -1|Adverse Event|0|||
163125451|NCT01378429|589166492|FG000|Overall Study|Noncompliance with study drug|1|||
163125452|NCT01378429|589166493|FG001|Overall Study|Noncompliance with study drug|0|||
163125453|NCT01064687|589166494|FG000|Overall Study|Adverse Event|9|||
163125454|NCT01064687|589166495|FG001|Overall Study|Adverse Event|4|||
163125455|NCT01064687|589166496|FG002|Overall Study|Adverse Event|10|||
163125456|NCT01064687|589166497|FG003|Overall Study|Adverse Event|3|||
163125457|NCT01064687|589166494|FG000|Overall Study|Death|1|||
163125458|NCT01064687|589166495|FG001|Overall Study|Death|1|||
163125459|NCT01064687|589166496|FG002|Overall Study|Death|0|||
163125460|NCT01064687|589166497|FG003|Overall Study|Death|0|||
163125461|NCT01064687|589166494|FG000|Overall Study|Entry Criteria Not Met|3|||
163125462|NCT01064687|589166495|FG001|Overall Study|Entry Criteria Not Met|0|||
163125463|NCT01064687|589166496|FG002|Overall Study|Entry Criteria Not Met|0|||
163125464|NCT01064687|589166497|FG003|Overall Study|Entry Criteria Not Met|0|||
163125465|NCT01064687|589166494|FG000|Overall Study|Lack of Efficacy|1|||
163125466|NCT01064687|589166495|FG001|Overall Study|Lack of Efficacy|0|||
163125467|NCT01064687|589166496|FG002|Overall Study|Lack of Efficacy|2|||
163125468|NCT01064687|589166497|FG003|Overall Study|Lack of Efficacy|3|||
163125469|NCT01064687|589166494|FG000|Overall Study|Lost to Follow-up|7|||
163125470|NCT01064687|589166495|FG001|Overall Study|Lost to Follow-up|10|||
163125471|NCT01064687|589166496|FG002|Overall Study|Lost to Follow-up|13|||
163125472|NCT01064687|589166497|FG003|Overall Study|Lost to Follow-up|5|||
163125473|NCT01064687|589166494|FG000|Overall Study|Physician Decision|2|||
163125474|NCT01064687|589166495|FG001|Overall Study|Physician Decision|2|||
163125475|NCT01064687|589166496|FG002|Overall Study|Physician Decision|0|||
163125476|NCT01064687|589166497|FG003|Overall Study|Physician Decision|0|||
163125477|NCT01064687|589166494|FG000|Overall Study|Protocol Violation|1|||
163125478|NCT01064687|589166495|FG001|Overall Study|Protocol Violation|1|||
163125479|NCT01064687|589166496|FG002|Overall Study|Protocol Violation|0|||
163125480|NCT01064687|589166497|FG003|Overall Study|Protocol Violation|1|||
163125481|NCT01064687|589166494|FG000|Overall Study|Sponsor Decision|0|||
163225569|NCT01340976|589542064|FG001|Overall Study|Other anemia treatment|0|||
163408174|NCT02432235|590204038|FG006|Overall Study|Miscellaneous|2|||
163125482|NCT01064687|589166495|FG001|Overall Study|Sponsor Decision|0|||
163125483|NCT01064687|589166496|FG002|Overall Study|Sponsor Decision|3|||
163125484|NCT01064687|589166497|FG003|Overall Study|Sponsor Decision|0|||
163125485|NCT01064687|589166494|FG000|Overall Study|Withdrawal by Subject|9|||
163125486|NCT01064687|589166495|FG001|Overall Study|Withdrawal by Subject|7|||
163125487|NCT01064687|589166496|FG002|Overall Study|Withdrawal by Subject|12|||
163125488|NCT01064687|589166497|FG003|Overall Study|Withdrawal by Subject|5|||
163125489|NCT01064687|589166494|FG000|Overall Study|Treatment Noncompliance|1|||
163125490|NCT01064687|589166495|FG001|Overall Study|Treatment Noncompliance|1|||
163125491|NCT01064687|589166496|FG002|Overall Study|Treatment Noncompliance|1|||
163125492|NCT01064687|589166497|FG003|Overall Study|Treatment Noncompliance|0|||
163341797|NCT02561195|589959611|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
163408175|NCT02432235|590204039|FG007|Overall Study|Miscellaneous|2|||
163225570|NCT01340976|589542065|FG002|Overall Study|Other anemia treatment|2|||
163225571|NCT01340976|589542066|FG003|Overall Study|Other anemia treatment|1|||
163225572|NCT01340976|589542067|FG004|Overall Study|Other anemia treatment|0|||
163225573|NCT01340976|589542068|FG005|Overall Study|Other anemia treatment|1|||
163225574|NCT01340976|589542063|FG000|Overall Study|Adverse Event|0|||
163225575|NCT01340976|589542064|FG001|Overall Study|Adverse Event|1|||
163225576|NCT01340976|589542065|FG002|Overall Study|Adverse Event|0|||
163225577|NCT01340976|589542066|FG003|Overall Study|Adverse Event|0|||
163225578|NCT01340976|589542067|FG004|Overall Study|Adverse Event|0|||
163225579|NCT01340976|589542068|FG005|Overall Study|Adverse Event|0|||
163225580|NCT02953821|589542069|FG000|Overall Study|Adverse Event|0|||
163225581|NCT02953821|589542070|FG001|Overall Study|Adverse Event|4|||
163225582|NCT02953821|589542069|FG000|Overall Study|Death|1|||
163341798|NCT02561195|589959612|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
163341799|NCT02561195|589959613|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
163341800|NCT02561195|589959614|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
163341801|NCT02561195|589959615|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
163341802|NCT02561195|589959616|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
163341803|NCT02561195|589959617|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
163225583|NCT02953821|589542070|FG001|Overall Study|Death|0|||
163225584|NCT02953821|589542069|FG000|Overall Study|Progressive Disease|5|||
163225585|NCT02953821|589542070|FG001|Overall Study|Progressive Disease|1|||
163225586|NCT02953821|589542069|FG000|Overall Study|Lost to Follow-up|2|||
163225587|NCT02953821|589542070|FG001|Overall Study|Lost to Follow-up|0|||
163225588|NCT02953821|589542069|FG000|Overall Study|Physician Decision|1|||
163225589|NCT02953821|589542070|FG001|Overall Study|Physician Decision|1|||
163225590|NCT02953821|589542069|FG000|Overall Study|Withdrawal by Subject|3|||
163225591|NCT02953821|589542070|FG001|Overall Study|Withdrawal by Subject|3|||
163225592|NCT02953821|589542069|FG000|Overall Study|Change of address|0|||
163225593|NCT02953821|589542070|FG001|Overall Study|Change of address|1|||
163225594|NCT02953821|589542069|FG000|Overall Study|Lack of Efficacy|1|||
163225595|NCT02953821|589542070|FG001|Overall Study|Lack of Efficacy|0|||
163225596|NCT02953821|589542069|FG000|Overall Study|Out of state for indeterminate time|0|||
163225597|NCT02953821|589542070|FG001|Overall Study|Out of state for indeterminate time|1|||
163225598|NCT02953821|589542069|FG000|Overall Study|No improvement|0|||
163225599|NCT02953821|589542070|FG001|Overall Study|No improvement|1|||
163225600|NCT02953821|589542069|FG000|Overall Study|Refused follow-up visit|2|||
163225601|NCT02953821|589542070|FG001|Overall Study|Refused follow-up visit|1|||
163225602|NCT03064126|589542071|FG000|Overall Study|Death|40|||
163225603|NCT03064126|589542072|FG001|Overall Study|Death|16|||
163225604|NCT03064126|589542073|FG002|Overall Study|Death|4|||
163225605|NCT03064126|589542074|FG003|Overall Study|Death|2|||
163225606|NCT03064126|589542071|FG000|Overall Study|Withdrawal by Subject|17|||
163225607|NCT03064126|589542072|FG001|Overall Study|Withdrawal by Subject|9|||
163225608|NCT03064126|589542073|FG002|Overall Study|Withdrawal by Subject|0|||
163225609|NCT03064126|589542074|FG003|Overall Study|Withdrawal by Subject|2|||
163225610|NCT03064126|589542071|FG000|Overall Study|Lost to Follow-up|7|||
163225611|NCT03064126|589542072|FG001|Overall Study|Lost to Follow-up|3|||
163225612|NCT03064126|589542073|FG002|Overall Study|Lost to Follow-up|0|||
163225613|NCT03064126|589542074|FG003|Overall Study|Lost to Follow-up|0|||
163225614|NCT03064126|589542071|FG000|Overall Study|Adverse Event|2|||
163225615|NCT03064126|589542072|FG001|Overall Study|Adverse Event|0|||
163225616|NCT03064126|589542073|FG002|Overall Study|Adverse Event|0|||
163225617|NCT03064126|589542074|FG003|Overall Study|Adverse Event|0|||
163225618|NCT03064126|589542071|FG000|Overall Study|Physician Decision|3|||
163225619|NCT03064126|589542072|FG001|Overall Study|Physician Decision|0|||
163225620|NCT03064126|589542073|FG002|Overall Study|Physician Decision|0|||
163225621|NCT03064126|589542074|FG003|Overall Study|Physician Decision|0|||
163225622|NCT03064126|589542071|FG000|Overall Study|Other reason for early termination|3|||
163225623|NCT03064126|589542072|FG001|Overall Study|Other reason for early termination|2|||
163225624|NCT03064126|589542073|FG002|Overall Study|Other reason for early termination|0|||
163225625|NCT03064126|589542074|FG003|Overall Study|Other reason for early termination|0|||
163225626|NCT03064126|589542071|FG000|Overall Study|Missed Visit|3|||
163341804|NCT02561195|589959618|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
163408176|NCT02432235|590204040|FG008|Overall Study|Miscellaneous|4|||
163225627|NCT03064126|589542072|FG001|Overall Study|Missed Visit|1|||
163225628|NCT03064126|589542073|FG002|Overall Study|Missed Visit|0|||
163225629|NCT03064126|589542074|FG003|Overall Study|Missed Visit|0|||
163225630|NCT03907683|589542080|FG000|Overall Study|Pregnancy|1|||
163225631|NCT03907683|589542080|FG000|Overall Study|Withdrawal by Subject|1|||
163225632|NCT03400332|589542081|FG000|Pre-Treatment|Other reasons|0|||
163225633|NCT03400332|589542082|FG001|Pre-Treatment|Other reasons|0|||
163225634|NCT03400332|589542083|FG002|Pre-Treatment|Other reasons|0|||
163225635|NCT03400332|589542084|FG003|Pre-Treatment|Other reasons|0|||
163225636|NCT03400332|589542085|FG004|Pre-Treatment|Other reasons|0|||
163225637|NCT03400332|589542086|FG005|Pre-Treatment|Other reasons|0|||
163341805|NCT02561195|589959605|FG000|Vaccination 1 to 3|Other|7|||
163341806|NCT02561195|589959606|FG001|Vaccination 1 to 3|Other|3|||
163225638|NCT03400332|589542087|FG006|Pre-Treatment|Other reasons|0|||
163225639|NCT03400332|589542088|FG007|Pre-Treatment|Other reasons|0|||
163225640|NCT03400332|589542089|FG008|Pre-Treatment|Other reasons|1|||
163225641|NCT03400332|589542081|FG000|Pre-Treatment|No longer met study criteria|0|||
163225642|NCT03400332|589542082|FG001|Pre-Treatment|No longer met study criteria|0|||
163225643|NCT03400332|589542083|FG002|Pre-Treatment|No longer met study criteria|0|||
163225644|NCT03400332|589542084|FG003|Pre-Treatment|No longer met study criteria|0|||
163225645|NCT03400332|589542085|FG004|Pre-Treatment|No longer met study criteria|0|||
163225646|NCT03400332|589542086|FG005|Pre-Treatment|No longer met study criteria|0|||
163225647|NCT03400332|589542087|FG006|Pre-Treatment|No longer met study criteria|0|||
163225648|NCT03400332|589542088|FG007|Pre-Treatment|No longer met study criteria|0|||
163225649|NCT03400332|589542089|FG008|Pre-Treatment|No longer met study criteria|1|||
163225650|NCT03400332|589542081|FG000|Pre-Treatment|Withdrawal by Subject|0|||
163225651|NCT03400332|589542082|FG001|Pre-Treatment|Withdrawal by Subject|0|||
163341807|NCT02561195|589959607|FG002|Vaccination 1 to 3|Other|1|||
163341808|NCT02561195|589959608|FG003|Vaccination 1 to 3|Other|7|||
163341809|NCT02561195|589959609|FG004|Vaccination 1 to 3|Other|5|||
163341810|NCT02561195|589959610|FG005|Vaccination 1 to 3|Other|1|||
163341811|NCT02561195|589959611|FG006|Vaccination 1 to 3|Other|0|||
163341812|NCT02561195|589959612|FG007|Vaccination 1 to 3|Other|0|||
163341813|NCT02561195|589959613|FG008|Vaccination 1 to 3|Other|0|||
163225652|NCT03400332|589542083|FG002|Pre-Treatment|Withdrawal by Subject|0|||
163225653|NCT03400332|589542084|FG003|Pre-Treatment|Withdrawal by Subject|0|||
163225654|NCT03400332|589542085|FG004|Pre-Treatment|Withdrawal by Subject|0|||
163225655|NCT03400332|589542086|FG005|Pre-Treatment|Withdrawal by Subject|0|||
163225656|NCT03400332|589542087|FG006|Pre-Treatment|Withdrawal by Subject|0|||
163225657|NCT03400332|589542088|FG007|Pre-Treatment|Withdrawal by Subject|0|||
163225658|NCT03400332|589542089|FG008|Pre-Treatment|Withdrawal by Subject|1|||
163225659|NCT03400332|589542081|FG000|Treatment|Participant withdrew consent|2|||
163225660|NCT03400332|589542082|FG001|Treatment|Participant withdrew consent|2|||
163225661|NCT03400332|589542083|FG002|Treatment|Participant withdrew consent|0|||
163225662|NCT03400332|589542084|FG003|Treatment|Participant withdrew consent|0|||
163225663|NCT03400332|589542085|FG004|Treatment|Participant withdrew consent|3|||
163225664|NCT03400332|589542086|FG005|Treatment|Participant withdrew consent|3|||
163225665|NCT03400332|589542087|FG006|Treatment|Participant withdrew consent|1|||
163225666|NCT03400332|589542088|FG007|Treatment|Participant withdrew consent|1|||
163225667|NCT03400332|589542089|FG008|Treatment|Participant withdrew consent|1|||
163225668|NCT03400332|589542081|FG000|Treatment|Other reasons|0|||
163225669|NCT03400332|589542082|FG001|Treatment|Other reasons|1|||
163225670|NCT03400332|589542083|FG002|Treatment|Other reasons|1|||
163225671|NCT03400332|589542084|FG003|Treatment|Other reasons|0|||
163225672|NCT03400332|589542085|FG004|Treatment|Other reasons|3|||
163225673|NCT03400332|589542086|FG005|Treatment|Other reasons|1|||
163225674|NCT03400332|589542087|FG006|Treatment|Other reasons|2|||
163225675|NCT03400332|589542088|FG007|Treatment|Other reasons|0|||
163225676|NCT03400332|589542089|FG008|Treatment|Other reasons|1|||
163225677|NCT03400332|589542081|FG000|Treatment|Lost to Follow-up|0|||
163225678|NCT03400332|589542082|FG001|Treatment|Lost to Follow-up|1|||
163225679|NCT03400332|589542083|FG002|Treatment|Lost to Follow-up|0|||
163225680|NCT03400332|589542084|FG003|Treatment|Lost to Follow-up|0|||
163225681|NCT03400332|589542085|FG004|Treatment|Lost to Follow-up|0|||
163225682|NCT03400332|589542086|FG005|Treatment|Lost to Follow-up|0|||
163225683|NCT03400332|589542087|FG006|Treatment|Lost to Follow-up|0|||
163225684|NCT03400332|589542088|FG007|Treatment|Lost to Follow-up|0|||
163225685|NCT03400332|589542089|FG008|Treatment|Lost to Follow-up|0|||
163225686|NCT03400332|589542081|FG000|Treatment|Death|3|||
163225687|NCT03400332|589542082|FG001|Treatment|Death|1|||
163225688|NCT03400332|589542083|FG002|Treatment|Death|2|||
163225689|NCT03400332|589542084|FG003|Treatment|Death|3|||
163225690|NCT03400332|589542085|FG004|Treatment|Death|6|||
163225691|NCT03400332|589542086|FG005|Treatment|Death|2|||
163225692|NCT03400332|589542087|FG006|Treatment|Death|1|||
163225693|NCT03400332|589542088|FG007|Treatment|Death|3|||
163341814|NCT02561195|589959614|FG009|Vaccination 1 to 3|Other|0|||
163341815|NCT02561195|589959615|FG010|Vaccination 1 to 3|Other|0|||
163408177|NCT02432235|590204041|FG009|Overall Study|Miscellaneous|0|||
163225694|NCT03400332|589542089|FG008|Treatment|Death|6|||
163225695|NCT00048542|589542090|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
163225696|NCT00048542|589542091|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
163225697|NCT00048542|589542092|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
163225698|NCT00048542|589542093|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
163225699|NCT00048542|589542094|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
163225700|NCT00048542|589542095|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
163225701|NCT00048542|589542096|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
163225702|NCT00048542|589542097|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
163341816|NCT02561195|589959616|FG011|Vaccination 1 to 3|Other|0|||
163341817|NCT02561195|589959617|FG012|Vaccination 1 to 3|Other|0|||
163341818|NCT02561195|589959618|FG013|Vaccination 1 to 3|Other|0|||
163341819|NCT02561195|589959605|FG000|Vaccination 1 to 3|Protocol Violation|1|||
163341820|NCT02561195|589959606|FG001|Vaccination 1 to 3|Protocol Violation|0|||
163408178|NCT02432235|590204042|FG010|Overall Study|Miscellaneous|0|||
163125493|NCT00619489|589166498|FG000|Overall Study|Adverse Event|0|||
163125494|NCT00619489|589166499|FG001|Overall Study|Adverse Event|7|||
163125495|NCT00619489|589166498|FG000|Overall Study|Withdrawal by Subject|1|||
163125496|NCT00619489|589166499|FG001|Overall Study|Withdrawal by Subject|1|||
163125497|NCT00619489|589166498|FG000|Overall Study|Lack of Efficacy|0|||
163125498|NCT00619489|589166499|FG001|Overall Study|Lack of Efficacy|11|||
163125499|NCT00619489|589166498|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
163125500|NCT00619489|589166499|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
163125501|NCT03134183|589166500|FG000|Overall Study|Withdrawal by Subject|1|||
163125502|NCT03134183|589166501|FG001|Overall Study|Withdrawal by Subject|1|||
163125503|NCT02265796|589166504|FG000|Overall Study|Death|1|||
163125504|NCT02265796|589166505|FG001|Overall Study|Death|0|||
163125505|NCT02265796|589166504|FG000|Overall Study|started on excluded medication|1|||
163125506|NCT02265796|589166505|FG001|Overall Study|started on excluded medication|0|||
163125507|NCT02265796|589166504|FG000|Overall Study|Withdrawal by Subject|1|||
163125508|NCT02265796|589166505|FG001|Overall Study|Withdrawal by Subject|1|||
163125509|NCT02477553|589166506|FG000|Overall Study|Screening up-to-date|12|||
163125510|NCT02477553|589166507|FG001|Overall Study|Screening up-to-date|13|||
163125511|NCT02477553|589166506|FG000|Overall Study|No MD visit|1|||
163125512|NCT02477553|589166507|FG001|Overall Study|No MD visit|1|||
163125513|NCT02477553|589166506|FG000|Overall Study|Workup consistent w/CRC|1|||
163125514|NCT02477553|589166507|FG001|Overall Study|Workup consistent w/CRC|1|||
163125515|NCT02477553|589166506|FG000|Overall Study|Technical issues with intervention|2|||
163125516|NCT02477553|589166507|FG001|Overall Study|Technical issues with intervention|0|||
163125517|NCT02477553|589166506|FG000|Overall Study|Elevated risk for CRC|2|||
163125518|NCT02477553|589166507|FG001|Overall Study|Elevated risk for CRC|2|||
163125519|NCT02477553|589166506|FG000|Overall Study|MD advised against screening|1|||
163125520|NCT02477553|589166507|FG001|Overall Study|MD advised against screening|3|||
163125521|NCT02477553|589166506|FG000|Overall Study|patient deceased|1|||
163125522|NCT02477553|589166507|FG001|Overall Study|patient deceased|0|||
163125523|NCT04311463|589166508|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
163125524|NCT04311463|589166509|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
163125525|NCT04311463|589166508|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
163125526|NCT04311463|589166509|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
163125527|NCT04311463|589166508|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
163125528|NCT04311463|589166509|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
163125529|NCT04023682|589166510|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
163125530|NCT00454649|589166511|FG000|Overall Study|Lack of Efficacy|2|||
163125531|NCT00454649|589166512|FG001|Overall Study|Lack of Efficacy|2|||
163125532|NCT00454649|589166513|FG002|Overall Study|Lack of Efficacy|10|||
163125533|NCT00454649|589166514|FG003|Overall Study|Lack of Efficacy|3|||
163125534|NCT00454649|589166515|FG004|Overall Study|Lack of Efficacy|0|||
163125535|NCT00454649|589166516|FG005|Overall Study|Lack of Efficacy|4|||
163125536|NCT00454649|589166517|FG006|Overall Study|Lack of Efficacy|5|||
163125537|NCT00454649|589166518|FG007|Overall Study|Lack of Efficacy|13|||
163125538|NCT00454649|589166519|FG008|Overall Study|Lack of Efficacy|10|||
163125539|NCT00454649|589166520|FG009|Overall Study|Lack of Efficacy|2|||
163125540|NCT00454649|589166511|FG000|Overall Study|Adverse Event|0|||
163125541|NCT00454649|589166512|FG001|Overall Study|Adverse Event|1|||
163125542|NCT00454649|589166513|FG002|Overall Study|Adverse Event|3|||
163125543|NCT00454649|589166514|FG003|Overall Study|Adverse Event|0|||
163125544|NCT00454649|589166515|FG004|Overall Study|Adverse Event|1|||
163125545|NCT00454649|589166516|FG005|Overall Study|Adverse Event|2|||
163125546|NCT00454649|589166517|FG006|Overall Study|Adverse Event|3|||
163125547|NCT00454649|589166518|FG007|Overall Study|Adverse Event|4|||
163125548|NCT00454649|589166519|FG008|Overall Study|Adverse Event|6|||
163125549|NCT00454649|589166520|FG009|Overall Study|Adverse Event|2|||
163125550|NCT00454649|589166511|FG000|Overall Study|Lost to Follow-up|0|||
163125551|NCT00454649|589166512|FG001|Overall Study|Lost to Follow-up|0|||
163125552|NCT00454649|589166513|FG002|Overall Study|Lost to Follow-up|1|||
163125553|NCT00454649|589166514|FG003|Overall Study|Lost to Follow-up|0|||
163125554|NCT00454649|589166515|FG004|Overall Study|Lost to Follow-up|0|||
163125555|NCT00454649|589166516|FG005|Overall Study|Lost to Follow-up|0|||
163125556|NCT00454649|589166517|FG006|Overall Study|Lost to Follow-up|1|||
163125557|NCT00454649|589166518|FG007|Overall Study|Lost to Follow-up|0|||
163125558|NCT00454649|589166519|FG008|Overall Study|Lost to Follow-up|0|||
163125559|NCT00454649|589166520|FG009|Overall Study|Lost to Follow-up|0|||
163125560|NCT00454649|589166511|FG000|Overall Study|Other|1|||
163125561|NCT00454649|589166512|FG001|Overall Study|Other|1|||
163125562|NCT00454649|589166513|FG002|Overall Study|Other|5|||
163125563|NCT00454649|589166514|FG003|Overall Study|Other|3|||
163125564|NCT00454649|589166515|FG004|Overall Study|Other|0|||
163125565|NCT00454649|589166516|FG005|Overall Study|Other|0|||
163125566|NCT00454649|589166517|FG006|Overall Study|Other|0|||
163125567|NCT00454649|589166518|FG007|Overall Study|Other|0|||
163125568|NCT00454649|589166519|FG008|Overall Study|Other|3|||
163125569|NCT00454649|589166520|FG009|Overall Study|Other|1|||
163225703|NCT00048542|589542090|FG000|Double-Blind Phase|Protocol Violation|0|||
163225704|NCT00048542|589542091|FG001|Double-Blind Phase|Protocol Violation|0|||
163225705|NCT00048542|589542092|FG002|Double-Blind Phase|Protocol Violation|1|||
163225706|NCT00048542|589542093|FG003|Double-Blind Phase|Protocol Violation|0|||
163225707|NCT00048542|589542094|FG004|Double-Blind Phase|Protocol Violation|0|||
163225708|NCT00048542|589542095|FG005|Double-Blind Phase|Protocol Violation|0|||
163225709|NCT00048542|589542096|FG006|Double-Blind Phase|Protocol Violation|0|||
163225710|NCT00048542|589542097|FG007|Double-Blind Phase|Protocol Violation|0|||
163225711|NCT00048542|589542090|FG000|Double-Blind Phase|Sponsor request or decision|2|||
163225712|NCT00048542|589542091|FG001|Double-Blind Phase|Sponsor request or decision|0|||
163225713|NCT00048542|589542092|FG002|Double-Blind Phase|Sponsor request or decision|0|||
163225714|NCT00048542|589542093|FG003|Double-Blind Phase|Sponsor request or decision|0|||
163225715|NCT00048542|589542094|FG004|Double-Blind Phase|Sponsor request or decision|0|||
163225716|NCT00048542|589542095|FG005|Double-Blind Phase|Sponsor request or decision|0|||
163225717|NCT00048542|589542096|FG006|Double-Blind Phase|Sponsor request or decision|0|||
163225718|NCT00048542|589542097|FG007|Double-Blind Phase|Sponsor request or decision|0|||
163225719|NCT00048542|589542090|FG000|Double-Blind Phase|Randomized in error|1|||
163225720|NCT00048542|589542091|FG001|Double-Blind Phase|Randomized in error|0|||
163225721|NCT00048542|589542092|FG002|Double-Blind Phase|Randomized in error|0|||
163225722|NCT00048542|589542093|FG003|Double-Blind Phase|Randomized in error|0|||
163225723|NCT00048542|589542094|FG004|Double-Blind Phase|Randomized in error|0|||
163225724|NCT00048542|589542095|FG005|Double-Blind Phase|Randomized in error|0|||
163225725|NCT00048542|589542096|FG006|Double-Blind Phase|Randomized in error|0|||
163225726|NCT00048542|589542097|FG007|Double-Blind Phase|Randomized in error|0|||
163225727|NCT00048542|589542090|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
163225728|NCT00048542|589542091|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
163225729|NCT00048542|589542092|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
163225730|NCT00048542|589542093|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
163225731|NCT00048542|589542094|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
163225732|NCT00048542|589542095|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
163225733|NCT00048542|589542096|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
163225734|NCT00048542|589542097|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
163225735|NCT00048542|589542090|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
163225736|NCT00048542|589542091|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
163225737|NCT00048542|589542092|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
163225738|NCT00048542|589542093|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
163225739|NCT00048542|589542094|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
163225740|NCT00048542|589542095|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
163225741|NCT00048542|589542096|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
163225742|NCT00048542|589542097|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
163225743|NCT00048542|589542090|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
163225744|NCT00048542|589542091|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
163225745|NCT00048542|589542092|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
163225746|NCT00048542|589542093|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
163225747|NCT00048542|589542094|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
163225748|NCT00048542|589542095|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
163225749|NCT00048542|589542096|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
163225750|NCT00048542|589542097|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
163225751|NCT00048542|589542090|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
163225752|NCT00048542|589542091|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
163225753|NCT00048542|589542092|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
163225754|NCT00048542|589542093|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
163225755|NCT00048542|589542094|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
163225756|NCT00048542|589542095|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
163225757|NCT00048542|589542096|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
163225758|NCT00048542|589542097|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
163225759|NCT00048542|589542090|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
163225760|NCT00048542|589542091|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
163225761|NCT00048542|589542092|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
163225762|NCT00048542|589542093|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
163225763|NCT00048542|589542094|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
163225764|NCT00048542|589542095|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
163408179|NCT02432235|590204043|FG011|Overall Study|Miscellaneous|1|||
163225765|NCT00048542|589542096|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
163225766|NCT00048542|589542097|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
163225767|NCT00048542|589542090|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
163408180|NCT00401752|590204044|FG000|Overall Study|Adverse Event|2|||
163408181|NCT00401752|590204045|FG001|Overall Study|Adverse Event|5|||
163408182|NCT00401752|590204044|FG000|Overall Study|Withdrawal by Subject|2|||
163408183|NCT00401752|590204045|FG001|Overall Study|Withdrawal by Subject|6|||
163225768|NCT00048542|589542091|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
163225769|NCT00048542|589542092|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
163225770|NCT00048542|589542093|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
163225771|NCT00048542|589542094|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
163225772|NCT00048542|589542095|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
163225773|NCT00048542|589542096|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
163225774|NCT00048542|589542097|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
163225775|NCT00048542|589542090|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
163225776|NCT00048542|589542091|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
163225777|NCT00048542|589542092|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
163225778|NCT00048542|589542093|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
163225779|NCT00048542|589542094|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
163225780|NCT00048542|589542095|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
163225781|NCT00048542|589542096|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
163225782|NCT00048542|589542097|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
163225783|NCT00048542|589542090|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
163225784|NCT00048542|589542091|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
163225785|NCT00048542|589542092|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
163225786|NCT00048542|589542093|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
163225787|NCT00048542|589542094|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
163225788|NCT00048542|589542095|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
163225789|NCT00048542|589542096|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
163225790|NCT00048542|589542097|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
163225791|NCT00048542|589542090|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
163225792|NCT00048542|589542091|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
163225793|NCT00048542|589542092|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
163225794|NCT00048542|589542093|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
163225795|NCT00048542|589542094|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
163225796|NCT00048542|589542095|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
163225797|NCT00048542|589542096|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
163225798|NCT00048542|589542097|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
163225799|NCT00048542|589542090|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
163225800|NCT00048542|589542091|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
163225801|NCT00048542|589542092|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
163225802|NCT00048542|589542093|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
163225803|NCT00048542|589542094|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
163225804|NCT00048542|589542095|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
163225805|NCT00048542|589542096|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
163225806|NCT00048542|589542097|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
163225807|NCT00048542|589542090|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
163225808|NCT00048542|589542091|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
163225809|NCT00048542|589542092|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
163225810|NCT00048542|589542093|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
163225811|NCT00048542|589542094|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
163225812|NCT00048542|589542095|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
163225813|NCT00048542|589542096|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
163225814|NCT00048542|589542097|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
163225815|NCT04033159|589542101|FG000|Washout Period|Physician Decision|0|||
163225816|NCT04033159|589542102|FG001|Washout Period|Physician Decision|1|||
163225817|NCT04033159|589542103|FG002|Washout Period|Physician Decision|0|||
163225818|NCT04033159|589542101|FG000|Washout Period|Study terminated by Sponsor|0|||
163225819|NCT04033159|589542102|FG001|Washout Period|Study terminated by Sponsor|7|||
163225820|NCT04033159|589542103|FG002|Washout Period|Study terminated by Sponsor|0|||
163225821|NCT04033159|589542101|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
163225822|NCT04033159|589542102|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
163225823|NCT04033159|589542103|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
163225824|NCT02027844|589542104|FG000|Overall Study|Withdrawal by Subject|3|||
163225825|NCT02027844|589542105|FG001|Overall Study|Withdrawal by Subject|2|||
163225826|NCT02027844|589542106|FG002|Overall Study|Withdrawal by Subject|1|||
163225827|NCT02027844|589542104|FG000|Overall Study|Lost to Follow-up|0|||
163225828|NCT02027844|589542105|FG001|Overall Study|Lost to Follow-up|2|||
163225829|NCT02027844|589542106|FG002|Overall Study|Lost to Follow-up|1|||
163225830|NCT02027844|589542104|FG000|Overall Study|Protocol Violation|0|||
163225831|NCT02027844|589542105|FG001|Overall Study|Protocol Violation|2|||
163225832|NCT02027844|589542106|FG002|Overall Study|Protocol Violation|0|||
163341821|NCT02561195|589959607|FG002|Vaccination 1 to 3|Protocol Violation|1|||
163225833|NCT02027844|589542104|FG000|Overall Study|Incomlete data|2|||
163225834|NCT02027844|589542105|FG001|Overall Study|Incomlete data|0|||
163225835|NCT02027844|589542106|FG002|Overall Study|Incomlete data|0|||
163225836|NCT01452412|589542117|FG000|Overall Study|Withdrawal by Subject|15|||
163225837|NCT01452412|589542118|FG001|Overall Study|Withdrawal by Subject|11|||
163225838|NCT01452412|589542117|FG000|Overall Study|Adverse Event|4|||
163225839|NCT01452412|589542118|FG001|Overall Study|Adverse Event|3|||
163225840|NCT01452412|589542117|FG000|Overall Study|Lost to Follow-up|5|||
163225841|NCT01452412|589542118|FG001|Overall Study|Lost to Follow-up|3|||
163225842|NCT01452412|589542117|FG000|Overall Study|Death|1|||
163225843|NCT01452412|589542118|FG001|Overall Study|Death|0|||
163225844|NCT01452412|589542117|FG000|Overall Study|Initiated dialysis|1|||
163225845|NCT01452412|589542118|FG001|Overall Study|Initiated dialysis|0|||
163225846|NCT01452412|589542117|FG000|Overall Study|Other|2|||
163225847|NCT01452412|589542118|FG001|Overall Study|Other|0|||
163225848|NCT02346136|589542119|FG000|Overall Study|Withdrawal by Subject|7|||
163225849|NCT02346136|589542120|FG001|Overall Study|Withdrawal by Subject|5|||
163225850|NCT02346136|589542119|FG000|Overall Study|Death|1|||
163225851|NCT02346136|589542120|FG001|Overall Study|Death|0|||
163225852|NCT02346136|589542119|FG000|Overall Study|Study termination|14|||
163225853|NCT02346136|589542120|FG001|Overall Study|Study termination|18|||
163225854|NCT03047135|589542121|FG000|Overall Study|Still being treated|3|||
163225855|NCT00323414|589542122|FG000|Overall Study|Withdrawal by Subject|0|||
163225856|NCT00323414|589542123|FG001|Overall Study|Withdrawal by Subject|1|||
163225857|NCT05619692|589542132|FG000|Overall Study|Adverse Event|2|||
163225858|NCT05619692|589542133|FG001|Overall Study|Adverse Event|2|||
163225859|NCT05619692|589542132|FG000|Overall Study|Withdrawal by Participant|3|||
163225860|NCT05619692|589542133|FG001|Overall Study|Withdrawal by Participant|4|||
163225861|NCT05619692|589542132|FG000|Overall Study|Lost to Follow-up|2|||
163225862|NCT05619692|589542133|FG001|Overall Study|Lost to Follow-up|1|||
163225863|NCT05619692|589542132|FG000|Overall Study|Randomized but not treated|1|||
163225864|NCT05619692|589542133|FG001|Overall Study|Randomized but not treated|3|||
163225865|NCT02457598|589542134|FG000|Overall Study|Progressive Disease|2|||
163225866|NCT02457598|589542135|FG001|Overall Study|Progressive Disease|2|||
163225867|NCT02457598|589542136|FG002|Overall Study|Progressive Disease|1|||
163225868|NCT02457598|589542137|FG003|Overall Study|Progressive Disease|11|||
163225869|NCT02457598|589542138|FG004|Overall Study|Progressive Disease|7|||
163225870|NCT02457598|589542139|FG005|Overall Study|Progressive Disease|3|||
163225871|NCT02457598|589542140|FG006|Overall Study|Progressive Disease|2|||
163225872|NCT02457598|589542141|FG007|Overall Study|Progressive Disease|1|||
163225873|NCT02457598|589542142|FG008|Overall Study|Progressive Disease|1|||
163225874|NCT02457598|589542143|FG009|Overall Study|Progressive Disease|2|||
163225875|NCT02457598|589542144|FG010|Overall Study|Progressive Disease|45|||
163225876|NCT02457598|589542145|FG011|Overall Study|Progressive Disease|6|||
163225877|NCT02457598|589542146|FG012|Overall Study|Progressive Disease|2|||
163225878|NCT02457598|589542147|FG013|Overall Study|Progressive Disease|2|||
163225879|NCT02457598|589542148|FG014|Overall Study|Progressive Disease|10|||
163225880|NCT02457598|589542149|FG015|Overall Study|Progressive Disease|1|||
163225881|NCT02457598|589542150|FG016|Overall Study|Progressive Disease|1|||
163225882|NCT02457598|589542134|FG000|Overall Study|Investigator's Discretion|0|||
163225883|NCT02457598|589542135|FG001|Overall Study|Investigator's Discretion|2|||
163225884|NCT02457598|589542136|FG002|Overall Study|Investigator's Discretion|2|||
163225885|NCT02457598|589542137|FG003|Overall Study|Investigator's Discretion|2|||
163225886|NCT02457598|589542138|FG004|Overall Study|Investigator's Discretion|0|||
163225887|NCT02457598|589542139|FG005|Overall Study|Investigator's Discretion|0|||
163225888|NCT02457598|589542140|FG006|Overall Study|Investigator's Discretion|0|||
163225889|NCT02457598|589542141|FG007|Overall Study|Investigator's Discretion|1|||
163225890|NCT02457598|589542142|FG008|Overall Study|Investigator's Discretion|2|||
163225891|NCT02457598|589542143|FG009|Overall Study|Investigator's Discretion|0|||
163225892|NCT02457598|589542144|FG010|Overall Study|Investigator's Discretion|10|||
163225893|NCT02457598|589542145|FG011|Overall Study|Investigator's Discretion|2|||
163341822|NCT02561195|589959608|FG003|Vaccination 1 to 3|Protocol Violation|2|||
163341823|NCT02561195|589959609|FG004|Vaccination 1 to 3|Protocol Violation|5|||
163341824|NCT02561195|589959610|FG005|Vaccination 1 to 3|Protocol Violation|2|||
163225894|NCT02457598|589542146|FG012|Overall Study|Investigator's Discretion|2|||
163225895|NCT02457598|589542147|FG013|Overall Study|Investigator's Discretion|1|||
163225896|NCT02457598|589542148|FG014|Overall Study|Investigator's Discretion|5|||
163225897|NCT02457598|589542149|FG015|Overall Study|Investigator's Discretion|0|||
163225898|NCT02457598|589542150|FG016|Overall Study|Investigator's Discretion|0|||
163225899|NCT02457598|589542134|FG000|Overall Study|Study Terminated by Sponsor|0|||
163225900|NCT02457598|589542135|FG001|Overall Study|Study Terminated by Sponsor|1|||
163225901|NCT02457598|589542136|FG002|Overall Study|Study Terminated by Sponsor|0|||
163225902|NCT02457598|589542137|FG003|Overall Study|Study Terminated by Sponsor|4|||
163225903|NCT02457598|589542138|FG004|Overall Study|Study Terminated by Sponsor|1|||
163225904|NCT02457598|589542139|FG005|Overall Study|Study Terminated by Sponsor|0|||
163225905|NCT02457598|589542140|FG006|Overall Study|Study Terminated by Sponsor|1|||
163225906|NCT02457598|589542141|FG007|Overall Study|Study Terminated by Sponsor|0|||
163225907|NCT02457598|589542142|FG008|Overall Study|Study Terminated by Sponsor|0|||
163225908|NCT02457598|589542143|FG009|Overall Study|Study Terminated by Sponsor|0|||
163225909|NCT02457598|589542144|FG010|Overall Study|Study Terminated by Sponsor|4|||
163225910|NCT02457598|589542145|FG011|Overall Study|Study Terminated by Sponsor|0|||
163225911|NCT02457598|589542146|FG012|Overall Study|Study Terminated by Sponsor|1|||
163225912|NCT02457598|589542147|FG013|Overall Study|Study Terminated by Sponsor|0|||
163225913|NCT02457598|589542148|FG014|Overall Study|Study Terminated by Sponsor|8|||
163225914|NCT02457598|589542149|FG015|Overall Study|Study Terminated by Sponsor|1|||
163225915|NCT02457598|589542150|FG016|Overall Study|Study Terminated by Sponsor|0|||
163225916|NCT02457598|589542134|FG000|Overall Study|Adverse Event|0|||
163225917|NCT02457598|589542135|FG001|Overall Study|Adverse Event|1|||
163225918|NCT02457598|589542136|FG002|Overall Study|Adverse Event|1|||
163225919|NCT02457598|589542137|FG003|Overall Study|Adverse Event|4|||
163225920|NCT02457598|589542138|FG004|Overall Study|Adverse Event|1|||
163225921|NCT02457598|589542139|FG005|Overall Study|Adverse Event|0|||
163225922|NCT02457598|589542140|FG006|Overall Study|Adverse Event|0|||
163225923|NCT02457598|589542141|FG007|Overall Study|Adverse Event|1|||
163225924|NCT02457598|589542142|FG008|Overall Study|Adverse Event|0|||
163225925|NCT02457598|589542143|FG009|Overall Study|Adverse Event|1|||
163225926|NCT02457598|589542144|FG010|Overall Study|Adverse Event|6|||
163225927|NCT02457598|589542145|FG011|Overall Study|Adverse Event|0|||
163225928|NCT02457598|589542146|FG012|Overall Study|Adverse Event|0|||
163225929|NCT02457598|589542147|FG013|Overall Study|Adverse Event|1|||
163225930|NCT02457598|589542148|FG014|Overall Study|Adverse Event|2|||
163225931|NCT02457598|589542149|FG015|Overall Study|Adverse Event|0|||
163225932|NCT02457598|589542150|FG016|Overall Study|Adverse Event|0|||
163225933|NCT02457598|589542134|FG000|Overall Study|Death|0|||
163225934|NCT02457598|589542135|FG001|Overall Study|Death|0|||
163225935|NCT02457598|589542136|FG002|Overall Study|Death|0|||
163225936|NCT02457598|589542137|FG003|Overall Study|Death|3|||
163225937|NCT02457598|589542138|FG004|Overall Study|Death|0|||
163225938|NCT02457598|589542139|FG005|Overall Study|Death|1|||
163225939|NCT02457598|589542140|FG006|Overall Study|Death|0|||
163225940|NCT02457598|589542141|FG007|Overall Study|Death|0|||
163225941|NCT02457598|589542142|FG008|Overall Study|Death|0|||
163225942|NCT02457598|589542143|FG009|Overall Study|Death|0|||
163225943|NCT02457598|589542144|FG010|Overall Study|Death|3|||
163225944|NCT02457598|589542145|FG011|Overall Study|Death|0|||
163225945|NCT02457598|589542146|FG012|Overall Study|Death|0|||
163225946|NCT02457598|589542147|FG013|Overall Study|Death|1|||
163225947|NCT02457598|589542148|FG014|Overall Study|Death|2|||
163225948|NCT02457598|589542149|FG015|Overall Study|Death|0|||
163225949|NCT02457598|589542150|FG016|Overall Study|Death|1|||
163225950|NCT02457598|589542134|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
163225951|NCT02457598|589542135|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
163225952|NCT02457598|589542136|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
163225953|NCT02457598|589542137|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
163225954|NCT02457598|589542138|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
163225955|NCT02457598|589542139|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
163225956|NCT02457598|589542140|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
163225957|NCT02457598|589542141|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
163225958|NCT02457598|589542142|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
163225959|NCT02457598|589542143|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
163225960|NCT02457598|589542144|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
163225961|NCT02457598|589542145|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
163225962|NCT02457598|589542146|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
163225963|NCT02457598|589542147|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
163225964|NCT02457598|589542148|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
163225965|NCT02457598|589542149|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
163225966|NCT02457598|589542150|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
163225967|NCT02457598|589542134|FG000|Overall Study|Withdrew Consent|0|||
163225968|NCT02457598|589542135|FG001|Overall Study|Withdrew Consent|0|||
163225969|NCT02457598|589542136|FG002|Overall Study|Withdrew Consent|0|||
163225970|NCT02457598|589542137|FG003|Overall Study|Withdrew Consent|0|||
163225971|NCT02457598|589542138|FG004|Overall Study|Withdrew Consent|0|||
163225972|NCT02457598|589542139|FG005|Overall Study|Withdrew Consent|0|||
163225973|NCT02457598|589542140|FG006|Overall Study|Withdrew Consent|0|||
163225974|NCT02457598|589542141|FG007|Overall Study|Withdrew Consent|2|||
163225975|NCT02457598|589542142|FG008|Overall Study|Withdrew Consent|0|||
163225976|NCT02457598|589542143|FG009|Overall Study|Withdrew Consent|0|||
163225977|NCT02457598|589542144|FG010|Overall Study|Withdrew Consent|3|||
163225978|NCT02457598|589542145|FG011|Overall Study|Withdrew Consent|0|||
163225979|NCT02457598|589542146|FG012|Overall Study|Withdrew Consent|0|||
163225980|NCT02457598|589542147|FG013|Overall Study|Withdrew Consent|1|||
163225981|NCT02457598|589542148|FG014|Overall Study|Withdrew Consent|0|||
163225982|NCT02457598|589542149|FG015|Overall Study|Withdrew Consent|0|||
163225983|NCT02457598|589542150|FG016|Overall Study|Withdrew Consent|0|||
163225984|NCT02457598|589542134|FG000|Overall Study|Unacceptable Toxicity|0|||
163225985|NCT02457598|589542135|FG001|Overall Study|Unacceptable Toxicity|0|||
163225986|NCT02457598|589542136|FG002|Overall Study|Unacceptable Toxicity|0|||
163341825|NCT02561195|589959611|FG006|Vaccination 1 to 3|Protocol Violation|0|||
163341826|NCT02561195|589959612|FG007|Vaccination 1 to 3|Protocol Violation|0|||
163341827|NCT02561195|589959613|FG008|Vaccination 1 to 3|Protocol Violation|0|||
163125570|NCT00454649|589166511|FG000|Overall Study|Withdrawal by Subject|0|||
163125571|NCT00454649|589166512|FG001|Overall Study|Withdrawal by Subject|0|||
163125572|NCT00454649|589166513|FG002|Overall Study|Withdrawal by Subject|0|||
163125573|NCT00454649|589166514|FG003|Overall Study|Withdrawal by Subject|0|||
163125574|NCT00454649|589166515|FG004|Overall Study|Withdrawal by Subject|0|||
163125575|NCT00454649|589166516|FG005|Overall Study|Withdrawal by Subject|1|||
163125576|NCT00454649|589166517|FG006|Overall Study|Withdrawal by Subject|0|||
163125577|NCT00454649|589166518|FG007|Overall Study|Withdrawal by Subject|2|||
163125578|NCT00454649|589166519|FG008|Overall Study|Withdrawal by Subject|1|||
163125579|NCT00454649|589166520|FG009|Overall Study|Withdrawal by Subject|0|||
163125580|NCT02745535|589166522|FG000|Overall Study|Death|1|||
163125581|NCT02745535|589166522|FG000|Overall Study|Adverse Event|3|||
163125582|NCT02745535|589166522|FG000|Overall Study|Lost to Follow-up|2|||
163125583|NCT00377364|589166527|FG000|Overall Study|Lost to Follow-up|1|||
163125584|NCT00377364|589166528|FG001|Overall Study|Lost to Follow-up|0|||
163125585|NCT00377364|589166527|FG000|Overall Study|Withdrawal by Subject|1|||
163125586|NCT00377364|589166528|FG001|Overall Study|Withdrawal by Subject|0|||
163125587|NCT01291277|589166529|FG000|Overall Study|Death|2|||
163125588|NCT01291277|589166530|FG001|Overall Study|Death|2|||
163125589|NCT01291277|589166529|FG000|Overall Study|Lost to Follow-up|3|||
163125590|NCT01291277|589166530|FG001|Overall Study|Lost to Follow-up|1|||
163125591|NCT03480009|589166534|FG000|Overall Study|Lost to Follow-up|4|||
163125592|NCT03480009|589166535|FG001|Overall Study|Lost to Follow-up|5|||
163125593|NCT03480009|589166536|FG002|Overall Study|Lost to Follow-up|4|||
163125594|NCT03480009|589166537|FG003|Overall Study|Lost to Follow-up|0|||
163125595|NCT01638559|589166538|FG000|Overall Study|Lost to Follow-up|1|||
163125596|NCT01638559|589166538|FG000|Overall Study|Withdrawal by Subject|1|||
163125597|NCT01638559|589166538|FG000|Overall Study|Subject declined to travel for biopsy|1|||
163125598|NCT00483002|589166539|FG000|Overall Study|Adverse Event|68|||
163125599|NCT00483002|589166539|FG000|Overall Study|Lack of Efficacy|555|||
163125600|NCT00483002|589166539|FG000|Overall Study|Lost to Follow-up|962|||
163125601|NCT00483002|589166539|FG000|Overall Study|Other|2|||
163125602|NCT00483002|589166539|FG000|Overall Study|Other|967|||
163125603|NCT02014584|589166540|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
163125604|NCT02014584|589166541|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
163125605|NCT02014584|589166542|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
163125606|NCT02014584|589166543|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
163125607|NCT02014584|589166544|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
163125608|NCT02014584|589166545|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
163125609|NCT02014584|589166540|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
163125610|NCT02014584|589166541|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
163125611|NCT02014584|589166542|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
163125612|NCT02014584|589166543|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
163125613|NCT02014584|589166544|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
163125614|NCT02014584|589166545|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
163125615|NCT02014584|589166540|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
163125616|NCT02014584|589166541|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
163125617|NCT02014584|589166542|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
163125618|NCT02014584|589166543|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
163125619|NCT02014584|589166544|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
163125620|NCT02014584|589166545|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
163125621|NCT02014584|589166540|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
163125622|NCT02014584|589166541|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
163125623|NCT02014584|589166542|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
163125624|NCT02014584|589166543|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
163125625|NCT02014584|589166544|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
163125626|NCT02014584|589166545|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
163125627|NCT02014584|589166540|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
163125628|NCT02014584|589166541|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
163125629|NCT02014584|589166542|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
163125630|NCT02014584|589166543|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
163125631|NCT02014584|589166544|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
163125632|NCT02014584|589166545|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
163125633|NCT02651220|589166549|FG000|Overall Study|Adverse Event|1|||
163125634|NCT02651220|589166550|FG001|Overall Study|Adverse Event|5|||
163125635|NCT02651220|589166551|FG002|Overall Study|Adverse Event|1|||
163125636|NCT02651220|589166549|FG000|Overall Study|Lost to Follow-up|8|||
163341828|NCT02561195|589959614|FG009|Vaccination 1 to 3|Protocol Violation|0|||
163341829|NCT02561195|589959615|FG010|Vaccination 1 to 3|Protocol Violation|0|||
163341830|NCT02561195|589959616|FG011|Vaccination 1 to 3|Protocol Violation|0|||
163225987|NCT02457598|589542137|FG003|Overall Study|Unacceptable Toxicity|0|||
163225988|NCT02457598|589542138|FG004|Overall Study|Unacceptable Toxicity|0|||
163225989|NCT02457598|589542139|FG005|Overall Study|Unacceptable Toxicity|0|||
163225990|NCT02457598|589542140|FG006|Overall Study|Unacceptable Toxicity|0|||
163225991|NCT02457598|589542141|FG007|Overall Study|Unacceptable Toxicity|0|||
163225992|NCT02457598|589542142|FG008|Overall Study|Unacceptable Toxicity|0|||
163225993|NCT02457598|589542143|FG009|Overall Study|Unacceptable Toxicity|0|||
163225994|NCT02457598|589542144|FG010|Overall Study|Unacceptable Toxicity|1|||
163225995|NCT02457598|589542145|FG011|Overall Study|Unacceptable Toxicity|0|||
163225996|NCT02457598|589542146|FG012|Overall Study|Unacceptable Toxicity|1|||
163225997|NCT02457598|589542147|FG013|Overall Study|Unacceptable Toxicity|1|||
163225998|NCT02457598|589542148|FG014|Overall Study|Unacceptable Toxicity|1|||
163225999|NCT02457598|589542149|FG015|Overall Study|Unacceptable Toxicity|0|||
163226000|NCT02457598|589542150|FG016|Overall Study|Unacceptable Toxicity|0|||
163226001|NCT02457598|589542134|FG000|Overall Study|Intercurrent Illness|0|||
163226002|NCT02457598|589542135|FG001|Overall Study|Intercurrent Illness|0|||
163226003|NCT02457598|589542136|FG002|Overall Study|Intercurrent Illness|0|||
163226004|NCT02457598|589542137|FG003|Overall Study|Intercurrent Illness|0|||
163226005|NCT02457598|589542138|FG004|Overall Study|Intercurrent Illness|0|||
163226006|NCT02457598|589542139|FG005|Overall Study|Intercurrent Illness|0|||
163226007|NCT02457598|589542140|FG006|Overall Study|Intercurrent Illness|0|||
163226008|NCT02457598|589542141|FG007|Overall Study|Intercurrent Illness|0|||
163226009|NCT02457598|589542142|FG008|Overall Study|Intercurrent Illness|0|||
163226010|NCT02457598|589542143|FG009|Overall Study|Intercurrent Illness|0|||
163226011|NCT02457598|589542144|FG010|Overall Study|Intercurrent Illness|1|||
163226012|NCT02457598|589542145|FG011|Overall Study|Intercurrent Illness|0|||
163226013|NCT02457598|589542146|FG012|Overall Study|Intercurrent Illness|0|||
163226014|NCT02457598|589542147|FG013|Overall Study|Intercurrent Illness|0|||
163226015|NCT02457598|589542148|FG014|Overall Study|Intercurrent Illness|0|||
163226016|NCT02457598|589542149|FG015|Overall Study|Intercurrent Illness|0|||
163226017|NCT02457598|589542150|FG016|Overall Study|Intercurrent Illness|0|||
163226018|NCT02457598|589542134|FG000|Overall Study|Protocol Violation|0|||
163226019|NCT02457598|589542135|FG001|Overall Study|Protocol Violation|0|||
163226020|NCT02457598|589542136|FG002|Overall Study|Protocol Violation|0|||
163226021|NCT02457598|589542137|FG003|Overall Study|Protocol Violation|0|||
163226022|NCT02457598|589542138|FG004|Overall Study|Protocol Violation|0|||
163226023|NCT02457598|589542139|FG005|Overall Study|Protocol Violation|0|||
163226024|NCT02457598|589542140|FG006|Overall Study|Protocol Violation|0|||
163226025|NCT02457598|589542141|FG007|Overall Study|Protocol Violation|0|||
163226026|NCT02457598|589542142|FG008|Overall Study|Protocol Violation|0|||
163226027|NCT02457598|589542143|FG009|Overall Study|Protocol Violation|0|||
163226028|NCT02457598|589542144|FG010|Overall Study|Protocol Violation|1|||
163226029|NCT02457598|589542145|FG011|Overall Study|Protocol Violation|0|||
163226030|NCT02457598|589542146|FG012|Overall Study|Protocol Violation|0|||
163226031|NCT02457598|589542147|FG013|Overall Study|Protocol Violation|0|||
163226032|NCT02457598|589542148|FG014|Overall Study|Protocol Violation|0|||
163226033|NCT02457598|589542149|FG015|Overall Study|Protocol Violation|0|||
163226034|NCT02457598|589542150|FG016|Overall Study|Protocol Violation|0|||
163226035|NCT02703636|589542152|FG000|Overall Study|Adverse Event|14|||
163226036|NCT02703636|589542152|FG000|Overall Study|Study stopped by sponsor|1|||
163226037|NCT02703636|589542152|FG000|Overall Study|Withdrawal by Subject|1|||
163226038|NCT03316885|589542158|FG000|Overall Study|Adverse Event|1|||
163226039|NCT03316885|589542158|FG000|Overall Study|Death|10|||
163226040|NCT03316885|589542158|FG000|Overall Study|Lost to Follow-up|4|||
163226041|NCT03316885|589542158|FG000|Overall Study|Withdrawal by Subject|9|||
163226042|NCT03316885|589542158|FG000|Overall Study|COVID related|8|||
163226043|NCT02196324|589542163|FG000|Overall Study|Withdrawal by Subject|8|||
163226044|NCT02196324|589542164|FG001|Overall Study|Withdrawal by Subject|4|||
163226045|NCT02196324|589542163|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
163226046|NCT02196324|589542164|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
163226047|NCT02196324|589542163|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
163226048|NCT02196324|589542164|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
163226049|NCT02196324|589542163|FG000|Overall Study|Other|1|||
163408184|NCT00401752|590204044|FG000|Overall Study|Lost to Follow-up|1|||
163408185|NCT00401752|590204045|FG001|Overall Study|Lost to Follow-up|4|||
163408186|NCT00401752|590204044|FG000|Overall Study|Development of any exclusion criteria|4|||
163226050|NCT02196324|589542164|FG001|Overall Study|Other|0|||
163226051|NCT00692770|589542166|FG000|Overall Study|Protocol Violation|2|||
163226052|NCT00692770|589542167|FG001|Overall Study|Protocol Violation|7|||
163226053|NCT00692770|589542166|FG000|Overall Study|Withdrawal by Subject|97|||
163226054|NCT00692770|589542167|FG001|Overall Study|Withdrawal by Subject|36|||
163226055|NCT00692770|589542166|FG000|Overall Study|Adverse Event|136|||
163226056|NCT00692770|589542167|FG001|Overall Study|Adverse Event|41|||
163226057|NCT00692770|589542166|FG000|Overall Study|Death|10|||
163226058|NCT00692770|589542167|FG001|Overall Study|Death|5|||
163226059|NCT00692770|589542166|FG000|Overall Study|Lost to Follow-up|7|||
163226060|NCT00692770|589542167|FG001|Overall Study|Lost to Follow-up|3|||
163341831|NCT02561195|589959617|FG012|Vaccination 1 to 3|Protocol Violation|0|||
163341832|NCT02561195|589959618|FG013|Vaccination 1 to 3|Protocol Violation|0|||
163341833|NCT02561195|589959605|FG000|Vaccination 1 to 3|Death|2|||
163341834|NCT02561195|589959606|FG001|Vaccination 1 to 3|Death|1|||
163341835|NCT02561195|589959607|FG002|Vaccination 1 to 3|Death|0|||
163341836|NCT02561195|589959608|FG003|Vaccination 1 to 3|Death|2|||
163341837|NCT02561195|589959609|FG004|Vaccination 1 to 3|Death|0|||
163341838|NCT02561195|589959610|FG005|Vaccination 1 to 3|Death|0|||
163341839|NCT02561195|589959611|FG006|Vaccination 1 to 3|Death|0|||
163341840|NCT02561195|589959612|FG007|Vaccination 1 to 3|Death|0|||
163341841|NCT02561195|589959613|FG008|Vaccination 1 to 3|Death|0|||
163341842|NCT02561195|589959614|FG009|Vaccination 1 to 3|Death|0|||
163341843|NCT02561195|589959615|FG010|Vaccination 1 to 3|Death|0|||
163341844|NCT02561195|589959616|FG011|Vaccination 1 to 3|Death|0|||
163341845|NCT02561195|589959617|FG012|Vaccination 1 to 3|Death|0|||
163341846|NCT02561195|589959618|FG013|Vaccination 1 to 3|Death|0|||
163341847|NCT02561195|589959605|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
163341848|NCT02561195|589959606|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
163341849|NCT02561195|589959607|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
163341850|NCT02561195|589959608|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
163341851|NCT02561195|589959609|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
163341852|NCT02561195|589959610|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
163341853|NCT02561195|589959611|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
163341854|NCT02561195|589959612|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
163341855|NCT02561195|589959613|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
163341856|NCT02561195|589959614|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
163341857|NCT02561195|589959615|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
163341858|NCT02561195|589959616|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
163341859|NCT02561195|589959617|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
163341860|NCT02561195|589959618|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
163341861|NCT02561195|589959605|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
163341862|NCT02561195|589959606|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
163341863|NCT02561195|589959607|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
163341864|NCT02561195|589959608|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
163341865|NCT02561195|589959609|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
163341866|NCT02561195|589959610|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
163341867|NCT02561195|589959611|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
163341868|NCT02561195|589959612|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
163341869|NCT02561195|589959613|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
163341870|NCT02561195|589959614|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
163125637|NCT02651220|589166550|FG001|Overall Study|Lost to Follow-up|14|||
163125638|NCT02651220|589166551|FG002|Overall Study|Lost to Follow-up|14|||
163125639|NCT02651220|589166549|FG000|Overall Study|Non-Compliance with Study Drug|4|||
163125640|NCT02651220|589166550|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163125641|NCT02651220|589166551|FG002|Overall Study|Non-Compliance with Study Drug|1|||
163125642|NCT02651220|589166549|FG000|Overall Study|Pregnancy|1|||
163125643|NCT02651220|589166550|FG001|Overall Study|Pregnancy|0|||
163125644|NCT02651220|589166551|FG002|Overall Study|Pregnancy|1|||
163125645|NCT02651220|589166549|FG000|Overall Study|Protocol Violation|0|||
163125646|NCT02651220|589166550|FG001|Overall Study|Protocol Violation|0|||
163125647|NCT02651220|589166551|FG002|Overall Study|Protocol Violation|1|||
163125648|NCT02651220|589166549|FG000|Overall Study|Withdrawal by Subject|5|||
163125649|NCT02651220|589166550|FG001|Overall Study|Withdrawal by Subject|6|||
163125650|NCT02651220|589166551|FG002|Overall Study|Withdrawal by Subject|8|||
163125651|NCT02651220|589166549|FG000|Overall Study|Miscellaneous|4|||
163125652|NCT02651220|589166550|FG001|Overall Study|Miscellaneous|1|||
163125653|NCT02651220|589166551|FG002|Overall Study|Miscellaneous|2|||
163125654|NCT02651220|589166549|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163125655|NCT02651220|589166550|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163125656|NCT02651220|589166551|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
163125657|NCT01274429|589166553|FG000|Overall Study|Study closed do to lack of funding|5|||
163125658|NCT01439373|589166554|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
163125659|NCT01439373|589166555|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
163125660|NCT01439373|589166554|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
163125661|NCT01439373|589166555|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
163125662|NCT04576897|589166558|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
163125663|NCT02593318|589166561|FG000|Overall Study|Withdrawal by Subject|1|||
163125664|NCT02593318|589166562|FG001|Overall Study|Withdrawal by Subject|1|||
163125665|NCT02806960|589168232|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
163125666|NCT02806960|589168233|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
163125667|NCT02806960|589168234|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
163125668|NCT02806960|589168235|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
163125669|NCT02522325|589168237|FG000|Overall Study|Adverse Event|0|||
163125670|NCT02522325|589168238|FG001|Overall Study|Adverse Event|1|||
163125671|NCT01209078|589168239|FG000|Overall Study|Adverse Event|5|||
163341871|NCT02561195|589959615|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
163341872|NCT02561195|589959616|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
163341873|NCT02561195|589959617|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
163341874|NCT02561195|589959618|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
163341875|NCT02561195|589959605|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163125672|NCT01209078|589168240|FG001|Overall Study|Adverse Event|0|||
163125673|NCT01209078|589168239|FG000|Overall Study|Lost to Follow-up|4|||
163125674|NCT01209078|589168240|FG001|Overall Study|Lost to Follow-up|0|||
163125675|NCT01209078|589168239|FG000|Overall Study|Physician Decision|5|||
163125676|NCT01209078|589168240|FG001|Overall Study|Physician Decision|2|||
163125677|NCT01209078|589168239|FG000|Overall Study|Withdrawal by Subject|2|||
163125678|NCT01209078|589168240|FG001|Overall Study|Withdrawal by Subject|1|||
163125679|NCT01629953|589168241|FG000|Overall Study|Death|3|||
163125680|NCT01629953|589168242|FG001|Overall Study|Death|1|||
163125681|NCT01629953|589168241|FG000|Overall Study|Lost to Follow-up|10|||
163125682|NCT01629953|589168242|FG001|Overall Study|Lost to Follow-up|14|||
163125683|NCT00448747|589168245|FG000|Overall Study|collapsed veins|1|||
163125684|NCT00448747|589168246|FG001|Overall Study|collapsed veins|0|||
163125685|NCT00387725|589168247|FG000|Overall Study|Adverse Event|0|||
163125686|NCT00387725|589168248|FG001|Overall Study|Adverse Event|0|||
163125687|NCT00387725|589168249|FG002|Overall Study|Adverse Event|0|||
163125688|NCT00387725|589168250|FG003|Overall Study|Adverse Event|1|||
163125689|NCT00387725|589168247|FG000|Overall Study|Protocol Violation|0|||
163125690|NCT00387725|589168248|FG001|Overall Study|Protocol Violation|1|||
163125691|NCT00387725|589168249|FG002|Overall Study|Protocol Violation|0|||
163125692|NCT00387725|589168250|FG003|Overall Study|Protocol Violation|0|||
163125693|NCT00387725|589168247|FG000|Overall Study|Withdrawal by Subject|1|||
163125694|NCT00387725|589168248|FG001|Overall Study|Withdrawal by Subject|0|||
163125695|NCT00387725|589168249|FG002|Overall Study|Withdrawal by Subject|1|||
163125696|NCT00387725|589168250|FG003|Overall Study|Withdrawal by Subject|0|||
163125697|NCT00387725|589168247|FG000|Overall Study|Parent/legal guardian request|0|||
163125698|NCT00387725|589168248|FG001|Overall Study|Parent/legal guardian request|0|||
163125699|NCT00387725|589168249|FG002|Overall Study|Parent/legal guardian request|1|||
163125700|NCT00387725|589168250|FG003|Overall Study|Parent/legal guardian request|1|||
163125701|NCT00568126|589168251|FG000|Overall Study|Adverse Event|3|||
163125702|NCT00568126|589168252|FG001|Overall Study|Adverse Event|0|||
163125703|NCT00568126|589168251|FG000|Overall Study|Withdrawal by Subject|2|||
163125704|NCT00568126|589168252|FG001|Overall Study|Withdrawal by Subject|3|||
163125705|NCT00568126|589168251|FG000|Overall Study|Lost to Follow-up|4|||
163125706|NCT00568126|589168252|FG001|Overall Study|Lost to Follow-up|3|||
163125707|NCT00568126|589168251|FG000|Overall Study|Lack of Efficacy|0|||
163125708|NCT00568126|589168252|FG001|Overall Study|Lack of Efficacy|1|||
163125709|NCT00568126|589168251|FG000|Overall Study|Physician Decision|2|||
163125710|NCT00568126|589168252|FG001|Overall Study|Physician Decision|2|||
163125711|NCT02429791|589168256|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
163125712|NCT02429791|589168257|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
163125713|NCT02429791|589168256|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
163125714|NCT02429791|589168257|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
163125715|NCT02429791|589168256|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
163125716|NCT02429791|589168257|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
163125717|NCT02429791|589168256|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
163125718|NCT02429791|589168257|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
163125719|NCT02429791|589168256|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
163125720|NCT02429791|589168257|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
163125721|NCT02429791|589168256|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
163125722|NCT02429791|589168257|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
163125723|NCT02429791|589168256|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
163125724|NCT02429791|589168257|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
163125725|NCT02429791|589168256|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
163125726|NCT02429791|589168257|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
163125727|NCT02429791|589168256|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
163125728|NCT02429791|589168257|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
163125729|NCT02429791|589168256|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
163125730|NCT02429791|589168257|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
163125731|NCT02429791|589168256|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
163125732|NCT02429791|589168257|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
163125733|NCT02429791|589168256|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
163125734|NCT02429791|589168257|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
163125735|NCT02429791|589168256|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
163125736|NCT02429791|589168257|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
163226061|NCT00692770|589542166|FG000|Overall Study|Non-compliant with study medication|11|||
163226062|NCT00692770|589542167|FG001|Overall Study|Non-compliant with study medication|5|||
163226063|NCT00692770|589542166|FG000|Overall Study|Progression by clinical judgment|2|||
163226064|NCT00692770|589542167|FG001|Overall Study|Progression by clinical judgment|3|||
163226065|NCT00692770|589542166|FG000|Overall Study|Physician decision not protocol driven|10|||
163226066|NCT00692770|589542167|FG001|Overall Study|Physician decision not protocol driven|14|||
163226067|NCT00692770|589542166|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
163226068|NCT00692770|589542167|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
163226069|NCT00692770|589542166|FG000|Overall Study|Protocol driven decision point|3|||
163226070|NCT00692770|589542167|FG001|Overall Study|Protocol driven decision point|7|||
163226071|NCT00692770|589542166|FG000|Overall Study|Completed all planned assessments|79|||
163226072|NCT00692770|589542167|FG001|Overall Study|Completed all planned assessments|101|||
163226073|NCT00692770|589542166|FG000|Overall Study|Radiological and clinical progression|8|||
163226074|NCT00692770|589542167|FG001|Overall Study|Radiological and clinical progression|8|||
163226075|NCT00692770|589542166|FG000|Overall Study|Clinical endpoint reached|16|||
163226076|NCT00692770|589542167|FG001|Overall Study|Clinical endpoint reached|43|||
163226077|NCT00692770|589542166|FG000|Overall Study|Study terminated by sponsor|2|||
163226078|NCT00692770|589542167|FG001|Overall Study|Study terminated by sponsor|2|||
163226079|NCT00692770|589542166|FG000|Overall Study|Randomized but not treated|3|||
163226080|NCT00692770|589542167|FG001|Overall Study|Randomized but not treated|4|||
163226081|NCT04248816|589542169|FG000|Overall Study|Ineligible post-randomization|7|||
163226082|NCT04248816|589542170|FG001|Overall Study|Ineligible post-randomization|21|||
163226083|NCT04248816|589542171|FG002|Overall Study|Ineligible post-randomization|25|||
163226084|NCT00344773|589542172|FG000|Overall Study|Adverse Event|2|||
163226085|NCT00344773|589542172|FG000|Overall Study|Objective Disease Progression|16|||
163226086|NCT00344773|589542172|FG000|Overall Study|Withdrawal by Subject|1|||
163226087|NCT00344773|589542172|FG000|Overall Study|Not Eligible for the study|2|||
163226088|NCT02849548|589542180|FG000|Overall Study|Lost to Follow-up|1|||
163226089|NCT02849548|589542181|FG001|Overall Study|Lost to Follow-up|2|||
163226090|NCT02849548|589542180|FG000|Overall Study|Protocol Violation|1|||
163226091|NCT02849548|589542181|FG001|Overall Study|Protocol Violation|0|||
163226092|NCT00714259|589542182|FG000|Overall Study|Death|2|||
163226093|NCT01012817|589544071|FG000|Overall Study|Withdrawal by Subject|0|||
163226094|NCT01012817|589544072|FG001|Overall Study|Withdrawal by Subject|0|||
163226095|NCT01012817|589544073|FG002|Overall Study|Withdrawal by Subject|0|||
163226096|NCT01012817|589544074|FG003|Overall Study|Withdrawal by Subject|1|||
163226097|NCT01012817|589544075|FG004|Overall Study|Withdrawal by Subject|0|||
163226098|NCT01012817|589544076|FG005|Overall Study|Withdrawal by Subject|0|||
163226099|NCT01012817|589544077|FG006|Overall Study|Withdrawal by Subject|0|||
163226100|NCT01012817|589544078|FG007|Overall Study|Withdrawal by Subject|1|||
163226101|NCT01012817|589544079|FG008|Overall Study|Withdrawal by Subject|0|||
163226102|NCT01012817|589544080|FG009|Overall Study|Withdrawal by Subject|0|||
163226103|NCT01012817|589544081|FG010|Overall Study|Withdrawal by Subject|1|||
163226104|NCT01012817|589544082|FG011|Overall Study|Withdrawal by Subject|1|||
163226105|NCT01012817|589544083|FG012|Overall Study|Withdrawal by Subject|0|||
163226106|NCT01012817|589544084|FG013|Overall Study|Withdrawal by Subject|1|||
163226107|NCT01012817|589544071|FG000|Overall Study|Adverse Event|0|||
163226108|NCT01012817|589544072|FG001|Overall Study|Adverse Event|0|||
163226109|NCT01012817|589544073|FG002|Overall Study|Adverse Event|0|||
163226110|NCT01012817|589544074|FG003|Overall Study|Adverse Event|0|||
163226111|NCT01012817|589544075|FG004|Overall Study|Adverse Event|0|||
163226112|NCT01012817|589544076|FG005|Overall Study|Adverse Event|1|||
163226113|NCT01012817|589544077|FG006|Overall Study|Adverse Event|0|||
163226114|NCT01012817|589544078|FG007|Overall Study|Adverse Event|0|||
163226115|NCT01012817|589544079|FG008|Overall Study|Adverse Event|0|||
163226116|NCT01012817|589544080|FG009|Overall Study|Adverse Event|0|||
163226117|NCT01012817|589544081|FG010|Overall Study|Adverse Event|1|||
163226118|NCT01012817|589544082|FG011|Overall Study|Adverse Event|0|||
163226119|NCT01012817|589544083|FG012|Overall Study|Adverse Event|0|||
163226120|NCT01012817|589544084|FG013|Overall Study|Adverse Event|1|||
163226121|NCT00634647|589544085|FG000|Overall Study|death on study|3|||
163226122|NCT00634647|589544085|FG000|Overall Study|refused further treatment|3|||
163226123|NCT00634647|589544085|FG000|Overall Study|declined to participate before treatment|1|||
163226124|NCT01896895|589544086|FG000|Double-blind MP|Physician Decision|0|||
163226125|NCT01896895|589544087|FG001|Double-blind MP|Physician Decision|0|||
163226126|NCT01896895|589544088|FG002|Double-blind MP|Physician Decision|1|||
163226127|NCT01896895|589544089|FG003|Double-blind MP|Physician Decision|0|||
163226128|NCT01896895|589544086|FG000|Double-blind MP|Withdrawal by Subject|0|||
163226129|NCT01896895|589544087|FG001|Double-blind MP|Withdrawal by Subject|2|||
163226130|NCT01896895|589544088|FG002|Double-blind MP|Withdrawal by Subject|1|||
163226131|NCT01896895|589544089|FG003|Double-blind MP|Withdrawal by Subject|0|||
163226132|NCT01896895|589544086|FG000|Double-blind MP|Lost to Follow-up|1|||
163226133|NCT01896895|589544087|FG001|Double-blind MP|Lost to Follow-up|0|||
163226134|NCT01896895|589544088|FG002|Double-blind MP|Lost to Follow-up|1|||
163226135|NCT01896895|589544089|FG003|Double-blind MP|Lost to Follow-up|0|||
163226136|NCT03277846|589544090|FG000|Overall Study|Inpatient stay too brief|12|||
163226137|NCT03277846|589544091|FG001|Overall Study|Inpatient stay too brief|11|||
163226138|NCT01589822|589544092|FG000|Overall Study|Withdrawal by Subject|1|||
163226139|NCT01589822|589544093|FG001|Overall Study|Withdrawal by Subject|2|||
163226140|NCT01589822|589544094|FG002|Overall Study|Withdrawal by Subject|0|||
163226141|NCT01589822|589544092|FG000|Overall Study|Death|1|||
163226142|NCT01589822|589544093|FG001|Overall Study|Death|0|||
163226143|NCT01589822|589544094|FG002|Overall Study|Death|0|||
163226144|NCT01589822|589544092|FG000|Overall Study|Missed 90 day visit|2|||
163226145|NCT01589822|589544093|FG001|Overall Study|Missed 90 day visit|1|||
163226146|NCT01589822|589544094|FG002|Overall Study|Missed 90 day visit|1|||
163226147|NCT00773175|589544098|FG000|Overall Study|Adverse Event|2|||
163226148|NCT00773175|589544099|FG001|Overall Study|Adverse Event|0|||
163226149|NCT00773175|589544098|FG000|Overall Study|Consent Withdrawn|0|||
163226150|NCT00773175|589544099|FG001|Overall Study|Consent Withdrawn|2|||
163226151|NCT05723770|589544100|FG000|Overall Study|Lost to Follow-up|4|||
163226152|NCT05723770|589544100|FG000|Overall Study|Withdrawal by Subject|2|||
163226153|NCT03795610|589544104|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
163226154|NCT03795610|589544104|FG000|Overall Study|Withdrawal by Subject|1|||
163226155|NCT03795610|589544104|FG000|Overall Study|Screen Failure (Unknown)|1|||
163226156|NCT02775344|589544105|FG000|Overall Study|No ovarian cyst identified|3|||
163226157|NCT02775344|589544106|FG001|Overall Study|No ovarian cyst identified|2|||
163226158|NCT03909165|589544115|FG000|Overall Study|Physician Decision|0|||
163226159|NCT03909165|589544116|FG001|Overall Study|Physician Decision|1|||
163226160|NCT03909165|589544117|FG002|Overall Study|Physician Decision|0|||
163226161|NCT03909165|589544118|FG003|Overall Study|Physician Decision|0|||
163226162|NCT03909165|589544119|FG004|Overall Study|Physician Decision|0|||
163226163|NCT03909165|589544115|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163226164|NCT03909165|589544116|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163226165|NCT03909165|589544117|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163226166|NCT03909165|589544118|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163226167|NCT03909165|589544119|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
163226168|NCT03909165|589544115|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
163226169|NCT03909165|589544116|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
163226170|NCT03909165|589544117|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
163226171|NCT03909165|589544118|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
163226172|NCT03909165|589544119|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
163226173|NCT03909165|589544115|FG000|Overall Study|Previous Drug Exposure|0|||
163226174|NCT03909165|589544116|FG001|Overall Study|Previous Drug Exposure|0|||
163226175|NCT03909165|589544117|FG002|Overall Study|Previous Drug Exposure|1|||
163226176|NCT03909165|589544118|FG003|Overall Study|Previous Drug Exposure|0|||
163226177|NCT03909165|589544119|FG004|Overall Study|Previous Drug Exposure|0|||
163226178|NCT03909165|589544115|FG000|Overall Study|Early Discharge|1|||
163226179|NCT03909165|589544116|FG001|Overall Study|Early Discharge|0|||
163226180|NCT03909165|589544117|FG002|Overall Study|Early Discharge|0|||
163226181|NCT03909165|589544118|FG003|Overall Study|Early Discharge|0|||
163226182|NCT03909165|589544119|FG004|Overall Study|Early Discharge|0|||
163226183|NCT06034496|589544120|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
163226184|NCT06034496|589544121|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
163226185|NCT06034496|589544120|FG000|Overall Study|Withdrawal by Subject|5|||
163226186|NCT06034496|589544121|FG001|Overall Study|Withdrawal by Subject|4|||
163226187|NCT03277261|589544126|FG000|Overall Study|Adverse Event|17|||
163226188|NCT03277261|589544127|FG001|Overall Study|Adverse Event|1|||
163226189|NCT03277261|589544126|FG000|Overall Study|Participant Withdrawal of Consent|6|||
163226190|NCT03277261|589544127|FG001|Overall Study|Participant Withdrawal of Consent|15|||
163226191|NCT03277261|589544126|FG000|Overall Study|Investigator / Sponsor Decision|4|||
163226192|NCT03277261|589544127|FG001|Overall Study|Investigator / Sponsor Decision|2|||
163226193|NCT03277261|589544126|FG000|Overall Study|Pregnancy|2|||
163226194|NCT03277261|589544127|FG001|Overall Study|Pregnancy|0|||
163226195|NCT03277261|589544126|FG000|Overall Study|Lost to Follow-up|2|||
163226196|NCT03277261|589544127|FG001|Overall Study|Lost to Follow-up|2|||
163226197|NCT03277261|589544126|FG000|Overall Study|Lack of Efficacy|2|||
163341876|NCT02561195|589959606|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163341877|NCT02561195|589959607|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163226198|NCT03277261|589544127|FG001|Overall Study|Lack of Efficacy|2|||
163226199|NCT03277261|589544126|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
163226200|NCT03277261|589544127|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
163226201|NCT03762083|589544128|FG000|Overall Study|Withdrawal by Subject|2|||
163226202|NCT03762083|589544128|FG000|Overall Study|Physician Decision|1|||
163226203|NCT01203072|589544129|FG000|Overall Study|Adverse Event|5|||
163226204|NCT01203072|589544130|FG001|Overall Study|Adverse Event|3|||
163226205|NCT01203072|589544131|FG002|Overall Study|Adverse Event|2|||
163226206|NCT01203072|589544132|FG003|Overall Study|Adverse Event|4|||
163341878|NCT02561195|589959608|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163341879|NCT02561195|589959609|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163341880|NCT02561195|589959610|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163341881|NCT02561195|589959611|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163341882|NCT02561195|589959612|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163341883|NCT02561195|589959613|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
163341884|NCT02561195|589959614|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
163341885|NCT02561195|589959615|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
163341886|NCT02561195|589959616|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
163341887|NCT02561195|589959617|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
163341888|NCT02561195|589959618|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163341889|NCT02561195|589959605|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
163341890|NCT02561195|589959606|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
163341891|NCT02561195|589959607|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
163125737|NCT02429791|589168256|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
163125738|NCT02429791|589168257|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
163226207|NCT01203072|589544133|FG004|Overall Study|Adverse Event|2|||
163226208|NCT01203072|589544129|FG000|Overall Study|Lack of Efficacy|1|||
163226209|NCT01203072|589544130|FG001|Overall Study|Lack of Efficacy|0|||
163226210|NCT01203072|589544131|FG002|Overall Study|Lack of Efficacy|0|||
163226211|NCT01203072|589544132|FG003|Overall Study|Lack of Efficacy|0|||
163226212|NCT01203072|589544133|FG004|Overall Study|Lack of Efficacy|0|||
163226213|NCT01203072|589544129|FG000|Overall Study|Lost to Follow-up|0|||
163226214|NCT01203072|589544130|FG001|Overall Study|Lost to Follow-up|1|||
163226215|NCT01203072|589544131|FG002|Overall Study|Lost to Follow-up|0|||
163226216|NCT01203072|589544132|FG003|Overall Study|Lost to Follow-up|0|||
163226217|NCT01203072|589544133|FG004|Overall Study|Lost to Follow-up|0|||
163226218|NCT01203072|589544129|FG000|Overall Study|Protocol Violation|2|||
163226219|NCT01203072|589544130|FG001|Overall Study|Protocol Violation|0|||
163226220|NCT01203072|589544131|FG002|Overall Study|Protocol Violation|0|||
163341892|NCT02561195|589959608|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
163125739|NCT02429791|589168256|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
163125740|NCT02429791|589168257|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
163125741|NCT02429791|589168256|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
163125742|NCT02429791|589168257|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
163125743|NCT02429791|589168256|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
163125744|NCT02429791|589168257|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
163125745|NCT02429791|589168256|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
163125746|NCT02429791|589168257|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
163125747|NCT02615691|589168258|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
163125748|NCT02615691|589168258|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
163125749|NCT02615691|589168258|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
163125750|NCT02615691|589168258|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
163125751|NCT04201093|589168259|FG000|Overall Study|Adverse Event|6|||
163125752|NCT04201093|589168260|FG001|Overall Study|Adverse Event|29|||
163125753|NCT04201093|589168261|FG002|Overall Study|Adverse Event|35|||
163125754|NCT04201093|589168259|FG000|Overall Study|Death|2|||
163125755|NCT04201093|589168260|FG001|Overall Study|Death|1|||
163125756|NCT04201093|589168261|FG002|Overall Study|Death|0|||
163125757|NCT04201093|589168259|FG000|Overall Study|Lack of Efficacy|5|||
163125758|NCT04201093|589168260|FG001|Overall Study|Lack of Efficacy|1|||
163125759|NCT04201093|589168261|FG002|Overall Study|Lack of Efficacy|2|||
163125760|NCT04201093|589168259|FG000|Overall Study|Lost to Follow-up|0|||
163125761|NCT04201093|589168260|FG001|Overall Study|Lost to Follow-up|0|||
163125762|NCT04201093|589168261|FG002|Overall Study|Lost to Follow-up|1|||
163125763|NCT04201093|589168259|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
163125764|NCT04201093|589168260|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
163125765|NCT04201093|589168261|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
163125766|NCT04201093|589168259|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
163125767|NCT04201093|589168260|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
163125768|NCT04201093|589168261|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
163125769|NCT04201093|589168259|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
163125770|NCT04201093|589168260|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
163125771|NCT04201093|589168261|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
163125772|NCT04201093|589168259|FG000|Overall Study|Physician Decision|1|||
163125773|NCT04201093|589168260|FG001|Overall Study|Physician Decision|0|||
163226221|NCT01203072|589544132|FG003|Overall Study|Protocol Violation|0|||
163226222|NCT01203072|589544133|FG004|Overall Study|Protocol Violation|1|||
163226223|NCT01203072|589544129|FG000|Overall Study|Withdrawal by Subject|2|||
163226224|NCT01203072|589544130|FG001|Overall Study|Withdrawal by Subject|2|||
163226225|NCT01203072|589544131|FG002|Overall Study|Withdrawal by Subject|1|||
163226226|NCT01203072|589544132|FG003|Overall Study|Withdrawal by Subject|2|||
163226227|NCT01203072|589544133|FG004|Overall Study|Withdrawal by Subject|3|||
163341893|NCT02561195|589959609|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
163341894|NCT02561195|589959610|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
163226228|NCT00116558|589544134|FG000|Overall Study|Death|11|||
163226229|NCT00116558|589544135|FG001|Overall Study|Death|5|||
163226230|NCT00116558|589544136|FG002|Overall Study|Death|3|||
163226231|NCT00116558|589544134|FG000|Overall Study|Withdrawal by Subject|17|||
163226232|NCT00116558|589544135|FG001|Overall Study|Withdrawal by Subject|3|||
163226233|NCT00116558|589544136|FG002|Overall Study|Withdrawal by Subject|12|||
163226234|NCT00116558|589544134|FG000|Overall Study|disease progression|3|||
163226235|NCT00116558|589544135|FG001|Overall Study|disease progression|7|||
163226236|NCT00116558|589544136|FG002|Overall Study|disease progression|18|||
163226237|NCT00235872|589544137|FG000|Overall Study|Adverse Event|34|||
163226238|NCT00235872|589544137|FG000|Overall Study|Death|1|||
163226239|NCT00235872|589544137|FG000|Overall Study|Lost to Follow-up|1|||
163226240|NCT00235872|589544137|FG000|Overall Study|Withdrawal by Subject|50|||
163226241|NCT00235872|589544137|FG000|Overall Study|Administrative reason|61|||
163341895|NCT02561195|589959611|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
163341896|NCT02561195|589959612|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
163341897|NCT02561195|589959613|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
163341898|NCT02561195|589959614|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
163341899|NCT02561195|589959615|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
163341900|NCT02561195|589959616|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
163341901|NCT02561195|589959617|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
163341902|NCT02561195|589959618|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
163341903|NCT02561195|589959605|FG000|Extension Stage (Vaccination 4)|Death|0|||
163341904|NCT02561195|589959606|FG001|Extension Stage (Vaccination 4)|Death|0|||
163341905|NCT02561195|589959607|FG002|Extension Stage (Vaccination 4)|Death|0|||
163341906|NCT02561195|589959608|FG003|Extension Stage (Vaccination 4)|Death|0|||
163341907|NCT02561195|589959609|FG004|Extension Stage (Vaccination 4)|Death|0|||
163341908|NCT02561195|589959610|FG005|Extension Stage (Vaccination 4)|Death|0|||
163341909|NCT02561195|589959611|FG006|Extension Stage (Vaccination 4)|Death|0|||
163341910|NCT02561195|589959612|FG007|Extension Stage (Vaccination 4)|Death|0|||
163341911|NCT02561195|589959613|FG008|Extension Stage (Vaccination 4)|Death|0|||
163341912|NCT02561195|589959614|FG009|Extension Stage (Vaccination 4)|Death|1|||
163341913|NCT02561195|589959615|FG010|Extension Stage (Vaccination 4)|Death|0|||
163341914|NCT02561195|589959616|FG011|Extension Stage (Vaccination 4)|Death|0|||
163341915|NCT02561195|589959617|FG012|Extension Stage (Vaccination 4)|Death|0|||
163341916|NCT02561195|589959618|FG013|Extension Stage (Vaccination 4)|Death|0|||
163341917|NCT02561195|589959605|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163341918|NCT02561195|589959606|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163341919|NCT02561195|589959607|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163341920|NCT02561195|589959608|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163341921|NCT02561195|589959609|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163341922|NCT02561195|589959610|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163226242|NCT00378014|589544138|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
163226243|NCT00378014|589544139|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
163341923|NCT02561195|589959611|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
163341924|NCT02561195|589959612|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
163125774|NCT04201093|589168261|FG002|Overall Study|Physician Decision|0|||
163125775|NCT04201093|589168259|FG000|Overall Study|Protocol Deviation|1|||
163125776|NCT04201093|589168260|FG001|Overall Study|Protocol Deviation|0|||
163125777|NCT04201093|589168261|FG002|Overall Study|Protocol Deviation|0|||
163125778|NCT04201093|589168259|FG000|Overall Study|Site Terminated by Sponsor|5|||
163125779|NCT04201093|589168260|FG001|Overall Study|Site Terminated by Sponsor|3|||
163125780|NCT04201093|589168261|FG002|Overall Study|Site Terminated by Sponsor|1|||
163125781|NCT04201093|589168259|FG000|Overall Study|Withdrawal by Subject|7|||
163125782|NCT04201093|589168260|FG001|Overall Study|Withdrawal by Subject|8|||
163125783|NCT04201093|589168261|FG002|Overall Study|Withdrawal by Subject|15|||
163125784|NCT04201093|589168259|FG000|Overall Study|Other|0|||
163125785|NCT04201093|589168260|FG001|Overall Study|Other|1|||
163125786|NCT04201093|589168261|FG002|Overall Study|Other|2|||
163125787|NCT00881504|589168262|FG000|Overall Study|Withdrawal by Subject|1|||
163125788|NCT01276223|589168263|FG000|Overall Study|Adverse Event|7|||
163125789|NCT01276223|589168264|FG001|Overall Study|Adverse Event|4|||
163125790|NCT01276223|589168265|FG002|Overall Study|Adverse Event|1|||
163125791|NCT01276223|589168263|FG000|Overall Study|Lost to Follow-up|0|||
163226244|NCT00378014|589544138|FG000|Core (Randomization to Month 11)|Graft loss|1|||
163226245|NCT00378014|589544139|FG001|Core (Randomization to Month 11)|Graft loss|2|||
163341925|NCT02561195|589959613|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163341926|NCT02561195|589959614|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163341927|NCT02561195|589959615|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
163125792|NCT01276223|589168264|FG001|Overall Study|Lost to Follow-up|0|||
163125793|NCT01276223|589168265|FG002|Overall Study|Lost to Follow-up|1|||
163125794|NCT01276223|589168263|FG000|Overall Study|Other|0|||
163125795|NCT01276223|589168264|FG001|Overall Study|Other|0|||
163226246|NCT00378014|589544138|FG000|Core (Randomization to Month 11)|Death|5|||
163341928|NCT02561195|589959616|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
163341929|NCT02561195|589959617|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
163341930|NCT02561195|589959618|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
163341931|NCT02561195|589959605|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163341932|NCT02561195|589959606|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163341933|NCT02561195|589959607|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163341934|NCT02561195|589959608|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163341935|NCT02561195|589959609|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163341936|NCT02561195|589959610|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163341937|NCT02561195|589959611|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163341938|NCT02561195|589959612|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163341939|NCT02561195|589959613|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163408187|NCT00401752|590204045|FG001|Overall Study|Development of any exclusion criteria|2|||
163125796|NCT01276223|589168265|FG002|Overall Study|Other|1|||
163125797|NCT01276223|589168263|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
163125798|NCT01276223|589168264|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
163125799|NCT01276223|589168265|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
163125800|NCT01276223|589168263|FG000|Overall Study|Protocol Violation|1|||
163125801|NCT01276223|589168264|FG001|Overall Study|Protocol Violation|0|||
163125802|NCT01276223|589168265|FG002|Overall Study|Protocol Violation|0|||
163125803|NCT02017522|589168266|FG000|Overall Study|Withdrawal by Subject|1|||
163125804|NCT02596230|589168267|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
163125805|NCT02596230|589168268|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
163125806|NCT02596230|589168269|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
163125807|NCT02596230|589168270|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
163408188|NCT00401752|590204044|FG000|Overall Study|Physician Decision|1|||
163125808|NCT02596230|589168271|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
163125809|NCT02596230|589168267|FG000|Objective 2, One Year|Lost to Follow-up|0|||
163125810|NCT02596230|589168268|FG001|Objective 2, One Year|Lost to Follow-up|41|||
163125811|NCT02596230|589168269|FG002|Objective 2, One Year|Lost to Follow-up|41|||
163125812|NCT02596230|589168270|FG003|Objective 2, One Year|Lost to Follow-up|32|||
163125813|NCT02596230|589168271|FG004|Objective 2, One Year|Lost to Follow-up|46|||
163125814|NCT02596230|589168267|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
163125815|NCT02596230|589168268|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
163125816|NCT02596230|589168269|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
163125817|NCT02596230|589168270|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
163125818|NCT02596230|589168271|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
163125819|NCT02596230|589168267|FG000|Objective 2, One Year|Adverse drug reaction|0|||
163125820|NCT02596230|589168268|FG001|Objective 2, One Year|Adverse drug reaction|1|||
163125821|NCT02596230|589168269|FG002|Objective 2, One Year|Adverse drug reaction|0|||
163125822|NCT02596230|589168270|FG003|Objective 2, One Year|Adverse drug reaction|0|||
163125823|NCT02596230|589168271|FG004|Objective 2, One Year|Adverse drug reaction|0|||
163125824|NCT02596230|589168267|FG000|Objective 2, One Year|Death|0|||
163125825|NCT02596230|589168268|FG001|Objective 2, One Year|Death|12|||
163125826|NCT02596230|589168269|FG002|Objective 2, One Year|Death|41|||
163125827|NCT02596230|589168270|FG003|Objective 2, One Year|Death|21|||
163125828|NCT02596230|589168271|FG004|Objective 2, One Year|Death|30|||
163125829|NCT02596230|589168267|FG000|Objective 2, One Year|Other|0|||
163125830|NCT02596230|589168268|FG001|Objective 2, One Year|Other|3|||
163125831|NCT02596230|589168269|FG002|Objective 2, One Year|Other|2|||
163125832|NCT02596230|589168270|FG003|Objective 2, One Year|Other|0|||
163125833|NCT02596230|589168271|FG004|Objective 2, One Year|Other|0|||
163125834|NCT00771615|589168272|FG000|Overall Study|Withdrawal by Subject|0|||
163125835|NCT00771615|589168273|FG001|Overall Study|Withdrawal by Subject|1|||
163125836|NCT00771615|589168274|FG002|Overall Study|Withdrawal by Subject|0|||
163125837|NCT00771615|589168275|FG003|Overall Study|Withdrawal by Subject|0|||
163125838|NCT00771615|589168276|FG004|Overall Study|Withdrawal by Subject|0|||
163125839|NCT00771615|589168277|FG005|Overall Study|Withdrawal by Subject|0|||
163125840|NCT00771615|589168278|FG006|Overall Study|Withdrawal by Subject|0|||
163125841|NCT00771615|589168279|FG007|Overall Study|Withdrawal by Subject|1|||
163408189|NCT00401752|590204045|FG001|Overall Study|Physician Decision|1|||
163408190|NCT01895322|590204046|FG000|Overall Study|Adverse Event|1|||
163408191|NCT01895322|590204046|FG000|Overall Study|Withdrawal by Subject|2|||
163125842|NCT00771615|589168280|FG008|Overall Study|Withdrawal by Subject|0|||
163125843|NCT00771615|589168272|FG000|Overall Study|Lost to Follow-up|1|||
163125844|NCT00771615|589168273|FG001|Overall Study|Lost to Follow-up|1|||
163125845|NCT00771615|589168274|FG002|Overall Study|Lost to Follow-up|1|||
163408192|NCT01895322|590204046|FG000|Overall Study|Protocol Violation|10|||
163125846|NCT00771615|589168275|FG003|Overall Study|Lost to Follow-up|1|||
163125847|NCT00771615|589168276|FG004|Overall Study|Lost to Follow-up|0|||
163125848|NCT00771615|589168277|FG005|Overall Study|Lost to Follow-up|1|||
163408193|NCT01347554|590204047|FG000|Overall Study|Lack of Efficacy|7|||
163408194|NCT01347554|590204048|FG001|Overall Study|Lack of Efficacy|11|||
163408195|NCT02228590|590204054|FG000|Overall Study|Withdrawal by Subject|1|||
163125849|NCT00771615|589168278|FG006|Overall Study|Lost to Follow-up|1|||
163125850|NCT00771615|589168279|FG007|Overall Study|Lost to Follow-up|0|||
163341940|NCT02561195|589959614|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163341941|NCT02561195|589959615|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163341942|NCT02561195|589959616|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
163341943|NCT02561195|589959617|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
163341944|NCT02561195|589959618|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
163341945|NCT02561195|589959605|FG000|Extension Stage (Vaccination 4)|Other|0|||
163341946|NCT02561195|589959606|FG001|Extension Stage (Vaccination 4)|Other|0|||
163341947|NCT02561195|589959607|FG002|Extension Stage (Vaccination 4)|Other|0|||
163341948|NCT02561195|589959608|FG003|Extension Stage (Vaccination 4)|Other|0|||
163341949|NCT02561195|589959609|FG004|Extension Stage (Vaccination 4)|Other|0|||
163341950|NCT02561195|589959610|FG005|Extension Stage (Vaccination 4)|Other|0|||
163341951|NCT02561195|589959611|FG006|Extension Stage (Vaccination 4)|Other|0|||
163341952|NCT02561195|589959612|FG007|Extension Stage (Vaccination 4)|Other|0|||
163341953|NCT02561195|589959613|FG008|Extension Stage (Vaccination 4)|Other|0|||
163341954|NCT02561195|589959614|FG009|Extension Stage (Vaccination 4)|Other|0|||
163341955|NCT02561195|589959615|FG010|Extension Stage (Vaccination 4)|Other|2|||
163341956|NCT02561195|589959616|FG011|Extension Stage (Vaccination 4)|Other|2|||
163341957|NCT02561195|589959617|FG012|Extension Stage (Vaccination 4)|Other|1|||
163341958|NCT02561195|589959618|FG013|Extension Stage (Vaccination 4)|Other|0|||
163341959|NCT02561195|589959605|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163341960|NCT02561195|589959606|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163341961|NCT02561195|589959607|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163341962|NCT02561195|589959608|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163341963|NCT02561195|589959609|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163341964|NCT02561195|589959610|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163341965|NCT02561195|589959611|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
163341966|NCT02561195|589959612|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163341967|NCT02561195|589959613|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163341968|NCT02561195|589959614|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163341969|NCT02561195|589959615|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
163341970|NCT02561195|589959616|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
163341971|NCT02561195|589959617|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163341972|NCT02561195|589959618|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
163341973|NCT03905512|589959619|FG000|Overall Study|Withdrawal by Subject|9|||
163341974|NCT03905512|589959620|FG001|Overall Study|Withdrawal by Subject|8|||
163341975|NCT03905512|589959619|FG000|Overall Study|Adverse Event|1|||
163341976|NCT03905512|589959620|FG001|Overall Study|Adverse Event|2|||
163341977|NCT03905512|589959619|FG000|Overall Study|Lost to Follow-up|4|||
163341978|NCT03905512|589959620|FG001|Overall Study|Lost to Follow-up|3|||
163341979|NCT03905512|589959619|FG000|Overall Study|Other than Specified|7|||
163341980|NCT03905512|589959620|FG001|Overall Study|Other than Specified|4|||
163341981|NCT00070317|589959627|FG000|Overall Study|Inevaluable (Never Treated)|1|||
163341982|NCT00070317|589959627|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
163341983|NCT00070317|589959627|FG000|Overall Study|Ineligible required test not done|1|||
163341984|NCT00070317|589959627|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
163341985|NCT00070317|589959627|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
163341986|NCT03987074|589959629|FG000|Overall Study|Withdrew Consent|1|||
163341987|NCT03987074|589959630|FG001|Overall Study|Withdrew Consent|1|||
163341988|NCT03987074|589959631|FG002|Overall Study|Withdrew Consent|0|||
163341989|NCT03987074|589959632|FG003|Overall Study|Withdrew Consent|2|||
163341990|NCT03987074|589959633|FG004|Overall Study|Withdrew Consent|1|||
163125851|NCT00771615|589168280|FG008|Overall Study|Lost to Follow-up|0|||
163125852|NCT02704689|589168282|FG000|Overall Study|Physician Decision|1|||
163125853|NCT02704689|589168282|FG000|Overall Study|Study device not implanted|2|||
163125854|NCT00802893|589168283|FG000|Overall Study|study terminated|3|||
163125855|NCT00320424|589168284|FG000|Overall Study|Adverse Event|3|||
163125856|NCT00320424|589168284|FG000|Overall Study|Other|3|||
163125857|NCT03270891|589168286|FG000|Overall Study|Lost to Follow-up|3|||
163125858|NCT03270891|589168287|FG001|Overall Study|Lost to Follow-up|6|||
163125859|NCT03270891|589168288|FG002|Overall Study|Lost to Follow-up|0|||
163125860|NCT03270891|589168286|FG000|Overall Study|Withdrawal by Subject|1|||
163125861|NCT03270891|589168287|FG001|Overall Study|Withdrawal by Subject|0|||
163125862|NCT03270891|589168288|FG002|Overall Study|Withdrawal by Subject|0|||
163125863|NCT03270891|589168286|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
163341991|NCT03987074|589959629|FG000|Overall Study|Adverse Event|2|||
163341992|NCT03987074|589959630|FG001|Overall Study|Adverse Event|1|||
163341993|NCT03987074|589959631|FG002|Overall Study|Adverse Event|0|||
163341994|NCT03987074|589959632|FG003|Overall Study|Adverse Event|0|||
163341995|NCT03987074|589959633|FG004|Overall Study|Adverse Event|1|||
163341996|NCT03987074|589959629|FG000|Overall Study|Lost to Follow-up|0|||
163341997|NCT03987074|589959630|FG001|Overall Study|Lost to Follow-up|0|||
163226247|NCT00378014|589544139|FG001|Core (Randomization to Month 11)|Death|3|||
163226248|NCT00378014|589544138|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
163226249|NCT00378014|589544139|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
163226250|NCT00378014|589544138|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
163226251|NCT00378014|589544139|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
163226252|NCT00378014|589544138|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
163226253|NCT00378014|589544139|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
163226254|NCT00378014|589544138|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
163226255|NCT00378014|589544139|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
163226256|NCT00378014|589544138|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
163226257|NCT00378014|589544139|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
163226258|NCT00378014|589544138|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
163226259|NCT00378014|589544139|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
163226260|NCT00378014|589544138|FG000|Extension (Month 12 to Month 59)|Death|1|||
163226261|NCT00378014|589544139|FG001|Extension (Month 12 to Month 59)|Death|2|||
163226262|NCT00378014|589544138|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
163226263|NCT00378014|589544139|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
163226264|NCT00378014|589544138|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
163226265|NCT00378014|589544139|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
163226266|NCT00378014|589544138|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
163226267|NCT00378014|589544139|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
163226268|NCT00378014|589544138|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
163226269|NCT00378014|589544139|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
163226270|NCT00414661|589544140|FG000|Overall Study|Death|2|||
163226271|NCT00414661|589544141|FG001|Overall Study|Death|5|||
163226272|NCT00414661|589544142|FG002|Overall Study|Death|0|||
163226273|NCT00414661|589544143|FG003|Overall Study|Death|0|||
163226274|NCT00414661|589544140|FG000|Overall Study|Lost to Follow-up|1|||
163226275|NCT00414661|589544141|FG001|Overall Study|Lost to Follow-up|4|||
163226276|NCT00414661|589544142|FG002|Overall Study|Lost to Follow-up|0|||
163226277|NCT00414661|589544143|FG003|Overall Study|Lost to Follow-up|1|||
163226278|NCT00414661|589544140|FG000|Overall Study|Withdrawal by Subject|5|||
163226279|NCT00414661|589544141|FG001|Overall Study|Withdrawal by Subject|2|||
163226280|NCT00414661|589544142|FG002|Overall Study|Withdrawal by Subject|2|||
163226281|NCT00414661|589544143|FG003|Overall Study|Withdrawal by Subject|2|||
163226282|NCT00414661|589544140|FG000|Overall Study|Other|6|||
163226283|NCT00414661|589544141|FG001|Overall Study|Other|3|||
163226284|NCT00414661|589544142|FG002|Overall Study|Other|0|||
163226285|NCT00414661|589544143|FG003|Overall Study|Other|0|||
163226286|NCT02852265|589544144|FG000|3-month Follow-up|Lost to Follow-up|1|||
163226287|NCT02852265|589544145|FG001|3-month Follow-up|Lost to Follow-up|1|||
163226288|NCT01143090|589544146|FG000|Overall Study|Lack of Efficacy|2|||
163226289|NCT01143090|589544146|FG000|Overall Study|Adverse Event|17|||
163226290|NCT01143090|589544146|FG000|Overall Study|Lost to Follow-up|9|||
163226291|NCT01143090|589544146|FG000|Overall Study|Protocol Violation|2|||
163226292|NCT01143090|589544146|FG000|Overall Study|Withdrawal by Subject|18|||
163226293|NCT01143090|589544146|FG000|Overall Study|Non-compliance with study drug|1|||
163226294|NCT01143090|589544146|FG000|Overall Study|Failure to meet eligibility criteria|1|||
163226295|NCT01143090|589544146|FG000|Overall Study|Administrative|1|||
163226296|NCT01800916|589544149|FG000|Test Period 1 (1 Week)|Convex product user|0|||
163226297|NCT01800916|589544150|FG001|Test Period 1 (1 Week)|Convex product user|0|||
163226298|NCT01800916|589544151|FG002|Test Period 1 (1 Week)|Convex product user|0|||
163226299|NCT01800916|589544152|FG003|Test Period 1 (1 Week)|Convex product user|1|||
163226300|NCT01800916|589544153|FG004|Test Period 1 (1 Week)|Convex product user|0|||
163226301|NCT01800916|589544154|FG005|Test Period 1 (1 Week)|Convex product user|0|||
163226302|NCT01800916|589544155|FG006|Test Period 1 (1 Week)|Convex product user|0|||
163226303|NCT01800916|589544156|FG007|Test Period 1 (1 Week)|Convex product user|0|||
163226304|NCT01800916|589544157|FG008|Test Period 1 (1 Week)|Convex product user|0|||
163341998|NCT03987074|589959631|FG002|Overall Study|Lost to Follow-up|1|||
163341999|NCT03987074|589959632|FG003|Overall Study|Lost to Follow-up|1|||
163342000|NCT03987074|589959633|FG004|Overall Study|Lost to Follow-up|0|||
163342001|NCT03987074|589959629|FG000|Overall Study|Investigator's Discretion|0|||
163342002|NCT03987074|589959630|FG001|Overall Study|Investigator's Discretion|0|||
163342003|NCT03987074|589959631|FG002|Overall Study|Investigator's Discretion|0|||
163342004|NCT03987074|589959632|FG003|Overall Study|Investigator's Discretion|1|||
163226305|NCT01800916|589544149|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
163226306|NCT01800916|589544150|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
163226307|NCT01800916|589544151|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
163226308|NCT01800916|589544152|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
163342005|NCT03987074|589959633|FG004|Overall Study|Investigator's Discretion|0|||
163226309|NCT01800916|589544153|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
163226310|NCT01800916|589544154|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
163342006|NCT00508144|589959634|FG000|Overall Study|Not eligible|6|||
163342007|NCT00508144|589959634|FG000|Overall Study|Death|5|||
163342008|NCT01661972|589959635|FG000|Overall Study|Adverse Event|1|||
163342009|NCT01661972|589959636|FG001|Overall Study|Adverse Event|2|||
163342010|NCT01661972|589959635|FG000|Overall Study|Death during Treatment period|1|||
163342011|NCT01661972|589959636|FG001|Overall Study|Death during Treatment period|1|||
163342012|NCT01661972|589959635|FG000|Overall Study|Withdrawal by Subject|0|||
163342013|NCT01661972|589959636|FG001|Overall Study|Withdrawal by Subject|1|||
163342014|NCT01084772|589959637|FG000|Baseline|Withdrawal by Subject|7|||
163342015|NCT01084772|589959638|FG001|Baseline|Withdrawal by Subject|6|||
163125864|NCT03270891|589168287|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
163125865|NCT03270891|589168288|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
163125866|NCT02540668|589168289|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
163125867|NCT02540668|589168290|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
163125868|NCT00849108|589168291|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
163125869|NCT00849108|589168292|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
163125870|NCT00849108|589168291|FG000|Cohort 2 Efficacy|Adverse Event|0|||
163125871|NCT00849108|589168292|FG001|Cohort 2 Efficacy|Adverse Event|1|||
163125872|NCT00849108|589168291|FG000|Cohort 2 Efficacy|Other|0|||
163125873|NCT00849108|589168292|FG001|Cohort 2 Efficacy|Other|9|||
163125874|NCT02294734|589168295|FG000|Overall Study|Adverse Event|5|||
163125875|NCT02294734|589168296|FG001|Overall Study|Adverse Event|5|||
163125876|NCT02294734|589168295|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
163125877|NCT02294734|589168296|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
163125878|NCT02294734|589168295|FG000|Overall Study|Lost to Follow-up|2|||
163125879|NCT02294734|589168296|FG001|Overall Study|Lost to Follow-up|0|||
163125880|NCT02294734|589168295|FG000|Overall Study|Physician Decision|2|||
163125881|NCT02294734|589168296|FG001|Overall Study|Physician Decision|1|||
163125882|NCT02294734|589168295|FG000|Overall Study|Withdrawal by Subject|4|||
163125883|NCT02294734|589168296|FG001|Overall Study|Withdrawal by Subject|2|||
163125884|NCT03157583|589168297|FG000|Overall Study|Other (did not meet study criteria)|1|||
163125885|NCT01943552|589168298|FG000|Overall Study|Adverse Event|3|||
163125886|NCT01943552|589168299|FG001|Overall Study|Adverse Event|2|||
163125887|NCT01943552|589168298|FG000|Overall Study|Withdrawal by Subject|6|||
163125888|NCT01943552|589168299|FG001|Overall Study|Withdrawal by Subject|6|||
163125889|NCT01943552|589168298|FG000|Overall Study|Other Reasons|16|||
163125890|NCT01943552|589168299|FG001|Overall Study|Other Reasons|17|||
163125891|NCT01475162|589168300|FG000|Overall Study|Physician Decision|1|||
163125892|NCT01475162|589168300|FG000|Overall Study|Death|10|||
163125893|NCT01475162|589168300|FG000|Overall Study|Study closed for safety|3|||
163125894|NCT00545103|589168301|FG000|Overall Study|Lack of Efficacy|48|||
163125895|NCT00545103|589168302|FG001|Overall Study|Lack of Efficacy|45|||
163125896|NCT00545103|589168303|FG002|Overall Study|Lack of Efficacy|31|||
163125897|NCT00545103|589168304|FG003|Overall Study|Lack of Efficacy|27|||
163125898|NCT00545103|589168301|FG000|Overall Study|Withdrawal by Subject|6|||
163125899|NCT00545103|589168302|FG001|Overall Study|Withdrawal by Subject|10|||
163125900|NCT00545103|589168303|FG002|Overall Study|Withdrawal by Subject|18|||
163125901|NCT00545103|589168304|FG003|Overall Study|Withdrawal by Subject|22|||
163125902|NCT00545103|589168301|FG000|Overall Study|Adverse Event|11|||
163125903|NCT00545103|589168302|FG001|Overall Study|Adverse Event|12|||
163125904|NCT00545103|589168303|FG002|Overall Study|Adverse Event|17|||
163125905|NCT00545103|589168304|FG003|Overall Study|Adverse Event|10|||
163125906|NCT00545103|589168301|FG000|Overall Study|Lost to Follow-up|4|||
163125907|NCT00545103|589168302|FG001|Overall Study|Lost to Follow-up|6|||
163125908|NCT00545103|589168303|FG002|Overall Study|Lost to Follow-up|3|||
163125909|NCT00545103|589168304|FG003|Overall Study|Lost to Follow-up|4|||
163125910|NCT00545103|589168301|FG000|Overall Study|Protocol Violation|1|||
163125911|NCT00545103|589168302|FG001|Overall Study|Protocol Violation|2|||
163125912|NCT00545103|589168303|FG002|Overall Study|Protocol Violation|3|||
163125913|NCT00545103|589168304|FG003|Overall Study|Protocol Violation|0|||
163125914|NCT00545103|589168301|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
163125915|NCT00545103|589168302|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
163125916|NCT00545103|589168303|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
163125917|NCT00545103|589168304|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
163125918|NCT00545103|589168301|FG000|Overall Study|Difficult to open package|0|||
163125919|NCT00545103|589168302|FG001|Overall Study|Difficult to open package|0|||
163342016|NCT01084772|589959637|FG000|3 Months|Death|1|||
163342017|NCT01084772|589959638|FG001|3 Months|Death|0|||
163125920|NCT00545103|589168303|FG002|Overall Study|Difficult to open package|0|||
163125921|NCT00545103|589168304|FG003|Overall Study|Difficult to open package|1|||
163125922|NCT00545103|589168301|FG000|Overall Study|Investigational product not taken|1|||
163125923|NCT00545103|589168302|FG001|Overall Study|Investigational product not taken|0|||
163125924|NCT00545103|589168303|FG002|Overall Study|Investigational product not taken|0|||
163125925|NCT00545103|589168304|FG003|Overall Study|Investigational product not taken|1|||
163125926|NCT00545103|589168301|FG000|Overall Study|Wish to start a family|0|||
163342018|NCT01084772|589959637|FG000|3 Months|Study Termination|2|||
163342019|NCT01084772|589959638|FG001|3 Months|Study Termination|2|||
163342020|NCT01084772|589959637|FG000|1 Year|Withdrawal by Subject|0|||
163342021|NCT01084772|589959638|FG001|1 Year|Withdrawal by Subject|1|||
163342022|NCT01084772|589959637|FG000|1 Year|Lost to Follow-up|3|||
163342023|NCT01084772|589959638|FG001|1 Year|Lost to Follow-up|0|||
163342024|NCT01084772|589959637|FG000|1 Year|Study Termination|0|||
163342025|NCT01084772|589959638|FG001|1 Year|Study Termination|7|||
163342026|NCT01084772|589959637|FG000|2 Years|Withdrawal by Subject|1|||
163342027|NCT01084772|589959638|FG001|2 Years|Withdrawal by Subject|0|||
163342028|NCT01084772|589959637|FG000|2 Years|Lost to Follow-up|5|||
163408196|NCT02111993|590204055|FG000|Overall Study|Physician Decision|5|||
163408197|NCT02111993|590204056|FG001|Overall Study|Physician Decision|4|||
163408198|NCT01400451|590204069|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
163125927|NCT00545103|589168302|FG001|Overall Study|Wish to start a family|0|||
163125928|NCT00545103|589168303|FG002|Overall Study|Wish to start a family|0|||
163125929|NCT00545103|589168304|FG003|Overall Study|Wish to start a family|1|||
163125930|NCT00545103|589168301|FG000|Overall Study|Diverticulitis crisis|0|||
163125931|NCT00545103|589168302|FG001|Overall Study|Diverticulitis crisis|0|||
163125932|NCT00545103|589168303|FG002|Overall Study|Diverticulitis crisis|0|||
163125933|NCT00545103|589168304|FG003|Overall Study|Diverticulitis crisis|1|||
163125934|NCT00545103|589168301|FG000|Overall Study|Personal reasons|1|||
163125935|NCT00545103|589168302|FG001|Overall Study|Personal reasons|0|||
163125936|NCT00545103|589168303|FG002|Overall Study|Personal reasons|0|||
163125937|NCT00545103|589168304|FG003|Overall Study|Personal reasons|0|||
163125938|NCT00545103|589168301|FG000|Overall Study|Subject's decision|1|||
163125939|NCT00545103|589168302|FG001|Overall Study|Subject's decision|0|||
163125940|NCT00545103|589168303|FG002|Overall Study|Subject's decision|0|||
163125941|NCT00545103|589168304|FG003|Overall Study|Subject's decision|0|||
163125942|NCT00545103|589168301|FG000|Overall Study|Noncompliance|0|||
163125943|NCT00545103|589168302|FG001|Overall Study|Noncompliance|1|||
163125944|NCT00545103|589168303|FG002|Overall Study|Noncompliance|0|||
163125945|NCT00545103|589168304|FG003|Overall Study|Noncompliance|0|||
163125946|NCT00545103|589168301|FG000|Overall Study|Investigator decision|0|||
163125947|NCT00545103|589168302|FG001|Overall Study|Investigator decision|0|||
163125948|NCT00545103|589168303|FG002|Overall Study|Investigator decision|1|||
163125949|NCT00545103|589168304|FG003|Overall Study|Investigator decision|0|||
163125950|NCT00545103|589168301|FG000|Overall Study|Subject moved|0|||
163125951|NCT00545103|589168302|FG001|Overall Study|Subject moved|1|||
163125952|NCT00545103|589168303|FG002|Overall Study|Subject moved|0|||
163125953|NCT00545103|589168304|FG003|Overall Study|Subject moved|0|||
163125954|NCT00545103|589168301|FG000|Overall Study|Use of prohibited medication|0|||
163125955|NCT00545103|589168302|FG001|Overall Study|Use of prohibited medication|0|||
163125956|NCT00545103|589168303|FG002|Overall Study|Use of prohibited medication|1|||
163125957|NCT00545103|589168304|FG003|Overall Study|Use of prohibited medication|0|||
163125958|NCT00545103|589168301|FG000|Overall Study|Does not want to take study drug anymore|1|||
163125959|NCT00545103|589168302|FG001|Overall Study|Does not want to take study drug anymore|0|||
163125960|NCT00545103|589168303|FG002|Overall Study|Does not want to take study drug anymore|1|||
163125961|NCT00545103|589168304|FG003|Overall Study|Does not want to take study drug anymore|0|||
163125962|NCT00545103|589168301|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
163125963|NCT00545103|589168302|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
163125964|NCT00545103|589168303|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
163125965|NCT00545103|589168304|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
163125966|NCT00545103|589168301|FG000|Overall Study|Death|0|||
163125967|NCT00545103|589168302|FG001|Overall Study|Death|1|||
163125968|NCT00545103|589168303|FG002|Overall Study|Death|0|||
163125969|NCT00545103|589168304|FG003|Overall Study|Death|0|||
163125970|NCT05026853|589168305|FG000|Overall Study|Cancelled appointment|1|||
163125971|NCT05026853|589168306|FG001|Overall Study|Cancelled appointment|0|||
163125972|NCT05026853|589168305|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
163125973|NCT05026853|589168306|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
163125974|NCT05026853|589168305|FG000|Overall Study|Did not complete 12-week survey|16|||
163125975|NCT05026853|589168306|FG001|Overall Study|Did not complete 12-week survey|16|||
163125976|NCT02358044|589168307|FG000|Overall Study|Adverse Event|0|||
163125977|NCT02358044|589168308|FG001|Overall Study|Adverse Event|1|||
163125978|NCT02358044|589168307|FG000|Overall Study|Lost to Follow-up|2|||
163125979|NCT02358044|589168308|FG001|Overall Study|Lost to Follow-up|1|||
163125980|NCT02358044|589168307|FG000|Overall Study|Physician Decision|0|||
163125981|NCT02358044|589168308|FG001|Overall Study|Physician Decision|1|||
163125982|NCT02358044|589168307|FG000|Overall Study|Withdrawal by Subject|0|||
163125983|NCT02358044|589168308|FG001|Overall Study|Withdrawal by Subject|4|||
163125984|NCT01732913|589168309|FG000|Overall Study|Study Terminated by Sponsor|105|||
163125985|NCT01732913|589168310|FG001|Overall Study|Study Terminated by Sponsor|55|||
163125986|NCT01732913|589168309|FG000|Overall Study|Withdrawal by Subject|27|||
163125987|NCT01732913|589168310|FG001|Overall Study|Withdrawal by Subject|4|||
163125988|NCT01732913|589168309|FG000|Overall Study|Physician Decision|14|||
163342029|NCT01084772|589959638|FG001|2 Years|Lost to Follow-up|2|||
163342030|NCT01084772|589959637|FG000|2 Years|Study Termination|3|||
163342031|NCT01084772|589959638|FG001|2 Years|Study Termination|2|||
163342032|NCT01517282|589959639|FG000|Overall Study|Consent withdrawn|0|||
163342033|NCT01517282|589959640|FG001|Overall Study|Consent withdrawn|1|||
163342034|NCT01517282|589959641|FG002|Overall Study|Consent withdrawn|1|||
163342035|NCT01517282|589959642|FG003|Overall Study|Consent withdrawn|1|||
163342036|NCT01517282|589959639|FG000|Overall Study|Physician Decision|1|||
163342037|NCT01517282|589959640|FG001|Overall Study|Physician Decision|0|||
163342038|NCT01517282|589959641|FG002|Overall Study|Physician Decision|0|||
163342039|NCT01517282|589959642|FG003|Overall Study|Physician Decision|0|||
163125989|NCT01732913|589168310|FG001|Overall Study|Physician Decision|7|||
163125990|NCT01732913|589168309|FG000|Overall Study|Other|7|||
163125991|NCT01732913|589168310|FG001|Overall Study|Other|1|||
163125992|NCT01732913|589168309|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
163125993|NCT01732913|589168310|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
163125994|NCT00903331|589168311|FG000|Overall Study|Death|4|||
163125995|NCT00903331|589168312|FG001|Overall Study|Death|8|||
163125996|NCT00903331|589168311|FG000|Overall Study|Withdrawal of consent|1|||
163125997|NCT00903331|589168312|FG001|Overall Study|Withdrawal of consent|8|||
163125998|NCT00903331|589168311|FG000|Overall Study|Lung transplant|0|||
163125999|NCT00903331|589168312|FG001|Overall Study|Lung transplant|2|||
163126000|NCT02723175|589168313|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
163126001|NCT02723175|589168314|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
163126002|NCT02723175|589168313|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
163126003|NCT02723175|589168314|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
163126004|NCT03233438|589168315|FG000|Overall Study|Lost to Follow-up|4|||
163126005|NCT03233438|589168316|FG001|Overall Study|Lost to Follow-up|9|||
163126006|NCT03233438|589168315|FG000|Overall Study|Withdrawal by Subject|2|||
163126007|NCT03233438|589168316|FG001|Overall Study|Withdrawal by Subject|1|||
163126008|NCT03233438|589168315|FG000|Overall Study|No recording of dalbavancin|0|||
163126009|NCT03233438|589168316|FG001|Overall Study|No recording of dalbavancin|1|||
163126010|NCT04109976|589168321|FG000|Overall Study|Withdrawal by Subject|1|||
163126011|NCT04109976|589168322|FG001|Overall Study|Withdrawal by Subject|0|||
163126012|NCT00257660|589168323|FG000|Overall Study|Lack of Efficacy|5|||
163126013|NCT00257660|589168324|FG001|Overall Study|Lack of Efficacy|23|||
163126014|NCT00257660|589168323|FG000|Overall Study|Withdrawal by Subject|2|||
163126015|NCT00257660|589168324|FG001|Overall Study|Withdrawal by Subject|0|||
163126016|NCT00257660|589168323|FG000|Overall Study|Lost to Follow-up|1|||
163126017|NCT00257660|589168324|FG001|Overall Study|Lost to Follow-up|0|||
163126018|NCT00257660|589168323|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
163126019|NCT00257660|589168324|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
163126020|NCT00257660|589168323|FG000|Overall Study|No longer wanted to do blood draws|1|||
163126021|NCT00257660|589168324|FG001|Overall Study|No longer wanted to do blood draws|0|||
163126022|NCT00491608|589168325|FG000|Overall Study|Death|2|||
163126023|NCT00491608|589168325|FG000|Overall Study|Withdrawal by Subject|1|||
163126024|NCT00413374|589168330|FG000|Overall Study|Ineligible due to screening criteria.|3|||
163126025|NCT00413374|589168331|FG001|Overall Study|Ineligible due to screening criteria.|0|||
163126026|NCT00413374|589168330|FG000|Overall Study|Adverse Event|1|||
163126027|NCT00413374|589168331|FG001|Overall Study|Adverse Event|0|||
163126028|NCT00413374|589168330|FG000|Overall Study|Lost to Follow-up|1|||
163126029|NCT00413374|589168331|FG001|Overall Study|Lost to Follow-up|0|||
163126030|NCT00413374|589168330|FG000|Overall Study|Surgery|1|||
163126031|NCT00413374|589168331|FG001|Overall Study|Surgery|0|||
163126032|NCT00552760|589168334|FG000|Overall Study|Adverse Event|3|||
163126033|NCT00552760|589168335|FG001|Overall Study|Adverse Event|5|||
163126034|NCT00552760|589168334|FG000|Overall Study|Relapsed- Depressed Event|10|||
163126035|NCT00552760|589168335|FG001|Overall Study|Relapsed- Depressed Event|16|||
163126036|NCT00552760|589168334|FG000|Overall Study|Relapse- Manic Event|3|||
163126037|NCT00552760|589168335|FG001|Overall Study|Relapse- Manic Event|3|||
163126038|NCT00552760|589168334|FG000|Overall Study|Relapsed- Mixed Event|3|||
163126039|NCT00552760|589168335|FG001|Overall Study|Relapsed- Mixed Event|5|||
163126040|NCT00552760|589168334|FG000|Overall Study|Protocol Violation|0|||
163126041|NCT00552760|589168335|FG001|Overall Study|Protocol Violation|1|||
163126042|NCT00552760|589168334|FG000|Overall Study|Lost to Follow-up|1|||
163126043|NCT00552760|589168335|FG001|Overall Study|Lost to Follow-up|1|||
163126044|NCT00552760|589168334|FG000|Overall Study|Non-compliance|1|||
163126045|NCT00552760|589168335|FG001|Overall Study|Non-compliance|1|||
163126046|NCT00552760|589168334|FG000|Overall Study|Medical Condition|1|||
163126047|NCT00552760|589168335|FG001|Overall Study|Medical Condition|1|||
163126048|NCT00552760|589168334|FG000|Overall Study|Withdrawal by Subject|3|||
163126049|NCT00552760|589168335|FG001|Overall Study|Withdrawal by Subject|0|||
163126050|NCT00552760|589168334|FG000|Overall Study|Medication Change|1|||
163126051|NCT00552760|589168335|FG001|Overall Study|Medication Change|0|||
163126052|NCT00494507|589168337|FG000|Double-Blind Phase|Adverse Event|2|||
163126053|NCT00494507|589168338|FG001|Double-Blind Phase|Adverse Event|0|||
163126054|NCT00494507|589168339|FG002|Double-Blind Phase|Adverse Event|1|||
163126055|NCT00494507|589168340|FG003|Double-Blind Phase|Adverse Event|0|||
163126056|NCT00494507|589168337|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
163126057|NCT00494507|589168338|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
163342040|NCT02942771|589959645|FG000|Overall Study|Adverse Event|1|||
163342041|NCT02942771|589959646|FG001|Overall Study|Adverse Event|0|||
163342042|NCT02942771|589959647|FG002|Overall Study|Adverse Event|0|||
163342043|NCT02942771|589959648|FG003|Overall Study|Adverse Event|0|||
163342044|NCT02942771|589959649|FG004|Overall Study|Adverse Event|2|||
163342045|NCT02942771|589959645|FG000|Overall Study|Lost to Follow-up|1|||
163342046|NCT02942771|589959646|FG001|Overall Study|Lost to Follow-up|0|||
163342047|NCT02942771|589959647|FG002|Overall Study|Lost to Follow-up|0|||
163342048|NCT02942771|589959648|FG003|Overall Study|Lost to Follow-up|0|||
163342049|NCT02942771|589959649|FG004|Overall Study|Lost to Follow-up|0|||
163342050|NCT02942771|589959645|FG000|Overall Study|Withdrawal by Subject|1|||
163342051|NCT02942771|589959646|FG001|Overall Study|Withdrawal by Subject|0|||
163342052|NCT02942771|589959647|FG002|Overall Study|Withdrawal by Subject|0|||
163342053|NCT02942771|589959648|FG003|Overall Study|Withdrawal by Subject|0|||
163342054|NCT02942771|589959649|FG004|Overall Study|Withdrawal by Subject|2|||
163342055|NCT02158806|589959650|FG000|Overall Study|Death|2|||
163342056|NCT02158806|589959651|FG001|Overall Study|Death|0|||
163342057|NCT02158806|589959650|FG000|Overall Study|Withdrawal by Subject|2|||
163342058|NCT02158806|589959651|FG001|Overall Study|Withdrawal by Subject|0|||
163342059|NCT02158806|589959650|FG000|Overall Study|Lost to Follow-up|0|||
163342060|NCT02158806|589959651|FG001|Overall Study|Lost to Follow-up|3|||
163342061|NCT02158806|589959650|FG000|Overall Study|Moved out of area|0|||
163342062|NCT02158806|589959651|FG001|Overall Study|Moved out of area|1|||
163342063|NCT02158806|589959650|FG000|Overall Study|Transferred to palliative care|0|||
163342064|NCT02158806|589959651|FG001|Overall Study|Transferred to palliative care|1|||
163342065|NCT01898299|589959655|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
163342066|NCT01898299|589959656|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
163342067|NCT02340806|589959657|FG000|Overall Study|Protocol Violation|2|||
163342068|NCT02340806|589959658|FG001|Overall Study|Protocol Violation|0|||
163342069|NCT02340806|589959657|FG000|Overall Study|epidural catheter replaced|2|||
163342070|NCT02340806|589959658|FG001|Overall Study|epidural catheter replaced|1|||
163342071|NCT02340806|589959657|FG000|Overall Study|history of chronic pain medication|1|||
163342072|NCT02340806|589959658|FG001|Overall Study|history of chronic pain medication|0|||
163226311|NCT01800916|589544155|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
163226312|NCT01800916|589544156|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
163226313|NCT01800916|589544157|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
163226314|NCT00559962|589544165|FG000|Overall Study|Adverse Event|1|||
163226315|NCT00559962|589544166|FG001|Overall Study|Adverse Event|7|||
163226316|NCT00559962|589544167|FG002|Overall Study|Adverse Event|8|||
163226317|NCT00559962|589544168|FG003|Overall Study|Adverse Event|5|||
163226318|NCT00559962|589544169|FG004|Overall Study|Adverse Event|11|||
163226319|NCT00559962|589544170|FG005|Overall Study|Adverse Event|4|||
163226320|NCT00559962|589544171|FG006|Overall Study|Adverse Event|4|||
163226321|NCT00559962|589544172|FG007|Overall Study|Adverse Event|2|||
163226322|NCT00559962|589544165|FG000|Overall Study|Lost to Follow-up|0|||
163226323|NCT00559962|589544166|FG001|Overall Study|Lost to Follow-up|1|||
163226324|NCT00559962|589544167|FG002|Overall Study|Lost to Follow-up|0|||
163226325|NCT00559962|589544168|FG003|Overall Study|Lost to Follow-up|0|||
163226326|NCT00559962|589544169|FG004|Overall Study|Lost to Follow-up|0|||
163226327|NCT00559962|589544170|FG005|Overall Study|Lost to Follow-up|0|||
163226328|NCT00559962|589544171|FG006|Overall Study|Lost to Follow-up|0|||
163226329|NCT00559962|589544172|FG007|Overall Study|Lost to Follow-up|0|||
163226330|NCT00559962|589544165|FG000|Overall Study|Withdrawal by Subject|1|||
163226331|NCT00559962|589544166|FG001|Overall Study|Withdrawal by Subject|1|||
163226332|NCT00559962|589544167|FG002|Overall Study|Withdrawal by Subject|2|||
163226333|NCT00559962|589544168|FG003|Overall Study|Withdrawal by Subject|0|||
163226334|NCT00559962|589544169|FG004|Overall Study|Withdrawal by Subject|3|||
163226335|NCT00559962|589544170|FG005|Overall Study|Withdrawal by Subject|1|||
163226336|NCT00559962|589544171|FG006|Overall Study|Withdrawal by Subject|0|||
163226337|NCT00559962|589544172|FG007|Overall Study|Withdrawal by Subject|2|||
163226338|NCT00559962|589544165|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
163226339|NCT00559962|589544166|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
163226340|NCT00559962|589544167|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
163226341|NCT00559962|589544168|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
163226342|NCT00559962|589544169|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
163226343|NCT00559962|589544170|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
163226344|NCT00559962|589544171|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
163226345|NCT00559962|589544172|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
163226346|NCT01639040|589544182|FG000|Overall Study|Adverse Event|1|||
163226347|NCT01639040|589544183|FG001|Overall Study|Adverse Event|0|||
163342073|NCT02340806|589959657|FG000|Overall Study|re-dose < 90 min of CSE|1|||
163342074|NCT02340806|589959658|FG001|Overall Study|re-dose < 90 min of CSE|3|||
163342075|NCT04520256|589959659|FG000|Overall Study|Lost to Follow-up|6|||
163342076|NCT04520256|589959660|FG001|Overall Study|Lost to Follow-up|4|||
163342077|NCT04520256|589959661|FG002|Overall Study|Lost to Follow-up|2|||
163342078|NCT04520256|589959662|FG003|Overall Study|Lost to Follow-up|3|||
163342079|NCT04520256|589959663|FG004|Overall Study|Lost to Follow-up|6|||
163342080|NCT04520256|589959664|FG005|Overall Study|Lost to Follow-up|6|||
163342081|NCT04520256|589959665|FG006|Overall Study|Lost to Follow-up|4|||
163226348|NCT04370691|589544184|FG000|Overall Study|Pending visit|48|||
163226349|NCT04370691|589544184|FG000|Overall Study|Have Not Reached Lower Window|15|||
163226350|NCT04370691|589544184|FG000|Overall Study|Termination|14|||
163226351|NCT04370691|589544184|FG000|Overall Study|Missed or Overdue|10|||
163226352|NCT00486265|589544185|FG000|Overall Study|Adverse Event|1|||
163226353|NCT00486265|589544185|FG000|Overall Study|Lack of Efficacy|8|||
163226354|NCT03013543|589544186|FG000|Overall Study|Withdrawal by Subject|0|||
163226355|NCT03013543|589544187|FG001|Overall Study|Withdrawal by Subject|2|||
163226356|NCT03013543|589544188|FG002|Overall Study|Withdrawal by Subject|0|||
163226357|NCT03013543|589544189|FG003|Overall Study|Withdrawal by Subject|5|||
163226358|NCT03013543|589544190|FG004|Overall Study|Withdrawal by Subject|6|||
163226359|NCT03013543|589544191|FG005|Overall Study|Withdrawal by Subject|2|||
163226360|NCT03013543|589544192|FG006|Overall Study|Withdrawal by Subject|3|||
163226361|NCT03013543|589544193|FG007|Overall Study|Withdrawal by Subject|1|||
163226362|NCT03013543|589544194|FG008|Overall Study|Withdrawal by Subject|0|||
163226363|NCT03013543|589544195|FG009|Overall Study|Withdrawal by Subject|4|||
163226364|NCT03013543|589544186|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
163226365|NCT03013543|589544187|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
163226366|NCT03013543|589544188|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
163226367|NCT03013543|589544189|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
163226368|NCT03013543|589544190|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
163226369|NCT03013543|589544191|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
163226370|NCT03013543|589544192|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
163226371|NCT03013543|589544193|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
163226372|NCT03013543|589544194|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
163226373|NCT03013543|589544195|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
163226374|NCT03013543|589544186|FG000|Overall Study|Other|0|||
163226375|NCT03013543|589544187|FG001|Overall Study|Other|0|||
163226376|NCT03013543|589544188|FG002|Overall Study|Other|2|||
163226377|NCT03013543|589544189|FG003|Overall Study|Other|0|||
163226378|NCT03013543|589544190|FG004|Overall Study|Other|2|||
163226379|NCT03013543|589544191|FG005|Overall Study|Other|0|||
163226380|NCT03013543|589544192|FG006|Overall Study|Other|0|||
163226381|NCT03013543|589544193|FG007|Overall Study|Other|0|||
163226382|NCT03013543|589544194|FG008|Overall Study|Other|1|||
163226383|NCT03013543|589544195|FG009|Overall Study|Other|0|||
163226384|NCT03013543|589544186|FG000|Overall Study|Adverse Event|0|||
163226385|NCT03013543|589544187|FG001|Overall Study|Adverse Event|0|||
163226386|NCT03013543|589544188|FG002|Overall Study|Adverse Event|0|||
163226387|NCT03013543|589544189|FG003|Overall Study|Adverse Event|3|||
163226388|NCT03013543|589544190|FG004|Overall Study|Adverse Event|2|||
163226389|NCT03013543|589544191|FG005|Overall Study|Adverse Event|1|||
163226390|NCT03013543|589544192|FG006|Overall Study|Adverse Event|3|||
163226391|NCT03013543|589544193|FG007|Overall Study|Adverse Event|8|||
163226392|NCT03013543|589544194|FG008|Overall Study|Adverse Event|0|||
163226393|NCT03013543|589544195|FG009|Overall Study|Adverse Event|2|||
163226394|NCT03013543|589544186|FG000|Overall Study|Death|0|||
163226395|NCT03013543|589544187|FG001|Overall Study|Death|0|||
163226396|NCT03013543|589544188|FG002|Overall Study|Death|0|||
163226397|NCT03013543|589544189|FG003|Overall Study|Death|1|||
163226398|NCT03013543|589544190|FG004|Overall Study|Death|0|||
163226399|NCT03013543|589544191|FG005|Overall Study|Death|0|||
163226400|NCT03013543|589544192|FG006|Overall Study|Death|0|||
163226401|NCT03013543|589544193|FG007|Overall Study|Death|0|||
163226402|NCT03013543|589544194|FG008|Overall Study|Death|0|||
163226403|NCT03013543|589544195|FG009|Overall Study|Death|0|||
163226404|NCT03013543|589544186|FG000|Overall Study|Lack of Efficacy|0|||
163226405|NCT03013543|589544187|FG001|Overall Study|Lack of Efficacy|0|||
163226406|NCT03013543|589544188|FG002|Overall Study|Lack of Efficacy|0|||
163226407|NCT03013543|589544189|FG003|Overall Study|Lack of Efficacy|1|||
163226408|NCT03013543|589544190|FG004|Overall Study|Lack of Efficacy|0|||
163226409|NCT03013543|589544191|FG005|Overall Study|Lack of Efficacy|0|||
163226410|NCT03013543|589544192|FG006|Overall Study|Lack of Efficacy|0|||
163226411|NCT03013543|589544193|FG007|Overall Study|Lack of Efficacy|0|||
163226412|NCT03013543|589544194|FG008|Overall Study|Lack of Efficacy|0|||
163342082|NCT04520256|589959666|FG007|Overall Study|Lost to Follow-up|6|||
163226413|NCT03013543|589544195|FG009|Overall Study|Lack of Efficacy|0|||
163226414|NCT03013543|589544186|FG000|Overall Study|Lost to Follow-up|0|||
163226415|NCT03013543|589544187|FG001|Overall Study|Lost to Follow-up|0|||
163226416|NCT03013543|589544188|FG002|Overall Study|Lost to Follow-up|0|||
163226417|NCT03013543|589544189|FG003|Overall Study|Lost to Follow-up|1|||
163342083|NCT04520256|589959667|FG008|Overall Study|Lost to Follow-up|1|||
163226418|NCT03013543|589544190|FG004|Overall Study|Lost to Follow-up|0|||
163226419|NCT03013543|589544191|FG005|Overall Study|Lost to Follow-up|0|||
163226420|NCT03013543|589544192|FG006|Overall Study|Lost to Follow-up|1|||
163226421|NCT03013543|589544193|FG007|Overall Study|Lost to Follow-up|0|||
163226422|NCT03013543|589544194|FG008|Overall Study|Lost to Follow-up|0|||
163226423|NCT03013543|589544195|FG009|Overall Study|Lost to Follow-up|2|||
163226424|NCT03013543|589544186|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163342084|NCT04520256|589959668|FG009|Overall Study|Lost to Follow-up|3|||
163342085|NCT04520256|589959669|FG010|Overall Study|Lost to Follow-up|3|||
163126058|NCT00494507|589168339|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
163126059|NCT00494507|589168340|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
163126060|NCT00494507|589168337|FG000|Double-Blind Phase|Subject Non-compliance|0|||
163126061|NCT00494507|589168338|FG001|Double-Blind Phase|Subject Non-compliance|0|||
163126062|NCT00494507|589168339|FG002|Double-Blind Phase|Subject Non-compliance|1|||
163126063|NCT00494507|589168340|FG003|Double-Blind Phase|Subject Non-compliance|0|||
163126064|NCT00494507|589168337|FG000|Double-Blind Phase|Negative DNA test|0|||
163126065|NCT00494507|589168338|FG001|Double-Blind Phase|Negative DNA test|0|||
163126066|NCT00494507|589168339|FG002|Double-Blind Phase|Negative DNA test|0|||
163126067|NCT00494507|589168340|FG003|Double-Blind Phase|Negative DNA test|1|||
163126068|NCT00494507|589168337|FG000|Open-Label Phase|Adverse Event|0|||
163126069|NCT00494507|589168338|FG001|Open-Label Phase|Adverse Event|1|||
163126070|NCT00494507|589168339|FG002|Open-Label Phase|Adverse Event|5|||
163126071|NCT00494507|589168340|FG003|Open-Label Phase|Adverse Event|3|||
163126072|NCT00494507|589168337|FG000|Open-Label Phase|Worsening Disease|0|||
163126073|NCT00494507|589168338|FG001|Open-Label Phase|Worsening Disease|0|||
163126074|NCT00494507|589168339|FG002|Open-Label Phase|Worsening Disease|0|||
163126075|NCT00494507|589168340|FG003|Open-Label Phase|Worsening Disease|2|||
163126076|NCT03615066|589168341|FG000|Main Study|Withdrew Consent|0|||
163126077|NCT03615066|589168342|FG001|Main Study|Withdrew Consent|1|||
163126078|NCT03615066|589168343|FG002|Main Study|Withdrew Consent|1|||
163126079|NCT03615066|589168341|FG000|Main Study|Lost to Follow-up|0|||
163126080|NCT03615066|589168342|FG001|Main Study|Lost to Follow-up|0|||
163126081|NCT03615066|589168343|FG002|Main Study|Lost to Follow-up|1|||
163126082|NCT03615066|589168341|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
163126083|NCT03615066|589168342|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
163126084|NCT03615066|589168343|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
163126085|NCT03615066|589168341|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
163126086|NCT03615066|589168342|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
163126087|NCT03615066|589168343|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
163126088|NCT03615066|589168341|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
163226425|NCT03013543|589544187|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163226426|NCT03013543|589544188|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163226427|NCT03013543|589544189|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163226428|NCT03013543|589544190|FG004|Overall Study|Non-Compliance With Study Drug|0|||
163226429|NCT03013543|589544191|FG005|Overall Study|Non-Compliance With Study Drug|0|||
163226430|NCT03013543|589544192|FG006|Overall Study|Non-Compliance With Study Drug|0|||
163226431|NCT03013543|589544193|FG007|Overall Study|Non-Compliance With Study Drug|0|||
163226432|NCT03013543|589544194|FG008|Overall Study|Non-Compliance With Study Drug|1|||
163226433|NCT03013543|589544195|FG009|Overall Study|Non-Compliance With Study Drug|0|||
163226434|NCT03013543|589544186|FG000|Overall Study|Physician Decision|0|||
163226435|NCT03013543|589544187|FG001|Overall Study|Physician Decision|0|||
163226436|NCT03013543|589544188|FG002|Overall Study|Physician Decision|0|||
163226437|NCT03013543|589544189|FG003|Overall Study|Physician Decision|0|||
163226438|NCT03013543|589544190|FG004|Overall Study|Physician Decision|1|||
163226439|NCT03013543|589544191|FG005|Overall Study|Physician Decision|0|||
163226440|NCT03013543|589544192|FG006|Overall Study|Physician Decision|0|||
163226441|NCT03013543|589544193|FG007|Overall Study|Physician Decision|0|||
163226442|NCT03013543|589544194|FG008|Overall Study|Physician Decision|0|||
163226443|NCT03013543|589544195|FG009|Overall Study|Physician Decision|0|||
163226444|NCT03013543|589544186|FG000|Overall Study|Protocol Violation|0|||
163226445|NCT03013543|589544187|FG001|Overall Study|Protocol Violation|0|||
163226446|NCT03013543|589544188|FG002|Overall Study|Protocol Violation|0|||
163226447|NCT03013543|589544189|FG003|Overall Study|Protocol Violation|0|||
163226448|NCT03013543|589544190|FG004|Overall Study|Protocol Violation|0|||
163226449|NCT03013543|589544191|FG005|Overall Study|Protocol Violation|0|||
163226450|NCT03013543|589544192|FG006|Overall Study|Protocol Violation|0|||
163226451|NCT03013543|589544193|FG007|Overall Study|Protocol Violation|0|||
163226452|NCT03013543|589544194|FG008|Overall Study|Protocol Violation|0|||
163226453|NCT03013543|589544195|FG009|Overall Study|Protocol Violation|1|||
163226454|NCT02552316|589544197|FG000|Overall Study|Withdrawal by Subject|1|||
163226455|NCT02552316|589544197|FG000|Overall Study|Withdrawal due to non-compliance|1|||
163226456|NCT04382911|589544198|FG000|Overall Study|unable to be imaged prior to surgery|2|||
163226457|NCT04116710|589544202|FG000|Overall Study|Death|4|||
163226458|NCT04116710|589544203|FG001|Overall Study|Death|6|||
163226459|NCT04116710|589544204|FG002|Overall Study|Death|3|||
163226460|NCT04116710|589544205|FG003|Overall Study|Death|1|||
163226461|NCT04116710|589544202|FG000|Overall Study|Withdrawal by Subject|0|||
163226462|NCT04116710|589544203|FG001|Overall Study|Withdrawal by Subject|0|||
163226463|NCT04116710|589544204|FG002|Overall Study|Withdrawal by Subject|0|||
163342086|NCT04520256|589959670|FG011|Overall Study|Lost to Follow-up|2|||
163226464|NCT04116710|589544205|FG003|Overall Study|Withdrawal by Subject|1|||
163226465|NCT01256593|589544206|FG000|Overall Study|Protocol Violation|26|||
163226466|NCT01256593|589544206|FG000|Overall Study|No Drug Administration Information|2|||
163342087|NCT04520256|589959671|FG012|Overall Study|Lost to Follow-up|5|||
163226467|NCT01256593|589544206|FG000|Overall Study|No Visit After Treatment|186|||
163226468|NCT01110915|589544211|FG000|Overall Study|Death|2|||
163226469|NCT01110915|589544212|FG001|Overall Study|Death|1|||
163226470|NCT01110915|589544211|FG000|Overall Study|Lost to Follow-up|1|||
163226471|NCT01110915|589544212|FG001|Overall Study|Lost to Follow-up|0|||
163226472|NCT01110915|589544211|FG000|Overall Study|Withdrawal by Subject|7|||
163226473|NCT01110915|589544212|FG001|Overall Study|Withdrawal by Subject|1|||
163226474|NCT02161718|589544215|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
163226475|NCT02161718|589544216|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
163226476|NCT02161718|589544217|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
163226477|NCT02161718|589544215|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
163226478|NCT02161718|589544216|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
163226479|NCT02161718|589544217|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
163226480|NCT02161718|589544215|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
163226481|NCT02161718|589544216|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
163226482|NCT02161718|589544217|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
163226483|NCT02161718|589544215|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
163226484|NCT02161718|589544216|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
163226485|NCT02161718|589544217|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
163226486|NCT02161718|589544215|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
163226487|NCT02161718|589544216|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
163226488|NCT02161718|589544217|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
163226489|NCT02161718|589544215|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
163226490|NCT02161718|589544216|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
163226491|NCT02161718|589544217|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
163226492|NCT02161718|589544215|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
163226493|NCT02161718|589544216|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
163226494|NCT02161718|589544217|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
163226495|NCT02161718|589544215|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
163226496|NCT02161718|589544216|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
163226497|NCT02161718|589544217|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
163226498|NCT02161718|589544215|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
163226499|NCT02161718|589544216|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
163226500|NCT02161718|589544217|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
163226501|NCT02161718|589544215|FG000|Post- Randomization Period|Lost to Follow-up|0|||
163226502|NCT02161718|589544216|FG001|Post- Randomization Period|Lost to Follow-up|9|||
163226503|NCT02161718|589544217|FG002|Post- Randomization Period|Lost to Follow-up|15|||
163226504|NCT02161718|589544215|FG000|Post- Randomization Period|Adverse Event|0|||
163226505|NCT02161718|589544216|FG001|Post- Randomization Period|Adverse Event|9|||
163226506|NCT02161718|589544217|FG002|Post- Randomization Period|Adverse Event|10|||
163226507|NCT02161718|589544215|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
163226508|NCT02161718|589544216|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
163226509|NCT02161718|589544217|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
163226510|NCT02161718|589544215|FG000|Post- Randomization Period|Physician Decision|0|||
163226511|NCT02161718|589544216|FG001|Post- Randomization Period|Physician Decision|2|||
163226512|NCT02161718|589544217|FG002|Post- Randomization Period|Physician Decision|4|||
163226513|NCT02161718|589544215|FG000|Post- Randomization Period|Protocol Violation|0|||
163226514|NCT02161718|589544216|FG001|Post- Randomization Period|Protocol Violation|2|||
163226515|NCT02161718|589544217|FG002|Post- Randomization Period|Protocol Violation|3|||
163226516|NCT02161718|589544215|FG000|Post- Randomization Period|Lack of Efficacy|0|||
163226517|NCT02161718|589544216|FG001|Post- Randomization Period|Lack of Efficacy|0|||
163226518|NCT02161718|589544217|FG002|Post- Randomization Period|Lack of Efficacy|1|||
163226519|NCT02161718|589544215|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
163226520|NCT02161718|589544216|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
163342088|NCT04520256|589959672|FG013|Overall Study|Lost to Follow-up|3|||
163342089|NCT04520256|589959673|FG014|Overall Study|Lost to Follow-up|3|||
163342090|NCT04520256|589959674|FG015|Overall Study|Lost to Follow-up|6|||
163342091|NCT04520256|589959675|FG016|Overall Study|Lost to Follow-up|6|||
163342092|NCT04520256|589959676|FG017|Overall Study|Lost to Follow-up|4|||
163226521|NCT02161718|589544217|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
163226522|NCT02161718|589544215|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
163226523|NCT02161718|589544216|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
163226524|NCT02161718|589544217|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
163226525|NCT02161718|589544215|FG000|Post- Randomization Period|Relocation|0|||
163226526|NCT02161718|589544216|FG001|Post- Randomization Period|Relocation|3|||
163226527|NCT02161718|589544217|FG002|Post- Randomization Period|Relocation|0|||
163226528|NCT02948842|589544220|FG000|Overall Study|Withdrawal by Subject|4|||
163226529|NCT01537783|589544221|FG000|Overall Study|Lost to Follow-up|11|||
163226530|NCT01537783|589544222|FG001|Overall Study|Lost to Follow-up|2|||
163342093|NCT04520256|589959677|FG018|Overall Study|Lost to Follow-up|3|||
163342094|NCT04520256|589959678|FG019|Overall Study|Lost to Follow-up|3|||
163226531|NCT02350309|589544224|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
163226532|NCT02350309|589544225|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
163226533|NCT02350309|589544226|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
163226534|NCT02350309|589544227|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
163226535|NCT02350309|589544228|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
163226536|NCT02350309|589544229|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
163226537|NCT02350309|589544224|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
163226538|NCT02350309|589544225|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
163226539|NCT02350309|589544226|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
163226540|NCT02350309|589544227|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
163226541|NCT02350309|589544228|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
163226542|NCT02350309|589544229|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
163226543|NCT00207142|589544230|FG000|Induction Phase|Adverse Event|9|||
163226544|NCT00207142|589544231|FG001|Induction Phase|Adverse Event|0|||
163226545|NCT00207142|589544232|FG002|Induction Phase|Adverse Event|0|||
163226546|NCT00207142|589544233|FG003|Induction Phase|Adverse Event|0|||
163226547|NCT00207142|589544230|FG000|Induction Phase|Death|1|||
163226548|NCT00207142|589544231|FG001|Induction Phase|Death|0|||
163226549|NCT00207142|589544232|FG002|Induction Phase|Death|0|||
163226550|NCT00207142|589544233|FG003|Induction Phase|Death|0|||
163226551|NCT00207142|589544230|FG000|Induction Phase|Lack of Efficacy|1|||
163226552|NCT00207142|589544231|FG001|Induction Phase|Lack of Efficacy|0|||
163226553|NCT00207142|589544232|FG002|Induction Phase|Lack of Efficacy|0|||
163226554|NCT00207142|589544233|FG003|Induction Phase|Lack of Efficacy|0|||
163226555|NCT00207142|589544230|FG000|Induction Phase|Lost to Follow-up|5|||
163226556|NCT00207142|589544231|FG001|Induction Phase|Lost to Follow-up|0|||
163226557|NCT00207142|589544232|FG002|Induction Phase|Lost to Follow-up|0|||
163226558|NCT00207142|589544233|FG003|Induction Phase|Lost to Follow-up|0|||
163226559|NCT00207142|589544230|FG000|Induction Phase|Physician Decision|2|||
163226560|NCT00207142|589544231|FG001|Induction Phase|Physician Decision|0|||
163226561|NCT00207142|589544232|FG002|Induction Phase|Physician Decision|0|||
163226562|NCT00207142|589544233|FG003|Induction Phase|Physician Decision|0|||
163226563|NCT00207142|589544230|FG000|Induction Phase|Poor/noncompliance|2|||
163226564|NCT00207142|589544231|FG001|Induction Phase|Poor/noncompliance|0|||
163226565|NCT00207142|589544232|FG002|Induction Phase|Poor/noncompliance|0|||
163226566|NCT00207142|589544233|FG003|Induction Phase|Poor/noncompliance|0|||
163226567|NCT00207142|589544230|FG000|Induction Phase|Pregnancy|1|||
163226568|NCT00207142|589544231|FG001|Induction Phase|Pregnancy|0|||
163226569|NCT00207142|589544232|FG002|Induction Phase|Pregnancy|0|||
163226570|NCT00207142|589544233|FG003|Induction Phase|Pregnancy|0|||
163226571|NCT00207142|589544230|FG000|Induction Phase|Subject no longer meets study criteria|3|||
163226572|NCT00207142|589544231|FG001|Induction Phase|Subject no longer meets study criteria|0|||
163226573|NCT00207142|589544232|FG002|Induction Phase|Subject no longer meets study criteria|0|||
163226574|NCT00207142|589544233|FG003|Induction Phase|Subject no longer meets study criteria|0|||
163126089|NCT03615066|589168342|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
163126090|NCT03615066|589168343|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
163126091|NCT00924404|589168346|FG000|Overall Study|Lost to Follow-up|6|||
163126092|NCT00924404|589168347|FG001|Overall Study|Lost to Follow-up|4|||
163126093|NCT03831945|589168350|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
163126094|NCT03831945|589168351|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
163226575|NCT00207142|589544230|FG000|Induction Phase|Withdrawal by Subject|4|||
163226576|NCT00207142|589544231|FG001|Induction Phase|Withdrawal by Subject|0|||
163226577|NCT00207142|589544232|FG002|Induction Phase|Withdrawal by Subject|0|||
163226578|NCT00207142|589544233|FG003|Induction Phase|Withdrawal by Subject|0|||
163226579|NCT00207142|589544230|FG000|Induction Phase|Incarceration|1|||
163226580|NCT00207142|589544231|FG001|Induction Phase|Incarceration|0|||
163126095|NCT03831945|589168350|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
163126096|NCT03831945|589168351|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
163126097|NCT03831945|589168350|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
163126098|NCT03831945|589168351|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
163126099|NCT03426631|589168352|FG000|Overall Study|Lost to Follow-up|0|||
163126100|NCT03426631|589168353|FG001|Overall Study|Lost to Follow-up|1|||
163126101|NCT00454181|589168354|FG000|Overall Study|Adverse Event|1|||
163126102|NCT00454181|589168355|FG001|Overall Study|Adverse Event|1|||
163126103|NCT00454181|589168354|FG000|Overall Study|Lost to Follow-up|11|||
163126104|NCT00454181|589168355|FG001|Overall Study|Lost to Follow-up|1|||
163226581|NCT00207142|589544232|FG002|Induction Phase|Incarceration|0|||
163226582|NCT00207142|589544233|FG003|Induction Phase|Incarceration|0|||
163226583|NCT00207142|589544230|FG000|Induction Phase|Missing lab data|1|||
163226584|NCT00207142|589544231|FG001|Induction Phase|Missing lab data|0|||
163226585|NCT00207142|589544232|FG002|Induction Phase|Missing lab data|0|||
163226586|NCT00207142|589544233|FG003|Induction Phase|Missing lab data|0|||
163226587|NCT00207142|589544230|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
163342095|NCT04520256|589959679|FG020|Overall Study|Lost to Follow-up|7|||
163342096|NCT04520256|589959680|FG021|Overall Study|Lost to Follow-up|3|||
163342097|NCT04520256|589959681|FG022|Overall Study|Lost to Follow-up|3|||
163342098|NCT04520256|589959682|FG023|Overall Study|Lost to Follow-up|8|||
163342099|NCT04520256|589959683|FG024|Overall Study|Lost to Follow-up|5|||
163342100|NCT04520256|589959684|FG025|Overall Study|Lost to Follow-up|4|||
163126105|NCT00454181|589168354|FG000|Overall Study|Protocol Violation|1|||
163126106|NCT00454181|589168355|FG001|Overall Study|Protocol Violation|1|||
163126107|NCT00454181|589168354|FG000|Overall Study|Withdrawal by Subject|2|||
163126108|NCT00454181|589168355|FG001|Overall Study|Withdrawal by Subject|0|||
163126109|NCT04032080|589168356|FG000|Overall Study|Death|6|||
163126110|NCT02096263|589168357|FG000|Overall Study|Adverse Event|1|||
163126111|NCT02096263|589168358|FG001|Overall Study|Adverse Event|0|||
163126112|NCT02096263|589168359|FG002|Overall Study|Adverse Event|1|||
163126113|NCT02096263|589168357|FG000|Overall Study|Lost to Follow-up|14|||
163126114|NCT02096263|589168358|FG001|Overall Study|Lost to Follow-up|18|||
163126115|NCT02096263|589168359|FG002|Overall Study|Lost to Follow-up|15|||
163126116|NCT02096263|589168357|FG000|Overall Study|Other|7|||
163126117|NCT02096263|589168358|FG001|Overall Study|Other|9|||
163126118|NCT02096263|589168359|FG002|Overall Study|Other|6|||
163126119|NCT02096263|589168357|FG000|Overall Study|Sponsor study termination|0|||
163126120|NCT02096263|589168358|FG001|Overall Study|Sponsor study termination|0|||
163126121|NCT02096263|589168359|FG002|Overall Study|Sponsor study termination|1|||
163126122|NCT02096263|589168357|FG000|Overall Study|Protocol Violation|7|||
163126123|NCT02096263|589168358|FG001|Overall Study|Protocol Violation|2|||
163126124|NCT02096263|589168359|FG002|Overall Study|Protocol Violation|8|||
163126125|NCT02096263|589168357|FG000|Overall Study|Withdrawal by Subject|5|||
163126126|NCT02096263|589168358|FG001|Overall Study|Withdrawal by Subject|7|||
163126127|NCT02096263|589168359|FG002|Overall Study|Withdrawal by Subject|8|||
163126128|NCT01571453|589168360|FG000|Overall Study|Adverse Event|14|||
163126129|NCT01571453|589168361|FG001|Overall Study|Adverse Event|32|||
163126130|NCT01571453|589168360|FG000|Overall Study|Lack of Efficacy|8|||
163126131|NCT01571453|589168361|FG001|Overall Study|Lack of Efficacy|3|||
163126132|NCT01571453|589168360|FG000|Overall Study|Non-compliance|2|||
163126133|NCT01571453|589168361|FG001|Overall Study|Non-compliance|4|||
163126134|NCT01571453|589168360|FG000|Overall Study|Protocol Violation|1|||
163126135|NCT01571453|589168361|FG001|Overall Study|Protocol Violation|5|||
163126136|NCT01571453|589168360|FG000|Overall Study|Withdrawal of consent|5|||
163126137|NCT01571453|589168361|FG001|Overall Study|Withdrawal of consent|13|||
163126138|NCT01571453|589168360|FG000|Overall Study|Lost to Follow-up|4|||
163126139|NCT01571453|589168361|FG001|Overall Study|Lost to Follow-up|2|||
163126140|NCT01571453|589168360|FG000|Overall Study|Administrative or other reason(s)|4|||
163126141|NCT01571453|589168361|FG001|Overall Study|Administrative or other reason(s)|3|||
163126142|NCT00521222|589168366|FG000|Overall Study|Lost to Follow-up|0|||
163126143|NCT00521222|589168367|FG001|Overall Study|Lost to Follow-up|0|||
163126144|NCT00521222|589168368|FG002|Overall Study|Lost to Follow-up|1|||
163126145|NCT00521222|589168369|FG003|Overall Study|Lost to Follow-up|1|||
163126146|NCT00521222|589168366|FG000|Overall Study|Withdrawal by Subject|0|||
163126147|NCT00521222|589168367|FG001|Overall Study|Withdrawal by Subject|0|||
163126148|NCT00521222|589168368|FG002|Overall Study|Withdrawal by Subject|2|||
163126149|NCT00521222|589168369|FG003|Overall Study|Withdrawal by Subject|0|||
163126150|NCT00521222|589168366|FG000|Overall Study|Physician Decision|0|||
163126151|NCT00521222|589168367|FG001|Overall Study|Physician Decision|1|||
163126152|NCT00521222|589168368|FG002|Overall Study|Physician Decision|0|||
163126153|NCT00521222|589168369|FG003|Overall Study|Physician Decision|1|||
163126154|NCT03109184|589169811|FG000|Overall Study|Lost to Follow-up|6|||
163126155|NCT03109184|589169812|FG001|Overall Study|Lost to Follow-up|6|||
163126156|NCT03109184|589169811|FG000|Overall Study|Withdrawal by Subject|1|||
163126157|NCT03109184|589169812|FG001|Overall Study|Withdrawal by Subject|1|||
163126158|NCT00602420|589169813|FG000|Overall Study|Death|1|||
163126159|NCT00602420|589169814|FG001|Overall Study|Death|4|||
163126160|NCT00602420|589169813|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
163126161|NCT00602420|589169814|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
163126162|NCT00602420|589169813|FG000|Overall Study|Withdrawal by Subject|18|||
163126163|NCT00602420|589169814|FG001|Overall Study|Withdrawal by Subject|17|||
163126164|NCT00602420|589169813|FG000|Overall Study|Adverse Event|1|||
163126165|NCT00602420|589169814|FG001|Overall Study|Adverse Event|0|||
163126166|NCT00649428|589169825|FG000|Overall Study|Adverse Event|2|||
163126167|NCT00649428|589169826|FG001|Overall Study|Adverse Event|2|||
163126168|NCT00649428|589169825|FG000|Overall Study|Withdrawal by Subject|6|||
163126169|NCT00649428|589169826|FG001|Overall Study|Withdrawal by Subject|6|||
163126170|NCT00649428|589169825|FG000|Overall Study|Lost to Follow-up|1|||
163126171|NCT00649428|589169826|FG001|Overall Study|Lost to Follow-up|3|||
163126172|NCT00649428|589169825|FG000|Overall Study|Insufficient manufacturing yield|5|||
163126173|NCT00649428|589169826|FG001|Overall Study|Insufficient manufacturing yield|1|||
163126174|NCT00649428|589169825|FG000|Overall Study|Protocol Violation|6|||
163126175|NCT00649428|589169826|FG001|Overall Study|Protocol Violation|2|||
163408199|NCT01400451|590204070|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
163126176|NCT00649428|589169825|FG000|Overall Study|Physician Decision|0|||
163126177|NCT00649428|589169826|FG001|Overall Study|Physician Decision|1|||
163126178|NCT02503501|589169828|FG000|Overall Study|Physician Decision|1|||
163126179|NCT02503501|589169829|FG001|Overall Study|Physician Decision|0|||
163126180|NCT02503501|589169828|FG000|Overall Study|Protocol Violation|0|||
163126181|NCT02503501|589169829|FG001|Overall Study|Protocol Violation|1|||
163126182|NCT02503501|589169828|FG000|Overall Study|Withdrawal by Subject|0|||
163126183|NCT02503501|589169829|FG001|Overall Study|Withdrawal by Subject|2|||
163126184|NCT01740401|589169830|FG000|Overall Study|Progression of disease|6|||
163126185|NCT01740401|589169830|FG000|Overall Study|Adverse Event|2|||
163126186|NCT01740401|589169830|FG000|Overall Study|Did not reach primary endpoint|2|||
163126187|NCT02315560|589169831|FG000|Overall Study|noncompliance by subjects|3|||
163126188|NCT02008227|589169832|FG000|Overall Study|Lost to Follow-up|7|||
163126189|NCT02008227|589169833|FG001|Overall Study|Lost to Follow-up|9|||
163126190|NCT02008227|589169832|FG000|Overall Study|Death|494|||
163126191|NCT02008227|589169833|FG001|Overall Study|Death|485|||
163126192|NCT02008227|589169832|FG000|Overall Study|Withdrawal by Subject|67|||
163126193|NCT02008227|589169833|FG001|Overall Study|Withdrawal by Subject|36|||
163126194|NCT02008227|589169832|FG000|Overall Study|Study Terminated By Sponsor|44|||
163126195|NCT02008227|589169833|FG001|Overall Study|Study Terminated By Sponsor|83|||
163126196|NCT04599465|589169834|FG000|Overall Study|Physician Decision|1|||
163126197|NCT04599465|589169834|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
163126198|NCT04566601|589169835|FG000|Overall Study|Other than listed|13|||
163126199|NCT04566601|589169836|FG001|Overall Study|Other than listed|4|||
163126200|NCT04566601|589169837|FG002|Overall Study|Other than listed|2|||
163126201|NCT04566601|589169838|FG003|Overall Study|Other than listed|1|||
163126202|NCT04566601|589169839|FG004|Overall Study|Other than listed|4|||
163126203|NCT04566601|589169835|FG000|Overall Study|Protocol deviation|3|||
163126204|NCT04566601|589169836|FG001|Overall Study|Protocol deviation|0|||
163126205|NCT04566601|589169837|FG002|Overall Study|Protocol deviation|1|||
163126206|NCT04566601|589169838|FG003|Overall Study|Protocol deviation|1|||
163126207|NCT04566601|589169839|FG004|Overall Study|Protocol deviation|1|||
163126208|NCT04566601|589169835|FG000|Overall Study|Technical problems|0|||
163126209|NCT04566601|589169836|FG001|Overall Study|Technical problems|0|||
163126210|NCT04566601|589169837|FG002|Overall Study|Technical problems|1|||
163126211|NCT04566601|589169838|FG003|Overall Study|Technical problems|0|||
163126212|NCT04566601|589169839|FG004|Overall Study|Technical problems|0|||
163126213|NCT04566601|589169835|FG000|Overall Study|No reason available|3|||
163126214|NCT04566601|589169836|FG001|Overall Study|No reason available|2|||
163126215|NCT04566601|589169837|FG002|Overall Study|No reason available|7|||
163126216|NCT04566601|589169838|FG003|Overall Study|No reason available|1|||
163126217|NCT04566601|589169839|FG004|Overall Study|No reason available|5|||
163126218|NCT04566601|589169835|FG000|Overall Study|Burden of study procedures|3|||
163126219|NCT04566601|589169836|FG001|Overall Study|Burden of study procedures|0|||
163126220|NCT04566601|589169837|FG002|Overall Study|Burden of study procedures|0|||
163126221|NCT04566601|589169838|FG003|Overall Study|Burden of study procedures|3|||
163126222|NCT04566601|589169839|FG004|Overall Study|Burden of study procedures|1|||
163126223|NCT04566601|589169835|FG000|Overall Study|Change of residence|2|||
163126224|NCT04566601|589169836|FG001|Overall Study|Change of residence|2|||
163126225|NCT04566601|589169837|FG002|Overall Study|Change of residence|0|||
163126226|NCT04566601|589169838|FG003|Overall Study|Change of residence|1|||
163126227|NCT04566601|589169839|FG004|Overall Study|Change of residence|2|||
163126228|NCT04566601|589169835|FG000|Overall Study|Perceived lack of efficacy|2|||
163126229|NCT04566601|589169836|FG001|Overall Study|Perceived lack of efficacy|0|||
163126230|NCT04566601|589169837|FG002|Overall Study|Perceived lack of efficacy|1|||
163126231|NCT04566601|589169838|FG003|Overall Study|Perceived lack of efficacy|1|||
163126232|NCT04566601|589169839|FG004|Overall Study|Perceived lack of efficacy|2|||
163126233|NCT04566601|589169835|FG000|Overall Study|Adverse Event|7|||
163126234|NCT04566601|589169836|FG001|Overall Study|Adverse Event|4|||
163126235|NCT04566601|589169837|FG002|Overall Study|Adverse Event|6|||
163126236|NCT04566601|589169838|FG003|Overall Study|Adverse Event|5|||
163126237|NCT04566601|589169839|FG004|Overall Study|Adverse Event|12|||
163126238|NCT00306527|589169844|FG000|Overall Study|Lost to Follow-up|3|||
163126239|NCT00306527|589169845|FG001|Overall Study|Lost to Follow-up|4|||
163126240|NCT00306527|589169846|FG002|Overall Study|Lost to Follow-up|3|||
163126241|NCT00306527|589169847|FG003|Overall Study|Lost to Follow-up|0|||
163126242|NCT00306527|589169844|FG000|Overall Study|Withdrawal by Subject|2|||
163126243|NCT00306527|589169845|FG001|Overall Study|Withdrawal by Subject|3|||
163126244|NCT00306527|589169846|FG002|Overall Study|Withdrawal by Subject|0|||
163126245|NCT00306527|589169847|FG003|Overall Study|Withdrawal by Subject|3|||
163126246|NCT00306527|589169844|FG000|Overall Study|Adverse Event|0|||
163126247|NCT00306527|589169845|FG001|Overall Study|Adverse Event|0|||
163126248|NCT00306527|589169846|FG002|Overall Study|Adverse Event|1|||
163126249|NCT00306527|589169847|FG003|Overall Study|Adverse Event|1|||
163126250|NCT00306527|589169844|FG000|Overall Study|Death|1|||
163126251|NCT00306527|589169845|FG001|Overall Study|Death|0|||
163126252|NCT00306527|589169846|FG002|Overall Study|Death|1|||
163126253|NCT00306527|589169847|FG003|Overall Study|Death|2|||
163226588|NCT00207142|589544231|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
163226589|NCT00207142|589544232|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
163226590|NCT00207142|589544233|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
163226591|NCT00207142|589544230|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
163226592|NCT00207142|589544231|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
163226593|NCT00207142|589544232|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
163226594|NCT00207142|589544233|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
163226595|NCT00207142|589544230|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
163226596|NCT00207142|589544231|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
163226597|NCT00207142|589544232|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
163226598|NCT00207142|589544233|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
163226599|NCT00207142|589544230|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
163226600|NCT00207142|589544231|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
163226601|NCT00207142|589544232|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
163226602|NCT00207142|589544233|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
163226603|NCT00207142|589544230|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
163226604|NCT00207142|589544231|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
163226605|NCT00207142|589544232|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
163226606|NCT00207142|589544233|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
163226607|NCT00207142|589544230|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
163226608|NCT00207142|589544231|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
163226609|NCT00207142|589544232|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
163126254|NCT02702180|589169848|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
163126255|NCT02702180|589169849|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
163126256|NCT02702180|589169850|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
163126257|NCT02702180|589169848|FG000|Double-blind Treatment Period|Adverse Event|0|||
163126258|NCT02702180|589169849|FG001|Double-blind Treatment Period|Adverse Event|0|||
163126259|NCT02702180|589169850|FG002|Double-blind Treatment Period|Adverse Event|1|||
163126260|NCT02702180|589169848|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
163126261|NCT02702180|589169849|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
163226610|NCT00207142|589544233|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
163226611|NCT00207142|589544230|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
163226612|NCT00207142|589544231|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
163226613|NCT00207142|589544232|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
163226614|NCT00207142|589544233|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
163226615|NCT00207142|589544230|FG000|Maintenance Phase/Rescue Phase|Death|0|||
163226616|NCT00207142|589544231|FG001|Maintenance Phase/Rescue Phase|Death|0|||
163226617|NCT00207142|589544232|FG002|Maintenance Phase/Rescue Phase|Death|0|||
163226618|NCT00207142|589544233|FG003|Maintenance Phase/Rescue Phase|Death|1|||
163226619|NCT00207142|589544230|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
163226620|NCT00207142|589544231|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
163226621|NCT00207142|589544232|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
163226622|NCT00207142|589544233|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
163226623|NCT01554618|589544234|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
163226624|NCT01554618|589544235|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
163226625|NCT01554618|589544234|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
163226626|NCT01554618|589544235|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
163226627|NCT01554618|589544234|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
163226628|NCT01554618|589544235|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
163226629|NCT01554618|589544234|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
163226630|NCT01554618|589544235|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
163226631|NCT01554618|589544234|FG000|Open-Label Extension Period|Physician Decision|0|||
163226632|NCT01554618|589544235|FG001|Open-Label Extension Period|Physician Decision|1|||
163226633|NCT01554618|589544234|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
163226634|NCT01554618|589544235|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
163226635|NCT01857063|589544236|FG000|Period 1 (7 Days)|Adverse Event|0|||
163226636|NCT01857063|589544237|FG001|Period 1 (7 Days)|Adverse Event|1|||
163126262|NCT02702180|589169850|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
163126263|NCT02702180|589169848|FG000|Double-blind Treatment Period|Protocol Violation|0|||
163126264|NCT02702180|589169849|FG001|Double-blind Treatment Period|Protocol Violation|0|||
163226637|NCT01857063|589544236|FG000|Period 1 (7 Days)|Physician Decision|1|||
163226638|NCT01857063|589544237|FG001|Period 1 (7 Days)|Physician Decision|0|||
163226639|NCT01857063|589544236|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
163226640|NCT01857063|589544237|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
163226641|NCT01857063|589544236|FG000|Period 2 (7 Days)|Adverse Event|2|||
163226642|NCT01857063|589544237|FG001|Period 2 (7 Days)|Adverse Event|1|||
163226643|NCT01857063|589544236|FG000|Period 2 (7 Days)|Physician Decision|1|||
163126265|NCT02702180|589169850|FG002|Double-blind Treatment Period|Protocol Violation|2|||
163126266|NCT02702180|589169848|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
163408200|NCT01400451|590204071|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
163408201|NCT01400451|590204069|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
163408202|NCT01400451|590204070|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
163408203|NCT01400451|590204071|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
163408204|NCT01400451|590204069|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
163408205|NCT01400451|590204070|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
163408206|NCT01400451|590204071|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
163408207|NCT01400451|590204069|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
163408208|NCT01400451|590204070|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
163408209|NCT01400451|590204071|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
163408210|NCT01400451|590204069|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
163408211|NCT01400451|590204070|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
163408212|NCT01400451|590204071|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
163408213|NCT01505634|590204073|FG000|Overall Study|Withdrawal by Subject|2|||
163408214|NCT01505634|590204074|FG001|Overall Study|Withdrawal by Subject|5|||
163408215|NCT01505634|590204075|FG002|Overall Study|Withdrawal by Subject|1|||
163408216|NCT01505634|590204073|FG000|Overall Study|Physician Decision|1|||
163408217|NCT01505634|590204074|FG001|Overall Study|Physician Decision|1|||
163408218|NCT01505634|590204075|FG002|Overall Study|Physician Decision|0|||
163408219|NCT01505634|590204073|FG000|Overall Study|Adverse Event|1|||
163408220|NCT01505634|590204074|FG001|Overall Study|Adverse Event|0|||
163408221|NCT01505634|590204075|FG002|Overall Study|Adverse Event|0|||
163408222|NCT01505634|590204073|FG000|Overall Study|Insufficient supply of drug at site|1|||
163408223|NCT01505634|590204074|FG001|Overall Study|Insufficient supply of drug at site|0|||
163126267|NCT02702180|589169849|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
163126268|NCT02702180|589169850|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
163126269|NCT02702180|589169848|FG000|Open-label Treatment Period|Withdrawn in error|0|||
163126270|NCT02702180|589169849|FG001|Open-label Treatment Period|Withdrawn in error|0|||
163126271|NCT02702180|589169850|FG002|Open-label Treatment Period|Withdrawn in error|1|||
163126272|NCT00785980|589169851|FG000|7 Day Washout Period|Protocol Violation|3|||
163126273|NCT02241343|589169864|FG000|Overall Study|Adverse Event|1|||
163126274|NCT04680975|589169865|FG000|Overall Study|Adverse Event|3|||
163126275|NCT04680975|589169865|FG000|Overall Study|Death|1|||
163126276|NCT04680975|589169865|FG000|Overall Study|Progressive Disease|1|||
163126277|NCT04680975|589169865|FG000|Overall Study|Withdrawal by Subject|1|||
163126278|NCT00753454|589169866|FG000|Overall Study|Adverse Event|4|||
163126279|NCT00753454|589169866|FG000|Overall Study|Lack of Efficacy|1|||
163126280|NCT00753454|589169866|FG000|Overall Study|Lost to Follow-up|3|||
163126281|NCT00753454|589169866|FG000|Overall Study|Withdrawal by Subject|5|||
163126282|NCT00753454|589169866|FG000|Overall Study|Investigator Decision|1|||
163126283|NCT05856227|589169869|FG000|Overall Study|Adverse Event|0|||
163126284|NCT05856227|589169870|FG001|Overall Study|Adverse Event|1|||
163126285|NCT05856227|589169869|FG000|Overall Study|Due to Investigator absence|1|||
163126286|NCT05856227|589169870|FG001|Overall Study|Due to Investigator absence|0|||
163126287|NCT05856227|589169869|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
163126288|NCT05856227|589169870|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
163126289|NCT01571232|589169871|FG000|Overall Study|Lost to Follow-up|0|||
163126290|NCT01571232|589169872|FG001|Overall Study|Lost to Follow-up|1|||
163126291|NCT01571232|589169871|FG000|Overall Study|Withdrawal by Subject|1|||
163126292|NCT01571232|589169872|FG001|Overall Study|Withdrawal by Subject|0|||
163126293|NCT01272869|589169873|FG000|Period 2 (14 Days)|Adverse Event|1|||
163126294|NCT01272869|589169874|FG001|Period 2 (14 Days)|Adverse Event|0|||
163126295|NCT02271945|589169875|FG000|Overall Study|Death|3|||
163126296|NCT02271945|589169876|FG001|Overall Study|Death|3|||
163126297|NCT02271945|589169875|FG000|Overall Study|Withdrawal by Subject|1|||
163126298|NCT02271945|589169876|FG001|Overall Study|Withdrawal by Subject|1|||
163126299|NCT02271945|589169875|FG000|Overall Study|Other|1|||
163126300|NCT02271945|589169876|FG001|Overall Study|Other|1|||
163126301|NCT00548717|589169877|FG000|Overall Study|Death|5|||
163126302|NCT00548717|589169878|FG001|Overall Study|Death|2|||
163126303|NCT00548717|589169877|FG000|Overall Study|Relapse|3|||
163126304|NCT00548717|589169878|FG001|Overall Study|Relapse|0|||
163126305|NCT00548717|589169877|FG000|Overall Study|Alternative treatment for GVHD|1|||
163126306|NCT00548717|589169878|FG001|Overall Study|Alternative treatment for GVHD|0|||
163126307|NCT00908037|589169886|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126308|NCT00908037|589169887|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126309|NCT00908037|589169888|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126310|NCT00908037|589169889|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126311|NCT00908037|589169890|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
163126312|NCT00908037|589169891|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126313|NCT00908037|589169892|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
163126314|NCT00908037|589169893|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126315|NCT00908037|589169894|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
163408224|NCT01505634|590204075|FG002|Overall Study|Insufficient supply of drug at site|0|||
163226644|NCT01857063|589544237|FG001|Period 2 (7 Days)|Physician Decision|1|||
163226645|NCT01857063|589544236|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
163226646|NCT01857063|589544237|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
163226647|NCT00058825|589544238|FG000|Overall Study|Relapse|9|||
163226648|NCT00058825|589544238|FG000|Overall Study|Progressive Disease|5|||
163226649|NCT00058825|589544238|FG000|Overall Study|Graft Failure|5|||
163226650|NCT00058825|589544238|FG000|Overall Study|Death|3|||
163226651|NCT01205165|589544240|FG000|Overall Study|Lost to Follow-up|2|||
163226652|NCT00329407|589544247|FG000|Overall Study|Withdrawal by Subject|1|||
163226653|NCT00978068|589544248|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
163226654|NCT00978068|589544249|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
163226655|NCT00978068|589544248|FG000|Overall Study|Death|1|||
163226656|NCT00978068|589544249|FG001|Overall Study|Death|2|||
163226657|NCT00978068|589544248|FG000|Overall Study|Lost to Follow-up|1|||
163226658|NCT00978068|589544249|FG001|Overall Study|Lost to Follow-up|2|||
163226659|NCT00978068|589544248|FG000|Overall Study|Physician Decision|0|||
163226660|NCT00978068|589544249|FG001|Overall Study|Physician Decision|1|||
163226661|NCT00978068|589544248|FG000|Overall Study|Unable to Comply with Study|0|||
163226662|NCT00978068|589544249|FG001|Overall Study|Unable to Comply with Study|2|||
163226663|NCT02275481|589544250|FG000|Overall Study|Death|2|||
163226664|NCT02275481|589544251|FG001|Overall Study|Death|1|||
163226665|NCT02275481|589544250|FG000|Overall Study|Lost to Follow-up|2|||
163226666|NCT02275481|589544251|FG001|Overall Study|Lost to Follow-up|0|||
163226667|NCT02275481|589544250|FG000|Overall Study|Withdrawal by Subject|3|||
163226668|NCT02275481|589544251|FG001|Overall Study|Withdrawal by Subject|0|||
163226669|NCT02275481|589544250|FG000|Overall Study|all other reasons combined|2|||
163226670|NCT02275481|589544251|FG001|Overall Study|all other reasons combined|1|||
163226671|NCT02275481|589544250|FG000|Overall Study|Physician Decision|0|||
163226672|NCT02275481|589544251|FG001|Overall Study|Physician Decision|1|||
163226673|NCT01215227|589544252|FG000|Overall Study|Adverse Event|11|||
163226674|NCT01215227|589544253|FG001|Overall Study|Adverse Event|11|||
163226675|NCT01215227|589544254|FG002|Overall Study|Adverse Event|4|||
163226676|NCT01215227|589544255|FG003|Overall Study|Adverse Event|8|||
163226677|NCT01215227|589544256|FG004|Overall Study|Adverse Event|7|||
163226678|NCT01215227|589544257|FG005|Overall Study|Adverse Event|6|||
163226679|NCT01215227|589544252|FG000|Overall Study|Treatment Failure|8|||
163342101|NCT04520256|589959685|FG026|Overall Study|Lost to Follow-up|3|||
163342102|NCT04520256|589959686|FG027|Overall Study|Lost to Follow-up|4|||
163342103|NCT04520256|589959687|FG028|Overall Study|Lost to Follow-up|3|||
163342104|NCT04520256|589959688|FG029|Overall Study|Lost to Follow-up|4|||
163342105|NCT04520256|589959689|FG030|Overall Study|Lost to Follow-up|4|||
163342106|NCT04520256|589959690|FG031|Overall Study|Lost to Follow-up|4|||
163342107|NCT00760877|589961231|FG000|Overall Study|Protocol Violation|1|||
163342108|NCT00760877|589961232|FG001|Overall Study|Protocol Violation|0|||
163342109|NCT00760877|589961231|FG000|Overall Study|Non-compliance with protocol treatment|2|||
163342110|NCT00760877|589961232|FG001|Overall Study|Non-compliance with protocol treatment|1|||
163342111|NCT00760877|589961231|FG000|Overall Study|Pregnancy|1|||
163342112|NCT00760877|589961232|FG001|Overall Study|Pregnancy|4|||
163342113|NCT00760877|589961231|FG000|Overall Study|Death|2|||
163342114|NCT00760877|589961232|FG001|Overall Study|Death|1|||
163342115|NCT00760877|589961231|FG000|Overall Study|Withdrawal by Subject|7|||
163342116|NCT00760877|589961232|FG001|Overall Study|Withdrawal by Subject|3|||
163342117|NCT00760877|589961231|FG000|Overall Study|Adverse Event|19|||
163342118|NCT00760877|589961232|FG001|Overall Study|Adverse Event|12|||
163342119|NCT00760877|589961231|FG000|Overall Study|Participant diagnosed with AML|0|||
163342120|NCT00760877|589961232|FG001|Overall Study|Participant diagnosed with AML|1|||
163342121|NCT00760877|589961231|FG000|Overall Study|Participant not eligible to cross-over|0|||
163342122|NCT00760877|589961232|FG001|Overall Study|Participant not eligible to cross-over|1|||
163342123|NCT00760877|589961231|FG000|Overall Study|Physician Decision|1|||
163342124|NCT00760877|589961232|FG001|Overall Study|Physician Decision|2|||
163342125|NCT00760877|589961231|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
163342126|NCT00760877|589961232|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
163342127|NCT00760877|589961231|FG000|Overall Study|Treatment failure|1|||
163342128|NCT00760877|589961232|FG001|Overall Study|Treatment failure|0|||
163342129|NCT04413149|589961233|FG000|Overall Study|Death|10|||
163226680|NCT01215227|589544253|FG001|Overall Study|Treatment Failure|4|||
163226681|NCT01215227|589544254|FG002|Overall Study|Treatment Failure|1|||
163226682|NCT01215227|589544255|FG003|Overall Study|Treatment Failure|5|||
163226683|NCT01215227|589544256|FG004|Overall Study|Treatment Failure|1|||
163226684|NCT01215227|589544257|FG005|Overall Study|Treatment Failure|1|||
163226685|NCT01215227|589544252|FG000|Overall Study|Lost to Follow-up|1|||
163226686|NCT01215227|589544253|FG001|Overall Study|Lost to Follow-up|4|||
163226687|NCT01215227|589544254|FG002|Overall Study|Lost to Follow-up|1|||
163226688|NCT01215227|589544255|FG003|Overall Study|Lost to Follow-up|1|||
163342130|NCT04413149|589961234|FG001|Overall Study|Death|5|||
163342131|NCT04413149|589961233|FG000|Overall Study|Lung transplantation|1|||
163342132|NCT04413149|589961234|FG001|Overall Study|Lung transplantation|0|||
163342133|NCT00676195|589961235|FG000|Overall Study|Lost to Follow-up|1|||
163342134|NCT00676195|589961235|FG000|Overall Study|Adverse Event|1|||
163342135|NCT00676195|589961235|FG000|Overall Study|Physician Decision|1|||
163342136|NCT02878590|589961236|FG000|Overall Study|Withdrawal by Subject|2|||
163342137|NCT01730118|589961237|FG000|Dose Escalation|Death on study|5|||
163126316|NCT00908037|589169895|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126317|NCT00908037|589169896|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126318|NCT00908037|589169897|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126319|NCT00908037|589169886|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126320|NCT00908037|589169887|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126321|NCT00908037|589169888|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126322|NCT00908037|589169889|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126323|NCT00908037|589169890|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
163126324|NCT00908037|589169891|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126325|NCT00908037|589169892|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126326|NCT00908037|589169893|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126327|NCT00908037|589169894|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
163126328|NCT00908037|589169895|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126329|NCT00908037|589169896|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126330|NCT00908037|589169897|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126331|NCT00908037|589169886|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126332|NCT00908037|589169887|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126333|NCT00908037|589169888|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126334|NCT00908037|589169889|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
163126335|NCT00908037|589169890|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126336|NCT00908037|589169891|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126337|NCT00908037|589169892|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
163126338|NCT00908037|589169893|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126339|NCT00908037|589169894|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126340|NCT00908037|589169895|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126341|NCT00908037|589169896|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126342|NCT00908037|589169897|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126343|NCT00908037|589169886|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126344|NCT00908037|589169887|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126345|NCT00908037|589169888|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126346|NCT00908037|589169889|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126347|NCT00908037|589169890|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126348|NCT00908037|589169891|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126349|NCT00908037|589169892|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126350|NCT00908037|589169893|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126351|NCT00908037|589169894|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126352|NCT00908037|589169895|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126353|NCT00908037|589169896|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126354|NCT00908037|589169897|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
163126355|NCT00908037|589169886|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126356|NCT00908037|589169887|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126357|NCT00908037|589169888|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126358|NCT00908037|589169889|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126359|NCT00908037|589169890|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126360|NCT00908037|589169891|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126361|NCT00908037|589169892|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126362|NCT00908037|589169893|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126363|NCT00908037|589169894|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126364|NCT00908037|589169895|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
163126365|NCT00908037|589169896|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126366|NCT00908037|589169897|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
163126367|NCT00908037|589169886|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126368|NCT00908037|589169887|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126369|NCT00908037|589169888|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126370|NCT00908037|589169889|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126371|NCT00908037|589169890|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126372|NCT00908037|589169891|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126373|NCT00908037|589169892|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126374|NCT00908037|589169893|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163342138|NCT01730118|589961238|FG001|Dose Escalation|Death on study|7|||
163342139|NCT01730118|589961239|FG002|Dose Escalation|Death on study|2|||
163342140|NCT01730118|589961240|FG003|Dose Escalation|Death on study|6|||
163342141|NCT01730118|589961241|FG004|Dose Escalation|Death on study|0|||
163342142|NCT01730118|589961242|FG005|Dose Escalation|Death on study|0|||
163342143|NCT01730118|589961243|FG006|Dose Escalation|Death on study|0|||
163342144|NCT01730118|589961237|FG000|Dose Escalation|Died before treatment|0|||
163342145|NCT01730118|589961238|FG001|Dose Escalation|Died before treatment|0|||
163342146|NCT01730118|589961239|FG002|Dose Escalation|Died before treatment|0|||
163342147|NCT01730118|589961240|FG003|Dose Escalation|Died before treatment|0|||
163342148|NCT01730118|589961241|FG004|Dose Escalation|Died before treatment|0|||
163342149|NCT01730118|589961242|FG005|Dose Escalation|Died before treatment|0|||
163342150|NCT01730118|589961243|FG006|Dose Escalation|Died before treatment|1|||
163342151|NCT01730118|589961237|FG000|Dose Escalation|Chose to start a different treatment|1|||
163342152|NCT01730118|589961238|FG001|Dose Escalation|Chose to start a different treatment|0|||
163342153|NCT01730118|589961239|FG002|Dose Escalation|Chose to start a different treatment|0|||
163342154|NCT01730118|589961240|FG003|Dose Escalation|Chose to start a different treatment|0|||
163342155|NCT01730118|589961241|FG004|Dose Escalation|Chose to start a different treatment|0|||
163342156|NCT01730118|589961242|FG005|Dose Escalation|Chose to start a different treatment|0|||
163342157|NCT01730118|589961243|FG006|Dose Escalation|Chose to start a different treatment|0|||
163342158|NCT01730118|589961237|FG000|Dose Escalation|Withdrawal by Subject|0|||
163342159|NCT01730118|589961238|FG001|Dose Escalation|Withdrawal by Subject|0|||
163342160|NCT01730118|589961239|FG002|Dose Escalation|Withdrawal by Subject|1|||
163342161|NCT01730118|589961240|FG003|Dose Escalation|Withdrawal by Subject|0|||
163342162|NCT01730118|589961241|FG004|Dose Escalation|Withdrawal by Subject|0|||
163342163|NCT01730118|589961242|FG005|Dose Escalation|Withdrawal by Subject|0|||
163342164|NCT01730118|589961243|FG006|Dose Escalation|Withdrawal by Subject|0|||
163342165|NCT01730118|589961237|FG000|Dose Escalation|Disease progression prior to treatment|0|||
163342166|NCT01730118|589961238|FG001|Dose Escalation|Disease progression prior to treatment|0|||
163342167|NCT01730118|589961239|FG002|Dose Escalation|Disease progression prior to treatment|0|||
163342168|NCT01730118|589961240|FG003|Dose Escalation|Disease progression prior to treatment|0|||
163342169|NCT01730118|589961241|FG004|Dose Escalation|Disease progression prior to treatment|0|||
163342170|NCT01730118|589961242|FG005|Dose Escalation|Disease progression prior to treatment|0|||
163342171|NCT01730118|589961243|FG006|Dose Escalation|Disease progression prior to treatment|1|||
163342172|NCT01730118|589961237|FG000|Dose Expansion|Death|0|||
163342173|NCT01730118|589961238|FG001|Dose Expansion|Death|0|||
163342174|NCT01730118|589961239|FG002|Dose Expansion|Death|0|||
163342175|NCT01730118|589961240|FG003|Dose Expansion|Death|0|||
163342176|NCT01730118|589961241|FG004|Dose Expansion|Death|1|||
163342177|NCT01730118|589961242|FG005|Dose Expansion|Death|0|||
163342178|NCT01730118|589961243|FG006|Dose Expansion|Death|0|||
163342179|NCT01730118|589961237|FG000|Dose Expansion|Other medical condition|0|||
163342180|NCT01730118|589961238|FG001|Dose Expansion|Other medical condition|0|||
163342181|NCT01730118|589961239|FG002|Dose Expansion|Other medical condition|0|||
163342182|NCT01730118|589961240|FG003|Dose Expansion|Other medical condition|0|||
163342183|NCT01730118|589961241|FG004|Dose Expansion|Other medical condition|1|||
163342184|NCT01730118|589961242|FG005|Dose Expansion|Other medical condition|0|||
163342185|NCT01730118|589961243|FG006|Dose Expansion|Other medical condition|0|||
163342186|NCT01730118|589961237|FG000|Dose Expansion|Withdrawal by Subject|0|||
163342187|NCT01730118|589961238|FG001|Dose Expansion|Withdrawal by Subject|0|||
163342188|NCT01730118|589961239|FG002|Dose Expansion|Withdrawal by Subject|0|||
163342189|NCT01730118|589961240|FG003|Dose Expansion|Withdrawal by Subject|0|||
163342190|NCT01730118|589961241|FG004|Dose Expansion|Withdrawal by Subject|1|||
163342191|NCT01730118|589961242|FG005|Dose Expansion|Withdrawal by Subject|0|||
163342192|NCT01730118|589961243|FG006|Dose Expansion|Withdrawal by Subject|0|||
163342193|NCT01730118|589961237|FG000|Dose Expansion|Disease progression|0|||
163342194|NCT01730118|589961238|FG001|Dose Expansion|Disease progression|0|||
163342195|NCT01730118|589961239|FG002|Dose Expansion|Disease progression|0|||
163342196|NCT01730118|589961240|FG003|Dose Expansion|Disease progression|0|||
163342197|NCT01730118|589961241|FG004|Dose Expansion|Disease progression|0|||
163342198|NCT01730118|589961242|FG005|Dose Expansion|Disease progression|1|||
163342199|NCT01730118|589961243|FG006|Dose Expansion|Disease progression|0|||
163342200|NCT01730118|589961237|FG000|Dose Expansion|Inability to return|0|||
163126375|NCT00908037|589169894|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126376|NCT00908037|589169895|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
163126377|NCT00908037|589169896|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126378|NCT00908037|589169897|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126379|NCT00908037|589169886|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163342201|NCT01730118|589961238|FG001|Dose Expansion|Inability to return|0|||
163342202|NCT01730118|589961239|FG002|Dose Expansion|Inability to return|0|||
163342203|NCT01730118|589961240|FG003|Dose Expansion|Inability to return|0|||
163342204|NCT01730118|589961241|FG004|Dose Expansion|Inability to return|0|||
163342205|NCT01730118|589961242|FG005|Dose Expansion|Inability to return|1|||
163342206|NCT01730118|589961243|FG006|Dose Expansion|Inability to return|0|||
163342207|NCT01730118|589961237|FG000|Dose Expansion|Physician Decision|0|||
163342208|NCT01730118|589961238|FG001|Dose Expansion|Physician Decision|0|||
163342209|NCT01730118|589961239|FG002|Dose Expansion|Physician Decision|0|||
163342210|NCT01730118|589961240|FG003|Dose Expansion|Physician Decision|0|||
163342211|NCT01730118|589961241|FG004|Dose Expansion|Physician Decision|0|||
163342212|NCT01730118|589961242|FG005|Dose Expansion|Physician Decision|1|||
163342213|NCT01730118|589961243|FG006|Dose Expansion|Physician Decision|0|||
163342214|NCT03978130|589961248|FG000|Overall Study|Lost to Follow-up|13|||
163342215|NCT03978130|589961249|FG001|Overall Study|Lost to Follow-up|14|||
163342216|NCT03978130|589961248|FG000|Overall Study|Withdrawal by Subject|12|||
163342217|NCT03978130|589961249|FG001|Overall Study|Withdrawal by Subject|2|||
163342218|NCT03978130|589961248|FG000|Overall Study|Adverse Event|2|||
163342219|NCT03978130|589961249|FG001|Overall Study|Adverse Event|1|||
163342220|NCT04049578|589961255|FG000|Overall Study|Physician Decision|1|||
163342221|NCT00668746|589961256|FG000|Overall Study|Lost to Follow-up|2|||
163342222|NCT00668746|589961257|FG001|Overall Study|Lost to Follow-up|1|||
163342223|NCT03409276|589961258|FG000|Overall Study|Withdrawal by Subject|0|||
163342224|NCT03409276|589961259|FG001|Overall Study|Withdrawal by Subject|0|||
163342225|NCT03409276|589961260|FG002|Overall Study|Withdrawal by Subject|0|||
163126380|NCT00908037|589169887|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126381|NCT00908037|589169888|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126382|NCT00908037|589169889|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126383|NCT00908037|589169890|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126384|NCT00908037|589169891|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126385|NCT00908037|589169892|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126386|NCT00908037|589169893|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126387|NCT00908037|589169894|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126388|NCT00908037|589169895|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163342226|NCT03409276|589961261|FG003|Overall Study|Withdrawal by Subject|0|||
163342227|NCT03409276|589961262|FG004|Overall Study|Withdrawal by Subject|1|||
163342228|NCT03409276|589961258|FG000|Overall Study|Lost to Follow-up|0|||
163342229|NCT03409276|589961259|FG001|Overall Study|Lost to Follow-up|0|||
163342230|NCT03409276|589961260|FG002|Overall Study|Lost to Follow-up|0|||
163126389|NCT00908037|589169896|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
163126390|NCT00908037|589169897|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126391|NCT00908037|589169886|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126392|NCT00908037|589169887|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126393|NCT00908037|589169888|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126394|NCT00908037|589169889|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126395|NCT00908037|589169890|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126396|NCT00908037|589169891|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126397|NCT00908037|589169892|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126398|NCT00908037|589169893|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126399|NCT00908037|589169894|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126400|NCT00908037|589169895|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
163126401|NCT00908037|589169896|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126402|NCT00908037|589169897|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126403|NCT00908037|589169886|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163342231|NCT03409276|589961261|FG003|Overall Study|Lost to Follow-up|2|||
163342232|NCT03409276|589961262|FG004|Overall Study|Lost to Follow-up|2|||
163342233|NCT05361304|589961272|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
163342234|NCT05361304|589961273|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
163126404|NCT00908037|589169887|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126405|NCT00908037|589169888|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126406|NCT00908037|589169889|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126407|NCT00908037|589169890|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126408|NCT00908037|589169891|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126409|NCT00908037|589169892|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163342235|NCT05361304|589961272|FG000|Overall Study|COVID-19 Related|1|||
163126410|NCT00908037|589169893|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126411|NCT00908037|589169894|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126412|NCT00908037|589169895|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163226689|NCT01215227|589544256|FG004|Overall Study|Lost to Follow-up|1|||
163226690|NCT01215227|589544257|FG005|Overall Study|Lost to Follow-up|2|||
163226691|NCT01215227|589544252|FG000|Overall Study|Subject Withdrew Consent|16|||
163342236|NCT05361304|589961273|FG001|Overall Study|COVID-19 Related|2|||
163342237|NCT05361304|589961272|FG000|Overall Study|Withdrawal by Subject|1|||
163342238|NCT05361304|589961273|FG001|Overall Study|Withdrawal by Subject|0|||
163342239|NCT03320941|589961274|FG000|Overall Study|subject/guardian decision|0|||
163126413|NCT00908037|589169896|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
163126414|NCT00908037|589169897|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126415|NCT02613169|589169898|FG000|Overall Study|Withdrawal by Subject|4|||
163126416|NCT02613169|589169899|FG001|Overall Study|Withdrawal by Subject|1|||
163126417|NCT02613169|589169898|FG000|Overall Study|Lost to Follow-up|0|||
163126418|NCT02613169|589169899|FG001|Overall Study|Lost to Follow-up|5|||
163126419|NCT02613169|589169898|FG000|Overall Study|HIV|0|||
163126420|NCT02613169|589169899|FG001|Overall Study|HIV|2|||
163126421|NCT02613169|589169898|FG000|Overall Study|No TB infection endpoint|14|||
163126422|NCT02613169|589169899|FG001|Overall Study|No TB infection endpoint|9|||
163126423|NCT03729245|589169900|FG000|Overall Study|Lost to Follow-up|5|||
163126424|NCT03729245|589169901|FG001|Overall Study|Lost to Follow-up|6|||
163126425|NCT03729245|589169900|FG000|Overall Study|Withdrawal by Subject|16|||
163126426|NCT03729245|589169901|FG001|Overall Study|Withdrawal by Subject|19|||
163126427|NCT03729245|589169900|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
163126428|NCT03729245|589169901|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
163126429|NCT00079677|589169913|FG000|Overall Study|Adverse Event|5|||
163126430|NCT00079677|589169914|FG001|Overall Study|Adverse Event|6|||
163126431|NCT00079677|589169913|FG000|Overall Study|Lack of Efficacy|1|||
163126432|NCT00079677|589169914|FG001|Overall Study|Lack of Efficacy|0|||
163126433|NCT00079677|589169913|FG000|Overall Study|Lost to Follow-up|2|||
163126434|NCT00079677|589169914|FG001|Overall Study|Lost to Follow-up|2|||
163126435|NCT00079677|589169913|FG000|Overall Study|Physician Decision|3|||
163126436|NCT00079677|589169914|FG001|Overall Study|Physician Decision|0|||
163126437|NCT00079677|589169913|FG000|Overall Study|Protocol Violation|2|||
163126438|NCT00079677|589169914|FG001|Overall Study|Protocol Violation|3|||
163126439|NCT00079677|589169913|FG000|Overall Study|Withdrawal by Subject|5|||
163126440|NCT00079677|589169914|FG001|Overall Study|Withdrawal by Subject|3|||
163126441|NCT00079677|589169913|FG000|Overall Study|Miscellaneous|2|||
163126442|NCT00079677|589169914|FG001|Overall Study|Miscellaneous|0|||
163126443|NCT01985360|589169915|FG000|Overall Study|Withdrawal by Subject|4|||
163126444|NCT01985360|589169916|FG001|Overall Study|Withdrawal by Subject|0|||
163126445|NCT01985360|589169915|FG000|Overall Study|Lost to Follow-up|5|||
163126446|NCT01985360|589169916|FG001|Overall Study|Lost to Follow-up|3|||
163126447|NCT04598269|589169917|FG000|Overall Study|Adverse Event|0|||
163126448|NCT04598269|589169918|FG001|Overall Study|Adverse Event|3|||
163126449|NCT04598269|589169917|FG000|Overall Study|Withdrawal by Subject|1|||
163126450|NCT04598269|589169918|FG001|Overall Study|Withdrawal by Subject|4|||
163126451|NCT04598269|589169917|FG000|Overall Study|Lost to Follow-up|1|||
163126452|NCT04598269|589169918|FG001|Overall Study|Lost to Follow-up|0|||
163126453|NCT04598269|589169917|FG000|Overall Study|Not Treated|2|||
163126454|NCT04598269|589169918|FG001|Overall Study|Not Treated|0|||
163126455|NCT00424190|589169919|FG000|Overall Study|Withdrew consent|3|||
163126456|NCT00424190|589169920|FG001|Overall Study|Withdrew consent|4|||
163126457|NCT00424190|589169919|FG000|Overall Study|Death|3|||
163126458|NCT00424190|589169920|FG001|Overall Study|Death|0|||
163126459|NCT00424190|589169919|FG000|Overall Study|Noncompliance|1|||
163126460|NCT00424190|589169920|FG001|Overall Study|Noncompliance|2|||
163126461|NCT00424190|589169919|FG000|Overall Study|Request of sponsor or investigator|0|||
163126462|NCT00424190|589169920|FG001|Overall Study|Request of sponsor or investigator|2|||
163126463|NCT00424190|589169919|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
163126464|NCT00424190|589169920|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
163126465|NCT00424190|589169919|FG000|Overall Study|Other|15|||
163126466|NCT00424190|589169920|FG001|Overall Study|Other|21|||
163126467|NCT00845065|589169922|FG000|Overall Study|Adverse Event|3|||
163126468|NCT00845065|589169923|FG001|Overall Study|Adverse Event|23|||
163126469|NCT00845065|589169922|FG000|Overall Study|Lack of Efficacy|43|||
163126470|NCT00845065|589169923|FG001|Overall Study|Lack of Efficacy|21|||
163126471|NCT00845065|589169922|FG000|Overall Study|Non-Medical Reasons|1|||
163126472|NCT00845065|589169923|FG001|Overall Study|Non-Medical Reasons|11|||
163126473|NCT02383433|589169924|FG000|Overall Study|Disease progression|2|||
163126474|NCT00952614|589169927|FG000|Overall Study|Death|3|||
163126475|NCT00952614|589169927|FG000|Overall Study|Lost to Follow-up|3|||
163126476|NCT00952614|589169927|FG000|Overall Study|other reason|1|||
163126477|NCT02963701|589169929|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
163126478|NCT02963701|589169930|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
163126479|NCT01345682|589169931|FG000|Overall Study|Progressive disease per RECIST|226|||
163126480|NCT01345682|589169932|FG001|Overall Study|Progressive disease per RECIST|93|||
163126481|NCT01345682|589169931|FG000|Overall Study|Worsening of underlying cancer disease|23|||
163126482|NCT01345682|589169932|FG001|Overall Study|Worsening of underlying cancer disease|12|||
163126483|NCT01345682|589169931|FG000|Overall Study|Adverse Event|51|||
163126484|NCT01345682|589169932|FG001|Overall Study|Adverse Event|41|||
163126485|NCT01345682|589169931|FG000|Overall Study|Non-compliance with protocol|0|||
163126486|NCT01345682|589169932|FG001|Overall Study|Non-compliance with protocol|1|||
163126487|NCT01345682|589169931|FG000|Overall Study|Lost to Follow-up|0|||
163126488|NCT01345682|589169932|FG001|Overall Study|Lost to Follow-up|1|||
163126489|NCT01345682|589169931|FG000|Overall Study|Refused to continue trial medication|16|||
163126490|NCT01345682|589169932|FG001|Overall Study|Refused to continue trial medication|9|||
163126491|NCT01345682|589169931|FG000|Overall Study|Not treated|2|||
163126492|NCT01345682|589169932|FG001|Overall Study|Not treated|1|||
163126493|NCT01345682|589169931|FG000|Overall Study|Reason other than those specified above|4|||
163126494|NCT01345682|589169932|FG001|Overall Study|Reason other than those specified above|3|||
163126495|NCT00896649|589169933|FG000|Overall Study|Physician Decision|1|||
163126496|NCT00896649|589169933|FG000|Overall Study|Pregnancy|1|||
163126497|NCT00896649|589169933|FG000|Overall Study|missing documentation|1|||
163126498|NCT00896649|589169933|FG000|Overall Study|technical difficulties|2|||
163126499|NCT01075984|589169935|FG000|Treatment Phase|Adverse Event|0|||
163126500|NCT01075984|589169936|FG001|Treatment Phase|Adverse Event|1|||
163126501|NCT01075984|589169937|FG002|Treatment Phase|Adverse Event|3|||
163126502|NCT01075984|589169938|FG003|Treatment Phase|Adverse Event|7|||
163126503|NCT01075984|589169939|FG004|Treatment Phase|Adverse Event|35|||
163126504|NCT01075984|589169935|FG000|Treatment Phase|Protocol Violation|0|||
163126505|NCT01075984|589169936|FG001|Treatment Phase|Protocol Violation|0|||
163126506|NCT01075984|589169937|FG002|Treatment Phase|Protocol Violation|1|||
163126507|NCT01075984|589169938|FG003|Treatment Phase|Protocol Violation|0|||
163126508|NCT01075984|589169939|FG004|Treatment Phase|Protocol Violation|3|||
163126509|NCT01075984|589169935|FG000|Treatment Phase|Withdrawal by Subject|0|||
163126510|NCT01075984|589169936|FG001|Treatment Phase|Withdrawal by Subject|0|||
163126511|NCT01075984|589169937|FG002|Treatment Phase|Withdrawal by Subject|2|||
163126512|NCT01075984|589169938|FG003|Treatment Phase|Withdrawal by Subject|0|||
163126513|NCT01075984|589169939|FG004|Treatment Phase|Withdrawal by Subject|15|||
163126514|NCT01075984|589169935|FG000|Treatment Phase|Treatment Failure|0|||
163126515|NCT01075984|589169936|FG001|Treatment Phase|Treatment Failure|0|||
163126516|NCT01075984|589169937|FG002|Treatment Phase|Treatment Failure|1|||
163126517|NCT01075984|589169938|FG003|Treatment Phase|Treatment Failure|0|||
163126518|NCT01075984|589169939|FG004|Treatment Phase|Treatment Failure|5|||
163126519|NCT01075984|589169935|FG000|Treatment Phase|Progression of disease|0|||
163126520|NCT01075984|589169936|FG001|Treatment Phase|Progression of disease|0|||
163126521|NCT01075984|589169937|FG002|Treatment Phase|Progression of disease|0|||
163126522|NCT01075984|589169938|FG003|Treatment Phase|Progression of disease|0|||
163126523|NCT01075984|589169939|FG004|Treatment Phase|Progression of disease|2|||
163126524|NCT01075984|589169935|FG000|Follow-up Phase|Protocol Violation|0|||
163126525|NCT01075984|589169936|FG001|Follow-up Phase|Protocol Violation|0|||
163126526|NCT01075984|589169937|FG002|Follow-up Phase|Protocol Violation|1|||
163126527|NCT01075984|589169938|FG003|Follow-up Phase|Protocol Violation|0|||
163126528|NCT01075984|589169939|FG004|Follow-up Phase|Protocol Violation|3|||
163126529|NCT01075984|589169935|FG000|Follow-up Phase|Adverse Event|0|||
163126530|NCT01075984|589169936|FG001|Follow-up Phase|Adverse Event|0|||
163126531|NCT01075984|589169937|FG002|Follow-up Phase|Adverse Event|0|||
163126532|NCT01075984|589169938|FG003|Follow-up Phase|Adverse Event|2|||
163126533|NCT01075984|589169939|FG004|Follow-up Phase|Adverse Event|27|||
163126534|NCT01075984|589169935|FG000|Follow-up Phase|Administrative|0|||
163126535|NCT01075984|589169936|FG001|Follow-up Phase|Administrative|0|||
163126536|NCT01075984|589169937|FG002|Follow-up Phase|Administrative|0|||
163126537|NCT01075984|589169938|FG003|Follow-up Phase|Administrative|0|||
163126538|NCT01075984|589169939|FG004|Follow-up Phase|Administrative|1|||
163126539|NCT01075984|589169935|FG000|Follow-up Phase|Withdrawal by Subject|0|||
163126540|NCT01075984|589169936|FG001|Follow-up Phase|Withdrawal by Subject|0|||
163126541|NCT01075984|589169937|FG002|Follow-up Phase|Withdrawal by Subject|0|||
163126542|NCT01075984|589169938|FG003|Follow-up Phase|Withdrawal by Subject|0|||
163126543|NCT01075984|589169939|FG004|Follow-up Phase|Withdrawal by Subject|10|||
163126544|NCT01075984|589169935|FG000|Follow-up Phase|Progression of disease|0|||
163126545|NCT01075984|589169936|FG001|Follow-up Phase|Progression of disease|0|||
163126546|NCT01075984|589169937|FG002|Follow-up Phase|Progression of disease|0|||
163126547|NCT01075984|589169938|FG003|Follow-up Phase|Progression of disease|0|||
163126548|NCT01075984|589169939|FG004|Follow-up Phase|Progression of disease|2|||
163126549|NCT01075984|589169935|FG000|Follow-up Phase|Treatment failure|0|||
163126550|NCT01075984|589169936|FG001|Follow-up Phase|Treatment failure|0|||
163126551|NCT01075984|589169937|FG002|Follow-up Phase|Treatment failure|0|||
163126552|NCT01075984|589169938|FG003|Follow-up Phase|Treatment failure|0|||
163408225|NCT01505634|590204073|FG000|Overall Study|Protocol Violation|2|||
163126553|NCT01075984|589169939|FG004|Follow-up Phase|Treatment failure|4|||
163126554|NCT03101085|589169940|FG000|Overall Study|Lost to Follow-up|0|||
163126555|NCT03101085|589169941|FG001|Overall Study|Lost to Follow-up|1|||
163126556|NCT02986854|589169943|FG000|Overall Study|Withdrawal by Subject|0|||
163126557|NCT02986854|589169944|FG001|Overall Study|Withdrawal by Subject|1|||
163126558|NCT02986854|589169945|FG002|Overall Study|Withdrawal by Subject|1|||
163126559|NCT02986854|589169943|FG000|Overall Study|Lost to Follow-up|3|||
163126560|NCT02986854|589169944|FG001|Overall Study|Lost to Follow-up|11|||
163126561|NCT02986854|589169945|FG002|Overall Study|Lost to Follow-up|2|||
163126562|NCT02039856|589169948|FG000|Overall Study|Death|5|||
163126563|NCT02039856|589169949|FG001|Overall Study|Death|3|||
163126564|NCT02039856|589169948|FG000|Overall Study|Partial survey completion|61|||
163126565|NCT02039856|589169949|FG001|Overall Study|Partial survey completion|26|||
163126566|NCT02039856|589169948|FG000|Overall Study|Lost to Follow-up|388|||
163126567|NCT02039856|589169949|FG001|Overall Study|Lost to Follow-up|206|||
163126568|NCT02039856|589169948|FG000|Overall Study|Withdrawal by Subject|1573|||
163126569|NCT02039856|589169949|FG001|Overall Study|Withdrawal by Subject|618|||
163126570|NCT00626405|589169961|FG000|Overall Study|Deemed Ineligible|1|||
163126571|NCT00626405|589169962|FG001|Overall Study|Deemed Ineligible|0|||
163126572|NCT00626405|589169961|FG000|Overall Study|Withdrawal by Subject|0|||
163126573|NCT00626405|589169962|FG001|Overall Study|Withdrawal by Subject|1|||
163126574|NCT01174173|589169963|FG000|Overall Study|drug-drug interaction|1|||
163154840|NCT00911170|589281449|FG001|Treatment Period|Disease progression|2|||
163154841|NCT00911170|589281448|FG000|Treatment Period|Physician Decision|5|||
163154842|NCT00911170|589281449|FG001|Treatment Period|Physician Decision|5|||
163154843|NCT00911170|589281448|FG000|Treatment Period|Lost to Follow-up|0|||
163154844|NCT00911170|589281449|FG001|Treatment Period|Lost to Follow-up|1|||
163154845|NCT00911170|589281448|FG000|Treatment Period|Death|6|||
163154846|NCT00911170|589281449|FG001|Treatment Period|Death|9|||
163154847|NCT00911170|589281448|FG000|Long Term Follow-Up|Continuing in study|274|||
163154848|NCT00911170|589281449|FG001|Long Term Follow-Up|Continuing in study|269|||
163154849|NCT00911170|589281448|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
163154850|NCT00911170|589281449|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
163154851|NCT00911170|589281448|FG000|Long Term Follow-Up|Physician Decision|5|||
163154852|NCT00911170|589281449|FG001|Long Term Follow-Up|Physician Decision|4|||
163154853|NCT00911170|589281448|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
163154854|NCT00911170|589281449|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
163154855|NCT00911170|589281448|FG000|Long Term Follow-Up|Death|116|||
163154856|NCT00911170|589281449|FG001|Long Term Follow-Up|Death|121|||
163154857|NCT02681523|589281450|FG000|Overall Study|Adverse Event|1|||
163154858|NCT02681523|589281450|FG000|Overall Study|Patient Non-compliance|1|||
163226692|NCT01215227|589544253|FG001|Overall Study|Subject Withdrew Consent|20|||
163226693|NCT01215227|589544254|FG002|Overall Study|Subject Withdrew Consent|7|||
163226694|NCT01215227|589544255|FG003|Overall Study|Subject Withdrew Consent|10|||
163226695|NCT01215227|589544256|FG004|Overall Study|Subject Withdrew Consent|11|||
163226696|NCT01215227|589544257|FG005|Overall Study|Subject Withdrew Consent|8|||
163226697|NCT01215227|589544252|FG000|Overall Study|Non-Compliance With Protocol|2|||
163226698|NCT01215227|589544253|FG001|Overall Study|Non-Compliance With Protocol|6|||
163226699|NCT01215227|589544254|FG002|Overall Study|Non-Compliance With Protocol|1|||
163226700|NCT01215227|589544255|FG003|Overall Study|Non-Compliance With Protocol|0|||
163226701|NCT01215227|589544256|FG004|Overall Study|Non-Compliance With Protocol|0|||
163226702|NCT01215227|589544257|FG005|Overall Study|Non-Compliance With Protocol|0|||
163226703|NCT01215227|589544252|FG000|Overall Study|Administrative|83|||
163226704|NCT01215227|589544253|FG001|Overall Study|Administrative|73|||
163226705|NCT01215227|589544254|FG002|Overall Study|Administrative|42|||
163226706|NCT01215227|589544255|FG003|Overall Study|Administrative|24|||
163226707|NCT01215227|589544256|FG004|Overall Study|Administrative|28|||
163226708|NCT01215227|589544257|FG005|Overall Study|Administrative|40|||
163226709|NCT01215227|589544252|FG000|Overall Study|Missing Status|0|||
163226710|NCT01215227|589544253|FG001|Overall Study|Missing Status|1|||
163226711|NCT01215227|589544254|FG002|Overall Study|Missing Status|0|||
163226712|NCT01215227|589544255|FG003|Overall Study|Missing Status|0|||
163226713|NCT01215227|589544256|FG004|Overall Study|Missing Status|0|||
163226714|NCT01215227|589544257|FG005|Overall Study|Missing Status|0|||
163226715|NCT01215227|589544252|FG000|Overall Study|Randomized but not treated|0|||
163226716|NCT01215227|589544253|FG001|Overall Study|Randomized but not treated|0|||
163226717|NCT01215227|589544254|FG002|Overall Study|Randomized but not treated|1|||
163226718|NCT01215227|589544255|FG003|Overall Study|Randomized but not treated|1|||
163342240|NCT03320941|589961275|FG001|Overall Study|subject/guardian decision|0|||
163342241|NCT03320941|589961276|FG002|Overall Study|subject/guardian decision|0|||
163226719|NCT01215227|589544256|FG004|Overall Study|Randomized but not treated|0|||
163342242|NCT03320941|589961277|FG003|Overall Study|subject/guardian decision|1|||
163342243|NCT03320941|589961278|FG004|Overall Study|subject/guardian decision|0|||
163342244|NCT02368691|589961280|FG000|Overall Study|Death|13|||
163342245|NCT02368691|589961280|FG000|Overall Study|Lack of Efficacy|15|||
163342246|NCT02368691|589961280|FG000|Overall Study|Physician Decision|4|||
163342247|NCT02069366|589961281|FG000|Overall Study|Lost to Follow-up|0|||
163342248|NCT02069366|589961282|FG001|Overall Study|Lost to Follow-up|0|||
163226720|NCT01215227|589544257|FG005|Overall Study|Randomized but not treated|1|||
163226721|NCT01393405|589544258|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
163226722|NCT01393405|589544259|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
163226723|NCT01393405|589544260|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
163226724|NCT01393405|589544258|FG000|Induction Period (week1-16)|Adverse Event|16|||
163226725|NCT01393405|589544259|FG001|Induction Period (week1-16)|Adverse Event|0|||
163226726|NCT01393405|589544260|FG002|Induction Period (week1-16)|Adverse Event|0|||
163226727|NCT01393405|589544258|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
163226728|NCT01393405|589544259|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
163226729|NCT01393405|589544260|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
163342249|NCT02069366|589961283|FG002|Overall Study|Lost to Follow-up|1|||
163342250|NCT02069366|589961284|FG003|Overall Study|Lost to Follow-up|0|||
163126575|NCT03775512|589172514|FG000|Overall Study|Death|1|||
163126576|NCT03775512|589172515|FG001|Overall Study|Death|1|||
163126577|NCT03775512|589172514|FG000|Overall Study|Withdrawal by Subject|7|||
163126578|NCT03775512|589172515|FG001|Overall Study|Withdrawal by Subject|4|||
163126579|NCT03775512|589172514|FG000|Overall Study|Lost to Follow-up|5|||
163126580|NCT03775512|589172515|FG001|Overall Study|Lost to Follow-up|5|||
163126581|NCT03775512|589172514|FG000|Overall Study|Excluded before Catheter insertion|14|||
163126582|NCT03775512|589172515|FG001|Overall Study|Excluded before Catheter insertion|5|||
163126583|NCT03775512|589172514|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
163126584|NCT03775512|589172515|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
163126585|NCT03775512|589172514|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
163126586|NCT03775512|589172515|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
163126587|NCT02629822|589172516|FG000|Base Study|Lost to Follow-up|2|||
163126588|NCT02629822|589172516|FG000|Base Study|Non-Compliance With Study Drug|1|||
163126589|NCT02629822|589172516|FG000|Extension Study|Adverse Event|1|||
163126590|NCT02629822|589172516|FG000|Extension Study|Lost to Follow-up|1|||
163126591|NCT01610336|589172517|FG000|Overall Study|Progressive Disease|4|||
163126592|NCT01610336|589172518|FG001|Overall Study|Progressive Disease|6|||
163126593|NCT01610336|589172519|FG002|Overall Study|Progressive Disease|6|||
163126594|NCT01610336|589172520|FG003|Overall Study|Progressive Disease|5|||
163126595|NCT01610336|589172521|FG004|Overall Study|Progressive Disease|3|||
163126596|NCT01610336|589172522|FG005|Overall Study|Progressive Disease|10|||
163126597|NCT01610336|589172523|FG006|Overall Study|Progressive Disease|1|||
163126598|NCT01610336|589172524|FG007|Overall Study|Progressive Disease|6|||
163126599|NCT01610336|589172525|FG008|Overall Study|Progressive Disease|6|||
163126600|NCT01610336|589172526|FG009|Overall Study|Progressive Disease|40|||
163126601|NCT01610336|589172527|FG010|Overall Study|Progressive Disease|36|||
163126602|NCT01610336|589172517|FG000|Overall Study|Adverse Event|0|||
163126603|NCT01610336|589172518|FG001|Overall Study|Adverse Event|0|||
163126604|NCT01610336|589172519|FG002|Overall Study|Adverse Event|0|||
163126605|NCT01610336|589172520|FG003|Overall Study|Adverse Event|1|||
163126606|NCT01610336|589172521|FG004|Overall Study|Adverse Event|1|||
163126607|NCT01610336|589172522|FG005|Overall Study|Adverse Event|1|||
163126608|NCT01610336|589172523|FG006|Overall Study|Adverse Event|0|||
163126609|NCT01610336|589172524|FG007|Overall Study|Adverse Event|0|||
163126610|NCT01610336|589172525|FG008|Overall Study|Adverse Event|2|||
163126611|NCT01610336|589172526|FG009|Overall Study|Adverse Event|8|||
163126612|NCT01610336|589172527|FG010|Overall Study|Adverse Event|6|||
163126613|NCT01610336|589172517|FG000|Overall Study|Subject/Guardian decision|1|||
163126614|NCT01610336|589172518|FG001|Overall Study|Subject/Guardian decision|1|||
163126615|NCT01610336|589172519|FG002|Overall Study|Subject/Guardian decision|0|||
163126616|NCT01610336|589172520|FG003|Overall Study|Subject/Guardian decision|1|||
163126617|NCT01610336|589172521|FG004|Overall Study|Subject/Guardian decision|0|||
163126618|NCT01610336|589172522|FG005|Overall Study|Subject/Guardian decision|0|||
163126619|NCT01610336|589172523|FG006|Overall Study|Subject/Guardian decision|0|||
163126620|NCT01610336|589172524|FG007|Overall Study|Subject/Guardian decision|1|||
163126621|NCT01610336|589172525|FG008|Overall Study|Subject/Guardian decision|0|||
163126622|NCT01610336|589172526|FG009|Overall Study|Subject/Guardian decision|2|||
163126623|NCT01610336|589172527|FG010|Overall Study|Subject/Guardian decision|2|||
163126624|NCT01610336|589172517|FG000|Overall Study|Death|0|||
163126625|NCT01610336|589172518|FG001|Overall Study|Death|0|||
163126626|NCT01610336|589172519|FG002|Overall Study|Death|0|||
163126627|NCT01610336|589172520|FG003|Overall Study|Death|0|||
163126628|NCT01610336|589172521|FG004|Overall Study|Death|0|||
163126629|NCT01610336|589172522|FG005|Overall Study|Death|1|||
163126630|NCT01610336|589172523|FG006|Overall Study|Death|3|||
163126631|NCT01610336|589172524|FG007|Overall Study|Death|0|||
163126632|NCT01610336|589172525|FG008|Overall Study|Death|0|||
163126633|NCT01610336|589172526|FG009|Overall Study|Death|1|||
163126634|NCT01610336|589172527|FG010|Overall Study|Death|2|||
163126635|NCT01610336|589172517|FG000|Overall Study|Non-Compliance with study treatment|0|||
163342251|NCT02069366|589961285|FG004|Overall Study|Lost to Follow-up|0|||
163342252|NCT02069366|589961286|FG005|Overall Study|Lost to Follow-up|2|||
163126636|NCT01610336|589172518|FG001|Overall Study|Non-Compliance with study treatment|0|||
163126637|NCT01610336|589172519|FG002|Overall Study|Non-Compliance with study treatment|0|||
163126638|NCT01610336|589172520|FG003|Overall Study|Non-Compliance with study treatment|0|||
163126639|NCT01610336|589172521|FG004|Overall Study|Non-Compliance with study treatment|0|||
163126640|NCT01610336|589172522|FG005|Overall Study|Non-Compliance with study treatment|0|||
163126641|NCT01610336|589172523|FG006|Overall Study|Non-Compliance with study treatment|0|||
163126642|NCT01610336|589172524|FG007|Overall Study|Non-Compliance with study treatment|0|||
163126643|NCT01610336|589172525|FG008|Overall Study|Non-Compliance with study treatment|0|||
163126644|NCT01610336|589172526|FG009|Overall Study|Non-Compliance with study treatment|1|||
163126645|NCT01610336|589172527|FG010|Overall Study|Non-Compliance with study treatment|0|||
163126646|NCT01610336|589172517|FG000|Overall Study|Physician Decision|0|||
163126647|NCT01610336|589172518|FG001|Overall Study|Physician Decision|0|||
163126648|NCT01610336|589172519|FG002|Overall Study|Physician Decision|0|||
163126649|NCT01610336|589172520|FG003|Overall Study|Physician Decision|0|||
163126650|NCT01610336|589172521|FG004|Overall Study|Physician Decision|0|||
163342253|NCT02069366|589961281|FG000|Overall Study|Protocol Violation|0|||
163342254|NCT02069366|589961282|FG001|Overall Study|Protocol Violation|0|||
163342255|NCT02069366|589961283|FG002|Overall Study|Protocol Violation|1|||
163342256|NCT02069366|589961284|FG003|Overall Study|Protocol Violation|0|||
163342257|NCT02069366|589961285|FG004|Overall Study|Protocol Violation|0|||
163342258|NCT02069366|589961286|FG005|Overall Study|Protocol Violation|0|||
163342259|NCT02069366|589961281|FG000|Overall Study|Withdrawal by Subject|1|||
163342260|NCT02069366|589961282|FG001|Overall Study|Withdrawal by Subject|0|||
163342261|NCT02069366|589961283|FG002|Overall Study|Withdrawal by Subject|1|||
163342262|NCT02069366|589961284|FG003|Overall Study|Withdrawal by Subject|2|||
163342263|NCT02069366|589961285|FG004|Overall Study|Withdrawal by Subject|0|||
163342264|NCT02069366|589961286|FG005|Overall Study|Withdrawal by Subject|0|||
163342265|NCT03314233|589961287|FG000|Overall Study|No longer eligible at time of delivery|1|||
163342266|NCT01797705|589961288|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
163342267|NCT01797705|589961288|FG000|Overall Study|Withdrawal by Subject|1|||
163342268|NCT01838447|589961289|FG000|Overall Study|Change in surgical plan|1|||
163342269|NCT01838447|589961290|FG001|Overall Study|Change in surgical plan|2|||
163342270|NCT01838447|589961289|FG000|Overall Study|Withdrawal by Subject|1|||
163342271|NCT01838447|589961290|FG001|Overall Study|Withdrawal by Subject|1|||
163342272|NCT02030847|589961292|FG000|Overall Study|Death|10|||
163342273|NCT02030847|589961292|FG000|Overall Study|Disease Progression|15|||
163126651|NCT01610336|589172522|FG005|Overall Study|Physician Decision|0|||
163126652|NCT01610336|589172523|FG006|Overall Study|Physician Decision|1|||
163126653|NCT01610336|589172524|FG007|Overall Study|Physician Decision|0|||
163126654|NCT01610336|589172525|FG008|Overall Study|Physician Decision|0|||
163126655|NCT01610336|589172526|FG009|Overall Study|Physician Decision|0|||
163126656|NCT01610336|589172527|FG010|Overall Study|Physician Decision|0|||
163126657|NCT01610336|589172517|FG000|Overall Study|Protocol Deviation|0|||
163126658|NCT01610336|589172518|FG001|Overall Study|Protocol Deviation|0|||
163126659|NCT01610336|589172519|FG002|Overall Study|Protocol Deviation|0|||
163126660|NCT01610336|589172520|FG003|Overall Study|Protocol Deviation|0|||
163126661|NCT01610336|589172521|FG004|Overall Study|Protocol Deviation|0|||
163126662|NCT01610336|589172522|FG005|Overall Study|Protocol Deviation|0|||
163126663|NCT01610336|589172523|FG006|Overall Study|Protocol Deviation|0|||
163126664|NCT01610336|589172524|FG007|Overall Study|Protocol Deviation|0|||
163126665|NCT01610336|589172525|FG008|Overall Study|Protocol Deviation|0|||
163126666|NCT01610336|589172526|FG009|Overall Study|Protocol Deviation|1|||
163126667|NCT01610336|589172527|FG010|Overall Study|Protocol Deviation|0|||
163126668|NCT01610336|589172517|FG000|Overall Study|Transfer to another trial|0|||
163126669|NCT01610336|589172518|FG001|Overall Study|Transfer to another trial|0|||
163126670|NCT01610336|589172519|FG002|Overall Study|Transfer to another trial|0|||
163126671|NCT01610336|589172520|FG003|Overall Study|Transfer to another trial|0|||
163126672|NCT01610336|589172521|FG004|Overall Study|Transfer to another trial|0|||
163126673|NCT01610336|589172522|FG005|Overall Study|Transfer to another trial|0|||
163126674|NCT01610336|589172523|FG006|Overall Study|Transfer to another trial|0|||
163126675|NCT01610336|589172524|FG007|Overall Study|Transfer to another trial|0|||
163126676|NCT01610336|589172525|FG008|Overall Study|Transfer to another trial|0|||
163126677|NCT01610336|589172526|FG009|Overall Study|Transfer to another trial|0|||
163126678|NCT01610336|589172527|FG010|Overall Study|Transfer to another trial|1|||
163126679|NCT00082407|589172528|FG000|Overall Study|Adverse Event|20|||
163126680|NCT00082407|589172529|FG001|Overall Study|Adverse Event|0|||
163126681|NCT00082407|589172528|FG000|Overall Study|Protocol Violation|14|||
163126682|NCT00082407|589172529|FG001|Overall Study|Protocol Violation|12|||
163126683|NCT00082407|589172528|FG000|Overall Study|Patient Decision|13|||
163126684|NCT00082407|589172529|FG001|Overall Study|Patient Decision|6|||
163126685|NCT00082407|589172528|FG000|Overall Study|Physician Decision|5|||
163126686|NCT00082407|589172529|FG001|Overall Study|Physician Decision|3|||
163126687|NCT00082407|589172528|FG000|Overall Study|Loss of Glucose Control|2|||
163342274|NCT02030847|589961292|FG000|Overall Study|New Cancer Therapy|8|||
163342275|NCT02030847|589961292|FG000|Overall Study|Physician Decision|3|||
163126688|NCT00082407|589172529|FG001|Overall Study|Loss of Glucose Control|2|||
163126689|NCT00082407|589172528|FG000|Overall Study|Death|2|||
163126690|NCT00082407|589172529|FG001|Overall Study|Death|1|||
163126691|NCT00082407|589172528|FG000|Overall Study|Lost to Follow-up|0|||
163126692|NCT00082407|589172529|FG001|Overall Study|Lost to Follow-up|3|||
163126693|NCT03464019|589172530|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
163126694|NCT03464019|589172531|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
163342276|NCT02030847|589961292|FG000|Overall Study|Withdrawal by Subject|1|||
163342277|NCT00168805|589961293|FG000|Overall Study|Adverse Event|7|||
163342278|NCT00168805|589961294|FG001|Overall Study|Adverse Event|11|||
163126695|NCT03464019|589172532|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
163126696|NCT03464019|589172530|FG000|NODE-301 Part 1|Ablation|0|||
163126697|NCT03464019|589172531|FG001|NODE-301 Part 1|Ablation|0|||
163126698|NCT03464019|589172532|FG002|NODE-301 Part 1|Ablation|16|||
163126699|NCT03464019|589172530|FG000|NODE-301 Part 1|Test Dose Failure|0|||
163126700|NCT03464019|589172531|FG001|NODE-301 Part 1|Test Dose Failure|0|||
163126701|NCT03464019|589172532|FG002|NODE-301 Part 1|Test Dose Failure|8|||
163342279|NCT00168805|589961295|FG002|Overall Study|Adverse Event|16|||
163342280|NCT00168805|589961293|FG000|Overall Study|Protocol Violation|12|||
163126702|NCT03464019|589172530|FG000|NODE-301 Part 1|Adverse Event|0|||
163126703|NCT03464019|589172531|FG001|NODE-301 Part 1|Adverse Event|0|||
163126704|NCT03464019|589172532|FG002|NODE-301 Part 1|Adverse Event|5|||
163126705|NCT03464019|589172530|FG000|NODE-301 Part 1|Physician Decision|0|||
163126706|NCT03464019|589172531|FG001|NODE-301 Part 1|Physician Decision|0|||
163126707|NCT03464019|589172532|FG002|NODE-301 Part 1|Physician Decision|4|||
163126708|NCT03464019|589172530|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
163126709|NCT03464019|589172531|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
163126710|NCT03464019|589172532|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
163126711|NCT03464019|589172530|FG000|NODE-301 Part 1|Protocol Violation|0|||
163126712|NCT03464019|589172531|FG001|NODE-301 Part 1|Protocol Violation|0|||
163126713|NCT03464019|589172532|FG002|NODE-301 Part 1|Protocol Violation|2|||
163126714|NCT03464019|589172530|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
163126715|NCT03464019|589172531|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
163126716|NCT03464019|589172532|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
163126717|NCT03464019|589172530|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
163126718|NCT03464019|589172531|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
163126719|NCT03464019|589172532|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
163126720|NCT03464019|589172530|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
163126721|NCT03464019|589172531|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
163126722|NCT03464019|589172532|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
163126723|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
163126724|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
163126725|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
163126726|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
163126727|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
163126728|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
163126729|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
163126730|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
163126731|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
163126732|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
163126733|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
163126734|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
163126735|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
163126736|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
163126737|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
163126738|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
163126739|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
163126740|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
163126741|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
163126742|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
163126743|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
163126744|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
163126745|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
163126746|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
163126747|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
163126748|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
163126749|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
163126750|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
163126751|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
163126752|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
163126753|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
163126754|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
163126755|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
163126756|NCT00767806|589172533|FG000|Overall Study|Adverse Event|30|||
163126757|NCT00767806|589172534|FG001|Overall Study|Adverse Event|11|||
163126758|NCT00767806|589172533|FG000|Overall Study|Withdrawal by Subject|8|||
163126759|NCT00767806|589172534|FG001|Overall Study|Withdrawal by Subject|13|||
163126760|NCT00767806|589172533|FG000|Overall Study|Protocol Violation|6|||
163126761|NCT00767806|589172534|FG001|Overall Study|Protocol Violation|5|||
163126762|NCT00767806|589172533|FG000|Overall Study|Lack of Efficacy|1|||
163126763|NCT00767806|589172534|FG001|Overall Study|Lack of Efficacy|9|||
163126764|NCT00767806|589172533|FG000|Overall Study|Physician Decision|4|||
163126765|NCT00767806|589172534|FG001|Overall Study|Physician Decision|3|||
163126766|NCT00767806|589172533|FG000|Overall Study|Lost to Follow-up|1|||
163126767|NCT00767806|589172534|FG001|Overall Study|Lost to Follow-up|4|||
163126768|NCT00767806|589172533|FG000|Overall Study|Entry Criteria Not Met|1|||
163126769|NCT00767806|589172534|FG001|Overall Study|Entry Criteria Not Met|1|||
163126770|NCT00767806|589172533|FG000|Overall Study|Sponsor Decision|0|||
163126771|NCT00767806|589172534|FG001|Overall Study|Sponsor Decision|1|||
163226730|NCT01393405|589544258|FG000|Maintenance Period Week|Lack of Efficacy|0|||
163126772|NCT02489942|589172535|FG000|Overall Study|Request by patient|602|||
163126773|NCT02489942|589172535|FG000|Overall Study|Improvement/remission|157|||
163126774|NCT02489942|589172535|FG000|Overall Study|No change/Progressive disease|263|||
163126775|NCT02489942|589172535|FG000|Overall Study|Adverse Event|522|||
163126776|NCT02489942|589172535|FG000|Overall Study|Other personal reasons|1218|||
163126777|NCT02489942|589172535|FG000|Overall Study|Lost to Follow-up|456|||
163126778|NCT02489942|589172535|FG000|Overall Study|Not continuously investigated|7|||
163126779|NCT02489942|589172535|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
163126780|NCT02489942|589172535|FG000|Overall Study|Multiple registration|1|||
163126781|NCT02489942|589172535|FG000|Overall Study|No patient visit after entry|100|||
163126782|NCT02489942|589172535|FG000|Overall Study|No treatment with Jardiance|2|||
163126783|NCT02489942|589172535|FG000|Overall Study|Patient received Jardiance before registration|1|||
163126784|NCT02489942|589172535|FG000|Overall Study|No CRF collected|86|||
163126785|NCT00858208|589172536|FG000|Overall Study|Adverse Event|3|||
163126786|NCT00858208|589172536|FG000|Overall Study|Lost to Follow-up|26|||
163126787|NCT00858208|589172536|FG000|Overall Study|Participant refused|40|||
163126788|NCT00858208|589172536|FG000|Overall Study|Other|10|||
163126789|NCT01272635|589172537|FG000|Overall Study|Lost to Follow-up|31|||
163126790|NCT01272635|589172538|FG001|Overall Study|Lost to Follow-up|20|||
163126791|NCT01272635|589172539|FG002|Overall Study|Lost to Follow-up|31|||
163126792|NCT01272635|589172540|FG003|Overall Study|Lost to Follow-up|23|||
163126793|NCT01543776|589172541|FG000|Overall Study|Withdrawal by Subject|2|||
163126794|NCT01543776|589172542|FG001|Overall Study|Withdrawal by Subject|2|||
163126795|NCT00567359|589172543|FG000|Overall Study|Withdrawal by Subject|1|||
163126796|NCT02352753|589172544|FG000|6-Month Dosing Period|Decision by sponsor|2|||
163126797|NCT02352753|589172544|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
163126798|NCT02352753|589172544|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
163126799|NCT02352753|589172544|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
163126800|NCT02352753|589172544|FG000|3-Month Dosing Period|Decision by sponsor|14|||
163126801|NCT02352753|589172544|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
163126802|NCT00539305|589172545|FG000|Overall Study|Adverse Event|1|||
163126803|NCT00539305|589172546|FG001|Overall Study|Adverse Event|0|||
163126804|NCT00539305|589172545|FG000|Overall Study|Substance Use|0|||
163126805|NCT00539305|589172546|FG001|Overall Study|Substance Use|1|||
163126806|NCT00539305|589172545|FG000|Overall Study|Withdrawal by Subject|0|||
163126807|NCT00539305|589172546|FG001|Overall Study|Withdrawal by Subject|1|||
163126808|NCT00126776|589172548|FG000|Overall Study|follow up complete on all patients|0|||
163126809|NCT00126776|589172549|FG001|Overall Study|follow up complete on all patients|0|||
163126810|NCT00679172|589172553|FG000|Overall Study|Non-compliance|1|||
163126811|NCT00679172|589172554|FG001|Overall Study|Non-compliance|1|||
163126812|NCT00679172|589172555|FG002|Overall Study|Non-compliance|0|||
163126813|NCT00679172|589172556|FG003|Overall Study|Non-compliance|1|||
163126814|NCT00679172|589172557|FG004|Overall Study|Non-compliance|0|||
163126815|NCT00679172|589172553|FG000|Overall Study|Other not specified|0|||
163126816|NCT00679172|589172554|FG001|Overall Study|Other not specified|0|||
163126817|NCT00679172|589172555|FG002|Overall Study|Other not specified|1|||
163126818|NCT00679172|589172556|FG003|Overall Study|Other not specified|0|||
163126819|NCT00679172|589172557|FG004|Overall Study|Other not specified|0|||
163126820|NCT00417963|589172558|FG000|Overall Study|Lost to Follow-up|3|||
163126821|NCT00417963|589172558|FG000|Overall Study|Withdrawal by Subject|18|||
163126822|NCT00417963|589172558|FG000|Overall Study|Death|17|||
163126823|NCT00417963|589172558|FG000|Overall Study|Study device could not be deployed|3|||
163126824|NCT01815840|589172559|FG000|Overall Study|Missing|1|||
163126825|NCT01815840|589172560|FG001|Overall Study|Missing|0|||
163126826|NCT01815840|589172559|FG000|Overall Study|Withdrew Consent|31|||
163126827|NCT01815840|589172560|FG001|Overall Study|Withdrew Consent|30|||
163126828|NCT01815840|589172559|FG000|Overall Study|Administrative/Other|1|||
163126829|NCT01815840|589172560|FG001|Overall Study|Administrative/Other|3|||
163126830|NCT01815840|589172559|FG000|Overall Study|Adverse Event|10|||
163342281|NCT00168805|589961294|FG001|Overall Study|Protocol Violation|11|||
163342282|NCT00168805|589961295|FG002|Overall Study|Protocol Violation|8|||
163342283|NCT00168805|589961293|FG000|Overall Study|Lost to Follow-up|12|||
163342284|NCT00168805|589961294|FG001|Overall Study|Lost to Follow-up|17|||
163342285|NCT00168805|589961295|FG002|Overall Study|Lost to Follow-up|11|||
163342286|NCT00168805|589961293|FG000|Overall Study|Withdrawal by Subject|16|||
163126831|NCT01815840|589172560|FG001|Overall Study|Adverse Event|16|||
163226731|NCT01393405|589544259|FG001|Maintenance Period Week|Lack of Efficacy|22|||
163126832|NCT01815840|589172559|FG000|Overall Study|Death|2|||
163126833|NCT01815840|589172560|FG001|Overall Study|Death|2|||
163226732|NCT01393405|589544260|FG002|Maintenance Period Week|Lack of Efficacy|22|||
163126834|NCT01815840|589172559|FG000|Overall Study|Disease progression|3|||
163126835|NCT01815840|589172560|FG001|Overall Study|Disease progression|2|||
163342287|NCT00168805|589961294|FG001|Overall Study|Withdrawal by Subject|18|||
163126836|NCT01815840|589172559|FG000|Overall Study|Investigators Decision|2|||
163226733|NCT01393405|589544258|FG000|Maintenance Period Week|Adverse Event|0|||
163126837|NCT01815840|589172560|FG001|Overall Study|Investigators Decision|3|||
163126838|NCT01815840|589172559|FG000|Overall Study|Lost to Follow-up|3|||
163126839|NCT01815840|589172560|FG001|Overall Study|Lost to Follow-up|6|||
163342288|NCT00168805|589961295|FG002|Overall Study|Withdrawal by Subject|21|||
163342289|NCT00168805|589961293|FG000|Overall Study|Other|24|||
163342290|NCT00168805|589961294|FG001|Overall Study|Other|21|||
163342291|NCT00168805|589961295|FG002|Overall Study|Other|22|||
163342292|NCT00168805|589961293|FG000|Treatment|Adverse Event|25|||
163342293|NCT00168805|589961294|FG001|Treatment|Adverse Event|26|||
163342294|NCT00168805|589961295|FG002|Treatment|Adverse Event|32|||
163342295|NCT00168805|589961293|FG000|Treatment|Protocol Violation|3|||
163342296|NCT00168805|589961294|FG001|Treatment|Protocol Violation|5|||
163342297|NCT00168805|589961295|FG002|Treatment|Protocol Violation|5|||
163342298|NCT00168805|589961293|FG000|Treatment|Withdrawal by Subject|3|||
163342299|NCT00168805|589961294|FG001|Treatment|Withdrawal by Subject|7|||
163342300|NCT00168805|589961295|FG002|Treatment|Withdrawal by Subject|8|||
163342301|NCT00168805|589961293|FG000|Treatment|Other|18|||
163342302|NCT00168805|589961294|FG001|Treatment|Other|18|||
163342303|NCT00168805|589961295|FG002|Treatment|Other|17|||
163342304|NCT01114217|589961296|FG000|Overall Study|Adverse Event|5|||
163342305|NCT01114217|589961297|FG001|Overall Study|Adverse Event|3|||
163342306|NCT01114217|589961296|FG000|Overall Study|Lost to Follow-up|17|||
163342307|NCT01114217|589961297|FG001|Overall Study|Lost to Follow-up|33|||
163342308|NCT01114217|589961296|FG000|Overall Study|Withdrawal by Subject|21|||
163342309|NCT01114217|589961297|FG001|Overall Study|Withdrawal by Subject|28|||
163342310|NCT01114217|589961296|FG000|Overall Study|Other-Clerical Error|3|||
163342311|NCT01114217|589961297|FG001|Overall Study|Other-Clerical Error|0|||
163342312|NCT01114217|589961296|FG000|Overall Study|Other-Early termination|6|||
163342313|NCT01114217|589961297|FG001|Overall Study|Other-Early termination|10|||
163342314|NCT01114217|589961296|FG000|Overall Study|Other-Procedure|1|||
163342315|NCT01114217|589961297|FG001|Overall Study|Other-Procedure|1|||
163342316|NCT01114217|589961296|FG000|Overall Study|Other-Pregnancy|2|||
163342317|NCT01114217|589961297|FG001|Overall Study|Other-Pregnancy|4|||
163342318|NCT01114217|589961296|FG000|Overall Study|Other-Protocol Violation|1|||
163342319|NCT01114217|589961297|FG001|Overall Study|Other-Protocol Violation|3|||
163342320|NCT01114217|589961296|FG000|Overall Study|Other-Lack of Efficacy|1|||
163342321|NCT01114217|589961297|FG001|Overall Study|Other-Lack of Efficacy|0|||
163342322|NCT01114217|589961296|FG000|Overall Study|Other-Non Compliance|2|||
163342323|NCT01114217|589961297|FG001|Overall Study|Other-Non Compliance|0|||
163342324|NCT01114217|589961296|FG000|Overall Study|Other-Physician Decision|1|||
163342325|NCT01114217|589961297|FG001|Overall Study|Other-Physician Decision|1|||
163342326|NCT01114217|589961296|FG000|Overall Study|Other-Sponsor Decision|10|||
163342327|NCT01114217|589961297|FG001|Overall Study|Other-Sponsor Decision|12|||
163342328|NCT01114217|589961296|FG000|Overall Study|Other-Study Termination|0|||
163342329|NCT01114217|589961297|FG001|Overall Study|Other-Study Termination|1|||
163342330|NCT01114217|589961296|FG000|Overall Study|Other-Study Withdrawn|1|||
163342331|NCT01114217|589961297|FG001|Overall Study|Other-Study Withdrawn|1|||
163342332|NCT01114217|589961296|FG000|Overall Study|Other-Site Stopped Communicating|2|||
163342333|NCT01114217|589961297|FG001|Overall Study|Other-Site Stopped Communicating|0|||
163342334|NCT01114217|589961296|FG000|Overall Study|Other-Lost to Follow-up|1|||
163342335|NCT01114217|589961297|FG001|Overall Study|Other-Lost to Follow-up|0|||
163342336|NCT01114217|589961296|FG000|Overall Study|Other-Withdrawal by Subject|1|||
163342337|NCT01114217|589961297|FG001|Overall Study|Other-Withdrawal by Subject|1|||
163342338|NCT01837719|589961298|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
163342339|NCT01837719|589961298|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
163342340|NCT01703988|589961299|FG000|Overall Study|Investigator Judgment|0|||
163342341|NCT01703988|589961300|FG001|Overall Study|Investigator Judgment|0|||
163342342|NCT01703988|589961301|FG002|Overall Study|Investigator Judgment|0|||
163126840|NCT01815840|589172559|FG000|Overall Study|Refused Treatment|5|||
163126841|NCT01815840|589172560|FG001|Overall Study|Refused Treatment|1|||
163126842|NCT01815840|589172559|FG000|Overall Study|Sponsor Termination Treatment|1|||
163126843|NCT01815840|589172560|FG001|Overall Study|Sponsor Termination Treatment|0|||
163342343|NCT01703988|589961302|FG003|Overall Study|Investigator Judgment|1|||
163342344|NCT06247488|589961303|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
163342345|NCT06247488|589961304|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
163342346|NCT06247488|589961305|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
163342347|NCT06247488|589961306|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
163342348|NCT06247488|589961307|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
163126844|NCT00434642|589172561|FG000|Blinded Treatment Phase|Adverse Event|12|||
163126845|NCT00434642|589172562|FG001|Blinded Treatment Phase|Adverse Event|58|||
163126846|NCT00434642|589172561|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
163342349|NCT06247488|589961308|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
163342350|NCT06247488|589961303|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
163342351|NCT06247488|589961304|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
163342352|NCT06247488|589961305|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
163342353|NCT06247488|589961306|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
163342354|NCT06247488|589961307|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
163342355|NCT06247488|589961308|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
163342356|NCT06247488|589961303|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
163126847|NCT00434642|589172562|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
163126848|NCT00434642|589172561|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
163126849|NCT00434642|589172562|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
163126850|NCT00434642|589172561|FG000|Blinded Treatment Phase|Physician Decision|19|||
163126851|NCT00434642|589172562|FG001|Blinded Treatment Phase|Physician Decision|27|||
163126852|NCT00434642|589172561|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
163126853|NCT00434642|589172562|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
163126854|NCT00434642|589172561|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
163126855|NCT00434642|589172562|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
163126856|NCT00434642|589172561|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
163126857|NCT00434642|589172562|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
163126858|NCT00434642|589172561|FG000|Open-label Treatment Phase|Adverse Event|0|||
163126859|NCT00434642|589172562|FG001|Open-label Treatment Phase|Adverse Event|5|||
163126860|NCT00434642|589172561|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
163126861|NCT00434642|589172562|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
163126862|NCT05011058|589172565|FG000|Overall Study|Sponsor Decision|2|||
163126863|NCT05011058|589172566|FG001|Overall Study|Sponsor Decision|0|||
163126864|NCT05011058|589172567|FG002|Overall Study|Sponsor Decision|14|||
163126865|NCT05011058|589172568|FG003|Overall Study|Sponsor Decision|0|||
163126866|NCT05011058|589172569|FG004|Overall Study|Sponsor Decision|0|||
163126867|NCT05011058|589172570|FG005|Overall Study|Sponsor Decision|1|||
163126868|NCT05011058|589172571|FG006|Overall Study|Sponsor Decision|0|||
163126869|NCT05011058|589172572|FG007|Overall Study|Sponsor Decision|5|||
163126870|NCT02455076|589172573|FG000|Inpatient|Withdrawal by Subject|1|||
163126871|NCT02455076|589172574|FG001|Inpatient|Withdrawal by Subject|0|||
163126872|NCT02455076|589172575|FG002|Inpatient|Withdrawal by Subject|0|||
163126873|NCT02455076|589172576|FG003|Inpatient|Withdrawal by Subject|0|||
163126874|NCT02455076|589172577|FG004|Inpatient|Withdrawal by Subject|0|||
163126875|NCT02455076|589172573|FG000|Inpatient|Discharged <24 h after admission|0|||
163126876|NCT02455076|589172574|FG001|Inpatient|Discharged <24 h after admission|1|||
163126877|NCT02455076|589172575|FG002|Inpatient|Discharged <24 h after admission|0|||
163126878|NCT02455076|589172576|FG003|Inpatient|Discharged <24 h after admission|0|||
163126879|NCT02455076|589172577|FG004|Inpatient|Discharged <24 h after admission|0|||
163126880|NCT02455076|589172573|FG000|Inpatient|Adverse Event|3|||
163126881|NCT02455076|589172574|FG001|Inpatient|Adverse Event|0|||
163126882|NCT02455076|589172575|FG002|Inpatient|Adverse Event|0|||
163126883|NCT02455076|589172576|FG003|Inpatient|Adverse Event|0|||
163126884|NCT02455076|589172577|FG004|Inpatient|Adverse Event|0|||
163126885|NCT02455076|589172573|FG000|Outpatient|Adverse Event|0|||
163126886|NCT02455076|589172574|FG001|Outpatient|Adverse Event|0|||
163126887|NCT02455076|589172575|FG002|Outpatient|Adverse Event|0|||
163126888|NCT02455076|589172576|FG003|Outpatient|Adverse Event|5|||
163126889|NCT02455076|589172577|FG004|Outpatient|Adverse Event|0|||
163126890|NCT02455076|589172573|FG000|Outpatient|Lost to Follow-up|0|||
163126891|NCT02455076|589172574|FG001|Outpatient|Lost to Follow-up|0|||
163126892|NCT02455076|589172575|FG002|Outpatient|Lost to Follow-up|0|||
163126893|NCT02455076|589172576|FG003|Outpatient|Lost to Follow-up|1|||
163126894|NCT02455076|589172577|FG004|Outpatient|Lost to Follow-up|12|||
163126895|NCT03908476|589172579|FG000|Overall Study|Death|3|||
163126896|NCT03908476|589172580|FG001|Overall Study|Death|0|||
163126897|NCT03908476|589172579|FG000|Overall Study|Lost to Follow-up|3|||
163126898|NCT03908476|589172580|FG001|Overall Study|Lost to Follow-up|1|||
163126899|NCT03908476|589172579|FG000|Overall Study|Withdrawal by Subject|7|||
163126900|NCT03908476|589172580|FG001|Overall Study|Withdrawal by Subject|1|||
163126901|NCT03908476|589172579|FG000|Overall Study|Physician Decision|2|||
163126902|NCT03908476|589172580|FG001|Overall Study|Physician Decision|0|||
163126903|NCT03908476|589172579|FG000|Overall Study|System Explanted and not Replaced|4|||
163126904|NCT03908476|589172580|FG001|Overall Study|System Explanted and not Replaced|0|||
163126905|NCT03908476|589172579|FG000|Overall Study|Intrathecal Pump|1|||
163126906|NCT03908476|589172580|FG001|Overall Study|Intrathecal Pump|0|||
163126907|NCT03908476|589172579|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
163126908|NCT03908476|589172580|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
163126909|NCT05194267|589172581|FG000|Overall Study|Withdrawal by Subject|2|||
163126910|NCT02868229|589172582|FG000|Overall Study|Adverse Event|1|||
163126911|NCT02868229|589172583|FG001|Overall Study|Adverse Event|0|||
163126912|NCT02868229|589172584|FG002|Overall Study|Adverse Event|0|||
163126913|NCT02868229|589172585|FG003|Overall Study|Adverse Event|1|||
163126914|NCT02868229|589172582|FG000|Overall Study|Death|0|||
163126915|NCT02868229|589172583|FG001|Overall Study|Death|0|||
163126916|NCT02868229|589172584|FG002|Overall Study|Death|1|||
163126917|NCT02868229|589172585|FG003|Overall Study|Death|1|||
163126918|NCT02868229|589172582|FG000|Overall Study|Missed dose|0|||
163126919|NCT02868229|589172583|FG001|Overall Study|Missed dose|0|||
163126920|NCT02868229|589172584|FG002|Overall Study|Missed dose|0|||
163126921|NCT02868229|589172585|FG003|Overall Study|Missed dose|3|||
163126922|NCT06151288|589172586|FG000|Overall Study|Lost to Follow-up|4|||
163126923|NCT06151288|589172587|FG001|Overall Study|Lost to Follow-up|2|||
163126924|NCT06151288|589172588|FG002|Overall Study|Lost to Follow-up|4|||
163342357|NCT06247488|589961304|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
163342358|NCT06247488|589961305|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
163342359|NCT06247488|589961306|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
163342360|NCT06247488|589961307|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
163342361|NCT06247488|589961308|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
163342362|NCT06247488|589961303|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
163342363|NCT06247488|589961304|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
163126925|NCT06151288|589172589|FG003|Overall Study|Lost to Follow-up|3|||
163126926|NCT06151288|589172586|FG000|Overall Study|Withdrawal by Subject|4|||
163126927|NCT06151288|589172587|FG001|Overall Study|Withdrawal by Subject|5|||
163126928|NCT06151288|589172588|FG002|Overall Study|Withdrawal by Subject|1|||
163126929|NCT06151288|589172589|FG003|Overall Study|Withdrawal by Subject|1|||
163126930|NCT00719680|589172593|FG000|Overall Study|Adverse Event|1|||
163126931|NCT00719680|589172593|FG000|Overall Study|Lost to Follow-up|1|||
163126932|NCT00719680|589172593|FG000|Overall Study|Withdrawal by Subject|3|||
163126933|NCT01646203|589172607|FG000|Overall Study|Adverse Event|2|||
163126934|NCT01646203|589172608|FG001|Overall Study|Adverse Event|0|||
163126935|NCT01646203|589172609|FG002|Overall Study|Adverse Event|1|||
163342364|NCT06247488|589961305|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
163342365|NCT06247488|589961306|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
163126936|NCT01646203|589172607|FG000|Overall Study|Withdrawal by Subject|0|||
163126937|NCT01646203|589172608|FG001|Overall Study|Withdrawal by Subject|1|||
163126938|NCT01646203|589172609|FG002|Overall Study|Withdrawal by Subject|0|||
163126939|NCT01646203|589172607|FG000|Overall Study|Physician's Decision|0|||
163126940|NCT01646203|589172608|FG001|Overall Study|Physician's Decision|1|||
163126941|NCT01646203|589172609|FG002|Overall Study|Physician's Decision|0|||
163126942|NCT04676867|589172610|FG000|Overall Study|Screen failure|0|||
163126943|NCT04676867|589172611|FG001|Overall Study|Screen failure|0|||
163126944|NCT04676867|589172612|FG002|Overall Study|Screen failure|6|||
163126945|NCT04676867|589172613|FG003|Overall Study|Screen failure|2|||
163126946|NCT04676867|589172610|FG000|Overall Study|Death|0|||
163126947|NCT04676867|589172611|FG001|Overall Study|Death|0|||
163126948|NCT04676867|589172612|FG002|Overall Study|Death|1|||
163126949|NCT04676867|589172613|FG003|Overall Study|Death|0|||
163126950|NCT04676867|589172610|FG000|Overall Study|Withdrawal by Subject|2|||
163126951|NCT04676867|589172611|FG001|Overall Study|Withdrawal by Subject|2|||
163126952|NCT04676867|589172612|FG002|Overall Study|Withdrawal by Subject|4|||
163126953|NCT04676867|589172613|FG003|Overall Study|Withdrawal by Subject|4|||
163126954|NCT04676867|589172610|FG000|Overall Study|Lost to Follow-up|1|||
163126955|NCT04676867|589172611|FG001|Overall Study|Lost to Follow-up|0|||
163126956|NCT04676867|589172612|FG002|Overall Study|Lost to Follow-up|0|||
163126957|NCT04676867|589172613|FG003|Overall Study|Lost to Follow-up|0|||
163126958|NCT00551291|589172617|FG000|Overall Study|Physician Decision|1|||
163126959|NCT04268173|589172618|FG000|Overall Study|Lost to Follow-up|75|||
163126960|NCT04268173|589172619|FG001|Overall Study|Lost to Follow-up|108|||
163126961|NCT01375608|589172620|FG000|Overall Study|Withdrawal by Subject|2|||
163126962|NCT01953913|589172621|FG000|Overall Study|Disease Progression|349|||
163126963|NCT01953913|589172621|FG000|Overall Study|Worsening of underlying cancer|22|||
163126964|NCT01953913|589172621|FG000|Overall Study|Adverse Event|20|||
163126965|NCT01953913|589172621|FG000|Overall Study|Protocol Violation|6|||
163126966|NCT01953913|589172621|FG000|Overall Study|Lost to Follow-up|4|||
163126967|NCT01953913|589172621|FG000|Overall Study|Withdrawal by Subject|32|||
163126968|NCT01953913|589172621|FG000|Overall Study|Other than listed|108|||
163126969|NCT01953913|589172621|FG000|Overall Study|Not Treated|1|||
163126970|NCT02925741|589172622|FG000|Overall Study|Withdrawal by Subject|11|||
163126971|NCT02925741|589172623|FG001|Overall Study|Withdrawal by Subject|0|||
163126972|NCT02437084|589172624|FG000|Overall Study|Withdrawal by Subject|2|||
163126973|NCT02437084|589172624|FG000|Overall Study|Physician Decision|1|||
163126974|NCT00710385|589172627|FG000|Overall Study|Did not qualify|1|||
163126975|NCT00710385|589172627|FG000|Overall Study|Withdrawal by Subject|1|||
163126976|NCT00710385|589172627|FG000|Overall Study|Undisclosed back pain|1|||
163126977|NCT00710385|589172627|FG000|Overall Study|Physician Decision|1|||
163342366|NCT06247488|589961307|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
163342367|NCT06247488|589961308|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
163126978|NCT00710385|589172627|FG000|Overall Study|Undisclosed excessive methadone use|1|||
163126979|NCT02976103|589172628|FG000|Overall Study|Withdrawal by Subject|1|||
163126980|NCT02976103|589172629|FG001|Overall Study|Withdrawal by Subject|0|||
163126981|NCT02976103|589172628|FG000|Overall Study|Lost to Follow-up|12|||
163342368|NCT06247488|589961303|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
163126982|NCT02976103|589172629|FG001|Overall Study|Lost to Follow-up|8|||
163126983|NCT00694304|589172630|FG000|Overall Study|Adverse Event|42|||
163126984|NCT00694304|589172630|FG000|Overall Study|Lack of Efficacy|35|||
163126985|NCT00694304|589172630|FG000|Overall Study|Non-compliance With Study Product|16|||
163126986|NCT00694304|589172630|FG000|Overall Study|Protocol Violation|6|||
163126987|NCT00694304|589172630|FG000|Overall Study|Withdrawal of Consent|61|||
163126988|NCT00694304|589172630|FG000|Overall Study|Lost to Follow-up|15|||
163126989|NCT00694304|589172630|FG000|Overall Study|Administrative or Other Reasons|32|||
163126990|NCT03040986|589172633|FG000|Overall Study|Hospice|1|||
163126991|NCT03040986|589172634|FG001|Overall Study|Hospice|0|||
163126992|NCT03040986|589172633|FG000|Overall Study|Adverse Event|2|||
163126993|NCT03040986|589172634|FG001|Overall Study|Adverse Event|1|||
163126994|NCT03040986|589172633|FG000|Overall Study|Disease progression on study|3|||
163126995|NCT03040986|589172634|FG001|Overall Study|Disease progression on study|1|||
163126996|NCT02228096|589172638|FG000|Overall Study|Study terminated by Sponsor|24|||
163126997|NCT02228096|589172638|FG000|Overall Study|Lack of Efficacy|18|||
163126998|NCT02228096|589172638|FG000|Overall Study|Death|12|||
163126999|NCT02228096|589172638|FG000|Overall Study|Physician Decision|3|||
163127000|NCT02228096|589172638|FG000|Overall Study|Subject/guardian decision|2|||
163127001|NCT02228096|589172638|FG000|Overall Study|New therapy for study indication|1|||
163127002|NCT02228096|589172638|FG000|Overall Study|Enrolled, not infused|11|||
163127003|NCT02925728|589172639|FG000|Overall Study|Death|3|||
163127004|NCT02925728|589172640|FG001|Overall Study|Death|5|||
163127005|NCT02925728|589172639|FG000|Overall Study|Physician Decision|1|||
163127006|NCT02925728|589172640|FG001|Overall Study|Physician Decision|0|||
163127007|NCT02925728|589172639|FG000|Overall Study|Withdrawal by Subject|1|||
163127008|NCT02925728|589172640|FG001|Overall Study|Withdrawal by Subject|0|||
163127009|NCT02102399|589172643|FG000|Overall Study|Withdrawal by Subject|6|||
163127010|NCT02102399|589172644|FG001|Overall Study|Withdrawal by Subject|4|||
163127011|NCT03652675|589172645|FG000|Overall Study|Lost to Follow-up|4|||
163127012|NCT03652675|589172646|FG001|Overall Study|Lost to Follow-up|4|||
163127013|NCT00086411|589172653|FG000|Overall Study|Lost to Follow-up|11|||
163127014|NCT00086411|589172654|FG001|Overall Study|Lost to Follow-up|11|||
163127015|NCT00086411|589172655|FG002|Overall Study|Lost to Follow-up|13|||
163127016|NCT00086411|589172656|FG003|Overall Study|Lost to Follow-up|12|||
163127017|NCT00695864|589172659|FG000|Placebo|Withdrawal by Subject|1|||
163127018|NCT00695864|589172659|FG000|Placebo|Physician Decision|4|||
163127019|NCT01624090|589172665|FG000|Overall Study|DLT, taken off therapy|0|||
163127020|NCT01624090|589172666|FG001|Overall Study|DLT, taken off therapy|1|||
163127021|NCT01624090|589172667|FG002|Overall Study|DLT, taken off therapy|0|||
163127022|NCT01624090|589172668|FG003|Overall Study|DLT, taken off therapy|0|||
163127023|NCT01624090|589172665|FG000|Overall Study|Withdrew prior to treatment|0|||
163127024|NCT01624090|589172666|FG001|Overall Study|Withdrew prior to treatment|1|||
163127025|NCT01624090|589172667|FG002|Overall Study|Withdrew prior to treatment|0|||
163127026|NCT01624090|589172668|FG003|Overall Study|Withdrew prior to treatment|0|||
163127027|NCT01624090|589172665|FG000|Overall Study|Died on study|0|||
163127028|NCT01624090|589172666|FG001|Overall Study|Died on study|0|||
163127029|NCT01624090|589172667|FG002|Overall Study|Died on study|2|||
163127030|NCT01624090|589172668|FG003|Overall Study|Died on study|0|||
163127031|NCT01624090|589172665|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
163127032|NCT01624090|589172666|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
163127033|NCT01624090|589172667|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
163127034|NCT01624090|589172668|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
163127035|NCT01624090|589172665|FG000|Overall Study|Dose escalated|0|||
163127036|NCT01624090|589172666|FG001|Overall Study|Dose escalated|0|||
163127037|NCT01624090|589172667|FG002|Overall Study|Dose escalated|3|||
163127038|NCT01624090|589172668|FG003|Overall Study|Dose escalated|0|||
163127039|NCT00752726|589172669|FG000|Overall Study|Lost to Follow-up|2|||
163127040|NCT00752726|589172670|FG001|Overall Study|Lost to Follow-up|1|||
163127041|NCT00752726|589172669|FG000|Overall Study|Adverse Event|3|||
163127042|NCT00752726|589172670|FG001|Overall Study|Adverse Event|0|||
163127043|NCT00752726|589172669|FG000|Overall Study|Withdrawal by Subject|5|||
163127044|NCT00752726|589172670|FG001|Overall Study|Withdrawal by Subject|10|||
163127045|NCT00752726|589172669|FG000|Overall Study|Other Reason|1|||
163127046|NCT00752726|589172670|FG001|Overall Study|Other Reason|2|||
163127047|NCT01403116|589172671|FG000|Overall Study|Adverse Event|7|||
163127048|NCT01403116|589172672|FG001|Overall Study|Adverse Event|4|||
163127049|NCT01403116|589172671|FG000|Overall Study|Lost to Follow-up|7|||
163127050|NCT01403116|589172672|FG001|Overall Study|Lost to Follow-up|5|||
163342369|NCT06247488|589961304|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
163127051|NCT01403116|589172671|FG000|Overall Study|Withdrawal by Subject|12|||
163127052|NCT01403116|589172672|FG001|Overall Study|Withdrawal by Subject|15|||
163127053|NCT01403116|589172671|FG000|Overall Study|Non-compliance of study drug|3|||
163127054|NCT01403116|589172672|FG001|Overall Study|Non-compliance of study drug|0|||
163127055|NCT01403116|589172671|FG000|Overall Study|Protocol Violation|0|||
163342370|NCT06247488|589961305|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
163342371|NCT06247488|589961306|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
163342372|NCT06247488|589961307|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
163127056|NCT01403116|589172672|FG001|Overall Study|Protocol Violation|1|||
163127057|NCT01403116|589172671|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
163127058|NCT01403116|589172672|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
163127059|NCT01403116|589172671|FG000|Overall Study|Hct >54%|2|||
163127060|NCT01403116|589172672|FG001|Overall Study|Hct >54%|0|||
163127061|NCT01403116|589172671|FG000|Overall Study|unable to keep appointments|0|||
163127062|NCT01403116|589172672|FG001|Overall Study|unable to keep appointments|2|||
163127063|NCT01895309|589172673|FG000|Overall Study|Adverse Event|13|||
163127064|NCT01895309|589172674|FG001|Overall Study|Adverse Event|17|||
163127065|NCT01895309|589172673|FG000|Overall Study|Protocol Violation|1|||
163127066|NCT01895309|589172674|FG001|Overall Study|Protocol Violation|0|||
163127067|NCT01895309|589172673|FG000|Overall Study|Lack of Efficacy|1|||
163127068|NCT01895309|589172674|FG001|Overall Study|Lack of Efficacy|3|||
163127069|NCT01895309|589172673|FG000|Overall Study|Lost to Follow-up|1|||
163127070|NCT01895309|589172674|FG001|Overall Study|Lost to Follow-up|3|||
163127071|NCT01895309|589172673|FG000|Overall Study|Physician Decision|15|||
163127072|NCT01895309|589172674|FG001|Overall Study|Physician Decision|10|||
163127073|NCT01895309|589172673|FG000|Overall Study|Withdrawal by Subject|9|||
163127074|NCT01895309|589172674|FG001|Overall Study|Withdrawal by Subject|18|||
163127075|NCT00042666|589172675|FG000|Overall Study|Adverse Event|2|||
163127076|NCT00042666|589172675|FG000|Overall Study|Death|4|||
163127077|NCT00042666|589172675|FG000|Overall Study|Protocol Violation|1|||
163127078|NCT00042666|589172675|FG000|Overall Study|Participant/Physician Perception|1|||
163127079|NCT00042666|589172675|FG000|Overall Study|Progressive Disease|41|||
163127080|NCT00042666|589172675|FG000|Overall Study|Other|1|||
163127081|NCT00042666|589172675|FG000|Overall Study|Other|4|||
163127082|NCT04232215|589172676|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
163127083|NCT04232215|589172677|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
163127084|NCT01555125|589172678|FG000|Induction Period|Lost to Follow-up|0|||
163127085|NCT01555125|589172679|FG001|Induction Period|Lost to Follow-up|2|||
163127086|NCT01555125|589172680|FG002|Induction Period|Lost to Follow-up|0|||
163127087|NCT01555125|589172681|FG003|Induction Period|Lost to Follow-up|0|||
163127088|NCT01555125|589172682|FG004|Induction Period|Lost to Follow-up|0|||
163127089|NCT01555125|589172678|FG000|Induction Period|Adverse Event|0|||
163127090|NCT01555125|589172679|FG001|Induction Period|Adverse Event|1|||
163127091|NCT01555125|589172680|FG002|Induction Period|Adverse Event|0|||
163127092|NCT01555125|589172681|FG003|Induction Period|Adverse Event|0|||
163127093|NCT01555125|589172682|FG004|Induction Period|Adverse Event|1|||
163127094|NCT01555125|589172678|FG000|Induction Period|Subject / guardian decision|0|||
163127095|NCT01555125|589172679|FG001|Induction Period|Subject / guardian decision|0|||
163127096|NCT01555125|589172680|FG002|Induction Period|Subject / guardian decision|0|||
163127097|NCT01555125|589172681|FG003|Induction Period|Subject / guardian decision|0|||
163127098|NCT01555125|589172682|FG004|Induction Period|Subject / guardian decision|2|||
163127099|NCT01555125|589172678|FG000|Induction Period|Death|1|||
163127100|NCT01555125|589172679|FG001|Induction Period|Death|0|||
163127101|NCT01555125|589172680|FG002|Induction Period|Death|0|||
163127102|NCT01555125|589172681|FG003|Induction Period|Death|0|||
163127103|NCT01555125|589172682|FG004|Induction Period|Death|0|||
163127104|NCT01555125|589172678|FG000|Maintenance Period|Adverse Event|1|||
163127105|NCT01555125|589172679|FG001|Maintenance Period|Adverse Event|1|||
163127106|NCT01555125|589172680|FG002|Maintenance Period|Adverse Event|0|||
163127107|NCT01555125|589172681|FG003|Maintenance Period|Adverse Event|0|||
163127108|NCT01555125|589172682|FG004|Maintenance Period|Adverse Event|0|||
163127109|NCT01555125|589172678|FG000|Maintenance Period|Subject / guardian decision|1|||
163127110|NCT01555125|589172679|FG001|Maintenance Period|Subject / guardian decision|2|||
163127111|NCT01555125|589172680|FG002|Maintenance Period|Subject / guardian decision|0|||
163127112|NCT01555125|589172681|FG003|Maintenance Period|Subject / guardian decision|0|||
163127113|NCT01555125|589172682|FG004|Maintenance Period|Subject / guardian decision|0|||
163127114|NCT01555125|589172678|FG000|Maintenance Period|Lost to Follow-up|2|||
163127115|NCT01555125|589172679|FG001|Maintenance Period|Lost to Follow-up|0|||
163127116|NCT01555125|589172680|FG002|Maintenance Period|Lost to Follow-up|0|||
163127117|NCT01555125|589172681|FG003|Maintenance Period|Lost to Follow-up|1|||
163127118|NCT01555125|589172682|FG004|Maintenance Period|Lost to Follow-up|0|||
163127119|NCT01555125|589172678|FG000|Maintenance Period|Lack of Efficacy|6|||
163127120|NCT01555125|589172679|FG001|Maintenance Period|Lack of Efficacy|1|||
163127121|NCT01555125|589172680|FG002|Maintenance Period|Lack of Efficacy|3|||
163127122|NCT01555125|589172681|FG003|Maintenance Period|Lack of Efficacy|0|||
163127123|NCT01555125|589172682|FG004|Maintenance Period|Lack of Efficacy|0|||
163127124|NCT01555125|589172678|FG000|Maintenance Period|Physician Decision|0|||
163127125|NCT01555125|589172679|FG001|Maintenance Period|Physician Decision|0|||
163127126|NCT01555125|589172680|FG002|Maintenance Period|Physician Decision|1|||
163127127|NCT01555125|589172681|FG003|Maintenance Period|Physician Decision|0|||
163127128|NCT01555125|589172682|FG004|Maintenance Period|Physician Decision|0|||
163127129|NCT01555125|589172678|FG000|Maintenance Period|Death|0|||
163127130|NCT01555125|589172679|FG001|Maintenance Period|Death|0|||
163127131|NCT01555125|589172680|FG002|Maintenance Period|Death|0|||
163127132|NCT01555125|589172681|FG003|Maintenance Period|Death|1|||
163127133|NCT01555125|589172682|FG004|Maintenance Period|Death|0|||
163127134|NCT01555125|589172678|FG000|Extension|Adverse Event|1|||
163127135|NCT01555125|589172679|FG001|Extension|Adverse Event|2|||
163408226|NCT01505634|590204074|FG001|Overall Study|Protocol Violation|0|||
163408227|NCT01505634|590204075|FG002|Overall Study|Protocol Violation|0|||
163127136|NCT01555125|589172680|FG002|Extension|Adverse Event|1|||
163127137|NCT01555125|589172681|FG003|Extension|Adverse Event|1|||
163127138|NCT01555125|589172682|FG004|Extension|Adverse Event|0|||
163408228|NCT01505634|590204073|FG000|Overall Study|Lost to Follow-up|1|||
163342373|NCT06247488|589961308|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
163342374|NCT06247488|589961303|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
163342375|NCT06247488|589961304|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
163342376|NCT06247488|589961305|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
163342377|NCT06247488|589961306|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
163342378|NCT06247488|589961307|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
163342379|NCT06247488|589961308|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
163342380|NCT06247488|589961303|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
163342381|NCT06247488|589961304|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
163127139|NCT01555125|589172678|FG000|Extension|Protocol deviation|1|||
163127140|NCT01555125|589172679|FG001|Extension|Protocol deviation|0|||
163127141|NCT01555125|589172680|FG002|Extension|Protocol deviation|0|||
163127142|NCT01555125|589172681|FG003|Extension|Protocol deviation|0|||
163127143|NCT01555125|589172682|FG004|Extension|Protocol deviation|0|||
163127144|NCT01555125|589172678|FG000|Extension|Lack of Efficacy|7|||
163127145|NCT01555125|589172679|FG001|Extension|Lack of Efficacy|6|||
163127146|NCT01555125|589172680|FG002|Extension|Lack of Efficacy|3|||
163127147|NCT01555125|589172681|FG003|Extension|Lack of Efficacy|0|||
163127148|NCT01555125|589172682|FG004|Extension|Lack of Efficacy|0|||
163127149|NCT01555125|589172678|FG000|Extension|Lost to Follow-up|2|||
163127150|NCT01555125|589172679|FG001|Extension|Lost to Follow-up|1|||
163127151|NCT01555125|589172680|FG002|Extension|Lost to Follow-up|2|||
163127152|NCT01555125|589172681|FG003|Extension|Lost to Follow-up|0|||
163127153|NCT01555125|589172682|FG004|Extension|Lost to Follow-up|0|||
163127154|NCT01555125|589172678|FG000|Extension|Study terminated by sponsor|32|||
163127155|NCT01555125|589172679|FG001|Extension|Study terminated by sponsor|33|||
163127156|NCT01555125|589172680|FG002|Extension|Study terminated by sponsor|16|||
163127157|NCT01555125|589172681|FG003|Extension|Study terminated by sponsor|20|||
163127158|NCT01555125|589172682|FG004|Extension|Study terminated by sponsor|0|||
163127159|NCT01555125|589172678|FG000|Extension|Subject/guardian decision|1|||
163127160|NCT01555125|589172679|FG001|Extension|Subject/guardian decision|9|||
163127161|NCT01555125|589172680|FG002|Extension|Subject/guardian decision|1|||
163127162|NCT01555125|589172681|FG003|Extension|Subject/guardian decision|0|||
163127163|NCT01555125|589172682|FG004|Extension|Subject/guardian decision|0|||
163127164|NCT01555125|589172678|FG000|Extension|Technical Problems|1|||
163127165|NCT01555125|589172679|FG001|Extension|Technical Problems|0|||
163127166|NCT01555125|589172680|FG002|Extension|Technical Problems|0|||
163127167|NCT01555125|589172681|FG003|Extension|Technical Problems|1|||
163127168|NCT01555125|589172682|FG004|Extension|Technical Problems|0|||
163127169|NCT01555125|589172678|FG000|Follow-Up Period|Lost to Follow-up|1|||
163127170|NCT01555125|589172679|FG001|Follow-Up Period|Lost to Follow-up|0|||
163127171|NCT01555125|589172680|FG002|Follow-Up Period|Lost to Follow-up|0|||
163127172|NCT01555125|589172681|FG003|Follow-Up Period|Lost to Follow-up|0|||
163127173|NCT01555125|589172682|FG004|Follow-Up Period|Lost to Follow-up|0|||
163127174|NCT01555125|589172678|FG000|Follow-Up Period|Subject / guardian decision|3|||
163127175|NCT01555125|589172679|FG001|Follow-Up Period|Subject / guardian decision|1|||
163127176|NCT01555125|589172680|FG002|Follow-Up Period|Subject / guardian decision|1|||
163127177|NCT01555125|589172681|FG003|Follow-Up Period|Subject / guardian decision|1|||
163127178|NCT01555125|589172682|FG004|Follow-Up Period|Subject / guardian decision|0|||
163127179|NCT04268745|589172685|FG000|Overall Study|Lost to Follow-up|2|||
163127180|NCT04268745|589172686|FG001|Overall Study|Lost to Follow-up|3|||
163127181|NCT04268745|589172685|FG000|Overall Study|Withdrawal by Subject|4|||
163127182|NCT04268745|589172686|FG001|Overall Study|Withdrawal by Subject|2|||
163127183|NCT04268745|589172685|FG000|Overall Study|Death in the family|1|||
163127184|NCT04268745|589172686|FG001|Overall Study|Death in the family|0|||
163127185|NCT01887353|589172688|FG000|Overall Study|Study stopped early|4|||
163127186|NCT01887353|589172689|FG001|Overall Study|Study stopped early|3|||
163127187|NCT05327361|589172692|FG000|Overall Study|Lost to Follow-up|4|||
163127188|NCT01078168|589172696|FG000|Overall Study|Physician Decision|0|||
163127189|NCT01078168|589172697|FG001|Overall Study|Physician Decision|1|||
163127190|NCT02467582|589174132|FG000|Allocation|Withdrawal by Subject|1|||
163342382|NCT06247488|589961305|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
163127191|NCT02467582|589174133|FG001|Allocation|Withdrawal by Subject|0|||
163127192|NCT02467582|589174132|FG000|Follow-up|Death|5|||
163342383|NCT06247488|589961306|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
163342384|NCT06247488|589961307|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
163408229|NCT01505634|590204074|FG001|Overall Study|Lost to Follow-up|4|||
163127193|NCT02467582|589174133|FG001|Follow-up|Death|4|||
163127194|NCT02467582|589174132|FG000|Follow-up|Lost to Follow-up|6|||
163127195|NCT02467582|589174133|FG001|Follow-up|Lost to Follow-up|5|||
163127196|NCT00742417|589174136|FG000|Randomized|Withdrawal by legal representative|0|||
163127197|NCT00742417|589174137|FG001|Randomized|Withdrawal by legal representative|1|||
163127198|NCT00742417|589174136|FG000|Randomized|Withdrawal by Subject|1|||
163127199|NCT00742417|589174137|FG001|Randomized|Withdrawal by Subject|0|||
163127200|NCT00742417|589174136|FG000|Randomized|Physician Decision|1|||
163127201|NCT00742417|589174137|FG001|Randomized|Physician Decision|0|||
163127202|NCT00742417|589174136|FG000|Intensive Period|Withdrawal by Subject|1|||
163342385|NCT06247488|589961308|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
163127203|NCT00742417|589174137|FG001|Intensive Period|Withdrawal by Subject|1|||
163127204|NCT00742417|589174136|FG000|Intensive Period|Adverse Event|2|||
163127205|NCT00742417|589174137|FG001|Intensive Period|Adverse Event|0|||
163127206|NCT00965575|589174142|FG000|Overall Study|subject unwillingness to swallow study c|1|||
163127207|NCT00965575|589174143|FG001|Overall Study|subject unwillingness to swallow study c|0|||
163127208|NCT01041287|589174146|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
163127209|NCT01041287|589174147|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
163127210|NCT01041287|589174146|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
163127211|NCT01041287|589174147|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
163127212|NCT02397057|589174148|FG000|Overall Study|Withdrawal by Subject|6|||
163127213|NCT02397057|589174149|FG001|Overall Study|Withdrawal by Subject|7|||
163127214|NCT02397057|589174148|FG000|Overall Study|Lost to Follow-up|4|||
163127215|NCT02397057|589174149|FG001|Overall Study|Lost to Follow-up|3|||
163127216|NCT02397057|589174148|FG000|Overall Study|Death|1|||
163127217|NCT02397057|589174149|FG001|Overall Study|Death|0|||
163127218|NCT02397057|589174148|FG000|Overall Study|Adverse Event|0|||
163127219|NCT02397057|589174149|FG001|Overall Study|Adverse Event|1|||
163127220|NCT02397057|589174148|FG000|Overall Study|Physician Decision|0|||
163127221|NCT02397057|589174149|FG001|Overall Study|Physician Decision|1|||
163127222|NCT02397057|589174148|FG000|Overall Study|Subject did not receive study drug|0|||
163127223|NCT02397057|589174149|FG001|Overall Study|Subject did not receive study drug|1|||
163127224|NCT00704288|589174151|FG000|Overall Treatment Period|Adverse Event|11|||
163127225|NCT00704288|589174152|FG001|Overall Treatment Period|Adverse Event|8|||
163127226|NCT00704288|589174153|FG002|Overall Treatment Period|Adverse Event|22|||
163127227|NCT00704288|589174151|FG000|Overall Treatment Period|Death|0|||
163127228|NCT00704288|589174152|FG001|Overall Treatment Period|Death|0|||
163127229|NCT00704288|589174153|FG002|Overall Treatment Period|Death|1|||
163127230|NCT00704288|589174151|FG000|Overall Treatment Period|Physician Decision|0|||
163127231|NCT00704288|589174152|FG001|Overall Treatment Period|Physician Decision|2|||
163127232|NCT00704288|589174153|FG002|Overall Treatment Period|Physician Decision|0|||
163127233|NCT00704288|589174151|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
163127234|NCT00704288|589174152|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
163127235|NCT00704288|589174153|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
163127236|NCT00704288|589174151|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
163127237|NCT00704288|589174152|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
163127238|NCT00704288|589174153|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
163127239|NCT00704288|589174151|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
163127240|NCT00704288|589174152|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
163127241|NCT00704288|589174153|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
163127242|NCT00704288|589174151|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
163127243|NCT00704288|589174152|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
163127244|NCT00704288|589174153|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
163127245|NCT00704288|589174151|FG000|Overall Treatment Period|Roll-over to another study|1|||
163127246|NCT00704288|589174152|FG001|Overall Treatment Period|Roll-over to another study|0|||
163127247|NCT00704288|589174153|FG002|Overall Treatment Period|Roll-over to another study|4|||
163127248|NCT00704288|589174151|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
163127249|NCT00704288|589174152|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
163127250|NCT00704288|589174153|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
163127251|NCT00704288|589174151|FG000|Extended Post Treatment Follow Up Period|Death|41|||
163127252|NCT00704288|589174152|FG001|Extended Post Treatment Follow Up Period|Death|50|||
163127253|NCT00704288|589174153|FG002|Extended Post Treatment Follow Up Period|Death|93|||
163127254|NCT00704288|589174151|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
163127255|NCT00704288|589174152|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
163127256|NCT00704288|589174153|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
163342386|NCT02995733|589961309|FG000|Overall Study|Study site closed|9|||
163342387|NCT02995733|589961310|FG001|Overall Study|Study site closed|10|||
163127257|NCT00704288|589174151|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
163127258|NCT00704288|589174152|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
163127259|NCT00704288|589174153|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
163226734|NCT01393405|589544259|FG001|Maintenance Period Week|Adverse Event|5|||
163226735|NCT01393405|589544260|FG002|Maintenance Period Week|Adverse Event|2|||
163342388|NCT02995733|589961309|FG000|Overall Study|Death|3|||
163127260|NCT00704288|589174151|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
163127261|NCT00704288|589174152|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
163127262|NCT00704288|589174153|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
163127263|NCT01055314|589174154|FG000|Overall Study|Adverse Event|7|||
163127264|NCT01055314|589174155|FG001|Overall Study|Adverse Event|4|||
163342389|NCT02995733|589961310|FG001|Overall Study|Death|4|||
163342390|NCT02995733|589961309|FG000|Overall Study|Withdrawal by Subject|6|||
163342391|NCT02995733|589961310|FG001|Overall Study|Withdrawal by Subject|2|||
163342392|NCT02995733|589961309|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
163342393|NCT02995733|589961310|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
163342394|NCT02995733|589961309|FG000|Overall Study|Lost to Follow-up|48|||
163342395|NCT02995733|589961310|FG001|Overall Study|Lost to Follow-up|37|||
163342396|NCT02995733|589961309|FG000|Overall Study|Other|0|||
163408230|NCT01505634|590204075|FG002|Overall Study|Lost to Follow-up|4|||
163408231|NCT01505634|590204073|FG000|Overall Study|Death|1|||
163408232|NCT01505634|590204074|FG001|Overall Study|Death|0|||
163408233|NCT01505634|590204075|FG002|Overall Study|Death|0|||
163408234|NCT01505634|590204073|FG000|Overall Study|In a conflict zone|0|||
163408235|NCT01505634|590204074|FG001|Overall Study|In a conflict zone|0|||
163408236|NCT01505634|590204075|FG002|Overall Study|In a conflict zone|1|||
163408237|NCT00960843|590204076|FG000|Overall Study|Lost to Follow-up|2|||
163408238|NCT00960843|590204077|FG001|Overall Study|Lost to Follow-up|0|||
163408239|NCT00960843|590204076|FG000|Overall Study|Protocol Violation|0|||
163408240|NCT00960843|590204077|FG001|Overall Study|Protocol Violation|4|||
163408241|NCT00960843|590204076|FG000|Overall Study|Repeated needle dislodgment|0|||
163408242|NCT00960843|590204077|FG001|Overall Study|Repeated needle dislodgment|1|||
163408243|NCT00254501|590204080|FG000|Overall Study|Lost to Follow-up|1|||
163408244|NCT00254501|590204081|FG001|Overall Study|Lost to Follow-up|1|||
163408245|NCT00317109|590204082|FG000|Overall Study|Withdrawal by Subject|2|||
163408246|NCT00317109|590204083|FG001|Overall Study|Withdrawal by Subject|0|||
163408247|NCT00317109|590204082|FG000|Overall Study|Migated/moved from study area|1|||
163408248|NCT00317109|590204083|FG001|Overall Study|Migated/moved from study area|0|||
163408249|NCT01508702|590204086|FG000|Overall Study|Adverse Event|7|||
163408250|NCT01508702|590204087|FG001|Overall Study|Adverse Event|3|||
163408251|NCT01508702|590204086|FG000|Overall Study|Gout flare|2|||
163408252|NCT01508702|590204087|FG001|Overall Study|Gout flare|0|||
163408253|NCT01508702|590204086|FG000|Overall Study|Protocol Violation|2|||
163408254|NCT01508702|590204087|FG001|Overall Study|Protocol Violation|1|||
163408255|NCT01508702|590204086|FG000|Overall Study|Lost to Follow-up|1|||
163408256|NCT01508702|590204087|FG001|Overall Study|Lost to Follow-up|2|||
163408257|NCT01508702|590204086|FG000|Overall Study|Withdrawal by Subject|11|||
163408258|NCT01508702|590204087|FG001|Overall Study|Withdrawal by Subject|7|||
163408259|NCT04472429|590204088|FG000|Randomized Period|Ongoing|90|||
163408260|NCT04472429|590204089|FG001|Randomized Period|Ongoing|40|||
163408261|NCT04472429|590204090|FG002|Randomized Period|Ongoing|0|||
163408262|NCT04472429|590204088|FG000|Randomized Period|Death|52|||
163408263|NCT04472429|590204089|FG001|Randomized Period|Death|37|||
163408264|NCT04472429|590204090|FG002|Randomized Period|Death|0|||
163408265|NCT04472429|590204088|FG000|Randomized Period|Lost to Follow-up|4|||
163408266|NCT04472429|590204089|FG001|Randomized Period|Lost to Follow-up|0|||
163408267|NCT04472429|590204090|FG002|Randomized Period|Lost to Follow-up|0|||
163408268|NCT04472429|590204088|FG000|Randomized Period|Physician Decision|1|||
163408269|NCT04472429|590204089|FG001|Randomized Period|Physician Decision|2|||
163408270|NCT04472429|590204090|FG002|Randomized Period|Physician Decision|0|||
163408271|NCT04472429|590204088|FG000|Randomized Period|Withdrawal by Subject|6|||
163408272|NCT04472429|590204089|FG001|Randomized Period|Withdrawal by Subject|5|||
163408273|NCT04472429|590204090|FG002|Randomized Period|Withdrawal by Subject|0|||
163408274|NCT04472429|590204088|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
163408275|NCT04472429|590204089|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
163408276|NCT04472429|590204090|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
163408277|NCT04472429|590204088|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
163408278|NCT04472429|590204089|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
163408279|NCT04472429|590204090|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
163408280|NCT04472429|590204088|FG000|Open-label Monotherapy Period|Ongoing|0|||
163408281|NCT04472429|590204089|FG001|Open-label Monotherapy Period|Ongoing|0|||
163408282|NCT04472429|590204090|FG002|Open-label Monotherapy Period|Ongoing|32|||
163408283|NCT04472429|590204088|FG000|Open-label Monotherapy Period|Death|0|||
163408284|NCT04472429|590204089|FG001|Open-label Monotherapy Period|Death|0|||
163408285|NCT04472429|590204090|FG002|Open-label Monotherapy Period|Death|35|||
163408286|NCT04472429|590204088|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
163127265|NCT01055314|589174154|FG000|Overall Study|Death|2|||
163127266|NCT01055314|589174155|FG001|Overall Study|Death|1|||
163342397|NCT02995733|589961310|FG001|Overall Study|Other|1|||
163342398|NCT01183013|589961313|FG000|Overall Study|Adverse Event|6|||
163408287|NCT04472429|590204089|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
163408288|NCT04472429|590204090|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
163408289|NCT01180660|590204091|FG000|Overall Study|Changed to open surgery|1|||
163408290|NCT01180660|590204092|FG001|Overall Study|Changed to open surgery|0|||
163127267|NCT01055314|589174154|FG000|Overall Study|Lack of Efficacy|11|||
163342399|NCT01183013|589961314|FG001|Overall Study|Adverse Event|8|||
163408291|NCT00250835|590204093|FG000|Overall Study|Withdrawal by Subject|1|||
163408292|NCT03461757|590204094|FG000|Overall Study|Adverse Event|1|||
163408293|NCT03461757|590204095|FG001|Overall Study|Adverse Event|0|||
163127268|NCT01055314|589174155|FG001|Overall Study|Lack of Efficacy|19|||
163127269|NCT01055314|589174154|FG000|Overall Study|Physician Decision|10|||
163127270|NCT01055314|589174155|FG001|Overall Study|Physician Decision|5|||
163127271|NCT01055314|589174154|FG000|Overall Study|Withdrawal by Subject|1|||
163127272|NCT01055314|589174155|FG001|Overall Study|Withdrawal by Subject|0|||
163127273|NCT01055314|589174154|FG000|Overall Study|Ineligible|3|||
163127274|NCT01055314|589174155|FG001|Overall Study|Ineligible|5|||
163127275|NCT01055314|589174154|FG000|Overall Study|Refusal of further protocol therapy|10|||
163127276|NCT01055314|589174155|FG001|Overall Study|Refusal of further protocol therapy|4|||
163127277|NCT01055314|589174154|FG000|Overall Study|No treatment|1|||
163127278|NCT01055314|589174155|FG001|Overall Study|No treatment|0|||
163127279|NCT04395690|589174156|FG000|Overall Study|Lost to Follow-up|1|||
163127280|NCT04395690|589174157|FG001|Overall Study|Lost to Follow-up|1|||
163127281|NCT03927144|589174158|FG000|Core Phase|Adverse Event|9|||
163127282|NCT03927144|589174159|FG001|Core Phase|Adverse Event|5|||
163127283|NCT03927144|589174158|FG000|Core Phase|Lost to Follow-up|3|||
163127284|NCT03927144|589174159|FG001|Core Phase|Lost to Follow-up|2|||
163127285|NCT03927144|589174158|FG000|Core Phase|New Therapy for Study Indication|0|||
163127286|NCT03927144|589174159|FG001|Core Phase|New Therapy for Study Indication|1|||
163127287|NCT03927144|589174158|FG000|Core Phase|No Longer Clinically Benefiting|4|||
163127288|NCT03927144|589174159|FG001|Core Phase|No Longer Clinically Benefiting|4|||
163127289|NCT03927144|589174158|FG000|Core Phase|Physician Decision|2|||
163127290|NCT03927144|589174159|FG001|Core Phase|Physician Decision|8|||
163127291|NCT03927144|589174158|FG000|Core Phase|Protocol Violation|2|||
163127292|NCT03927144|589174159|FG001|Core Phase|Protocol Violation|2|||
163127293|NCT03927144|589174158|FG000|Core Phase|Withdrawal by Subject|16|||
163127294|NCT03927144|589174159|FG001|Core Phase|Withdrawal by Subject|40|||
163127295|NCT03927144|589174158|FG000|Extension Phase|Adverse Event|2|||
163127296|NCT03927144|589174159|FG001|Extension Phase|Adverse Event|1|||
163127297|NCT03927144|589174158|FG000|Extension Phase|No longer clinically benefiting|4|||
163127298|NCT03927144|589174159|FG001|Extension Phase|No longer clinically benefiting|5|||
163127299|NCT03927144|589174158|FG000|Extension Phase|Pregnancy|1|||
163127300|NCT03927144|589174159|FG001|Extension Phase|Pregnancy|0|||
163127301|NCT03927144|589174158|FG000|Extension Phase|Protocol Violation|0|||
163127302|NCT03927144|589174159|FG001|Extension Phase|Protocol Violation|1|||
163127303|NCT03927144|589174158|FG000|Extension Phase|Withdrawal by Subject|8|||
163127304|NCT03927144|589174159|FG001|Extension Phase|Withdrawal by Subject|3|||
163127305|NCT03909152|589174160|FG000|Overall Study|Adverse Event|14|||
163127306|NCT03909152|589174161|FG001|Overall Study|Adverse Event|5|||
163127307|NCT03909152|589174162|FG002|Overall Study|Adverse Event|1|||
163127308|NCT03909152|589174163|FG003|Overall Study|Adverse Event|14|||
163127309|NCT00615030|589174166|FG000|Period I|Administrative problem|0|||
163127310|NCT00615030|589174167|FG001|Period I|Administrative problem|0|||
163127311|NCT00615030|589174168|FG002|Period I|Administrative problem|0|||
163127312|NCT00615030|589174169|FG003|Period I|Administrative problem|0|||
163127313|NCT00615030|589174170|FG004|Period I|Administrative problem|1|||
163127314|NCT00615030|589174171|FG005|Period I|Administrative problem|0|||
163127315|NCT00615030|589174172|FG006|Period I|Administrative problem|0|||
163127316|NCT00615030|589174173|FG007|Period I|Administrative problem|0|||
163127317|NCT00615030|589174174|FG008|Period I|Administrative problem|0|||
163127318|NCT00615030|589174175|FG009|Period I|Administrative problem|0|||
163127319|NCT00615030|589174176|FG010|Period I|Administrative problem|0|||
163127320|NCT00615030|589174177|FG011|Period I|Administrative problem|0|||
163127321|NCT00615030|589174166|FG000|Period I|Protocol deviation|1|||
163127322|NCT00615030|589174167|FG001|Period I|Protocol deviation|0|||
163127323|NCT00615030|589174168|FG002|Period I|Protocol deviation|0|||
163127324|NCT00615030|589174169|FG003|Period I|Protocol deviation|0|||
163127325|NCT00615030|589174170|FG004|Period I|Protocol deviation|0|||
163127326|NCT00615030|589174171|FG005|Period I|Protocol deviation|0|||
163127327|NCT00615030|589174172|FG006|Period I|Protocol deviation|0|||
163127328|NCT00615030|589174173|FG007|Period I|Protocol deviation|0|||
163127329|NCT00615030|589174174|FG008|Period I|Protocol deviation|0|||
163127330|NCT00615030|589174175|FG009|Period I|Protocol deviation|0|||
163127331|NCT00615030|589174176|FG010|Period I|Protocol deviation|0|||
163127332|NCT00615030|589174177|FG011|Period I|Protocol deviation|0|||
163127333|NCT00615030|589174166|FG000|Period I|Subject withdrew consent|0|||
163127334|NCT00615030|589174167|FG001|Period I|Subject withdrew consent|0|||
163127335|NCT00615030|589174168|FG002|Period I|Subject withdrew consent|0|||
163127336|NCT00615030|589174169|FG003|Period I|Subject withdrew consent|0|||
163127337|NCT00615030|589174170|FG004|Period I|Subject withdrew consent|0|||
163127338|NCT00615030|589174171|FG005|Period I|Subject withdrew consent|0|||
163127339|NCT00615030|589174172|FG006|Period I|Subject withdrew consent|0|||
163127340|NCT00615030|589174173|FG007|Period I|Subject withdrew consent|0|||
163127341|NCT00615030|589174174|FG008|Period I|Subject withdrew consent|1|||
163127342|NCT00615030|589174175|FG009|Period I|Subject withdrew consent|0|||
163127343|NCT00615030|589174176|FG010|Period I|Subject withdrew consent|1|||
163127344|NCT00615030|589174177|FG011|Period I|Subject withdrew consent|1|||
163127345|NCT00615030|589174166|FG000|Period I|Abnormal laboratory value(s)|0|||
163127346|NCT00615030|589174167|FG001|Period I|Abnormal laboratory value(s)|0|||
163127347|NCT00615030|589174168|FG002|Period I|Abnormal laboratory value(s)|0|||
163342400|NCT01183013|589961315|FG002|Overall Study|Adverse Event|5|||
163342401|NCT01183013|589961316|FG003|Overall Study|Adverse Event|5|||
163342402|NCT01183013|589961317|FG004|Overall Study|Adverse Event|10|||
163342403|NCT01183013|589961318|FG005|Overall Study|Adverse Event|10|||
163342404|NCT01183013|589961319|FG006|Overall Study|Adverse Event|6|||
163342405|NCT01183013|589961313|FG000|Overall Study|Lack of Efficacy|3|||
163342406|NCT01183013|589961314|FG001|Overall Study|Lack of Efficacy|2|||
163342407|NCT01183013|589961315|FG002|Overall Study|Lack of Efficacy|1|||
163342408|NCT01183013|589961316|FG003|Overall Study|Lack of Efficacy|2|||
163342409|NCT01183013|589961317|FG004|Overall Study|Lack of Efficacy|1|||
163342410|NCT01183013|589961318|FG005|Overall Study|Lack of Efficacy|2|||
163342411|NCT01183013|589961319|FG006|Overall Study|Lack of Efficacy|0|||
163342412|NCT01183013|589961313|FG000|Overall Study|Protocol Violation|5|||
163342413|NCT01183013|589961314|FG001|Overall Study|Protocol Violation|2|||
163342414|NCT01183013|589961315|FG002|Overall Study|Protocol Violation|4|||
163342415|NCT01183013|589961316|FG003|Overall Study|Protocol Violation|0|||
163342416|NCT01183013|589961317|FG004|Overall Study|Protocol Violation|4|||
163342417|NCT01183013|589961318|FG005|Overall Study|Protocol Violation|3|||
163342418|NCT01183013|589961319|FG006|Overall Study|Protocol Violation|3|||
163342419|NCT01183013|589961313|FG000|Overall Study|Lost to Follow-up|7|||
163342420|NCT01183013|589961314|FG001|Overall Study|Lost to Follow-up|3|||
163342421|NCT01183013|589961315|FG002|Overall Study|Lost to Follow-up|4|||
163342422|NCT01183013|589961316|FG003|Overall Study|Lost to Follow-up|3|||
163342423|NCT01183013|589961317|FG004|Overall Study|Lost to Follow-up|2|||
163342424|NCT01183013|589961318|FG005|Overall Study|Lost to Follow-up|6|||
163342425|NCT01183013|589961319|FG006|Overall Study|Lost to Follow-up|5|||
163342426|NCT01183013|589961313|FG000|Overall Study|Withdrawal by Subject|9|||
163342427|NCT01183013|589961314|FG001|Overall Study|Withdrawal by Subject|13|||
163342428|NCT01183013|589961315|FG002|Overall Study|Withdrawal by Subject|10|||
163342429|NCT01183013|589961316|FG003|Overall Study|Withdrawal by Subject|8|||
163342430|NCT01183013|589961317|FG004|Overall Study|Withdrawal by Subject|7|||
163342431|NCT01183013|589961318|FG005|Overall Study|Withdrawal by Subject|9|||
163342432|NCT01183013|589961319|FG006|Overall Study|Withdrawal by Subject|10|||
163342433|NCT01183013|589961313|FG000|Overall Study|Reasons other than stated above|15|||
163342434|NCT01183013|589961314|FG001|Overall Study|Reasons other than stated above|11|||
163342435|NCT01183013|589961315|FG002|Overall Study|Reasons other than stated above|17|||
163342436|NCT01183013|589961316|FG003|Overall Study|Reasons other than stated above|12|||
163342437|NCT01183013|589961317|FG004|Overall Study|Reasons other than stated above|12|||
163342438|NCT01183013|589961318|FG005|Overall Study|Reasons other than stated above|15|||
163342439|NCT01183013|589961319|FG006|Overall Study|Reasons other than stated above|13|||
163342440|NCT04468633|589961323|FG000|Overall Study|Withdrawal by Subject|4|||
163342441|NCT04468633|589961324|FG001|Overall Study|Withdrawal by Subject|0|||
163342442|NCT00460434|589961327|FG000|Overall Study|Lost to Follow-up|3|||
163342443|NCT00460434|589961328|FG001|Overall Study|Lost to Follow-up|7|||
163342444|NCT01498445|589961329|FG000|Overall Study|Lack of Efficacy|0|||
163342445|NCT01498445|589961330|FG001|Overall Study|Lack of Efficacy|0|||
163342446|NCT01498445|589961331|FG002|Overall Study|Lack of Efficacy|1|||
163342447|NCT01498445|589961332|FG003|Overall Study|Lack of Efficacy|2|||
163342448|NCT01498445|589961333|FG004|Overall Study|Lack of Efficacy|0|||
163342449|NCT01498445|589961334|FG005|Overall Study|Lack of Efficacy|0|||
163342450|NCT01498445|589961329|FG000|Overall Study|Screen Failure|0|||
163342451|NCT01498445|589961330|FG001|Overall Study|Screen Failure|0|||
163342452|NCT01498445|589961331|FG002|Overall Study|Screen Failure|0|||
163342453|NCT01498445|589961332|FG003|Overall Study|Screen Failure|0|||
163342454|NCT01498445|589961333|FG004|Overall Study|Screen Failure|1|||
163342455|NCT01498445|589961334|FG005|Overall Study|Screen Failure|1|||
163342456|NCT04739306|589961335|FG000|Main Study Period|Adverse Event|6|||
163127348|NCT00615030|589174169|FG003|Period I|Abnormal laboratory value(s)|0|||
163127349|NCT00615030|589174170|FG004|Period I|Abnormal laboratory value(s)|0|||
163342457|NCT04739306|589961336|FG001|Main Study Period|Adverse Event|7|||
163342458|NCT04739306|589961335|FG000|Main Study Period|Lost to Follow-up|4|||
163342459|NCT04739306|589961336|FG001|Main Study Period|Lost to Follow-up|6|||
163342460|NCT04739306|589961335|FG000|Main Study Period|Physician Decision|1|||
163342461|NCT04739306|589961336|FG001|Main Study Period|Physician Decision|1|||
163342462|NCT04739306|589961335|FG000|Main Study Period|Withdrawal by Subject|8|||
163342463|NCT04739306|589961336|FG001|Main Study Period|Withdrawal by Subject|6|||
163342464|NCT04739306|589961335|FG000|Main Study Period|Protocol Violation|0|||
163342465|NCT04739306|589961336|FG001|Main Study Period|Protocol Violation|1|||
163342466|NCT04739306|589961335|FG000|Main Study Period|War in Ukraine|1|||
163342467|NCT04739306|589961336|FG001|Main Study Period|War in Ukraine|1|||
163342468|NCT02722278|589961339|FG000|Overall Study|Withdrawal by Subject|5|||
163342469|NCT02722278|589961340|FG001|Overall Study|Withdrawal by Subject|3|||
163342470|NCT02722278|589961339|FG000|Overall Study|Adverse Event|4|||
163342471|NCT02722278|589961340|FG001|Overall Study|Adverse Event|1|||
163342472|NCT02722278|589961339|FG000|Overall Study|Lost to Follow-up|2|||
163342473|NCT02722278|589961340|FG001|Overall Study|Lost to Follow-up|0|||
163342474|NCT02722278|589961339|FG000|Overall Study|Protocol Violation|1|||
163342475|NCT02722278|589961340|FG001|Overall Study|Protocol Violation|0|||
163342476|NCT02722278|589961339|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
163342477|NCT02722278|589961340|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
163342478|NCT02722278|589961339|FG000|Overall Study|Subject declined after tx assignment|0|||
163342479|NCT02722278|589961340|FG001|Overall Study|Subject declined after tx assignment|1|||
163342480|NCT02722278|589961339|FG000|Overall Study|Site closure not study related|0|||
163342481|NCT02722278|589961340|FG001|Overall Study|Site closure not study related|1|||
163342482|NCT02465866|589961341|FG000|Period 3|Withdrawal by Subject|0|||
163342483|NCT02465866|589961342|FG001|Period 3|Withdrawal by Subject|1|||
163342484|NCT02465866|589961343|FG002|Period 3|Withdrawal by Subject|0|||
163342485|NCT02465866|589961344|FG003|Period 3|Withdrawal by Subject|0|||
163342486|NCT00203502|589961345|FG000|Overall Study|Death|1|||
163342487|NCT02023099|589961346|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
163342488|NCT02023099|589961347|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
163342489|NCT02023099|589961348|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
163342490|NCT02023099|589961346|FG000|Overall Study|Withdrawn Consent|3|||
163342491|NCT02023099|589961347|FG001|Overall Study|Withdrawn Consent|0|||
163127350|NCT00615030|589174171|FG005|Period I|Abnormal laboratory value(s)|1|||
163127351|NCT00615030|589174172|FG006|Period I|Abnormal laboratory value(s)|0|||
163127352|NCT00615030|589174173|FG007|Period I|Abnormal laboratory value(s)|0|||
163127353|NCT00615030|589174174|FG008|Period I|Abnormal laboratory value(s)|0|||
163127354|NCT00615030|589174175|FG009|Period I|Abnormal laboratory value(s)|0|||
163127355|NCT00615030|589174176|FG010|Period I|Abnormal laboratory value(s)|0|||
163127356|NCT00615030|589174177|FG011|Period I|Abnormal laboratory value(s)|0|||
163127357|NCT00615030|589174166|FG000|Period II|Adverse Event|0|||
163127358|NCT00615030|589174167|FG001|Period II|Adverse Event|0|||
163127359|NCT00615030|589174168|FG002|Period II|Adverse Event|1|||
163127360|NCT00615030|589174169|FG003|Period II|Adverse Event|0|||
163127361|NCT00615030|589174170|FG004|Period II|Adverse Event|0|||
163127362|NCT00615030|589174171|FG005|Period II|Adverse Event|0|||
163127363|NCT00615030|589174172|FG006|Period II|Adverse Event|0|||
163127364|NCT00615030|589174173|FG007|Period II|Adverse Event|0|||
163127365|NCT00615030|589174174|FG008|Period II|Adverse Event|1|||
163127366|NCT00615030|589174175|FG009|Period II|Adverse Event|0|||
163127367|NCT00615030|589174176|FG010|Period II|Adverse Event|0|||
163127368|NCT00615030|589174177|FG011|Period II|Adverse Event|0|||
163127369|NCT00615030|589174166|FG000|Period II|Subject withdrew consent|0|||
163127370|NCT00615030|589174167|FG001|Period II|Subject withdrew consent|0|||
163127371|NCT00615030|589174168|FG002|Period II|Subject withdrew consent|0|||
163127372|NCT00615030|589174169|FG003|Period II|Subject withdrew consent|1|||
163127373|NCT00615030|589174170|FG004|Period II|Subject withdrew consent|0|||
163127374|NCT00615030|589174171|FG005|Period II|Subject withdrew consent|0|||
163127375|NCT00615030|589174172|FG006|Period II|Subject withdrew consent|1|||
163127376|NCT00615030|589174173|FG007|Period II|Subject withdrew consent|0|||
163127377|NCT00615030|589174174|FG008|Period II|Subject withdrew consent|0|||
163127378|NCT00615030|589174175|FG009|Period II|Subject withdrew consent|0|||
163127379|NCT00615030|589174176|FG010|Period II|Subject withdrew consent|0|||
163127380|NCT00615030|589174177|FG011|Period II|Subject withdrew consent|0|||
163127381|NCT00615030|589174166|FG000|Period III|Administrative problems|1|||
163127382|NCT00615030|589174167|FG001|Period III|Administrative problems|0|||
163127383|NCT00615030|589174168|FG002|Period III|Administrative problems|0|||
163127384|NCT00615030|589174169|FG003|Period III|Administrative problems|1|||
163127385|NCT00615030|589174170|FG004|Period III|Administrative problems|0|||
163127386|NCT00615030|589174171|FG005|Period III|Administrative problems|0|||
163127387|NCT00615030|589174172|FG006|Period III|Administrative problems|0|||
163127388|NCT00615030|589174173|FG007|Period III|Administrative problems|0|||
163127389|NCT00615030|589174174|FG008|Period III|Administrative problems|0|||
163127390|NCT00615030|589174175|FG009|Period III|Administrative problems|0|||
163127391|NCT00615030|589174176|FG010|Period III|Administrative problems|0|||
163127392|NCT00615030|589174177|FG011|Period III|Administrative problems|0|||
163127393|NCT03002311|589174190|FG000|Overall Study|Lost to Follow-up|13|||
163127394|NCT03002311|589174191|FG001|Overall Study|Lost to Follow-up|26|||
163342492|NCT02023099|589961348|FG002|Overall Study|Withdrawn Consent|1|||
163342493|NCT02023099|589961346|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
163342494|NCT02023099|589961347|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
163342495|NCT02023099|589961348|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
163342496|NCT04175392|589961349|FG000|Overall Study|Withdrawal by Subject|3|||
163342497|NCT04175392|589961350|FG001|Overall Study|Withdrawal by Subject|2|||
163342498|NCT01469819|589961351|FG000|Overall Study|Withdrawal by Subject|1|||
163342499|NCT01469819|589961351|FG000|Overall Study|Did not meet inclusionary criteria|2|||
163127395|NCT03002311|589174190|FG000|Overall Study|Referral provider called to schedule app|3|||
163127396|NCT03002311|589174191|FG001|Overall Study|Referral provider called to schedule app|3|||
163127397|NCT03002311|589174190|FG000|Overall Study|Physician Decision|3|||
163127398|NCT03002311|589174191|FG001|Overall Study|Physician Decision|1|||
163127399|NCT00308074|589174192|FG000|Overall Study|Withdrawal by Subject|1|||
163127400|NCT01329939|589174196|FG000|Overall Study|Lost to Follow-up|3|||
163127401|NCT01329939|589174197|FG001|Overall Study|Lost to Follow-up|0|||
163127402|NCT01329939|589174198|FG002|Overall Study|Lost to Follow-up|1|||
163342500|NCT01469819|589961351|FG000|Overall Study|Could not swallow SmartPill|2|||
163342501|NCT01469819|589961351|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
163342502|NCT00561678|589961352|FG000|Overall Study|Withdrawal by Subject|4|||
163342503|NCT00561678|589961353|FG001|Overall Study|Withdrawal by Subject|3|||
163342504|NCT00561678|589961352|FG000|Overall Study|surgery cancelled|1|||
163342505|NCT00561678|589961353|FG001|Overall Study|surgery cancelled|1|||
163342506|NCT00561678|589961352|FG000|Overall Study|surgery rescheduled to different site|2|||
163342507|NCT00561678|589961353|FG001|Overall Study|surgery rescheduled to different site|2|||
163342508|NCT00561678|589961352|FG000|Overall Study|anesthesia provider refusal|1|||
163342509|NCT00561678|589961353|FG001|Overall Study|anesthesia provider refusal|0|||
163342510|NCT01403805|589961354|FG000|Overall Study|Withdrawal by Subject|0|||
163342511|NCT01403805|589961355|FG001|Overall Study|Withdrawal by Subject|4|||
163342512|NCT01403805|589961354|FG000|Overall Study|Lost to Follow-up|0|||
163127403|NCT01329939|589174199|FG003|Overall Study|Lost to Follow-up|2|||
163127404|NCT01329939|589174196|FG000|Overall Study|Withdrawal by Subject|0|||
163127405|NCT01329939|589174197|FG001|Overall Study|Withdrawal by Subject|1|||
163127406|NCT01329939|589174198|FG002|Overall Study|Withdrawal by Subject|0|||
163127407|NCT01329939|589174199|FG003|Overall Study|Withdrawal by Subject|0|||
163127408|NCT01329939|589174196|FG000|Overall Study|Adverse Event|0|||
163127409|NCT01329939|589174197|FG001|Overall Study|Adverse Event|0|||
163127410|NCT01329939|589174198|FG002|Overall Study|Adverse Event|0|||
163127411|NCT01329939|589174199|FG003|Overall Study|Adverse Event|3|||
163127412|NCT03722524|589174200|FG000|Overall Study|Protocol Violation|86|||
163127413|NCT03722524|589174200|FG000|Overall Study|Adverse Event|7|||
163127414|NCT03722524|589174200|FG000|Overall Study|Lost to Follow-up|1|||
163127415|NCT03722524|589174200|FG000|Overall Study|Reason is not stated|1|||
163127416|NCT03722524|589174200|FG000|Overall Study|Physician Decision|1|||
163127417|NCT03722524|589174200|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
163127418|NCT04369950|589174202|FG000|Overall Study|Protocol Violation|2|||
163127419|NCT04369950|589174203|FG001|Overall Study|Protocol Violation|2|||
163127420|NCT00989963|589174204|FG000|Overall Study|Adverse Event|1|||
163127421|NCT00989963|589174205|FG001|Overall Study|Adverse Event|1|||
163127422|NCT00989963|589174206|FG002|Overall Study|Adverse Event|1|||
163127423|NCT01240200|589174214|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
163127424|NCT01240200|589174215|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
163127425|NCT04071158|589174219|FG000|Overall Study|Lost to Follow-up|1|||
163127426|NCT04071158|589174220|FG001|Overall Study|Lost to Follow-up|2|||
163127427|NCT04071158|589174221|FG002|Overall Study|Lost to Follow-up|3|||
163127428|NCT04071158|589174222|FG003|Overall Study|Lost to Follow-up|3|||
163127429|NCT04071158|589174223|FG004|Overall Study|Lost to Follow-up|5|||
163127430|NCT04071158|589174219|FG000|Overall Study|Randomized but not treated|2|||
163127431|NCT04071158|589174220|FG001|Overall Study|Randomized but not treated|2|||
163127432|NCT04071158|589174221|FG002|Overall Study|Randomized but not treated|0|||
163127433|NCT04071158|589174222|FG003|Overall Study|Randomized but not treated|0|||
163127434|NCT04071158|589174223|FG004|Overall Study|Randomized but not treated|0|||
163127435|NCT01178099|589174224|FG000|Overall Study|Physician Decision|0|||
163127436|NCT01178099|589174225|FG001|Overall Study|Physician Decision|1|||
163127437|NCT02473367|589174226|FG000|Wait 1|Withdrawal by Subject|1|||
163127438|NCT02473367|589174226|FG000|Period 4|Lost to Follow-up|1|||
163127439|NCT04816721|589174227|FG000|Overall Study|Withdrawal by Subject|0|||
163127440|NCT04816721|589174228|FG001|Overall Study|Withdrawal by Subject|2|||
163127441|NCT04816721|589174229|FG002|Overall Study|Withdrawal by Subject|0|||
163127442|NCT04816721|589174230|FG003|Overall Study|Withdrawal by Subject|1|||
163127443|NCT04816721|589174231|FG004|Overall Study|Withdrawal by Subject|1|||
163127444|NCT04816721|589174232|FG005|Overall Study|Withdrawal by Subject|0|||
163127445|NCT04816721|589174233|FG006|Overall Study|Withdrawal by Subject|0|||
163127446|NCT04816721|589174234|FG007|Overall Study|Withdrawal by Subject|0|||
163127447|NCT04816721|589174227|FG000|Overall Study|Miscellaneous|0|||
163127448|NCT04816721|589174228|FG001|Overall Study|Miscellaneous|0|||
163127449|NCT04816721|589174229|FG002|Overall Study|Miscellaneous|0|||
163127450|NCT04816721|589174230|FG003|Overall Study|Miscellaneous|0|||
163127451|NCT04816721|589174231|FG004|Overall Study|Miscellaneous|0|||
163127452|NCT04816721|589174232|FG005|Overall Study|Miscellaneous|1|||
163127453|NCT04816721|589174233|FG006|Overall Study|Miscellaneous|0|||
163342513|NCT01403805|589961355|FG001|Overall Study|Lost to Follow-up|2|||
163342514|NCT01403805|589961354|FG000|Overall Study|Death|0|||
163342515|NCT01403805|589961355|FG001|Overall Study|Death|1|||
163342516|NCT01103141|589961356|FG000|Overall Study|Death|0|||
163127454|NCT04816721|589174234|FG007|Overall Study|Miscellaneous|0|||
163127455|NCT04816721|589174227|FG000|Overall Study|Lost to Follow-up|0|||
163127456|NCT04816721|589174228|FG001|Overall Study|Lost to Follow-up|0|||
163127457|NCT04816721|589174229|FG002|Overall Study|Lost to Follow-up|0|||
163127458|NCT04816721|589174230|FG003|Overall Study|Lost to Follow-up|1|||
163342517|NCT01103141|589961357|FG001|Overall Study|Death|1|||
163342518|NCT01103141|589961356|FG000|Overall Study|Lost to Follow-up|2|||
163342519|NCT01103141|589961357|FG001|Overall Study|Lost to Follow-up|1|||
163127459|NCT04816721|589174231|FG004|Overall Study|Lost to Follow-up|0|||
163127460|NCT04816721|589174232|FG005|Overall Study|Lost to Follow-up|0|||
163342520|NCT01695993|589961360|FG000|Overall Study|Lost to Follow-up|2|||
163342521|NCT01695993|589961361|FG001|Overall Study|Lost to Follow-up|1|||
163342522|NCT01695993|589961362|FG002|Overall Study|Lost to Follow-up|3|||
163342523|NCT01695993|589961360|FG000|Overall Study|Withdrawal by Subject|2|||
163342524|NCT01695993|589961361|FG001|Overall Study|Withdrawal by Subject|2|||
163342525|NCT01695993|589961362|FG002|Overall Study|Withdrawal by Subject|2|||
163342526|NCT01695993|589961360|FG000|Overall Study|To ill to continue|1|||
163342527|NCT01695993|589961361|FG001|Overall Study|To ill to continue|2|||
163342528|NCT01695993|589961362|FG002|Overall Study|To ill to continue|0|||
163342529|NCT01695993|589961360|FG000|Overall Study|Changed Medical Facility|0|||
163342530|NCT01695993|589961361|FG001|Overall Study|Changed Medical Facility|0|||
163342531|NCT01695993|589961362|FG002|Overall Study|Changed Medical Facility|1|||
163342532|NCT00472199|589961363|FG000|Overall Study|Adverse Event|19|||
163342533|NCT00472199|589961364|FG001|Overall Study|Adverse Event|23|||
163342534|NCT00472199|589961363|FG000|Overall Study|Lack of Efficacy|4|||
163342535|NCT00472199|589961364|FG001|Overall Study|Lack of Efficacy|25|||
163342536|NCT00472199|589961363|FG000|Overall Study|Lost to Follow-up|2|||
163342537|NCT00472199|589961364|FG001|Overall Study|Lost to Follow-up|4|||
163342538|NCT00472199|589961363|FG000|Overall Study|Protocol Violation|3|||
163342539|NCT00472199|589961364|FG001|Overall Study|Protocol Violation|2|||
163342540|NCT00472199|589961363|FG000|Overall Study|Withdrawal by Subject|6|||
163342541|NCT00472199|589961364|FG001|Overall Study|Withdrawal by Subject|5|||
163342542|NCT00472199|589961363|FG000|Overall Study|personal reason|0|||
163342543|NCT00472199|589961364|FG001|Overall Study|personal reason|1|||
163342544|NCT00472199|589961363|FG000|Overall Study|patient was asymptomatic|1|||
163342545|NCT00472199|589961364|FG001|Overall Study|patient was asymptomatic|0|||
163342546|NCT01601821|589961368|FG000|Overall Study|Death|2|||
163342547|NCT01601821|589961369|FG001|Overall Study|Death|5|||
163342548|NCT01601821|589961368|FG000|Overall Study|Protocol Violation|2|||
163342549|NCT01601821|589961369|FG001|Overall Study|Protocol Violation|2|||
163342550|NCT01601821|589961368|FG000|Overall Study|Lost to Follow-up|6|||
163342551|NCT01601821|589961369|FG001|Overall Study|Lost to Follow-up|14|||
163342552|NCT01601821|589961368|FG000|Overall Study|Withdrawal by Subject|1|||
163342553|NCT01601821|589961369|FG001|Overall Study|Withdrawal by Subject|0|||
163342554|NCT01601821|589961368|FG000|Overall Study|Graft Loss|6|||
163342555|NCT01601821|589961369|FG001|Overall Study|Graft Loss|6|||
163342556|NCT01601821|589961368|FG000|Overall Study|Study Events|7|||
163342557|NCT01601821|589961369|FG001|Overall Study|Study Events|1|||
163342558|NCT01601821|589961368|FG000|Overall Study|Other|5|||
163342559|NCT01601821|589961369|FG001|Overall Study|Other|1|||
163342560|NCT01901302|589961373|FG000|Overall Study|Adverse Event|2|||
163342561|NCT01901302|589961374|FG001|Overall Study|Adverse Event|1|||
163342562|NCT01901302|589961373|FG000|Overall Study|Lack of Efficacy|0|||
163342563|NCT01901302|589961374|FG001|Overall Study|Lack of Efficacy|2|||
163342564|NCT01901302|589961373|FG000|Overall Study|Study Terminated by Sponsor|23|||
163342565|NCT01901302|589961374|FG001|Overall Study|Study Terminated by Sponsor|20|||
163342566|NCT01901302|589961373|FG000|Overall Study|Withdrawal by Subject|2|||
163342567|NCT01901302|589961374|FG001|Overall Study|Withdrawal by Subject|0|||
163127461|NCT04816721|589174233|FG006|Overall Study|Lost to Follow-up|0|||
163127462|NCT04816721|589174234|FG007|Overall Study|Lost to Follow-up|0|||
163127463|NCT03194438|589174237|FG000|Overall Study|Withdrawal by Subject|2|||
163127464|NCT01286740|589174238|FG000|Overall Study|Enrolled but not treated|1|||
163127465|NCT01286740|589174238|FG000|Overall Study|Protocol Violation|1|||
163127466|NCT02717130|589174244|FG000|Overall Study|Withdrawal by Subject|1|||
163127467|NCT02717130|589174244|FG000|Overall Study|Adverse Event|1|||
163127468|NCT02717130|589174244|FG000|Overall Study|Physician Decision|1|||
163127469|NCT02717130|589174244|FG000|Overall Study|Study Closure|4|||
163342568|NCT00848198|589961376|FG000|Overall Study|Incomplete Case Report Forms|15|||
163342569|NCT02062827|589961377|FG000|Overall Study|Death|1|||
163342570|NCT02062827|589961378|FG001|Overall Study|Death|0|||
163342571|NCT02062827|589961379|FG002|Overall Study|Death|0|||
163342572|NCT02062827|589961380|FG003|Overall Study|Death|0|||
163342573|NCT02062827|589961381|FG004|Overall Study|Death|0|||
163342574|NCT02062827|589961382|FG005|Overall Study|Death|0|||
163342575|NCT02062827|589961383|FG006|Overall Study|Death|0|||
163342576|NCT02062827|589961384|FG007|Overall Study|Death|0|||
163342577|NCT02062827|589961377|FG000|Overall Study|Withdrawal by Subject|3|||
163127470|NCT02335424|589174245|FG000|Overall Study|Withdrawal by Subject|19|||
163127471|NCT02335424|589174245|FG000|Overall Study|Adverse Event|25|||
163342578|NCT02062827|589961378|FG001|Overall Study|Withdrawal by Subject|1|||
163342579|NCT02062827|589961379|FG002|Overall Study|Withdrawal by Subject|1|||
163342580|NCT02062827|589961380|FG003|Overall Study|Withdrawal by Subject|2|||
163342581|NCT02062827|589961381|FG004|Overall Study|Withdrawal by Subject|6|||
163342582|NCT02062827|589961382|FG005|Overall Study|Withdrawal by Subject|0|||
163342583|NCT02062827|589961383|FG006|Overall Study|Withdrawal by Subject|5|||
163342584|NCT02062827|589961384|FG007|Overall Study|Withdrawal by Subject|0|||
163342585|NCT02062827|589961377|FG000|Overall Study|Screen Fail|0|||
163342586|NCT02062827|589961378|FG001|Overall Study|Screen Fail|0|||
163342587|NCT02062827|589961379|FG002|Overall Study|Screen Fail|0|||
163342588|NCT02062827|589961380|FG003|Overall Study|Screen Fail|0|||
163342589|NCT02062827|589961381|FG004|Overall Study|Screen Fail|0|||
163342590|NCT02062827|589961382|FG005|Overall Study|Screen Fail|0|||
163342591|NCT02062827|589961383|FG006|Overall Study|Screen Fail|0|||
163342592|NCT02062827|589961384|FG007|Overall Study|Screen Fail|8|||
163342593|NCT03708744|589961385|FG000|Overall Study|Withdrawal by Subject|0|||
163342594|NCT03708744|589961386|FG001|Overall Study|Withdrawal by Subject|0|||
163342595|NCT03708744|589961387|FG002|Overall Study|Withdrawal by Subject|1|||
163342596|NCT03708744|589961388|FG003|Overall Study|Withdrawal by Subject|0|||
163342597|NCT04930263|589961389|FG000|Overall Study|Withdrawal by Subject|3|||
163342598|NCT04930263|589961390|FG001|Overall Study|Withdrawal by Subject|5|||
163127472|NCT02335424|589174245|FG000|Overall Study|Death|273|||
163127473|NCT02335424|589174245|FG000|Overall Study|Lost to Follow-up|3|||
163127474|NCT02335424|589174245|FG000|Overall Study|Physician Decision|13|||
163127475|NCT02335424|589174245|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
163127476|NCT02335424|589174245|FG000|Overall Study|Protocol Violation|1|||
163127477|NCT02335424|589174245|FG000|Overall Study|Screen failure|1|||
163127478|NCT01141478|589174246|FG000|Overall Study|Withdrawal by Subject|1|||
163127479|NCT01141478|589174247|FG001|Overall Study|Withdrawal by Subject|1|||
163127480|NCT01581619|589174250|FG000|Overall Study|Withdrawal by Subject|1|||
163127481|NCT01581619|589174250|FG000|Overall Study|Lost to Follow-up|1|||
163127482|NCT00290498|589174251|FG000|Overall Study|Death|2|||
163127483|NCT00290498|589174252|FG001|Overall Study|Death|0|||
163127484|NCT00290498|589174251|FG000|Overall Study|Physician Decision|1|||
163127485|NCT00290498|589174252|FG001|Overall Study|Physician Decision|0|||
163127486|NCT00290498|589174251|FG000|Overall Study|Withdrawal by Subject|1|||
163127487|NCT00290498|589174252|FG001|Overall Study|Withdrawal by Subject|0|||
163127488|NCT00290498|589174251|FG000|Overall Study|Ineligible|3|||
163127489|NCT00290498|589174252|FG001|Overall Study|Ineligible|0|||
163127490|NCT00290498|589174251|FG000|Overall Study|Non-Compliance|1|||
163127491|NCT00290498|589174252|FG001|Overall Study|Non-Compliance|0|||
163127492|NCT00599638|589174253|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
163127493|NCT00599638|589174254|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
163127494|NCT00599638|589174255|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
163127495|NCT00599638|589174256|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
163127496|NCT00599638|589174253|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
163127497|NCT00599638|589174254|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
163127498|NCT00599638|589174255|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
163127499|NCT00599638|589174256|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
163127500|NCT00599638|589174253|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
163127501|NCT00599638|589174254|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
163127502|NCT00599638|589174255|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
163127503|NCT00599638|589174256|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
163127504|NCT00599638|589174253|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
163127505|NCT00599638|589174254|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
163127506|NCT00599638|589174255|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
163127507|NCT00599638|589174256|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
163127508|NCT00599638|589174253|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
163127509|NCT00599638|589174254|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
163127510|NCT00599638|589174255|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
163127511|NCT00599638|589174256|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
163127512|NCT00599638|589174253|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
163127513|NCT00599638|589174254|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
163127514|NCT00599638|589174255|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
163127515|NCT00599638|589174256|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
163127516|NCT00599638|589174253|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
163127517|NCT00599638|589174254|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
163127518|NCT00599638|589174255|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
163127519|NCT00599638|589174256|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
163127520|NCT00599638|589174253|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
163127521|NCT00599638|589174254|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
163127522|NCT00599638|589174255|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
163127523|NCT00599638|589174256|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
163127524|NCT00599638|589174253|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
163127525|NCT00599638|589174254|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
163127526|NCT00599638|589174255|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
163127527|NCT00599638|589174256|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
163127528|NCT03006887|589174260|FG000|Overall Study|Adverse Event|1|||
163127529|NCT03836677|589174261|FG000|Period 1|Adverse Event|0|||
163127530|NCT03836677|589174262|FG001|Period 1|Adverse Event|1|||
163127531|NCT03836677|589174261|FG000|Period 2|Severe non-compliance to protocol|1|||
163342599|NCT02812706|589961392|FG000|Phase 1|Adverse Event|0|||
163342600|NCT02812706|589961393|FG001|Phase 1|Adverse Event|2|||
163342601|NCT02812706|589961394|FG002|Phase 1|Adverse Event|0|||
163342602|NCT02812706|589961392|FG000|Phase 1|Progressive disease|3|||
163342603|NCT02812706|589961393|FG001|Phase 1|Progressive disease|3|||
163342604|NCT02812706|589961394|FG002|Phase 1|Progressive disease|0|||
163342605|NCT02812706|589961392|FG000|Phase 2|Adverse Event|0|||
163342606|NCT02812706|589961393|FG001|Phase 2|Adverse Event|0|||
163342607|NCT02812706|589961394|FG002|Phase 2|Adverse Event|2|||
163342608|NCT02812706|589961392|FG000|Phase 2|Progressive disease|0|||
163342609|NCT02812706|589961393|FG001|Phase 2|Progressive disease|0|||
163342610|NCT02812706|589961394|FG002|Phase 2|Progressive disease|22|||
163342611|NCT02812706|589961392|FG000|Phase 2|Other-Unspecified|0|||
163342612|NCT02812706|589961393|FG001|Phase 2|Other-Unspecified|0|||
163342613|NCT02812706|589961394|FG002|Phase 2|Other-Unspecified|4|||
163342614|NCT02138838|589961399|FG000|Overall Study|Study Closure|7|||
163342615|NCT02138838|589961400|FG001|Overall Study|Study Closure|6|||
163342616|NCT02138838|589961399|FG000|Overall Study|Withdrawal by Subject|1|||
163342617|NCT02138838|589961400|FG001|Overall Study|Withdrawal by Subject|5|||
163342618|NCT01294644|589961403|FG000|Overall Study|Adverse Event|2|||
163342619|NCT01294644|589961404|FG001|Overall Study|Adverse Event|0|||
163127532|NCT03836677|589174262|FG001|Period 2|Severe non-compliance to protocol|0|||
163127533|NCT02895945|589174263|FG000|Overall Study|Physician Decision|2|||
163127534|NCT02895945|589174264|FG001|Overall Study|Physician Decision|1|||
163127535|NCT00462748|589174265|FG000|Overall Study|Adverse Event|7|||
163127536|NCT00462748|589174266|FG001|Overall Study|Adverse Event|5|||
163127537|NCT00462748|589174267|FG002|Overall Study|Adverse Event|9|||
163127538|NCT00462748|589174265|FG000|Overall Study|Protocol Violation|0|||
163127539|NCT00462748|589174266|FG001|Overall Study|Protocol Violation|2|||
163127540|NCT00462748|589174267|FG002|Overall Study|Protocol Violation|1|||
163127541|NCT00462748|589174265|FG000|Overall Study|Withdrew consent|3|||
163127542|NCT00462748|589174266|FG001|Overall Study|Withdrew consent|3|||
163127543|NCT00462748|589174267|FG002|Overall Study|Withdrew consent|0|||
163127544|NCT00462748|589174265|FG000|Overall Study|Lost to Follow-up|1|||
163127545|NCT00462748|589174266|FG001|Overall Study|Lost to Follow-up|1|||
163127546|NCT00462748|589174267|FG002|Overall Study|Lost to Follow-up|1|||
163127547|NCT00462748|589174265|FG000|Overall Study|Discontinued after 41 days Rx|1|||
163127548|NCT00462748|589174266|FG001|Overall Study|Discontinued after 41 days Rx|0|||
163127549|NCT00462748|589174267|FG002|Overall Study|Discontinued after 41 days Rx|0|||
163127550|NCT03429543|589174268|FG000|Overall Study|Adverse Event|1|||
163127551|NCT03429543|589174269|FG001|Overall Study|Adverse Event|1|||
163127552|NCT03429543|589174270|FG002|Overall Study|Adverse Event|0|||
163127553|NCT03429543|589174271|FG003|Overall Study|Adverse Event|0|||
163127554|NCT03429543|589174272|FG004|Overall Study|Adverse Event|0|||
163127555|NCT03429543|589174273|FG005|Overall Study|Adverse Event|2|||
163127556|NCT03429543|589174274|FG006|Overall Study|Adverse Event|0|||
163127557|NCT03429543|589174268|FG000|Overall Study|Lost to Follow-up|1|||
163127558|NCT03429543|589174269|FG001|Overall Study|Lost to Follow-up|0|||
163127559|NCT03429543|589174270|FG002|Overall Study|Lost to Follow-up|0|||
163127560|NCT03429543|589174271|FG003|Overall Study|Lost to Follow-up|0|||
163127561|NCT03429543|589174272|FG004|Overall Study|Lost to Follow-up|1|||
163127562|NCT03429543|589174273|FG005|Overall Study|Lost to Follow-up|0|||
163127563|NCT03429543|589174274|FG006|Overall Study|Lost to Follow-up|0|||
163127564|NCT03429543|589174268|FG000|Overall Study|Withdrawal by Subject|5|||
163127565|NCT03429543|589174269|FG001|Overall Study|Withdrawal by Subject|0|||
163127566|NCT03429543|589174270|FG002|Overall Study|Withdrawal by Subject|1|||
163127567|NCT03429543|589174271|FG003|Overall Study|Withdrawal by Subject|2|||
163127568|NCT03429543|589174272|FG004|Overall Study|Withdrawal by Subject|6|||
163127569|NCT03429543|589174273|FG005|Overall Study|Withdrawal by Subject|3|||
163127570|NCT03429543|589174274|FG006|Overall Study|Withdrawal by Subject|1|||
163127571|NCT03429543|589174268|FG000|Overall Study|Other reason than listed|0|||
163127572|NCT03429543|589174269|FG001|Overall Study|Other reason than listed|1|||
163127573|NCT03429543|589174270|FG002|Overall Study|Other reason than listed|0|||
163127574|NCT03429543|589174271|FG003|Overall Study|Other reason than listed|0|||
163127575|NCT03429543|589174272|FG004|Overall Study|Other reason than listed|4|||
163342620|NCT01294644|589961405|FG002|Overall Study|Adverse Event|1|||
163342621|NCT01294644|589961403|FG000|Overall Study|Withdrawal by Subject|3|||
163127576|NCT03429543|589174273|FG005|Overall Study|Other reason than listed|4|||
163127577|NCT03429543|589174274|FG006|Overall Study|Other reason than listed|0|||
163127578|NCT03429543|589174268|FG000|Overall Study|Not treated|0|||
163127579|NCT03429543|589174269|FG001|Overall Study|Not treated|0|||
163127580|NCT03429543|589174270|FG002|Overall Study|Not treated|0|||
163127581|NCT03429543|589174271|FG003|Overall Study|Not treated|0|||
163342622|NCT01294644|589961404|FG001|Overall Study|Withdrawal by Subject|7|||
163127582|NCT03429543|589174272|FG004|Overall Study|Not treated|1|||
163127583|NCT03429543|589174273|FG005|Overall Study|Not treated|0|||
163127584|NCT03429543|589174274|FG006|Overall Study|Not treated|0|||
163127585|NCT01600092|589174275|FG000|Overall Study|Adverse Event|2|||
163342623|NCT01294644|589961405|FG002|Overall Study|Withdrawal by Subject|4|||
163342624|NCT01294644|589961403|FG000|Overall Study|Lost to Follow-up|3|||
163342625|NCT01294644|589961404|FG001|Overall Study|Lost to Follow-up|2|||
163127586|NCT01600092|589174276|FG001|Overall Study|Adverse Event|0|||
163342626|NCT01294644|589961405|FG002|Overall Study|Lost to Follow-up|5|||
163342627|NCT01294644|589961403|FG000|Overall Study|Miscellaneous Reason|2|||
163127587|NCT01600092|589174275|FG000|Overall Study|Lost to Follow-up|4|||
163127588|NCT01600092|589174276|FG001|Overall Study|Lost to Follow-up|6|||
163127589|NCT01600092|589174275|FG000|Overall Study|Withdrawal by parent/guardian|8|||
163127590|NCT01600092|589174276|FG001|Overall Study|Withdrawal by parent/guardian|6|||
163127591|NCT01600092|589174275|FG000|Overall Study|Physician Decision|1|||
163127592|NCT01600092|589174276|FG001|Overall Study|Physician Decision|1|||
163127593|NCT01600092|589174275|FG000|Overall Study|Randomized but not vaccinated|3|||
163127594|NCT01600092|589174276|FG001|Overall Study|Randomized but not vaccinated|3|||
163127595|NCT01561963|589174277|FG000|Overall Study|Adverse Event|1|||
163127596|NCT00637572|589174285|FG000|Overall Study|Adverse Event|1|||
163127597|NCT00637572|589174286|FG001|Overall Study|Adverse Event|2|||
163127598|NCT00637572|589174285|FG000|Overall Study|Death|0|||
163127599|NCT00637572|589174286|FG001|Overall Study|Death|1|||
163127600|NCT00637572|589174285|FG000|Overall Study|Lost to Follow-up|0|||
163127601|NCT00637572|589174286|FG001|Overall Study|Lost to Follow-up|1|||
163127602|NCT00637572|589174285|FG000|Overall Study|Physician Decision|1|||
163127603|NCT00637572|589174286|FG001|Overall Study|Physician Decision|1|||
163127604|NCT00637572|589174285|FG000|Overall Study|Withdrawal by Subject|0|||
163127605|NCT00637572|589174286|FG001|Overall Study|Withdrawal by Subject|2|||
163127606|NCT00637572|589174285|FG000|Overall Study|Illicit Drug Use|1|||
163127607|NCT00637572|589174286|FG001|Overall Study|Illicit Drug Use|0|||
163127608|NCT04667104|589174288|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
163127609|NCT04667104|589174289|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
163127610|NCT04667104|589174290|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
163127611|NCT05066165|589176454|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
163127612|NCT05066165|589176455|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
163127613|NCT05066165|589176454|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
163127614|NCT05066165|589176455|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
163127615|NCT03210961|589176456|FG000|Overall Study|Adverse Event|0|||
163127616|NCT03210961|589176457|FG001|Overall Study|Adverse Event|0|||
163127617|NCT03210961|589176458|FG002|Overall Study|Adverse Event|0|||
163127618|NCT03210961|589176459|FG003|Overall Study|Adverse Event|0|||
163127619|NCT03210961|589176460|FG004|Overall Study|Adverse Event|0|||
163127620|NCT03210961|589176461|FG005|Overall Study|Adverse Event|0|||
163127621|NCT03210961|589176462|FG006|Overall Study|Adverse Event|0|||
163127622|NCT03210961|589176463|FG007|Overall Study|Adverse Event|0|||
163127623|NCT03210961|589176464|FG008|Overall Study|Adverse Event|0|||
163127624|NCT03210961|589176465|FG009|Overall Study|Adverse Event|0|||
163127625|NCT03210961|589176466|FG010|Overall Study|Adverse Event|0|||
163127626|NCT03210961|589176467|FG011|Overall Study|Adverse Event|0|||
163127627|NCT03210961|589176468|FG012|Overall Study|Adverse Event|0|||
163127628|NCT03210961|589176469|FG013|Overall Study|Adverse Event|1|||
163127629|NCT03210961|589176470|FG014|Overall Study|Adverse Event|0|||
163127630|NCT03210961|589176456|FG000|Overall Study|Lost to Follow-up|0|||
163127631|NCT03210961|589176457|FG001|Overall Study|Lost to Follow-up|0|||
163127632|NCT03210961|589176458|FG002|Overall Study|Lost to Follow-up|0|||
163127633|NCT03210961|589176459|FG003|Overall Study|Lost to Follow-up|0|||
163127634|NCT03210961|589176460|FG004|Overall Study|Lost to Follow-up|0|||
163127635|NCT03210961|589176461|FG005|Overall Study|Lost to Follow-up|0|||
163127636|NCT03210961|589176462|FG006|Overall Study|Lost to Follow-up|0|||
163127637|NCT03210961|589176463|FG007|Overall Study|Lost to Follow-up|0|||
163127638|NCT03210961|589176464|FG008|Overall Study|Lost to Follow-up|0|||
163127639|NCT03210961|589176465|FG009|Overall Study|Lost to Follow-up|0|||
163127640|NCT03210961|589176466|FG010|Overall Study|Lost to Follow-up|0|||
163127641|NCT03210961|589176467|FG011|Overall Study|Lost to Follow-up|0|||
163127642|NCT03210961|589176468|FG012|Overall Study|Lost to Follow-up|0|||
163127643|NCT03210961|589176469|FG013|Overall Study|Lost to Follow-up|0|||
163127644|NCT03210961|589176470|FG014|Overall Study|Lost to Follow-up|1|||
163127645|NCT03210961|589176456|FG000|Overall Study|Withdrawal by Subject|0|||
163127646|NCT03210961|589176457|FG001|Overall Study|Withdrawal by Subject|0|||
163127647|NCT03210961|589176458|FG002|Overall Study|Withdrawal by Subject|0|||
163127648|NCT03210961|589176459|FG003|Overall Study|Withdrawal by Subject|0|||
163127649|NCT03210961|589176460|FG004|Overall Study|Withdrawal by Subject|0|||
163127650|NCT03210961|589176461|FG005|Overall Study|Withdrawal by Subject|0|||
163127651|NCT03210961|589176462|FG006|Overall Study|Withdrawal by Subject|0|||
163127652|NCT03210961|589176463|FG007|Overall Study|Withdrawal by Subject|0|||
163342628|NCT01294644|589961404|FG001|Overall Study|Miscellaneous Reason|1|||
163127653|NCT03210961|589176464|FG008|Overall Study|Withdrawal by Subject|0|||
163127654|NCT03210961|589176465|FG009|Overall Study|Withdrawal by Subject|0|||
163127655|NCT03210961|589176466|FG010|Overall Study|Withdrawal by Subject|0|||
163127656|NCT03210961|589176467|FG011|Overall Study|Withdrawal by Subject|0|||
163127657|NCT03210961|589176468|FG012|Overall Study|Withdrawal by Subject|0|||
163127658|NCT03210961|589176469|FG013|Overall Study|Withdrawal by Subject|0|||
163127659|NCT03210961|589176470|FG014|Overall Study|Withdrawal by Subject|1|||
163127660|NCT03210961|589176456|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
163342629|NCT01294644|589961405|FG002|Overall Study|Miscellaneous Reason|4|||
163127661|NCT03210961|589176457|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
163342630|NCT04433091|589961407|FG000|Overall Study|Lost to Follow-up|1|||
163342631|NCT04433091|589961408|FG001|Overall Study|Lost to Follow-up|0|||
163342632|NCT04433091|589961407|FG000|Overall Study|Withdrawn .|2|||
163342633|NCT04433091|589961408|FG001|Overall Study|Withdrawn .|4|||
163342634|NCT02880293|589962663|FG000|Overall Study|Inevaluable|5|||
163342635|NCT02101554|589962664|FG000|Overall Study|Protocol Violation|0|||
163127662|NCT03210961|589176458|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127663|NCT03210961|589176459|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127664|NCT03210961|589176460|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127665|NCT03210961|589176461|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127666|NCT03210961|589176462|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127667|NCT03210961|589176463|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127668|NCT03210961|589176464|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
163342636|NCT02101554|589962665|FG001|Overall Study|Protocol Violation|1|||
163342637|NCT02101554|589962666|FG002|Overall Study|Protocol Violation|0|||
163342638|NCT02101554|589962664|FG000|Overall Study|Insufficient Clinical Response|0|||
163342639|NCT02101554|589962665|FG001|Overall Study|Insufficient Clinical Response|2|||
163342640|NCT02101554|589962666|FG002|Overall Study|Insufficient Clinical Response|0|||
163342641|NCT02101554|589962664|FG000|Overall Study|Adverse Event|2|||
163342642|NCT02101554|589962665|FG001|Overall Study|Adverse Event|1|||
163342643|NCT02101554|589962666|FG002|Overall Study|Adverse Event|1|||
163342644|NCT02101554|589962664|FG000|Overall Study|Lost to Follow-up|0|||
163408294|NCT03461757|590204094|FG000|Overall Study|Lost to Follow-up|13|||
163127669|NCT03210961|589176465|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127670|NCT03210961|589176466|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127671|NCT03210961|589176467|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127672|NCT03210961|589176468|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127673|NCT03210961|589176469|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
163127674|NCT03210961|589176470|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127675|NCT03210961|589176456|FG000|Overall Study|Other|0|||
163127676|NCT03210961|589176457|FG001|Overall Study|Other|0|||
163127677|NCT03210961|589176458|FG002|Overall Study|Other|0|||
163127678|NCT03210961|589176459|FG003|Overall Study|Other|1|||
163127679|NCT03210961|589176460|FG004|Overall Study|Other|0|||
163127680|NCT03210961|589176461|FG005|Overall Study|Other|0|||
163127681|NCT03210961|589176462|FG006|Overall Study|Other|1|||
163127682|NCT03210961|589176463|FG007|Overall Study|Other|0|||
163127683|NCT03210961|589176464|FG008|Overall Study|Other|0|||
163127684|NCT03210961|589176465|FG009|Overall Study|Other|0|||
163127685|NCT03210961|589176466|FG010|Overall Study|Other|1|||
163127686|NCT03210961|589176467|FG011|Overall Study|Other|0|||
163127687|NCT03210961|589176468|FG012|Overall Study|Other|2|||
163127688|NCT03210961|589176469|FG013|Overall Study|Other|2|||
163127689|NCT03210961|589176470|FG014|Overall Study|Other|0|||
163127690|NCT03343626|589176471|FG000|Overall Study|Lost to Follow-up|4|||
163127691|NCT03343626|589176472|FG001|Overall Study|Lost to Follow-up|3|||
163127692|NCT03343626|589176473|FG002|Overall Study|Lost to Follow-up|2|||
163127693|NCT03343626|589176474|FG003|Overall Study|Lost to Follow-up|5|||
163127694|NCT03343626|589176475|FG004|Overall Study|Lost to Follow-up|4|||
163127695|NCT03343626|589176476|FG005|Overall Study|Lost to Follow-up|4|||
163127696|NCT03343626|589176477|FG006|Overall Study|Lost to Follow-up|4|||
163127697|NCT03343626|589176478|FG007|Overall Study|Lost to Follow-up|7|||
163127698|NCT03343626|589176471|FG000|Overall Study|Withdrawal of Consent|2|||
163127699|NCT03343626|589176472|FG001|Overall Study|Withdrawal of Consent|1|||
163127700|NCT03343626|589176473|FG002|Overall Study|Withdrawal of Consent|0|||
163127701|NCT03343626|589176474|FG003|Overall Study|Withdrawal of Consent|3|||
163127702|NCT03343626|589176475|FG004|Overall Study|Withdrawal of Consent|3|||
163127703|NCT03343626|589176476|FG005|Overall Study|Withdrawal of Consent|1|||
163127704|NCT03343626|589176477|FG006|Overall Study|Withdrawal of Consent|1|||
163127705|NCT03343626|589176478|FG007|Overall Study|Withdrawal of Consent|2|||
163127706|NCT03343626|589176471|FG000|Overall Study|Reason not Specified|0|||
163127707|NCT03343626|589176472|FG001|Overall Study|Reason not Specified|1|||
163127708|NCT03343626|589176473|FG002|Overall Study|Reason not Specified|0|||
163127709|NCT03343626|589176474|FG003|Overall Study|Reason not Specified|0|||
163127710|NCT03343626|589176475|FG004|Overall Study|Reason not Specified|0|||
163127711|NCT03343626|589176476|FG005|Overall Study|Reason not Specified|0|||
163127712|NCT03343626|589176477|FG006|Overall Study|Reason not Specified|0|||
163342645|NCT02101554|589962665|FG001|Overall Study|Lost to Follow-up|1|||
163408295|NCT03461757|590204095|FG001|Overall Study|Lost to Follow-up|7|||
163408296|NCT03461757|590204094|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
163127713|NCT03343626|589176478|FG007|Overall Study|Reason not Specified|1|||
163127714|NCT03343626|589176471|FG000|Overall Study|Data Entry Error|0|||
163342646|NCT02101554|589962666|FG002|Overall Study|Lost to Follow-up|0|||
163342647|NCT02101554|589962664|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
163342648|NCT02101554|589962665|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
163342649|NCT02101554|589962666|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
163342650|NCT04385849|589962667|FG000|Overall Study|Lost to Follow-up|1|||
163342651|NCT04385849|589962668|FG001|Overall Study|Lost to Follow-up|0|||
163127715|NCT03343626|589176472|FG001|Overall Study|Data Entry Error|0|||
163127716|NCT03343626|589176473|FG002|Overall Study|Data Entry Error|0|||
163127717|NCT03343626|589176474|FG003|Overall Study|Data Entry Error|0|||
163127718|NCT03343626|589176475|FG004|Overall Study|Data Entry Error|0|||
163127719|NCT03343626|589176476|FG005|Overall Study|Data Entry Error|0|||
163127720|NCT03343626|589176477|FG006|Overall Study|Data Entry Error|0|||
163127721|NCT03343626|589176478|FG007|Overall Study|Data Entry Error|1|||
163127722|NCT03592368|589176482|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
163127723|NCT03592368|589176483|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
163127724|NCT03592368|589176484|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
163127725|NCT03592368|589176485|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
163127726|NCT03592368|589176482|FG000|Overall Study|Adverse Event|0|||
163127727|NCT03592368|589176483|FG001|Overall Study|Adverse Event|0|||
163127728|NCT03592368|589176484|FG002|Overall Study|Adverse Event|0|||
163127729|NCT03592368|589176485|FG003|Overall Study|Adverse Event|1|||
163127730|NCT03592368|589176482|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
163127731|NCT03592368|589176483|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
163127732|NCT03592368|589176484|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
163127733|NCT03592368|589176485|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
163127734|NCT03047031|589176488|FG000|Overall Study|Other than listed|1|||
163127735|NCT03047031|589176489|FG001|Overall Study|Other than listed|0|||
163127736|NCT03047031|589176490|FG002|Overall Study|Other than listed|0|||
163127737|NCT03047031|589176488|FG000|Overall Study|Lost to Follow-up|4|||
163127738|NCT03047031|589176489|FG001|Overall Study|Lost to Follow-up|0|||
163127739|NCT03047031|589176490|FG002|Overall Study|Lost to Follow-up|0|||
163127740|NCT03047031|589176488|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
163127741|NCT03047031|589176489|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
163127742|NCT03047031|589176490|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
163127743|NCT03047031|589176488|FG000|Overall Study|Adverse Event|1|||
163127744|NCT03047031|589176489|FG001|Overall Study|Adverse Event|0|||
163127745|NCT03047031|589176490|FG002|Overall Study|Adverse Event|0|||
163127746|NCT03047031|589176488|FG000|Overall Study|Withdrawal by Subject|2|||
163127747|NCT03047031|589176489|FG001|Overall Study|Withdrawal by Subject|0|||
163127748|NCT03047031|589176490|FG002|Overall Study|Withdrawal by Subject|0|||
163127749|NCT03047031|589176488|FG000|Overall Study|Change to other medication|2|||
163127750|NCT03047031|589176489|FG001|Overall Study|Change to other medication|0|||
163127751|NCT03047031|589176490|FG002|Overall Study|Change to other medication|0|||
163127752|NCT03047031|589176488|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
163127753|NCT03047031|589176489|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
163127754|NCT03047031|589176490|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
163127755|NCT02814175|589176491|FG000|Part 1|Adverse Event|2|||
163127756|NCT02814175|589176492|FG001|Part 1|Adverse Event|3|||
163127757|NCT02814175|589176493|FG002|Part 1|Adverse Event|0|||
163127758|NCT02814175|589176494|FG003|Part 1|Adverse Event|0|||
163127759|NCT02814175|589176495|FG004|Part 1|Adverse Event|0|||
163127760|NCT02814175|589176496|FG005|Part 1|Adverse Event|0|||
163127761|NCT02814175|589176491|FG000|Part 1|Withdrawal Consent|8|||
163127762|NCT02814175|589176492|FG001|Part 1|Withdrawal Consent|1|||
163127763|NCT02814175|589176493|FG002|Part 1|Withdrawal Consent|0|||
163127764|NCT02814175|589176494|FG003|Part 1|Withdrawal Consent|0|||
163127765|NCT02814175|589176495|FG004|Part 1|Withdrawal Consent|0|||
163127766|NCT02814175|589176496|FG005|Part 1|Withdrawal Consent|0|||
163127767|NCT02814175|589176491|FG000|Part 1|Lost to Follow-up|1|||
163127768|NCT02814175|589176492|FG001|Part 1|Lost to Follow-up|0|||
163127769|NCT02814175|589176493|FG002|Part 1|Lost to Follow-up|0|||
163127770|NCT02814175|589176494|FG003|Part 1|Lost to Follow-up|0|||
163127771|NCT02814175|589176495|FG004|Part 1|Lost to Follow-up|0|||
163127772|NCT02814175|589176496|FG005|Part 1|Lost to Follow-up|0|||
163127773|NCT02814175|589176491|FG000|Part 1|Lack of Efficacy|1|||
163127774|NCT02814175|589176492|FG001|Part 1|Lack of Efficacy|2|||
163342652|NCT02011568|589962669|FG000|Overall Study|Withdrawal by Subject|8|||
163342653|NCT02011568|589962670|FG001|Overall Study|Withdrawal by Subject|10|||
163342654|NCT02011568|589962669|FG000|Overall Study|Physician Decision|1|||
163342655|NCT02011568|589962670|FG001|Overall Study|Physician Decision|3|||
163342656|NCT01038128|589962672|FG000|Overall Study|Lack of Efficacy|1|||
163127775|NCT02814175|589176493|FG002|Part 1|Lack of Efficacy|0|||
163127776|NCT02814175|589176494|FG003|Part 1|Lack of Efficacy|0|||
163127777|NCT02814175|589176495|FG004|Part 1|Lack of Efficacy|0|||
163127778|NCT02814175|589176496|FG005|Part 1|Lack of Efficacy|0|||
163127779|NCT02814175|589176491|FG000|Part 2|Adverse Event|0|||
163127780|NCT02814175|589176492|FG001|Part 2|Adverse Event|0|||
163127781|NCT02814175|589176493|FG002|Part 2|Adverse Event|0|||
163342657|NCT01038128|589962672|FG000|Overall Study|Lost to Follow-up|1|||
163342658|NCT01038128|589962672|FG000|Overall Study|Withdrawal by Subject|2|||
163127782|NCT02814175|589176494|FG003|Part 2|Adverse Event|1|||
163127783|NCT02814175|589176495|FG004|Part 2|Adverse Event|1|||
163342659|NCT00396409|589962677|FG000|Period 1 - 2007|Adverse Event|0|||
163342660|NCT00396409|589962678|FG001|Period 1 - 2007|Adverse Event|1|||
163342661|NCT00396409|589962677|FG000|Period 1 - 2007|Lack of Efficacy|0|||
163342662|NCT00396409|589962678|FG001|Period 1 - 2007|Lack of Efficacy|1|||
163342663|NCT00396409|589962677|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
163342664|NCT00396409|589962678|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
163342665|NCT00396409|589962677|FG000|Period 1 - 2007|Lost to Follow-up|2|||
163342666|NCT00396409|589962678|FG001|Period 1 - 2007|Lost to Follow-up|3|||
163342667|NCT00396409|589962677|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
163342668|NCT00396409|589962678|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
163342669|NCT00396409|589962677|FG000|Period 2 - 2008|Protocol Violation|1|||
163342670|NCT00396409|589962678|FG001|Period 2 - 2008|Protocol Violation|0|||
163342671|NCT00396409|589962677|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
163408297|NCT03461757|590204095|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
163408298|NCT03461757|590204094|FG000|Overall Study|Non-compliance with study treatment|0|||
163408299|NCT03461757|590204095|FG001|Overall Study|Non-compliance with study treatment|1|||
163408300|NCT03461757|590204094|FG000|Overall Study|Pregnancy|2|||
163408301|NCT03461757|590204095|FG001|Overall Study|Pregnancy|0|||
163408302|NCT03461757|590204094|FG000|Overall Study|Protocol Violation|1|||
163408303|NCT03461757|590204095|FG001|Overall Study|Protocol Violation|1|||
163408304|NCT03461757|590204094|FG000|Overall Study|Withdrawal by Subject|7|||
163408305|NCT03461757|590204095|FG001|Overall Study|Withdrawal by Subject|7|||
163408306|NCT03461757|590204094|FG000|Overall Study|Other Reasons|1|||
163408307|NCT03461757|590204095|FG001|Overall Study|Other Reasons|4|||
163408308|NCT03861559|590204096|FG000|Overall Study|Adverse Event|0|||
163408309|NCT03861559|590204097|FG001|Overall Study|Adverse Event|2|||
163408310|NCT03861559|590204096|FG000|Overall Study|Treatment failure|0|||
163408311|NCT03861559|590204097|FG001|Overall Study|Treatment failure|2|||
163408312|NCT03861559|590204096|FG000|Overall Study|Noncompliance|1|||
163408313|NCT03861559|590204097|FG001|Overall Study|Noncompliance|1|||
163408314|NCT03861559|590204096|FG000|Overall Study|Did not meet eligibility requirements|1|||
163408315|NCT03861559|590204097|FG001|Overall Study|Did not meet eligibility requirements|0|||
163408316|NCT00879697|590204100|FG000|Overall Study|Physician Decision|2|||
163127784|NCT02814175|589176496|FG005|Part 2|Adverse Event|2|||
163127785|NCT02814175|589176491|FG000|Part 2|Withdrawal Consent|0|||
163127786|NCT02814175|589176492|FG001|Part 2|Withdrawal Consent|0|||
163127787|NCT02814175|589176493|FG002|Part 2|Withdrawal Consent|0|||
163127788|NCT02814175|589176494|FG003|Part 2|Withdrawal Consent|2|||
163127789|NCT02814175|589176495|FG004|Part 2|Withdrawal Consent|1|||
163127790|NCT02814175|589176496|FG005|Part 2|Withdrawal Consent|1|||
163127791|NCT02814175|589176491|FG000|Part 2|Lost to Follow-up|0|||
163127792|NCT02814175|589176492|FG001|Part 2|Lost to Follow-up|0|||
163127793|NCT02814175|589176493|FG002|Part 2|Lost to Follow-up|0|||
163127794|NCT02814175|589176494|FG003|Part 2|Lost to Follow-up|1|||
163127795|NCT02814175|589176495|FG004|Part 2|Lost to Follow-up|0|||
163127796|NCT02814175|589176496|FG005|Part 2|Lost to Follow-up|0|||
163127797|NCT02814175|589176491|FG000|Part 2|Lack of Efficacy|0|||
163127798|NCT02814175|589176492|FG001|Part 2|Lack of Efficacy|0|||
163127799|NCT02814175|589176493|FG002|Part 2|Lack of Efficacy|0|||
163127800|NCT02814175|589176494|FG003|Part 2|Lack of Efficacy|0|||
163127801|NCT02814175|589176495|FG004|Part 2|Lack of Efficacy|0|||
163127802|NCT02814175|589176496|FG005|Part 2|Lack of Efficacy|3|||
163127803|NCT04207749|589176509|FG000|Overall Study|Lost to Follow-up|0|||
163127804|NCT04207749|589176510|FG001|Overall Study|Lost to Follow-up|2|||
163127805|NCT04207749|589176509|FG000|Overall Study|Protocol Violation|0|||
163342672|NCT00396409|589962678|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
163342673|NCT00396409|589962677|FG000|Period 2 - 2008|Lost to Follow-up|3|||
163342674|NCT00396409|589962678|FG001|Period 2 - 2008|Lost to Follow-up|1|||
163342675|NCT00331799|589962679|FG000|Overall Study|Withdrawal by Subject|2|||
163408317|NCT00879697|590204101|FG001|Overall Study|Physician Decision|2|||
163408318|NCT02500121|590204102|FG000|Overall Study|Lost to Follow-up|0|||
163408319|NCT02500121|590204103|FG001|Overall Study|Lost to Follow-up|1|||
163408320|NCT02500121|590204102|FG000|Overall Study|Withdrawal by Subject|1|||
163408321|NCT02500121|590204103|FG001|Overall Study|Withdrawal by Subject|1|||
163127806|NCT04207749|589176510|FG001|Overall Study|Protocol Violation|1|||
163127807|NCT04207749|589176509|FG000|Overall Study|Withdrawal by Subject|3|||
163127808|NCT04207749|589176510|FG001|Overall Study|Withdrawal by Subject|0|||
163127809|NCT04207749|589176509|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
163342676|NCT00331799|589962679|FG000|Overall Study|Sedation|1|||
163342677|NCT02889809|589962680|FG000|Overall Study|Withdrawal by Subject|30|||
163342678|NCT02889809|589962681|FG001|Overall Study|Withdrawal by Subject|21|||
163342679|NCT02889809|589962680|FG000|Overall Study|Lost to Follow-up|1|||
163342680|NCT02889809|589962681|FG001|Overall Study|Lost to Follow-up|1|||
163408322|NCT02500121|590204102|FG000|Overall Study|Death|26|||
163127810|NCT04207749|589176510|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
163127811|NCT01971008|589176511|FG000|Overall Study|Protocol Violation|2|||
163408323|NCT02500121|590204103|FG001|Overall Study|Death|24|||
163127812|NCT01971008|589176512|FG001|Overall Study|Protocol Violation|1|||
163127813|NCT03416127|589176513|FG000|Overall Study|Withdrawal by Subject|0|||
163127814|NCT03416127|589176514|FG001|Overall Study|Withdrawal by Subject|1|||
163127815|NCT03416127|589176515|FG002|Overall Study|Withdrawal by Subject|1|||
163127816|NCT00924508|589176516|FG000|Overall Study|Withdrawal by Subject|3|||
163127817|NCT00495625|589176517|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
163127818|NCT01912339|589176518|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
163127819|NCT01912339|589176519|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
163127820|NCT01912339|589176520|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
163127821|NCT01912339|589176518|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
163127822|NCT01912339|589176519|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
163127823|NCT01912339|589176520|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
163127824|NCT01912339|589176518|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
163127825|NCT01912339|589176519|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
163127826|NCT01912339|589176520|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
163127827|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
163127828|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
163127829|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
163127830|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
163127831|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
163127832|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
163127833|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
163127834|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
163127835|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
163127836|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
163127837|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
163127838|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
163127839|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
163127840|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
163127841|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
163127842|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
163127843|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
163127844|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
163127845|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
163127846|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
163127847|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
163127848|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
163127849|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
163127850|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
163127851|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
163127852|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
163127853|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
163127854|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
163127855|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
163127856|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
163127857|NCT03679624|589176521|FG000|Overall Study|Adverse Event|1|||
163127858|NCT03679624|589176522|FG001|Overall Study|Adverse Event|0|||
163127859|NCT00741013|589176523|FG000|Overall Study|Adverse Event|1|||
163127860|NCT00741013|589176524|FG001|Overall Study|Adverse Event|0|||
163127861|NCT00741013|589176525|FG002|Overall Study|Adverse Event|0|||
163127862|NCT00741013|589176523|FG000|Overall Study|Withdrawal by Subject|0|||
163127863|NCT00741013|589176524|FG001|Overall Study|Withdrawal by Subject|0|||
163127864|NCT00741013|589176525|FG002|Overall Study|Withdrawal by Subject|1|||
163127865|NCT00741013|589176523|FG000|Overall Study|Discovered failed screen after enrolled|0|||
163127866|NCT00741013|589176524|FG001|Overall Study|Discovered failed screen after enrolled|2|||
163127867|NCT00741013|589176525|FG002|Overall Study|Discovered failed screen after enrolled|0|||
163127868|NCT01754493|589176527|FG000|Overall Study|Adverse Event|1|||
163127869|NCT01754493|589176527|FG000|Overall Study|Lost to Follow-up|3|||
163127870|NCT01754493|589176527|FG000|Overall Study|Withdrawal by Subject|1|||
163127871|NCT01754493|589176527|FG000|Overall Study|Moved out of town|1|||
163127872|NCT01754493|589176527|FG000|Overall Study|Scheduling conflict|1|||
163127873|NCT02702414|589176530|FG000|Overall Study|Death|96|||
163127874|NCT02702414|589176531|FG001|Overall Study|Death|42|||
163127875|NCT02702414|589176530|FG000|Overall Study|Lost to Follow-up|0|||
163127876|NCT02702414|589176531|FG001|Overall Study|Lost to Follow-up|1|||
163226736|NCT01393405|589544258|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
163226737|NCT01393405|589544259|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
163342681|NCT02889809|589962680|FG000|Overall Study|Site Closed|12|||
163342682|NCT02889809|589962681|FG001|Overall Study|Site Closed|11|||
163342683|NCT03785210|589962683|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
163342684|NCT03785210|589962684|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
163342685|NCT02213458|589962685|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
163342686|NCT02213458|589962686|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
163342687|NCT02213458|589962685|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
163342688|NCT02213458|589962686|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
163342689|NCT02213458|589962685|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
163342690|NCT02213458|589962686|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
163342691|NCT02213458|589962685|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
163342692|NCT02213458|589962686|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
163342693|NCT02213458|589962685|FG000|Overall Study|Refused re-consent|6|||
163342694|NCT02213458|589962686|FG001|Overall Study|Refused re-consent|0|||
163342695|NCT02213458|589962685|FG000|Overall Study|Lost to Follow-up|2|||
163342696|NCT02213458|589962686|FG001|Overall Study|Lost to Follow-up|2|||
163342697|NCT02213458|589962685|FG000|Overall Study|Withdrawal by Subject|26|||
163342698|NCT02213458|589962686|FG001|Overall Study|Withdrawal by Subject|8|||
163342699|NCT04043806|589962687|FG000|Overall Study|Commercial drug is available for participants|13|||
163342700|NCT04043806|589962687|FG000|Overall Study|Physician Decision|2|||
163342701|NCT04043806|589962687|FG000|Overall Study|Other|12|||
163342702|NCT04043806|589962687|FG000|Overall Study|Adverse Event|2|||
163127877|NCT02702414|589176530|FG000|Overall Study|Withdrawal by Subject|0|||
163127878|NCT02702414|589176531|FG001|Overall Study|Withdrawal by Subject|1|||
163127879|NCT02702414|589176530|FG000|Overall Study|Protocol Violation|1|||
163127880|NCT02702414|589176531|FG001|Overall Study|Protocol Violation|0|||
163127881|NCT02702414|589176530|FG000|Overall Study|Sponsor Decision|8|||
163127882|NCT02702414|589176531|FG001|Overall Study|Sponsor Decision|7|||
163127883|NCT04541628|589176532|FG000|Overall Study|Study Terminated|1|||
163127884|NCT04541628|589176533|FG001|Overall Study|Study Terminated|1|||
163127885|NCT04541628|589176534|FG002|Overall Study|Study Terminated|1|||
163127886|NCT01452919|589176538|FG000|Open-Label Treatment|Adverse Event|5|||
163127887|NCT01452919|589176539|FG001|Open-Label Treatment|Adverse Event|0|||
163127888|NCT01452919|589176540|FG002|Open-Label Treatment|Adverse Event|0|||
163127889|NCT01452919|589176538|FG000|Open-Label Treatment|Lost to Follow-up|4|||
163127890|NCT01452919|589176539|FG001|Open-Label Treatment|Lost to Follow-up|0|||
163127891|NCT01452919|589176540|FG002|Open-Label Treatment|Lost to Follow-up|0|||
163127892|NCT01452919|589176538|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
163127893|NCT01452919|589176539|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
163127894|NCT01452919|589176540|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
163127895|NCT01452919|589176538|FG000|Open-Label Treatment|Protocol Violation|4|||
163127896|NCT01452919|589176539|FG001|Open-Label Treatment|Protocol Violation|0|||
163127897|NCT01452919|589176540|FG002|Open-Label Treatment|Protocol Violation|0|||
163127898|NCT01452919|589176538|FG000|Open-Label Treatment|Sponsor Decision|1|||
163127899|NCT01452919|589176539|FG001|Open-Label Treatment|Sponsor Decision|0|||
163127900|NCT01452919|589176540|FG002|Open-Label Treatment|Sponsor Decision|0|||
163127901|NCT01452919|589176538|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
163127902|NCT01452919|589176539|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
163127903|NCT01452919|589176540|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
163127904|NCT01452919|589176538|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
163127905|NCT01452919|589176539|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
163127906|NCT01452919|589176540|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
163127907|NCT01452919|589176538|FG000|Randomization Treatment|Adverse Event|0|||
163127908|NCT01452919|589176539|FG001|Randomization Treatment|Adverse Event|0|||
163127909|NCT01452919|589176540|FG002|Randomization Treatment|Adverse Event|2|||
163127910|NCT01452919|589176538|FG000|Randomization Treatment|Sponsor Decision|0|||
163127911|NCT01452919|589176539|FG001|Randomization Treatment|Sponsor Decision|1|||
163127912|NCT01452919|589176540|FG002|Randomization Treatment|Sponsor Decision|0|||
163127913|NCT01452919|589176538|FG000|Randomization Treatment|Withdrawal by Subject|0|||
163127914|NCT01452919|589176539|FG001|Randomization Treatment|Withdrawal by Subject|1|||
163127915|NCT01452919|589176540|FG002|Randomization Treatment|Withdrawal by Subject|0|||
163127916|NCT01452919|589176538|FG000|Randomization Treatment|Subject is moving or has moved|0|||
163127917|NCT01452919|589176539|FG001|Randomization Treatment|Subject is moving or has moved|1|||
163127918|NCT01452919|589176540|FG002|Randomization Treatment|Subject is moving or has moved|0|||
163127919|NCT00859937|589176541|FG000|Overall Study|Protocol Violation|1|||
163342703|NCT04043806|589962687|FG000|Overall Study|Lost to Follow-up|6|||
163342704|NCT04043806|589962687|FG000|Overall Study|Other non-compliance|2|||
163127920|NCT00859937|589176542|FG001|Overall Study|Protocol Violation|0|||
163127921|NCT00151476|589176543|FG000|FAP Identified Subjects|Protocol Violation|0|||
163127922|NCT00151476|589176544|FG001|FAP Identified Subjects|Protocol Violation|1|||
163342705|NCT04043806|589962687|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
163342706|NCT04043806|589962687|FG000|Overall Study|Never Dosed|1|||
163127923|NCT00151476|589176543|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
163342707|NCT03166215|589962692|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
163342708|NCT03166215|589962693|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
163127924|NCT00151476|589176544|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
163127925|NCT00151476|589176543|FG000|FAP Analyzed Subjects|Other study participation|0|||
163127926|NCT00151476|589176544|FG001|FAP Analyzed Subjects|Other study participation|1|||
163127927|NCT03446456|589176545|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
163127928|NCT03446456|589176546|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
163127929|NCT03446456|589176545|FG000|Overall Study|Lost to Follow-up|1|||
163127930|NCT03446456|589176546|FG001|Overall Study|Lost to Follow-up|3|||
163127931|NCT03446456|589176545|FG000|Overall Study|Participant failed the toxicology test|1|||
163127932|NCT03446456|589176546|FG001|Overall Study|Participant failed the toxicology test|0|||
163127933|NCT03446456|589176545|FG000|Overall Study|Break down of the experimental equipment|1|||
163127934|NCT03446456|589176546|FG001|Overall Study|Break down of the experimental equipment|0|||
163127935|NCT00658814|589176549|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
163127936|NCT00658814|589176550|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
163127937|NCT00658814|589176549|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
163127938|NCT00658814|589176550|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
163127939|NCT00658814|589176549|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
163127940|NCT00658814|589176550|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
163127941|NCT00658814|589176549|FG000|Remission Induction Chemotherapy|Death|1|||
163127942|NCT00658814|589176550|FG001|Remission Induction Chemotherapy|Death|4|||
163127943|NCT00658814|589176549|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
163127944|NCT00658814|589176550|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
163127945|NCT00658814|589176549|FG000|Remission Induction Chemotherapy|Not eligible|1|||
163127946|NCT00658814|589176550|FG001|Remission Induction Chemotherapy|Not eligible|2|||
163127947|NCT00658814|589176549|FG000|Consolidation Therapy|Not protocol specified|0|||
163127948|NCT00658814|589176550|FG001|Consolidation Therapy|Not protocol specified|1|||
163127949|NCT00658814|589176549|FG000|Consolidation Therapy|Not eligible|2|||
163127950|NCT00658814|589176550|FG001|Consolidation Therapy|Not eligible|2|||
163127951|NCT00658814|589176549|FG000|Maintenance Therapy|Adverse Event|1|||
163127952|NCT00658814|589176550|FG001|Maintenance Therapy|Adverse Event|1|||
163127953|NCT00658814|589176549|FG000|Maintenance Therapy|Not protocol specified|1|||
163127954|NCT00658814|589176550|FG001|Maintenance Therapy|Not protocol specified|0|||
163127955|NCT00658814|589176549|FG000|Maintenance Therapy|Not eligible|1|||
163127956|NCT00658814|589176550|FG001|Maintenance Therapy|Not eligible|0|||
163127957|NCT00455143|589176553|FG000|Overall Study|Physician Decision|1|||
163127958|NCT00455143|589176553|FG000|Overall Study|Withdrawal by Subject|1|||
163127959|NCT00455143|589176553|FG000|Overall Study|Staff was not avail to follow patient|2|||
163127960|NCT00455143|589176553|FG000|Overall Study|No longer met Inclusion Criteria|1|||
163127961|NCT00455143|589176553|FG000|Overall Study|Surgical time, staff not available|1|||
163127962|NCT00549770|589176556|FG000|Overall Study|Protocol deviation|1|||
163127963|NCT00549770|589176557|FG001|Overall Study|Protocol deviation|1|||
163127964|NCT00549770|589176558|FG002|Overall Study|Protocol deviation|1|||
163127965|NCT00549770|589176559|FG003|Overall Study|Protocol deviation|2|||
163127966|NCT00549770|589176560|FG004|Overall Study|Protocol deviation|2|||
163127967|NCT00549770|589176561|FG005|Overall Study|Protocol deviation|2|||
163127968|NCT00549770|589176562|FG006|Overall Study|Protocol deviation|1|||
163127969|NCT00549770|589176563|FG007|Overall Study|Protocol deviation|2|||
163127970|NCT00549770|589176556|FG000|Overall Study|Administrative problems|0|||
163127971|NCT00549770|589176557|FG001|Overall Study|Administrative problems|1|||
163127972|NCT00549770|589176558|FG002|Overall Study|Administrative problems|0|||
163127973|NCT00549770|589176559|FG003|Overall Study|Administrative problems|0|||
163127974|NCT00549770|589176560|FG004|Overall Study|Administrative problems|0|||
163127975|NCT00549770|589176561|FG005|Overall Study|Administrative problems|0|||
163127976|NCT00549770|589176562|FG006|Overall Study|Administrative problems|0|||
163127977|NCT00549770|589176563|FG007|Overall Study|Administrative problems|1|||
163127978|NCT00549770|589176556|FG000|Overall Study|Lost to Follow-up|0|||
163127979|NCT00549770|589176557|FG001|Overall Study|Lost to Follow-up|0|||
163127980|NCT00549770|589176558|FG002|Overall Study|Lost to Follow-up|2|||
163127981|NCT00549770|589176559|FG003|Overall Study|Lost to Follow-up|2|||
163127982|NCT00549770|589176560|FG004|Overall Study|Lost to Follow-up|3|||
163127983|NCT00549770|589176561|FG005|Overall Study|Lost to Follow-up|2|||
163127984|NCT00549770|589176562|FG006|Overall Study|Lost to Follow-up|0|||
163127985|NCT00549770|589176563|FG007|Overall Study|Lost to Follow-up|0|||
163342709|NCT03166215|589962694|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
163342710|NCT03166215|589962692|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
163342711|NCT03166215|589962693|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
163342712|NCT03166215|589962694|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
163342713|NCT04362176|589962697|FG000|Overall Study|Lost to Follow-up|5|||
163342714|NCT04362176|589962698|FG001|Overall Study|Lost to Follow-up|8|||
163342715|NCT04362176|589962697|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
163342716|NCT04362176|589962698|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
163342717|NCT04985604|589962699|FG000|Overall Study|Death|4|||
163127986|NCT00549770|589176556|FG000|Overall Study|Withdrawal by Subject|4|||
163127987|NCT00549770|589176557|FG001|Overall Study|Withdrawal by Subject|6|||
163342718|NCT04985604|589962700|FG001|Overall Study|Death|6|||
163342719|NCT04985604|589962699|FG000|Overall Study|Withdrawal by Subject|0|||
163342720|NCT04985604|589962700|FG001|Overall Study|Withdrawal by Subject|1|||
163342721|NCT04598776|589962701|FG000|Overall Study|Protocol Violation|5|||
163342722|NCT04598776|589962701|FG000|Overall Study|Physician Decision|4|||
163342723|NCT02282761|589962702|FG000|Overall Study|Death|0|||
163127988|NCT00549770|589176558|FG002|Overall Study|Withdrawal by Subject|4|||
163127989|NCT00549770|589176559|FG003|Overall Study|Withdrawal by Subject|5|||
163127990|NCT00549770|589176560|FG004|Overall Study|Withdrawal by Subject|6|||
163127991|NCT00549770|589176561|FG005|Overall Study|Withdrawal by Subject|6|||
163127992|NCT00549770|589176562|FG006|Overall Study|Withdrawal by Subject|4|||
163127993|NCT00549770|589176563|FG007|Overall Study|Withdrawal by Subject|9|||
163127994|NCT00549770|589176556|FG000|Overall Study|Lack of Efficacy|1|||
163127995|NCT00549770|589176557|FG001|Overall Study|Lack of Efficacy|0|||
163127996|NCT00549770|589176558|FG002|Overall Study|Lack of Efficacy|2|||
163127997|NCT00549770|589176559|FG003|Overall Study|Lack of Efficacy|3|||
163127998|NCT00549770|589176560|FG004|Overall Study|Lack of Efficacy|5|||
163127999|NCT00549770|589176561|FG005|Overall Study|Lack of Efficacy|1|||
163128000|NCT00549770|589176562|FG006|Overall Study|Lack of Efficacy|3|||
163128001|NCT00549770|589176563|FG007|Overall Study|Lack of Efficacy|8|||
163128002|NCT00549770|589176556|FG000|Overall Study|Abnormal test procedure results|0|||
163128003|NCT00549770|589176557|FG001|Overall Study|Abnormal test procedure results|0|||
163128004|NCT00549770|589176558|FG002|Overall Study|Abnormal test procedure results|0|||
163128005|NCT00549770|589176559|FG003|Overall Study|Abnormal test procedure results|2|||
163128006|NCT00549770|589176560|FG004|Overall Study|Abnormal test procedure results|0|||
163128007|NCT00549770|589176561|FG005|Overall Study|Abnormal test procedure results|1|||
163128008|NCT00549770|589176562|FG006|Overall Study|Abnormal test procedure results|1|||
163128009|NCT00549770|589176563|FG007|Overall Study|Abnormal test procedure results|1|||
163128010|NCT00549770|589176556|FG000|Overall Study|Abnormal laboratory values|0|||
163128011|NCT00549770|589176557|FG001|Overall Study|Abnormal laboratory values|0|||
163128012|NCT00549770|589176558|FG002|Overall Study|Abnormal laboratory values|0|||
163128013|NCT00549770|589176559|FG003|Overall Study|Abnormal laboratory values|0|||
163128014|NCT00549770|589176560|FG004|Overall Study|Abnormal laboratory values|0|||
163128015|NCT00549770|589176561|FG005|Overall Study|Abnormal laboratory values|1|||
163128016|NCT00549770|589176562|FG006|Overall Study|Abnormal laboratory values|0|||
163128017|NCT00549770|589176563|FG007|Overall Study|Abnormal laboratory values|0|||
163128018|NCT00549770|589176556|FG000|Overall Study|Adverse Event|1|||
163128019|NCT00549770|589176557|FG001|Overall Study|Adverse Event|3|||
163128020|NCT00549770|589176558|FG002|Overall Study|Adverse Event|1|||
163128021|NCT00549770|589176559|FG003|Overall Study|Adverse Event|2|||
163128022|NCT00549770|589176560|FG004|Overall Study|Adverse Event|1|||
163128023|NCT00549770|589176561|FG005|Overall Study|Adverse Event|0|||
163128024|NCT00549770|589176562|FG006|Overall Study|Adverse Event|5|||
163128025|NCT00549770|589176563|FG007|Overall Study|Adverse Event|4|||
163128026|NCT04856904|589176566|FG000|Overall Study|Physician Decision|1|||
163128027|NCT04856904|589176567|FG001|Overall Study|Physician Decision|1|||
163128028|NCT04856904|589176566|FG000|Overall Study|Withdrawal by Subject|13|||
163128029|NCT04856904|589176567|FG001|Overall Study|Withdrawal by Subject|13|||
163128030|NCT04856904|589176566|FG000|Overall Study|Adverse Event|1|||
163128031|NCT04856904|589176567|FG001|Overall Study|Adverse Event|1|||
163128032|NCT04856904|589176566|FG000|Overall Study|Non-compliance with study drug|1|||
163128033|NCT04856904|589176567|FG001|Overall Study|Non-compliance with study drug|1|||
163128034|NCT04856904|589176566|FG000|Overall Study|Lost to Follow-up|4|||
163128035|NCT04856904|589176567|FG001|Overall Study|Lost to Follow-up|4|||
163128036|NCT04856904|589176566|FG000|Overall Study|Withdrawal by Subject|1|||
163128037|NCT04856904|589176567|FG001|Overall Study|Withdrawal by Subject|1|||
163128038|NCT04856904|589176566|FG000|Overall Study|Protocol Violation|1|||
163128039|NCT04856904|589176567|FG001|Overall Study|Protocol Violation|1|||
163128040|NCT02712424|589176568|FG000|Overall Study|Lost to Follow-up|34|||
163128041|NCT02712424|589176569|FG001|Overall Study|Lost to Follow-up|32|||
163128042|NCT00847015|589176570|FG000|Overall Study|Withdrawal by Subject|1|||
163128043|NCT00847015|589176570|FG000|Overall Study|declined any surgery|1|||
163128044|NCT00847015|589176570|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
163342724|NCT02282761|589962703|FG001|Overall Study|Death|0|||
163342725|NCT02282761|589962704|FG002|Overall Study|Death|1|||
163128045|NCT01641822|589176573|FG000|Run-in Phase|Noncompliance with study drug|1|||
163128046|NCT01641822|589176574|FG001|Run-in Phase|Noncompliance with study drug|0|||
163128047|NCT01641822|589176575|FG002|Run-in Phase|Noncompliance with study drug|0|||
163128048|NCT01641822|589176573|FG000|Run-in Phase|Adverse Event|3|||
163128049|NCT01641822|589176574|FG001|Run-in Phase|Adverse Event|0|||
163128050|NCT01641822|589176575|FG002|Run-in Phase|Adverse Event|0|||
163342726|NCT02282761|589962702|FG000|Overall Study|Adverse Event|6|||
163128051|NCT01641822|589176573|FG000|Run-in Phase|Withdrew consent|1|||
163128052|NCT01641822|589176574|FG001|Run-in Phase|Withdrew consent|0|||
163128053|NCT01641822|589176575|FG002|Run-in Phase|Withdrew consent|0|||
163128054|NCT01641822|589176573|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
163342727|NCT02282761|589962703|FG001|Overall Study|Adverse Event|2|||
163128055|NCT01641822|589176574|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
163128056|NCT01641822|589176575|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
163128057|NCT01641822|589176573|FG000|Comparative Phase|Noncompliance with study drug|0|||
163128058|NCT01641822|589176574|FG001|Comparative Phase|Noncompliance with study drug|1|||
163128059|NCT01641822|589176575|FG002|Comparative Phase|Noncompliance with study drug|0|||
163128060|NCT01641822|589176573|FG000|Comparative Phase|Investigator's discretion|0|||
163128061|NCT01641822|589176574|FG001|Comparative Phase|Investigator's discretion|0|||
163128062|NCT01641822|589176575|FG002|Comparative Phase|Investigator's discretion|1|||
163128063|NCT01641822|589176573|FG000|Comparative Phase|Pregnancy|0|||
163128064|NCT01641822|589176574|FG001|Comparative Phase|Pregnancy|0|||
163128065|NCT01641822|589176575|FG002|Comparative Phase|Pregnancy|1|||
163128066|NCT01641822|589176573|FG000|Comparative Phase|Adverse event, serious fatal|0|||
163128067|NCT01641822|589176574|FG001|Comparative Phase|Adverse event, serious fatal|1|||
163128068|NCT01641822|589176575|FG002|Comparative Phase|Adverse event, serious fatal|0|||
163342728|NCT02282761|589962704|FG002|Overall Study|Adverse Event|0|||
163128069|NCT01641822|589176573|FG000|Comparative Phase|Withdrew consent|0|||
163128070|NCT01641822|589176574|FG001|Comparative Phase|Withdrew consent|3|||
163128071|NCT01641822|589176575|FG002|Comparative Phase|Withdrew consent|7|||
163128072|NCT01641822|589176573|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
163128073|NCT01641822|589176574|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
163128074|NCT01641822|589176575|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
163128075|NCT02760810|589176576|FG000|Overall Study|Protocol Violation|1|||
163128076|NCT02421601|589176577|FG000|Overall Study|Adverse Event|4|||
163128077|NCT02421601|589176577|FG000|Overall Study|Lack of Efficacy|5|||
163128078|NCT02421601|589176577|FG000|Overall Study|Physician Decision|1|||
163128079|NCT02421601|589176577|FG000|Overall Study|Withdrawal by Subject|31|||
163128080|NCT02421601|589176577|FG000|Overall Study|Others|41|||
163128081|NCT03847909|589176582|FG000|Overall Study|Withdrawal by Subject|1|||
163128082|NCT03847909|589176583|FG001|Overall Study|Withdrawal by Subject|1|||
163342729|NCT02282761|589962702|FG000|Overall Study|Lack of Efficacy|11|||
163342730|NCT02282761|589962703|FG001|Overall Study|Lack of Efficacy|6|||
163342731|NCT02282761|589962704|FG002|Overall Study|Lack of Efficacy|17|||
163342732|NCT02282761|589962702|FG000|Overall Study|Lost to Follow-up|2|||
163342733|NCT02282761|589962703|FG001|Overall Study|Lost to Follow-up|2|||
163342734|NCT02282761|589962704|FG002|Overall Study|Lost to Follow-up|1|||
163342735|NCT02282761|589962702|FG000|Overall Study|Physician Decision|0|||
163342736|NCT02282761|589962703|FG001|Overall Study|Physician Decision|0|||
163342737|NCT02282761|589962704|FG002|Overall Study|Physician Decision|2|||
163342738|NCT02282761|589962702|FG000|Overall Study|Withdrawal by Subject|8|||
163342739|NCT02282761|589962703|FG001|Overall Study|Withdrawal by Subject|10|||
163342740|NCT02282761|589962704|FG002|Overall Study|Withdrawal by Subject|16|||
163342741|NCT02282761|589962702|FG000|Overall Study|Other|3|||
163342742|NCT02282761|589962703|FG001|Overall Study|Other|2|||
163342743|NCT02282761|589962704|FG002|Overall Study|Other|1|||
163342744|NCT00658632|589962707|FG000|Overall Study|Adverse Event|13|||
163342745|NCT00658632|589962708|FG001|Overall Study|Adverse Event|11|||
163342746|NCT00658632|589962707|FG000|Overall Study|Lost to Follow-up|25|||
163342747|NCT00658632|589962708|FG001|Overall Study|Lost to Follow-up|23|||
163342748|NCT00658632|589962707|FG000|Overall Study|Withdrawal by Subject|10|||
163342749|NCT00658632|589962708|FG001|Overall Study|Withdrawal by Subject|7|||
163342750|NCT00658632|589962707|FG000|Overall Study|Lack of Efficacy|0|||
163342751|NCT00658632|589962708|FG001|Overall Study|Lack of Efficacy|1|||
163342752|NCT00658632|589962707|FG000|Overall Study|Withdrawal of consent|8|||
163342753|NCT00658632|589962708|FG001|Overall Study|Withdrawal of consent|14|||
163342754|NCT00658632|589962707|FG000|Overall Study|Pregnancy|1|||
163342755|NCT00658632|589962708|FG001|Overall Study|Pregnancy|1|||
163128083|NCT00869401|589176584|FG000|Overall Study|Withdrawal by Subject|0|||
163128084|NCT00869401|589176585|FG001|Overall Study|Withdrawal by Subject|0|||
163128085|NCT00869401|589176586|FG002|Overall Study|Withdrawal by Subject|0|||
163342756|NCT00658632|589962707|FG000|Overall Study|Other|7|||
163342757|NCT00658632|589962708|FG001|Overall Study|Other|8|||
163128086|NCT00869401|589176587|FG003|Overall Study|Withdrawal by Subject|5|||
163128087|NCT00869401|589176588|FG004|Overall Study|Withdrawal by Subject|3|||
163128088|NCT00581360|589176589|FG000|Overall Study|Withdrawal by Subject|1|||
163342758|NCT06312566|589962709|FG000|Overall Study|Protocol Violation|0|||
163342759|NCT06312566|589962710|FG001|Overall Study|Protocol Violation|1|||
163342760|NCT02632045|589962711|FG000|Overall Study|Withdrawal by Subject|1|||
163128089|NCT00082381|589176590|FG000|Overall Study|Adverse Event|27|||
163128090|NCT00082381|589176591|FG001|Overall Study|Adverse Event|2|||
163128091|NCT00082381|589176590|FG000|Overall Study|Lost to Follow-up|5|||
163342761|NCT02632045|589962712|FG001|Overall Study|Withdrawal by Subject|2|||
163342762|NCT04551053|589962713|FG000|Overall Study|Death|10|||
163342763|NCT04551053|589962714|FG001|Overall Study|Death|9|||
163342764|NCT04551053|589962713|FG000|Overall Study|Lost to Follow-up|0|||
163128092|NCT00082381|589176591|FG001|Overall Study|Lost to Follow-up|7|||
163342765|NCT04551053|589962714|FG001|Overall Study|Lost to Follow-up|2|||
163342766|NCT04551053|589962713|FG000|Overall Study|Study Terminated by Sponsor|57|||
163128093|NCT00082381|589176590|FG000|Overall Study|Patient Decision|8|||
163128094|NCT00082381|589176591|FG001|Overall Study|Patient Decision|4|||
163128095|NCT00082381|589176590|FG000|Overall Study|Physician Decision|1|||
163128096|NCT00082381|589176591|FG001|Overall Study|Physician Decision|2|||
163128097|NCT00082381|589176590|FG000|Overall Study|Protocol Violation|10|||
163128098|NCT00082381|589176591|FG001|Overall Study|Protocol Violation|11|||
163128099|NCT00082381|589176590|FG000|Overall Study|Loss of Glucose Control|4|||
163128100|NCT00082381|589176591|FG001|Overall Study|Loss of Glucose Control|0|||
163128101|NCT02345330|589176595|FG000|Overall Study|Death|1|||
163128102|NCT02345330|589176595|FG000|Overall Study|Progressive Disease|2|||
163128103|NCT00109577|589176596|FG000|Overall Study|Withdrawal by Subject|3|||
163128104|NCT00109577|589176597|FG001|Overall Study|Withdrawal by Subject|3|||
163128105|NCT03322423|589176598|FG000|Period 1|Subject no longer eligible|0|||
163128106|NCT03322423|589176599|FG001|Period 1|Subject no longer eligible|1|||
163128107|NCT03322423|589176598|FG000|Period 1|Withdrawal by Subject|0|||
163128108|NCT03322423|589176599|FG001|Period 1|Withdrawal by Subject|1|||
163128109|NCT03322423|589176598|FG000|Period 1|Incorrect Lens Dispensed|1|||
163128110|NCT03322423|589176599|FG001|Period 1|Incorrect Lens Dispensed|0|||
163128111|NCT03322423|589176598|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
163128112|NCT03322423|589176599|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
163128113|NCT03322423|589176598|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
163128114|NCT03322423|589176599|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
163128115|NCT03322423|589176598|FG000|Period 2|Protocol Violation|1|||
163128116|NCT03322423|589176599|FG001|Period 2|Protocol Violation|0|||
163128117|NCT03322423|589176598|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
163128118|NCT03322423|589176599|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
163128119|NCT04891107|589176600|FG000|Overall Study|Physician Decision|1|||
163128120|NCT04891107|589176600|FG000|Overall Study|Withdrawal by Subject|1|||
163128121|NCT04891107|589176600|FG000|Overall Study|Screen failure after consent|1|||
163128122|NCT02453555|589176601|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
163128123|NCT02453555|589176602|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
163128124|NCT02453555|589176603|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
163128125|NCT02453555|589176604|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
163128126|NCT02453555|589176605|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
163128127|NCT02453555|589176606|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
163128128|NCT02453555|589176601|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
163128129|NCT02453555|589176602|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
163128130|NCT02453555|589176603|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
163128131|NCT02453555|589176604|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
163128132|NCT02453555|589176605|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
163128133|NCT02453555|589176606|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
163128134|NCT02453555|589176601|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
163128135|NCT02453555|589176602|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
163128136|NCT02453555|589176603|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
163128137|NCT02453555|589176604|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
163128138|NCT02453555|589176605|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
163128139|NCT02453555|589176606|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
163128140|NCT02453555|589176601|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
163128141|NCT02453555|589176602|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
163128142|NCT02453555|589176603|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
163128143|NCT02453555|589176604|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
163128144|NCT02453555|589176605|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
163128145|NCT02453555|589176606|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
163128146|NCT02453555|589176601|FG000|Extension Period|Adverse Event|0|||
163128147|NCT02453555|589176602|FG001|Extension Period|Adverse Event|0|||
163128148|NCT02453555|589176603|FG002|Extension Period|Adverse Event|1|||
163128149|NCT02453555|589176604|FG003|Extension Period|Adverse Event|2|||
163128150|NCT02453555|589176605|FG004|Extension Period|Adverse Event|1|||
163128151|NCT02453555|589176606|FG005|Extension Period|Adverse Event|1|||
163128152|NCT02453555|589176601|FG000|Extension Period|Protocol Violation|0|||
163128153|NCT02453555|589176602|FG001|Extension Period|Protocol Violation|0|||
163128154|NCT02453555|589176603|FG002|Extension Period|Protocol Violation|1|||
163128155|NCT02453555|589176604|FG003|Extension Period|Protocol Violation|0|||
163128156|NCT02453555|589176605|FG004|Extension Period|Protocol Violation|0|||
163128157|NCT02453555|589176606|FG005|Extension Period|Protocol Violation|0|||
163128158|NCT02453555|589176601|FG000|Extension Period|Withdrawal by Subject|0|||
163128159|NCT02453555|589176602|FG001|Extension Period|Withdrawal by Subject|0|||
163128160|NCT02453555|589176603|FG002|Extension Period|Withdrawal by Subject|1|||
163128161|NCT02453555|589176604|FG003|Extension Period|Withdrawal by Subject|0|||
163128162|NCT02453555|589176605|FG004|Extension Period|Withdrawal by Subject|0|||
163128163|NCT02453555|589176606|FG005|Extension Period|Withdrawal by Subject|0|||
163128164|NCT03689855|589176611|FG000|Overall Study|Adverse Event|3|||
163342767|NCT04551053|589962714|FG001|Overall Study|Study Terminated by Sponsor|65|||
163342768|NCT04551053|589962713|FG000|Overall Study|Withdrawal by Subject|12|||
163342769|NCT04551053|589962714|FG001|Overall Study|Withdrawal by Subject|5|||
163342770|NCT04551053|589962713|FG000|Overall Study|Adverse Event|2|||
163342771|NCT04551053|589962714|FG001|Overall Study|Adverse Event|0|||
163342772|NCT04551053|589962713|FG000|Overall Study|Lack of Efficacy|2|||
163342773|NCT04551053|589962714|FG001|Overall Study|Lack of Efficacy|1|||
163342774|NCT04551053|589962713|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
163342775|NCT04551053|589962714|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
163342776|NCT04551053|589962713|FG000|Overall Study|Splenapendectomi|1|||
163342777|NCT04551053|589962714|FG001|Overall Study|Splenapendectomi|0|||
163342778|NCT04551053|589962713|FG000|Overall Study|Medical Decision|1|||
163342779|NCT04551053|589962714|FG001|Overall Study|Medical Decision|1|||
163342780|NCT03861078|589962715|FG000|Overall Study|COVID-19 shut down|4|||
163342781|NCT03861078|589962715|FG000|Overall Study|Lost to Follow-up|1|||
163342782|NCT03861078|589962715|FG000|Overall Study|Protocol Violation|2|||
163342783|NCT03861078|589962715|FG000|Overall Study|lack of venous access|1|||
163342784|NCT03503188|589962716|FG000|Overall Study|Non eligible in the sub study|0|||
163342785|NCT03503188|589962717|FG001|Overall Study|Non eligible in the sub study|1|||
163342786|NCT01699178|589962718|FG000|Overall Study|Adverse Event|1|||
163342787|NCT01699178|589962719|FG001|Overall Study|Adverse Event|5|||
163342788|NCT01699178|589962718|FG000|Overall Study|Lost to Follow-up|1|||
163342789|NCT01699178|589962719|FG001|Overall Study|Lost to Follow-up|6|||
163342790|NCT01699178|589962718|FG000|Overall Study|Non-compliance with Study Drug|3|||
163342791|NCT01699178|589962719|FG001|Overall Study|Non-compliance with Study Drug|1|||
163342792|NCT01699178|589962718|FG000|Overall Study|Physician Decision|1|||
163342793|NCT01699178|589962719|FG001|Overall Study|Physician Decision|0|||
163342794|NCT01699178|589962718|FG000|Overall Study|Withdrawal by Subject|4|||
163342795|NCT01699178|589962719|FG001|Overall Study|Withdrawal by Subject|12|||
163342796|NCT01699178|589962718|FG000|Overall Study|Hematocrit >54%|1|||
163128165|NCT03689855|589176611|FG000|Overall Study|Withdrawal by Subject|1|||
163128166|NCT03178669|589176612|FG000|Overall Study|Adverse Event|4|||
163342797|NCT01699178|589962719|FG001|Overall Study|Hematocrit >54%|1|||
163342798|NCT01699178|589962718|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
163342799|NCT01699178|589962719|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
163342800|NCT01699178|589962718|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
163342801|NCT01699178|589962719|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
163342802|NCT03547167|589962725|FG000|Overall Study|Withdrawal by Subject|34|||
163342803|NCT03547167|589962726|FG001|Overall Study|Withdrawal by Subject|12|||
163342804|NCT03547167|589962725|FG000|Overall Study|Screen Failure|0|||
163342805|NCT03547167|589962726|FG001|Overall Study|Screen Failure|1|||
163342806|NCT03547167|589962725|FG000|Overall Study|Lost to Follow-up|59|||
163342807|NCT03547167|589962726|FG001|Overall Study|Lost to Follow-up|15|||
163342808|NCT03547167|589962725|FG000|Overall Study|Death|4|||
163342809|NCT03547167|589962726|FG001|Overall Study|Death|2|||
163342810|NCT00645411|589962727|FG000|Overall Study|Adverse Event|0|||
163342811|NCT00645411|589962728|FG001|Overall Study|Adverse Event|0|||
163342812|NCT00645411|589962729|FG002|Overall Study|Adverse Event|0|||
163342813|NCT00645411|589962730|FG003|Overall Study|Adverse Event|2|||
163342814|NCT00645411|589962727|FG000|Overall Study|Withdrawal by Subject|2|||
163342815|NCT00645411|589962728|FG001|Overall Study|Withdrawal by Subject|1|||
163342816|NCT00645411|589962729|FG002|Overall Study|Withdrawal by Subject|19|||
163342817|NCT00645411|589962730|FG003|Overall Study|Withdrawal by Subject|21|||
163128167|NCT03178669|589176613|FG001|Overall Study|Adverse Event|1|||
163128168|NCT03178669|589176614|FG002|Overall Study|Adverse Event|4|||
163128169|NCT03178669|589176615|FG003|Overall Study|Adverse Event|2|||
163128170|NCT03178669|589176616|FG004|Overall Study|Adverse Event|2|||
163128171|NCT03178669|589176612|FG000|Overall Study|Lack of Efficacy|0|||
163128172|NCT03178669|589176613|FG001|Overall Study|Lack of Efficacy|0|||
163128173|NCT03178669|589176614|FG002|Overall Study|Lack of Efficacy|2|||
163128174|NCT03178669|589176615|FG003|Overall Study|Lack of Efficacy|0|||
163128175|NCT03178669|589176616|FG004|Overall Study|Lack of Efficacy|1|||
163342818|NCT00645411|589962727|FG000|Overall Study|Lost to Follow-up|10|||
163342819|NCT00645411|589962728|FG001|Overall Study|Lost to Follow-up|5|||
163342820|NCT00645411|589962729|FG002|Overall Study|Lost to Follow-up|124|||
163342821|NCT00645411|589962730|FG003|Overall Study|Lost to Follow-up|75|||
163342822|NCT00645411|589962727|FG000|Overall Study|Protocol Violation|1|||
163342823|NCT00645411|589962728|FG001|Overall Study|Protocol Violation|0|||
163342824|NCT00645411|589962729|FG002|Overall Study|Protocol Violation|1|||
163128176|NCT03178669|589176612|FG000|Overall Study|Physician Decision|0|||
163128177|NCT03178669|589176613|FG001|Overall Study|Physician Decision|0|||
163128178|NCT03178669|589176614|FG002|Overall Study|Physician Decision|0|||
163128179|NCT03178669|589176615|FG003|Overall Study|Physician Decision|0|||
163128180|NCT03178669|589176616|FG004|Overall Study|Physician Decision|1|||
163342825|NCT00645411|589962730|FG003|Overall Study|Protocol Violation|0|||
163342826|NCT00645411|589962727|FG000|Overall Study|Inappropriate enrollment|0|||
163342827|NCT00645411|589962728|FG001|Overall Study|Inappropriate enrollment|0|||
163342828|NCT00645411|589962729|FG002|Overall Study|Inappropriate enrollment|4|||
163342829|NCT00645411|589962730|FG003|Overall Study|Inappropriate enrollment|1|||
163342830|NCT00645411|589962727|FG000|Overall Study|Unable to classify|0|||
163342831|NCT00645411|589962728|FG001|Overall Study|Unable to classify|0|||
163342832|NCT00645411|589962729|FG002|Overall Study|Unable to classify|3|||
163342833|NCT00645411|589962730|FG003|Overall Study|Unable to classify|4|||
163342834|NCT03100370|589962734|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163342835|NCT03100370|589962735|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163342836|NCT03100370|589962736|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163342837|NCT03100370|589962737|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
163342838|NCT03100370|589962738|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163342839|NCT03100370|589962739|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163342840|NCT02674399|589962740|FG000|Overall Study|Lost to Follow-up|2|||
163342841|NCT02674399|589962741|FG001|Overall Study|Lost to Follow-up|0|||
163342842|NCT01867307|589962742|FG000|Overall Study|Protocol Violation|2|||
163342843|NCT01867307|589962743|FG001|Overall Study|Protocol Violation|0|||
163342844|NCT01867307|589962742|FG000|Overall Study|Other Adverse Event|1|||
163342845|NCT01867307|589962743|FG001|Overall Study|Other Adverse Event|3|||
163342846|NCT00091572|589962755|FG000|Overall Study|Lost to Follow-up|1|||
163342847|NCT00091572|589962756|FG001|Overall Study|Lost to Follow-up|1|||
163342848|NCT00091572|589962755|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
163342849|NCT00091572|589962756|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
163342850|NCT00091572|589962755|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
163342851|NCT00091572|589962756|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
163342852|NCT00091572|589962755|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
163342853|NCT00091572|589962756|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
163342854|NCT00091572|589962755|FG000|Overall Study|Other Reason|6|||
163342855|NCT00091572|589962756|FG001|Overall Study|Other Reason|13|||
163342856|NCT00091572|589962755|FG000|Overall Study|Ongoing (still on treatment)|8|||
163342857|NCT00091572|589962756|FG001|Overall Study|Ongoing (still on treatment)|12|||
163342858|NCT00091572|589962755|FG000|Overall Study|Major Protocol Violation|2|||
163342859|NCT00091572|589962756|FG001|Overall Study|Major Protocol Violation|0|||
163342860|NCT00091572|589962755|FG000|Overall Study|Toxicity (Related AE)|53|||
163342861|NCT00091572|589962756|FG001|Overall Study|Toxicity (Related AE)|9|||
163342862|NCT03122548|589962761|FG000|Overall Study|Death|2|||
163342863|NCT03122548|589962761|FG000|Overall Study|Progression - subject went into hospice|1|||
163342864|NCT03122548|589962761|FG000|Overall Study|Study Terminated by Sponsor|2|||
163342865|NCT01199302|589962767|FG000|Overall Study|Adverse Event|1|||
163342866|NCT01199302|589962768|FG001|Overall Study|Adverse Event|1|||
163342867|NCT01199302|589962769|FG002|Overall Study|Adverse Event|2|||
163342868|NCT01199302|589962770|FG003|Overall Study|Adverse Event|0|||
163342869|NCT01199302|589962767|FG000|Overall Study|Withdrawal by Subject|2|||
163342870|NCT01199302|589962768|FG001|Overall Study|Withdrawal by Subject|2|||
163342871|NCT01199302|589962769|FG002|Overall Study|Withdrawal by Subject|3|||
163342872|NCT01199302|589962770|FG003|Overall Study|Withdrawal by Subject|0|||
163342873|NCT01199302|589962767|FG000|Overall Study|Disease Progression|3|||
163342874|NCT01199302|589962768|FG001|Overall Study|Disease Progression|4|||
163342875|NCT01199302|589962769|FG002|Overall Study|Disease Progression|4|||
163128181|NCT03178669|589176612|FG000|Overall Study|Withdrawal by Subject|1|||
163128182|NCT03178669|589176613|FG001|Overall Study|Withdrawal by Subject|0|||
163128183|NCT03178669|589176614|FG002|Overall Study|Withdrawal by Subject|1|||
163128184|NCT03178669|589176615|FG003|Overall Study|Withdrawal by Subject|1|||
163128185|NCT03178669|589176616|FG004|Overall Study|Withdrawal by Subject|0|||
163128186|NCT03178669|589176612|FG000|Overall Study|Lost to Follow-up|0|||
163128187|NCT03178669|589176613|FG001|Overall Study|Lost to Follow-up|0|||
163128188|NCT03178669|589176614|FG002|Overall Study|Lost to Follow-up|0|||
163128189|NCT03178669|589176615|FG003|Overall Study|Lost to Follow-up|1|||
163128190|NCT03178669|589176616|FG004|Overall Study|Lost to Follow-up|0|||
163342876|NCT01199302|589962770|FG003|Overall Study|Disease Progression|2|||
163128191|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
163128192|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
163128193|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
163342877|NCT01199302|589962767|FG000|Overall Study|Study Termination|13|||
163342878|NCT01199302|589962768|FG001|Overall Study|Study Termination|8|||
163342879|NCT01199302|589962769|FG002|Overall Study|Study Termination|11|||
163408324|NCT01836783|590204107|FG000|Overall Study|Withdrawal by Subject|0|||
163128194|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
163342880|NCT01199302|589962770|FG003|Overall Study|Study Termination|9|||
163342881|NCT01199302|589962767|FG000|Overall Study|Lost to Follow-up|0|||
163342882|NCT01199302|589962768|FG001|Overall Study|Lost to Follow-up|1|||
163342883|NCT01199302|589962769|FG002|Overall Study|Lost to Follow-up|0|||
163342884|NCT01199302|589962770|FG003|Overall Study|Lost to Follow-up|0|||
163342885|NCT01199302|589962767|FG000|Overall Study|Other|1|||
163128195|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
163342886|NCT01199302|589962768|FG001|Overall Study|Other|0|||
163342887|NCT01199302|589962769|FG002|Overall Study|Other|0|||
163128196|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
163128197|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
163128198|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
163128199|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
163128200|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
163128201|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
163128202|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
163128203|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
163128204|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
163128205|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
163128206|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
163128207|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
163128208|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
163128209|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
163128210|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
163128211|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
163128212|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
163128213|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
163128214|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
163128215|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
163128216|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
163128217|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
163128218|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
163128219|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
163128220|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
163128221|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
163128222|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
163128223|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
163128224|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
163128225|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
163128226|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
163128227|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
163128228|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
163128229|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
163128230|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
163128231|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
163128232|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
163128233|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
163128234|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
163128235|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128236|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128237|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
163128238|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128239|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128240|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
163128241|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128242|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128243|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128244|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128245|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128246|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
163128247|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128248|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128249|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128250|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128251|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128252|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128253|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128254|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128255|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128256|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163342888|NCT01199302|589962770|FG003|Overall Study|Other|0|||
163128257|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128258|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128259|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
163342889|NCT01634165|589962772|FG000|Period 2|Adverse Event|0|||
163342890|NCT01634165|589962773|FG001|Period 2|Adverse Event|1|||
163342891|NCT01634165|589962774|FG002|Period 2|Adverse Event|0|||
163342892|NCT01634165|589962775|FG003|Period 2|Adverse Event|0|||
163342893|NCT04097535|589962778|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
163342894|NCT03070301|589962779|FG000|Overall Study|Progression of disease|16|||
163342895|NCT03070301|589962779|FG000|Overall Study|Physician Decision|3|||
163342896|NCT03070301|589962779|FG000|Overall Study|Withdrawal by Subject|1|||
163342897|NCT03820024|589962780|FG000|Overall Study|Physician Decision|1|||
163342898|NCT03820024|589962781|FG001|Overall Study|Physician Decision|2|||
163342899|NCT03322514|589964228|FG000|Overall Study|Withdrawal by Subject|1|||
163342900|NCT03322514|589964229|FG001|Overall Study|Withdrawal by Subject|1|||
163342901|NCT00088452|589964230|FG000|Overall Study|Did not receive intervention|1|||
163342902|NCT00088452|589964231|FG001|Overall Study|Did not receive intervention|0|||
163342903|NCT00088452|589964232|FG002|Overall Study|Did not receive intervention|1|||
163342904|NCT02081196|589964234|FG000|Overall Study|Lost to Follow-up|1|||
163342905|NCT00961298|589964235|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
163342906|NCT00961298|589964235|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
163342907|NCT00961298|589964235|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
163342908|NCT04044352|589964238|FG000|Overall Study|Lost to Follow-up|9|||
163342909|NCT04044352|589964238|FG000|Overall Study|Withdrawal by Subject|2|||
163342910|NCT00814632|589964242|FG000|Overall Study|Lack of Efficacy|2|||
163342911|NCT02514577|589964251|FG000|Overall Study|Lost to Follow-up|6|||
163342912|NCT02514577|589964252|FG001|Overall Study|Lost to Follow-up|6|||
163342913|NCT02514577|589964251|FG000|Overall Study|Protocol Violation|1|||
163342914|NCT02514577|589964252|FG001|Overall Study|Protocol Violation|0|||
163342915|NCT02514577|589964251|FG000|Overall Study|Withdrawal by Subject|6|||
163342916|NCT02514577|589964252|FG001|Overall Study|Withdrawal by Subject|6|||
163342917|NCT02514577|589964251|FG000|Overall Study|Adverse Event|1|||
163342918|NCT02514577|589964252|FG001|Overall Study|Adverse Event|1|||
163342919|NCT00489489|589964253|FG000|Overall Study|Not treated due to protocol violation|0|||
163342920|NCT00489489|589964254|FG001|Overall Study|Not treated due to protocol violation|1|||
163342921|NCT00489489|589964255|FG002|Overall Study|Not treated due to protocol violation|1|||
163342922|NCT00489489|589964253|FG000|Overall Study|Adverse Event|1|||
163342923|NCT00489489|589964254|FG001|Overall Study|Adverse Event|1|||
163342924|NCT00489489|589964255|FG002|Overall Study|Adverse Event|1|||
163342925|NCT00489489|589964253|FG000|Overall Study|Protocol Violation|1|||
163342926|NCT00489489|589964254|FG001|Overall Study|Protocol Violation|0|||
163342927|NCT00489489|589964255|FG002|Overall Study|Protocol Violation|1|||
163342928|NCT00489489|589964253|FG000|Overall Study|Progressive disease|0|||
163342929|NCT00489489|589964254|FG001|Overall Study|Progressive disease|1|||
163342930|NCT00489489|589964255|FG002|Overall Study|Progressive disease|0|||
163342931|NCT00489489|589964253|FG000|Overall Study|Participant did not wish to continue|1|||
163342932|NCT00489489|589964254|FG001|Overall Study|Participant did not wish to continue|1|||
163342933|NCT00489489|589964255|FG002|Overall Study|Participant did not wish to continue|0|||
163342934|NCT00489489|589964253|FG000|Overall Study|Other than above|0|||
163342935|NCT00489489|589964254|FG001|Overall Study|Other than above|1|||
163342936|NCT00489489|589964255|FG002|Overall Study|Other than above|0|||
163342937|NCT02136797|589964258|FG000|Overall Study|Not Treated|8|||
163342938|NCT04523571|589964259|FG000|Received 2 Doses|Withdrawal by Subject|0|||
163342939|NCT04523571|589964260|FG001|Received 2 Doses|Withdrawal by Subject|0|||
163342940|NCT04523571|589964261|FG002|Received 2 Doses|Withdrawal by Subject|0|||
163342941|NCT04523571|589964262|FG003|Received 2 Doses|Withdrawal by Subject|1|||
163342942|NCT04523571|589964263|FG004|Received 2 Doses|Withdrawal by Subject|1|||
163342943|NCT04523571|589964264|FG005|Received 2 Doses|Withdrawal by Subject|0|||
163342944|NCT04523571|589964259|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
163342945|NCT04523571|589964260|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
163342946|NCT04523571|589964261|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
163342947|NCT04523571|589964262|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
163342948|NCT04523571|589964263|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
163342949|NCT04523571|589964264|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
163342950|NCT04523571|589964259|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
163342951|NCT04523571|589964260|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
163342952|NCT04523571|589964261|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
163342953|NCT04523571|589964262|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
163342954|NCT04523571|589964263|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
163342955|NCT04523571|589964264|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
163342956|NCT04523571|589964259|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
163342957|NCT04523571|589964260|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
163342958|NCT04523571|589964261|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
163342959|NCT04523571|589964262|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
163342960|NCT04523571|589964263|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
163342961|NCT04523571|589964264|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
163342962|NCT04198428|589964265|FG000|Overall Study|Withdrawal by Subject|150|||
163128260|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128261|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163342963|NCT04198428|589964266|FG001|Overall Study|Withdrawal by Subject|156|||
163342964|NCT00627523|589964268|FG000|Overall Study|Lack of Efficacy|1|||
163342965|NCT00627523|589964269|FG001|Overall Study|Lack of Efficacy|0|||
163342966|NCT00627523|589964268|FG000|Overall Study|Withdrawal by Subject|0|||
163342967|NCT00627523|589964269|FG001|Overall Study|Withdrawal by Subject|2|||
163342968|NCT00627523|589964268|FG000|Overall Study|Other|1|||
163342969|NCT00627523|589964269|FG001|Overall Study|Other|0|||
163342970|NCT03344458|589964278|FG000|Overall Study|Physician Decision|1|||
163342971|NCT03344458|589964278|FG000|Overall Study|Withdrawal by Subject|16|||
163342972|NCT03344458|589964278|FG000|Overall Study|Other reasons|10|||
163342973|NCT03344458|589964278|FG000|Overall Study|Lost to Follow-up|9|||
163342974|NCT03344458|589964278|FG000|Overall Study|Protocol Violation|3|||
163342975|NCT04203199|589964281|FG000|First Intervention Period|Lost to Follow-up|0|||
163342976|NCT04203199|589964282|FG001|First Intervention Period|Lost to Follow-up|1|||
163342977|NCT04203199|589964281|FG000|Second Intervention Period|Medication change|1|||
163342978|NCT04203199|589964282|FG001|Second Intervention Period|Medication change|0|||
163342979|NCT03960437|589964283|FG000|Overall Study|Removed by PI|4|||
163342980|NCT03960437|589964283|FG000|Overall Study|Lost to Follow-up|2|||
163342981|NCT03960437|589964283|FG000|Overall Study|Withdrawal by Subject|1|||
163342982|NCT03960437|589964283|FG000|Overall Study|Death|2|||
163342983|NCT01136733|589964289|FG000|Phase 1b|Adverse Event|0|||
163342984|NCT01136733|589964290|FG001|Phase 1b|Adverse Event|3|||
163342985|NCT01136733|589964291|FG002|Phase 1b|Adverse Event|1|||
163342986|NCT01136733|589964292|FG003|Phase 1b|Adverse Event|0|||
163342987|NCT01136733|589964293|FG004|Phase 1b|Adverse Event|0|||
163342988|NCT01136733|589964294|FG005|Phase 1b|Adverse Event|0|||
163342989|NCT01136733|589964295|FG006|Phase 1b|Adverse Event|0|||
163342990|NCT01136733|589964289|FG000|Phase 1b|Participant Choice|0|||
163342991|NCT01136733|589964290|FG001|Phase 1b|Participant Choice|0|||
163342992|NCT01136733|589964291|FG002|Phase 1b|Participant Choice|1|||
163342993|NCT01136733|589964292|FG003|Phase 1b|Participant Choice|0|||
163342994|NCT01136733|589964293|FG004|Phase 1b|Participant Choice|0|||
163342995|NCT01136733|589964294|FG005|Phase 1b|Participant Choice|0|||
163342996|NCT01136733|589964295|FG006|Phase 1b|Participant Choice|0|||
163342997|NCT01136733|589964289|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
163342998|NCT01136733|589964290|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
163342999|NCT01136733|589964291|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
163343000|NCT01136733|589964292|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
163343001|NCT01136733|589964293|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
163343002|NCT01136733|589964294|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
163343003|NCT01136733|589964295|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
163343004|NCT01136733|589964289|FG000|Phase 1b|Clinical Progression|1|||
163343005|NCT01136733|589964290|FG001|Phase 1b|Clinical Progression|1|||
163343006|NCT01136733|589964291|FG002|Phase 1b|Clinical Progression|0|||
163343007|NCT01136733|589964292|FG003|Phase 1b|Clinical Progression|0|||
163343008|NCT01136733|589964293|FG004|Phase 1b|Clinical Progression|0|||
163343009|NCT01136733|589964294|FG005|Phase 1b|Clinical Progression|0|||
163343010|NCT01136733|589964295|FG006|Phase 1b|Clinical Progression|0|||
163343011|NCT01136733|589964289|FG000|Phase 2|Disease Progression|0|||
163343012|NCT01136733|589964290|FG001|Phase 2|Disease Progression|0|||
163343013|NCT01136733|589964291|FG002|Phase 2|Disease Progression|0|||
163343014|NCT01136733|589964292|FG003|Phase 2|Disease Progression|0|||
163343015|NCT01136733|589964293|FG004|Phase 2|Disease Progression|30|||
163343016|NCT01136733|589964294|FG005|Phase 2|Disease Progression|32|||
163343017|NCT01136733|589964295|FG006|Phase 2|Disease Progression|38|||
163343018|NCT01136733|589964289|FG000|Phase 2|Adverse Event|0|||
163343019|NCT01136733|589964290|FG001|Phase 2|Adverse Event|0|||
163343020|NCT01136733|589964291|FG002|Phase 2|Adverse Event|0|||
163343021|NCT01136733|589964292|FG003|Phase 2|Adverse Event|0|||
163343022|NCT01136733|589964293|FG004|Phase 2|Adverse Event|11|||
163343023|NCT01136733|589964294|FG005|Phase 2|Adverse Event|13|||
163343024|NCT01136733|589964295|FG006|Phase 2|Adverse Event|5|||
163343025|NCT01136733|589964289|FG000|Phase 2|Participant Choice|0|||
163343026|NCT01136733|589964290|FG001|Phase 2|Participant Choice|0|||
163343027|NCT01136733|589964291|FG002|Phase 2|Participant Choice|0|||
163343028|NCT01136733|589964292|FG003|Phase 2|Participant Choice|0|||
163343029|NCT01136733|589964293|FG004|Phase 2|Participant Choice|3|||
163343030|NCT01136733|589964294|FG005|Phase 2|Participant Choice|0|||
163343031|NCT01136733|589964295|FG006|Phase 2|Participant Choice|1|||
163343032|NCT01136733|589964289|FG000|Phase 2|Administrative-Withdrew Consent|0|||
163343033|NCT01136733|589964290|FG001|Phase 2|Administrative-Withdrew Consent|0|||
163343034|NCT01136733|589964291|FG002|Phase 2|Administrative-Withdrew Consent|0|||
163343035|NCT01136733|589964292|FG003|Phase 2|Administrative-Withdrew Consent|0|||
163343036|NCT01136733|589964293|FG004|Phase 2|Administrative-Withdrew Consent|1|||
163343037|NCT01136733|589964294|FG005|Phase 2|Administrative-Withdrew Consent|0|||
163343038|NCT01136733|589964295|FG006|Phase 2|Administrative-Withdrew Consent|0|||
163343039|NCT01136733|589964289|FG000|Phase 2|Other|0|||
163343040|NCT01136733|589964290|FG001|Phase 2|Other|0|||
163343041|NCT01136733|589964291|FG002|Phase 2|Other|0|||
163343042|NCT01136733|589964292|FG003|Phase 2|Other|0|||
163343043|NCT01136733|589964293|FG004|Phase 2|Other|6|||
163343044|NCT01136733|589964294|FG005|Phase 2|Other|7|||
163343045|NCT01136733|589964295|FG006|Phase 2|Other|6|||
163343046|NCT01882088|589964297|FG000|Overall Study|Intolerance of esophageal manometry|1|||
163343047|NCT01882088|589964297|FG000|Overall Study|no possibility to place the catheter|1|||
163343048|NCT01882088|589964297|FG000|Overall Study|Protocol Violation|1|||
163343049|NCT01882088|589964297|FG000|Overall Study|inadequate pH-impedance tracings|2|||
163343050|NCT02186015|589964298|FG000|Overall Study|Physician Decision|1|||
163343051|NCT02186015|589964299|FG001|Overall Study|Physician Decision|0|||
163343052|NCT01533181|589964302|FG000|Overall Study|Disease progression pre-active treatment|0|||
163343053|NCT01533181|589964303|FG001|Overall Study|Disease progression pre-active treatment|1|||
163343054|NCT01533181|589964302|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
163343055|NCT01533181|589964303|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
163343056|NCT02720198|589964304|FG000|Overall Study|Withdrawal by Subject|0|||
163343057|NCT02720198|589964305|FG001|Overall Study|Withdrawal by Subject|1|||
163128262|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128263|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128264|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163343058|NCT02592434|589964308|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
163128265|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128266|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128267|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128268|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
163128269|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
163128270|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
163128271|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
163128272|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
163128273|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
163128274|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
163128275|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
163128276|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
163128277|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
163128278|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
163128279|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
163128280|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
163128281|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
163128282|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
163128283|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
163128284|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
163128285|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
163128286|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
163128287|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
163128288|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
163128289|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
163128290|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
163128291|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
163128292|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
163128293|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
163128294|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
163128295|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
163128296|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
163128297|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
163128298|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
163128299|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
163128300|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
163128301|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
163343059|NCT02592434|589964309|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
163343060|NCT02592434|589964310|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
163343061|NCT02592434|589964308|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
163343062|NCT02592434|589964309|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
163343063|NCT02592434|589964310|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
163343064|NCT02592434|589964308|FG000|Open-Label Phase (18 Weeks)|Other|3|||
163343065|NCT02592434|589964309|FG001|Open-Label Phase (18 Weeks)|Other|0|||
163343066|NCT02592434|589964310|FG002|Open-Label Phase (18 Weeks)|Other|0|||
163128302|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
163128303|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
163128304|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
163128305|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
163128306|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
163128307|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
163128308|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
163128309|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
163128310|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
163128311|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
163128312|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128313|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128314|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128315|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128316|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128317|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128318|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
163128319|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128320|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
163128321|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128322|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
163128323|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
163128324|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
163128325|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
163128326|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
163128327|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
163128328|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
163128329|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
163128330|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
163128331|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
163128332|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
163128333|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
163128334|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128335|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128336|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128337|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128338|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128339|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128340|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
163128341|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128342|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
163128343|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128344|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128345|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128346|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128347|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128348|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128349|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128350|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128351|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128352|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128353|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
163128354|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128355|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128356|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128357|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128358|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128359|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128360|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128361|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128362|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
163128363|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128364|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128365|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128366|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128367|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128368|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128369|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128370|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128371|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128372|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128373|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128374|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128375|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
163128376|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
163128377|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
163128378|NCT01300455|589176628|FG000|Washout|Withdrawal by Subject|1|||
163128379|NCT01300455|589176629|FG001|Washout|Withdrawal by Subject|0|||
163128380|NCT00778895|589176642|FG000|Active Phase|Adverse Event|3|||
163128381|NCT00778895|589176643|FG001|Active Phase|Adverse Event|1|||
163128382|NCT00778895|589176644|FG002|Active Phase|Adverse Event|0|||
163128383|NCT00778895|589176642|FG000|Active Phase|Withdrawal by Subject|1|||
163128384|NCT00778895|589176643|FG001|Active Phase|Withdrawal by Subject|4|||
163128385|NCT00778895|589176644|FG002|Active Phase|Withdrawal by Subject|0|||
163128386|NCT00778895|589176642|FG000|Active Phase|Lost to Follow-up|1|||
163128387|NCT00778895|589176643|FG001|Active Phase|Lost to Follow-up|1|||
163128388|NCT00778895|589176644|FG002|Active Phase|Lost to Follow-up|0|||
163128389|NCT00778895|589176642|FG000|Active Phase|Other|2|||
163128390|NCT00778895|589176643|FG001|Active Phase|Other|0|||
163128391|NCT00778895|589176644|FG002|Active Phase|Other|0|||
163128392|NCT00778895|589176642|FG000|ESFU Phase|Adverse Event|2|||
163128393|NCT00778895|589176643|FG001|ESFU Phase|Adverse Event|1|||
163128394|NCT00778895|589176644|FG002|ESFU Phase|Adverse Event|0|||
163128395|NCT00778895|589176642|FG000|ESFU Phase|Withdrawal by Subject|1|||
163128396|NCT00778895|589176643|FG001|ESFU Phase|Withdrawal by Subject|4|||
163128397|NCT00778895|589176644|FG002|ESFU Phase|Withdrawal by Subject|0|||
163128398|NCT00778895|589176642|FG000|ESFU Phase|Lost to Follow-up|6|||
163128399|NCT00778895|589176643|FG001|ESFU Phase|Lost to Follow-up|7|||
163128400|NCT00778895|589176644|FG002|ESFU Phase|Lost to Follow-up|2|||
163343067|NCT02592434|589964308|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
163343068|NCT02592434|589964309|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
163343069|NCT02592434|589964310|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
163343070|NCT02592434|589964308|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
163343071|NCT02592434|589964309|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
163343072|NCT02592434|589964310|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
163343073|NCT02592434|589964308|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
163343074|NCT02592434|589964309|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
163343075|NCT02592434|589964310|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
163128401|NCT00778895|589176642|FG000|ESFU Phase|Other|2|||
163128402|NCT00778895|589176643|FG001|ESFU Phase|Other|0|||
163128403|NCT00778895|589176644|FG002|ESFU Phase|Other|0|||
163128404|NCT03332160|589176645|FG000|Overall Study|Withdrawal by Subject|1|||
163128405|NCT03332160|589176646|FG001|Overall Study|Withdrawal by Subject|1|||
163128406|NCT03332160|589176645|FG000|Overall Study|Adverse Event|0|||
163128407|NCT03332160|589176646|FG001|Overall Study|Adverse Event|1|||
163128408|NCT03332160|589176645|FG000|Overall Study|Developed Exclusion Criteria|0|||
163128409|NCT03332160|589176646|FG001|Overall Study|Developed Exclusion Criteria|1|||
163128410|NCT03332160|589176645|FG000|Overall Study|Non-adherence to treatment|0|||
163128411|NCT03332160|589176646|FG001|Overall Study|Non-adherence to treatment|2|||
163128412|NCT00576576|589176650|FG000|Overall Study|Lost to Follow-up|6|||
163128413|NCT00576576|589176650|FG000|Overall Study|Protocol Violation|1|||
163128414|NCT00718770|589176657|FG000|Overall Study|Adverse Event|1|||
163128415|NCT00718770|589176657|FG000|Overall Study|Lack of Efficacy|1|||
163128416|NCT00718770|589176657|FG000|Overall Study|Lack of Efficacy|1|||
163128417|NCT00718770|589176657|FG000|Overall Study|Adverse Event|1|||
163128418|NCT00718770|589176657|FG000|Overall Study|Lack of Efficacy|1|||
163128419|NCT00718770|589176657|FG000|Overall Study|Adverse Event|1|||
163128420|NCT00718770|589176657|FG000|Overall Study|Lack of Efficacy|1|||
163128421|NCT00718770|589176657|FG000|Overall Study|Adverse Event|1|||
163128422|NCT00772109|589176658|FG000|Overall Study|Serious adverse event|1|||
163128423|NCT00772109|589176659|FG001|Overall Study|Serious adverse event|0|||
163343076|NCT02592434|589964308|FG000|Double Blind Phase (26 Weeks)|Other|0|||
163343077|NCT02592434|589964309|FG001|Double Blind Phase (26 Weeks)|Other|1|||
163408325|NCT01836783|590204108|FG001|Overall Study|Withdrawal by Subject|2|||
163128424|NCT00772109|589176660|FG002|Overall Study|Serious adverse event|1|||
163128425|NCT00772109|589176661|FG003|Overall Study|Serious adverse event|0|||
163128426|NCT00772109|589176658|FG000|Overall Study|Protocol Violation|5|||
163128427|NCT00772109|589176659|FG001|Overall Study|Protocol Violation|8|||
163128428|NCT00772109|589176660|FG002|Overall Study|Protocol Violation|7|||
163128429|NCT00772109|589176661|FG003|Overall Study|Protocol Violation|6|||
163128430|NCT00772109|589176658|FG000|Overall Study|Lost to Follow-up|7|||
163128431|NCT00772109|589176659|FG001|Overall Study|Lost to Follow-up|3|||
163128432|NCT00772109|589176660|FG002|Overall Study|Lost to Follow-up|5|||
163128433|NCT00772109|589176661|FG003|Overall Study|Lost to Follow-up|9|||
163128434|NCT00772109|589176658|FG000|Overall Study|Withdrawal by Subject|8|||
163128435|NCT00772109|589176659|FG001|Overall Study|Withdrawal by Subject|8|||
163128436|NCT00772109|589176660|FG002|Overall Study|Withdrawal by Subject|6|||
163128437|NCT00772109|589176661|FG003|Overall Study|Withdrawal by Subject|16|||
163128438|NCT00410605|589176662|FG000|Overall Study|Adverse Event|12|||
163128439|NCT00410605|589176662|FG000|Overall Study|Physician Decision|3|||
163128440|NCT00410605|589176662|FG000|Overall Study|Withdrawal by Subject|5|||
163128441|NCT00410605|589176662|FG000|Overall Study|Started Non-Protocol Therapy|3|||
163128442|NCT00410605|589176662|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
163128443|NCT00410605|589176662|FG000|Overall Study|Transferred to another Institution|1|||
163128444|NCT04583956|589176663|FG000|Overall Study|Death|9|||
163128445|NCT04583956|589176664|FG001|Overall Study|Death|11|||
163128446|NCT04583956|589176663|FG000|Overall Study|Lost to Follow-up|7|||
163128447|NCT04583956|589176664|FG001|Overall Study|Lost to Follow-up|9|||
163128448|NCT04583956|589176663|FG000|Overall Study|Protocol Violation|2|||
163128449|NCT04583956|589176664|FG001|Overall Study|Protocol Violation|0|||
163128450|NCT04583956|589176663|FG000|Overall Study|Withdrawal by Subject|0|||
163128451|NCT04583956|589176664|FG001|Overall Study|Withdrawal by Subject|2|||
163128452|NCT04583956|589176663|FG000|Overall Study|Randomized but not dosed|2|||
163128453|NCT04583956|589176664|FG001|Overall Study|Randomized but not dosed|3|||
163128454|NCT04583956|589176663|FG000|Overall Study|Withdrawal of consent before product administration|1|||
163128455|NCT04583956|589176664|FG001|Overall Study|Withdrawal of consent before product administration|0|||
163128456|NCT01370265|589178011|FG000|First Intervention|Adverse Event|1|||
163128457|NCT01370265|589178012|FG001|First Intervention|Adverse Event|1|||
163128458|NCT00703924|589178013|FG000|Overall Study|Withdrawal by Subject|1|||
163128459|NCT00703924|589178014|FG001|Overall Study|Withdrawal by Subject|1|||
163128460|NCT01900054|589178026|FG000|Overall Study|Physician Decision|1|||
163128461|NCT01900054|589178026|FG000|Overall Study|Withdrawal by Subject|1|||
163128462|NCT01959841|589178029|FG000|Overall Study|Adverse Event|1|||
163128463|NCT01959841|589178030|FG001|Overall Study|Adverse Event|3|||
163343078|NCT02592434|589964310|FG002|Double Blind Phase (26 Weeks)|Other|0|||
163343079|NCT02592434|589964308|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
163343080|NCT02592434|589964309|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
163343081|NCT02592434|589964310|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
163343082|NCT02592434|589964308|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
163343083|NCT02592434|589964309|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
163343084|NCT02592434|589964310|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
163343085|NCT02592434|589964308|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
163343086|NCT02592434|589964309|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
163343087|NCT02592434|589964310|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
163343088|NCT00147745|589964311|FG000|Overall Study|Withdrawal by Subject|1|||
163343089|NCT00147745|589964312|FG001|Overall Study|Withdrawal by Subject|0|||
163343090|NCT00147745|589964313|FG002|Overall Study|Withdrawal by Subject|0|||
163343091|NCT01757171|589964314|FG000|Overall Study|Adverse Event|5|||
163343092|NCT01757171|589964315|FG001|Overall Study|Adverse Event|1|||
163343093|NCT01757171|589964314|FG000|Overall Study|Disease Progression|1|||
163343094|NCT01757171|589964315|FG001|Overall Study|Disease Progression|0|||
163343095|NCT01757171|589964314|FG000|Overall Study|Hospitalization|1|||
163343096|NCT01757171|589964315|FG001|Overall Study|Hospitalization|0|||
163128464|NCT01959841|589178031|FG002|Overall Study|Adverse Event|2|||
163128465|NCT01959841|589178029|FG000|Overall Study|Lack of Efficacy|5|||
163128466|NCT01959841|589178030|FG001|Overall Study|Lack of Efficacy|0|||
163128467|NCT01959841|589178031|FG002|Overall Study|Lack of Efficacy|0|||
163128468|NCT01959841|589178029|FG000|Overall Study|Lost to Follow-up|1|||
163128469|NCT01959841|589178030|FG001|Overall Study|Lost to Follow-up|1|||
163128470|NCT01959841|589178031|FG002|Overall Study|Lost to Follow-up|0|||
163343097|NCT01757171|589964314|FG000|Overall Study|ECOG decline|1|||
163408326|NCT04942925|590204111|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
163128471|NCT01959841|589178029|FG000|Overall Study|Physician Decision|0|||
163343098|NCT01757171|589964315|FG001|Overall Study|ECOG decline|0|||
163343099|NCT00105521|589964317|FG000|Overall Study|Other|1|||
163343100|NCT00105521|589964318|FG001|Overall Study|Other|1|||
163343101|NCT00105521|589964319|FG002|Overall Study|Other|2|||
163343102|NCT00105521|589964320|FG003|Overall Study|Other|0|||
163408327|NCT04942925|590204112|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
163408328|NCT04942925|590204111|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
163128472|NCT01959841|589178030|FG001|Overall Study|Physician Decision|2|||
163128473|NCT01959841|589178031|FG002|Overall Study|Physician Decision|3|||
163128474|NCT01959841|589178029|FG000|Overall Study|Protocol Violation|16|||
163128475|NCT01959841|589178030|FG001|Overall Study|Protocol Violation|23|||
163128476|NCT01959841|589178031|FG002|Overall Study|Protocol Violation|16|||
163128477|NCT01959841|589178029|FG000|Overall Study|Withdrawal by Subject|7|||
163128478|NCT01959841|589178030|FG001|Overall Study|Withdrawal by Subject|7|||
163128479|NCT01959841|589178031|FG002|Overall Study|Withdrawal by Subject|5|||
163128480|NCT01959841|589178029|FG000|Overall Study|Clinical laboratory value|2|||
163128481|NCT01959841|589178030|FG001|Overall Study|Clinical laboratory value|6|||
163128482|NCT01959841|589178031|FG002|Overall Study|Clinical laboratory value|6|||
163128483|NCT01959841|589178029|FG000|Overall Study|Platelet count below on day1 or 4|11|||
163128484|NCT01959841|589178030|FG001|Overall Study|Platelet count below on day1 or 4|15|||
163128485|NCT01959841|589178031|FG002|Overall Study|Platelet count below on day1 or 4|11|||
163128486|NCT01450098|589178033|FG000|Period 3|Protocol Violation|0|||
163128487|NCT01450098|589178034|FG001|Period 3|Protocol Violation|1|||
163128488|NCT01450098|589178033|FG000|Period 3|Withdrawal by Subject|0|||
163128489|NCT01450098|589178034|FG001|Period 3|Withdrawal by Subject|2|||
163128490|NCT00655629|589178043|FG000|Overall Study|Adverse Event|4|||
163128491|NCT00655629|589178044|FG001|Overall Study|Adverse Event|1|||
163128492|NCT00655629|589178043|FG000|Overall Study|Lack of Efficacy|2|||
163128493|NCT00655629|589178044|FG001|Overall Study|Lack of Efficacy|12|||
163128494|NCT00655629|589178043|FG000|Overall Study|Lost to Follow-up|4|||
163128495|NCT00655629|589178044|FG001|Overall Study|Lost to Follow-up|3|||
163128496|NCT00655629|589178043|FG000|Overall Study|Protocol Violation|5|||
163128497|NCT00655629|589178044|FG001|Overall Study|Protocol Violation|3|||
163128498|NCT00655629|589178043|FG000|Overall Study|consent withdrawn|6|||
163128499|NCT00655629|589178044|FG001|Overall Study|consent withdrawn|4|||
163128500|NCT01835223|589178047|FG000|Overall Study|Adverse Event|1|||
163128501|NCT01835223|589178048|FG001|Overall Study|Adverse Event|0|||
163128502|NCT01835223|589178047|FG000|Overall Study|Withdrawal by Subject|2|||
163128503|NCT01835223|589178048|FG001|Overall Study|Withdrawal by Subject|0|||
163128504|NCT01835223|589178047|FG000|Overall Study|Disease progression|2|||
163128505|NCT01835223|589178048|FG001|Overall Study|Disease progression|1|||
163128506|NCT01835223|589178047|FG000|Overall Study|Became Inelligible|4|||
163128507|NCT01835223|589178048|FG001|Overall Study|Became Inelligible|0|||
163128508|NCT04097379|589178052|FG000|Overall Study|Adverse Event|1|||
163128509|NCT04097379|589178053|FG001|Overall Study|Adverse Event|0|||
163128510|NCT04097379|589178054|FG002|Overall Study|Adverse Event|0|||
163128511|NCT04097379|589178055|FG003|Overall Study|Adverse Event|0|||
163128512|NCT04097379|589178052|FG000|Overall Study|Physician Decision|0|||
163128513|NCT04097379|589178053|FG001|Overall Study|Physician Decision|1|||
163128514|NCT04097379|589178054|FG002|Overall Study|Physician Decision|0|||
163128515|NCT04097379|589178055|FG003|Overall Study|Physician Decision|0|||
163128516|NCT03387020|589178056|FG000|Overall Study|Adverse Event|0|||
163128517|NCT03387020|589178057|FG001|Overall Study|Adverse Event|2|||
163128518|NCT03387020|589178058|FG002|Overall Study|Adverse Event|0|||
163128519|NCT03387020|589178056|FG000|Overall Study|Withdrawal by Subject|2|||
163128520|NCT03387020|589178057|FG001|Overall Study|Withdrawal by Subject|0|||
163128521|NCT03387020|589178058|FG002|Overall Study|Withdrawal by Subject|0|||
163128522|NCT01425632|589178059|FG000|Overall Study|Adverse Event|0|||
163128523|NCT01425632|589178060|FG001|Overall Study|Adverse Event|1|||
163128524|NCT01425632|589178061|FG002|Overall Study|Adverse Event|1|||
163128525|NCT01425632|589178059|FG000|Overall Study|Physician Decision|1|||
163128526|NCT01425632|589178060|FG001|Overall Study|Physician Decision|0|||
163128527|NCT01425632|589178061|FG002|Overall Study|Physician Decision|0|||
163128528|NCT01425632|589178059|FG000|Overall Study|Protocol Violation|0|||
163128529|NCT01425632|589178060|FG001|Overall Study|Protocol Violation|0|||
163128530|NCT01425632|589178061|FG002|Overall Study|Protocol Violation|2|||
163128531|NCT01425632|589178059|FG000|Overall Study|Withdrawal by Subject|0|||
163128532|NCT01425632|589178060|FG001|Overall Study|Withdrawal by Subject|0|||
163128533|NCT01425632|589178061|FG002|Overall Study|Withdrawal by Subject|1|||
163128534|NCT03461146|589178062|FG000|Overall Study|Adverse Event|2|||
163128535|NCT03461146|589178062|FG000|Overall Study|Physician Decision|1|||
163128536|NCT02140047|589178063|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163128537|NCT02140047|589178064|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163128538|NCT02140047|589178065|FG002|Overall Study|Withdrawal by parent/guardian|0|||
163128539|NCT04617496|589178066|FG000|Overall Study|Death|2|||
163343103|NCT00105521|589964317|FG000|Overall Study|Adverse Event|10|||
163343104|NCT00105521|589964318|FG001|Overall Study|Adverse Event|4|||
163128540|NCT04617496|589178067|FG001|Overall Study|Death|1|||
163343105|NCT00105521|589964319|FG002|Overall Study|Adverse Event|10|||
163343106|NCT00105521|589964320|FG003|Overall Study|Adverse Event|8|||
163343107|NCT00105521|589964317|FG000|Overall Study|Withdrawal by Subject|1|||
163128541|NCT04617496|589178066|FG000|Overall Study|Lost to Follow-up|3|||
163128542|NCT04617496|589178067|FG001|Overall Study|Lost to Follow-up|3|||
163128543|NCT00200356|589178072|FG000|Overall Study|Lack of Efficacy|3|||
163128544|NCT00200356|589178073|FG001|Overall Study|Lack of Efficacy|3|||
163128545|NCT00200356|589178072|FG000|Overall Study|Protocol Violation|4|||
163128546|NCT00200356|589178073|FG001|Overall Study|Protocol Violation|4|||
163128547|NCT00200356|589178072|FG000|Overall Study|Nontreatment|1|||
163128548|NCT00200356|589178073|FG001|Overall Study|Nontreatment|0|||
163128549|NCT04530552|589178076|FG000|Overall Study|Physician Decision|0|||
163128550|NCT04530552|589178077|FG001|Overall Study|Physician Decision|1|||
163128551|NCT04530552|589178076|FG000|Overall Study|Withdrawal by Subject|0|||
163128552|NCT04530552|589178077|FG001|Overall Study|Withdrawal by Subject|1|||
163128553|NCT04530552|589178076|FG000|Overall Study|Adverse Event|0|||
163128554|NCT04530552|589178077|FG001|Overall Study|Adverse Event|1|||
163128555|NCT04530552|589178076|FG000|Overall Study|No surgery|0|||
163128556|NCT04530552|589178077|FG001|Overall Study|No surgery|1|||
163128557|NCT00454584|589178084|FG000|Controlled Period|Adverse Event|5|||
163128558|NCT00454584|589178085|FG001|Controlled Period|Adverse Event|2|||
163128559|NCT00454584|589178086|FG002|Controlled Period|Adverse Event|1|||
163128560|NCT00454584|589178087|FG003|Controlled Period|Adverse Event|0|||
163128561|NCT00454584|589178088|FG004|Controlled Period|Adverse Event|0|||
163128562|NCT00454584|589178089|FG005|Controlled Period|Adverse Event|0|||
163128563|NCT00454584|589178084|FG000|Controlled Period|Lost to Follow-up|1|||
163343108|NCT00105521|589964318|FG001|Overall Study|Withdrawal by Subject|0|||
163128564|NCT00454584|589178085|FG001|Controlled Period|Lost to Follow-up|2|||
163128565|NCT00454584|589178086|FG002|Controlled Period|Lost to Follow-up|2|||
163128566|NCT00454584|589178087|FG003|Controlled Period|Lost to Follow-up|0|||
163128567|NCT00454584|589178088|FG004|Controlled Period|Lost to Follow-up|0|||
163128568|NCT00454584|589178089|FG005|Controlled Period|Lost to Follow-up|0|||
163128569|NCT00454584|589178084|FG000|Controlled Period|Other|5|||
163128570|NCT00454584|589178085|FG001|Controlled Period|Other|4|||
163128571|NCT00454584|589178086|FG002|Controlled Period|Other|2|||
163128572|NCT00454584|589178087|FG003|Controlled Period|Other|0|||
163128573|NCT00454584|589178088|FG004|Controlled Period|Other|0|||
163128574|NCT00454584|589178089|FG005|Controlled Period|Other|0|||
163128575|NCT00454584|589178084|FG000|After Controlled Period|Adverse Event|0|||
163128576|NCT00454584|589178085|FG001|After Controlled Period|Adverse Event|0|||
163128577|NCT00454584|589178086|FG002|After Controlled Period|Adverse Event|0|||
163128578|NCT00454584|589178087|FG003|After Controlled Period|Adverse Event|9|||
163128579|NCT00454584|589178088|FG004|After Controlled Period|Adverse Event|3|||
163128580|NCT00454584|589178089|FG005|After Controlled Period|Adverse Event|9|||
163128581|NCT00454584|589178084|FG000|After Controlled Period|Lack of Efficacy|0|||
163128582|NCT00454584|589178085|FG001|After Controlled Period|Lack of Efficacy|0|||
163128583|NCT00454584|589178086|FG002|After Controlled Period|Lack of Efficacy|0|||
163128584|NCT00454584|589178087|FG003|After Controlled Period|Lack of Efficacy|1|||
163128585|NCT00454584|589178088|FG004|After Controlled Period|Lack of Efficacy|0|||
163128586|NCT00454584|589178089|FG005|After Controlled Period|Lack of Efficacy|0|||
163128587|NCT00454584|589178084|FG000|After Controlled Period|Lost to Follow-up|0|||
163128588|NCT00454584|589178085|FG001|After Controlled Period|Lost to Follow-up|0|||
163128589|NCT00454584|589178086|FG002|After Controlled Period|Lost to Follow-up|0|||
163128590|NCT00454584|589178087|FG003|After Controlled Period|Lost to Follow-up|2|||
163128591|NCT00454584|589178088|FG004|After Controlled Period|Lost to Follow-up|4|||
163128592|NCT00454584|589178089|FG005|After Controlled Period|Lost to Follow-up|6|||
163128593|NCT00454584|589178084|FG000|After Controlled Period|Other|0|||
163128594|NCT00454584|589178085|FG001|After Controlled Period|Other|0|||
163128595|NCT00454584|589178086|FG002|After Controlled Period|Other|0|||
163128596|NCT00454584|589178087|FG003|After Controlled Period|Other|1|||
163128597|NCT00454584|589178088|FG004|After Controlled Period|Other|0|||
163128598|NCT00454584|589178089|FG005|After Controlled Period|Other|0|||
163128599|NCT00454584|589178084|FG000|After Controlled Period|Other|0|||
163128600|NCT00454584|589178085|FG001|After Controlled Period|Other|0|||
163128601|NCT00454584|589178086|FG002|After Controlled Period|Other|0|||
163128602|NCT00454584|589178087|FG003|After Controlled Period|Other|13|||
163128603|NCT00454584|589178088|FG004|After Controlled Period|Other|5|||
163128604|NCT00454584|589178089|FG005|After Controlled Period|Other|17|||
163128605|NCT02250664|589178090|FG000|Overall Study|Lost to Follow-up|18|||
163128606|NCT02250664|589178091|FG001|Overall Study|Lost to Follow-up|28|||
163128607|NCT02250664|589178092|FG002|Overall Study|Lost to Follow-up|33|||
163128608|NCT02250664|589178090|FG000|Overall Study|Personal Reasons|7|||
163128609|NCT02250664|589178091|FG001|Overall Study|Personal Reasons|8|||
163128610|NCT02250664|589178092|FG002|Overall Study|Personal Reasons|14|||
163128611|NCT02250664|589178090|FG000|Overall Study|Adverse Event|6|||
163128612|NCT02250664|589178091|FG001|Overall Study|Adverse Event|3|||
163128613|NCT02250664|589178092|FG002|Overall Study|Adverse Event|8|||
163128614|NCT02250664|589178090|FG000|Overall Study|Incarcerated|2|||
163128615|NCT02250664|589178091|FG001|Overall Study|Incarcerated|1|||
163128616|NCT02250664|589178092|FG002|Overall Study|Incarcerated|2|||
163128617|NCT02250664|589178090|FG000|Overall Study|Withdrawal by Subject|0|||
163128618|NCT02250664|589178091|FG001|Overall Study|Withdrawal by Subject|1|||
163128619|NCT02250664|589178092|FG002|Overall Study|Withdrawal by Subject|2|||
163128620|NCT02250664|589178090|FG000|Overall Study|Death|0|||
163128621|NCT02250664|589178091|FG001|Overall Study|Death|1|||
163343109|NCT00105521|589964319|FG002|Overall Study|Withdrawal by Subject|1|||
163128622|NCT02250664|589178092|FG002|Overall Study|Death|1|||
163128623|NCT02250664|589178090|FG000|Overall Study|Physician Decision|1|||
163128624|NCT02250664|589178091|FG001|Overall Study|Physician Decision|3|||
163128625|NCT02250664|589178092|FG002|Overall Study|Physician Decision|1|||
163128626|NCT02250664|589178090|FG000|Overall Study|Protocol Violation|1|||
163128627|NCT02250664|589178091|FG001|Overall Study|Protocol Violation|0|||
163128628|NCT02250664|589178092|FG002|Overall Study|Protocol Violation|1|||
163128629|NCT02250664|589178090|FG000|Overall Study|Reason unknown|1|||
163128630|NCT02250664|589178091|FG001|Overall Study|Reason unknown|0|||
163128631|NCT02250664|589178092|FG002|Overall Study|Reason unknown|0|||
163128632|NCT00490022|589178094|FG000|Overall Study|Adverse Event|0|||
163128633|NCT00490022|589178095|FG001|Overall Study|Adverse Event|2|||
163128634|NCT00490022|589178094|FG000|Overall Study|Withdrawal by Subject|1|||
163128635|NCT00490022|589178095|FG001|Overall Study|Withdrawal by Subject|0|||
163128636|NCT00490022|589178094|FG000|Overall Study|Subject failed to disclose concommitant|0|||
163128637|NCT00490022|589178095|FG001|Overall Study|Subject failed to disclose concommitant|1|||
163128638|NCT00975143|589178098|FG000|Overall Study|Adverse Event|19|||
163128639|NCT00975143|589178099|FG001|Overall Study|Adverse Event|15|||
163128640|NCT00975143|589178098|FG000|Overall Study|Withdrawal by Subject|15|||
163128641|NCT00975143|589178099|FG001|Overall Study|Withdrawal by Subject|15|||
163128642|NCT00975143|589178098|FG000|Overall Study|Lost to Follow-up|20|||
163128643|NCT00975143|589178099|FG001|Overall Study|Lost to Follow-up|16|||
163128644|NCT00975143|589178098|FG000|Overall Study|Non-compliance|5|||
163128645|NCT00975143|589178099|FG001|Overall Study|Non-compliance|8|||
163128646|NCT00975143|589178098|FG000|Overall Study|Physician Decision|1|||
163128647|NCT00975143|589178099|FG001|Overall Study|Physician Decision|2|||
163128648|NCT00975143|589178098|FG000|Overall Study|Details not available|10|||
163128649|NCT00975143|589178099|FG001|Overall Study|Details not available|4|||
163128650|NCT01753401|589178100|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
163128651|NCT01753401|589178101|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
163128652|NCT01753401|589178102|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
163128653|NCT01753401|589178103|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
163128654|NCT01753401|589178100|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
163128655|NCT01753401|589178101|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
163128656|NCT01753401|589178102|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
163128657|NCT01753401|589178103|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
163128658|NCT01753401|589178100|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
163128659|NCT01753401|589178101|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
163128660|NCT01753401|589178102|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
163128661|NCT01753401|589178103|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
163128662|NCT01753401|589178100|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
163128663|NCT01753401|589178101|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
163128664|NCT01753401|589178102|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
163128665|NCT01753401|589178103|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
163128666|NCT01753401|589178100|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
163128667|NCT01753401|589178101|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
163128668|NCT01753401|589178102|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
163128669|NCT01753401|589178103|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
163128670|NCT01753401|589178100|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
163128671|NCT01753401|589178101|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
163128672|NCT01753401|589178102|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
163128673|NCT01753401|589178103|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
163128674|NCT01753401|589178100|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
163128675|NCT01753401|589178101|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
163128676|NCT01753401|589178102|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
163128677|NCT01753401|589178103|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
163128678|NCT03129360|589178104|FG000|Overall Study|Did not meet entry criteria|0|||
163128679|NCT03129360|589178105|FG001|Overall Study|Did not meet entry criteria|2|||
163128680|NCT03129360|589178106|FG002|Overall Study|Did not meet entry criteria|1|||
163128681|NCT03129360|589178104|FG000|Overall Study|Excluded due to motion in scanner|1|||
163128682|NCT03129360|589178105|FG001|Overall Study|Excluded due to motion in scanner|0|||
163128683|NCT03129360|589178106|FG002|Overall Study|Excluded due to motion in scanner|0|||
163128684|NCT01729208|589178109|FG000|Baseline|Physician Decision|5|||
163128685|NCT01729208|589178110|FG001|Baseline|Physician Decision|4|||
163128686|NCT01729208|589178109|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
163128687|NCT01729208|589178110|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
163343110|NCT00105521|589964320|FG003|Overall Study|Withdrawal by Subject|4|||
163343111|NCT00105521|589964317|FG000|Overall Study|Lack of Efficacy|0|||
163343112|NCT00105521|589964318|FG001|Overall Study|Lack of Efficacy|0|||
163128688|NCT01729208|589178109|FG000|12 Months Follow-up|Lost to Follow-up|3|||
163128689|NCT01729208|589178110|FG001|12 Months Follow-up|Lost to Follow-up|3|||
163128690|NCT01729208|589178109|FG000|24 Months Follow-up|Lost to Follow-up|3|||
163343113|NCT00105521|589964319|FG002|Overall Study|Lack of Efficacy|0|||
163343114|NCT00105521|589964320|FG003|Overall Study|Lack of Efficacy|1|||
163343115|NCT00105521|589964317|FG000|Overall Study|Protocol Violation|3|||
163128691|NCT01729208|589178110|FG001|24 Months Follow-up|Lost to Follow-up|0|||
163128692|NCT01729208|589178109|FG000|36 Months Follow-up|Physician Decision|1|||
163128693|NCT01729208|589178110|FG001|36 Months Follow-up|Physician Decision|0|||
163128694|NCT01729208|589178109|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
163128695|NCT01729208|589178110|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
163128696|NCT02428413|589178111|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
163128697|NCT02428413|589178112|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
163128698|NCT02428413|589178111|FG000|Overall Study|Protocol Violation|1|||
163128699|NCT02428413|589178112|FG001|Overall Study|Protocol Violation|2|||
163343116|NCT00105521|589964318|FG001|Overall Study|Protocol Violation|5|||
163343117|NCT00105521|589964319|FG002|Overall Study|Protocol Violation|4|||
163343118|NCT00105521|589964320|FG003|Overall Study|Protocol Violation|4|||
163343119|NCT00105521|589964317|FG000|Overall Study|Lost to Follow-up|0|||
163343120|NCT00105521|589964318|FG001|Overall Study|Lost to Follow-up|1|||
163343121|NCT00105521|589964319|FG002|Overall Study|Lost to Follow-up|0|||
163343122|NCT00105521|589964320|FG003|Overall Study|Lost to Follow-up|0|||
163343123|NCT00385697|589964324|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
163343124|NCT00385697|589964325|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
163343125|NCT00385697|589964326|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
163343126|NCT00385697|589964327|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
163343127|NCT00385697|589964328|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
163343128|NCT00385697|589964324|FG000|Open-label Segment 1|Lost to Follow-up|1|||
163343129|NCT00385697|589964325|FG001|Open-label Segment 1|Lost to Follow-up|0|||
163343130|NCT00385697|589964326|FG002|Open-label Segment 1|Lost to Follow-up|0|||
163343131|NCT00385697|589964327|FG003|Open-label Segment 1|Lost to Follow-up|0|||
163408329|NCT04942925|590204112|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
163128700|NCT02428413|589178111|FG000|Overall Study|Case Cancelled|2|||
163128701|NCT02428413|589178112|FG001|Overall Study|Case Cancelled|0|||
163128702|NCT02428413|589178111|FG000|Overall Study|Missed Cases|1|||
163128703|NCT02428413|589178112|FG001|Overall Study|Missed Cases|2|||
163128704|NCT02428413|589178111|FG000|Overall Study|Nurse Refusal|1|||
163128705|NCT02428413|589178112|FG001|Overall Study|Nurse Refusal|0|||
163128706|NCT00295932|589178113|FG000|Overall Study|Not Treated|0|||
163128707|NCT00295932|589178114|FG001|Overall Study|Not Treated|0|||
163128708|NCT00295932|589178115|FG002|Overall Study|Not Treated|0|||
163128709|NCT00295932|589178116|FG003|Overall Study|Not Treated|0|||
163128710|NCT00295932|589178117|FG004|Overall Study|Not Treated|0|||
163128711|NCT00295932|589178118|FG005|Overall Study|Not Treated|0|||
163128712|NCT00295932|589178119|FG006|Overall Study|Not Treated|0|||
163128713|NCT00295932|589178120|FG007|Overall Study|Not Treated|0|||
163128714|NCT00295932|589178121|FG008|Overall Study|Not Treated|0|||
163128715|NCT00295932|589178122|FG009|Overall Study|Not Treated|0|||
163128716|NCT00295932|589178123|FG010|Overall Study|Not Treated|1|||
163128717|NCT02409719|589178126|FG000|Overall Study|Lost to Follow-up|3|||
163128718|NCT02409719|589178127|FG001|Overall Study|Lost to Follow-up|3|||
163128719|NCT00565136|589178132|FG000|Overall Study|Lost to Follow-up|1|||
163128720|NCT00565136|589178132|FG000|Overall Study|Withdrawal by Subject|1|||
163128721|NCT00565136|589178132|FG000|Overall Study|Protocol Violation|1|||
163128722|NCT01026220|589178133|FG000|Induction|Death|1|||
163128723|NCT01026220|589178134|FG001|Induction|Death|0|||
163128724|NCT01026220|589178135|FG002|Induction|Death|0|||
163128725|NCT01026220|589178133|FG000|Induction|Lack of Efficacy|2|||
163128726|NCT01026220|589178134|FG001|Induction|Lack of Efficacy|0|||
163128727|NCT01026220|589178135|FG002|Induction|Lack of Efficacy|0|||
163128728|NCT01026220|589178133|FG000|Induction|Physician Decision|12|||
163128729|NCT01026220|589178134|FG001|Induction|Physician Decision|0|||
163128730|NCT01026220|589178135|FG002|Induction|Physician Decision|0|||
163128731|NCT01026220|589178133|FG000|Induction|Withdrawal by Subject|9|||
163128732|NCT01026220|589178134|FG001|Induction|Withdrawal by Subject|0|||
163128733|NCT01026220|589178135|FG002|Induction|Withdrawal by Subject|0|||
163128734|NCT01026220|589178133|FG000|Induction|Ineligible|1|||
163128735|NCT01026220|589178134|FG001|Induction|Ineligible|0|||
163128736|NCT01026220|589178135|FG002|Induction|Ineligible|0|||
163128737|NCT01026220|589178133|FG000|Consolidation Maintenance|Death|0|||
163128738|NCT01026220|589178134|FG001|Consolidation Maintenance|Death|1|||
163128739|NCT01026220|589178135|FG002|Consolidation Maintenance|Death|0|||
163343132|NCT00385697|589964328|FG004|Open-label Segment 1|Lost to Follow-up|0|||
163343133|NCT00385697|589964324|FG000|Double-blind Segment 2|Adverse Event|0|||
163128740|NCT01026220|589178133|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
163128741|NCT01026220|589178134|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
163128742|NCT01026220|589178135|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
163128743|NCT01026220|589178133|FG000|Consolidation Maintenance|Physician Decision|0|||
163128744|NCT01026220|589178134|FG001|Consolidation Maintenance|Physician Decision|2|||
163128745|NCT01026220|589178135|FG002|Consolidation Maintenance|Physician Decision|7|||
163128746|NCT01026220|589178133|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
163128747|NCT01026220|589178134|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
163128748|NCT01026220|589178135|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
163128749|NCT01459913|589178136|FG000|Overall Study|Adverse Event|0|||
163128750|NCT01459913|589178137|FG001|Overall Study|Adverse Event|0|||
163128751|NCT01459913|589178138|FG002|Overall Study|Adverse Event|0|||
163128752|NCT01459913|589178139|FG003|Overall Study|Adverse Event|3|||
163128753|NCT01459913|589178136|FG000|Overall Study|Withdrawal by Subject|4|||
163343134|NCT00385697|589964325|FG001|Double-blind Segment 2|Adverse Event|3|||
163343135|NCT00385697|589964326|FG002|Double-blind Segment 2|Adverse Event|1|||
163343136|NCT00385697|589964327|FG003|Double-blind Segment 2|Adverse Event|0|||
163128754|NCT01459913|589178137|FG001|Overall Study|Withdrawal by Subject|0|||
163128755|NCT01459913|589178138|FG002|Overall Study|Withdrawal by Subject|0|||
163128756|NCT01459913|589178139|FG003|Overall Study|Withdrawal by Subject|5|||
163128757|NCT01459913|589178136|FG000|Overall Study|Lost to Follow-up|7|||
163128758|NCT01459913|589178137|FG001|Overall Study|Lost to Follow-up|4|||
163128759|NCT01459913|589178138|FG002|Overall Study|Lost to Follow-up|1|||
163128760|NCT01459913|589178139|FG003|Overall Study|Lost to Follow-up|8|||
163128761|NCT01459913|589178136|FG000|Overall Study|Death|0|||
163128762|NCT01459913|589178137|FG001|Overall Study|Death|0|||
163128763|NCT01459913|589178138|FG002|Overall Study|Death|0|||
163128764|NCT01459913|589178139|FG003|Overall Study|Death|1|||
163128765|NCT01459913|589178136|FG000|Overall Study|Non- Compliance|0|||
163128766|NCT01459913|589178137|FG001|Overall Study|Non- Compliance|0|||
163128767|NCT01459913|589178138|FG002|Overall Study|Non- Compliance|0|||
163128768|NCT01459913|589178139|FG003|Overall Study|Non- Compliance|3|||
163128769|NCT01459913|589178136|FG000|Overall Study|Physician Decision|0|||
163128770|NCT01459913|589178137|FG001|Overall Study|Physician Decision|1|||
163128771|NCT01459913|589178138|FG002|Overall Study|Physician Decision|0|||
163128772|NCT01459913|589178139|FG003|Overall Study|Physician Decision|0|||
163128773|NCT01459913|589178136|FG000|Overall Study|Study Terminated by Sponsor|30|||
163128774|NCT01459913|589178137|FG001|Overall Study|Study Terminated by Sponsor|15|||
163128775|NCT01459913|589178138|FG002|Overall Study|Study Terminated by Sponsor|9|||
163128776|NCT01459913|589178139|FG003|Overall Study|Study Terminated by Sponsor|11|||
163128777|NCT01459913|589178136|FG000|Overall Study|Other|0|||
163128778|NCT01459913|589178137|FG001|Overall Study|Other|0|||
163128779|NCT01459913|589178138|FG002|Overall Study|Other|3|||
163128780|NCT01459913|589178139|FG003|Overall Study|Other|1|||
163128781|NCT01459913|589178136|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
163128782|NCT01459913|589178137|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
163128783|NCT01459913|589178138|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
163128784|NCT01459913|589178139|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
163128785|NCT05096312|589178142|FG000|Overall Study|Lost to Follow-up|2|||
163128786|NCT05096312|589178143|FG001|Overall Study|Lost to Follow-up|4|||
163128787|NCT05096312|589178142|FG000|Overall Study|Adverse Event|1|||
163128788|NCT05096312|589178143|FG001|Overall Study|Adverse Event|0|||
163128789|NCT03135210|589178144|FG000|Overall Study|Death|0|||
163128790|NCT03135210|589178145|FG001|Overall Study|Death|1|||
163128791|NCT03517566|589178146|FG000|Overall Study|Adverse Event|5|||
163128792|NCT03517566|589178147|FG001|Overall Study|Adverse Event|2|||
163128793|NCT03517566|589178148|FG002|Overall Study|Adverse Event|2|||
163128794|NCT03517566|589178149|FG003|Overall Study|Adverse Event|8|||
163128795|NCT03517566|589178150|FG004|Overall Study|Adverse Event|7|||
163128796|NCT03517566|589178146|FG000|Overall Study|Lack of Efficacy|3|||
163128797|NCT03517566|589178147|FG001|Overall Study|Lack of Efficacy|2|||
163128798|NCT03517566|589178148|FG002|Overall Study|Lack of Efficacy|1|||
163128799|NCT03517566|589178149|FG003|Overall Study|Lack of Efficacy|1|||
163128800|NCT03517566|589178150|FG004|Overall Study|Lack of Efficacy|4|||
163128801|NCT03517566|589178146|FG000|Overall Study|Lost to Follow-up|3|||
163128802|NCT03517566|589178147|FG001|Overall Study|Lost to Follow-up|1|||
163128803|NCT03517566|589178148|FG002|Overall Study|Lost to Follow-up|1|||
163128804|NCT03517566|589178149|FG003|Overall Study|Lost to Follow-up|1|||
163128805|NCT03517566|589178150|FG004|Overall Study|Lost to Follow-up|0|||
163128806|NCT03517566|589178146|FG000|Overall Study|Physician Decision|1|||
163128807|NCT03517566|589178147|FG001|Overall Study|Physician Decision|1|||
163128808|NCT03517566|589178148|FG002|Overall Study|Physician Decision|0|||
163128809|NCT03517566|589178149|FG003|Overall Study|Physician Decision|1|||
163128810|NCT03517566|589178150|FG004|Overall Study|Physician Decision|0|||
163128811|NCT03517566|589178146|FG000|Overall Study|Pregnancy|0|||
163128812|NCT03517566|589178147|FG001|Overall Study|Pregnancy|1|||
163343137|NCT00385697|589964328|FG004|Double-blind Segment 2|Adverse Event|0|||
163128813|NCT03517566|589178148|FG002|Overall Study|Pregnancy|0|||
163343138|NCT00385697|589964324|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
163343139|NCT00385697|589964325|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
163343140|NCT00385697|589964326|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
163343141|NCT00385697|589964327|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
163128814|NCT03517566|589178149|FG003|Overall Study|Pregnancy|0|||
163128815|NCT03517566|589178150|FG004|Overall Study|Pregnancy|0|||
163128816|NCT03517566|589178146|FG000|Overall Study|Protocol Deviation|0|||
163128817|NCT03517566|589178147|FG001|Overall Study|Protocol Deviation|1|||
163128818|NCT03517566|589178148|FG002|Overall Study|Protocol Deviation|0|||
163128819|NCT03517566|589178149|FG003|Overall Study|Protocol Deviation|1|||
163128820|NCT03517566|589178150|FG004|Overall Study|Protocol Deviation|1|||
163128821|NCT03517566|589178146|FG000|Overall Study|Study terminated by Sponsor|11|||
163128822|NCT03517566|589178147|FG001|Overall Study|Study terminated by Sponsor|5|||
163128823|NCT03517566|589178148|FG002|Overall Study|Study terminated by Sponsor|6|||
163128824|NCT03517566|589178149|FG003|Overall Study|Study terminated by Sponsor|14|||
163128825|NCT03517566|589178150|FG004|Overall Study|Study terminated by Sponsor|12|||
163128826|NCT03517566|589178146|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
163128827|NCT03517566|589178147|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
163343142|NCT00385697|589964328|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
163128828|NCT03517566|589178148|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
163128829|NCT03517566|589178149|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
163128830|NCT03517566|589178150|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
163128831|NCT00671437|589178151|FG000|Overall Study|Progressive disease before C1 week 8|8|||
163128832|NCT00671437|589178151|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
163128833|NCT00671437|589178151|FG000|Overall Study|Adverse Event|3|||
163128834|NCT00671437|589178151|FG000|Overall Study|Ineligible post-hoc|1|||
163128835|NCT04349033|589178152|FG000|Overall Study|Lost to Follow-up|3|||
163128836|NCT04349033|589178153|FG001|Overall Study|Lost to Follow-up|1|||
163128837|NCT04349033|589178154|FG002|Overall Study|Lost to Follow-up|1|||
163128838|NCT01704456|589178158|FG000|Overall Study|Lost to Follow-up|8|||
163128839|NCT01704456|589178159|FG001|Overall Study|Lost to Follow-up|14|||
163128840|NCT00915551|589178165|FG000|Overall Study|Withdrawal by Subject|0|||
163128841|NCT00915551|589178166|FG001|Overall Study|Withdrawal by Subject|1|||
163128842|NCT04390841|589178167|FG000|Overall Study|Withdrawal by Subject|2|||
163128843|NCT02540291|589178168|FG000|Overall Study|Death|7|||
163128844|NCT02540291|589178169|FG001|Overall Study|Death|7|||
163128845|NCT02540291|589178170|FG002|Overall Study|Death|5|||
163128846|NCT02540291|589178171|FG003|Overall Study|Death|7|||
163128847|NCT02540291|589178168|FG000|Overall Study|Lost to Follow-up|0|||
163128848|NCT02540291|589178169|FG001|Overall Study|Lost to Follow-up|0|||
163128849|NCT02540291|589178170|FG002|Overall Study|Lost to Follow-up|1|||
163128850|NCT02540291|589178171|FG003|Overall Study|Lost to Follow-up|0|||
163128851|NCT02540291|589178168|FG000|Overall Study|Withdrawal Of Consent|0|||
163128852|NCT02540291|589178169|FG001|Overall Study|Withdrawal Of Consent|1|||
163128853|NCT02540291|589178170|FG002|Overall Study|Withdrawal Of Consent|0|||
163128854|NCT02540291|589178171|FG003|Overall Study|Withdrawal Of Consent|0|||
163128855|NCT02540291|589178168|FG000|Overall Study|Study Terminated By Sponsor|1|||
163128856|NCT02540291|589178169|FG001|Overall Study|Study Terminated By Sponsor|0|||
163128857|NCT02540291|589178170|FG002|Overall Study|Study Terminated By Sponsor|0|||
163128858|NCT02540291|589178171|FG003|Overall Study|Study Terminated By Sponsor|0|||
163128859|NCT02540291|589178168|FG000|Overall Study|Other|0|||
163128860|NCT02540291|589178169|FG001|Overall Study|Other|0|||
163128861|NCT02540291|589178170|FG002|Overall Study|Other|1|||
163128862|NCT02540291|589178171|FG003|Overall Study|Other|0|||
163128863|NCT01031979|589179763|FG000|Overall Study|Lost to Follow-up|5|||
163128864|NCT01031979|589179764|FG001|Overall Study|Lost to Follow-up|4|||
163128865|NCT03831100|589179765|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
163128866|NCT03831100|589179766|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
163128867|NCT02454478|589179769|FG000|Overall Study|Incomplete DLT Evaluation|1|||
163128868|NCT01732770|589179770|FG000|Overall Study|Lost to Follow-up|2|||
163128869|NCT01732770|589179771|FG001|Overall Study|Lost to Follow-up|3|||
163128870|NCT01732770|589179770|FG000|Overall Study|Withdrawal by Subject|5|||
163128871|NCT01732770|589179771|FG001|Overall Study|Withdrawal by Subject|3|||
163128872|NCT01732770|589179770|FG000|Overall Study|Decision by Sponsor|2|||
163128873|NCT01732770|589179771|FG001|Overall Study|Decision by Sponsor|2|||
163128874|NCT01732770|589179770|FG000|Overall Study|Death|1|||
163128875|NCT01732770|589179771|FG001|Overall Study|Death|0|||
163128876|NCT03229109|589179772|FG000|Overall Study|Withdrawal by Subject|0|||
163128877|NCT03229109|589179773|FG001|Overall Study|Withdrawal by Subject|0|||
163128878|NCT03229109|589179774|FG002|Overall Study|Withdrawal by Subject|0|||
163128879|NCT03229109|589179775|FG003|Overall Study|Withdrawal by Subject|1|||
163128880|NCT03329196|589179778|FG000|Overall Study|Adverse Event|10|||
163128881|NCT03329196|589179779|FG001|Overall Study|Adverse Event|5|||
163128882|NCT03329196|589179778|FG000|Overall Study|Physician Decision|2|||
163128883|NCT03329196|589179779|FG001|Overall Study|Physician Decision|2|||
163128884|NCT03329196|589179778|FG000|Overall Study|Withdrawal by Subject|11|||
163128885|NCT03329196|589179779|FG001|Overall Study|Withdrawal by Subject|3|||
163128886|NCT03329196|589179778|FG000|Overall Study|Hepatic function abnormalities|0|||
163128887|NCT03329196|589179779|FG001|Overall Study|Hepatic function abnormalities|1|||
163128888|NCT03329196|589179778|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
163128889|NCT03329196|589179779|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
163128890|NCT03329196|589179778|FG000|Overall Study|Difficult to control Hb|2|||
163128891|NCT03329196|589179779|FG001|Overall Study|Difficult to control Hb|3|||
163128892|NCT03329196|589179778|FG000|Overall Study|Dialysis or renal transplant|13|||
163128893|NCT03329196|589179779|FG001|Overall Study|Dialysis or renal transplant|15|||
163128894|NCT04481750|589179783|FG000|Period 1 (Fasted)|Adverse Event|0|||
163343143|NCT00385697|589964324|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
163343144|NCT00385697|589964325|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
163128895|NCT04481750|589179784|FG001|Period 1 (Fasted)|Adverse Event|0|||
163128896|NCT04481750|589179785|FG002|Period 1 (Fasted)|Adverse Event|1|||
163128897|NCT04481750|589179786|FG003|Period 1 (Fasted)|Adverse Event|0|||
163128898|NCT04481750|589179787|FG004|Period 1 (Fasted)|Adverse Event|0|||
163128899|NCT04481750|589179788|FG005|Period 1 (Fasted)|Adverse Event|0|||
163226738|NCT01393405|589544260|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
163128900|NCT04481750|589179789|FG006|Period 1 (Fasted)|Adverse Event|0|||
163128901|NCT04481750|589179790|FG007|Period 1 (Fasted)|Adverse Event|0|||
163128902|NCT04481750|589179791|FG008|Period 1 (Fasted)|Adverse Event|0|||
163128903|NCT04481750|589179792|FG009|Period 1 (Fasted)|Adverse Event|0|||
163128904|NCT04481750|589179793|FG010|Period 1 (Fasted)|Adverse Event|0|||
163128905|NCT03176771|589179794|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
163128906|NCT03176771|589179795|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
163128907|NCT03176771|589179796|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
163128908|NCT03176771|589179797|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
163128909|NCT03176771|589179798|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
163128910|NCT03176771|589179794|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
163128911|NCT03176771|589179795|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
163128912|NCT03176771|589179796|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
163128913|NCT03176771|589179797|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
163128914|NCT03176771|589179798|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
163128915|NCT03176771|589179794|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
163128916|NCT03176771|589179795|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
163128917|NCT03176771|589179796|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
163128918|NCT03176771|589179797|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
163128919|NCT03176771|589179798|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
163128920|NCT03176771|589179794|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
163128921|NCT03176771|589179795|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
163128922|NCT03176771|589179796|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
163128923|NCT03176771|589179797|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
163128924|NCT03176771|589179798|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
163128925|NCT03176771|589179794|FG000|Double-Blind Extension Period|Adverse Event|0|||
163128926|NCT03176771|589179795|FG001|Double-Blind Extension Period|Adverse Event|0|||
163128927|NCT03176771|589179796|FG002|Double-Blind Extension Period|Adverse Event|0|||
163128928|NCT03176771|589179797|FG003|Double-Blind Extension Period|Adverse Event|15|||
163128929|NCT03176771|589179798|FG004|Double-Blind Extension Period|Adverse Event|18|||
163128930|NCT03176771|589179794|FG000|Double-Blind Extension Period|Death|0|||
163128931|NCT03176771|589179795|FG001|Double-Blind Extension Period|Death|0|||
163128932|NCT03176771|589179796|FG002|Double-Blind Extension Period|Death|0|||
163128933|NCT03176771|589179797|FG003|Double-Blind Extension Period|Death|3|||
163128934|NCT03176771|589179798|FG004|Double-Blind Extension Period|Death|4|||
163128935|NCT03176771|589179794|FG000|Double-Blind Extension Period|Physician Decision|0|||
163128936|NCT03176771|589179795|FG001|Double-Blind Extension Period|Physician Decision|0|||
163128937|NCT03176771|589179796|FG002|Double-Blind Extension Period|Physician Decision|0|||
163128938|NCT03176771|589179797|FG003|Double-Blind Extension Period|Physician Decision|3|||
163128939|NCT03176771|589179798|FG004|Double-Blind Extension Period|Physician Decision|1|||
163128940|NCT03176771|589179794|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
163128941|NCT03176771|589179795|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
163128942|NCT03176771|589179796|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
163128943|NCT03176771|589179797|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
163128944|NCT03176771|589179798|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
163128945|NCT03439137|589179799|FG000|Overall Study|Adverse Event|16|||
163128946|NCT03439137|589179800|FG001|Overall Study|Adverse Event|12|||
163128947|NCT03439137|589179799|FG000|Overall Study|Physician Decision|0|||
163128948|NCT03439137|589179800|FG001|Overall Study|Physician Decision|5|||
163128949|NCT03439137|589179799|FG000|Overall Study|Withdrawal by Subject|14|||
163128950|NCT03439137|589179800|FG001|Overall Study|Withdrawal by Subject|4|||
163128951|NCT03439137|589179799|FG000|Overall Study|Conducting rescue therapy|2|||
163128952|NCT03439137|589179800|FG001|Overall Study|Conducting rescue therapy|1|||
163128953|NCT03439137|589179799|FG000|Overall Study|Difficult to control Hb|10|||
163128954|NCT03439137|589179800|FG001|Overall Study|Difficult to control Hb|2|||
163128955|NCT03439137|589179799|FG000|Overall Study|Initiation of a renal transplant|0|||
163128956|NCT03439137|589179800|FG001|Overall Study|Initiation of a renal transplant|2|||
163128957|NCT00691028|589179801|FG000|Open-label Period|Adverse Event|0|||
163128958|NCT00691028|589179802|FG001|Open-label Period|Adverse Event|0|||
163128959|NCT00691028|589179803|FG002|Open-label Period|Adverse Event|0|||
163128960|NCT00691028|589179804|FG003|Open-label Period|Adverse Event|16|||
163128961|NCT00691028|589179801|FG000|Open-label Period|Withdrawal by Subject|0|||
163128962|NCT00691028|589179802|FG001|Open-label Period|Withdrawal by Subject|0|||
163128963|NCT00691028|589179803|FG002|Open-label Period|Withdrawal by Subject|0|||
163128964|NCT00691028|589179804|FG003|Open-label Period|Withdrawal by Subject|3|||
163128965|NCT00691028|589179801|FG000|Open-label Period|not come to a hospital|0|||
163128966|NCT00691028|589179802|FG001|Open-label Period|not come to a hospital|0|||
163128967|NCT00691028|589179803|FG002|Open-label Period|not come to a hospital|0|||
163128968|NCT00691028|589179804|FG003|Open-label Period|not come to a hospital|1|||
163128969|NCT00691028|589179801|FG000|Double-blind Period|Adverse Event|8|||
163128970|NCT00691028|589179802|FG001|Double-blind Period|Adverse Event|9|||
163128971|NCT00691028|589179803|FG002|Double-blind Period|Adverse Event|6|||
163128972|NCT00691028|589179804|FG003|Double-blind Period|Adverse Event|0|||
163128973|NCT00691028|589179801|FG000|Double-blind Period|Lack of Efficacy|4|||
163128974|NCT00691028|589179802|FG001|Double-blind Period|Lack of Efficacy|3|||
163128975|NCT00691028|589179803|FG002|Double-blind Period|Lack of Efficacy|2|||
163128976|NCT00691028|589179804|FG003|Double-blind Period|Lack of Efficacy|0|||
163128977|NCT00691028|589179801|FG000|Double-blind Period|Withdrawal by Subject|1|||
163128978|NCT00691028|589179802|FG001|Double-blind Period|Withdrawal by Subject|0|||
163128979|NCT00691028|589179803|FG002|Double-blind Period|Withdrawal by Subject|1|||
163128980|NCT00691028|589179804|FG003|Double-blind Period|Withdrawal by Subject|0|||
163128981|NCT00691028|589179801|FG000|Double-blind Period|not come to a hospital.|0|||
163128982|NCT00691028|589179802|FG001|Double-blind Period|not come to a hospital.|1|||
163128983|NCT00691028|589179803|FG002|Double-blind Period|not come to a hospital.|0|||
163128984|NCT00691028|589179804|FG003|Double-blind Period|not come to a hospital.|0|||
163128985|NCT04512976|589179809|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
163128986|NCT04512976|589179810|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
163128987|NCT04512976|589179811|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
163128988|NCT04512976|589179812|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
163128989|NCT04512976|589179813|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
163128990|NCT04512976|589179814|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
163128991|NCT05249569|589179818|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
163128992|NCT03703856|589179819|FG000|Enrolled in study|Withdrawal by Subject|23|||
163128993|NCT03703856|589179819|FG000|Titrated to full dose|Withdrawal by Subject|5|||
163128994|NCT03703856|589179819|FG000|16 week assessment|Withdrawal by Subject|1|||
163128995|NCT03703856|589179819|FG000|24 week assessment|Withdrawal by Subject|1|||
163128996|NCT01596335|589179820|FG000|Overall Study|exacerbation of primary disease|5|||
163128997|NCT01596335|589179821|FG001|Overall Study|exacerbation of primary disease|9|||
163128998|NCT03402386|589179822|FG000|Overall Study|Adverse Event|3|||
163128999|NCT03402386|589179822|FG000|Overall Study|Physician Decision|1|||
163129000|NCT03402386|589179822|FG000|Overall Study|Difficult to control Hb|2|||
163129001|NCT01585155|589179826|FG000|Overall Study|Adverse Event|1|||
163129002|NCT01585155|589179826|FG000|Overall Study|Lack of Efficacy|2|||
163129003|NCT01585155|589179826|FG000|Overall Study|Worsening ulcerative colitis|2|||
163129004|NCT01192412|589179828|FG000|Overall Study|Lost to Follow-up|2|||
163129005|NCT01192412|589179829|FG001|Overall Study|Lost to Follow-up|1|||
163129006|NCT01192412|589179828|FG000|Overall Study|Withdrawal by Subject|2|||
163129007|NCT01192412|589179829|FG001|Overall Study|Withdrawal by Subject|1|||
163129008|NCT02421588|589179830|FG000|Overall Study|Non-treatment-related AE|8|||
163129009|NCT02421588|589179831|FG001|Overall Study|Non-treatment-related AE|8|||
163129010|NCT02421588|589179830|FG000|Overall Study|Progressive disease|152|||
163129011|NCT02421588|589179831|FG001|Overall Study|Progressive disease|135|||
163129012|NCT02421588|589179830|FG000|Overall Study|Death|11|||
163129013|NCT02421588|589179831|FG001|Overall Study|Death|3|||
163129014|NCT02421588|589179830|FG000|Overall Study|Physician Decision|8|||
163343145|NCT00385697|589964326|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
163343146|NCT00385697|589964327|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
163343147|NCT00385697|589964328|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
163129015|NCT02421588|589179831|FG001|Overall Study|Physician Decision|17|||
163129016|NCT02421588|589179830|FG000|Overall Study|Other reason not specified|3|||
163129017|NCT02421588|589179831|FG001|Overall Study|Other reason not specified|1|||
163129018|NCT02421588|589179830|FG000|Overall Study|Symptomatic deterioration|13|||
163129019|NCT02421588|589179831|FG001|Overall Study|Symptomatic deterioration|19|||
163129020|NCT02421588|589179830|FG000|Overall Study|Treatment-related AE|10|||
163129021|NCT02421588|589179831|FG001|Overall Study|Treatment-related AE|14|||
163129022|NCT02421588|589179830|FG000|Overall Study|Withdrawal by Subject|14|||
163129023|NCT02421588|589179831|FG001|Overall Study|Withdrawal by Subject|16|||
163129024|NCT02421588|589179830|FG000|Overall Study|Not treated|2|||
163129025|NCT02421588|589179831|FG001|Overall Study|Not treated|8|||
163129026|NCT04254913|589179834|FG000|Overall Study|Adverse Event|1|||
163129027|NCT01004952|589179835|FG000|Overall Study|Lost to Follow-up|0|||
163129028|NCT01004952|589179836|FG001|Overall Study|Lost to Follow-up|11|||
163343148|NCT00385697|589964324|FG000|Double-blind Segment 2|Other|0|||
163343149|NCT00385697|589964325|FG001|Double-blind Segment 2|Other|2|||
163343150|NCT00385697|589964326|FG002|Double-blind Segment 2|Other|0|||
163129029|NCT01004952|589179835|FG000|Overall Study|Withdrawal by Subject|0|||
163129030|NCT01004952|589179836|FG001|Overall Study|Withdrawal by Subject|5|||
163129031|NCT01359943|589179837|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
163129032|NCT01359943|589179838|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
163129033|NCT01359943|589179839|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
163129034|NCT01359943|589179837|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
163129035|NCT01359943|589179838|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
163129036|NCT01359943|589179839|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
163343151|NCT00385697|589964327|FG003|Double-blind Segment 2|Other|0|||
163343152|NCT00385697|589964328|FG004|Double-blind Segment 2|Other|0|||
163343153|NCT00510783|589964331|FG000|Overall Study|Lost to Follow-up|29|||
163129037|NCT01359943|589179837|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
163129038|NCT01359943|589179838|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
163129039|NCT01359943|589179839|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
163129040|NCT01359943|589179837|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
163129041|NCT01359943|589179838|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
163129042|NCT01359943|589179839|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
163129043|NCT01359943|589179837|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
163129044|NCT01359943|589179838|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
163129045|NCT01359943|589179839|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
163129046|NCT01359943|589179837|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
163129047|NCT01359943|589179838|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
163129048|NCT01359943|589179839|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
163129049|NCT01359943|589179837|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
163129050|NCT01359943|589179838|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
163129051|NCT01359943|589179839|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
163129052|NCT01359943|589179837|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
163343154|NCT00510783|589964332|FG001|Overall Study|Lost to Follow-up|25|||
163343155|NCT00510783|589964331|FG000|Overall Study|Withdrawal by Subject|2|||
163343156|NCT00510783|589964332|FG001|Overall Study|Withdrawal by Subject|3|||
163343157|NCT00510783|589964331|FG000|Overall Study|Protocol Violation|0|||
163343158|NCT00510783|589964332|FG001|Overall Study|Protocol Violation|1|||
163343159|NCT00316121|589964333|FG000|Overall Study|Death|1|||
163343160|NCT00316121|589964334|FG001|Overall Study|Death|0|||
163343161|NCT00316121|589964333|FG000|Overall Study|Lost to Follow-up|14|||
163343162|NCT00316121|589964334|FG001|Overall Study|Lost to Follow-up|8|||
163343163|NCT00316121|589964333|FG000|Overall Study|Withdrawal by Subject|2|||
163343164|NCT00316121|589964334|FG001|Overall Study|Withdrawal by Subject|0|||
163343165|NCT00316121|589964333|FG000|Overall Study|Reason is missing|1|||
163343166|NCT00316121|589964334|FG001|Overall Study|Reason is missing|0|||
163343167|NCT00316121|589964333|FG000|Overall Study|Subject relocated|1|||
163343168|NCT00316121|589964334|FG001|Overall Study|Subject relocated|1|||
163343169|NCT00316121|589964333|FG000|Overall Study|Subject refused to return|1|||
163343170|NCT00316121|589964334|FG001|Overall Study|Subject refused to return|0|||
163343171|NCT00316121|589964333|FG000|Overall Study|Subject no show for visit x 3|1|||
163343172|NCT00316121|589964334|FG001|Overall Study|Subject no show for visit x 3|0|||
163343173|NCT00316121|589964333|FG000|Overall Study|Subject did not have 24 month visit|1|||
163343174|NCT00316121|589964334|FG001|Overall Study|Subject did not have 24 month visit|0|||
163343175|NCT00460577|589964342|FG000|Overall Study|Protocol Violation|2|||
163343176|NCT00460577|589964343|FG001|Overall Study|Protocol Violation|6|||
163343177|NCT01721109|589964349|FG000|Overall Study|Lack of Efficacy|1|||
163343178|NCT01721109|589964349|FG000|Overall Study|Non- Compliance with Study Drug|3|||
163343179|NCT01721109|589964349|FG000|Overall Study|Withdrew Consent|1|||
163343180|NCT01721109|589964349|FG000|Overall Study|Lost to Follow-up|2|||
163343181|NCT00134056|589964350|FG000|Randomization|Not eligible for assigned treatment|22|||
163343182|NCT00134056|589964351|FG001|Randomization|Not eligible for assigned treatment|20|||
163343183|NCT00134056|589964350|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
163343184|NCT00134056|589964351|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
163343185|NCT00134056|589964350|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
163343186|NCT00134056|589964351|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
163343187|NCT00134056|589964350|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
163343188|NCT00134056|589964351|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
163343189|NCT00134056|589964350|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
163343190|NCT00134056|589964351|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
163343191|NCT00742560|589964353|FG000|Overall Study|Adverse Event|0|||
163343192|NCT00742560|589964354|FG001|Overall Study|Adverse Event|0|||
163343193|NCT00742560|589964355|FG002|Overall Study|Adverse Event|1|||
163343194|NCT00742560|589964356|FG003|Overall Study|Adverse Event|1|||
163343195|NCT00742560|589964357|FG004|Overall Study|Adverse Event|1|||
163343196|NCT00742560|589964353|FG000|Overall Study|Death|0|||
163343197|NCT00742560|589964354|FG001|Overall Study|Death|2|||
163343198|NCT00742560|589964355|FG002|Overall Study|Death|0|||
163343199|NCT00742560|589964356|FG003|Overall Study|Death|2|||
163408330|NCT02124564|590204116|FG000|Treatment Period|Adverse Event|2|||
163343200|NCT00742560|589964357|FG004|Overall Study|Death|3|||
163343201|NCT00742560|589964353|FG000|Overall Study|Subject's Decision|1|||
163343202|NCT00742560|589964354|FG001|Overall Study|Subject's Decision|0|||
163343203|NCT00742560|589964355|FG002|Overall Study|Subject's Decision|2|||
163343204|NCT00742560|589964356|FG003|Overall Study|Subject's Decision|3|||
163343205|NCT00742560|589964357|FG004|Overall Study|Subject's Decision|3|||
163343206|NCT00742560|589964353|FG000|Overall Study|Investigator's Decision|0|||
163343207|NCT00742560|589964354|FG001|Overall Study|Investigator's Decision|0|||
163343208|NCT00742560|589964355|FG002|Overall Study|Investigator's Decision|4|||
163343209|NCT00742560|589964356|FG003|Overall Study|Investigator's Decision|1|||
163343210|NCT00742560|589964357|FG004|Overall Study|Investigator's Decision|0|||
163343211|NCT00742560|589964353|FG000|Overall Study|Disease Progression|1|||
163343212|NCT00742560|589964354|FG001|Overall Study|Disease Progression|0|||
163343213|NCT00742560|589964355|FG002|Overall Study|Disease Progression|5|||
163343214|NCT00742560|589964356|FG003|Overall Study|Disease Progression|17|||
163343215|NCT00742560|589964357|FG004|Overall Study|Disease Progression|16|||
163343216|NCT00742560|589964353|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
163129053|NCT01359943|589179838|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
163129054|NCT01359943|589179839|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
163129055|NCT01359943|589179837|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
163129056|NCT01359943|589179838|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
163129057|NCT01359943|589179839|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
163129058|NCT01359943|589179837|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
163129059|NCT01359943|589179838|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
163129060|NCT01359943|589179839|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
163129061|NCT01359943|589179837|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
163129062|NCT01359943|589179838|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
163129063|NCT01359943|589179839|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
163129064|NCT01359943|589179837|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
163129065|NCT01359943|589179838|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
163129066|NCT01359943|589179839|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
163129067|NCT01359943|589179837|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
163129068|NCT01359943|589179838|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
163129069|NCT01359943|589179839|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
163129070|NCT01359943|589179837|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
163129071|NCT01359943|589179838|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
163129072|NCT01359943|589179839|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
163129073|NCT01359943|589179837|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
163129074|NCT01359943|589179838|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
163129075|NCT01359943|589179839|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
163129076|NCT01529034|589179840|FG000|Overall Study|Discontinued prior to study treatment|14|||
163129077|NCT01529034|589179840|FG000|Overall Study|Site closure|62|||
163129078|NCT01529034|589179840|FG000|Overall Study|Study termination|29|||
163129079|NCT01529034|589179840|FG000|Overall Study|Withdrawal by Subject|25|||
163129080|NCT01529034|589179840|FG000|Overall Study|No treated SCs within protocol window|13|||
163129081|NCT01529034|589179840|FG000|Overall Study|Noncompliance|8|||
163129082|NCT01529034|589179840|FG000|Overall Study|Caregiver no longer available|7|||
163129083|NCT01529034|589179840|FG000|Overall Study|Adverse Event|4|||
163129084|NCT01529034|589179840|FG000|Overall Study|Protocol Violation|4|||
163129085|NCT01529034|589179840|FG000|Overall Study|Lack of Efficacy|4|||
163129086|NCT01529034|589179840|FG000|Overall Study|Investigator no longer available|2|||
163129087|NCT01529034|589179840|FG000|Overall Study|Study drug not available|2|||
163129088|NCT02911142|589179843|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
163129089|NCT02911142|589179843|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
163129090|NCT02911142|589179843|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
163129091|NCT02911142|589179843|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
163129092|NCT03436693|589179844|FG000|Overall Study|Adverse Event|22|||
163129093|NCT03436693|589179845|FG001|Overall Study|Adverse Event|10|||
163129094|NCT03436693|589179844|FG000|Overall Study|Physician Decision|3|||
163129095|NCT03436693|589179845|FG001|Overall Study|Physician Decision|3|||
163129096|NCT03436693|589179844|FG000|Overall Study|Withdrawal by Subject|4|||
163129097|NCT03436693|589179845|FG001|Overall Study|Withdrawal by Subject|13|||
163129098|NCT03436693|589179844|FG000|Overall Study|Progressive Disease|1|||
163129099|NCT03436693|589179845|FG001|Overall Study|Progressive Disease|1|||
163129100|NCT04481789|589179846|FG000|Period 1|Withdrawal by Subject|1|||
163129101|NCT04481789|589179847|FG001|Period 1|Withdrawal by Subject|0|||
163129102|NCT04481789|589179848|FG002|Period 1|Withdrawal by Subject|0|||
163129103|NCT04481789|589179849|FG003|Period 1|Withdrawal by Subject|0|||
163129104|NCT04481789|589179850|FG004|Period 1|Withdrawal by Subject|0|||
163129105|NCT04481789|589179851|FG005|Period 1|Withdrawal by Subject|0|||
163129106|NCT05216224|589179852|FG000|Overall Study|Adverse Event|6|||
163129107|NCT05216224|589179853|FG001|Overall Study|Adverse Event|3|||
163129108|NCT05216224|589179852|FG000|Overall Study|Lack of Efficacy|1|||
163129109|NCT05216224|589179853|FG001|Overall Study|Lack of Efficacy|0|||
163343217|NCT00742560|589964354|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
163343218|NCT00742560|589964355|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
163343219|NCT00742560|589964356|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
163129110|NCT05216224|589179852|FG000|Overall Study|Lost to Follow-up|8|||
163129111|NCT05216224|589179853|FG001|Overall Study|Lost to Follow-up|6|||
163129112|NCT05216224|589179852|FG000|Overall Study|Protocol Violation|1|||
163129113|NCT05216224|589179853|FG001|Overall Study|Protocol Violation|1|||
163129114|NCT05216224|589179852|FG000|Overall Study|Withdrawal by Subject|6|||
163343220|NCT00742560|589964357|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
163343221|NCT00742560|589964353|FG000|Overall Study|Other|0|||
163343222|NCT00742560|589964354|FG001|Overall Study|Other|1|||
163343223|NCT00742560|589964355|FG002|Overall Study|Other|8|||
163343224|NCT00742560|589964356|FG003|Overall Study|Other|9|||
163343225|NCT00742560|589964357|FG004|Overall Study|Other|9|||
163343226|NCT00742560|589964353|FG000|Overall Study|MIssing|0|||
163343227|NCT00742560|589964354|FG001|Overall Study|MIssing|0|||
163343228|NCT00742560|589964355|FG002|Overall Study|MIssing|0|||
163343229|NCT00742560|589964356|FG003|Overall Study|MIssing|0|||
163343230|NCT00742560|589964357|FG004|Overall Study|MIssing|1|||
163343231|NCT01536795|589964359|FG000|Overall Study|Lost to Follow-up|0|||
163343232|NCT01536795|589964360|FG001|Overall Study|Lost to Follow-up|2|||
163343233|NCT01536795|589964359|FG000|Overall Study|Lack of Efficacy|1|||
163343234|NCT01536795|589964360|FG001|Overall Study|Lack of Efficacy|0|||
163343235|NCT02267746|589964361|FG000|Overall Study|Adverse Event|0|||
163343236|NCT02267746|589964362|FG001|Overall Study|Adverse Event|2|||
163343237|NCT02267746|589964363|FG002|Overall Study|Adverse Event|1|||
163343238|NCT02267746|589964361|FG000|Overall Study|Protocol Violation|8|||
163129115|NCT05216224|589179853|FG001|Overall Study|Withdrawal by Subject|5|||
163129116|NCT05216224|589179852|FG000|Overall Study|Other than specified|1|||
163129117|NCT05216224|589179853|FG001|Overall Study|Other than specified|0|||
163129118|NCT03245008|589179854|FG000|Overall Study|Adverse Event|15|||
163129119|NCT03245008|589179855|FG001|Overall Study|Adverse Event|18|||
163129120|NCT03245008|589179856|FG002|Overall Study|Adverse Event|15|||
163129121|NCT03245008|589179857|FG003|Overall Study|Adverse Event|0|||
163129122|NCT03245008|589179858|FG004|Overall Study|Adverse Event|1|||
163129123|NCT03245008|589179854|FG000|Overall Study|Lack of Efficacy|0|||
163129124|NCT03245008|589179855|FG001|Overall Study|Lack of Efficacy|1|||
163129125|NCT03245008|589179856|FG002|Overall Study|Lack of Efficacy|0|||
163129126|NCT03245008|589179857|FG003|Overall Study|Lack of Efficacy|0|||
163129127|NCT03245008|589179858|FG004|Overall Study|Lack of Efficacy|0|||
163129128|NCT03245008|589179854|FG000|Overall Study|Lost to Follow-up|4|||
163129129|NCT03245008|589179855|FG001|Overall Study|Lost to Follow-up|1|||
163129130|NCT03245008|589179856|FG002|Overall Study|Lost to Follow-up|0|||
163129131|NCT03245008|589179857|FG003|Overall Study|Lost to Follow-up|0|||
163129132|NCT03245008|589179858|FG004|Overall Study|Lost to Follow-up|1|||
163129133|NCT03245008|589179854|FG000|Overall Study|Physician Decision|1|||
163129134|NCT03245008|589179855|FG001|Overall Study|Physician Decision|3|||
163129135|NCT03245008|589179856|FG002|Overall Study|Physician Decision|4|||
163129136|NCT03245008|589179857|FG003|Overall Study|Physician Decision|0|||
163129137|NCT03245008|589179858|FG004|Overall Study|Physician Decision|0|||
163129138|NCT03245008|589179854|FG000|Overall Study|Protocol Violation|0|||
163129139|NCT03245008|589179855|FG001|Overall Study|Protocol Violation|1|||
163129140|NCT03245008|589179856|FG002|Overall Study|Protocol Violation|0|||
163129141|NCT03245008|589179857|FG003|Overall Study|Protocol Violation|0|||
163129142|NCT03245008|589179858|FG004|Overall Study|Protocol Violation|0|||
163129143|NCT03245008|589179854|FG000|Overall Study|Withdrawal by Subject|20|||
163129144|NCT03245008|589179855|FG001|Overall Study|Withdrawal by Subject|19|||
163129145|NCT03245008|589179856|FG002|Overall Study|Withdrawal by Subject|11|||
163129146|NCT03245008|589179857|FG003|Overall Study|Withdrawal by Subject|0|||
163129147|NCT03245008|589179858|FG004|Overall Study|Withdrawal by Subject|0|||
163129148|NCT03245008|589179854|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
163129149|NCT03245008|589179855|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
163129150|NCT03245008|589179856|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
163129151|NCT03245008|589179857|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
163129152|NCT03245008|589179858|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
163129153|NCT03245008|589179854|FG000|Overall Study|Failure to meet randomization criteria|0|||
163129154|NCT03245008|589179855|FG001|Overall Study|Failure to meet randomization criteria|1|||
163129155|NCT03245008|589179856|FG002|Overall Study|Failure to meet randomization criteria|0|||
163129156|NCT03245008|589179857|FG003|Overall Study|Failure to meet randomization criteria|1|||
163129157|NCT03245008|589179858|FG004|Overall Study|Failure to meet randomization criteria|0|||
163129158|NCT04655144|589179864|FG000|Overall Study|Consumed THC|1|||
163129159|NCT04655144|589179865|FG001|Overall Study|Consumed THC|0|||
163129160|NCT04655144|589179864|FG000|Overall Study|Unilateral embolization|0|||
163129161|NCT04655144|589179865|FG001|Overall Study|Unilateral embolization|1|||
163343239|NCT02267746|589964362|FG001|Overall Study|Protocol Violation|7|||
163343240|NCT02267746|589964363|FG002|Overall Study|Protocol Violation|3|||
163408331|NCT02124564|590204116|FG000|Treatment Period|Lack of Efficacy|3|||
163129162|NCT04317742|589179866|FG000|Overall Study|Lost to Follow-up|57|||
163129163|NCT04317742|589179867|FG001|Overall Study|Lost to Follow-up|59|||
163129164|NCT04317742|589179866|FG000|Overall Study|Pregnancy|1|||
163129165|NCT04317742|589179867|FG001|Overall Study|Pregnancy|1|||
163129166|NCT04317742|589179866|FG000|Overall Study|Withdrawal by Subject|46|||
163129167|NCT04317742|589179867|FG001|Overall Study|Withdrawal by Subject|24|||
163343241|NCT02267746|589964361|FG000|Overall Study|Lack of Efficacy|11|||
163343242|NCT02267746|589964362|FG001|Overall Study|Lack of Efficacy|11|||
163343243|NCT02267746|589964363|FG002|Overall Study|Lack of Efficacy|15|||
163343244|NCT02267746|589964361|FG000|Overall Study|Protocol Violation|1|||
163343245|NCT02267746|589964362|FG001|Overall Study|Protocol Violation|2|||
163343246|NCT02267746|589964363|FG002|Overall Study|Protocol Violation|1|||
163129168|NCT01580670|589179868|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
163129169|NCT01580670|589179868|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
163129170|NCT02678923|589179869|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
163129171|NCT02678923|589179870|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
163129172|NCT02678923|589179869|FG000|Overall Study|Withdrawal by Subject|3|||
163129173|NCT02678923|589179870|FG001|Overall Study|Withdrawal by Subject|2|||
163129174|NCT02678923|589179869|FG000|Overall Study|Lost to Follow-up|1|||
163129175|NCT02678923|589179870|FG001|Overall Study|Lost to Follow-up|0|||
163129176|NCT02678923|589179869|FG000|Overall Study|Did Not Return for Study Visits|1|||
163129177|NCT02678923|589179870|FG001|Overall Study|Did Not Return for Study Visits|0|||
163129178|NCT03266172|589179871|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
163129179|NCT03266172|589179872|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
163129180|NCT03266172|589179873|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
163129181|NCT03266172|589179871|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
163129182|NCT03266172|589179872|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
163129183|NCT03266172|589179873|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
163129184|NCT03266172|589179871|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
163129185|NCT03266172|589179872|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
163129186|NCT03266172|589179873|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
163129187|NCT03266172|589179871|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
163129188|NCT03266172|589179872|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
163129189|NCT03266172|589179873|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
163129190|NCT03266172|589179871|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
163129191|NCT03266172|589179872|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
163129192|NCT03266172|589179873|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
163129193|NCT03266172|589179871|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
163129194|NCT03266172|589179872|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
163129195|NCT03266172|589179873|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
163129196|NCT01554514|589179874|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
163129197|NCT01554514|589179874|FG000|Overall Study|Physician Decision|1|||
163129198|NCT01422824|589179875|FG000|Overall Study|Case record form not evaluated|1|||
163129199|NCT01422824|589179875|FG000|Overall Study|Lost to Follow-up|37|||
163129200|NCT00470418|589179876|FG000|Overall Study|Withdrawal by Subject|1|||
163129201|NCT00470418|589179877|FG001|Overall Study|Withdrawal by Subject|0|||
163129202|NCT02879578|589179880|FG000|Overall Study|Adverse Event|1|||
163129203|NCT02879578|589179881|FG001|Overall Study|Adverse Event|2|||
163129204|NCT02879578|589179882|FG002|Overall Study|Adverse Event|14|||
163129205|NCT02879578|589179880|FG000|Overall Study|Protocol Violation|0|||
163129206|NCT02879578|589179881|FG001|Overall Study|Protocol Violation|1|||
163129207|NCT02879578|589179882|FG002|Overall Study|Protocol Violation|1|||
163129208|NCT02879578|589179880|FG000|Overall Study|Withdrawal by Subject|8|||
163129209|NCT02879578|589179881|FG001|Overall Study|Withdrawal by Subject|6|||
163129210|NCT02879578|589179882|FG002|Overall Study|Withdrawal by Subject|9|||
163129211|NCT02879578|589179880|FG000|Overall Study|Lost to Follow-up|1|||
163129212|NCT02879578|589179881|FG001|Overall Study|Lost to Follow-up|0|||
163129213|NCT02879578|589179882|FG002|Overall Study|Lost to Follow-up|4|||
163129214|NCT02879578|589179880|FG000|Overall Study|Physician Decision|0|||
163129215|NCT02879578|589179881|FG001|Overall Study|Physician Decision|0|||
163129216|NCT02879578|589179882|FG002|Overall Study|Physician Decision|4|||
163129217|NCT01879072|589179884|FG000|Overall Study|Withdrawal by Subject|121|||
163129218|NCT01879072|589179884|FG000|Overall Study|Not Transplanted|30|||
163129219|NCT02666105|589179891|FG000|Overall Study|Death|1|||
163129220|NCT00411632|589179892|FG000|Overall Study|Death|1|||
163129221|NCT01264419|589179893|FG000|Overall Study|Lost to Follow-up|3|||
163129222|NCT00659230|589179894|FG000|Overall Study|Lost to Follow-up|2|||
163129223|NCT00659230|589179895|FG001|Overall Study|Lost to Follow-up|5|||
163129224|NCT00659230|589179894|FG000|Overall Study|Lost source documentation|5|||
163129225|NCT00659230|589179895|FG001|Overall Study|Lost source documentation|4|||
163129226|NCT00659230|589179894|FG000|Overall Study|Did not return post-randomization|2|||
163343247|NCT02267746|589964361|FG000|Overall Study|Miscellaneous|1|||
163343248|NCT02267746|589964362|FG001|Overall Study|Miscellaneous|0|||
163343249|NCT02267746|589964363|FG002|Overall Study|Miscellaneous|1|||
163129227|NCT00659230|589179895|FG001|Overall Study|Did not return post-randomization|3|||
163129228|NCT05138419|589180856|FG000|Overall Study|Study terminated before participant completed.|0|||
163129229|NCT05138419|589180857|FG001|Overall Study|Study terminated before participant completed.|0|||
163343250|NCT05008224|589964364|FG000|Overall Study|Death|3|||
163129230|NCT05138419|589180858|FG002|Overall Study|Study terminated before participant completed.|1|||
163129231|NCT01048853|589180859|FG000|Overall Study|Death|1|||
163129232|NCT01048853|589180860|FG001|Overall Study|Death|0|||
163129233|NCT01048853|589180861|FG002|Overall Study|Death|0|||
163129234|NCT01048853|589180859|FG000|Overall Study|Lost to Follow-up|1|||
163129235|NCT01048853|589180860|FG001|Overall Study|Lost to Follow-up|4|||
163129236|NCT01048853|589180861|FG002|Overall Study|Lost to Follow-up|0|||
163343251|NCT05008224|589964364|FG000|Overall Study|Lost to Follow-up|2|||
163343252|NCT05008224|589964364|FG000|Overall Study|Did Not Continue on Extension Study|39|||
163343253|NCT05008224|589964364|FG000|Overall Study|Transferred to Extension Study|100|||
163129237|NCT01532570|589180866|FG000|Overall Study|Lack of Efficacy|1|||
163129238|NCT01532570|589180867|FG001|Overall Study|Lack of Efficacy|0|||
163129239|NCT01532570|589180868|FG002|Overall Study|Lack of Efficacy|0|||
163129240|NCT01532570|589180869|FG003|Overall Study|Lack of Efficacy|0|||
163129241|NCT01532570|589180866|FG000|Overall Study|Withdrawal by Subject|0|||
163129242|NCT01532570|589180867|FG001|Overall Study|Withdrawal by Subject|1|||
163129243|NCT01532570|589180868|FG002|Overall Study|Withdrawal by Subject|0|||
163129244|NCT01532570|589180869|FG003|Overall Study|Withdrawal by Subject|0|||
163129245|NCT00805766|589180870|FG000|Screening Period|Adverse Event|1|||
163129246|NCT00805766|589180870|FG000|Screening Period|Lack of Efficacy|2|||
163129247|NCT00805766|589180870|FG000|Screening Period|Pregnancy|1|||
163129248|NCT00805766|589180870|FG000|Screening Period|Responder|2|||
163129249|NCT00805766|589180870|FG000|Increased Dose Period|Adverse Event|4|||
163129250|NCT00805766|589180870|FG000|Increased Dose Period|Lack of Efficacy|7|||
163129251|NCT00805766|589180870|FG000|Increased Dose Period|Pregnancy|1|||
163129252|NCT00805766|589180870|FG000|Increased Dose Period|Withdrawal by Subject|1|||
163129253|NCT02354222|589180871|FG000|Overall Study|Adverse Event|0|||
163129254|NCT02354222|589180872|FG001|Overall Study|Adverse Event|3|||
163129255|NCT02354222|589180871|FG000|Overall Study|Physician Decision|1|||
163129256|NCT02354222|589180872|FG001|Overall Study|Physician Decision|1|||
163129257|NCT02354222|589180871|FG000|Overall Study|Pregnancy|1|||
163129258|NCT02354222|589180872|FG001|Overall Study|Pregnancy|0|||
163129259|NCT02354222|589180871|FG000|Overall Study|Withdrawal by Subject|2|||
163129260|NCT02354222|589180872|FG001|Overall Study|Withdrawal by Subject|3|||
163129261|NCT02354222|589180871|FG000|Overall Study|Conflict with the stopping criteria|0|||
163129262|NCT02354222|589180872|FG001|Overall Study|Conflict with the stopping criteria|4|||
163129263|NCT04300218|589180873|FG000|Overall Study|Lost to Follow-up|6|||
163129264|NCT04300218|589180874|FG001|Overall Study|Lost to Follow-up|8|||
163129265|NCT05451940|589180875|FG000|Treatment Period|Physician Decision|1|||
163129266|NCT03645863|589180876|FG000|Overall Study|Withdrawal by Subject|1|||
163129267|NCT03645863|589180877|FG001|Overall Study|Withdrawal by Subject|0|||
163129268|NCT03645863|589180878|FG002|Overall Study|Withdrawal by Subject|0|||
163129269|NCT02220907|589180879|FG000|Overall Study|Adverse Event|7|||
163129270|NCT02220907|589180879|FG000|Overall Study|Physician Decision|1|||
163129271|NCT02220907|589180879|FG000|Overall Study|Withdrawal by Subject|2|||
163129272|NCT02220907|589180879|FG000|Overall Study|Conflict with the stopping criteria|1|||
163129273|NCT00542815|589180880|FG000|Overall Study|Adverse Event|19|||
163129274|NCT00542815|589180881|FG001|Overall Study|Adverse Event|6|||
163129275|NCT00542815|589180882|FG002|Overall Study|Adverse Event|9|||
163129276|NCT00542815|589180880|FG000|Overall Study|Death|10|||
163129277|NCT00542815|589180881|FG001|Overall Study|Death|7|||
163129278|NCT00542815|589180882|FG002|Overall Study|Death|3|||
163129279|NCT00542815|589180880|FG000|Overall Study|Lack of Efficacy|9|||
163129280|NCT00542815|589180881|FG001|Overall Study|Lack of Efficacy|2|||
163129281|NCT00542815|589180882|FG002|Overall Study|Lack of Efficacy|0|||
163129282|NCT00542815|589180880|FG000|Overall Study|Physician Decision|2|||
163129283|NCT00542815|589180881|FG001|Overall Study|Physician Decision|1|||
163129284|NCT00542815|589180882|FG002|Overall Study|Physician Decision|0|||
163129285|NCT00542815|589180880|FG000|Overall Study|Protocol Violation|1|||
163129286|NCT00542815|589180881|FG001|Overall Study|Protocol Violation|1|||
163129287|NCT00542815|589180882|FG002|Overall Study|Protocol Violation|2|||
163129288|NCT00542815|589180880|FG000|Overall Study|Withdrawal by Subject|41|||
163129289|NCT00542815|589180881|FG001|Overall Study|Withdrawal by Subject|5|||
163129290|NCT00542815|589180882|FG002|Overall Study|Withdrawal by Subject|8|||
163129291|NCT00542815|589180880|FG000|Overall Study|Other reasons|24|||
163129292|NCT00542815|589180881|FG001|Overall Study|Other reasons|10|||
163129293|NCT00542815|589180882|FG002|Overall Study|Other reasons|10|||
163129294|NCT01966445|589180891|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
163129295|NCT01966445|589180892|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
163129296|NCT01966445|589180893|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
163129297|NCT01966445|589180894|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
163129298|NCT01966445|589180895|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
163129299|NCT01966445|589180896|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
163129300|NCT01966445|589180897|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
163129301|NCT01966445|589180891|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
163129302|NCT01966445|589180892|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
163129303|NCT01966445|589180893|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
163129304|NCT01966445|589180894|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
163129305|NCT01966445|589180895|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
163129306|NCT01966445|589180896|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
163129307|NCT01966445|589180897|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
163129308|NCT01966445|589180891|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
163343254|NCT05008224|589964364|FG000|Overall Study|Withdrawal by Subject|2|||
163343255|NCT00348283|589964365|FG000|Induction|Adverse Event|0|||
163129309|NCT01966445|589180892|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
163129310|NCT01966445|589180893|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
163129311|NCT01966445|589180894|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
163129312|NCT01966445|589180895|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
163129313|NCT01966445|589180896|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
163129314|NCT01966445|589180897|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
163129315|NCT01966445|589180891|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
163129316|NCT01966445|589180892|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
163129317|NCT01966445|589180893|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
163129318|NCT01966445|589180894|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
163129319|NCT01966445|589180895|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
163129320|NCT01966445|589180896|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
163129321|NCT01966445|589180897|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
163129322|NCT01966445|589180891|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
163129323|NCT01966445|589180892|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
163129324|NCT01966445|589180893|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
163129325|NCT01966445|589180894|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
163129326|NCT01966445|589180895|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
163129327|NCT01966445|589180896|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
163129328|NCT01966445|589180897|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
163129329|NCT01374178|589180898|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
163129330|NCT01374178|589180899|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
163129331|NCT01374178|589180898|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
163129332|NCT01374178|589180899|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
163129333|NCT01716104|589180900|FG000|Overall Study|Do not meet inclusion criteria|6|||
163129334|NCT01716104|589180901|FG001|Overall Study|Do not meet inclusion criteria|7|||
163129335|NCT00117793|589180902|FG000|Overall Study|Withdrawal by Subject|12|||
163129336|NCT01818492|589180907|FG000|Overall Study|Adverse Event|2|||
163129337|NCT01818492|589180907|FG000|Overall Study|Death|3|||
163129338|NCT01818492|589180907|FG000|Overall Study|Withdrawal by Subject|1|||
163129339|NCT01818492|589180907|FG000|Overall Study|Additional therapy when not allowed PP|4|||
163129340|NCT00885482|589180908|FG000|Overall Study|Pregnancy|1|||
163129341|NCT00885482|589180908|FG000|Overall Study|Lack of Efficacy|1|||
163129342|NCT00885482|589180908|FG000|Overall Study|Death|1|||
163129343|NCT00885482|589180908|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
163129344|NCT02772978|589180909|FG000|Overall Study|Withdrawal by Subject|1|||
163129345|NCT02772978|589180910|FG001|Overall Study|Withdrawal by Subject|1|||
163129346|NCT02438813|589180911|FG000|Overall Study|Patient Decision|59|||
163129347|NCT02438813|589180911|FG000|Overall Study|Patient Lost to Follow-Up|137|||
163129348|NCT02438813|589180911|FG000|Overall Study|Study Ended by Sponsor|80|||
163129349|NCT02438813|589180911|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
163129350|NCT00409344|589180913|FG000|Overall Study|no enrollment|0|||
163129351|NCT00409344|589180914|FG001|Overall Study|no enrollment|0|||
163129352|NCT01069705|589180922|FG000|Overall Study|Adverse Event|1|||
163129353|NCT01069705|589180922|FG000|Overall Study|Withdrawal by Subject|2|||
163129354|NCT03624127|589180923|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
163129355|NCT03624127|589180924|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
163129356|NCT03624127|589180925|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
163129357|NCT03624127|589180923|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
163129358|NCT03624127|589180924|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
163129359|NCT03624127|589180925|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
163129360|NCT03624127|589180923|FG000|Treatment Week 0 - Week 16|Death|0|||
163129361|NCT03624127|589180924|FG001|Treatment Week 0 - Week 16|Death|1|||
163129362|NCT03624127|589180925|FG002|Treatment Week 0 - Week 16|Death|0|||
163129363|NCT03624127|589180923|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
163129364|NCT03624127|589180924|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
163129365|NCT03624127|589180925|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
163129366|NCT03624127|589180923|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
163129367|NCT03624127|589180924|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
163129368|NCT03624127|589180925|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
163129369|NCT03624127|589180923|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
163129370|NCT03624127|589180924|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
163129371|NCT03624127|589180925|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
163129372|NCT03624127|589180923|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
163129373|NCT03624127|589180924|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
163129374|NCT03624127|589180925|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
163129375|NCT03624127|589180923|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
163129376|NCT03624127|589180924|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
163129377|NCT03624127|589180925|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
163129378|NCT03624127|589180923|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
163129379|NCT03624127|589180924|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
163129380|NCT03624127|589180925|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
163129381|NCT03624127|589180923|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
163129382|NCT03624127|589180924|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
163343256|NCT00348283|589964366|FG001|Induction|Adverse Event|2|||
163343257|NCT00348283|589964365|FG000|Induction|Protocol Violation|0|||
163343258|NCT00348283|589964366|FG001|Induction|Protocol Violation|4|||
163343259|NCT00348283|589964365|FG000|Double Blind|Adverse Event|2|||
163343260|NCT00348283|589964366|FG001|Double Blind|Adverse Event|5|||
163343261|NCT00348283|589964365|FG000|Double Blind|Withdrawal by Subject|1|||
163343262|NCT00348283|589964366|FG001|Double Blind|Withdrawal by Subject|1|||
163343263|NCT00348283|589964365|FG000|Double Blind|Protocol Violation|0|||
163343264|NCT00348283|589964366|FG001|Double Blind|Protocol Violation|1|||
163343265|NCT00348283|589964365|FG000|Double Blind|Lack of Efficacy|2|||
163343266|NCT00348283|589964366|FG001|Double Blind|Lack of Efficacy|2|||
163343267|NCT00348283|589964365|FG000|Double Blind|Pregnancy|0|||
163343268|NCT00348283|589964366|FG001|Double Blind|Pregnancy|1|||
163343269|NCT00348283|589964365|FG000|Open Label|Adverse Event|0|||
163343270|NCT00348283|589964366|FG001|Open Label|Adverse Event|8|||
163343271|NCT00348283|589964365|FG000|Open Label|Withdrawal by Subject|0|||
163343272|NCT00348283|589964366|FG001|Open Label|Withdrawal by Subject|4|||
163343273|NCT00348283|589964365|FG000|Open Label|Lost to Follow-up|0|||
163343274|NCT00348283|589964366|FG001|Open Label|Lost to Follow-up|1|||
163343275|NCT00348283|589964365|FG000|Open Label|Lack of Efficacy|0|||
163343276|NCT00348283|589964366|FG001|Open Label|Lack of Efficacy|13|||
163343277|NCT00348283|589964365|FG000|Open Label|Administrative reasons|0|||
163343278|NCT00348283|589964366|FG001|Open Label|Administrative reasons|5|||
163343279|NCT00348283|589964365|FG000|Open Label|Subject moved to the United States|0|||
163343280|NCT00348283|589964366|FG001|Open Label|Subject moved to the United States|1|||
163343281|NCT00348283|589964365|FG000|Open Label|Pregnancy|0|||
163129383|NCT03624127|589180925|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
163129384|NCT03624127|589180923|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
163129385|NCT03624127|589180924|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
163129386|NCT03624127|589180925|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
163129387|NCT03624127|589180923|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
163129388|NCT03624127|589180924|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
163129389|NCT03624127|589180925|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
163129390|NCT03624127|589180923|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
163129391|NCT03624127|589180924|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
163129392|NCT03624127|589180925|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
163129393|NCT03624127|589180923|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
163129394|NCT03624127|589180924|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
163129395|NCT03624127|589180925|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
163129396|NCT03624127|589180923|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
163129397|NCT03624127|589180924|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
163129398|NCT03624127|589180925|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
163129399|NCT03624127|589180923|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
163129400|NCT03624127|589180924|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
163129401|NCT03624127|589180925|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
163129402|NCT03624127|589180923|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
163129403|NCT03624127|589180924|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
163129404|NCT03624127|589180925|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
163129405|NCT03624127|589180923|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
163129406|NCT03624127|589180924|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
163129407|NCT03624127|589180925|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
163129408|NCT03624127|589180923|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
163129409|NCT03624127|589180924|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
163129410|NCT03624127|589180925|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
163129411|NCT03624127|589180923|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
163129412|NCT03624127|589180924|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
163129413|NCT03624127|589180925|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
163129414|NCT03624127|589180923|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
163129415|NCT03624127|589180924|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
163129416|NCT03624127|589180925|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
163129417|NCT00666224|589182256|FG000|Double-Blind|Adverse Event|15|||
163129418|NCT00666224|589182257|FG001|Double-Blind|Adverse Event|5|||
163343282|NCT00348283|589964366|FG001|Open Label|Pregnancy|1|||
163343283|NCT00348283|589964365|FG000|Open Label|Sponsor decision|0|||
163343284|NCT00348283|589964366|FG001|Open Label|Sponsor decision|1|||
163343285|NCT00596960|589964369|FG000|Overall Study|Death|1|||
163343286|NCT00596960|589964370|FG001|Overall Study|Death|2|||
163343287|NCT00596960|589964369|FG000|Overall Study|Lost to Follow-up|6|||
163343288|NCT00596960|589964370|FG001|Overall Study|Lost to Follow-up|5|||
163343289|NCT00596960|589964369|FG000|Overall Study|Withdrawal by Subject|1|||
163343290|NCT00596960|589964370|FG001|Overall Study|Withdrawal by Subject|0|||
163343291|NCT00596960|589964369|FG000|Overall Study|Incarcerated|2|||
163343292|NCT00596960|589964370|FG001|Overall Study|Incarcerated|0|||
163343293|NCT00596960|589964369|FG000|Overall Study|Physician Decision|1|||
163343294|NCT00596960|589964370|FG001|Overall Study|Physician Decision|0|||
163343295|NCT00596960|589964369|FG000|Overall Study|Protocol Violation|0|||
163343296|NCT00596960|589964370|FG001|Overall Study|Protocol Violation|1|||
163343297|NCT00596960|589964369|FG000|Overall Study|No alcohol use data|0|||
163343298|NCT00596960|589964370|FG001|Overall Study|No alcohol use data|1|||
163343299|NCT04016415|589964371|FG000|Overall Study|Adverse Event|2|||
163343300|NCT04016415|589964372|FG001|Overall Study|Adverse Event|1|||
163343301|NCT04016415|589964371|FG000|Overall Study|Lost to Follow-up|6|||
163343302|NCT04016415|589964372|FG001|Overall Study|Lost to Follow-up|2|||
163343303|NCT04016415|589964371|FG000|Overall Study|Physician Decision|5|||
163343304|NCT04016415|589964372|FG001|Overall Study|Physician Decision|1|||
163343305|NCT04016415|589964371|FG000|Overall Study|Pregnancy|0|||
163343306|NCT04016415|589964372|FG001|Overall Study|Pregnancy|1|||
163343307|NCT04016415|589964371|FG000|Overall Study|Withdrawal by Subject|24|||
163343308|NCT04016415|589964372|FG001|Overall Study|Withdrawal by Subject|27|||
163343309|NCT04016415|589964371|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
163343310|NCT04016415|589964372|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
163343311|NCT01885559|589964373|FG000|Overall Study|Lost to Follow-up|15|||
163343312|NCT01885559|589964374|FG001|Overall Study|Lost to Follow-up|16|||
163343313|NCT01885559|589964373|FG000|Overall Study|Less than full participation|9|||
163343314|NCT01885559|589964374|FG001|Overall Study|Less than full participation|19|||
163343315|NCT01885559|589964373|FG000|Overall Study|Protocol Violation|0|||
163343316|NCT01885559|589964374|FG001|Overall Study|Protocol Violation|1|||
163343317|NCT00705614|589966391|FG000|Initial Intervention|Adverse Event|40|||
163343318|NCT00705614|589966392|FG001|Initial Intervention|Adverse Event|21|||
163343319|NCT00705614|589966391|FG000|Initial Intervention|Lost to Follow-up|310|||
163343320|NCT00705614|589966392|FG001|Initial Intervention|Lost to Follow-up|191|||
163343321|NCT00705614|589966391|FG000|Initial Intervention|Withdrawal by Subject|114|||
163343322|NCT00705614|589966392|FG001|Initial Intervention|Withdrawal by Subject|71|||
163343323|NCT00705614|589966391|FG000|Initial Intervention|Administrative Reason|51|||
163343324|NCT00705614|589966392|FG001|Initial Intervention|Administrative Reason|38|||
163343325|NCT00705614|589966391|FG000|Initial Intervention|Status completion unknown|3|||
163343326|NCT00705614|589966392|FG001|Initial Intervention|Status completion unknown|0|||
163343327|NCT00705614|589966391|FG000|Switch to Remicade|Adverse Event|0|||
163343328|NCT00705614|589966392|FG001|Switch to Remicade|Adverse Event|5|||
163343329|NCT00705614|589966391|FG000|Switch to Remicade|Lost to Follow-up|0|||
163343330|NCT00705614|589966392|FG001|Switch to Remicade|Lost to Follow-up|23|||
163343331|NCT00705614|589966391|FG000|Switch to Remicade|Withdrawal by Subject|0|||
163343332|NCT00705614|589966392|FG001|Switch to Remicade|Withdrawal by Subject|12|||
163343333|NCT00705614|589966391|FG000|Switch to Remicade|Administrative Reason|0|||
163343334|NCT00705614|589966392|FG001|Switch to Remicade|Administrative Reason|9|||
163343335|NCT02661490|589966393|FG000|Overall Study|Lost to Follow-up|0|||
163343336|NCT02661490|589966394|FG001|Overall Study|Lost to Follow-up|1|||
163343337|NCT02661490|589966395|FG002|Overall Study|Lost to Follow-up|0|||
163343338|NCT02661490|589966396|FG003|Overall Study|Lost to Follow-up|0|||
163343339|NCT02661490|589966397|FG004|Overall Study|Lost to Follow-up|2|||
163129419|NCT00666224|589182256|FG000|Double-Blind|Lost to Follow-up|2|||
163129420|NCT00666224|589182257|FG001|Double-Blind|Lost to Follow-up|2|||
163129421|NCT00666224|589182256|FG000|Double-Blind|Withdrawal by Subject|18|||
163129422|NCT00666224|589182257|FG001|Double-Blind|Withdrawal by Subject|14|||
163129423|NCT00666224|589182256|FG000|Double-Blind|Physician Decision|0|||
163129424|NCT00666224|589182257|FG001|Double-Blind|Physician Decision|3|||
163129425|NCT00666224|589182256|FG000|Double-Blind|Sponsor decision|1|||
163129426|NCT00666224|589182257|FG001|Double-Blind|Sponsor decision|0|||
163129427|NCT00666224|589182256|FG000|Double-Blind|Pregnancy|3|||
163129428|NCT00666224|589182257|FG001|Double-Blind|Pregnancy|2|||
163129429|NCT00666224|589182256|FG000|Double-Blind|Noncompliance|1|||
163343340|NCT02661490|589966393|FG000|Overall Study|Withdrawal by Subject|2|||
163343341|NCT02661490|589966394|FG001|Overall Study|Withdrawal by Subject|0|||
163343342|NCT02661490|589966395|FG002|Overall Study|Withdrawal by Subject|2|||
163129430|NCT00666224|589182257|FG001|Double-Blind|Noncompliance|0|||
163129431|NCT00666224|589182256|FG000|Double-Blind|Death|1|||
163343343|NCT02661490|589966396|FG003|Overall Study|Withdrawal by Subject|0|||
163343344|NCT02661490|589966397|FG004|Overall Study|Withdrawal by Subject|0|||
163343345|NCT02661490|589966393|FG000|Overall Study|Death|1|||
163343346|NCT02661490|589966394|FG001|Overall Study|Death|1|||
163343347|NCT02661490|589966395|FG002|Overall Study|Death|0|||
163343348|NCT02661490|589966396|FG003|Overall Study|Death|1|||
163343349|NCT02661490|589966397|FG004|Overall Study|Death|0|||
163343350|NCT02661490|589966393|FG000|Overall Study|Reason not Specified|0|||
163343351|NCT02661490|589966394|FG001|Overall Study|Reason not Specified|0|||
163343352|NCT02661490|589966395|FG002|Overall Study|Reason not Specified|0|||
163343353|NCT02661490|589966396|FG003|Overall Study|Reason not Specified|0|||
163343354|NCT02661490|589966397|FG004|Overall Study|Reason not Specified|1|||
163129432|NCT00666224|589182257|FG001|Double-Blind|Death|0|||
163129433|NCT00666224|589182256|FG000|Double-Blind|Undefined/Unknown|4|||
163129434|NCT00666224|589182257|FG001|Double-Blind|Undefined/Unknown|1|||
163129435|NCT00666224|589182256|FG000|Open-Label|Adverse Event|8|||
163129436|NCT00666224|589182257|FG001|Open-Label|Adverse Event|43|||
163129437|NCT00666224|589182256|FG000|Open-Label|Lost to Follow-up|4|||
163129438|NCT00666224|589182257|FG001|Open-Label|Lost to Follow-up|5|||
163129439|NCT00666224|589182256|FG000|Open-Label|Withdrawal by Subject|12|||
163129440|NCT00666224|589182257|FG001|Open-Label|Withdrawal by Subject|25|||
163129441|NCT00666224|589182256|FG000|Open-Label|Physician Decision|7|||
163129442|NCT00666224|589182257|FG001|Open-Label|Physician Decision|5|||
163129443|NCT00666224|589182256|FG000|Open-Label|Pregnancy|1|||
163129444|NCT00666224|589182257|FG001|Open-Label|Pregnancy|5|||
163129445|NCT00666224|589182256|FG000|Open-Label|Noncompliance|2|||
163129446|NCT00666224|589182257|FG001|Open-Label|Noncompliance|1|||
163129447|NCT00666224|589182256|FG000|Open-Label|Undefined/Unknown|1|||
163129448|NCT00666224|589182257|FG001|Open-Label|Undefined/Unknown|1|||
163129449|NCT03521141|589182258|FG000|Overall Study|Death|1|||
163129450|NCT03521141|589182259|FG001|Overall Study|Death|0|||
163129451|NCT03521141|589182260|FG002|Overall Study|Death|1|||
163129452|NCT03828617|589182262|FG000|Overall Study|Lost to Follow-up|22|||
163129453|NCT03828617|589182263|FG001|Overall Study|Lost to Follow-up|12|||
163129454|NCT03828617|589182264|FG002|Overall Study|Lost to Follow-up|23|||
163129455|NCT03828617|589182265|FG003|Overall Study|Lost to Follow-up|7|||
163129456|NCT03828617|589182262|FG000|Overall Study|No longer met eligibility criteria|0|||
163129457|NCT03828617|589182263|FG001|Overall Study|No longer met eligibility criteria|1|||
163129458|NCT03828617|589182264|FG002|Overall Study|No longer met eligibility criteria|1|||
163129459|NCT03828617|589182265|FG003|Overall Study|No longer met eligibility criteria|3|||
163129460|NCT03828617|589182262|FG000|Overall Study|Protocol Violation|0|||
163129461|NCT03828617|589182263|FG001|Overall Study|Protocol Violation|2|||
163129462|NCT03828617|589182264|FG002|Overall Study|Protocol Violation|0|||
163129463|NCT03828617|589182265|FG003|Overall Study|Protocol Violation|0|||
163129464|NCT03828617|589182262|FG000|Overall Study|Withdrawal by Subject|2|||
163129465|NCT03828617|589182263|FG001|Overall Study|Withdrawal by Subject|0|||
163129466|NCT03828617|589182264|FG002|Overall Study|Withdrawal by Subject|2|||
163129467|NCT03828617|589182265|FG003|Overall Study|Withdrawal by Subject|0|||
163129468|NCT03354273|589182266|FG000|Overall Study|Adverse Event|5|||
163129469|NCT03354273|589182266|FG000|Overall Study|Screen Failure|21|||
163129470|NCT03354273|589182266|FG000|Overall Study|Withdrawal by Subject|34|||
163129471|NCT03354273|589182266|FG000|Overall Study|Technical Problems|30|||
163129472|NCT03354273|589182266|FG000|Overall Study|Lost to Follow-up|4|||
163129473|NCT03354273|589182266|FG000|Overall Study|Investigator Decision|3|||
163129474|NCT03354273|589182266|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
163129475|NCT03354273|589182266|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
163129476|NCT03354273|589182266|FG000|Overall Study|COVID-19 Restrictions|9|||
163129477|NCT03354273|589182266|FG000|Overall Study|Other|5|||
163129478|NCT00303485|589182267|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
163129479|NCT00303485|589182268|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
163129480|NCT00303485|589182267|FG000|Overall Study|Failure to return|0|||
163129481|NCT00303485|589182268|FG001|Overall Study|Failure to return|1|||
163129482|NCT00303485|589182267|FG000|Overall Study|Withdrawal by Subject|1|||
163129483|NCT00303485|589182268|FG001|Overall Study|Withdrawal by Subject|0|||
163129484|NCT00971243|589182269|FG000|Double Blind Period|Adverse Event|2|||
163129485|NCT00971243|589182270|FG001|Double Blind Period|Adverse Event|3|||
163129486|NCT00971243|589182271|FG002|Double Blind Period|Adverse Event|2|||
163129487|NCT00971243|589182272|FG003|Double Blind Period|Adverse Event|2|||
163129488|NCT00971243|589182273|FG004|Double Blind Period|Adverse Event|3|||
163129489|NCT00971243|589182269|FG000|Double Blind Period|Lost to Follow-up|0|||
163129490|NCT00971243|589182270|FG001|Double Blind Period|Lost to Follow-up|1|||
163129491|NCT00971243|589182271|FG002|Double Blind Period|Lost to Follow-up|1|||
163343355|NCT01232569|589966398|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
163343356|NCT01232569|589966399|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
163343357|NCT01232569|589966400|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
163343358|NCT01232569|589966401|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
163129492|NCT00971243|589182272|FG003|Double Blind Period|Lost to Follow-up|0|||
163129493|NCT00971243|589182273|FG004|Double Blind Period|Lost to Follow-up|1|||
163129494|NCT00971243|589182269|FG000|Double Blind Period|Physician Decision|10|||
163129495|NCT00971243|589182270|FG001|Double Blind Period|Physician Decision|6|||
163129496|NCT00971243|589182271|FG002|Double Blind Period|Physician Decision|7|||
163129497|NCT00971243|589182272|FG003|Double Blind Period|Physician Decision|6|||
163129498|NCT00971243|589182273|FG004|Double Blind Period|Physician Decision|7|||
163129499|NCT00971243|589182269|FG000|Double Blind Period|Protocol Violation|2|||
163129500|NCT00971243|589182270|FG001|Double Blind Period|Protocol Violation|0|||
163129501|NCT00971243|589182271|FG002|Double Blind Period|Protocol Violation|3|||
163129502|NCT00971243|589182272|FG003|Double Blind Period|Protocol Violation|2|||
163129503|NCT00971243|589182273|FG004|Double Blind Period|Protocol Violation|2|||
163129504|NCT00971243|589182269|FG000|Double Blind Period|Withdrawal by Subject|4|||
163129505|NCT00971243|589182270|FG001|Double Blind Period|Withdrawal by Subject|1|||
163129506|NCT00971243|589182271|FG002|Double Blind Period|Withdrawal by Subject|4|||
163129507|NCT00971243|589182272|FG003|Double Blind Period|Withdrawal by Subject|4|||
163129508|NCT00971243|589182273|FG004|Double Blind Period|Withdrawal by Subject|4|||
163129509|NCT00971243|589182269|FG000|Double Blind Period|Other reasons|1|||
163129510|NCT00971243|589182270|FG001|Double Blind Period|Other reasons|0|||
163129511|NCT00971243|589182271|FG002|Double Blind Period|Other reasons|2|||
163129512|NCT00971243|589182272|FG003|Double Blind Period|Other reasons|0|||
163129513|NCT00971243|589182273|FG004|Double Blind Period|Other reasons|1|||
163129514|NCT00971243|589182269|FG000|Open-label Period|Adverse Event|1|||
163129515|NCT00971243|589182270|FG001|Open-label Period|Adverse Event|0|||
163129516|NCT00971243|589182271|FG002|Open-label Period|Adverse Event|1|||
163129517|NCT00971243|589182272|FG003|Open-label Period|Adverse Event|1|||
163129518|NCT00971243|589182273|FG004|Open-label Period|Adverse Event|0|||
163129519|NCT00971243|589182269|FG000|Open-label Period|Physician Decision|5|||
163129520|NCT00971243|589182270|FG001|Open-label Period|Physician Decision|9|||
163129521|NCT00971243|589182271|FG002|Open-label Period|Physician Decision|3|||
163129522|NCT00971243|589182272|FG003|Open-label Period|Physician Decision|7|||
163129523|NCT00971243|589182273|FG004|Open-label Period|Physician Decision|2|||
163129524|NCT00971243|589182269|FG000|Open-label Period|Protocol Violation|1|||
163129525|NCT00971243|589182270|FG001|Open-label Period|Protocol Violation|1|||
163129526|NCT00971243|589182271|FG002|Open-label Period|Protocol Violation|1|||
163129527|NCT00971243|589182272|FG003|Open-label Period|Protocol Violation|0|||
163343359|NCT01232569|589966398|FG000|Double-blind Treatment Period|Escape|2|||
163343360|NCT01232569|589966399|FG001|Double-blind Treatment Period|Escape|2|||
163129528|NCT00971243|589182273|FG004|Open-label Period|Protocol Violation|1|||
163129529|NCT00971243|589182269|FG000|Open-label Period|Withdrawal by Subject|1|||
163129530|NCT00971243|589182270|FG001|Open-label Period|Withdrawal by Subject|0|||
163129531|NCT00971243|589182271|FG002|Open-label Period|Withdrawal by Subject|0|||
163129532|NCT00971243|589182272|FG003|Open-label Period|Withdrawal by Subject|2|||
163129533|NCT00971243|589182273|FG004|Open-label Period|Withdrawal by Subject|1|||
163129534|NCT00971243|589182269|FG000|Open-label Period|Other reason|0|||
163129535|NCT00971243|589182270|FG001|Open-label Period|Other reason|0|||
163129536|NCT00971243|589182271|FG002|Open-label Period|Other reason|0|||
163129537|NCT00971243|589182272|FG003|Open-label Period|Other reason|0|||
163129538|NCT00971243|589182273|FG004|Open-label Period|Other reason|2|||
163129539|NCT04099511|589182277|FG000|Overall Study|Lost to Follow-up|2|||
163129540|NCT04099511|589182278|FG001|Overall Study|Lost to Follow-up|2|||
163129541|NCT04099511|589182277|FG000|Overall Study|Withdrawal by Subject|8|||
163129542|NCT04099511|589182278|FG001|Overall Study|Withdrawal by Subject|4|||
163129543|NCT06581094|589182281|FG000|Overall Study|Lost to Follow-up|1|||
163129544|NCT06581094|589182282|FG001|Overall Study|Lost to Follow-up|1|||
163129545|NCT05740618|589182283|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|1|||
163129546|NCT05740618|589182283|FG000|Overall Study|Physician Decision|1|||
163129547|NCT04588389|589182284|FG000|Overall Study|Issues with anesthesia during surgery|2|||
163129548|NCT04588389|589182285|FG001|Overall Study|Issues with anesthesia during surgery|0|||
163129549|NCT04588389|589182286|FG002|Overall Study|Issues with anesthesia during surgery|0|||
163129550|NCT02354235|589182290|FG000|Overall Study|Adverse Event|2|||
163129551|NCT02354235|589182291|FG001|Overall Study|Adverse Event|2|||
163129552|NCT02354235|589182290|FG000|Overall Study|Physician Decision|0|||
163129553|NCT02354235|589182291|FG001|Overall Study|Physician Decision|1|||
163129554|NCT02354235|589182290|FG000|Overall Study|Withdrawal by Subject|1|||
163129555|NCT02354235|589182291|FG001|Overall Study|Withdrawal by Subject|3|||
163129556|NCT02354235|589182290|FG000|Overall Study|Conflict with the stopping criteria|0|||
163129557|NCT02354235|589182291|FG001|Overall Study|Conflict with the stopping criteria|1|||
163129558|NCT06045507|589182292|FG000|Overall Study|Death|0|||
163129559|NCT06045507|589182293|FG001|Overall Study|Death|0|||
163129560|NCT06045507|589182294|FG002|Overall Study|Death|1|||
163129561|NCT06045507|589182295|FG003|Overall Study|Death|0|||
163129562|NCT06045507|589182292|FG000|Overall Study|Lost to Follow-up|3|||
163129563|NCT06045507|589182293|FG001|Overall Study|Lost to Follow-up|3|||
163129564|NCT06045507|589182294|FG002|Overall Study|Lost to Follow-up|0|||
163129565|NCT06045507|589182295|FG003|Overall Study|Lost to Follow-up|0|||
163129566|NCT06045507|589182292|FG000|Overall Study|Randomized by mistake (no study treatment given)|0|||
163129567|NCT06045507|589182293|FG001|Overall Study|Randomized by mistake (no study treatment given)|1|||
163129568|NCT06045507|589182294|FG002|Overall Study|Randomized by mistake (no study treatment given)|1|||
163129569|NCT06045507|589182295|FG003|Overall Study|Randomized by mistake (no study treatment given)|0|||
163129570|NCT06045507|589182292|FG000|Overall Study|Withdrawal by Subject|4|||
163129571|NCT06045507|589182293|FG001|Overall Study|Withdrawal by Subject|1|||
163129572|NCT06045507|589182294|FG002|Overall Study|Withdrawal by Subject|0|||
163129573|NCT06045507|589182295|FG003|Overall Study|Withdrawal by Subject|2|||
163129574|NCT06045507|589182292|FG000|Overall Study|Miscellaneous|2|||
163129575|NCT06045507|589182293|FG001|Overall Study|Miscellaneous|0|||
163129576|NCT06045507|589182294|FG002|Overall Study|Miscellaneous|0|||
163129577|NCT06045507|589182295|FG003|Overall Study|Miscellaneous|1|||
163343361|NCT01232569|589966400|FG002|Double-blind Treatment Period|Escape|0|||
163343362|NCT01232569|589966401|FG003|Double-blind Treatment Period|Escape|0|||
163343363|NCT01232569|589966398|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
163343364|NCT01232569|589966399|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
163343365|NCT01232569|589966400|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
163343366|NCT01232569|589966401|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
163343367|NCT01232569|589966398|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
163343368|NCT01232569|589966399|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
163343369|NCT01232569|589966400|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
163343370|NCT01232569|589966401|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
163343371|NCT01232569|589966398|FG000|Double-blind Treatment Period|Physician Decision|1|||
163343372|NCT01232569|589966399|FG001|Double-blind Treatment Period|Physician Decision|0|||
163343373|NCT01232569|589966400|FG002|Double-blind Treatment Period|Physician Decision|0|||
163343374|NCT01232569|589966401|FG003|Double-blind Treatment Period|Physician Decision|0|||
163343375|NCT01232569|589966398|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
163343376|NCT01232569|589966399|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
163343377|NCT01232569|589966400|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
163343378|NCT01232569|589966401|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
163343379|NCT01232569|589966398|FG000|Double-blind Treatment Period|Death|2|||
163343380|NCT01232569|589966399|FG001|Double-blind Treatment Period|Death|0|||
163129578|NCT03688100|589182297|FG000|Overall Study|Lost to Follow-up|21|||
163129579|NCT03688100|589182298|FG001|Overall Study|Lost to Follow-up|15|||
163129580|NCT03688100|589182299|FG002|Overall Study|Lost to Follow-up|15|||
163129581|NCT03688100|589182300|FG003|Overall Study|Lost to Follow-up|18|||
163129582|NCT03688100|589182297|FG000|Overall Study|Withdrawal by Subject|19|||
163129583|NCT03688100|589182298|FG001|Overall Study|Withdrawal by Subject|16|||
163129584|NCT03688100|589182299|FG002|Overall Study|Withdrawal by Subject|0|||
163129585|NCT03688100|589182300|FG003|Overall Study|Withdrawal by Subject|0|||
163129586|NCT03688100|589182297|FG000|Overall Study|Death|36|||
163129587|NCT03688100|589182298|FG001|Overall Study|Death|27|||
163129588|NCT03688100|589182299|FG002|Overall Study|Death|0|||
163129589|NCT03688100|589182300|FG003|Overall Study|Death|0|||
163129590|NCT02479139|589182306|FG000|Overall Study|Lost to Follow-up|2|||
163129591|NCT02479139|589182307|FG001|Overall Study|Lost to Follow-up|4|||
163129592|NCT02479139|589182308|FG002|Overall Study|Lost to Follow-up|4|||
163129593|NCT02479139|589182309|FG003|Overall Study|Lost to Follow-up|2|||
163129594|NCT02479139|589182310|FG004|Overall Study|Lost to Follow-up|3|||
163129595|NCT02479139|589182311|FG005|Overall Study|Lost to Follow-up|5|||
163129596|NCT02479139|589182306|FG000|Overall Study|Withdrew Consent|5|||
163129597|NCT02479139|589182307|FG001|Overall Study|Withdrew Consent|6|||
163129598|NCT02479139|589182308|FG002|Overall Study|Withdrew Consent|1|||
163129599|NCT02479139|589182309|FG003|Overall Study|Withdrew Consent|4|||
163129600|NCT02479139|589182310|FG004|Overall Study|Withdrew Consent|1|||
163129601|NCT02479139|589182311|FG005|Overall Study|Withdrew Consent|1|||
163129602|NCT02479139|589182306|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
163129603|NCT02479139|589182307|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
163129604|NCT02479139|589182308|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
163129605|NCT02479139|589182309|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
163129606|NCT02479139|589182310|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
163129607|NCT02479139|589182311|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
163129608|NCT02479139|589182306|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163129609|NCT02479139|589182307|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163129610|NCT02479139|589182308|FG002|Overall Study|Other Miscellaneous Reasons|1|||
163129611|NCT02479139|589182309|FG003|Overall Study|Other Miscellaneous Reasons|1|||
163129612|NCT02479139|589182310|FG004|Overall Study|Other Miscellaneous Reasons|1|||
163129613|NCT02479139|589182311|FG005|Overall Study|Other Miscellaneous Reasons|0|||
163129614|NCT00084656|589182312|FG000|Overall Study|Other reasons|0|||
163129615|NCT00084656|589182313|FG001|Overall Study|Other reasons|12|||
163129616|NCT00084656|589182314|FG002|Overall Study|Other reasons|11|||
163129617|NCT00084656|589182312|FG000|Overall Study|Withdrawal by Subject|15|||
163129618|NCT00084656|589182313|FG001|Overall Study|Withdrawal by Subject|4|||
163129619|NCT00084656|589182314|FG002|Overall Study|Withdrawal by Subject|4|||
163129620|NCT00084656|589182312|FG000|Overall Study|Disease relapse|0|||
163129621|NCT00084656|589182313|FG001|Overall Study|Disease relapse|9|||
163343381|NCT01232569|589966400|FG002|Double-blind Treatment Period|Death|0|||
163408332|NCT02124564|590204116|FG000|Treatment Period|Withdrawal by Subject|2|||
163408333|NCT01100437|590204117|FG000|Titration/Stabilization|Adverse Event|0|||
163129622|NCT00084656|589182314|FG002|Overall Study|Disease relapse|10|||
163129623|NCT00084656|589182312|FG000|Overall Study|Disease progression|9|||
163129624|NCT00084656|589182313|FG001|Overall Study|Disease progression|0|||
163129625|NCT00084656|589182314|FG002|Overall Study|Disease progression|0|||
163129626|NCT00084656|589182312|FG000|Overall Study|Lost to Follow-up|1|||
163343382|NCT01232569|589966401|FG003|Double-blind Treatment Period|Death|0|||
163343383|NCT02388932|589966402|FG000|Overall Study|Death|1|||
163408334|NCT01100437|590204118|FG001|Titration/Stabilization|Adverse Event|0|||
163129627|NCT00084656|589182313|FG001|Overall Study|Lost to Follow-up|0|||
163129628|NCT00084656|589182314|FG002|Overall Study|Lost to Follow-up|1|||
163129629|NCT04033068|589182318|FG000|Overall Study|Withdrawal by Subject|0|||
163129630|NCT04033068|589182319|FG001|Overall Study|Withdrawal by Subject|0|||
163129631|NCT04033068|589182320|FG002|Overall Study|Withdrawal by Subject|1|||
163129632|NCT04033068|589182321|FG003|Overall Study|Withdrawal by Subject|0|||
163129633|NCT04033068|589182318|FG000|Overall Study|Lost to Follow-up|0|||
163129634|NCT04033068|589182319|FG001|Overall Study|Lost to Follow-up|1|||
163129635|NCT04033068|589182320|FG002|Overall Study|Lost to Follow-up|0|||
163129636|NCT04033068|589182321|FG003|Overall Study|Lost to Follow-up|0|||
163129637|NCT04033068|589182318|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
163129638|NCT04033068|589182319|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
163129639|NCT04033068|589182320|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
163129640|NCT04033068|589182321|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
163129641|NCT01817959|589182322|FG000|Overall Study|Graft loss|1|||
163129642|NCT01817959|589182323|FG001|Overall Study|Graft loss|1|||
163129643|NCT01817959|589182322|FG000|Overall Study|forbidden medication|1|||
163129644|NCT01817959|589182323|FG001|Overall Study|forbidden medication|1|||
163129645|NCT01817959|589182322|FG000|Overall Study|Adverse Event|1|||
163129646|NCT01817959|589182323|FG001|Overall Study|Adverse Event|0|||
163129647|NCT01817959|589182322|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
163129648|NCT01817959|589182323|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
163129649|NCT03235089|589182324|FG000|Overall Study|Lost to Follow-up|1|||
163129650|NCT03235089|589182325|FG001|Overall Study|Lost to Follow-up|1|||
163129651|NCT03235089|589182324|FG000|Overall Study|Physician Decision|2|||
163129652|NCT03235089|589182325|FG001|Overall Study|Physician Decision|2|||
163129653|NCT03238924|589182330|FG000|Overall Study|Withdrawal by Subject|2|||
163129654|NCT03238924|589182331|FG001|Overall Study|Withdrawal by Subject|2|||
163129655|NCT03576716|589182332|FG000|Overall Study|Withdrawal by Subject|0|||
163129656|NCT03576716|589182333|FG001|Overall Study|Withdrawal by Subject|1|||
163129657|NCT00559988|589182334|FG000|Overall Study|Death|147|||
163129658|NCT00559988|589182335|FG001|Overall Study|Death|140|||
163129659|NCT00559988|589182334|FG000|Overall Study|Withdrawal by Subject|152|||
163129660|NCT00559988|589182335|FG001|Overall Study|Withdrawal by Subject|139|||
163129661|NCT00559988|589182334|FG000|Overall Study|Lost to Follow-up|42|||
163129662|NCT00559988|589182335|FG001|Overall Study|Lost to Follow-up|56|||
163129663|NCT00559988|589182334|FG000|Overall Study|ICD device explanted|10|||
163129664|NCT00559988|589182335|FG001|Overall Study|ICD device explanted|17|||
163129665|NCT02891382|589182336|FG000|Overall Study|Lost to Follow-up|3|||
163129666|NCT02891382|589182337|FG001|Overall Study|Lost to Follow-up|4|||
163129667|NCT02891382|589182338|FG002|Overall Study|Lost to Follow-up|5|||
163129668|NCT02891382|589182339|FG003|Overall Study|Lost to Follow-up|3|||
163129669|NCT02891382|589182340|FG004|Overall Study|Lost to Follow-up|4|||
163129670|NCT02516228|589182341|FG000|Overall Study|Lost to Follow-up|1|||
163129671|NCT02516228|589182341|FG000|Overall Study|Withdrawal by Subject|1|||
163129672|NCT02516228|589182341|FG000|Overall Study|Physician Decision|1|||
163129673|NCT03916484|589182342|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
163129674|NCT03916484|589182343|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
163129675|NCT03916484|589182344|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
163129676|NCT03916484|589182345|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
163129677|NCT03916484|589182342|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
163129678|NCT03916484|589182343|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
163129679|NCT03916484|589182344|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
163129680|NCT03916484|589182345|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
163129681|NCT01123707|589182347|FG000|Overall Study|Lost to Follow-up|3|||
163129682|NCT01123707|589182348|FG001|Overall Study|Lost to Follow-up|1|||
163129683|NCT01123707|589182349|FG002|Overall Study|Lost to Follow-up|3|||
163129684|NCT01123707|589182350|FG003|Overall Study|Lost to Follow-up|2|||
163129685|NCT01123707|589182347|FG000|Overall Study|Adverse Event|5|||
163129686|NCT01123707|589182348|FG001|Overall Study|Adverse Event|7|||
163129687|NCT01123707|589182349|FG002|Overall Study|Adverse Event|5|||
163129688|NCT01123707|589182350|FG003|Overall Study|Adverse Event|3|||
163129689|NCT01123707|589182347|FG000|Overall Study|Sponsor Discontinued Study|30|||
163129690|NCT01123707|589182348|FG001|Overall Study|Sponsor Discontinued Study|24|||
163129691|NCT01123707|589182349|FG002|Overall Study|Sponsor Discontinued Study|25|||
163129692|NCT01123707|589182350|FG003|Overall Study|Sponsor Discontinued Study|40|||
163129693|NCT01123707|589182347|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
163129694|NCT01123707|589182348|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
163129695|NCT01123707|589182349|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
163129696|NCT01123707|589182350|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
163129697|NCT01123707|589182347|FG000|Overall Study|Investigator Withdrew Participant|0|||
163129698|NCT01123707|589182348|FG001|Overall Study|Investigator Withdrew Participant|1|||
163129699|NCT01123707|589182349|FG002|Overall Study|Investigator Withdrew Participant|1|||
163129700|NCT01123707|589182350|FG003|Overall Study|Investigator Withdrew Participant|1|||
163129701|NCT01123707|589182347|FG000|Overall Study|Subject Withdrew Consent|4|||
163129702|NCT01123707|589182348|FG001|Overall Study|Subject Withdrew Consent|5|||
163343384|NCT05335005|589966405|FG000|Overall Study|Lost to Follow-up|1|||
163343385|NCT05927753|589966406|FG000|Overall Study|Withdrawal by Subject|0|||
163343386|NCT05927753|589966407|FG001|Overall Study|Withdrawal by Subject|2|||
163343387|NCT05927753|589966406|FG000|Overall Study|Physician Decision|0|||
163343388|NCT05927753|589966407|FG001|Overall Study|Physician Decision|1|||
163343389|NCT02123797|589966408|FG000|Baseline Intervention|Death|9|||
163343390|NCT02123797|589966409|FG001|Baseline Intervention|Death|16|||
163343391|NCT02123797|589966410|FG002|Baseline Intervention|Death|0|||
163343392|NCT02123797|589966411|FG003|Baseline Intervention|Death|0|||
163343393|NCT02123797|589966412|FG004|Baseline Intervention|Death|0|||
163408335|NCT01100437|590204119|FG002|Titration/Stabilization|Adverse Event|4|||
163408336|NCT01100437|590204117|FG000|Titration/Stabilization|Non-compliance|0|||
163408337|NCT01100437|590204118|FG001|Titration/Stabilization|Non-compliance|0|||
163408338|NCT01100437|590204119|FG002|Titration/Stabilization|Non-compliance|1|||
163408339|NCT01100437|590204117|FG000|Titration/Stabilization|Sponsor canceled study|0|||
163408340|NCT01100437|590204118|FG001|Titration/Stabilization|Sponsor canceled study|0|||
163408341|NCT01100437|590204119|FG002|Titration/Stabilization|Sponsor canceled study|1|||
163408342|NCT01100437|590204117|FG000|Maintenance|Withdrawal by Subject|0|||
163408343|NCT01100437|590204118|FG001|Maintenance|Withdrawal by Subject|0|||
163408344|NCT01100437|590204119|FG002|Maintenance|Withdrawal by Subject|1|||
163408345|NCT01100437|590204117|FG000|Maintenance|Sponsor termination of study|0|||
163408346|NCT01100437|590204118|FG001|Maintenance|Sponsor termination of study|0|||
163408347|NCT01100437|590204119|FG002|Maintenance|Sponsor termination of study|1|||
163408348|NCT04489888|590204120|FG000|Overall Study|Death|75|||
163408349|NCT04489888|590204120|FG000|Overall Study|Sponsor Decision|26|||
163408350|NCT02867995|590204126|FG000|Overall Study|Withdrawal by Subject|0|||
163408351|NCT02867995|590204127|FG001|Overall Study|Withdrawal by Subject|1|||
163408352|NCT02867995|590204126|FG000|Overall Study|Lost to Follow-up|0|||
163408353|NCT02867995|590204127|FG001|Overall Study|Lost to Follow-up|2|||
163408354|NCT01534533|590204128|FG000|Overall Study|Lost to Follow-up|3|||
163408355|NCT01534533|590204129|FG001|Overall Study|Lost to Follow-up|0|||
163408356|NCT01534533|590204130|FG002|Overall Study|Lost to Follow-up|4|||
163408357|NCT01534533|590204131|FG003|Overall Study|Lost to Follow-up|3|||
163408358|NCT01534533|590204128|FG000|Overall Study|Withdrawal by Subject|5|||
163408359|NCT01534533|590204129|FG001|Overall Study|Withdrawal by Subject|3|||
163408360|NCT01534533|590204130|FG002|Overall Study|Withdrawal by Subject|4|||
163408361|NCT01534533|590204131|FG003|Overall Study|Withdrawal by Subject|1|||
163408362|NCT05131204|590205493|FG000|Overall Study|Sponsor request|2|||
163408363|NCT05131204|590205494|FG001|Overall Study|Sponsor request|1|||
163408364|NCT02469090|590205496|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
163408365|NCT02469090|590205497|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
163408366|NCT02469090|590205498|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
163408367|NCT02469090|590205496|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
163408368|NCT02469090|590205497|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
163408369|NCT02469090|590205498|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
163408370|NCT02469090|590205496|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
163408371|NCT02469090|590205497|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
163408372|NCT02469090|590205498|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
163408373|NCT02469090|590205496|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
163408374|NCT02469090|590205497|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
163408375|NCT02469090|590205498|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
163408376|NCT02469090|590205496|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
163408377|NCT02469090|590205497|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
163408378|NCT02469090|590205498|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
163408379|NCT02469090|590205496|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
163408380|NCT02469090|590205497|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
163408381|NCT02469090|590205498|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
163408382|NCT02469090|590205496|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
163408383|NCT02469090|590205497|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
163408384|NCT02469090|590205498|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
163129703|NCT01123707|589182349|FG002|Overall Study|Subject Withdrew Consent|1|||
163129704|NCT01123707|589182350|FG003|Overall Study|Subject Withdrew Consent|2|||
163129705|NCT01123707|589182347|FG000|Overall Study|Lack of Efficacy|1|||
163129706|NCT01123707|589182348|FG001|Overall Study|Lack of Efficacy|2|||
163129707|NCT01123707|589182349|FG002|Overall Study|Lack of Efficacy|1|||
163129708|NCT01123707|589182350|FG003|Overall Study|Lack of Efficacy|0|||
163129709|NCT01123707|589182347|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
163408385|NCT02469090|590205496|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
163408386|NCT02469090|590205497|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
163408387|NCT02469090|590205498|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
163129710|NCT01123707|589182348|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
163343394|NCT02123797|589966408|FG000|Baseline Intervention|Withdrawal by Subject|2|||
163343395|NCT02123797|589966409|FG001|Baseline Intervention|Withdrawal by Subject|8|||
163343396|NCT02123797|589966410|FG002|Baseline Intervention|Withdrawal by Subject|0|||
163343397|NCT02123797|589966411|FG003|Baseline Intervention|Withdrawal by Subject|0|||
163343398|NCT02123797|589966412|FG004|Baseline Intervention|Withdrawal by Subject|0|||
163343399|NCT02123797|589966408|FG000|Baseline Intervention|Relocation|2|||
163343400|NCT02123797|589966409|FG001|Baseline Intervention|Relocation|0|||
163343401|NCT02123797|589966410|FG002|Baseline Intervention|Relocation|0|||
163343402|NCT02123797|589966411|FG003|Baseline Intervention|Relocation|0|||
163343403|NCT02123797|589966412|FG004|Baseline Intervention|Relocation|0|||
163343404|NCT02123797|589966408|FG000|Baseline Intervention|Out of window for initial survey|6|||
163129711|NCT01123707|589182349|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
163129712|NCT01123707|589182350|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
163129713|NCT03281304|589182353|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
163129714|NCT03281304|589182354|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
163129715|NCT03281304|589182353|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
163129716|NCT03281304|589182354|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
163129717|NCT03281304|589182353|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
163129718|NCT03281304|589182354|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
163129719|NCT03281304|589182353|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
163129720|NCT03281304|589182354|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
163129721|NCT03281304|589182353|FG000|Treatment Phase (up to 42 Months)|Death|0|||
163129722|NCT03281304|589182354|FG001|Treatment Phase (up to 42 Months)|Death|1|||
163129723|NCT03281304|589182353|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
163129724|NCT03281304|589182354|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
163129725|NCT03281304|589182353|FG000|Treatment Phase (up to 42 Months)|Other|0|||
163129726|NCT03281304|589182354|FG001|Treatment Phase (up to 42 Months)|Other|2|||
163129727|NCT03281304|589182353|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
163129728|NCT03281304|589182354|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
163129729|NCT00858637|589182355|FG000|Active Comparison Phase|Adverse Event|14|||
163129730|NCT00858637|589182356|FG001|Active Comparison Phase|Adverse Event|0|||
163129731|NCT00858637|589182357|FG002|Active Comparison Phase|Adverse Event|0|||
163129732|NCT00858637|589182358|FG003|Active Comparison Phase|Adverse Event|9|||
163129733|NCT00858637|589182359|FG004|Active Comparison Phase|Adverse Event|0|||
163129734|NCT00858637|589182360|FG005|Active Comparison Phase|Adverse Event|0|||
163129735|NCT00858637|589182355|FG000|Active Comparison Phase|Death|1|||
163129736|NCT00858637|589182356|FG001|Active Comparison Phase|Death|0|||
163129737|NCT00858637|589182357|FG002|Active Comparison Phase|Death|0|||
163129738|NCT00858637|589182358|FG003|Active Comparison Phase|Death|1|||
163129739|NCT00858637|589182359|FG004|Active Comparison Phase|Death|0|||
163129740|NCT00858637|589182360|FG005|Active Comparison Phase|Death|0|||
163129741|NCT00858637|589182355|FG000|Active Comparison Phase|Physician Decision|1|||
163129742|NCT00858637|589182356|FG001|Active Comparison Phase|Physician Decision|0|||
163129743|NCT00858637|589182357|FG002|Active Comparison Phase|Physician Decision|0|||
163129744|NCT00858637|589182358|FG003|Active Comparison Phase|Physician Decision|1|||
163129745|NCT00858637|589182359|FG004|Active Comparison Phase|Physician Decision|0|||
163129746|NCT00858637|589182360|FG005|Active Comparison Phase|Physician Decision|0|||
163129747|NCT00858637|589182355|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
163129748|NCT00858637|589182356|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
163129749|NCT00858637|589182357|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
163129750|NCT00858637|589182358|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
163129751|NCT00858637|589182359|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
163129752|NCT00858637|589182360|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
163129753|NCT00858637|589182355|FG000|Active Comparison Phase|Other Reasons|1|||
163129754|NCT00858637|589182356|FG001|Active Comparison Phase|Other Reasons|0|||
163129755|NCT00858637|589182357|FG002|Active Comparison Phase|Other Reasons|0|||
163129756|NCT00858637|589182358|FG003|Active Comparison Phase|Other Reasons|1|||
163129757|NCT00858637|589182359|FG004|Active Comparison Phase|Other Reasons|0|||
163129758|NCT00858637|589182360|FG005|Active Comparison Phase|Other Reasons|0|||
163129759|NCT00858637|589182355|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
163129760|NCT00858637|589182356|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
163129761|NCT00858637|589182357|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
163129762|NCT00858637|589182358|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
163129763|NCT00858637|589182359|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
163129764|NCT00858637|589182360|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
163129765|NCT00858637|589182355|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
163129766|NCT00858637|589182356|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
163343405|NCT02123797|589966409|FG001|Baseline Intervention|Out of window for initial survey|13|||
163129767|NCT00858637|589182357|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
163129768|NCT00858637|589182358|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
163129769|NCT00858637|589182359|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
163343406|NCT02123797|589966410|FG002|Baseline Intervention|Out of window for initial survey|0|||
163129770|NCT00858637|589182360|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
163129771|NCT02292706|589182361|FG000|Overall Study|Lost to Follow-up|20|||
163129772|NCT02292706|589182362|FG001|Overall Study|Lost to Follow-up|44|||
163343407|NCT02123797|589966411|FG003|Baseline Intervention|Out of window for initial survey|0|||
163343408|NCT02123797|589966412|FG004|Baseline Intervention|Out of window for initial survey|0|||
163129773|NCT02292706|589182363|FG002|Overall Study|Lost to Follow-up|24|||
163129774|NCT02292706|589182364|FG003|Overall Study|Lost to Follow-up|61|||
163129775|NCT02292706|589182365|FG004|Overall Study|Lost to Follow-up|21|||
163129776|NCT02292706|589182366|FG005|Overall Study|Lost to Follow-up|52|||
163129777|NCT02292706|589182367|FG006|Overall Study|Lost to Follow-up|25|||
163129778|NCT02292706|589182368|FG007|Overall Study|Lost to Follow-up|0|||
163129779|NCT02292706|589182361|FG000|Overall Study|Withdrew consent|15|||
163129780|NCT02292706|589182362|FG001|Overall Study|Withdrew consent|56|||
163129781|NCT02292706|589182363|FG002|Overall Study|Withdrew consent|43|||
163129782|NCT02292706|589182364|FG003|Overall Study|Withdrew consent|36|||
163129783|NCT02292706|589182365|FG004|Overall Study|Withdrew consent|13|||
163129784|NCT02292706|589182366|FG005|Overall Study|Withdrew consent|51|||
163129785|NCT02292706|589182367|FG006|Overall Study|Withdrew consent|20|||
163129786|NCT02292706|589182368|FG007|Overall Study|Withdrew consent|0|||
163129787|NCT02292706|589182361|FG000|Overall Study|Death|3|||
163129788|NCT02292706|589182362|FG001|Overall Study|Death|11|||
163129789|NCT02292706|589182363|FG002|Overall Study|Death|16|||
163129790|NCT02292706|589182364|FG003|Overall Study|Death|22|||
163129791|NCT02292706|589182365|FG004|Overall Study|Death|8|||
163129792|NCT02292706|589182366|FG005|Overall Study|Death|17|||
163129793|NCT02292706|589182367|FG006|Overall Study|Death|3|||
163129794|NCT02292706|589182368|FG007|Overall Study|Death|0|||
163129795|NCT02292706|589182361|FG000|Overall Study|Study terminated by sponsor|0|||
163129796|NCT02292706|589182362|FG001|Overall Study|Study terminated by sponsor|9|||
163129797|NCT02292706|589182363|FG002|Overall Study|Study terminated by sponsor|4|||
163129798|NCT02292706|589182364|FG003|Overall Study|Study terminated by sponsor|21|||
163129799|NCT02292706|589182365|FG004|Overall Study|Study terminated by sponsor|11|||
163129800|NCT02292706|589182366|FG005|Overall Study|Study terminated by sponsor|13|||
163129801|NCT02292706|589182367|FG006|Overall Study|Study terminated by sponsor|3|||
163129802|NCT02292706|589182368|FG007|Overall Study|Study terminated by sponsor|0|||
163129803|NCT02292706|589182361|FG000|Overall Study|Investigator's discretion|4|||
163129804|NCT02292706|589182362|FG001|Overall Study|Investigator's discretion|9|||
163129805|NCT02292706|589182363|FG002|Overall Study|Investigator's discretion|7|||
163129806|NCT02292706|589182364|FG003|Overall Study|Investigator's discretion|11|||
163129807|NCT02292706|589182365|FG004|Overall Study|Investigator's discretion|4|||
163129808|NCT02292706|589182366|FG005|Overall Study|Investigator's discretion|10|||
163129809|NCT02292706|589182367|FG006|Overall Study|Investigator's discretion|1|||
163129810|NCT02292706|589182368|FG007|Overall Study|Investigator's discretion|0|||
163129811|NCT02292706|589182361|FG000|Overall Study|Liver transplant|1|||
163129812|NCT02292706|589182362|FG001|Overall Study|Liver transplant|1|||
163129813|NCT02292706|589182363|FG002|Overall Study|Liver transplant|11|||
163129814|NCT02292706|589182364|FG003|Overall Study|Liver transplant|16|||
163129815|NCT02292706|589182365|FG004|Overall Study|Liver transplant|5|||
163129816|NCT02292706|589182366|FG005|Overall Study|Liver transplant|6|||
163129817|NCT02292706|589182367|FG006|Overall Study|Liver transplant|5|||
163129818|NCT02292706|589182368|FG007|Overall Study|Liver transplant|0|||
163129819|NCT02292706|589182361|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
163129820|NCT02292706|589182362|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
163129821|NCT02292706|589182363|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
163129822|NCT02292706|589182364|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
163129823|NCT02292706|589182365|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
163129824|NCT02292706|589182366|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
163129825|NCT02292706|589182367|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
163129826|NCT02292706|589182368|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
163129827|NCT02292706|589182361|FG000|Overall Study|Subject terminated by sponsor|1|||
163226739|NCT01393405|589544258|FG000|Maintenance Period Week|Lost to Follow-up|0|||
163226740|NCT01393405|589544259|FG001|Maintenance Period Week|Lost to Follow-up|1|||
163226741|NCT01393405|589544260|FG002|Maintenance Period Week|Lost to Follow-up|0|||
163226742|NCT02281552|589544261|FG000|Overall Study|Medication error|1|||
163226743|NCT02281552|589544262|FG001|Overall Study|Medication error|0|||
163226744|NCT02281552|589544261|FG000|Overall Study|Insufficient clinical response|0|||
163226745|NCT02281552|589544262|FG001|Overall Study|Insufficient clinical response|1|||
163226746|NCT02281552|589544261|FG000|Overall Study|Adverse Event|3|||
163226747|NCT02281552|589544262|FG001|Overall Study|Adverse Event|9|||
163226748|NCT01434290|589544263|FG000|Overall Study|Protocol Violation|6|||
163343409|NCT02123797|589966408|FG000|Baseline Intervention|Lost to Follow-up|0|||
163129828|NCT02292706|589182362|FG001|Overall Study|Subject terminated by sponsor|0|||
163129829|NCT02292706|589182363|FG002|Overall Study|Subject terminated by sponsor|0|||
163129830|NCT02292706|589182364|FG003|Overall Study|Subject terminated by sponsor|2|||
163129831|NCT02292706|589182365|FG004|Overall Study|Subject terminated by sponsor|1|||
163129832|NCT02292706|589182366|FG005|Overall Study|Subject terminated by sponsor|0|||
163129833|NCT02292706|589182367|FG006|Overall Study|Subject terminated by sponsor|0|||
163129834|NCT02292706|589182368|FG007|Overall Study|Subject terminated by sponsor|0|||
163226749|NCT01434290|589544264|FG001|Overall Study|Protocol Violation|3|||
163129835|NCT02292706|589182361|FG000|Overall Study|Missing|0|||
163129836|NCT02292706|589182362|FG001|Overall Study|Missing|0|||
163129837|NCT02292706|589182363|FG002|Overall Study|Missing|1|||
163129838|NCT02292706|589182364|FG003|Overall Study|Missing|1|||
163129839|NCT02292706|589182365|FG004|Overall Study|Missing|0|||
163129840|NCT02292706|589182366|FG005|Overall Study|Missing|1|||
163129841|NCT02292706|589182367|FG006|Overall Study|Missing|0|||
163129842|NCT02292706|589182368|FG007|Overall Study|Missing|0|||
163129843|NCT02292706|589182361|FG000|Overall Study|Virologic relapse or reinfection|1|||
163129844|NCT02292706|589182362|FG001|Overall Study|Virologic relapse or reinfection|0|||
163129845|NCT02292706|589182363|FG002|Overall Study|Virologic relapse or reinfection|0|||
163129846|NCT02292706|589182364|FG003|Overall Study|Virologic relapse or reinfection|1|||
163129847|NCT02292706|589182365|FG004|Overall Study|Virologic relapse or reinfection|0|||
163129848|NCT02292706|589182366|FG005|Overall Study|Virologic relapse or reinfection|1|||
163129849|NCT02292706|589182367|FG006|Overall Study|Virologic relapse or reinfection|0|||
163129850|NCT02292706|589182368|FG007|Overall Study|Virologic relapse or reinfection|0|||
163129851|NCT02725866|589182373|FG000|Overall Study|Failure to return|6|||
163129852|NCT02725866|589182373|FG000|Overall Study|Withdrew consent|3|||
163129853|NCT02725866|589182373|FG000|Overall Study|Insufficient virological response|1|||
163129854|NCT02725866|589182373|FG000|Overall Study|Other, not specified|4|||
163129855|NCT01990612|589182374|FG000|Overall Study|Lost to Follow-up|2|||
163129856|NCT01990612|589182375|FG001|Overall Study|Lost to Follow-up|1|||
163129857|NCT01990612|589182374|FG000|Overall Study|Withdrawal by Subject|5|||
163129858|NCT01990612|589182375|FG001|Overall Study|Withdrawal by Subject|2|||
163129859|NCT02188849|589182378|FG000|Overall Study|Lost to Follow-up|3|||
163129860|NCT02188849|589182379|FG001|Overall Study|Lost to Follow-up|8|||
163129861|NCT02980133|589182381|FG000|Overall Study|Other than specified|1|||
163129862|NCT02980133|589182382|FG001|Overall Study|Other than specified|1|||
163129863|NCT02980133|589182383|FG002|Overall Study|Other than specified|2|||
163129864|NCT02980133|589182384|FG003|Overall Study|Other than specified|2|||
163129865|NCT02980133|589182381|FG000|Overall Study|Lost to Follow-up|0|||
163129866|NCT02980133|589182382|FG001|Overall Study|Lost to Follow-up|0|||
163129867|NCT02980133|589182383|FG002|Overall Study|Lost to Follow-up|1|||
163129868|NCT02980133|589182384|FG003|Overall Study|Lost to Follow-up|3|||
163129869|NCT02980133|589182381|FG000|Overall Study|Protocol Violation|0|||
163129870|NCT02980133|589182382|FG001|Overall Study|Protocol Violation|1|||
163129871|NCT02980133|589182383|FG002|Overall Study|Protocol Violation|0|||
163129872|NCT02980133|589182384|FG003|Overall Study|Protocol Violation|0|||
163129873|NCT02980133|589182381|FG000|Overall Study|Withdrawal by parent/guardian|6|||
163129874|NCT02980133|589182382|FG001|Overall Study|Withdrawal by parent/guardian|3|||
163129875|NCT02980133|589182383|FG002|Overall Study|Withdrawal by parent/guardian|3|||
163129876|NCT02980133|589182384|FG003|Overall Study|Withdrawal by parent/guardian|1|||
163129877|NCT02980133|589182381|FG000|Overall Study|Withdrawal by Subject|0|||
163129878|NCT02980133|589182382|FG001|Overall Study|Withdrawal by Subject|0|||
163129879|NCT02980133|589182383|FG002|Overall Study|Withdrawal by Subject|1|||
163129880|NCT02980133|589182384|FG003|Overall Study|Withdrawal by Subject|0|||
163129881|NCT03208088|589182391|FG000|Period 2|Withdrawal by Subject|0|||
163129882|NCT03208088|589182392|FG001|Period 2|Withdrawal by Subject|0|||
163129883|NCT03208088|589182393|FG002|Period 2|Withdrawal by Subject|0|||
163129884|NCT03208088|589182394|FG003|Period 2|Withdrawal by Subject|0|||
163129885|NCT03208088|589182395|FG004|Period 2|Withdrawal by Subject|0|||
163129886|NCT03208088|589182396|FG005|Period 2|Withdrawal by Subject|0|||
163129887|NCT03208088|589182397|FG006|Period 2|Withdrawal by Subject|0|||
163129888|NCT03208088|589182398|FG007|Period 2|Withdrawal by Subject|0|||
163129889|NCT03208088|589182399|FG008|Period 2|Withdrawal by Subject|1|||
163129890|NCT03208088|589182400|FG009|Period 2|Withdrawal by Subject|0|||
163129891|NCT03208088|589182391|FG000|Period 3|Unsatisfactory Test Article|0|||
163129892|NCT03208088|589182392|FG001|Period 3|Unsatisfactory Test Article|0|||
163129893|NCT03208088|589182393|FG002|Period 3|Unsatisfactory Test Article|0|||
163129894|NCT03208088|589182394|FG003|Period 3|Unsatisfactory Test Article|1|||
163129895|NCT03208088|589182395|FG004|Period 3|Unsatisfactory Test Article|0|||
163129896|NCT03208088|589182396|FG005|Period 3|Unsatisfactory Test Article|0|||
163129897|NCT03208088|589182397|FG006|Period 3|Unsatisfactory Test Article|0|||
163129898|NCT03208088|589182398|FG007|Period 3|Unsatisfactory Test Article|0|||
163129899|NCT03208088|589182399|FG008|Period 3|Unsatisfactory Test Article|0|||
163129900|NCT03208088|589182400|FG009|Period 3|Unsatisfactory Test Article|0|||
163129901|NCT03208088|589182391|FG000|Period 4|Unsatisfactory Test Article|0|||
163129902|NCT03208088|589182392|FG001|Period 4|Unsatisfactory Test Article|0|||
163129903|NCT03208088|589182393|FG002|Period 4|Unsatisfactory Test Article|0|||
163226750|NCT01434290|589544263|FG000|Overall Study|No protocol treatment|2|||
163226751|NCT01434290|589544264|FG001|Overall Study|No protocol treatment|4|||
163129904|NCT03208088|589182394|FG003|Period 4|Unsatisfactory Test Article|1|||
163129905|NCT03208088|589182395|FG004|Period 4|Unsatisfactory Test Article|0|||
163129906|NCT03208088|589182396|FG005|Period 4|Unsatisfactory Test Article|0|||
163129907|NCT03208088|589182397|FG006|Period 4|Unsatisfactory Test Article|0|||
163129908|NCT03208088|589182398|FG007|Period 4|Unsatisfactory Test Article|0|||
163129909|NCT03208088|589182399|FG008|Period 4|Unsatisfactory Test Article|0|||
163129910|NCT03208088|589182400|FG009|Period 4|Unsatisfactory Test Article|0|||
163129911|NCT00605345|589182406|FG000|Overall Study|Withdrawal by Subject|1|||
163129912|NCT00605345|589182407|FG001|Overall Study|Withdrawal by Subject|0|||
163129913|NCT00605345|589182406|FG000|Overall Study|Adverse Event|0|||
163129914|NCT00605345|589182407|FG001|Overall Study|Adverse Event|1|||
163129915|NCT00605345|589182406|FG000|Overall Study|Protocol Violation|0|||
163129916|NCT00605345|589182407|FG001|Overall Study|Protocol Violation|2|||
163129917|NCT02577016|589182408|FG000|Overall Study|Adverse Event|2|||
163129918|NCT02577016|589182409|FG001|Overall Study|Adverse Event|1|||
163129919|NCT02577016|589182408|FG000|Overall Study|Physician Decision|0|||
163129920|NCT02577016|589182409|FG001|Overall Study|Physician Decision|1|||
163129921|NCT02942485|589184078|FG000|Overall Study|Lost to Follow-up|1|||
163129922|NCT02942485|589184079|FG001|Overall Study|Lost to Follow-up|0|||
163129923|NCT00902174|589184083|FG000|Overall Study|Adverse Event|27|||
163129924|NCT00902174|589184084|FG001|Overall Study|Adverse Event|7|||
163129925|NCT00902174|589184083|FG000|Overall Study|Lack of Efficacy|1|||
163129926|NCT00902174|589184084|FG001|Overall Study|Lack of Efficacy|5|||
163129927|NCT00902174|589184083|FG000|Overall Study|Death|2|||
163129928|NCT00902174|589184084|FG001|Overall Study|Death|2|||
163129929|NCT00902174|589184083|FG000|Overall Study|Withdrawal by Subject|2|||
163129930|NCT00902174|589184084|FG001|Overall Study|Withdrawal by Subject|1|||
163129931|NCT00902174|589184083|FG000|Overall Study|Abnormal labs|1|||
163129932|NCT00902174|589184084|FG001|Overall Study|Abnormal labs|1|||
163129933|NCT00902174|589184083|FG000|Overall Study|Protocol Violation|1|||
163129934|NCT00902174|589184084|FG001|Overall Study|Protocol Violation|1|||
163129935|NCT00902174|589184083|FG000|Overall Study|Administration problem|0|||
163129936|NCT00902174|589184084|FG001|Overall Study|Administration problem|1|||
163129937|NCT00989781|589184087|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
163129938|NCT00989781|589184088|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
163129939|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
163129940|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
163129941|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
163129942|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
163129943|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
163129944|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
163129945|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
163129946|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
163129947|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
163129948|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
163129949|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
163129950|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
163129951|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
163129952|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
163129953|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
163129954|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
163129955|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
163129956|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
163129957|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
163129958|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
163129959|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
163129960|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
163129961|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
163129962|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
163129963|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
163129964|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
163129965|NCT01532869|589184089|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
163129966|NCT01532869|589184090|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
163129967|NCT01532869|589184089|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
163129968|NCT01532869|589184090|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
163129969|NCT01532869|589184089|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
163129970|NCT01532869|589184090|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
163129971|NCT01532869|589184089|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
163129972|NCT01532869|589184090|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
163129973|NCT01331291|589184091|FG000|Overall Study|Lack of Efficacy|2|||
163129974|NCT01331291|589184092|FG001|Overall Study|Lack of Efficacy|8|||
163129975|NCT01331291|589184091|FG000|Overall Study|Death|0|||
163129976|NCT01331291|589184092|FG001|Overall Study|Death|1|||
163129977|NCT01389323|589184098|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
163129978|NCT01389323|589184098|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
163129979|NCT01389323|589184098|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
163129980|NCT01389323|589184098|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
163226752|NCT01224639|589544265|FG000|Overall Study|Withdrawal by Subject|0|||
163226753|NCT01224639|589544266|FG001|Overall Study|Withdrawal by Subject|0|||
163226754|NCT01224639|589544267|FG002|Overall Study|Withdrawal by Subject|0|||
163226755|NCT01224639|589544268|FG003|Overall Study|Withdrawal by Subject|0|||
163226756|NCT01224639|589544269|FG004|Overall Study|Withdrawal by Subject|2|||
163226757|NCT01224639|589544270|FG005|Overall Study|Withdrawal by Subject|0|||
163226758|NCT01224639|589544271|FG006|Overall Study|Withdrawal by Subject|1|||
163226759|NCT01224639|589544272|FG007|Overall Study|Withdrawal by Subject|1|||
163226760|NCT01224639|589544265|FG000|Overall Study|Adverse Event|0|||
163226761|NCT01224639|589544266|FG001|Overall Study|Adverse Event|0|||
163226762|NCT01224639|589544267|FG002|Overall Study|Adverse Event|0|||
163226763|NCT01224639|589544268|FG003|Overall Study|Adverse Event|0|||
163226764|NCT01224639|589544269|FG004|Overall Study|Adverse Event|0|||
163226765|NCT01224639|589544270|FG005|Overall Study|Adverse Event|0|||
163226766|NCT01224639|589544271|FG006|Overall Study|Adverse Event|0|||
163226767|NCT01224639|589544272|FG007|Overall Study|Adverse Event|1|||
163226768|NCT04656132|589544273|FG000|Overall Study|Lost to Follow-up|4|||
163226769|NCT04656132|589544273|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
163226770|NCT04365699|589544274|FG000|Overall Study|Death|2|||
163226771|NCT04365699|589544275|FG001|Overall Study|Death|5|||
163226772|NCT04365699|589544276|FG002|Overall Study|Death|15|||
163226773|NCT00834912|589544278|FG000|Treatment Period 1|Adverse Event|0|||
163226774|NCT00834912|589544279|FG001|Treatment Period 1|Adverse Event|1|||
163226775|NCT00834912|589544280|FG002|Treatment Period 1|Adverse Event|0|||
163226776|NCT00834912|589544281|FG003|Treatment Period 1|Adverse Event|1|||
163226777|NCT00834912|589544282|FG004|Treatment Period 1|Adverse Event|0|||
163226778|NCT00834912|589544283|FG005|Treatment Period 1|Adverse Event|0|||
163226779|NCT00834912|589544278|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163226780|NCT00834912|589544279|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163226781|NCT00834912|589544280|FG002|Treatment Period 2|Withdrawal by Subject|1|||
163226782|NCT00834912|589544281|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163226783|NCT00834912|589544282|FG004|Treatment Period 2|Withdrawal by Subject|1|||
163226784|NCT00834912|589544283|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163226785|NCT01399593|589544287|FG000|Overall Study|Physician Decision|1|||
163226786|NCT01399593|589544288|FG001|Overall Study|Physician Decision|0|||
163226787|NCT01399593|589544287|FG000|Overall Study|Adverse Event|1|||
163226788|NCT01399593|589544288|FG001|Overall Study|Adverse Event|0|||
163226789|NCT01399593|589544287|FG000|Overall Study|Death|1|||
163226790|NCT01399593|589544288|FG001|Overall Study|Death|1|||
163226791|NCT01399593|589544287|FG000|Overall Study|Transplantectomy|0|||
163226792|NCT01399593|589544288|FG001|Overall Study|Transplantectomy|1|||
163226793|NCT02357147|589544290|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
163226794|NCT02357147|589544291|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
163226795|NCT02357147|589544290|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
163226796|NCT02357147|589544291|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
163226797|NCT02357147|589544290|FG000|Combination Treatment Phase|Investigator Discretion|1|||
163226798|NCT02357147|589544291|FG001|Combination Treatment Phase|Investigator Discretion|1|||
163226799|NCT02357147|589544290|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
163226800|NCT02357147|589544291|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
163226801|NCT02357147|589544290|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
163226802|NCT02357147|589544291|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
163226803|NCT02357147|589544290|FG000|Combination Treatment Phase|Adverse Event|12|||
163226804|NCT02357147|589544291|FG001|Combination Treatment Phase|Adverse Event|4|||
163226805|NCT02357147|589544290|FG000|Combination Treatment Phase|Death|1|||
163226806|NCT02357147|589544291|FG001|Combination Treatment Phase|Death|1|||
163226807|NCT02357147|589544290|FG000|Combination Treatment Phase|Sponsor Decision|0|||
163226808|NCT02357147|589544291|FG001|Combination Treatment Phase|Sponsor Decision|12|||
163226809|NCT02357147|589544290|FG000|Combination Treatment Phase|Other|1|||
163226810|NCT02357147|589544291|FG001|Combination Treatment Phase|Other|0|||
163226811|NCT02357147|589544290|FG000|Combination Treatment Phase|Not treated|0|||
163226812|NCT02357147|589544291|FG001|Combination Treatment Phase|Not treated|2|||
163226813|NCT02357147|589544290|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
163226814|NCT02357147|589544291|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
163226815|NCT02357147|589544290|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163226816|NCT02357147|589544291|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
163226817|NCT02357147|589544290|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
163226818|NCT02357147|589544291|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
163226819|NCT02357147|589544290|FG000|Maintenance Treatment Phase|Adverse Event|0|||
163226820|NCT02357147|589544291|FG001|Maintenance Treatment Phase|Adverse Event|3|||
163226821|NCT02357147|589544290|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
163226822|NCT02357147|589544291|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
163226823|NCT02357147|589544290|FG000|Maintenance Treatment Phase|Not Treated|1|||
163226824|NCT02357147|589544291|FG001|Maintenance Treatment Phase|Not Treated|0|||
163226825|NCT02365636|589546076|FG000|Overall Study|Adverse Event|3|||
163129981|NCT01389323|589184098|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
163129982|NCT01389323|589184098|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
163129983|NCT01389323|589184098|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
163129984|NCT01389323|589184098|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
163129985|NCT01389323|589184098|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
163129986|NCT01389323|589184098|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
163129987|NCT01389323|589184098|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
163129988|NCT01805037|589184100|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
163129989|NCT01805037|589184101|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
163129990|NCT01805037|589184100|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
163129991|NCT01805037|589184101|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
163129992|NCT01805037|589184100|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
163129993|NCT01805037|589184101|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
163129994|NCT01805037|589184100|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
163129995|NCT01805037|589184101|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
163129996|NCT01805037|589184100|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
163129997|NCT01805037|589184101|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
163129998|NCT01805037|589184100|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
163129999|NCT01805037|589184101|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
163130000|NCT01805037|589184100|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
163130001|NCT01805037|589184101|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
163130002|NCT01805037|589184100|FG000|Follow Up (up to 3 Years)|Death|0|||
163130003|NCT01805037|589184101|FG001|Follow Up (up to 3 Years)|Death|2|||
163130004|NCT01805037|589184100|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
163130005|NCT01805037|589184101|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
163130006|NCT01805037|589184100|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
163130007|NCT01805037|589184101|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
163130008|NCT01270256|589184102|FG000|Overall Study|Withdrawal by Subject|1|||
163130009|NCT01270256|589184103|FG001|Overall Study|Withdrawal by Subject|0|||
163130010|NCT04566692|589184108|FG000|Overall Study|Adverse Event|2|||
163130011|NCT04566692|589184109|FG001|Overall Study|Adverse Event|0|||
163130012|NCT04566692|589184108|FG000|Overall Study|Withdrawal by Subject|1|||
163130013|NCT04566692|589184109|FG001|Overall Study|Withdrawal by Subject|1|||
163130014|NCT01183468|589184110|FG000|Overall Study|Lost to Follow-up|2|||
163130015|NCT01183468|589184111|FG001|Overall Study|Lost to Follow-up|1|||
163130016|NCT01183468|589184112|FG002|Overall Study|Lost to Follow-up|0|||
163130017|NCT01183468|589184113|FG003|Overall Study|Lost to Follow-up|0|||
163130018|NCT01183468|589184110|FG000|Overall Study|Physician Decision|1|||
163130019|NCT01183468|589184111|FG001|Overall Study|Physician Decision|0|||
163130020|NCT01183468|589184112|FG002|Overall Study|Physician Decision|0|||
163130021|NCT01183468|589184113|FG003|Overall Study|Physician Decision|0|||
163130022|NCT01183468|589184110|FG000|Overall Study|Withdrawal by Subject|0|||
163130023|NCT01183468|589184111|FG001|Overall Study|Withdrawal by Subject|1|||
163130024|NCT01183468|589184112|FG002|Overall Study|Withdrawal by Subject|0|||
163130025|NCT01183468|589184113|FG003|Overall Study|Withdrawal by Subject|0|||
163130026|NCT00590577|589184114|FG000|Overall Study|Lack of Efficacy|31|||
163130027|NCT00590577|589184115|FG001|Overall Study|Lack of Efficacy|28|||
163130028|NCT00590577|589184116|FG002|Overall Study|Lack of Efficacy|23|||
163130029|NCT00590577|589184117|FG003|Overall Study|Lack of Efficacy|45|||
163130030|NCT00590577|589184114|FG000|Overall Study|Withdrawal by Subject|23|||
163130031|NCT00590577|589184115|FG001|Overall Study|Withdrawal by Subject|28|||
163130032|NCT00590577|589184116|FG002|Overall Study|Withdrawal by Subject|30|||
163130033|NCT00590577|589184117|FG003|Overall Study|Withdrawal by Subject|26|||
163130034|NCT00590577|589184114|FG000|Overall Study|Adverse Event|10|||
163130035|NCT00590577|589184115|FG001|Overall Study|Adverse Event|10|||
163130036|NCT00590577|589184116|FG002|Overall Study|Adverse Event|13|||
163130037|NCT00590577|589184117|FG003|Overall Study|Adverse Event|11|||
163130038|NCT00590577|589184114|FG000|Overall Study|Lost to Follow-up|12|||
163130039|NCT00590577|589184115|FG001|Overall Study|Lost to Follow-up|6|||
163130040|NCT00590577|589184116|FG002|Overall Study|Lost to Follow-up|6|||
163130041|NCT00590577|589184117|FG003|Overall Study|Lost to Follow-up|9|||
163130042|NCT00590577|589184114|FG000|Overall Study|Pregnancy|0|||
163130043|NCT00590577|589184115|FG001|Overall Study|Pregnancy|1|||
163130044|NCT00590577|589184116|FG002|Overall Study|Pregnancy|0|||
163130045|NCT00590577|589184117|FG003|Overall Study|Pregnancy|0|||
163130046|NCT00590577|589184114|FG000|Overall Study|Various reasons|1|||
163130047|NCT00590577|589184115|FG001|Overall Study|Various reasons|3|||
163130048|NCT00590577|589184116|FG002|Overall Study|Various reasons|1|||
163130049|NCT00590577|589184117|FG003|Overall Study|Various reasons|2|||
163130050|NCT03927404|589184119|FG000|Overall Study|Withdrawal by Subject|1|||
163130051|NCT01229449|589184120|FG000|Overall Study|Withdrawal by Subject|0|||
163130052|NCT01229449|589184121|FG001|Overall Study|Withdrawal by Subject|3|||
163226826|NCT02365636|589546077|FG001|Overall Study|Adverse Event|3|||
163226827|NCT02365636|589546078|FG002|Overall Study|Adverse Event|2|||
163408388|NCT03823391|590205503|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
163130053|NCT01229449|589184122|FG002|Overall Study|Withdrawal by Subject|0|||
163130054|NCT01229449|589184123|FG003|Overall Study|Withdrawal by Subject|1|||
163130055|NCT01229449|589184124|FG004|Overall Study|Withdrawal by Subject|1|||
163130056|NCT01229449|589184120|FG000|Overall Study|Lost to Follow-up|1|||
163130057|NCT01229449|589184121|FG001|Overall Study|Lost to Follow-up|1|||
163130058|NCT01229449|589184122|FG002|Overall Study|Lost to Follow-up|1|||
163130059|NCT01229449|589184123|FG003|Overall Study|Lost to Follow-up|0|||
163130060|NCT01229449|589184124|FG004|Overall Study|Lost to Follow-up|0|||
163130061|NCT01229449|589184120|FG000|Overall Study|Physician Decision|0|||
163130062|NCT01229449|589184121|FG001|Overall Study|Physician Decision|0|||
163130063|NCT01229449|589184122|FG002|Overall Study|Physician Decision|1|||
163130064|NCT01229449|589184123|FG003|Overall Study|Physician Decision|0|||
163130065|NCT01229449|589184124|FG004|Overall Study|Physician Decision|0|||
163130066|NCT03203291|589184127|FG000|Overall Study|Withdrawal by Subject|1|||
163130067|NCT01300260|589184129|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
163130068|NCT01300260|589184130|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
163130069|NCT01300260|589184129|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
163130070|NCT01300260|589184130|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
163130071|NCT01300260|589184129|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
163130072|NCT01300260|589184130|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
163130073|NCT05098509|589184133|FG000|Overall Study|Withdrawal by Subject|0|||
163130074|NCT05098509|589184134|FG001|Overall Study|Withdrawal by Subject|0|||
163130075|NCT05098509|589184135|FG002|Overall Study|Withdrawal by Subject|1|||
163130076|NCT05098509|589184136|FG003|Overall Study|Withdrawal by Subject|0|||
163130077|NCT05098509|589184133|FG000|Overall Study|Early study termination|1|||
163130078|NCT05098509|589184134|FG001|Overall Study|Early study termination|1|||
163130079|NCT05098509|589184135|FG002|Overall Study|Early study termination|1|||
163130080|NCT05098509|589184136|FG003|Overall Study|Early study termination|0|||
163130081|NCT01147848|589184137|FG000|Run-in Period|Screen Failure|623|||
163130082|NCT01147848|589184138|FG001|Run-in Period|Screen Failure|0|||
163130083|NCT01147848|589184139|FG002|Run-in Period|Screen Failure|0|||
163130084|NCT01147848|589184137|FG000|Run-in Period|Run-in Failure|135|||
163130085|NCT01147848|589184138|FG001|Run-in Period|Run-in Failure|0|||
163130086|NCT01147848|589184139|FG002|Run-in Period|Run-in Failure|0|||
163130087|NCT01147848|589184137|FG000|Randomized Phase|Adverse Event|0|||
163130088|NCT01147848|589184138|FG001|Randomized Phase|Adverse Event|6|||
163130089|NCT01147848|589184139|FG002|Randomized Phase|Adverse Event|8|||
163130090|NCT01147848|589184137|FG000|Randomized Phase|Lack of Efficacy|0|||
163130091|NCT01147848|589184138|FG001|Randomized Phase|Lack of Efficacy|20|||
163130092|NCT01147848|589184139|FG002|Randomized Phase|Lack of Efficacy|11|||
163130093|NCT01147848|589184137|FG000|Randomized Phase|Protocol Violation|0|||
163130094|NCT01147848|589184138|FG001|Randomized Phase|Protocol Violation|7|||
163130095|NCT01147848|589184139|FG002|Randomized Phase|Protocol Violation|10|||
163130096|NCT01147848|589184137|FG000|Randomized Phase|Lost to Follow-up|0|||
163130097|NCT01147848|589184138|FG001|Randomized Phase|Lost to Follow-up|5|||
163130098|NCT01147848|589184139|FG002|Randomized Phase|Lost to Follow-up|7|||
163130099|NCT01147848|589184137|FG000|Randomized Phase|Physician Decision|0|||
163130100|NCT01147848|589184138|FG001|Randomized Phase|Physician Decision|0|||
163130101|NCT01147848|589184139|FG002|Randomized Phase|Physician Decision|1|||
163130102|NCT01147848|589184137|FG000|Randomized Phase|Withdrawal by Subject|0|||
163130103|NCT01147848|589184138|FG001|Randomized Phase|Withdrawal by Subject|7|||
163130104|NCT01147848|589184139|FG002|Randomized Phase|Withdrawal by Subject|9|||
163130105|NCT02540265|589184140|FG000|Overall Study|Lost to Follow-up|0|||
163130106|NCT02540265|589184141|FG001|Overall Study|Lost to Follow-up|0|||
163130107|NCT02540265|589184142|FG002|Overall Study|Lost to Follow-up|1|||
163130108|NCT03157037|589184145|FG000|Overall Study|Death|1|||
163130109|NCT00324233|589184146|FG000|First Period|unable to insert catheter|1|||
163130110|NCT00324233|589184147|FG001|First Period|unable to insert catheter|0|||
163130111|NCT00324233|589184146|FG000|Second Period|unable to insert catheter|1|||
163130112|NCT00324233|589184147|FG001|Second Period|unable to insert catheter|1|||
163130113|NCT00324233|589184146|FG000|Second Period|Protocol Violation|4|||
163130114|NCT00324233|589184147|FG001|Second Period|Protocol Violation|6|||
163130115|NCT01972789|589184148|FG000|Overall Study|Adverse Event|11|||
163130116|NCT01972789|589184149|FG001|Overall Study|Adverse Event|4|||
163130117|NCT01972789|589184148|FG000|Overall Study|Subject withdrew consent|14|||
163408389|NCT03823391|590205504|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
163130118|NCT01972789|589184149|FG001|Overall Study|Subject withdrew consent|12|||
163408390|NCT03823391|590205503|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
163130119|NCT01972789|589184148|FG000|Overall Study|Lost to Follow-up|4|||
163130120|NCT01972789|589184149|FG001|Overall Study|Lost to Follow-up|7|||
163130121|NCT01972789|589184148|FG000|Overall Study|Death|7|||
163130122|NCT01972789|589184149|FG001|Overall Study|Death|5|||
163130123|NCT01972789|589184148|FG000|Overall Study|Protocol deviation|1|||
163130124|NCT01972789|589184149|FG001|Overall Study|Protocol deviation|0|||
163130125|NCT01972789|589184148|FG000|Overall Study|Physician Decision|3|||
163130126|NCT01972789|589184149|FG001|Overall Study|Physician Decision|2|||
163130127|NCT00666965|589184152|FG000|Overall Study|Adverse Event|0|||
163226828|NCT02365636|589546076|FG000|Overall Study|Protocol Violation|1|||
163226829|NCT02365636|589546077|FG001|Overall Study|Protocol Violation|4|||
163226830|NCT02365636|589546078|FG002|Overall Study|Protocol Violation|0|||
163226831|NCT02365636|589546076|FG000|Overall Study|Lost to Follow-up|0|||
163226832|NCT02365636|589546077|FG001|Overall Study|Lost to Follow-up|0|||
163226833|NCT02365636|589546078|FG002|Overall Study|Lost to Follow-up|1|||
163226834|NCT02365636|589546076|FG000|Overall Study|Other|2|||
163226835|NCT02365636|589546077|FG001|Overall Study|Other|0|||
163226836|NCT02365636|589546078|FG002|Overall Study|Other|0|||
163226837|NCT03912233|589546079|FG000|Overall Study|Adverse Event|1|||
163226838|NCT03912233|589546080|FG001|Overall Study|Adverse Event|0|||
163226839|NCT03912233|589546081|FG002|Overall Study|Adverse Event|0|||
163226840|NCT03912233|589546082|FG003|Overall Study|Adverse Event|0|||
163226841|NCT03912233|589546083|FG004|Overall Study|Adverse Event|0|||
163226842|NCT03912233|589546084|FG005|Overall Study|Adverse Event|0|||
163226843|NCT03912233|589546079|FG000|Overall Study|Physician Decision|1|||
163226844|NCT03912233|589546080|FG001|Overall Study|Physician Decision|0|||
163226845|NCT03912233|589546081|FG002|Overall Study|Physician Decision|0|||
163226846|NCT03912233|589546082|FG003|Overall Study|Physician Decision|0|||
163226847|NCT03912233|589546083|FG004|Overall Study|Physician Decision|0|||
163130128|NCT00666965|589184153|FG001|Overall Study|Adverse Event|2|||
163130129|NCT00666965|589184154|FG002|Overall Study|Adverse Event|1|||
163130130|NCT00666965|589184155|FG003|Overall Study|Adverse Event|9|||
163130131|NCT00666965|589184152|FG000|Overall Study|Lack of Efficacy|1|||
163130132|NCT00666965|589184153|FG001|Overall Study|Lack of Efficacy|1|||
163130133|NCT00666965|589184154|FG002|Overall Study|Lack of Efficacy|0|||
163130134|NCT00666965|589184155|FG003|Overall Study|Lack of Efficacy|0|||
163130135|NCT00666965|589184152|FG000|Overall Study|Protocol Violation|0|||
163130136|NCT00666965|589184153|FG001|Overall Study|Protocol Violation|0|||
163130137|NCT00666965|589184154|FG002|Overall Study|Protocol Violation|0|||
163130138|NCT00666965|589184155|FG003|Overall Study|Protocol Violation|2|||
163130139|NCT00666965|589184152|FG000|Overall Study|Discontinuation criteria|2|||
163130140|NCT00666965|589184153|FG001|Overall Study|Discontinuation criteria|1|||
163130141|NCT00666965|589184154|FG002|Overall Study|Discontinuation criteria|1|||
163130142|NCT00666965|589184155|FG003|Overall Study|Discontinuation criteria|2|||
163130143|NCT00666965|589184152|FG000|Overall Study|Withdrawal by Subject|0|||
163130144|NCT00666965|589184153|FG001|Overall Study|Withdrawal by Subject|0|||
163130145|NCT00666965|589184154|FG002|Overall Study|Withdrawal by Subject|0|||
163130146|NCT00666965|589184155|FG003|Overall Study|Withdrawal by Subject|2|||
163130147|NCT03596450|589184161|FG000|Overall Study|Death|9|||
163130148|NCT03596450|589184162|FG001|Overall Study|Death|9|||
163130149|NCT03596450|589184161|FG000|Overall Study|Protocol Violation|18|||
163130150|NCT03596450|589184162|FG001|Overall Study|Protocol Violation|26|||
163130151|NCT03596450|589184161|FG000|Overall Study|Lost to Follow-up|50|||
163130152|NCT03596450|589184162|FG001|Overall Study|Lost to Follow-up|56|||
163130153|NCT03596450|589184161|FG000|Overall Study|Adverse Event|14|||
163130154|NCT03596450|589184162|FG001|Overall Study|Adverse Event|7|||
163130155|NCT03596450|589184161|FG000|Overall Study|Withdrawal by Subject|38|||
163130156|NCT03596450|589184162|FG001|Overall Study|Withdrawal by Subject|36|||
163130157|NCT03596450|589184161|FG000|Overall Study|Accidentally Randomized|2|||
163130158|NCT03596450|589184162|FG001|Overall Study|Accidentally Randomized|0|||
163130159|NCT03596450|589184161|FG000|Overall Study|Other reasons|48|||
163130160|NCT03596450|589184162|FG001|Overall Study|Other reasons|53|||
163130161|NCT03596450|589184161|FG000|Overall Study|Pregnancy|2|||
163130162|NCT03596450|589184162|FG001|Overall Study|Pregnancy|0|||
163130163|NCT00498355|589184163|FG000|Overall Study|Lost to Follow-up|1|||
163130164|NCT03262441|589184174|FG000|Overall Study|Withdrawal by Subject|1|||
163130165|NCT02607228|589184175|FG000|Overall Study|Progressive Disease|4|||
163130166|NCT02607228|589184176|FG001|Overall Study|Progressive Disease|3|||
163130167|NCT02607228|589184177|FG002|Overall Study|Progressive Disease|1|||
163130168|NCT02607228|589184178|FG003|Overall Study|Progressive Disease|5|||
163130169|NCT02607228|589184179|FG004|Overall Study|Progressive Disease|4|||
163130170|NCT02607228|589184180|FG005|Overall Study|Progressive Disease|3|||
163130171|NCT02607228|589184181|FG006|Overall Study|Progressive Disease|1|||
163226848|NCT03912233|589546084|FG005|Overall Study|Physician Decision|0|||
163226849|NCT03912233|589546079|FG000|Overall Study|Other|0|||
163226850|NCT03912233|589546080|FG001|Overall Study|Other|0|||
163130172|NCT02607228|589184175|FG000|Overall Study|Adverse Event|1|||
163130173|NCT02607228|589184176|FG001|Overall Study|Adverse Event|0|||
163130174|NCT02607228|589184177|FG002|Overall Study|Adverse Event|1|||
163130175|NCT02607228|589184178|FG003|Overall Study|Adverse Event|0|||
163130176|NCT02607228|589184179|FG004|Overall Study|Adverse Event|1|||
163130177|NCT02607228|589184180|FG005|Overall Study|Adverse Event|1|||
163130178|NCT02607228|589184181|FG006|Overall Study|Adverse Event|1|||
163130179|NCT02607228|589184175|FG000|Overall Study|Investigator's Discretion|0|||
163130180|NCT02607228|589184176|FG001|Overall Study|Investigator's Discretion|0|||
163226851|NCT03912233|589546081|FG002|Overall Study|Other|0|||
163226852|NCT03912233|589546082|FG003|Overall Study|Other|0|||
163226853|NCT03912233|589546083|FG004|Overall Study|Other|7|||
163226854|NCT03912233|589546084|FG005|Overall Study|Other|12|||
163226855|NCT02583256|589546087|FG000|Overall Study|Withdrawal by Subject|0|||
163226856|NCT02583256|589546088|FG001|Overall Study|Withdrawal by Subject|1|||
163226857|NCT02583256|589546089|FG002|Overall Study|Withdrawal by Subject|1|||
163226858|NCT02583256|589546090|FG003|Overall Study|Withdrawal by Subject|0|||
163226859|NCT02583256|589546087|FG000|Overall Study|Lost to Follow-up|1|||
163226860|NCT02583256|589546088|FG001|Overall Study|Lost to Follow-up|1|||
163226861|NCT02583256|589546089|FG002|Overall Study|Lost to Follow-up|0|||
163226862|NCT02583256|589546090|FG003|Overall Study|Lost to Follow-up|1|||
163226863|NCT02583256|589546087|FG000|Overall Study|Administrative/Other|2|||
163226864|NCT02583256|589546088|FG001|Overall Study|Administrative/Other|0|||
163226865|NCT02583256|589546089|FG002|Overall Study|Administrative/Other|1|||
163226866|NCT02583256|589546090|FG003|Overall Study|Administrative/Other|2|||
163226867|NCT02177266|589546096|FG000|Overall Study|Adverse Event|0|||
163226868|NCT02177266|589546097|FG001|Overall Study|Adverse Event|1|||
163226869|NCT02177266|589546096|FG000|Overall Study|Withdrawal by Subject|1|||
163226870|NCT02177266|589546097|FG001|Overall Study|Withdrawal by Subject|0|||
163226871|NCT01023659|589546098|FG000|Overall Study|Lost to Follow-up|73|||
163226872|NCT01023659|589546099|FG001|Overall Study|Lost to Follow-up|228|||
163226873|NCT01023659|589546100|FG002|Overall Study|Lost to Follow-up|99|||
163226874|NCT04537806|589546101|FG000|Overall Study|Randomized but not treated|1|||
163226875|NCT04537806|589546102|FG001|Overall Study|Randomized but not treated|0|||
163226876|NCT04537806|589546101|FG000|Overall Study|Adverse Event|1|||
163226877|NCT04537806|589546102|FG001|Overall Study|Adverse Event|1|||
163226878|NCT03019627|589546105|FG000|Overall Study|Adverse Event|8|||
163226879|NCT03019627|589546106|FG001|Overall Study|Adverse Event|0|||
163226880|NCT03019627|589546105|FG000|Overall Study|Unrelated to adverse event|1|||
163226881|NCT03019627|589546106|FG001|Overall Study|Unrelated to adverse event|3|||
163226882|NCT03019627|589546105|FG000|Overall Study|Lost to Follow-up|2|||
163226883|NCT03019627|589546106|FG001|Overall Study|Lost to Follow-up|1|||
163226884|NCT03019627|589546105|FG000|Overall Study|not compliance|2|||
163226885|NCT03019627|589546106|FG001|Overall Study|not compliance|2|||
163226886|NCT03019627|589546105|FG000|Overall Study|Other|2|||
163226887|NCT03019627|589546106|FG001|Overall Study|Other|2|||
163226888|NCT01802775|589546107|FG000|Overall Study|Death|0|||
163226889|NCT01802775|589546108|FG001|Overall Study|Death|3|||
163226890|NCT01802775|589546107|FG000|Overall Study|Reason not provided|0|||
163226891|NCT01802775|589546108|FG001|Overall Study|Reason not provided|1|||
163226892|NCT01802775|589546107|FG000|Overall Study|Physician Decision|1|||
163343410|NCT02123797|589966409|FG001|Baseline Intervention|Lost to Follow-up|5|||
163343411|NCT02123797|589966410|FG002|Baseline Intervention|Lost to Follow-up|0|||
163343412|NCT02123797|589966411|FG003|Baseline Intervention|Lost to Follow-up|0|||
163343413|NCT02123797|589966412|FG004|Baseline Intervention|Lost to Follow-up|0|||
163226893|NCT01802775|589546108|FG001|Overall Study|Physician Decision|0|||
163226894|NCT01802775|589546107|FG000|Overall Study|Adverse Event|1|||
163226895|NCT01802775|589546108|FG001|Overall Study|Adverse Event|1|||
163226896|NCT01802775|589546107|FG000|Overall Study|Withdrawal by Subject|3|||
163343414|NCT02123797|589966408|FG000|Baseline Intervention|Other Disease|3|||
163343415|NCT02123797|589966409|FG001|Baseline Intervention|Other Disease|0|||
163343416|NCT02123797|589966410|FG002|Baseline Intervention|Other Disease|0|||
163343417|NCT02123797|589966411|FG003|Baseline Intervention|Other Disease|0|||
163343418|NCT02123797|589966412|FG004|Baseline Intervention|Other Disease|0|||
163343419|NCT02123797|589966408|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
163343420|NCT02123797|589966409|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
163343421|NCT02123797|589966410|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
163343422|NCT02123797|589966411|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
163343423|NCT02123797|589966412|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
163343424|NCT02123797|589966408|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
163343425|NCT02123797|589966409|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
163343426|NCT02123797|589966410|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
163343427|NCT02123797|589966411|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
163343428|NCT02123797|589966412|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
163343429|NCT02123797|589966408|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
163343430|NCT02123797|589966409|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
163226897|NCT01802775|589546108|FG001|Overall Study|Withdrawal by Subject|5|||
163226898|NCT01802775|589546107|FG000|Overall Study|Lost to Follow-up|1|||
163226899|NCT01802775|589546108|FG001|Overall Study|Lost to Follow-up|2|||
163226900|NCT00519649|589546111|FG000|Overall Study|Withdrawal by Subject|1|||
163226901|NCT01465802|589546112|FG000|Overall Study|Study terminated by sponsor|1|||
163226902|NCT01465802|589546113|FG001|Overall Study|Study terminated by sponsor|0|||
163226903|NCT01465802|589546114|FG002|Overall Study|Study terminated by sponsor|0|||
163343431|NCT02123797|589966410|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
163226904|NCT01465802|589546115|FG003|Overall Study|Study terminated by sponsor|1|||
163226905|NCT01465802|589546116|FG004|Overall Study|Study terminated by sponsor|7|||
163226906|NCT01465802|589546112|FG000|Overall Study|Withdrawal by Subject|7|||
163226907|NCT01465802|589546113|FG001|Overall Study|Withdrawal by Subject|7|||
163226908|NCT01465802|589546114|FG002|Overall Study|Withdrawal by Subject|0|||
163226909|NCT01465802|589546115|FG003|Overall Study|Withdrawal by Subject|8|||
163343432|NCT02123797|589966411|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
163130181|NCT02607228|589184177|FG002|Overall Study|Investigator's Discretion|1|||
163130182|NCT02607228|589184178|FG003|Overall Study|Investigator's Discretion|0|||
163130183|NCT02607228|589184179|FG004|Overall Study|Investigator's Discretion|0|||
163130184|NCT02607228|589184180|FG005|Overall Study|Investigator's Discretion|1|||
163130185|NCT02607228|589184181|FG006|Overall Study|Investigator's Discretion|0|||
163130186|NCT02607228|589184175|FG000|Overall Study|Withdrew Consent|0|||
163130187|NCT02607228|589184176|FG001|Overall Study|Withdrew Consent|1|||
163130188|NCT02607228|589184177|FG002|Overall Study|Withdrew Consent|0|||
163130189|NCT02607228|589184178|FG003|Overall Study|Withdrew Consent|0|||
163130190|NCT02607228|589184179|FG004|Overall Study|Withdrew Consent|0|||
163130191|NCT02607228|589184180|FG005|Overall Study|Withdrew Consent|1|||
163130192|NCT02607228|589184181|FG006|Overall Study|Withdrew Consent|0|||
163130193|NCT02607228|589184175|FG000|Overall Study|Study Terminated by Sponsor|0|||
163130194|NCT02607228|589184176|FG001|Overall Study|Study Terminated by Sponsor|0|||
163130195|NCT02607228|589184177|FG002|Overall Study|Study Terminated by Sponsor|0|||
163130196|NCT02607228|589184178|FG003|Overall Study|Study Terminated by Sponsor|1|||
163130197|NCT02607228|589184179|FG004|Overall Study|Study Terminated by Sponsor|0|||
163130198|NCT02607228|589184180|FG005|Overall Study|Study Terminated by Sponsor|0|||
163130199|NCT02607228|589184181|FG006|Overall Study|Study Terminated by Sponsor|0|||
163130200|NCT01455194|589184189|FG000|Overall Study|Screen Failure|20|||
163130201|NCT01455194|589184190|FG001|Overall Study|Screen Failure|0|||
163130202|NCT01455194|589184191|FG002|Overall Study|Screen Failure|0|||
163130203|NCT01455194|589184192|FG003|Overall Study|Screen Failure|0|||
163130204|NCT01455194|589184189|FG000|Overall Study|Randomisation Failure|90|||
163130205|NCT01455194|589184190|FG001|Overall Study|Randomisation Failure|0|||
163130206|NCT01455194|589184191|FG002|Overall Study|Randomisation Failure|0|||
163130207|NCT01455194|589184192|FG003|Overall Study|Randomisation Failure|0|||
163130208|NCT01455194|589184189|FG000|Overall Study|Deterioration in asthma|12|||
163130209|NCT01455194|589184190|FG001|Overall Study|Deterioration in asthma|6|||
163130210|NCT01455194|589184191|FG002|Overall Study|Deterioration in asthma|14|||
163130211|NCT01455194|589184192|FG003|Overall Study|Deterioration in asthma|9|||
163130212|NCT01455194|589184189|FG000|Overall Study|Adverse Event|1|||
163130213|NCT01455194|589184190|FG001|Overall Study|Adverse Event|1|||
163130214|NCT01455194|589184191|FG002|Overall Study|Adverse Event|1|||
163130215|NCT01455194|589184192|FG003|Overall Study|Adverse Event|3|||
163130216|NCT01455194|589184189|FG000|Overall Study|Withdrawal by Subject|21|||
163130217|NCT01455194|589184190|FG001|Overall Study|Withdrawal by Subject|16|||
163130218|NCT01455194|589184191|FG002|Overall Study|Withdrawal by Subject|12|||
163130219|NCT01455194|589184192|FG003|Overall Study|Withdrawal by Subject|9|||
163130220|NCT01455194|589184189|FG000|Overall Study|Lost to Follow-up|2|||
163130221|NCT01455194|589184190|FG001|Overall Study|Lost to Follow-up|0|||
163130222|NCT01455194|589184191|FG002|Overall Study|Lost to Follow-up|1|||
163130223|NCT01455194|589184192|FG003|Overall Study|Lost to Follow-up|1|||
163130224|NCT01455194|589184189|FG000|Overall Study|Pregnancy|0|||
163130225|NCT01455194|589184190|FG001|Overall Study|Pregnancy|1|||
163130226|NCT01455194|589184191|FG002|Overall Study|Pregnancy|1|||
163130227|NCT01455194|589184192|FG003|Overall Study|Pregnancy|0|||
163130228|NCT01455194|589184189|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
163130229|NCT01455194|589184190|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
163130230|NCT01455194|589184191|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
163130231|NCT01455194|589184192|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
163130232|NCT01455194|589184189|FG000|Overall Study|Miscellaneous|4|||
163130233|NCT01455194|589184190|FG001|Overall Study|Miscellaneous|5|||
163130234|NCT01455194|589184191|FG002|Overall Study|Miscellaneous|1|||
163130235|NCT01455194|589184192|FG003|Overall Study|Miscellaneous|4|||
163130236|NCT05090852|589184193|FG000|Overall Study|Physician Decision|5|||
163130237|NCT00504894|589184194|FG000|Overall Study|fMRI technical problems|1|||
163130238|NCT00504894|589184195|FG001|Overall Study|fMRI technical problems|1|||
163130239|NCT00504894|589184196|FG002|Overall Study|fMRI technical problems|0|||
163130240|NCT00504894|589184194|FG000|Overall Study|Withdrawal by Subject|0|||
163130241|NCT00504894|589184195|FG001|Overall Study|Withdrawal by Subject|1|||
163130242|NCT00504894|589184196|FG002|Overall Study|Withdrawal by Subject|0|||
163130243|NCT00504894|589184194|FG000|Overall Study|Infusion technical problems|0|||
163130244|NCT00504894|589184195|FG001|Overall Study|Infusion technical problems|1|||
163130245|NCT00504894|589184196|FG002|Overall Study|Infusion technical problems|0|||
163130246|NCT00504894|589184194|FG000|Overall Study|poor subject data|2|||
163130247|NCT00504894|589184195|FG001|Overall Study|poor subject data|0|||
163130248|NCT00504894|589184196|FG002|Overall Study|poor subject data|0|||
163130249|NCT01196416|589184197|FG000|Overall Study|Withdrawal by Subject|2|||
163130250|NCT00148941|589184198|FG000|Overall Study|Lost to Follow-up|17|||
163130251|NCT00148941|589184199|FG001|Overall Study|Lost to Follow-up|24|||
163130252|NCT00148941|589184200|FG002|Overall Study|Lost to Follow-up|18|||
163130253|NCT00148941|589184201|FG003|Overall Study|Lost to Follow-up|22|||
163130254|NCT00148941|589184198|FG000|Overall Study|Withdrawal by Subject|1|||
163130255|NCT00148941|589184199|FG001|Overall Study|Withdrawal by Subject|0|||
163130256|NCT00148941|589184200|FG002|Overall Study|Withdrawal by Subject|1|||
163226910|NCT01465802|589546116|FG004|Overall Study|Withdrawal by Subject|1|||
163226911|NCT01465802|589546112|FG000|Overall Study|Lost to Follow-up|1|||
163226912|NCT01465802|589546113|FG001|Overall Study|Lost to Follow-up|1|||
163226913|NCT01465802|589546114|FG002|Overall Study|Lost to Follow-up|0|||
163226914|NCT01465802|589546115|FG003|Overall Study|Lost to Follow-up|0|||
163226915|NCT01465802|589546116|FG004|Overall Study|Lost to Follow-up|0|||
163226916|NCT01465802|589546112|FG000|Overall Study|Reason not specified|9|||
163226917|NCT01465802|589546113|FG001|Overall Study|Reason not specified|4|||
163226918|NCT01465802|589546114|FG002|Overall Study|Reason not specified|0|||
163226919|NCT01465802|589546115|FG003|Overall Study|Reason not specified|10|||
163226920|NCT01465802|589546116|FG004|Overall Study|Reason not specified|2|||
163226921|NCT01465802|589546112|FG000|Overall Study|Death|15|||
163226922|NCT01465802|589546113|FG001|Overall Study|Death|12|||
163226923|NCT01465802|589546114|FG002|Overall Study|Death|0|||
163226924|NCT01465802|589546115|FG003|Overall Study|Death|10|||
163226925|NCT01465802|589546116|FG004|Overall Study|Death|2|||
163226926|NCT01067352|589546117|FG000|Overall Study|Withdrawal by Subject|1|||
163226927|NCT01067352|589546118|FG001|Overall Study|Withdrawal by Subject|2|||
163226928|NCT01067352|589546119|FG002|Overall Study|Withdrawal by Subject|1|||
163226929|NCT01067352|589546117|FG000|Overall Study|Physician Decision|0|||
163226930|NCT01067352|589546118|FG001|Overall Study|Physician Decision|1|||
163226931|NCT01067352|589546119|FG002|Overall Study|Physician Decision|0|||
163226932|NCT02103478|589546120|FG000|Overall Study|Adverse Event|0|||
163226933|NCT02103478|589546121|FG001|Overall Study|Adverse Event|0|||
163226934|NCT02103478|589546122|FG002|Overall Study|Adverse Event|1|||
163226935|NCT02103478|589546123|FG003|Overall Study|Adverse Event|1|||
163226936|NCT02103478|589546124|FG004|Overall Study|Adverse Event|2|||
163226937|NCT02103478|589546125|FG005|Overall Study|Adverse Event|1|||
163226938|NCT02103478|589546126|FG006|Overall Study|Adverse Event|0|||
163226939|NCT02103478|589546127|FG007|Overall Study|Adverse Event|0|||
163226940|NCT02103478|589546128|FG008|Overall Study|Adverse Event|0|||
163226941|NCT02103478|589546120|FG000|Overall Study|Death|2|||
163226942|NCT02103478|589546121|FG001|Overall Study|Death|2|||
163226943|NCT02103478|589546122|FG002|Overall Study|Death|1|||
163226944|NCT02103478|589546123|FG003|Overall Study|Death|1|||
163226945|NCT02103478|589546124|FG004|Overall Study|Death|5|||
163226946|NCT02103478|589546125|FG005|Overall Study|Death|15|||
163226947|NCT02103478|589546126|FG006|Overall Study|Death|14|||
163226948|NCT02103478|589546127|FG007|Overall Study|Death|10|||
163226949|NCT02103478|589546128|FG008|Overall Study|Death|11|||
163226950|NCT02103478|589546120|FG000|Overall Study|Progressive Disease|2|||
163226951|NCT02103478|589546121|FG001|Overall Study|Progressive Disease|1|||
163226952|NCT02103478|589546122|FG002|Overall Study|Progressive Disease|2|||
163226953|NCT02103478|589546123|FG003|Overall Study|Progressive Disease|0|||
163226954|NCT02103478|589546124|FG004|Overall Study|Progressive Disease|9|||
163226955|NCT02103478|589546125|FG005|Overall Study|Progressive Disease|1|||
163226956|NCT02103478|589546126|FG006|Overall Study|Progressive Disease|2|||
163226957|NCT02103478|589546127|FG007|Overall Study|Progressive Disease|0|||
163226958|NCT02103478|589546128|FG008|Overall Study|Progressive Disease|1|||
163226959|NCT02103478|589546120|FG000|Overall Study|Withdrawal by Subject|2|||
163226960|NCT02103478|589546121|FG001|Overall Study|Withdrawal by Subject|0|||
163226961|NCT02103478|589546122|FG002|Overall Study|Withdrawal by Subject|0|||
163226962|NCT02103478|589546123|FG003|Overall Study|Withdrawal by Subject|4|||
163226963|NCT02103478|589546124|FG004|Overall Study|Withdrawal by Subject|0|||
163226964|NCT02103478|589546125|FG005|Overall Study|Withdrawal by Subject|0|||
163226965|NCT02103478|589546126|FG006|Overall Study|Withdrawal by Subject|1|||
163226966|NCT02103478|589546127|FG007|Overall Study|Withdrawal by Subject|1|||
163226967|NCT02103478|589546128|FG008|Overall Study|Withdrawal by Subject|0|||
163226968|NCT02103478|589546120|FG000|Overall Study|Lost to Follow-up|0|||
163226969|NCT02103478|589546121|FG001|Overall Study|Lost to Follow-up|0|||
163226970|NCT02103478|589546122|FG002|Overall Study|Lost to Follow-up|0|||
163226971|NCT02103478|589546123|FG003|Overall Study|Lost to Follow-up|0|||
163226972|NCT02103478|589546124|FG004|Overall Study|Lost to Follow-up|0|||
163226973|NCT02103478|589546125|FG005|Overall Study|Lost to Follow-up|0|||
163226974|NCT02103478|589546126|FG006|Overall Study|Lost to Follow-up|0|||
163226975|NCT02103478|589546127|FG007|Overall Study|Lost to Follow-up|1|||
163226976|NCT02103478|589546128|FG008|Overall Study|Lost to Follow-up|0|||
163226977|NCT02103478|589546120|FG000|Overall Study|Other|1|||
163226978|NCT02103478|589546121|FG001|Overall Study|Other|3|||
163226979|NCT02103478|589546122|FG002|Overall Study|Other|2|||
163226980|NCT02103478|589546123|FG003|Overall Study|Other|0|||
163226981|NCT02103478|589546124|FG004|Overall Study|Other|3|||
163226982|NCT02103478|589546125|FG005|Overall Study|Other|8|||
163226983|NCT02103478|589546126|FG006|Overall Study|Other|8|||
163226984|NCT02103478|589546127|FG007|Overall Study|Other|4|||
163226985|NCT02103478|589546128|FG008|Overall Study|Other|2|||
163226986|NCT03219333|589546129|FG000|Overall Study|Withdrawal by Subject|9|||
163226987|NCT03219333|589546130|FG001|Overall Study|Withdrawal by Subject|4|||
163226988|NCT03219333|589546129|FG000|Overall Study|Lost to Follow-up|1|||
163226989|NCT03219333|589546130|FG001|Overall Study|Lost to Follow-up|1|||
163226990|NCT03219333|589546129|FG000|Overall Study|Death|104|||
163226991|NCT03219333|589546130|FG001|Overall Study|Death|72|||
163226992|NCT03219333|589546129|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
163226993|NCT03219333|589546130|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
163226994|NCT03219333|589546129|FG000|Overall Study|Other|2|||
163408391|NCT03823391|590205504|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
163408392|NCT05882318|590205505|FG000|Overall Study|Withdrawal by Subject|1|||
163408393|NCT05882318|590205506|FG001|Overall Study|Withdrawal by Subject|0|||
163226995|NCT03219333|589546130|FG001|Overall Study|Other|2|||
163226996|NCT00723606|589546131|FG000|Overall Study|Adverse Event|2|||
163226997|NCT00723606|589546132|FG001|Overall Study|Adverse Event|5|||
163226998|NCT00723606|589546131|FG000|Overall Study|Other|2|||
163226999|NCT00723606|589546132|FG001|Overall Study|Other|0|||
163227000|NCT00723606|589546131|FG000|Overall Study|Withdrawal by Subject|0|||
163227001|NCT00723606|589546132|FG001|Overall Study|Withdrawal by Subject|2|||
163227002|NCT02566759|589546133|FG000|All Parts|Withdrawal by Subject|0|||
163227003|NCT02566759|589546134|FG001|All Parts|Withdrawal by Subject|1|||
163227004|NCT02566759|589546135|FG002|All Parts|Withdrawal by Subject|0|||
163227005|NCT02566759|589546136|FG003|All Parts|Withdrawal by Subject|0|||
163227006|NCT02566759|589546137|FG004|All Parts|Withdrawal by Subject|0|||
163227007|NCT02566759|589546138|FG005|All Parts|Withdrawal by Subject|0|||
163227008|NCT02566759|589546139|FG006|All Parts|Withdrawal by Subject|0|||
163227009|NCT02566759|589546140|FG007|All Parts|Withdrawal by Subject|0|||
163227010|NCT02566759|589546141|FG008|All Parts|Withdrawal by Subject|0|||
163227011|NCT02566759|589546142|FG009|All Parts|Withdrawal by Subject|0|||
163227012|NCT02566759|589546143|FG010|All Parts|Withdrawal by Subject|0|||
163227013|NCT02566759|589546144|FG011|All Parts|Withdrawal by Subject|0|||
163227014|NCT02566759|589546145|FG012|All Parts|Withdrawal by Subject|0|||
163227015|NCT02566759|589546146|FG013|All Parts|Withdrawal by Subject|0|||
163227016|NCT02566759|589546147|FG014|All Parts|Withdrawal by Subject|0|||
163227017|NCT02566759|589546148|FG015|All Parts|Withdrawal by Subject|0|||
163227018|NCT02566759|589546149|FG016|All Parts|Withdrawal by Subject|0|||
163227019|NCT02566759|589546133|FG000|All Parts|Adverse Event|0|||
163227020|NCT02566759|589546134|FG001|All Parts|Adverse Event|0|||
163227021|NCT02566759|589546135|FG002|All Parts|Adverse Event|0|||
163227022|NCT02566759|589546136|FG003|All Parts|Adverse Event|0|||
163227023|NCT02566759|589546137|FG004|All Parts|Adverse Event|0|||
163227024|NCT02566759|589546138|FG005|All Parts|Adverse Event|0|||
163227025|NCT02566759|589546139|FG006|All Parts|Adverse Event|0|||
163227026|NCT02566759|589546140|FG007|All Parts|Adverse Event|0|||
163227027|NCT02566759|589546141|FG008|All Parts|Adverse Event|0|||
163227028|NCT02566759|589546142|FG009|All Parts|Adverse Event|0|||
163227029|NCT02566759|589546143|FG010|All Parts|Adverse Event|0|||
163227030|NCT02566759|589546144|FG011|All Parts|Adverse Event|0|||
163227031|NCT02566759|589546145|FG012|All Parts|Adverse Event|1|||
163227032|NCT02566759|589546146|FG013|All Parts|Adverse Event|3|||
163227033|NCT02566759|589546147|FG014|All Parts|Adverse Event|0|||
163227034|NCT02566759|589546148|FG015|All Parts|Adverse Event|0|||
163227035|NCT02566759|589546149|FG016|All Parts|Adverse Event|0|||
163227036|NCT02566759|589546133|FG000|All Parts|Other|0|||
163227037|NCT02566759|589546134|FG001|All Parts|Other|0|||
163227038|NCT02566759|589546135|FG002|All Parts|Other|0|||
163227039|NCT02566759|589546136|FG003|All Parts|Other|0|||
163227040|NCT02566759|589546137|FG004|All Parts|Other|0|||
163227041|NCT02566759|589546138|FG005|All Parts|Other|0|||
163227042|NCT02566759|589546139|FG006|All Parts|Other|0|||
163227043|NCT02566759|589546140|FG007|All Parts|Other|0|||
163227044|NCT02566759|589546141|FG008|All Parts|Other|0|||
163227045|NCT02566759|589546142|FG009|All Parts|Other|0|||
163227046|NCT02566759|589546143|FG010|All Parts|Other|0|||
163227047|NCT02566759|589546144|FG011|All Parts|Other|0|||
163227048|NCT02566759|589546145|FG012|All Parts|Other|0|||
163227049|NCT02566759|589546146|FG013|All Parts|Other|2|||
163227050|NCT02566759|589546147|FG014|All Parts|Other|0|||
163227051|NCT02566759|589546148|FG015|All Parts|Other|0|||
163227052|NCT02566759|589546149|FG016|All Parts|Other|0|||
163227053|NCT02566759|589546133|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163227054|NCT02566759|589546134|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163408394|NCT05882318|590205505|FG000|Overall Study|Protocol Violation|0|||
163408395|NCT05882318|590205506|FG001|Overall Study|Protocol Violation|1|||
163227055|NCT02566759|589546135|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163227056|NCT02566759|589546136|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163227057|NCT02566759|589546137|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163227058|NCT02566759|589546138|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163227059|NCT02566759|589546139|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163227060|NCT02566759|589546140|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163227061|NCT02566759|589546141|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163227062|NCT02566759|589546142|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163227063|NCT02566759|589546143|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163227064|NCT02566759|589546144|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163408396|NCT05030311|590205507|FG000|Overall Study|Technical problems|0|||
163227065|NCT02566759|589546145|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163227066|NCT02566759|589546146|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163227067|NCT02566759|589546147|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163227068|NCT02566759|589546148|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
163227069|NCT02566759|589546149|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
163227070|NCT01096784|589546150|FG000|Overall Study|Withdrawal by Subject|2|||
163227071|NCT01096784|589546151|FG001|Overall Study|Withdrawal by Subject|1|||
163227072|NCT01096784|589546150|FG000|Overall Study|Adverse Event|11|||
163227073|NCT01096784|589546151|FG001|Overall Study|Adverse Event|9|||
163227074|NCT01096784|589546150|FG000|Overall Study|Protocol Deviation|2|||
163227075|NCT01096784|589546151|FG001|Overall Study|Protocol Deviation|2|||
163227076|NCT01096784|589546150|FG000|Overall Study|Administrative Decision|0|||
163227077|NCT01096784|589546151|FG001|Overall Study|Administrative Decision|1|||
163227078|NCT01096784|589546150|FG000|Overall Study|Other Unspecified|0|||
163227079|NCT01096784|589546151|FG001|Overall Study|Other Unspecified|1|||
163227080|NCT00976898|589546152|FG000|Overall Study|Protocol Violation|1|||
163227081|NCT00976898|589546152|FG000|Overall Study|Adverse Event|1|||
163227082|NCT00976898|589546152|FG000|Overall Study|Physician Decision|1|||
163227083|NCT00976898|589546152|FG000|Overall Study|Liver Transplant|1|||
163227084|NCT00976898|589546152|FG000|Overall Study|Progressive Disease|1|||
163227085|NCT05107128|589546153|FG000|Overall Study|Adverse Event|2|||
163227086|NCT05107128|589546154|FG001|Overall Study|Adverse Event|0|||
163227087|NCT05107128|589546153|FG000|Overall Study|Withdrawal by Subject|3|||
163227088|NCT05107128|589546154|FG001|Overall Study|Withdrawal by Subject|3|||
163227089|NCT05107128|589546153|FG000|Overall Study|Withdrawal of Consent|0|||
163227090|NCT05107128|589546154|FG001|Overall Study|Withdrawal of Consent|1|||
163227091|NCT05107128|589546153|FG000|Overall Study|Reason Not Specified|2|||
163227092|NCT05107128|589546154|FG001|Overall Study|Reason Not Specified|0|||
163227093|NCT03761628|589546155|FG000|Overall Study|Withdrawal by Subject|3|||
163227094|NCT03761628|589546155|FG000|Overall Study|Physician Decision|1|||
163227095|NCT03761628|589546155|FG000|Overall Study|Pregnancy|1|||
163227096|NCT03761628|589546155|FG000|Overall Study|Lost to Follow-up|1|||
163227097|NCT01470469|589546158|FG000|Overall Study|Withdrawal by Subject|4|||
163227098|NCT01470469|589546159|FG001|Overall Study|Withdrawal by Subject|6|||
163227099|NCT01470469|589546158|FG000|Overall Study|Lack of Efficacy|1|||
163227100|NCT01470469|589546159|FG001|Overall Study|Lack of Efficacy|7|||
163227101|NCT01470469|589546158|FG000|Overall Study|Adverse Event|0|||
163227102|NCT01470469|589546159|FG001|Overall Study|Adverse Event|7|||
163227103|NCT01470469|589546158|FG000|Overall Study|Lost to Follow-up|2|||
163227104|NCT01470469|589546159|FG001|Overall Study|Lost to Follow-up|2|||
163227105|NCT01470469|589546158|FG000|Overall Study|Protocol Violation|1|||
163227106|NCT01470469|589546159|FG001|Overall Study|Protocol Violation|1|||
163227107|NCT01470469|589546158|FG000|Overall Study|Other|2|||
163227108|NCT01470469|589546159|FG001|Overall Study|Other|1|||
163227109|NCT05459129|589546160|FG000|Overall Study|Death|1|||
163227110|NCT05459129|589546161|FG001|Overall Study|Death|0|||
163227111|NCT05459129|589546160|FG000|Overall Study|Study Terminated By Sponsor|5|||
163227112|NCT05459129|589546161|FG001|Overall Study|Study Terminated By Sponsor|6|||
163227113|NCT04649151|589546169|FG000|Overall Study|Pregnancy|0|||
163227114|NCT04649151|589546170|FG001|Overall Study|Pregnancy|0|||
163227115|NCT04649151|589546171|FG002|Overall Study|Pregnancy|0|||
163227116|NCT04649151|589546172|FG003|Overall Study|Pregnancy|0|||
163227117|NCT04649151|589546173|FG004|Overall Study|Pregnancy|3|||
163227118|NCT04649151|589546169|FG000|Overall Study|Physician Decision|10|||
163227119|NCT04649151|589546170|FG001|Overall Study|Physician Decision|0|||
163227120|NCT04649151|589546171|FG002|Overall Study|Physician Decision|0|||
163227121|NCT04649151|589546172|FG003|Overall Study|Physician Decision|1|||
163227122|NCT04649151|589546173|FG004|Overall Study|Physician Decision|1|||
163227123|NCT04649151|589546169|FG000|Overall Study|Protocol Deviation|25|||
163227124|NCT04649151|589546170|FG001|Overall Study|Protocol Deviation|3|||
163227125|NCT04649151|589546171|FG002|Overall Study|Protocol Deviation|0|||
163227126|NCT04649151|589546172|FG003|Overall Study|Protocol Deviation|0|||
163227127|NCT04649151|589546173|FG004|Overall Study|Protocol Deviation|0|||
163343433|NCT02123797|589966412|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
163343434|NCT02123797|589966408|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
163227128|NCT04649151|589546169|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
163227129|NCT04649151|589546170|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
163227130|NCT04649151|589546171|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
163227131|NCT04649151|589546172|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
163227132|NCT04649151|589546173|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
163227133|NCT04649151|589546169|FG000|Overall Study|Withdrawal by Subject|370|||
163227134|NCT04649151|589546170|FG001|Overall Study|Withdrawal by Subject|113|||
163227135|NCT04649151|589546171|FG002|Overall Study|Withdrawal by Subject|2|||
163343435|NCT02123797|589966409|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
163227136|NCT04649151|589546172|FG003|Overall Study|Withdrawal by Subject|7|||
163227137|NCT04649151|589546173|FG004|Overall Study|Withdrawal by Subject|15|||
163408397|NCT05030311|590205508|FG001|Overall Study|Technical problems|1|||
163227138|NCT04649151|589546169|FG000|Overall Study|Adverse Event|1|||
163227139|NCT04649151|589546170|FG001|Overall Study|Adverse Event|0|||
163227140|NCT04649151|589546171|FG002|Overall Study|Adverse Event|0|||
163227141|NCT04649151|589546172|FG003|Overall Study|Adverse Event|0|||
163227142|NCT04649151|589546173|FG004|Overall Study|Adverse Event|0|||
163227143|NCT04649151|589546169|FG000|Overall Study|Lost to Follow-up|256|||
163227144|NCT04649151|589546170|FG001|Overall Study|Lost to Follow-up|29|||
163227145|NCT04649151|589546171|FG002|Overall Study|Lost to Follow-up|10|||
163227146|NCT04649151|589546172|FG003|Overall Study|Lost to Follow-up|3|||
163227147|NCT04649151|589546173|FG004|Overall Study|Lost to Follow-up|6|||
163227148|NCT04649151|589546169|FG000|Overall Study|Other than specified|59|||
163227149|NCT04649151|589546170|FG001|Overall Study|Other than specified|294|||
163227150|NCT04649151|589546171|FG002|Overall Study|Other than specified|0|||
163227151|NCT04649151|589546172|FG003|Overall Study|Other than specified|0|||
163227152|NCT04649151|589546173|FG004|Overall Study|Other than specified|4|||
163227153|NCT04649151|589546169|FG000|Overall Study|Death|0|||
163227154|NCT04649151|589546170|FG001|Overall Study|Death|0|||
163227155|NCT04649151|589546171|FG002|Overall Study|Death|0|||
163227156|NCT04649151|589546172|FG003|Overall Study|Death|0|||
163227157|NCT04649151|589546173|FG004|Overall Study|Death|1|||
163227158|NCT03752619|589546174|FG000|Overall Study|Lost to Follow-up|2|||
163227159|NCT03752619|589546175|FG001|Overall Study|Lost to Follow-up|1|||
163227160|NCT03752619|589546174|FG000|Overall Study|Withdrawal by Subject|1|||
163227161|NCT03752619|589546175|FG001|Overall Study|Withdrawal by Subject|1|||
163227162|NCT03752619|589546174|FG000|Overall Study|Adverse Event|0|||
163227163|NCT03752619|589546175|FG001|Overall Study|Adverse Event|1|||
163227164|NCT04476017|589546176|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
163227165|NCT04476017|589546177|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
163227166|NCT03362502|589546178|FG000|Overall Study|Death|0|||
163227167|NCT03362502|589546179|FG001|Overall Study|Death|0|||
163227168|NCT03362502|589546180|FG002|Overall Study|Death|1|||
163227169|NCT02018458|589546183|FG000|Overall Study|Death|4|||
163227170|NCT00727714|589546189|FG000|Overall Study|Lost to Follow-up|2|||
163227171|NCT00325234|589546192|FG000|Overall Study|Adverse Event|10|||
163227172|NCT00325234|589546193|FG001|Overall Study|Adverse Event|7|||
163227173|NCT00325234|589546192|FG000|Overall Study|Death due to Study Disease|1|||
163227174|NCT00325234|589546193|FG001|Overall Study|Death due to Study Disease|0|||
163227175|NCT00325234|589546192|FG000|Overall Study|Entry Criteria Not Met|1|||
163227176|NCT00325234|589546193|FG001|Overall Study|Entry Criteria Not Met|2|||
163227177|NCT00325234|589546192|FG000|Overall Study|Subject Decision|6|||
163227178|NCT00325234|589546193|FG001|Overall Study|Subject Decision|8|||
163227179|NCT00325234|589546192|FG000|Overall Study|Physician Decision|17|||
163227180|NCT00325234|589546193|FG001|Overall Study|Physician Decision|12|||
163227181|NCT00325234|589546192|FG000|Overall Study|Progressive Disease|34|||
163227182|NCT00325234|589546193|FG001|Overall Study|Progressive Disease|37|||
163227183|NCT01234467|589546194|FG000|Overall Study|Adverse Event|3|||
163227184|NCT01234467|589546194|FG000|Overall Study|Death|2|||
163227185|NCT01234467|589546194|FG000|Overall Study|Withdrawal by Subject|2|||
163227186|NCT01234467|589546194|FG000|Overall Study|Disease Progression|2|||
163227187|NCT01234467|589546194|FG000|Overall Study|Clinical deterioration|1|||
163227188|NCT01234467|589546194|FG000|Overall Study|Physician Decision|1|||
163227189|NCT01234467|589546194|FG000|Overall Study|Other complicating disease (stroke)|1|||
163227190|NCT01120210|589546197|FG000|MAIN INFUSION|Adverse Event|1|||
163227191|NCT01120210|589546198|FG001|MAIN INFUSION|Adverse Event|0|||
163227192|NCT01120210|589546197|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
163227193|NCT01120210|589546198|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
163227194|NCT04049760|589546206|FG000|Overall Study|Withdrawal by Subject|1|||
163227195|NCT03995953|589546209|FG000|Overall Study|Death|3|||
163227196|NCT03995953|589546210|FG001|Overall Study|Death|0|||
163227197|NCT03995953|589546211|FG002|Overall Study|Death|3|||
163227198|NCT03995953|589546212|FG003|Overall Study|Death|0|||
163227199|NCT03995953|589546213|FG004|Overall Study|Death|3|||
163227200|NCT03995953|589546214|FG005|Overall Study|Death|0|||
163227201|NCT03995953|589546215|FG006|Overall Study|Death|0|||
163227202|NCT03995953|589546216|FG007|Overall Study|Death|0|||
163227203|NCT03995953|589546217|FG008|Overall Study|Death|1|||
163227204|NCT03995953|589546218|FG009|Overall Study|Death|0|||
163343436|NCT02123797|589966410|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
163343437|NCT02123797|589966411|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
163343438|NCT02123797|589966412|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
163227205|NCT03995953|589546219|FG010|Overall Study|Death|0|||
163227206|NCT03995953|589546220|FG011|Overall Study|Death|0|||
163227207|NCT03995953|589546209|FG000|Overall Study|Lost to Follow-up|6|||
163227208|NCT03995953|589546210|FG001|Overall Study|Lost to Follow-up|54|||
163227209|NCT03995953|589546211|FG002|Overall Study|Lost to Follow-up|3|||
163227210|NCT03995953|589546212|FG003|Overall Study|Lost to Follow-up|32|||
163227211|NCT03995953|589546213|FG004|Overall Study|Lost to Follow-up|5|||
163227212|NCT03995953|589546214|FG005|Overall Study|Lost to Follow-up|44|||
163227213|NCT03995953|589546215|FG006|Overall Study|Lost to Follow-up|0|||
163227214|NCT03995953|589546216|FG007|Overall Study|Lost to Follow-up|31|||
163227215|NCT03995953|589546217|FG008|Overall Study|Lost to Follow-up|8|||
163227216|NCT03995953|589546218|FG009|Overall Study|Lost to Follow-up|36|||
163227217|NCT03995953|589546219|FG010|Overall Study|Lost to Follow-up|5|||
163343439|NCT02123797|589966408|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
163343440|NCT02123797|589966409|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
163343441|NCT02123797|589966410|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
163343442|NCT02123797|589966411|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
163343443|NCT02123797|589966412|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
163343444|NCT02123797|589966408|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
163227218|NCT03995953|589546220|FG011|Overall Study|Lost to Follow-up|41|||
163227219|NCT03995953|589546209|FG000|Overall Study|Withdrawal by Subject|4|||
163227220|NCT03995953|589546210|FG001|Overall Study|Withdrawal by Subject|0|||
163227221|NCT03995953|589546211|FG002|Overall Study|Withdrawal by Subject|1|||
163227222|NCT03995953|589546212|FG003|Overall Study|Withdrawal by Subject|0|||
163227223|NCT03995953|589546213|FG004|Overall Study|Withdrawal by Subject|1|||
163227224|NCT03995953|589546214|FG005|Overall Study|Withdrawal by Subject|0|||
163227225|NCT03995953|589546215|FG006|Overall Study|Withdrawal by Subject|1|||
163227226|NCT03995953|589546216|FG007|Overall Study|Withdrawal by Subject|0|||
163227227|NCT03995953|589546217|FG008|Overall Study|Withdrawal by Subject|3|||
163227228|NCT03995953|589546218|FG009|Overall Study|Withdrawal by Subject|0|||
163227229|NCT03995953|589546219|FG010|Overall Study|Withdrawal by Subject|3|||
163227230|NCT03995953|589546220|FG011|Overall Study|Withdrawal by Subject|0|||
163227231|NCT03995953|589546209|FG000|Overall Study|Health Issues|0|||
163227232|NCT03995953|589546210|FG001|Overall Study|Health Issues|0|||
163227233|NCT03995953|589546211|FG002|Overall Study|Health Issues|0|||
163227234|NCT03995953|589546212|FG003|Overall Study|Health Issues|0|||
163227235|NCT03995953|589546213|FG004|Overall Study|Health Issues|1|||
163227236|NCT03995953|589546214|FG005|Overall Study|Health Issues|0|||
163227237|NCT03995953|589546215|FG006|Overall Study|Health Issues|0|||
163227238|NCT03995953|589546216|FG007|Overall Study|Health Issues|0|||
163227239|NCT03995953|589546217|FG008|Overall Study|Health Issues|4|||
163227240|NCT03995953|589546218|FG009|Overall Study|Health Issues|0|||
163227241|NCT03995953|589546219|FG010|Overall Study|Health Issues|0|||
163227242|NCT03995953|589546220|FG011|Overall Study|Health Issues|0|||
163227243|NCT03995953|589546209|FG000|Overall Study|Relocated|11|||
163227244|NCT03995953|589546210|FG001|Overall Study|Relocated|0|||
163227245|NCT03995953|589546211|FG002|Overall Study|Relocated|16|||
163227246|NCT03995953|589546212|FG003|Overall Study|Relocated|0|||
163227247|NCT03995953|589546213|FG004|Overall Study|Relocated|14|||
163227248|NCT03995953|589546214|FG005|Overall Study|Relocated|0|||
163227249|NCT03995953|589546215|FG006|Overall Study|Relocated|16|||
163227250|NCT03995953|589546216|FG007|Overall Study|Relocated|0|||
163227251|NCT03995953|589546217|FG008|Overall Study|Relocated|14|||
163227252|NCT03995953|589546218|FG009|Overall Study|Relocated|0|||
163227253|NCT03995953|589546219|FG010|Overall Study|Relocated|15|||
163227254|NCT03995953|589546220|FG011|Overall Study|Relocated|0|||
163227255|NCT02130765|589546221|FG000|Overall Study|Did not receive treatment|4|||
163227256|NCT02130765|589546222|FG001|Overall Study|Did not receive treatment|0|||
163227257|NCT02130765|589546223|FG002|Overall Study|Did not receive treatment|0|||
163227258|NCT02130765|589546224|FG003|Overall Study|Did not receive treatment|0|||
163227259|NCT02388997|589546225|FG000|Overall Study|Adverse Event|1|||
163227260|NCT02388997|589546226|FG001|Overall Study|Adverse Event|2|||
163227261|NCT02388997|589546225|FG000|Overall Study|Withdrawal by Subject|2|||
163227262|NCT02388997|589546226|FG001|Overall Study|Withdrawal by Subject|1|||
163227263|NCT02388997|589546225|FG000|Overall Study|Lung function exclusion criteria|0|||
163227264|NCT02388997|589546226|FG001|Overall Study|Lung function exclusion criteria|2|||
163227265|NCT02388997|589546225|FG000|Overall Study|Tested positive for virus during run-in|0|||
163227266|NCT02388997|589546226|FG001|Overall Study|Tested positive for virus during run-in|1|||
163227267|NCT00006184|589546229|FG000|Overall Study|Death|1|||
163227268|NCT00006184|589546230|FG001|Overall Study|Death|0|||
163343445|NCT02123797|589966409|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
163343446|NCT02123797|589966410|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
163343447|NCT02123797|589966411|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
163343448|NCT02123797|589966412|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
163343449|NCT02123797|589966408|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
163343450|NCT02123797|589966409|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
163343451|NCT02123797|589966410|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
163343452|NCT02123797|589966411|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
163343453|NCT02123797|589966412|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
163227269|NCT01256710|589546231|FG000|Overall Study|Death|449|||
163227270|NCT01256710|589546231|FG000|Overall Study|System Explant|67|||
163227271|NCT01256710|589546231|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
163227272|NCT01256710|589546231|FG000|Overall Study|Lost to Follow-up|67|||
163227273|NCT01256710|589546231|FG000|Overall Study|Withdrawal by Subject|29|||
163227274|NCT01256710|589546231|FG000|Overall Study|Physician Decision|9|||
163227275|NCT01256710|589546231|FG000|Overall Study|Subject Noncompliance|2|||
163227276|NCT01256710|589546231|FG000|Overall Study|Study Terminated by Sponsor|273|||
163227277|NCT01838642|589546232|FG000|Overall Study|Died on study|1|||
163130257|NCT00148941|589184201|FG003|Overall Study|Withdrawal by Subject|0|||
163130258|NCT00148941|589184198|FG000|Overall Study|Other|0|||
163130259|NCT00148941|589184199|FG001|Overall Study|Other|0|||
163130260|NCT00148941|589184200|FG002|Overall Study|Other|1|||
163130261|NCT00148941|589184201|FG003|Overall Study|Other|2|||
163130262|NCT02673684|589184202|FG000|Overall Study|Study not completed d/t loss of funding|9|||
163130263|NCT02673684|589184203|FG001|Overall Study|Study not completed d/t loss of funding|8|||
163130264|NCT01092663|589184206|FG000|Overall Study|Withdrawal by Subject|3|||
163130265|NCT01092663|589184207|FG001|Overall Study|Withdrawal by Subject|2|||
163130266|NCT01092663|589184206|FG000|Overall Study|Glucose >300mg/dL|1|||
163130267|NCT01092663|589184207|FG001|Overall Study|Glucose >300mg/dL|0|||
163130268|NCT01092663|589184206|FG000|Overall Study|High fasting triglyceride|2|||
163130269|NCT01092663|589184207|FG001|Overall Study|High fasting triglyceride|0|||
163130270|NCT01092663|589184206|FG000|Overall Study|Adverse Event|1|||
163130271|NCT01092663|589184207|FG001|Overall Study|Adverse Event|1|||
163130272|NCT01092663|589184206|FG000|Overall Study|Protocol Violation|0|||
163130273|NCT01092663|589184207|FG001|Overall Study|Protocol Violation|1|||
163130274|NCT00788710|589184208|FG000|Overall Study|Adverse Event|1|||
163130275|NCT00788710|589184209|FG001|Overall Study|Adverse Event|3|||
163130276|NCT00788710|589184210|FG002|Overall Study|Adverse Event|4|||
163130277|NCT00788710|589184208|FG000|Overall Study|Lack of Efficacy|0|||
163130278|NCT00788710|589184209|FG001|Overall Study|Lack of Efficacy|0|||
163130279|NCT00788710|589184210|FG002|Overall Study|Lack of Efficacy|1|||
163130280|NCT00788710|589184208|FG000|Overall Study|Lost to Follow-up|0|||
163130281|NCT00788710|589184209|FG001|Overall Study|Lost to Follow-up|1|||
163130282|NCT00788710|589184210|FG002|Overall Study|Lost to Follow-up|0|||
163130283|NCT00788710|589184208|FG000|Overall Study|Physician Decision|2|||
163130284|NCT00788710|589184209|FG001|Overall Study|Physician Decision|1|||
163130285|NCT00788710|589184210|FG002|Overall Study|Physician Decision|0|||
163130286|NCT00788710|589184208|FG000|Overall Study|Protocol Violation|0|||
163130287|NCT00788710|589184209|FG001|Overall Study|Protocol Violation|1|||
163130288|NCT00788710|589184210|FG002|Overall Study|Protocol Violation|1|||
163130289|NCT00788710|589184208|FG000|Overall Study|Withdrawal by Subject|2|||
163130290|NCT00788710|589184209|FG001|Overall Study|Withdrawal by Subject|2|||
163130291|NCT00788710|589184210|FG002|Overall Study|Withdrawal by Subject|0|||
163130292|NCT01008904|589184211|FG000|Overall Study|Lost to Follow-up|1|||
163130293|NCT01008904|589184211|FG000|Overall Study|Adverse Event|2|||
163130294|NCT01008904|589184211|FG000|Overall Study|unexpected unrelated surgery|1|||
163130295|NCT03908970|589184212|FG000|Overall Study|Adverse Event|7|||
163130296|NCT03908970|589184213|FG001|Overall Study|Adverse Event|21|||
163130297|NCT03908970|589184212|FG000|Overall Study|Physician Decision|1|||
163130298|NCT03908970|589184213|FG001|Overall Study|Physician Decision|4|||
163130299|NCT03908970|589184212|FG000|Overall Study|Withdrawal by Subject|9|||
163130300|NCT03908970|589184213|FG001|Overall Study|Withdrawal by Subject|22|||
163130301|NCT04407234|589184214|FG000|Overall Study|Adverse Event|3|||
163130302|NCT04407234|589184215|FG001|Overall Study|Adverse Event|3|||
163130303|NCT00727558|589184221|FG000|Overall Study|Lens issue|0|||
163130304|NCT00727558|589184222|FG001|Overall Study|Lens issue|1|||
163130305|NCT00727558|589184221|FG000|Overall Study|Adverse Event|0|||
163130306|NCT00727558|589184222|FG001|Overall Study|Adverse Event|1|||
163130307|NCT00727558|589184221|FG000|Overall Study|Subject unable to return for follow-up|1|||
163130308|NCT00727558|589184222|FG001|Overall Study|Subject unable to return for follow-up|1|||
163130309|NCT00727558|589184221|FG000|Overall Study|Lost to Follow-up|1|||
163130310|NCT00727558|589184222|FG001|Overall Study|Lost to Follow-up|0|||
163130311|NCT02262754|589184225|FG000|Overall Study|Adverse Event|3|||
163130312|NCT02262754|589184226|FG001|Overall Study|Adverse Event|4|||
163130313|NCT02262754|589184227|FG002|Overall Study|Adverse Event|0|||
163130314|NCT02262754|589184225|FG000|Overall Study|Lack of Efficacy|2|||
163130315|NCT02262754|589184226|FG001|Overall Study|Lack of Efficacy|0|||
163130316|NCT02262754|589184227|FG002|Overall Study|Lack of Efficacy|1|||
163130317|NCT02262754|589184225|FG000|Overall Study|Lost to Follow-up|0|||
163130318|NCT02262754|589184226|FG001|Overall Study|Lost to Follow-up|0|||
163130319|NCT02262754|589184227|FG002|Overall Study|Lost to Follow-up|1|||
163130320|NCT02262754|589184225|FG000|Overall Study|No longer meets eligibility criteria|0|||
163130321|NCT02262754|589184226|FG001|Overall Study|No longer meets eligibility criteria|1|||
163130322|NCT02262754|589184227|FG002|Overall Study|No longer meets eligibility criteria|0|||
163130323|NCT02262754|589184225|FG000|Overall Study|Study terminated by sponsor|5|||
163130324|NCT02262754|589184226|FG001|Overall Study|Study terminated by sponsor|4|||
163227278|NCT04019041|589546235|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
163130325|NCT02262754|589184227|FG002|Overall Study|Study terminated by sponsor|4|||
163227279|NCT04019041|589546236|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
163130326|NCT02262754|589184225|FG000|Overall Study|Protocol Violation|1|||
163130327|NCT02262754|589184226|FG001|Overall Study|Protocol Violation|0|||
163130328|NCT02262754|589184227|FG002|Overall Study|Protocol Violation|0|||
163227280|NCT04019041|589546237|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
163130329|NCT02262754|589184225|FG000|Overall Study|Withdrawal by Subject|1|||
163130330|NCT02262754|589184226|FG001|Overall Study|Withdrawal by Subject|0|||
163130331|NCT02262754|589184227|FG002|Overall Study|Withdrawal by Subject|1|||
163343454|NCT02123797|589966408|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
163343455|NCT02123797|589966409|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
163343456|NCT02123797|589966410|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
163343457|NCT02123797|589966411|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
163343458|NCT02123797|589966412|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
163343459|NCT02123797|589966408|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
163343460|NCT02123797|589966409|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
163343461|NCT02123797|589966410|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
163343462|NCT02123797|589966411|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
163343463|NCT02123797|589966412|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
163343464|NCT01375777|589966414|FG000|Overall Study|Withdrawal by Subject|0|||
163343465|NCT01375777|589966415|FG001|Overall Study|Withdrawal by Subject|2|||
163343466|NCT01375777|589966416|FG002|Overall Study|Withdrawal by Subject|1|||
163343467|NCT01375777|589966417|FG003|Overall Study|Withdrawal by Subject|0|||
163343468|NCT01375777|589966418|FG004|Overall Study|Withdrawal by Subject|1|||
163343469|NCT01375777|589966419|FG005|Overall Study|Withdrawal by Subject|1|||
163343470|NCT01375777|589966420|FG006|Overall Study|Withdrawal by Subject|1|||
163343471|NCT01375777|589966421|FG007|Overall Study|Withdrawal by Subject|2|||
163343472|NCT01375777|589966422|FG008|Overall Study|Withdrawal by Subject|1|||
163343473|NCT01375777|589966414|FG000|Overall Study|Lost to Follow-up|1|||
163343474|NCT01375777|589966415|FG001|Overall Study|Lost to Follow-up|0|||
163343475|NCT01375777|589966416|FG002|Overall Study|Lost to Follow-up|0|||
163343476|NCT01375777|589966417|FG003|Overall Study|Lost to Follow-up|0|||
163343477|NCT01375777|589966418|FG004|Overall Study|Lost to Follow-up|0|||
163343478|NCT01375777|589966419|FG005|Overall Study|Lost to Follow-up|0|||
163343479|NCT01375777|589966420|FG006|Overall Study|Lost to Follow-up|1|||
163343480|NCT01375777|589966421|FG007|Overall Study|Lost to Follow-up|0|||
163343481|NCT01375777|589966422|FG008|Overall Study|Lost to Follow-up|0|||
163343482|NCT01375777|589966414|FG000|Overall Study|Other|1|||
163343483|NCT01375777|589966415|FG001|Overall Study|Other|1|||
163343484|NCT01375777|589966416|FG002|Overall Study|Other|0|||
163343485|NCT01375777|589966417|FG003|Overall Study|Other|0|||
163343486|NCT01375777|589966418|FG004|Overall Study|Other|0|||
163343487|NCT01375777|589966419|FG005|Overall Study|Other|0|||
163343488|NCT01375777|589966420|FG006|Overall Study|Other|0|||
163343489|NCT01375777|589966421|FG007|Overall Study|Other|0|||
163343490|NCT01375777|589966422|FG008|Overall Study|Other|1|||
163343491|NCT00355784|589966423|FG000|Overall Study|Withdrawal by Subject|0|||
163343492|NCT00355784|589966424|FG001|Overall Study|Withdrawal by Subject|0|||
163343493|NCT00355784|589966425|FG002|Overall Study|Withdrawal by Subject|2|||
163343494|NCT03602053|589966432|FG000|Overall Study|Withdrawal by Subject|7|||
163343495|NCT03602053|589966433|FG001|Overall Study|Withdrawal by Subject|9|||
163343496|NCT03602053|589966434|FG002|Overall Study|Withdrawal by Subject|7|||
163343497|NCT03602053|589966432|FG000|Overall Study|Lost to Follow-up|5|||
163343498|NCT03602053|589966433|FG001|Overall Study|Lost to Follow-up|6|||
163343499|NCT03602053|589966434|FG002|Overall Study|Lost to Follow-up|0|||
163343500|NCT03602053|589966432|FG000|Overall Study|Protocol Violation|3|||
163343501|NCT03602053|589966433|FG001|Overall Study|Protocol Violation|0|||
163343502|NCT03602053|589966434|FG002|Overall Study|Protocol Violation|4|||
163343503|NCT03602053|589966432|FG000|Overall Study|Physician Decision|1|||
163343504|NCT03602053|589966433|FG001|Overall Study|Physician Decision|0|||
163343505|NCT03602053|589966434|FG002|Overall Study|Physician Decision|0|||
163343506|NCT03602053|589966432|FG000|Overall Study|migration|2|||
163343507|NCT03602053|589966433|FG001|Overall Study|migration|3|||
163343508|NCT03602053|589966434|FG002|Overall Study|migration|0|||
163343509|NCT03602053|589966432|FG000|Overall Study|Other|1|||
163408398|NCT05030311|590205507|FG000|Overall Study|Withdrawal by Subject|31|||
163408399|NCT05030311|590205508|FG001|Overall Study|Withdrawal by Subject|17|||
163408400|NCT05030311|590205507|FG000|Overall Study|Adverse Event|13|||
163130332|NCT02262754|589184225|FG000|Overall Study|Other|4|||
163130333|NCT02262754|589184226|FG001|Overall Study|Other|0|||
163130334|NCT02262754|589184227|FG002|Overall Study|Other|2|||
163130335|NCT04079114|589184231|FG000|Overall Study|Study prematuely terminated.|166|||
163130336|NCT00629798|589184236|FG000|Overall Study|Not Treated|4|||
163130337|NCT02126839|589184237|FG000|Overall Study|Adverse Event|0|||
163130338|NCT02126839|589184238|FG001|Overall Study|Adverse Event|1|||
163343510|NCT03602053|589966433|FG001|Overall Study|Other|0|||
163343511|NCT03602053|589966434|FG002|Overall Study|Other|0|||
163343512|NCT03672188|589966441|FG000|Overall Study|Withdrawal by Subject|0|||
163343513|NCT03672188|589966442|FG001|Overall Study|Withdrawal by Subject|0|||
163343514|NCT03672188|589966443|FG002|Overall Study|Withdrawal by Subject|0|||
163343515|NCT03672188|589966444|FG003|Overall Study|Withdrawal by Subject|3|||
163130339|NCT02126839|589184237|FG000|Overall Study|Withdrawal by Subject|1|||
163343516|NCT03672188|589966445|FG004|Overall Study|Withdrawal by Subject|0|||
163343517|NCT03672188|589966446|FG005|Overall Study|Withdrawal by Subject|0|||
163343518|NCT03672188|589966447|FG006|Overall Study|Withdrawal by Subject|0|||
163343519|NCT03672188|589966448|FG007|Overall Study|Withdrawal by Subject|0|||
163343520|NCT03672188|589966449|FG008|Overall Study|Withdrawal by Subject|0|||
163227281|NCT04019041|589546238|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
163227282|NCT04019041|589546239|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
163227283|NCT04019041|589546240|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
163227284|NCT04019041|589546235|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
163227285|NCT04019041|589546236|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
163227286|NCT04019041|589546237|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
163227287|NCT04019041|589546238|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
163227288|NCT04019041|589546239|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
163227289|NCT04019041|589546240|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
163227290|NCT04019041|589546235|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
163227291|NCT04019041|589546236|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
163227292|NCT04019041|589546237|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
163227293|NCT04019041|589546238|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
163227294|NCT04019041|589546239|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
163227295|NCT04019041|589546240|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
163227296|NCT04019041|589546235|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
163343521|NCT03672188|589966450|FG009|Overall Study|Withdrawal by Subject|0|||
163343522|NCT03672188|589966451|FG010|Overall Study|Withdrawal by Subject|0|||
163343523|NCT03672188|589966452|FG011|Overall Study|Withdrawal by Subject|0|||
163227297|NCT04019041|589546236|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
163227298|NCT04019041|589546237|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
163227299|NCT04019041|589546238|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
163227300|NCT04019041|589546239|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
163227301|NCT04019041|589546240|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
163227302|NCT04019041|589546235|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
163227303|NCT04019041|589546236|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
163227304|NCT04019041|589546237|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
163227305|NCT04019041|589546238|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
163227306|NCT04019041|589546239|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
163227307|NCT04019041|589546240|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
163227308|NCT04019041|589546235|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
163227309|NCT04019041|589546236|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
163227310|NCT04019041|589546237|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
163227311|NCT04019041|589546238|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
163227312|NCT04019041|589546239|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
163227313|NCT04019041|589546240|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
163227314|NCT04019041|589546235|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
163227315|NCT04019041|589546236|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
163227316|NCT04019041|589546237|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
163227317|NCT04019041|589546238|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
163227318|NCT04019041|589546239|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
163227319|NCT04019041|589546240|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
163227320|NCT04019041|589546235|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
163227321|NCT04019041|589546236|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
163227322|NCT04019041|589546237|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
163227323|NCT04019041|589546238|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
163227324|NCT04019041|589546239|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
163227325|NCT04019041|589546240|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
163227326|NCT04019041|589546235|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
163227327|NCT04019041|589546236|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
163227328|NCT04019041|589546237|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
163227329|NCT04019041|589546238|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
163227330|NCT04019041|589546239|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
163227331|NCT04019041|589546240|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
163227332|NCT03925727|589546241|FG000|Overall Study|Adverse Event|4|||
163227333|NCT03925727|589546242|FG001|Overall Study|Adverse Event|0|||
163343524|NCT03672188|589966453|FG012|Overall Study|Withdrawal by Subject|0|||
163343525|NCT03672188|589966454|FG013|Overall Study|Withdrawal by Subject|0|||
163343526|NCT03672188|589966455|FG014|Overall Study|Withdrawal by Subject|0|||
163343527|NCT03672188|589966441|FG000|Overall Study|Death|0|||
163227334|NCT03925727|589546243|FG002|Overall Study|Adverse Event|3|||
163227335|NCT03925727|589546241|FG000|Overall Study|Protocol Violation|1|||
163227336|NCT03925727|589546242|FG001|Overall Study|Protocol Violation|2|||
163227337|NCT03925727|589546243|FG002|Overall Study|Protocol Violation|2|||
163227338|NCT03925727|589546241|FG000|Overall Study|Withdrawal by Subject|3|||
163227339|NCT03925727|589546242|FG001|Overall Study|Withdrawal by Subject|2|||
163343528|NCT03672188|589966442|FG001|Overall Study|Death|0|||
163343529|NCT03672188|589966443|FG002|Overall Study|Death|0|||
163227340|NCT03925727|589546243|FG002|Overall Study|Withdrawal by Subject|4|||
163227341|NCT03925727|589546241|FG000|Overall Study|Administrative Reasons|3|||
163227342|NCT03925727|589546242|FG001|Overall Study|Administrative Reasons|1|||
163227343|NCT03925727|589546243|FG002|Overall Study|Administrative Reasons|2|||
163227344|NCT03925727|589546241|FG000|Overall Study|Randomized in error or Disqualified|8|||
163227345|NCT03925727|589546242|FG001|Overall Study|Randomized in error or Disqualified|1|||
163227346|NCT03925727|589546243|FG002|Overall Study|Randomized in error or Disqualified|7|||
163227347|NCT00213148|589546244|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
163227348|NCT00213148|589546245|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
163227349|NCT00213148|589546246|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
163227350|NCT00213148|589546247|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
163227351|NCT00213148|589546248|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
163227352|NCT00213148|589546244|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
163227353|NCT00213148|589546245|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
163227354|NCT00213148|589546246|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
163227355|NCT00213148|589546247|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
163227356|NCT00213148|589546248|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
163227357|NCT00213148|589546244|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
163227358|NCT00213148|589546245|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
163227359|NCT00213148|589546246|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
163227360|NCT00213148|589546247|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
163227361|NCT00213148|589546248|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
163227362|NCT00213148|589546244|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
163343530|NCT03672188|589966444|FG003|Overall Study|Death|0|||
163343531|NCT03672188|589966445|FG004|Overall Study|Death|0|||
163343532|NCT03672188|589966446|FG005|Overall Study|Death|0|||
163343533|NCT03672188|589966447|FG006|Overall Study|Death|0|||
163343534|NCT03672188|589966448|FG007|Overall Study|Death|0|||
163343535|NCT03672188|589966449|FG008|Overall Study|Death|0|||
163343536|NCT03672188|589966450|FG009|Overall Study|Death|0|||
163343537|NCT03672188|589966451|FG010|Overall Study|Death|0|||
163343538|NCT03672188|589966452|FG011|Overall Study|Death|0|||
163343539|NCT03672188|589966453|FG012|Overall Study|Death|1|||
163343540|NCT03672188|589966454|FG013|Overall Study|Death|0|||
163343541|NCT03672188|589966455|FG014|Overall Study|Death|0|||
163343542|NCT03672188|589966441|FG000|Overall Study|Lost to Follow-up|0|||
163343543|NCT03672188|589966442|FG001|Overall Study|Lost to Follow-up|0|||
163343544|NCT03672188|589966443|FG002|Overall Study|Lost to Follow-up|1|||
163343545|NCT03672188|589966444|FG003|Overall Study|Lost to Follow-up|0|||
163343546|NCT03672188|589966445|FG004|Overall Study|Lost to Follow-up|0|||
163343547|NCT03672188|589966446|FG005|Overall Study|Lost to Follow-up|0|||
163343548|NCT03672188|589966447|FG006|Overall Study|Lost to Follow-up|0|||
163343549|NCT03672188|589966448|FG007|Overall Study|Lost to Follow-up|0|||
163343550|NCT03672188|589966449|FG008|Overall Study|Lost to Follow-up|0|||
163343551|NCT03672188|589966450|FG009|Overall Study|Lost to Follow-up|0|||
163343552|NCT03672188|589966451|FG010|Overall Study|Lost to Follow-up|0|||
163343553|NCT03672188|589966452|FG011|Overall Study|Lost to Follow-up|0|||
163343554|NCT03672188|589966453|FG012|Overall Study|Lost to Follow-up|0|||
163343555|NCT03672188|589966454|FG013|Overall Study|Lost to Follow-up|0|||
163343556|NCT03672188|589966455|FG014|Overall Study|Lost to Follow-up|0|||
163343557|NCT01234675|589966456|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
163343558|NCT01234675|589966457|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
163343559|NCT01234675|589966456|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
163408401|NCT05030311|590205508|FG001|Overall Study|Adverse Event|5|||
163227363|NCT00213148|589546245|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
163227364|NCT00213148|589546246|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
163227365|NCT00213148|589546247|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
163227366|NCT00213148|589546248|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
163227367|NCT00213148|589546244|FG000|Cycle 1 (1 Month)|Other|3|||
163343560|NCT01234675|589966457|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
163343561|NCT03997409|589966458|FG000|Overall Study|Protocol Violation|1|||
163343562|NCT03997409|589966459|FG001|Overall Study|Protocol Violation|1|||
163343563|NCT03997409|589966460|FG002|Overall Study|Protocol Violation|0|||
163343564|NCT03997409|589966458|FG000|Overall Study|Withdrawal by Subject|3|||
163343565|NCT03997409|589966459|FG001|Overall Study|Withdrawal by Subject|0|||
163343566|NCT03997409|589966460|FG002|Overall Study|Withdrawal by Subject|0|||
163343567|NCT03997409|589966458|FG000|Overall Study|Lost to Follow-up|0|||
163343568|NCT03997409|589966459|FG001|Overall Study|Lost to Follow-up|0|||
163343569|NCT03997409|589966460|FG002|Overall Study|Lost to Follow-up|1|||
163343570|NCT03696342|589966461|FG000|Overall Study|Lost to Follow-up|1|||
163343571|NCT03696342|589966462|FG001|Overall Study|Lost to Follow-up|0|||
163343572|NCT02409732|589966463|FG000|Overall Study|Withdrawal by Subject|4|||
163343573|NCT02409732|589966463|FG000|Overall Study|Lost to Follow-up|2|||
163343574|NCT01753323|589966465|FG000|Overall Study|Lack of Efficacy|0|||
163227368|NCT00213148|589546245|FG001|Cycle 1 (1 Month)|Other|0|||
163227369|NCT00213148|589546246|FG002|Cycle 1 (1 Month)|Other|2|||
163227370|NCT00213148|589546247|FG003|Cycle 1 (1 Month)|Other|2|||
163343575|NCT01753323|589966466|FG001|Overall Study|Lack of Efficacy|0|||
163343576|NCT01753323|589966467|FG002|Overall Study|Lack of Efficacy|8|||
163343577|NCT01753323|589966465|FG000|Overall Study|Protocol deviation|1|||
163343578|NCT01753323|589966466|FG001|Overall Study|Protocol deviation|0|||
163343579|NCT01753323|589966467|FG002|Overall Study|Protocol deviation|0|||
163343580|NCT01753323|589966465|FG000|Overall Study|Adverse Event|0|||
163343581|NCT01753323|589966466|FG001|Overall Study|Adverse Event|0|||
163343582|NCT01753323|589966467|FG002|Overall Study|Adverse Event|1|||
163130340|NCT02126839|589184238|FG001|Overall Study|Withdrawal by Subject|0|||
163130341|NCT02126839|589184237|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163130342|NCT02126839|589184238|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163130343|NCT02126839|589184237|FG000|Overall Study|Protocol Violation|2|||
163130344|NCT02126839|589184238|FG001|Overall Study|Protocol Violation|3|||
163130345|NCT02126839|589184237|FG000|Overall Study|Sponsor request|0|||
163130346|NCT02126839|589184238|FG001|Overall Study|Sponsor request|1|||
163130347|NCT02126839|589184237|FG000|Overall Study|Lost to Follow-up|1|||
163130348|NCT02126839|589184238|FG001|Overall Study|Lost to Follow-up|4|||
163130349|NCT02126839|589184237|FG000|Overall Study|Other|5|||
163130350|NCT02126839|589184238|FG001|Overall Study|Other|5|||
163130351|NCT01108523|589184239|FG000|Overall Study|Protocol Violation|4|||
163130352|NCT00687531|589184240|FG000|Overall Study|Did not meet protocol eligibility|104|||
163130353|NCT00687531|589184240|FG000|Overall Study|Adverse Event|5|||
163130354|NCT00687531|589184240|FG000|Overall Study|Lost to Follow-up|26|||
163130355|NCT00547521|589184243|FG000|Short Term Study (4 Months)|Adverse Event|1|||
163130356|NCT00547521|589184244|FG001|Short Term Study (4 Months)|Adverse Event|0|||
163130357|NCT00547521|589184243|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
163130358|NCT00547521|589184244|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
163130359|NCT00547521|589184243|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
163130360|NCT00547521|589184244|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
163130361|NCT00547521|589184243|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
163130362|NCT00547521|589184244|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
163130363|NCT00547521|589184243|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
163130364|NCT00547521|589184244|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
163130365|NCT00547521|589184243|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
163130366|NCT00547521|589184244|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
163130367|NCT00547521|589184243|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
163130368|NCT00547521|589184244|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
163130369|NCT00547521|589184243|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
163130370|NCT00547521|589184244|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
163130371|NCT00547521|589184243|FG000|Long Term Extension (LTE) Study|Other|0|||
163130372|NCT00547521|589184244|FG001|Long Term Extension (LTE) Study|Other|2|||
163130373|NCT00547521|589184243|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
163130374|NCT00547521|589184244|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
163130375|NCT03077919|589186251|FG000|Overall Study|Lost to Follow-up|4|||
163130376|NCT03077919|589186252|FG001|Overall Study|Lost to Follow-up|1|||
163130377|NCT00826618|589186253|FG000|Overall Study|Withdrawal by Subject|1|||
163130378|NCT01487265|589186256|FG000|Overall Study|Adverse Event|8|||
163130379|NCT01487265|589186256|FG000|Overall Study|Withdrawal by Subject|5|||
163130380|NCT01487265|589186256|FG000|Overall Study|Disease Progression|21|||
163130381|NCT01487265|589186256|FG000|Overall Study|Death|2|||
163130382|NCT01487265|589186256|FG000|Overall Study|Still on Treatment|1|||
163130383|NCT01496469|589186266|FG000|Overall Study|Adverse Event|1|||
163130384|NCT01496469|589186267|FG001|Overall Study|Adverse Event|0|||
163130385|NCT01496469|589186266|FG000|Overall Study|Protocol Violation|2|||
163130386|NCT01496469|589186267|FG001|Overall Study|Protocol Violation|0|||
163130387|NCT01496469|589186266|FG000|Overall Study|Lost to Follow-up|1|||
163130388|NCT01496469|589186267|FG001|Overall Study|Lost to Follow-up|1|||
163130389|NCT01496469|589186266|FG000|Overall Study|Withdrawal by Subject|4|||
163130390|NCT01496469|589186267|FG001|Overall Study|Withdrawal by Subject|4|||
163130391|NCT01496469|589186266|FG000|Overall Study|BP exceeds protocol limits|1|||
163130392|NCT01496469|589186267|FG001|Overall Study|BP exceeds protocol limits|2|||
163130393|NCT01496469|589186266|FG000|Overall Study|Other|1|||
163130394|NCT01496469|589186267|FG001|Overall Study|Other|1|||
163343583|NCT01870999|589966468|FG000|Overall Study|Adverse Event|0|||
163130395|NCT00193180|589186269|FG000|Overall Study|Lack of Efficacy|1|||
163130396|NCT00193180|589186269|FG000|Overall Study|Adverse Event|8|||
163130397|NCT00193180|589186269|FG000|Overall Study|Protocol Violation|1|||
163130398|NCT02219334|589186270|FG000|Overall Study|Withdrawal by Subject|1|||
163343584|NCT01870999|589966469|FG001|Overall Study|Adverse Event|4|||
163130399|NCT02219334|589186271|FG001|Overall Study|Withdrawal by Subject|0|||
163130400|NCT02219334|589186270|FG000|Overall Study|Protocol Violation|7|||
163130401|NCT02219334|589186271|FG001|Overall Study|Protocol Violation|3|||
163130402|NCT02688985|589186279|FG000|Overall Study|Adverse Event|1|||
163130403|NCT02688985|589186280|FG001|Overall Study|Adverse Event|2|||
163130404|NCT02688985|589186281|FG002|Overall Study|Adverse Event|2|||
163130405|NCT02688985|589186282|FG003|Overall Study|Adverse Event|0|||
163130406|NCT02688985|589186283|FG004|Overall Study|Adverse Event|0|||
163343585|NCT01870999|589966470|FG002|Overall Study|Adverse Event|1|||
163343586|NCT01870999|589966468|FG000|Overall Study|Subject met withdrawal criteria|3|||
163343587|NCT01870999|589966469|FG001|Overall Study|Subject met withdrawal criteria|2|||
163343588|NCT01870999|589966470|FG002|Overall Study|Subject met withdrawal criteria|0|||
163343589|NCT01870999|589966468|FG000|Overall Study|Subject withdrawn by Investigator|1|||
163343590|NCT01870999|589966469|FG001|Overall Study|Subject withdrawn by Investigator|0|||
163343591|NCT01870999|589966470|FG002|Overall Study|Subject withdrawn by Investigator|0|||
163343592|NCT01870999|589966468|FG000|Overall Study|Withdrawal by Subject|0|||
163343593|NCT01870999|589966469|FG001|Overall Study|Withdrawal by Subject|2|||
163343594|NCT01870999|589966470|FG002|Overall Study|Withdrawal by Subject|5|||
163343595|NCT01870999|589966468|FG000|Overall Study|Protocol Violation|0|||
163343596|NCT01870999|589966469|FG001|Overall Study|Protocol Violation|0|||
163343597|NCT01870999|589966470|FG002|Overall Study|Protocol Violation|1|||
163343598|NCT01636258|589966471|FG000|Overall Study|Lost to Follow-up|1|||
163343599|NCT01636258|589966472|FG001|Overall Study|Lost to Follow-up|0|||
163343600|NCT01838499|589966473|FG000|Overall Study|Protocol Violation|0|||
163343601|NCT01838499|589966474|FG001|Overall Study|Protocol Violation|1|||
163343602|NCT01838499|589966473|FG000|Overall Study|Lost to Follow-up|2|||
163343603|NCT01838499|589966474|FG001|Overall Study|Lost to Follow-up|4|||
163343604|NCT01838499|589966473|FG000|Overall Study|Lack of Efficacy|1|||
163343605|NCT01838499|589966474|FG001|Overall Study|Lack of Efficacy|2|||
163343606|NCT01838499|589966473|FG000|Overall Study|Adverse Event|2|||
163343607|NCT01838499|589966474|FG001|Overall Study|Adverse Event|1|||
163343608|NCT01838499|589966473|FG000|Overall Study|Withdrawal by Subject|19|||
163343609|NCT01838499|589966474|FG001|Overall Study|Withdrawal by Subject|9|||
163343610|NCT03614923|589966475|FG000|Overall Study|Withdrawal by Subject|2|||
163343611|NCT03614923|589966476|FG001|Overall Study|Withdrawal by Subject|1|||
163343612|NCT03614923|589966477|FG002|Overall Study|Withdrawal by Subject|1|||
163343613|NCT03614923|589966475|FG000|Overall Study|Adverse Event|0|||
163343614|NCT03614923|589966476|FG001|Overall Study|Adverse Event|2|||
163343615|NCT03614923|589966477|FG002|Overall Study|Adverse Event|1|||
163343616|NCT03614923|589966475|FG000|Overall Study|Lost to Follow-up|1|||
163343617|NCT03614923|589966476|FG001|Overall Study|Lost to Follow-up|0|||
163343618|NCT03614923|589966477|FG002|Overall Study|Lost to Follow-up|1|||
163343619|NCT03614923|589966475|FG000|Overall Study|Lack of Efficacy|2|||
163343620|NCT03614923|589966476|FG001|Overall Study|Lack of Efficacy|0|||
163343621|NCT03614923|589966477|FG002|Overall Study|Lack of Efficacy|1|||
163343622|NCT03614923|589966475|FG000|Overall Study|Non-compliance|0|||
163343623|NCT03614923|589966476|FG001|Overall Study|Non-compliance|1|||
163343624|NCT03614923|589966477|FG002|Overall Study|Non-compliance|0|||
163343625|NCT03614923|589966475|FG000|Overall Study|Other|0|||
163343626|NCT03614923|589966476|FG001|Overall Study|Other|1|||
163343627|NCT03614923|589966477|FG002|Overall Study|Other|1|||
163343628|NCT00116584|589966488|FG000|Overall Study|Withdrawal by Subject|1|||
163343629|NCT00116584|589966489|FG001|Overall Study|Withdrawal by Subject|0|||
163343630|NCT00116584|589966488|FG000|Overall Study|Protocol Violation|1|||
163343631|NCT00116584|589966489|FG001|Overall Study|Protocol Violation|1|||
163343632|NCT03034772|589966490|FG000|Overall Study|Adverse Event|0|||
163343633|NCT03034772|589966491|FG001|Overall Study|Adverse Event|1|||
163343634|NCT03034772|589966490|FG000|Overall Study|Withdrawal by Subject|0|||
163343635|NCT03034772|589966491|FG001|Overall Study|Withdrawal by Subject|1|||
163343636|NCT01745380|589966492|FG000|Overall Study|Lost to Follow-up|1|||
163343637|NCT01745380|589966493|FG001|Overall Study|Lost to Follow-up|0|||
163343638|NCT01745380|589966492|FG000|Overall Study|Lack of Efficacy|0|||
163343639|NCT01745380|589966493|FG001|Overall Study|Lack of Efficacy|1|||
163343640|NCT02660034|589966494|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
163343641|NCT02660034|589966495|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
163343642|NCT02660034|589966496|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
163343643|NCT02660034|589966497|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
163343644|NCT02660034|589966498|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
163343645|NCT02660034|589966499|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
163343646|NCT02660034|589966500|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
163130407|NCT02688985|589186279|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
163130408|NCT02688985|589186280|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
163130409|NCT02688985|589186281|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
163343647|NCT02660034|589966501|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
163343648|NCT02660034|589966502|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
163343649|NCT02660034|589966503|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
163343650|NCT02660034|589966504|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
163343651|NCT02660034|589966505|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
163343652|NCT02660034|589966506|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
163227371|NCT00213148|589546248|FG004|Cycle 1 (1 Month)|Other|7|||
163343653|NCT02660034|589966507|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
163343654|NCT02660034|589966494|FG000|Overall Study|Progressive Disease (Clinical)|7|||
163343655|NCT02660034|589966495|FG001|Overall Study|Progressive Disease (Clinical)|8|||
163343656|NCT02660034|589966496|FG002|Overall Study|Progressive Disease (Clinical)|3|||
163343657|NCT02660034|589966497|FG003|Overall Study|Progressive Disease (Clinical)|9|||
163343658|NCT02660034|589966498|FG004|Overall Study|Progressive Disease (Clinical)|3|||
163130410|NCT02688985|589186282|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
163130411|NCT02688985|589186283|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
163130412|NCT02688985|589186279|FG000|Overall Study|Death|0|||
163130413|NCT02688985|589186280|FG001|Overall Study|Death|0|||
163130414|NCT02688985|589186281|FG002|Overall Study|Death|0|||
163130415|NCT02688985|589186282|FG003|Overall Study|Death|0|||
163130416|NCT02688985|589186283|FG004|Overall Study|Death|1|||
163130417|NCT02688985|589186279|FG000|Overall Study|Lack of Efficacy|0|||
163130418|NCT02688985|589186280|FG001|Overall Study|Lack of Efficacy|0|||
163130419|NCT02688985|589186281|FG002|Overall Study|Lack of Efficacy|0|||
163130420|NCT02688985|589186282|FG003|Overall Study|Lack of Efficacy|0|||
163343659|NCT02660034|589966499|FG005|Overall Study|Progressive Disease (Clinical)|0|||
163343660|NCT02660034|589966500|FG006|Overall Study|Progressive Disease (Clinical)|0|||
163343661|NCT02660034|589966501|FG007|Overall Study|Progressive Disease (Clinical)|0|||
163343662|NCT02660034|589966502|FG008|Overall Study|Progressive Disease (Clinical)|0|||
163343663|NCT02660034|589966503|FG009|Overall Study|Progressive Disease (Clinical)|0|||
163343664|NCT02660034|589966504|FG010|Overall Study|Progressive Disease (Clinical)|0|||
163343665|NCT02660034|589966505|FG011|Overall Study|Progressive Disease (Clinical)|0|||
163343666|NCT02660034|589966506|FG012|Overall Study|Progressive Disease (Clinical)|0|||
163343667|NCT02660034|589966507|FG013|Overall Study|Progressive Disease (Clinical)|0|||
163343668|NCT02660034|589966494|FG000|Overall Study|Lost to Follow-up|0|||
163343669|NCT02660034|589966495|FG001|Overall Study|Lost to Follow-up|0|||
163343670|NCT02660034|589966496|FG002|Overall Study|Lost to Follow-up|1|||
163343671|NCT02660034|589966497|FG003|Overall Study|Lost to Follow-up|1|||
163343672|NCT02660034|589966498|FG004|Overall Study|Lost to Follow-up|0|||
163343673|NCT02660034|589966499|FG005|Overall Study|Lost to Follow-up|0|||
163343674|NCT02660034|589966500|FG006|Overall Study|Lost to Follow-up|0|||
163343675|NCT02660034|589966501|FG007|Overall Study|Lost to Follow-up|0|||
163343676|NCT02660034|589966502|FG008|Overall Study|Lost to Follow-up|0|||
163343677|NCT02660034|589966503|FG009|Overall Study|Lost to Follow-up|1|||
163343678|NCT02660034|589966504|FG010|Overall Study|Lost to Follow-up|1|||
163343679|NCT02660034|589966505|FG011|Overall Study|Lost to Follow-up|1|||
163343680|NCT02660034|589966506|FG012|Overall Study|Lost to Follow-up|0|||
163343681|NCT02660034|589966507|FG013|Overall Study|Lost to Follow-up|0|||
163343682|NCT02660034|589966494|FG000|Overall Study|Participant moved into special access scheme|1|||
163343683|NCT02660034|589966495|FG001|Overall Study|Participant moved into special access scheme|2|||
163343684|NCT02660034|589966496|FG002|Overall Study|Participant moved into special access scheme|0|||
163343685|NCT02660034|589966497|FG003|Overall Study|Participant moved into special access scheme|0|||
163343686|NCT02660034|589966498|FG004|Overall Study|Participant moved into special access scheme|0|||
163343687|NCT02660034|589966499|FG005|Overall Study|Participant moved into special access scheme|0|||
163343688|NCT02660034|589966500|FG006|Overall Study|Participant moved into special access scheme|0|||
163343689|NCT02660034|589966501|FG007|Overall Study|Participant moved into special access scheme|0|||
163343690|NCT02660034|589966502|FG008|Overall Study|Participant moved into special access scheme|0|||
163343691|NCT02660034|589966503|FG009|Overall Study|Participant moved into special access scheme|0|||
163343692|NCT02660034|589966504|FG010|Overall Study|Participant moved into special access scheme|0|||
163343693|NCT02660034|589966505|FG011|Overall Study|Participant moved into special access scheme|0|||
163343694|NCT02660034|589966506|FG012|Overall Study|Participant moved into special access scheme|0|||
163343695|NCT02660034|589966507|FG013|Overall Study|Participant moved into special access scheme|0|||
163343696|NCT02660034|589966494|FG000|Overall Study|Adverse Event|1|||
163343697|NCT02660034|589966495|FG001|Overall Study|Adverse Event|0|||
163343698|NCT02660034|589966496|FG002|Overall Study|Adverse Event|0|||
163343699|NCT02660034|589966497|FG003|Overall Study|Adverse Event|0|||
163343700|NCT02660034|589966498|FG004|Overall Study|Adverse Event|0|||
163343701|NCT02660034|589966499|FG005|Overall Study|Adverse Event|0|||
163343702|NCT02660034|589966500|FG006|Overall Study|Adverse Event|0|||
163343703|NCT02660034|589966501|FG007|Overall Study|Adverse Event|0|||
163343704|NCT02660034|589966502|FG008|Overall Study|Adverse Event|0|||
163343705|NCT02660034|589966503|FG009|Overall Study|Adverse Event|0|||
163343706|NCT02660034|589966504|FG010|Overall Study|Adverse Event|0|||
163343707|NCT02660034|589966505|FG011|Overall Study|Adverse Event|0|||
163343708|NCT02660034|589966506|FG012|Overall Study|Adverse Event|0|||
163343709|NCT02660034|589966507|FG013|Overall Study|Adverse Event|0|||
163343710|NCT02660034|589966494|FG000|Overall Study|Sponsor Decision|0|||
163130421|NCT02688985|589186283|FG004|Overall Study|Lack of Efficacy|1|||
163130422|NCT02688985|589186279|FG000|Overall Study|Lost to Follow-up|2|||
163130423|NCT02688985|589186280|FG001|Overall Study|Lost to Follow-up|0|||
163130424|NCT02688985|589186281|FG002|Overall Study|Lost to Follow-up|1|||
163130425|NCT02688985|589186282|FG003|Overall Study|Lost to Follow-up|1|||
163343711|NCT02660034|589966495|FG001|Overall Study|Sponsor Decision|1|||
163343712|NCT02660034|589966496|FG002|Overall Study|Sponsor Decision|2|||
163343713|NCT02660034|589966497|FG003|Overall Study|Sponsor Decision|2|||
163130426|NCT02688985|589186283|FG004|Overall Study|Lost to Follow-up|1|||
163130427|NCT02688985|589186279|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163130428|NCT02688985|589186280|FG001|Overall Study|Non-Compliance With Study Drug|3|||
163130429|NCT02688985|589186281|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163130430|NCT02688985|589186282|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163130431|NCT02688985|589186283|FG004|Overall Study|Non-Compliance With Study Drug|1|||
163130432|NCT02688985|589186279|FG000|Overall Study|Other|3|||
163130433|NCT02688985|589186280|FG001|Overall Study|Other|4|||
163130434|NCT02688985|589186281|FG002|Overall Study|Other|1|||
163130435|NCT02688985|589186282|FG003|Overall Study|Other|0|||
163130436|NCT02688985|589186283|FG004|Overall Study|Other|0|||
163130437|NCT02688985|589186279|FG000|Overall Study|Physician Decision|2|||
163130438|NCT02688985|589186280|FG001|Overall Study|Physician Decision|2|||
163130439|NCT02688985|589186281|FG002|Overall Study|Physician Decision|0|||
163130440|NCT02688985|589186282|FG003|Overall Study|Physician Decision|0|||
163130441|NCT02688985|589186283|FG004|Overall Study|Physician Decision|1|||
163130442|NCT02688985|589186279|FG000|Overall Study|Pregnancy|0|||
163130443|NCT02688985|589186280|FG001|Overall Study|Pregnancy|0|||
163130444|NCT02688985|589186281|FG002|Overall Study|Pregnancy|2|||
163130445|NCT02688985|589186282|FG003|Overall Study|Pregnancy|1|||
163130446|NCT02688985|589186283|FG004|Overall Study|Pregnancy|0|||
163130447|NCT02688985|589186279|FG000|Overall Study|Study Terminated By Sponsor|0|||
163130448|NCT02688985|589186280|FG001|Overall Study|Study Terminated By Sponsor|0|||
163130449|NCT02688985|589186281|FG002|Overall Study|Study Terminated By Sponsor|0|||
163130450|NCT02688985|589186282|FG003|Overall Study|Study Terminated By Sponsor|1|||
163130451|NCT02688985|589186283|FG004|Overall Study|Study Terminated By Sponsor|0|||
163130452|NCT02688985|589186279|FG000|Overall Study|Withdrawal by Subject|2|||
163130453|NCT02688985|589186280|FG001|Overall Study|Withdrawal by Subject|8|||
163130454|NCT02688985|589186281|FG002|Overall Study|Withdrawal by Subject|7|||
163130455|NCT02688985|589186282|FG003|Overall Study|Withdrawal by Subject|1|||
163130456|NCT02688985|589186283|FG004|Overall Study|Withdrawal by Subject|4|||
163130457|NCT01964963|589186286|FG000|Overall Study|Case Report Forms Uncollected|888|||
163130458|NCT01964963|589186286|FG000|Overall Study|Protocol Deviation|50|||
163130459|NCT01964963|589186286|FG000|Overall Study|Data Reliability was not Assured|5|||
163130460|NCT00930553|589186287|FG000|Overall Study|Adverse Event|1|||
163130461|NCT00930553|589186287|FG000|Overall Study|Lack of Efficacy|7|||
163130462|NCT00930553|589186287|FG000|Overall Study|Physician Decision|39|||
163130463|NCT00930553|589186287|FG000|Overall Study|Protocol Violation|1|||
163130464|NCT00930553|589186287|FG000|Overall Study|Pregnancy|1|||
163130465|NCT00930553|589186287|FG000|Overall Study|Withdrawal by Subject|88|||
163130466|NCT00930553|589186287|FG000|Overall Study|Lost to Follow-up|25|||
163130467|NCT00930553|589186287|FG000|Overall Study|Death|9|||
163130468|NCT00930553|589186287|FG000|Overall Study|Study terminated by sponsor|24|||
163130469|NCT00930553|589186287|FG000|Overall Study|Other than specified above|28|||
163130470|NCT01726582|589186288|FG000|Overall Study|Physician Decision|99|||
163130471|NCT01726582|589186288|FG000|Overall Study|Death|85|||
163130472|NCT01235234|589186289|FG000|Overall Study|Adverse Event|2|||
163130473|NCT01235234|589186290|FG001|Overall Study|Adverse Event|2|||
163130474|NCT01235234|589186291|FG002|Overall Study|Adverse Event|1|||
163130475|NCT02630472|589186292|FG000|Overall Study|Physician Decision|10|||
163130476|NCT02630472|589186293|FG001|Overall Study|Physician Decision|0|||
163130477|NCT01832155|589186298|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
163130478|NCT01832155|589186299|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
163130479|NCT01832155|589186298|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
163130480|NCT01832155|589186299|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
163130481|NCT00787189|589186300|FG000|Overall Study|Lost to Follow-up|2|||
163130482|NCT00787189|589186301|FG001|Overall Study|Lost to Follow-up|2|||
163130483|NCT01279616|589186302|FG000|Overall Study|donor could not be located|5|||
163130484|NCT01279616|589186302|FG000|Overall Study|no signs of sickle cell disease|2|||
163130485|NCT00842543|589186305|FG000|Overall Study|Withdrawal by Subject|2|||
163130486|NCT00842543|589186306|FG001|Overall Study|Withdrawal by Subject|0|||
163130487|NCT00842543|589186307|FG002|Overall Study|Withdrawal by Subject|3|||
163130488|NCT00842543|589186308|FG003|Overall Study|Withdrawal by Subject|4|||
163130489|NCT01483183|589186313|FG000|Overall Study|Physician Decision|0|||
163130490|NCT01483183|589186314|FG001|Overall Study|Physician Decision|0|||
163130491|NCT01483183|589186315|FG002|Overall Study|Physician Decision|0|||
163130492|NCT01483183|589186316|FG003|Overall Study|Physician Decision|0|||
163130493|NCT01483183|589186317|FG004|Overall Study|Physician Decision|0|||
163130494|NCT01483183|589186318|FG005|Overall Study|Physician Decision|0|||
163130495|NCT01483183|589186319|FG006|Overall Study|Physician Decision|2|||
163130496|NCT01483183|589186320|FG007|Overall Study|Physician Decision|0|||
163130497|NCT01483183|589186321|FG008|Overall Study|Physician Decision|0|||
163130498|NCT01483183|589186322|FG009|Overall Study|Physician Decision|0|||
163130499|NCT01483183|589186313|FG000|Overall Study|Withdrawal by Subject|0|||
163130500|NCT01483183|589186314|FG001|Overall Study|Withdrawal by Subject|0|||
163130501|NCT01483183|589186315|FG002|Overall Study|Withdrawal by Subject|0|||
163130502|NCT01483183|589186316|FG003|Overall Study|Withdrawal by Subject|0|||
163130503|NCT01483183|589186317|FG004|Overall Study|Withdrawal by Subject|0|||
163130504|NCT01483183|589186318|FG005|Overall Study|Withdrawal by Subject|0|||
163130505|NCT01483183|589186319|FG006|Overall Study|Withdrawal by Subject|0|||
163130506|NCT01483183|589186320|FG007|Overall Study|Withdrawal by Subject|0|||
163130507|NCT01483183|589186321|FG008|Overall Study|Withdrawal by Subject|0|||
163130508|NCT01483183|589186322|FG009|Overall Study|Withdrawal by Subject|1|||
163130509|NCT00239928|589186323|FG000|Overall Study|Lack of Efficacy|1|||
163130510|NCT00239928|589186323|FG000|Overall Study|Adverse Event|4|||
163130511|NCT00239928|589186323|FG000|Overall Study|Not need to continue study|3|||
163130512|NCT00239928|589186323|FG000|Overall Study|Withdrawal by Subject|2|||
163130513|NCT04302545|589186333|FG000|Overall Study|Lost to Follow-up|3|||
163130514|NCT04302545|589186334|FG001|Overall Study|Lost to Follow-up|4|||
163130515|NCT02516592|589186335|FG000|Overall Study|Patient withdrew consent|5|||
163130516|NCT02516592|589186336|FG001|Overall Study|Patient withdrew consent|2|||
163130517|NCT02516592|589186335|FG000|Overall Study|Protocol deviation|4|||
163130518|NCT02516592|589186336|FG001|Overall Study|Protocol deviation|4|||
163130519|NCT02516592|589186335|FG000|Overall Study|Lost to Follow-up|2|||
163130520|NCT02516592|589186336|FG001|Overall Study|Lost to Follow-up|3|||
163130521|NCT02516592|589186335|FG000|Overall Study|Patient/guardian decision|2|||
163130522|NCT02516592|589186336|FG001|Overall Study|Patient/guardian decision|1|||
163130523|NCT02516592|589186335|FG000|Overall Study|Adverse Event|1|||
163130524|NCT02516592|589186336|FG001|Overall Study|Adverse Event|2|||
163130525|NCT02516592|589186335|FG000|Overall Study|Abnormal test procedure result|1|||
163130526|NCT02516592|589186336|FG001|Overall Study|Abnormal test procedure result|0|||
163130527|NCT02516592|589186335|FG000|Overall Study|Death|1|||
163130528|NCT02516592|589186336|FG001|Overall Study|Death|1|||
163130529|NCT00300365|589186338|FG000|Overall Study|Lost to Follow-up|1|||
163130530|NCT00300365|589186339|FG001|Overall Study|Lost to Follow-up|0|||
163130531|NCT00300365|589186338|FG000|Overall Study|Physician Decision|2|||
163130532|NCT00300365|589186339|FG001|Overall Study|Physician Decision|0|||
163130533|NCT00300365|589186338|FG000|Overall Study|Withdrawal by Subject|1|||
163130534|NCT00300365|589186339|FG001|Overall Study|Withdrawal by Subject|0|||
163130535|NCT00300365|589186338|FG000|Overall Study|Adverse Event|0|||
163130536|NCT00300365|589186339|FG001|Overall Study|Adverse Event|2|||
163130537|NCT00764673|589186341|FG000|Overall Study|Death|1|||
163130538|NCT00764673|589186341|FG000|Overall Study|Lost to Follow-up|3|||
163130539|NCT00764673|589186341|FG000|Overall Study|Withdrawal by Subject|6|||
163130540|NCT00764673|589186341|FG000|Overall Study|Revision of Device|2|||
163130541|NCT01438177|589186342|FG000|Overall Study|Withdrawal by Subject|1|||
163130542|NCT01438177|589186342|FG000|Overall Study|Initiation of new therapy|1|||
163130543|NCT01727336|589186343|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
163130544|NCT01727336|589186344|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
163130545|NCT01727336|589186345|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
163130546|NCT01727336|589186346|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
163130547|NCT01727336|589186347|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
163130548|NCT01727336|589186348|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
163130549|NCT01727336|589186343|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
163130550|NCT01727336|589186344|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
163130551|NCT01727336|589186345|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
163130552|NCT01727336|589186346|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
163130553|NCT01727336|589186347|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
163130554|NCT01727336|589186348|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
163130555|NCT01727336|589186343|FG000|Part 2 Blinded|Death|0|||
163130556|NCT01727336|589186344|FG001|Part 2 Blinded|Death|0|||
163130557|NCT01727336|589186345|FG002|Part 2 Blinded|Death|0|||
163130558|NCT01727336|589186346|FG003|Part 2 Blinded|Death|0|||
163130559|NCT01727336|589186347|FG004|Part 2 Blinded|Death|20|||
163130560|NCT01727336|589186348|FG005|Part 2 Blinded|Death|16|||
163130561|NCT01727336|589186343|FG000|Part 2 Blinded|Lack of Efficacy|0|||
163130562|NCT01727336|589186344|FG001|Part 2 Blinded|Lack of Efficacy|0|||
163130563|NCT01727336|589186345|FG002|Part 2 Blinded|Lack of Efficacy|0|||
163130564|NCT01727336|589186346|FG003|Part 2 Blinded|Lack of Efficacy|0|||
163130565|NCT01727336|589186347|FG004|Part 2 Blinded|Lack of Efficacy|42|||
163130566|NCT01727336|589186348|FG005|Part 2 Blinded|Lack of Efficacy|44|||
163130567|NCT01727336|589186343|FG000|Part 2 Blinded|Lost to Follow-up|0|||
163130568|NCT01727336|589186344|FG001|Part 2 Blinded|Lost to Follow-up|0|||
163130569|NCT01727336|589186345|FG002|Part 2 Blinded|Lost to Follow-up|0|||
163343714|NCT02660034|589966498|FG004|Overall Study|Sponsor Decision|3|||
163343715|NCT02660034|589966499|FG005|Overall Study|Sponsor Decision|0|||
163130570|NCT01727336|589186346|FG003|Part 2 Blinded|Lost to Follow-up|0|||
163130571|NCT01727336|589186347|FG004|Part 2 Blinded|Lost to Follow-up|0|||
163130572|NCT01727336|589186348|FG005|Part 2 Blinded|Lost to Follow-up|1|||
163130573|NCT01727336|589186343|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
163130574|NCT01727336|589186344|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
163130575|NCT01727336|589186345|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
163130576|NCT01727336|589186346|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
163130577|NCT01727336|589186347|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
163130578|NCT01727336|589186348|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
163130579|NCT01727336|589186343|FG000|Part 2 Blinded|use of prohibited medications|0|||
163130580|NCT01727336|589186344|FG001|Part 2 Blinded|use of prohibited medications|0|||
163130581|NCT01727336|589186345|FG002|Part 2 Blinded|use of prohibited medications|0|||
163130582|NCT01727336|589186346|FG003|Part 2 Blinded|use of prohibited medications|0|||
163130583|NCT01727336|589186347|FG004|Part 2 Blinded|use of prohibited medications|1|||
163130584|NCT01727336|589186348|FG005|Part 2 Blinded|use of prohibited medications|3|||
163130585|NCT00619099|589186349|FG000|Overall Study|Progressive Disease|7|||
163130586|NCT00619099|589186350|FG001|Overall Study|Progressive Disease|5|||
163130587|NCT00619099|589186349|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
163130588|NCT00619099|589186350|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
163130589|NCT00619099|589186349|FG000|Overall Study|Adverse Event|4|||
163130590|NCT00619099|589186350|FG001|Overall Study|Adverse Event|3|||
163130591|NCT00619099|589186349|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
163130592|NCT00619099|589186350|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
163130593|NCT00619099|589186349|FG000|Overall Study|Withdrawal by Subject|10|||
163130594|NCT00619099|589186350|FG001|Overall Study|Withdrawal by Subject|2|||
163130595|NCT00619099|589186349|FG000|Overall Study|Physician Decision|9|||
163130596|NCT00619099|589186350|FG001|Overall Study|Physician Decision|6|||
163130597|NCT04058886|589186353|FG000|Overall Study|Withdrawal by Subject|4|||
163130598|NCT04058886|589186353|FG000|Overall Study|Inadequate deafness interpreter service|1|||
163130599|NCT00699335|589186356|FG000|Overall Study|Combination of multiple reasons|176|||
163130600|NCT00699335|589186356|FG000|Overall Study|Missing data|52|||
163130601|NCT01717326|589186365|FG000|Overall Study|Death|0|||
163130602|NCT01717326|589186366|FG001|Overall Study|Death|0|||
163130603|NCT01717326|589186367|FG002|Overall Study|Death|0|||
163130604|NCT01717326|589186368|FG003|Overall Study|Death|0|||
163130605|NCT01717326|589186369|FG004|Overall Study|Death|0|||
163130606|NCT01717326|589186370|FG005|Overall Study|Death|0|||
163130607|NCT01717326|589186371|FG006|Overall Study|Death|0|||
163130608|NCT01717326|589186372|FG007|Overall Study|Death|0|||
163130609|NCT01717326|589186373|FG008|Overall Study|Death|0|||
163130610|NCT01717326|589186374|FG009|Overall Study|Death|0|||
163130611|NCT01717326|589186375|FG010|Overall Study|Death|1|||
163130612|NCT01717326|589186376|FG011|Overall Study|Death|0|||
163130613|NCT01717326|589186377|FG012|Overall Study|Death|0|||
163130614|NCT01717326|589186378|FG013|Overall Study|Death|0|||
163130615|NCT01717326|589186379|FG014|Overall Study|Death|0|||
163130616|NCT01717326|589186380|FG015|Overall Study|Death|0|||
163130617|NCT01717326|589186381|FG016|Overall Study|Death|0|||
163130618|NCT01717326|589186382|FG017|Overall Study|Death|0|||
163130619|NCT01717326|589186383|FG018|Overall Study|Death|0|||
163130620|NCT01717326|589186384|FG019|Overall Study|Death|0|||
163130621|NCT01717326|589186365|FG000|Overall Study|Lost to Follow-up|3|||
163130622|NCT01717326|589186366|FG001|Overall Study|Lost to Follow-up|0|||
163130623|NCT01717326|589186367|FG002|Overall Study|Lost to Follow-up|0|||
163130624|NCT01717326|589186368|FG003|Overall Study|Lost to Follow-up|2|||
163130625|NCT01717326|589186369|FG004|Overall Study|Lost to Follow-up|1|||
163130626|NCT01717326|589186370|FG005|Overall Study|Lost to Follow-up|0|||
163130627|NCT01717326|589186371|FG006|Overall Study|Lost to Follow-up|1|||
163130628|NCT01717326|589186372|FG007|Overall Study|Lost to Follow-up|0|||
163130629|NCT01717326|589186373|FG008|Overall Study|Lost to Follow-up|0|||
163130630|NCT01717326|589186374|FG009|Overall Study|Lost to Follow-up|0|||
163130631|NCT01717326|589186375|FG010|Overall Study|Lost to Follow-up|1|||
163130632|NCT01717326|589186376|FG011|Overall Study|Lost to Follow-up|0|||
163130633|NCT01717326|589186377|FG012|Overall Study|Lost to Follow-up|0|||
163130634|NCT01717326|589186378|FG013|Overall Study|Lost to Follow-up|0|||
163130635|NCT01717326|589186379|FG014|Overall Study|Lost to Follow-up|0|||
163130636|NCT01717326|589186380|FG015|Overall Study|Lost to Follow-up|2|||
163130637|NCT01717326|589186381|FG016|Overall Study|Lost to Follow-up|1|||
163130638|NCT01717326|589186382|FG017|Overall Study|Lost to Follow-up|0|||
163130639|NCT01717326|589186383|FG018|Overall Study|Lost to Follow-up|2|||
163130640|NCT01717326|589186384|FG019|Overall Study|Lost to Follow-up|3|||
163130641|NCT01717326|589186365|FG000|Overall Study|Physician Decision|0|||
163130642|NCT01717326|589186366|FG001|Overall Study|Physician Decision|0|||
163130643|NCT01717326|589186367|FG002|Overall Study|Physician Decision|0|||
163130644|NCT01717326|589186368|FG003|Overall Study|Physician Decision|0|||
163130645|NCT01717326|589186369|FG004|Overall Study|Physician Decision|0|||
163130646|NCT01717326|589186370|FG005|Overall Study|Physician Decision|0|||
163408402|NCT05030311|590205507|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
163130647|NCT01717326|589186371|FG006|Overall Study|Physician Decision|0|||
163130648|NCT01717326|589186372|FG007|Overall Study|Physician Decision|0|||
163130649|NCT01717326|589186373|FG008|Overall Study|Physician Decision|0|||
163130650|NCT01717326|589186374|FG009|Overall Study|Physician Decision|1|||
163130651|NCT01717326|589186375|FG010|Overall Study|Physician Decision|0|||
163130652|NCT01717326|589186376|FG011|Overall Study|Physician Decision|0|||
163130653|NCT01717326|589186377|FG012|Overall Study|Physician Decision|0|||
163130654|NCT01717326|589186378|FG013|Overall Study|Physician Decision|0|||
163130655|NCT01717326|589186379|FG014|Overall Study|Physician Decision|0|||
163130656|NCT01717326|589186380|FG015|Overall Study|Physician Decision|0|||
163130657|NCT01717326|589186381|FG016|Overall Study|Physician Decision|0|||
163130658|NCT01717326|589186382|FG017|Overall Study|Physician Decision|0|||
163130659|NCT01717326|589186383|FG018|Overall Study|Physician Decision|0|||
163130660|NCT01717326|589186384|FG019|Overall Study|Physician Decision|0|||
163130661|NCT01717326|589186365|FG000|Overall Study|Protocol Violation|0|||
163130662|NCT01717326|589186366|FG001|Overall Study|Protocol Violation|0|||
163227372|NCT00213148|589546244|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
163227373|NCT00213148|589546245|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
163227374|NCT00213148|589546246|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
163227375|NCT00213148|589546247|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
163227376|NCT00213148|589546248|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
163227377|NCT00213148|589546244|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
163227378|NCT00213148|589546245|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
163227379|NCT00213148|589546246|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
163227380|NCT00213148|589546247|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
163227381|NCT00213148|589546248|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
163227382|NCT00213148|589546244|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
163227383|NCT00213148|589546245|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
163227384|NCT00213148|589546246|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
163227385|NCT00213148|589546247|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
163227386|NCT00213148|589546248|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
163227387|NCT00213148|589546244|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
163227388|NCT00213148|589546245|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
163227389|NCT00213148|589546246|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
163227390|NCT00213148|589546247|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
163227391|NCT00213148|589546248|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
163227392|NCT00213148|589546244|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
163227393|NCT00213148|589546245|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
163227394|NCT00213148|589546246|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
163227395|NCT00213148|589546247|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
163227396|NCT00213148|589546248|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
163227397|NCT00213148|589546244|FG000|Cycle 2 (1 Month)|Other|2|||
163227398|NCT00213148|589546245|FG001|Cycle 2 (1 Month)|Other|1|||
163227399|NCT00213148|589546246|FG002|Cycle 2 (1 Month)|Other|2|||
163227400|NCT00213148|589546247|FG003|Cycle 2 (1 Month)|Other|8|||
163227401|NCT00213148|589546248|FG004|Cycle 2 (1 Month)|Other|7|||
163227402|NCT00213148|589546244|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
163227403|NCT00213148|589546245|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
163227404|NCT00213148|589546246|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
163227405|NCT00213148|589546247|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
163227406|NCT00213148|589546248|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
163227407|NCT00213148|589546244|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
163227408|NCT00213148|589546245|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
163227409|NCT00213148|589546246|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
163227410|NCT00213148|589546247|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
163227411|NCT00213148|589546248|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
163227412|NCT00213148|589546244|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
163227413|NCT00213148|589546245|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
163227414|NCT00213148|589546246|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
163227415|NCT00213148|589546247|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
163227416|NCT00213148|589546248|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
163227417|NCT00213148|589546244|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
163227418|NCT00213148|589546245|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
163227419|NCT00213148|589546246|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
163227420|NCT00213148|589546247|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
163227421|NCT00213148|589546248|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
163227422|NCT00213148|589546244|FG000|Cycle 3 (1 Month)|Other|0|||
163227423|NCT00213148|589546245|FG001|Cycle 3 (1 Month)|Other|0|||
163227424|NCT00213148|589546246|FG002|Cycle 3 (1 Month)|Other|1|||
163227425|NCT00213148|589546247|FG003|Cycle 3 (1 Month)|Other|1|||
163227426|NCT00213148|589546248|FG004|Cycle 3 (1 Month)|Other|0|||
163227427|NCT02321462|589546251|FG000|Overall Study|Withdrawal by Subject|5|||
163343716|NCT02660034|589966500|FG006|Overall Study|Sponsor Decision|0|||
163343717|NCT02660034|589966501|FG007|Overall Study|Sponsor Decision|0|||
163343718|NCT02660034|589966502|FG008|Overall Study|Sponsor Decision|0|||
163343719|NCT02660034|589966503|FG009|Overall Study|Sponsor Decision|0|||
163343720|NCT02660034|589966504|FG010|Overall Study|Sponsor Decision|0|||
163343721|NCT02660034|589966505|FG011|Overall Study|Sponsor Decision|0|||
163343722|NCT02660034|589966506|FG012|Overall Study|Sponsor Decision|0|||
163343723|NCT02660034|589966507|FG013|Overall Study|Sponsor Decision|1|||
163343724|NCT02660034|589966494|FG000|Overall Study|Withdrawal by Subject|0|||
163343725|NCT02660034|589966495|FG001|Overall Study|Withdrawal by Subject|0|||
163343726|NCT02660034|589966496|FG002|Overall Study|Withdrawal by Subject|0|||
163343727|NCT02660034|589966497|FG003|Overall Study|Withdrawal by Subject|0|||
163343728|NCT02660034|589966498|FG004|Overall Study|Withdrawal by Subject|0|||
163227428|NCT02321462|589546252|FG001|Overall Study|Withdrawal by Subject|2|||
163227429|NCT02321462|589546251|FG000|Overall Study|Subject withdrawn before any treatment|1|||
163227430|NCT02321462|589546252|FG001|Overall Study|Subject withdrawn before any treatment|1|||
163227431|NCT03044197|589546256|FG000|Overall Study|Withdrawal by Subject|3|||
163227432|NCT03044197|589546257|FG001|Overall Study|Withdrawal by Subject|1|||
163343729|NCT02660034|589966499|FG005|Overall Study|Withdrawal by Subject|0|||
163343730|NCT02660034|589966500|FG006|Overall Study|Withdrawal by Subject|1|||
163343731|NCT02660034|589966501|FG007|Overall Study|Withdrawal by Subject|1|||
163130663|NCT01717326|589186367|FG002|Overall Study|Protocol Violation|0|||
163130664|NCT01717326|589186368|FG003|Overall Study|Protocol Violation|0|||
163130665|NCT01717326|589186369|FG004|Overall Study|Protocol Violation|1|||
163130666|NCT01717326|589186370|FG005|Overall Study|Protocol Violation|0|||
163130667|NCT01717326|589186371|FG006|Overall Study|Protocol Violation|0|||
163130668|NCT01717326|589186372|FG007|Overall Study|Protocol Violation|0|||
163130669|NCT01717326|589186373|FG008|Overall Study|Protocol Violation|0|||
163130670|NCT01717326|589186374|FG009|Overall Study|Protocol Violation|0|||
163130671|NCT01717326|589186375|FG010|Overall Study|Protocol Violation|0|||
163130672|NCT01717326|589186376|FG011|Overall Study|Protocol Violation|0|||
163130673|NCT01717326|589186377|FG012|Overall Study|Protocol Violation|0|||
163130674|NCT01717326|589186378|FG013|Overall Study|Protocol Violation|0|||
163130675|NCT01717326|589186379|FG014|Overall Study|Protocol Violation|0|||
163130676|NCT01717326|589186380|FG015|Overall Study|Protocol Violation|0|||
163130677|NCT01717326|589186381|FG016|Overall Study|Protocol Violation|0|||
163130678|NCT01717326|589186382|FG017|Overall Study|Protocol Violation|0|||
163130679|NCT01717326|589186383|FG018|Overall Study|Protocol Violation|0|||
163130680|NCT01717326|589186384|FG019|Overall Study|Protocol Violation|0|||
163130681|NCT01717326|589186365|FG000|Overall Study|Withdrawal by Subject|0|||
163130682|NCT01717326|589186366|FG001|Overall Study|Withdrawal by Subject|1|||
163130683|NCT01717326|589186367|FG002|Overall Study|Withdrawal by Subject|0|||
163130684|NCT01717326|589186368|FG003|Overall Study|Withdrawal by Subject|0|||
163130685|NCT01717326|589186369|FG004|Overall Study|Withdrawal by Subject|0|||
163130686|NCT01717326|589186370|FG005|Overall Study|Withdrawal by Subject|0|||
163130687|NCT01717326|589186371|FG006|Overall Study|Withdrawal by Subject|0|||
163130688|NCT01717326|589186372|FG007|Overall Study|Withdrawal by Subject|0|||
163130689|NCT01717326|589186373|FG008|Overall Study|Withdrawal by Subject|0|||
163130690|NCT01717326|589186374|FG009|Overall Study|Withdrawal by Subject|1|||
163130691|NCT01717326|589186375|FG010|Overall Study|Withdrawal by Subject|0|||
163130692|NCT01717326|589186376|FG011|Overall Study|Withdrawal by Subject|0|||
163130693|NCT01717326|589186377|FG012|Overall Study|Withdrawal by Subject|1|||
163130694|NCT01717326|589186378|FG013|Overall Study|Withdrawal by Subject|0|||
163130695|NCT01717326|589186379|FG014|Overall Study|Withdrawal by Subject|0|||
163130696|NCT01717326|589186380|FG015|Overall Study|Withdrawal by Subject|1|||
163130697|NCT01717326|589186381|FG016|Overall Study|Withdrawal by Subject|0|||
163130698|NCT01717326|589186382|FG017|Overall Study|Withdrawal by Subject|0|||
163130699|NCT01717326|589186383|FG018|Overall Study|Withdrawal by Subject|2|||
163130700|NCT01717326|589186384|FG019|Overall Study|Withdrawal by Subject|3|||
163130701|NCT01299116|589186385|FG000|Overall Study|Lost to Follow-up|65|||
163130702|NCT01299116|589186386|FG001|Overall Study|Lost to Follow-up|9|||
163130703|NCT01299116|589186387|FG002|Overall Study|Lost to Follow-up|11|||
163130704|NCT00488826|589186392|FG000|Overall Study|Withdrawal by Subject|40|||
163130705|NCT00488826|589186393|FG001|Overall Study|Withdrawal by Subject|35|||
163130706|NCT00488826|589186394|FG002|Overall Study|Withdrawal by Subject|19|||
163130707|NCT00488826|589186392|FG000|Overall Study|Protocol Violation|0|||
163130708|NCT00488826|589186393|FG001|Overall Study|Protocol Violation|0|||
163130709|NCT00488826|589186394|FG002|Overall Study|Protocol Violation|2|||
163130710|NCT00488826|589186392|FG000|Overall Study|Adverse Event|9|||
163130711|NCT00488826|589186393|FG001|Overall Study|Adverse Event|15|||
163130712|NCT00488826|589186394|FG002|Overall Study|Adverse Event|4|||
163130713|NCT00488826|589186392|FG000|Overall Study|Lost to Follow-up|5|||
163130714|NCT00488826|589186393|FG001|Overall Study|Lost to Follow-up|1|||
163130715|NCT00488826|589186394|FG002|Overall Study|Lost to Follow-up|0|||
163130716|NCT00488826|589186392|FG000|Overall Study|Protocol Deviations|2|||
163130717|NCT00488826|589186393|FG001|Overall Study|Protocol Deviations|1|||
163130718|NCT00488826|589186394|FG002|Overall Study|Protocol Deviations|1|||
163130719|NCT02974842|589186397|FG000|Overall Study|Withdrawal by Subject|4|||
163130720|NCT02974842|589186397|FG000|Overall Study|Screen failures|4|||
163130721|NCT01959243|589186398|FG000|Overall Study|Investigator Decision|3|||
163130722|NCT01959243|589186399|FG001|Overall Study|Investigator Decision|0|||
163130723|NCT01959243|589186398|FG000|Overall Study|Adverse Event|5|||
163130724|NCT01959243|589186399|FG001|Overall Study|Adverse Event|2|||
163130725|NCT01959243|589186398|FG000|Overall Study|Administrative reasons|2|||
163130726|NCT01959243|589186399|FG001|Overall Study|Administrative reasons|1|||
163130727|NCT01959243|589186398|FG000|Overall Study|Lost to Follow-up|3|||
163130728|NCT01959243|589186399|FG001|Overall Study|Lost to Follow-up|1|||
163130729|NCT00812565|589186402|FG000|Overall Study|Did Not Receive Study Medication|1|||
163130730|NCT00812565|589186403|FG001|Overall Study|Did Not Receive Study Medication|1|||
163227433|NCT01574352|589546259|FG000|Overall Study|Withdrawal by Subject|6|||
163130731|NCT00812565|589186404|FG002|Overall Study|Did Not Receive Study Medication|0|||
163130732|NCT00812565|589186405|FG003|Overall Study|Did Not Receive Study Medication|0|||
163130733|NCT00812565|589186406|FG004|Overall Study|Did Not Receive Study Medication|0|||
163130734|NCT00812565|589186407|FG005|Overall Study|Did Not Receive Study Medication|0|||
163343732|NCT02660034|589966502|FG008|Overall Study|Withdrawal by Subject|1|||
163343733|NCT02660034|589966503|FG009|Overall Study|Withdrawal by Subject|0|||
163130735|NCT00812565|589186408|FG006|Overall Study|Did Not Receive Study Medication|0|||
163130736|NCT00812565|589186409|FG007|Overall Study|Did Not Receive Study Medication|0|||
163130737|NCT00812565|589186402|FG000|Overall Study|Adverse Event|0|||
163130738|NCT00812565|589186403|FG001|Overall Study|Adverse Event|0|||
163130739|NCT00812565|589186404|FG002|Overall Study|Adverse Event|0|||
163130740|NCT00812565|589186405|FG003|Overall Study|Adverse Event|2|||
163130741|NCT00812565|589186406|FG004|Overall Study|Adverse Event|0|||
163130742|NCT00812565|589186407|FG005|Overall Study|Adverse Event|0|||
163130743|NCT00812565|589186408|FG006|Overall Study|Adverse Event|0|||
163130744|NCT00812565|589186409|FG007|Overall Study|Adverse Event|1|||
163130745|NCT00812565|589186402|FG000|Overall Study|Did Not Come to Study Visit|1|||
163130746|NCT00812565|589186403|FG001|Overall Study|Did Not Come to Study Visit|0|||
163130747|NCT00812565|589186404|FG002|Overall Study|Did Not Come to Study Visit|0|||
163130748|NCT00812565|589186405|FG003|Overall Study|Did Not Come to Study Visit|0|||
163130749|NCT00812565|589186406|FG004|Overall Study|Did Not Come to Study Visit|0|||
163130750|NCT00812565|589186407|FG005|Overall Study|Did Not Come to Study Visit|0|||
163130751|NCT00812565|589186408|FG006|Overall Study|Did Not Come to Study Visit|0|||
163130752|NCT00812565|589186409|FG007|Overall Study|Did Not Come to Study Visit|0|||
163130753|NCT00812565|589186402|FG000|Overall Study|Withdrawal of Consent|1|||
163130754|NCT00812565|589186403|FG001|Overall Study|Withdrawal of Consent|0|||
163130755|NCT00812565|589186404|FG002|Overall Study|Withdrawal of Consent|0|||
163130756|NCT00812565|589186405|FG003|Overall Study|Withdrawal of Consent|0|||
163130757|NCT00812565|589186406|FG004|Overall Study|Withdrawal of Consent|1|||
163130758|NCT00812565|589186407|FG005|Overall Study|Withdrawal of Consent|0|||
163130759|NCT00812565|589186408|FG006|Overall Study|Withdrawal of Consent|0|||
163130760|NCT00812565|589186409|FG007|Overall Study|Withdrawal of Consent|0|||
163130761|NCT00812565|589186402|FG000|Overall Study|Reason Not Specified|0|||
163130762|NCT00812565|589186403|FG001|Overall Study|Reason Not Specified|0|||
163130763|NCT00812565|589186404|FG002|Overall Study|Reason Not Specified|0|||
163130764|NCT00812565|589186405|FG003|Overall Study|Reason Not Specified|0|||
163130765|NCT00812565|589186406|FG004|Overall Study|Reason Not Specified|0|||
163130766|NCT00812565|589186407|FG005|Overall Study|Reason Not Specified|1|||
163130767|NCT00812565|589186408|FG006|Overall Study|Reason Not Specified|0|||
163130768|NCT00812565|589186409|FG007|Overall Study|Reason Not Specified|0|||
163130769|NCT02596945|589186410|FG000|Overall Study|No documentation of study drug dosing|3|||
163130770|NCT02596945|589186410|FG000|Overall Study|Other|32|||
163130771|NCT02596945|589186410|FG000|Overall Study|Change to hemodialysis|15|||
163130772|NCT02596945|589186410|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
163130773|NCT02596945|589186410|FG000|Overall Study|Withdrawal by Subject|1|||
163130774|NCT02596945|589186410|FG000|Overall Study|Missing|1|||
163130775|NCT00422383|589186411|FG000|Overall Study|Adverse Event|5|||
163130776|NCT00422383|589186412|FG001|Overall Study|Adverse Event|3|||
163130777|NCT00422383|589186413|FG002|Overall Study|Adverse Event|1|||
163130778|NCT00422383|589186414|FG003|Overall Study|Adverse Event|1|||
163130779|NCT00422383|589186415|FG004|Overall Study|Adverse Event|0|||
163130780|NCT00422383|589186411|FG000|Overall Study|Lack of Efficacy|4|||
163130781|NCT00422383|589186412|FG001|Overall Study|Lack of Efficacy|4|||
163130782|NCT00422383|589186413|FG002|Overall Study|Lack of Efficacy|2|||
163130783|NCT00422383|589186414|FG003|Overall Study|Lack of Efficacy|1|||
163130784|NCT00422383|589186415|FG004|Overall Study|Lack of Efficacy|1|||
163130785|NCT00422383|589186411|FG000|Overall Study|Lost to Follow-up|0|||
163130786|NCT00422383|589186412|FG001|Overall Study|Lost to Follow-up|1|||
163130787|NCT00422383|589186413|FG002|Overall Study|Lost to Follow-up|0|||
163130788|NCT00422383|589186414|FG003|Overall Study|Lost to Follow-up|0|||
163130789|NCT00422383|589186415|FG004|Overall Study|Lost to Follow-up|1|||
163130790|NCT00422383|589186411|FG000|Overall Study|Protocol Violation|1|||
163130791|NCT00422383|589186412|FG001|Overall Study|Protocol Violation|1|||
163130792|NCT00422383|589186413|FG002|Overall Study|Protocol Violation|1|||
163130793|NCT00422383|589186414|FG003|Overall Study|Protocol Violation|0|||
163130794|NCT00422383|589186415|FG004|Overall Study|Protocol Violation|0|||
163130795|NCT00422383|589186411|FG000|Overall Study|Withdrawal by Subject|5|||
163130796|NCT00422383|589186412|FG001|Overall Study|Withdrawal by Subject|5|||
163130797|NCT00422383|589186413|FG002|Overall Study|Withdrawal by Subject|0|||
163130798|NCT00422383|589186414|FG003|Overall Study|Withdrawal by Subject|0|||
163130799|NCT00422383|589186415|FG004|Overall Study|Withdrawal by Subject|1|||
163408403|NCT05030311|590205508|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
163130800|NCT00566254|589186416|FG000|Overall Study|Adverse Event|3|||
163130801|NCT00566254|589186417|FG001|Overall Study|Adverse Event|1|||
163130802|NCT00566254|589186416|FG000|Overall Study|Protocol Violation|1|||
163130803|NCT00566254|589186417|FG001|Overall Study|Protocol Violation|3|||
163130804|NCT00566254|589186416|FG000|Overall Study|Withdrawal by Subject|1|||
163130805|NCT00566254|589186417|FG001|Overall Study|Withdrawal by Subject|2|||
163130806|NCT00566254|589186416|FG000|Overall Study|Lack of Efficacy|5|||
163130807|NCT00566254|589186417|FG001|Overall Study|Lack of Efficacy|6|||
163130808|NCT00566254|589186416|FG000|Overall Study|Other|0|||
163130809|NCT00566254|589186417|FG001|Overall Study|Other|2|||
163130810|NCT00238238|589186418|FG000|Overall Study|Withdrawal by Subject|0|||
163130811|NCT00238238|589186419|FG001|Overall Study|Withdrawal by Subject|3|||
163130812|NCT00238238|589186420|FG002|Overall Study|Withdrawal by Subject|0|||
163130813|NCT01007838|589186421|FG000|Overall Study|Withdrawal by Subject|1|||
163130814|NCT01007838|589186422|FG001|Overall Study|Withdrawal by Subject|0|||
163130815|NCT01007838|589186423|FG002|Overall Study|Withdrawal by Subject|0|||
163130816|NCT01007838|589186424|FG003|Overall Study|Withdrawal by Subject|0|||
163130817|NCT01007838|589186421|FG000|Overall Study|Physician Decision|1|||
163130818|NCT01007838|589186422|FG001|Overall Study|Physician Decision|0|||
163130819|NCT01007838|589186423|FG002|Overall Study|Physician Decision|0|||
163130820|NCT01007838|589186424|FG003|Overall Study|Physician Decision|0|||
163130821|NCT01007838|589186421|FG000|Overall Study|Started home haemodialysis|1|||
163130822|NCT01007838|589186422|FG001|Overall Study|Started home haemodialysis|0|||
163130823|NCT01007838|589186423|FG002|Overall Study|Started home haemodialysis|0|||
163130824|NCT01007838|589186424|FG003|Overall Study|Started home haemodialysis|0|||
163130825|NCT02277119|589186428|FG000|Overall Study|Lack of Efficacy|1|||
163130826|NCT02277119|589186429|FG001|Overall Study|Lack of Efficacy|1|||
163130827|NCT02277119|589186430|FG002|Overall Study|Lack of Efficacy|1|||
163130828|NCT02277119|589186428|FG000|Overall Study|Protocol Violation|2|||
163130829|NCT02277119|589186429|FG001|Overall Study|Protocol Violation|3|||
163130830|NCT02277119|589186430|FG002|Overall Study|Protocol Violation|7|||
163130831|NCT01345669|589186431|FG000|Overall Study|Primary tumour recurrence|53|||
163130832|NCT01345669|589186432|FG001|Overall Study|Primary tumour recurrence|32|||
163130833|NCT01345669|589186431|FG000|Overall Study|Second primary tumour|4|||
163130834|NCT01345669|589186432|FG001|Overall Study|Second primary tumour|3|||
163130835|NCT01345669|589186431|FG000|Overall Study|Adverse Event|63|||
163130836|NCT01345669|589186432|FG001|Overall Study|Adverse Event|9|||
163130837|NCT01345669|589186431|FG000|Overall Study|Protocol Violation|3|||
163130838|NCT01345669|589186432|FG001|Overall Study|Protocol Violation|1|||
163130839|NCT01345669|589186431|FG000|Overall Study|Lost to Follow-up|1|||
163130840|NCT01345669|589186432|FG001|Overall Study|Lost to Follow-up|1|||
163130841|NCT01345669|589186431|FG000|Overall Study|Withdrawal by Subject|52|||
163130842|NCT01345669|589186432|FG001|Overall Study|Withdrawal by Subject|13|||
163130843|NCT01345669|589186431|FG000|Overall Study|Other Reasons|111|||
163130844|NCT01345669|589186432|FG001|Overall Study|Other Reasons|60|||
163130845|NCT04699461|589186433|FG000|Overall Study|Withdrawal by Subject|1|||
163130846|NCT04699461|589186434|FG001|Overall Study|Withdrawal by Subject|0|||
163130847|NCT04699461|589186433|FG000|Overall Study|Study termination by sponsor|2|||
163130848|NCT04699461|589186434|FG001|Overall Study|Study termination by sponsor|1|||
163130849|NCT04699461|589186433|FG000|Overall Study|Death|1|||
163130850|NCT04699461|589186434|FG001|Overall Study|Death|0|||
163130851|NCT04699461|589186433|FG000|Overall Study|Radiographic progression|0|||
163130852|NCT04699461|589186434|FG001|Overall Study|Radiographic progression|1|||
163130853|NCT01793883|589186435|FG000|Overall Study|Withdrawal by Subject|3|||
163130854|NCT01793883|589186436|FG001|Overall Study|Withdrawal by Subject|7|||
163130855|NCT01793883|589186437|FG002|Overall Study|Withdrawal by Subject|3|||
163130856|NCT01793883|589186435|FG000|Overall Study|Subject noncompliance|0|||
163130857|NCT01793883|589186436|FG001|Overall Study|Subject noncompliance|1|||
163130858|NCT01793883|589186437|FG002|Overall Study|Subject noncompliance|1|||
163130859|NCT01793883|589186435|FG000|Overall Study|Lost to Follow-up|5|||
163130860|NCT01793883|589186436|FG001|Overall Study|Lost to Follow-up|1|||
163130861|NCT01793883|589186437|FG002|Overall Study|Lost to Follow-up|3|||
163130862|NCT01793883|589186435|FG000|Overall Study|Randomized in error|1|||
163130863|NCT01793883|589186436|FG001|Overall Study|Randomized in error|0|||
163130864|NCT01793883|589186437|FG002|Overall Study|Randomized in error|0|||
163130865|NCT01793883|589186435|FG000|Overall Study|Unable to complete spriometry|1|||
163130866|NCT01793883|589186436|FG001|Overall Study|Unable to complete spriometry|0|||
163130867|NCT01793883|589186437|FG002|Overall Study|Unable to complete spriometry|0|||
163130868|NCT01793883|589186435|FG000|Overall Study|Unable to complete measurements|1|||
163130869|NCT01793883|589186436|FG001|Overall Study|Unable to complete measurements|0|||
163130870|NCT01793883|589186437|FG002|Overall Study|Unable to complete measurements|0|||
163130871|NCT01793883|589186435|FG000|Overall Study|Met exclusion criteria|1|||
163130872|NCT01793883|589186436|FG001|Overall Study|Met exclusion criteria|0|||
163130873|NCT01793883|589186437|FG002|Overall Study|Met exclusion criteria|0|||
163130874|NCT01793883|589186435|FG000|Overall Study|Dosing error|0|||
163130875|NCT01793883|589186436|FG001|Overall Study|Dosing error|1|||
163130876|NCT01793883|589186437|FG002|Overall Study|Dosing error|0|||
163130877|NCT01793883|589186435|FG000|Overall Study|Respiratory distress during spirometry|0|||
163130878|NCT01793883|589186436|FG001|Overall Study|Respiratory distress during spirometry|0|||
163130879|NCT01793883|589186437|FG002|Overall Study|Respiratory distress during spirometry|1|||
163130880|NCT00761527|589186440|FG000|Overall Study|Adverse Event|3|||
163130881|NCT00761527|589186440|FG000|Overall Study|Poor Compliance|8|||
163130882|NCT00761527|589186440|FG000|Overall Study|Lost to Follow-up|9|||
163130883|NCT00761527|589186440|FG000|Overall Study|Unknown reason|2|||
163130884|NCT02301624|589186443|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
163130885|NCT02301624|589186444|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
163130886|NCT02301624|589186443|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
163408404|NCT05030311|590205507|FG000|Overall Study|Physician Decision|5|||
163408405|NCT05030311|590205508|FG001|Overall Study|Physician Decision|2|||
163130887|NCT02301624|589186444|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
163130888|NCT02301624|589186443|FG000|Open-label Maintenance Phase|Adverse Event|2|||
163130889|NCT02301624|589186444|FG001|Open-label Maintenance Phase|Adverse Event|5|||
163130890|NCT02301624|589186443|FG000|Open-label Maintenance Phase|Physician Decision|3|||
163130891|NCT02301624|589186444|FG001|Open-label Maintenance Phase|Physician Decision|3|||
163130892|NCT02301624|589186443|FG000|Open-label Maintenance Phase|Death|2|||
163130893|NCT02301624|589186444|FG001|Open-label Maintenance Phase|Death|1|||
163130894|NCT02301624|589186443|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
163130895|NCT02301624|589186444|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
163130896|NCT00895310|589186445|FG000|Overall Study|Withdrawal by Subject|1|||
163130897|NCT03738618|589188150|FG000|Overall Study|Protocol deviation|23|||
163130898|NCT03738618|589188151|FG001|Overall Study|Protocol deviation|0|||
163130899|NCT03738618|589188150|FG000|Overall Study|Adverse Event|4|||
163130900|NCT03738618|589188151|FG001|Overall Study|Adverse Event|0|||
163130901|NCT03738618|589188150|FG000|Overall Study|Lost to Follow-up|2|||
163130902|NCT03738618|589188151|FG001|Overall Study|Lost to Follow-up|0|||
163130903|NCT03738618|589188150|FG000|Overall Study|Randomization failure|1|||
163130904|NCT03738618|589188151|FG001|Overall Study|Randomization failure|0|||
163130905|NCT03738618|589188150|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
163130906|NCT03738618|589188151|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
163130907|NCT03738618|589188150|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
163130908|NCT03738618|589188151|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
163130909|NCT01271725|589188156|FG000|Part A|Progressive disease according to RECIST|8|||
163130910|NCT01271725|589188157|FG001|Part A|Progressive disease according to RECIST|0|||
163130911|NCT01271725|589188156|FG000|Part A|Clinical signs/symptoms of progression|2|||
163130912|NCT01271725|589188157|FG001|Part A|Clinical signs/symptoms of progression|0|||
163130913|NCT01271725|589188156|FG000|Part A|Other Adverse Event|8|||
163130914|NCT01271725|589188157|FG001|Part A|Other Adverse Event|0|||
163130915|NCT01271725|589188156|FG000|Part A|Lost to Follow-up|1|||
163130916|NCT01271725|589188157|FG001|Part A|Lost to Follow-up|0|||
163130917|NCT01271725|589188156|FG000|Part A|Withdrawal by Subject|12|||
163130918|NCT01271725|589188157|FG001|Part A|Withdrawal by Subject|0|||
163130919|NCT01271725|589188156|FG000|Part A|Other than specified|3|||
163130920|NCT01271725|589188157|FG001|Part A|Other than specified|0|||
163130921|NCT01271725|589188156|FG000|Part A|Protocol Violation|1|||
163130922|NCT01271725|589188157|FG001|Part A|Protocol Violation|0|||
163130923|NCT01271725|589188156|FG000|Part B|Other than specified|0|||
163130924|NCT01271725|589188157|FG001|Part B|Other than specified|2|||
163130925|NCT01271725|589188156|FG000|Part B|Clinical signs/symptoms of progression|0|||
163130926|NCT01271725|589188157|FG001|Part B|Clinical signs/symptoms of progression|2|||
163130927|NCT01271725|589188156|FG000|Part B|Other Adverse Event|0|||
163130928|NCT01271725|589188157|FG001|Part B|Other Adverse Event|1|||
163130929|NCT01271725|589188156|FG000|Part B|Protocol Violation|0|||
163130930|NCT01271725|589188157|FG001|Part B|Protocol Violation|1|||
163130931|NCT01271725|589188156|FG000|Part B|Withdrawal by Subject|0|||
163130932|NCT01271725|589188157|FG001|Part B|Withdrawal by Subject|6|||
163130933|NCT00801229|589188158|FG000|Signed Consent|Withdrawal by Subject|2|||
163130934|NCT00801229|589188159|FG001|Signed Consent|Withdrawal by Subject|2|||
163130935|NCT00801229|589188158|FG000|Signed Consent|Found Ineligible|1|||
163130936|NCT00801229|589188159|FG001|Signed Consent|Found Ineligible|1|||
163130937|NCT00801229|589188158|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
163130938|NCT00801229|589188159|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
163130939|NCT00801229|589188158|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
163130940|NCT00801229|589188159|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
163130941|NCT00801229|589188158|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
163130942|NCT00801229|589188159|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
163130943|NCT00801229|589188158|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
163130944|NCT00801229|589188159|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
163130945|NCT00801229|589188158|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
163130946|NCT00801229|589188159|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
163130947|NCT00801229|589188158|FG000|Received Study Drug/Placebo|Adverse Event|1|||
163130948|NCT00801229|589188159|FG001|Received Study Drug/Placebo|Adverse Event|1|||
163130949|NCT03826186|589188160|FG000|Overall Study|Protocol Violation|2|||
163130950|NCT03826186|589188161|FG001|Overall Study|Protocol Violation|0|||
163130951|NCT03826186|589188160|FG000|Overall Study|Withdrawal by Subject|1|||
163130952|NCT03826186|589188161|FG001|Overall Study|Withdrawal by Subject|0|||
163130953|NCT02950480|589188164|FG000|Overall Study|Withdrawal by Subject|1|||
163408406|NCT05030311|590205507|FG000|Overall Study|Lost to Follow-up|5|||
163130954|NCT02950480|589188165|FG001|Overall Study|Withdrawal by Subject|0|||
163130955|NCT01363661|589188166|FG000|Overall Study|Adverse Event|9|||
163130956|NCT01363661|589188167|FG001|Overall Study|Adverse Event|2|||
163130957|NCT01363661|589188166|FG000|Overall Study|Withdrawal by Subject|1|||
163130958|NCT01363661|589188167|FG001|Overall Study|Withdrawal by Subject|1|||
163130959|NCT01363661|589188166|FG000|Overall Study|Protocol Violation|1|||
163130960|NCT01363661|589188167|FG001|Overall Study|Protocol Violation|0|||
163343734|NCT02660034|589966504|FG010|Overall Study|Withdrawal by Subject|0|||
163343735|NCT02660034|589966505|FG011|Overall Study|Withdrawal by Subject|1|||
163343736|NCT02660034|589966506|FG012|Overall Study|Withdrawal by Subject|2|||
163343737|NCT02660034|589966507|FG013|Overall Study|Withdrawal by Subject|0|||
163343738|NCT02660034|589966494|FG000|Overall Study|Death|0|||
163343739|NCT02660034|589966495|FG001|Overall Study|Death|0|||
163343740|NCT02660034|589966496|FG002|Overall Study|Death|0|||
163343741|NCT02660034|589966497|FG003|Overall Study|Death|0|||
163130961|NCT01363661|589188166|FG000|Overall Study|Lost to Follow-up|3|||
163130962|NCT01363661|589188167|FG001|Overall Study|Lost to Follow-up|1|||
163130963|NCT00705367|589188174|FG000|Long-term Extension Period|Adverse Event|2|||
163130964|NCT00705367|589188175|FG001|Long-term Extension Period|Adverse Event|0|||
163130965|NCT00705367|589188174|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
163130966|NCT00705367|589188175|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
163130967|NCT00705367|589188174|FG000|Long-term Extension Period|Lack of Efficacy|1|||
163130968|NCT00705367|589188175|FG001|Long-term Extension Period|Lack of Efficacy|0|||
163130969|NCT00705367|589188174|FG000|Long-term Extension Period|No longer met study criteria|1|||
163130970|NCT00705367|589188175|FG001|Long-term Extension Period|No longer met study criteria|0|||
163130971|NCT00705367|589188174|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
163130972|NCT00705367|589188175|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
163130973|NCT01959139|589188176|FG000|Phase II|Disease progression|0|||
163130974|NCT01959139|589188177|FG001|Phase II|Disease progression|0|||
163130975|NCT01959139|589188178|FG002|Phase II|Disease progression|26|||
163130976|NCT01959139|589188179|FG003|Phase II|Disease progression|34|||
163130977|NCT01959139|589188176|FG000|Phase II|Adverse Event|0|||
163130978|NCT01959139|589188177|FG001|Phase II|Adverse Event|0|||
163130979|NCT01959139|589188178|FG002|Phase II|Adverse Event|10|||
163130980|NCT01959139|589188179|FG003|Phase II|Adverse Event|11|||
163130981|NCT01959139|589188176|FG000|Phase II|Patient Refusal|0|||
163130982|NCT01959139|589188177|FG001|Phase II|Patient Refusal|0|||
163130983|NCT01959139|589188178|FG002|Phase II|Patient Refusal|5|||
163130984|NCT01959139|589188179|FG003|Phase II|Patient Refusal|4|||
163130985|NCT01959139|589188176|FG000|Phase II|Death|0|||
163130986|NCT01959139|589188177|FG001|Phase II|Death|0|||
163130987|NCT01959139|589188178|FG002|Phase II|Death|3|||
163130988|NCT01959139|589188179|FG003|Phase II|Death|1|||
163130989|NCT01959139|589188176|FG000|Phase II|Other/Unknown|0|||
163130990|NCT01959139|589188177|FG001|Phase II|Other/Unknown|0|||
163130991|NCT01959139|589188178|FG002|Phase II|Other/Unknown|8|||
163130992|NCT01959139|589188179|FG003|Phase II|Other/Unknown|5|||
163130993|NCT01959139|589188176|FG000|Phase II|On treatment|0|||
163130994|NCT01959139|589188177|FG001|Phase II|On treatment|0|||
163130995|NCT01959139|589188178|FG002|Phase II|On treatment|4|||
163130996|NCT01959139|589188179|FG003|Phase II|On treatment|0|||
163130997|NCT01378325|589188182|FG000|Overall Study|Protocol Violation|0|||
163130998|NCT01378325|589188183|FG001|Overall Study|Protocol Violation|1|||
163130999|NCT02255461|589188184|FG000|Overall Study|Adverse Event|0|||
163131000|NCT02255461|589188185|FG001|Overall Study|Adverse Event|1|||
163131001|NCT02255461|589188186|FG002|Overall Study|Adverse Event|0|||
163131002|NCT02255461|589188187|FG003|Overall Study|Adverse Event|0|||
163131003|NCT02255461|589188188|FG004|Overall Study|Adverse Event|1|||
163131004|NCT02255461|589188184|FG000|Overall Study|Withdrawal by Subject|0|||
163131005|NCT02255461|589188185|FG001|Overall Study|Withdrawal by Subject|0|||
163131006|NCT02255461|589188186|FG002|Overall Study|Withdrawal by Subject|1|||
163131007|NCT02255461|589188187|FG003|Overall Study|Withdrawal by Subject|0|||
163131008|NCT02255461|589188188|FG004|Overall Study|Withdrawal by Subject|1|||
163131009|NCT02255461|589188184|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
163131010|NCT02255461|589188185|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
163227434|NCT01574352|589546260|FG001|Overall Study|Withdrawal by Subject|13|||
163131011|NCT02255461|589188186|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
163131012|NCT02255461|589188187|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
163131013|NCT02255461|589188188|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
163131014|NCT01559675|589188189|FG000|Overall Study|Protocol Violation|1|||
163131015|NCT01559675|589188190|FG001|Overall Study|Protocol Violation|2|||
163131016|NCT01559675|589188189|FG000|Overall Study|2nd operation on same patient excluded|14|||
163131017|NCT01559675|589188190|FG001|Overall Study|2nd operation on same patient excluded|12|||
163131018|NCT01357551|589188193|FG000|Overall Study|Withdrawal by Subject|6|||
163131019|NCT01357551|589188194|FG001|Overall Study|Withdrawal by Subject|4|||
163131020|NCT01357551|589188193|FG000|Overall Study|Death|0|||
163131021|NCT01357551|589188194|FG001|Overall Study|Death|1|||
163131022|NCT01357551|589188193|FG000|Overall Study|Lost to Follow-up|16|||
163131023|NCT01357551|589188194|FG001|Overall Study|Lost to Follow-up|6|||
163131024|NCT00891228|589188198|FG000|Overall Study|Adverse Event|0|||
163131025|NCT00891228|589188199|FG001|Overall Study|Adverse Event|2|||
163131026|NCT00891228|589188200|FG002|Overall Study|Adverse Event|3|||
163227435|NCT01574352|589546259|FG000|Overall Study|Injury in non-camp related sport|1|||
163343742|NCT02660034|589966498|FG004|Overall Study|Death|0|||
163343743|NCT02660034|589966499|FG005|Overall Study|Death|13|||
163343744|NCT02660034|589966500|FG006|Overall Study|Death|14|||
163343745|NCT02660034|589966501|FG007|Overall Study|Death|10|||
163343746|NCT02660034|589966502|FG008|Overall Study|Death|9|||
163343747|NCT02660034|589966503|FG009|Overall Study|Death|21|||
163343748|NCT02660034|589966504|FG010|Overall Study|Death|17|||
163343749|NCT02660034|589966505|FG011|Overall Study|Death|15|||
163343750|NCT02660034|589966506|FG012|Overall Study|Death|18|||
163343751|NCT02660034|589966507|FG013|Overall Study|Death|7|||
163343752|NCT02660034|589966494|FG000|Overall Study|Physician Decision|0|||
163343753|NCT02660034|589966495|FG001|Overall Study|Physician Decision|0|||
163343754|NCT02660034|589966496|FG002|Overall Study|Physician Decision|0|||
163343755|NCT02660034|589966497|FG003|Overall Study|Physician Decision|0|||
163343756|NCT02660034|589966498|FG004|Overall Study|Physician Decision|0|||
163343757|NCT02660034|589966499|FG005|Overall Study|Physician Decision|0|||
163343758|NCT02660034|589966500|FG006|Overall Study|Physician Decision|0|||
163343759|NCT02660034|589966501|FG007|Overall Study|Physician Decision|0|||
163343760|NCT02660034|589966502|FG008|Overall Study|Physician Decision|0|||
163343761|NCT02660034|589966503|FG009|Overall Study|Physician Decision|0|||
163343762|NCT02660034|589966504|FG010|Overall Study|Physician Decision|0|||
163343763|NCT02660034|589966505|FG011|Overall Study|Physician Decision|0|||
163343764|NCT02660034|589966506|FG012|Overall Study|Physician Decision|0|||
163343765|NCT02660034|589966507|FG013|Overall Study|Physician Decision|1|||
163343766|NCT02660034|589966494|FG000|Overall Study|Participants transferred to LTE|0|||
163343767|NCT02660034|589966495|FG001|Overall Study|Participants transferred to LTE|0|||
163343768|NCT02660034|589966496|FG002|Overall Study|Participants transferred to LTE|0|||
163343769|NCT02660034|589966497|FG003|Overall Study|Participants transferred to LTE|0|||
163343770|NCT02660034|589966498|FG004|Overall Study|Participants transferred to LTE|0|||
163343771|NCT02660034|589966499|FG005|Overall Study|Participants transferred to LTE|10|||
163343772|NCT02660034|589966500|FG006|Overall Study|Participants transferred to LTE|8|||
163343773|NCT02660034|589966501|FG007|Overall Study|Participants transferred to LTE|8|||
163343774|NCT02660034|589966502|FG008|Overall Study|Participants transferred to LTE|10|||
163343775|NCT02660034|589966503|FG009|Overall Study|Participants transferred to LTE|1|||
163343776|NCT02660034|589966504|FG010|Overall Study|Participants transferred to LTE|2|||
163343777|NCT02660034|589966505|FG011|Overall Study|Participants transferred to LTE|4|||
163343778|NCT02660034|589966506|FG012|Overall Study|Participants transferred to LTE|1|||
163343779|NCT02660034|589966507|FG013|Overall Study|Participants transferred to LTE|1|||
163343780|NCT01106586|589966514|FG000|Overall Study|Adverse Event|9|||
163343781|NCT01106586|589966515|FG001|Overall Study|Adverse Event|15|||
163343782|NCT01106586|589966514|FG000|Overall Study|Death|1|||
163343783|NCT01106586|589966515|FG001|Overall Study|Death|3|||
163343784|NCT01106586|589966514|FG000|Overall Study|Pregnancy|2|||
163343785|NCT01106586|589966515|FG001|Overall Study|Pregnancy|2|||
163343786|NCT01106586|589966514|FG000|Overall Study|Lack of Efficacy|1|||
163343787|NCT01106586|589966515|FG001|Overall Study|Lack of Efficacy|0|||
163343788|NCT01106586|589966514|FG000|Overall Study|Investigator's Discretion|5|||
163343789|NCT01106586|589966515|FG001|Overall Study|Investigator's Discretion|8|||
163343790|NCT01106586|589966514|FG000|Overall Study|Withdrew Consent|18|||
163343791|NCT01106586|589966515|FG001|Overall Study|Withdrew Consent|30|||
163343792|NCT01106586|589966514|FG000|Overall Study|Lost to Follow-up|24|||
163343793|NCT01106586|589966515|FG001|Overall Study|Lost to Follow-up|20|||
163343794|NCT01106586|589966514|FG000|Overall Study|Participant Noncompliance|12|||
163343795|NCT01106586|589966515|FG001|Overall Study|Participant Noncompliance|10|||
163343796|NCT01106586|589966514|FG000|Overall Study|Protocol Violation|1|||
163343797|NCT01106586|589966515|FG001|Overall Study|Protocol Violation|0|||
163343798|NCT01106586|589966514|FG000|Overall Study|Participant Transferred to Another Study|212|||
163343799|NCT01106586|589966515|FG001|Overall Study|Participant Transferred to Another Study|197|||
163343800|NCT03045302|589966519|FG000|Overall Study|Pre-treatment adverse event|1|||
163343801|NCT05878522|589966523|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163343802|NCT05878522|589966524|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163343803|NCT05878522|589966525|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163343804|NCT05878522|589966526|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163343805|NCT05878522|589966527|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163343806|NCT05878522|589966528|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163343807|NCT05878522|589966529|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163343808|NCT05878522|589966530|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163343809|NCT05878522|589966531|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
163343810|NCT05878522|589966532|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163343811|NCT05878522|589966533|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163343812|NCT05878522|589966534|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163343813|NCT05878522|589966523|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
163343814|NCT05878522|589966524|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163343815|NCT05878522|589966525|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163343816|NCT05878522|589966526|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163343817|NCT05878522|589966527|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163408407|NCT05030311|590205508|FG001|Overall Study|Lost to Follow-up|1|||
163131027|NCT00891228|589188198|FG000|Overall Study|Withdrawal by Subject|2|||
163131028|NCT00891228|589188199|FG001|Overall Study|Withdrawal by Subject|4|||
163131029|NCT00891228|589188200|FG002|Overall Study|Withdrawal by Subject|5|||
163131030|NCT00891228|589188198|FG000|Overall Study|Protocol Violation|3|||
163131031|NCT00891228|589188199|FG001|Overall Study|Protocol Violation|1|||
163131032|NCT00891228|589188200|FG002|Overall Study|Protocol Violation|2|||
163131033|NCT00891228|589188198|FG000|Overall Study|Physician Decision|2|||
163131034|NCT00891228|589188199|FG001|Overall Study|Physician Decision|1|||
163131035|NCT00891228|589188200|FG002|Overall Study|Physician Decision|0|||
163131036|NCT00891228|589188198|FG000|Overall Study|Lost to Follow-up|4|||
163131037|NCT00891228|589188199|FG001|Overall Study|Lost to Follow-up|4|||
163131038|NCT00891228|589188200|FG002|Overall Study|Lost to Follow-up|5|||
163131039|NCT00891228|589188198|FG000|Overall Study|Pregnancy|0|||
163131040|NCT00891228|589188199|FG001|Overall Study|Pregnancy|1|||
163131041|NCT00891228|589188200|FG002|Overall Study|Pregnancy|0|||
163131042|NCT03704688|589188211|FG000|Overall Study|Adverse Event|0|||
163131043|NCT03704688|589188212|FG001|Overall Study|Adverse Event|0|||
163131044|NCT03704688|589188213|FG002|Overall Study|Adverse Event|0|||
163131045|NCT03704688|589188214|FG003|Overall Study|Adverse Event|4|||
163131046|NCT03704688|589188215|FG004|Overall Study|Adverse Event|1|||
163131047|NCT03704688|589188216|FG005|Overall Study|Adverse Event|0|||
163131048|NCT03704688|589188211|FG000|Overall Study|Disease Progression|0|||
163131049|NCT03704688|589188212|FG001|Overall Study|Disease Progression|0|||
163131050|NCT03704688|589188213|FG002|Overall Study|Disease Progression|0|||
163131051|NCT03704688|589188214|FG003|Overall Study|Disease Progression|3|||
163131052|NCT03704688|589188215|FG004|Overall Study|Disease Progression|1|||
163131053|NCT03704688|589188216|FG005|Overall Study|Disease Progression|0|||
163131054|NCT03704688|589188211|FG000|Overall Study|Death|0|||
163131055|NCT03704688|589188212|FG001|Overall Study|Death|0|||
163131056|NCT03704688|589188213|FG002|Overall Study|Death|0|||
163131057|NCT03704688|589188214|FG003|Overall Study|Death|0|||
163131058|NCT03704688|589188215|FG004|Overall Study|Death|3|||
163131059|NCT03704688|589188216|FG005|Overall Study|Death|0|||
163131060|NCT00847886|589188218|FG000|Overall Study|Adverse Event|0|||
163131061|NCT00847886|589188219|FG001|Overall Study|Adverse Event|1|||
163131062|NCT00413036|589188220|FG000|Overall Study|Adverse Event|44|||
163131063|NCT00413036|589188220|FG000|Overall Study|Lack of Efficacy|129|||
163131064|NCT00413036|589188220|FG000|Overall Study|Withdrawal by Subject|7|||
163131065|NCT00413036|589188220|FG000|Overall Study|Death|9|||
163131066|NCT00413036|589188220|FG000|Overall Study|Other|26|||
163131067|NCT00413036|589188220|FG000|Overall Study|Missing|2|||
163131068|NCT00183625|589188221|FG000|Overall Study|Withdrawal by Subject|18|||
163131069|NCT00183625|589188222|FG001|Overall Study|Withdrawal by Subject|18|||
163131070|NCT00183625|589188223|FG002|Overall Study|Withdrawal by Subject|19|||
163131071|NCT00183625|589188224|FG003|Overall Study|Withdrawal by Subject|14|||
163131072|NCT01369641|589188225|FG000|Overall Study|Withdrawal by Subject|1|||
163131073|NCT02524158|589188226|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
163131074|NCT02524158|589188227|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
163131075|NCT02524158|589188226|FG000|12-weeks Assessment|Lost to Follow-up|18|||
163131076|NCT02524158|589188227|FG001|12-weeks Assessment|Lost to Follow-up|12|||
163131077|NCT02524158|589188226|FG000|6-month Assessment|Withdrawal by Subject|1|||
163131078|NCT02524158|589188227|FG001|6-month Assessment|Withdrawal by Subject|1|||
163131079|NCT02524158|589188226|FG000|6-month Assessment|Lost to Follow-up|21|||
163131080|NCT02524158|589188227|FG001|6-month Assessment|Lost to Follow-up|20|||
163131081|NCT01835158|589188228|FG000|Overall Study|Withdrawal by Subject|1|||
163131082|NCT01835158|589188229|FG001|Overall Study|Withdrawal by Subject|6|||
163131083|NCT00596830|589188230|FG000|Overall Study|Death|258|||
163131084|NCT00596830|589188231|FG001|Overall Study|Death|247|||
163131085|NCT00596830|589188230|FG000|Overall Study|Lost to Follow-up|7|||
163131086|NCT00596830|589188231|FG001|Overall Study|Lost to Follow-up|11|||
163131087|NCT00596830|589188230|FG000|Overall Study|Withdrawal by Subject|22|||
163131088|NCT00596830|589188231|FG001|Overall Study|Withdrawal by Subject|12|||
163131089|NCT00596830|589188230|FG000|Overall Study|Study terminated by sponsor|51|||
163227436|NCT01574352|589546260|FG001|Overall Study|Injury in non-camp related sport|0|||
163227437|NCT00245765|589546261|FG000|Overall Study|Adverse Event|1|||
163343818|NCT05878522|589966528|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163343819|NCT05878522|589966529|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163343820|NCT05878522|589966530|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163343821|NCT05878522|589966531|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163343822|NCT05878522|589966532|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
163343823|NCT05878522|589966533|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163131090|NCT00596830|589188231|FG001|Overall Study|Study terminated by sponsor|62|||
163343824|NCT05878522|589966534|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163131091|NCT00596830|589188230|FG000|Overall Study|Follow-up was discontinued|1|||
163227438|NCT00245765|589546262|FG001|Overall Study|Adverse Event|1|||
163131092|NCT00596830|589188231|FG001|Overall Study|Follow-up was discontinued|0|||
163131093|NCT00596830|589188230|FG000|Overall Study|Randomized but not treated|3|||
163131094|NCT00596830|589188231|FG001|Overall Study|Randomized but not treated|7|||
163343825|NCT05878522|589966523|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163131095|NCT00887926|589188232|FG000|Overall Study|Withdrawal by Subject|0|||
163131096|NCT00887926|589188233|FG001|Overall Study|Withdrawal by Subject|1|||
163131097|NCT00887926|589188234|FG002|Overall Study|Withdrawal by Subject|0|||
163131098|NCT00887926|589188235|FG003|Overall Study|Withdrawal by Subject|0|||
163131099|NCT04427072|589188238|FG000|Randomized Treatment Phase|Progressive disease|9|||
163131100|NCT04427072|589188239|FG001|Randomized Treatment Phase|Progressive disease|4|||
163131101|NCT04427072|589188238|FG000|Randomized Treatment Phase|Adverse Event|3|||
163131102|NCT04427072|589188239|FG001|Randomized Treatment Phase|Adverse Event|1|||
163131103|NCT04427072|589188238|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
163131104|NCT04427072|589188239|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
163131105|NCT04427072|589188238|FG000|Randomized Treatment Phase|Death|0|||
163131106|NCT04427072|589188239|FG001|Randomized Treatment Phase|Death|1|||
163131107|NCT04427072|589188238|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
163131108|NCT04427072|589188239|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
163131109|NCT04427072|589188238|FG000|Extension Treatment Phase|Progressive disease|0|||
163131110|NCT04427072|589188239|FG001|Extension Treatment Phase|Progressive disease|5|||
163131111|NCT01110382|589188244|FG000|Overall Study|Withdrawal by Subject|0|||
163131112|NCT01110382|589188245|FG001|Overall Study|Withdrawal by Subject|1|||
163131113|NCT01110382|589188244|FG000|Overall Study|Protocol Violation|0|||
163131114|NCT01110382|589188245|FG001|Overall Study|Protocol Violation|1|||
163131115|NCT00098306|589188246|FG000|Double Blind|Randomized, not treated|9|||
163131116|NCT00098306|589188247|FG001|Double Blind|Randomized, not treated|5|||
163131117|NCT00098306|589188248|FG002|Double Blind|Randomized, not treated|2|||
163131118|NCT00098306|589188249|FG003|Double Blind|Randomized, not treated|0|||
163131119|NCT00098306|589188250|FG004|Double Blind|Randomized, not treated|0|||
163131120|NCT00098306|589188251|FG005|Double Blind|Randomized, not treated|0|||
163131121|NCT00098306|589188252|FG006|Double Blind|Randomized, not treated|0|||
163131122|NCT00098306|589188246|FG000|Double Blind|Ongoing at cut-off date|151|||
163131123|NCT00098306|589188247|FG001|Double Blind|Ongoing at cut-off date|166|||
163131124|NCT00098306|589188248|FG002|Double Blind|Ongoing at cut-off date|72|||
163131125|NCT00098306|589188249|FG003|Double Blind|Ongoing at cut-off date|0|||
163131126|NCT00098306|589188250|FG004|Double Blind|Ongoing at cut-off date|0|||
163131127|NCT00098306|589188251|FG005|Double Blind|Ongoing at cut-off date|0|||
163131128|NCT00098306|589188252|FG006|Double Blind|Ongoing at cut-off date|0|||
163131129|NCT00098306|589188246|FG000|Double Blind|Adverse Event|11|||
163131130|NCT00098306|589188247|FG001|Double Blind|Adverse Event|10|||
163131131|NCT00098306|589188248|FG002|Double Blind|Adverse Event|6|||
163131132|NCT00098306|589188249|FG003|Double Blind|Adverse Event|0|||
163131133|NCT00098306|589188250|FG004|Double Blind|Adverse Event|0|||
163131134|NCT00098306|589188251|FG005|Double Blind|Adverse Event|0|||
163131135|NCT00098306|589188252|FG006|Double Blind|Adverse Event|0|||
163131136|NCT00098306|589188246|FG000|Double Blind|Lack of Efficacy|43|||
163131137|NCT00098306|589188247|FG001|Double Blind|Lack of Efficacy|34|||
163131138|NCT00098306|589188248|FG002|Double Blind|Lack of Efficacy|17|||
163131139|NCT00098306|589188249|FG003|Double Blind|Lack of Efficacy|0|||
163131140|NCT00098306|589188250|FG004|Double Blind|Lack of Efficacy|0|||
163131141|NCT00098306|589188251|FG005|Double Blind|Lack of Efficacy|0|||
163131142|NCT00098306|589188252|FG006|Double Blind|Lack of Efficacy|0|||
163131143|NCT00098306|589188246|FG000|Double Blind|Death|1|||
163131144|NCT00098306|589188247|FG001|Double Blind|Death|4|||
163131145|NCT00098306|589188248|FG002|Double Blind|Death|1|||
163131146|NCT00098306|589188249|FG003|Double Blind|Death|0|||
163131147|NCT00098306|589188250|FG004|Double Blind|Death|0|||
163131148|NCT00098306|589188251|FG005|Double Blind|Death|0|||
163131149|NCT00098306|589188252|FG006|Double Blind|Death|0|||
163131150|NCT00098306|589188246|FG000|Double Blind|Participant defaulted|19|||
163131151|NCT00098306|589188247|FG001|Double Blind|Participant defaulted|18|||
163131152|NCT00098306|589188248|FG002|Double Blind|Participant defaulted|11|||
163131153|NCT00098306|589188249|FG003|Double Blind|Participant defaulted|0|||
163131154|NCT00098306|589188250|FG004|Double Blind|Participant defaulted|0|||
163408408|NCT05030311|590205507|FG000|Overall Study|Protocol Violation|4|||
163408409|NCT05030311|590205508|FG001|Overall Study|Protocol Violation|4|||
163408410|NCT03042468|590205509|FG000|Overall Study|Death|0|||
163408411|NCT03042468|590205510|FG001|Overall Study|Death|1|||
163131155|NCT00098306|589188251|FG005|Double Blind|Participant defaulted|0|||
163131156|NCT00098306|589188252|FG006|Double Blind|Participant defaulted|0|||
163131157|NCT00098306|589188246|FG000|Double Blind|Un-specified|7|||
163131158|NCT00098306|589188247|FG001|Double Blind|Un-specified|3|||
163131159|NCT00098306|589188248|FG002|Double Blind|Un-specified|11|||
163227439|NCT00245765|589546263|FG002|Overall Study|Adverse Event|0|||
163227440|NCT00245765|589546261|FG000|Overall Study|Lack of Efficacy|14|||
163227441|NCT00245765|589546262|FG001|Overall Study|Lack of Efficacy|7|||
163408412|NCT03042468|590205511|FG002|Overall Study|Death|1|||
163131160|NCT00098306|589188249|FG003|Double Blind|Un-specified|0|||
163131161|NCT00098306|589188250|FG004|Double Blind|Un-specified|0|||
163131162|NCT00098306|589188251|FG005|Double Blind|Un-specified|0|||
163131163|NCT00098306|589188252|FG006|Double Blind|Un-specified|0|||
163131164|NCT00098306|589188246|FG000|Open Label|Lack of Efficacy|0|||
163408413|NCT03042468|590205512|FG003|Overall Study|Death|0|||
163343826|NCT05878522|589966524|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
163343827|NCT05878522|589966525|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163343828|NCT05878522|589966526|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
163343829|NCT05878522|589966527|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163343830|NCT05878522|589966528|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163343831|NCT05878522|589966529|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163343832|NCT05878522|589966530|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163343833|NCT05878522|589966531|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163343834|NCT05878522|589966532|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163343835|NCT05878522|589966533|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163343836|NCT05878522|589966534|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163343837|NCT05878522|589966523|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163343838|NCT05878522|589966524|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163343839|NCT05878522|589966525|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163343840|NCT05878522|589966526|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163343841|NCT05878522|589966527|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
163343842|NCT05878522|589966528|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163343843|NCT05878522|589966529|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163343844|NCT05878522|589966530|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163343845|NCT05878522|589966531|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163343846|NCT05878522|589966532|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163343847|NCT05878522|589966533|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163343848|NCT05878522|589966534|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163343849|NCT05263492|589966535|FG000|Overall Study|Adverse Event|1|||
163343850|NCT05263492|589966535|FG000|Overall Study|Disease progression during active treatment|3|||
163343851|NCT03747575|589966536|FG000|Overall Study|Withdrawal by Subject|6|||
163343852|NCT03747575|589966537|FG001|Overall Study|Withdrawal by Subject|3|||
163408414|NCT03042468|590205513|FG004|Overall Study|Death|0|||
163408415|NCT03042468|590205514|FG005|Overall Study|Death|0|||
163343853|NCT03747575|589966536|FG000|Overall Study|Lost to Follow-up|3|||
163343854|NCT03747575|589966537|FG001|Overall Study|Lost to Follow-up|3|||
163343855|NCT03747575|589966536|FG000|Overall Study|Adverse Event|0|||
163343856|NCT03747575|589966537|FG001|Overall Study|Adverse Event|1|||
163343857|NCT03953079|589966539|FG000|Core Study|Withdrawal by Subject|1|||
163343858|NCT03953079|589966540|FG001|Core Study|Withdrawal by Subject|2|||
163343859|NCT03953079|589966541|FG002|Core Study|Withdrawal by Subject|1|||
163343860|NCT03953079|589966539|FG000|Core Study|COVID-19|0|||
163343861|NCT03953079|589966540|FG001|Core Study|COVID-19|1|||
163343862|NCT03953079|589966541|FG002|Core Study|COVID-19|0|||
163343863|NCT03953079|589966539|FG000|Core Study|Difficulties leaving the house|0|||
163343864|NCT03953079|589966540|FG001|Core Study|Difficulties leaving the house|1|||
163343865|NCT03953079|589966541|FG002|Core Study|Difficulties leaving the house|0|||
163343866|NCT03953079|589966539|FG000|Extension Study|Withdrawal by Subject|1|||
163343867|NCT03953079|589966540|FG001|Extension Study|Withdrawal by Subject|0|||
163343868|NCT03953079|589966541|FG002|Extension Study|Withdrawal by Subject|0|||
163343869|NCT03953079|589966539|FG000|Extension Study|Received Rescue Treatment|5|||
163343870|NCT03953079|589966540|FG001|Extension Study|Received Rescue Treatment|6|||
163343871|NCT03953079|589966541|FG002|Extension Study|Received Rescue Treatment|5|||
163343872|NCT00936065|589966542|FG000|Overall Study|Adverse Event|1|||
163343873|NCT00936065|589966543|FG001|Overall Study|Adverse Event|0|||
163343874|NCT00936065|589966544|FG002|Overall Study|Adverse Event|1|||
163343875|NCT00936065|589966542|FG000|Overall Study|Lack of Efficacy|1|||
163343876|NCT00936065|589966543|FG001|Overall Study|Lack of Efficacy|0|||
163343877|NCT00936065|589966544|FG002|Overall Study|Lack of Efficacy|1|||
163343878|NCT00936065|589966542|FG000|Overall Study|Lost to Follow-up|1|||
163343879|NCT00936065|589966543|FG001|Overall Study|Lost to Follow-up|0|||
163343880|NCT00936065|589966544|FG002|Overall Study|Lost to Follow-up|0|||
163408416|NCT03042468|590205509|FG000|Overall Study|Withdrawal by Subject|0|||
163408417|NCT03042468|590205510|FG001|Overall Study|Withdrawal by Subject|0|||
163408418|NCT03042468|590205511|FG002|Overall Study|Withdrawal by Subject|0|||
163408419|NCT03042468|590205512|FG003|Overall Study|Withdrawal by Subject|0|||
163131165|NCT00098306|589188247|FG001|Open Label|Lack of Efficacy|0|||
163408420|NCT03042468|590205513|FG004|Overall Study|Withdrawal by Subject|0|||
163343881|NCT00936065|589966542|FG000|Overall Study|Protocol Violation|1|||
163343882|NCT00936065|589966543|FG001|Overall Study|Protocol Violation|2|||
163343883|NCT00936065|589966544|FG002|Overall Study|Protocol Violation|1|||
163343884|NCT00936065|589966542|FG000|Overall Study|Withdrawal by Subject|0|||
163343885|NCT00936065|589966543|FG001|Overall Study|Withdrawal by Subject|2|||
163343886|NCT00936065|589966544|FG002|Overall Study|Withdrawal by Subject|4|||
163343887|NCT02260154|589966548|FG000|Overall Study|Screening failure|2|||
163343888|NCT03560206|589966549|FG000|Overall Study|Lost to Follow-up|19|||
163343889|NCT03560206|589966550|FG001|Overall Study|Lost to Follow-up|11|||
163343890|NCT03560206|589966549|FG000|Overall Study|Withdrawal by Subject|2|||
163343891|NCT03560206|589966550|FG001|Overall Study|Withdrawal by Subject|4|||
163408421|NCT03042468|590205514|FG005|Overall Study|Withdrawal by Subject|1|||
163131166|NCT00098306|589188248|FG002|Open Label|Lack of Efficacy|0|||
163131167|NCT00098306|589188249|FG003|Open Label|Lack of Efficacy|13|||
163131168|NCT00098306|589188250|FG004|Open Label|Lack of Efficacy|0|||
163131169|NCT00098306|589188251|FG005|Open Label|Lack of Efficacy|0|||
163131170|NCT00098306|589188252|FG006|Open Label|Lack of Efficacy|0|||
163131171|NCT00098306|589188246|FG000|Open Label|Adverse Event|0|||
163131172|NCT00098306|589188247|FG001|Open Label|Adverse Event|0|||
163131173|NCT00098306|589188248|FG002|Open Label|Adverse Event|0|||
163131174|NCT00098306|589188249|FG003|Open Label|Adverse Event|2|||
163131175|NCT00098306|589188250|FG004|Open Label|Adverse Event|0|||
163131176|NCT00098306|589188251|FG005|Open Label|Adverse Event|0|||
163131177|NCT00098306|589188252|FG006|Open Label|Adverse Event|0|||
163131178|NCT00098306|589188246|FG000|Open Label|Death|0|||
163131179|NCT00098306|589188247|FG001|Open Label|Death|0|||
163131180|NCT00098306|589188248|FG002|Open Label|Death|0|||
163131181|NCT00098306|589188249|FG003|Open Label|Death|4|||
163131182|NCT00098306|589188250|FG004|Open Label|Death|0|||
163131183|NCT00098306|589188251|FG005|Open Label|Death|0|||
163131184|NCT00098306|589188252|FG006|Open Label|Death|0|||
163131185|NCT00098306|589188246|FG000|Open Label|Participant defaulted|0|||
163131186|NCT00098306|589188247|FG001|Open Label|Participant defaulted|0|||
163131187|NCT00098306|589188248|FG002|Open Label|Participant defaulted|0|||
163131188|NCT00098306|589188249|FG003|Open Label|Participant defaulted|24|||
163131189|NCT00098306|589188250|FG004|Open Label|Participant defaulted|0|||
163131190|NCT00098306|589188251|FG005|Open Label|Participant defaulted|0|||
163131191|NCT00098306|589188252|FG006|Open Label|Participant defaulted|0|||
163131192|NCT00098306|589188246|FG000|Open Label|Un-specified|0|||
163131193|NCT00098306|589188247|FG001|Open Label|Un-specified|0|||
163343892|NCT03560206|589966549|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
163343893|NCT03560206|589966550|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
163343894|NCT03560206|589966549|FG000|Overall Study|Busy schedule|14|||
163343895|NCT03560206|589966550|FG001|Overall Study|Busy schedule|2|||
163343896|NCT03560206|589966549|FG000|Overall Study|patients' new health condition such as cancer|10|||
163343897|NCT03560206|589966550|FG001|Overall Study|patients' new health condition such as cancer|1|||
163343898|NCT01549951|589966551|FG000|Overall Study|Adverse Event|15|||
163343899|NCT01549951|589966551|FG000|Overall Study|Withdrawal by Subject|2|||
163343900|NCT01549951|589966551|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
163343901|NCT01549951|589966551|FG000|Overall Study|Progressive disease|29|||
163343902|NCT01549951|589966551|FG000|Overall Study|Symptomatic deterioration|1|||
163343903|NCT01549951|589966551|FG000|Overall Study|Other|2|||
163343904|NCT00738400|589966554|FG000|Overall Study|Adverse Event|3|||
163343905|NCT00738400|589966555|FG001|Overall Study|Adverse Event|1|||
163131194|NCT00098306|589188248|FG002|Open Label|Un-specified|0|||
163131195|NCT00098306|589188249|FG003|Open Label|Un-specified|15|||
163131196|NCT00098306|589188250|FG004|Open Label|Un-specified|0|||
163131197|NCT00098306|589188251|FG005|Open Label|Un-specified|0|||
163131198|NCT00098306|589188252|FG006|Open Label|Un-specified|0|||
163131199|NCT00098306|589188246|FG000|Open Label|Ongoing at cut-off date|0|||
163131200|NCT00098306|589188247|FG001|Open Label|Ongoing at cut-off date|0|||
163131201|NCT00098306|589188248|FG002|Open Label|Ongoing at cut-off date|0|||
163131202|NCT00098306|589188249|FG003|Open Label|Ongoing at cut-off date|269|||
163131203|NCT00098306|589188250|FG004|Open Label|Ongoing at cut-off date|62|||
163131204|NCT00098306|589188251|FG005|Open Label|Ongoing at cut-off date|0|||
163131205|NCT00098306|589188252|FG006|Open Label|Ongoing at cut-off date|0|||
163131206|NCT00098306|589188246|FG000|Observational Phase|Death|0|||
163131207|NCT00098306|589188247|FG001|Observational Phase|Death|0|||
163131208|NCT00098306|589188248|FG002|Observational Phase|Death|0|||
163131209|NCT00098306|589188249|FG003|Observational Phase|Death|0|||
163131210|NCT00098306|589188250|FG004|Observational Phase|Death|0|||
163131211|NCT00098306|589188251|FG005|Observational Phase|Death|5|||
163131212|NCT00098306|589188252|FG006|Observational Phase|Death|4|||
163131213|NCT00098306|589188246|FG000|Observational Phase|Participant defaulted|0|||
163131214|NCT00098306|589188247|FG001|Observational Phase|Participant defaulted|0|||
163131215|NCT00098306|589188248|FG002|Observational Phase|Participant defaulted|0|||
163131216|NCT00098306|589188249|FG003|Observational Phase|Participant defaulted|0|||
163131217|NCT00098306|589188250|FG004|Observational Phase|Participant defaulted|0|||
163227442|NCT00245765|589546263|FG002|Overall Study|Lack of Efficacy|0|||
163227443|NCT00245765|589546261|FG000|Overall Study|Lost to Follow-up|1|||
163227444|NCT00245765|589546262|FG001|Overall Study|Lost to Follow-up|2|||
163343906|NCT00738400|589966554|FG000|Overall Study|Withdrawal by Subject|0|||
163343907|NCT00738400|589966555|FG001|Overall Study|Withdrawal by Subject|1|||
163343908|NCT00738400|589966554|FG000|Overall Study|Lack of Efficacy|0|||
163131218|NCT00098306|589188251|FG005|Observational Phase|Participant defaulted|34|||
163131219|NCT00098306|589188252|FG006|Observational Phase|Participant defaulted|18|||
163131220|NCT00098306|589188246|FG000|Observational Phase|Un-specified|0|||
163131221|NCT00098306|589188247|FG001|Observational Phase|Un-specified|0|||
163131222|NCT00098306|589188248|FG002|Observational Phase|Un-specified|0|||
163131223|NCT00098306|589188249|FG003|Observational Phase|Un-specified|0|||
163131224|NCT00098306|589188250|FG004|Observational Phase|Un-specified|0|||
163131225|NCT00098306|589188251|FG005|Observational Phase|Un-specified|7|||
163131226|NCT00098306|589188252|FG006|Observational Phase|Un-specified|4|||
163131227|NCT00077649|589188253|FG000|Overall Study|Adverse Event|5|||
163131228|NCT00077649|589188254|FG001|Overall Study|Adverse Event|1|||
163131229|NCT00077649|589188255|FG002|Overall Study|Adverse Event|7|||
163131230|NCT00077649|589188256|FG003|Overall Study|Adverse Event|9|||
163131231|NCT00077649|589188253|FG000|Overall Study|Lack of Efficacy|5|||
163131232|NCT00077649|589188254|FG001|Overall Study|Lack of Efficacy|3|||
163131233|NCT00077649|589188255|FG002|Overall Study|Lack of Efficacy|3|||
163131234|NCT00077649|589188256|FG003|Overall Study|Lack of Efficacy|2|||
163131235|NCT00077649|589188253|FG000|Overall Study|Withdrawal by Subject|0|||
163131236|NCT00077649|589188254|FG001|Overall Study|Withdrawal by Subject|1|||
163131237|NCT00077649|589188255|FG002|Overall Study|Withdrawal by Subject|1|||
163131238|NCT00077649|589188256|FG003|Overall Study|Withdrawal by Subject|2|||
163131239|NCT00077649|589188253|FG000|Overall Study|Lost to Follow-up|2|||
163131240|NCT00077649|589188254|FG001|Overall Study|Lost to Follow-up|2|||
163131241|NCT00077649|589188255|FG002|Overall Study|Lost to Follow-up|3|||
163131242|NCT00077649|589188256|FG003|Overall Study|Lost to Follow-up|2|||
163131243|NCT00077649|589188253|FG000|Overall Study|Abnormality of Laboratory Test|1|||
163131244|NCT00077649|589188254|FG001|Overall Study|Abnormality of Laboratory Test|2|||
163131245|NCT00077649|589188255|FG002|Overall Study|Abnormality of Laboratory Test|1|||
163131246|NCT00077649|589188256|FG003|Overall Study|Abnormality of Laboratory Test|2|||
163131247|NCT00077649|589188253|FG000|Overall Study|Randomized but never dosed|1|||
163131248|NCT00077649|589188254|FG001|Overall Study|Randomized but never dosed|0|||
163131249|NCT00077649|589188255|FG002|Overall Study|Randomized but never dosed|0|||
163131250|NCT00077649|589188256|FG003|Overall Study|Randomized but never dosed|0|||
163131251|NCT03550404|589188259|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
163131252|NCT03550404|589188260|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
163131253|NCT03550404|589188261|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
163227445|NCT00245765|589546263|FG002|Overall Study|Lost to Follow-up|0|||
163227446|NCT00245765|589546261|FG000|Overall Study|Withdrawal by Subject|1|||
163227447|NCT00245765|589546262|FG001|Overall Study|Withdrawal by Subject|0|||
163227448|NCT00245765|589546263|FG002|Overall Study|Withdrawal by Subject|3|||
163227449|NCT00245765|589546261|FG000|Overall Study|Other reason|2|||
163227450|NCT00245765|589546262|FG001|Overall Study|Other reason|0|||
163227451|NCT00245765|589546263|FG002|Overall Study|Other reason|1|||
163227452|NCT00245765|589546261|FG000|Overall Study|Other|13|||
163227453|NCT00245765|589546262|FG001|Overall Study|Other|4|||
163227454|NCT00245765|589546263|FG002|Overall Study|Other|4|||
163227455|NCT00660348|589546264|FG000|Overall Study|Withdrawal by Subject|1|||
163227456|NCT00660348|589546265|FG001|Overall Study|Withdrawal by Subject|0|||
163227457|NCT02741115|589546266|FG000|Overall Study|Adverse Event|1|||
163227458|NCT02741115|589546267|FG001|Overall Study|Adverse Event|0|||
163227459|NCT02741115|589546266|FG000|Overall Study|Lost to Follow-up|7|||
163227460|NCT02741115|589546267|FG001|Overall Study|Lost to Follow-up|4|||
163227461|NCT02741115|589546266|FG000|Overall Study|Withdrawal by Subject|4|||
163227462|NCT02741115|589546267|FG001|Overall Study|Withdrawal by Subject|2|||
163227463|NCT06425458|589546268|FG000|Overall Study|Removed by study team|2|||
163227464|NCT06425458|589546268|FG000|Overall Study|Lost to Follow-up|5|||
163227465|NCT03945981|589546271|FG000|Overall Study|Lost to Follow-up|12|||
163227466|NCT03945981|589546271|FG000|Overall Study|Physician Decision|4|||
163227467|NCT03945981|589546271|FG000|Overall Study|Withdrawal by Subject|6|||
163227468|NCT03945981|589546271|FG000|Overall Study|Protocol Violation|1|||
163227469|NCT00256698|589546274|FG000|Overall Study|Withdrawal by Subject|7|||
163227470|NCT00256698|589546275|FG001|Overall Study|Withdrawal by Subject|7|||
163227471|NCT00256698|589546274|FG000|Overall Study|Adverse Event|13|||
163227472|NCT00256698|589546275|FG001|Overall Study|Adverse Event|6|||
163227473|NCT00256698|589546274|FG000|Overall Study|Protocol Violation|6|||
163227474|NCT00256698|589546275|FG001|Overall Study|Protocol Violation|5|||
163227475|NCT00256698|589546274|FG000|Overall Study|Lost to Follow-up|1|||
163227476|NCT00256698|589546275|FG001|Overall Study|Lost to Follow-up|3|||
163227477|NCT00256698|589546274|FG000|Overall Study|disease progression|97|||
163227478|NCT00256698|589546275|FG001|Overall Study|disease progression|105|||
163227479|NCT00256698|589546274|FG000|Overall Study|still ongoing at data cut-off|41|||
163343909|NCT00738400|589966555|FG001|Overall Study|Lack of Efficacy|1|||
163343910|NCT00738400|589966554|FG000|Overall Study|Lost to Follow-up|0|||
163227480|NCT00256698|589546275|FG001|Overall Study|still ongoing at data cut-off|46|||
163343911|NCT00738400|589966555|FG001|Overall Study|Lost to Follow-up|3|||
163131254|NCT03550404|589188259|FG000|Phase 2|Vacated position|1|||
163131255|NCT03550404|589188260|FG001|Phase 2|Vacated position|0|||
163131256|NCT03550404|589188261|FG002|Phase 2|Vacated position|0|||
163131257|NCT00820222|589188263|FG000|Overall Study|Lost to Follow-up|10|||
163227481|NCT00256698|589546274|FG000|Overall Study|withdrawn due to osteoporosis|1|||
163227482|NCT00256698|589546275|FG001|Overall Study|withdrawn due to osteoporosis|0|||
163227483|NCT00256698|589546274|FG000|Overall Study|Prematurely Discontinued|1|||
163227484|NCT00256698|589546275|FG001|Overall Study|Prematurely Discontinued|0|||
163227485|NCT03548584|589547905|FG000|Overall Study|Lost to Follow-up|0|||
163227486|NCT03548584|589547906|FG001|Overall Study|Lost to Follow-up|0|||
163343912|NCT00738400|589966554|FG000|Overall Study|Protocol Violation|1|||
163343913|NCT00738400|589966555|FG001|Overall Study|Protocol Violation|0|||
163343914|NCT00738400|589966554|FG000|Overall Study|Non-compliant with study medication|0|||
163343915|NCT00738400|589966555|FG001|Overall Study|Non-compliant with study medication|1|||
163343916|NCT02255474|589966556|FG000|Overall Study|Lost to Follow-up|1|||
163343917|NCT02255474|589966557|FG001|Overall Study|Lost to Follow-up|1|||
163343918|NCT02255474|589966558|FG002|Overall Study|Lost to Follow-up|3|||
163343919|NCT02255474|589966556|FG000|Overall Study|Withdrawal by Subject|1|||
163343920|NCT02255474|589966557|FG001|Overall Study|Withdrawal by Subject|1|||
163343921|NCT02255474|589966558|FG002|Overall Study|Withdrawal by Subject|0|||
163343922|NCT02993926|589966562|FG000|Enantone Treatment Phase|Adverse Event|1|||
163343923|NCT02993926|589966563|FG001|Enantone Treatment Phase|Adverse Event|0|||
163343924|NCT02993926|589966564|FG002|Enantone Treatment Phase|Adverse Event|0|||
163343925|NCT02993926|589966562|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
163343926|NCT02993926|589966563|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
163343927|NCT02993926|589966564|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
163343928|NCT02993926|589966562|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
163343929|NCT02993926|589966563|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
163343930|NCT02993926|589966564|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
163343931|NCT02993926|589966562|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
163343932|NCT02993926|589966563|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
163343933|NCT02993926|589966564|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
163343934|NCT02009865|589966568|FG000|Overall Study|Adverse Event|0|||
163343935|NCT02009865|589966569|FG001|Overall Study|Adverse Event|2|||
163343936|NCT02009865|589966568|FG000|Overall Study|Protocol Violation|0|||
163343937|NCT02009865|589966569|FG001|Overall Study|Protocol Violation|2|||
163343938|NCT02009865|589966568|FG000|Overall Study|Withdrawal by Subject|1|||
163343939|NCT02009865|589966569|FG001|Overall Study|Withdrawal by Subject|1|||
163343940|NCT01760876|589966570|FG000|Overall Study|Non-cardiac death (head injury)|1|||
163343941|NCT01760876|589966570|FG000|Overall Study|Carcinoma of prostate|1|||
163343942|NCT01760876|589966570|FG000|Overall Study|Impaired renal function|1|||
163343943|NCT01760876|589966570|FG000|Overall Study|Major depression|1|||
163343944|NCT01760876|589966570|FG000|Overall Study|Very poor baseline OCT quality|2|||
163343945|NCT00732498|589966573|FG000|Overall Study|Ineligible|1|||
163343946|NCT00732498|589966573|FG000|Overall Study|Adverse Event|2|||
163343947|NCT00732498|589966573|FG000|Overall Study|Physician Decision|3|||
163343948|NCT03394508|589966574|FG000|Overall Study|Protocol Violation|0|||
163343949|NCT03394508|589966575|FG001|Overall Study|Protocol Violation|3|||
163343950|NCT03394508|589966574|FG000|Overall Study|Lost to Follow-up|1|||
163343951|NCT03394508|589966575|FG001|Overall Study|Lost to Follow-up|0|||
163343952|NCT04295499|589966576|FG000|Overall Study|moving out of state|1|||
163343953|NCT04295499|589966577|FG001|Overall Study|moving out of state|0|||
163343954|NCT04295499|589966576|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
163343955|NCT04295499|589966577|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
163343956|NCT00308113|589966578|FG000|Overall Study|Protocol closure|0|||
163343957|NCT00308113|589966579|FG001|Overall Study|Protocol closure|0|||
163343958|NCT00308113|589966580|FG002|Overall Study|Protocol closure|0|||
163343959|NCT00308113|589966581|FG003|Overall Study|Protocol closure|1|||
163343960|NCT03556891|589966584|FG000|Initial Pivotal Study|Adverse Event|4|||
163343961|NCT03556891|589966584|FG000|Initial Pivotal Study|MRI Need|3|||
163343962|NCT03556891|589966584|FG000|Initial Pivotal Study|Device Failure|1|||
163343963|NCT03556891|589966584|FG000|Initial Pivotal Study|Death|1|||
163343964|NCT03556891|589966584|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
163343965|NCT03556891|589966584|FG000|Initial Pivotal Study|Missing at random|1|||
163343966|NCT03556891|589966584|FG000|Initial Pivotal Study|Missing due to COVID|1|||
163343967|NCT03556891|589966584|FG000|Initial Pivotal Study|Protocol Violation|1|||
163343968|NCT01002547|589968341|FG000|Overall Study|Withdrawal by Subject|4|||
163343969|NCT01002547|589968342|FG001|Overall Study|Withdrawal by Subject|0|||
163343970|NCT01002547|589968343|FG002|Overall Study|Withdrawal by Subject|5|||
163343971|NCT01002547|589968341|FG000|Overall Study|Lost to Follow-up|2|||
163343972|NCT01002547|589968342|FG001|Overall Study|Lost to Follow-up|1|||
163343973|NCT01002547|589968343|FG002|Overall Study|Lost to Follow-up|1|||
163343974|NCT01002547|589968341|FG000|Overall Study|Physician Decision|1|||
163343975|NCT01002547|589968342|FG001|Overall Study|Physician Decision|0|||
163343976|NCT01002547|589968343|FG002|Overall Study|Physician Decision|0|||
163343977|NCT01002547|589968341|FG000|Overall Study|Death|0|||
163343978|NCT01002547|589968342|FG001|Overall Study|Death|2|||
163343979|NCT01002547|589968343|FG002|Overall Study|Death|2|||
163343980|NCT01002547|589968341|FG000|Overall Study|Adverse Event|1|||
163343981|NCT01002547|589968342|FG001|Overall Study|Adverse Event|0|||
163343982|NCT01002547|589968343|FG002|Overall Study|Adverse Event|0|||
163343983|NCT01184859|589968351|FG000|Period 1: Single Dose|Insufficient urine production|0|||
163343984|NCT01184859|589968352|FG001|Period 1: Single Dose|Insufficient urine production|1|||
163227487|NCT03548584|589547907|FG002|Overall Study|Lost to Follow-up|1|||
163343985|NCT01184859|589968353|FG002|Period 1: Single Dose|Insufficient urine production|0|||
163343986|NCT01184859|589968354|FG003|Period 1: Single Dose|Insufficient urine production|0|||
163343987|NCT01184859|589968355|FG004|Period 1: Single Dose|Insufficient urine production|0|||
163343988|NCT01184859|589968351|FG000|Period 1: Single Dose|Protocol Violation|0|||
163343989|NCT01184859|589968352|FG001|Period 1: Single Dose|Protocol Violation|1|||
163343990|NCT01184859|589968353|FG002|Period 1: Single Dose|Protocol Violation|0|||
163343991|NCT01184859|589968354|FG003|Period 1: Single Dose|Protocol Violation|0|||
163343992|NCT01184859|589968355|FG004|Period 1: Single Dose|Protocol Violation|0|||
163343993|NCT01184859|589968351|FG000|Period 1: Single Dose|Adverse Event|0|||
163343994|NCT01184859|589968352|FG001|Period 1: Single Dose|Adverse Event|0|||
163343995|NCT01184859|589968353|FG002|Period 1: Single Dose|Adverse Event|0|||
163343996|NCT01184859|589968354|FG003|Period 1: Single Dose|Adverse Event|0|||
163343997|NCT01184859|589968355|FG004|Period 1: Single Dose|Adverse Event|1|||
163343998|NCT01184859|589968351|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
163343999|NCT01184859|589968352|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
163344000|NCT01184859|589968353|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
163408422|NCT03042468|590205509|FG000|Overall Study|Lost to Follow-up|0|||
163408423|NCT03042468|590205510|FG001|Overall Study|Lost to Follow-up|0|||
163131258|NCT00820222|589188264|FG001|Overall Study|Lost to Follow-up|9|||
163131259|NCT00820222|589188263|FG000|Overall Study|Withdrawal by Subject|19|||
163131260|NCT00820222|589188264|FG001|Overall Study|Withdrawal by Subject|21|||
163131261|NCT00820222|589188263|FG000|Overall Study|Physician Decision|93|||
163131262|NCT00820222|589188264|FG001|Overall Study|Physician Decision|88|||
163131263|NCT00820222|589188263|FG000|Overall Study|Sponsor Terminated Study|43|||
163131264|NCT00820222|589188264|FG001|Overall Study|Sponsor Terminated Study|65|||
163131265|NCT00820222|589188263|FG000|Overall Study|Unkown|11|||
163131266|NCT00820222|589188264|FG001|Overall Study|Unkown|7|||
163131267|NCT02690714|589188265|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
163131268|NCT02690714|589188265|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
163131269|NCT00293020|589188266|FG000|Overall Study|Withdrawal by Subject|34|||
163131270|NCT00293020|589188266|FG000|Overall Study|Adverse Event|30|||
163131271|NCT00293020|589188266|FG000|Overall Study|Death|32|||
163131272|NCT00293020|589188266|FG000|Overall Study|Lack of Efficacy|12|||
163131273|NCT00293020|589188266|FG000|Overall Study|Lost to Follow-up|4|||
163131274|NCT00293020|589188266|FG000|Overall Study|Protocol Violation|6|||
163131275|NCT00293020|589188266|FG000|Overall Study|Physician Decision|21|||
163131276|NCT00293020|589188266|FG000|Overall Study|Other Reason|22|||
163131277|NCT00293020|589188266|FG000|Overall Study|No dose taken|1|||
163131278|NCT01336023|589188267|FG000|Week 0 to Week 26|Adverse Event|8|||
163131279|NCT01336023|589188268|FG001|Week 0 to Week 26|Adverse Event|10|||
163131280|NCT01336023|589188269|FG002|Week 0 to Week 26|Adverse Event|24|||
163131281|NCT01336023|589188267|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
163131282|NCT01336023|589188268|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
163131283|NCT01336023|589188269|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
163131284|NCT01336023|589188267|FG000|Week 0 to Week 26|Protocol Violation|1|||
163131285|NCT01336023|589188268|FG001|Week 0 to Week 26|Protocol Violation|2|||
163131286|NCT01336023|589188269|FG002|Week 0 to Week 26|Protocol Violation|0|||
163131287|NCT01336023|589188267|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
163131288|NCT01336023|589188268|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
163131289|NCT01336023|589188269|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
163131290|NCT01336023|589188267|FG000|Week 0 to Week 26|Unclassified|5|||
163131291|NCT01336023|589188268|FG001|Week 0 to Week 26|Unclassified|16|||
163131292|NCT01336023|589188269|FG002|Week 0 to Week 26|Unclassified|9|||
163131293|NCT01336023|589188267|FG000|Week 27 to 52|Adverse Event|1|||
163131294|NCT01336023|589188268|FG001|Week 27 to 52|Adverse Event|5|||
163131295|NCT01336023|589188269|FG002|Week 27 to 52|Adverse Event|2|||
163131296|NCT01336023|589188267|FG000|Week 27 to 52|Protocol Violation|0|||
163131297|NCT01336023|589188268|FG001|Week 27 to 52|Protocol Violation|2|||
163131298|NCT01336023|589188269|FG002|Week 27 to 52|Protocol Violation|1|||
163131299|NCT01336023|589188267|FG000|Week 27 to 52|Withdrawal Criteria|14|||
163131300|NCT01336023|589188268|FG001|Week 27 to 52|Withdrawal Criteria|19|||
163131301|NCT01336023|589188269|FG002|Week 27 to 52|Withdrawal Criteria|16|||
163131302|NCT01336023|589188267|FG000|Week 27 to 52|Unclassified|13|||
163131303|NCT01336023|589188268|FG001|Week 27 to 52|Unclassified|18|||
163131304|NCT01336023|589188269|FG002|Week 27 to 52|Unclassified|9|||
163131305|NCT01894022|589188272|FG000|Overall Study|Death|1|||
163131306|NCT01894022|589188273|FG001|Overall Study|Death|0|||
163344001|NCT01184859|589968354|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
163131307|NCT01894022|589188272|FG000|Overall Study|Adverse Event, non-fatal|1|||
163131308|NCT01894022|589188273|FG001|Overall Study|Adverse Event, non-fatal|0|||
163131309|NCT01894022|589188272|FG000|Overall Study|Study Closed/terminated|7|||
163131310|NCT01894022|589188273|FG001|Overall Study|Study Closed/terminated|10|||
163131311|NCT04496453|589188274|FG000|Overall Study|Lost to Follow-up|6|||
163131312|NCT00767819|589188275|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
163131313|NCT00767819|589188276|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
163344002|NCT01184859|589968355|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
163131314|NCT00767819|589188277|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
163408424|NCT03042468|590205511|FG002|Overall Study|Lost to Follow-up|0|||
163131315|NCT00767819|589188275|FG000|Overall Study|Withdrawal by Subject|1|||
163131316|NCT00767819|589188276|FG001|Overall Study|Withdrawal by Subject|1|||
163227488|NCT03548584|589547905|FG000|Overall Study|Adverse Event|1|||
163227489|NCT03548584|589547906|FG001|Overall Study|Adverse Event|11|||
163227490|NCT03548584|589547907|FG002|Overall Study|Adverse Event|5|||
163227491|NCT03548584|589547905|FG000|Overall Study|Site Terminated by Sponsor|1|||
163227492|NCT03548584|589547906|FG001|Overall Study|Site Terminated by Sponsor|3|||
163227493|NCT03548584|589547907|FG002|Overall Study|Site Terminated by Sponsor|2|||
163227494|NCT03548584|589547905|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
163227495|NCT03548584|589547906|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
163227496|NCT03548584|589547907|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
163227497|NCT03548584|589547905|FG000|Overall Study|Lack of Efficacy|0|||
163227498|NCT03548584|589547906|FG001|Overall Study|Lack of Efficacy|1|||
163227499|NCT03548584|589547907|FG002|Overall Study|Lack of Efficacy|0|||
163227500|NCT03548584|589547905|FG000|Overall Study|Non-compliance with Study Drug|0|||
163227501|NCT03548584|589547906|FG001|Overall Study|Non-compliance with Study Drug|1|||
163227502|NCT03548584|589547907|FG002|Overall Study|Non-compliance with Study Drug|0|||
163227503|NCT03548584|589547905|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
163227504|NCT03548584|589547906|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
163227505|NCT03548584|589547907|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
163227506|NCT04346615|589547908|FG000|Overall Study|Lost to Follow-up|0|||
163227507|NCT04346615|589547909|FG001|Overall Study|Lost to Follow-up|2|||
163227508|NCT04346615|589547908|FG000|Overall Study|Withdrawal by Subject|1|||
163227509|NCT04346615|589547909|FG001|Overall Study|Withdrawal by Subject|0|||
163227510|NCT04346615|589547908|FG000|Overall Study|Death|5|||
163227511|NCT04346615|589547909|FG001|Overall Study|Death|1|||
163227512|NCT04346615|589547908|FG000|Overall Study|Other|0|||
163227513|NCT04346615|589547909|FG001|Overall Study|Other|2|||
163227514|NCT04346615|589547908|FG000|Overall Study|Randomized not treated|1|||
163227515|NCT04346615|589547909|FG001|Overall Study|Randomized not treated|0|||
163227516|NCT02096835|589547917|FG000|Overall Study|Withdrawal by Subject|1|||
163227517|NCT02096835|589547918|FG001|Overall Study|Withdrawal by Subject|0|||
163227518|NCT02096835|589547919|FG002|Overall Study|Withdrawal by Subject|0|||
163227519|NCT02096835|589547917|FG000|Overall Study|converted to open procedures|1|||
163227520|NCT02096835|589547918|FG001|Overall Study|converted to open procedures|0|||
163227521|NCT02096835|589547919|FG002|Overall Study|converted to open procedures|0|||
163227522|NCT02096835|589547917|FG000|Overall Study|Lost to Follow-up|1|||
163227523|NCT02096835|589547918|FG001|Overall Study|Lost to Follow-up|0|||
163227524|NCT02096835|589547919|FG002|Overall Study|Lost to Follow-up|1|||
163227525|NCT01677195|589547920|FG000|Overall Study|Lost to Follow-up|14|||
163227526|NCT01677195|589547921|FG001|Overall Study|Lost to Follow-up|22|||
163227527|NCT01677195|589547922|FG002|Overall Study|Lost to Follow-up|22|||
163227528|NCT01677195|589547920|FG000|Overall Study|Withdrawal by Subject|1|||
163227529|NCT01677195|589547921|FG001|Overall Study|Withdrawal by Subject|0|||
163227530|NCT01677195|589547922|FG002|Overall Study|Withdrawal by Subject|1|||
163227531|NCT01677195|589547920|FG000|Overall Study|Adverse Event|6|||
163227532|NCT01677195|589547921|FG001|Overall Study|Adverse Event|4|||
163227533|NCT01677195|589547922|FG002|Overall Study|Adverse Event|1|||
163227534|NCT01677195|589547920|FG000|Overall Study|Physician Decision|1|||
163227535|NCT01677195|589547921|FG001|Overall Study|Physician Decision|2|||
163227536|NCT01677195|589547922|FG002|Overall Study|Physician Decision|2|||
163227537|NCT01677195|589547920|FG000|Overall Study|Pregnancy|0|||
163227538|NCT01677195|589547921|FG001|Overall Study|Pregnancy|1|||
163227539|NCT01677195|589547922|FG002|Overall Study|Pregnancy|0|||
163227540|NCT01677195|589547920|FG000|Overall Study|Protocol Violation|7|||
163227541|NCT01677195|589547921|FG001|Overall Study|Protocol Violation|3|||
163227542|NCT01677195|589547922|FG002|Overall Study|Protocol Violation|4|||
163227543|NCT04368429|589547923|FG000|Overall Study|Adverse Event|1|||
163344003|NCT01184859|589968351|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
163344004|NCT01184859|589968352|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
163344005|NCT01184859|589968353|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
163344006|NCT01184859|589968354|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
163227544|NCT04368429|589547924|FG001|Overall Study|Adverse Event|0|||
163227545|NCT03633396|589547927|FG000|Overall Study|Withdrawal by Subject|4|||
163227546|NCT03633396|589547928|FG001|Overall Study|Withdrawal by Subject|4|||
163227547|NCT03633396|589547927|FG000|Overall Study|Adverse Event|1|||
163227548|NCT03633396|589547928|FG001|Overall Study|Adverse Event|1|||
163227549|NCT03633396|589547927|FG000|Overall Study|Lack of Efficacy|1|||
163227550|NCT03633396|589547928|FG001|Overall Study|Lack of Efficacy|0|||
163227551|NCT03633396|589547927|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
163227552|NCT03633396|589547928|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
163227553|NCT00023673|589547929|FG000|Overall Study|Ineligible / no protocol treatment|0|||
163227554|NCT00023673|589547930|FG001|Overall Study|Ineligible / no protocol treatment|0|||
163227555|NCT00023673|589547931|FG002|Overall Study|Ineligible / no protocol treatment|0|||
163227556|NCT00023673|589547932|FG003|Overall Study|Ineligible / no protocol treatment|1|||
163344007|NCT01184859|589968355|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
163227557|NCT00023673|589547929|FG000|Overall Study|Patient withdrew consent|0|||
163131317|NCT00767819|589188277|FG002|Overall Study|Withdrawal by Subject|0|||
163131318|NCT00767819|589188275|FG000|Overall Study|Administrative problems|0|||
163131319|NCT00767819|589188276|FG001|Overall Study|Administrative problems|1|||
163131320|NCT00767819|589188277|FG002|Overall Study|Administrative problems|0|||
163131321|NCT00767819|589188275|FG000|Overall Study|Death|2|||
163131322|NCT00767819|589188276|FG001|Overall Study|Death|3|||
163131323|NCT00767819|589188277|FG002|Overall Study|Death|0|||
163131324|NCT00767819|589188275|FG000|Overall Study|Adverse Event|2|||
163131325|NCT00767819|589188276|FG001|Overall Study|Adverse Event|0|||
163131326|NCT00767819|589188277|FG002|Overall Study|Adverse Event|0|||
163131327|NCT00767819|589188275|FG000|Overall Study|Abnormal lab values|1|||
163131328|NCT00767819|589188276|FG001|Overall Study|Abnormal lab values|0|||
163131329|NCT00767819|589188277|FG002|Overall Study|Abnormal lab values|0|||
163131330|NCT00767819|589188275|FG000|Overall Study|Lost to Follow-up|1|||
163131331|NCT00767819|589188276|FG001|Overall Study|Lost to Follow-up|0|||
163131332|NCT00767819|589188277|FG002|Overall Study|Lost to Follow-up|0|||
163131333|NCT03916081|589188278|FG000|Overall Study|Adverse Event|1|||
163131334|NCT03916081|589188279|FG001|Overall Study|Adverse Event|0|||
163131335|NCT03916081|589188280|FG002|Overall Study|Adverse Event|0|||
163131336|NCT03916081|589188278|FG000|Overall Study|Physician Decision|0|||
163131337|NCT03916081|589188279|FG001|Overall Study|Physician Decision|0|||
163131338|NCT03916081|589188280|FG002|Overall Study|Physician Decision|1|||
163131339|NCT03916081|589188278|FG000|Overall Study|Lost to Follow-up|0|||
163131340|NCT03916081|589188279|FG001|Overall Study|Lost to Follow-up|1|||
163131341|NCT03916081|589188280|FG002|Overall Study|Lost to Follow-up|0|||
163131342|NCT03916081|589188278|FG000|Overall Study|Withdrawal by Subject|3|||
163131343|NCT03916081|589188279|FG001|Overall Study|Withdrawal by Subject|0|||
163131344|NCT03916081|589188280|FG002|Overall Study|Withdrawal by Subject|1|||
163131345|NCT03916081|589188278|FG000|Overall Study|Worsening of AD|0|||
163131346|NCT03916081|589188279|FG001|Overall Study|Worsening of AD|0|||
163131347|NCT03916081|589188280|FG002|Overall Study|Worsening of AD|1|||
163131348|NCT00235716|589188281|FG000|Overall Study|Death|26|||
163131349|NCT00235716|589188282|FG001|Overall Study|Death|39|||
163131350|NCT00235716|589188283|FG002|Overall Study|Death|32|||
163131351|NCT00235716|589188284|FG003|Overall Study|Death|31|||
163131352|NCT00235716|589188281|FG000|Overall Study|Withdrawal by Subject|23|||
163131353|NCT00235716|589188282|FG001|Overall Study|Withdrawal by Subject|19|||
163131354|NCT00235716|589188283|FG002|Overall Study|Withdrawal by Subject|17|||
163131355|NCT00235716|589188284|FG003|Overall Study|Withdrawal by Subject|18|||
163131356|NCT00235716|589188281|FG000|Overall Study|Lost to Follow-up|12|||
163131357|NCT00235716|589188282|FG001|Overall Study|Lost to Follow-up|7|||
163131358|NCT00235716|589188283|FG002|Overall Study|Lost to Follow-up|14|||
163131359|NCT00235716|589188284|FG003|Overall Study|Lost to Follow-up|10|||
163131360|NCT00235716|589188281|FG000|Overall Study|Adverse Event|1|||
163131361|NCT00235716|589188282|FG001|Overall Study|Adverse Event|1|||
163131362|NCT00235716|589188283|FG002|Overall Study|Adverse Event|1|||
163131363|NCT00235716|589188284|FG003|Overall Study|Adverse Event|0|||
163131364|NCT00235716|589188281|FG000|Overall Study|Physician Decision|0|||
163131365|NCT00235716|589188282|FG001|Overall Study|Physician Decision|1|||
163131366|NCT00235716|589188283|FG002|Overall Study|Physician Decision|1|||
163131367|NCT00235716|589188284|FG003|Overall Study|Physician Decision|3|||
163131368|NCT01545050|589188285|FG000|Overall Study|Lack of Efficacy|0|||
163131369|NCT01545050|589188286|FG001|Overall Study|Lack of Efficacy|0|||
163131370|NCT01545050|589188287|FG002|Overall Study|Lack of Efficacy|0|||
163131371|NCT01545050|589188288|FG003|Overall Study|Lack of Efficacy|3|||
163131372|NCT01545050|589188289|FG004|Overall Study|Lack of Efficacy|2|||
163131373|NCT01545050|589188285|FG000|Overall Study|Adverse Event|1|||
163131374|NCT01545050|589188286|FG001|Overall Study|Adverse Event|1|||
163131375|NCT01545050|589188287|FG002|Overall Study|Adverse Event|2|||
163131376|NCT01545050|589188288|FG003|Overall Study|Adverse Event|2|||
163131377|NCT01545050|589188289|FG004|Overall Study|Adverse Event|0|||
163131378|NCT01545050|589188285|FG000|Overall Study|Discontinued study treatment|1|||
163131379|NCT01545050|589188286|FG001|Overall Study|Discontinued study treatment|0|||
163131380|NCT01545050|589188287|FG002|Overall Study|Discontinued study treatment|0|||
163131381|NCT01545050|589188288|FG003|Overall Study|Discontinued study treatment|0|||
163131382|NCT01545050|589188289|FG004|Overall Study|Discontinued study treatment|0|||
163131383|NCT01545050|589188285|FG000|Overall Study|Withdrawal by Subject|1|||
163131384|NCT01545050|589188286|FG001|Overall Study|Withdrawal by Subject|0|||
163131385|NCT01545050|589188287|FG002|Overall Study|Withdrawal by Subject|0|||
163131386|NCT01545050|589188288|FG003|Overall Study|Withdrawal by Subject|2|||
163131387|NCT01545050|589188289|FG004|Overall Study|Withdrawal by Subject|1|||
163131388|NCT01545050|589188285|FG000|Overall Study|Participant no longer meets study criteria|0|||
163131389|NCT01545050|589188286|FG001|Overall Study|Participant no longer meets study criteria|2|||
163131390|NCT01545050|589188287|FG002|Overall Study|Participant no longer meets study criteria|0|||
163131391|NCT01545050|589188288|FG003|Overall Study|Participant no longer meets study criteria|0|||
163408425|NCT03042468|590205512|FG003|Overall Study|Lost to Follow-up|0|||
163131392|NCT01545050|589188289|FG004|Overall Study|Participant no longer meets study criteria|1|||
163131393|NCT01545050|589188285|FG000|Overall Study|Administrative reason by sponsor|4|||
163344008|NCT00434577|589968358|FG000|Months 0-3|Serious Adverse Event|0|||
163344009|NCT00434577|589968359|FG001|Months 0-3|Serious Adverse Event|0|||
163344010|NCT00434577|589968360|FG002|Months 0-3|Serious Adverse Event|1|||
163344011|NCT00434577|589968361|FG003|Months 0-3|Serious Adverse Event|0|||
163344012|NCT00434577|589968362|FG004|Months 0-3|Serious Adverse Event|0|||
163344013|NCT00434577|589968358|FG000|Months 0-3|Adverse Event|0|||
163344014|NCT00434577|589968359|FG001|Months 0-3|Adverse Event|1|||
163131394|NCT01545050|589188286|FG001|Overall Study|Administrative reason by sponsor|2|||
163131395|NCT01545050|589188287|FG002|Overall Study|Administrative reason by sponsor|3|||
163131396|NCT01545050|589188288|FG003|Overall Study|Administrative reason by sponsor|5|||
163131397|NCT01545050|589188289|FG004|Overall Study|Administrative reason by sponsor|5|||
163131398|NCT02249182|589188290|FG000|Treatment Phase|Lost to Follow-up|4|||
163131399|NCT02249182|589188291|FG001|Treatment Phase|Lost to Follow-up|0|||
163131400|NCT02249182|589188292|FG002|Treatment Phase|Lost to Follow-up|0|||
163131401|NCT02249182|589188293|FG003|Treatment Phase|Lost to Follow-up|0|||
163131402|NCT02249182|589188294|FG004|Treatment Phase|Lost to Follow-up|0|||
163131403|NCT03244826|589188301|FG000|Overall Study|Withdrawal by Subject|2|||
163131404|NCT03244826|589188302|FG001|Overall Study|Withdrawal by Subject|0|||
163131405|NCT03244826|589188301|FG000|Overall Study|Transplant delayed or withdrawn|12|||
163131406|NCT03244826|589188302|FG001|Overall Study|Transplant delayed or withdrawn|10|||
163131407|NCT04356040|589188303|FG000|Overall Study|Death|2|||
163131408|NCT04356040|589188304|FG001|Overall Study|Death|0|||
163131409|NCT04356040|589188303|FG000|Overall Study|Lost to Follow-up|1|||
163131410|NCT04356040|589188304|FG001|Overall Study|Lost to Follow-up|0|||
163131411|NCT04356040|589188303|FG000|Overall Study|Physician Decision|0|||
163131412|NCT04356040|589188304|FG001|Overall Study|Physician Decision|1|||
163131413|NCT04356040|589188303|FG000|Overall Study|Withdrawal by Subject|13|||
163131414|NCT04356040|589188304|FG001|Overall Study|Withdrawal by Subject|1|||
163131415|NCT04356040|589188303|FG000|Overall Study|Enrollment Pause|10|||
163131416|NCT04356040|589188304|FG001|Overall Study|Enrollment Pause|0|||
163131417|NCT04356040|589188303|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
163131418|NCT04356040|589188304|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
163131419|NCT04356040|589188303|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
163131420|NCT04356040|589188304|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
163131421|NCT04356040|589188303|FG000|Overall Study|PI left institution|3|||
163131422|NCT04356040|589188304|FG001|Overall Study|PI left institution|0|||
163131423|NCT00416455|589188305|FG000|Overall Study|PET / CT not done|3|||
163131424|NCT00416455|589188306|FG001|Overall Study|PET / CT not done|5|||
163131425|NCT00416455|589188305|FG000|Overall Study|PET / CT poor quality|2|||
163131426|NCT00416455|589188306|FG001|Overall Study|PET / CT poor quality|1|||
163131427|NCT00416455|589188305|FG000|Overall Study|Inadequate pathology|11|||
163131428|NCT00416455|589188306|FG001|Overall Study|Inadequate pathology|2|||
163131429|NCT00360568|589188307|FG000|Overall Study|Adverse Event|1|||
163131430|NCT00360568|589188308|FG001|Overall Study|Adverse Event|2|||
163131431|NCT00360568|589188307|FG000|Overall Study|Lack of Efficacy|1|||
163131432|NCT00360568|589188308|FG001|Overall Study|Lack of Efficacy|0|||
163131433|NCT00360568|589188307|FG000|Overall Study|Withdrawal by Subject|0|||
163131434|NCT00360568|589188308|FG001|Overall Study|Withdrawal by Subject|3|||
163131435|NCT01008449|589188309|FG000|Overall Study|Lost to Follow-up|29|||
163131436|NCT01008449|589188310|FG001|Overall Study|Lost to Follow-up|19|||
163131437|NCT01114438|589188311|FG000|Overall Study|Adverse Event|10|||
163131438|NCT01114438|589188311|FG000|Overall Study|concomitant medication|1|||
163131439|NCT01114438|589188311|FG000|Overall Study|Physician Decision|1|||
163131440|NCT01114438|589188311|FG000|Overall Study|Withdrawal by Subject|2|||
163131441|NCT00428844|589188314|FG000|Completed Study Drug Treatment|Adverse Event|2|||
163131442|NCT00428844|589188315|FG001|Completed Study Drug Treatment|Adverse Event|4|||
163131443|NCT00428844|589188316|FG002|Completed Study Drug Treatment|Adverse Event|4|||
163131444|NCT00428844|589188314|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
163131445|NCT00428844|589188315|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
163131446|NCT00428844|589188316|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
163131447|NCT00428844|589188314|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
163344015|NCT00434577|589968360|FG002|Months 0-3|Adverse Event|1|||
163131448|NCT00428844|589188315|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
163131449|NCT00428844|589188316|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
163131450|NCT00428844|589188314|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
163131451|NCT00428844|589188315|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
163131452|NCT00428844|589188316|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
163344016|NCT00434577|589968361|FG003|Months 0-3|Adverse Event|0|||
163344017|NCT00434577|589968362|FG004|Months 0-3|Adverse Event|0|||
163131453|NCT00428844|589188314|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
163131454|NCT00428844|589188315|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
163131455|NCT00428844|589188316|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
163344018|NCT00434577|589968358|FG000|Months 0-3|Lost to Follow-up|0|||
163344019|NCT00434577|589968359|FG001|Months 0-3|Lost to Follow-up|0|||
163344020|NCT00434577|589968360|FG002|Months 0-3|Lost to Follow-up|0|||
163344021|NCT00434577|589968361|FG003|Months 0-3|Lost to Follow-up|0|||
163131456|NCT00428844|589188314|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
163131457|NCT00428844|589188315|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
163131458|NCT00428844|589188316|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
163131459|NCT00428844|589188314|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
163131460|NCT00428844|589188315|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
163131461|NCT00428844|589188316|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
163131462|NCT00428844|589188314|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
163131463|NCT00428844|589188315|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
163131464|NCT00428844|589188316|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
163131465|NCT00428844|589188314|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
163131466|NCT00428844|589188315|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
163131467|NCT00428844|589188316|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
163131468|NCT03043651|589188319|FG000|Overall Study|Death|1|||
163131469|NCT03043651|589188319|FG000|Overall Study|Progressive Disease|2|||
163131470|NCT03043651|589188319|FG000|Overall Study|Adverse Event|2|||
163131471|NCT03043651|589188319|FG000|Overall Study|Withdrawal by Subject|4|||
163131472|NCT03043651|589188319|FG000|Overall Study|Study Terminated by Sponsor|39|||
163131473|NCT02353728|589188320|FG000|Overall Study|Subject non-compliance|1|||
163131474|NCT02611817|589190936|FG000|Open-label Induction Phase|Reason not Specified|9|||
163131475|NCT02611817|589190937|FG001|Open-label Induction Phase|Reason not Specified|0|||
163131476|NCT02611817|589190938|FG002|Open-label Induction Phase|Reason not Specified|0|||
163131477|NCT02611817|589190936|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
163131478|NCT02611817|589190937|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
163131479|NCT02611817|589190938|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
163131480|NCT02611817|589190936|FG000|Open-label Induction Phase|Pregnancy|1|||
163131481|NCT02611817|589190937|FG001|Open-label Induction Phase|Pregnancy|0|||
163131482|NCT02611817|589190938|FG002|Open-label Induction Phase|Pregnancy|0|||
163131483|NCT02611817|589190936|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
163131484|NCT02611817|589190937|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
163131485|NCT02611817|589190938|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
163131486|NCT02611817|589190936|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
163131487|NCT02611817|589190937|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
163131488|NCT02611817|589190938|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
163131489|NCT02611817|589190936|FG000|Open-label Induction Phase|Protocol Violation|5|||
163131490|NCT02611817|589190937|FG001|Open-label Induction Phase|Protocol Violation|0|||
163131491|NCT02611817|589190938|FG002|Open-label Induction Phase|Protocol Violation|0|||
163131492|NCT02611817|589190936|FG000|Open-label Induction Phase|Adverse Event|16|||
163131493|NCT02611817|589190937|FG001|Open-label Induction Phase|Adverse Event|0|||
163131494|NCT02611817|589190938|FG002|Open-label Induction Phase|Adverse Event|0|||
163131495|NCT02611817|589190936|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
163131496|NCT02611817|589190937|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
163131497|NCT02611817|589190938|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
163131498|NCT02611817|589190936|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
163131499|NCT02611817|589190937|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
163131500|NCT02611817|589190938|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
163131501|NCT02611817|589190936|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
163131502|NCT02611817|589190937|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
163131503|NCT02611817|589190938|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
163131504|NCT02611817|589190936|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
163131505|NCT02611817|589190937|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
163131506|NCT02611817|589190938|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
163131507|NCT02611817|589190936|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
163131508|NCT02611817|589190937|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
163131509|NCT02611817|589190938|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
163131510|NCT02611817|589190936|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
163131511|NCT02611817|589190937|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
163131512|NCT02611817|589190938|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
163131513|NCT02611817|589190936|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
163131514|NCT02611817|589190937|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
163131515|NCT02611817|589190938|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
163131516|NCT00265317|589190939|FG000|Lead-In|Objective progression or relapse|6|||
163131517|NCT00265317|589190940|FG001|Lead-In|Objective progression or relapse|11|||
163131518|NCT00265317|589190941|FG002|Lead-In|Objective progression or relapse|0|||
163131519|NCT00265317|589190942|FG003|Lead-In|Objective progression or relapse|0|||
163131520|NCT00265317|589190939|FG000|Lead-In|Adverse Event|2|||
163131521|NCT00265317|589190940|FG001|Lead-In|Adverse Event|1|||
163131522|NCT00265317|589190941|FG002|Lead-In|Adverse Event|0|||
163131523|NCT00265317|589190942|FG003|Lead-In|Adverse Event|0|||
163131524|NCT00265317|589190939|FG000|Lead-In|Death|3|||
163131525|NCT00265317|589190940|FG001|Lead-In|Death|5|||
163131526|NCT00265317|589190941|FG002|Lead-In|Death|0|||
163131527|NCT00265317|589190942|FG003|Lead-In|Death|0|||
163131528|NCT00265317|589190939|FG000|Lead-In|Withdrawal/other than adverse event|1|||
163131529|NCT00265317|589190940|FG001|Lead-In|Withdrawal/other than adverse event|0|||
163131530|NCT00265317|589190941|FG002|Lead-In|Withdrawal/other than adverse event|0|||
163131531|NCT00265317|589190942|FG003|Lead-In|Withdrawal/other than adverse event|0|||
163131532|NCT00265317|589190939|FG000|Phase 2|Objective progression or relapse|0|||
163131533|NCT00265317|589190940|FG001|Phase 2|Objective progression or relapse|0|||
163131534|NCT00265317|589190941|FG002|Phase 2|Objective progression or relapse|37|||
163131535|NCT00265317|589190942|FG003|Phase 2|Objective progression or relapse|38|||
163131536|NCT00265317|589190939|FG000|Phase 2|Global deterioration of health status|0|||
163131537|NCT00265317|589190940|FG001|Phase 2|Global deterioration of health status|0|||
163131538|NCT00265317|589190941|FG002|Phase 2|Global deterioration of health status|3|||
163131539|NCT00265317|589190942|FG003|Phase 2|Global deterioration of health status|0|||
163131540|NCT00265317|589190939|FG000|Phase 2|Adverse Event|0|||
163131541|NCT00265317|589190940|FG001|Phase 2|Adverse Event|0|||
163131542|NCT00265317|589190941|FG002|Phase 2|Adverse Event|7|||
163131543|NCT00265317|589190942|FG003|Phase 2|Adverse Event|5|||
163131544|NCT00265317|589190939|FG000|Phase 2|Death|0|||
163227558|NCT00023673|589547930|FG001|Overall Study|Patient withdrew consent|0|||
163227559|NCT00023673|589547931|FG002|Overall Study|Patient withdrew consent|0|||
163227560|NCT00023673|589547932|FG003|Overall Study|Patient withdrew consent|1|||
163227561|NCT00110266|589547933|FG000|Overall Study|Adverse Event|27|||
163227562|NCT00110266|589547933|FG000|Overall Study|Abnormal laboratory value|15|||
163344022|NCT00434577|589968362|FG004|Months 0-3|Lost to Follow-up|2|||
163344023|NCT00434577|589968358|FG000|Months 0-3|Protocol Violation|1|||
163344024|NCT00434577|589968359|FG001|Months 0-3|Protocol Violation|0|||
163344025|NCT00434577|589968360|FG002|Months 0-3|Protocol Violation|1|||
163344026|NCT00434577|589968361|FG003|Months 0-3|Protocol Violation|0|||
163344027|NCT00434577|589968362|FG004|Months 0-3|Protocol Violation|0|||
163344028|NCT00434577|589968358|FG000|Months 0-3|Withdrawal by Subject|2|||
163344029|NCT00434577|589968359|FG001|Months 0-3|Withdrawal by Subject|1|||
163344030|NCT00434577|589968360|FG002|Months 0-3|Withdrawal by Subject|1|||
163344031|NCT00434577|589968361|FG003|Months 0-3|Withdrawal by Subject|1|||
163344032|NCT00434577|589968362|FG004|Months 0-3|Withdrawal by Subject|1|||
163344033|NCT01537120|589968370|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
163344034|NCT01537120|589968370|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
163344035|NCT00958711|589968374|FG000|Overall Study|Withdrawal by Subject|0|||
163344036|NCT00958711|589968375|FG001|Overall Study|Withdrawal by Subject|4|||
163344037|NCT00958711|589968374|FG000|Overall Study|Physician Decision|5|||
163344038|NCT00958711|589968375|FG001|Overall Study|Physician Decision|7|||
163344039|NCT00958711|589968374|FG000|Overall Study|Lost to Follow-up|4|||
163344040|NCT00958711|589968375|FG001|Overall Study|Lost to Follow-up|1|||
163344041|NCT00958711|589968374|FG000|Overall Study|Other|2|||
163344042|NCT00958711|589968375|FG001|Overall Study|Other|5|||
163344043|NCT00958711|589968374|FG000|Overall Study|Death|1|||
163344044|NCT00958711|589968375|FG001|Overall Study|Death|2|||
163344045|NCT00958711|589968374|FG000|Overall Study|Adverse Event|1|||
163344046|NCT00958711|589968375|FG001|Overall Study|Adverse Event|2|||
163344047|NCT03722485|589968376|FG000|Overall Study|Withdrawal by Subject|1|||
163344048|NCT03722485|589968377|FG001|Overall Study|Withdrawal by Subject|0|||
163344049|NCT03722485|589968376|FG000|Overall Study|Adverse Event|0|||
163344050|NCT03722485|589968377|FG001|Overall Study|Adverse Event|2|||
163344051|NCT03722485|589968376|FG000|Overall Study|subject discharged prior to study completion|1|||
163344052|NCT03722485|589968377|FG001|Overall Study|subject discharged prior to study completion|5|||
163344053|NCT03722485|589968376|FG000|Overall Study|eligibility criteria not met|2|||
163344054|NCT03722485|589968377|FG001|Overall Study|eligibility criteria not met|0|||
163344055|NCT03087851|589968382|FG000|Overall Study|Withdraw on medical grounds|0|||
163344056|NCT03087851|589968383|FG001|Overall Study|Withdraw on medical grounds|1|||
163344057|NCT03087851|589968384|FG002|Overall Study|Withdraw on medical grounds|2|||
163344058|NCT00644332|589968385|FG000|Overall Study|Adverse Event|11|||
163344059|NCT00644332|589968385|FG000|Overall Study|Withdrawal by Subject|6|||
163344060|NCT00644332|589968385|FG000|Overall Study|Completion Status Unknown|2|||
163344061|NCT00644332|589968385|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
163344062|NCT00644332|589968385|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
163344063|NCT00409006|589968387|FG000|Overall Study|Death|15|||
163344064|NCT00409006|589968388|FG001|Overall Study|Death|6|||
163344065|NCT00409006|589968387|FG000|Overall Study|Lost to Follow-up|1|||
163344066|NCT00409006|589968388|FG001|Overall Study|Lost to Follow-up|2|||
163344067|NCT00409006|589968387|FG000|Overall Study|Withdrawal by Subject|3|||
163344068|NCT00409006|589968388|FG001|Overall Study|Withdrawal by Subject|2|||
163344069|NCT00409006|589968387|FG000|Overall Study|Physician Decision|1|||
163131545|NCT00265317|589190940|FG001|Phase 2|Death|0|||
163131546|NCT00265317|589190941|FG002|Phase 2|Death|12|||
163131547|NCT00265317|589190942|FG003|Phase 2|Death|15|||
163131548|NCT00265317|589190939|FG000|Phase 2|Protocol Violation|0|||
163131549|NCT00265317|589190940|FG001|Phase 2|Protocol Violation|0|||
163227563|NCT00110266|589547933|FG000|Overall Study|Withdrawal by Subject|16|||
163344070|NCT00409006|589968388|FG001|Overall Study|Physician Decision|2|||
163344071|NCT03050372|589968389|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
163344072|NCT03050372|589968390|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
163344073|NCT03050372|589968389|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
163344074|NCT03050372|589968390|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
163344075|NCT00443755|589968393|FG000|Overall Study|Withdrawal by Subject|2|||
163344076|NCT00443755|589968394|FG001|Overall Study|Withdrawal by Subject|1|||
163344077|NCT02775214|589968395|FG000|Overall Study|Withdrawal by Subject|2|||
163344078|NCT02775214|589968396|FG001|Overall Study|Withdrawal by Subject|0|||
163344079|NCT02706834|589968397|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
163344080|NCT02706834|589968398|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
163344081|NCT02706834|589968399|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
163344082|NCT02706834|589968400|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
163344083|NCT02706834|589968401|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
163344084|NCT02706834|589968402|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
163344085|NCT02706834|589968403|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
163344086|NCT02706834|589968404|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
163344087|NCT02706834|589968405|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
163344088|NCT02706834|589968406|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
163344089|NCT02706834|589968407|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
163344090|NCT02706834|589968397|FG000|Overall Study|Lost to Follow-up|0|||
163344091|NCT02706834|589968398|FG001|Overall Study|Lost to Follow-up|0|||
163344092|NCT02706834|589968399|FG002|Overall Study|Lost to Follow-up|1|||
163344093|NCT02706834|589968400|FG003|Overall Study|Lost to Follow-up|0|||
163344094|NCT02706834|589968401|FG004|Overall Study|Lost to Follow-up|0|||
163344095|NCT02706834|589968402|FG005|Overall Study|Lost to Follow-up|0|||
163344096|NCT02706834|589968403|FG006|Overall Study|Lost to Follow-up|0|||
163344097|NCT02706834|589968404|FG007|Overall Study|Lost to Follow-up|0|||
163344098|NCT02706834|589968405|FG008|Overall Study|Lost to Follow-up|0|||
163344099|NCT02706834|589968406|FG009|Overall Study|Lost to Follow-up|0|||
163344100|NCT02706834|589968407|FG010|Overall Study|Lost to Follow-up|0|||
163131550|NCT00265317|589190941|FG002|Phase 2|Protocol Violation|1|||
163344101|NCT02706834|589968397|FG000|Overall Study|Voluntary Withdrawal|1|||
163344102|NCT02706834|589968398|FG001|Overall Study|Voluntary Withdrawal|0|||
163344103|NCT02706834|589968399|FG002|Overall Study|Voluntary Withdrawal|0|||
163344104|NCT02706834|589968400|FG003|Overall Study|Voluntary Withdrawal|0|||
163131551|NCT00265317|589190942|FG003|Phase 2|Protocol Violation|4|||
163131552|NCT00265317|589190939|FG000|Phase 2|Lost to Follow-up|0|||
163131553|NCT00265317|589190940|FG001|Phase 2|Lost to Follow-up|0|||
163131554|NCT00265317|589190941|FG002|Phase 2|Lost to Follow-up|0|||
163131555|NCT00265317|589190942|FG003|Phase 2|Lost to Follow-up|1|||
163131556|NCT00265317|589190939|FG000|Phase 2|Withdrawal/other than adverse event|0|||
163131557|NCT00265317|589190940|FG001|Phase 2|Withdrawal/other than adverse event|0|||
163131558|NCT00265317|589190941|FG002|Phase 2|Withdrawal/other than adverse event|2|||
163131559|NCT00265317|589190942|FG003|Phase 2|Withdrawal/other than adverse event|1|||
163131560|NCT00265317|589190939|FG000|Phase 2|Study terminated by sponsor|0|||
163131561|NCT00265317|589190940|FG001|Phase 2|Study terminated by sponsor|0|||
163131562|NCT00265317|589190941|FG002|Phase 2|Study terminated by sponsor|1|||
163131563|NCT00265317|589190942|FG003|Phase 2|Study terminated by sponsor|0|||
163131564|NCT00265317|589190939|FG000|Phase 2|Other|0|||
163131565|NCT00265317|589190940|FG001|Phase 2|Other|0|||
163131566|NCT00265317|589190941|FG002|Phase 2|Other|1|||
163131567|NCT00265317|589190942|FG003|Phase 2|Other|1|||
163131568|NCT00732875|589190945|FG000|Overall Study|Adverse Event|16|||
163131569|NCT00732875|589190945|FG000|Overall Study|Withdrawal by Subject|6|||
163131570|NCT00732875|589190945|FG000|Overall Study|Lack of Efficacy|13|||
163131571|NCT02300259|589190946|FG000|Period 1|Adverse Event|0|||
163131572|NCT02300259|589190947|FG001|Period 1|Adverse Event|0|||
163131573|NCT02300259|589190948|FG002|Period 1|Adverse Event|1|||
163131574|NCT02300259|589190946|FG000|Period 1|Withdrawal by Subject|0|||
163131575|NCT02300259|589190947|FG001|Period 1|Withdrawal by Subject|0|||
163131576|NCT02300259|589190948|FG002|Period 1|Withdrawal by Subject|1|||
163131577|NCT02300259|589190946|FG000|Period 2|Adverse Event|1|||
163131578|NCT02300259|589190947|FG001|Period 2|Adverse Event|0|||
163131579|NCT02300259|589190948|FG002|Period 2|Adverse Event|0|||
163131580|NCT02300259|589190946|FG000|Period 2|Withdrawal by Subject|0|||
163131581|NCT02300259|589190947|FG001|Period 2|Withdrawal by Subject|0|||
163131582|NCT02300259|589190948|FG002|Period 2|Withdrawal by Subject|1|||
163408426|NCT03042468|590205513|FG004|Overall Study|Lost to Follow-up|1|||
163131583|NCT02737475|589190949|FG000|Overall Study|Other reasons|0|||
163131584|NCT02737475|589190950|FG001|Overall Study|Other reasons|0|||
163408427|NCT03042468|590205514|FG005|Overall Study|Lost to Follow-up|1|||
163131585|NCT02737475|589190951|FG002|Overall Study|Other reasons|0|||
163131586|NCT02737475|589190952|FG003|Overall Study|Other reasons|0|||
163131587|NCT02737475|589190953|FG004|Overall Study|Other reasons|1|||
163131588|NCT02737475|589190954|FG005|Overall Study|Other reasons|1|||
163131589|NCT02737475|589190955|FG006|Overall Study|Other reasons|0|||
163131590|NCT02737475|589190956|FG007|Overall Study|Other reasons|0|||
163131591|NCT02737475|589190957|FG008|Overall Study|Other reasons|1|||
163131592|NCT02737475|589190958|FG009|Overall Study|Other reasons|0|||
163344105|NCT02706834|589968401|FG004|Overall Study|Voluntary Withdrawal|0|||
163344106|NCT02706834|589968402|FG005|Overall Study|Voluntary Withdrawal|0|||
163344107|NCT02706834|589968403|FG006|Overall Study|Voluntary Withdrawal|0|||
163344108|NCT02706834|589968404|FG007|Overall Study|Voluntary Withdrawal|0|||
163344109|NCT02706834|589968405|FG008|Overall Study|Voluntary Withdrawal|0|||
163344110|NCT02706834|589968406|FG009|Overall Study|Voluntary Withdrawal|1|||
163344111|NCT02706834|589968407|FG010|Overall Study|Voluntary Withdrawal|0|||
163344112|NCT02706834|589968397|FG000|Overall Study|Other Reason Not Specified|1|||
163344113|NCT02706834|589968398|FG001|Overall Study|Other Reason Not Specified|0|||
163131593|NCT02737475|589190959|FG010|Overall Study|Other reasons|1|||
163131594|NCT02737475|589190960|FG011|Overall Study|Other reasons|0|||
163131595|NCT02737475|589190961|FG012|Overall Study|Other reasons|0|||
163131596|NCT02737475|589190962|FG013|Overall Study|Other reasons|0|||
163131597|NCT02737475|589190963|FG014|Overall Study|Other reasons|0|||
163131598|NCT02737475|589190964|FG015|Overall Study|Other reasons|0|||
163131599|NCT02737475|589190965|FG016|Overall Study|Other reasons|0|||
163131600|NCT02737475|589190966|FG017|Overall Study|Other reasons|0|||
163131601|NCT02737475|589190967|FG018|Overall Study|Other reasons|0|||
163131602|NCT02737475|589190968|FG019|Overall Study|Other reasons|0|||
163131603|NCT02737475|589190969|FG020|Overall Study|Other reasons|0|||
163131604|NCT02737475|589190970|FG021|Overall Study|Other reasons|1|||
163131605|NCT02737475|589190971|FG022|Overall Study|Other reasons|0|||
163131606|NCT02737475|589190972|FG023|Overall Study|Other reasons|1|||
163131607|NCT02737475|589190973|FG024|Overall Study|Other reasons|1|||
163131608|NCT02737475|589190974|FG025|Overall Study|Other reasons|1|||
163131609|NCT02737475|589190975|FG026|Overall Study|Other reasons|0|||
163131610|NCT02737475|589190949|FG000|Overall Study|Death|1|||
163131611|NCT02737475|589190950|FG001|Overall Study|Death|0|||
163131612|NCT02737475|589190951|FG002|Overall Study|Death|0|||
163131613|NCT02737475|589190952|FG003|Overall Study|Death|1|||
163131614|NCT02737475|589190953|FG004|Overall Study|Death|0|||
163131615|NCT02737475|589190954|FG005|Overall Study|Death|0|||
163131616|NCT02737475|589190955|FG006|Overall Study|Death|0|||
163131617|NCT02737475|589190956|FG007|Overall Study|Death|2|||
163131618|NCT02737475|589190957|FG008|Overall Study|Death|0|||
163131619|NCT02737475|589190958|FG009|Overall Study|Death|0|||
163131620|NCT02737475|589190959|FG010|Overall Study|Death|0|||
163131621|NCT02737475|589190960|FG011|Overall Study|Death|4|||
163131622|NCT02737475|589190961|FG012|Overall Study|Death|2|||
163131623|NCT02737475|589190962|FG013|Overall Study|Death|2|||
163131624|NCT02737475|589190963|FG014|Overall Study|Death|0|||
163131625|NCT02737475|589190964|FG015|Overall Study|Death|2|||
163131626|NCT02737475|589190965|FG016|Overall Study|Death|2|||
163131627|NCT02737475|589190966|FG017|Overall Study|Death|2|||
163131628|NCT02737475|589190967|FG018|Overall Study|Death|1|||
163131629|NCT02737475|589190968|FG019|Overall Study|Death|0|||
163131630|NCT02737475|589190969|FG020|Overall Study|Death|0|||
163131631|NCT02737475|589190970|FG021|Overall Study|Death|0|||
163131632|NCT02737475|589190971|FG022|Overall Study|Death|0|||
163131633|NCT02737475|589190972|FG023|Overall Study|Death|0|||
163131634|NCT02737475|589190973|FG024|Overall Study|Death|0|||
163131635|NCT02737475|589190974|FG025|Overall Study|Death|0|||
163131636|NCT02737475|589190975|FG026|Overall Study|Death|0|||
163131637|NCT02737475|589190949|FG000|Overall Study|Participant withdrew consent|0|||
163131638|NCT02737475|589190950|FG001|Overall Study|Participant withdrew consent|0|||
163131639|NCT02737475|589190951|FG002|Overall Study|Participant withdrew consent|0|||
163131640|NCT02737475|589190952|FG003|Overall Study|Participant withdrew consent|0|||
163131641|NCT02737475|589190953|FG004|Overall Study|Participant withdrew consent|0|||
163131642|NCT02737475|589190954|FG005|Overall Study|Participant withdrew consent|2|||
163131643|NCT02737475|589190955|FG006|Overall Study|Participant withdrew consent|0|||
163131644|NCT02737475|589190956|FG007|Overall Study|Participant withdrew consent|0|||
163131645|NCT02737475|589190957|FG008|Overall Study|Participant withdrew consent|0|||
163131646|NCT02737475|589190958|FG009|Overall Study|Participant withdrew consent|0|||
163131647|NCT02737475|589190959|FG010|Overall Study|Participant withdrew consent|0|||
163344114|NCT02706834|589968399|FG002|Overall Study|Other Reason Not Specified|0|||
163131648|NCT02737475|589190960|FG011|Overall Study|Participant withdrew consent|0|||
163131649|NCT02737475|589190961|FG012|Overall Study|Participant withdrew consent|0|||
163344115|NCT02706834|589968400|FG003|Overall Study|Other Reason Not Specified|0|||
163344116|NCT02706834|589968401|FG004|Overall Study|Other Reason Not Specified|1|||
163344117|NCT02706834|589968402|FG005|Overall Study|Other Reason Not Specified|0|||
163131650|NCT02737475|589190962|FG013|Overall Study|Participant withdrew consent|0|||
163131651|NCT02737475|589190963|FG014|Overall Study|Participant withdrew consent|1|||
163131652|NCT02737475|589190964|FG015|Overall Study|Participant withdrew consent|0|||
163131653|NCT02737475|589190965|FG016|Overall Study|Participant withdrew consent|0|||
163131654|NCT02737475|589190966|FG017|Overall Study|Participant withdrew consent|2|||
163131655|NCT02737475|589190967|FG018|Overall Study|Participant withdrew consent|1|||
163131656|NCT02737475|589190968|FG019|Overall Study|Participant withdrew consent|0|||
163131657|NCT02737475|589190969|FG020|Overall Study|Participant withdrew consent|2|||
163131658|NCT02737475|589190970|FG021|Overall Study|Participant withdrew consent|0|||
163227564|NCT00110266|589547933|FG000|Overall Study|Death|17|||
163227565|NCT00110266|589547933|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163227566|NCT00110266|589547933|FG000|Overall Study|Participant condition no longer requires study drug|1|||
163227567|NCT00667342|589547938|FG000|Overall Study|Protocol Violation|1|||
163227568|NCT00667342|589547939|FG001|Overall Study|Protocol Violation|0|||
163227569|NCT00667342|589547940|FG002|Overall Study|Protocol Violation|0|||
163227570|NCT00667342|589547938|FG000|Overall Study|Withdrawal by Subject|1|||
163227571|NCT00667342|589547939|FG001|Overall Study|Withdrawal by Subject|0|||
163227572|NCT00667342|589547940|FG002|Overall Study|Withdrawal by Subject|0|||
163227573|NCT00667342|589547938|FG000|Overall Study|Physician Decision|3|||
163227574|NCT00667342|589547939|FG001|Overall Study|Physician Decision|0|||
163227575|NCT00667342|589547940|FG002|Overall Study|Physician Decision|0|||
163227576|NCT00667342|589547938|FG000|Overall Study|Relapse or tumor progression|9|||
163227577|NCT00667342|589547939|FG001|Overall Study|Relapse or tumor progression|0|||
163227578|NCT00667342|589547940|FG002|Overall Study|Relapse or tumor progression|7|||
163227579|NCT00667342|589547938|FG000|Overall Study|Adverse Event|0|||
163227580|NCT00667342|589547939|FG001|Overall Study|Adverse Event|0|||
163227581|NCT00667342|589547940|FG002|Overall Study|Adverse Event|1|||
163227582|NCT00667342|589547938|FG000|Overall Study|Ineligible|0|||
163227583|NCT00667342|589547939|FG001|Overall Study|Ineligible|0|||
163227584|NCT00667342|589547940|FG002|Overall Study|Ineligible|1|||
163227585|NCT01433263|589547941|FG000|Overall Study|Adverse Event|3|||
163227586|NCT01433263|589547942|FG001|Overall Study|Adverse Event|1|||
163227587|NCT01433263|589547941|FG000|Overall Study|Death|5|||
163227588|NCT01433263|589547942|FG001|Overall Study|Death|3|||
163227589|NCT01433263|589547941|FG000|Overall Study|Lost to Follow-up|0|||
163227590|NCT01433263|589547942|FG001|Overall Study|Lost to Follow-up|1|||
163227591|NCT01433263|589547941|FG000|Overall Study|Protocol Deviation|1|||
163227592|NCT01433263|589547942|FG001|Overall Study|Protocol Deviation|0|||
163227593|NCT01433263|589547941|FG000|Overall Study|Withdrawal by Subject|10|||
163227594|NCT01433263|589547942|FG001|Overall Study|Withdrawal by Subject|7|||
163227595|NCT00293384|589547943|FG000|Overall Study|Non-compliance|2|||
163227596|NCT00293384|589547943|FG000|Overall Study|Missed dosage/study drug|1|||
163227597|NCT00293384|589547943|FG000|Overall Study|Ineligible|2|||
163227598|NCT04709237|589547945|FG000|Overall Study|Lost to Follow-up|1|||
163227599|NCT04709237|589547946|FG001|Overall Study|Lost to Follow-up|0|||
163227600|NCT04709237|589547947|FG002|Overall Study|Lost to Follow-up|0|||
163227601|NCT02610192|589547948|FG000|Overall Study|Received other treatment|8|||
163227602|NCT02610192|589547948|FG000|Overall Study|Physician Decision|1|||
163227603|NCT01359592|589547950|FG000|Initial Registration|Adverse Event|1|||
163227604|NCT01359592|589547951|FG001|Initial Registration|Adverse Event|0|||
163227605|NCT01359592|589547952|FG002|Initial Registration|Adverse Event|0|||
163227606|NCT01359592|589547953|FG003|Initial Registration|Adverse Event|0|||
163227607|NCT01359592|589547950|FG000|Initial Registration|Death|1|||
163227608|NCT01359592|589547951|FG001|Initial Registration|Death|0|||
163227609|NCT01359592|589547952|FG002|Initial Registration|Death|0|||
163227610|NCT01359592|589547953|FG003|Initial Registration|Death|0|||
163227611|NCT01359592|589547950|FG000|Initial Registration|Other reason not protocol specified|1|||
163227612|NCT01359592|589547951|FG001|Initial Registration|Other reason not protocol specified|0|||
163227613|NCT01359592|589547952|FG002|Initial Registration|Other reason not protocol specified|0|||
163344118|NCT02706834|589968403|FG006|Overall Study|Other Reason Not Specified|0|||
163227614|NCT01359592|589547953|FG003|Initial Registration|Other reason not protocol specified|0|||
163344119|NCT02706834|589968404|FG007|Overall Study|Other Reason Not Specified|0|||
163344120|NCT02706834|589968405|FG008|Overall Study|Other Reason Not Specified|0|||
163344121|NCT02706834|589968406|FG009|Overall Study|Other Reason Not Specified|0|||
163344122|NCT02706834|589968407|FG010|Overall Study|Other Reason Not Specified|0|||
163344123|NCT00678899|589968413|FG000|Overall Study|Adverse Event|1|||
163344124|NCT02543294|589968414|FG000|Overall Study|Lost to Follow-up|3|||
163344125|NCT02543294|589968414|FG000|Overall Study|Physician Decision|2|||
163344126|NCT02543294|589968414|FG000|Overall Study|Withdrawal by Subject|7|||
163344127|NCT01107353|589968420|FG000|Overall Study|Positive Drug Screen|1|||
163344128|NCT01107353|589968421|FG001|Overall Study|Positive Drug Screen|0|||
163344129|NCT02798861|589968424|FG000|Overall Study|Lost to Follow-up|22|||
163344130|NCT02798861|589968424|FG000|Overall Study|Withdrawal by Subject|1|||
163344131|NCT04879823|589968432|FG000|Overall Study|Physician Decision|3|||
163344132|NCT04879823|589968433|FG001|Overall Study|Physician Decision|1|||
163227615|NCT01359592|589547950|FG000|Initial Registration|Ineligible|26|||
163227616|NCT01359592|589547951|FG001|Initial Registration|Ineligible|0|||
163227617|NCT01359592|589547952|FG002|Initial Registration|Ineligible|0|||
163227618|NCT01359592|589547953|FG003|Initial Registration|Ineligible|0|||
163227619|NCT01359592|589547950|FG000|PET-Directed Therapy|Adverse Event|0|||
163227620|NCT01359592|589547951|FG001|PET-Directed Therapy|Adverse Event|0|||
163227621|NCT01359592|589547952|FG002|PET-Directed Therapy|Adverse Event|1|||
163227622|NCT01359592|589547953|FG003|PET-Directed Therapy|Adverse Event|0|||
163227623|NCT01359592|589547950|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
163227624|NCT01359592|589547951|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
163227625|NCT01359592|589547952|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
163227626|NCT01359592|589547953|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
163227627|NCT01359592|589547950|FG000|PET-Directed Therapy|Ineligible|0|||
163227628|NCT01359592|589547951|FG001|PET-Directed Therapy|Ineligible|0|||
163227629|NCT01359592|589547952|FG002|PET-Directed Therapy|Ineligible|24|||
163227630|NCT01359592|589547953|FG003|PET-Directed Therapy|Ineligible|0|||
163227631|NCT00326612|589547956|FG000|Overall Study|They did not have a seizure requiring tx|129|||
163227632|NCT00326612|589547957|FG001|Overall Study|They did not have a seizure requiring tx|137|||
163227633|NCT00419562|589547958|FG000|Overall Study|Lost to Follow-up|12|||
163227634|NCT00419562|589547959|FG001|Overall Study|Lost to Follow-up|13|||
163227635|NCT00419562|589547958|FG000|Overall Study|Withdrawal by Subject|20|||
163227636|NCT00419562|589547959|FG001|Overall Study|Withdrawal by Subject|18|||
163227637|NCT00419562|589547958|FG000|Overall Study|Participant Institutionalized|1|||
163227638|NCT00419562|589547959|FG001|Overall Study|Participant Institutionalized|0|||
163131659|NCT02737475|589190971|FG022|Overall Study|Participant withdrew consent|0|||
163131660|NCT02737475|589190972|FG023|Overall Study|Participant withdrew consent|0|||
163131661|NCT02737475|589190973|FG024|Overall Study|Participant withdrew consent|0|||
163131662|NCT02737475|589190974|FG025|Overall Study|Participant withdrew consent|0|||
163131663|NCT02737475|589190975|FG026|Overall Study|Participant withdrew consent|0|||
163131664|NCT02737475|589190949|FG000|Overall Study|Lost to Follow-up|0|||
163131665|NCT02737475|589190950|FG001|Overall Study|Lost to Follow-up|0|||
163131666|NCT02737475|589190951|FG002|Overall Study|Lost to Follow-up|0|||
163131667|NCT02737475|589190952|FG003|Overall Study|Lost to Follow-up|0|||
163131668|NCT02737475|589190953|FG004|Overall Study|Lost to Follow-up|0|||
163131669|NCT02737475|589190954|FG005|Overall Study|Lost to Follow-up|0|||
163131670|NCT02737475|589190955|FG006|Overall Study|Lost to Follow-up|0|||
163131671|NCT02737475|589190956|FG007|Overall Study|Lost to Follow-up|0|||
163131672|NCT02737475|589190957|FG008|Overall Study|Lost to Follow-up|0|||
163131673|NCT02737475|589190958|FG009|Overall Study|Lost to Follow-up|0|||
163131674|NCT02737475|589190959|FG010|Overall Study|Lost to Follow-up|0|||
163131675|NCT02737475|589190960|FG011|Overall Study|Lost to Follow-up|0|||
163131676|NCT02737475|589190961|FG012|Overall Study|Lost to Follow-up|0|||
163131677|NCT02737475|589190962|FG013|Overall Study|Lost to Follow-up|0|||
163131678|NCT02737475|589190963|FG014|Overall Study|Lost to Follow-up|0|||
163131679|NCT02737475|589190964|FG015|Overall Study|Lost to Follow-up|1|||
163131680|NCT02737475|589190965|FG016|Overall Study|Lost to Follow-up|0|||
163131681|NCT02737475|589190966|FG017|Overall Study|Lost to Follow-up|0|||
163131682|NCT02737475|589190967|FG018|Overall Study|Lost to Follow-up|0|||
163131683|NCT02737475|589190968|FG019|Overall Study|Lost to Follow-up|0|||
163131684|NCT02737475|589190969|FG020|Overall Study|Lost to Follow-up|0|||
163131685|NCT02737475|589190970|FG021|Overall Study|Lost to Follow-up|0|||
163131686|NCT02737475|589190971|FG022|Overall Study|Lost to Follow-up|0|||
163131687|NCT02737475|589190972|FG023|Overall Study|Lost to Follow-up|0|||
163131688|NCT02737475|589190973|FG024|Overall Study|Lost to Follow-up|0|||
163131689|NCT02737475|589190974|FG025|Overall Study|Lost to Follow-up|0|||
163131690|NCT02737475|589190975|FG026|Overall Study|Lost to Follow-up|0|||
163131691|NCT02737475|589190949|FG000|Overall Study|Disease Progression|0|||
163131692|NCT02737475|589190950|FG001|Overall Study|Disease Progression|0|||
163131693|NCT02737475|589190951|FG002|Overall Study|Disease Progression|0|||
163131694|NCT02737475|589190952|FG003|Overall Study|Disease Progression|0|||
163131695|NCT02737475|589190953|FG004|Overall Study|Disease Progression|0|||
163131696|NCT02737475|589190954|FG005|Overall Study|Disease Progression|0|||
163131697|NCT02737475|589190955|FG006|Overall Study|Disease Progression|0|||
163131698|NCT02737475|589190956|FG007|Overall Study|Disease Progression|0|||
163131699|NCT02737475|589190957|FG008|Overall Study|Disease Progression|0|||
163131700|NCT02737475|589190958|FG009|Overall Study|Disease Progression|0|||
163131701|NCT02737475|589190959|FG010|Overall Study|Disease Progression|0|||
163131702|NCT02737475|589190960|FG011|Overall Study|Disease Progression|0|||
163131703|NCT02737475|589190961|FG012|Overall Study|Disease Progression|0|||
163131704|NCT02737475|589190962|FG013|Overall Study|Disease Progression|0|||
163131705|NCT02737475|589190963|FG014|Overall Study|Disease Progression|0|||
163131706|NCT02737475|589190964|FG015|Overall Study|Disease Progression|0|||
163131707|NCT02737475|589190965|FG016|Overall Study|Disease Progression|0|||
163131708|NCT02737475|589190966|FG017|Overall Study|Disease Progression|0|||
163131709|NCT02737475|589190967|FG018|Overall Study|Disease Progression|0|||
163131710|NCT02737475|589190968|FG019|Overall Study|Disease Progression|0|||
163131711|NCT02737475|589190969|FG020|Overall Study|Disease Progression|0|||
163131712|NCT02737475|589190970|FG021|Overall Study|Disease Progression|0|||
163131713|NCT02737475|589190971|FG022|Overall Study|Disease Progression|0|||
163131714|NCT02737475|589190972|FG023|Overall Study|Disease Progression|0|||
163131715|NCT02737475|589190973|FG024|Overall Study|Disease Progression|0|||
163131716|NCT02737475|589190974|FG025|Overall Study|Disease Progression|0|||
163131717|NCT02737475|589190975|FG026|Overall Study|Disease Progression|1|||
163131718|NCT02510001|589190976|FG000|Overall Study|Early disease progression|0|||
163131719|NCT02510001|589190977|FG001|Overall Study|Early disease progression|0|||
163131720|NCT02510001|589190978|FG002|Overall Study|Early disease progression|0|||
163131721|NCT02510001|589190979|FG003|Overall Study|Early disease progression|1|||
163227639|NCT00355238|589547960|FG000|Overall Study|Adverse event unrelated to study drug|2|||
163227640|NCT00355238|589547961|FG001|Overall Study|Adverse event unrelated to study drug|2|||
163227641|NCT00355238|589547962|FG002|Overall Study|Adverse event unrelated to study drug|0|||
163227642|NCT00355238|589547963|FG003|Overall Study|Adverse event unrelated to study drug|1|||
163227643|NCT00355238|589547960|FG000|Overall Study|Death|1|||
163227644|NCT00355238|589547961|FG001|Overall Study|Death|0|||
163227645|NCT00355238|589547962|FG002|Overall Study|Death|0|||
163227646|NCT00355238|589547963|FG003|Overall Study|Death|0|||
163227647|NCT00355238|589547960|FG000|Overall Study|Disease progression|37|||
163227648|NCT00355238|589547961|FG001|Overall Study|Disease progression|36|||
163227649|NCT00355238|589547962|FG002|Overall Study|Disease progression|16|||
163227650|NCT00355238|589547963|FG003|Overall Study|Disease progression|11|||
163227651|NCT00355238|589547960|FG000|Overall Study|Study drug toxicity|11|||
163227652|NCT00355238|589547961|FG001|Overall Study|Study drug toxicity|7|||
163344133|NCT04879823|589968432|FG000|Overall Study|Protocol Violation|2|||
163227653|NCT00355238|589547962|FG002|Overall Study|Study drug toxicity|5|||
163227654|NCT00355238|589547963|FG003|Overall Study|Study drug toxicity|2|||
163227655|NCT00355238|589547960|FG000|Overall Study|Participant withdrew consent|3|||
163227656|NCT00355238|589547961|FG001|Overall Study|Participant withdrew consent|1|||
163227657|NCT00355238|589547962|FG002|Overall Study|Participant withdrew consent|0|||
163227658|NCT00355238|589547963|FG003|Overall Study|Participant withdrew consent|0|||
163227659|NCT00355238|589547960|FG000|Overall Study|Participant request to discontinue study treatment|1|||
163227660|NCT00355238|589547961|FG001|Overall Study|Participant request to discontinue study treatment|0|||
163227661|NCT00355238|589547962|FG002|Overall Study|Participant request to discontinue study treatment|1|||
163227662|NCT00355238|589547963|FG003|Overall Study|Participant request to discontinue study treatment|0|||
163227663|NCT01454934|589547964|FG000|Overall Study|Clinical progression|28|||
163227664|NCT01454934|589547965|FG001|Overall Study|Clinical progression|25|||
163227665|NCT01454934|589547964|FG000|Overall Study|Other|6|||
163227666|NCT01454934|589547965|FG001|Overall Study|Other|17|||
163227667|NCT01454934|589547964|FG000|Overall Study|Adverse Event|28|||
163227668|NCT01454934|589547965|FG001|Overall Study|Adverse Event|24|||
163227669|NCT01454934|589547964|FG000|Overall Study|Withdrawn consent|2|||
163227670|NCT01454934|589547965|FG001|Overall Study|Withdrawn consent|5|||
163227671|NCT01454934|589547964|FG000|Overall Study|Withdrawal by Subject|11|||
163227672|NCT01454934|589547965|FG001|Overall Study|Withdrawal by Subject|15|||
163227673|NCT01454934|589547964|FG000|Overall Study|Disease progression|194|||
163227674|NCT01454934|589547965|FG001|Overall Study|Disease progression|181|||
163227675|NCT01454934|589547964|FG000|Overall Study|Lost to Follow-up|0|||
163227676|NCT01454934|589547965|FG001|Overall Study|Lost to Follow-up|1|||
163227677|NCT01454934|589547964|FG000|Overall Study|Not treated|1|||
163227678|NCT01454934|589547965|FG001|Overall Study|Not treated|2|||
163227679|NCT00480636|589547966|FG000|Overall Study|Death|12|||
163227680|NCT00480636|589547966|FG000|Overall Study|Lost to Follow-up|4|||
163227681|NCT00480636|589547966|FG000|Overall Study|Other|2|||
163227682|NCT00480636|589547966|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
163227683|NCT00546715|589547967|FG000|Overall Study|Withdrawal by Subject|0|||
163227684|NCT00546715|589547968|FG001|Overall Study|Withdrawal by Subject|1|||
163227685|NCT00546715|589547969|FG002|Overall Study|Withdrawal by Subject|0|||
163227686|NCT00546715|589547970|FG003|Overall Study|Withdrawal by Subject|0|||
163227687|NCT01018264|589547971|FG000|Overall Study|Withdrawal by Subject|1|||
163227688|NCT01018264|589547972|FG001|Overall Study|Withdrawal by Subject|0|||
163227689|NCT01018264|589547971|FG000|Overall Study|Lost to Follow-up|0|||
163227690|NCT01018264|589547972|FG001|Overall Study|Lost to Follow-up|1|||
163227691|NCT03746522|589547974|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
163227692|NCT03746522|589547975|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
163227693|NCT03746522|589547976|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
163227694|NCT03746522|589547974|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
163227695|NCT03746522|589547975|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
163227696|NCT03746522|589547976|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
163227697|NCT03746522|589547974|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
163344134|NCT04879823|589968433|FG001|Overall Study|Protocol Violation|3|||
163344135|NCT04879823|589968432|FG000|Overall Study|Lost to Follow-up|43|||
163344136|NCT04879823|589968433|FG001|Overall Study|Lost to Follow-up|35|||
163344137|NCT00730925|589968434|FG000|Overall Study|Progressive Disease|21|||
163227698|NCT03746522|589547975|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
163227699|NCT03746522|589547976|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
163227700|NCT03746522|589547974|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
163227701|NCT03746522|589547975|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
163227702|NCT03746522|589547976|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
163227703|NCT03746522|589547974|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
163227704|NCT03746522|589547975|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
163227705|NCT03746522|589547976|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
163344138|NCT00730925|589968434|FG000|Overall Study|Dose reducing Event|2|||
163227706|NCT03323099|589547977|FG000|Overall Study|Withdrawal by Subject|6|||
163344139|NCT00730925|589968434|FG000|Overall Study|Other Averse Event|7|||
163344140|NCT00730925|589968434|FG000|Overall Study|Protocol Violation|1|||
163344141|NCT00730925|589968434|FG000|Overall Study|Withdrawal by Subject|1|||
163227707|NCT03323099|589547978|FG001|Overall Study|Withdrawal by Subject|12|||
163227708|NCT03323099|589547977|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
163227709|NCT03323099|589547978|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
163227710|NCT00767676|589547981|FG000|Overall Study|Investigator error|54|||
163344142|NCT00730925|589968434|FG000|Overall Study|Switch to combination therapy|8|||
163131722|NCT02510001|589190980|FG004|Overall Study|Early disease progression|1|||
163131723|NCT02510001|589190981|FG005|Overall Study|Early disease progression|1|||
163131724|NCT02510001|589190982|FG006|Overall Study|Early disease progression|0|||
163131725|NCT02510001|589190983|FG007|Overall Study|Early disease progression|0|||
163131726|NCT02510001|589190976|FG000|Overall Study|Adverse Event|0|||
163131727|NCT02510001|589190977|FG001|Overall Study|Adverse Event|0|||
163131728|NCT02510001|589190978|FG002|Overall Study|Adverse Event|0|||
163131729|NCT02510001|589190979|FG003|Overall Study|Adverse Event|1|||
163131730|NCT02510001|589190980|FG004|Overall Study|Adverse Event|2|||
163131731|NCT02510001|589190981|FG005|Overall Study|Adverse Event|1|||
163131732|NCT02510001|589190982|FG006|Overall Study|Adverse Event|2|||
163131733|NCT02510001|589190983|FG007|Overall Study|Adverse Event|5|||
163131734|NCT02510001|589190976|FG000|Overall Study|Physician Decision|0|||
163131735|NCT02510001|589190977|FG001|Overall Study|Physician Decision|0|||
163131736|NCT02510001|589190978|FG002|Overall Study|Physician Decision|0|||
163131737|NCT02510001|589190979|FG003|Overall Study|Physician Decision|0|||
163131738|NCT02510001|589190980|FG004|Overall Study|Physician Decision|1|||
163131739|NCT02510001|589190981|FG005|Overall Study|Physician Decision|0|||
163131740|NCT02510001|589190982|FG006|Overall Study|Physician Decision|0|||
163131741|NCT02510001|589190983|FG007|Overall Study|Physician Decision|0|||
163131742|NCT02510001|589190976|FG000|Overall Study|Withdrawal by Subject|0|||
163131743|NCT02510001|589190977|FG001|Overall Study|Withdrawal by Subject|0|||
163131744|NCT02510001|589190978|FG002|Overall Study|Withdrawal by Subject|0|||
163131745|NCT02510001|589190979|FG003|Overall Study|Withdrawal by Subject|0|||
163131746|NCT02510001|589190980|FG004|Overall Study|Withdrawal by Subject|0|||
163131747|NCT02510001|589190981|FG005|Overall Study|Withdrawal by Subject|0|||
163131748|NCT02510001|589190982|FG006|Overall Study|Withdrawal by Subject|0|||
163131749|NCT02510001|589190983|FG007|Overall Study|Withdrawal by Subject|2|||
163131750|NCT00711971|589190995|FG000|Overall Study|Lost to Follow-up|3|||
163131751|NCT00711971|589190996|FG001|Overall Study|Lost to Follow-up|4|||
163131752|NCT00711971|589190997|FG002|Overall Study|Lost to Follow-up|1|||
163131753|NCT00887549|589191000|FG000|Induction Therapy|Adverse Event|8|||
163131754|NCT00887549|589191000|FG000|Induction Therapy|Physician Decision|1|||
163131755|NCT00887549|589191000|FG000|Induction Therapy|Progressive Disease|13|||
163131756|NCT00887549|589191000|FG000|Induction Therapy|Death due to Study Disease|4|||
163131757|NCT00887549|589191000|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
163131758|NCT00887549|589191000|FG000|Maintenance Therapy|Adverse Event|16|||
163131759|NCT00887549|589191000|FG000|Maintenance Therapy|Physician Decision|1|||
163131760|NCT00887549|589191000|FG000|Maintenance Therapy|Progressive Disease|25|||
163131761|NCT00887549|589191000|FG000|Maintenance Therapy|Death due to adverse event|1|||
163131762|NCT01858740|589191002|FG000|Overall Study|Death|4|||
163131763|NCT02097030|589191009|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
163131764|NCT02097030|589191010|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
163131765|NCT02097030|589191009|FG000|First Intervention (3 Days)|Visual Acuity|0|||
163131766|NCT02097030|589191010|FG001|First Intervention (3 Days)|Visual Acuity|1|||
163131767|NCT01919801|589191011|FG000|Overall Study|Withdrawal by Subject|1|||
163131768|NCT01919801|589191012|FG001|Overall Study|Withdrawal by Subject|0|||
163131769|NCT01919801|589191011|FG000|Overall Study|Physician Decision|0|||
163131770|NCT01919801|589191012|FG001|Overall Study|Physician Decision|1|||
163131771|NCT01919801|589191011|FG000|Overall Study|Lost to Follow-up|0|||
163131772|NCT01919801|589191012|FG001|Overall Study|Lost to Follow-up|1|||
163131773|NCT01919801|589191011|FG000|Overall Study|Other|0|||
163131774|NCT01919801|589191012|FG001|Overall Study|Other|1|||
163131775|NCT01677858|589191017|FG000|Overall Study|Adverse Event|0|||
163131776|NCT01677858|589191018|FG001|Overall Study|Adverse Event|0|||
163131777|NCT01677858|589191019|FG002|Overall Study|Adverse Event|2|||
163131778|NCT01677858|589191020|FG003|Overall Study|Adverse Event|3|||
163131779|NCT01677858|589191021|FG004|Overall Study|Adverse Event|13|||
163131780|NCT01677858|589191017|FG000|Overall Study|Death|0|||
163131781|NCT01677858|589191018|FG001|Overall Study|Death|0|||
163131782|NCT01677858|589191019|FG002|Overall Study|Death|0|||
163131783|NCT01677858|589191020|FG003|Overall Study|Death|0|||
163131784|NCT01677858|589191021|FG004|Overall Study|Death|1|||
163131785|NCT01677858|589191017|FG000|Overall Study|Physician Decision|1|||
163131786|NCT01677858|589191018|FG001|Overall Study|Physician Decision|0|||
163131787|NCT01677858|589191019|FG002|Overall Study|Physician Decision|2|||
163131788|NCT01677858|589191020|FG003|Overall Study|Physician Decision|0|||
163131789|NCT01677858|589191021|FG004|Overall Study|Physician Decision|12|||
163131790|NCT01677858|589191017|FG000|Overall Study|Progressive Disease|2|||
163131791|NCT01677858|589191018|FG001|Overall Study|Progressive Disease|1|||
163131792|NCT01677858|589191019|FG002|Overall Study|Progressive Disease|9|||
163131793|NCT01677858|589191020|FG003|Overall Study|Progressive Disease|3|||
163131794|NCT01677858|589191021|FG004|Overall Study|Progressive Disease|43|||
163131795|NCT01677858|589191017|FG000|Overall Study|Withdrawal by Subject|0|||
163131796|NCT01677858|589191018|FG001|Overall Study|Withdrawal by Subject|1|||
163131797|NCT01677858|589191019|FG002|Overall Study|Withdrawal by Subject|1|||
163131798|NCT01677858|589191020|FG003|Overall Study|Withdrawal by Subject|0|||
163131799|NCT01677858|589191021|FG004|Overall Study|Withdrawal by Subject|15|||
163131800|NCT01677858|589191017|FG000|Overall Study|Lost to Follow-up|0|||
163131801|NCT01677858|589191018|FG001|Overall Study|Lost to Follow-up|0|||
163131802|NCT01677858|589191019|FG002|Overall Study|Lost to Follow-up|0|||
163131803|NCT01677858|589191020|FG003|Overall Study|Lost to Follow-up|0|||
163131804|NCT01677858|589191021|FG004|Overall Study|Lost to Follow-up|1|||
163131805|NCT00988091|589191022|FG000|Double-blind Period|Withdrawal by Subject|15|||
163131806|NCT00988091|589191023|FG001|Double-blind Period|Withdrawal by Subject|13|||
163131807|NCT00988091|589191022|FG000|Double-blind Period|Lost to Follow-up|12|||
163131808|NCT00988091|589191023|FG001|Double-blind Period|Lost to Follow-up|14|||
163131809|NCT00988091|589191022|FG000|Double-blind Period|Other|8|||
163131810|NCT00988091|589191023|FG001|Double-blind Period|Other|8|||
163131811|NCT00988091|589191022|FG000|Double-blind Period|Adverse Event|6|||
163131812|NCT00988091|589191023|FG001|Double-blind Period|Adverse Event|9|||
163131813|NCT00988091|589191022|FG000|Double-blind Period|Use of exclusionary medication|2|||
163131814|NCT00988091|589191023|FG001|Double-blind Period|Use of exclusionary medication|3|||
163131815|NCT00988091|589191022|FG000|Open-label Period|Adverse Event|4|||
163131816|NCT00988091|589191023|FG001|Open-label Period|Adverse Event|7|||
163131817|NCT00988091|589191022|FG000|Open-label Period|Use of exclusionary medication|1|||
163131818|NCT00988091|589191023|FG001|Open-label Period|Use of exclusionary medication|1|||
163131819|NCT00988091|589191022|FG000|Open-label Period|Protocol Violation|1|||
163131820|NCT00988091|589191023|FG001|Open-label Period|Protocol Violation|1|||
163131821|NCT00988091|589191022|FG000|Open-label Period|Withdrawal by Subject|10|||
163131822|NCT00988091|589191023|FG001|Open-label Period|Withdrawal by Subject|16|||
163131823|NCT00988091|589191022|FG000|Open-label Period|Lost to Follow-up|3|||
163131824|NCT00988091|589191023|FG001|Open-label Period|Lost to Follow-up|5|||
163131825|NCT00988091|589191022|FG000|Open-label Period|Other|2|||
163131826|NCT00988091|589191023|FG001|Open-label Period|Other|3|||
163131827|NCT03078855|589191027|FG000|Overall Study|Lack of Efficacy|62|||
163131828|NCT03078855|589191028|FG001|Overall Study|Lack of Efficacy|31|||
163131829|NCT03078855|589191027|FG000|Overall Study|Death|1|||
163131830|NCT03078855|589191028|FG001|Overall Study|Death|0|||
163131831|NCT03078855|589191027|FG000|Overall Study|Withdrawal by Subject|12|||
163131832|NCT03078855|589191028|FG001|Overall Study|Withdrawal by Subject|6|||
163131833|NCT03078855|589191027|FG000|Overall Study|Physician Decision|3|||
163131834|NCT03078855|589191028|FG001|Overall Study|Physician Decision|2|||
163131835|NCT03078855|589191027|FG000|Overall Study|Second Malignancy|4|||
163131836|NCT03078855|589191028|FG001|Overall Study|Second Malignancy|0|||
163131837|NCT03078855|589191027|FG000|Overall Study|Ineligible|2|||
163131838|NCT03078855|589191028|FG001|Overall Study|Ineligible|0|||
163131839|NCT03078855|589191027|FG000|Overall Study|Withdrew before day 1 treatment|2|||
163131840|NCT03078855|589191028|FG001|Overall Study|Withdrew before day 1 treatment|1|||
163131841|NCT00391027|589191029|FG000|Overall Study|Adverse Event|8|||
163131842|NCT00391027|589191030|FG001|Overall Study|Adverse Event|8|||
163131843|NCT00391027|589191029|FG000|Overall Study|Lack of Efficacy|3|||
163131844|NCT00391027|589191030|FG001|Overall Study|Lack of Efficacy|0|||
163131845|NCT00391027|589191029|FG000|Overall Study|Withdrawal by Subject|10|||
163131846|NCT00391027|589191030|FG001|Overall Study|Withdrawal by Subject|1|||
163131847|NCT00391027|589191029|FG000|Overall Study|Other|4|||
163131848|NCT00391027|589191030|FG001|Overall Study|Other|3|||
163131849|NCT03194646|589191031|FG000|Overall Study|Adverse Event|24|||
163131850|NCT03194646|589191032|FG001|Overall Study|Adverse Event|25|||
163131851|NCT03194646|589191033|FG002|Overall Study|Adverse Event|14|||
163131852|NCT03194646|589191034|FG003|Overall Study|Adverse Event|17|||
163131853|NCT03194646|589191031|FG000|Overall Study|Lack of Efficacy|4|||
163131854|NCT03194646|589191032|FG001|Overall Study|Lack of Efficacy|2|||
163131855|NCT03194646|589191033|FG002|Overall Study|Lack of Efficacy|2|||
163131856|NCT03194646|589191034|FG003|Overall Study|Lack of Efficacy|12|||
163131857|NCT03194646|589191031|FG000|Overall Study|Lost to Follow-up|30|||
163131858|NCT03194646|589191032|FG001|Overall Study|Lost to Follow-up|22|||
163131859|NCT03194646|589191033|FG002|Overall Study|Lost to Follow-up|12|||
163131860|NCT03194646|589191034|FG003|Overall Study|Lost to Follow-up|35|||
163131861|NCT03194646|589191031|FG000|Overall Study|Non-compliance with study drug|4|||
163131862|NCT03194646|589191032|FG001|Overall Study|Non-compliance with study drug|0|||
163227711|NCT05132127|589547985|FG000|Overall Study|Adverse Event|1|||
163227712|NCT05220397|589547986|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
163131863|NCT03194646|589191033|FG002|Overall Study|Non-compliance with study drug|1|||
163131864|NCT03194646|589191034|FG003|Overall Study|Non-compliance with study drug|1|||
163131865|NCT03194646|589191031|FG000|Overall Study|Other|89|||
163131866|NCT03194646|589191032|FG001|Overall Study|Other|68|||
163131867|NCT03194646|589191033|FG002|Overall Study|Other|34|||
163131868|NCT03194646|589191034|FG003|Overall Study|Other|31|||
163131869|NCT03194646|589191031|FG000|Overall Study|Physician Decision|7|||
163131870|NCT03194646|589191032|FG001|Overall Study|Physician Decision|9|||
163131871|NCT03194646|589191033|FG002|Overall Study|Physician Decision|5|||
163344143|NCT00730925|589968434|FG000|Overall Study|Other|1|||
163131872|NCT03194646|589191034|FG003|Overall Study|Physician Decision|4|||
163131873|NCT03194646|589191031|FG000|Overall Study|Pregnancy|4|||
163131874|NCT03194646|589191032|FG001|Overall Study|Pregnancy|5|||
163131875|NCT03194646|589191033|FG002|Overall Study|Pregnancy|1|||
163131876|NCT03194646|589191034|FG003|Overall Study|Pregnancy|2|||
163131877|NCT03194646|589191031|FG000|Overall Study|Protocol Violation|4|||
163131878|NCT03194646|589191032|FG001|Overall Study|Protocol Violation|2|||
163131879|NCT03194646|589191033|FG002|Overall Study|Protocol Violation|1|||
163131880|NCT03194646|589191034|FG003|Overall Study|Protocol Violation|1|||
163131881|NCT03194646|589191031|FG000|Overall Study|Site terminated by sponsor|0|||
163131882|NCT03194646|589191032|FG001|Overall Study|Site terminated by sponsor|0|||
163131883|NCT03194646|589191033|FG002|Overall Study|Site terminated by sponsor|2|||
163131884|NCT03194646|589191034|FG003|Overall Study|Site terminated by sponsor|0|||
163131885|NCT03194646|589191031|FG000|Overall Study|Study terminated by sponsor|62|||
163131886|NCT03194646|589191032|FG001|Overall Study|Study terminated by sponsor|61|||
163131887|NCT03194646|589191033|FG002|Overall Study|Study terminated by sponsor|30|||
163131888|NCT03194646|589191034|FG003|Overall Study|Study terminated by sponsor|34|||
163131889|NCT03194646|589191031|FG000|Overall Study|Withdrawal by Subject|75|||
163131890|NCT03194646|589191032|FG001|Overall Study|Withdrawal by Subject|74|||
163131891|NCT03194646|589191033|FG002|Overall Study|Withdrawal by Subject|36|||
163131892|NCT03194646|589191034|FG003|Overall Study|Withdrawal by Subject|131|||
163131893|NCT03194646|589191031|FG000|Overall Study|Missing|1|||
163131894|NCT03194646|589191032|FG001|Overall Study|Missing|0|||
163131895|NCT03194646|589191033|FG002|Overall Study|Missing|1|||
163131896|NCT03194646|589191034|FG003|Overall Study|Missing|12|||
163131897|NCT04869358|589191035|FG000|Overall Study|Wish to have children.|1|||
163131898|NCT04869358|589191036|FG001|Overall Study|Wish to have children.|0|||
163131899|NCT04869358|589191037|FG002|Overall Study|Wish to have children.|0|||
163131900|NCT04869358|589191038|FG003|Overall Study|Wish to have children.|0|||
163131901|NCT05232864|589191039|FG000|Overall Study|Adverse Event|0|||
163131902|NCT05232864|589191040|FG001|Overall Study|Adverse Event|1|||
163131903|NCT05232864|589191039|FG000|Overall Study|Study terminated by sponsor|16|||
163131904|NCT05232864|589191040|FG001|Overall Study|Study terminated by sponsor|14|||
163131905|NCT04765202|589191044|FG000|Overall Study|Lost to Follow-up|1|||
163131906|NCT04765202|589191045|FG001|Overall Study|Lost to Follow-up|1|||
163131907|NCT04765202|589191046|FG002|Overall Study|Lost to Follow-up|2|||
163131908|NCT04765202|589191047|FG003|Overall Study|Lost to Follow-up|2|||
163131909|NCT04765202|589191044|FG000|Overall Study|Physician Decision|0|||
163131910|NCT04765202|589191045|FG001|Overall Study|Physician Decision|0|||
163131911|NCT04765202|589191046|FG002|Overall Study|Physician Decision|1|||
163131912|NCT04765202|589191047|FG003|Overall Study|Physician Decision|1|||
163131913|NCT04929249|589191048|FG000|Overall Study|Adverse Event|2|||
163131914|NCT04929249|589191049|FG001|Overall Study|Adverse Event|1|||
163131915|NCT04929249|589191048|FG000|Overall Study|Death|2|||
163131916|NCT04929249|589191049|FG001|Overall Study|Death|1|||
163131917|NCT04929249|589191048|FG000|Overall Study|Lost to Follow-up|3|||
163131918|NCT04929249|589191049|FG001|Overall Study|Lost to Follow-up|11|||
163131919|NCT04929249|589191048|FG000|Overall Study|Technical problems|0|||
163131920|NCT04929249|589191049|FG001|Overall Study|Technical problems|1|||
163131921|NCT04929249|589191048|FG000|Overall Study|Subject decision|6|||
163131922|NCT04929249|589191049|FG001|Overall Study|Subject decision|8|||
163131923|NCT04929249|589191048|FG000|Overall Study|Withdrew consent|0|||
163131924|NCT04929249|589191049|FG001|Overall Study|Withdrew consent|8|||
163131925|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
163131926|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
163131927|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
163131928|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
163131929|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Death|2|||
163131930|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Death|2|||
163131931|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Death|0|||
163344144|NCT02137239|589968435|FG000|Overall Study|Discontinued Study Treatment|0|||
163131932|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Death|0|||
163131933|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
163131934|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
163131935|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
163131936|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
163131937|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
163131938|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
163131939|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
163131940|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
163131941|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
163131942|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
163131943|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
163131944|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
163131945|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
163227713|NCT05220397|589547987|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
163227714|NCT05220397|589547988|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
163227715|NCT05220397|589547989|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
163227716|NCT05220397|589547990|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
163227717|NCT02659020|589547991|FG000|Overall Study|Adverse Event|0|||
163227718|NCT02659020|589547992|FG001|Overall Study|Adverse Event|0|||
163227719|NCT02659020|589547993|FG002|Overall Study|Adverse Event|0|||
163227720|NCT02659020|589547994|FG003|Overall Study|Adverse Event|2|||
163227721|NCT02659020|589547995|FG004|Overall Study|Adverse Event|0|||
163227722|NCT02659020|589547996|FG005|Overall Study|Adverse Event|0|||
163227723|NCT02659020|589547997|FG006|Overall Study|Adverse Event|2|||
163227724|NCT02659020|589547991|FG000|Overall Study|Lost to Follow-up|1|||
163227725|NCT02659020|589547992|FG001|Overall Study|Lost to Follow-up|2|||
163227726|NCT02659020|589547993|FG002|Overall Study|Lost to Follow-up|1|||
163227727|NCT02659020|589547994|FG003|Overall Study|Lost to Follow-up|6|||
163227728|NCT02659020|589547995|FG004|Overall Study|Lost to Follow-up|1|||
163227729|NCT02659020|589547996|FG005|Overall Study|Lost to Follow-up|5|||
163227730|NCT02659020|589547997|FG006|Overall Study|Lost to Follow-up|0|||
163227731|NCT02659020|589547991|FG000|Overall Study|Physician Decision|0|||
163227732|NCT02659020|589547992|FG001|Overall Study|Physician Decision|0|||
163227733|NCT02659020|589547993|FG002|Overall Study|Physician Decision|0|||
163227734|NCT02659020|589547994|FG003|Overall Study|Physician Decision|1|||
163227735|NCT02659020|589547995|FG004|Overall Study|Physician Decision|1|||
163227736|NCT02659020|589547996|FG005|Overall Study|Physician Decision|0|||
163227737|NCT02659020|589547997|FG006|Overall Study|Physician Decision|1|||
163227738|NCT02659020|589547991|FG000|Overall Study|Withdrawal by Subject|2|||
163227739|NCT02659020|589547992|FG001|Overall Study|Withdrawal by Subject|1|||
163227740|NCT02659020|589547993|FG002|Overall Study|Withdrawal by Subject|0|||
163227741|NCT02659020|589547994|FG003|Overall Study|Withdrawal by Subject|3|||
163227742|NCT02659020|589547995|FG004|Overall Study|Withdrawal by Subject|3|||
163227743|NCT02659020|589547996|FG005|Overall Study|Withdrawal by Subject|6|||
163227744|NCT02659020|589547997|FG006|Overall Study|Withdrawal by Subject|3|||
163227745|NCT02659020|589547991|FG000|Overall Study|Progressive Disease|0|||
163227746|NCT02659020|589547992|FG001|Overall Study|Progressive Disease|0|||
163227747|NCT02659020|589547993|FG002|Overall Study|Progressive Disease|0|||
163227748|NCT02659020|589547994|FG003|Overall Study|Progressive Disease|4|||
163227749|NCT02659020|589547995|FG004|Overall Study|Progressive Disease|1|||
163227750|NCT02659020|589547996|FG005|Overall Study|Progressive Disease|0|||
163227751|NCT02659020|589547997|FG006|Overall Study|Progressive Disease|2|||
163227752|NCT02052739|589547998|FG000|Overall Study|Withdrew due to Adverse Event|3|||
163227753|NCT02052739|589547999|FG001|Overall Study|Withdrew due to Adverse Event|0|||
163227754|NCT02052739|589547998|FG000|Overall Study|Participant Died|2|||
163227755|NCT02052739|589547999|FG001|Overall Study|Participant Died|1|||
163227756|NCT02043015|589548000|FG000|Overall Study|Lost to Follow-up|4|||
163227757|NCT02043015|589548000|FG000|Overall Study|Withdrawal by Subject|4|||
163227758|NCT02043015|589548000|FG000|Overall Study|Removed once target enrollment reached|15|||
163227759|NCT02043015|589548000|FG000|Overall Study|Participant moved away from study city|4|||
163227760|NCT02043015|589548000|FG000|Overall Study|Incarceration|1|||
163227761|NCT00393939|589548004|FG000|Overall Study|Protocol Violation|1|||
163227762|NCT00393939|589548005|FG001|Overall Study|Protocol Violation|1|||
163227763|NCT00393939|589548004|FG000|Overall Study|Lost to Follow-up|2|||
163227764|NCT00393939|589548005|FG001|Overall Study|Lost to Follow-up|4|||
163227765|NCT00393939|589548004|FG000|Overall Study|Death|10|||
163227766|NCT00393939|589548005|FG001|Overall Study|Death|4|||
163344145|NCT02137239|589968436|FG001|Overall Study|Discontinued Study Treatment|3|||
163344146|NCT02137239|589968435|FG000|Overall Study|Withdrew Consent|1|||
163344147|NCT02137239|589968436|FG001|Overall Study|Withdrew Consent|1|||
163344148|NCT02137239|589968435|FG000|Overall Study|Adverse Event|2|||
163344149|NCT02137239|589968436|FG001|Overall Study|Adverse Event|2|||
163344150|NCT04057937|589968437|FG000|Placebo-controlled Phase|Adverse Event|3|||
163344151|NCT04057937|589968438|FG001|Placebo-controlled Phase|Adverse Event|0|||
163344152|NCT04057937|589968437|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
163344153|NCT04057937|589968438|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
163344154|NCT04057937|589968437|FG000|Active-treatment Phase|Pregnancy|0|||
163344155|NCT04057937|589968438|FG001|Active-treatment Phase|Pregnancy|1|||
163344156|NCT04057937|589968437|FG000|Active-treatment Phase|Physician Decision|0|||
163227767|NCT00393939|589548004|FG000|Overall Study|Sponsor|5|||
163227768|NCT00393939|589548005|FG001|Overall Study|Sponsor|13|||
163227769|NCT00393939|589548004|FG000|Overall Study|Objective progression or relapse|239|||
163227770|NCT00393939|589548005|FG001|Overall Study|Objective progression or relapse|223|||
163227771|NCT00393939|589548004|FG000|Overall Study|Withdrawal by Subject|2|||
163227772|NCT00393939|589548005|FG001|Overall Study|Withdrawal by Subject|7|||
163227773|NCT00393939|589548004|FG000|Overall Study|Other|37|||
163227774|NCT00393939|589548005|FG001|Overall Study|Other|45|||
163227775|NCT01494610|589548006|FG000|Period 1|Withdrawal by Subject|1|||
163227776|NCT01494610|589548007|FG001|Period 1|Withdrawal by Subject|1|||
163227777|NCT01494610|589548006|FG000|Period 3|Adverse Event|1|||
163227778|NCT01494610|589548007|FG001|Period 3|Adverse Event|0|||
163344157|NCT04057937|589968438|FG001|Active-treatment Phase|Physician Decision|1|||
163344158|NCT02029521|589968439|FG000|Overall Study|Protocol Violation|1|||
163344159|NCT02029521|589968440|FG001|Overall Study|Protocol Violation|0|||
163344160|NCT02029521|589968439|FG000|Overall Study|Withdrawal by Subject|1|||
163344161|NCT02029521|589968440|FG001|Overall Study|Withdrawal by Subject|1|||
163344162|NCT01072396|589968441|FG000|Period One|Adverse Event|1|||
163344163|NCT01072396|589968442|FG001|Period One|Adverse Event|1|||
163344164|NCT01072396|589968441|FG000|Period One|Protocol Violation|2|||
163344165|NCT01072396|589968442|FG001|Period One|Protocol Violation|1|||
163344166|NCT01072396|589968441|FG000|Period One|Withdrawal by Subject|2|||
163344167|NCT01072396|589968442|FG001|Period One|Withdrawal by Subject|0|||
163344168|NCT01072396|589968441|FG000|Washout Period|Missing termination information|0|||
163344169|NCT01072396|589968442|FG001|Washout Period|Missing termination information|1|||
163131946|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
163131947|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
163131948|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
163131949|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
163131950|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
163131951|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
163131952|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
163131953|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
163131954|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
163131955|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
163131956|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
163131957|NCT03068754|589191050|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
163131958|NCT03068754|589191051|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
163131959|NCT03068754|589191052|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
163131960|NCT03068754|589191053|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
163131961|NCT03068754|589191050|FG000|Open Label Extension Period (OLE)|Death|0|||
163131962|NCT03068754|589191051|FG001|Open Label Extension Period (OLE)|Death|0|||
163131963|NCT03068754|589191052|FG002|Open Label Extension Period (OLE)|Death|0|||
163131964|NCT03068754|589191053|FG003|Open Label Extension Period (OLE)|Death|1|||
163131965|NCT03068754|589191050|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
163131966|NCT03068754|589191051|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
163131967|NCT03068754|589191052|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
163131968|NCT03068754|589191053|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
163131969|NCT03068754|589191050|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
163131970|NCT03068754|589191051|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
163131971|NCT03068754|589191052|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
163131972|NCT03068754|589191053|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
163131973|NCT03068754|589191050|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
163131974|NCT03068754|589191051|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
163131975|NCT03068754|589191052|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
163131976|NCT03068754|589191053|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
163131977|NCT03068754|589191050|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
163131978|NCT03068754|589191051|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
163131979|NCT03068754|589191052|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
163131980|NCT03068754|589191053|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
163131981|NCT00129467|589191054|FG000|Received Intervention|Death|1|||
163131982|NCT00129467|589191055|FG001|Received Intervention|Death|1|||
163131983|NCT00129467|589191054|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
163131984|NCT00129467|589191055|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
163131985|NCT00129467|589191054|FG000|Received Intervention|Delirium|2|||
163131986|NCT00129467|589191055|FG001|Received Intervention|Delirium|0|||
163131987|NCT00129467|589191054|FG000|Received Intervention|Withdrawal by Subject|1|||
163131988|NCT00129467|589191055|FG001|Received Intervention|Withdrawal by Subject|0|||
163131989|NCT00129467|589191054|FG000|Received Intervention|Nausea|1|||
163131990|NCT00129467|589191055|FG001|Received Intervention|Nausea|0|||
163131991|NCT00129467|589191054|FG000|Received Intervention|Intolerance to citalopram|0|||
163131992|NCT00129467|589191055|FG001|Received Intervention|Intolerance to citalopram|1|||
163131993|NCT00129467|589191054|FG000|Received Intervention|Dizzyness, fatigue|0|||
163131994|NCT00129467|589191055|FG001|Received Intervention|Dizzyness, fatigue|1|||
163131995|NCT00129467|589191054|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
163131996|NCT00129467|589191055|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
163131997|NCT00129467|589191054|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
163344170|NCT01072396|589968441|FG000|Period Two|Adverse Event|0|||
163344171|NCT01072396|589968442|FG001|Period Two|Adverse Event|3|||
163344172|NCT01072396|589968441|FG000|Period Two|Lost to Follow-up|1|||
163344173|NCT01072396|589968442|FG001|Period Two|Lost to Follow-up|0|||
163344174|NCT02446912|589968443|FG000|Overall Study|Adverse Event|3|||
163227779|NCT01494610|589548006|FG000|Period 3|Withdrawal by Subject|1|||
163227780|NCT01494610|589548007|FG001|Period 3|Withdrawal by Subject|0|||
163227781|NCT01494610|589548006|FG000|Period 4|Protocol Violation|1|||
163227782|NCT01494610|589548007|FG001|Period 4|Protocol Violation|0|||
163227783|NCT02385799|589548008|FG000|Overall Study|Lost to Follow-up|1|||
163227784|NCT02385799|589548009|FG001|Overall Study|Lost to Follow-up|2|||
163227785|NCT02385799|589548008|FG000|Overall Study|Adverse Event|4|||
163227786|NCT02385799|589548009|FG001|Overall Study|Adverse Event|2|||
163227787|NCT02385799|589548008|FG000|Overall Study|Withdrawal by Subject|0|||
163227788|NCT02385799|589548009|FG001|Overall Study|Withdrawal by Subject|4|||
163227789|NCT04958109|589548010|FG000|Overall Study|Withdrawal by Subject|0|||
163227790|NCT04958109|589548011|FG001|Overall Study|Withdrawal by Subject|1|||
163227791|NCT04958109|589548010|FG000|Overall Study|Lost to Follow-up|0|||
163227792|NCT04958109|589548011|FG001|Overall Study|Lost to Follow-up|1|||
163227793|NCT00715793|589548012|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
163227794|NCT00715793|589548013|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
163227795|NCT00715793|589548012|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
163227796|NCT00715793|589548013|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
163227797|NCT02346240|589548014|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227798|NCT02346240|589548015|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
163227799|NCT02346240|589548016|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
163227800|NCT02346240|589548017|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
163227801|NCT02346240|589548018|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227802|NCT02346240|589548019|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227803|NCT02346240|589548020|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227804|NCT02346240|589548021|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227805|NCT02346240|589548022|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227806|NCT02346240|589548023|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227807|NCT02346240|589548024|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227808|NCT02346240|589548025|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227809|NCT02346240|589548026|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227810|NCT02346240|589548027|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227811|NCT02346240|589548028|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227812|NCT02346240|589548029|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227813|NCT02346240|589548030|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227814|NCT02346240|589548031|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227815|NCT02346240|589548032|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227816|NCT02346240|589548033|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227817|NCT02346240|589548034|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227818|NCT02346240|589548035|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227819|NCT02346240|589548036|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227820|NCT02346240|589548037|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163227821|NCT02346240|589548014|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227822|NCT02346240|589548015|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
163227823|NCT02346240|589548016|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227824|NCT02346240|589548017|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227825|NCT02346240|589548018|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227826|NCT02346240|589548019|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227827|NCT02346240|589548020|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227828|NCT02346240|589548021|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227829|NCT02346240|589548022|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227830|NCT02346240|589548023|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227831|NCT02346240|589548024|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227832|NCT02346240|589548025|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227833|NCT02346240|589548026|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227834|NCT02346240|589548027|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163131998|NCT00129467|589191055|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
163131999|NCT01009086|589191056|FG000|Overall Study|Lack of Efficacy|16|||
163132000|NCT01009086|589191057|FG001|Overall Study|Lack of Efficacy|15|||
163132001|NCT01009086|589191058|FG002|Overall Study|Lack of Efficacy|9|||
163132002|NCT01009086|589191056|FG000|Overall Study|Lost to Follow-up|4|||
163132003|NCT01009086|589191057|FG001|Overall Study|Lost to Follow-up|5|||
163132004|NCT01009086|589191058|FG002|Overall Study|Lost to Follow-up|3|||
163132005|NCT01009086|589191056|FG000|Overall Study|Adverse Event|12|||
163132006|NCT01009086|589191057|FG001|Overall Study|Adverse Event|11|||
163132007|NCT01009086|589191058|FG002|Overall Study|Adverse Event|8|||
163227835|NCT02346240|589548028|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227836|NCT02346240|589548029|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163132008|NCT01009086|589191056|FG000|Overall Study|Withdrawal by Subject|9|||
163132009|NCT01009086|589191057|FG001|Overall Study|Withdrawal by Subject|11|||
163227837|NCT02346240|589548030|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227838|NCT02346240|589548031|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227839|NCT02346240|589548032|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227840|NCT02346240|589548033|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227841|NCT02346240|589548034|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227842|NCT02346240|589548035|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227843|NCT02346240|589548036|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227844|NCT02346240|589548037|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163227845|NCT02346240|589548014|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227846|NCT02346240|589548015|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
163227847|NCT02346240|589548016|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227848|NCT02346240|589548017|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227849|NCT02346240|589548018|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227850|NCT02346240|589548019|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227851|NCT02346240|589548020|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227852|NCT02346240|589548021|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227853|NCT02346240|589548022|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227854|NCT02346240|589548023|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227855|NCT02346240|589548024|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227856|NCT02346240|589548025|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227857|NCT02346240|589548026|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227858|NCT02346240|589548027|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227859|NCT02346240|589548028|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227860|NCT02346240|589548029|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227861|NCT02346240|589548030|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227862|NCT02346240|589548031|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227863|NCT02346240|589548032|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227864|NCT02346240|589548033|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227865|NCT02346240|589548034|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227866|NCT02346240|589548035|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227867|NCT02346240|589548036|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227868|NCT02346240|589548037|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163227869|NCT02346240|589548014|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
163227870|NCT02346240|589548015|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
163227871|NCT02346240|589548016|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
163227872|NCT02346240|589548017|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
163227873|NCT02346240|589548018|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227874|NCT02346240|589548019|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227875|NCT02346240|589548020|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227876|NCT02346240|589548021|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227877|NCT02346240|589548022|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227878|NCT02346240|589548023|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227879|NCT02346240|589548024|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227880|NCT02346240|589548025|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227881|NCT02346240|589548026|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227882|NCT02346240|589548027|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227883|NCT02346240|589548028|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227884|NCT02346240|589548029|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227885|NCT02346240|589548030|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227886|NCT02346240|589548031|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227887|NCT02346240|589548032|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227888|NCT02346240|589548033|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227889|NCT02346240|589548034|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227890|NCT02346240|589548035|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227891|NCT02346240|589548036|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227892|NCT02346240|589548037|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
163227893|NCT02346240|589548014|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
163227894|NCT02346240|589548015|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
163227895|NCT02346240|589548016|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
163227896|NCT02346240|589548017|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
163344175|NCT02446912|589968444|FG001|Overall Study|Adverse Event|13|||
163344176|NCT02446912|589968445|FG002|Overall Study|Adverse Event|5|||
163344177|NCT02446912|589968443|FG000|Overall Study|Condition under investigation worsened|0|||
163344178|NCT02446912|589968444|FG001|Overall Study|Condition under investigation worsened|1|||
163344179|NCT02446912|589968445|FG002|Overall Study|Condition under investigation worsened|1|||
163344180|NCT02446912|589968443|FG000|Overall Study|Study-specific withdrawal criteria|1|||
163344181|NCT02446912|589968444|FG001|Overall Study|Study-specific withdrawal criteria|0|||
163344182|NCT02446912|589968445|FG002|Overall Study|Study-specific withdrawal criteria|0|||
163344183|NCT02446912|589968443|FG000|Overall Study|Lack of Efficacy|1|||
163344184|NCT02446912|589968444|FG001|Overall Study|Lack of Efficacy|4|||
163344185|NCT02446912|589968445|FG002|Overall Study|Lack of Efficacy|7|||
163344186|NCT02446912|589968443|FG000|Overall Study|Lost to Follow-up|0|||
163344187|NCT02446912|589968444|FG001|Overall Study|Lost to Follow-up|0|||
163344188|NCT02446912|589968445|FG002|Overall Study|Lost to Follow-up|2|||
163132010|NCT01009086|589191058|FG002|Overall Study|Withdrawal by Subject|13|||
163344189|NCT02446912|589968443|FG000|Overall Study|Severe non-compliance to protocol|1|||
163344190|NCT02446912|589968444|FG001|Overall Study|Severe non-compliance to protocol|0|||
163344191|NCT02446912|589968445|FG002|Overall Study|Severe non-compliance to protocol|1|||
163344192|NCT02446912|589968443|FG000|Overall Study|Withdrawal by Subject|10|||
163344193|NCT02446912|589968444|FG001|Overall Study|Withdrawal by Subject|15|||
163344194|NCT02446912|589968445|FG002|Overall Study|Withdrawal by Subject|15|||
163344195|NCT02446912|589968443|FG000|Overall Study|Miscellaneous|2|||
163344196|NCT02446912|589968444|FG001|Overall Study|Miscellaneous|2|||
163344197|NCT02446912|589968445|FG002|Overall Study|Miscellaneous|4|||
163344198|NCT01268488|589968446|FG000|Overall Study|Adverse Event|3|||
163344199|NCT01268488|589968446|FG000|Overall Study|Physician Decision|2|||
163344200|NCT02058992|589968452|FG000|Overall Study|Lost to Follow-up|4|||
163344201|NCT02058992|589968452|FG000|Overall Study|Protocol Violation|92|||
163132011|NCT01009086|589191056|FG000|Overall Study|Other|3|||
163132012|NCT01009086|589191057|FG001|Overall Study|Other|5|||
163132013|NCT01009086|589191058|FG002|Overall Study|Other|1|||
163132014|NCT02202538|589191071|FG000|Overall Study|Withdrawal by Subject|5|||
163132015|NCT02202538|589191071|FG000|Overall Study|Did not meet all inclusion criteria|2|||
163132016|NCT02202538|589191071|FG000|Overall Study|Investigator Decision|1|||
163132017|NCT01853878|589191072|FG000|Overall Study|Recurrence|2|||
163132018|NCT01853878|589191073|FG001|Overall Study|Recurrence|0|||
163132019|NCT01853878|589191072|FG000|Overall Study|Adverse Event|2|||
163132020|NCT01853878|589191073|FG001|Overall Study|Adverse Event|0|||
163132021|NCT01853878|589191072|FG000|Overall Study|Withdrawal by Subject|3|||
163132022|NCT01853878|589191073|FG001|Overall Study|Withdrawal by Subject|1|||
163132023|NCT01853878|589191072|FG000|Overall Study|Migrated/moved from the study area|1|||
163132024|NCT01853878|589191073|FG001|Overall Study|Migrated/moved from the study area|0|||
163132025|NCT01853878|589191072|FG000|Overall Study|Other|55|||
163132026|NCT01853878|589191073|FG001|Overall Study|Other|43|||
163132027|NCT01846741|589191074|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
163132028|NCT01361178|589191075|FG000|Overall Study|Death|13|||
163132029|NCT01361178|589191076|FG001|Overall Study|Death|0|||
163132030|NCT04294147|589191079|FG000|Overall Study|Protocol Violation|2|||
163132031|NCT04294147|589191080|FG001|Overall Study|Protocol Violation|0|||
163132032|NCT01371305|589191088|FG000|Overall Study|Adverse Event|0|||
163132033|NCT01371305|589191089|FG001|Overall Study|Adverse Event|0|||
163132034|NCT01371305|589191090|FG002|Overall Study|Adverse Event|0|||
163132035|NCT01371305|589191091|FG003|Overall Study|Adverse Event|2|||
163132036|NCT01371305|589191092|FG004|Overall Study|Adverse Event|1|||
163132037|NCT01371305|589191093|FG005|Overall Study|Adverse Event|0|||
163132038|NCT01371305|589191088|FG000|Overall Study|Study terminated by sponsor|0|||
163132039|NCT01371305|589191089|FG001|Overall Study|Study terminated by sponsor|0|||
163132040|NCT01371305|589191090|FG002|Overall Study|Study terminated by sponsor|0|||
163132041|NCT01371305|589191091|FG003|Overall Study|Study terminated by sponsor|0|||
163132042|NCT01371305|589191092|FG004|Overall Study|Study terminated by sponsor|3|||
163132043|NCT01371305|589191093|FG005|Overall Study|Study terminated by sponsor|1|||
163132044|NCT01371305|589191088|FG000|Overall Study|Subject request|0|||
163132045|NCT01371305|589191089|FG001|Overall Study|Subject request|0|||
163132046|NCT01371305|589191090|FG002|Overall Study|Subject request|0|||
163132047|NCT01371305|589191091|FG003|Overall Study|Subject request|0|||
163132048|NCT01371305|589191092|FG004|Overall Study|Subject request|0|||
163132049|NCT01371305|589191093|FG005|Overall Study|Subject request|1|||
163132050|NCT04038567|589191094|FG000|Overall Study|Lost to Follow-up|6|||
163132051|NCT04038567|589191095|FG001|Overall Study|Lost to Follow-up|4|||
163132052|NCT04038567|589191096|FG002|Overall Study|Lost to Follow-up|5|||
163132053|NCT04038567|589191097|FG003|Overall Study|Lost to Follow-up|4|||
163132054|NCT04038567|589191098|FG004|Overall Study|Lost to Follow-up|6|||
163132055|NCT04038567|589191099|FG005|Overall Study|Lost to Follow-up|4|||
163132056|NCT04038567|589191100|FG006|Overall Study|Lost to Follow-up|4|||
163132057|NCT04038567|589191101|FG007|Overall Study|Lost to Follow-up|1|||
163132058|NCT04038567|589191094|FG000|Overall Study|Withdrawal by Subject|2|||
163132059|NCT04038567|589191095|FG001|Overall Study|Withdrawal by Subject|1|||
163344202|NCT02058992|589968452|FG000|Overall Study|CRF Uncollected|20|||
163344203|NCT02991456|589968453|FG000|Overall Study|Adverse Event|2|||
163344204|NCT02991456|589968454|FG001|Overall Study|Adverse Event|0|||
163132060|NCT04038567|589191096|FG002|Overall Study|Withdrawal by Subject|1|||
163132061|NCT04038567|589191097|FG003|Overall Study|Withdrawal by Subject|1|||
163132062|NCT04038567|589191098|FG004|Overall Study|Withdrawal by Subject|4|||
163132063|NCT04038567|589191099|FG005|Overall Study|Withdrawal by Subject|1|||
163132064|NCT04038567|589191100|FG006|Overall Study|Withdrawal by Subject|1|||
163344205|NCT02991456|589968453|FG000|Overall Study|Lost to Follow-up|0|||
163344206|NCT02991456|589968454|FG001|Overall Study|Lost to Follow-up|2|||
163344207|NCT02991456|589968453|FG000|Overall Study|Withdrawal by Subject|1|||
163344208|NCT02991456|589968454|FG001|Overall Study|Withdrawal by Subject|0|||
163344209|NCT03689452|589968456|FG000|Overall Study|Lost to Follow-up|1|||
163344210|NCT03689452|589968457|FG001|Overall Study|Lost to Follow-up|1|||
163344211|NCT00525915|589968458|FG000|Overall Study|Non-Compliance|0|||
163344212|NCT00525915|589968459|FG001|Overall Study|Non-Compliance|1|||
163344213|NCT00525915|589968458|FG000|Overall Study|Disease Progression|5|||
163344214|NCT00525915|589968459|FG001|Overall Study|Disease Progression|6|||
163344215|NCT00525915|589968458|FG000|Overall Study|Withdrawal by Subject|1|||
163344216|NCT00525915|589968459|FG001|Overall Study|Withdrawal by Subject|0|||
163344217|NCT00525915|589968458|FG000|Overall Study|Refused Surgery|1|||
163344218|NCT00525915|589968459|FG001|Overall Study|Refused Surgery|2|||
163344219|NCT00525915|589968458|FG000|Overall Study|Unrelated illness|1|||
163344220|NCT00525915|589968459|FG001|Overall Study|Unrelated illness|0|||
163344221|NCT00267865|589968462|FG000|Induction Treatment|Died before completing.|2|||
163344222|NCT00267865|589968462|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
163344223|NCT01755598|589968466|FG000|Overall Study|Other|109|||
163344224|NCT01755598|589968467|FG001|Overall Study|Other|109|||
163344225|NCT01755598|589968466|FG000|Overall Study|Lost to Follow-up|32|||
163344226|NCT01755598|589968467|FG001|Overall Study|Lost to Follow-up|43|||
163344227|NCT01755598|589968466|FG000|Overall Study|Migrated/moved from study area|76|||
163344228|NCT01755598|589968467|FG001|Overall Study|Migrated/moved from study area|65|||
163344229|NCT01755598|589968466|FG000|Overall Study|Withdrawal by Subject|22|||
163344230|NCT01755598|589968467|FG001|Overall Study|Withdrawal by Subject|31|||
163344231|NCT01755598|589968466|FG000|Overall Study|Protocol Violation|7|||
163344232|NCT01755598|589968467|FG001|Overall Study|Protocol Violation|7|||
163344233|NCT01755598|589968466|FG000|Overall Study|Adverse Event|19|||
163344234|NCT01755598|589968467|FG001|Overall Study|Adverse Event|28|||
163344235|NCT02332889|589968468|FG000|Overall Study|Physician Decision|1|||
163344236|NCT02135445|589968469|FG000|Overall Study|Lost to Follow-up|1|||
163344237|NCT02135445|589968470|FG001|Overall Study|Lost to Follow-up|0|||
163344238|NCT02135445|589968469|FG000|Overall Study|Withdrawal by Subject|1|||
163344239|NCT02135445|589968470|FG001|Overall Study|Withdrawal by Subject|0|||
163344240|NCT02819141|589968471|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
163344241|NCT02819141|589968472|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
163344242|NCT00635570|589969956|FG000|Overall Study|Lost to Follow-up|8|||
163344243|NCT00635570|589969957|FG001|Overall Study|Lost to Follow-up|8|||
163344244|NCT00635570|589969956|FG000|Overall Study|Withdrawal by Subject|1|||
163344245|NCT00635570|589969957|FG001|Overall Study|Withdrawal by Subject|1|||
163344246|NCT00635570|589969956|FG000|Overall Study|Adverse Event|2|||
163344247|NCT00635570|589969957|FG001|Overall Study|Adverse Event|0|||
163344248|NCT00635570|589969956|FG000|Overall Study|Physician Decision|1|||
163132065|NCT04038567|589191101|FG007|Overall Study|Withdrawal by Subject|1|||
163132066|NCT04038567|589191094|FG000|Overall Study|missed survey window|1|||
163132067|NCT04038567|589191095|FG001|Overall Study|missed survey window|2|||
163132068|NCT04038567|589191096|FG002|Overall Study|missed survey window|0|||
163132069|NCT04038567|589191097|FG003|Overall Study|missed survey window|0|||
163132070|NCT04038567|589191098|FG004|Overall Study|missed survey window|1|||
163132071|NCT04038567|589191099|FG005|Overall Study|missed survey window|1|||
163132072|NCT04038567|589191100|FG006|Overall Study|missed survey window|2|||
163132073|NCT04038567|589191101|FG007|Overall Study|missed survey window|2|||
163132074|NCT04038567|589191094|FG000|Overall Study|technical issues|0|||
163132075|NCT04038567|589191095|FG001|Overall Study|technical issues|0|||
163132076|NCT04038567|589191096|FG002|Overall Study|technical issues|0|||
163132077|NCT04038567|589191097|FG003|Overall Study|technical issues|0|||
163132078|NCT04038567|589191098|FG004|Overall Study|technical issues|0|||
163132079|NCT04038567|589191099|FG005|Overall Study|technical issues|0|||
163132080|NCT04038567|589191100|FG006|Overall Study|technical issues|1|||
163132081|NCT04038567|589191101|FG007|Overall Study|technical issues|0|||
163132082|NCT04038567|589191094|FG000|Overall Study|Medical issues (i.e., illness)|0|||
163132083|NCT04038567|589191095|FG001|Overall Study|Medical issues (i.e., illness)|1|||
163132084|NCT04038567|589191096|FG002|Overall Study|Medical issues (i.e., illness)|2|||
163132085|NCT04038567|589191097|FG003|Overall Study|Medical issues (i.e., illness)|1|||
163132086|NCT04038567|589191098|FG004|Overall Study|Medical issues (i.e., illness)|1|||
163132087|NCT04038567|589191099|FG005|Overall Study|Medical issues (i.e., illness)|1|||
163132088|NCT04038567|589191100|FG006|Overall Study|Medical issues (i.e., illness)|0|||
163344249|NCT00635570|589969957|FG001|Overall Study|Physician Decision|0|||
163344250|NCT00635570|589969956|FG000|Overall Study|Did not complete survey|2|||
163344251|NCT00635570|589969957|FG001|Overall Study|Did not complete survey|1|||
163344252|NCT00635570|589969956|FG000|Overall Study|Early termination(No sexual activity)|1|||
163344253|NCT00635570|589969957|FG001|Overall Study|Early termination(No sexual activity)|1|||
163344254|NCT02176356|589969958|FG000|Overall Study|Screen Failure|14|||
163344255|NCT02176356|589969958|FG000|Overall Study|Lost to Follow-up|4|||
163344256|NCT02176356|589969958|FG000|Overall Study|Personal Reasons|3|||
163132089|NCT04038567|589191101|FG007|Overall Study|Medical issues (i.e., illness)|0|||
163227897|NCT02346240|589548018|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227898|NCT02346240|589548019|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163344257|NCT02176356|589969958|FG000|Overall Study|Other Miscellaneous Reasons|2|||
163344258|NCT00381888|589969959|FG000|Overall Study|Death|1|||
163344259|NCT00381888|589969959|FG000|Overall Study|Withdrawal by Subject|1|||
163344260|NCT00381888|589969959|FG000|Overall Study|Physician Decision|1|||
163344261|NCT00381888|589969959|FG000|Overall Study|Protocol Violation|9|||
163344262|NCT00381888|589969959|FG000|Overall Study|Had laparoscopic surgery|2|||
163344263|NCT00381888|589969959|FG000|Overall Study|Surgery was cancelled|2|||
163344264|NCT00381888|589969959|FG000|Overall Study|Adverse Event|1|||
163344265|NCT02255435|589969963|FG000|Overall Study|Patient's Limited Time Availability|0|||
163344266|NCT02255435|589969964|FG001|Overall Study|Patient's Limited Time Availability|0|||
163344267|NCT02255435|589969965|FG002|Overall Study|Patient's Limited Time Availability|0|||
163344268|NCT02255435|589969966|FG003|Overall Study|Patient's Limited Time Availability|0|||
163344269|NCT02255435|589969967|FG004|Overall Study|Patient's Limited Time Availability|0|||
163344270|NCT02255435|589969968|FG005|Overall Study|Patient's Limited Time Availability|0|||
163344271|NCT02255435|589969969|FG006|Overall Study|Patient's Limited Time Availability|0|||
163344272|NCT02255435|589969970|FG007|Overall Study|Patient's Limited Time Availability|1|||
163344273|NCT02255435|589969971|FG008|Overall Study|Patient's Limited Time Availability|0|||
163344274|NCT02255435|589969972|FG009|Overall Study|Patient's Limited Time Availability|0|||
163344275|NCT02255435|589969963|FG000|Overall Study|Withdrawal by Subject|0|||
163344276|NCT02255435|589969964|FG001|Overall Study|Withdrawal by Subject|0|||
163344277|NCT02255435|589969965|FG002|Overall Study|Withdrawal by Subject|0|||
163344278|NCT02255435|589969966|FG003|Overall Study|Withdrawal by Subject|0|||
163344279|NCT02255435|589969967|FG004|Overall Study|Withdrawal by Subject|0|||
163344280|NCT02255435|589969968|FG005|Overall Study|Withdrawal by Subject|0|||
163344281|NCT02255435|589969969|FG006|Overall Study|Withdrawal by Subject|0|||
163344282|NCT02255435|589969970|FG007|Overall Study|Withdrawal by Subject|0|||
163344283|NCT02255435|589969971|FG008|Overall Study|Withdrawal by Subject|1|||
163344284|NCT02255435|589969972|FG009|Overall Study|Withdrawal by Subject|4|||
163344285|NCT02255435|589969963|FG000|Overall Study|Administrative reasons|0|||
163344286|NCT02255435|589969964|FG001|Overall Study|Administrative reasons|0|||
163344287|NCT02255435|589969965|FG002|Overall Study|Administrative reasons|0|||
163344288|NCT02255435|589969966|FG003|Overall Study|Administrative reasons|0|||
163344289|NCT02255435|589969967|FG004|Overall Study|Administrative reasons|0|||
163344290|NCT02255435|589969968|FG005|Overall Study|Administrative reasons|0|||
163344291|NCT02255435|589969969|FG006|Overall Study|Administrative reasons|0|||
163344292|NCT02255435|589969970|FG007|Overall Study|Administrative reasons|0|||
163344293|NCT02255435|589969971|FG008|Overall Study|Administrative reasons|0|||
163344294|NCT02255435|589969972|FG009|Overall Study|Administrative reasons|2|||
163344295|NCT01809691|589969973|FG000|Overall Study|Currently on Treatment|192|||
163344296|NCT01809691|589969974|FG001|Overall Study|Currently on Treatment|100|||
163344297|NCT01809691|589969973|FG000|Overall Study|No Protocol Treatment|10|||
163227899|NCT02346240|589548020|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227900|NCT02346240|589548021|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227901|NCT02346240|589548022|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227902|NCT02346240|589548023|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227903|NCT02346240|589548024|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227904|NCT02346240|589548025|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227905|NCT02346240|589548026|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227906|NCT02346240|589548027|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227907|NCT02346240|589548028|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227908|NCT02346240|589548029|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227909|NCT02346240|589548030|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227910|NCT02346240|589548031|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227911|NCT02346240|589548032|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227912|NCT02346240|589548033|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163344298|NCT01809691|589969974|FG001|Overall Study|No Protocol Treatment|11|||
163344299|NCT01809691|589969973|FG000|Overall Study|Adverse Event|80|||
163344300|NCT01809691|589969974|FG001|Overall Study|Adverse Event|21|||
163227913|NCT02346240|589548034|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227914|NCT02346240|589548035|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163227915|NCT02346240|589548036|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163344301|NCT01809691|589969973|FG000|Overall Study|Disease Progression|226|||
163344302|NCT01809691|589969974|FG001|Overall Study|Disease Progression|372|||
163344303|NCT01809691|589969973|FG000|Overall Study|Death|26|||
163344304|NCT01809691|589969974|FG001|Overall Study|Death|13|||
163344305|NCT01809691|589969973|FG000|Overall Study|Participant Refusal|70|||
163344306|NCT01809691|589969974|FG001|Overall Study|Participant Refusal|72|||
163344307|NCT01809691|589969973|FG000|Overall Study|Other, Not Specified|34|||
163344308|NCT01809691|589969974|FG001|Overall Study|Other, Not Specified|52|||
163132090|NCT04038567|589191094|FG000|Overall Study|Death|0|||
163132091|NCT04038567|589191095|FG001|Overall Study|Death|0|||
163132092|NCT04038567|589191096|FG002|Overall Study|Death|0|||
163132093|NCT04038567|589191097|FG003|Overall Study|Death|1|||
163132094|NCT04038567|589191098|FG004|Overall Study|Death|1|||
163132095|NCT04038567|589191099|FG005|Overall Study|Death|0|||
163132096|NCT04038567|589191100|FG006|Overall Study|Death|0|||
163132097|NCT04038567|589191101|FG007|Overall Study|Death|1|||
163132098|NCT02726022|589191102|FG000|Overall Study|Adverse Event|14|||
163132099|NCT02726022|589191102|FG000|Overall Study|Treatment Failure|8|||
163132100|NCT02726022|589191102|FG000|Overall Study|Poor Compliance|13|||
163132101|NCT02726022|589191102|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
163132102|NCT02999633|589191103|FG000|Overall Study|Adverse Event|2|||
163132103|NCT02999633|589191103|FG000|Overall Study|Progressive disease|12|||
163132104|NCT02456857|589191108|FG000|Overall Study|Disease Progression|4|||
163132105|NCT00781859|589191109|FG000|Overall Study|Adverse Event|2|||
163132106|NCT00781859|589191110|FG001|Overall Study|Adverse Event|2|||
163132107|NCT00781859|589191109|FG000|Overall Study|Withdrawal by Subject|8|||
163132108|NCT00781859|589191110|FG001|Overall Study|Withdrawal by Subject|4|||
163132109|NCT00781859|589191109|FG000|Overall Study|Lost to Follow-up|6|||
163132110|NCT00781859|589191110|FG001|Overall Study|Lost to Follow-up|3|||
163132111|NCT00781859|589191109|FG000|Overall Study|Death|3|||
163132112|NCT00781859|589191110|FG001|Overall Study|Death|0|||
163132113|NCT01138501|589191111|FG000|Overall Study|Protocol Violation|2|||
163132114|NCT01138501|589191111|FG000|Overall Study|Withdrawal by Subject|3|||
163132115|NCT01220180|589191113|FG000|Overall Study|Lost to Follow-up|76|||
163132116|NCT01220180|589191113|FG000|Overall Study|Other|72|||
163132117|NCT01220180|589191113|FG000|Overall Study|Adverse Event|35|||
163132118|NCT01220180|589191113|FG000|Overall Study|Lack of Efficacy|22|||
163132119|NCT01220180|589191113|FG000|Overall Study|Death|1|||
163132120|NCT01220180|589191113|FG000|Overall Study|Randomized but not treated|1|||
163132121|NCT01990859|589191114|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
163132122|NCT01990859|589191114|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
163132123|NCT00348309|589191115|FG000|Overall Study|Adverse Event|56|||
163132124|NCT00348309|589191116|FG001|Overall Study|Adverse Event|28|||
163132125|NCT00348309|589191117|FG002|Overall Study|Adverse Event|63|||
163132126|NCT00348309|589191115|FG000|Overall Study|Lost to Follow-up|6|||
163132127|NCT00348309|589191116|FG001|Overall Study|Lost to Follow-up|7|||
163132128|NCT00348309|589191117|FG002|Overall Study|Lost to Follow-up|4|||
163132129|NCT00348309|589191115|FG000|Overall Study|Protocol Violation|7|||
163132130|NCT00348309|589191116|FG001|Overall Study|Protocol Violation|12|||
163132131|NCT00348309|589191117|FG002|Overall Study|Protocol Violation|7|||
163132132|NCT00348309|589191115|FG000|Overall Study|Withdrawal by Subject|33|||
163132133|NCT00348309|589191116|FG001|Overall Study|Withdrawal by Subject|37|||
163132134|NCT00348309|589191117|FG002|Overall Study|Withdrawal by Subject|40|||
163132135|NCT00348309|589191115|FG000|Overall Study|Non-compliance|8|||
163132136|NCT00348309|589191116|FG001|Overall Study|Non-compliance|6|||
163132137|NCT00348309|589191117|FG002|Overall Study|Non-compliance|8|||
163132138|NCT00348309|589191115|FG000|Overall Study|Death of caregiver|1|||
163132139|NCT00348309|589191116|FG001|Overall Study|Death of caregiver|0|||
163132140|NCT00348309|589191117|FG002|Overall Study|Death of caregiver|1|||
163132141|NCT00348309|589191115|FG000|Overall Study|Lack of insight, dementia|1|||
163132142|NCT00348309|589191116|FG001|Overall Study|Lack of insight, dementia|0|||
163132143|NCT00348309|589191117|FG002|Overall Study|Lack of insight, dementia|0|||
163132144|NCT00348309|589191115|FG000|Overall Study|Wrong bottle allocated|1|||
163132145|NCT00348309|589191116|FG001|Overall Study|Wrong bottle allocated|0|||
163132146|NCT00348309|589191117|FG002|Overall Study|Wrong bottle allocated|0|||
163132147|NCT00348309|589191115|FG000|Overall Study|Caregiver sick|1|||
163132148|NCT00348309|589191116|FG001|Overall Study|Caregiver sick|0|||
163132149|NCT00348309|589191117|FG002|Overall Study|Caregiver sick|0|||
163132150|NCT00348309|589191115|FG000|Overall Study|Use of prohibited medication|5|||
163132151|NCT00348309|589191116|FG001|Overall Study|Use of prohibited medication|2|||
163132152|NCT00348309|589191117|FG002|Overall Study|Use of prohibited medication|2|||
163132153|NCT00348309|589191115|FG000|Overall Study|Caregiver withdrawal|3|||
163132154|NCT00348309|589191116|FG001|Overall Study|Caregiver withdrawal|0|||
163132155|NCT00348309|589191117|FG002|Overall Study|Caregiver withdrawal|7|||
163132156|NCT00348309|589191115|FG000|Overall Study|Unable to complete ET visit|1|||
163132157|NCT00348309|589191116|FG001|Overall Study|Unable to complete ET visit|0|||
163132158|NCT00348309|589191117|FG002|Overall Study|Unable to complete ET visit|0|||
163344309|NCT03694210|589969975|FG000|Overall Study|Death|1|||
163344310|NCT03694210|589969975|FG000|Overall Study|Screen Failure|7|||
163344311|NCT00907517|589969980|FG000|Overall Study|Progressive Disease|3|||
163344312|NCT00907517|589969981|FG001|Overall Study|Progressive Disease|3|||
163132159|NCT00348309|589191115|FG000|Overall Study|PI closing medical practice|1|||
163132160|NCT00348309|589191116|FG001|Overall Study|PI closing medical practice|0|||
163132161|NCT00348309|589191117|FG002|Overall Study|PI closing medical practice|0|||
163344313|NCT00907517|589969982|FG002|Overall Study|Progressive Disease|4|||
163132162|NCT00348309|589191115|FG000|Overall Study|Principal investigator's decision|1|||
163344314|NCT00907517|589969983|FG003|Overall Study|Progressive Disease|4|||
163132163|NCT00348309|589191116|FG001|Overall Study|Principal investigator's decision|0|||
163132164|NCT00348309|589191117|FG002|Overall Study|Principal investigator's decision|0|||
163132165|NCT00348309|589191115|FG000|Overall Study|No disponibility of medication|1|||
163132166|NCT00348309|589191116|FG001|Overall Study|No disponibility of medication|0|||
163132167|NCT00348309|589191117|FG002|Overall Study|No disponibility of medication|0|||
163132168|NCT00348309|589191115|FG000|Overall Study|Worsened neurodegenerative disease|1|||
163132169|NCT00348309|589191116|FG001|Overall Study|Worsened neurodegenerative disease|0|||
163344315|NCT00907517|589969984|FG004|Overall Study|Progressive Disease|4|||
163344316|NCT00907517|589969980|FG000|Overall Study|Symptomatic Deterioration|0|||
163344317|NCT00907517|589969981|FG001|Overall Study|Symptomatic Deterioration|0|||
163344318|NCT00907517|589969982|FG002|Overall Study|Symptomatic Deterioration|0|||
163344319|NCT00907517|589969983|FG003|Overall Study|Symptomatic Deterioration|0|||
163344320|NCT00907517|589969984|FG004|Overall Study|Symptomatic Deterioration|1|||
163344321|NCT02475733|589970007|FG000|Overall Study|Withdrawal by Subject|1|||
163344322|NCT02475733|589970008|FG001|Overall Study|Withdrawal by Subject|0|||
163344323|NCT02475733|589970007|FG000|Overall Study|Physician Decision|1|||
163344324|NCT02475733|589970008|FG001|Overall Study|Physician Decision|0|||
163344325|NCT02131155|589970009|FG000|Overall Study|Adverse Event|1|||
163344326|NCT02131155|589970010|FG001|Overall Study|Adverse Event|0|||
163344327|NCT02131155|589970009|FG000|Overall Study|Treatment completed|1|||
163344328|NCT02131155|589970010|FG001|Overall Study|Treatment completed|0|||
163344329|NCT02131155|589970009|FG000|Overall Study|Primary tumour recurrence|2|||
163344330|NCT02131155|589970010|FG001|Overall Study|Primary tumour recurrence|1|||
163344331|NCT02131155|589970009|FG000|Overall Study|Refused to continue study medication|1|||
163344332|NCT02131155|589970010|FG001|Overall Study|Refused to continue study medication|0|||
163344333|NCT02131155|589970009|FG000|Overall Study|Study early termination|20|||
163344334|NCT02131155|589970010|FG001|Overall Study|Study early termination|10|||
163344335|NCT01887418|589970011|FG000|Overall Study|Travelling difficulties|0|||
163344336|NCT01887418|589970012|FG001|Overall Study|Travelling difficulties|0|||
163344337|NCT01887418|589970013|FG002|Overall Study|Travelling difficulties|1|||
163344338|NCT01014013|589970016|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
163344339|NCT01014013|589970017|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
163344340|NCT01014013|589970016|FG000|Overall Study|Clinical adverse experience|4|||
163344341|NCT01014013|589970017|FG001|Overall Study|Clinical adverse experience|2|||
163344342|NCT01014013|589970016|FG000|Overall Study|Laboratory adverse experience|1|||
163344343|NCT01014013|589970017|FG001|Overall Study|Laboratory adverse experience|1|||
163344344|NCT01014013|589970016|FG000|Overall Study|Protocol Violation|1|||
163344345|NCT01014013|589970017|FG001|Overall Study|Protocol Violation|3|||
163344346|NCT01014013|589970016|FG000|Overall Study|Withdrawal by Subject|7|||
163344347|NCT01014013|589970017|FG001|Overall Study|Withdrawal by Subject|4|||
163344348|NCT01014013|589970016|FG000|Overall Study|Clinical/microbiologic failure|1|||
163344349|NCT01014013|589970017|FG001|Overall Study|Clinical/microbiologic failure|2|||
163344350|NCT01014013|589970016|FG000|Overall Study|Pathogen culture = no growth|26|||
163344351|NCT01014013|589970017|FG001|Overall Study|Pathogen culture = no growth|34|||
163344352|NCT01014013|589970016|FG000|Overall Study|Negative urine culture|2|||
163344353|NCT01014013|589970017|FG001|Overall Study|Negative urine culture|0|||
163344354|NCT01014013|589970016|FG000|Overall Study|Pathogen resistant|7|||
163344355|NCT01014013|589970017|FG001|Overall Study|Pathogen resistant|4|||
163344356|NCT01014013|589970016|FG000|Overall Study|Physician Decision|0|||
163344357|NCT01014013|589970017|FG001|Overall Study|Physician Decision|1|||
163344358|NCT01014013|589970016|FG000|Overall Study|Another antibiotic therapy required|0|||
163344359|NCT01014013|589970017|FG001|Overall Study|Another antibiotic therapy required|1|||
163344360|NCT01014013|589970016|FG000|Overall Study|Appendectomy|1|||
163344361|NCT01014013|589970017|FG001|Overall Study|Appendectomy|0|||
163344362|NCT01014013|589970016|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
163344363|NCT01014013|589970017|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
163344364|NCT00442559|589970024|FG000|Overall Study|Lost to Follow-up|32|||
163344365|NCT00442559|589970025|FG001|Overall Study|Lost to Follow-up|34|||
163344366|NCT00442559|589970024|FG000|Overall Study|Protocol Violation|1|||
163344367|NCT00442559|589970025|FG001|Overall Study|Protocol Violation|1|||
163344368|NCT00442559|589970024|FG000|Overall Study|Withdrawal by Subject|1|||
163344369|NCT00442559|589970025|FG001|Overall Study|Withdrawal by Subject|0|||
163344370|NCT03906240|589970026|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
163344371|NCT03906240|589970027|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
163344372|NCT03906240|589970026|FG000|Overall Study|Lost to Follow-up|1|||
163344373|NCT03906240|589970027|FG001|Overall Study|Lost to Follow-up|0|||
163344374|NCT03906240|589970026|FG000|Overall Study|Withdrawal by Subject|0|||
163344375|NCT03906240|589970027|FG001|Overall Study|Withdrawal by Subject|1|||
163344376|NCT03575572|589970028|FG000|Overall Study|Withdrawal by Subject|2|||
163344377|NCT03575572|589970028|FG000|Overall Study|Physician Decision|2|||
163227916|NCT02346240|589548037|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
163344378|NCT03647709|589970030|FG000|Overall Study|Lost to Follow-up|5|||
163344379|NCT03647709|589970030|FG000|Overall Study|Physician Decision|6|||
163344380|NCT03647709|589970030|FG000|Overall Study|Withdrawal by Subject|3|||
163344381|NCT05287178|589970031|FG000|Overall Study|Lost to Follow-up|2|||
163344382|NCT01426217|589970032|FG000|Overall Study|lost sample|8|||
163344383|NCT01426217|589970033|FG001|Overall Study|lost sample|14|||
163344384|NCT01920178|589970034|FG000|Overall Study|Lost to Follow-up|2|||
163344385|NCT01920178|589970035|FG001|Overall Study|Lost to Follow-up|1|||
163344386|NCT03023878|589970036|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
163344387|NCT03023878|589970036|FG000|Pre-Study Run-In Period|Death|1|||
163344388|NCT03023878|589970036|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
163344389|NCT03023878|589970036|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
163344390|NCT03023878|589970036|FG000|Treatment Period|Disease Progression|1|||
163344391|NCT03023878|589970036|FG000|Treatment Period|Withdrawal by Subject|1|||
163344392|NCT03023878|589970036|FG000|Treatment Period|Adverse Event|1|||
163344393|NCT03023878|589970036|FG000|Long Term Follow-Up Period|Death|2|||
163344394|NCT01812837|589970037|FG000|Overall Study|Lost to Follow-up|1|||
163344395|NCT01812837|589970038|FG001|Overall Study|Lost to Follow-up|1|||
163344396|NCT01812837|589970039|FG002|Overall Study|Lost to Follow-up|0|||
163344397|NCT01812837|589970037|FG000|Overall Study|Protocol Violation|1|||
163344398|NCT01812837|589970038|FG001|Overall Study|Protocol Violation|0|||
163344399|NCT01812837|589970039|FG002|Overall Study|Protocol Violation|0|||
163344400|NCT00288353|589970044|FG000|Overall Study|Lack of Efficacy|2|||
163344401|NCT00288353|589970045|FG001|Overall Study|Lack of Efficacy|2|||
163344402|NCT00288353|589970044|FG000|Overall Study|Withdrawal by Subject|5|||
163344403|NCT00288353|589970045|FG001|Overall Study|Withdrawal by Subject|5|||
163344404|NCT05234632|589970046|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
163344405|NCT05234632|589970047|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
163344406|NCT05234632|589970046|FG000|Overall Study|Withdrawal by Subject|2|||
163344407|NCT05234632|589970047|FG001|Overall Study|Withdrawal by Subject|0|||
163344408|NCT05234632|589970046|FG000|Overall Study|Adverse Event|0|||
163344409|NCT05234632|589970047|FG001|Overall Study|Adverse Event|4|||
163344410|NCT05234632|589970046|FG000|Overall Study|Physician Decision|1|||
163344411|NCT05234632|589970047|FG001|Overall Study|Physician Decision|1|||
163344412|NCT05234632|589970046|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
163344413|NCT05234632|589970047|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
163344414|NCT05234632|589970046|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
163344415|NCT05234632|589970047|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
163344416|NCT04799587|589970048|FG000|Overall Study|Withdrawal by Subject|0|||
163344417|NCT04799587|589970049|FG001|Overall Study|Withdrawal by Subject|1|||
163344418|NCT00728884|589970050|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
163344419|NCT00728884|589970050|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
163344420|NCT05216835|589970052|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
163344421|NCT05216835|589970053|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
163344422|NCT05216835|589970054|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
163344423|NCT05216835|589970055|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
163344424|NCT05216835|589970056|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
163344425|NCT05216835|589970057|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
163344426|NCT05216835|589970058|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
163344427|NCT05216835|589970059|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
163344428|NCT05216835|589970052|FG000|Overall Study|Death|0|||
163344429|NCT05216835|589970053|FG001|Overall Study|Death|0|||
163344430|NCT05216835|589970054|FG002|Overall Study|Death|0|||
163344431|NCT05216835|589970055|FG003|Overall Study|Death|1|||
163344432|NCT05216835|589970056|FG004|Overall Study|Death|1|||
163344433|NCT05216835|589970057|FG005|Overall Study|Death|1|||
163344434|NCT05216835|589970058|FG006|Overall Study|Death|1|||
163344435|NCT05216835|589970059|FG007|Overall Study|Death|1|||
163344436|NCT05216835|589970052|FG000|Overall Study|Physician Decision|0|||
163344437|NCT05216835|589970053|FG001|Overall Study|Physician Decision|0|||
163344438|NCT05216835|589970054|FG002|Overall Study|Physician Decision|0|||
163344439|NCT05216835|589970055|FG003|Overall Study|Physician Decision|0|||
163344440|NCT05216835|589970056|FG004|Overall Study|Physician Decision|0|||
163344441|NCT05216835|589970057|FG005|Overall Study|Physician Decision|1|||
163344442|NCT05216835|589970058|FG006|Overall Study|Physician Decision|1|||
163344443|NCT05216835|589970059|FG007|Overall Study|Physician Decision|0|||
163344444|NCT05216835|589970052|FG000|Overall Study|Study terminated by Sponsor|0|||
163344445|NCT05216835|589970053|FG001|Overall Study|Study terminated by Sponsor|0|||
163344446|NCT05216835|589970054|FG002|Overall Study|Study terminated by Sponsor|0|||
163344447|NCT05216835|589970055|FG003|Overall Study|Study terminated by Sponsor|0|||
163344448|NCT05216835|589970056|FG004|Overall Study|Study terminated by Sponsor|0|||
163344449|NCT05216835|589970057|FG005|Overall Study|Study terminated by Sponsor|0|||
163344450|NCT05216835|589970058|FG006|Overall Study|Study terminated by Sponsor|0|||
163344451|NCT05216835|589970059|FG007|Overall Study|Study terminated by Sponsor|1|||
163344452|NCT05216835|589970052|FG000|Overall Study|Withdrawal by Subject|1|||
163344453|NCT05216835|589970053|FG001|Overall Study|Withdrawal by Subject|0|||
163344454|NCT05216835|589970054|FG002|Overall Study|Withdrawal by Subject|1|||
163408428|NCT01485627|590205515|FG000|Overall Study|Patient withdrew|6|||
163408429|NCT01485627|590205516|FG001|Overall Study|Patient withdrew|5|||
163344455|NCT05216835|589970055|FG003|Overall Study|Withdrawal by Subject|0|||
163344456|NCT05216835|589970056|FG004|Overall Study|Withdrawal by Subject|1|||
163344457|NCT05216835|589970057|FG005|Overall Study|Withdrawal by Subject|0|||
163344458|NCT05216835|589970058|FG006|Overall Study|Withdrawal by Subject|0|||
163344459|NCT05216835|589970059|FG007|Overall Study|Withdrawal by Subject|1|||
163344460|NCT05216835|589970052|FG000|Overall Study|Other|0|||
163344461|NCT05216835|589970053|FG001|Overall Study|Other|1|||
163344462|NCT05216835|589970054|FG002|Overall Study|Other|0|||
163344463|NCT05216835|589970055|FG003|Overall Study|Other|0|||
163344464|NCT05216835|589970056|FG004|Overall Study|Other|0|||
163344465|NCT05216835|589970057|FG005|Overall Study|Other|0|||
163344466|NCT05216835|589970058|FG006|Overall Study|Other|0|||
163344467|NCT05216835|589970059|FG007|Overall Study|Other|0|||
163344468|NCT02849509|589970060|FG000|Overall Study|Worsening of disease under study|1|||
163344469|NCT02849509|589970061|FG001|Overall Study|Worsening of disease under study|1|||
163344470|NCT02849509|589970062|FG002|Overall Study|Worsening of disease under study|1|||
163344471|NCT02849509|589970060|FG000|Overall Study|Worsening of other pre-existing disease|0|||
163344472|NCT02849509|589970061|FG001|Overall Study|Worsening of other pre-existing disease|1|||
163344473|NCT02849509|589970062|FG002|Overall Study|Worsening of other pre-existing disease|2|||
163344474|NCT02849509|589970060|FG000|Overall Study|Other adverse event|36|||
163344475|NCT02849509|589970061|FG001|Overall Study|Other adverse event|41|||
163344476|NCT02849509|589970062|FG002|Overall Study|Other adverse event|8|||
163344477|NCT02849509|589970060|FG000|Overall Study|Withdrawal by Subject|6|||
163344478|NCT02849509|589970061|FG001|Overall Study|Withdrawal by Subject|17|||
163344479|NCT02849509|589970062|FG002|Overall Study|Withdrawal by Subject|12|||
163344480|NCT02849509|589970060|FG000|Overall Study|Lost to Follow-up|27|||
163344481|NCT02849509|589970061|FG001|Overall Study|Lost to Follow-up|67|||
163344482|NCT02849509|589970062|FG002|Overall Study|Lost to Follow-up|36|||
163344483|NCT02849509|589970060|FG000|Overall Study|Other, reason not specified|14|||
163344484|NCT02849509|589970061|FG001|Overall Study|Other, reason not specified|29|||
163344485|NCT02849509|589970062|FG002|Overall Study|Other, reason not specified|25|||
163344486|NCT02849509|589970060|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
163344487|NCT02849509|589970061|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
163344488|NCT02849509|589970062|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
163344489|NCT00617708|589970063|FG000|Overall Study|Adverse Event|0|||
163344490|NCT00617708|589970064|FG001|Overall Study|Adverse Event|6|||
163344491|NCT00617708|589970065|FG002|Overall Study|Adverse Event|9|||
163344492|NCT00617708|589970063|FG000|Overall Study|Withdrawal by Subject|1|||
163344493|NCT00617708|589970064|FG001|Overall Study|Withdrawal by Subject|1|||
163344494|NCT00617708|589970065|FG002|Overall Study|Withdrawal by Subject|7|||
163344495|NCT00617708|589970063|FG000|Overall Study|Death|0|||
163344496|NCT00617708|589970064|FG001|Overall Study|Death|6|||
163344497|NCT00617708|589970065|FG002|Overall Study|Death|5|||
163344498|NCT00617708|589970063|FG000|Overall Study|Progression/Relapse|7|||
163344499|NCT00617708|589970064|FG001|Overall Study|Progression/Relapse|40|||
163344500|NCT00617708|589970065|FG002|Overall Study|Progression/Relapse|36|||
163344501|NCT00617708|589970063|FG000|Overall Study|Not protocol specified|1|||
163344502|NCT00617708|589970064|FG001|Overall Study|Not protocol specified|4|||
163344503|NCT00617708|589970065|FG002|Overall Study|Not protocol specified|2|||
163344504|NCT00617708|589970063|FG000|Overall Study|Not eligible|1|||
163344505|NCT00617708|589970064|FG001|Overall Study|Not eligible|3|||
163344506|NCT00617708|589970065|FG002|Overall Study|Not eligible|5|||
163344507|NCT01075815|589970066|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
163344508|NCT01075815|589970067|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
163344509|NCT01075815|589970066|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
163344510|NCT01075815|589970067|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
163344511|NCT01075815|589970066|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
163344512|NCT01075815|589970067|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
163344513|NCT02374476|589970076|FG000|VT Induced Ablation|Screening Failures|36|||
163344514|NCT02374476|589970077|FG001|VT Induced Ablation|Screening Failures|0|||
163344515|NCT02374476|589970078|FG002|VT Induced Ablation|Screening Failures|0|||
163344516|NCT02374476|589970076|FG000|Arm Assignment|Withdrawal by Subject|0|||
163344517|NCT02374476|589970077|FG001|Arm Assignment|Withdrawal by Subject|0|||
163344518|NCT02374476|589970078|FG002|Arm Assignment|Withdrawal by Subject|1|||
163344519|NCT05431543|589970081|FG000|Overall Study|Medical History|1|||
163344520|NCT05431543|589970082|FG001|Overall Study|Medical History|0|||
163344521|NCT05431543|589970083|FG002|Overall Study|Medical History|0|||
163344522|NCT02924051|589970084|FG000|Overall Study|Withdrawal by Subject|1|||
163132170|NCT00348309|589191117|FG002|Overall Study|Worsened neurodegenerative disease|0|||
163132171|NCT00348309|589191115|FG000|Overall Study|Cognitive and behaviour worsening|2|||
163344523|NCT02924051|589970085|FG001|Overall Study|Withdrawal by Subject|9|||
163344524|NCT02784535|589970086|FG000|Overall Study|Adverse Event|1|||
163344525|NCT02784535|589970087|FG001|Overall Study|Adverse Event|0|||
163344526|NCT02784535|589970086|FG000|Overall Study|Withdrawal by Subject|0|||
163344527|NCT02784535|589970087|FG001|Overall Study|Withdrawal by Subject|1|||
163344528|NCT02784535|589970086|FG000|Overall Study|Physician Decision|0|||
163227917|NCT02346240|589548014|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227918|NCT02346240|589548015|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
163227919|NCT02346240|589548016|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227920|NCT02346240|589548017|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
163227921|NCT02346240|589548018|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227922|NCT02346240|589548019|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227923|NCT02346240|589548020|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227924|NCT02346240|589548021|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227925|NCT02346240|589548022|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227926|NCT02346240|589548023|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227927|NCT02346240|589548024|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227928|NCT02346240|589548025|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227929|NCT02346240|589548026|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227930|NCT02346240|589548027|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227931|NCT02346240|589548028|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227932|NCT02346240|589548029|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227933|NCT02346240|589548030|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227934|NCT02346240|589548031|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227935|NCT02346240|589548032|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227936|NCT02346240|589548033|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227937|NCT02346240|589548034|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227938|NCT02346240|589548035|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227939|NCT02346240|589548036|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227940|NCT02346240|589548037|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163227941|NCT02346240|589548014|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227942|NCT02346240|589548015|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227943|NCT02346240|589548016|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
163227944|NCT02346240|589548017|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227945|NCT02346240|589548018|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227946|NCT02346240|589548019|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227947|NCT02346240|589548020|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227948|NCT02346240|589548021|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227949|NCT02346240|589548022|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227950|NCT02346240|589548023|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227951|NCT02346240|589548024|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227952|NCT02346240|589548025|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227953|NCT02346240|589548026|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227954|NCT02346240|589548027|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227955|NCT02346240|589548028|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227956|NCT02346240|589548029|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227957|NCT02346240|589548030|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227958|NCT02346240|589548031|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227959|NCT02346240|589548032|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227960|NCT02346240|589548033|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227961|NCT02346240|589548034|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227962|NCT02346240|589548035|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227963|NCT02346240|589548036|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227964|NCT02346240|589548037|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163227965|NCT02346240|589548014|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227966|NCT02346240|589548015|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227967|NCT02346240|589548016|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227968|NCT02346240|589548017|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227969|NCT02346240|589548018|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227970|NCT02346240|589548019|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227971|NCT02346240|589548020|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227972|NCT02346240|589548021|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
163227973|NCT02346240|589548022|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
163344529|NCT02784535|589970087|FG001|Overall Study|Physician Decision|1|||
163344530|NCT00914732|589970088|FG000|Overall Study|Lost to Follow-up|6|||
163344531|NCT00914732|589970089|FG001|Overall Study|Lost to Follow-up|7|||
163344532|NCT00914732|589970090|FG002|Overall Study|Lost to Follow-up|9|||
163344533|NCT00914732|589970088|FG000|Overall Study|Withdrawal by Subject|3|||
163344534|NCT00914732|589970089|FG001|Overall Study|Withdrawal by Subject|0|||
163227974|NCT02346240|589548023|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163344535|NCT00914732|589970090|FG002|Overall Study|Withdrawal by Subject|2|||
163344536|NCT00914732|589970088|FG000|Overall Study|Adverse Event|1|||
163344537|NCT00914732|589970089|FG001|Overall Study|Adverse Event|0|||
163344538|NCT00914732|589970090|FG002|Overall Study|Adverse Event|0|||
163344539|NCT02130401|589970091|FG000|Overall Study|Poor enrollment|6|||
163344540|NCT03005106|589970092|FG000|Overall Study|Lost to Follow-up|16|||
163344541|NCT03005106|589970092|FG000|Overall Study|Adverse Event|1|||
163344542|NCT03005106|589970092|FG000|Overall Study|Physician Decision|1|||
163344543|NCT03005106|589970092|FG000|Overall Study|Death|2|||
163344544|NCT00321672|589970095|FG000|Overall Study|Withdrawal by Subject|5|||
163344545|NCT00321672|589970096|FG001|Overall Study|Withdrawal by Subject|1|||
163132172|NCT00348309|589191116|FG001|Overall Study|Cognitive and behaviour worsening|0|||
163132173|NCT00348309|589191117|FG002|Overall Study|Cognitive and behaviour worsening|0|||
163132174|NCT00348309|589191115|FG000|Overall Study|Worsening of alzheimer|1|||
163132175|NCT00348309|589191116|FG001|Overall Study|Worsening of alzheimer|0|||
163132176|NCT00348309|589191117|FG002|Overall Study|Worsening of alzheimer|1|||
163132177|NCT00348309|589191115|FG000|Overall Study|Did not appear in time for Visit 3|1|||
163132178|NCT00348309|589191116|FG001|Overall Study|Did not appear in time for Visit 3|0|||
163132179|NCT00348309|589191117|FG002|Overall Study|Did not appear in time for Visit 3|0|||
163132180|NCT00348309|589191115|FG000|Overall Study|Participant died|2|||
163132181|NCT00348309|589191116|FG001|Overall Study|Participant died|1|||
163132182|NCT00348309|589191117|FG002|Overall Study|Participant died|1|||
163132183|NCT00348309|589191115|FG000|Overall Study|Decision of sponsor|1|||
163132184|NCT00348309|589191116|FG001|Overall Study|Decision of sponsor|0|||
163132185|NCT00348309|589191117|FG002|Overall Study|Decision of sponsor|0|||
163132186|NCT00348309|589191115|FG000|Overall Study|Ineffectiveness of treatment|0|||
163132187|NCT00348309|589191116|FG001|Overall Study|Ineffectiveness of treatment|1|||
163132188|NCT00348309|589191117|FG002|Overall Study|Ineffectiveness of treatment|0|||
163132189|NCT00348309|589191115|FG000|Overall Study|A foul of exclusion criteria|0|||
163132190|NCT00348309|589191116|FG001|Overall Study|A foul of exclusion criteria|1|||
163132191|NCT00348309|589191117|FG002|Overall Study|A foul of exclusion criteria|0|||
163132192|NCT00348309|589191115|FG000|Overall Study|Participant was hospitalized|0|||
163132193|NCT00348309|589191116|FG001|Overall Study|Participant was hospitalized|1|||
163132194|NCT00348309|589191117|FG002|Overall Study|Participant was hospitalized|0|||
163132195|NCT00348309|589191115|FG000|Overall Study|Sponsor refuseal|0|||
163132196|NCT00348309|589191116|FG001|Overall Study|Sponsor refuseal|1|||
163132197|NCT00348309|589191117|FG002|Overall Study|Sponsor refuseal|1|||
163132198|NCT00348309|589191115|FG000|Overall Study|Forgot often medication|0|||
163132199|NCT00348309|589191116|FG001|Overall Study|Forgot often medication|1|||
163132200|NCT00348309|589191117|FG002|Overall Study|Forgot often medication|0|||
163132201|NCT00348309|589191115|FG000|Overall Study|Medical Monitor decision|0|||
163132202|NCT00348309|589191116|FG001|Overall Study|Medical Monitor decision|0|||
163132203|NCT00348309|589191117|FG002|Overall Study|Medical Monitor decision|1|||
163132204|NCT00348309|589191115|FG000|Overall Study|Increased dose of Aricept|0|||
163132205|NCT00348309|589191116|FG001|Overall Study|Increased dose of Aricept|0|||
163132206|NCT00348309|589191117|FG002|Overall Study|Increased dose of Aricept|1|||
163132207|NCT00348309|589191115|FG000|Overall Study|Site closure|0|||
163132208|NCT00348309|589191116|FG001|Overall Study|Site closure|0|||
163132209|NCT00348309|589191117|FG002|Overall Study|Site closure|1|||
163132210|NCT00348309|589191115|FG000|Overall Study|Adverse event not attended|0|||
163132211|NCT00348309|589191116|FG001|Overall Study|Adverse event not attended|0|||
163132212|NCT00348309|589191117|FG002|Overall Study|Adverse event not attended|1|||
163132213|NCT00348309|589191115|FG000|Overall Study|ECG abnormal|0|||
163132214|NCT00348309|589191116|FG001|Overall Study|ECG abnormal|0|||
163132215|NCT00348309|589191117|FG002|Overall Study|ECG abnormal|2|||
163132216|NCT00348309|589191115|FG000|Overall Study|Cardiologist recommendations|0|||
163132217|NCT00348309|589191116|FG001|Overall Study|Cardiologist recommendations|0|||
163132218|NCT00348309|589191117|FG002|Overall Study|Cardiologist recommendations|1|||
163132219|NCT00348309|589191115|FG000|Overall Study|HCV career|0|||
163132220|NCT00348309|589191116|FG001|Overall Study|HCV career|0|||
163132221|NCT00348309|589191117|FG002|Overall Study|HCV career|1|||
163132222|NCT00622388|589191118|FG000|Overall Study|Disease Progression|47|||
163132223|NCT00622388|589191118|FG000|Overall Study|Adverse Event|6|||
163132224|NCT00622388|589191118|FG000|Overall Study|Protocol Violation|3|||
163132225|NCT00622388|589191118|FG000|Overall Study|Participant Refusal|1|||
163132226|NCT00622388|589191118|FG000|Overall Study|Death|3|||
163132227|NCT00622388|589191118|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
163132228|NCT00622388|589191118|FG000|Overall Study|Took Prohibited Medication|2|||
163132229|NCT00622388|589191118|FG000|Overall Study|Withdrew Consent|1|||
163132230|NCT00622388|589191118|FG000|Overall Study|Insurance Expired|1|||
163132231|NCT01364389|589191121|FG000|Overall Study|Withdrawal by Subject|0|||
163132232|NCT01364389|589191122|FG001|Overall Study|Withdrawal by Subject|1|||
163132233|NCT01364389|589191123|FG002|Overall Study|Withdrawal by Subject|0|||
163132234|NCT01364389|589191121|FG000|Overall Study|Protocol deviation|0|||
163344546|NCT00321672|589970097|FG002|Overall Study|Withdrawal by Subject|2|||
163344547|NCT00321672|589970098|FG003|Overall Study|Withdrawal by Subject|0|||
163132235|NCT01364389|589191122|FG001|Overall Study|Protocol deviation|0|||
163132236|NCT01364389|589191123|FG002|Overall Study|Protocol deviation|1|||
163227975|NCT02346240|589548024|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227976|NCT02346240|589548025|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227977|NCT02346240|589548026|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227978|NCT02346240|589548027|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
163227979|NCT02346240|589548028|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
163227980|NCT02346240|589548029|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
163227981|NCT02346240|589548030|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
163227982|NCT02346240|589548031|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227983|NCT02346240|589548032|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227984|NCT02346240|589548033|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227985|NCT02346240|589548034|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227986|NCT02346240|589548035|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227987|NCT02346240|589548036|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227988|NCT02346240|589548037|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163227989|NCT02346240|589548014|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163227990|NCT02346240|589548015|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163227991|NCT02346240|589548016|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163227992|NCT02346240|589548017|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163227993|NCT02346240|589548018|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163227994|NCT02346240|589548019|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163227995|NCT02346240|589548020|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163227996|NCT02346240|589548021|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163227997|NCT02346240|589548022|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163227998|NCT02346240|589548023|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163227999|NCT02346240|589548024|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163228000|NCT02346240|589548025|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163228001|NCT02346240|589548026|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163228002|NCT02346240|589548027|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
163228003|NCT02346240|589548028|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163228004|NCT02346240|589548029|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
163228005|NCT02346240|589548030|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163228006|NCT02346240|589548031|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163228007|NCT02346240|589548032|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163228008|NCT02346240|589548033|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163228009|NCT02346240|589548034|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163228010|NCT02346240|589548035|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163228011|NCT02346240|589548036|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163228012|NCT02346240|589548037|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163228013|NCT02346240|589548014|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228014|NCT02346240|589548015|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228015|NCT02346240|589548016|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228016|NCT02346240|589548017|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228017|NCT02346240|589548018|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228018|NCT02346240|589548019|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228019|NCT02346240|589548020|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228020|NCT02346240|589548021|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228021|NCT02346240|589548022|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228022|NCT02346240|589548023|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228023|NCT02346240|589548024|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228024|NCT02346240|589548025|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228025|NCT02346240|589548026|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228026|NCT02346240|589548027|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163132237|NCT01364389|589191121|FG000|Overall Study|Administrative problems|1|||
163132238|NCT01364389|589191122|FG001|Overall Study|Administrative problems|0|||
163132239|NCT01364389|589191123|FG002|Overall Study|Administrative problems|0|||
163132240|NCT01364389|589191121|FG000|Overall Study|Adverse Event|1|||
163132241|NCT01364389|589191122|FG001|Overall Study|Adverse Event|0|||
163132242|NCT01364389|589191123|FG002|Overall Study|Adverse Event|0|||
163132243|NCT01534195|589191124|FG000|Overall Study|Withdrawal by Subject|1|||
163132244|NCT01534195|589191125|FG001|Overall Study|Withdrawal by Subject|1|||
163132245|NCT02554981|589191126|FG000|Overall Study|Adverse Event|1|||
163132246|NCT02554981|589191126|FG000|Overall Study|Administrative Reasons|1|||
163132247|NCT02554981|589191126|FG000|Overall Study|Other Miscellaneous Reasons|3|||
163132248|NCT03068767|589191133|FG000|Overall Study|Lost to Follow-up|7|||
163132249|NCT03068767|589191134|FG001|Overall Study|Lost to Follow-up|3|||
163132250|NCT03068767|589191133|FG000|Overall Study|Protocol Violation|3|||
163132251|NCT03068767|589191134|FG001|Overall Study|Protocol Violation|0|||
163132252|NCT00061633|589191135|FG000|Overall Study|Adverse Event|1|||
163344548|NCT00321672|589970095|FG000|Overall Study|Noncompliance|1|||
163344549|NCT00321672|589970096|FG001|Overall Study|Noncompliance|2|||
163344550|NCT00321672|589970097|FG002|Overall Study|Noncompliance|1|||
163344551|NCT00321672|589970098|FG003|Overall Study|Noncompliance|0|||
163344552|NCT00321672|589970095|FG000|Overall Study|Adverse Event|1|||
163344553|NCT00321672|589970096|FG001|Overall Study|Adverse Event|1|||
163344554|NCT00321672|589970097|FG002|Overall Study|Adverse Event|0|||
163344555|NCT00321672|589970098|FG003|Overall Study|Adverse Event|0|||
163344556|NCT00321672|589970095|FG000|Overall Study|Lack of Efficacy|1|||
163344557|NCT00321672|589970096|FG001|Overall Study|Lack of Efficacy|1|||
163344558|NCT00321672|589970097|FG002|Overall Study|Lack of Efficacy|0|||
163344559|NCT00321672|589970098|FG003|Overall Study|Lack of Efficacy|0|||
163344560|NCT00321672|589970095|FG000|Overall Study|Lost to Follow-up|2|||
163344561|NCT00321672|589970096|FG001|Overall Study|Lost to Follow-up|0|||
163344562|NCT00321672|589970097|FG002|Overall Study|Lost to Follow-up|4|||
163344563|NCT00321672|589970098|FG003|Overall Study|Lost to Follow-up|2|||
163344564|NCT00321672|589970095|FG000|Overall Study|Death|1|||
163344565|NCT00321672|589970096|FG001|Overall Study|Death|0|||
163344566|NCT00321672|589970097|FG002|Overall Study|Death|0|||
163344567|NCT00321672|589970098|FG003|Overall Study|Death|0|||
163344568|NCT00321672|589970095|FG000|Overall Study|Too far to travel for visits|1|||
163344569|NCT00321672|589970096|FG001|Overall Study|Too far to travel for visits|0|||
163344570|NCT00321672|589970097|FG002|Overall Study|Too far to travel for visits|0|||
163344571|NCT00321672|589970098|FG003|Overall Study|Too far to travel for visits|0|||
163344572|NCT00321672|589970095|FG000|Overall Study|Incarcerated|0|||
163344573|NCT00321672|589970096|FG001|Overall Study|Incarcerated|0|||
163344574|NCT00321672|589970097|FG002|Overall Study|Incarcerated|2|||
163344575|NCT00321672|589970098|FG003|Overall Study|Incarcerated|0|||
163344576|NCT00321672|589970095|FG000|Overall Study|Moved out of state|0|||
163344577|NCT00321672|589970096|FG001|Overall Study|Moved out of state|1|||
163344578|NCT00321672|589970097|FG002|Overall Study|Moved out of state|1|||
163344579|NCT00321672|589970098|FG003|Overall Study|Moved out of state|0|||
163344580|NCT00321672|589970095|FG000|Overall Study|Protocol Violation|0|||
163344581|NCT00321672|589970096|FG001|Overall Study|Protocol Violation|0|||
163344582|NCT00321672|589970097|FG002|Overall Study|Protocol Violation|1|||
163344583|NCT00321672|589970098|FG003|Overall Study|Protocol Violation|0|||
163344584|NCT00321672|589970095|FG000|Overall Study|Diagnosis of testicular cancer|0|||
163344585|NCT00321672|589970096|FG001|Overall Study|Diagnosis of testicular cancer|1|||
163344586|NCT00321672|589970097|FG002|Overall Study|Diagnosis of testicular cancer|0|||
163344587|NCT00321672|589970098|FG003|Overall Study|Diagnosis of testicular cancer|0|||
163344588|NCT00321672|589970095|FG000|Overall Study|Extensive travel required for new job|0|||
163344589|NCT00321672|589970096|FG001|Overall Study|Extensive travel required for new job|1|||
163344590|NCT00321672|589970097|FG002|Overall Study|Extensive travel required for new job|0|||
163344591|NCT00321672|589970098|FG003|Overall Study|Extensive travel required for new job|0|||
163344592|NCT00512902|589970099|FG000|Overall Study|Adverse Event|7|||
163344593|NCT00512902|589970099|FG000|Overall Study|Lost to Follow-up|1|||
163344594|NCT02389894|589970100|FG000|Overall Study|Death|4|||
163344595|NCT02389894|589970101|FG001|Overall Study|Death|5|||
163344596|NCT02389894|589970102|FG002|Overall Study|Death|3|||
163344597|NCT02389894|589970100|FG000|Overall Study|Withdrawal by Subject|2|||
163344598|NCT02389894|589970101|FG001|Overall Study|Withdrawal by Subject|4|||
163344599|NCT02389894|589970102|FG002|Overall Study|Withdrawal by Subject|5|||
163344600|NCT02389894|589970100|FG000|Overall Study|Lost to Follow-up|2|||
163344601|NCT02389894|589970101|FG001|Overall Study|Lost to Follow-up|1|||
163344602|NCT02389894|589970102|FG002|Overall Study|Lost to Follow-up|1|||
163344603|NCT00145496|589970103|FG000|Overall Study|Adverse Event|42|||
163344604|NCT00145496|589970104|FG001|Overall Study|Adverse Event|30|||
163344605|NCT00145496|589970103|FG000|Overall Study|Lack of Efficacy|12|||
163344606|NCT00145496|589970104|FG001|Overall Study|Lack of Efficacy|7|||
163344607|NCT00145496|589970103|FG000|Overall Study|Withdrawal by Subject|32|||
163132253|NCT00061633|589191136|FG001|Overall Study|Adverse Event|2|||
163132254|NCT00061633|589191135|FG000|Overall Study|Withdrawal by Subject|2|||
163132255|NCT00061633|589191136|FG001|Overall Study|Withdrawal by Subject|2|||
163132256|NCT00061633|589191135|FG000|Overall Study|Lost to Follow-up|1|||
163132257|NCT00061633|589191136|FG001|Overall Study|Lost to Follow-up|4|||
163132258|NCT00061633|589191135|FG000|Overall Study|Other|1|||
163344608|NCT00145496|589970104|FG001|Overall Study|Withdrawal by Subject|26|||
163344609|NCT00145496|589970103|FG000|Overall Study|Lost to Follow-up|12|||
163344610|NCT00145496|589970104|FG001|Overall Study|Lost to Follow-up|5|||
163132259|NCT00061633|589191136|FG001|Overall Study|Other|1|||
163132260|NCT00061633|589191135|FG000|Overall Study|Never received study treatment|0|||
163344611|NCT00145496|589970103|FG000|Overall Study|Other|25|||
163344612|NCT00145496|589970104|FG001|Overall Study|Other|13|||
163344613|NCT01429285|589970109|FG000|Overall Study|Protocol Violation|9|||
163344614|NCT01429285|589970110|FG001|Overall Study|Protocol Violation|4|||
163344615|NCT01429285|589970109|FG000|Overall Study|Missing Data|5|||
163344616|NCT01429285|589970110|FG001|Overall Study|Missing Data|3|||
163344617|NCT01429285|589970109|FG000|Overall Study|Erroneously Enrolled Twice|8|||
163344618|NCT01429285|589970110|FG001|Overall Study|Erroneously Enrolled Twice|2|||
163132261|NCT00061633|589191136|FG001|Overall Study|Never received study treatment|2|||
163132262|NCT01431963|589191137|FG000|Overall Study|Adverse Event|18|||
163132263|NCT01431963|589191137|FG000|Overall Study|Lack of Efficacy|7|||
163132264|NCT01431963|589191137|FG000|Overall Study|Protocol Violation|1|||
163132265|NCT01431963|589191137|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
163132266|NCT01431963|589191137|FG000|Overall Study|Physician Decision|4|||
163132267|NCT01431963|589191137|FG000|Overall Study|Withdrawal by Subject|3|||
163132268|NCT02475278|589194188|FG000|Overall Study|Lost to Follow-up|1|||
163132269|NCT02475278|589194188|FG000|Overall Study|Reason Not Specified|1|||
163132270|NCT01946152|589194189|FG000|Overall Study|Adverse Event|1|||
163132271|NCT01946152|589194190|FG001|Overall Study|Adverse Event|0|||
163132272|NCT01946152|589194191|FG002|Overall Study|Adverse Event|0|||
163132273|NCT01946152|589194192|FG003|Overall Study|Adverse Event|0|||
163132274|NCT01946152|589194189|FG000|Overall Study|Withdrawal by Subject|0|||
163132275|NCT01946152|589194190|FG001|Overall Study|Withdrawal by Subject|2|||
163132276|NCT01946152|589194191|FG002|Overall Study|Withdrawal by Subject|0|||
163132277|NCT01946152|589194192|FG003|Overall Study|Withdrawal by Subject|0|||
163132278|NCT01946152|589194189|FG000|Overall Study|Progression|0|||
163132279|NCT01946152|589194190|FG001|Overall Study|Progression|1|||
163132280|NCT01946152|589194191|FG002|Overall Study|Progression|4|||
163132281|NCT01946152|589194192|FG003|Overall Study|Progression|7|||
163132282|NCT01946152|589194189|FG000|Overall Study|Physician Decision|0|||
163132283|NCT01946152|589194190|FG001|Overall Study|Physician Decision|0|||
163132284|NCT01946152|589194191|FG002|Overall Study|Physician Decision|1|||
163132285|NCT01946152|589194192|FG003|Overall Study|Physician Decision|0|||
163132286|NCT01946152|589194189|FG000|Overall Study|Second malignancy|0|||
163132287|NCT01946152|589194190|FG001|Overall Study|Second malignancy|0|||
163132288|NCT01946152|589194191|FG002|Overall Study|Second malignancy|1|||
163132289|NCT01946152|589194192|FG003|Overall Study|Second malignancy|0|||
163132290|NCT01946152|589194189|FG000|Overall Study|Adverse Event|0|||
163132291|NCT01946152|589194190|FG001|Overall Study|Adverse Event|0|||
163132292|NCT01946152|589194191|FG002|Overall Study|Adverse Event|0|||
163132293|NCT01946152|589194192|FG003|Overall Study|Adverse Event|1|||
163132294|NCT03712787|589194193|FG000|Overall Study|Adverse Event|2|||
163132295|NCT03712787|589194194|FG001|Overall Study|Adverse Event|3|||
163132296|NCT03712787|589194195|FG002|Overall Study|Adverse Event|0|||
163132297|NCT03712787|589194196|FG003|Overall Study|Adverse Event|4|||
163132298|NCT03712787|589194193|FG000|Overall Study|Withdrawal by Subject|4|||
163132299|NCT03712787|589194194|FG001|Overall Study|Withdrawal by Subject|14|||
163132300|NCT03712787|589194195|FG002|Overall Study|Withdrawal by Subject|12|||
163132301|NCT03712787|589194196|FG003|Overall Study|Withdrawal by Subject|8|||
163132302|NCT03712787|589194193|FG000|Overall Study|Lost to Follow-up|1|||
163132303|NCT03712787|589194194|FG001|Overall Study|Lost to Follow-up|1|||
163132304|NCT03712787|589194195|FG002|Overall Study|Lost to Follow-up|2|||
163132305|NCT03712787|589194196|FG003|Overall Study|Lost to Follow-up|1|||
163132306|NCT03712787|589194193|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
163132307|NCT03712787|589194194|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
163132308|NCT03712787|589194195|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
163132309|NCT03712787|589194196|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
163132310|NCT03712787|589194193|FG000|Overall Study|COVID-19 Infection|0|||
163132311|NCT03712787|589194194|FG001|Overall Study|COVID-19 Infection|1|||
163132312|NCT03712787|589194195|FG002|Overall Study|COVID-19 Infection|0|||
163132313|NCT03712787|589194196|FG003|Overall Study|COVID-19 Infection|0|||
163132314|NCT03712787|589194193|FG000|Overall Study|Other, Not Specified|79|||
163132315|NCT03712787|589194194|FG001|Overall Study|Other, Not Specified|77|||
163132316|NCT03712787|589194195|FG002|Overall Study|Other, Not Specified|74|||
163132317|NCT03712787|589194196|FG003|Overall Study|Other, Not Specified|78|||
163132318|NCT01865448|589194197|FG000|Overall Study|Adverse Event|1|||
163344619|NCT00990314|589970113|FG000|Overall Study|Death|2|||
163344620|NCT00990314|589970113|FG000|Overall Study|Adverse Event|2|||
163344621|NCT00990314|589970113|FG000|Overall Study|Withdrawal by Subject|3|||
163344622|NCT00990314|589970113|FG000|Overall Study|Non-Compliance|1|||
163132319|NCT01865448|589194198|FG001|Overall Study|Adverse Event|1|||
163132320|NCT01865448|589194197|FG000|Overall Study|Pregnancy|0|||
163132321|NCT01865448|589194198|FG001|Overall Study|Pregnancy|1|||
163132322|NCT01865448|589194197|FG000|Overall Study|dropout unrelated to study|1|||
163132323|NCT01865448|589194198|FG001|Overall Study|dropout unrelated to study|1|||
163132324|NCT03499314|589194199|FG000|Overall Study|Time Commitment|1|||
163132325|NCT03499314|589194200|FG001|Overall Study|Time Commitment|2|||
163132326|NCT03499314|589194199|FG000|Overall Study|Medical issue unrelated to research study|1|||
163132327|NCT03499314|589194200|FG001|Overall Study|Medical issue unrelated to research study|1|||
163132328|NCT01618695|589194201|FG000|Core Phase|Adverse Event|4|||
163132329|NCT01618695|589194202|FG001|Core Phase|Adverse Event|5|||
163132330|NCT01618695|589194203|FG002|Core Phase|Adverse Event|15|||
163132331|NCT01618695|589194204|FG003|Core Phase|Adverse Event|20|||
163132332|NCT01618695|589194201|FG000|Core Phase|Lost to Follow-up|0|||
163132333|NCT01618695|589194202|FG001|Core Phase|Lost to Follow-up|0|||
163132334|NCT01618695|589194203|FG002|Core Phase|Lost to Follow-up|1|||
163132335|NCT01618695|589194204|FG003|Core Phase|Lost to Follow-up|0|||
163228027|NCT02346240|589548028|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
163228028|NCT02346240|589548029|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228029|NCT02346240|589548030|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228030|NCT02346240|589548031|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228031|NCT02346240|589548032|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228032|NCT02346240|589548033|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228033|NCT02346240|589548034|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228034|NCT02346240|589548035|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228035|NCT02346240|589548036|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228036|NCT02346240|589548037|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163228037|NCT02346240|589548014|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163228038|NCT02346240|589548015|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163228039|NCT02346240|589548016|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163228040|NCT02346240|589548017|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163228041|NCT02346240|589548018|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163228042|NCT02346240|589548019|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163228043|NCT02346240|589548020|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163228044|NCT02346240|589548021|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163228045|NCT02346240|589548022|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163228046|NCT02346240|589548023|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163228047|NCT02346240|589548024|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163228048|NCT02346240|589548025|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
163228049|NCT02346240|589548026|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163228050|NCT02346240|589548027|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
163228051|NCT02346240|589548028|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
163228052|NCT02346240|589548029|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
163228053|NCT02346240|589548030|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163228054|NCT02346240|589548031|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163228055|NCT02346240|589548032|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163228056|NCT02346240|589548033|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163228057|NCT02346240|589548034|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163228058|NCT02346240|589548035|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163228059|NCT02346240|589548036|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163228060|NCT02346240|589548037|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163228061|NCT02346240|589548014|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228062|NCT02346240|589548015|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228063|NCT02346240|589548016|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228064|NCT02346240|589548017|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228065|NCT02346240|589548018|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228066|NCT02346240|589548019|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228067|NCT02346240|589548020|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228068|NCT02346240|589548021|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228069|NCT02346240|589548022|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228070|NCT02346240|589548023|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228071|NCT02346240|589548024|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228072|NCT02346240|589548025|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228073|NCT02346240|589548026|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228074|NCT02346240|589548027|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
163228075|NCT02346240|589548028|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
163228076|NCT02346240|589548029|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
163228077|NCT02346240|589548030|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
163228078|NCT02346240|589548031|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228079|NCT02346240|589548032|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228080|NCT02346240|589548033|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228081|NCT02346240|589548034|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228082|NCT02346240|589548035|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228083|NCT02346240|589548036|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228084|NCT02346240|589548037|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163228085|NCT02346240|589548014|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228086|NCT02346240|589548015|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228087|NCT02346240|589548016|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163408430|NCT01485627|590205515|FG000|Overall Study|Patient died|3|||
163344623|NCT00990314|589970113|FG000|Overall Study|Physician Decision|3|||
163344624|NCT00990314|589970113|FG000|Overall Study|Lack of Efficacy|1|||
163344625|NCT02676778|589970116|FG000|Overall Study|Disease Progression|7|||
163344626|NCT02676778|589970117|FG001|Overall Study|Disease Progression|3|||
163344627|NCT02676778|589970118|FG002|Overall Study|Disease Progression|1|||
163344628|NCT02676778|589970116|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
163344629|NCT02676778|589970117|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
163344630|NCT02676778|589970118|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
163344631|NCT02676778|589970116|FG000|Overall Study|Withdrawal by Subject|3|||
163344632|NCT02676778|589970117|FG001|Overall Study|Withdrawal by Subject|2|||
163344633|NCT02676778|589970118|FG002|Overall Study|Withdrawal by Subject|0|||
163344634|NCT02676778|589970116|FG000|Overall Study|Other|4|||
163344635|NCT02676778|589970117|FG001|Overall Study|Other|3|||
163344636|NCT02676778|589970118|FG002|Overall Study|Other|0|||
163344637|NCT02676778|589970116|FG000|Overall Study|Adverse Event|2|||
163344638|NCT02676778|589970117|FG001|Overall Study|Adverse Event|3|||
163344639|NCT02676778|589970118|FG002|Overall Study|Adverse Event|0|||
163344640|NCT00925288|589972001|FG000|Overall Study|Lost to Follow-up|9|||
163344641|NCT00925288|589972002|FG001|Overall Study|Lost to Follow-up|7|||
163344642|NCT02151643|589972003|FG000|Overall Study|Adverse Event|2|||
163344643|NCT02151643|589972004|FG001|Overall Study|Adverse Event|0|||
163344644|NCT02151643|589972005|FG002|Overall Study|Adverse Event|1|||
163344645|NCT02151643|589972006|FG003|Overall Study|Adverse Event|4|||
163344646|NCT02151643|589972007|FG004|Overall Study|Adverse Event|0|||
163344647|NCT02151643|589972003|FG000|Overall Study|Withdrawal by Subject|0|||
163344648|NCT02151643|589972004|FG001|Overall Study|Withdrawal by Subject|1|||
163344649|NCT02151643|589972005|FG002|Overall Study|Withdrawal by Subject|1|||
163344650|NCT02151643|589972006|FG003|Overall Study|Withdrawal by Subject|1|||
163344651|NCT02151643|589972007|FG004|Overall Study|Withdrawal by Subject|1|||
163344652|NCT02151643|589972003|FG000|Overall Study|Hyperphosphataemia|1|||
163344653|NCT02151643|589972004|FG001|Overall Study|Hyperphosphataemia|0|||
163344654|NCT02151643|589972005|FG002|Overall Study|Hyperphosphataemia|0|||
163344655|NCT02151643|589972006|FG003|Overall Study|Hyperphosphataemia|0|||
163344656|NCT02151643|589972007|FG004|Overall Study|Hyperphosphataemia|1|||
163344657|NCT02151643|589972003|FG000|Overall Study|High Ferritin levels|3|||
163344658|NCT02151643|589972004|FG001|Overall Study|High Ferritin levels|3|||
163344659|NCT02151643|589972005|FG002|Overall Study|High Ferritin levels|2|||
163344660|NCT02151643|589972006|FG003|Overall Study|High Ferritin levels|2|||
163344661|NCT02151643|589972007|FG004|Overall Study|High Ferritin levels|1|||
163344662|NCT04307134|589972008|FG000|Overall Study|Lost to Follow-up|2|||
163344663|NCT04307134|589972008|FG000|Overall Study|Withdrawal by Subject|3|||
163344664|NCT04307134|589972008|FG000|Overall Study|Other|3|||
163344665|NCT04307134|589972008|FG000|Overall Study|Death|21|||
163344666|NCT04307134|589972008|FG000|Overall Study|Enrolled but not Treated|1|||
163344667|NCT03541200|589972012|FG000|Overall Study|Adverse Event|19|||
163344668|NCT03541200|589972012|FG000|Overall Study|Death|1|||
163344669|NCT03541200|589972012|FG000|Overall Study|Lost to Follow-up|10|||
163344670|NCT03541200|589972012|FG000|Overall Study|Physician Decision|1|||
163344671|NCT03541200|589972012|FG000|Overall Study|Protocol Violation|51|||
163344672|NCT03541200|589972012|FG000|Overall Study|Withdrawal by Subject|23|||
163344673|NCT03541200|589972012|FG000|Overall Study|other|8|||
163344674|NCT03508830|589972013|FG000|Overall Study|Withdrawal by Subject|3|||
163344675|NCT03508830|589972014|FG001|Overall Study|Withdrawal by Subject|4|||
163344676|NCT03508830|589972013|FG000|Overall Study|Physician Decision|2|||
163344677|NCT03508830|589972014|FG001|Overall Study|Physician Decision|2|||
163344678|NCT02522299|589972015|FG000|Overall Study|Adverse Event|2|||
163344679|NCT02522299|589972016|FG001|Overall Study|Adverse Event|0|||
163344680|NCT02522299|589972015|FG000|Overall Study|Physician Decision|0|||
163344681|NCT02522299|589972016|FG001|Overall Study|Physician Decision|1|||
163344682|NCT02522299|589972015|FG000|Overall Study|Withdrawal by Subject|2|||
163344683|NCT02522299|589972016|FG001|Overall Study|Withdrawal by Subject|0|||
163344684|NCT02097056|589972019|FG000|Overall Study|Protocol Violation|2|||
163344685|NCT02097056|589972019|FG000|Overall Study|Withdrawal by Subject|15|||
163408431|NCT01485627|590205516|FG001|Overall Study|Patient died|1|||
163408432|NCT01485627|590205515|FG000|Overall Study|Patient lost to followup|0|||
163344686|NCT02097056|589972019|FG000|Overall Study|Lost to Follow-up|2|||
163408433|NCT01485627|590205516|FG001|Overall Study|Patient lost to followup|1|||
163408434|NCT01485627|590205515|FG000|Overall Study|Caregiver withdrew|3|||
163408435|NCT01485627|590205516|FG001|Overall Study|Caregiver withdrew|3|||
163344687|NCT02097056|589972019|FG000|Overall Study|Adverse Event|37|||
163344688|NCT02097056|589972019|FG000|Overall Study|Other|2|||
163344689|NCT04908800|589972020|FG000|Overall Study|Adverse Event|0|||
163344690|NCT04908800|589972021|FG001|Overall Study|Adverse Event|0|||
163344691|NCT04908800|589972022|FG002|Overall Study|Adverse Event|0|||
163344692|NCT04908800|589972023|FG003|Overall Study|Adverse Event|0|||
163344693|NCT04908800|589972024|FG004|Overall Study|Adverse Event|0|||
163344694|NCT04908800|589972025|FG005|Overall Study|Adverse Event|0|||
163408436|NCT01485627|590205515|FG000|Overall Study|Caregiver lost to follow up|11|||
163408437|NCT01485627|590205516|FG001|Overall Study|Caregiver lost to follow up|12|||
163132336|NCT01618695|589194201|FG000|Core Phase|Withdrawal by Subject|16|||
163132337|NCT01618695|589194202|FG001|Core Phase|Withdrawal by Subject|11|||
163132338|NCT01618695|589194203|FG002|Core Phase|Withdrawal by Subject|9|||
163132339|NCT01618695|589194204|FG003|Core Phase|Withdrawal by Subject|13|||
163132340|NCT01618695|589194201|FG000|Core Phase|Pregnancy|2|||
163132341|NCT01618695|589194202|FG001|Core Phase|Pregnancy|0|||
163132342|NCT01618695|589194203|FG002|Core Phase|Pregnancy|0|||
163132343|NCT01618695|589194204|FG003|Core Phase|Pregnancy|0|||
163132344|NCT01618695|589194201|FG000|Core Phase|Lack of Efficacy|1|||
163132345|NCT01618695|589194202|FG001|Core Phase|Lack of Efficacy|2|||
163132346|NCT01618695|589194203|FG002|Core Phase|Lack of Efficacy|1|||
163132347|NCT01618695|589194204|FG003|Core Phase|Lack of Efficacy|1|||
163132348|NCT01618695|589194201|FG000|Core Phase|Other than specified|1|||
163132349|NCT01618695|589194202|FG001|Core Phase|Other than specified|2|||
163132350|NCT01618695|589194203|FG002|Core Phase|Other than specified|2|||
163132351|NCT01618695|589194204|FG003|Core Phase|Other than specified|2|||
163132352|NCT01618695|589194201|FG000|Core Phase|Not treated|1|||
163132353|NCT01618695|589194202|FG001|Core Phase|Not treated|0|||
163132354|NCT01618695|589194203|FG002|Core Phase|Not treated|2|||
163132355|NCT01618695|589194204|FG003|Core Phase|Not treated|0|||
163132356|NCT01618695|589194201|FG000|Extension Phase|Lack of Efficacy|17|||
163132357|NCT01618695|589194202|FG001|Extension Phase|Lack of Efficacy|33|||
163132358|NCT01618695|589194203|FG002|Extension Phase|Lack of Efficacy|26|||
163132359|NCT01618695|589194204|FG003|Extension Phase|Lack of Efficacy|24|||
163132360|NCT01618695|589194201|FG000|Extension Phase|Pregnancy|2|||
163132361|NCT01618695|589194202|FG001|Extension Phase|Pregnancy|0|||
163132362|NCT01618695|589194203|FG002|Extension Phase|Pregnancy|1|||
163132363|NCT01618695|589194204|FG003|Extension Phase|Pregnancy|1|||
163132364|NCT01618695|589194201|FG000|Extension Phase|Withdrawal by Subject|43|||
163132365|NCT01618695|589194202|FG001|Extension Phase|Withdrawal by Subject|48|||
163132366|NCT01618695|589194203|FG002|Extension Phase|Withdrawal by Subject|42|||
163132367|NCT01618695|589194204|FG003|Extension Phase|Withdrawal by Subject|33|||
163132368|NCT01618695|589194201|FG000|Extension Phase|Adverse Event|18|||
163132369|NCT01618695|589194202|FG001|Extension Phase|Adverse Event|16|||
163132370|NCT01618695|589194203|FG002|Extension Phase|Adverse Event|9|||
163132371|NCT01618695|589194204|FG003|Extension Phase|Adverse Event|20|||
163132372|NCT01618695|589194201|FG000|Extension Phase|Lost to Follow-up|2|||
163132373|NCT01618695|589194202|FG001|Extension Phase|Lost to Follow-up|1|||
163132374|NCT01618695|589194203|FG002|Extension Phase|Lost to Follow-up|1|||
163132375|NCT01618695|589194204|FG003|Extension Phase|Lost to Follow-up|1|||
163132376|NCT01618695|589194201|FG000|Extension Phase|Other than specified|13|||
163132377|NCT01618695|589194202|FG001|Extension Phase|Other than specified|18|||
163132378|NCT01618695|589194203|FG002|Extension Phase|Other than specified|13|||
163132379|NCT01618695|589194204|FG003|Extension Phase|Other than specified|18|||
163132380|NCT02291419|589194206|FG000|Overall Study|Early study termination|1|||
163132381|NCT02291419|589194207|FG001|Overall Study|Early study termination|5|||
163132382|NCT00931606|589194210|FG000|Overall Study|Death|1|||
163132383|NCT00931606|589194211|FG001|Overall Study|Death|3|||
163132384|NCT00931606|589194212|FG002|Overall Study|Death|2|||
163132385|NCT00931606|589194213|FG003|Overall Study|Death|0|||
163132386|NCT00931606|589194210|FG000|Overall Study|Lost to Follow-up|0|||
163132387|NCT00931606|589194211|FG001|Overall Study|Lost to Follow-up|1|||
163132388|NCT00931606|589194212|FG002|Overall Study|Lost to Follow-up|0|||
163132389|NCT00931606|589194213|FG003|Overall Study|Lost to Follow-up|0|||
163132390|NCT00931606|589194210|FG000|Overall Study|Physician Decision|0|||
163132391|NCT00931606|589194211|FG001|Overall Study|Physician Decision|0|||
163132392|NCT00931606|589194212|FG002|Overall Study|Physician Decision|3|||
163132393|NCT00931606|589194213|FG003|Overall Study|Physician Decision|0|||
163132394|NCT00931606|589194210|FG000|Overall Study|Sponsor Decision|1|||
163132395|NCT00931606|589194211|FG001|Overall Study|Sponsor Decision|4|||
163132396|NCT00931606|589194212|FG002|Overall Study|Sponsor Decision|0|||
163132397|NCT00931606|589194213|FG003|Overall Study|Sponsor Decision|2|||
163132398|NCT00931606|589194210|FG000|Overall Study|Withdrawal by Subject|3|||
163132399|NCT00931606|589194211|FG001|Overall Study|Withdrawal by Subject|1|||
163132400|NCT00931606|589194212|FG002|Overall Study|Withdrawal by Subject|1|||
163132401|NCT00931606|589194213|FG003|Overall Study|Withdrawal by Subject|1|||
163132402|NCT00871338|589194214|FG000|Prior to Booster|Withdrawal by Subject|1|||
163132403|NCT00871338|589194215|FG001|Prior to Booster|Withdrawal by Subject|3|||
163132404|NCT00871338|589194214|FG000|Prior to Booster|Lost to Follow-up|1|||
163132405|NCT00871338|589194215|FG001|Prior to Booster|Lost to Follow-up|0|||
163132406|NCT02391363|589194216|FG000|Overall Study|Lost to Follow-up|5|||
163132407|NCT02391363|589194217|FG001|Overall Study|Lost to Follow-up|5|||
163132408|NCT02391363|589194216|FG000|Overall Study|Withdrawal by Subject|6|||
163132409|NCT02391363|589194217|FG001|Overall Study|Withdrawal by Subject|3|||
163132410|NCT00799266|589194218|FG000|Overall Study|Adverse Event|0|||
163132411|NCT00799266|589194219|FG001|Overall Study|Adverse Event|1|||
163132412|NCT00799266|589194218|FG000|Overall Study|Subject withdrew consent|3|||
163132413|NCT00799266|589194219|FG001|Overall Study|Subject withdrew consent|0|||
163132414|NCT01016600|589194220|FG000|Overall Study|Did not start treatment|1|||
163132415|NCT01016600|589194221|FG001|Overall Study|Did not start treatment|0|||
163344695|NCT04908800|589972026|FG006|Overall Study|Adverse Event|0|||
163344696|NCT04908800|589972027|FG007|Overall Study|Adverse Event|0|||
163344697|NCT04908800|589972028|FG008|Overall Study|Adverse Event|0|||
163344698|NCT04908800|589972029|FG009|Overall Study|Adverse Event|0|||
163344699|NCT04908800|589972030|FG010|Overall Study|Adverse Event|1|||
163344700|NCT04908800|589972031|FG011|Overall Study|Adverse Event|0|||
163344701|NCT04908800|589972032|FG012|Overall Study|Adverse Event|0|||
163344702|NCT03751280|589972033|FG000|Overall Study|Adverse Event|0|||
163344703|NCT03751280|589972034|FG001|Overall Study|Adverse Event|1|||
163344704|NCT03751280|589972033|FG000|Overall Study|Lost to Follow-up|3|||
163344705|NCT03751280|589972034|FG001|Overall Study|Lost to Follow-up|5|||
163344706|NCT03751280|589972033|FG000|Overall Study|Physician Decision|0|||
163344707|NCT03751280|589972034|FG001|Overall Study|Physician Decision|2|||
163344708|NCT03751280|589972033|FG000|Overall Study|Protocol Violation|0|||
163344709|NCT03751280|589972034|FG001|Overall Study|Protocol Violation|2|||
163344710|NCT03751280|589972033|FG000|Overall Study|Withdrawal by Subject|5|||
163344711|NCT03751280|589972034|FG001|Overall Study|Withdrawal by Subject|2|||
163344712|NCT00296504|589972035|FG000|Interim Analysis|Withdrawal by Subject|8|||
163344713|NCT00296504|589972036|FG001|Interim Analysis|Withdrawal by Subject|0|||
163344714|NCT00296504|589972037|FG002|Interim Analysis|Withdrawal by Subject|12|||
163344715|NCT00296504|589972038|FG003|Interim Analysis|Withdrawal by Subject|0|||
163344716|NCT00296504|589972039|FG004|Interim Analysis|Withdrawal by Subject|5|||
163408438|NCT01485627|590205515|FG000|Overall Study|Caregiver died|1|||
163132416|NCT01016600|589194222|FG002|Overall Study|Did not start treatment|0|||
163132417|NCT01016600|589194223|FG003|Overall Study|Did not start treatment|0|||
163228088|NCT02346240|589548017|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228089|NCT02346240|589548018|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163132418|NCT00872599|589194224|FG000|Second Washout Period|Adverse Event|1|||
163132419|NCT00872599|589194225|FG001|Second Washout Period|Adverse Event|1|||
163132420|NCT04794270|589194226|FG000|Period 1|Non Compliance|1|||
163132421|NCT04794270|589194227|FG001|Period 1|Non Compliance|0|||
163132422|NCT04794270|589194226|FG000|Period 1|Adverse Event|1|||
163132423|NCT04794270|589194227|FG001|Period 1|Adverse Event|0|||
163132424|NCT04794270|589194226|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
163132425|NCT04794270|589194227|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
163228090|NCT02346240|589548019|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228091|NCT02346240|589548020|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
163228092|NCT02346240|589548021|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228093|NCT02346240|589548022|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228094|NCT02346240|589548023|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228095|NCT02346240|589548024|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228096|NCT02346240|589548025|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228097|NCT02346240|589548026|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228098|NCT02346240|589548027|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228099|NCT02346240|589548028|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228100|NCT02346240|589548029|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228101|NCT02346240|589548030|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228102|NCT02346240|589548031|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228103|NCT02346240|589548032|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228104|NCT02346240|589548033|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228105|NCT02346240|589548034|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228106|NCT02346240|589548035|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228107|NCT02346240|589548036|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228108|NCT02346240|589548037|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163228109|NCT02346240|589548014|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228110|NCT02346240|589548015|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228111|NCT02346240|589548016|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228112|NCT02346240|589548017|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228113|NCT02346240|589548018|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228114|NCT02346240|589548019|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228115|NCT02346240|589548020|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228116|NCT02346240|589548021|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163344717|NCT00296504|589972040|FG005|Interim Analysis|Withdrawal by Subject|5|||
163344718|NCT00296504|589972041|FG006|Interim Analysis|Withdrawal by Subject|9|||
163408439|NCT01485627|590205516|FG001|Overall Study|Caregiver died|0|||
163408440|NCT01485627|590205515|FG000|Overall Study|caregiver was not bereaved|42|||
163408441|NCT01485627|590205516|FG001|Overall Study|caregiver was not bereaved|35|||
163132426|NCT01504841|589194241|FG000|Overall Study|Withdrawal by Subject|1|||
163132427|NCT01504841|589194242|FG001|Overall Study|Withdrawal by Subject|1|||
163132428|NCT01504841|589194243|FG002|Overall Study|Withdrawal by Subject|0|||
163132429|NCT03149055|589194250|FG000|Overall Study|Not treated|4|||
163132430|NCT04440813|589194251|FG000|Overall Study|Lost to Follow-up|5|||
163132431|NCT04440813|589194252|FG001|Overall Study|Lost to Follow-up|5|||
163132432|NCT00660179|589194253|FG000|Overall Study|Death|44|||
163132433|NCT00660179|589194254|FG001|Overall Study|Death|47|||
163132434|NCT00660179|589194255|FG002|Overall Study|Death|34|||
163132435|NCT00660179|589194253|FG000|Overall Study|Withdrawal of consent|4|||
163132436|NCT00660179|589194254|FG001|Overall Study|Withdrawal of consent|6|||
163132437|NCT00660179|589194255|FG002|Overall Study|Withdrawal of consent|4|||
163132438|NCT00660179|589194253|FG000|Overall Study|Lost to Follow-up|7|||
163132439|NCT00660179|589194254|FG001|Overall Study|Lost to Follow-up|5|||
163132440|NCT00660179|589194255|FG002|Overall Study|Lost to Follow-up|2|||
163132441|NCT00660179|589194253|FG000|Overall Study|Administrative reason|0|||
163132442|NCT00660179|589194254|FG001|Overall Study|Administrative reason|0|||
163132443|NCT00660179|589194255|FG002|Overall Study|Administrative reason|1|||
163132444|NCT00660179|589194253|FG000|Overall Study|Incorrect randomization|1|||
163132445|NCT00660179|589194254|FG001|Overall Study|Incorrect randomization|0|||
163132446|NCT00660179|589194255|FG002|Overall Study|Incorrect randomization|0|||
163132447|NCT00291018|589194262|FG000|Overall Study|Not Consented or Declined PAS|12|||
163132448|NCT00291018|589194263|FG001|Overall Study|Not Consented or Declined PAS|15|||
163132449|NCT00291018|589194264|FG002|Overall Study|Not Consented or Declined PAS|15|||
163132450|NCT00291018|589194262|FG000|Overall Study|Death|3|||
163132451|NCT00291018|589194263|FG001|Overall Study|Death|3|||
163132452|NCT00291018|589194264|FG002|Overall Study|Death|4|||
163132453|NCT00291018|589194262|FG000|Overall Study|Withdrawal by Subject|2|||
163132454|NCT00291018|589194263|FG001|Overall Study|Withdrawal by Subject|8|||
163132455|NCT00291018|589194264|FG002|Overall Study|Withdrawal by Subject|1|||
163132456|NCT00291018|589194262|FG000|Overall Study|Failures|5|||
163132457|NCT00291018|589194263|FG001|Overall Study|Failures|12|||
163132458|NCT00291018|589194264|FG002|Overall Study|Failures|5|||
163132459|NCT00291018|589194262|FG000|Overall Study|Lost to Follow-up|3|||
163132460|NCT00291018|589194263|FG001|Overall Study|Lost to Follow-up|4|||
163132461|NCT00291018|589194264|FG002|Overall Study|Lost to Follow-up|18|||
163132462|NCT01504412|589194265|FG000|Overall Study|Adverse Event|1|||
163132463|NCT01504412|589194266|FG001|Overall Study|Adverse Event|8|||
163132464|NCT01504412|589194267|FG002|Overall Study|Adverse Event|1|||
163132465|NCT01504412|589194268|FG003|Overall Study|Adverse Event|7|||
163132466|NCT01504412|589194269|FG004|Overall Study|Adverse Event|10|||
163132467|NCT01504412|589194265|FG000|Overall Study|Withdrawal by Subject|2|||
163132468|NCT01504412|589194266|FG001|Overall Study|Withdrawal by Subject|1|||
163132469|NCT01504412|589194267|FG002|Overall Study|Withdrawal by Subject|1|||
163132470|NCT01504412|589194268|FG003|Overall Study|Withdrawal by Subject|5|||
163132471|NCT01504412|589194269|FG004|Overall Study|Withdrawal by Subject|1|||
163132472|NCT01504412|589194265|FG000|Overall Study|Other|2|||
163132473|NCT01504412|589194266|FG001|Overall Study|Other|1|||
163132474|NCT01504412|589194267|FG002|Overall Study|Other|1|||
163132475|NCT01504412|589194268|FG003|Overall Study|Other|6|||
163132476|NCT01504412|589194269|FG004|Overall Study|Other|1|||
163132477|NCT01504412|589194265|FG000|Overall Study|Lost to Follow-up|0|||
163132478|NCT01504412|589194266|FG001|Overall Study|Lost to Follow-up|2|||
163132479|NCT01504412|589194267|FG002|Overall Study|Lost to Follow-up|0|||
163132480|NCT01504412|589194268|FG003|Overall Study|Lost to Follow-up|0|||
163132481|NCT01504412|589194269|FG004|Overall Study|Lost to Follow-up|0|||
163132482|NCT01504412|589194265|FG000|Overall Study|Lack of Efficacy|0|||
163132483|NCT01504412|589194266|FG001|Overall Study|Lack of Efficacy|0|||
163132484|NCT01504412|589194267|FG002|Overall Study|Lack of Efficacy|1|||
163132485|NCT01504412|589194268|FG003|Overall Study|Lack of Efficacy|0|||
163132486|NCT01504412|589194269|FG004|Overall Study|Lack of Efficacy|1|||
163132487|NCT01504412|589194265|FG000|Overall Study|Death|0|||
163132488|NCT01504412|589194266|FG001|Overall Study|Death|0|||
163132489|NCT01504412|589194267|FG002|Overall Study|Death|0|||
163132490|NCT01504412|589194268|FG003|Overall Study|Death|1|||
163132491|NCT01504412|589194269|FG004|Overall Study|Death|0|||
163132492|NCT00630344|589194270|FG000|Overall Study|Adverse Event|5|||
163228117|NCT02346240|589548022|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
163344719|NCT00296504|589972042|FG007|Interim Analysis|Withdrawal by Subject|3|||
163132493|NCT00630344|589194270|FG000|Overall Study|Progressive Disease|19|||
163132494|NCT00630344|589194270|FG000|Overall Study|Physician Decision|9|||
163132495|NCT00630344|589194270|FG000|Overall Study|Withdrawal by Subject|1|||
163344720|NCT00296504|589972043|FG008|Interim Analysis|Withdrawal by Subject|0|||
163132496|NCT00630344|589194270|FG000|Overall Study|Intercurrent Illness|1|||
163132497|NCT00630344|589194270|FG000|Overall Study|Other|1|||
163132498|NCT05362058|589194272|FG000|Treatment Period|Adverse Event|3|||
163344721|NCT00296504|589972035|FG000|Interim Analysis|Lost to Follow-up|13|||
163132499|NCT05362058|589194273|FG001|Treatment Period|Adverse Event|3|||
163132500|NCT05362058|589194272|FG000|Treatment Period|Assigned treatment by mistake|3|||
163132501|NCT05362058|589194273|FG001|Treatment Period|Assigned treatment by mistake|4|||
163132502|NCT05362058|589194272|FG000|Treatment Period|Death|1|||
163132503|NCT05362058|589194273|FG001|Treatment Period|Death|1|||
163132504|NCT05362058|589194272|FG000|Treatment Period|Lost to Follow-up|6|||
163132505|NCT05362058|589194273|FG001|Treatment Period|Lost to Follow-up|3|||
163132506|NCT05362058|589194272|FG000|Treatment Period|Non-compliance with study drug|0|||
163132507|NCT05362058|589194273|FG001|Treatment Period|Non-compliance with study drug|1|||
163132508|NCT05362058|589194272|FG000|Treatment Period|Physician Decision|1|||
163132509|NCT05362058|589194273|FG001|Treatment Period|Physician Decision|0|||
163132510|NCT05362058|589194272|FG000|Treatment Period|Protocol deviation|1|||
163132511|NCT05362058|589194273|FG001|Treatment Period|Protocol deviation|0|||
163132512|NCT05362058|589194272|FG000|Treatment Period|Withdrawal by Subject|10|||
163132513|NCT05362058|589194273|FG001|Treatment Period|Withdrawal by Subject|11|||
163132514|NCT05362058|589194272|FG000|Follow-Up Period|Death|1|||
163132515|NCT05362058|589194273|FG001|Follow-Up Period|Death|0|||
163132516|NCT05362058|589194272|FG000|Follow-Up Period|Lost to Follow-up|2|||
163132517|NCT05362058|589194273|FG001|Follow-Up Period|Lost to Follow-up|1|||
163132518|NCT05362058|589194272|FG000|Follow-Up Period|Protocol deviation|1|||
163132519|NCT05362058|589194273|FG001|Follow-Up Period|Protocol deviation|1|||
163132520|NCT05362058|589194272|FG000|Follow-Up Period|Withdrawal by Subject|0|||
163132521|NCT05362058|589194273|FG001|Follow-Up Period|Withdrawal by Subject|3|||
163132522|NCT04774926|589194274|FG000|Overall Study|Adverse Event|15|||
163132523|NCT04774926|589194274|FG000|Overall Study|Lost to Follow-up|3|||
163132524|NCT04774926|589194274|FG000|Overall Study|Physician Decision|6|||
163132525|NCT04774926|589194274|FG000|Overall Study|Withdrawal by Subject|3|||
163132526|NCT04774926|589194274|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
163132527|NCT01393639|589194275|FG000|Overall Study|Protocol Violation|0|||
163132528|NCT01393639|589194276|FG001|Overall Study|Protocol Violation|0|||
163132529|NCT01393639|589194277|FG002|Overall Study|Protocol Violation|0|||
163132530|NCT01393639|589194278|FG003|Overall Study|Protocol Violation|1|||
163132531|NCT01393639|589194279|FG004|Overall Study|Protocol Violation|0|||
163132532|NCT01393639|589194280|FG005|Overall Study|Protocol Violation|0|||
163132533|NCT01393639|589194281|FG006|Overall Study|Protocol Violation|0|||
163132534|NCT01393639|589194275|FG000|Overall Study|Other|0|||
163132535|NCT01393639|589194276|FG001|Overall Study|Other|2|||
163132536|NCT01393639|589194277|FG002|Overall Study|Other|0|||
163132537|NCT01393639|589194278|FG003|Overall Study|Other|2|||
163132538|NCT01393639|589194279|FG004|Overall Study|Other|1|||
163132539|NCT01393639|589194280|FG005|Overall Study|Other|0|||
163132540|NCT01393639|589194281|FG006|Overall Study|Other|1|||
163132541|NCT01393639|589194275|FG000|Overall Study|Withdrawal by Subject|1|||
163132542|NCT01393639|589194276|FG001|Overall Study|Withdrawal by Subject|1|||
163132543|NCT01393639|589194277|FG002|Overall Study|Withdrawal by Subject|0|||
163132544|NCT01393639|589194278|FG003|Overall Study|Withdrawal by Subject|0|||
163132545|NCT01393639|589194279|FG004|Overall Study|Withdrawal by Subject|0|||
163132546|NCT01393639|589194280|FG005|Overall Study|Withdrawal by Subject|0|||
163132547|NCT01393639|589194281|FG006|Overall Study|Withdrawal by Subject|1|||
163132548|NCT01393639|589194275|FG000|Overall Study|Medication error without associated AE|0|||
163132549|NCT01393639|589194276|FG001|Overall Study|Medication error without associated AE|0|||
163132550|NCT01393639|589194277|FG002|Overall Study|Medication error without associated AE|0|||
163132551|NCT01393639|589194278|FG003|Overall Study|Medication error without associated AE|0|||
163132552|NCT01393639|589194279|FG004|Overall Study|Medication error without associated AE|0|||
163132553|NCT01393639|589194280|FG005|Overall Study|Medication error without associated AE|0|||
163132554|NCT01393639|589194281|FG006|Overall Study|Medication error without associated AE|1|||
163132555|NCT01393639|589194275|FG000|Overall Study|Lost to Follow-up|0|||
163132556|NCT01393639|589194276|FG001|Overall Study|Lost to Follow-up|1|||
163132557|NCT01393639|589194277|FG002|Overall Study|Lost to Follow-up|0|||
163132558|NCT01393639|589194278|FG003|Overall Study|Lost to Follow-up|0|||
163132559|NCT01393639|589194279|FG004|Overall Study|Lost to Follow-up|0|||
163132560|NCT01393639|589194280|FG005|Overall Study|Lost to Follow-up|0|||
163132561|NCT01393639|589194281|FG006|Overall Study|Lost to Follow-up|1|||
163132562|NCT01393639|589194275|FG000|Overall Study|Lack of Efficacy|0|||
163132563|NCT01393639|589194276|FG001|Overall Study|Lack of Efficacy|0|||
163132564|NCT01393639|589194277|FG002|Overall Study|Lack of Efficacy|0|||
163132565|NCT01393639|589194278|FG003|Overall Study|Lack of Efficacy|0|||
163132566|NCT01393639|589194279|FG004|Overall Study|Lack of Efficacy|0|||
163344722|NCT00296504|589972036|FG001|Interim Analysis|Lost to Follow-up|3|||
163344723|NCT00296504|589972037|FG002|Interim Analysis|Lost to Follow-up|26|||
163344724|NCT00296504|589972038|FG003|Interim Analysis|Lost to Follow-up|8|||
163344725|NCT00296504|589972039|FG004|Interim Analysis|Lost to Follow-up|14|||
163344726|NCT00296504|589972040|FG005|Interim Analysis|Lost to Follow-up|4|||
163344727|NCT00296504|589972041|FG006|Interim Analysis|Lost to Follow-up|11|||
163132567|NCT01393639|589194280|FG005|Overall Study|Lack of Efficacy|0|||
163132568|NCT01393639|589194281|FG006|Overall Study|Lack of Efficacy|1|||
163132569|NCT01393639|589194275|FG000|Overall Study|Adverse Event|2|||
163132570|NCT01393639|589194276|FG001|Overall Study|Adverse Event|3|||
163132571|NCT01393639|589194277|FG002|Overall Study|Adverse Event|1|||
163132572|NCT01393639|589194278|FG003|Overall Study|Adverse Event|2|||
163132573|NCT01393639|589194279|FG004|Overall Study|Adverse Event|0|||
163132574|NCT01393639|589194280|FG005|Overall Study|Adverse Event|2|||
163132575|NCT01393639|589194281|FG006|Overall Study|Adverse Event|3|||
163228118|NCT02346240|589548023|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228119|NCT02346240|589548024|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228120|NCT02346240|589548025|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
163228121|NCT02346240|589548026|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228122|NCT02346240|589548027|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
163228123|NCT02346240|589548028|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
163228124|NCT02346240|589548029|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228125|NCT02346240|589548030|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228126|NCT02346240|589548031|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228127|NCT02346240|589548032|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228128|NCT02346240|589548033|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228129|NCT02346240|589548034|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228130|NCT02346240|589548035|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228131|NCT02346240|589548036|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228132|NCT02346240|589548037|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163228133|NCT02346240|589548014|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228134|NCT02346240|589548015|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228135|NCT02346240|589548016|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228136|NCT02346240|589548017|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163132576|NCT03626545|589194282|FG000|Overall Study|Progressive disease|3|||
163132577|NCT03626545|589194283|FG001|Overall Study|Progressive disease|82|||
163132578|NCT03626545|589194284|FG002|Overall Study|Progressive disease|85|||
163132579|NCT03626545|589194282|FG000|Overall Study|Adverse Event|3|||
163132580|NCT03626545|589194283|FG001|Overall Study|Adverse Event|13|||
163132581|NCT03626545|589194284|FG002|Overall Study|Adverse Event|10|||
163132582|NCT03626545|589194282|FG000|Overall Study|Physician Decision|1|||
163132583|NCT03626545|589194283|FG001|Overall Study|Physician Decision|18|||
163132584|NCT03626545|589194284|FG002|Overall Study|Physician Decision|14|||
163132585|NCT03626545|589194282|FG000|Overall Study|Subject Decision|0|||
163132586|NCT03626545|589194283|FG001|Overall Study|Subject Decision|5|||
163132587|NCT03626545|589194284|FG002|Overall Study|Subject Decision|5|||
163132588|NCT03626545|589194282|FG000|Overall Study|Death|1|||
163132589|NCT03626545|589194283|FG001|Overall Study|Death|1|||
163132590|NCT03626545|589194284|FG002|Overall Study|Death|1|||
163132591|NCT03626545|589194282|FG000|Overall Study|Protocol Deviation|0|||
163132592|NCT03626545|589194283|FG001|Overall Study|Protocol Deviation|1|||
163132593|NCT03626545|589194284|FG002|Overall Study|Protocol Deviation|1|||
163132594|NCT03626545|589194282|FG000|Overall Study|Guardian Decision|0|||
163132595|NCT03626545|589194283|FG001|Overall Study|Guardian Decision|0|||
163132596|NCT03626545|589194284|FG002|Overall Study|Guardian Decision|1|||
163132597|NCT01440816|589194286|FG000|Overall Study|Disease Progression|0|||
163132598|NCT01440816|589194287|FG001|Overall Study|Disease Progression|9|||
163132599|NCT01440816|589194286|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
163132600|NCT01440816|589194287|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
163132601|NCT02462720|589194291|FG000|Part 2|Withdrawal by Subject|1|||
163132602|NCT02462720|589194292|FG001|Part 2|Withdrawal by Subject|0|||
163132603|NCT02462720|589194291|FG000|Part 2|Protocol Violation|0|||
163132604|NCT02462720|589194292|FG001|Part 2|Protocol Violation|1|||
163132605|NCT05173012|589194297|FG000|Overall Study|Adverse Event|2|||
163132606|NCT05173012|589194298|FG001|Overall Study|Adverse Event|3|||
163132607|NCT05173012|589194299|FG002|Overall Study|Adverse Event|4|||
163132608|NCT05173012|589194300|FG003|Overall Study|Adverse Event|13|||
163132609|NCT05173012|589194301|FG004|Overall Study|Adverse Event|0|||
163132610|NCT05173012|589194302|FG005|Overall Study|Adverse Event|0|||
163132611|NCT05173012|589194303|FG006|Overall Study|Adverse Event|2|||
163132612|NCT05173012|589194304|FG007|Overall Study|Adverse Event|4|||
163132613|NCT05173012|589194297|FG000|Overall Study|Lost to Follow-up|0|||
163132614|NCT05173012|589194298|FG001|Overall Study|Lost to Follow-up|0|||
163132615|NCT05173012|589194299|FG002|Overall Study|Lost to Follow-up|0|||
163132616|NCT05173012|589194300|FG003|Overall Study|Lost to Follow-up|1|||
163132617|NCT05173012|589194301|FG004|Overall Study|Lost to Follow-up|0|||
163132618|NCT05173012|589194302|FG005|Overall Study|Lost to Follow-up|0|||
163132619|NCT05173012|589194303|FG006|Overall Study|Lost to Follow-up|0|||
163132620|NCT05173012|589194304|FG007|Overall Study|Lost to Follow-up|0|||
163132621|NCT05173012|589194297|FG000|Overall Study|Withdrawal by Subject|1|||
163132622|NCT05173012|589194298|FG001|Overall Study|Withdrawal by Subject|0|||
163132623|NCT05173012|589194299|FG002|Overall Study|Withdrawal by Subject|1|||
163132624|NCT05173012|589194300|FG003|Overall Study|Withdrawal by Subject|3|||
163132625|NCT05173012|589194301|FG004|Overall Study|Withdrawal by Subject|1|||
163132626|NCT05173012|589194302|FG005|Overall Study|Withdrawal by Subject|0|||
163132627|NCT05173012|589194303|FG006|Overall Study|Withdrawal by Subject|1|||
163408442|NCT01425203|590205517|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
163408443|NCT01425203|590205518|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
163408444|NCT01425203|590205519|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
163408445|NCT01425203|590205517|FG000|Treatment Phase|Failure at futility timepoint|8|||
163408446|NCT01425203|590205518|FG001|Treatment Phase|Failure at futility timepoint|27|||
163408447|NCT01425203|590205519|FG002|Treatment Phase|Failure at futility timepoint|0|||
163408448|NCT01425203|590205517|FG000|Treatment Phase|Other virologic failure criteria|5|||
163408449|NCT01425203|590205518|FG001|Treatment Phase|Other virologic failure criteria|3|||
163408450|NCT01425203|590205519|FG002|Treatment Phase|Other virologic failure criteria|0|||
163408451|NCT01425203|590205517|FG000|Treatment Phase|Unidentified reasons|11|||
163408452|NCT01425203|590205518|FG001|Treatment Phase|Unidentified reasons|5|||
163408453|NCT01425203|590205519|FG002|Treatment Phase|Unidentified reasons|0|||
163408454|NCT01425203|590205517|FG000|Treatment Phase|Did not receive treatment|0|||
163408455|NCT01425203|590205518|FG001|Treatment Phase|Did not receive treatment|1|||
163408456|NCT01425203|590205519|FG002|Treatment Phase|Did not receive treatment|0|||
163408457|NCT01425203|590205517|FG000|Crossover Phase|Failure at futility timepoint|0|||
163408458|NCT01425203|590205518|FG001|Crossover Phase|Failure at futility timepoint|0|||
163408459|NCT01425203|590205519|FG002|Crossover Phase|Failure at futility timepoint|3|||
163408460|NCT01425203|590205517|FG000|Crossover Phase|Other virologic failure criteria|0|||
163408461|NCT01425203|590205518|FG001|Crossover Phase|Other virologic failure criteria|0|||
163408462|NCT01425203|590205519|FG002|Crossover Phase|Other virologic failure criteria|3|||
163408463|NCT00290433|590205522|FG000|Overall Study|Disease Progression|13|||
163408464|NCT00290433|590205522|FG000|Overall Study|Adverse Event|14|||
163132628|NCT05173012|589194304|FG007|Overall Study|Withdrawal by Subject|0|||
163132629|NCT05173012|589194297|FG000|Overall Study|Protocol Deviation|0|||
163132630|NCT05173012|589194298|FG001|Overall Study|Protocol Deviation|0|||
163132631|NCT05173012|589194299|FG002|Overall Study|Protocol Deviation|0|||
163132632|NCT05173012|589194300|FG003|Overall Study|Protocol Deviation|1|||
163132633|NCT05173012|589194301|FG004|Overall Study|Protocol Deviation|0|||
163132634|NCT05173012|589194302|FG005|Overall Study|Protocol Deviation|0|||
163132635|NCT05173012|589194303|FG006|Overall Study|Protocol Deviation|0|||
163132636|NCT05173012|589194304|FG007|Overall Study|Protocol Deviation|0|||
163132637|NCT05173012|589194297|FG000|Overall Study|Other|0|||
163132638|NCT05173012|589194298|FG001|Overall Study|Other|0|||
163132639|NCT05173012|589194299|FG002|Overall Study|Other|0|||
163132640|NCT05173012|589194300|FG003|Overall Study|Other|2|||
163132641|NCT05173012|589194301|FG004|Overall Study|Other|0|||
163132642|NCT05173012|589194302|FG005|Overall Study|Other|0|||
163132643|NCT05173012|589194303|FG006|Overall Study|Other|0|||
163132644|NCT05173012|589194304|FG007|Overall Study|Other|0|||
163132645|NCT03668613|589194305|FG000|Overall Study|Adverse Event|1|||
163132646|NCT03668613|589194306|FG001|Overall Study|Adverse Event|2|||
163132647|NCT03668613|589194305|FG000|Overall Study|Lack of Efficacy|5|||
163132648|NCT03668613|589194306|FG001|Overall Study|Lack of Efficacy|1|||
163132649|NCT03668613|589194305|FG000|Overall Study|Pregnancy|0|||
163132650|NCT03668613|589194306|FG001|Overall Study|Pregnancy|2|||
163132651|NCT03668613|589194305|FG000|Overall Study|Protocol Violation|1|||
163132652|NCT03668613|589194306|FG001|Overall Study|Protocol Violation|0|||
163132653|NCT03668613|589194305|FG000|Overall Study|Physician Decision|1|||
163132654|NCT03668613|589194306|FG001|Overall Study|Physician Decision|0|||
163132655|NCT03668613|589194305|FG000|Overall Study|Withdrawal by Subject|2|||
163132656|NCT03668613|589194306|FG001|Overall Study|Withdrawal by Subject|1|||
163132657|NCT03668613|589194305|FG000|Overall Study|Guardian decision|1|||
163132658|NCT03668613|589194306|FG001|Overall Study|Guardian decision|0|||
163132659|NCT00286494|589194309|FG000|Overall Study|Hyperglycemic rescue|12|||
163132660|NCT00286494|589194310|FG001|Overall Study|Hyperglycemic rescue|19|||
163132661|NCT00286494|589194311|FG002|Overall Study|Hyperglycemic rescue|18|||
163132662|NCT00286494|589194309|FG000|Overall Study|Withdrawal by Subject|2|||
163132663|NCT00286494|589194310|FG001|Overall Study|Withdrawal by Subject|10|||
163132664|NCT00286494|589194311|FG002|Overall Study|Withdrawal by Subject|9|||
163132665|NCT00286494|589194309|FG000|Overall Study|Adverse Event|3|||
163132666|NCT00286494|589194310|FG001|Overall Study|Adverse Event|8|||
163132667|NCT00286494|589194311|FG002|Overall Study|Adverse Event|6|||
163132668|NCT00286494|589194309|FG000|Overall Study|Physician Decision|5|||
163132669|NCT00286494|589194310|FG001|Overall Study|Physician Decision|5|||
163132670|NCT00286494|589194311|FG002|Overall Study|Physician Decision|1|||
163132671|NCT00286494|589194309|FG000|Overall Study|Lost to Follow-up|3|||
163228137|NCT02346240|589548018|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163132672|NCT00286494|589194310|FG001|Overall Study|Lost to Follow-up|1|||
163132673|NCT00286494|589194311|FG002|Overall Study|Lost to Follow-up|3|||
163132674|NCT00286494|589194309|FG000|Overall Study|Protocol Violation|1|||
163228138|NCT02346240|589548019|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163132675|NCT00286494|589194310|FG001|Overall Study|Protocol Violation|1|||
163132676|NCT00286494|589194311|FG002|Overall Study|Protocol Violation|2|||
163132677|NCT04776317|589194312|FG000|Overall Study|Physician Decision|0|||
163132678|NCT04776317|589194313|FG001|Overall Study|Physician Decision|1|||
163132679|NCT04776317|589194314|FG002|Overall Study|Physician Decision|0|||
163228139|NCT02346240|589548020|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228140|NCT02346240|589548021|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228141|NCT02346240|589548022|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228142|NCT02346240|589548023|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
163228143|NCT02346240|589548024|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228144|NCT02346240|589548025|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228145|NCT02346240|589548026|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228146|NCT02346240|589548027|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228147|NCT02346240|589548028|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228148|NCT02346240|589548029|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228149|NCT02346240|589548030|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228150|NCT02346240|589548031|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228151|NCT02346240|589548032|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228152|NCT02346240|589548033|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228153|NCT02346240|589548034|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163344728|NCT00296504|589972042|FG007|Interim Analysis|Lost to Follow-up|4|||
163344729|NCT00296504|589972043|FG008|Interim Analysis|Lost to Follow-up|0|||
163344730|NCT00296504|589972035|FG000|Interim Analysis|Clinical Progression|1|||
163344731|NCT00296504|589972036|FG001|Interim Analysis|Clinical Progression|0|||
163344732|NCT00296504|589972037|FG002|Interim Analysis|Clinical Progression|1|||
163344733|NCT00296504|589972038|FG003|Interim Analysis|Clinical Progression|1|||
163344734|NCT00296504|589972039|FG004|Interim Analysis|Clinical Progression|0|||
163344735|NCT00296504|589972040|FG005|Interim Analysis|Clinical Progression|2|||
163344736|NCT00296504|589972041|FG006|Interim Analysis|Clinical Progression|1|||
163344737|NCT00296504|589972042|FG007|Interim Analysis|Clinical Progression|2|||
163344738|NCT00296504|589972043|FG008|Interim Analysis|Clinical Progression|0|||
163344739|NCT00296504|589972035|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
163344740|NCT00296504|589972036|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
163344741|NCT00296504|589972037|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
163344742|NCT00296504|589972038|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
163344743|NCT00296504|589972039|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
163344744|NCT00296504|589972040|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
163344745|NCT00296504|589972041|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
163344746|NCT00296504|589972042|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
163344747|NCT00296504|589972043|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
163344748|NCT00296504|589972035|FG000|Interim Analysis|Adverse Event|0|||
163344749|NCT00296504|589972036|FG001|Interim Analysis|Adverse Event|0|||
163344750|NCT00296504|589972037|FG002|Interim Analysis|Adverse Event|13|||
163344751|NCT00296504|589972038|FG003|Interim Analysis|Adverse Event|4|||
163344752|NCT00296504|589972039|FG004|Interim Analysis|Adverse Event|6|||
163344753|NCT00296504|589972040|FG005|Interim Analysis|Adverse Event|3|||
163344754|NCT00296504|589972041|FG006|Interim Analysis|Adverse Event|4|||
163344755|NCT00296504|589972042|FG007|Interim Analysis|Adverse Event|5|||
163344756|NCT00296504|589972043|FG008|Interim Analysis|Adverse Event|0|||
163344757|NCT00296504|589972035|FG000|Interim Analysis|Protocol Violation|0|||
163344758|NCT00296504|589972036|FG001|Interim Analysis|Protocol Violation|0|||
163344759|NCT00296504|589972037|FG002|Interim Analysis|Protocol Violation|2|||
163344760|NCT00296504|589972038|FG003|Interim Analysis|Protocol Violation|0|||
163344761|NCT00296504|589972039|FG004|Interim Analysis|Protocol Violation|1|||
163344762|NCT00296504|589972040|FG005|Interim Analysis|Protocol Violation|0|||
163344763|NCT00296504|589972041|FG006|Interim Analysis|Protocol Violation|0|||
163344764|NCT00296504|589972042|FG007|Interim Analysis|Protocol Violation|1|||
163344765|NCT00296504|589972043|FG008|Interim Analysis|Protocol Violation|0|||
163344766|NCT00296504|589972035|FG000|Interim Analysis|Insufficient CD4 Response|0|||
163344767|NCT00296504|589972036|FG001|Interim Analysis|Insufficient CD4 Response|0|||
163344768|NCT00296504|589972037|FG002|Interim Analysis|Insufficient CD4 Response|0|||
163344769|NCT00296504|589972038|FG003|Interim Analysis|Insufficient CD4 Response|0|||
163344770|NCT00296504|589972039|FG004|Interim Analysis|Insufficient CD4 Response|1|||
163344771|NCT00296504|589972040|FG005|Interim Analysis|Insufficient CD4 Response|1|||
163344772|NCT00296504|589972041|FG006|Interim Analysis|Insufficient CD4 Response|0|||
163344773|NCT00296504|589972042|FG007|Interim Analysis|Insufficient CD4 Response|0|||
163344774|NCT00296504|589972043|FG008|Interim Analysis|Insufficient CD4 Response|0|||
163344775|NCT00296504|589972035|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
163344776|NCT00296504|589972036|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
163408465|NCT00290433|590205522|FG000|Overall Study|Withdrawal by Subject|1|||
163344777|NCT00296504|589972037|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
163344778|NCT00296504|589972038|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
163344779|NCT00296504|589972039|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
163408466|NCT00290433|590205522|FG000|Overall Study|Non-Compliance|1|||
163408467|NCT00290433|590205522|FG000|Overall Study|Congestive Heart Failure|1|||
163132680|NCT04776317|589194315|FG003|Overall Study|Physician Decision|0|||
163132681|NCT04776317|589194316|FG004|Overall Study|Physician Decision|0|||
163132682|NCT04776317|589194317|FG005|Overall Study|Physician Decision|0|||
163132683|NCT04776317|589194318|FG006|Overall Study|Physician Decision|0|||
163132684|NCT04776317|589194319|FG007|Overall Study|Physician Decision|0|||
163132685|NCT04776317|589194320|FG008|Overall Study|Physician Decision|0|||
163132686|NCT04776317|589194321|FG009|Overall Study|Physician Decision|0|||
163132687|NCT04776317|589194322|FG010|Overall Study|Physician Decision|0|||
163132688|NCT04776317|589194323|FG011|Overall Study|Physician Decision|0|||
163132689|NCT04776317|589194324|FG012|Overall Study|Physician Decision|0|||
163132690|NCT04776317|589194325|FG013|Overall Study|Physician Decision|0|||
163132691|NCT04776317|589194326|FG014|Overall Study|Physician Decision|0|||
163132692|NCT04776317|589194312|FG000|Overall Study|Protocol Violation|0|||
163132693|NCT04776317|589194313|FG001|Overall Study|Protocol Violation|0|||
163132694|NCT04776317|589194314|FG002|Overall Study|Protocol Violation|1|||
163132695|NCT04776317|589194315|FG003|Overall Study|Protocol Violation|0|||
163132696|NCT04776317|589194316|FG004|Overall Study|Protocol Violation|0|||
163132697|NCT04776317|589194317|FG005|Overall Study|Protocol Violation|0|||
163132698|NCT04776317|589194318|FG006|Overall Study|Protocol Violation|0|||
163132699|NCT04776317|589194319|FG007|Overall Study|Protocol Violation|0|||
163132700|NCT04776317|589194320|FG008|Overall Study|Protocol Violation|0|||
163132701|NCT04776317|589194321|FG009|Overall Study|Protocol Violation|0|||
163132702|NCT04776317|589194322|FG010|Overall Study|Protocol Violation|0|||
163132703|NCT04776317|589194323|FG011|Overall Study|Protocol Violation|0|||
163132704|NCT04776317|589194324|FG012|Overall Study|Protocol Violation|0|||
163132705|NCT04776317|589194325|FG013|Overall Study|Protocol Violation|0|||
163132706|NCT04776317|589194326|FG014|Overall Study|Protocol Violation|0|||
163132707|NCT04776317|589194312|FG000|Overall Study|Withdrawal by Subject|0|||
163132708|NCT04776317|589194313|FG001|Overall Study|Withdrawal by Subject|0|||
163132709|NCT04776317|589194314|FG002|Overall Study|Withdrawal by Subject|0|||
163132710|NCT04776317|589194315|FG003|Overall Study|Withdrawal by Subject|0|||
163132711|NCT04776317|589194316|FG004|Overall Study|Withdrawal by Subject|1|||
163132712|NCT04776317|589194317|FG005|Overall Study|Withdrawal by Subject|0|||
163132713|NCT04776317|589194318|FG006|Overall Study|Withdrawal by Subject|0|||
163132714|NCT04776317|589194319|FG007|Overall Study|Withdrawal by Subject|0|||
163132715|NCT04776317|589194320|FG008|Overall Study|Withdrawal by Subject|0|||
163132716|NCT04776317|589194321|FG009|Overall Study|Withdrawal by Subject|0|||
163132717|NCT04776317|589194322|FG010|Overall Study|Withdrawal by Subject|0|||
163132718|NCT04776317|589194323|FG011|Overall Study|Withdrawal by Subject|0|||
163132719|NCT04776317|589194324|FG012|Overall Study|Withdrawal by Subject|0|||
163132720|NCT04776317|589194325|FG013|Overall Study|Withdrawal by Subject|0|||
163132721|NCT04776317|589194326|FG014|Overall Study|Withdrawal by Subject|0|||
163132722|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
163132723|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
163132724|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
163132725|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
163132726|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
163132727|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
163132728|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
163132729|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
163132730|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
163132731|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
163132732|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
163132733|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
163132734|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
163132735|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
163228154|NCT02346240|589548035|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228155|NCT02346240|589548036|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163228156|NCT02346240|589548037|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163132736|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
163132737|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
163132738|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
163132739|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
163132740|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
163132741|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
163132742|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
163132743|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
163132744|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
163132745|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
163132746|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
163132747|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
163228157|NCT02346240|589548014|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228158|NCT02346240|589548015|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228159|NCT02346240|589548016|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228160|NCT02346240|589548017|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228161|NCT02346240|589548018|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228162|NCT02346240|589548019|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228163|NCT02346240|589548020|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228164|NCT02346240|589548021|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228165|NCT02346240|589548022|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228166|NCT02346240|589548023|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228167|NCT02346240|589548024|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
163228168|NCT02346240|589548025|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228169|NCT02346240|589548026|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228170|NCT02346240|589548027|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228171|NCT02346240|589548028|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228172|NCT02346240|589548029|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228173|NCT02346240|589548030|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228174|NCT02346240|589548031|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228175|NCT02346240|589548032|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228176|NCT02346240|589548033|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228177|NCT02346240|589548034|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228178|NCT02346240|589548035|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228179|NCT02346240|589548036|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228180|NCT02346240|589548037|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163228181|NCT02346240|589548014|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228182|NCT02346240|589548015|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228183|NCT02346240|589548016|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228184|NCT02346240|589548017|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163344780|NCT00296504|589972040|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
163344781|NCT00296504|589972041|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
163344782|NCT00296504|589972042|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
163344783|NCT00296504|589972043|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
163344784|NCT00296504|589972035|FG000|Interim Analysis|Pregnancy|4|||
163344785|NCT00296504|589972036|FG001|Interim Analysis|Pregnancy|1|||
163344786|NCT00296504|589972037|FG002|Interim Analysis|Pregnancy|4|||
163344787|NCT00296504|589972038|FG003|Interim Analysis|Pregnancy|2|||
163344788|NCT00296504|589972039|FG004|Interim Analysis|Pregnancy|0|||
163344789|NCT00296504|589972040|FG005|Interim Analysis|Pregnancy|1|||
163344790|NCT00296504|589972041|FG006|Interim Analysis|Pregnancy|1|||
163344791|NCT00296504|589972042|FG007|Interim Analysis|Pregnancy|1|||
163344792|NCT00296504|589972043|FG008|Interim Analysis|Pregnancy|0|||
163344793|NCT00296504|589972035|FG000|Interim Analysis|Death|1|||
163344794|NCT00296504|589972036|FG001|Interim Analysis|Death|0|||
163344795|NCT00296504|589972037|FG002|Interim Analysis|Death|3|||
163344796|NCT00296504|589972038|FG003|Interim Analysis|Death|0|||
163344797|NCT00296504|589972039|FG004|Interim Analysis|Death|0|||
163408468|NCT00290433|590205522|FG000|Overall Study|Transplant in CR|5|||
163132748|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132749|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
163132750|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
163132751|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132752|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132753|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
163132754|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
163132755|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132756|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132757|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132758|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132759|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132760|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132761|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132762|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
163132763|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
163132764|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163344798|NCT00296504|589972040|FG005|Interim Analysis|Death|0|||
163344799|NCT00296504|589972041|FG006|Interim Analysis|Death|0|||
163344800|NCT00296504|589972042|FG007|Interim Analysis|Death|0|||
163344801|NCT00296504|589972043|FG008|Interim Analysis|Death|0|||
163344802|NCT00296504|589972035|FG000|Interim Analysis|Participant Non-compliant|0|||
163344803|NCT00296504|589972036|FG001|Interim Analysis|Participant Non-compliant|1|||
163344804|NCT00296504|589972037|FG002|Interim Analysis|Participant Non-compliant|2|||
163344805|NCT00296504|589972038|FG003|Interim Analysis|Participant Non-compliant|1|||
163344806|NCT00296504|589972039|FG004|Interim Analysis|Participant Non-compliant|1|||
163344807|NCT00296504|589972040|FG005|Interim Analysis|Participant Non-compliant|3|||
163344808|NCT00296504|589972041|FG006|Interim Analysis|Participant Non-compliant|6|||
163344809|NCT00296504|589972042|FG007|Interim Analysis|Participant Non-compliant|2|||
163344810|NCT00296504|589972043|FG008|Interim Analysis|Participant Non-compliant|0|||
163344811|NCT00296504|589972035|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
163344812|NCT00296504|589972036|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
163344813|NCT00296504|589972037|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
163344814|NCT00296504|589972038|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
163344815|NCT00296504|589972039|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
163344816|NCT00296504|589972040|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
163344817|NCT00296504|589972041|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
163344818|NCT00296504|589972042|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
163344819|NCT00296504|589972043|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
163344820|NCT00296504|589972035|FG000|Interim Analysis|To Simplify Treatment|0|||
163408469|NCT00290433|590205522|FG000|Overall Study|Unrelated Infection/Death|1|||
163408470|NCT02264990|590205527|FG000|Overall Study|Death|255|||
163132765|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132766|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132767|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
163132768|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132769|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
163132770|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132771|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132772|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132773|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132774|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132775|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132776|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132777|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
163132778|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132779|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132780|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132781|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
163132782|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132783|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132784|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132785|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132786|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132787|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132788|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132789|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132790|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
163132791|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132792|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132793|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
163132794|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132795|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132796|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132797|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132798|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132799|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132800|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132801|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
163132802|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132803|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132804|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132805|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132806|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132807|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132808|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163344821|NCT00296504|589972036|FG001|Interim Analysis|To Simplify Treatment|0|||
163228185|NCT02346240|589548018|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228186|NCT02346240|589548019|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228187|NCT02346240|589548020|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228188|NCT02346240|589548021|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228189|NCT02346240|589548022|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228190|NCT02346240|589548023|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228191|NCT02346240|589548024|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228192|NCT02346240|589548025|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228193|NCT02346240|589548026|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228194|NCT02346240|589548027|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228195|NCT02346240|589548028|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
163228196|NCT02346240|589548029|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228197|NCT02346240|589548030|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228198|NCT02346240|589548031|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228199|NCT02346240|589548032|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228200|NCT02346240|589548033|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228201|NCT02346240|589548034|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228202|NCT02346240|589548035|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228203|NCT02346240|589548036|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228204|NCT02346240|589548037|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163228205|NCT02346240|589548014|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228206|NCT02346240|589548015|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228207|NCT02346240|589548016|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228208|NCT02346240|589548017|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228209|NCT02346240|589548018|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228210|NCT02346240|589548019|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228211|NCT02346240|589548020|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228212|NCT02346240|589548021|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228213|NCT02346240|589548022|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228214|NCT02346240|589548023|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228215|NCT02346240|589548024|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228216|NCT02346240|589548025|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228217|NCT02346240|589548026|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228218|NCT02346240|589548027|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228219|NCT02346240|589548028|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
163228220|NCT02346240|589548029|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228221|NCT02346240|589548030|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228222|NCT02346240|589548031|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228223|NCT02346240|589548032|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228224|NCT02346240|589548033|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228225|NCT02346240|589548034|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163344822|NCT00296504|589972037|FG002|Interim Analysis|To Simplify Treatment|1|||
163344823|NCT00296504|589972038|FG003|Interim Analysis|To Simplify Treatment|0|||
163344824|NCT00296504|589972039|FG004|Interim Analysis|To Simplify Treatment|0|||
163132809|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132810|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132811|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132812|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132813|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
163132814|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132815|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132816|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132817|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132818|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132819|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132820|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132821|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132822|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132823|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132824|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132825|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132826|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132827|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163344825|NCT00296504|589972040|FG005|Interim Analysis|To Simplify Treatment|0|||
163344826|NCT00296504|589972041|FG006|Interim Analysis|To Simplify Treatment|2|||
163344827|NCT00296504|589972042|FG007|Interim Analysis|To Simplify Treatment|0|||
163344828|NCT00296504|589972043|FG008|Interim Analysis|To Simplify Treatment|0|||
163344829|NCT00296504|589972035|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
163344830|NCT00296504|589972036|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
163344831|NCT00296504|589972037|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
163344832|NCT00296504|589972038|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
163344833|NCT00296504|589972039|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
163344834|NCT00296504|589972040|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
163344835|NCT00296504|589972041|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
163344836|NCT00296504|589972042|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
163344837|NCT00296504|589972043|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
163344838|NCT00296504|589972035|FG000|Interim Analysis|Participant Moved|1|||
163344839|NCT00296504|589972036|FG001|Interim Analysis|Participant Moved|0|||
163344840|NCT00296504|589972037|FG002|Interim Analysis|Participant Moved|1|||
163344841|NCT00296504|589972038|FG003|Interim Analysis|Participant Moved|0|||
163344842|NCT00296504|589972039|FG004|Interim Analysis|Participant Moved|0|||
163344843|NCT00296504|589972040|FG005|Interim Analysis|Participant Moved|1|||
163344844|NCT00296504|589972041|FG006|Interim Analysis|Participant Moved|1|||
163344845|NCT00296504|589972042|FG007|Interim Analysis|Participant Moved|0|||
163344846|NCT00296504|589972043|FG008|Interim Analysis|Participant Moved|0|||
163344847|NCT00296504|589972035|FG000|Interim Analysis|Participant Was Incarcerated|2|||
163344848|NCT00296504|589972036|FG001|Interim Analysis|Participant Was Incarcerated|0|||
163344849|NCT00296504|589972037|FG002|Interim Analysis|Participant Was Incarcerated|1|||
163344850|NCT00296504|589972038|FG003|Interim Analysis|Participant Was Incarcerated|0|||
163344851|NCT00296504|589972039|FG004|Interim Analysis|Participant Was Incarcerated|0|||
163344852|NCT00296504|589972040|FG005|Interim Analysis|Participant Was Incarcerated|0|||
163344853|NCT00296504|589972041|FG006|Interim Analysis|Participant Was Incarcerated|0|||
163344854|NCT00296504|589972042|FG007|Interim Analysis|Participant Was Incarcerated|0|||
163344855|NCT00296504|589972043|FG008|Interim Analysis|Participant Was Incarcerated|0|||
163344856|NCT00296504|589972035|FG000|Interim Analysis|Resistance to FPV|0|||
163344857|NCT00296504|589972036|FG001|Interim Analysis|Resistance to FPV|0|||
163344858|NCT00296504|589972037|FG002|Interim Analysis|Resistance to FPV|1|||
163344859|NCT00296504|589972038|FG003|Interim Analysis|Resistance to FPV|0|||
163344860|NCT00296504|589972039|FG004|Interim Analysis|Resistance to FPV|0|||
163344861|NCT00296504|589972040|FG005|Interim Analysis|Resistance to FPV|0|||
163344862|NCT00296504|589972041|FG006|Interim Analysis|Resistance to FPV|0|||
163344863|NCT00296504|589972042|FG007|Interim Analysis|Resistance to FPV|0|||
163344864|NCT00296504|589972043|FG008|Interim Analysis|Resistance to FPV|0|||
163344865|NCT00296504|589972035|FG000|Interim Analysis|Physician Decision|0|||
163344866|NCT00296504|589972036|FG001|Interim Analysis|Physician Decision|0|||
163344867|NCT00296504|589972037|FG002|Interim Analysis|Physician Decision|1|||
163344868|NCT00296504|589972038|FG003|Interim Analysis|Physician Decision|0|||
163344869|NCT00296504|589972039|FG004|Interim Analysis|Physician Decision|0|||
163344870|NCT00296504|589972040|FG005|Interim Analysis|Physician Decision|0|||
163344871|NCT00296504|589972041|FG006|Interim Analysis|Physician Decision|0|||
163344872|NCT00296504|589972042|FG007|Interim Analysis|Physician Decision|0|||
163344873|NCT00296504|589972043|FG008|Interim Analysis|Physician Decision|0|||
163344874|NCT00296504|589972035|FG000|Interim Analysis|Principle Investigator Discretion|2|||
163344875|NCT00296504|589972036|FG001|Interim Analysis|Principle Investigator Discretion|0|||
163344876|NCT00296504|589972037|FG002|Interim Analysis|Principle Investigator Discretion|1|||
163344877|NCT00296504|589972038|FG003|Interim Analysis|Principle Investigator Discretion|1|||
163344878|NCT00296504|589972039|FG004|Interim Analysis|Principle Investigator Discretion|0|||
163344879|NCT00296504|589972040|FG005|Interim Analysis|Principle Investigator Discretion|0|||
163344880|NCT00296504|589972041|FG006|Interim Analysis|Principle Investigator Discretion|0|||
163344881|NCT00296504|589972042|FG007|Interim Analysis|Principle Investigator Discretion|0|||
163344882|NCT00296504|589972043|FG008|Interim Analysis|Principle Investigator Discretion|0|||
163344883|NCT00296504|589972035|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
163344884|NCT00296504|589972036|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
163344885|NCT00296504|589972037|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
163344886|NCT00296504|589972038|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
163344887|NCT00296504|589972039|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
163344888|NCT00296504|589972040|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
163344889|NCT00296504|589972041|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
163344890|NCT00296504|589972042|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
163344891|NCT00296504|589972043|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
163344892|NCT00296504|589972035|FG000|Interim Analysis|Non-adherence|2|||
163344893|NCT00296504|589972036|FG001|Interim Analysis|Non-adherence|0|||
163344894|NCT00296504|589972037|FG002|Interim Analysis|Non-adherence|0|||
163344895|NCT00296504|589972038|FG003|Interim Analysis|Non-adherence|0|||
163228226|NCT02346240|589548035|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228227|NCT02346240|589548036|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228228|NCT02346240|589548037|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163228229|NCT02346240|589548014|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228230|NCT02346240|589548015|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228231|NCT02346240|589548016|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228232|NCT02346240|589548017|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228233|NCT02346240|589548018|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228234|NCT02346240|589548019|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228235|NCT02346240|589548020|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228236|NCT02346240|589548021|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228237|NCT02346240|589548022|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228238|NCT02346240|589548023|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228239|NCT02346240|589548024|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228240|NCT02346240|589548025|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228241|NCT02346240|589548026|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228242|NCT02346240|589548027|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163344896|NCT00296504|589972039|FG004|Interim Analysis|Non-adherence|1|||
163344897|NCT00296504|589972040|FG005|Interim Analysis|Non-adherence|0|||
163344898|NCT00296504|589972041|FG006|Interim Analysis|Non-adherence|0|||
163344899|NCT00296504|589972042|FG007|Interim Analysis|Non-adherence|1|||
163344900|NCT00296504|589972043|FG008|Interim Analysis|Non-adherence|0|||
163344901|NCT00296504|589972035|FG000|Interim Analysis|Site Closing|1|||
163344902|NCT00296504|589972036|FG001|Interim Analysis|Site Closing|0|||
163132828|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132829|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132830|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132831|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132832|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
163132833|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132834|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132835|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132836|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132837|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132838|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132839|NCT03100058|589194328|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132840|NCT03100058|589194329|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132841|NCT03100058|589194330|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132842|NCT03100058|589194331|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132843|NCT03100058|589194332|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132844|NCT03100058|589194333|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132845|NCT03100058|589194334|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132846|NCT03100058|589194335|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132847|NCT03100058|589194336|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132848|NCT03100058|589194337|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132849|NCT03100058|589194338|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
163132850|NCT03100058|589194339|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
163132851|NCT03100058|589194340|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
163132852|NCT03100058|589194328|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132853|NCT03100058|589194329|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132854|NCT03100058|589194330|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132855|NCT03100058|589194331|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132856|NCT03100058|589194332|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132857|NCT03100058|589194333|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132858|NCT03100058|589194334|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132859|NCT03100058|589194335|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132860|NCT03100058|589194336|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132861|NCT03100058|589194337|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132862|NCT03100058|589194338|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
163132863|NCT03100058|589194339|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
163132864|NCT03100058|589194340|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132865|NCT03100058|589194328|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132866|NCT03100058|589194329|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132867|NCT03100058|589194330|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163344903|NCT00296504|589972037|FG002|Interim Analysis|Site Closing|0|||
163344904|NCT00296504|589972038|FG003|Interim Analysis|Site Closing|0|||
163344905|NCT00296504|589972039|FG004|Interim Analysis|Site Closing|0|||
163344906|NCT00296504|589972040|FG005|Interim Analysis|Site Closing|1|||
163344907|NCT00296504|589972041|FG006|Interim Analysis|Site Closing|2|||
163344908|NCT00296504|589972042|FG007|Interim Analysis|Site Closing|0|||
163344909|NCT00296504|589972043|FG008|Interim Analysis|Site Closing|0|||
163344910|NCT00296504|589972035|FG000|Interim Analysis|Lack of Personnel at Site|1|||
163344911|NCT00296504|589972036|FG001|Interim Analysis|Lack of Personnel at Site|0|||
163344912|NCT00296504|589972037|FG002|Interim Analysis|Lack of Personnel at Site|0|||
163344913|NCT00296504|589972038|FG003|Interim Analysis|Lack of Personnel at Site|0|||
163344914|NCT00296504|589972039|FG004|Interim Analysis|Lack of Personnel at Site|0|||
163344915|NCT00296504|589972040|FG005|Interim Analysis|Lack of Personnel at Site|0|||
163228243|NCT02346240|589548028|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
163228244|NCT02346240|589548029|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228245|NCT02346240|589548030|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228246|NCT02346240|589548031|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228247|NCT02346240|589548032|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228248|NCT02346240|589548033|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228249|NCT02346240|589548034|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228250|NCT02346240|589548035|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228251|NCT02346240|589548036|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228252|NCT02346240|589548037|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163228253|NCT02346240|589548014|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228254|NCT02346240|589548015|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228255|NCT02346240|589548016|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228256|NCT02346240|589548017|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228257|NCT02346240|589548018|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228258|NCT02346240|589548019|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228259|NCT02346240|589548020|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228260|NCT02346240|589548021|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228261|NCT02346240|589548022|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228262|NCT02346240|589548023|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228263|NCT02346240|589548024|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228264|NCT02346240|589548025|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228265|NCT02346240|589548026|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228266|NCT02346240|589548027|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228267|NCT02346240|589548028|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228268|NCT02346240|589548029|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228269|NCT02346240|589548030|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163228270|NCT02346240|589548031|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
163228271|NCT02346240|589548032|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
163228272|NCT02346240|589548033|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
163228273|NCT02346240|589548034|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
163228274|NCT02346240|589548035|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
163228275|NCT02346240|589548036|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
163228276|NCT02346240|589548037|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
163228277|NCT02346240|589548014|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228278|NCT02346240|589548015|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228279|NCT02346240|589548016|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228280|NCT02346240|589548017|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228281|NCT02346240|589548018|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228282|NCT02346240|589548019|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228283|NCT02346240|589548020|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228284|NCT02346240|589548021|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228285|NCT02346240|589548022|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228286|NCT02346240|589548023|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228287|NCT02346240|589548024|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
163344916|NCT00296504|589972041|FG006|Interim Analysis|Lack of Personnel at Site|0|||
163344917|NCT00296504|589972042|FG007|Interim Analysis|Lack of Personnel at Site|0|||
163344918|NCT00296504|589972043|FG008|Interim Analysis|Lack of Personnel at Site|0|||
163344919|NCT00296504|589972035|FG000|Interim Analysis|Missed Schedule Date|1|||
163344920|NCT00296504|589972036|FG001|Interim Analysis|Missed Schedule Date|0|||
163344921|NCT00296504|589972037|FG002|Interim Analysis|Missed Schedule Date|0|||
163344922|NCT00296504|589972038|FG003|Interim Analysis|Missed Schedule Date|0|||
163344923|NCT00296504|589972039|FG004|Interim Analysis|Missed Schedule Date|0|||
163344924|NCT00296504|589972040|FG005|Interim Analysis|Missed Schedule Date|0|||
163228288|NCT02346240|589548025|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228289|NCT02346240|589548026|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228290|NCT02346240|589548027|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228291|NCT02346240|589548028|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228292|NCT02346240|589548029|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228293|NCT02346240|589548030|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228294|NCT02346240|589548031|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228295|NCT02346240|589548032|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
163228296|NCT02346240|589548033|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
163228297|NCT02346240|589548034|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228298|NCT02346240|589548035|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
163228299|NCT02346240|589548036|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228300|NCT02346240|589548037|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
163228301|NCT02346240|589548014|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228302|NCT02346240|589548015|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228303|NCT02346240|589548016|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228304|NCT02346240|589548017|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228305|NCT02346240|589548018|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228306|NCT02346240|589548019|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228307|NCT02346240|589548020|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228308|NCT02346240|589548021|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228309|NCT02346240|589548022|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228310|NCT02346240|589548023|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228311|NCT02346240|589548024|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228312|NCT02346240|589548025|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228313|NCT02346240|589548026|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228314|NCT02346240|589548027|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228315|NCT02346240|589548028|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228316|NCT02346240|589548029|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228317|NCT02346240|589548030|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228318|NCT02346240|589548031|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228319|NCT02346240|589548032|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
163228320|NCT02346240|589548033|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228321|NCT02346240|589548034|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228322|NCT02346240|589548035|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
163228323|NCT02346240|589548036|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228324|NCT02346240|589548037|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163228325|NCT02346240|589548014|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228326|NCT02346240|589548015|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228327|NCT02346240|589548016|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228328|NCT02346240|589548017|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163344925|NCT00296504|589972041|FG006|Interim Analysis|Missed Schedule Date|0|||
163344926|NCT00296504|589972042|FG007|Interim Analysis|Missed Schedule Date|0|||
163344927|NCT00296504|589972043|FG008|Interim Analysis|Missed Schedule Date|0|||
163344928|NCT00296504|589972035|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
163344929|NCT00296504|589972036|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
163344930|NCT00296504|589972037|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
163132868|NCT03100058|589194331|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132869|NCT03100058|589194332|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132870|NCT03100058|589194333|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132871|NCT03100058|589194334|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132872|NCT03100058|589194335|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132873|NCT03100058|589194336|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132874|NCT03100058|589194337|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
163132875|NCT03100058|589194338|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
163132876|NCT03100058|589194339|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132877|NCT03100058|589194340|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
163132878|NCT03100058|589194328|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132879|NCT03100058|589194329|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132880|NCT03100058|589194330|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132881|NCT03100058|589194331|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132882|NCT03100058|589194332|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132883|NCT03100058|589194333|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132884|NCT03100058|589194334|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132885|NCT03100058|589194335|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132886|NCT03100058|589194336|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132887|NCT03100058|589194337|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163344931|NCT00296504|589972038|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
163344932|NCT00296504|589972039|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
163344933|NCT00296504|589972040|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
163132888|NCT03100058|589194338|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
163132889|NCT03100058|589194339|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132890|NCT03100058|589194340|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132891|NCT03100058|589194328|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132892|NCT03100058|589194329|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132893|NCT03100058|589194330|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132894|NCT03100058|589194331|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132895|NCT03100058|589194332|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132896|NCT03100058|589194333|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132897|NCT03100058|589194334|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132898|NCT03100058|589194335|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132899|NCT03100058|589194336|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132900|NCT03100058|589194337|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132901|NCT03100058|589194338|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132902|NCT03100058|589194339|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132903|NCT03100058|589194340|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
163132904|NCT03100058|589194328|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132905|NCT03100058|589194329|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132906|NCT03100058|589194330|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132907|NCT03100058|589194331|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132908|NCT03100058|589194332|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132909|NCT03100058|589194333|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132910|NCT03100058|589194334|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132911|NCT03100058|589194335|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132912|NCT03100058|589194336|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132913|NCT03100058|589194337|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
163132914|NCT03100058|589194338|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132915|NCT03100058|589194339|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132916|NCT03100058|589194340|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132917|NCT03671304|589194343|FG000|Overall Study|study terminated|7|||
163132918|NCT01067144|589194344|FG000|Treatment|Did not receive allocated intervention|4|||
163132919|NCT01067144|589194345|FG001|Treatment|Did not receive allocated intervention|7|||
163132920|NCT01067144|589194344|FG000|Follow-up|Lost to Follow-up|22|||
163132921|NCT01067144|589194345|FG001|Follow-up|Lost to Follow-up|12|||
163132922|NCT01067144|589194344|FG000|Follow-up|Censored owing to second surgery|19|||
163132923|NCT01067144|589194345|FG001|Follow-up|Censored owing to second surgery|28|||
163132924|NCT01067144|589194344|FG000|Follow-up|Withdrawal by Subject|18|||
163132925|NCT01067144|589194345|FG001|Follow-up|Withdrawal by Subject|14|||
163132926|NCT01067144|589194344|FG000|Follow-up|Surgery cancelled|0|||
163132927|NCT01067144|589194345|FG001|Follow-up|Surgery cancelled|1|||
163132928|NCT01067144|589194344|FG000|Follow-up|Death|0|||
163132929|NCT01067144|589194345|FG001|Follow-up|Death|1|||
163132930|NCT02718716|589194347|FG000|Overall Study|Lack of Efficacy|1|||
163132931|NCT02718716|589194348|FG001|Overall Study|Lack of Efficacy|0|||
163132932|NCT02718716|589194349|FG002|Overall Study|Lack of Efficacy|0|||
163132933|NCT02718716|589194350|FG003|Overall Study|Lack of Efficacy|0|||
163132934|NCT02718716|589194351|FG004|Overall Study|Lack of Efficacy|0|||
163132935|NCT00532298|589194352|FG000|Overall Study|Adverse Event|1|||
163132936|NCT00532298|589194353|FG001|Overall Study|Adverse Event|0|||
163132937|NCT00532298|589194354|FG002|Overall Study|Adverse Event|0|||
163132938|NCT00532298|589194355|FG003|Overall Study|Adverse Event|0|||
163132939|NCT00532298|589194356|FG004|Overall Study|Adverse Event|1|||
163132940|NCT00532298|589194357|FG005|Overall Study|Adverse Event|1|||
163132941|NCT00532298|589194352|FG000|Overall Study|Lost to Follow-up|1|||
163132942|NCT00532298|589194353|FG001|Overall Study|Lost to Follow-up|1|||
163132943|NCT00532298|589194354|FG002|Overall Study|Lost to Follow-up|1|||
163132944|NCT00532298|589194355|FG003|Overall Study|Lost to Follow-up|0|||
163132945|NCT00532298|589194356|FG004|Overall Study|Lost to Follow-up|0|||
163132946|NCT00532298|589194357|FG005|Overall Study|Lost to Follow-up|1|||
163132947|NCT00479856|589194358|FG000|Overall Study|Adverse Event|1|||
163132948|NCT00479856|589194358|FG000|Overall Study|Withdrawal by Subject|1|||
163132949|NCT00479856|589194358|FG000|Overall Study|Physician Decision|1|||
163132950|NCT02141360|589194363|FG000|Overall Study|Withdrawal by Subject|6|||
163132951|NCT02141360|589194364|FG001|Overall Study|Withdrawal by Subject|0|||
163132952|NCT02141360|589194365|FG002|Overall Study|Withdrawal by Subject|0|||
163132953|NCT02141360|589194363|FG000|Overall Study|Study Terminated before Visit|1|||
163344934|NCT00296504|589972041|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
163344935|NCT00296504|589972042|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
163344936|NCT00296504|589972043|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
163132954|NCT02141360|589194364|FG001|Overall Study|Study Terminated before Visit|0|||
163132955|NCT02141360|589194365|FG002|Overall Study|Study Terminated before Visit|0|||
163132956|NCT00646399|589194366|FG000|Overall Study|Death|63|||
163132957|NCT00646399|589194367|FG001|Overall Study|Death|53|||
163132958|NCT00646399|589194366|FG000|Overall Study|Withdrawal by Subject|9|||
163132959|NCT00646399|589194367|FG001|Overall Study|Withdrawal by Subject|10|||
163132960|NCT00646399|589194366|FG000|Overall Study|Other Reason|11|||
163132961|NCT00646399|589194367|FG001|Overall Study|Other Reason|11|||
163132962|NCT00661622|589194368|FG000|Overall Study|Protocol Violation|1|||
163132963|NCT00661622|589194369|FG001|Overall Study|Protocol Violation|0|||
163132964|NCT02332291|589194374|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
163132965|NCT02332291|589194375|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
163132966|NCT02332291|589194374|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
163132967|NCT02332291|589194375|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
163132968|NCT02332291|589194374|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
163132969|NCT02332291|589194375|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
163132970|NCT02332291|589194374|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
163132971|NCT02332291|589194375|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
163132972|NCT02332291|589194374|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
163132973|NCT02332291|589194375|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
163132974|NCT02332291|589194374|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
163132975|NCT02332291|589194375|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
163132976|NCT01424228|589194378|FG000|Overall Study|Withdrawal by Subject|27|||
163132977|NCT01424228|589194379|FG001|Overall Study|Withdrawal by Subject|11|||
163132978|NCT01424228|589194378|FG000|Overall Study|Adverse Event|10|||
163132979|NCT01424228|589194379|FG001|Overall Study|Adverse Event|14|||
163132980|NCT01424228|589194378|FG000|Overall Study|Sponsor's decision|9|||
163132981|NCT01424228|589194379|FG001|Overall Study|Sponsor's decision|12|||
163132982|NCT01424228|589194378|FG000|Overall Study|Lack of Efficacy|5|||
163132983|NCT01424228|589194379|FG001|Overall Study|Lack of Efficacy|7|||
163132984|NCT01424228|589194378|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
163132985|NCT01424228|589194379|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
163132986|NCT01424228|589194378|FG000|Overall Study|Non-compliance|2|||
163132987|NCT01424228|589194379|FG001|Overall Study|Non-compliance|0|||
163132988|NCT01424228|589194378|FG000|Overall Study|Worsening of symptoms|1|||
163132989|NCT01424228|589194379|FG001|Overall Study|Worsening of symptoms|0|||
163132990|NCT01424228|589194378|FG000|Overall Study|Unplanned journey|0|||
163132991|NCT01424228|589194379|FG001|Overall Study|Unplanned journey|1|||
163132992|NCT00844558|589194380|FG000|Overall Study|Withdrawal by Subject|9|||
163132993|NCT00844558|589194381|FG001|Overall Study|Withdrawal by Subject|2|||
163132994|NCT00844558|589194380|FG000|Overall Study|Death|1|||
163132995|NCT00844558|589194381|FG001|Overall Study|Death|0|||
163132996|NCT00844558|589194380|FG000|Overall Study|Protocol Violation|1|||
163132997|NCT00844558|589194381|FG001|Overall Study|Protocol Violation|1|||
163132998|NCT00844558|589194380|FG000|Overall Study|Lost to Follow-up|0|||
163344937|NCT00296504|589972035|FG000|Interim Analysis|Participant Stopped|0|||
163344938|NCT00296504|589972036|FG001|Interim Analysis|Participant Stopped|0|||
163344939|NCT00296504|589972037|FG002|Interim Analysis|Participant Stopped|0|||
163344940|NCT00296504|589972038|FG003|Interim Analysis|Participant Stopped|0|||
163344941|NCT00296504|589972039|FG004|Interim Analysis|Participant Stopped|1|||
163344942|NCT00296504|589972040|FG005|Interim Analysis|Participant Stopped|0|||
163344943|NCT00296504|589972041|FG006|Interim Analysis|Participant Stopped|0|||
163344944|NCT00296504|589972042|FG007|Interim Analysis|Participant Stopped|0|||
163344945|NCT00296504|589972043|FG008|Interim Analysis|Participant Stopped|0|||
163344946|NCT00296504|589972035|FG000|Interim Analysis|Physician and Participant Decision|0|||
163344947|NCT00296504|589972036|FG001|Interim Analysis|Physician and Participant Decision|0|||
163344948|NCT00296504|589972037|FG002|Interim Analysis|Physician and Participant Decision|0|||
163344949|NCT00296504|589972038|FG003|Interim Analysis|Physician and Participant Decision|0|||
163344950|NCT00296504|589972039|FG004|Interim Analysis|Physician and Participant Decision|0|||
163344951|NCT00296504|589972040|FG005|Interim Analysis|Physician and Participant Decision|1|||
163344952|NCT00296504|589972041|FG006|Interim Analysis|Physician and Participant Decision|0|||
163344953|NCT00296504|589972042|FG007|Interim Analysis|Physician and Participant Decision|0|||
163344954|NCT00296504|589972043|FG008|Interim Analysis|Physician and Participant Decision|0|||
163344955|NCT00296504|589972035|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
163344956|NCT00296504|589972036|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
163344957|NCT00296504|589972037|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
163344958|NCT00296504|589972038|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
163132999|NCT00844558|589194381|FG001|Overall Study|Lost to Follow-up|1|||
163344959|NCT00296504|589972039|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
163344960|NCT00296504|589972040|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
163344961|NCT00296504|589972041|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
163344962|NCT00296504|589972042|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
163133000|NCT00844558|589194380|FG000|Overall Study|Physician Decision|1|||
163133001|NCT00844558|589194381|FG001|Overall Study|Physician Decision|0|||
163133002|NCT01068158|589194386|FG000|Overall Study|Withdrawal by Subject|1|||
163133003|NCT01068158|589194387|FG001|Overall Study|Withdrawal by Subject|2|||
163133004|NCT01068158|589194386|FG000|Overall Study|Lost to Follow-up|7|||
163133005|NCT01068158|589194387|FG001|Overall Study|Lost to Follow-up|0|||
163133006|NCT01068158|589194386|FG000|Overall Study|Protocol Violation|0|||
163133007|NCT01068158|589194387|FG001|Overall Study|Protocol Violation|2|||
163133008|NCT02478255|589194388|FG000|Overall Study|Physician Decision|6|||
163133009|NCT02478255|589194389|FG001|Overall Study|Physician Decision|0|||
163133010|NCT02478255|589194388|FG000|Overall Study|Withdrawal by Subject|2|||
163133011|NCT02478255|589194389|FG001|Overall Study|Withdrawal by Subject|0|||
163133012|NCT02813889|589195680|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
163133013|NCT02813889|589195681|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
163133014|NCT02974257|589195685|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
163133015|NCT02974257|589195686|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
163133016|NCT02974257|589195685|FG000|Overall Study|Clinical indication for thiamine|1|||
163133017|NCT02974257|589195686|FG001|Overall Study|Clinical indication for thiamine|0|||
163133018|NCT02974257|589195685|FG000|Overall Study|Already on thiamine|1|||
163133019|NCT02974257|589195686|FG001|Overall Study|Already on thiamine|0|||
163133020|NCT02974257|589195685|FG000|Overall Study|Extubated prior to study drug|0|||
163133021|NCT02974257|589195686|FG001|Overall Study|Extubated prior to study drug|1|||
163133022|NCT02974257|589195685|FG000|Overall Study|Death|0|||
163133023|NCT02974257|589195686|FG001|Overall Study|Death|1|||
163133024|NCT00398567|589195687|FG000|Overall Study|Disease Progression|3|||
163133025|NCT00398567|589195688|FG001|Overall Study|Disease Progression|4|||
163133026|NCT00398567|589195689|FG002|Overall Study|Disease Progression|27|||
163133027|NCT00398567|589195687|FG000|Overall Study|Withdrawal by Subject|1|||
163133028|NCT00398567|589195688|FG001|Overall Study|Withdrawal by Subject|0|||
163133029|NCT00398567|589195689|FG002|Overall Study|Withdrawal by Subject|4|||
163133030|NCT00398567|589195687|FG000|Overall Study|Adverse Event|0|||
163133031|NCT00398567|589195688|FG001|Overall Study|Adverse Event|0|||
163133032|NCT00398567|589195689|FG002|Overall Study|Adverse Event|2|||
163133033|NCT00398567|589195687|FG000|Overall Study|Protocol Violation|0|||
163133034|NCT00398567|589195688|FG001|Overall Study|Protocol Violation|0|||
163133035|NCT00398567|589195689|FG002|Overall Study|Protocol Violation|1|||
163133036|NCT00793325|589195690|FG000|Overall Study|Protocol Violation|18|||
163133037|NCT00793325|589195690|FG000|Overall Study|Lost to Follow-up|1|||
163133038|NCT03250182|589195696|FG000|Overall Study|Withdrawal by Subject|1|||
163133039|NCT03472950|589195699|FG000|Overall Study|Lost to Follow-up|0|||
163133040|NCT03472950|589195700|FG001|Overall Study|Lost to Follow-up|1|||
163133041|NCT03472950|589195699|FG000|Overall Study|Adverse Event|0|||
163133042|NCT03472950|589195700|FG001|Overall Study|Adverse Event|3|||
163133043|NCT03386487|589195703|FG000|Overall Study|Lost to Follow-up|5|||
163133044|NCT03386487|589195704|FG001|Overall Study|Lost to Follow-up|6|||
163133045|NCT03386487|589195703|FG000|Overall Study|Withdrawal by Subject|11|||
163133046|NCT03386487|589195704|FG001|Overall Study|Withdrawal by Subject|7|||
163133047|NCT03386487|589195703|FG000|Overall Study|Physician Decision|11|||
163133048|NCT03386487|589195704|FG001|Overall Study|Physician Decision|8|||
163133049|NCT01068769|589195705|FG000|Overall Study|Ineligible|1|||
163133050|NCT00517361|589195708|FG000|Overall Study|Death|6|||
163133051|NCT00517361|589195708|FG000|Overall Study|The study was terminated|5|||
163133052|NCT01858766|589195709|FG000|Overall Study|Randomized but Never Treated|0|||
163133053|NCT01858766|589195710|FG001|Overall Study|Randomized but Never Treated|0|||
163133054|NCT01858766|589195711|FG002|Overall Study|Randomized but Never Treated|0|||
163133055|NCT01858766|589195712|FG003|Overall Study|Randomized but Never Treated|0|||
163133056|NCT01858766|589195713|FG004|Overall Study|Randomized but Never Treated|0|||
163133057|NCT01858766|589195714|FG005|Overall Study|Randomized but Never Treated|1|||
163133058|NCT01858766|589195715|FG006|Overall Study|Randomized but Never Treated|0|||
163133059|NCT01858766|589195716|FG007|Overall Study|Randomized but Never Treated|0|||
163133060|NCT01858766|589195717|FG008|Overall Study|Randomized but Never Treated|0|||
163133061|NCT01858766|589195718|FG009|Overall Study|Randomized but Never Treated|0|||
163133062|NCT01858766|589195719|FG010|Overall Study|Randomized but Never Treated|0|||
163133063|NCT01858766|589195720|FG011|Overall Study|Randomized but Never Treated|0|||
163133064|NCT01858766|589195721|FG012|Overall Study|Randomized but Never Treated|0|||
163133065|NCT01858766|589195722|FG013|Overall Study|Randomized but Never Treated|0|||
163133066|NCT01858766|589195723|FG014|Overall Study|Randomized but Never Treated|0|||
163344963|NCT00296504|589972043|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
163344964|NCT00296504|589972035|FG000|Interim Analysis|Study Ended|0|||
163133067|NCT01858766|589195724|FG015|Overall Study|Randomized but Never Treated|0|||
163133068|NCT01858766|589195725|FG016|Overall Study|Randomized but Never Treated|0|||
163133069|NCT01858766|589195726|FG017|Overall Study|Randomized but Never Treated|1|||
163133070|NCT01858766|589195727|FG018|Overall Study|Randomized but Never Treated|0|||
163344965|NCT00296504|589972036|FG001|Interim Analysis|Study Ended|0|||
163228329|NCT02346240|589548018|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228330|NCT02346240|589548019|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228331|NCT02346240|589548020|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228332|NCT02346240|589548021|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228333|NCT02346240|589548022|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228334|NCT02346240|589548023|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228335|NCT02346240|589548024|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228336|NCT02346240|589548025|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228337|NCT02346240|589548026|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228338|NCT02346240|589548027|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228339|NCT02346240|589548028|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163344966|NCT00296504|589972037|FG002|Interim Analysis|Study Ended|0|||
163344967|NCT00296504|589972038|FG003|Interim Analysis|Study Ended|0|||
163344968|NCT00296504|589972039|FG004|Interim Analysis|Study Ended|0|||
163344969|NCT00296504|589972040|FG005|Interim Analysis|Study Ended|0|||
163344970|NCT00296504|589972041|FG006|Interim Analysis|Study Ended|1|||
163344971|NCT00296504|589972042|FG007|Interim Analysis|Study Ended|0|||
163344972|NCT00296504|589972043|FG008|Interim Analysis|Study Ended|0|||
163344973|NCT00296504|589972035|FG000|Interim Analysis|Participant Needed Interferon|0|||
163344974|NCT00296504|589972036|FG001|Interim Analysis|Participant Needed Interferon|0|||
163344975|NCT00296504|589972037|FG002|Interim Analysis|Participant Needed Interferon|0|||
163344976|NCT00296504|589972038|FG003|Interim Analysis|Participant Needed Interferon|0|||
163344977|NCT00296504|589972039|FG004|Interim Analysis|Participant Needed Interferon|0|||
163344978|NCT00296504|589972040|FG005|Interim Analysis|Participant Needed Interferon|0|||
163344979|NCT00296504|589972041|FG006|Interim Analysis|Participant Needed Interferon|0|||
163344980|NCT00296504|589972042|FG007|Interim Analysis|Participant Needed Interferon|1|||
163344981|NCT00296504|589972043|FG008|Interim Analysis|Participant Needed Interferon|0|||
163344982|NCT00296504|589972035|FG000|Interim Analysis|Ongoing|32|||
163344983|NCT00296504|589972036|FG001|Interim Analysis|Ongoing|12|||
163344984|NCT00296504|589972037|FG002|Interim Analysis|Ongoing|16|||
163344985|NCT00296504|589972038|FG003|Interim Analysis|Ongoing|22|||
163344986|NCT00296504|589972039|FG004|Interim Analysis|Ongoing|0|||
163344987|NCT00296504|589972040|FG005|Interim Analysis|Ongoing|0|||
163344988|NCT00296504|589972041|FG006|Interim Analysis|Ongoing|30|||
163344989|NCT00296504|589972042|FG007|Interim Analysis|Ongoing|1|||
163344990|NCT00296504|589972043|FG008|Interim Analysis|Ongoing|0|||
163344991|NCT00296504|589972035|FG000|Final Analysis|Withdrawal by Subject|0|||
163344992|NCT00296504|589972036|FG001|Final Analysis|Withdrawal by Subject|0|||
163344993|NCT00296504|589972037|FG002|Final Analysis|Withdrawal by Subject|0|||
163344994|NCT00296504|589972038|FG003|Final Analysis|Withdrawal by Subject|0|||
163344995|NCT00296504|589972039|FG004|Final Analysis|Withdrawal by Subject|0|||
163344996|NCT00296504|589972040|FG005|Final Analysis|Withdrawal by Subject|0|||
163344997|NCT00296504|589972041|FG006|Final Analysis|Withdrawal by Subject|0|||
163344998|NCT00296504|589972042|FG007|Final Analysis|Withdrawal by Subject|0|||
163344999|NCT00296504|589972043|FG008|Final Analysis|Withdrawal by Subject|1|||
163345000|NCT00296504|589972035|FG000|Final Analysis|Lost to Follow-up|0|||
163345001|NCT00296504|589972036|FG001|Final Analysis|Lost to Follow-up|0|||
163345002|NCT00296504|589972037|FG002|Final Analysis|Lost to Follow-up|0|||
163345003|NCT00296504|589972038|FG003|Final Analysis|Lost to Follow-up|0|||
163345004|NCT00296504|589972039|FG004|Final Analysis|Lost to Follow-up|0|||
163345005|NCT00296504|589972040|FG005|Final Analysis|Lost to Follow-up|0|||
163345006|NCT00296504|589972041|FG006|Final Analysis|Lost to Follow-up|0|||
163345007|NCT00296504|589972042|FG007|Final Analysis|Lost to Follow-up|0|||
163345008|NCT00296504|589972043|FG008|Final Analysis|Lost to Follow-up|5|||
163228340|NCT02346240|589548029|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228341|NCT02346240|589548030|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228342|NCT02346240|589548031|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228343|NCT02346240|589548032|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228344|NCT02346240|589548033|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228345|NCT02346240|589548034|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163345009|NCT00296504|589972035|FG000|Final Analysis|Insufficient Viral Load Response|0|||
163345010|NCT00296504|589972036|FG001|Final Analysis|Insufficient Viral Load Response|0|||
163345011|NCT00296504|589972037|FG002|Final Analysis|Insufficient Viral Load Response|0|||
163345012|NCT00296504|589972038|FG003|Final Analysis|Insufficient Viral Load Response|0|||
163345013|NCT00296504|589972039|FG004|Final Analysis|Insufficient Viral Load Response|0|||
163345014|NCT00296504|589972040|FG005|Final Analysis|Insufficient Viral Load Response|0|||
163345015|NCT00296504|589972041|FG006|Final Analysis|Insufficient Viral Load Response|0|||
163345016|NCT00296504|589972042|FG007|Final Analysis|Insufficient Viral Load Response|0|||
163345017|NCT00296504|589972043|FG008|Final Analysis|Insufficient Viral Load Response|6|||
163345018|NCT00296504|589972035|FG000|Final Analysis|Adverse Event|0|||
163345019|NCT00296504|589972036|FG001|Final Analysis|Adverse Event|0|||
163345020|NCT00296504|589972037|FG002|Final Analysis|Adverse Event|0|||
163345021|NCT00296504|589972038|FG003|Final Analysis|Adverse Event|0|||
163228346|NCT02346240|589548035|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
163228347|NCT02346240|589548036|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228348|NCT02346240|589548037|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
163228349|NCT02346240|589548014|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228350|NCT02346240|589548015|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228351|NCT02346240|589548016|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228352|NCT02346240|589548017|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228353|NCT02346240|589548018|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228354|NCT02346240|589548019|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228355|NCT02346240|589548020|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228356|NCT02346240|589548021|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228357|NCT02346240|589548022|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228358|NCT02346240|589548023|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228359|NCT02346240|589548024|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228360|NCT02346240|589548025|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228361|NCT02346240|589548026|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228362|NCT02346240|589548027|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228363|NCT02346240|589548028|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228364|NCT02346240|589548029|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228365|NCT02346240|589548030|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228366|NCT02346240|589548031|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
163228367|NCT02346240|589548032|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
163228368|NCT02346240|589548033|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
163228369|NCT02346240|589548034|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163228370|NCT02346240|589548035|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
163228371|NCT02346240|589548036|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
163228372|NCT02346240|589548037|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
163228373|NCT02346240|589548014|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228374|NCT02346240|589548015|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228375|NCT02346240|589548016|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228376|NCT02346240|589548017|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228377|NCT02346240|589548018|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228378|NCT02346240|589548019|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228379|NCT02346240|589548020|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228380|NCT02346240|589548021|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228381|NCT02346240|589548022|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228382|NCT02346240|589548023|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228383|NCT02346240|589548024|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228384|NCT02346240|589548025|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228385|NCT02346240|589548026|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228386|NCT02346240|589548027|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228387|NCT02346240|589548028|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228388|NCT02346240|589548029|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228389|NCT02346240|589548030|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228390|NCT02346240|589548031|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228391|NCT02346240|589548032|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
163228392|NCT02346240|589548033|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
163228393|NCT02346240|589548034|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163228394|NCT02346240|589548035|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
163228395|NCT02346240|589548036|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
163228396|NCT02346240|589548037|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
163228397|NCT02346240|589548014|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228398|NCT02346240|589548015|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228399|NCT02346240|589548016|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228400|NCT02346240|589548017|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228401|NCT02346240|589548018|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228402|NCT02346240|589548019|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228403|NCT02346240|589548020|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228404|NCT02346240|589548021|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228405|NCT02346240|589548022|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228406|NCT02346240|589548023|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228407|NCT02346240|589548024|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163408471|NCT02264990|590205528|FG001|Overall Study|Death|250|||
163345022|NCT00296504|589972039|FG004|Final Analysis|Adverse Event|0|||
163345023|NCT00296504|589972040|FG005|Final Analysis|Adverse Event|0|||
163345024|NCT00296504|589972041|FG006|Final Analysis|Adverse Event|0|||
163345025|NCT00296504|589972042|FG007|Final Analysis|Adverse Event|0|||
163345026|NCT00296504|589972043|FG008|Final Analysis|Adverse Event|2|||
163133071|NCT01858766|589195709|FG000|Overall Study|Death|0|||
163133072|NCT01858766|589195710|FG001|Overall Study|Death|0|||
163133073|NCT01858766|589195711|FG002|Overall Study|Death|1|||
163133074|NCT01858766|589195712|FG003|Overall Study|Death|0|||
163133075|NCT01858766|589195713|FG004|Overall Study|Death|0|||
163133076|NCT01858766|589195714|FG005|Overall Study|Death|0|||
163133077|NCT01858766|589195715|FG006|Overall Study|Death|0|||
163133078|NCT01858766|589195716|FG007|Overall Study|Death|0|||
163133079|NCT01858766|589195717|FG008|Overall Study|Death|0|||
163133080|NCT01858766|589195718|FG009|Overall Study|Death|0|||
163133081|NCT01858766|589195719|FG010|Overall Study|Death|0|||
163133082|NCT01858766|589195720|FG011|Overall Study|Death|0|||
163133083|NCT01858766|589195721|FG012|Overall Study|Death|0|||
163133084|NCT01858766|589195722|FG013|Overall Study|Death|0|||
163133085|NCT01858766|589195723|FG014|Overall Study|Death|0|||
163133086|NCT01858766|589195724|FG015|Overall Study|Death|0|||
163133087|NCT01858766|589195725|FG016|Overall Study|Death|0|||
163133088|NCT01858766|589195726|FG017|Overall Study|Death|0|||
163133089|NCT01858766|589195727|FG018|Overall Study|Death|0|||
163133090|NCT01858766|589195709|FG000|Overall Study|Lack of Efficacy|1|||
163133091|NCT01858766|589195710|FG001|Overall Study|Lack of Efficacy|0|||
163133092|NCT01858766|589195711|FG002|Overall Study|Lack of Efficacy|0|||
163133093|NCT01858766|589195712|FG003|Overall Study|Lack of Efficacy|0|||
163133094|NCT01858766|589195713|FG004|Overall Study|Lack of Efficacy|1|||
163133095|NCT01858766|589195714|FG005|Overall Study|Lack of Efficacy|2|||
163133096|NCT01858766|589195715|FG006|Overall Study|Lack of Efficacy|0|||
163133097|NCT01858766|589195716|FG007|Overall Study|Lack of Efficacy|0|||
163133098|NCT01858766|589195717|FG008|Overall Study|Lack of Efficacy|0|||
163133099|NCT01858766|589195718|FG009|Overall Study|Lack of Efficacy|0|||
163345027|NCT00296504|589972035|FG000|Final Analysis|Pregnancy|0|||
163345028|NCT00296504|589972036|FG001|Final Analysis|Pregnancy|0|||
163345029|NCT00296504|589972037|FG002|Final Analysis|Pregnancy|0|||
163345030|NCT00296504|589972038|FG003|Final Analysis|Pregnancy|0|||
163345031|NCT00296504|589972039|FG004|Final Analysis|Pregnancy|0|||
163345032|NCT00296504|589972040|FG005|Final Analysis|Pregnancy|0|||
163345033|NCT00296504|589972041|FG006|Final Analysis|Pregnancy|0|||
163345034|NCT00296504|589972042|FG007|Final Analysis|Pregnancy|0|||
163345035|NCT00296504|589972043|FG008|Final Analysis|Pregnancy|4|||
163345036|NCT00296504|589972035|FG000|Final Analysis|Tuberculosis|0|||
163345037|NCT00296504|589972036|FG001|Final Analysis|Tuberculosis|0|||
163408472|NCT02264990|590205527|FG000|Overall Study|Withdrawal by Subject|4|||
163408473|NCT02264990|590205528|FG001|Overall Study|Withdrawal by Subject|5|||
163133100|NCT01858766|589195719|FG010|Overall Study|Lack of Efficacy|0|||
163133101|NCT01858766|589195720|FG011|Overall Study|Lack of Efficacy|3|||
163133102|NCT01858766|589195721|FG012|Overall Study|Lack of Efficacy|5|||
163133103|NCT01858766|589195722|FG013|Overall Study|Lack of Efficacy|3|||
163133104|NCT01858766|589195723|FG014|Overall Study|Lack of Efficacy|5|||
163133105|NCT01858766|589195724|FG015|Overall Study|Lack of Efficacy|5|||
163133106|NCT01858766|589195725|FG016|Overall Study|Lack of Efficacy|2|||
163133107|NCT01858766|589195726|FG017|Overall Study|Lack of Efficacy|3|||
163133108|NCT01858766|589195727|FG018|Overall Study|Lack of Efficacy|3|||
163133109|NCT01858766|589195709|FG000|Overall Study|Lost to Follow-up|0|||
163133110|NCT01858766|589195710|FG001|Overall Study|Lost to Follow-up|0|||
163133111|NCT01858766|589195711|FG002|Overall Study|Lost to Follow-up|0|||
163133112|NCT01858766|589195712|FG003|Overall Study|Lost to Follow-up|0|||
163133113|NCT01858766|589195713|FG004|Overall Study|Lost to Follow-up|0|||
163133114|NCT01858766|589195714|FG005|Overall Study|Lost to Follow-up|1|||
163133115|NCT01858766|589195715|FG006|Overall Study|Lost to Follow-up|0|||
163133116|NCT01858766|589195716|FG007|Overall Study|Lost to Follow-up|2|||
163133117|NCT01858766|589195717|FG008|Overall Study|Lost to Follow-up|0|||
163133118|NCT01858766|589195718|FG009|Overall Study|Lost to Follow-up|0|||
163133119|NCT01858766|589195719|FG010|Overall Study|Lost to Follow-up|0|||
163133120|NCT01858766|589195720|FG011|Overall Study|Lost to Follow-up|1|||
163133121|NCT01858766|589195721|FG012|Overall Study|Lost to Follow-up|0|||
163133122|NCT01858766|589195722|FG013|Overall Study|Lost to Follow-up|0|||
163133123|NCT01858766|589195723|FG014|Overall Study|Lost to Follow-up|3|||
163408474|NCT02264990|590205527|FG000|Overall Study|Lost to Follow-up|1|||
163133124|NCT01858766|589195724|FG015|Overall Study|Lost to Follow-up|1|||
163133125|NCT01858766|589195725|FG016|Overall Study|Lost to Follow-up|1|||
163133126|NCT01858766|589195726|FG017|Overall Study|Lost to Follow-up|0|||
163133127|NCT01858766|589195727|FG018|Overall Study|Lost to Follow-up|1|||
163133128|NCT01858766|589195709|FG000|Overall Study|Withdrew Consent|0|||
163133129|NCT01858766|589195710|FG001|Overall Study|Withdrew Consent|0|||
163133130|NCT01858766|589195711|FG002|Overall Study|Withdrew Consent|0|||
163345038|NCT00296504|589972037|FG002|Final Analysis|Tuberculosis|0|||
163345039|NCT00296504|589972038|FG003|Final Analysis|Tuberculosis|0|||
163345040|NCT00296504|589972039|FG004|Final Analysis|Tuberculosis|0|||
163345041|NCT00296504|589972040|FG005|Final Analysis|Tuberculosis|0|||
163228408|NCT02346240|589548025|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228409|NCT02346240|589548026|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228410|NCT02346240|589548027|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228411|NCT02346240|589548028|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228412|NCT02346240|589548029|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228413|NCT02346240|589548030|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228414|NCT02346240|589548031|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228415|NCT02346240|589548032|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
163228416|NCT02346240|589548033|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228417|NCT02346240|589548034|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163228418|NCT02346240|589548035|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
163228419|NCT02346240|589548036|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
163228420|NCT02346240|589548037|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
163228421|NCT02346240|589548014|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228422|NCT02346240|589548015|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228423|NCT02346240|589548016|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228424|NCT02346240|589548017|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228425|NCT02346240|589548018|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228426|NCT02346240|589548019|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228427|NCT02346240|589548020|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228428|NCT02346240|589548021|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228429|NCT02346240|589548022|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228430|NCT02346240|589548023|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228431|NCT02346240|589548024|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228432|NCT02346240|589548025|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228433|NCT02346240|589548026|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228434|NCT02346240|589548027|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228435|NCT02346240|589548028|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228436|NCT02346240|589548029|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228437|NCT02346240|589548030|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228438|NCT02346240|589548031|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228439|NCT02346240|589548032|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
163228440|NCT02346240|589548033|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228441|NCT02346240|589548034|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163345042|NCT00296504|589972041|FG006|Final Analysis|Tuberculosis|0|||
163345043|NCT00296504|589972042|FG007|Final Analysis|Tuberculosis|0|||
163133131|NCT01858766|589195712|FG003|Overall Study|Withdrew Consent|0|||
163133132|NCT01858766|589195713|FG004|Overall Study|Withdrew Consent|0|||
163133133|NCT01858766|589195714|FG005|Overall Study|Withdrew Consent|0|||
163133134|NCT01858766|589195715|FG006|Overall Study|Withdrew Consent|0|||
163133135|NCT01858766|589195716|FG007|Overall Study|Withdrew Consent|0|||
163133136|NCT01858766|589195717|FG008|Overall Study|Withdrew Consent|0|||
163133137|NCT01858766|589195718|FG009|Overall Study|Withdrew Consent|0|||
163133138|NCT01858766|589195719|FG010|Overall Study|Withdrew Consent|0|||
163133139|NCT01858766|589195720|FG011|Overall Study|Withdrew Consent|1|||
163133140|NCT01858766|589195721|FG012|Overall Study|Withdrew Consent|0|||
163133141|NCT01858766|589195722|FG013|Overall Study|Withdrew Consent|0|||
163133142|NCT01858766|589195723|FG014|Overall Study|Withdrew Consent|0|||
163133143|NCT01858766|589195724|FG015|Overall Study|Withdrew Consent|0|||
163133144|NCT01858766|589195725|FG016|Overall Study|Withdrew Consent|0|||
163133145|NCT01858766|589195726|FG017|Overall Study|Withdrew Consent|0|||
163133146|NCT01858766|589195727|FG018|Overall Study|Withdrew Consent|0|||
163133147|NCT00894361|589195738|FG000|Overall Study|deaths and less than 2 years followup|24|||
163133148|NCT00894361|589195739|FG001|Overall Study|deaths and less than 2 years followup|64|||
163133149|NCT04207060|589195744|FG000|Overall Study|Lost to Follow-up|2|||
163133150|NCT04207060|589195745|FG001|Overall Study|Lost to Follow-up|0|||
163133151|NCT05438576|589195746|FG000|Overall Study|Death|1|||
163133152|NCT05438576|589195747|FG001|Overall Study|Death|1|||
163133153|NCT05438576|589195746|FG000|Overall Study|Withdrawal by Subject|4|||
163133154|NCT05438576|589195747|FG001|Overall Study|Withdrawal by Subject|2|||
163133155|NCT05438576|589195746|FG000|Overall Study|Not Eligible|2|||
163133156|NCT05438576|589195747|FG001|Overall Study|Not Eligible|1|||
163133157|NCT05438576|589195746|FG000|Overall Study|Did not complete baseline testing|22|||
163133158|NCT05438576|589195747|FG001|Overall Study|Did not complete baseline testing|4|||
163133159|NCT02881762|589195750|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
163133160|NCT02881762|589195751|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163133161|NCT00245037|589195752|FG000|Overall Study|Death|17|||
163133162|NCT00296140|589195754|FG000|Overall Study|Lost to Follow-up|1|||
163133163|NCT00296140|589195755|FG001|Overall Study|Lost to Follow-up|0|||
163133164|NCT00296140|589195754|FG000|Overall Study|Withdrawal by Subject|1|||
163133165|NCT00296140|589195755|FG001|Overall Study|Withdrawal by Subject|0|||
163133166|NCT00296140|589195754|FG000|Overall Study|Discharge to Nursing Home|1|||
163133167|NCT00296140|589195755|FG001|Overall Study|Discharge to Nursing Home|0|||
163133168|NCT00774800|589195756|FG000|Intervention 4|Withdrawal by Subject|1|||
163133169|NCT01843062|589195757|FG000|Overall Study|Protocol Violation|1|||
163133170|NCT01843062|589195758|FG001|Overall Study|Protocol Violation|0|||
163133171|NCT01843062|589195757|FG000|Overall Study|New treatment following progression|2|||
163133172|NCT01843062|589195758|FG001|Overall Study|New treatment following progression|0|||
163133173|NCT01843062|589195757|FG000|Overall Study|Pregnancy|1|||
163133174|NCT01843062|589195758|FG001|Overall Study|Pregnancy|0|||
163133175|NCT01843062|589195757|FG000|Overall Study|Adverse Event|2|||
163133176|NCT01843062|589195758|FG001|Overall Study|Adverse Event|0|||
163133177|NCT01843062|589195757|FG000|Overall Study|Incorrect randomisation|1|||
163133178|NCT01843062|589195758|FG001|Overall Study|Incorrect randomisation|0|||
163133179|NCT01843062|589195757|FG000|Overall Study|Withdrawal by Subject|12|||
163133180|NCT01843062|589195758|FG001|Overall Study|Withdrawal by Subject|3|||
163133181|NCT01843062|589195757|FG000|Overall Study|Death|1|||
163133182|NCT01843062|589195758|FG001|Overall Study|Death|2|||
163133183|NCT01843062|589195757|FG000|Overall Study|Lost to Follow-up|2|||
163133184|NCT01843062|589195758|FG001|Overall Study|Lost to Follow-up|4|||
163133185|NCT00994422|589195759|FG000|Overall Study|Lost to Follow-up|7|||
163133186|NCT00994422|589195760|FG001|Overall Study|Lost to Follow-up|1|||
163133187|NCT02669212|589195761|FG000|Overall Study|Lost to Follow-up|1|||
163133188|NCT02669212|589195762|FG001|Overall Study|Lost to Follow-up|0|||
163133189|NCT02669212|589195761|FG000|Overall Study|Medical Condition|3|||
163133190|NCT02669212|589195762|FG001|Overall Study|Medical Condition|4|||
163133191|NCT02669212|589195761|FG000|Overall Study|Withdrawal by Subject|0|||
163133192|NCT02669212|589195762|FG001|Overall Study|Withdrawal by Subject|2|||
163133193|NCT02669212|589195761|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
163133194|NCT02669212|589195762|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
163133195|NCT03549104|589195765|FG000|Overall Study|Withdrawal by Subject|5|||
163133196|NCT03549104|589195766|FG001|Overall Study|Withdrawal by Subject|2|||
163133197|NCT03549104|589195765|FG000|Overall Study|Covid shelter in place|1|||
163133198|NCT03549104|589195766|FG001|Overall Study|Covid shelter in place|2|||
163133199|NCT04124705|589195767|FG000|Titration Period|Adverse Event|9|||
163133200|NCT04124705|589195768|FG001|Titration Period|Adverse Event|5|||
163133201|NCT04124705|589195767|FG000|Titration Period|Withdrawal by Subject|6|||
163133202|NCT04124705|589195768|FG001|Titration Period|Withdrawal by Subject|3|||
163133203|NCT04124705|589195767|FG000|Titration Period|Lost to Follow-up|0|||
163133204|NCT04124705|589195768|FG001|Titration Period|Lost to Follow-up|1|||
163133205|NCT04124705|589195767|FG000|Titration Period|Death|1|||
163133206|NCT04124705|589195768|FG001|Titration Period|Death|1|||
163133207|NCT04124705|589195767|FG000|Titration Period|Lack of Efficacy|2|||
163133208|NCT04124705|589195768|FG001|Titration Period|Lack of Efficacy|0|||
163133209|NCT04124705|589195767|FG000|Titration Period|Physician Decision|2|||
163133210|NCT04124705|589195768|FG001|Titration Period|Physician Decision|0|||
163133211|NCT04124705|589195767|FG000|Titration Period|Non-compliance with Study Drug|2|||
163133212|NCT04124705|589195768|FG001|Titration Period|Non-compliance with Study Drug|0|||
163133213|NCT04124705|589195767|FG000|Titration Period|Other|4|||
163133214|NCT04124705|589195768|FG001|Titration Period|Other|9|||
163133215|NCT04124705|589195767|FG000|Stabilization Period|Adverse Event|4|||
163133216|NCT04124705|589195768|FG001|Stabilization Period|Adverse Event|2|||
163133217|NCT04124705|589195767|FG000|Stabilization Period|Withdrawal by Subject|1|||
163133218|NCT04124705|589195768|FG001|Stabilization Period|Withdrawal by Subject|1|||
163133219|NCT04124705|589195767|FG000|Stabilization Period|Lost to Follow-up|0|||
163133220|NCT04124705|589195768|FG001|Stabilization Period|Lost to Follow-up|1|||
163133221|NCT04124705|589195767|FG000|Stabilization Period|Lack of Efficacy|4|||
163133222|NCT04124705|589195768|FG001|Stabilization Period|Lack of Efficacy|2|||
163133223|NCT04124705|589195767|FG000|Stabilization Period|Protocol Deviation|0|||
163133224|NCT04124705|589195768|FG001|Stabilization Period|Protocol Deviation|2|||
163133225|NCT04124705|589195767|FG000|Stabilization Period|Other|2|||
163133226|NCT04124705|589195768|FG001|Stabilization Period|Other|2|||
163133227|NCT04164732|589195769|FG000|Treatment run-in Period|Adverse Event|4|||
163133228|NCT04164732|589195770|FG001|Treatment run-in Period|Adverse Event|0|||
163133229|NCT04164732|589195771|FG002|Treatment run-in Period|Adverse Event|0|||
163133230|NCT04164732|589195769|FG000|Treatment run-in Period|Physician Decision|1|||
163133231|NCT04164732|589195770|FG001|Treatment run-in Period|Physician Decision|0|||
163133232|NCT04164732|589195771|FG002|Treatment run-in Period|Physician Decision|0|||
163133233|NCT04164732|589195769|FG000|Treatment run-in Period|Screen Failure|1|||
163133234|NCT04164732|589195770|FG001|Treatment run-in Period|Screen Failure|0|||
163133235|NCT04164732|589195771|FG002|Treatment run-in Period|Screen Failure|0|||
163133236|NCT04164732|589195769|FG000|Randomized Treatment Period|Adverse Event|0|||
163133237|NCT04164732|589195770|FG001|Randomized Treatment Period|Adverse Event|1|||
163133238|NCT04164732|589195771|FG002|Randomized Treatment Period|Adverse Event|0|||
163228442|NCT02346240|589548035|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228443|NCT02346240|589548036|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228444|NCT02346240|589548037|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163228445|NCT02681302|589548038|FG000|Overall Study|Withdrawal by Subject|1|||
163228446|NCT02681302|589548039|FG001|Overall Study|Withdrawal by Subject|1|||
163228447|NCT02681302|589548040|FG002|Overall Study|Withdrawal by Subject|0|||
163228448|NCT02681302|589548041|FG003|Overall Study|Withdrawal by Subject|0|||
163228449|NCT02681302|589548042|FG004|Overall Study|Withdrawal by Subject|1|||
163228450|NCT02681302|589548043|FG005|Overall Study|Withdrawal by Subject|0|||
163228451|NCT02681302|589548038|FG000|Overall Study|Screen Failure|2|||
163228452|NCT02681302|589548039|FG001|Overall Study|Screen Failure|4|||
163228453|NCT02681302|589548040|FG002|Overall Study|Screen Failure|2|||
163228454|NCT02681302|589548041|FG003|Overall Study|Screen Failure|0|||
163228455|NCT02681302|589548042|FG004|Overall Study|Screen Failure|1|||
163228456|NCT02681302|589548043|FG005|Overall Study|Screen Failure|1|||
163228457|NCT02681302|589548038|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
163228458|NCT02681302|589548039|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
163228459|NCT02681302|589548040|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
163228460|NCT02681302|589548041|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
163228461|NCT02681302|589548042|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
163228462|NCT02681302|589548043|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
163228463|NCT02942017|589548044|FG000|Overall Study|Adverse Event|0|||
163228464|NCT02942017|589548045|FG001|Overall Study|Adverse Event|1|||
163228465|NCT02942017|589548044|FG000|Overall Study|Withdrawal by Subject|0|||
163228466|NCT02942017|589548045|FG001|Overall Study|Withdrawal by Subject|1|||
163228467|NCT02942017|589548044|FG000|Overall Study|Lost to Follow-up|1|||
163228468|NCT02942017|589548045|FG001|Overall Study|Lost to Follow-up|1|||
163228469|NCT02942017|589548044|FG000|Overall Study|Randomized but not dosed|1|||
163228470|NCT02942017|589548045|FG001|Overall Study|Randomized but not dosed|3|||
163228471|NCT00477672|589548046|FG000|Overall Study|Adverse Event|3|||
163228472|NCT00477672|589548047|FG001|Overall Study|Adverse Event|5|||
163228473|NCT00477672|589548048|FG002|Overall Study|Adverse Event|6|||
163228474|NCT00477672|589548046|FG000|Overall Study|Death|0|||
163228475|NCT00477672|589548047|FG001|Overall Study|Death|1|||
163228476|NCT00477672|589548048|FG002|Overall Study|Death|0|||
163228477|NCT00477672|589548046|FG000|Overall Study|Disease progression|0|||
163228478|NCT00477672|589548047|FG001|Overall Study|Disease progression|1|||
163228479|NCT00477672|589548048|FG002|Overall Study|Disease progression|0|||
163228480|NCT00477672|589548046|FG000|Overall Study|Physician Decision|1|||
163228481|NCT00477672|589548047|FG001|Overall Study|Physician Decision|0|||
163228482|NCT00477672|589548048|FG002|Overall Study|Physician Decision|0|||
163228483|NCT00477672|589548046|FG000|Overall Study|Protocol noncompliance|0|||
163228484|NCT00477672|589548047|FG001|Overall Study|Protocol noncompliance|2|||
163228485|NCT00477672|589548048|FG002|Overall Study|Protocol noncompliance|0|||
163228486|NCT00477672|589548046|FG000|Overall Study|Consent withdrawn|2|||
163228487|NCT00477672|589548047|FG001|Overall Study|Consent withdrawn|5|||
163228488|NCT00477672|589548048|FG002|Overall Study|Consent withdrawn|10|||
163228489|NCT00477672|589548046|FG000|Overall Study|Discretion of Sponsor|1|||
163228490|NCT00477672|589548047|FG001|Overall Study|Discretion of Sponsor|2|||
163228491|NCT00477672|589548048|FG002|Overall Study|Discretion of Sponsor|0|||
163228492|NCT00838565|589548049|FG000|Overall Study|Withdrawal by Subject|0|||
163228493|NCT00838565|589548050|FG001|Overall Study|Withdrawal by Subject|0|||
163228494|NCT00838565|589548051|FG002|Overall Study|Withdrawal by Subject|1|||
163228495|NCT00838565|589548052|FG003|Overall Study|Withdrawal by Subject|0|||
163228496|NCT00838565|589548053|FG004|Overall Study|Withdrawal by Subject|0|||
163228497|NCT00838565|589548054|FG005|Overall Study|Withdrawal by Subject|2|||
163228498|NCT00838565|589548049|FG000|Overall Study|Other|0|||
163228499|NCT00838565|589548050|FG001|Overall Study|Other|2|||
163228500|NCT00838565|589548051|FG002|Overall Study|Other|0|||
163228501|NCT00838565|589548052|FG003|Overall Study|Other|0|||
163228502|NCT00838565|589548053|FG004|Overall Study|Other|0|||
163228503|NCT00838565|589548054|FG005|Overall Study|Other|0|||
163228504|NCT00838565|589548049|FG000|Overall Study|Randomized but not Treated|0|||
163228505|NCT00838565|589548050|FG001|Overall Study|Randomized but not Treated|1|||
163228506|NCT00838565|589548051|FG002|Overall Study|Randomized but not Treated|0|||
163228507|NCT00838565|589548052|FG003|Overall Study|Randomized but not Treated|0|||
163228508|NCT00838565|589548053|FG004|Overall Study|Randomized but not Treated|0|||
163228509|NCT00838565|589548054|FG005|Overall Study|Randomized but not Treated|0|||
163228510|NCT00458484|589548055|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
163228511|NCT00458484|589548056|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
163408475|NCT02264990|590205528|FG001|Overall Study|Lost to Follow-up|3|||
163228512|NCT00458484|589548057|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
163228513|NCT00458484|589548058|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
163228514|NCT00458484|589548059|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
163228515|NCT00458484|589548060|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
163345044|NCT00296504|589972043|FG008|Final Analysis|Tuberculosis|1|||
163345045|NCT00296504|589972035|FG000|Final Analysis|Participant Moved to Another Country|0|||
163133239|NCT04164732|589195769|FG000|Randomized Treatment Period|Protocol Deviation|0|||
163133240|NCT04164732|589195770|FG001|Randomized Treatment Period|Protocol Deviation|1|||
163133241|NCT04164732|589195771|FG002|Randomized Treatment Period|Protocol Deviation|1|||
163133242|NCT04164732|589195769|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
163133243|NCT04164732|589195770|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
163133244|NCT04164732|589195771|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
163133245|NCT00395850|589195778|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
163133246|NCT00395850|589195779|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
163133247|NCT00395850|589195780|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
163133248|NCT00395850|589195781|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
163133249|NCT00395850|589195778|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
163133250|NCT00395850|589195779|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
163133251|NCT00395850|589195780|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
163133252|NCT00395850|589195781|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
163133253|NCT00395850|589195778|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
163133254|NCT00395850|589195779|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
163133255|NCT00395850|589195780|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
163228516|NCT00458484|589548061|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
163228517|NCT04907032|589548062|FG000|Overall Study|Withdrawal by Subject|7|||
163228518|NCT04907032|589548063|FG001|Overall Study|Withdrawal by Subject|1|||
163228519|NCT02253810|589548064|FG000|Overall Study|Withdrawal by Subject|2|||
163228520|NCT02253810|589548065|FG001|Overall Study|Withdrawal by Subject|1|||
163228521|NCT02253810|589548064|FG000|Overall Study|Unknown concomitant procedure|3|||
163228522|NCT02253810|589548065|FG001|Overall Study|Unknown concomitant procedure|2|||
163228523|NCT00291668|589548067|FG000|Overall Study|Lack of Efficacy|1|||
163228524|NCT00291668|589548068|FG001|Overall Study|Lack of Efficacy|0|||
163228525|NCT00291668|589548069|FG002|Overall Study|Lack of Efficacy|0|||
163228526|NCT00291668|589548067|FG000|Overall Study|SAE, non-fatal|1|||
163228527|NCT00291668|589548068|FG001|Overall Study|SAE, non-fatal|1|||
163228528|NCT00291668|589548069|FG002|Overall Study|SAE, non-fatal|1|||
163228529|NCT00291668|589548067|FG000|Overall Study|AE, non-serious non-fatal|1|||
163228530|NCT00291668|589548068|FG001|Overall Study|AE, non-serious non-fatal|0|||
163228531|NCT00291668|589548069|FG002|Overall Study|AE, non-serious non-fatal|0|||
163228532|NCT00291668|589548067|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
163228533|NCT00291668|589548068|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
163228534|NCT00291668|589548069|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
163228535|NCT01557400|589548070|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
163228536|NCT01557400|589548070|FG000|Overall Study|Adverse Event|3|||
163228537|NCT01557400|589548070|FG000|Overall Study|Lost to Follow-up|5|||
163228538|NCT01557400|589548070|FG000|Overall Study|Withdrawal by Subject|9|||
163228539|NCT03962543|589548087|FG000|Treatment Phase|Death|0|||
163228540|NCT03962543|589548088|FG001|Treatment Phase|Death|1|||
163228541|NCT03962543|589548087|FG000|Treatment Phase|Withdrawal by Subject|3|||
163228542|NCT03962543|589548088|FG001|Treatment Phase|Withdrawal by Subject|0|||
163228543|NCT03962543|589548087|FG000|Treatment Phase|Adverse Event|3|||
163228544|NCT03962543|589548088|FG001|Treatment Phase|Adverse Event|12|||
163228545|NCT03962543|589548087|FG000|Treatment Phase|Lost to Follow-up|1|||
163228546|NCT03962543|589548088|FG001|Treatment Phase|Lost to Follow-up|2|||
163228547|NCT03962543|589548087|FG000|Treatment Phase|Radiographic PD|9|||
163228548|NCT03962543|589548088|FG001|Treatment Phase|Radiographic PD|3|||
163228549|NCT03962543|589548087|FG000|Treatment Phase|Participant Decision|3|||
163228550|NCT03962543|589548088|FG001|Treatment Phase|Participant Decision|8|||
163228551|NCT03962543|589548087|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
163228552|NCT03962543|589548088|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
163228553|NCT03962543|589548087|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
163228554|NCT03962543|589548088|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
163228555|NCT03962543|589548087|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
163228556|NCT03962543|589548088|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
163228557|NCT03962543|589548087|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
163228558|NCT03962543|589548088|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
163228559|NCT03962543|589548087|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
163228560|NCT03962543|589548088|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
163228561|NCT03962543|589548087|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
163228562|NCT03962543|589548088|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
163228563|NCT03962543|589548087|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
163228564|NCT03962543|589548088|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
163228565|NCT03962543|589548087|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
163228566|NCT03962543|589548088|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
163228567|NCT03962543|589548087|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
163228568|NCT03962543|589548088|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
163228569|NCT03962543|589548087|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
163228570|NCT03962543|589548088|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
163228571|NCT02777125|589548089|FG000|Overall Study|Consent form violation|14|||
163228572|NCT02777125|589548090|FG001|Overall Study|Consent form violation|12|||
163228573|NCT02777125|589548089|FG000|Overall Study|Assent form violation|21|||
163228574|NCT02777125|589548090|FG001|Overall Study|Assent form violation|23|||
163228575|NCT02777125|589548089|FG000|Overall Study|Protocol Violation|8|||
163228576|NCT02777125|589548090|FG001|Overall Study|Protocol Violation|12|||
163228577|NCT02917031|589548091|FG000|Overall Study|Reason not specified|7|||
163228578|NCT02917031|589548092|FG001|Overall Study|Reason not specified|5|||
163228579|NCT02917031|589548093|FG002|Overall Study|Reason not specified|6|||
163228580|NCT02917031|589548091|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
163228581|NCT02917031|589548092|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
163228582|NCT02917031|589548093|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
163228583|NCT02917031|589548091|FG000|Overall Study|Withdrawal by Subject|3|||
163228584|NCT02917031|589548092|FG001|Overall Study|Withdrawal by Subject|3|||
163228585|NCT02917031|589548093|FG002|Overall Study|Withdrawal by Subject|0|||
163228586|NCT02917031|589548091|FG000|Overall Study|Physician Decision|1|||
163228587|NCT02917031|589548092|FG001|Overall Study|Physician Decision|0|||
163228588|NCT02917031|589548093|FG002|Overall Study|Physician Decision|0|||
163228589|NCT02917031|589548091|FG000|Overall Study|Adverse Event|4|||
163228590|NCT02917031|589548092|FG001|Overall Study|Adverse Event|1|||
163228591|NCT02917031|589548093|FG002|Overall Study|Adverse Event|5|||
163228592|NCT02917031|589548091|FG000|Overall Study|Death|2|||
163228593|NCT02917031|589548092|FG001|Overall Study|Death|3|||
163228594|NCT02917031|589548093|FG002|Overall Study|Death|4|||
163228595|NCT00640510|589549600|FG000|Overall Study|Lack of Efficacy|0|||
163228596|NCT00640510|589549601|FG001|Overall Study|Lack of Efficacy|1|||
163228597|NCT00640510|589549600|FG000|Overall Study|Protocol Violation|1|||
163228598|NCT00640510|589549601|FG001|Overall Study|Protocol Violation|0|||
163228599|NCT00640510|589549600|FG000|Overall Study|Physician Decision|0|||
163228600|NCT00640510|589549601|FG001|Overall Study|Physician Decision|1|||
163228601|NCT01440322|589549602|FG000|Overall Study|Discomfort|2|||
163228602|NCT01440322|589549603|FG001|Overall Study|Discomfort|0|||
163228603|NCT01440322|589549602|FG000|Overall Study|Biomicroscopy|1|||
163228604|NCT01440322|589549603|FG001|Overall Study|Biomicroscopy|0|||
163228605|NCT01440322|589549602|FG000|Overall Study|Symptoms and Problems|1|||
163228606|NCT01440322|589549603|FG001|Overall Study|Symptoms and Problems|0|||
163228607|NCT01440322|589549602|FG000|Overall Study|Unacceptable Subjective Vision|1|||
163228608|NCT01440322|589549603|FG001|Overall Study|Unacceptable Subjective Vision|0|||
163228609|NCT01440322|589549602|FG000|Overall Study|Other Product Related|1|||
163228610|NCT01440322|589549603|FG001|Overall Study|Other Product Related|0|||
163228611|NCT01440322|589549602|FG000|Overall Study|Unrelated Medical Problem|0|||
163228612|NCT01440322|589549603|FG001|Overall Study|Unrelated Medical Problem|1|||
163228613|NCT01440322|589549602|FG000|Overall Study|Other Non-Product Related|1|||
163228614|NCT01440322|589549603|FG001|Overall Study|Other Non-Product Related|0|||
163228615|NCT04300296|589549607|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
163228616|NCT04300296|589549608|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
163228617|NCT04300296|589549609|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
163228618|NCT04300296|589549610|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
163228619|NCT04300296|589549611|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
163228620|NCT04300296|589549612|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
163228621|NCT04300296|589549607|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
163228622|NCT04300296|589549608|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
163228623|NCT04300296|589549609|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
163228624|NCT04300296|589549610|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
163228625|NCT04300296|589549611|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
163228626|NCT04300296|589549612|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
163345046|NCT00296504|589972036|FG001|Final Analysis|Participant Moved to Another Country|0|||
163228627|NCT04300296|589549607|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
163345047|NCT00296504|589972037|FG002|Final Analysis|Participant Moved to Another Country|0|||
163345048|NCT00296504|589972038|FG003|Final Analysis|Participant Moved to Another Country|0|||
163345049|NCT00296504|589972039|FG004|Final Analysis|Participant Moved to Another Country|0|||
163345050|NCT00296504|589972040|FG005|Final Analysis|Participant Moved to Another Country|0|||
163228628|NCT04300296|589549608|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
163228629|NCT04300296|589549609|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
163228630|NCT04300296|589549610|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
163228631|NCT04300296|589549611|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
163345051|NCT00296504|589972041|FG006|Final Analysis|Participant Moved to Another Country|0|||
163345052|NCT00296504|589972042|FG007|Final Analysis|Participant Moved to Another Country|0|||
163345053|NCT00296504|589972043|FG008|Final Analysis|Participant Moved to Another Country|1|||
163133256|NCT00395850|589195781|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
163133257|NCT00395850|589195778|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
163133258|NCT00395850|589195779|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
163133259|NCT00395850|589195780|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
163133260|NCT00395850|589195781|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
163133261|NCT00395850|589195778|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
163133262|NCT00395850|589195779|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
163133263|NCT00395850|589195780|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
163133264|NCT00395850|589195781|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
163133265|NCT00395850|589195778|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
163133266|NCT00395850|589195779|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
163133267|NCT00395850|589195780|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
163133268|NCT00395850|589195781|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
163133269|NCT00395850|589195778|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
163133270|NCT00395850|589195779|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
163133271|NCT00395850|589195780|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
163133272|NCT00395850|589195781|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
163133273|NCT02540993|589195786|FG000|Overall Study|Lost to Follow-up|5|||
163133274|NCT02540993|589195787|FG001|Overall Study|Lost to Follow-up|3|||
163133275|NCT02540993|589195786|FG000|Overall Study|Withdrawal by Subject|4|||
163133276|NCT02540993|589195787|FG001|Overall Study|Withdrawal by Subject|6|||
163133277|NCT02540993|589195786|FG000|Overall Study|GCP violations|33|||
163133278|NCT02540993|589195787|FG001|Overall Study|GCP violations|27|||
163133279|NCT00932165|589195788|FG000|Overall Study|Lost to Follow-up|1|||
163133280|NCT00588094|589195789|FG000|Overall Study|Adverse Event|3|||
163133281|NCT00588094|589195789|FG000|Overall Study|Progression of Disease|2|||
163133282|NCT02951429|589195792|FG000|Overall Study|Adverse Event|3|||
163133283|NCT02951429|589195793|FG001|Overall Study|Adverse Event|7|||
163133284|NCT02951429|589195792|FG000|Overall Study|Death|28|||
163133285|NCT02951429|589195793|FG001|Overall Study|Death|36|||
163133286|NCT02951429|589195792|FG000|Overall Study|Lack of Efficacy|0|||
163133287|NCT02951429|589195793|FG001|Overall Study|Lack of Efficacy|1|||
163133288|NCT02951429|589195792|FG000|Overall Study|Lost to Follow-up|0|||
163133289|NCT02951429|589195793|FG001|Overall Study|Lost to Follow-up|1|||
163133290|NCT02951429|589195792|FG000|Overall Study|Lung Transplantation|9|||
163133291|NCT02951429|589195793|FG001|Overall Study|Lung Transplantation|6|||
163133292|NCT02951429|589195792|FG000|Overall Study|Other|1|||
163133293|NCT02951429|589195793|FG001|Overall Study|Other|3|||
163133294|NCT02951429|589195792|FG000|Overall Study|Progressive Disease|1|||
163133295|NCT02951429|589195793|FG001|Overall Study|Progressive Disease|1|||
163133296|NCT02951429|589195792|FG000|Overall Study|Withdrawal by Subject|7|||
163133297|NCT02951429|589195793|FG001|Overall Study|Withdrawal by Subject|11|||
163133298|NCT02951429|589195792|FG000|Overall Study|Participant ongoing in the study|23|||
163133299|NCT02951429|589195793|FG001|Overall Study|Participant ongoing in the study|17|||
163133300|NCT03997825|589195796|FG000|Overall Study|Death|3|||
163133301|NCT03997825|589195796|FG000|Overall Study|Lost to Follow-up|10|||
163133302|NCT03997825|589195796|FG000|Overall Study|Withdrawal by Subject|3|||
163133303|NCT03997825|589195796|FG000|Overall Study|Refused participation|1|||
163133304|NCT00465647|589195798|FG000|Overall Study|Administrative|2|||
163133305|NCT00465647|589195799|FG001|Overall Study|Administrative|2|||
163133306|NCT00465647|589195800|FG002|Overall Study|Administrative|3|||
163133307|NCT00465647|589195801|FG003|Overall Study|Administrative|2|||
163133308|NCT00465647|589195798|FG000|Overall Study|Adverse Event|2|||
163133309|NCT00465647|589195799|FG001|Overall Study|Adverse Event|0|||
163133310|NCT00465647|589195800|FG002|Overall Study|Adverse Event|3|||
163133311|NCT00465647|589195801|FG003|Overall Study|Adverse Event|2|||
163133312|NCT00465647|589195798|FG000|Overall Study|Withdrawal by Subject|1|||
163133313|NCT00465647|589195799|FG001|Overall Study|Withdrawal by Subject|2|||
163133314|NCT00465647|589195800|FG002|Overall Study|Withdrawal by Subject|2|||
163133315|NCT00465647|589195801|FG003|Overall Study|Withdrawal by Subject|7|||
163133316|NCT00465647|589195798|FG000|Overall Study|"The other reasons included loss of IV"|8|||
163133317|NCT00465647|589195799|FG001|Overall Study|"The other reasons included loss of IV"|4|||
163133318|NCT00465647|589195800|FG002|Overall Study|"The other reasons included loss of IV"|3|||
163133319|NCT00465647|589195801|FG003|Overall Study|"The other reasons included loss of IV"|2|||
163133320|NCT01628965|589195802|FG000|Overall Study|Adverse Event|30|||
163133321|NCT01628965|589195802|FG000|Overall Study|Lack of Efficacy|7|||
163133322|NCT01628965|589195802|FG000|Overall Study|Withdrawal by Subject|3|||
163133323|NCT01628965|589195802|FG000|Overall Study|Lost to Follow-up|1|||
163133324|NCT01628965|589195802|FG000|Overall Study|Discontinuation criteria|8|||
163133325|NCT04356352|589195807|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
163133326|NCT04356352|589195808|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
163133327|NCT04356352|589195809|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
163133328|NCT04356352|589195807|FG000|Overall Study|Protocol Violation|0|||
163133329|NCT04356352|589195808|FG001|Overall Study|Protocol Violation|3|||
163133330|NCT04356352|589195809|FG002|Overall Study|Protocol Violation|1|||
163133331|NCT01983774|589195815|FG000|Overall Study|Lung Transplant|0|||
163133332|NCT01983774|589195816|FG001|Overall Study|Lung Transplant|1|||
163133333|NCT01983774|589195815|FG000|Overall Study|Lost to Follow-up|1|||
163133334|NCT01983774|589195816|FG001|Overall Study|Lost to Follow-up|0|||
163133335|NCT01339897|589195817|FG000|Overall Study|Adverse Event|1|||
163133336|NCT01339897|589195818|FG001|Overall Study|Adverse Event|0|||
163133337|NCT01339897|589195819|FG002|Overall Study|Adverse Event|0|||
163133338|NCT01339897|589195820|FG003|Overall Study|Adverse Event|1|||
163133339|NCT00847197|589195821|FG000|Overall Study|Adverse Event|21|||
163133340|NCT00847197|589195822|FG001|Overall Study|Adverse Event|3|||
163133341|NCT00847197|589195821|FG000|Overall Study|Protocol Violation|0|||
163133342|NCT00847197|589195822|FG001|Overall Study|Protocol Violation|1|||
163133343|NCT00847197|589195821|FG000|Overall Study|Withdrawal by Subject|3|||
163133344|NCT00847197|589195822|FG001|Overall Study|Withdrawal by Subject|1|||
163133345|NCT00830180|589195825|FG000|Overall Study|Adverse Event|6|||
163133346|NCT00830180|589195825|FG000|Overall Study|Death|11|||
163133347|NCT00830180|589195825|FG000|Overall Study|Insufficient clinical response|1|||
163133348|NCT00830180|589195825|FG000|Overall Study|Withdrawal by Subject|5|||
163133349|NCT00830180|589195825|FG000|Overall Study|Progressive disease|2|||
163133350|NCT00830180|589195825|FG000|Overall Study|Other - Unspecified|1|||
163133351|NCT01832532|589195826|FG000|Overall Study|Withdrawal by Subject|5|||
163133352|NCT01832532|589195827|FG001|Overall Study|Withdrawal by Subject|2|||
163133353|NCT01630889|589195828|FG000|Overall Study|Death|2|||
163133354|NCT01630889|589195828|FG000|Overall Study|Withdrawal by Subject|1|||
163133355|NCT01630889|589195828|FG000|Overall Study|Other than Specified|2|||
163133356|NCT01630889|589195828|FG000|Overall Study|Lost to Follow-up|4|||
163133357|NCT01630889|589195828|FG000|Overall Study|Other|1|||
163133358|NCT03824587|589195835|FG000|Run-in Period|Screen Failure|0|||
163133359|NCT03824587|589195836|FG001|Run-in Period|Screen Failure|275|||
163133360|NCT03824587|589195835|FG000|Treatment Period|Adverse Event|4|||
163133361|NCT03824587|589195836|FG001|Treatment Period|Adverse Event|1|||
163133362|NCT03824587|589195835|FG000|Treatment Period|Withdrawal by Subject|0|||
163133363|NCT03824587|589195836|FG001|Treatment Period|Withdrawal by Subject|1|||
163133364|NCT03824587|589195835|FG000|Treatment Period|Kidney Transplant|1|||
163133365|NCT03824587|589195836|FG001|Treatment Period|Kidney Transplant|1|||
163133366|NCT01300572|589195837|FG000|Overall Study|HAMA + post dosimetry|1|||
163133367|NCT01368081|589195838|FG000|Overall Study|Adverse Event|4|||
163133368|NCT01368081|589195839|FG001|Overall Study|Adverse Event|4|||
163133369|NCT01368081|589195840|FG002|Overall Study|Adverse Event|3|||
163133370|NCT01368081|589195841|FG003|Overall Study|Adverse Event|2|||
163133371|NCT01368081|589195842|FG004|Overall Study|Adverse Event|2|||
163133372|NCT01368081|589195843|FG005|Overall Study|Adverse Event|5|||
163133373|NCT01368081|589195844|FG006|Overall Study|Adverse Event|6|||
163133374|NCT01368081|589195845|FG007|Overall Study|Adverse Event|2|||
163133375|NCT01368081|589195846|FG008|Overall Study|Adverse Event|3|||
163133376|NCT01368081|589195847|FG009|Overall Study|Adverse Event|5|||
163133377|NCT01368081|589195848|FG010|Overall Study|Adverse Event|6|||
163133378|NCT01368081|589195849|FG011|Overall Study|Adverse Event|1|||
163133379|NCT01368081|589195850|FG012|Overall Study|Adverse Event|3|||
163133380|NCT01368081|589195838|FG000|Overall Study|Lack of Efficacy|0|||
163133381|NCT01368081|589195839|FG001|Overall Study|Lack of Efficacy|1|||
163133382|NCT01368081|589195840|FG002|Overall Study|Lack of Efficacy|0|||
163133383|NCT01368081|589195841|FG003|Overall Study|Lack of Efficacy|1|||
163133384|NCT01368081|589195842|FG004|Overall Study|Lack of Efficacy|0|||
163133385|NCT01368081|589195843|FG005|Overall Study|Lack of Efficacy|0|||
163133386|NCT01368081|589195844|FG006|Overall Study|Lack of Efficacy|0|||
163133387|NCT01368081|589195845|FG007|Overall Study|Lack of Efficacy|2|||
163133388|NCT01368081|589195846|FG008|Overall Study|Lack of Efficacy|0|||
163133389|NCT01368081|589195847|FG009|Overall Study|Lack of Efficacy|0|||
163133390|NCT01368081|589195848|FG010|Overall Study|Lack of Efficacy|0|||
163133391|NCT01368081|589195849|FG011|Overall Study|Lack of Efficacy|0|||
163133392|NCT01368081|589195850|FG012|Overall Study|Lack of Efficacy|0|||
163133393|NCT01368081|589195838|FG000|Overall Study|Protocol Violation|0|||
163133394|NCT01368081|589195839|FG001|Overall Study|Protocol Violation|0|||
163133395|NCT01368081|589195840|FG002|Overall Study|Protocol Violation|0|||
163133396|NCT01368081|589195841|FG003|Overall Study|Protocol Violation|0|||
163133397|NCT01368081|589195842|FG004|Overall Study|Protocol Violation|0|||
163133398|NCT01368081|589195843|FG005|Overall Study|Protocol Violation|1|||
163133399|NCT01368081|589195844|FG006|Overall Study|Protocol Violation|0|||
163133400|NCT01368081|589195845|FG007|Overall Study|Protocol Violation|1|||
163133401|NCT01368081|589195846|FG008|Overall Study|Protocol Violation|0|||
163133402|NCT01368081|589195847|FG009|Overall Study|Protocol Violation|0|||
163133403|NCT01368081|589195848|FG010|Overall Study|Protocol Violation|0|||
163133404|NCT01368081|589195849|FG011|Overall Study|Protocol Violation|0|||
163133405|NCT01368081|589195850|FG012|Overall Study|Protocol Violation|0|||
163133406|NCT01368081|589195838|FG000|Overall Study|Lost to Follow-up|0|||
163133407|NCT01368081|589195839|FG001|Overall Study|Lost to Follow-up|0|||
163345054|NCT00296504|589972035|FG000|Final Analysis|Poor Adherence|0|||
163345055|NCT00296504|589972036|FG001|Final Analysis|Poor Adherence|0|||
163345056|NCT00296504|589972037|FG002|Final Analysis|Poor Adherence|0|||
163345057|NCT00296504|589972038|FG003|Final Analysis|Poor Adherence|0|||
163345058|NCT00296504|589972039|FG004|Final Analysis|Poor Adherence|0|||
163345059|NCT00296504|589972040|FG005|Final Analysis|Poor Adherence|0|||
163345060|NCT00296504|589972041|FG006|Final Analysis|Poor Adherence|0|||
163345061|NCT00296504|589972042|FG007|Final Analysis|Poor Adherence|0|||
163345062|NCT00296504|589972043|FG008|Final Analysis|Poor Adherence|1|||
163345063|NCT02162771|589972044|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
163345064|NCT02162771|589972045|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
163345065|NCT02162771|589972044|FG000|Core Study Period (Part 2)|Adverse Event|4|||
163345066|NCT02162771|589972045|FG001|Core Study Period (Part 2)|Adverse Event|1|||
163345067|NCT02162771|589972044|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
163345068|NCT02162771|589972045|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
163345069|NCT02162771|589972044|FG000|Core Study Period (Part 2)|Physician Decision|0|||
163345070|NCT02162771|589972045|FG001|Core Study Period (Part 2)|Physician Decision|2|||
163345071|NCT02162771|589972044|FG000|Core Study Period (Part 2)|Death|1|||
163345072|NCT02162771|589972045|FG001|Core Study Period (Part 2)|Death|0|||
163345073|NCT02162771|589972044|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
163345074|NCT02162771|589972045|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
163345075|NCT02162771|589972044|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
163345076|NCT02162771|589972045|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
163345077|NCT02162771|589972044|FG000|Maintenance Study Period (Part 2)|Death|2|||
163345078|NCT02162771|589972045|FG001|Maintenance Study Period (Part 2)|Death|1|||
163345079|NCT02162771|589972044|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
163345080|NCT02162771|589972045|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
163345081|NCT02162771|589972044|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
163345082|NCT02162771|589972045|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
163345083|NCT02162771|589972044|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
163345084|NCT02162771|589972045|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
163345085|NCT01078571|589972049|FG000|Overall Study|Adverse Event|36|||
163345086|NCT01078571|589972049|FG000|Overall Study|Lack of effectiveness|36|||
163345087|NCT01078571|589972049|FG000|Overall Study|Reason not reported|21|||
163345088|NCT01078571|589972049|FG000|Overall Study|Withdrawal by Subject|12|||
163345089|NCT01078571|589972049|FG000|Overall Study|Lost to Follow-up|8|||
163345090|NCT01078571|589972049|FG000|Overall Study|Protocol Violation|2|||
163345091|NCT01047306|589972051|FG000|Overall Study|Withdrawal by Subject|2|||
163345092|NCT01047306|589972052|FG001|Overall Study|Withdrawal by Subject|0|||
163345093|NCT01047306|589972051|FG000|Overall Study|Lost to Follow-up|1|||
163345094|NCT01047306|589972052|FG001|Overall Study|Lost to Follow-up|0|||
163133408|NCT01368081|589195840|FG002|Overall Study|Lost to Follow-up|0|||
163133409|NCT01368081|589195841|FG003|Overall Study|Lost to Follow-up|0|||
163133410|NCT01368081|589195842|FG004|Overall Study|Lost to Follow-up|0|||
163133411|NCT01368081|589195843|FG005|Overall Study|Lost to Follow-up|0|||
163133412|NCT01368081|589195844|FG006|Overall Study|Lost to Follow-up|0|||
163133413|NCT01368081|589195845|FG007|Overall Study|Lost to Follow-up|0|||
163133414|NCT01368081|589195846|FG008|Overall Study|Lost to Follow-up|0|||
163133415|NCT01368081|589195847|FG009|Overall Study|Lost to Follow-up|0|||
163133416|NCT01368081|589195848|FG010|Overall Study|Lost to Follow-up|0|||
163133417|NCT01368081|589195849|FG011|Overall Study|Lost to Follow-up|0|||
163133418|NCT01368081|589195850|FG012|Overall Study|Lost to Follow-up|1|||
163133419|NCT01368081|589195838|FG000|Overall Study|Withdrawal by Subject|4|||
163133420|NCT01368081|589195839|FG001|Overall Study|Withdrawal by Subject|4|||
163133421|NCT01368081|589195840|FG002|Overall Study|Withdrawal by Subject|1|||
163133422|NCT01368081|589195841|FG003|Overall Study|Withdrawal by Subject|1|||
163133423|NCT01368081|589195842|FG004|Overall Study|Withdrawal by Subject|0|||
163133424|NCT01368081|589195843|FG005|Overall Study|Withdrawal by Subject|3|||
163345095|NCT01878253|589972053|FG000|Overall Study|Death|1|||
163345096|NCT01878253|589972053|FG000|Overall Study|SIdus System Removal|3|||
163345097|NCT01878253|589972053|FG000|Overall Study|Withdrawal by Subject|1|||
163345098|NCT01878253|589972053|FG000|Overall Study|Lost to Follow-up|2|||
163345099|NCT01878253|589972053|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
163345100|NCT04393779|589972056|FG000|Overall Study|Death|1|||
163345101|NCT04393779|589972056|FG000|Overall Study|Device reintervention or explant|4|||
163345102|NCT03802513|589972057|FG000|Overall Study|Lost to Follow-up|1|||
163345103|NCT01190228|589972061|FG000|Overall Study|Protocol Violation|4|||
163345104|NCT01190228|589972062|FG001|Overall Study|Protocol Violation|0|||
163345105|NCT01190228|589972063|FG002|Overall Study|Protocol Violation|0|||
163345106|NCT01190228|589972061|FG000|Overall Study|Withdrawal by Subject|1|||
163345107|NCT01190228|589972062|FG001|Overall Study|Withdrawal by Subject|0|||
163345108|NCT01190228|589972063|FG002|Overall Study|Withdrawal by Subject|0|||
163345109|NCT01395914|589972069|FG000|Overall Study|Unrelated to study drug AE|6|||
163345110|NCT01395914|589972070|FG001|Overall Study|Unrelated to study drug AE|1|||
163133425|NCT01368081|589195844|FG006|Overall Study|Withdrawal by Subject|4|||
163133426|NCT01368081|589195845|FG007|Overall Study|Withdrawal by Subject|2|||
163133427|NCT01368081|589195846|FG008|Overall Study|Withdrawal by Subject|5|||
163133428|NCT01368081|589195847|FG009|Overall Study|Withdrawal by Subject|4|||
163133429|NCT01368081|589195848|FG010|Overall Study|Withdrawal by Subject|3|||
163133430|NCT01368081|589195849|FG011|Overall Study|Withdrawal by Subject|2|||
163133431|NCT01368081|589195850|FG012|Overall Study|Withdrawal by Subject|0|||
163133432|NCT01368081|589195838|FG000|Overall Study|Other reason not defined above|2|||
163133433|NCT01368081|589195839|FG001|Overall Study|Other reason not defined above|0|||
163133434|NCT01368081|589195840|FG002|Overall Study|Other reason not defined above|0|||
163133435|NCT01368081|589195841|FG003|Overall Study|Other reason not defined above|1|||
163133436|NCT01368081|589195842|FG004|Overall Study|Other reason not defined above|0|||
163133437|NCT01368081|589195843|FG005|Overall Study|Other reason not defined above|1|||
163133438|NCT01368081|589195844|FG006|Overall Study|Other reason not defined above|2|||
163133439|NCT01368081|589195845|FG007|Overall Study|Other reason not defined above|0|||
163133440|NCT01368081|589195846|FG008|Overall Study|Other reason not defined above|0|||
163133441|NCT01368081|589195847|FG009|Overall Study|Other reason not defined above|1|||
163133442|NCT01368081|589195848|FG010|Overall Study|Other reason not defined above|0|||
163133443|NCT01368081|589195849|FG011|Overall Study|Other reason not defined above|0|||
163133444|NCT01368081|589195850|FG012|Overall Study|Other reason not defined above|3|||
163133445|NCT02461745|589195852|FG000|Overall Study|Lack of Efficacy|9|||
163133446|NCT02461745|589195853|FG001|Overall Study|Lack of Efficacy|1|||
163133447|NCT02461745|589195852|FG000|Overall Study|Lost to Follow-up|2|||
163133448|NCT02461745|589195853|FG001|Overall Study|Lost to Follow-up|2|||
163133449|NCT02461745|589195852|FG000|Overall Study|Withdrawal by Subject|3|||
163133450|NCT02461745|589195853|FG001|Overall Study|Withdrawal by Subject|1|||
163133451|NCT02921087|589195854|FG000|Overall Study|Withdrawal by Subject|0|||
163133452|NCT02921087|589195855|FG001|Overall Study|Withdrawal by Subject|1|||
163133453|NCT05128578|589197472|FG000|Overall Study|Withdrawal by Subject|9|||
163133454|NCT05128578|589197472|FG000|Overall Study|Lost to Follow-up|5|||
163133455|NCT01128244|589197473|FG000|Overall Study|Adverse Event|1|||
163133456|NCT01128244|589197473|FG000|Overall Study|Scheduling conflict|2|||
163133457|NCT02837029|589197474|FG000|Screening|Failed to meet screening requirements.|7|||
163133458|NCT02837029|589197475|FG001|Screening|Failed to meet screening requirements.|3|||
163133459|NCT02837029|589197476|FG002|Screening|Failed to meet screening requirements.|0|||
163133460|NCT02837029|589197474|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
163133461|NCT02837029|589197475|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
163133462|NCT02837029|589197476|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
163133463|NCT02837029|589197474|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
163133464|NCT02837029|589197475|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
163133465|NCT02837029|589197476|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
163133466|NCT02837029|589197474|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
163133467|NCT02837029|589197475|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
163133468|NCT02837029|589197476|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
163133469|NCT02837029|589197474|FG000|Cycle 2 and Beyond|Adverse Event|1|||
163133470|NCT02837029|589197475|FG001|Cycle 2 and Beyond|Adverse Event|0|||
163133471|NCT02837029|589197476|FG002|Cycle 2 and Beyond|Adverse Event|0|||
163133472|NCT02837029|589197474|FG000|2 Year Follow-up|Death|6|||
163133473|NCT02837029|589197475|FG001|2 Year Follow-up|Death|7|||
163133474|NCT02837029|589197476|FG002|2 Year Follow-up|Death|0|||
163133475|NCT01363908|589197477|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
163133476|NCT01363908|589197478|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
163133477|NCT01363908|589197477|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
163133478|NCT01363908|589197478|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
163133479|NCT01363908|589197477|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
163133480|NCT01363908|589197478|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
163133481|NCT01363908|589197477|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
163133482|NCT01363908|589197478|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
163133483|NCT05258149|589197479|FG000|Period 1|Protocol Deviation|1|||
163133484|NCT05258149|589197480|FG001|Period 1|Protocol Deviation|0|||
163133485|NCT05258149|589197479|FG000|Period 1|Adverse Event|0|||
163133486|NCT05258149|589197480|FG001|Period 1|Adverse Event|1|||
163133487|NCT05258149|589197479|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
163133488|NCT05258149|589197480|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
163133489|NCT05258149|589197479|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
163133490|NCT05258149|589197480|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
163133491|NCT05258149|589197479|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
163133492|NCT05258149|589197480|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
163133493|NCT03437577|589197483|FG000|Pre-Randomization|Withdrawal by Subject|0|||
163133494|NCT03437577|589197484|FG001|Pre-Randomization|Withdrawal by Subject|0|||
163133495|NCT03437577|589197485|FG002|Pre-Randomization|Withdrawal by Subject|10|||
163133496|NCT03437577|589197483|FG000|Post-Randomization|Physician Decision|0|||
163133497|NCT03437577|589197484|FG001|Post-Randomization|Physician Decision|2|||
163133498|NCT03437577|589197485|FG002|Post-Randomization|Physician Decision|0|||
163133499|NCT04273893|589197493|FG000|Overall Study|Withdrawal by Subject|0|||
163133500|NCT04273893|589197494|FG001|Overall Study|Withdrawal by Subject|2|||
163133501|NCT04273893|589197493|FG000|Overall Study|Treatment of Disease Progression|0|||
163133502|NCT04273893|589197494|FG001|Overall Study|Treatment of Disease Progression|2|||
163133503|NCT04273893|589197493|FG000|Overall Study|Death|1|||
163133504|NCT04273893|589197494|FG001|Overall Study|Death|2|||
163133505|NCT04273893|589197493|FG000|Overall Study|Lost to Follow-up|0|||
163133506|NCT04273893|589197494|FG001|Overall Study|Lost to Follow-up|2|||
163133507|NCT04273893|589197493|FG000|Overall Study|Physician Decision|1|||
163133508|NCT04273893|589197494|FG001|Overall Study|Physician Decision|0|||
163133509|NCT00100789|589197499|FG000|Overall Study|Adverse Event|10|||
163133510|NCT00100789|589197499|FG000|Overall Study|Withdrawal by Subject|1|||
163133511|NCT00100789|589197499|FG000|Overall Study|Progression/relapse|42|||
163133512|NCT00100789|589197499|FG000|Overall Study|Death|2|||
163133513|NCT00100789|589197499|FG000|Overall Study|Not protocol specified|5|||
163133514|NCT00100789|589197499|FG000|Overall Study|Ineligible|3|||
163133515|NCT00100789|589197499|FG000|Overall Study|Never received treatment|1|||
163133516|NCT02936843|589197500|FG000|Overall Study|Lost to Follow-up|3|||
163133517|NCT02936843|589197501|FG001|Overall Study|Lost to Follow-up|1|||
163133518|NCT02936843|589197500|FG000|Overall Study|Withdrawal by Subject|1|||
163133519|NCT02936843|589197501|FG001|Overall Study|Withdrawal by Subject|1|||
163133520|NCT01393821|589197502|FG000|Overall Study|Cancel|1|||
163133521|NCT01393821|589197503|FG001|Overall Study|Cancel|1|||
163133522|NCT01393821|589197502|FG000|Overall Study|not evaluable for primary endpoint|4|||
163133523|NCT01393821|589197503|FG001|Overall Study|not evaluable for primary endpoint|2|||
163133524|NCT01948063|589197515|FG000|Overall Study|Boston MCI halted research protocol|0|||
163133525|NCT01948063|589197516|FG001|Overall Study|Boston MCI halted research protocol|1|||
163133526|NCT01948063|589197515|FG000|Overall Study|Discovered an enrollment in other study|0|||
163133527|NCT01948063|589197516|FG001|Overall Study|Discovered an enrollment in other study|1|||
163133528|NCT01948063|589197515|FG000|Overall Study|Blood samples were accidentally thawed|1|||
163133529|NCT01948063|589197516|FG001|Overall Study|Blood samples were accidentally thawed|0|||
163133530|NCT00880191|589197524|FG000|Overall Study|Refused further treatment|4|||
163133531|NCT00880191|589197525|FG001|Overall Study|Refused further treatment|1|||
163133532|NCT00880191|589197524|FG000|Overall Study|Adverse Event|8|||
163133533|NCT00880191|589197525|FG001|Overall Study|Adverse Event|6|||
163133534|NCT00880191|589197524|FG000|Overall Study|Hospitalization/efficacy|1|||
163133535|NCT00880191|589197525|FG001|Overall Study|Hospitalization/efficacy|1|||
163133536|NCT00773747|589197530|FG000|Overall Study|Lack of Efficacy|112|||
163133537|NCT00773747|589197531|FG001|Overall Study|Lack of Efficacy|144|||
163133538|NCT00773747|589197530|FG000|Overall Study|Physician Decision|26|||
163133539|NCT00773747|589197531|FG001|Overall Study|Physician Decision|18|||
163133540|NCT00773747|589197530|FG000|Overall Study|Lost to Follow-up|0|||
163133541|NCT00773747|589197531|FG001|Overall Study|Lost to Follow-up|1|||
163133542|NCT00773747|589197530|FG000|Overall Study|Protocol Violation|2|||
163133543|NCT00773747|589197531|FG001|Overall Study|Protocol Violation|2|||
163133544|NCT00773747|589197530|FG000|Overall Study|Withdrawal by Subject|89|||
163133545|NCT00773747|589197531|FG001|Overall Study|Withdrawal by Subject|61|||
163133546|NCT00773747|589197530|FG000|Overall Study|Adverse Event|61|||
163133547|NCT00773747|589197531|FG001|Overall Study|Adverse Event|62|||
163133548|NCT00773747|589197530|FG000|Overall Study|Death|5|||
163133549|NCT00773747|589197531|FG001|Overall Study|Death|8|||
163133550|NCT00773747|589197530|FG000|Overall Study|Not Treated|2|||
163133551|NCT00773747|589197531|FG001|Overall Study|Not Treated|0|||
163133552|NCT00836186|589197532|FG000|Overall Study|Blood could not be drawn|1|||
163133553|NCT04079816|589197533|FG000|Overall Study|Request of Subject|2|||
163133554|NCT04079816|589197533|FG000|Overall Study|Unable to draw samples|1|||
163133555|NCT03422536|589197534|FG000|Randomized|Physician Decision|1|||
163133556|NCT03422536|589197535|FG001|Randomized|Physician Decision|1|||
163133557|NCT03422536|589197534|FG000|Allocation - Received Intervention|Disease progression|19|||
163133558|NCT03422536|589197535|FG001|Allocation - Received Intervention|Disease progression|25|||
163133559|NCT03422536|589197534|FG000|Allocation - Received Intervention|Death|1|||
163133560|NCT03422536|589197535|FG001|Allocation - Received Intervention|Death|3|||
163345111|NCT01395914|589972069|FG000|Overall Study|Death|23|||
163345112|NCT01395914|589972070|FG001|Overall Study|Death|17|||
163133561|NCT03422536|589197534|FG000|Allocation - Received Intervention|Adverse Event|1|||
163133562|NCT03422536|589197535|FG001|Allocation - Received Intervention|Adverse Event|0|||
163133563|NCT03422536|589197534|FG000|Allocation - Received Intervention|Physician Decision|1|||
163133564|NCT03422536|589197535|FG001|Allocation - Received Intervention|Physician Decision|1|||
163133565|NCT03422536|589197534|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
163133566|NCT03422536|589197535|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
163133567|NCT03422536|589197534|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
163133568|NCT03422536|589197535|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
163133569|NCT01973998|589197536|FG000|Overall Study|Death|2|||
163133570|NCT01973998|589197537|FG001|Overall Study|Death|2|||
163133571|NCT01636986|589197540|FG000|Overall Study|Withdrawal by Subject|0|||
163133572|NCT01636986|589197541|FG001|Overall Study|Withdrawal by Subject|1|||
163345113|NCT01395914|589972069|FG000|Overall Study|Other|9|||
163345114|NCT01395914|589972070|FG001|Overall Study|Other|3|||
163228632|NCT04300296|589549612|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
163228633|NCT04300296|589549607|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
163228634|NCT04300296|589549608|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
163228635|NCT04300296|589549609|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
163228636|NCT04300296|589549610|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
163228637|NCT04300296|589549611|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
163228638|NCT04300296|589549612|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
163228639|NCT04300296|589549607|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
163228640|NCT04300296|589549608|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
163228641|NCT04300296|589549609|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
163228642|NCT04300296|589549610|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
163228643|NCT04300296|589549611|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
163228644|NCT04300296|589549612|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
163228645|NCT04300296|589549607|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
163228646|NCT04300296|589549608|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
163228647|NCT04300296|589549609|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
163228648|NCT04300296|589549610|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
163228649|NCT04300296|589549611|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
163228650|NCT04300296|589549612|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
163228651|NCT04300296|589549607|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
163228652|NCT04300296|589549608|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
163228653|NCT04300296|589549609|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
163228654|NCT04300296|589549610|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
163228655|NCT04300296|589549611|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
163228656|NCT04300296|589549612|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
163228657|NCT05044234|589549613|FG000|Overall Study|Lost to Follow-up|2|||
163228658|NCT05044234|589549614|FG001|Overall Study|Lost to Follow-up|1|||
163228659|NCT05044234|589549615|FG002|Overall Study|Lost to Follow-up|1|||
163228660|NCT05044234|589549616|FG003|Overall Study|Lost to Follow-up|2|||
163228661|NCT05044234|589549613|FG000|Overall Study|Withdrawal by Subject|6|||
163228662|NCT05044234|589549614|FG001|Overall Study|Withdrawal by Subject|4|||
163228663|NCT05044234|589549615|FG002|Overall Study|Withdrawal by Subject|5|||
163228664|NCT05044234|589549616|FG003|Overall Study|Withdrawal by Subject|8|||
163228665|NCT05044234|589549613|FG000|Overall Study|Study terminated by Sponsor|21|||
163228666|NCT05044234|589549614|FG001|Overall Study|Study terminated by Sponsor|21|||
163228667|NCT05044234|589549615|FG002|Overall Study|Study terminated by Sponsor|20|||
163228668|NCT05044234|589549616|FG003|Overall Study|Study terminated by Sponsor|14|||
163228669|NCT05044234|589549613|FG000|Overall Study|Other, not specified|0|||
163228670|NCT05044234|589549614|FG001|Overall Study|Other, not specified|0|||
163228671|NCT05044234|589549615|FG002|Overall Study|Other, not specified|1|||
163228672|NCT05044234|589549616|FG003|Overall Study|Other, not specified|2|||
163228673|NCT05044234|589549613|FG000|Overall Study|Delayed data entry|0|||
163228674|NCT05044234|589549614|FG001|Overall Study|Delayed data entry|0|||
163228675|NCT05044234|589549615|FG002|Overall Study|Delayed data entry|0|||
163228676|NCT05044234|589549616|FG003|Overall Study|Delayed data entry|1|||
163228677|NCT00279708|589549622|FG000|Overall Study|Withdrawal by Subject|2|||
163228678|NCT00279708|589549623|FG001|Overall Study|Withdrawal by Subject|3|||
163228679|NCT00279708|589549622|FG000|Overall Study|Adverse Event|1|||
163228680|NCT00279708|589549623|FG001|Overall Study|Adverse Event|1|||
163228681|NCT02624284|589549624|FG000|Overall Study|Withdrawal by Subject|3|||
163228682|NCT02624284|589549625|FG001|Overall Study|Withdrawal by Subject|6|||
163228683|NCT02624284|589549626|FG002|Overall Study|Withdrawal by Subject|3|||
163228684|NCT02624284|589549624|FG000|Overall Study|Protocol Violation|9|||
163228685|NCT02624284|589549625|FG001|Overall Study|Protocol Violation|10|||
163228686|NCT02624284|589549626|FG002|Overall Study|Protocol Violation|7|||
163228687|NCT02624284|589549624|FG000|Overall Study|Revealed exclusionary condition|2|||
163228688|NCT02624284|589549625|FG001|Overall Study|Revealed exclusionary condition|2|||
163228689|NCT02624284|589549626|FG002|Overall Study|Revealed exclusionary condition|0|||
163228690|NCT02624284|589549624|FG000|Overall Study|Adverse Event|0|||
163228691|NCT02624284|589549625|FG001|Overall Study|Adverse Event|0|||
163228692|NCT02624284|589549626|FG002|Overall Study|Adverse Event|1|||
163228693|NCT02940691|589549627|FG000|Overall Study|Lost to Follow-up|5|||
163228694|NCT02940691|589549627|FG000|Overall Study|Incarceration|1|||
163228695|NCT02506816|589549628|FG000|Overall Study|Adverse Event|3|||
163228696|NCT02477020|589549635|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
163228697|NCT02477020|589549636|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
163228698|NCT02477020|589549635|FG000|Overall Study|Voluntary Withdrawal|7|||
163228699|NCT02477020|589549636|FG001|Overall Study|Voluntary Withdrawal|16|||
163228700|NCT02477020|589549635|FG000|Overall Study|Reason not Specified|3|||
163228701|NCT02477020|589549636|FG001|Overall Study|Reason not Specified|1|||
163228702|NCT02477020|589549635|FG000|Overall Study|Lack of Efficacy|14|||
163228703|NCT02477020|589549636|FG001|Overall Study|Lack of Efficacy|5|||
163228704|NCT03852316|589549637|FG000|Overall Study|Protocol Violation|1|||
163228705|NCT03852316|589549637|FG000|Overall Study|Withdrawal by Subject|2|||
163228706|NCT03852316|589549637|FG000|Overall Study|Enrolled but Device not Utilized|1|||
163228707|NCT01049919|589549638|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
163228708|NCT01049919|589549639|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
163228709|NCT01049919|589549638|FG000|Overall Study|Withdrawal by Subject|5|||
163228710|NCT01049919|589549639|FG001|Overall Study|Withdrawal by Subject|0|||
163228711|NCT01049919|589549638|FG000|Overall Study|Lost to Follow-up|6|||
163228712|NCT01049919|589549639|FG001|Overall Study|Lost to Follow-up|1|||
163228713|NCT01049919|589549638|FG000|Overall Study|Physician Decision|2|||
163228714|NCT01049919|589549639|FG001|Overall Study|Physician Decision|0|||
163228715|NCT01049919|589549638|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
163228716|NCT01049919|589549639|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
163228717|NCT01049919|589549638|FG000|Overall Study|Early study termination by sponsor.|2|||
163228718|NCT01049919|589549639|FG001|Overall Study|Early study termination by sponsor.|0|||
163228719|NCT04354831|589549640|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
163228720|NCT04354831|589549641|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
163228721|NCT00812929|589549642|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
163228722|NCT00812929|589549643|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
163228723|NCT00812929|589549644|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
163228724|NCT00812929|589549645|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
163228725|NCT00812929|589549646|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
163228726|NCT00812929|589549647|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
163228727|NCT00812929|589549648|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
163228728|NCT00812929|589549649|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
163228729|NCT00812929|589549650|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
163228730|NCT00812929|589549651|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
163228731|NCT00812929|589549642|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
163228732|NCT00812929|589549643|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
163228733|NCT00812929|589549644|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
163228734|NCT00812929|589549645|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
163228735|NCT00812929|589549646|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
163228736|NCT00812929|589549647|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
163228737|NCT00812929|589549648|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
163228738|NCT00812929|589549649|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
163228739|NCT00812929|589549650|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
163228740|NCT00812929|589549651|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
163228741|NCT00812929|589549642|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
163228742|NCT00812929|589549643|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
163228743|NCT00812929|589549644|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
163228744|NCT00812929|589549645|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
163228745|NCT00812929|589549646|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
163228746|NCT00812929|589549647|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
163228747|NCT00812929|589549648|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
163228748|NCT00812929|589549649|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
163228749|NCT00812929|589549650|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
163228750|NCT00812929|589549651|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
163228751|NCT02504372|589549653|FG000|Overall Study|Death|136|||
163228752|NCT02504372|589549654|FG001|Overall Study|Death|154|||
163228753|NCT02504372|589549653|FG000|Overall Study|Lost to Follow-up|0|||
163228754|NCT02504372|589549654|FG001|Overall Study|Lost to Follow-up|2|||
163228755|NCT02504372|589549653|FG000|Overall Study|Withdrawal of consent|25|||
163228756|NCT02504372|589549654|FG001|Overall Study|Withdrawal of consent|16|||
163228757|NCT02504372|589549653|FG000|Overall Study|Participants ongoing|429|||
163228758|NCT02504372|589549654|FG001|Overall Study|Participants ongoing|415|||
163228759|NCT02975934|589549655|FG000|Treatment Phase|Never initiated study drug|0|||
163228760|NCT02975934|589549656|FG001|Treatment Phase|Never initiated study drug|5|||
163228761|NCT02975934|589549657|FG002|Treatment Phase|Never initiated study drug|0|||
163228762|NCT02075840|589549659|FG000|Overall Study|Withdrawal by Subject|13|||
163228763|NCT02075840|589549660|FG001|Overall Study|Withdrawal by Subject|22|||
163228764|NCT02075840|589549659|FG000|Overall Study|Reason not specified|1|||
163228765|NCT02075840|589549660|FG001|Overall Study|Reason not specified|0|||
163228766|NCT02075840|589549659|FG000|Overall Study|Adverse Event|0|||
163408476|NCT02264990|590205527|FG000|Overall Study|Other|0|||
163228767|NCT02075840|589549660|FG001|Overall Study|Adverse Event|2|||
163228768|NCT02075840|589549659|FG000|Overall Study|Death|35|||
163228769|NCT02075840|589549660|FG001|Overall Study|Death|40|||
163228770|NCT02075840|589549659|FG000|Overall Study|Lost to Follow-up|3|||
163228771|NCT02075840|589549660|FG001|Overall Study|Lost to Follow-up|2|||
163228772|NCT02075840|589549659|FG000|Overall Study|Physician Decision|1|||
163228773|NCT02075840|589549660|FG001|Overall Study|Physician Decision|3|||
163228774|NCT02075840|589549659|FG000|Overall Study|Ongoing at CCOD|99|||
163228775|NCT02075840|589549660|FG001|Overall Study|Ongoing at CCOD|82|||
163408477|NCT02264990|590205528|FG001|Overall Study|Other|1|||
163228776|NCT03491150|589549663|FG000|Overall Study|Adverse Event|1|||
163228777|NCT03491150|589549664|FG001|Overall Study|Adverse Event|0|||
163228778|NCT03491150|589549663|FG000|Overall Study|Study Terminated by Sponsor|74|||
163228779|NCT03491150|589549664|FG001|Overall Study|Study Terminated by Sponsor|70|||
163228780|NCT03491150|589549663|FG000|Overall Study|Other|0|||
163228781|NCT03491150|589549664|FG001|Overall Study|Other|1|||
163228782|NCT03491150|589549663|FG000|Overall Study|Withdrawal by Subject|1|||
163228783|NCT03491150|589549664|FG001|Overall Study|Withdrawal by Subject|2|||
163228784|NCT02644967|589549667|FG000|Overall Study|Death|26|||
163345115|NCT01395914|589972069|FG000|Overall Study|Withdrawal by patient|27|||
163228785|NCT02644967|589549667|FG000|Overall Study|Physician Decision|1|||
163228786|NCT02644967|589549667|FG000|Overall Study|Withdrawal by Subject|2|||
163228787|NCT02644967|589549667|FG000|Overall Study|Protocol Violation|1|||
163228788|NCT02644967|589549667|FG000|Overall Study|Progressive Disease|1|||
163228789|NCT02644967|589549667|FG000|Overall Study|Study Terminated by Sponsor|4|||
163228790|NCT02287896|589549668|FG000|Second Injection Visit|Withdrawal by Subject|0|||
163228791|NCT02287896|589549669|FG001|Second Injection Visit|Withdrawal by Subject|1|||
163228792|NCT05179421|589549670|FG000|First Infusion Day|Adverse Event|1|||
163228793|NCT05179421|589549671|FG001|First Infusion Day|Adverse Event|0|||
163228794|NCT00813124|589549672|FG000|Overall Study|Death|2|||
163228795|NCT00813124|589549672|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
163228796|NCT00813124|589549672|FG000|Overall Study|Withdrawal by Subject|1|||
163228797|NCT01077960|589549673|FG000|Overall Study|Adverse Event|6|||
163228798|NCT01077960|589549673|FG000|Overall Study|Protocol Violation|3|||
163228799|NCT01077960|589549673|FG000|Overall Study|Lost to Follow-up|5|||
163228800|NCT01077960|589549673|FG000|Overall Study|Subject decision|1|||
163228801|NCT01077960|589549673|FG000|Overall Study|Reason unspecified|1|||
163228802|NCT03837899|589549677|FG000|Overall Study|Death|6|||
163228803|NCT03837899|589549678|FG001|Overall Study|Death|8|||
163228804|NCT03837899|589549679|FG002|Overall Study|Death|3|||
163228805|NCT03837899|589549680|FG003|Overall Study|Death|7|||
163228806|NCT03837899|589549681|FG004|Overall Study|Death|8|||
163228807|NCT03837899|589549682|FG005|Overall Study|Death|7|||
163228808|NCT03837899|589549677|FG000|Overall Study|Moved to post-trial access program|0|||
163228809|NCT03837899|589549678|FG001|Overall Study|Moved to post-trial access program|1|||
163228810|NCT03837899|589549679|FG002|Overall Study|Moved to post-trial access program|0|||
163228811|NCT03837899|589549680|FG003|Overall Study|Moved to post-trial access program|0|||
163228812|NCT03837899|589549681|FG004|Overall Study|Moved to post-trial access program|0|||
163228813|NCT03837899|589549682|FG005|Overall Study|Moved to post-trial access program|0|||
163228814|NCT03837899|589549677|FG000|Overall Study|Other|0|||
163228815|NCT03837899|589549678|FG001|Overall Study|Other|0|||
163228816|NCT03837899|589549679|FG002|Overall Study|Other|0|||
163228817|NCT03837899|589549680|FG003|Overall Study|Other|0|||
163228818|NCT03837899|589549681|FG004|Overall Study|Other|0|||
163228819|NCT03837899|589549682|FG005|Overall Study|Other|2|||
163228820|NCT03837899|589549677|FG000|Overall Study|Lost to Follow-up|0|||
163228821|NCT03837899|589549678|FG001|Overall Study|Lost to Follow-up|1|||
163228822|NCT03837899|589549679|FG002|Overall Study|Lost to Follow-up|0|||
163228823|NCT03837899|589549680|FG003|Overall Study|Lost to Follow-up|0|||
163228824|NCT03837899|589549681|FG004|Overall Study|Lost to Follow-up|0|||
163228825|NCT03837899|589549682|FG005|Overall Study|Lost to Follow-up|0|||
163345116|NCT01395914|589972070|FG001|Overall Study|Withdrawal by patient|14|||
163345117|NCT01395914|589972069|FG000|Overall Study|Study drug-related AE|1|||
163345118|NCT01395914|589972070|FG001|Overall Study|Study drug-related AE|0|||
163345119|NCT01395914|589972069|FG000|Overall Study|Lost to Follow-up|6|||
163345120|NCT01395914|589972070|FG001|Overall Study|Lost to Follow-up|2|||
163345121|NCT01648699|589972071|FG000|Overall Study|Death|1|||
163345122|NCT01648699|589972071|FG000|Overall Study|Lost to Follow-up|2|||
163345123|NCT01648699|589972071|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
163345124|NCT04930445|589972073|FG000|Overall Study|Adverse Event|7|||
163345125|NCT04930445|589972073|FG000|Overall Study|Lost to Follow-up|1|||
163345126|NCT04930445|589972073|FG000|Overall Study|Physician Decision|1|||
163228826|NCT03837899|589549677|FG000|Overall Study|Withdrawal by Subject|0|||
163228827|NCT03837899|589549678|FG001|Overall Study|Withdrawal by Subject|0|||
163228828|NCT03837899|589549679|FG002|Overall Study|Withdrawal by Subject|0|||
163228829|NCT03837899|589549680|FG003|Overall Study|Withdrawal by Subject|1|||
163228830|NCT03837899|589549681|FG004|Overall Study|Withdrawal by Subject|0|||
163228831|NCT03837899|589549682|FG005|Overall Study|Withdrawal by Subject|0|||
163228832|NCT03837899|589549677|FG000|Overall Study|Study specific discontinuation criteria|0|||
163228833|NCT03837899|589549678|FG001|Overall Study|Study specific discontinuation criteria|1|||
163228834|NCT03837899|589549679|FG002|Overall Study|Study specific discontinuation criteria|0|||
163228835|NCT03837899|589549680|FG003|Overall Study|Study specific discontinuation criteria|0|||
163345127|NCT04930445|589972073|FG000|Overall Study|Lack of Efficacy|1|||
163345128|NCT04930445|589972073|FG000|Overall Study|Study Terminated by Sponsor|245|||
163345129|NCT04930445|589972073|FG000|Overall Study|Screen Failure|8|||
163345130|NCT04930445|589972073|FG000|Overall Study|Other|2|||
163345131|NCT00975130|589972074|FG000|Study Part 1|Adverse Event|150|||
163345132|NCT00975130|589972075|FG001|Study Part 1|Adverse Event|0|||
163228836|NCT03837899|589549681|FG004|Overall Study|Study specific discontinuation criteria|3|||
163133573|NCT01636986|589197540|FG000|Overall Study|Corneal Staining|0|||
163133574|NCT01636986|589197541|FG001|Overall Study|Corneal Staining|1|||
163133575|NCT02160145|589197544|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
163133576|NCT02160145|589197545|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
163133577|NCT02160145|589197546|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
163133578|NCT02160145|589197544|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
163133579|NCT02160145|589197545|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
163133580|NCT02160145|589197546|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
163133581|NCT02160145|589197544|FG000|Randomized Double-blind Period|Subject decision|0|||
163133582|NCT02160145|589197545|FG001|Randomized Double-blind Period|Subject decision|21|||
163133583|NCT02160145|589197546|FG002|Randomized Double-blind Period|Subject decision|20|||
163133584|NCT02160145|589197544|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
163133585|NCT02160145|589197545|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
163133586|NCT02160145|589197546|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
163133587|NCT02160145|589197544|FG000|Randomized Double-blind Period|Physician Decision|0|||
163133588|NCT02160145|589197545|FG001|Randomized Double-blind Period|Physician Decision|7|||
163133589|NCT02160145|589197546|FG002|Randomized Double-blind Period|Physician Decision|5|||
163133590|NCT00705146|589197550|FG000|Overall Study|Lost to Follow-up|1|||
163133591|NCT00705146|589197551|FG001|Overall Study|Lost to Follow-up|1|||
163133592|NCT01620528|589197552|FG000|Treatment Period|Did Not Receive Study Drug|0|||
163133593|NCT01620528|589197553|FG001|Treatment Period|Did Not Receive Study Drug|0|||
163133594|NCT01620528|589197554|FG002|Treatment Period|Did Not Receive Study Drug|1|||
163133595|NCT01620528|589197552|FG000|Treatment Period|Withdrawal by Subject|35|||
163133596|NCT01620528|589197553|FG001|Treatment Period|Withdrawal by Subject|21|||
163133597|NCT01620528|589197554|FG002|Treatment Period|Withdrawal by Subject|16|||
163133598|NCT01620528|589197552|FG000|Treatment Period|Adverse Event|17|||
163133599|NCT01620528|589197553|FG001|Treatment Period|Adverse Event|13|||
163133600|NCT01620528|589197554|FG002|Treatment Period|Adverse Event|21|||
163133601|NCT01620528|589197552|FG000|Treatment Period|Lost to Follow-up|16|||
163133602|NCT01620528|589197553|FG001|Treatment Period|Lost to Follow-up|8|||
163133603|NCT01620528|589197554|FG002|Treatment Period|Lost to Follow-up|14|||
163133604|NCT01620528|589197552|FG000|Treatment Period|Other|9|||
163133605|NCT01620528|589197553|FG001|Treatment Period|Other|5|||
163133606|NCT01620528|589197554|FG002|Treatment Period|Other|7|||
163133607|NCT01620528|589197552|FG000|Treatment Period|Subject Noncompliant|11|||
163133608|NCT01620528|589197553|FG001|Treatment Period|Subject Noncompliant|2|||
163133609|NCT01620528|589197554|FG002|Treatment Period|Subject Noncompliant|2|||
163133610|NCT01620528|589197552|FG000|Treatment Period|Pregnancy|7|||
163133611|NCT01620528|589197553|FG001|Treatment Period|Pregnancy|2|||
163133612|NCT01620528|589197554|FG002|Treatment Period|Pregnancy|2|||
163133613|NCT01620528|589197552|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
163133614|NCT01620528|589197553|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
163133615|NCT01620528|589197554|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
163133616|NCT01620528|589197552|FG000|Treatment Period|Exclusionary Medication Received|0|||
163133617|NCT01620528|589197553|FG001|Treatment Period|Exclusionary Medication Received|1|||
163133618|NCT01620528|589197554|FG002|Treatment Period|Exclusionary Medication Received|0|||
163133619|NCT01620528|589197552|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
163133620|NCT01620528|589197553|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
163133621|NCT01620528|589197554|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
163133622|NCT01620528|589197552|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
163133623|NCT01620528|589197553|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
163133624|NCT01620528|589197554|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
163133625|NCT01620528|589197552|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
163133626|NCT01620528|589197553|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
163133627|NCT01620528|589197554|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
163133628|NCT01620528|589197552|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
163133629|NCT01620528|589197553|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
163133630|NCT01620528|589197554|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
163133631|NCT01620528|589197552|FG000|Post-Treatment Follow-Up Period|Other|6|||
163133632|NCT01620528|589197553|FG001|Post-Treatment Follow-Up Period|Other|4|||
163133633|NCT01620528|589197554|FG002|Post-Treatment Follow-Up Period|Other|2|||
163133634|NCT01457846|589197561|FG000|Overall Study|Death before treatment|1|||
163133635|NCT01457846|589197562|FG001|Overall Study|Death before treatment|2|||
163133636|NCT01457846|589197561|FG000|Overall Study|Did not receive treatment|0|||
163133637|NCT01457846|589197562|FG001|Overall Study|Did not receive treatment|1|||
163133638|NCT01457846|589197561|FG000|Overall Study|Death|27|||
163133639|NCT01457846|589197562|FG001|Overall Study|Death|16|||
163133640|NCT01457846|589197561|FG000|Overall Study|Unclassified reason for not completed|11|||
163133641|NCT01457846|589197562|FG001|Overall Study|Unclassified reason for not completed|10|||
163133642|NCT01457846|589197561|FG000|Overall Study|Withdrawal by Subject|1|||
163133643|NCT01457846|589197562|FG001|Overall Study|Withdrawal by Subject|1|||
163133644|NCT01457846|589197561|FG000|Overall Study|Lost to Follow-up|1|||
163133645|NCT01457846|589197562|FG001|Overall Study|Lost to Follow-up|0|||
163133646|NCT00383162|589197563|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
163133647|NCT00383162|589197564|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
163133648|NCT00383162|589197563|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
163133649|NCT00383162|589197564|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
163133650|NCT00383162|589197563|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
163133651|NCT00383162|589197564|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
163133652|NCT00383162|589197563|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
163133653|NCT00383162|589197564|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
163133654|NCT00383162|589197563|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
163133655|NCT00383162|589197564|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
163133656|NCT00383162|589197563|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
163133657|NCT00383162|589197564|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
163133658|NCT00383162|589197563|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
163133659|NCT00383162|589197564|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
163133660|NCT00383162|589197563|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
163133661|NCT00383162|589197564|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
163133662|NCT00383162|589197563|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
163133663|NCT00383162|589197564|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
163133664|NCT01153698|589197565|FG000|Overall Study|Adverse Event|12|||
163133665|NCT01153698|589197565|FG000|Overall Study|Lost to Follow-up|4|||
163133666|NCT01153698|589197565|FG000|Overall Study|Withdrawal by Subject|2|||
163133667|NCT01153698|589197565|FG000|Overall Study|Switch to other anticoagulants|4|||
163133668|NCT01153698|589197565|FG000|Overall Study|Other|2|||
163133669|NCT01153698|589197565|FG000|Overall Study|Not treated with Pradaxa|5|||
163133670|NCT05392803|589197568|FG000|Overall Study|Lost to Follow-up|0|||
163133671|NCT05392803|589197569|FG001|Overall Study|Lost to Follow-up|2|||
163133672|NCT01240135|589197570|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
163133673|NCT01240135|589197571|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
163133674|NCT01240135|589197570|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
163133675|NCT01240135|589197571|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
163133676|NCT02220712|589197572|FG000|Overall Study|Adverse Event|1|||
163133677|NCT02220712|589197572|FG000|Overall Study|Withdrawal by Subject|2|||
163133678|NCT02220712|589197572|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
163133679|NCT00760838|589197576|FG000|Overall Study|Adverse Event|1|||
163133680|NCT00760838|589197577|FG001|Overall Study|Adverse Event|1|||
163133681|NCT00760838|589197576|FG000|Overall Study|Lack of Efficacy|1|||
163133682|NCT00760838|589197577|FG001|Overall Study|Lack of Efficacy|0|||
163133683|NCT00760838|589197576|FG000|Overall Study|Lost to Follow-up|2|||
163133684|NCT00760838|589197577|FG001|Overall Study|Lost to Follow-up|0|||
163133685|NCT00760838|589197576|FG000|Overall Study|Withdrawal by Subject|1|||
163133686|NCT00760838|589197577|FG001|Overall Study|Withdrawal by Subject|1|||
163133687|NCT00923845|589197578|FG000|Induction Therapy|Poor performance status|0|||
163133688|NCT00923845|589197579|FG001|Induction Therapy|Poor performance status|2|||
163133689|NCT01743040|589197584|FG000|Overall Study|Death|1|||
163133690|NCT01743040|589197584|FG000|Overall Study|Lost to Follow-up|66|||
163133691|NCT01743040|589197584|FG000|Overall Study|Physician Decision|40|||
163133692|NCT01743040|589197584|FG000|Overall Study|Protocol Violation|1|||
163133693|NCT01743040|589197584|FG000|Overall Study|Withdrawal by Subject|121|||
163133694|NCT04378114|589197585|FG000|Overall Study|Withdrawal by Subject|5|||
163133695|NCT00392990|589197587|FG000|Treatment on Study|Adverse Event|3|||
163133696|NCT00392990|589197588|FG001|Treatment on Study|Adverse Event|1|||
163133697|NCT00392990|589197587|FG000|Follow up for 2 Years|Death|4|||
163133698|NCT00392990|589197588|FG001|Follow up for 2 Years|Death|0|||
163133699|NCT00825812|589197592|FG000|Overall Study|Never entered follow up|0|||
163133700|NCT00825812|589197593|FG001|Overall Study|Never entered follow up|0|||
163133701|NCT00825812|589197594|FG002|Overall Study|Never entered follow up|0|||
163133702|NCT00825812|589197595|FG003|Overall Study|Never entered follow up|1|||
163133703|NCT00825812|589197592|FG000|Overall Study|Adverse Event|0|||
163133704|NCT00825812|589197593|FG001|Overall Study|Adverse Event|0|||
163133705|NCT00825812|589197594|FG002|Overall Study|Adverse Event|0|||
163133706|NCT00825812|589197595|FG003|Overall Study|Adverse Event|1|||
163133707|NCT00825812|589197592|FG000|Overall Study|Subject withdrew consent|0|||
163133708|NCT00825812|589197593|FG001|Overall Study|Subject withdrew consent|0|||
163133709|NCT00825812|589197594|FG002|Overall Study|Subject withdrew consent|3|||
163133710|NCT00825812|589197595|FG003|Overall Study|Subject withdrew consent|2|||
163133711|NCT00825812|589197592|FG000|Overall Study|Non-compliance with protocol|0|||
163133712|NCT00825812|589197593|FG001|Overall Study|Non-compliance with protocol|0|||
163133713|NCT00825812|589197594|FG002|Overall Study|Non-compliance with protocol|0|||
163133714|NCT00825812|589197595|FG003|Overall Study|Non-compliance with protocol|1|||
163133715|NCT00825812|589197592|FG000|Overall Study|Administrative|0|||
163133716|NCT00825812|589197593|FG001|Overall Study|Administrative|1|||
163133717|NCT00825812|589197594|FG002|Overall Study|Administrative|3|||
163133718|NCT00825812|589197595|FG003|Overall Study|Administrative|5|||
163133719|NCT00991406|589197597|FG000|Overall Study|One participant did not respond to FES.|1|||
163133720|NCT00986362|589197598|FG000|Overall Study|Death|2|||
163133721|NCT00986362|589197599|FG001|Overall Study|Death|0|||
163133722|NCT00986362|589197598|FG000|Overall Study|Lost to Follow-up|0|||
163133723|NCT00986362|589197599|FG001|Overall Study|Lost to Follow-up|1|||
163133724|NCT03755661|589197604|FG000|Overall Study|Lost to Follow-up|1|||
163133725|NCT03755661|589197605|FG001|Overall Study|Lost to Follow-up|0|||
163133726|NCT02038075|589197606|FG000|Overall Study|Withdrawal by Subject|3|||
163133727|NCT02038075|589197607|FG001|Overall Study|Withdrawal by Subject|0|||
163133728|NCT04000581|589197608|FG000|Overall Study|Withdrawal by Subject|0|||
163133729|NCT04000581|589197609|FG001|Overall Study|Withdrawal by Subject|1|||
163133730|NCT00895453|589197613|FG000|Overall Study|Lost to Follow-up|25|||
163133731|NCT00895453|589197614|FG001|Overall Study|Lost to Follow-up|25|||
163133732|NCT00895453|589197615|FG002|Overall Study|Lost to Follow-up|23|||
163133733|NCT02519595|589197616|FG000|Overall Study|Protocol Violation|8|||
163133734|NCT02519595|589197617|FG001|Overall Study|Protocol Violation|22|||
163133735|NCT02519595|589197618|FG002|Overall Study|Protocol Violation|16|||
163133736|NCT03188510|589197621|FG000|Overall Study|Inappropriate behavior with site staff|0|||
163133737|NCT03188510|589197622|FG001|Overall Study|Inappropriate behavior with site staff|1|||
163133738|NCT03188510|589197623|FG002|Overall Study|Inappropriate behavior with site staff|0|||
163133739|NCT01736618|589197626|FG000|Overall Study|Death|294|||
163133740|NCT01736618|589197626|FG000|Overall Study|Lost to Follow-up|193|||
163133741|NCT01736618|589197626|FG000|Overall Study|Withdrawal by Subject|54|||
163133742|NCT01736618|589197626|FG000|Overall Study|Subject unable to be followed at study location|223|||
163133743|NCT01736618|589197626|FG000|Overall Study|Physician Decision|33|||
163133744|NCT01736618|589197626|FG000|Overall Study|Transplant or removal of target organ|19|||
163133745|NCT01736618|589197626|FG000|Overall Study|Change in indication or condition|78|||
163133746|NCT01736618|589197626|FG000|Overall Study|Study device explant|103|||
163133747|NCT01736618|589197626|FG000|Overall Study|Unable to complete implant|2|||
163133748|NCT04167137|589197628|FG000|Overall Study|Disease progression|1|||
163133749|NCT04167137|589197629|FG001|Overall Study|Disease progression|1|||
163133750|NCT04167137|589197630|FG002|Overall Study|Disease progression|3|||
163133751|NCT04167137|589197631|FG003|Overall Study|Disease progression|3|||
163133752|NCT04167137|589197632|FG004|Overall Study|Disease progression|2|||
163133753|NCT04167137|589197633|FG005|Overall Study|Disease progression|3|||
163133754|NCT04167137|589197634|FG006|Overall Study|Disease progression|2|||
163133755|NCT04167137|589197635|FG007|Overall Study|Disease progression|2|||
163133756|NCT04167137|589197628|FG000|Overall Study|Withdrawal by Subject|1|||
163133757|NCT04167137|589197629|FG001|Overall Study|Withdrawal by Subject|0|||
163133758|NCT04167137|589197630|FG002|Overall Study|Withdrawal by Subject|0|||
163133759|NCT04167137|589197631|FG003|Overall Study|Withdrawal by Subject|1|||
163133760|NCT04167137|589197632|FG004|Overall Study|Withdrawal by Subject|0|||
163133761|NCT04167137|589197633|FG005|Overall Study|Withdrawal by Subject|2|||
163133762|NCT04167137|589197634|FG006|Overall Study|Withdrawal by Subject|1|||
163133763|NCT04167137|589197635|FG007|Overall Study|Withdrawal by Subject|0|||
163133764|NCT04167137|589197628|FG000|Overall Study|Adverse Event|0|||
163133765|NCT04167137|589197629|FG001|Overall Study|Adverse Event|0|||
163133766|NCT04167137|589197630|FG002|Overall Study|Adverse Event|0|||
163133767|NCT04167137|589197631|FG003|Overall Study|Adverse Event|0|||
163133768|NCT04167137|589197632|FG004|Overall Study|Adverse Event|0|||
163133769|NCT04167137|589197633|FG005|Overall Study|Adverse Event|1|||
163133770|NCT04167137|589197634|FG006|Overall Study|Adverse Event|0|||
163133771|NCT04167137|589197635|FG007|Overall Study|Adverse Event|1|||
163133772|NCT04167137|589197628|FG000|Overall Study|Physician Decision|0|||
163133773|NCT04167137|589197629|FG001|Overall Study|Physician Decision|0|||
163133774|NCT04167137|589197630|FG002|Overall Study|Physician Decision|0|||
163133775|NCT04167137|589197631|FG003|Overall Study|Physician Decision|1|||
163345133|NCT00975130|589972076|FG002|Study Part 1|Adverse Event|0|||
163133776|NCT04167137|589197632|FG004|Overall Study|Physician Decision|0|||
163133777|NCT04167137|589197633|FG005|Overall Study|Physician Decision|0|||
163133778|NCT04167137|589197634|FG006|Overall Study|Physician Decision|1|||
163133779|NCT04167137|589197635|FG007|Overall Study|Physician Decision|0|||
163133780|NCT04167137|589197628|FG000|Overall Study|Death|0|||
163133781|NCT04167137|589197629|FG001|Overall Study|Death|1|||
163345134|NCT00975130|589972074|FG000|Study Part 1|Lost to Follow-up|19|||
163133782|NCT04167137|589197630|FG002|Overall Study|Death|0|||
163133783|NCT04167137|589197631|FG003|Overall Study|Death|0|||
163133784|NCT04167137|589197632|FG004|Overall Study|Death|0|||
163133785|NCT04167137|589197633|FG005|Overall Study|Death|0|||
163345135|NCT00975130|589972075|FG001|Study Part 1|Lost to Follow-up|0|||
163133786|NCT04167137|589197634|FG006|Overall Study|Death|0|||
163133787|NCT04167137|589197635|FG007|Overall Study|Death|0|||
163133788|NCT04167137|589197628|FG000|Overall Study|Study terminated by Sponsor|0|||
163133789|NCT04167137|589197629|FG001|Overall Study|Study terminated by Sponsor|0|||
163133790|NCT04167137|589197630|FG002|Overall Study|Study terminated by Sponsor|0|||
163133791|NCT04167137|589197631|FG003|Overall Study|Study terminated by Sponsor|0|||
163133792|NCT04167137|589197632|FG004|Overall Study|Study terminated by Sponsor|0|||
163133793|NCT04167137|589197633|FG005|Overall Study|Study terminated by Sponsor|0|||
163133794|NCT04167137|589197634|FG006|Overall Study|Study terminated by Sponsor|0|||
163133795|NCT04167137|589197635|FG007|Overall Study|Study terminated by Sponsor|1|||
163133796|NCT00211887|589197638|FG000|Overall Study|Adverse Event|8|||
163133797|NCT00211887|589197639|FG001|Overall Study|Adverse Event|4|||
163133798|NCT00211887|589197640|FG002|Overall Study|Adverse Event|6|||
163133799|NCT00211887|589197638|FG000|Overall Study|Death|1|||
163133800|NCT00211887|589197639|FG001|Overall Study|Death|1|||
163133801|NCT00211887|589197640|FG002|Overall Study|Death|1|||
163133802|NCT00211887|589197638|FG000|Overall Study|Lost to Follow-up|28|||
163133803|NCT00211887|589197639|FG001|Overall Study|Lost to Follow-up|13|||
163133804|NCT00211887|589197640|FG002|Overall Study|Lost to Follow-up|9|||
163133805|NCT00211887|589197638|FG000|Overall Study|Non-medical reason|31|||
163133806|NCT00211887|589197639|FG001|Overall Study|Non-medical reason|14|||
163133807|NCT00211887|589197640|FG002|Overall Study|Non-medical reason|8|||
163133808|NCT00211887|589197638|FG000|Overall Study|Other medical reason|15|||
163133809|NCT00211887|589197639|FG001|Overall Study|Other medical reason|11|||
163133810|NCT00211887|589197640|FG002|Overall Study|Other medical reason|7|||
163133811|NCT00211887|589197638|FG000|Overall Study|Side effects|19|||
163133812|NCT00211887|589197639|FG001|Overall Study|Side effects|13|||
163133813|NCT00211887|589197640|FG002|Overall Study|Side effects|5|||
163133814|NCT03058692|589200018|FG000|Overall Study|Lost to Follow-up|2|||
163133815|NCT03058692|589200019|FG001|Overall Study|Lost to Follow-up|1|||
163133816|NCT03058692|589200018|FG000|Overall Study|Withdrawal by Subject|1|||
163133817|NCT03058692|589200019|FG001|Overall Study|Withdrawal by Subject|1|||
163133818|NCT05111249|589200024|FG000|Overall Study|Lost to Follow-up|0|||
163133819|NCT05111249|589200025|FG001|Overall Study|Lost to Follow-up|2|||
163133820|NCT05111249|589200024|FG000|Overall Study|Physician Decision|0|||
163133821|NCT05111249|589200025|FG001|Overall Study|Physician Decision|1|||
163133822|NCT05111249|589200024|FG000|Overall Study|Participant decision|1|||
163133823|NCT05111249|589200025|FG001|Overall Study|Participant decision|5|||
163133824|NCT01702025|589200033|FG000|Overall Study|Equipment failure|1|||
163133825|NCT01702025|589200034|FG001|Overall Study|Equipment failure|0|||
163133826|NCT01702025|589200035|FG002|Overall Study|Equipment failure|0|||
163133827|NCT01702025|589200036|FG003|Overall Study|Equipment failure|0|||
163133828|NCT01702025|589200033|FG000|Overall Study|Adverse Event|1|||
163133829|NCT01702025|589200034|FG001|Overall Study|Adverse Event|1|||
163133830|NCT01702025|589200035|FG002|Overall Study|Adverse Event|1|||
163133831|NCT01702025|589200036|FG003|Overall Study|Adverse Event|0|||
163133832|NCT02679755|589200037|FG000|Overall Study|Death|0|||
163133833|NCT02679755|589200038|FG001|Overall Study|Death|3|||
163133834|NCT02679755|589200037|FG000|Overall Study|Global deterioration of health status|1|||
163133835|NCT02679755|589200038|FG001|Overall Study|Global deterioration of health status|8|||
163133836|NCT02679755|589200037|FG000|Overall Study|Lost to Follow-up|1|||
163133837|NCT02679755|589200038|FG001|Overall Study|Lost to Follow-up|0|||
163133838|NCT02679755|589200037|FG000|Overall Study|Objective progression or relapse|24|||
163133839|NCT02679755|589200038|FG001|Overall Study|Objective progression or relapse|83|||
163133840|NCT02679755|589200037|FG000|Overall Study|Not defined|0|||
163133841|NCT02679755|589200038|FG001|Overall Study|Not defined|2|||
163133842|NCT02679755|589200037|FG000|Overall Study|Withdrawal by participant|6|||
163133843|NCT02679755|589200038|FG001|Overall Study|Withdrawal by participant|3|||
163133844|NCT02679755|589200037|FG000|Overall Study|Adverse Event|1|||
163133845|NCT02679755|589200038|FG001|Overall Study|Adverse Event|4|||
163133846|NCT02679755|589200037|FG000|Overall Study|Adverse events not related to study drug|1|||
163133847|NCT02679755|589200038|FG001|Overall Study|Adverse events not related to study drug|2|||
163133848|NCT01061359|589200039|FG000|Overall Study|Death|32|||
163133849|NCT01061359|589200039|FG000|Overall Study|Lost to Follow-up|1072|||
163133850|NCT01061359|589200039|FG000|Overall Study|Relapse|187|||
163345136|NCT00975130|589972076|FG002|Study Part 1|Lost to Follow-up|0|||
163345137|NCT00975130|589972074|FG000|Study Part 1|Withdrawal by Subject|61|||
163345138|NCT00975130|589972075|FG001|Study Part 1|Withdrawal by Subject|0|||
163133851|NCT01061359|589200039|FG000|Overall Study|Secondary neoplasm|11|||
163133852|NCT03038126|589200041|FG000|Overall Study|Death|1|||
163133853|NCT03038126|589200042|FG001|Overall Study|Death|1|||
163133854|NCT03038126|589200041|FG000|Overall Study|Withdrawal by Subject|5|||
163133855|NCT03038126|589200042|FG001|Overall Study|Withdrawal by Subject|0|||
163133856|NCT03038126|589200041|FG000|Overall Study|Lost to Follow-up|0|||
163133857|NCT03038126|589200042|FG001|Overall Study|Lost to Follow-up|1|||
163133858|NCT03038126|589200041|FG000|Overall Study|Long Term Hospitalization|2|||
163133859|NCT03038126|589200042|FG001|Overall Study|Long Term Hospitalization|0|||
163133860|NCT03038126|589200041|FG000|Overall Study|Too Ill to Participate|1|||
163133861|NCT03038126|589200042|FG001|Overall Study|Too Ill to Participate|2|||
163345139|NCT00975130|589972076|FG002|Study Part 1|Withdrawal by Subject|0|||
163345140|NCT00975130|589972074|FG000|Study Part 1|Protocol Violation|13|||
163133862|NCT02610777|589200043|FG000|Overall Study|Lost to Follow-up|1|||
163133863|NCT02610777|589200044|FG001|Overall Study|Lost to Follow-up|0|||
163133864|NCT02610777|589200043|FG000|Overall Study|Site Terminated by Sponsor|9|||
163133865|NCT02610777|589200044|FG001|Overall Study|Site Terminated by Sponsor|8|||
163345141|NCT00975130|589972075|FG001|Study Part 1|Protocol Violation|0|||
163133866|NCT02610777|589200043|FG000|Overall Study|Withdrawal by Subject|2|||
163133867|NCT02610777|589200044|FG001|Overall Study|Withdrawal by Subject|2|||
163133868|NCT02610777|589200043|FG000|Overall Study|Reason not Specified|0|||
163133869|NCT02610777|589200044|FG001|Overall Study|Reason not Specified|1|||
163133870|NCT02610777|589200043|FG000|Overall Study|Death|50|||
163133871|NCT02610777|589200044|FG001|Overall Study|Death|47|||
163133872|NCT01724866|589200045|FG000|Overall Study|Adverse Event|0|||
163133873|NCT01724866|589200046|FG001|Overall Study|Adverse Event|0|||
163133874|NCT01724866|589200047|FG002|Overall Study|Adverse Event|1|||
163133875|NCT01724866|589200048|FG003|Overall Study|Adverse Event|1|||
163133876|NCT01724866|589200045|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
163133877|NCT01724866|589200046|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
163133878|NCT01724866|589200047|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
163133879|NCT01724866|589200048|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
163133880|NCT01724866|589200045|FG000|Overall Study|Investigator's Discretion|0|||
163133881|NCT01724866|589200046|FG001|Overall Study|Investigator's Discretion|1|||
163133882|NCT01724866|589200047|FG002|Overall Study|Investigator's Discretion|1|||
163133883|NCT01724866|589200048|FG003|Overall Study|Investigator's Discretion|0|||
163133884|NCT01724866|589200045|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
163133885|NCT01724866|589200046|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
163133886|NCT01724866|589200047|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
163133887|NCT01724866|589200048|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
163133888|NCT01724866|589200045|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
163133889|NCT01724866|589200046|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
163133890|NCT01724866|589200047|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
163133891|NCT01724866|589200048|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
163133892|NCT00411671|589200053|FG000|Overall Study|Adverse Event|15|||
163133893|NCT00411671|589200053|FG000|Overall Study|Death|2|||
163133894|NCT00411671|589200053|FG000|Overall Study|Lost to Follow-up|3|||
163133895|NCT01173601|589200054|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
163133896|NCT01173601|589200055|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163133897|NCT01173601|589200056|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163133898|NCT01173601|589200057|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163133899|NCT01173601|589200058|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163133900|NCT01173601|589200054|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
163133901|NCT01173601|589200055|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163133902|NCT01173601|589200056|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163133903|NCT01173601|589200057|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163133904|NCT01173601|589200058|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163133905|NCT01173601|589200054|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
163133906|NCT01173601|589200055|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163133907|NCT01173601|589200056|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163133908|NCT01173601|589200057|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163133909|NCT01173601|589200058|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163133910|NCT01173601|589200054|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
163133911|NCT01173601|589200055|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163133912|NCT01173601|589200056|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163133913|NCT01173601|589200057|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163133914|NCT01173601|589200058|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163133915|NCT01173601|589200054|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
163133916|NCT01173601|589200055|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163133917|NCT01173601|589200056|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163133918|NCT01173601|589200057|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163133919|NCT01173601|589200058|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163133920|NCT01173601|589200054|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
163133921|NCT01173601|589200055|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163133922|NCT01173601|589200056|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163133923|NCT01173601|589200057|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163133924|NCT01173601|589200058|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163133925|NCT01173601|589200054|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
163133926|NCT01173601|589200055|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163133927|NCT01173601|589200056|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163133928|NCT01173601|589200057|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163345142|NCT00975130|589972076|FG002|Study Part 1|Protocol Violation|0|||
163345143|NCT00975130|589972074|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
163133929|NCT01173601|589200058|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163133930|NCT01173601|589200054|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
163133931|NCT01173601|589200055|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
163133932|NCT01173601|589200056|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
163133933|NCT01173601|589200057|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
163133934|NCT01173601|589200058|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
163133935|NCT01173601|589200054|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
163133936|NCT01173601|589200055|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
163133937|NCT01173601|589200056|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
163133938|NCT01173601|589200057|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
163133939|NCT01173601|589200058|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
163133940|NCT01173601|589200054|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
163133941|NCT01173601|589200055|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
163133942|NCT01173601|589200056|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
163133943|NCT01173601|589200057|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
163133944|NCT01173601|589200058|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
163133945|NCT01173601|589200054|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
163133946|NCT01173601|589200055|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
163133947|NCT01173601|589200056|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
163133948|NCT01173601|589200057|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
163133949|NCT01173601|589200058|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
163133950|NCT01173601|589200054|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
163133951|NCT01173601|589200055|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
163133952|NCT01173601|589200056|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
163133953|NCT01173601|589200057|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
163133954|NCT01173601|589200058|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
163133955|NCT01173601|589200054|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
163133956|NCT01173601|589200055|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
163133957|NCT01173601|589200056|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
163133958|NCT01173601|589200057|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
163133959|NCT01173601|589200058|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
163133960|NCT01173601|589200054|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
163133961|NCT01173601|589200055|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
163133962|NCT01173601|589200056|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
163133963|NCT01173601|589200057|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
163133964|NCT01173601|589200058|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
163133965|NCT04737278|589200059|FG000|Overall Study|Lost to Follow-up|1|||
163133966|NCT04737278|589200060|FG001|Overall Study|Lost to Follow-up|1|||
163133967|NCT04737278|589200059|FG000|Overall Study|Withdrawal by Subject|1|||
163133968|NCT04737278|589200060|FG001|Overall Study|Withdrawal by Subject|0|||
163133969|NCT04737278|589200059|FG000|Overall Study|Protocol Violation|1|||
163133970|NCT04737278|589200060|FG001|Overall Study|Protocol Violation|1|||
163133971|NCT04737278|589200059|FG000|Overall Study|failure to complete questionnaire|1|||
163345144|NCT00975130|589972075|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
163345145|NCT00975130|589972076|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
163133972|NCT04737278|589200060|FG001|Overall Study|failure to complete questionnaire|1|||
163133973|NCT00546000|589200065|FG000|Overall Study|Adverse Event|1|||
163133974|NCT00546000|589200065|FG000|Overall Study|Lost to Follow-up|1|||
163133975|NCT00546000|589200065|FG000|Overall Study|Baseline HPA Axis Supression|2|||
163133976|NCT03688074|589200070|FG000|Overall Study|Adverse Event|0|||
163133977|NCT03688074|589200071|FG001|Overall Study|Adverse Event|1|||
163133978|NCT03688074|589200070|FG000|Overall Study|Other|1|||
163133979|NCT03688074|589200071|FG001|Overall Study|Other|0|||
163133980|NCT01362608|589200072|FG000|Overall Study|Protocol Violation|0|||
163133981|NCT01362608|589200073|FG001|Overall Study|Protocol Violation|1|||
163133982|NCT01362608|589200072|FG000|Overall Study|Lost to Follow-up|3|||
163133983|NCT01362608|589200073|FG001|Overall Study|Lost to Follow-up|1|||
163133984|NCT01362608|589200072|FG000|Overall Study|Withdrawal by Subject|1|||
163133985|NCT01362608|589200073|FG001|Overall Study|Withdrawal by Subject|2|||
163133986|NCT01362608|589200072|FG000|Overall Study|Lack of Efficacy|0|||
163133987|NCT01362608|589200073|FG001|Overall Study|Lack of Efficacy|2|||
163133988|NCT01362608|589200072|FG000|Overall Study|Adverse Event|0|||
163133989|NCT01362608|589200073|FG001|Overall Study|Adverse Event|2|||
163133990|NCT04171219|589200081|FG000|Overall Study|Adverse Event|1|||
163133991|NCT04171219|589200082|FG001|Overall Study|Adverse Event|0|||
163133992|NCT04171219|589200081|FG000|Overall Study|Death|0|||
163133993|NCT04171219|589200082|FG001|Overall Study|Death|1|||
163133994|NCT04171219|589200081|FG000|Overall Study|Lack of Efficacy|9|||
163345146|NCT00975130|589972074|FG000|Study Part 1|Administrative|4|||
163345147|NCT00975130|589972075|FG001|Study Part 1|Administrative|0|||
163133995|NCT04171219|589200082|FG001|Overall Study|Lack of Efficacy|13|||
163133996|NCT04171219|589200081|FG000|Overall Study|Withdrawal by Subject|1|||
163133997|NCT04171219|589200082|FG001|Overall Study|Withdrawal by Subject|2|||
163133998|NCT04171219|589200081|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
163133999|NCT04171219|589200082|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
163134000|NCT04171219|589200081|FG000|Overall Study|Clinical PD/Patient choice|1|||
163134001|NCT04171219|589200082|FG001|Overall Study|Clinical PD/Patient choice|0|||
163134002|NCT04171219|589200081|FG000|Overall Study|Toxicity/ Patient choice|1|||
163134003|NCT04171219|589200082|FG001|Overall Study|Toxicity/ Patient choice|0|||
163134004|NCT04809285|589200083|FG000|Phase 1|Lost to Follow-up|6|||
163134005|NCT04809285|589200083|FG000|Phase 1|Protocol Violation|2|||
163134006|NCT04809285|589200083|FG000|Phase 1|Physician Decision|3|||
163134007|NCT04809285|589200083|FG000|Phase 1|Withdrawal by Subject|29|||
163134008|NCT04809285|589200083|FG000|Phase 2|Protocol Violation|3|||
163134009|NCT04809285|589200083|FG000|Phase 2|Withdrawal by Subject|4|||
163134010|NCT03350815|589200084|FG000|Period 1|Adverse Event|10|||
163134011|NCT03350815|589200085|FG001|Period 1|Adverse Event|0|||
163134012|NCT03350815|589200086|FG002|Period 1|Adverse Event|0|||
163134013|NCT03350815|589200087|FG003|Period 1|Adverse Event|0|||
163134014|NCT03350815|589200084|FG000|Period 1|Technical problems|1|||
163134015|NCT03350815|589200085|FG001|Period 1|Technical problems|0|||
163134016|NCT03350815|589200086|FG002|Period 1|Technical problems|0|||
163134017|NCT03350815|589200087|FG003|Period 1|Technical problems|0|||
163134018|NCT03350815|589200084|FG000|Period 1|Lost to Follow-up|3|||
163134019|NCT03350815|589200085|FG001|Period 1|Lost to Follow-up|0|||
163134020|NCT03350815|589200086|FG002|Period 1|Lost to Follow-up|0|||
163134021|NCT03350815|589200087|FG003|Period 1|Lost to Follow-up|0|||
163134022|NCT03350815|589200084|FG000|Period 1|Physician Decision|1|||
163134023|NCT03350815|589200085|FG001|Period 1|Physician Decision|0|||
163134024|NCT03350815|589200086|FG002|Period 1|Physician Decision|0|||
163134025|NCT03350815|589200087|FG003|Period 1|Physician Decision|0|||
163134026|NCT03350815|589200084|FG000|Period 1|Withdrawal by Subject|8|||
163134027|NCT03350815|589200085|FG001|Period 1|Withdrawal by Subject|0|||
163134028|NCT03350815|589200086|FG002|Period 1|Withdrawal by Subject|0|||
163134029|NCT03350815|589200087|FG003|Period 1|Withdrawal by Subject|0|||
163134030|NCT03350815|589200084|FG000|Period 1|Lack of Efficacy|15|||
163134031|NCT03350815|589200085|FG001|Period 1|Lack of Efficacy|0|||
163134032|NCT03350815|589200086|FG002|Period 1|Lack of Efficacy|0|||
163134033|NCT03350815|589200087|FG003|Period 1|Lack of Efficacy|0|||
163134034|NCT03350815|589200084|FG000|Period 1|Non-compliance with study treatment|2|||
163134035|NCT03350815|589200085|FG001|Period 1|Non-compliance with study treatment|0|||
163134036|NCT03350815|589200086|FG002|Period 1|Non-compliance with study treatment|0|||
163134037|NCT03350815|589200087|FG003|Period 1|Non-compliance with study treatment|0|||
163134038|NCT03350815|589200084|FG000|Period 1|Protocol Violation|3|||
163134039|NCT03350815|589200085|FG001|Period 1|Protocol Violation|0|||
163134040|NCT03350815|589200086|FG002|Period 1|Protocol Violation|0|||
163134041|NCT03350815|589200087|FG003|Period 1|Protocol Violation|0|||
163134042|NCT03350815|589200084|FG000|Period 2|Adverse Event|0|||
163134043|NCT03350815|589200085|FG001|Period 2|Adverse Event|3|||
163134044|NCT03350815|589200086|FG002|Period 2|Adverse Event|5|||
163134045|NCT03350815|589200087|FG003|Period 2|Adverse Event|0|||
163134046|NCT03350815|589200084|FG000|Period 2|Technical problem|0|||
163134047|NCT03350815|589200085|FG001|Period 2|Technical problem|1|||
163134048|NCT03350815|589200086|FG002|Period 2|Technical problem|0|||
163134049|NCT03350815|589200087|FG003|Period 2|Technical problem|0|||
163134050|NCT03350815|589200084|FG000|Period 2|Lost to Follow-up|0|||
163134051|NCT03350815|589200085|FG001|Period 2|Lost to Follow-up|3|||
163134052|NCT03350815|589200086|FG002|Period 2|Lost to Follow-up|3|||
163134053|NCT03350815|589200087|FG003|Period 2|Lost to Follow-up|0|||
163134054|NCT03350815|589200084|FG000|Period 2|Physician Decision|0|||
163134055|NCT03350815|589200085|FG001|Period 2|Physician Decision|0|||
163134056|NCT03350815|589200086|FG002|Period 2|Physician Decision|1|||
163134057|NCT03350815|589200087|FG003|Period 2|Physician Decision|0|||
163134058|NCT03350815|589200084|FG000|Period 2|Withdrawal by Subject|0|||
163134059|NCT03350815|589200085|FG001|Period 2|Withdrawal by Subject|3|||
163134060|NCT03350815|589200086|FG002|Period 2|Withdrawal by Subject|4|||
163345148|NCT00975130|589972076|FG002|Study Part 1|Administrative|0|||
163134061|NCT03350815|589200087|FG003|Period 2|Withdrawal by Subject|0|||
163134062|NCT03350815|589200084|FG000|Period 2|Lack of Efficacy|0|||
163134063|NCT03350815|589200085|FG001|Period 2|Lack of Efficacy|6|||
163134064|NCT03350815|589200086|FG002|Period 2|Lack of Efficacy|2|||
163134065|NCT03350815|589200087|FG003|Period 2|Lack of Efficacy|0|||
163228837|NCT03837899|589549682|FG005|Overall Study|Study specific discontinuation criteria|1|||
163134066|NCT03350815|589200084|FG000|Period 2|Protocol Violation|0|||
163345149|NCT00975130|589972074|FG000|Study Part 1|Withdrew Consent|24|||
163345150|NCT00975130|589972075|FG001|Study Part 1|Withdrew Consent|0|||
163134067|NCT03350815|589200085|FG001|Period 2|Protocol Violation|0|||
163134068|NCT03350815|589200086|FG002|Period 2|Protocol Violation|1|||
163134069|NCT03350815|589200087|FG003|Period 2|Protocol Violation|0|||
163134070|NCT03350815|589200084|FG000|Period 2|New therapy for study indication|0|||
163134071|NCT03350815|589200085|FG001|Period 2|New therapy for study indication|0|||
163134072|NCT03350815|589200086|FG002|Period 2|New therapy for study indication|1|||
163134073|NCT03350815|589200087|FG003|Period 2|New therapy for study indication|0|||
163134074|NCT03526146|589200088|FG000|Overall Study|Lost to Follow-up|5|||
163134075|NCT03526146|589200088|FG000|Overall Study|Withdrawal by Subject|6|||
163134076|NCT03526146|589200088|FG000|Overall Study|class canceled due to COVID-19|4|||
163345151|NCT00975130|589972076|FG002|Study Part 1|Withdrew Consent|0|||
163345152|NCT00975130|589972074|FG000|Study Part 2|Adverse Event|0|||
163345153|NCT00975130|589972075|FG001|Study Part 2|Adverse Event|14|||
163134077|NCT02828436|589200091|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
163134078|NCT02828436|589200092|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
163134079|NCT02828436|589200091|FG000|Period 1|Lost to Follow-up|0|||
163134080|NCT02828436|589200092|FG001|Period 1|Lost to Follow-up|1|||
163134081|NCT02828436|589200091|FG000|Period 2|Withdrawal by Subject|4|||
163134082|NCT02828436|589200092|FG001|Period 2|Withdrawal by Subject|0|||
163134083|NCT02828436|589200091|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
163134084|NCT02828436|589200092|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
163134085|NCT02828436|589200091|FG000|Period 2|Lost to Follow-up|1|||
163134086|NCT02828436|589200092|FG001|Period 2|Lost to Follow-up|0|||
163134087|NCT02644343|589200093|FG000|Overall Study|Withdrawal by Subject|1|||
163134088|NCT00536471|589200094|FG000|Overall Study|Lost to Follow-up|48|||
163134089|NCT00536471|589200095|FG001|Overall Study|Lost to Follow-up|23|||
163134090|NCT00536471|589200096|FG002|Overall Study|Lost to Follow-up|48|||
163134091|NCT00536471|589200097|FG003|Overall Study|Lost to Follow-up|22|||
163134092|NCT00536471|589200094|FG000|Overall Study|Adverse Event|32|||
163134093|NCT00536471|589200095|FG001|Overall Study|Adverse Event|16|||
163134094|NCT00536471|589200096|FG002|Overall Study|Adverse Event|28|||
163134095|NCT00536471|589200097|FG003|Overall Study|Adverse Event|13|||
163134096|NCT00536471|589200094|FG000|Overall Study|Withdrawal by Subject|40|||
163134097|NCT00536471|589200095|FG001|Overall Study|Withdrawal by Subject|24|||
163134098|NCT00536471|589200096|FG002|Overall Study|Withdrawal by Subject|43|||
163134099|NCT00536471|589200097|FG003|Overall Study|Withdrawal by Subject|21|||
163134100|NCT00536471|589200094|FG000|Overall Study|Lack of Efficacy|17|||
163134101|NCT00536471|589200095|FG001|Overall Study|Lack of Efficacy|18|||
163134102|NCT00536471|589200096|FG002|Overall Study|Lack of Efficacy|11|||
163134103|NCT00536471|589200097|FG003|Overall Study|Lack of Efficacy|9|||
163134104|NCT00536471|589200094|FG000|Overall Study|Protocol Violation|8|||
163134105|NCT00536471|589200095|FG001|Overall Study|Protocol Violation|1|||
163134106|NCT00536471|589200096|FG002|Overall Study|Protocol Violation|2|||
163134107|NCT00536471|589200097|FG003|Overall Study|Protocol Violation|3|||
163134108|NCT00536471|589200094|FG000|Overall Study|Physician Decision|11|||
163134109|NCT00536471|589200095|FG001|Overall Study|Physician Decision|1|||
163134110|NCT00536471|589200096|FG002|Overall Study|Physician Decision|3|||
163134111|NCT00536471|589200097|FG003|Overall Study|Physician Decision|2|||
163134112|NCT00536471|589200094|FG000|Overall Study|Death|0|||
163134113|NCT00536471|589200095|FG001|Overall Study|Death|0|||
163134114|NCT00536471|589200096|FG002|Overall Study|Death|1|||
163134115|NCT00536471|589200097|FG003|Overall Study|Death|2|||
163134116|NCT00536471|589200094|FG000|Overall Study|Sponsor Decision|0|||
163134117|NCT00536471|589200095|FG001|Overall Study|Sponsor Decision|1|||
163134118|NCT00536471|589200096|FG002|Overall Study|Sponsor Decision|3|||
163134119|NCT00536471|589200097|FG003|Overall Study|Sponsor Decision|2|||
163134120|NCT01442714|589200098|FG000|Overall Study|Death|11|||
163134121|NCT01442714|589200098|FG000|Overall Study|Withdrawal by Subject|1|||
163134122|NCT01979952|589200109|FG000|Overall Study|Adverse Event|4|||
163134123|NCT01979952|589200110|FG001|Overall Study|Adverse Event|5|||
163134124|NCT01979952|589200109|FG000|Overall Study|Protocol Violation|1|||
163134125|NCT01979952|589200110|FG001|Overall Study|Protocol Violation|0|||
163134126|NCT01979952|589200109|FG000|Overall Study|Withdrawal by Subject|2|||
163134127|NCT01979952|589200110|FG001|Overall Study|Withdrawal by Subject|1|||
163134128|NCT01979952|589200109|FG000|Overall Study|Other than specified above|1|||
163134129|NCT01979952|589200110|FG001|Overall Study|Other than specified above|0|||
163134130|NCT00203424|589200112|FG000|Treatment Period|Withdrawal by Subject|4|||
163134131|NCT00203424|589200112|FG000|Treatment Period|Adverse Event|5|||
163134132|NCT00203424|589200112|FG000|Treatment Period|progressive disease|2|||
163134133|NCT00203424|589200112|FG000|Follow-up Period|Withdrawal by Subject|1|||
163134134|NCT00203424|589200112|FG000|Follow-up Period|progressive disease|4|||
163134135|NCT00203424|589200112|FG000|Follow-up Period|Lost to Follow-up|1|||
163134136|NCT01053988|589200113|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
163345154|NCT00975130|589972076|FG002|Study Part 2|Adverse Event|7|||
163345155|NCT00975130|589972074|FG000|Study Part 2|Lost to Follow-up|0|||
163345156|NCT00975130|589972075|FG001|Study Part 2|Lost to Follow-up|0|||
163134137|NCT01053988|589200114|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163134138|NCT01053988|589200115|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163134139|NCT01053988|589200116|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163134140|NCT01053988|589200117|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163134141|NCT01053988|589200118|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163134142|NCT01053988|589200113|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
163134143|NCT01053988|589200114|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163134144|NCT01053988|589200115|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163134145|NCT01053988|589200116|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163134146|NCT01053988|589200117|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163134147|NCT01053988|589200118|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163134148|NCT01053988|589200113|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
163134149|NCT01053988|589200114|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163134150|NCT01053988|589200115|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163134151|NCT01053988|589200116|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163134152|NCT01053988|589200117|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163134153|NCT01053988|589200118|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163134154|NCT01053988|589200113|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
163134155|NCT01053988|589200114|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
163134156|NCT01053988|589200115|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
163134157|NCT01053988|589200116|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
163134158|NCT01053988|589200117|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
163134159|NCT01053988|589200118|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
163134160|NCT01053988|589200113|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
163134161|NCT01053988|589200114|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
163134162|NCT01053988|589200115|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
163134163|NCT01053988|589200116|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
163134164|NCT01053988|589200117|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
163134165|NCT01053988|589200118|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
163134166|NCT01053988|589200113|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
163134167|NCT01053988|589200114|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163134168|NCT01053988|589200115|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163134169|NCT01053988|589200116|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163134170|NCT01053988|589200117|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163134171|NCT01053988|589200118|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163134172|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
163134173|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
163134174|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
163134175|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
163134176|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
163134177|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
163134178|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
163134179|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
163134180|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
163134181|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
163134182|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
163134183|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
163134184|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
163134185|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
163134186|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
163134187|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
163228838|NCT01403974|589549683|FG000|Overall Study|Progressive disease according to RECIST|3|||
163228839|NCT01403974|589549684|FG001|Overall Study|Progressive disease according to RECIST|3|||
163228840|NCT01403974|589549685|FG002|Overall Study|Progressive disease according to RECIST|2|||
163228841|NCT01403974|589549686|FG003|Overall Study|Progressive disease according to RECIST|3|||
163228842|NCT01403974|589549687|FG004|Overall Study|Progressive disease according to RECIST|3|||
163228843|NCT01403974|589549688|FG005|Overall Study|Progressive disease according to RECIST|2|||
163228844|NCT01403974|589549689|FG006|Overall Study|Progressive disease according to RECIST|3|||
163228845|NCT01403974|589549690|FG007|Overall Study|Progressive disease according to RECIST|2|||
163228846|NCT01403974|589549691|FG008|Overall Study|Progressive disease according to RECIST|6|||
163228847|NCT01403974|589549692|FG009|Overall Study|Progressive disease according to RECIST|2|||
163134188|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
163134189|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
163134190|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
163134191|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
163134192|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
163228848|NCT01403974|589549693|FG010|Overall Study|Progressive disease according to RECIST|3|||
163228849|NCT01403974|589549694|FG011|Overall Study|Progressive disease according to RECIST|2|||
163345157|NCT00975130|589972076|FG002|Study Part 2|Lost to Follow-up|1|||
163134193|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
163134194|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
163134195|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
163134196|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
163134197|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
163134198|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
163134199|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
163134200|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
163134201|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
163134202|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163134203|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
163134204|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163134205|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
163134206|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
163134207|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
163134208|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
163134209|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
163134210|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
163134211|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
163228850|NCT01403974|589549695|FG012|Overall Study|Progressive disease according to RECIST|2|||
163228851|NCT01403974|589549696|FG013|Overall Study|Progressive disease according to RECIST|3|||
163228852|NCT01403974|589549697|FG014|Overall Study|Progressive disease according to RECIST|1|||
163228853|NCT01403974|589549698|FG015|Overall Study|Progressive disease according to RECIST|8|||
163228854|NCT01403974|589549683|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
163228855|NCT01403974|589549684|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
163228856|NCT01403974|589549685|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
163228857|NCT01403974|589549686|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
163228858|NCT01403974|589549687|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
163228859|NCT01403974|589549688|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
163228860|NCT01403974|589549689|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
163228861|NCT01403974|589549690|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
163228862|NCT01403974|589549691|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
163228863|NCT01403974|589549692|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
163228864|NCT01403974|589549693|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
163228865|NCT01403974|589549694|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
163228866|NCT01403974|589549695|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
163228867|NCT01403974|589549696|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
163228868|NCT01403974|589549697|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
163228869|NCT01403974|589549698|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
163228870|NCT01403974|589549683|FG000|Overall Study|Refused to continue study medication|0|||
163228871|NCT01403974|589549684|FG001|Overall Study|Refused to continue study medication|0|||
163228872|NCT01403974|589549685|FG002|Overall Study|Refused to continue study medication|0|||
163228873|NCT01403974|589549686|FG003|Overall Study|Refused to continue study medication|0|||
163228874|NCT01403974|589549687|FG004|Overall Study|Refused to continue study medication|0|||
163228875|NCT01403974|589549688|FG005|Overall Study|Refused to continue study medication|1|||
163228876|NCT01403974|589549689|FG006|Overall Study|Refused to continue study medication|0|||
163228877|NCT01403974|589549690|FG007|Overall Study|Refused to continue study medication|0|||
163228878|NCT01403974|589549691|FG008|Overall Study|Refused to continue study medication|1|||
163228879|NCT01403974|589549692|FG009|Overall Study|Refused to continue study medication|0|||
163228880|NCT01403974|589549693|FG010|Overall Study|Refused to continue study medication|1|||
163228881|NCT01403974|589549694|FG011|Overall Study|Refused to continue study medication|0|||
163228882|NCT01403974|589549695|FG012|Overall Study|Refused to continue study medication|0|||
163228883|NCT01403974|589549696|FG013|Overall Study|Refused to continue study medication|0|||
163134212|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
163228884|NCT01403974|589549697|FG014|Overall Study|Refused to continue study medication|0|||
163228885|NCT01403974|589549698|FG015|Overall Study|Refused to continue study medication|4|||
163228886|NCT01403974|589549683|FG000|Overall Study|Adverse Event|0|||
163228887|NCT01403974|589549684|FG001|Overall Study|Adverse Event|0|||
163228888|NCT01403974|589549685|FG002|Overall Study|Adverse Event|1|||
163228889|NCT01403974|589549686|FG003|Overall Study|Adverse Event|0|||
163228890|NCT01403974|589549687|FG004|Overall Study|Adverse Event|0|||
163228891|NCT01403974|589549688|FG005|Overall Study|Adverse Event|0|||
163228892|NCT01403974|589549689|FG006|Overall Study|Adverse Event|0|||
163228893|NCT01403974|589549690|FG007|Overall Study|Adverse Event|1|||
163228894|NCT01403974|589549691|FG008|Overall Study|Adverse Event|0|||
163228895|NCT01403974|589549692|FG009|Overall Study|Adverse Event|0|||
163345158|NCT00975130|589972074|FG000|Study Part 2|Withdrawal by Subject|0|||
163408478|NCT03031301|590205530|FG000|Overall Study|Protocol Violation|4|||
163228896|NCT01403974|589549693|FG010|Overall Study|Adverse Event|0|||
163228897|NCT01403974|589549694|FG011|Overall Study|Adverse Event|0|||
163228898|NCT01403974|589549695|FG012|Overall Study|Adverse Event|1|||
163228899|NCT01403974|589549696|FG013|Overall Study|Adverse Event|0|||
163228900|NCT01403974|589549697|FG014|Overall Study|Adverse Event|0|||
163228901|NCT01403974|589549698|FG015|Overall Study|Adverse Event|0|||
163228902|NCT01403974|589549683|FG000|Overall Study|Other than specified|0|||
163228903|NCT01403974|589549684|FG001|Overall Study|Other than specified|0|||
163228904|NCT01403974|589549685|FG002|Overall Study|Other than specified|0|||
163228905|NCT01403974|589549686|FG003|Overall Study|Other than specified|0|||
163228906|NCT01403974|589549687|FG004|Overall Study|Other than specified|0|||
163228907|NCT01403974|589549688|FG005|Overall Study|Other than specified|0|||
163228908|NCT01403974|589549689|FG006|Overall Study|Other than specified|0|||
163228909|NCT01403974|589549690|FG007|Overall Study|Other than specified|0|||
163228910|NCT01403974|589549691|FG008|Overall Study|Other than specified|0|||
163228911|NCT01403974|589549692|FG009|Overall Study|Other than specified|1|||
163228912|NCT01403974|589549693|FG010|Overall Study|Other than specified|0|||
163228913|NCT01403974|589549694|FG011|Overall Study|Other than specified|1|||
163228914|NCT01403974|589549695|FG012|Overall Study|Other than specified|0|||
163228915|NCT01403974|589549696|FG013|Overall Study|Other than specified|0|||
163228916|NCT01403974|589549697|FG014|Overall Study|Other than specified|0|||
163228917|NCT01403974|589549698|FG015|Overall Study|Other than specified|0|||
163345159|NCT00975130|589972075|FG001|Study Part 2|Withdrawal by Subject|13|||
163345160|NCT00975130|589972076|FG002|Study Part 2|Withdrawal by Subject|5|||
163345161|NCT00975130|589972074|FG000|Study Part 2|Withdrew Consent|0|||
163345162|NCT00975130|589972075|FG001|Study Part 2|Withdrew Consent|6|||
163345163|NCT00975130|589972076|FG002|Study Part 2|Withdrew Consent|2|||
163345164|NCT00975130|589972074|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
163345165|NCT00975130|589972075|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
163345166|NCT00975130|589972076|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
163134213|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
163134214|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
163134215|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
163134216|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
163134217|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
163134218|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
163134219|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
163134220|NCT01922271|589200120|FG000|WASHOUT Period|Withdrawal by Subject|1|||
163134221|NCT01922271|589200121|FG001|WASHOUT Period|Withdrawal by Subject|0|||
163134222|NCT00719355|589200122|FG000|Overall Study|Death|0|||
163134223|NCT00719355|589200123|FG001|Overall Study|Death|1|||
163134224|NCT00719355|589200122|FG000|Overall Study|Medical|14|||
163134225|NCT00719355|589200123|FG001|Overall Study|Medical|5|||
163134226|NCT00719355|589200122|FG000|Overall Study|Compliance|4|||
163134227|NCT00719355|589200123|FG001|Overall Study|Compliance|6|||
163134228|NCT00719355|589200122|FG000|Overall Study|Moved|0|||
163134229|NCT00719355|589200123|FG001|Overall Study|Moved|1|||
163134230|NCT01856582|589200124|FG000|Overall Study|Died prior to Boost infusion|1|||
163134231|NCT01824355|589200125|FG000|Overall Study|Adverse Event|2|||
163134232|NCT01824355|589200125|FG000|Overall Study|unevaluable reference method results per|1|||
163134233|NCT01331109|589200126|FG000|Overall Study|Adverse Event|6|||
163134234|NCT01331109|589200126|FG000|Overall Study|Lack of Efficacy|2|||
163134235|NCT01331109|589200126|FG000|Overall Study|Protocol Violation|3|||
163134236|NCT01331109|589200126|FG000|Overall Study|Withdrawal by Subject|7|||
163134237|NCT01331109|589200126|FG000|Overall Study|Lost to Follow-up|1|||
163134238|NCT01331109|589200126|FG000|Overall Study|Study Terminated by Sponsor|38|||
163134239|NCT03688620|589200132|FG000|Overall Study|Other|0|||
163134240|NCT03688620|589200133|FG001|Overall Study|Other|0|||
163134241|NCT03688620|589200134|FG002|Overall Study|Other|1|||
163134242|NCT03688620|589200132|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
163134243|NCT03688620|589200133|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
163345167|NCT00975130|589972074|FG000|Study Part 2|Administrative|0|||
163345168|NCT00975130|589972075|FG001|Study Part 2|Administrative|1|||
163134244|NCT03688620|589200134|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
163134245|NCT03688620|589200132|FG000|Overall Study|Lost to Follow-up|16|||
163134246|NCT03688620|589200133|FG001|Overall Study|Lost to Follow-up|0|||
163134247|NCT03688620|589200134|FG002|Overall Study|Lost to Follow-up|1|||
163134248|NCT03688620|589200132|FG000|Overall Study|Withdrawal by Subject|0|||
163134249|NCT03688620|589200133|FG001|Overall Study|Withdrawal by Subject|0|||
163134250|NCT03688620|589200134|FG002|Overall Study|Withdrawal by Subject|6|||
163134251|NCT02828020|589200135|FG000|Treatment Period|Adverse Event|3|||
163228918|NCT01526889|589549699|FG000|Treatment Period|Adverse Event|2|||
163228919|NCT01526889|589549700|FG001|Treatment Period|Adverse Event|0|||
163228920|NCT01526889|589549699|FG000|Treatment Extension Period|Administrative problems|1|||
163228921|NCT01526889|589549700|FG001|Treatment Extension Period|Administrative problems|0|||
163228922|NCT03571516|589549703|FG000|Overall Study|Severe diarrhea|1|||
163228923|NCT03571516|589549704|FG001|Overall Study|Severe diarrhea|0|||
163228924|NCT03571516|589549703|FG000|Overall Study|Withdrawal by Subject|0|||
163228925|NCT03571516|589549704|FG001|Overall Study|Withdrawal by Subject|1|||
163228926|NCT00613509|589549708|FG000|Cycle 1|Adverse Event|2|||
163228927|NCT00613509|589549709|FG001|Cycle 1|Adverse Event|1|||
163228928|NCT00613509|589549708|FG000|Cycle 1|Disease Progression|2|||
163228929|NCT00613509|589549709|FG001|Cycle 1|Disease Progression|6|||
163228930|NCT00613509|589549708|FG000|Cycle 1|Unacceptable Toxicity|1|||
163228931|NCT00613509|589549709|FG001|Cycle 1|Unacceptable Toxicity|0|||
163228932|NCT00613509|589549708|FG000|Cycle 1|Other administrative reason|0|||
163228933|NCT00613509|589549709|FG001|Cycle 1|Other administrative reason|1|||
163228934|NCT03465878|589549710|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
163228935|NCT03465878|589549711|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
163228936|NCT03465878|589549712|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
163228937|NCT03465878|589549713|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
163228938|NCT03465878|589549710|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
163228939|NCT03465878|589549711|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
163228940|NCT03465878|589549712|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
163228941|NCT03465878|589549713|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
163228942|NCT03465878|589549710|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
163228943|NCT03465878|589549711|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
163228944|NCT03465878|589549712|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
163228945|NCT03465878|589549713|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
163228946|NCT02540954|589549714|FG000|Overall Study|Physician Decision|3|||
163228947|NCT02540954|589549715|FG001|Overall Study|Physician Decision|1|||
163228948|NCT02540954|589549714|FG000|Overall Study|Withdrawal by Subject|6|||
163228949|NCT02540954|589549715|FG001|Overall Study|Withdrawal by Subject|5|||
163228950|NCT02540954|589549714|FG000|Overall Study|Lost to Follow-up|1|||
163228951|NCT02540954|589549715|FG001|Overall Study|Lost to Follow-up|1|||
163228952|NCT02540954|589549714|FG000|Overall Study|Adverse Event|4|||
163228953|NCT02540954|589549715|FG001|Overall Study|Adverse Event|2|||
163228954|NCT02540954|589549714|FG000|Overall Study|Death|0|||
163228955|NCT02540954|589549715|FG001|Overall Study|Death|3|||
163228956|NCT02540954|589549714|FG000|Overall Study|Treatment failure|1|||
163228957|NCT02540954|589549715|FG001|Overall Study|Treatment failure|0|||
163228958|NCT02540954|589549714|FG000|Overall Study|Other reason|4|||
163228959|NCT02540954|589549715|FG001|Overall Study|Other reason|2|||
163228960|NCT02448875|589549719|FG000|Overall Study|Adverse Event|2|||
163228961|NCT02448875|589549720|FG001|Overall Study|Adverse Event|1|||
163228962|NCT02448875|589549721|FG002|Overall Study|Adverse Event|0|||
163228963|NCT02448875|589549719|FG000|Overall Study|Lost to Follow-up|1|||
163134252|NCT02828020|589200136|FG001|Treatment Period|Adverse Event|1|||
163134253|NCT02828020|589200137|FG002|Treatment Period|Adverse Event|1|||
163134254|NCT02828020|589200135|FG000|Treatment Period|Withdrawal of Consent|10|||
163134255|NCT02828020|589200136|FG001|Treatment Period|Withdrawal of Consent|14|||
163134256|NCT02828020|589200137|FG002|Treatment Period|Withdrawal of Consent|9|||
163134257|NCT02828020|589200135|FG000|Treatment Period|Lost to Follow-up|21|||
163134258|NCT02828020|589200136|FG001|Treatment Period|Lost to Follow-up|24|||
163134259|NCT02828020|589200137|FG002|Treatment Period|Lost to Follow-up|18|||
163134260|NCT02828020|589200135|FG000|Treatment Period|Lack of Qualifying Event|44|||
163134261|NCT02828020|589200136|FG001|Treatment Period|Lack of Qualifying Event|53|||
163134262|NCT02828020|589200137|FG002|Treatment Period|Lack of Qualifying Event|43|||
163134263|NCT02828020|589200135|FG000|Treatment Period|Pregnancy|0|||
163134264|NCT02828020|589200136|FG001|Treatment Period|Pregnancy|2|||
163134265|NCT02828020|589200137|FG002|Treatment Period|Pregnancy|0|||
163134266|NCT02828020|589200135|FG000|Treatment Period|Protocol Violation|2|||
163134267|NCT02828020|589200136|FG001|Treatment Period|Protocol Violation|4|||
163134268|NCT02828020|589200137|FG002|Treatment Period|Protocol Violation|7|||
163134269|NCT02828020|589200135|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
163228964|NCT02448875|589549720|FG001|Overall Study|Lost to Follow-up|0|||
163228965|NCT02448875|589549721|FG002|Overall Study|Lost to Follow-up|0|||
163345169|NCT00975130|589972076|FG002|Study Part 2|Administrative|0|||
163345170|NCT00975130|589972074|FG000|Study Part 2|Protocol Violation|0|||
163345171|NCT00975130|589972075|FG001|Study Part 2|Protocol Violation|0|||
163228966|NCT02448875|589549719|FG000|Overall Study|Investigator Decision|3|||
163228967|NCT02448875|589549720|FG001|Overall Study|Investigator Decision|0|||
163134270|NCT02828020|589200136|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
163134271|NCT02828020|589200137|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
163134272|NCT02828020|589200135|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
163134273|NCT02828020|589200136|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
163228968|NCT02448875|589549721|FG002|Overall Study|Investigator Decision|1|||
163228969|NCT02448875|589549719|FG000|Overall Study|Withdrawal by Subject|1|||
163228970|NCT02448875|589549720|FG001|Overall Study|Withdrawal by Subject|0|||
163228971|NCT02448875|589549721|FG002|Overall Study|Withdrawal by Subject|0|||
163228972|NCT01806896|589549722|FG000|Overall Study|Adverse Event|2|||
163134274|NCT02828020|589200137|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
163134275|NCT02828020|589200135|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
163134276|NCT02828020|589200136|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
163134277|NCT02828020|589200137|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
163134278|NCT02828020|589200135|FG000|Safety Follow-up Period|Protocol Violation|0|||
163134279|NCT02828020|589200136|FG001|Safety Follow-up Period|Protocol Violation|2|||
163134280|NCT02828020|589200137|FG002|Safety Follow-up Period|Protocol Violation|1|||
163134281|NCT02828020|589200135|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
163134282|NCT02828020|589200136|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
163134283|NCT02828020|589200137|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
163134284|NCT01183065|589200139|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
163134285|NCT02578186|589200140|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
163134286|NCT02578186|589200141|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
163134287|NCT02578186|589200140|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
163134288|NCT02578186|589200141|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
163134289|NCT03657095|589200142|FG000|Overall Study|Withdrawal by Subject|1|||
163134290|NCT03657095|589200143|FG001|Overall Study|Withdrawal by Subject|1|||
163134291|NCT03657095|589200142|FG000|Overall Study|Adverse Event|0|||
163134292|NCT03657095|589200143|FG001|Overall Study|Adverse Event|3|||
163134293|NCT03657095|589200142|FG000|Overall Study|Study Terminated by Sponsor|58|||
163134294|NCT03657095|589200143|FG001|Overall Study|Study Terminated by Sponsor|49|||
163134295|NCT01894243|589200144|FG000|Overall Study|Adverse Event|0|||
163134296|NCT01894243|589200145|FG001|Overall Study|Adverse Event|1|||
163134297|NCT01894243|589200146|FG002|Overall Study|Adverse Event|2|||
163134298|NCT01894243|589200144|FG000|Overall Study|Death|0|||
163134299|NCT01894243|589200145|FG001|Overall Study|Death|0|||
163134300|NCT01894243|589200146|FG002|Overall Study|Death|3|||
163134301|NCT01894243|589200144|FG000|Overall Study|Lack of Efficacy|3|||
163134302|NCT01894243|589200145|FG001|Overall Study|Lack of Efficacy|3|||
163134303|NCT01894243|589200146|FG002|Overall Study|Lack of Efficacy|1|||
163134304|NCT01894243|589200144|FG000|Overall Study|Condition under investigation worsened|8|||
163134305|NCT01894243|589200145|FG001|Overall Study|Condition under investigation worsened|6|||
163134306|NCT01894243|589200146|FG002|Overall Study|Condition under investigation worsened|2|||
163134307|NCT01894243|589200144|FG000|Overall Study|Subject decision|1|||
163134308|NCT01894243|589200145|FG001|Overall Study|Subject decision|0|||
163134309|NCT01894243|589200146|FG002|Overall Study|Subject decision|0|||
163134310|NCT01894243|589200144|FG000|Overall Study|Other|1|||
163134311|NCT01894243|589200145|FG001|Overall Study|Other|0|||
163134312|NCT01894243|589200146|FG002|Overall Study|Other|0|||
163134313|NCT00828750|589200149|FG000|Overall Study|Lack of Efficacy|3|||
163134314|NCT00828750|589200149|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
163134315|NCT04006392|589200150|FG000|Overall Study|Lost to Follow-up|0|||
163134316|NCT04006392|589200151|FG001|Overall Study|Lost to Follow-up|1|||
163134317|NCT01067469|589200152|FG000|Overall Study|Withdrawal by Subject|0|||
163345172|NCT00975130|589972076|FG002|Study Part 2|Protocol Violation|1|||
163345173|NCT01261793|589972077|FG000|Overall Study|Lack of Efficacy|44|||
163345174|NCT01261793|589972078|FG001|Overall Study|Lack of Efficacy|37|||
163345175|NCT01261793|589972079|FG002|Overall Study|Lack of Efficacy|32|||
163345176|NCT01261793|589972077|FG000|Overall Study|Protocol Violation|3|||
163345177|NCT01261793|589972078|FG001|Overall Study|Protocol Violation|5|||
163345178|NCT01261793|589972079|FG002|Overall Study|Protocol Violation|6|||
163345179|NCT01261793|589972077|FG000|Overall Study|Lost to Follow-up|10|||
163345180|NCT01261793|589972078|FG001|Overall Study|Lost to Follow-up|3|||
163345181|NCT01261793|589972079|FG002|Overall Study|Lost to Follow-up|7|||
163345182|NCT01261793|589972077|FG000|Overall Study|Withdrawal by Subject|12|||
163345183|NCT01261793|589972078|FG001|Overall Study|Withdrawal by Subject|14|||
163345184|NCT01261793|589972079|FG002|Overall Study|Withdrawal by Subject|14|||
163345185|NCT01261793|589972077|FG000|Overall Study|Death|3|||
163345186|NCT01261793|589972078|FG001|Overall Study|Death|1|||
163345187|NCT01261793|589972079|FG002|Overall Study|Death|0|||
163345188|NCT01261793|589972077|FG000|Overall Study|Adverse Event|9|||
163345189|NCT01261793|589972078|FG001|Overall Study|Adverse Event|24|||
163345190|NCT01261793|589972079|FG002|Overall Study|Adverse Event|19|||
163345191|NCT01261793|589972077|FG000|Overall Study|Patient non-availability|1|||
163345192|NCT01261793|589972078|FG001|Overall Study|Patient non-availability|1|||
163345193|NCT01261793|589972079|FG002|Overall Study|Patient non-availability|1|||
163345194|NCT01261793|589972077|FG000|Overall Study|Suspected pregnancy|1|||
163345195|NCT01261793|589972078|FG001|Overall Study|Suspected pregnancy|1|||
163134318|NCT01067469|589200153|FG001|Overall Study|Withdrawal by Subject|1|||
163134319|NCT01067469|589200152|FG000|Overall Study|Disease Progression|0|||
163134320|NCT01067469|589200153|FG001|Overall Study|Disease Progression|1|||
163134321|NCT01620944|589200154|FG000|Overall Study|Early termination of Study|2|||
163228973|NCT01806896|589549723|FG001|Overall Study|Adverse Event|0|||
163345196|NCT01261793|589972079|FG002|Overall Study|Suspected pregnancy|0|||
163345197|NCT01261793|589972077|FG000|Overall Study|Patient non-compliance|1|||
163345198|NCT01261793|589972078|FG001|Overall Study|Patient non-compliance|0|||
163345199|NCT01261793|589972079|FG002|Overall Study|Patient non-compliance|1|||
163134322|NCT01620944|589200155|FG001|Overall Study|Early termination of Study|1|||
163134323|NCT03597061|589200156|FG000|Overall Study|Lost to Follow-up|1|||
163134324|NCT03597061|589200157|FG001|Overall Study|Lost to Follow-up|0|||
163134325|NCT03597061|589200156|FG000|Overall Study|Protocol Violation|0|||
163134326|NCT03597061|589200157|FG001|Overall Study|Protocol Violation|1|||
163134327|NCT01748825|589200158|FG000|Dose Escalation|Refused further treatment|2|||
163134328|NCT01748825|589200159|FG001|Dose Escalation|Refused further treatment|2|||
163134329|NCT01748825|589200160|FG002|Dose Escalation|Refused further treatment|0|||
163134330|NCT01748825|589200161|FG003|Dose Escalation|Refused further treatment|0|||
163134331|NCT01748825|589200162|FG004|Dose Escalation|Refused further treatment|1|||
163134332|NCT01748825|589200163|FG005|Dose Escalation|Refused further treatment|2|||
163134333|NCT01748825|589200164|FG006|Dose Escalation|Refused further treatment|0|||
163134334|NCT01748825|589200165|FG007|Dose Escalation|Refused further treatment|0|||
163134335|NCT01748825|589200166|FG008|Dose Escalation|Refused further treatment|0|||
163134336|NCT01748825|589200167|FG009|Dose Escalation|Refused further treatment|0|||
163134337|NCT01748825|589200158|FG000|Dose Escalation|Switched to alternative treatment|0|||
163134338|NCT01748825|589200159|FG001|Dose Escalation|Switched to alternative treatment|0|||
163134339|NCT01748825|589200160|FG002|Dose Escalation|Switched to alternative treatment|0|||
163134340|NCT01748825|589200161|FG003|Dose Escalation|Switched to alternative treatment|1|||
163134341|NCT01748825|589200162|FG004|Dose Escalation|Switched to alternative treatment|0|||
163134342|NCT01748825|589200163|FG005|Dose Escalation|Switched to alternative treatment|0|||
163134343|NCT01748825|589200164|FG006|Dose Escalation|Switched to alternative treatment|0|||
163134344|NCT01748825|589200165|FG007|Dose Escalation|Switched to alternative treatment|0|||
163134345|NCT01748825|589200166|FG008|Dose Escalation|Switched to alternative treatment|0|||
163134346|NCT01748825|589200167|FG009|Dose Escalation|Switched to alternative treatment|0|||
163134347|NCT01748825|589200158|FG000|Dose Escalation|Adverse Event|0|||
163134348|NCT01748825|589200159|FG001|Dose Escalation|Adverse Event|0|||
163134349|NCT01748825|589200160|FG002|Dose Escalation|Adverse Event|0|||
163134350|NCT01748825|589200161|FG003|Dose Escalation|Adverse Event|0|||
163134351|NCT01748825|589200162|FG004|Dose Escalation|Adverse Event|0|||
163134352|NCT01748825|589200163|FG005|Dose Escalation|Adverse Event|0|||
163134353|NCT01748825|589200164|FG006|Dose Escalation|Adverse Event|1|||
163134354|NCT01748825|589200165|FG007|Dose Escalation|Adverse Event|0|||
163134355|NCT01748825|589200166|FG008|Dose Escalation|Adverse Event|0|||
163134356|NCT01748825|589200167|FG009|Dose Escalation|Adverse Event|0|||
163345200|NCT01261793|589972077|FG000|Overall Study|Patient pregnant|1|||
163345201|NCT01261793|589972078|FG001|Overall Study|Patient pregnant|0|||
163345202|NCT01261793|589972079|FG002|Overall Study|Patient pregnant|0|||
163345203|NCT01261793|589972077|FG000|Overall Study|Outside the study area|0|||
163345204|NCT01261793|589972078|FG001|Overall Study|Outside the study area|2|||
163345205|NCT01261793|589972079|FG002|Overall Study|Outside the study area|1|||
163345206|NCT01261793|589972077|FG000|Overall Study|Lack of efficacy & patient not available|0|||
163345207|NCT01261793|589972078|FG001|Overall Study|Lack of efficacy & patient not available|1|||
163345208|NCT01261793|589972079|FG002|Overall Study|Lack of efficacy & patient not available|0|||
163345209|NCT01261793|589972077|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
163345210|NCT01261793|589972078|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
163345211|NCT01261793|589972079|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
163408479|NCT03031301|590205531|FG001|Overall Study|Protocol Violation|8|||
163134357|NCT01748825|589200158|FG000|Dose Expansion|Refused further treatment|0|||
163134358|NCT01748825|589200159|FG001|Dose Expansion|Refused further treatment|0|||
163134359|NCT01748825|589200160|FG002|Dose Expansion|Refused further treatment|0|||
163134360|NCT01748825|589200161|FG003|Dose Expansion|Refused further treatment|0|||
163134361|NCT01748825|589200162|FG004|Dose Expansion|Refused further treatment|0|||
163134362|NCT01748825|589200163|FG005|Dose Expansion|Refused further treatment|0|||
163134363|NCT01748825|589200164|FG006|Dose Expansion|Refused further treatment|0|||
163134364|NCT01748825|589200165|FG007|Dose Expansion|Refused further treatment|0|||
163134365|NCT01748825|589200166|FG008|Dose Expansion|Refused further treatment|1|||
163134366|NCT01748825|589200167|FG009|Dose Expansion|Refused further treatment|1|||
163134367|NCT01748825|589200158|FG000|Dose Expansion|Switched to alternative treatment|0|||
163134368|NCT01748825|589200159|FG001|Dose Expansion|Switched to alternative treatment|0|||
163134369|NCT01748825|589200160|FG002|Dose Expansion|Switched to alternative treatment|0|||
163134370|NCT01748825|589200161|FG003|Dose Expansion|Switched to alternative treatment|0|||
163134371|NCT01748825|589200162|FG004|Dose Expansion|Switched to alternative treatment|0|||
163134372|NCT01748825|589200163|FG005|Dose Expansion|Switched to alternative treatment|0|||
163134373|NCT01748825|589200164|FG006|Dose Expansion|Switched to alternative treatment|0|||
163228974|NCT01806896|589549722|FG000|Overall Study|Other|1|||
163345212|NCT01261793|589972077|FG000|Overall Study|Randomization error|0|||
163345213|NCT01261793|589972078|FG001|Overall Study|Randomization error|1|||
163134374|NCT01748825|589200165|FG007|Dose Expansion|Switched to alternative treatment|0|||
163134375|NCT01748825|589200166|FG008|Dose Expansion|Switched to alternative treatment|0|||
163345214|NCT01261793|589972079|FG002|Overall Study|Randomization error|0|||
163134376|NCT01748825|589200167|FG009|Dose Expansion|Switched to alternative treatment|1|||
163134377|NCT01748825|589200158|FG000|Dose Expansion|Adverse Event|0|||
163408480|NCT03031301|590205530|FG000|Overall Study|Withdrawal by Subject|7|||
163228975|NCT01806896|589549723|FG001|Overall Study|Other|0|||
163345215|NCT01261793|589972077|FG000|Overall Study|Patient unable to start IV line|0|||
163134378|NCT01748825|589200159|FG001|Dose Expansion|Adverse Event|0|||
163134379|NCT01748825|589200160|FG002|Dose Expansion|Adverse Event|0|||
163345216|NCT01261793|589972078|FG001|Overall Study|Patient unable to start IV line|0|||
163345217|NCT01261793|589972079|FG002|Overall Study|Patient unable to start IV line|1|||
163345218|NCT03219216|589972082|FG000|Overall Study|Lost to Follow-up|0|||
163345219|NCT03219216|589972083|FG001|Overall Study|Lost to Follow-up|1|||
163345220|NCT03305458|589972086|FG000|Overall Study|Withdrawal by Subject|50|||
163345221|NCT03305458|589972087|FG001|Overall Study|Withdrawal by Subject|46|||
163134380|NCT01748825|589200161|FG003|Dose Expansion|Adverse Event|0|||
163134381|NCT01748825|589200162|FG004|Dose Expansion|Adverse Event|0|||
163134382|NCT01748825|589200163|FG005|Dose Expansion|Adverse Event|0|||
163134383|NCT01748825|589200164|FG006|Dose Expansion|Adverse Event|0|||
163134384|NCT01748825|589200165|FG007|Dose Expansion|Adverse Event|0|||
163134385|NCT01748825|589200166|FG008|Dose Expansion|Adverse Event|0|||
163134386|NCT01748825|589200167|FG009|Dose Expansion|Adverse Event|3|||
163134387|NCT01748825|589200158|FG000|Dose Expansion|Physician Decision|0|||
163134388|NCT01748825|589200159|FG001|Dose Expansion|Physician Decision|0|||
163134389|NCT01748825|589200160|FG002|Dose Expansion|Physician Decision|0|||
163345222|NCT03305458|589972088|FG002|Overall Study|Withdrawal by Subject|93|||
163345223|NCT03305458|589972086|FG000|Overall Study|Lost to Follow-up|85|||
163345224|NCT03305458|589972087|FG001|Overall Study|Lost to Follow-up|85|||
163345225|NCT03305458|589972088|FG002|Overall Study|Lost to Follow-up|35|||
163134390|NCT01748825|589200161|FG003|Dose Expansion|Physician Decision|0|||
163134391|NCT01748825|589200162|FG004|Dose Expansion|Physician Decision|0|||
163345226|NCT05615870|589972093|FG000|Overall Study|Lost to Follow-up|10|||
163345227|NCT05615870|589972094|FG001|Overall Study|Lost to Follow-up|13|||
163345228|NCT05615870|589972093|FG000|Overall Study|Physician Decision|2|||
163345229|NCT05615870|589972094|FG001|Overall Study|Physician Decision|0|||
163345230|NCT05615870|589972093|FG000|Overall Study|Withdrawal by Subject|0|||
163345231|NCT05615870|589972094|FG001|Overall Study|Withdrawal by Subject|2|||
163345232|NCT05615870|589972093|FG000|Overall Study|Protocol Violation|0|||
163345233|NCT05615870|589972094|FG001|Overall Study|Protocol Violation|3|||
163345234|NCT05615870|589972093|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
163345235|NCT05615870|589972094|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
163345236|NCT05615870|589972093|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
163345237|NCT05615870|589972094|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
163345238|NCT05615870|589972093|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
163345239|NCT05615870|589972094|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
163345240|NCT03520036|589972097|FG000|Overall Study|Adverse Event|1|||
163345241|NCT03520036|589972098|FG001|Overall Study|Adverse Event|2|||
163345242|NCT03520036|589972099|FG002|Overall Study|Adverse Event|0|||
163345243|NCT03520036|589972097|FG000|Overall Study|Protocol Violation|1|||
163345244|NCT03520036|589972098|FG001|Overall Study|Protocol Violation|0|||
163345245|NCT03520036|589972099|FG002|Overall Study|Protocol Violation|0|||
163345246|NCT03520036|589972097|FG000|Overall Study|Withdrawal by Subject|0|||
163345247|NCT03520036|589972098|FG001|Overall Study|Withdrawal by Subject|1|||
163345248|NCT03520036|589972099|FG002|Overall Study|Withdrawal by Subject|4|||
163345249|NCT03520036|589972097|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
163345250|NCT03520036|589972098|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
163345251|NCT03520036|589972099|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
163134392|NCT01748825|589200163|FG005|Dose Expansion|Physician Decision|0|||
163134393|NCT01748825|589200164|FG006|Dose Expansion|Physician Decision|0|||
163134394|NCT01748825|589200165|FG007|Dose Expansion|Physician Decision|0|||
163134395|NCT01748825|589200166|FG008|Dose Expansion|Physician Decision|1|||
163134396|NCT01748825|589200167|FG009|Dose Expansion|Physician Decision|0|||
163134397|NCT01730586|589200171|FG000|Overall Study|Progressive Disease|2|||
163134398|NCT01730586|589200171|FG000|Overall Study|Inadequate Trial|8|||
163134399|NCT01730586|589200171|FG000|Overall Study|Adverse Event|2|||
163134400|NCT01730586|589200171|FG000|Overall Study|Hospice|1|||
163134401|NCT03777059|589201531|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
163134402|NCT03777059|589201532|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
163345252|NCT01855399|589972100|FG000|6 Month|Lost to Follow-up|12|||
163345253|NCT01855399|589972101|FG001|6 Month|Lost to Follow-up|9|||
163345254|NCT01855399|589972100|FG000|6 Month|Withdrawal by Subject|8|||
163345255|NCT01855399|589972101|FG001|6 Month|Withdrawal by Subject|6|||
163345256|NCT01855399|589972100|FG000|12 Month|Lost to Follow-up|7|||
163345257|NCT01855399|589972101|FG001|12 Month|Lost to Follow-up|11|||
163345258|NCT03019289|589972102|FG000|Overall Study|Adverse Event|1|||
163134403|NCT03777059|589201533|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
163134404|NCT03777059|589201534|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
163134405|NCT03777059|589201531|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
163134406|NCT03777059|589201532|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
163134407|NCT03777059|589201533|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
163134408|NCT03777059|589201534|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
163134409|NCT03777059|589201531|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
163134410|NCT03777059|589201532|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
163134411|NCT03777059|589201533|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
163134412|NCT03777059|589201534|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
163134413|NCT03777059|589201531|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
163134414|NCT03777059|589201532|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
163134415|NCT03777059|589201533|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
163134416|NCT03777059|589201534|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
163134417|NCT03777059|589201531|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
163134418|NCT03777059|589201532|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
163134419|NCT03777059|589201533|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
163134420|NCT03777059|589201534|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
163134421|NCT03777059|589201531|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
163134422|NCT03777059|589201532|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
163228976|NCT02434770|589549724|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
163228977|NCT02434770|589549725|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
163228978|NCT02434770|589549726|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
163228979|NCT02434770|589549724|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
163228980|NCT02434770|589549725|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
163228981|NCT02434770|589549726|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
163228982|NCT02434770|589549724|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
163228983|NCT02434770|589549725|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
163228984|NCT02434770|589549726|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
163228985|NCT02434770|589549724|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
163228986|NCT02434770|589549725|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
163228987|NCT02434770|589549726|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
163228988|NCT02434770|589549724|FG000|Week 1 to Week 18|Death|1|||
163228989|NCT02434770|589549725|FG001|Week 1 to Week 18|Death|0|||
163228990|NCT02434770|589549726|FG002|Week 1 to Week 18|Death|0|||
163228991|NCT02434770|589549724|FG000|Week 18 to Week|Lost to Follow-up|2|||
163228992|NCT02434770|589549725|FG001|Week 18 to Week|Lost to Follow-up|2|||
163408481|NCT03031301|590205531|FG001|Overall Study|Withdrawal by Subject|4|||
163408482|NCT03031301|590205530|FG000|Overall Study|Lost to Follow-up|4|||
163408483|NCT03031301|590205531|FG001|Overall Study|Lost to Follow-up|12|||
163408484|NCT03031301|590205530|FG000|Overall Study|Noncompliance|1|||
163408485|NCT03031301|590205531|FG001|Overall Study|Noncompliance|3|||
163408486|NCT03031301|590205530|FG000|Overall Study|Technical issue|1|||
163408487|NCT03031301|590205531|FG001|Overall Study|Technical issue|1|||
163408488|NCT03031301|590205530|FG000|Overall Study|Adverse Event|1|||
163408489|NCT03031301|590205531|FG001|Overall Study|Adverse Event|0|||
163408490|NCT00267748|590205532|FG000|Non-randomized Period|Progressive disease|10|||
163408491|NCT00267748|590205533|FG001|Non-randomized Period|Progressive disease|0|||
163408492|NCT00267748|590205534|FG002|Non-randomized Period|Progressive disease|0|||
163408493|NCT00267748|590205532|FG000|Non-randomized Period|Adverse Event|8|||
163408494|NCT00267748|590205533|FG001|Non-randomized Period|Adverse Event|0|||
163408495|NCT00267748|590205534|FG002|Non-randomized Period|Adverse Event|0|||
163408496|NCT00267748|590205532|FG000|Non-randomized Period|Death|1|||
163408497|NCT00267748|590205533|FG001|Non-randomized Period|Death|0|||
163408498|NCT00267748|590205534|FG002|Non-randomized Period|Death|0|||
163408499|NCT00267748|590205532|FG000|Non-randomized Period|Participant not willing to participate|1|||
163408500|NCT00267748|590205533|FG001|Non-randomized Period|Participant not willing to participate|0|||
163408501|NCT00267748|590205534|FG002|Non-randomized Period|Participant not willing to participate|0|||
163408502|NCT00267748|590205532|FG000|Non-randomized Period|Other|3|||
163408503|NCT00267748|590205533|FG001|Non-randomized Period|Other|0|||
163408504|NCT00267748|590205534|FG002|Non-randomized Period|Other|0|||
163408505|NCT00267748|590205532|FG000|Randomized Period|Death|0|||
163134423|NCT03777059|589201533|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
163134424|NCT03777059|589201534|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
163228993|NCT02434770|589549726|FG002|Week 18 to Week|Lost to Follow-up|1|||
163228994|NCT02434770|589549724|FG000|Week 18 to Week|Withdrawal by Subject|0|||
163228995|NCT02434770|589549725|FG001|Week 18 to Week|Withdrawal by Subject|0|||
163228996|NCT02434770|589549726|FG002|Week 18 to Week|Withdrawal by Subject|2|||
163228997|NCT02434770|589549724|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
163408506|NCT00267748|590205533|FG001|Randomized Period|Death|2|||
163408507|NCT00267748|590205534|FG002|Randomized Period|Death|3|||
163408508|NCT00267748|590205532|FG000|Randomized Period|Adverse Event|0|||
163408509|NCT00267748|590205533|FG001|Randomized Period|Adverse Event|23|||
163408510|NCT00267748|590205534|FG002|Randomized Period|Adverse Event|25|||
163408511|NCT00267748|590205532|FG000|Randomized Period|Global deterioration of health status|0|||
163408512|NCT00267748|590205533|FG001|Randomized Period|Global deterioration of health status|6|||
163408513|NCT00267748|590205534|FG002|Randomized Period|Global deterioration of health status|7|||
163228998|NCT02434770|589549725|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
163345259|NCT03019289|589972103|FG001|Overall Study|Adverse Event|0|||
163345260|NCT03019289|589972104|FG002|Overall Study|Adverse Event|0|||
163345261|NCT03019289|589972105|FG003|Overall Study|Adverse Event|0|||
163345262|NCT03019289|589972106|FG004|Overall Study|Adverse Event|0|||
163345263|NCT03019289|589972107|FG005|Overall Study|Adverse Event|0|||
163345264|NCT03019289|589972108|FG006|Overall Study|Adverse Event|0|||
163345265|NCT03019289|589972109|FG007|Overall Study|Adverse Event|0|||
163345266|NCT03019289|589972110|FG008|Overall Study|Adverse Event|1|||
163345267|NCT03019289|589972102|FG000|Overall Study|Other|1|||
163345268|NCT03019289|589972103|FG001|Overall Study|Other|0|||
163345269|NCT03019289|589972104|FG002|Overall Study|Other|0|||
163345270|NCT03019289|589972105|FG003|Overall Study|Other|0|||
163345271|NCT03019289|589972106|FG004|Overall Study|Other|0|||
163345272|NCT03019289|589972107|FG005|Overall Study|Other|0|||
163345273|NCT03019289|589972108|FG006|Overall Study|Other|0|||
163134425|NCT03777059|589201531|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
163134426|NCT03777059|589201532|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
163345274|NCT03019289|589972109|FG007|Overall Study|Other|0|||
163345275|NCT03019289|589972110|FG008|Overall Study|Other|0|||
163345276|NCT04743999|589972111|FG000|3-month Questionnaire|Death|1|||
163345277|NCT04743999|589972111|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
163345278|NCT04743999|589972111|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
163345279|NCT04743999|589972111|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
163134427|NCT03777059|589201533|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
163134428|NCT03777059|589201534|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
163134429|NCT03777059|589201531|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
163134430|NCT03777059|589201532|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
163134431|NCT03777059|589201533|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
163134432|NCT03777059|589201534|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
163134433|NCT03777059|589201531|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
163134434|NCT03777059|589201532|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
163134435|NCT03777059|589201533|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
163134436|NCT03777059|589201534|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
163134437|NCT03777059|589201531|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
163134438|NCT03777059|589201532|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
163134439|NCT03777059|589201533|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
163134440|NCT03777059|589201534|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
163134441|NCT03777059|589201531|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
163134442|NCT03777059|589201532|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
163134443|NCT03777059|589201533|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
163134444|NCT03777059|589201534|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
163134445|NCT03056339|589201538|FG000|Overall Study|Failed Requirements|0|||
163134446|NCT03056339|589201539|FG001|Overall Study|Failed Requirements|2|||
163134447|NCT03056339|589201540|FG002|Overall Study|Failed Requirements|7|||
163134448|NCT03056339|589201541|FG003|Overall Study|Failed Requirements|1|||
163134449|NCT04506502|589201545|FG000|Overall Study|Withdrawal by Subject|1|||
163134450|NCT04506502|589201545|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
163134451|NCT01449006|589201546|FG000|Overall Study|Lost to Follow-up|1|||
163134452|NCT01449006|589201547|FG001|Overall Study|Lost to Follow-up|0|||
163134453|NCT01449006|589201546|FG000|Overall Study|Withdrawal by Subject|1|||
163134454|NCT01449006|589201547|FG001|Overall Study|Withdrawal by Subject|0|||
163134455|NCT01449006|589201546|FG000|Overall Study|Protocol Violation|1|||
163134456|NCT01449006|589201547|FG001|Overall Study|Protocol Violation|0|||
163134457|NCT02517541|589201550|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
163134458|NCT02517541|589201550|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
163134459|NCT02517541|589201550|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
163134460|NCT02517541|589201550|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
163134461|NCT02517541|589201550|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
163134462|NCT02517541|589201550|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
163134463|NCT02034877|589201551|FG000|Overall Study|Lost to Follow-up|0|||
163134464|NCT02034877|589201552|FG001|Overall Study|Lost to Follow-up|3|||
163134465|NCT02034877|589201551|FG000|Overall Study|No Longer Willing to Participate|0|||
163134466|NCT02034877|589201552|FG001|Overall Study|No Longer Willing to Participate|3|||
163134467|NCT03574779|589201556|FG000|Overall Study|Screening failure|13|||
163345280|NCT01721759|589972112|FG000|Treatment Period|Disease Progression|85|||
163345281|NCT01721759|589972112|FG000|Treatment Period|Study drug toxicity|14|||
163345282|NCT01721759|589972112|FG000|Treatment Period|Death|1|||
163345283|NCT01721759|589972112|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
163345284|NCT01721759|589972112|FG000|Treatment Period|Participant request to withdraw|3|||
163345285|NCT01721759|589972112|FG000|Treatment Period|Other Reasons|3|||
163134468|NCT03574779|589201557|FG001|Overall Study|Screening failure|83|||
163134469|NCT02003534|589201566|FG000|Overall Study|Lost to Follow-up|47|||
163134470|NCT04112303|589201567|FG000|Overall Study|Death|1|||
163228999|NCT02434770|589549726|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
163229000|NCT01282424|589549730|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
163229001|NCT01282424|589549730|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
163229002|NCT01282424|589549730|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
163229003|NCT01282424|589549730|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
163229004|NCT01282424|589549730|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
163229005|NCT01282424|589549730|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
163229006|NCT01282424|589549730|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
163229007|NCT01282424|589549730|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
163229008|NCT03316872|589549731|FG000|Overall Study|Death|1|||
163229009|NCT04074317|589549732|FG000|Third Period|Withdrawal by Subject|0|||
163229010|NCT04074317|589549733|FG001|Third Period|Withdrawal by Subject|0|||
163229011|NCT04074317|589549734|FG002|Third Period|Withdrawal by Subject|0|||
163229012|NCT04074317|589549735|FG003|Third Period|Withdrawal by Subject|1|||
163229013|NCT04074317|589549736|FG004|Third Period|Withdrawal by Subject|0|||
163229014|NCT04074317|589549737|FG005|Third Period|Withdrawal by Subject|0|||
163229015|NCT02283788|589549740|FG000|Overall Study|Adverse Event|1|||
163229016|NCT02283788|589549741|FG001|Overall Study|Adverse Event|3|||
163229017|NCT02283788|589549742|FG002|Overall Study|Adverse Event|5|||
163229018|NCT02283788|589549743|FG003|Overall Study|Adverse Event|1|||
163229019|NCT02283788|589549740|FG000|Overall Study|Withdrawal by Subject|0|||
163229020|NCT02283788|589549741|FG001|Overall Study|Withdrawal by Subject|1|||
163229021|NCT02283788|589549742|FG002|Overall Study|Withdrawal by Subject|0|||
163229022|NCT02283788|589549743|FG003|Overall Study|Withdrawal by Subject|1|||
163229023|NCT02742103|589551395|FG000|Overall Study|Protocol Violation|1|||
163229024|NCT02742103|589551396|FG001|Overall Study|Protocol Violation|0|||
163229025|NCT02742103|589551395|FG000|Overall Study|Death|2|||
163229026|NCT02742103|589551396|FG001|Overall Study|Death|2|||
163229027|NCT02742103|589551395|FG000|Overall Study|Adverse Event|1|||
163229028|NCT02742103|589551396|FG001|Overall Study|Adverse Event|0|||
163229029|NCT02742103|589551395|FG000|Overall Study|Moved to another town|0|||
163229030|NCT02742103|589551396|FG001|Overall Study|Moved to another town|1|||
163229031|NCT02742103|589551395|FG000|Overall Study|Withdrawal by Subject|5|||
163229032|NCT02742103|589551396|FG001|Overall Study|Withdrawal by Subject|2|||
163229033|NCT00533949|589551399|FG000|Overall Study|Protocol Violation|12|||
163229034|NCT00533949|589551400|FG001|Overall Study|Protocol Violation|12|||
163229035|NCT00533949|589551401|FG002|Overall Study|Protocol Violation|9|||
163229036|NCT00533949|589551402|FG003|Overall Study|Protocol Violation|9|||
163229037|NCT00533949|589551399|FG000|Overall Study|Withdrawal by Subject|3|||
163229038|NCT00533949|589551400|FG001|Overall Study|Withdrawal by Subject|2|||
163229039|NCT00533949|589551401|FG002|Overall Study|Withdrawal by Subject|1|||
163229040|NCT00533949|589551402|FG003|Overall Study|Withdrawal by Subject|1|||
163229041|NCT00727194|589551403|FG000|Screening Period|Low QMG scores|0|||
163229042|NCT00727194|589551404|FG001|Screening Period|Low QMG scores|0|||
163229043|NCT00727194|589551405|FG002|Screening Period|Low QMG scores|6|||
163229044|NCT00727194|589551403|FG000|Screening Period|Lacked AChR antibodies|0|||
163229045|NCT00727194|589551404|FG001|Screening Period|Lacked AChR antibodies|0|||
163229046|NCT00727194|589551405|FG002|Screening Period|Lacked AChR antibodies|5|||
163229047|NCT00727194|589551403|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
163229048|NCT00727194|589551404|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
163229049|NCT00727194|589551405|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
163229050|NCT00727194|589551403|FG000|Screening Period|Severe infections|0|||
163229051|NCT00727194|589551404|FG001|Screening Period|Severe infections|0|||
163229052|NCT00727194|589551405|FG002|Screening Period|Severe infections|2|||
163229053|NCT00727194|589551403|FG000|Screening Period|History of thymoma|0|||
163229054|NCT00727194|589551404|FG001|Screening Period|History of thymoma|0|||
163229055|NCT00727194|589551405|FG002|Screening Period|History of thymoma|1|||
163229056|NCT00727194|589551403|FG000|Treatment Period 2|Lack of Efficacy|0|||
163229057|NCT00727194|589551404|FG001|Treatment Period 2|Lack of Efficacy|1|||
163229058|NCT00727194|589551405|FG002|Treatment Period 2|Lack of Efficacy|0|||
163408514|NCT00267748|590205532|FG000|Randomized Period|Lost to Follow-up|0|||
163229059|NCT04269161|589551412|FG000|Overall Study|Change of modality and no longer eligible|3|||
163229060|NCT04269161|589551413|FG001|Overall Study|Change of modality and no longer eligible|3|||
163229061|NCT04269161|589551412|FG000|Overall Study|Required procedure outside of NICU|1|||
163229062|NCT04269161|589551413|FG001|Overall Study|Required procedure outside of NICU|0|||
163229063|NCT04269161|589551412|FG000|Overall Study|Equipment issue|1|||
163229064|NCT04269161|589551413|FG001|Overall Study|Equipment issue|1|||
163229065|NCT02472756|589551414|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
163229066|NCT02472756|589551414|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
163229067|NCT02472756|589551414|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
163229068|NCT02472756|589551414|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
163229069|NCT02472756|589551414|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
163229070|NCT02896127|589551419|FG000|COMPLETED WEEK 52|Adverse Event|9|||
163229071|NCT02896127|589551420|FG001|COMPLETED WEEK 52|Adverse Event|2|||
163345286|NCT01721759|589972112|FG000|End of Study Period|Participant Withdrew Consent|5|||
163134471|NCT01685697|589201568|FG000|Overall Study|Protocol Violation|3|||
163134472|NCT01685697|589201569|FG001|Overall Study|Protocol Violation|3|||
163134473|NCT02703324|589201570|FG000|Period Two|Withdrawal by Subject|0|||
163134474|NCT02703324|589201571|FG001|Period Two|Withdrawal by Subject|0|||
163134475|NCT02703324|589201572|FG002|Period Two|Withdrawal by Subject|1|||
163134476|NCT02703324|589201573|FG003|Period Two|Withdrawal by Subject|0|||
163134477|NCT02703324|589201574|FG004|Period Two|Withdrawal by Subject|0|||
163134478|NCT02703324|589201575|FG005|Period Two|Withdrawal by Subject|0|||
163134479|NCT04303572|589201578|FG000|Overall Study|Study closed due to poor enrollment|1|||
163134480|NCT06312592|589201579|FG000|Overall Study|Lost to Follow-up|29|||
163134481|NCT06312592|589201580|FG001|Overall Study|Lost to Follow-up|13|||
163134482|NCT03517228|589201583|FG000|Overall Study|Withdrawal by Subject|2|||
163134483|NCT03517228|589201583|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
163134484|NCT03517228|589201583|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
163134485|NCT03517228|589201583|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
163134486|NCT03517228|589201583|FG000|Overall Study|Canceled due to device being updated|1|||
163134487|NCT03517228|589201583|FG000|Overall Study|No V Cares in stock|1|||
163134488|NCT03517228|589201583|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
163134489|NCT03781414|589201588|FG000|Overall Study|Study terminated by sponsor|39|||
163134490|NCT03781414|589201589|FG001|Overall Study|Study terminated by sponsor|34|||
163134491|NCT03781414|589201590|FG002|Overall Study|Study terminated by sponsor|25|||
163134492|NCT03781414|589201588|FG000|Overall Study|Adverse Event|3|||
163134493|NCT03781414|589201589|FG001|Overall Study|Adverse Event|6|||
163134494|NCT03781414|589201590|FG002|Overall Study|Adverse Event|3|||
163134495|NCT03781414|589201588|FG000|Overall Study|Physician Decision|2|||
163134496|NCT03781414|589201589|FG001|Overall Study|Physician Decision|0|||
163134497|NCT03781414|589201590|FG002|Overall Study|Physician Decision|1|||
163134498|NCT03781414|589201588|FG000|Overall Study|Withdrawal by Subject|2|||
163134499|NCT03781414|589201589|FG001|Overall Study|Withdrawal by Subject|3|||
163134500|NCT03781414|589201590|FG002|Overall Study|Withdrawal by Subject|3|||
163134501|NCT03781414|589201588|FG000|Overall Study|Death|1|||
163134502|NCT03781414|589201589|FG001|Overall Study|Death|4|||
163134503|NCT03781414|589201590|FG002|Overall Study|Death|0|||
163134504|NCT03781414|589201588|FG000|Overall Study|Lost to Follow-up|1|||
163134505|NCT03781414|589201589|FG001|Overall Study|Lost to Follow-up|1|||
163134506|NCT03781414|589201590|FG002|Overall Study|Lost to Follow-up|0|||
163134507|NCT01620762|589201593|FG000|Overall Study|Protocol Violation|1|||
163134508|NCT01620762|589201594|FG001|Overall Study|Protocol Violation|1|||
163134509|NCT01620762|589201595|FG002|Overall Study|Protocol Violation|1|||
163134510|NCT01620762|589201593|FG000|Overall Study|Adverse Event|9|||
163134511|NCT01620762|589201594|FG001|Overall Study|Adverse Event|5|||
163134512|NCT01620762|589201595|FG002|Overall Study|Adverse Event|2|||
163134513|NCT01620762|589201593|FG000|Overall Study|Withdrawal by Subject|23|||
163134514|NCT01620762|589201594|FG001|Overall Study|Withdrawal by Subject|26|||
163134515|NCT01620762|589201595|FG002|Overall Study|Withdrawal by Subject|27|||
163134516|NCT01620762|589201593|FG000|Overall Study|Lost to Follow-up|11|||
163134517|NCT01620762|589201594|FG001|Overall Study|Lost to Follow-up|17|||
163134518|NCT01620762|589201595|FG002|Overall Study|Lost to Follow-up|10|||
163134519|NCT01620762|589201593|FG000|Overall Study|Protocol deviation|1|||
163134520|NCT01620762|589201594|FG001|Overall Study|Protocol deviation|1|||
163134521|NCT01620762|589201595|FG002|Overall Study|Protocol deviation|6|||
163134522|NCT01620762|589201593|FG000|Overall Study|Subject deterioration|0|||
163134523|NCT01620762|589201594|FG001|Overall Study|Subject deterioration|1|||
163134524|NCT01620762|589201595|FG002|Overall Study|Subject deterioration|1|||
163134525|NCT01620762|589201593|FG000|Overall Study|Non-specified|3|||
163134526|NCT01620762|589201594|FG001|Overall Study|Non-specified|6|||
163134527|NCT01620762|589201595|FG002|Overall Study|Non-specified|5|||
163134528|NCT01620762|589201593|FG000|Overall Study|Use of prohibted therapies|0|||
163134529|NCT01620762|589201594|FG001|Overall Study|Use of prohibted therapies|1|||
163134530|NCT01620762|589201595|FG002|Overall Study|Use of prohibted therapies|1|||
163134531|NCT02161757|589201606|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
163134532|NCT02161757|589201607|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
163134533|NCT02161757|589201608|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
163134534|NCT02161757|589201606|FG000|Treatment Through Study Completion|Adverse Event|1|||
163134535|NCT02161757|589201607|FG001|Treatment Through Study Completion|Adverse Event|1|||
163134536|NCT02161757|589201608|FG002|Treatment Through Study Completion|Adverse Event|0|||
163134537|NCT02161757|589201606|FG000|Treatment Through Study Completion|Protocol Violation|0|||
163134538|NCT02161757|589201607|FG001|Treatment Through Study Completion|Protocol Violation|1|||
163134539|NCT02161757|589201608|FG002|Treatment Through Study Completion|Protocol Violation|2|||
163134540|NCT02161757|589201606|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
163134541|NCT02161757|589201607|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
163134542|NCT02161757|589201608|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
163134543|NCT02161757|589201606|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
163134544|NCT02161757|589201607|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
163134545|NCT02161757|589201608|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
163134546|NCT02161757|589201606|FG000|Treatment Through Study Completion|Other|20|||
163134547|NCT02161757|589201607|FG001|Treatment Through Study Completion|Other|19|||
163134548|NCT02161757|589201608|FG002|Treatment Through Study Completion|Other|12|||
163134549|NCT02161757|589201606|FG000|Treatment Through Study Completion|Death|2|||
163134550|NCT02161757|589201607|FG001|Treatment Through Study Completion|Death|1|||
163134551|NCT02161757|589201608|FG002|Treatment Through Study Completion|Death|1|||
163134552|NCT00391625|589201609|FG000|Month 14|Withdrawal by Subject|1|||
163134553|NCT00391625|589201609|FG000|Month 50|Physician Decision|1|||
163134554|NCT03664765|589201612|FG000|Overall Study|Withdrawal by Subject|4|||
163134555|NCT03664765|589201613|FG001|Overall Study|Withdrawal by Subject|1|||
163134556|NCT03664765|589201612|FG000|Overall Study|Lost to Follow-up|0|||
163134557|NCT03664765|589201613|FG001|Overall Study|Lost to Follow-up|1|||
163134558|NCT02106403|589201618|FG000|Follow-Up Visit 3|Other Reason|0|||
163134559|NCT02106403|589201619|FG001|Follow-Up Visit 3|Other Reason|0|||
163134560|NCT02106403|589201620|FG002|Follow-Up Visit 3|Other Reason|0|||
163134561|NCT02106403|589201621|FG003|Follow-Up Visit 3|Other Reason|0|||
163134562|NCT02106403|589201622|FG004|Follow-Up Visit 3|Other Reason|0|||
163134563|NCT02106403|589201623|FG005|Follow-Up Visit 3|Other Reason|1|||
163134564|NCT01496846|589201624|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
163134565|NCT01496846|589201625|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
163134566|NCT01496846|589201626|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
163134567|NCT01496846|589201627|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
163134568|NCT01496846|589201628|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
163134569|NCT01496846|589201629|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
163134570|NCT01772576|589201630|FG000|Overall Study|Death|15|||
163134571|NCT01772576|589201630|FG000|Overall Study|Protocol Violation|1|||
163134572|NCT01772576|589201630|FG000|Overall Study|Lost to Follow-up|3|||
163134573|NCT01772576|589201630|FG000|Overall Study|Study device not used|3|||
163134574|NCT01772576|589201630|FG000|Overall Study|Adverse Event|6|||
163134575|NCT01772576|589201630|FG000|Overall Study|Withdrawal by Subject|6|||
163134576|NCT01128946|589201644|FG000|Period I|Protocol Violation|0|||
163134577|NCT01128946|589201645|FG001|Period I|Protocol Violation|1|||
163134578|NCT01128946|589201646|FG002|Period I|Protocol Violation|0|||
163134579|NCT01128946|589201647|FG003|Period I|Protocol Violation|0|||
163134580|NCT01128946|589201644|FG000|Period I|Withdrawal by Subject|0|||
163134581|NCT01128946|589201645|FG001|Period I|Withdrawal by Subject|0|||
163134582|NCT01128946|589201646|FG002|Period I|Withdrawal by Subject|1|||
163134583|NCT01128946|589201647|FG003|Period I|Withdrawal by Subject|1|||
163134584|NCT01128946|589201644|FG000|Period II|Protocol Violation|0|||
163134585|NCT01128946|589201645|FG001|Period II|Protocol Violation|1|||
163134586|NCT01128946|589201646|FG002|Period II|Protocol Violation|0|||
163345287|NCT01721759|589972112|FG000|End of Study Period|Death|101|||
163134587|NCT01128946|589201647|FG003|Period II|Protocol Violation|0|||
163134588|NCT01128946|589201644|FG000|Period II|Withdrawal by Subject|0|||
163134589|NCT01128946|589201645|FG001|Period II|Withdrawal by Subject|0|||
163134590|NCT01128946|589201646|FG002|Period II|Withdrawal by Subject|0|||
163134591|NCT01128946|589201647|FG003|Period II|Withdrawal by Subject|1|||
163134592|NCT01128946|589201644|FG000|Period III|Protocol Violation|1|||
163134593|NCT01128946|589201645|FG001|Period III|Protocol Violation|0|||
163134594|NCT01128946|589201646|FG002|Period III|Protocol Violation|0|||
163134595|NCT01128946|589201647|FG003|Period III|Protocol Violation|0|||
163134596|NCT00527904|589201648|FG000|Overall Study|Adverse Event|45|||
163134597|NCT00527904|589201648|FG000|Overall Study|Withdrawal by Subject|21|||
163134598|NCT00527904|589201648|FG000|Overall Study|Lost to Follow-up|8|||
163134599|NCT00527904|589201648|FG000|Overall Study|misc|22|||
163134600|NCT02873338|589201652|FG000|Overall Study|Adverse Event|0|||
163134601|NCT02873338|589201653|FG001|Overall Study|Adverse Event|2|||
163134602|NCT02873338|589201654|FG002|Overall Study|Adverse Event|1|||
163134603|NCT02873338|589201652|FG000|Overall Study|Death|2|||
163134604|NCT02873338|589201653|FG001|Overall Study|Death|1|||
163134605|NCT02873338|589201654|FG002|Overall Study|Death|1|||
163134606|NCT02873338|589201652|FG000|Overall Study|Withdrawal by Subject|2|||
163134607|NCT02873338|589201653|FG001|Overall Study|Withdrawal by Subject|1|||
163134608|NCT02873338|589201654|FG002|Overall Study|Withdrawal by Subject|3|||
163134609|NCT02873338|589201652|FG000|Overall Study|Lack of Efficacy|0|||
163134610|NCT02873338|589201653|FG001|Overall Study|Lack of Efficacy|2|||
163134611|NCT02873338|589201654|FG002|Overall Study|Lack of Efficacy|0|||
163134612|NCT02873338|589201652|FG000|Overall Study|Other or Missing|14|||
163134613|NCT02873338|589201653|FG001|Overall Study|Other or Missing|15|||
163134614|NCT02873338|589201654|FG002|Overall Study|Other or Missing|13|||
163134615|NCT00766051|589201656|FG000|Overall Study|Withdrawal by Subject|2|||
163134616|NCT00766051|589201657|FG001|Overall Study|Withdrawal by Subject|0|||
163134617|NCT01320202|589201658|FG000|Overall Study|Adverse Event|5|||
163134618|NCT01320202|589201659|FG001|Overall Study|Adverse Event|5|||
163345288|NCT01721759|589972112|FG000|End of Study Period|Lost to Follow-up|1|||
163134619|NCT01320202|589201658|FG000|Overall Study|Death|5|||
163134620|NCT01320202|589201659|FG001|Overall Study|Death|3|||
163134621|NCT01320202|589201658|FG000|Overall Study|Lost to Follow-up|1|||
163134622|NCT01320202|589201659|FG001|Overall Study|Lost to Follow-up|0|||
163134623|NCT01320202|589201658|FG000|Overall Study|Physician Decision|3|||
163134624|NCT01320202|589201659|FG001|Overall Study|Physician Decision|1|||
163134625|NCT01320202|589201658|FG000|Overall Study|Protocol Violation|2|||
163134626|NCT01320202|589201659|FG001|Overall Study|Protocol Violation|1|||
163134627|NCT01320202|589201658|FG000|Overall Study|Withdrawal by Subject|10|||
163134628|NCT01320202|589201659|FG001|Overall Study|Withdrawal by Subject|3|||
163134629|NCT01320202|589201658|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
163134630|NCT01320202|589201659|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
163134631|NCT01320202|589201658|FG000|Overall Study|kidney transplant|1|||
163134632|NCT01320202|589201659|FG001|Overall Study|kidney transplant|2|||
163134633|NCT01320202|589201658|FG000|Overall Study|blood transfusion|1|||
163134634|NCT01320202|589201659|FG001|Overall Study|blood transfusion|7|||
163134635|NCT01320202|589201658|FG000|Overall Study|moved/changed dialysis|5|||
163134636|NCT01320202|589201659|FG001|Overall Study|moved/changed dialysis|2|||
163134637|NCT01320202|589201658|FG000|Overall Study|sponsor request|2|||
163134638|NCT01320202|589201659|FG001|Overall Study|sponsor request|0|||
163134639|NCT01320202|589201658|FG000|Overall Study|ineligible|3|||
163134640|NCT01320202|589201659|FG001|Overall Study|ineligible|0|||
163134641|NCT01320202|589201658|FG000|Overall Study|regained renal function|1|||
163134642|NCT01320202|589201659|FG001|Overall Study|regained renal function|0|||
163134643|NCT00635882|589201660|FG000|Overall Study|Protocol Violation|1|||
163134644|NCT00635882|589201661|FG001|Overall Study|Protocol Violation|0|||
163134645|NCT00635882|589201662|FG002|Overall Study|Protocol Violation|0|||
163134646|NCT00635882|589201663|FG003|Overall Study|Protocol Violation|0|||
163134647|NCT00635882|589201664|FG004|Overall Study|Protocol Violation|0|||
163134648|NCT00635882|589201665|FG005|Overall Study|Protocol Violation|0|||
163134649|NCT02006979|589201666|FG000|Overall Study|Withdrawal by Subject|1|||
163134650|NCT02006979|589201667|FG001|Overall Study|Withdrawal by Subject|1|||
163134651|NCT02006979|589201666|FG000|Overall Study|Protocol Violation|0|||
163134652|NCT02006979|589201667|FG001|Overall Study|Protocol Violation|1|||
163134653|NCT03477838|589201672|FG000|Overall Study|Lost to Follow-up|14|||
163134654|NCT00850538|589201674|FG000|Overall Study|unable/unwilling to complete MRI|13|||
163134655|NCT00850538|589201674|FG000|Overall Study|specimen missed due to scheduling error|14|||
163134656|NCT00850538|589201674|FG000|Overall Study|specimen unusable|7|||
163134657|NCT00850538|589201674|FG000|Overall Study|Withdrawal by Subject|3|||
163134658|NCT00850538|589201674|FG000|Overall Study|radiology error|2|||
163134659|NCT00850538|589201674|FG000|Overall Study|Protocol Violation|2|||
163134660|NCT01088399|589201680|FG000|Overall Study|Adverse Event|211|||
163134661|NCT01088399|589201681|FG001|Overall Study|Adverse Event|16|||
163134662|NCT01088399|589201682|FG002|Overall Study|Adverse Event|0|||
163134663|NCT01088399|589201680|FG000|Overall Study|Death|204|||
163134664|NCT01088399|589201681|FG001|Overall Study|Death|45|||
163134665|NCT01088399|589201682|FG002|Overall Study|Death|0|||
163134666|NCT01088399|589201680|FG000|Overall Study|Lack of Efficacy|298|||
163134667|NCT01088399|589201681|FG001|Overall Study|Lack of Efficacy|7|||
163134668|NCT01088399|589201682|FG002|Overall Study|Lack of Efficacy|5|||
163134669|NCT01088399|589201680|FG000|Overall Study|Lost to Follow-up|1070|||
163134670|NCT01088399|589201681|FG001|Overall Study|Lost to Follow-up|278|||
163134671|NCT01088399|589201682|FG002|Overall Study|Lost to Follow-up|58|||
163134672|NCT01088399|589201680|FG000|Overall Study|Physician Decision|531|||
163134673|NCT01088399|589201681|FG001|Overall Study|Physician Decision|88|||
163134674|NCT01088399|589201682|FG002|Overall Study|Physician Decision|16|||
163134675|NCT01088399|589201680|FG000|Overall Study|Withdrawal by Subject|544|||
163134676|NCT01088399|589201681|FG001|Overall Study|Withdrawal by Subject|195|||
163134677|NCT01088399|589201682|FG002|Overall Study|Withdrawal by Subject|33|||
163134678|NCT01088399|589201680|FG000|Overall Study|Change to or start of somatropin therapy|234|||
163134679|NCT01088399|589201681|FG001|Overall Study|Change to or start of somatropin therapy|17|||
163134680|NCT01088399|589201682|FG002|Overall Study|Change to or start of somatropin therapy|12|||
163134681|NCT01088399|589201680|FG000|Overall Study|Sponsor decision|1573|||
163134682|NCT01088399|589201681|FG001|Overall Study|Sponsor decision|298|||
163134683|NCT01088399|589201682|FG002|Overall Study|Sponsor decision|7|||
163134684|NCT01088399|589201680|FG000|Overall Study|Protocol Violation|10|||
163134685|NCT01088399|589201681|FG001|Overall Study|Protocol Violation|1|||
163134686|NCT01088399|589201682|FG002|Overall Study|Protocol Violation|0|||
163134687|NCT01088399|589201680|FG000|Overall Study|Enrollment criteria not met|48|||
163134688|NCT01088399|589201681|FG001|Overall Study|Enrollment criteria not met|119|||
163134689|NCT01088399|589201682|FG002|Overall Study|Enrollment criteria not met|70|||
163134690|NCT01088399|589201680|FG000|Overall Study|Study summary visit not completed|2398|||
163134691|NCT01088399|589201681|FG001|Overall Study|Study summary visit not completed|283|||
163134692|NCT01088399|589201682|FG002|Overall Study|Study summary visit not completed|80|||
163134693|NCT03193736|589201683|FG000|Overall Study|Death|2|||
163134694|NCT03193736|589201683|FG000|Overall Study|Withdrawal by Subject|1|||
163134695|NCT03193736|589201683|FG000|Overall Study|Lost to Follow-up|1|||
163134696|NCT03193736|589201683|FG000|Overall Study|implant not received|1|||
163408515|NCT00267748|590205533|FG001|Randomized Period|Lost to Follow-up|1|||
163134697|NCT00852241|589201684|FG000|Overall Study|Physician Decision|18|||
163134698|NCT02697435|589201685|FG000|Overall Study|Withdrawal by Subject|1|||
163134699|NCT02697435|589201686|FG001|Overall Study|Withdrawal by Subject|0|||
163134700|NCT02697435|589201685|FG000|Overall Study|Physician Decision|0|||
163134701|NCT02697435|589201686|FG001|Overall Study|Physician Decision|4|||
163134702|NCT04230213|589201687|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
163134703|NCT04230213|589201688|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
163134704|NCT04230213|589201689|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
163134705|NCT04230213|589201687|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
163134706|NCT04230213|589201688|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
163134707|NCT04230213|589201689|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
163134708|NCT04230213|589201687|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
163134709|NCT04230213|589201688|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
163134710|NCT04230213|589201689|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
163134711|NCT04230213|589201687|FG000|TP2: Week 10 to Week 16|Other|0|||
163134712|NCT04230213|589201688|FG001|TP2: Week 10 to Week 16|Other|2|||
163134713|NCT04230213|589201689|FG002|TP2: Week 10 to Week 16|Other|1|||
163134714|NCT04230213|589201687|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
163134715|NCT04230213|589201688|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
163134716|NCT04230213|589201689|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
163134717|NCT04230213|589201687|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
163134718|NCT04230213|589201688|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
163134719|NCT04230213|589201689|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
163134720|NCT04230213|589201687|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
163134721|NCT04230213|589201688|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
163134722|NCT04230213|589201689|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
163134723|NCT04230213|589201687|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
163134724|NCT04230213|589201688|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
163134725|NCT04230213|589201689|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
163134726|NCT04230213|589201687|FG000|TP3: Week 16 to Week 22|Other|0|||
163134727|NCT04230213|589201688|FG001|TP3: Week 16 to Week 22|Other|1|||
163134728|NCT04230213|589201689|FG002|TP3: Week 16 to Week 22|Other|3|||
163134729|NCT04230213|589201687|FG000|TP4: Week 22 to Week 32|Other|0|||
163134730|NCT04230213|589201688|FG001|TP4: Week 22 to Week 32|Other|5|||
163134731|NCT04230213|589201689|FG002|TP4: Week 22 to Week 32|Other|5|||
163134732|NCT04230213|589201687|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
163134733|NCT04230213|589201688|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
163134734|NCT04230213|589201689|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
163134735|NCT04230213|589201687|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
163134736|NCT04230213|589201688|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
163134737|NCT04230213|589201689|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
163134738|NCT04230213|589201687|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
163134739|NCT04230213|589201688|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
163134740|NCT04230213|589201689|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
163134741|NCT04230213|589201687|FG000|Follow up: Week 32 to Week 36|Other|0|||
163134742|NCT04230213|589201688|FG001|Follow up: Week 32 to Week 36|Other|1|||
163134743|NCT04230213|589201689|FG002|Follow up: Week 32 to Week 36|Other|1|||
163134744|NCT00619307|589201701|FG000|Overall Study|Adverse Event|0|||
163134745|NCT00619307|589201702|FG001|Overall Study|Adverse Event|1|||
163134746|NCT00619307|589201701|FG000|Overall Study|Lost to Follow-up|0|||
163134747|NCT00619307|589201702|FG001|Overall Study|Lost to Follow-up|1|||
163134748|NCT00619307|589201701|FG000|Overall Study|Protocol Violation|3|||
163134749|NCT00619307|589201702|FG001|Overall Study|Protocol Violation|0|||
163134750|NCT00619307|589201701|FG000|Overall Study|Withdrew consent|1|||
163134751|NCT00619307|589201702|FG001|Overall Study|Withdrew consent|0|||
163134752|NCT00619307|589201701|FG000|Overall Study|Severe migraine|0|||
163134753|NCT00619307|589201702|FG001|Overall Study|Severe migraine|1|||
163134754|NCT00619307|589201701|FG000|Overall Study|MS attack plus steroids|0|||
163345289|NCT01721759|589972112|FG000|End of Study Period|Other Reasons|10|||
163345290|NCT03926117|589972113|FG000|Overall Study|Unclassified|1|||
163345291|NCT03926117|589972114|FG001|Overall Study|Unclassified|4|||
163345292|NCT03926117|589972115|FG002|Overall Study|Unclassified|1|||
163345293|NCT03926117|589972116|FG003|Overall Study|Unclassified|4|||
163134755|NCT00619307|589201702|FG001|Overall Study|MS attack plus steroids|1|||
163134756|NCT00861471|589201705|FG000|Overall Study|Withdrawal by Subject|1|||
163134757|NCT00861471|589201705|FG000|Overall Study|Adverse Event|2|||
163134758|NCT00861471|589201705|FG000|Overall Study|Lack of Efficacy|3|||
163134759|NCT00861471|589201705|FG000|Overall Study|treatment for lumbar laminectomy|1|||
163134760|NCT00861471|589201705|FG000|Overall Study|Physician Decision|2|||
163134761|NCT02069392|589201708|FG000|Overall Study|Withdrawal by Subject|4|||
163134762|NCT02069392|589201709|FG001|Overall Study|Withdrawal by Subject|2|||
163345294|NCT03926117|589972113|FG000|Overall Study|Withdrawal by Subject|3|||
163134763|NCT00269633|589201710|FG000|Overall Study|Withdrawal by Subject|1|||
163134764|NCT00269633|589201711|FG001|Overall Study|Withdrawal by Subject|0|||
163134765|NCT01574651|589201712|FG000|Overall Study|Lost to Follow-up|2|||
163134766|NCT01574651|589201713|FG001|Overall Study|Lost to Follow-up|4|||
163134767|NCT01574651|589201712|FG000|Overall Study|Administrative problems|0|||
163134768|NCT01574651|589201713|FG001|Overall Study|Administrative problems|1|||
163134769|NCT01574651|589201712|FG000|Overall Study|Death|3|||
163134770|NCT01574651|589201713|FG001|Overall Study|Death|3|||
163134771|NCT01574651|589201712|FG000|Overall Study|Patient's inability to use the device|0|||
163134772|NCT01574651|589201713|FG001|Overall Study|Patient's inability to use the device|1|||
163134773|NCT01574651|589201712|FG000|Overall Study|Adverse Event|36|||
163134774|NCT01574651|589201713|FG001|Overall Study|Adverse Event|27|||
163134775|NCT01574651|589201712|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163134776|NCT01574651|589201713|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163134777|NCT01574651|589201712|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163134778|NCT01574651|589201713|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163134779|NCT01574651|589201712|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
163134780|NCT01574651|589201713|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163134781|NCT01574651|589201712|FG000|Overall Study|Protocol Violation|3|||
163134782|NCT01574651|589201713|FG001|Overall Study|Protocol Violation|5|||
163134783|NCT01574651|589201712|FG000|Overall Study|Withdrawal by Subject|9|||
163134784|NCT01574651|589201713|FG001|Overall Study|Withdrawal by Subject|10|||
163134785|NCT04412707|589201714|FG000|Cycle 1|Death|0|||
163134786|NCT04412707|589201715|FG001|Cycle 1|Death|3|||
163134787|NCT04412707|589201714|FG000|Cycle 1|Disease progression|1|||
163134788|NCT04412707|589201715|FG001|Cycle 1|Disease progression|2|||
163134789|NCT04412707|589201714|FG000|Cycle 2|Death|0|||
163134790|NCT04412707|589201715|FG001|Cycle 2|Death|1|||
163134791|NCT04412707|589201714|FG000|Cycle 2|Disease progression|3|||
163134792|NCT04412707|589201715|FG001|Cycle 2|Disease progression|0|||
163134793|NCT04412707|589201714|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
163134794|NCT04412707|589201715|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
163134795|NCT04412707|589201714|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
163134796|NCT04412707|589201715|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
163134797|NCT04412707|589201714|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
163134798|NCT04412707|589201715|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
163134799|NCT04412707|589201714|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
163134800|NCT04412707|589201715|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
163134801|NCT00699608|589203919|FG000|First Intervention|Withdrawal by Subject|0|||
163134802|NCT00699608|589203920|FG001|First Intervention|Withdrawal by Subject|0|||
163134803|NCT00699608|589203921|FG002|First Intervention|Withdrawal by Subject|1|||
163134804|NCT00699608|589203922|FG003|First Intervention|Withdrawal by Subject|0|||
163134805|NCT00699608|589203923|FG004|First Intervention|Withdrawal by Subject|0|||
163134806|NCT00699608|589203924|FG005|First Intervention|Withdrawal by Subject|0|||
163134807|NCT00699608|589203919|FG000|First Intervention|Protocol Violation|0|||
163134808|NCT00699608|589203920|FG001|First Intervention|Protocol Violation|0|||
163134809|NCT00699608|589203921|FG002|First Intervention|Protocol Violation|0|||
163134810|NCT00699608|589203922|FG003|First Intervention|Protocol Violation|0|||
163134811|NCT00699608|589203923|FG004|First Intervention|Protocol Violation|1|||
163134812|NCT00699608|589203924|FG005|First Intervention|Protocol Violation|0|||
163134813|NCT00699608|589203919|FG000|Second Intervention|Adverse Event|0|||
163134814|NCT00699608|589203920|FG001|Second Intervention|Adverse Event|0|||
163134815|NCT00699608|589203921|FG002|Second Intervention|Adverse Event|1|||
163134816|NCT00699608|589203922|FG003|Second Intervention|Adverse Event|0|||
163134817|NCT00699608|589203923|FG004|Second Intervention|Adverse Event|0|||
163134818|NCT00699608|589203924|FG005|Second Intervention|Adverse Event|0|||
163134819|NCT00699608|589203919|FG000|Second Intervention|Withdrawal by Subject|0|||
163134820|NCT00699608|589203920|FG001|Second Intervention|Withdrawal by Subject|0|||
163134821|NCT00699608|589203921|FG002|Second Intervention|Withdrawal by Subject|0|||
163134822|NCT00699608|589203922|FG003|Second Intervention|Withdrawal by Subject|1|||
163134823|NCT00699608|589203923|FG004|Second Intervention|Withdrawal by Subject|0|||
163134824|NCT00699608|589203924|FG005|Second Intervention|Withdrawal by Subject|0|||
163134825|NCT04306510|589203929|FG000|Overall Study|Voluntarily withdrawal|1|||
163134826|NCT04306510|589203929|FG000|Overall Study|Enrolled but Not Treated|1|||
163134827|NCT04720417|589203930|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
163134828|NCT03329092|589203931|FG000|Overall Study|Other|2|||
163134829|NCT03329092|589203932|FG001|Overall Study|Other|2|||
163134830|NCT03329092|589203931|FG000|Overall Study|Withdrawal by Subject|16|||
163134831|NCT03329092|589203932|FG001|Overall Study|Withdrawal by Subject|3|||
163134832|NCT03329092|589203931|FG000|Overall Study|Physician Decision|1|||
163134833|NCT03329092|589203932|FG001|Overall Study|Physician Decision|0|||
163134834|NCT03329092|589203931|FG000|Overall Study|Death|17|||
163134835|NCT03329092|589203932|FG001|Overall Study|Death|11|||
163134836|NCT03329092|589203931|FG000|Overall Study|Adverse Event|3|||
163134837|NCT03329092|589203932|FG001|Overall Study|Adverse Event|1|||
163134838|NCT03329092|589203931|FG000|Overall Study|Lost to Follow-up|1|||
163134839|NCT03329092|589203932|FG001|Overall Study|Lost to Follow-up|1|||
163134840|NCT04878211|589203933|FG000|Overall Study|Lost to Follow-up|0|||
163134841|NCT04878211|589203934|FG001|Overall Study|Lost to Follow-up|0|||
163134842|NCT04878211|589203935|FG002|Overall Study|Lost to Follow-up|0|||
163134843|NCT04878211|589203936|FG003|Overall Study|Lost to Follow-up|1|||
163345295|NCT03926117|589972114|FG001|Overall Study|Withdrawal by Subject|0|||
163345296|NCT03926117|589972115|FG002|Overall Study|Withdrawal by Subject|1|||
163345297|NCT03926117|589972116|FG003|Overall Study|Withdrawal by Subject|1|||
163345298|NCT03926117|589972113|FG000|Overall Study|Lost to Follow-up|0|||
163345299|NCT03926117|589972114|FG001|Overall Study|Lost to Follow-up|2|||
163345300|NCT03926117|589972115|FG002|Overall Study|Lost to Follow-up|1|||
163345301|NCT03926117|589972116|FG003|Overall Study|Lost to Follow-up|0|||
163345302|NCT03926117|589972113|FG000|Overall Study|Adverse Event|1|||
163345303|NCT03926117|589972114|FG001|Overall Study|Adverse Event|2|||
163345304|NCT03926117|589972115|FG002|Overall Study|Adverse Event|3|||
163345305|NCT03926117|589972116|FG003|Overall Study|Adverse Event|1|||
163345306|NCT03926117|589972113|FG000|Overall Study|Randomized but not treated|1|||
163345307|NCT03926117|589972114|FG001|Overall Study|Randomized but not treated|1|||
163345308|NCT03926117|589972115|FG002|Overall Study|Randomized but not treated|0|||
163345309|NCT03926117|589972116|FG003|Overall Study|Randomized but not treated|1|||
163345310|NCT01334606|589972117|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
163345311|NCT02312245|589972118|FG000|Overall Study|Death|0|||
163345312|NCT02312245|589972119|FG001|Overall Study|Death|0|||
163345313|NCT02312245|589972120|FG002|Overall Study|Death|0|||
163345314|NCT02312245|589972121|FG003|Overall Study|Death|1|||
163345315|NCT02312245|589972118|FG000|Overall Study|Withdrawal by Subject|1|||
163345316|NCT02312245|589972119|FG001|Overall Study|Withdrawal by Subject|1|||
163345317|NCT02312245|589972120|FG002|Overall Study|Withdrawal by Subject|0|||
163345318|NCT02312245|589972121|FG003|Overall Study|Withdrawal by Subject|2|||
163345319|NCT02312245|589972118|FG000|Overall Study|Alternative Therapy|1|||
163345320|NCT02312245|589972119|FG001|Overall Study|Alternative Therapy|0|||
163345321|NCT02312245|589972120|FG002|Overall Study|Alternative Therapy|0|||
163134844|NCT04878211|589203937|FG004|Overall Study|Lost to Follow-up|0|||
163134845|NCT04878211|589203938|FG005|Overall Study|Lost to Follow-up|1|||
163134846|NCT04878211|589203933|FG000|Overall Study|Protocol deviation|1|||
163134847|NCT04878211|589203934|FG001|Overall Study|Protocol deviation|0|||
163134848|NCT04878211|589203935|FG002|Overall Study|Protocol deviation|0|||
163134849|NCT04878211|589203936|FG003|Overall Study|Protocol deviation|0|||
163134850|NCT04878211|589203937|FG004|Overall Study|Protocol deviation|0|||
163134851|NCT04878211|589203938|FG005|Overall Study|Protocol deviation|0|||
163134852|NCT04878211|589203933|FG000|Overall Study|Study terminated by sponsor|0|||
163134853|NCT04878211|589203934|FG001|Overall Study|Study terminated by sponsor|0|||
163134854|NCT04878211|589203935|FG002|Overall Study|Study terminated by sponsor|0|||
163134855|NCT04878211|589203936|FG003|Overall Study|Study terminated by sponsor|0|||
163134856|NCT04878211|589203937|FG004|Overall Study|Study terminated by sponsor|9|||
163134857|NCT04878211|589203938|FG005|Overall Study|Study terminated by sponsor|4|||
163134858|NCT04878211|589203933|FG000|Overall Study|Subject decision|0|||
163134859|NCT04878211|589203934|FG001|Overall Study|Subject decision|0|||
163134860|NCT04878211|589203935|FG002|Overall Study|Subject decision|0|||
163134861|NCT04878211|589203936|FG003|Overall Study|Subject decision|0|||
163134862|NCT04878211|589203937|FG004|Overall Study|Subject decision|1|||
163134863|NCT04878211|589203938|FG005|Overall Study|Subject decision|0|||
163134864|NCT01036321|589203941|FG000|Overall Study|Ineligible after randomization|0|||
163134865|NCT01036321|589203942|FG001|Overall Study|Ineligible after randomization|1|||
163134866|NCT01036321|589203941|FG000|Overall Study|Withdrawal by Subject|3|||
163134867|NCT01036321|589203942|FG001|Overall Study|Withdrawal by Subject|2|||
163134868|NCT01036321|589203941|FG000|Overall Study|Adverse Event|2|||
163134869|NCT01036321|589203942|FG001|Overall Study|Adverse Event|1|||
163134870|NCT03755882|589203943|FG000|Period 1|Protocol Violation|1|||
163134871|NCT03755882|589203944|FG001|Period 1|Protocol Violation|0|||
163134872|NCT03755882|589203943|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
163134873|NCT03755882|589203944|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
163134874|NCT00381693|589203945|FG000|Overall Study|Death|1|||
163134875|NCT00381693|589203945|FG000|Overall Study|Adverse Event|4|||
163134876|NCT00381693|589203945|FG000|Overall Study|Patient Choice|1|||
163134877|NCT00381693|589203945|FG000|Overall Study|Progression|2|||
163134878|NCT01687101|589203946|FG000|Overall Study|Lost to Follow-up|7|||
163134879|NCT02598297|589203947|FG000|Overall Study|Study terminated by Sponsor|21|||
163134880|NCT02598297|589203948|FG001|Overall Study|Study terminated by Sponsor|23|||
163134881|NCT02598297|589203947|FG000|Overall Study|Adverse Event|1|||
163134882|NCT02598297|589203948|FG001|Overall Study|Adverse Event|1|||
163229072|NCT02896127|589551419|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
163345322|NCT02312245|589972121|FG003|Overall Study|Alternative Therapy|0|||
163345323|NCT02312245|589972118|FG000|Overall Study|Progression|0|||
163134883|NCT02598297|589203947|FG000|Overall Study|Physician Decision|1|||
163134884|NCT02598297|589203948|FG001|Overall Study|Physician Decision|0|||
163134885|NCT02598297|589203947|FG000|Overall Study|Subject/guardian decision|1|||
163134886|NCT02598297|589203948|FG001|Overall Study|Subject/guardian decision|0|||
163345324|NCT02312245|589972119|FG001|Overall Study|Progression|0|||
163345325|NCT02312245|589972120|FG002|Overall Study|Progression|0|||
163345326|NCT02312245|589972121|FG003|Overall Study|Progression|5|||
163345327|NCT02312245|589972118|FG000|Overall Study|Patient went to hospice|0|||
163345328|NCT02312245|589972119|FG001|Overall Study|Patient went to hospice|0|||
163134887|NCT02598297|589203947|FG000|Overall Study|Followed for survival|1|||
163229073|NCT02896127|589551420|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
163229074|NCT02896127|589551419|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
163229075|NCT02896127|589551420|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
163229076|NCT02896127|589551419|FG000|COMPLETED WEEK 52|Physician Decision|1|||
163229077|NCT02896127|589551420|FG001|COMPLETED WEEK 52|Physician Decision|1|||
163229078|NCT02896127|589551419|FG000|COMPLETED WEEK 52|Pregnancy|2|||
163229079|NCT02896127|589551420|FG001|COMPLETED WEEK 52|Pregnancy|0|||
163229080|NCT02896127|589551419|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
163229081|NCT02896127|589551420|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
163229082|NCT02896127|589551419|FG000|COMPLETED WEEK 52|Technical problems|1|||
163229083|NCT02896127|589551420|FG001|COMPLETED WEEK 52|Technical problems|0|||
163229084|NCT02896127|589551419|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
163229085|NCT02896127|589551420|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
163229086|NCT02896127|589551419|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
163229087|NCT02896127|589551420|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
163229088|NCT02896127|589551419|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
163229089|NCT02896127|589551420|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
163229090|NCT02896127|589551419|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
163229091|NCT02896127|589551420|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
163229092|NCT02896127|589551419|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
163229093|NCT02896127|589551420|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
163229094|NCT01782313|589551421|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
163229095|NCT01782313|589551421|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
163229096|NCT01782313|589551421|FG000|Treated Cycle 3|Progressive Disease|21|||
163229097|NCT01782313|589551421|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
163229098|NCT01782313|589551421|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
163229099|NCT01782313|589551421|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
163229100|NCT01782313|589551421|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
163229101|NCT01782313|589551421|FG000|Survival Follow up|Lost to Follow-up|1|||
163229102|NCT00958776|589551422|FG000|Overall Study|Adverse Event|0|||
163229103|NCT00958776|589551423|FG001|Overall Study|Adverse Event|1|||
163229104|NCT00958776|589551422|FG000|Overall Study|Physician Decision|1|||
163229105|NCT00958776|589551423|FG001|Overall Study|Physician Decision|0|||
163229106|NCT00958776|589551422|FG000|Overall Study|Lost to Follow-up|2|||
163229107|NCT00958776|589551423|FG001|Overall Study|Lost to Follow-up|6|||
163229108|NCT00958776|589551422|FG000|Overall Study|Withdrawal by Subject|7|||
163229109|NCT00958776|589551423|FG001|Overall Study|Withdrawal by Subject|16|||
163229110|NCT00958776|589551422|FG000|Overall Study|Protocol Violation|1|||
163229111|NCT00958776|589551423|FG001|Overall Study|Protocol Violation|1|||
163229112|NCT00958776|589551422|FG000|Overall Study|Death|2|||
163229113|NCT00958776|589551423|FG001|Overall Study|Death|1|||
163229114|NCT00958776|589551422|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
163229115|NCT00958776|589551423|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
163229116|NCT00958776|589551422|FG000|Overall Study|Missing|1|||
163229117|NCT00958776|589551423|FG001|Overall Study|Missing|1|||
163229118|NCT00326911|589551424|FG000|Overall Study|Hospitalization prior to treatment|0|||
163229119|NCT00326911|589551425|FG001|Overall Study|Hospitalization prior to treatment|1|||
163229120|NCT00326911|589551424|FG000|Overall Study|Physician decision prior to treatment|1|||
163229121|NCT00326911|589551425|FG001|Overall Study|Physician decision prior to treatment|0|||
163229122|NCT00326911|589551424|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
163229123|NCT00326911|589551425|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
163229124|NCT00418691|589551434|FG000|Overall Study|Lost to Follow-up|1|||
163229125|NCT00418691|589551435|FG001|Overall Study|Lost to Follow-up|2|||
163229126|NCT00418691|589551436|FG002|Overall Study|Lost to Follow-up|3|||
163229127|NCT00418691|589551434|FG000|Overall Study|Started new medication voiding entry|0|||
163229128|NCT00418691|589551435|FG001|Overall Study|Started new medication voiding entry|0|||
163229129|NCT00418691|589551436|FG002|Overall Study|Started new medication voiding entry|1|||
163229130|NCT00418691|589551434|FG000|Overall Study|Progressive Disease|1|||
163229131|NCT00418691|589551435|FG001|Overall Study|Progressive Disease|0|||
163229132|NCT00418691|589551436|FG002|Overall Study|Progressive Disease|1|||
163229133|NCT00501540|589551437|FG000|Overall Study|Death|5|||
163229134|NCT02331446|589551438|FG000|Overall Study|Lost to Follow-up|2|||
163229135|NCT02331446|589551439|FG001|Overall Study|Lost to Follow-up|1|||
163229136|NCT02331446|589551440|FG002|Overall Study|Lost to Follow-up|0|||
163229137|NCT02331446|589551441|FG003|Overall Study|Lost to Follow-up|1|||
163229138|NCT02331446|589551438|FG000|Overall Study|Personal Problem|2|||
163229139|NCT02331446|589551439|FG001|Overall Study|Personal Problem|0|||
163229140|NCT02331446|589551440|FG002|Overall Study|Personal Problem|0|||
163229141|NCT02331446|589551441|FG003|Overall Study|Personal Problem|0|||
163229142|NCT02331446|589551438|FG000|Overall Study|Disease|0|||
163229143|NCT02331446|589551439|FG001|Overall Study|Disease|2|||
163229144|NCT02331446|589551440|FG002|Overall Study|Disease|2|||
163229145|NCT02331446|589551441|FG003|Overall Study|Disease|1|||
163229146|NCT02331446|589551438|FG000|Overall Study|Physician Decision|0|||
163134888|NCT02598297|589203948|FG001|Overall Study|Followed for survival|0|||
163134889|NCT03040674|589203950|FG000|Overall Study|Lost to Follow-up|225|||
163134890|NCT03040674|589203950|FG000|Overall Study|Death|23|||
163134891|NCT02206035|589203952|FG000|Overall Study|Physician Decision|10|||
163134892|NCT02206035|589203953|FG001|Overall Study|Physician Decision|0|||
163134893|NCT02206035|589203954|FG002|Overall Study|Physician Decision|175|||
163134894|NCT01934010|589203955|FG000|Overall Study|Adverse Event|1|||
163134895|NCT01934010|589203956|FG001|Overall Study|Adverse Event|1|||
163134896|NCT01934010|589203957|FG002|Overall Study|Adverse Event|0|||
163134897|NCT01934010|589203955|FG000|Overall Study|Withdrawal by Subject|15|||
163134898|NCT01934010|589203956|FG001|Overall Study|Withdrawal by Subject|6|||
163134899|NCT01934010|589203957|FG002|Overall Study|Withdrawal by Subject|2|||
163134900|NCT01934010|589203955|FG000|Overall Study|Lost to Follow-up|7|||
163134901|NCT01934010|589203956|FG001|Overall Study|Lost to Follow-up|4|||
163134902|NCT01934010|589203957|FG002|Overall Study|Lost to Follow-up|0|||
163134903|NCT00377858|589203959|FG000|Overall Study|Withdrawal by Subject|12|||
163134904|NCT00377858|589203960|FG001|Overall Study|Withdrawal by Subject|11|||
163134905|NCT00377858|589203959|FG000|Overall Study|Lost to Follow-up|6|||
163134906|NCT00377858|589203960|FG001|Overall Study|Lost to Follow-up|1|||
163134907|NCT00377858|589203959|FG000|Overall Study|Physician Decision|5|||
163134908|NCT00377858|589203960|FG001|Overall Study|Physician Decision|5|||
163134909|NCT00377858|589203959|FG000|Overall Study|Protocol Violation|3|||
163134910|NCT00377858|589203960|FG001|Overall Study|Protocol Violation|4|||
163134911|NCT00377858|589203959|FG000|Overall Study|Adverse Event|2|||
163134912|NCT00377858|589203960|FG001|Overall Study|Adverse Event|1|||
163134913|NCT00377858|589203959|FG000|Overall Study|Entry Criteria Not Met|2|||
163134914|NCT00377858|589203960|FG001|Overall Study|Entry Criteria Not Met|0|||
163134915|NCT00377858|589203959|FG000|Overall Study|Sponsor Decision|1|||
163134916|NCT00377858|589203960|FG001|Overall Study|Sponsor Decision|2|||
163134917|NCT00377858|589203959|FG000|Overall Study|Death|0|||
163134918|NCT00377858|589203960|FG001|Overall Study|Death|3|||
163134919|NCT02506192|589203961|FG000|Overall Study|Withdrawal by Subject|1|||
163134920|NCT02506192|589203962|FG001|Overall Study|Withdrawal by Subject|1|||
163134921|NCT04042909|589203963|FG000|Overall Study|Withdrawal by Subject|1|||
163134922|NCT04042909|589203964|FG001|Overall Study|Withdrawal by Subject|0|||
163134923|NCT04042909|589203965|FG002|Overall Study|Withdrawal by Subject|0|||
163134924|NCT04042909|589203963|FG000|Overall Study|duplicate cases|2|||
163134925|NCT04042909|589203964|FG001|Overall Study|duplicate cases|0|||
163134926|NCT04042909|589203965|FG002|Overall Study|duplicate cases|0|||
163134927|NCT04042909|589203963|FG000|Overall Study|technical problem|0|||
163134928|NCT04042909|589203964|FG001|Overall Study|technical problem|1|||
163134929|NCT04042909|589203965|FG002|Overall Study|technical problem|0|||
163134930|NCT03785405|589203966|FG000|Overall Study|Adverse Event|16|||
163134931|NCT03785405|589203967|FG001|Overall Study|Adverse Event|1|||
163134932|NCT03785405|589203966|FG000|Overall Study|Death|6|||
163134933|NCT03785405|589203967|FG001|Overall Study|Death|4|||
163134934|NCT03785405|589203966|FG000|Overall Study|Guardian decision|4|||
163134935|NCT03785405|589203967|FG001|Overall Study|Guardian decision|1|||
163134936|NCT03785405|589203966|FG000|Overall Study|Lost to Follow-up|1|||
163134937|NCT03785405|589203967|FG001|Overall Study|Lost to Follow-up|0|||
163134938|NCT03785405|589203966|FG000|Overall Study|Physician Decision|8|||
163134939|NCT03785405|589203967|FG001|Overall Study|Physician Decision|5|||
163134940|NCT03785405|589203966|FG000|Overall Study|Participant decision|2|||
163134941|NCT03785405|589203967|FG001|Overall Study|Participant decision|0|||
163134942|NCT03785405|589203966|FG000|Overall Study|Other|1|||
163134943|NCT03785405|589203967|FG001|Overall Study|Other|0|||
163134944|NCT03785405|589203966|FG000|Overall Study|No treatment was received|0|||
163134945|NCT03785405|589203967|FG001|Overall Study|No treatment was received|1|||
163134946|NCT03705559|589203968|FG000|Overall Study|COVID Shut down|1|||
163134947|NCT06041919|589203974|FG000|Overall Study|Lost to Follow-up|1|||
163134948|NCT06041919|589203975|FG001|Overall Study|Lost to Follow-up|0|||
163134949|NCT06041919|589203976|FG002|Overall Study|Lost to Follow-up|0|||
163134950|NCT06041919|589203977|FG003|Overall Study|Lost to Follow-up|0|||
163134951|NCT06041919|589203978|FG004|Overall Study|Lost to Follow-up|0|||
163134952|NCT06041919|589203974|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
163134953|NCT06041919|589203975|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
163134954|NCT06041919|589203976|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
163134955|NCT06041919|589203977|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
163134956|NCT06041919|589203978|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
163134957|NCT01147055|589203979|FG000|First Intervention Period|Lost to Follow-up|1|||
163134958|NCT01147055|589203980|FG001|First Intervention Period|Lost to Follow-up|0|||
163134959|NCT02576795|589203981|FG000|Overall Study|Lost to Follow-up|0|||
163134960|NCT02576795|589203982|FG001|Overall Study|Lost to Follow-up|0|||
163134961|NCT02576795|589203983|FG002|Overall Study|Lost to Follow-up|1|||
163134962|NCT02576795|589203984|FG003|Overall Study|Lost to Follow-up|0|||
163134963|NCT03724890|589203985|FG000|Overall Study|Death|2|||
163134964|NCT03724890|589203986|FG001|Overall Study|Death|6|||
163134965|NCT03724890|589203987|FG002|Overall Study|Death|3|||
163134966|NCT03724890|589203988|FG003|Overall Study|Death|5|||
163134967|NCT03724890|589203989|FG004|Overall Study|Death|2|||
163134968|NCT03724890|589203990|FG005|Overall Study|Death|0|||
163134969|NCT03724890|589203991|FG006|Overall Study|Death|2|||
163134970|NCT03724890|589203992|FG007|Overall Study|Death|3|||
163134971|NCT03724890|589203993|FG008|Overall Study|Death|4|||
163134972|NCT03724890|589203994|FG009|Overall Study|Death|2|||
163134973|NCT03724890|589203995|FG010|Overall Study|Death|2|||
163134974|NCT03724890|589203985|FG000|Overall Study|Lost to Follow-up|0|||
163134975|NCT03724890|589203986|FG001|Overall Study|Lost to Follow-up|3|||
163134976|NCT03724890|589203987|FG002|Overall Study|Lost to Follow-up|0|||
163134977|NCT03724890|589203988|FG003|Overall Study|Lost to Follow-up|1|||
163134978|NCT03724890|589203989|FG004|Overall Study|Lost to Follow-up|2|||
163134979|NCT03724890|589203990|FG005|Overall Study|Lost to Follow-up|2|||
163134980|NCT03724890|589203991|FG006|Overall Study|Lost to Follow-up|1|||
163134981|NCT03724890|589203992|FG007|Overall Study|Lost to Follow-up|0|||
163134982|NCT03724890|589203993|FG008|Overall Study|Lost to Follow-up|2|||
163134983|NCT03724890|589203994|FG009|Overall Study|Lost to Follow-up|0|||
163134984|NCT03724890|589203995|FG010|Overall Study|Lost to Follow-up|0|||
163134985|NCT03724890|589203985|FG000|Overall Study|Withdrawal by Subject|1|||
163134986|NCT03724890|589203986|FG001|Overall Study|Withdrawal by Subject|2|||
163134987|NCT03724890|589203987|FG002|Overall Study|Withdrawal by Subject|1|||
163134988|NCT03724890|589203988|FG003|Overall Study|Withdrawal by Subject|0|||
163134989|NCT03724890|589203989|FG004|Overall Study|Withdrawal by Subject|0|||
163134990|NCT03724890|589203990|FG005|Overall Study|Withdrawal by Subject|1|||
163134991|NCT03724890|589203991|FG006|Overall Study|Withdrawal by Subject|0|||
163134992|NCT03724890|589203992|FG007|Overall Study|Withdrawal by Subject|0|||
163134993|NCT03724890|589203993|FG008|Overall Study|Withdrawal by Subject|2|||
163134994|NCT03724890|589203994|FG009|Overall Study|Withdrawal by Subject|2|||
163134995|NCT03724890|589203995|FG010|Overall Study|Withdrawal by Subject|1|||
163134996|NCT03724890|589203985|FG000|Overall Study|Other|1|||
163134997|NCT03724890|589203986|FG001|Overall Study|Other|0|||
163134998|NCT03724890|589203987|FG002|Overall Study|Other|0|||
163134999|NCT03724890|589203988|FG003|Overall Study|Other|0|||
163135000|NCT03724890|589203989|FG004|Overall Study|Other|0|||
163135001|NCT03724890|589203990|FG005|Overall Study|Other|0|||
163135002|NCT03724890|589203991|FG006|Overall Study|Other|0|||
163135003|NCT03724890|589203992|FG007|Overall Study|Other|1|||
163135004|NCT03724890|589203993|FG008|Overall Study|Other|1|||
163135005|NCT03724890|589203994|FG009|Overall Study|Other|0|||
163135006|NCT03724890|589203995|FG010|Overall Study|Other|2|||
163135007|NCT02362464|589203997|FG000|Overall Study|Switched to alternative therapy|1|||
163135008|NCT02362464|589203997|FG000|Overall Study|Refused further treatment|1|||
163135009|NCT02362464|589203997|FG000|Overall Study|Physician Decision|4|||
163135010|NCT02123823|589203998|FG000|Overall Study|Lack of Efficacy|0|||
163135011|NCT02123823|589203999|FG001|Overall Study|Lack of Efficacy|2|||
163135012|NCT02123823|589204000|FG002|Overall Study|Lack of Efficacy|8|||
163135013|NCT02123823|589204001|FG003|Overall Study|Lack of Efficacy|10|||
163135014|NCT02123823|589203998|FG000|Overall Study|Progressive disease|3|||
163135015|NCT02123823|589203999|FG001|Overall Study|Progressive disease|19|||
163135016|NCT02123823|589204000|FG002|Overall Study|Progressive disease|52|||
163135017|NCT02123823|589204001|FG003|Overall Study|Progressive disease|53|||
163135018|NCT02123823|589203998|FG000|Overall Study|Withdrawal by Subject|0|||
163135019|NCT02123823|589203999|FG001|Overall Study|Withdrawal by Subject|0|||
163135020|NCT02123823|589204000|FG002|Overall Study|Withdrawal by Subject|7|||
163135021|NCT02123823|589204001|FG003|Overall Study|Withdrawal by Subject|2|||
163135022|NCT02123823|589203998|FG000|Overall Study|Adverse Event|0|||
163135023|NCT02123823|589203999|FG001|Overall Study|Adverse Event|0|||
163135024|NCT02123823|589204000|FG002|Overall Study|Adverse Event|3|||
163135025|NCT02123823|589204001|FG003|Overall Study|Adverse Event|5|||
163135026|NCT01635855|589204036|FG000|Overall Study|Withdrawal by Subject|4|||
163135027|NCT02104947|589204039|FG000|Overall Study|Withdrawal by Subject|10|||
163135028|NCT02104947|589204040|FG001|Overall Study|Withdrawal by Subject|3|||
163135029|NCT02104947|589204039|FG000|Overall Study|Lost to Follow-up|4|||
163135030|NCT02104947|589204040|FG001|Overall Study|Lost to Follow-up|4|||
163135031|NCT02104947|589204039|FG000|Overall Study|Protocol Violation|6|||
163135032|NCT02104947|589204040|FG001|Overall Study|Protocol Violation|8|||
163135033|NCT02104947|589204039|FG000|Overall Study|Adverse Event|57|||
163135034|NCT02104947|589204040|FG001|Overall Study|Adverse Event|38|||
163135035|NCT02104947|589204039|FG000|Overall Study|Other than stated above|2|||
163135036|NCT02104947|589204040|FG001|Overall Study|Other than stated above|3|||
163135037|NCT01844778|589204041|FG000|Overall Study|Protocol deviation|0|||
163135038|NCT01844778|589204042|FG001|Overall Study|Protocol deviation|1|||
163135039|NCT01844778|589204043|FG002|Overall Study|Protocol deviation|2|||
163135040|NCT01844778|589204041|FG000|Overall Study|Withdrawal by Subject|2|||
163135041|NCT01844778|589204042|FG001|Overall Study|Withdrawal by Subject|0|||
163135042|NCT01844778|589204043|FG002|Overall Study|Withdrawal by Subject|0|||
163135043|NCT01844778|589204041|FG000|Overall Study|Adverse Event|0|||
163135044|NCT01844778|589204042|FG001|Overall Study|Adverse Event|2|||
163135045|NCT01844778|589204043|FG002|Overall Study|Adverse Event|2|||
163229147|NCT02331446|589551439|FG001|Overall Study|Physician Decision|1|||
163135046|NCT00095173|589204044|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
163135047|NCT00095173|589204045|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
163135048|NCT00095173|589204046|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
163135049|NCT00095173|589204047|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
163135050|NCT00095173|589204048|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
163135051|NCT00095173|589204049|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
163135052|NCT00095173|589204044|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
163135053|NCT00095173|589204045|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
163135054|NCT00095173|589204046|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
163135055|NCT00095173|589204047|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
163135056|NCT00095173|589204048|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
163135057|NCT00095173|589204049|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
163135058|NCT00095173|589204044|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
163135059|NCT00095173|589204045|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
163135060|NCT00095173|589204046|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
163135061|NCT00095173|589204047|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
163135062|NCT00095173|589204048|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
163135063|NCT00095173|589204049|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
163135064|NCT00095173|589204044|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
163135065|NCT00095173|589204045|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
163135066|NCT00095173|589204046|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
163135067|NCT00095173|589204047|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
163135068|NCT00095173|589204048|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
163135069|NCT00095173|589204049|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
163135070|NCT00095173|589204044|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
163135071|NCT00095173|589204045|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
163135072|NCT00095173|589204046|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
163135073|NCT00095173|589204047|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
163135074|NCT00095173|589204048|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
163135075|NCT00095173|589204049|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
163135076|NCT00095173|589204044|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
163135077|NCT00095173|589204045|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
163135078|NCT00095173|589204046|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
163135079|NCT00095173|589204047|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
163135080|NCT00095173|589204048|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
163135081|NCT00095173|589204049|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
163135082|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Death|0|||
163135083|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Death|0|||
163135084|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Death|0|||
163135085|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Death|0|||
163135086|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Death|0|||
163135087|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Death|1|||
163135088|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
163135089|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
163135090|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
163135091|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
163135092|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
163135093|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
163135094|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
163135095|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
163135096|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
163135097|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
163135098|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
163135099|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
163135100|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
163135101|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
163135102|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
163135103|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
163135104|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
163135105|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
163135106|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
163135107|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
163135108|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
163229148|NCT02331446|589551440|FG002|Overall Study|Physician Decision|0|||
163229149|NCT02331446|589551441|FG003|Overall Study|Physician Decision|1|||
163229150|NCT02331446|589551438|FG000|Overall Study|Lost before baseline analysis|0|||
163229151|NCT02331446|589551439|FG001|Overall Study|Lost before baseline analysis|1|||
163229152|NCT02331446|589551440|FG002|Overall Study|Lost before baseline analysis|1|||
163135109|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
163135110|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
163135111|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
163135112|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
163135113|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
163135114|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
163135115|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
163135116|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
163135117|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
163135118|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
163135119|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
163135120|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
163135121|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
163135122|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
163135123|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
163135124|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
163135125|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
163135126|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
163135127|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
163135128|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
163135129|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
163135130|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Other|0|||
163135131|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Other|0|||
163135132|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Other|0|||
163135133|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Other|4|||
163135134|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Other|6|||
163135135|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Other|8|||
163135136|NCT02343406|589204050|FG000|Overall Study|Progressive disease|72|||
163135137|NCT02343406|589204051|FG001|Overall Study|Progressive disease|70|||
163135138|NCT02343406|589204052|FG002|Overall Study|Progressive disease|43|||
163229153|NCT02331446|589551441|FG003|Overall Study|Lost before baseline analysis|0|||
163229154|NCT02984995|589551442|FG000|Overall Study|Required stem cell transplant|13|||
163229155|NCT02984995|589551443|FG001|Overall Study|Required stem cell transplant|2|||
163229156|NCT02984995|589551442|FG000|Overall Study|Progressive disease|11|||
163229157|NCT02984995|589551443|FG001|Overall Study|Progressive disease|1|||
163229158|NCT02984995|589551442|FG000|Overall Study|Adverse Event|1|||
163229159|NCT02984995|589551443|FG001|Overall Study|Adverse Event|0|||
163229160|NCT04182100|589551444|FG000|Overall Study|Adverse Event|1|||
163229161|NCT04182100|589551444|FG000|Overall Study|Withdrawal by Subject|1|||
163229162|NCT00433654|589551446|FG000|Overall Study|Death|4|||
163229163|NCT00433654|589551447|FG001|Overall Study|Death|0|||
163229164|NCT00433654|589551446|FG000|Overall Study|Missed visit|6|||
163229165|NCT00433654|589551447|FG001|Overall Study|Missed visit|3|||
163229166|NCT00433654|589551446|FG000|Overall Study|Subject not yet due for visit|4|||
163229167|NCT00433654|589551447|FG001|Overall Study|Subject not yet due for visit|0|||
163229168|NCT00433654|589551446|FG000|Overall Study|Withdrawal by Subject|1|||
163229169|NCT00433654|589551447|FG001|Overall Study|Withdrawal by Subject|2|||
163229170|NCT00499603|589551473|FG000|Overall Study|Adverse Event|0|||
163229171|NCT00499603|589551474|FG001|Overall Study|Adverse Event|1|||
163229172|NCT00937547|589551475|FG000|Overall Study|misdiagnosis|1|||
163229173|NCT00937547|589551476|FG001|Overall Study|misdiagnosis|6|||
163229174|NCT00937547|589551477|FG002|Overall Study|misdiagnosis|7|||
163229175|NCT04439240|589551478|FG000|Overall Study|Ineligible|2|||
163229176|NCT04439240|589551478|FG000|Overall Study|Never started treatment|2|||
163229177|NCT04439240|589551478|FG000|Overall Study|Adverse Event|12|||
163229178|NCT04439240|589551478|FG000|Overall Study|Death|2|||
163229179|NCT04439240|589551478|FG000|Overall Study|Disease progression|25|||
163229180|NCT04439240|589551478|FG000|Overall Study|Other diseases|2|||
163229181|NCT04439240|589551478|FG000|Overall Study|Withdrawal by Subject|3|||
163229182|NCT04439240|589551478|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
163229183|NCT04439240|589551478|FG000|Overall Study|Symptomatic decline|1|||
163229184|NCT04439240|589551478|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
163229185|NCT04439240|589551478|FG000|Overall Study|Clinical progression|1|||
163229186|NCT00079274|589551480|FG000|Overall Study|Withdrawal by Subject|111|||
163229187|NCT00079274|589551481|FG001|Overall Study|Withdrawal by Subject|10|||
163229188|NCT00079274|589551482|FG002|Overall Study|Withdrawal by Subject|12|||
163229189|NCT00079274|589551483|FG003|Overall Study|Withdrawal by Subject|163|||
163229190|NCT00079274|589551484|FG004|Overall Study|Withdrawal by Subject|7|||
163229191|NCT00079274|589551485|FG005|Overall Study|Withdrawal by Subject|8|||
163229192|NCT00079274|589551486|FG006|Overall Study|Withdrawal by Subject|0|||
163229193|NCT00079274|589551480|FG000|Overall Study|Adverse Event|130|||
163229194|NCT00079274|589551481|FG001|Overall Study|Adverse Event|8|||
163135139|NCT02343406|589204053|FG003|Overall Study|Progressive disease|15|||
163135140|NCT02343406|589204054|FG004|Overall Study|Progressive disease|5|||
163135141|NCT02343406|589204050|FG000|Overall Study|Adverse Event|6|||
163135142|NCT02343406|589204051|FG001|Overall Study|Adverse Event|8|||
163345329|NCT02312245|589972120|FG002|Overall Study|Patient went to hospice|0|||
163345330|NCT02312245|589972121|FG003|Overall Study|Patient went to hospice|1|||
163135143|NCT02343406|589204052|FG002|Overall Study|Adverse Event|6|||
163135144|NCT02343406|589204053|FG003|Overall Study|Adverse Event|3|||
163135145|NCT02343406|589204054|FG004|Overall Study|Adverse Event|0|||
163135146|NCT02343406|589204050|FG000|Overall Study|Withdrawal by Subject|6|||
163135147|NCT02343406|589204051|FG001|Overall Study|Withdrawal by Subject|4|||
163135148|NCT02343406|589204052|FG002|Overall Study|Withdrawal by Subject|8|||
163135149|NCT02343406|589204053|FG003|Overall Study|Withdrawal by Subject|3|||
163135150|NCT02343406|589204054|FG004|Overall Study|Withdrawal by Subject|0|||
163135151|NCT02343406|589204050|FG000|Overall Study|Death|2|||
163135152|NCT02343406|589204051|FG001|Overall Study|Death|1|||
163135153|NCT02343406|589204052|FG002|Overall Study|Death|0|||
163345331|NCT02312245|589972118|FG000|Overall Study|Ineligible|1|||
163135154|NCT02343406|589204053|FG003|Overall Study|Death|0|||
163135155|NCT02343406|589204054|FG004|Overall Study|Death|0|||
163135156|NCT02343406|589204050|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
163135157|NCT02343406|589204051|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
163135158|NCT02343406|589204052|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
163135159|NCT02343406|589204053|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
163135160|NCT02343406|589204054|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
163135161|NCT02343406|589204050|FG000|Overall Study|Other primary malignancy|0|||
163135162|NCT02343406|589204051|FG001|Overall Study|Other primary malignancy|1|||
163135163|NCT02343406|589204052|FG002|Overall Study|Other primary malignancy|0|||
163135164|NCT02343406|589204053|FG003|Overall Study|Other primary malignancy|0|||
163135165|NCT02343406|589204054|FG004|Overall Study|Other primary malignancy|0|||
163135166|NCT02343406|589204050|FG000|Overall Study|Other, not specified|2|||
163135167|NCT02343406|589204051|FG001|Overall Study|Other, not specified|1|||
163135168|NCT02343406|589204052|FG002|Overall Study|Other, not specified|1|||
163135169|NCT02343406|589204053|FG003|Overall Study|Other, not specified|4|||
163135170|NCT02343406|589204054|FG004|Overall Study|Other, not specified|0|||
163135171|NCT00548145|589204055|FG000|Overall Study|Death|0|||
163135172|NCT00548145|589204056|FG001|Overall Study|Death|1|||
163135173|NCT00548145|589204055|FG000|Overall Study|Withdrawal by Subject|0|||
163135174|NCT00548145|589204056|FG001|Overall Study|Withdrawal by Subject|2|||
163135175|NCT00548145|589204055|FG000|Overall Study|Physician Decision|1|||
163135176|NCT00548145|589204056|FG001|Overall Study|Physician Decision|1|||
163135177|NCT00874848|589204057|FG000|Overall Study|Adverse Event|13|||
163135178|NCT00874848|589204058|FG001|Overall Study|Adverse Event|2|||
163135179|NCT00874848|589204057|FG000|Overall Study|Progressive neoplastic disease|38|||
163135180|NCT00874848|589204058|FG001|Overall Study|Progressive neoplastic disease|18|||
163135181|NCT00874848|589204057|FG000|Overall Study|Withdrawal by Subject|7|||
163135182|NCT00874848|589204058|FG001|Overall Study|Withdrawal by Subject|4|||
163135183|NCT00874848|589204057|FG000|Overall Study|Noncompliance|1|||
163135184|NCT00874848|589204058|FG001|Overall Study|Noncompliance|1|||
163135185|NCT00874848|589204057|FG000|Overall Study|Failure to comply with protocol|0|||
163135186|NCT00874848|589204058|FG001|Overall Study|Failure to comply with protocol|1|||
163135187|NCT00874848|589204057|FG000|Overall Study|Physician Decision|0|||
163135188|NCT00874848|589204058|FG001|Overall Study|Physician Decision|2|||
163135189|NCT03301350|589204067|FG000|Overall Study|Withdrawal by Subject|4|||
163135190|NCT03301350|589204067|FG000|Overall Study|Adverse Event|1|||
163135191|NCT03301350|589204067|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
163135192|NCT03301350|589204067|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
163135193|NCT03301350|589204067|FG000|Overall Study|no detail provided|1|||
163135194|NCT00379912|589204068|FG000|Overall Study|Lack of Efficacy|1|||
163135195|NCT00379912|589204069|FG001|Overall Study|Lack of Efficacy|0|||
163135196|NCT04698993|589204070|FG000|Overall Study|PCR results not accessible|2|||
163135197|NCT04698993|589204071|FG001|Overall Study|PCR results not accessible|7|||
163135198|NCT04698993|589204070|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
163135199|NCT04698993|589204071|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
163135200|NCT01371734|589204072|FG000|Overall Study|Other|2|||
163135201|NCT01371734|589204073|FG001|Overall Study|Other|1|||
163135202|NCT01371734|589204074|FG002|Overall Study|Other|2|||
163135203|NCT01371734|589204072|FG000|Overall Study|Withdrawal by Subject|3|||
163135204|NCT01371734|589204073|FG001|Overall Study|Withdrawal by Subject|4|||
163135205|NCT01371734|589204074|FG002|Overall Study|Withdrawal by Subject|9|||
163135206|NCT01371734|589204072|FG000|Overall Study|Lost to Follow-up|5|||
163135207|NCT01371734|589204073|FG001|Overall Study|Lost to Follow-up|3|||
163135208|NCT01371734|589204074|FG002|Overall Study|Lost to Follow-up|1|||
163345332|NCT02312245|589972119|FG001|Overall Study|Ineligible|0|||
163345333|NCT02312245|589972120|FG002|Overall Study|Ineligible|0|||
163135209|NCT01371734|589204072|FG000|Overall Study|Protocol Violation|3|||
163345334|NCT02312245|589972121|FG003|Overall Study|Ineligible|0|||
163135210|NCT01371734|589204073|FG001|Overall Study|Protocol Violation|1|||
163135211|NCT01371734|589204074|FG002|Overall Study|Protocol Violation|2|||
163135212|NCT01371734|589204072|FG000|Overall Study|Adverse Event|8|||
163135213|NCT01371734|589204073|FG001|Overall Study|Adverse Event|8|||
163135214|NCT01371734|589204074|FG002|Overall Study|Adverse Event|3|||
163135215|NCT01371734|589204072|FG000|Overall Study|Lack of Efficacy|2|||
163135216|NCT01371734|589204073|FG001|Overall Study|Lack of Efficacy|2|||
163135217|NCT01371734|589204074|FG002|Overall Study|Lack of Efficacy|0|||
163135218|NCT00206440|589204075|FG000|Overall Study|Protocol Violation|1|||
163135219|NCT00206440|589204076|FG001|Overall Study|Protocol Violation|2|||
163135220|NCT00206440|589204075|FG000|Overall Study|Adverse Event|4|||
163135221|NCT00206440|589204076|FG001|Overall Study|Adverse Event|2|||
163135222|NCT00958165|589204077|FG000|Overall Study|Lost to Follow-up|5|||
163135223|NCT00958165|589204077|FG000|Overall Study|Not eligible|9|||
163135224|NCT00145574|589204078|FG000|Double Blind|Adverse Event|0|||
163135225|NCT00145574|589204079|FG001|Double Blind|Adverse Event|3|||
163135226|NCT00145574|589204080|FG002|Double Blind|Adverse Event|1|||
163135227|NCT00145574|589204078|FG000|Double Blind|Withdrawal by Subject|1|||
163135228|NCT00145574|589204079|FG001|Double Blind|Withdrawal by Subject|1|||
163135229|NCT00145574|589204080|FG002|Double Blind|Withdrawal by Subject|1|||
163135230|NCT00145574|589204078|FG000|Double Blind|required restricted medicine|0|||
163135231|NCT00145574|589204079|FG001|Double Blind|required restricted medicine|1|||
163135232|NCT00145574|589204080|FG002|Double Blind|required restricted medicine|0|||
163135233|NCT00145574|589204078|FG000|Open Label Long-term Extension|Adverse Event|0|||
163135234|NCT00145574|589204079|FG001|Open Label Long-term Extension|Adverse Event|0|||
163135235|NCT00145574|589204080|FG002|Open Label Long-term Extension|Adverse Event|5|||
163135236|NCT00145574|589204078|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
163135237|NCT00145574|589204079|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
163135238|NCT00145574|589204080|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
163135239|NCT00145574|589204078|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
163135240|NCT00145574|589204079|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
163135241|NCT00145574|589204080|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
163135242|NCT00145574|589204078|FG000|Open Label Long-term Extension|required restricted medicine|0|||
163135243|NCT00145574|589204079|FG001|Open Label Long-term Extension|required restricted medicine|0|||
163135244|NCT00145574|589204080|FG002|Open Label Long-term Extension|required restricted medicine|1|||
163135245|NCT00621140|589204081|FG000|Overall Study|Adverse Event|4|||
163135246|NCT00621140|589204082|FG001|Overall Study|Adverse Event|5|||
163135247|NCT00621140|589204081|FG000|Overall Study|Lost to Follow-up|1|||
163135248|NCT00621140|589204082|FG001|Overall Study|Lost to Follow-up|2|||
163135249|NCT00621140|589204081|FG000|Overall Study|Withdrawal by Subject|4|||
163135250|NCT00621140|589204082|FG001|Overall Study|Withdrawal by Subject|6|||
163135251|NCT00621140|589204081|FG000|Overall Study|Other incl. lack of efficacy|6|||
163135252|NCT00621140|589204082|FG001|Overall Study|Other incl. lack of efficacy|5|||
163135253|NCT01298765|589204084|FG000|Titration Period|Adverse Event|26|||
163135254|NCT01298765|589204084|FG000|Titration Period|Death|1|||
163135255|NCT01298765|589204084|FG000|Titration Period|Lack of Efficacy|21|||
163135256|NCT01298765|589204084|FG000|Titration Period|Lost to Follow-up|9|||
163135257|NCT01298765|589204084|FG000|Titration Period|Physician Decision|1|||
163135258|NCT01298765|589204084|FG000|Titration Period|Withdrawal by Subject|10|||
163135259|NCT01298765|589204084|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
163135260|NCT01298765|589204084|FG000|Long-Term Treatment Period|Adverse Event|19|||
163135261|NCT01298765|589204084|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
163229195|NCT00079274|589551482|FG002|Overall Study|Adverse Event|8|||
163345335|NCT01123200|589972122|FG000|Overall Study|Withdrawal by Subject|1|||
163345336|NCT01288729|589972127|FG000|Overall Study|Withdrawal by Subject|1|||
163135262|NCT01298765|589204084|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
163135263|NCT01298765|589204084|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
163135264|NCT01298765|589204084|FG000|Long-Term Treatment Period|Physician Decision|1|||
163135265|NCT01298765|589204084|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
163135266|NCT03565237|589204085|FG000|Overall Study|Non-compliance of Investigational Product|1|||
163135267|NCT03565237|589204085|FG000|Overall Study|Physician Decision|1|||
163135268|NCT01140061|589204088|FG000|Part I|Adverse Event|1|||
163135269|NCT01140061|589204089|FG001|Part I|Adverse Event|0|||
163135270|NCT01140061|589204090|FG002|Part I|Adverse Event|0|||
163135271|NCT01140061|589204091|FG003|Part I|Adverse Event|0|||
163135272|NCT01140061|589204092|FG004|Part I|Adverse Event|0|||
163135273|NCT01140061|589204093|FG005|Part I|Adverse Event|0|||
163135274|NCT01140061|589204094|FG006|Part I|Adverse Event|0|||
163135275|NCT01140061|589204095|FG007|Part I|Adverse Event|0|||
163135276|NCT01140061|589204096|FG008|Part I|Adverse Event|0|||
163135277|NCT01140061|589204097|FG009|Part I|Adverse Event|0|||
163135278|NCT01140061|589204088|FG000|Extension|Laboratory Adverse Event|0|||
163229196|NCT00079274|589551483|FG003|Overall Study|Adverse Event|184|||
163229197|NCT00079274|589551484|FG004|Overall Study|Adverse Event|7|||
163345337|NCT01288729|589972128|FG001|Overall Study|Withdrawal by Subject|0|||
163345338|NCT03214198|589972129|FG000|Overall Study|Case Report Forms Uncollected|18|||
163135279|NCT01140061|589204089|FG001|Extension|Laboratory Adverse Event|0|||
163135280|NCT01140061|589204090|FG002|Extension|Laboratory Adverse Event|0|||
163135281|NCT01140061|589204091|FG003|Extension|Laboratory Adverse Event|0|||
163135282|NCT01140061|589204092|FG004|Extension|Laboratory Adverse Event|0|||
163135283|NCT01140061|589204093|FG005|Extension|Laboratory Adverse Event|0|||
163135284|NCT01140061|589204094|FG006|Extension|Laboratory Adverse Event|0|||
163135285|NCT01140061|589204095|FG007|Extension|Laboratory Adverse Event|0|||
163135286|NCT01140061|589204096|FG008|Extension|Laboratory Adverse Event|0|||
163135287|NCT01140061|589204097|FG009|Extension|Laboratory Adverse Event|1|||
163135288|NCT00428389|589204098|FG000|Core Phase|Adverse Event|6|||
163135289|NCT00428389|589204099|FG001|Core Phase|Adverse Event|4|||
163135290|NCT00428389|589204098|FG000|Core Phase|Lack of Efficacy|2|||
163135291|NCT00428389|589204099|FG001|Core Phase|Lack of Efficacy|0|||
163135292|NCT00428389|589204098|FG000|Core Phase|Abnormal test procedure result(s)|0|||
163135293|NCT00428389|589204099|FG001|Core Phase|Abnormal test procedure result(s)|1|||
163135294|NCT00428389|589204098|FG000|Core Phase|Withdrawal by Subject|3|||
163135295|NCT00428389|589204099|FG001|Core Phase|Withdrawal by Subject|4|||
163135296|NCT00428389|589204098|FG000|Core Phase|Protocol deviation|0|||
163135297|NCT00428389|589204099|FG001|Core Phase|Protocol deviation|2|||
163135298|NCT00428389|589204098|FG000|Extension Phase|Adverse Event|17|||
163135299|NCT00428389|589204099|FG001|Extension Phase|Adverse Event|11|||
163135300|NCT00428389|589204098|FG000|Extension Phase|Lack of Efficacy|4|||
163135301|NCT00428389|589204099|FG001|Extension Phase|Lack of Efficacy|3|||
163135302|NCT00428389|589204098|FG000|Extension Phase|Withdrawal by Subject|6|||
163135303|NCT00428389|589204099|FG001|Extension Phase|Withdrawal by Subject|6|||
163135304|NCT00428389|589204098|FG000|Extension Phase|Lost to Follow-up|0|||
163135305|NCT00428389|589204099|FG001|Extension Phase|Lost to Follow-up|3|||
163135306|NCT00428389|589204098|FG000|Extension Phase|Death|1|||
163135307|NCT00428389|589204099|FG001|Extension Phase|Death|0|||
163135308|NCT00428389|589204098|FG000|Extension Phase|Protocol Violation|3|||
163135309|NCT00428389|589204099|FG001|Extension Phase|Protocol Violation|2|||
163135310|NCT00428389|589204098|FG000|Extension Phase|Administrative problems|1|||
163135311|NCT00428389|589204099|FG001|Extension Phase|Administrative problems|1|||
163135312|NCT02669121|589204100|FG000|Overall Study|Adverse Event|4|||
163135313|NCT02669121|589204101|FG001|Overall Study|Adverse Event|5|||
163135314|NCT02669121|589204100|FG000|Overall Study|Lost to Follow-up|15|||
163135315|NCT02669121|589204101|FG001|Overall Study|Lost to Follow-up|27|||
163135316|NCT02669121|589204100|FG000|Overall Study|Withdrawal by Subject|132|||
163135317|NCT02669121|589204101|FG001|Overall Study|Withdrawal by Subject|140|||
163135318|NCT02669121|589204100|FG000|Overall Study|Pregnancy|0|||
163135319|NCT02669121|589204101|FG001|Overall Study|Pregnancy|1|||
163135320|NCT02669121|589204100|FG000|Overall Study|Discharged from US Military Active Service|117|||
163135321|NCT02669121|589204101|FG001|Overall Study|Discharged from US Military Active Service|91|||
163135322|NCT02669121|589204100|FG000|Overall Study|Reason not Specified|22|||
163135323|NCT02669121|589204101|FG001|Overall Study|Reason not Specified|18|||
163135324|NCT03216746|589204102|FG000|Overall Study|Lost to Follow-up|6|||
163135325|NCT03216746|589204103|FG001|Overall Study|Lost to Follow-up|8|||
163135326|NCT03216746|589204104|FG002|Overall Study|Lost to Follow-up|5|||
163135327|NCT03216746|589204105|FG003|Overall Study|Lost to Follow-up|6|||
163135328|NCT04384523|589204106|FG000|Overall Study|Lost to Follow-up|0|||
163135329|NCT04384523|589204107|FG001|Overall Study|Lost to Follow-up|0|||
163135330|NCT04384523|589204108|FG002|Overall Study|Lost to Follow-up|0|||
163135331|NCT04384523|589204109|FG003|Overall Study|Lost to Follow-up|0|||
163135332|NCT04384523|589204110|FG004|Overall Study|Lost to Follow-up|0|||
163135333|NCT04384523|589204111|FG005|Overall Study|Lost to Follow-up|1|||
163135334|NCT04384523|589204106|FG000|Overall Study|Protocol Violation|0|||
163135335|NCT04384523|589204107|FG001|Overall Study|Protocol Violation|1|||
163135336|NCT04384523|589204108|FG002|Overall Study|Protocol Violation|0|||
163135337|NCT04384523|589204109|FG003|Overall Study|Protocol Violation|0|||
163135338|NCT04384523|589204110|FG004|Overall Study|Protocol Violation|0|||
163135339|NCT04384523|589204111|FG005|Overall Study|Protocol Violation|0|||
163135340|NCT04384523|589204106|FG000|Overall Study|Withdrawal by Subject|1|||
163135341|NCT04384523|589204107|FG001|Overall Study|Withdrawal by Subject|0|||
163135342|NCT04384523|589204108|FG002|Overall Study|Withdrawal by Subject|0|||
163135343|NCT04384523|589204109|FG003|Overall Study|Withdrawal by Subject|0|||
163135344|NCT04384523|589204110|FG004|Overall Study|Withdrawal by Subject|0|||
163135345|NCT04384523|589204111|FG005|Overall Study|Withdrawal by Subject|0|||
163135346|NCT00835341|589204112|FG000|Overall Study|Lost to Follow-up|3|||
163135347|NCT00835341|589204113|FG001|Overall Study|Lost to Follow-up|12|||
163135348|NCT01098305|589204115|FG000|Overall Study|Lost to Follow-up|31|||
163135349|NCT01098305|589204116|FG001|Overall Study|Lost to Follow-up|33|||
163135350|NCT03170193|589204127|FG000|Overall Study|Withdrawal by Subject|0|||
163135351|NCT03170193|589204128|FG001|Overall Study|Withdrawal by Subject|0|||
163135352|NCT03170193|589204129|FG002|Overall Study|Withdrawal by Subject|0|||
163135353|NCT03170193|589204130|FG003|Overall Study|Withdrawal by Subject|1|||
163408516|NCT00267748|590205534|FG002|Randomized Period|Lost to Follow-up|0|||
163135354|NCT03170193|589204131|FG004|Overall Study|Withdrawal by Subject|0|||
163135355|NCT03170193|589204132|FG005|Overall Study|Withdrawal by Subject|0|||
163135356|NCT03170193|589204133|FG006|Overall Study|Withdrawal by Subject|0|||
163135357|NCT03170193|589204127|FG000|Overall Study|Lost to Follow-up|1|||
163135358|NCT03170193|589204128|FG001|Overall Study|Lost to Follow-up|1|||
163135359|NCT03170193|589204129|FG002|Overall Study|Lost to Follow-up|0|||
163135360|NCT03170193|589204130|FG003|Overall Study|Lost to Follow-up|0|||
163135361|NCT03170193|589204131|FG004|Overall Study|Lost to Follow-up|0|||
163135362|NCT03170193|589204132|FG005|Overall Study|Lost to Follow-up|0|||
163135363|NCT03170193|589204133|FG006|Overall Study|Lost to Follow-up|0|||
163135364|NCT03848949|589204137|FG000|Overall Study|Lost to Follow-up|5|||
163135365|NCT03848949|589204138|FG001|Overall Study|Lost to Follow-up|7|||
163135366|NCT00118430|589204149|FG000|Overall Study|Withdrawal by Subject|6|||
163135367|NCT00118430|589204150|FG001|Overall Study|Withdrawal by Subject|2|||
163135368|NCT00118430|589204151|FG002|Overall Study|Withdrawal by Subject|0|||
163135369|NCT00118430|589204149|FG000|Overall Study|Lost to Follow-up|15|||
163135370|NCT00118430|589204150|FG001|Overall Study|Lost to Follow-up|22|||
163135371|NCT00118430|589204151|FG002|Overall Study|Lost to Follow-up|28|||
163135372|NCT00534976|589204152|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
163135373|NCT00534976|589204153|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
163135374|NCT00534976|589204152|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
163135375|NCT00534976|589204153|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
163135376|NCT00534976|589204152|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
163135377|NCT00534976|589204153|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
163135378|NCT02147288|589204154|FG000|Overall Study|post-operative hematoma|1|||
163135379|NCT02147288|589204155|FG001|Overall Study|post-operative hematoma|1|||
163135380|NCT02147288|589204156|FG002|Overall Study|post-operative hematoma|0|||
163135381|NCT02147288|589204157|FG003|Overall Study|post-operative hematoma|0|||
163135382|NCT02147288|589204158|FG004|Overall Study|post-operative hematoma|0|||
163135383|NCT02147288|589204159|FG005|Overall Study|post-operative hematoma|0|||
163135384|NCT02147288|589204160|FG006|Overall Study|post-operative hematoma|0|||
163135385|NCT02147288|589204161|FG007|Overall Study|post-operative hematoma|0|||
163135386|NCT02147288|589204162|FG008|Overall Study|post-operative hematoma|0|||
163135387|NCT02147288|589204163|FG009|Overall Study|post-operative hematoma|0|||
163135388|NCT02147288|589204154|FG000|Overall Study|complications from concurrent hernia rep|0|||
163135389|NCT02147288|589204155|FG001|Overall Study|complications from concurrent hernia rep|1|||
163135390|NCT02147288|589204156|FG002|Overall Study|complications from concurrent hernia rep|0|||
163135391|NCT02147288|589204157|FG003|Overall Study|complications from concurrent hernia rep|0|||
163135392|NCT02147288|589204158|FG004|Overall Study|complications from concurrent hernia rep|0|||
163135393|NCT02147288|589204159|FG005|Overall Study|complications from concurrent hernia rep|0|||
163135394|NCT02147288|589204160|FG006|Overall Study|complications from concurrent hernia rep|0|||
163135395|NCT02147288|589204161|FG007|Overall Study|complications from concurrent hernia rep|0|||
163135396|NCT02147288|589204162|FG008|Overall Study|complications from concurrent hernia rep|0|||
163135397|NCT02147288|589204163|FG009|Overall Study|complications from concurrent hernia rep|0|||
163135398|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Adverse Event|33|||
163135399|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
163135400|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
163135401|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
163135402|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Physician Decision|6|||
163135403|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
163135404|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
163135405|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
163135406|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
163135407|NCT00965419|589204164|FG000|Follow-up Phase|Adverse Event|9|||
163135408|NCT00965419|589204164|FG000|Follow-up Phase|Protocol Violation|4|||
163135409|NCT00965419|589204164|FG000|Follow-up Phase|Withdrawal by Subject|8|||
163135410|NCT00965419|589204164|FG000|Follow-up Phase|Physician Decision|4|||
163135411|NCT00965419|589204164|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
163135412|NCT00965419|589204164|FG000|Follow-up Phase|Lack of Efficacy|28|||
163135413|NCT00264537|589204165|FG000|Overall Study|Death|0|||
163135414|NCT00264537|589204166|FG001|Overall Study|Death|3|||
163135415|NCT00264537|589204167|FG002|Overall Study|Death|3|||
163135416|NCT00264537|589204168|FG003|Overall Study|Death|2|||
163135417|NCT00264537|589204165|FG000|Overall Study|Lost to Follow-up|3|||
163135418|NCT00264537|589204166|FG001|Overall Study|Lost to Follow-up|4|||
163135419|NCT00264537|589204167|FG002|Overall Study|Lost to Follow-up|7|||
163135420|NCT00264537|589204168|FG003|Overall Study|Lost to Follow-up|6|||
163229198|NCT00079274|589551485|FG005|Overall Study|Adverse Event|8|||
163135421|NCT00264537|589204165|FG000|Overall Study|Adverse Event|21|||
163135422|NCT00264537|589204166|FG001|Overall Study|Adverse Event|32|||
163135423|NCT00264537|589204167|FG002|Overall Study|Adverse Event|24|||
163135424|NCT00264537|589204168|FG003|Overall Study|Adverse Event|34|||
163135425|NCT00264537|589204165|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
163135426|NCT00264537|589204166|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
163135427|NCT00264537|589204167|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
163135428|NCT00264537|589204168|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
163135429|NCT00264537|589204165|FG000|Overall Study|Other|21|||
163135430|NCT00264537|589204166|FG001|Overall Study|Other|11|||
163135431|NCT00264537|589204167|FG002|Overall Study|Other|10|||
163135432|NCT00264537|589204168|FG003|Overall Study|Other|11|||
163135433|NCT00264537|589204165|FG000|Overall Study|Not treated|0|||
163135434|NCT00264537|589204166|FG001|Overall Study|Not treated|2|||
163135435|NCT00264537|589204167|FG002|Overall Study|Not treated|1|||
163135436|NCT00264537|589204168|FG003|Overall Study|Not treated|0|||
163135437|NCT00615017|589206064|FG000|Overall Study|Adverse Event|0|||
163135438|NCT00615017|589206065|FG001|Overall Study|Adverse Event|1|||
163135439|NCT00615017|589206066|FG002|Overall Study|Adverse Event|2|||
163135440|NCT00615017|589206067|FG003|Overall Study|Adverse Event|0|||
163135441|NCT00615017|589206068|FG004|Overall Study|Adverse Event|0|||
163135442|NCT00615017|589206069|FG005|Overall Study|Adverse Event|1|||
163135443|NCT00615017|589206064|FG000|Overall Study|Death|0|||
163135444|NCT00615017|589206065|FG001|Overall Study|Death|0|||
163135445|NCT00615017|589206066|FG002|Overall Study|Death|2|||
163135446|NCT00615017|589206067|FG003|Overall Study|Death|0|||
163135447|NCT00615017|589206068|FG004|Overall Study|Death|1|||
163135448|NCT00615017|589206069|FG005|Overall Study|Death|1|||
163135449|NCT00615017|589206064|FG000|Overall Study|Sepsis resolved|0|||
163135450|NCT00615017|589206065|FG001|Overall Study|Sepsis resolved|0|||
163135451|NCT00615017|589206066|FG002|Overall Study|Sepsis resolved|1|||
163135452|NCT00615017|589206067|FG003|Overall Study|Sepsis resolved|0|||
163135453|NCT00615017|589206068|FG004|Overall Study|Sepsis resolved|0|||
163135454|NCT00615017|589206069|FG005|Overall Study|Sepsis resolved|0|||
163135455|NCT00615017|589206064|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
163135456|NCT00615017|589206065|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
163135457|NCT00615017|589206066|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
163135458|NCT00615017|589206067|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
163135459|NCT00615017|589206068|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
163135460|NCT00615017|589206069|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
163135461|NCT00615017|589206064|FG000|Overall Study|Physician discontinued drug|0|||
163135462|NCT00615017|589206065|FG001|Overall Study|Physician discontinued drug|0|||
163135463|NCT00615017|589206066|FG002|Overall Study|Physician discontinued drug|0|||
163135464|NCT00615017|589206067|FG003|Overall Study|Physician discontinued drug|0|||
163135465|NCT00615017|589206068|FG004|Overall Study|Physician discontinued drug|0|||
163135466|NCT00615017|589206069|FG005|Overall Study|Physician discontinued drug|1|||
163135467|NCT00806988|589206070|FG000|Overall Study|Death|15|||
163135468|NCT00806988|589206071|FG001|Overall Study|Death|16|||
163135469|NCT00806988|589206070|FG000|Overall Study|Withdrawal by Subject|8|||
163135470|NCT00806988|589206071|FG001|Overall Study|Withdrawal by Subject|8|||
163135471|NCT00806988|589206070|FG000|Overall Study|Lost to Follow-up|4|||
163135472|NCT00806988|589206071|FG001|Overall Study|Lost to Follow-up|19|||
163135473|NCT04775953|589206073|FG000|Overall Study|Lost to Follow-up|6|||
163135474|NCT04775953|589206074|FG001|Overall Study|Lost to Follow-up|11|||
163135475|NCT04775953|589206073|FG000|Overall Study|Death|5|||
163135476|NCT04775953|589206074|FG001|Overall Study|Death|4|||
163135477|NCT04775953|589206073|FG000|Overall Study|Withdrawal by Subject|3|||
163135478|NCT04775953|589206074|FG001|Overall Study|Withdrawal by Subject|3|||
163135479|NCT04775953|589206073|FG000|Overall Study|Protocol Violation|2|||
163135480|NCT04775953|589206074|FG001|Overall Study|Protocol Violation|0|||
163135481|NCT04775953|589206073|FG000|Overall Study|Participant non-compliance|0|||
163135482|NCT04775953|589206074|FG001|Overall Study|Participant non-compliance|1|||
163135483|NCT01698814|589206075|FG000|Overall Study|Adverse Event|0|||
163135484|NCT01698814|589206076|FG001|Overall Study|Adverse Event|2|||
163135485|NCT01698814|589206075|FG000|Overall Study|Lost to Follow-up|0|||
163135486|NCT01698814|589206076|FG001|Overall Study|Lost to Follow-up|1|||
163135487|NCT01698814|589206075|FG000|Overall Study|Pregnancy|1|||
163135488|NCT01698814|589206076|FG001|Overall Study|Pregnancy|0|||
163135489|NCT01698814|589206075|FG000|Overall Study|Randomized in error|1|||
163135490|NCT01698814|589206076|FG001|Overall Study|Randomized in error|0|||
163135491|NCT00855959|589206077|FG000|Overall Study|Adverse Event|2|||
163135492|NCT00855959|589206077|FG000|Overall Study|Lost to Follow-up|2|||
163135493|NCT00855959|589206077|FG000|Overall Study|Withdrawal by Subject|3|||
163229199|NCT00079274|589551486|FG006|Overall Study|Adverse Event|0|||
163229200|NCT00079274|589551480|FG000|Overall Study|Recurrence|21|||
163345339|NCT03214198|589972129|FG000|Overall Study|Protocol Deviation|18|||
163135494|NCT00855959|589206077|FG000|Overall Study|Pregnancy|1|||
163135495|NCT00855959|589206077|FG000|Overall Study|Incorrect enrolment|1|||
163135496|NCT04014062|589206078|FG000|Period I: Dosing|Medical Grounds|4|||
163135497|NCT04014062|589206079|FG001|Period I: Dosing|Medical Grounds|5|||
163135498|NCT04014062|589206078|FG000|Period I: Dosing|Withdrawal by Subject|3|||
163135499|NCT04014062|589206079|FG001|Period I: Dosing|Withdrawal by Subject|1|||
163135500|NCT01424501|589206080|FG000|Overall Study|Withdrawal by Subject|1|||
163135501|NCT01424501|589206081|FG001|Overall Study|Withdrawal by Subject|0|||
163135502|NCT01424501|589206082|FG002|Overall Study|Withdrawal by Subject|1|||
163229201|NCT00079274|589551481|FG001|Overall Study|Recurrence|0|||
163229202|NCT00079274|589551482|FG002|Overall Study|Recurrence|1|||
163135503|NCT01424501|589206083|FG003|Overall Study|Withdrawal by Subject|0|||
163135504|NCT01424501|589206084|FG004|Overall Study|Withdrawal by Subject|0|||
163135505|NCT01424501|589206085|FG005|Overall Study|Withdrawal by Subject|0|||
163135506|NCT01424501|589206080|FG000|Overall Study|Lost to Follow-up|0|||
163135507|NCT01424501|589206081|FG001|Overall Study|Lost to Follow-up|1|||
163135508|NCT01424501|589206082|FG002|Overall Study|Lost to Follow-up|1|||
163135509|NCT01424501|589206083|FG003|Overall Study|Lost to Follow-up|0|||
163135510|NCT01424501|589206084|FG004|Overall Study|Lost to Follow-up|0|||
163135511|NCT01424501|589206085|FG005|Overall Study|Lost to Follow-up|0|||
163135512|NCT01980095|589206086|FG000|Overall Study|Lost to Follow-up|6|||
163135513|NCT01980095|589206087|FG001|Overall Study|Lost to Follow-up|7|||
163135514|NCT01980095|589206086|FG000|Overall Study|Withdrawal by Subject|2|||
163135515|NCT01980095|589206087|FG001|Overall Study|Withdrawal by Subject|3|||
163135516|NCT01980095|589206086|FG000|Overall Study|Poor compliance|5|||
163135517|NCT01980095|589206087|FG001|Overall Study|Poor compliance|0|||
163135518|NCT01980095|589206086|FG000|Overall Study|Safety issue|0|||
163135519|NCT01980095|589206087|FG001|Overall Study|Safety issue|1|||
163135520|NCT01980095|589206086|FG000|Overall Study|Study drug discontinued|1|||
163135521|NCT01980095|589206087|FG001|Overall Study|Study drug discontinued|0|||
163135522|NCT01980095|589206086|FG000|Overall Study|Randomized by mistake|1|||
163135523|NCT01980095|589206087|FG001|Overall Study|Randomized by mistake|0|||
163135524|NCT02783599|589206094|FG000|Overall Study|Progressive disease|23|||
163135525|NCT02783599|589206094|FG000|Overall Study|Surgical Resection|10|||
163135526|NCT02783599|589206094|FG000|Overall Study|Adverse Event|4|||
163135527|NCT02783599|589206094|FG000|Overall Study|Physician Decision|2|||
163135528|NCT02783599|589206094|FG000|Overall Study|Death|1|||
163135529|NCT00856544|589206095|FG000|Overall Study|Randomized but not treated|3|||
163135530|NCT00856544|589206096|FG001|Overall Study|Randomized but not treated|0|||
163135531|NCT00856544|589206097|FG002|Overall Study|Randomized but not treated|0|||
163135532|NCT00856544|589206098|FG003|Overall Study|Randomized but not treated|0|||
163135533|NCT00856544|589206095|FG000|Overall Study|Death|0|||
163135534|NCT00856544|589206096|FG001|Overall Study|Death|2|||
163135535|NCT00856544|589206097|FG002|Overall Study|Death|0|||
163135536|NCT00856544|589206098|FG003|Overall Study|Death|0|||
163135537|NCT00856544|589206095|FG000|Overall Study|Adverse Event|20|||
163135538|NCT00856544|589206096|FG001|Overall Study|Adverse Event|29|||
163135539|NCT00856544|589206097|FG002|Overall Study|Adverse Event|2|||
163135540|NCT00856544|589206098|FG003|Overall Study|Adverse Event|3|||
163135541|NCT00856544|589206095|FG000|Overall Study|Lack of Efficacy|16|||
163135542|NCT00856544|589206096|FG001|Overall Study|Lack of Efficacy|12|||
163135543|NCT00856544|589206097|FG002|Overall Study|Lack of Efficacy|3|||
163135544|NCT00856544|589206098|FG003|Overall Study|Lack of Efficacy|3|||
163135545|NCT00856544|589206095|FG000|Overall Study|Other|9|||
163135546|NCT00856544|589206096|FG001|Overall Study|Other|16|||
163135547|NCT00856544|589206097|FG002|Overall Study|Other|1|||
163135548|NCT00856544|589206098|FG003|Overall Study|Other|6|||
163135549|NCT00856544|589206095|FG000|Overall Study|Lost to Follow-up|1|||
163135550|NCT00856544|589206096|FG001|Overall Study|Lost to Follow-up|2|||
163135551|NCT00856544|589206097|FG002|Overall Study|Lost to Follow-up|2|||
163135552|NCT00856544|589206098|FG003|Overall Study|Lost to Follow-up|0|||
163135553|NCT00856544|589206095|FG000|Overall Study|Withdrawal by Subject|8|||
163135554|NCT00856544|589206096|FG001|Overall Study|Withdrawal by Subject|5|||
163135555|NCT00856544|589206097|FG002|Overall Study|Withdrawal by Subject|0|||
163135556|NCT00856544|589206098|FG003|Overall Study|Withdrawal by Subject|1|||
163135557|NCT01564732|589206099|FG000|Overall Study|Early termination by the study sponsor|6|||
163135558|NCT01564732|589206100|FG001|Overall Study|Early termination by the study sponsor|5|||
163135559|NCT00394706|589206106|FG000|Overall Study|Withdrawal by Subject|2|||
163135560|NCT00394706|589206107|FG001|Overall Study|Withdrawal by Subject|0|||
163135561|NCT00394706|589206108|FG002|Overall Study|Withdrawal by Subject|1|||
163135562|NCT00394706|589206109|FG003|Overall Study|Withdrawal by Subject|0|||
163135563|NCT00394706|589206110|FG004|Overall Study|Withdrawal by Subject|0|||
163135564|NCT00394706|589206111|FG005|Overall Study|Withdrawal by Subject|2|||
163135565|NCT00394706|589206112|FG006|Overall Study|Withdrawal by Subject|1|||
163135566|NCT00394706|589206113|FG007|Overall Study|Withdrawal by Subject|0|||
163135567|NCT00394706|589206106|FG000|Overall Study|Lost to Follow-up|2|||
163135568|NCT00394706|589206107|FG001|Overall Study|Lost to Follow-up|2|||
163229203|NCT00079274|589551483|FG003|Overall Study|Recurrence|15|||
163229204|NCT00079274|589551484|FG004|Overall Study|Recurrence|0|||
163135569|NCT00394706|589206108|FG002|Overall Study|Lost to Follow-up|8|||
163135570|NCT00394706|589206109|FG003|Overall Study|Lost to Follow-up|1|||
163135571|NCT00394706|589206110|FG004|Overall Study|Lost to Follow-up|2|||
163135572|NCT00394706|589206111|FG005|Overall Study|Lost to Follow-up|5|||
163135573|NCT00394706|589206112|FG006|Overall Study|Lost to Follow-up|2|||
163135574|NCT00394706|589206113|FG007|Overall Study|Lost to Follow-up|0|||
163135575|NCT03920254|589206114|FG000|Overall Study|Adverse Event|1|||
163135576|NCT03920254|589206115|FG001|Overall Study|Adverse Event|0|||
163135577|NCT03920254|589206116|FG002|Overall Study|Adverse Event|0|||
163135578|NCT03920254|589206114|FG000|Overall Study|Physician Decision|0|||
163135579|NCT03920254|589206115|FG001|Overall Study|Physician Decision|1|||
163229205|NCT00079274|589551485|FG005|Overall Study|Recurrence|2|||
163135580|NCT03920254|589206116|FG002|Overall Study|Physician Decision|2|||
163135581|NCT03920254|589206114|FG000|Overall Study|Study Terminated By Sponsor|12|||
163345340|NCT02577315|589972130|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
163345341|NCT02577315|589972131|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
163345342|NCT03686176|589972134|FG000|Overall Study|Procedure cancelled|1|||
163345343|NCT03686176|589972135|FG001|Overall Study|Procedure cancelled|0|||
163345344|NCT03686176|589972136|FG002|Overall Study|Procedure cancelled|0|||
163135582|NCT03920254|589206115|FG001|Overall Study|Study Terminated By Sponsor|17|||
163345345|NCT03686176|589972134|FG000|Overall Study|VR Malfunction|1|||
163345346|NCT03686176|589972135|FG001|Overall Study|VR Malfunction|0|||
163135583|NCT03920254|589206116|FG002|Overall Study|Study Terminated By Sponsor|12|||
163135584|NCT03920254|589206114|FG000|Overall Study|Withdrawal by Subject|0|||
163135585|NCT03920254|589206115|FG001|Overall Study|Withdrawal by Subject|0|||
163135586|NCT03920254|589206116|FG002|Overall Study|Withdrawal by Subject|1|||
163135587|NCT05274269|589206117|FG000|Overall Study|Adverse Event|0|||
163135588|NCT05274269|589206118|FG001|Overall Study|Adverse Event|3|||
163135589|NCT05274269|589206117|FG000|Overall Study|Death|0|||
163135590|NCT05274269|589206118|FG001|Overall Study|Death|1|||
163135591|NCT05274269|589206117|FG000|Overall Study|Other|0|||
163135592|NCT05274269|589206118|FG001|Overall Study|Other|2|||
163135593|NCT05274269|589206117|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
163135594|NCT05274269|589206118|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
163135595|NCT01746368|589206119|FG000|Overall Study|Lost to Follow-up|2|||
163135596|NCT01746368|589206120|FG001|Overall Study|Lost to Follow-up|0|||
163135597|NCT01746368|589206119|FG000|Overall Study|Withdrawal by Subject|0|||
163135598|NCT01746368|589206120|FG001|Overall Study|Withdrawal by Subject|1|||
163135599|NCT05636852|589206121|FG000|Overall Study|Withdrawal by Subject|1|||
163135600|NCT05636852|589206121|FG000|Overall Study|Other than specified|1|||
163135601|NCT03534141|589206122|FG000|Overall Study|Enrolled in other clinical trial|1|||
163135602|NCT03534141|589206123|FG001|Overall Study|Enrolled in other clinical trial|0|||
163135603|NCT03534141|589206122|FG000|Overall Study|Liver transplant aborted after randomization|0|||
163135604|NCT03534141|589206123|FG001|Overall Study|Liver transplant aborted after randomization|2|||
163135605|NCT03534141|589206122|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
163135606|NCT03534141|589206123|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
163135607|NCT00709618|589206124|FG000|Overall Study|Withdrawal by Subject|4|||
163135608|NCT00709618|589206124|FG000|Overall Study|Lost to Follow-up|1|||
163135609|NCT00709618|589206124|FG000|Overall Study|Study Closed/Terminated|25|||
163135610|NCT01415401|589206133|FG000|Overall Study|Adverse Event|5|||
163135611|NCT01415401|589206133|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
163135612|NCT01415401|589206133|FG000|Overall Study|Terminated by Sponsor|1|||
163135613|NCT01746225|589206135|FG000|Overall Study|Death|1|||
163135614|NCT01746225|589206136|FG001|Overall Study|Death|0|||
163135615|NCT01746225|589206137|FG002|Overall Study|Death|1|||
163135616|NCT01746225|589206135|FG000|Overall Study|Withdrawal by Subject|5|||
163135617|NCT01746225|589206136|FG001|Overall Study|Withdrawal by Subject|15|||
163135618|NCT01746225|589206137|FG002|Overall Study|Withdrawal by Subject|19|||
163135619|NCT01746225|589206135|FG000|Overall Study|Physician Decision|14|||
163135620|NCT01746225|589206136|FG001|Overall Study|Physician Decision|11|||
163135621|NCT01746225|589206137|FG002|Overall Study|Physician Decision|3|||
163135622|NCT01746225|589206135|FG000|Overall Study|Adverse Event|15|||
163135623|NCT01746225|589206136|FG001|Overall Study|Adverse Event|12|||
163135624|NCT01746225|589206137|FG002|Overall Study|Adverse Event|17|||
163135625|NCT01746225|589206135|FG000|Overall Study|Continuing Treatment|5|||
163135626|NCT01746225|589206136|FG001|Overall Study|Continuing Treatment|8|||
163135627|NCT01746225|589206137|FG002|Overall Study|Continuing Treatment|3|||
163135628|NCT00595478|589206138|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
163135629|NCT00595478|589206139|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
163135630|NCT00595478|589206138|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
163135631|NCT00595478|589206139|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
163135632|NCT02713828|589206140|FG000|Overall Study|Death|2|||
163135633|NCT02713828|589206141|FG001|Overall Study|Death|0|||
163135634|NCT02713828|589206140|FG000|Overall Study|Withdrawal by Subject|1|||
163135635|NCT02713828|589206141|FG001|Overall Study|Withdrawal by Subject|0|||
163135636|NCT02713828|589206140|FG000|Overall Study|study terminated but patient allowed to|2|||
163135637|NCT02713828|589206141|FG001|Overall Study|study terminated but patient allowed to|0|||
163135638|NCT03302247|589206142|FG000|Overall Study|the study has closed prematurely|2|||
163135639|NCT03302247|589206142|FG000|Overall Study|Death|1|||
163135640|NCT02708355|589206143|FG000|Overall Study|Adverse Event|1|||
163345347|NCT03686176|589972136|FG002|Overall Study|VR Malfunction|0|||
163345348|NCT03530345|589972142|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
163229206|NCT00079274|589551486|FG006|Overall Study|Recurrence|0|||
163345349|NCT03530345|589972143|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
163135641|NCT02708355|589206144|FG001|Overall Study|Adverse Event|0|||
163135642|NCT02708355|589206145|FG002|Overall Study|Adverse Event|0|||
163135643|NCT04090242|589206146|FG000|Overall Study|Withdrawal by Subject|1|||
163135644|NCT04090242|589206147|FG001|Overall Study|Withdrawal by Subject|0|||
163408517|NCT00267748|590205532|FG000|Randomized Period|Objective progression or relapse|0|||
163408518|NCT00267748|590205533|FG001|Randomized Period|Objective progression or relapse|77|||
163408519|NCT00267748|590205534|FG002|Randomized Period|Objective progression or relapse|86|||
163408520|NCT00267748|590205532|FG000|Randomized Period|Withdrawal by Subject|0|||
163135645|NCT02687581|589206148|FG000|Overall Study|Withdrawal by Subject|1|||
163135646|NCT02687581|589206149|FG001|Overall Study|Withdrawal by Subject|0|||
163135647|NCT02687581|589206150|FG002|Overall Study|Withdrawal by Subject|0|||
163135648|NCT02687581|589206151|FG003|Overall Study|Withdrawal by Subject|1|||
163135649|NCT02687581|589206148|FG000|Overall Study|Lost to Follow-up|2|||
163135650|NCT02687581|589206149|FG001|Overall Study|Lost to Follow-up|2|||
163135651|NCT02687581|589206150|FG002|Overall Study|Lost to Follow-up|0|||
163135652|NCT02687581|589206151|FG003|Overall Study|Lost to Follow-up|0|||
163135653|NCT02687581|589206148|FG000|Overall Study|the device is too small for the patient.|1|||
163135654|NCT02687581|589206149|FG001|Overall Study|the device is too small for the patient.|0|||
163135655|NCT02687581|589206150|FG002|Overall Study|the device is too small for the patient.|0|||
163135656|NCT02687581|589206151|FG003|Overall Study|the device is too small for the patient.|0|||
163135657|NCT04405076|589206152|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
163135658|NCT04405076|589206153|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
163135659|NCT04405076|589206154|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
163135660|NCT04405076|589206155|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
163135661|NCT04405076|589206156|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
163135662|NCT04405076|589206157|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
163135663|NCT04405076|589206158|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
163135664|NCT04405076|589206159|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
163135665|NCT04405076|589206160|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
163135666|NCT04405076|589206152|FG000|Part A (Blinded Phase)|Physician Decision|1|||
163135667|NCT04405076|589206153|FG001|Part A (Blinded Phase)|Physician Decision|2|||
163135668|NCT04405076|589206154|FG002|Part A (Blinded Phase)|Physician Decision|0|||
163135669|NCT04405076|589206155|FG003|Part A (Blinded Phase)|Physician Decision|0|||
163135670|NCT04405076|589206156|FG004|Part A (Blinded Phase)|Physician Decision|0|||
163135671|NCT04405076|589206157|FG005|Part A (Blinded Phase)|Physician Decision|0|||
163135672|NCT04405076|589206158|FG006|Part A (Blinded Phase)|Physician Decision|0|||
163135673|NCT04405076|589206159|FG007|Part A (Blinded Phase)|Physician Decision|0|||
163135674|NCT04405076|589206160|FG008|Part A (Blinded Phase)|Physician Decision|0|||
163135675|NCT04405076|589206152|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
163135676|NCT04405076|589206153|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
163135677|NCT04405076|589206154|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
163135678|NCT04405076|589206155|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
163135679|NCT04405076|589206156|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
163135680|NCT04405076|589206157|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
163135681|NCT04405076|589206158|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
163135682|NCT04405076|589206159|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
163135683|NCT04405076|589206160|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
163135684|NCT04405076|589206152|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
163135685|NCT04405076|589206153|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135686|NCT04405076|589206154|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135687|NCT04405076|589206155|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135688|NCT04405076|589206156|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135689|NCT04405076|589206157|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135690|NCT04405076|589206158|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135691|NCT04405076|589206159|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135692|NCT04405076|589206160|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135693|NCT04405076|589206152|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
163135694|NCT04405076|589206153|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
163135695|NCT04405076|589206154|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
163135696|NCT04405076|589206155|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
163135697|NCT04405076|589206156|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
163135698|NCT04405076|589206157|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
163135699|NCT04405076|589206158|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
163135700|NCT04405076|589206159|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
163135701|NCT04405076|589206160|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
163135702|NCT04405076|589206152|FG000|Part A (Blinded Phase)|Other than Specified|0|||
163135703|NCT04405076|589206153|FG001|Part A (Blinded Phase)|Other than Specified|0|||
163135704|NCT04405076|589206154|FG002|Part A (Blinded Phase)|Other than Specified|3|||
163135705|NCT04405076|589206155|FG003|Part A (Blinded Phase)|Other than Specified|0|||
163135706|NCT04405076|589206156|FG004|Part A (Blinded Phase)|Other than Specified|0|||
163408521|NCT00267748|590205533|FG001|Randomized Period|Withdrawal by Subject|9|||
163408522|NCT00267748|590205534|FG002|Randomized Period|Withdrawal by Subject|2|||
163229207|NCT00079274|589551480|FG000|Overall Study|Alternate Treatment|6|||
163408523|NCT00267748|590205532|FG000|Randomized Period|Other|0|||
163345350|NCT03530345|589972142|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
163135707|NCT04405076|589206157|FG005|Part A (Blinded Phase)|Other than Specified|0|||
163135708|NCT04405076|589206158|FG006|Part A (Blinded Phase)|Other than Specified|0|||
163135709|NCT04405076|589206159|FG007|Part A (Blinded Phase)|Other than Specified|0|||
163135710|NCT04405076|589206160|FG008|Part A (Blinded Phase)|Other than Specified|0|||
163135711|NCT04405076|589206152|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
163135712|NCT04405076|589206153|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
163135713|NCT04405076|589206154|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
163135714|NCT04405076|589206155|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
163135715|NCT04405076|589206156|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
163135716|NCT04405076|589206157|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
163135717|NCT04405076|589206158|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
163135718|NCT04405076|589206159|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
163135719|NCT04405076|589206160|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
163135720|NCT04405076|589206152|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135721|NCT04405076|589206153|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135722|NCT04405076|589206154|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135723|NCT04405076|589206155|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135724|NCT04405076|589206156|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
163135725|NCT04405076|589206157|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135726|NCT04405076|589206158|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135727|NCT04405076|589206159|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135728|NCT04405076|589206160|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135729|NCT04405076|589206152|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
163135730|NCT04405076|589206153|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
163135731|NCT04405076|589206154|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
163135732|NCT04405076|589206155|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
163135733|NCT04405076|589206156|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
163135734|NCT04405076|589206157|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
163135735|NCT04405076|589206158|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
163135736|NCT04405076|589206159|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
163135737|NCT04405076|589206160|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
163135738|NCT04405076|589206152|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
163135739|NCT04405076|589206153|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
163135740|NCT04405076|589206154|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
163135741|NCT04405076|589206155|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
163135742|NCT04405076|589206156|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
163135743|NCT04405076|589206157|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
163135744|NCT04405076|589206158|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
163135745|NCT04405076|589206159|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
163135746|NCT04405076|589206160|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
163135747|NCT04405076|589206152|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135748|NCT04405076|589206153|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135749|NCT04405076|589206154|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135750|NCT04405076|589206155|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135751|NCT04405076|589206156|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135752|NCT04405076|589206157|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135753|NCT04405076|589206158|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
163135754|NCT04405076|589206159|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135755|NCT04405076|589206160|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135756|NCT01019369|589206161|FG000|Overall Study|Lost to Follow-up|10|||
163135757|NCT01019369|589206162|FG001|Overall Study|Lost to Follow-up|6|||
163135758|NCT01019369|589206161|FG000|Overall Study|Withdrawal by Subject|0|||
163135759|NCT01019369|589206162|FG001|Overall Study|Withdrawal by Subject|1|||
163135760|NCT02513472|589206163|FG000|Overall Study|Radiological Disease Progression|45|||
163135761|NCT02513472|589206164|FG001|Overall Study|Radiological Disease Progression|57|||
163135762|NCT02513472|589206163|FG000|Overall Study|Clinical Disease Progression|5|||
163135763|NCT02513472|589206164|FG001|Overall Study|Clinical Disease Progression|13|||
163135764|NCT02513472|589206163|FG000|Overall Study|Adverse Event|8|||
163135765|NCT02513472|589206164|FG001|Overall Study|Adverse Event|11|||
163135766|NCT02513472|589206163|FG000|Overall Study|Withdrawal by Subject|0|||
163135767|NCT02513472|589206164|FG001|Overall Study|Withdrawal by Subject|4|||
163135768|NCT02513472|589206163|FG000|Overall Study|Subject Choice|2|||
163345351|NCT03530345|589972143|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
163345352|NCT03530345|589972142|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
163135769|NCT02513472|589206164|FG001|Overall Study|Subject Choice|7|||
163135770|NCT02513472|589206163|FG000|Overall Study|Treatment Completed as per Protocol|3|||
163135771|NCT02513472|589206164|FG001|Overall Study|Treatment Completed as per Protocol|3|||
163135772|NCT02513472|589206163|FG000|Overall Study|Other|3|||
163135773|NCT02513472|589206164|FG001|Overall Study|Other|6|||
163135774|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
163135775|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
163135776|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
163135777|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Death|0|||
163135778|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Death|2|||
163135779|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Death|0|||
163135780|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
163135781|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
163135782|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
163135783|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
163135784|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
163135785|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
163135786|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
163135787|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
163135788|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
163135789|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
163135790|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
163135791|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
163135792|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
163135793|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
163135794|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
163135795|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Recovery|1|||
163135796|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Recovery|0|||
163135797|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Recovery|1|||
163135798|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
163135799|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
163135800|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
163135801|NCT00195663|589206165|FG000|Open-Label Extension Period|Adverse Event|21|||
163135802|NCT00195663|589206166|FG001|Open-Label Extension Period|Adverse Event|32|||
163135803|NCT00195663|589206167|FG002|Open-Label Extension Period|Adverse Event|36|||
163135804|NCT00195663|589206165|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
163135805|NCT00195663|589206166|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
163135806|NCT00195663|589206167|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
163135807|NCT00195663|589206165|FG000|Open-Label Extension Period|Recovery|0|||
163135808|NCT00195663|589206166|FG001|Open-Label Extension Period|Recovery|2|||
163135809|NCT00195663|589206167|FG002|Open-Label Extension Period|Recovery|2|||
163135810|NCT00195663|589206165|FG000|Open-Label Extension Period|Protocol Violation|3|||
163135811|NCT00195663|589206166|FG001|Open-Label Extension Period|Protocol Violation|4|||
163135812|NCT00195663|589206167|FG002|Open-Label Extension Period|Protocol Violation|4|||
163135813|NCT00195663|589206165|FG000|Open-Label Extension Period|Death|2|||
163135814|NCT00195663|589206166|FG001|Open-Label Extension Period|Death|2|||
163135815|NCT00195663|589206167|FG002|Open-Label Extension Period|Death|2|||
163135816|NCT00195663|589206165|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
163135817|NCT00195663|589206166|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
163135818|NCT00195663|589206167|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
163135819|NCT00195663|589206165|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
163135820|NCT00195663|589206166|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
163135821|NCT00195663|589206167|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
163135822|NCT00195663|589206165|FG000|Open-Label Extension Period|Administrative reasons|11|||
163135823|NCT00195663|589206166|FG001|Open-Label Extension Period|Administrative reasons|11|||
163135824|NCT00195663|589206167|FG002|Open-Label Extension Period|Administrative reasons|13|||
163135825|NCT01380834|589206168|FG000|Overall Study|Physician Decision|1|||
163135826|NCT01380834|589206169|FG001|Overall Study|Physician Decision|0|||
163345353|NCT03530345|589972143|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
163345354|NCT03530345|589972142|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
163345355|NCT03530345|589972143|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
163345356|NCT02442622|589972144|FG000|Overall Study|Withdrawal by Subject|3|||
163135827|NCT03214406|589206170|FG000|Overall Study|did not meet enrollment criteria|9|||
163135828|NCT03214406|589206171|FG001|Overall Study|did not meet enrollment criteria|13|||
163135829|NCT03214406|589206170|FG000|Overall Study|Withdrawal by Subject|1|||
163135830|NCT03214406|589206171|FG001|Overall Study|Withdrawal by Subject|0|||
163135831|NCT03214406|589206170|FG000|Overall Study|Lost to Follow-up|0|||
163135832|NCT03214406|589206171|FG001|Overall Study|Lost to Follow-up|2|||
163135833|NCT00604695|589206172|FG000|Overall Study|Did not receive first bolus.|0|||
163135834|NCT00604695|589206173|FG001|Overall Study|Did not receive first bolus.|4|||
163135835|NCT04310566|589206179|FG000|Period 1|Study Termination due to COVID-19|15|||
163135836|NCT04310566|589206180|FG001|Period 1|Study Termination due to COVID-19|17|||
163135837|NCT04310566|589206179|FG000|Period 1|Protocol Violation|0|||
163135838|NCT04310566|589206180|FG001|Period 1|Protocol Violation|1|||
163135839|NCT04310566|589206179|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
163135840|NCT04310566|589206180|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
163135841|NCT04310566|589206179|FG000|Period 1|Lost to Follow-up|1|||
163135842|NCT04310566|589206180|FG001|Period 1|Lost to Follow-up|0|||
163135843|NCT04310566|589206179|FG000|Period 1|Withdrawal by Subject|0|||
163135844|NCT04310566|589206180|FG001|Period 1|Withdrawal by Subject|1|||
163135845|NCT04310566|589206179|FG000|Period 2|Study Termination|7|||
163135846|NCT04310566|589206180|FG001|Period 2|Study Termination|5|||
163135847|NCT04677504|589206182|FG000|Overall Study|Death|51|||
163135848|NCT04677504|589206183|FG001|Overall Study|Death|49|||
163135849|NCT04677504|589206182|FG000|Overall Study|Progressive Disease|1|||
163135850|NCT04677504|589206183|FG001|Overall Study|Progressive Disease|0|||
163135851|NCT04677504|589206182|FG000|Overall Study|Symptomatic Deterioration|1|||
163135852|NCT04677504|589206183|FG001|Overall Study|Symptomatic Deterioration|0|||
163135853|NCT04677504|589206182|FG000|Overall Study|Withdrawal by Subject|2|||
163135854|NCT04677504|589206183|FG001|Overall Study|Withdrawal by Subject|5|||
163135855|NCT04677504|589206182|FG000|Overall Study|Study Terminated By Sponsor|28|||
163135856|NCT04677504|589206183|FG001|Overall Study|Study Terminated By Sponsor|24|||
163135857|NCT04677504|589206182|FG000|Overall Study|Adverse Event|0|||
163135858|NCT04677504|589206183|FG001|Overall Study|Adverse Event|1|||
163135859|NCT03182907|589206184|FG000|Overall Study|Death|3|||
163135860|NCT03182907|589206185|FG001|Overall Study|Death|0|||
163229208|NCT00079274|589551481|FG001|Overall Study|Alternate Treatment|1|||
163229209|NCT00079274|589551482|FG002|Overall Study|Alternate Treatment|0|||
163135861|NCT03182907|589206184|FG000|Overall Study|Protocol Violation|4|||
163229210|NCT00079274|589551483|FG003|Overall Study|Alternate Treatment|3|||
163229211|NCT00079274|589551484|FG004|Overall Study|Alternate Treatment|0|||
163229212|NCT00079274|589551485|FG005|Overall Study|Alternate Treatment|0|||
163229213|NCT00079274|589551486|FG006|Overall Study|Alternate Treatment|0|||
163229214|NCT00079274|589551480|FG000|Overall Study|Other Medical Problems|6|||
163229215|NCT00079274|589551481|FG001|Overall Study|Other Medical Problems|1|||
163229216|NCT00079274|589551482|FG002|Overall Study|Other Medical Problems|0|||
163229217|NCT00079274|589551483|FG003|Overall Study|Other Medical Problems|7|||
163229218|NCT00079274|589551484|FG004|Overall Study|Other Medical Problems|0|||
163229219|NCT00079274|589551485|FG005|Overall Study|Other Medical Problems|0|||
163229220|NCT00079274|589551486|FG006|Overall Study|Other Medical Problems|0|||
163229221|NCT00079274|589551480|FG000|Overall Study|Death|4|||
163229222|NCT00079274|589551481|FG001|Overall Study|Death|0|||
163229223|NCT00079274|589551482|FG002|Overall Study|Death|1|||
163229224|NCT00079274|589551483|FG003|Overall Study|Death|15|||
163229225|NCT00079274|589551484|FG004|Overall Study|Death|0|||
163229226|NCT00079274|589551485|FG005|Overall Study|Death|0|||
163345357|NCT02442622|589972145|FG001|Overall Study|Withdrawal by Subject|1|||
163345358|NCT02938520|589972146|FG000|Overall Study|On-going at the time of analysis|258|||
163345359|NCT02938520|589972147|FG001|Overall Study|On-going at the time of analysis|261|||
163345360|NCT02938520|589972146|FG000|Overall Study|Physician Decision|2|||
163345361|NCT02938520|589972147|FG001|Overall Study|Physician Decision|5|||
163135862|NCT03182907|589206185|FG001|Overall Study|Protocol Violation|0|||
163135863|NCT03182907|589206184|FG000|Overall Study|Lost to Follow-up|1|||
163135864|NCT03182907|589206185|FG001|Overall Study|Lost to Follow-up|0|||
163135865|NCT03182907|589206184|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163135866|NCT03182907|589206185|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
163135867|NCT01711645|589206188|FG000|Overall Study|Withdrawal by Subject|8|||
163345362|NCT02938520|589972146|FG000|Overall Study|Lost to Follow-up|2|||
163345363|NCT02938520|589972147|FG001|Overall Study|Lost to Follow-up|2|||
163345364|NCT02938520|589972146|FG000|Overall Study|Withdrawal by Subject|7|||
163345365|NCT02938520|589972147|FG001|Overall Study|Withdrawal by Subject|7|||
163135868|NCT01711645|589206188|FG000|Overall Study|Lost to Follow-up|6|||
163135869|NCT01711645|589206188|FG000|Overall Study|Physician Decision|5|||
163135870|NCT00172042|589206194|FG000|Overall Study|Adverse Event|27|||
163135871|NCT00172042|589206195|FG001|Overall Study|Adverse Event|13|||
163135872|NCT00172042|589206194|FG000|Overall Study|Abnormal laboratory value(s)|5|||
163135873|NCT00172042|589206195|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163135874|NCT00172042|589206194|FG000|Overall Study|Abnormal test procedure(s)|0|||
163135875|NCT00172042|589206195|FG001|Overall Study|Abnormal test procedure(s)|3|||
163135876|NCT00172042|589206194|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
163135877|NCT00172042|589206195|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
163229227|NCT00079274|589551486|FG006|Overall Study|Death|0|||
163229228|NCT00079274|589551480|FG000|Overall Study|Cytogenetic resistance|0|||
163229229|NCT00079274|589551481|FG001|Overall Study|Cytogenetic resistance|0|||
163229230|NCT00079274|589551482|FG002|Overall Study|Cytogenetic resistance|0|||
163229231|NCT00079274|589551483|FG003|Overall Study|Cytogenetic resistance|2|||
163229232|NCT00079274|589551484|FG004|Overall Study|Cytogenetic resistance|0|||
163135878|NCT00172042|589206194|FG000|Overall Study|Patient no longer requires study drug|10|||
163135879|NCT00172042|589206195|FG001|Overall Study|Patient no longer requires study drug|8|||
163135880|NCT00172042|589206194|FG000|Overall Study|Protocol Violation|8|||
163135881|NCT00172042|589206195|FG001|Overall Study|Protocol Violation|7|||
163135882|NCT00172042|589206194|FG000|Overall Study|Withdrawal by Subject|37|||
163135883|NCT00172042|589206195|FG001|Overall Study|Withdrawal by Subject|25|||
163135884|NCT00172042|589206194|FG000|Overall Study|Lost to Follow-up|3|||
163135885|NCT00172042|589206195|FG001|Overall Study|Lost to Follow-up|5|||
163135886|NCT00172042|589206194|FG000|Overall Study|Administrative problems|13|||
163135887|NCT00172042|589206195|FG001|Overall Study|Administrative problems|10|||
163135888|NCT00172042|589206194|FG000|Overall Study|Death|42|||
163135889|NCT00172042|589206195|FG001|Overall Study|Death|42|||
163135890|NCT00384332|589206196|FG000|Overall Study|Lost to Follow-up|4|||
163135891|NCT00384332|589206197|FG001|Overall Study|Lost to Follow-up|0|||
163135892|NCT00375518|589206198|FG000|Overall Study|Withdrawal by Subject|2|||
163135893|NCT00375518|589206199|FG001|Overall Study|Withdrawal by Subject|10|||
163135894|NCT00375518|589206198|FG000|Overall Study|Patient Not Treated|6|||
163135895|NCT00375518|589206199|FG001|Overall Study|Patient Not Treated|6|||
163135896|NCT00375518|589206198|FG000|Overall Study|Death|0|||
163135897|NCT00375518|589206199|FG001|Overall Study|Death|1|||
163135898|NCT01771250|589206200|FG000|Period 1|Met exclusion criteria|1|||
163135899|NCT01771250|589206201|FG001|Period 1|Met exclusion criteria|0|||
163135900|NCT02058563|589206202|FG000|Overall Study|Lost to Follow-up|26|||
163135901|NCT02058563|589206203|FG001|Overall Study|Lost to Follow-up|22|||
163135902|NCT02058563|589206202|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
163135903|NCT02058563|589206203|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
163135904|NCT02058563|589206202|FG000|Overall Study|Consent Withdrawal|1|||
163135905|NCT02058563|589206203|FG001|Overall Study|Consent Withdrawal|1|||
163135906|NCT02058563|589206202|FG000|Overall Study|Other (patient incarcerated)|0|||
163135907|NCT02058563|589206203|FG001|Overall Study|Other (patient incarcerated)|1|||
163135908|NCT01180296|589206204|FG000|Overall Study|Protocol Violation|1|||
163135909|NCT01180296|589206205|FG001|Overall Study|Protocol Violation|2|||
163135910|NCT00166439|589206206|FG000|Overall Study|Ineligible|5|||
163135911|NCT02560012|589206207|FG000|Overall Study|Study Terminated|2|||
163135912|NCT00483938|589206208|FG000|Overall Study|Protocol Violation|0|||
163135913|NCT00483938|589206209|FG001|Overall Study|Protocol Violation|0|||
163135914|NCT00483938|589206210|FG002|Overall Study|Protocol Violation|0|||
163135915|NCT00483938|589206211|FG003|Overall Study|Protocol Violation|0|||
163135916|NCT00483938|589206212|FG004|Overall Study|Protocol Violation|0|||
163135917|NCT00483938|589206213|FG005|Overall Study|Protocol Violation|0|||
163135918|NCT00483938|589206214|FG006|Overall Study|Protocol Violation|3|||
163135919|NCT00483938|589206208|FG000|Overall Study|Withdrawal by Subject|1|||
163135920|NCT00483938|589206209|FG001|Overall Study|Withdrawal by Subject|6|||
163135921|NCT00483938|589206210|FG002|Overall Study|Withdrawal by Subject|0|||
163135922|NCT00483938|589206211|FG003|Overall Study|Withdrawal by Subject|0|||
163135923|NCT00483938|589206212|FG004|Overall Study|Withdrawal by Subject|1|||
163135924|NCT00483938|589206213|FG005|Overall Study|Withdrawal by Subject|3|||
163135925|NCT00483938|589206214|FG006|Overall Study|Withdrawal by Subject|2|||
163135926|NCT00483938|589206208|FG000|Overall Study|Lost to Follow-up|1|||
163135927|NCT00483938|589206209|FG001|Overall Study|Lost to Follow-up|2|||
163135928|NCT00483938|589206210|FG002|Overall Study|Lost to Follow-up|0|||
163135929|NCT00483938|589206211|FG003|Overall Study|Lost to Follow-up|2|||
163135930|NCT00483938|589206212|FG004|Overall Study|Lost to Follow-up|1|||
163135931|NCT00483938|589206213|FG005|Overall Study|Lost to Follow-up|1|||
163135932|NCT00483938|589206214|FG006|Overall Study|Lost to Follow-up|3|||
163135933|NCT00483938|589206208|FG000|Overall Study|Death|0|||
163135934|NCT00483938|589206209|FG001|Overall Study|Death|2|||
163135935|NCT00483938|589206210|FG002|Overall Study|Death|0|||
163135936|NCT00483938|589206211|FG003|Overall Study|Death|0|||
163135937|NCT00483938|589206212|FG004|Overall Study|Death|0|||
163135938|NCT00483938|589206213|FG005|Overall Study|Death|0|||
163135939|NCT00483938|589206214|FG006|Overall Study|Death|0|||
163135940|NCT00483938|589206208|FG000|Overall Study|Other|3|||
163135941|NCT00483938|589206209|FG001|Overall Study|Other|9|||
163135942|NCT00483938|589206210|FG002|Overall Study|Other|0|||
163135943|NCT00483938|589206211|FG003|Overall Study|Other|4|||
163135944|NCT00483938|589206212|FG004|Overall Study|Other|0|||
163135945|NCT00483938|589206213|FG005|Overall Study|Other|4|||
163135946|NCT00483938|589206214|FG006|Overall Study|Other|32|||
163135947|NCT03052816|589206217|FG000|Overall Study|Withdrawal by Subject|1|||
163135948|NCT03052816|589206218|FG001|Overall Study|Withdrawal by Subject|0|||
163408524|NCT00267748|590205533|FG001|Randomized Period|Other|9|||
163135949|NCT03052816|589206217|FG000|Overall Study|Desired opioids|2|||
163135950|NCT03052816|589206218|FG001|Overall Study|Desired opioids|0|||
163135951|NCT00042991|589206219|FG000|Overall Study|Adverse Event|1|||
163135952|NCT00042991|589206220|FG001|Overall Study|Adverse Event|4|||
163135953|NCT00042991|589206221|FG002|Overall Study|Adverse Event|2|||
163135954|NCT00042991|589206222|FG003|Overall Study|Adverse Event|0|||
163135955|NCT00042991|589206223|FG004|Overall Study|Adverse Event|0|||
163135956|NCT00042991|589206224|FG005|Overall Study|Adverse Event|1|||
163135957|NCT00042991|589206225|FG006|Overall Study|Adverse Event|0|||
163135958|NCT00042991|589206219|FG000|Overall Study|Withdrawal by Subject|0|||
163135959|NCT00042991|589206220|FG001|Overall Study|Withdrawal by Subject|7|||
163135960|NCT00042991|589206221|FG002|Overall Study|Withdrawal by Subject|2|||
163135961|NCT00042991|589206222|FG003|Overall Study|Withdrawal by Subject|0|||
163135962|NCT00042991|589206223|FG004|Overall Study|Withdrawal by Subject|1|||
163135963|NCT00042991|589206224|FG005|Overall Study|Withdrawal by Subject|0|||
163135964|NCT00042991|589206225|FG006|Overall Study|Withdrawal by Subject|0|||
163135965|NCT00042991|589206219|FG000|Overall Study|Disease Progression|5|||
163135966|NCT00042991|589206220|FG001|Overall Study|Disease Progression|29|||
163135967|NCT00042991|589206221|FG002|Overall Study|Disease Progression|2|||
163135968|NCT00042991|589206222|FG003|Overall Study|Disease Progression|2|||
163135969|NCT00042991|589206223|FG004|Overall Study|Disease Progression|1|||
163135970|NCT00042991|589206224|FG005|Overall Study|Disease Progression|4|||
163135971|NCT00042991|589206225|FG006|Overall Study|Disease Progression|2|||
163135972|NCT00042991|589206219|FG000|Overall Study|Alternative Therapy|0|||
163135973|NCT00042991|589206220|FG001|Overall Study|Alternative Therapy|0|||
163135974|NCT00042991|589206221|FG002|Overall Study|Alternative Therapy|0|||
163135975|NCT00042991|589206222|FG003|Overall Study|Alternative Therapy|0|||
163135976|NCT00042991|589206223|FG004|Overall Study|Alternative Therapy|1|||
163135977|NCT00042991|589206224|FG005|Overall Study|Alternative Therapy|0|||
163135978|NCT00042991|589206225|FG006|Overall Study|Alternative Therapy|0|||
163135979|NCT03369236|589206228|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
163135980|NCT03369236|589206229|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
163135981|NCT03369236|589206228|FG000|Open-label Extension Period|Lack of Efficacy|2|||
163135982|NCT03369236|589206229|FG001|Open-label Extension Period|Lack of Efficacy|1|||
163135983|NCT03369236|589206228|FG000|Open-label Extension Period|Adverse Event|0|||
163135984|NCT03369236|589206229|FG001|Open-label Extension Period|Adverse Event|1|||
163135985|NCT03369236|589206228|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
163135986|NCT03369236|589206229|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
163135987|NCT02508428|589206235|FG000|Overall Study|Death|32|||
163135988|NCT02508428|589206236|FG001|Overall Study|Death|33|||
163135989|NCT02508428|589206235|FG000|Overall Study|Liner revised|3|||
163135990|NCT02508428|589206236|FG001|Overall Study|Liner revised|19|||
163135991|NCT02508428|589206235|FG000|Overall Study|Incomplete follow-up|17|||
163135992|NCT02508428|589206236|FG001|Overall Study|Incomplete follow-up|15|||
163135993|NCT00368641|589207762|FG000|Overall Study|Adverse Event|2|||
163135994|NCT00368641|589207763|FG001|Overall Study|Adverse Event|1|||
163135995|NCT00368641|589207762|FG000|Overall Study|Death|1|||
163135996|NCT00368641|589207763|FG001|Overall Study|Death|0|||
163135997|NCT00368641|589207762|FG000|Overall Study|Withdrawal by Subject|1|||
163135998|NCT00368641|589207763|FG001|Overall Study|Withdrawal by Subject|0|||
163135999|NCT00368641|589207762|FG000|Overall Study|Sponsor decision to terminate study|2|||
163136000|NCT00368641|589207763|FG001|Overall Study|Sponsor decision to terminate study|5|||
163136001|NCT04343755|589207764|FG000|Overall Study|Death|11|||
163136002|NCT04343755|589207764|FG000|Overall Study|Screen Failure|1|||
163136003|NCT00108862|589207765|FG000|Overall Study|Death|31|||
163136004|NCT00108862|589207766|FG001|Overall Study|Death|37|||
163136005|NCT00108862|589207765|FG000|Overall Study|Withdrawal by Subject|10|||
163136006|NCT00108862|589207766|FG001|Overall Study|Withdrawal by Subject|6|||
163136007|NCT00108862|589207765|FG000|Overall Study|Lost to Follow-up|27|||
163136008|NCT00108862|589207766|FG001|Overall Study|Lost to Follow-up|19|||
163136009|NCT00687804|589207769|FG000|Core Study|Adverse Event|5|||
163136010|NCT00687804|589207770|FG001|Core Study|Adverse Event|3|||
163136011|NCT00687804|589207771|FG002|Core Study|Adverse Event|3|||
163136012|NCT00687804|589207769|FG000|Core Study|Abnormal laboratory value(s)|1|||
163136013|NCT00687804|589207770|FG001|Core Study|Abnormal laboratory value(s)|0|||
163136014|NCT00687804|589207771|FG002|Core Study|Abnormal laboratory value(s)|0|||
163136015|NCT00687804|589207769|FG000|Core Study|Lack of Efficacy|1|||
163136016|NCT00687804|589207770|FG001|Core Study|Lack of Efficacy|1|||
163136017|NCT00687804|589207771|FG002|Core Study|Lack of Efficacy|1|||
163136018|NCT00687804|589207769|FG000|Core Study|Withdrawal by Subject|4|||
163136019|NCT00687804|589207770|FG001|Core Study|Withdrawal by Subject|7|||
163136020|NCT00687804|589207771|FG002|Core Study|Withdrawal by Subject|7|||
163136021|NCT00687804|589207769|FG000|Core Study|Lost to Follow-up|0|||
163136022|NCT00687804|589207770|FG001|Core Study|Lost to Follow-up|1|||
163136023|NCT00687804|589207771|FG002|Core Study|Lost to Follow-up|0|||
163136024|NCT00687804|589207769|FG000|Core Study|Death|2|||
163136025|NCT00687804|589207770|FG001|Core Study|Death|2|||
163136026|NCT00687804|589207771|FG002|Core Study|Death|2|||
163136027|NCT00687804|589207769|FG000|Core Study|Protocol Violation|1|||
163136028|NCT00687804|589207770|FG001|Core Study|Protocol Violation|1|||
163136029|NCT00687804|589207771|FG002|Core Study|Protocol Violation|0|||
163136030|NCT00687804|589207769|FG000|Open-Label Extension Study|Adverse Event|2|||
163136031|NCT00687804|589207770|FG001|Open-Label Extension Study|Adverse Event|2|||
163136032|NCT00687804|589207771|FG002|Open-Label Extension Study|Adverse Event|2|||
163136033|NCT00687804|589207769|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
163136034|NCT00687804|589207770|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
163345366|NCT02938520|589972146|FG000|Overall Study|Protocol Violation|0|||
163136035|NCT00687804|589207771|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
163136036|NCT00687804|589207769|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
163136037|NCT00687804|589207770|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
163136038|NCT00687804|589207771|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
163136039|NCT00687804|589207769|FG000|Open-Label Extension Study|Administrative problems|1|||
163136040|NCT00687804|589207770|FG001|Open-Label Extension Study|Administrative problems|1|||
163136041|NCT00687804|589207771|FG002|Open-Label Extension Study|Administrative problems|0|||
163136042|NCT00687804|589207769|FG000|Open-Label Extension Study|Death|2|||
163136043|NCT00687804|589207770|FG001|Open-Label Extension Study|Death|3|||
163136044|NCT00687804|589207771|FG002|Open-Label Extension Study|Death|3|||
163136045|NCT04390880|589207772|FG000|Overall Study|Withdrawal by Subject|1|||
163136046|NCT02557542|589207773|FG000|Overall Study|Poor recruitment|3|||
163136047|NCT02557542|589207774|FG001|Overall Study|Poor recruitment|0|||
163136048|NCT00195091|589207775|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
163136049|NCT00475709|589207779|FG000|Overall Study|Did not meet eligibility criteria|8|||
163136050|NCT00475709|589207779|FG000|Overall Study|Death|41|||
163136051|NCT00475709|589207779|FG000|Overall Study|Device Explant|6|||
163136052|NCT00475709|589207779|FG000|Overall Study|Lost to Follow-up|21|||
163136053|NCT00555672|589207782|FG000|Overall Study|Death|0|||
163136054|NCT00555672|589207783|FG001|Overall Study|Death|2|||
163136055|NCT00555672|589207782|FG000|Overall Study|Adverse Event|8|||
163136056|NCT00555672|589207783|FG001|Overall Study|Adverse Event|2|||
163136057|NCT00555672|589207782|FG000|Overall Study|Objective progression or relapse|11|||
163136058|NCT00555672|589207783|FG001|Overall Study|Objective progression or relapse|5|||
163136059|NCT00555672|589207782|FG000|Overall Study|Other|3|||
163136060|NCT00555672|589207783|FG001|Overall Study|Other|1|||
163136061|NCT00555672|589207782|FG000|Overall Study|Participant refused|2|||
163136062|NCT00555672|589207783|FG001|Overall Study|Participant refused|0|||
163136063|NCT04526145|589207784|FG000|Overall Study|Withdrawal by Subject|5|||
163136064|NCT02305238|589207791|FG000|Overall Study|Death|2|||
163136065|NCT02305238|589207792|FG001|Overall Study|Death|1|||
163136066|NCT02305238|589207793|FG002|Overall Study|Death|0|||
163136067|NCT02305238|589207791|FG000|Overall Study|Progressive disease|4|||
163136068|NCT02305238|589207792|FG001|Overall Study|Progressive disease|4|||
163136069|NCT02305238|589207793|FG002|Overall Study|Progressive disease|0|||
163136070|NCT02305238|589207791|FG000|Overall Study|Logistical difficulties|1|||
163136071|NCT02305238|589207792|FG001|Overall Study|Logistical difficulties|3|||
163136072|NCT02305238|589207793|FG002|Overall Study|Logistical difficulties|0|||
163136073|NCT02305238|589207791|FG000|Overall Study|Protocol Violation|0|||
163136074|NCT02305238|589207792|FG001|Overall Study|Protocol Violation|3|||
163136075|NCT02305238|589207793|FG002|Overall Study|Protocol Violation|0|||
163136076|NCT02305238|589207791|FG000|Overall Study|Physician Decision|2|||
163136077|NCT02305238|589207792|FG001|Overall Study|Physician Decision|1|||
163136078|NCT02305238|589207793|FG002|Overall Study|Physician Decision|0|||
163136079|NCT02305238|589207791|FG000|Overall Study|Adverse Event|4|||
163136080|NCT02305238|589207792|FG001|Overall Study|Adverse Event|2|||
163136081|NCT02305238|589207793|FG002|Overall Study|Adverse Event|0|||
163136082|NCT02305238|589207791|FG000|Overall Study|Withdrawal by Subject|3|||
163136083|NCT02305238|589207792|FG001|Overall Study|Withdrawal by Subject|4|||
163136084|NCT02305238|589207793|FG002|Overall Study|Withdrawal by Subject|0|||
163136085|NCT02305238|589207791|FG000|Overall Study|Randomized failure|0|||
163136086|NCT02305238|589207792|FG001|Overall Study|Randomized failure|0|||
163136087|NCT02305238|589207793|FG002|Overall Study|Randomized failure|8|||
163136088|NCT02305238|589207791|FG000|Overall Study|Required procedure failed|0|||
163136089|NCT02305238|589207792|FG001|Overall Study|Required procedure failed|1|||
163136090|NCT02305238|589207793|FG002|Overall Study|Required procedure failed|0|||
163136091|NCT01746173|589207794|FG000|Overall Study|Disease Progression|2|||
163136092|NCT02218008|589207797|FG000|Stage 1 (S1)|Adverse Event|6|||
163136093|NCT02218008|589207798|FG001|Stage 1 (S1)|Adverse Event|5|||
163136094|NCT02218008|589207799|FG002|Stage 1 (S1)|Adverse Event|11|||
163136095|NCT02218008|589207800|FG003|Stage 1 (S1)|Adverse Event|0|||
163136096|NCT02218008|589207801|FG004|Stage 1 (S1)|Adverse Event|0|||
163136097|NCT02218008|589207802|FG005|Stage 1 (S1)|Adverse Event|0|||
163136098|NCT02218008|589207797|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
163136099|NCT02218008|589207798|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
163136100|NCT02218008|589207799|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
163136101|NCT02218008|589207800|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
163136102|NCT02218008|589207801|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
163136103|NCT02218008|589207802|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
163136104|NCT02218008|589207797|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
163136105|NCT02218008|589207798|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
163136106|NCT02218008|589207799|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
163136107|NCT02218008|589207800|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
163136108|NCT02218008|589207801|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
163136109|NCT02218008|589207802|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
163136110|NCT02218008|589207797|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
163136111|NCT02218008|589207798|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
163136112|NCT02218008|589207799|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
163136113|NCT02218008|589207800|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
163136114|NCT02218008|589207801|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
163136115|NCT02218008|589207802|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
163136116|NCT02218008|589207797|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
163136117|NCT02218008|589207798|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
163136118|NCT02218008|589207799|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
163136119|NCT02218008|589207800|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
163136120|NCT02218008|589207801|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
163136121|NCT02218008|589207802|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
163136122|NCT02218008|589207797|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
163136123|NCT02218008|589207798|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
163136124|NCT02218008|589207799|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
163136125|NCT02218008|589207800|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
163136126|NCT02218008|589207801|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
163136127|NCT02218008|589207802|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
163136128|NCT02218008|589207797|FG000|Stage 1 (S1)|Pregnancy|0|||
163136129|NCT02218008|589207798|FG001|Stage 1 (S1)|Pregnancy|0|||
163136130|NCT02218008|589207799|FG002|Stage 1 (S1)|Pregnancy|1|||
163136131|NCT02218008|589207800|FG003|Stage 1 (S1)|Pregnancy|0|||
163136132|NCT02218008|589207801|FG004|Stage 1 (S1)|Pregnancy|0|||
163136133|NCT02218008|589207802|FG005|Stage 1 (S1)|Pregnancy|0|||
163136134|NCT02218008|589207797|FG000|Stage 1 (S1)|Protocol Violation|0|||
163136135|NCT02218008|589207798|FG001|Stage 1 (S1)|Protocol Violation|0|||
163136136|NCT02218008|589207799|FG002|Stage 1 (S1)|Protocol Violation|1|||
163136137|NCT02218008|589207800|FG003|Stage 1 (S1)|Protocol Violation|0|||
163136138|NCT02218008|589207801|FG004|Stage 1 (S1)|Protocol Violation|0|||
163136139|NCT02218008|589207802|FG005|Stage 1 (S1)|Protocol Violation|0|||
163136140|NCT02218008|589207797|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
163136141|NCT02218008|589207798|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
163136142|NCT02218008|589207799|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
163136143|NCT02218008|589207800|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
163136144|NCT02218008|589207801|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
163136145|NCT02218008|589207802|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
163136146|NCT02218008|589207797|FG000|Stage 2 (S2)|Adverse Event|0|||
163136147|NCT02218008|589207798|FG001|Stage 2 (S2)|Adverse Event|0|||
163136148|NCT02218008|589207799|FG002|Stage 2 (S2)|Adverse Event|0|||
163136149|NCT02218008|589207800|FG003|Stage 2 (S2)|Adverse Event|2|||
163136150|NCT02218008|589207801|FG004|Stage 2 (S2)|Adverse Event|3|||
163136151|NCT02218008|589207802|FG005|Stage 2 (S2)|Adverse Event|3|||
163136152|NCT02218008|589207797|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
163136153|NCT02218008|589207798|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
163136154|NCT02218008|589207799|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
163136155|NCT02218008|589207800|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
163136156|NCT02218008|589207801|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
163136157|NCT02218008|589207802|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
163136158|NCT02218008|589207797|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
163136159|NCT02218008|589207798|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
163136160|NCT02218008|589207799|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
163136161|NCT02218008|589207800|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
163136162|NCT02218008|589207801|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
163136163|NCT02218008|589207802|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
163136164|NCT02218008|589207797|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
163136165|NCT02218008|589207798|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
163136166|NCT02218008|589207799|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
163136167|NCT02218008|589207800|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
163136168|NCT02218008|589207801|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
163136169|NCT02218008|589207802|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
163136170|NCT02218008|589207797|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
163136171|NCT02218008|589207798|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
163136172|NCT02218008|589207799|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
163136173|NCT02218008|589207800|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
163136174|NCT02218008|589207801|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
163136175|NCT02218008|589207802|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
163136176|NCT00408434|589207807|FG000|Overall Study|Adverse Event|0|||
163136177|NCT00408434|589207808|FG001|Overall Study|Adverse Event|0|||
163136178|NCT00408434|589207809|FG002|Overall Study|Adverse Event|1|||
163136179|NCT00408434|589207810|FG003|Overall Study|Adverse Event|0|||
163136180|NCT00408434|589207811|FG004|Overall Study|Adverse Event|0|||
163136181|NCT00408434|589207812|FG005|Overall Study|Adverse Event|0|||
163136182|NCT00408434|589207813|FG006|Overall Study|Adverse Event|0|||
163136183|NCT00408434|589207807|FG000|Overall Study|Progressive disease|6|||
163136184|NCT00408434|589207808|FG001|Overall Study|Progressive disease|3|||
163136185|NCT00408434|589207809|FG002|Overall Study|Progressive disease|4|||
163345367|NCT02938520|589972147|FG001|Overall Study|Protocol Violation|1|||
163345368|NCT02938520|589972146|FG000|Overall Study|Lack of Efficacy|5|||
163345369|NCT02938520|589972147|FG001|Overall Study|Lack of Efficacy|3|||
163136186|NCT00408434|589207810|FG003|Overall Study|Progressive disease|3|||
163136187|NCT00408434|589207811|FG004|Overall Study|Progressive disease|3|||
163136188|NCT00408434|589207812|FG005|Overall Study|Progressive disease|1|||
163136189|NCT00408434|589207813|FG006|Overall Study|Progressive disease|4|||
163136190|NCT00408434|589207807|FG000|Overall Study|Other|0|||
163136191|NCT00408434|589207808|FG001|Overall Study|Other|0|||
163136192|NCT00408434|589207809|FG002|Overall Study|Other|1|||
163136193|NCT00408434|589207810|FG003|Overall Study|Other|0|||
163136194|NCT00408434|589207811|FG004|Overall Study|Other|2|||
163136195|NCT00408434|589207812|FG005|Overall Study|Other|1|||
163136196|NCT00408434|589207813|FG006|Overall Study|Other|0|||
163136197|NCT00408434|589207807|FG000|Overall Study|Terminated by Investigator|0|||
163136198|NCT00408434|589207808|FG001|Overall Study|Terminated by Investigator|0|||
163136199|NCT00408434|589207809|FG002|Overall Study|Terminated by Investigator|0|||
163136200|NCT00408434|589207810|FG003|Overall Study|Terminated by Investigator|0|||
163136201|NCT00408434|589207811|FG004|Overall Study|Terminated by Investigator|1|||
163136202|NCT00408434|589207812|FG005|Overall Study|Terminated by Investigator|1|||
163136203|NCT00408434|589207813|FG006|Overall Study|Terminated by Investigator|0|||
163136204|NCT00106353|589207814|FG000|Part 1|Disease progression|3|||
163136205|NCT00106353|589207815|FG001|Part 1|Disease progression|4|||
163136206|NCT00106353|589207816|FG002|Part 1|Disease progression|1|||
163136207|NCT00106353|589207817|FG003|Part 1|Disease progression|3|||
163136208|NCT00106353|589207818|FG004|Part 1|Disease progression|0|||
163136209|NCT00106353|589207819|FG005|Part 1|Disease progression|0|||
163136210|NCT00106353|589207820|FG006|Part 1|Disease progression|0|||
163136211|NCT00106353|589207814|FG000|Part 1|Withdrawal by Subject|0|||
163136212|NCT00106353|589207815|FG001|Part 1|Withdrawal by Subject|0|||
163136213|NCT00106353|589207816|FG002|Part 1|Withdrawal by Subject|1|||
163136214|NCT00106353|589207817|FG003|Part 1|Withdrawal by Subject|2|||
163136215|NCT00106353|589207818|FG004|Part 1|Withdrawal by Subject|0|||
163136216|NCT00106353|589207819|FG005|Part 1|Withdrawal by Subject|0|||
163136217|NCT00106353|589207820|FG006|Part 1|Withdrawal by Subject|0|||
163136218|NCT00106353|589207814|FG000|Part 1|Symptomatic deterioration|0|||
163136219|NCT00106353|589207815|FG001|Part 1|Symptomatic deterioration|0|||
163136220|NCT00106353|589207816|FG002|Part 1|Symptomatic deterioration|1|||
163136221|NCT00106353|589207817|FG003|Part 1|Symptomatic deterioration|0|||
163136222|NCT00106353|589207818|FG004|Part 1|Symptomatic deterioration|0|||
163136223|NCT00106353|589207819|FG005|Part 1|Symptomatic deterioration|0|||
163136224|NCT00106353|589207820|FG006|Part 1|Symptomatic deterioration|0|||
163136225|NCT00106353|589207814|FG000|Part 1|Entered follow-up phase|1|||
163136226|NCT00106353|589207815|FG001|Part 1|Entered follow-up phase|1|||
163136227|NCT00106353|589207816|FG002|Part 1|Entered follow-up phase|0|||
163136228|NCT00106353|589207817|FG003|Part 1|Entered follow-up phase|1|||
163136229|NCT00106353|589207818|FG004|Part 1|Entered follow-up phase|0|||
163136230|NCT00106353|589207819|FG005|Part 1|Entered follow-up phase|0|||
163136231|NCT00106353|589207820|FG006|Part 1|Entered follow-up phase|0|||
163136232|NCT00106353|589207814|FG000|Part 1|Adverse Event|0|||
163136233|NCT00106353|589207815|FG001|Part 1|Adverse Event|0|||
163136234|NCT00106353|589207816|FG002|Part 1|Adverse Event|0|||
163136235|NCT00106353|589207817|FG003|Part 1|Adverse Event|1|||
163136236|NCT00106353|589207818|FG004|Part 1|Adverse Event|0|||
163136237|NCT00106353|589207819|FG005|Part 1|Adverse Event|0|||
163136238|NCT00106353|589207820|FG006|Part 1|Adverse Event|0|||
163136239|NCT00106353|589207814|FG000|Part 2|Disease progression|0|||
163136240|NCT00106353|589207815|FG001|Part 2|Disease progression|0|||
163136241|NCT00106353|589207816|FG002|Part 2|Disease progression|0|||
163136242|NCT00106353|589207817|FG003|Part 2|Disease progression|0|||
163136243|NCT00106353|589207818|FG004|Part 2|Disease progression|8|||
163136244|NCT00106353|589207819|FG005|Part 2|Disease progression|14|||
163136245|NCT00106353|589207820|FG006|Part 2|Disease progression|13|||
163136246|NCT00106353|589207814|FG000|Part 2|Death|0|||
163136247|NCT00106353|589207815|FG001|Part 2|Death|0|||
163136248|NCT00106353|589207816|FG002|Part 2|Death|0|||
163136249|NCT00106353|589207817|FG003|Part 2|Death|0|||
163136250|NCT00106353|589207818|FG004|Part 2|Death|3|||
163136251|NCT00106353|589207819|FG005|Part 2|Death|0|||
163136252|NCT00106353|589207820|FG006|Part 2|Death|1|||
163229233|NCT00079274|589551485|FG005|Overall Study|Cytogenetic resistance|0|||
163136253|NCT00106353|589207814|FG000|Part 2|Symptomatic deterioration|0|||
163229234|NCT00079274|589551486|FG006|Overall Study|Cytogenetic resistance|0|||
163229235|NCT00079274|589551480|FG000|Overall Study|Other|43|||
163229236|NCT00079274|589551481|FG001|Overall Study|Other|7|||
163229237|NCT00079274|589551482|FG002|Overall Study|Other|5|||
163136254|NCT00106353|589207815|FG001|Part 2|Symptomatic deterioration|0|||
163136255|NCT00106353|589207816|FG002|Part 2|Symptomatic deterioration|0|||
163136256|NCT00106353|589207817|FG003|Part 2|Symptomatic deterioration|0|||
163136257|NCT00106353|589207818|FG004|Part 2|Symptomatic deterioration|3|||
163136258|NCT00106353|589207819|FG005|Part 2|Symptomatic deterioration|0|||
163136259|NCT00106353|589207820|FG006|Part 2|Symptomatic deterioration|0|||
163136260|NCT00106353|589207814|FG000|Part 2|Adverse Event|0|||
163136261|NCT00106353|589207815|FG001|Part 2|Adverse Event|0|||
163136262|NCT00106353|589207816|FG002|Part 2|Adverse Event|0|||
163136263|NCT00106353|589207817|FG003|Part 2|Adverse Event|0|||
163229238|NCT00079274|589551483|FG003|Overall Study|Other|55|||
163229239|NCT00079274|589551484|FG004|Overall Study|Other|1|||
163345370|NCT02938520|589972146|FG000|Overall Study|Adverse Event|9|||
163345371|NCT02938520|589972147|FG001|Overall Study|Adverse Event|4|||
163345372|NCT01732627|589973077|FG000|Overall Study|Withdrawal by Subject|1|||
163345373|NCT01732627|589973078|FG001|Overall Study|Withdrawal by Subject|0|||
163345374|NCT02305797|589973079|FG000|Overall Study|Adverse Event|11|||
163345375|NCT02305797|589973080|FG001|Overall Study|Adverse Event|2|||
163345376|NCT02305797|589973079|FG000|Overall Study|Withdrawal by Subject|9|||
163345377|NCT02305797|589973080|FG001|Overall Study|Withdrawal by Subject|10|||
163345378|NCT02305797|589973079|FG000|Overall Study|Lack of Efficacy|6|||
163345379|NCT02305797|589973080|FG001|Overall Study|Lack of Efficacy|0|||
163345380|NCT02305797|589973079|FG000|Overall Study|Lost to Follow-up|5|||
163345381|NCT02305797|589973080|FG001|Overall Study|Lost to Follow-up|11|||
163345382|NCT02305797|589973079|FG000|Overall Study|Pregnancy|0|||
163345383|NCT02305797|589973080|FG001|Overall Study|Pregnancy|2|||
163345384|NCT02305797|589973079|FG000|Overall Study|Noncompliance|14|||
163345385|NCT02305797|589973080|FG001|Overall Study|Noncompliance|12|||
163345386|NCT02305797|589973079|FG000|Overall Study|Reason not collected|0|||
163345387|NCT02305797|589973080|FG001|Overall Study|Reason not collected|1|||
163345388|NCT00449033|589973090|FG000|Treatment Period|Adverse Event|117|||
163345389|NCT00449033|589973091|FG001|Treatment Period|Adverse Event|83|||
163345390|NCT00449033|589973090|FG000|Treatment Period|Death|21|||
163345391|NCT00449033|589973091|FG001|Treatment Period|Death|12|||
163345392|NCT00449033|589973090|FG000|Treatment Period|Lost to Follow-up|0|||
163345393|NCT00449033|589973091|FG001|Treatment Period|Lost to Follow-up|2|||
163345394|NCT00449033|589973090|FG000|Treatment Period|Physician Decision|4|||
163345395|NCT00449033|589973091|FG001|Treatment Period|Physician Decision|5|||
163345396|NCT00449033|589973090|FG000|Treatment Period|Protocol Violation|8|||
163345397|NCT00449033|589973091|FG001|Treatment Period|Protocol Violation|7|||
163345398|NCT00449033|589973090|FG000|Treatment Period|Disease Progression|231|||
163345399|NCT00449033|589973091|FG001|Treatment Period|Disease Progression|288|||
163345400|NCT00449033|589973090|FG000|Treatment Period|Consent Withdrawn|36|||
163345401|NCT00449033|589973091|FG001|Treatment Period|Consent Withdrawn|20|||
163345402|NCT00449033|589973090|FG000|Treatment Period|Amended Protocol Criteria|22|||
163345403|NCT00449033|589973091|FG001|Treatment Period|Amended Protocol Criteria|18|||
163345404|NCT00449033|589973090|FG000|Treatment Period|Non-compliance|7|||
163345405|NCT00449033|589973091|FG001|Treatment Period|Non-compliance|8|||
163345406|NCT00449033|589973090|FG000|Treatment Period|Second Malignancy|0|||
163345407|NCT00449033|589973091|FG001|Treatment Period|Second Malignancy|1|||
163345408|NCT00449033|589973090|FG000|Treatment Period|Reason Missing|0|||
163345409|NCT00449033|589973091|FG001|Treatment Period|Reason Missing|4|||
163345410|NCT00449033|589973090|FG000|Treatment Period|Treatment Ongoing|6|||
163345411|NCT00449033|589973091|FG001|Treatment Period|Treatment Ongoing|4|||
163345412|NCT00449033|589973090|FG000|Follow-up Period|Death|299|||
163345413|NCT00449033|589973091|FG001|Follow-up Period|Death|311|||
163345414|NCT00449033|589973090|FG000|Follow-up Period|Lost to Follow-up|6|||
163345415|NCT00449033|589973091|FG001|Follow-up Period|Lost to Follow-up|10|||
163345416|NCT00449033|589973090|FG000|Follow-up Period|Reason Missing|120|||
163345417|NCT00449033|589973091|FG001|Follow-up Period|Reason Missing|113|||
163345418|NCT04115319|589973092|FG000|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|2|||
163345419|NCT04115319|589973093|FG001|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|0|||
163345420|NCT04115319|589973092|FG000|Overall Study|Withdrawal by participant|17|||
163345421|NCT04115319|589973093|FG001|Overall Study|Withdrawal by participant|9|||
163345422|NCT04115319|589973092|FG000|Overall Study|Geopolitical Conflict Related|2|||
163345423|NCT04115319|589973093|FG001|Overall Study|Geopolitical Conflict Related|1|||
163345424|NCT04115319|589973092|FG000|Overall Study|COVID-19 Related|1|||
163345425|NCT04115319|589973093|FG001|Overall Study|COVID-19 Related|0|||
163345426|NCT04115319|589973092|FG000|Overall Study|Adverse Event|48|||
163345427|NCT04115319|589973093|FG001|Overall Study|Adverse Event|21|||
163345428|NCT04115319|589973092|FG000|Overall Study|Noncompliance with Study Drug|5|||
163345429|NCT04115319|589973093|FG001|Overall Study|Noncompliance with Study Drug|1|||
163345430|NCT04115319|589973092|FG000|Overall Study|Lack of Efficacy|6|||
163345431|NCT04115319|589973093|FG001|Overall Study|Lack of Efficacy|2|||
163345432|NCT04115319|589973092|FG000|Overall Study|Lost to Follow-up|6|||
163345433|NCT04115319|589973093|FG001|Overall Study|Lost to Follow-up|7|||
163345434|NCT04115319|589973092|FG000|Overall Study|Protocol Deviation|5|||
163345435|NCT04115319|589973093|FG001|Overall Study|Protocol Deviation|1|||
163345436|NCT04115319|589973092|FG000|Overall Study|Participant relocated|5|||
163345437|NCT04115319|589973093|FG001|Overall Study|Participant relocated|2|||
163345438|NCT04115319|589973092|FG000|Overall Study|Personal Reasons|0|||
163345439|NCT04115319|589973093|FG001|Overall Study|Personal Reasons|1|||
163345440|NCT04115319|589973092|FG000|Overall Study|Deemed Unsuitable for Participation|1|||
163345441|NCT04115319|589973093|FG001|Overall Study|Deemed Unsuitable for Participation|0|||
163408525|NCT00267748|590205534|FG002|Randomized Period|Other|6|||
163345442|NCT04803214|589973096|FG000|Overall Study|Adverse Event|1|||
163345443|NCT04803214|589973097|FG001|Overall Study|Adverse Event|0|||
163345444|NCT04803214|589973096|FG000|Overall Study|Withdrawal by Subject|1|||
163345445|NCT04803214|589973097|FG001|Overall Study|Withdrawal by Subject|2|||
163136264|NCT00106353|589207818|FG004|Part 2|Adverse Event|0|||
163345446|NCT04803214|589973096|FG000|Overall Study|Lost to Follow-up|2|||
163136265|NCT00106353|589207819|FG005|Part 2|Adverse Event|2|||
163136266|NCT00106353|589207820|FG006|Part 2|Adverse Event|1|||
163136267|NCT00106353|589207814|FG000|Part 2|Other|0|||
163136268|NCT00106353|589207815|FG001|Part 2|Other|0|||
163136269|NCT00106353|589207816|FG002|Part 2|Other|0|||
163136270|NCT00106353|589207817|FG003|Part 2|Other|0|||
163136271|NCT00106353|589207818|FG004|Part 2|Other|1|||
163136272|NCT00106353|589207819|FG005|Part 2|Other|1|||
163136273|NCT00106353|589207820|FG006|Part 2|Other|1|||
163136274|NCT00106353|589207814|FG000|Part 2|Withdrawal by Subject|0|||
163136275|NCT00106353|589207815|FG001|Part 2|Withdrawal by Subject|0|||
163136276|NCT00106353|589207816|FG002|Part 2|Withdrawal by Subject|0|||
163136277|NCT00106353|589207817|FG003|Part 2|Withdrawal by Subject|0|||
163136278|NCT00106353|589207818|FG004|Part 2|Withdrawal by Subject|1|||
163136279|NCT00106353|589207819|FG005|Part 2|Withdrawal by Subject|0|||
163136280|NCT00106353|589207820|FG006|Part 2|Withdrawal by Subject|0|||
163136281|NCT00106353|589207814|FG000|Part 2|Physician Decision|0|||
163136282|NCT00106353|589207815|FG001|Part 2|Physician Decision|0|||
163136283|NCT00106353|589207816|FG002|Part 2|Physician Decision|0|||
163136284|NCT00106353|589207817|FG003|Part 2|Physician Decision|0|||
163136285|NCT00106353|589207818|FG004|Part 2|Physician Decision|0|||
163136286|NCT00106353|589207819|FG005|Part 2|Physician Decision|1|||
163136287|NCT00106353|589207820|FG006|Part 2|Physician Decision|0|||
163136288|NCT04039217|589207821|FG000|Overall Study|Lost to Follow-up|1|||
163136289|NCT01278797|589207822|FG000|Period 1|Adverse Event|0|||
163136290|NCT01278797|589207823|FG001|Period 1|Adverse Event|1|||
163136291|NCT01278797|589207822|FG000|Period 1|Protocol Violation|1|||
163136292|NCT01278797|589207823|FG001|Period 1|Protocol Violation|0|||
163136293|NCT00588354|589207824|FG000|Baseline to 2 Weeks|Adverse Event|1|||
163136294|NCT00588354|589207825|FG001|Baseline to 2 Weeks|Adverse Event|0|||
163136295|NCT00588354|589207824|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
163136296|NCT00588354|589207825|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
163136297|NCT00588354|589207824|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
163136298|NCT00588354|589207825|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
163136299|NCT03364309|589207826|FG000|Induction Period|Adverse Event|4|||
163136300|NCT03364309|589207827|FG001|Induction Period|Adverse Event|0|||
163136301|NCT03364309|589207828|FG002|Induction Period|Adverse Event|1|||
163136302|NCT03364309|589207829|FG003|Induction Period|Adverse Event|0|||
163136303|NCT03364309|589207830|FG004|Induction Period|Adverse Event|0|||
163136304|NCT03364309|589207831|FG005|Induction Period|Adverse Event|0|||
163136305|NCT03364309|589207832|FG006|Induction Period|Adverse Event|0|||
163136306|NCT03364309|589207833|FG007|Induction Period|Adverse Event|0|||
163136307|NCT03364309|589207834|FG008|Induction Period|Adverse Event|0|||
163136308|NCT03364309|589207835|FG009|Induction Period|Adverse Event|0|||
163136309|NCT03364309|589207836|FG010|Induction Period|Adverse Event|0|||
163136310|NCT03364309|589207837|FG011|Induction Period|Adverse Event|0|||
163136311|NCT03364309|589207838|FG012|Induction Period|Adverse Event|0|||
163136312|NCT03364309|589207839|FG013|Induction Period|Adverse Event|0|||
163136313|NCT03364309|589207840|FG014|Induction Period|Adverse Event|0|||
163136314|NCT03364309|589207841|FG015|Induction Period|Adverse Event|0|||
163136315|NCT03364309|589207842|FG016|Induction Period|Adverse Event|0|||
163136316|NCT03364309|589207843|FG017|Induction Period|Adverse Event|0|||
163136317|NCT03364309|589207844|FG018|Induction Period|Adverse Event|0|||
163136318|NCT03364309|589207826|FG000|Induction Period|Withdrawal by Subject|1|||
163136319|NCT03364309|589207827|FG001|Induction Period|Withdrawal by Subject|3|||
163136320|NCT03364309|589207828|FG002|Induction Period|Withdrawal by Subject|0|||
163136321|NCT03364309|589207829|FG003|Induction Period|Withdrawal by Subject|0|||
163136322|NCT03364309|589207830|FG004|Induction Period|Withdrawal by Subject|0|||
163136323|NCT03364309|589207831|FG005|Induction Period|Withdrawal by Subject|0|||
163136324|NCT03364309|589207832|FG006|Induction Period|Withdrawal by Subject|0|||
163136325|NCT03364309|589207833|FG007|Induction Period|Withdrawal by Subject|0|||
163136326|NCT03364309|589207834|FG008|Induction Period|Withdrawal by Subject|0|||
163136327|NCT03364309|589207835|FG009|Induction Period|Withdrawal by Subject|0|||
163136328|NCT03364309|589207836|FG010|Induction Period|Withdrawal by Subject|0|||
163136329|NCT03364309|589207837|FG011|Induction Period|Withdrawal by Subject|0|||
163136330|NCT03364309|589207838|FG012|Induction Period|Withdrawal by Subject|0|||
163345447|NCT04803214|589973097|FG001|Overall Study|Lost to Follow-up|4|||
163345448|NCT04803214|589973096|FG000|Overall Study|Physician Decision|1|||
163136331|NCT03364309|589207839|FG013|Induction Period|Withdrawal by Subject|0|||
163136332|NCT03364309|589207840|FG014|Induction Period|Withdrawal by Subject|0|||
163136333|NCT03364309|589207841|FG015|Induction Period|Withdrawal by Subject|0|||
163136334|NCT03364309|589207842|FG016|Induction Period|Withdrawal by Subject|0|||
163136335|NCT03364309|589207843|FG017|Induction Period|Withdrawal by Subject|0|||
163136336|NCT03364309|589207844|FG018|Induction Period|Withdrawal by Subject|0|||
163136337|NCT03364309|589207826|FG000|Induction Period|Lost to Follow-up|1|||
163136338|NCT03364309|589207827|FG001|Induction Period|Lost to Follow-up|0|||
163136339|NCT03364309|589207828|FG002|Induction Period|Lost to Follow-up|0|||
163136340|NCT03364309|589207829|FG003|Induction Period|Lost to Follow-up|0|||
163136341|NCT03364309|589207830|FG004|Induction Period|Lost to Follow-up|0|||
163229240|NCT00079274|589551485|FG005|Overall Study|Other|2|||
163229241|NCT00079274|589551486|FG006|Overall Study|Other|0|||
163229242|NCT00280566|589551491|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
163229243|NCT00280566|589551492|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
163229244|NCT00280566|589551493|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
163229245|NCT00280566|589551491|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
163229246|NCT00280566|589551492|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
163229247|NCT00280566|589551493|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
163229248|NCT00280566|589551491|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
163229249|NCT00280566|589551492|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
163229250|NCT00280566|589551493|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
163229251|NCT00280566|589551491|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
163229252|NCT00280566|589551492|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
163229253|NCT00280566|589551493|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
163229254|NCT00280566|589551491|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
163229255|NCT00280566|589551492|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
163229256|NCT00280566|589551493|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
163229257|NCT00280566|589551491|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
163229258|NCT00280566|589551492|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
163229259|NCT00280566|589551493|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
163229260|NCT00280566|589551491|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
163229261|NCT00280566|589551492|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
163229262|NCT00280566|589551493|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
163229263|NCT00280566|589551491|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
163229264|NCT00280566|589551492|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
163229265|NCT00280566|589551493|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
163229266|NCT00280566|589551491|FG000|Period 2 Double Blind|Adverse Event|0|||
163229267|NCT00280566|589551492|FG001|Period 2 Double Blind|Adverse Event|11|||
163229268|NCT00280566|589551493|FG002|Period 2 Double Blind|Adverse Event|15|||
163229269|NCT00280566|589551491|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
163229270|NCT00280566|589551492|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
163229271|NCT00280566|589551493|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
163229272|NCT00280566|589551491|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
163229273|NCT00280566|589551492|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
163229274|NCT00280566|589551493|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
163229275|NCT00280566|589551491|FG000|Period 2 Double Blind|miscellaneous|0|||
163229276|NCT00280566|589551492|FG001|Period 2 Double Blind|miscellaneous|10|||
163229277|NCT00280566|589551493|FG002|Period 2 Double Blind|miscellaneous|5|||
163229278|NCT01147653|589551494|FG000|Year 2|Withdrawal by Subject|2|||
163229279|NCT01147653|589551495|FG001|Year 2|Withdrawal by Subject|3|||
163345449|NCT04803214|589973097|FG001|Overall Study|Physician Decision|1|||
163345450|NCT04803214|589973096|FG000|Overall Study|Missed 12 month visit|0|||
163345451|NCT04803214|589973097|FG001|Overall Study|Missed 12 month visit|3|||
163136342|NCT03364309|589207831|FG005|Induction Period|Lost to Follow-up|0|||
163136343|NCT03364309|589207832|FG006|Induction Period|Lost to Follow-up|0|||
163136344|NCT03364309|589207833|FG007|Induction Period|Lost to Follow-up|0|||
163136345|NCT03364309|589207834|FG008|Induction Period|Lost to Follow-up|0|||
163136346|NCT03364309|589207835|FG009|Induction Period|Lost to Follow-up|0|||
163136347|NCT03364309|589207836|FG010|Induction Period|Lost to Follow-up|0|||
163136348|NCT03364309|589207837|FG011|Induction Period|Lost to Follow-up|0|||
163136349|NCT03364309|589207838|FG012|Induction Period|Lost to Follow-up|0|||
163136350|NCT03364309|589207839|FG013|Induction Period|Lost to Follow-up|0|||
163136351|NCT03364309|589207840|FG014|Induction Period|Lost to Follow-up|0|||
163136352|NCT03364309|589207841|FG015|Induction Period|Lost to Follow-up|0|||
163136353|NCT03364309|589207842|FG016|Induction Period|Lost to Follow-up|0|||
163136354|NCT03364309|589207843|FG017|Induction Period|Lost to Follow-up|0|||
163136355|NCT03364309|589207844|FG018|Induction Period|Lost to Follow-up|0|||
163136356|NCT03364309|589207826|FG000|Induction Period|Physician Decision|0|||
163136357|NCT03364309|589207827|FG001|Induction Period|Physician Decision|1|||
163136358|NCT03364309|589207828|FG002|Induction Period|Physician Decision|0|||
163136359|NCT03364309|589207829|FG003|Induction Period|Physician Decision|0|||
163136360|NCT03364309|589207830|FG004|Induction Period|Physician Decision|0|||
163136361|NCT03364309|589207831|FG005|Induction Period|Physician Decision|0|||
163136362|NCT03364309|589207832|FG006|Induction Period|Physician Decision|0|||
163136363|NCT03364309|589207833|FG007|Induction Period|Physician Decision|0|||
163229280|NCT01302392|589551498|FG000|Overall Study|Lost to Follow-up|1|||
163229281|NCT01302392|589551499|FG001|Overall Study|Lost to Follow-up|0|||
163229282|NCT01302392|589551498|FG000|Overall Study|Withdrawal by Subject|6|||
163229283|NCT01302392|589551499|FG001|Overall Study|Withdrawal by Subject|1|||
163229284|NCT00670228|589551500|FG000|Overall Study|Adverse Event|1|||
163229285|NCT00670228|589551501|FG001|Overall Study|Adverse Event|0|||
163229286|NCT00670228|589551500|FG000|Overall Study|Death or MACE|0|||
163229287|NCT00670228|589551501|FG001|Overall Study|Death or MACE|1|||
163229288|NCT00670228|589551500|FG000|Overall Study|Not treated|2|||
163408526|NCT00267748|590205532|FG000|Randomized Period|randomized but not treated|0|||
163408527|NCT00267748|590205533|FG001|Randomized Period|randomized but not treated|0|||
163408528|NCT00267748|590205534|FG002|Randomized Period|randomized but not treated|3|||
163408529|NCT02275338|590205538|FG000|Overall Study|Adverse Event|15|||
163408530|NCT02275338|590205538|FG000|Overall Study|Lack of Efficacy|3|||
163408531|NCT02275338|590205538|FG000|Overall Study|Withdrawal by Subject|4|||
163408532|NCT02275338|590205538|FG000|Overall Study|Disease progression (death)|1|||
163408533|NCT02275338|590205538|FG000|Overall Study|Ineligible to start Phase 2|4|||
163408534|NCT02275338|590205538|FG000|Overall Study|Reason not specified|5|||
163408535|NCT02275338|590205538|FG000|Overall Study|Does not meet entry criteria|1|||
163408536|NCT01100944|590205539|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
163408537|NCT01100944|590205540|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
163408538|NCT01100944|590205541|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
163408539|NCT01100944|590205539|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
163408540|NCT01100944|590205540|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
163408541|NCT01100944|590205541|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
163408542|NCT01100944|590205539|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
163408543|NCT01100944|590205540|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
163408544|NCT01100944|590205541|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
163408545|NCT01100944|590205539|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
163408546|NCT01100944|590205540|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
163408547|NCT01100944|590205541|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
163408548|NCT01665807|590205545|FG000|Overall Study|Withdrawal by Subject|2|||
163408549|NCT01665807|590205546|FG001|Overall Study|Withdrawal by Subject|0|||
163408550|NCT01665807|590205547|FG002|Overall Study|Withdrawal by Subject|1|||
163408551|NCT03603496|590205549|FG000|Overall Study|Death|19|||
163408552|NCT03603496|590205550|FG001|Overall Study|Death|24|||
163408553|NCT03603496|590205549|FG000|Overall Study|Lost to Follow-up|141|||
163408554|NCT03603496|590205550|FG001|Overall Study|Lost to Follow-up|141|||
163408555|NCT03603496|590205549|FG000|Overall Study|Withdrawal by Subject|26|||
163408556|NCT03603496|590205550|FG001|Overall Study|Withdrawal by Subject|20|||
163408557|NCT00004259|590205553|FG000|Overall Study|Protocol Violation|1|||
163408558|NCT00004259|590205554|FG001|Overall Study|Protocol Violation|2|||
163408559|NCT00004259|590205555|FG002|Overall Study|Protocol Violation|0|||
163408560|NCT00004259|590205556|FG003|Overall Study|Protocol Violation|0|||
163408561|NCT00004259|590205553|FG000|Overall Study|Withdrawal by Subject|0|||
163408562|NCT00004259|590205554|FG001|Overall Study|Withdrawal by Subject|2|||
163408563|NCT00004259|590205555|FG002|Overall Study|Withdrawal by Subject|0|||
163408564|NCT00004259|590205556|FG003|Overall Study|Withdrawal by Subject|0|||
163408565|NCT03594227|590205557|FG000|Overall Study|Adverse Event|2|||
163408566|NCT03594227|590205558|FG001|Overall Study|Adverse Event|1|||
163345452|NCT02256488|589973100|FG000|Overall Study|Lost to Follow-up|6|||
163345453|NCT02256488|589973101|FG001|Overall Study|Lost to Follow-up|6|||
163345454|NCT02256488|589973102|FG002|Overall Study|Lost to Follow-up|9|||
163345455|NCT02256488|589973103|FG003|Overall Study|Lost to Follow-up|3|||
163345456|NCT02256488|589973100|FG000|Overall Study|OTHER|1|||
163345457|NCT02256488|589973101|FG001|Overall Study|OTHER|0|||
163345458|NCT02256488|589973102|FG002|Overall Study|OTHER|1|||
163345459|NCT02256488|589973103|FG003|Overall Study|OTHER|1|||
163345460|NCT02256488|589973100|FG000|Overall Study|Withdrawal by Subject|1|||
163345461|NCT02256488|589973101|FG001|Overall Study|Withdrawal by Subject|0|||
163345462|NCT02256488|589973102|FG002|Overall Study|Withdrawal by Subject|0|||
163345463|NCT02256488|589973103|FG003|Overall Study|Withdrawal by Subject|2|||
163345464|NCT03562117|589973104|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
163345465|NCT03562117|589973105|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
163345466|NCT03562117|589973106|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
163345467|NCT03928821|589973107|FG000|Overall Study|Death|0|||
163345468|NCT03928821|589973108|FG001|Overall Study|Death|1|||
163345469|NCT03928821|589973109|FG002|Overall Study|Death|0|||
163408567|NCT03594227|590205559|FG002|Overall Study|Adverse Event|0|||
163408568|NCT03594227|590205560|FG003|Overall Study|Adverse Event|2|||
163408569|NCT03594227|590205557|FG000|Overall Study|Lost to Follow-up|1|||
163408570|NCT03594227|590205558|FG001|Overall Study|Lost to Follow-up|1|||
163408571|NCT03594227|590205559|FG002|Overall Study|Lost to Follow-up|1|||
163408572|NCT03594227|590205560|FG003|Overall Study|Lost to Follow-up|0|||
163408573|NCT03594227|590205557|FG000|Overall Study|Withdrawal by Subject|1|||
163408574|NCT03594227|590205558|FG001|Overall Study|Withdrawal by Subject|1|||
163408575|NCT03594227|590205559|FG002|Overall Study|Withdrawal by Subject|1|||
163408576|NCT03594227|590205560|FG003|Overall Study|Withdrawal by Subject|1|||
163408577|NCT03594227|590205557|FG000|Overall Study|Pregnancy|0|||
163345470|NCT03928821|589973110|FG003|Overall Study|Death|0|||
163345471|NCT03928821|589973107|FG000|Overall Study|Lost to Follow-up|0|||
163345472|NCT03928821|589973108|FG001|Overall Study|Lost to Follow-up|2|||
163345473|NCT03928821|589973109|FG002|Overall Study|Lost to Follow-up|3|||
163345474|NCT03928821|589973110|FG003|Overall Study|Lost to Follow-up|0|||
163345475|NCT03928821|589973107|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
163229289|NCT00670228|589551501|FG001|Overall Study|Not treated|2|||
163229290|NCT00670228|589551500|FG000|Overall Study|Not meeting the selection criteria|2|||
163229291|NCT00670228|589551501|FG001|Overall Study|Not meeting the selection criteria|0|||
163229292|NCT03604692|589551502|FG000|Overall Study|Investigator's Decision|0|||
163229293|NCT03604692|589551503|FG001|Overall Study|Investigator's Decision|0|||
163229294|NCT03604692|589551504|FG002|Overall Study|Investigator's Decision|0|||
163229295|NCT03604692|589551505|FG003|Overall Study|Investigator's Decision|1|||
163229296|NCT03604692|589551506|FG004|Overall Study|Investigator's Decision|0|||
163229297|NCT03604692|589551507|FG005|Overall Study|Investigator's Decision|7|||
163229298|NCT03604692|589551502|FG000|Overall Study|Withdrawal by Subject|0|||
163229299|NCT03604692|589551503|FG001|Overall Study|Withdrawal by Subject|0|||
163229300|NCT03604692|589551504|FG002|Overall Study|Withdrawal by Subject|0|||
163229301|NCT03604692|589551505|FG003|Overall Study|Withdrawal by Subject|0|||
163229302|NCT03604692|589551506|FG004|Overall Study|Withdrawal by Subject|0|||
163229303|NCT03604692|589551507|FG005|Overall Study|Withdrawal by Subject|2|||
163229304|NCT03604692|589551502|FG000|Overall Study|Progressive Disease|1|||
163229305|NCT03604692|589551503|FG001|Overall Study|Progressive Disease|0|||
163229306|NCT03604692|589551504|FG002|Overall Study|Progressive Disease|1|||
163229307|NCT03604692|589551505|FG003|Overall Study|Progressive Disease|0|||
163229308|NCT03604692|589551506|FG004|Overall Study|Progressive Disease|3|||
163229309|NCT03604692|589551507|FG005|Overall Study|Progressive Disease|4|||
163229310|NCT03604692|589551502|FG000|Overall Study|Difficulty Coming into Site|0|||
163229311|NCT03604692|589551503|FG001|Overall Study|Difficulty Coming into Site|0|||
163229312|NCT03604692|589551504|FG002|Overall Study|Difficulty Coming into Site|0|||
163229313|NCT03604692|589551505|FG003|Overall Study|Difficulty Coming into Site|0|||
163229314|NCT03604692|589551506|FG004|Overall Study|Difficulty Coming into Site|0|||
163229315|NCT03604692|589551507|FG005|Overall Study|Difficulty Coming into Site|1|||
163229316|NCT03604692|589551502|FG000|Overall Study|Death|0|||
163229317|NCT03604692|589551503|FG001|Overall Study|Death|0|||
163229318|NCT03604692|589551504|FG002|Overall Study|Death|1|||
163229319|NCT03604692|589551505|FG003|Overall Study|Death|0|||
163229320|NCT03604692|589551506|FG004|Overall Study|Death|0|||
163229321|NCT03604692|589551507|FG005|Overall Study|Death|0|||
163229322|NCT03604692|589551502|FG000|Overall Study|Drug Intolerance|0|||
163229323|NCT03604692|589551503|FG001|Overall Study|Drug Intolerance|0|||
163229324|NCT03604692|589551504|FG002|Overall Study|Drug Intolerance|0|||
163229325|NCT03604692|589551505|FG003|Overall Study|Drug Intolerance|1|||
163229326|NCT03604692|589551506|FG004|Overall Study|Drug Intolerance|0|||
163229327|NCT03604692|589551507|FG005|Overall Study|Drug Intolerance|0|||
163229328|NCT03604692|589551502|FG000|Overall Study|Noncompliance with follow-up visit|0|||
163229329|NCT03604692|589551503|FG001|Overall Study|Noncompliance with follow-up visit|0|||
163229330|NCT03604692|589551504|FG002|Overall Study|Noncompliance with follow-up visit|0|||
163229331|NCT03604692|589551505|FG003|Overall Study|Noncompliance with follow-up visit|1|||
163229332|NCT03604692|589551506|FG004|Overall Study|Noncompliance with follow-up visit|0|||
163229333|NCT03604692|589551507|FG005|Overall Study|Noncompliance with follow-up visit|0|||
163229334|NCT03604692|589551502|FG000|Overall Study|Not Treated|0|||
163229335|NCT03604692|589551503|FG001|Overall Study|Not Treated|0|||
163229336|NCT03604692|589551504|FG002|Overall Study|Not Treated|0|||
163229337|NCT03604692|589551505|FG003|Overall Study|Not Treated|0|||
163345476|NCT03928821|589973108|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
163136364|NCT03364309|589207834|FG008|Induction Period|Physician Decision|0|||
163136365|NCT03364309|589207835|FG009|Induction Period|Physician Decision|0|||
163136366|NCT03364309|589207836|FG010|Induction Period|Physician Decision|0|||
163136367|NCT03364309|589207837|FG011|Induction Period|Physician Decision|0|||
163136368|NCT03364309|589207838|FG012|Induction Period|Physician Decision|0|||
163136369|NCT03364309|589207839|FG013|Induction Period|Physician Decision|0|||
163136370|NCT03364309|589207840|FG014|Induction Period|Physician Decision|0|||
163136371|NCT03364309|589207841|FG015|Induction Period|Physician Decision|0|||
163136372|NCT03364309|589207842|FG016|Induction Period|Physician Decision|0|||
163136373|NCT03364309|589207843|FG017|Induction Period|Physician Decision|0|||
163136374|NCT03364309|589207844|FG018|Induction Period|Physician Decision|0|||
163136375|NCT03364309|589207826|FG000|Maintenance Period|Withdrawal by Subject|0|||
163136376|NCT03364309|589207827|FG001|Maintenance Period|Withdrawal by Subject|0|||
163136377|NCT03364309|589207828|FG002|Maintenance Period|Withdrawal by Subject|0|||
163136378|NCT03364309|589207829|FG003|Maintenance Period|Withdrawal by Subject|1|||
163229338|NCT03604692|589551506|FG004|Overall Study|Not Treated|1|||
163229339|NCT03604692|589551507|FG005|Overall Study|Not Treated|0|||
163229340|NCT00637195|589551508|FG000|Overall Study|Lost to Follow-up|1|||
163229341|NCT00637195|589551509|FG001|Overall Study|Lost to Follow-up|0|||
163229342|NCT00637195|589551508|FG000|Overall Study|Other|2|||
163229343|NCT00637195|589551509|FG001|Overall Study|Other|0|||
163229344|NCT00637195|589551508|FG000|Overall Study|Withdrawal by Subject|0|||
163229345|NCT00637195|589551509|FG001|Overall Study|Withdrawal by Subject|1|||
163229346|NCT00547703|589551512|FG000|Overall Study|Lost to Follow-up|1|||
163229347|NCT00547703|589551513|FG001|Overall Study|Lost to Follow-up|0|||
163229348|NCT01193556|589551519|FG000|Overall Study|Study termination|26|||
163229349|NCT01193556|589551520|FG001|Overall Study|Study termination|25|||
163229350|NCT01696032|589551521|FG000|Overall Study|Withdrawal by Subject|0|||
163136379|NCT03364309|589207830|FG004|Maintenance Period|Withdrawal by Subject|3|||
163136380|NCT03364309|589207831|FG005|Maintenance Period|Withdrawal by Subject|1|||
163136381|NCT03364309|589207832|FG006|Maintenance Period|Withdrawal by Subject|3|||
163136382|NCT03364309|589207833|FG007|Maintenance Period|Withdrawal by Subject|0|||
163136383|NCT03364309|589207834|FG008|Maintenance Period|Withdrawal by Subject|1|||
163136384|NCT03364309|589207835|FG009|Maintenance Period|Withdrawal by Subject|1|||
163136385|NCT03364309|589207836|FG010|Maintenance Period|Withdrawal by Subject|2|||
163136386|NCT03364309|589207837|FG011|Maintenance Period|Withdrawal by Subject|0|||
163136387|NCT03364309|589207838|FG012|Maintenance Period|Withdrawal by Subject|0|||
163136388|NCT03364309|589207839|FG013|Maintenance Period|Withdrawal by Subject|0|||
163136389|NCT03364309|589207840|FG014|Maintenance Period|Withdrawal by Subject|0|||
163136390|NCT03364309|589207841|FG015|Maintenance Period|Withdrawal by Subject|0|||
163136391|NCT03364309|589207842|FG016|Maintenance Period|Withdrawal by Subject|0|||
163136392|NCT03364309|589207843|FG017|Maintenance Period|Withdrawal by Subject|0|||
163136393|NCT03364309|589207844|FG018|Maintenance Period|Withdrawal by Subject|0|||
163136394|NCT03364309|589207826|FG000|Maintenance Period|Adverse Event|0|||
163136395|NCT03364309|589207827|FG001|Maintenance Period|Adverse Event|0|||
163136396|NCT03364309|589207828|FG002|Maintenance Period|Adverse Event|0|||
163136397|NCT03364309|589207829|FG003|Maintenance Period|Adverse Event|0|||
163136398|NCT03364309|589207830|FG004|Maintenance Period|Adverse Event|2|||
163136399|NCT03364309|589207831|FG005|Maintenance Period|Adverse Event|0|||
163136400|NCT03364309|589207832|FG006|Maintenance Period|Adverse Event|3|||
163136401|NCT03364309|589207833|FG007|Maintenance Period|Adverse Event|0|||
163136402|NCT03364309|589207834|FG008|Maintenance Period|Adverse Event|1|||
163136403|NCT03364309|589207835|FG009|Maintenance Period|Adverse Event|0|||
163136404|NCT03364309|589207836|FG010|Maintenance Period|Adverse Event|2|||
163136405|NCT03364309|589207837|FG011|Maintenance Period|Adverse Event|0|||
163136406|NCT03364309|589207838|FG012|Maintenance Period|Adverse Event|0|||
163136407|NCT03364309|589207839|FG013|Maintenance Period|Adverse Event|0|||
163136408|NCT03364309|589207840|FG014|Maintenance Period|Adverse Event|0|||
163136409|NCT03364309|589207841|FG015|Maintenance Period|Adverse Event|0|||
163136410|NCT03364309|589207842|FG016|Maintenance Period|Adverse Event|0|||
163136411|NCT03364309|589207843|FG017|Maintenance Period|Adverse Event|0|||
163136412|NCT03364309|589207844|FG018|Maintenance Period|Adverse Event|0|||
163136413|NCT03364309|589207826|FG000|Maintenance Period|Relapsed|0|||
163136414|NCT03364309|589207827|FG001|Maintenance Period|Relapsed|0|||
163136415|NCT03364309|589207828|FG002|Maintenance Period|Relapsed|0|||
163136416|NCT03364309|589207829|FG003|Maintenance Period|Relapsed|43|||
163136417|NCT03364309|589207830|FG004|Maintenance Period|Relapsed|7|||
163136418|NCT03364309|589207831|FG005|Maintenance Period|Relapsed|45|||
163136419|NCT03364309|589207832|FG006|Maintenance Period|Relapsed|10|||
163136420|NCT03364309|589207833|FG007|Maintenance Period|Relapsed|2|||
163136421|NCT03364309|589207834|FG008|Maintenance Period|Relapsed|0|||
163136422|NCT03364309|589207835|FG009|Maintenance Period|Relapsed|0|||
163136423|NCT03364309|589207836|FG010|Maintenance Period|Relapsed|0|||
163136424|NCT03364309|589207837|FG011|Maintenance Period|Relapsed|0|||
163136425|NCT03364309|589207838|FG012|Maintenance Period|Relapsed|0|||
163136426|NCT03364309|589207839|FG013|Maintenance Period|Relapsed|0|||
163136427|NCT03364309|589207840|FG014|Maintenance Period|Relapsed|0|||
163136428|NCT03364309|589207841|FG015|Maintenance Period|Relapsed|0|||
163136429|NCT03364309|589207842|FG016|Maintenance Period|Relapsed|0|||
163136430|NCT03364309|589207843|FG017|Maintenance Period|Relapsed|0|||
163136431|NCT03364309|589207844|FG018|Maintenance Period|Relapsed|0|||
163136432|NCT03364309|589207826|FG000|Maintenance Period|Lack of Efficacy|0|||
163136433|NCT03364309|589207827|FG001|Maintenance Period|Lack of Efficacy|0|||
163136434|NCT03364309|589207828|FG002|Maintenance Period|Lack of Efficacy|0|||
163136435|NCT03364309|589207829|FG003|Maintenance Period|Lack of Efficacy|0|||
163136436|NCT03364309|589207830|FG004|Maintenance Period|Lack of Efficacy|0|||
163136437|NCT03364309|589207831|FG005|Maintenance Period|Lack of Efficacy|0|||
163136438|NCT03364309|589207832|FG006|Maintenance Period|Lack of Efficacy|0|||
163136439|NCT03364309|589207833|FG007|Maintenance Period|Lack of Efficacy|0|||
163136440|NCT03364309|589207834|FG008|Maintenance Period|Lack of Efficacy|1|||
163136441|NCT03364309|589207835|FG009|Maintenance Period|Lack of Efficacy|3|||
163136442|NCT03364309|589207836|FG010|Maintenance Period|Lack of Efficacy|2|||
163136443|NCT03364309|589207837|FG011|Maintenance Period|Lack of Efficacy|0|||
163136444|NCT03364309|589207838|FG012|Maintenance Period|Lack of Efficacy|0|||
163136445|NCT03364309|589207839|FG013|Maintenance Period|Lack of Efficacy|0|||
163136446|NCT03364309|589207840|FG014|Maintenance Period|Lack of Efficacy|0|||
163136447|NCT03364309|589207841|FG015|Maintenance Period|Lack of Efficacy|0|||
163136448|NCT03364309|589207842|FG016|Maintenance Period|Lack of Efficacy|0|||
163136449|NCT03364309|589207843|FG017|Maintenance Period|Lack of Efficacy|0|||
163136450|NCT03364309|589207844|FG018|Maintenance Period|Lack of Efficacy|0|||
163136451|NCT03364309|589207826|FG000|Maintenance Period|Death|0|||
163136452|NCT03364309|589207827|FG001|Maintenance Period|Death|0|||
163136453|NCT03364309|589207828|FG002|Maintenance Period|Death|0|||
163136454|NCT03364309|589207829|FG003|Maintenance Period|Death|0|||
163136455|NCT03364309|589207830|FG004|Maintenance Period|Death|0|||
163136456|NCT03364309|589207831|FG005|Maintenance Period|Death|0|||
163136457|NCT03364309|589207832|FG006|Maintenance Period|Death|0|||
163136458|NCT03364309|589207833|FG007|Maintenance Period|Death|0|||
163136459|NCT03364309|589207834|FG008|Maintenance Period|Death|1|||
163136460|NCT03364309|589207835|FG009|Maintenance Period|Death|0|||
163136461|NCT03364309|589207836|FG010|Maintenance Period|Death|0|||
163136462|NCT03364309|589207837|FG011|Maintenance Period|Death|0|||
163136463|NCT03364309|589207838|FG012|Maintenance Period|Death|0|||
163136464|NCT03364309|589207839|FG013|Maintenance Period|Death|0|||
163136465|NCT03364309|589207840|FG014|Maintenance Period|Death|0|||
163136466|NCT03364309|589207841|FG015|Maintenance Period|Death|0|||
163136467|NCT03364309|589207842|FG016|Maintenance Period|Death|0|||
163136468|NCT03364309|589207843|FG017|Maintenance Period|Death|0|||
163136469|NCT03364309|589207844|FG018|Maintenance Period|Death|0|||
163136470|NCT03364309|589207826|FG000|Maintenance Period|Lost to Follow-up|0|||
163136471|NCT03364309|589207827|FG001|Maintenance Period|Lost to Follow-up|0|||
163136472|NCT03364309|589207828|FG002|Maintenance Period|Lost to Follow-up|0|||
163136473|NCT03364309|589207829|FG003|Maintenance Period|Lost to Follow-up|0|||
163136474|NCT03364309|589207830|FG004|Maintenance Period|Lost to Follow-up|0|||
163136475|NCT03364309|589207831|FG005|Maintenance Period|Lost to Follow-up|0|||
163136476|NCT03364309|589207832|FG006|Maintenance Period|Lost to Follow-up|0|||
163136477|NCT03364309|589207833|FG007|Maintenance Period|Lost to Follow-up|0|||
163136478|NCT03364309|589207834|FG008|Maintenance Period|Lost to Follow-up|1|||
163136479|NCT03364309|589207835|FG009|Maintenance Period|Lost to Follow-up|0|||
163136480|NCT03364309|589207836|FG010|Maintenance Period|Lost to Follow-up|0|||
163136481|NCT03364309|589207837|FG011|Maintenance Period|Lost to Follow-up|0|||
163136482|NCT03364309|589207838|FG012|Maintenance Period|Lost to Follow-up|0|||
163136483|NCT03364309|589207839|FG013|Maintenance Period|Lost to Follow-up|0|||
163136484|NCT03364309|589207840|FG014|Maintenance Period|Lost to Follow-up|0|||
163136485|NCT03364309|589207841|FG015|Maintenance Period|Lost to Follow-up|0|||
163136486|NCT03364309|589207842|FG016|Maintenance Period|Lost to Follow-up|0|||
163136487|NCT03364309|589207843|FG017|Maintenance Period|Lost to Follow-up|0|||
163136488|NCT03364309|589207844|FG018|Maintenance Period|Lost to Follow-up|0|||
163136489|NCT03364309|589207826|FG000|Maintenance Period|Miscellaneous|0|||
163136490|NCT03364309|589207827|FG001|Maintenance Period|Miscellaneous|0|||
163136491|NCT03364309|589207828|FG002|Maintenance Period|Miscellaneous|0|||
163136492|NCT03364309|589207829|FG003|Maintenance Period|Miscellaneous|0|||
163136493|NCT03364309|589207830|FG004|Maintenance Period|Miscellaneous|0|||
163136494|NCT03364309|589207831|FG005|Maintenance Period|Miscellaneous|0|||
163136495|NCT03364309|589207832|FG006|Maintenance Period|Miscellaneous|0|||
163136496|NCT03364309|589207833|FG007|Maintenance Period|Miscellaneous|0|||
163136497|NCT03364309|589207834|FG008|Maintenance Period|Miscellaneous|1|||
163136498|NCT03364309|589207835|FG009|Maintenance Period|Miscellaneous|0|||
163136499|NCT03364309|589207836|FG010|Maintenance Period|Miscellaneous|0|||
163136500|NCT03364309|589207837|FG011|Maintenance Period|Miscellaneous|0|||
163136501|NCT03364309|589207838|FG012|Maintenance Period|Miscellaneous|0|||
163136502|NCT03364309|589207839|FG013|Maintenance Period|Miscellaneous|0|||
163136503|NCT03364309|589207840|FG014|Maintenance Period|Miscellaneous|0|||
163136504|NCT03364309|589207841|FG015|Maintenance Period|Miscellaneous|0|||
163136505|NCT03364309|589207842|FG016|Maintenance Period|Miscellaneous|0|||
163136506|NCT03364309|589207843|FG017|Maintenance Period|Miscellaneous|0|||
163136507|NCT03364309|589207844|FG018|Maintenance Period|Miscellaneous|0|||
163136508|NCT03364309|589207826|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136509|NCT03364309|589207827|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136510|NCT03364309|589207828|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136511|NCT03364309|589207829|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136512|NCT03364309|589207830|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136513|NCT03364309|589207831|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136514|NCT03364309|589207832|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136515|NCT03364309|589207833|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136516|NCT03364309|589207834|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136517|NCT03364309|589207835|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136518|NCT03364309|589207836|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136519|NCT03364309|589207837|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136520|NCT03364309|589207838|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136521|NCT03364309|589207839|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
163136522|NCT03364309|589207840|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
163229351|NCT01696032|589551522|FG001|Overall Study|Withdrawal by Subject|0|||
163408578|NCT03594227|590205558|FG001|Overall Study|Pregnancy|1|||
163136523|NCT03364309|589207841|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
163136524|NCT03364309|589207842|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136525|NCT03364309|589207843|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136526|NCT03364309|589207844|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136527|NCT03364309|589207826|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136528|NCT03364309|589207827|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136529|NCT03364309|589207828|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136530|NCT03364309|589207829|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
163408579|NCT03594227|590205559|FG002|Overall Study|Pregnancy|0|||
163136531|NCT03364309|589207830|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136532|NCT03364309|589207831|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136533|NCT03364309|589207832|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136534|NCT03364309|589207833|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136535|NCT03364309|589207834|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136536|NCT03364309|589207835|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136537|NCT03364309|589207836|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136538|NCT03364309|589207837|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136539|NCT03364309|589207838|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136540|NCT03364309|589207839|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136541|NCT03364309|589207840|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
163136542|NCT03364309|589207841|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136543|NCT03364309|589207842|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136544|NCT03364309|589207843|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136545|NCT03364309|589207844|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136546|NCT03364309|589207826|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
163136547|NCT03364309|589207827|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
163136548|NCT03364309|589207828|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
163136549|NCT03364309|589207829|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
163136550|NCT03364309|589207830|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
163136551|NCT03364309|589207831|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
163136552|NCT03364309|589207832|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
163136553|NCT03364309|589207833|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
163136554|NCT03364309|589207834|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
163136555|NCT03364309|589207835|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
163136556|NCT03364309|589207836|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
163136557|NCT03364309|589207837|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
163136558|NCT03364309|589207838|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
163136559|NCT03364309|589207839|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
163136560|NCT03364309|589207840|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
163136561|NCT03364309|589207841|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
163136562|NCT03364309|589207842|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
163136563|NCT03364309|589207843|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
163136564|NCT03364309|589207844|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
163136565|NCT03364309|589207826|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136566|NCT03364309|589207827|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136567|NCT03364309|589207828|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136568|NCT03364309|589207829|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136569|NCT03364309|589207830|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136570|NCT03364309|589207831|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136571|NCT03364309|589207832|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136572|NCT03364309|589207833|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136573|NCT03364309|589207834|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136574|NCT03364309|589207835|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136575|NCT03364309|589207836|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136576|NCT03364309|589207837|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136577|NCT03364309|589207838|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136578|NCT03364309|589207839|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136579|NCT03364309|589207840|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136580|NCT03364309|589207841|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136581|NCT03364309|589207842|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
163136582|NCT03364309|589207843|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
163136583|NCT03364309|589207844|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
163136584|NCT03364309|589207826|FG000|Post-Treatment Followup Period|Adverse Event|0|||
163136585|NCT03364309|589207827|FG001|Post-Treatment Followup Period|Adverse Event|0|||
163136586|NCT03364309|589207828|FG002|Post-Treatment Followup Period|Adverse Event|0|||
163136587|NCT03364309|589207829|FG003|Post-Treatment Followup Period|Adverse Event|0|||
163136588|NCT03364309|589207830|FG004|Post-Treatment Followup Period|Adverse Event|0|||
163136589|NCT03364309|589207831|FG005|Post-Treatment Followup Period|Adverse Event|0|||
163136590|NCT03364309|589207832|FG006|Post-Treatment Followup Period|Adverse Event|0|||
163136591|NCT03364309|589207833|FG007|Post-Treatment Followup Period|Adverse Event|0|||
163136592|NCT03364309|589207834|FG008|Post-Treatment Followup Period|Adverse Event|0|||
163136593|NCT03364309|589207835|FG009|Post-Treatment Followup Period|Adverse Event|0|||
163136594|NCT03364309|589207836|FG010|Post-Treatment Followup Period|Adverse Event|0|||
163136595|NCT03364309|589207837|FG011|Post-Treatment Followup Period|Adverse Event|0|||
163136596|NCT03364309|589207838|FG012|Post-Treatment Followup Period|Adverse Event|0|||
163136597|NCT03364309|589207839|FG013|Post-Treatment Followup Period|Adverse Event|0|||
163136598|NCT03364309|589207840|FG014|Post-Treatment Followup Period|Adverse Event|0|||
163136599|NCT03364309|589207841|FG015|Post-Treatment Followup Period|Adverse Event|0|||
163136600|NCT03364309|589207842|FG016|Post-Treatment Followup Period|Adverse Event|2|||
163345477|NCT03928821|589973109|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
163345478|NCT03928821|589973110|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
163345479|NCT03138499|589973117|FG000|Overall Study|Lost to Follow-up|1|||
163345480|NCT03138499|589973118|FG001|Overall Study|Lost to Follow-up|0|||
163345481|NCT03138499|589973117|FG000|Overall Study|Participants withdrew consent|1|||
163345482|NCT03138499|589973118|FG001|Overall Study|Participants withdrew consent|0|||
163136601|NCT03364309|589207843|FG017|Post-Treatment Followup Period|Adverse Event|6|||
163136602|NCT03364309|589207844|FG018|Post-Treatment Followup Period|Adverse Event|1|||
163136603|NCT03364309|589207826|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136604|NCT03364309|589207827|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136605|NCT03364309|589207828|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136606|NCT03364309|589207829|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136607|NCT03364309|589207830|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136608|NCT03364309|589207831|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136609|NCT03364309|589207832|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136610|NCT03364309|589207833|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136611|NCT03364309|589207834|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136612|NCT03364309|589207835|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136613|NCT03364309|589207836|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136614|NCT03364309|589207837|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136615|NCT03364309|589207838|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136616|NCT03364309|589207839|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136617|NCT03364309|589207840|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136618|NCT03364309|589207841|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136619|NCT03364309|589207842|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136620|NCT03364309|589207843|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
163136621|NCT03364309|589207844|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136622|NCT03364309|589207826|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
163136623|NCT03364309|589207827|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
163136624|NCT03364309|589207828|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
163136625|NCT03364309|589207829|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
163136626|NCT03364309|589207830|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
163136627|NCT03364309|589207831|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
163136628|NCT03364309|589207832|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
163136629|NCT03364309|589207833|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
163136630|NCT03364309|589207834|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
163136631|NCT03364309|589207835|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
163136632|NCT03364309|589207836|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
163136633|NCT03364309|589207837|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
163136634|NCT03364309|589207838|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
163136635|NCT03364309|589207839|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
163136636|NCT03364309|589207840|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
163136637|NCT03364309|589207841|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
163136638|NCT03364309|589207842|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
163136639|NCT03364309|589207843|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
163136640|NCT03364309|589207844|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
163136641|NCT01371552|589207845|FG000|Part 1, First 3 Days|Inconvenience|0|||
163136642|NCT01371552|589207846|FG001|Part 1, First 3 Days|Inconvenience|0|||
163136643|NCT01371552|589207847|FG002|Part 1, First 3 Days|Inconvenience|1|||
163136644|NCT01371552|589207848|FG003|Part 1, First 3 Days|Inconvenience|0|||
163136645|NCT01371552|589207849|FG004|Part 1, First 3 Days|Inconvenience|0|||
163136646|NCT01371552|589207850|FG005|Part 1, First 3 Days|Inconvenience|0|||
163136647|NCT00167310|589207851|FG000|Overall Study|Protocol Violation|5|||
163136648|NCT00167310|589207852|FG001|Overall Study|Protocol Violation|3|||
163136649|NCT00167310|589207851|FG000|Overall Study|Withdrawal by Subject|3|||
163136650|NCT00167310|589207852|FG001|Overall Study|Withdrawal by Subject|7|||
163136651|NCT00615992|589207853|FG000|Overall Study|Protocol Violation|67|||
163136652|NCT04522141|589207855|FG000|Overall Study|Withdrawal by Subject|1|||
163136653|NCT04522141|589207856|FG001|Overall Study|Withdrawal by Subject|0|||
163136654|NCT03052049|589207857|FG000|Overall Study|Withdrawal by Subject|2|||
163136655|NCT03508609|589207858|FG000|Overall Study|Withdrawal by Subject|1|||
163136656|NCT02328027|589207859|FG000|Overall Study|Withdrawal by Subject|0|||
163345483|NCT03138499|589973117|FG000|Overall Study|Participant discontinued study before treatment|0|||
163136657|NCT02328027|589207860|FG001|Overall Study|Withdrawal by Subject|1|||
163345484|NCT03138499|589973118|FG001|Overall Study|Participant discontinued study before treatment|1|||
163136658|NCT03304873|589207861|FG000|Overall Study|Lost to Follow-up|1|||
163136659|NCT03304873|589207862|FG001|Overall Study|Lost to Follow-up|8|||
163136660|NCT03319212|589207863|FG000|Overall Study|Discontinued as moving out of local area|0|||
163136661|NCT03319212|589207864|FG001|Overall Study|Discontinued as moving out of local area|1|||
163136662|NCT03319212|589207863|FG000|Overall Study|Adverse Event|2|||
163136663|NCT03319212|589207864|FG001|Overall Study|Adverse Event|2|||
163345485|NCT03138499|589973117|FG000|Overall Study|Disease Progression|2|||
163229352|NCT01696032|589551523|FG002|Overall Study|Withdrawal by Subject|1|||
163229353|NCT01696032|589551524|FG003|Overall Study|Withdrawal by Subject|2|||
163229354|NCT01696032|589551521|FG000|Overall Study|Death|14|||
163229355|NCT01696032|589551522|FG001|Overall Study|Death|4|||
163229356|NCT01696032|589551523|FG002|Overall Study|Death|43|||
163229357|NCT01696032|589551524|FG003|Overall Study|Death|18|||
163229358|NCT01696032|589551521|FG000|Overall Study|Lost to Follow-up|0|||
163136664|NCT03319212|589207863|FG000|Overall Study|Withdrawal by Subject|0|||
163136665|NCT03319212|589207864|FG001|Overall Study|Withdrawal by Subject|1|||
163136666|NCT03319212|589207863|FG000|Overall Study|Lost to Follow-up|0|||
163136667|NCT03319212|589207864|FG001|Overall Study|Lost to Follow-up|1|||
163136668|NCT03319212|589207863|FG000|Overall Study|Physician Decision|1|||
163136669|NCT03319212|589207864|FG001|Overall Study|Physician Decision|0|||
163136670|NCT00400569|589207865|FG000|Overall Study|Death|1|||
163229359|NCT01696032|589551522|FG001|Overall Study|Lost to Follow-up|1|||
163229360|NCT01696032|589551523|FG002|Overall Study|Lost to Follow-up|0|||
163229361|NCT01696032|589551524|FG003|Overall Study|Lost to Follow-up|0|||
163229362|NCT01696032|589551521|FG000|Overall Study|Database lock|0|||
163229363|NCT01696032|589551522|FG001|Overall Study|Database lock|1|||
163229364|NCT01696032|589551523|FG002|Overall Study|Database lock|7|||
163229365|NCT01696032|589551524|FG003|Overall Study|Database lock|2|||
163229366|NCT00376168|589551527|FG000|Overall Study|Adverse Event|1|||
163229367|NCT00376168|589551528|FG001|Overall Study|Adverse Event|1|||
163229368|NCT00376168|589551527|FG000|Overall Study|Pregnancy|1|||
163229369|NCT00376168|589551528|FG001|Overall Study|Pregnancy|0|||
163229370|NCT01020019|589551529|FG000|Overall Study|Lost to Follow-up|21|||
163229371|NCT01020019|589551530|FG001|Overall Study|Lost to Follow-up|18|||
163229372|NCT01020019|589551529|FG000|Overall Study|Adverse Event|1|||
163229373|NCT01020019|589551530|FG001|Overall Study|Adverse Event|5|||
163229374|NCT01020019|589551529|FG000|Overall Study|not interested in treatment|4|||
163229375|NCT01020019|589551530|FG001|Overall Study|not interested in treatment|4|||
163229376|NCT01020019|589551529|FG000|Overall Study|moving|0|||
163229377|NCT01020019|589551530|FG001|Overall Study|moving|2|||
163229378|NCT05091528|589551531|FG000|Overall Study|Study Termination by Sponsor|0|||
163229379|NCT05091528|589551532|FG001|Overall Study|Study Termination by Sponsor|1|||
163229380|NCT05091528|589551533|FG002|Overall Study|Study Termination by Sponsor|0|||
163229381|NCT05091528|589551534|FG003|Overall Study|Study Termination by Sponsor|1|||
163229382|NCT02214121|589551537|FG000|Part A|Patient decision|2|||
163229383|NCT02214121|589551538|FG001|Part A|Patient decision|0|||
163229384|NCT02214121|589551539|FG002|Part A|Patient decision|0|||
163229385|NCT02214121|589551537|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
163229386|NCT02214121|589551538|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
163229387|NCT02214121|589551539|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
163229388|NCT02214121|589551537|FG000|Part A|Other|1|||
163229389|NCT02214121|589551538|FG001|Part A|Other|0|||
163229390|NCT02214121|589551539|FG002|Part A|Other|0|||
163229391|NCT02214121|589551537|FG000|Part B|Patient decision|0|||
163229392|NCT02214121|589551538|FG001|Part B|Patient decision|1|||
163229393|NCT02214121|589551539|FG002|Part B|Patient decision|0|||
163229394|NCT02214121|589551537|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
163229395|NCT02214121|589551538|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
163229396|NCT02214121|589551539|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
163229397|NCT02214121|589551537|FG000|Part B|Lost to Follow-up|0|||
163229398|NCT02214121|589551538|FG001|Part B|Lost to Follow-up|0|||
163229399|NCT02214121|589551539|FG002|Part B|Lost to Follow-up|1|||
163229400|NCT02375672|589551540|FG000|Overall Study|remain on follow up|20|||
163229401|NCT02203591|589551541|FG000|Overall Study|Did not meet treatment day baseline|147|||
163229402|NCT02203591|589551542|FG001|Overall Study|Did not meet treatment day baseline|141|||
163229403|NCT02203591|589551543|FG002|Overall Study|Did not meet treatment day baseline|150|||
163229404|NCT02203591|589551544|FG003|Overall Study|Did not meet treatment day baseline|45|||
163229405|NCT02203591|589551545|FG004|Overall Study|Did not meet treatment day baseline|33|||
163229406|NCT02203591|589551546|FG005|Overall Study|Did not meet treatment day baseline|35|||
163136671|NCT01868477|589207867|FG000|Overall Study|Adverse Event|2|||
163229407|NCT02203591|589551547|FG006|Overall Study|Did not meet treatment day baseline|29|||
163229408|NCT02203591|589551548|FG007|Overall Study|Did not meet treatment day baseline|12|||
163229409|NCT02203591|589551541|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
163136672|NCT01868477|589207868|FG001|Overall Study|Adverse Event|4|||
163136673|NCT01868477|589207867|FG000|Overall Study|Disease progression|1|||
163229410|NCT02203591|589551542|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
163229411|NCT02203591|589551543|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
163229412|NCT02203591|589551544|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
163229413|NCT02203591|589551545|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
163229414|NCT02203591|589551546|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
163229415|NCT02203591|589551547|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
163229416|NCT02203591|589551548|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
163229417|NCT04115358|589551549|FG000|Overall Study|exfoliation|0|||
163229418|NCT04115358|589551550|FG001|Overall Study|exfoliation|0|||
163136674|NCT01868477|589207868|FG001|Overall Study|Disease progression|1|||
163136675|NCT01868477|589207867|FG000|Overall Study|Withdrawal by Subject|1|||
163136676|NCT01868477|589207868|FG001|Overall Study|Withdrawal by Subject|0|||
163136677|NCT02465203|589207870|FG000|Overall Study|Protocol Violation|1|||
163136678|NCT02465203|589207871|FG001|Overall Study|Protocol Violation|1|||
163136679|NCT02465203|589207872|FG002|Overall Study|Protocol Violation|1|||
163136680|NCT02465203|589207870|FG000|Overall Study|Study terminated by sponsor|50|||
163136681|NCT02465203|589207871|FG001|Overall Study|Study terminated by sponsor|34|||
163136682|NCT02465203|589207872|FG002|Overall Study|Study terminated by sponsor|11|||
163136683|NCT02465203|589207870|FG000|Overall Study|New therapy for study indication|4|||
163136684|NCT02465203|589207871|FG001|Overall Study|New therapy for study indication|0|||
163136685|NCT02465203|589207872|FG002|Overall Study|New therapy for study indication|0|||
163136686|NCT02465203|589207870|FG000|Overall Study|Patient/guardian decision|1|||
163136687|NCT02465203|589207871|FG001|Overall Study|Patient/guardian decision|1|||
163136688|NCT02465203|589207872|FG002|Overall Study|Patient/guardian decision|1|||
163136689|NCT00620113|589207873|FG000|Overall Study|Adverse Event|3|||
163136690|NCT00620113|589207874|FG001|Overall Study|Adverse Event|2|||
163136691|NCT00620113|589207875|FG002|Overall Study|Adverse Event|2|||
163136692|NCT00620113|589207876|FG003|Overall Study|Adverse Event|1|||
163136693|NCT00620113|589207873|FG000|Overall Study|Lack of Efficacy|2|||
163136694|NCT00620113|589207874|FG001|Overall Study|Lack of Efficacy|3|||
163136695|NCT00620113|589207875|FG002|Overall Study|Lack of Efficacy|0|||
163136696|NCT00620113|589207876|FG003|Overall Study|Lack of Efficacy|2|||
163136697|NCT00620113|589207873|FG000|Overall Study|Physician Decision|1|||
163136698|NCT00620113|589207874|FG001|Overall Study|Physician Decision|0|||
163136699|NCT00620113|589207875|FG002|Overall Study|Physician Decision|0|||
163136700|NCT00620113|589207876|FG003|Overall Study|Physician Decision|2|||
163136701|NCT00620113|589207873|FG000|Overall Study|Protocol Violation|2|||
163136702|NCT00620113|589207874|FG001|Overall Study|Protocol Violation|1|||
163136703|NCT00620113|589207875|FG002|Overall Study|Protocol Violation|0|||
163136704|NCT00620113|589207876|FG003|Overall Study|Protocol Violation|0|||
163136705|NCT00620113|589207873|FG000|Overall Study|Withdrawal by Subject|5|||
163136706|NCT00620113|589207874|FG001|Overall Study|Withdrawal by Subject|1|||
163136707|NCT00620113|589207875|FG002|Overall Study|Withdrawal by Subject|3|||
163136708|NCT00620113|589207876|FG003|Overall Study|Withdrawal by Subject|5|||
163136709|NCT04072887|589207883|FG000|Overall Study|Withdrawal by Subject|3|||
163136710|NCT04072887|589207884|FG001|Overall Study|Withdrawal by Subject|8|||
163136711|NCT04072887|589207885|FG002|Overall Study|Withdrawal by Subject|1|||
163136712|NCT04072887|589207886|FG003|Overall Study|Withdrawal by Subject|3|||
163136713|NCT04072887|589207887|FG004|Overall Study|Withdrawal by Subject|3|||
163136714|NCT04072887|589207888|FG005|Overall Study|Withdrawal by Subject|13|||
163136715|NCT04072887|589207883|FG000|Overall Study|Adverse Event|2|||
163136716|NCT04072887|589207884|FG001|Overall Study|Adverse Event|4|||
163136717|NCT04072887|589207885|FG002|Overall Study|Adverse Event|1|||
163136718|NCT04072887|589207886|FG003|Overall Study|Adverse Event|4|||
163136719|NCT04072887|589207887|FG004|Overall Study|Adverse Event|0|||
163136720|NCT04072887|589207888|FG005|Overall Study|Adverse Event|1|||
163136721|NCT04072887|589207883|FG000|Overall Study|Physician Decision|2|||
163136722|NCT04072887|589207884|FG001|Overall Study|Physician Decision|0|||
163136723|NCT04072887|589207885|FG002|Overall Study|Physician Decision|0|||
163136724|NCT04072887|589207886|FG003|Overall Study|Physician Decision|0|||
163136725|NCT04072887|589207887|FG004|Overall Study|Physician Decision|0|||
163136726|NCT04072887|589207888|FG005|Overall Study|Physician Decision|1|||
163136727|NCT04072887|589207883|FG000|Overall Study|Lost to Follow-up|1|||
163136728|NCT04072887|589207884|FG001|Overall Study|Lost to Follow-up|3|||
163136729|NCT04072887|589207885|FG002|Overall Study|Lost to Follow-up|0|||
163136730|NCT04072887|589207886|FG003|Overall Study|Lost to Follow-up|0|||
163345486|NCT03138499|589973118|FG001|Overall Study|Disease Progression|6|||
163345487|NCT03138499|589973117|FG000|Overall Study|Study drug toxicity|2|||
163345488|NCT03138499|589973118|FG001|Overall Study|Study drug toxicity|2|||
163345489|NCT03138499|589973117|FG000|Overall Study|Participant request to discontinue study treatment|1|||
163345490|NCT03138499|589973118|FG001|Overall Study|Participant request to discontinue study treatment|1|||
163345491|NCT03138499|589973117|FG000|Overall Study|Other reasons|2|||
163136731|NCT04072887|589207887|FG004|Overall Study|Lost to Follow-up|0|||
163136732|NCT04072887|589207888|FG005|Overall Study|Lost to Follow-up|0|||
163136733|NCT04072887|589207883|FG000|Overall Study|Death|0|||
163136734|NCT04072887|589207884|FG001|Overall Study|Death|2|||
163136735|NCT04072887|589207885|FG002|Overall Study|Death|0|||
163136736|NCT04072887|589207886|FG003|Overall Study|Death|2|||
163136737|NCT04072887|589207887|FG004|Overall Study|Death|3|||
163136738|NCT04072887|589207888|FG005|Overall Study|Death|0|||
163136739|NCT00856297|589207889|FG000|Overall Study|Unable to classify|2|||
163136740|NCT00856297|589207890|FG001|Overall Study|Unable to classify|0|||
163136741|NCT00856297|589207891|FG002|Overall Study|Unable to classify|0|||
163136742|NCT00856297|589207892|FG003|Overall Study|Unable to classify|0|||
163136743|NCT00856297|589207893|FG004|Overall Study|Unable to classify|0|||
163136744|NCT00423449|589207896|FG000|Overall Study|Clinical Adverse Event|1|||
163136745|NCT00423449|589207897|FG001|Overall Study|Clinical Adverse Event|0|||
163345492|NCT03138499|589973118|FG001|Overall Study|Other reasons|0|||
163136746|NCT00423449|589207898|FG002|Overall Study|Clinical Adverse Event|1|||
163136747|NCT00423449|589207899|FG003|Overall Study|Clinical Adverse Event|8|||
163136748|NCT00423449|589207900|FG004|Overall Study|Clinical Adverse Event|2|||
163136749|NCT00423449|589207896|FG000|Overall Study|Death|1|||
163136750|NCT00423449|589207897|FG001|Overall Study|Death|0|||
163136751|NCT00423449|589207898|FG002|Overall Study|Death|2|||
163136752|NCT00423449|589207899|FG003|Overall Study|Death|1|||
163136753|NCT00423449|589207900|FG004|Overall Study|Death|1|||
163136754|NCT00423449|589207896|FG000|Overall Study|Progressive Disease|1|||
163136755|NCT00423449|589207897|FG001|Overall Study|Progressive Disease|3|||
163136756|NCT00423449|589207898|FG002|Overall Study|Progressive Disease|8|||
163136757|NCT00423449|589207899|FG003|Overall Study|Progressive Disease|11|||
163136758|NCT00423449|589207900|FG004|Overall Study|Progressive Disease|4|||
163136759|NCT00423449|589207896|FG000|Overall Study|Laboratory Adverse Event|0|||
163136760|NCT00423449|589207897|FG001|Overall Study|Laboratory Adverse Event|1|||
163136761|NCT00423449|589207898|FG002|Overall Study|Laboratory Adverse Event|2|||
163136762|NCT00423449|589207899|FG003|Overall Study|Laboratory Adverse Event|0|||
163136763|NCT00423449|589207900|FG004|Overall Study|Laboratory Adverse Event|0|||
163136764|NCT00423449|589207896|FG000|Overall Study|Other|0|||
163136765|NCT00423449|589207897|FG001|Overall Study|Other|0|||
163136766|NCT00423449|589207898|FG002|Overall Study|Other|0|||
163136767|NCT00423449|589207899|FG003|Overall Study|Other|1|||
163136768|NCT00423449|589207900|FG004|Overall Study|Other|0|||
163136769|NCT00423449|589207896|FG000|Overall Study|Protocol Violation|0|||
163136770|NCT00423449|589207897|FG001|Overall Study|Protocol Violation|0|||
163136771|NCT00423449|589207898|FG002|Overall Study|Protocol Violation|2|||
163136772|NCT00423449|589207899|FG003|Overall Study|Protocol Violation|1|||
163136773|NCT00423449|589207900|FG004|Overall Study|Protocol Violation|0|||
163136774|NCT01153724|589207901|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163136775|NCT01153724|589207901|FG000|Treatment Period 2|Adverse Event|1|||
163136776|NCT01153724|589207901|FG000|Treatment Period 2|Other reason not defined above|1|||
163136777|NCT04371666|589207906|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
163136778|NCT04371666|589207907|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
163136779|NCT04371666|589207906|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
163136780|NCT04371666|589207907|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
163136781|NCT04371666|589207906|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
163136782|NCT04371666|589207907|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
163136783|NCT04371666|589207906|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
163136784|NCT04371666|589207907|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
163136785|NCT04371666|589207906|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
163136786|NCT04371666|589207907|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
163136787|NCT04371666|589207906|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
163136788|NCT04371666|589207907|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
163136789|NCT00445770|589207908|FG000|Overall Study|Adverse Event|9|||
163136790|NCT00445770|589207909|FG001|Overall Study|Adverse Event|15|||
163136791|NCT00445770|589207910|FG002|Overall Study|Adverse Event|19|||
163136792|NCT00445770|589207908|FG000|Overall Study|Lack of Efficacy|38|||
163136793|NCT00445770|589207909|FG001|Overall Study|Lack of Efficacy|13|||
163136794|NCT00445770|589207910|FG002|Overall Study|Lack of Efficacy|6|||
163136795|NCT00445770|589207908|FG000|Overall Study|Lost to Follow-up|0|||
163136796|NCT00445770|589207909|FG001|Overall Study|Lost to Follow-up|2|||
163136797|NCT00445770|589207910|FG002|Overall Study|Lost to Follow-up|0|||
163136798|NCT00445770|589207908|FG000|Overall Study|Other|6|||
163136799|NCT00445770|589207909|FG001|Overall Study|Other|5|||
163136800|NCT00445770|589207910|FG002|Overall Study|Other|6|||
163136801|NCT00947115|589207911|FG000|Overall Study|Missed reporting interval|3|||
163136802|NCT00947115|589207912|FG001|Overall Study|Missed reporting interval|4|||
163136803|NCT00947115|589207913|FG002|Overall Study|Missed reporting interval|2|||
163136804|NCT00947115|589207911|FG000|Overall Study|Physician Decision|0|||
163136805|NCT00947115|589207912|FG001|Overall Study|Physician Decision|2|||
163136806|NCT00947115|589207913|FG002|Overall Study|Physician Decision|0|||
163136807|NCT00947115|589207911|FG000|Overall Study|Death|0|||
163136808|NCT00947115|589207912|FG001|Overall Study|Death|1|||
163136809|NCT00947115|589207913|FG002|Overall Study|Death|1|||
163136810|NCT00947115|589207911|FG000|Overall Study|Migrated from study area|2|||
163136811|NCT00947115|589207912|FG001|Overall Study|Migrated from study area|0|||
163136812|NCT00947115|589207913|FG002|Overall Study|Migrated from study area|0|||
163136813|NCT00947115|589207911|FG000|Overall Study|Withdrawal by Subject|1|||
163136814|NCT00947115|589207912|FG001|Overall Study|Withdrawal by Subject|3|||
163136815|NCT00947115|589207913|FG002|Overall Study|Withdrawal by Subject|4|||
163136816|NCT00947115|589207911|FG000|Overall Study|Lost to Follow-up|11|||
163136817|NCT00947115|589207912|FG001|Overall Study|Lost to Follow-up|12|||
163136818|NCT00947115|589207913|FG002|Overall Study|Lost to Follow-up|8|||
163136819|NCT02092025|589207914|FG000|Overall Study|Case Report Forms Uncollected|44|||
163136820|NCT02092025|589207914|FG000|Overall Study|Protocol Deviation|24|||
163136821|NCT02927938|589207915|FG000|Overall Study|Death|0|||
163136822|NCT02927938|589207916|FG001|Overall Study|Death|1|||
163408580|NCT03594227|590205560|FG003|Overall Study|Pregnancy|0|||
163408581|NCT03594227|590205557|FG000|Overall Study|Sponsor Decision|0|||
163408582|NCT03594227|590205558|FG001|Overall Study|Sponsor Decision|0|||
163408583|NCT03594227|590205559|FG002|Overall Study|Sponsor Decision|0|||
163408584|NCT03594227|590205560|FG003|Overall Study|Sponsor Decision|1|||
163136823|NCT02927938|589207917|FG002|Overall Study|Death|0|||
163136824|NCT02927938|589207918|FG003|Overall Study|Death|4|||
163136825|NCT02927938|589207915|FG000|Overall Study|Early Study Termination|1|||
163136826|NCT02927938|589207916|FG001|Overall Study|Early Study Termination|5|||
163136827|NCT02927938|589207917|FG002|Overall Study|Early Study Termination|4|||
163136828|NCT02927938|589207918|FG003|Overall Study|Early Study Termination|3|||
163136829|NCT03228212|589207921|FG000|Period 1|Adverse Event|1|||
163136830|NCT03228212|589207922|FG001|Period 1|Adverse Event|0|||
163136831|NCT03228212|589207921|FG000|Period 1|no longer meets eligibility criteria|0|||
163136832|NCT03228212|589207922|FG001|Period 1|no longer meets eligibility criteria|1|||
163136833|NCT03228212|589207921|FG000|Period 2|Lost to Follow-up|1|||
163136834|NCT03228212|589207922|FG001|Period 2|Lost to Follow-up|0|||
163136835|NCT00934128|589207923|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
163136836|NCT00934128|589207924|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
163136837|NCT00934128|589207923|FG000|First Intervention (2 Hours)|Adverse Event|4|||
163136838|NCT00934128|589207924|FG001|First Intervention (2 Hours)|Adverse Event|1|||
163136839|NCT00934128|589207923|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
163136840|NCT00934128|589207924|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
163136841|NCT00934128|589207923|FG000|Washout Period (1 Hour)|Patient preference|1|||
163136842|NCT00934128|589207924|FG001|Washout Period (1 Hour)|Patient preference|3|||
163136843|NCT00934128|589207923|FG000|Washout Period (1 Hour)|Pain|1|||
163136844|NCT00934128|589207924|FG001|Washout Period (1 Hour)|Pain|0|||
163136845|NCT00934128|589207923|FG000|Washout Period (1 Hour)|Too tired|1|||
163136846|NCT00934128|589207924|FG001|Washout Period (1 Hour)|Too tired|0|||
163136847|NCT00934128|589207923|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
163136848|NCT00934128|589207924|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
163136849|NCT00934128|589207923|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
163136850|NCT00934128|589207924|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
163136851|NCT02834247|589207925|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
163136852|NCT02834247|589207926|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
163136853|NCT02834247|589207927|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
163136854|NCT02834247|589207928|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
163136855|NCT02834247|589207925|FG000|Dose Escalation Phase|Death|5|||
163136856|NCT02834247|589207926|FG001|Dose Escalation Phase|Death|6|||
163136857|NCT02834247|589207927|FG002|Dose Escalation Phase|Death|5|||
163136858|NCT02834247|589207928|FG003|Dose Escalation Phase|Death|0|||
163136859|NCT02834247|589207925|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
163136860|NCT02834247|589207926|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
163136861|NCT02834247|589207927|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
163136862|NCT02834247|589207928|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
163136863|NCT02834247|589207925|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
163136864|NCT02834247|589207926|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
163136865|NCT02834247|589207927|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
163136866|NCT02834247|589207928|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
163136867|NCT02834247|589207925|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
163136868|NCT02834247|589207926|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
163136869|NCT02834247|589207927|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
163136870|NCT02834247|589207928|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
163136871|NCT02834247|589207925|FG000|Dose Expansion Phase|Death|0|||
163136872|NCT02834247|589207926|FG001|Dose Expansion Phase|Death|0|||
163136873|NCT02834247|589207927|FG002|Dose Expansion Phase|Death|0|||
163136874|NCT02834247|589207928|FG003|Dose Expansion Phase|Death|8|||
163136875|NCT02834247|589207925|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
163136876|NCT02834247|589207926|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
163136877|NCT02834247|589207927|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
163136878|NCT02834247|589207928|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
163408585|NCT03594227|590205557|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
163408586|NCT03594227|590205558|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
163136879|NCT02834247|589207925|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
163136880|NCT02834247|589207926|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
163136881|NCT02834247|589207927|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
163136882|NCT02834247|589207928|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
163136883|NCT01807299|589207935|FG000|Overall Study|Protocol Violation|3|||
163136884|NCT01807299|589207936|FG001|Overall Study|Protocol Violation|1|||
163136885|NCT01807299|589207937|FG002|Overall Study|Protocol Violation|0|||
163136886|NCT01807299|589207938|FG003|Overall Study|Protocol Violation|2|||
163136887|NCT02476006|589207939|FG000|Overall Study|Death|4|||
163136888|NCT02476006|589207939|FG000|Overall Study|Lack of treatment efficacy|2|||
163408587|NCT03594227|590205559|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
163136889|NCT02476006|589207939|FG000|Overall Study|Pregnancy|1|||
163136890|NCT02476006|589207939|FG000|Overall Study|Participant did not wish to continue|39|||
163136891|NCT02476006|589207939|FG000|Overall Study|Adverse Event|41|||
163136892|NCT02476006|589207939|FG000|Overall Study|Poor compliance to study protocol|3|||
163136893|NCT02476006|589207939|FG000|Overall Study|Sponsor decision|6|||
163136894|NCT02476006|589207939|FG000|Overall Study|Lost to Follow-up|5|||
163136895|NCT02476006|589207939|FG000|Overall Study|Physician Decision|5|||
163136896|NCT02476006|589207939|FG000|Overall Study|Study ended treatment not available|4|||
163136897|NCT02476006|589207939|FG000|Overall Study|Switched to commercial drug|4|||
163136898|NCT02476006|589207939|FG000|Overall Study|Excluded from study|1|||
163136899|NCT02476006|589207939|FG000|Overall Study|Protocol Violation|1|||
163136900|NCT02476006|589207939|FG000|Overall Study|Enrolled but not treated|4|||
163136901|NCT00811174|589207940|FG000|Overall Study|Protocol Violation|2|||
163136902|NCT00811174|589207940|FG000|Overall Study|Sponsors Decision|1|||
163136903|NCT00447226|589209471|FG000|12-Week Open-label Phase|Adverse Event|0|||
163136904|NCT00447226|589209472|FG001|12-Week Open-label Phase|Adverse Event|3|||
163136905|NCT00447226|589209471|FG000|12-Week Open-label Phase|Protocol Violation|0|||
163136906|NCT00447226|589209472|FG001|12-Week Open-label Phase|Protocol Violation|1|||
163136907|NCT00447226|589209471|FG000|12-Week Open-label Phase|Disease Progression|0|||
163136908|NCT00447226|589209472|FG001|12-Week Open-label Phase|Disease Progression|20|||
163136909|NCT00447226|589209471|FG000|12-Week Open-label Phase|Physician Decision|0|||
163136910|NCT00447226|589209472|FG001|12-Week Open-label Phase|Physician Decision|1|||
163136911|NCT00447226|589209471|FG000|Double-blind Phase|Disease Progression|4|||
163136912|NCT00447226|589209472|FG001|Double-blind Phase|Disease Progression|3|||
163136913|NCT03449758|589209480|FG000|Overall Study|Major protocol deviation|1|||
163136914|NCT03449758|589209480|FG000|Overall Study|Treatment inefficacy|5|||
163136915|NCT03449758|589209480|FG000|Overall Study|Adverse Event|9|||
163136916|NCT03449758|589209480|FG000|Overall Study|Consent withdrawal|1|||
163136917|NCT03449758|589209480|FG000|Overall Study|Other unspecified reason|3|||
163136918|NCT00584012|589209489|FG000|Overall Study|Withdrawal by Subject|1|||
163136919|NCT02451943|589209492|FG000|Overall Study|Withdrawal by Subject|13|||
163136920|NCT02451943|589209493|FG001|Overall Study|Withdrawal by Subject|16|||
163136921|NCT02451943|589209492|FG000|Overall Study|Lost to Follow-up|3|||
163136922|NCT02451943|589209493|FG001|Overall Study|Lost to Follow-up|4|||
163136923|NCT02451943|589209492|FG000|Overall Study|Sponsor Decision|0|||
163136924|NCT02451943|589209493|FG001|Overall Study|Sponsor Decision|4|||
163136925|NCT03937713|589209494|FG000|Overall Study|Withdrawal by Subject|3|||
163136926|NCT03937713|589209495|FG001|Overall Study|Withdrawal by Subject|6|||
163136927|NCT03937713|589209494|FG000|Overall Study|Lost to Follow-up|1|||
163136928|NCT03937713|589209495|FG001|Overall Study|Lost to Follow-up|0|||
163136929|NCT02871635|589209496|FG000|Overall Study|Primary lack of efficacy|4|||
163136930|NCT02871635|589209497|FG001|Overall Study|Primary lack of efficacy|4|||
163136931|NCT02871635|589209496|FG000|Overall Study|Protocol Violation|3|||
163136932|NCT02871635|589209497|FG001|Overall Study|Protocol Violation|1|||
163136933|NCT02871635|589209496|FG000|Overall Study|Lost to Follow-up|1|||
163136934|NCT02871635|589209497|FG001|Overall Study|Lost to Follow-up|2|||
163136935|NCT02871635|589209496|FG000|Overall Study|Pregnancy|0|||
163136936|NCT02871635|589209497|FG001|Overall Study|Pregnancy|2|||
163136937|NCT02871635|589209496|FG000|Overall Study|Physician Decision|1|||
163136938|NCT02871635|589209497|FG001|Overall Study|Physician Decision|1|||
163136939|NCT02871635|589209496|FG000|Overall Study|Withdrawal by Subject|3|||
163136940|NCT02871635|589209497|FG001|Overall Study|Withdrawal by Subject|4|||
163136941|NCT02871635|589209496|FG000|Overall Study|Adverse Event|4|||
163136942|NCT02871635|589209497|FG001|Overall Study|Adverse Event|4|||
163136943|NCT02871635|589209496|FG000|Overall Study|Secondary lack of efficacy|2|||
163136944|NCT02871635|589209497|FG001|Overall Study|Secondary lack of efficacy|1|||
163136945|NCT02420379|589209498|FG000|Overall Study|Withdrawal by Subject|0|||
163136946|NCT02420379|589209499|FG001|Overall Study|Withdrawal by Subject|3|||
163136947|NCT02420379|589209498|FG000|Overall Study|Unable to complete due to schooling|0|||
163136948|NCT02420379|589209499|FG001|Overall Study|Unable to complete due to schooling|1|||
163136949|NCT02420379|589209498|FG000|Overall Study|Transitioned to commercial drug|1|||
163136950|NCT02420379|589209499|FG001|Overall Study|Transitioned to commercial drug|0|||
163136951|NCT01402817|589209500|FG000|Overall Study|Withdrawal by Subject|3|||
163136952|NCT01402817|589209500|FG000|Overall Study|Study Suspended by FDA|8|||
163136953|NCT00502671|589209501|FG000|Overall Study|Disease Progression|13|||
163136954|NCT00502671|589209501|FG000|Overall Study|Personal Reasons|22|||
163136955|NCT00502671|589209501|FG000|Overall Study|Lost to Follow-up|7|||
163136956|NCT00502671|589209501|FG000|Overall Study|Protocol Violation|16|||
163136957|NCT00502671|589209501|FG000|Overall Study|Adverse Event|19|||
163136958|NCT00681629|589209508|FG000|Overall Study|Study termination|4|||
163136959|NCT00681629|589209509|FG001|Overall Study|Study termination|2|||
163136960|NCT00681629|589209508|FG000|Overall Study|Adverse Event|1|||
163136961|NCT00681629|589209509|FG001|Overall Study|Adverse Event|0|||
163136962|NCT01410890|589209511|FG000|Overall Study|Withdrawal by Subject|0|||
163136963|NCT01410890|589209512|FG001|Overall Study|Withdrawal by Subject|1|||
163136964|NCT00412893|589209513|FG000|Overall Study|Adverse Event|31|||
163136965|NCT00412893|589209514|FG001|Overall Study|Adverse Event|53|||
163136966|NCT00412893|589209513|FG000|Overall Study|Death|17|||
163136967|NCT00412893|589209514|FG001|Overall Study|Death|21|||
163136968|NCT00412893|589209513|FG000|Overall Study|Insufficient Therapeutic Response|39|||
163136969|NCT00412893|589209514|FG001|Overall Study|Insufficient Therapeutic Response|23|||
163136970|NCT00412893|589209513|FG000|Overall Study|Lost to Follow-up|2|||
163136971|NCT00412893|589209514|FG001|Overall Study|Lost to Follow-up|1|||
163136972|NCT00412893|589209513|FG000|Overall Study|Violation of Selection at Entry|17|||
163136973|NCT00412893|589209514|FG001|Overall Study|Violation of Selection at Entry|10|||
163136974|NCT00412893|589209513|FG000|Overall Study|Other Protocol Violation|10|||
163136975|NCT00412893|589209514|FG001|Overall Study|Other Protocol Violation|6|||
163136976|NCT00412893|589209513|FG000|Overall Study|Did Not Cooperate|12|||
163136977|NCT00412893|589209514|FG001|Overall Study|Did Not Cooperate|9|||
163136978|NCT00412893|589209513|FG000|Overall Study|Administrative Reason|12|||
163136979|NCT00412893|589209514|FG001|Overall Study|Administrative Reason|15|||
163136980|NCT00412893|589209513|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
163136981|NCT00412893|589209514|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
163136982|NCT03951077|589209515|FG000|Overall Study|Adverse Event|1|||
163136983|NCT03951077|589209516|FG001|Overall Study|Adverse Event|0|||
163136984|NCT03951077|589209517|FG002|Overall Study|Adverse Event|0|||
163136985|NCT03951077|589209518|FG003|Overall Study|Adverse Event|0|||
163136986|NCT03951077|589209519|FG004|Overall Study|Adverse Event|0|||
163136987|NCT03951077|589209520|FG005|Overall Study|Adverse Event|0|||
163136988|NCT03951077|589209515|FG000|Overall Study|Withdrawal by Subject|3|||
163136989|NCT03951077|589209516|FG001|Overall Study|Withdrawal by Subject|3|||
163136990|NCT03951077|589209517|FG002|Overall Study|Withdrawal by Subject|0|||
163136991|NCT03951077|589209518|FG003|Overall Study|Withdrawal by Subject|3|||
163136992|NCT03951077|589209519|FG004|Overall Study|Withdrawal by Subject|3|||
163136993|NCT03951077|589209520|FG005|Overall Study|Withdrawal by Subject|2|||
163136994|NCT03951077|589209515|FG000|Overall Study|Lost to Follow-up|1|||
163136995|NCT03951077|589209516|FG001|Overall Study|Lost to Follow-up|1|||
163136996|NCT03951077|589209517|FG002|Overall Study|Lost to Follow-up|2|||
163136997|NCT03951077|589209518|FG003|Overall Study|Lost to Follow-up|3|||
163136998|NCT03951077|589209519|FG004|Overall Study|Lost to Follow-up|2|||
163136999|NCT03951077|589209520|FG005|Overall Study|Lost to Follow-up|3|||
163137000|NCT03951077|589209515|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
163137001|NCT03951077|589209516|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
163137002|NCT03951077|589209517|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
163137003|NCT03951077|589209518|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
163137004|NCT03951077|589209519|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
163137005|NCT03951077|589209520|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
163137006|NCT03951077|589209515|FG000|Overall Study|Other, Not Specified|12|||
163137007|NCT03951077|589209516|FG001|Overall Study|Other, Not Specified|10|||
163137008|NCT03951077|589209517|FG002|Overall Study|Other, Not Specified|10|||
163137009|NCT03951077|589209518|FG003|Overall Study|Other, Not Specified|5|||
163137010|NCT03951077|589209519|FG004|Overall Study|Other, Not Specified|9|||
163137011|NCT03951077|589209520|FG005|Overall Study|Other, Not Specified|6|||
163137012|NCT03951077|589209515|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
163137013|NCT03951077|589209516|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
163137014|NCT03951077|589209517|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
163137015|NCT03951077|589209518|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
163137016|NCT03951077|589209519|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
163137017|NCT03951077|589209520|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
163137018|NCT00086047|589209521|FG000|Overall Study|Lost to Follow-up|7|||
163137019|NCT00086047|589209522|FG001|Overall Study|Lost to Follow-up|6|||
163137020|NCT00086047|589209521|FG000|Overall Study|Physician Decision|0|||
163137021|NCT00086047|589209522|FG001|Overall Study|Physician Decision|1|||
163137022|NCT01395901|589209523|FG000|Overall Study|Lost to Follow-up|4|||
163137023|NCT01395901|589209524|FG001|Overall Study|Lost to Follow-up|0|||
163137024|NCT01395901|589209523|FG000|Overall Study|Randomized but not received study drug|5|||
163137025|NCT01395901|589209524|FG001|Overall Study|Randomized but not received study drug|4|||
163137026|NCT01395901|589209523|FG000|Overall Study|Adverse Event|0|||
163137027|NCT01395901|589209524|FG001|Overall Study|Adverse Event|1|||
163345493|NCT01636778|589973119|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
163137028|NCT01395901|589209523|FG000|Overall Study|Withdrawal of consent|1|||
163137029|NCT01395901|589209524|FG001|Overall Study|Withdrawal of consent|0|||
163137030|NCT03579940|589209529|FG000|Period 2|Withdrawal by Subject|0|||
163137031|NCT03579940|589209530|FG001|Period 2|Withdrawal by Subject|0|||
163137032|NCT03579940|589209531|FG002|Period 2|Withdrawal by Subject|1|||
163137033|NCT03579940|589209532|FG003|Period 2|Withdrawal by Subject|0|||
163137034|NCT03579940|589209533|FG004|Period 2|Withdrawal by Subject|0|||
163137035|NCT03579940|589209534|FG005|Period 2|Withdrawal by Subject|0|||
163137036|NCT03579940|589209535|FG006|Period 2|Withdrawal by Subject|0|||
163137037|NCT03579940|589209536|FG007|Period 2|Withdrawal by Subject|0|||
163137038|NCT03579940|589209537|FG008|Period 2|Withdrawal by Subject|0|||
163137039|NCT03579940|589209538|FG009|Period 2|Withdrawal by Subject|0|||
163137040|NCT03579940|589209539|FG010|Period 2|Withdrawal by Subject|0|||
163137041|NCT01217944|589209540|FG000|Overall Study|Protocol Violation|1|||
163137042|NCT01217944|589209541|FG001|Overall Study|Protocol Violation|1|||
163137043|NCT01217944|589209542|FG002|Overall Study|Protocol Violation|0|||
163137044|NCT01217944|589209540|FG000|Overall Study|Lost to Follow-up|3|||
163137045|NCT01217944|589209541|FG001|Overall Study|Lost to Follow-up|1|||
163137046|NCT01217944|589209542|FG002|Overall Study|Lost to Follow-up|0|||
163137047|NCT01217944|589209540|FG000|Overall Study|Withdrawal by Subject|1|||
163137048|NCT01217944|589209541|FG001|Overall Study|Withdrawal by Subject|2|||
163137049|NCT01217944|589209542|FG002|Overall Study|Withdrawal by Subject|0|||
163137050|NCT01217944|589209540|FG000|Overall Study|Lack of Efficacy|1|||
163137051|NCT01217944|589209541|FG001|Overall Study|Lack of Efficacy|0|||
163137052|NCT01217944|589209542|FG002|Overall Study|Lack of Efficacy|0|||
163137053|NCT01751984|589209543|FG000|Overall Study|Adverse Event|5|||
163137054|NCT01751984|589209544|FG001|Overall Study|Adverse Event|3|||
163137055|NCT01751984|589209543|FG000|Overall Study|Withdrawal by Subject|0|||
163137056|NCT01751984|589209544|FG001|Overall Study|Withdrawal by Subject|1|||
163137057|NCT01751984|589209543|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
163137058|NCT01751984|589209544|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
163137059|NCT00587158|589209545|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
163137060|NCT00587158|589209546|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
163137061|NCT00587158|589209545|FG000|Overall Study|Physician Decision|0|||
163137062|NCT00587158|589209546|FG001|Overall Study|Physician Decision|1|||
163137063|NCT00587158|589209545|FG000|Overall Study|Lost to Follow-up|1|||
163137064|NCT00587158|589209546|FG001|Overall Study|Lost to Follow-up|2|||
163137065|NCT00587158|589209545|FG000|Overall Study|Death|0|||
163137066|NCT00587158|589209546|FG001|Overall Study|Death|1|||
163137067|NCT00587158|589209545|FG000|Overall Study|Subject did not want to take study med|0|||
163137068|NCT00587158|589209546|FG001|Overall Study|Subject did not want to take study med|1|||
163137069|NCT01136408|589209547|FG000|Overall Study|Adverse Event|4|||
163137070|NCT01136408|589209548|FG001|Overall Study|Adverse Event|8|||
163137071|NCT01136408|589209549|FG002|Overall Study|Adverse Event|4|||
163137072|NCT01136408|589209547|FG000|Overall Study|Protocol Violation|1|||
163137073|NCT01136408|589209548|FG001|Overall Study|Protocol Violation|1|||
163137074|NCT01136408|589209549|FG002|Overall Study|Protocol Violation|1|||
163137075|NCT02274792|589209550|FG000|Overall Study|Withdrawal by Subject|13|||
163137076|NCT02274792|589209550|FG000|Overall Study|Lost to Follow-up|8|||
163137077|NCT02274792|589209550|FG000|Overall Study|Protocol Specified Criteria|2|||
163137078|NCT02274792|589209550|FG000|Overall Study|Sponsor Decision|2|||
163137079|NCT02751580|589209551|FG000|Overall Study|Lost to Follow-up|4|||
163137080|NCT02751580|589209551|FG000|Overall Study|Death|2|||
163137081|NCT04854551|589209562|FG000|Overall Study|Withdrawal by Subject|1|||
163137082|NCT04854551|589209563|FG001|Overall Study|Withdrawal by Subject|1|||
163137083|NCT01076036|589209566|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
163137084|NCT02221674|589209567|FG000|Overall Study|Lost to Follow-up|1|||
163137085|NCT02221674|589209568|FG001|Overall Study|Lost to Follow-up|0|||
163137086|NCT02221674|589209569|FG002|Overall Study|Lost to Follow-up|0|||
163137087|NCT05292131|589209570|FG000|Overall Study|Lost to Follow-up|1|||
163137088|NCT05292131|589209571|FG001|Overall Study|Lost to Follow-up|1|||
163137089|NCT05292131|589209570|FG000|Overall Study|Withdrawal by Subject|0|||
163137090|NCT05292131|589209571|FG001|Overall Study|Withdrawal by Subject|1|||
163137091|NCT01345188|589209572|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
163137092|NCT01345188|589209572|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
163137093|NCT04752358|589209573|FG000|Overall Study|Death|2|||
163137094|NCT04752358|589209574|FG001|Overall Study|Death|1|||
163137095|NCT04607837|589209575|FG000|Overall Study|Adverse Event|8|||
163137096|NCT04607837|589209576|FG001|Overall Study|Adverse Event|2|||
163137097|NCT04607837|589209575|FG000|Overall Study|Withdrawal by Subject|8|||
163137098|NCT04607837|589209576|FG001|Overall Study|Withdrawal by Subject|7|||
163137099|NCT04607837|589209575|FG000|Overall Study|Physician Decision|2|||
163137100|NCT04607837|589209576|FG001|Overall Study|Physician Decision|0|||
163137101|NCT04607837|589209575|FG000|Overall Study|Lack of Efficacy|2|||
163137102|NCT04607837|589209576|FG001|Overall Study|Lack of Efficacy|0|||
163137103|NCT04607837|589209575|FG000|Overall Study|Participant terminated by sponsor|1|||
163137104|NCT04607837|589209576|FG001|Overall Study|Participant terminated by sponsor|0|||
163137105|NCT04607837|589209575|FG000|Overall Study|Disease worsening|36|||
163137106|NCT04607837|589209576|FG001|Overall Study|Disease worsening|36|||
163137107|NCT04607837|589209575|FG000|Overall Study|Other|1|||
163345494|NCT01636778|589973120|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
163345495|NCT01636778|589973121|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
163345496|NCT01636778|589973119|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
163345497|NCT01636778|589973120|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
163137108|NCT04607837|589209576|FG001|Overall Study|Other|0|||
163137109|NCT02023996|589209586|FG000|Overall Study|Protocol Violation|6|||
163137110|NCT00465452|589209587|FG000|Overall Study|Adverse Event|1|||
163229419|NCT04115358|589551551|FG002|Overall Study|exfoliation|1|||
163137111|NCT05236257|589209591|FG000|Overall Study|Ongoing with study treatment|29|||
163137112|NCT05236257|589209592|FG001|Overall Study|Ongoing with study treatment|1|||
163137113|NCT05236257|589209591|FG000|Overall Study|Discontinued study treatment|22|||
163137114|NCT05236257|589209592|FG001|Overall Study|Discontinued study treatment|41|||
163137115|NCT05870865|589209593|FG000|Randomized|Did not receive study treatment|2|||
163137116|NCT05870865|589209594|FG001|Randomized|Did not receive study treatment|4|||
163137117|NCT05870865|589209595|FG002|Randomized|Did not receive study treatment|4|||
163137118|NCT05870865|589209596|FG003|Randomized|Did not receive study treatment|3|||
163137119|NCT05870865|589209593|FG000|Treatment Period|Adverse Event|1|||
163137120|NCT05870865|589209594|FG001|Treatment Period|Adverse Event|1|||
163137121|NCT05870865|589209595|FG002|Treatment Period|Adverse Event|1|||
163137122|NCT05870865|589209596|FG003|Treatment Period|Adverse Event|1|||
163137123|NCT05870865|589209593|FG000|Treatment Period|Lost to Follow-up|0|||
163137124|NCT05870865|589209594|FG001|Treatment Period|Lost to Follow-up|1|||
163137125|NCT05870865|589209595|FG002|Treatment Period|Lost to Follow-up|2|||
163137126|NCT05870865|589209596|FG003|Treatment Period|Lost to Follow-up|0|||
163137127|NCT05870865|589209593|FG000|Treatment Period|Protocol Violation|0|||
163137128|NCT05870865|589209594|FG001|Treatment Period|Protocol Violation|0|||
163137129|NCT05870865|589209595|FG002|Treatment Period|Protocol Violation|0|||
163137130|NCT05870865|589209596|FG003|Treatment Period|Protocol Violation|1|||
163137131|NCT05870865|589209593|FG000|Treatment Period|Withdrawal by Subject|0|||
163137132|NCT05870865|589209594|FG001|Treatment Period|Withdrawal by Subject|1|||
163137133|NCT05870865|589209595|FG002|Treatment Period|Withdrawal by Subject|1|||
163137134|NCT05870865|589209596|FG003|Treatment Period|Withdrawal by Subject|1|||
163137135|NCT03828019|589209598|FG000|Overall Study|Withdrawal by Subject|3|||
163137136|NCT03828019|589209599|FG001|Overall Study|Withdrawal by Subject|8|||
163137137|NCT03828019|589209598|FG000|Overall Study|Lost to Follow-up|1|||
163137138|NCT03828019|589209599|FG001|Overall Study|Lost to Follow-up|6|||
163137139|NCT03828019|589209598|FG000|Overall Study|Incarcerated|1|||
163137140|NCT03828019|589209599|FG001|Overall Study|Incarcerated|0|||
163137141|NCT03828019|589209598|FG000|Overall Study|Adverse Event|0|||
163137142|NCT03828019|589209599|FG001|Overall Study|Adverse Event|1|||
163137143|NCT05715242|589209600|FG000|Overall Study|Lost to Follow-up|0|||
163137144|NCT05715242|589209601|FG001|Overall Study|Lost to Follow-up|0|||
163137145|NCT05715242|589209602|FG002|Overall Study|Lost to Follow-up|1|||
163137146|NCT05715242|589209603|FG003|Overall Study|Lost to Follow-up|0|||
163137147|NCT05715242|589209604|FG004|Overall Study|Lost to Follow-up|0|||
163137148|NCT05715242|589209605|FG005|Overall Study|Lost to Follow-up|1|||
163137149|NCT05715242|589209606|FG006|Overall Study|Lost to Follow-up|0|||
163137150|NCT05715242|589209607|FG007|Overall Study|Lost to Follow-up|0|||
163137151|NCT05715242|589209608|FG008|Overall Study|Lost to Follow-up|0|||
163137152|NCT05715242|589209609|FG009|Overall Study|Lost to Follow-up|0|||
163137153|NCT05715242|589209610|FG010|Overall Study|Lost to Follow-up|0|||
163137154|NCT05715242|589209611|FG011|Overall Study|Lost to Follow-up|0|||
163137155|NCT05715242|589209612|FG012|Overall Study|Lost to Follow-up|0|||
163137156|NCT05715242|589209613|FG013|Overall Study|Lost to Follow-up|0|||
163137157|NCT05715242|589209614|FG014|Overall Study|Lost to Follow-up|0|||
163137158|NCT05715242|589209615|FG015|Overall Study|Lost to Follow-up|0|||
163137159|NCT03400176|589209616|FG000|Dose Escalation|Progressive disease|1|||
163137160|NCT03400176|589209617|FG001|Dose Escalation|Progressive disease|1|||
163137161|NCT03400176|589209618|FG002|Dose Escalation|Progressive disease|0|||
163137162|NCT03400176|589209619|FG003|Dose Escalation|Progressive disease|0|||
163137163|NCT03400176|589209620|FG004|Dose Escalation|Progressive disease|1|||
163137164|NCT03400176|589209616|FG000|Dose Escalation|Patient decision|0|||
163137165|NCT03400176|589209617|FG001|Dose Escalation|Patient decision|0|||
163137166|NCT03400176|589209618|FG002|Dose Escalation|Patient decision|0|||
163137167|NCT03400176|589209619|FG003|Dose Escalation|Patient decision|0|||
163137168|NCT03400176|589209620|FG004|Dose Escalation|Patient decision|1|||
163137169|NCT03400176|589209616|FG000|Dose Expansion|Patient decision|0|||
163137170|NCT03400176|589209617|FG001|Dose Expansion|Patient decision|0|||
163137171|NCT03400176|589209618|FG002|Dose Expansion|Patient decision|0|||
163137172|NCT03400176|589209619|FG003|Dose Expansion|Patient decision|1|||
163137173|NCT03400176|589209620|FG004|Dose Expansion|Patient decision|0|||
163137174|NCT03400176|589209616|FG000|Dose Expansion|Adverse Event|0|||
163137175|NCT03400176|589209617|FG001|Dose Expansion|Adverse Event|0|||
163137176|NCT03400176|589209618|FG002|Dose Expansion|Adverse Event|0|||
163137177|NCT03400176|589209619|FG003|Dose Expansion|Adverse Event|1|||
163137178|NCT03400176|589209620|FG004|Dose Expansion|Adverse Event|0|||
163137179|NCT03400176|589209616|FG000|Dose Expansion|Physician Decision|0|||
163137180|NCT03400176|589209617|FG001|Dose Expansion|Physician Decision|0|||
163137181|NCT03400176|589209618|FG002|Dose Expansion|Physician Decision|0|||
163137182|NCT03400176|589209619|FG003|Dose Expansion|Physician Decision|1|||
163137183|NCT03400176|589209620|FG004|Dose Expansion|Physician Decision|0|||
163137184|NCT03400176|589209616|FG000|Dose Expansion|Progressive disease|0|||
163137185|NCT03400176|589209617|FG001|Dose Expansion|Progressive disease|0|||
163137186|NCT03400176|589209618|FG002|Dose Expansion|Progressive disease|1|||
163137187|NCT03400176|589209619|FG003|Dose Expansion|Progressive disease|1|||
163137188|NCT03400176|589209620|FG004|Dose Expansion|Progressive disease|0|||
163137189|NCT01090063|589209628|FG000|Screen|Screen Failed|4|||
163137190|NCT01090063|589209628|FG000|Treatment|Withdrawal by Subject|4|||
163137191|NCT00048347|589209629|FG000|Overall Study|Screen failure|2|||
163137192|NCT02863328|589209630|FG000|Overall Study|Lost to Follow-up|4|||
163137193|NCT02863328|589209631|FG001|Overall Study|Lost to Follow-up|10|||
163137194|NCT02863328|589209630|FG000|Overall Study|Withdrawal by Subject|7|||
163137195|NCT02863328|589209631|FG001|Overall Study|Withdrawal by Subject|12|||
163137196|NCT02863328|589209630|FG000|Overall Study|Died|0|||
163137197|NCT02863328|589209631|FG001|Overall Study|Died|1|||
163137198|NCT04565951|589209634|FG000|Overall Study|Lost to Follow-up|66|||
163137199|NCT04565951|589209635|FG001|Overall Study|Lost to Follow-up|38|||
163137200|NCT04565951|589209634|FG000|Overall Study|Withdrawal by Subject|14|||
163137201|NCT04565951|589209635|FG001|Overall Study|Withdrawal by Subject|7|||
163137202|NCT04565951|589209634|FG000|Overall Study|Death|0|||
163137203|NCT04565951|589209635|FG001|Overall Study|Death|1|||
163137204|NCT00429169|589209636|FG000|Overall Study|Lost to Follow-up|0|||
163137205|NCT00429169|589209637|FG001|Overall Study|Lost to Follow-up|1|||
163137206|NCT00429169|589209636|FG000|Overall Study|Ineligibility discovered after entry|2|||
163137207|NCT00429169|589209637|FG001|Overall Study|Ineligibility discovered after entry|1|||
163137208|NCT02936635|589211285|FG000|Overall Study|Adverse Event|43|||
163137209|NCT02936635|589211286|FG001|Overall Study|Adverse Event|25|||
163137210|NCT02936635|589211285|FG000|Overall Study|Progressive Disease|10|||
163137211|NCT02936635|589211286|FG001|Overall Study|Progressive Disease|18|||
163137212|NCT02936635|589211285|FG000|Overall Study|Sponsor Discretion|10|||
163137213|NCT02936635|589211286|FG001|Overall Study|Sponsor Discretion|16|||
163137214|NCT02936635|589211285|FG000|Overall Study|Death|9|||
163137215|NCT02936635|589211286|FG001|Overall Study|Death|15|||
163137216|NCT02936635|589211285|FG000|Overall Study|Withdrawal by Subject|8|||
163137217|NCT02936635|589211286|FG001|Overall Study|Withdrawal by Subject|15|||
163137218|NCT02936635|589211285|FG000|Overall Study|Physician Decision|2|||
163137219|NCT02936635|589211286|FG001|Overall Study|Physician Decision|9|||
163137220|NCT02936635|589211285|FG000|Overall Study|Lost to Follow-up|1|||
163137221|NCT02936635|589211286|FG001|Overall Study|Lost to Follow-up|2|||
163137222|NCT02936635|589211285|FG000|Overall Study|Protocol Violation|1|||
163137223|NCT02936635|589211286|FG001|Overall Study|Protocol Violation|0|||
163137224|NCT02936635|589211285|FG000|Overall Study|Lack of effect/Entry into other study|31|||
163137225|NCT02936635|589211286|FG001|Overall Study|Lack of effect/Entry into other study|65|||
163137226|NCT02407223|589211287|FG000|Overall Study|Adverse Event|1|||
163137227|NCT02407223|589211288|FG001|Overall Study|Adverse Event|0|||
163137228|NCT02407223|589211289|FG002|Overall Study|Adverse Event|1|||
163137229|NCT02407223|589211287|FG000|Overall Study|Lack of Efficacy|6|||
163137230|NCT02407223|589211288|FG001|Overall Study|Lack of Efficacy|6|||
163137231|NCT02407223|589211289|FG002|Overall Study|Lack of Efficacy|4|||
163137232|NCT02407223|589211287|FG000|Overall Study|Lost to Follow-up|1|||
163137233|NCT02407223|589211288|FG001|Overall Study|Lost to Follow-up|0|||
163137234|NCT02407223|589211289|FG002|Overall Study|Lost to Follow-up|2|||
163137235|NCT02407223|589211287|FG000|Overall Study|Withdrawal by Subject|2|||
163137236|NCT02407223|589211288|FG001|Overall Study|Withdrawal by Subject|4|||
163137237|NCT02407223|589211289|FG002|Overall Study|Withdrawal by Subject|4|||
163137238|NCT02407223|589211287|FG000|Overall Study|Study Terminated by Sponsor|77|||
163137239|NCT02407223|589211288|FG001|Overall Study|Study Terminated by Sponsor|80|||
163137240|NCT02407223|589211289|FG002|Overall Study|Study Terminated by Sponsor|86|||
163137241|NCT02407223|589211287|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
163137242|NCT02407223|589211288|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
163137243|NCT02407223|589211289|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
163137244|NCT02407223|589211287|FG000|Overall Study|Other|29|||
163137245|NCT02407223|589211288|FG001|Overall Study|Other|27|||
163137246|NCT02407223|589211289|FG002|Overall Study|Other|25|||
163137247|NCT01478971|589211290|FG000|Standard of Care Period|Adverse Event|1|||
163137248|NCT01478971|589211290|FG000|Standard of Care Period|Withdrawal by Subject|3|||
163137249|NCT01478971|589211290|FG000|Standard of Care Period|Death|8|||
163137250|NCT01478971|589211290|FG000|Standard of Care Period|Lost to Follow-up|9|||
163137251|NCT01478971|589211290|FG000|Standard of Care Period|Other|4|||
163137252|NCT01478971|589211290|FG000|Peginesatide Treatment Period|Adverse Event|1|||
163137253|NCT01478971|589211290|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
163137254|NCT01478971|589211290|FG000|Peginesatide Treatment Period|Death|4|||
163137255|NCT01478971|589211290|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
163137256|NCT01478971|589211290|FG000|Peginesatide Treatment Period|Other|4|||
163137257|NCT04404556|589211291|FG000|Intervention|Withdrawal by Subject|15|||
163137258|NCT04404556|589211292|FG001|Intervention|Withdrawal by Subject|3|||
163137259|NCT04404556|589211291|FG000|Intervention|Did not complete all intervention sessions|2|||
163137260|NCT04404556|589211292|FG001|Intervention|Did not complete all intervention sessions|1|||
163137261|NCT04404556|589211291|FG000|Post-Intervention|Missing Data|1|||
163137262|NCT04404556|589211292|FG001|Post-Intervention|Missing Data|2|||
163137263|NCT04404556|589211291|FG000|Follow-up 1|Withdrawal by Subject|5|||
163137264|NCT04404556|589211292|FG001|Follow-up 1|Withdrawal by Subject|1|||
163137265|NCT04404556|589211291|FG000|Follow-up 1|Missing Data|4|||
163229420|NCT01573624|589551554|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
163229421|NCT01573624|589551555|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
163229422|NCT01573624|589551556|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
163229423|NCT01573624|589551557|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
163229424|NCT01573624|589551558|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
163229425|NCT01573624|589551559|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
163229426|NCT01573624|589551560|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
163229427|NCT01573624|589551554|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
163229428|NCT01573624|589551555|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
163229429|NCT01573624|589551556|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
163229430|NCT01573624|589551557|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
163229431|NCT01573624|589551558|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
163229432|NCT01573624|589551559|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
163229433|NCT01573624|589551560|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
163229434|NCT01573624|589551554|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
163229435|NCT01573624|589551555|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
163229436|NCT01573624|589551556|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
163229437|NCT01573624|589551557|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
163229438|NCT01573624|589551558|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
163229439|NCT01573624|589551559|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
163229440|NCT01573624|589551560|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
163229441|NCT01573624|589551554|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163229442|NCT01573624|589551555|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163229443|NCT01573624|589551556|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163229444|NCT01573624|589551557|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163229445|NCT01573624|589551558|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163229446|NCT01573624|589551559|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
163229447|NCT01573624|589551560|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163229448|NCT01573624|589551554|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
163229449|NCT01573624|589551555|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
163229450|NCT01573624|589551556|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
163229451|NCT01573624|589551557|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
163229452|NCT01573624|589551558|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
163229453|NCT01573624|589551559|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
163229454|NCT01573624|589551560|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
163229455|NCT01573624|589551554|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
163229456|NCT01573624|589551555|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
163229457|NCT01573624|589551556|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
163229458|NCT01573624|589551557|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
163229459|NCT01573624|589551558|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
163229460|NCT01573624|589551559|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
163229461|NCT01573624|589551560|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
163229462|NCT01573624|589551554|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
163229463|NCT01573624|589551555|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
163229464|NCT01573624|589551556|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
163229465|NCT01573624|589551557|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
163229466|NCT01573624|589551558|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
163229467|NCT01573624|589551559|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
163229468|NCT01573624|589551560|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
163229469|NCT01573624|589551554|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
163229470|NCT01573624|589551555|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
163229471|NCT01573624|589551556|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
163229472|NCT01573624|589551557|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
163229473|NCT01573624|589551558|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
163229474|NCT01573624|589551559|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
163229475|NCT01573624|589551560|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
163229476|NCT01573624|589551554|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
163229477|NCT01573624|589551555|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
163229478|NCT01573624|589551556|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
163229479|NCT01573624|589551557|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
163229480|NCT01573624|589551558|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
163345498|NCT01636778|589973121|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
163137266|NCT04404556|589211292|FG001|Follow-up 1|Missing Data|7|||
163137267|NCT04404556|589211291|FG000|Follow-up 2|Withdrawal by Subject|1|||
163137268|NCT04404556|589211292|FG001|Follow-up 2|Withdrawal by Subject|1|||
163137269|NCT04404556|589211291|FG000|Follow-up 2|Missing Data|6|||
163137270|NCT04404556|589211292|FG001|Follow-up 2|Missing Data|5|||
163137271|NCT00763386|589211301|FG000|Overall Study|Adverse Event|43|||
163137272|NCT00763386|589211302|FG001|Overall Study|Adverse Event|33|||
163137273|NCT00763386|589211301|FG000|Overall Study|Death|1|||
163137274|NCT00763386|589211302|FG001|Overall Study|Death|2|||
163137275|NCT00763386|589211301|FG000|Overall Study|Lost to Follow-up|3|||
163137276|NCT00763386|589211302|FG001|Overall Study|Lost to Follow-up|3|||
163137277|NCT00763386|589211301|FG000|Overall Study|Withdrawal by Subject|0|||
163137278|NCT00763386|589211302|FG001|Overall Study|Withdrawal by Subject|1|||
163137279|NCT00763386|589211301|FG000|Overall Study|CRF missing|0|||
163137280|NCT00763386|589211302|FG001|Overall Study|CRF missing|1|||
163137281|NCT00763386|589211301|FG000|Overall Study|Study Prosthesis Removed|1|||
163137282|NCT00763386|589211302|FG001|Overall Study|Study Prosthesis Removed|0|||
163137283|NCT00922623|589211303|FG000|Overall Study|Other|4|||
163137284|NCT00922623|589211303|FG000|Overall Study|Lost to Follow-up|1|||
163137285|NCT02451917|589211304|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
163137286|NCT02451917|589211305|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
163137287|NCT02451917|589211304|FG000|First Intervention (24 Weeks)|Death|0|||
163137288|NCT02451917|589211305|FG001|First Intervention (24 Weeks)|Death|1|||
163137289|NCT02451917|589211304|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
163137290|NCT02451917|589211305|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
163137291|NCT00853151|589211310|FG000|Overall Study|Adverse Event|1|||
163137292|NCT00853151|589211311|FG001|Overall Study|Adverse Event|4|||
163137293|NCT00853151|589211312|FG002|Overall Study|Adverse Event|2|||
163137294|NCT00853151|589211313|FG003|Overall Study|Adverse Event|0|||
163137295|NCT00853151|589211310|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
163137296|NCT00853151|589211311|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163137297|NCT00853151|589211312|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163137298|NCT00853151|589211313|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163137299|NCT00853151|589211310|FG000|Overall Study|Lost to Follow-up|2|||
163137300|NCT00853151|589211311|FG001|Overall Study|Lost to Follow-up|0|||
163137301|NCT00853151|589211312|FG002|Overall Study|Lost to Follow-up|3|||
163137302|NCT00853151|589211313|FG003|Overall Study|Lost to Follow-up|0|||
163137303|NCT00853151|589211310|FG000|Overall Study|Death|1|||
163137304|NCT00853151|589211311|FG001|Overall Study|Death|0|||
163137305|NCT00853151|589211312|FG002|Overall Study|Death|0|||
163137306|NCT00853151|589211313|FG003|Overall Study|Death|1|||
163137307|NCT00853151|589211310|FG000|Overall Study|Protocol Violation|0|||
163137308|NCT00853151|589211311|FG001|Overall Study|Protocol Violation|0|||
163137309|NCT00853151|589211312|FG002|Overall Study|Protocol Violation|0|||
163137310|NCT00853151|589211313|FG003|Overall Study|Protocol Violation|1|||
163137311|NCT00853151|589211310|FG000|Overall Study|Withdrawal by Subject|5|||
163137312|NCT00853151|589211311|FG001|Overall Study|Withdrawal by Subject|4|||
163137313|NCT00853151|589211312|FG002|Overall Study|Withdrawal by Subject|2|||
163137314|NCT00853151|589211313|FG003|Overall Study|Withdrawal by Subject|1|||
163137315|NCT00853151|589211310|FG000|Overall Study|Physician Decision|0|||
163137316|NCT00853151|589211311|FG001|Overall Study|Physician Decision|2|||
163137317|NCT00853151|589211312|FG002|Overall Study|Physician Decision|1|||
163137318|NCT00853151|589211313|FG003|Overall Study|Physician Decision|0|||
163137319|NCT00853151|589211310|FG000|Overall Study|Sponsor Decision|0|||
163137320|NCT00853151|589211311|FG001|Overall Study|Sponsor Decision|3|||
163137321|NCT00853151|589211312|FG002|Overall Study|Sponsor Decision|0|||
163137322|NCT00853151|589211313|FG003|Overall Study|Sponsor Decision|0|||
163137323|NCT01510158|589211314|FG000|Overall Study|Adverse Event|7|||
163137324|NCT01510158|589211315|FG001|Overall Study|Adverse Event|8|||
163137325|NCT01510158|589211316|FG002|Overall Study|Adverse Event|5|||
163137326|NCT01510158|589211314|FG000|Overall Study|Gout flare|1|||
163137327|NCT01510158|589211315|FG001|Overall Study|Gout flare|0|||
163137328|NCT01510158|589211316|FG002|Overall Study|Gout flare|0|||
163137329|NCT01510158|589211314|FG000|Overall Study|Protocol Violation|17|||
163137330|NCT01510158|589211315|FG001|Overall Study|Protocol Violation|16|||
163137331|NCT01510158|589211316|FG002|Overall Study|Protocol Violation|24|||
163137332|NCT01510158|589211314|FG000|Overall Study|Sponsor terminated study.|2|||
163345499|NCT01636778|589973119|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
163137333|NCT01510158|589211315|FG001|Overall Study|Sponsor terminated study.|0|||
163137334|NCT01510158|589211316|FG002|Overall Study|Sponsor terminated study.|2|||
163345500|NCT01636778|589973120|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
163137335|NCT01510158|589211314|FG000|Overall Study|Lost to Follow-up|13|||
163137336|NCT01510158|589211315|FG001|Overall Study|Lost to Follow-up|16|||
163229481|NCT01573624|589551559|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
163229482|NCT01573624|589551560|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
163137337|NCT01510158|589211316|FG002|Overall Study|Lost to Follow-up|9|||
163137338|NCT01510158|589211314|FG000|Overall Study|Withdrawal by Subject|10|||
163137339|NCT01510158|589211315|FG001|Overall Study|Withdrawal by Subject|13|||
163137340|NCT01510158|589211316|FG002|Overall Study|Withdrawal by Subject|10|||
163345501|NCT01636778|589973121|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
163345502|NCT01636778|589973119|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
163345503|NCT01636778|589973120|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
163345504|NCT01636778|589973121|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
163345505|NCT01636778|589973119|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
163137341|NCT01510158|589211314|FG000|Overall Study|Death|1|||
163137342|NCT01510158|589211315|FG001|Overall Study|Death|0|||
163137343|NCT01510158|589211316|FG002|Overall Study|Death|0|||
163137344|NCT03078556|589211317|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
163137345|NCT03078556|589211318|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
163137346|NCT03078556|589211319|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
163137347|NCT03078556|589211320|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
163137348|NCT03078556|589211317|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
163137349|NCT03078556|589211318|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
163137350|NCT03078556|589211319|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
163137351|NCT03078556|589211320|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
163137352|NCT03078556|589211317|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
163137353|NCT03078556|589211318|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
163137354|NCT03078556|589211319|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
163137355|NCT03078556|589211320|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
163137356|NCT03078556|589211317|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
163137357|NCT03078556|589211318|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
163137358|NCT03078556|589211319|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
163137359|NCT03078556|589211320|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
163137360|NCT00832416|589211327|FG000|Overall Study|Lack of Efficacy|17|||
163137361|NCT00832416|589211328|FG001|Overall Study|Lack of Efficacy|15|||
163137362|NCT00832416|589211329|FG002|Overall Study|Lack of Efficacy|13|||
163137363|NCT00832416|589211330|FG003|Overall Study|Lack of Efficacy|52|||
163137364|NCT00832416|589211327|FG000|Overall Study|Withdrawal by Subject|5|||
163137365|NCT00832416|589211328|FG001|Overall Study|Withdrawal by Subject|7|||
163137366|NCT00832416|589211329|FG002|Overall Study|Withdrawal by Subject|2|||
163137367|NCT00832416|589211330|FG003|Overall Study|Withdrawal by Subject|10|||
163137368|NCT00832416|589211327|FG000|Overall Study|Physician Decision|2|||
163137369|NCT00832416|589211328|FG001|Overall Study|Physician Decision|12|||
163137370|NCT00832416|589211329|FG002|Overall Study|Physician Decision|5|||
163137371|NCT00832416|589211330|FG003|Overall Study|Physician Decision|10|||
163137372|NCT00832416|589211327|FG000|Overall Study|Administrative|0|||
163137373|NCT00832416|589211328|FG001|Overall Study|Administrative|0|||
163137374|NCT00832416|589211329|FG002|Overall Study|Administrative|0|||
163137375|NCT00832416|589211330|FG003|Overall Study|Administrative|1|||
163137376|NCT00832416|589211327|FG000|Overall Study|Adverse Event|21|||
163137377|NCT00832416|589211328|FG001|Overall Study|Adverse Event|19|||
163137378|NCT00832416|589211329|FG002|Overall Study|Adverse Event|41|||
163137379|NCT00832416|589211330|FG003|Overall Study|Adverse Event|10|||
163137380|NCT00832416|589211327|FG000|Overall Study|Death|1|||
163137381|NCT00832416|589211328|FG001|Overall Study|Death|0|||
163137382|NCT00832416|589211329|FG002|Overall Study|Death|0|||
163137383|NCT00832416|589211330|FG003|Overall Study|Death|0|||
163137384|NCT04421482|589211337|FG000|Overall Study|Physician Decision|1|||
163137385|NCT00571038|589211340|FG000|Overall Study|Lost to Follow-up|1|||
163137386|NCT00571038|589211341|FG001|Overall Study|Lost to Follow-up|4|||
163137387|NCT00571038|589211340|FG000|Overall Study|Death|7|||
163137388|NCT00571038|589211341|FG001|Overall Study|Death|5|||
163137389|NCT00571038|589211340|FG000|Overall Study|Withdrawal by Subject|1|||
163137390|NCT00571038|589211341|FG001|Overall Study|Withdrawal by Subject|3|||
163137391|NCT00571038|589211340|FG000|Overall Study|Moved out of state|2|||
163137392|NCT00571038|589211341|FG001|Overall Study|Moved out of state|2|||
163137393|NCT05786508|589211342|FG000|Overall Study|Withdrawal by Subject|2|||
163137394|NCT05786508|589211343|FG001|Overall Study|Withdrawal by Subject|0|||
163137395|NCT04426318|589211344|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
163137396|NCT04426318|589211345|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
163345506|NCT01636778|589973120|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
163137397|NCT02588261|589211348|FG000|Overall Study|Study Terminated by Sponsor|157|||
163137398|NCT02588261|589211349|FG001|Overall Study|Study Terminated by Sponsor|142|||
163137399|NCT02588261|589211348|FG000|Overall Study|Protocol Deviation|1|||
163137400|NCT02588261|589211349|FG001|Overall Study|Protocol Deviation|0|||
163137401|NCT02588261|589211348|FG000|Overall Study|Death|1|||
163137402|NCT02588261|589211349|FG001|Overall Study|Death|2|||
163137403|NCT02588261|589211348|FG000|Overall Study|Withdrawal by Subject|12|||
163137404|NCT02588261|589211349|FG001|Overall Study|Withdrawal by Subject|8|||
163345507|NCT01636778|589973121|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
163137405|NCT02588261|589211348|FG000|Overall Study|Noncompliance with Study Drug|0|||
163137406|NCT02588261|589211349|FG001|Overall Study|Noncompliance with Study Drug|1|||
163137407|NCT02588261|589211348|FG000|Overall Study|Miscellaneous|5|||
163137408|NCT02588261|589211349|FG001|Overall Study|Miscellaneous|4|||
163137409|NCT02588261|589211348|FG000|Overall Study|Progressive Disease|61|||
163408588|NCT03594227|590205560|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
163408589|NCT00109707|590205565|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
163408590|NCT00109707|590205566|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
163408591|NCT00109707|590205567|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
163408592|NCT00109707|590205565|FG000|Overall Study|Abnormal laboratory values|1|||
163408593|NCT00109707|590205566|FG001|Overall Study|Abnormal laboratory values|0|||
163408594|NCT00109707|590205567|FG002|Overall Study|Abnormal laboratory values|0|||
163408595|NCT00109707|590205565|FG000|Overall Study|Administrative problems|2|||
163408596|NCT00109707|590205566|FG001|Overall Study|Administrative problems|0|||
163408597|NCT00109707|590205567|FG002|Overall Study|Administrative problems|1|||
163408598|NCT00109707|590205565|FG000|Overall Study|Adverse Event|10|||
163408599|NCT00109707|590205566|FG001|Overall Study|Adverse Event|2|||
163408600|NCT00109707|590205567|FG002|Overall Study|Adverse Event|3|||
163408601|NCT00109707|590205565|FG000|Overall Study|Death|4|||
163408602|NCT00109707|590205566|FG001|Overall Study|Death|0|||
163408603|NCT00109707|590205567|FG002|Overall Study|Death|0|||
163408604|NCT00109707|590205565|FG000|Overall Study|Disease progression|12|||
163408605|NCT00109707|590205566|FG001|Overall Study|Disease progression|4|||
163408606|NCT00109707|590205567|FG002|Overall Study|Disease progression|3|||
163408607|NCT00109707|590205565|FG000|Overall Study|Lost to Follow-up|3|||
163408608|NCT00109707|590205566|FG001|Overall Study|Lost to Follow-up|0|||
163408609|NCT00109707|590205567|FG002|Overall Study|Lost to Follow-up|0|||
163408610|NCT00109707|590205565|FG000|Overall Study|Protocol Violation|1|||
163408611|NCT00109707|590205566|FG001|Overall Study|Protocol Violation|0|||
163408612|NCT00109707|590205567|FG002|Overall Study|Protocol Violation|0|||
163408613|NCT00109707|590205565|FG000|Overall Study|Patient withdrew consent|6|||
163408614|NCT00109707|590205566|FG001|Overall Study|Patient withdrew consent|1|||
163408615|NCT00109707|590205567|FG002|Overall Study|Patient withdrew consent|0|||
163408616|NCT01618214|590205573|FG000|Overall Study|Adverse Event|3|||
163408617|NCT01618214|590205574|FG001|Overall Study|Adverse Event|1|||
163408618|NCT01618214|590205573|FG000|Overall Study|Lack of Efficacy|1|||
163408619|NCT01618214|590205574|FG001|Overall Study|Lack of Efficacy|1|||
163408620|NCT01618214|590205573|FG000|Overall Study|Protocol Violation|1|||
163408621|NCT01618214|590205574|FG001|Overall Study|Protocol Violation|4|||
163408622|NCT01618214|590205573|FG000|Overall Study|Withdrawal Criteria|1|||
163408623|NCT01618214|590205574|FG001|Overall Study|Withdrawal Criteria|2|||
163408624|NCT01618214|590205573|FG000|Overall Study|Unclassified|4|||
163408625|NCT01618214|590205574|FG001|Overall Study|Unclassified|5|||
163408626|NCT00623428|590205577|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
163345508|NCT01636778|589973119|FG000|Follow-up Period After Part 2|Other|0|||
163345509|NCT01636778|589973120|FG001|Follow-up Period After Part 2|Other|0|||
163345510|NCT01636778|589973121|FG002|Follow-up Period After Part 2|Other|1|||
163345511|NCT01636778|589973119|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
163345512|NCT01636778|589973120|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
163345513|NCT01636778|589973121|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
163345514|NCT01636778|589973119|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
163345515|NCT01636778|589973120|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
163345516|NCT01636778|589973121|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
163345517|NCT00990821|589973124|FG000|Overall Study|Withdrawal by Subject|0|||
163408627|NCT00623428|590205578|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
163408628|NCT00623428|590205577|FG000|Treatment Period|Death|0|||
163408629|NCT00623428|590205578|FG001|Treatment Period|Death|1|||
163408630|NCT00623428|590205577|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
163408631|NCT00623428|590205578|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
163408632|NCT00623428|590205577|FG000|Treatment Period|Insufficient therapeutic response|0|||
163345518|NCT00990821|589973125|FG001|Overall Study|Withdrawal by Subject|2|||
163408633|NCT00623428|590205578|FG001|Treatment Period|Insufficient therapeutic response|2|||
163408634|NCT00623428|590205577|FG000|Treatment Period|Other|0|||
163408635|NCT00623428|590205578|FG001|Treatment Period|Other|1|||
163408636|NCT00623428|590205577|FG000|Treatment Period|Withdrawal by Subject|0|||
163408637|NCT00623428|590205578|FG001|Treatment Period|Withdrawal by Subject|1|||
163408638|NCT00623428|590205577|FG000|Follow-up Period|Relapse post-treatment|11|||
163408639|NCT00623428|590205578|FG001|Follow-up Period|Relapse post-treatment|3|||
163408640|NCT00623428|590205577|FG000|Follow-up Period|Failure to return|10|||
163408641|NCT00623428|590205578|FG001|Follow-up Period|Failure to return|2|||
163408642|NCT00623428|590205577|FG000|Follow-up Period|Patient withdrew consent|5|||
163408643|NCT00623428|590205578|FG001|Follow-up Period|Patient withdrew consent|4|||
163408644|NCT00623428|590205577|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
163408645|NCT00623428|590205578|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
163408646|NCT00623428|590205577|FG000|Follow-up Period|Did not cooperate|0|||
163408647|NCT00623428|590205578|FG001|Follow-up Period|Did not cooperate|3|||
163408648|NCT00623428|590205577|FG000|Follow-up Period|Reason not specified|1|||
163408649|NCT00623428|590205578|FG001|Follow-up Period|Reason not specified|1|||
163408650|NCT00623428|590205577|FG000|Follow-up Period|Death|0|||
163137410|NCT02588261|589211349|FG001|Overall Study|Progressive Disease|82|||
163137411|NCT02588261|589211348|FG000|Overall Study|Adverse Event|29|||
163137412|NCT02588261|589211349|FG001|Overall Study|Adverse Event|24|||
163137413|NCT02588261|589211348|FG000|Overall Study|Lost to Follow-up|1|||
163137414|NCT02588261|589211349|FG001|Overall Study|Lost to Follow-up|0|||
163137415|NCT03781778|589211350|FG000|Overall Study|Withdrawal by Subject|2|||
163137416|NCT03781778|589211351|FG001|Overall Study|Withdrawal by Subject|2|||
163137417|NCT02287467|589211352|FG000|Overall Study|Protocol Violation|12|||
163137418|NCT02287467|589211353|FG001|Overall Study|Protocol Violation|9|||
163137419|NCT01456169|589211356|FG000|Overall Study|Adverse Event|1|||
163137420|NCT01456169|589211357|FG001|Overall Study|Adverse Event|2|||
163137421|NCT01456169|589211358|FG002|Overall Study|Adverse Event|7|||
163137422|NCT01456169|589211356|FG000|Overall Study|Major Protocol Deviation|3|||
163137423|NCT01456169|589211357|FG001|Overall Study|Major Protocol Deviation|2|||
163137424|NCT01456169|589211358|FG002|Overall Study|Major Protocol Deviation|3|||
163137425|NCT01456169|589211356|FG000|Overall Study|Voluntary Withdrawal|3|||
163137426|NCT01456169|589211357|FG001|Overall Study|Voluntary Withdrawal|0|||
163137427|NCT01456169|589211358|FG002|Overall Study|Voluntary Withdrawal|2|||
163137428|NCT01456169|589211356|FG000|Overall Study|Lack of Efficacy|2|||
163137429|NCT01456169|589211357|FG001|Overall Study|Lack of Efficacy|0|||
163137430|NCT01456169|589211358|FG002|Overall Study|Lack of Efficacy|0|||
163137431|NCT01456169|589211356|FG000|Overall Study|Other|1|||
163137432|NCT01456169|589211357|FG001|Overall Study|Other|1|||
163137433|NCT01456169|589211358|FG002|Overall Study|Other|0|||
163137434|NCT02292446|589211359|FG000|Overall Study|Adverse Event|12|||
163137435|NCT02292446|589211359|FG000|Overall Study|Death|1|||
163137436|NCT02292446|589211359|FG000|Overall Study|Disease progression|2|||
163137437|NCT02292446|589211359|FG000|Overall Study|Subject/guardian decision|2|||
163137438|NCT02292446|589211359|FG000|Overall Study|Withdrawal by Subject|3|||
163137439|NCT02652156|589211360|FG000|Overall Study|Physician Decision|1|||
163137440|NCT02652156|589211361|FG001|Overall Study|Physician Decision|0|||
163137441|NCT02652156|589211362|FG002|Overall Study|Physician Decision|0|||
163137442|NCT00496080|589211365|FG000|Overall Study|Lost to Follow-up|9|||
163137443|NCT00496080|589211365|FG000|Overall Study|Surgical re-intervention|7|||
163345519|NCT00990821|589973126|FG002|Overall Study|Withdrawal by Subject|0|||
163345520|NCT00990821|589973127|FG003|Overall Study|Withdrawal by Subject|0|||
163345521|NCT00990821|589973128|FG004|Overall Study|Withdrawal by Subject|3|||
163345522|NCT00990821|589973129|FG005|Overall Study|Withdrawal by Subject|3|||
163345523|NCT00990821|589973130|FG006|Overall Study|Withdrawal by Subject|1|||
163345524|NCT00990821|589973131|FG007|Overall Study|Withdrawal by Subject|0|||
163345525|NCT00990821|589973132|FG008|Overall Study|Withdrawal by Subject|0|||
163345526|NCT00990821|589973133|FG009|Overall Study|Withdrawal by Subject|1|||
163137444|NCT00496080|589211365|FG000|Overall Study|Withdrawal by Subject|5|||
163137445|NCT00496080|589211365|FG000|Overall Study|Physician Decision|6|||
163137446|NCT02741596|589211366|FG000|Overall Study|Adverse Event|1|||
163137447|NCT02741596|589211367|FG001|Overall Study|Adverse Event|5|||
163137448|NCT02741596|589211366|FG000|Overall Study|Lost to Follow-up|1|||
163137449|NCT02741596|589211367|FG001|Overall Study|Lost to Follow-up|1|||
163137450|NCT02741596|589211366|FG000|Overall Study|Physician Decision|2|||
163137451|NCT02741596|589211367|FG001|Overall Study|Physician Decision|1|||
163137452|NCT02741596|589211366|FG000|Overall Study|Pregnancy|3|||
163137453|NCT02741596|589211367|FG001|Overall Study|Pregnancy|1|||
163137454|NCT02741596|589211366|FG000|Overall Study|Other (Unspecified)|0|||
163137455|NCT02741596|589211367|FG001|Overall Study|Other (Unspecified)|3|||
163137456|NCT02741596|589211366|FG000|Overall Study|Subject withdrawn-Other|17|||
163137457|NCT02741596|589211367|FG001|Overall Study|Subject withdrawn-Other|4|||
163137458|NCT02741596|589211366|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
163137459|NCT02741596|589211367|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
163137460|NCT03329846|589211368|FG000|Overall Study|Disease progression|4|||
163137461|NCT03329846|589211369|FG001|Overall Study|Disease progression|6|||
163137462|NCT03329846|589211368|FG000|Overall Study|Study drug toxicity|1|||
163137463|NCT03329846|589211369|FG001|Overall Study|Study drug toxicity|0|||
163137464|NCT03329846|589211368|FG000|Overall Study|Participant request to discontinue treatment|0|||
163137465|NCT03329846|589211369|FG001|Overall Study|Participant request to discontinue treatment|1|||
163137466|NCT03329846|589211368|FG000|Overall Study|Participant withdrew consent|1|||
163137467|NCT03329846|589211369|FG001|Overall Study|Participant withdrew consent|0|||
163137468|NCT03329846|589211368|FG000|Overall Study|Other reasons|2|||
163137469|NCT03329846|589211369|FG001|Overall Study|Other reasons|2|||
163137470|NCT00479336|589211370|FG000|Overall Study|Adverse Event|1|||
163137471|NCT00479336|589211371|FG001|Overall Study|Adverse Event|1|||
163137472|NCT00479336|589211372|FG002|Overall Study|Adverse Event|1|||
163137473|NCT00479336|589211373|FG003|Overall Study|Adverse Event|3|||
163137474|NCT00479336|589211370|FG000|Overall Study|Lack of Efficacy|1|||
163137475|NCT00479336|589211371|FG001|Overall Study|Lack of Efficacy|0|||
163137476|NCT00479336|589211372|FG002|Overall Study|Lack of Efficacy|0|||
163137477|NCT00479336|589211373|FG003|Overall Study|Lack of Efficacy|0|||
163137478|NCT00479336|589211370|FG000|Overall Study|Protocol Violation|0|||
163137479|NCT00479336|589211371|FG001|Overall Study|Protocol Violation|1|||
163408651|NCT00623428|590205578|FG001|Follow-up Period|Death|1|||
163408652|NCT02937818|590205579|FG000|Overall Study|Participants decision|2|||
163408653|NCT02937818|590205580|FG001|Overall Study|Participants decision|1|||
163408654|NCT02937818|590205581|FG002|Overall Study|Participants decision|1|||
163408655|NCT02937818|590205582|FG003|Overall Study|Participants decision|1|||
163408656|NCT02937818|590205579|FG000|Overall Study|Adverse Event|2|||
163408657|NCT02937818|590205580|FG001|Overall Study|Adverse Event|4|||
163408658|NCT02937818|590205581|FG002|Overall Study|Adverse Event|1|||
163408659|NCT02937818|590205582|FG003|Overall Study|Adverse Event|1|||
163408660|NCT02937818|590205579|FG000|Overall Study|Disease progression|17|||
163408661|NCT02937818|590205580|FG001|Overall Study|Disease progression|15|||
163408662|NCT02937818|590205581|FG002|Overall Study|Disease progression|7|||
163408663|NCT02937818|590205582|FG003|Overall Study|Disease progression|19|||
163408664|NCT02937818|590205579|FG000|Overall Study|Condition under investigation worsened|0|||
163408665|NCT02937818|590205580|FG001|Overall Study|Condition under investigation worsened|0|||
163408666|NCT02937818|590205581|FG002|Overall Study|Condition under investigation worsened|1|||
163408667|NCT02937818|590205582|FG003|Overall Study|Condition under investigation worsened|0|||
163408668|NCT01692301|590205583|FG000|Overall Study|Adverse Event|15|||
163408669|NCT01692301|590205584|FG001|Overall Study|Adverse Event|12|||
163408670|NCT01692301|590205583|FG000|Overall Study|Death|1|||
163408671|NCT01692301|590205584|FG001|Overall Study|Death|2|||
163408672|NCT01692301|590205583|FG000|Overall Study|Lack of Efficacy|0|||
163408673|NCT01692301|590205584|FG001|Overall Study|Lack of Efficacy|5|||
163408674|NCT01692301|590205583|FG000|Overall Study|Non-compliance with study treatment|1|||
163408675|NCT01692301|590205584|FG001|Overall Study|Non-compliance with study treatment|2|||
163408676|NCT01692301|590205583|FG000|Overall Study|Protocol deviation|9|||
163408677|NCT01692301|590205584|FG001|Overall Study|Protocol deviation|2|||
163408678|NCT01692301|590205583|FG000|Overall Study|Patient/guardian decision|16|||
163408679|NCT01692301|590205584|FG001|Overall Study|Patient/guardian decision|15|||
163408680|NCT01692301|590205583|FG000|Overall Study|Technical problems|0|||
163408681|NCT01692301|590205584|FG001|Overall Study|Technical problems|1|||
163408682|NCT01692301|590205583|FG000|Overall Study|Physician Decision|2|||
163408683|NCT01692301|590205584|FG001|Overall Study|Physician Decision|2|||
163408684|NCT01692301|590205583|FG000|Overall Study|Lost to Follow-up|1|||
163408685|NCT01692301|590205584|FG001|Overall Study|Lost to Follow-up|1|||
163408686|NCT00574275|590205585|FG000|Overall Study|Randomized but not treated|2|||
163408687|NCT00574275|590205586|FG001|Overall Study|Randomized but not treated|3|||
163408688|NCT00574275|590205585|FG000|Overall Study|Adverse Event|32|||
163408689|NCT00574275|590205586|FG001|Overall Study|Adverse Event|76|||
163408690|NCT00574275|590205585|FG000|Overall Study|Disease progression|160|||
163408691|NCT00574275|590205586|FG001|Overall Study|Disease progression|146|||
163408692|NCT00574275|590205585|FG000|Overall Study|Lost to Follow-up|2|||
163408693|NCT00574275|590205586|FG001|Overall Study|Lost to Follow-up|1|||
163408694|NCT00574275|590205585|FG000|Overall Study|Study stopped based on DMC decision|62|||
163408695|NCT00574275|590205586|FG001|Overall Study|Study stopped based on DMC decision|23|||
163408696|NCT00574275|590205585|FG000|Overall Study|Withdrawal by Subject|15|||
163408697|NCT00574275|590205586|FG001|Overall Study|Withdrawal by Subject|17|||
163408698|NCT00574275|590205585|FG000|Overall Study|Error calculating tumor measurement|1|||
163408699|NCT00574275|590205586|FG001|Overall Study|Error calculating tumor measurement|0|||
163408700|NCT00574275|590205585|FG000|Overall Study|Physician Decision|1|||
163408701|NCT00574275|590205586|FG001|Overall Study|Physician Decision|1|||
163408702|NCT00574275|590205585|FG000|Overall Study|Protocol Violation|0|||
163408703|NCT00574275|590205586|FG001|Overall Study|Protocol Violation|1|||
163408704|NCT00574275|590205585|FG000|Overall Study|Patient and Investigator decision|0|||
163408705|NCT00574275|590205586|FG001|Overall Study|Patient and Investigator decision|1|||
163408706|NCT00574275|590205585|FG000|Overall Study|Insurance change|0|||
163408707|NCT00574275|590205586|FG001|Overall Study|Insurance change|1|||
163408708|NCT00574275|590205585|FG000|Overall Study|Operation for curative intent|0|||
163408709|NCT00574275|590205586|FG001|Overall Study|Operation for curative intent|1|||
163408710|NCT00889265|590205589|FG000|Overall Study|Adverse Event|1|||
163408711|NCT00889265|590205589|FG000|Overall Study|Lost to Follow-up|5|||
163408712|NCT00889265|590205589|FG000|Overall Study|Protocol Violation|1|||
163408713|NCT03028870|590205590|FG000|Overall Study|Adverse Event|7|||
163408714|NCT03028870|590205591|FG001|Overall Study|Adverse Event|4|||
163408715|NCT03028870|590205592|FG002|Overall Study|Adverse Event|3|||
163408716|NCT03028870|590205593|FG003|Overall Study|Adverse Event|3|||
163408717|NCT03028870|590205590|FG000|Overall Study|Withdrawal by Subject|1|||
163408718|NCT03028870|590205591|FG001|Overall Study|Withdrawal by Subject|1|||
163408719|NCT03028870|590205592|FG002|Overall Study|Withdrawal by Subject|1|||
163408720|NCT03028870|590205593|FG003|Overall Study|Withdrawal by Subject|2|||
163408721|NCT03028870|590205590|FG000|Overall Study|Lost to Follow-up|1|||
163408722|NCT03028870|590205591|FG001|Overall Study|Lost to Follow-up|0|||
163408723|NCT03028870|590205592|FG002|Overall Study|Lost to Follow-up|0|||
163408724|NCT03028870|590205593|FG003|Overall Study|Lost to Follow-up|0|||
163408725|NCT03028870|590205590|FG000|Overall Study|Lack of Efficacy|3|||
163408726|NCT03028870|590205591|FG001|Overall Study|Lack of Efficacy|0|||
163408727|NCT03028870|590205592|FG002|Overall Study|Lack of Efficacy|0|||
163408728|NCT03028870|590205593|FG003|Overall Study|Lack of Efficacy|0|||
163345527|NCT00990821|589973134|FG010|Overall Study|Withdrawal by Subject|3|||
163345528|NCT00990821|589973135|FG011|Overall Study|Withdrawal by Subject|5|||
163345529|NCT00990821|589973136|FG012|Overall Study|Withdrawal by Subject|2|||
163345530|NCT00990821|589973137|FG013|Overall Study|Withdrawal by Subject|1|||
163345531|NCT04150250|589973138|FG000|Overall Study|Lost to Follow-up|0|||
163137480|NCT00479336|589211372|FG002|Overall Study|Protocol Violation|0|||
163137481|NCT00479336|589211373|FG003|Overall Study|Protocol Violation|0|||
163137482|NCT00479336|589211370|FG000|Overall Study|Withdrawal by Subject|1|||
163137483|NCT00479336|589211371|FG001|Overall Study|Withdrawal by Subject|2|||
163137484|NCT00479336|589211372|FG002|Overall Study|Withdrawal by Subject|0|||
163137485|NCT00479336|589211373|FG003|Overall Study|Withdrawal by Subject|0|||
163137486|NCT00479336|589211370|FG000|Overall Study|Physician Decision|0|||
163137487|NCT00479336|589211371|FG001|Overall Study|Physician Decision|1|||
163137488|NCT00479336|589211372|FG002|Overall Study|Physician Decision|0|||
163137489|NCT00479336|589211373|FG003|Overall Study|Physician Decision|2|||
163137490|NCT00479336|589211370|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
163137491|NCT00479336|589211371|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
163137492|NCT00479336|589211372|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
163137493|NCT00479336|589211373|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
163137494|NCT02021643|589211374|FG000|Overall Study|Enrolled but Never Treated|1|||
163137495|NCT02021643|589211375|FG001|Overall Study|Enrolled but Never Treated|0|||
163137496|NCT02021643|589211376|FG002|Overall Study|Enrolled but Never Treated|0|||
163137497|NCT02021643|589211377|FG003|Overall Study|Enrolled but Never Treated|0|||
163137498|NCT02021643|589211374|FG000|Overall Study|Adverse Event|0|||
163137499|NCT02021643|589211375|FG001|Overall Study|Adverse Event|1|||
163137500|NCT02021643|589211376|FG002|Overall Study|Adverse Event|0|||
163137501|NCT02021643|589211377|FG003|Overall Study|Adverse Event|0|||
163137502|NCT02021643|589211374|FG000|Overall Study|Death|0|||
163137503|NCT02021643|589211375|FG001|Overall Study|Death|1|||
163137504|NCT02021643|589211376|FG002|Overall Study|Death|0|||
163137505|NCT02021643|589211377|FG003|Overall Study|Death|0|||
163137506|NCT02021643|589211374|FG000|Overall Study|Investigator's Discretion|1|||
163137507|NCT02021643|589211375|FG001|Overall Study|Investigator's Discretion|0|||
163137508|NCT02021643|589211376|FG002|Overall Study|Investigator's Discretion|0|||
163137509|NCT02021643|589211377|FG003|Overall Study|Investigator's Discretion|0|||
163137510|NCT02021643|589211374|FG000|Overall Study|Lack of Efficacy|7|||
163137511|NCT02021643|589211375|FG001|Overall Study|Lack of Efficacy|6|||
163137512|NCT02021643|589211376|FG002|Overall Study|Lack of Efficacy|0|||
163137513|NCT02021643|589211377|FG003|Overall Study|Lack of Efficacy|12|||
163137514|NCT02021643|589211374|FG000|Overall Study|Lost to Follow-up|0|||
163137515|NCT02021643|589211375|FG001|Overall Study|Lost to Follow-up|1|||
163137516|NCT02021643|589211376|FG002|Overall Study|Lost to Follow-up|0|||
163137517|NCT02021643|589211377|FG003|Overall Study|Lost to Follow-up|0|||
163137518|NCT02021643|589211374|FG000|Overall Study|Withdrew Consent|0|||
163137519|NCT02021643|589211375|FG001|Overall Study|Withdrew Consent|1|||
163137520|NCT02021643|589211376|FG002|Overall Study|Withdrew Consent|0|||
163137521|NCT02021643|589211377|FG003|Overall Study|Withdrew Consent|0|||
163137522|NCT02631551|589211378|FG000|Overall Study|Adverse Event|1|||
163137523|NCT02631551|589211379|FG001|Overall Study|Adverse Event|2|||
163137524|NCT02631551|589211380|FG002|Overall Study|Adverse Event|4|||
163137525|NCT02631551|589211381|FG003|Overall Study|Adverse Event|0|||
163137526|NCT02631551|589211378|FG000|Overall Study|Lack of Efficacy|0|||
163137527|NCT02631551|589211379|FG001|Overall Study|Lack of Efficacy|0|||
163137528|NCT02631551|589211380|FG002|Overall Study|Lack of Efficacy|1|||
163137529|NCT02631551|589211381|FG003|Overall Study|Lack of Efficacy|0|||
163137530|NCT02631551|589211378|FG000|Overall Study|Lost to Follow-up|1|||
163137531|NCT02631551|589211379|FG001|Overall Study|Lost to Follow-up|2|||
163137532|NCT02631551|589211380|FG002|Overall Study|Lost to Follow-up|0|||
163137533|NCT02631551|589211381|FG003|Overall Study|Lost to Follow-up|3|||
163137534|NCT02631551|589211378|FG000|Overall Study|Withdrawal by Subject|2|||
163137535|NCT02631551|589211379|FG001|Overall Study|Withdrawal by Subject|2|||
163137536|NCT02631551|589211380|FG002|Overall Study|Withdrawal by Subject|0|||
163137537|NCT02631551|589211381|FG003|Overall Study|Withdrawal by Subject|5|||
163137538|NCT02631551|589211378|FG000|Overall Study|Protocol deviation|3|||
163137539|NCT02631551|589211379|FG001|Overall Study|Protocol deviation|6|||
163137540|NCT02631551|589211380|FG002|Overall Study|Protocol deviation|3|||
163137541|NCT02631551|589211381|FG003|Overall Study|Protocol deviation|0|||
163137542|NCT02631551|589211378|FG000|Overall Study|Non-compliance with study procedures|0|||
163137543|NCT02631551|589211379|FG001|Overall Study|Non-compliance with study procedures|0|||
163137544|NCT02631551|589211380|FG002|Overall Study|Non-compliance with study procedures|1|||
163345532|NCT04150250|589973139|FG001|Overall Study|Lost to Follow-up|2|||
163137545|NCT02631551|589211381|FG003|Overall Study|Non-compliance with study procedures|1|||
163137546|NCT02631551|589211378|FG000|Overall Study|Non-compliance with study drug|1|||
163137547|NCT02631551|589211379|FG001|Overall Study|Non-compliance with study drug|0|||
163137548|NCT02631551|589211380|FG002|Overall Study|Non-compliance with study drug|0|||
163137549|NCT02631551|589211381|FG003|Overall Study|Non-compliance with study drug|0|||
163345533|NCT00170950|589973145|FG000|Overall Study|Death|236|||
163229483|NCT01573624|589551554|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
163229484|NCT01573624|589551555|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
163345534|NCT00170950|589973146|FG001|Overall Study|Death|274|||
163345535|NCT00170950|589973145|FG000|Overall Study|Withdrawal by Subject|496|||
163345536|NCT00170950|589973146|FG001|Overall Study|Withdrawal by Subject|498|||
163345537|NCT00170950|589973145|FG000|Overall Study|Lost to Follow-up|134|||
163345538|NCT00170950|589973146|FG001|Overall Study|Lost to Follow-up|115|||
163345539|NCT00170950|589973145|FG000|Overall Study|Missing|2|||
163345540|NCT00170950|589973146|FG001|Overall Study|Missing|1|||
163345541|NCT00170950|589973145|FG000|Overall Study|Termination Data Not Recorded|17|||
163345542|NCT00170950|589973146|FG001|Overall Study|Termination Data Not Recorded|22|||
163345543|NCT00748098|589973147|FG000|First Treatment Intervention Period|Adverse Event|1|||
163345544|NCT00748098|589973148|FG001|First Treatment Intervention Period|Adverse Event|1|||
163345545|NCT00748098|589973147|FG000|First Treatment Intervention Period|Protocol Violation|1|||
163345546|NCT00748098|589973148|FG001|First Treatment Intervention Period|Protocol Violation|0|||
163345547|NCT00748098|589973147|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
163345548|NCT00748098|589973148|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
163345549|NCT00748098|589973147|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
163345550|NCT00748098|589973148|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
163345551|NCT00748098|589973147|FG000|First Taper Period|Protocol Violation|1|||
163345552|NCT00748098|589973148|FG001|First Taper Period|Protocol Violation|0|||
163345553|NCT00748098|589973147|FG000|First Taper Period|Withdrawal by Subject|2|||
163345554|NCT00748098|589973148|FG001|First Taper Period|Withdrawal by Subject|0|||
163345555|NCT00748098|589973147|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
163345556|NCT00748098|589973148|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
163345557|NCT00748098|589973147|FG000|1-Week Washout Period|Adverse Event|0|||
163345558|NCT00748098|589973148|FG001|1-Week Washout Period|Adverse Event|1|||
163345559|NCT00748098|589973147|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
163345560|NCT00748098|589973148|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
163345561|NCT00748098|589973147|FG000|Second Treatment Intervention Period|Adverse Event|4|||
163345562|NCT00748098|589973148|FG001|Second Treatment Intervention Period|Adverse Event|1|||
163345563|NCT00748098|589973147|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
163345564|NCT00748098|589973148|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
163345565|NCT00748098|589973147|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
163345566|NCT00748098|589973148|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
163345567|NCT04448561|589973154|FG000|Overall Study|Noncompliance|1|||
163345568|NCT04448561|589973155|FG001|Overall Study|Noncompliance|0|||
163345571|NCT03602859|589973161|FG000|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|10|||
163345572|NCT03602859|589973162|FG001|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
163345573|NCT03602859|589973163|FG002|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
163345574|NCT03602859|589973164|FG003|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
163345575|NCT03602859|589973161|FG000|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|2|||
163345576|NCT03602859|589973162|FG001|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
163345577|NCT03602859|589973163|FG002|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
163345578|NCT03602859|589973164|FG003|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
163345579|NCT03602859|589973161|FG000|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|3|||
163345580|NCT03602859|589973162|FG001|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
163345581|NCT03602859|589973163|FG002|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
163345582|NCT03602859|589973164|FG003|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
163345583|NCT03602859|589973161|FG000|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|6|||
163345584|NCT03602859|589973162|FG001|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
163345585|NCT03602859|589973163|FG002|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
163345586|NCT03602859|589973164|FG003|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
163345587|NCT03602859|589973161|FG000|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|10|||
163345588|NCT03602859|589973162|FG001|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
163345589|NCT03602859|589973163|FG002|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
163345590|NCT03602859|589973164|FG003|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
163345591|NCT03602859|589973161|FG000|Chemotherapy Run-In Period (Cycle 1)|Death|10|||
163345592|NCT03602859|589973162|FG001|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
163345593|NCT03602859|589973163|FG002|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
163345594|NCT03602859|589973164|FG003|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
163229485|NCT01573624|589551556|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
163345595|NCT03602859|589973161|FG000|Chemotherapy Run-In Period (Cycle 1)|Other|27|||
163408729|NCT03028870|590205590|FG000|Overall Study|Administrative|5|||
163408730|NCT03028870|590205591|FG001|Overall Study|Administrative|5|||
163137550|NCT02631551|589211378|FG000|Overall Study|Other, specific reasons not collected|5|||
163137551|NCT02631551|589211379|FG001|Overall Study|Other, specific reasons not collected|7|||
163137552|NCT02631551|589211380|FG002|Overall Study|Other, specific reasons not collected|2|||
163137553|NCT02631551|589211381|FG003|Overall Study|Other, specific reasons not collected|2|||
163137554|NCT04390243|589211387|FG000|Overall Study|Death|1|||
163137555|NCT04390243|589211387|FG000|Overall Study|Disease Progression|4|||
163137556|NCT04390243|589211387|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
163137557|NCT01521507|589211394|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
163137558|NCT01521507|589211395|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
163137559|NCT01521507|589211394|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
163137560|NCT01521507|589211395|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
163137561|NCT01521507|589211394|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
163137562|NCT01521507|589211395|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
163137563|NCT01521507|589211394|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
163137564|NCT01521507|589211395|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
163137565|NCT01521507|589211394|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
163137566|NCT01521507|589211395|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
163137567|NCT01521507|589211394|FG000|Stage 2: Observational Design|Physician Decision|1|||
163137568|NCT01521507|589211395|FG001|Stage 2: Observational Design|Physician Decision|0|||
163137569|NCT04034004|589211396|FG000|Overall Study|Withdrawal by Subject|1|||
163137570|NCT04034004|589211397|FG001|Overall Study|Withdrawal by Subject|2|||
163137571|NCT04034004|589211398|FG002|Overall Study|Withdrawal by Subject|2|||
163137572|NCT04034004|589211399|FG003|Overall Study|Withdrawal by Subject|3|||
163137573|NCT04034004|589211396|FG000|Overall Study|could not find vein to administer IV|2|||
163137574|NCT04034004|589211397|FG001|Overall Study|could not find vein to administer IV|1|||
163137575|NCT04034004|589211398|FG002|Overall Study|could not find vein to administer IV|0|||
163137576|NCT04034004|589211399|FG003|Overall Study|could not find vein to administer IV|0|||
163137577|NCT04034004|589211396|FG000|Overall Study|nurse accidentally unblinded subject|0|||
163137578|NCT04034004|589211397|FG001|Overall Study|nurse accidentally unblinded subject|0|||
163137579|NCT04034004|589211398|FG002|Overall Study|nurse accidentally unblinded subject|0|||
163137580|NCT04034004|589211399|FG003|Overall Study|nurse accidentally unblinded subject|1|||
163137581|NCT04317040|589211400|FG000|Overall Study|Lost to Follow-up|2|||
163137582|NCT04317040|589211401|FG001|Overall Study|Lost to Follow-up|0|||
163137583|NCT04317040|589211400|FG000|Overall Study|Death|16|||
163137584|NCT04317040|589211401|FG001|Overall Study|Death|18|||
163137585|NCT04317040|589211400|FG000|Overall Study|Withdrawal by Subject|0|||
163137586|NCT04317040|589211401|FG001|Overall Study|Withdrawal by Subject|1|||
163137587|NCT04317040|589211400|FG000|Overall Study|Incomplete assessments|0|||
163137588|NCT04317040|589211401|FG001|Overall Study|Incomplete assessments|1|||
163137589|NCT03672292|589211402|FG000|Overall Study|Adverse Event|3|||
163137590|NCT03672292|589211403|FG001|Overall Study|Adverse Event|1|||
163137591|NCT03672292|589211402|FG000|Overall Study|Physician Decision|0|||
163137592|NCT03672292|589211403|FG001|Overall Study|Physician Decision|1|||
163137593|NCT03672292|589211402|FG000|Overall Study|Withdrawal by Subject|1|||
163137594|NCT03672292|589211403|FG001|Overall Study|Withdrawal by Subject|2|||
163137595|NCT00799903|589211404|FG000|Overall Study|Investigator Site Closed|25|||
163137596|NCT00799903|589211405|FG001|Overall Study|Investigator Site Closed|23|||
163137597|NCT00799903|589211404|FG000|Overall Study|Withdrawal by Subject|179|||
163137598|NCT00799903|589211405|FG001|Overall Study|Withdrawal by Subject|175|||
163137599|NCT00799903|589211404|FG000|Overall Study|Lost to Follow-up|69|||
163137600|NCT00799903|589211405|FG001|Overall Study|Lost to Follow-up|80|||
163137601|NCT02518971|589211406|FG000|Overall Study|Lost to Follow-up|0|||
163137602|NCT02518971|589211407|FG001|Overall Study|Lost to Follow-up|1|||
163137603|NCT02518971|589211406|FG000|Overall Study|Physician Decision|6|||
163137604|NCT02518971|589211407|FG001|Overall Study|Physician Decision|6|||
163137605|NCT02518971|589211406|FG000|Overall Study|Protocol Violation|6|||
163137606|NCT02518971|589211407|FG001|Overall Study|Protocol Violation|4|||
163137607|NCT02518971|589211406|FG000|Overall Study|Withdrawal by Subject|4|||
163137608|NCT02518971|589211407|FG001|Overall Study|Withdrawal by Subject|5|||
163137609|NCT02518971|589211406|FG000|Overall Study|Side effects|1|||
163137610|NCT02518971|589211407|FG001|Overall Study|Side effects|0|||
163137611|NCT02518971|589211406|FG000|Overall Study|medication lost in mail|0|||
163137612|NCT02518971|589211407|FG001|Overall Study|medication lost in mail|1|||
163137613|NCT02518971|589211406|FG000|Overall Study|eligibility criteria no longer met|6|||
163137614|NCT02518971|589211407|FG001|Overall Study|eligibility criteria no longer met|3|||
163137615|NCT03088917|589211408|FG000|Overall Study|In care/cured elsewhere|15|||
163137616|NCT03088917|589211408|FG000|Overall Study|Refuse re-evaluation|13|||
163137617|NCT03088917|589211408|FG000|Overall Study|Contact not established|13|||
163137618|NCT03088917|589211408|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
163137619|NCT03088917|589211408|FG000|Overall Study|Moved outside study region|50|||
163137620|NCT01514201|589211413|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
163137621|NCT01514201|589211414|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
163408731|NCT03028870|590205592|FG002|Overall Study|Administrative|12|||
163229486|NCT01573624|589551557|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
163229487|NCT01573624|589551558|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
163229488|NCT01573624|589551559|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
163229489|NCT01573624|589551560|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
163229490|NCT01573624|589551554|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
163229491|NCT01573624|589551555|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
163229492|NCT01573624|589551556|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
163229493|NCT01573624|589551557|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
163229494|NCT01573624|589551558|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
163229495|NCT01573624|589551559|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
163229496|NCT01573624|589551560|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
163229497|NCT01573624|589551554|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
163229498|NCT01573624|589551555|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
163229499|NCT01573624|589551556|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
163229500|NCT01573624|589551557|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
163229501|NCT01573624|589551558|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
163229502|NCT01573624|589551559|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
163229503|NCT01573624|589551560|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
163229504|NCT01573624|589551554|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
163229505|NCT01573624|589551555|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
163229506|NCT01573624|589551556|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
163229507|NCT01573624|589551557|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
163229508|NCT01573624|589551558|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
163229509|NCT01573624|589551559|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
163345596|NCT03602859|589973162|FG001|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
163345597|NCT03602859|589973163|FG002|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
163345598|NCT03602859|589973164|FG003|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
163345599|NCT03602859|589973161|FG000|Chemotherapy Run-In Period (Cycle 1)|Missing|1|||
163137622|NCT01514201|589211415|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
163137623|NCT01514201|589211416|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
163137624|NCT01514201|589211413|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
163137625|NCT01514201|589211414|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
163137626|NCT01514201|589211415|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
163137627|NCT01514201|589211416|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
163137628|NCT01514201|589211413|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
163137629|NCT01514201|589211414|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
163137630|NCT01514201|589211415|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
163137631|NCT01514201|589211416|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
163137632|NCT01514201|589211413|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
163137633|NCT01514201|589211414|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
163137634|NCT01514201|589211415|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
163137635|NCT01514201|589211416|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
163137636|NCT01514201|589211413|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
163137637|NCT01514201|589211414|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
163137638|NCT01514201|589211415|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
163137639|NCT01514201|589211416|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
163137640|NCT01514201|589211413|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
163137641|NCT01514201|589211414|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
163137642|NCT01514201|589211415|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
163137643|NCT01514201|589211416|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
163137644|NCT01514201|589211413|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
163137645|NCT01514201|589211414|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
163137646|NCT01514201|589211415|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
163137647|NCT01514201|589211416|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
163137648|NCT01514201|589211413|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
163137649|NCT01514201|589211414|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
163137650|NCT01514201|589211415|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
163137651|NCT01514201|589211416|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
163137652|NCT01514201|589211413|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
163137653|NCT01514201|589211414|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
163137654|NCT01514201|589211415|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
163137655|NCT01514201|589211416|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
163137656|NCT01514201|589211413|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
163345600|NCT03602859|589973162|FG001|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
163345601|NCT03602859|589973163|FG002|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
163345602|NCT03602859|589973164|FG003|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
163345603|NCT03602859|589973161|FG000|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|10|||
163345604|NCT03602859|589973162|FG001|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
163345605|NCT03602859|589973163|FG002|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
163345606|NCT03602859|589973164|FG003|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
163345607|NCT03602859|589973161|FG000|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|0|||
163345608|NCT03602859|589973162|FG001|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|1|||
163345609|NCT03602859|589973163|FG002|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|5|||
163345610|NCT03602859|589973164|FG003|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|3|||
163345611|NCT03602859|589973161|FG000|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|0|||
163345612|NCT03602859|589973162|FG001|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|7|||
163345613|NCT03602859|589973163|FG002|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|11|||
163345614|NCT03602859|589973164|FG003|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|25|||
163345615|NCT03602859|589973161|FG000|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|0|||
163345616|NCT03602859|589973162|FG001|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|7|||
163345617|NCT03602859|589973163|FG002|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|14|||
163345618|NCT03602859|589973164|FG003|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|15|||
163345619|NCT03602859|589973161|FG000|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|0|||
163345620|NCT03602859|589973162|FG001|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|2|||
163345621|NCT03602859|589973163|FG002|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|1|||
163345622|NCT03602859|589973164|FG003|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|5|||
163345623|NCT03602859|589973161|FG000|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|0|||
163345624|NCT03602859|589973162|FG001|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
163345625|NCT03602859|589973163|FG002|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
163345626|NCT03602859|589973164|FG003|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|8|||
163345627|NCT03602859|589973161|FG000|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|0|||
163345628|NCT03602859|589973162|FG001|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|9|||
163345629|NCT03602859|589973163|FG002|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|11|||
163345630|NCT03602859|589973164|FG003|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|29|||
163408732|NCT03028870|590205593|FG003|Overall Study|Administrative|4|||
163137657|NCT01514201|589211414|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
163137658|NCT01514201|589211415|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
163137659|NCT01514201|589211416|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
163137660|NCT01514201|589211413|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
163137661|NCT01514201|589211414|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
163137662|NCT01514201|589211415|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
163137663|NCT01514201|589211416|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
163137664|NCT01514201|589211413|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
163137665|NCT01514201|589211414|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
163137666|NCT01514201|589211415|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
163137667|NCT01514201|589211416|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
163137668|NCT02735343|589211419|FG000|Overall Study|screen fail|0|||
163137669|NCT02735343|589211420|FG001|Overall Study|screen fail|2|||
163137670|NCT00566852|589211431|FG000|Overall Study|Protocol Violation|22|||
163137671|NCT00566852|589211432|FG001|Overall Study|Protocol Violation|24|||
163137672|NCT00566852|589211431|FG000|Overall Study|Death|95|||
163137673|NCT00566852|589211432|FG001|Overall Study|Death|78|||
163137674|NCT00566852|589211431|FG000|Overall Study|Withdrawal by Subject|30|||
163137675|NCT00566852|589211432|FG001|Overall Study|Withdrawal by Subject|25|||
163137676|NCT00566852|589211431|FG000|Overall Study|Patient refusal|37|||
163137677|NCT00566852|589211432|FG001|Overall Study|Patient refusal|37|||
163137678|NCT00566852|589211431|FG000|Overall Study|Not tested due to disability|6|||
163137679|NCT00566852|589211432|FG001|Overall Study|Not tested due to disability|12|||
163137680|NCT00566852|589211431|FG000|Overall Study|Missing reason not specified|1|||
163137681|NCT00566852|589211432|FG001|Overall Study|Missing reason not specified|2|||
163137682|NCT00566852|589211431|FG000|Overall Study|Missing reason not reported|16|||
163137683|NCT00566852|589211432|FG001|Overall Study|Missing reason not reported|20|||
163137684|NCT04531241|589211435|FG000|Period 1|Withdrawal by Subject|2|||
163137685|NCT04531241|589211436|FG001|Period 1|Withdrawal by Subject|0|||
163137686|NCT04531241|589211435|FG000|Period 1|Dispesed incorrect lens power|1|||
163137687|NCT04531241|589211436|FG001|Period 1|Dispesed incorrect lens power|0|||
163137688|NCT04531241|589211435|FG000|Period 1|Protocol Violation|1|||
163137689|NCT04531241|589211436|FG001|Period 1|Protocol Violation|0|||
163137690|NCT04531241|589211435|FG000|Period 1|No longer eligible|0|||
163137691|NCT04531241|589211436|FG001|Period 1|No longer eligible|1|||
163137692|NCT04531241|589211435|FG000|Period 1|Lens Discomfort|0|||
163229510|NCT01573624|589551560|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
163229511|NCT01573624|589551554|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
163229512|NCT01573624|589551555|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
163229513|NCT01573624|589551556|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
163229514|NCT01573624|589551557|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
163229515|NCT01573624|589551558|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
163229516|NCT01573624|589551559|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
163229517|NCT01573624|589551560|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
163229518|NCT01573624|589551554|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
163229519|NCT01573624|589551555|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
163229520|NCT01573624|589551556|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
163229521|NCT01573624|589551557|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
163229522|NCT01573624|589551558|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
163229523|NCT01573624|589551559|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
163229524|NCT01573624|589551560|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
163229525|NCT01573624|589551554|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
163229526|NCT01573624|589551555|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
163229527|NCT01573624|589551556|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
163229528|NCT01573624|589551557|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
163229529|NCT01573624|589551558|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
163229530|NCT01573624|589551559|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
163229531|NCT01573624|589551560|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
163229532|NCT01573624|589551554|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
163229533|NCT01573624|589551555|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
163229534|NCT01573624|589551556|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
163229535|NCT01573624|589551557|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
163229536|NCT01573624|589551558|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
163229537|NCT01573624|589551559|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
163229538|NCT01573624|589551560|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
163229539|NCT01573624|589551554|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
163229540|NCT01573624|589551555|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
163229541|NCT01573624|589551556|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
163229542|NCT01573624|589551557|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
163229543|NCT01573624|589551558|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
163229544|NCT01573624|589551559|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
163229545|NCT01573624|589551560|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
163229546|NCT01573624|589551554|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
163229547|NCT01573624|589551555|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
163229548|NCT01573624|589551556|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
163229549|NCT01573624|589551557|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
163229550|NCT01573624|589551558|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
163229551|NCT01573624|589551559|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
163229552|NCT01573624|589551560|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
163229553|NCT01573624|589551554|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
163229554|NCT01573624|589551555|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
163229555|NCT01573624|589551556|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
163229556|NCT01573624|589551557|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
163229557|NCT01573624|589551558|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
163229558|NCT01573624|589551559|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
163229559|NCT01573624|589551560|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
163229560|NCT01573624|589551554|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
163229561|NCT01573624|589551555|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
163229562|NCT01573624|589551556|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
163229563|NCT01573624|589551557|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
163229564|NCT01573624|589551558|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
163229565|NCT01573624|589551559|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
163345631|NCT03602859|589973161|FG000|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
163345632|NCT03602859|589973162|FG001|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
163345633|NCT03602859|589973163|FG002|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
163345634|NCT03602859|589973164|FG003|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|1|||
163345635|NCT03602859|589973161|FG000|Chemo Treatment Period (Cycle 2 to 6)|Death|0|||
163345636|NCT03602859|589973162|FG001|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
163408733|NCT01967537|590205596|FG000|Overall Study|Withdrawal by Subject|52|||
163408734|NCT01967537|590205596|FG000|Overall Study|Refuse treatment|2|||
163408735|NCT01967537|590205596|FG000|Overall Study|Lost to Follow-up|6|||
163408736|NCT02425826|590205598|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
163408737|NCT02425826|590205599|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
163408738|NCT02425826|590205600|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
163408739|NCT02425826|590205598|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
163408740|NCT02425826|590205599|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
163408741|NCT02425826|590205600|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
163408742|NCT02425826|590205598|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
163408743|NCT02425826|590205599|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
163408744|NCT02425826|590205600|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
163408745|NCT02425826|590205598|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
163408746|NCT02425826|590205599|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
163408747|NCT02425826|590205600|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
163408748|NCT02425826|590205598|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
163408749|NCT02425826|590205599|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
163408750|NCT02425826|590205600|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
163408751|NCT02425826|590205598|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
163408752|NCT02425826|590205599|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
163408753|NCT02425826|590205600|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
163408754|NCT02425826|590205598|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
163408755|NCT02425826|590205599|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
163408756|NCT02425826|590205600|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
163408757|NCT02425826|590205598|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
163408758|NCT02425826|590205599|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
163408759|NCT02425826|590205600|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
163408760|NCT02425826|590205598|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
163408761|NCT02425826|590205599|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
163408762|NCT02425826|590205600|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
163408763|NCT02425826|590205598|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
163408764|NCT02425826|590205599|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
163408765|NCT02425826|590205600|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
163408766|NCT03829657|590205608|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
163408767|NCT03829657|590205609|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
163408768|NCT03829657|590205610|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
163408769|NCT03829657|590205611|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
163408770|NCT03829657|590205612|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
163408771|NCT03829657|590205608|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
163408772|NCT03829657|590205609|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
163408773|NCT03829657|590205610|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
163408774|NCT03829657|590205611|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
163408775|NCT03829657|590205612|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
163408776|NCT03829657|590205608|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
163408777|NCT03829657|590205609|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
163408778|NCT03829657|590205610|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
163408779|NCT03829657|590205611|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
163408780|NCT03829657|590205612|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
163408781|NCT03829657|590205608|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
163408782|NCT03829657|590205609|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
163408783|NCT03829657|590205610|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
163408784|NCT03829657|590205611|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
163408785|NCT03829657|590205612|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
163408786|NCT03829657|590205608|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
163137693|NCT04531241|589211436|FG001|Period 1|Lens Discomfort|1|||
163137694|NCT04531241|589211435|FG000|Period 2|Covid-19 Related|1|||
163137695|NCT04531241|589211436|FG001|Period 2|Covid-19 Related|1|||
163137696|NCT02715609|589211437|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
163137697|NCT02715609|589211438|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
163137698|NCT02715609|589211439|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
163137699|NCT02715609|589211437|FG000|Overall Study|Withdrawal by Subject|0|||
163137700|NCT02715609|589211438|FG001|Overall Study|Withdrawal by Subject|0|||
163137701|NCT02715609|589211439|FG002|Overall Study|Withdrawal by Subject|1|||
163137702|NCT03983304|589211440|FG000|Overall Study|Withdrawal by Subject|5|||
163137703|NCT03983304|589211440|FG000|Overall Study|Lost to Follow-up|2|||
163137704|NCT01702246|589211441|FG000|Overall Study|Lost to Follow-up|2|||
163137705|NCT01702246|589211441|FG000|Overall Study|Withdrawal by Subject|2|||
163137706|NCT01702246|589211441|FG000|Overall Study|Physician Decision|1|||
163137707|NCT01518374|589211444|FG000|Overall Study|Withdrawal by Subject|2|||
163137708|NCT01518374|589211444|FG000|Overall Study|Protocol Violation|3|||
163137709|NCT01518374|589211444|FG000|Overall Study|Lost to Follow-up|2|||
163137710|NCT04209205|589211447|FG000|Overall Study|Adverse Event|2|||
163137711|NCT04209205|589211448|FG001|Overall Study|Adverse Event|3|||
163137712|NCT04209205|589211447|FG000|Overall Study|Lost to Follow-up|3|||
163137713|NCT04209205|589211448|FG001|Overall Study|Lost to Follow-up|1|||
163137714|NCT04209205|589211447|FG000|Overall Study|Physician Decision|1|||
163137715|NCT04209205|589211448|FG001|Overall Study|Physician Decision|1|||
163137716|NCT04209205|589211447|FG000|Overall Study|Subject decision|10|||
163137717|NCT04209205|589211448|FG001|Overall Study|Subject decision|10|||
163137718|NCT04209205|589211447|FG000|Overall Study|Progressive disease|1|||
163137719|NCT04209205|589211448|FG001|Overall Study|Progressive disease|0|||
163137720|NCT04209205|589211447|FG000|Overall Study|Protocol deviation|0|||
163137721|NCT04209205|589211448|FG001|Overall Study|Protocol deviation|1|||
163137722|NCT04209205|589211447|FG000|Overall Study|New therapy for study indication|1|||
163137723|NCT04209205|589211448|FG001|Overall Study|New therapy for study indication|0|||
163137724|NCT04209205|589211447|FG000|Overall Study|Adverse event - placebo not switched|0|||
163137725|NCT04209205|589211448|FG001|Overall Study|Adverse event - placebo not switched|1|||
163137726|NCT04209205|589211447|FG000|Overall Study|Subject decision - placebo not switched|0|||
163137727|NCT04209205|589211448|FG001|Overall Study|Subject decision - placebo not switched|5|||
163137728|NCT04209205|589211447|FG000|Overall Study|Death - placebo not switched|0|||
163137729|NCT04209205|589211448|FG001|Overall Study|Death - placebo not switched|1|||
163137730|NCT00999544|589213025|FG000|Overall Study|Withdrawal by Subject|1|||
163137731|NCT01392547|589213026|FG000|Overall Study|Adverse Event|2|||
163137732|NCT01392547|589213026|FG000|Overall Study|Non-compliance|2|||
163137733|NCT01392547|589213026|FG000|Overall Study|Withdrawal criteria|3|||
163137734|NCT01392547|589213026|FG000|Overall Study|Unclassified|1|||
163137735|NCT00950846|589213031|FG000|Overall Study|Death|6|||
163137736|NCT00950846|589213031|FG000|Overall Study|Lost to Follow-up|3|||
163137737|NCT00950846|589213031|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
163137738|NCT01799226|589213032|FG000|Overall Study|Withdrawal by Subject|1|||
163137739|NCT01799226|589213033|FG001|Overall Study|Withdrawal by Subject|0|||
163137740|NCT01799226|589213032|FG000|Overall Study|Disqualified at Day 14|1|||
163137741|NCT01799226|589213033|FG001|Overall Study|Disqualified at Day 14|0|||
163137742|NCT02178995|589213034|FG000|Double Blind|Adverse Event|0|||
163137743|NCT02178995|589213035|FG001|Double Blind|Adverse Event|0|||
163137744|NCT02178995|589213036|FG002|Double Blind|Adverse Event|0|||
163137745|NCT02178995|589213037|FG003|Double Blind|Adverse Event|0|||
163137746|NCT02178995|589213038|FG004|Double Blind|Adverse Event|0|||
163137747|NCT02178995|589213039|FG005|Double Blind|Adverse Event|1|||
163137748|NCT02178995|589213040|FG006|Double Blind|Adverse Event|0|||
163137749|NCT02178995|589213041|FG007|Double Blind|Adverse Event|1|||
163137750|NCT02178995|589213042|FG008|Double Blind|Adverse Event|1|||
163137751|NCT02178995|589213034|FG000|Double Blind|Lost to Follow-up|0|||
163137752|NCT02178995|589213035|FG001|Double Blind|Lost to Follow-up|1|||
163137753|NCT02178995|589213036|FG002|Double Blind|Lost to Follow-up|0|||
163137754|NCT02178995|589213037|FG003|Double Blind|Lost to Follow-up|0|||
163137755|NCT02178995|589213038|FG004|Double Blind|Lost to Follow-up|0|||
163137756|NCT02178995|589213039|FG005|Double Blind|Lost to Follow-up|0|||
163137757|NCT02178995|589213040|FG006|Double Blind|Lost to Follow-up|0|||
163137758|NCT02178995|589213041|FG007|Double Blind|Lost to Follow-up|1|||
163137759|NCT02178995|589213042|FG008|Double Blind|Lost to Follow-up|0|||
163137760|NCT02178995|589213034|FG000|Open Label|Adverse Event|2|||
163137761|NCT02178995|589213035|FG001|Open Label|Adverse Event|0|||
163137762|NCT02178995|589213036|FG002|Open Label|Adverse Event|0|||
163229566|NCT01573624|589551560|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
163229567|NCT01573624|589551554|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
163137763|NCT02178995|589213037|FG003|Open Label|Adverse Event|0|||
163137764|NCT02178995|589213038|FG004|Open Label|Adverse Event|0|||
163345637|NCT03602859|589973163|FG002|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
163345638|NCT03602859|589973164|FG003|Chemo Treatment Period (Cycle 2 to 6)|Death|5|||
163345639|NCT03602859|589973161|FG000|Chemo Treatment Period (Cycle 2 to 6)|Other|0|||
163137765|NCT02178995|589213039|FG005|Open Label|Adverse Event|0|||
163137766|NCT02178995|589213040|FG006|Open Label|Adverse Event|0|||
163137767|NCT02178995|589213041|FG007|Open Label|Adverse Event|0|||
163137768|NCT02178995|589213042|FG008|Open Label|Adverse Event|0|||
163137769|NCT02114606|589213044|FG000|Overall Study|Unable to swallow Cytosponge|6|||
163137770|NCT00981461|589213045|FG000|Overall Study|Lost to Follow-up|5|||
163137771|NCT00981461|589213046|FG001|Overall Study|Lost to Follow-up|2|||
163137772|NCT01388907|589213047|FG000|Overall Study|Adverse Event|2|||
163137773|NCT01388907|589213048|FG001|Overall Study|Adverse Event|0|||
163137774|NCT03361293|589213049|FG000|Overall Study|Lost to Follow-up|0|||
163137775|NCT03361293|589213050|FG001|Overall Study|Lost to Follow-up|2|||
163137776|NCT03361293|589213049|FG000|Overall Study|Withdrawal by Subject|1|||
163229568|NCT01573624|589551555|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
163229569|NCT01573624|589551556|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
163229570|NCT01573624|589551557|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
163229571|NCT01573624|589551558|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
163229572|NCT01573624|589551559|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
163229573|NCT01573624|589551560|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
163229574|NCT01573624|589551554|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
163229575|NCT01573624|589551555|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163229576|NCT01573624|589551556|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163229577|NCT01573624|589551557|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163229578|NCT01573624|589551558|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
163229579|NCT01573624|589551559|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
163229580|NCT01573624|589551560|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
163229581|NCT01573624|589551554|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
163229582|NCT01573624|589551555|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
163229583|NCT01573624|589551556|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
163229584|NCT01573624|589551557|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
163229585|NCT01573624|589551558|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
163229586|NCT01573624|589551559|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
163229587|NCT01573624|589551560|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
163229588|NCT01573624|589551554|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
163229589|NCT01573624|589551555|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
163229590|NCT01573624|589551556|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
163229591|NCT01573624|589551557|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
163229592|NCT01573624|589551558|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
163229593|NCT01573624|589551559|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
163229594|NCT01573624|589551560|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
163229595|NCT01573624|589551554|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
163229596|NCT01573624|589551555|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
163229597|NCT01573624|589551556|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
163229598|NCT01573624|589551557|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
163229599|NCT01573624|589551558|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
163229600|NCT01573624|589551559|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
163229601|NCT01573624|589551560|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
163229602|NCT01573624|589551554|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
163229603|NCT01573624|589551555|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
163229604|NCT01573624|589551556|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
163229605|NCT01573624|589551557|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
163229606|NCT01573624|589551558|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
163229607|NCT01573624|589551559|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
163229608|NCT01573624|589551560|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
163229609|NCT04399161|589551561|FG000|Overall Study|Withdrawal by Subject|1|||
163229610|NCT04399161|589551562|FG001|Overall Study|Withdrawal by Subject|0|||
163229611|NCT04399161|589551563|FG002|Overall Study|Withdrawal by Subject|2|||
163229612|NCT04399161|589551561|FG000|Overall Study|Protocol Violation|1|||
163229613|NCT04399161|589551562|FG001|Overall Study|Protocol Violation|2|||
163229614|NCT04399161|589551563|FG002|Overall Study|Protocol Violation|0|||
163229615|NCT03417141|589551564|FG000|Overall Study|Withdrawal by Subject|1|||
163229616|NCT03417141|589551564|FG000|Overall Study|Protocol Violation|3|||
163229617|NCT01723228|589551565|FG000|Overall Study|Adverse Event|2|||
163229618|NCT01723228|589551566|FG001|Overall Study|Adverse Event|6|||
163229619|NCT01723228|589551565|FG000|Overall Study|Withdrawal by Subject|2|||
163229620|NCT01723228|589551566|FG001|Overall Study|Withdrawal by Subject|1|||
163229621|NCT01723228|589551565|FG000|Overall Study|Protocol Violation|0|||
163229622|NCT01723228|589551566|FG001|Overall Study|Protocol Violation|2|||
163229623|NCT01723228|589551565|FG000|Overall Study|Lost to Follow-up|2|||
163229624|NCT01723228|589551566|FG001|Overall Study|Lost to Follow-up|1|||
163229625|NCT01723228|589551565|FG000|Overall Study|Other|2|||
163229626|NCT01723228|589551566|FG001|Overall Study|Other|1|||
163229627|NCT01864291|589551567|FG000|Overall Study|need for revision surgery|2|||
163229628|NCT01282216|589551568|FG000|Overall Study|Graft failure|0|||
163229629|NCT01282216|589551569|FG001|Overall Study|Graft failure|0|||
163229630|NCT01282216|589551570|FG002|Overall Study|Graft failure|3|||
163345640|NCT03602859|589973162|FG001|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
163345641|NCT03602859|589973163|FG002|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
163345642|NCT03602859|589973164|FG003|Chemo Treatment Period (Cycle 2 to 6)|Other|9|||
163345643|NCT03602859|589973161|FG000|Maintenance Period (Cycle 7 to 89)|Ongoing|0|||
163345644|NCT03602859|589973162|FG001|Maintenance Period (Cycle 7 to 89)|Ongoing|3|||
163137777|NCT03361293|589213050|FG001|Overall Study|Withdrawal by Subject|3|||
163137778|NCT01910402|589213051|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
163137779|NCT01910402|589213052|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
163137780|NCT01910402|589213053|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
163137781|NCT01910402|589213051|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
163137782|NCT01910402|589213052|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
163137783|NCT01910402|589213053|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
163137784|NCT01910402|589213051|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
163137785|NCT01910402|589213052|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
163137786|NCT01910402|589213053|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
163137787|NCT01910402|589213051|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
163137788|NCT01910402|589213052|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
163137789|NCT01910402|589213053|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
163137790|NCT01910402|589213051|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
163137791|NCT01910402|589213052|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
163137792|NCT01910402|589213053|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
163137793|NCT01910402|589213051|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
163137794|NCT01910402|589213052|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
163137795|NCT01910402|589213053|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
163137796|NCT01910402|589213051|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
163137797|NCT01910402|589213052|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
163137798|NCT01910402|589213053|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
163137799|NCT01910402|589213051|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
163137800|NCT01910402|589213052|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
163137801|NCT01910402|589213053|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
163137802|NCT01910402|589213051|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
163137803|NCT01910402|589213052|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
163137804|NCT01910402|589213053|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
163137805|NCT01910402|589213051|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
163137806|NCT01910402|589213052|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
163137807|NCT01910402|589213053|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
163137808|NCT01910402|589213051|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
163137809|NCT01910402|589213052|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
163137810|NCT01910402|589213053|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
163137811|NCT01910402|589213051|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
163137812|NCT01910402|589213052|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
163137813|NCT01910402|589213053|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
163137814|NCT01910402|589213051|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
163137815|NCT01910402|589213052|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
163137816|NCT01910402|589213053|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
163137817|NCT00483405|589213054|FG000|Overall Study|Adverse Event|8|||
163137818|NCT00483405|589213054|FG000|Overall Study|Lack of Efficacy|14|||
163137819|NCT00483405|589213054|FG000|Overall Study|Death|3|||
163137820|NCT00483405|589213054|FG000|Overall Study|Withdrawal by Subject|2|||
163137821|NCT00483405|589213054|FG000|Overall Study|Other complicating disease|1|||
163137822|NCT03010319|589213055|FG000|Overall Study|Adverse Event|15|||
163137823|NCT03010319|589213056|FG001|Overall Study|Adverse Event|9|||
163137824|NCT03010319|589213055|FG000|Overall Study|Withdrawal by Subject|1|||
163137825|NCT03010319|589213056|FG001|Overall Study|Withdrawal by Subject|6|||
163137826|NCT03010319|589213055|FG000|Overall Study|Physician Decision|2|||
163137827|NCT03010319|589213056|FG001|Overall Study|Physician Decision|4|||
163137828|NCT03010319|589213055|FG000|Overall Study|Sponsor requested withdrawal|2|||
163137829|NCT03010319|589213056|FG001|Overall Study|Sponsor requested withdrawal|2|||
163137830|NCT03010319|589213055|FG000|Overall Study|Death|1|||
163137831|NCT03010319|589213056|FG001|Overall Study|Death|0|||
163137832|NCT03010319|589213055|FG000|Overall Study|Lost to Follow-up|0|||
163137833|NCT03010319|589213056|FG001|Overall Study|Lost to Follow-up|1|||
163137834|NCT03010319|589213055|FG000|Overall Study|Other Reason|5|||
163137835|NCT03010319|589213056|FG001|Overall Study|Other Reason|7|||
163137836|NCT02128724|589213057|FG000|Overall Study|Death|1|||
163137837|NCT02128724|589213058|FG001|Overall Study|Death|0|||
163137838|NCT02128724|589213059|FG002|Overall Study|Death|0|||
163137839|NCT02128724|589213060|FG003|Overall Study|Death|0|||
163345645|NCT03602859|589973163|FG002|Maintenance Period (Cycle 7 to 89)|Ongoing|23|||
163345646|NCT03602859|589973164|FG003|Maintenance Period (Cycle 7 to 89)|Ongoing|42|||
163137840|NCT02128724|589213057|FG000|Overall Study|Adverse Event|0|||
163137841|NCT02128724|589213058|FG001|Overall Study|Adverse Event|1|||
163137842|NCT02128724|589213059|FG002|Overall Study|Adverse Event|0|||
163137843|NCT02128724|589213060|FG003|Overall Study|Adverse Event|0|||
163229631|NCT01282216|589551571|FG003|Overall Study|Graft failure|2|||
163345647|NCT03602859|589973161|FG000|Maintenance Period (Cycle 7 to 89)|Adverse Event|0|||
163345648|NCT03602859|589973162|FG001|Maintenance Period (Cycle 7 to 89)|Adverse Event|6|||
163345649|NCT03602859|589973163|FG002|Maintenance Period (Cycle 7 to 89)|Adverse Event|24|||
163345650|NCT03602859|589973164|FG003|Maintenance Period (Cycle 7 to 89)|Adverse Event|91|||
163345651|NCT03602859|589973161|FG000|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
163345652|NCT03602859|589973162|FG001|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
163345653|NCT03602859|589973163|FG002|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|1|||
163345654|NCT03602859|589973164|FG003|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|2|||
163345655|NCT03602859|589973161|FG000|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|0|||
163345656|NCT03602859|589973162|FG001|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|83|||
163345657|NCT03602859|589973163|FG002|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|251|||
163345658|NCT03602859|589973164|FG003|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|356|||
163345659|NCT03602859|589973161|FG000|Maintenance Period (Cycle 7 to 89)|Risk to Patient|0|||
163345660|NCT03602859|589973162|FG001|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
163345661|NCT03602859|589973163|FG002|Maintenance Period (Cycle 7 to 89)|Risk to Patient|1|||
163345662|NCT03602859|589973164|FG003|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
163345663|NCT03602859|589973161|FG000|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|0|||
163345664|NCT03602859|589973162|FG001|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
163345665|NCT03602859|589973163|FG002|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
163345666|NCT03602859|589973164|FG003|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|5|||
163345667|NCT03602859|589973161|FG000|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|0|||
163345668|NCT03602859|589973162|FG001|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|7|||
163345669|NCT03602859|589973163|FG002|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|22|||
163345670|NCT03602859|589973164|FG003|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|48|||
163345671|NCT03602859|589973161|FG000|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
163345672|NCT03602859|589973162|FG001|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
163345673|NCT03602859|589973163|FG002|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
163345674|NCT03602859|589973164|FG003|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
163345675|NCT03602859|589973161|FG000|Maintenance Period (Cycle 7 to 89)|Death|0|||
163345676|NCT03602859|589973162|FG001|Maintenance Period (Cycle 7 to 89)|Death|0|||
163345677|NCT03602859|589973163|FG002|Maintenance Period (Cycle 7 to 89)|Death|1|||
163345678|NCT03602859|589973164|FG003|Maintenance Period (Cycle 7 to 89)|Death|7|||
163345679|NCT03602859|589973161|FG000|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
163345680|NCT03602859|589973162|FG001|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|18|||
163345681|NCT03602859|589973163|FG002|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
163345682|NCT03602859|589973164|FG003|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
163345683|NCT03602859|589973161|FG000|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
163345684|NCT03602859|589973162|FG001|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
163408787|NCT03829657|590205609|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
163408788|NCT03829657|590205610|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
163424267|NCT03304522|590258212|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
163137844|NCT02128724|589213057|FG000|Overall Study|Physician Decision|0|||
163137845|NCT02128724|589213058|FG001|Overall Study|Physician Decision|0|||
163137846|NCT02128724|589213059|FG002|Overall Study|Physician Decision|0|||
163137847|NCT02128724|589213060|FG003|Overall Study|Physician Decision|2|||
163137848|NCT02128724|589213057|FG000|Overall Study|Withdrawal by Subject|0|||
163137849|NCT02128724|589213058|FG001|Overall Study|Withdrawal by Subject|0|||
163137850|NCT02128724|589213059|FG002|Overall Study|Withdrawal by Subject|0|||
163137851|NCT02128724|589213060|FG003|Overall Study|Withdrawal by Subject|1|||
163137852|NCT04829916|589213062|FG000|Overall Study|Withdrawal by Subject|1|||
163137853|NCT04829916|589213063|FG001|Overall Study|Withdrawal by Subject|0|||
163137854|NCT03594773|589213067|FG000|Overall Study|Withdrawal by Subject|3|||
163137855|NCT03594773|589213068|FG001|Overall Study|Withdrawal by Subject|2|||
163137856|NCT03594773|589213067|FG000|Overall Study|Lost to Follow-up|3|||
163137857|NCT03594773|589213068|FG001|Overall Study|Lost to Follow-up|4|||
163137858|NCT04098809|589213071|FG000|Overall Study|Withdrawal by Subject|1|||
163137859|NCT04098809|589213072|FG001|Overall Study|Withdrawal by Subject|3|||
163137860|NCT04098809|589213071|FG000|Overall Study|Physician Decision|2|||
163137861|NCT04098809|589213072|FG001|Overall Study|Physician Decision|1|||
163137862|NCT00193206|589213073|FG000|Preoperative Therapy|Lack of Efficacy|2|||
163137863|NCT00193206|589213073|FG000|Preoperative Therapy|Adverse Event|2|||
163229632|NCT01282216|589551568|FG000|Overall Study|Physician Decision|0|||
163137864|NCT00193206|589213073|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
163137865|NCT00193206|589213073|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
163137866|NCT00193206|589213073|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
163137867|NCT00193206|589213073|FG000|Postoperative Therapy|Physician Decision|3|||
163229633|NCT01282216|589551569|FG001|Overall Study|Physician Decision|0|||
163229634|NCT01282216|589551570|FG002|Overall Study|Physician Decision|11|||
163229635|NCT01282216|589551571|FG003|Overall Study|Physician Decision|0|||
163229636|NCT01282216|589551568|FG000|Overall Study|Relapse|0|||
163229637|NCT01282216|589551569|FG001|Overall Study|Relapse|0|||
163229638|NCT01282216|589551570|FG002|Overall Study|Relapse|17|||
163229639|NCT01282216|589551571|FG003|Overall Study|Relapse|6|||
163229640|NCT01282216|589551568|FG000|Overall Study|Death|0|||
163229641|NCT01282216|589551569|FG001|Overall Study|Death|0|||
163229642|NCT01282216|589551570|FG002|Overall Study|Death|2|||
163229643|NCT01282216|589551571|FG003|Overall Study|Death|0|||
163229644|NCT02239536|589551576|FG000|Overall Study|Non-neoplastic polyp|23|||
163229645|NCT02239536|589551577|FG001|Overall Study|Non-neoplastic polyp|17|||
163229646|NCT01038778|589551578|FG000|Overall Study|Withdrawal by Subject|0|||
163229647|NCT01038778|589551579|FG001|Overall Study|Withdrawal by Subject|2|||
163229648|NCT01038778|589551580|FG002|Overall Study|Withdrawal by Subject|3|||
163229649|NCT02349711|589552823|FG000|Overall Study|Withdrawal by Subject|2|||
163229650|NCT02349711|589552824|FG001|Overall Study|Withdrawal by Subject|1|||
163229651|NCT02349711|589552823|FG000|Overall Study|Lost to Follow-up|1|||
163229652|NCT02349711|589552824|FG001|Overall Study|Lost to Follow-up|1|||
163229653|NCT01610700|589552828|FG000|Overall Study|Adverse Event|3|||
163229654|NCT01610700|589552829|FG001|Overall Study|Adverse Event|1|||
163229655|NCT01610700|589552828|FG000|Overall Study|Withdrawal by Subject|0|||
163229656|NCT01610700|589552829|FG001|Overall Study|Withdrawal by Subject|1|||
163229657|NCT01610700|589552828|FG000|Overall Study|subject took one dose of street cannabis|0|||
163229658|NCT01610700|589552829|FG001|Overall Study|subject took one dose of street cannabis|1|||
163229659|NCT02143414|589552831|FG000|Induction|Adverse Event|1|||
163229660|NCT02143414|589552832|FG001|Induction|Adverse Event|2|||
163229661|NCT02143414|589552831|FG000|Induction|Death|1|||
163229662|NCT02143414|589552832|FG001|Induction|Death|2|||
163229663|NCT02143414|589552831|FG000|Induction|Patient refusal|1|||
163229664|NCT02143414|589552832|FG001|Induction|Patient refusal|1|||
163229665|NCT02143414|589552831|FG000|Induction|Refractory|1|||
163229666|NCT02143414|589552832|FG001|Induction|Refractory|0|||
163229667|NCT02143414|589552831|FG000|Induction|Began alternative treatment|1|||
163229668|NCT02143414|589552832|FG001|Induction|Began alternative treatment|0|||
163345685|NCT03602859|589973163|FG002|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
163345686|NCT03602859|589973164|FG003|Maintenance Period (Cycle 7 to 89)|Investigator decision|1|||
163345687|NCT03602859|589973161|FG000|Maintenance Period (Cycle 7 to 89)|Other|0|||
163345688|NCT03602859|589973162|FG001|Maintenance Period (Cycle 7 to 89)|Other|2|||
163345689|NCT03602859|589973163|FG002|Maintenance Period (Cycle 7 to 89)|Other|2|||
163345690|NCT03602859|589973164|FG003|Maintenance Period (Cycle 7 to 89)|Other|12|||
163345691|NCT00506922|589974255|FG000|Overall Study|Physician Decision|0|||
163345692|NCT00506922|589974256|FG001|Overall Study|Physician Decision|0|||
163408789|NCT03829657|590205611|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
163137868|NCT00193206|589213073|FG000|Postoperative Therapy|Intercurrent Illness|2|||
163345693|NCT00506922|589974257|FG002|Overall Study|Physician Decision|0|||
163345694|NCT00506922|589974258|FG003|Overall Study|Physician Decision|2|||
163345695|NCT00506922|589974259|FG004|Overall Study|Physician Decision|0|||
163345696|NCT00506922|589974255|FG000|Overall Study|Withdrawal by Subject|0|||
163137869|NCT00193206|589213073|FG000|Postoperative Therapy|Lack of Efficacy|1|||
163137870|NCT00193206|589213073|FG000|Postoperative Therapy|Protocol Violation|1|||
163137871|NCT01200368|589213078|FG000|Infant Series|Adverse Event|2|||
163137872|NCT01200368|589213079|FG001|Infant Series|Adverse Event|2|||
163137873|NCT01200368|589213080|FG002|Infant Series|Adverse Event|3|||
163137874|NCT01200368|589213078|FG000|Infant Series|Withdrawal by Subject|0|||
163137875|NCT01200368|589213079|FG001|Infant Series|Withdrawal by Subject|2|||
163137876|NCT01200368|589213080|FG002|Infant Series|Withdrawal by Subject|2|||
163137877|NCT01200368|589213078|FG000|Infant Series|Did not meet entrance criteria|0|||
163137878|NCT01200368|589213079|FG001|Infant Series|Did not meet entrance criteria|1|||
163345697|NCT00506922|589974256|FG001|Overall Study|Withdrawal by Subject|0|||
163345698|NCT00506922|589974257|FG002|Overall Study|Withdrawal by Subject|0|||
163424268|NCT03304522|590258211|FG000|Overall Study|Other|0|||
163137879|NCT01200368|589213080|FG002|Infant Series|Did not meet entrance criteria|0|||
163229669|NCT02143414|589552831|FG000|Induction|Ineligible for postremission|5|||
163229670|NCT02143414|589552832|FG001|Induction|Ineligible for postremission|1|||
163229671|NCT02143414|589552831|FG000|Post-remission|Adverse Event|0|||
163229672|NCT02143414|589552832|FG001|Post-remission|Adverse Event|2|||
163229673|NCT02143414|589552831|FG000|Post-remission|Disease progression/relapse|5|||
163229674|NCT02143414|589552832|FG001|Post-remission|Disease progression/relapse|0|||
163229675|NCT02143414|589552831|FG000|Maintenance|Adverse Event|4|||
163229676|NCT02143414|589552832|FG001|Maintenance|Adverse Event|6|||
163229677|NCT02143414|589552831|FG000|Maintenance|Disease progression/relapse|3|||
163229678|NCT02143414|589552832|FG001|Maintenance|Disease progression/relapse|2|||
163229679|NCT02143414|589552831|FG000|Maintenance|Patient refusal|2|||
163229680|NCT02143414|589552832|FG001|Maintenance|Patient refusal|1|||
163229681|NCT02143414|589552831|FG000|Maintenance|Physician Decision|1|||
163345699|NCT00506922|589974258|FG003|Overall Study|Withdrawal by Subject|0|||
163229682|NCT02143414|589552832|FG001|Maintenance|Physician Decision|0|||
163229683|NCT02143414|589552831|FG000|Maintenance|Death|0|||
163229684|NCT02143414|589552832|FG001|Maintenance|Death|1|||
163229685|NCT02143414|589552831|FG000|Maintenance|On protocol treatment|0|||
163229686|NCT02143414|589552832|FG001|Maintenance|On protocol treatment|6|||
163229687|NCT00978731|589552836|FG000|Overall Study|Death|4|||
163229688|NCT00978731|589552837|FG001|Overall Study|Death|1|||
163229689|NCT00978731|589552838|FG002|Overall Study|Death|1|||
163229690|NCT00978731|589552839|FG003|Overall Study|Death|0|||
163229691|NCT00978731|589552836|FG000|Overall Study|Lost to Follow-up|0|||
163229692|NCT00978731|589552837|FG001|Overall Study|Lost to Follow-up|0|||
163229693|NCT00978731|589552838|FG002|Overall Study|Lost to Follow-up|0|||
163229694|NCT00978731|589552839|FG003|Overall Study|Lost to Follow-up|1|||
163229695|NCT00978731|589552836|FG000|Overall Study|Adverse Event|5|||
163229696|NCT00978731|589552837|FG001|Overall Study|Adverse Event|2|||
163229697|NCT00978731|589552838|FG002|Overall Study|Adverse Event|0|||
163229698|NCT00978731|589552839|FG003|Overall Study|Adverse Event|0|||
163229699|NCT00978731|589552836|FG000|Overall Study|Participant's request|1|||
163229700|NCT00978731|589552837|FG001|Overall Study|Participant's request|0|||
163229701|NCT00978731|589552838|FG002|Overall Study|Participant's request|0|||
163229702|NCT00978731|589552839|FG003|Overall Study|Participant's request|0|||
163229703|NCT00978731|589552836|FG000|Overall Study|Administrative reason|3|||
163229704|NCT00978731|589552837|FG001|Overall Study|Administrative reason|3|||
163229705|NCT00978731|589552838|FG002|Overall Study|Administrative reason|1|||
163229706|NCT00978731|589552839|FG003|Overall Study|Administrative reason|0|||
163229707|NCT00978731|589552836|FG000|Overall Study|Deterioration without progression|0|||
163229708|NCT00978731|589552837|FG001|Overall Study|Deterioration without progression|1|||
163229709|NCT00978731|589552838|FG002|Overall Study|Deterioration without progression|0|||
163229710|NCT00978731|589552839|FG003|Overall Study|Deterioration without progression|0|||
163229711|NCT00978731|589552836|FG000|Overall Study|Disease progression/relapse|5|||
163229712|NCT00978731|589552837|FG001|Overall Study|Disease progression/relapse|4|||
163229713|NCT00978731|589552838|FG002|Overall Study|Disease progression/relapse|2|||
163229714|NCT00978731|589552839|FG003|Overall Study|Disease progression/relapse|2|||
163229715|NCT00978731|589552836|FG000|Overall Study|Study closure|3|||
163229716|NCT00978731|589552837|FG001|Overall Study|Study closure|4|||
163229717|NCT00978731|589552838|FG002|Overall Study|Study closure|1|||
163229718|NCT00978731|589552839|FG003|Overall Study|Study closure|1|||
163229719|NCT00978731|589552836|FG000|Overall Study|No response|1|||
163229720|NCT00978731|589552837|FG001|Overall Study|No response|0|||
163229721|NCT00978731|589552838|FG002|Overall Study|No response|0|||
163229722|NCT00978731|589552839|FG003|Overall Study|No response|0|||
163229723|NCT02649972|589552844|FG000|Overall Study|Not treated|1|||
163229724|NCT01428193|589552845|FG000|Overall Study|Physician Decision|1|||
163229725|NCT01428193|589552845|FG000|Overall Study|Elevated screening liver enzymes|1|||
163229726|NCT00357370|589552850|FG000|Cohort 2|Lack of Efficacy|0|||
163229727|NCT00357370|589552851|FG001|Cohort 2|Lack of Efficacy|2|||
163229728|NCT00357370|589552852|FG002|Cohort 2|Lack of Efficacy|1|||
163229729|NCT00357370|589552850|FG000|Cohort 2|Adverse Event|1|||
163229730|NCT00357370|589552851|FG001|Cohort 2|Adverse Event|1|||
163229731|NCT00357370|589552852|FG002|Cohort 2|Adverse Event|1|||
163229732|NCT00357370|589552850|FG000|Cohort 2|Lost to Follow-up|0|||
163229733|NCT00357370|589552851|FG001|Cohort 2|Lost to Follow-up|1|||
163229734|NCT00357370|589552852|FG002|Cohort 2|Lost to Follow-up|0|||
163229735|NCT00357370|589552850|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
163229736|NCT00357370|589552851|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
163229737|NCT00357370|589552852|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
163229738|NCT00357370|589552850|FG000|Cohort 2|Withdrawal by Subject|0|||
163229739|NCT00357370|589552851|FG001|Cohort 2|Withdrawal by Subject|2|||
163229740|NCT00357370|589552852|FG002|Cohort 2|Withdrawal by Subject|0|||
163229741|NCT01632800|589552854|FG000|Overall Study|Subject did not fit in apparatus|1|||
163229742|NCT01502644|589552857|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
163229743|NCT01502644|589552858|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
163229744|NCT01502644|589552859|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
163229745|NCT01502644|589552860|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
163408790|NCT03829657|590205612|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
163408791|NCT03829657|590205608|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
163408792|NCT03829657|590205609|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
163424269|NCT03304522|590258212|FG001|Overall Study|Other|1|||
163229746|NCT01502644|589552857|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
163229747|NCT01502644|589552858|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
163229748|NCT01502644|589552859|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
163229749|NCT01502644|589552860|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
163229750|NCT01502644|589552857|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
163229751|NCT01502644|589552858|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
163229752|NCT01502644|589552859|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
163229753|NCT01502644|589552860|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
163345700|NCT00506922|589974259|FG004|Overall Study|Withdrawal by Subject|1|||
163137880|NCT01200368|589213078|FG000|Infant Series|Randomized, not vaccinated|0|||
163137881|NCT01200368|589213079|FG001|Infant Series|Randomized, not vaccinated|1|||
163137882|NCT01200368|589213080|FG002|Infant Series|Randomized, not vaccinated|1|||
163137883|NCT01200368|589213078|FG000|Infant Series|Other|1|||
163137884|NCT01200368|589213079|FG001|Infant Series|Other|0|||
163137885|NCT01200368|589213080|FG002|Infant Series|Other|0|||
163137886|NCT01200368|589213078|FG000|After Infant Series|Adverse Event|6|||
163137887|NCT01200368|589213079|FG001|After Infant Series|Adverse Event|6|||
163137888|NCT01200368|589213080|FG002|After Infant Series|Adverse Event|3|||
163137889|NCT01200368|589213078|FG000|After Infant Series|Withdrawal by Subject|10|||
163137890|NCT01200368|589213079|FG001|After Infant Series|Withdrawal by Subject|8|||
163137891|NCT01200368|589213080|FG002|After Infant Series|Withdrawal by Subject|4|||
163137892|NCT01200368|589213078|FG000|After Infant Series|Lost to Follow-up|1|||
163137893|NCT01200368|589213079|FG001|After Infant Series|Lost to Follow-up|0|||
163137894|NCT01200368|589213080|FG002|After Infant Series|Lost to Follow-up|0|||
163137895|NCT01200368|589213078|FG000|After Infant Series|Other|1|||
163137896|NCT01200368|589213079|FG001|After Infant Series|Other|2|||
163137897|NCT01200368|589213080|FG002|After Infant Series|Other|2|||
163137898|NCT01200368|589213078|FG000|Toddler Dose|Adverse Event|0|||
163137899|NCT01200368|589213079|FG001|Toddler Dose|Adverse Event|3|||
163137900|NCT01200368|589213080|FG002|Toddler Dose|Adverse Event|1|||
163137901|NCT01290757|589213081|FG000|Overall Study|Adverse Event|1|||
163137902|NCT01290757|589213082|FG001|Overall Study|Adverse Event|0|||
163137903|NCT01290757|589213081|FG000|Overall Study|Protocol Violation|1|||
163137904|NCT01290757|589213082|FG001|Overall Study|Protocol Violation|1|||
163137905|NCT01290757|589213081|FG000|Overall Study|Other|0|||
163137906|NCT01290757|589213082|FG001|Overall Study|Other|1|||
163137907|NCT00570310|589213083|FG000|Overall Study|Adverse Event|1|||
163137908|NCT00570310|589213084|FG001|Overall Study|Adverse Event|2|||
163137909|NCT00570310|589213083|FG000|Overall Study|Lack of Efficacy|1|||
163137910|NCT00570310|589213084|FG001|Overall Study|Lack of Efficacy|4|||
163137911|NCT03066193|589213087|FG000|Overall Study|Withdrawal by Subject|1|||
163137912|NCT00181766|589213097|FG000|Overall Study|Lost to Follow-up|6|||
163229754|NCT01502644|589552857|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
163229755|NCT01502644|589552858|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
163229756|NCT01502644|589552859|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
163229757|NCT01502644|589552860|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
163229758|NCT01502644|589552857|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
163229759|NCT01502644|589552858|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
163229760|NCT01502644|589552859|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
163229761|NCT01502644|589552860|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
163229762|NCT03306264|589552863|FG000|Overall Study|Death|33|||
163229763|NCT03306264|589552864|FG001|Overall Study|Death|25|||
163229764|NCT03306264|589552865|FG002|Overall Study|Death|34|||
163229765|NCT03306264|589552866|FG003|Overall Study|Death|34|||
163229766|NCT03306264|589552863|FG000|Overall Study|Complete Consent Withdrawal|4|||
163229767|NCT03306264|589552864|FG001|Overall Study|Complete Consent Withdrawal|4|||
163229768|NCT03306264|589552865|FG002|Overall Study|Complete Consent Withdrawal|1|||
163229769|NCT03306264|589552866|FG003|Overall Study|Complete Consent Withdrawal|8|||
163229770|NCT03306264|589552863|FG000|Overall Study|Lost to Follow-up|1|||
163229771|NCT03306264|589552864|FG001|Overall Study|Lost to Follow-up|0|||
163229772|NCT03306264|589552865|FG002|Overall Study|Lost to Follow-up|1|||
163229773|NCT03306264|589552866|FG003|Overall Study|Lost to Follow-up|0|||
163229774|NCT03306264|589552863|FG000|Overall Study|Rollover to ASTX727-06|10|||
163229775|NCT03306264|589552864|FG001|Overall Study|Rollover to ASTX727-06|18|||
163229776|NCT03306264|589552865|FG002|Overall Study|Rollover to ASTX727-06|4|||
163229777|NCT03306264|589552866|FG003|Overall Study|Rollover to ASTX727-06|2|||
163229778|NCT03306264|589552863|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
163229779|NCT03306264|589552864|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
163137913|NCT00181766|589213097|FG000|Overall Study|Adverse Event|4|||
163137914|NCT00181766|589213097|FG000|Overall Study|non-compliance|2|||
163229780|NCT03306264|589552865|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
163137915|NCT00757237|589213102|FG000|Overall Study|Lost to Follow-up|0|||
163137916|NCT00757237|589213103|FG001|Overall Study|Lost to Follow-up|1|||
163137917|NCT00757237|589213102|FG000|Overall Study|Protocol Violation|0|||
163137918|NCT00757237|589213103|FG001|Overall Study|Protocol Violation|2|||
163137919|NCT00757237|589213102|FG000|Overall Study|Physician Decision|2|||
163229781|NCT03306264|589552866|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
163137920|NCT00757237|589213103|FG001|Overall Study|Physician Decision|3|||
163137921|NCT00757237|589213102|FG000|Overall Study|Withdrawal by Subject|8|||
163137922|NCT00757237|589213103|FG001|Overall Study|Withdrawal by Subject|12|||
163137923|NCT00757237|589213102|FG000|Overall Study|Safety or Tolerability|3|||
163137924|NCT00757237|589213103|FG001|Overall Study|Safety or Tolerability|5|||
163229782|NCT02722928|589552870|FG000|Overall Study|Standard CT was not as required per prot|5|||
163229783|NCT02722928|589552871|FG001|Overall Study|Standard CT was not as required per prot|13|||
163229784|NCT02722928|589552870|FG000|Overall Study|Required Intraoperative MRI|5|||
163229785|NCT02722928|589552871|FG001|Overall Study|Required Intraoperative MRI|7|||
163229786|NCT00094653|589552872|FG000|Overall Study|Death|306|||
163229787|NCT00094653|589552873|FG001|Overall Study|Death|100|||
163229788|NCT00094653|589552874|FG002|Overall Study|Death|119|||
163229789|NCT00094653|589552872|FG000|Overall Study|Subject Withdrew Consent|10|||
163229790|NCT00094653|589552873|FG001|Overall Study|Subject Withdrew Consent|2|||
163229791|NCT00094653|589552874|FG002|Overall Study|Subject Withdrew Consent|3|||
163229792|NCT00094653|589552872|FG000|Overall Study|Other|2|||
163229793|NCT00094653|589552873|FG001|Overall Study|Other|2|||
163229794|NCT00094653|589552874|FG002|Overall Study|Other|2|||
163229795|NCT00094653|589552872|FG000|Overall Study|Lost to Follow-up|3|||
163229796|NCT00094653|589552873|FG001|Overall Study|Lost to Follow-up|2|||
163345701|NCT04816708|589974265|FG000|Overall Study|Lost to Follow-up|10|||
163345702|NCT04816708|589974266|FG001|Overall Study|Lost to Follow-up|4|||
163345703|NCT03596905|589974267|FG000|Overall Study|Protocol Violation|0|||
163345704|NCT03596905|589974268|FG001|Overall Study|Protocol Violation|0|||
163345705|NCT03596905|589974269|FG002|Overall Study|Protocol Violation|0|||
163345706|NCT03596905|589974270|FG003|Overall Study|Protocol Violation|0|||
163345707|NCT03596905|589974271|FG004|Overall Study|Protocol Violation|1|||
163345708|NCT03596905|589974272|FG005|Overall Study|Protocol Violation|0|||
163345709|NCT03596905|589974273|FG006|Overall Study|Protocol Violation|0|||
163345710|NCT03596905|589974267|FG000|Overall Study|Withdrawal by Subject|0|||
163345711|NCT03596905|589974268|FG001|Overall Study|Withdrawal by Subject|2|||
163345712|NCT03596905|589974269|FG002|Overall Study|Withdrawal by Subject|1|||
163345713|NCT03596905|589974270|FG003|Overall Study|Withdrawal by Subject|0|||
163345714|NCT03596905|589974271|FG004|Overall Study|Withdrawal by Subject|2|||
163345715|NCT03596905|589974272|FG005|Overall Study|Withdrawal by Subject|0|||
163345716|NCT03596905|589974273|FG006|Overall Study|Withdrawal by Subject|0|||
163345717|NCT03596905|589974267|FG000|Overall Study|Participant moved and was unable to complete study|0|||
163345718|NCT03596905|589974268|FG001|Overall Study|Participant moved and was unable to complete study|1|||
163345719|NCT03596905|589974269|FG002|Overall Study|Participant moved and was unable to complete study|0|||
163345720|NCT03596905|589974270|FG003|Overall Study|Participant moved and was unable to complete study|0|||
163345721|NCT03596905|589974271|FG004|Overall Study|Participant moved and was unable to complete study|0|||
163345722|NCT03596905|589974272|FG005|Overall Study|Participant moved and was unable to complete study|0|||
163345723|NCT03596905|589974273|FG006|Overall Study|Participant moved and was unable to complete study|0|||
163345724|NCT03596905|589974267|FG000|Overall Study|Adverse Event|0|||
163345725|NCT03596905|589974268|FG001|Overall Study|Adverse Event|0|||
163345726|NCT03596905|589974269|FG002|Overall Study|Adverse Event|0|||
163345727|NCT03596905|589974270|FG003|Overall Study|Adverse Event|0|||
163345728|NCT03596905|589974271|FG004|Overall Study|Adverse Event|0|||
163345729|NCT03596905|589974272|FG005|Overall Study|Adverse Event|0|||
163345730|NCT03596905|589974273|FG006|Overall Study|Adverse Event|1|||
163345731|NCT03596905|589974267|FG000|Overall Study|Non-Compliance with eDiary|1|||
163345732|NCT03596905|589974268|FG001|Overall Study|Non-Compliance with eDiary|0|||
163345733|NCT03596905|589974269|FG002|Overall Study|Non-Compliance with eDiary|0|||
163345734|NCT03596905|589974270|FG003|Overall Study|Non-Compliance with eDiary|0|||
163345735|NCT03596905|589974271|FG004|Overall Study|Non-Compliance with eDiary|1|||
163345736|NCT03596905|589974272|FG005|Overall Study|Non-Compliance with eDiary|0|||
163345737|NCT03596905|589974273|FG006|Overall Study|Non-Compliance with eDiary|2|||
163345738|NCT03596905|589974267|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163345739|NCT03596905|589974268|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163345740|NCT03596905|589974269|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163229797|NCT00094653|589552874|FG002|Overall Study|Lost to Follow-up|1|||
163229798|NCT00094653|589552872|FG000|Overall Study|Protocol Violation|0|||
163345741|NCT03596905|589974270|FG003|Overall Study|Non-Compliance with Study Drug|0|||
163345742|NCT03596905|589974271|FG004|Overall Study|Non-Compliance with Study Drug|1|||
163345743|NCT03596905|589974272|FG005|Overall Study|Non-Compliance with Study Drug|0|||
163345744|NCT03596905|589974273|FG006|Overall Study|Non-Compliance with Study Drug|0|||
163345745|NCT03596905|589974267|FG000|Overall Study|Lost to Follow-up|0|||
163345746|NCT03596905|589974268|FG001|Overall Study|Lost to Follow-up|0|||
163345747|NCT03596905|589974269|FG002|Overall Study|Lost to Follow-up|0|||
163345748|NCT03596905|589974270|FG003|Overall Study|Lost to Follow-up|0|||
163345749|NCT03596905|589974271|FG004|Overall Study|Lost to Follow-up|0|||
163345750|NCT03596905|589974272|FG005|Overall Study|Lost to Follow-up|1|||
163345751|NCT03596905|589974273|FG006|Overall Study|Lost to Follow-up|0|||
163345752|NCT00508274|589974274|FG000|Overall Study|Adverse Event|5|||
163345753|NCT00508274|589974274|FG000|Overall Study|Death|7|||
163345754|NCT00508274|589974274|FG000|Overall Study|Disease progression|32|||
163345755|NCT00508274|589974274|FG000|Overall Study|Withdrawal by Subject|1|||
163345756|NCT00508274|589974274|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
163345757|NCT00508274|589974274|FG000|Overall Study|Missing|3|||
163229799|NCT00094653|589552873|FG001|Overall Study|Protocol Violation|0|||
163229800|NCT00094653|589552874|FG002|Overall Study|Protocol Violation|1|||
163229801|NCT05059600|589552877|FG000|Overall Study|Enrolled but not Treated|10|||
163229802|NCT02152995|589552878|FG000|Overall Study|Withdrawal by Subject|1|||
163229803|NCT02152995|589552879|FG001|Overall Study|Withdrawal by Subject|0|||
163229804|NCT01565291|589552880|FG000|Overall Study|Withdrawal by Subject|1|||
163229805|NCT01565291|589552881|FG001|Overall Study|Withdrawal by Subject|0|||
163229806|NCT04552587|589552887|FG000|Overall Study|Lost to Follow-up|4|||
163229807|NCT01822132|589552888|FG000|Overall Study|Lost to Follow-up|4|||
163229808|NCT01822132|589552889|FG001|Overall Study|Lost to Follow-up|2|||
163229809|NCT00313612|589552890|FG000|Overall Study|Patient never received treatment|0|||
163229810|NCT00313612|589552891|FG001|Overall Study|Patient never received treatment|1|||
163229811|NCT00677807|589552894|FG000|Overall Study|Adverse Event|4|||
163229812|NCT00677807|589552895|FG001|Overall Study|Adverse Event|1|||
163229813|NCT00677807|589552896|FG002|Overall Study|Adverse Event|6|||
163229814|NCT00677807|589552894|FG000|Overall Study|Lack of Efficacy|0|||
163229815|NCT00677807|589552895|FG001|Overall Study|Lack of Efficacy|0|||
163229816|NCT00677807|589552896|FG002|Overall Study|Lack of Efficacy|2|||
163229817|NCT00677807|589552894|FG000|Overall Study|Participant no longer needs study drug|0|||
163229818|NCT00677807|589552895|FG001|Overall Study|Participant no longer needs study drug|0|||
163229819|NCT00677807|589552896|FG002|Overall Study|Participant no longer needs study drug|1|||
163229820|NCT00677807|589552894|FG000|Overall Study|Withdrawal by Subject|10|||
163229821|NCT00677807|589552895|FG001|Overall Study|Withdrawal by Subject|3|||
163229822|NCT00677807|589552896|FG002|Overall Study|Withdrawal by Subject|6|||
163229823|NCT00677807|589552894|FG000|Overall Study|Lost to Follow-up|2|||
163229824|NCT00677807|589552895|FG001|Overall Study|Lost to Follow-up|2|||
163229825|NCT00677807|589552896|FG002|Overall Study|Lost to Follow-up|2|||
163229826|NCT00677807|589552894|FG000|Overall Study|Administrative problems|1|||
163229827|NCT00677807|589552895|FG001|Overall Study|Administrative problems|1|||
163229828|NCT00677807|589552896|FG002|Overall Study|Administrative problems|2|||
163229829|NCT00677807|589552894|FG000|Overall Study|Death|0|||
163229830|NCT00677807|589552895|FG001|Overall Study|Death|1|||
163229831|NCT00677807|589552896|FG002|Overall Study|Death|1|||
163229832|NCT00677807|589552894|FG000|Overall Study|Protocol Deviation|1|||
163229833|NCT00677807|589552895|FG001|Overall Study|Protocol Deviation|3|||
163345758|NCT00197106|589974275|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
163345759|NCT00197106|589974276|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
163345760|NCT00197106|589974277|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
163345761|NCT00197106|589974275|FG000|Overall Treatment Period|Lack of Efficacy|0|||
163137925|NCT00757237|589213102|FG000|Overall Study|Other|0|||
163137926|NCT00757237|589213103|FG001|Overall Study|Other|2|||
163137927|NCT01843023|589213104|FG000|Overall Study|Death|1|||
163137928|NCT01843023|589213105|FG001|Overall Study|Death|0|||
163137929|NCT01843023|589213104|FG000|Overall Study|Lost to Follow-up|24|||
163137930|NCT01843023|589213105|FG001|Overall Study|Lost to Follow-up|29|||
163137931|NCT01843023|589213104|FG000|Overall Study|Withdrawal by Subject|8|||
163137932|NCT01843023|589213105|FG001|Overall Study|Withdrawal by Subject|6|||
163137933|NCT01397461|589213107|FG000|Overall Study|Withdrawal by Subject|2|||
163345762|NCT00197106|589974276|FG001|Overall Treatment Period|Lack of Efficacy|1|||
163345763|NCT00197106|589974277|FG002|Overall Treatment Period|Lack of Efficacy|0|||
163345764|NCT00197106|589974275|FG000|Overall Treatment Period|Lost to Follow-up|0|||
163345765|NCT00197106|589974276|FG001|Overall Treatment Period|Lost to Follow-up|0|||
163345766|NCT00197106|589974277|FG002|Overall Treatment Period|Lost to Follow-up|2|||
163345767|NCT00197106|589974275|FG000|Overall Treatment Period|Protocol Violation|0|||
163137934|NCT01397461|589213108|FG001|Overall Study|Withdrawal by Subject|1|||
163137935|NCT01397461|589213109|FG002|Overall Study|Withdrawal by Subject|0|||
163137936|NCT01397461|589213107|FG000|Overall Study|Lost to Follow-up|0|||
163137937|NCT01397461|589213108|FG001|Overall Study|Lost to Follow-up|2|||
163137938|NCT01397461|589213109|FG002|Overall Study|Lost to Follow-up|1|||
163137939|NCT01397461|589213107|FG000|Overall Study|Lack of Efficacy|0|||
163137940|NCT01397461|589213108|FG001|Overall Study|Lack of Efficacy|3|||
163137941|NCT01397461|589213109|FG002|Overall Study|Lack of Efficacy|0|||
163137942|NCT01397461|589213107|FG000|Overall Study|Not treated|0|||
163229834|NCT00677807|589552896|FG002|Overall Study|Protocol Deviation|0|||
163345768|NCT00197106|589974276|FG001|Overall Treatment Period|Protocol Violation|0|||
163345769|NCT00197106|589974277|FG002|Overall Treatment Period|Protocol Violation|2|||
163345770|NCT00197106|589974275|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
163345771|NCT00197106|589974276|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
163137943|NCT01397461|589213108|FG001|Overall Study|Not treated|0|||
163229835|NCT01393743|589552897|FG000|Core Study|Adverse Event|5|||
163345772|NCT00197106|589974277|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
163137944|NCT01397461|589213109|FG002|Overall Study|Not treated|1|||
163137945|NCT04980612|589213126|FG000|Overall Study|Withdrawal by Subject|7|||
163229836|NCT01393743|589552898|FG001|Core Study|Adverse Event|9|||
163229837|NCT01393743|589552899|FG002|Core Study|Adverse Event|0|||
163229838|NCT01393743|589552897|FG000|Core Study|Lost to Follow-up|1|||
163229839|NCT01393743|589552898|FG001|Core Study|Lost to Follow-up|1|||
163229840|NCT01393743|589552899|FG002|Core Study|Lost to Follow-up|0|||
163229841|NCT01393743|589552897|FG000|Core Study|Participant's Choice|2|||
163229842|NCT01393743|589552898|FG001|Core Study|Participant's Choice|3|||
163229843|NCT01393743|589552899|FG002|Core Study|Participant's Choice|0|||
163345773|NCT02531126|589974281|FG000|Overall Study|Non-compliance with protocol/protocol deviation|5|||
163137946|NCT04980612|589213127|FG001|Overall Study|Withdrawal by Subject|5|||
163137947|NCT05730387|589213128|FG000|Overall Study|Stillbirth|0|||
163137948|NCT05730387|589213129|FG001|Overall Study|Stillbirth|262|||
163137949|NCT05730387|589213128|FG000|Overall Study|Died during or after delivery|2|||
163137950|NCT05730387|589213129|FG001|Overall Study|Died during or after delivery|85|||
163137951|NCT05730387|589213128|FG000|Overall Study|Died after being admitted|0|||
163137952|NCT05730387|589213129|FG001|Overall Study|Died after being admitted|44|||
163137953|NCT05730387|589213128|FG000|Overall Study|Lost to Follow-up|69|||
163137954|NCT05730387|589213129|FG001|Overall Study|Lost to Follow-up|77|||
163137955|NCT03364738|589213132|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
163137956|NCT03364738|589213132|FG000|Overall Study|Withdrawal by Subject|1|||
163137957|NCT03364738|589213132|FG000|Overall Study|Adverse Event|1|||
163137958|NCT03245398|589213133|FG000|Overall Study|Travelled to another island|1|||
163137959|NCT03245398|589213134|FG001|Overall Study|Travelled to another island|0|||
163137960|NCT00637416|589213138|FG000|Overall Study|Lost to Follow-up|1|||
163137961|NCT00637416|589213139|FG001|Overall Study|Lost to Follow-up|1|||
163137962|NCT00637416|589213138|FG000|Overall Study|Unable to take study drug|0|||
163137963|NCT00637416|589213139|FG001|Overall Study|Unable to take study drug|1|||
163137964|NCT04137731|589213142|FG000|Overall Study|Surgery Cancellation|1|||
163137965|NCT04137731|589213143|FG001|Overall Study|Surgery Cancellation|2|||
163137966|NCT04137731|589213142|FG000|Overall Study|Withdrawal by Subject|2|||
163137967|NCT04137731|589213143|FG001|Overall Study|Withdrawal by Subject|0|||
163137968|NCT04137731|589213142|FG000|Overall Study|Protocol Violation|0|||
163137969|NCT04137731|589213143|FG001|Overall Study|Protocol Violation|1|||
163137970|NCT02204072|589213148|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
163137971|NCT02204072|589213149|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
163137972|NCT02204072|589213150|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
163137973|NCT02204072|589213151|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
163137974|NCT02204072|589213152|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
163137975|NCT02204072|589213148|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
163137976|NCT02204072|589213149|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
163137977|NCT02204072|589213150|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
163137978|NCT02204072|589213151|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
163137979|NCT02204072|589213152|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
163137980|NCT02204072|589213148|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
163137981|NCT02204072|589213149|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
163137982|NCT02204072|589213150|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
163137983|NCT02204072|589213151|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
163137984|NCT02204072|589213152|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
163137985|NCT02204072|589213148|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
163137986|NCT02204072|589213149|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
163137987|NCT02204072|589213150|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
163137988|NCT02204072|589213151|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
163137989|NCT02204072|589213152|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
163137990|NCT00310817|589213153|FG000|Overall Study|AE or Death|3|||
163137991|NCT00310817|589213154|FG001|Overall Study|AE or Death|1|||
163137992|NCT00310817|589213155|FG002|Overall Study|AE or Death|0|||
163137993|NCT00310817|589213156|FG003|Overall Study|AE or Death|0|||
163137994|NCT00310817|589213153|FG000|Overall Study|Withdrawal by Subject|1|||
163137995|NCT00310817|589213154|FG001|Overall Study|Withdrawal by Subject|4|||
163137996|NCT00310817|589213155|FG002|Overall Study|Withdrawal by Subject|6|||
163137997|NCT00310817|589213156|FG003|Overall Study|Withdrawal by Subject|7|||
163137998|NCT00310817|589213153|FG000|Overall Study|Lost to Follow-up|2|||
163137999|NCT00310817|589213154|FG001|Overall Study|Lost to Follow-up|1|||
163138000|NCT00310817|589213155|FG002|Overall Study|Lost to Follow-up|0|||
163138001|NCT00310817|589213156|FG003|Overall Study|Lost to Follow-up|0|||
163138002|NCT00310817|589213153|FG000|Overall Study|Inappropriate Enrollment|1|||
163138003|NCT00310817|589213154|FG001|Overall Study|Inappropriate Enrollment|0|||
163138004|NCT00310817|589213155|FG002|Overall Study|Inappropriate Enrollment|1|||
163138005|NCT00310817|589213156|FG003|Overall Study|Inappropriate Enrollment|0|||
163138006|NCT00310817|589213153|FG000|Overall Study|Protocol Violation|1|||
163138007|NCT00310817|589213154|FG001|Overall Study|Protocol Violation|1|||
163138008|NCT00310817|589213155|FG002|Overall Study|Protocol Violation|1|||
163138009|NCT00310817|589213156|FG003|Overall Study|Protocol Violation|1|||
163138010|NCT00310817|589213153|FG000|Overall Study|Unable to classify|3|||
163138011|NCT00310817|589213154|FG001|Overall Study|Unable to classify|1|||
163138012|NCT00310817|589213155|FG002|Overall Study|Unable to classify|0|||
163138013|NCT00310817|589213156|FG003|Overall Study|Unable to classify|0|||
163138014|NCT01587040|589213162|FG000|Overall Study|Protocol Violation|0|||
163138015|NCT01587040|589213163|FG001|Overall Study|Protocol Violation|0|||
163229844|NCT01393743|589552897|FG000|Core Study|Inadequate therapeutic effect|2|||
163229845|NCT01393743|589552898|FG001|Core Study|Inadequate therapeutic effect|0|||
163229846|NCT01393743|589552899|FG002|Core Study|Inadequate therapeutic effect|0|||
163229847|NCT01393743|589552897|FG000|Extension Phase|Adverse Event|0|||
163229848|NCT01393743|589552898|FG001|Extension Phase|Adverse Event|0|||
163229849|NCT01393743|589552899|FG002|Extension Phase|Adverse Event|12|||
163229850|NCT01393743|589552897|FG000|Extension Phase|Lost to Follow-up|0|||
163229851|NCT01393743|589552898|FG001|Extension Phase|Lost to Follow-up|0|||
163229852|NCT01393743|589552899|FG002|Extension Phase|Lost to Follow-up|2|||
163229853|NCT01393743|589552897|FG000|Extension Phase|Participant choice|0|||
163229854|NCT01393743|589552898|FG001|Extension Phase|Participant choice|0|||
163229855|NCT01393743|589552899|FG002|Extension Phase|Participant choice|16|||
163229856|NCT01393743|589552897|FG000|Extension Phase|Inadequate therapeutic effect|0|||
163229857|NCT01393743|589552898|FG001|Extension Phase|Inadequate therapeutic effect|0|||
163229858|NCT01393743|589552899|FG002|Extension Phase|Inadequate therapeutic effect|7|||
163229859|NCT01393743|589552897|FG000|Extension Phase|Withdrawal by Subject|0|||
163229860|NCT01393743|589552898|FG001|Extension Phase|Withdrawal by Subject|0|||
163229861|NCT01393743|589552899|FG002|Extension Phase|Withdrawal by Subject|8|||
163229862|NCT01393743|589552897|FG000|Extension Phase|Pregnancy|0|||
163229863|NCT01393743|589552898|FG001|Extension Phase|Pregnancy|0|||
163229864|NCT01393743|589552899|FG002|Extension Phase|Pregnancy|1|||
163229865|NCT01393743|589552897|FG000|Extension Phase|Other|0|||
163138016|NCT01587040|589213164|FG002|Overall Study|Protocol Violation|1|||
163138017|NCT01587040|589213165|FG003|Overall Study|Protocol Violation|0|||
163138018|NCT01587040|589213162|FG000|Overall Study|Adverse Event|0|||
163138019|NCT01587040|589213163|FG001|Overall Study|Adverse Event|1|||
163138020|NCT01587040|589213164|FG002|Overall Study|Adverse Event|10|||
163138021|NCT01587040|589213165|FG003|Overall Study|Adverse Event|0|||
163138022|NCT01587040|589213162|FG000|Overall Study|Disease progression|12|||
163138023|NCT01587040|589213163|FG001|Overall Study|Disease progression|1|||
163138024|NCT01587040|589213164|FG002|Overall Study|Disease progression|15|||
163138025|NCT01587040|589213165|FG003|Overall Study|Disease progression|3|||
163138026|NCT01587040|589213162|FG000|Overall Study|Other than specified|5|||
163138027|NCT01587040|589213163|FG001|Overall Study|Other than specified|1|||
163138028|NCT01587040|589213164|FG002|Overall Study|Other than specified|11|||
163138029|NCT01587040|589213165|FG003|Overall Study|Other than specified|1|||
163138030|NCT00367835|589213169|FG000|Overall Study|Adverse Event|14|||
163138031|NCT00367835|589213170|FG001|Overall Study|Adverse Event|1|||
163138032|NCT00367835|589213169|FG000|Overall Study|Protocol Violation|1|||
163138033|NCT00367835|589213170|FG001|Overall Study|Protocol Violation|7|||
163138034|NCT00367835|589213169|FG000|Overall Study|Withdrawal by Subject|7|||
163138035|NCT00367835|589213170|FG001|Overall Study|Withdrawal by Subject|6|||
163138036|NCT00367835|589213169|FG000|Overall Study|Lost to Follow-up|1|||
163138037|NCT00367835|589213170|FG001|Overall Study|Lost to Follow-up|4|||
163138038|NCT00367835|589213169|FG000|Overall Study|Lack of Efficacy|3|||
163138039|NCT00367835|589213170|FG001|Overall Study|Lack of Efficacy|12|||
163138040|NCT00367835|589213169|FG000|Overall Study|Subject in juvenile detention center|1|||
163138041|NCT00367835|589213170|FG001|Overall Study|Subject in juvenile detention center|0|||
163138042|NCT00367835|589213169|FG000|Overall Study|refused blood collection|1|||
163138043|NCT00367835|589213170|FG001|Overall Study|refused blood collection|0|||
163138044|NCT00367835|589213169|FG000|Overall Study|Did not respond to calls|1|||
163138045|NCT00367835|589213170|FG001|Overall Study|Did not respond to calls|0|||
163138046|NCT00367835|589213169|FG000|Overall Study|History of lead poisoning|0|||
163138047|NCT00367835|589213170|FG001|Overall Study|History of lead poisoning|1|||
163138048|NCT04346654|589213172|FG000|Overall Study|Adverse Event|2|||
163138049|NCT04346654|589213173|FG001|Overall Study|Adverse Event|0|||
163138050|NCT04346654|589213172|FG000|Overall Study|Non-response|1|||
163138051|NCT04346654|589213173|FG001|Overall Study|Non-response|1|||
163138052|NCT04346654|589213172|FG000|Overall Study|Withdrawal by Subject|2|||
163138053|NCT04346654|589213173|FG001|Overall Study|Withdrawal by Subject|0|||
163138054|NCT04346654|589213172|FG000|Overall Study|Lost to Follow-up|0|||
163229866|NCT01393743|589552898|FG001|Extension Phase|Other|0|||
163229867|NCT01393743|589552899|FG002|Extension Phase|Other|14|||
163345774|NCT02531126|589974282|FG001|Overall Study|Non-compliance with protocol/protocol deviation|0|||
163345775|NCT02531126|589974283|FG002|Overall Study|Non-compliance with protocol/protocol deviation|3|||
163345776|NCT02531126|589974284|FG003|Overall Study|Non-compliance with protocol/protocol deviation|0|||
163138055|NCT04346654|589213173|FG001|Overall Study|Lost to Follow-up|1|||
163138056|NCT04346654|589213172|FG000|Overall Study|Pregnancy|0|||
163138057|NCT04346654|589213173|FG001|Overall Study|Pregnancy|1|||
163138058|NCT00999518|589213177|FG000|Overall Study|Adverse Event|1|||
163229868|NCT00989833|589552904|FG000|Overall Study|Lost to Follow-up|0|||
163229869|NCT00989833|589552905|FG001|Overall Study|Lost to Follow-up|1|||
163229870|NCT00989833|589552906|FG002|Overall Study|Lost to Follow-up|0|||
163229871|NCT00989833|589552904|FG000|Overall Study|Protocol Violation|1|||
163229872|NCT00989833|589552905|FG001|Overall Study|Protocol Violation|2|||
163138059|NCT00999518|589213178|FG001|Overall Study|Adverse Event|6|||
163229873|NCT00989833|589552906|FG002|Overall Study|Protocol Violation|1|||
163138060|NCT00999518|589213179|FG002|Overall Study|Adverse Event|3|||
163138061|NCT00999518|589213180|FG003|Overall Study|Adverse Event|1|||
163229874|NCT00989833|589552904|FG000|Overall Study|Withdrawal by Subject|0|||
163138062|NCT00999518|589213181|FG004|Overall Study|Adverse Event|2|||
163138063|NCT00999518|589213177|FG000|Overall Study|Lack of Efficacy|2|||
163138064|NCT00999518|589213178|FG001|Overall Study|Lack of Efficacy|0|||
163138065|NCT00999518|589213179|FG002|Overall Study|Lack of Efficacy|0|||
163138066|NCT00999518|589213180|FG003|Overall Study|Lack of Efficacy|2|||
163138067|NCT00999518|589213181|FG004|Overall Study|Lack of Efficacy|2|||
163138068|NCT00999518|589213177|FG000|Overall Study|Lost to Follow-up|0|||
163138069|NCT00999518|589213178|FG001|Overall Study|Lost to Follow-up|0|||
163138070|NCT00999518|589213179|FG002|Overall Study|Lost to Follow-up|0|||
163138071|NCT00999518|589213180|FG003|Overall Study|Lost to Follow-up|4|||
163138072|NCT00999518|589213181|FG004|Overall Study|Lost to Follow-up|1|||
163138073|NCT00999518|589213177|FG000|Overall Study|Did not meet entrance criteria|0|||
163138074|NCT00999518|589213178|FG001|Overall Study|Did not meet entrance criteria|0|||
163138075|NCT00999518|589213179|FG002|Overall Study|Did not meet entrance criteria|0|||
163138076|NCT00999518|589213180|FG003|Overall Study|Did not meet entrance criteria|0|||
163138077|NCT00999518|589213181|FG004|Overall Study|Did not meet entrance criteria|1|||
163138078|NCT00999518|589213177|FG000|Overall Study|Study terminated by sponsor|10|||
163138079|NCT00999518|589213178|FG001|Overall Study|Study terminated by sponsor|6|||
163138080|NCT00999518|589213179|FG002|Overall Study|Study terminated by sponsor|5|||
163138081|NCT00999518|589213180|FG003|Overall Study|Study terminated by sponsor|5|||
163138082|NCT00999518|589213181|FG004|Overall Study|Study terminated by sponsor|9|||
163138083|NCT00999518|589213177|FG000|Overall Study|Pregnancy|0|||
163138084|NCT00999518|589213178|FG001|Overall Study|Pregnancy|0|||
163138085|NCT00999518|589213179|FG002|Overall Study|Pregnancy|1|||
163138086|NCT00999518|589213180|FG003|Overall Study|Pregnancy|0|||
163138087|NCT00999518|589213181|FG004|Overall Study|Pregnancy|0|||
163138088|NCT00999518|589213177|FG000|Overall Study|Protocol Violation|0|||
163138089|NCT00999518|589213178|FG001|Overall Study|Protocol Violation|1|||
163138090|NCT00999518|589213179|FG002|Overall Study|Protocol Violation|0|||
163138091|NCT00999518|589213180|FG003|Overall Study|Protocol Violation|0|||
163138092|NCT00999518|589213181|FG004|Overall Study|Protocol Violation|2|||
163138093|NCT00999518|589213177|FG000|Overall Study|Withdrawal by Subject|5|||
163138094|NCT00999518|589213178|FG001|Overall Study|Withdrawal by Subject|4|||
163138095|NCT00999518|589213179|FG002|Overall Study|Withdrawal by Subject|10|||
163138096|NCT00999518|589213180|FG003|Overall Study|Withdrawal by Subject|6|||
163138097|NCT00999518|589213181|FG004|Overall Study|Withdrawal by Subject|1|||
163138098|NCT00999518|589213177|FG000|Overall Study|Other|5|||
163138099|NCT00999518|589213178|FG001|Overall Study|Other|7|||
163138100|NCT00999518|589213179|FG002|Overall Study|Other|1|||
163138101|NCT00999518|589213180|FG003|Overall Study|Other|4|||
163138102|NCT00999518|589213181|FG004|Overall Study|Other|5|||
163138103|NCT00999518|589213177|FG000|Overall Study|Randomized but not Treated|1|||
163138104|NCT00999518|589213178|FG001|Overall Study|Randomized but not Treated|1|||
163138105|NCT00999518|589213179|FG002|Overall Study|Randomized but not Treated|2|||
163138106|NCT00999518|589213180|FG003|Overall Study|Randomized but not Treated|0|||
163138107|NCT00999518|589213181|FG004|Overall Study|Randomized but not Treated|1|||
163138108|NCT01811186|589213182|FG000|Overall Study|Adverse Event|54|||
163138109|NCT01811186|589213183|FG001|Overall Study|Adverse Event|38|||
163138110|NCT01811186|589213182|FG000|Overall Study|Protocol Violation|5|||
163138111|NCT01811186|589213183|FG001|Overall Study|Protocol Violation|6|||
163138112|NCT01811186|589213182|FG000|Overall Study|Withdrawal by Subject|5|||
163138113|NCT01811186|589213183|FG001|Overall Study|Withdrawal by Subject|10|||
163138114|NCT01811186|589213182|FG000|Overall Study|Lack of Efficacy|3|||
163138115|NCT01811186|589213183|FG001|Overall Study|Lack of Efficacy|6|||
163138116|NCT01811186|589213182|FG000|Overall Study|Lost to Follow-up|4|||
163138117|NCT01811186|589213183|FG001|Overall Study|Lost to Follow-up|2|||
163138118|NCT01445080|589213188|FG000|Overall Study|Adverse Event|5|||
163138119|NCT01445080|589213189|FG001|Overall Study|Adverse Event|3|||
163138120|NCT01445080|589213190|FG002|Overall Study|Adverse Event|11|||
163138121|NCT01445080|589213191|FG003|Overall Study|Adverse Event|6|||
163138122|NCT01445080|589213192|FG004|Overall Study|Adverse Event|2|||
163138123|NCT01445080|589213193|FG005|Overall Study|Adverse Event|3|||
163138124|NCT01445080|589213194|FG006|Overall Study|Adverse Event|0|||
163138125|NCT01445080|589213195|FG007|Overall Study|Adverse Event|3|||
163138126|NCT01445080|589213196|FG008|Overall Study|Adverse Event|10|||
163138127|NCT01445080|589213188|FG000|Overall Study|Physician Decision|0|||
163138128|NCT01445080|589213189|FG001|Overall Study|Physician Decision|0|||
163138129|NCT01445080|589213190|FG002|Overall Study|Physician Decision|1|||
163138130|NCT01445080|589213191|FG003|Overall Study|Physician Decision|0|||
163138131|NCT01445080|589213192|FG004|Overall Study|Physician Decision|0|||
163138132|NCT01445080|589213193|FG005|Overall Study|Physician Decision|3|||
163138133|NCT01445080|589213194|FG006|Overall Study|Physician Decision|2|||
163138134|NCT01445080|589213195|FG007|Overall Study|Physician Decision|2|||
163138135|NCT01445080|589213196|FG008|Overall Study|Physician Decision|0|||
163138136|NCT01445080|589213188|FG000|Overall Study|Withdrawal by Subject|1|||
163138137|NCT01445080|589213189|FG001|Overall Study|Withdrawal by Subject|0|||
163138138|NCT01445080|589213190|FG002|Overall Study|Withdrawal by Subject|0|||
163138139|NCT01445080|589213191|FG003|Overall Study|Withdrawal by Subject|1|||
163138140|NCT01445080|589213192|FG004|Overall Study|Withdrawal by Subject|0|||
163138141|NCT01445080|589213193|FG005|Overall Study|Withdrawal by Subject|0|||
163138142|NCT01445080|589213194|FG006|Overall Study|Withdrawal by Subject|0|||
163138143|NCT01445080|589213195|FG007|Overall Study|Withdrawal by Subject|0|||
163138144|NCT01445080|589213196|FG008|Overall Study|Withdrawal by Subject|2|||
163138145|NCT01445080|589213188|FG000|Overall Study|Ineligible/Inevaluable|1|||
163138146|NCT01445080|589213189|FG001|Overall Study|Ineligible/Inevaluable|2|||
163138147|NCT01445080|589213190|FG002|Overall Study|Ineligible/Inevaluable|0|||
163138148|NCT01445080|589213191|FG003|Overall Study|Ineligible/Inevaluable|1|||
163138149|NCT01445080|589213192|FG004|Overall Study|Ineligible/Inevaluable|2|||
163138150|NCT01445080|589213193|FG005|Overall Study|Ineligible/Inevaluable|3|||
163138151|NCT01445080|589213194|FG006|Overall Study|Ineligible/Inevaluable|0|||
163138152|NCT01445080|589213195|FG007|Overall Study|Ineligible/Inevaluable|0|||
163138153|NCT01445080|589213196|FG008|Overall Study|Ineligible/Inevaluable|6|||
163138154|NCT03887221|589213197|FG000|Overall Study|Protocol Violation|1|||
163138155|NCT03887221|589213198|FG001|Overall Study|Protocol Violation|0|||
163138156|NCT02123576|589213199|FG000|Overall Study|Adverse Event|1|||
163138157|NCT02123576|589213200|FG001|Overall Study|Adverse Event|0|||
163138158|NCT04864639|589215005|FG000|Overall Study|Death|1|||
163138159|NCT04864639|589215005|FG000|Overall Study|Lost to Follow-up|1|||
163138160|NCT04050618|589215006|FG000|First Intervention|Withdrawal by Subject|2|||
163138161|NCT04050618|589215007|FG001|First Intervention|Withdrawal by Subject|0|||
163138162|NCT04050618|589215006|FG000|Second Intervention|Withdrawal by Subject|1|||
163138163|NCT04050618|589215007|FG001|Second Intervention|Withdrawal by Subject|0|||
163138164|NCT01101035|589215014|FG000|Overall Study|Adverse Event|191|||
163138165|NCT01101035|589215015|FG001|Overall Study|Adverse Event|172|||
163138166|NCT01101035|589215014|FG000|Overall Study|Major Protocol Deviation|52|||
163138167|NCT01101035|589215015|FG001|Overall Study|Major Protocol Deviation|46|||
163138168|NCT01101035|589215014|FG000|Overall Study|Lost to Follow-up|226|||
163229875|NCT00989833|589552905|FG001|Overall Study|Withdrawal by Subject|0|||
163229876|NCT00989833|589552906|FG002|Overall Study|Withdrawal by Subject|1|||
163229877|NCT00989833|589552904|FG000|Overall Study|Incorrectly randomized|1|||
163229878|NCT00989833|589552905|FG001|Overall Study|Incorrectly randomized|0|||
163229879|NCT00989833|589552906|FG002|Overall Study|Incorrectly randomized|0|||
163229880|NCT01420081|589552908|FG000|Overall Study|Death|1|||
163229881|NCT01420081|589552909|FG001|Overall Study|Death|0|||
163229882|NCT01420081|589552910|FG002|Overall Study|Death|8|||
163229883|NCT01420081|589552911|FG003|Overall Study|Death|0|||
163229884|NCT01420081|589552912|FG004|Overall Study|Death|7|||
163229885|NCT01420081|589552913|FG005|Overall Study|Death|12|||
163229886|NCT01420081|589552914|FG006|Overall Study|Death|0|||
163229887|NCT01420081|589552915|FG007|Overall Study|Death|1|||
163229888|NCT01420081|589552916|FG008|Overall Study|Death|1|||
163229889|NCT01420081|589552908|FG000|Overall Study|Lost to Follow-up|0|||
163229890|NCT01420081|589552909|FG001|Overall Study|Lost to Follow-up|0|||
163229891|NCT01420081|589552910|FG002|Overall Study|Lost to Follow-up|0|||
163229892|NCT01420081|589552911|FG003|Overall Study|Lost to Follow-up|0|||
163229893|NCT01420081|589552912|FG004|Overall Study|Lost to Follow-up|1|||
163229894|NCT01420081|589552913|FG005|Overall Study|Lost to Follow-up|1|||
163229895|NCT01420081|589552914|FG006|Overall Study|Lost to Follow-up|0|||
163229896|NCT01420081|589552915|FG007|Overall Study|Lost to Follow-up|0|||
163229897|NCT01420081|589552916|FG008|Overall Study|Lost to Follow-up|0|||
163229898|NCT01420081|589552908|FG000|Overall Study|Study Terminated by Sponsor|2|||
163229899|NCT01420081|589552909|FG001|Overall Study|Study Terminated by Sponsor|1|||
163229900|NCT01420081|589552910|FG002|Overall Study|Study Terminated by Sponsor|1|||
163229901|NCT01420081|589552911|FG003|Overall Study|Study Terminated by Sponsor|3|||
163229902|NCT01420081|589552912|FG004|Overall Study|Study Terminated by Sponsor|11|||
163229903|NCT01420081|589552913|FG005|Overall Study|Study Terminated by Sponsor|7|||
163229904|NCT01420081|589552914|FG006|Overall Study|Study Terminated by Sponsor|3|||
163229905|NCT01420081|589552915|FG007|Overall Study|Study Terminated by Sponsor|2|||
163229906|NCT01420081|589552916|FG008|Overall Study|Study Terminated by Sponsor|2|||
163229907|NCT01420081|589552908|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
163138169|NCT01101035|589215015|FG001|Overall Study|Lost to Follow-up|223|||
163138170|NCT01101035|589215014|FG000|Overall Study|Voluntary Withdrawal|595|||
163138171|NCT01101035|589215015|FG001|Overall Study|Voluntary Withdrawal|587|||
163138172|NCT01101035|589215014|FG000|Overall Study|Reason not Specified|333|||
163138173|NCT01101035|589215015|FG001|Overall Study|Reason not Specified|363|||
163138174|NCT00713544|589215024|FG000|Overall Study|Adverse Event|5|||
163229908|NCT01420081|589552909|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
163138175|NCT00713544|589215025|FG001|Overall Study|Adverse Event|3|||
163138176|NCT00713544|589215026|FG002|Overall Study|Adverse Event|7|||
163138177|NCT00713544|589215027|FG003|Overall Study|Adverse Event|7|||
163229909|NCT01420081|589552910|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
163229910|NCT01420081|589552911|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
163229911|NCT01420081|589552912|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
163229912|NCT01420081|589552913|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
163229913|NCT01420081|589552914|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
163229914|NCT01420081|589552915|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
163229915|NCT01420081|589552916|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
163229916|NCT01420081|589552908|FG000|Overall Study|Other Reasons|0|||
163229917|NCT01420081|589552909|FG001|Overall Study|Other Reasons|0|||
163229918|NCT01420081|589552910|FG002|Overall Study|Other Reasons|1|||
163229919|NCT01420081|589552911|FG003|Overall Study|Other Reasons|0|||
163229920|NCT01420081|589552912|FG004|Overall Study|Other Reasons|0|||
163229921|NCT01420081|589552913|FG005|Overall Study|Other Reasons|0|||
163229922|NCT01420081|589552914|FG006|Overall Study|Other Reasons|0|||
163229923|NCT01420081|589552915|FG007|Overall Study|Other Reasons|0|||
163229924|NCT01420081|589552916|FG008|Overall Study|Other Reasons|0|||
163229925|NCT00678561|589552918|FG000|Overall Study|Adverse Event|0|||
163229926|NCT00678561|589552919|FG001|Overall Study|Adverse Event|1|||
163229927|NCT00678561|589552920|FG002|Overall Study|Adverse Event|1|||
163229928|NCT00678561|589552921|FG003|Overall Study|Adverse Event|0|||
163229929|NCT00678561|589552922|FG004|Overall Study|Adverse Event|1|||
163229930|NCT00678561|589552923|FG005|Overall Study|Adverse Event|0|||
163229931|NCT00678561|589552924|FG006|Overall Study|Adverse Event|0|||
163229932|NCT00678561|589552925|FG007|Overall Study|Adverse Event|0|||
163229933|NCT00678561|589552918|FG000|Overall Study|Protocol Violation|0|||
163229934|NCT00678561|589552919|FG001|Overall Study|Protocol Violation|0|||
163229935|NCT00678561|589552920|FG002|Overall Study|Protocol Violation|0|||
163229936|NCT00678561|589552921|FG003|Overall Study|Protocol Violation|0|||
163229937|NCT00678561|589552922|FG004|Overall Study|Protocol Violation|1|||
163229938|NCT00678561|589552923|FG005|Overall Study|Protocol Violation|1|||
163229939|NCT00678561|589552924|FG006|Overall Study|Protocol Violation|0|||
163229940|NCT00678561|589552925|FG007|Overall Study|Protocol Violation|0|||
163229941|NCT00678561|589552918|FG000|Overall Study|Withdrawal by Subject|0|||
163229942|NCT00678561|589552919|FG001|Overall Study|Withdrawal by Subject|0|||
163229943|NCT00678561|589552920|FG002|Overall Study|Withdrawal by Subject|0|||
163229944|NCT00678561|589552921|FG003|Overall Study|Withdrawal by Subject|0|||
163229945|NCT00678561|589552922|FG004|Overall Study|Withdrawal by Subject|0|||
163229946|NCT00678561|589552923|FG005|Overall Study|Withdrawal by Subject|0|||
163229947|NCT00678561|589552924|FG006|Overall Study|Withdrawal by Subject|0|||
163229948|NCT00678561|589552925|FG007|Overall Study|Withdrawal by Subject|1|||
163229949|NCT03080961|589552926|FG000|Overall Study|Withdrawal by Subject|3|||
163229950|NCT03508219|589552933|FG000|Overall Study|Death|2|||
163229951|NCT03508219|589552933|FG000|Overall Study|Withdrawal by Subject|1|||
163229952|NCT03508219|589552933|FG000|Overall Study|Lost to Follow-up|4|||
163229953|NCT03508219|589552933|FG000|Overall Study|Missed visit|2|||
163229954|NCT04466891|589552934|FG000|Overall Study|Death|60|||
163229955|NCT04466891|589552935|FG001|Overall Study|Death|6|||
163229956|NCT04466891|589552934|FG000|Overall Study|Withdrawal by Subject|8|||
163229957|NCT04466891|589552935|FG001|Overall Study|Withdrawal by Subject|1|||
163229958|NCT04466891|589552934|FG000|Overall Study|Study terminated by sponsor|5|||
163229959|NCT04466891|589552935|FG001|Overall Study|Study terminated by sponsor|0|||
163229960|NCT04466891|589552934|FG000|Overall Study|Lost to Follow-up|2|||
163229961|NCT04466891|589552935|FG001|Overall Study|Lost to Follow-up|0|||
163229962|NCT04466891|589552934|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
163229963|NCT04466891|589552935|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
163345777|NCT02531126|589974281|FG000|Overall Study|Adverse Event|16|||
163345778|NCT02531126|589974282|FG001|Overall Study|Adverse Event|13|||
163345779|NCT02531126|589974283|FG002|Overall Study|Adverse Event|27|||
163345780|NCT02531126|589974284|FG003|Overall Study|Adverse Event|4|||
163345781|NCT02531126|589974281|FG000|Overall Study|Lack of Efficacy|50|||
163345782|NCT02531126|589974282|FG001|Overall Study|Lack of Efficacy|32|||
163345783|NCT02531126|589974283|FG002|Overall Study|Lack of Efficacy|121|||
163345784|NCT02531126|589974284|FG003|Overall Study|Lack of Efficacy|0|||
163345785|NCT02531126|589974281|FG000|Overall Study|Withdrawal by Subject|38|||
163345786|NCT02531126|589974282|FG001|Overall Study|Withdrawal by Subject|31|||
163345787|NCT02531126|589974283|FG002|Overall Study|Withdrawal by Subject|96|||
163345788|NCT02531126|589974284|FG003|Overall Study|Withdrawal by Subject|6|||
163345789|NCT02531126|589974281|FG000|Overall Study|Pregnancy|2|||
163345790|NCT02531126|589974282|FG001|Overall Study|Pregnancy|3|||
163229964|NCT00445328|589552936|FG000|Overall Study|Death|0|||
163229965|NCT00445328|589552937|FG001|Overall Study|Death|1|||
163229966|NCT00445328|589552936|FG000|Overall Study|Adverse Event|0|||
163229967|NCT00445328|589552937|FG001|Overall Study|Adverse Event|3|||
163345791|NCT02531126|589974283|FG002|Overall Study|Pregnancy|2|||
163229968|NCT00445328|589552936|FG000|Overall Study|Other|0|||
163229969|NCT00445328|589552937|FG001|Overall Study|Other|2|||
163229970|NCT00445328|589552936|FG000|Overall Study|Withdrawal by Subject|2|||
163229971|NCT00445328|589552937|FG001|Overall Study|Withdrawal by Subject|0|||
163229972|NCT00445328|589552936|FG000|Overall Study|Protocol Violation|1|||
163229973|NCT00445328|589552937|FG001|Overall Study|Protocol Violation|0|||
163229974|NCT00590954|589552940|FG000|Overall Study|Inevaluable|2|||
163229975|NCT03107988|589554139|FG000|Overall Study|Adverse Event|0|||
163229976|NCT03107988|589554140|FG001|Overall Study|Adverse Event|0|||
163345792|NCT02531126|589974284|FG003|Overall Study|Pregnancy|0|||
163345793|NCT02531126|589974281|FG000|Overall Study|Switched to commercial drug|2|||
163229977|NCT03107988|589554141|FG002|Overall Study|Adverse Event|0|||
163229978|NCT03107988|589554142|FG003|Overall Study|Adverse Event|1|||
163229979|NCT03107988|589554143|FG004|Overall Study|Adverse Event|0|||
163229980|NCT03107988|589554144|FG005|Overall Study|Adverse Event|1|||
163229981|NCT03107988|589554145|FG006|Overall Study|Adverse Event|0|||
163229982|NCT03107988|589554146|FG007|Overall Study|Adverse Event|1|||
163229983|NCT03107988|589554147|FG008|Overall Study|Adverse Event|0|||
163229984|NCT03107988|589554148|FG009|Overall Study|Adverse Event|0|||
163229985|NCT03107988|589554149|FG010|Overall Study|Adverse Event|0|||
163229986|NCT03107988|589554150|FG011|Overall Study|Adverse Event|0|||
163229987|NCT03107988|589554151|FG012|Overall Study|Adverse Event|0|||
163229988|NCT03107988|589554139|FG000|Overall Study|Disease Progression or Relapse|1|||
163229989|NCT03107988|589554140|FG001|Overall Study|Disease Progression or Relapse|2|||
163229990|NCT03107988|589554141|FG002|Overall Study|Disease Progression or Relapse|2|||
163229991|NCT03107988|589554142|FG003|Overall Study|Disease Progression or Relapse|5|||
163229992|NCT03107988|589554143|FG004|Overall Study|Disease Progression or Relapse|1|||
163229993|NCT03107988|589554144|FG005|Overall Study|Disease Progression or Relapse|1|||
163229994|NCT03107988|589554145|FG006|Overall Study|Disease Progression or Relapse|0|||
163229995|NCT03107988|589554146|FG007|Overall Study|Disease Progression or Relapse|0|||
163229996|NCT03107988|589554147|FG008|Overall Study|Disease Progression or Relapse|0|||
163229997|NCT03107988|589554148|FG009|Overall Study|Disease Progression or Relapse|1|||
163229998|NCT03107988|589554149|FG010|Overall Study|Disease Progression or Relapse|4|||
163229999|NCT03107988|589554150|FG011|Overall Study|Disease Progression or Relapse|0|||
163230000|NCT03107988|589554151|FG012|Overall Study|Disease Progression or Relapse|0|||
163230001|NCT03107988|589554139|FG000|Overall Study|Ineligible|0|||
163230002|NCT03107988|589554140|FG001|Overall Study|Ineligible|0|||
163230003|NCT03107988|589554141|FG002|Overall Study|Ineligible|0|||
163230004|NCT03107988|589554142|FG003|Overall Study|Ineligible|0|||
163230005|NCT03107988|589554143|FG004|Overall Study|Ineligible|0|||
163230006|NCT03107988|589554144|FG005|Overall Study|Ineligible|0|||
163230007|NCT03107988|589554145|FG006|Overall Study|Ineligible|0|||
163230008|NCT03107988|589554146|FG007|Overall Study|Ineligible|0|||
163230009|NCT03107988|589554147|FG008|Overall Study|Ineligible|1|||
163230010|NCT03107988|589554148|FG009|Overall Study|Ineligible|0|||
163230011|NCT03107988|589554149|FG010|Overall Study|Ineligible|0|||
163230012|NCT03107988|589554150|FG011|Overall Study|Ineligible|0|||
163230013|NCT03107988|589554151|FG012|Overall Study|Ineligible|0|||
163230014|NCT01344057|589554152|FG000|Overall Study|Premature Withdrawal|1|||
163230015|NCT00529386|589554153|FG000|Overall Study|Lost to Follow-up|1|||
163230016|NCT04027686|589554154|FG000|Overall Study|Lost to Follow-up|2|||
163230017|NCT04027686|589554155|FG001|Overall Study|Lost to Follow-up|0|||
163230018|NCT04027686|589554154|FG000|Overall Study|Withdrawal by Subject|0|||
163230019|NCT04027686|589554155|FG001|Overall Study|Withdrawal by Subject|1|||
163230020|NCT02939404|589554156|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
163230021|NCT02939404|589554157|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
163230022|NCT02939404|589554156|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
163230023|NCT02939404|589554157|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
163230024|NCT04456699|589554159|FG000|Overall Study|Death|48|||
163230025|NCT04456699|589554160|FG001|Overall Study|Death|50|||
163230026|NCT04456699|589554161|FG002|Overall Study|Death|52|||
163230027|NCT04456699|589554159|FG000|Overall Study|Physician Decision|0|||
163230028|NCT04456699|589554160|FG001|Overall Study|Physician Decision|0|||
163230029|NCT04456699|589554161|FG002|Overall Study|Physician Decision|2|||
163230030|NCT04456699|589554159|FG000|Overall Study|Sponsor Decision|55|||
163230031|NCT04456699|589554160|FG001|Overall Study|Sponsor Decision|61|||
163230032|NCT04456699|589554161|FG002|Overall Study|Sponsor Decision|50|||
163230033|NCT04456699|589554159|FG000|Overall Study|Withdrawal by Subject|8|||
163230034|NCT04456699|589554160|FG001|Overall Study|Withdrawal by Subject|4|||
163345794|NCT02531126|589974282|FG001|Overall Study|Switched to commercial drug|4|||
163345795|NCT02531126|589974283|FG002|Overall Study|Switched to commercial drug|4|||
163345796|NCT02531126|589974284|FG003|Overall Study|Switched to commercial drug|0|||
163345797|NCT02531126|589974281|FG000|Overall Study|Other reasons|23|||
163345798|NCT02531126|589974282|FG001|Overall Study|Other reasons|29|||
163230035|NCT04456699|589554161|FG002|Overall Study|Withdrawal by Subject|5|||
163230036|NCT02075437|589554162|FG000|Overall Study|Withdrawal by Subject|5|||
163230037|NCT02075437|589554162|FG000|Overall Study|Lost to Follow-up|1|||
163345799|NCT02531126|589974283|FG002|Overall Study|Other reasons|27|||
163345800|NCT02531126|589974284|FG003|Overall Study|Other reasons|15|||
163345801|NCT02531126|589974281|FG000|Overall Study|Physician Decision|6|||
163230038|NCT03921411|589554167|FG000|Overall Study|Withdrawal by Subject|1|||
163230039|NCT03921411|589554167|FG000|Overall Study|Protocol Deviation|2|||
163345802|NCT02531126|589974282|FG001|Overall Study|Physician Decision|6|||
163345803|NCT02531126|589974283|FG002|Overall Study|Physician Decision|28|||
163345804|NCT02531126|589974284|FG003|Overall Study|Physician Decision|0|||
163424270|NCT03367871|590258213|FG000|Overall Study|Lost to Follow-up|1|||
163230040|NCT03921411|589554167|FG000|Overall Study|Enrolled, but never treated|2|||
163230041|NCT02114879|589554168|FG000|Overall Study|Withdrawal by Subject|9|||
163230042|NCT02114879|589554169|FG001|Overall Study|Withdrawal by Subject|5|||
163230043|NCT02114879|589554168|FG000|Overall Study|Death|6|||
163230044|NCT02114879|589554169|FG001|Overall Study|Death|11|||
163230045|NCT02114879|589554168|FG000|Overall Study|Lost to Follow-up|4|||
163408793|NCT03829657|590205610|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
163408794|NCT03829657|590205611|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
163408795|NCT03829657|590205612|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
163408796|NCT03829657|590205608|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
163408797|NCT03829657|590205609|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
163408798|NCT03829657|590205610|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
163408799|NCT03829657|590205611|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
163408800|NCT03829657|590205612|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
163408801|NCT03829657|590205608|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
163408802|NCT03829657|590205609|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
163408803|NCT03829657|590205610|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
163408804|NCT03829657|590205611|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
163408805|NCT03829657|590205612|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
163408806|NCT03829657|590205608|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
163408807|NCT03829657|590205609|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
163408808|NCT03829657|590205610|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
163408809|NCT03829657|590205611|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
163408810|NCT03829657|590205612|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
163408811|NCT03829657|590205608|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
163408812|NCT03829657|590205609|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
163408813|NCT03829657|590205610|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
163408814|NCT03829657|590205611|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
163408815|NCT03829657|590205612|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
163408816|NCT01014689|590205613|FG000|Overall Study|Lack of Efficacy|0|||
163408817|NCT01014689|590205614|FG001|Overall Study|Lack of Efficacy|1|||
163408818|NCT01014689|590205613|FG000|Overall Study|Adverse Event|3|||
163408819|NCT01014689|590205614|FG001|Overall Study|Adverse Event|0|||
163408820|NCT01014689|590205613|FG000|Overall Study|Withdrawal by Subject|5|||
163408821|NCT01014689|590205614|FG001|Overall Study|Withdrawal by Subject|4|||
163408822|NCT01014689|590205613|FG000|Overall Study|Protocol Violation|1|||
163408823|NCT01014689|590205614|FG001|Overall Study|Protocol Violation|1|||
163408824|NCT01014689|590205613|FG000|Overall Study|Lost to Follow-up|3|||
163408825|NCT01014689|590205614|FG001|Overall Study|Lost to Follow-up|7|||
163408826|NCT01014689|590205613|FG000|Overall Study|Pregnancy|1|||
163408827|NCT01014689|590205614|FG001|Overall Study|Pregnancy|0|||
163408828|NCT04418076|590205616|FG000|Overall Study|Death|1|||
163408829|NCT04418076|590205617|FG001|Overall Study|Death|0|||
163408830|NCT04418076|590205618|FG002|Overall Study|Death|0|||
163408831|NCT04418076|590205619|FG003|Overall Study|Death|0|||
163408832|NCT04418076|590205616|FG000|Overall Study|Lost to Follow-up|2|||
163408833|NCT04418076|590205617|FG001|Overall Study|Lost to Follow-up|5|||
163408834|NCT04418076|590205618|FG002|Overall Study|Lost to Follow-up|1|||
163408835|NCT04418076|590205619|FG003|Overall Study|Lost to Follow-up|2|||
163408836|NCT04418076|590205616|FG000|Overall Study|Withdrawal by Subject|1|||
163138178|NCT00713544|589215028|FG004|Overall Study|Adverse Event|3|||
163138179|NCT00713544|589215029|FG005|Overall Study|Adverse Event|5|||
163138180|NCT00713544|589215024|FG000|Overall Study|Withdrawal by Subject|2|||
163138181|NCT00713544|589215025|FG001|Overall Study|Withdrawal by Subject|0|||
163138182|NCT00713544|589215026|FG002|Overall Study|Withdrawal by Subject|3|||
163138183|NCT00713544|589215027|FG003|Overall Study|Withdrawal by Subject|2|||
163138184|NCT00713544|589215028|FG004|Overall Study|Withdrawal by Subject|3|||
163138185|NCT00713544|589215029|FG005|Overall Study|Withdrawal by Subject|1|||
163138186|NCT00713544|589215024|FG000|Overall Study|Protocol Violation|0|||
163138187|NCT00713544|589215025|FG001|Overall Study|Protocol Violation|0|||
163138188|NCT00713544|589215026|FG002|Overall Study|Protocol Violation|0|||
163138189|NCT00713544|589215027|FG003|Overall Study|Protocol Violation|0|||
163138190|NCT00713544|589215028|FG004|Overall Study|Protocol Violation|0|||
163138191|NCT00713544|589215029|FG005|Overall Study|Protocol Violation|1|||
163138192|NCT00713544|589215024|FG000|Overall Study|Physician Decision|0|||
163138193|NCT00713544|589215025|FG001|Overall Study|Physician Decision|0|||
163138194|NCT00713544|589215026|FG002|Overall Study|Physician Decision|0|||
163138195|NCT00713544|589215027|FG003|Overall Study|Physician Decision|0|||
163138196|NCT00713544|589215028|FG004|Overall Study|Physician Decision|0|||
163138197|NCT00713544|589215029|FG005|Overall Study|Physician Decision|2|||
163138198|NCT00713544|589215024|FG000|Overall Study|Lack of Efficacy|0|||
163408837|NCT04418076|590205617|FG001|Overall Study|Withdrawal by Subject|0|||
163408838|NCT04418076|590205618|FG002|Overall Study|Withdrawal by Subject|1|||
163408839|NCT04418076|590205619|FG003|Overall Study|Withdrawal by Subject|1|||
163408840|NCT04418076|590205616|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
163138199|NCT00713544|589215025|FG001|Overall Study|Lack of Efficacy|1|||
163138200|NCT00713544|589215026|FG002|Overall Study|Lack of Efficacy|0|||
163138201|NCT00713544|589215027|FG003|Overall Study|Lack of Efficacy|1|||
163138202|NCT00713544|589215028|FG004|Overall Study|Lack of Efficacy|1|||
163138203|NCT00713544|589215029|FG005|Overall Study|Lack of Efficacy|0|||
163345805|NCT02531126|589974281|FG000|Overall Study|Non-compliance with investigational drug|1|||
163345806|NCT02531126|589974282|FG001|Overall Study|Non-compliance with investigational drug|0|||
163345807|NCT02531126|589974283|FG002|Overall Study|Non-compliance with investigational drug|0|||
163345808|NCT02531126|589974284|FG003|Overall Study|Non-compliance with investigational drug|0|||
163345809|NCT00111839|589974285|FG000|Overall Study|Disease Progression|30|||
163345810|NCT00111839|589974286|FG001|Overall Study|Disease Progression|33|||
163345811|NCT00111839|589974287|FG002|Overall Study|Disease Progression|33|||
163345812|NCT00111839|589974285|FG000|Overall Study|Adverse Event|5|||
163345813|NCT00111839|589974286|FG001|Overall Study|Adverse Event|3|||
163345814|NCT00111839|589974287|FG002|Overall Study|Adverse Event|1|||
163345815|NCT00111839|589974285|FG000|Overall Study|Protocol Violation|2|||
163345816|NCT00111839|589974286|FG001|Overall Study|Protocol Violation|4|||
163345817|NCT00111839|589974287|FG002|Overall Study|Protocol Violation|2|||
163345818|NCT00111839|589974285|FG000|Overall Study|Death|1|||
163345819|NCT00111839|589974286|FG001|Overall Study|Death|1|||
163345820|NCT00111839|589974287|FG002|Overall Study|Death|6|||
163345821|NCT00111839|589974285|FG000|Overall Study|Withdrawal by Subject|2|||
163345822|NCT00111839|589974286|FG001|Overall Study|Withdrawal by Subject|2|||
163345823|NCT00111839|589974287|FG002|Overall Study|Withdrawal by Subject|2|||
163345824|NCT00111839|589974285|FG000|Overall Study|Lost to Follow-up|1|||
163345825|NCT00111839|589974286|FG001|Overall Study|Lost to Follow-up|0|||
163230046|NCT02114879|589554169|FG001|Overall Study|Lost to Follow-up|6|||
163230047|NCT02114879|589554168|FG000|Overall Study|Physician Decision|0|||
163230048|NCT02114879|589554169|FG001|Overall Study|Physician Decision|2|||
163230049|NCT03120013|589554170|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163230050|NCT03120013|589554171|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
163230051|NCT02098109|589554173|FG000|Overall Study|Protocol Violation|3|||
163230052|NCT02098109|589554174|FG001|Overall Study|Protocol Violation|0|||
163230053|NCT01541826|589554176|FG000|Overall Study|Lost to Follow-up|2|||
163230054|NCT01541826|589554177|FG001|Overall Study|Lost to Follow-up|3|||
163230055|NCT01541826|589554178|FG002|Overall Study|Lost to Follow-up|0|||
163230056|NCT01541826|589554176|FG000|Overall Study|Withdrawal by Subject|2|||
163230057|NCT01541826|589554177|FG001|Overall Study|Withdrawal by Subject|0|||
163230058|NCT01541826|589554178|FG002|Overall Study|Withdrawal by Subject|0|||
163230059|NCT00480779|589554181|FG000|Overall Study|Other|2|||
163230060|NCT00480779|589554182|FG001|Overall Study|Other|0|||
163230061|NCT00480779|589554181|FG000|Overall Study|Job and Health-related|0|||
163230062|NCT00480779|589554182|FG001|Overall Study|Job and Health-related|3|||
163230063|NCT01365273|589554183|FG000|Overall Study|Lost to Follow-up|1|||
163230064|NCT01365273|589554184|FG001|Overall Study|Lost to Follow-up|0|||
163230065|NCT01365273|589554183|FG000|Overall Study|Protocol Violation|0|||
163230066|NCT01365273|589554184|FG001|Overall Study|Protocol Violation|1|||
163230067|NCT01365273|589554183|FG000|Overall Study|Physician Decision|1|||
163230068|NCT01365273|589554184|FG001|Overall Study|Physician Decision|0|||
163230069|NCT00854581|589554189|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
163230070|NCT00854581|589554189|FG000|Induction (Up to Day 21)|Death|1|||
163230071|NCT00854581|589554189|FG000|Induction (Up to Day 21)|Physician Decision|1|||
163230072|NCT00854581|589554189|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
163230073|NCT04847674|589554190|FG000|Overall Study|Withdrawal by Subject|0|||
163230074|NCT04847674|589554191|FG001|Overall Study|Withdrawal by Subject|1|||
163230075|NCT04847674|589554192|FG002|Overall Study|Withdrawal by Subject|0|||
163230076|NCT04847674|589554190|FG000|Overall Study|Lost to Follow-up|0|||
163230077|NCT04847674|589554191|FG001|Overall Study|Lost to Follow-up|0|||
163230078|NCT04847674|589554192|FG002|Overall Study|Lost to Follow-up|2|||
163230079|NCT04847674|589554190|FG000|Overall Study|Other than specified|21|||
163345826|NCT00111839|589974287|FG002|Overall Study|Lost to Follow-up|0|||
163345827|NCT00111839|589974285|FG000|Overall Study|Logistical Constraint|1|||
163345828|NCT00111839|589974286|FG001|Overall Study|Logistical Constraint|0|||
163345829|NCT00111839|589974287|FG002|Overall Study|Logistical Constraint|0|||
163345830|NCT00111839|589974285|FG000|Overall Study|Other|6|||
163345831|NCT00111839|589974286|FG001|Overall Study|Other|3|||
163230080|NCT04847674|589554191|FG001|Overall Study|Other than specified|20|||
163230081|NCT04847674|589554192|FG002|Overall Study|Other than specified|20|||
163230082|NCT02705820|589554195|FG000|Overall Study|Death|2|||
163230083|NCT02705820|589554195|FG000|Overall Study|Disease Progression|34|||
163230084|NCT02705820|589554195|FG000|Overall Study|Clinical Deterioration|3|||
163230085|NCT02702401|589554197|FG000|Overall Study|Death|242|||
163230086|NCT02702401|589554198|FG001|Overall Study|Death|125|||
163230087|NCT02702401|589554197|FG000|Overall Study|Withdrawal by Subject|15|||
163230088|NCT02702401|589554198|FG001|Overall Study|Withdrawal by Subject|5|||
163230089|NCT02702401|589554197|FG000|Overall Study|Sponsor Decision|19|||
163345832|NCT00111839|589974287|FG002|Overall Study|Other|3|||
163230090|NCT02702401|589554198|FG001|Overall Study|Sponsor Decision|3|||
163230091|NCT02702401|589554197|FG000|Overall Study|Physician Decision|1|||
163230092|NCT02702401|589554198|FG001|Overall Study|Physician Decision|2|||
163345833|NCT00111839|589974285|FG000|Overall Study|Randomized but Not Treated|0|||
163345834|NCT00111839|589974286|FG001|Overall Study|Randomized but Not Treated|0|||
163345835|NCT00111839|589974287|FG002|Overall Study|Randomized but Not Treated|2|||
163230093|NCT02702401|589554197|FG000|Overall Study|Lost to Follow-up|1|||
163230094|NCT02702401|589554198|FG001|Overall Study|Lost to Follow-up|0|||
163230095|NCT01524770|589554206|FG000|First Intervention|Withdrawal by Subject|1|||
163230096|NCT01524770|589554207|FG001|First Intervention|Withdrawal by Subject|0|||
163230097|NCT01524770|589554206|FG000|First Intervention|Adverse Event|1|||
163230098|NCT01524770|589554207|FG001|First Intervention|Adverse Event|1|||
163230099|NCT01524770|589554206|FG000|First Intervention|Protocol Violation|1|||
163230100|NCT01524770|589554207|FG001|First Intervention|Protocol Violation|0|||
163230101|NCT00689481|589554208|FG000|Overall Study|Adverse Event|7|||
163230102|NCT00689481|589554209|FG001|Overall Study|Adverse Event|1|||
163230103|NCT00689481|589554208|FG000|Overall Study|Lost to Follow-up|4|||
163230104|NCT00689481|589554209|FG001|Overall Study|Lost to Follow-up|3|||
163230105|NCT00689481|589554208|FG000|Overall Study|Lack of Efficacy|4|||
163230106|NCT00689481|589554209|FG001|Overall Study|Lack of Efficacy|3|||
163230107|NCT00689481|589554208|FG000|Overall Study|Non-compliance with study treatment|1|||
163230108|NCT00689481|589554209|FG001|Overall Study|Non-compliance with study treatment|1|||
163230109|NCT00689481|589554208|FG000|Overall Study|Withdrawal by Subject|8|||
163230110|NCT00689481|589554209|FG001|Overall Study|Withdrawal by Subject|4|||
163230111|NCT00689481|589554208|FG000|Overall Study|Excluded medication started during study|0|||
163230112|NCT00689481|589554209|FG001|Overall Study|Excluded medication started during study|1|||
163230113|NCT00689481|589554208|FG000|Overall Study|Subject early term, left on vacation|0|||
163230114|NCT00689481|589554209|FG001|Overall Study|Subject early term, left on vacation|1|||
163230115|NCT03337724|589554210|FG000|Overall Study|Reason not Specified|12|||
163230116|NCT03337724|589554211|FG001|Overall Study|Reason not Specified|21|||
163230117|NCT03337724|589554212|FG002|Overall Study|Reason not Specified|9|||
163230118|NCT03337724|589554213|FG003|Overall Study|Reason not Specified|9|||
163230119|NCT03337724|589554214|FG004|Overall Study|Reason not Specified|29|||
163230120|NCT03337724|589554210|FG000|Overall Study|Withdrawal by Subject|13|||
163230121|NCT03337724|589554211|FG001|Overall Study|Withdrawal by Subject|15|||
163230122|NCT03337724|589554212|FG002|Overall Study|Withdrawal by Subject|4|||
163230123|NCT03337724|589554213|FG003|Overall Study|Withdrawal by Subject|15|||
163230124|NCT03337724|589554214|FG004|Overall Study|Withdrawal by Subject|6|||
163230125|NCT03337724|589554210|FG000|Overall Study|Protocol Deviation|0|||
163230126|NCT03337724|589554211|FG001|Overall Study|Protocol Deviation|1|||
163230127|NCT03337724|589554212|FG002|Overall Study|Protocol Deviation|1|||
163230128|NCT03337724|589554213|FG003|Overall Study|Protocol Deviation|1|||
163230129|NCT03337724|589554214|FG004|Overall Study|Protocol Deviation|0|||
163230130|NCT03337724|589554210|FG000|Overall Study|Adverse Event|1|||
163230131|NCT03337724|589554211|FG001|Overall Study|Adverse Event|1|||
163230132|NCT03337724|589554212|FG002|Overall Study|Adverse Event|0|||
163230133|NCT03337724|589554213|FG003|Overall Study|Adverse Event|1|||
163230134|NCT03337724|589554214|FG004|Overall Study|Adverse Event|0|||
163230135|NCT03337724|589554210|FG000|Overall Study|Death|40|||
163230136|NCT03337724|589554211|FG001|Overall Study|Death|89|||
163230137|NCT03337724|589554212|FG002|Overall Study|Death|43|||
163230138|NCT03337724|589554213|FG003|Overall Study|Death|76|||
163230139|NCT03337724|589554214|FG004|Overall Study|Death|50|||
163230140|NCT03337724|589554210|FG000|Overall Study|Lost to Follow-up|5|||
163230141|NCT03337724|589554211|FG001|Overall Study|Lost to Follow-up|5|||
163230142|NCT03337724|589554212|FG002|Overall Study|Lost to Follow-up|4|||
163230143|NCT03337724|589554213|FG003|Overall Study|Lost to Follow-up|7|||
163230144|NCT03337724|589554214|FG004|Overall Study|Lost to Follow-up|4|||
163230145|NCT03337724|589554210|FG000|Overall Study|Physician Decision|16|||
163230146|NCT03337724|589554211|FG001|Overall Study|Physician Decision|34|||
163230147|NCT03337724|589554212|FG002|Overall Study|Physician Decision|14|||
163230148|NCT03337724|589554213|FG003|Overall Study|Physician Decision|34|||
163230149|NCT03337724|589554214|FG004|Overall Study|Physician Decision|13|||
163230150|NCT03337724|589554210|FG000|Overall Study|Progressive Disease|0|||
163230151|NCT03337724|589554211|FG001|Overall Study|Progressive Disease|2|||
163345836|NCT00377312|589974288|FG000|Overall Study|Adverse Event|1|||
163345837|NCT00377312|589974289|FG001|Overall Study|Adverse Event|1|||
163345838|NCT00382408|589974292|FG000|Overall Study|Did not meet protocol requirement|3|||
163345839|NCT00382408|589974293|FG001|Overall Study|Did not meet protocol requirement|3|||
163345840|NCT00382408|589974292|FG000|Overall Study|Protocol Violation|2|||
163230152|NCT03337724|589554212|FG002|Overall Study|Progressive Disease|1|||
163230153|NCT03337724|589554213|FG003|Overall Study|Progressive Disease|2|||
163230154|NCT03337724|589554214|FG004|Overall Study|Progressive Disease|0|||
163230155|NCT03337724|589554210|FG000|Overall Study|Symptomatic Deterioration|0|||
163230156|NCT03337724|589554211|FG001|Overall Study|Symptomatic Deterioration|0|||
163230157|NCT03337724|589554212|FG002|Overall Study|Symptomatic Deterioration|0|||
163230158|NCT03337724|589554213|FG003|Overall Study|Symptomatic Deterioration|1|||
163230159|NCT03337724|589554214|FG004|Overall Study|Symptomatic Deterioration|0|||
163230160|NCT00528528|589554215|FG000|Overall Study|Lost to Follow-up|0|||
163345841|NCT00382408|589974293|FG001|Overall Study|Protocol Violation|2|||
163345842|NCT00382408|589974292|FG000|Overall Study|Physician Decision|1|||
163230161|NCT00528528|589554216|FG001|Overall Study|Lost to Follow-up|0|||
163230162|NCT00528528|589554217|FG002|Overall Study|Lost to Follow-up|1|||
163230163|NCT00528528|589554218|FG003|Overall Study|Lost to Follow-up|1|||
163345843|NCT00382408|589974293|FG001|Overall Study|Physician Decision|0|||
163345844|NCT00382408|589974292|FG000|Overall Study|Withdrawal by Subject|17|||
163345845|NCT00382408|589974293|FG001|Overall Study|Withdrawal by Subject|6|||
163345846|NCT00382408|589974292|FG000|Overall Study|Pregnancy|2|||
163345847|NCT00382408|589974293|FG001|Overall Study|Pregnancy|0|||
163345848|NCT00382408|589974292|FG000|Overall Study|Lost to Follow-up|19|||
163345849|NCT00382408|589974293|FG001|Overall Study|Lost to Follow-up|8|||
163345850|NCT00382408|589974292|FG000|Overall Study|Other|100|||
163345851|NCT00382408|589974293|FG001|Overall Study|Other|35|||
163345852|NCT00762723|589974294|FG000|Overall Study|Study Terminated slow enrollement|5|||
163345853|NCT00762723|589974295|FG001|Overall Study|Study Terminated slow enrollement|5|||
163345854|NCT00762723|589974296|FG002|Overall Study|Study Terminated slow enrollement|3|||
163345855|NCT01572493|589974299|FG000|Overall Study|Physician Decision|1|||
163345856|NCT01572493|589974300|FG001|Overall Study|Physician Decision|0|||
163345857|NCT01572493|589974301|FG002|Overall Study|Physician Decision|0|||
163345858|NCT01572493|589974302|FG003|Overall Study|Physician Decision|0|||
163345859|NCT01572493|589974303|FG004|Overall Study|Physician Decision|0|||
163345860|NCT01572493|589974304|FG005|Overall Study|Physician Decision|0|||
163345861|NCT01572493|589974305|FG006|Overall Study|Physician Decision|0|||
163345862|NCT01572493|589974306|FG007|Overall Study|Physician Decision|0|||
163345863|NCT01572493|589974307|FG008|Overall Study|Physician Decision|0|||
163345864|NCT01572493|589974299|FG000|Overall Study|Switched to alternative treatment|0|||
163345865|NCT01572493|589974300|FG001|Overall Study|Switched to alternative treatment|1|||
163345866|NCT01572493|589974301|FG002|Overall Study|Switched to alternative treatment|2|||
163345867|NCT01572493|589974302|FG003|Overall Study|Switched to alternative treatment|1|||
163345868|NCT01572493|589974303|FG004|Overall Study|Switched to alternative treatment|2|||
163345869|NCT01572493|589974304|FG005|Overall Study|Switched to alternative treatment|0|||
163345870|NCT01572493|589974305|FG006|Overall Study|Switched to alternative treatment|2|||
163345871|NCT01572493|589974306|FG007|Overall Study|Switched to alternative treatment|0|||
163345872|NCT01572493|589974307|FG008|Overall Study|Switched to alternative treatment|2|||
163345873|NCT01572493|589974299|FG000|Overall Study|Death|0|||
163345874|NCT01572493|589974300|FG001|Overall Study|Death|0|||
163345875|NCT01572493|589974301|FG002|Overall Study|Death|0|||
163345876|NCT01572493|589974302|FG003|Overall Study|Death|1|||
163345877|NCT01572493|589974303|FG004|Overall Study|Death|0|||
163345878|NCT01572493|589974304|FG005|Overall Study|Death|1|||
163345879|NCT01572493|589974305|FG006|Overall Study|Death|0|||
163345880|NCT01572493|589974306|FG007|Overall Study|Death|0|||
163345881|NCT01572493|589974307|FG008|Overall Study|Death|0|||
163345882|NCT01572493|589974299|FG000|Overall Study|Adverse Event|0|||
163345883|NCT01572493|589974300|FG001|Overall Study|Adverse Event|0|||
163345884|NCT01572493|589974301|FG002|Overall Study|Adverse Event|0|||
163345885|NCT01572493|589974302|FG003|Overall Study|Adverse Event|0|||
163345886|NCT01572493|589974303|FG004|Overall Study|Adverse Event|0|||
163345887|NCT01572493|589974304|FG005|Overall Study|Adverse Event|0|||
163345888|NCT01572493|589974305|FG006|Overall Study|Adverse Event|1|||
163345889|NCT01572493|589974306|FG007|Overall Study|Adverse Event|0|||
163345890|NCT01572493|589974307|FG008|Overall Study|Adverse Event|0|||
163345891|NCT00609245|589974308|FG000|Overall Study|Adverse Event|1|||
163345892|NCT02236598|589974309|FG000|Overall Study|Adverse Event|0|||
163345893|NCT02236598|589974310|FG001|Overall Study|Adverse Event|1|||
163345894|NCT02236598|589974309|FG000|Overall Study|Withdrawal by Subject|0|||
163345895|NCT02236598|589974310|FG001|Overall Study|Withdrawal by Subject|1|||
163230164|NCT00528528|589554215|FG000|Overall Study|Ineligible to continue the trial|0|||
163230165|NCT00528528|589554216|FG001|Overall Study|Ineligible to continue the trial|0|||
163230166|NCT00528528|589554217|FG002|Overall Study|Ineligible to continue the trial|0|||
163230167|NCT00528528|589554218|FG003|Overall Study|Ineligible to continue the trial|1|||
163230168|NCT00528528|589554215|FG000|Overall Study|Other|0|||
163230169|NCT00528528|589554216|FG001|Overall Study|Other|1|||
163230170|NCT00528528|589554217|FG002|Overall Study|Other|0|||
163230171|NCT00528528|589554218|FG003|Overall Study|Other|0|||
163230172|NCT00528528|589554215|FG000|Overall Study|Withdrawal by Subject|3|||
163230173|NCT00528528|589554216|FG001|Overall Study|Withdrawal by Subject|2|||
163230174|NCT00528528|589554217|FG002|Overall Study|Withdrawal by Subject|1|||
163230175|NCT00528528|589554218|FG003|Overall Study|Withdrawal by Subject|1|||
163345896|NCT03132753|589974313|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
163345897|NCT03132753|589974314|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
163345898|NCT03132753|589974313|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
163345899|NCT03132753|589974314|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
163345900|NCT00084747|589974315|FG000|Overall Study|Relapsed|8|||
163345901|NCT00084747|589974315|FG000|Overall Study|Death|3|||
163345902|NCT00084747|589974315|FG000|Overall Study|Withdrawal by Subject|2|||
163345903|NCT01446042|589974319|FG000|Overall Study|Withdrawal by Subject|12|||
163345904|NCT01446042|589974320|FG001|Overall Study|Withdrawal by Subject|2|||
163345905|NCT01446042|589974321|FG002|Overall Study|Withdrawal by Subject|4|||
163230176|NCT00528528|589554215|FG000|Overall Study|Ongoing participant|0|||
163230177|NCT00528528|589554216|FG001|Overall Study|Ongoing participant|0|||
163345906|NCT01446042|589974319|FG000|Overall Study|Adverse Event|1|||
163345907|NCT01446042|589974320|FG001|Overall Study|Adverse Event|0|||
163345908|NCT01446042|589974321|FG002|Overall Study|Adverse Event|4|||
163345909|NCT01446042|589974319|FG000|Overall Study|Lost to Follow-up|5|||
163345910|NCT01446042|589974320|FG001|Overall Study|Lost to Follow-up|0|||
163345911|NCT01446042|589974321|FG002|Overall Study|Lost to Follow-up|0|||
163345912|NCT01446042|589974319|FG000|Overall Study|Other reasons|2|||
163345913|NCT01446042|589974320|FG001|Overall Study|Other reasons|1|||
163345914|NCT01446042|589974321|FG002|Overall Study|Other reasons|1|||
163345915|NCT05714345|589974329|FG000|Overall Study|Death|1|||
163345916|NCT05714345|589974330|FG001|Overall Study|Death|1|||
163345917|NCT01323309|589974336|FG000|Overall Study|Death|9|||
163345918|NCT01323309|589974337|FG001|Overall Study|Death|15|||
163345919|NCT01323309|589974338|FG002|Overall Study|Death|5|||
163345920|NCT01323309|589974336|FG000|Overall Study|Lost to Follow-up|11|||
163345921|NCT01323309|589974337|FG001|Overall Study|Lost to Follow-up|14|||
163345922|NCT01323309|589974338|FG002|Overall Study|Lost to Follow-up|24|||
163345923|NCT01323309|589974336|FG000|Overall Study|Withdrawal by Subject|14|||
163345924|NCT01323309|589974337|FG001|Overall Study|Withdrawal by Subject|14|||
163345925|NCT01323309|589974338|FG002|Overall Study|Withdrawal by Subject|18|||
163345926|NCT01323309|589974336|FG000|Overall Study|Disease progression|5|||
163345927|NCT01323309|589974337|FG001|Overall Study|Disease progression|11|||
163345928|NCT01323309|589974338|FG002|Overall Study|Disease progression|4|||
163345929|NCT03048058|589974340|FG000|Overall Study|Lost to Follow-up|4|||
163345930|NCT03048058|589974341|FG001|Overall Study|Lost to Follow-up|0|||
163345931|NCT03048058|589974340|FG000|Overall Study|Withdrawal by Subject|0|||
163345932|NCT03048058|589974341|FG001|Overall Study|Withdrawal by Subject|4|||
163138204|NCT00713544|589215024|FG000|Overall Study|Lost to Follow-up|0|||
163138205|NCT00713544|589215025|FG001|Overall Study|Lost to Follow-up|0|||
163138206|NCT00713544|589215026|FG002|Overall Study|Lost to Follow-up|1|||
163138207|NCT00713544|589215027|FG003|Overall Study|Lost to Follow-up|0|||
163138208|NCT00713544|589215028|FG004|Overall Study|Lost to Follow-up|0|||
163138209|NCT00713544|589215029|FG005|Overall Study|Lost to Follow-up|0|||
163138210|NCT00713544|589215024|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
163345933|NCT01257698|589974350|FG000|Overall Study|Protocol Violation|4|||
163345934|NCT01257698|589974351|FG001|Overall Study|Protocol Violation|0|||
163345935|NCT00274846|589974357|FG000|Overall Study|Did not receive adequate NK cells|1|||
163345936|NCT04601857|589974358|FG000|Overall Study|Adverse Event/Serious Adverse Event|3|||
163345937|NCT04601857|589974359|FG001|Overall Study|Adverse Event/Serious Adverse Event|7|||
163345938|NCT04601857|589974358|FG000|Overall Study|Disease Progression|2|||
163345939|NCT04601857|589974359|FG001|Overall Study|Disease Progression|4|||
163345940|NCT04601857|589974358|FG000|Overall Study|Clinical Disease Progression|2|||
163345941|NCT04601857|589974359|FG001|Overall Study|Clinical Disease Progression|1|||
163345942|NCT04601857|589974358|FG000|Overall Study|Radiological Progression|4|||
163345943|NCT04601857|589974359|FG001|Overall Study|Radiological Progression|11|||
163345944|NCT04601857|589974358|FG000|Overall Study|Death|1|||
163345945|NCT04601857|589974359|FG001|Overall Study|Death|0|||
163345946|NCT04601857|589974358|FG000|Overall Study|Reason Not Specified|0|||
163345947|NCT04601857|589974359|FG001|Overall Study|Reason Not Specified|1|||
163345948|NCT04601857|589974358|FG000|Overall Study|At the Participant's Request|0|||
163345949|NCT04601857|589974359|FG001|Overall Study|At the Participant's Request|1|||
163345950|NCT00980954|589974360|FG000|Overall Study|Protocol Violation|9|||
163345951|NCT00980954|589974361|FG001|Overall Study|Protocol Violation|15|||
163345952|NCT04736472|589974362|FG000|Overall Study|Lost to Follow-up|1|||
163345953|NCT04736472|589974363|FG001|Overall Study|Lost to Follow-up|0|||
163345954|NCT04736472|589974364|FG002|Overall Study|Lost to Follow-up|0|||
163345955|NCT04736472|589974362|FG000|Overall Study|Withdrawal by Subject|2|||
163345956|NCT04736472|589974363|FG001|Overall Study|Withdrawal by Subject|0|||
163345957|NCT04736472|589974364|FG002|Overall Study|Withdrawal by Subject|0|||
163345958|NCT04736472|589974362|FG000|Overall Study|Protocol Violation|48|||
163345959|NCT04736472|589974363|FG001|Overall Study|Protocol Violation|0|||
163345960|NCT04736472|589974364|FG002|Overall Study|Protocol Violation|6|||
163345961|NCT02268526|589974365|FG000|Overall Study|Adverse Event|0|||
163345962|NCT02268526|589974366|FG001|Overall Study|Adverse Event|2|||
163345963|NCT02268526|589974367|FG002|Overall Study|Adverse Event|1|||
163138211|NCT00713544|589215025|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
163138212|NCT00713544|589215026|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
163138213|NCT00713544|589215027|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
163138214|NCT00713544|589215028|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
163138215|NCT00713544|589215029|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
163345964|NCT02268526|589974365|FG000|Overall Study|Death|1|||
163345965|NCT02268526|589974366|FG001|Overall Study|Death|11|||
163345966|NCT02268526|589974367|FG002|Overall Study|Death|0|||
163345967|NCT02268526|589974365|FG000|Overall Study|protocol deviation|0|||
163345968|NCT02268526|589974366|FG001|Overall Study|protocol deviation|1|||
163345969|NCT02268526|589974367|FG002|Overall Study|protocol deviation|0|||
163345970|NCT02268526|589974365|FG000|Overall Study|Physician Decision|0|||
163345971|NCT02268526|589974366|FG001|Overall Study|Physician Decision|0|||
163345972|NCT02268526|589974367|FG002|Overall Study|Physician Decision|1|||
163345973|NCT02268526|589974365|FG000|Overall Study|Subject/guardian decision|0|||
163345974|NCT02268526|589974366|FG001|Overall Study|Subject/guardian decision|7|||
163345975|NCT02268526|589974367|FG002|Overall Study|Subject/guardian decision|3|||
163345976|NCT02332824|589974370|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
163345977|NCT02332824|589974371|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
163345978|NCT02332824|589974372|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
163230178|NCT00528528|589554217|FG002|Overall Study|Ongoing participant|1|||
163230179|NCT00528528|589554218|FG003|Overall Study|Ongoing participant|0|||
163230180|NCT00773097|589554219|FG000|Overall Study|Withdrawal by Subject|1|||
163230181|NCT00773097|589554219|FG000|Overall Study|Physician Decision|6|||
163230182|NCT04602624|589554223|FG000|Overall Study|Protocol Deviation|1|||
163230183|NCT04602624|589554223|FG000|Overall Study|Withdrawal by Participant|1|||
163230184|NCT04084769|589554224|FG000|Overall Study|Protocol Violation|1|||
163230185|NCT04084769|589554225|FG001|Overall Study|Protocol Violation|3|||
163230186|NCT04084769|589554226|FG002|Overall Study|Protocol Violation|0|||
163230187|NCT04084769|589554227|FG003|Overall Study|Protocol Violation|1|||
163230188|NCT04084769|589554224|FG000|Overall Study|Withdrawal by Subject|0|||
163230189|NCT04084769|589554225|FG001|Overall Study|Withdrawal by Subject|1|||
163230190|NCT04084769|589554226|FG002|Overall Study|Withdrawal by Subject|0|||
163230191|NCT04084769|589554227|FG003|Overall Study|Withdrawal by Subject|0|||
163230192|NCT04084769|589554224|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163230193|NCT04084769|589554225|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163230194|NCT04084769|589554226|FG002|Overall Study|Withdrawal by parent/guardian|0|||
163230195|NCT04084769|589554227|FG003|Overall Study|Withdrawal by parent/guardian|1|||
163230196|NCT04084769|589554224|FG000|Overall Study|Lost to Follow-up|2|||
163230197|NCT04084769|589554225|FG001|Overall Study|Lost to Follow-up|0|||
163230198|NCT04084769|589554226|FG002|Overall Study|Lost to Follow-up|0|||
163230199|NCT04084769|589554227|FG003|Overall Study|Lost to Follow-up|0|||
163230200|NCT00316199|589554228|FG000|Overall Study|Adverse Event|2|||
163230201|NCT00316199|589554228|FG000|Overall Study|Death|8|||
163230202|NCT00316199|589554228|FG000|Overall Study|Lost to Follow-up|2|||
163230203|NCT04477304|589554229|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
163230204|NCT04477304|589554230|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
163230205|NCT02782949|589554232|FG000|Overall Study|Protocol Violation|1|||
163230206|NCT02782949|589554233|FG001|Overall Study|Protocol Violation|0|||
163230207|NCT02782949|589554232|FG000|Overall Study|Withdrawal by Subject|0|||
163230208|NCT02782949|589554233|FG001|Overall Study|Withdrawal by Subject|1|||
163230209|NCT03238911|589554236|FG000|Overall Study|Withdrawal by Subject|1|||
163230210|NCT03238911|589554237|FG001|Overall Study|Withdrawal by Subject|2|||
163230211|NCT03238911|589554236|FG000|Overall Study|Lost to Follow-up|2|||
163230212|NCT03238911|589554237|FG001|Overall Study|Lost to Follow-up|1|||
163230213|NCT03091192|589554241|FG000|Overall Study|Study terminated by sponsor|21|||
163230214|NCT03091192|589554242|FG001|Overall Study|Study terminated by sponsor|14|||
163230215|NCT03091192|589554241|FG000|Overall Study|Death|9|||
163230216|NCT03091192|589554242|FG001|Overall Study|Death|13|||
163230217|NCT03091192|589554241|FG000|Overall Study|Withdrawal by Subject|2|||
163230218|NCT03091192|589554242|FG001|Overall Study|Withdrawal by Subject|0|||
163230219|NCT03091192|589554241|FG000|Overall Study|Lost to Follow-up|1|||
163230220|NCT03091192|589554242|FG001|Overall Study|Lost to Follow-up|0|||
163230221|NCT05645432|589554243|FG000|Overall Study|Withdrawal by Subject|1|||
163230222|NCT03195478|589554244|FG000|Overall Study|Disease Progression|5|||
163230223|NCT03195478|589554245|FG001|Overall Study|Disease Progression|4|||
163230224|NCT03195478|589554246|FG002|Overall Study|Disease Progression|6|||
163230225|NCT03195478|589554247|FG003|Overall Study|Disease Progression|1|||
163230226|NCT03195478|589554244|FG000|Overall Study|Study Drug Toxicity|2|||
163230227|NCT03195478|589554245|FG001|Overall Study|Study Drug Toxicity|0|||
163230228|NCT03195478|589554246|FG002|Overall Study|Study Drug Toxicity|0|||
163230229|NCT03195478|589554247|FG003|Overall Study|Study Drug Toxicity|1|||
163230230|NCT03195478|589554244|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
163230231|NCT03195478|589554245|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
163345979|NCT02332824|589974373|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
163230232|NCT03195478|589554246|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
163230233|NCT03195478|589554247|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
163230234|NCT03195478|589554244|FG000|Overall Study|Participant Withdrew Consent|1|||
163230235|NCT03195478|589554245|FG001|Overall Study|Participant Withdrew Consent|0|||
163230236|NCT03195478|589554246|FG002|Overall Study|Participant Withdrew Consent|0|||
163230237|NCT03195478|589554247|FG003|Overall Study|Participant Withdrew Consent|0|||
163230238|NCT03195478|589554244|FG000|Overall Study|Maximum Clinical benefit|0|||
163230239|NCT03195478|589554245|FG001|Overall Study|Maximum Clinical benefit|0|||
163230240|NCT03195478|589554246|FG002|Overall Study|Maximum Clinical benefit|1|||
163230241|NCT03195478|589554247|FG003|Overall Study|Maximum Clinical benefit|0|||
163230242|NCT03195478|589554244|FG000|Overall Study|Other Reasons|0|||
163230243|NCT03195478|589554245|FG001|Overall Study|Other Reasons|0|||
163230244|NCT03195478|589554246|FG002|Overall Study|Other Reasons|1|||
163230245|NCT03195478|589554247|FG003|Overall Study|Other Reasons|0|||
163345980|NCT02332824|589974374|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
163345981|NCT02332824|589974375|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
163345982|NCT02332824|589974370|FG000|Overall Study|Voluntary Withdrawal|1|||
163345983|NCT02332824|589974371|FG001|Overall Study|Voluntary Withdrawal|0|||
163345984|NCT02332824|589974372|FG002|Overall Study|Voluntary Withdrawal|0|||
163345985|NCT02332824|589974373|FG003|Overall Study|Voluntary Withdrawal|0|||
163345986|NCT02332824|589974374|FG004|Overall Study|Voluntary Withdrawal|0|||
163345987|NCT02332824|589974375|FG005|Overall Study|Voluntary Withdrawal|0|||
163345988|NCT02332824|589974370|FG000|Overall Study|Inconvenient schedule|1|||
163345989|NCT02332824|589974371|FG001|Overall Study|Inconvenient schedule|1|||
163345990|NCT02332824|589974372|FG002|Overall Study|Inconvenient schedule|0|||
163345991|NCT02332824|589974373|FG003|Overall Study|Inconvenient schedule|0|||
163345992|NCT02332824|589974374|FG004|Overall Study|Inconvenient schedule|0|||
163345993|NCT02332824|589974375|FG005|Overall Study|Inconvenient schedule|0|||
163345994|NCT02332824|589974370|FG000|Overall Study|Transfer|0|||
163345995|NCT02332824|589974371|FG001|Overall Study|Transfer|0|||
163345996|NCT02332824|589974372|FG002|Overall Study|Transfer|1|||
163345997|NCT02332824|589974373|FG003|Overall Study|Transfer|1|||
163345998|NCT02332824|589974374|FG004|Overall Study|Transfer|0|||
163345999|NCT02332824|589974375|FG005|Overall Study|Transfer|0|||
163346000|NCT00498797|589974376|FG000|Overall Study|Withdrawal by Subject|4|||
163346001|NCT00498797|589974377|FG001|Overall Study|Withdrawal by Subject|2|||
163346002|NCT00498797|589974376|FG000|Overall Study|Adverse Event|12|||
163346003|NCT00498797|589974377|FG001|Overall Study|Adverse Event|5|||
163346004|NCT00498797|589974376|FG000|Overall Study|Condition under investigation worsened|19|||
163346005|NCT00498797|589974377|FG001|Overall Study|Condition under investigation worsened|21|||
163346006|NCT00498797|589974376|FG000|Overall Study|Other|3|||
163346007|NCT00498797|589974377|FG001|Overall Study|Other|1|||
163346008|NCT01052714|589974380|FG000|Overall Study|Adverse Event|6|||
163346009|NCT01052714|589974381|FG001|Overall Study|Adverse Event|3|||
163346010|NCT01052714|589974382|FG002|Overall Study|Adverse Event|0|||
163346011|NCT01052714|589974380|FG000|Overall Study|Death|1|||
163346012|NCT01052714|589974381|FG001|Overall Study|Death|2|||
163346013|NCT01052714|589974382|FG002|Overall Study|Death|0|||
163346014|NCT01052714|589974380|FG000|Overall Study|Lost to Follow-up|2|||
163346015|NCT01052714|589974381|FG001|Overall Study|Lost to Follow-up|3|||
163346016|NCT01052714|589974382|FG002|Overall Study|Lost to Follow-up|0|||
163346017|NCT01052714|589974380|FG000|Overall Study|Physician Decision|9|||
163346018|NCT01052714|589974381|FG001|Overall Study|Physician Decision|9|||
163346019|NCT01052714|589974382|FG002|Overall Study|Physician Decision|1|||
163346020|NCT01052714|589974380|FG000|Overall Study|Withdrawal by Subject|7|||
163346021|NCT01052714|589974381|FG001|Overall Study|Withdrawal by Subject|12|||
163346022|NCT01052714|589974382|FG002|Overall Study|Withdrawal by Subject|1|||
163346023|NCT00417989|589974386|FG000|Overall Study|Withdrawal by Subject|13|||
163346024|NCT00417989|589974387|FG001|Overall Study|Withdrawal by Subject|13|||
163346025|NCT00417989|589974386|FG000|Overall Study|Lost to Follow-up|1|||
163346026|NCT00417989|589974387|FG001|Overall Study|Lost to Follow-up|6|||
163346027|NCT00417989|589974386|FG000|Overall Study|Protocol Violation|1|||
163346028|NCT00417989|589974387|FG001|Overall Study|Protocol Violation|0|||
163346029|NCT00417989|589974386|FG000|Overall Study|Death|0|||
163346030|NCT00417989|589974387|FG001|Overall Study|Death|1|||
163408841|NCT04418076|590205617|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
163408842|NCT04418076|590205618|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
163408843|NCT04418076|590205619|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
163346031|NCT00417989|589974386|FG000|Overall Study|Physician Decision|5|||
163346032|NCT00417989|589974387|FG001|Overall Study|Physician Decision|2|||
163346033|NCT04212299|589974391|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
163346034|NCT05379023|589974392|FG000|Overall Study|Lost to Follow-up|1|||
163346035|NCT05379023|589974393|FG001|Overall Study|Lost to Follow-up|0|||
163346036|NCT05379023|589974394|FG002|Overall Study|Lost to Follow-up|0|||
163346037|NCT05379023|589974392|FG000|Overall Study|Withdrawal by Subject|2|||
163408844|NCT01344876|590205621|FG000|Overall Study|Adverse Event|0|||
163346038|NCT05379023|589974393|FG001|Overall Study|Withdrawal by Subject|0|||
163346039|NCT05379023|589974394|FG002|Overall Study|Withdrawal by Subject|0|||
163346040|NCT02675998|589976317|FG000|8-Week Treatment Period|Adverse Event|6|||
163346041|NCT02675998|589976318|FG001|8-Week Treatment Period|Adverse Event|5|||
163346042|NCT02675998|589976319|FG002|8-Week Treatment Period|Adverse Event|6|||
163346043|NCT02675998|589976320|FG003|8-Week Treatment Period|Adverse Event|0|||
163346044|NCT02675998|589976317|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
163346045|NCT02675998|589976318|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
163346046|NCT02675998|589976319|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
163346047|NCT02675998|589976320|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
163346048|NCT02675998|589976317|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
163346049|NCT02675998|589976318|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
163346050|NCT02675998|589976319|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
163346051|NCT02675998|589976320|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
163346052|NCT02675998|589976317|FG000|8-Week Treatment Period|Physician Decision|1|||
163230246|NCT03370341|589555931|FG000|Overall Study|Lost to Follow-up|0|||
163230247|NCT03370341|589555932|FG001|Overall Study|Lost to Follow-up|1|||
163230248|NCT01707004|589555935|FG000|Overall Study|Physician Decision|3|||
163230249|NCT02573324|589555939|FG000|Overall Study|Withdrawal by Subject|26|||
163230250|NCT02573324|589555940|FG001|Overall Study|Withdrawal by Subject|23|||
163230251|NCT02573324|589555941|FG002|Overall Study|Withdrawal by Subject|3|||
163230252|NCT02573324|589555939|FG000|Overall Study|Lost to Follow-up|4|||
163230253|NCT02573324|589555940|FG001|Overall Study|Lost to Follow-up|5|||
163230254|NCT02573324|589555941|FG002|Overall Study|Lost to Follow-up|0|||
163230255|NCT02573324|589555939|FG000|Overall Study|Study Terminated by Sponsor|107|||
163230256|NCT02573324|589555940|FG001|Overall Study|Study Terminated by Sponsor|89|||
163230257|NCT02573324|589555941|FG002|Overall Study|Study Terminated by Sponsor|2|||
163230258|NCT02573324|589555939|FG000|Overall Study|Death|182|||
163230259|NCT02573324|589555940|FG001|Overall Study|Death|200|||
163230260|NCT02573324|589555941|FG002|Overall Study|Death|1|||
163230261|NCT02573324|589555939|FG000|Overall Study|Other, Not Specified|20|||
163230262|NCT02573324|589555940|FG001|Overall Study|Other, Not Specified|27|||
163230263|NCT02573324|589555941|FG002|Overall Study|Other, Not Specified|0|||
163230264|NCT02573324|589555939|FG000|Overall Study|Unknown Reason|2|||
163230265|NCT02573324|589555940|FG001|Overall Study|Unknown Reason|0|||
163230266|NCT02573324|589555941|FG002|Overall Study|Unknown Reason|0|||
163230267|NCT01607905|589555942|FG000|Overall Study|Withdrawal by participant|7|||
163230268|NCT01607905|589555943|FG001|Overall Study|Withdrawal by participant|2|||
163230269|NCT01607905|589555944|FG002|Overall Study|Withdrawal by participant|4|||
163230270|NCT01607905|589555945|FG003|Overall Study|Withdrawal by participant|6|||
163230271|NCT01607905|589555946|FG004|Overall Study|Withdrawal by participant|0|||
163230272|NCT01607905|589555947|FG005|Overall Study|Withdrawal by participant|4|||
163230273|NCT01607905|589555948|FG006|Overall Study|Withdrawal by participant|12|||
163230274|NCT01607905|589555942|FG000|Overall Study|Incidence or severity of AEs|5|||
163230275|NCT01607905|589555943|FG001|Overall Study|Incidence or severity of AEs|1|||
163230276|NCT01607905|589555944|FG002|Overall Study|Incidence or severity of AEs|1|||
163230277|NCT01607905|589555945|FG003|Overall Study|Incidence or severity of AEs|3|||
163230278|NCT01607905|589555946|FG004|Overall Study|Incidence or severity of AEs|0|||
163230279|NCT01607905|589555947|FG005|Overall Study|Incidence or severity of AEs|2|||
163230280|NCT01607905|589555948|FG006|Overall Study|Incidence or severity of AEs|8|||
163230281|NCT01607905|589555942|FG000|Overall Study|Disease progression|44|||
163230282|NCT01607905|589555943|FG001|Overall Study|Disease progression|16|||
163230283|NCT01607905|589555944|FG002|Overall Study|Disease progression|15|||
163230284|NCT01607905|589555945|FG003|Overall Study|Disease progression|11|||
163230285|NCT01607905|589555946|FG004|Overall Study|Disease progression|6|||
163230286|NCT01607905|589555947|FG005|Overall Study|Disease progression|7|||
163230287|NCT01607905|589555948|FG006|Overall Study|Disease progression|21|||
163230288|NCT01607905|589555942|FG000|Overall Study|Non-compliance with study procedures|0|||
163230289|NCT01607905|589555943|FG001|Overall Study|Non-compliance with study procedures|0|||
163230290|NCT01607905|589555944|FG002|Overall Study|Non-compliance with study procedures|0|||
163230291|NCT01607905|589555945|FG003|Overall Study|Non-compliance with study procedures|0|||
163230292|NCT01607905|589555946|FG004|Overall Study|Non-compliance with study procedures|0|||
163230293|NCT01607905|589555947|FG005|Overall Study|Non-compliance with study procedures|0|||
163230294|NCT01607905|589555948|FG006|Overall Study|Non-compliance with study procedures|1|||
163230295|NCT01607905|589555942|FG000|Overall Study|Death|1|||
163230296|NCT01607905|589555943|FG001|Overall Study|Death|1|||
163230297|NCT01607905|589555944|FG002|Overall Study|Death|1|||
163230298|NCT01607905|589555945|FG003|Overall Study|Death|1|||
163230299|NCT01607905|589555946|FG004|Overall Study|Death|0|||
163230300|NCT01607905|589555947|FG005|Overall Study|Death|0|||
163230301|NCT01607905|589555948|FG006|Overall Study|Death|3|||
163230302|NCT01607905|589555942|FG000|Overall Study|Other treatments become available|1|||
163230303|NCT01607905|589555943|FG001|Overall Study|Other treatments become available|0|||
163230304|NCT01607905|589555944|FG002|Overall Study|Other treatments become available|0|||
163230305|NCT01607905|589555945|FG003|Overall Study|Other treatments become available|0|||
163230306|NCT01607905|589555946|FG004|Overall Study|Other treatments become available|0|||
163230307|NCT01607905|589555947|FG005|Overall Study|Other treatments become available|0|||
163230308|NCT01607905|589555948|FG006|Overall Study|Other treatments become available|1|||
163230309|NCT01607905|589555942|FG000|Overall Study|Investigator discretion|0|||
163230310|NCT01607905|589555943|FG001|Overall Study|Investigator discretion|0|||
163346053|NCT02675998|589976318|FG001|8-Week Treatment Period|Physician Decision|0|||
163346054|NCT02675998|589976319|FG002|8-Week Treatment Period|Physician Decision|2|||
163346055|NCT02675998|589976320|FG003|8-Week Treatment Period|Physician Decision|0|||
163346056|NCT02675998|589976317|FG000|8-Week Treatment Period|GI side Effects|1|||
163230311|NCT01607905|589555944|FG002|Overall Study|Investigator discretion|0|||
163230312|NCT01607905|589555945|FG003|Overall Study|Investigator discretion|0|||
163230313|NCT01607905|589555946|FG004|Overall Study|Investigator discretion|0|||
163230314|NCT01607905|589555947|FG005|Overall Study|Investigator discretion|1|||
163230315|NCT01607905|589555948|FG006|Overall Study|Investigator discretion|0|||
163230316|NCT01607905|589555942|FG000|Overall Study|Other|1|||
163230317|NCT01607905|589555943|FG001|Overall Study|Other|0|||
163230318|NCT01607905|589555944|FG002|Overall Study|Other|0|||
163230319|NCT01607905|589555945|FG003|Overall Study|Other|0|||
163230320|NCT01607905|589555946|FG004|Overall Study|Other|0|||
163230321|NCT01607905|589555947|FG005|Overall Study|Other|0|||
163230322|NCT01607905|589555948|FG006|Overall Study|Other|1|||
163230323|NCT01607905|589555942|FG000|Overall Study|Randomized but not treated|1|||
163230324|NCT01607905|589555943|FG001|Overall Study|Randomized but not treated|0|||
163230325|NCT01607905|589555944|FG002|Overall Study|Randomized but not treated|0|||
163230326|NCT01607905|589555945|FG003|Overall Study|Randomized but not treated|0|||
163230327|NCT01607905|589555946|FG004|Overall Study|Randomized but not treated|1|||
163230328|NCT01607905|589555947|FG005|Overall Study|Randomized but not treated|1|||
163230329|NCT01607905|589555948|FG006|Overall Study|Randomized but not treated|0|||
163230330|NCT00941733|589555949|FG000|Overall Study|Death|24|||
163230331|NCT00941733|589555950|FG001|Overall Study|Death|10|||
163230332|NCT00941733|589555949|FG000|Overall Study|Withdrawal by Subject|14|||
163230333|NCT00941733|589555950|FG001|Overall Study|Withdrawal by Subject|6|||
163230334|NCT00941733|589555949|FG000|Overall Study|Adverse Event|20|||
163230335|NCT00941733|589555950|FG001|Overall Study|Adverse Event|4|||
163230336|NCT00941733|589555949|FG000|Overall Study|Lost to Follow-up|1|||
163230337|NCT00941733|589555950|FG001|Overall Study|Lost to Follow-up|2|||
163230338|NCT00941733|589555949|FG000|Overall Study|Protocol Violation|15|||
163230339|NCT00941733|589555950|FG001|Overall Study|Protocol Violation|6|||
163230340|NCT00194012|589555951|FG000|Randomized Phase|Lack of Efficacy|8|||
163230341|NCT00194012|589555952|FG001|Randomized Phase|Lack of Efficacy|18|||
163230342|NCT00194012|589555951|FG000|Randomized Phase|Study nonadherence|2|||
163230343|NCT00194012|589555952|FG001|Randomized Phase|Study nonadherence|1|||
163230344|NCT00194012|589555951|FG000|Randomized Phase|Withdrawal by Subject|3|||
163230345|NCT00194012|589555952|FG001|Randomized Phase|Withdrawal by Subject|3|||
163230346|NCT00194012|589555951|FG000|Randomized Phase|Adverse Event|2|||
163230347|NCT00194012|589555952|FG001|Randomized Phase|Adverse Event|1|||
163230348|NCT00194012|589555951|FG000|Randomized Phase|Participant reported having a rash|1|||
163230349|NCT00194012|589555952|FG001|Randomized Phase|Participant reported having a rash|0|||
163230350|NCT00194012|589555951|FG000|Randomized Phase|Emesis and enuresis|0|||
163230351|NCT00194012|589555952|FG001|Randomized Phase|Emesis and enuresis|1|||
163230352|NCT00194012|589555951|FG000|Randomized Phase|Oral/nasal twitching|0|||
163230353|NCT00194012|589555952|FG001|Randomized Phase|Oral/nasal twitching|1|||
163230354|NCT00194012|589555951|FG000|Open Label Extension (OLE)|Weight Gain|1|||
163230355|NCT00194012|589555952|FG001|Open Label Extension (OLE)|Weight Gain|0|||
163230356|NCT00194012|589555951|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
163230357|NCT00194012|589555952|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
163230358|NCT00194012|589555951|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
163230359|NCT00194012|589555952|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
163230360|NCT00194012|589555951|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
163230361|NCT00194012|589555952|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
163230362|NCT01105533|589555953|FG000|Overall Study|Death|0|||
163230363|NCT01105533|589555954|FG001|Overall Study|Death|0|||
163230364|NCT01105533|589555955|FG002|Overall Study|Death|0|||
163230365|NCT01105533|589555956|FG003|Overall Study|Death|0|||
163230366|NCT01105533|589555957|FG004|Overall Study|Death|1|||
163230367|NCT01105533|589555958|FG005|Overall Study|Death|0|||
163230368|NCT01105533|589555959|FG006|Overall Study|Death|0|||
163230369|NCT01105533|589555960|FG007|Overall Study|Death|0|||
163230370|NCT01105533|589555961|FG008|Overall Study|Death|0|||
163230371|NCT01105533|589555953|FG000|Overall Study|Lack of Efficacy|1|||
163230372|NCT01105533|589555954|FG001|Overall Study|Lack of Efficacy|1|||
163230373|NCT01105533|589555955|FG002|Overall Study|Lack of Efficacy|3|||
163230374|NCT01105533|589555956|FG003|Overall Study|Lack of Efficacy|3|||
163230375|NCT01105533|589555957|FG004|Overall Study|Lack of Efficacy|4|||
163346057|NCT02675998|589976318|FG001|8-Week Treatment Period|GI side Effects|4|||
163346058|NCT02675998|589976319|FG002|8-Week Treatment Period|GI side Effects|2|||
163230376|NCT01105533|589555958|FG005|Overall Study|Lack of Efficacy|5|||
163230377|NCT01105533|589555959|FG006|Overall Study|Lack of Efficacy|3|||
163230378|NCT01105533|589555960|FG007|Overall Study|Lack of Efficacy|2|||
163230379|NCT01105533|589555961|FG008|Overall Study|Lack of Efficacy|9|||
163230380|NCT01105533|589555953|FG000|Overall Study|Adverse Event|0|||
163230381|NCT01105533|589555954|FG001|Overall Study|Adverse Event|0|||
163230382|NCT01105533|589555955|FG002|Overall Study|Adverse Event|0|||
163346059|NCT02675998|589976320|FG003|8-Week Treatment Period|GI side Effects|0|||
163230383|NCT01105533|589555956|FG003|Overall Study|Adverse Event|0|||
163230384|NCT01105533|589555957|FG004|Overall Study|Adverse Event|1|||
163230385|NCT01105533|589555958|FG005|Overall Study|Adverse Event|2|||
163230386|NCT01105533|589555959|FG006|Overall Study|Adverse Event|2|||
163230387|NCT01105533|589555960|FG007|Overall Study|Adverse Event|0|||
163230388|NCT01105533|589555961|FG008|Overall Study|Adverse Event|1|||
163230389|NCT01105533|589555953|FG000|Overall Study|Other|0|||
163230390|NCT01105533|589555954|FG001|Overall Study|Other|0|||
163230391|NCT01105533|589555955|FG002|Overall Study|Other|0|||
163230392|NCT01105533|589555956|FG003|Overall Study|Other|0|||
163230393|NCT01105533|589555957|FG004|Overall Study|Other|1|||
163230394|NCT01105533|589555958|FG005|Overall Study|Other|0|||
163346060|NCT02675998|589976317|FG000|8-Week Treatment Period|Protocol Violation|1|||
163346061|NCT02675998|589976318|FG001|8-Week Treatment Period|Protocol Violation|1|||
163346062|NCT02675998|589976319|FG002|8-Week Treatment Period|Protocol Violation|1|||
163346063|NCT02675998|589976320|FG003|8-Week Treatment Period|Protocol Violation|0|||
163346064|NCT02675998|589976317|FG000|8-Week Treatment Period|Other|3|||
163346065|NCT02675998|589976318|FG001|8-Week Treatment Period|Other|1|||
163346066|NCT02675998|589976319|FG002|8-Week Treatment Period|Other|2|||
163408845|NCT01344876|590205622|FG001|Overall Study|Adverse Event|0|||
163408846|NCT01344876|590205623|FG002|Overall Study|Adverse Event|0|||
163408847|NCT01344876|590205624|FG003|Overall Study|Adverse Event|0|||
163138216|NCT00713544|589215024|FG000|Overall Study|Incorrect enrollment|0|||
163138217|NCT00713544|589215025|FG001|Overall Study|Incorrect enrollment|1|||
163138218|NCT00713544|589215026|FG002|Overall Study|Incorrect enrollment|0|||
163138219|NCT00713544|589215027|FG003|Overall Study|Incorrect enrollment|0|||
163138220|NCT00713544|589215028|FG004|Overall Study|Incorrect enrollment|0|||
163138221|NCT00713544|589215029|FG005|Overall Study|Incorrect enrollment|0|||
163138222|NCT00713544|589215024|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
163138223|NCT00713544|589215025|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
163138224|NCT00713544|589215026|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
163138225|NCT00713544|589215027|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
163138226|NCT00713544|589215028|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
163138227|NCT00713544|589215029|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
163138228|NCT00269919|589215030|FG000|Overall Study|Other|26|||
163138229|NCT00269919|589215030|FG000|Overall Study|Started but not treated|1|||
163138230|NCT01641601|589215033|FG000|Overall Study|Study discontinued.|3|||
163138231|NCT01641601|589215034|FG001|Overall Study|Study discontinued.|5|||
163138232|NCT01957202|589215035|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138233|NCT01957202|589215036|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
163138234|NCT01957202|589215037|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138235|NCT01957202|589215038|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138236|NCT01957202|589215039|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138237|NCT01957202|589215040|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138238|NCT01957202|589215041|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138239|NCT01957202|589215042|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138240|NCT01957202|589215043|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138241|NCT01957202|589215044|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138242|NCT01957202|589215045|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138243|NCT01957202|589215046|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138244|NCT01957202|589215047|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138245|NCT01957202|589215048|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138246|NCT01957202|589215049|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138247|NCT01957202|589215050|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138248|NCT01957202|589215051|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
163138249|NCT01957202|589215052|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138250|NCT01957202|589215035|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138251|NCT01957202|589215036|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138252|NCT01957202|589215037|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138253|NCT01957202|589215038|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138254|NCT01957202|589215039|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138255|NCT01957202|589215040|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138256|NCT01957202|589215041|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138257|NCT01957202|589215042|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138258|NCT01957202|589215043|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138259|NCT01957202|589215044|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138260|NCT01957202|589215045|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138261|NCT01957202|589215046|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
163346067|NCT02675998|589976320|FG003|8-Week Treatment Period|Other|0|||
163408848|NCT01344876|590205625|FG004|Overall Study|Adverse Event|1|||
163408849|NCT01344876|590205621|FG000|Overall Study|Withdrawal by Subject|0|||
163408850|NCT01344876|590205622|FG001|Overall Study|Withdrawal by Subject|0|||
163408851|NCT01344876|590205623|FG002|Overall Study|Withdrawal by Subject|1|||
163230395|NCT01105533|589555959|FG006|Overall Study|Other|3|||
163346068|NCT02675998|589976317|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
163346069|NCT02675998|589976318|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
163346070|NCT02675998|589976319|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
163346071|NCT02675998|589976320|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
163346072|NCT02675998|589976317|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
163346073|NCT02675998|589976318|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
163346074|NCT02675998|589976319|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
163408852|NCT01344876|590205624|FG003|Overall Study|Withdrawal by Subject|0|||
163346075|NCT02675998|589976320|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
163408853|NCT01344876|590205625|FG004|Overall Study|Withdrawal by Subject|0|||
163408854|NCT01344876|590205621|FG000|Overall Study|Definite progression of primary disease|1|||
163346076|NCT02675998|589976317|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
163346077|NCT02675998|589976318|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
163346078|NCT02675998|589976319|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
163346079|NCT02675998|589976320|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
163346080|NCT02675998|589976317|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
163346081|NCT02675998|589976318|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
163346082|NCT02675998|589976319|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
163138262|NCT01957202|589215047|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138263|NCT01957202|589215048|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138264|NCT01957202|589215049|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138265|NCT01957202|589215050|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138266|NCT01957202|589215051|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
163138267|NCT01957202|589215052|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138268|NCT02640547|589215053|FG000|Overall Study|Failure to Return|1|||
163138269|NCT02640547|589215053|FG000|Overall Study|Withdrawal by Subject|1|||
163138270|NCT02640547|589215053|FG000|Overall Study|Death|6|||
163138271|NCT02640547|589215053|FG000|Overall Study|Miscellaneous|3|||
163138272|NCT00080301|589215056|FG000|Overall Study|Randomized but Never Treated|5|||
163138273|NCT00080301|589215057|FG001|Overall Study|Randomized but Never Treated|10|||
163138274|NCT00080301|589215056|FG000|Overall Study|Still on Treatment as of CSR date|0|||
163138275|NCT00080301|589215057|FG001|Overall Study|Still on Treatment as of CSR date|1|||
163138276|NCT00991939|589215058|FG000|Overall Study|Lost to Follow-up|0|||
163138277|NCT00991939|589215059|FG001|Overall Study|Lost to Follow-up|1|||
163138278|NCT00991939|589215058|FG000|Overall Study|Withdrawal by Subject|1|||
163138279|NCT00991939|589215059|FG001|Overall Study|Withdrawal by Subject|0|||
163138280|NCT00991939|589215058|FG000|Overall Study|Entire study terminated|4|||
163138281|NCT00991939|589215059|FG001|Overall Study|Entire study terminated|1|||
163138282|NCT01965704|589215060|FG000|Overall Study|Withdrawal by Subject|2|||
163138283|NCT01965704|589215061|FG001|Overall Study|Withdrawal by Subject|2|||
163138284|NCT01965704|589215062|FG002|Overall Study|Withdrawal by Subject|1|||
163138285|NCT01965704|589215063|FG003|Overall Study|Withdrawal by Subject|1|||
163138286|NCT01965704|589215060|FG000|Overall Study|Delivered at home|1|||
163138287|NCT01965704|589215061|FG001|Overall Study|Delivered at home|1|||
163138288|NCT01965704|589215062|FG002|Overall Study|Delivered at home|0|||
163138289|NCT01965704|589215063|FG003|Overall Study|Delivered at home|0|||
163138290|NCT01965704|589215060|FG000|Overall Study|Experienced complications|0|||
163138291|NCT01965704|589215061|FG001|Overall Study|Experienced complications|0|||
163138292|NCT01965704|589215062|FG002|Overall Study|Experienced complications|2|||
163138293|NCT01965704|589215063|FG003|Overall Study|Experienced complications|2|||
163138294|NCT01965704|589215060|FG000|Overall Study|Adverse Event|0|||
163138295|NCT01965704|589215061|FG001|Overall Study|Adverse Event|0|||
163138296|NCT01965704|589215062|FG002|Overall Study|Adverse Event|1|||
163138297|NCT01965704|589215063|FG003|Overall Study|Adverse Event|1|||
163138298|NCT01965704|589215060|FG000|Overall Study|Did not meet inclusion criteria|0|||
163138299|NCT01965704|589215061|FG001|Overall Study|Did not meet inclusion criteria|0|||
163138300|NCT01965704|589215062|FG002|Overall Study|Did not meet inclusion criteria|1|||
163138301|NCT01965704|589215063|FG003|Overall Study|Did not meet inclusion criteria|1|||
163138302|NCT02524171|589215065|FG000|6-month Follow-up|Lost to Follow-up|53|||
163138303|NCT02524171|589215066|FG001|6-month Follow-up|Lost to Follow-up|45|||
163138304|NCT02524171|589215065|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
163138305|NCT02524171|589215066|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
163138306|NCT02868554|589215071|FG000|Overall Study|Lost to Follow-up|3|||
163138307|NCT02868554|589215072|FG001|Overall Study|Lost to Follow-up|0|||
163138308|NCT02868554|589215073|FG002|Overall Study|Lost to Follow-up|1|||
163138309|NCT05150990|589215074|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
163138310|NCT05150990|589215075|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
163138311|NCT05150990|589215074|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
163138312|NCT05150990|589215075|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
163138313|NCT05150990|589215074|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
163138314|NCT05150990|589215075|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
163138315|NCT05150990|589215074|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
163138316|NCT05150990|589215075|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
163138317|NCT05150990|589215074|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
163138318|NCT05150990|589215075|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
163138319|NCT05150990|589215074|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
163138320|NCT05150990|589215075|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
163138321|NCT05150990|589215074|FG000|Overall Study|Death (unrelated to the intervention)|1|||
163138322|NCT05150990|589215075|FG001|Overall Study|Death (unrelated to the intervention)|2|||
163138323|NCT05447663|589215078|FG000|Overall Study|Study terminated by Sponsor|5|||
163230396|NCT01105533|589555960|FG007|Overall Study|Other|1|||
163230397|NCT01105533|589555961|FG008|Overall Study|Other|2|||
163230398|NCT01105533|589555953|FG000|Overall Study|Physician Decision|0|||
163230399|NCT01105533|589555954|FG001|Overall Study|Physician Decision|0|||
163230400|NCT01105533|589555955|FG002|Overall Study|Physician Decision|0|||
163230401|NCT01105533|589555956|FG003|Overall Study|Physician Decision|0|||
163230402|NCT01105533|589555957|FG004|Overall Study|Physician Decision|0|||
163230403|NCT01105533|589555958|FG005|Overall Study|Physician Decision|0|||
163230404|NCT01105533|589555959|FG006|Overall Study|Physician Decision|0|||
163230405|NCT01105533|589555960|FG007|Overall Study|Physician Decision|1|||
163230406|NCT01105533|589555961|FG008|Overall Study|Physician Decision|0|||
163230407|NCT03892889|589555962|FG000|Overall Study|Adverse Event|17|||
163230408|NCT03892889|589555962|FG000|Overall Study|Lack of Efficacy|1|||
163230409|NCT03892889|589555962|FG000|Overall Study|Lost to Follow-up|46|||
163230410|NCT03892889|589555962|FG000|Overall Study|Non-compliance with study drug|22|||
163230411|NCT03892889|589555962|FG000|Overall Study|Pregnancy|1|||
163230412|NCT03892889|589555962|FG000|Overall Study|Protocol Deviation|3|||
163230413|NCT03892889|589555962|FG000|Overall Study|Withdrawal by Subject|50|||
163230414|NCT03892889|589555962|FG000|Overall Study|Withdrawal by Caregiver|1|||
163230415|NCT03892889|589555962|FG000|Overall Study|Study Terminated by Sponsor|50|||
163230416|NCT03892889|589555962|FG000|Overall Study|Physician Decision|8|||
163230417|NCT03892889|589555962|FG000|Overall Study|Reason not Specified|5|||
163230418|NCT01639001|589555968|FG000|Overall Study|Refused further follow-up|9|||
163230419|NCT01639001|589555969|FG001|Overall Study|Refused further follow-up|12|||
163230420|NCT01639001|589555968|FG000|Overall Study|Lost to Follow-up|3|||
163230421|NCT01639001|589555969|FG001|Overall Study|Lost to Follow-up|0|||
163230422|NCT01639001|589555968|FG000|Overall Study|Death|62|||
163230423|NCT01639001|589555969|FG001|Overall Study|Death|61|||
163230424|NCT01639001|589555968|FG000|Overall Study|Randomized but not treated|0|||
163230425|NCT01639001|589555969|FG001|Overall Study|Randomized but not treated|2|||
163230426|NCT01639001|589555968|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
163230427|NCT01639001|589555969|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
163230428|NCT02097134|589555970|FG000|Overall Study|Physician Decision|4|||
163230429|NCT02097134|589555970|FG000|Overall Study|Non-Protocol Therapy|1|||
163230430|NCT02097134|589555970|FG000|Overall Study|Progressive Disease|3|||
163230431|NCT02097134|589555970|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
163230432|NCT00679341|589555972|FG000|Overall Study|Disease progression|42|||
163230433|NCT00679341|589555973|FG001|Overall Study|Disease progression|36|||
163230434|NCT00679341|589555972|FG000|Overall Study|Adverse Event|5|||
163230435|NCT00679341|589555973|FG001|Overall Study|Adverse Event|6|||
163230436|NCT00679341|589555972|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
163230437|NCT00679341|589555973|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
163230438|NCT00679341|589555972|FG000|Overall Study|Death|1|||
163230439|NCT00679341|589555973|FG001|Overall Study|Death|1|||
163230440|NCT00679341|589555972|FG000|Overall Study|Other|1|||
163230441|NCT00679341|589555973|FG001|Overall Study|Other|0|||
163230442|NCT00679341|589555972|FG000|Overall Study|Physician Decision|1|||
163230443|NCT00679341|589555973|FG001|Overall Study|Physician Decision|0|||
163230444|NCT00679341|589555972|FG000|Overall Study|Not treated|0|||
163230445|NCT00679341|589555973|FG001|Overall Study|Not treated|2|||
163230446|NCT00679341|589555972|FG000|Overall Study|Physician/patient decision to withdraw|0|||
163230447|NCT00679341|589555973|FG001|Overall Study|Physician/patient decision to withdraw|6|||
163230448|NCT00298896|589555977|FG000|Overall Study|Death|3|||
163230449|NCT00298896|589555977|FG000|Overall Study|Physician Decision|2|||
163230450|NCT00298896|589555977|FG000|Overall Study|Intercurrent Illness|1|||
163230451|NCT00298896|589555977|FG000|Overall Study|Disease Progression|41|||
163230452|NCT00298896|589555977|FG000|Overall Study|Withdrawal by Subject|2|||
163230453|NCT00298896|589555977|FG000|Overall Study|Assigned to treatment in error|1|||
163230454|NCT02880371|589555978|FG000|Phase 1b|Lost to Follow-up|1|||
163230455|NCT02880371|589555979|FG001|Phase 1b|Lost to Follow-up|0|||
163230456|NCT02880371|589555980|FG002|Phase 1b|Lost to Follow-up|0|||
163230457|NCT02880371|589555981|FG003|Phase 1b|Lost to Follow-up|0|||
163230458|NCT02880371|589555982|FG004|Phase 1b|Lost to Follow-up|0|||
163230459|NCT02880371|589555983|FG005|Phase 1b|Lost to Follow-up|0|||
163230460|NCT02880371|589555984|FG006|Phase 1b|Lost to Follow-up|0|||
163230461|NCT02880371|589555985|FG007|Phase 1b|Lost to Follow-up|0|||
163230462|NCT02880371|589555978|FG000|Phase 1b|Participants terminated by Sponsor|1|||
163230463|NCT02880371|589555979|FG001|Phase 1b|Participants terminated by Sponsor|0|||
163230464|NCT02880371|589555980|FG002|Phase 1b|Participants terminated by Sponsor|0|||
163230465|NCT02880371|589555981|FG003|Phase 1b|Participants terminated by Sponsor|0|||
163230466|NCT02880371|589555982|FG004|Phase 1b|Participants terminated by Sponsor|0|||
163230467|NCT02880371|589555983|FG005|Phase 1b|Participants terminated by Sponsor|0|||
163230468|NCT02880371|589555984|FG006|Phase 1b|Participants terminated by Sponsor|0|||
163230469|NCT02880371|589555985|FG007|Phase 1b|Participants terminated by Sponsor|0|||
163230470|NCT02880371|589555978|FG000|Phase 1b|Withdrawal by Subject|0|||
163230471|NCT02880371|589555979|FG001|Phase 1b|Withdrawal by Subject|0|||
163230472|NCT02880371|589555980|FG002|Phase 1b|Withdrawal by Subject|1|||
163346083|NCT02675998|589976320|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
163346084|NCT02675998|589976317|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
163138324|NCT05447663|589215078|FG000|Overall Study|Death|2|||
163138325|NCT05447663|589215078|FG000|Overall Study|Withdrawal by Subject|1|||
163138326|NCT01100320|589215079|FG000|Period 1|Withdrawal by Subject|2|||
163138327|NCT01100320|589215080|FG001|Period 1|Withdrawal by Subject|4|||
163138328|NCT01100320|589215079|FG000|Period 1|Positive Drug Screen|1|||
163138329|NCT01100320|589215080|FG001|Period 1|Positive Drug Screen|1|||
163138330|NCT01100320|589215079|FG000|Period 1|Adverse Event|2|||
163138331|NCT01100320|589215080|FG001|Period 1|Adverse Event|2|||
163138332|NCT01100320|589215079|FG000|Period 2|Withdrawal by Subject|1|||
163138333|NCT01100320|589215080|FG001|Period 2|Withdrawal by Subject|1|||
163138334|NCT04181762|589215081|FG000|Overall Study|Adverse Event|1|||
163138335|NCT04181762|589215082|FG001|Overall Study|Adverse Event|3|||
163138336|NCT04181762|589215081|FG000|Overall Study|Lost to Follow-up|1|||
163138337|NCT04181762|589215082|FG001|Overall Study|Lost to Follow-up|1|||
163138338|NCT04181762|589215081|FG000|Overall Study|Physician Decision|1|||
163138339|NCT04181762|589215082|FG001|Overall Study|Physician Decision|3|||
163138340|NCT04181762|589215081|FG000|Overall Study|Pregnancy|0|||
163138341|NCT04181762|589215082|FG001|Overall Study|Pregnancy|1|||
163138342|NCT04181762|589215081|FG000|Overall Study|Lack of Efficacy|2|||
163138343|NCT04181762|589215082|FG001|Overall Study|Lack of Efficacy|2|||
163138344|NCT04181762|589215081|FG000|Overall Study|Study terminated by sponsor|95|||
163138345|NCT04181762|589215082|FG001|Overall Study|Study terminated by sponsor|97|||
163138346|NCT04181762|589215081|FG000|Overall Study|Subject decision|11|||
163138347|NCT04181762|589215082|FG001|Overall Study|Subject decision|4|||
163138348|NCT04181762|589215081|FG000|Overall Study|Death|1|||
163138349|NCT04181762|589215082|FG001|Overall Study|Death|1|||
163138350|NCT04181762|589215081|FG000|Overall Study|Protocol deviation|1|||
163138351|NCT04181762|589215082|FG001|Overall Study|Protocol deviation|0|||
163138352|NCT04181762|589215081|FG000|Overall Study|Withdrawal of informed consent|1|||
163138353|NCT04181762|589215082|FG001|Overall Study|Withdrawal of informed consent|3|||
163138354|NCT04669301|589215083|FG000|Overall Study|Lost to Follow-up|0|||
163138355|NCT04669301|589215084|FG001|Overall Study|Lost to Follow-up|1|||
163138356|NCT04669301|589215085|FG002|Overall Study|Lost to Follow-up|0|||
163138357|NCT04669301|589215083|FG000|Overall Study|Withdrawal by Subject|3|||
163138358|NCT04669301|589215084|FG001|Overall Study|Withdrawal by Subject|2|||
163138359|NCT04669301|589215085|FG002|Overall Study|Withdrawal by Subject|0|||
163138360|NCT02586727|589215086|FG000|Overall Study|Lost to Follow-up|1|||
163138361|NCT02586727|589215087|FG001|Overall Study|Lost to Follow-up|0|||
163138362|NCT05888181|589215088|FG000|Overall Study|Lost to Follow-up|1|||
163138363|NCT05888181|589215089|FG001|Overall Study|Lost to Follow-up|1|||
163138364|NCT05888181|589215090|FG002|Overall Study|Lost to Follow-up|0|||
163138365|NCT02534909|589215093|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
163138366|NCT00132808|589215096|FG000|Stratum I|Adverse Event|2|||
163138367|NCT00132808|589215097|FG001|Stratum I|Adverse Event|1|||
163138368|NCT00132808|589215098|FG002|Stratum I|Adverse Event|0|||
163138369|NCT00132808|589215096|FG000|Stratum I|Lost to Follow-up|3|||
163138370|NCT00132808|589215097|FG001|Stratum I|Lost to Follow-up|4|||
163138371|NCT00132808|589215098|FG002|Stratum I|Lost to Follow-up|1|||
163138372|NCT00132808|589215096|FG000|Stratum I|Withdrawal by Subject|4|||
163138373|NCT00132808|589215097|FG001|Stratum I|Withdrawal by Subject|7|||
163138374|NCT00132808|589215098|FG002|Stratum I|Withdrawal by Subject|3|||
163138375|NCT00132808|589215096|FG000|Stratum I|Abnormal test procedure result (s)|0|||
163138376|NCT00132808|589215097|FG001|Stratum I|Abnormal test procedure result (s)|0|||
163138377|NCT00132808|589215098|FG002|Stratum I|Abnormal test procedure result (s)|1|||
163138378|NCT00132808|589215096|FG000|Stratum II|Adverse Event|1|||
163138379|NCT00132808|589215097|FG001|Stratum II|Adverse Event|2|||
163138380|NCT00132808|589215098|FG002|Stratum II|Adverse Event|1|||
163138381|NCT00132808|589215096|FG000|Stratum II|Death|1|||
163138382|NCT00132808|589215097|FG001|Stratum II|Death|0|||
163138383|NCT00132808|589215098|FG002|Stratum II|Death|0|||
163138384|NCT00132808|589215096|FG000|Stratum II|Lost to Follow-up|2|||
163138385|NCT00132808|589215097|FG001|Stratum II|Lost to Follow-up|2|||
163138386|NCT00132808|589215098|FG002|Stratum II|Lost to Follow-up|1|||
163138387|NCT00132808|589215096|FG000|Stratum II|Protocol Violation|0|||
163138388|NCT00132808|589215097|FG001|Stratum II|Protocol Violation|2|||
163138389|NCT00132808|589215098|FG002|Stratum II|Protocol Violation|1|||
163138390|NCT00132808|589215096|FG000|Stratum II|Withdrawal by Subject|4|||
163138391|NCT00132808|589215097|FG001|Stratum II|Withdrawal by Subject|9|||
163138392|NCT00132808|589215098|FG002|Stratum II|Withdrawal by Subject|6|||
163138393|NCT00577824|589215102|FG000|Overall Study|Adverse Event|6|||
163138394|NCT00577824|589215103|FG001|Overall Study|Adverse Event|18|||
163138395|NCT00577824|589215104|FG002|Overall Study|Adverse Event|1|||
163138396|NCT00577824|589215102|FG000|Overall Study|Patient decision|0|||
163138397|NCT00577824|589215103|FG001|Overall Study|Patient decision|1|||
163138398|NCT00577824|589215104|FG002|Overall Study|Patient decision|1|||
163138399|NCT00577824|589215102|FG000|Overall Study|Protocol Violation|1|||
163138400|NCT00577824|589215103|FG001|Overall Study|Protocol Violation|1|||
163138401|NCT00577824|589215104|FG002|Overall Study|Protocol Violation|0|||
163230473|NCT02880371|589555981|FG003|Phase 1b|Withdrawal by Subject|0|||
163230474|NCT02880371|589555982|FG004|Phase 1b|Withdrawal by Subject|0|||
163230475|NCT02880371|589555983|FG005|Phase 1b|Withdrawal by Subject|0|||
163230476|NCT02880371|589555984|FG006|Phase 1b|Withdrawal by Subject|0|||
163230477|NCT02880371|589555985|FG007|Phase 1b|Withdrawal by Subject|0|||
163230478|NCT02880371|589555978|FG000|Phase 1b|Death|4|||
163230479|NCT02880371|589555979|FG001|Phase 1b|Death|6|||
163230480|NCT02880371|589555980|FG002|Phase 1b|Death|5|||
163230481|NCT02880371|589555981|FG003|Phase 1b|Death|1|||
163230482|NCT02880371|589555982|FG004|Phase 1b|Death|0|||
163230483|NCT02880371|589555983|FG005|Phase 1b|Death|0|||
163230484|NCT02880371|589555984|FG006|Phase 1b|Death|0|||
163230485|NCT02880371|589555985|FG007|Phase 1b|Death|0|||
163230486|NCT02880371|589555978|FG000|Phase 1b|Enrolled but not Treated|0|||
163230487|NCT02880371|589555979|FG001|Phase 1b|Enrolled but not Treated|1|||
163230488|NCT02880371|589555980|FG002|Phase 1b|Enrolled but not Treated|0|||
163230489|NCT02880371|589555981|FG003|Phase 1b|Enrolled but not Treated|0|||
163230490|NCT02880371|589555982|FG004|Phase 1b|Enrolled but not Treated|0|||
163230491|NCT02880371|589555983|FG005|Phase 1b|Enrolled but not Treated|0|||
163230492|NCT02880371|589555984|FG006|Phase 1b|Enrolled but not Treated|0|||
163230493|NCT02880371|589555985|FG007|Phase 1b|Enrolled but not Treated|0|||
163230494|NCT02880371|589555978|FG000|Phase 2|Enrolled but not Treated|0|||
163230495|NCT02880371|589555979|FG001|Phase 2|Enrolled but not Treated|0|||
163230496|NCT02880371|589555980|FG002|Phase 2|Enrolled but not Treated|0|||
163230497|NCT02880371|589555981|FG003|Phase 2|Enrolled but not Treated|0|||
163230498|NCT02880371|589555982|FG004|Phase 2|Enrolled but not Treated|0|||
163230499|NCT02880371|589555983|FG005|Phase 2|Enrolled but not Treated|1|||
163230500|NCT02880371|589555984|FG006|Phase 2|Enrolled but not Treated|1|||
163230501|NCT02880371|589555985|FG007|Phase 2|Enrolled but not Treated|0|||
163230502|NCT02880371|589555978|FG000|Phase 2|Other|0|||
163230503|NCT02880371|589555979|FG001|Phase 2|Other|0|||
163230504|NCT02880371|589555980|FG002|Phase 2|Other|0|||
163230505|NCT02880371|589555981|FG003|Phase 2|Other|0|||
163230506|NCT02880371|589555982|FG004|Phase 2|Other|0|||
163230507|NCT02880371|589555983|FG005|Phase 2|Other|1|||
163230508|NCT02880371|589555984|FG006|Phase 2|Other|2|||
163230509|NCT02880371|589555985|FG007|Phase 2|Other|1|||
163230510|NCT02880371|589555978|FG000|Phase 2|Participants terminated by Sponsor|0|||
163230511|NCT02880371|589555979|FG001|Phase 2|Participants terminated by Sponsor|0|||
163230512|NCT02880371|589555980|FG002|Phase 2|Participants terminated by Sponsor|0|||
163230513|NCT02880371|589555981|FG003|Phase 2|Participants terminated by Sponsor|0|||
163230514|NCT02880371|589555982|FG004|Phase 2|Participants terminated by Sponsor|1|||
163230515|NCT02880371|589555983|FG005|Phase 2|Participants terminated by Sponsor|6|||
163230516|NCT02880371|589555984|FG006|Phase 2|Participants terminated by Sponsor|1|||
163230517|NCT02880371|589555985|FG007|Phase 2|Participants terminated by Sponsor|5|||
163230518|NCT02880371|589555978|FG000|Phase 2|Death|0|||
163230519|NCT02880371|589555979|FG001|Phase 2|Death|0|||
163230520|NCT02880371|589555980|FG002|Phase 2|Death|0|||
163230521|NCT02880371|589555981|FG003|Phase 2|Death|0|||
163230522|NCT02880371|589555982|FG004|Phase 2|Death|1|||
163230523|NCT02880371|589555983|FG005|Phase 2|Death|10|||
163230524|NCT02880371|589555984|FG006|Phase 2|Death|20|||
163230525|NCT02880371|589555985|FG007|Phase 2|Death|5|||
163230526|NCT02880371|589555978|FG000|Phase 2|Lost to Follow-up|0|||
163408855|NCT01344876|590205622|FG001|Overall Study|Definite progression of primary disease|0|||
163408856|NCT01344876|590205623|FG002|Overall Study|Definite progression of primary disease|0|||
163408857|NCT01344876|590205624|FG003|Overall Study|Definite progression of primary disease|3|||
163408858|NCT01344876|590205625|FG004|Overall Study|Definite progression of primary disease|0|||
163230527|NCT02880371|589555979|FG001|Phase 2|Lost to Follow-up|0|||
163230528|NCT02880371|589555980|FG002|Phase 2|Lost to Follow-up|0|||
163230529|NCT02880371|589555981|FG003|Phase 2|Lost to Follow-up|0|||
163230530|NCT02880371|589555982|FG004|Phase 2|Lost to Follow-up|0|||
163230531|NCT02880371|589555983|FG005|Phase 2|Lost to Follow-up|0|||
163230532|NCT02880371|589555984|FG006|Phase 2|Lost to Follow-up|3|||
163408859|NCT05107765|590205626|FG000|Overall Study|Lost to Follow-up|4|||
163408860|NCT05107765|590205627|FG001|Overall Study|Lost to Follow-up|1|||
163230533|NCT02880371|589555985|FG007|Phase 2|Lost to Follow-up|0|||
163230534|NCT02880371|589555978|FG000|Phase 2|Withdrawal by Subject|0|||
163230535|NCT02880371|589555979|FG001|Phase 2|Withdrawal by Subject|0|||
163230536|NCT02880371|589555980|FG002|Phase 2|Withdrawal by Subject|0|||
163230537|NCT02880371|589555981|FG003|Phase 2|Withdrawal by Subject|0|||
163230538|NCT02880371|589555982|FG004|Phase 2|Withdrawal by Subject|0|||
163230539|NCT02880371|589555983|FG005|Phase 2|Withdrawal by Subject|1|||
163230540|NCT02880371|589555984|FG006|Phase 2|Withdrawal by Subject|1|||
163230541|NCT02880371|589555985|FG007|Phase 2|Withdrawal by Subject|0|||
163408861|NCT05107765|590205626|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
163230542|NCT02880371|589555978|FG000|Phase 2|End of Study page not completed by error|0|||
163230543|NCT02880371|589555979|FG001|Phase 2|End of Study page not completed by error|0|||
163230544|NCT02880371|589555980|FG002|Phase 2|End of Study page not completed by error|0|||
163230545|NCT02880371|589555981|FG003|Phase 2|End of Study page not completed by error|0|||
163230546|NCT02880371|589555982|FG004|Phase 2|End of Study page not completed by error|0|||
163230547|NCT02880371|589555983|FG005|Phase 2|End of Study page not completed by error|1|||
163346085|NCT02675998|589976318|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
163346086|NCT02675998|589976319|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
163346087|NCT02675998|589976320|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
163346088|NCT02561078|589976329|FG000|Overall Study|Adverse Event|5|||
163346089|NCT02561078|589976330|FG001|Overall Study|Adverse Event|2|||
163346090|NCT02561078|589976329|FG000|Overall Study|Death|2|||
163346091|NCT02561078|589976330|FG001|Overall Study|Death|1|||
163346092|NCT02561078|589976329|FG000|Overall Study|Lost to Follow-up|2|||
163346093|NCT02561078|589976330|FG001|Overall Study|Lost to Follow-up|6|||
163346094|NCT02561078|589976329|FG000|Overall Study|Non-Compliance with Study Drug|6|||
163346095|NCT02561078|589976330|FG001|Overall Study|Non-Compliance with Study Drug|3|||
163346096|NCT02561078|589976329|FG000|Overall Study|Physician Decision|2|||
163346097|NCT02561078|589976330|FG001|Overall Study|Physician Decision|3|||
163346098|NCT02561078|589976329|FG000|Overall Study|Withdrawal by Subject|13|||
163346099|NCT02561078|589976330|FG001|Overall Study|Withdrawal by Subject|10|||
163346100|NCT00598871|589976331|FG000|Overall Study|Adverse Event|0|||
163346101|NCT00598871|589976332|FG001|Overall Study|Adverse Event|1|||
163346102|NCT01194271|589976333|FG000|Overall Study|Withdrawal by Subject|1|||
163346103|NCT01194271|589976333|FG000|Overall Study|Ineligible, Screen Failure|1|||
163346104|NCT01194271|589976333|FG000|Overall Study|Death|1|||
163346105|NCT00443898|589976334|FG000|Overall Study|Adverse Event|0|||
163346106|NCT00443898|589976335|FG001|Overall Study|Adverse Event|0|||
163346107|NCT00443898|589976336|FG002|Overall Study|Adverse Event|1|||
163346108|NCT00443898|589976337|FG003|Overall Study|Adverse Event|1|||
163346109|NCT00443898|589976334|FG000|Overall Study|Lack of Efficacy|2|||
163346110|NCT00443898|589976335|FG001|Overall Study|Lack of Efficacy|3|||
163346111|NCT00443898|589976336|FG002|Overall Study|Lack of Efficacy|3|||
163346112|NCT00443898|589976337|FG003|Overall Study|Lack of Efficacy|1|||
163346113|NCT00443898|589976334|FG000|Overall Study|Protocol Violation|1|||
163346114|NCT00443898|589976335|FG001|Overall Study|Protocol Violation|1|||
163346115|NCT00443898|589976336|FG002|Overall Study|Protocol Violation|1|||
163346116|NCT00443898|589976337|FG003|Overall Study|Protocol Violation|0|||
163346117|NCT00443898|589976334|FG000|Overall Study|Withdrawal by Subject|11|||
163346118|NCT00443898|589976335|FG001|Overall Study|Withdrawal by Subject|10|||
163346119|NCT00443898|589976336|FG002|Overall Study|Withdrawal by Subject|10|||
163346120|NCT00443898|589976337|FG003|Overall Study|Withdrawal by Subject|6|||
163346121|NCT00443898|589976334|FG000|Overall Study|Lost to Follow-up|10|||
163346122|NCT00443898|589976335|FG001|Overall Study|Lost to Follow-up|10|||
163346123|NCT00443898|589976336|FG002|Overall Study|Lost to Follow-up|14|||
163346124|NCT00443898|589976337|FG003|Overall Study|Lost to Follow-up|10|||
163346125|NCT00443898|589976334|FG000|Overall Study|Death|0|||
163346126|NCT00443898|589976335|FG001|Overall Study|Death|1|||
163346127|NCT00443898|589976336|FG002|Overall Study|Death|0|||
163346128|NCT00443898|589976337|FG003|Overall Study|Death|0|||
163346129|NCT00043186|589976338|FG000|Overall Study|Physician Decision|0|||
163346130|NCT00043186|589976339|FG001|Overall Study|Physician Decision|0|||
163346131|NCT00043186|589976340|FG002|Overall Study|Physician Decision|3|||
163346132|NCT00043186|589976341|FG003|Overall Study|Physician Decision|0|||
163346133|NCT00043186|589976342|FG004|Overall Study|Physician Decision|1|||
163346134|NCT00043186|589976343|FG005|Overall Study|Physician Decision|0|||
163346135|NCT00043186|589976344|FG006|Overall Study|Physician Decision|0|||
163346136|NCT00043186|589976345|FG007|Overall Study|Physician Decision|1|||
163346137|NCT00043186|589976346|FG008|Overall Study|Physician Decision|1|||
163346138|NCT00043186|589976338|FG000|Overall Study|Adverse Event|2|||
163346139|NCT00043186|589976339|FG001|Overall Study|Adverse Event|2|||
163346140|NCT00043186|589976340|FG002|Overall Study|Adverse Event|2|||
163346141|NCT00043186|589976341|FG003|Overall Study|Adverse Event|3|||
163346142|NCT00043186|589976342|FG004|Overall Study|Adverse Event|2|||
163346143|NCT00043186|589976343|FG005|Overall Study|Adverse Event|1|||
163346144|NCT00043186|589976344|FG006|Overall Study|Adverse Event|2|||
163408862|NCT05107765|590205627|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
163230548|NCT02880371|589555984|FG006|Phase 2|End of Study page not completed by error|0|||
163346145|NCT00043186|589976345|FG007|Overall Study|Adverse Event|1|||
163346146|NCT00043186|589976346|FG008|Overall Study|Adverse Event|3|||
163346147|NCT00043186|589976338|FG000|Overall Study|Withdrawal by Subject|11|||
163346148|NCT00043186|589976339|FG001|Overall Study|Withdrawal by Subject|8|||
163346149|NCT00043186|589976340|FG002|Overall Study|Withdrawal by Subject|11|||
163346150|NCT00043186|589976341|FG003|Overall Study|Withdrawal by Subject|13|||
163346151|NCT00043186|589976342|FG004|Overall Study|Withdrawal by Subject|14|||
163346152|NCT00043186|589976343|FG005|Overall Study|Withdrawal by Subject|6|||
163346153|NCT00043186|589976344|FG006|Overall Study|Withdrawal by Subject|12|||
163346154|NCT00043186|589976345|FG007|Overall Study|Withdrawal by Subject|9|||
163346155|NCT00043186|589976346|FG008|Overall Study|Withdrawal by Subject|10|||
163346156|NCT00043186|589976338|FG000|Overall Study|Death|0|||
163346157|NCT00043186|589976339|FG001|Overall Study|Death|0|||
163346158|NCT00043186|589976340|FG002|Overall Study|Death|1|||
163346159|NCT00043186|589976341|FG003|Overall Study|Death|0|||
163346160|NCT00043186|589976342|FG004|Overall Study|Death|0|||
163346161|NCT00043186|589976343|FG005|Overall Study|Death|0|||
163230549|NCT02880371|589555985|FG007|Phase 2|End of Study page not completed by error|0|||
163230550|NCT03285646|589555990|FG000|Overall Study|Adverse Event|1|||
163230551|NCT03285646|589555991|FG001|Overall Study|Adverse Event|0|||
163230552|NCT03285646|589555990|FG000|Overall Study|Withdrawal by Subject|10|||
163230553|NCT03285646|589555991|FG001|Overall Study|Withdrawal by Subject|2|||
163230554|NCT03285646|589555990|FG000|Overall Study|Lost to Follow-up|2|||
163230555|NCT03285646|589555991|FG001|Overall Study|Lost to Follow-up|1|||
163230556|NCT03285646|589555990|FG000|Overall Study|Investigator/Sponsor Decision|0|||
163230557|NCT03285646|589555991|FG001|Overall Study|Investigator/Sponsor Decision|1|||
163346162|NCT00043186|589976344|FG006|Overall Study|Death|2|||
163346163|NCT00043186|589976345|FG007|Overall Study|Death|0|||
163346164|NCT00043186|589976346|FG008|Overall Study|Death|0|||
163346165|NCT00043186|589976338|FG000|Overall Study|Disease progression|1|||
163346166|NCT00043186|589976339|FG001|Overall Study|Disease progression|0|||
163346167|NCT00043186|589976340|FG002|Overall Study|Disease progression|0|||
163346168|NCT00043186|589976341|FG003|Overall Study|Disease progression|3|||
163346169|NCT00043186|589976342|FG004|Overall Study|Disease progression|0|||
163346170|NCT00043186|589976343|FG005|Overall Study|Disease progression|0|||
163346171|NCT00043186|589976344|FG006|Overall Study|Disease progression|0|||
163346172|NCT00043186|589976345|FG007|Overall Study|Disease progression|4|||
163346173|NCT00043186|589976346|FG008|Overall Study|Disease progression|0|||
163346174|NCT00043186|589976338|FG000|Overall Study|Ineligibility determined|0|||
163346175|NCT00043186|589976339|FG001|Overall Study|Ineligibility determined|0|||
163346176|NCT00043186|589976340|FG002|Overall Study|Ineligibility determined|0|||
163346177|NCT00043186|589976341|FG003|Overall Study|Ineligibility determined|0|||
163346178|NCT00043186|589976342|FG004|Overall Study|Ineligibility determined|0|||
163346179|NCT00043186|589976343|FG005|Overall Study|Ineligibility determined|0|||
163346180|NCT00043186|589976344|FG006|Overall Study|Ineligibility determined|0|||
163346181|NCT00043186|589976345|FG007|Overall Study|Ineligibility determined|0|||
163346182|NCT00043186|589976346|FG008|Overall Study|Ineligibility determined|1|||
163138402|NCT00362648|589215105|FG000|Overall Study|Adverse Event|12|||
163138403|NCT00362648|589215106|FG001|Overall Study|Adverse Event|21|||
163138404|NCT00362648|589215107|FG002|Overall Study|Adverse Event|1|||
163138405|NCT00362648|589215108|FG003|Overall Study|Adverse Event|0|||
163138406|NCT00362648|589215105|FG000|Overall Study|Lost to Follow-up|62|||
163138407|NCT00362648|589215106|FG001|Overall Study|Lost to Follow-up|69|||
163138408|NCT00362648|589215107|FG002|Overall Study|Lost to Follow-up|4|||
163138409|NCT00362648|589215108|FG003|Overall Study|Lost to Follow-up|3|||
163138410|NCT00362648|589215105|FG000|Overall Study|Protocol Violation|4|||
163138411|NCT00362648|589215106|FG001|Overall Study|Protocol Violation|2|||
163138412|NCT00362648|589215107|FG002|Overall Study|Protocol Violation|2|||
163138413|NCT00362648|589215108|FG003|Overall Study|Protocol Violation|2|||
163138414|NCT00362648|589215105|FG000|Overall Study|Withdrawal by Subject|48|||
163138415|NCT00362648|589215106|FG001|Overall Study|Withdrawal by Subject|42|||
163138416|NCT00362648|589215107|FG002|Overall Study|Withdrawal by Subject|2|||
163138417|NCT00362648|589215108|FG003|Overall Study|Withdrawal by Subject|6|||
163138418|NCT04752332|589215117|FG000|Overall Study|Adverse Event|3|||
163138419|NCT04752332|589215118|FG001|Overall Study|Adverse Event|1|||
163138420|NCT04752332|589215117|FG000|Overall Study|Disease Relapse|1|||
163138421|NCT04752332|589215118|FG001|Overall Study|Disease Relapse|0|||
163138422|NCT04752332|589215117|FG000|Overall Study|Non-compliance With Study Drug|2|||
163138423|NCT04752332|589215118|FG001|Overall Study|Non-compliance With Study Drug|0|||
163138424|NCT04752332|589215117|FG000|Overall Study|Physician Decision|2|||
163138425|NCT04752332|589215118|FG001|Overall Study|Physician Decision|1|||
163138426|NCT04752332|589215117|FG000|Overall Study|Protocol Violation|1|||
163138427|NCT04752332|589215118|FG001|Overall Study|Protocol Violation|1|||
163138428|NCT04752332|589215117|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
163138429|NCT04752332|589215118|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
163138430|NCT04752332|589215117|FG000|Overall Study|Study Terminated by Sponsor|10|||
163138431|NCT04752332|589215118|FG001|Overall Study|Study Terminated by Sponsor|48|||
163138432|NCT04752332|589215117|FG000|Overall Study|Withdrawal by Subject|11|||
163230558|NCT02660359|589555992|FG000|Overall Study|Protocol Deviation|0|||
163230559|NCT02660359|589555993|FG001|Overall Study|Protocol Deviation|0|||
163346183|NCT00043186|589976338|FG000|Overall Study|Lost to Follow-up|3|||
163346184|NCT00043186|589976339|FG001|Overall Study|Lost to Follow-up|5|||
163346185|NCT00043186|589976340|FG002|Overall Study|Lost to Follow-up|1|||
163346186|NCT00043186|589976341|FG003|Overall Study|Lost to Follow-up|1|||
163138433|NCT04752332|589215118|FG001|Overall Study|Withdrawal by Subject|3|||
163230560|NCT02660359|589555994|FG002|Overall Study|Protocol Deviation|1|||
163346187|NCT00043186|589976342|FG004|Overall Study|Lost to Follow-up|1|||
163346188|NCT00043186|589976343|FG005|Overall Study|Lost to Follow-up|1|||
163346189|NCT00043186|589976344|FG006|Overall Study|Lost to Follow-up|1|||
163138434|NCT00924443|589215119|FG000|Overall Study|Physician Decision|2|||
163138435|NCT00924443|589215119|FG000|Overall Study|Protocol Violation|1|||
163138436|NCT00286429|589215120|FG000|Overall Study|Adverse Event|4|||
163138437|NCT00286429|589215121|FG001|Overall Study|Adverse Event|1|||
163346190|NCT00043186|589976345|FG007|Overall Study|Lost to Follow-up|1|||
163346191|NCT00043186|589976346|FG008|Overall Study|Lost to Follow-up|2|||
163346192|NCT00043186|589976338|FG000|Overall Study|Noncompliance|0|||
163408863|NCT05107765|590205626|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
163408864|NCT05107765|590205627|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
163408865|NCT00562588|590205628|FG000|Overall Study|Adverse Event|40|||
163408866|NCT00562588|590205629|FG001|Overall Study|Adverse Event|58|||
163408867|NCT00562588|590205628|FG000|Overall Study|Protocol Violation|30|||
163408868|NCT00562588|590205629|FG001|Overall Study|Protocol Violation|26|||
163408869|NCT00562588|590205628|FG000|Overall Study|Lost to Follow-up|12|||
163408870|NCT00562588|590205629|FG001|Overall Study|Lost to Follow-up|4|||
163408871|NCT00562588|590205628|FG000|Overall Study|Withdrawal by Subject|10|||
163408872|NCT00562588|590205629|FG001|Overall Study|Withdrawal by Subject|9|||
163408873|NCT00562588|590205628|FG000|Overall Study|Other|0|||
163408874|NCT00562588|590205629|FG001|Overall Study|Other|2|||
163408875|NCT03368170|590207417|FG000|Overall Study|Adverse Event|2|||
163346193|NCT00043186|589976339|FG001|Overall Study|Noncompliance|0|||
163346194|NCT00043186|589976340|FG002|Overall Study|Noncompliance|1|||
163346195|NCT00043186|589976341|FG003|Overall Study|Noncompliance|1|||
163346196|NCT00043186|589976342|FG004|Overall Study|Noncompliance|0|||
163346197|NCT00043186|589976343|FG005|Overall Study|Noncompliance|0|||
163346198|NCT00043186|589976344|FG006|Overall Study|Noncompliance|0|||
163346199|NCT00043186|589976345|FG007|Overall Study|Noncompliance|0|||
163346200|NCT00043186|589976346|FG008|Overall Study|Noncompliance|0|||
163346201|NCT00043186|589976338|FG000|Overall Study|Other|0|||
163346202|NCT00043186|589976339|FG001|Overall Study|Other|0|||
163346203|NCT00043186|589976340|FG002|Overall Study|Other|1|||
163346204|NCT00043186|589976341|FG003|Overall Study|Other|1|||
163346205|NCT00043186|589976342|FG004|Overall Study|Other|0|||
163346206|NCT00043186|589976343|FG005|Overall Study|Other|0|||
163346207|NCT00043186|589976344|FG006|Overall Study|Other|0|||
163346208|NCT00043186|589976345|FG007|Overall Study|Other|0|||
163346209|NCT00043186|589976346|FG008|Overall Study|Other|0|||
163346210|NCT04050722|589976350|FG000|Overall Study|Withdrawal by Subject|1|||
163346211|NCT04050722|589976351|FG001|Overall Study|Withdrawal by Subject|0|||
163346212|NCT01145417|589976352|FG000|Overall Study|Death|1|||
163346213|NCT01145417|589976353|FG001|Overall Study|Death|0|||
163346214|NCT01145417|589976352|FG000|Overall Study|Lost to Follow-up|2|||
163346215|NCT01145417|589976353|FG001|Overall Study|Lost to Follow-up|1|||
163346216|NCT01145417|589976352|FG000|Overall Study|Withdrawal by Subject|1|||
163346217|NCT01145417|589976353|FG001|Overall Study|Withdrawal by Subject|2|||
163346218|NCT01145417|589976352|FG000|Overall Study|Pregnancy|1|||
163346219|NCT01145417|589976353|FG001|Overall Study|Pregnancy|0|||
163346220|NCT01145417|589976352|FG000|Overall Study|Adverse Event|0|||
163346221|NCT01145417|589976353|FG001|Overall Study|Adverse Event|1|||
163346222|NCT01145417|589976352|FG000|Overall Study|Study terminated by sponsor|35|||
163346223|NCT01145417|589976353|FG001|Overall Study|Study terminated by sponsor|43|||
163346224|NCT01145417|589976352|FG000|Overall Study|Other|1|||
163346225|NCT01145417|589976353|FG001|Overall Study|Other|0|||
163346226|NCT03924947|589976354|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
163346227|NCT03924947|589976355|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
163346228|NCT03924947|589976356|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
163346229|NCT03924947|589976357|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
163346230|NCT03924947|589976358|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
163346231|NCT03924947|589976359|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
163346232|NCT03085433|589976360|FG000|Overall Study|Withdrawal by Subject|2|||
163346233|NCT03085433|589976361|FG001|Overall Study|Withdrawal by Subject|4|||
163408876|NCT03368170|590207418|FG001|Overall Study|Adverse Event|1|||
163408877|NCT03047980|590207419|FG000|Overall Study|Adverse Event|1|||
163408878|NCT02164981|590207420|FG000|Started|Withdrawal by Subject|2|||
163408879|NCT02164981|590207421|FG001|Started|Withdrawal by Subject|1|||
163408880|NCT02164981|590207422|FG002|Started|Withdrawal by Subject|0|||
163138438|NCT00286429|589215122|FG002|Overall Study|Adverse Event|6|||
163138439|NCT00286429|589215120|FG000|Overall Study|Lack of Efficacy|52|||
163138440|NCT00286429|589215121|FG001|Overall Study|Lack of Efficacy|27|||
163346234|NCT03085433|589976360|FG000|Overall Study|Physician Decision|33|||
163408881|NCT02164981|590207420|FG000|Started|Protocol Violation|2|||
163408882|NCT02164981|590207421|FG001|Started|Protocol Violation|0|||
163408883|NCT02164981|590207422|FG002|Started|Protocol Violation|0|||
163408884|NCT02164981|590207420|FG000|Started|Adverse Event|1|||
163346235|NCT03085433|589976361|FG001|Overall Study|Physician Decision|50|||
163346236|NCT03809039|589976362|FG000|Part 1|Withdrawal by Subject|1|||
163346237|NCT03809039|589976363|FG001|Part 1|Withdrawal by Subject|0|||
163346238|NCT03809039|589976364|FG002|Part 1|Withdrawal by Subject|0|||
163346239|NCT03809039|589976365|FG003|Part 1|Withdrawal by Subject|1|||
163346240|NCT03809039|589976366|FG004|Part 1|Withdrawal by Subject|0|||
163346241|NCT03809039|589976367|FG005|Part 1|Withdrawal by Subject|0|||
163346242|NCT03809039|589976368|FG006|Part 1|Withdrawal by Subject|0|||
163138441|NCT00286429|589215122|FG002|Overall Study|Lack of Efficacy|25|||
163346243|NCT03809039|589976369|FG007|Part 1|Withdrawal by Subject|0|||
163346244|NCT03809039|589976370|FG008|Part 1|Withdrawal by Subject|0|||
163408885|NCT02164981|590207421|FG001|Started|Adverse Event|2|||
163408886|NCT02164981|590207422|FG002|Started|Adverse Event|0|||
163138442|NCT00286429|589215120|FG000|Overall Study|Lost to Follow-up|2|||
163138443|NCT00286429|589215121|FG001|Overall Study|Lost to Follow-up|4|||
163138444|NCT00286429|589215122|FG002|Overall Study|Lost to Follow-up|3|||
163138445|NCT00286429|589215120|FG000|Overall Study|Physician Decision|10|||
163138446|NCT00286429|589215121|FG001|Overall Study|Physician Decision|7|||
163138447|NCT00286429|589215122|FG002|Overall Study|Physician Decision|7|||
163138448|NCT00286429|589215120|FG000|Overall Study|Protocol Violation|3|||
163138449|NCT00286429|589215121|FG001|Overall Study|Protocol Violation|5|||
163138450|NCT00286429|589215122|FG002|Overall Study|Protocol Violation|4|||
163138451|NCT00286429|589215120|FG000|Overall Study|Withdrawal by Subject|3|||
163138452|NCT00286429|589215121|FG001|Overall Study|Withdrawal by Subject|2|||
163138453|NCT00286429|589215122|FG002|Overall Study|Withdrawal by Subject|6|||
163138454|NCT00286429|589215120|FG000|Overall Study|Administrative Error|1|||
163138455|NCT00286429|589215121|FG001|Overall Study|Administrative Error|1|||
163138456|NCT00286429|589215122|FG002|Overall Study|Administrative Error|1|||
163138457|NCT00286429|589215120|FG000|Overall Study|Administrative Decision|0|||
163138458|NCT00286429|589215121|FG001|Overall Study|Administrative Decision|1|||
163138459|NCT00286429|589215122|FG002|Overall Study|Administrative Decision|0|||
163138460|NCT03197376|589215126|FG000|Primary and Booster Phase|Adverse Event|0|||
163138461|NCT03197376|589215127|FG001|Primary and Booster Phase|Adverse Event|0|||
163138462|NCT03197376|589215128|FG002|Primary and Booster Phase|Adverse Event|0|||
163138463|NCT03197376|589215129|FG003|Primary and Booster Phase|Adverse Event|1|||
163138464|NCT03197376|589215126|FG000|Primary and Booster Phase|Death|1|||
163138465|NCT03197376|589215127|FG001|Primary and Booster Phase|Death|0|||
163138466|NCT03197376|589215128|FG002|Primary and Booster Phase|Death|0|||
163138467|NCT03197376|589215129|FG003|Primary and Booster Phase|Death|2|||
163138468|NCT03197376|589215126|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
163138469|NCT03197376|589215127|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
163138470|NCT03197376|589215128|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
163138471|NCT03197376|589215129|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
163138472|NCT03197376|589215126|FG000|Primary and Booster Phase|Physician Decision|1|||
163138473|NCT03197376|589215127|FG001|Primary and Booster Phase|Physician Decision|0|||
163138474|NCT03197376|589215128|FG002|Primary and Booster Phase|Physician Decision|1|||
163138475|NCT03197376|589215129|FG003|Primary and Booster Phase|Physician Decision|3|||
163138476|NCT03197376|589215126|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
163138477|NCT03197376|589215127|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
163138478|NCT03197376|589215128|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
163138479|NCT03197376|589215129|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
163138480|NCT03197376|589215126|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
163138481|NCT03197376|589215127|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
163138482|NCT03197376|589215128|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
163138483|NCT03197376|589215129|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
163138484|NCT03197376|589215126|FG000|Primary and Booster Phase|Not vaccine related|1|||
163138485|NCT03197376|589215127|FG001|Primary and Booster Phase|Not vaccine related|2|||
163138486|NCT03197376|589215128|FG002|Primary and Booster Phase|Not vaccine related|0|||
163138487|NCT03197376|589215129|FG003|Primary and Booster Phase|Not vaccine related|6|||
163138488|NCT03197376|589215126|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
163138489|NCT03197376|589215127|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
163138490|NCT03197376|589215128|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
163138491|NCT03197376|589215129|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
163138492|NCT03197376|589215126|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
163138493|NCT03197376|589215127|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
163138494|NCT03197376|589215128|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
163138495|NCT03197376|589215129|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
163138496|NCT03197376|589215126|FG000|Immune Persistence Phase|Not vaccine related|1|||
163138497|NCT03197376|589215127|FG001|Immune Persistence Phase|Not vaccine related|0|||
163138498|NCT03197376|589215128|FG002|Immune Persistence Phase|Not vaccine related|1|||
163138499|NCT03197376|589215129|FG003|Immune Persistence Phase|Not vaccine related|1|||
163138500|NCT02978833|589215133|FG000|Overall Study|Study terminated|1|||
163138501|NCT02978833|589215134|FG001|Overall Study|Study terminated|1|||
163138502|NCT01123395|589215137|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
163138503|NCT01123395|589215138|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
163138504|NCT00186901|589215139|FG000|Overall Study|Pregnancy|6|||
163138505|NCT00186901|589215140|FG001|Overall Study|Pregnancy|3|||
163138506|NCT00186901|589215141|FG002|Overall Study|Pregnancy|0|||
163138507|NCT00186901|589215139|FG000|Overall Study|Lost to Follow-up|6|||
163138508|NCT00186901|589215140|FG001|Overall Study|Lost to Follow-up|3|||
163138509|NCT00186901|589215141|FG002|Overall Study|Lost to Follow-up|0|||
163138510|NCT00186901|589215139|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
163138511|NCT00186901|589215140|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
163138512|NCT00186901|589215141|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
163138513|NCT00186901|589215139|FG000|Overall Study|ALL relapse or second malignancy|1|||
163138514|NCT00186901|589215140|FG001|Overall Study|ALL relapse or second malignancy|2|||
163230561|NCT02660359|589555992|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
163230562|NCT02660359|589555993|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
163230563|NCT02660359|589555994|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
163230564|NCT02660359|589555992|FG000|Overall Study|Lack of Efficacy|1|||
163230565|NCT02660359|589555993|FG001|Overall Study|Lack of Efficacy|1|||
163230566|NCT02660359|589555994|FG002|Overall Study|Lack of Efficacy|1|||
163230567|NCT02660359|589555992|FG000|Overall Study|Adverse Event|0|||
163230568|NCT02660359|589555993|FG001|Overall Study|Adverse Event|1|||
163230569|NCT02660359|589555994|FG002|Overall Study|Adverse Event|0|||
163230570|NCT02660359|589555992|FG000|Overall Study|Other|2|||
163230571|NCT02660359|589555993|FG001|Overall Study|Other|1|||
163230572|NCT02660359|589555994|FG002|Overall Study|Other|3|||
163230573|NCT02660359|589555992|FG000|Overall Study|Withdrawal by Subject|7|||
163230574|NCT02660359|589555993|FG001|Overall Study|Withdrawal by Subject|5|||
163230575|NCT02660359|589555994|FG002|Overall Study|Withdrawal by Subject|8|||
163230576|NCT02660359|589555992|FG000|Overall Study|Lost to Follow-up|3|||
163230577|NCT02660359|589555993|FG001|Overall Study|Lost to Follow-up|3|||
163230578|NCT02660359|589555994|FG002|Overall Study|Lost to Follow-up|0|||
163230579|NCT04101526|589555997|FG000|Overall Study|Did not complete all sleep diary entries|0|||
163230580|NCT04101526|589555998|FG001|Overall Study|Did not complete all sleep diary entries|1|||
163230581|NCT02944578|589555999|FG000|Overall Study|Physician Decision|1|||
163230582|NCT02944578|589556000|FG001|Overall Study|Physician Decision|0|||
163230583|NCT00548808|589556003|FG000|Overall Study|Lost to Follow-up|9|||
163230584|NCT00548808|589556004|FG001|Overall Study|Lost to Follow-up|3|||
163230585|NCT00548808|589556003|FG000|Overall Study|Protocol Violation|8|||
163230586|NCT00548808|589556004|FG001|Overall Study|Protocol Violation|8|||
163230587|NCT00548808|589556003|FG000|Overall Study|Withdrawal by Subject|8|||
163230588|NCT00548808|589556004|FG001|Overall Study|Withdrawal by Subject|4|||
163230589|NCT00548808|589556003|FG000|Overall Study|Physician Decision|6|||
163230590|NCT00548808|589556004|FG001|Overall Study|Physician Decision|3|||
163230591|NCT00548808|589556003|FG000|Overall Study|Adverse Event|4|||
163230592|NCT00548808|589556004|FG001|Overall Study|Adverse Event|5|||
163230593|NCT00548808|589556003|FG000|Overall Study|Death|2|||
163230594|NCT00548808|589556004|FG001|Overall Study|Death|0|||
163230595|NCT00548808|589556003|FG000|Overall Study|Entry Criteria Not Met|2|||
163230596|NCT00548808|589556004|FG001|Overall Study|Entry Criteria Not Met|2|||
163230597|NCT00548808|589556003|FG000|Overall Study|Lack of Efficacy|2|||
163230598|NCT00548808|589556004|FG001|Overall Study|Lack of Efficacy|0|||
163230599|NCT00548808|589556003|FG000|Overall Study|Sponsor Decision|1|||
163230600|NCT00548808|589556004|FG001|Overall Study|Sponsor Decision|1|||
163230601|NCT00424372|589556006|FG000|Overall Study|Death|1|||
163230602|NCT00424372|589556006|FG000|Overall Study|Adverse Event|18|||
163230603|NCT00424372|589556006|FG000|Overall Study|Lack of Efficacy|6|||
163230604|NCT00424372|589556006|FG000|Overall Study|Withdrawal by Subject|4|||
163230605|NCT00424372|589556006|FG000|Overall Study|Protocol Violation|1|||
163230606|NCT00424372|589556006|FG000|Overall Study|Health deterioration|1|||
163230607|NCT04879745|589556008|FG000|Overall Study|Lost to Follow-up|4|||
163230608|NCT04879745|589556009|FG001|Overall Study|Lost to Follow-up|1|||
163230609|NCT00120042|589556010|FG000|Overall Study|all completed protocl|0|||
163230610|NCT00120042|589556011|FG001|Overall Study|all completed protocl|0|||
163230611|NCT00120042|589556012|FG002|Overall Study|all completed protocl|0|||
163230612|NCT04532112|589556015|FG000|Overall Study|Adverse Event|3|||
163230613|NCT04532112|589556016|FG001|Overall Study|Adverse Event|0|||
163230614|NCT03592641|589556017|FG000|Overall Study|Withdrawal by Subject|1|||
163230615|NCT01126541|589556019|FG000|Overall Study|Adverse Event|0|||
163230616|NCT01126541|589556020|FG001|Overall Study|Adverse Event|2|||
163230617|NCT01126541|589556021|FG002|Overall Study|Adverse Event|4|||
163230618|NCT01126541|589556019|FG000|Overall Study|Death|0|||
163230619|NCT01126541|589556020|FG001|Overall Study|Death|1|||
163230620|NCT01126541|589556021|FG002|Overall Study|Death|0|||
163230621|NCT01126541|589556019|FG000|Overall Study|Lack of Efficacy|6|||
163230622|NCT01126541|589556020|FG001|Overall Study|Lack of Efficacy|1|||
163230623|NCT01126541|589556021|FG002|Overall Study|Lack of Efficacy|11|||
163230624|NCT01126541|589556019|FG000|Overall Study|Lost to Follow-up|1|||
163230625|NCT01126541|589556020|FG001|Overall Study|Lost to Follow-up|2|||
163230626|NCT01126541|589556021|FG002|Overall Study|Lost to Follow-up|2|||
163230627|NCT01126541|589556019|FG000|Overall Study|Withdrawal by Subject|2|||
163230628|NCT01126541|589556020|FG001|Overall Study|Withdrawal by Subject|5|||
163230629|NCT01126541|589556021|FG002|Overall Study|Withdrawal by Subject|6|||
163230630|NCT01126541|589556019|FG000|Overall Study|Protocol Violation|0|||
163230631|NCT01126541|589556020|FG001|Overall Study|Protocol Violation|0|||
163346245|NCT03809039|589976362|FG000|Part 3|Withdrawn by study termination|0|||
163230632|NCT01126541|589556021|FG002|Overall Study|Protocol Violation|1|||
163230633|NCT01126541|589556019|FG000|Overall Study|Administrative reason or other|1|||
163230634|NCT01126541|589556020|FG001|Overall Study|Administrative reason or other|1|||
163230635|NCT01126541|589556021|FG002|Overall Study|Administrative reason or other|2|||
163230636|NCT02664038|589556025|FG000|13 Week|Lost to Follow-up|7|||
163230637|NCT02664038|589556026|FG001|13 Week|Lost to Follow-up|14|||
163230638|NCT02664038|589556025|FG000|13 Week|Withdrawal by Subject|1|||
163346246|NCT03809039|589976363|FG001|Part 3|Withdrawn by study termination|0|||
163346247|NCT03809039|589976364|FG002|Part 3|Withdrawn by study termination|0|||
163138515|NCT00186901|589215141|FG002|Overall Study|ALL relapse or second malignancy|0|||
163138516|NCT00186901|589215139|FG000|Overall Study|Withdrawal by Subject|4|||
163138517|NCT00186901|589215140|FG001|Overall Study|Withdrawal by Subject|5|||
163138518|NCT00186901|589215141|FG002|Overall Study|Withdrawal by Subject|0|||
163138519|NCT00186901|589215139|FG000|Overall Study|Open label|3|||
163138520|NCT00186901|589215140|FG001|Overall Study|Open label|2|||
163138521|NCT00186901|589215141|FG002|Overall Study|Open label|0|||
163138522|NCT00186901|589215139|FG000|Overall Study|Limited adherence to study requirements|20|||
163138523|NCT00186901|589215140|FG001|Overall Study|Limited adherence to study requirements|23|||
163138524|NCT00186901|589215141|FG002|Overall Study|Limited adherence to study requirements|0|||
163138525|NCT00186901|589215139|FG000|Overall Study|Bone Mineral Density > 0|0|||
163138526|NCT00186901|589215140|FG001|Overall Study|Bone Mineral Density > 0|0|||
163138527|NCT00186901|589215141|FG002|Overall Study|Bone Mineral Density > 0|149|||
163138528|NCT00782483|589215147|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
163138529|NCT01052077|589215148|FG000|Phase A|Lost to Follow-up|22|||
163138530|NCT01052077|589215149|FG001|Phase A|Lost to Follow-up|0|||
163138531|NCT01052077|589215150|FG002|Phase A|Lost to Follow-up|0|||
163138532|NCT01052077|589215151|FG003|Phase A|Lost to Follow-up|0|||
163138533|NCT01052077|589215148|FG000|Phase A|Adverse Event|32|||
163138534|NCT01052077|589215149|FG001|Phase A|Adverse Event|0|||
163138535|NCT01052077|589215150|FG002|Phase A|Adverse Event|0|||
163138536|NCT01052077|589215151|FG003|Phase A|Adverse Event|0|||
163138537|NCT01052077|589215148|FG000|Phase A|Met Withdrawal Criteria|26|||
163138538|NCT01052077|589215149|FG001|Phase A|Met Withdrawal Criteria|0|||
163138539|NCT01052077|589215150|FG002|Phase A|Met Withdrawal Criteria|0|||
163138540|NCT01052077|589215151|FG003|Phase A|Met Withdrawal Criteria|0|||
163138541|NCT01052077|589215148|FG000|Phase A|Physician Decision|10|||
163138542|NCT01052077|589215149|FG001|Phase A|Physician Decision|0|||
163138543|NCT01052077|589215150|FG002|Phase A|Physician Decision|0|||
163138544|NCT01052077|589215151|FG003|Phase A|Physician Decision|0|||
163138545|NCT01052077|589215148|FG000|Phase A|Withdrawal by Subject|29|||
163138546|NCT01052077|589215149|FG001|Phase A|Withdrawal by Subject|0|||
163138547|NCT01052077|589215150|FG002|Phase A|Withdrawal by Subject|0|||
163138548|NCT01052077|589215151|FG003|Phase A|Withdrawal by Subject|0|||
163138549|NCT01052077|589215148|FG000|Phase A|Protocol Deviation|27|||
163138550|NCT01052077|589215149|FG001|Phase A|Protocol Deviation|0|||
163138551|NCT01052077|589215150|FG002|Phase A|Protocol Deviation|0|||
163138552|NCT01052077|589215151|FG003|Phase A|Protocol Deviation|0|||
163138553|NCT01052077|589215148|FG000|Phase B|Lost to Follow-up|0|||
163138554|NCT01052077|589215149|FG001|Phase B|Lost to Follow-up|2|||
163138555|NCT01052077|589215150|FG002|Phase B|Lost to Follow-up|3|||
163138556|NCT01052077|589215151|FG003|Phase B|Lost to Follow-up|0|||
163138557|NCT01052077|589215148|FG000|Phase B|Adverse Event|0|||
163138558|NCT01052077|589215149|FG001|Phase B|Adverse Event|9|||
163138559|NCT01052077|589215150|FG002|Phase B|Adverse Event|2|||
163138560|NCT01052077|589215151|FG003|Phase B|Adverse Event|0|||
163138561|NCT01052077|589215148|FG000|Phase B|Met Withdrawal Criteria|0|||
163138562|NCT01052077|589215149|FG001|Phase B|Met Withdrawal Criteria|2|||
163138563|NCT01052077|589215150|FG002|Phase B|Met Withdrawal Criteria|1|||
163138564|NCT01052077|589215151|FG003|Phase B|Met Withdrawal Criteria|0|||
163138565|NCT01052077|589215148|FG000|Phase B|Physician Decision|0|||
163138566|NCT01052077|589215149|FG001|Phase B|Physician Decision|1|||
163138567|NCT01052077|589215150|FG002|Phase B|Physician Decision|1|||
163138568|NCT01052077|589215151|FG003|Phase B|Physician Decision|0|||
163138569|NCT01052077|589215148|FG000|Phase B|Withdrawal by Subject|0|||
163138570|NCT01052077|589215149|FG001|Phase B|Withdrawal by Subject|0|||
163138571|NCT01052077|589215150|FG002|Phase B|Withdrawal by Subject|5|||
163138572|NCT01052077|589215151|FG003|Phase B|Withdrawal by Subject|0|||
163138573|NCT01052077|589215148|FG000|Phase B|Protocol Deviation|0|||
163138574|NCT01052077|589215149|FG001|Phase B|Protocol Deviation|3|||
163138575|NCT01052077|589215150|FG002|Phase B|Protocol Deviation|4|||
163138576|NCT01052077|589215151|FG003|Phase B|Protocol Deviation|0|||
163138577|NCT01052077|589215148|FG000|Phase B|Lack of Efficacy|0|||
163138578|NCT01052077|589215149|FG001|Phase B|Lack of Efficacy|1|||
163346248|NCT03809039|589976365|FG003|Part 3|Withdrawn by study termination|0|||
163346249|NCT03809039|589976366|FG004|Part 3|Withdrawn by study termination|0|||
163138579|NCT01052077|589215150|FG002|Phase B|Lack of Efficacy|0|||
163138580|NCT01052077|589215151|FG003|Phase B|Lack of Efficacy|0|||
163138581|NCT01052077|589215148|FG000|Phase A+|Lost to Follow-up|0|||
163138582|NCT01052077|589215149|FG001|Phase A+|Lost to Follow-up|0|||
163138583|NCT01052077|589215150|FG002|Phase A+|Lost to Follow-up|0|||
163138584|NCT01052077|589215151|FG003|Phase A+|Lost to Follow-up|8|||
163138585|NCT01052077|589215148|FG000|Phase A+|Adverse Event|0|||
163138586|NCT01052077|589215149|FG001|Phase A+|Adverse Event|0|||
163138587|NCT01052077|589215150|FG002|Phase A+|Adverse Event|0|||
163138588|NCT01052077|589215151|FG003|Phase A+|Adverse Event|4|||
163138589|NCT01052077|589215148|FG000|Phase A+|Met Withdrawal Criteria|0|||
163138590|NCT01052077|589215149|FG001|Phase A+|Met Withdrawal Criteria|0|||
163138591|NCT01052077|589215150|FG002|Phase A+|Met Withdrawal Criteria|0|||
163408887|NCT02164981|590207420|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
163408888|NCT02164981|590207421|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
163408889|NCT02164981|590207422|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
163408890|NCT02164981|590207420|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
163408891|NCT02164981|590207421|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
163408892|NCT02164981|590207422|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
163408893|NCT02164981|590207420|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
163408894|NCT02164981|590207421|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
163408895|NCT02164981|590207422|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
163408896|NCT01761266|590207428|FG000|Overall Study|Death|415|||
163408897|NCT01761266|590207429|FG001|Overall Study|Death|402|||
163408898|NCT01761266|590207428|FG000|Overall Study|Lost to Follow-up|8|||
163408899|NCT01761266|590207429|FG001|Overall Study|Lost to Follow-up|12|||
163408900|NCT01761266|590207428|FG000|Overall Study|Withdrawal by Subject|14|||
163408901|NCT01761266|590207429|FG001|Overall Study|Withdrawal by Subject|10|||
163408902|NCT01761266|590207428|FG000|Overall Study|Sponsor Decision|41|||
163408903|NCT01761266|590207429|FG001|Overall Study|Sponsor Decision|52|||
163408904|NCT01662440|590207430|FG000|Overall Study|Adverse Event|1|||
163408905|NCT01662440|590207431|FG001|Overall Study|Adverse Event|0|||
163408906|NCT01662440|590207432|FG002|Overall Study|Adverse Event|0|||
163408907|NCT01662440|590207433|FG003|Overall Study|Adverse Event|1|||
163408908|NCT01662440|590207430|FG000|Overall Study|Death|0|||
163408909|NCT01662440|590207431|FG001|Overall Study|Death|1|||
163408910|NCT01662440|590207432|FG002|Overall Study|Death|0|||
163408911|NCT01662440|590207433|FG003|Overall Study|Death|0|||
163408912|NCT01662440|590207430|FG000|Overall Study|Lost to Follow-up|2|||
163408913|NCT01662440|590207431|FG001|Overall Study|Lost to Follow-up|2|||
163408914|NCT01662440|590207432|FG002|Overall Study|Lost to Follow-up|4|||
163408915|NCT01662440|590207433|FG003|Overall Study|Lost to Follow-up|1|||
163408916|NCT01662440|590207430|FG000|Overall Study|Subject moved to another country.|0|||
163408917|NCT01662440|590207431|FG001|Overall Study|Subject moved to another country.|1|||
163408918|NCT01662440|590207432|FG002|Overall Study|Subject moved to another country.|0|||
163408919|NCT01662440|590207433|FG003|Overall Study|Subject moved to another country.|0|||
163408920|NCT01662440|590207430|FG000|Overall Study|Protocol Violation|1|||
163408921|NCT01662440|590207431|FG001|Overall Study|Protocol Violation|0|||
163408922|NCT01662440|590207432|FG002|Overall Study|Protocol Violation|0|||
163408923|NCT01662440|590207433|FG003|Overall Study|Protocol Violation|0|||
163408924|NCT01662440|590207430|FG000|Overall Study|Withdrawal by Subject|5|||
163408925|NCT01662440|590207431|FG001|Overall Study|Withdrawal by Subject|2|||
163408926|NCT01662440|590207432|FG002|Overall Study|Withdrawal by Subject|2|||
163408927|NCT01662440|590207433|FG003|Overall Study|Withdrawal by Subject|2|||
163408928|NCT00112905|590207434|FG000|Overall Study|Adverse Event|4|||
163408929|NCT00112905|590207434|FG000|Overall Study|Death|1|||
163408930|NCT00112905|590207434|FG000|Overall Study|Ineligibility|5|||
163408931|NCT00112905|590207434|FG000|Overall Study|Alternative treatment|1|||
163408932|NCT00112905|590207434|FG000|Overall Study|performance status was deteiorating|1|||
163408933|NCT01765673|590207435|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
163408934|NCT03257267|590207440|FG000|Overall Study|Adverse Event|17|||
163408935|NCT03257267|590207441|FG001|Overall Study|Adverse Event|7|||
163408936|NCT03257267|590207440|FG000|Overall Study|Death|96|||
163408937|NCT03257267|590207441|FG001|Overall Study|Death|98|||
163408938|NCT03257267|590207440|FG000|Overall Study|Lost to Follow-up|2|||
163408939|NCT03257267|590207441|FG001|Overall Study|Lost to Follow-up|2|||
163408940|NCT03257267|590207440|FG000|Overall Study|Non-compliance with Study Drug|0|||
163408941|NCT03257267|590207441|FG001|Overall Study|Non-compliance with Study Drug|2|||
163408942|NCT03257267|590207440|FG000|Overall Study|Participant Decision|35|||
163408943|NCT03257267|590207441|FG001|Overall Study|Participant Decision|43|||
163408944|NCT03257267|590207440|FG000|Overall Study|Sponsor Decision|1|||
163408945|NCT03257267|590207441|FG001|Overall Study|Sponsor Decision|0|||
163408946|NCT03257267|590207440|FG000|Overall Study|Physician Decision|1|||
163408947|NCT03257267|590207441|FG001|Overall Study|Physician Decision|3|||
163408948|NCT03257267|590207440|FG000|Overall Study|Disease Progression|109|||
163138592|NCT01052077|589215151|FG003|Phase A+|Met Withdrawal Criteria|2|||
163138593|NCT01052077|589215148|FG000|Phase A+|Withdrawal by Subject|0|||
163138594|NCT01052077|589215149|FG001|Phase A+|Withdrawal by Subject|0|||
163138595|NCT01052077|589215150|FG002|Phase A+|Withdrawal by Subject|0|||
163138596|NCT01052077|589215151|FG003|Phase A+|Withdrawal by Subject|7|||
163138597|NCT00003199|589215159|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
163138598|NCT00003199|589215159|FG000|Overall Study|Lack of insurance clearance|2|||
163138599|NCT00003199|589215159|FG000|Overall Study|Screen fail|15|||
163138600|NCT02487030|589215160|FG000|Overall Study|Lack of Efficacy|2|||
163138601|NCT02487030|589215161|FG001|Overall Study|Lack of Efficacy|4|||
163138602|NCT02487030|589215162|FG002|Overall Study|Lack of Efficacy|1|||
163138603|NCT02487030|589215163|FG003|Overall Study|Lack of Efficacy|0|||
163138604|NCT02487030|589215164|FG004|Overall Study|Lack of Efficacy|1|||
163138605|NCT02487030|589215165|FG005|Overall Study|Lack of Efficacy|0|||
163138606|NCT02487030|589215166|FG006|Overall Study|Lack of Efficacy|0|||
163408949|NCT03257267|590207441|FG001|Overall Study|Disease Progression|121|||
163408950|NCT03257267|590207440|FG000|Overall Study|Withdrawal by Subject|8|||
163230639|NCT02664038|589556026|FG001|13 Week|Withdrawal by Subject|0|||
163230640|NCT02664038|589556025|FG000|26 Week|Lost to Follow-up|5|||
163230641|NCT02664038|589556026|FG001|26 Week|Lost to Follow-up|4|||
163230642|NCT06640829|589556033|FG000|Overall Study|Withdrawal by Subject|1|||
163230643|NCT06640829|589556033|FG000|Overall Study|Lost to Follow-up|1|||
163230644|NCT00673452|589556038|FG000|Acute Double-Blind Phase|Adverse Event|41|||
163230645|NCT00673452|589556039|FG001|Acute Double-Blind Phase|Adverse Event|24|||
163230646|NCT00673452|589556038|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
163230647|NCT00673452|589556039|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
163230648|NCT00673452|589556038|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
163346250|NCT03809039|589976367|FG005|Part 3|Withdrawn by study termination|0|||
163346251|NCT03809039|589976368|FG006|Part 3|Withdrawn by study termination|0|||
163346252|NCT03809039|589976369|FG007|Part 3|Withdrawn by study termination|2|||
163346253|NCT03809039|589976370|FG008|Part 3|Withdrawn by study termination|6|||
163346254|NCT03451292|589976371|FG000|Overall Study|Death|44|||
163346255|NCT03451292|589976372|FG001|Overall Study|Death|59|||
163230649|NCT00673452|589556039|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
163230650|NCT00673452|589556038|FG000|Acute Double-Blind Phase|Physician Decision|0|||
163230651|NCT00673452|589556039|FG001|Acute Double-Blind Phase|Physician Decision|6|||
163230652|NCT00673452|589556038|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
163230653|NCT00673452|589556039|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
163230654|NCT00673452|589556038|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
163230655|NCT00673452|589556039|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
163230656|NCT00673452|589556038|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
163230657|NCT00673452|589556039|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
163230658|NCT00673452|589556038|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
163230659|NCT00673452|589556039|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
163230660|NCT00673452|589556038|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
163230661|NCT00673452|589556039|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
163230662|NCT00673452|589556038|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
163230663|NCT00673452|589556039|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
163230664|NCT00673452|589556038|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
163230665|NCT00673452|589556039|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
163230666|NCT00673452|589556038|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
163230667|NCT00673452|589556039|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
163230668|NCT00673452|589556038|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
163230669|NCT00673452|589556039|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
163230670|NCT00673452|589556038|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
163230671|NCT00673452|589556039|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
163230672|NCT00673452|589556038|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
163230673|NCT00673452|589556039|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
163230674|NCT03025828|589556040|FG000|Overall Study|Lost to Follow-up|1|||
163230675|NCT02519712|589556043|FG000|Overall Study|Disease Relapse|1|||
163230676|NCT02519712|589556043|FG000|Overall Study|Disease Progression|1|||
163230677|NCT02519712|589556043|FG000|Overall Study|Accruals are donors|2|||
163230678|NCT02908529|589556054|FG000|Overall Study|Lost to Follow-up|0|||
163230679|NCT02908529|589556055|FG001|Overall Study|Lost to Follow-up|2|||
163230680|NCT04497987|589556056|FG000|Overall Study|Adverse Event|1|||
163230681|NCT04497987|589556057|FG001|Overall Study|Adverse Event|0|||
163230682|NCT04497987|589556056|FG000|Overall Study|Death|21|||
163346256|NCT03451292|589976371|FG000|Overall Study|Withdrawal by Subject|18|||
163346257|NCT03451292|589976372|FG001|Overall Study|Withdrawal by Subject|13|||
163346258|NCT03451292|589976371|FG000|Overall Study|Transplantation|18|||
163346259|NCT03451292|589976372|FG001|Overall Study|Transplantation|12|||
163346260|NCT03451292|589976371|FG000|Overall Study|Lost to Follow-up|4|||
163346261|NCT03451292|589976372|FG001|Overall Study|Lost to Follow-up|12|||
163346262|NCT03451292|589976371|FG000|Overall Study|Physician Decision|4|||
163346263|NCT03451292|589976372|FG001|Overall Study|Physician Decision|3|||
163346264|NCT03451292|589976371|FG000|Overall Study|Adverse Event|3|||
163346265|NCT03451292|589976372|FG001|Overall Study|Adverse Event|3|||
163408951|NCT03257267|590207441|FG001|Overall Study|Withdrawal by Subject|26|||
163346266|NCT03451292|589976371|FG000|Overall Study|Non-compliance with Study Drug|2|||
163408952|NCT03257267|590207440|FG000|Overall Study|Other|0|||
163230683|NCT04497987|589556057|FG001|Overall Study|Death|13|||
163230684|NCT04497987|589556056|FG000|Overall Study|Lost to Follow-up|19|||
163230685|NCT04497987|589556057|FG001|Overall Study|Lost to Follow-up|17|||
163230686|NCT04497987|589556056|FG000|Overall Study|Other - as reported by the investigator|22|||
163230687|NCT04497987|589556057|FG001|Overall Study|Other - as reported by the investigator|16|||
163346267|NCT03451292|589976372|FG001|Overall Study|Non-compliance with Study Drug|0|||
163346268|NCT05271552|589976373|FG000|Overall Study|Adverse Event|4|||
163346269|NCT05271552|589976374|FG001|Overall Study|Adverse Event|6|||
163408953|NCT03257267|590207441|FG001|Overall Study|Other|2|||
163230688|NCT04497987|589556056|FG000|Overall Study|Physician Decision|1|||
163346270|NCT05271552|589976375|FG002|Overall Study|Adverse Event|3|||
163346271|NCT05271552|589976373|FG000|Overall Study|Death|1|||
163346272|NCT05271552|589976374|FG001|Overall Study|Death|1|||
163346273|NCT05271552|589976375|FG002|Overall Study|Death|1|||
163346274|NCT05271552|589976373|FG000|Overall Study|Lost to Follow-up|1|||
163346275|NCT05271552|589976374|FG001|Overall Study|Lost to Follow-up|5|||
163138607|NCT02487030|589215160|FG000|Overall Study|Lost to Follow-up|0|||
163138608|NCT02487030|589215161|FG001|Overall Study|Lost to Follow-up|0|||
163138609|NCT02487030|589215162|FG002|Overall Study|Lost to Follow-up|1|||
163138610|NCT02487030|589215163|FG003|Overall Study|Lost to Follow-up|1|||
163138611|NCT02487030|589215164|FG004|Overall Study|Lost to Follow-up|0|||
163138612|NCT02487030|589215165|FG005|Overall Study|Lost to Follow-up|1|||
163138613|NCT02487030|589215166|FG006|Overall Study|Lost to Follow-up|0|||
163138614|NCT02487030|589215160|FG000|Overall Study|Adverse Event|0|||
163138615|NCT02487030|589215161|FG001|Overall Study|Adverse Event|0|||
163138616|NCT02487030|589215162|FG002|Overall Study|Adverse Event|0|||
163138617|NCT02487030|589215163|FG003|Overall Study|Adverse Event|1|||
163138618|NCT02487030|589215164|FG004|Overall Study|Adverse Event|0|||
163138619|NCT02487030|589215165|FG005|Overall Study|Adverse Event|0|||
163138620|NCT02487030|589215166|FG006|Overall Study|Adverse Event|0|||
163138621|NCT02487030|589215160|FG000|Overall Study|Death|0|||
163138622|NCT02487030|589215161|FG001|Overall Study|Death|0|||
163138623|NCT02487030|589215162|FG002|Overall Study|Death|0|||
163138624|NCT02487030|589215163|FG003|Overall Study|Death|0|||
163138625|NCT02487030|589215164|FG004|Overall Study|Death|1|||
163138626|NCT02487030|589215165|FG005|Overall Study|Death|0|||
163138627|NCT02487030|589215166|FG006|Overall Study|Death|0|||
163138628|NCT03857542|589215167|FG000|Overall Study|Adverse Event|1|||
163138629|NCT03857542|589215168|FG001|Overall Study|Adverse Event|3|||
163138630|NCT03857542|589215167|FG000|Overall Study|Withdrawal by Subject|2|||
163138631|NCT03857542|589215168|FG001|Overall Study|Withdrawal by Subject|1|||
163138632|NCT03857542|589215167|FG000|Overall Study|Lost to Follow-up|2|||
163138633|NCT03857542|589215168|FG001|Overall Study|Lost to Follow-up|1|||
163138634|NCT03857542|589215167|FG000|Overall Study|Reason not Specified|1|||
163138635|NCT03857542|589215168|FG001|Overall Study|Reason not Specified|0|||
163138636|NCT00900029|589215169|FG000|Overall Study|Lost to Follow-up|0|||
163138637|NCT00900029|589215170|FG001|Overall Study|Lost to Follow-up|2|||
163138638|NCT00900029|589215171|FG002|Overall Study|Lost to Follow-up|1|||
163138639|NCT00900029|589215172|FG003|Overall Study|Lost to Follow-up|4|||
163138640|NCT00900029|589215173|FG004|Overall Study|Lost to Follow-up|4|||
163138641|NCT00900029|589215169|FG000|Overall Study|Withdrawal by Subject|2|||
163138642|NCT00900029|589215170|FG001|Overall Study|Withdrawal by Subject|2|||
163138643|NCT00900029|589215171|FG002|Overall Study|Withdrawal by Subject|1|||
163138644|NCT00900029|589215172|FG003|Overall Study|Withdrawal by Subject|1|||
163138645|NCT00900029|589215173|FG004|Overall Study|Withdrawal by Subject|1|||
163138646|NCT00900029|589215169|FG000|Overall Study|Adverse Event|0|||
163138647|NCT00900029|589215170|FG001|Overall Study|Adverse Event|0|||
163138648|NCT00900029|589215171|FG002|Overall Study|Adverse Event|1|||
163138649|NCT00900029|589215172|FG003|Overall Study|Adverse Event|1|||
163138650|NCT00900029|589215173|FG004|Overall Study|Adverse Event|1|||
163138651|NCT00900029|589215169|FG000|Overall Study|Death|1|||
163138652|NCT00900029|589215170|FG001|Overall Study|Death|0|||
163138653|NCT00900029|589215171|FG002|Overall Study|Death|0|||
163138654|NCT00900029|589215172|FG003|Overall Study|Death|1|||
163138655|NCT00900029|589215173|FG004|Overall Study|Death|0|||
163138656|NCT02709330|589215175|FG000|Overall Study|Death|5|||
163138657|NCT02709330|589215176|FG001|Overall Study|Death|0|||
163138658|NCT02709330|589215175|FG000|Overall Study|Lost to Follow-up|2|||
163138659|NCT02709330|589215176|FG001|Overall Study|Lost to Follow-up|0|||
163138660|NCT02709330|589215175|FG000|Overall Study|Physician Decision|2|||
163138661|NCT02709330|589215176|FG001|Overall Study|Physician Decision|0|||
163138662|NCT02709330|589215175|FG000|Overall Study|Withdrawal by Subject|4|||
163138663|NCT02709330|589215176|FG001|Overall Study|Withdrawal by Subject|0|||
163138664|NCT02587819|589215179|FG000|Overall Study|Adverse Event|1|||
163138665|NCT02587819|589215179|FG000|Overall Study|Lost to Follow-up|1|||
163138666|NCT00859547|589217781|FG000|Overall Study|Lost to Follow-up|1|||
163138667|NCT00859547|589217781|FG000|Overall Study|Parent withdrew consent|1|||
163138668|NCT00786799|589217782|FG000|Overall Study|Lost to Follow-up|1|||
163230689|NCT04497987|589556057|FG001|Overall Study|Physician Decision|0|||
163230690|NCT04497987|589556056|FG000|Overall Study|Withdrawal by Subject|35|||
163346276|NCT05271552|589976375|FG002|Overall Study|Lost to Follow-up|4|||
163138669|NCT00786799|589217783|FG001|Overall Study|Lost to Follow-up|1|||
163138670|NCT02544503|589217784|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
163138671|NCT02544503|589217785|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
163138672|NCT02544503|589217784|FG000|Overall Study|Lost to Follow-up|9|||
163138673|NCT02544503|589217785|FG001|Overall Study|Lost to Follow-up|0|||
163138674|NCT02544503|589217784|FG000|Overall Study|Withdrawal by Subject|1|||
163138675|NCT02544503|589217785|FG001|Overall Study|Withdrawal by Subject|0|||
163138676|NCT04640311|589217786|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
163138677|NCT04640311|589217787|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163230691|NCT04497987|589556057|FG001|Overall Study|Withdrawal by Subject|21|||
163230692|NCT04579679|589556065|FG000|Overall Study|New Antitumor Therapy|6|||
163230693|NCT04579679|589556066|FG001|Overall Study|New Antitumor Therapy|4|||
163230694|NCT04579679|589556067|FG002|Overall Study|New Antitumor Therapy|7|||
163230695|NCT04579679|589556068|FG003|Overall Study|New Antitumor Therapy|0|||
163230696|NCT04579679|589556065|FG000|Overall Study|Withdrawal of Consent|1|||
163230697|NCT04579679|589556066|FG001|Overall Study|Withdrawal of Consent|1|||
163230698|NCT04579679|589556067|FG002|Overall Study|Withdrawal of Consent|2|||
163230699|NCT04579679|589556068|FG003|Overall Study|Withdrawal of Consent|4|||
163230700|NCT04579679|589556065|FG000|Overall Study|Death|2|||
163230701|NCT04579679|589556066|FG001|Overall Study|Death|2|||
163230702|NCT04579679|589556067|FG002|Overall Study|Death|2|||
163230703|NCT04579679|589556068|FG003|Overall Study|Death|0|||
163230704|NCT04579679|589556065|FG000|Overall Study|Adverse Event|0|||
163230705|NCT04579679|589556066|FG001|Overall Study|Adverse Event|4|||
163230706|NCT04579679|589556067|FG002|Overall Study|Adverse Event|0|||
163230707|NCT04579679|589556068|FG003|Overall Study|Adverse Event|0|||
163230708|NCT04579679|589556065|FG000|Overall Study|Disease Progression|9|||
163230709|NCT04579679|589556066|FG001|Overall Study|Disease Progression|13|||
163230710|NCT04579679|589556067|FG002|Overall Study|Disease Progression|7|||
163230711|NCT04579679|589556068|FG003|Overall Study|Disease Progression|0|||
163230712|NCT04579679|589556065|FG000|Overall Study|Physician Decision|0|||
163230713|NCT04579679|589556066|FG001|Overall Study|Physician Decision|0|||
163230714|NCT04579679|589556067|FG002|Overall Study|Physician Decision|1|||
163230715|NCT04579679|589556068|FG003|Overall Study|Physician Decision|0|||
163230716|NCT04579679|589556065|FG000|Overall Study|Study Terminated by Sponsor|2|||
163230717|NCT04579679|589556066|FG001|Overall Study|Study Terminated by Sponsor|7|||
163230718|NCT04579679|589556067|FG002|Overall Study|Study Terminated by Sponsor|1|||
163230719|NCT04579679|589556068|FG003|Overall Study|Study Terminated by Sponsor|0|||
163230720|NCT06023394|589556072|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
163230721|NCT06023394|589556073|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
163230722|NCT06023394|589556072|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
163230723|NCT06023394|589556073|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
163230724|NCT06023394|589556072|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
163230725|NCT06023394|589556073|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
163230726|NCT06023394|589556072|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
163230727|NCT06023394|589556073|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
163230728|NCT02556710|589558128|FG000|Overall Study|Surgical treatment|3|||
163230729|NCT02556710|589558129|FG001|Overall Study|Surgical treatment|0|||
163230730|NCT02556710|589558128|FG000|Overall Study|Required proscribed pain medication|2|||
163230731|NCT02556710|589558129|FG001|Overall Study|Required proscribed pain medication|1|||
163230732|NCT02556710|589558128|FG000|Overall Study|Lack of Efficacy|1|||
163230733|NCT02556710|589558129|FG001|Overall Study|Lack of Efficacy|0|||
163230734|NCT02556710|589558128|FG000|Overall Study|Worsening osteoarthritis|1|||
163230735|NCT02556710|589558129|FG001|Overall Study|Worsening osteoarthritis|0|||
163230736|NCT02556710|589558128|FG000|Overall Study|Moved out of state|1|||
163230737|NCT02556710|589558129|FG001|Overall Study|Moved out of state|0|||
163230738|NCT02556710|589558128|FG000|Overall Study|Missing reason|3|||
163230739|NCT02556710|589558129|FG001|Overall Study|Missing reason|1|||
163230740|NCT02556710|589558128|FG000|Overall Study|Pain as lack of efficacy|0|||
163230741|NCT02556710|589558129|FG001|Overall Study|Pain as lack of efficacy|4|||
163230742|NCT00630877|589558132|FG000|Overall Study|Adverse Event|11|||
163230743|NCT00630877|589558133|FG001|Overall Study|Adverse Event|8|||
163230744|NCT00630877|589558134|FG002|Overall Study|Adverse Event|7|||
163230745|NCT00630877|589558132|FG000|Overall Study|Withdrawal by Subject|3|||
163230746|NCT00630877|589558133|FG001|Overall Study|Withdrawal by Subject|4|||
163230747|NCT00630877|589558134|FG002|Overall Study|Withdrawal by Subject|0|||
163230748|NCT00630877|589558132|FG000|Overall Study|Lost to Follow-up|2|||
163230749|NCT00630877|589558133|FG001|Overall Study|Lost to Follow-up|0|||
163230750|NCT00630877|589558134|FG002|Overall Study|Lost to Follow-up|0|||
163230751|NCT00630877|589558132|FG000|Overall Study|Noncompliance|2|||
163230752|NCT00630877|589558133|FG001|Overall Study|Noncompliance|3|||
163230753|NCT00630877|589558134|FG002|Overall Study|Noncompliance|1|||
163230754|NCT00630877|589558132|FG000|Overall Study|Protocol violation|1|||
163230755|NCT00630877|589558133|FG001|Overall Study|Protocol violation|0|||
163230756|NCT00630877|589558134|FG002|Overall Study|Protocol violation|1|||
163230757|NCT00630877|589558132|FG000|Overall Study|Personal reasons|0|||
163230758|NCT00630877|589558133|FG001|Overall Study|Personal reasons|0|||
163230759|NCT00630877|589558134|FG002|Overall Study|Personal reasons|1|||
163230760|NCT02453594|589558138|FG000|Overall Study|Protocol Violation|0|||
163230761|NCT02453594|589558139|FG001|Overall Study|Protocol Violation|0|||
163230762|NCT02453594|589558140|FG002|Overall Study|Protocol Violation|1|||
163230763|NCT02453594|589558138|FG000|Overall Study|Cohort Was Closed|17|||
163230764|NCT02453594|589558139|FG001|Overall Study|Cohort Was Closed|21|||
163230765|NCT02453594|589558140|FG002|Overall Study|Cohort Was Closed|14|||
163230766|NCT02453594|589558138|FG000|Overall Study|Death|20|||
163230767|NCT02453594|589558139|FG001|Overall Study|Death|24|||
163346277|NCT05271552|589976373|FG000|Overall Study|Withdrawal by Subject|0|||
163346278|NCT05271552|589976374|FG001|Overall Study|Withdrawal by Subject|4|||
163346279|NCT05271552|589976375|FG002|Overall Study|Withdrawal by Subject|7|||
163346280|NCT05271552|589976373|FG000|Overall Study|Other medical reason.|1|||
163346281|NCT05271552|589976374|FG001|Overall Study|Other medical reason.|2|||
163346282|NCT05271552|589976375|FG002|Overall Study|Other medical reason.|0|||
163346283|NCT05271552|589976373|FG000|Overall Study|Other|3|||
163346284|NCT05271552|589976374|FG001|Overall Study|Other|3|||
163346285|NCT05271552|589976375|FG002|Overall Study|Other|6|||
163346286|NCT03840993|589976381|FG000|Overall Study|Adverse Event|1|||
163346287|NCT03840993|589976382|FG001|Overall Study|Adverse Event|0|||
163346288|NCT03840993|589976381|FG000|Overall Study|Lost to Follow-up|4|||
163346289|NCT03840993|589976382|FG001|Overall Study|Lost to Follow-up|0|||
163138678|NCT04640311|589217788|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138679|NCT04640311|589217789|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138680|NCT04640311|589217790|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138681|NCT04640311|589217791|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138682|NCT04640311|589217792|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138683|NCT04640311|589217793|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138684|NCT04640311|589217794|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138685|NCT04640311|589217795|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138686|NCT04640311|589217796|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138687|NCT04640311|589217797|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138688|NCT04640311|589217798|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138689|NCT04640311|589217786|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138690|NCT04640311|589217787|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
163138691|NCT04640311|589217788|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138692|NCT04640311|589217789|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138693|NCT04640311|589217790|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138694|NCT04640311|589217791|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138695|NCT04640311|589217792|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138696|NCT04640311|589217793|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138697|NCT04640311|589217794|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138698|NCT04640311|589217795|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138699|NCT04640311|589217796|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138700|NCT04640311|589217797|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138701|NCT04640311|589217798|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138702|NCT04640311|589217786|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138703|NCT04640311|589217787|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
163138704|NCT04640311|589217788|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138705|NCT04640311|589217789|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138706|NCT04640311|589217790|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138707|NCT04640311|589217791|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138708|NCT04640311|589217792|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138709|NCT04640311|589217793|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138710|NCT04640311|589217794|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138711|NCT04640311|589217795|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138712|NCT04640311|589217796|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138713|NCT04640311|589217797|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138714|NCT04640311|589217798|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138715|NCT04640311|589217786|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
163138716|NCT04640311|589217787|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
163138717|NCT04640311|589217788|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
163138718|NCT04640311|589217789|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138719|NCT04640311|589217790|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163230768|NCT02453594|589558140|FG002|Overall Study|Death|16|||
163346290|NCT03840993|589976381|FG000|Overall Study|Physician Decision|0|||
163346291|NCT03840993|589976382|FG001|Overall Study|Physician Decision|1|||
163346292|NCT03840993|589976381|FG000|Overall Study|Pregnancy|0|||
163346293|NCT03840993|589976382|FG001|Overall Study|Pregnancy|1|||
163408954|NCT03445000|590207442|FG000|Overall Study|Disease progression|8|||
163230769|NCT02453594|589558138|FG000|Overall Study|Lost to Follow-up|6|||
163230770|NCT02453594|589558139|FG001|Overall Study|Lost to Follow-up|14|||
163230771|NCT02453594|589558140|FG002|Overall Study|Lost to Follow-up|2|||
163230772|NCT02453594|589558138|FG000|Overall Study|Physician Decision|2|||
163230773|NCT02453594|589558139|FG001|Overall Study|Physician Decision|4|||
163230774|NCT02453594|589558140|FG002|Overall Study|Physician Decision|0|||
163230775|NCT02453594|589558138|FG000|Overall Study|Site Terminated by Sponsor|1|||
163230776|NCT02453594|589558139|FG001|Overall Study|Site Terminated by Sponsor|0|||
163230777|NCT02453594|589558140|FG002|Overall Study|Site Terminated by Sponsor|1|||
163230778|NCT02453594|589558138|FG000|Overall Study|Transitioned to Extension Study|16|||
163230779|NCT02453594|589558139|FG001|Overall Study|Transitioned to Extension Study|9|||
163230780|NCT02453594|589558140|FG002|Overall Study|Transitioned to Extension Study|16|||
163230781|NCT02453594|589558138|FG000|Overall Study|Withdrawal by Subject|7|||
163230782|NCT02453594|589558139|FG001|Overall Study|Withdrawal by Subject|9|||
163230783|NCT02453594|589558140|FG002|Overall Study|Withdrawal by Subject|11|||
163230784|NCT01694706|589558149|FG000|Overall Study|Adverse Event|0|||
163230785|NCT01694706|589558150|FG001|Overall Study|Adverse Event|1|||
163230786|NCT01694706|589558151|FG002|Overall Study|Adverse Event|0|||
163230787|NCT01694706|589558149|FG000|Overall Study|other reason not defined above|1|||
163230788|NCT01694706|589558150|FG001|Overall Study|other reason not defined above|0|||
163230789|NCT01694706|589558151|FG002|Overall Study|other reason not defined above|0|||
163230790|NCT00451282|589558152|FG000|Overall Study|Lost to Follow-up|6|||
163230791|NCT00451282|589558153|FG001|Overall Study|Lost to Follow-up|5|||
163230792|NCT01797536|589558154|FG000|Overall Study|Adverse Event|0|||
163230793|NCT01797536|589558155|FG001|Overall Study|Adverse Event|1|||
163230794|NCT01797536|589558156|FG002|Overall Study|Adverse Event|0|||
163230795|NCT01797536|589558157|FG003|Overall Study|Adverse Event|0|||
163230796|NCT00098839|589558158|FG000|Overall Study|Adverse Event|5|||
163230797|NCT00098839|589558159|FG001|Overall Study|Adverse Event|2|||
163230798|NCT00098839|589558158|FG000|Overall Study|Death|1|||
163230799|NCT00098839|589558159|FG001|Overall Study|Death|2|||
163230800|NCT00098839|589558158|FG000|Overall Study|Physician Decision|4|||
163230801|NCT00098839|589558159|FG001|Overall Study|Physician Decision|14|||
163230802|NCT00098839|589558158|FG000|Overall Study|Withdrawal by Subject|1|||
163230803|NCT00098839|589558159|FG001|Overall Study|Withdrawal by Subject|0|||
163230804|NCT00098839|589558158|FG000|Overall Study|Refusal of further protocol therapy|3|||
163230805|NCT00098839|589558159|FG001|Overall Study|Refusal of further protocol therapy|1|||
163230806|NCT00098839|589558158|FG000|Overall Study|Relapse|6|||
163230807|NCT00098839|589558159|FG001|Overall Study|Relapse|3|||
163230808|NCT00098839|589558158|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
163230809|NCT00098839|589558159|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
163230810|NCT00098839|589558158|FG000|Overall Study|Ineligible|2|||
163230811|NCT00098839|589558159|FG001|Overall Study|Ineligible|0|||
163230812|NCT00456092|589558160|FG000|Extension Phase|Grade 2 or Greater AE|2|||
163230813|NCT00456092|589558161|FG001|Extension Phase|Grade 2 or Greater AE|2|||
163230814|NCT00456092|589558162|FG002|Extension Phase|Grade 2 or Greater AE|0|||
163230815|NCT00456092|589558163|FG003|Extension Phase|Grade 2 or Greater AE|0|||
163230816|NCT00456092|589558164|FG004|Extension Phase|Grade 2 or Greater AE|2|||
163230817|NCT00456092|589558160|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
163230818|NCT00456092|589558161|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
163230819|NCT00456092|589558162|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
163230820|NCT00456092|589558163|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
163230821|NCT00456092|589558164|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
163230822|NCT00456092|589558160|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
163230823|NCT00456092|589558161|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
163230824|NCT00456092|589558162|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
163230825|NCT00456092|589558163|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
163230826|NCT00456092|589558164|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
163230827|NCT00456092|589558160|FG000|Extension Phase|Withdrew Consent|2|||
163230828|NCT00456092|589558161|FG001|Extension Phase|Withdrew Consent|0|||
163230829|NCT00456092|589558162|FG002|Extension Phase|Withdrew Consent|0|||
163230830|NCT00456092|589558163|FG003|Extension Phase|Withdrew Consent|0|||
163346294|NCT03840993|589976381|FG000|Overall Study|Withdrawal by Subject|1|||
163346295|NCT03840993|589976382|FG001|Overall Study|Withdrawal by Subject|3|||
163346296|NCT03840993|589976381|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
163346297|NCT03840993|589976382|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
163346298|NCT01090076|589976383|FG000|Overall Study|Death|1|||
163346299|NCT01090076|589976384|FG001|Overall Study|Death|1|||
163346300|NCT01090076|589976383|FG000|Overall Study|Withdrawal by Subject|0|||
163346301|NCT01090076|589976384|FG001|Overall Study|Withdrawal by Subject|1|||
163346302|NCT02176018|589976385|FG000|Overall Study|Adverse Event|0|||
163346303|NCT02176018|589976386|FG001|Overall Study|Adverse Event|2|||
163346304|NCT02176018|589976385|FG000|Overall Study|Lost to Follow-up|3|||
163346305|NCT02176018|589976386|FG001|Overall Study|Lost to Follow-up|1|||
163346306|NCT02176018|589976385|FG000|Overall Study|Protocol Violation|1|||
163346307|NCT02176018|589976386|FG001|Overall Study|Protocol Violation|1|||
163408955|NCT03445000|590207442|FG000|Overall Study|Adverse Event|3|||
163408956|NCT03445000|590207442|FG000|Overall Study|Death|2|||
163408957|NCT03445000|590207442|FG000|Overall Study|Physician Decision|1|||
163408958|NCT01982292|590207443|FG000|Overall Study|Adverse Event|2|||
163408959|NCT01982292|590207444|FG001|Overall Study|Adverse Event|0|||
163408960|NCT01982292|590207443|FG000|Overall Study|Death|1|||
163408961|NCT01982292|590207444|FG001|Overall Study|Death|0|||
163408962|NCT01982292|590207443|FG000|Overall Study|Lost to Follow-up|2|||
163408963|NCT01982292|590207444|FG001|Overall Study|Lost to Follow-up|0|||
163408964|NCT01982292|590207443|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
163408965|NCT01982292|590207444|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
163408966|NCT01982292|590207443|FG000|Overall Study|Protocol Deviation|1|||
163408967|NCT01982292|590207444|FG001|Overall Study|Protocol Deviation|0|||
163408968|NCT01982292|590207443|FG000|Overall Study|Patient/Guardian Decision|3|||
163230831|NCT00456092|589558164|FG004|Extension Phase|Withdrew Consent|0|||
163230832|NCT00456092|589558160|FG000|Extension Phase|Lost to Follow-up|1|||
163230833|NCT00456092|589558161|FG001|Extension Phase|Lost to Follow-up|1|||
163230834|NCT00456092|589558162|FG002|Extension Phase|Lost to Follow-up|0|||
163230835|NCT00456092|589558163|FG003|Extension Phase|Lost to Follow-up|0|||
163230836|NCT00456092|589558164|FG004|Extension Phase|Lost to Follow-up|1|||
163230837|NCT00456092|589558160|FG000|Extension Phase|Other|2|||
163230838|NCT00456092|589558161|FG001|Extension Phase|Other|0|||
163230839|NCT00456092|589558162|FG002|Extension Phase|Other|0|||
163230840|NCT00456092|589558163|FG003|Extension Phase|Other|1|||
163230841|NCT00456092|589558164|FG004|Extension Phase|Other|1|||
163230842|NCT00456092|589558160|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
163230843|NCT00456092|589558161|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
163230844|NCT00456092|589558162|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
163230845|NCT00456092|589558163|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
163230846|NCT00456092|589558164|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
163230847|NCT00456092|589558160|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
163230848|NCT00456092|589558161|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
163230849|NCT00456092|589558162|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
163230850|NCT00456092|589558163|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
163230851|NCT00456092|589558164|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
163230852|NCT00456092|589558160|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
163230853|NCT00456092|589558161|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
163230854|NCT00456092|589558162|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
163230855|NCT00456092|589558163|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
163230856|NCT00456092|589558164|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
163230857|NCT00456092|589558160|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
163230858|NCT00456092|589558161|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
163230859|NCT00456092|589558162|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
163230860|NCT00456092|589558163|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
163230861|NCT00456092|589558164|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
163230862|NCT00456092|589558160|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
163230863|NCT00456092|589558161|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
163230864|NCT00456092|589558162|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
163230865|NCT00456092|589558163|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
163230866|NCT00456092|589558164|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
163230867|NCT00456092|589558160|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
163230868|NCT00456092|589558161|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
163230869|NCT00456092|589558162|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
163230870|NCT00456092|589558163|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
163230871|NCT00456092|589558164|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
163230872|NCT00456092|589558160|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
163230873|NCT00456092|589558161|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
163230874|NCT00456092|589558162|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
163230875|NCT00456092|589558163|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
163230876|NCT00456092|589558164|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
163230877|NCT00456092|589558160|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
163230878|NCT00456092|589558161|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
163408969|NCT01982292|590207444|FG001|Overall Study|Patient/Guardian Decision|1|||
163408970|NCT01982292|590207443|FG000|Overall Study|Technical Problems|2|||
163408971|NCT01982292|590207444|FG001|Overall Study|Technical Problems|0|||
163408972|NCT03409744|590207445|FG000|Overall Study|Death|2|||
163408973|NCT03409744|590207445|FG000|Overall Study|Physician Decision|5|||
163408974|NCT03409744|590207445|FG000|Overall Study|Pregnancy|1|||
163230879|NCT00456092|589558162|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
163230880|NCT00456092|589558163|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
163408975|NCT03409744|590207445|FG000|Overall Study|Lost to Follow-up|1|||
163408976|NCT03409744|590207445|FG000|Overall Study|Protocol Violation|1|||
163230881|NCT00456092|589558164|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
163230882|NCT00456092|589558160|FG000|Treatment Phase (12 Weeks)|Other|1|||
163230883|NCT00456092|589558161|FG001|Treatment Phase (12 Weeks)|Other|0|||
163230884|NCT00456092|589558162|FG002|Treatment Phase (12 Weeks)|Other|1|||
163230885|NCT00456092|589558163|FG003|Treatment Phase (12 Weeks)|Other|0|||
163230886|NCT00456092|589558164|FG004|Treatment Phase (12 Weeks)|Other|0|||
163230887|NCT00844545|589558166|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
163230888|NCT00844545|589558166|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
163230889|NCT00844545|589558166|FG000|Extension Treatment Period|Adverse Event|2|||
163230890|NCT00844545|589558166|FG000|Post Treatment Period|Withdrawal by Subject|1|||
163230891|NCT01358981|589558169|FG000|Period 1|Withdrawal by Subject|0|||
163230892|NCT01358981|589558170|FG001|Period 1|Withdrawal by Subject|0|||
163230893|NCT01358981|589558171|FG002|Period 1|Withdrawal by Subject|0|||
163230894|NCT01358981|589558172|FG003|Period 1|Withdrawal by Subject|1|||
163230895|NCT01358981|589558173|FG004|Period 1|Withdrawal by Subject|0|||
163230896|NCT01358981|589558174|FG005|Period 1|Withdrawal by Subject|0|||
163230897|NCT01358981|589558175|FG006|Period 1|Withdrawal by Subject|0|||
163230898|NCT01252290|589558178|FG000|Overall Study|Withdrawal by Subject|1|||
163230899|NCT02247349|589558179|FG000|Overall Study|Disease Progression|7|||
163230900|NCT02247349|589558180|FG001|Overall Study|Disease Progression|4|||
163230901|NCT02247349|589558181|FG002|Overall Study|Disease Progression|26|||
163230902|NCT02247349|589558182|FG003|Overall Study|Disease Progression|31|||
163230903|NCT02247349|589558183|FG004|Overall Study|Disease Progression|16|||
163230904|NCT02247349|589558184|FG005|Overall Study|Disease Progression|6|||
163230905|NCT02247349|589558179|FG000|Overall Study|Study drug toxicity|0|||
163230906|NCT02247349|589558180|FG001|Overall Study|Study drug toxicity|1|||
163230907|NCT02247349|589558181|FG002|Overall Study|Study drug toxicity|1|||
163230908|NCT02247349|589558182|FG003|Overall Study|Study drug toxicity|1|||
163230909|NCT02247349|589558183|FG004|Overall Study|Study drug toxicity|2|||
163230910|NCT02247349|589558184|FG005|Overall Study|Study drug toxicity|2|||
163230911|NCT02247349|589558179|FG000|Overall Study|Death|0|||
163230912|NCT02247349|589558180|FG001|Overall Study|Death|0|||
163230913|NCT02247349|589558181|FG002|Overall Study|Death|0|||
163230914|NCT02247349|589558182|FG003|Overall Study|Death|1|||
163230915|NCT02247349|589558183|FG004|Overall Study|Death|0|||
163230916|NCT02247349|589558184|FG005|Overall Study|Death|0|||
163230917|NCT02247349|589558179|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
163230918|NCT02247349|589558180|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
163230919|NCT02247349|589558181|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
163230920|NCT02247349|589558182|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
163230921|NCT02247349|589558183|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
163230922|NCT02247349|589558184|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
163230923|NCT02247349|589558179|FG000|Overall Study|Participant request to discontinue study treatment|0|||
163230924|NCT02247349|589558180|FG001|Overall Study|Participant request to discontinue study treatment|0|||
163230925|NCT02247349|589558181|FG002|Overall Study|Participant request to discontinue study treatment|1|||
163230926|NCT02247349|589558182|FG003|Overall Study|Participant request to discontinue study treatment|2|||
163230927|NCT02247349|589558183|FG004|Overall Study|Participant request to discontinue study treatment|1|||
163230928|NCT02247349|589558184|FG005|Overall Study|Participant request to discontinue study treatment|0|||
163230929|NCT02247349|589558179|FG000|Overall Study|Withdrawal by Subject|0|||
163230930|NCT02247349|589558180|FG001|Overall Study|Withdrawal by Subject|1|||
163230931|NCT02247349|589558181|FG002|Overall Study|Withdrawal by Subject|0|||
163230932|NCT02247349|589558182|FG003|Overall Study|Withdrawal by Subject|0|||
163230933|NCT02247349|589558183|FG004|Overall Study|Withdrawal by Subject|0|||
163230934|NCT02247349|589558184|FG005|Overall Study|Withdrawal by Subject|0|||
163230935|NCT02247349|589558179|FG000|Overall Study|Administrative reason by sponsor|0|||
163230936|NCT02247349|589558180|FG001|Overall Study|Administrative reason by sponsor|0|||
163230937|NCT02247349|589558181|FG002|Overall Study|Administrative reason by sponsor|0|||
163230938|NCT02247349|589558182|FG003|Overall Study|Administrative reason by sponsor|0|||
163230939|NCT02247349|589558183|FG004|Overall Study|Administrative reason by sponsor|1|||
163230940|NCT02247349|589558184|FG005|Overall Study|Administrative reason by sponsor|0|||
163230941|NCT02247349|589558179|FG000|Overall Study|Other reasons|0|||
163230942|NCT02247349|589558180|FG001|Overall Study|Other reasons|0|||
163230943|NCT02247349|589558181|FG002|Overall Study|Other reasons|1|||
163230944|NCT02247349|589558182|FG003|Overall Study|Other reasons|0|||
163230945|NCT02247349|589558183|FG004|Overall Study|Other reasons|0|||
163230946|NCT02247349|589558184|FG005|Overall Study|Other reasons|0|||
163230947|NCT00617240|589558186|FG000|Overall Study|Lack of Efficacy|1|||
163230948|NCT00617240|589558187|FG001|Overall Study|Lack of Efficacy|0|||
163230949|NCT01611259|589558188|FG000|Overall Study|Physician Decision|1|||
163230950|NCT01611259|589558188|FG000|Overall Study|Lack of Efficacy|2|||
163230951|NCT01611259|589558188|FG000|Overall Study|Adverse Event|4|||
163230952|NCT01611259|589558188|FG000|Overall Study|Withdrawal by Subject|7|||
163230953|NCT04936685|589558189|FG000|Overall Study|Protocol Violation|1|||
163230954|NCT04936685|589558190|FG001|Overall Study|Protocol Violation|0|||
163230955|NCT00382733|589558192|FG000|Overall Study|Withdrawal by Subject|0|||
163230956|NCT00382733|589558193|FG001|Overall Study|Withdrawal by Subject|1|||
163230957|NCT00382733|589558194|FG002|Overall Study|Withdrawal by Subject|0|||
163346308|NCT02176018|589976385|FG000|Overall Study|Withdrawal by Subject|1|||
163346309|NCT02176018|589976386|FG001|Overall Study|Withdrawal by Subject|2|||
163346310|NCT03022045|589976388|FG000|Overall Study|Adverse Event|0|||
163346311|NCT03022045|589976389|FG001|Overall Study|Adverse Event|1|||
163346312|NCT03022045|589976388|FG000|Overall Study|Withdrawal by Subject|1|||
163346313|NCT03022045|589976389|FG001|Overall Study|Withdrawal by Subject|1|||
163346314|NCT03275402|589976390|FG000|Overall Study|Death|17|||
163346315|NCT03275402|589976390|FG000|Overall Study|Study terminated by sponsor|21|||
163346316|NCT03275402|589976390|FG000|Overall Study|Withdrawal by Subject|1|||
163346317|NCT02253147|589976391|FG000|Overall Study|Protocol Violation|30|||
163346318|NCT02253147|589976391|FG000|Overall Study|Did not consent to study extension|9|||
163346319|NCT02253147|589976391|FG000|Overall Study|Conditional re-treatment at W52|5|||
163346320|NCT02253147|589976391|FG000|Overall Study|Lost to Follow-up|2|||
163346321|NCT02253147|589976391|FG000|Overall Study|Withdrawal by Subject|1|||
163230958|NCT00382733|589558195|FG003|Overall Study|Withdrawal by Subject|0|||
163230959|NCT00382733|589558196|FG004|Overall Study|Withdrawal by Subject|0|||
163230960|NCT03049813|589558197|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
163230961|NCT03049813|589558198|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
163230962|NCT03049813|589558199|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
163230963|NCT03049813|589558200|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
163230964|NCT03049813|589558197|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
163230965|NCT03049813|589558198|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
163230966|NCT03049813|589558199|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
163230967|NCT03049813|589558200|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
163230968|NCT03049813|589558197|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
163230969|NCT03049813|589558198|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
163230970|NCT03049813|589558199|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
163230971|NCT03049813|589558200|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
163230972|NCT03049813|589558197|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
163230973|NCT03049813|589558198|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
163230974|NCT03049813|589558199|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
163230975|NCT03049813|589558200|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
163230976|NCT00179413|589558201|FG000|Overall Study|Adverse Event|38|||
163230977|NCT00179413|589558202|FG001|Overall Study|Adverse Event|20|||
163230978|NCT00179413|589558201|FG000|Overall Study|Withdrawal by Subject|87|||
163230979|NCT00179413|589558202|FG001|Overall Study|Withdrawal by Subject|95|||
163230980|NCT03075644|589558205|FG000|Overall Study|Withdrawal by Subject|1|||
163230981|NCT03075644|589558206|FG001|Overall Study|Withdrawal by Subject|1|||
163230982|NCT01813019|589558207|FG000|Overall Study|Adverse Event|0|||
163230983|NCT01813019|589558208|FG001|Overall Study|Adverse Event|3|||
163230984|NCT01813019|589558207|FG000|Overall Study|Withdrawal by Subject|3|||
163230985|NCT01813019|589558208|FG001|Overall Study|Withdrawal by Subject|2|||
163230986|NCT01813019|589558207|FG000|Overall Study|administrative problems|2|||
163230987|NCT01813019|589558208|FG001|Overall Study|administrative problems|0|||
163230988|NCT01813019|589558207|FG000|Overall Study|Protocol Deviation|2|||
163230989|NCT01813019|589558208|FG001|Overall Study|Protocol Deviation|1|||
163230990|NCT00439140|589558209|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
163230991|NCT00439140|589558210|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
163230992|NCT00439140|589558211|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
163230993|NCT00439140|589558209|FG000|Treatment Cycle 1|Personal reasons|0|||
163230994|NCT00439140|589558210|FG001|Treatment Cycle 1|Personal reasons|2|||
163230995|NCT00439140|589558211|FG002|Treatment Cycle 1|Personal reasons|0|||
163230996|NCT00439140|589558209|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
163230997|NCT00439140|589558210|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
163230998|NCT00439140|589558211|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
163230999|NCT00439140|589558209|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
163231000|NCT00439140|589558210|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
163231001|NCT00439140|589558211|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
163231002|NCT00439140|589558209|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
163231003|NCT00439140|589558210|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
163231004|NCT00439140|589558211|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
163231005|NCT01458171|589558217|FG000|Overall Study|Adverse Event|1|||
163231006|NCT00578565|589558222|FG000|Overall Study|Adverse Event|3|||
163231007|NCT01192152|589558223|FG000|Period 1|left prematurely (while on treatment B)|0|||
163231008|NCT01192152|589558224|FG001|Period 1|left prematurely (while on treatment B)|1|||
163231009|NCT01192152|589558223|FG000|Period 3|family emergency|1|||
163346322|NCT02986659|589976392|FG000|First Intervention Period|Adverse Event|3|||
163346323|NCT02986659|589976393|FG001|First Intervention Period|Adverse Event|1|||
163231010|NCT01192152|589558224|FG001|Period 3|family emergency|0|||
163231011|NCT02143843|589558226|FG000|Overall Study|Adverse Event|8|||
163231012|NCT02143843|589558226|FG000|Overall Study|Lack of Efficacy|2|||
163346324|NCT02986659|589976392|FG000|First Intervention Period|Lost to Follow-up|1|||
163231013|NCT02143843|589558226|FG000|Overall Study|Withdrawal by Subject|2|||
163231014|NCT01339390|589558227|FG000|Overall Study|Death|32|||
163231015|NCT01339390|589558228|FG001|Overall Study|Death|29|||
163231016|NCT01339390|589558227|FG000|Overall Study|Lost to Follow-up|125|||
163231017|NCT01339390|589558228|FG001|Overall Study|Lost to Follow-up|127|||
163231018|NCT00378703|589558229|FG000|Overall Study|Disease progression|59|||
163231019|NCT00378703|589558230|FG001|Overall Study|Disease progression|43|||
163231020|NCT00378703|589558231|FG002|Overall Study|Disease progression|48|||
163231021|NCT00378703|589558232|FG003|Overall Study|Disease progression|49|||
163231022|NCT00378703|589558229|FG000|Overall Study|Adverse Event|11|||
163231023|NCT00378703|589558230|FG001|Overall Study|Adverse Event|17|||
163231024|NCT00378703|589558231|FG002|Overall Study|Adverse Event|20|||
163231025|NCT00378703|589558232|FG003|Overall Study|Adverse Event|18|||
163231026|NCT00378703|589558229|FG000|Overall Study|Death|2|||
163231027|NCT00378703|589558230|FG001|Overall Study|Death|2|||
163231028|NCT00378703|589558231|FG002|Overall Study|Death|4|||
163231029|NCT00378703|589558232|FG003|Overall Study|Death|3|||
163231030|NCT00378703|589558229|FG000|Overall Study|Withdrawal by Subject|4|||
163231031|NCT00378703|589558230|FG001|Overall Study|Withdrawal by Subject|8|||
163231032|NCT00378703|589558231|FG002|Overall Study|Withdrawal by Subject|5|||
163231033|NCT00378703|589558232|FG003|Overall Study|Withdrawal by Subject|7|||
163231034|NCT00378703|589558229|FG000|Overall Study|Physician Decision|1|||
163231035|NCT00378703|589558230|FG001|Overall Study|Physician Decision|4|||
163231036|NCT00378703|589558231|FG002|Overall Study|Physician Decision|1|||
163231037|NCT00378703|589558232|FG003|Overall Study|Physician Decision|0|||
163231038|NCT00378703|589558229|FG000|Overall Study|Alternative therapy|4|||
163231039|NCT00378703|589558230|FG001|Overall Study|Alternative therapy|2|||
163231040|NCT00378703|589558231|FG002|Overall Study|Alternative therapy|0|||
163231041|NCT00378703|589558232|FG003|Overall Study|Alternative therapy|0|||
163231042|NCT00378703|589558229|FG000|Overall Study|Other complicated disease|0|||
163231043|NCT00378703|589558230|FG001|Overall Study|Other complicated disease|2|||
163231044|NCT00378703|589558231|FG002|Overall Study|Other complicated disease|2|||
163231045|NCT00378703|589558232|FG003|Overall Study|Other complicated disease|0|||
163231046|NCT00378703|589558229|FG000|Overall Study|Symptomatic deterioration|0|||
163231047|NCT00378703|589558230|FG001|Overall Study|Symptomatic deterioration|1|||
163231048|NCT00378703|589558231|FG002|Overall Study|Symptomatic deterioration|0|||
163231049|NCT00378703|589558232|FG003|Overall Study|Symptomatic deterioration|2|||
163231050|NCT00378703|589558229|FG000|Overall Study|Surgery|1|||
163231051|NCT00378703|589558230|FG001|Overall Study|Surgery|0|||
163231052|NCT00378703|589558231|FG002|Overall Study|Surgery|0|||
163231053|NCT00378703|589558232|FG003|Overall Study|Surgery|1|||
163231054|NCT00378703|589558229|FG000|Overall Study|Joint decision of physician and patient|1|||
163231055|NCT00378703|589558230|FG001|Overall Study|Joint decision of physician and patient|0|||
163231056|NCT00378703|589558231|FG002|Overall Study|Joint decision of physician and patient|0|||
163231057|NCT00378703|589558232|FG003|Overall Study|Joint decision of physician and patient|0|||
163231058|NCT00378703|589558229|FG000|Overall Study|Adverse events and progressive disease|0|||
163231059|NCT00378703|589558230|FG001|Overall Study|Adverse events and progressive disease|0|||
163231060|NCT00378703|589558231|FG002|Overall Study|Adverse events and progressive disease|0|||
163231061|NCT00378703|589558232|FG003|Overall Study|Adverse events and progressive disease|1|||
163231062|NCT00378703|589558229|FG000|Overall Study|Relocation|0|||
163231063|NCT00378703|589558230|FG001|Overall Study|Relocation|0|||
163231064|NCT00378703|589558231|FG002|Overall Study|Relocation|1|||
163231065|NCT00378703|589558232|FG003|Overall Study|Relocation|0|||
163231066|NCT00378703|589558229|FG000|Overall Study|Ineligible|4|||
163231067|NCT00378703|589558230|FG001|Overall Study|Ineligible|7|||
163231068|NCT00378703|589558231|FG002|Overall Study|Ineligible|7|||
163231069|NCT00378703|589558232|FG003|Overall Study|Ineligible|7|||
163231070|NCT00378703|589558229|FG000|Overall Study|Never started treatment|1|||
163231071|NCT00378703|589558230|FG001|Overall Study|Never started treatment|4|||
163231072|NCT00378703|589558231|FG002|Overall Study|Never started treatment|0|||
163231073|NCT00378703|589558232|FG003|Overall Study|Never started treatment|0|||
163231074|NCT00378703|589558229|FG000|Overall Study|Other|1|||
163231075|NCT00378703|589558230|FG001|Overall Study|Other|1|||
163231076|NCT00378703|589558231|FG002|Overall Study|Other|2|||
163231077|NCT00378703|589558232|FG003|Overall Study|Other|3|||
163231078|NCT03181542|589558235|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
163231079|NCT03181542|589558236|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
163231080|NCT01462357|589558243|FG000|Overall Study|Death|0|||
163231081|NCT01462357|589558244|FG001|Overall Study|Death|0|||
163231082|NCT01462357|589558245|FG002|Overall Study|Death|1|||
163231083|NCT01462357|589558243|FG000|Overall Study|Withdrawal by Subject|3|||
163231084|NCT01462357|589558244|FG001|Overall Study|Withdrawal by Subject|11|||
163231085|NCT01462357|589558245|FG002|Overall Study|Withdrawal by Subject|3|||
163231086|NCT01462357|589558243|FG000|Overall Study|Migrated/moved from study area|2|||
163231087|NCT01462357|589558244|FG001|Overall Study|Migrated/moved from study area|3|||
163231088|NCT01462357|589558245|FG002|Overall Study|Migrated/moved from study area|1|||
163231089|NCT01462357|589558243|FG000|Overall Study|Lost to Follow-up|3|||
163231090|NCT01462357|589558244|FG001|Overall Study|Lost to Follow-up|5|||
163346325|NCT02986659|589976393|FG001|First Intervention Period|Lost to Follow-up|0|||
163346326|NCT02986659|589976392|FG000|First Intervention Period|Withdrawal by Subject|0|||
163346327|NCT02986659|589976393|FG001|First Intervention Period|Withdrawal by Subject|1|||
163346328|NCT02986659|589976392|FG000|Second Intervention Period|Adverse Event|0|||
163346329|NCT02986659|589976393|FG001|Second Intervention Period|Adverse Event|6|||
163346330|NCT02469077|589976396|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
163346331|NCT02469077|589976397|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
163346332|NCT02469077|589976396|FG000|Post Randomization/Intervention Period|Relocated|1|||
163346333|NCT02469077|589976397|FG001|Post Randomization/Intervention Period|Relocated|1|||
163346334|NCT02469077|589976396|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
163346335|NCT02469077|589976397|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
163346336|NCT02469077|589976396|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
163346337|NCT02469077|589976397|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
163346338|NCT02973477|589976398|FG000|First Intervention|Lost to Follow-up|0|||
163346339|NCT02973477|589976399|FG001|First Intervention|Lost to Follow-up|2|||
163346340|NCT02973477|589976398|FG000|Washout|Withdrawal by Subject|1|||
163346341|NCT02973477|589976399|FG001|Washout|Withdrawal by Subject|0|||
163346342|NCT02973477|589976398|FG000|Second Intervention|Lost to Follow-up|1|||
163346343|NCT02973477|589976399|FG001|Second Intervention|Lost to Follow-up|0|||
163346344|NCT02402465|589976401|FG000|Overall Study|Withdrawal by Subject|0|||
163346345|NCT02402465|589976402|FG001|Overall Study|Withdrawal by Subject|0|||
163346346|NCT02402465|589976403|FG002|Overall Study|Withdrawal by Subject|0|||
163346347|NCT02402465|589976404|FG003|Overall Study|Withdrawal by Subject|0|||
163346348|NCT02402465|589976405|FG004|Overall Study|Withdrawal by Subject|0|||
163346349|NCT02402465|589976406|FG005|Overall Study|Withdrawal by Subject|1|||
163346350|NCT02402465|589976401|FG000|Overall Study|Lost to Follow-up|0|||
163346351|NCT02402465|589976402|FG001|Overall Study|Lost to Follow-up|1|||
163346352|NCT02402465|589976403|FG002|Overall Study|Lost to Follow-up|0|||
163346353|NCT02402465|589976404|FG003|Overall Study|Lost to Follow-up|0|||
163346354|NCT02402465|589976405|FG004|Overall Study|Lost to Follow-up|1|||
163346355|NCT02402465|589976406|FG005|Overall Study|Lost to Follow-up|0|||
163346356|NCT01284634|589976407|FG000|Overall Study|Adverse Event|1|||
163346357|NCT01284634|589976408|FG001|Overall Study|Adverse Event|0|||
163346358|NCT01284634|589976409|FG002|Overall Study|Adverse Event|2|||
163346359|NCT01284634|589976410|FG003|Overall Study|Adverse Event|1|||
163346360|NCT03807700|589976411|FG000|Overall Study|Withdrawal by Subject|2|||
163346361|NCT03807700|589976412|FG001|Overall Study|Withdrawal by Subject|1|||
163346362|NCT01059526|589976413|FG000|Overall Study|Patient enrolled but not treated|20|||
163346363|NCT01059526|589976414|FG001|Overall Study|Patient enrolled but not treated|17|||
163346364|NCT01059526|589976413|FG000|Overall Study|Adverse Event|2|||
163346365|NCT01059526|589976414|FG001|Overall Study|Adverse Event|2|||
163346366|NCT01059526|589976413|FG000|Overall Study|Protocol Violation|0|||
163346367|NCT01059526|589976414|FG001|Overall Study|Protocol Violation|1|||
163346368|NCT01059526|589976413|FG000|Overall Study|Withdrawal by Subject|3|||
163346369|NCT01059526|589976414|FG001|Overall Study|Withdrawal by Subject|1|||
163346370|NCT01059526|589976413|FG000|Overall Study|Lost to Follow-up|4|||
163346371|NCT01059526|589976414|FG001|Overall Study|Lost to Follow-up|1|||
163346372|NCT01059526|589976413|FG000|Overall Study|Patient found to be dermatographic|1|||
163346373|NCT01059526|589976414|FG001|Overall Study|Patient found to be dermatographic|0|||
163346374|NCT02720081|589976415|FG000|Overall Study|Adverse Event|0|||
163346375|NCT02720081|589976416|FG001|Overall Study|Adverse Event|3|||
163346376|NCT02720081|589976415|FG000|Overall Study|Protocol Violation|4|||
163346377|NCT02720081|589976416|FG001|Overall Study|Protocol Violation|1|||
163346378|NCT01732588|589976417|FG000|First Intervention (7 Days)|Adverse Event|0|||
163346379|NCT01732588|589976418|FG001|First Intervention (7 Days)|Adverse Event|1|||
163346380|NCT01732588|589976419|FG002|First Intervention (7 Days)|Adverse Event|0|||
163346381|NCT05012397|589976422|FG000|Overall Study|Death|10|||
163346382|NCT05012397|589976422|FG000|Overall Study|Physician Decision|9|||
163346383|NCT05012397|589976422|FG000|Overall Study|Withdrawal by Subject|5|||
163346384|NCT05012397|589976422|FG000|Overall Study|Lost to Follow-up|2|||
163346385|NCT03334747|589976431|FG000|Treatment Phase|Technical problems|0|||
163346386|NCT03334747|589976432|FG001|Treatment Phase|Technical problems|0|||
163346387|NCT03334747|589976433|FG002|Treatment Phase|Technical problems|0|||
163346388|NCT03334747|589976434|FG003|Treatment Phase|Technical problems|0|||
163346389|NCT03334747|589976435|FG004|Treatment Phase|Technical problems|1|||
163346390|NCT03334747|589976436|FG005|Treatment Phase|Technical problems|0|||
163346391|NCT03334747|589976437|FG006|Treatment Phase|Technical problems|0|||
163346392|NCT03334747|589976438|FG007|Treatment Phase|Technical problems|0|||
163346393|NCT03334747|589976439|FG008|Treatment Phase|Technical problems|0|||
163346394|NCT03334747|589976431|FG000|Treatment Phase|Subject/guardian decision|1|||
163346395|NCT03334747|589976432|FG001|Treatment Phase|Subject/guardian decision|0|||
163346396|NCT03334747|589976433|FG002|Treatment Phase|Subject/guardian decision|0|||
163346397|NCT03334747|589976434|FG003|Treatment Phase|Subject/guardian decision|0|||
163346398|NCT03334747|589976435|FG004|Treatment Phase|Subject/guardian decision|0|||
163346399|NCT03334747|589976436|FG005|Treatment Phase|Subject/guardian decision|1|||
163346400|NCT03334747|589976437|FG006|Treatment Phase|Subject/guardian decision|0|||
163346401|NCT03334747|589976438|FG007|Treatment Phase|Subject/guardian decision|0|||
163346402|NCT03334747|589976439|FG008|Treatment Phase|Subject/guardian decision|0|||
163346403|NCT03334747|589976431|FG000|Follow-Up Phase|Subject/guardian decision|0|||
163346404|NCT03334747|589976432|FG001|Follow-Up Phase|Subject/guardian decision|0|||
163346405|NCT03334747|589976433|FG002|Follow-Up Phase|Subject/guardian decision|0|||
163346406|NCT03334747|589976434|FG003|Follow-Up Phase|Subject/guardian decision|0|||
163346407|NCT03334747|589976435|FG004|Follow-Up Phase|Subject/guardian decision|0|||
163346408|NCT03334747|589976436|FG005|Follow-Up Phase|Subject/guardian decision|0|||
163346409|NCT03334747|589976437|FG006|Follow-Up Phase|Subject/guardian decision|1|||
163346410|NCT03334747|589976438|FG007|Follow-Up Phase|Subject/guardian decision|0|||
163346411|NCT03334747|589976439|FG008|Follow-Up Phase|Subject/guardian decision|1|||
163346412|NCT00938041|589976440|FG000|Overall Study|Lost to Follow-up|6|||
163346413|NCT00938041|589976440|FG000|Overall Study|Received Alternative Therapy|1|||
163346414|NCT00938041|589976440|FG000|Overall Study|Progressive Disease|5|||
163346415|NCT00938041|589976440|FG000|Overall Study|Death|12|||
163346416|NCT00938041|589976440|FG000|Overall Study|Adrenal Insufficiency|3|||
163346417|NCT02504502|589976441|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
163346418|NCT02504502|589976442|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
163346419|NCT02504502|589976441|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
163346420|NCT02504502|589976442|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
163346421|NCT03042559|589976446|FG000|Overall Study|drop out|1|||
163346422|NCT03042559|589976447|FG001|Overall Study|drop out|1|||
163346423|NCT01536535|589976451|FG000|Overall Study|Withdrawal by Subject|10|||
163346424|NCT01536535|589976452|FG001|Overall Study|Withdrawal by Subject|5|||
163346425|NCT01536535|589976451|FG000|Overall Study|Lost to Follow-up|4|||
163346426|NCT01536535|589976452|FG001|Overall Study|Lost to Follow-up|6|||
163346427|NCT01536535|589976451|FG000|Overall Study|Physician Decision|1|||
163346428|NCT01536535|589976452|FG001|Overall Study|Physician Decision|1|||
163346429|NCT01536535|589976451|FG000|Overall Study|Participant moved|0|||
163346430|NCT01536535|589976452|FG001|Overall Study|Participant moved|1|||
163346431|NCT00428441|589976453|FG000|Overall Study|Lost to Follow-up|1|||
163346432|NCT01475370|589976454|FG000|Overall Study|Exacerbation of primary disease|2|||
163138720|NCT04640311|589217791|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138721|NCT04640311|589217792|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138722|NCT04640311|589217793|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138723|NCT04640311|589217794|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138724|NCT04640311|589217795|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138725|NCT04640311|589217796|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138726|NCT04640311|589217797|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138727|NCT04640311|589217798|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138728|NCT04640311|589217786|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138729|NCT04640311|589217787|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138730|NCT04640311|589217788|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
163138731|NCT04640311|589217789|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138732|NCT04640311|589217790|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138733|NCT04640311|589217791|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138734|NCT04640311|589217792|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138735|NCT04640311|589217793|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138736|NCT04640311|589217794|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138737|NCT04640311|589217795|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138738|NCT04640311|589217796|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138739|NCT04640311|589217797|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138740|NCT04640311|589217798|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138741|NCT04640311|589217786|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138742|NCT04640311|589217787|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138743|NCT04640311|589217788|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138744|NCT04640311|589217789|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
163138745|NCT04640311|589217790|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138746|NCT04640311|589217791|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138747|NCT04640311|589217792|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
163138748|NCT04640311|589217793|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138749|NCT04640311|589217794|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138750|NCT04640311|589217795|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163231091|NCT01462357|589558245|FG002|Overall Study|Lost to Follow-up|7|||
163346433|NCT01475370|589976455|FG001|Overall Study|Exacerbation of primary disease|2|||
163346434|NCT01475370|589976456|FG002|Overall Study|Exacerbation of primary disease|2|||
163346435|NCT01475370|589976454|FG000|Overall Study|Study drug administration difficult|0|||
163231092|NCT04292730|589558254|FG000|Overall Study|Lost to Follow-up|8|||
163346436|NCT01475370|589976455|FG001|Overall Study|Study drug administration difficult|1|||
163346437|NCT01475370|589976456|FG002|Overall Study|Study drug administration difficult|1|||
163138751|NCT04640311|589217796|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138752|NCT04640311|589217797|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138753|NCT04640311|589217798|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138754|NCT04640311|589217786|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138755|NCT04640311|589217787|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138756|NCT04640311|589217788|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138757|NCT04640311|589217789|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138758|NCT04640311|589217790|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138759|NCT04640311|589217791|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
163138760|NCT04640311|589217792|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138761|NCT04640311|589217793|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138762|NCT04640311|589217794|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
163138763|NCT04640311|589217795|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138764|NCT04640311|589217796|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138765|NCT04640311|589217797|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138766|NCT04640311|589217798|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138767|NCT04640311|589217786|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138768|NCT04640311|589217787|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138769|NCT04640311|589217788|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138770|NCT04640311|589217789|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138771|NCT04640311|589217790|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138772|NCT04640311|589217791|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138773|NCT04640311|589217792|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
163138774|NCT04640311|589217793|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138775|NCT04640311|589217794|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138776|NCT04640311|589217795|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138777|NCT04640311|589217796|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
163138778|NCT04640311|589217797|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138779|NCT04640311|589217798|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138780|NCT04640311|589217786|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138781|NCT04640311|589217787|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138782|NCT04640311|589217788|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138783|NCT04640311|589217789|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138784|NCT04640311|589217790|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138785|NCT04640311|589217791|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138786|NCT04640311|589217792|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138787|NCT04640311|589217793|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138788|NCT04640311|589217794|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138789|NCT04640311|589217795|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138790|NCT04640311|589217796|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138791|NCT04640311|589217797|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
163138792|NCT04640311|589217798|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138793|NCT03906071|589217799|FG000|Overall Study|Death|180|||
163138794|NCT03906071|589217800|FG001|Overall Study|Death|185|||
163138795|NCT03906071|589217799|FG000|Overall Study|Lost to Follow-up|3|||
163138796|NCT03906071|589217800|FG001|Overall Study|Lost to Follow-up|3|||
163138797|NCT03906071|589217799|FG000|Overall Study|Withdrawal by Subject|15|||
163138798|NCT03906071|589217800|FG001|Overall Study|Withdrawal by Subject|27|||
163138799|NCT03906071|589217799|FG000|Overall Study|Other|2|||
163138800|NCT03906071|589217800|FG001|Overall Study|Other|1|||
163138801|NCT02152761|589217801|FG000|Epoch: Treatment Epoch|Technical problems|0|||
163138802|NCT02152761|589217802|FG001|Epoch: Treatment Epoch|Technical problems|0|||
163138803|NCT02152761|589217803|FG002|Epoch: Treatment Epoch|Technical problems|0|||
163138804|NCT02152761|589217804|FG003|Epoch: Treatment Epoch|Technical problems|1|||
163138805|NCT02152761|589217801|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
163138806|NCT02152761|589217802|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
163138807|NCT02152761|589217803|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
163138808|NCT02152761|589217804|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
163138809|NCT02152761|589217801|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
163138810|NCT02152761|589217802|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
163231093|NCT04292730|589558255|FG001|Overall Study|Lost to Follow-up|12|||
163138811|NCT02152761|589217803|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
163138812|NCT02152761|589217804|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
163231094|NCT04292730|589558256|FG002|Overall Study|Lost to Follow-up|12|||
163408977|NCT04872101|590207446|FG000|Overall Study|Withdrawal by Subject|10|||
163408978|NCT04872101|590207447|FG001|Overall Study|Withdrawal by Subject|16|||
163408979|NCT04872101|590207446|FG000|Overall Study|Lack of Efficacy|6|||
163408980|NCT04872101|590207447|FG001|Overall Study|Lack of Efficacy|14|||
163408981|NCT04872101|590207446|FG000|Overall Study|Adverse Event|1|||
163408982|NCT04872101|590207447|FG001|Overall Study|Adverse Event|6|||
163408983|NCT04872101|590207446|FG000|Overall Study|Lost to Follow-up|2|||
163408984|NCT04872101|590207447|FG001|Overall Study|Lost to Follow-up|1|||
163408985|NCT04872101|590207446|FG000|Overall Study|Pregnancy|2|||
163408986|NCT04872101|590207447|FG001|Overall Study|Pregnancy|0|||
163408987|NCT04872101|590207446|FG000|Overall Study|Prohibited Medication|1|||
163408988|NCT04872101|590207447|FG001|Overall Study|Prohibited Medication|0|||
163408989|NCT04872101|590207446|FG000|Overall Study|Not dosed|1|||
163408990|NCT04872101|590207447|FG001|Overall Study|Not dosed|0|||
163408991|NCT05804877|590207448|FG000|Overall Study|Lost to Follow-up|1|||
163408992|NCT05804877|590207449|FG001|Overall Study|Lost to Follow-up|3|||
163408993|NCT05804877|590207448|FG000|Overall Study|Withdrawal by Subject|1|||
163408994|NCT05804877|590207449|FG001|Overall Study|Withdrawal by Subject|0|||
163408995|NCT05804877|590207448|FG000|Overall Study|Withdrawal by Subject|1|||
163408996|NCT05804877|590207449|FG001|Overall Study|Withdrawal by Subject|0|||
163408997|NCT00879229|590207450|FG000|Overall Study|Study terminated by Sponsor|13|||
163408998|NCT00879229|590207451|FG001|Overall Study|Study terminated by Sponsor|12|||
163408999|NCT00879229|590207450|FG000|Overall Study|Death|4|||
163409000|NCT00879229|590207451|FG001|Overall Study|Death|2|||
163409001|NCT00879229|590207450|FG000|Overall Study|Adverse Event|2|||
163409002|NCT00879229|590207451|FG001|Overall Study|Adverse Event|0|||
163409003|NCT00879229|590207450|FG000|Overall Study|Withdrawal by Subject|1|||
163409004|NCT00879229|590207451|FG001|Overall Study|Withdrawal by Subject|0|||
163409005|NCT00879229|590207450|FG000|Overall Study|Clinical status did not improve|1|||
163409006|NCT00879229|590207451|FG001|Overall Study|Clinical status did not improve|0|||
163409007|NCT00879229|590207450|FG000|Overall Study|Other|1|||
163409008|NCT00879229|590207451|FG001|Overall Study|Other|0|||
163409009|NCT00264004|590207452|FG000|Overall Study|Adverse Event|2|||
163409010|NCT00264004|590207453|FG001|Overall Study|Adverse Event|3|||
163409011|NCT00264004|590207454|FG002|Overall Study|Adverse Event|6|||
163409012|NCT00264004|590207455|FG003|Overall Study|Adverse Event|4|||
163409013|NCT00264004|590207452|FG000|Overall Study|Withdrawal by Subject|0|||
163409014|NCT00264004|590207453|FG001|Overall Study|Withdrawal by Subject|1|||
163409015|NCT00264004|590207454|FG002|Overall Study|Withdrawal by Subject|2|||
163409016|NCT00264004|590207455|FG003|Overall Study|Withdrawal by Subject|2|||
163409017|NCT00264004|590207452|FG000|Overall Study|Other|2|||
163409018|NCT00264004|590207453|FG001|Overall Study|Other|2|||
163409019|NCT00264004|590207454|FG002|Overall Study|Other|0|||
163409020|NCT00264004|590207455|FG003|Overall Study|Other|3|||
163409021|NCT00264004|590207452|FG000|Overall Study|Development study specific disc. crit.|1|||
163409022|NCT00264004|590207453|FG001|Overall Study|Development study specific disc. crit.|0|||
163409023|NCT00264004|590207454|FG002|Overall Study|Development study specific disc. crit.|1|||
163409024|NCT00264004|590207455|FG003|Overall Study|Development study specific disc. crit.|0|||
163409025|NCT00264004|590207452|FG000|Overall Study|Cond. under inv. worsened|9|||
163409026|NCT00264004|590207453|FG001|Overall Study|Cond. under inv. worsened|5|||
163409027|NCT00264004|590207454|FG002|Overall Study|Cond. under inv. worsened|3|||
163409028|NCT00264004|590207455|FG003|Overall Study|Cond. under inv. worsened|4|||
163409029|NCT00264004|590207452|FG000|Overall Study|Not treated|3|||
163409030|NCT00264004|590207453|FG001|Overall Study|Not treated|0|||
163409031|NCT00264004|590207454|FG002|Overall Study|Not treated|2|||
163409032|NCT00264004|590207455|FG003|Overall Study|Not treated|2|||
163409033|NCT02475681|590207456|FG000|Overall Study|Death|16|||
163409034|NCT02475681|590207457|FG001|Overall Study|Death|6|||
163409035|NCT02475681|590207458|FG002|Overall Study|Death|9|||
163409036|NCT02475681|590207456|FG000|Overall Study|Physician Decision|0|||
163409037|NCT02475681|590207457|FG001|Overall Study|Physician Decision|3|||
163409038|NCT02475681|590207458|FG002|Overall Study|Physician Decision|1|||
163409039|NCT02475681|590207456|FG000|Overall Study|Withdrawal by Subject|12|||
163409040|NCT02475681|590207457|FG001|Overall Study|Withdrawal by Subject|6|||
163409041|NCT02475681|590207458|FG002|Overall Study|Withdrawal by Subject|9|||
163231095|NCT04292730|589558257|FG003|Overall Study|Lost to Follow-up|48|||
163409042|NCT02475681|590207456|FG000|Overall Study|Lost to Follow-up|2|||
163409043|NCT02475681|590207457|FG001|Overall Study|Lost to Follow-up|1|||
163409044|NCT02475681|590207458|FG002|Overall Study|Lost to Follow-up|3|||
163409045|NCT02475681|590207456|FG000|Overall Study|Ongoing in Study|0|||
163409046|NCT02475681|590207457|FG001|Overall Study|Ongoing in Study|163|||
163409047|NCT02475681|590207458|FG002|Overall Study|Ongoing in Study|157|||
163409048|NCT02475681|590207456|FG000|Overall Study|Reasons other than above listed|2|||
163409049|NCT02475681|590207457|FG001|Overall Study|Reasons other than above listed|0|||
163409050|NCT02475681|590207458|FG002|Overall Study|Reasons other than above listed|0|||
163409051|NCT01262365|590207465|FG000|Overall Study|Lack of Efficacy|35|||
163409052|NCT01262365|590207466|FG001|Overall Study|Lack of Efficacy|30|||
163409053|NCT01262365|590207467|FG002|Overall Study|Lack of Efficacy|47|||
163231096|NCT04292730|589558254|FG000|Overall Study|Death|2|||
163409054|NCT01262365|590207465|FG000|Overall Study|Protocol Violation|3|||
163409055|NCT01262365|590207466|FG001|Overall Study|Protocol Violation|1|||
163409056|NCT01262365|590207467|FG002|Overall Study|Protocol Violation|1|||
163409057|NCT01262365|590207465|FG000|Overall Study|Lost to Follow-up|3|||
163409058|NCT01262365|590207466|FG001|Overall Study|Lost to Follow-up|7|||
163409059|NCT01262365|590207467|FG002|Overall Study|Lost to Follow-up|6|||
163409060|NCT01262365|590207465|FG000|Overall Study|Withdrawal by Subject|17|||
163409061|NCT01262365|590207466|FG001|Overall Study|Withdrawal by Subject|22|||
163409062|NCT01262365|590207467|FG002|Overall Study|Withdrawal by Subject|22|||
163409063|NCT01262365|590207465|FG000|Overall Study|Death|1|||
163409064|NCT01262365|590207466|FG001|Overall Study|Death|2|||
163409065|NCT01262365|590207467|FG002|Overall Study|Death|1|||
163409066|NCT01262365|590207465|FG000|Overall Study|Adverse Event|26|||
163409067|NCT01262365|590207466|FG001|Overall Study|Adverse Event|16|||
163409068|NCT01262365|590207467|FG002|Overall Study|Adverse Event|11|||
163409069|NCT01262365|590207465|FG000|Overall Study|sponsor decision|1|||
163409070|NCT01262365|590207466|FG001|Overall Study|sponsor decision|1|||
163409071|NCT01262365|590207467|FG002|Overall Study|sponsor decision|0|||
163409072|NCT01262365|590207465|FG000|Overall Study|Randomization error|1|||
163409073|NCT01262365|590207466|FG001|Overall Study|Randomization error|0|||
163409074|NCT01262365|590207467|FG002|Overall Study|Randomization error|2|||
163409075|NCT01262365|590207465|FG000|Overall Study|Non-compliance|1|||
163409076|NCT01262365|590207466|FG001|Overall Study|Non-compliance|0|||
163346438|NCT01475370|589976454|FG000|Overall Study|Other than specified|1|||
163346439|NCT01475370|589976455|FG001|Overall Study|Other than specified|0|||
163346440|NCT01475370|589976456|FG002|Overall Study|Other than specified|0|||
163346441|NCT04203160|589976457|FG000|Overall Study|Alternative Therapy|3|||
163346442|NCT04203160|589976458|FG001|Overall Study|Alternative Therapy|0|||
163346443|NCT04203160|589976459|FG002|Overall Study|Alternative Therapy|1|||
163346444|NCT04203160|589976460|FG003|Overall Study|Alternative Therapy|0|||
163346445|NCT04203160|589976461|FG004|Overall Study|Alternative Therapy|0|||
163346446|NCT04203160|589976462|FG005|Overall Study|Alternative Therapy|2|||
163346447|NCT04203160|589976457|FG000|Overall Study|Withdrawal by Subject|4|||
163346448|NCT04203160|589976458|FG001|Overall Study|Withdrawal by Subject|5|||
163346449|NCT04203160|589976459|FG002|Overall Study|Withdrawal by Subject|0|||
163346450|NCT04203160|589976460|FG003|Overall Study|Withdrawal by Subject|0|||
163346451|NCT04203160|589976461|FG004|Overall Study|Withdrawal by Subject|0|||
163346452|NCT04203160|589976462|FG005|Overall Study|Withdrawal by Subject|4|||
163346453|NCT04203160|589976457|FG000|Overall Study|Adverse Event|7|||
163346454|NCT04203160|589976458|FG001|Overall Study|Adverse Event|5|||
163346455|NCT04203160|589976459|FG002|Overall Study|Adverse Event|0|||
163346456|NCT04203160|589976460|FG003|Overall Study|Adverse Event|0|||
163346457|NCT04203160|589976461|FG004|Overall Study|Adverse Event|0|||
163346458|NCT04203160|589976462|FG005|Overall Study|Adverse Event|0|||
163346459|NCT04203160|589976457|FG000|Overall Study|Sponsor Termination|1|||
163346460|NCT04203160|589976458|FG001|Overall Study|Sponsor Termination|0|||
163346461|NCT04203160|589976459|FG002|Overall Study|Sponsor Termination|0|||
163346462|NCT04203160|589976460|FG003|Overall Study|Sponsor Termination|0|||
163346463|NCT04203160|589976461|FG004|Overall Study|Sponsor Termination|0|||
163346464|NCT04203160|589976462|FG005|Overall Study|Sponsor Termination|0|||
163346465|NCT04203160|589976457|FG000|Overall Study|Physician Decision|3|||
163346466|NCT04203160|589976458|FG001|Overall Study|Physician Decision|2|||
163346467|NCT04203160|589976459|FG002|Overall Study|Physician Decision|0|||
163346468|NCT04203160|589976460|FG003|Overall Study|Physician Decision|0|||
163346469|NCT04203160|589976461|FG004|Overall Study|Physician Decision|0|||
163346470|NCT04203160|589976462|FG005|Overall Study|Physician Decision|0|||
163346471|NCT00679549|589976464|FG000|Overall Study|dropout|2|||
163346472|NCT00679549|589976465|FG001|Overall Study|dropout|4|||
163346473|NCT00679549|589976464|FG000|Overall Study|missing outcome echocardiograms|4|||
163346474|NCT00679549|589976465|FG001|Overall Study|missing outcome echocardiograms|5|||
163346475|NCT02744898|589976468|FG000|Overall Study|Progressive Disease|2|||
163346476|NCT02744898|589976468|FG000|Overall Study|Physician Decision|1|||
163346477|NCT02744898|589976468|FG000|Overall Study|Toxicity|1|||
163409077|NCT01262365|590207467|FG002|Overall Study|Non-compliance|2|||
163409078|NCT01262365|590207465|FG000|Overall Study|Suspected pregnancy|1|||
163409079|NCT01262365|590207466|FG001|Overall Study|Suspected pregnancy|0|||
163409080|NCT01262365|590207467|FG002|Overall Study|Suspected pregnancy|0|||
163409081|NCT01262365|590207465|FG000|Overall Study|Patient pregnant|1|||
163409082|NCT01262365|590207466|FG001|Overall Study|Patient pregnant|0|||
163346478|NCT04474691|589976469|FG000|Overall Study|Withdrawal by Subject|9|||
163346479|NCT04372186|589976470|FG000|Overall Study|Death|24|||
163346480|NCT04372186|589976471|FG001|Overall Study|Death|11|||
163346481|NCT04372186|589976470|FG000|Overall Study|Transferred to a different facility for care|0|||
163346482|NCT04372186|589976471|FG001|Overall Study|Transferred to a different facility for care|2|||
163409083|NCT01262365|590207467|FG002|Overall Study|Patient pregnant|1|||
163409084|NCT01262365|590207465|FG000|Overall Study|Toxicity related to study drug|0|||
163409085|NCT01262365|590207466|FG001|Overall Study|Toxicity related to study drug|1|||
163409086|NCT01262365|590207467|FG002|Overall Study|Toxicity related to study drug|0|||
163409087|NCT01262365|590207465|FG000|Overall Study|Cannot tolerate the protocol|0|||
163409088|NCT01262365|590207466|FG001|Overall Study|Cannot tolerate the protocol|1|||
163409089|NCT01262365|590207467|FG002|Overall Study|Cannot tolerate the protocol|0|||
163409090|NCT01262365|590207465|FG000|Overall Study|Patient unavailable|0|||
163409091|NCT01262365|590207466|FG001|Overall Study|Patient unavailable|0|||
163409092|NCT01262365|590207467|FG002|Overall Study|Patient unavailable|1|||
163409093|NCT00527605|590207468|FG000|Overall Study|Adverse Event|3|||
163409094|NCT00527605|590207469|FG001|Overall Study|Adverse Event|0|||
163409095|NCT00527605|590207468|FG000|Overall Study|Withdrawal by Subject|3|||
163409096|NCT00527605|590207469|FG001|Overall Study|Withdrawal by Subject|7|||
163409097|NCT00527605|590207468|FG000|Overall Study|Lost to Follow-up|6|||
163409098|NCT00527605|590207469|FG001|Overall Study|Lost to Follow-up|2|||
163409099|NCT00527605|590207468|FG000|Overall Study|Protocol Violation|1|||
163409100|NCT00527605|590207469|FG001|Overall Study|Protocol Violation|2|||
163409101|NCT01363986|590207475|FG000|Overall Study|Disease progression|1|||
163409102|NCT02605642|590207476|FG000|Overall Study|Other|11|||
163409103|NCT02605642|590207477|FG001|Overall Study|Other|1|||
163409104|NCT02605642|590207476|FG000|Overall Study|Participant non-compliance|2|||
163409105|NCT02605642|590207477|FG001|Overall Study|Participant non-compliance|4|||
163409106|NCT02605642|590207476|FG000|Overall Study|Physician Decision|10|||
163409107|NCT02605642|590207477|FG001|Overall Study|Physician Decision|0|||
163409108|NCT02605642|590207476|FG000|Overall Study|Lost to Follow-up|12|||
163409109|NCT02605642|590207477|FG001|Overall Study|Lost to Follow-up|1|||
163409110|NCT02605642|590207476|FG000|Overall Study|Adverse Event|14|||
163409111|NCT02605642|590207477|FG001|Overall Study|Adverse Event|2|||
163409112|NCT02605642|590207476|FG000|Overall Study|Withdrawal by Subject|23|||
163409113|NCT02605642|590207477|FG001|Overall Study|Withdrawal by Subject|2|||
163409114|NCT02605642|590207476|FG000|Overall Study|Lack of response|24|||
163409115|NCT02605642|590207477|FG001|Overall Study|Lack of response|11|||
163409116|NCT02111564|590207480|FG000|Overall Study|Death|109|||
163409117|NCT02111564|590207481|FG001|Overall Study|Death|120|||
163409118|NCT02111564|590207480|FG000|Overall Study|Lost to Follow-up|2|||
163409119|NCT02111564|590207481|FG001|Overall Study|Lost to Follow-up|3|||
163409120|NCT02111564|590207480|FG000|Overall Study|Withdrawal by Subject|20|||
163409121|NCT02111564|590207481|FG001|Overall Study|Withdrawal by Subject|20|||
163409122|NCT00687362|590207482|FG000|Overall Study|Protocol Violation|2|||
163409123|NCT00687362|590207482|FG000|Overall Study|Withdrawal by Subject|1|||
163409124|NCT03704194|590207492|FG000|Overall Study|Withdrawal by Subject|0|||
163409125|NCT03704194|590207493|FG001|Overall Study|Withdrawal by Subject|1|||
163409126|NCT00925015|590207494|FG000|Overall Study|Adverse Event|1|||
163409127|NCT00925015|590207495|FG001|Overall Study|Adverse Event|2|||
163409128|NCT00925015|590207496|FG002|Overall Study|Adverse Event|1|||
163409129|NCT00925015|590207494|FG000|Overall Study|Physician Decision|0|||
163409130|NCT00925015|590207495|FG001|Overall Study|Physician Decision|1|||
163409131|NCT00925015|590207496|FG002|Overall Study|Physician Decision|0|||
163409132|NCT00925015|590207494|FG000|Overall Study|Progressive Disease|7|||
163409133|NCT00925015|590207495|FG001|Overall Study|Progressive Disease|3|||
163409134|NCT00925015|590207496|FG002|Overall Study|Progressive Disease|4|||
163138813|NCT02152761|589217801|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
163138814|NCT02152761|589217802|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
163138815|NCT02152761|589217803|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
163138816|NCT02152761|589217804|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
163138817|NCT02152761|589217801|FG000|Epoch: Treatment Epoch|Death|0|||
163138818|NCT02152761|589217802|FG001|Epoch: Treatment Epoch|Death|3|||
163138819|NCT02152761|589217803|FG002|Epoch: Treatment Epoch|Death|1|||
163138820|NCT02152761|589217804|FG003|Epoch: Treatment Epoch|Death|0|||
163138821|NCT02152761|589217801|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
163138822|NCT02152761|589217802|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
163138823|NCT02152761|589217803|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
163138824|NCT02152761|589217804|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
163138825|NCT02152761|589217801|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
163138826|NCT02152761|589217802|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
163409135|NCT00925015|590207494|FG000|Overall Study|Withdrawal by Subject|0|||
163409136|NCT00925015|590207495|FG001|Overall Study|Withdrawal by Subject|0|||
163409137|NCT00925015|590207496|FG002|Overall Study|Withdrawal by Subject|1|||
163138827|NCT02152761|589217803|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
163138828|NCT02152761|589217804|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
163138829|NCT02152761|589217801|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
163138830|NCT02152761|589217802|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
163409138|NCT00179309|590207499|FG000|Treatment|Toxicity|2|||
163409139|NCT00179309|590207500|FG001|Treatment|Toxicity|3|||
163409140|NCT00179309|590207499|FG000|Treatment|Withdrawal by Subject|1|||
163409141|NCT00179309|590207500|FG001|Treatment|Withdrawal by Subject|2|||
163409142|NCT00179309|590207499|FG000|Treatment|Allergy|1|||
163409143|NCT00179309|590207500|FG001|Treatment|Allergy|0|||
163409144|NCT04986202|590207501|FG000|Overall Study|Death|10|||
163409145|NCT04986202|590207502|FG001|Overall Study|Death|3|||
163409146|NCT04986202|590207503|FG002|Overall Study|Death|10|||
163409147|NCT04986202|590207501|FG000|Overall Study|Physician Decision|3|||
163346483|NCT01911819|589976476|FG000|Overall Study|Adverse Event|0|||
163346484|NCT01911819|589976477|FG001|Overall Study|Adverse Event|1|||
163346485|NCT01911819|589976478|FG002|Overall Study|Adverse Event|0|||
163346486|NCT01911819|589976476|FG000|Overall Study|Withdrawal by Subject|1|||
163346487|NCT01911819|589976477|FG001|Overall Study|Withdrawal by Subject|1|||
163409148|NCT04986202|590207502|FG001|Overall Study|Physician Decision|1|||
163409149|NCT04986202|590207503|FG002|Overall Study|Physician Decision|2|||
163409150|NCT04986202|590207501|FG000|Overall Study|Withdrawal by Subject|4|||
163409151|NCT04986202|590207502|FG001|Overall Study|Withdrawal by Subject|2|||
163409152|NCT04986202|590207503|FG002|Overall Study|Withdrawal by Subject|4|||
163409153|NCT03806127|590207510|FG000|Overall Study|Withdrawal by Subject|4|||
163409154|NCT03806127|590207511|FG001|Overall Study|Withdrawal by Subject|5|||
163409155|NCT03806127|590207510|FG000|Overall Study|Protocol Violation|3|||
163409156|NCT03806127|590207511|FG001|Overall Study|Protocol Violation|1|||
163409157|NCT03806127|590207510|FG000|Overall Study|Adverse Event|3|||
163409158|NCT03806127|590207511|FG001|Overall Study|Adverse Event|0|||
163409159|NCT03806127|590207510|FG000|Overall Study|Unable to Complete Procedures|0|||
163409160|NCT03806127|590207511|FG001|Overall Study|Unable to Complete Procedures|1|||
163409161|NCT03806127|590207510|FG000|Overall Study|Pregnancy|0|||
163409162|NCT03806127|590207511|FG001|Overall Study|Pregnancy|1|||
163409163|NCT03806127|590207510|FG000|Overall Study|Lost to Follow-up|5|||
163409164|NCT03806127|590207511|FG001|Overall Study|Lost to Follow-up|1|||
163409165|NCT03806127|590207510|FG000|Overall Study|Physician Decision|1|||
163409166|NCT03806127|590207511|FG001|Overall Study|Physician Decision|1|||
163409167|NCT03806127|590207510|FG000|Overall Study|Could Not Come Due to Covid|1|||
163346488|NCT01911819|589976478|FG002|Overall Study|Withdrawal by Subject|0|||
163346489|NCT01207453|589976479|FG000|First Intervention|Adverse Event|2|||
163346490|NCT01207453|589976480|FG001|First Intervention|Adverse Event|1|||
163346491|NCT01207453|589976479|FG000|Washout|Adverse Event|1|||
163346492|NCT01207453|589976480|FG001|Washout|Adverse Event|0|||
163346493|NCT01207453|589976479|FG000|Washout|Lost to Follow-up|1|||
163346494|NCT01207453|589976480|FG001|Washout|Lost to Follow-up|0|||
163138831|NCT02152761|589217803|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
163138832|NCT02152761|589217804|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
163138833|NCT02152761|589217801|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
163138834|NCT02152761|589217802|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
163138835|NCT02152761|589217803|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
163138836|NCT02152761|589217804|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
163138837|NCT02152761|589217801|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
163138838|NCT02152761|589217802|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
163138839|NCT02152761|589217803|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
163138840|NCT02152761|589217804|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
163138841|NCT01797263|589217805|FG000|Overall Study|Withdrawal by Subject|21|||
163138842|NCT01797263|589217806|FG001|Overall Study|Withdrawal by Subject|25|||
163138843|NCT01797263|589217805|FG000|Overall Study|Death|1|||
163138844|NCT01797263|589217806|FG001|Overall Study|Death|0|||
163138845|NCT01797263|589217805|FG000|Overall Study|Lost to Follow-up|15|||
163138846|NCT01797263|589217806|FG001|Overall Study|Lost to Follow-up|15|||
163138847|NCT01485094|589217807|FG000|Overall Study|Adverse Event|1|||
163138848|NCT01485094|589217808|FG001|Overall Study|Adverse Event|1|||
163138849|NCT01485094|589217809|FG002|Overall Study|Adverse Event|1|||
163138850|NCT01485094|589217807|FG000|Overall Study|Lost to Follow-up|1|||
163138851|NCT01485094|589217808|FG001|Overall Study|Lost to Follow-up|0|||
163138852|NCT01485094|589217809|FG002|Overall Study|Lost to Follow-up|0|||
163138853|NCT01485094|589217807|FG000|Overall Study|Withdrawal by Subject|1|||
163138854|NCT01485094|589217808|FG001|Overall Study|Withdrawal by Subject|1|||
163138855|NCT01485094|589217809|FG002|Overall Study|Withdrawal by Subject|0|||
163138856|NCT02859246|589217815|FG000|Overall Study|Screen fails|3|||
163138857|NCT02859246|589217815|FG000|Overall Study|Adverse Event|1|||
163409168|NCT03806127|590207511|FG001|Overall Study|Could Not Come Due to Covid|0|||
163409169|NCT03806127|590207510|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
163409170|NCT03806127|590207511|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
163409171|NCT03806127|590207510|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
163409172|NCT03806127|590207511|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
163138858|NCT02859246|589217815|FG000|Overall Study|Withdrawal by Subject|1|||
163138859|NCT00855816|589217818|FG000|Overall Study|Withdrawal by Subject|22|||
163138860|NCT00855816|589217819|FG001|Overall Study|Withdrawal by Subject|15|||
163138861|NCT00855816|589217818|FG000|Overall Study|Lost to Follow-up|3|||
163138862|NCT00855816|589217819|FG001|Overall Study|Lost to Follow-up|5|||
163138863|NCT00855816|589217818|FG000|Overall Study|Death|1|||
163138864|NCT00855816|589217819|FG001|Overall Study|Death|0|||
163138865|NCT00855816|589217818|FG000|Overall Study|Became ineligible|0|||
163138866|NCT00855816|589217819|FG001|Overall Study|Became ineligible|1|||
163138867|NCT00337207|589217826|FG000|Overall Study|Withdrawal by Subject|3|||
163138868|NCT03188432|589217827|FG000|Overall Study|Death|3|||
163346495|NCT01207453|589976479|FG000|2nd Intervention|Adverse Event|1|||
163409173|NCT03806127|590207510|FG000|Overall Study|Covid 19 Restrictions|2|||
163231097|NCT04292730|589558255|FG001|Overall Study|Death|2|||
163231098|NCT04292730|589558256|FG002|Overall Study|Death|4|||
163231099|NCT04292730|589558257|FG003|Overall Study|Death|12|||
163231100|NCT04292730|589558254|FG000|Overall Study|Withdrew Consent|2|||
163231101|NCT04292730|589558255|FG001|Overall Study|Withdrew Consent|2|||
163231102|NCT04292730|589558256|FG002|Overall Study|Withdrew Consent|5|||
163231103|NCT04292730|589558257|FG003|Overall Study|Withdrew Consent|6|||
163231104|NCT04292730|589558254|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163231105|NCT04292730|589558255|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163231106|NCT04292730|589558256|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163231107|NCT04292730|589558257|FG003|Overall Study|Non-Compliance with Study Drug|0|||
163231108|NCT04292730|589558254|FG000|Overall Study|Protocol Violation|0|||
163231109|NCT04292730|589558255|FG001|Overall Study|Protocol Violation|0|||
163231110|NCT04292730|589558256|FG002|Overall Study|Protocol Violation|1|||
163231111|NCT04292730|589558257|FG003|Overall Study|Protocol Violation|0|||
163231112|NCT04292730|589558254|FG000|Overall Study|Randomized but not Treated|8|||
163231113|NCT04292730|589558255|FG001|Overall Study|Randomized but not Treated|4|||
163231114|NCT04292730|589558256|FG002|Overall Study|Randomized but not Treated|0|||
163231115|NCT04292730|589558257|FG003|Overall Study|Randomized but not Treated|14|||
163231116|NCT01527292|589558258|FG000|Overall Study|Physician Decision|0|||
163231117|NCT01527292|589558259|FG001|Overall Study|Physician Decision|3|||
163231118|NCT00314366|589558262|FG000|Overall Study|not treated due to patient medical condi|1|||
163231119|NCT00314366|589558263|FG001|Overall Study|not treated due to patient medical condi|0|||
163231120|NCT01482767|589558264|FG000|Overall Study|Death|1|||
163231121|NCT01482767|589558265|FG001|Overall Study|Death|1|||
163231122|NCT01482767|589558264|FG000|Overall Study|Withdrawal by Subject|7|||
163231123|NCT01482767|589558265|FG001|Overall Study|Withdrawal by Subject|5|||
163231124|NCT01482767|589558264|FG000|Overall Study|Lost to Follow-up|12|||
163231125|NCT01482767|589558265|FG001|Overall Study|Lost to Follow-up|6|||
163231126|NCT01482767|589558264|FG000|Overall Study|Adverse Event|0|||
163231127|NCT01482767|589558265|FG001|Overall Study|Adverse Event|3|||
163231128|NCT01482767|589558264|FG000|Overall Study|Site closure|22|||
163231129|NCT01482767|589558265|FG001|Overall Study|Site closure|14|||
163231130|NCT01482767|589558264|FG000|Overall Study|Non-adherence to study requirements|4|||
163231131|NCT01482767|589558265|FG001|Overall Study|Non-adherence to study requirements|7|||
163231132|NCT01482767|589558264|FG000|Overall Study|Alternate HCV treatment|7|||
163231133|NCT01482767|589558265|FG001|Overall Study|Alternate HCV treatment|8|||
163231134|NCT01482767|589558264|FG000|Overall Study|Ineligible|0|||
163231135|NCT01482767|589558265|FG001|Overall Study|Ineligible|5|||
163231136|NCT01482767|589558264|FG000|Overall Study|Nurse error|1|||
163231137|NCT01482767|589558265|FG001|Overall Study|Nurse error|0|||
163231138|NCT03400033|589558275|FG000|Overall Study|Withdrawal by Subject|1|||
163231139|NCT03400033|589558276|FG001|Overall Study|Withdrawal by Subject|2|||
163231140|NCT01247090|589558279|FG000|Overall Study|Physician Decision|1|||
163231141|NCT01247090|589558280|FG001|Overall Study|Physician Decision|0|||
163231142|NCT01247090|589558281|FG002|Overall Study|Physician Decision|0|||
163231143|NCT01247090|589558279|FG000|Overall Study|Withdrawal by Subject|0|||
163231144|NCT01247090|589558280|FG001|Overall Study|Withdrawal by Subject|1|||
163231145|NCT01247090|589558281|FG002|Overall Study|Withdrawal by Subject|0|||
163231146|NCT00006916|589558283|FG000|Overall Study|Device not inserted|4|||
163231147|NCT00006916|589558283|FG000|Overall Study|Complication of device insertion|1|||
163231148|NCT02457325|589558288|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
163231149|NCT02457325|589558289|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
163231150|NCT01541930|589558294|FG000|Overall Study|Withdrawal by Subject|1|||
163231151|NCT03385239|589558295|FG000|Overall Study|Voluntary Withdrawal|2|||
163231152|NCT03385239|589558296|FG001|Overall Study|Voluntary Withdrawal|3|||
163231153|NCT03385239|589558297|FG002|Overall Study|Voluntary Withdrawal|2|||
163231154|NCT03385239|589558298|FG003|Overall Study|Voluntary Withdrawal|3|||
163231155|NCT03385239|589558299|FG004|Overall Study|Voluntary Withdrawal|0|||
163231156|NCT03385239|589558295|FG000|Overall Study|Adverse Event|0|||
163346496|NCT01207453|589976480|FG001|2nd Intervention|Adverse Event|2|||
163346497|NCT01207453|589976479|FG000|2nd Intervention|Lost to Follow-up|1|||
163346498|NCT01207453|589976480|FG001|2nd Intervention|Lost to Follow-up|0|||
163231157|NCT03385239|589558296|FG001|Overall Study|Adverse Event|0|||
163231158|NCT03385239|589558297|FG002|Overall Study|Adverse Event|1|||
163231159|NCT03385239|589558298|FG003|Overall Study|Adverse Event|0|||
163231160|NCT03385239|589558299|FG004|Overall Study|Adverse Event|0|||
163231161|NCT03385239|589558295|FG000|Overall Study|Other|0|||
163231162|NCT03385239|589558296|FG001|Overall Study|Other|0|||
163231163|NCT03385239|589558297|FG002|Overall Study|Other|0|||
163231164|NCT03385239|589558298|FG003|Overall Study|Other|1|||
163231165|NCT03385239|589558299|FG004|Overall Study|Other|0|||
163231166|NCT01574703|589558300|FG000|Overall Study|Adverse Event|0|||
163231167|NCT01574703|589558301|FG001|Overall Study|Adverse Event|2|||
163231168|NCT01574703|589558302|FG002|Overall Study|Adverse Event|1|||
163231169|NCT01574703|589558303|FG003|Overall Study|Adverse Event|1|||
163231170|NCT01574703|589558300|FG000|Overall Study|Protocol Violation|0|||
163231171|NCT01574703|589558301|FG001|Overall Study|Protocol Violation|0|||
163346499|NCT02951052|589976483|FG000|Overall Study|Adverse Event|13|||
163231172|NCT01574703|589558302|FG002|Overall Study|Protocol Violation|0|||
163231173|NCT01574703|589558303|FG003|Overall Study|Protocol Violation|1|||
163231174|NCT01574703|589558300|FG000|Overall Study|Unspecified Reason|27|||
163231175|NCT01574703|589558301|FG001|Overall Study|Unspecified Reason|15|||
163231176|NCT01574703|589558302|FG002|Overall Study|Unspecified Reason|20|||
163231177|NCT01574703|589558303|FG003|Overall Study|Unspecified Reason|16|||
163231178|NCT01574703|589558300|FG000|Overall Study|Withdrawal by Subject|53|||
163231179|NCT01574703|589558301|FG001|Overall Study|Withdrawal by Subject|52|||
163231180|NCT01574703|589558302|FG002|Overall Study|Withdrawal by Subject|36|||
163231181|NCT01574703|589558303|FG003|Overall Study|Withdrawal by Subject|61|||
163231182|NCT01574703|589558300|FG000|Overall Study|Met Withdrawal Criteria|0|||
163231183|NCT01574703|589558301|FG001|Overall Study|Met Withdrawal Criteria|1|||
163231184|NCT01574703|589558302|FG002|Overall Study|Met Withdrawal Criteria|1|||
163138869|NCT03188432|589217827|FG000|Overall Study|Withdrawal by Subject|15|||
163138870|NCT03188432|589217827|FG000|Overall Study|Did not complete protocol treatment|9|||
163346500|NCT02951052|589976484|FG001|Overall Study|Adverse Event|5|||
163346501|NCT02951052|589976483|FG000|Overall Study|Withdrawal by Subject|1|||
163346502|NCT02951052|589976484|FG001|Overall Study|Withdrawal by Subject|5|||
163346503|NCT02951052|589976483|FG000|Overall Study|Physician Decision|2|||
163346504|NCT02951052|589976484|FG001|Overall Study|Physician Decision|0|||
163231185|NCT01574703|589558303|FG003|Overall Study|Met Withdrawal Criteria|0|||
163231186|NCT01574703|589558300|FG000|Overall Study|Lost to Follow-up|43|||
163231187|NCT01574703|589558301|FG001|Overall Study|Lost to Follow-up|41|||
163231188|NCT01574703|589558302|FG002|Overall Study|Lost to Follow-up|46|||
163231189|NCT01574703|589558303|FG003|Overall Study|Lost to Follow-up|35|||
163231190|NCT01574703|589558300|FG000|Overall Study|Death|2|||
163231191|NCT01574703|589558301|FG001|Overall Study|Death|1|||
163231192|NCT01574703|589558302|FG002|Overall Study|Death|1|||
163231193|NCT01574703|589558303|FG003|Overall Study|Death|0|||
163231194|NCT02553421|589558308|FG000|Overall Study|Lost to Follow-up|21|||
163231195|NCT02553421|589558309|FG001|Overall Study|Lost to Follow-up|1|||
163231196|NCT02553421|589558308|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
163231197|NCT02553421|589558309|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
163231198|NCT02553421|589558308|FG000|Overall Study|Improper Device Placement|3|||
163231199|NCT02553421|589558309|FG001|Overall Study|Improper Device Placement|0|||
163231200|NCT03890367|589558318|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163231201|NCT03890367|589558319|FG001|Overall Study|Withdrawal by parent/guardian|3|||
163231202|NCT03890367|589558320|FG002|Overall Study|Withdrawal by parent/guardian|0|||
163231203|NCT03890367|589558318|FG000|Overall Study|Protocol deviation|2|||
163231204|NCT03890367|589558319|FG001|Overall Study|Protocol deviation|2|||
163231205|NCT03890367|589558320|FG002|Overall Study|Protocol deviation|1|||
163231206|NCT03890367|589558318|FG000|Overall Study|Lost to Follow-up|1|||
163231207|NCT03890367|589558319|FG001|Overall Study|Lost to Follow-up|1|||
163231208|NCT03890367|589558320|FG002|Overall Study|Lost to Follow-up|0|||
163231209|NCT04524403|589560282|FG000|Overall Study|Withdrawal by Subject|10|||
163231210|NCT04524403|589560283|FG001|Overall Study|Withdrawal by Subject|3|||
163231211|NCT04524403|589560284|FG002|Overall Study|Withdrawal by Subject|8|||
163231212|NCT04524403|589560282|FG000|Overall Study|Lost to Follow-up|3|||
163231213|NCT04524403|589560283|FG001|Overall Study|Lost to Follow-up|4|||
163231214|NCT04524403|589560284|FG002|Overall Study|Lost to Follow-up|3|||
163231215|NCT04524403|589560282|FG000|Overall Study|Adverse Event|3|||
163231216|NCT04524403|589560283|FG001|Overall Study|Adverse Event|1|||
163231217|NCT04524403|589560284|FG002|Overall Study|Adverse Event|4|||
163231218|NCT04524403|589560282|FG000|Overall Study|Non-compliant with study drug|1|||
163231219|NCT04524403|589560283|FG001|Overall Study|Non-compliant with study drug|2|||
163231220|NCT04524403|589560284|FG002|Overall Study|Non-compliant with study drug|3|||
163231221|NCT04524403|589560282|FG000|Overall Study|Moved|0|||
163231222|NCT04524403|589560283|FG001|Overall Study|Moved|1|||
163231223|NCT04524403|589560284|FG002|Overall Study|Moved|0|||
163346505|NCT02951052|589976483|FG000|Overall Study|Lost to Follow-up|1|||
163346506|NCT02951052|589976484|FG001|Overall Study|Lost to Follow-up|1|||
163346507|NCT02951052|589976483|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
163346508|NCT02951052|589976484|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
163346509|NCT02951052|589976483|FG000|Overall Study|Protocol Violation|5|||
163231224|NCT00991302|589560285|FG000|Overall Study|Death|0|||
163231225|NCT00991302|589560286|FG001|Overall Study|Death|1|||
163231226|NCT00991302|589560285|FG000|Overall Study|Lost to Follow-up|14|||
163231227|NCT00991302|589560286|FG001|Overall Study|Lost to Follow-up|12|||
163231228|NCT01709318|589560287|FG000|Overall Study|Adverse Event|3|||
163231229|NCT01709318|589560288|FG001|Overall Study|Adverse Event|4|||
163231230|NCT01709318|589560289|FG002|Overall Study|Adverse Event|2|||
163231231|NCT01709318|589560290|FG003|Overall Study|Adverse Event|2|||
163346510|NCT02951052|589976484|FG001|Overall Study|Protocol Violation|3|||
163231232|NCT01709318|589560291|FG004|Overall Study|Adverse Event|0|||
163231233|NCT01709318|589560292|FG005|Overall Study|Adverse Event|1|||
163231234|NCT01709318|589560293|FG006|Overall Study|Adverse Event|2|||
163231235|NCT01709318|589560287|FG000|Overall Study|Lost to Follow-up|2|||
163346511|NCT02951052|589976483|FG000|Overall Study|Lack of Efficacy|3|||
163346512|NCT02951052|589976484|FG001|Overall Study|Lack of Efficacy|4|||
163346513|NCT02951052|589976483|FG000|Overall Study|Ongoing|1|||
163346514|NCT02951052|589976484|FG001|Overall Study|Ongoing|0|||
163346515|NCT01904019|589977617|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
163346516|NCT01904019|589977617|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
163346517|NCT01904019|589977617|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
163346518|NCT01904019|589977617|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
163346519|NCT01904019|589977617|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
163346520|NCT01904019|589977617|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
163346521|NCT00509821|589977618|FG000|Study Period 1 (Induction)|Death|0|||
163346522|NCT00509821|589977619|FG001|Study Period 1 (Induction)|Death|1|||
163346523|NCT00509821|589977618|FG000|Study Period 1 (Induction)|Adverse Event|0|||
163346524|NCT00509821|589977619|FG001|Study Period 1 (Induction)|Adverse Event|2|||
163346525|NCT00509821|589977618|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
163346526|NCT00509821|589977619|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
163346527|NCT01816685|589977620|FG000|Overall Study|Lost to Follow-up|7|||
163346528|NCT01816685|589977621|FG001|Overall Study|Lost to Follow-up|9|||
163346529|NCT01816685|589977620|FG000|Overall Study|Surgery Cancelled|3|||
163346530|NCT01816685|589977621|FG001|Overall Study|Surgery Cancelled|2|||
163346531|NCT01157351|589977622|FG000|Overall Study|Adverse Event|5|||
163346532|NCT01157351|589977623|FG001|Overall Study|Adverse Event|4|||
163346533|NCT01157351|589977622|FG000|Overall Study|Death|1|||
163346534|NCT01157351|589977623|FG001|Overall Study|Death|0|||
163346535|NCT01157351|589977622|FG000|Overall Study|Lost to Follow-up|53|||
163346536|NCT01157351|589977623|FG001|Overall Study|Lost to Follow-up|55|||
163346537|NCT01157351|589977622|FG000|Overall Study|Withdrawal by Subject|37|||
163346538|NCT01157351|589977623|FG001|Overall Study|Withdrawal by Subject|27|||
163346539|NCT01157351|589977622|FG000|Overall Study|Physician Decision|5|||
163346540|NCT01157351|589977623|FG001|Overall Study|Physician Decision|4|||
163346541|NCT01157351|589977622|FG000|Overall Study|Protocol Violation|0|||
163346542|NCT01157351|589977623|FG001|Overall Study|Protocol Violation|1|||
163346543|NCT01157351|589977622|FG000|Overall Study|Other|32|||
163346544|NCT01157351|589977623|FG001|Overall Study|Other|36|||
163346545|NCT01157351|589977622|FG000|Overall Study|Noncompliance with Study Drug|0|||
163346546|NCT01157351|589977623|FG001|Overall Study|Noncompliance with Study Drug|3|||
163346547|NCT01157351|589977622|FG000|Overall Study|Randomized but not Treated|4|||
163346548|NCT01157351|589977623|FG001|Overall Study|Randomized but not Treated|2|||
163346549|NCT01589523|589977624|FG000|Overall Study|Withdrawal by Subject|1|||
163346550|NCT00332488|589977625|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
163346551|NCT00332488|589977626|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
163346552|NCT00332488|589977627|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
163346553|NCT00332488|589977625|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
163346554|NCT00332488|589977626|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
163346555|NCT00332488|589977627|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
163346556|NCT00332488|589977625|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
163346557|NCT00332488|589977626|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
163346558|NCT00332488|589977627|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
163346559|NCT00332488|589977625|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
163346560|NCT00332488|589977626|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
163346561|NCT00332488|589977627|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
163346562|NCT00332488|589977625|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
163346563|NCT00332488|589977626|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
163346564|NCT00332488|589977627|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
163346565|NCT00332488|589977625|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
163346566|NCT00332488|589977626|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
163346567|NCT00332488|589977627|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
163346568|NCT00332488|589977625|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
163346569|NCT00332488|589977626|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
163346570|NCT00332488|589977627|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
163346571|NCT00332488|589977625|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
163346572|NCT00332488|589977626|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
163346573|NCT00332488|589977627|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
163346574|NCT00332488|589977625|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
163346575|NCT00332488|589977626|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
163346576|NCT00332488|589977627|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
163346577|NCT00332488|589977625|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
163346578|NCT00332488|589977626|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
163346579|NCT00332488|589977627|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
163346580|NCT00332488|589977625|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
163346581|NCT00332488|589977626|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
163346582|NCT00332488|589977627|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
163346583|NCT00332488|589977625|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
163231236|NCT01709318|589560288|FG001|Overall Study|Lost to Follow-up|0|||
163231237|NCT01709318|589560289|FG002|Overall Study|Lost to Follow-up|0|||
163231238|NCT01709318|589560290|FG003|Overall Study|Lost to Follow-up|0|||
163231239|NCT01709318|589560291|FG004|Overall Study|Lost to Follow-up|1|||
163231240|NCT01709318|589560292|FG005|Overall Study|Lost to Follow-up|1|||
163231241|NCT01709318|589560293|FG006|Overall Study|Lost to Follow-up|1|||
163231242|NCT01709318|589560287|FG000|Overall Study|Non-compliance with Study Drug|0|||
163231243|NCT01709318|589560288|FG001|Overall Study|Non-compliance with Study Drug|2|||
163231244|NCT01709318|589560289|FG002|Overall Study|Non-compliance with Study Drug|1|||
163231245|NCT01709318|589560290|FG003|Overall Study|Non-compliance with Study Drug|1|||
163231246|NCT01709318|589560291|FG004|Overall Study|Non-compliance with Study Drug|0|||
163231247|NCT01709318|589560292|FG005|Overall Study|Non-compliance with Study Drug|0|||
163231248|NCT01709318|589560293|FG006|Overall Study|Non-compliance with Study Drug|2|||
163231249|NCT01709318|589560287|FG000|Overall Study|Physician Decision|0|||
163231250|NCT01709318|589560288|FG001|Overall Study|Physician Decision|0|||
163231251|NCT01709318|589560289|FG002|Overall Study|Physician Decision|0|||
163231252|NCT01709318|589560290|FG003|Overall Study|Physician Decision|0|||
163231253|NCT01709318|589560291|FG004|Overall Study|Physician Decision|0|||
163231254|NCT01709318|589560292|FG005|Overall Study|Physician Decision|0|||
163231255|NCT01709318|589560293|FG006|Overall Study|Physician Decision|1|||
163231256|NCT01709318|589560287|FG000|Overall Study|Pregnancy|0|||
163231257|NCT01709318|589560288|FG001|Overall Study|Pregnancy|0|||
163231258|NCT01709318|589560289|FG002|Overall Study|Pregnancy|0|||
163231259|NCT01709318|589560290|FG003|Overall Study|Pregnancy|0|||
163231260|NCT01709318|589560291|FG004|Overall Study|Pregnancy|1|||
163231261|NCT01709318|589560292|FG005|Overall Study|Pregnancy|0|||
163231262|NCT01709318|589560293|FG006|Overall Study|Pregnancy|0|||
163231263|NCT01709318|589560287|FG000|Overall Study|Protocol Violation|0|||
163231264|NCT01709318|589560288|FG001|Overall Study|Protocol Violation|0|||
163231265|NCT01709318|589560289|FG002|Overall Study|Protocol Violation|0|||
163231266|NCT01709318|589560290|FG003|Overall Study|Protocol Violation|0|||
163231267|NCT01709318|589560291|FG004|Overall Study|Protocol Violation|2|||
163231268|NCT01709318|589560292|FG005|Overall Study|Protocol Violation|0|||
163231269|NCT01709318|589560293|FG006|Overall Study|Protocol Violation|1|||
163231270|NCT01709318|589560287|FG000|Overall Study|Technical Problems|1|||
163231271|NCT01709318|589560288|FG001|Overall Study|Technical Problems|0|||
163231272|NCT01709318|589560289|FG002|Overall Study|Technical Problems|0|||
163231273|NCT01709318|589560290|FG003|Overall Study|Technical Problems|0|||
163231274|NCT01709318|589560291|FG004|Overall Study|Technical Problems|0|||
163231275|NCT01709318|589560292|FG005|Overall Study|Technical Problems|0|||
163231276|NCT01709318|589560293|FG006|Overall Study|Technical Problems|0|||
163231277|NCT01709318|589560287|FG000|Overall Study|Withdrawal by Subject|3|||
163231278|NCT01709318|589560288|FG001|Overall Study|Withdrawal by Subject|0|||
163231279|NCT01709318|589560289|FG002|Overall Study|Withdrawal by Subject|3|||
163231280|NCT01709318|589560290|FG003|Overall Study|Withdrawal by Subject|3|||
163231281|NCT01709318|589560291|FG004|Overall Study|Withdrawal by Subject|0|||
163231282|NCT01709318|589560292|FG005|Overall Study|Withdrawal by Subject|2|||
163231283|NCT01709318|589560293|FG006|Overall Study|Withdrawal by Subject|4|||
163231284|NCT01709318|589560287|FG000|Overall Study|Other Protocol Specified Criteria|0|||
163346584|NCT00332488|589977626|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
163346585|NCT00332488|589977627|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
163346586|NCT00792259|589977628|FG000|Overall Study|Poor Quality Scans|1|||
163346587|NCT00792259|589977629|FG001|Overall Study|Poor Quality Scans|0|||
163346588|NCT00792259|589977630|FG002|Overall Study|Poor Quality Scans|0|||
163346589|NCT00371462|589977631|FG000|Overall Study|Withdrawal by Subject|1|||
163346590|NCT00371462|589977632|FG001|Overall Study|Withdrawal by Subject|0|||
163346591|NCT00371462|589977631|FG000|Overall Study|Other|7|||
163346592|NCT00371462|589977632|FG001|Overall Study|Other|8|||
163346593|NCT03721978|589977633|FG000|Overall Study|Withdrawal by Subject|6|||
163346594|NCT03721978|589977634|FG001|Overall Study|Withdrawal by Subject|1|||
163346595|NCT03721978|589977633|FG000|Overall Study|Adverse Event|1|||
163346596|NCT03721978|589977634|FG001|Overall Study|Adverse Event|1|||
163346597|NCT03721978|589977633|FG000|Overall Study|Progressive Disease|1|||
163346598|NCT03721978|589977634|FG001|Overall Study|Progressive Disease|0|||
163346599|NCT03721978|589977633|FG000|Overall Study|Lost to Follow-up|5|||
163409174|NCT03806127|590207511|FG001|Overall Study|Covid 19 Restrictions|0|||
163231285|NCT01709318|589560288|FG001|Overall Study|Other Protocol Specified Criteria|1|||
163409175|NCT03806127|590207510|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
163231286|NCT01709318|589560289|FG002|Overall Study|Other Protocol Specified Criteria|0|||
163231287|NCT01709318|589560290|FG003|Overall Study|Other Protocol Specified Criteria|0|||
163231288|NCT01709318|589560291|FG004|Overall Study|Other Protocol Specified Criteria|0|||
163231289|NCT01709318|589560292|FG005|Overall Study|Other Protocol Specified Criteria|0|||
163231290|NCT01709318|589560293|FG006|Overall Study|Other Protocol Specified Criteria|0|||
163231291|NCT00646958|589560298|FG000|Overall Study|Lack of Efficacy|1|||
163231292|NCT00646958|589560299|FG001|Overall Study|Lack of Efficacy|0|||
163231293|NCT00646958|589560300|FG002|Overall Study|Lack of Efficacy|0|||
163231294|NCT00646958|589560298|FG000|Overall Study|Adverse Event|4|||
163346600|NCT03721978|589977634|FG001|Overall Study|Lost to Follow-up|1|||
163231295|NCT00646958|589560299|FG001|Overall Study|Adverse Event|0|||
163346601|NCT03721978|589977633|FG000|Overall Study|Reason not Specified|0|||
163346602|NCT03721978|589977634|FG001|Overall Study|Reason not Specified|2|||
163346603|NCT05244226|589977635|FG000|Overall Study|Adverse Event|1|||
163346604|NCT05244226|589977636|FG001|Overall Study|Adverse Event|0|||
163346605|NCT05244226|589977637|FG002|Overall Study|Adverse Event|0|||
163346606|NCT05244226|589977635|FG000|Overall Study|Lost to Follow-up|0|||
163346607|NCT05244226|589977636|FG001|Overall Study|Lost to Follow-up|0|||
163346608|NCT05244226|589977637|FG002|Overall Study|Lost to Follow-up|1|||
163346609|NCT05244226|589977635|FG000|Overall Study|Protocol Violation|0|||
163346610|NCT05244226|589977636|FG001|Overall Study|Protocol Violation|2|||
163346611|NCT05244226|589977637|FG002|Overall Study|Protocol Violation|2|||
163346612|NCT00917462|589977638|FG000|Overall Study|Clinical Deterioration|1|||
163346613|NCT01441583|589977639|FG000|Overall Study|Withdrawal by Subject|1|||
163346614|NCT01441583|589977640|FG001|Overall Study|Withdrawal by Subject|1|||
163346615|NCT01441583|589977641|FG002|Overall Study|Withdrawal by Subject|1|||
163346616|NCT01441583|589977639|FG000|Overall Study|Death|1|||
163346617|NCT01441583|589977640|FG001|Overall Study|Death|0|||
163346618|NCT01441583|589977641|FG002|Overall Study|Death|4|||
163346619|NCT01441583|589977639|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
163346620|NCT01441583|589977640|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
163346621|NCT01441583|589977641|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
163346622|NCT03341312|589977642|FG000|Period 1|Withdrawal by Subject|0|||
163346623|NCT03341312|589977643|FG001|Period 1|Withdrawal by Subject|1|||
163231296|NCT00646958|589560300|FG002|Overall Study|Adverse Event|0|||
163231297|NCT00646958|589560298|FG000|Overall Study|Lost to Follow-up|1|||
163231298|NCT00646958|589560299|FG001|Overall Study|Lost to Follow-up|5|||
163231299|NCT00646958|589560300|FG002|Overall Study|Lost to Follow-up|7|||
163231300|NCT00646958|589560298|FG000|Overall Study|Protocol Violation|1|||
163231301|NCT00646958|589560299|FG001|Overall Study|Protocol Violation|1|||
163231302|NCT00646958|589560300|FG002|Overall Study|Protocol Violation|0|||
163231303|NCT00646958|589560298|FG000|Overall Study|Abnormal screening lab tests|1|||
163231304|NCT00646958|589560299|FG001|Overall Study|Abnormal screening lab tests|1|||
163231305|NCT00646958|589560300|FG002|Overall Study|Abnormal screening lab tests|0|||
163231306|NCT00646958|589560298|FG000|Overall Study|Withdrawal by Subject|1|||
163231307|NCT00646958|589560299|FG001|Overall Study|Withdrawal by Subject|2|||
163231308|NCT00646958|589560300|FG002|Overall Study|Withdrawal by Subject|0|||
163231309|NCT00646958|589560298|FG000|Overall Study|Did not receive study drug|2|||
163231310|NCT00646958|589560299|FG001|Overall Study|Did not receive study drug|0|||
163231311|NCT00646958|589560300|FG002|Overall Study|Did not receive study drug|2|||
163346624|NCT03341312|589977644|FG002|Period 1|Withdrawal by Subject|0|||
163346625|NCT03341312|589977645|FG003|Period 1|Withdrawal by Subject|0|||
163346626|NCT05372913|589977649|FG000|Overall Study|Withdrawal by Subject|0|||
163346627|NCT05372913|589977650|FG001|Overall Study|Withdrawal by Subject|2|||
163346628|NCT05372913|589977649|FG000|Overall Study|Protocol Violation|2|||
163346629|NCT05372913|589977650|FG001|Overall Study|Protocol Violation|2|||
163346630|NCT05372913|589977649|FG000|Overall Study|Adverse Event|0|||
163346631|NCT05372913|589977650|FG001|Overall Study|Adverse Event|1|||
163346632|NCT03303521|589977651|FG000|Overall Study|Withdrawal by Subject|2|||
163346633|NCT03303521|589977652|FG001|Overall Study|Withdrawal by Subject|0|||
163346634|NCT03303521|589977651|FG000|Overall Study|Death|1|||
163346635|NCT03303521|589977652|FG001|Overall Study|Death|0|||
163346636|NCT03303521|589977651|FG000|Overall Study|Kidney transplantation|0|||
163346637|NCT03303521|589977652|FG001|Overall Study|Kidney transplantation|1|||
163346638|NCT03303521|589977651|FG000|Overall Study|Investigational product discontinuation|0|||
163346639|NCT03303521|589977652|FG001|Overall Study|Investigational product discontinuation|1|||
163346640|NCT03303521|589977651|FG000|Overall Study|Transferred to non-study dialysis center|1|||
163346641|NCT03303521|589977652|FG001|Overall Study|Transferred to non-study dialysis center|0|||
163346642|NCT03303521|589977651|FG000|Overall Study|Non-comliance to study protocol|0|||
163346643|NCT03303521|589977652|FG001|Overall Study|Non-comliance to study protocol|1|||
163346644|NCT03303521|589977651|FG000|Overall Study|Adverse Event|1|||
163346645|NCT03303521|589977652|FG001|Overall Study|Adverse Event|0|||
163346646|NCT00191984|589977653|FG000|Overall Study|Disease Progression|21|||
163231312|NCT00827372|589560301|FG000|Overall Study|Adverse Event|5|||
163346647|NCT00191984|589977653|FG000|Overall Study|Adverse Event|4|||
163346648|NCT00191984|589977653|FG000|Overall Study|Death|2|||
163346649|NCT00191984|589977653|FG000|Overall Study|Entry Criteria Exclusion|1|||
163346650|NCT00191984|589977653|FG000|Overall Study|Withdrawal by Subject|7|||
163346651|NCT00191984|589977653|FG000|Overall Study|Physician Decision|4|||
163346652|NCT01654289|589977654|FG000|Overall Study|Withdrawal by Subject|10|||
163231313|NCT00827372|589560301|FG000|Overall Study|Lack of Efficacy|3|||
163231314|NCT02139644|589560302|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
163231315|NCT02139644|589560303|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163346653|NCT01654289|589977655|FG001|Overall Study|Withdrawal by Subject|8|||
163346654|NCT01654289|589977656|FG002|Overall Study|Withdrawal by Subject|5|||
163346655|NCT01654289|589977654|FG000|Overall Study|Withdrew from intervention only|17|||
163346656|NCT01654289|589977655|FG001|Overall Study|Withdrew from intervention only|20|||
163346657|NCT01654289|589977656|FG002|Overall Study|Withdrew from intervention only|0|||
163346658|NCT00005908|589977658|FG000|Overall Study|Withdrawal by Subject|1|||
163346659|NCT00005908|589977659|FG001|Overall Study|Withdrawal by Subject|0|||
163346660|NCT04748445|589977662|FG000|Overall Study|No longer met eligibility criteria|12|||
163346661|NCT04748445|589977662|FG000|Overall Study|Other|36|||
163346662|NCT04748445|589977662|FG000|Overall Study|Withdrawal by Subject|553|||
163346663|NCT04748445|589977662|FG000|Overall Study|Lost to Follow-up|30|||
163346664|NCT04736602|589977663|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
163346665|NCT04736602|589977663|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
163346666|NCT01485991|589977670|FG000|Overall Study|Adverse Event|0|||
163346667|NCT01485991|589977671|FG001|Overall Study|Adverse Event|4|||
163346668|NCT01485991|589977670|FG000|Overall Study|Lost to Follow-up|13|||
163346669|NCT01485991|589977671|FG001|Overall Study|Lost to Follow-up|10|||
163346670|NCT01485991|589977670|FG000|Overall Study|Withdrawal by Subject|13|||
163346671|NCT01485991|589977671|FG001|Overall Study|Withdrawal by Subject|20|||
163346672|NCT01485991|589977670|FG000|Overall Study|randomized but not treated|6|||
163346673|NCT01485991|589977671|FG001|Overall Study|randomized but not treated|2|||
163346674|NCT02538471|589977672|FG000|Overall Study|Progression of disease|2|||
163346675|NCT02350127|589977673|FG000|4-Month Assessment|Withdrawal by Subject|10|||
163346676|NCT02350127|589977674|FG001|4-Month Assessment|Withdrawal by Subject|9|||
163346677|NCT02350127|589977673|FG000|4-Month Assessment|Death|1|||
163346678|NCT02350127|589977674|FG001|4-Month Assessment|Death|0|||
163346679|NCT02350127|589977673|FG000|8-Month Assessment|Death|1|||
163346680|NCT02350127|589977674|FG001|8-Month Assessment|Death|1|||
163346681|NCT02350127|589977673|FG000|8-Month Assessment|Withdrawal by Subject|5|||
163346682|NCT02350127|589977674|FG001|8-Month Assessment|Withdrawal by Subject|8|||
163346683|NCT00157209|589977675|FG000|Overall Study|Ongoing at data cut-off|10|||
163346684|NCT00157209|589977676|FG001|Overall Study|Ongoing at data cut-off|0|||
163346685|NCT01348763|589977677|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
163346686|NCT01348763|589977677|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
163346687|NCT01247922|589977687|FG000|Overall Study|Disease progression|4|||
163346688|NCT01876823|589977688|FG000|Overall Study|Withdrawal by Subject|5|||
163346689|NCT01876823|589977688|FG000|Overall Study|Physician Decision|2|||
163346690|NCT01876823|589977688|FG000|Overall Study|Patients moved|2|||
163346691|NCT00577096|589977689|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
163346692|NCT00577096|589977690|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
163346693|NCT00577096|589977689|FG000|Short Term Participation|Withdrawal by Subject|3|||
163346694|NCT00577096|589977690|FG001|Short Term Participation|Withdrawal by Subject|5|||
163346695|NCT00577096|589977689|FG000|Short Term Participation|Death|1|||
163346696|NCT00577096|589977690|FG001|Short Term Participation|Death|1|||
163346697|NCT00440037|589977696|FG000|Overall Study|Withdrawal by Subject|6|||
163346698|NCT00440037|589977696|FG000|Overall Study|Administrative decision|3|||
163346699|NCT00794573|589977697|FG000|Overall Study|Death|3|||
163346700|NCT00794573|589977698|FG001|Overall Study|Death|0|||
163346701|NCT00794573|589977697|FG000|Overall Study|Withdrawal by Subject|9|||
163346702|NCT00794573|589977698|FG001|Overall Study|Withdrawal by Subject|12|||
163346703|NCT00794573|589977697|FG000|Overall Study|Lost to Follow-up|26|||
163346704|NCT00794573|589977698|FG001|Overall Study|Lost to Follow-up|33|||
163346705|NCT03740919|589977699|FG000|Lead-in Period|Lost to Follow-up|1|||
163346706|NCT03740919|589977700|FG001|Lead-in Period|Lost to Follow-up|0|||
163346707|NCT03740919|589977701|FG002|Lead-in Period|Lost to Follow-up|0|||
163346708|NCT03740919|589977702|FG003|Lead-in Period|Lost to Follow-up|0|||
163346709|NCT03740919|589977699|FG000|Lead-in Period|Physician Decision|2|||
163346710|NCT03740919|589977700|FG001|Lead-in Period|Physician Decision|0|||
163346711|NCT03740919|589977701|FG002|Lead-in Period|Physician Decision|0|||
163346712|NCT03740919|589977702|FG003|Lead-in Period|Physician Decision|0|||
163346713|NCT03740919|589977699|FG000|Lead-in Period|Protocol Violation|1|||
163346714|NCT03740919|589977700|FG001|Lead-in Period|Protocol Violation|0|||
163346715|NCT03740919|589977701|FG002|Lead-in Period|Protocol Violation|0|||
163346716|NCT03740919|589977702|FG003|Lead-in Period|Protocol Violation|0|||
163346717|NCT03740919|589977699|FG000|Lead-in Period|Withdrawal by Subject|10|||
163346718|NCT03740919|589977700|FG001|Lead-in Period|Withdrawal by Subject|0|||
163346719|NCT03740919|589977701|FG002|Lead-in Period|Withdrawal by Subject|0|||
163346720|NCT03740919|589977702|FG003|Lead-in Period|Withdrawal by Subject|0|||
163346721|NCT03740919|589977699|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
163346722|NCT03740919|589977700|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
163346723|NCT03740919|589977701|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
163346724|NCT03740919|589977702|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
163346725|NCT03740919|589977699|FG000|Lead-in Period|Study Task Too Burdensome|1|||
163346726|NCT03740919|589977700|FG001|Lead-in Period|Study Task Too Burdensome|0|||
163346727|NCT03740919|589977701|FG002|Lead-in Period|Study Task Too Burdensome|0|||
163346728|NCT03740919|589977702|FG003|Lead-in Period|Study Task Too Burdensome|0|||
163138881|NCT02562716|589217830|FG000|Overall Study|Adverse Event|7|||
163346729|NCT03740919|589977699|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
163346730|NCT03740919|589977700|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
163231316|NCT02139644|589560304|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163231317|NCT02139644|589560305|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163231318|NCT02139644|589560306|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163231319|NCT02139644|589560307|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163231320|NCT02139644|589560302|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
163231321|NCT02139644|589560303|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163231322|NCT02139644|589560304|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163231323|NCT02139644|589560305|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163231324|NCT02139644|589560306|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163231325|NCT02139644|589560307|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163231326|NCT02139644|589560302|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
163231327|NCT02139644|589560303|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163231328|NCT02139644|589560304|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163231329|NCT02139644|589560305|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163231330|NCT02139644|589560306|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163231331|NCT02139644|589560307|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163231332|NCT02139644|589560302|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
163231333|NCT02139644|589560303|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163231334|NCT02139644|589560304|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163231335|NCT02139644|589560305|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163231336|NCT02139644|589560306|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163231337|NCT02139644|589560307|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163231338|NCT02139644|589560302|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
163231339|NCT02139644|589560303|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163231340|NCT02139644|589560304|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163231341|NCT02139644|589560305|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163231342|NCT02139644|589560306|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163231343|NCT02139644|589560307|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163231344|NCT02139644|589560302|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
163231345|NCT02139644|589560303|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
163231346|NCT02139644|589560304|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
163231347|NCT02139644|589560305|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
163231348|NCT02139644|589560306|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
163231349|NCT02139644|589560307|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
163231350|NCT02139644|589560302|FG000|Run-In Period (Pre-assignment)|Other|6|||
163231351|NCT02139644|589560303|FG001|Run-In Period (Pre-assignment)|Other|0|||
163231352|NCT02139644|589560304|FG002|Run-In Period (Pre-assignment)|Other|0|||
163231353|NCT02139644|589560305|FG003|Run-In Period (Pre-assignment)|Other|0|||
163231354|NCT02139644|589560306|FG004|Run-In Period (Pre-assignment)|Other|0|||
163231355|NCT02139644|589560307|FG005|Run-In Period (Pre-assignment)|Other|0|||
163231356|NCT02139644|589560302|FG000|Treatment Period|Adverse Event|0|||
163231357|NCT02139644|589560303|FG001|Treatment Period|Adverse Event|0|||
163231358|NCT02139644|589560304|FG002|Treatment Period|Adverse Event|3|||
163231359|NCT02139644|589560305|FG003|Treatment Period|Adverse Event|2|||
163231360|NCT02139644|589560306|FG004|Treatment Period|Adverse Event|1|||
163231361|NCT02139644|589560307|FG005|Treatment Period|Adverse Event|6|||
163231362|NCT02139644|589560302|FG000|Treatment Period|Withdrawal by Subject|0|||
163231363|NCT02139644|589560303|FG001|Treatment Period|Withdrawal by Subject|0|||
163231364|NCT02139644|589560304|FG002|Treatment Period|Withdrawal by Subject|2|||
163231365|NCT02139644|589560305|FG003|Treatment Period|Withdrawal by Subject|2|||
163231366|NCT02139644|589560306|FG004|Treatment Period|Withdrawal by Subject|3|||
163231367|NCT02139644|589560307|FG005|Treatment Period|Withdrawal by Subject|2|||
163231368|NCT02139644|589560302|FG000|Treatment Period|Non-compliance|0|||
163231369|NCT02139644|589560303|FG001|Treatment Period|Non-compliance|0|||
163346731|NCT03740919|589977701|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
163346732|NCT03740919|589977702|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
163346733|NCT03740919|589977699|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
163346734|NCT03740919|589977700|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
163346735|NCT03740919|589977701|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
163346736|NCT03740919|589977702|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
163346737|NCT03740919|589977699|FG000|Treatment Period|Adverse Event|0|||
163231370|NCT02139644|589560304|FG002|Treatment Period|Non-compliance|0|||
163346738|NCT03740919|589977700|FG001|Treatment Period|Adverse Event|0|||
163346739|NCT03740919|589977701|FG002|Treatment Period|Adverse Event|2|||
163231371|NCT02139644|589560305|FG003|Treatment Period|Non-compliance|1|||
163231372|NCT02139644|589560306|FG004|Treatment Period|Non-compliance|0|||
163231373|NCT02139644|589560307|FG005|Treatment Period|Non-compliance|0|||
163231374|NCT02139644|589560302|FG000|Treatment Period|Protocol Violation|0|||
163231375|NCT02139644|589560303|FG001|Treatment Period|Protocol Violation|0|||
163231376|NCT02139644|589560304|FG002|Treatment Period|Protocol Violation|0|||
163346740|NCT03740919|589977702|FG003|Treatment Period|Adverse Event|0|||
163346741|NCT03740919|589977699|FG000|Treatment Period|Protocol Violation|0|||
163138882|NCT02562716|589217831|FG001|Overall Study|Adverse Event|14|||
163138883|NCT02562716|589217830|FG000|Overall Study|Withdrawal unrelated to AE|7|||
163138884|NCT02562716|589217831|FG001|Overall Study|Withdrawal unrelated to AE|1|||
163138885|NCT02562716|589217830|FG000|Overall Study|Progression|8|||
163138886|NCT02562716|589217831|FG001|Overall Study|Progression|10|||
163138887|NCT02562716|589217830|FG000|Overall Study|Death|2|||
163138888|NCT02562716|589217831|FG001|Overall Study|Death|1|||
163138889|NCT02562716|589217830|FG000|Overall Study|Not protocol specified|4|||
163138890|NCT02562716|589217831|FG001|Overall Study|Not protocol specified|2|||
163138891|NCT02753946|589217832|FG000|Overall Study|Adverse Event|7|||
163138892|NCT02753946|589217833|FG001|Overall Study|Adverse Event|6|||
163138893|NCT02753946|589217832|FG000|Overall Study|Withdrawal by Subject|6|||
163138894|NCT02753946|589217833|FG001|Overall Study|Withdrawal by Subject|1|||
163138895|NCT02753946|589217832|FG000|Overall Study|Lack of Efficacy|1|||
163138896|NCT02753946|589217833|FG001|Overall Study|Lack of Efficacy|0|||
163138897|NCT02753946|589217832|FG000|Overall Study|Physician Decision|0|||
163138898|NCT02753946|589217833|FG001|Overall Study|Physician Decision|2|||
163138899|NCT02175017|589217834|FG000|Overall Study|Did not receive the investigational product|1|||
163138900|NCT02175017|589217835|FG001|Overall Study|Did not receive the investigational product|2|||
163138901|NCT02175017|589217834|FG000|Overall Study|Withdrawal by Subject|6|||
163138902|NCT02175017|589217835|FG001|Overall Study|Withdrawal by Subject|3|||
163138903|NCT02175017|589217834|FG000|Overall Study|Met an exclusion criteria|0|||
163138904|NCT02175017|589217835|FG001|Overall Study|Met an exclusion criteria|1|||
163138905|NCT02175017|589217834|FG000|Overall Study|Adverse Event|3|||
163138906|NCT02175017|589217835|FG001|Overall Study|Adverse Event|10|||
163138907|NCT02175017|589217834|FG000|Overall Study|Disease progression|20|||
163138908|NCT02175017|589217835|FG001|Overall Study|Disease progression|27|||
163138909|NCT02175017|589217834|FG000|Overall Study|Other than above reasons|3|||
163138910|NCT02175017|589217835|FG001|Overall Study|Other than above reasons|0|||
163138911|NCT04915729|589217836|FG000|Overall Study|Lost to Follow-up|20|||
163138912|NCT04915729|589217837|FG001|Overall Study|Lost to Follow-up|10|||
163138913|NCT04915729|589217836|FG000|Overall Study|Withdrawal by Subject|12|||
163138914|NCT04915729|589217837|FG001|Overall Study|Withdrawal by Subject|5|||
163138915|NCT04915729|589217836|FG000|Overall Study|Death|34|||
163138916|NCT04915729|589217837|FG001|Overall Study|Death|44|||
163138917|NCT04915729|589217836|FG000|Overall Study|not treated|3|||
163138918|NCT04915729|589217837|FG001|Overall Study|not treated|6|||
163138919|NCT04915729|589217836|FG000|Overall Study|Investigator removed subject|1|||
163138920|NCT04915729|589217837|FG001|Overall Study|Investigator removed subject|2|||
163138921|NCT04915729|589217836|FG000|Overall Study|questionnaire result not evaluated|1|||
163138922|NCT04915729|589217837|FG001|Overall Study|questionnaire result not evaluated|0|||
163138923|NCT04915729|589217836|FG000|Overall Study|refuse of hospital visit|1|||
163138924|NCT04915729|589217837|FG001|Overall Study|refuse of hospital visit|3|||
163138925|NCT04915729|589217836|FG000|Overall Study|Subject withdrew|1|||
163138926|NCT04915729|589217837|FG001|Overall Study|Subject withdrew|0|||
163138927|NCT04961541|589217838|FG000|Overall Study|Adverse Event|0|||
163138928|NCT04961541|589217839|FG001|Overall Study|Adverse Event|0|||
163138929|NCT04961541|589217840|FG002|Overall Study|Adverse Event|0|||
163138930|NCT04961541|589217841|FG003|Overall Study|Adverse Event|0|||
163138931|NCT04961541|589217842|FG004|Overall Study|Adverse Event|0|||
163138932|NCT04961541|589217843|FG005|Overall Study|Adverse Event|1|||
163138933|NCT04961541|589217844|FG006|Overall Study|Adverse Event|0|||
163138934|NCT04961541|589217845|FG007|Overall Study|Adverse Event|0|||
163138935|NCT04961541|589217846|FG008|Overall Study|Adverse Event|0|||
163138936|NCT04961541|589217847|FG009|Overall Study|Adverse Event|0|||
163138937|NCT04961541|589217848|FG010|Overall Study|Adverse Event|0|||
163138938|NCT04961541|589217849|FG011|Overall Study|Adverse Event|0|||
163138939|NCT04961541|589217850|FG012|Overall Study|Adverse Event|0|||
163138940|NCT04961541|589217851|FG013|Overall Study|Adverse Event|0|||
163138941|NCT04961541|589217838|FG000|Overall Study|Lost to Follow-up|0|||
163138942|NCT04961541|589217839|FG001|Overall Study|Lost to Follow-up|0|||
163138943|NCT04961541|589217840|FG002|Overall Study|Lost to Follow-up|3|||
163138944|NCT04961541|589217841|FG003|Overall Study|Lost to Follow-up|0|||
163138945|NCT04961541|589217842|FG004|Overall Study|Lost to Follow-up|0|||
163138946|NCT04961541|589217843|FG005|Overall Study|Lost to Follow-up|0|||
163138947|NCT04961541|589217844|FG006|Overall Study|Lost to Follow-up|1|||
163138948|NCT04961541|589217845|FG007|Overall Study|Lost to Follow-up|1|||
163138949|NCT04961541|589217846|FG008|Overall Study|Lost to Follow-up|0|||
163138950|NCT04961541|589217847|FG009|Overall Study|Lost to Follow-up|1|||
163138951|NCT04961541|589217848|FG010|Overall Study|Lost to Follow-up|0|||
163138952|NCT04961541|589217849|FG011|Overall Study|Lost to Follow-up|0|||
163138953|NCT04961541|589217850|FG012|Overall Study|Lost to Follow-up|1|||
163138954|NCT04961541|589217851|FG013|Overall Study|Lost to Follow-up|0|||
163138955|NCT04961541|589217838|FG000|Overall Study|Withdrawal by Subject|0|||
163138956|NCT04961541|589217839|FG001|Overall Study|Withdrawal by Subject|0|||
163138957|NCT04961541|589217840|FG002|Overall Study|Withdrawal by Subject|1|||
163138958|NCT04961541|589217841|FG003|Overall Study|Withdrawal by Subject|1|||
163346742|NCT03740919|589977700|FG001|Treatment Period|Protocol Violation|1|||
163346743|NCT03740919|589977701|FG002|Treatment Period|Protocol Violation|0|||
163346744|NCT03740919|589977702|FG003|Treatment Period|Protocol Violation|0|||
163138959|NCT04961541|589217842|FG004|Overall Study|Withdrawal by Subject|0|||
163138960|NCT04961541|589217843|FG005|Overall Study|Withdrawal by Subject|0|||
163138961|NCT04961541|589217844|FG006|Overall Study|Withdrawal by Subject|0|||
163138962|NCT04961541|589217845|FG007|Overall Study|Withdrawal by Subject|0|||
163138963|NCT04961541|589217846|FG008|Overall Study|Withdrawal by Subject|0|||
163138964|NCT04961541|589217847|FG009|Overall Study|Withdrawal by Subject|1|||
163138965|NCT04961541|589217848|FG010|Overall Study|Withdrawal by Subject|0|||
163138966|NCT04961541|589217849|FG011|Overall Study|Withdrawal by Subject|0|||
163138967|NCT04961541|589217850|FG012|Overall Study|Withdrawal by Subject|0|||
163138968|NCT04961541|589217851|FG013|Overall Study|Withdrawal by Subject|0|||
163138969|NCT00466921|589217852|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
163138970|NCT00466921|589217852|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
163138971|NCT00466921|589217852|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
163138972|NCT00466921|589217852|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
163138973|NCT00466921|589217852|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
163138974|NCT00466921|589217852|FG000|Follow up for a Minimum of 1 Year|Death|6|||
163138975|NCT03305770|589217853|FG000|Overall Study|Physician Decision - prior to dispense|0|||
163138976|NCT03305770|589217854|FG001|Overall Study|Physician Decision - prior to dispense|1|||
163138977|NCT03305770|589217853|FG000|Overall Study|Subject moved|1|||
163138978|NCT03305770|589217854|FG001|Overall Study|Subject moved|0|||
163138979|NCT03539601|589217855|FG000|Overall Study|Withdraw by parent/guardian|1|||
163138980|NCT03539601|589217856|FG001|Overall Study|Withdraw by parent/guardian|0|||
163138981|NCT03539601|589217857|FG002|Overall Study|Withdraw by parent/guardian|1|||
163138982|NCT03539601|589217858|FG003|Overall Study|Withdraw by parent/guardian|0|||
163138983|NCT03539601|589217855|FG000|Overall Study|Adverse Event|0|||
163138984|NCT03539601|589217856|FG001|Overall Study|Adverse Event|2|||
163138985|NCT03539601|589217857|FG002|Overall Study|Adverse Event|0|||
163138986|NCT03539601|589217858|FG003|Overall Study|Adverse Event|0|||
163138987|NCT03539601|589217855|FG000|Overall Study|Lost to Follow-up|2|||
163138988|NCT03539601|589217856|FG001|Overall Study|Lost to Follow-up|4|||
163138989|NCT03539601|589217857|FG002|Overall Study|Lost to Follow-up|5|||
163138990|NCT03539601|589217858|FG003|Overall Study|Lost to Follow-up|0|||
163138991|NCT03539601|589217855|FG000|Overall Study|Withdrawal by Subject|2|||
163138992|NCT03539601|589217856|FG001|Overall Study|Withdrawal by Subject|0|||
163138993|NCT03539601|589217857|FG002|Overall Study|Withdrawal by Subject|0|||
163138994|NCT03539601|589217858|FG003|Overall Study|Withdrawal by Subject|1|||
163138995|NCT03539601|589217855|FG000|Overall Study|Randomized but not treated|1|||
163138996|NCT03539601|589217856|FG001|Overall Study|Randomized but not treated|1|||
163138997|NCT03539601|589217857|FG002|Overall Study|Randomized but not treated|0|||
163138998|NCT03539601|589217858|FG003|Overall Study|Randomized but not treated|0|||
163138999|NCT03710642|589217859|FG000|Overall Study|Adverse Event|5|||
163139000|NCT03710642|589217860|FG001|Overall Study|Adverse Event|1|||
163139001|NCT03710642|589217859|FG000|Overall Study|non-site physician recommendation|1|||
163139002|NCT03710642|589217860|FG001|Overall Study|non-site physician recommendation|0|||
163139003|NCT03710642|589217859|FG000|Overall Study|Participant unwilling or unable to participate|1|||
163139004|NCT03710642|589217860|FG001|Overall Study|Participant unwilling or unable to participate|1|||
163139005|NCT03710642|589217859|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
163139006|NCT03710642|589217860|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
163139007|NCT03710642|589217859|FG000|Overall Study|NA-no code provided|1|||
163139008|NCT03710642|589217860|FG001|Overall Study|NA-no code provided|0|||
163139009|NCT03710642|589217859|FG000|Overall Study|Withdrawal by Subject|1|||
163139010|NCT03710642|589217860|FG001|Overall Study|Withdrawal by Subject|0|||
163139011|NCT00226811|589217861|FG000|Overall Study|Death|8|||
163139012|NCT00226811|589217861|FG000|Overall Study|Adverse Event|11|||
163139013|NCT00226811|589217861|FG000|Overall Study|Lack of Efficacy|55|||
163139014|NCT00226811|589217861|FG000|Overall Study|Withdrawal by Subject|2|||
163139015|NCT01633541|589217865|FG000|Overall Study|Death|1|||
163139016|NCT01633541|589217866|FG001|Overall Study|Death|0|||
163139017|NCT01010971|589217869|FG000|Overall Study|Adverse Event|2|||
163139018|NCT01010971|589217870|FG001|Overall Study|Adverse Event|4|||
163139019|NCT01010971|589217871|FG002|Overall Study|Adverse Event|3|||
163139020|NCT01010971|589217869|FG000|Overall Study|Withdrawal by Subject|0|||
163139021|NCT01010971|589217870|FG001|Overall Study|Withdrawal by Subject|2|||
163139022|NCT01010971|589217871|FG002|Overall Study|Withdrawal by Subject|5|||
163139023|NCT01010971|589217869|FG000|Overall Study|Lost to Follow-up|0|||
163139024|NCT01010971|589217870|FG001|Overall Study|Lost to Follow-up|2|||
163139025|NCT01010971|589217871|FG002|Overall Study|Lost to Follow-up|3|||
163139026|NCT01010971|589217869|FG000|Overall Study|Other|1|||
163139027|NCT01010971|589217870|FG001|Overall Study|Other|0|||
163139028|NCT01010971|589217871|FG002|Overall Study|Other|2|||
163139029|NCT02330055|589217874|FG000|Overall Study|technical issues|2|||
163139030|NCT02330055|589217875|FG001|Overall Study|technical issues|0|||
163139031|NCT02330055|589217874|FG000|Overall Study|participant forgot to wear device|5|||
163409176|NCT03806127|590207511|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
163409177|NCT03806127|590207510|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
163409178|NCT03806127|590207511|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
163409179|NCT01289015|590207516|FG000|Overall Study|Protocol Violation|12|||
163409180|NCT01289015|590207517|FG001|Overall Study|Protocol Violation|9|||
163409181|NCT01289015|590207516|FG000|Overall Study|Adverse Event|3|||
163409182|NCT01289015|590207517|FG001|Overall Study|Adverse Event|0|||
163409183|NCT01289015|590207516|FG000|Overall Study|Lost to Follow-up|33|||
163409184|NCT01289015|590207517|FG001|Overall Study|Lost to Follow-up|17|||
163409185|NCT01289015|590207516|FG000|Overall Study|Withdrawal by Subject|17|||
163409186|NCT01289015|590207517|FG001|Overall Study|Withdrawal by Subject|8|||
163409187|NCT01289015|590207516|FG000|Overall Study|Disease progression|1|||
163409188|NCT01289015|590207517|FG001|Overall Study|Disease progression|0|||
163409189|NCT01289015|590207516|FG000|Overall Study|Negative baseline culture and others|33|||
163409190|NCT01289015|590207517|FG001|Overall Study|Negative baseline culture and others|20|||
163409191|NCT05980299|590207522|FG000|Overall Study|Death|28|||
163409192|NCT05980299|590207523|FG001|Overall Study|Death|0|||
163409193|NCT05980299|590207522|FG000|Overall Study|Discharged from Nursing Home|9|||
163409194|NCT05980299|590207523|FG001|Overall Study|Discharged from Nursing Home|0|||
163409195|NCT05980299|590207522|FG000|Overall Study|Lost to Follow-up|0|||
163409196|NCT05980299|590207523|FG001|Overall Study|Lost to Follow-up|10|||
163409197|NCT01294800|590207531|FG000|Overall Study|Adverse Event|7|||
163409198|NCT01294800|590207532|FG001|Overall Study|Adverse Event|6|||
163409199|NCT01294800|590207533|FG002|Overall Study|Adverse Event|12|||
163409200|NCT01294800|590207534|FG003|Overall Study|Adverse Event|5|||
163409201|NCT01294800|590207531|FG000|Overall Study|Subject Withdrew Consent|2|||
163409202|NCT01294800|590207532|FG001|Overall Study|Subject Withdrew Consent|2|||
163409203|NCT01294800|590207533|FG002|Overall Study|Subject Withdrew Consent|2|||
163409204|NCT01294800|590207534|FG003|Overall Study|Subject Withdrew Consent|11|||
163409205|NCT01294800|590207531|FG000|Overall Study|Lost to Follow-up|0|||
163409206|NCT01294800|590207532|FG001|Overall Study|Lost to Follow-up|0|||
163409207|NCT01294800|590207533|FG002|Overall Study|Lost to Follow-up|1|||
163409208|NCT01294800|590207534|FG003|Overall Study|Lost to Follow-up|0|||
163409209|NCT01294800|590207531|FG000|Overall Study|Non-compliance With Protocol|0|||
163409210|NCT01294800|590207532|FG001|Overall Study|Non-compliance With Protocol|1|||
163409211|NCT01294800|590207533|FG002|Overall Study|Non-compliance With Protocol|1|||
163409212|NCT01294800|590207534|FG003|Overall Study|Non-compliance With Protocol|0|||
163409213|NCT01294800|590207531|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
163409214|NCT01294800|590207532|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
163409215|NCT01294800|590207533|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
163409216|NCT01294800|590207534|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
163409217|NCT01662895|590207535|FG000|Overall Study|Lost to Follow-up|0|||
163409218|NCT01662895|590207536|FG001|Overall Study|Lost to Follow-up|1|||
163409219|NCT01441063|590207537|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
163409220|NCT01441063|590207537|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
163409221|NCT00493038|590207538|FG000|Treatment|Adverse Event|8|||
163409222|NCT00493038|590207539|FG001|Treatment|Adverse Event|4|||
163409223|NCT00493038|590207538|FG000|Treatment|Lost to Follow-up|5|||
163409224|NCT00493038|590207539|FG001|Treatment|Lost to Follow-up|3|||
163409225|NCT00493038|590207538|FG000|Treatment|Withdrawal by Subject|11|||
163409226|NCT00493038|590207539|FG001|Treatment|Withdrawal by Subject|12|||
163409227|NCT00493038|590207538|FG000|Treatment|Other|0|||
163409228|NCT00493038|590207539|FG001|Treatment|Other|1|||
163139032|NCT02330055|589217875|FG001|Overall Study|participant forgot to wear device|5|||
163139033|NCT02330055|589217874|FG000|Overall Study|data for less than 60 minutes|3|||
163139034|NCT02330055|589217875|FG001|Overall Study|data for less than 60 minutes|3|||
163139035|NCT02330055|589217874|FG000|Overall Study|participant did not sleep|0|||
163139036|NCT02330055|589217875|FG001|Overall Study|participant did not sleep|1|||
163139037|NCT05729568|589217877|FG000|Overall Study|Still on Study|52|||
163139038|NCT05729568|589217878|FG001|Overall Study|Still on Study|26|||
163139039|NCT05729568|589217877|FG000|Overall Study|Randomized but Never Treated|3|||
163139040|NCT05729568|589217878|FG001|Overall Study|Randomized but Never Treated|0|||
163139041|NCT05729568|589217877|FG000|Overall Study|Adverse Event|0|||
163139042|NCT05729568|589217878|FG001|Overall Study|Adverse Event|1|||
163139043|NCT05729568|589217877|FG000|Overall Study|Investigator's Discretion|1|||
163139044|NCT05729568|589217878|FG001|Overall Study|Investigator's Discretion|0|||
163409229|NCT00493038|590207538|FG000|Follow-up|Lost to Follow-up|1|||
163409230|NCT00493038|590207539|FG001|Follow-up|Lost to Follow-up|0|||
163409231|NCT01639833|590207566|FG000|Overall Study|Death|4|||
163409232|NCT01639833|590207567|FG001|Overall Study|Death|2|||
163409233|NCT01639833|590207566|FG000|Overall Study|Withdrawal by Subject|2|||
163409234|NCT01639833|590207567|FG001|Overall Study|Withdrawal by Subject|2|||
163409235|NCT01888640|590207568|FG000|Overall Study|Lost to Follow-up|1|||
163409236|NCT01888640|590207569|FG001|Overall Study|Lost to Follow-up|2|||
163139045|NCT00550953|589217879|FG000|Overall Study|Adverse Event|4|||
163139046|NCT00550953|589217880|FG001|Overall Study|Adverse Event|3|||
163409237|NCT01888640|590207570|FG002|Overall Study|Lost to Follow-up|0|||
163231377|NCT02139644|589560305|FG003|Treatment Period|Protocol Violation|1|||
163231378|NCT02139644|589560306|FG004|Treatment Period|Protocol Violation|1|||
163231379|NCT02139644|589560307|FG005|Treatment Period|Protocol Violation|1|||
163231380|NCT02139644|589560302|FG000|Treatment Period|Disease progression|0|||
163231381|NCT02139644|589560303|FG001|Treatment Period|Disease progression|0|||
163231382|NCT02139644|589560304|FG002|Treatment Period|Disease progression|0|||
163231383|NCT02139644|589560305|FG003|Treatment Period|Disease progression|1|||
163231384|NCT02139644|589560306|FG004|Treatment Period|Disease progression|1|||
163231385|NCT02139644|589560307|FG005|Treatment Period|Disease progression|2|||
163231386|NCT02139644|589560302|FG000|Treatment Period|Lost to Follow-up|0|||
163231387|NCT02139644|589560303|FG001|Treatment Period|Lost to Follow-up|0|||
163231388|NCT02139644|589560304|FG002|Treatment Period|Lost to Follow-up|1|||
163231389|NCT02139644|589560305|FG003|Treatment Period|Lost to Follow-up|1|||
163231390|NCT02139644|589560306|FG004|Treatment Period|Lost to Follow-up|1|||
163139047|NCT00550953|589217879|FG000|Overall Study|Not able to visit the site|2|||
163139048|NCT00550953|589217880|FG001|Overall Study|Not able to visit the site|3|||
163139049|NCT01502228|589217881|FG000|Overall Study|Death|1|||
163139050|NCT02326597|589217886|FG000|Overall Study|Lost to Follow-up|42|||
163231391|NCT02139644|589560307|FG005|Treatment Period|Lost to Follow-up|1|||
163231392|NCT02139644|589560302|FG000|Treatment Period|Lack of Efficacy|0|||
163231393|NCT02139644|589560303|FG001|Treatment Period|Lack of Efficacy|0|||
163231394|NCT02139644|589560304|FG002|Treatment Period|Lack of Efficacy|1|||
163231395|NCT02139644|589560305|FG003|Treatment Period|Lack of Efficacy|0|||
163231396|NCT02139644|589560306|FG004|Treatment Period|Lack of Efficacy|1|||
163231397|NCT02139644|589560307|FG005|Treatment Period|Lack of Efficacy|4|||
163346745|NCT03740919|589977699|FG000|Treatment Period|Withdrawal by Subject|0|||
163346746|NCT03740919|589977700|FG001|Treatment Period|Withdrawal by Subject|7|||
163346747|NCT03740919|589977701|FG002|Treatment Period|Withdrawal by Subject|6|||
163346748|NCT03740919|589977702|FG003|Treatment Period|Withdrawal by Subject|2|||
163346749|NCT03740919|589977699|FG000|Treatment Period|Terminated by Sponsor|0|||
163346750|NCT03740919|589977700|FG001|Treatment Period|Terminated by Sponsor|1|||
163346751|NCT03740919|589977701|FG002|Treatment Period|Terminated by Sponsor|0|||
163346752|NCT03740919|589977702|FG003|Treatment Period|Terminated by Sponsor|0|||
163346753|NCT03740919|589977699|FG000|Treatment Period|Issue with Insulin Pump|0|||
163346754|NCT03740919|589977700|FG001|Treatment Period|Issue with Insulin Pump|1|||
163346755|NCT03740919|589977701|FG002|Treatment Period|Issue with Insulin Pump|0|||
163346756|NCT03740919|589977702|FG003|Treatment Period|Issue with Insulin Pump|0|||
163346757|NCT03740919|589977699|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
163346758|NCT03740919|589977700|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
163346759|NCT03740919|589977701|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
163346760|NCT03740919|589977702|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
163346761|NCT03740919|589977699|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
163139051|NCT02326597|589217887|FG001|Overall Study|Lost to Follow-up|32|||
163139052|NCT00428948|589217888|FG000|Overall Study|Lost to Follow-up|15|||
163139053|NCT00428948|589217889|FG001|Overall Study|Lost to Follow-up|8|||
163139054|NCT00428948|589217888|FG000|Overall Study|Adverse Event|148|||
163139055|NCT00428948|589217889|FG001|Overall Study|Adverse Event|24|||
163139056|NCT00428948|589217888|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
163139057|NCT00428948|589217889|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
163139058|NCT00428948|589217888|FG000|Overall Study|Investigator Withdrew Subject|3|||
163139059|NCT00428948|589217889|FG001|Overall Study|Investigator Withdrew Subject|4|||
163139060|NCT00428948|589217888|FG000|Overall Study|Subject Withdrew Consent|50|||
163139061|NCT00428948|589217889|FG001|Overall Study|Subject Withdrew Consent|30|||
163139062|NCT00428948|589217888|FG000|Overall Study|Protocol Deviation|1|||
163139063|NCT00428948|589217889|FG001|Overall Study|Protocol Deviation|1|||
163139064|NCT02119663|589217894|FG000|Overall Study|Disease progression|26|||
163139065|NCT02119663|589217895|FG001|Overall Study|Disease progression|27|||
163139066|NCT02119663|589217894|FG000|Overall Study|Adverse Event|5|||
163139067|NCT02119663|589217895|FG001|Overall Study|Adverse Event|5|||
163139068|NCT02119663|589217894|FG000|Overall Study|Death|3|||
163139069|NCT02119663|589217895|FG001|Overall Study|Death|2|||
163139070|NCT02119663|589217894|FG000|Overall Study|Physician Decision|1|||
163139071|NCT02119663|589217895|FG001|Overall Study|Physician Decision|2|||
163139072|NCT02119663|589217894|FG000|Overall Study|Other unspecified|2|||
163139073|NCT02119663|589217895|FG001|Overall Study|Other unspecified|0|||
163231398|NCT02139644|589560302|FG000|Treatment Period|Other|0|||
163231399|NCT02139644|589560303|FG001|Treatment Period|Other|3|||
163231400|NCT02139644|589560304|FG002|Treatment Period|Other|1|||
163346762|NCT03740919|589977700|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
163346763|NCT03740919|589977701|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
163346764|NCT03740919|589977702|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
163139074|NCT02119663|589217894|FG000|Overall Study|Subject decision|0|||
163139075|NCT02119663|589217895|FG001|Overall Study|Subject decision|1|||
163139076|NCT02119663|589217894|FG000|Overall Study|Study Terminated by the Sponsor|3|||
163139077|NCT02119663|589217895|FG001|Overall Study|Study Terminated by the Sponsor|4|||
163231401|NCT02139644|589560305|FG003|Treatment Period|Other|1|||
163231402|NCT02139644|589560306|FG004|Treatment Period|Other|0|||
163231403|NCT02139644|589560307|FG005|Treatment Period|Other|1|||
163231404|NCT01312909|589560308|FG000|Overall Study|Randomized but not treated|1|||
163231405|NCT01312909|589560309|FG001|Overall Study|Randomized but not treated|3|||
163231406|NCT01312909|589560310|FG002|Overall Study|Randomized but not treated|1|||
163231407|NCT01312909|589560308|FG000|Overall Study|Adverse Event|1|||
163231408|NCT01312909|589560309|FG001|Overall Study|Adverse Event|0|||
163231409|NCT01312909|589560310|FG002|Overall Study|Adverse Event|3|||
163231410|NCT01312909|589560308|FG000|Overall Study|Protocol Violation|2|||
163231411|NCT01312909|589560309|FG001|Overall Study|Protocol Violation|0|||
163231412|NCT01312909|589560310|FG002|Overall Study|Protocol Violation|2|||
163231413|NCT01312909|589560308|FG000|Overall Study|Other|9|||
163231414|NCT01312909|589560309|FG001|Overall Study|Other|6|||
163231415|NCT01312909|589560310|FG002|Overall Study|Other|11|||
163231416|NCT01312909|589560308|FG000|Overall Study|Withdrawal by Subject|8|||
163231417|NCT01312909|589560309|FG001|Overall Study|Withdrawal by Subject|10|||
163231418|NCT01312909|589560310|FG002|Overall Study|Withdrawal by Subject|7|||
163231419|NCT01312909|589560308|FG000|Overall Study|Lost to Follow-up|21|||
163231420|NCT01312909|589560309|FG001|Overall Study|Lost to Follow-up|17|||
163231421|NCT01312909|589560310|FG002|Overall Study|Lost to Follow-up|20|||
163231422|NCT01312909|589560308|FG000|Overall Study|Insufficient clinical response|0|||
163231423|NCT01312909|589560309|FG001|Overall Study|Insufficient clinical response|0|||
163231424|NCT01312909|589560310|FG002|Overall Study|Insufficient clinical response|1|||
163231425|NCT01312909|589560308|FG000|Overall Study|Entrance criteria not met|0|||
163231426|NCT01312909|589560309|FG001|Overall Study|Entrance criteria not met|0|||
163231427|NCT01312909|589560310|FG002|Overall Study|Entrance criteria not met|2|||
163231428|NCT02200042|589560311|FG000|Overall Study|Withdrawal by Subject|0|||
163231429|NCT02200042|589560312|FG001|Overall Study|Withdrawal by Subject|1|||
163231430|NCT00306592|589560315|FG000|Overall Study|Adverse Event|8|||
163231431|NCT00306592|589560316|FG001|Overall Study|Adverse Event|15|||
163231432|NCT00306592|589560315|FG000|Overall Study|Lost to Follow-up|1|||
163231433|NCT00306592|589560316|FG001|Overall Study|Lost to Follow-up|0|||
163231434|NCT00306592|589560315|FG000|Overall Study|Noncompliance|0|||
163231435|NCT00306592|589560316|FG001|Overall Study|Noncompliance|2|||
163231436|NCT00306592|589560315|FG000|Overall Study|Persistent Antibodies|6|||
163231437|NCT00306592|589560316|FG001|Overall Study|Persistent Antibodies|3|||
163231438|NCT00306592|589560315|FG000|Overall Study|Voluntary|10|||
163231439|NCT00306592|589560316|FG001|Overall Study|Voluntary|6|||
163231440|NCT00306592|589560315|FG000|Overall Study|Other|5|||
163231441|NCT00306592|589560316|FG001|Overall Study|Other|10|||
163231442|NCT00306592|589560315|FG000|Overall Study|Other|1|||
163231443|NCT00306592|589560316|FG001|Overall Study|Other|2|||
163231444|NCT00306592|589560315|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
163231445|NCT00306592|589560316|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
163231446|NCT01923181|589560317|FG000|Overall Study|Protocol Violation|2|||
163231447|NCT01923181|589560318|FG001|Overall Study|Protocol Violation|2|||
163231448|NCT01923181|589560319|FG002|Overall Study|Protocol Violation|0|||
163231449|NCT01923181|589560320|FG003|Overall Study|Protocol Violation|2|||
163231450|NCT01923181|589560321|FG004|Overall Study|Protocol Violation|2|||
163231451|NCT01923181|589560322|FG005|Overall Study|Protocol Violation|1|||
163231452|NCT01923181|589560323|FG006|Overall Study|Protocol Violation|1|||
163231453|NCT01923181|589560324|FG007|Overall Study|Protocol Violation|2|||
163231454|NCT01923181|589560325|FG008|Overall Study|Protocol Violation|1|||
163231455|NCT01923181|589560317|FG000|Overall Study|Withdrawal by Subject|0|||
163231456|NCT01923181|589560318|FG001|Overall Study|Withdrawal by Subject|1|||
163231457|NCT01923181|589560319|FG002|Overall Study|Withdrawal by Subject|0|||
163231458|NCT01923181|589560320|FG003|Overall Study|Withdrawal by Subject|1|||
163231459|NCT01923181|589560321|FG004|Overall Study|Withdrawal by Subject|4|||
163409238|NCT01888640|590207568|FG000|Overall Study|Withdrawal by Subject|15|||
163409239|NCT01888640|590207569|FG001|Overall Study|Withdrawal by Subject|11|||
163231460|NCT01923181|589560322|FG005|Overall Study|Withdrawal by Subject|2|||
163231461|NCT01923181|589560323|FG006|Overall Study|Withdrawal by Subject|4|||
163231462|NCT01923181|589560324|FG007|Overall Study|Withdrawal by Subject|3|||
163231463|NCT01923181|589560325|FG008|Overall Study|Withdrawal by Subject|1|||
163231464|NCT01923181|589560317|FG000|Overall Study|Other|1|||
163231465|NCT01923181|589560318|FG001|Overall Study|Other|0|||
163231466|NCT01923181|589560319|FG002|Overall Study|Other|0|||
163231467|NCT01923181|589560320|FG003|Overall Study|Other|1|||
163231468|NCT01923181|589560321|FG004|Overall Study|Other|0|||
163231469|NCT01923181|589560322|FG005|Overall Study|Other|0|||
163231470|NCT01923181|589560323|FG006|Overall Study|Other|0|||
163231471|NCT01923181|589560324|FG007|Overall Study|Other|0|||
163231472|NCT01923181|589560325|FG008|Overall Study|Other|0|||
163231473|NCT01923181|589560317|FG000|Overall Study|Lost to Follow-up|0|||
163231474|NCT01923181|589560318|FG001|Overall Study|Lost to Follow-up|3|||
163231475|NCT01923181|589560319|FG002|Overall Study|Lost to Follow-up|2|||
163231476|NCT01923181|589560320|FG003|Overall Study|Lost to Follow-up|1|||
163231477|NCT01923181|589560321|FG004|Overall Study|Lost to Follow-up|2|||
163231478|NCT01923181|589560322|FG005|Overall Study|Lost to Follow-up|1|||
163231479|NCT01923181|589560323|FG006|Overall Study|Lost to Follow-up|3|||
163231480|NCT01923181|589560324|FG007|Overall Study|Lost to Follow-up|3|||
163231481|NCT01923181|589560325|FG008|Overall Study|Lost to Follow-up|1|||
163409240|NCT01888640|590207570|FG002|Overall Study|Withdrawal by Subject|4|||
163409241|NCT01888640|590207568|FG000|Overall Study|Minimum dose not met|10|||
163231482|NCT00654628|589560327|FG000|6-week Active Treatment Period|Adverse Event|9|||
163231483|NCT00654628|589560327|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
163231484|NCT00654628|589560327|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
163231485|NCT00654628|589560327|FG000|6-week Active Treatment Period|Out of window period|1|||
163231486|NCT00654628|589560327|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
163231487|NCT00654628|589560327|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
163231488|NCT00912405|589560330|FG000|Overall Study|Lost to Follow-up|5|||
163231489|NCT00953329|589560331|FG000|Overall Study|Lack of Efficacy|1|||
163231490|NCT01434823|589560334|FG000|Overall Study|Incomplete data in medical record|4|||
163231491|NCT01434823|589560335|FG001|Overall Study|Incomplete data in medical record|7|||
163231492|NCT02167035|589560341|FG000|Overall Study|Adverse Event|2|||
163231493|NCT02167035|589560342|FG001|Overall Study|Adverse Event|2|||
163231494|NCT02167035|589560341|FG000|Overall Study|Lost to Follow-up|3|||
163231495|NCT02167035|589560342|FG001|Overall Study|Lost to Follow-up|3|||
163231496|NCT02167035|589560341|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
163231497|NCT02167035|589560342|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
163231498|NCT00796861|589560343|FG000|Overall Study|Withdrawal by Subject|2|||
163231499|NCT00796861|589560343|FG000|Overall Study|Death|2|||
163231500|NCT00403455|589560353|FG000|Overall Study|Withdrawal by Subject|1|||
163346765|NCT03740919|589977699|FG000|Treatment Period|Not Completing Diary|0|||
163346766|NCT03740919|589977700|FG001|Treatment Period|Not Completing Diary|0|||
163346767|NCT03740919|589977701|FG002|Treatment Period|Not Completing Diary|1|||
163346768|NCT03740919|589977702|FG003|Treatment Period|Not Completing Diary|0|||
163346769|NCT03740919|589977699|FG000|Treatment Period|Insulin Painful to Participant|0|||
163346770|NCT03740919|589977700|FG001|Treatment Period|Insulin Painful to Participant|0|||
163346771|NCT03740919|589977701|FG002|Treatment Period|Insulin Painful to Participant|1|||
163346772|NCT03740919|589977702|FG003|Treatment Period|Insulin Painful to Participant|0|||
163346773|NCT04374253|589977710|FG000|Overall Study|Adverse Event|0|||
163346774|NCT04374253|589977711|FG001|Overall Study|Adverse Event|26|||
163346775|NCT04374253|589977712|FG002|Overall Study|Adverse Event|2|||
163346776|NCT04374253|589977713|FG003|Overall Study|Adverse Event|12|||
163346777|NCT04374253|589977710|FG000|Overall Study|Study terminated by sponsor|13|||
163346778|NCT04374253|589977711|FG001|Overall Study|Study terminated by sponsor|593|||
163346779|NCT04374253|589977712|FG002|Overall Study|Study terminated by sponsor|21|||
163346780|NCT04374253|589977713|FG003|Overall Study|Study terminated by sponsor|567|||
163346781|NCT04374253|589977710|FG000|Overall Study|Withdrawal by Subject|0|||
163346782|NCT04374253|589977711|FG001|Overall Study|Withdrawal by Subject|55|||
163346783|NCT04374253|589977712|FG002|Overall Study|Withdrawal by Subject|3|||
163346784|NCT04374253|589977713|FG003|Overall Study|Withdrawal by Subject|40|||
163346785|NCT04374253|589977710|FG000|Overall Study|Physician Decision|1|||
163346786|NCT04374253|589977711|FG001|Overall Study|Physician Decision|10|||
163346787|NCT04374253|589977712|FG002|Overall Study|Physician Decision|1|||
163346788|NCT04374253|589977713|FG003|Overall Study|Physician Decision|10|||
163346789|NCT04374253|589977710|FG000|Overall Study|Protocol Violation|0|||
163346790|NCT04374253|589977711|FG001|Overall Study|Protocol Violation|0|||
163346791|NCT04374253|589977712|FG002|Overall Study|Protocol Violation|0|||
163346792|NCT04374253|589977713|FG003|Overall Study|Protocol Violation|2|||
163346793|NCT04374253|589977710|FG000|Overall Study|Death|0|||
163346794|NCT04374253|589977711|FG001|Overall Study|Death|3|||
163346795|NCT04374253|589977712|FG002|Overall Study|Death|1|||
163346796|NCT04374253|589977713|FG003|Overall Study|Death|1|||
163346797|NCT04374253|589977710|FG000|Overall Study|Lack of Efficacy|0|||
163346798|NCT04374253|589977711|FG001|Overall Study|Lack of Efficacy|0|||
163346799|NCT04374253|589977712|FG002|Overall Study|Lack of Efficacy|0|||
163346800|NCT04374253|589977713|FG003|Overall Study|Lack of Efficacy|1|||
163346801|NCT04374253|589977710|FG000|Overall Study|Lost to Follow-up|1|||
163346802|NCT04374253|589977711|FG001|Overall Study|Lost to Follow-up|1|||
163346803|NCT04374253|589977712|FG002|Overall Study|Lost to Follow-up|0|||
163346804|NCT04374253|589977713|FG003|Overall Study|Lost to Follow-up|2|||
163346805|NCT04374253|589977710|FG000|Overall Study|Reason Not Specified|0|||
163346806|NCT04374253|589977711|FG001|Overall Study|Reason Not Specified|8|||
163346807|NCT04374253|589977712|FG002|Overall Study|Reason Not Specified|0|||
163346808|NCT04374253|589977713|FG003|Overall Study|Reason Not Specified|8|||
163346809|NCT00448344|589977717|FG000|Overall Study|Lost to Follow-up|20|||
163346810|NCT00448344|589977718|FG001|Overall Study|Lost to Follow-up|22|||
163346811|NCT00448344|589977717|FG000|Overall Study|Withdrawal by Subject|6|||
163346812|NCT00448344|589977718|FG001|Overall Study|Withdrawal by Subject|8|||
163346813|NCT00448344|589977717|FG000|Overall Study|Death|3|||
163346814|NCT00448344|589977718|FG001|Overall Study|Death|4|||
163346815|NCT00448344|589977717|FG000|Overall Study|Physician Decision|1|||
163346816|NCT00448344|589977718|FG001|Overall Study|Physician Decision|2|||
163346817|NCT04382053|589977722|FG000|Overall Study|Death|6|||
163346818|NCT04382053|589977723|FG001|Overall Study|Death|8|||
163346819|NCT04382053|589977722|FG000|Overall Study|Lost to Follow-up|0|||
163231501|NCT04574362|589560354|FG000|Overall Study|Other|0|||
163231502|NCT04574362|589560355|FG001|Overall Study|Other|5|||
163231503|NCT04574362|589560354|FG000|Overall Study|COVID-19|0|||
163231504|NCT04574362|589560355|FG001|Overall Study|COVID-19|1|||
163231505|NCT04574362|589560354|FG000|Overall Study|Adverse Event|1|||
163231506|NCT04574362|589560355|FG001|Overall Study|Adverse Event|1|||
163231507|NCT04574362|589560354|FG000|Overall Study|Withdrawal by Subject|2|||
163231508|NCT04574362|589560355|FG001|Overall Study|Withdrawal by Subject|4|||
163231509|NCT04574362|589560354|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
163231510|NCT04574362|589560355|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
163231511|NCT04574362|589560354|FG000|Overall Study|Participant refused to come to the hospital|1|||
163231512|NCT04574362|589560355|FG001|Overall Study|Participant refused to come to the hospital|0|||
163231513|NCT04574362|589560354|FG000|Overall Study|Participant refused the visit|1|||
163231514|NCT04574362|589560355|FG001|Overall Study|Participant refused the visit|0|||
163231515|NCT04574362|589560354|FG000|Overall Study|Participant quit early because of business trip|1|||
163231516|NCT04574362|589560355|FG001|Overall Study|Participant quit early because of business trip|0|||
163231517|NCT01785524|589560356|FG000|Overall Study|Withdrawal by Subject|2|||
163231518|NCT01785524|589560357|FG001|Overall Study|Withdrawal by Subject|2|||
163231519|NCT01060384|589560358|FG000|Overall Study|Withdrawal by Subject|0|||
163231520|NCT01060384|589560359|FG001|Overall Study|Withdrawal by Subject|1|||
163231521|NCT01060384|589560360|FG002|Overall Study|Withdrawal by Subject|0|||
163231522|NCT01060384|589560361|FG003|Overall Study|Withdrawal by Subject|0|||
163231523|NCT01060384|589560362|FG004|Overall Study|Withdrawal by Subject|0|||
163231524|NCT01060384|589560358|FG000|Overall Study|Death|0|||
163231525|NCT01060384|589560359|FG001|Overall Study|Death|0|||
163231526|NCT01060384|589560360|FG002|Overall Study|Death|0|||
163231527|NCT01060384|589560361|FG003|Overall Study|Death|0|||
163231528|NCT01060384|589560362|FG004|Overall Study|Death|1|||
163231529|NCT01060384|589560358|FG000|Overall Study|Intercurrent illness|0|||
163231530|NCT01060384|589560359|FG001|Overall Study|Intercurrent illness|0|||
163231531|NCT01060384|589560360|FG002|Overall Study|Intercurrent illness|0|||
163231532|NCT01060384|589560361|FG003|Overall Study|Intercurrent illness|0|||
163231533|NCT01060384|589560362|FG004|Overall Study|Intercurrent illness|1|||
163231534|NCT01332305|589560363|FG000|Overall Study|Adverse Event|1|||
163231535|NCT01332305|589560364|FG001|Overall Study|Adverse Event|4|||
163231536|NCT01332305|589560365|FG002|Overall Study|Adverse Event|6|||
163231537|NCT01332305|589560366|FG003|Overall Study|Adverse Event|3|||
163231538|NCT01332305|589560367|FG004|Overall Study|Adverse Event|5|||
163231539|NCT01332305|589560363|FG000|Overall Study|Withdrawal by Subject|6|||
163231540|NCT01332305|589560364|FG001|Overall Study|Withdrawal by Subject|5|||
163231541|NCT01332305|589560365|FG002|Overall Study|Withdrawal by Subject|4|||
163231542|NCT01332305|589560366|FG003|Overall Study|Withdrawal by Subject|1|||
163231543|NCT01332305|589560367|FG004|Overall Study|Withdrawal by Subject|0|||
163231544|NCT01332305|589560363|FG000|Overall Study|Lost to Follow-up|0|||
163231545|NCT01332305|589560364|FG001|Overall Study|Lost to Follow-up|2|||
163231546|NCT01332305|589560365|FG002|Overall Study|Lost to Follow-up|3|||
163231547|NCT01332305|589560366|FG003|Overall Study|Lost to Follow-up|2|||
163231548|NCT01332305|589560367|FG004|Overall Study|Lost to Follow-up|3|||
163231549|NCT01332305|589560363|FG000|Overall Study|Protocol Violation|1|||
163231550|NCT01332305|589560364|FG001|Overall Study|Protocol Violation|2|||
163231551|NCT01332305|589560365|FG002|Overall Study|Protocol Violation|1|||
163231552|NCT01332305|589560366|FG003|Overall Study|Protocol Violation|0|||
163231553|NCT01332305|589560367|FG004|Overall Study|Protocol Violation|3|||
163231554|NCT01332305|589560363|FG000|Overall Study|Withdrawal by Sponsor|1|||
163231555|NCT01332305|589560364|FG001|Overall Study|Withdrawal by Sponsor|0|||
163231556|NCT01332305|589560365|FG002|Overall Study|Withdrawal by Sponsor|0|||
163231557|NCT01332305|589560366|FG003|Overall Study|Withdrawal by Sponsor|1|||
163231558|NCT01332305|589560367|FG004|Overall Study|Withdrawal by Sponsor|1|||
163231559|NCT01332305|589560363|FG000|Overall Study|Treatment Failure|1|||
163231560|NCT01332305|589560364|FG001|Overall Study|Treatment Failure|1|||
163231561|NCT01332305|589560365|FG002|Overall Study|Treatment Failure|0|||
163231562|NCT01332305|589560366|FG003|Overall Study|Treatment Failure|0|||
163231563|NCT01332305|589560367|FG004|Overall Study|Treatment Failure|0|||
163231564|NCT01332305|589560363|FG000|Overall Study|Physician Decision|0|||
163231565|NCT01332305|589560364|FG001|Overall Study|Physician Decision|0|||
163231566|NCT01332305|589560365|FG002|Overall Study|Physician Decision|0|||
163231567|NCT01332305|589560366|FG003|Overall Study|Physician Decision|1|||
163231568|NCT01332305|589560367|FG004|Overall Study|Physician Decision|0|||
163231569|NCT01600040|589560370|FG000|Overall Study|Withdrawal by Subject|1|||
163231570|NCT01401530|589560374|FG000|Overall Study|Disease Progression|1|||
163231571|NCT01401530|589560375|FG001|Overall Study|Disease Progression|2|||
163231572|NCT01401530|589560376|FG002|Overall Study|Disease Progression|1|||
163231573|NCT01401530|589560374|FG000|Overall Study|Adverse Event|1|||
163231574|NCT01401530|589560375|FG001|Overall Study|Adverse Event|1|||
163231575|NCT01401530|589560376|FG002|Overall Study|Adverse Event|1|||
163231576|NCT01401530|589560374|FG000|Overall Study|Participant Choice|1|||
163231577|NCT01401530|589560375|FG001|Overall Study|Participant Choice|2|||
163231578|NCT01401530|589560376|FG002|Overall Study|Participant Choice|1|||
163231579|NCT01401530|589560374|FG000|Overall Study|Physician Decision|0|||
163231580|NCT01401530|589560375|FG001|Overall Study|Physician Decision|1|||
163231581|NCT01401530|589560376|FG002|Overall Study|Physician Decision|0|||
163231582|NCT03670810|589560377|FG000|Main Study|Adverse Event|37|||
163231583|NCT03670810|589560378|FG001|Main Study|Adverse Event|38|||
163231584|NCT03670810|589560379|FG002|Main Study|Adverse Event|3|||
163231585|NCT03670810|589560380|FG003|Main Study|Adverse Event|4|||
163231586|NCT03670810|589560381|FG004|Main Study|Adverse Event|4|||
163231587|NCT03670810|589560382|FG005|Main Study|Adverse Event|5|||
163231588|NCT03670810|589560383|FG006|Main Study|Adverse Event|0|||
163231589|NCT03670810|589560384|FG007|Main Study|Adverse Event|0|||
163231590|NCT03670810|589560385|FG008|Main Study|Adverse Event|0|||
163231591|NCT03670810|589560377|FG000|Main Study|Lack of Efficacy|8|||
163231592|NCT03670810|589560378|FG001|Main Study|Lack of Efficacy|9|||
163231593|NCT03670810|589560379|FG002|Main Study|Lack of Efficacy|3|||
163231594|NCT03670810|589560380|FG003|Main Study|Lack of Efficacy|4|||
163231595|NCT03670810|589560381|FG004|Main Study|Lack of Efficacy|0|||
163231596|NCT03670810|589560382|FG005|Main Study|Lack of Efficacy|0|||
163231597|NCT03670810|589560383|FG006|Main Study|Lack of Efficacy|0|||
163231598|NCT03670810|589560384|FG007|Main Study|Lack of Efficacy|0|||
163231599|NCT03670810|589560385|FG008|Main Study|Lack of Efficacy|0|||
163231600|NCT03670810|589560377|FG000|Main Study|Lost to Follow-up|9|||
163231601|NCT03670810|589560378|FG001|Main Study|Lost to Follow-up|7|||
163231602|NCT03670810|589560379|FG002|Main Study|Lost to Follow-up|4|||
163231603|NCT03670810|589560380|FG003|Main Study|Lost to Follow-up|6|||
163231604|NCT03670810|589560381|FG004|Main Study|Lost to Follow-up|1|||
163231605|NCT03670810|589560382|FG005|Main Study|Lost to Follow-up|0|||
163231606|NCT03670810|589560383|FG006|Main Study|Lost to Follow-up|0|||
163231607|NCT03670810|589560384|FG007|Main Study|Lost to Follow-up|0|||
163231608|NCT03670810|589560385|FG008|Main Study|Lost to Follow-up|0|||
163231609|NCT03670810|589560377|FG000|Main Study|Non-compliance with Study Drug|0|||
163231610|NCT03670810|589560378|FG001|Main Study|Non-compliance with Study Drug|2|||
163231611|NCT03670810|589560379|FG002|Main Study|Non-compliance with Study Drug|3|||
163231612|NCT03670810|589560380|FG003|Main Study|Non-compliance with Study Drug|0|||
163231613|NCT03670810|589560381|FG004|Main Study|Non-compliance with Study Drug|0|||
163231614|NCT03670810|589560382|FG005|Main Study|Non-compliance with Study Drug|0|||
163231615|NCT03670810|589560383|FG006|Main Study|Non-compliance with Study Drug|0|||
163231616|NCT03670810|589560384|FG007|Main Study|Non-compliance with Study Drug|1|||
163231617|NCT03670810|589560385|FG008|Main Study|Non-compliance with Study Drug|0|||
163231618|NCT03670810|589560377|FG000|Main Study|Physician Decision|3|||
163231619|NCT03670810|589560378|FG001|Main Study|Physician Decision|0|||
163231620|NCT03670810|589560379|FG002|Main Study|Physician Decision|1|||
163231621|NCT03670810|589560380|FG003|Main Study|Physician Decision|0|||
163231622|NCT03670810|589560381|FG004|Main Study|Physician Decision|0|||
163231623|NCT03670810|589560382|FG005|Main Study|Physician Decision|0|||
163231624|NCT03670810|589560383|FG006|Main Study|Physician Decision|1|||
163231625|NCT03670810|589560384|FG007|Main Study|Physician Decision|1|||
163231626|NCT03670810|589560385|FG008|Main Study|Physician Decision|0|||
163231627|NCT03670810|589560377|FG000|Main Study|Pregnancy|1|||
163231628|NCT03670810|589560378|FG001|Main Study|Pregnancy|2|||
163231629|NCT03670810|589560379|FG002|Main Study|Pregnancy|0|||
163231630|NCT03670810|589560380|FG003|Main Study|Pregnancy|0|||
163231631|NCT03670810|589560381|FG004|Main Study|Pregnancy|0|||
163231632|NCT03670810|589560382|FG005|Main Study|Pregnancy|0|||
163231633|NCT03670810|589560383|FG006|Main Study|Pregnancy|0|||
163231634|NCT03670810|589560384|FG007|Main Study|Pregnancy|0|||
163231635|NCT03670810|589560385|FG008|Main Study|Pregnancy|0|||
163231636|NCT03670810|589560377|FG000|Main Study|Protocol Deviation|2|||
163231637|NCT03670810|589560378|FG001|Main Study|Protocol Deviation|12|||
163231638|NCT03670810|589560379|FG002|Main Study|Protocol Deviation|8|||
163231639|NCT03670810|589560380|FG003|Main Study|Protocol Deviation|4|||
163231640|NCT03670810|589560381|FG004|Main Study|Protocol Deviation|0|||
163231641|NCT03670810|589560382|FG005|Main Study|Protocol Deviation|0|||
163231642|NCT03670810|589560383|FG006|Main Study|Protocol Deviation|0|||
163231643|NCT03670810|589560384|FG007|Main Study|Protocol Deviation|0|||
163409242|NCT01888640|590207569|FG001|Overall Study|Minimum dose not met|16|||
163409243|NCT01888640|590207570|FG002|Overall Study|Minimum dose not met|0|||
163231644|NCT03670810|589560385|FG008|Main Study|Protocol Deviation|0|||
163231645|NCT03670810|589560377|FG000|Main Study|Withdrawal by Subject|21|||
163231646|NCT03670810|589560378|FG001|Main Study|Withdrawal by Subject|21|||
163231647|NCT03670810|589560379|FG002|Main Study|Withdrawal by Subject|8|||
163231648|NCT03670810|589560380|FG003|Main Study|Withdrawal by Subject|9|||
163231649|NCT03670810|589560381|FG004|Main Study|Withdrawal by Subject|5|||
163231650|NCT03670810|589560382|FG005|Main Study|Withdrawal by Subject|2|||
163231651|NCT03670810|589560383|FG006|Main Study|Withdrawal by Subject|1|||
163231652|NCT03670810|589560384|FG007|Main Study|Withdrawal by Subject|1|||
163231653|NCT03670810|589560385|FG008|Main Study|Withdrawal by Subject|0|||
163231654|NCT03670810|589560377|FG000|Main Study|Participant did not want to take the three other treatments|1|||
163231655|NCT03670810|589560378|FG001|Main Study|Participant did not want to take the three other treatments|0|||
163231656|NCT03670810|589560379|FG002|Main Study|Participant did not want to take the three other treatments|0|||
163346820|NCT04382053|589977723|FG001|Overall Study|Lost to Follow-up|2|||
163346821|NCT04382053|589977722|FG000|Overall Study|Protocol Deviation|1|||
163346822|NCT04382053|589977723|FG001|Overall Study|Protocol Deviation|2|||
163346823|NCT04382053|589977722|FG000|Overall Study|Withdrawal by Subject|2|||
163346824|NCT04382053|589977723|FG001|Overall Study|Withdrawal by Subject|1|||
163346825|NCT01399905|589977726|FG000|Overall Study|Withdrawal by Subject|1|||
163346826|NCT01399905|589977727|FG001|Overall Study|Withdrawal by Subject|1|||
163346827|NCT01945086|589977728|FG000|Overall Study|Withdrawal by Subject|1|||
163346828|NCT01945086|589977729|FG001|Overall Study|Withdrawal by Subject|0|||
163346829|NCT01945086|589977730|FG002|Overall Study|Withdrawal by Subject|1|||
163346830|NCT01945086|589977728|FG000|Overall Study|Adverse Event|0|||
163346831|NCT01945086|589977729|FG001|Overall Study|Adverse Event|0|||
163346832|NCT01945086|589977730|FG002|Overall Study|Adverse Event|1|||
163346833|NCT01808144|589977731|FG000|Overall Study|Death|1|||
163346834|NCT01808144|589977732|FG001|Overall Study|Death|0|||
163346835|NCT01808144|589977731|FG000|Overall Study|Withdrawal by Subject|16|||
163346836|NCT01808144|589977732|FG001|Overall Study|Withdrawal by Subject|23|||
163346837|NCT01808144|589977731|FG000|Overall Study|Lost to Follow-up|6|||
163346838|NCT01808144|589977732|FG001|Overall Study|Lost to Follow-up|3|||
163346839|NCT01808144|589977731|FG000|Overall Study|Protocol Violation|6|||
163346840|NCT01808144|589977732|FG001|Overall Study|Protocol Violation|6|||
163346841|NCT01808144|589977731|FG000|Overall Study|Gout flare|0|||
163346842|NCT01808144|589977732|FG001|Overall Study|Gout flare|1|||
163346843|NCT01808144|589977731|FG000|Overall Study|Adverse Event|11|||
163346844|NCT01808144|589977732|FG001|Overall Study|Adverse Event|15|||
163346845|NCT02093897|589979273|FG000|Overall Study|Physician Decision|1|||
163346846|NCT02093897|589979273|FG000|Overall Study|Planned age group closure - no's reached|17|||
163346847|NCT02093897|589979273|FG000|Overall Study|Adverse event, non-fatal|1|||
163346848|NCT02972242|589979274|FG000|Overall Study|Withdrawal by Subject|1|||
163346849|NCT02972242|589979275|FG001|Overall Study|Withdrawal by Subject|0|||
163346850|NCT04572997|589979279|FG000|Overall Study|Adverse Event|1|||
163346851|NCT03098797|589979280|FG000|Part 2 Open Label Extension|Adverse Event|2|||
163346852|NCT03098797|589979281|FG001|Part 2 Open Label Extension|Adverse Event|0|||
163346853|NCT02329223|589979282|FG000|Overall Study|Withdrawal by Subject|1|||
163346854|NCT02329223|589979283|FG001|Overall Study|Withdrawal by Subject|2|||
163346855|NCT02329223|589979284|FG002|Overall Study|Withdrawal by Subject|5|||
163346856|NCT02329223|589979282|FG000|Overall Study|Physician Decision|0|||
163346857|NCT02329223|589979283|FG001|Overall Study|Physician Decision|0|||
163346858|NCT02329223|589979284|FG002|Overall Study|Physician Decision|1|||
163346859|NCT02329223|589979282|FG000|Overall Study|Adverse Event|0|||
163346860|NCT02329223|589979283|FG001|Overall Study|Adverse Event|1|||
163346861|NCT02329223|589979284|FG002|Overall Study|Adverse Event|0|||
163346862|NCT00651937|589979285|FG000|Overall Study|Withdrawal by Subject|4|||
163346863|NCT00651937|589979286|FG001|Overall Study|Withdrawal by Subject|1|||
163346864|NCT00552513|589979292|FG000|Overall Study|Lost to Follow-up|5|||
163346865|NCT00552513|589979293|FG001|Overall Study|Lost to Follow-up|1|||
163346866|NCT02720185|589979296|FG000|Overall Study|Lost to Follow-up|1|||
163346867|NCT02507687|589979299|FG000|Overall Study|Adverse Event|3|||
163346868|NCT02507687|589979300|FG001|Overall Study|Adverse Event|2|||
163346869|NCT02507687|589979301|FG002|Overall Study|Adverse Event|2|||
163346870|NCT02507687|589979302|FG003|Overall Study|Adverse Event|2|||
163346871|NCT02507687|589979299|FG000|Overall Study|Withdrawal by Subject|1|||
163346872|NCT02507687|589979300|FG001|Overall Study|Withdrawal by Subject|4|||
163346873|NCT02507687|589979301|FG002|Overall Study|Withdrawal by Subject|6|||
163346874|NCT02507687|589979302|FG003|Overall Study|Withdrawal by Subject|6|||
163346875|NCT02507687|589979299|FG000|Overall Study|Protocol Violation|1|||
163346876|NCT02507687|589979300|FG001|Overall Study|Protocol Violation|0|||
163346877|NCT02507687|589979301|FG002|Overall Study|Protocol Violation|2|||
163346878|NCT02507687|589979302|FG003|Overall Study|Protocol Violation|0|||
163346879|NCT02507687|589979299|FG000|Overall Study|Lost to Follow-up|0|||
163346880|NCT02507687|589979300|FG001|Overall Study|Lost to Follow-up|0|||
163346881|NCT02507687|589979301|FG002|Overall Study|Lost to Follow-up|2|||
163346882|NCT02507687|589979302|FG003|Overall Study|Lost to Follow-up|1|||
163346883|NCT02507687|589979299|FG000|Overall Study|Screen Failure|0|||
163346884|NCT02507687|589979300|FG001|Overall Study|Screen Failure|0|||
163409244|NCT01888640|590207568|FG000|Overall Study|Given wrong unit (placebo)|1|||
163346885|NCT02507687|589979301|FG002|Overall Study|Screen Failure|1|||
163346886|NCT02507687|589979302|FG003|Overall Study|Screen Failure|0|||
163346887|NCT02507687|589979299|FG000|Overall Study|Other, Not Specified|0|||
163346888|NCT02507687|589979300|FG001|Overall Study|Other, Not Specified|0|||
163346889|NCT02507687|589979301|FG002|Overall Study|Other, Not Specified|2|||
163346890|NCT02507687|589979302|FG003|Overall Study|Other, Not Specified|4|||
163346891|NCT00275301|589979303|FG000|Overall Study|Adverse Event|5|||
163346892|NCT04357964|589979304|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
163346893|NCT04357964|589979305|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
163409245|NCT01888640|590207569|FG001|Overall Study|Given wrong unit (placebo)|0|||
163346894|NCT04357964|589979304|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
163231657|NCT03670810|589560380|FG003|Main Study|Participant did not want to take the three other treatments|0|||
163231658|NCT03670810|589560381|FG004|Main Study|Participant did not want to take the three other treatments|0|||
163231659|NCT03670810|589560382|FG005|Main Study|Participant did not want to take the three other treatments|0|||
163231660|NCT03670810|589560383|FG006|Main Study|Participant did not want to take the three other treatments|0|||
163231661|NCT03670810|589560384|FG007|Main Study|Participant did not want to take the three other treatments|0|||
163231662|NCT03670810|589560385|FG008|Main Study|Participant did not want to take the three other treatments|0|||
163231663|NCT03670810|589560377|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
163231664|NCT03670810|589560378|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
163231665|NCT03670810|589560379|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
163231666|NCT03670810|589560380|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
163231667|NCT03670810|589560381|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
163231668|NCT03670810|589560382|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
163231669|NCT03670810|589560383|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
163231670|NCT03670810|589560384|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
163231671|NCT03670810|589560385|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
163231672|NCT03670810|589560377|FG000|Main Study|Travel and Coronavirus issues|0|||
163231673|NCT03670810|589560378|FG001|Main Study|Travel and Coronavirus issues|0|||
163231674|NCT03670810|589560379|FG002|Main Study|Travel and Coronavirus issues|0|||
163231675|NCT03670810|589560380|FG003|Main Study|Travel and Coronavirus issues|1|||
163231676|NCT03670810|589560381|FG004|Main Study|Travel and Coronavirus issues|0|||
163231677|NCT03670810|589560382|FG005|Main Study|Travel and Coronavirus issues|0|||
163231678|NCT03670810|589560383|FG006|Main Study|Travel and Coronavirus issues|0|||
163231679|NCT03670810|589560384|FG007|Main Study|Travel and Coronavirus issues|0|||
163231680|NCT03670810|589560385|FG008|Main Study|Travel and Coronavirus issues|0|||
163231681|NCT03670810|589560377|FG000|Open Label Extension|Protocol Deviation|0|||
163231682|NCT03670810|589560378|FG001|Open Label Extension|Protocol Deviation|0|||
163231683|NCT03670810|589560379|FG002|Open Label Extension|Protocol Deviation|0|||
163231684|NCT03670810|589560380|FG003|Open Label Extension|Protocol Deviation|0|||
163231685|NCT03670810|589560381|FG004|Open Label Extension|Protocol Deviation|0|||
163231686|NCT03670810|589560382|FG005|Open Label Extension|Protocol Deviation|0|||
163231687|NCT03670810|589560383|FG006|Open Label Extension|Protocol Deviation|0|||
163231688|NCT03670810|589560384|FG007|Open Label Extension|Protocol Deviation|0|||
163231689|NCT03670810|589560385|FG008|Open Label Extension|Protocol Deviation|5|||
163231690|NCT03670810|589560377|FG000|Open Label Extension|Death|0|||
163231691|NCT03670810|589560378|FG001|Open Label Extension|Death|0|||
163231692|NCT03670810|589560379|FG002|Open Label Extension|Death|0|||
163231693|NCT03670810|589560380|FG003|Open Label Extension|Death|0|||
163231694|NCT03670810|589560381|FG004|Open Label Extension|Death|0|||
163231695|NCT03670810|589560382|FG005|Open Label Extension|Death|0|||
163231696|NCT03670810|589560383|FG006|Open Label Extension|Death|0|||
163231697|NCT03670810|589560384|FG007|Open Label Extension|Death|0|||
163231698|NCT03670810|589560385|FG008|Open Label Extension|Death|1|||
163231699|NCT03670810|589560377|FG000|Open Label Extension|COVID-19|0|||
163231700|NCT03670810|589560378|FG001|Open Label Extension|COVID-19|0|||
163231701|NCT03670810|589560379|FG002|Open Label Extension|COVID-19|0|||
163231702|NCT03670810|589560380|FG003|Open Label Extension|COVID-19|0|||
163231703|NCT03670810|589560381|FG004|Open Label Extension|COVID-19|0|||
163231704|NCT03670810|589560382|FG005|Open Label Extension|COVID-19|0|||
163231705|NCT03670810|589560383|FG006|Open Label Extension|COVID-19|0|||
163231706|NCT03670810|589560384|FG007|Open Label Extension|COVID-19|0|||
163231707|NCT03670810|589560385|FG008|Open Label Extension|COVID-19|1|||
163231708|NCT03670810|589560377|FG000|Open Label Extension|Lack of Efficacy|0|||
163231709|NCT03670810|589560378|FG001|Open Label Extension|Lack of Efficacy|0|||
163231710|NCT03670810|589560379|FG002|Open Label Extension|Lack of Efficacy|0|||
163231711|NCT03670810|589560380|FG003|Open Label Extension|Lack of Efficacy|0|||
163231712|NCT03670810|589560381|FG004|Open Label Extension|Lack of Efficacy|0|||
163231713|NCT03670810|589560382|FG005|Open Label Extension|Lack of Efficacy|0|||
163231714|NCT03670810|589560383|FG006|Open Label Extension|Lack of Efficacy|0|||
163231715|NCT03670810|589560384|FG007|Open Label Extension|Lack of Efficacy|0|||
163231716|NCT03670810|589560385|FG008|Open Label Extension|Lack of Efficacy|39|||
163231717|NCT03670810|589560377|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
163231718|NCT03670810|589560378|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
163231719|NCT03670810|589560379|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
163231720|NCT03670810|589560380|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
163231721|NCT03670810|589560381|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
163231722|NCT03670810|589560382|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
163231723|NCT03670810|589560383|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
163231724|NCT03670810|589560384|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
163231725|NCT03670810|589560385|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
163231726|NCT03670810|589560377|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
163231727|NCT03670810|589560378|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
163231728|NCT03670810|589560379|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
163231729|NCT03670810|589560380|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
163231730|NCT03670810|589560381|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
163231731|NCT03670810|589560382|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
163231732|NCT03670810|589560383|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
163231733|NCT03670810|589560384|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
163231734|NCT03670810|589560385|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
163231735|NCT03670810|589560377|FG000|Open Label Extension|Withdrawal by Subject|0|||
163231736|NCT03670810|589560378|FG001|Open Label Extension|Withdrawal by Subject|0|||
163231737|NCT03670810|589560379|FG002|Open Label Extension|Withdrawal by Subject|0|||
163231738|NCT03670810|589560380|FG003|Open Label Extension|Withdrawal by Subject|0|||
163231739|NCT03670810|589560381|FG004|Open Label Extension|Withdrawal by Subject|0|||
163231740|NCT03670810|589560382|FG005|Open Label Extension|Withdrawal by Subject|0|||
163231741|NCT03670810|589560383|FG006|Open Label Extension|Withdrawal by Subject|0|||
163231742|NCT03670810|589560384|FG007|Open Label Extension|Withdrawal by Subject|0|||
163231743|NCT03670810|589560385|FG008|Open Label Extension|Withdrawal by Subject|46|||
163231744|NCT03670810|589560377|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
163231745|NCT03670810|589560378|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
163231746|NCT03670810|589560379|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
163231747|NCT03670810|589560380|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
163231748|NCT03670810|589560381|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
163231749|NCT03670810|589560382|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
163231750|NCT03670810|589560383|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
163231751|NCT03670810|589560384|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
163231752|NCT03670810|589560385|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
163231753|NCT03670810|589560377|FG000|Open Label Extension|Physician Decision|0|||
163231754|NCT03670810|589560378|FG001|Open Label Extension|Physician Decision|0|||
163231755|NCT03670810|589560379|FG002|Open Label Extension|Physician Decision|0|||
163231756|NCT03670810|589560380|FG003|Open Label Extension|Physician Decision|0|||
163231757|NCT03670810|589560381|FG004|Open Label Extension|Physician Decision|0|||
163231758|NCT03670810|589560382|FG005|Open Label Extension|Physician Decision|0|||
163231759|NCT03670810|589560383|FG006|Open Label Extension|Physician Decision|0|||
163231760|NCT03670810|589560384|FG007|Open Label Extension|Physician Decision|0|||
163231761|NCT03670810|589560385|FG008|Open Label Extension|Physician Decision|2|||
163231762|NCT03670810|589560377|FG000|Open Label Extension|Non-compliance with study drug|0|||
163231763|NCT03670810|589560378|FG001|Open Label Extension|Non-compliance with study drug|0|||
163231764|NCT03670810|589560379|FG002|Open Label Extension|Non-compliance with study drug|0|||
163231765|NCT03670810|589560380|FG003|Open Label Extension|Non-compliance with study drug|0|||
163231766|NCT03670810|589560381|FG004|Open Label Extension|Non-compliance with study drug|0|||
163231767|NCT03670810|589560382|FG005|Open Label Extension|Non-compliance with study drug|0|||
163231768|NCT03670810|589560383|FG006|Open Label Extension|Non-compliance with study drug|0|||
163231769|NCT03670810|589560384|FG007|Open Label Extension|Non-compliance with study drug|0|||
163231770|NCT03670810|589560385|FG008|Open Label Extension|Non-compliance with study drug|5|||
163231771|NCT03670810|589560377|FG000|Open Label Extension|Pregnancy|0|||
163231772|NCT03670810|589560378|FG001|Open Label Extension|Pregnancy|0|||
163231773|NCT03670810|589560379|FG002|Open Label Extension|Pregnancy|0|||
163231774|NCT03670810|589560380|FG003|Open Label Extension|Pregnancy|0|||
163346895|NCT04357964|589979305|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
163346896|NCT04357964|589979304|FG000|Overall Study|Adipose sample was insufficient quality|0|||
163346897|NCT04357964|589979305|FG001|Overall Study|Adipose sample was insufficient quality|1|||
163346898|NCT00733226|589979306|FG000|Overall Study|Withdrawal by Subject|1|||
163346899|NCT00733226|589979307|FG001|Overall Study|Withdrawal by Subject|0|||
163346900|NCT00733226|589979306|FG000|Overall Study|Lost to Follow-up|2|||
163346901|NCT00733226|589979307|FG001|Overall Study|Lost to Follow-up|0|||
163346902|NCT00733226|589979306|FG000|Overall Study|moved to another place|2|||
163346903|NCT00733226|589979307|FG001|Overall Study|moved to another place|0|||
163346904|NCT00349622|589979314|FG000|Overall Study|Death|168|||
163346905|NCT00349622|589979315|FG001|Overall Study|Death|86|||
163346906|NCT00349622|589979314|FG000|Overall Study|Lost to Follow-up|5|||
163346907|NCT00349622|589979315|FG001|Overall Study|Lost to Follow-up|1|||
163231775|NCT03670810|589560381|FG004|Open Label Extension|Pregnancy|0|||
163231776|NCT03670810|589560382|FG005|Open Label Extension|Pregnancy|0|||
163231777|NCT03670810|589560383|FG006|Open Label Extension|Pregnancy|0|||
163346908|NCT00349622|589979314|FG000|Overall Study|Withdrawal by Subject|5|||
163346909|NCT00349622|589979315|FG001|Overall Study|Withdrawal by Subject|9|||
163409246|NCT01888640|590207570|FG002|Overall Study|Given wrong unit (placebo)|0|||
163139078|NCT01248949|589217896|FG000|Overall Study|Lost to Follow-up|2|||
163139079|NCT01248949|589217897|FG001|Overall Study|Lost to Follow-up|2|||
163139080|NCT01248949|589217898|FG002|Overall Study|Lost to Follow-up|2|||
163139081|NCT01248949|589217899|FG003|Overall Study|Lost to Follow-up|1|||
163139082|NCT01248949|589217900|FG004|Overall Study|Lost to Follow-up|0|||
163139083|NCT01248949|589217896|FG000|Overall Study|Withdrawal by Subject|5|||
163139084|NCT01248949|589217897|FG001|Overall Study|Withdrawal by Subject|3|||
163139085|NCT01248949|589217898|FG002|Overall Study|Withdrawal by Subject|11|||
163139086|NCT01248949|589217899|FG003|Overall Study|Withdrawal by Subject|3|||
163139087|NCT01248949|589217900|FG004|Overall Study|Withdrawal by Subject|1|||
163139088|NCT01248949|589217896|FG000|Overall Study|Death|22|||
163139089|NCT01248949|589217897|FG001|Overall Study|Death|7|||
163139090|NCT01248949|589217898|FG002|Overall Study|Death|21|||
163139091|NCT01248949|589217899|FG003|Overall Study|Death|6|||
163139092|NCT01248949|589217900|FG004|Overall Study|Death|2|||
163139093|NCT01248949|589217896|FG000|Overall Study|Alternative Therapy|1|||
163139094|NCT01248949|589217897|FG001|Overall Study|Alternative Therapy|0|||
163139095|NCT01248949|589217898|FG002|Overall Study|Alternative Therapy|0|||
163139096|NCT01248949|589217899|FG003|Overall Study|Alternative Therapy|0|||
163139097|NCT01248949|589217900|FG004|Overall Study|Alternative Therapy|0|||
163139098|NCT01248949|589217896|FG000|Overall Study|Alternative Therapy.|1|||
163139099|NCT01248949|589217897|FG001|Overall Study|Alternative Therapy.|0|||
163139100|NCT01248949|589217898|FG002|Overall Study|Alternative Therapy.|0|||
163139101|NCT01248949|589217899|FG003|Overall Study|Alternative Therapy.|0|||
163139102|NCT01248949|589217900|FG004|Overall Study|Alternative Therapy.|0|||
163139103|NCT01248949|589217896|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
163139104|NCT01248949|589217897|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
163139105|NCT01248949|589217898|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
163139106|NCT01248949|589217899|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
163139107|NCT01248949|589217900|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
163139108|NCT01248949|589217896|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
163139109|NCT01248949|589217897|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
163139110|NCT01248949|589217898|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
163139111|NCT01248949|589217899|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
163139112|NCT01248949|589217900|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
163139113|NCT01248949|589217896|FG000|Overall Study|Participant Went To Hospice|0|||
163139114|NCT01248949|589217897|FG001|Overall Study|Participant Went To Hospice|0|||
163139115|NCT01248949|589217898|FG002|Overall Study|Participant Went To Hospice|1|||
163139116|NCT01248949|589217899|FG003|Overall Study|Participant Went To Hospice|0|||
163139117|NCT01248949|589217900|FG004|Overall Study|Participant Went To Hospice|0|||
163139118|NCT01248949|589217896|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
163139119|NCT01248949|589217897|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
163139120|NCT01248949|589217898|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
163139121|NCT01248949|589217899|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
163139122|NCT01248949|589217900|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
163139123|NCT01248949|589217896|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
163139124|NCT01248949|589217897|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
163139125|NCT01248949|589217898|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
163139126|NCT01248949|589217899|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
163139127|NCT01248949|589217900|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
163139128|NCT01248949|589217896|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
163139129|NCT01248949|589217897|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
163139130|NCT01248949|589217898|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
163139131|NCT01248949|589217899|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
163139132|NCT01248949|589217900|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
163139133|NCT01248949|589217896|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
163139134|NCT01248949|589217897|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
163139135|NCT01248949|589217898|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
163139136|NCT01248949|589217899|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
163139137|NCT01248949|589217900|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
163139138|NCT03245775|589217903|FG000|Overall Study|Lost to Follow-up|25|||
163139139|NCT03245775|589217904|FG001|Overall Study|Lost to Follow-up|26|||
163139140|NCT03245775|589217905|FG002|Overall Study|Lost to Follow-up|16|||
163139141|NCT03245775|589217906|FG003|Overall Study|Lost to Follow-up|16|||
163139142|NCT01099397|589217908|FG000|Overall Study|Lost to Follow-up|4|||
163139143|NCT01099397|589217908|FG000|Overall Study|Protocol Violation|4|||
163139144|NCT01099397|589217908|FG000|Overall Study|Withdrawal by Subject|5|||
163139145|NCT02363959|589217909|FG000|Overall Study|Medical instability|1|||
163139146|NCT02363959|589217910|FG001|Overall Study|Medical instability|0|||
163139147|NCT00950248|589217913|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
163139148|NCT00950248|589217914|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
163139149|NCT00950248|589217915|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
163139150|NCT00950248|589217913|FG000|Year 1: Baseline|worsening of symptoms|2|||
163409247|NCT01888640|590207568|FG000|Overall Study|Excluded for prior TENS|0|||
163139151|NCT00950248|589217914|FG001|Year 1: Baseline|worsening of symptoms|0|||
163139152|NCT00950248|589217915|FG002|Year 1: Baseline|worsening of symptoms|0|||
163139153|NCT00950248|589217913|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
163139154|NCT00950248|589217914|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
163139155|NCT00950248|589217915|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
163139156|NCT00950248|589217913|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
163139157|NCT00950248|589217914|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
163139158|NCT00950248|589217915|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
163139159|NCT00950248|589217913|FG000|Year 2&3 Treatment Randomization|Death|0|||
163139160|NCT00950248|589217914|FG001|Year 2&3 Treatment Randomization|Death|0|||
163139161|NCT00950248|589217915|FG002|Year 2&3 Treatment Randomization|Death|1|||
163139162|NCT00950248|589217913|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
163139163|NCT00950248|589217914|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
163139164|NCT00950248|589217915|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
163139165|NCT00940498|589217919|FG000|Overall Study|Death|2|||
163139166|NCT00940498|589217920|FG001|Overall Study|Death|0|||
163139167|NCT00940498|589217921|FG002|Overall Study|Death|0|||
163139168|NCT00940498|589217922|FG003|Overall Study|Death|1|||
163139169|NCT00940498|589217923|FG004|Overall Study|Death|5|||
163139170|NCT00940498|589217924|FG005|Overall Study|Death|0|||
163139171|NCT00940498|589217925|FG006|Overall Study|Death|1|||
163139172|NCT00940498|589217926|FG007|Overall Study|Death|0|||
163139173|NCT00940498|589217919|FG000|Overall Study|Lost to Follow-up|1|||
163139174|NCT00940498|589217920|FG001|Overall Study|Lost to Follow-up|1|||
163139175|NCT00940498|589217921|FG002|Overall Study|Lost to Follow-up|2|||
163139176|NCT00940498|589217922|FG003|Overall Study|Lost to Follow-up|0|||
163139177|NCT00940498|589217923|FG004|Overall Study|Lost to Follow-up|1|||
163139178|NCT00940498|589217924|FG005|Overall Study|Lost to Follow-up|0|||
163139179|NCT00940498|589217925|FG006|Overall Study|Lost to Follow-up|0|||
163139180|NCT00940498|589217926|FG007|Overall Study|Lost to Follow-up|1|||
163139181|NCT00940498|589217919|FG000|Overall Study|Disease Progression|0|||
163139182|NCT00940498|589217920|FG001|Overall Study|Disease Progression|0|||
163139183|NCT00940498|589217921|FG002|Overall Study|Disease Progression|1|||
163139184|NCT00940498|589217922|FG003|Overall Study|Disease Progression|1|||
163139185|NCT00940498|589217923|FG004|Overall Study|Disease Progression|0|||
163139186|NCT00940498|589217924|FG005|Overall Study|Disease Progression|1|||
163139187|NCT00940498|589217925|FG006|Overall Study|Disease Progression|0|||
163139188|NCT00940498|589217926|FG007|Overall Study|Disease Progression|0|||
163139189|NCT00940498|589217919|FG000|Overall Study|Physician Decision|0|||
163139190|NCT00940498|589217920|FG001|Overall Study|Physician Decision|0|||
163139191|NCT00940498|589217921|FG002|Overall Study|Physician Decision|0|||
163139192|NCT00940498|589217922|FG003|Overall Study|Physician Decision|0|||
163139193|NCT00940498|589217923|FG004|Overall Study|Physician Decision|2|||
163139194|NCT00940498|589217924|FG005|Overall Study|Physician Decision|0|||
163139195|NCT00940498|589217925|FG006|Overall Study|Physician Decision|0|||
163139196|NCT00940498|589217926|FG007|Overall Study|Physician Decision|0|||
163139197|NCT00940498|589217919|FG000|Overall Study|Not treated due to disease related pain|0|||
163139198|NCT00940498|589217920|FG001|Overall Study|Not treated due to disease related pain|0|||
163139199|NCT00940498|589217921|FG002|Overall Study|Not treated due to disease related pain|0|||
163139200|NCT00940498|589217922|FG003|Overall Study|Not treated due to disease related pain|0|||
163139201|NCT00940498|589217923|FG004|Overall Study|Not treated due to disease related pain|1|||
163139202|NCT00940498|589217924|FG005|Overall Study|Not treated due to disease related pain|0|||
163139203|NCT00940498|589217925|FG006|Overall Study|Not treated due to disease related pain|0|||
163139204|NCT00940498|589217926|FG007|Overall Study|Not treated due to disease related pain|0|||
163139205|NCT00650845|589217928|FG000|Overall Study|Withdrawal by Subject|5|||
163139206|NCT00650845|589217929|FG001|Overall Study|Withdrawal by Subject|0|||
163139207|NCT00650845|589217928|FG000|Overall Study|Protocol Violation|0|||
163139208|NCT00650845|589217929|FG001|Overall Study|Protocol Violation|13|||
163139209|NCT01594931|589219777|FG000|Overall Study|Adverse Event|3|||
163139210|NCT01594931|589219778|FG001|Overall Study|Adverse Event|1|||
163139211|NCT01594931|589219779|FG002|Overall Study|Adverse Event|1|||
163139212|NCT01594931|589219777|FG000|Overall Study|Withdrawal by Subject|2|||
163139213|NCT01594931|589219778|FG001|Overall Study|Withdrawal by Subject|1|||
163139214|NCT01594931|589219779|FG002|Overall Study|Withdrawal by Subject|1|||
163139215|NCT01594931|589219777|FG000|Overall Study|Lack of Efficacy|7|||
163139216|NCT01594931|589219778|FG001|Overall Study|Lack of Efficacy|2|||
163139217|NCT01594931|589219779|FG002|Overall Study|Lack of Efficacy|2|||
163139218|NCT01594931|589219777|FG000|Overall Study|Lost to Follow-up|4|||
163139219|NCT01594931|589219778|FG001|Overall Study|Lost to Follow-up|3|||
163139220|NCT01594931|589219779|FG002|Overall Study|Lost to Follow-up|3|||
163139221|NCT01594931|589219777|FG000|Overall Study|Protocol Violation|2|||
163139222|NCT01594931|589219778|FG001|Overall Study|Protocol Violation|1|||
163139223|NCT01594931|589219779|FG002|Overall Study|Protocol Violation|0|||
163139224|NCT01594931|589219777|FG000|Overall Study|No defiined|11|||
163139225|NCT01594931|589219778|FG001|Overall Study|No defiined|4|||
163139226|NCT01594931|589219779|FG002|Overall Study|No defiined|7|||
163231778|NCT03670810|589560384|FG007|Open Label Extension|Pregnancy|0|||
163231779|NCT03670810|589560385|FG008|Open Label Extension|Pregnancy|3|||
163231780|NCT03670810|589560377|FG000|Open Label Extension|Adverse Event|0|||
163231781|NCT03670810|589560378|FG001|Open Label Extension|Adverse Event|0|||
163231782|NCT03670810|589560379|FG002|Open Label Extension|Adverse Event|0|||
163231783|NCT03670810|589560380|FG003|Open Label Extension|Adverse Event|0|||
163231784|NCT03670810|589560381|FG004|Open Label Extension|Adverse Event|0|||
163231785|NCT03670810|589560382|FG005|Open Label Extension|Adverse Event|0|||
163231786|NCT03670810|589560383|FG006|Open Label Extension|Adverse Event|0|||
163231787|NCT03670810|589560384|FG007|Open Label Extension|Adverse Event|0|||
163231788|NCT03670810|589560385|FG008|Open Label Extension|Adverse Event|24|||
163231789|NCT03670810|589560377|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
163231790|NCT03670810|589560378|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
163231791|NCT03670810|589560379|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
163231792|NCT03670810|589560380|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
163231793|NCT03670810|589560381|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
163231794|NCT03670810|589560382|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
163231795|NCT03670810|589560383|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
163231796|NCT03670810|589560384|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
163231797|NCT03670810|589560385|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
163231798|NCT03670810|589560377|FG000|Open Label Extension|Lost to Follow-up|0|||
163231799|NCT03670810|589560378|FG001|Open Label Extension|Lost to Follow-up|0|||
163231800|NCT03670810|589560379|FG002|Open Label Extension|Lost to Follow-up|0|||
163231801|NCT03670810|589560380|FG003|Open Label Extension|Lost to Follow-up|0|||
163231802|NCT03670810|589560381|FG004|Open Label Extension|Lost to Follow-up|0|||
163231803|NCT03670810|589560382|FG005|Open Label Extension|Lost to Follow-up|0|||
163231804|NCT03670810|589560383|FG006|Open Label Extension|Lost to Follow-up|0|||
163231805|NCT03670810|589560384|FG007|Open Label Extension|Lost to Follow-up|0|||
163231806|NCT03670810|589560385|FG008|Open Label Extension|Lost to Follow-up|23|||
163231807|NCT00678691|589560386|FG000|Overall Study|Adverse Event|6|||
163231808|NCT00678691|589560387|FG001|Overall Study|Adverse Event|4|||
163231809|NCT00779766|589560394|FG000|Month 24|Serious Adverse Event|2|||
163231810|NCT00779766|589560395|FG001|Month 24|Serious Adverse Event|3|||
163231811|NCT00779766|589560394|FG000|Month 24|Adverse Event|3|||
163231812|NCT00779766|589560395|FG001|Month 24|Adverse Event|3|||
163231813|NCT00779766|589560394|FG000|Month 24|Protocol Violation|3|||
163231814|NCT00779766|589560395|FG001|Month 24|Protocol Violation|1|||
163231815|NCT00779766|589560394|FG000|Month 24|Withdrawal by Subject|159|||
163231816|NCT00779766|589560395|FG001|Month 24|Withdrawal by Subject|127|||
163231817|NCT00779766|589560394|FG000|Month 24|Migrated/moved from study area|138|||
163231818|NCT00779766|589560395|FG001|Month 24|Migrated/moved from study area|162|||
163231819|NCT00779766|589560394|FG000|Month 24|Lost to Follow-up|9|||
163231820|NCT00779766|589560395|FG001|Month 24|Lost to Follow-up|9|||
163231821|NCT00779766|589560394|FG000|Month 24|Other|18|||
163231822|NCT00779766|589560395|FG001|Month 24|Other|27|||
163231823|NCT00779766|589560394|FG000|Month 48|Withdrawal by Subject|68|||
163231824|NCT00779766|589560395|FG001|Month 48|Withdrawal by Subject|63|||
163231825|NCT00779766|589560394|FG000|Month 48|Migrated/moved from study area|76|||
163231826|NCT00779766|589560395|FG001|Month 48|Migrated/moved from study area|75|||
163231827|NCT00779766|589560394|FG000|Month 48|Lost to Follow-up|29|||
163231828|NCT00779766|589560395|FG001|Month 48|Lost to Follow-up|30|||
163231829|NCT00779766|589560394|FG000|Month 48|Other|1|||
163231830|NCT00779766|589560395|FG001|Month 48|Other|0|||
163231831|NCT00779766|589560394|FG000|Month 72|Withdrawal by Subject|55|||
163231832|NCT00779766|589560395|FG001|Month 72|Withdrawal by Subject|71|||
163231833|NCT00779766|589560394|FG000|Month 72|Migrated/moved from study area|124|||
163231834|NCT00779766|589560395|FG001|Month 72|Migrated/moved from study area|109|||
163231835|NCT00779766|589560394|FG000|Month 72|Lost to Follow-up|6|||
163231836|NCT00779766|589560395|FG001|Month 72|Lost to Follow-up|8|||
163231837|NCT00779766|589560394|FG000|Month 72|Other|0|||
163231838|NCT00779766|589560395|FG001|Month 72|Other|1|||
163231839|NCT01412424|589560396|FG000|Core Treatment Period|Treatment Failure|24|||
163231840|NCT01412424|589560396|FG000|Core Treatment Period|Adverse Event|21|||
163231841|NCT01412424|589560396|FG000|Core Treatment Period|Patient Request|5|||
163231842|NCT01412424|589560396|FG000|Core Treatment Period|Lost to Follow-up|2|||
163231843|NCT01412424|589560396|FG000|Core Treatment Period|Sponsor Request|1|||
163231844|NCT01412424|589560396|FG000|Extension Treatment Period|Adverse Event|2|||
163231845|NCT01412424|589560396|FG000|Extension Treatment Period|Treatment Failure|2|||
163231846|NCT01412424|589560396|FG000|Extension Treatment Period|Patient Request|2|||
163231847|NCT02410811|589560400|FG000|Overall Study|Withdrawal by Subject|0|||
163231848|NCT02410811|589560401|FG001|Overall Study|Withdrawal by Subject|0|||
163231849|NCT02410811|589560402|FG002|Overall Study|Withdrawal by Subject|1|||
163231850|NCT02410811|589560403|FG003|Overall Study|Withdrawal by Subject|0|||
163231851|NCT00353366|589560404|FG000|Overall Study|Adverse Event|8|||
163231852|NCT00353366|589560404|FG000|Overall Study|Protocol Violation|12|||
163231853|NCT00353366|589560404|FG000|Overall Study|Withdrawal by Subject|12|||
163231854|NCT00353366|589560404|FG000|Overall Study|Lost to Follow-up|92|||
163231855|NCT00353366|589560404|FG000|Overall Study|Other|19|||
163231856|NCT00259857|589560405|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
163231857|NCT00259857|589560406|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
163231858|NCT00259857|589560405|FG000|24 Months Treatment|Lost to Follow-up|0|||
163231859|NCT00259857|589560406|FG001|24 Months Treatment|Lost to Follow-up|3|||
163231860|NCT05267054|589560407|FG000|Overall Study|Death|13|||
163231861|NCT05267054|589560408|FG001|Overall Study|Death|14|||
163231862|NCT05267054|589560407|FG000|Overall Study|Study Ended by Sponsor|9|||
163231863|NCT05267054|589560408|FG001|Overall Study|Study Ended by Sponsor|13|||
163231864|NCT05267054|589560407|FG000|Overall Study|Lost to Follow-up|1|||
163231865|NCT05267054|589560408|FG001|Overall Study|Lost to Follow-up|1|||
163231866|NCT05267054|589560407|FG000|Overall Study|Withdrawal by Subject|1|||
163231867|NCT05267054|589560408|FG001|Overall Study|Withdrawal by Subject|1|||
163231868|NCT01552226|589560411|FG000|Overall Study|Withdrawal by Subject|4|||
163231869|NCT01552226|589560412|FG001|Overall Study|Withdrawal by Subject|4|||
163231870|NCT01469065|589560416|FG000|Overall Study|Lack of Efficacy|0|||
163231871|NCT01469065|589560417|FG001|Overall Study|Lack of Efficacy|0|||
163231872|NCT01469065|589560418|FG002|Overall Study|Lack of Efficacy|0|||
163231873|NCT01469065|589560419|FG003|Overall Study|Lack of Efficacy|0|||
163231874|NCT01469065|589560420|FG004|Overall Study|Lack of Efficacy|1|||
163231875|NCT01469065|589560416|FG000|Overall Study|Other|0|||
163231876|NCT01469065|589560417|FG001|Overall Study|Other|1|||
163231877|NCT01469065|589560418|FG002|Overall Study|Other|0|||
163231878|NCT01469065|589560419|FG003|Overall Study|Other|0|||
163231879|NCT01469065|589560420|FG004|Overall Study|Other|0|||
163231880|NCT04542070|589560421|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
163231881|NCT04542070|589560422|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
163231882|NCT04542070|589560423|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
163231883|NCT04542070|589560424|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
163231884|NCT04542070|589560421|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
163231885|NCT04542070|589560422|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
163231886|NCT04542070|589560423|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
163231887|NCT04542070|589560424|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
163231888|NCT04542070|589560421|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
163231889|NCT04542070|589560422|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
163231890|NCT04542070|589560423|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
163231891|NCT04542070|589560424|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
163231892|NCT04542070|589560421|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
163231893|NCT04542070|589560422|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
163231894|NCT04542070|589560423|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
163231895|NCT04542070|589560424|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
163231896|NCT04542070|589560421|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
163231897|NCT04542070|589560422|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
163231898|NCT04542070|589560423|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
163231899|NCT04542070|589560424|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
163231900|NCT04542070|589560421|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
163231901|NCT04542070|589560422|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
163231902|NCT04542070|589560423|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
163231903|NCT04542070|589560424|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
163231904|NCT04542070|589560421|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
163231905|NCT04542070|589560422|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
163231906|NCT04542070|589560423|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
163231907|NCT04542070|589560424|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
163231908|NCT04542070|589560421|FG000|Maintenance + Extension Period|Adverse Event|10|||
163231909|NCT04542070|589560422|FG001|Maintenance + Extension Period|Adverse Event|2|||
163231910|NCT04542070|589560423|FG002|Maintenance + Extension Period|Adverse Event|0|||
163231911|NCT04542070|589560424|FG003|Maintenance + Extension Period|Adverse Event|0|||
163231912|NCT04542070|589560421|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
163346910|NCT03296566|589979318|FG000|Overall Study|Lost to Follow-up|19|||
163346911|NCT03296566|589979319|FG001|Overall Study|Lost to Follow-up|46|||
163231913|NCT04542070|589560422|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
163231914|NCT04542070|589560423|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
163231915|NCT04542070|589560424|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
163231916|NCT04542070|589560421|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
163346912|NCT03296566|589979318|FG000|Overall Study|Withdrawal by Subject|0|||
163346913|NCT03296566|589979319|FG001|Overall Study|Withdrawal by Subject|3|||
163231917|NCT04542070|589560422|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
163346914|NCT03511378|589979323|FG000|Overall Study|Withdrawal by Subject|2|||
163346915|NCT03511378|589979324|FG001|Overall Study|Withdrawal by Subject|2|||
163231918|NCT04542070|589560423|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
163231919|NCT04542070|589560424|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
163231920|NCT04542070|589560421|FG000|Maintenance + Extension Period|Physician Decision|1|||
163231921|NCT04542070|589560422|FG001|Maintenance + Extension Period|Physician Decision|1|||
163231922|NCT04542070|589560423|FG002|Maintenance + Extension Period|Physician Decision|0|||
163231923|NCT04542070|589560424|FG003|Maintenance + Extension Period|Physician Decision|0|||
163231924|NCT04542070|589560421|FG000|Maintenance + Extension Period|Protocol Violation|2|||
163231925|NCT04542070|589560422|FG001|Maintenance + Extension Period|Protocol Violation|5|||
163231926|NCT04542070|589560423|FG002|Maintenance + Extension Period|Protocol Violation|0|||
163231927|NCT04542070|589560424|FG003|Maintenance + Extension Period|Protocol Violation|0|||
163231928|NCT04542070|589560421|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
163231929|NCT04542070|589560422|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
163231930|NCT04542070|589560423|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
163231931|NCT04542070|589560424|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
163231932|NCT04542070|589560421|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
163231933|NCT04542070|589560422|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
163231934|NCT04542070|589560423|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
163231935|NCT04542070|589560424|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
163231936|NCT04542070|589560421|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
163231937|NCT04542070|589560422|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
163231938|NCT04542070|589560423|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
163231939|NCT04542070|589560424|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
163231940|NCT04542070|589560421|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
163231941|NCT04542070|589560422|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
163231942|NCT04542070|589560423|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
163231943|NCT04542070|589560424|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
163231944|NCT04542070|589560421|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
163231945|NCT04542070|589560422|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
163231946|NCT04542070|589560423|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
163231947|NCT04542070|589560424|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
163231948|NCT04542070|589560421|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
163231949|NCT04542070|589560422|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
163231950|NCT04542070|589560423|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
163231951|NCT04542070|589560424|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
163231952|NCT04542070|589560421|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
163231953|NCT04542070|589560422|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
163231954|NCT04542070|589560423|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
163231955|NCT04542070|589560424|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
163231956|NCT03511560|589560427|FG000|Overall Study|Death|0|||
163231957|NCT03511560|589560428|FG001|Overall Study|Death|1|||
163231958|NCT03511560|589560427|FG000|Overall Study|Adverse Event|0|||
163231959|NCT03511560|589560428|FG001|Overall Study|Adverse Event|2|||
163231960|NCT03511560|589560427|FG000|Overall Study|Transplant cancelled|0|||
163231961|NCT03511560|589560428|FG001|Overall Study|Transplant cancelled|1|||
163231962|NCT03511560|589560427|FG000|Overall Study|Patient switched to another drug|1|||
163231963|NCT03511560|589560428|FG001|Overall Study|Patient switched to another drug|0|||
163231964|NCT02751983|589560435|FG000|Treatment|Stopped ACT, but Remained in study|2|||
163231965|NCT02751983|589560436|FG001|Treatment|Stopped ACT, but Remained in study|0|||
163231966|NCT02751983|589560435|FG000|Treatment|Discharged prior to beginning ACT|2|||
163231967|NCT02751983|589560436|FG001|Treatment|Discharged prior to beginning ACT|0|||
163231968|NCT02751983|589560435|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
163231969|NCT02751983|589560436|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
163231970|NCT02751983|589560435|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
163231971|NCT02751983|589560436|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
163231972|NCT02751983|589560435|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
163231973|NCT02751983|589560436|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
163231974|NCT02167256|589560437|FG000|Overall Study|Adverse Event|13|||
163231975|NCT02167256|589560438|FG001|Overall Study|Adverse Event|6|||
163231976|NCT02167256|589560437|FG000|Overall Study|Withdrawal by Subject|4|||
163346916|NCT03511378|589979323|FG000|Overall Study|Patient not coming or schedule visit|1|||
163231977|NCT02167256|589560438|FG001|Overall Study|Withdrawal by Subject|4|||
163231978|NCT02167256|589560437|FG000|Overall Study|non-compliance|3|||
163231979|NCT02167256|589560438|FG001|Overall Study|non-compliance|0|||
163231980|NCT02167256|589560437|FG000|Overall Study|Study partner unable to participate|1|||
163231981|NCT02167256|589560438|FG001|Overall Study|Study partner unable to participate|0|||
163231982|NCT03467425|589560439|FG000|Overall Study|Adverse Event|9|||
163231983|NCT03467425|589560440|FG001|Overall Study|Adverse Event|9|||
163231984|NCT03467425|589560439|FG000|Overall Study|Lack of Efficacy|3|||
163346917|NCT03511378|589979324|FG001|Overall Study|Patient not coming or schedule visit|0|||
163346918|NCT01503515|589979327|FG000|Overall Study|Adverse Event|4|||
163346919|NCT01503515|589979328|FG001|Overall Study|Adverse Event|5|||
163231985|NCT03467425|589560440|FG001|Overall Study|Lack of Efficacy|1|||
163231986|NCT03467425|589560439|FG000|Overall Study|Protocol Violation|0|||
163231987|NCT03467425|589560440|FG001|Overall Study|Protocol Violation|1|||
163231988|NCT03467425|589560439|FG000|Overall Study|Lost to Follow-up|18|||
163231989|NCT03467425|589560440|FG001|Overall Study|Lost to Follow-up|25|||
163231990|NCT03467425|589560439|FG000|Overall Study|Physician Decision|2|||
163231991|NCT03467425|589560440|FG001|Overall Study|Physician Decision|1|||
163231992|NCT03467425|589560439|FG000|Overall Study|Withdrawal by Subject|15|||
163231993|NCT03467425|589560440|FG001|Overall Study|Withdrawal by Subject|17|||
163231994|NCT00025883|589560441|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
163231995|NCT00025883|589560441|FG000|Overall Study|no baseline data|1|||
163231996|NCT00025883|589560441|FG000|Overall Study|Death|1|||
163231997|NCT00025883|589560441|FG000|Overall Study|Adverse Event|1|||
163231998|NCT00025883|589560441|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
163231999|NCT01451424|589560442|FG000|Overall Study|Withdrawal by Subject|1|||
163232000|NCT01451424|589560443|FG001|Overall Study|Withdrawal by Subject|1|||
163232001|NCT01451424|589560444|FG002|Overall Study|Withdrawal by Subject|0|||
163232002|NCT01451424|589560445|FG003|Overall Study|Withdrawal by Subject|2|||
163232003|NCT01451424|589560442|FG000|Overall Study|Lost to Follow-up|0|||
163232004|NCT01451424|589560443|FG001|Overall Study|Lost to Follow-up|1|||
163232005|NCT01451424|589560444|FG002|Overall Study|Lost to Follow-up|0|||
163232006|NCT01451424|589560445|FG003|Overall Study|Lost to Follow-up|1|||
163232007|NCT01451424|589560442|FG000|Overall Study|Physician Decision|0|||
163232008|NCT01451424|589560443|FG001|Overall Study|Physician Decision|0|||
163232009|NCT01451424|589560444|FG002|Overall Study|Physician Decision|1|||
163232010|NCT01451424|589560445|FG003|Overall Study|Physician Decision|1|||
163232011|NCT01451424|589560442|FG000|Overall Study|Adverse Event|0|||
163232012|NCT01451424|589560443|FG001|Overall Study|Adverse Event|0|||
163232013|NCT01451424|589560444|FG002|Overall Study|Adverse Event|0|||
163232014|NCT01451424|589560445|FG003|Overall Study|Adverse Event|1|||
163232015|NCT02920983|589560446|FG000|Dispense 1|Unacceptable Lens Fit|0|||
163232016|NCT02920983|589560447|FG001|Dispense 1|Unacceptable Lens Fit|0|||
163232017|NCT02920983|589560448|FG002|Dispense 1|Unacceptable Lens Fit|0|||
163232018|NCT02920983|589560449|FG003|Dispense 1|Unacceptable Lens Fit|0|||
163232019|NCT02920983|589560450|FG004|Dispense 1|Unacceptable Lens Fit|1|||
163232020|NCT02920983|589560451|FG005|Dispense 1|Unacceptable Lens Fit|0|||
163232021|NCT02920983|589560446|FG000|Dispense 2|Unscceptable lens fit|1|||
163232022|NCT02920983|589560447|FG001|Dispense 2|Unscceptable lens fit|0|||
163232023|NCT02920983|589560448|FG002|Dispense 2|Unscceptable lens fit|0|||
163232024|NCT02920983|589560449|FG003|Dispense 2|Unscceptable lens fit|0|||
163232025|NCT02920983|589560450|FG004|Dispense 2|Unscceptable lens fit|1|||
163232026|NCT02920983|589560451|FG005|Dispense 2|Unscceptable lens fit|0|||
163232027|NCT02920983|589560446|FG000|Dispense 3|Unacceptable Lens Fit|1|||
163232028|NCT02920983|589560447|FG001|Dispense 3|Unacceptable Lens Fit|1|||
163232029|NCT02920983|589560448|FG002|Dispense 3|Unacceptable Lens Fit|0|||
163232030|NCT02920983|589560449|FG003|Dispense 3|Unacceptable Lens Fit|0|||
163232031|NCT02920983|589560450|FG004|Dispense 3|Unacceptable Lens Fit|1|||
163232032|NCT02920983|589560451|FG005|Dispense 3|Unacceptable Lens Fit|0|||
163232033|NCT01387607|589560457|FG000|Overall Study|Adverse Event|23|||
163232034|NCT01387607|589560458|FG001|Overall Study|Adverse Event|11|||
163232035|NCT01387607|589560457|FG000|Overall Study|Lack of Efficacy|8|||
163232036|NCT01387607|589560458|FG001|Overall Study|Lack of Efficacy|6|||
163232037|NCT01387607|589560457|FG000|Overall Study|Lost to Follow-up|2|||
163232038|NCT01387607|589560458|FG001|Overall Study|Lost to Follow-up|1|||
163232039|NCT01387607|589560457|FG000|Overall Study|No longer meets eligibility criteria|0|||
163232040|NCT01387607|589560458|FG001|Overall Study|No longer meets eligibility criteria|1|||
163232041|NCT01387607|589560457|FG000|Overall Study|Protocol Violation|1|||
163232042|NCT01387607|589560458|FG001|Overall Study|Protocol Violation|5|||
163232043|NCT01387607|589560457|FG000|Overall Study|Withdrawal by Subject|13|||
163346920|NCT01503515|589979327|FG000|Overall Study|Death|0|||
163346921|NCT01503515|589979328|FG001|Overall Study|Death|1|||
163232044|NCT01387607|589560458|FG001|Overall Study|Withdrawal by Subject|14|||
163232045|NCT01387607|589560457|FG000|Overall Study|Other|1|||
163232046|NCT01387607|589560458|FG001|Overall Study|Other|1|||
163232047|NCT01387607|589560457|FG000|Overall Study|Randomized, not treated|3|||
163346922|NCT01503515|589979327|FG000|Overall Study|Physician Decision|14|||
163346923|NCT01503515|589979328|FG001|Overall Study|Physician Decision|23|||
163346924|NCT01503515|589979327|FG000|Overall Study|Withdrawal by Subject|0|||
163232048|NCT01387607|589560458|FG001|Overall Study|Randomized, not treated|6|||
163232049|NCT03665038|589560459|FG000|Overall Study|Lost to Follow-up|0|||
163232050|NCT03665038|589560460|FG001|Overall Study|Lost to Follow-up|0|||
163232051|NCT03665038|589560461|FG002|Overall Study|Lost to Follow-up|1|||
163232052|NCT03013491|589560462|FG000|Main Study|Death|2|||
163232053|NCT03013491|589560463|FG001|Main Study|Death|2|||
163232054|NCT03013491|589560464|FG002|Main Study|Death|5|||
163232055|NCT03013491|589560465|FG003|Main Study|Death|3|||
163232056|NCT03013491|589560466|FG004|Main Study|Death|9|||
163232057|NCT03013491|589560467|FG005|Main Study|Death|12|||
163346925|NCT01503515|589979328|FG001|Overall Study|Withdrawal by Subject|1|||
163232058|NCT03013491|589560468|FG006|Main Study|Death|3|||
163232059|NCT03013491|589560469|FG007|Main Study|Death|5|||
163232060|NCT03013491|589560470|FG008|Main Study|Death|1|||
163232061|NCT03013491|589560471|FG009|Main Study|Death|2|||
163232062|NCT03013491|589560472|FG010|Main Study|Death|4|||
163232063|NCT03013491|589560473|FG011|Main Study|Death|1|||
163232064|NCT03013491|589560474|FG012|Main Study|Death|1|||
163232065|NCT03013491|589560475|FG013|Main Study|Death|4|||
163232066|NCT03013491|589560476|FG014|Main Study|Death|0|||
163232067|NCT03013491|589560477|FG015|Main Study|Death|3|||
163232068|NCT03013491|589560478|FG016|Main Study|Death|5|||
163232069|NCT03013491|589560479|FG017|Main Study|Death|1|||
163232070|NCT03013491|589560480|FG018|Main Study|Death|47|||
163232071|NCT03013491|589560462|FG000|Main Study|Lost to Follow-up|0|||
163232072|NCT03013491|589560463|FG001|Main Study|Lost to Follow-up|0|||
163232073|NCT03013491|589560464|FG002|Main Study|Lost to Follow-up|1|||
163232074|NCT03013491|589560465|FG003|Main Study|Lost to Follow-up|0|||
163232075|NCT03013491|589560466|FG004|Main Study|Lost to Follow-up|1|||
163232076|NCT03013491|589560467|FG005|Main Study|Lost to Follow-up|0|||
163232077|NCT03013491|589560468|FG006|Main Study|Lost to Follow-up|0|||
163232078|NCT03013491|589560469|FG007|Main Study|Lost to Follow-up|0|||
163232079|NCT03013491|589560470|FG008|Main Study|Lost to Follow-up|0|||
163232080|NCT03013491|589560471|FG009|Main Study|Lost to Follow-up|0|||
163232081|NCT03013491|589560472|FG010|Main Study|Lost to Follow-up|0|||
163232082|NCT03013491|589560473|FG011|Main Study|Lost to Follow-up|0|||
163232083|NCT03013491|589560474|FG012|Main Study|Lost to Follow-up|0|||
163232084|NCT03013491|589560475|FG013|Main Study|Lost to Follow-up|0|||
163232085|NCT03013491|589560476|FG014|Main Study|Lost to Follow-up|0|||
163232086|NCT03013491|589560477|FG015|Main Study|Lost to Follow-up|0|||
163232087|NCT03013491|589560478|FG016|Main Study|Lost to Follow-up|0|||
163232088|NCT03013491|589560479|FG017|Main Study|Lost to Follow-up|0|||
163232089|NCT03013491|589560480|FG018|Main Study|Lost to Follow-up|3|||
163232090|NCT03013491|589560462|FG000|Main Study|Termination of the study by Sponsor|0|||
163232091|NCT03013491|589560463|FG001|Main Study|Termination of the study by Sponsor|0|||
163232092|NCT03013491|589560464|FG002|Main Study|Termination of the study by Sponsor|2|||
163232093|NCT03013491|589560465|FG003|Main Study|Termination of the study by Sponsor|0|||
163232094|NCT03013491|589560466|FG004|Main Study|Termination of the study by Sponsor|1|||
163232095|NCT03013491|589560467|FG005|Main Study|Termination of the study by Sponsor|2|||
163232096|NCT03013491|589560468|FG006|Main Study|Termination of the study by Sponsor|0|||
163232097|NCT03013491|589560469|FG007|Main Study|Termination of the study by Sponsor|0|||
163232098|NCT03013491|589560470|FG008|Main Study|Termination of the study by Sponsor|1|||
163232099|NCT03013491|589560471|FG009|Main Study|Termination of the study by Sponsor|1|||
163232100|NCT03013491|589560472|FG010|Main Study|Termination of the study by Sponsor|1|||
163232101|NCT03013491|589560473|FG011|Main Study|Termination of the study by Sponsor|2|||
163232102|NCT03013491|589560474|FG012|Main Study|Termination of the study by Sponsor|0|||
163232103|NCT03013491|589560475|FG013|Main Study|Termination of the study by Sponsor|0|||
163232104|NCT03013491|589560476|FG014|Main Study|Termination of the study by Sponsor|0|||
163232105|NCT03013491|589560477|FG015|Main Study|Termination of the study by Sponsor|0|||
163232106|NCT03013491|589560478|FG016|Main Study|Termination of the study by Sponsor|0|||
163232107|NCT03013491|589560479|FG017|Main Study|Termination of the study by Sponsor|1|||
163232108|NCT03013491|589560480|FG018|Main Study|Termination of the study by Sponsor|13|||
163232109|NCT03013491|589560462|FG000|Main Study|Withdrawal by Subject|0|||
163232110|NCT03013491|589560463|FG001|Main Study|Withdrawal by Subject|0|||
163232111|NCT03013491|589560464|FG002|Main Study|Withdrawal by Subject|0|||
163232112|NCT03013491|589560465|FG003|Main Study|Withdrawal by Subject|4|||
163232113|NCT03013491|589560466|FG004|Main Study|Withdrawal by Subject|2|||
163232114|NCT03013491|589560467|FG005|Main Study|Withdrawal by Subject|1|||
163346926|NCT01503515|589979327|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
163346927|NCT01503515|589979328|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
163346928|NCT01503515|589979327|FG000|Overall Study|Ineligible|1|||
163346929|NCT01503515|589979328|FG001|Overall Study|Ineligible|1|||
163232115|NCT03013491|589560468|FG006|Main Study|Withdrawal by Subject|0|||
163232116|NCT03013491|589560469|FG007|Main Study|Withdrawal by Subject|0|||
163346930|NCT01350102|589979329|FG000|Overall Study|Adverse Event|0|||
163232117|NCT03013491|589560470|FG008|Main Study|Withdrawal by Subject|0|||
163232118|NCT03013491|589560471|FG009|Main Study|Withdrawal by Subject|0|||
163232119|NCT03013491|589560472|FG010|Main Study|Withdrawal by Subject|1|||
163232120|NCT03013491|589560473|FG011|Main Study|Withdrawal by Subject|2|||
163232121|NCT03013491|589560474|FG012|Main Study|Withdrawal by Subject|0|||
163232122|NCT03013491|589560475|FG013|Main Study|Withdrawal by Subject|2|||
163232123|NCT03013491|589560476|FG014|Main Study|Withdrawal by Subject|0|||
163232124|NCT03013491|589560477|FG015|Main Study|Withdrawal by Subject|0|||
163232125|NCT03013491|589560478|FG016|Main Study|Withdrawal by Subject|0|||
163232126|NCT03013491|589560479|FG017|Main Study|Withdrawal by Subject|0|||
163232127|NCT03013491|589560480|FG018|Main Study|Withdrawal by Subject|18|||
163232128|NCT03013491|589560462|FG000|Main Study|Disease progression|0|||
163232129|NCT03013491|589560463|FG001|Main Study|Disease progression|0|||
163232130|NCT03013491|589560464|FG002|Main Study|Disease progression|0|||
163232131|NCT03013491|589560465|FG003|Main Study|Disease progression|1|||
163232132|NCT03013491|589560466|FG004|Main Study|Disease progression|0|||
163346931|NCT01350102|589979330|FG001|Overall Study|Adverse Event|0|||
163346932|NCT01350102|589979331|FG002|Overall Study|Adverse Event|1|||
163346933|NCT01350102|589979332|FG003|Overall Study|Adverse Event|0|||
163346934|NCT00550771|589979334|FG000|Overall Study|Adverse Event|11|||
163346935|NCT00550771|589979335|FG001|Overall Study|Adverse Event|3|||
163346936|NCT00550771|589979334|FG000|Overall Study|Discontinued for study-related reasons|0|||
163346937|NCT00550771|589979335|FG001|Overall Study|Discontinued for study-related reasons|1|||
163346938|NCT00550771|589979334|FG000|Overall Study|Physician Decision|2|||
163346939|NCT00550771|589979335|FG001|Overall Study|Physician Decision|0|||
163346940|NCT00550771|589979334|FG000|Overall Study|Withdrawal by Subject|0|||
163346941|NCT00550771|589979335|FG001|Overall Study|Withdrawal by Subject|1|||
163346942|NCT00550771|589979334|FG000|Overall Study|Protocol Violation|4|||
163346943|NCT00550771|589979335|FG001|Overall Study|Protocol Violation|5|||
163346944|NCT03022578|589979338|FG000|Overall Study|Adverse Event|1|||
163346945|NCT03022578|589979338|FG000|Overall Study|Lack of Efficacy|2|||
163346946|NCT03022578|589979338|FG000|Overall Study|Withdrawal by Subject|1|||
163346947|NCT03681353|589979339|FG000|Overall Study|Lost to Follow-up|2|||
163346948|NCT03681353|589979339|FG000|Overall Study|Withdrawal by Subject|3|||
163346949|NCT03681353|589979339|FG000|Overall Study|withdrawn by PI|2|||
163346950|NCT00726388|589979342|FG000|Overall Study|Withdrawal by Subject|5|||
163346951|NCT00726388|589979342|FG000|Overall Study|Adverse Event|3|||
163346952|NCT00726388|589979342|FG000|Overall Study|Lost to Follow-up|10|||
163346953|NCT00726388|589979342|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
163346954|NCT00726388|589979342|FG000|Overall Study|Other|5|||
163346955|NCT00726388|589979342|FG000|Overall Study|Enrolled, Not Treated|79|||
163346956|NCT01797562|589979348|FG000|Overall Study|Protocol Violation|5|||
163346957|NCT01116440|589979351|FG000|Treatment|Withdrawal by Subject|2|||
163346958|NCT01116440|589979352|FG001|Treatment|Withdrawal by Subject|2|||
163346959|NCT01116440|589979351|FG000|Treatment|Lost to Follow-up|1|||
163346960|NCT01116440|589979352|FG001|Treatment|Lost to Follow-up|1|||
163346961|NCT01116440|589979351|FG000|Treatment|Protocol Violation|0|||
163346962|NCT01116440|589979352|FG001|Treatment|Protocol Violation|2|||
163346963|NCT01116440|589979351|FG000|Treatment|Lack of Efficacy|0|||
163346964|NCT01116440|589979352|FG001|Treatment|Lack of Efficacy|1|||
163346965|NCT01116440|589979351|FG000|Treatment|Adverse Event|0|||
163346966|NCT01116440|589979352|FG001|Treatment|Adverse Event|1|||
163346967|NCT01116440|589979351|FG000|Withdrawal|Withdrawal by Subject|0|||
163346968|NCT01116440|589979352|FG001|Withdrawal|Withdrawal by Subject|1|||
163346969|NCT01116440|589979351|FG000|Withdrawal|Lost to Follow-up|0|||
163346970|NCT01116440|589979352|FG001|Withdrawal|Lost to Follow-up|1|||
163346971|NCT01116440|589979351|FG000|Follow-up|Lost to Follow-up|0|||
163346972|NCT01116440|589979352|FG001|Follow-up|Lost to Follow-up|1|||
163346973|NCT01116440|589979351|FG000|Follow-up|Withdrawal by Subject|0|||
163346974|NCT01116440|589979352|FG001|Follow-up|Withdrawal by Subject|1|||
163346975|NCT01126879|589979355|FG000|Overall Study|Progressive Disease|3|||
163346976|NCT01126879|589979356|FG001|Overall Study|Progressive Disease|1|||
163346977|NCT01126879|589979355|FG000|Overall Study|Withdrawal by Subject|1|||
163346978|NCT01126879|589979356|FG001|Overall Study|Withdrawal by Subject|0|||
163346979|NCT01126879|589979355|FG000|Overall Study|Adverse Event|0|||
163346980|NCT01126879|589979356|FG001|Overall Study|Adverse Event|1|||
163346981|NCT01126879|589979355|FG000|Overall Study|Physician Decision|1|||
163346982|NCT01126879|589979356|FG001|Overall Study|Physician Decision|0|||
163346983|NCT03441789|589979364|FG000|Overall Study|Withdrawal by Subject|1|||
163346984|NCT03441789|589979365|FG001|Overall Study|Withdrawal by Subject|1|||
163346985|NCT03441789|589979364|FG000|Overall Study|Adverse Event|0|||
163346986|NCT03441789|589979365|FG001|Overall Study|Adverse Event|1|||
163346987|NCT03441789|589979364|FG000|Overall Study|Protocol Violation|0|||
163346988|NCT03441789|589979365|FG001|Overall Study|Protocol Violation|1|||
163346989|NCT03441789|589979364|FG000|Overall Study|Lost to Follow-up|0|||
163232133|NCT03013491|589560467|FG005|Main Study|Disease progression|0|||
163232134|NCT03013491|589560468|FG006|Main Study|Disease progression|0|||
163232135|NCT03013491|589560469|FG007|Main Study|Disease progression|0|||
163232136|NCT03013491|589560470|FG008|Main Study|Disease progression|1|||
163232137|NCT03013491|589560471|FG009|Main Study|Disease progression|0|||
163232138|NCT03013491|589560472|FG010|Main Study|Disease progression|1|||
163346990|NCT03441789|589979365|FG001|Overall Study|Lost to Follow-up|1|||
163346991|NCT01780545|589979366|FG000|Overall Study|Withdrawal by Subject|3|||
163346992|NCT01780545|589979367|FG001|Overall Study|Withdrawal by Subject|1|||
163346993|NCT01780545|589979366|FG000|Overall Study|Lost to Follow-up|1|||
163232139|NCT03013491|589560473|FG011|Main Study|Disease progression|0|||
163346994|NCT01780545|589979367|FG001|Overall Study|Lost to Follow-up|1|||
163346995|NCT00744796|589979369|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
163346996|NCT02581189|589979370|FG000|Overall Study|Failure to return|36|||
163346997|NCT02581189|589979370|FG000|Overall Study|Withdrew consent|5|||
163346998|NCT02581189|589979370|FG000|Overall Study|Death|3|||
163346999|NCT02581189|589979370|FG000|Overall Study|Insufficient virological response|2|||
163347000|NCT02581189|589979370|FG000|Overall Study|Other, not specified|7|||
163232140|NCT03013491|589560474|FG012|Main Study|Disease progression|0|||
163347001|NCT01514864|589979371|FG000|Overall Study|Disease progression|7|||
163232141|NCT03013491|589560475|FG013|Main Study|Disease progression|0|||
163232142|NCT03013491|589560476|FG014|Main Study|Disease progression|0|||
163232143|NCT03013491|589560477|FG015|Main Study|Disease progression|0|||
163232144|NCT03013491|589560478|FG016|Main Study|Disease progression|0|||
163232145|NCT03013491|589560479|FG017|Main Study|Disease progression|0|||
163232146|NCT03013491|589560480|FG018|Main Study|Disease progression|4|||
163232147|NCT03013491|589560462|FG000|Main Study|Symptomatic deterioration|0|||
163232148|NCT03013491|589560463|FG001|Main Study|Symptomatic deterioration|0|||
163232149|NCT03013491|589560464|FG002|Main Study|Symptomatic deterioration|0|||
163232150|NCT03013491|589560465|FG003|Main Study|Symptomatic deterioration|0|||
163232151|NCT03013491|589560466|FG004|Main Study|Symptomatic deterioration|0|||
163232152|NCT03013491|589560467|FG005|Main Study|Symptomatic deterioration|1|||
163232153|NCT03013491|589560468|FG006|Main Study|Symptomatic deterioration|0|||
163232154|NCT03013491|589560469|FG007|Main Study|Symptomatic deterioration|0|||
163232155|NCT03013491|589560470|FG008|Main Study|Symptomatic deterioration|0|||
163232156|NCT03013491|589560471|FG009|Main Study|Symptomatic deterioration|0|||
163232157|NCT03013491|589560472|FG010|Main Study|Symptomatic deterioration|0|||
163232158|NCT03013491|589560473|FG011|Main Study|Symptomatic deterioration|0|||
163232159|NCT03013491|589560474|FG012|Main Study|Symptomatic deterioration|0|||
163232160|NCT03013491|589560475|FG013|Main Study|Symptomatic deterioration|0|||
163232161|NCT03013491|589560476|FG014|Main Study|Symptomatic deterioration|0|||
163232162|NCT03013491|589560477|FG015|Main Study|Symptomatic deterioration|0|||
163232163|NCT03013491|589560478|FG016|Main Study|Symptomatic deterioration|0|||
163232164|NCT03013491|589560479|FG017|Main Study|Symptomatic deterioration|0|||
163232165|NCT03013491|589560480|FG018|Main Study|Symptomatic deterioration|0|||
163232166|NCT03013491|589560462|FG000|Main Study|Protocol version 8.0 approval|0|||
163232167|NCT03013491|589560463|FG001|Main Study|Protocol version 8.0 approval|0|||
163232168|NCT03013491|589560464|FG002|Main Study|Protocol version 8.0 approval|0|||
163232169|NCT03013491|589560465|FG003|Main Study|Protocol version 8.0 approval|0|||
163232170|NCT03013491|589560466|FG004|Main Study|Protocol version 8.0 approval|0|||
163232171|NCT03013491|589560467|FG005|Main Study|Protocol version 8.0 approval|0|||
163232172|NCT03013491|589560468|FG006|Main Study|Protocol version 8.0 approval|0|||
163232173|NCT03013491|589560469|FG007|Main Study|Protocol version 8.0 approval|0|||
163232174|NCT03013491|589560470|FG008|Main Study|Protocol version 8.0 approval|0|||
163232175|NCT03013491|589560471|FG009|Main Study|Protocol version 8.0 approval|0|||
163347002|NCT01514864|589979372|FG001|Overall Study|Disease progression|5|||
163347003|NCT01514864|589979371|FG000|Overall Study|Study drug toxicity|2|||
163347004|NCT01514864|589979372|FG001|Overall Study|Study drug toxicity|0|||
163347005|NCT05135156|589979376|FG000|Overall Study|Lost to Follow-up|0|||
163347006|NCT05135156|589979377|FG001|Overall Study|Lost to Follow-up|0|||
163347007|NCT05135156|589979378|FG002|Overall Study|Lost to Follow-up|2|||
163347008|NCT01379521|589979381|FG000|Overall Study -Treatment Period|Adverse Event|3|||
163347009|NCT01379521|589979382|FG001|Overall Study -Treatment Period|Adverse Event|0|||
163347010|NCT01379521|589979381|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
163347011|NCT01379521|589979382|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
163347012|NCT01379521|589979381|FG000|Overall Study -Treatment Period|Disease Progression|23|||
163347013|NCT01379521|589979382|FG001|Overall Study -Treatment Period|Disease Progression|22|||
163347014|NCT01379521|589979381|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
163347015|NCT01379521|589979382|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
163347016|NCT01379521|589979381|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
163347017|NCT01379521|589979382|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
163347018|NCT01379521|589979381|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
163347019|NCT01379521|589979382|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
163347020|NCT01379521|589979381|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
163347021|NCT01379521|589979382|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
163347022|NCT01379521|589979381|FG000|Overall Study -Treatment Period|Death|2|||
163347023|NCT01379521|589979382|FG001|Overall Study -Treatment Period|Death|1|||
163347024|NCT01379521|589979381|FG000|Post-Treatment Evaluations|Disease Progression|22|||
163347025|NCT01379521|589979382|FG001|Post-Treatment Evaluations|Disease Progression|20|||
163347026|NCT01379521|589979381|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
163347027|NCT01379521|589979382|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
163347028|NCT01379521|589979381|FG000|Post-Treatment Evaluations|Death|1|||
163347029|NCT01379521|589979382|FG001|Post-Treatment Evaluations|Death|0|||
163347030|NCT00404547|589979385|FG000|Overall Study|Adverse Event|39|||
163347031|NCT00404547|589979386|FG001|Overall Study|Adverse Event|6|||
163347032|NCT00404547|589979385|FG000|Overall Study|Withdrawal by Subject|19|||
163347033|NCT00404547|589979386|FG001|Overall Study|Withdrawal by Subject|2|||
163232176|NCT03013491|589560472|FG010|Main Study|Protocol version 8.0 approval|1|||
163232177|NCT03013491|589560473|FG011|Main Study|Protocol version 8.0 approval|0|||
163347034|NCT00404547|589979385|FG000|Overall Study|Protocol Violation|0|||
163347035|NCT00404547|589979386|FG001|Overall Study|Protocol Violation|1|||
163347036|NCT00404547|589979385|FG000|Overall Study|Lost to Follow-up|20|||
163347037|NCT00404547|589979386|FG001|Overall Study|Lost to Follow-up|9|||
163347038|NCT00404547|589979385|FG000|Overall Study|Lack of compliance|5|||
163232178|NCT03013491|589560474|FG012|Main Study|Protocol version 8.0 approval|0|||
163232179|NCT03013491|589560475|FG013|Main Study|Protocol version 8.0 approval|0|||
163232180|NCT03013491|589560476|FG014|Main Study|Protocol version 8.0 approval|0|||
163232181|NCT03013491|589560477|FG015|Main Study|Protocol version 8.0 approval|0|||
163232182|NCT03013491|589560478|FG016|Main Study|Protocol version 8.0 approval|0|||
163232183|NCT03013491|589560479|FG017|Main Study|Protocol version 8.0 approval|0|||
163232184|NCT03013491|589560480|FG018|Main Study|Protocol version 8.0 approval|0|||
163232185|NCT03013491|589560462|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
163232186|NCT03013491|589560463|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
163232187|NCT03013491|589560464|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
163232188|NCT03013491|589560465|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
163232189|NCT03013491|589560466|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
163232190|NCT03013491|589560467|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
163232191|NCT03013491|589560468|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
163232192|NCT03013491|589560469|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
163232193|NCT03013491|589560470|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
163232194|NCT03013491|589560471|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
163232195|NCT03013491|589560472|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
163232196|NCT03013491|589560473|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
163232197|NCT03013491|589560474|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
163232198|NCT03013491|589560475|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
163232199|NCT03013491|589560476|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
163232200|NCT03013491|589560477|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
163232201|NCT03013491|589560478|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
163232202|NCT03013491|589560479|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
163232203|NCT03013491|589560480|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
163232204|NCT03013491|589560462|FG000|Main Study|Start of new anticancer therapy|0|||
163232205|NCT03013491|589560463|FG001|Main Study|Start of new anticancer therapy|0|||
163232206|NCT03013491|589560464|FG002|Main Study|Start of new anticancer therapy|0|||
163232207|NCT03013491|589560465|FG003|Main Study|Start of new anticancer therapy|0|||
163232208|NCT03013491|589560466|FG004|Main Study|Start of new anticancer therapy|0|||
163232209|NCT03013491|589560467|FG005|Main Study|Start of new anticancer therapy|0|||
163232210|NCT03013491|589560468|FG006|Main Study|Start of new anticancer therapy|0|||
163232211|NCT03013491|589560469|FG007|Main Study|Start of new anticancer therapy|0|||
163232212|NCT03013491|589560470|FG008|Main Study|Start of new anticancer therapy|0|||
163232213|NCT03013491|589560471|FG009|Main Study|Start of new anticancer therapy|0|||
163232214|NCT03013491|589560472|FG010|Main Study|Start of new anticancer therapy|0|||
163232215|NCT03013491|589560473|FG011|Main Study|Start of new anticancer therapy|0|||
163232216|NCT03013491|589560474|FG012|Main Study|Start of new anticancer therapy|0|||
163232217|NCT03013491|589560475|FG013|Main Study|Start of new anticancer therapy|0|||
163232218|NCT03013491|589560476|FG014|Main Study|Start of new anticancer therapy|0|||
163232219|NCT03013491|589560477|FG015|Main Study|Start of new anticancer therapy|0|||
163232220|NCT03013491|589560478|FG016|Main Study|Start of new anticancer therapy|0|||
163232221|NCT03013491|589560479|FG017|Main Study|Start of new anticancer therapy|0|||
163232222|NCT03013491|589560480|FG018|Main Study|Start of new anticancer therapy|2|||
163232223|NCT03013491|589560462|FG000|Long-term Extension|Disease progression|0|||
163232224|NCT03013491|589560463|FG001|Long-term Extension|Disease progression|0|||
163232225|NCT03013491|589560464|FG002|Long-term Extension|Disease progression|0|||
163232226|NCT03013491|589560465|FG003|Long-term Extension|Disease progression|1|||
163232227|NCT03013491|589560466|FG004|Long-term Extension|Disease progression|0|||
163232228|NCT03013491|589560467|FG005|Long-term Extension|Disease progression|0|||
163232229|NCT03013491|589560468|FG006|Long-term Extension|Disease progression|0|||
163232230|NCT03013491|589560469|FG007|Long-term Extension|Disease progression|0|||
163232231|NCT03013491|589560470|FG008|Long-term Extension|Disease progression|0|||
163232232|NCT03013491|589560471|FG009|Long-term Extension|Disease progression|0|||
163232233|NCT03013491|589560472|FG010|Long-term Extension|Disease progression|0|||
163232234|NCT03013491|589560473|FG011|Long-term Extension|Disease progression|0|||
163232235|NCT03013491|589560474|FG012|Long-term Extension|Disease progression|0|||
163232236|NCT03013491|589560475|FG013|Long-term Extension|Disease progression|0|||
163232237|NCT03013491|589560476|FG014|Long-term Extension|Disease progression|0|||
163232238|NCT03013491|589560477|FG015|Long-term Extension|Disease progression|0|||
163232239|NCT03013491|589560478|FG016|Long-term Extension|Disease progression|0|||
163232240|NCT03013491|589560479|FG017|Long-term Extension|Disease progression|0|||
163232241|NCT03013491|589560480|FG018|Long-term Extension|Disease progression|1|||
163232242|NCT03013491|589560462|FG000|Long-term Extension|Withdrawal by Subject|0|||
163232243|NCT03013491|589560463|FG001|Long-term Extension|Withdrawal by Subject|0|||
163232244|NCT03013491|589560464|FG002|Long-term Extension|Withdrawal by Subject|0|||
163232245|NCT03013491|589560465|FG003|Long-term Extension|Withdrawal by Subject|0|||
163409248|NCT01888640|590207569|FG001|Overall Study|Excluded for prior TENS|1|||
163409249|NCT01888640|590207570|FG002|Overall Study|Excluded for prior TENS|0|||
163232246|NCT03013491|589560466|FG004|Long-term Extension|Withdrawal by Subject|0|||
163232247|NCT03013491|589560467|FG005|Long-term Extension|Withdrawal by Subject|0|||
163232248|NCT03013491|589560468|FG006|Long-term Extension|Withdrawal by Subject|0|||
163232249|NCT03013491|589560469|FG007|Long-term Extension|Withdrawal by Subject|1|||
163232250|NCT03013491|589560470|FG008|Long-term Extension|Withdrawal by Subject|0|||
163232251|NCT03013491|589560471|FG009|Long-term Extension|Withdrawal by Subject|0|||
163232252|NCT03013491|589560472|FG010|Long-term Extension|Withdrawal by Subject|0|||
163232253|NCT03013491|589560473|FG011|Long-term Extension|Withdrawal by Subject|0|||
163232254|NCT03013491|589560474|FG012|Long-term Extension|Withdrawal by Subject|0|||
163232255|NCT03013491|589560475|FG013|Long-term Extension|Withdrawal by Subject|0|||
163232256|NCT03013491|589560476|FG014|Long-term Extension|Withdrawal by Subject|0|||
163232257|NCT03013491|589560477|FG015|Long-term Extension|Withdrawal by Subject|0|||
163232258|NCT03013491|589560478|FG016|Long-term Extension|Withdrawal by Subject|0|||
163232259|NCT03013491|589560479|FG017|Long-term Extension|Withdrawal by Subject|0|||
163232260|NCT03013491|589560480|FG018|Long-term Extension|Withdrawal by Subject|0|||
163232261|NCT03013491|589560462|FG000|Long-term Extension|Adverse Event|0|||
163232262|NCT03013491|589560463|FG001|Long-term Extension|Adverse Event|0|||
163232263|NCT03013491|589560464|FG002|Long-term Extension|Adverse Event|0|||
163232264|NCT03013491|589560465|FG003|Long-term Extension|Adverse Event|0|||
163232265|NCT03013491|589560466|FG004|Long-term Extension|Adverse Event|0|||
163232266|NCT03013491|589560467|FG005|Long-term Extension|Adverse Event|0|||
163232267|NCT03013491|589560468|FG006|Long-term Extension|Adverse Event|0|||
163232268|NCT03013491|589560469|FG007|Long-term Extension|Adverse Event|0|||
163232269|NCT03013491|589560470|FG008|Long-term Extension|Adverse Event|0|||
163232270|NCT03013491|589560471|FG009|Long-term Extension|Adverse Event|0|||
163232271|NCT03013491|589560472|FG010|Long-term Extension|Adverse Event|0|||
163232272|NCT03013491|589560473|FG011|Long-term Extension|Adverse Event|0|||
163232273|NCT03013491|589560474|FG012|Long-term Extension|Adverse Event|0|||
163232274|NCT03013491|589560475|FG013|Long-term Extension|Adverse Event|0|||
163232275|NCT03013491|589560476|FG014|Long-term Extension|Adverse Event|0|||
163232276|NCT03013491|589560477|FG015|Long-term Extension|Adverse Event|0|||
163232277|NCT03013491|589560478|FG016|Long-term Extension|Adverse Event|0|||
163232278|NCT03013491|589560479|FG017|Long-term Extension|Adverse Event|0|||
163232279|NCT03013491|589560480|FG018|Long-term Extension|Adverse Event|1|||
163232280|NCT03013491|589560462|FG000|Long-term Extension|Death|0|||
163232281|NCT03013491|589560463|FG001|Long-term Extension|Death|0|||
163232282|NCT03013491|589560464|FG002|Long-term Extension|Death|0|||
163232283|NCT03013491|589560465|FG003|Long-term Extension|Death|0|||
163232284|NCT03013491|589560466|FG004|Long-term Extension|Death|0|||
163232285|NCT03013491|589560467|FG005|Long-term Extension|Death|0|||
163232286|NCT03013491|589560468|FG006|Long-term Extension|Death|0|||
163232287|NCT03013491|589560469|FG007|Long-term Extension|Death|0|||
163232288|NCT03013491|589560470|FG008|Long-term Extension|Death|0|||
163232289|NCT03013491|589560471|FG009|Long-term Extension|Death|0|||
163232290|NCT03013491|589560472|FG010|Long-term Extension|Death|0|||
163232291|NCT03013491|589560473|FG011|Long-term Extension|Death|0|||
163232292|NCT03013491|589560474|FG012|Long-term Extension|Death|0|||
163232293|NCT03013491|589560475|FG013|Long-term Extension|Death|0|||
163232294|NCT03013491|589560476|FG014|Long-term Extension|Death|0|||
163232295|NCT03013491|589560477|FG015|Long-term Extension|Death|0|||
163232296|NCT03013491|589560478|FG016|Long-term Extension|Death|0|||
163232297|NCT03013491|589560479|FG017|Long-term Extension|Death|0|||
163232298|NCT03013491|589560480|FG018|Long-term Extension|Death|1|||
163232299|NCT02383758|589562350|FG000|Overall Study|Withdrawal by Subject|0|||
163232300|NCT02383758|589562351|FG001|Overall Study|Withdrawal by Subject|2|||
163232301|NCT03085927|589562352|FG000|Overall Study|Withdrawal by Subject|1|||
163232302|NCT03085927|589562353|FG001|Overall Study|Withdrawal by Subject|4|||
163232303|NCT03085927|589562352|FG000|Overall Study|Lost to Follow-up|3|||
163232304|NCT03085927|589562353|FG001|Overall Study|Lost to Follow-up|1|||
163232305|NCT03085927|589562352|FG000|Overall Study|Death|1|||
163232306|NCT03085927|589562353|FG001|Overall Study|Death|0|||
163232307|NCT03085927|589562352|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
163232308|NCT03085927|589562353|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
163232309|NCT03085927|589562352|FG000|Overall Study|Dyad Became Ineligible|0|||
163232310|NCT03085927|589562353|FG001|Overall Study|Dyad Became Ineligible|1|||
163232311|NCT02564471|589562354|FG000|Overall Study|Adverse Event|1|||
163232312|NCT02564471|589562355|FG001|Overall Study|Adverse Event|0|||
163232313|NCT02564471|589562356|FG002|Overall Study|Adverse Event|0|||
163232314|NCT02564471|589562357|FG003|Overall Study|Adverse Event|0|||
163232315|NCT02564471|589562354|FG000|Overall Study|Withdrawal by Subject|2|||
163232316|NCT02564471|589562355|FG001|Overall Study|Withdrawal by Subject|1|||
163232317|NCT02564471|589562356|FG002|Overall Study|Withdrawal by Subject|3|||
163232318|NCT02564471|589562357|FG003|Overall Study|Withdrawal by Subject|0|||
163232319|NCT02564471|589562354|FG000|Overall Study|Lost to Follow-up|0|||
163232320|NCT02564471|589562355|FG001|Overall Study|Lost to Follow-up|2|||
163232321|NCT02564471|589562356|FG002|Overall Study|Lost to Follow-up|0|||
163232322|NCT02564471|589562357|FG003|Overall Study|Lost to Follow-up|0|||
163232323|NCT02033889|589562361|FG000|Overall Study|Adverse Event|3|||
163232324|NCT02033889|589562362|FG001|Overall Study|Adverse Event|1|||
163232325|NCT02033889|589562363|FG002|Overall Study|Adverse Event|3|||
163232326|NCT02033889|589562361|FG000|Overall Study|Death|3|||
163232327|NCT02033889|589562362|FG001|Overall Study|Death|1|||
163232328|NCT02033889|589562363|FG002|Overall Study|Death|2|||
163232329|NCT02033889|589562361|FG000|Overall Study|Excluded Medication|1|||
163232330|NCT02033889|589562362|FG001|Overall Study|Excluded Medication|1|||
163232331|NCT02033889|589562363|FG002|Overall Study|Excluded Medication|0|||
163232332|NCT02033889|589562361|FG000|Overall Study|Lost to Follow-up|8|||
163232333|NCT02033889|589562362|FG001|Overall Study|Lost to Follow-up|5|||
163232334|NCT02033889|589562363|FG002|Overall Study|Lost to Follow-up|6|||
163232335|NCT02033889|589562361|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163232336|NCT02033889|589562362|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163232337|NCT02033889|589562363|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163232338|NCT02033889|589562361|FG000|Overall Study|Physician Decision|0|||
163232339|NCT02033889|589562362|FG001|Overall Study|Physician Decision|1|||
163232340|NCT02033889|589562363|FG002|Overall Study|Physician Decision|1|||
163232341|NCT02033889|589562361|FG000|Overall Study|Participant moved|0|||
163232342|NCT02033889|589562362|FG001|Overall Study|Participant moved|1|||
163232343|NCT02033889|589562363|FG002|Overall Study|Participant moved|0|||
163232344|NCT02033889|589562361|FG000|Overall Study|Withdrawal by Subject|18|||
163232345|NCT02033889|589562362|FG001|Overall Study|Withdrawal by Subject|10|||
163232346|NCT02033889|589562363|FG002|Overall Study|Withdrawal by Subject|13|||
163232347|NCT01640301|589562364|FG000|Overall Study|Death|0|||
163232348|NCT01640301|589562365|FG001|Overall Study|Death|8|||
163232349|NCT00659646|589562366|FG000|Overall Study|Protocol Violation|12|||
163232350|NCT00659646|589562367|FG001|Overall Study|Protocol Violation|8|||
163232351|NCT00659646|589562366|FG000|Overall Study|Adverse Event|1|||
163232352|NCT00659646|589562367|FG001|Overall Study|Adverse Event|0|||
163232353|NCT00659646|589562366|FG000|Overall Study|Lost to Follow-up|1|||
163232354|NCT00659646|589562367|FG001|Overall Study|Lost to Follow-up|0|||
163232355|NCT00659646|589562366|FG000|Overall Study|protocol noncompliance after randomized|1|||
163232356|NCT00659646|589562367|FG001|Overall Study|protocol noncompliance after randomized|0|||
163232357|NCT02391948|589562372|FG000|6-month Assessment|Death|0|||
163232358|NCT02391948|589562373|FG001|6-month Assessment|Death|0|||
163232359|NCT02391948|589562374|FG002|6-month Assessment|Death|0|||
163232360|NCT02391948|589562375|FG003|6-month Assessment|Death|0|||
163232361|NCT02391948|589562376|FG004|6-month Assessment|Death|1|||
163232362|NCT02391948|589562372|FG000|6-month Assessment|Withdrawal by Subject|0|||
163232363|NCT02391948|589562373|FG001|6-month Assessment|Withdrawal by Subject|0|||
163232364|NCT02391948|589562374|FG002|6-month Assessment|Withdrawal by Subject|1|||
163232365|NCT02391948|589562375|FG003|6-month Assessment|Withdrawal by Subject|2|||
163232366|NCT02391948|589562376|FG004|6-month Assessment|Withdrawal by Subject|0|||
163232367|NCT02391948|589562372|FG000|6-month Assessment|Lost to Follow-up|4|||
163232368|NCT02391948|589562373|FG001|6-month Assessment|Lost to Follow-up|5|||
163232369|NCT02391948|589562374|FG002|6-month Assessment|Lost to Follow-up|2|||
163232370|NCT02391948|589562375|FG003|6-month Assessment|Lost to Follow-up|3|||
163232371|NCT02391948|589562376|FG004|6-month Assessment|Lost to Follow-up|1|||
163232372|NCT02391948|589562372|FG000|6-month Assessment|Medical issue/illness|1|||
163232373|NCT02391948|589562373|FG001|6-month Assessment|Medical issue/illness|1|||
163232374|NCT02391948|589562374|FG002|6-month Assessment|Medical issue/illness|0|||
163232375|NCT02391948|589562375|FG003|6-month Assessment|Medical issue/illness|0|||
163232376|NCT02391948|589562376|FG004|6-month Assessment|Medical issue/illness|0|||
163232377|NCT02391948|589562372|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
163232378|NCT02391948|589562373|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
163232379|NCT02391948|589562374|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
163347039|NCT00404547|589979386|FG001|Overall Study|Lack of compliance|1|||
163347040|NCT00404547|589979385|FG000|Overall Study|Other|4|||
163347041|NCT00404547|589979386|FG001|Overall Study|Other|0|||
163347042|NCT00404547|589979385|FG000|Overall Study|Reason not stated|3|||
163232380|NCT02391948|589562375|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
163232381|NCT02391948|589562376|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
163232382|NCT02391948|589562372|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
163232383|NCT02391948|589562373|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
163232384|NCT02391948|589562374|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
163232385|NCT02391948|589562375|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
163232386|NCT02391948|589562376|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
163232387|NCT02391948|589562372|FG000|12-month Assessment|Death|0|||
163232388|NCT02391948|589562373|FG001|12-month Assessment|Death|0|||
163232389|NCT02391948|589562374|FG002|12-month Assessment|Death|0|||
163232390|NCT02391948|589562375|FG003|12-month Assessment|Death|1|||
163232391|NCT02391948|589562376|FG004|12-month Assessment|Death|0|||
163232392|NCT02391948|589562372|FG000|12-month Assessment|Withdrawal by Subject|1|||
163232393|NCT02391948|589562373|FG001|12-month Assessment|Withdrawal by Subject|0|||
163232394|NCT02391948|589562374|FG002|12-month Assessment|Withdrawal by Subject|0|||
163232395|NCT02391948|589562375|FG003|12-month Assessment|Withdrawal by Subject|1|||
163232396|NCT02391948|589562376|FG004|12-month Assessment|Withdrawal by Subject|0|||
163232397|NCT02391948|589562372|FG000|12-month Assessment|Lost to Follow-up|5|||
163232398|NCT02391948|589562373|FG001|12-month Assessment|Lost to Follow-up|4|||
163232399|NCT02391948|589562374|FG002|12-month Assessment|Lost to Follow-up|4|||
163232400|NCT02391948|589562375|FG003|12-month Assessment|Lost to Follow-up|4|||
163232401|NCT02391948|589562376|FG004|12-month Assessment|Lost to Follow-up|5|||
163232402|NCT02391948|589562372|FG000|12-month Assessment|Medical issue/illness|0|||
163232403|NCT02391948|589562373|FG001|12-month Assessment|Medical issue/illness|1|||
163232404|NCT02391948|589562374|FG002|12-month Assessment|Medical issue/illness|0|||
163232405|NCT02391948|589562375|FG003|12-month Assessment|Medical issue/illness|1|||
163232406|NCT02391948|589562376|FG004|12-month Assessment|Medical issue/illness|0|||
163232407|NCT02391948|589562372|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
163232408|NCT02391948|589562373|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
163232409|NCT02391948|589562374|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
163232410|NCT02391948|589562375|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
163232411|NCT02391948|589562376|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
163232412|NCT02391948|589562372|FG000|18-month Assessment|Death|0|||
163232413|NCT02391948|589562373|FG001|18-month Assessment|Death|0|||
163232414|NCT02391948|589562374|FG002|18-month Assessment|Death|0|||
163232415|NCT02391948|589562375|FG003|18-month Assessment|Death|1|||
163232416|NCT02391948|589562376|FG004|18-month Assessment|Death|1|||
163232417|NCT02391948|589562372|FG000|18-month Assessment|Withdrawal by Subject|1|||
163232418|NCT02391948|589562373|FG001|18-month Assessment|Withdrawal by Subject|0|||
163232419|NCT02391948|589562374|FG002|18-month Assessment|Withdrawal by Subject|0|||
163232420|NCT02391948|589562375|FG003|18-month Assessment|Withdrawal by Subject|1|||
163232421|NCT02391948|589562376|FG004|18-month Assessment|Withdrawal by Subject|0|||
163232422|NCT02391948|589562372|FG000|18-month Assessment|Lost to Follow-up|2|||
163232423|NCT02391948|589562373|FG001|18-month Assessment|Lost to Follow-up|6|||
163232424|NCT02391948|589562374|FG002|18-month Assessment|Lost to Follow-up|2|||
163232425|NCT02391948|589562375|FG003|18-month Assessment|Lost to Follow-up|2|||
163232426|NCT02391948|589562376|FG004|18-month Assessment|Lost to Follow-up|3|||
163232427|NCT02391948|589562372|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
163232428|NCT02391948|589562373|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
163232429|NCT02391948|589562374|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
163232430|NCT02391948|589562375|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
163232431|NCT02391948|589562376|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
163232432|NCT02391948|589562372|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
163232433|NCT02391948|589562373|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
163232434|NCT02391948|589562374|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
163232435|NCT02391948|589562375|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
163232436|NCT02391948|589562376|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
163232437|NCT02391948|589562372|FG000|24-month Assessment|Death|0|||
163232438|NCT02391948|589562373|FG001|24-month Assessment|Death|0|||
163232439|NCT02391948|589562374|FG002|24-month Assessment|Death|0|||
163232440|NCT02391948|589562375|FG003|24-month Assessment|Death|0|||
163232441|NCT02391948|589562376|FG004|24-month Assessment|Death|1|||
163232442|NCT02391948|589562372|FG000|24-month Assessment|Withdrawal by Subject|1|||
163232443|NCT02391948|589562373|FG001|24-month Assessment|Withdrawal by Subject|1|||
163232444|NCT02391948|589562374|FG002|24-month Assessment|Withdrawal by Subject|0|||
163232445|NCT02391948|589562375|FG003|24-month Assessment|Withdrawal by Subject|0|||
163232446|NCT02391948|589562376|FG004|24-month Assessment|Withdrawal by Subject|1|||
163232447|NCT02391948|589562372|FG000|24-month Assessment|Lost to Follow-up|5|||
163232448|NCT02391948|589562373|FG001|24-month Assessment|Lost to Follow-up|4|||
163232449|NCT02391948|589562374|FG002|24-month Assessment|Lost to Follow-up|0|||
163232450|NCT02391948|589562375|FG003|24-month Assessment|Lost to Follow-up|0|||
163232451|NCT02391948|589562376|FG004|24-month Assessment|Lost to Follow-up|0|||
163232452|NCT02391948|589562372|FG000|24-month Assessment|Medical issue/illness|0|||
163232453|NCT02391948|589562373|FG001|24-month Assessment|Medical issue/illness|0|||
163232454|NCT02391948|589562374|FG002|24-month Assessment|Medical issue/illness|1|||
163232455|NCT02391948|589562375|FG003|24-month Assessment|Medical issue/illness|0|||
163232456|NCT02391948|589562376|FG004|24-month Assessment|Medical issue/illness|0|||
163232457|NCT02391948|589562372|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
163232458|NCT02391948|589562373|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
163232459|NCT02391948|589562374|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
163232460|NCT02391948|589562375|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
163232461|NCT02391948|589562376|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
163232462|NCT02348489|589562377|FG000|Overall Study|Death|336|||
163232463|NCT02348489|589562378|FG001|Overall Study|Death|335|||
163232464|NCT02348489|589562377|FG000|Overall Study|Withdrawal by Subject|14|||
163232465|NCT02348489|589562378|FG001|Overall Study|Withdrawal by Subject|27|||
163232466|NCT02348489|589562377|FG000|Overall Study|Lost to Follow-up|3|||
163232467|NCT02348489|589562378|FG001|Overall Study|Lost to Follow-up|5|||
163232468|NCT01969838|589562379|FG000|Double-blind Phase|Adverse Event|10|||
163232469|NCT01969838|589562380|FG001|Double-blind Phase|Adverse Event|4|||
163232470|NCT01969838|589562381|FG002|Double-blind Phase|Adverse Event|0|||
163232471|NCT01969838|589562382|FG003|Double-blind Phase|Adverse Event|0|||
163409250|NCT01888640|590207568|FG000|Overall Study|Researcher Termination of Participant|0|||
163409251|NCT01888640|590207569|FG001|Overall Study|Researcher Termination of Participant|1|||
163409252|NCT01888640|590207570|FG002|Overall Study|Researcher Termination of Participant|1|||
163409253|NCT01277549|590207571|FG000|Overall Study|Failed to meet eligibility criteria|13|||
163409254|NCT01277549|590207572|FG001|Overall Study|Failed to meet eligibility criteria|9|||
163409255|NCT01277549|590207571|FG000|Overall Study|Withdrawal by Subject|1|||
163409256|NCT01277549|590207572|FG001|Overall Study|Withdrawal by Subject|3|||
163409257|NCT01277549|590207571|FG000|Overall Study|Protocol Violation|10|||
163409258|NCT01277549|590207572|FG001|Overall Study|Protocol Violation|1|||
163409259|NCT01277549|590207571|FG000|Overall Study|Physician Decision|2|||
163409260|NCT01277549|590207572|FG001|Overall Study|Physician Decision|1|||
163409261|NCT01142726|590207575|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
163409262|NCT01142726|590207576|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
163409263|NCT01142726|590207577|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
163409264|NCT01142726|590207575|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
163409265|NCT01142726|590207576|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
163409266|NCT01142726|590207577|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
163409267|NCT01142726|590207575|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
163409268|NCT01142726|590207576|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
163409269|NCT01142726|590207577|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
163409270|NCT01142726|590207575|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
163409271|NCT01142726|590207576|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
163409272|NCT01142726|590207577|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
163409273|NCT01142726|590207575|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
163409274|NCT01142726|590207576|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
163139227|NCT01929226|589219784|FG000|Overall Study|Lost to Follow-up|4|||
163139228|NCT01929226|589219785|FG001|Overall Study|Lost to Follow-up|0|||
163139229|NCT01929226|589219784|FG000|Overall Study|Withdrawal by Subject|1|||
163139230|NCT01929226|589219785|FG001|Overall Study|Withdrawal by Subject|1|||
163139231|NCT01525615|589219786|FG000|Overall Study|Adverse Event|11|||
163139232|NCT01525615|589219787|FG001|Overall Study|Adverse Event|7|||
163139233|NCT01525615|589219788|FG002|Overall Study|Adverse Event|5|||
163139234|NCT01525615|589219786|FG000|Overall Study|Lost to Follow-up|1|||
163139235|NCT01525615|589219787|FG001|Overall Study|Lost to Follow-up|0|||
163139236|NCT01525615|589219788|FG002|Overall Study|Lost to Follow-up|0|||
163139237|NCT01525615|589219786|FG000|Overall Study|Withdrawal by Subject|1|||
163139238|NCT01525615|589219787|FG001|Overall Study|Withdrawal by Subject|0|||
163139239|NCT01525615|589219788|FG002|Overall Study|Withdrawal by Subject|0|||
163139240|NCT01525615|589219786|FG000|Overall Study|Other reason not described above|1|||
163139241|NCT01525615|589219787|FG001|Overall Study|Other reason not described above|0|||
163139242|NCT01525615|589219788|FG002|Overall Study|Other reason not described above|1|||
163139243|NCT00217425|589219789|FG000|Overall Study|Never started treatment|2|||
163139244|NCT00217425|589219789|FG000|Overall Study|Patient ineligible|5|||
163139245|NCT00217425|589219789|FG000|Overall Study|Lack of Efficacy|13|||
163139246|NCT00217425|589219789|FG000|Overall Study|Adverse Event|8|||
163139247|NCT00217425|589219789|FG000|Overall Study|Withdrawal by Subject|4|||
163139248|NCT00217425|589219789|FG000|Overall Study|Other complicating disease|1|||
163139249|NCT00217425|589219789|FG000|Overall Study|Other|4|||
163139250|NCT01473732|589219792|FG000|Overall Study|Adverse Event|1|||
163139251|NCT01473732|589219793|FG001|Overall Study|Adverse Event|0|||
163139252|NCT01473732|589219792|FG000|Overall Study|Death|1|||
163139253|NCT01473732|589219793|FG001|Overall Study|Death|0|||
163139254|NCT00330759|589219797|FG000|Overall Study|Death|316|||
163139255|NCT00330759|589219798|FG001|Overall Study|Death|310|||
163139256|NCT00330759|589219797|FG000|Overall Study|Disease progression|104|||
163139257|NCT00330759|589219798|FG001|Overall Study|Disease progression|126|||
163139258|NCT00330759|589219797|FG000|Overall Study|Withdrawal by Subject|143|||
163139259|NCT00330759|589219798|FG001|Overall Study|Withdrawal by Subject|124|||
163139260|NCT00330759|589219797|FG000|Overall Study|Adverse Event|48|||
163139261|NCT00330759|589219798|FG001|Overall Study|Adverse Event|36|||
163139262|NCT00330759|589219797|FG000|Overall Study|Participant request|31|||
163139263|NCT00330759|589219798|FG001|Overall Study|Participant request|22|||
163139264|NCT00330759|589219797|FG000|Overall Study|Lost to Follow-up|16|||
163139265|NCT00330759|589219798|FG001|Overall Study|Lost to Follow-up|22|||
163139266|NCT00330759|589219797|FG000|Overall Study|Noncompliance|15|||
163139267|NCT00330759|589219798|FG001|Overall Study|Noncompliance|17|||
163139268|NCT00330759|589219797|FG000|Overall Study|Physician Decision|1|||
163139269|NCT00330759|589219798|FG001|Overall Study|Physician Decision|2|||
163139270|NCT00330759|589219797|FG000|Overall Study|Protocol deviation|0|||
163139271|NCT00330759|589219798|FG001|Overall Study|Protocol deviation|2|||
163139272|NCT00330759|589219797|FG000|Overall Study|Ineligibility determined|2|||
163139273|NCT00330759|589219798|FG001|Overall Study|Ineligibility determined|1|||
163139274|NCT00330759|589219797|FG000|Overall Study|Other|36|||
163139275|NCT00330759|589219798|FG001|Overall Study|Other|44|||
163139276|NCT00671034|589219799|FG000|Overall Study|Adverse Event|5|||
163347043|NCT00404547|589979386|FG001|Overall Study|Reason not stated|6|||
163139277|NCT00671034|589219800|FG001|Overall Study|Adverse Event|7|||
163139278|NCT00671034|589219801|FG002|Overall Study|Adverse Event|1|||
163139279|NCT00671034|589219799|FG000|Overall Study|Death|3|||
163139280|NCT00671034|589219800|FG001|Overall Study|Death|2|||
163139281|NCT00671034|589219801|FG002|Overall Study|Death|1|||
163139282|NCT00671034|589219799|FG000|Overall Study|Physician Decision|12|||
163139283|NCT00671034|589219800|FG001|Overall Study|Physician Decision|4|||
163139284|NCT00671034|589219801|FG002|Overall Study|Physician Decision|5|||
163139285|NCT00671034|589219799|FG000|Overall Study|VHR ALL feature|8|||
163139286|NCT00671034|589219800|FG001|Overall Study|VHR ALL feature|3|||
163139287|NCT00671034|589219801|FG002|Overall Study|VHR ALL feature|5|||
163139288|NCT00671034|589219799|FG000|Overall Study|Refusal|5|||
163139289|NCT00671034|589219800|FG001|Overall Study|Refusal|3|||
163139290|NCT00671034|589219801|FG002|Overall Study|Refusal|5|||
163139291|NCT00671034|589219799|FG000|Overall Study|includes Alternative therapy, etc.|6|||
163139292|NCT00671034|589219800|FG001|Overall Study|includes Alternative therapy, etc.|1|||
163139293|NCT00671034|589219801|FG002|Overall Study|includes Alternative therapy, etc.|7|||
163139294|NCT02380287|589219803|FG000|Overall Study|Adverse Event|0|||
163139295|NCT02380287|589219804|FG001|Overall Study|Adverse Event|0|||
163139296|NCT02380287|589219805|FG002|Overall Study|Adverse Event|1|||
163139297|NCT02380287|589219806|FG003|Overall Study|Adverse Event|0|||
163139298|NCT02380287|589219807|FG004|Overall Study|Adverse Event|0|||
163139299|NCT02380287|589219808|FG005|Overall Study|Adverse Event|0|||
163139300|NCT02380287|589219809|FG006|Overall Study|Adverse Event|0|||
163139301|NCT02380287|589219810|FG007|Overall Study|Adverse Event|0|||
163139302|NCT04473963|589219827|FG000|Overall Study|Withdrawal by Subject|1|||
163139303|NCT04473963|589219828|FG001|Overall Study|Withdrawal by Subject|1|||
163139304|NCT04473963|589219829|FG002|Overall Study|Withdrawal by Subject|0|||
163139305|NCT04473963|589219827|FG000|Overall Study|Not inducible in AF|0|||
163139306|NCT04473963|589219828|FG001|Overall Study|Not inducible in AF|0|||
163139307|NCT04473963|589219829|FG002|Overall Study|Not inducible in AF|2|||
163139308|NCT04685798|589219830|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
163139309|NCT00592904|589219835|FG000|Overall Study|Adverse Event|15|||
163139310|NCT00592904|589219836|FG001|Overall Study|Adverse Event|25|||
163139311|NCT00592904|589219837|FG002|Overall Study|Adverse Event|13|||
163139312|NCT00592904|589219838|FG003|Overall Study|Adverse Event|5|||
163139313|NCT00592904|589219835|FG000|Overall Study|Protocol Violation|1|||
163139314|NCT00592904|589219836|FG001|Overall Study|Protocol Violation|1|||
163139315|NCT00592904|589219837|FG002|Overall Study|Protocol Violation|0|||
163139316|NCT00592904|589219838|FG003|Overall Study|Protocol Violation|1|||
163139317|NCT00592904|589219835|FG000|Overall Study|Withdrawal by Subject|4|||
163139318|NCT00592904|589219836|FG001|Overall Study|Withdrawal by Subject|16|||
163139319|NCT00592904|589219837|FG002|Overall Study|Withdrawal by Subject|1|||
163139320|NCT00592904|589219838|FG003|Overall Study|Withdrawal by Subject|2|||
163139321|NCT00592904|589219835|FG000|Overall Study|Lack of Efficacy|2|||
163139322|NCT00592904|589219836|FG001|Overall Study|Lack of Efficacy|7|||
163139323|NCT00592904|589219837|FG002|Overall Study|Lack of Efficacy|2|||
163139324|NCT00592904|589219838|FG003|Overall Study|Lack of Efficacy|3|||
163139325|NCT00592904|589219835|FG000|Overall Study|Physician Decision|0|||
163139326|NCT00592904|589219836|FG001|Overall Study|Physician Decision|3|||
163139327|NCT00592904|589219837|FG002|Overall Study|Physician Decision|1|||
163139328|NCT00592904|589219838|FG003|Overall Study|Physician Decision|0|||
163139329|NCT00592904|589219835|FG000|Overall Study|Other|3|||
163139330|NCT00592904|589219836|FG001|Overall Study|Other|3|||
163139331|NCT00592904|589219837|FG002|Overall Study|Other|0|||
163139332|NCT00592904|589219838|FG003|Overall Study|Other|0|||
163139333|NCT00824473|589219841|FG000|Overall Study|Adverse Event|4|||
163139334|NCT00824473|589219842|FG001|Overall Study|Adverse Event|5|||
163139335|NCT00824473|589219841|FG000|Overall Study|Lack of Efficacy|2|||
163139336|NCT00824473|589219842|FG001|Overall Study|Lack of Efficacy|2|||
163139337|NCT00824473|589219841|FG000|Overall Study|Protocol Violation|2|||
163139338|NCT00824473|589219842|FG001|Overall Study|Protocol Violation|0|||
163139339|NCT00824473|589219841|FG000|Overall Study|Non-Compliance|4|||
163139340|NCT00824473|589219842|FG001|Overall Study|Non-Compliance|2|||
163139341|NCT00824473|589219841|FG000|Overall Study|Withdrawal by Subject|2|||
163139342|NCT00824473|589219842|FG001|Overall Study|Withdrawal by Subject|3|||
163139343|NCT00824473|589219841|FG000|Overall Study|Other|1|||
163139344|NCT00824473|589219842|FG001|Overall Study|Other|1|||
163139345|NCT01359904|589219843|FG000|Overall Study|Withdrawal by Subject|1|||
163139346|NCT01359904|589219844|FG001|Overall Study|Withdrawal by Subject|0|||
163139347|NCT01550757|589219845|FG000|Overall Study|Lost to Follow-up|21|||
163139348|NCT01550757|589219846|FG001|Overall Study|Lost to Follow-up|14|||
163139349|NCT01550757|589219847|FG002|Overall Study|Lost to Follow-up|42|||
163139350|NCT01550757|589219848|FG003|Overall Study|Lost to Follow-up|53|||
163139351|NCT01550757|589219845|FG000|Overall Study|Withdrawal by Subject|2|||
163139352|NCT01550757|589219846|FG001|Overall Study|Withdrawal by Subject|0|||
163232472|NCT01969838|589562379|FG000|Double-blind Phase|Death|5|||
163232473|NCT01969838|589562380|FG001|Double-blind Phase|Death|2|||
163232474|NCT01969838|589562381|FG002|Double-blind Phase|Death|0|||
163232475|NCT01969838|589562382|FG003|Double-blind Phase|Death|0|||
163232476|NCT01969838|589562379|FG000|Double-blind Phase|Physician Decision|5|||
163232477|NCT01969838|589562380|FG001|Double-blind Phase|Physician Decision|1|||
163232478|NCT01969838|589562381|FG002|Double-blind Phase|Physician Decision|0|||
163232479|NCT01969838|589562382|FG003|Double-blind Phase|Physician Decision|0|||
163232480|NCT01969838|589562379|FG000|Double-blind Phase|Subject Decision|4|||
163232481|NCT01969838|589562380|FG001|Double-blind Phase|Subject Decision|2|||
163232482|NCT01969838|589562381|FG002|Double-blind Phase|Subject Decision|0|||
163232483|NCT01969838|589562382|FG003|Double-blind Phase|Subject Decision|0|||
163232484|NCT01969838|589562379|FG000|Double-blind Phase|Disease Progression|2|||
163232485|NCT01969838|589562380|FG001|Double-blind Phase|Disease Progression|0|||
163232486|NCT01969838|589562381|FG002|Double-blind Phase|Disease Progression|0|||
163232487|NCT01969838|589562382|FG003|Double-blind Phase|Disease Progression|0|||
163232488|NCT01969838|589562379|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
163232489|NCT01969838|589562380|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
163232490|NCT01969838|589562381|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
163232491|NCT01969838|589562382|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
163232492|NCT01969838|589562379|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
163232493|NCT01969838|589562380|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
163232494|NCT01969838|589562381|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
163232495|NCT01969838|589562382|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
163232496|NCT01969838|589562379|FG000|Open-label Phase|Adverse Event|0|||
163232497|NCT01969838|589562380|FG001|Open-label Phase|Adverse Event|0|||
163232498|NCT01969838|589562381|FG002|Open-label Phase|Adverse Event|37|||
163232499|NCT01969838|589562382|FG003|Open-label Phase|Adverse Event|49|||
163232500|NCT01969838|589562379|FG000|Open-label Phase|Disease Progression|0|||
163232501|NCT01969838|589562380|FG001|Open-label Phase|Disease Progression|0|||
163232502|NCT01969838|589562381|FG002|Open-label Phase|Disease Progression|26|||
163232503|NCT01969838|589562382|FG003|Open-label Phase|Disease Progression|27|||
163232504|NCT01969838|589562379|FG000|Open-label Phase|Lack of Efficacy|0|||
163232505|NCT01969838|589562380|FG001|Open-label Phase|Lack of Efficacy|0|||
163232506|NCT01969838|589562381|FG002|Open-label Phase|Lack of Efficacy|17|||
163232507|NCT01969838|589562382|FG003|Open-label Phase|Lack of Efficacy|19|||
163232508|NCT01969838|589562379|FG000|Open-label Phase|Subject Decision|0|||
163232509|NCT01969838|589562380|FG001|Open-label Phase|Subject Decision|0|||
163232510|NCT01969838|589562381|FG002|Open-label Phase|Subject Decision|14|||
163232511|NCT01969838|589562382|FG003|Open-label Phase|Subject Decision|15|||
163232512|NCT01969838|589562379|FG000|Open-label Phase|Death|0|||
163232513|NCT01969838|589562380|FG001|Open-label Phase|Death|0|||
163232514|NCT01969838|589562381|FG002|Open-label Phase|Death|13|||
163232515|NCT01969838|589562382|FG003|Open-label Phase|Death|11|||
163232516|NCT01969838|589562379|FG000|Open-label Phase|Physician Decision|0|||
163232517|NCT01969838|589562380|FG001|Open-label Phase|Physician Decision|0|||
163232518|NCT01969838|589562381|FG002|Open-label Phase|Physician Decision|9|||
163232519|NCT01969838|589562382|FG003|Open-label Phase|Physician Decision|14|||
163232520|NCT01969838|589562379|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
163232521|NCT01969838|589562380|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
163232522|NCT01969838|589562381|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
163232523|NCT01969838|589562382|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
163232524|NCT00408993|589562383|FG000|Overall Study|Adverse Event|15|||
163232525|NCT00408993|589562384|FG001|Overall Study|Adverse Event|4|||
163232526|NCT00408993|589562383|FG000|Overall Study|Protocol Violation|1|||
163232527|NCT00408993|589562384|FG001|Overall Study|Protocol Violation|6|||
163232528|NCT00408993|589562383|FG000|Overall Study|Lack of Efficacy|1|||
163232529|NCT00408993|589562384|FG001|Overall Study|Lack of Efficacy|4|||
163232530|NCT00408993|589562383|FG000|Overall Study|Withdrawal by Subject|2|||
163232531|NCT00408993|589562384|FG001|Overall Study|Withdrawal by Subject|3|||
163232532|NCT04193202|589562385|FG000|Overall Study|Adverse Event|2|||
163232533|NCT04193202|589562386|FG001|Overall Study|Adverse Event|1|||
163232534|NCT04193202|589562385|FG000|Overall Study|Death|0|||
163232535|NCT04193202|589562386|FG001|Overall Study|Death|1|||
163232536|NCT04193202|589562385|FG000|Overall Study|Physician Decision|1|||
163232537|NCT04193202|589562386|FG001|Overall Study|Physician Decision|1|||
163232538|NCT04193202|589562385|FG000|Overall Study|Protocol Violation|2|||
163232539|NCT04193202|589562386|FG001|Overall Study|Protocol Violation|2|||
163232540|NCT04193202|589562385|FG000|Overall Study|Withdrawal by Subject|11|||
163232541|NCT04193202|589562386|FG001|Overall Study|Withdrawal by Subject|5|||
163232542|NCT01777997|589562387|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
163232543|NCT01777997|589562387|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
163232544|NCT01777997|589562387|FG000|Weeks 48 to 72/96 on ART|Death|1|||
163232545|NCT01777997|589562387|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
163232546|NCT02488629|589562389|FG000|Overall Study|Lack of Efficacy|3|||
163232547|NCT02488629|589562390|FG001|Overall Study|Lack of Efficacy|1|||
163232548|NCT02488629|589562391|FG002|Overall Study|Lack of Efficacy|0|||
163232549|NCT02488629|589562392|FG003|Overall Study|Lack of Efficacy|0|||
163232550|NCT02488629|589562389|FG000|Overall Study|Withdrawal by Subject|0|||
163232551|NCT02488629|589562390|FG001|Overall Study|Withdrawal by Subject|1|||
163232552|NCT02488629|589562391|FG002|Overall Study|Withdrawal by Subject|0|||
163232553|NCT02488629|589562392|FG003|Overall Study|Withdrawal by Subject|0|||
163232554|NCT02932891|589562393|FG000|Overall Study|Lost to Follow-up|2|||
163232555|NCT02932891|589562393|FG000|Overall Study|HPA Suppress|2|||
163232556|NCT04622254|589562394|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
163347044|NCT00475735|589979387|FG000|Treatment Period 1|Adverse Event|2|||
163347045|NCT00475735|589979388|FG001|Treatment Period 1|Adverse Event|0|||
163347046|NCT00475735|589979389|FG002|Treatment Period 1|Adverse Event|0|||
163347047|NCT00475735|589979390|FG003|Treatment Period 1|Adverse Event|0|||
163347048|NCT00475735|589979391|FG004|Treatment Period 1|Adverse Event|0|||
163347049|NCT00475735|589979392|FG005|Treatment Period 1|Adverse Event|0|||
163347050|NCT00475735|589979387|FG000|Treatment Period 1|Lack of Efficacy|1|||
163347051|NCT00475735|589979388|FG001|Treatment Period 1|Lack of Efficacy|0|||
163347052|NCT00475735|589979389|FG002|Treatment Period 1|Lack of Efficacy|0|||
163347053|NCT00475735|589979390|FG003|Treatment Period 1|Lack of Efficacy|0|||
163347054|NCT00475735|589979391|FG004|Treatment Period 1|Lack of Efficacy|0|||
163347055|NCT00475735|589979392|FG005|Treatment Period 1|Lack of Efficacy|0|||
163347056|NCT00475735|589979387|FG000|Treatment Period 1|Lost to Follow-up|0|||
163347057|NCT00475735|589979388|FG001|Treatment Period 1|Lost to Follow-up|0|||
163347058|NCT00475735|589979389|FG002|Treatment Period 1|Lost to Follow-up|0|||
163347059|NCT00475735|589979390|FG003|Treatment Period 1|Lost to Follow-up|0|||
163347060|NCT00475735|589979391|FG004|Treatment Period 1|Lost to Follow-up|0|||
163347061|NCT00475735|589979392|FG005|Treatment Period 1|Lost to Follow-up|1|||
163347062|NCT00475735|589979387|FG000|Treatment Period 1|Protocol Violation|0|||
163347063|NCT00475735|589979388|FG001|Treatment Period 1|Protocol Violation|0|||
163347064|NCT00475735|589979389|FG002|Treatment Period 1|Protocol Violation|0|||
163347065|NCT00475735|589979390|FG003|Treatment Period 1|Protocol Violation|1|||
163347066|NCT00475735|589979391|FG004|Treatment Period 1|Protocol Violation|0|||
163347067|NCT00475735|589979392|FG005|Treatment Period 1|Protocol Violation|0|||
163347068|NCT00475735|589979387|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163347069|NCT00475735|589979388|FG001|Treatment Period 1|Withdrawal by Subject|1|||
163347070|NCT00475735|589979389|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163347071|NCT00475735|589979390|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163347072|NCT00475735|589979391|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163347073|NCT00475735|589979392|FG005|Treatment Period 1|Withdrawal by Subject|0|||
163347074|NCT00475735|589979387|FG000|Treatment Period 1|DC due to AE but continuing|0|||
163347075|NCT00475735|589979388|FG001|Treatment Period 1|DC due to AE but continuing|0|||
163347076|NCT00475735|589979389|FG002|Treatment Period 1|DC due to AE but continuing|0|||
163347077|NCT00475735|589979390|FG003|Treatment Period 1|DC due to AE but continuing|1|||
163347078|NCT00475735|589979391|FG004|Treatment Period 1|DC due to AE but continuing|2|||
163347079|NCT00475735|589979392|FG005|Treatment Period 1|DC due to AE but continuing|2|||
163347080|NCT00475735|589979387|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
163347081|NCT00475735|589979388|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
163347082|NCT00475735|589979389|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
163347083|NCT00475735|589979390|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
163347084|NCT00475735|589979391|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
163347085|NCT00475735|589979392|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
163347086|NCT00475735|589979387|FG000|Treatment Washout|Lost to Follow-up|0|||
163347087|NCT00475735|589979388|FG001|Treatment Washout|Lost to Follow-up|1|||
163347088|NCT00475735|589979389|FG002|Treatment Washout|Lost to Follow-up|0|||
163347089|NCT00475735|589979390|FG003|Treatment Washout|Lost to Follow-up|0|||
163347090|NCT00475735|589979391|FG004|Treatment Washout|Lost to Follow-up|0|||
163347091|NCT00475735|589979392|FG005|Treatment Washout|Lost to Follow-up|0|||
163347092|NCT00475735|589979387|FG000|Treatment Washout|Protocol Violation|0|||
163347093|NCT00475735|589979388|FG001|Treatment Washout|Protocol Violation|1|||
163347094|NCT00475735|589979389|FG002|Treatment Washout|Protocol Violation|0|||
163347095|NCT00475735|589979390|FG003|Treatment Washout|Protocol Violation|0|||
163347096|NCT00475735|589979391|FG004|Treatment Washout|Protocol Violation|0|||
163347097|NCT00475735|589979392|FG005|Treatment Washout|Protocol Violation|0|||
163347098|NCT00475735|589979387|FG000|Treatment Period 2|Adverse Event|0|||
163347099|NCT00475735|589979388|FG001|Treatment Period 2|Adverse Event|1|||
163347100|NCT00475735|589979389|FG002|Treatment Period 2|Adverse Event|0|||
163347101|NCT00475735|589979390|FG003|Treatment Period 2|Adverse Event|2|||
163347102|NCT00475735|589979391|FG004|Treatment Period 2|Adverse Event|0|||
163347103|NCT00475735|589979392|FG005|Treatment Period 2|Adverse Event|0|||
163347104|NCT00475735|589979387|FG000|Treatment Period 2|Lack of Efficacy|0|||
163232557|NCT04622254|589562395|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
163347105|NCT00475735|589979388|FG001|Treatment Period 2|Lack of Efficacy|0|||
163347106|NCT00475735|589979389|FG002|Treatment Period 2|Lack of Efficacy|0|||
163347107|NCT00475735|589979390|FG003|Treatment Period 2|Lack of Efficacy|0|||
163347108|NCT00475735|589979391|FG004|Treatment Period 2|Lack of Efficacy|0|||
163347109|NCT00475735|589979392|FG005|Treatment Period 2|Lack of Efficacy|1|||
163409275|NCT01142726|590207577|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
163409276|NCT01142726|590207575|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
163232558|NCT04622254|589562396|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
163232559|NCT04622254|589562397|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
163232560|NCT04622254|589562398|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
163232561|NCT04622254|589562399|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
163232562|NCT04622254|589562394|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
163232563|NCT04622254|589562395|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
163232564|NCT04622254|589562396|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
163232565|NCT04622254|589562397|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
163232566|NCT04622254|589562398|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
163232567|NCT04622254|589562399|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
163232568|NCT04622254|589562394|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
163232569|NCT04622254|589562395|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
163232570|NCT04622254|589562396|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
163232571|NCT04622254|589562397|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
163232572|NCT04622254|589562398|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
163232573|NCT04622254|589562399|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
163232574|NCT04622254|589562394|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
163232575|NCT04622254|589562395|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
163232576|NCT04622254|589562396|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
163232577|NCT04622254|589562397|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
163232578|NCT04622254|589562398|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
163232579|NCT04622254|589562399|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
163232580|NCT04622254|589562394|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
163232581|NCT04622254|589562395|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
163232582|NCT04622254|589562396|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
163232583|NCT04622254|589562397|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
163232584|NCT04622254|589562398|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
163232585|NCT04622254|589562399|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
163232586|NCT04622254|589562394|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
163232587|NCT04622254|589562395|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
163232588|NCT04622254|589562396|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
163232589|NCT04622254|589562397|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
163232590|NCT04622254|589562398|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
163232591|NCT04622254|589562399|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
163232592|NCT04622254|589562394|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
163232593|NCT04622254|589562395|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
163232594|NCT04622254|589562396|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
163232595|NCT04622254|589562397|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
163232596|NCT04622254|589562398|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
163232597|NCT04622254|589562399|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
163232598|NCT04622254|589562394|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
163232599|NCT04622254|589562395|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
163232600|NCT04622254|589562396|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
163232601|NCT04622254|589562397|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
163232602|NCT04622254|589562398|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
163232603|NCT04622254|589562399|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
163232604|NCT04622254|589562394|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
163232605|NCT04622254|589562395|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
163232606|NCT04622254|589562396|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
163232607|NCT04622254|589562397|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
163232608|NCT04622254|589562398|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
163232609|NCT04622254|589562399|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
163232610|NCT04622254|589562394|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
163232611|NCT04622254|589562395|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
163232612|NCT04622254|589562396|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
163232613|NCT04622254|589562397|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
163409277|NCT01142726|590207576|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
163409278|NCT01142726|590207577|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
163409279|NCT01142726|590207575|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
163232614|NCT04622254|589562398|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
163232615|NCT04622254|589562399|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
163232616|NCT04622254|589562394|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
163232617|NCT04622254|589562395|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
163232618|NCT04622254|589562396|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
163232619|NCT04622254|589562397|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
163232620|NCT04622254|589562398|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
163232621|NCT04622254|589562399|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
163232622|NCT02652624|589562400|FG000|Randomized Phase|Pregnancy|3|||
163232623|NCT02652624|589562401|FG001|Randomized Phase|Pregnancy|1|||
163232624|NCT02652624|589562400|FG000|Randomized Phase|Investigator's Discretion|0|||
163232625|NCT02652624|589562401|FG001|Randomized Phase|Investigator's Discretion|2|||
163232626|NCT02652624|589562400|FG000|Randomized Phase|Death|0|||
163232627|NCT02652624|589562401|FG001|Randomized Phase|Death|1|||
163232628|NCT02652624|589562400|FG000|Randomized Phase|Lost to Follow-up|0|||
163232629|NCT02652624|589562401|FG001|Randomized Phase|Lost to Follow-up|1|||
163232630|NCT02652624|589562400|FG000|Extension Phase|Lost to Follow-up|3|||
163232631|NCT02652624|589562401|FG001|Extension Phase|Lost to Follow-up|1|||
163232632|NCT02652624|589562400|FG000|Extension Phase|Pregnancy|1|||
163232633|NCT02652624|589562401|FG001|Extension Phase|Pregnancy|1|||
163232634|NCT02652624|589562400|FG000|Extension Phase|Adverse Event|0|||
163232635|NCT02652624|589562401|FG001|Extension Phase|Adverse Event|1|||
163232636|NCT02652624|589562400|FG000|Extension Phase|Withdrew Consent|0|||
163232637|NCT02652624|589562401|FG001|Extension Phase|Withdrew Consent|1|||
163232638|NCT00577122|589562402|FG000|Overall Study|Adverse Event|0|||
163232639|NCT00577122|589562403|FG001|Overall Study|Adverse Event|2|||
163232640|NCT00577122|589562402|FG000|Overall Study|Progression, relapse during active trt|6|||
163232641|NCT00577122|589562403|FG001|Overall Study|Progression, relapse during active trt|8|||
163232642|NCT00577122|589562402|FG000|Overall Study|Prog, refract disease during active trt|8|||
163232643|NCT00577122|589562403|FG001|Overall Study|Prog, refract disease during active trt|5|||
163232644|NCT00577122|589562402|FG000|Overall Study|Alternative Therapy|0|||
163232645|NCT00577122|589562403|FG001|Overall Study|Alternative Therapy|1|||
163232646|NCT03228680|589562404|FG000|Overall Study|Adverse Event|13|||
163232647|NCT03228680|589562405|FG001|Overall Study|Adverse Event|18|||
163232648|NCT03228680|589562404|FG000|Overall Study|Randomization failure|0|||
163232649|NCT03228680|589562405|FG001|Overall Study|Randomization failure|1|||
163232650|NCT03228680|589562404|FG000|Overall Study|Withdrawal by Subject|1|||
163232651|NCT03228680|589562405|FG001|Overall Study|Withdrawal by Subject|0|||
163232652|NCT03228680|589562404|FG000|Overall Study|Other|9|||
163232653|NCT03228680|589562405|FG001|Overall Study|Other|16|||
163232654|NCT02252081|589562406|FG000|Overall Study|Withdrawal by Subject|2|||
163232655|NCT02252081|589562407|FG001|Overall Study|Withdrawal by Subject|1|||
163232656|NCT02252081|589562406|FG000|Overall Study|Adverse Event|4|||
163232657|NCT02252081|589562407|FG001|Overall Study|Adverse Event|1|||
163232658|NCT02252081|589562406|FG000|Overall Study|non compliance & others|0|||
163232659|NCT02252081|589562407|FG001|Overall Study|non compliance & others|2|||
163232660|NCT03732638|589562414|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
163232661|NCT03732638|589562415|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
163232662|NCT03732638|589562414|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
163232663|NCT03732638|589562415|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
163232664|NCT03732638|589562414|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
163232665|NCT03732638|589562415|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
163232666|NCT03732638|589562414|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
163232667|NCT03732638|589562415|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
163232668|NCT03732638|589562414|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
163232669|NCT03732638|589562415|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
163232670|NCT03732638|589562414|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
163232671|NCT03732638|589562415|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
163232672|NCT03732638|589562414|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
163232673|NCT03732638|589562415|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
163232674|NCT03732638|589562414|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
163232675|NCT03732638|589562415|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
163232676|NCT03732638|589562414|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
163232677|NCT03732638|589562415|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
163232678|NCT03732638|589562414|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
163232679|NCT03732638|589562415|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
163347110|NCT00475735|589979387|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163347111|NCT00475735|589979388|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163347112|NCT00475735|589979389|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163347113|NCT00475735|589979390|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163347114|NCT00475735|589979391|FG004|Treatment Period 2|Withdrawal by Subject|1|||
163347115|NCT00475735|589979392|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163347116|NCT01187407|589979393|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
163347117|NCT01187407|589979394|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163347118|NCT01187407|589979395|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163232680|NCT03732638|589562414|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
163347119|NCT01187407|589979396|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163232681|NCT03732638|589562415|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
163232682|NCT03732638|589562414|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
163139353|NCT01550757|589219847|FG002|Overall Study|Withdrawal by Subject|3|||
163139354|NCT01550757|589219848|FG003|Overall Study|Withdrawal by Subject|1|||
163139355|NCT02342223|589219849|FG000|Overall Study|Lost to Follow-up|1|||
163139356|NCT03018691|589219850|FG000|Overall Study|Adverse Event|1|||
163139357|NCT03018691|589219851|FG001|Overall Study|Adverse Event|1|||
163139358|NCT03018691|589219852|FG002|Overall Study|Adverse Event|4|||
163139359|NCT03018691|589219850|FG000|Overall Study|Lack of Efficacy|0|||
163139360|NCT03018691|589219851|FG001|Overall Study|Lack of Efficacy|0|||
163139361|NCT03018691|589219852|FG002|Overall Study|Lack of Efficacy|1|||
163139362|NCT03018691|589219850|FG000|Overall Study|Withdrawal by Subject|0|||
163139363|NCT03018691|589219851|FG001|Overall Study|Withdrawal by Subject|0|||
163139364|NCT03018691|589219852|FG002|Overall Study|Withdrawal by Subject|1|||
163139365|NCT03018691|589219850|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163139366|NCT03018691|589219851|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163139367|NCT03018691|589219852|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163139368|NCT03369418|589219853|FG000|Overall Study|Withdrawal by Subject|3|||
163139369|NCT03369418|589219854|FG001|Overall Study|Withdrawal by Subject|3|||
163139370|NCT01426958|589219855|FG000|Overall Study|Adverse Event|2|||
163139371|NCT01172535|589219858|FG000|Overall Study|Death|3|||
163139372|NCT01172535|589219858|FG000|Overall Study|Withdrawal by Subject|2|||
163139373|NCT01172535|589219858|FG000|Overall Study|Lost to Follow-up|1|||
163139374|NCT01172535|589219858|FG000|Overall Study|Ineligible at study entry|1|||
163139375|NCT01172535|589219858|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
163139376|NCT05280717|589219859|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
163139377|NCT05280717|589219860|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
163139378|NCT05280717|589219861|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
163139379|NCT05280717|589219862|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
163139380|NCT05280717|589219863|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
163139381|NCT05280717|589219864|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
163139382|NCT05280717|589219865|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
163139383|NCT05280717|589219859|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
163139384|NCT05280717|589219860|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
163139385|NCT05280717|589219861|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
163139386|NCT05280717|589219862|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
163139387|NCT05280717|589219863|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
163139388|NCT05280717|589219864|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
163139389|NCT05280717|589219865|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
163139390|NCT05280717|589219859|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
163139391|NCT05280717|589219860|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
163139392|NCT05280717|589219861|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
163139393|NCT05280717|589219862|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
163139394|NCT05280717|589219863|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
163139395|NCT05280717|589219864|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
163139396|NCT05280717|589219865|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
163139397|NCT05280717|589219859|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
163139398|NCT05280717|589219860|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
163139399|NCT05280717|589219861|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
163139400|NCT05280717|589219862|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
163139401|NCT05280717|589219863|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
163139402|NCT05280717|589219864|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
163139403|NCT05280717|589219865|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
163139404|NCT05280717|589219859|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
163139405|NCT05280717|589219860|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
163139406|NCT05280717|589219861|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
163139407|NCT05280717|589219862|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
163139408|NCT05280717|589219863|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
163139409|NCT05280717|589219864|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
163139410|NCT05280717|589219865|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
163139411|NCT05280717|589219859|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
163139412|NCT05280717|589219860|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
163139413|NCT05280717|589219861|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
163139414|NCT05280717|589219862|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
163347120|NCT01187407|589979397|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163347121|NCT01187407|589979393|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
163347122|NCT01187407|589979394|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163347123|NCT01187407|589979395|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163347124|NCT01187407|589979396|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163347125|NCT01187407|589979397|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163347126|NCT01187407|589979393|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
163347127|NCT01187407|589979394|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163347128|NCT01187407|589979395|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163347129|NCT01187407|589979396|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163347130|NCT01187407|589979397|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163347131|NCT01187407|589979393|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
163347132|NCT01187407|589979394|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163347133|NCT01187407|589979395|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163347134|NCT01187407|589979396|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163347135|NCT01187407|589979397|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163347136|NCT01187407|589979393|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
163347137|NCT01187407|589979394|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163347138|NCT01187407|589979395|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163347139|NCT01187407|589979396|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163347140|NCT01187407|589979397|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163347141|NCT01187407|589979393|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
163347142|NCT01187407|589979394|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163347143|NCT01187407|589979395|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163347144|NCT01187407|589979396|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163347145|NCT01187407|589979397|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163347146|NCT01187407|589979393|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
163347147|NCT01187407|589979394|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163347148|NCT01187407|589979395|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163347149|NCT01187407|589979396|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163347150|NCT01187407|589979397|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163347151|NCT01187407|589979393|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
163347152|NCT01187407|589979394|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
163347153|NCT01187407|589979395|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
163347154|NCT01187407|589979396|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
163347155|NCT01187407|589979397|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
163347156|NCT01187407|589979393|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
163347157|NCT01187407|589979394|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
163347158|NCT01187407|589979395|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
163347159|NCT01187407|589979396|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
163347160|NCT01187407|589979397|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
163347161|NCT01187407|589979393|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
163347162|NCT01187407|589979394|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
163347163|NCT01187407|589979395|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
163347164|NCT01187407|589979396|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
163347165|NCT01187407|589979397|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
163347166|NCT01187407|589979393|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
163347167|NCT01187407|589979394|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
163347168|NCT01187407|589979395|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
163347169|NCT01187407|589979396|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
163347170|NCT01187407|589979397|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
163347171|NCT01187407|589979393|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
163347172|NCT01187407|589979394|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
163347173|NCT01187407|589979395|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
163347174|NCT01187407|589979396|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
163347175|NCT01187407|589979397|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
163347176|NCT01187407|589979393|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
163347177|NCT01187407|589979394|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
163347178|NCT01187407|589979395|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
163347179|NCT01187407|589979396|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
163347180|NCT01187407|589979397|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
163347181|NCT01187407|589979393|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
163347182|NCT01187407|589979394|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
163347183|NCT01187407|589979395|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
163347184|NCT01187407|589979396|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
163347185|NCT01187407|589979397|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
163347186|NCT02382406|589979400|FG000|Study Treatment|Disease Progression|8|||
163232683|NCT03732638|589562415|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
163232684|NCT03732638|589562414|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
163232685|NCT03732638|589562415|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
163232686|NCT03732638|589562414|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
163232687|NCT03732638|589562415|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
163232688|NCT03732638|589562414|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
163232689|NCT03732638|589562415|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
163232690|NCT03732638|589562414|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
163232691|NCT03732638|589562415|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
163232692|NCT03732638|589562414|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
163232693|NCT03732638|589562415|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
163232694|NCT03732638|589562414|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
163232695|NCT03732638|589562415|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
163232696|NCT03732638|589562414|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
163232697|NCT03732638|589562415|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
163232698|NCT03732638|589562414|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
163232699|NCT03732638|589562415|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
163232700|NCT03732638|589562414|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
163232701|NCT03732638|589562415|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
163232702|NCT03732638|589562414|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
163232703|NCT03732638|589562415|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
163232704|NCT03732638|589562414|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
163232705|NCT03732638|589562415|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
163232706|NCT03732638|589562414|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
163232707|NCT03732638|589562415|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
163232708|NCT00642304|589562416|FG000|Overall Study|Adverse Event|1|||
163232709|NCT00642304|589562416|FG000|Overall Study|Death|1|||
163232710|NCT00642304|589562416|FG000|Overall Study|Blood transfusion|2|||
163232711|NCT00642304|589562416|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
163232712|NCT00642304|589562416|FG000|Overall Study|Transplantation|1|||
163232713|NCT03192150|589562417|FG000|Overall Study|Adverse Event|14|||
163232714|NCT03192150|589562418|FG001|Overall Study|Adverse Event|12|||
163232715|NCT03192150|589562417|FG000|Overall Study|Lack of Efficacy|23|||
163232716|NCT03192150|589562418|FG001|Overall Study|Lack of Efficacy|30|||
163232717|NCT03192150|589562417|FG000|Overall Study|Lost to Follow-up|1|||
163232718|NCT03192150|589562418|FG001|Overall Study|Lost to Follow-up|1|||
163232719|NCT03192150|589562417|FG000|Overall Study|Withdrawal by Subject|4|||
163232720|NCT03192150|589562418|FG001|Overall Study|Withdrawal by Subject|2|||
163232721|NCT03192150|589562417|FG000|Overall Study|Protocol Violation|5|||
163232722|NCT03192150|589562418|FG001|Overall Study|Protocol Violation|2|||
163347187|NCT02382406|589979401|FG001|Study Treatment|Disease Progression|0|||
163347188|NCT02382406|589979402|FG002|Study Treatment|Disease Progression|20|||
163139415|NCT05280717|589219863|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
163139416|NCT05280717|589219864|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
163139417|NCT05280717|589219865|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
163139418|NCT00740584|589219866|FG000|Overall Study|Withdrawal by Subject|1|||
163139419|NCT01461707|589219867|FG000|Overall Study|Withdrawal by Subject|1|||
163139420|NCT01461707|589219868|FG001|Overall Study|Withdrawal by Subject|0|||
163139421|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
163139422|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
163139423|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
163139424|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
163139425|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
163139426|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
163139427|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
163139428|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
163139429|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
163139430|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
163139431|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
163139432|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
163139433|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
163139434|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
163139435|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
163139436|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
163139437|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
163232723|NCT03192150|589562417|FG000|Overall Study|Surgery Canceled|6|||
163232724|NCT03192150|589562418|FG001|Overall Study|Surgery Canceled|2|||
163232725|NCT03192150|589562417|FG000|Overall Study|Other-Various Administrative Reasons|2|||
163232726|NCT03192150|589562418|FG001|Overall Study|Other-Various Administrative Reasons|5|||
163347189|NCT02382406|589979400|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
163347190|NCT02382406|589979401|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
163139438|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
163139439|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
163139440|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
163139441|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
163139442|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
163139443|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
163139444|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
163139445|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
163139446|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
163139447|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
163139448|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
163139449|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
163139450|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
163139451|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
163139452|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
163139453|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
163139454|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
163139455|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
163139456|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
163139457|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
163139458|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
163139459|NCT01196026|589219876|FG000|Overall Study|Withdrawal by Subject|1|||
163139460|NCT01196026|589219877|FG001|Overall Study|Withdrawal by Subject|4|||
163139461|NCT01196026|589219878|FG002|Overall Study|Withdrawal by Subject|0|||
163139462|NCT01196026|589219879|FG003|Overall Study|Withdrawal by Subject|0|||
163139463|NCT01196026|589219880|FG004|Overall Study|Withdrawal by Subject|0|||
163139464|NCT01196026|589219881|FG005|Overall Study|Withdrawal by Subject|0|||
163139465|NCT01196026|589219876|FG000|Overall Study|Lost to Follow-up|0|||
163139466|NCT01196026|589219877|FG001|Overall Study|Lost to Follow-up|3|||
163139467|NCT01196026|589219878|FG002|Overall Study|Lost to Follow-up|0|||
163139468|NCT01196026|589219879|FG003|Overall Study|Lost to Follow-up|0|||
163139469|NCT01196026|589219880|FG004|Overall Study|Lost to Follow-up|1|||
163139470|NCT01196026|589219881|FG005|Overall Study|Lost to Follow-up|0|||
163139471|NCT01196026|589219876|FG000|Overall Study|Other|0|||
163139472|NCT01196026|589219877|FG001|Overall Study|Other|1|||
163139473|NCT01196026|589219878|FG002|Overall Study|Other|0|||
163139474|NCT01196026|589219879|FG003|Overall Study|Other|0|||
163139475|NCT01196026|589219880|FG004|Overall Study|Other|0|||
163139476|NCT01196026|589219881|FG005|Overall Study|Other|0|||
163139477|NCT02336230|589219891|FG000|Overall Study|Adverse Event|1|||
163139478|NCT02336230|589219891|FG000|Overall Study|Withdrawal of consent|1|||
163139479|NCT02336230|589219891|FG000|Overall Study|Death|9|||
163139480|NCT02336230|589219891|FG000|Overall Study|Dose not received due to shipping delay|1|||
163139481|NCT02336230|589219891|FG000|Overall Study|Discontinuation of MSC infusion|1|||
163139482|NCT01620086|589219898|FG000|Overall Study|Withdrawal by Subject|3|||
163139483|NCT01620086|589219899|FG001|Overall Study|Withdrawal by Subject|3|||
163139484|NCT01620086|589219900|FG002|Overall Study|Withdrawal by Subject|0|||
163139485|NCT01620086|589219898|FG000|Overall Study|failed study criteria|1|||
163139486|NCT01620086|589219899|FG001|Overall Study|failed study criteria|4|||
163139487|NCT01620086|589219900|FG002|Overall Study|failed study criteria|0|||
163139488|NCT01620086|589219898|FG000|Overall Study|Physician Decision|1|||
163139489|NCT01620086|589219899|FG001|Overall Study|Physician Decision|0|||
163139490|NCT01620086|589219900|FG002|Overall Study|Physician Decision|0|||
163139491|NCT01695135|589219901|FG000|Double-blind Treatment Phase|Progressive disease|50|||
163139492|NCT01695135|589219902|FG001|Double-blind Treatment Phase|Progressive disease|110|||
163139493|NCT01695135|589219903|FG002|Double-blind Treatment Phase|Progressive disease|0|||
163139494|NCT01695135|589219904|FG003|Double-blind Treatment Phase|Progressive disease|0|||
163139495|NCT01695135|589219901|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
163139496|NCT01695135|589219902|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
163139497|NCT01695135|589219903|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
163139498|NCT01695135|589219904|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
163139499|NCT01695135|589219901|FG000|Double-blind Treatment Phase|Adverse Event|7|||
163139500|NCT01695135|589219902|FG001|Double-blind Treatment Phase|Adverse Event|7|||
163139501|NCT01695135|589219903|FG002|Double-blind Treatment Phase|Adverse Event|0|||
163139502|NCT01695135|589219904|FG003|Double-blind Treatment Phase|Adverse Event|0|||
163139503|NCT01695135|589219901|FG000|Double-blind Treatment Phase|Other|1|||
163139504|NCT01695135|589219902|FG001|Double-blind Treatment Phase|Other|3|||
163139505|NCT01695135|589219903|FG002|Double-blind Treatment Phase|Other|0|||
163139506|NCT01695135|589219904|FG003|Double-blind Treatment Phase|Other|0|||
163139507|NCT01695135|589219901|FG000|Double-blind Treatment Phase|Physician Decision|6|||
163232727|NCT00482391|589562419|FG000|Overall Study|Withdrawal by Subject|1|||
163232728|NCT00482391|589562419|FG000|Overall Study|Adverse Event|1|||
163232729|NCT00482391|589562419|FG000|Overall Study|Death|1|||
163232730|NCT01274637|589562424|FG000|Overall Study|Withdrawal by Subject|0|||
163232731|NCT01274637|589562425|FG001|Overall Study|Withdrawal by Subject|1|||
163232732|NCT01274637|589562424|FG000|Overall Study|Lost to Follow-up|0|||
163232733|NCT01274637|589562425|FG001|Overall Study|Lost to Follow-up|1|||
163232734|NCT02606136|589562446|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
163232735|NCT02606136|589562446|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
163232736|NCT02606136|589562446|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
163232737|NCT02606136|589562446|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
163232738|NCT03296696|589562447|FG000|Overall Study|Started Other Antitumor Therapy|1|||
163232739|NCT03296696|589562448|FG001|Overall Study|Started Other Antitumor Therapy|2|||
163232740|NCT03296696|589562449|FG002|Overall Study|Started Other Antitumor Therapy|1|||
163232741|NCT03296696|589562450|FG003|Overall Study|Started Other Antitumor Therapy|2|||
163232742|NCT03296696|589562451|FG004|Overall Study|Started Other Antitumor Therapy|1|||
163232743|NCT03296696|589562452|FG005|Overall Study|Started Other Antitumor Therapy|1|||
163232744|NCT03296696|589562453|FG006|Overall Study|Started Other Antitumor Therapy|2|||
163232745|NCT03296696|589562454|FG007|Overall Study|Started Other Antitumor Therapy|3|||
163232746|NCT03296696|589562455|FG008|Overall Study|Started Other Antitumor Therapy|1|||
163232747|NCT03296696|589562456|FG009|Overall Study|Started Other Antitumor Therapy|0|||
163232748|NCT03296696|589562447|FG000|Overall Study|Death|0|||
163232749|NCT03296696|589562448|FG001|Overall Study|Death|1|||
163232750|NCT03296696|589562449|FG002|Overall Study|Death|1|||
163232751|NCT03296696|589562450|FG003|Overall Study|Death|2|||
163232752|NCT03296696|589562451|FG004|Overall Study|Death|2|||
163232753|NCT03296696|589562452|FG005|Overall Study|Death|3|||
163232754|NCT03296696|589562453|FG006|Overall Study|Death|1|||
163232755|NCT03296696|589562454|FG007|Overall Study|Death|2|||
163232756|NCT03296696|589562455|FG008|Overall Study|Death|0|||
163232757|NCT03296696|589562456|FG009|Overall Study|Death|0|||
163232758|NCT03296696|589562447|FG000|Overall Study|Withdrawal by Subject|0|||
163232759|NCT03296696|589562448|FG001|Overall Study|Withdrawal by Subject|0|||
163232760|NCT03296696|589562449|FG002|Overall Study|Withdrawal by Subject|1|||
163232761|NCT03296696|589562450|FG003|Overall Study|Withdrawal by Subject|0|||
163232762|NCT03296696|589562451|FG004|Overall Study|Withdrawal by Subject|1|||
163232763|NCT03296696|589562452|FG005|Overall Study|Withdrawal by Subject|0|||
163232764|NCT03296696|589562453|FG006|Overall Study|Withdrawal by Subject|0|||
163232765|NCT03296696|589562454|FG007|Overall Study|Withdrawal by Subject|0|||
163232766|NCT03296696|589562455|FG008|Overall Study|Withdrawal by Subject|0|||
163232767|NCT03296696|589562456|FG009|Overall Study|Withdrawal by Subject|1|||
163232768|NCT04694131|589562459|FG000|Overall Study|Withdrawal by Subject|7|||
163232769|NCT04694131|589562459|FG000|Overall Study|Screen Failure|1|||
163232770|NCT04694131|589562459|FG000|Overall Study|High stimulation threshold|3|||
163232771|NCT01350128|589562460|FG000|Overall Study|Withdrawal by Subject|3|||
163232772|NCT01350128|589562460|FG000|Overall Study|Protocol discontinuation criteria|8|||
163232773|NCT01350128|589562460|FG000|Overall Study|Physician Decision|1|||
163232774|NCT01350128|589562460|FG000|Overall Study|Lost to Follow-up|2|||
163232775|NCT02399085|589562464|FG000|Overall Study|Adverse Event|16|||
163232776|NCT02399085|589562464|FG000|Overall Study|Death|2|||
163232777|NCT02399085|589562464|FG000|Overall Study|Withdrawal by Subject|8|||
163232778|NCT02399085|589562464|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
163232779|NCT02399085|589562464|FG000|Overall Study|Physician Decision|5|||
163232780|NCT01859715|589562465|FG000|Overall Study|No 2nd VAS|16|||
163232781|NCT01859715|589562466|FG001|Overall Study|No 2nd VAS|8|||
163232782|NCT01859715|589562467|FG002|Overall Study|No 2nd VAS|23|||
163232783|NCT00086580|589562471|FG000|Treatment Period|Disease progression|9|||
163232784|NCT00086580|589562472|FG001|Treatment Period|Disease progression|8|||
163232785|NCT00086580|589562471|FG000|Treatment Period|Unable to comply with protocol|3|||
163232786|NCT00086580|589562472|FG001|Treatment Period|Unable to comply with protocol|1|||
163232787|NCT00086580|589562471|FG000|Treatment Period|Withdrawal by Subject|7|||
163232788|NCT00086580|589562472|FG001|Treatment Period|Withdrawal by Subject|8|||
163232789|NCT00086580|589562471|FG000|Treatment Period|Physician Decision|13|||
163232790|NCT00086580|589562472|FG001|Treatment Period|Physician Decision|7|||
163232791|NCT00086580|589562471|FG000|Treatment Period|AE - not treatment related|7|||
163232792|NCT00086580|589562472|FG001|Treatment Period|AE - not treatment related|7|||
163232793|NCT00086580|589562471|FG000|Treatment Period|Toxicity - treatment related|15|||
163232794|NCT00086580|589562472|FG001|Treatment Period|Toxicity - treatment related|15|||
163232795|NCT00086580|589562471|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
163232796|NCT00086580|589562472|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
163232797|NCT00086580|589562471|FG000|Treatment Period|Death|5|||
163347191|NCT02382406|589979402|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
163232798|NCT00086580|589562472|FG001|Treatment Period|Death|7|||
163232799|NCT00086580|589562471|FG000|Treatment Period|Other|5|||
163232800|NCT00086580|589562472|FG001|Treatment Period|Other|3|||
163232801|NCT00086580|589562471|FG000|Follow-up Period|Disease progression|72|||
163232802|NCT00086580|589562472|FG001|Follow-up Period|Disease progression|99|||
163232803|NCT00086580|589562471|FG000|Follow-up Period|Unable to comply with protocol|5|||
163232804|NCT00086580|589562472|FG001|Follow-up Period|Unable to comply with protocol|0|||
163232805|NCT00086580|589562471|FG000|Follow-up Period|Withdrawal by Subject|6|||
163232806|NCT00086580|589562472|FG001|Follow-up Period|Withdrawal by Subject|6|||
163232807|NCT00086580|589562471|FG000|Follow-up Period|Physician Decision|0|||
163232808|NCT00086580|589562472|FG001|Follow-up Period|Physician Decision|1|||
163232809|NCT00086580|589562471|FG000|Follow-up Period|AE - not related|1|||
163232810|NCT00086580|589562472|FG001|Follow-up Period|AE - not related|0|||
163232811|NCT00086580|589562471|FG000|Follow-up Period|Death|13|||
163232812|NCT00086580|589562472|FG001|Follow-up Period|Death|7|||
163232813|NCT00086580|589562471|FG000|Follow-up Period|Other|7|||
163232814|NCT00086580|589562472|FG001|Follow-up Period|Other|6|||
163232815|NCT00086580|589562471|FG000|Observation Period|Unable to comply with protocol|1|||
163232816|NCT00086580|589562472|FG001|Observation Period|Unable to comply with protocol|1|||
163232817|NCT00086580|589562471|FG000|Observation Period|Withdrawal by Subject|4|||
163232818|NCT00086580|589562472|FG001|Observation Period|Withdrawal by Subject|2|||
163232819|NCT00086580|589562471|FG000|Observation Period|Death|33|||
163232820|NCT00086580|589562472|FG001|Observation Period|Death|55|||
163232821|NCT00086580|589562471|FG000|Observation Period|Other|8|||
163232822|NCT00086580|589562472|FG001|Observation Period|Other|7|||
163232823|NCT00806546|589562479|FG000|Overall Study|Enrolled, not treated|35|||
163232824|NCT00806546|589562479|FG000|Overall Study|Lost to Follow-up|32|||
163232825|NCT00806546|589562479|FG000|Overall Study|Adverse Event|74|||
163232826|NCT00806546|589562479|FG000|Overall Study|Withdrawal by Subject|75|||
163232827|NCT00806546|589562479|FG000|Overall Study|Protocol Violation|49|||
163232828|NCT00806546|589562479|FG000|Overall Study|Various|42|||
163232829|NCT00558103|589562482|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
163232830|NCT00558103|589562483|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
163232831|NCT00558103|589562484|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
163232832|NCT00558103|589562485|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
163232833|NCT00558103|589562486|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
163232834|NCT00558103|589562487|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
163232835|NCT00558103|589562482|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
163232836|NCT00558103|589562483|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
163232837|NCT00558103|589562484|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
163232838|NCT00558103|589562485|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
163232839|NCT00558103|589562486|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
163232840|NCT00558103|589562487|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
163232841|NCT00558103|589562482|FG000|Randomized Treatment Phase|Disease Progression|1|||
163232842|NCT00558103|589562483|FG001|Randomized Treatment Phase|Disease Progression|0|||
163232843|NCT00558103|589562484|FG002|Randomized Treatment Phase|Disease Progression|1|||
163232844|NCT00558103|589562485|FG003|Randomized Treatment Phase|Disease Progression|0|||
163232845|NCT00558103|589562486|FG004|Randomized Treatment Phase|Disease Progression|0|||
163232846|NCT00558103|589562487|FG005|Randomized Treatment Phase|Disease Progression|0|||
163232847|NCT00558103|589562482|FG000|Randomized Treatment Phase|Adverse Event|0|||
163232848|NCT00558103|589562483|FG001|Randomized Treatment Phase|Adverse Event|0|||
163232849|NCT00558103|589562484|FG002|Randomized Treatment Phase|Adverse Event|0|||
163232850|NCT00558103|589562485|FG003|Randomized Treatment Phase|Adverse Event|1|||
163232851|NCT00558103|589562486|FG004|Randomized Treatment Phase|Adverse Event|1|||
163232852|NCT00558103|589562487|FG005|Randomized Treatment Phase|Adverse Event|0|||
163232853|NCT00558103|589562482|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
163232854|NCT00558103|589562483|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
163232855|NCT00558103|589562484|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
163232856|NCT00558103|589562485|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
163232857|NCT00558103|589562486|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
163232858|NCT00558103|589562487|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
163232859|NCT00558103|589562482|FG000|Monotherapy Extension Phase|Disease Progression|0|||
163232860|NCT00558103|589562483|FG001|Monotherapy Extension Phase|Disease Progression|0|||
163232861|NCT00558103|589562484|FG002|Monotherapy Extension Phase|Disease Progression|0|||
163232862|NCT00558103|589562485|FG003|Monotherapy Extension Phase|Disease Progression|0|||
163232863|NCT00558103|589562486|FG004|Monotherapy Extension Phase|Disease Progression|0|||
163232864|NCT00558103|589562487|FG005|Monotherapy Extension Phase|Disease Progression|8|||
163232865|NCT00308711|589562488|FG000|Overall Study|Withdrawal by Subject|1|||
163232866|NCT00308711|589562489|FG001|Overall Study|Withdrawal by Subject|0|||
163232867|NCT00308711|589562490|FG002|Overall Study|Withdrawal by Subject|1|||
163232868|NCT00308711|589562488|FG000|Overall Study|Protocol Violation|0|||
163232869|NCT00308711|589562489|FG001|Overall Study|Protocol Violation|1|||
163232870|NCT00308711|589562490|FG002|Overall Study|Protocol Violation|1|||
163232871|NCT00308711|589562488|FG000|Overall Study|Lost to Follow-up|0|||
163232872|NCT00308711|589562489|FG001|Overall Study|Lost to Follow-up|1|||
163232873|NCT00308711|589562490|FG002|Overall Study|Lost to Follow-up|0|||
163232874|NCT00308711|589562488|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
163232875|NCT00308711|589562489|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
163232876|NCT00308711|589562490|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
163232877|NCT00308711|589562488|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
163232878|NCT00308711|589562489|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
163232879|NCT00308711|589562490|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
163232880|NCT03139916|589562493|FG000|Overall Study|Withdrawal by Subject|2|||
163232881|NCT03139916|589562493|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
163232882|NCT01957475|589562494|FG000|Test Period 1|Withdrawal by Subject|1|||
163232883|NCT01957475|589562495|FG001|Test Period 1|Withdrawal by Subject|0|||
163232884|NCT01957475|589562494|FG000|Test Period 1|Other|1|||
163232885|NCT01957475|589562495|FG001|Test Period 1|Other|0|||
163232886|NCT01957475|589562494|FG000|Test Period 1|Lack of Efficacy|0|||
163232887|NCT01957475|589562495|FG001|Test Period 1|Lack of Efficacy|1|||
163232888|NCT01957475|589562494|FG000|Test Period 2|Adverse Event|1|||
163232889|NCT01957475|589562495|FG001|Test Period 2|Adverse Event|0|||
163232890|NCT02469610|589562496|FG000|Overall Study|Death|1|||
163232891|NCT02469610|589562497|FG001|Overall Study|Death|0|||
163232892|NCT02469610|589562496|FG000|Overall Study|Lost to Follow-up|1|||
163232893|NCT02469610|589562497|FG001|Overall Study|Lost to Follow-up|0|||
163232894|NCT02469610|589562496|FG000|Overall Study|exclusion criteria|2|||
163232895|NCT02469610|589562497|FG001|Overall Study|exclusion criteria|1|||
163232896|NCT00414388|589562500|FG000|Overall Study|Adverse Event|1|||
163232897|NCT02318693|589562501|FG000|Overall Study|Protocol Violation|0|||
163232898|NCT02318693|589562502|FG001|Overall Study|Protocol Violation|1|||
163232899|NCT03591575|589562503|FG000|Overall Study|Adverse Event|2|||
163232900|NCT03591575|589562504|FG001|Overall Study|Adverse Event|0|||
163232901|NCT03591575|589562503|FG000|Overall Study|Withdrawal by Subject|4|||
163232902|NCT03591575|589562504|FG001|Overall Study|Withdrawal by Subject|1|||
163232903|NCT00813358|589562507|FG000|Overall Study|Death|32|||
163232904|NCT00813358|589562507|FG000|Overall Study|Lost to Follow-up|12|||
163232905|NCT00813358|589562507|FG000|Overall Study|other endpoints|5|||
163232906|NCT00813358|589562507|FG000|Overall Study|Withdrawal by Subject|20|||
163232907|NCT00218543|589562508|FG000|Overall Study|Lost to Follow-up|8|||
163232908|NCT00218543|589562508|FG000|Overall Study|relocated|1|||
163232909|NCT00218543|589562508|FG000|Overall Study|Withdrawal by Subject|1|||
163232910|NCT00218543|589562508|FG000|Overall Study|Physician Decision|3|||
163232911|NCT00218543|589562508|FG000|Overall Study|Adverse Event|2|||
163232912|NCT03265119|589562509|FG000|Overall Study|Adverse Event|2|||
163232913|NCT03265119|589562510|FG001|Overall Study|Adverse Event|1|||
163232914|NCT03265119|589562509|FG000|Overall Study|Lack of Efficacy|3|||
163232915|NCT03265119|589562510|FG001|Overall Study|Lack of Efficacy|0|||
163232916|NCT03265119|589562509|FG000|Overall Study|Protocol Violation|1|||
163232917|NCT03265119|589562510|FG001|Overall Study|Protocol Violation|2|||
163232918|NCT03265119|589562509|FG000|Overall Study|Withdrawal by Subject|2|||
163232919|NCT03265119|589562510|FG001|Overall Study|Withdrawal by Subject|4|||
163232920|NCT03265119|589562509|FG000|Overall Study|Lost to Follow-up|1|||
163232921|NCT03265119|589562510|FG001|Overall Study|Lost to Follow-up|0|||
163232922|NCT03265119|589562509|FG000|Overall Study|Lack of Compliance|1|||
163232923|NCT03265119|589562510|FG001|Overall Study|Lack of Compliance|0|||
163232924|NCT04740034|589562511|FG000|Overall Study|Death|0|||
163232925|NCT04740034|589562512|FG001|Overall Study|Death|1|||
163232926|NCT04740034|589562513|FG002|Overall Study|Death|2|||
163232927|NCT04740034|589562514|FG003|Overall Study|Death|3|||
163232928|NCT04740034|589562515|FG004|Overall Study|Death|4|||
163232929|NCT04740034|589562516|FG005|Overall Study|Death|4|||
163232930|NCT04740034|589562517|FG006|Overall Study|Death|2|||
163232931|NCT04740034|589562518|FG007|Overall Study|Death|2|||
163232932|NCT04740034|589562519|FG008|Overall Study|Death|2|||
163232933|NCT04740034|589562520|FG009|Overall Study|Death|4|||
163232934|NCT04740034|589562521|FG010|Overall Study|Death|0|||
163232935|NCT04740034|589562511|FG000|Overall Study|Lost to Follow-up|0|||
163232936|NCT04740034|589562512|FG001|Overall Study|Lost to Follow-up|0|||
163232937|NCT04740034|589562513|FG002|Overall Study|Lost to Follow-up|0|||
163232938|NCT04740034|589562514|FG003|Overall Study|Lost to Follow-up|1|||
163232939|NCT04740034|589562515|FG004|Overall Study|Lost to Follow-up|2|||
163232940|NCT04740034|589562516|FG005|Overall Study|Lost to Follow-up|2|||
163409280|NCT01142726|590207576|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
163232941|NCT04740034|589562517|FG006|Overall Study|Lost to Follow-up|0|||
163232942|NCT04740034|589562518|FG007|Overall Study|Lost to Follow-up|0|||
163232943|NCT04740034|589562519|FG008|Overall Study|Lost to Follow-up|0|||
163232944|NCT04740034|589562520|FG009|Overall Study|Lost to Follow-up|1|||
163232945|NCT04740034|589562521|FG010|Overall Study|Lost to Follow-up|0|||
163232946|NCT04740034|589562511|FG000|Overall Study|Withdrawal by Subject|1|||
163232947|NCT04740034|589562512|FG001|Overall Study|Withdrawal by Subject|0|||
163232948|NCT04740034|589562513|FG002|Overall Study|Withdrawal by Subject|0|||
163232949|NCT04740034|589562514|FG003|Overall Study|Withdrawal by Subject|0|||
163232950|NCT04740034|589562515|FG004|Overall Study|Withdrawal by Subject|0|||
163232951|NCT04740034|589562516|FG005|Overall Study|Withdrawal by Subject|0|||
163232952|NCT04740034|589562517|FG006|Overall Study|Withdrawal by Subject|0|||
163232953|NCT04740034|589562518|FG007|Overall Study|Withdrawal by Subject|1|||
163409281|NCT01142726|590207577|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
163409282|NCT01142726|590207575|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
163409283|NCT01142726|590207576|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
163409284|NCT01142726|590207577|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
163409285|NCT01142726|590207575|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
163409286|NCT01142726|590207576|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
163409287|NCT01142726|590207577|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
163409288|NCT01142726|590207575|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
163409289|NCT01142726|590207576|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
163409290|NCT01142726|590207577|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
163409291|NCT01142726|590207575|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
163409292|NCT01142726|590207576|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
163409293|NCT01142726|590207577|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
163409294|NCT01142726|590207575|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
163347192|NCT02382406|589979400|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
163347193|NCT02382406|589979401|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
163347194|NCT02382406|589979402|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
163347195|NCT02382406|589979400|FG000|Study Treatment|symptomatic deterioration|1|||
163347196|NCT02382406|589979401|FG001|Study Treatment|symptomatic deterioration|0|||
163347197|NCT02382406|589979402|FG002|Study Treatment|symptomatic deterioration|1|||
163347198|NCT02382406|589979400|FG000|Study Treatment|Death|0|||
163347199|NCT02382406|589979401|FG001|Study Treatment|Death|0|||
163347200|NCT02382406|589979402|FG002|Study Treatment|Death|2|||
163347201|NCT02382406|589979400|FG000|Follow up|Death|11|||
163347202|NCT02382406|589979401|FG001|Follow up|Death|0|||
163409295|NCT01142726|590207576|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
163409296|NCT01142726|590207577|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
163409297|NCT01142726|590207575|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
163409298|NCT01142726|590207576|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
163409299|NCT01142726|590207577|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
163409300|NCT01142726|590207575|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
163409301|NCT01142726|590207576|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
163409302|NCT01142726|590207577|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
163409303|NCT01142726|590207575|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
163409304|NCT01142726|590207576|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
163409305|NCT01142726|590207577|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
163232954|NCT04740034|589562519|FG008|Overall Study|Withdrawal by Subject|0|||
163347203|NCT02382406|589979402|FG002|Follow up|Death|19|||
163347204|NCT02382406|589979400|FG000|Follow up|Symptomatic deterioration|1|||
163347205|NCT02382406|589979401|FG001|Follow up|Symptomatic deterioration|0|||
163347206|NCT02382406|589979402|FG002|Follow up|Symptomatic deterioration|1|||
163347207|NCT02382406|589979400|FG000|Follow up|Patient Refused Follow-up|1|||
163347208|NCT02382406|589979401|FG001|Follow up|Patient Refused Follow-up|0|||
163347209|NCT02382406|589979402|FG002|Follow up|Patient Refused Follow-up|0|||
163347210|NCT02382406|589979400|FG000|Follow up|Study Terminated|1|||
163347211|NCT02382406|589979401|FG001|Follow up|Study Terminated|0|||
163347212|NCT02382406|589979402|FG002|Follow up|Study Terminated|8|||
163347213|NCT02382406|589979400|FG000|Follow up|Withdrawal by Subject|0|||
163347214|NCT02382406|589979401|FG001|Follow up|Withdrawal by Subject|0|||
163347215|NCT02382406|589979402|FG002|Follow up|Withdrawal by Subject|2|||
163347216|NCT01713998|589979403|FG000|Overall Study|Lost to Follow-up|2|||
163347217|NCT01713998|589979404|FG001|Overall Study|Lost to Follow-up|0|||
163347218|NCT01713998|589979405|FG002|Overall Study|Lost to Follow-up|2|||
163232955|NCT04740034|589562520|FG009|Overall Study|Withdrawal by Subject|1|||
163232956|NCT04740034|589562521|FG010|Overall Study|Withdrawal by Subject|0|||
163232957|NCT04740034|589562511|FG000|Overall Study|Decision by sponsor|0|||
163232958|NCT04740034|589562512|FG001|Overall Study|Decision by sponsor|0|||
163232959|NCT04740034|589562513|FG002|Overall Study|Decision by sponsor|1|||
163232960|NCT04740034|589562514|FG003|Overall Study|Decision by sponsor|0|||
163232961|NCT04740034|589562515|FG004|Overall Study|Decision by sponsor|0|||
163232962|NCT04740034|589562516|FG005|Overall Study|Decision by sponsor|0|||
163232963|NCT04740034|589562517|FG006|Overall Study|Decision by sponsor|1|||
163347219|NCT01713998|589979403|FG000|Overall Study|Withdrawal by Subject|1|||
163347220|NCT01713998|589979404|FG001|Overall Study|Withdrawal by Subject|0|||
163347221|NCT01713998|589979405|FG002|Overall Study|Withdrawal by Subject|0|||
163347222|NCT00125853|589979406|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
163347223|NCT00125853|589979407|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
163347224|NCT00050167|589979413|FG000|Overall Study|not eligible not invasive|1|||
163347225|NCT00050167|589979414|FG001|Overall Study|not eligible not invasive|1|||
163347226|NCT01363297|589979415|FG000|Overall Study|Other|0|||
163347227|NCT01363297|589979416|FG001|Overall Study|Other|0|||
163347228|NCT01363297|589979417|FG002|Overall Study|Other|0|||
163232964|NCT04740034|589562518|FG007|Overall Study|Decision by sponsor|2|||
163347229|NCT01363297|589979418|FG003|Overall Study|Other|0|||
163347230|NCT01363297|589979419|FG004|Overall Study|Other|1|||
163347231|NCT01363297|589979415|FG000|Overall Study|Death|3|||
163347232|NCT01363297|589979416|FG001|Overall Study|Death|6|||
163347233|NCT01363297|589979417|FG002|Overall Study|Death|6|||
163347234|NCT01363297|589979418|FG003|Overall Study|Death|10|||
163347235|NCT01363297|589979419|FG004|Overall Study|Death|30|||
163347236|NCT02038803|589979420|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
163347237|NCT02038803|589979420|FG000|Overall Study|Lost to Follow-up|1|||
163347238|NCT04754594|589979421|FG000|Blinded Period|Withdrawal by Subject|4|||
163347239|NCT04754594|589979422|FG001|Blinded Period|Withdrawal by Subject|9|||
163139508|NCT01695135|589219902|FG001|Double-blind Treatment Phase|Physician Decision|3|||
163139509|NCT01695135|589219903|FG002|Double-blind Treatment Phase|Physician Decision|0|||
163139510|NCT01695135|589219904|FG003|Double-blind Treatment Phase|Physician Decision|0|||
163139511|NCT01695135|589219901|FG000|Double-blind Treatment Phase|Death|1|||
163139512|NCT01695135|589219902|FG001|Double-blind Treatment Phase|Death|1|||
163139513|NCT01695135|589219903|FG002|Double-blind Treatment Phase|Death|0|||
163139514|NCT01695135|589219904|FG003|Double-blind Treatment Phase|Death|0|||
163139515|NCT01695135|589219901|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
163139516|NCT01695135|589219902|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
163139517|NCT01695135|589219903|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
163139518|NCT01695135|589219904|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
163139519|NCT01695135|589219901|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
163139520|NCT01695135|589219902|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
163139521|NCT01695135|589219903|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
163139522|NCT01695135|589219904|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
163139523|NCT01695135|589219901|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
163139524|NCT01695135|589219902|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
163139525|NCT01695135|589219903|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
163139526|NCT01695135|589219904|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
163139527|NCT01695135|589219901|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
163139528|NCT01695135|589219902|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
163139529|NCT01695135|589219903|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
163139530|NCT01695135|589219904|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
163139531|NCT01695135|589219901|FG000|Open Label Extension Treatment Phase|Other|0|||
163139532|NCT01695135|589219902|FG001|Open Label Extension Treatment Phase|Other|0|||
163139533|NCT01695135|589219903|FG002|Open Label Extension Treatment Phase|Other|4|||
163139534|NCT01695135|589219904|FG003|Open Label Extension Treatment Phase|Other|7|||
163139535|NCT01695135|589219901|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
163139536|NCT01695135|589219902|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
163139537|NCT01695135|589219903|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
163139538|NCT01695135|589219904|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
163139539|NCT01695135|589219901|FG000|Open Label Extension Treatment Phase|Death|0|||
163139540|NCT01695135|589219902|FG001|Open Label Extension Treatment Phase|Death|0|||
163139541|NCT01695135|589219903|FG002|Open Label Extension Treatment Phase|Death|2|||
163139542|NCT01695135|589219904|FG003|Open Label Extension Treatment Phase|Death|7|||
163139543|NCT01695135|589219901|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
163139544|NCT01695135|589219902|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
163139545|NCT01695135|589219903|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
163139546|NCT01695135|589219904|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
163139547|NCT00580723|589219910|FG000|Overall Study|Did not want to participate in extension|3|||
163139548|NCT00580723|589219910|FG000|Overall Study|Lost to Follow-up|5|||
163139549|NCT00684996|589219911|FG000|Overall Study|Adverse Event|1|||
163139550|NCT00684996|589219911|FG000|Overall Study|Refusal unrelated to adverse event|1|||
163139551|NCT00684996|589219911|FG000|Overall Study|Progression/relapse|2|||
163139552|NCT00684996|589219911|FG000|Overall Study|Other reasons not protocol specified|1|||
163139553|NCT02519439|589219914|FG000|Overall Study|Study Termination|19|||
163139554|NCT02519439|589219914|FG000|Overall Study|Withdrawal by Subject|1|||
163139555|NCT02519439|589219914|FG000|Overall Study|Adverse Event|1|||
163139556|NCT03030417|589219921|FG000|Dose Expansion|Disease progression before treatment|0|||
163139557|NCT03030417|589219922|FG001|Dose Expansion|Disease progression before treatment|0|||
163139558|NCT03030417|589219923|FG002|Dose Expansion|Disease progression before treatment|0|||
163139559|NCT03030417|589219924|FG003|Dose Expansion|Disease progression before treatment|0|||
163139560|NCT03030417|589219925|FG004|Dose Expansion|Disease progression before treatment|0|||
163139561|NCT03030417|589219926|FG005|Dose Expansion|Disease progression before treatment|0|||
163139562|NCT03030417|589219927|FG006|Dose Expansion|Disease progression before treatment|0|||
163347240|NCT04754594|589979423|FG002|Blinded Period|Withdrawal by Subject|0|||
163347241|NCT04754594|589979424|FG003|Blinded Period|Withdrawal by Subject|0|||
163347242|NCT04754594|589979421|FG000|Blinded Period|Protocol Violation|2|||
163232965|NCT04740034|589562519|FG008|Overall Study|Decision by sponsor|1|||
163232966|NCT04740034|589562520|FG009|Overall Study|Decision by sponsor|1|||
163232967|NCT04740034|589562521|FG010|Overall Study|Decision by sponsor|2|||
163232968|NCT00600821|589564149|FG000|Overall Study|Death|45|||
163232969|NCT00600821|589564150|FG001|Overall Study|Death|46|||
163232970|NCT00600821|589564149|FG000|Overall Study|Lost to Follow-up|2|||
163232971|NCT00600821|589564150|FG001|Overall Study|Lost to Follow-up|2|||
163232972|NCT00600821|589564149|FG000|Overall Study|Withdrawal by Subject|1|||
163232973|NCT00600821|589564150|FG001|Overall Study|Withdrawal by Subject|1|||
163232974|NCT00600821|589564149|FG000|Overall Study|Terminated by sponsor|8|||
163232975|NCT00600821|589564150|FG001|Overall Study|Terminated by sponsor|6|||
163232976|NCT00600821|589564149|FG000|Overall Study|Objective progression or relapse|0|||
163232977|NCT00600821|589564150|FG001|Overall Study|Objective progression or relapse|1|||
163232978|NCT00600821|589564149|FG000|Overall Study|Randomized but not treated|0|||
163232979|NCT00600821|589564150|FG001|Overall Study|Randomized but not treated|1|||
163232980|NCT00600821|589564149|FG000|Overall Study|Other|2|||
163232981|NCT00600821|589564150|FG001|Overall Study|Other|3|||
163232982|NCT02602288|589564153|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
163232983|NCT02602288|589564154|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
163232984|NCT02602288|589564153|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
163232985|NCT02602288|589564154|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
163232986|NCT02602288|589564153|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
163232987|NCT02602288|589564154|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
163232988|NCT02602288|589564153|FG000|12 Month Follow-up|Lost to Follow-up|0|||
163232989|NCT02602288|589564154|FG001|12 Month Follow-up|Lost to Follow-up|4|||
163232990|NCT02602288|589564153|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
163232991|NCT02602288|589564154|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
163232992|NCT01310413|589564155|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
163232993|NCT01310413|589564156|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
163232994|NCT01310413|589564157|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
163232995|NCT01310413|589564158|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
163232996|NCT01310413|589564159|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
163232997|NCT01310413|589564160|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
163232998|NCT01310413|589564161|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
163232999|NCT01310413|589564155|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
163233000|NCT01310413|589564156|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
163233001|NCT01310413|589564157|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
163233002|NCT01310413|589564158|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
163233003|NCT01310413|589564159|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
163233004|NCT01310413|589564160|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
163233005|NCT01310413|589564161|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
163233006|NCT01310413|589564155|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
163233007|NCT01310413|589564156|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
163233008|NCT01310413|589564157|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
163233009|NCT01310413|589564158|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
163233010|NCT01310413|589564159|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
163233011|NCT01310413|589564160|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
163233012|NCT01310413|589564161|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
163233013|NCT01310413|589564155|FG000|Day 0 to Day 385|Other|1|||
163233014|NCT01310413|589564156|FG001|Day 0 to Day 385|Other|0|||
163233015|NCT01310413|589564157|FG002|Day 0 to Day 385|Other|3|||
163233016|NCT01310413|589564158|FG003|Day 0 to Day 385|Other|0|||
163233017|NCT01310413|589564159|FG004|Day 0 to Day 385|Other|0|||
163233018|NCT01310413|589564160|FG005|Day 0 to Day 385|Other|0|||
163233019|NCT01310413|589564161|FG006|Day 0 to Day 385|Other|0|||
163233020|NCT01310413|589564155|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
163233021|NCT01310413|589564156|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
163233022|NCT01310413|589564157|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
163233023|NCT01310413|589564158|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
163233024|NCT01310413|589564159|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
163233025|NCT01310413|589564160|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
163233026|NCT01310413|589564161|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
163233027|NCT01310413|589564155|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
163233028|NCT01310413|589564156|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
163233029|NCT01310413|589564157|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
163233030|NCT01310413|589564158|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
163233031|NCT01310413|589564159|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
163233032|NCT01310413|589564160|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
163233033|NCT01310413|589564161|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
163233034|NCT01076400|589564163|FG000|Overall Study|Adverse Event|2|||
163233035|NCT01076400|589564164|FG001|Overall Study|Adverse Event|0|||
163233036|NCT01076400|589564165|FG002|Overall Study|Adverse Event|0|||
163233037|NCT01076400|589564163|FG000|Overall Study|Progressive Disease|5|||
163233038|NCT01076400|589564164|FG001|Overall Study|Progressive Disease|0|||
163233039|NCT01076400|589564165|FG002|Overall Study|Progressive Disease|0|||
163233040|NCT02066298|589564168|FG000|Overall Study|Lost to Follow-up|3|||
163233041|NCT02066298|589564169|FG001|Overall Study|Lost to Follow-up|2|||
163233042|NCT02066298|589564170|FG002|Overall Study|Lost to Follow-up|3|||
163233043|NCT02066298|589564171|FG003|Overall Study|Lost to Follow-up|2|||
163233044|NCT02066298|589564172|FG004|Overall Study|Lost to Follow-up|3|||
163233045|NCT02066298|589564173|FG005|Overall Study|Lost to Follow-up|4|||
163233046|NCT02066298|589564168|FG000|Overall Study|Withdrawal by Subject|6|||
163233047|NCT02066298|589564169|FG001|Overall Study|Withdrawal by Subject|6|||
163233048|NCT02066298|589564170|FG002|Overall Study|Withdrawal by Subject|6|||
163233049|NCT02066298|589564171|FG003|Overall Study|Withdrawal by Subject|4|||
163233050|NCT02066298|589564172|FG004|Overall Study|Withdrawal by Subject|5|||
163233051|NCT02066298|589564173|FG005|Overall Study|Withdrawal by Subject|8|||
163233052|NCT02066298|589564168|FG000|Overall Study|Physician Decision|0|||
163233053|NCT02066298|589564169|FG001|Overall Study|Physician Decision|0|||
163233054|NCT02066298|589564170|FG002|Overall Study|Physician Decision|1|||
163233055|NCT02066298|589564171|FG003|Overall Study|Physician Decision|0|||
163233056|NCT02066298|589564172|FG004|Overall Study|Physician Decision|1|||
163233057|NCT02066298|589564173|FG005|Overall Study|Physician Decision|0|||
163233058|NCT01643473|589564174|FG000|Overall Study|Lost to Follow-up|1|||
163233059|NCT01643473|589564175|FG001|Overall Study|Lost to Follow-up|0|||
163233060|NCT01519518|589564176|FG000|Overall Study|Consent not available|7|||
163233061|NCT01519518|589564177|FG001|Overall Study|Consent not available|10|||
163233062|NCT01265953|589564183|FG000|Overall Study|Non compliance|5|||
163233063|NCT01265953|589564184|FG001|Overall Study|Non compliance|3|||
163233064|NCT00182689|589564185|FG000|Overall Study|Adverse Event|8|||
163233065|NCT00182689|589564186|FG001|Overall Study|Adverse Event|11|||
163233066|NCT00182689|589564185|FG000|Overall Study|Withdrawal by Subject|2|||
163233067|NCT00182689|589564186|FG001|Overall Study|Withdrawal by Subject|2|||
163233068|NCT00182689|589564185|FG000|Overall Study|Progression|27|||
163233069|NCT00182689|589564186|FG001|Overall Study|Progression|29|||
163233070|NCT00182689|589564185|FG000|Overall Study|Death|1|||
163233071|NCT00182689|589564186|FG001|Overall Study|Death|0|||
163233072|NCT00182689|589564185|FG000|Overall Study|not protocol specified|0|||
163233073|NCT00182689|589564186|FG001|Overall Study|not protocol specified|3|||
163233074|NCT00182689|589564185|FG000|Overall Study|Ineligible|1|||
163233075|NCT00182689|589564186|FG001|Overall Study|Ineligible|4|||
163233076|NCT00182689|589564185|FG000|Overall Study|Never received treatment|1|||
163233077|NCT00182689|589564186|FG001|Overall Study|Never received treatment|0|||
163233078|NCT00201006|589564188|FG000|Overall Study|Withdrawal by Subject|7|||
163233079|NCT00201006|589564189|FG001|Overall Study|Withdrawal by Subject|2|||
163233080|NCT00201006|589564190|FG002|Overall Study|Withdrawal by Subject|3|||
163233081|NCT00201006|589564188|FG000|Overall Study|Adverse Event|1|||
163233082|NCT00201006|589564189|FG001|Overall Study|Adverse Event|0|||
163233083|NCT00201006|589564190|FG002|Overall Study|Adverse Event|1|||
163233084|NCT02148003|589564193|FG000|Overall Study|Failed inclusion criteria|1|||
163233085|NCT02148003|589564194|FG001|Overall Study|Failed inclusion criteria|0|||
163233086|NCT02148003|589564193|FG000|Overall Study|Met exclusion criteria|0|||
163233087|NCT02148003|589564194|FG001|Overall Study|Met exclusion criteria|1|||
163233088|NCT02148003|589564193|FG000|Overall Study|Withdrawal by Subject|0|||
163233089|NCT02148003|589564194|FG001|Overall Study|Withdrawal by Subject|1|||
163233090|NCT02039427|589564195|FG000|Overall Study|Duration of surgery > 3h|1|||
163233091|NCT02039427|589564196|FG001|Overall Study|Duration of surgery > 3h|1|||
163233092|NCT02039427|589564197|FG002|Overall Study|Duration of surgery > 3h|0|||
163233093|NCT02039427|589564198|FG003|Overall Study|Duration of surgery > 3h|0|||
163233094|NCT02039427|589564195|FG000|Overall Study|Withdrawal on concent|0|||
163347243|NCT04754594|589979422|FG001|Blinded Period|Protocol Violation|2|||
163347244|NCT04754594|589979423|FG002|Blinded Period|Protocol Violation|0|||
163347245|NCT04754594|589979424|FG003|Blinded Period|Protocol Violation|0|||
163347246|NCT04754594|589979421|FG000|Blinded Period|Lost to Follow-up|1|||
163347247|NCT04754594|589979422|FG001|Blinded Period|Lost to Follow-up|1|||
163347248|NCT04754594|589979423|FG002|Blinded Period|Lost to Follow-up|0|||
163347249|NCT04754594|589979424|FG003|Blinded Period|Lost to Follow-up|0|||
163347250|NCT04754594|589979421|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
163347251|NCT04754594|589979422|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
163347252|NCT04754594|589979423|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
163233095|NCT02039427|589564196|FG001|Overall Study|Withdrawal on concent|0|||
163233096|NCT02039427|589564197|FG002|Overall Study|Withdrawal on concent|0|||
163233097|NCT02039427|589564198|FG003|Overall Study|Withdrawal on concent|1|||
163233098|NCT02039427|589564195|FG000|Overall Study|Cancellation of surgery|0|||
163233099|NCT02039427|589564196|FG001|Overall Study|Cancellation of surgery|0|||
163233100|NCT02039427|589564197|FG002|Overall Study|Cancellation of surgery|1|||
163233101|NCT02039427|589564198|FG003|Overall Study|Cancellation of surgery|0|||
163233102|NCT02039427|589564195|FG000|Overall Study|Loss of follow - up|1|||
163233103|NCT02039427|589564196|FG001|Overall Study|Loss of follow - up|0|||
163347253|NCT04754594|589979424|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
163409306|NCT01142726|590207575|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
163233104|NCT02039427|589564197|FG002|Overall Study|Loss of follow - up|2|||
163233105|NCT02039427|589564198|FG003|Overall Study|Loss of follow - up|4|||
163233106|NCT02039427|589564195|FG000|Overall Study|Steroid Use|1|||
163233107|NCT02039427|589564196|FG001|Overall Study|Steroid Use|0|||
163233108|NCT02039427|589564197|FG002|Overall Study|Steroid Use|0|||
163233109|NCT02039427|589564198|FG003|Overall Study|Steroid Use|0|||
163233110|NCT03160703|589564200|FG000|Overall Study|Withdrawal by Subject|0|||
163233111|NCT03160703|589564201|FG001|Overall Study|Withdrawal by Subject|0|||
163233112|NCT03160703|589564202|FG002|Overall Study|Withdrawal by Subject|0|||
163233113|NCT03160703|589564203|FG003|Overall Study|Withdrawal by Subject|1|||
163233114|NCT00087568|589564204|FG000|Overall Study|Adverse Event|4|||
163233115|NCT00087568|589564205|FG001|Overall Study|Adverse Event|0|||
163233116|NCT00087568|589564204|FG000|Overall Study|Withdrawal by Subject|1|||
163233117|NCT00087568|589564205|FG001|Overall Study|Withdrawal by Subject|1|||
163233118|NCT00087568|589564204|FG000|Overall Study|Lost to Follow-up|1|||
163233119|NCT00087568|589564205|FG001|Overall Study|Lost to Follow-up|0|||
163233120|NCT00087568|589564204|FG000|Overall Study|Lack of Efficacy|24|||
163233121|NCT00087568|589564205|FG001|Overall Study|Lack of Efficacy|1|||
163233122|NCT03728582|589564210|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
163233123|NCT03728582|589564211|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
163233124|NCT03728582|589564210|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
163233125|NCT03728582|589564211|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
163347254|NCT04754594|589979421|FG000|Unblinded Period|Withdrawal by Subject|6|||
163347255|NCT04754594|589979422|FG001|Unblinded Period|Withdrawal by Subject|8|||
163347256|NCT04754594|589979423|FG002|Unblinded Period|Withdrawal by Subject|0|||
163347257|NCT04754594|589979424|FG003|Unblinded Period|Withdrawal by Subject|0|||
163233126|NCT02992899|589564212|FG000|Overall Study|Withdrawal by Subject|1|||
163233127|NCT02992899|589564213|FG001|Overall Study|Withdrawal by Subject|0|||
163233128|NCT02992899|589564212|FG000|Overall Study|Lost to Follow-up|1|||
163233129|NCT02992899|589564213|FG001|Overall Study|Lost to Follow-up|3|||
163233130|NCT02738775|589564214|FG000|Overall Study|Withdrawal by Subject|0|||
163233131|NCT02738775|589564215|FG001|Overall Study|Withdrawal by Subject|1|||
163233132|NCT02738775|589564216|FG002|Overall Study|Withdrawal by Subject|0|||
163233133|NCT02738775|589564217|FG003|Overall Study|Withdrawal by Subject|0|||
163233134|NCT02738775|589564218|FG004|Overall Study|Withdrawal by Subject|0|||
163233135|NCT02738775|589564219|FG005|Overall Study|Withdrawal by Subject|0|||
163233136|NCT02738775|589564214|FG000|Overall Study|Adverse Event|0|||
163233137|NCT02738775|589564215|FG001|Overall Study|Adverse Event|0|||
163233138|NCT02738775|589564216|FG002|Overall Study|Adverse Event|0|||
163233139|NCT02738775|589564217|FG003|Overall Study|Adverse Event|1|||
163233140|NCT02738775|589564218|FG004|Overall Study|Adverse Event|0|||
163233141|NCT02738775|589564219|FG005|Overall Study|Adverse Event|0|||
163233142|NCT02738775|589564214|FG000|Overall Study|Pregnancy|0|||
163233143|NCT02738775|589564215|FG001|Overall Study|Pregnancy|1|||
163233144|NCT02738775|589564216|FG002|Overall Study|Pregnancy|0|||
163233145|NCT02738775|589564217|FG003|Overall Study|Pregnancy|0|||
163233146|NCT02738775|589564218|FG004|Overall Study|Pregnancy|0|||
163233147|NCT02738775|589564219|FG005|Overall Study|Pregnancy|0|||
163233148|NCT02738775|589564214|FG000|Overall Study|Missing|0|||
163233149|NCT02738775|589564215|FG001|Overall Study|Missing|0|||
163233150|NCT02738775|589564216|FG002|Overall Study|Missing|0|||
163233151|NCT02738775|589564217|FG003|Overall Study|Missing|0|||
163233152|NCT02738775|589564218|FG004|Overall Study|Missing|0|||
163233153|NCT02738775|589564219|FG005|Overall Study|Missing|1|||
163233154|NCT02370888|589564220|FG000|Overall Study|disease progression|2|||
163233155|NCT02370888|589564220|FG000|Overall Study|did not meet chimerism criteria|6|||
163233156|NCT00047463|589564221|FG000|Overall Study|Withdrawal by Subject|0|||
163233157|NCT00047463|589564222|FG001|Overall Study|Withdrawal by Subject|3|||
163233158|NCT01824303|589564227|FG000|Randomized Study|Withdrawal by Subject|1|||
163233159|NCT01824303|589564228|FG001|Randomized Study|Withdrawal by Subject|1|||
163233160|NCT01824303|589564227|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
163233161|NCT01824303|589564228|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
163347258|NCT04754594|589979421|FG000|Unblinded Period|Lost to Follow-up|5|||
163233162|NCT03235024|589564229|FG000|Overall Study|Adverse Event|2|||
163233163|NCT03235024|589564230|FG001|Overall Study|Adverse Event|2|||
163233164|NCT03235024|589564229|FG000|Overall Study|Death|1|||
163233165|NCT03235024|589564230|FG001|Overall Study|Death|0|||
163233166|NCT03235024|589564229|FG000|Overall Study|Lost to Follow-up|2|||
163233167|NCT03235024|589564230|FG001|Overall Study|Lost to Follow-up|5|||
163233168|NCT03235024|589564229|FG000|Overall Study|Protocol Violation|1|||
163233169|NCT03235024|589564230|FG001|Overall Study|Protocol Violation|0|||
163233170|NCT03235024|589564229|FG000|Overall Study|Withdrawal by Subject|0|||
163233171|NCT03235024|589564230|FG001|Overall Study|Withdrawal by Subject|3|||
163233172|NCT02357576|589564231|FG000|Treatment Period|Withdrawal by Subject|0|||
163233173|NCT02357576|589564232|FG001|Treatment Period|Withdrawal by Subject|1|||
163233174|NCT02357576|589564231|FG000|Treatment Period|Physician Decision|0|||
163233175|NCT02357576|589564232|FG001|Treatment Period|Physician Decision|1|||
163233176|NCT02357576|589564231|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
163233177|NCT02357576|589564232|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
163139563|NCT03030417|589219928|FG007|Dose Expansion|Disease progression before treatment|0|||
163139564|NCT03030417|589219929|FG008|Dose Expansion|Disease progression before treatment|0|||
163139565|NCT03030417|589219930|FG009|Dose Expansion|Disease progression before treatment|0|||
163139566|NCT03030417|589219931|FG010|Dose Expansion|Disease progression before treatment|0|||
163139567|NCT03030417|589219932|FG011|Dose Expansion|Disease progression before treatment|0|||
163139568|NCT03030417|589219933|FG012|Dose Expansion|Disease progression before treatment|1|||
163139569|NCT01078441|589219934|FG000|Overall Study|Withdrawal by Subject|1|||
163139570|NCT00216671|589219935|FG000|Overall Study|Adverse Event|4|||
163139571|NCT00216671|589219936|FG001|Overall Study|Adverse Event|9|||
163139572|NCT00216671|589219935|FG000|Overall Study|Pregnancy|0|||
163139573|NCT00216671|589219936|FG001|Overall Study|Pregnancy|1|||
163139574|NCT00216671|589219935|FG000|Overall Study|Withdrawal by Subject|4|||
163139575|NCT00216671|589219936|FG001|Overall Study|Withdrawal by Subject|2|||
163139576|NCT00216671|589219935|FG000|Overall Study|Refused Injections|3|||
163139577|NCT00216671|589219936|FG001|Overall Study|Refused Injections|13|||
163139578|NCT00216671|589219935|FG000|Overall Study|No Need to Continue Medication|1|||
163139579|NCT00216671|589219936|FG001|Overall Study|No Need to Continue Medication|1|||
163139580|NCT00216671|589219935|FG000|Overall Study|Insufficient Response|9|||
163139581|NCT00216671|589219936|FG001|Overall Study|Insufficient Response|4|||
163139582|NCT00216671|589219935|FG000|Overall Study|Lost to Follow-up|3|||
163139583|NCT00216671|589219936|FG001|Overall Study|Lost to Follow-up|5|||
163139584|NCT00216671|589219935|FG000|Overall Study|Non compliant|2|||
163139585|NCT00216671|589219936|FG001|Overall Study|Non compliant|2|||
163139586|NCT00216671|589219935|FG000|Overall Study|Ineligible|0|||
163139587|NCT00216671|589219936|FG001|Overall Study|Ineligible|2|||
163139588|NCT00216671|589219935|FG000|Overall Study|Physician Decision|1|||
163139589|NCT00216671|589219936|FG001|Overall Study|Physician Decision|1|||
163139590|NCT00216671|589219935|FG000|Overall Study|Protocol Violation|3|||
163139591|NCT00216671|589219936|FG001|Overall Study|Protocol Violation|5|||
163139592|NCT00216671|589219935|FG000|Overall Study|Relapse|1|||
163139593|NCT00216671|589219936|FG001|Overall Study|Relapse|0|||
163139594|NCT00216671|589219935|FG000|Overall Study|Investigator Illness|0|||
163139595|NCT00216671|589219936|FG001|Overall Study|Investigator Illness|1|||
163139596|NCT00216671|589219935|FG000|Overall Study|Patient Moved|0|||
163139597|NCT00216671|589219936|FG001|Overall Study|Patient Moved|1|||
163139598|NCT00216671|589219935|FG000|Overall Study|Ineligible, no efficacy data|2|||
163139599|NCT00216671|589219936|FG001|Overall Study|Ineligible, no efficacy data|2|||
163139600|NCT00216671|589219935|FG000|Overall Study|Insufficient Response Adverse Event|2|||
163139601|NCT00216671|589219936|FG001|Overall Study|Insufficient Response Adverse Event|1|||
163139602|NCT02714569|589219937|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
163139603|NCT02714569|589219938|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
163139604|NCT02714569|589219939|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
163139605|NCT02714569|589219940|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
163139606|NCT02714569|589219941|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
163139607|NCT02714569|589219942|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
163139608|NCT02714569|589219943|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
163139609|NCT02714569|589219944|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
163139610|NCT02714569|589219945|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
163139611|NCT02714569|589219946|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
163139612|NCT02714569|589219947|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
163139613|NCT02714569|589219937|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139614|NCT02714569|589219938|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139615|NCT02714569|589219939|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139616|NCT02714569|589219940|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
163139617|NCT02714569|589219941|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139618|NCT02714569|589219942|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139619|NCT02714569|589219943|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139620|NCT02714569|589219944|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139621|NCT02714569|589219945|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139622|NCT02714569|589219946|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139623|NCT02714569|589219947|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139624|NCT02714569|589219937|FG000|Part A Third Intervention|Adverse Event|0|||
163139625|NCT02714569|589219938|FG001|Part A Third Intervention|Adverse Event|0|||
163139626|NCT02714569|589219939|FG002|Part A Third Intervention|Adverse Event|1|||
163139627|NCT02714569|589219940|FG003|Part A Third Intervention|Adverse Event|0|||
163139628|NCT02714569|589219941|FG004|Part A Third Intervention|Adverse Event|0|||
163139629|NCT02714569|589219942|FG005|Part A Third Intervention|Adverse Event|0|||
163139630|NCT02714569|589219943|FG006|Part A Third Intervention|Adverse Event|0|||
163139631|NCT02714569|589219944|FG007|Part A Third Intervention|Adverse Event|0|||
163139632|NCT02714569|589219945|FG008|Part A Third Intervention|Adverse Event|0|||
163139633|NCT02714569|589219946|FG009|Part A Third Intervention|Adverse Event|0|||
163139634|NCT02714569|589219947|FG010|Part A Third Intervention|Adverse Event|0|||
163139635|NCT02714569|589219937|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
163139636|NCT02714569|589219938|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139637|NCT02714569|589219939|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139638|NCT02714569|589219940|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139639|NCT02714569|589219941|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139640|NCT02714569|589219942|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
163139641|NCT02714569|589219943|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139642|NCT02714569|589219944|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139643|NCT02714569|589219945|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139644|NCT02714569|589219946|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139645|NCT02714569|589219947|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139646|NCT02714569|589219937|FG000|Part B (Overall)|Lost to Follow-up|0|||
163139647|NCT02714569|589219938|FG001|Part B (Overall)|Lost to Follow-up|0|||
163139648|NCT02714569|589219939|FG002|Part B (Overall)|Lost to Follow-up|0|||
163139649|NCT02714569|589219940|FG003|Part B (Overall)|Lost to Follow-up|0|||
163139650|NCT02714569|589219941|FG004|Part B (Overall)|Lost to Follow-up|0|||
163139651|NCT02714569|589219942|FG005|Part B (Overall)|Lost to Follow-up|0|||
163139652|NCT02714569|589219943|FG006|Part B (Overall)|Lost to Follow-up|1|||
163139653|NCT02714569|589219944|FG007|Part B (Overall)|Lost to Follow-up|0|||
163139654|NCT02714569|589219945|FG008|Part B (Overall)|Lost to Follow-up|0|||
163139655|NCT02714569|589219946|FG009|Part B (Overall)|Lost to Follow-up|0|||
163139656|NCT02714569|589219947|FG010|Part B (Overall)|Lost to Follow-up|0|||
163139657|NCT02714569|589219937|FG000|Part B (Overall)|Withdrawal by Subject|0|||
163139658|NCT02714569|589219938|FG001|Part B (Overall)|Withdrawal by Subject|0|||
163139659|NCT02714569|589219939|FG002|Part B (Overall)|Withdrawal by Subject|0|||
163139660|NCT02714569|589219940|FG003|Part B (Overall)|Withdrawal by Subject|0|||
163139661|NCT02714569|589219941|FG004|Part B (Overall)|Withdrawal by Subject|0|||
163139662|NCT02714569|589219942|FG005|Part B (Overall)|Withdrawal by Subject|0|||
163139663|NCT02714569|589219943|FG006|Part B (Overall)|Withdrawal by Subject|0|||
163139664|NCT02714569|589219944|FG007|Part B (Overall)|Withdrawal by Subject|1|||
163139665|NCT02714569|589219945|FG008|Part B (Overall)|Withdrawal by Subject|0|||
163139666|NCT02714569|589219946|FG009|Part B (Overall)|Withdrawal by Subject|1|||
163139667|NCT02714569|589219947|FG010|Part B (Overall)|Withdrawal by Subject|0|||
163139668|NCT02714569|589219937|FG000|Part B (Overall)|Adverse Event|0|||
163139669|NCT02714569|589219938|FG001|Part B (Overall)|Adverse Event|0|||
163139670|NCT02714569|589219939|FG002|Part B (Overall)|Adverse Event|0|||
163139671|NCT02714569|589219940|FG003|Part B (Overall)|Adverse Event|0|||
163139672|NCT02714569|589219941|FG004|Part B (Overall)|Adverse Event|0|||
163139673|NCT02714569|589219942|FG005|Part B (Overall)|Adverse Event|0|||
163139674|NCT02714569|589219943|FG006|Part B (Overall)|Adverse Event|0|||
163139675|NCT02714569|589219944|FG007|Part B (Overall)|Adverse Event|0|||
163139676|NCT02714569|589219945|FG008|Part B (Overall)|Adverse Event|0|||
163139677|NCT02714569|589219946|FG009|Part B (Overall)|Adverse Event|1|||
163139678|NCT02714569|589219947|FG010|Part B (Overall)|Adverse Event|0|||
163139679|NCT01684202|589219948|FG000|Dose-escalation Period|Adverse Event|0|||
163139680|NCT01684202|589219949|FG001|Dose-escalation Period|Adverse Event|1|||
163139681|NCT01684202|589219950|FG002|Dose-escalation Period|Adverse Event|0|||
163139682|NCT01684202|589219951|FG003|Dose-escalation Period|Adverse Event|0|||
163139683|NCT01684202|589219948|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
163139684|NCT01684202|589219949|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
163139685|NCT01684202|589219950|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
163139686|NCT01684202|589219951|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
163139687|NCT01684202|589219948|FG000|Maintenance Period|Adverse Event|1|||
163139688|NCT01684202|589219949|FG001|Maintenance Period|Adverse Event|1|||
163139689|NCT01684202|589219950|FG002|Maintenance Period|Adverse Event|1|||
163139690|NCT01684202|589219951|FG003|Maintenance Period|Adverse Event|1|||
163139691|NCT01684202|589219948|FG000|Maintenance Period|Physician Decision|0|||
163139692|NCT01684202|589219949|FG001|Maintenance Period|Physician Decision|1|||
163139693|NCT01684202|589219950|FG002|Maintenance Period|Physician Decision|0|||
163139694|NCT01684202|589219951|FG003|Maintenance Period|Physician Decision|0|||
163139695|NCT01684202|589219948|FG000|Maintenance Period|Withdrawal by Subject|0|||
163139696|NCT01684202|589219949|FG001|Maintenance Period|Withdrawal by Subject|1|||
163139697|NCT01684202|589219950|FG002|Maintenance Period|Withdrawal by Subject|0|||
163139698|NCT01684202|589219951|FG003|Maintenance Period|Withdrawal by Subject|0|||
163139699|NCT00191308|589219952|FG000|Overall Study|Adverse Event|1|||
163139700|NCT00779025|589219953|FG000|Overall Study|Withdrawal by Subject|1|||
163139701|NCT01970306|589219957|FG000|Overall Study|Not eligible|3|||
163139702|NCT01970306|589219957|FG000|Overall Study|Not able to be treated|9|||
163139703|NCT02741635|589219958|FG000|Overall Study|Withdrawal by Subject|1|||
163139704|NCT01427933|589219959|FG000|Overall Study|Withdrawal by Subject|5|||
163139705|NCT01427933|589219960|FG001|Overall Study|Withdrawal by Subject|8|||
163139706|NCT01427933|589219959|FG000|Overall Study|Lost to Follow-up|1|||
163139707|NCT01427933|589219960|FG001|Overall Study|Lost to Follow-up|5|||
163139708|NCT01427933|589219959|FG000|Overall Study|Other|1|||
163233178|NCT02357576|589564231|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
163233179|NCT02357576|589564232|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
163233180|NCT02357576|589564231|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
163233181|NCT02357576|589564232|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
163233182|NCT02357576|589564231|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
163233183|NCT02357576|589564232|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
163233184|NCT00261716|589564233|FG000|Overall Study|Withdrawal by Subject|6|||
163233185|NCT00261716|589564234|FG001|Overall Study|Withdrawal by Subject|8|||
163233186|NCT00261716|589564233|FG000|Overall Study|Lost to Follow-up|0|||
163233187|NCT00261716|589564234|FG001|Overall Study|Lost to Follow-up|2|||
163233188|NCT00699699|589564237|FG000|Overall Study|Adverse Event|36|||
163233189|NCT00699699|589564237|FG000|Overall Study|Individual different reasons|21|||
163233190|NCT02047110|589564238|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
163233191|NCT02047110|589564239|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
163233192|NCT02047110|589564240|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
163233193|NCT02047110|589564241|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
163233194|NCT02047110|589564238|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
163233195|NCT02047110|589564239|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
163233196|NCT02047110|589564240|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
163233197|NCT02047110|589564241|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
163233198|NCT02047110|589564238|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
163233199|NCT02047110|589564239|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
163233200|NCT02047110|589564240|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
163233201|NCT02047110|589564241|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
163233202|NCT02047110|589564238|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
163233203|NCT02047110|589564239|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
163233204|NCT02047110|589564240|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
163233205|NCT02047110|589564241|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
163233206|NCT02047110|589564238|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
163233207|NCT02047110|589564239|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
163233208|NCT02047110|589564240|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
163233209|NCT02047110|589564241|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
163233210|NCT02047110|589564238|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
163233211|NCT02047110|589564239|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
163233212|NCT02047110|589564240|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
163233213|NCT02047110|589564241|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
163233214|NCT02047110|589564238|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
163233215|NCT02047110|589564239|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
163233216|NCT02047110|589564240|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
163233217|NCT02047110|589564241|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
163233218|NCT02047110|589564238|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
163233219|NCT02047110|589564239|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
163233220|NCT02047110|589564240|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
163233221|NCT02047110|589564241|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
163233222|NCT02047110|589564238|FG000|Escape Treatment Period|Adverse Event|1|||
163233223|NCT02047110|589564239|FG001|Escape Treatment Period|Adverse Event|2|||
163233224|NCT02047110|589564240|FG002|Escape Treatment Period|Adverse Event|2|||
163233225|NCT02047110|589564241|FG003|Escape Treatment Period|Adverse Event|0|||
163233226|NCT02047110|589564238|FG000|Escape Treatment Period|Other than specified|1|||
163233227|NCT02047110|589564239|FG001|Escape Treatment Period|Other than specified|2|||
163233228|NCT02047110|589564240|FG002|Escape Treatment Period|Other than specified|0|||
163233229|NCT02047110|589564241|FG003|Escape Treatment Period|Other than specified|1|||
163233230|NCT02047110|589564238|FG000|OLE Treatment Period|Other than specified|0|||
163233231|NCT02047110|589564239|FG001|OLE Treatment Period|Other than specified|0|||
163233232|NCT02047110|589564240|FG002|OLE Treatment Period|Other than specified|1|||
163233233|NCT02047110|589564241|FG003|OLE Treatment Period|Other than specified|0|||
163233234|NCT00705575|589564242|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163233235|NCT00705575|589564243|FG001|Overall Study|Abnormal laboratory value(s)|3|||
163233236|NCT00705575|589564242|FG000|Overall Study|Abnormal test procedure result(s)|2|||
163233237|NCT00705575|589564243|FG001|Overall Study|Abnormal test procedure result(s)|12|||
163233238|NCT00705575|589564242|FG000|Overall Study|Adverse Event|11|||
163233239|NCT00705575|589564243|FG001|Overall Study|Adverse Event|15|||
163233240|NCT00705575|589564242|FG000|Overall Study|Lost to Follow-up|3|||
163233241|NCT00705575|589564243|FG001|Overall Study|Lost to Follow-up|4|||
163233242|NCT00705575|589564242|FG000|Overall Study|Protocol Violation|2|||
163233243|NCT00705575|589564243|FG001|Overall Study|Protocol Violation|2|||
163233244|NCT00705575|589564242|FG000|Overall Study|Withdrawal by Subject|5|||
163233245|NCT00705575|589564243|FG001|Overall Study|Withdrawal by Subject|10|||
163233246|NCT01000051|589564245|FG000|Overall Study|Withdrawal by Subject|1|||
163233247|NCT01000051|589564246|FG001|Overall Study|Withdrawal by Subject|1|||
163233248|NCT01000051|589564245|FG000|Overall Study|Disease Progression|1|||
163233249|NCT01000051|589564246|FG001|Overall Study|Disease Progression|0|||
163233250|NCT01000051|589564245|FG000|Overall Study|Serious noncompliance|1|||
163233251|NCT01000051|589564246|FG001|Overall Study|Serious noncompliance|0|||
163233252|NCT02170727|589564247|FG000|Overall Study|Lost to Follow-up|1|||
163233253|NCT02170727|589564248|FG001|Overall Study|Lost to Follow-up|0|||
163233254|NCT02170727|589564247|FG000|Overall Study|Withdrawal by Subject|2|||
163233255|NCT02170727|589564248|FG001|Overall Study|Withdrawal by Subject|0|||
163233256|NCT01959581|589564251|FG000|Overall Study|Lost to Follow-up|5|||
163233257|NCT03304379|589564262|FG000|Overall Study|Protocol Violation|8|||
163233258|NCT03304379|589564263|FG001|Overall Study|Protocol Violation|10|||
163233259|NCT03304379|589564264|FG002|Overall Study|Protocol Violation|5|||
163233260|NCT03304379|589564265|FG003|Overall Study|Protocol Violation|0|||
163233261|NCT03304379|589564266|FG004|Overall Study|Protocol Violation|2|||
163233262|NCT03304379|589564262|FG000|Overall Study|Adverse Event|4|||
163233263|NCT03304379|589564263|FG001|Overall Study|Adverse Event|20|||
163233264|NCT03304379|589564264|FG002|Overall Study|Adverse Event|17|||
163233265|NCT03304379|589564265|FG003|Overall Study|Adverse Event|1|||
163233266|NCT03304379|589564266|FG004|Overall Study|Adverse Event|0|||
163233267|NCT03304379|589564262|FG000|Overall Study|Lack of Efficacy|17|||
163233268|NCT03304379|589564263|FG001|Overall Study|Lack of Efficacy|16|||
163233269|NCT03304379|589564264|FG002|Overall Study|Lack of Efficacy|20|||
163233270|NCT03304379|589564265|FG003|Overall Study|Lack of Efficacy|0|||
163233271|NCT03304379|589564266|FG004|Overall Study|Lack of Efficacy|0|||
163233272|NCT03304379|589564262|FG000|Overall Study|Physician Decision|6|||
163233273|NCT03304379|589564263|FG001|Overall Study|Physician Decision|10|||
163233274|NCT03304379|589564264|FG002|Overall Study|Physician Decision|6|||
163233275|NCT03304379|589564265|FG003|Overall Study|Physician Decision|9|||
163233276|NCT03304379|589564266|FG004|Overall Study|Physician Decision|10|||
163233277|NCT03304379|589564262|FG000|Overall Study|Withdrawal by Subject|26|||
163233278|NCT03304379|589564263|FG001|Overall Study|Withdrawal by Subject|58|||
163233279|NCT03304379|589564264|FG002|Overall Study|Withdrawal by Subject|66|||
163233280|NCT03304379|589564265|FG003|Overall Study|Withdrawal by Subject|3|||
163233281|NCT03304379|589564266|FG004|Overall Study|Withdrawal by Subject|5|||
163233282|NCT03304379|589564262|FG000|Overall Study|Lost to Follow-up|8|||
163233283|NCT03304379|589564263|FG001|Overall Study|Lost to Follow-up|24|||
163233284|NCT03304379|589564264|FG002|Overall Study|Lost to Follow-up|35|||
163233285|NCT03304379|589564265|FG003|Overall Study|Lost to Follow-up|4|||
163233286|NCT03304379|589564266|FG004|Overall Study|Lost to Follow-up|0|||
163233287|NCT03304379|589564262|FG000|Overall Study|Death|1|||
163233288|NCT03304379|589564263|FG001|Overall Study|Death|2|||
163233289|NCT03304379|589564264|FG002|Overall Study|Death|0|||
163233290|NCT03304379|589564265|FG003|Overall Study|Death|0|||
163233291|NCT03304379|589564266|FG004|Overall Study|Death|0|||
163233292|NCT03304379|589564262|FG000|Overall Study|Other|0|||
163233293|NCT03304379|589564263|FG001|Overall Study|Other|1|||
163233294|NCT03304379|589564264|FG002|Overall Study|Other|0|||
163233295|NCT03304379|589564265|FG003|Overall Study|Other|0|||
163233296|NCT03304379|589564266|FG004|Overall Study|Other|0|||
163233297|NCT02802345|589564274|FG000|Overall Study|Not Treated|0|||
163233298|NCT02802345|589564275|FG001|Overall Study|Not Treated|1|||
163233299|NCT02802345|589564274|FG000|Overall Study|Adverse Event|28|||
163233300|NCT02802345|589564275|FG001|Overall Study|Adverse Event|20|||
163233301|NCT02802345|589564274|FG000|Overall Study|Withdrawal by Subject|3|||
163233302|NCT02802345|589564275|FG001|Overall Study|Withdrawal by Subject|3|||
163347259|NCT04754594|589979422|FG001|Unblinded Period|Lost to Follow-up|3|||
163347260|NCT04754594|589979423|FG002|Unblinded Period|Lost to Follow-up|0|||
163347261|NCT04754594|589979424|FG003|Unblinded Period|Lost to Follow-up|0|||
163347262|NCT04754594|589979421|FG000|Unblinded Period|Protocol Violation|2|||
163347263|NCT04754594|589979422|FG001|Unblinded Period|Protocol Violation|4|||
163347264|NCT04754594|589979423|FG002|Unblinded Period|Protocol Violation|0|||
163347265|NCT04754594|589979424|FG003|Unblinded Period|Protocol Violation|0|||
163347266|NCT04754594|589979421|FG000|Unblinded Period|Other|3|||
163233303|NCT02802345|589564274|FG000|Overall Study|Protocol Violation|0|||
163233304|NCT02802345|589564275|FG001|Overall Study|Protocol Violation|1|||
163233305|NCT02802345|589564274|FG000|Overall Study|Other than listed|1|||
163233306|NCT02802345|589564275|FG001|Overall Study|Other than listed|5|||
163233307|NCT03969212|589564276|FG000|Overall Study|Adverse Event|1|||
163233308|NCT03969212|589564277|FG001|Overall Study|Adverse Event|0|||
163233309|NCT03969212|589564278|FG002|Overall Study|Adverse Event|0|||
163233310|NCT03969212|589564279|FG003|Overall Study|Adverse Event|0|||
163233311|NCT03969212|589564276|FG000|Overall Study|Lost to Follow-up|2|||
163233312|NCT03969212|589564277|FG001|Overall Study|Lost to Follow-up|2|||
163233313|NCT03969212|589564278|FG002|Overall Study|Lost to Follow-up|2|||
163347267|NCT04754594|589979422|FG001|Unblinded Period|Other|0|||
163347268|NCT04754594|589979423|FG002|Unblinded Period|Other|0|||
163233314|NCT03969212|589564279|FG003|Overall Study|Lost to Follow-up|2|||
163233315|NCT03969212|589564276|FG000|Overall Study|Protocol Violation|0|||
163233316|NCT03969212|589564277|FG001|Overall Study|Protocol Violation|0|||
163233317|NCT03969212|589564278|FG002|Overall Study|Protocol Violation|0|||
163233318|NCT03969212|589564279|FG003|Overall Study|Protocol Violation|1|||
163233319|NCT03969212|589564276|FG000|Overall Study|Withdrawal by Subject|7|||
163233320|NCT03969212|589564277|FG001|Overall Study|Withdrawal by Subject|13|||
163233321|NCT03969212|589564278|FG002|Overall Study|Withdrawal by Subject|5|||
163233322|NCT03969212|589564279|FG003|Overall Study|Withdrawal by Subject|11|||
163233323|NCT03969212|589564276|FG000|Overall Study|Physician Decision|0|||
163233324|NCT03969212|589564277|FG001|Overall Study|Physician Decision|0|||
163233325|NCT03969212|589564278|FG002|Overall Study|Physician Decision|1|||
163233326|NCT03969212|589564279|FG003|Overall Study|Physician Decision|0|||
163233327|NCT03969212|589564276|FG000|Overall Study|Reason not Specified|22|||
163233328|NCT03969212|589564277|FG001|Overall Study|Reason not Specified|23|||
163233329|NCT03969212|589564278|FG002|Overall Study|Reason not Specified|28|||
163233330|NCT03969212|589564279|FG003|Overall Study|Reason not Specified|26|||
163233331|NCT02075320|589564281|FG000|Overall Study|Withdrawal by Subject|2|||
163233332|NCT03773757|589564282|FG000|Overall Study|Withdrawal by Subject|2|||
163233333|NCT03773757|589564283|FG001|Overall Study|Withdrawal by Subject|4|||
163233334|NCT00057746|589564284|FG000|Overall Study|Withdrawal by Subject|0|||
163233335|NCT00057746|589564285|FG001|Overall Study|Withdrawal by Subject|0|||
163233336|NCT00057746|589564286|FG002|Overall Study|Withdrawal by Subject|1|||
163233337|NCT02985736|589564291|FG000|Overall Study|Lost to Follow-up|3|||
163233338|NCT00550836|589564292|FG000|Overall Study|Withdrawal by Subject|3|||
163233339|NCT00550836|589564293|FG001|Overall Study|Withdrawal by Subject|9|||
163233340|NCT01856543|589564294|FG000|Overall Study|Treatment discontinued|6|||
163233341|NCT01856543|589564295|FG001|Overall Study|Treatment discontinued|3|||
163233342|NCT01856543|589564294|FG000|Overall Study|Withdrawn before start|7|||
163233343|NCT01856543|589564295|FG001|Overall Study|Withdrawn before start|3|||
163233344|NCT04545515|589564296|FG000|Overall Study|Adverse Event|1|||
163233345|NCT04545515|589564296|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
163233346|NCT04545515|589564296|FG000|Overall Study|Commercial drug is available for participant|7|||
163233347|NCT01552772|589564297|FG000|Overall Study|Lost to Follow-up|2|||
163233348|NCT01552772|589564297|FG000|Overall Study|Adverse Event|1|||
163233349|NCT01552772|589564297|FG000|Overall Study|Protocol Deviation|1|||
163233350|NCT01848990|589564299|FG000|Overall Study|Adverse Event|6|||
163233351|NCT01848990|589564300|FG001|Overall Study|Adverse Event|2|||
163233352|NCT01848990|589564301|FG002|Overall Study|Adverse Event|0|||
163233353|NCT01848990|589564299|FG000|Overall Study|Lost to Follow-up|6|||
163233354|NCT01848990|589564300|FG001|Overall Study|Lost to Follow-up|2|||
163233355|NCT01848990|589564301|FG002|Overall Study|Lost to Follow-up|2|||
163233356|NCT01848990|589564299|FG000|Overall Study|Protocol Violation|1|||
163233357|NCT01848990|589564300|FG001|Overall Study|Protocol Violation|1|||
163233358|NCT01848990|589564301|FG002|Overall Study|Protocol Violation|0|||
163233359|NCT01848990|589564299|FG000|Overall Study|Withdrawal by Subject|29|||
163233360|NCT01848990|589564300|FG001|Overall Study|Withdrawal by Subject|10|||
163233361|NCT01848990|589564301|FG002|Overall Study|Withdrawal by Subject|11|||
163233362|NCT01848990|589564299|FG000|Overall Study|Physician Decision|1|||
163233363|NCT01848990|589564300|FG001|Overall Study|Physician Decision|1|||
163233364|NCT01848990|589564301|FG002|Overall Study|Physician Decision|0|||
163233365|NCT01848990|589564299|FG000|Overall Study|Non Compliance|1|||
163233366|NCT01848990|589564300|FG001|Overall Study|Non Compliance|0|||
163233367|NCT01848990|589564301|FG002|Overall Study|Non Compliance|0|||
163233368|NCT01848990|589564299|FG000|Overall Study|Death|1|||
163233369|NCT01848990|589564300|FG001|Overall Study|Death|0|||
163233370|NCT01848990|589564301|FG002|Overall Study|Death|1|||
163233371|NCT01848990|589564299|FG000|Overall Study|Other|1|||
163233372|NCT01848990|589564300|FG001|Overall Study|Other|4|||
163233373|NCT01848990|589564301|FG002|Overall Study|Other|2|||
163233374|NCT00700011|589564302|FG000|Overall Study|Death|0|||
163233375|NCT00700011|589564303|FG001|Overall Study|Death|1|||
163347269|NCT04754594|589979424|FG003|Unblinded Period|Other|0|||
163347270|NCT04754594|589979421|FG000|Infant Participants|Withdrawal by Subject|0|||
163347271|NCT04754594|589979422|FG001|Infant Participants|Withdrawal by Subject|0|||
163347272|NCT04754594|589979423|FG002|Infant Participants|Withdrawal by Subject|9|||
163347273|NCT04754594|589979424|FG003|Infant Participants|Withdrawal by Subject|17|||
163233376|NCT00004031|589564304|FG000|Overall Study|Adverse Event|5|||
163233377|NCT00004031|589564305|FG001|Overall Study|Adverse Event|0|||
163233378|NCT00004031|589564304|FG000|Overall Study|Refusal unrelated to adverse events|2|||
163233379|NCT00004031|589564305|FG001|Overall Study|Refusal unrelated to adverse events|11|||
163233380|NCT00004031|589564304|FG000|Overall Study|Progression/relapse|9|||
163233381|NCT00004031|589564305|FG001|Overall Study|Progression/relapse|4|||
163233382|NCT00004031|589564304|FG000|Overall Study|Death|3|||
163347274|NCT04754594|589979421|FG000|Infant Participants|Lost to Follow-up|0|||
163347275|NCT04754594|589979422|FG001|Infant Participants|Lost to Follow-up|0|||
163233383|NCT00004031|589564305|FG001|Overall Study|Death|1|||
163233384|NCT00004031|589564304|FG000|Overall Study|Other- not protocol specified|3|||
163233385|NCT00004031|589564305|FG001|Overall Study|Other- not protocol specified|3|||
163233386|NCT00004031|589564304|FG000|Overall Study|Reason under review|3|||
163233387|NCT00004031|589564305|FG001|Overall Study|Reason under review|2|||
163233388|NCT00512096|589564309|FG000|Overall Study|Adverse Event|2|||
163233389|NCT00512096|589564309|FG000|Overall Study|Withdrawal by Subject|2|||
163233390|NCT00512096|589564309|FG000|Overall Study|Lack of Efficacy|3|||
163233391|NCT00298038|589564316|FG000|Overall Study|Lost to Follow-up|0|||
163233392|NCT00298038|589564317|FG001|Overall Study|Lost to Follow-up|1|||
163233393|NCT00298038|589564316|FG000|Overall Study|Liver Transplant|0|||
163233394|NCT00298038|589564317|FG001|Overall Study|Liver Transplant|1|||
163233395|NCT00298038|589564316|FG000|Overall Study|Protocol Violation|1|||
163233396|NCT00298038|589564317|FG001|Overall Study|Protocol Violation|3|||
163233397|NCT00298038|589564316|FG000|Overall Study|Death|6|||
163233398|NCT00298038|589564317|FG001|Overall Study|Death|3|||
163233399|NCT00298038|589564316|FG000|Overall Study|Withdrawal by Subject|6|||
163233400|NCT00298038|589564317|FG001|Overall Study|Withdrawal by Subject|9|||
163233401|NCT00298038|589564316|FG000|Overall Study|Adverse Event|8|||
163233402|NCT00298038|589564317|FG001|Overall Study|Adverse Event|7|||
163233403|NCT00298038|589564316|FG000|Overall Study|Breakthrough overt HE episode|28|||
163233404|NCT00298038|589564317|FG001|Overall Study|Breakthrough overt HE episode|69|||
163233405|NCT00298038|589564316|FG000|Overall Study|Noncompliance|1|||
163233406|NCT00298038|589564317|FG001|Overall Study|Noncompliance|0|||
163233407|NCT00298038|589564316|FG000|Overall Study|Cocaine Abuse|1|||
163233408|NCT00298038|589564317|FG001|Overall Study|Cocaine Abuse|0|||
163233409|NCT00298038|589564316|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
163233410|NCT00298038|589564317|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
163233411|NCT02696096|589564318|FG000|Overall Study|ruled out at screening|1|||
163233412|NCT02696096|589564318|FG000|Overall Study|did not attend second fMRI|1|||
163233413|NCT01940705|589564319|FG000|Overall Study|Lost to Follow-up|1|||
163233414|NCT01940705|589564320|FG001|Overall Study|Lost to Follow-up|3|||
163233415|NCT01940705|589564321|FG002|Overall Study|Lost to Follow-up|2|||
163233416|NCT01940705|589564322|FG003|Overall Study|Lost to Follow-up|2|||
163233417|NCT01940705|589564319|FG000|Overall Study|Withdrawal by Subject|2|||
163233418|NCT01940705|589564320|FG001|Overall Study|Withdrawal by Subject|2|||
163233419|NCT01940705|589564321|FG002|Overall Study|Withdrawal by Subject|3|||
163233420|NCT01940705|589564322|FG003|Overall Study|Withdrawal by Subject|2|||
163233421|NCT01940705|589564319|FG000|Overall Study|Intervention not given|0|||
163233422|NCT01940705|589564320|FG001|Overall Study|Intervention not given|3|||
163233423|NCT01940705|589564321|FG002|Overall Study|Intervention not given|3|||
163233424|NCT01940705|589564322|FG003|Overall Study|Intervention not given|0|||
163233425|NCT01940705|589564319|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
163233426|NCT01940705|589564320|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
163233427|NCT01940705|589564321|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
163233428|NCT01940705|589564322|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
163233429|NCT02447991|589564323|FG000|Overall Study|Withdrawn by subject - no data|0|||
163233430|NCT02447991|589564324|FG001|Overall Study|Withdrawn by subject - no data|2|||
163233431|NCT02447991|589564323|FG000|Overall Study|Withdrawn by Subject - with data|4|||
163347276|NCT04754594|589979423|FG002|Infant Participants|Lost to Follow-up|4|||
163347277|NCT04754594|589979424|FG003|Infant Participants|Lost to Follow-up|10|||
163347278|NCT04754594|589979421|FG000|Infant Participants|Death|0|||
163347279|NCT04754594|589979422|FG001|Infant Participants|Death|0|||
163347280|NCT04754594|589979423|FG002|Infant Participants|Death|1|||
163347281|NCT04754594|589979424|FG003|Infant Participants|Death|1|||
163347282|NCT04754594|589979421|FG000|Infant Participants|Other|0|||
163347283|NCT04754594|589979422|FG001|Infant Participants|Other|0|||
163347284|NCT04754594|589979423|FG002|Infant Participants|Other|1|||
163347285|NCT04754594|589979424|FG003|Infant Participants|Other|1|||
163347286|NCT02116582|589979425|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
163347287|NCT02116582|589979425|FG000|Overall Study|Adverse Event|22|||
163233432|NCT02447991|589564324|FG001|Overall Study|Withdrawn by Subject - with data|4|||
163233433|NCT02447991|589564323|FG000|Overall Study|Lost to Follow-up - no data|3|||
163233434|NCT02447991|589564324|FG001|Overall Study|Lost to Follow-up - no data|6|||
163347288|NCT02116582|589979425|FG000|Overall Study|Death|9|||
163347289|NCT02116582|589979425|FG000|Overall Study|Progressive Disease|148|||
163347290|NCT02116582|589979425|FG000|Overall Study|Protocol Violation|3|||
163347291|NCT02116582|589979425|FG000|Overall Study|Withdrawal by Subject|8|||
163347292|NCT02116582|589979425|FG000|Overall Study|Other: Miscellaneous|11|||
163233435|NCT02447991|589564323|FG000|Overall Study|Lost to follow-up - with data|0|||
163347293|NCT02116582|589979425|FG000|Overall Study|Lost to Follow-up|1|||
163233436|NCT02447991|589564324|FG001|Overall Study|Lost to follow-up - with data|3|||
163233437|NCT02447991|589564323|FG000|Overall Study|End of study - no treatment results|3|||
163233438|NCT02447991|589564324|FG001|Overall Study|End of study - no treatment results|6|||
163233439|NCT02447991|589564323|FG000|Overall Study|End of study - partial treatment results|0|||
163233440|NCT02447991|589564324|FG001|Overall Study|End of study - partial treatment results|9|||
163233441|NCT03551210|589564325|FG000|Overall Study|Adverse Event|5|||
163347294|NCT02116582|589979425|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
163233442|NCT03551210|589564326|FG001|Overall Study|Adverse Event|6|||
163233443|NCT03551210|589564325|FG000|Overall Study|Withdrawal by Subject|1|||
163347295|NCT00832650|589979426|FG000|Overall Study|Randomized but not treated|0|||
163347296|NCT00832650|589979427|FG001|Overall Study|Randomized but not treated|0|||
163347297|NCT00832650|589979428|FG002|Overall Study|Randomized but not treated|1|||
163139709|NCT01427933|589219960|FG001|Overall Study|Other|0|||
163139710|NCT01427933|589219959|FG000|Overall Study|Investigator's Decision|1|||
163139711|NCT01427933|589219960|FG001|Overall Study|Investigator's Decision|0|||
163139712|NCT03472326|589219961|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
163139713|NCT03472326|589219962|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
163139714|NCT03472326|589219963|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
163139715|NCT03472326|589219964|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
163139716|NCT03472326|589219961|FG000|Part 2: Combination Therapy|Pregnancy|0|||
163139717|NCT03472326|589219962|FG001|Part 2: Combination Therapy|Pregnancy|0|||
163139718|NCT03472326|589219963|FG002|Part 2: Combination Therapy|Pregnancy|0|||
163139719|NCT03472326|589219964|FG003|Part 2: Combination Therapy|Pregnancy|1|||
163139720|NCT00773513|589219965|FG000|Overall Study|Renal Transplant|254|||
163139721|NCT00773513|589219966|FG001|Overall Study|Renal Transplant|263|||
163139722|NCT00773513|589219965|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
163139723|NCT00773513|589219966|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
163139724|NCT00773513|589219965|FG000|Overall Study|Withdrew Consent|68|||
163139725|NCT00773513|589219966|FG001|Overall Study|Withdrew Consent|69|||
163139726|NCT00773513|589219965|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
163139727|NCT00773513|589219966|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
163139728|NCT00773513|589219965|FG000|Overall Study|Failure to Return|22|||
163139729|NCT00773513|589219966|FG001|Overall Study|Failure to Return|8|||
163139730|NCT00773513|589219965|FG000|Overall Study|Insufficient Therapeutic Response|1|||
163139731|NCT00773513|589219966|FG001|Overall Study|Insufficient Therapeutic Response|18|||
163139732|NCT00773513|589219965|FG000|Overall Study|Reason Not Specified|159|||
163139733|NCT00773513|589219966|FG001|Overall Study|Reason Not Specified|126|||
163139734|NCT00773513|589219965|FG000|Overall Study|Death|531|||
163139735|NCT00773513|589219966|FG001|Overall Study|Death|545|||
163139736|NCT01221350|589219967|FG000|Overall Study|Discontinued intervention (GERD)|1|||
163139737|NCT01221350|589219968|FG001|Overall Study|Discontinued intervention (GERD)|0|||
163139738|NCT01221350|589219967|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
163139739|NCT01221350|589219968|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
163139740|NCT01221350|589219967|FG000|Overall Study|Withdrawal by Subject|4|||
163139741|NCT01221350|589219968|FG001|Overall Study|Withdrawal by Subject|2|||
163139742|NCT04739436|589219969|FG000|Overall Study|Lost to Follow-up|21|||
163139743|NCT04739436|589219970|FG001|Overall Study|Lost to Follow-up|23|||
163139744|NCT04739436|589219969|FG000|Overall Study|Withdrawal by Subject|4|||
163139745|NCT04739436|589219970|FG001|Overall Study|Withdrawal by Subject|6|||
163139746|NCT04739436|589219969|FG000|Overall Study|not randomized properly|1|||
163139747|NCT04739436|589219970|FG001|Overall Study|not randomized properly|0|||
163139748|NCT00413218|589221924|FG000|Overall Study|Randomized but didn't receive study drug|2|||
163139749|NCT00413218|589221925|FG001|Overall Study|Randomized but didn't receive study drug|8|||
163139750|NCT00413218|589221924|FG000|Overall Study|Death|57|||
163139751|NCT00413218|589221925|FG001|Overall Study|Death|56|||
163139752|NCT00413218|589221924|FG000|Overall Study|Lost to Follow-up|14|||
163139753|NCT00413218|589221925|FG001|Overall Study|Lost to Follow-up|17|||
163139754|NCT00413218|589221924|FG000|Overall Study|Admin|20|||
163139755|NCT00413218|589221925|FG001|Overall Study|Admin|14|||
163139756|NCT00413218|589221924|FG000|Overall Study|Missing|1|||
163139757|NCT00413218|589221925|FG001|Overall Study|Missing|0|||
163139758|NCT00413218|589221924|FG000|Overall Study|Withdrawal by Subject|9|||
163139759|NCT00413218|589221925|FG001|Overall Study|Withdrawal by Subject|1|||
163139760|NCT00837213|589221926|FG000|Overall Study|Lost to Follow-up|3|||
163139761|NCT00837213|589221927|FG001|Overall Study|Lost to Follow-up|2|||
163139762|NCT00837213|589221926|FG000|Overall Study|Withdrawal by Subject|2|||
163139763|NCT00837213|589221927|FG001|Overall Study|Withdrawal by Subject|2|||
163139764|NCT00837213|589221926|FG000|Overall Study|not stated|1|||
163139765|NCT00837213|589221927|FG001|Overall Study|not stated|1|||
163139766|NCT01479868|589221929|FG000|Overall Study|Adverse Event|1|||
163139767|NCT01479868|589221929|FG000|Overall Study|Lost to Follow-up|4|||
163139768|NCT01479868|589221929|FG000|Overall Study|Protocol Violation|1|||
163139769|NCT01479868|589221929|FG000|Overall Study|Withdrawal by Subject|1|||
163139770|NCT01479868|589221929|FG000|Overall Study|Sponsor's Decision|1|||
163139771|NCT01479868|589221929|FG000|Overall Study|Initiation of new HCV Therapy|1|||
163139772|NCT01618669|589221930|FG000|Overall Study|Lost to Follow-up|1|||
163139773|NCT01618669|589221931|FG001|Overall Study|Lost to Follow-up|1|||
163139774|NCT01618669|589221930|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
163139775|NCT01618669|589221931|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
163139776|NCT01618669|589221930|FG000|Overall Study|Adverse Event|16|||
163139777|NCT01618669|589221931|FG001|Overall Study|Adverse Event|7|||
163139778|NCT01618669|589221930|FG000|Overall Study|Protocol Violation|5|||
163139779|NCT01618669|589221931|FG001|Overall Study|Protocol Violation|3|||
163139780|NCT01618669|589221930|FG000|Overall Study|Withdrawal by Subject|9|||
163139781|NCT01618669|589221931|FG001|Overall Study|Withdrawal by Subject|9|||
163139782|NCT01618669|589221930|FG000|Overall Study|Miscellaneous Reason|0|||
163139783|NCT01618669|589221931|FG001|Overall Study|Miscellaneous Reason|1|||
163347298|NCT03356145|589979429|FG000|Overall Study|Withdrawal by Subject|2|||
163233444|NCT03551210|589564326|FG001|Overall Study|Withdrawal by Subject|7|||
163233445|NCT03551210|589564325|FG000|Overall Study|Needed in other antibiotic treatment|2|||
163233446|NCT03551210|589564326|FG001|Overall Study|Needed in other antibiotic treatment|5|||
163233447|NCT03551210|589564325|FG000|Overall Study|Lost to Follow-up|1|||
163233448|NCT03551210|589564326|FG001|Overall Study|Lost to Follow-up|1|||
163233449|NCT03551210|589564325|FG000|Overall Study|Absence of visit 4 and 5|1|||
163233450|NCT03551210|589564326|FG001|Overall Study|Absence of visit 4 and 5|0|||
163233451|NCT03551210|589564325|FG000|Overall Study|No drug for dispensing|0|||
163233452|NCT03551210|589564326|FG001|Overall Study|No drug for dispensing|1|||
163233453|NCT04260191|589566111|FG000|Overall Study|Decision by Sponsor|0|||
163233454|NCT04260191|589566112|FG001|Overall Study|Decision by Sponsor|1|||
163233455|NCT04260191|589566113|FG002|Overall Study|Decision by Sponsor|0|||
163233456|NCT04260191|589566111|FG000|Overall Study|Withdrawal by Subject|1|||
163233457|NCT04260191|589566112|FG001|Overall Study|Withdrawal by Subject|0|||
163233458|NCT04260191|589566113|FG002|Overall Study|Withdrawal by Subject|3|||
163233459|NCT04260191|589566111|FG000|Overall Study|Death|4|||
163233460|NCT04260191|589566112|FG001|Overall Study|Death|3|||
163233461|NCT04260191|589566113|FG002|Overall Study|Death|2|||
163233462|NCT02343458|589566114|FG000|Overall Study|Adverse Event|15|||
163233463|NCT02343458|589566115|FG001|Overall Study|Adverse Event|14|||
163233464|NCT02343458|589566116|FG002|Overall Study|Adverse Event|15|||
163233465|NCT02343458|589566117|FG003|Overall Study|Adverse Event|3|||
163233466|NCT02343458|589566114|FG000|Overall Study|Lack of Efficacy|3|||
163233467|NCT02343458|589566115|FG001|Overall Study|Lack of Efficacy|8|||
163233468|NCT02343458|589566116|FG002|Overall Study|Lack of Efficacy|4|||
163233469|NCT02343458|589566117|FG003|Overall Study|Lack of Efficacy|8|||
163233470|NCT02343458|589566114|FG000|Overall Study|Withdrawal by Subject|18|||
163233471|NCT02343458|589566115|FG001|Overall Study|Withdrawal by Subject|17|||
163233472|NCT02343458|589566116|FG002|Overall Study|Withdrawal by Subject|23|||
163233473|NCT02343458|589566117|FG003|Overall Study|Withdrawal by Subject|14|||
163233474|NCT02343458|589566114|FG000|Overall Study|Physician Decision|1|||
163233475|NCT02343458|589566115|FG001|Overall Study|Physician Decision|4|||
163233476|NCT02343458|589566116|FG002|Overall Study|Physician Decision|2|||
163233477|NCT02343458|589566117|FG003|Overall Study|Physician Decision|2|||
163233478|NCT02343458|589566114|FG000|Overall Study|Lost to Follow-up|5|||
163233479|NCT02343458|589566115|FG001|Overall Study|Lost to Follow-up|5|||
163233480|NCT02343458|589566116|FG002|Overall Study|Lost to Follow-up|3|||
163233481|NCT02343458|589566117|FG003|Overall Study|Lost to Follow-up|1|||
163233482|NCT02343458|589566114|FG000|Overall Study|Protocol Violation|2|||
163233483|NCT02343458|589566115|FG001|Overall Study|Protocol Violation|5|||
163233484|NCT02343458|589566116|FG002|Overall Study|Protocol Violation|2|||
163233485|NCT02343458|589566117|FG003|Overall Study|Protocol Violation|2|||
163233486|NCT02343458|589566114|FG000|Overall Study|Protocol Specified Criteria|17|||
163233487|NCT02343458|589566115|FG001|Overall Study|Protocol Specified Criteria|13|||
163233488|NCT02343458|589566116|FG002|Overall Study|Protocol Specified Criteria|14|||
163233489|NCT02343458|589566117|FG003|Overall Study|Protocol Specified Criteria|8|||
163233490|NCT01913041|589566118|FG000|Overall Study|Protocol Violation|35|||
163233491|NCT01913041|589566118|FG000|Overall Study|Withdrawal by Subject|3|||
163233492|NCT01913041|589566118|FG000|Overall Study|Physician Decision|1|||
163233493|NCT01513317|589566119|FG000|Overall Study|Withdrawal by Subject|15|||
163233494|NCT01513317|589566120|FG001|Overall Study|Withdrawal by Subject|4|||
163233495|NCT01513317|589566119|FG000|Overall Study|Death|1|||
163233496|NCT01513317|589566120|FG001|Overall Study|Death|1|||
163233497|NCT01513317|589566119|FG000|Overall Study|Study terminated by sponsor|18|||
163233498|NCT01513317|589566120|FG001|Overall Study|Study terminated by sponsor|18|||
163233499|NCT01513317|589566119|FG000|Overall Study|Other|0|||
163233500|NCT01513317|589566120|FG001|Overall Study|Other|1|||
163233501|NCT02564198|589566121|FG000|Overall Study|Withdrawal by Subject|2|||
163233502|NCT02564198|589566122|FG001|Overall Study|Withdrawal by Subject|4|||
163233503|NCT02564198|589566123|FG002|Overall Study|Withdrawal by Subject|0|||
163233504|NCT02564198|589566121|FG000|Overall Study|Adverse Event|0|||
163233505|NCT02564198|589566122|FG001|Overall Study|Adverse Event|1|||
163233506|NCT02564198|589566123|FG002|Overall Study|Adverse Event|0|||
163233507|NCT02866682|589566126|FG000|Overall Study|Death|0|||
163233508|NCT02866682|589566127|FG001|Overall Study|Death|1|||
163233509|NCT02866682|589566126|FG000|Overall Study|Lost to Follow-up|0|||
163233510|NCT02866682|589566127|FG001|Overall Study|Lost to Follow-up|4|||
163233511|NCT02866682|589566126|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
163233512|NCT02866682|589566127|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
163233513|NCT02866682|589566126|FG000|Overall Study|Other|0|||
163233514|NCT02866682|589566127|FG001|Overall Study|Other|1|||
163233515|NCT01750268|589566128|FG000|Overall Study|Lost to Follow-up|0|||
163233516|NCT01750268|589566129|FG001|Overall Study|Lost to Follow-up|2|||
163233517|NCT01750268|589566128|FG000|Overall Study|Physician Decision|0|||
163233518|NCT01750268|589566129|FG001|Overall Study|Physician Decision|3|||
163233519|NCT01750268|589566128|FG000|Overall Study|Withdrawal by Subject|2|||
163233520|NCT01750268|589566129|FG001|Overall Study|Withdrawal by Subject|0|||
163233521|NCT02086591|589566132|FG000|Overall Study|Adverse Event|1|||
163233522|NCT02086591|589566132|FG000|Overall Study|Withdrawal by Subject|1|||
163233523|NCT02086591|589566132|FG000|Overall Study|protocol terminated|3|||
163233524|NCT01529645|589566133|FG000|Overall Study|Lost to Follow-up|0|||
163233525|NCT01529645|589566134|FG001|Overall Study|Lost to Follow-up|1|||
163233526|NCT01529645|589566135|FG002|Overall Study|Lost to Follow-up|1|||
163233527|NCT01529645|589566136|FG003|Overall Study|Lost to Follow-up|1|||
163233528|NCT01529645|589566137|FG004|Overall Study|Lost to Follow-up|1|||
163233529|NCT01529645|589566138|FG005|Overall Study|Lost to Follow-up|0|||
163233530|NCT01529645|589566139|FG006|Overall Study|Lost to Follow-up|2|||
163233531|NCT01529645|589566140|FG007|Overall Study|Lost to Follow-up|0|||
163233532|NCT01529645|589566141|FG008|Overall Study|Lost to Follow-up|1|||
163233533|NCT01529645|589566142|FG009|Overall Study|Lost to Follow-up|0|||
163233534|NCT01529645|589566133|FG000|Overall Study|SAE - Premature contractions|0|||
163233535|NCT01529645|589566134|FG001|Overall Study|SAE - Premature contractions|0|||
163233536|NCT01529645|589566135|FG002|Overall Study|SAE - Premature contractions|1|||
163233537|NCT01529645|589566136|FG003|Overall Study|SAE - Premature contractions|0|||
163233538|NCT01529645|589566137|FG004|Overall Study|SAE - Premature contractions|0|||
163233539|NCT01529645|589566138|FG005|Overall Study|SAE - Premature contractions|0|||
163233540|NCT01529645|589566139|FG006|Overall Study|SAE - Premature contractions|0|||
163233541|NCT01529645|589566140|FG007|Overall Study|SAE - Premature contractions|0|||
163233542|NCT01529645|589566141|FG008|Overall Study|SAE - Premature contractions|0|||
163233543|NCT01529645|589566142|FG009|Overall Study|SAE - Premature contractions|0|||
163233544|NCT01529645|589566133|FG000|Overall Study|Withdrawal by Subject|2|||
163233545|NCT01529645|589566134|FG001|Overall Study|Withdrawal by Subject|0|||
163233546|NCT01529645|589566135|FG002|Overall Study|Withdrawal by Subject|0|||
163233547|NCT01529645|589566136|FG003|Overall Study|Withdrawal by Subject|1|||
163233548|NCT01529645|589566137|FG004|Overall Study|Withdrawal by Subject|1|||
163233549|NCT01529645|589566138|FG005|Overall Study|Withdrawal by Subject|1|||
163233550|NCT01529645|589566139|FG006|Overall Study|Withdrawal by Subject|0|||
163233551|NCT01529645|589566140|FG007|Overall Study|Withdrawal by Subject|0|||
163233552|NCT01529645|589566141|FG008|Overall Study|Withdrawal by Subject|0|||
163233553|NCT01529645|589566142|FG009|Overall Study|Withdrawal by Subject|0|||
163233554|NCT00274716|589566147|FG000|Phase A|Other non-reported reason|4|||
163233555|NCT00274716|589566148|FG001|Phase A|Other non-reported reason|2|||
163233556|NCT00274716|589566149|FG002|Phase A|Other non-reported reason|1|||
163233557|NCT00274716|589566150|FG003|Phase A|Other non-reported reason|2|||
163233558|NCT00274716|589566151|FG004|Phase A|Other non-reported reason|0|||
163233559|NCT00274716|589566152|FG005|Phase A|Other non-reported reason|1|||
163233560|NCT00274716|589566147|FG000|Phase A|Participant moved|0|||
163233561|NCT00274716|589566148|FG001|Phase A|Participant moved|0|||
163233562|NCT00274716|589566149|FG002|Phase A|Participant moved|1|||
163233563|NCT00274716|589566150|FG003|Phase A|Participant moved|0|||
163233564|NCT00274716|589566151|FG004|Phase A|Participant moved|0|||
163233565|NCT00274716|589566152|FG005|Phase A|Participant moved|1|||
163233566|NCT00274716|589566147|FG000|Phase A|Site Terminated|0|||
163233567|NCT00274716|589566148|FG001|Phase A|Site Terminated|0|||
163233568|NCT00274716|589566149|FG002|Phase A|Site Terminated|0|||
163233569|NCT00274716|589566150|FG003|Phase A|Site Terminated|1|||
163233570|NCT00274716|589566151|FG004|Phase A|Site Terminated|0|||
163233571|NCT00274716|589566152|FG005|Phase A|Site Terminated|0|||
163233572|NCT00274716|589566147|FG000|Phase A|Protocol Violation|1|||
163233573|NCT00274716|589566148|FG001|Phase A|Protocol Violation|0|||
163347299|NCT03356145|589979430|FG001|Overall Study|Withdrawal by Subject|1|||
163233574|NCT00274716|589566149|FG002|Phase A|Protocol Violation|0|||
163233575|NCT00274716|589566150|FG003|Phase A|Protocol Violation|1|||
163233576|NCT00274716|589566151|FG004|Phase A|Protocol Violation|0|||
163233577|NCT00274716|589566152|FG005|Phase A|Protocol Violation|0|||
163233578|NCT00274716|589566147|FG000|Phase A|Met criteria for discontinuation|1|||
163233579|NCT00274716|589566148|FG001|Phase A|Met criteria for discontinuation|1|||
163233580|NCT00274716|589566149|FG002|Phase A|Met criteria for discontinuation|0|||
163233581|NCT00274716|589566150|FG003|Phase A|Met criteria for discontinuation|0|||
163233582|NCT00274716|589566151|FG004|Phase A|Met criteria for discontinuation|0|||
163233583|NCT00274716|589566152|FG005|Phase A|Met criteria for discontinuation|0|||
163233584|NCT00274716|589566147|FG000|Phase A|Withdrawal by Subject|2|||
163233585|NCT00274716|589566148|FG001|Phase A|Withdrawal by Subject|2|||
163233586|NCT00274716|589566149|FG002|Phase A|Withdrawal by Subject|1|||
163233587|NCT00274716|589566150|FG003|Phase A|Withdrawal by Subject|3|||
163233588|NCT00274716|589566151|FG004|Phase A|Withdrawal by Subject|0|||
163233589|NCT00274716|589566152|FG005|Phase A|Withdrawal by Subject|1|||
163233590|NCT00274716|589566147|FG000|Phase A|Adverse Event|2|||
163233591|NCT00274716|589566148|FG001|Phase A|Adverse Event|3|||
163233592|NCT00274716|589566149|FG002|Phase A|Adverse Event|3|||
163233593|NCT00274716|589566150|FG003|Phase A|Adverse Event|0|||
163233594|NCT00274716|589566151|FG004|Phase A|Adverse Event|2|||
163233595|NCT00274716|589566152|FG005|Phase A|Adverse Event|0|||
163233596|NCT00274716|589566147|FG000|Phase A|Completed but did not enter Phase B|1|||
163233597|NCT00274716|589566148|FG001|Phase A|Completed but did not enter Phase B|2|||
163233598|NCT00274716|589566149|FG002|Phase A|Completed but did not enter Phase B|2|||
163233599|NCT00274716|589566150|FG003|Phase A|Completed but did not enter Phase B|2|||
163233600|NCT00274716|589566151|FG004|Phase A|Completed but did not enter Phase B|1|||
163233601|NCT00274716|589566152|FG005|Phase A|Completed but did not enter Phase B|1|||
163233602|NCT00274716|589566147|FG000|Phase B|Adverse Event|0|||
163233603|NCT00274716|589566148|FG001|Phase B|Adverse Event|0|||
163233604|NCT00274716|589566149|FG002|Phase B|Adverse Event|2|||
163233605|NCT00274716|589566150|FG003|Phase B|Adverse Event|0|||
163233606|NCT00274716|589566151|FG004|Phase B|Adverse Event|0|||
163233607|NCT00274716|589566152|FG005|Phase B|Adverse Event|1|||
163233608|NCT00274716|589566147|FG000|Phase B|Protocol Violation|0|||
163233609|NCT00274716|589566148|FG001|Phase B|Protocol Violation|2|||
163233610|NCT00274716|589566149|FG002|Phase B|Protocol Violation|0|||
163233611|NCT00274716|589566150|FG003|Phase B|Protocol Violation|0|||
163233612|NCT00274716|589566151|FG004|Phase B|Protocol Violation|0|||
163233613|NCT00274716|589566152|FG005|Phase B|Protocol Violation|0|||
163233614|NCT00274716|589566147|FG000|Phase B|Withdrawal by Subject|0|||
163233615|NCT00274716|589566148|FG001|Phase B|Withdrawal by Subject|1|||
163233616|NCT00274716|589566149|FG002|Phase B|Withdrawal by Subject|0|||
163233617|NCT00274716|589566150|FG003|Phase B|Withdrawal by Subject|0|||
163233618|NCT00274716|589566151|FG004|Phase B|Withdrawal by Subject|0|||
163233619|NCT00274716|589566152|FG005|Phase B|Withdrawal by Subject|0|||
163233620|NCT00274716|589566147|FG000|Phase B|Participant moved|1|||
163233621|NCT00274716|589566148|FG001|Phase B|Participant moved|0|||
163233622|NCT00274716|589566149|FG002|Phase B|Participant moved|0|||
163233623|NCT00274716|589566150|FG003|Phase B|Participant moved|0|||
163233624|NCT00274716|589566151|FG004|Phase B|Participant moved|0|||
163233625|NCT00274716|589566152|FG005|Phase B|Participant moved|0|||
163233626|NCT00274716|589566147|FG000|Phase B|Other non-reported reason|0|||
163233627|NCT00274716|589566148|FG001|Phase B|Other non-reported reason|0|||
163233628|NCT00274716|589566149|FG002|Phase B|Other non-reported reason|1|||
163233629|NCT00274716|589566150|FG003|Phase B|Other non-reported reason|1|||
163233630|NCT00274716|589566151|FG004|Phase B|Other non-reported reason|0|||
163233631|NCT00274716|589566152|FG005|Phase B|Other non-reported reason|0|||
163233632|NCT00274716|589566147|FG000|Phase B|Lost to Follow-up|0|||
163233633|NCT00274716|589566148|FG001|Phase B|Lost to Follow-up|1|||
163233634|NCT00274716|589566149|FG002|Phase B|Lost to Follow-up|0|||
163233635|NCT00274716|589566150|FG003|Phase B|Lost to Follow-up|0|||
163233636|NCT00274716|589566151|FG004|Phase B|Lost to Follow-up|0|||
163233637|NCT00274716|589566152|FG005|Phase B|Lost to Follow-up|0|||
163233638|NCT01257204|589566153|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
163233639|NCT01257204|589566154|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
163233640|NCT01257204|589566155|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
163233641|NCT01257204|589566153|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
163233642|NCT01257204|589566154|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
163233643|NCT01257204|589566155|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
163233644|NCT01257204|589566153|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
163233645|NCT01257204|589566154|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
163233646|NCT01257204|589566155|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
163233647|NCT01257204|589566153|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
163233648|NCT01257204|589566154|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
163233649|NCT01257204|589566155|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
163233650|NCT01257204|589566153|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
163233651|NCT01257204|589566154|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
163233652|NCT01257204|589566155|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
163233653|NCT01257204|589566153|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
163233654|NCT01257204|589566154|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
163347300|NCT03356145|589979429|FG000|Overall Study|Did not meet inclusion criteria|1|||
163233655|NCT01257204|589566155|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
163233656|NCT01257204|589566153|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
163233657|NCT01257204|589566154|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
163233658|NCT01257204|589566155|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
163233659|NCT01257204|589566153|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
163233660|NCT01257204|589566154|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
163233661|NCT01257204|589566155|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
163233662|NCT01257204|589566153|FG000|Follow-up Period (up to Week 48)|Other|0|||
163233663|NCT01257204|589566154|FG001|Follow-up Period (up to Week 48)|Other|0|||
163233664|NCT01257204|589566155|FG002|Follow-up Period (up to Week 48)|Other|5|||
163233665|NCT03394391|589566156|FG000|Overall Study|Lost to Follow-up|1|||
163233666|NCT03394391|589566157|FG001|Overall Study|Lost to Follow-up|2|||
163233667|NCT00723801|589566163|FG000|Overall Study|Lost to Follow-up|1|||
163233668|NCT00723801|589566164|FG001|Overall Study|Lost to Follow-up|2|||
163233669|NCT00723801|589566163|FG000|Overall Study|Protocol Violation|2|||
163233670|NCT00723801|589566164|FG001|Overall Study|Protocol Violation|1|||
163233671|NCT02489981|589566168|FG000|Overall Study|Adverse Event|21|||
163233672|NCT02489981|589566168|FG000|Overall Study|Insufficient effectiveness|16|||
163233673|NCT02489981|589566168|FG000|Overall Study|Improved|31|||
163233674|NCT02489981|589566168|FG000|Overall Study|Lost to Follow-up|31|||
163233675|NCT02489981|589566168|FG000|Overall Study|Other than listed|28|||
163233676|NCT01565993|589566176|FG000|Overall Study|Physician Decision|0|||
163233677|NCT01565993|589566177|FG001|Overall Study|Physician Decision|3|||
163233678|NCT04086472|589566180|FG000|Overall Study|Lost to Follow-up|1|||
163233679|NCT04086472|589566181|FG001|Overall Study|Lost to Follow-up|0|||
163233680|NCT04086472|589566182|FG002|Overall Study|Lost to Follow-up|0|||
163233681|NCT04086472|589566183|FG003|Overall Study|Lost to Follow-up|0|||
163233682|NCT04086472|589566184|FG004|Overall Study|Lost to Follow-up|1|||
163233683|NCT04086472|589566180|FG000|Overall Study|Physician Decision|0|||
163233684|NCT04086472|589566181|FG001|Overall Study|Physician Decision|1|||
163233685|NCT04086472|589566182|FG002|Overall Study|Physician Decision|1|||
163233686|NCT04086472|589566183|FG003|Overall Study|Physician Decision|0|||
163233687|NCT04086472|589566184|FG004|Overall Study|Physician Decision|0|||
163233688|NCT04086472|589566180|FG000|Overall Study|Withdrawal by Subject|1|||
163233689|NCT04086472|589566181|FG001|Overall Study|Withdrawal by Subject|1|||
163233690|NCT04086472|589566182|FG002|Overall Study|Withdrawal by Subject|1|||
163233691|NCT04086472|589566183|FG003|Overall Study|Withdrawal by Subject|0|||
163233692|NCT04086472|589566184|FG004|Overall Study|Withdrawal by Subject|0|||
163233693|NCT04086472|589566180|FG000|Overall Study|Various reasons|2|||
163233694|NCT04086472|589566181|FG001|Overall Study|Various reasons|0|||
163233695|NCT04086472|589566182|FG002|Overall Study|Various reasons|0|||
163233696|NCT04086472|589566183|FG003|Overall Study|Various reasons|3|||
163233697|NCT04086472|589566184|FG004|Overall Study|Various reasons|1|||
163233698|NCT03348904|589566185|FG000|Overall Study|Administrative reason by the sponsor|0|||
163233699|NCT03348904|589566186|FG001|Overall Study|Administrative reason by the sponsor|1|||
163233700|NCT03348904|589566187|FG002|Overall Study|Administrative reason by the sponsor|0|||
163233701|NCT00436280|589566193|FG000|Period 1: Induction|Adverse Event|8|||
163233702|NCT00436280|589566193|FG000|Period 1: Induction|Progressive Disease|12|||
163233703|NCT00436280|589566193|FG000|Period 1: Induction|Stable Disease|6|||
163233704|NCT00436280|589566193|FG000|Period 1: Induction|Withdrawal by Subject|1|||
163233705|NCT00436280|589566193|FG000|Period 1: Induction|Death|1|||
163233706|NCT00436280|589566193|FG000|Period 2: Consolidation|Adverse Event|1|||
163233707|NCT00436280|589566193|FG000|Period 2: Consolidation|Progressive Disease|10|||
163233708|NCT00436280|589566193|FG000|Period 2: Consolidation|Stable Disease|1|||
163233709|NCT00436280|589566193|FG000|Period 2: Consolidation|Physician Decision|2|||
163233710|NCT00436280|589566193|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
163233711|NCT00436280|589566193|FG000|Period 2: Consolidation|Death|1|||
163233712|NCT00436280|589566193|FG000|Period 3: Maintenance|Adverse Event|6|||
163233713|NCT00436280|589566193|FG000|Period 3: Maintenance|Progressive Disease|12|||
163233714|NCT01532687|589566198|FG000|Overall Study|Death|2|||
163233715|NCT01532687|589566199|FG001|Overall Study|Death|0|||
163233716|NCT01532687|589566198|FG000|Overall Study|Adverse Event|6|||
163233717|NCT01532687|589566199|FG001|Overall Study|Adverse Event|1|||
163233718|NCT01532687|589566198|FG000|Overall Study|Withdrawal by Subject|1|||
163233719|NCT01532687|589566199|FG001|Overall Study|Withdrawal by Subject|0|||
163233720|NCT01532687|589566198|FG000|Overall Study|Physician Decision|2|||
163233721|NCT01532687|589566199|FG001|Overall Study|Physician Decision|1|||
163233722|NCT01532687|589566198|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
163233723|NCT01532687|589566199|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
163233724|NCT04116229|589566200|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
163233725|NCT04116229|589566201|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
163233726|NCT04116229|589566200|FG000|Overall Study|Scheduling not possible.|0|||
163233727|NCT04116229|589566201|FG001|Overall Study|Scheduling not possible.|1|||
163233728|NCT02809976|589566204|FG000|Overall Study|Lost to Follow-up|1|||
163233729|NCT02809976|589566204|FG000|Overall Study|Withdrawal by Subject|1|||
163233730|NCT01513291|589566205|FG000|Treatment Period|Adverse Event|8|||
163233731|NCT01513291|589566206|FG001|Treatment Period|Adverse Event|4|||
163233732|NCT01513291|589566207|FG002|Treatment Period|Adverse Event|0|||
163347301|NCT03356145|589979430|FG001|Overall Study|Did not meet inclusion criteria|0|||
163347302|NCT00714688|589979440|FG000|Overall Study|Lack of Efficacy|14|||
163347303|NCT00714688|589979441|FG001|Overall Study|Lack of Efficacy|1|||
163347304|NCT00714688|589979442|FG002|Overall Study|Lack of Efficacy|4|||
163347305|NCT00714688|589979440|FG000|Overall Study|Withdrawal by Subject|4|||
163347306|NCT00714688|589979441|FG001|Overall Study|Withdrawal by Subject|3|||
163233733|NCT01513291|589566208|FG003|Treatment Period|Adverse Event|0|||
163233734|NCT01513291|589566209|FG004|Treatment Period|Adverse Event|0|||
163233735|NCT01513291|589566205|FG000|Treatment Period|Lack of Efficacy|3|||
163233736|NCT01513291|589566206|FG001|Treatment Period|Lack of Efficacy|0|||
163233737|NCT01513291|589566207|FG002|Treatment Period|Lack of Efficacy|0|||
163233738|NCT01513291|589566208|FG003|Treatment Period|Lack of Efficacy|0|||
163233739|NCT01513291|589566209|FG004|Treatment Period|Lack of Efficacy|0|||
163233740|NCT01513291|589566205|FG000|Treatment Period|Lost to Follow-up|2|||
163347307|NCT00714688|589979442|FG002|Overall Study|Withdrawal by Subject|3|||
163233741|NCT01513291|589566206|FG001|Treatment Period|Lost to Follow-up|3|||
163233742|NCT01513291|589566207|FG002|Treatment Period|Lost to Follow-up|0|||
163233743|NCT01513291|589566208|FG003|Treatment Period|Lost to Follow-up|0|||
163233744|NCT01513291|589566209|FG004|Treatment Period|Lost to Follow-up|0|||
163233745|NCT01513291|589566205|FG000|Treatment Period|Physician Decision|1|||
163347308|NCT00714688|589979440|FG000|Overall Study|Lost to Follow-up|5|||
163347309|NCT00714688|589979441|FG001|Overall Study|Lost to Follow-up|2|||
163347310|NCT00714688|589979442|FG002|Overall Study|Lost to Follow-up|0|||
163347311|NCT00714688|589979440|FG000|Overall Study|Adverse Event|2|||
163347312|NCT00714688|589979441|FG001|Overall Study|Adverse Event|15|||
163347313|NCT00714688|589979442|FG002|Overall Study|Adverse Event|19|||
163347314|NCT00714688|589979440|FG000|Overall Study|Subject Non-compliant|3|||
163347315|NCT00714688|589979441|FG001|Overall Study|Subject Non-compliant|5|||
163347316|NCT00714688|589979442|FG002|Overall Study|Subject Non-compliant|5|||
163347317|NCT00714688|589979440|FG000|Overall Study|Ineligible to Continue the Study|0|||
163347318|NCT00714688|589979441|FG001|Overall Study|Ineligible to Continue the Study|1|||
163347319|NCT00714688|589979442|FG002|Overall Study|Ineligible to Continue the Study|1|||
163347320|NCT00714688|589979440|FG000|Overall Study|Sponsor's Decision|0|||
163347321|NCT00714688|589979441|FG001|Overall Study|Sponsor's Decision|2|||
163347322|NCT00714688|589979442|FG002|Overall Study|Sponsor's Decision|0|||
163347323|NCT00714688|589979440|FG000|Overall Study|Other|1|||
163347324|NCT00714688|589979441|FG001|Overall Study|Other|6|||
163347325|NCT00714688|589979442|FG002|Overall Study|Other|5|||
163347326|NCT01786551|589979443|FG000|Overall Study|Participant withdrew consent|2|||
163347327|NCT01524887|589979444|FG000|Overall Study|Withdrawal by Subject|6|||
163347328|NCT01524887|589979445|FG001|Overall Study|Withdrawal by Subject|2|||
163347329|NCT01524887|589979446|FG002|Overall Study|Withdrawal by Subject|3|||
163347330|NCT01524887|589979444|FG000|Overall Study|Adverse Event|5|||
163347331|NCT01524887|589979445|FG001|Overall Study|Adverse Event|1|||
163347332|NCT01524887|589979446|FG002|Overall Study|Adverse Event|1|||
163347333|NCT01524887|589979444|FG000|Overall Study|Protocol Violation|0|||
163347334|NCT01524887|589979445|FG001|Overall Study|Protocol Violation|0|||
163347335|NCT01524887|589979446|FG002|Overall Study|Protocol Violation|1|||
163347336|NCT01524887|589979444|FG000|Overall Study|Study termination|73|||
163347337|NCT01524887|589979445|FG001|Overall Study|Study termination|87|||
163347338|NCT01524887|589979446|FG002|Overall Study|Study termination|79|||
163347339|NCT01524887|589979444|FG000|Overall Study|Withdrawal by Caregiver|0|||
163347340|NCT01524887|589979445|FG001|Overall Study|Withdrawal by Caregiver|0|||
163347341|NCT01524887|589979446|FG002|Overall Study|Withdrawal by Caregiver|2|||
163347342|NCT01524887|589979444|FG000|Overall Study|Use of prohibited medication|1|||
163347343|NCT01524887|589979445|FG001|Overall Study|Use of prohibited medication|0|||
163347344|NCT01524887|589979446|FG002|Overall Study|Use of prohibited medication|0|||
163347345|NCT03993054|589979449|FG000|Overall Study|PI Decision|1|||
163347346|NCT00383500|589979450|FG000|Overall Study|Withdrawal by Subject|8|||
163347347|NCT00383500|589979451|FG001|Overall Study|Withdrawal by Subject|3|||
163347348|NCT00383500|589979452|FG002|Overall Study|Withdrawal by Subject|0|||
163347349|NCT00383500|589979450|FG000|Overall Study|Lost to Follow-up|0|||
163347350|NCT00383500|589979451|FG001|Overall Study|Lost to Follow-up|0|||
163347351|NCT00383500|589979452|FG002|Overall Study|Lost to Follow-up|2|||
163347352|NCT02956278|589981497|FG000|Overall Study|Withdrawal by Subject|6|||
163347353|NCT02956278|589981498|FG001|Overall Study|Withdrawal by Subject|2|||
163347354|NCT02956278|589981499|FG002|Overall Study|Withdrawal by Subject|0|||
163347355|NCT01967719|589981500|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
163347356|NCT01967719|589981501|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
163347357|NCT01967719|589981502|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
163347358|NCT01967719|589981503|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
163347359|NCT01967719|589981500|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
163347360|NCT01967719|589981501|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
163347361|NCT01967719|589981502|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
163347362|NCT01967719|589981503|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
163347363|NCT00961896|589981512|FG000|Overall Study|Abnormal laboratory value|0|||
163347364|NCT00961896|589981513|FG001|Overall Study|Abnormal laboratory value|0|||
163347365|NCT00961896|589981514|FG002|Overall Study|Abnormal laboratory value|1|||
163347366|NCT00848393|589981515|FG000|Overall Study|Protocol Violation|0|||
163347367|NCT00848393|589981516|FG001|Overall Study|Protocol Violation|0|||
163347368|NCT00848393|589981517|FG002|Overall Study|Protocol Violation|1|||
163347369|NCT00848393|589981515|FG000|Overall Study|surgical complications unrelated to stud|0|||
163347370|NCT00848393|589981516|FG001|Overall Study|surgical complications unrelated to stud|0|||
163347371|NCT00848393|589981517|FG002|Overall Study|surgical complications unrelated to stud|2|||
163347372|NCT00755716|589981520|FG000|Overall Study|Adverse Event|1|||
163347373|NCT00755716|589981521|FG001|Overall Study|Adverse Event|4|||
163347374|NCT00755716|589981522|FG002|Overall Study|Adverse Event|1|||
163347375|NCT00755716|589981520|FG000|Overall Study|Lack of Efficacy|2|||
163347376|NCT00755716|589981521|FG001|Overall Study|Lack of Efficacy|0|||
163347377|NCT00755716|589981522|FG002|Overall Study|Lack of Efficacy|0|||
163347378|NCT00755716|589981520|FG000|Overall Study|Lost to Follow-up|5|||
163347379|NCT00755716|589981521|FG001|Overall Study|Lost to Follow-up|3|||
163347380|NCT00755716|589981522|FG002|Overall Study|Lost to Follow-up|1|||
163347381|NCT00755716|589981520|FG000|Overall Study|work schedule issues|0|||
163347382|NCT00755716|589981521|FG001|Overall Study|work schedule issues|1|||
163347383|NCT00755716|589981522|FG002|Overall Study|work schedule issues|1|||
163347384|NCT02229396|589981523|FG000|Overall Study|Adverse Event|6|||
163347385|NCT02229396|589981524|FG001|Overall Study|Adverse Event|12|||
163347386|NCT02229396|589981525|FG002|Overall Study|Adverse Event|12|||
163347387|NCT02229396|589981523|FG000|Overall Study|Death|2|||
163347388|NCT02229396|589981524|FG001|Overall Study|Death|3|||
163347389|NCT02229396|589981525|FG002|Overall Study|Death|1|||
163347390|NCT02229396|589981523|FG000|Overall Study|Lost to Follow-up|14|||
163347391|NCT02229396|589981524|FG001|Overall Study|Lost to Follow-up|14|||
163347392|NCT02229396|589981525|FG002|Overall Study|Lost to Follow-up|21|||
163347393|NCT02229396|589981523|FG000|Overall Study|Protocol Violation|2|||
163347394|NCT02229396|589981524|FG001|Overall Study|Protocol Violation|1|||
163347395|NCT02229396|589981525|FG002|Overall Study|Protocol Violation|0|||
163347396|NCT02229396|589981523|FG000|Overall Study|Patient Incorrectly Randomized|0|||
163347397|NCT02229396|589981524|FG001|Overall Study|Patient Incorrectly Randomized|0|||
163347398|NCT02229396|589981525|FG002|Overall Study|Patient Incorrectly Randomized|1|||
163347399|NCT02229396|589981523|FG000|Overall Study|Other|10|||
163347400|NCT02229396|589981524|FG001|Overall Study|Other|18|||
163347401|NCT02229396|589981525|FG002|Overall Study|Other|15|||
163347402|NCT02229396|589981523|FG000|Overall Study|Withdrawal by Subject|42|||
163347403|NCT02229396|589981524|FG001|Overall Study|Withdrawal by Subject|28|||
163347404|NCT02229396|589981525|FG002|Overall Study|Withdrawal by Subject|41|||
163347405|NCT02229396|589981523|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
163347406|NCT02229396|589981524|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
163347407|NCT02229396|589981525|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
163347408|NCT02229396|589981523|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
163347409|NCT02229396|589981524|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
163347410|NCT02229396|589981525|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
163347411|NCT02679079|589981529|FG000|Overall Study|Adverse Event|2|||
163347412|NCT02679079|589981530|FG001|Overall Study|Adverse Event|0|||
163347413|NCT02679079|589981531|FG002|Overall Study|Adverse Event|2|||
163347414|NCT02679079|589981529|FG000|Overall Study|Protocol Violation|0|||
163347415|NCT02679079|589981530|FG001|Overall Study|Protocol Violation|1|||
163347416|NCT02679079|589981531|FG002|Overall Study|Protocol Violation|0|||
163347417|NCT02679079|589981529|FG000|Overall Study|Withdrawal by Subject|2|||
163347418|NCT02679079|589981530|FG001|Overall Study|Withdrawal by Subject|1|||
163347419|NCT02679079|589981531|FG002|Overall Study|Withdrawal by Subject|0|||
163347420|NCT00520403|589981532|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
163347421|NCT00520403|589981532|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
163347422|NCT00520403|589981532|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
163347423|NCT00520403|589981532|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
163347424|NCT00520403|589981532|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
163347425|NCT00520403|589981532|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
163347426|NCT00520403|589981532|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
163347427|NCT00520403|589981532|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
163347428|NCT00805285|589981535|FG000|Overall Study|Lack of Efficacy|1|||
163347429|NCT00839306|589981539|FG000|Overall Study|Adverse Event|3|||
163347430|NCT00839306|589981540|FG001|Overall Study|Adverse Event|5|||
163347431|NCT00839306|589981539|FG000|Overall Study|Lost to Follow-up|6|||
163347432|NCT00839306|589981540|FG001|Overall Study|Lost to Follow-up|9|||
163347433|NCT00839306|589981539|FG000|Overall Study|Withdrawal by Subject|5|||
163347434|NCT00839306|589981540|FG001|Overall Study|Withdrawal by Subject|7|||
163347435|NCT00839306|589981539|FG000|Overall Study|Lack of Efficacy|5|||
163347436|NCT00839306|589981540|FG001|Overall Study|Lack of Efficacy|4|||
163347437|NCT00839306|589981539|FG000|Overall Study|Other|6|||
163347438|NCT00839306|589981540|FG001|Overall Study|Other|18|||
163347439|NCT01812707|589981541|FG000|Overall Study|Adverse Event|0|||
163347440|NCT01812707|589981542|FG001|Overall Study|Adverse Event|0|||
163347441|NCT01812707|589981543|FG002|Overall Study|Adverse Event|0|||
163347442|NCT01812707|589981544|FG003|Overall Study|Adverse Event|2|||
163347443|NCT01812707|589981541|FG000|Overall Study|Poor compliance to protocol|1|||
163347444|NCT01812707|589981542|FG001|Overall Study|Poor compliance to protocol|0|||
163347445|NCT01812707|589981543|FG002|Overall Study|Poor compliance to protocol|0|||
163347446|NCT01812707|589981544|FG003|Overall Study|Poor compliance to protocol|0|||
163347447|NCT01812707|589981541|FG000|Overall Study|Consent withdrawn by participant|1|||
163139784|NCT01508169|589221932|FG000|Overall Study|Adverse Event|1|||
163139785|NCT01508169|589221933|FG001|Overall Study|Adverse Event|0|||
163139786|NCT01508169|589221932|FG000|Overall Study|Withdrawal by Subject|1|||
163139787|NCT01508169|589221933|FG001|Overall Study|Withdrawal by Subject|0|||
163347448|NCT01812707|589981542|FG001|Overall Study|Consent withdrawn by participant|0|||
163347449|NCT01812707|589981543|FG002|Overall Study|Consent withdrawn by participant|0|||
163347450|NCT01812707|589981544|FG003|Overall Study|Consent withdrawn by participant|0|||
163347451|NCT05060237|589981546|FG000|Overall Study|Withdrawal by Subject|4|||
163139788|NCT01508169|589221932|FG000|Overall Study|Lost to Follow-up|1|||
163347452|NCT05060237|589981546|FG000|Overall Study|Screening failure|8|||
163347453|NCT01066897|589981547|FG000|Overall Study|Withdrawal by Subject|1|||
163347454|NCT01066897|589981548|FG001|Overall Study|Withdrawal by Subject|0|||
163347455|NCT01066897|589981547|FG000|Overall Study|stopped study after developing the flu.|1|||
163347456|NCT01066897|589981548|FG001|Overall Study|stopped study after developing the flu.|0|||
163347457|NCT01697592|589981551|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
163347458|NCT01697592|589981552|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163347459|NCT01697592|589981553|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163347460|NCT01697592|589981554|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163347461|NCT01697592|589981555|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163347462|NCT01697592|589981556|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163347463|NCT01697592|589981557|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163347464|NCT01697592|589981558|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163347465|NCT01697592|589981559|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163347466|NCT01697592|589981560|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163347467|NCT01697592|589981551|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163347468|NCT01697592|589981552|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163347469|NCT01697592|589981553|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163347470|NCT01697592|589981554|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163347471|NCT01697592|589981555|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163347472|NCT01697592|589981556|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
163347473|NCT01697592|589981557|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163347474|NCT01697592|589981558|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163347475|NCT01697592|589981559|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163347476|NCT01697592|589981560|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163347477|NCT01697592|589981551|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
163347478|NCT01697592|589981552|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163347479|NCT01697592|589981553|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163347480|NCT01697592|589981554|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163347481|NCT01697592|589981555|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163347482|NCT01697592|589981556|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163347483|NCT01697592|589981557|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163347484|NCT01697592|589981558|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163347485|NCT01697592|589981559|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163347486|NCT01697592|589981560|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163347487|NCT01697592|589981551|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
163347488|NCT01697592|589981552|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
163347489|NCT01697592|589981553|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
163347490|NCT01697592|589981554|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
163347491|NCT01697592|589981555|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
163347492|NCT01697592|589981556|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
163347493|NCT01697592|589981557|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
163347494|NCT01697592|589981558|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
163347495|NCT01697592|589981559|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
163347496|NCT01697592|589981560|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
163347497|NCT01697592|589981551|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
163347498|NCT01697592|589981552|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
163347499|NCT01697592|589981553|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
163347500|NCT01697592|589981554|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
163347501|NCT01697592|589981555|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
163347502|NCT01697592|589981556|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
163347503|NCT01697592|589981557|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
163347504|NCT01697592|589981558|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
163347505|NCT01697592|589981559|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
163347506|NCT01697592|589981560|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
163233746|NCT01513291|589566206|FG001|Treatment Period|Physician Decision|0|||
163233747|NCT01513291|589566207|FG002|Treatment Period|Physician Decision|0|||
163233748|NCT01513291|589566208|FG003|Treatment Period|Physician Decision|0|||
163233749|NCT01513291|589566209|FG004|Treatment Period|Physician Decision|0|||
163233750|NCT01513291|589566205|FG000|Treatment Period|Protocol Violation|1|||
163233751|NCT01513291|589566206|FG001|Treatment Period|Protocol Violation|2|||
163233752|NCT01513291|589566207|FG002|Treatment Period|Protocol Violation|0|||
163233753|NCT01513291|589566208|FG003|Treatment Period|Protocol Violation|0|||
163233754|NCT01513291|589566209|FG004|Treatment Period|Protocol Violation|0|||
163347507|NCT01697592|589981551|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
163347508|NCT01697592|589981552|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
163347509|NCT01697592|589981553|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
163347510|NCT01697592|589981554|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
163347511|NCT01697592|589981555|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
163233755|NCT01513291|589566205|FG000|Treatment Period|Withdrawal by Subject|8|||
163233756|NCT01513291|589566206|FG001|Treatment Period|Withdrawal by Subject|5|||
163347512|NCT01697592|589981556|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
163347513|NCT01697592|589981557|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
163233757|NCT01513291|589566207|FG002|Treatment Period|Withdrawal by Subject|0|||
163233758|NCT01513291|589566208|FG003|Treatment Period|Withdrawal by Subject|0|||
163347514|NCT01697592|589981558|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
163347515|NCT01697592|589981559|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
163347516|NCT01697592|589981560|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
163347517|NCT01697592|589981551|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
163347518|NCT01697592|589981552|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
163347519|NCT01697592|589981553|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
163347520|NCT01697592|589981554|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
163347521|NCT01697592|589981555|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
163347522|NCT01697592|589981556|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
163347523|NCT01697592|589981557|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
163347524|NCT01697592|589981558|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
163347525|NCT01697592|589981559|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
163347526|NCT01697592|589981560|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
163347527|NCT01697592|589981551|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
163347528|NCT01697592|589981552|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
163347529|NCT01697592|589981553|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
163347530|NCT01697592|589981554|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
163347531|NCT01697592|589981555|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
163347532|NCT01697592|589981556|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
163347533|NCT01697592|589981557|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
163347534|NCT01697592|589981558|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
163347535|NCT01697592|589981559|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
163347536|NCT01697592|589981560|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
163347537|NCT02396758|589981561|FG000|Overall Study|Withdrawal by Subject|2|||
163347538|NCT02396758|589981562|FG001|Overall Study|Withdrawal by Subject|0|||
163347539|NCT02396758|589981563|FG002|Overall Study|Withdrawal by Subject|0|||
163347540|NCT02396758|589981564|FG003|Overall Study|Withdrawal by Subject|1|||
163347541|NCT02396758|589981561|FG000|Overall Study|Lost to Follow-up|8|||
163347542|NCT02396758|589981562|FG001|Overall Study|Lost to Follow-up|5|||
163347543|NCT02396758|589981563|FG002|Overall Study|Lost to Follow-up|3|||
163347544|NCT02396758|589981564|FG003|Overall Study|Lost to Follow-up|3|||
163347545|NCT02396758|589981561|FG000|Overall Study|Death|1|||
163347546|NCT02396758|589981562|FG001|Overall Study|Death|1|||
163347547|NCT02396758|589981563|FG002|Overall Study|Death|0|||
163347548|NCT02396758|589981564|FG003|Overall Study|Death|1|||
163347549|NCT02396758|589981561|FG000|Overall Study|Randomized but not treated|1|||
163139789|NCT01508169|589221933|FG001|Overall Study|Lost to Follow-up|2|||
163139790|NCT03600740|589221942|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
163139791|NCT00556998|589221947|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
163139792|NCT00556998|589221947|FG000|Voriconazole Intravenous (IV)|Other|4|||
163139793|NCT00556998|589221947|FG000|Voriconazole Oral|Adverse Event|1|||
163139794|NCT00556998|589221947|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
163139795|NCT02721875|589221948|FG000|Overall Study|Progressive disease/relapse|1|||
163139796|NCT02721875|589221949|FG001|Overall Study|Progressive disease/relapse|0|||
163139797|NCT02888106|589221950|FG000|Overall Study|Withdrawal by Subject|1|||
163139798|NCT02888106|589221951|FG001|Overall Study|Withdrawal by Subject|2|||
163139799|NCT02888106|589221952|FG002|Overall Study|Withdrawal by Subject|0|||
163139800|NCT02888106|589221953|FG003|Overall Study|Withdrawal by Subject|1|||
163139801|NCT02888106|589221954|FG004|Overall Study|Withdrawal by Subject|0|||
163139802|NCT02888106|589221955|FG005|Overall Study|Withdrawal by Subject|0|||
163139803|NCT02888106|589221950|FG000|Overall Study|Lost to Follow-up|1|||
163139804|NCT02888106|589221951|FG001|Overall Study|Lost to Follow-up|0|||
163139805|NCT02888106|589221952|FG002|Overall Study|Lost to Follow-up|0|||
163139806|NCT02888106|589221953|FG003|Overall Study|Lost to Follow-up|1|||
163139807|NCT02888106|589221954|FG004|Overall Study|Lost to Follow-up|0|||
163139808|NCT02888106|589221955|FG005|Overall Study|Lost to Follow-up|1|||
163139809|NCT02888106|589221950|FG000|Overall Study|Adverse Event|2|||
163139810|NCT02888106|589221951|FG001|Overall Study|Adverse Event|0|||
163139811|NCT02888106|589221952|FG002|Overall Study|Adverse Event|0|||
163139812|NCT02888106|589221953|FG003|Overall Study|Adverse Event|0|||
163139813|NCT02888106|589221954|FG004|Overall Study|Adverse Event|0|||
163139814|NCT02888106|589221955|FG005|Overall Study|Adverse Event|0|||
163139815|NCT02888106|589221950|FG000|Overall Study|Withdrawal of consent|0|||
163139816|NCT02888106|589221951|FG001|Overall Study|Withdrawal of consent|0|||
163139817|NCT02888106|589221952|FG002|Overall Study|Withdrawal of consent|0|||
163139818|NCT02888106|589221953|FG003|Overall Study|Withdrawal of consent|0|||
163347550|NCT02396758|589981562|FG001|Overall Study|Randomized but not treated|0|||
163347551|NCT02396758|589981563|FG002|Overall Study|Randomized but not treated|1|||
163347552|NCT02396758|589981564|FG003|Overall Study|Randomized but not treated|0|||
163347553|NCT01631825|589981565|FG000|Overall Study|Adverse Event|42|||
163347554|NCT01631825|589981565|FG000|Overall Study|Lack of Efficacy|7|||
163139819|NCT02888106|589221954|FG004|Overall Study|Withdrawal of consent|1|||
163139820|NCT02888106|589221955|FG005|Overall Study|Withdrawal of consent|0|||
163139821|NCT02888106|589221950|FG000|Overall Study|Pregnancy|1|||
163139822|NCT02888106|589221951|FG001|Overall Study|Pregnancy|0|||
163139823|NCT02888106|589221952|FG002|Overall Study|Pregnancy|0|||
163139824|NCT02888106|589221953|FG003|Overall Study|Pregnancy|0|||
163139825|NCT02888106|589221954|FG004|Overall Study|Pregnancy|0|||
163139826|NCT02888106|589221955|FG005|Overall Study|Pregnancy|0|||
163139827|NCT01425801|589221961|FG000|Period 1|Withdrawal by Subject|0|||
163139828|NCT01425801|589221962|FG001|Period 1|Withdrawal by Subject|0|||
163139829|NCT01425801|589221963|FG002|Period 1|Withdrawal by Subject|0|||
163139830|NCT01425801|589221964|FG003|Period 1|Withdrawal by Subject|0|||
163139831|NCT01425801|589221965|FG004|Period 1|Withdrawal by Subject|1|||
163139832|NCT01425801|589221966|FG005|Period 1|Withdrawal by Subject|0|||
163139833|NCT01425801|589221961|FG000|Period 2|Withdrawal by Subject|0|||
163139834|NCT01425801|589221962|FG001|Period 2|Withdrawal by Subject|0|||
163139835|NCT01425801|589221963|FG002|Period 2|Withdrawal by Subject|0|||
163139836|NCT01425801|589221964|FG003|Period 2|Withdrawal by Subject|0|||
163139837|NCT01425801|589221965|FG004|Period 2|Withdrawal by Subject|1|||
163139838|NCT01425801|589221966|FG005|Period 2|Withdrawal by Subject|0|||
163139839|NCT01425801|589221961|FG000|Period 3|Stability criteria not fullfilled|0|||
163139840|NCT01425801|589221962|FG001|Period 3|Stability criteria not fullfilled|0|||
163139841|NCT01425801|589221963|FG002|Period 3|Stability criteria not fullfilled|1|||
163139842|NCT01425801|589221964|FG003|Period 3|Stability criteria not fullfilled|0|||
163139843|NCT01425801|589221965|FG004|Period 3|Stability criteria not fullfilled|0|||
163139844|NCT01425801|589221966|FG005|Period 3|Stability criteria not fullfilled|0|||
163139845|NCT01425801|589221961|FG000|Period 4|Not able to maintain visit schedule|0|||
163139846|NCT01425801|589221962|FG001|Period 4|Not able to maintain visit schedule|0|||
163139847|NCT01425801|589221963|FG002|Period 4|Not able to maintain visit schedule|1|||
163139848|NCT01425801|589221964|FG003|Period 4|Not able to maintain visit schedule|0|||
163139849|NCT01425801|589221965|FG004|Period 4|Not able to maintain visit schedule|0|||
163139850|NCT01425801|589221966|FG005|Period 4|Not able to maintain visit schedule|0|||
163139851|NCT03386721|589221967|FG000|Overall Study|Death|12|||
163139852|NCT03386721|589221968|FG001|Overall Study|Death|21|||
163139853|NCT03386721|589221969|FG002|Overall Study|Death|2|||
163139854|NCT03386721|589221970|FG003|Overall Study|Death|5|||
163139855|NCT03386721|589221971|FG004|Overall Study|Death|1|||
163139856|NCT03386721|589221972|FG005|Overall Study|Death|12|||
163139857|NCT03386721|589221973|FG006|Overall Study|Death|1|||
163139858|NCT03386721|589221974|FG007|Overall Study|Death|1|||
163139859|NCT03386721|589221975|FG008|Overall Study|Death|12|||
163139860|NCT03386721|589221976|FG009|Overall Study|Death|20|||
163139861|NCT03386721|589221977|FG010|Overall Study|Death|21|||
163139862|NCT03386721|589221978|FG011|Overall Study|Death|21|||
163139863|NCT03386721|589221979|FG012|Overall Study|Death|14|||
163139864|NCT03386721|589221980|FG013|Overall Study|Death|2|||
163139865|NCT03386721|589221981|FG014|Overall Study|Death|1|||
163139866|NCT03386721|589221967|FG000|Overall Study|Lost to Follow-up|1|||
163139867|NCT03386721|589221968|FG001|Overall Study|Lost to Follow-up|3|||
163139868|NCT03386721|589221969|FG002|Overall Study|Lost to Follow-up|0|||
163139869|NCT03386721|589221970|FG003|Overall Study|Lost to Follow-up|0|||
163139870|NCT03386721|589221971|FG004|Overall Study|Lost to Follow-up|0|||
163139871|NCT03386721|589221972|FG005|Overall Study|Lost to Follow-up|2|||
163139872|NCT03386721|589221973|FG006|Overall Study|Lost to Follow-up|1|||
163139873|NCT03386721|589221974|FG007|Overall Study|Lost to Follow-up|0|||
163139874|NCT03386721|589221975|FG008|Overall Study|Lost to Follow-up|1|||
163139875|NCT03386721|589221976|FG009|Overall Study|Lost to Follow-up|2|||
163139876|NCT03386721|589221977|FG010|Overall Study|Lost to Follow-up|1|||
163139877|NCT03386721|589221978|FG011|Overall Study|Lost to Follow-up|0|||
163139878|NCT03386721|589221979|FG012|Overall Study|Lost to Follow-up|0|||
163139879|NCT03386721|589221980|FG013|Overall Study|Lost to Follow-up|0|||
163139880|NCT03386721|589221981|FG014|Overall Study|Lost to Follow-up|0|||
163139881|NCT03386721|589221967|FG000|Overall Study|Reason not specified|3|||
163139882|NCT03386721|589221968|FG001|Overall Study|Reason not specified|0|||
163139883|NCT03386721|589221969|FG002|Overall Study|Reason not specified|0|||
163139884|NCT03386721|589221970|FG003|Overall Study|Reason not specified|0|||
163139885|NCT03386721|589221971|FG004|Overall Study|Reason not specified|0|||
163139886|NCT03386721|589221972|FG005|Overall Study|Reason not specified|3|||
163139887|NCT03386721|589221973|FG006|Overall Study|Reason not specified|1|||
163139888|NCT03386721|589221974|FG007|Overall Study|Reason not specified|0|||
163139889|NCT03386721|589221975|FG008|Overall Study|Reason not specified|0|||
163139890|NCT03386721|589221976|FG009|Overall Study|Reason not specified|1|||
163139891|NCT03386721|589221977|FG010|Overall Study|Reason not specified|2|||
163139892|NCT03386721|589221978|FG011|Overall Study|Reason not specified|6|||
163139893|NCT03386721|589221979|FG012|Overall Study|Reason not specified|1|||
163139894|NCT03386721|589221980|FG013|Overall Study|Reason not specified|0|||
163233759|NCT01513291|589566209|FG004|Treatment Period|Withdrawal by Subject|0|||
163139895|NCT03386721|589221981|FG014|Overall Study|Reason not specified|0|||
163139896|NCT03386721|589221967|FG000|Overall Study|Progressive Disease|0|||
163139897|NCT03386721|589221968|FG001|Overall Study|Progressive Disease|0|||
163139898|NCT03386721|589221969|FG002|Overall Study|Progressive Disease|1|||
163139899|NCT03386721|589221970|FG003|Overall Study|Progressive Disease|0|||
163233760|NCT01513291|589566205|FG000|Treatment Period|Randomized not treated|0|||
163233761|NCT01513291|589566206|FG001|Treatment Period|Randomized not treated|2|||
163233762|NCT01513291|589566207|FG002|Treatment Period|Randomized not treated|0|||
163409307|NCT01142726|590207576|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
163139900|NCT03386721|589221971|FG004|Overall Study|Progressive Disease|0|||
163139901|NCT03386721|589221972|FG005|Overall Study|Progressive Disease|1|||
163139902|NCT03386721|589221973|FG006|Overall Study|Progressive Disease|0|||
163139903|NCT03386721|589221974|FG007|Overall Study|Progressive Disease|0|||
163139904|NCT03386721|589221975|FG008|Overall Study|Progressive Disease|2|||
163139905|NCT03386721|589221976|FG009|Overall Study|Progressive Disease|1|||
163139906|NCT03386721|589221977|FG010|Overall Study|Progressive Disease|1|||
163139907|NCT03386721|589221978|FG011|Overall Study|Progressive Disease|0|||
163139908|NCT03386721|589221979|FG012|Overall Study|Progressive Disease|1|||
163139909|NCT03386721|589221980|FG013|Overall Study|Progressive Disease|0|||
163139910|NCT03386721|589221981|FG014|Overall Study|Progressive Disease|0|||
163139911|NCT03386721|589221967|FG000|Overall Study|Site Terminated by Sponsor|5|||
163139912|NCT03386721|589221968|FG001|Overall Study|Site Terminated by Sponsor|5|||
163139913|NCT03386721|589221969|FG002|Overall Study|Site Terminated by Sponsor|0|||
163139914|NCT03386721|589221970|FG003|Overall Study|Site Terminated by Sponsor|0|||
163139915|NCT03386721|589221971|FG004|Overall Study|Site Terminated by Sponsor|1|||
163139916|NCT03386721|589221972|FG005|Overall Study|Site Terminated by Sponsor|3|||
163139917|NCT03386721|589221973|FG006|Overall Study|Site Terminated by Sponsor|0|||
163139918|NCT03386721|589221974|FG007|Overall Study|Site Terminated by Sponsor|1|||
163139919|NCT03386721|589221975|FG008|Overall Study|Site Terminated by Sponsor|4|||
163139920|NCT03386721|589221976|FG009|Overall Study|Site Terminated by Sponsor|5|||
163139921|NCT03386721|589221977|FG010|Overall Study|Site Terminated by Sponsor|3|||
163139922|NCT03386721|589221978|FG011|Overall Study|Site Terminated by Sponsor|11|||
163139923|NCT03386721|589221979|FG012|Overall Study|Site Terminated by Sponsor|6|||
163139924|NCT03386721|589221980|FG013|Overall Study|Site Terminated by Sponsor|0|||
163139925|NCT03386721|589221981|FG014|Overall Study|Site Terminated by Sponsor|0|||
163139926|NCT03386721|589221967|FG000|Overall Study|Symptomatic Deterioration|0|||
163139927|NCT03386721|589221968|FG001|Overall Study|Symptomatic Deterioration|0|||
163139928|NCT03386721|589221969|FG002|Overall Study|Symptomatic Deterioration|0|||
163139929|NCT03386721|589221970|FG003|Overall Study|Symptomatic Deterioration|0|||
163139930|NCT03386721|589221971|FG004|Overall Study|Symptomatic Deterioration|0|||
163139931|NCT03386721|589221972|FG005|Overall Study|Symptomatic Deterioration|0|||
163139932|NCT03386721|589221973|FG006|Overall Study|Symptomatic Deterioration|0|||
163139933|NCT03386721|589221974|FG007|Overall Study|Symptomatic Deterioration|0|||
163139934|NCT03386721|589221975|FG008|Overall Study|Symptomatic Deterioration|1|||
163139935|NCT03386721|589221976|FG009|Overall Study|Symptomatic Deterioration|0|||
163139936|NCT03386721|589221977|FG010|Overall Study|Symptomatic Deterioration|0|||
163139937|NCT03386721|589221978|FG011|Overall Study|Symptomatic Deterioration|1|||
163139938|NCT03386721|589221979|FG012|Overall Study|Symptomatic Deterioration|0|||
163139939|NCT03386721|589221980|FG013|Overall Study|Symptomatic Deterioration|0|||
163139940|NCT03386721|589221981|FG014|Overall Study|Symptomatic Deterioration|0|||
163139941|NCT03386721|589221967|FG000|Overall Study|Withdrawal by Subject|1|||
163139942|NCT03386721|589221968|FG001|Overall Study|Withdrawal by Subject|2|||
163139943|NCT03386721|589221969|FG002|Overall Study|Withdrawal by Subject|0|||
163139944|NCT03386721|589221970|FG003|Overall Study|Withdrawal by Subject|0|||
163139945|NCT03386721|589221971|FG004|Overall Study|Withdrawal by Subject|0|||
163139946|NCT03386721|589221972|FG005|Overall Study|Withdrawal by Subject|0|||
163139947|NCT03386721|589221973|FG006|Overall Study|Withdrawal by Subject|0|||
163139948|NCT03386721|589221974|FG007|Overall Study|Withdrawal by Subject|0|||
163139949|NCT03386721|589221975|FG008|Overall Study|Withdrawal by Subject|2|||
163139950|NCT03386721|589221976|FG009|Overall Study|Withdrawal by Subject|1|||
163139951|NCT03386721|589221977|FG010|Overall Study|Withdrawal by Subject|3|||
163139952|NCT03386721|589221978|FG011|Overall Study|Withdrawal by Subject|2|||
163139953|NCT03386721|589221979|FG012|Overall Study|Withdrawal by Subject|3|||
163139954|NCT03386721|589221980|FG013|Overall Study|Withdrawal by Subject|0|||
163139955|NCT03386721|589221981|FG014|Overall Study|Withdrawal by Subject|0|||
163139956|NCT03066596|589221982|FG000|Overall Study|Withdrawal by Subject|4|||
163139957|NCT03066596|589221983|FG001|Overall Study|Withdrawal by Subject|2|||
163139958|NCT03066596|589221982|FG000|Overall Study|Lost to Follow-up|14|||
163139959|NCT03066596|589221983|FG001|Overall Study|Lost to Follow-up|10|||
163139960|NCT00700713|589221984|FG000|Overall Study|Protocol Violation|1|||
163139961|NCT00700713|589221985|FG001|Overall Study|Protocol Violation|0|||
163233763|NCT01513291|589566208|FG003|Treatment Period|Randomized not treated|0|||
163139962|NCT00700713|589221986|FG002|Overall Study|Protocol Violation|1|||
163139963|NCT00700713|589221984|FG000|Overall Study|Withdrawal by Subject|0|||
163139964|NCT00700713|589221985|FG001|Overall Study|Withdrawal by Subject|0|||
163139965|NCT00700713|589221986|FG002|Overall Study|Withdrawal by Subject|1|||
163139966|NCT03797586|589221987|FG000|Overall Study|Lost to Follow-up|3|||
163139967|NCT03797586|589221988|FG001|Overall Study|Lost to Follow-up|6|||
163139968|NCT03797586|589221987|FG000|Overall Study|Death|1|||
163139969|NCT03797586|589221988|FG001|Overall Study|Death|1|||
163139970|NCT03797586|589221987|FG000|Overall Study|Adverse Event|0|||
163139971|NCT03797586|589221988|FG001|Overall Study|Adverse Event|2|||
163233764|NCT01513291|589566209|FG004|Treatment Period|Randomized not treated|0|||
163347555|NCT01631825|589981565|FG000|Overall Study|Withdrawal by Subject|9|||
163347556|NCT01631825|589981565|FG000|Overall Study|Protocol Violation|4|||
163347557|NCT01631825|589981565|FG000|Overall Study|Discontinuation criteria|1|||
163347558|NCT01631825|589981565|FG000|Overall Study|Physician Decision|2|||
163139972|NCT02959437|589221989|FG000|Overall Study|Death|33|||
163139973|NCT02959437|589221990|FG001|Overall Study|Death|3|||
163139974|NCT02959437|589221991|FG002|Overall Study|Death|0|||
163139975|NCT02959437|589221992|FG003|Overall Study|Death|0|||
163139976|NCT02959437|589221989|FG000|Overall Study|Lost to Follow-up|3|||
163139977|NCT02959437|589221990|FG001|Overall Study|Lost to Follow-up|1|||
163139978|NCT02959437|589221991|FG002|Overall Study|Lost to Follow-up|0|||
163139979|NCT02959437|589221992|FG003|Overall Study|Lost to Follow-up|0|||
163139980|NCT02959437|589221989|FG000|Overall Study|Withdrawal by Subject|11|||
163139981|NCT02959437|589221990|FG001|Overall Study|Withdrawal by Subject|3|||
163139982|NCT02959437|589221991|FG002|Overall Study|Withdrawal by Subject|0|||
163139983|NCT02959437|589221992|FG003|Overall Study|Withdrawal by Subject|0|||
163139984|NCT02959437|589221989|FG000|Overall Study|Progressive Disease|9|||
163139985|NCT02959437|589221990|FG001|Overall Study|Progressive Disease|1|||
163139986|NCT02959437|589221991|FG002|Overall Study|Progressive Disease|0|||
163139987|NCT02959437|589221992|FG003|Overall Study|Progressive Disease|0|||
163139988|NCT02959437|589221989|FG000|Overall Study|Study Terminated by Sponsor|4|||
163139989|NCT02959437|589221990|FG001|Overall Study|Study Terminated by Sponsor|0|||
163139990|NCT02959437|589221991|FG002|Overall Study|Study Terminated by Sponsor|0|||
163139991|NCT02959437|589221992|FG003|Overall Study|Study Terminated by Sponsor|0|||
163139992|NCT02959437|589221989|FG000|Overall Study|Other Unspecified|2|||
163139993|NCT02959437|589221990|FG001|Overall Study|Other Unspecified|0|||
163139994|NCT02959437|589221991|FG002|Overall Study|Other Unspecified|0|||
163139995|NCT02959437|589221992|FG003|Overall Study|Other Unspecified|0|||
163139996|NCT02864901|589221993|FG000|Overall Study|Withdrawal by Subject|1|||
163139997|NCT02864901|589221994|FG001|Overall Study|Withdrawal by Subject|0|||
163139998|NCT02728089|589221997|FG000|Overall Study|Physician Decision|2|||
163139999|NCT02728089|589221997|FG000|Overall Study|Withdrawal by Subject|1|||
163140000|NCT01369784|589222002|FG000|Overall Study|Protocol Violation|12|||
163140001|NCT01219985|589222003|FG000|Overall Study|Physician Decision|20|||
163140002|NCT03359174|589222004|FG000|Overall Study|Adverse Event|1|||
163140003|NCT02680665|589222005|FG000|Overall Study|No visit after the first prescription|5|||
163140004|NCT02905266|589222006|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
163140005|NCT02905266|589222007|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
163140006|NCT02905266|589222006|FG000|Treatment Phase Part 1|Disease Progression|6|||
163140007|NCT02905266|589222007|FG001|Treatment Phase Part 1|Disease Progression|7|||
163140008|NCT02905266|589222006|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
163140009|NCT02905266|589222007|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
163140010|NCT02905266|589222006|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
163140011|NCT02905266|589222007|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
163140012|NCT02905266|589222006|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
163140013|NCT02905266|589222007|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
163140014|NCT02905266|589222006|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
163140015|NCT02905266|589222007|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
163140016|NCT02905266|589222006|FG000|Transition From Part 1 to Part 2|Death|0|||
163140017|NCT02905266|589222007|FG001|Transition From Part 1 to Part 2|Death|1|||
163140018|NCT02905266|589222006|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
163140019|NCT02905266|589222007|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
163140020|NCT02905266|589222006|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
163140021|NCT02905266|589222007|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
163140022|NCT02905266|589222006|FG000|Maintenance Phase Part 2|Disease Progression|9|||
163140023|NCT02905266|589222007|FG001|Maintenance Phase Part 2|Disease Progression|2|||
163140024|NCT02905266|589222006|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
163140025|NCT02905266|589222007|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
163140026|NCT02905266|589222006|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
163140027|NCT02905266|589222007|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
163140028|NCT00596752|589222010|FG000|Overall Study|Other Reason|44|||
163140029|NCT00596752|589222011|FG001|Overall Study|Other Reason|49|||
163140030|NCT00596752|589222010|FG000|Overall Study|Adverse Event|34|||
163140031|NCT00596752|589222011|FG001|Overall Study|Adverse Event|34|||
163140032|NCT00596752|589222010|FG000|Overall Study|Lost to Follow-up|22|||
163140033|NCT00596752|589222011|FG001|Overall Study|Lost to Follow-up|38|||
163140034|NCT00596752|589222010|FG000|Overall Study|Withdrawal by Subject|12|||
163140035|NCT00596752|589222011|FG001|Overall Study|Withdrawal by Subject|9|||
163140036|NCT00596752|589222010|FG000|Overall Study|Unsatisfactory Compliance|9|||
163140037|NCT00596752|589222011|FG001|Overall Study|Unsatisfactory Compliance|6|||
163140038|NCT00596752|589222010|FG000|Overall Study|Lack of Efficacy|4|||
163140039|NCT00596752|589222011|FG001|Overall Study|Lack of Efficacy|7|||
163140040|NCT00596752|589222010|FG000|Overall Study|Protocol Violation|1|||
163140041|NCT00596752|589222011|FG001|Overall Study|Protocol Violation|0|||
163233765|NCT01513291|589566205|FG000|Run-out Period|Lost to Follow-up|0|||
163233766|NCT01513291|589566206|FG001|Run-out Period|Lost to Follow-up|0|||
163233767|NCT01513291|589566207|FG002|Run-out Period|Lost to Follow-up|0|||
163233768|NCT01513291|589566208|FG003|Run-out Period|Lost to Follow-up|1|||
163233769|NCT01513291|589566209|FG004|Run-out Period|Lost to Follow-up|0|||
163233770|NCT01513291|589566205|FG000|Run-out Period|Withdrawal by Subject|0|||
163233771|NCT01513291|589566206|FG001|Run-out Period|Withdrawal by Subject|0|||
163233772|NCT01513291|589566207|FG002|Run-out Period|Withdrawal by Subject|0|||
163233773|NCT01513291|589566208|FG003|Run-out Period|Withdrawal by Subject|1|||
163233774|NCT01513291|589566209|FG004|Run-out Period|Withdrawal by Subject|0|||
163233775|NCT01163682|589566211|FG000|Overall Study|Lost to Follow-up|6|||
163233776|NCT01163682|589566212|FG001|Overall Study|Lost to Follow-up|9|||
163233777|NCT01034397|589566213|FG000|Overall Study|Lack of compliance|0|||
163233778|NCT01034397|589566214|FG001|Overall Study|Lack of compliance|1|||
163233779|NCT01034397|589566213|FG000|Overall Study|Lack of Efficacy|3|||
163233780|NCT01034397|589566214|FG001|Overall Study|Lack of Efficacy|0|||
163233781|NCT01034397|589566213|FG000|Overall Study|Adverse Event|4|||
163233782|NCT01034397|589566214|FG001|Overall Study|Adverse Event|0|||
163233783|NCT01034397|589566213|FG000|Overall Study|Other|0|||
163233784|NCT01034397|589566214|FG001|Overall Study|Other|1|||
163233785|NCT00211081|589566218|FG000|Overall Study|Withdrawal by Subject|2|||
163233786|NCT01931839|589566219|FG000|Overall Study|Death|0|||
163233787|NCT01931839|589566220|FG001|Overall Study|Death|1|||
163233788|NCT01931839|589566221|FG002|Overall Study|Death|2|||
163233789|NCT01931839|589566222|FG003|Overall Study|Death|0|||
163233790|NCT01931839|589566223|FG004|Overall Study|Death|0|||
163233791|NCT01931839|589566224|FG005|Overall Study|Death|0|||
163233792|NCT01931839|589566225|FG006|Overall Study|Death|0|||
163233793|NCT01931839|589566219|FG000|Overall Study|Physician Decision|1|||
163233794|NCT01931839|589566220|FG001|Overall Study|Physician Decision|0|||
163233795|NCT01931839|589566221|FG002|Overall Study|Physician Decision|1|||
163233796|NCT01931839|589566222|FG003|Overall Study|Physician Decision|0|||
163233797|NCT01931839|589566223|FG004|Overall Study|Physician Decision|0|||
163233798|NCT01931839|589566224|FG005|Overall Study|Physician Decision|0|||
163233799|NCT01931839|589566225|FG006|Overall Study|Physician Decision|1|||
163233800|NCT01931839|589566219|FG000|Overall Study|Withdrawal of consent|0|||
163233801|NCT01931839|589566220|FG001|Overall Study|Withdrawal of consent|0|||
163233802|NCT01931839|589566221|FG002|Overall Study|Withdrawal of consent|0|||
163233803|NCT01931839|589566222|FG003|Overall Study|Withdrawal of consent|0|||
163233804|NCT01931839|589566223|FG004|Overall Study|Withdrawal of consent|1|||
163233805|NCT01931839|589566224|FG005|Overall Study|Withdrawal of consent|0|||
163233806|NCT01931839|589566225|FG006|Overall Study|Withdrawal of consent|0|||
163233807|NCT01931839|589566219|FG000|Overall Study|Adverse Event|9|||
163233808|NCT01931839|589566220|FG001|Overall Study|Adverse Event|4|||
163233809|NCT01931839|589566221|FG002|Overall Study|Adverse Event|1|||
163233810|NCT01931839|589566222|FG003|Overall Study|Adverse Event|3|||
163233811|NCT01931839|589566223|FG004|Overall Study|Adverse Event|0|||
163233812|NCT01931839|589566224|FG005|Overall Study|Adverse Event|0|||
163233813|NCT01931839|589566225|FG006|Overall Study|Adverse Event|1|||
163233814|NCT01931839|589566219|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
163233815|NCT01931839|589566220|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
163233816|NCT01931839|589566221|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
163233817|NCT01931839|589566222|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
163233818|NCT01931839|589566223|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
163347559|NCT02110225|589981566|FG000|Overall Study|Lost to Follow-up|0|||
163347560|NCT02110225|589981567|FG001|Overall Study|Lost to Follow-up|1|||
163233819|NCT01931839|589566224|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
163233820|NCT01931839|589566225|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
163233821|NCT01931839|589566219|FG000|Overall Study|Other non-compliance|15|||
163233822|NCT01931839|589566220|FG001|Overall Study|Other non-compliance|9|||
163233823|NCT01931839|589566221|FG002|Overall Study|Other non-compliance|12|||
163233824|NCT01931839|589566222|FG003|Overall Study|Other non-compliance|3|||
163233825|NCT01931839|589566223|FG004|Overall Study|Other non-compliance|0|||
163233826|NCT01931839|589566224|FG005|Overall Study|Other non-compliance|3|||
163233827|NCT01931839|589566225|FG006|Overall Study|Other non-compliance|0|||
163233828|NCT01931839|589566219|FG000|Overall Study|Lost to Follow-up|1|||
163233829|NCT01931839|589566220|FG001|Overall Study|Lost to Follow-up|2|||
163233830|NCT01931839|589566221|FG002|Overall Study|Lost to Follow-up|4|||
163233831|NCT01931839|589566222|FG003|Overall Study|Lost to Follow-up|5|||
163233832|NCT01931839|589566223|FG004|Overall Study|Lost to Follow-up|0|||
163233833|NCT01931839|589566224|FG005|Overall Study|Lost to Follow-up|0|||
163233834|NCT01931839|589566225|FG006|Overall Study|Lost to Follow-up|0|||
163233835|NCT01931839|589566219|FG000|Overall Study|Other|4|||
163233836|NCT01931839|589566220|FG001|Overall Study|Other|2|||
163233837|NCT01931839|589566221|FG002|Overall Study|Other|6|||
163233838|NCT01931839|589566222|FG003|Overall Study|Other|0|||
163233839|NCT01931839|589566223|FG004|Overall Study|Other|0|||
163233840|NCT01931839|589566224|FG005|Overall Study|Other|0|||
163233841|NCT01931839|589566225|FG006|Overall Study|Other|0|||
163233842|NCT01263873|589566226|FG000|Overall Study|One provider unable to complete numbers|1|||
163233843|NCT01263873|589566227|FG001|Overall Study|One provider unable to complete numbers|1|||
163233844|NCT00113516|589566228|FG000|Part 1|Adverse Event|6|||
163233845|NCT00113516|589566229|FG001|Part 1|Adverse Event|0|||
163233846|NCT00113516|589566228|FG000|Part 1|Death|3|||
163233847|NCT00113516|589566229|FG001|Part 1|Death|0|||
163233848|NCT00113516|589566228|FG000|Part 1|Other|3|||
163233849|NCT00113516|589566229|FG001|Part 1|Other|0|||
163233850|NCT00113516|589566228|FG000|Part 1|Withdrawal by Subject|2|||
163233851|NCT00113516|589566229|FG001|Part 1|Withdrawal by Subject|0|||
163233852|NCT00113516|589566228|FG000|Part 1|Lack of Efficacy|2|||
163233853|NCT00113516|589566229|FG001|Part 1|Lack of Efficacy|0|||
163233854|NCT00113516|589566228|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
163233855|NCT00113516|589566229|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
163233856|NCT00113516|589566228|FG000|Part 1|Laboratory Abnormality|1|||
163233857|NCT00113516|589566229|FG001|Part 1|Laboratory Abnormality|0|||
163233858|NCT00113516|589566228|FG000|Part 1|Ongoing|1|||
163233859|NCT00113516|589566229|FG001|Part 1|Ongoing|0|||
163233860|NCT00113516|589566228|FG000|Part 1|Missing|65|||
163233861|NCT00113516|589566229|FG001|Part 1|Missing|0|||
163233862|NCT00113516|589566228|FG000|Part 2|Adverse Event|0|||
163233863|NCT00113516|589566229|FG001|Part 2|Adverse Event|16|||
163233864|NCT00113516|589566228|FG000|Part 2|Death|0|||
163233865|NCT00113516|589566229|FG001|Part 2|Death|5|||
163233866|NCT00113516|589566228|FG000|Part 2|Lack of Efficacy|0|||
163233867|NCT00113516|589566229|FG001|Part 2|Lack of Efficacy|37|||
163233868|NCT00113516|589566228|FG000|Part 2|Withdrawal by Subject|0|||
163233869|NCT00113516|589566229|FG001|Part 2|Withdrawal by Subject|3|||
163233870|NCT00113516|589566228|FG000|Part 2|Other|0|||
163233871|NCT00113516|589566229|FG001|Part 2|Other|3|||
163233872|NCT00113516|589566228|FG000|Part 2|Laboratory Abnormality|0|||
163233873|NCT00113516|589566229|FG001|Part 2|Laboratory Abnormality|1|||
163233874|NCT00113516|589566228|FG000|Part 2|Ongoing|0|||
163233875|NCT00113516|589566229|FG001|Part 2|Ongoing|1|||
163233876|NCT03217136|589566238|FG000|Overall Study|Lost to Follow-up|2|||
163233877|NCT03217136|589566239|FG001|Overall Study|Lost to Follow-up|1|||
163233878|NCT03217136|589566238|FG000|Overall Study|Site Randomized Participant in Error|0|||
163233879|NCT03217136|589566239|FG001|Overall Study|Site Randomized Participant in Error|1|||
163233880|NCT03217136|589566238|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
163233881|NCT03217136|589566239|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
163233882|NCT03217136|589566238|FG000|Overall Study|Dispensing Error|1|||
163233883|NCT03217136|589566239|FG001|Overall Study|Dispensing Error|0|||
163233884|NCT03217136|589566238|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163233885|NCT03217136|589566239|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163233886|NCT03755765|589566240|FG000|Overall Study|Withdrawal by Subject|2|||
163233887|NCT03755765|589566241|FG001|Overall Study|Withdrawal by Subject|4|||
163233888|NCT03755765|589566242|FG002|Overall Study|Withdrawal by Subject|4|||
163233889|NCT02104557|589566243|FG000|Overall Study|Adverse Event|24|||
163233890|NCT02104557|589566243|FG000|Overall Study|Lost to Follow-up|34|||
163233891|NCT02104557|589566243|FG000|Overall Study|Violated the usage and dosage|14|||
163233892|NCT02104557|589566243|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
163233893|NCT02104557|589566243|FG000|Overall Study|Administered Sayana prior to the contract|1|||
163233894|NCT02104557|589566243|FG000|Overall Study|Other|17|||
163233895|NCT02104557|589566243|FG000|Overall Study|Change to other contraception methods|5|||
163233896|NCT02104557|589566243|FG000|Overall Study|Discontinuation due to no pain|1|||
163233897|NCT02104557|589566243|FG000|Overall Study|Withdrawal consent|2|||
163233898|NCT02104557|589566243|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
163233899|NCT02104557|589566243|FG000|Overall Study|Discontinuation of contraception|9|||
163233900|NCT01158222|589566247|FG000|Overall Study|Not eligible for intermediate phase|17|||
163233901|NCT00111228|589566250|FG000|Overall Study|Withdrawal by Subject|5|||
163233902|NCT00111228|589566251|FG001|Overall Study|Withdrawal by Subject|1|||
163233903|NCT00111228|589566252|FG002|Overall Study|Withdrawal by Subject|0|||
163233904|NCT02579616|589566253|FG000|Overall Study|Participants did not receive treatment|3|||
163233905|NCT01430585|589566254|FG000|Overall Study|Death|1|||
163233906|NCT01430585|589566254|FG000|Overall Study|Objective Progression or Relapse|3|||
163233907|NCT01430585|589566254|FG000|Overall Study|Study Terminated by Sponsor|3|||
163233908|NCT01430585|589566254|FG000|Overall Study|Other|7|||
163233909|NCT01448850|589566255|FG000|Overall Study|Death|3|||
163233910|NCT01448850|589566256|FG001|Overall Study|Death|6|||
163233911|NCT01448850|589566255|FG000|Overall Study|Withdrawal by Subject|13|||
163233912|NCT01448850|589566256|FG001|Overall Study|Withdrawal by Subject|21|||
163233913|NCT01448850|589566255|FG000|Overall Study|Lost to Follow-up|3|||
163233914|NCT01448850|589566256|FG001|Overall Study|Lost to Follow-up|1|||
163233915|NCT01448850|589566255|FG000|Overall Study|Other|15|||
163233916|NCT01448850|589566256|FG001|Overall Study|Other|12|||
163233917|NCT01490060|589566259|FG000|Cycle 1|Change of Treatment|0|||
163233918|NCT01490060|589566260|FG001|Cycle 1|Change of Treatment|1|||
163233919|NCT01490060|589566261|FG002|Cycle 1|Change of Treatment|1|||
163233920|NCT01490060|589566262|FG003|Cycle 1|Change of Treatment|1|||
163233921|NCT01490060|589566259|FG000|Cycle 1|Insurance Denied|0|||
163233922|NCT01490060|589566260|FG001|Cycle 1|Insurance Denied|0|||
163233923|NCT01490060|589566261|FG002|Cycle 1|Insurance Denied|2|||
163233924|NCT01490060|589566262|FG003|Cycle 1|Insurance Denied|0|||
163233925|NCT01490060|589566259|FG000|Cycle 1|Withdrawal by Subject|0|||
163233926|NCT01490060|589566260|FG001|Cycle 1|Withdrawal by Subject|0|||
163233927|NCT01490060|589566261|FG002|Cycle 1|Withdrawal by Subject|0|||
163233928|NCT01490060|589566262|FG003|Cycle 1|Withdrawal by Subject|1|||
163233929|NCT01490060|589566259|FG000|Cycle 1|Treatment at Another Facility|0|||
163233930|NCT01490060|589566260|FG001|Cycle 1|Treatment at Another Facility|0|||
163233931|NCT01490060|589566261|FG002|Cycle 1|Treatment at Another Facility|0|||
163233932|NCT01490060|589566262|FG003|Cycle 1|Treatment at Another Facility|1|||
163233933|NCT01490060|589566259|FG000|Cycle 2|Change of Treatment|1|||
163233934|NCT01490060|589566260|FG001|Cycle 2|Change of Treatment|1|||
163233935|NCT01490060|589566261|FG002|Cycle 2|Change of Treatment|0|||
163233936|NCT01490060|589566262|FG003|Cycle 2|Change of Treatment|0|||
163233937|NCT01490060|589566259|FG000|Cycle 2|Non-Compliance|0|||
163233938|NCT01490060|589566260|FG001|Cycle 2|Non-Compliance|0|||
163233939|NCT01490060|589566261|FG002|Cycle 2|Non-Compliance|1|||
163233940|NCT01490060|589566262|FG003|Cycle 2|Non-Compliance|0|||
163233941|NCT01490060|589566259|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
163233942|NCT01490060|589566260|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
163233943|NCT01490060|589566261|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
163233944|NCT01490060|589566262|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
163233945|NCT02464969|589566263|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
163233946|NCT02464969|589566264|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
163233947|NCT02464969|589566263|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
163233948|NCT02464969|589566264|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
163233949|NCT02464969|589566263|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
163233950|NCT02464969|589566264|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
163233951|NCT02464969|589566263|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
163233952|NCT02464969|589566264|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
163233953|NCT02464969|589566263|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
163233954|NCT02464969|589566264|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
163233955|NCT02464969|589566263|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
163233956|NCT02464969|589566264|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
163233957|NCT02464969|589566263|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
163233958|NCT02464969|589566264|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
163233959|NCT02464969|589566263|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
163233960|NCT02464969|589566264|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
163233961|NCT02464969|589566263|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
163233962|NCT02464969|589566264|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
163233963|NCT02464969|589566263|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
163233964|NCT02464969|589566264|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
163233965|NCT02464969|589566263|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
163233966|NCT02464969|589566264|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
163233967|NCT02863354|589566265|FG000|Year 1|Lost to Follow-up|1|||
163233968|NCT02863354|589566266|FG001|Year 1|Lost to Follow-up|1|||
163233969|NCT02863354|589566265|FG000|Year 1|Withdrawal by Subject|3|||
163233970|NCT02863354|589566266|FG001|Year 1|Withdrawal by Subject|0|||
163233971|NCT02863354|589566265|FG000|Year 1|Death|0|||
163233972|NCT02863354|589566266|FG001|Year 1|Death|1|||
163233973|NCT02863354|589566265|FG000|Year 2|Lost to Follow-up|2|||
163233974|NCT02863354|589566266|FG001|Year 2|Lost to Follow-up|2|||
163233975|NCT00720876|589566272|FG000|Overall Study|found to be ineligible after starting tx|2|||
163233976|NCT03495908|589566274|FG000|Overall Study|Withdrawal by Subject|3|||
163233977|NCT03495908|589566275|FG001|Overall Study|Withdrawal by Subject|1|||
163233978|NCT03495908|589566274|FG000|Overall Study|Lost to Follow-up|1|||
163233979|NCT03495908|589566275|FG001|Overall Study|Lost to Follow-up|4|||
163233980|NCT03495908|589566274|FG000|Overall Study|Adverse Event|0|||
163233981|NCT03495908|589566275|FG001|Overall Study|Adverse Event|2|||
163233982|NCT03495908|589566274|FG000|Overall Study|Death|1|||
163233983|NCT03495908|589566275|FG001|Overall Study|Death|0|||
163233984|NCT03495908|589566274|FG000|Overall Study|Physician Decision|5|||
163233985|NCT03495908|589566275|FG001|Overall Study|Physician Decision|4|||
163233986|NCT03495908|589566274|FG000|Overall Study|No documented reason|0|||
163233987|NCT03495908|589566275|FG001|Overall Study|No documented reason|2|||
163233988|NCT01109316|589566276|FG000|Study Period 1|Adverse Event|0|||
163233989|NCT01109316|589566277|FG001|Study Period 1|Adverse Event|0|||
163233990|NCT01109316|589566278|FG002|Study Period 1|Adverse Event|1|||
163233991|NCT01109316|589566279|FG003|Study Period 1|Adverse Event|0|||
163233992|NCT01109316|589566280|FG004|Study Period 1|Adverse Event|0|||
163233993|NCT01109316|589566281|FG005|Study Period 1|Adverse Event|0|||
163233994|NCT01109316|589566276|FG000|Study Period 1|Lost to Follow-up|0|||
163233995|NCT01109316|589566277|FG001|Study Period 1|Lost to Follow-up|0|||
163233996|NCT01109316|589566278|FG002|Study Period 1|Lost to Follow-up|1|||
163233997|NCT01109316|589566279|FG003|Study Period 1|Lost to Follow-up|1|||
163233998|NCT01109316|589566280|FG004|Study Period 1|Lost to Follow-up|0|||
163233999|NCT01109316|589566281|FG005|Study Period 1|Lost to Follow-up|0|||
163234000|NCT01109316|589566276|FG000|Study Period 1|Withdrawal by Subject|0|||
163234001|NCT01109316|589566277|FG001|Study Period 1|Withdrawal by Subject|0|||
163234002|NCT01109316|589566278|FG002|Study Period 1|Withdrawal by Subject|1|||
163234003|NCT01109316|589566279|FG003|Study Period 1|Withdrawal by Subject|0|||
163234004|NCT01109316|589566280|FG004|Study Period 1|Withdrawal by Subject|2|||
163234005|NCT01109316|589566281|FG005|Study Period 1|Withdrawal by Subject|0|||
163234006|NCT01109316|589566276|FG000|Study Period 1|Sponsor Decision|0|||
163234007|NCT01109316|589566277|FG001|Study Period 1|Sponsor Decision|0|||
163234008|NCT01109316|589566278|FG002|Study Period 1|Sponsor Decision|0|||
163234009|NCT01109316|589566279|FG003|Study Period 1|Sponsor Decision|0|||
163234010|NCT01109316|589566280|FG004|Study Period 1|Sponsor Decision|0|||
163234011|NCT01109316|589566281|FG005|Study Period 1|Sponsor Decision|2|||
163234012|NCT01109316|589566276|FG000|Study Period 2|Entry Criteria Not Met|0|||
163234013|NCT01109316|589566277|FG001|Study Period 2|Entry Criteria Not Met|1|||
163234014|NCT01109316|589566278|FG002|Study Period 2|Entry Criteria Not Met|0|||
163234015|NCT01109316|589566279|FG003|Study Period 2|Entry Criteria Not Met|0|||
163234016|NCT01109316|589566280|FG004|Study Period 2|Entry Criteria Not Met|0|||
163234017|NCT01109316|589566281|FG005|Study Period 2|Entry Criteria Not Met|0|||
163234018|NCT01109316|589566276|FG000|Study Period 2|Physician Decision|0|||
163234019|NCT01109316|589566277|FG001|Study Period 2|Physician Decision|0|||
163234020|NCT01109316|589566278|FG002|Study Period 2|Physician Decision|0|||
163234021|NCT01109316|589566279|FG003|Study Period 2|Physician Decision|1|||
163234022|NCT01109316|589566280|FG004|Study Period 2|Physician Decision|0|||
163234023|NCT01109316|589566281|FG005|Study Period 2|Physician Decision|0|||
163234024|NCT01109316|589566276|FG000|Study Period 2|Protocol Violation|1|||
163234025|NCT01109316|589566277|FG001|Study Period 2|Protocol Violation|0|||
163234026|NCT01109316|589566278|FG002|Study Period 2|Protocol Violation|0|||
163234027|NCT01109316|589566279|FG003|Study Period 2|Protocol Violation|0|||
163234028|NCT01109316|589566280|FG004|Study Period 2|Protocol Violation|0|||
163234029|NCT01109316|589566281|FG005|Study Period 2|Protocol Violation|0|||
163234030|NCT01109316|589566276|FG000|Study Period 2|Withdrawal by Subject|0|||
163234031|NCT01109316|589566277|FG001|Study Period 2|Withdrawal by Subject|0|||
163234032|NCT01109316|589566278|FG002|Study Period 2|Withdrawal by Subject|1|||
163234033|NCT01109316|589566279|FG003|Study Period 2|Withdrawal by Subject|0|||
163234034|NCT01109316|589566280|FG004|Study Period 2|Withdrawal by Subject|0|||
163234035|NCT01109316|589566281|FG005|Study Period 2|Withdrawal by Subject|1|||
163234036|NCT01109316|589566276|FG000|Study Period 3|Lost to Follow-up|0|||
163234037|NCT01109316|589566277|FG001|Study Period 3|Lost to Follow-up|0|||
163234038|NCT01109316|589566278|FG002|Study Period 3|Lost to Follow-up|0|||
163234039|NCT01109316|589566279|FG003|Study Period 3|Lost to Follow-up|0|||
163234040|NCT01109316|589566280|FG004|Study Period 3|Lost to Follow-up|1|||
163234041|NCT01109316|589566281|FG005|Study Period 3|Lost to Follow-up|0|||
163234042|NCT01109316|589566276|FG000|Study Period 3|Withdrawal by Subject|1|||
163234043|NCT01109316|589566277|FG001|Study Period 3|Withdrawal by Subject|0|||
163234044|NCT01109316|589566278|FG002|Study Period 3|Withdrawal by Subject|0|||
163234045|NCT01109316|589566279|FG003|Study Period 3|Withdrawal by Subject|0|||
163234046|NCT01109316|589566280|FG004|Study Period 3|Withdrawal by Subject|1|||
163234047|NCT01109316|589566281|FG005|Study Period 3|Withdrawal by Subject|0|||
163234048|NCT01559311|589566284|FG000|Overall Study|Protocol Violation|0|||
163234049|NCT01559311|589566285|FG001|Overall Study|Protocol Violation|0|||
163234050|NCT01559311|589566286|FG002|Overall Study|Protocol Violation|2|||
163234051|NCT01559311|589566284|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
163234052|NCT01559311|589566285|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
163234053|NCT01559311|589566286|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
163234054|NCT01559311|589566284|FG000|Overall Study|Withdrawal by Subject|2|||
163234055|NCT01559311|589566285|FG001|Overall Study|Withdrawal by Subject|1|||
163234056|NCT01559311|589566286|FG002|Overall Study|Withdrawal by Subject|0|||
163234057|NCT01559311|589566284|FG000|Overall Study|Death|0|||
163234058|NCT01559311|589566285|FG001|Overall Study|Death|2|||
163234059|NCT01559311|589566286|FG002|Overall Study|Death|3|||
163234060|NCT01559311|589566284|FG000|Overall Study|Lost to Follow-up|0|||
163234061|NCT01559311|589566285|FG001|Overall Study|Lost to Follow-up|3|||
163234062|NCT01559311|589566286|FG002|Overall Study|Lost to Follow-up|2|||
163234063|NCT01559311|589566284|FG000|Overall Study|Adverse Event|0|||
163234064|NCT01559311|589566285|FG001|Overall Study|Adverse Event|0|||
163234065|NCT01559311|589566286|FG002|Overall Study|Adverse Event|1|||
163347561|NCT02110225|589981568|FG002|Overall Study|Lost to Follow-up|0|||
163234066|NCT03027466|589566287|FG000|Overall Study|Opting out of the app|1869|||
163234067|NCT03027466|589566288|FG001|Overall Study|Opting out of the app|1819|||
163234068|NCT03027466|589566289|FG002|Overall Study|Opting out of the app|1743|||
163234069|NCT03027466|589566290|FG003|Overall Study|Opting out of the app|1821|||
163234070|NCT03286140|589566291|FG000|Overall Study|Withdrawal by Subject|10|||
163234071|NCT03286140|589566292|FG001|Overall Study|Withdrawal by Subject|5|||
163234072|NCT03286140|589566291|FG000|Overall Study|Lost to Follow-up|5|||
163234073|NCT03286140|589566292|FG001|Overall Study|Lost to Follow-up|10|||
163234074|NCT03286140|589566291|FG000|Overall Study|Failure to comply|0|||
163234075|NCT03286140|589566292|FG001|Overall Study|Failure to comply|1|||
163347562|NCT00265096|589981569|FG000|Overall Study|Adverse Event|14|||
163347563|NCT00265096|589981570|FG001|Overall Study|Adverse Event|18|||
163140042|NCT04445662|589222016|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
163140043|NCT04445662|589222017|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
163140044|NCT04445662|589222016|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
163140045|NCT04445662|589222017|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
163140046|NCT04445662|589222016|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
163140047|NCT04445662|589222017|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
163140048|NCT04445662|589222016|FG000|Post-treatment (12-24 weeks)|Death|1|||
163140049|NCT04445662|589222017|FG001|Post-treatment (12-24 weeks)|Death|0|||
163140050|NCT04089761|589222018|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
163140051|NCT04089761|589222018|FG000|"Run In Phase"|Lost to Follow-up|1|||
163140052|NCT04089761|589222018|FG000|"Treatment Phase"|No evaluable data|5|||
163140053|NCT04089761|589222018|FG000|"Treatment Phase"|Lost to Follow-up|1|||
163140054|NCT04896593|589222020|FG000|Overall Study|Withdrawal by Subject|2|||
163140055|NCT04896593|589222020|FG000|Overall Study|Lost to Follow-up|1|||
163140056|NCT04896593|589222020|FG000|Overall Study|Did not complete onboarding|2|||
163140057|NCT02915978|589222021|FG000|Overall Study|Adverse Event|2|||
163140058|NCT02915978|589222022|FG001|Overall Study|Adverse Event|1|||
163140059|NCT02915978|589222023|FG002|Overall Study|Adverse Event|0|||
163140060|NCT02451124|589222024|FG000|Overall Study|Withdrawal by Subject|1|||
163140061|NCT00892775|589222025|FG000|Overall Study|Protocol Violation|1|||
163140062|NCT00892775|589222026|FG001|Overall Study|Protocol Violation|0|||
163140063|NCT00892775|589222025|FG000|Overall Study|Subject difficulties with blood drawing|1|||
163140064|NCT00892775|589222026|FG001|Overall Study|Subject difficulties with blood drawing|0|||
163140065|NCT00892775|589222025|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
163140066|NCT00892775|589222026|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
163140067|NCT00892775|589222025|FG000|Overall Study|Migrated/ moved from study area|1|||
163140068|NCT00892775|589222026|FG001|Overall Study|Migrated/ moved from study area|0|||
163140069|NCT00892775|589222025|FG000|Overall Study|Withdrawal by Subject|0|||
163140070|NCT00892775|589222026|FG001|Overall Study|Withdrawal by Subject|1|||
163140071|NCT00892775|589222025|FG000|Overall Study|Lost to Follow-up|1|||
163140072|NCT00892775|589222026|FG001|Overall Study|Lost to Follow-up|0|||
163140073|NCT01870726|589222027|FG000|Overall Study|Withdrawal of informed consent|0|||
163140074|NCT01870726|589222028|FG001|Overall Study|Withdrawal of informed consent|0|||
163140075|NCT01870726|589222029|FG002|Overall Study|Withdrawal of informed consent|0|||
163140076|NCT01870726|589222030|FG003|Overall Study|Withdrawal of informed consent|1|||
163140077|NCT01870726|589222031|FG004|Overall Study|Withdrawal of informed consent|0|||
163140078|NCT01870726|589222032|FG005|Overall Study|Withdrawal of informed consent|0|||
163140079|NCT01870726|589222033|FG006|Overall Study|Withdrawal of informed consent|0|||
163140080|NCT01870726|589222027|FG000|Overall Study|Withdrawal by Subject|0|||
163140081|NCT01870726|589222028|FG001|Overall Study|Withdrawal by Subject|1|||
163140082|NCT01870726|589222029|FG002|Overall Study|Withdrawal by Subject|0|||
163140083|NCT01870726|589222030|FG003|Overall Study|Withdrawal by Subject|0|||
163140084|NCT01870726|589222031|FG004|Overall Study|Withdrawal by Subject|0|||
163140085|NCT01870726|589222032|FG005|Overall Study|Withdrawal by Subject|0|||
163140086|NCT01870726|589222033|FG006|Overall Study|Withdrawal by Subject|0|||
163140087|NCT01870726|589222027|FG000|Overall Study|Adverse Event|0|||
163140088|NCT01870726|589222028|FG001|Overall Study|Adverse Event|0|||
163140089|NCT01870726|589222029|FG002|Overall Study|Adverse Event|0|||
163140090|NCT01870726|589222030|FG003|Overall Study|Adverse Event|0|||
163140091|NCT01870726|589222031|FG004|Overall Study|Adverse Event|1|||
163140092|NCT01870726|589222032|FG005|Overall Study|Adverse Event|1|||
163140093|NCT01870726|589222033|FG006|Overall Study|Adverse Event|0|||
163140094|NCT01870726|589222027|FG000|Overall Study|Progressive disease|5|||
163140095|NCT01870726|589222028|FG001|Overall Study|Progressive disease|5|||
163140096|NCT01870726|589222029|FG002|Overall Study|Progressive disease|4|||
163140097|NCT01870726|589222030|FG003|Overall Study|Progressive disease|5|||
163140098|NCT01870726|589222031|FG004|Overall Study|Progressive disease|6|||
163140099|NCT01870726|589222032|FG005|Overall Study|Progressive disease|4|||
163140100|NCT01870726|589222033|FG006|Overall Study|Progressive disease|10|||
163140101|NCT00103740|589222038|FG000|Period 1 - Core|Adverse Event|1|||
163140102|NCT00103740|589222039|FG001|Period 1 - Core|Adverse Event|0|||
163140103|NCT00103740|589222038|FG000|Period 1 - Core|Protocol Violation|3|||
163140104|NCT00103740|589222039|FG001|Period 1 - Core|Protocol Violation|2|||
163140105|NCT00103740|589222038|FG000|Period 1 - Core|Patient withdrew consent|3|||
163140106|NCT00103740|589222039|FG001|Period 1 - Core|Patient withdrew consent|2|||
163140107|NCT00103740|589222038|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
163140108|NCT00103740|589222039|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
163347564|NCT00265096|589981571|FG002|Overall Study|Adverse Event|18|||
163347565|NCT00265096|589981569|FG000|Overall Study|Lost to Follow-up|2|||
163347566|NCT00265096|589981570|FG001|Overall Study|Lost to Follow-up|5|||
163347567|NCT00265096|589981571|FG002|Overall Study|Lost to Follow-up|3|||
163140109|NCT00103740|589222038|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
163347568|NCT00265096|589981569|FG000|Overall Study|Death|0|||
163347569|NCT00265096|589981570|FG001|Overall Study|Death|1|||
163140110|NCT00103740|589222039|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
163140111|NCT00103740|589222038|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
163234076|NCT01826825|589566293|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
163234077|NCT01826825|589566294|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
163234078|NCT01858194|589566295|FG000|Overall Study|Total Artificial Heart Implant|0|||
163234079|NCT01858194|589566296|FG001|Overall Study|Total Artificial Heart Implant|1|||
163234080|NCT01858194|589566295|FG000|Overall Study|Lost to Follow-up|0|||
163234081|NCT01858194|589566296|FG001|Overall Study|Lost to Follow-up|1|||
163234082|NCT02158039|589566297|FG000|Overall Study|Withdrawal by Subject|1|||
163234083|NCT02158039|589566297|FG000|Overall Study|Screen Failure|9|||
163234084|NCT02563028|589566299|FG000|Overall Study|Lack of equipment|1|||
163234085|NCT02563028|589566299|FG000|Overall Study|Unable to elicit VEP post induction|1|||
163234086|NCT02052466|589566300|FG000|Overall Study|Withdrawal by Subject|1|||
163234087|NCT02052466|589566300|FG000|Overall Study|Acromial fracture|1|||
163234088|NCT00829621|589566301|FG000|Overall Study|Death|1|||
163234089|NCT00829621|589566302|FG001|Overall Study|Death|0|||
163234090|NCT00829621|589566301|FG000|Overall Study|Lost to Follow-up|3|||
163234091|NCT00829621|589566302|FG001|Overall Study|Lost to Follow-up|4|||
163234092|NCT02293005|589567613|FG000|Overall Study|Adverse Event|2|||
163234093|NCT02293005|589567613|FG000|Overall Study|Death|4|||
163234094|NCT02293005|589567613|FG000|Overall Study|Lost to Follow-up|1|||
163234095|NCT02293005|589567613|FG000|Overall Study|Withdrawal by Subject|2|||
163234096|NCT02293005|589567613|FG000|Overall Study|Progression|17|||
163234097|NCT02766608|589567614|FG000|Overall Study|Adverse Event|27|||
163234098|NCT02766608|589567615|FG001|Overall Study|Adverse Event|22|||
163234099|NCT02766608|589567616|FG002|Overall Study|Adverse Event|17|||
163140112|NCT00103740|589222039|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
163140113|NCT00103740|589222038|FG000|Period 2 - Extended Observation Period|Death|6|||
163140114|NCT00103740|589222039|FG001|Period 2 - Extended Observation Period|Death|2|||
163140115|NCT00103740|589222038|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
163140116|NCT00103740|589222039|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
163140117|NCT03691571|589222040|FG000|Overall Study|Withdrawal by Subject|9|||
163140118|NCT03691571|589222041|FG001|Overall Study|Withdrawal by Subject|2|||
163140119|NCT01463306|589222042|FG000|Overall Study|Adverse Event|6|||
163140120|NCT01463306|589222043|FG001|Overall Study|Adverse Event|9|||
163140121|NCT01463306|589222044|FG002|Overall Study|Adverse Event|3|||
163140122|NCT01463306|589222042|FG000|Overall Study|Death|3|||
163140123|NCT01463306|589222043|FG001|Overall Study|Death|3|||
163140124|NCT01463306|589222044|FG002|Overall Study|Death|0|||
163140125|NCT01463306|589222042|FG000|Overall Study|Lack of Efficacy|22|||
163140126|NCT01463306|589222043|FG001|Overall Study|Lack of Efficacy|16|||
163140127|NCT01463306|589222044|FG002|Overall Study|Lack of Efficacy|1|||
163140128|NCT01463306|589222042|FG000|Overall Study|Lost to Follow-up|5|||
163140129|NCT01463306|589222043|FG001|Overall Study|Lost to Follow-up|2|||
163140130|NCT01463306|589222044|FG002|Overall Study|Lost to Follow-up|0|||
163140131|NCT01463306|589222042|FG000|Overall Study|Protocol Violation|4|||
163140132|NCT01463306|589222043|FG001|Overall Study|Protocol Violation|0|||
163140133|NCT01463306|589222044|FG002|Overall Study|Protocol Violation|0|||
163140134|NCT01463306|589222042|FG000|Overall Study|Withdrawal by Subject|19|||
163140135|NCT01463306|589222043|FG001|Overall Study|Withdrawal by Subject|9|||
163140136|NCT01463306|589222044|FG002|Overall Study|Withdrawal by Subject|1|||
163140137|NCT01463306|589222042|FG000|Overall Study|Other|26|||
163140138|NCT01463306|589222043|FG001|Overall Study|Other|13|||
163140139|NCT01463306|589222044|FG002|Overall Study|Other|0|||
163140140|NCT01463306|589222042|FG000|Overall Study|Approval expiry at site|1|||
163140141|NCT01463306|589222043|FG001|Overall Study|Approval expiry at site|0|||
163140142|NCT01463306|589222044|FG002|Overall Study|Approval expiry at site|0|||
163140143|NCT00250276|589222049|FG000|Overall Study|Serious Adverse Event|0|||
163140144|NCT00250276|589222050|FG001|Overall Study|Serious Adverse Event|0|||
163140145|NCT00250276|589222051|FG002|Overall Study|Serious Adverse Event|1|||
163140146|NCT00250276|589222052|FG003|Overall Study|Serious Adverse Event|0|||
163140147|NCT00250276|589222049|FG000|Overall Study|Non-serious Adverse Event|2|||
163140148|NCT00250276|589222050|FG001|Overall Study|Non-serious Adverse Event|0|||
163140149|NCT00250276|589222051|FG002|Overall Study|Non-serious Adverse Event|0|||
163140150|NCT00250276|589222052|FG003|Overall Study|Non-serious Adverse Event|2|||
163140151|NCT00250276|589222049|FG000|Overall Study|Protocol Violation|0|||
163140152|NCT00250276|589222050|FG001|Overall Study|Protocol Violation|1|||
163234100|NCT02766608|589567617|FG003|Overall Study|Adverse Event|13|||
163234101|NCT02766608|589567618|FG004|Overall Study|Adverse Event|12|||
163234102|NCT02766608|589567614|FG000|Overall Study|Withdrawal by Subject|21|||
163234103|NCT02766608|589567615|FG001|Overall Study|Withdrawal by Subject|20|||
163234104|NCT02766608|589567616|FG002|Overall Study|Withdrawal by Subject|24|||
163140153|NCT00250276|589222051|FG002|Overall Study|Protocol Violation|0|||
163140154|NCT00250276|589222052|FG003|Overall Study|Protocol Violation|0|||
163347570|NCT00265096|589981571|FG002|Overall Study|Death|2|||
163347571|NCT00265096|589981569|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
163347572|NCT00265096|589981570|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
163347573|NCT00265096|589981571|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
163347574|NCT00265096|589981569|FG000|Overall Study|Other|11|||
163347575|NCT00265096|589981570|FG001|Overall Study|Other|19|||
163347576|NCT00265096|589981571|FG002|Overall Study|Other|10|||
163347577|NCT00774306|589981572|FG000|Overall Study|Adverse Event|3|||
163347578|NCT00774306|589981573|FG001|Overall Study|Adverse Event|0|||
163347579|NCT00774306|589981574|FG002|Overall Study|Adverse Event|0|||
163347580|NCT00774306|589981575|FG003|Overall Study|Adverse Event|0|||
163347581|NCT00774306|589981572|FG000|Overall Study|Protocol Violation|2|||
163347582|NCT00774306|589981573|FG001|Overall Study|Protocol Violation|0|||
163347583|NCT00774306|589981574|FG002|Overall Study|Protocol Violation|3|||
163347584|NCT00774306|589981575|FG003|Overall Study|Protocol Violation|0|||
163347585|NCT00774306|589981572|FG000|Overall Study|Withdrawal by Subject|6|||
163347586|NCT00774306|589981573|FG001|Overall Study|Withdrawal by Subject|1|||
163347587|NCT00774306|589981574|FG002|Overall Study|Withdrawal by Subject|1|||
163347588|NCT00774306|589981575|FG003|Overall Study|Withdrawal by Subject|0|||
163347589|NCT00774306|589981572|FG000|Overall Study|Lost to Follow-up|6|||
163347590|NCT00774306|589981573|FG001|Overall Study|Lost to Follow-up|0|||
163347591|NCT00774306|589981574|FG002|Overall Study|Lost to Follow-up|4|||
163347592|NCT00774306|589981575|FG003|Overall Study|Lost to Follow-up|5|||
163347593|NCT00774306|589981572|FG000|Overall Study|Death|1|||
163347594|NCT00774306|589981573|FG001|Overall Study|Death|1|||
163347595|NCT00774306|589981574|FG002|Overall Study|Death|0|||
163347596|NCT00774306|589981575|FG003|Overall Study|Death|0|||
163347597|NCT03568708|589981579|FG000|Overall Study|Withdrawal by Subject|1|||
163347598|NCT03568708|589981580|FG001|Overall Study|Withdrawal by Subject|1|||
163347599|NCT03568708|589981579|FG000|Overall Study|Lost to Follow-up|0|||
163347600|NCT03568708|589981580|FG001|Overall Study|Lost to Follow-up|1|||
163347601|NCT00666835|589981581|FG000|Overall Study|Withdrawal by Subject|5|||
163347602|NCT00666835|589981582|FG001|Overall Study|Withdrawal by Subject|2|||
163347603|NCT00666835|589981581|FG000|Overall Study|Lack of Efficacy|0|||
163347604|NCT00666835|589981582|FG001|Overall Study|Lack of Efficacy|1|||
163347605|NCT00666835|589981581|FG000|Overall Study|Incl./excl. not fulfilled|7|||
163347606|NCT00666835|589981582|FG001|Overall Study|Incl./excl. not fulfilled|2|||
163347607|NCT00666835|589981581|FG000|Overall Study|Adverse Event|7|||
163347608|NCT00666835|589981582|FG001|Overall Study|Adverse Event|6|||
163347609|NCT00666835|589981581|FG000|Overall Study|Protocol Violation|2|||
163347610|NCT00666835|589981582|FG001|Overall Study|Protocol Violation|0|||
163347611|NCT00666835|589981581|FG000|Overall Study|Death|15|||
163347612|NCT00666835|589981582|FG001|Overall Study|Death|4|||
163347613|NCT00666835|589981581|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
163347614|NCT00666835|589981582|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
163347615|NCT00666835|589981581|FG000|Overall Study|Hemoglobulin concentration|4|||
163347616|NCT00666835|589981582|FG001|Overall Study|Hemoglobulin concentration|3|||
163347617|NCT00666835|589981581|FG000|Overall Study|Planned operation|2|||
163347618|NCT00666835|589981582|FG001|Overall Study|Planned operation|0|||
163347619|NCT00666835|589981581|FG000|Overall Study|Physician Decision|1|||
163347620|NCT00666835|589981582|FG001|Overall Study|Physician Decision|2|||
163347621|NCT00511147|589981583|FG000|Overall Study|Withdrawal by Subject|1|||
163347622|NCT00511147|589981583|FG000|Overall Study|Disease progression|5|||
163347623|NCT00511147|589981583|FG000|Overall Study|Required platelet transfusion|1|||
163347624|NCT00899379|589981584|FG000|Overall Study|Adverse Event|2|||
163347625|NCT00899379|589981585|FG001|Overall Study|Adverse Event|2|||
163347626|NCT00899379|589981586|FG002|Overall Study|Adverse Event|1|||
163347627|NCT00899379|589981587|FG003|Overall Study|Adverse Event|1|||
163347628|NCT00899379|589981588|FG004|Overall Study|Adverse Event|2|||
163347629|NCT00899379|589981584|FG000|Overall Study|Lack of Efficacy|0|||
163347630|NCT00899379|589981585|FG001|Overall Study|Lack of Efficacy|4|||
163140155|NCT00250276|589222049|FG000|Overall Study|Withdrawal by Subject|1|||
163140156|NCT00250276|589222050|FG001|Overall Study|Withdrawal by Subject|2|||
163347631|NCT00899379|589981586|FG002|Overall Study|Lack of Efficacy|3|||
163347632|NCT00899379|589981587|FG003|Overall Study|Lack of Efficacy|0|||
163347633|NCT00899379|589981588|FG004|Overall Study|Lack of Efficacy|1|||
163347634|NCT00899379|589981584|FG000|Overall Study|Lost to Follow-up|9|||
163347635|NCT00899379|589981585|FG001|Overall Study|Lost to Follow-up|3|||
163347636|NCT00899379|589981586|FG002|Overall Study|Lost to Follow-up|0|||
163347637|NCT00899379|589981587|FG003|Overall Study|Lost to Follow-up|6|||
163347638|NCT00899379|589981588|FG004|Overall Study|Lost to Follow-up|2|||
163347639|NCT00899379|589981584|FG000|Overall Study|Protocol Violation|0|||
163347640|NCT00899379|589981585|FG001|Overall Study|Protocol Violation|0|||
163347641|NCT00899379|589981586|FG002|Overall Study|Protocol Violation|1|||
163347642|NCT00899379|589981587|FG003|Overall Study|Protocol Violation|1|||
163347643|NCT00899379|589981588|FG004|Overall Study|Protocol Violation|0|||
163347644|NCT00899379|589981584|FG000|Overall Study|Withdrawal by Subject|2|||
163347645|NCT00899379|589981585|FG001|Overall Study|Withdrawal by Subject|4|||
163140157|NCT00250276|589222051|FG002|Overall Study|Withdrawal by Subject|3|||
163140158|NCT00250276|589222052|FG003|Overall Study|Withdrawal by Subject|2|||
163140159|NCT00250276|589222049|FG000|Overall Study|Migrated/moved from study area|3|||
163140160|NCT00250276|589222050|FG001|Overall Study|Migrated/moved from study area|0|||
163140161|NCT00250276|589222051|FG002|Overall Study|Migrated/moved from study area|2|||
163140162|NCT00250276|589222052|FG003|Overall Study|Migrated/moved from study area|7|||
163140163|NCT00250276|589222049|FG000|Overall Study|Lost to Follow-up|11|||
163140164|NCT00250276|589222050|FG001|Overall Study|Lost to Follow-up|18|||
163140165|NCT00250276|589222051|FG002|Overall Study|Lost to Follow-up|13|||
163140166|NCT00250276|589222052|FG003|Overall Study|Lost to Follow-up|8|||
163140167|NCT00555217|589222053|FG000|Overall Study|Withdrawal by Subject|35|||
163140168|NCT00555217|589222054|FG001|Overall Study|Withdrawal by Subject|31|||
163140169|NCT00555217|589222053|FG000|Overall Study|Lost to Follow-up|19|||
163140170|NCT00555217|589222054|FG001|Overall Study|Lost to Follow-up|20|||
163140171|NCT00555217|589222053|FG000|Overall Study|close out sites|21|||
163140172|NCT00555217|589222054|FG001|Overall Study|close out sites|17|||
163140173|NCT01546688|589222055|FG000|Overall Study|Adverse Event|0|||
163140174|NCT01546688|589222056|FG001|Overall Study|Adverse Event|4|||
163140175|NCT01546688|589222055|FG000|Overall Study|Withdrawal by Subject|2|||
163140176|NCT01546688|589222056|FG001|Overall Study|Withdrawal by Subject|1|||
163140177|NCT01546688|589222055|FG000|Overall Study|Lack of Efficacy|1|||
163140178|NCT01546688|589222056|FG001|Overall Study|Lack of Efficacy|0|||
163140179|NCT01657292|589222062|FG000|Overall Study|Adverse Event|6|||
163140180|NCT01657292|589222062|FG000|Overall Study|Withdrawal by Subject|2|||
163140181|NCT01657292|589222062|FG000|Overall Study|Violation of eligibility criteria|1|||
163140182|NCT01657292|589222062|FG000|Overall Study|Change of therapy|1|||
163140183|NCT03566082|589222063|FG000|Overall Study|Death|7|||
163140184|NCT03566082|589222063|FG000|Overall Study|Failures (revision required)|2|||
163140185|NCT03566082|589222063|FG000|Overall Study|Lost to Follow-up|8|||
163140186|NCT00983385|589222064|FG000|Observation Period|Not eligible to be dosed|20|||
163234105|NCT02766608|589567617|FG003|Overall Study|Withdrawal by Subject|13|||
163140187|NCT00983385|589222064|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
163234106|NCT02766608|589567618|FG004|Overall Study|Withdrawal by Subject|10|||
163234107|NCT02766608|589567614|FG000|Overall Study|Lack of Efficacy|16|||
163140188|NCT02663622|589222065|FG000|Overall Study|Death|3|||
163140189|NCT02663622|589222066|FG001|Overall Study|Death|1|||
163140190|NCT02663622|589222067|FG002|Overall Study|Death|1|||
163234108|NCT02766608|589567615|FG001|Overall Study|Lack of Efficacy|15|||
163234109|NCT02766608|589567616|FG002|Overall Study|Lack of Efficacy|32|||
163234110|NCT02766608|589567617|FG003|Overall Study|Lack of Efficacy|8|||
163234111|NCT02766608|589567618|FG004|Overall Study|Lack of Efficacy|2|||
163234112|NCT02766608|589567614|FG000|Overall Study|Lost to Follow-up|6|||
163234113|NCT02766608|589567615|FG001|Overall Study|Lost to Follow-up|3|||
163234114|NCT02766608|589567616|FG002|Overall Study|Lost to Follow-up|5|||
163234115|NCT02766608|589567617|FG003|Overall Study|Lost to Follow-up|2|||
163234116|NCT02766608|589567618|FG004|Overall Study|Lost to Follow-up|2|||
163234117|NCT02766608|589567614|FG000|Overall Study|Physician Decision|3|||
163234118|NCT02766608|589567615|FG001|Overall Study|Physician Decision|2|||
163234119|NCT02766608|589567616|FG002|Overall Study|Physician Decision|3|||
163234120|NCT02766608|589567617|FG003|Overall Study|Physician Decision|1|||
163234121|NCT02766608|589567618|FG004|Overall Study|Physician Decision|2|||
163234122|NCT02766608|589567614|FG000|Overall Study|Protocol disc criteria|3|||
163234123|NCT02766608|589567615|FG001|Overall Study|Protocol disc criteria|3|||
163234124|NCT02766608|589567616|FG002|Overall Study|Protocol disc criteria|4|||
163234125|NCT02766608|589567617|FG003|Overall Study|Protocol disc criteria|0|||
163234126|NCT02766608|589567618|FG004|Overall Study|Protocol disc criteria|0|||
163234127|NCT02766608|589567614|FG000|Overall Study|Protocol Violation|0|||
163234128|NCT02766608|589567615|FG001|Overall Study|Protocol Violation|4|||
163234129|NCT02766608|589567616|FG002|Overall Study|Protocol Violation|4|||
163234130|NCT02766608|589567617|FG003|Overall Study|Protocol Violation|0|||
163234131|NCT02766608|589567618|FG004|Overall Study|Protocol Violation|1|||
163234132|NCT02766608|589567614|FG000|Overall Study|Administrative Reasons|3|||
163234133|NCT02766608|589567615|FG001|Overall Study|Administrative Reasons|1|||
163234134|NCT02766608|589567616|FG002|Overall Study|Administrative Reasons|1|||
163234135|NCT02766608|589567617|FG003|Overall Study|Administrative Reasons|0|||
163234136|NCT02766608|589567618|FG004|Overall Study|Administrative Reasons|0|||
163234137|NCT02648698|589567621|FG000|Overall Study|Protocol Violation|1|||
163234138|NCT02648698|589567622|FG001|Overall Study|Protocol Violation|5|||
163234139|NCT03143829|589567625|FG000|Overall Study|Withdrawal by Subject|2|||
163234140|NCT03143829|589567626|FG001|Overall Study|Withdrawal by Subject|5|||
163234141|NCT03143829|589567625|FG000|Overall Study|Lost to Follow-up|0|||
163234142|NCT03143829|589567626|FG001|Overall Study|Lost to Follow-up|2|||
163234143|NCT03143829|589567625|FG000|Overall Study|Death|1|||
163234144|NCT03143829|589567626|FG001|Overall Study|Death|1|||
163234145|NCT03143829|589567625|FG000|Overall Study|changed treatment, no longer eligible|2|||
163234146|NCT03143829|589567626|FG001|Overall Study|changed treatment, no longer eligible|2|||
163234147|NCT00672477|589567627|FG000|Overall Study|Adverse Event|10|||
163234148|NCT00672477|589567628|FG001|Overall Study|Adverse Event|7|||
163347646|NCT00899379|589981586|FG002|Overall Study|Withdrawal by Subject|2|||
163347647|NCT00899379|589981587|FG003|Overall Study|Withdrawal by Subject|3|||
163347648|NCT00899379|589981588|FG004|Overall Study|Withdrawal by Subject|6|||
163347649|NCT00899379|589981584|FG000|Overall Study|Pregnancy|0|||
163347650|NCT00899379|589981585|FG001|Overall Study|Pregnancy|0|||
163347651|NCT00899379|589981586|FG002|Overall Study|Pregnancy|1|||
163347652|NCT00899379|589981587|FG003|Overall Study|Pregnancy|0|||
163347653|NCT00899379|589981588|FG004|Overall Study|Pregnancy|1|||
163347654|NCT00899379|589981584|FG000|Overall Study|Patient Uncooperative|0|||
163347655|NCT00899379|589981585|FG001|Overall Study|Patient Uncooperative|1|||
163347656|NCT00899379|589981586|FG002|Overall Study|Patient Uncooperative|0|||
163347657|NCT00899379|589981587|FG003|Overall Study|Patient Uncooperative|1|||
163347658|NCT00899379|589981588|FG004|Overall Study|Patient Uncooperative|2|||
163347659|NCT00899379|589981584|FG000|Overall Study|Abnormal Baseline ECG|0|||
163347660|NCT00899379|589981585|FG001|Overall Study|Abnormal Baseline ECG|0|||
163347661|NCT00899379|589981586|FG002|Overall Study|Abnormal Baseline ECG|0|||
163347662|NCT00899379|589981587|FG003|Overall Study|Abnormal Baseline ECG|1|||
163347663|NCT00899379|589981588|FG004|Overall Study|Abnormal Baseline ECG|0|||
163347664|NCT00899379|589981584|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
163347665|NCT00899379|589981585|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
163347666|NCT00899379|589981586|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
163347667|NCT00899379|589981587|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
163347668|NCT00899379|589981588|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
163347669|NCT00899379|589981584|FG000|Overall Study|Not Completed/Entered Extn|5|||
163347670|NCT00899379|589981585|FG001|Overall Study|Not Completed/Entered Extn|1|||
163347671|NCT00899379|589981586|FG002|Overall Study|Not Completed/Entered Extn|6|||
163347672|NCT00899379|589981587|FG003|Overall Study|Not Completed/Entered Extn|4|||
163347673|NCT00899379|589981588|FG004|Overall Study|Not Completed/Entered Extn|3|||
163347674|NCT00899379|589981584|FG000|Overall Study|Study Terminated|3|||
163347675|NCT00899379|589981585|FG001|Overall Study|Study Terminated|0|||
163140191|NCT02663622|589222068|FG003|Overall Study|Death|8|||
163140192|NCT02663622|589222065|FG000|Overall Study|Protocol Violation|0|||
163140193|NCT02663622|589222066|FG001|Overall Study|Protocol Violation|0|||
163140194|NCT02663622|589222067|FG002|Overall Study|Protocol Violation|0|||
163140195|NCT02663622|589222068|FG003|Overall Study|Protocol Violation|1|||
163140196|NCT00930930|589222070|FG000|Overall Study|Death|1|||
163140197|NCT00930930|589222071|FG001|Overall Study|Death|0|||
163140198|NCT00930930|589222070|FG000|Overall Study|Physician Decision|1|||
163140199|NCT00930930|589222071|FG001|Overall Study|Physician Decision|0|||
163140200|NCT00930930|589222070|FG000|Overall Study|Adverse Event|13|||
163140201|NCT00930930|589222071|FG001|Overall Study|Adverse Event|3|||
163140202|NCT00930930|589222070|FG000|Overall Study|Withdrawal by Subject|3|||
163140203|NCT00930930|589222071|FG001|Overall Study|Withdrawal by Subject|1|||
163140204|NCT00930930|589222070|FG000|Overall Study|Disease progression|2|||
163140205|NCT00930930|589222071|FG001|Overall Study|Disease progression|3|||
163140206|NCT00930930|589222070|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
163140207|NCT00930930|589222071|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
163140208|NCT00930930|589222070|FG000|Overall Study|patients not compliant|1|||
163140209|NCT00930930|589222071|FG001|Overall Study|patients not compliant|1|||
163140210|NCT00163020|589222072|FG000|Overall Study|Lost to Follow-up|0|||
163140211|NCT00163020|589222073|FG001|Overall Study|Lost to Follow-up|2|||
163140212|NCT03790111|589224199|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
163140213|NCT00985673|589224202|FG000|Overall Study|Lost to Follow-up|6|||
163140214|NCT00985673|589224203|FG001|Overall Study|Lost to Follow-up|7|||
163140215|NCT00985673|589224204|FG002|Overall Study|Lost to Follow-up|6|||
163140216|NCT00985673|589224205|FG003|Overall Study|Lost to Follow-up|10|||
163140217|NCT00985673|589224206|FG004|Overall Study|Lost to Follow-up|5|||
163140218|NCT00985673|589224207|FG005|Overall Study|Lost to Follow-up|3|||
163140219|NCT00985673|589224202|FG000|Overall Study|Withdrawal by Subject|0|||
163140220|NCT00985673|589224203|FG001|Overall Study|Withdrawal by Subject|4|||
163140221|NCT00985673|589224204|FG002|Overall Study|Withdrawal by Subject|5|||
163140222|NCT00985673|589224205|FG003|Overall Study|Withdrawal by Subject|2|||
163140223|NCT00985673|589224206|FG004|Overall Study|Withdrawal by Subject|2|||
163140224|NCT00985673|589224207|FG005|Overall Study|Withdrawal by Subject|3|||
163140225|NCT00985673|589224202|FG000|Overall Study|Other|1|||
163140226|NCT00985673|589224203|FG001|Overall Study|Other|0|||
163140227|NCT00985673|589224204|FG002|Overall Study|Other|1|||
163140228|NCT00985673|589224205|FG003|Overall Study|Other|0|||
163140229|NCT00985673|589224206|FG004|Overall Study|Other|1|||
163140230|NCT00985673|589224207|FG005|Overall Study|Other|0|||
163140231|NCT02252146|589224208|FG000|Overall Study|Lack of Efficacy|4|||
163140232|NCT02252146|589224208|FG000|Overall Study|Entered hospice care|1|||
163140233|NCT02252146|589224208|FG000|Overall Study|Inability to travel to study site|1|||
163140234|NCT00531284|589224209|FG000|Overall Study|Progressive Disease|1|||
163347676|NCT00899379|589981586|FG002|Overall Study|Study Terminated|3|||
163347677|NCT00899379|589981587|FG003|Overall Study|Study Terminated|3|||
163140235|NCT00531284|589224210|FG001|Overall Study|Progressive Disease|3|||
163140236|NCT00531284|589224211|FG002|Overall Study|Progressive Disease|5|||
163234149|NCT00672477|589567627|FG000|Overall Study|Death|7|||
163234150|NCT00672477|589567628|FG001|Overall Study|Death|11|||
163234151|NCT00672477|589567627|FG000|Overall Study|Physician Decision|2|||
163234152|NCT00672477|589567628|FG001|Overall Study|Physician Decision|0|||
163234153|NCT00672477|589567627|FG000|Overall Study|Protocol Violation|1|||
163234154|NCT00672477|589567628|FG001|Overall Study|Protocol Violation|1|||
163234155|NCT00672477|589567627|FG000|Overall Study|Withdrawal by Subject|5|||
163234156|NCT00672477|589567628|FG001|Overall Study|Withdrawal by Subject|3|||
163234157|NCT00672477|589567627|FG000|Overall Study|Lack of Efficacy|1|||
163234158|NCT00672477|589567628|FG001|Overall Study|Lack of Efficacy|1|||
163234159|NCT00672477|589567627|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
163234160|NCT00672477|589567628|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
163234161|NCT00938431|589567632|FG000|Overall Study|Adverse Event|5|||
163234162|NCT00938431|589567633|FG001|Overall Study|Adverse Event|8|||
163234163|NCT00938431|589567634|FG002|Overall Study|Adverse Event|6|||
163234164|NCT00938431|589567632|FG000|Overall Study|Lack of Efficacy|0|||
163234165|NCT00938431|589567633|FG001|Overall Study|Lack of Efficacy|1|||
163234166|NCT00938431|589567634|FG002|Overall Study|Lack of Efficacy|0|||
163234167|NCT00938431|589567632|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
163234168|NCT00938431|589567633|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
163234169|NCT00938431|589567634|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
163234170|NCT00938431|589567632|FG000|Overall Study|Dosing compliance issue|0|||
163234171|NCT00938431|589567633|FG001|Overall Study|Dosing compliance issue|0|||
163234172|NCT00938431|589567634|FG002|Overall Study|Dosing compliance issue|1|||
163234173|NCT00938431|589567632|FG000|Overall Study|Reached maximum dose early|0|||
163234174|NCT00938431|589567633|FG001|Overall Study|Reached maximum dose early|0|||
163234175|NCT00938431|589567634|FG002|Overall Study|Reached maximum dose early|1|||
163234176|NCT03738865|589567639|FG000|Overall Study|Withdrawal by Subject|3|||
163234177|NCT03738865|589567640|FG001|Overall Study|Withdrawal by Subject|3|||
163234178|NCT03738865|589567639|FG000|Overall Study|Adverse Event|2|||
163234179|NCT03738865|589567640|FG001|Overall Study|Adverse Event|0|||
163234180|NCT03738865|589567639|FG000|Overall Study|Physician Decision|0|||
163234181|NCT03738865|589567640|FG001|Overall Study|Physician Decision|1|||
163234182|NCT03455855|589567641|FG000|Overall Study|Lost to Follow-up|4|||
163234183|NCT03455855|589567642|FG001|Overall Study|Lost to Follow-up|2|||
163234184|NCT00924950|589567643|FG000|Overall Study|Lost to Follow-up|2|||
163234185|NCT01602315|589567644|FG000|Overall Study|Protocol Violation|0|||
163234186|NCT01602315|589567645|FG001|Overall Study|Protocol Violation|0|||
163234187|NCT01602315|589567646|FG002|Overall Study|Protocol Violation|0|||
163234188|NCT01602315|589567647|FG003|Overall Study|Protocol Violation|0|||
163234189|NCT01602315|589567648|FG004|Overall Study|Protocol Violation|0|||
163234190|NCT01602315|589567649|FG005|Overall Study|Protocol Violation|1|||
163234191|NCT01602315|589567650|FG006|Overall Study|Protocol Violation|0|||
163234192|NCT01602315|589567644|FG000|Overall Study|Physician Decision|2|||
163234193|NCT01602315|589567645|FG001|Overall Study|Physician Decision|0|||
163234194|NCT01602315|589567646|FG002|Overall Study|Physician Decision|0|||
163234195|NCT01602315|589567647|FG003|Overall Study|Physician Decision|0|||
163234196|NCT01602315|589567648|FG004|Overall Study|Physician Decision|2|||
163234197|NCT01602315|589567649|FG005|Overall Study|Physician Decision|1|||
163234198|NCT01602315|589567650|FG006|Overall Study|Physician Decision|1|||
163234199|NCT01602315|589567644|FG000|Overall Study|Disease progression|6|||
163234200|NCT01602315|589567645|FG001|Overall Study|Disease progression|3|||
163234201|NCT01602315|589567646|FG002|Overall Study|Disease progression|10|||
163234202|NCT01602315|589567647|FG003|Overall Study|Disease progression|1|||
163234203|NCT01602315|589567648|FG004|Overall Study|Disease progression|41|||
163234204|NCT01602315|589567649|FG005|Overall Study|Disease progression|12|||
163234205|NCT01602315|589567650|FG006|Overall Study|Disease progression|15|||
163234206|NCT01602315|589567644|FG000|Overall Study|Death|1|||
163234207|NCT01602315|589567645|FG001|Overall Study|Death|1|||
163234208|NCT01602315|589567646|FG002|Overall Study|Death|1|||
163234209|NCT01602315|589567647|FG003|Overall Study|Death|1|||
163234210|NCT01602315|589567648|FG004|Overall Study|Death|7|||
163234211|NCT01602315|589567649|FG005|Overall Study|Death|2|||
163234212|NCT01602315|589567650|FG006|Overall Study|Death|2|||
163234213|NCT01602315|589567644|FG000|Overall Study|Withdrawal by Subject|2|||
163234214|NCT01602315|589567645|FG001|Overall Study|Withdrawal by Subject|0|||
163234215|NCT01602315|589567646|FG002|Overall Study|Withdrawal by Subject|2|||
163234216|NCT01602315|589567647|FG003|Overall Study|Withdrawal by Subject|0|||
163234217|NCT01602315|589567648|FG004|Overall Study|Withdrawal by Subject|6|||
163234218|NCT01602315|589567649|FG005|Overall Study|Withdrawal by Subject|0|||
163234219|NCT01602315|589567650|FG006|Overall Study|Withdrawal by Subject|1|||
163234220|NCT01602315|589567644|FG000|Overall Study|Adverse Event|5|||
163234221|NCT01602315|589567645|FG001|Overall Study|Adverse Event|1|||
163234222|NCT01602315|589567646|FG002|Overall Study|Adverse Event|5|||
163234223|NCT01602315|589567647|FG003|Overall Study|Adverse Event|4|||
163234224|NCT01602315|589567648|FG004|Overall Study|Adverse Event|15|||
163234225|NCT01602315|589567649|FG005|Overall Study|Adverse Event|3|||
163234226|NCT01602315|589567650|FG006|Overall Study|Adverse Event|9|||
163234227|NCT01602315|589567644|FG000|Overall Study|Subject/guardian decision|0|||
163347678|NCT00899379|589981588|FG004|Overall Study|Study Terminated|1|||
163234228|NCT01602315|589567645|FG001|Overall Study|Subject/guardian decision|0|||
163234229|NCT01602315|589567646|FG002|Overall Study|Subject/guardian decision|0|||
163234230|NCT01602315|589567647|FG003|Overall Study|Subject/guardian decision|0|||
163234231|NCT01602315|589567648|FG004|Overall Study|Subject/guardian decision|0|||
163234232|NCT01602315|589567649|FG005|Overall Study|Subject/guardian decision|0|||
163234233|NCT01602315|589567650|FG006|Overall Study|Subject/guardian decision|1|||
163234234|NCT01602315|589567644|FG000|Overall Study|Cross-over patients to combo treatment|0|||
163234235|NCT01602315|589567645|FG001|Overall Study|Cross-over patients to combo treatment|0|||
163234236|NCT01602315|589567646|FG002|Overall Study|Cross-over patients to combo treatment|0|||
163234237|NCT01602315|589567647|FG003|Overall Study|Cross-over patients to combo treatment|0|||
163234238|NCT01602315|589567648|FG004|Overall Study|Cross-over patients to combo treatment|0|||
163234239|NCT01602315|589567649|FG005|Overall Study|Cross-over patients to combo treatment|16|||
163234240|NCT01602315|589567650|FG006|Overall Study|Cross-over patients to combo treatment|0|||
163234241|NCT02212730|589567653|FG000|Overall Study|Tumor not of the required cell histology|1|||
163234242|NCT02212730|589567654|FG001|Overall Study|Tumor not of the required cell histology|0|||
163234243|NCT02212730|589567653|FG000|Overall Study|Withdrawal by Subject|1|||
163234244|NCT02212730|589567654|FG001|Overall Study|Withdrawal by Subject|0|||
163234245|NCT02212730|589567653|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
163234246|NCT02212730|589567654|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
163234247|NCT00961259|589567655|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
163234248|NCT00961259|589567656|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
163234249|NCT00961259|589567657|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
163234250|NCT02691455|589567660|FG000|Overall Study|Withdrawal by Subject|1|||
163234251|NCT02691455|589567661|FG001|Overall Study|Withdrawal by Subject|2|||
163234252|NCT02691455|589567660|FG000|Overall Study|Lost to Follow-up|15|||
163234253|NCT02691455|589567661|FG001|Overall Study|Lost to Follow-up|15|||
163234254|NCT02057757|589567662|FG000|Overall Study|Withdrawal by Subject|3|||
163234255|NCT02057757|589567663|FG001|Overall Study|Withdrawal by Subject|5|||
163234256|NCT02057757|589567662|FG000|Overall Study|Death|2|||
163234257|NCT02057757|589567663|FG001|Overall Study|Death|0|||
163234258|NCT02057757|589567662|FG000|Overall Study|Lost to Follow-up|8|||
163234259|NCT02057757|589567663|FG001|Overall Study|Lost to Follow-up|3|||
163234260|NCT02057757|589567662|FG000|Overall Study|Non-compliance|1|||
163234261|NCT02057757|589567663|FG001|Overall Study|Non-compliance|0|||
163234262|NCT00440271|589567664|FG000|Overall Study|Protocol Violation|1|||
163234263|NCT00440271|589567665|FG001|Overall Study|Protocol Violation|1|||
163234264|NCT00440271|589567664|FG000|Overall Study|Adverse Event|0|||
163234265|NCT00440271|589567665|FG001|Overall Study|Adverse Event|1|||
163234266|NCT00440271|589567664|FG000|Overall Study|Lost to Follow-up|1|||
163234267|NCT00440271|589567665|FG001|Overall Study|Lost to Follow-up|0|||
163234268|NCT00440271|589567664|FG000|Overall Study|Withdrawal by Subject|0|||
163234269|NCT00440271|589567665|FG001|Overall Study|Withdrawal by Subject|2|||
163234270|NCT00440271|589567664|FG000|Overall Study|Lack of Efficacy|0|||
163234271|NCT00440271|589567665|FG001|Overall Study|Lack of Efficacy|1|||
163234272|NCT00440271|589567664|FG000|Overall Study|Due to closure of trial|8|||
163234273|NCT00440271|589567665|FG001|Overall Study|Due to closure of trial|10|||
163234274|NCT00440271|589567664|FG000|Overall Study|Other|2|||
163234275|NCT00440271|589567665|FG001|Overall Study|Other|0|||
163234276|NCT00048724|589567669|FG000|Overall Study|Adverse Event|53|||
163234277|NCT00048724|589567670|FG001|Overall Study|Adverse Event|12|||
163234278|NCT00048724|589567669|FG000|Overall Study|Withdrawal by Subject|34|||
163234279|NCT00048724|589567670|FG001|Overall Study|Withdrawal by Subject|54|||
163234280|NCT00048724|589567669|FG000|Overall Study|Lost to Follow-up|5|||
163234281|NCT00048724|589567670|FG001|Overall Study|Lost to Follow-up|5|||
163234282|NCT00048724|589567669|FG000|Overall Study|Protocol-defined Clinical Event|17|||
163234283|NCT00048724|589567670|FG001|Overall Study|Protocol-defined Clinical Event|32|||
163234284|NCT00048724|589567669|FG000|Overall Study|Noncompliance With Protocol|4|||
163234285|NCT00048724|589567670|FG001|Overall Study|Noncompliance With Protocol|12|||
163234286|NCT00048724|589567669|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
163234287|NCT00048724|589567670|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
163234288|NCT00048724|589567669|FG000|Overall Study|Administrative|1|||
163234289|NCT00048724|589567670|FG001|Overall Study|Administrative|1|||
163234290|NCT03586869|589567671|FG000|Overall Study|Progressive Disease|3|||
163234291|NCT00226941|589567672|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
163234292|NCT00226941|589567673|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
163234293|NCT00226941|589567674|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
163234294|NCT00226941|589567675|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
163234295|NCT00226941|589567672|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
163234296|NCT00226941|589567673|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
163234297|NCT00226941|589567674|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
163234298|NCT00226941|589567675|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
163234299|NCT02732847|589567676|FG000|Overall Study|some filled early|42|||
163234300|NCT02732847|589567677|FG001|Overall Study|some filled early|42|||
163234301|NCT00724451|589567678|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
163234302|NCT00724451|589567678|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
163234303|NCT00724451|589567678|FG000|Overall Study|Not Eligible for Treatment|431|||
163234304|NCT00724451|589567678|FG000|Overall Study|Participant Refused Treatment|89|||
163234305|NCT00724451|589567678|FG000|Overall Study|Never Started Treatment|89|||
163234306|NCT00724451|589567678|FG000|Overall Study|Unknown; No Data Sources Available|9|||
163234307|NCT00724451|589567678|FG000|Overall Study|Physician Decision|116|||
163234308|NCT00724451|589567678|FG000|Overall Study|Withdrawal by Subject|45|||
163234309|NCT00724451|589567678|FG000|Overall Study|Investigator + Participant Decision|13|||
163234310|NCT00414050|589567680|FG000|Overall Study|Adverse Event|1|||
163234311|NCT00414050|589567681|FG001|Overall Study|Adverse Event|1|||
163234312|NCT00414050|589567682|FG002|Overall Study|Adverse Event|1|||
163234313|NCT00414050|589567683|FG003|Overall Study|Adverse Event|1|||
163234314|NCT00414050|589567680|FG000|Overall Study|Lost to Follow-up|2|||
163234315|NCT00414050|589567681|FG001|Overall Study|Lost to Follow-up|2|||
163234316|NCT00414050|589567682|FG002|Overall Study|Lost to Follow-up|1|||
163234317|NCT00414050|589567683|FG003|Overall Study|Lost to Follow-up|1|||
163234318|NCT00414050|589567680|FG000|Overall Study|Withdrawal by Subject|5|||
163234319|NCT00414050|589567681|FG001|Overall Study|Withdrawal by Subject|3|||
163234320|NCT00414050|589567682|FG002|Overall Study|Withdrawal by Subject|2|||
163234321|NCT00414050|589567683|FG003|Overall Study|Withdrawal by Subject|4|||
163234322|NCT00414050|589567680|FG000|Overall Study|Subject discontinued for other reason|1|||
163234323|NCT00414050|589567681|FG001|Overall Study|Subject discontinued for other reason|2|||
163234324|NCT00414050|589567682|FG002|Overall Study|Subject discontinued for other reason|2|||
163234325|NCT00414050|589567683|FG003|Overall Study|Subject discontinued for other reason|1|||
163234326|NCT00414050|589567680|FG000|Overall Study|Subject Moved|0|||
163234327|NCT00414050|589567681|FG001|Overall Study|Subject Moved|0|||
163234328|NCT00414050|589567682|FG002|Overall Study|Subject Moved|0|||
163234329|NCT00414050|589567683|FG003|Overall Study|Subject Moved|1|||
163234330|NCT00515827|589567690|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
163234331|NCT00515827|589567691|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
163234332|NCT00515827|589567690|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
163234333|NCT00515827|589567691|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
163234334|NCT03254134|589567693|FG000|Overall Study|Not eligible patients|599|||
163234335|NCT03254134|589567694|FG001|Overall Study|Not eligible patients|3630|||
163234336|NCT00205712|589567695|FG000|Overall Study|Lost to Follow-up|0|||
163347679|NCT00899379|589981584|FG000|Overall Study|Lost to Follow-up|3|||
163347680|NCT00899379|589981585|FG001|Overall Study|Lost to Follow-up|1|||
163347681|NCT00899379|589981586|FG002|Overall Study|Lost to Follow-up|0|||
163347682|NCT00899379|589981587|FG003|Overall Study|Lost to Follow-up|2|||
163347683|NCT00899379|589981588|FG004|Overall Study|Lost to Follow-up|5|||
163347684|NCT00899379|589981584|FG000|Overall Study|Withdrawal by Subject|4|||
163347685|NCT00899379|589981585|FG001|Overall Study|Withdrawal by Subject|7|||
163347686|NCT00899379|589981586|FG002|Overall Study|Withdrawal by Subject|4|||
163347687|NCT00899379|589981587|FG003|Overall Study|Withdrawal by Subject|7|||
163347688|NCT00899379|589981588|FG004|Overall Study|Withdrawal by Subject|2|||
163347689|NCT00899379|589981584|FG000|Overall Study|Pregnancy|1|||
163347690|NCT00899379|589981585|FG001|Overall Study|Pregnancy|0|||
163347691|NCT00899379|589981586|FG002|Overall Study|Pregnancy|0|||
163347692|NCT00899379|589981587|FG003|Overall Study|Pregnancy|0|||
163347693|NCT00899379|589981588|FG004|Overall Study|Pregnancy|0|||
163347694|NCT00899379|589981584|FG000|Overall Study|Patient Uncooperative|0|||
163347695|NCT00899379|589981585|FG001|Overall Study|Patient Uncooperative|0|||
163347696|NCT00899379|589981586|FG002|Overall Study|Patient Uncooperative|0|||
163347697|NCT00899379|589981587|FG003|Overall Study|Patient Uncooperative|1|||
163347698|NCT00899379|589981588|FG004|Overall Study|Patient Uncooperative|0|||
163347699|NCT00899379|589981584|FG000|Overall Study|Abnormal Prestudy Labs|0|||
163347700|NCT00899379|589981585|FG001|Overall Study|Abnormal Prestudy Labs|0|||
163347701|NCT00899379|589981586|FG002|Overall Study|Abnormal Prestudy Labs|0|||
163347702|NCT00899379|589981587|FG003|Overall Study|Abnormal Prestudy Labs|0|||
163347703|NCT00899379|589981588|FG004|Overall Study|Abnormal Prestudy Labs|2|||
163347704|NCT00899379|589981584|FG000|Overall Study|Abnormal Baseline ECG|0|||
163347705|NCT00899379|589981585|FG001|Overall Study|Abnormal Baseline ECG|0|||
163347706|NCT00899379|589981586|FG002|Overall Study|Abnormal Baseline ECG|1|||
163347707|NCT00899379|589981587|FG003|Overall Study|Abnormal Baseline ECG|1|||
163347708|NCT00899379|589981588|FG004|Overall Study|Abnormal Baseline ECG|0|||
163347709|NCT00899379|589981584|FG000|Overall Study|No Attack Pretreatment|3|||
163347710|NCT00899379|589981585|FG001|Overall Study|No Attack Pretreatment|5|||
163347711|NCT00899379|589981586|FG002|Overall Study|No Attack Pretreatment|5|||
163347712|NCT00899379|589981587|FG003|Overall Study|No Attack Pretreatment|6|||
163347713|NCT00899379|589981588|FG004|Overall Study|No Attack Pretreatment|4|||
163347714|NCT00899379|589981584|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
163347715|NCT00899379|589981585|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
163347716|NCT00899379|589981586|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
163347717|NCT00899379|589981587|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
163347718|NCT00899379|589981588|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
163347719|NCT00899379|589981584|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
163347720|NCT00899379|589981585|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
163347721|NCT00899379|589981586|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
163347722|NCT00899379|589981587|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
163347723|NCT00899379|589981588|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
163347724|NCT00809783|589981589|FG000|Overall Study|Death|1|||
163347725|NCT00809783|589981590|FG001|Overall Study|Death|0|||
163347726|NCT00809783|589981591|FG002|Overall Study|Death|0|||
163347727|NCT00809783|589981589|FG000|Overall Study|Adverse Event|34|||
163347728|NCT00809783|589981590|FG001|Overall Study|Adverse Event|52|||
163347729|NCT00809783|589981591|FG002|Overall Study|Adverse Event|71|||
163347730|NCT00809783|589981589|FG000|Overall Study|Lack of Efficacy|39|||
163347731|NCT00809783|589981590|FG001|Overall Study|Lack of Efficacy|52|||
163347732|NCT00809783|589981591|FG002|Overall Study|Lack of Efficacy|63|||
163347733|NCT00809783|589981589|FG000|Overall Study|Lost to Follow-up|0|||
163347734|NCT00809783|589981590|FG001|Overall Study|Lost to Follow-up|3|||
163347735|NCT00809783|589981591|FG002|Overall Study|Lost to Follow-up|4|||
163347736|NCT00809783|589981589|FG000|Overall Study|Withdrawal by Subject|47|||
163347737|NCT00809783|589981590|FG001|Overall Study|Withdrawal by Subject|72|||
163347738|NCT00809783|589981591|FG002|Overall Study|Withdrawal by Subject|64|||
163347739|NCT00809783|589981589|FG000|Overall Study|Protocol Violation|2|||
163347740|NCT00809783|589981590|FG001|Overall Study|Protocol Violation|6|||
163347741|NCT00809783|589981591|FG002|Overall Study|Protocol Violation|5|||
163347742|NCT00809783|589981589|FG000|Overall Study|Randomized, but not treated|3|||
163347743|NCT00809783|589981590|FG001|Overall Study|Randomized, but not treated|0|||
163347744|NCT00809783|589981591|FG002|Overall Study|Randomized, but not treated|2|||
163347745|NCT00809783|589981589|FG000|Overall Study|Study Terminated by Sponsor|378|||
163347746|NCT00809783|589981590|FG001|Overall Study|Study Terminated by Sponsor|626|||
163347747|NCT00809783|589981591|FG002|Overall Study|Study Terminated by Sponsor|565|||
163347748|NCT00809783|589981589|FG000|Overall Study|Other|21|||
163347749|NCT00809783|589981590|FG001|Overall Study|Other|21|||
163347750|NCT00809783|589981591|FG002|Overall Study|Other|16|||
163347751|NCT00126555|589981592|FG000|Overall Study|Withdrawal by Subject|1|||
163347752|NCT00126555|589981592|FG000|Overall Study|Adverse Event|2|||
163347753|NCT00126555|589981592|FG000|Overall Study|Progressive Disease|3|||
163347754|NCT02254681|589981608|FG000|Overall Study|Lack of Efficacy|6|||
163347755|NCT00396097|589981609|FG000|Overall Study|Withdrawal by Subject|17|||
163347756|NCT00396097|589981610|FG001|Overall Study|Withdrawal by Subject|17|||
163347757|NCT00396097|589981609|FG000|Overall Study|Lost to Follow-up|4|||
163347758|NCT00396097|589981610|FG001|Overall Study|Lost to Follow-up|9|||
163347759|NCT00396097|589981609|FG000|Overall Study|Other|3|||
163347760|NCT00396097|589981610|FG001|Overall Study|Other|5|||
163347761|NCT00396097|589981609|FG000|Overall Study|Protocol Violation|0|||
163347762|NCT00396097|589981610|FG001|Overall Study|Protocol Violation|6|||
163347763|NCT00396097|589981609|FG000|Overall Study|Adverse Event|1|||
163347764|NCT00396097|589981610|FG001|Overall Study|Adverse Event|5|||
163347765|NCT00396097|589981609|FG000|Overall Study|Insufficient Clinical Response|1|||
163347766|NCT00396097|589981610|FG001|Overall Study|Insufficient Clinical Response|4|||
163347767|NCT03461211|589981611|FG000|Overall Study|Adverse Event|1|||
163347768|NCT03461211|589981612|FG001|Overall Study|Adverse Event|1|||
163347769|NCT03461211|589981611|FG000|Overall Study|Lack of Efficacy|0|||
163140237|NCT00531284|589224212|FG003|Overall Study|Progressive Disease|42|||
163140238|NCT00531284|589224213|FG004|Overall Study|Progressive Disease|4|||
163140239|NCT00531284|589224214|FG005|Overall Study|Progressive Disease|4|||
163140240|NCT00531284|589224215|FG006|Overall Study|Progressive Disease|3|||
163140241|NCT00531284|589224216|FG007|Overall Study|Progressive Disease|8|||
163140242|NCT00531284|589224217|FG008|Overall Study|Progressive Disease|6|||
163140243|NCT00531284|589224218|FG009|Overall Study|Progressive Disease|3|||
163140244|NCT00531284|589224219|FG010|Overall Study|Progressive Disease|3|||
163140245|NCT00531284|589224220|FG011|Overall Study|Progressive Disease|14|||
163140246|NCT00531284|589224221|FG012|Overall Study|Progressive Disease|2|||
163140247|NCT00531284|589224222|FG013|Overall Study|Progressive Disease|1|||
163140248|NCT00531284|589224223|FG014|Overall Study|Progressive Disease|2|||
163140249|NCT00531284|589224224|FG015|Overall Study|Progressive Disease|11|||
163347770|NCT03461211|589981612|FG001|Overall Study|Lack of Efficacy|1|||
163347771|NCT02316847|589981614|FG000|Overall Study|Adverse Event|0|||
163140250|NCT00531284|589224225|FG016|Overall Study|Progressive Disease|5|||
163140251|NCT00531284|589224209|FG000|Overall Study|Adverse Event|0|||
163347772|NCT02316847|589981615|FG001|Overall Study|Adverse Event|3|||
163347773|NCT02316847|589981614|FG000|Overall Study|Lost to Follow-up|0|||
163140252|NCT00531284|589224210|FG001|Overall Study|Adverse Event|1|||
163347774|NCT02316847|589981615|FG001|Overall Study|Lost to Follow-up|2|||
163347775|NCT02316847|589981614|FG000|Overall Study|Physician Decision|0|||
163347776|NCT02316847|589981615|FG001|Overall Study|Physician Decision|1|||
163347777|NCT02316847|589981614|FG000|Overall Study|Pregnancy|0|||
163347778|NCT02316847|589981615|FG001|Overall Study|Pregnancy|1|||
163140253|NCT00531284|589224211|FG002|Overall Study|Adverse Event|1|||
163140254|NCT00531284|589224212|FG003|Overall Study|Adverse Event|7|||
163347779|NCT02316847|589981614|FG000|Overall Study|Withdrawal by Subject|2|||
163347780|NCT02316847|589981615|FG001|Overall Study|Withdrawal by Subject|9|||
163140255|NCT00531284|589224213|FG004|Overall Study|Adverse Event|0|||
163140256|NCT00531284|589224214|FG005|Overall Study|Adverse Event|2|||
163140257|NCT00531284|589224215|FG006|Overall Study|Adverse Event|3|||
163140258|NCT00531284|589224216|FG007|Overall Study|Adverse Event|2|||
163140259|NCT00531284|589224217|FG008|Overall Study|Adverse Event|3|||
163140260|NCT00531284|589224218|FG009|Overall Study|Adverse Event|0|||
163140261|NCT00531284|589224219|FG010|Overall Study|Adverse Event|0|||
163140262|NCT00531284|589224220|FG011|Overall Study|Adverse Event|5|||
163140263|NCT00531284|589224221|FG012|Overall Study|Adverse Event|0|||
163347781|NCT02316847|589981614|FG000|Overall Study|Noncompliance with study drug|0|||
163347782|NCT02316847|589981615|FG001|Overall Study|Noncompliance with study drug|3|||
163347783|NCT02316847|589981614|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
163347784|NCT02316847|589981615|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
163347785|NCT01370018|589981616|FG000|Overall Study|Did not meet criteria for analysis|1|||
163347786|NCT01525641|589981617|FG000|Overall Study|Case report form not collected|25|||
163347787|NCT01525641|589981617|FG000|Overall Study|No visit since the first visit|16|||
163347788|NCT01525641|589981617|FG000|Overall Study|Adverse Event|73|||
163347789|NCT01525641|589981617|FG000|Overall Study|Lack of Efficacy|24|||
163347790|NCT01525641|589981617|FG000|Overall Study|Improvement|5|||
163347791|NCT01525641|589981617|FG000|Overall Study|Lost to follow-up (relocation)|1|||
163347792|NCT01525641|589981617|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
163347793|NCT01525641|589981617|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
163347794|NCT01525641|589981617|FG000|Overall Study|Other than stated above|7|||
163347795|NCT02204319|589981618|FG000|Overall Study|Pregnancy|1|||
163347796|NCT02204319|589981618|FG000|Overall Study|Withdrawal by Subject|2|||
163347797|NCT02959177|589981624|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
163347798|NCT02959177|589981625|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
163347799|NCT02959177|589981626|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
163347800|NCT02959177|589981624|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
163347801|NCT02959177|589981625|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
163347802|NCT02959177|589981626|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
163347803|NCT02959177|589981624|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
163347804|NCT02959177|589981625|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
163347805|NCT02959177|589981626|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
163347806|NCT02959177|589981624|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
163347807|NCT02959177|589981625|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
163347808|NCT02959177|589981626|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
163347809|NCT02959177|589981624|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
163347810|NCT02959177|589981625|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
163347811|NCT02959177|589981626|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
163347812|NCT02959177|589981624|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
163347813|NCT02959177|589981625|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
163347814|NCT02959177|589981626|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
163347815|NCT02959177|589981624|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
163347816|NCT02959177|589981625|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
163347817|NCT02959177|589981626|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
163347818|NCT03544229|589981627|FG000|Overall Study|Adverse Event|1|||
163347819|NCT03544229|589981628|FG001|Overall Study|Adverse Event|0|||
163347820|NCT03544229|589981629|FG002|Overall Study|Adverse Event|1|||
163347821|NCT03544229|589981630|FG003|Overall Study|Adverse Event|0|||
163347822|NCT03544229|589981627|FG000|Overall Study|Protocol Deviation|0|||
163347823|NCT03544229|589981628|FG001|Overall Study|Protocol Deviation|0|||
163347824|NCT03544229|589981629|FG002|Overall Study|Protocol Deviation|1|||
163347825|NCT03544229|589981630|FG003|Overall Study|Protocol Deviation|0|||
163347826|NCT03544229|589981627|FG000|Overall Study|Lost to Follow-up|3|||
163347827|NCT03544229|589981628|FG001|Overall Study|Lost to Follow-up|0|||
163347828|NCT03544229|589981629|FG002|Overall Study|Lost to Follow-up|0|||
163347829|NCT03544229|589981630|FG003|Overall Study|Lost to Follow-up|2|||
163347830|NCT03544229|589981627|FG000|Overall Study|Voluntary Withdrawal|2|||
163347831|NCT03544229|589981628|FG001|Overall Study|Voluntary Withdrawal|1|||
163347832|NCT03544229|589981629|FG002|Overall Study|Voluntary Withdrawal|3|||
163347833|NCT03544229|589981630|FG003|Overall Study|Voluntary Withdrawal|0|||
163347834|NCT03544229|589981627|FG000|Overall Study|Lack of Efficacy|0|||
163347835|NCT03544229|589981628|FG001|Overall Study|Lack of Efficacy|1|||
163347836|NCT03544229|589981629|FG002|Overall Study|Lack of Efficacy|0|||
163347837|NCT03544229|589981630|FG003|Overall Study|Lack of Efficacy|0|||
163347838|NCT02460562|589981631|FG000|Overall Study|Lost to Follow-up|15|||
163347839|NCT02460562|589981632|FG001|Overall Study|Lost to Follow-up|16|||
163347840|NCT01061775|589981633|FG000|Overall Study|Physician Decision|2|||
163140264|NCT00531284|589224222|FG013|Overall Study|Adverse Event|1|||
163140265|NCT00531284|589224223|FG014|Overall Study|Adverse Event|1|||
163347841|NCT01061775|589981633|FG000|Overall Study|Lost to Follow-up|1|||
163347842|NCT00588341|589981634|FG000|Overall Study|Withdrawal by Subject|3|||
163347843|NCT00588341|589981634|FG000|Overall Study|Not treated due to metastatic disease|1|||
163140266|NCT00531284|589224224|FG015|Overall Study|Adverse Event|0|||
163234337|NCT00205712|589567696|FG001|Overall Study|Lost to Follow-up|1|||
163234338|NCT01009099|589567697|FG000|Overall Study|Lost to Follow-up|1|||
163234339|NCT01009099|589567698|FG001|Overall Study|Lost to Follow-up|0|||
163234340|NCT01009099|589567697|FG000|Overall Study|Physician Decision|3|||
163234341|NCT01009099|589567698|FG001|Overall Study|Physician Decision|2|||
163234342|NCT01009099|589567697|FG000|Overall Study|Withdrawal by Subject|1|||
163234343|NCT01009099|589567698|FG001|Overall Study|Withdrawal by Subject|1|||
163234344|NCT01009099|589567697|FG000|Overall Study|Death|0|||
163234345|NCT01009099|589567698|FG001|Overall Study|Death|1|||
163234346|NCT02188485|589567703|FG000|Overall Study|Withdrawal by Subject|2|||
163234347|NCT02188485|589567704|FG001|Overall Study|Withdrawal by Subject|1|||
163234348|NCT02188485|589567703|FG000|Overall Study|PI withdrew, lack of capacity|0|||
163234349|NCT02188485|589567704|FG001|Overall Study|PI withdrew, lack of capacity|2|||
163234350|NCT00799617|589567705|FG000|Main Testosterone Trial|Randomized in error|1|||
163234351|NCT00799617|589567706|FG001|Main Testosterone Trial|Randomized in error|1|||
163234352|NCT00799617|589567705|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
163234353|NCT00799617|589567706|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
163234354|NCT00799617|589567705|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
163234355|NCT00799617|589567706|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
163234356|NCT00799617|589567705|FG000|Sexual Funtion Trial|No Baseline Data|4|||
163234357|NCT00799617|589567706|FG001|Sexual Funtion Trial|No Baseline Data|7|||
163234358|NCT00799617|589567705|FG000|Physical Function Trial|Lost to Follow-up|6|||
163234359|NCT00799617|589567706|FG001|Physical Function Trial|Lost to Follow-up|11|||
163234360|NCT00799617|589567705|FG000|Vitality Trial|Lost to Follow-up|7|||
163234361|NCT00799617|589567706|FG001|Vitality Trial|Lost to Follow-up|22|||
163234362|NCT00799617|589567705|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
163234363|NCT00799617|589567706|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
163234364|NCT00799617|589567705|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
163234365|NCT00799617|589567706|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
163234366|NCT00799617|589567705|FG000|Bone Trial|Month 12 scan not available|6|||
163234367|NCT00799617|589567706|FG001|Bone Trial|Month 12 scan not available|16|||
163234368|NCT00799617|589567705|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
163234369|NCT00799617|589567706|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
163234370|NCT00799617|589567705|FG000|Anemia Trial|Withdrawal by Subject|3|||
163234371|NCT00799617|589567706|FG001|Anemia Trial|Withdrawal by Subject|3|||
163234372|NCT01712984|589567707|FG000|Overall Study|Adverse Event|0|||
163234373|NCT01712984|589567708|FG001|Overall Study|Adverse Event|0|||
163234374|NCT01712984|589567709|FG002|Overall Study|Adverse Event|1|||
163234375|NCT01712984|589567707|FG000|Overall Study|Protocol Violation|2|||
163234376|NCT01712984|589567708|FG001|Overall Study|Protocol Violation|0|||
163234377|NCT01712984|589567709|FG002|Overall Study|Protocol Violation|1|||
163234378|NCT01712984|589567707|FG000|Overall Study|Lost to Follow-up|8|||
163234379|NCT01712984|589567708|FG001|Overall Study|Lost to Follow-up|10|||
163234380|NCT01712984|589567709|FG002|Overall Study|Lost to Follow-up|1|||
163234381|NCT01712984|589567707|FG000|Overall Study|Withdrawal by Subject|6|||
163234382|NCT01712984|589567708|FG001|Overall Study|Withdrawal by Subject|6|||
163234383|NCT01712984|589567709|FG002|Overall Study|Withdrawal by Subject|7|||
163234384|NCT00096044|589567712|FG000|Overall Study|Withdrawal by Subject|9|||
163140267|NCT00531284|589224225|FG016|Overall Study|Adverse Event|2|||
163140268|NCT00531284|589224209|FG000|Overall Study|Withdrawal by Subject|1|||
163140269|NCT00531284|589224210|FG001|Overall Study|Withdrawal by Subject|0|||
163140270|NCT00531284|589224211|FG002|Overall Study|Withdrawal by Subject|0|||
163140271|NCT00531284|589224212|FG003|Overall Study|Withdrawal by Subject|4|||
163140272|NCT00531284|589224213|FG004|Overall Study|Withdrawal by Subject|0|||
163140273|NCT00531284|589224214|FG005|Overall Study|Withdrawal by Subject|0|||
163140274|NCT00531284|589224215|FG006|Overall Study|Withdrawal by Subject|0|||
163140275|NCT00531284|589224216|FG007|Overall Study|Withdrawal by Subject|0|||
163140276|NCT00531284|589224217|FG008|Overall Study|Withdrawal by Subject|0|||
163140277|NCT00531284|589224218|FG009|Overall Study|Withdrawal by Subject|0|||
163140278|NCT00531284|589224219|FG010|Overall Study|Withdrawal by Subject|0|||
163140279|NCT00531284|589224220|FG011|Overall Study|Withdrawal by Subject|3|||
163140280|NCT00531284|589224221|FG012|Overall Study|Withdrawal by Subject|0|||
163140281|NCT00531284|589224222|FG013|Overall Study|Withdrawal by Subject|1|||
163140282|NCT00531284|589224223|FG014|Overall Study|Withdrawal by Subject|0|||
163140283|NCT00531284|589224224|FG015|Overall Study|Withdrawal by Subject|1|||
163234385|NCT00096044|589567712|FG000|Overall Study|Adverse Event|21|||
163234386|NCT00096044|589567712|FG000|Overall Study|Disease Progression|4|||
163234387|NCT03149237|589567713|FG000|Overall Study|Withdrawal by Subject|4|||
163234388|NCT03149237|589567714|FG001|Overall Study|Withdrawal by Subject|5|||
163234389|NCT02442830|589567715|FG000|Overall Study|Technical Failure|0|||
163234390|NCT02442830|589567716|FG001|Overall Study|Technical Failure|1|||
163140284|NCT00531284|589224225|FG016|Overall Study|Withdrawal by Subject|1|||
163234391|NCT00595582|589567718|FG000|Overall Study|Pilot study that PI terminated|2|||
163347844|NCT00588341|589981634|FG000|Overall Study|Patient ineligible|1|||
163234392|NCT00595582|589567718|FG000|Overall Study|Lost to Follow-up|1|||
163234393|NCT00595582|589567718|FG000|Overall Study|Adverse Event|2|||
163347845|NCT02642159|589981635|FG000|Overall Study|Randomized but not treated|1|||
163234394|NCT00595582|589567718|FG000|Overall Study|Physician Decision|5|||
163234395|NCT03851016|589567719|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
163234396|NCT03851016|589567720|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
163234397|NCT03878134|589567721|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
163234398|NCT00586469|589567722|FG000|Overall Study|Adverse Event|0|||
163234399|NCT00586469|589567723|FG001|Overall Study|Adverse Event|1|||
163234400|NCT04055116|589567726|FG000|First Intervention|Physician Decision|2|||
163234401|NCT04055116|589567727|FG001|First Intervention|Physician Decision|7|||
163234402|NCT01660412|589567733|FG000|Overall Study|Protocol Violation|0|||
163234403|NCT01660412|589567734|FG001|Overall Study|Protocol Violation|3|||
163234404|NCT04258839|589569291|FG000|Overall Study|Adverse Event|2|||
163234405|NCT04258839|589569292|FG001|Overall Study|Adverse Event|4|||
163234406|NCT04258839|589569291|FG000|Overall Study|Lack of Efficacy|0|||
163234407|NCT04258839|589569292|FG001|Overall Study|Lack of Efficacy|2|||
163234408|NCT04258839|589569291|FG000|Overall Study|Lost to Follow-up|2|||
163234409|NCT04258839|589569292|FG001|Overall Study|Lost to Follow-up|0|||
163234410|NCT04258839|589569291|FG000|Overall Study|Withdrawal by Subject|1|||
163234411|NCT04258839|589569292|FG001|Overall Study|Withdrawal by Subject|2|||
163234412|NCT04258839|589569291|FG000|Overall Study|Withdrawal by Caregiver|5|||
163234413|NCT04258839|589569292|FG001|Overall Study|Withdrawal by Caregiver|6|||
163234414|NCT04258839|589569291|FG000|Overall Study|Reason not Specified|0|||
163234415|NCT04258839|589569292|FG001|Overall Study|Reason not Specified|1|||
163234416|NCT03328897|589569293|FG000|Randomized-treatment Epoch|Adverse Event|4|||
163234417|NCT03328897|589569294|FG001|Randomized-treatment Epoch|Adverse Event|1|||
163234418|NCT03328897|589569295|FG002|Randomized-treatment Epoch|Adverse Event|1|||
163234419|NCT03328897|589569293|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
163234420|NCT03328897|589569294|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
163234421|NCT03328897|589569295|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
163234422|NCT03328897|589569293|FG000|Randomized-treatment Epoch|Pregnancy|3|||
163234423|NCT03328897|589569294|FG001|Randomized-treatment Epoch|Pregnancy|0|||
163234424|NCT03328897|589569295|FG002|Randomized-treatment Epoch|Pregnancy|0|||
163234425|NCT03328897|589569293|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
163234426|NCT03328897|589569294|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
163234427|NCT03328897|589569295|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
163234428|NCT03328897|589569293|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
163234429|NCT03328897|589569294|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
163234430|NCT03328897|589569295|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
163234431|NCT03328897|589569293|FG000|Follow-up Epoch|Adverse Event|4|||
163234432|NCT03328897|589569294|FG001|Follow-up Epoch|Adverse Event|0|||
163234433|NCT03328897|589569295|FG002|Follow-up Epoch|Adverse Event|1|||
163234434|NCT03328897|589569293|FG000|Follow-up Epoch|Lack of Efficacy|1|||
163234435|NCT03328897|589569294|FG001|Follow-up Epoch|Lack of Efficacy|1|||
163234436|NCT03328897|589569295|FG002|Follow-up Epoch|Lack of Efficacy|1|||
163234437|NCT03328897|589569293|FG000|Follow-up Epoch|Lost to Follow-up|0|||
163234438|NCT03328897|589569294|FG001|Follow-up Epoch|Lost to Follow-up|1|||
163234439|NCT03328897|589569295|FG002|Follow-up Epoch|Lost to Follow-up|0|||
163234440|NCT03328897|589569293|FG000|Follow-up Epoch|Pregnancy|1|||
163234441|NCT03328897|589569294|FG001|Follow-up Epoch|Pregnancy|0|||
163234442|NCT03328897|589569295|FG002|Follow-up Epoch|Pregnancy|0|||
163234443|NCT03328897|589569293|FG000|Follow-up Epoch|Patient/guardian decision|2|||
163234444|NCT03328897|589569294|FG001|Follow-up Epoch|Patient/guardian decision|1|||
163234445|NCT03328897|589569295|FG002|Follow-up Epoch|Patient/guardian decision|0|||
163234446|NCT00608829|589569296|FG000|Overall Study|Death|6|||
163234447|NCT00608829|589569296|FG000|Overall Study|Withdrawal by Subject|4|||
163234448|NCT00608829|589569296|FG000|Overall Study|Subject refuses to follow up or return.|5|||
163234449|NCT02080091|589569299|FG000|Overall Study|Study Terminated|22|||
163234450|NCT02080091|589569299|FG000|Overall Study|Death|1|||
163234451|NCT02080091|589569299|FG000|Overall Study|Withdrawal by Subject|1|||
163234452|NCT02080091|589569299|FG000|Overall Study|Other|1|||
163347846|NCT02642159|589981636|FG001|Overall Study|Randomized but not treated|0|||
163347847|NCT02642159|589981635|FG000|Overall Study|Adverse Event|10|||
163347848|NCT02642159|589981636|FG001|Overall Study|Adverse Event|4|||
163347849|NCT02642159|589981635|FG000|Overall Study|Withdrawal by Subject|9|||
163347850|NCT02642159|589981636|FG001|Overall Study|Withdrawal by Subject|1|||
163234453|NCT03019536|589569301|FG000|Overall Study|Withdrawal by Subject|1|||
163234454|NCT03019536|589569302|FG001|Overall Study|Withdrawal by Subject|1|||
163234455|NCT03019536|589569303|FG002|Overall Study|Withdrawal by Subject|0|||
163234456|NCT03019536|589569301|FG000|Overall Study|Adverse Event|0|||
163234457|NCT03019536|589569302|FG001|Overall Study|Adverse Event|0|||
163234458|NCT03019536|589569303|FG002|Overall Study|Adverse Event|2|||
163234459|NCT00317772|589569309|FG000|Overall Study|Adverse Event|0|||
163234460|NCT00317772|589569310|FG001|Overall Study|Adverse Event|0|||
163234461|NCT00317772|589569311|FG002|Overall Study|Adverse Event|0|||
163234462|NCT00317772|589569312|FG003|Overall Study|Adverse Event|2|||
163234463|NCT00317772|589569309|FG000|Overall Study|Disease Progression|2|||
163347851|NCT02642159|589981635|FG000|Overall Study|Poor compliance to study protocol|1|||
163409308|NCT01142726|590207577|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
163409309|NCT01568593|590207578|FG000|Overall Study|Lack of Efficacy|4|||
163409310|NCT01568593|590207579|FG001|Overall Study|Lack of Efficacy|1|||
163409311|NCT01568593|590207578|FG000|Overall Study|Adverse Event|3|||
163409312|NCT01568593|590207579|FG001|Overall Study|Adverse Event|2|||
163409313|NCT02109484|590207580|FG000|Overall Study|Lost to Follow-up|0|||
163409314|NCT02109484|590207581|FG001|Overall Study|Lost to Follow-up|0|||
163409315|NCT02109484|590207582|FG002|Overall Study|Lost to Follow-up|0|||
163234464|NCT00317772|589569310|FG001|Overall Study|Disease Progression|2|||
163234465|NCT00317772|589569311|FG002|Overall Study|Disease Progression|1|||
163234466|NCT00317772|589569312|FG003|Overall Study|Disease Progression|7|||
163234467|NCT00966940|589569313|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
163234468|NCT00966940|589569314|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
163234469|NCT00966940|589569313|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
163234470|NCT00966940|589569314|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
163234471|NCT01040871|589569317|FG000|Overall Study|Adverse Event|6|||
163234472|NCT01040871|589569318|FG001|Overall Study|Adverse Event|2|||
163234473|NCT01040871|589569317|FG000|Overall Study|Withdrawal by Subject|2|||
163234474|NCT01040871|589569318|FG001|Overall Study|Withdrawal by Subject|0|||
163234475|NCT01040871|589569317|FG000|Overall Study|Death|1|||
163234476|NCT01040871|589569318|FG001|Overall Study|Death|3|||
163234477|NCT01040871|589569317|FG000|Overall Study|Lack of Efficacy|1|||
163234478|NCT01040871|589569318|FG001|Overall Study|Lack of Efficacy|1|||
163234479|NCT01040871|589569317|FG000|Overall Study|drug supply issue|1|||
163234480|NCT01040871|589569318|FG001|Overall Study|drug supply issue|0|||
163234481|NCT01040871|589569317|FG000|Overall Study|Randomized and Not Treated|2|||
163234482|NCT01040871|589569318|FG001|Overall Study|Randomized and Not Treated|1|||
163347852|NCT02642159|589981636|FG001|Overall Study|Poor compliance to study protocol|0|||
163347853|NCT02642159|589981635|FG000|Overall Study|Other than specified above|10|||
163347854|NCT02642159|589981636|FG001|Overall Study|Other than specified above|3|||
163347855|NCT03746483|589981639|FG000|Overall Study|Adverse Event|0|||
163347856|NCT03746483|589981640|FG001|Overall Study|Adverse Event|1|||
163347857|NCT03746483|589981639|FG000|Overall Study|Lack of Efficacy|3|||
163347858|NCT03746483|589981640|FG001|Overall Study|Lack of Efficacy|2|||
163347859|NCT03746483|589981639|FG000|Overall Study|Lost to Follow-up|1|||
163347860|NCT03746483|589981640|FG001|Overall Study|Lost to Follow-up|0|||
163347861|NCT03746483|589981639|FG000|Overall Study|Protocol Violation|2|||
163347862|NCT03746483|589981640|FG001|Overall Study|Protocol Violation|0|||
163347863|NCT00853021|589981641|FG000|Overall Study|Adverse Event|2|||
163347864|NCT00853021|589981641|FG000|Overall Study|Withdrawal by Subject|2|||
163347865|NCT00853021|589981641|FG000|Overall Study|Death|1|||
163347866|NCT02864147|589981642|FG000|Overall Study|Withdrawal by Subject|3|||
163347867|NCT02864147|589981643|FG001|Overall Study|Withdrawal by Subject|2|||
163347868|NCT02864147|589981644|FG002|Overall Study|Withdrawal by Subject|1|||
163347869|NCT02864147|589981642|FG000|Overall Study|Lost to Follow-up|0|||
163347870|NCT02864147|589981643|FG001|Overall Study|Lost to Follow-up|4|||
163347871|NCT02864147|589981644|FG002|Overall Study|Lost to Follow-up|0|||
163347872|NCT02864147|589981642|FG000|Overall Study|Adverse Event|0|||
163347873|NCT02864147|589981643|FG001|Overall Study|Adverse Event|1|||
163347874|NCT02864147|589981644|FG002|Overall Study|Adverse Event|0|||
163347875|NCT02864147|589981642|FG000|Overall Study|Pregnancy|4|||
163347876|NCT02864147|589981643|FG001|Overall Study|Pregnancy|0|||
163347877|NCT02864147|589981644|FG002|Overall Study|Pregnancy|0|||
163347878|NCT02864147|589981642|FG000|Overall Study|Physician Decision|0|||
163347879|NCT02864147|589981643|FG001|Overall Study|Physician Decision|0|||
163347880|NCT02864147|589981644|FG002|Overall Study|Physician Decision|1|||
163347881|NCT02864147|589981642|FG000|Overall Study|Opted for excisional procedures|0|||
163347882|NCT02864147|589981643|FG001|Overall Study|Opted for excisional procedures|0|||
163347883|NCT02864147|589981644|FG002|Overall Study|Opted for excisional procedures|3|||
163347884|NCT02269917|589981645|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
163347885|NCT02269917|589981646|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
163409316|NCT02109484|590207583|FG003|Overall Study|Lost to Follow-up|1|||
163409317|NCT02109484|590207584|FG004|Overall Study|Lost to Follow-up|1|||
163409318|NCT02109484|590207585|FG005|Overall Study|Lost to Follow-up|0|||
163234483|NCT02886572|589569319|FG000|Overall Study|Death|8|||
163409319|NCT02109484|590207586|FG006|Overall Study|Lost to Follow-up|1|||
163409320|NCT02109484|590207587|FG007|Overall Study|Lost to Follow-up|0|||
163234484|NCT03087591|589569320|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
163234485|NCT03087591|589569320|FG000|Overall Study|Withdrawal by Subject|1|||
163234486|NCT02621606|589569321|FG000|Overall Study|Withdrawal by Subject|0|||
163347886|NCT02269917|589981647|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
163347887|NCT02269917|589981645|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
163347888|NCT02269917|589981646|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
163347889|NCT02269917|589981647|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
163347890|NCT02269917|589981645|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
163347891|NCT02269917|589981646|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
163409321|NCT02109484|590207580|FG000|Overall Study|Withdrawal by Subject|0|||
163234487|NCT02621606|589569322|FG001|Overall Study|Withdrawal by Subject|1|||
163234488|NCT02621606|589569323|FG002|Overall Study|Withdrawal by Subject|0|||
163234489|NCT01175824|589569324|FG000|Overall Study|Adverse Event|2|||
163234490|NCT01175824|589569325|FG001|Overall Study|Adverse Event|1|||
163234491|NCT01175824|589569324|FG000|Overall Study|Lack of Efficacy|2|||
163234492|NCT01175824|589569325|FG001|Overall Study|Lack of Efficacy|0|||
163234493|NCT01175824|589569324|FG000|Overall Study|Lost to Follow-up|0|||
163234494|NCT01175824|589569325|FG001|Overall Study|Lost to Follow-up|1|||
163234495|NCT01175824|589569324|FG000|Overall Study|Physician Decision|0|||
163234496|NCT01175824|589569325|FG001|Overall Study|Physician Decision|4|||
163234497|NCT01175824|589569324|FG000|Overall Study|Protocol Violation|2|||
163234498|NCT01175824|589569325|FG001|Overall Study|Protocol Violation|5|||
163234499|NCT01175824|589569324|FG000|Overall Study|Withdrawal by Subject|3|||
163234500|NCT01175824|589569325|FG001|Overall Study|Withdrawal by Subject|7|||
163234501|NCT01175824|589569324|FG000|Overall Study|Sponsor Decision|1|||
163234502|NCT01175824|589569325|FG001|Overall Study|Sponsor Decision|0|||
163234503|NCT01175824|589569324|FG000|Overall Study|Entry Criteria Not Met|6|||
163234504|NCT01175824|589569325|FG001|Overall Study|Entry Criteria Not Met|4|||
163234505|NCT01774903|589569326|FG000|Overall Study|Adverse Event|7|||
163234506|NCT01774903|589569326|FG000|Overall Study|Withdrawal by Subject|2|||
163234507|NCT01774903|589569326|FG000|Overall Study|Lack of Efficacy|1|||
163234508|NCT01774903|589569326|FG000|Overall Study|Ineligible to continue the trial|1|||
163234509|NCT00982319|589569327|FG000|Overall Study|Surgery date change|1|||
163234510|NCT00982319|589569328|FG001|Overall Study|Surgery date change|0|||
163234511|NCT00982319|589569327|FG000|Overall Study|Preop values out of acceptable range|1|||
163234512|NCT00982319|589569328|FG001|Overall Study|Preop values out of acceptable range|1|||
163234513|NCT00982319|589569327|FG000|Overall Study|Pregnancy|0|||
163234514|NCT00982319|589569328|FG001|Overall Study|Pregnancy|1|||
163234515|NCT00767000|589569329|FG000|54-week Study|Adverse Event|4|||
163234516|NCT00767000|589569330|FG001|54-week Study|Adverse Event|6|||
163234517|NCT00767000|589569331|FG002|54-week Study|Adverse Event|6|||
163234518|NCT00767000|589569332|FG003|54-week Study|Adverse Event|8|||
163234519|NCT00767000|589569333|FG004|54-week Study|Adverse Event|4|||
163234520|NCT00767000|589569329|FG000|54-week Study|Creaninine/creatinine clearance|2|||
163234521|NCT00767000|589569330|FG001|54-week Study|Creaninine/creatinine clearance|1|||
163234522|NCT00767000|589569331|FG002|54-week Study|Creaninine/creatinine clearance|2|||
163234523|NCT00767000|589569332|FG003|54-week Study|Creaninine/creatinine clearance|2|||
163234524|NCT00767000|589569333|FG004|54-week Study|Creaninine/creatinine clearance|4|||
163234525|NCT00767000|589569329|FG000|54-week Study|Hyperglycemia|0|||
163234526|NCT00767000|589569330|FG001|54-week Study|Hyperglycemia|0|||
163234527|NCT00767000|589569331|FG002|54-week Study|Hyperglycemia|1|||
163234528|NCT00767000|589569332|FG003|54-week Study|Hyperglycemia|0|||
163234529|NCT00767000|589569333|FG004|54-week Study|Hyperglycemia|1|||
163234530|NCT00767000|589569329|FG000|54-week Study|Hypoglycemia|0|||
163234531|NCT00767000|589569330|FG001|54-week Study|Hypoglycemia|1|||
163234532|NCT00767000|589569331|FG002|54-week Study|Hypoglycemia|0|||
163234533|NCT00767000|589569332|FG003|54-week Study|Hypoglycemia|0|||
163234534|NCT00767000|589569333|FG004|54-week Study|Hypoglycemia|0|||
163234535|NCT00767000|589569329|FG000|54-week Study|Interruption of study medication|0|||
163234536|NCT00767000|589569330|FG001|54-week Study|Interruption of study medication|0|||
163234537|NCT00767000|589569331|FG002|54-week Study|Interruption of study medication|1|||
163234538|NCT00767000|589569332|FG003|54-week Study|Interruption of study medication|0|||
163234539|NCT00767000|589569333|FG004|54-week Study|Interruption of study medication|0|||
163234540|NCT00767000|589569329|FG000|54-week Study|Lack of Efficacy|2|||
163234541|NCT00767000|589569330|FG001|54-week Study|Lack of Efficacy|0|||
163234542|NCT00767000|589569331|FG002|54-week Study|Lack of Efficacy|1|||
163234543|NCT00767000|589569332|FG003|54-week Study|Lack of Efficacy|0|||
163234544|NCT00767000|589569333|FG004|54-week Study|Lack of Efficacy|5|||
163347892|NCT02269917|589981647|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
163347893|NCT02269917|589981645|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
163347894|NCT02269917|589981646|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
163347895|NCT02269917|589981647|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
163234545|NCT00767000|589569329|FG000|54-week Study|Lost to Follow-up|4|||
163347896|NCT02269917|589981645|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
163347897|NCT02269917|589981646|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
163234546|NCT00767000|589569330|FG001|54-week Study|Lost to Follow-up|0|||
163347898|NCT02269917|589981647|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
163347899|NCT02269917|589981645|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
163347900|NCT02269917|589981646|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
163234547|NCT00767000|589569331|FG002|54-week Study|Lost to Follow-up|1|||
163234548|NCT00767000|589569332|FG003|54-week Study|Lost to Follow-up|4|||
163234549|NCT00767000|589569333|FG004|54-week Study|Lost to Follow-up|2|||
163234550|NCT00767000|589569329|FG000|54-week Study|Physician Decision|4|||
163234551|NCT00767000|589569330|FG001|54-week Study|Physician Decision|0|||
163234552|NCT00767000|589569331|FG002|54-week Study|Physician Decision|1|||
163234553|NCT00767000|589569332|FG003|54-week Study|Physician Decision|1|||
163409322|NCT02109484|590207581|FG001|Overall Study|Withdrawal by Subject|0|||
163409323|NCT02109484|590207582|FG002|Overall Study|Withdrawal by Subject|0|||
163409324|NCT02109484|590207583|FG003|Overall Study|Withdrawal by Subject|0|||
163234554|NCT00767000|589569333|FG004|54-week Study|Physician Decision|1|||
163234555|NCT00767000|589569329|FG000|54-week Study|Progressive disease|0|||
163234556|NCT00767000|589569330|FG001|54-week Study|Progressive disease|0|||
163234557|NCT00767000|589569331|FG002|54-week Study|Progressive disease|1|||
163234558|NCT00767000|589569332|FG003|54-week Study|Progressive disease|0|||
163234559|NCT00767000|589569333|FG004|54-week Study|Progressive disease|0|||
163234560|NCT00767000|589569329|FG000|54-week Study|Protocol Violation|0|||
163234561|NCT00767000|589569330|FG001|54-week Study|Protocol Violation|0|||
163234562|NCT00767000|589569331|FG002|54-week Study|Protocol Violation|1|||
163409325|NCT02109484|590207584|FG004|Overall Study|Withdrawal by Subject|1|||
163409326|NCT02109484|590207585|FG005|Overall Study|Withdrawal by Subject|1|||
163409327|NCT02109484|590207586|FG006|Overall Study|Withdrawal by Subject|1|||
163234563|NCT00767000|589569332|FG003|54-week Study|Protocol Violation|2|||
163234564|NCT00767000|589569333|FG004|54-week Study|Protocol Violation|0|||
163234565|NCT00767000|589569329|FG000|54-week Study|Withdrawal by Subject|2|||
163234566|NCT00767000|589569330|FG001|54-week Study|Withdrawal by Subject|3|||
163234567|NCT00767000|589569331|FG002|54-week Study|Withdrawal by Subject|5|||
163234568|NCT00767000|589569332|FG003|54-week Study|Withdrawal by Subject|11|||
163234569|NCT00767000|589569333|FG004|54-week Study|Withdrawal by Subject|13|||
163234570|NCT00767000|589569329|FG000|54-week Study|Study terminated by sponsor|90|||
163234571|NCT00767000|589569330|FG001|54-week Study|Study terminated by sponsor|102|||
163234572|NCT00767000|589569331|FG002|54-week Study|Study terminated by sponsor|89|||
163409328|NCT02109484|590207587|FG007|Overall Study|Withdrawal by Subject|0|||
163409329|NCT02109484|590207580|FG000|Overall Study|Physician Decision|0|||
163409330|NCT02109484|590207581|FG001|Overall Study|Physician Decision|0|||
163409331|NCT02109484|590207582|FG002|Overall Study|Physician Decision|0|||
163409332|NCT02109484|590207583|FG003|Overall Study|Physician Decision|0|||
163409333|NCT02109484|590207584|FG004|Overall Study|Physician Decision|2|||
163409334|NCT02109484|590207585|FG005|Overall Study|Physician Decision|0|||
163409335|NCT02109484|590207586|FG006|Overall Study|Physician Decision|0|||
163409336|NCT02109484|590207587|FG007|Overall Study|Physician Decision|0|||
163409337|NCT02109484|590207580|FG000|Overall Study|Death|0|||
163409338|NCT02109484|590207581|FG001|Overall Study|Death|0|||
163409339|NCT02109484|590207582|FG002|Overall Study|Death|0|||
163409340|NCT02109484|590207583|FG003|Overall Study|Death|0|||
163409341|NCT02109484|590207584|FG004|Overall Study|Death|0|||
163409342|NCT02109484|590207585|FG005|Overall Study|Death|0|||
163409343|NCT02109484|590207586|FG006|Overall Study|Death|0|||
163409344|NCT02109484|590207587|FG007|Overall Study|Death|2|||
163409345|NCT02109484|590207580|FG000|Overall Study|Moved away from study area|0|||
163409346|NCT02109484|590207581|FG001|Overall Study|Moved away from study area|0|||
163409347|NCT02109484|590207582|FG002|Overall Study|Moved away from study area|0|||
163409348|NCT02109484|590207583|FG003|Overall Study|Moved away from study area|0|||
163409349|NCT02109484|590207584|FG004|Overall Study|Moved away from study area|0|||
163409350|NCT02109484|590207585|FG005|Overall Study|Moved away from study area|0|||
163409351|NCT02109484|590207586|FG006|Overall Study|Moved away from study area|1|||
163409352|NCT02109484|590207587|FG007|Overall Study|Moved away from study area|1|||
163409353|NCT00796315|590207588|FG000|Overall Study|Protocol Violation|0|||
163409354|NCT00796315|590207589|FG001|Overall Study|Protocol Violation|1|||
163409355|NCT00796315|590207590|FG002|Overall Study|Protocol Violation|0|||
163234573|NCT00767000|589569332|FG003|54-week Study|Study terminated by sponsor|196|||
163234574|NCT00767000|589569333|FG004|54-week Study|Study terminated by sponsor|194|||
163234575|NCT00767000|589569329|FG000|54-week Study|Reason not reported|0|||
163234576|NCT00767000|589569330|FG001|54-week Study|Reason not reported|0|||
163234577|NCT00767000|589569331|FG002|54-week Study|Reason not reported|0|||
163234578|NCT00767000|589569332|FG003|54-week Study|Reason not reported|1|||
163234579|NCT00767000|589569333|FG004|54-week Study|Reason not reported|0|||
163234580|NCT00767000|589569329|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
163409356|NCT01294579|590207596|FG000|Overall Study|Disease progression|12|||
163409357|NCT01294579|590207596|FG000|Overall Study|Adverse Event|11|||
163409358|NCT01294579|590207596|FG000|Overall Study|Study closed/terminated|3|||
163409359|NCT01294579|590207596|FG000|Overall Study|Lost to Follow-up|1|||
163409360|NCT01294579|590207596|FG000|Overall Study|Physician Decision|3|||
163409361|NCT01294579|590207596|FG000|Overall Study|Withdrawal by Subject|5|||
163234581|NCT00767000|589569330|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
163234582|NCT00767000|589569331|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
163234583|NCT00767000|589569332|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
163234584|NCT00767000|589569333|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
163234585|NCT01252251|589569340|FG000|Overall Study|Withdrawal by Subject|1|||
163234586|NCT01324024|589569341|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
163234587|NCT01324024|589569342|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
163409362|NCT02788747|590207597|FG000|Overall Study|Adverse Event|1|||
163409363|NCT02788747|590207598|FG001|Overall Study|Adverse Event|0|||
163409364|NCT02788747|590207599|FG002|Overall Study|Adverse Event|0|||
163409365|NCT00562354|590207602|FG000|Overall Study|Physician Decision|0|||
163347901|NCT02269917|589981647|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
163347902|NCT02269917|589981645|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
163347903|NCT02269917|589981646|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
163347904|NCT02269917|589981647|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
163347905|NCT02269917|589981645|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
163140285|NCT00531284|589224209|FG000|Overall Study|Other|1|||
163140286|NCT00531284|589224210|FG001|Overall Study|Other|0|||
163140287|NCT00531284|589224211|FG002|Overall Study|Other|0|||
163140288|NCT00531284|589224212|FG003|Overall Study|Other|10|||
163140289|NCT00531284|589224213|FG004|Overall Study|Other|2|||
163140290|NCT00531284|589224214|FG005|Overall Study|Other|1|||
163140291|NCT00531284|589224215|FG006|Overall Study|Other|0|||
163140292|NCT00531284|589224216|FG007|Overall Study|Other|0|||
163140293|NCT00531284|589224217|FG008|Overall Study|Other|2|||
163140294|NCT00531284|589224218|FG009|Overall Study|Other|1|||
163140295|NCT00531284|589224219|FG010|Overall Study|Other|0|||
163140296|NCT00531284|589224220|FG011|Overall Study|Other|2|||
163140297|NCT00531284|589224221|FG012|Overall Study|Other|0|||
163140298|NCT00531284|589224222|FG013|Overall Study|Other|0|||
163140299|NCT00531284|589224223|FG014|Overall Study|Other|1|||
163140300|NCT00531284|589224224|FG015|Overall Study|Other|0|||
163140301|NCT00531284|589224225|FG016|Overall Study|Other|0|||
163140302|NCT03057496|589224226|FG000|Overall Study|Withdrawal by Subject|8|||
163140303|NCT03057496|589224226|FG000|Overall Study|Lost to Follow-up|5|||
163140304|NCT03057496|589224226|FG000|Overall Study|Did not use device during home trial|3|||
163140305|NCT03057496|589224226|FG000|Overall Study|Device failure|2|||
163140306|NCT00280917|589224227|FG000|Overall Study|Adverse Event|1|||
163140307|NCT00280917|589224228|FG001|Overall Study|Adverse Event|1|||
163140308|NCT00280917|589224229|FG002|Overall Study|Adverse Event|4|||
163140309|NCT00280917|589224230|FG003|Overall Study|Adverse Event|1|||
163140310|NCT00280917|589224227|FG000|Overall Study|Change Therapy|1|||
163140311|NCT00280917|589224228|FG001|Overall Study|Change Therapy|2|||
163140312|NCT00280917|589224229|FG002|Overall Study|Change Therapy|0|||
163140313|NCT00280917|589224230|FG003|Overall Study|Change Therapy|0|||
163140314|NCT00280917|589224227|FG000|Overall Study|Withdrawal by Subject|0|||
163140315|NCT00280917|589224228|FG001|Overall Study|Withdrawal by Subject|2|||
163140316|NCT00280917|589224229|FG002|Overall Study|Withdrawal by Subject|0|||
163140317|NCT00280917|589224230|FG003|Overall Study|Withdrawal by Subject|1|||
163140318|NCT00280917|589224227|FG000|Overall Study|Noncompliance|0|||
163140319|NCT00280917|589224228|FG001|Overall Study|Noncompliance|1|||
163140320|NCT00280917|589224229|FG002|Overall Study|Noncompliance|2|||
163140321|NCT00280917|589224230|FG003|Overall Study|Noncompliance|0|||
163140322|NCT03310723|589224234|FG000|Overall Study|Withdrawal by Subject|0|||
163140323|NCT03310723|589224235|FG001|Overall Study|Withdrawal by Subject|1|||
163140324|NCT03310723|589224234|FG000|Overall Study|Protocol Violation|0|||
163140325|NCT03310723|589224235|FG001|Overall Study|Protocol Violation|2|||
163140326|NCT02098746|589224236|FG000|Overall Study|Changes of Investigator|2|||
163140327|NCT02098746|589224236|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163140328|NCT02098746|589224236|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
163140329|NCT02098746|589224236|FG000|Overall Study|Data Not Available After Treatment|1|||
163140330|NCT00997035|589224237|FG000|3-week Followup Visit|Lost to Follow-up|9|||
163140331|NCT00997035|589224238|FG001|3-week Followup Visit|Lost to Follow-up|6|||
163140332|NCT00997035|589224237|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
163140333|NCT00997035|589224238|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
163140334|NCT01508312|589224239|FG000|Overall Study|Lost to Follow-up|1|||
163140335|NCT01508312|589224240|FG001|Overall Study|Lost to Follow-up|0|||
163140336|NCT01508312|589224241|FG002|Overall Study|Lost to Follow-up|0|||
163140337|NCT01508312|589224242|FG003|Overall Study|Lost to Follow-up|0|||
163140338|NCT01508312|589224239|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
163140339|NCT01508312|589224240|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
163140340|NCT01508312|589224241|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
163140341|NCT01508312|589224242|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
163140342|NCT01508312|589224239|FG000|Overall Study|Adverse Event|0|||
163347906|NCT02269917|589981646|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
163347907|NCT02269917|589981647|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
163140343|NCT01508312|589224240|FG001|Overall Study|Adverse Event|0|||
163140344|NCT01508312|589224241|FG002|Overall Study|Adverse Event|2|||
163140345|NCT01508312|589224242|FG003|Overall Study|Adverse Event|0|||
163140346|NCT01508312|589224239|FG000|Overall Study|Lack of Efficacy|0|||
163140347|NCT01508312|589224240|FG001|Overall Study|Lack of Efficacy|0|||
163140348|NCT01508312|589224241|FG002|Overall Study|Lack of Efficacy|1|||
163140349|NCT01508312|589224242|FG003|Overall Study|Lack of Efficacy|0|||
163140350|NCT01508312|589224239|FG000|Overall Study|Withdrawal by Subject|0|||
163140351|NCT01508312|589224240|FG001|Overall Study|Withdrawal by Subject|0|||
163140352|NCT01508312|589224241|FG002|Overall Study|Withdrawal by Subject|1|||
163140353|NCT01508312|589224242|FG003|Overall Study|Withdrawal by Subject|0|||
163234588|NCT00097591|589569344|FG000|Overall Study|Withdrawal of consent|342|||
163234589|NCT00097591|589569345|FG001|Overall Study|Withdrawal of consent|323|||
163234590|NCT00097591|589569344|FG000|Overall Study|Less than 6 months on study drug|9|||
163234591|NCT00097591|589569345|FG001|Overall Study|Less than 6 months on study drug|7|||
163234592|NCT00097591|589569344|FG000|Overall Study|Unable to attend termination visit|53|||
163234593|NCT00097591|589569345|FG001|Overall Study|Unable to attend termination visit|51|||
163234594|NCT00097591|589569344|FG000|Overall Study|Lost to follow up|6|||
163234595|NCT00097591|589569345|FG001|Overall Study|Lost to follow up|10|||
163234596|NCT00097591|589569344|FG000|Overall Study|Other|0|||
163234597|NCT00097591|589569345|FG001|Overall Study|Other|3|||
163234598|NCT01743092|589569346|FG000|Overall Study|Lost to Follow-up|14|||
163234599|NCT01743092|589569347|FG001|Overall Study|Lost to Follow-up|15|||
163234600|NCT03603964|589569348|FG000|Overall Study|Death|9|||
163234601|NCT03603964|589569348|FG000|Overall Study|Withdrawal by participant|7|||
163234602|NCT03603964|589569348|FG000|Overall Study|Study terminated by Sponsor|19|||
163234603|NCT00563797|589569349|FG000|Overall Study|Lost to Follow-up|7|||
163234604|NCT00563797|589569350|FG001|Overall Study|Lost to Follow-up|2|||
163234605|NCT00009737|589569353|FG000|Overall Study|Adverse Event|112|||
163234606|NCT00009737|589569354|FG001|Overall Study|Adverse Event|75|||
163234607|NCT00009737|589569353|FG000|Overall Study|Death|4|||
163234608|NCT00009737|589569354|FG001|Overall Study|Death|6|||
163234609|NCT00009737|589569353|FG000|Overall Study|Lack of Efficacy|17|||
163234610|NCT00009737|589569354|FG001|Overall Study|Lack of Efficacy|15|||
163234611|NCT00009737|589569353|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
163234612|NCT00009737|589569354|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
163234613|NCT00009737|589569353|FG000|Overall Study|Other Protocol Violation|1|||
163234614|NCT00009737|589569354|FG001|Overall Study|Other Protocol Violation|0|||
163234615|NCT00009737|589569353|FG000|Overall Study|Refused Treatment|15|||
163234616|NCT00009737|589569354|FG001|Overall Study|Refused Treatment|16|||
163234617|NCT00009737|589569353|FG000|Overall Study|Lost to Follow-up|1|||
163234618|NCT00009737|589569354|FG001|Overall Study|Lost to Follow-up|1|||
163234619|NCT00009737|589569353|FG000|Overall Study|Administrative/Other Reasons|7|||
163234620|NCT00009737|589569354|FG001|Overall Study|Administrative/Other Reasons|1|||
163234621|NCT00530023|589569355|FG000|Overall Study|Withdrawal by Subject|0|||
163234622|NCT00530023|589569356|FG001|Overall Study|Withdrawal by Subject|1|||
163234623|NCT00003498|589569357|FG000|Overall Study|Not evaluable.|4|||
163234624|NCT01877421|589569365|FG000|Phase 2|Lost to Follow-up|0|||
163234625|NCT01877421|589569366|FG001|Phase 2|Lost to Follow-up|0|||
163234626|NCT01877421|589569367|FG002|Phase 2|Lost to Follow-up|0|||
163234627|NCT01877421|589569368|FG003|Phase 2|Lost to Follow-up|0|||
163234628|NCT01877421|589569369|FG004|Phase 2|Lost to Follow-up|0|||
163234629|NCT01877421|589569370|FG005|Phase 2|Lost to Follow-up|0|||
163234630|NCT01877421|589569371|FG006|Phase 2|Lost to Follow-up|1|||
163234631|NCT01877421|589569372|FG007|Phase 2|Lost to Follow-up|0|||
163234632|NCT01877421|589569373|FG008|Phase 2|Lost to Follow-up|0|||
163234633|NCT01877421|589569374|FG009|Phase 2|Lost to Follow-up|0|||
163234634|NCT01877421|589569375|FG010|Phase 2|Lost to Follow-up|0|||
163234635|NCT01877421|589569376|FG011|Phase 2|Lost to Follow-up|0|||
163234636|NCT01877421|589569377|FG012|Phase 2|Lost to Follow-up|0|||
163234637|NCT01877421|589569378|FG013|Phase 2|Lost to Follow-up|0|||
163234638|NCT01877421|589569379|FG014|Phase 2|Lost to Follow-up|0|||
163234639|NCT01877421|589569380|FG015|Phase 2|Lost to Follow-up|0|||
163234640|NCT01877421|589569381|FG016|Phase 2|Lost to Follow-up|0|||
163234641|NCT01877421|589569382|FG017|Phase 2|Lost to Follow-up|0|||
163234642|NCT01877421|589569365|FG000|Phase 2|Withdrawal by Subject|0|||
163234643|NCT01877421|589569366|FG001|Phase 2|Withdrawal by Subject|0|||
163234644|NCT01877421|589569367|FG002|Phase 2|Withdrawal by Subject|0|||
163234645|NCT01877421|589569368|FG003|Phase 2|Withdrawal by Subject|0|||
163234646|NCT01877421|589569369|FG004|Phase 2|Withdrawal by Subject|0|||
163234647|NCT01877421|589569370|FG005|Phase 2|Withdrawal by Subject|0|||
163234648|NCT01877421|589569371|FG006|Phase 2|Withdrawal by Subject|0|||
163234649|NCT01877421|589569372|FG007|Phase 2|Withdrawal by Subject|0|||
163234650|NCT01877421|589569373|FG008|Phase 2|Withdrawal by Subject|1|||
163234651|NCT01877421|589569374|FG009|Phase 2|Withdrawal by Subject|0|||
163234652|NCT01877421|589569375|FG010|Phase 2|Withdrawal by Subject|1|||
163234653|NCT01877421|589569376|FG011|Phase 2|Withdrawal by Subject|0|||
163234654|NCT01877421|589569377|FG012|Phase 2|Withdrawal by Subject|1|||
163234655|NCT01877421|589569378|FG013|Phase 2|Withdrawal by Subject|0|||
163234656|NCT01877421|589569379|FG014|Phase 2|Withdrawal by Subject|0|||
163234657|NCT01877421|589569380|FG015|Phase 2|Withdrawal by Subject|1|||
163234658|NCT01877421|589569381|FG016|Phase 2|Withdrawal by Subject|0|||
163234659|NCT01877421|589569382|FG017|Phase 2|Withdrawal by Subject|0|||
163234660|NCT01877421|589569365|FG000|Phase 2|Protocol Violation|0|||
163234661|NCT01877421|589569366|FG001|Phase 2|Protocol Violation|0|||
163234662|NCT01877421|589569367|FG002|Phase 2|Protocol Violation|0|||
163234663|NCT01877421|589569368|FG003|Phase 2|Protocol Violation|0|||
163234664|NCT01877421|589569369|FG004|Phase 2|Protocol Violation|0|||
163234665|NCT01877421|589569370|FG005|Phase 2|Protocol Violation|0|||
163347908|NCT02269917|589981645|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
163347909|NCT02269917|589981646|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
163347910|NCT02269917|589981647|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
163347911|NCT02269917|589981645|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
163347912|NCT02269917|589981646|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
163347913|NCT02269917|589981647|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
163347914|NCT02269917|589981645|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
163347915|NCT02269917|589981646|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
163347916|NCT02269917|589981647|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
163347917|NCT02269917|589981645|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
163347918|NCT02269917|589981646|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
163347919|NCT02269917|589981647|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
163347920|NCT02269917|589981645|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
163347921|NCT02269917|589981646|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
163347922|NCT02269917|589981647|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
163347923|NCT02269917|589981645|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
163347924|NCT02269917|589981646|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
163347925|NCT02269917|589981647|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
163347926|NCT02269917|589981645|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
163347927|NCT02269917|589981646|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
163347928|NCT02269917|589981647|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
163347929|NCT02269917|589981645|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
163347930|NCT02269917|589981646|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
163347931|NCT02269917|589981647|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
163347932|NCT01770509|589981648|FG000|Overall Study|Injury|0|||
163347933|NCT01770509|589981649|FG001|Overall Study|Injury|1|||
163347934|NCT01770509|589981648|FG000|Overall Study|Lost to Follow-up|1|||
163347935|NCT01770509|589981649|FG001|Overall Study|Lost to Follow-up|2|||
163347936|NCT02865135|589981653|FG000|Overall Study|Death|0|||
163347937|NCT02865135|589981654|FG001|Overall Study|Death|1|||
163347938|NCT02865135|589981655|FG002|Overall Study|Death|0|||
163347939|NCT02865135|589981653|FG000|Overall Study|Progression|6|||
163347940|NCT02865135|589981654|FG001|Overall Study|Progression|2|||
163347941|NCT02865135|589981655|FG002|Overall Study|Progression|2|||
163347942|NCT00985621|589981656|FG000|Overall Study|Adverse Event|2|||
163347943|NCT00985621|589981657|FG001|Overall Study|Adverse Event|3|||
163347944|NCT00985621|589981658|FG002|Overall Study|Adverse Event|4|||
163347945|NCT00985621|589981659|FG003|Overall Study|Adverse Event|16|||
163347946|NCT00985621|589981656|FG000|Overall Study|Lack of Efficacy|10|||
163347947|NCT00985621|589981657|FG001|Overall Study|Lack of Efficacy|6|||
163347948|NCT00985621|589981658|FG002|Overall Study|Lack of Efficacy|5|||
163347949|NCT00985621|589981659|FG003|Overall Study|Lack of Efficacy|12|||
163347950|NCT00985621|589981656|FG000|Overall Study|Lost to Follow-up|2|||
163347951|NCT00985621|589981657|FG001|Overall Study|Lost to Follow-up|3|||
163347952|NCT00985621|589981658|FG002|Overall Study|Lost to Follow-up|4|||
163347953|NCT00985621|589981659|FG003|Overall Study|Lost to Follow-up|4|||
163347954|NCT00985621|589981656|FG000|Overall Study|Study Terminated by Sponsor|89|||
163347955|NCT00985621|589981657|FG001|Overall Study|Study Terminated by Sponsor|108|||
163347956|NCT00985621|589981658|FG002|Overall Study|Study Terminated by Sponsor|99|||
163347957|NCT00985621|589981659|FG003|Overall Study|Study Terminated by Sponsor|92|||
163347958|NCT00985621|589981656|FG000|Overall Study|Protocol Violation|1|||
163347959|NCT00985621|589981657|FG001|Overall Study|Protocol Violation|1|||
163347960|NCT00985621|589981658|FG002|Overall Study|Protocol Violation|1|||
163347961|NCT00985621|589981659|FG003|Overall Study|Protocol Violation|0|||
163347962|NCT00985621|589981656|FG000|Overall Study|Withdrawal by Subject|8|||
163347963|NCT00985621|589981657|FG001|Overall Study|Withdrawal by Subject|10|||
163347964|NCT00985621|589981658|FG002|Overall Study|Withdrawal by Subject|8|||
163347965|NCT00985621|589981659|FG003|Overall Study|Withdrawal by Subject|12|||
163347966|NCT00985621|589981656|FG000|Overall Study|Other|1|||
163347967|NCT00985621|589981657|FG001|Overall Study|Other|0|||
163347968|NCT00985621|589981658|FG002|Overall Study|Other|0|||
163347969|NCT00985621|589981659|FG003|Overall Study|Other|0|||
163347970|NCT00985621|589981656|FG000|Overall Study|Randomized but not Treated|1|||
163347971|NCT00985621|589981657|FG001|Overall Study|Randomized but not Treated|0|||
163347972|NCT00985621|589981658|FG002|Overall Study|Randomized but not Treated|2|||
163347973|NCT00985621|589981659|FG003|Overall Study|Randomized but not Treated|1|||
163347974|NCT04394624|589981663|FG000|Overall Study|Adverse Event|6|||
163347975|NCT04394624|589981664|FG001|Overall Study|Adverse Event|0|||
163347976|NCT04394624|589981663|FG000|Overall Study|Progressive disease|24|||
163347977|NCT04394624|589981664|FG001|Overall Study|Progressive disease|0|||
163347978|NCT04394624|589981663|FG000|Overall Study|Not related to COVID-19|1|||
163347979|NCT04394624|589981664|FG001|Overall Study|Not related to COVID-19|0|||
163347980|NCT00905255|589981665|FG000|Overall Study|Adverse Event|7|||
163347981|NCT00905255|589981666|FG001|Overall Study|Adverse Event|5|||
163347982|NCT00905255|589981665|FG000|Overall Study|Withdrawal by Subject|5|||
163347983|NCT00905255|589981666|FG001|Overall Study|Withdrawal by Subject|4|||
163409366|NCT00562354|590207603|FG001|Overall Study|Physician Decision|1|||
163409367|NCT00562354|590207602|FG000|Overall Study|Lost to Follow-up|0|||
163409368|NCT00562354|590207603|FG001|Overall Study|Lost to Follow-up|1|||
163409369|NCT00784654|590207604|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
163409370|NCT00784654|590207605|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
163409371|NCT00784654|590207606|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
163409372|NCT00784654|590207604|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
163409373|NCT00784654|590207605|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
163409374|NCT00784654|590207606|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
163409375|NCT00784654|590207604|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
163409376|NCT00784654|590207605|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
163409377|NCT00784654|590207606|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
163409378|NCT00784654|590207604|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
163409379|NCT00784654|590207605|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
163409380|NCT00784654|590207606|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
163409381|NCT00784654|590207604|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
163409382|NCT00784654|590207605|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
163409383|NCT00784654|590207606|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
163140354|NCT02222558|589224243|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
163140355|NCT02222558|589224244|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
163140356|NCT02222558|589224245|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
163140357|NCT02222558|589224246|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
163140358|NCT02222558|589224247|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
163140359|NCT02222558|589224248|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
163140360|NCT02222558|589224243|FG000|Period 3|Withdrawal by Subject|0|||
163140361|NCT02222558|589224244|FG001|Period 3|Withdrawal by Subject|0|||
163140362|NCT02222558|589224245|FG002|Period 3|Withdrawal by Subject|0|||
163140363|NCT02222558|589224246|FG003|Period 3|Withdrawal by Subject|0|||
163140364|NCT02222558|589224247|FG004|Period 3|Withdrawal by Subject|0|||
163140365|NCT02222558|589224248|FG005|Period 3|Withdrawal by Subject|1|||
163140366|NCT02322281|589224249|FG000|Overall Study|Progressive Disease|42|||
163140367|NCT02322281|589224250|FG001|Overall Study|Progressive Disease|14|||
163140368|NCT02322281|589224251|FG002|Overall Study|Progressive Disease|49|||
163140369|NCT02322281|589224249|FG000|Overall Study|Adverse Event|3|||
163140370|NCT02322281|589224250|FG001|Overall Study|Adverse Event|4|||
163140371|NCT02322281|589224251|FG002|Overall Study|Adverse Event|6|||
163140372|NCT02322281|589224249|FG000|Overall Study|Death|3|||
163140373|NCT02322281|589224250|FG001|Overall Study|Death|3|||
163140374|NCT02322281|589224251|FG002|Overall Study|Death|3|||
163140375|NCT02322281|589224249|FG000|Overall Study|Withdrawal by Subject|1|||
163140376|NCT02322281|589224250|FG001|Overall Study|Withdrawal by Subject|1|||
163140377|NCT02322281|589224251|FG002|Overall Study|Withdrawal by Subject|6|||
163140378|NCT02322281|589224249|FG000|Overall Study|Physician Decision|2|||
163140379|NCT02322281|589224250|FG001|Overall Study|Physician Decision|0|||
163140380|NCT02322281|589224251|FG002|Overall Study|Physician Decision|5|||
163140381|NCT02322281|589224249|FG000|Overall Study|Study Terminated by Sponsor|2|||
163140382|NCT02322281|589224250|FG001|Overall Study|Study Terminated by Sponsor|0|||
163140383|NCT02322281|589224251|FG002|Overall Study|Study Terminated by Sponsor|0|||
163140384|NCT02322281|589224249|FG000|Overall Study|Missing|0|||
163140385|NCT02322281|589224250|FG001|Overall Study|Missing|0|||
163140386|NCT02322281|589224251|FG002|Overall Study|Missing|1|||
163140387|NCT02322281|589224249|FG000|Overall Study|Miscellaneous|0|||
163140388|NCT02322281|589224250|FG001|Overall Study|Miscellaneous|0|||
163140389|NCT02322281|589224251|FG002|Overall Study|Miscellaneous|4|||
163140390|NCT00936702|589224252|FG000|Overall Study|Disease progression|34|||
163140391|NCT00936702|589224252|FG000|Overall Study|Adverse Event|8|||
163140392|NCT00936702|589224252|FG000|Overall Study|Withdrawal by Subject|2|||
163140393|NCT00936702|589224252|FG000|Overall Study|Alternative Treatment|1|||
163140394|NCT00936702|589224252|FG000|Overall Study|Other|1|||
163140395|NCT00354679|589224253|FG000|Overall Study|Patient Not Treated|1|||
163140396|NCT03456076|589224254|FG000|Overall Study|Withdrawal by Subject|5|||
163140397|NCT03456076|589224255|FG001|Overall Study|Withdrawal by Subject|9|||
163140398|NCT03456076|589224254|FG000|Overall Study|Protocol deviation|0|||
163140399|NCT03456076|589224255|FG001|Overall Study|Protocol deviation|1|||
163140400|NCT03456076|589224254|FG000|Overall Study|Lost to Follow-up|0|||
163140401|NCT03456076|589224255|FG001|Overall Study|Lost to Follow-up|1|||
163140402|NCT03456076|589224254|FG000|Overall Study|Death|2|||
163140403|NCT03456076|589224255|FG001|Overall Study|Death|5|||
163140404|NCT03456076|589224254|FG000|Overall Study|Study ongoing|123|||
163140405|NCT03456076|589224255|FG001|Overall Study|Study ongoing|111|||
163140406|NCT00466440|589224256|FG000|Overall Study|Adverse Event|0|||
163140407|NCT00466440|589224257|FG001|Overall Study|Adverse Event|3|||
163140408|NCT00466440|589224258|FG002|Overall Study|Adverse Event|1|||
163140409|NCT00466440|589224256|FG000|Overall Study|Death|1|||
163140410|NCT00466440|589224257|FG001|Overall Study|Death|1|||
163140411|NCT00466440|589224258|FG002|Overall Study|Death|0|||
163140412|NCT00466440|589224256|FG000|Overall Study|Progressive disease|13|||
163140413|NCT00466440|589224257|FG001|Overall Study|Progressive disease|5|||
163140414|NCT00466440|589224258|FG002|Overall Study|Progressive disease|4|||
163140415|NCT00466440|589224256|FG000|Overall Study|Lost to Follow-up|0|||
163140416|NCT00466440|589224257|FG001|Overall Study|Lost to Follow-up|1|||
163140417|NCT00466440|589224258|FG002|Overall Study|Lost to Follow-up|0|||
163140418|NCT00466440|589224256|FG000|Overall Study|Physician Decision|0|||
163140419|NCT00466440|589224257|FG001|Overall Study|Physician Decision|1|||
163140420|NCT00466440|589224258|FG002|Overall Study|Physician Decision|2|||
163140421|NCT00466440|589224256|FG000|Overall Study|Protocol entry criteria not met|0|||
163140422|NCT00466440|589224257|FG001|Overall Study|Protocol entry criteria not met|0|||
163140423|NCT00466440|589224258|FG002|Overall Study|Protocol entry criteria not met|4|||
163140424|NCT00466440|589224256|FG000|Overall Study|Withdrawal by Subject|0|||
163140425|NCT00466440|589224257|FG001|Overall Study|Withdrawal by Subject|1|||
163140426|NCT00466440|589224258|FG002|Overall Study|Withdrawal by Subject|0|||
163140427|NCT00466440|589224256|FG000|Overall Study|Sponsor decision|0|||
163140428|NCT00466440|589224257|FG001|Overall Study|Sponsor decision|0|||
163140429|NCT00466440|589224258|FG002|Overall Study|Sponsor decision|1|||
163140430|NCT03187132|589224261|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
163140431|NCT03187132|589224262|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
163140432|NCT03187132|589224261|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
163140433|NCT03187132|589224262|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
163140434|NCT03187132|589224261|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
163140435|NCT03187132|589224262|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
163140436|NCT03187132|589224261|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
163140437|NCT03187132|589224262|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
163140438|NCT03187132|589224261|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
163140439|NCT03187132|589224262|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
163140440|NCT03187132|589224261|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
163140441|NCT03187132|589224262|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
163140442|NCT03187132|589224261|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
163140443|NCT03187132|589224262|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
163140444|NCT03187132|589224261|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
163140445|NCT03187132|589224262|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
163140446|NCT03187132|589224261|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
163140447|NCT03187132|589224262|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
163140448|NCT03187132|589224261|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
163140449|NCT03187132|589224262|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
163140450|NCT03187132|589224261|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
163140451|NCT03187132|589224262|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
163140452|NCT03191630|589224265|FG000|Overall Study|Lost to Follow-up|7|||
163140453|NCT03191630|589224266|FG001|Overall Study|Lost to Follow-up|7|||
163140454|NCT02525588|589224267|FG000|Overall Study|Death|3|||
163140455|NCT02525588|589224268|FG001|Overall Study|Death|1|||
163140456|NCT02525588|589224267|FG000|Overall Study|Lost to Follow-up|2|||
163140457|NCT02525588|589224268|FG001|Overall Study|Lost to Follow-up|0|||
163140458|NCT02525588|589224267|FG000|Overall Study|Withdrawal by Subject|1|||
163140459|NCT02525588|589224268|FG001|Overall Study|Withdrawal by Subject|1|||
163140460|NCT02525588|589224267|FG000|Overall Study|Adverse Event|0|||
163140461|NCT02525588|589224268|FG001|Overall Study|Adverse Event|1|||
163140462|NCT00714415|589224279|FG000|Overall Study|Lack of Efficacy|1|||
163140463|NCT00714415|589224280|FG001|Overall Study|Lack of Efficacy|0|||
163140464|NCT00714415|589224279|FG000|Overall Study|Death|1|||
163140465|NCT00714415|589224280|FG001|Overall Study|Death|0|||
163140466|NCT02073682|589224295|FG000|Overall Study|Low Creatinine Clearance|1|||
163140467|NCT02073682|589224296|FG001|Overall Study|Low Creatinine Clearance|2|||
163140468|NCT02073682|589224295|FG000|Overall Study|Death|86|||
163140469|NCT02073682|589224296|FG001|Overall Study|Death|100|||
163140470|NCT02073682|589224295|FG000|Overall Study|Cancer Cured|10|||
163140471|NCT02073682|589224296|FG001|Overall Study|Cancer Cured|15|||
163140472|NCT02073682|589224295|FG000|Overall Study|ID: Patient Noncompliance|1|||
163140473|NCT02073682|589224296|FG001|Overall Study|ID: Patient Noncompliance|2|||
163140474|NCT02073682|589224295|FG000|Overall Study|ID: Palliative Treatment Only|10|||
163140475|NCT02073682|589224296|FG001|Overall Study|ID: Palliative Treatment Only|7|||
163140476|NCT02073682|589224295|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
163140477|NCT02073682|589224296|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
163140478|NCT02073682|589224295|FG000|Overall Study|Platelet Count <50,000/mL|1|||
163140479|NCT02073682|589224296|FG001|Overall Study|Platelet Count <50,000/mL|2|||
163140480|NCT02073682|589224295|FG000|Overall Study|Surgery/Medical Procedure|3|||
163140481|NCT02073682|589224296|FG001|Overall Study|Surgery/Medical Procedure|1|||
163140482|NCT02073682|589224295|FG000|Overall Study|Withdrawal by Subject|6|||
163140483|NCT02073682|589224296|FG001|Overall Study|Withdrawal by Subject|8|||
163140484|NCT02073682|589224295|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
163140485|NCT02073682|589224296|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
163140486|NCT02073682|589224295|FG000|Overall Study|Cancer Progression|53|||
163140487|NCT02073682|589224296|FG001|Overall Study|Cancer Progression|33|||
163140488|NCT02073682|589224295|FG000|Overall Study|Protocol Violation|1|||
163140489|NCT02073682|589224296|FG001|Overall Study|Protocol Violation|0|||
163140490|NCT02073682|589224295|FG000|Overall Study|Adverse Event|79|||
163140491|NCT02073682|589224296|FG001|Overall Study|Adverse Event|62|||
163140492|NCT02073682|589224295|FG000|Overall Study|No reason provided|11|||
163140493|NCT02073682|589224296|FG001|Overall Study|No reason provided|9|||
163140494|NCT02073682|589224295|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
163140495|NCT02073682|589224296|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
163140496|NCT02073682|589224295|FG000|Overall Study|Lost to Follow-up|1|||
163140497|NCT02073682|589224296|FG001|Overall Study|Lost to Follow-up|1|||
163140498|NCT02073682|589224295|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
163140499|NCT02073682|589224296|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
163140500|NCT04435366|589224302|FG000|Year 1 (12 Months)|Adverse Event|3|||
163140501|NCT04435366|589224303|FG001|Year 1 (12 Months)|Adverse Event|0|||
163140502|NCT04435366|589224304|FG002|Year 1 (12 Months)|Adverse Event|2|||
163140503|NCT04435366|589224302|FG000|Year 1 (12 Months)|Death|2|||
163140504|NCT04435366|589224303|FG001|Year 1 (12 Months)|Death|0|||
163140505|NCT04435366|589224304|FG002|Year 1 (12 Months)|Death|1|||
163140506|NCT04435366|589224302|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
163140507|NCT04435366|589224303|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
163140508|NCT04435366|589224304|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
163140509|NCT04435366|589224302|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
163140510|NCT04435366|589224303|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
163140511|NCT04435366|589224304|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
163140512|NCT04435366|589224302|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
163140513|NCT04435366|589224303|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
163140514|NCT04435366|589224304|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
163140515|NCT04435366|589224302|FG000|Year 1 (12 Months)|Not treated|0|||
163140516|NCT04435366|589224303|FG001|Year 1 (12 Months)|Not treated|0|||
163140517|NCT04435366|589224304|FG002|Year 1 (12 Months)|Not treated|1|||
163140518|NCT04435366|589224302|FG000|Year 2 (12 Months)|Death|1|||
163140519|NCT04435366|589224303|FG001|Year 2 (12 Months)|Death|4|||
163140520|NCT04435366|589224304|FG002|Year 2 (12 Months)|Death|6|||
163140521|NCT04435366|589224302|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
163140522|NCT04435366|589224303|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
163140523|NCT04435366|589224304|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
163140524|NCT04435366|589224302|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
163140525|NCT04435366|589224303|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
163140526|NCT04435366|589224304|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
163140527|NCT04435366|589224302|FG000|Year 2 (12 Months)|Adverse Event|2|||
163140528|NCT04435366|589224303|FG001|Year 2 (12 Months)|Adverse Event|1|||
163140529|NCT04435366|589224304|FG002|Year 2 (12 Months)|Adverse Event|6|||
163140530|NCT01687296|589224305|FG000|Overall Study|Lack of Efficacy|1|||
163140531|NCT01687296|589224306|FG001|Overall Study|Lack of Efficacy|1|||
163140532|NCT01687296|589224305|FG000|Overall Study|Protocol Violation|0|||
163140533|NCT01687296|589224306|FG001|Overall Study|Protocol Violation|1|||
163140534|NCT01687296|589224305|FG000|Overall Study|Withdrawal by Subject|6|||
163140535|NCT01687296|589224306|FG001|Overall Study|Withdrawal by Subject|3|||
163140536|NCT04497116|589224308|FG000|Overall Study|Lost to Follow-up|1|||
163140537|NCT04497116|589224309|FG001|Overall Study|Lost to Follow-up|0|||
163140538|NCT04497116|589224310|FG002|Overall Study|Lost to Follow-up|0|||
163140539|NCT04497116|589224311|FG003|Overall Study|Lost to Follow-up|0|||
163140540|NCT04497116|589224312|FG004|Overall Study|Lost to Follow-up|0|||
163140541|NCT04497116|589224313|FG005|Overall Study|Lost to Follow-up|0|||
163140542|NCT04497116|589224314|FG006|Overall Study|Lost to Follow-up|0|||
163140543|NCT04497116|589224315|FG007|Overall Study|Lost to Follow-up|3|||
163140544|NCT04497116|589224316|FG008|Overall Study|Lost to Follow-up|3|||
163140545|NCT04497116|589224317|FG009|Overall Study|Lost to Follow-up|0|||
163140546|NCT04497116|589224318|FG010|Overall Study|Lost to Follow-up|0|||
163140547|NCT04497116|589224319|FG011|Overall Study|Lost to Follow-up|0|||
163140548|NCT04497116|589224320|FG012|Overall Study|Lost to Follow-up|0|||
163409384|NCT00784654|590207604|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
163409385|NCT00784654|590207605|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
163140549|NCT04497116|589224321|FG013|Overall Study|Lost to Follow-up|0|||
163140550|NCT04497116|589224322|FG014|Overall Study|Lost to Follow-up|0|||
163140551|NCT04497116|589224323|FG015|Overall Study|Lost to Follow-up|0|||
163140552|NCT04497116|589224324|FG016|Overall Study|Lost to Follow-up|0|||
163140553|NCT04497116|589224325|FG017|Overall Study|Lost to Follow-up|0|||
163140554|NCT04497116|589224326|FG018|Overall Study|Lost to Follow-up|0|||
163140555|NCT04497116|589224327|FG019|Overall Study|Lost to Follow-up|0|||
163140556|NCT04497116|589224328|FG020|Overall Study|Lost to Follow-up|0|||
163140557|NCT04497116|589224329|FG021|Overall Study|Lost to Follow-up|0|||
163140558|NCT04497116|589224330|FG022|Overall Study|Lost to Follow-up|1|||
163140559|NCT04497116|589224331|FG023|Overall Study|Lost to Follow-up|0|||
163140560|NCT04497116|589224332|FG024|Overall Study|Lost to Follow-up|0|||
163140561|NCT04497116|589224308|FG000|Overall Study|Sponsor decision to terminate study|0|||
163140562|NCT04497116|589224309|FG001|Overall Study|Sponsor decision to terminate study|0|||
163140563|NCT04497116|589224310|FG002|Overall Study|Sponsor decision to terminate study|0|||
163140564|NCT04497116|589224311|FG003|Overall Study|Sponsor decision to terminate study|0|||
163140565|NCT04497116|589224312|FG004|Overall Study|Sponsor decision to terminate study|0|||
163140566|NCT04497116|589224313|FG005|Overall Study|Sponsor decision to terminate study|0|||
163140567|NCT04497116|589224314|FG006|Overall Study|Sponsor decision to terminate study|1|||
163140568|NCT04497116|589224315|FG007|Overall Study|Sponsor decision to terminate study|0|||
163140569|NCT04497116|589224316|FG008|Overall Study|Sponsor decision to terminate study|0|||
163140570|NCT04497116|589224317|FG009|Overall Study|Sponsor decision to terminate study|1|||
163140571|NCT04497116|589224318|FG010|Overall Study|Sponsor decision to terminate study|0|||
163140572|NCT04497116|589224319|FG011|Overall Study|Sponsor decision to terminate study|0|||
163140573|NCT04497116|589224320|FG012|Overall Study|Sponsor decision to terminate study|0|||
163140574|NCT04497116|589224321|FG013|Overall Study|Sponsor decision to terminate study|0|||
163140575|NCT04497116|589224322|FG014|Overall Study|Sponsor decision to terminate study|0|||
163140576|NCT04497116|589224323|FG015|Overall Study|Sponsor decision to terminate study|0|||
163140577|NCT04497116|589224324|FG016|Overall Study|Sponsor decision to terminate study|0|||
163140578|NCT04497116|589224325|FG017|Overall Study|Sponsor decision to terminate study|0|||
163140579|NCT04497116|589224326|FG018|Overall Study|Sponsor decision to terminate study|0|||
163140580|NCT04497116|589224327|FG019|Overall Study|Sponsor decision to terminate study|1|||
163140581|NCT04497116|589224328|FG020|Overall Study|Sponsor decision to terminate study|0|||
163140582|NCT04497116|589224329|FG021|Overall Study|Sponsor decision to terminate study|0|||
163140583|NCT04497116|589224330|FG022|Overall Study|Sponsor decision to terminate study|0|||
163140584|NCT04497116|589224331|FG023|Overall Study|Sponsor decision to terminate study|0|||
163140585|NCT04497116|589224332|FG024|Overall Study|Sponsor decision to terminate study|0|||
163140586|NCT04497116|589224308|FG000|Overall Study|Death|4|||
163140587|NCT04497116|589224309|FG001|Overall Study|Death|5|||
163140588|NCT04497116|589224310|FG002|Overall Study|Death|2|||
163140589|NCT04497116|589224311|FG003|Overall Study|Death|2|||
163140590|NCT04497116|589224312|FG004|Overall Study|Death|1|||
163140591|NCT04497116|589224313|FG005|Overall Study|Death|1|||
163140592|NCT04497116|589224314|FG006|Overall Study|Death|3|||
163140593|NCT04497116|589224315|FG007|Overall Study|Death|10|||
163140594|NCT04497116|589224316|FG008|Overall Study|Death|37|||
163140595|NCT04497116|589224317|FG009|Overall Study|Death|17|||
163140596|NCT04497116|589224318|FG010|Overall Study|Death|2|||
163140597|NCT04497116|589224319|FG011|Overall Study|Death|1|||
163140598|NCT04497116|589224320|FG012|Overall Study|Death|1|||
163140599|NCT04497116|589224321|FG013|Overall Study|Death|3|||
163140600|NCT04497116|589224322|FG014|Overall Study|Death|18|||
163140601|NCT04497116|589224323|FG015|Overall Study|Death|3|||
163140602|NCT04497116|589224324|FG016|Overall Study|Death|2|||
163140603|NCT04497116|589224325|FG017|Overall Study|Death|1|||
163140604|NCT04497116|589224326|FG018|Overall Study|Death|4|||
163140605|NCT04497116|589224327|FG019|Overall Study|Death|17|||
163140606|NCT04497116|589224328|FG020|Overall Study|Death|1|||
163140607|NCT04497116|589224329|FG021|Overall Study|Death|0|||
163140608|NCT04497116|589224330|FG022|Overall Study|Death|3|||
163140609|NCT04497116|589224331|FG023|Overall Study|Death|5|||
163140610|NCT04497116|589224332|FG024|Overall Study|Death|4|||
163140611|NCT04497116|589224308|FG000|Overall Study|Withdrawal by Subject|1|||
163140612|NCT04497116|589224309|FG001|Overall Study|Withdrawal by Subject|0|||
163140613|NCT04497116|589224310|FG002|Overall Study|Withdrawal by Subject|1|||
163140614|NCT04497116|589224311|FG003|Overall Study|Withdrawal by Subject|0|||
163140615|NCT04497116|589224312|FG004|Overall Study|Withdrawal by Subject|0|||
163140616|NCT04497116|589224313|FG005|Overall Study|Withdrawal by Subject|0|||
163140617|NCT04497116|589224314|FG006|Overall Study|Withdrawal by Subject|0|||
163140618|NCT04497116|589224315|FG007|Overall Study|Withdrawal by Subject|7|||
163140619|NCT04497116|589224316|FG008|Overall Study|Withdrawal by Subject|14|||
163140620|NCT04497116|589224317|FG009|Overall Study|Withdrawal by Subject|3|||
163140621|NCT04497116|589224318|FG010|Overall Study|Withdrawal by Subject|3|||
163140622|NCT04497116|589224319|FG011|Overall Study|Withdrawal by Subject|0|||
163140623|NCT04497116|589224320|FG012|Overall Study|Withdrawal by Subject|1|||
163140624|NCT04497116|589224321|FG013|Overall Study|Withdrawal by Subject|0|||
163140625|NCT04497116|589224322|FG014|Overall Study|Withdrawal by Subject|7|||
163140626|NCT04497116|589224323|FG015|Overall Study|Withdrawal by Subject|1|||
163140627|NCT04497116|589224324|FG016|Overall Study|Withdrawal by Subject|3|||
163140628|NCT04497116|589224325|FG017|Overall Study|Withdrawal by Subject|1|||
163140629|NCT04497116|589224326|FG018|Overall Study|Withdrawal by Subject|1|||
163140630|NCT04497116|589224327|FG019|Overall Study|Withdrawal by Subject|5|||
163140631|NCT04497116|589224328|FG020|Overall Study|Withdrawal by Subject|2|||
163140632|NCT04497116|589224329|FG021|Overall Study|Withdrawal by Subject|2|||
163140633|NCT04497116|589224330|FG022|Overall Study|Withdrawal by Subject|2|||
163140634|NCT04497116|589224331|FG023|Overall Study|Withdrawal by Subject|4|||
163140635|NCT04497116|589224332|FG024|Overall Study|Withdrawal by Subject|3|||
163140636|NCT04497116|589224308|FG000|Overall Study|Physician Decision|0|||
163140637|NCT04497116|589224309|FG001|Overall Study|Physician Decision|0|||
163140638|NCT04497116|589224310|FG002|Overall Study|Physician Decision|0|||
163140639|NCT04497116|589224311|FG003|Overall Study|Physician Decision|0|||
163140640|NCT04497116|589224312|FG004|Overall Study|Physician Decision|0|||
163140641|NCT04497116|589224313|FG005|Overall Study|Physician Decision|0|||
163140642|NCT04497116|589224314|FG006|Overall Study|Physician Decision|0|||
163347984|NCT00905255|589981665|FG000|Overall Study|Familial and Personal Reasons|1|||
163347985|NCT00905255|589981666|FG001|Overall Study|Familial and Personal Reasons|0|||
163347986|NCT01774929|589981667|FG000|Overall Study|Adverse Event|3|||
163347987|NCT02418819|589981669|FG000|Overall Study|Adverse Event|0|||
163347988|NCT02418819|589981670|FG001|Overall Study|Adverse Event|0|||
163347989|NCT02418819|589981671|FG002|Overall Study|Adverse Event|1|||
163347990|NCT02418819|589981672|FG003|Overall Study|Adverse Event|0|||
163347991|NCT02418819|589981669|FG000|Overall Study|Lost to Follow-up|1|||
163347992|NCT02418819|589981670|FG001|Overall Study|Lost to Follow-up|0|||
163347993|NCT02418819|589981671|FG002|Overall Study|Lost to Follow-up|0|||
163347994|NCT02418819|589981672|FG003|Overall Study|Lost to Follow-up|0|||
163347995|NCT02418819|589981669|FG000|Overall Study|No longer meets eligibility criteria|0|||
163347996|NCT02418819|589981670|FG001|Overall Study|No longer meets eligibility criteria|0|||
163347997|NCT02418819|589981671|FG002|Overall Study|No longer meets eligibility criteria|1|||
163347998|NCT02418819|589981672|FG003|Overall Study|No longer meets eligibility criteria|0|||
163347999|NCT02418819|589981669|FG000|Overall Study|No longer willing to participate|0|||
163348000|NCT02418819|589981670|FG001|Overall Study|No longer willing to participate|0|||
163348001|NCT02418819|589981671|FG002|Overall Study|No longer willing to participate|2|||
163348002|NCT02418819|589981672|FG003|Overall Study|No longer willing to participate|1|||
163348003|NCT01332318|589981673|FG000|Overall Study|Adverse Event|0|||
163348004|NCT01332318|589981674|FG001|Overall Study|Adverse Event|3|||
163348005|NCT01332318|589981675|FG002|Overall Study|Adverse Event|0|||
163348006|NCT01332318|589981676|FG003|Overall Study|Adverse Event|0|||
163348007|NCT01332318|589981673|FG000|Overall Study|Withdrawal by Subject|1|||
163348008|NCT01332318|589981674|FG001|Overall Study|Withdrawal by Subject|1|||
163348009|NCT01332318|589981675|FG002|Overall Study|Withdrawal by Subject|0|||
163348010|NCT01332318|589981676|FG003|Overall Study|Withdrawal by Subject|1|||
163348011|NCT01332318|589981673|FG000|Overall Study|Protocol Violation|1|||
163348012|NCT01332318|589981674|FG001|Overall Study|Protocol Violation|0|||
163348013|NCT01332318|589981675|FG002|Overall Study|Protocol Violation|1|||
163348014|NCT01332318|589981676|FG003|Overall Study|Protocol Violation|1|||
163348015|NCT02040532|589981677|FG000|Overall Study|Lost to Follow-up|1|||
163348016|NCT02040532|589981677|FG000|Overall Study|Physician Decision|4|||
163348017|NCT02040532|589981677|FG000|Overall Study|Adverse Event|4|||
163348018|NCT02040532|589981677|FG000|Overall Study|Withdrawal by Subject|3|||
163348019|NCT00676663|589981678|FG000|Overall Study|Death|43|||
163348020|NCT00676663|589981679|FG001|Overall Study|Death|27|||
163348021|NCT00676663|589981678|FG000|Overall Study|Withdrew Consent|1|||
163348022|NCT00676663|589981679|FG001|Overall Study|Withdrew Consent|8|||
163348023|NCT00676663|589981678|FG000|Overall Study|Lost to Follow-up|1|||
163348024|NCT00676663|589981679|FG001|Overall Study|Lost to Follow-up|3|||
163348025|NCT01772147|589983346|FG000|Overall Study|Adverse Event|13|||
163348026|NCT01772147|589983347|FG001|Overall Study|Adverse Event|10|||
163348027|NCT01772147|589983348|FG002|Overall Study|Adverse Event|6|||
163348028|NCT01772147|589983346|FG000|Overall Study|Withdrew Consent|7|||
163348029|NCT01772147|589983347|FG001|Overall Study|Withdrew Consent|8|||
163348030|NCT01772147|589983348|FG002|Overall Study|Withdrew Consent|4|||
163348031|NCT01772147|589983346|FG000|Overall Study|Lost to Follow-up|1|||
163348032|NCT01772147|589983347|FG001|Overall Study|Lost to Follow-up|0|||
163348033|NCT01772147|589983348|FG002|Overall Study|Lost to Follow-up|1|||
163348034|NCT01772147|589983346|FG000|Overall Study|Protocol Deviation|2|||
163348035|NCT01772147|589983347|FG001|Overall Study|Protocol Deviation|1|||
163348036|NCT01772147|589983348|FG002|Overall Study|Protocol Deviation|1|||
163348037|NCT01772147|589983346|FG000|Overall Study|Lack of Efficacy|8|||
163348038|NCT01772147|589983347|FG001|Overall Study|Lack of Efficacy|6|||
163348039|NCT01772147|589983348|FG002|Overall Study|Lack of Efficacy|6|||
163348040|NCT00796614|589983349|FG000|Overall Study|Adverse Event|1|||
163348041|NCT00796614|589983350|FG001|Overall Study|Adverse Event|2|||
163348042|NCT00796614|589983351|FG002|Overall Study|Adverse Event|0|||
163348043|NCT00796614|589983352|FG003|Overall Study|Adverse Event|0|||
163348044|NCT00796614|589983349|FG000|Overall Study|Protocol Violation|0|||
163348045|NCT00796614|589983350|FG001|Overall Study|Protocol Violation|0|||
163348046|NCT00796614|589983351|FG002|Overall Study|Protocol Violation|2|||
163348047|NCT00796614|589983352|FG003|Overall Study|Protocol Violation|0|||
163348048|NCT00796614|589983349|FG000|Overall Study|Lost to Follow-up|2|||
163348049|NCT00796614|589983350|FG001|Overall Study|Lost to Follow-up|2|||
163348050|NCT00796614|589983351|FG002|Overall Study|Lost to Follow-up|1|||
163140643|NCT04497116|589224315|FG007|Overall Study|Physician Decision|0|||
163140644|NCT04497116|589224316|FG008|Overall Study|Physician Decision|0|||
163140645|NCT04497116|589224317|FG009|Overall Study|Physician Decision|0|||
163140646|NCT04497116|589224318|FG010|Overall Study|Physician Decision|0|||
163140647|NCT04497116|589224319|FG011|Overall Study|Physician Decision|0|||
163140648|NCT04497116|589224320|FG012|Overall Study|Physician Decision|0|||
163140649|NCT04497116|589224321|FG013|Overall Study|Physician Decision|0|||
163348051|NCT00796614|589983352|FG003|Overall Study|Lost to Follow-up|0|||
163140650|NCT04497116|589224322|FG014|Overall Study|Physician Decision|0|||
163140651|NCT04497116|589224323|FG015|Overall Study|Physician Decision|0|||
163348052|NCT00796614|589983349|FG000|Overall Study|Withdrawal by Subject|1|||
163348053|NCT00796614|589983350|FG001|Overall Study|Withdrawal by Subject|0|||
163140652|NCT04497116|589224324|FG016|Overall Study|Physician Decision|0|||
163140653|NCT04497116|589224325|FG017|Overall Study|Physician Decision|0|||
163140654|NCT04497116|589224326|FG018|Overall Study|Physician Decision|0|||
163140655|NCT04497116|589224327|FG019|Overall Study|Physician Decision|0|||
163140656|NCT04497116|589224328|FG020|Overall Study|Physician Decision|0|||
163140657|NCT04497116|589224329|FG021|Overall Study|Physician Decision|0|||
163348054|NCT00796614|589983351|FG002|Overall Study|Withdrawal by Subject|0|||
163140658|NCT04497116|589224330|FG022|Overall Study|Physician Decision|0|||
163140659|NCT04497116|589224331|FG023|Overall Study|Physician Decision|1|||
163140660|NCT04497116|589224332|FG024|Overall Study|Physician Decision|0|||
163140661|NCT04497116|589224308|FG000|Overall Study|Clinical Progression Related|0|||
163140662|NCT04497116|589224309|FG001|Overall Study|Clinical Progression Related|0|||
163140663|NCT04497116|589224310|FG002|Overall Study|Clinical Progression Related|0|||
163140664|NCT04497116|589224311|FG003|Overall Study|Clinical Progression Related|0|||
163140665|NCT04497116|589224312|FG004|Overall Study|Clinical Progression Related|0|||
163140666|NCT04497116|589224313|FG005|Overall Study|Clinical Progression Related|0|||
163140667|NCT04497116|589224314|FG006|Overall Study|Clinical Progression Related|0|||
163140668|NCT04497116|589224315|FG007|Overall Study|Clinical Progression Related|0|||
163348055|NCT00796614|589983352|FG003|Overall Study|Withdrawal by Subject|1|||
163348056|NCT00796614|589983349|FG000|Overall Study|Other than stated|1|||
163348057|NCT00796614|589983350|FG001|Overall Study|Other than stated|0|||
163348058|NCT00796614|589983351|FG002|Overall Study|Other than stated|0|||
163348059|NCT00796614|589983352|FG003|Overall Study|Other than stated|0|||
163348060|NCT00740597|589983353|FG000|Overall Study|insurance would not cover treatment|1|||
163140669|NCT04497116|589224316|FG008|Overall Study|Clinical Progression Related|0|||
163140670|NCT04497116|589224317|FG009|Overall Study|Clinical Progression Related|1|||
163140671|NCT04497116|589224318|FG010|Overall Study|Clinical Progression Related|0|||
163140672|NCT04497116|589224319|FG011|Overall Study|Clinical Progression Related|0|||
163140673|NCT04497116|589224320|FG012|Overall Study|Clinical Progression Related|0|||
163140674|NCT04497116|589224321|FG013|Overall Study|Clinical Progression Related|0|||
163140675|NCT04497116|589224322|FG014|Overall Study|Clinical Progression Related|0|||
163140676|NCT04497116|589224323|FG015|Overall Study|Clinical Progression Related|0|||
163140677|NCT04497116|589224324|FG016|Overall Study|Clinical Progression Related|0|||
163140678|NCT04497116|589224325|FG017|Overall Study|Clinical Progression Related|0|||
163140679|NCT04497116|589224326|FG018|Overall Study|Clinical Progression Related|0|||
163140680|NCT04497116|589224327|FG019|Overall Study|Clinical Progression Related|0|||
163140681|NCT04497116|589224328|FG020|Overall Study|Clinical Progression Related|0|||
163140682|NCT04497116|589224329|FG021|Overall Study|Clinical Progression Related|0|||
163140683|NCT04497116|589224330|FG022|Overall Study|Clinical Progression Related|0|||
163140684|NCT04497116|589224331|FG023|Overall Study|Clinical Progression Related|0|||
163140685|NCT04497116|589224332|FG024|Overall Study|Clinical Progression Related|0|||
163140686|NCT05963022|589224336|FG000|Overall Study|Adverse Event|0|||
163140687|NCT05963022|589224337|FG001|Overall Study|Adverse Event|1|||
163140688|NCT05963022|589224338|FG002|Overall Study|Adverse Event|1|||
163140689|NCT05963022|589224339|FG003|Overall Study|Adverse Event|0|||
163140690|NCT05963022|589224336|FG000|Overall Study|Protocol Violation|0|||
163140691|NCT05963022|589224337|FG001|Overall Study|Protocol Violation|3|||
163140692|NCT05963022|589224338|FG002|Overall Study|Protocol Violation|0|||
163140693|NCT05963022|589224339|FG003|Overall Study|Protocol Violation|0|||
163140694|NCT05963022|589224336|FG000|Overall Study|Pregnancy|0|||
163140695|NCT05963022|589224337|FG001|Overall Study|Pregnancy|1|||
163140696|NCT05963022|589224338|FG002|Overall Study|Pregnancy|1|||
163140697|NCT05963022|589224339|FG003|Overall Study|Pregnancy|1|||
163140698|NCT05963022|589224336|FG000|Overall Study|Withdrawal by Subject|0|||
163140699|NCT05963022|589224337|FG001|Overall Study|Withdrawal by Subject|0|||
163140700|NCT05963022|589224338|FG002|Overall Study|Withdrawal by Subject|2|||
163140701|NCT05963022|589224339|FG003|Overall Study|Withdrawal by Subject|1|||
163140702|NCT05963022|589224336|FG000|Overall Study|Lost to Follow-up|0|||
163140703|NCT05963022|589224337|FG001|Overall Study|Lost to Follow-up|0|||
163140704|NCT05963022|589224338|FG002|Overall Study|Lost to Follow-up|0|||
163140705|NCT05963022|589224339|FG003|Overall Study|Lost to Follow-up|1|||
163140706|NCT05963022|589224336|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
163140707|NCT05963022|589224337|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
163348061|NCT01983462|589983360|FG000|Overall Study|Adverse Event|1|||
163140708|NCT05963022|589224338|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
163140709|NCT05963022|589224339|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
163140710|NCT02698826|589224342|FG000|Overall Study|Death|13|||
163140711|NCT02698826|589224342|FG000|Overall Study|Adverse Event|1|||
163140712|NCT02915263|589224347|FG000|Overall Study|Covid|3|||
163140713|NCT02915263|589224348|FG001|Overall Study|Covid|2|||
163140714|NCT02478463|589224349|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
163140715|NCT02478463|589224349|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
163140716|NCT02478463|589224349|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
163140717|NCT01358825|589224350|FG000|Overall Study|Blood sample not drawn|0|||
163409386|NCT00784654|590207606|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
163409387|NCT00784654|590207604|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
163409388|NCT00784654|590207605|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
163409389|NCT00784654|590207606|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
163409390|NCT00784654|590207604|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
163409391|NCT00784654|590207605|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
163409392|NCT00784654|590207606|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
163409393|NCT00784654|590207604|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
163409394|NCT00784654|590207605|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
163409395|NCT00784654|590207606|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
163409396|NCT00784654|590207604|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
163409397|NCT00784654|590207605|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
163409398|NCT00784654|590207606|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
163409399|NCT00784654|590207604|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
163409400|NCT00784654|590207605|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
163409401|NCT00784654|590207606|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
163409402|NCT00784654|590207604|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
163409403|NCT00784654|590207605|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
163409404|NCT00784654|590207606|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
163409405|NCT00784654|590207604|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
163409406|NCT00784654|590207605|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
163409407|NCT00784654|590207606|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
163409408|NCT00784654|590207604|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163409409|NCT00784654|590207605|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
163409410|NCT00784654|590207606|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
163409411|NCT00784654|590207604|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
163409412|NCT00784654|590207605|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
163409413|NCT00784654|590207606|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
163409414|NCT00784654|590207604|FG000|Randomized Withdrawal Period|Adverse Event|0|||
163409415|NCT00784654|590207605|FG001|Randomized Withdrawal Period|Adverse Event|1|||
163409416|NCT00784654|590207606|FG002|Randomized Withdrawal Period|Adverse Event|1|||
163409417|NCT00784654|590207604|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
163409418|NCT00784654|590207605|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
163409419|NCT00784654|590207606|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
163409420|NCT00784654|590207604|FG000|Randomized Withdrawal Period|Family reasons|0|||
163409421|NCT00784654|590207605|FG001|Randomized Withdrawal Period|Family reasons|0|||
163409422|NCT00784654|590207606|FG002|Randomized Withdrawal Period|Family reasons|1|||
163409423|NCT01430455|590207622|FG000|Overall Study|Withdrawal by Subject|1|||
163409424|NCT01430455|590207622|FG000|Overall Study|Switched to follow-up phase|1|||
163409425|NCT05061719|590207623|FG000|Overall Study|Adverse Event|60|||
163409426|NCT05061719|590207623|FG000|Overall Study|Death|1|||
163409427|NCT05061719|590207623|FG000|Overall Study|Lack of Efficacy|7|||
163409428|NCT05061719|590207623|FG000|Overall Study|Lost to Follow-up|5|||
163409429|NCT05061719|590207623|FG000|Overall Study|Pregnancy|1|||
163409430|NCT05061719|590207623|FG000|Overall Study|Protocol Violation|8|||
163409431|NCT05061719|590207623|FG000|Overall Study|Withdrawal by Subject|41|||
163409432|NCT05061719|590207623|FG000|Overall Study|Site Closure|2|||
163409433|NCT02600507|590209387|FG000|Overall Study|Adverse Event|3|||
163409434|NCT02600507|590209388|FG001|Overall Study|Adverse Event|15|||
163409435|NCT02600507|590209389|FG002|Overall Study|Adverse Event|5|||
163409436|NCT02600507|590209387|FG000|Overall Study|Lack of Efficacy|3|||
163409437|NCT02600507|590209388|FG001|Overall Study|Lack of Efficacy|8|||
163409438|NCT02600507|590209389|FG002|Overall Study|Lack of Efficacy|5|||
163409439|NCT02600507|590209387|FG000|Overall Study|Lost to Follow-up|3|||
163409440|NCT02600507|590209388|FG001|Overall Study|Lost to Follow-up|5|||
163409441|NCT02600507|590209389|FG002|Overall Study|Lost to Follow-up|2|||
163409442|NCT02600507|590209387|FG000|Overall Study|Protocol Violation|12|||
163409443|NCT02600507|590209388|FG001|Overall Study|Protocol Violation|4|||
163409444|NCT02600507|590209389|FG002|Overall Study|Protocol Violation|4|||
163409445|NCT02600507|590209387|FG000|Overall Study|Physician Decision|1|||
163409446|NCT02600507|590209388|FG001|Overall Study|Physician Decision|0|||
163409447|NCT02600507|590209389|FG002|Overall Study|Physician Decision|1|||
163409448|NCT02600507|590209387|FG000|Overall Study|Withdrawal by Subject|7|||
163409449|NCT02600507|590209388|FG001|Overall Study|Withdrawal by Subject|11|||
163409450|NCT02600507|590209389|FG002|Overall Study|Withdrawal by Subject|7|||
163409451|NCT02600507|590209387|FG000|Overall Study|Other|0|||
163409452|NCT02600507|590209388|FG001|Overall Study|Other|1|||
163409453|NCT02600507|590209389|FG002|Overall Study|Other|1|||
163140718|NCT01358825|589224351|FG001|Overall Study|Blood sample not drawn|1|||
163140719|NCT01177007|589224352|FG000|Overall Study|Lost to Follow-up|2|||
163140720|NCT01177007|589224352|FG000|Overall Study|Death|4|||
163140721|NCT01177007|589224352|FG000|Overall Study|Entered hospice care|5|||
163140722|NCT01177007|589224352|FG000|Overall Study|Required additional Y90 treatment|6|||
163140723|NCT01177007|589224352|FG000|Overall Study|Change in treatment modality|21|||
163140724|NCT01702558|589224353|FG000|Overall Study|Withdrawal by Subject|0|||
163140725|NCT01702558|589224354|FG001|Overall Study|Withdrawal by Subject|0|||
163140726|NCT01702558|589224355|FG002|Overall Study|Withdrawal by Subject|0|||
163234666|NCT01877421|589569371|FG006|Phase 2|Protocol Violation|0|||
163234667|NCT01877421|589569372|FG007|Phase 2|Protocol Violation|0|||
163234668|NCT01877421|589569373|FG008|Phase 2|Protocol Violation|0|||
163234669|NCT01877421|589569374|FG009|Phase 2|Protocol Violation|0|||
163234670|NCT01877421|589569375|FG010|Phase 2|Protocol Violation|1|||
163234671|NCT01877421|589569376|FG011|Phase 2|Protocol Violation|0|||
163234672|NCT01877421|589569377|FG012|Phase 2|Protocol Violation|0|||
163234673|NCT01877421|589569378|FG013|Phase 2|Protocol Violation|0|||
163234674|NCT01877421|589569379|FG014|Phase 2|Protocol Violation|0|||
163234675|NCT01877421|589569380|FG015|Phase 2|Protocol Violation|0|||
163234676|NCT01877421|589569381|FG016|Phase 2|Protocol Violation|0|||
163234677|NCT01877421|589569382|FG017|Phase 2|Protocol Violation|0|||
163234678|NCT01416805|589569386|FG000|Overall Study|Lost to Follow-up|4|||
163234679|NCT01416805|589569387|FG001|Overall Study|Lost to Follow-up|4|||
163234680|NCT02604589|589569394|FG000|Overall Study|catheter dislodgement|0|||
163234681|NCT02604589|589569395|FG001|Overall Study|catheter dislodgement|0|||
163234682|NCT02604589|589569396|FG002|Overall Study|catheter dislodgement|1|||
163234683|NCT04632940|589569405|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
163234684|NCT04632940|589569406|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
163234685|NCT04632940|589569405|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
163234686|NCT04632940|589569406|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
163234687|NCT04632940|589569405|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
163234688|NCT04632940|589569406|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
163234689|NCT04632940|589569405|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
163234690|NCT04632940|589569406|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
163234691|NCT04632940|589569405|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
163234692|NCT04632940|589569406|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
163234693|NCT04632940|589569405|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
163234694|NCT04632940|589569406|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
163234695|NCT04632940|589569405|FG000|OLE Period (52 Weeks)|Other than specified|0|||
163348062|NCT01983462|589983361|FG001|Overall Study|Adverse Event|0|||
163234696|NCT04632940|589569406|FG001|OLE Period (52 Weeks)|Other than specified|1|||
163234697|NCT04632940|589569405|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
163234698|NCT04632940|589569406|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
163234699|NCT00179647|589569410|FG000|Overall Study|Adverse Event|294|||
163234700|NCT00179647|589569410|FG000|Overall Study|Lack of Efficacy|478|||
163234701|NCT00179647|589569410|FG000|Overall Study|Withdrawal by Subject|83|||
163234702|NCT00179647|589569410|FG000|Overall Study|Lost to Follow-up|4|||
163234703|NCT00179647|589569410|FG000|Overall Study|Death|94|||
163234704|NCT00179647|589569410|FG000|Overall Study|Other|960|||
163234705|NCT00622635|589569411|FG000|Treatment Period 1|Adverse Event|0|||
163234706|NCT00622635|589569412|FG001|Treatment Period 1|Adverse Event|0|||
163234707|NCT00622635|589569413|FG002|Treatment Period 1|Adverse Event|1|||
163234708|NCT00622635|589569414|FG003|Treatment Period 1|Adverse Event|0|||
163234709|NCT00622635|589569415|FG004|Treatment Period 1|Adverse Event|0|||
163234710|NCT00622635|589569416|FG005|Treatment Period 1|Adverse Event|0|||
163234711|NCT00622635|589569411|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163234712|NCT00622635|589569412|FG001|Treatment Period 1|Withdrawal by Subject|1|||
163234713|NCT00622635|589569413|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163234714|NCT00622635|589569414|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163234715|NCT00622635|589569415|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163348063|NCT01983462|589983362|FG002|Overall Study|Adverse Event|0|||
163348064|NCT01902381|589983363|FG000|Overall Study|Withdrawal by Subject|1|||
163348065|NCT02762500|589983364|FG000|Overall Study|Lack of Efficacy|1|||
163348066|NCT02762500|589983365|FG001|Overall Study|Lack of Efficacy|0|||
163348067|NCT02762500|589983364|FG000|Overall Study|Withdrawal by Subject|1|||
163348068|NCT02762500|589983365|FG001|Overall Study|Withdrawal by Subject|1|||
163348069|NCT02762500|589983364|FG000|Overall Study|Adverse Event|0|||
163348070|NCT02762500|589983365|FG001|Overall Study|Adverse Event|2|||
163348071|NCT00488319|589983366|FG000|Overall Study|Adverse Event|1|||
163140727|NCT01702558|589224356|FG003|Overall Study|Withdrawal by Subject|12|||
163140728|NCT01702558|589224357|FG004|Overall Study|Withdrawal by Subject|4|||
163234716|NCT00622635|589569416|FG005|Treatment Period 1|Withdrawal by Subject|0|||
163234717|NCT00622635|589569411|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
163234718|NCT00622635|589569412|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
163234719|NCT00622635|589569413|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
163234720|NCT00622635|589569414|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
163234721|NCT00622635|589569415|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
163348072|NCT00488319|589983367|FG001|Overall Study|Adverse Event|2|||
163234722|NCT00622635|589569416|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
163234723|NCT00622635|589569411|FG000|Treatment Period 2|Adverse Event|1|||
163234724|NCT00622635|589569412|FG001|Treatment Period 2|Adverse Event|0|||
163234725|NCT00622635|589569413|FG002|Treatment Period 2|Adverse Event|0|||
163234726|NCT00622635|589569414|FG003|Treatment Period 2|Adverse Event|0|||
163234727|NCT00622635|589569415|FG004|Treatment Period 2|Adverse Event|0|||
163234728|NCT00622635|589569416|FG005|Treatment Period 2|Adverse Event|0|||
163234729|NCT00622635|589569411|FG000|Treatment Period 3|Adverse Event|0|||
163234730|NCT00622635|589569412|FG001|Treatment Period 3|Adverse Event|0|||
163234731|NCT00622635|589569413|FG002|Treatment Period 3|Adverse Event|0|||
163234732|NCT00622635|589569414|FG003|Treatment Period 3|Adverse Event|2|||
163234733|NCT00622635|589569415|FG004|Treatment Period 3|Adverse Event|0|||
163234734|NCT00622635|589569416|FG005|Treatment Period 3|Adverse Event|0|||
163234735|NCT00622635|589569411|FG000|Treatment Period 3|Withdrawal by Subject|0|||
163234736|NCT00622635|589569412|FG001|Treatment Period 3|Withdrawal by Subject|0|||
163234737|NCT00622635|589569413|FG002|Treatment Period 3|Withdrawal by Subject|0|||
163234738|NCT00622635|589569414|FG003|Treatment Period 3|Withdrawal by Subject|1|||
163234739|NCT00622635|589569415|FG004|Treatment Period 3|Withdrawal by Subject|0|||
163234740|NCT00622635|589569416|FG005|Treatment Period 3|Withdrawal by Subject|0|||
163234741|NCT05013905|589569417|FG000|Overall Study|Adverse Event|1|||
163348073|NCT00488319|589983368|FG002|Overall Study|Adverse Event|23|||
163348074|NCT00488319|589983366|FG000|Overall Study|Lack of Efficacy|6|||
163348075|NCT00488319|589983367|FG001|Overall Study|Lack of Efficacy|12|||
163348076|NCT00488319|589983368|FG002|Overall Study|Lack of Efficacy|27|||
163348077|NCT00488319|589983366|FG000|Overall Study|Lost to Follow-up|3|||
163348078|NCT00488319|589983367|FG001|Overall Study|Lost to Follow-up|5|||
163348079|NCT00488319|589983368|FG002|Overall Study|Lost to Follow-up|16|||
163348080|NCT00488319|589983366|FG000|Overall Study|Withdrawal by Subject|5|||
163348081|NCT00488319|589983367|FG001|Overall Study|Withdrawal by Subject|20|||
163348082|NCT00488319|589983368|FG002|Overall Study|Withdrawal by Subject|44|||
163348083|NCT00488319|589983366|FG000|Overall Study|Other reasons for withdrawal|0|||
163348084|NCT00488319|589983367|FG001|Overall Study|Other reasons for withdrawal|4|||
163348085|NCT00488319|589983368|FG002|Overall Study|Other reasons for withdrawal|12|||
163348086|NCT00784277|589983373|FG000|IR Treatment|Adverse Event|4|||
163348087|NCT00784277|589983374|FG001|IR Treatment|Adverse Event|8|||
163348088|NCT00784277|589983375|FG002|IR Treatment|Adverse Event|19|||
163348089|NCT00784277|589983376|FG003|IR Treatment|Adverse Event|35|||
163348090|NCT00784277|589983377|FG004|IR Treatment|Adverse Event|0|||
163348091|NCT00784277|589983378|FG005|IR Treatment|Adverse Event|0|||
163348092|NCT00784277|589983379|FG006|IR Treatment|Adverse Event|0|||
163348093|NCT00784277|589983373|FG000|IR Treatment|Lack of Efficacy|4|||
163348094|NCT00784277|589983374|FG001|IR Treatment|Lack of Efficacy|4|||
163348095|NCT00784277|589983375|FG002|IR Treatment|Lack of Efficacy|1|||
163348096|NCT00784277|589983376|FG003|IR Treatment|Lack of Efficacy|0|||
163348097|NCT00784277|589983377|FG004|IR Treatment|Lack of Efficacy|0|||
163348098|NCT00784277|589983378|FG005|IR Treatment|Lack of Efficacy|0|||
163348099|NCT00784277|589983379|FG006|IR Treatment|Lack of Efficacy|0|||
163348100|NCT00784277|589983373|FG000|IR Treatment|Lost to Follow-up|1|||
163348101|NCT00784277|589983374|FG001|IR Treatment|Lost to Follow-up|0|||
163348102|NCT00784277|589983375|FG002|IR Treatment|Lost to Follow-up|1|||
163348103|NCT00784277|589983376|FG003|IR Treatment|Lost to Follow-up|0|||
163348104|NCT00784277|589983377|FG004|IR Treatment|Lost to Follow-up|0|||
163348105|NCT00784277|589983378|FG005|IR Treatment|Lost to Follow-up|0|||
163348106|NCT00784277|589983379|FG006|IR Treatment|Lost to Follow-up|0|||
163348107|NCT00784277|589983373|FG000|IR Treatment|Withdrawal by Subject|5|||
163348108|NCT00784277|589983374|FG001|IR Treatment|Withdrawal by Subject|1|||
163348109|NCT00784277|589983375|FG002|IR Treatment|Withdrawal by Subject|4|||
163348110|NCT00784277|589983376|FG003|IR Treatment|Withdrawal by Subject|6|||
163348111|NCT00784277|589983377|FG004|IR Treatment|Withdrawal by Subject|0|||
163348112|NCT00784277|589983378|FG005|IR Treatment|Withdrawal by Subject|0|||
163348113|NCT00784277|589983379|FG006|IR Treatment|Withdrawal by Subject|0|||
163348114|NCT00784277|589983373|FG000|IR Treatment|Resolution Of Pain|0|||
163348115|NCT00784277|589983374|FG001|IR Treatment|Resolution Of Pain|1|||
163348116|NCT00784277|589983375|FG002|IR Treatment|Resolution Of Pain|0|||
163348117|NCT00784277|589983376|FG003|IR Treatment|Resolution Of Pain|0|||
163348118|NCT00784277|589983377|FG004|IR Treatment|Resolution Of Pain|0|||
163348119|NCT00784277|589983378|FG005|IR Treatment|Resolution Of Pain|0|||
163348120|NCT00784277|589983379|FG006|IR Treatment|Resolution Of Pain|0|||
163409454|NCT05048719|590209390|FG000|Overall Study|Withdrawal by Subject|2|||
163348121|NCT00784277|589983373|FG000|IR Treatment|Other|2|||
163348122|NCT00784277|589983374|FG001|IR Treatment|Other|3|||
163348123|NCT00784277|589983375|FG002|IR Treatment|Other|3|||
163348124|NCT00784277|589983376|FG003|IR Treatment|Other|2|||
163348125|NCT00784277|589983377|FG004|IR Treatment|Other|0|||
163409455|NCT05048719|590209391|FG001|Overall Study|Withdrawal by Subject|1|||
163234742|NCT05013905|589569417|FG000|Overall Study|Lack of Efficacy|1|||
163234743|NCT01849588|589569420|FG000|Overall Study|Lack of Efficacy|3|||
163234744|NCT02550652|589569430|FG000|Overall Study|Death|1|||
163234745|NCT02550652|589569431|FG001|Overall Study|Death|4|||
163348126|NCT00784277|589983378|FG005|IR Treatment|Other|0|||
163234746|NCT02550652|589569430|FG000|Overall Study|Lack of Efficacy|1|||
163234747|NCT02550652|589569431|FG001|Overall Study|Lack of Efficacy|0|||
163234748|NCT02550652|589569430|FG000|Overall Study|Withdrawal by Subject|4|||
163234749|NCT02550652|589569431|FG001|Overall Study|Withdrawal by Subject|7|||
163234750|NCT02550652|589569430|FG000|Overall Study|Post Trial Access|1|||
163234751|NCT02550652|589569431|FG001|Overall Study|Post Trial Access|0|||
163234752|NCT02550652|589569430|FG000|Overall Study|Lost to Follow-up|1|||
163234753|NCT02550652|589569431|FG001|Overall Study|Lost to Follow-up|3|||
163234754|NCT02550652|589569430|FG000|Overall Study|Physician Decision|0|||
163234755|NCT02550652|589569431|FG001|Overall Study|Physician Decision|2|||
163234756|NCT02550652|589569430|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
163234757|NCT02550652|589569431|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
163234758|NCT01706250|589569432|FG000|Overall Study|Lost to Follow-up|2|||
163234759|NCT02486406|589569433|FG000|Overall Study|Withdrew consent|1|||
163234760|NCT02486406|589569434|FG001|Overall Study|Withdrew consent|0|||
163234761|NCT02486406|589569435|FG002|Overall Study|Withdrew consent|0|||
163234762|NCT02486406|589569436|FG003|Overall Study|Withdrew consent|1|||
163234763|NCT02486406|589569433|FG000|Overall Study|Lost to Follow-up|1|||
163234764|NCT02486406|589569434|FG001|Overall Study|Lost to Follow-up|3|||
163234765|NCT02486406|589569435|FG002|Overall Study|Lost to Follow-up|1|||
163234766|NCT02486406|589569436|FG003|Overall Study|Lost to Follow-up|3|||
163234767|NCT02486406|589569433|FG000|Overall Study|Other, not specified|0|||
163234768|NCT02486406|589569434|FG001|Overall Study|Other, not specified|0|||
163234769|NCT02486406|589569435|FG002|Overall Study|Other, not specified|1|||
163234770|NCT02486406|589569436|FG003|Overall Study|Other, not specified|0|||
163234771|NCT03509948|589569463|FG000|Overall Study|Protocol Violation|0|||
163234772|NCT03509948|589569464|FG001|Overall Study|Protocol Violation|1|||
163234773|NCT04587193|589569471|FG000|Overall Study|Screen failure after consent|3|||
163234774|NCT04587193|589569472|FG001|Overall Study|Screen failure after consent|0|||
163234775|NCT04587193|589569471|FG000|Overall Study|Device broke during study|3|||
163234776|NCT04587193|589569472|FG001|Overall Study|Device broke during study|2|||
163234777|NCT00508742|589569473|FG000|Period 1: Infant Series|Adverse Event|5|||
163234778|NCT00508742|589569474|FG001|Period 1: Infant Series|Adverse Event|4|||
163234779|NCT00508742|589569473|FG000|Period 1: Infant Series|Protocol Violation|1|||
163234780|NCT00508742|589569474|FG001|Period 1: Infant Series|Protocol Violation|0|||
163234781|NCT00508742|589569473|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
163234782|NCT00508742|589569474|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
163234783|NCT00508742|589569473|FG000|Period 1: Infant Series|Physician Decision|1|||
163234784|NCT00508742|589569474|FG001|Period 1: Infant Series|Physician Decision|0|||
163234785|NCT00508742|589569473|FG000|Period 1: Infant Series|Other|4|||
163234786|NCT00508742|589569474|FG001|Period 1: Infant Series|Other|1|||
163234787|NCT00508742|589569473|FG000|Period 2: After Infant Series|Adverse Event|2|||
163234788|NCT00508742|589569474|FG001|Period 2: After Infant Series|Adverse Event|6|||
163234789|NCT00508742|589569473|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
163234790|NCT00508742|589569474|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
163234791|NCT00508742|589569473|FG000|Period 2: After Infant Series|Protocol Violation|1|||
163234792|NCT00508742|589569474|FG001|Period 2: After Infant Series|Protocol Violation|0|||
163234793|NCT00508742|589569473|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
163234794|NCT00508742|589569474|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
163234795|NCT00508742|589569473|FG000|Period 2: After Infant Series|Failed to Return|1|||
163234796|NCT00508742|589569474|FG001|Period 2: After Infant Series|Failed to Return|0|||
163234797|NCT00508742|589569473|FG000|Period 2: After Infant Series|Other|2|||
163234798|NCT00508742|589569474|FG001|Period 2: After Infant Series|Other|1|||
163234799|NCT00508742|589569473|FG000|Period 3: Toddler Dose|Adverse Event|1|||
163234800|NCT00508742|589569474|FG001|Period 3: Toddler Dose|Adverse Event|0|||
163234801|NCT00508742|589569473|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
163234802|NCT00508742|589569474|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
163234803|NCT00508742|589569473|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
163234804|NCT00508742|589569474|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
163234805|NCT00508742|589569473|FG000|Period 3: Toddler Dose|Other|5|||
163234806|NCT00508742|589569474|FG001|Period 3: Toddler Dose|Other|4|||
163234807|NCT02501096|589569475|FG000|Overall Study|Lost to Follow-up|0|||
163234808|NCT02501096|589569476|FG001|Overall Study|Lost to Follow-up|0|||
163234809|NCT02501096|589569477|FG002|Overall Study|Lost to Follow-up|0|||
163234810|NCT02501096|589569478|FG003|Overall Study|Lost to Follow-up|0|||
163234811|NCT02501096|589569479|FG004|Overall Study|Lost to Follow-up|1|||
163234812|NCT02501096|589569480|FG005|Overall Study|Lost to Follow-up|1|||
163234813|NCT02501096|589569481|FG006|Overall Study|Lost to Follow-up|3|||
163234814|NCT02501096|589569482|FG007|Overall Study|Lost to Follow-up|0|||
163234815|NCT02501096|589569483|FG008|Overall Study|Lost to Follow-up|0|||
163234816|NCT02501096|589569475|FG000|Overall Study|Withdrawal by Subject|1|||
163234817|NCT02501096|589569476|FG001|Overall Study|Withdrawal by Subject|0|||
163234818|NCT02501096|589569477|FG002|Overall Study|Withdrawal by Subject|7|||
163234819|NCT02501096|589569478|FG003|Overall Study|Withdrawal by Subject|13|||
163234820|NCT02501096|589569479|FG004|Overall Study|Withdrawal by Subject|2|||
163234821|NCT02501096|589569480|FG005|Overall Study|Withdrawal by Subject|2|||
163234822|NCT02501096|589569481|FG006|Overall Study|Withdrawal by Subject|2|||
163234823|NCT02501096|589569482|FG007|Overall Study|Withdrawal by Subject|3|||
163234824|NCT02501096|589569483|FG008|Overall Study|Withdrawal by Subject|0|||
163234825|NCT02501096|589569475|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
163234826|NCT02501096|589569476|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
163234827|NCT02501096|589569477|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
163234828|NCT02501096|589569478|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
163234829|NCT02501096|589569479|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
163234830|NCT02501096|589569480|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
163234831|NCT02501096|589569481|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
163234832|NCT02501096|589569482|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
163234833|NCT02501096|589569483|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
163234834|NCT02501096|589569475|FG000|Overall Study|Death|1|||
163234835|NCT02501096|589569476|FG001|Overall Study|Death|1|||
163234836|NCT02501096|589569477|FG002|Overall Study|Death|88|||
163234837|NCT02501096|589569478|FG003|Overall Study|Death|74|||
163234838|NCT02501096|589569479|FG004|Overall Study|Death|15|||
163234839|NCT02501096|589569480|FG005|Overall Study|Death|16|||
163234840|NCT02501096|589569481|FG006|Overall Study|Death|15|||
163234841|NCT02501096|589569482|FG007|Overall Study|Death|16|||
163234842|NCT02501096|589569483|FG008|Overall Study|Death|1|||
163234843|NCT00437034|589569484|FG000|Overall Study|Adverse Event|1|||
163234844|NCT00437034|589569484|FG000|Overall Study|Disease progression during treatment|5|||
163234845|NCT01976845|589569485|FG000|Overall Study|Physician Decision|8|||
163234846|NCT01976845|589569486|FG001|Overall Study|Physician Decision|8|||
163234847|NCT01976845|589569487|FG002|Overall Study|Physician Decision|3|||
163234848|NCT01818336|589570821|FG000|Overall Study|Declined retest visit|0|||
163234849|NCT01818336|589570822|FG001|Overall Study|Declined retest visit|11|||
163234850|NCT01818336|589570821|FG000|Overall Study|Lost to Follow-up|0|||
163234851|NCT01818336|589570822|FG001|Overall Study|Lost to Follow-up|1|||
163234852|NCT03042312|589570825|FG000|Overall Study|Administrative Reason|1|||
163234853|NCT03042312|589570826|FG001|Overall Study|Administrative Reason|1|||
163234854|NCT03042312|589570825|FG000|Overall Study|Adverse Event|0|||
163234855|NCT03042312|589570826|FG001|Overall Study|Adverse Event|1|||
163234856|NCT03042312|589570825|FG000|Overall Study|Lost to Follow-up|1|||
163234857|NCT03042312|589570826|FG001|Overall Study|Lost to Follow-up|3|||
163234858|NCT03042312|589570825|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
163234859|NCT03042312|589570826|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
163234860|NCT03042312|589570825|FG000|Overall Study|Withdrawal by Subject|4|||
163234861|NCT03042312|589570826|FG001|Overall Study|Withdrawal by Subject|5|||
163234862|NCT03422003|589570836|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
163234863|NCT03422003|589570837|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
163234864|NCT03422003|589570836|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
163234865|NCT03422003|589570837|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
163234866|NCT00975975|589570840|FG000|Overall Study|Death|6|||
163234867|NCT00812812|589570845|FG000|Overall Study|Adverse Event|2|||
163348127|NCT00784277|589983379|FG006|IR Treatment|Other|0|||
163348128|NCT00784277|589983373|FG000|ER Treatment|Adverse Event|0|||
163348129|NCT00784277|589983374|FG001|ER Treatment|Adverse Event|0|||
163348130|NCT00784277|589983375|FG002|ER Treatment|Adverse Event|0|||
163140729|NCT01702558|589224353|FG000|Overall Study|Lost to Follow-up|0|||
163140730|NCT01702558|589224354|FG001|Overall Study|Lost to Follow-up|0|||
163140731|NCT01702558|589224355|FG002|Overall Study|Lost to Follow-up|0|||
163140732|NCT01702558|589224356|FG003|Overall Study|Lost to Follow-up|3|||
163140733|NCT01702558|589224357|FG004|Overall Study|Lost to Follow-up|0|||
163140734|NCT01702558|589224353|FG000|Overall Study|Death|4|||
163140735|NCT01702558|589224354|FG001|Overall Study|Death|3|||
163234868|NCT00812812|589570846|FG001|Overall Study|Adverse Event|1|||
163234869|NCT00812812|589570845|FG000|Overall Study|Lack of Efficacy|1|||
163234870|NCT00812812|589570846|FG001|Overall Study|Lack of Efficacy|0|||
163234871|NCT00812812|589570845|FG000|Overall Study|Lost to Follow-up|0|||
163234872|NCT00812812|589570846|FG001|Overall Study|Lost to Follow-up|1|||
163234873|NCT00812812|589570845|FG000|Overall Study|Withdrawal by Subject|0|||
163234874|NCT00812812|589570846|FG001|Overall Study|Withdrawal by Subject|2|||
163234875|NCT02114892|589570847|FG000|Overall Study|Lost to Follow-up|1|||
163234876|NCT02114892|589570848|FG001|Overall Study|Lost to Follow-up|2|||
163234877|NCT02178475|589570853|FG000|Overall Study|Withdrawal by Subject|7|||
163234878|NCT02178475|589570853|FG000|Overall Study|Lost to Follow-up|10|||
163348131|NCT00784277|589983376|FG003|ER Treatment|Adverse Event|0|||
163348132|NCT00784277|589983377|FG004|ER Treatment|Adverse Event|1|||
163348133|NCT00784277|589983378|FG005|ER Treatment|Adverse Event|7|||
163140736|NCT01702558|589224355|FG002|Overall Study|Death|3|||
163140737|NCT01702558|589224356|FG003|Overall Study|Death|16|||
163140738|NCT01702558|589224357|FG004|Overall Study|Death|20|||
163348134|NCT00784277|589983379|FG006|ER Treatment|Adverse Event|7|||
163348135|NCT00784277|589983373|FG000|ER Treatment|Lack of Efficacy|0|||
163348136|NCT00784277|589983374|FG001|ER Treatment|Lack of Efficacy|0|||
163348137|NCT00784277|589983375|FG002|ER Treatment|Lack of Efficacy|0|||
163348138|NCT00784277|589983376|FG003|ER Treatment|Lack of Efficacy|0|||
163348139|NCT00784277|589983377|FG004|ER Treatment|Lack of Efficacy|3|||
163348140|NCT00784277|589983378|FG005|ER Treatment|Lack of Efficacy|4|||
163348141|NCT00784277|589983379|FG006|ER Treatment|Lack of Efficacy|0|||
163348142|NCT00784277|589983373|FG000|ER Treatment|Lost to Follow-up|0|||
163348143|NCT00784277|589983374|FG001|ER Treatment|Lost to Follow-up|0|||
163348144|NCT00784277|589983375|FG002|ER Treatment|Lost to Follow-up|0|||
163348145|NCT00784277|589983376|FG003|ER Treatment|Lost to Follow-up|0|||
163409456|NCT05048719|590209392|FG002|Overall Study|Withdrawal by Subject|3|||
163409457|NCT05048719|590209393|FG003|Overall Study|Withdrawal by Subject|1|||
163409458|NCT05048719|590209394|FG004|Overall Study|Withdrawal by Subject|0|||
163409459|NCT05048719|590209395|FG005|Overall Study|Withdrawal by Subject|2|||
163409460|NCT05048719|590209396|FG006|Overall Study|Withdrawal by Subject|1|||
163409461|NCT05048719|590209397|FG007|Overall Study|Withdrawal by Subject|1|||
163140739|NCT01702558|589224353|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
163140740|NCT01702558|589224354|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
163140741|NCT01702558|589224355|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
163140742|NCT01702558|589224356|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
163140743|NCT01702558|589224357|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
163140744|NCT01702558|589224353|FG000|Overall Study|Study Terminated by Sponsor|0|||
163140745|NCT01702558|589224354|FG001|Overall Study|Study Terminated by Sponsor|1|||
163140746|NCT01702558|589224355|FG002|Overall Study|Study Terminated by Sponsor|0|||
163140747|NCT01702558|589224356|FG003|Overall Study|Study Terminated by Sponsor|0|||
163140748|NCT01702558|589224357|FG004|Overall Study|Study Terminated by Sponsor|1|||
163140749|NCT01702558|589224353|FG000|Overall Study|Other|0|||
163140750|NCT01702558|589224354|FG001|Overall Study|Other|0|||
163140751|NCT01702558|589224355|FG002|Overall Study|Other|0|||
163140752|NCT01702558|589224356|FG003|Overall Study|Other|16|||
163140753|NCT01702558|589224357|FG004|Overall Study|Other|17|||
163140754|NCT03259087|589224363|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
163140755|NCT03259087|589224364|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
163140756|NCT03259087|589224365|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
163140757|NCT03259087|589224366|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
163140758|NCT03259087|589224367|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
163140759|NCT03259087|589224363|FG000|Period 2 of Part 2|Adverse Event|0|||
163140760|NCT03259087|589224364|FG001|Period 2 of Part 2|Adverse Event|0|||
163140761|NCT03259087|589224365|FG002|Period 2 of Part 2|Adverse Event|0|||
163140762|NCT03259087|589224366|FG003|Period 2 of Part 2|Adverse Event|0|||
163140763|NCT03259087|589224367|FG004|Period 2 of Part 2|Adverse Event|1|||
163140764|NCT04524858|589224368|FG000|Overall Study|Adverse Event|1|||
163140765|NCT03571204|589224369|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
163140766|NCT03571204|589224370|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
163140767|NCT03571204|589224371|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
163140768|NCT03571204|589224369|FG000|Overall Study|Physician Decision|0|||
163140769|NCT03571204|589224370|FG001|Overall Study|Physician Decision|1|||
163140770|NCT03571204|589224371|FG002|Overall Study|Physician Decision|0|||
163140771|NCT02396212|589224372|FG000|Overall Study|Adverse Event|1|||
163140772|NCT02396212|589224372|FG000|Overall Study|Lack of Efficacy|2|||
163140773|NCT01623115|589224373|FG000|Overall Study|Randomized but not treated|0|||
163140774|NCT01623115|589224374|FG001|Overall Study|Randomized but not treated|1|||
163140775|NCT01623115|589224373|FG000|Overall Study|Physician Decision|1|||
163140776|NCT01623115|589224374|FG001|Overall Study|Physician Decision|0|||
163140777|NCT01623115|589224373|FG000|Overall Study|Participants moved|1|||
163140778|NCT01623115|589224374|FG001|Overall Study|Participants moved|5|||
163140779|NCT01623115|589224373|FG000|Overall Study|Adverse Event|10|||
163140780|NCT01623115|589224374|FG001|Overall Study|Adverse Event|13|||
163140781|NCT01623115|589224373|FG000|Overall Study|Poor compliance to protocol|4|||
163140782|NCT01623115|589224374|FG001|Overall Study|Poor compliance to protocol|10|||
163140783|NCT01623115|589224373|FG000|Overall Study|Consent withdrawn by participant|2|||
163140784|NCT01623115|589224374|FG001|Overall Study|Consent withdrawn by participant|6|||
163140785|NCT01623115|589224373|FG000|Overall Study|Related to study drug administration|0|||
163140786|NCT01623115|589224374|FG001|Overall Study|Related to study drug administration|2|||
163140787|NCT01623115|589224373|FG000|Overall Study|Last visit outside protocol visit window|14|||
163140788|NCT01623115|589224374|FG001|Overall Study|Last visit outside protocol visit window|26|||
163140789|NCT01623115|589224373|FG000|Overall Study|Site closure|1|||
163140790|NCT01623115|589224374|FG001|Overall Study|Site closure|7|||
163140791|NCT01623115|589224373|FG000|Overall Study|Death|0|||
163140792|NCT01623115|589224374|FG001|Overall Study|Death|4|||
163140793|NCT01623115|589224373|FG000|Overall Study|Other than specified above|0|||
163348146|NCT00784277|589983377|FG004|ER Treatment|Lost to Follow-up|0|||
163348147|NCT00784277|589983378|FG005|ER Treatment|Lost to Follow-up|2|||
163140794|NCT01623115|589224374|FG001|Overall Study|Other than specified above|3|||
163409462|NCT05048719|590209398|FG008|Overall Study|Withdrawal by Subject|0|||
163409463|NCT05048719|590209390|FG000|Overall Study|Death|1|||
163234879|NCT02178475|589570853|FG000|Overall Study|Death|13|||
163234880|NCT02178475|589570853|FG000|Overall Study|Protocol-specified Criteria|99|||
163234881|NCT04327934|589570854|FG000|Overall Study|Did not qualify|7|||
163234882|NCT04327934|589570855|FG001|Overall Study|Did not qualify|4|||
163234883|NCT04327934|589570854|FG000|Overall Study|Physician Decision|0|||
163234884|NCT04327934|589570855|FG001|Overall Study|Physician Decision|1|||
163234885|NCT02443298|589570856|FG000|Overall Study|Adverse Event|3|||
163234886|NCT02443298|589570857|FG001|Overall Study|Adverse Event|3|||
163234887|NCT02443298|589570856|FG000|Overall Study|Withdrawal by Subject|1|||
163234888|NCT02443298|589570857|FG001|Overall Study|Withdrawal by Subject|2|||
163234889|NCT03095417|589570858|FG000|Overall Study|missed|1|||
163234890|NCT03095417|589570859|FG001|Overall Study|missed|2|||
163234891|NCT03095417|589570860|FG002|Overall Study|missed|0|||
163234892|NCT03095417|589570861|FG003|Overall Study|missed|1|||
163234893|NCT03095417|589570858|FG000|Overall Study|Lost to Follow-up|2|||
163234894|NCT03095417|589570859|FG001|Overall Study|Lost to Follow-up|2|||
163234895|NCT03095417|589570860|FG002|Overall Study|Lost to Follow-up|1|||
163234896|NCT03095417|589570861|FG003|Overall Study|Lost to Follow-up|0|||
163234897|NCT03095417|589570858|FG000|Overall Study|refusal|0|||
163348148|NCT00784277|589983379|FG006|ER Treatment|Lost to Follow-up|0|||
163348149|NCT00784277|589983373|FG000|ER Treatment|Withdrawal by Subject|0|||
163348150|NCT00784277|589983374|FG001|ER Treatment|Withdrawal by Subject|0|||
163348151|NCT00784277|589983375|FG002|ER Treatment|Withdrawal by Subject|0|||
163348152|NCT00784277|589983376|FG003|ER Treatment|Withdrawal by Subject|0|||
163234898|NCT03095417|589570859|FG001|Overall Study|refusal|1|||
163234899|NCT03095417|589570860|FG002|Overall Study|refusal|0|||
163234900|NCT03095417|589570861|FG003|Overall Study|refusal|1|||
163234901|NCT03095417|589570858|FG000|Overall Study|Withdrawal by Subject|8|||
163234902|NCT03095417|589570859|FG001|Overall Study|Withdrawal by Subject|2|||
163234903|NCT03095417|589570860|FG002|Overall Study|Withdrawal by Subject|5|||
163234904|NCT03095417|589570861|FG003|Overall Study|Withdrawal by Subject|4|||
163234905|NCT03095417|589570858|FG000|Overall Study|Physician Decision|1|||
163234906|NCT03095417|589570859|FG001|Overall Study|Physician Decision|2|||
163234907|NCT03095417|589570860|FG002|Overall Study|Physician Decision|2|||
163234908|NCT03095417|589570861|FG003|Overall Study|Physician Decision|2|||
163348153|NCT00784277|589983377|FG004|ER Treatment|Withdrawal by Subject|2|||
163348154|NCT00784277|589983378|FG005|ER Treatment|Withdrawal by Subject|5|||
163348155|NCT00784277|589983379|FG006|ER Treatment|Withdrawal by Subject|3|||
163348156|NCT00784277|589983373|FG000|ER Treatment|Study Medication Non-Compliant|0|||
163348157|NCT00784277|589983374|FG001|ER Treatment|Study Medication Non-Compliant|0|||
163348158|NCT00784277|589983375|FG002|ER Treatment|Study Medication Non-Compliant|0|||
163348159|NCT00784277|589983376|FG003|ER Treatment|Study Medication Non-Compliant|0|||
163348160|NCT00784277|589983377|FG004|ER Treatment|Study Medication Non-Compliant|2|||
163348161|NCT00784277|589983378|FG005|ER Treatment|Study Medication Non-Compliant|3|||
163348162|NCT00784277|589983379|FG006|ER Treatment|Study Medication Non-Compliant|3|||
163348163|NCT00784277|589983373|FG000|ER Treatment|Other|0|||
163348164|NCT00784277|589983374|FG001|ER Treatment|Other|0|||
163348165|NCT00784277|589983375|FG002|ER Treatment|Other|0|||
163348166|NCT00784277|589983376|FG003|ER Treatment|Other|0|||
163348167|NCT00784277|589983377|FG004|ER Treatment|Other|1|||
163348168|NCT00784277|589983378|FG005|ER Treatment|Other|3|||
163348169|NCT00784277|589983379|FG006|ER Treatment|Other|2|||
163348170|NCT01093222|589983380|FG000|Overall Study|Ineligible|6|||
163348171|NCT01093222|589983380|FG000|Overall Study|Adverse Event|7|||
163348172|NCT01093222|589983380|FG000|Overall Study|Progression/relapse|24|||
163348173|NCT01093222|589983380|FG000|Overall Study|Death|2|||
163348174|NCT01093222|589983380|FG000|Overall Study|Not protocol specified|1|||
163348175|NCT04194541|589983381|FG000|Day 1 Through 13|Lost to Follow-up|3|||
163348176|NCT04194541|589983381|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
163348177|NCT04194541|589983381|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
163348178|NCT02567227|589983382|FG000|9 Weeks|Adverse Event|5|||
163348179|NCT02567227|589983383|FG001|9 Weeks|Adverse Event|5|||
163234909|NCT03095417|589570858|FG000|Overall Study|Death|1|||
163234910|NCT03095417|589570859|FG001|Overall Study|Death|2|||
163348180|NCT02567227|589983382|FG000|9 Weeks|Withdrawal by Subject|18|||
163348181|NCT02567227|589983383|FG001|9 Weeks|Withdrawal by Subject|8|||
163348182|NCT02567227|589983382|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
163348183|NCT02567227|589983383|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
163348184|NCT02567227|589983382|FG000|6 Month|Death|2|||
163348185|NCT02567227|589983383|FG001|6 Month|Death|0|||
163348186|NCT02567227|589983382|FG000|6 Month|Lost to Follow-up|43|||
163348187|NCT02567227|589983383|FG001|6 Month|Lost to Follow-up|40|||
163348188|NCT02567227|589983382|FG000|12 Months|Lost to Follow-up|31|||
163234911|NCT03095417|589570860|FG002|Overall Study|Death|1|||
163234912|NCT03095417|589570861|FG003|Overall Study|Death|3|||
163234913|NCT02571452|589570862|FG000|Overall Study Treatment|Protocol Violation|0|||
163409464|NCT05048719|590209391|FG001|Overall Study|Death|0|||
163234914|NCT02571452|589570863|FG001|Overall Study Treatment|Protocol Violation|1|||
163234915|NCT02571452|589570862|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
163234916|NCT02571452|589570863|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
163234917|NCT02571452|589570862|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
163234918|NCT02571452|589570863|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
163234919|NCT03698773|589570877|FG000|Overall Study|Lost to Follow-up|2|||
163234920|NCT03698773|589570878|FG001|Overall Study|Lost to Follow-up|1|||
163234921|NCT01158924|589570879|FG000|Overall Study|Withdrawal by Subject|1|||
163234922|NCT01158924|589570880|FG001|Overall Study|Withdrawal by Subject|2|||
163234923|NCT01158924|589570879|FG000|Overall Study|Lost to Follow-up|0|||
163234924|NCT01158924|589570880|FG001|Overall Study|Lost to Follow-up|1|||
163348189|NCT02567227|589983383|FG001|12 Months|Lost to Follow-up|32|||
163348190|NCT02567227|589983382|FG000|12 Months|Death|0|||
163348191|NCT02567227|589983383|FG001|12 Months|Death|2|||
163348192|NCT00187135|589983384|FG000|Visit One|Withdrawal by Subject|1|||
163140795|NCT04950465|589224375|FG000|Overall Study|Lost to Follow-up|1|||
163140796|NCT04950465|589224376|FG001|Overall Study|Lost to Follow-up|0|||
163140797|NCT04950465|589224377|FG002|Overall Study|Lost to Follow-up|0|||
163140798|NCT01788566|589224380|FG000|Overall Study|Death|4|||
163140799|NCT01788566|589224380|FG000|Overall Study|Adverse Event|1|||
163140800|NCT01788566|589224380|FG000|Overall Study|Clinical Progressive Disease|3|||
163140801|NCT00857285|589224383|FG000|Overall Study|Adverse Event|4|||
163140802|NCT00857285|589224384|FG001|Overall Study|Adverse Event|2|||
163140803|NCT00857285|589224383|FG000|Overall Study|Lack of Efficacy|0|||
163140804|NCT00857285|589224384|FG001|Overall Study|Lack of Efficacy|2|||
163140805|NCT00857285|589224383|FG000|Overall Study|Protocol Violation|3|||
163140806|NCT00857285|589224384|FG001|Overall Study|Protocol Violation|1|||
163140807|NCT00857285|589224383|FG000|Overall Study|Withdrawal by Subject|4|||
163140808|NCT00857285|589224384|FG001|Overall Study|Withdrawal by Subject|0|||
163140809|NCT00857285|589224383|FG000|Overall Study|Randomization criteria not met|1|||
163140810|NCT00857285|589224384|FG001|Overall Study|Randomization criteria not met|1|||
163140811|NCT04797780|589224385|FG000|Overall Study|Lost to Follow-up|1|||
163140812|NCT04797780|589224386|FG001|Overall Study|Lost to Follow-up|1|||
163140813|NCT04797780|589224385|FG000|Overall Study|Withdrawal by Subject|14|||
163140814|NCT04797780|589224386|FG001|Overall Study|Withdrawal by Subject|9|||
163140815|NCT04797780|589224385|FG000|Overall Study|Death|49|||
163140816|NCT04797780|589224386|FG001|Overall Study|Death|20|||
163140817|NCT02940496|589224387|FG000|Overall Study|Adverse Event|1|||
163140818|NCT02940496|589224388|FG001|Overall Study|Adverse Event|0|||
163140819|NCT02940496|589224387|FG000|Overall Study|Death|2|||
163140820|NCT02940496|589224388|FG001|Overall Study|Death|0|||
163140821|NCT02940496|589224387|FG000|Overall Study|Hospice Care|1|||
163140822|NCT02940496|589224388|FG001|Overall Study|Hospice Care|0|||
163140823|NCT02940496|589224387|FG000|Overall Study|No MRE Done|1|||
163140824|NCT02940496|589224388|FG001|Overall Study|No MRE Done|0|||
163140825|NCT02940496|589224387|FG000|Overall Study|MRE Failure|1|||
163140826|NCT02940496|589224388|FG001|Overall Study|MRE Failure|0|||
163140827|NCT05973006|589224389|FG000|Overall Study|Early termination|3|||
163140828|NCT05973006|589224390|FG001|Overall Study|Early termination|9|||
163140829|NCT05167825|589224391|FG000|Overall Study|Ongoing|3|||
163140830|NCT01807598|589224392|FG000|Overall Study|Withdrawal by Subject|4|||
163140831|NCT01807598|589224392|FG000|Overall Study|Adverse Event|1|||
163140832|NCT01807598|589224392|FG000|Overall Study|Other Physician Decision|1|||
163140833|NCT03622814|589224404|FG000|Overall Study|Lost to Follow-up|8|||
163140834|NCT03622814|589224405|FG001|Overall Study|Lost to Follow-up|14|||
163140835|NCT04417361|589224406|FG000|Overall Study|Withdrawal by Subject|1|||
163140836|NCT04417361|589224407|FG001|Overall Study|Withdrawal by Subject|0|||
163140837|NCT04417361|589224406|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
163140838|NCT04417361|589224407|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
163140839|NCT00165672|589224408|FG000|Overall Study|Adverse Event|0|||
163140840|NCT00165672|589224409|FG001|Overall Study|Adverse Event|1|||
163140841|NCT03868943|589224410|FG000|Overall Study|Adverse Event|1|||
163140842|NCT03543137|589224413|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
163140843|NCT03543137|589224414|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
163140844|NCT03543137|589224413|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
163140845|NCT03543137|589224414|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
163140846|NCT03543137|589224413|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
163140847|NCT03543137|589224414|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
163140848|NCT01045694|589224415|FG000|Overall Study|Withdrawal by Subject|2|||
163140849|NCT01900652|589224416|FG000|Overall Study|Progressive Disease|1|||
163140850|NCT01900652|589224417|FG001|Overall Study|Progressive Disease|0|||
163140851|NCT01900652|589224416|FG000|Overall Study|Consent withdrawn by subject|1|||
163140852|NCT01900652|589224417|FG001|Overall Study|Consent withdrawn by subject|1|||
163140853|NCT01900652|589224416|FG000|Overall Study|Death|3|||
163140854|NCT01900652|589224417|FG001|Overall Study|Death|0|||
163140855|NCT01900652|589224416|FG000|Overall Study|Adverse Event|2|||
163140856|NCT01900652|589224417|FG001|Overall Study|Adverse Event|1|||
163140857|NCT01900652|589224416|FG000|Overall Study|Physician Decision|1|||
163140858|NCT01900652|589224417|FG001|Overall Study|Physician Decision|1|||
163234925|NCT01260922|589570884|FG000|First Intervention|Withdrawal by Subject|0|||
163234926|NCT01260922|589570885|FG001|First Intervention|Withdrawal by Subject|1|||
163234927|NCT01260922|589570884|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
163234928|NCT01260922|589570885|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
163234929|NCT01260922|589570884|FG000|Second Intervention|Emesis|0|||
163234930|NCT01260922|589570885|FG001|Second Intervention|Emesis|2|||
163234931|NCT03732248|589570888|FG000|Overall Study|Withdrawal by Subject|1|||
163234932|NCT03732248|589570889|FG001|Overall Study|Withdrawal by Subject|0|||
163234933|NCT01599650|589570890|FG000|Overall Study|Administrative issue|1|||
163234934|NCT01599650|589570891|FG001|Overall Study|Administrative issue|0|||
163234935|NCT01599650|589570892|FG002|Overall Study|Administrative issue|1|||
163234936|NCT01599650|589570890|FG000|Overall Study|Physician Decision|2|||
163234937|NCT01599650|589570891|FG001|Overall Study|Physician Decision|0|||
163234938|NCT01599650|589570892|FG002|Overall Study|Physician Decision|7|||
163234939|NCT01599650|589570890|FG000|Overall Study|Protocol Violation|0|||
163234940|NCT01599650|589570891|FG001|Overall Study|Protocol Violation|3|||
163234941|NCT01599650|589570892|FG002|Overall Study|Protocol Violation|0|||
163234942|NCT01599650|589570890|FG000|Overall Study|Death|2|||
163234943|NCT01599650|589570891|FG001|Overall Study|Death|1|||
163234944|NCT01599650|589570892|FG002|Overall Study|Death|2|||
163234945|NCT01599650|589570890|FG000|Overall Study|Lost to Follow-up|3|||
163234946|NCT01599650|589570891|FG001|Overall Study|Lost to Follow-up|3|||
163234947|NCT01599650|589570892|FG002|Overall Study|Lost to Follow-up|3|||
163234948|NCT01599650|589570890|FG000|Overall Study|Withdrawal by Subject|11|||
163234949|NCT01599650|589570891|FG001|Overall Study|Withdrawal by Subject|11|||
163234950|NCT01599650|589570892|FG002|Overall Study|Withdrawal by Subject|10|||
163234951|NCT01599650|589570890|FG000|Overall Study|Adverse Event|3|||
163234952|NCT01599650|589570891|FG001|Overall Study|Adverse Event|8|||
163234953|NCT01599650|589570892|FG002|Overall Study|Adverse Event|4|||
163234954|NCT01731171|589570893|FG000|Overall Study|Withdrawal by Subject|4|||
163234955|NCT01731171|589570894|FG001|Overall Study|Withdrawal by Subject|1|||
163234956|NCT01731171|589570893|FG000|Overall Study|Lost to Follow-up|3|||
163234957|NCT01731171|589570894|FG001|Overall Study|Lost to Follow-up|2|||
163234958|NCT01731171|589570893|FG000|Overall Study|Moved out of Area|0|||
163234959|NCT01731171|589570894|FG001|Overall Study|Moved out of Area|2|||
163234960|NCT01731171|589570893|FG000|Overall Study|Terminated for Lack of Adherence|0|||
163234961|NCT01731171|589570894|FG001|Overall Study|Terminated for Lack of Adherence|1|||
163234962|NCT01731171|589570893|FG000|Overall Study|Terminated for Safety Reasons|0|||
163234963|NCT01731171|589570894|FG001|Overall Study|Terminated for Safety Reasons|1|||
163234964|NCT01410110|589570895|FG000|Overall Study|Withdrawal by Subject|4|||
163234965|NCT01410110|589570896|FG001|Overall Study|Withdrawal by Subject|2|||
163234966|NCT01700946|589570897|FG000|Overall Study|Lost to Follow-up|1|||
163234967|NCT01700946|589570898|FG001|Overall Study|Lost to Follow-up|0|||
163234968|NCT01700946|589570897|FG000|Overall Study|Physician Decision|7|||
163234969|NCT01700946|589570898|FG001|Overall Study|Physician Decision|12|||
163234970|NCT01700946|589570897|FG000|Overall Study|Withdrawal by Subject|0|||
163234971|NCT01700946|589570898|FG001|Overall Study|Withdrawal by Subject|2|||
163234972|NCT01700946|589570897|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
163234973|NCT01700946|589570898|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
163234974|NCT01700946|589570897|FG000|Overall Study|Relapse|2|||
163234975|NCT01700946|589570898|FG001|Overall Study|Relapse|1|||
163234976|NCT01700946|589570897|FG000|Overall Study|Unacceptable toxicity|1|||
163234977|NCT01700946|589570898|FG001|Overall Study|Unacceptable toxicity|0|||
163234978|NCT00684424|589570899|FG000|Overall Study|Adverse Event|1|||
163234979|NCT00684424|589570899|FG000|Overall Study|Lost to Follow-up|2|||
163234980|NCT00684424|589570899|FG000|Overall Study|Other|2|||
163234981|NCT01649856|589570902|FG000|Overall Study|Withdrawal by Subject|14|||
163234982|NCT01649856|589570903|FG001|Overall Study|Withdrawal by Subject|14|||
163234983|NCT01649856|589570902|FG000|Overall Study|Protocol Violation|4|||
163234984|NCT01649856|589570903|FG001|Overall Study|Protocol Violation|4|||
163234985|NCT01649856|589570902|FG000|Overall Study|Treatment Failure|1|||
163234986|NCT01649856|589570903|FG001|Overall Study|Treatment Failure|1|||
163234987|NCT01649856|589570902|FG000|Overall Study|Death|69|||
163234988|NCT01649856|589570903|FG001|Overall Study|Death|34|||
163234989|NCT01649856|589570902|FG000|Overall Study|Stable or Progressed Disease|5|||
163234990|NCT01649856|589570903|FG001|Overall Study|Stable or Progressed Disease|3|||
163234991|NCT01649856|589570902|FG000|Overall Study|Lost to Follow-up|20|||
163234992|NCT01649856|589570903|FG001|Overall Study|Lost to Follow-up|16|||
163234993|NCT01649856|589570902|FG000|Overall Study|Lack of Compliance|6|||
163234994|NCT01649856|589570903|FG001|Overall Study|Lack of Compliance|1|||
163234995|NCT01649856|589570902|FG000|Overall Study|Other|20|||
163234996|NCT01649856|589570903|FG001|Overall Study|Other|5|||
163234997|NCT00835406|589570904|FG000|Period: First Intervention|Adverse Event|0|||
163234998|NCT00835406|589570905|FG001|Period: First Intervention|Adverse Event|1|||
163234999|NCT00835406|589570904|FG000|Period: First Intervention|Withdrawal by Subject|2|||
163235000|NCT00835406|589570905|FG001|Period: First Intervention|Withdrawal by Subject|0|||
163235001|NCT00835406|589570904|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
163235002|NCT00835406|589570905|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
163235003|NCT00281840|589570906|FG000|Overall Study|Adverse Event|12|||
163235004|NCT00281840|589570906|FG000|Overall Study|Physician Decision|6|||
163140859|NCT03761810|589224418|FG000|Overall Study|Adverse Event|12|||
163140860|NCT03761810|589224419|FG001|Overall Study|Adverse Event|0|||
163140861|NCT03761810|589224418|FG000|Overall Study|Lost to Follow-up|15|||
163140862|NCT03761810|589224419|FG001|Overall Study|Lost to Follow-up|7|||
163348193|NCT00187135|589983385|FG001|Visit One|Withdrawal by Subject|0|||
163348194|NCT00187135|589983386|FG002|Visit One|Withdrawal by Subject|0|||
163348195|NCT00187135|589983387|FG003|Visit One|Withdrawal by Subject|0|||
163348196|NCT00187135|589983388|FG004|Visit One|Withdrawal by Subject|0|||
163348197|NCT00187135|589983389|FG005|Visit One|Withdrawal by Subject|1|||
163348198|NCT00187135|589983384|FG000|Visit One|Physician Decision|3|||
163348199|NCT00187135|589983385|FG001|Visit One|Physician Decision|1|||
163348200|NCT00187135|589983386|FG002|Visit One|Physician Decision|0|||
163348201|NCT00187135|589983387|FG003|Visit One|Physician Decision|0|||
163348202|NCT00187135|589983388|FG004|Visit One|Physician Decision|0|||
163348203|NCT00187135|589983389|FG005|Visit One|Physician Decision|1|||
163348204|NCT00187135|589983384|FG000|Visit Two|Death|0|||
163348205|NCT00187135|589983385|FG001|Visit Two|Death|0|||
163348206|NCT00187135|589983386|FG002|Visit Two|Death|0|||
163348207|NCT00187135|589983387|FG003|Visit Two|Death|1|||
163348208|NCT00187135|589983388|FG004|Visit Two|Death|0|||
163348209|NCT00187135|589983389|FG005|Visit Two|Death|1|||
163348210|NCT00187135|589983384|FG000|Visit Two|Physician Decision|1|||
163348211|NCT00187135|589983385|FG001|Visit Two|Physician Decision|0|||
163348212|NCT00187135|589983386|FG002|Visit Two|Physician Decision|0|||
163348213|NCT00187135|589983387|FG003|Visit Two|Physician Decision|0|||
163348214|NCT00187135|589983388|FG004|Visit Two|Physician Decision|0|||
163348215|NCT00187135|589983389|FG005|Visit Two|Physician Decision|0|||
163348216|NCT00187135|589983384|FG000|Visit Two|Withdrawal by Subject|1|||
163348217|NCT00187135|589983385|FG001|Visit Two|Withdrawal by Subject|1|||
163348218|NCT00187135|589983386|FG002|Visit Two|Withdrawal by Subject|1|||
163348219|NCT00187135|589983387|FG003|Visit Two|Withdrawal by Subject|0|||
163348220|NCT00187135|589983388|FG004|Visit Two|Withdrawal by Subject|1|||
163348221|NCT00187135|589983389|FG005|Visit Two|Withdrawal by Subject|1|||
163348222|NCT00187135|589983384|FG000|Visit Two|Study Discontinued|3|||
163348223|NCT00187135|589983385|FG001|Visit Two|Study Discontinued|2|||
163348224|NCT00187135|589983386|FG002|Visit Two|Study Discontinued|1|||
163348225|NCT00187135|589983387|FG003|Visit Two|Study Discontinued|7|||
163348226|NCT00187135|589983388|FG004|Visit Two|Study Discontinued|5|||
163348227|NCT00187135|589983389|FG005|Visit Two|Study Discontinued|6|||
163348228|NCT00187135|589983384|FG000|Visit Three|Death|0|||
163348229|NCT00187135|589983385|FG001|Visit Three|Death|0|||
163348230|NCT00187135|589983386|FG002|Visit Three|Death|1|||
163348231|NCT00187135|589983387|FG003|Visit Three|Death|0|||
163348232|NCT00187135|589983388|FG004|Visit Three|Death|1|||
163348233|NCT00187135|589983389|FG005|Visit Three|Death|0|||
163348234|NCT00187135|589983384|FG000|Visit Three|Withdrawal by Subject|0|||
163348235|NCT00187135|589983385|FG001|Visit Three|Withdrawal by Subject|1|||
163348236|NCT00187135|589983386|FG002|Visit Three|Withdrawal by Subject|1|||
163348237|NCT00187135|589983387|FG003|Visit Three|Withdrawal by Subject|2|||
163348238|NCT00187135|589983388|FG004|Visit Three|Withdrawal by Subject|0|||
163348239|NCT00187135|589983389|FG005|Visit Three|Withdrawal by Subject|0|||
163348240|NCT00187135|589983384|FG000|Visit Three|Study Discontinued|7|||
163348241|NCT00187135|589983385|FG001|Visit Three|Study Discontinued|6|||
163348242|NCT00187135|589983386|FG002|Visit Three|Study Discontinued|7|||
163348243|NCT00187135|589983387|FG003|Visit Three|Study Discontinued|7|||
163348244|NCT00187135|589983388|FG004|Visit Three|Study Discontinued|7|||
163348245|NCT00187135|589983389|FG005|Visit Three|Study Discontinued|6|||
163348246|NCT01924806|589983394|FG000|Overall Study|Physician Decision|2|||
163348247|NCT01924806|589983395|FG001|Overall Study|Physician Decision|1|||
163140863|NCT03761810|589224418|FG000|Overall Study|Pregnancy|1|||
163140864|NCT03761810|589224419|FG001|Overall Study|Pregnancy|0|||
163348248|NCT01954771|589983396|FG000|Overall Study|Missing HbA1c of end-point|1|||
163348249|NCT01954771|589983397|FG001|Overall Study|Missing HbA1c of end-point|1|||
163348250|NCT01954771|589983398|FG002|Overall Study|Missing HbA1c of end-point|0|||
163348251|NCT01954771|589983396|FG000|Overall Study|Missing CGMS of end-point|1|||
163348252|NCT01954771|589983397|FG001|Overall Study|Missing CGMS of end-point|1|||
163348253|NCT01954771|589983398|FG002|Overall Study|Missing CGMS of end-point|0|||
163348254|NCT01954771|589983396|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
163348255|NCT01954771|589983397|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
163348256|NCT01954771|589983398|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
163348257|NCT02498418|589983402|FG000|Overall Study|Lack of Efficacy|0|||
163348258|NCT02498418|589983403|FG001|Overall Study|Lack of Efficacy|0|||
163348259|NCT02498418|589983404|FG002|Overall Study|Lack of Efficacy|1|||
163348260|NCT02498418|589983402|FG000|Overall Study|Withdrawal by Subject|2|||
163140865|NCT03761810|589224418|FG000|Overall Study|Withdrawal by Subject|14|||
163348261|NCT02498418|589983403|FG001|Overall Study|Withdrawal by Subject|0|||
163348262|NCT02498418|589983404|FG002|Overall Study|Withdrawal by Subject|3|||
163348263|NCT02498418|589983402|FG000|Overall Study|Lost to Follow-up|0|||
163348264|NCT02498418|589983403|FG001|Overall Study|Lost to Follow-up|1|||
163348265|NCT02498418|589983404|FG002|Overall Study|Lost to Follow-up|1|||
163348266|NCT02498418|589983402|FG000|Overall Study|Participant taken prohibited medication|0|||
163348267|NCT02498418|589983403|FG001|Overall Study|Participant taken prohibited medication|1|||
163140866|NCT03761810|589224419|FG001|Overall Study|Withdrawal by Subject|5|||
163140867|NCT03761810|589224418|FG000|Overall Study|Physician Decision|1|||
163140868|NCT03761810|589224419|FG001|Overall Study|Physician Decision|0|||
163140869|NCT03761810|589224418|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
163140870|NCT03761810|589224419|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163140871|NCT03761810|589224418|FG000|Overall Study|Other Than Specified|1|||
163140872|NCT03761810|589224419|FG001|Overall Study|Other Than Specified|0|||
163140873|NCT00869518|589224420|FG000|Overall Study|Lost to Follow-up|1|||
163140874|NCT00869518|589224421|FG001|Overall Study|Lost to Follow-up|1|||
163140875|NCT04178720|589224422|FG000|Overall Study|Withdrawal by Subject|2|||
163140876|NCT04178720|589224423|FG001|Overall Study|Withdrawal by Subject|0|||
163140877|NCT04178720|589224422|FG000|Overall Study|Relocation|0|||
163140878|NCT04178720|589224423|FG001|Overall Study|Relocation|1|||
163140879|NCT03922620|589224424|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
163140880|NCT03922620|589224425|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
163140881|NCT00511238|589224426|FG000|Overall Study|Adverse Event|13|||
163140882|NCT00511238|589224427|FG001|Overall Study|Adverse Event|33|||
163140883|NCT00511238|589224426|FG000|Overall Study|Withdrawal by Subject|2|||
163140884|NCT00511238|589224427|FG001|Overall Study|Withdrawal by Subject|22|||
163140885|NCT00511238|589224426|FG000|Overall Study|Progressive Disease|23|||
163140886|NCT00511238|589224427|FG001|Overall Study|Progressive Disease|157|||
163140887|NCT00511238|589224426|FG000|Overall Study|various reasons|4|||
163140888|NCT00511238|589224427|FG001|Overall Study|various reasons|14|||
163140889|NCT01633788|589226126|FG000|Overall Study|Adverse Event|1|||
163140890|NCT01633788|589226127|FG001|Overall Study|Adverse Event|3|||
163140891|NCT01633788|589226128|FG002|Overall Study|Adverse Event|3|||
163140892|NCT01633788|589226129|FG003|Overall Study|Adverse Event|3|||
163140893|NCT01633788|589226126|FG000|Overall Study|Lost to Follow-up|2|||
163140894|NCT01633788|589226127|FG001|Overall Study|Lost to Follow-up|2|||
163140895|NCT01633788|589226128|FG002|Overall Study|Lost to Follow-up|2|||
163140896|NCT01633788|589226129|FG003|Overall Study|Lost to Follow-up|0|||
163140897|NCT01633788|589226126|FG000|Overall Study|Personal Reasons|3|||
163140898|NCT01633788|589226127|FG001|Overall Study|Personal Reasons|1|||
163140899|NCT01633788|589226128|FG002|Overall Study|Personal Reasons|1|||
163140900|NCT01633788|589226129|FG003|Overall Study|Personal Reasons|3|||
163140901|NCT01633788|589226126|FG000|Overall Study|Protocol Violation|1|||
163140902|NCT01633788|589226127|FG001|Overall Study|Protocol Violation|0|||
163140903|NCT01633788|589226128|FG002|Overall Study|Protocol Violation|1|||
163140904|NCT01633788|589226129|FG003|Overall Study|Protocol Violation|0|||
163140905|NCT01633788|589226126|FG000|Overall Study|Other Reasons|0|||
163140906|NCT01633788|589226127|FG001|Overall Study|Other Reasons|2|||
163140907|NCT01633788|589226128|FG002|Overall Study|Other Reasons|3|||
163140908|NCT01633788|589226129|FG003|Overall Study|Other Reasons|7|||
163140909|NCT01389882|589226135|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
163140910|NCT01389882|589226136|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
163140911|NCT01389882|589226135|FG000|Overall Study|Withdrawal by Subject|0|||
163140912|NCT01389882|589226136|FG001|Overall Study|Withdrawal by Subject|1|||
163140913|NCT03811340|589226138|FG000|Overall Study|subjects did not complete the survey.|90|||
163140914|NCT01045967|589226139|FG000|Second Intervention|Protocol Violation|0|||
163140915|NCT01045967|589226140|FG001|Second Intervention|Protocol Violation|1|||
163140916|NCT00404651|589226142|FG000|Overall Study|Serious Adverse Event|0|||
163140917|NCT00404651|589226143|FG001|Overall Study|Serious Adverse Event|0|||
163140918|NCT00404651|589226144|FG002|Overall Study|Serious Adverse Event|2|||
163140919|NCT00404651|589226145|FG003|Overall Study|Serious Adverse Event|0|||
163140920|NCT00404651|589226142|FG000|Overall Study|Protocol Violation|10|||
163140921|NCT00404651|589226143|FG001|Overall Study|Protocol Violation|5|||
163140922|NCT00404651|589226144|FG002|Overall Study|Protocol Violation|14|||
163140923|NCT00404651|589226145|FG003|Overall Study|Protocol Violation|5|||
163140924|NCT00404651|589226142|FG000|Overall Study|Lost to Follow-up|15|||
163140925|NCT00404651|589226143|FG001|Overall Study|Lost to Follow-up|11|||
163140926|NCT00404651|589226144|FG002|Overall Study|Lost to Follow-up|13|||
163140927|NCT00404651|589226145|FG003|Overall Study|Lost to Follow-up|10|||
163140928|NCT00404651|589226142|FG000|Overall Study|Withdrawal by Subject|14|||
163140929|NCT00404651|589226143|FG001|Overall Study|Withdrawal by Subject|12|||
163140930|NCT00404651|589226144|FG002|Overall Study|Withdrawal by Subject|16|||
163140931|NCT00404651|589226145|FG003|Overall Study|Withdrawal by Subject|6|||
163140932|NCT02471014|589226158|FG000|Overall Study|Lost to Follow-up|2|||
163140933|NCT02471014|589226159|FG001|Overall Study|Lost to Follow-up|2|||
163140934|NCT02532465|589226169|FG000|Overall Study|Protocol Violation|1|||
163348268|NCT02498418|589983404|FG002|Overall Study|Participant taken prohibited medication|1|||
163348269|NCT03635775|589983406|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
163140935|NCT02532465|589226170|FG001|Overall Study|Protocol Violation|0|||
163140936|NCT02532465|589226169|FG000|Overall Study|Lack of Efficacy|0|||
163140937|NCT02532465|589226170|FG001|Overall Study|Lack of Efficacy|1|||
163140938|NCT02045095|589226178|FG000|Overall Study|Other|0|||
163140939|NCT02045095|589226179|FG001|Overall Study|Other|0|||
163348270|NCT03635775|589983407|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
163348271|NCT03635775|589983408|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
163348272|NCT03635775|589983409|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
163348273|NCT01026103|589983410|FG000|Overall Study|Physician Decision|1|||
163348274|NCT01026103|589983410|FG000|Overall Study|did not receive study device bc of error|1|||
163348275|NCT00762502|589983411|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
163348276|NCT00762502|589983412|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
163348277|NCT00762502|589983413|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
163348278|NCT00762502|589983411|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
163140940|NCT02045095|589226180|FG002|Overall Study|Other|1|||
163140941|NCT02045095|589226181|FG003|Overall Study|Other|0|||
163140942|NCT02045095|589226182|FG004|Overall Study|Other|0|||
163140943|NCT02045095|589226183|FG005|Overall Study|Other|2|||
163140944|NCT02045095|589226184|FG006|Overall Study|Other|0|||
163140945|NCT02045095|589226178|FG000|Overall Study|Progressive Disease|3|||
163140946|NCT02045095|589226179|FG001|Overall Study|Progressive Disease|3|||
163140947|NCT02045095|589226180|FG002|Overall Study|Progressive Disease|2|||
163140948|NCT02045095|589226181|FG003|Overall Study|Progressive Disease|4|||
163140949|NCT02045095|589226182|FG004|Overall Study|Progressive Disease|2|||
163140950|NCT02045095|589226183|FG005|Overall Study|Progressive Disease|4|||
163140951|NCT02045095|589226184|FG006|Overall Study|Progressive Disease|1|||
163140952|NCT02045095|589226178|FG000|Overall Study|Withdrawal by Subject|0|||
163140953|NCT02045095|589226179|FG001|Overall Study|Withdrawal by Subject|0|||
163140954|NCT02045095|589226180|FG002|Overall Study|Withdrawal by Subject|0|||
163140955|NCT02045095|589226181|FG003|Overall Study|Withdrawal by Subject|0|||
163140956|NCT02045095|589226182|FG004|Overall Study|Withdrawal by Subject|3|||
163140957|NCT02045095|589226183|FG005|Overall Study|Withdrawal by Subject|0|||
163140958|NCT02045095|589226184|FG006|Overall Study|Withdrawal by Subject|0|||
163140959|NCT02045095|589226178|FG000|Overall Study|Adverse Event|0|||
163140960|NCT02045095|589226179|FG001|Overall Study|Adverse Event|1|||
163140961|NCT02045095|589226180|FG002|Overall Study|Adverse Event|1|||
163140962|NCT02045095|589226181|FG003|Overall Study|Adverse Event|0|||
163140963|NCT02045095|589226182|FG004|Overall Study|Adverse Event|0|||
163140964|NCT02045095|589226183|FG005|Overall Study|Adverse Event|2|||
163140965|NCT02045095|589226184|FG006|Overall Study|Adverse Event|0|||
163140966|NCT01450761|589226187|FG000|Randomization|Subject no longer meets study criteria|1|||
163140967|NCT01450761|589226188|FG001|Randomization|Subject no longer meets study criteria|2|||
163140968|NCT01450761|589226187|FG000|Randomization|Withdrawal by Subject|2|||
163140969|NCT01450761|589226188|FG001|Randomization|Withdrawal by Subject|0|||
163140970|NCT01450761|589226187|FG000|Randomization|Disease progression|0|||
163140971|NCT01450761|589226188|FG001|Randomization|Disease progression|2|||
163140972|NCT01450761|589226187|FG000|Randomization|Adverse Event unrelated to study drug|1|||
163140973|NCT01450761|589226188|FG001|Randomization|Adverse Event unrelated to study drug|0|||
163140974|NCT01450761|589226187|FG000|Randomization|Other|0|||
163140975|NCT01450761|589226188|FG001|Randomization|Other|1|||
163140976|NCT01450761|589226187|FG000|Lead-in Chemotherapy|Disease progression|33|||
163140977|NCT01450761|589226188|FG001|Lead-in Chemotherapy|Disease progression|32|||
163140978|NCT01450761|589226187|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
163140979|NCT01450761|589226188|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
163140980|NCT01450761|589226187|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
163140981|NCT01450761|589226188|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
163140982|NCT01450761|589226187|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
163140983|NCT01450761|589226188|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
163140984|NCT01450761|589226187|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
163140985|NCT01450761|589226188|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
163140986|NCT01450761|589226187|FG000|Lead-in Chemotherapy|Death|3|||
163140987|NCT01450761|589226188|FG001|Lead-in Chemotherapy|Death|3|||
163140988|NCT01450761|589226187|FG000|Lead-in Chemotherapy|Other|2|||
163140989|NCT01450761|589226188|FG001|Lead-in Chemotherapy|Other|2|||
163140990|NCT01450761|589226187|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
163140991|NCT01450761|589226188|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
163140992|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
163140993|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
163140994|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
163140995|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
163140996|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
163140997|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
163140998|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
163140999|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
163141000|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
163141001|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
163141002|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Death|5|||
163141003|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Death|6|||
163141004|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
163141005|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
163141006|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
163141007|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
163141008|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
163141009|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
163141010|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
163141011|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
163141012|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
163141013|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
163141014|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
163141015|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
163141016|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
163141017|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
163141018|NCT01818596|589226189|FG000|Overall Study|Enrolled but Not Treated|4|||
163141019|NCT01818596|589226190|FG001|Overall Study|Enrolled but Not Treated|0|||
163141020|NCT01818596|589226189|FG000|Overall Study|Adverse Event|7|||
163141021|NCT01818596|589226190|FG001|Overall Study|Adverse Event|0|||
163141022|NCT01818596|589226189|FG000|Overall Study|Death|3|||
163141023|NCT01818596|589226190|FG001|Overall Study|Death|0|||
163141024|NCT01818596|589226189|FG000|Overall Study|Investigator's Discretion|4|||
163141025|NCT01818596|589226190|FG001|Overall Study|Investigator's Discretion|0|||
163141026|NCT01818596|589226189|FG000|Overall Study|Protocol Violation|1|||
163141027|NCT01818596|589226190|FG001|Overall Study|Protocol Violation|0|||
163141028|NCT01818596|589226189|FG000|Overall Study|Withdrew Consent|5|||
163141029|NCT01818596|589226190|FG001|Overall Study|Withdrew Consent|0|||
163141030|NCT01818596|589226189|FG000|Overall Study|Lost to Follow-up|7|||
163141031|NCT01818596|589226190|FG001|Overall Study|Lost to Follow-up|0|||
163141032|NCT03801174|589226191|FG000|Overall Study|Withdrawal by Subject|14|||
163141033|NCT03801174|589226192|FG001|Overall Study|Withdrawal by Subject|15|||
163141034|NCT03801174|589226191|FG000|Overall Study|Death|1|||
163141035|NCT03801174|589226192|FG001|Overall Study|Death|0|||
163141036|NCT03801174|589226191|FG000|Overall Study|Pregnancy|2|||
163141037|NCT03801174|589226192|FG001|Overall Study|Pregnancy|2|||
163141038|NCT03801174|589226191|FG000|Overall Study|Lost to Follow-up|19|||
163141039|NCT03801174|589226192|FG001|Overall Study|Lost to Follow-up|10|||
163141040|NCT03801174|589226191|FG000|Overall Study|Other|4|||
163141041|NCT03801174|589226192|FG001|Overall Study|Other|3|||
163141042|NCT03801174|589226191|FG000|Overall Study|Lack of Efficacy|4|||
163141043|NCT03801174|589226192|FG001|Overall Study|Lack of Efficacy|0|||
163141044|NCT03801174|589226191|FG000|Overall Study|Unwilling to complete activities|5|||
163141045|NCT03801174|589226192|FG001|Overall Study|Unwilling to complete activities|6|||
163141046|NCT03801174|589226191|FG000|Overall Study|Moved out of area|3|||
163141047|NCT03801174|589226192|FG001|Overall Study|Moved out of area|0|||
163141048|NCT04112810|589226193|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
163141049|NCT01539759|589226195|FG000|Overall Study|Lost to Follow-up|6|||
163141050|NCT01539759|589226196|FG001|Overall Study|Lost to Follow-up|8|||
163141051|NCT01076959|589226197|FG000|Overall Study|Adverse Event|767|||
163141052|NCT01076959|589226197|FG000|Overall Study|Lack of Efficacy|849|||
163141053|NCT01076959|589226197|FG000|Overall Study|Non-compliance|274|||
163141054|NCT01076959|589226197|FG000|Overall Study|Lost to Follow-up|241|||
163141055|NCT01076959|589226197|FG000|Overall Study|Other|119|||
163141056|NCT04170543|589226201|FG000|Overall Study|Death|1|||
163141057|NCT04170543|589226202|FG001|Overall Study|Death|1|||
163141058|NCT04170543|589226203|FG002|Overall Study|Death|1|||
163141059|NCT04170543|589226204|FG003|Overall Study|Death|1|||
163141060|NCT04170543|589226205|FG004|Overall Study|Death|1|||
163141061|NCT04170543|589226201|FG000|Overall Study|Lost to Follow-up|3|||
163141062|NCT04170543|589226202|FG001|Overall Study|Lost to Follow-up|3|||
163141063|NCT04170543|589226203|FG002|Overall Study|Lost to Follow-up|0|||
163141064|NCT04170543|589226204|FG003|Overall Study|Lost to Follow-up|3|||
163141065|NCT04170543|589226205|FG004|Overall Study|Lost to Follow-up|1|||
163141066|NCT04170543|589226201|FG000|Overall Study|Withdrawal by Subject|13|||
163141067|NCT04170543|589226202|FG001|Overall Study|Withdrawal by Subject|6|||
163141068|NCT04170543|589226203|FG002|Overall Study|Withdrawal by Subject|5|||
163141069|NCT04170543|589226204|FG003|Overall Study|Withdrawal by Subject|4|||
163141070|NCT04170543|589226205|FG004|Overall Study|Withdrawal by Subject|9|||
163141071|NCT04170543|589226201|FG000|Overall Study|Not able to transition to phase 2b|8|||
163141072|NCT04170543|589226202|FG001|Overall Study|Not able to transition to phase 2b|0|||
163141073|NCT04170543|589226203|FG002|Overall Study|Not able to transition to phase 2b|10|||
163141074|NCT04170543|589226204|FG003|Overall Study|Not able to transition to phase 2b|0|||
163141075|NCT04170543|589226205|FG004|Overall Study|Not able to transition to phase 2b|6|||
163141076|NCT04170543|589226201|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
163141077|NCT04170543|589226202|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
163141078|NCT04170543|589226203|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
163348279|NCT00762502|589983412|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
163348280|NCT00762502|589983413|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
163348281|NCT00762502|589983411|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
163348282|NCT00762502|589983412|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
163348283|NCT00762502|589983413|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
163348284|NCT01675050|589983418|FG000|Period One Treatment|Withdrawal by Subject|1|||
163348285|NCT01675050|589983419|FG001|Period One Treatment|Withdrawal by Subject|0|||
163348286|NCT00745121|589983420|FG000|Overall Study|Death|3|||
163348287|NCT00745121|589983421|FG001|Overall Study|Death|0|||
163348288|NCT00745121|589983420|FG000|Overall Study|Adverse Event|1|||
163348289|NCT00745121|589983421|FG001|Overall Study|Adverse Event|0|||
163348290|NCT00745121|589983420|FG000|Overall Study|Lost to Follow-up|1|||
163348291|NCT00745121|589983421|FG001|Overall Study|Lost to Follow-up|0|||
163348292|NCT00745121|589983420|FG000|Overall Study|Withdrawal by Subject|4|||
163348293|NCT00745121|589983421|FG001|Overall Study|Withdrawal by Subject|2|||
163348294|NCT03280108|589983425|FG000|Overall Study|Lost to Follow-up|2|||
163348295|NCT03280108|589983426|FG001|Overall Study|Lost to Follow-up|0|||
163348296|NCT02996097|589983427|FG000|Overall Study|Lost to Follow-up|11|||
163348297|NCT02996097|589983428|FG001|Overall Study|Lost to Follow-up|11|||
163348298|NCT01820637|589983429|FG000|Overall Study|Death|2|||
163348299|NCT01820637|589983429|FG000|Overall Study|Withdrawal by Subject|1|||
163348300|NCT00264498|589983430|FG000|Randomized Treatment|Death|0|||
163348301|NCT00264498|589983431|FG001|Randomized Treatment|Death|3|||
163348302|NCT00264498|589983430|FG000|Randomized Treatment|Withdrawal by Subject|0|||
163348303|NCT00264498|589983431|FG001|Randomized Treatment|Withdrawal by Subject|1|||
163348304|NCT00264498|589983430|FG000|Randomized Treatment|Objective disease Progression|13|||
163348305|NCT00264498|589983431|FG001|Randomized Treatment|Objective disease Progression|14|||
163348306|NCT00264498|589983430|FG000|Randomized Treatment|Physician Decision|1|||
163348307|NCT00264498|589983431|FG001|Randomized Treatment|Physician Decision|0|||
163348308|NCT00264498|589983430|FG000|Randomized Treatment|Incorrectly randomized|1|||
163348309|NCT00264498|589983431|FG001|Randomized Treatment|Incorrectly randomized|0|||
163348310|NCT00264498|589983430|FG000|Randomized Treatment|Study Closure|1|||
163348311|NCT00264498|589983431|FG001|Randomized Treatment|Study Closure|0|||
163348312|NCT00264498|589983430|FG000|Randomized Treatment|Protocol Violation|1|||
163348313|NCT00264498|589983431|FG001|Randomized Treatment|Protocol Violation|0|||
163348314|NCT00264498|589983430|FG000|Crossover Treatment|Death|1|||
163348315|NCT00264498|589983431|FG001|Crossover Treatment|Death|3|||
163348316|NCT00264498|589983430|FG000|Crossover Treatment|Objective disease progression|4|||
163348317|NCT00264498|589983431|FG001|Crossover Treatment|Objective disease progression|5|||
163348318|NCT00264498|589983430|FG000|Crossover Treatment|Study closure|0|||
163348319|NCT00264498|589983431|FG001|Crossover Treatment|Study closure|1|||
163348320|NCT00264498|589983430|FG000|Crossover Treatment|Withdrawal by Subject|1|||
163348321|NCT00264498|589983431|FG001|Crossover Treatment|Withdrawal by Subject|0|||
163348322|NCT03794609|589983432|FG000|Overall Study|Other|10|||
163348323|NCT03794609|589983432|FG000|Overall Study|Withdrawal by Subject|66|||
163348324|NCT03794609|589983432|FG000|Overall Study|The child is enrolled in an interventional study|70|||
163348325|NCT03794609|589983432|FG000|Overall Study|Inclusion/exclusion criteria|8|||
163348326|NCT03794609|589983432|FG000|Overall Study|At sponsor's request|151|||
163348327|NCT03794609|589983432|FG000|Overall Study|Physician Decision|1|||
163348328|NCT03794609|589983432|FG000|Overall Study|Lost to Follow-up|5|||
163348329|NCT03638258|589983433|FG000|Overall Study|Adverse Event|1|||
163348330|NCT03638258|589983434|FG001|Overall Study|Adverse Event|0|||
163348331|NCT03638258|589983435|FG002|Overall Study|Adverse Event|2|||
163348332|NCT03638258|589983433|FG000|Overall Study|Lost to Follow-up|2|||
163348333|NCT03638258|589983434|FG001|Overall Study|Lost to Follow-up|4|||
163348334|NCT03638258|589983435|FG002|Overall Study|Lost to Follow-up|5|||
163348335|NCT03638258|589983433|FG000|Overall Study|Pregnancy|0|||
163348336|NCT03638258|589983434|FG001|Overall Study|Pregnancy|0|||
163348337|NCT03638258|589983435|FG002|Overall Study|Pregnancy|1|||
163348338|NCT03638258|589983433|FG000|Overall Study|Protocol Violation|0|||
163348339|NCT03638258|589983434|FG001|Overall Study|Protocol Violation|0|||
163348340|NCT03638258|589983435|FG002|Overall Study|Protocol Violation|1|||
163348341|NCT03638258|589983433|FG000|Overall Study|Withdrawal by Subject|4|||
163348342|NCT03638258|589983434|FG001|Overall Study|Withdrawal by Subject|5|||
163348343|NCT03638258|589983435|FG002|Overall Study|Withdrawal by Subject|12|||
163348344|NCT03638258|589983433|FG000|Overall Study|Lack of Efficacy|0|||
163348345|NCT03638258|589983434|FG001|Overall Study|Lack of Efficacy|0|||
163348346|NCT03638258|589983435|FG002|Overall Study|Lack of Efficacy|2|||
163348347|NCT04543942|589983436|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
163348348|NCT04543942|589983437|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
163348349|NCT04543942|589983436|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
163348350|NCT04543942|589983437|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
163348351|NCT02205476|589983438|FG000|Overall Study|Study termination by Sponsor|7|||
163348352|NCT02205476|589983439|FG001|Overall Study|Study termination by Sponsor|3|||
163348353|NCT01313299|589983450|FG000|Overall Study|Adverse Event|3|||
163348354|NCT01313299|589983451|FG001|Overall Study|Adverse Event|1|||
163348355|NCT01313299|589983452|FG002|Overall Study|Adverse Event|1|||
163409465|NCT05048719|590209392|FG002|Overall Study|Death|0|||
163409466|NCT05048719|590209393|FG003|Overall Study|Death|0|||
163409467|NCT05048719|590209394|FG004|Overall Study|Death|0|||
163409468|NCT05048719|590209395|FG005|Overall Study|Death|0|||
163141079|NCT04170543|589226204|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
163348356|NCT01313299|589983450|FG000|Overall Study|Lost to Follow-up|1|||
163348357|NCT01313299|589983451|FG001|Overall Study|Lost to Follow-up|0|||
163348358|NCT01313299|589983452|FG002|Overall Study|Lost to Follow-up|0|||
163348359|NCT01313299|589983450|FG000|Overall Study|Protocol Violation|2|||
163348360|NCT01313299|589983451|FG001|Overall Study|Protocol Violation|0|||
163348361|NCT01313299|589983452|FG002|Overall Study|Protocol Violation|0|||
163348362|NCT01313299|589983450|FG000|Overall Study|Withdrawal by Subject|1|||
163348363|NCT01313299|589983451|FG001|Overall Study|Withdrawal by Subject|0|||
163348364|NCT01313299|589983452|FG002|Overall Study|Withdrawal by Subject|2|||
163348365|NCT01313299|589983450|FG000|Overall Study|Family reason and moved out of state|0|||
163348366|NCT01313299|589983451|FG001|Overall Study|Family reason and moved out of state|2|||
163348367|NCT01313299|589983452|FG002|Overall Study|Family reason and moved out of state|0|||
163348368|NCT01313299|589983450|FG000|Overall Study|Lack of subject compliance|0|||
163348369|NCT01313299|589983451|FG001|Overall Study|Lack of subject compliance|0|||
163348370|NCT01313299|589983452|FG002|Overall Study|Lack of subject compliance|1|||
163348371|NCT02506881|589983453|FG000|First Intervention (Day 1)|Protocol Violation|0|||
163348372|NCT02506881|589983454|FG001|First Intervention (Day 1)|Protocol Violation|0|||
163348373|NCT02506881|589983455|FG002|First Intervention (Day 1)|Protocol Violation|1|||
163348374|NCT02506881|589983456|FG003|First Intervention (Day 1)|Protocol Violation|0|||
163348375|NCT02506881|589983453|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
163348376|NCT02506881|589983454|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
163348377|NCT02506881|589983455|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
163348378|NCT02506881|589983456|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
163348379|NCT02506881|589983453|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
163348380|NCT02506881|589983454|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
163348381|NCT02506881|589983455|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
163348382|NCT02506881|589983456|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
163348383|NCT01919398|589983457|FG000|Overall Study|Progressive Disease|0|||
163348384|NCT01919398|589983458|FG001|Overall Study|Progressive Disease|0|||
163348385|NCT01919398|589983459|FG002|Overall Study|Progressive Disease|4|||
163348386|NCT02391545|589983465|FG000|Overall Study|Death|0|||
163348387|NCT02391545|589983466|FG001|Overall Study|Death|2|||
163348388|NCT02391545|589983465|FG000|Overall Study|Lost to Follow-up|0|||
163348389|NCT02391545|589983466|FG001|Overall Study|Lost to Follow-up|1|||
163348390|NCT02391545|589983465|FG000|Overall Study|Termination of study by sponsor|20|||
163348391|NCT02391545|589983466|FG001|Overall Study|Termination of study by sponsor|20|||
163348392|NCT02391545|589983465|FG000|Overall Study|Withdrawal by Subject|0|||
163348393|NCT02391545|589983466|FG001|Overall Study|Withdrawal by Subject|1|||
163409469|NCT05048719|590209396|FG006|Overall Study|Death|0|||
163141080|NCT04170543|589226205|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
163141081|NCT04170543|589226201|FG000|Overall Study|Not Treated|0|||
163141082|NCT04170543|589226202|FG001|Overall Study|Not Treated|0|||
163141083|NCT04170543|589226203|FG002|Overall Study|Not Treated|0|||
163141084|NCT04170543|589226204|FG003|Overall Study|Not Treated|0|||
163141085|NCT04170543|589226205|FG004|Overall Study|Not Treated|2|||
163141086|NCT04170543|589226201|FG000|Overall Study|(CRF)|16|||
163141087|NCT04170543|589226202|FG001|Overall Study|(CRF)|15|||
163141088|NCT04170543|589226203|FG002|Overall Study|(CRF)|12|||
163141089|NCT04170543|589226204|FG003|Overall Study|(CRF)|17|||
163141090|NCT04170543|589226205|FG004|Overall Study|(CRF)|17|||
163141091|NCT04170543|589226201|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
163141092|NCT04170543|589226202|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
163141093|NCT04170543|589226203|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
163141094|NCT04170543|589226204|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
163141095|NCT04170543|589226205|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
163141096|NCT00770601|589226206|FG000|Overall Study|Withdrawal by Subject|1|||
163141097|NCT01987102|589226207|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
163141098|NCT01987102|589226208|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
163348394|NCT02391545|589983465|FG000|Overall Study|Other Reasons|6|||
163348395|NCT02391545|589983466|FG001|Overall Study|Other Reasons|4|||
163348396|NCT02016690|589983467|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
163141099|NCT01987102|589226207|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
163141100|NCT01987102|589226208|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
163348397|NCT02016690|589983467|FG000|Overall Study|Excluded from SAS: Duplication|2|||
163348398|NCT02016690|589983467|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
163348399|NCT02016690|589983467|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
163348400|NCT02016690|589983467|FG000|Overall Study|Did not meet inclusion criteria|13|||
163348401|NCT02016690|589983467|FG000|Overall Study|Hospitalized for RSV at study start|3|||
163409470|NCT05048719|590209397|FG007|Overall Study|Death|0|||
163409471|NCT05048719|590209398|FG008|Overall Study|Death|0|||
163409472|NCT05048719|590209390|FG000|Overall Study|Adverse Event|0|||
163348402|NCT01222078|589983468|FG000|Overall Study|Early termination of the study|1|||
163348403|NCT04089332|589983469|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
163348404|NCT04089332|589983469|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
163348405|NCT04089332|589983469|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
163348406|NCT02588027|589983478|FG000|Overall Study|Withdrawal by Subject|1|||
163348407|NCT02588027|589983479|FG001|Overall Study|Withdrawal by Subject|3|||
163348408|NCT02588027|589983478|FG000|Overall Study|Protocol Violation|4|||
163348409|NCT02588027|589983479|FG001|Overall Study|Protocol Violation|1|||
163348410|NCT00603278|589983483|FG000|Overall Study|Lack of Efficacy|35|||
163348411|NCT00603278|589983484|FG001|Overall Study|Lack of Efficacy|10|||
163141101|NCT01987102|589226207|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
163141102|NCT01987102|589226208|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
163141103|NCT01987102|589226207|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
163141104|NCT01987102|589226208|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
163141105|NCT01987102|589226207|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
163141106|NCT01987102|589226208|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
163141107|NCT01987102|589226207|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
163141108|NCT01987102|589226208|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
163141109|NCT04378270|589226211|FG000|Overall Study|Lack of Efficacy|1|||
163141110|NCT04378270|589226211|FG000|Overall Study|Withdrawal by Subject|1|||
163141111|NCT04378270|589226211|FG000|Overall Study|Screen Failure|1|||
163141112|NCT04378270|589226211|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
163141113|NCT01327599|589226212|FG000|Overall Study|Adverse Event|1|||
163141114|NCT01327599|589226212|FG000|Overall Study|Could Not Attend Visit|1|||
163141115|NCT01327599|589226212|FG000|Overall Study|Withdrawal of Consent|1|||
163141116|NCT01236521|589226213|FG000|Overall Study|Withdrawal by Subject|12|||
163141117|NCT01236521|589226214|FG001|Overall Study|Withdrawal by Subject|17|||
163141118|NCT01236521|589226213|FG000|Overall Study|Death|2|||
163141119|NCT01236521|589226214|FG001|Overall Study|Death|1|||
163141120|NCT01236521|589226213|FG000|Overall Study|Lost to Follow-up|9|||
163141121|NCT01236521|589226214|FG001|Overall Study|Lost to Follow-up|7|||
163141122|NCT03201419|589226220|FG000|Overall Study|Adverse Event|3|||
163141123|NCT03201419|589226221|FG001|Overall Study|Adverse Event|1|||
163141124|NCT03201419|589226222|FG002|Overall Study|Adverse Event|0|||
163141125|NCT03201419|589226223|FG003|Overall Study|Adverse Event|0|||
163141126|NCT03201419|589226224|FG004|Overall Study|Adverse Event|1|||
163141127|NCT03201419|589226225|FG005|Overall Study|Adverse Event|1|||
163141128|NCT03201419|589226226|FG006|Overall Study|Adverse Event|5|||
163141129|NCT03201419|589226227|FG007|Overall Study|Adverse Event|0|||
163141130|NCT03201419|589226228|FG008|Overall Study|Adverse Event|0|||
163141131|NCT03201419|589226220|FG000|Overall Study|Lost to Follow-up|1|||
163141132|NCT03201419|589226221|FG001|Overall Study|Lost to Follow-up|0|||
163141133|NCT03201419|589226222|FG002|Overall Study|Lost to Follow-up|0|||
163141134|NCT03201419|589226223|FG003|Overall Study|Lost to Follow-up|0|||
163141135|NCT03201419|589226224|FG004|Overall Study|Lost to Follow-up|0|||
163141136|NCT03201419|589226225|FG005|Overall Study|Lost to Follow-up|0|||
163141137|NCT03201419|589226226|FG006|Overall Study|Lost to Follow-up|0|||
163141138|NCT03201419|589226227|FG007|Overall Study|Lost to Follow-up|0|||
163141139|NCT03201419|589226228|FG008|Overall Study|Lost to Follow-up|0|||
163141140|NCT03201419|589226220|FG000|Overall Study|Protocol Deviation|0|||
163141141|NCT03201419|589226221|FG001|Overall Study|Protocol Deviation|0|||
163141142|NCT03201419|589226222|FG002|Overall Study|Protocol Deviation|0|||
163141143|NCT03201419|589226223|FG003|Overall Study|Protocol Deviation|0|||
163141144|NCT03201419|589226224|FG004|Overall Study|Protocol Deviation|0|||
163141145|NCT03201419|589226225|FG005|Overall Study|Protocol Deviation|0|||
163141146|NCT03201419|589226226|FG006|Overall Study|Protocol Deviation|1|||
163141147|NCT03201419|589226227|FG007|Overall Study|Protocol Deviation|0|||
163141148|NCT03201419|589226228|FG008|Overall Study|Protocol Deviation|0|||
163141149|NCT03201419|589226220|FG000|Overall Study|Withdrawal by Subject|4|||
163141150|NCT03201419|589226221|FG001|Overall Study|Withdrawal by Subject|2|||
163141151|NCT03201419|589226222|FG002|Overall Study|Withdrawal by Subject|1|||
163141152|NCT03201419|589226223|FG003|Overall Study|Withdrawal by Subject|0|||
163141153|NCT03201419|589226224|FG004|Overall Study|Withdrawal by Subject|0|||
163141154|NCT03201419|589226225|FG005|Overall Study|Withdrawal by Subject|0|||
163141155|NCT03201419|589226226|FG006|Overall Study|Withdrawal by Subject|0|||
163141156|NCT03201419|589226227|FG007|Overall Study|Withdrawal by Subject|1|||
163348412|NCT00603278|589983485|FG002|Overall Study|Lack of Efficacy|11|||
163141157|NCT03201419|589226228|FG008|Overall Study|Withdrawal by Subject|2|||
163141158|NCT03201419|589226220|FG000|Overall Study|Other|0|||
163141159|NCT03201419|589226221|FG001|Overall Study|Other|0|||
163141160|NCT03201419|589226222|FG002|Overall Study|Other|1|||
163141161|NCT03201419|589226223|FG003|Overall Study|Other|0|||
163348413|NCT00603278|589983486|FG003|Overall Study|Lack of Efficacy|8|||
163141162|NCT03201419|589226224|FG004|Overall Study|Other|0|||
163141163|NCT03201419|589226225|FG005|Overall Study|Other|0|||
163141164|NCT03201419|589226226|FG006|Overall Study|Other|0|||
163141165|NCT03201419|589226227|FG007|Overall Study|Other|0|||
163348414|NCT00603278|589983487|FG004|Overall Study|Lack of Efficacy|7|||
163235005|NCT00281840|589570906|FG000|Overall Study|Withdrawal by Subject|3|||
163235006|NCT00281840|589570906|FG000|Overall Study|Disease Progression|2|||
163235007|NCT00281840|589570906|FG000|Overall Study|exceed maximum delay in treatment|1|||
163235008|NCT00281840|589570906|FG000|Overall Study|Complicating Disease|1|||
163235009|NCT01079234|589570909|FG000|Main: Week 0 to 26|Adverse Event|5|||
163235010|NCT01079234|589570910|FG001|Main: Week 0 to 26|Adverse Event|4|||
163235011|NCT01079234|589570911|FG002|Main: Week 0 to 26|Adverse Event|1|||
163235012|NCT01079234|589570912|FG003|Main: Week 0 to 26|Adverse Event|0|||
163235013|NCT01079234|589570909|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
163235014|NCT01079234|589570910|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
163235015|NCT01079234|589570911|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
163235016|NCT01079234|589570912|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
163235017|NCT01079234|589570909|FG000|Main: Week 0 to 26|Protocol Violation|6|||
163235018|NCT01079234|589570910|FG001|Main: Week 0 to 26|Protocol Violation|2|||
163235019|NCT01079234|589570911|FG002|Main: Week 0 to 26|Protocol Violation|4|||
163235020|NCT01079234|589570912|FG003|Main: Week 0 to 26|Protocol Violation|0|||
163235021|NCT01079234|589570909|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
163235022|NCT01079234|589570910|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
163235023|NCT01079234|589570911|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
163235024|NCT01079234|589570912|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
163235025|NCT01079234|589570909|FG000|Main: Week 0 to 26|Unclassified|7|||
163235026|NCT01079234|589570910|FG001|Main: Week 0 to 26|Unclassified|13|||
163235027|NCT01079234|589570911|FG002|Main: Week 0 to 26|Unclassified|4|||
163235028|NCT01079234|589570912|FG003|Main: Week 0 to 26|Unclassified|0|||
163235029|NCT01079234|589570909|FG000|Extension: Week 27 to 52|Adverse Event|0|||
163235030|NCT01079234|589570910|FG001|Extension: Week 27 to 52|Adverse Event|0|||
163235031|NCT01079234|589570911|FG002|Extension: Week 27 to 52|Adverse Event|1|||
163235032|NCT01079234|589570912|FG003|Extension: Week 27 to 52|Adverse Event|0|||
163235033|NCT01079234|589570909|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
163235034|NCT01079234|589570910|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
163235035|NCT01079234|589570911|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
163235036|NCT01079234|589570912|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
163235037|NCT01079234|589570909|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
163235038|NCT01079234|589570910|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
163235039|NCT01079234|589570911|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
163235040|NCT01079234|589570912|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
163235041|NCT01079234|589570909|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
163235042|NCT01079234|589570910|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
163235043|NCT01079234|589570911|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
163235044|NCT01079234|589570912|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
163235045|NCT01079234|589570909|FG000|Extension: Week 27 to 52|Unclassified|0|||
163235046|NCT01079234|589570910|FG001|Extension: Week 27 to 52|Unclassified|0|||
163235047|NCT01079234|589570911|FG002|Extension: Week 27 to 52|Unclassified|4|||
163235048|NCT01079234|589570912|FG003|Extension: Week 27 to 52|Unclassified|7|||
163235049|NCT01071512|589570917|FG000|Overall Study|Adverse Event|1|||
163235050|NCT01071512|589570917|FG000|Overall Study|Development of antibodies to drug|2|||
163235051|NCT01071512|589570917|FG000|Overall Study|positive anti-JC virus antibody test|2|||
163235052|NCT00183872|589570918|FG000|Overall Study|Death|3|||
163235053|NCT00183872|589570918|FG000|Overall Study|Adverse Event|9|||
163235054|NCT00183872|589570918|FG000|Overall Study|Withdrawal by Subject|2|||
163235055|NCT00183872|589570918|FG000|Overall Study|Drug delayed more than 28 days|2|||
163235056|NCT00853658|589570920|FG000|Overall Study|Death|713|||
163235057|NCT00853658|589570921|FG001|Overall Study|Death|768|||
163235058|NCT00853658|589570922|FG002|Overall Study|Death|753|||
163235059|NCT00853658|589570920|FG000|Overall Study|Lost to Follow-up|11|||
163235060|NCT00853658|589570921|FG001|Overall Study|Lost to Follow-up|6|||
163235061|NCT00853658|589570922|FG002|Overall Study|Lost to Follow-up|11|||
163235062|NCT00853658|589570920|FG000|Overall Study|H.A. Request|26|||
163235063|NCT00853658|589570921|FG001|Overall Study|H.A. Request|23|||
163235064|NCT00853658|589570922|FG002|Overall Study|H.A. Request|19|||
163235065|NCT00853658|589570920|FG000|Overall Study|IRB request|0|||
163235066|NCT00853658|589570921|FG001|Overall Study|IRB request|0|||
163235067|NCT00853658|589570922|FG002|Overall Study|IRB request|2|||
163348415|NCT00603278|589983488|FG005|Overall Study|Lack of Efficacy|14|||
163348416|NCT00603278|589983483|FG000|Overall Study|Adverse Event|0|||
163348417|NCT00603278|589983484|FG001|Overall Study|Adverse Event|3|||
163235068|NCT00853658|589570920|FG000|Overall Study|Vital Status known (alive) at study end|2|||
163235069|NCT00853658|589570921|FG001|Overall Study|Vital Status known (alive) at study end|3|||
163235070|NCT00853658|589570922|FG002|Overall Study|Vital Status known (alive) at study end|3|||
163348418|NCT00603278|589983485|FG002|Overall Study|Adverse Event|1|||
163348419|NCT00603278|589983486|FG003|Overall Study|Adverse Event|0|||
163348420|NCT00603278|589983487|FG004|Overall Study|Adverse Event|2|||
163235071|NCT00853658|589570920|FG000|Overall Study|Vital Status unknown at study end|1|||
163235072|NCT00853658|589570921|FG001|Overall Study|Vital Status unknown at study end|1|||
163235073|NCT00853658|589570922|FG002|Overall Study|Vital Status unknown at study end|0|||
163235074|NCT00853658|589570920|FG000|Overall Study|Vital Status at study end N/A|8|||
163409473|NCT05048719|590209391|FG001|Overall Study|Adverse Event|1|||
163409474|NCT05048719|590209392|FG002|Overall Study|Adverse Event|2|||
163409475|NCT05048719|590209393|FG003|Overall Study|Adverse Event|0|||
163409476|NCT05048719|590209394|FG004|Overall Study|Adverse Event|1|||
163409477|NCT05048719|590209395|FG005|Overall Study|Adverse Event|0|||
163409478|NCT05048719|590209396|FG006|Overall Study|Adverse Event|0|||
163409479|NCT05048719|590209397|FG007|Overall Study|Adverse Event|0|||
163409480|NCT05048719|590209398|FG008|Overall Study|Adverse Event|0|||
163409481|NCT05048719|590209390|FG000|Overall Study|Lost to Follow-up|0|||
163409482|NCT05048719|590209391|FG001|Overall Study|Lost to Follow-up|0|||
163409483|NCT05048719|590209392|FG002|Overall Study|Lost to Follow-up|1|||
163409484|NCT05048719|590209393|FG003|Overall Study|Lost to Follow-up|3|||
163409485|NCT05048719|590209394|FG004|Overall Study|Lost to Follow-up|1|||
163409486|NCT05048719|590209395|FG005|Overall Study|Lost to Follow-up|1|||
163409487|NCT05048719|590209396|FG006|Overall Study|Lost to Follow-up|1|||
163409488|NCT05048719|590209397|FG007|Overall Study|Lost to Follow-up|1|||
163409489|NCT05048719|590209398|FG008|Overall Study|Lost to Follow-up|0|||
163409490|NCT05048719|590209390|FG000|Overall Study|Physician Decision|0|||
163409491|NCT05048719|590209391|FG001|Overall Study|Physician Decision|0|||
163409492|NCT05048719|590209392|FG002|Overall Study|Physician Decision|0|||
163409493|NCT05048719|590209393|FG003|Overall Study|Physician Decision|0|||
163409494|NCT05048719|590209394|FG004|Overall Study|Physician Decision|0|||
163409495|NCT05048719|590209395|FG005|Overall Study|Physician Decision|0|||
163409496|NCT05048719|590209396|FG006|Overall Study|Physician Decision|0|||
163409497|NCT05048719|590209397|FG007|Overall Study|Physician Decision|1|||
163409498|NCT05048719|590209398|FG008|Overall Study|Physician Decision|1|||
163409499|NCT05048719|590209390|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
163409500|NCT05048719|590209391|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163409501|NCT05048719|590209392|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163409502|NCT05048719|590209393|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163409503|NCT05048719|590209394|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163409504|NCT05048719|590209395|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163141166|NCT03201419|589226228|FG008|Overall Study|Other|0|||
163141167|NCT05864586|589226236|FG000|Overall Study|Ineligible|4|||
163141168|NCT05864586|589226237|FG001|Overall Study|Ineligible|12|||
163141169|NCT05864586|589226236|FG000|Overall Study|Pregnancy|0|||
163141170|NCT05864586|589226237|FG001|Overall Study|Pregnancy|1|||
163141171|NCT05864586|589226236|FG000|Overall Study|Withdrawal by Subject|0|||
163141172|NCT05864586|589226237|FG001|Overall Study|Withdrawal by Subject|1|||
163141173|NCT03635424|589226238|FG000|Overall Study|Adverse Event|1|||
163141174|NCT03635424|589226238|FG000|Overall Study|Death|1|||
163141175|NCT03635424|589226238|FG000|Overall Study|Device not implanted|1|||
163141176|NCT02701283|589226239|FG000|Overall Study|Death|25|||
163141177|NCT02701283|589226240|FG001|Overall Study|Death|29|||
163141178|NCT02701283|589226241|FG002|Overall Study|Death|19|||
163141179|NCT02701283|589226239|FG000|Overall Study|Lost to Follow-up|3|||
163141180|NCT02701283|589226240|FG001|Overall Study|Lost to Follow-up|8|||
163141181|NCT02701283|589226241|FG002|Overall Study|Lost to Follow-up|1|||
163348421|NCT00603278|589983488|FG005|Overall Study|Adverse Event|1|||
163348422|NCT00603278|589983483|FG000|Overall Study|Withdrawal by Subject|2|||
163348423|NCT00603278|589983484|FG001|Overall Study|Withdrawal by Subject|3|||
163348424|NCT00603278|589983485|FG002|Overall Study|Withdrawal by Subject|1|||
163348425|NCT00603278|589983486|FG003|Overall Study|Withdrawal by Subject|2|||
163348426|NCT00603278|589983487|FG004|Overall Study|Withdrawal by Subject|1|||
163348427|NCT00603278|589983488|FG005|Overall Study|Withdrawal by Subject|2|||
163348428|NCT00603278|589983483|FG000|Overall Study|Protocol Violation|3|||
163348429|NCT00603278|589983484|FG001|Overall Study|Protocol Violation|0|||
163348430|NCT00603278|589983485|FG002|Overall Study|Protocol Violation|1|||
163348431|NCT00603278|589983486|FG003|Overall Study|Protocol Violation|1|||
163348432|NCT00603278|589983487|FG004|Overall Study|Protocol Violation|0|||
163348433|NCT00603278|589983488|FG005|Overall Study|Protocol Violation|1|||
163348434|NCT00603278|589983483|FG000|Overall Study|Physician Decision|0|||
163348435|NCT00603278|589983484|FG001|Overall Study|Physician Decision|1|||
163348436|NCT00603278|589983485|FG002|Overall Study|Physician Decision|0|||
163348437|NCT00603278|589983486|FG003|Overall Study|Physician Decision|0|||
163409505|NCT05048719|590209396|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163409506|NCT05048719|590209397|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163141182|NCT02701283|589226239|FG000|Overall Study|Withdrawal by Subject|12|||
163141183|NCT02701283|589226240|FG001|Overall Study|Withdrawal by Subject|41|||
163141184|NCT02701283|589226241|FG002|Overall Study|Withdrawal by Subject|1|||
163141185|NCT02701283|589226239|FG000|Overall Study|Missed 2-year visit|22|||
163141186|NCT02701283|589226240|FG001|Overall Study|Missed 2-year visit|27|||
163141187|NCT02701283|589226241|FG002|Overall Study|Missed 2-year visit|0|||
163235075|NCT00853658|589570921|FG001|Overall Study|Vital Status at study end N/A|10|||
163235076|NCT00853658|589570922|FG002|Overall Study|Vital Status at study end N/A|10|||
163235077|NCT00853658|589570920|FG000|Overall Study|Patient's request|21|||
163235078|NCT00853658|589570921|FG001|Overall Study|Patient's request|17|||
163235079|NCT00853658|589570922|FG002|Overall Study|Patient's request|11|||
163235080|NCT00853658|589570920|FG000|Overall Study|Missing study completion information|5|||
163235081|NCT00853658|589570921|FG001|Overall Study|Missing study completion information|4|||
163235082|NCT00853658|589570922|FG002|Overall Study|Missing study completion information|6|||
163235083|NCT02797262|589570923|FG000|Overall Study|Withdrawal by Subject|5|||
163235084|NCT02797262|589570924|FG001|Overall Study|Withdrawal by Subject|1|||
163235085|NCT02797262|589570923|FG000|Overall Study|Lost to Follow-up|10|||
163235086|NCT02797262|589570924|FG001|Overall Study|Lost to Follow-up|7|||
163235087|NCT02797262|589570923|FG000|Overall Study|Death|1|||
163235088|NCT02797262|589570924|FG001|Overall Study|Death|2|||
163235089|NCT02797262|589570923|FG000|Overall Study|Adverse Event|1|||
163235090|NCT02797262|589570924|FG001|Overall Study|Adverse Event|0|||
163235091|NCT02797262|589570923|FG000|Overall Study|COVID-19|2|||
163235092|NCT02797262|589570924|FG001|Overall Study|COVID-19|1|||
163235093|NCT02797262|589570923|FG000|Overall Study|Out-of-country|1|||
163235094|NCT02797262|589570924|FG001|Overall Study|Out-of-country|0|||
163235095|NCT01600586|589570925|FG000|Overall Study|Physician Decision|3|||
163235096|NCT01600586|589570926|FG001|Overall Study|Physician Decision|3|||
163235097|NCT01227512|589570928|FG000|Overall Study|Physician Decision|6|||
163141188|NCT02701283|589226239|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
163141189|NCT02701283|589226240|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
163141190|NCT02701283|589226241|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
163141191|NCT04544956|589226242|FG000|Overall Study|Withdrawal by Subject|1|||
163141192|NCT04266795|589226243|FG000|Overall Study|Adverse Event|10|||
163141193|NCT04266795|589226244|FG001|Overall Study|Adverse Event|19|||
163141194|NCT04266795|589226243|FG000|Overall Study|Death|7|||
163141195|NCT04266795|589226244|FG001|Overall Study|Death|8|||
163141196|NCT04266795|589226243|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
163141197|NCT04266795|589226244|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
163141198|NCT04266795|589226243|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
163141199|NCT04266795|589226244|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163141200|NCT04266795|589226243|FG000|Overall Study|Progressive Disease|12|||
163141201|NCT04266795|589226244|FG001|Overall Study|Progressive Disease|9|||
163141202|NCT04266795|589226243|FG000|Overall Study|Withdrawal by Patient|5|||
163141203|NCT04266795|589226244|FG001|Overall Study|Withdrawal by Patient|6|||
163141204|NCT04266795|589226243|FG000|Overall Study|Disease Relapse|3|||
163141205|NCT04266795|589226244|FG001|Overall Study|Disease Relapse|6|||
163141206|NCT04266795|589226243|FG000|Overall Study|Reason not Specified|12|||
163141207|NCT04266795|589226244|FG001|Overall Study|Reason not Specified|10|||
163141208|NCT04266795|589226243|FG000|Overall Study|Participants Ongoing on Treatment|25|||
163141209|NCT04266795|589226244|FG001|Overall Study|Participants Ongoing on Treatment|23|||
163141210|NCT00699660|589226247|FG000|Overall Study|Lost to Follow-up|4|||
163141211|NCT00699660|589226248|FG001|Overall Study|Lost to Follow-up|2|||
163141212|NCT00699660|589226247|FG000|Overall Study|missing reports and recording failures|10|||
163141213|NCT00699660|589226248|FG001|Overall Study|missing reports and recording failures|6|||
163141214|NCT03915470|589226249|FG000|Overall Study|Death|3|||
163141215|NCT03915470|589226250|FG001|Overall Study|Death|1|||
163141216|NCT03915470|589226249|FG000|Overall Study|Adverse Event|1|||
163141217|NCT03915470|589226250|FG001|Overall Study|Adverse Event|0|||
163141218|NCT03915470|589226249|FG000|Overall Study|Physician Decision|1|||
163141219|NCT03915470|589226250|FG001|Overall Study|Physician Decision|0|||
163141220|NCT03915470|589226249|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
163141221|NCT03915470|589226250|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
163141222|NCT03160898|589226251|FG000|Overall Study|Adverse Event|4|||
163141223|NCT03160898|589226252|FG001|Overall Study|Adverse Event|8|||
163141224|NCT03160898|589226253|FG002|Overall Study|Adverse Event|7|||
163141225|NCT03160898|589226254|FG003|Overall Study|Adverse Event|10|||
163141226|NCT03160898|589226251|FG000|Overall Study|Death|1|||
163141227|NCT03160898|589226252|FG001|Overall Study|Death|0|||
163348438|NCT00603278|589983487|FG004|Overall Study|Physician Decision|2|||
163141228|NCT03160898|589226253|FG002|Overall Study|Death|0|||
163141229|NCT03160898|589226254|FG003|Overall Study|Death|1|||
163141230|NCT03160898|589226251|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
163235098|NCT01227512|589570929|FG001|Overall Study|Physician Decision|6|||
163141231|NCT03160898|589226252|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
163141232|NCT03160898|589226253|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
163235099|NCT01227512|589570928|FG000|Overall Study|Adverse Event|4|||
163235100|NCT01227512|589570929|FG001|Overall Study|Adverse Event|3|||
163235101|NCT01227512|589570928|FG000|Overall Study|Withdrawal by Subject|3|||
163235102|NCT01227512|589570929|FG001|Overall Study|Withdrawal by Subject|0|||
163235103|NCT01227512|589570928|FG000|Overall Study|Participant met withdrawal criteria|0|||
163141233|NCT03160898|589226254|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
163141234|NCT03160898|589226251|FG000|Overall Study|Lost to Follow-up|1|||
163235104|NCT01227512|589570929|FG001|Overall Study|Participant met withdrawal criteria|1|||
163348439|NCT00603278|589983488|FG005|Overall Study|Physician Decision|1|||
163348440|NCT00603278|589983483|FG000|Overall Study|Lost to Follow-up|1|||
163235105|NCT01978184|589570930|FG000|Overall Study|Progressive disease|5|||
163235106|NCT01978184|589570931|FG001|Overall Study|Progressive disease|5|||
163235107|NCT01978184|589570930|FG000|Overall Study|Other than PDA|2|||
163235108|NCT01978184|589570931|FG001|Overall Study|Other than PDA|2|||
163235109|NCT01978184|589570930|FG000|Overall Study|Physician Decision|0|||
163235110|NCT01978184|589570931|FG001|Overall Study|Physician Decision|3|||
163235111|NCT01978184|589570930|FG000|Overall Study|Noncompliance|1|||
163235112|NCT01978184|589570931|FG001|Overall Study|Noncompliance|2|||
163235113|NCT01978184|589570930|FG000|Overall Study|Death|1|||
163235114|NCT01978184|589570931|FG001|Overall Study|Death|0|||
163235115|NCT01978184|589570930|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
163235116|NCT01978184|589570931|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
163235117|NCT01069289|589570933|FG000|Overall Study|Withdrawal by Subject|15|||
163235118|NCT01069289|589570934|FG001|Overall Study|Withdrawal by Subject|26|||
163235119|NCT01069289|589570933|FG000|Overall Study|Adverse Event|21|||
163235120|NCT01069289|589570934|FG001|Overall Study|Adverse Event|28|||
163235121|NCT01069289|589570933|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
163235122|NCT01069289|589570934|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
163235123|NCT01069289|589570933|FG000|Overall Study|Severe non-compliance to protocol|3|||
163235124|NCT01069289|589570934|FG001|Overall Study|Severe non-compliance to protocol|2|||
163235125|NCT01069289|589570933|FG000|Overall Study|Due to deteriorating health condition|1|||
163235126|NCT01069289|589570934|FG001|Overall Study|Due to deteriorating health condition|0|||
163235127|NCT02707640|589570935|FG000|Overall Study|Adverse Event|4|||
163235128|NCT02707640|589570936|FG001|Overall Study|Adverse Event|2|||
163235129|NCT02707640|589570935|FG000|Overall Study|Death|1|||
163235130|NCT02707640|589570936|FG001|Overall Study|Death|2|||
163235131|NCT02707640|589570935|FG000|Overall Study|Physician Decision|2|||
163235132|NCT02707640|589570936|FG001|Overall Study|Physician Decision|0|||
163235133|NCT02707640|589570935|FG000|Overall Study|Withdrawal by Subject|0|||
163235134|NCT02707640|589570936|FG001|Overall Study|Withdrawal by Subject|1|||
163235135|NCT02707640|589570935|FG000|Overall Study|Participant's Personal Decision|1|||
163235136|NCT02707640|589570936|FG001|Overall Study|Participant's Personal Decision|2|||
163235137|NCT02707640|589570935|FG000|Overall Study|Sponsor Discretion|1|||
163235138|NCT02707640|589570936|FG001|Overall Study|Sponsor Discretion|0|||
163235139|NCT02517905|589570937|FG000|Overall Study|Lost to Follow-up|4|||
163235140|NCT02517905|589570938|FG001|Overall Study|Lost to Follow-up|0|||
163235141|NCT02517905|589570937|FG000|Overall Study|Withdrawal by Subject|4|||
163235142|NCT02517905|589570938|FG001|Overall Study|Withdrawal by Subject|0|||
163235143|NCT02517905|589570937|FG000|Overall Study|Screen failure|2|||
163235144|NCT02517905|589570938|FG001|Overall Study|Screen failure|2|||
163235145|NCT00023452|589570939|FG000|Overall Study|Ineligible for Study|163|||
163235146|NCT00023452|589570940|FG001|Overall Study|Ineligible for Study|159|||
163235147|NCT00023452|589570939|FG000|Overall Study|Out of Window|129|||
163235148|NCT00023452|589570940|FG001|Overall Study|Out of Window|69|||
163235149|NCT00023452|589570939|FG000|Overall Study|Death|2|||
163235150|NCT00023452|589570940|FG001|Overall Study|Death|0|||
163235151|NCT00023452|589570939|FG000|Overall Study|Withdrawal by Subject|66|||
163235152|NCT00023452|589570940|FG001|Overall Study|Withdrawal by Subject|54|||
163235153|NCT00023452|589570939|FG000|Overall Study|Adverse Event|139|||
163235154|NCT00023452|589570940|FG001|Overall Study|Adverse Event|196|||
163235155|NCT00023452|589570939|FG000|Overall Study|Lost to Follow-up|293|||
163235156|NCT00023452|589570940|FG001|Overall Study|Lost to Follow-up|60|||
163235157|NCT00023452|589570939|FG000|Overall Study|Physician Decision|49|||
163235158|NCT00023452|589570940|FG001|Overall Study|Physician Decision|21|||
163235159|NCT00023452|589570939|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
163235160|NCT00023452|589570940|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
163235161|NCT00023452|589570939|FG000|Overall Study|Pregnant|53|||
163235162|NCT00023452|589570940|FG001|Overall Study|Pregnant|20|||
163235163|NCT00023452|589570939|FG000|Overall Study|Other|204|||
163235164|NCT00023452|589570940|FG001|Overall Study|Other|69|||
163235165|NCT05789875|589570941|FG000|Overall Study|Lost to Follow-up|6|||
163235166|NCT01994395|589570942|FG000|Overall Study|Withdrawal by Subject|1|||
163348441|NCT00603278|589983484|FG001|Overall Study|Lost to Follow-up|0|||
163348442|NCT00603278|589983485|FG002|Overall Study|Lost to Follow-up|0|||
163348443|NCT00603278|589983486|FG003|Overall Study|Lost to Follow-up|0|||
163348444|NCT00603278|589983487|FG004|Overall Study|Lost to Follow-up|1|||
163348445|NCT00603278|589983488|FG005|Overall Study|Lost to Follow-up|0|||
163348446|NCT00500539|589983489|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
163348447|NCT00500539|589983489|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
163235167|NCT01994395|589570943|FG001|Overall Study|Withdrawal by Subject|2|||
163235168|NCT00459134|589570951|FG000|Overall Study|Physician Decision|1|||
163348448|NCT00500539|589983489|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
163235169|NCT00459134|589570952|FG001|Overall Study|Physician Decision|1|||
163235170|NCT00459134|589570951|FG000|Overall Study|Withdrawal by Subject|8|||
163235171|NCT00459134|589570952|FG001|Overall Study|Withdrawal by Subject|7|||
163235172|NCT00459134|589570951|FG000|Overall Study|Lost to Follow-up|6|||
163235173|NCT00459134|589570952|FG001|Overall Study|Lost to Follow-up|7|||
163235174|NCT00459134|589570951|FG000|Overall Study|Surgery|1|||
163235175|NCT00459134|589570952|FG001|Overall Study|Surgery|2|||
163235176|NCT00459134|589570951|FG000|Overall Study|Toxicity|4|||
163235177|NCT00459134|589570952|FG001|Overall Study|Toxicity|5|||
163235178|NCT00459134|589570951|FG000|Overall Study|Progression|1|||
163235179|NCT00459134|589570952|FG001|Overall Study|Progression|0|||
163235180|NCT00459134|589570951|FG000|Overall Study|Multiple Reasons|2|||
163235181|NCT00459134|589570952|FG001|Overall Study|Multiple Reasons|3|||
163235182|NCT02770391|589570953|FG000|Overall Study|Lost to Follow-up|2|||
163235183|NCT02770391|589570953|FG000|Overall Study|Withdrawal by Subject|1|||
163235184|NCT02770391|589570953|FG000|Overall Study|Surgery delayed unevaluable|2|||
163235185|NCT02770391|589570953|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
163235186|NCT03333486|589570954|FG000|Overall Study|Withdrawal by Subject|1|||
163235187|NCT03333486|589570954|FG000|Overall Study|Lost to Follow-up|1|||
163235188|NCT01755416|589570960|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
163235189|NCT01755416|589570961|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
163235190|NCT02805257|589572686|FG000|Overall Study|Lost to Follow-up|7|||
163235191|NCT02805257|589572687|FG001|Overall Study|Lost to Follow-up|6|||
163235192|NCT02805257|589572686|FG000|Overall Study|Death|0|||
163235193|NCT02805257|589572687|FG001|Overall Study|Death|1|||
163235194|NCT00612066|589572688|FG000|Overall Study|Adverse Event|1|||
163235195|NCT01043874|589572692|FG000|Overall Study|Adverse Event|3|||
163235196|NCT01043874|589572692|FG000|Overall Study|Withdrawal by Subject|1|||
163235197|NCT01043874|589572692|FG000|Overall Study|Lack of Efficacy|1|||
163235198|NCT01043874|589572692|FG000|Overall Study|Administrative Problems|1|||
163235199|NCT01337089|589572693|FG000|Overall Study|Adverse Event|237|||
163235200|NCT01337089|589572693|FG000|Overall Study|Withdrawal by Subject|129|||
163235201|NCT01337089|589572693|FG000|Overall Study|Withdrawal by Investigator|33|||
163235202|NCT01337089|589572693|FG000|Overall Study|Met Withdrawal Criteria|3|||
163235203|NCT01337089|589572693|FG000|Overall Study|Lost to Follow-up|2|||
163235204|NCT01404312|589572694|FG000|Overall Study|Death|21|||
163235205|NCT01404312|589572695|FG001|Overall Study|Death|27|||
163235206|NCT01404312|589572694|FG000|Overall Study|Withdrawal by Subject|15|||
163235207|NCT01404312|589572695|FG001|Overall Study|Withdrawal by Subject|18|||
163235208|NCT01404312|589572694|FG000|Overall Study|Participant Unable to get to clinic|93|||
163235209|NCT01404312|589572695|FG001|Overall Study|Participant Unable to get to clinic|103|||
163235210|NCT01404312|589572694|FG000|Overall Study|Lost to Follow-up|115|||
163235211|NCT01404312|589572695|FG001|Overall Study|Lost to Follow-up|111|||
163235212|NCT01404312|589572694|FG000|Overall Study|Site closed|22|||
163235213|NCT01404312|589572695|FG001|Overall Study|Site closed|21|||
163235214|NCT01404312|589572694|FG000|Overall Study|Participant not willing to adhere to req|31|||
163235215|NCT01404312|589572695|FG001|Overall Study|Participant not willing to adhere to req|29|||
163235216|NCT01404312|589572694|FG000|Overall Study|Severe debilitation, unable to continue|1|||
163235217|NCT01404312|589572695|FG001|Overall Study|Severe debilitation, unable to continue|2|||
163235218|NCT02627677|589572697|FG000|Overall Study|Adverse event (not progressive disease)|1|||
163235219|NCT02627677|589572698|FG001|Overall Study|Adverse event (not progressive disease)|4|||
163235220|NCT02627677|589572699|FG002|Overall Study|Adverse event (not progressive disease)|1|||
163235221|NCT02627677|589572697|FG000|Overall Study|Progressive disease|1|||
163235222|NCT02627677|589572698|FG001|Overall Study|Progressive disease|3|||
163235223|NCT02627677|589572699|FG002|Overall Study|Progressive disease|0|||
163235224|NCT02627677|589572697|FG000|Overall Study|Lack of Efficacy|1|||
163235225|NCT02627677|589572698|FG001|Overall Study|Lack of Efficacy|2|||
163235226|NCT02627677|589572699|FG002|Overall Study|Lack of Efficacy|0|||
163235227|NCT02627677|589572697|FG000|Overall Study|Lost to Follow-up|0|||
163235228|NCT02627677|589572698|FG001|Overall Study|Lost to Follow-up|0|||
163235229|NCT02627677|589572699|FG002|Overall Study|Lost to Follow-up|1|||
163235230|NCT02627677|589572697|FG000|Overall Study|Pregnancy|0|||
163235231|NCT02627677|589572698|FG001|Overall Study|Pregnancy|1|||
163348449|NCT00500539|589983489|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
163348450|NCT00500539|589983489|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
163348451|NCT00500539|589983489|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
163348452|NCT00500539|589983489|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
163348453|NCT00500539|589983489|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
163235232|NCT02627677|589572699|FG002|Overall Study|Pregnancy|0|||
163235233|NCT02627677|589572697|FG000|Overall Study|Study Terminated by Sponsor|5|||
163235234|NCT02627677|589572698|FG001|Overall Study|Study Terminated by Sponsor|10|||
163235235|NCT02627677|589572699|FG002|Overall Study|Study Terminated by Sponsor|6|||
163235236|NCT02627677|589572697|FG000|Overall Study|Physician Decision|0|||
163235237|NCT02627677|589572698|FG001|Overall Study|Physician Decision|0|||
163235238|NCT02627677|589572699|FG002|Overall Study|Physician Decision|2|||
163235239|NCT02627677|589572697|FG000|Overall Study|Withdrawal by Subject|2|||
163235240|NCT02627677|589572698|FG001|Overall Study|Withdrawal by Subject|1|||
163235241|NCT02627677|589572699|FG002|Overall Study|Withdrawal by Subject|1|||
163235242|NCT02627677|589572697|FG000|Overall Study|Reason not Specified|0|||
163235243|NCT02627677|589572698|FG001|Overall Study|Reason not Specified|0|||
163235244|NCT02627677|589572699|FG002|Overall Study|Reason not Specified|1|||
163235245|NCT02627677|589572697|FG000|Overall Study|Randomized but not Treated|1|||
163235246|NCT02627677|589572698|FG001|Overall Study|Randomized but not Treated|0|||
163235247|NCT02627677|589572699|FG002|Overall Study|Randomized but not Treated|0|||
163235248|NCT00071487|589572705|FG000|52-Week Double-Blind Period|Adverse Event|5|||
163235249|NCT00071487|589572706|FG001|52-Week Double-Blind Period|Adverse Event|8|||
163235250|NCT00071487|589572707|FG002|52-Week Double-Blind Period|Adverse Event|4|||
163235251|NCT00071487|589572708|FG003|52-Week Double-Blind Period|Adverse Event|8|||
163235252|NCT00071487|589572705|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
163235253|NCT00071487|589572706|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
163235254|NCT00071487|589572707|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
163235255|NCT00071487|589572708|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
163235256|NCT00071487|589572705|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
163235257|NCT00071487|589572706|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
163235258|NCT00071487|589572707|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
163235259|NCT00071487|589572708|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
163235260|NCT00071487|589572705|FG000|52-Week Double-Blind Period|Physician Decision|1|||
163235261|NCT00071487|589572706|FG001|52-Week Double-Blind Period|Physician Decision|0|||
163235262|NCT00071487|589572707|FG002|52-Week Double-Blind Period|Physician Decision|0|||
163235263|NCT00071487|589572708|FG003|52-Week Double-Blind Period|Physician Decision|0|||
163235264|NCT00071487|589572705|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
163235265|NCT00071487|589572706|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
163235266|NCT00071487|589572707|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
163235267|NCT00071487|589572708|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
163235268|NCT00071487|589572705|FG000|52-Week Double-Blind Period|Pregnancy|0|||
163235269|NCT00071487|589572706|FG001|52-Week Double-Blind Period|Pregnancy|1|||
163235270|NCT00071487|589572707|FG002|52-Week Double-Blind Period|Pregnancy|0|||
163235271|NCT00071487|589572708|FG003|52-Week Double-Blind Period|Pregnancy|0|||
163235272|NCT00071487|589572705|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
163235273|NCT00071487|589572706|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
163235274|NCT00071487|589572707|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
163235275|NCT00071487|589572708|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
163235276|NCT00071487|589572705|FG000|52-Week Double-Blind Period|Death|0|||
163235277|NCT00071487|589572706|FG001|52-Week Double-Blind Period|Death|1|||
163235278|NCT00071487|589572707|FG002|52-Week Double-Blind Period|Death|0|||
163235279|NCT00071487|589572708|FG003|52-Week Double-Blind Period|Death|0|||
163235280|NCT00071487|589572705|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
163235281|NCT00071487|589572706|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
163235282|NCT00071487|589572707|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
163235283|NCT00071487|589572708|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
163235284|NCT00071487|589572705|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
163235285|NCT00071487|589572706|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
163235286|NCT00071487|589572707|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
163235287|NCT00071487|589572708|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
163235288|NCT00071487|589572705|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
163235289|NCT00071487|589572706|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
163235290|NCT00071487|589572707|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
163235291|NCT00071487|589572708|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
163235292|NCT00071487|589572705|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
163235293|NCT00071487|589572706|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
163235294|NCT00071487|589572707|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
163235295|NCT00071487|589572708|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
163235296|NCT00071487|589572705|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
163235297|NCT00071487|589572706|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
163235298|NCT00071487|589572707|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
163235299|NCT00071487|589572708|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
163235300|NCT00071487|589572705|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
163235301|NCT00071487|589572706|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
163235302|NCT00071487|589572707|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
163235303|NCT00071487|589572708|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
163348454|NCT00500539|589983489|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
163348455|NCT00500539|589983489|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
163348456|NCT00500539|589983489|FG000|Follow-up Period (16 Weeks)|Death|1|||
163348457|NCT00500539|589983489|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
163235304|NCT00071487|589572705|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
163235305|NCT00071487|589572706|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
163348458|NCT00500539|589983489|FG000|Follow-up Period (16 Weeks)|Missing|3|||
163235306|NCT00071487|589572707|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
163348459|NCT04853394|589983490|FG000|Follow-up Interviews|Lost to Follow-up|22|||
163348460|NCT04853394|589983491|FG001|Follow-up Interviews|Lost to Follow-up|15|||
163348461|NCT01123642|589983494|FG000|Overall Study|Lost to Follow-up|23|||
163235307|NCT00071487|589572708|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
163235308|NCT02696850|589572711|FG000|Overall Study|Withdrawal by Subject|3|||
163235309|NCT02696850|589572712|FG001|Overall Study|Withdrawal by Subject|3|||
163348462|NCT01123642|589983494|FG000|Overall Study|Withdrawal by Subject|9|||
163348463|NCT01123642|589983494|FG000|Overall Study|ineligible at baseline assessment|36|||
163348464|NCT04853238|589983495|FG000|Overall Study|Death|4|||
163348465|NCT04853238|589983496|FG001|Overall Study|Death|0|||
163348466|NCT04853238|589983497|FG002|Overall Study|Death|2|||
163348467|NCT04853238|589983495|FG000|Overall Study|Lost to Follow-up|16|||
163141235|NCT03160898|589226252|FG001|Overall Study|Lost to Follow-up|1|||
163141236|NCT03160898|589226253|FG002|Overall Study|Lost to Follow-up|1|||
163141237|NCT03160898|589226254|FG003|Overall Study|Lost to Follow-up|2|||
163141238|NCT03160898|589226251|FG000|Overall Study|Physician Decision|1|||
163141239|NCT03160898|589226252|FG001|Overall Study|Physician Decision|0|||
163141240|NCT03160898|589226253|FG002|Overall Study|Physician Decision|0|||
163141241|NCT03160898|589226254|FG003|Overall Study|Physician Decision|1|||
163141242|NCT03160898|589226251|FG000|Overall Study|Progressive Disease|4|||
163141243|NCT03160898|589226252|FG001|Overall Study|Progressive Disease|1|||
163141244|NCT03160898|589226253|FG002|Overall Study|Progressive Disease|2|||
163141245|NCT03160898|589226254|FG003|Overall Study|Progressive Disease|1|||
163141246|NCT03160898|589226251|FG000|Overall Study|Protocol Violation|1|||
163141247|NCT03160898|589226252|FG001|Overall Study|Protocol Violation|0|||
163141248|NCT03160898|589226253|FG002|Overall Study|Protocol Violation|2|||
163141249|NCT03160898|589226254|FG003|Overall Study|Protocol Violation|0|||
163141250|NCT03160898|589226251|FG000|Overall Study|Sponsor Discretion|2|||
163141251|NCT03160898|589226252|FG001|Overall Study|Sponsor Discretion|0|||
163141252|NCT03160898|589226253|FG002|Overall Study|Sponsor Discretion|0|||
163141253|NCT03160898|589226254|FG003|Overall Study|Sponsor Discretion|0|||
163141254|NCT03160898|589226251|FG000|Overall Study|Withdrawal by Subject|1|||
163141255|NCT03160898|589226252|FG001|Overall Study|Withdrawal by Subject|3|||
163141256|NCT03160898|589226253|FG002|Overall Study|Withdrawal by Subject|2|||
163141257|NCT03160898|589226254|FG003|Overall Study|Withdrawal by Subject|1|||
163141258|NCT03160898|589226251|FG000|Overall Study|Other|2|||
163141259|NCT03160898|589226252|FG001|Overall Study|Other|0|||
163141260|NCT03160898|589226253|FG002|Overall Study|Other|2|||
163141261|NCT03160898|589226254|FG003|Overall Study|Other|2|||
163141262|NCT03405818|589226257|FG000|Overall Study|Withdrawal by Subject|4|||
163141263|NCT03405818|589226257|FG000|Overall Study|Lost to Follow-up|4|||
163141264|NCT00434109|589226258|FG000|Overall Study|Physician Decision|9|||
163141265|NCT00434109|589226258|FG000|Overall Study|Adverse Event|5|||
163141266|NCT00434109|589226258|FG000|Overall Study|Protocol Violation|1|||
163141267|NCT00434109|589226258|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
163141268|NCT04186871|589226261|FG000|Overall Study|Lack of Efficacy|0|||
163141269|NCT04186871|589226262|FG001|Overall Study|Lack of Efficacy|1|||
163141270|NCT04186871|589226263|FG002|Overall Study|Lack of Efficacy|0|||
163141271|NCT04186871|589226264|FG003|Overall Study|Lack of Efficacy|0|||
163141272|NCT04186871|589226265|FG004|Overall Study|Lack of Efficacy|1|||
163141273|NCT04186871|589226266|FG005|Overall Study|Lack of Efficacy|1|||
163141274|NCT04186871|589226261|FG000|Overall Study|Adverse Event|1|||
163141275|NCT04186871|589226262|FG001|Overall Study|Adverse Event|1|||
163141276|NCT04186871|589226263|FG002|Overall Study|Adverse Event|0|||
163141277|NCT04186871|589226264|FG003|Overall Study|Adverse Event|0|||
163141278|NCT04186871|589226265|FG004|Overall Study|Adverse Event|0|||
163141279|NCT04186871|589226266|FG005|Overall Study|Adverse Event|2|||
163141280|NCT04186871|589226261|FG000|Overall Study|Study terminated by sponsor|1|||
163141281|NCT04186871|589226262|FG001|Overall Study|Study terminated by sponsor|2|||
163141282|NCT04186871|589226263|FG002|Overall Study|Study terminated by sponsor|0|||
163141283|NCT04186871|589226264|FG003|Overall Study|Study terminated by sponsor|1|||
163141284|NCT04186871|589226265|FG004|Overall Study|Study terminated by sponsor|0|||
163141285|NCT04186871|589226266|FG005|Overall Study|Study terminated by sponsor|0|||
163141286|NCT04186871|589226261|FG000|Overall Study|Other reasons|0|||
163141287|NCT04186871|589226262|FG001|Overall Study|Other reasons|0|||
163141288|NCT04186871|589226263|FG002|Overall Study|Other reasons|0|||
163141289|NCT04186871|589226264|FG003|Overall Study|Other reasons|0|||
163141290|NCT04186871|589226265|FG004|Overall Study|Other reasons|0|||
163141291|NCT04186871|589226266|FG005|Overall Study|Other reasons|1|||
163141292|NCT04186871|589226261|FG000|Overall Study|Withdrawal by Subject|0|||
163141293|NCT04186871|589226262|FG001|Overall Study|Withdrawal by Subject|0|||
163141294|NCT04186871|589226263|FG002|Overall Study|Withdrawal by Subject|0|||
163141295|NCT04186871|589226264|FG003|Overall Study|Withdrawal by Subject|0|||
163141296|NCT04186871|589226265|FG004|Overall Study|Withdrawal by Subject|0|||
163141297|NCT04186871|589226266|FG005|Overall Study|Withdrawal by Subject|1|||
163141298|NCT04186871|589226261|FG000|Overall Study|Lost to Follow-up|0|||
163141299|NCT04186871|589226262|FG001|Overall Study|Lost to Follow-up|0|||
163141300|NCT04186871|589226263|FG002|Overall Study|Lost to Follow-up|0|||
163141301|NCT04186871|589226264|FG003|Overall Study|Lost to Follow-up|0|||
163348468|NCT04853238|589983496|FG001|Overall Study|Lost to Follow-up|2|||
163141302|NCT04186871|589226265|FG004|Overall Study|Lost to Follow-up|0|||
163141303|NCT04186871|589226266|FG005|Overall Study|Lost to Follow-up|1|||
163141304|NCT00549445|589226273|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
163141305|NCT00549445|589226274|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
163141306|NCT03932760|589226275|FG000|Overall Study|Became Ineligible|2|||
163409507|NCT05048719|590209398|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163409508|NCT05048719|590209390|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163409509|NCT05048719|590209391|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
163409510|NCT05048719|590209392|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163409511|NCT05048719|590209393|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163141307|NCT03932760|589226276|FG001|Overall Study|Became Ineligible|5|||
163141308|NCT03932760|589226275|FG000|Overall Study|Withdrawal by Subject|6|||
163141309|NCT03932760|589226276|FG001|Overall Study|Withdrawal by Subject|6|||
163141310|NCT04725500|589226277|FG000|Screening|Screen Failure|26|||
163348469|NCT04853238|589983497|FG002|Overall Study|Lost to Follow-up|37|||
163348470|NCT04853238|589983495|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
163348471|NCT04853238|589983496|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
163348472|NCT04853238|589983497|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
163348473|NCT04853238|589983495|FG000|Overall Study|Withdrawal by Subject|6|||
163348474|NCT04853238|589983496|FG001|Overall Study|Withdrawal by Subject|0|||
163348475|NCT04853238|589983497|FG002|Overall Study|Withdrawal by Subject|21|||
163348476|NCT04853238|589983495|FG000|Overall Study|Physician Decision|0|||
163141311|NCT04725500|589226277|FG000|Screening|Withdrawal by Subject|1|||
163141312|NCT04725500|589226277|FG000|2 Week Take Home|Screen Fail|5|||
163141313|NCT01467505|589227858|FG000|Overall Study|Adverse Event|1|||
163141314|NCT01467505|589227859|FG001|Overall Study|Adverse Event|0|||
163141315|NCT01467505|589227858|FG000|Overall Study|Withdrawal by Subject|4|||
163141316|NCT01467505|589227859|FG001|Overall Study|Withdrawal by Subject|0|||
163141317|NCT01467505|589227858|FG000|Overall Study|Study Terminated by Sponsor|28|||
163141318|NCT01467505|589227859|FG001|Overall Study|Study Terminated by Sponsor|3|||
163141319|NCT00227721|589227860|FG000|Overall Study|On study, but never treated.|1|||
163141320|NCT00383786|589227863|FG000|Overall Study|Protocol Violation|2|||
163141321|NCT00383786|589227864|FG001|Overall Study|Protocol Violation|6|||
163141322|NCT00383786|589227863|FG000|Overall Study|Withdrawal by Subject|2|||
163141323|NCT00383786|589227864|FG001|Overall Study|Withdrawal by Subject|5|||
163141324|NCT00383786|589227863|FG000|Overall Study|Physician Decision|0|||
163141325|NCT00383786|589227864|FG001|Overall Study|Physician Decision|1|||
163141326|NCT02219464|589227868|FG000|Overall Study|Withdrawal by Subject|1|||
163141327|NCT02219464|589227869|FG001|Overall Study|Withdrawal by Subject|0|||
163141328|NCT02219464|589227868|FG000|Overall Study|case cancelled|1|||
163348477|NCT04853238|589983496|FG001|Overall Study|Physician Decision|0|||
163348478|NCT04853238|589983497|FG002|Overall Study|Physician Decision|2|||
163348479|NCT04853238|589983495|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
163348480|NCT04853238|589983496|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
163348481|NCT04853238|589983497|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
163348482|NCT00730847|589985288|FG000|Overall Study|Adverse Event|1|||
163348483|NCT00730847|589985288|FG000|Overall Study|Protocol Violation|2|||
163348484|NCT00730847|589985288|FG000|Overall Study|Withdrawal by Subject|16|||
163348485|NCT00730847|589985288|FG000|Overall Study|Lost to Follow-up|67|||
163348486|NCT00730847|589985288|FG000|Overall Study|Unknown completion status|21|||
163348487|NCT00730847|589985288|FG000|Overall Study|Other|24|||
163348488|NCT00280683|589985289|FG000|Overall Study|Withdrawal by Subject|1|||
163348489|NCT00280683|589985290|FG001|Overall Study|Withdrawal by Subject|2|||
163348490|NCT00280683|589985289|FG000|Overall Study|Adverse Event|1|||
163348491|NCT00280683|589985290|FG001|Overall Study|Adverse Event|1|||
163348492|NCT01243411|589985291|FG000|Overall Study|Withdrawal by Subject|18|||
163348493|NCT01243411|589985291|FG000|Overall Study|Lost to Follow-up|10|||
163348494|NCT01243411|589985291|FG000|Overall Study|Adverse Event|5|||
163348495|NCT01243411|589985291|FG000|Overall Study|Other|8|||
163348496|NCT00632931|589985309|FG000|Part 1, Period 1|Protocol Violation|1|||
163348497|NCT00632931|589985310|FG001|Part 1, Period 1|Protocol Violation|0|||
163348498|NCT00632931|589985311|FG002|Part 1, Period 1|Protocol Violation|0|||
163348499|NCT00632931|589985309|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
163348500|NCT00632931|589985310|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
163348501|NCT00632931|589985311|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
163348502|NCT00632931|589985309|FG000|Part 2|Adverse Event|0|||
163348503|NCT00632931|589985310|FG001|Part 2|Adverse Event|0|||
163141329|NCT02219464|589227869|FG001|Overall Study|case cancelled|0|||
163348504|NCT00632931|589985311|FG002|Part 2|Adverse Event|3|||
163348505|NCT00632931|589985309|FG000|Part 2|Death|0|||
163348506|NCT00632931|589985310|FG001|Part 2|Death|0|||
163348507|NCT00632931|589985311|FG002|Part 2|Death|1|||
163348508|NCT00632931|589985309|FG000|Part 2|Lack of Efficacy|0|||
163348509|NCT00632931|589985310|FG001|Part 2|Lack of Efficacy|0|||
163348510|NCT00632931|589985311|FG002|Part 2|Lack of Efficacy|17|||
163348511|NCT00632931|589985309|FG000|Part 2|Withdrawal by Subject|0|||
163348512|NCT00632931|589985310|FG001|Part 2|Withdrawal by Subject|0|||
163348513|NCT00632931|589985311|FG002|Part 2|Withdrawal by Subject|3|||
163348514|NCT02499835|589985317|FG000|Overall Study|Withdrawal by Subject|1|||
163348515|NCT02499835|589985318|FG001|Overall Study|Withdrawal by Subject|0|||
163348516|NCT02499835|589985319|FG002|Overall Study|Withdrawal by Subject|0|||
163348517|NCT02499835|589985320|FG003|Overall Study|Withdrawal by Subject|1|||
163348518|NCT02499835|589985317|FG000|Overall Study|Physician Decision|0|||
163348519|NCT02499835|589985318|FG001|Overall Study|Physician Decision|3|||
163348520|NCT02499835|589985319|FG002|Overall Study|Physician Decision|18|||
163348521|NCT02499835|589985320|FG003|Overall Study|Physician Decision|7|||
163348522|NCT02499835|589985317|FG000|Overall Study|Adverse Event|0|||
163348523|NCT02499835|589985318|FG001|Overall Study|Adverse Event|0|||
163348524|NCT02499835|589985319|FG002|Overall Study|Adverse Event|0|||
163348525|NCT02499835|589985320|FG003|Overall Study|Adverse Event|1|||
163348526|NCT02499835|589985317|FG000|Overall Study|Disease progression|2|||
163348527|NCT02499835|589985318|FG001|Overall Study|Disease progression|1|||
163348528|NCT02499835|589985319|FG002|Overall Study|Disease progression|0|||
163348529|NCT02499835|589985320|FG003|Overall Study|Disease progression|7|||
163348530|NCT03319719|589985328|FG000|Overall Study|Lost to Follow-up|1|||
163348531|NCT03193216|589985329|FG000|Overall Study|Lost to Follow-up|1|||
163348532|NCT03193216|589985330|FG001|Overall Study|Lost to Follow-up|0|||
163348533|NCT03193216|589985329|FG000|Overall Study|Withdrawal by Subject|5|||
163348534|NCT03193216|589985330|FG001|Overall Study|Withdrawal by Subject|0|||
163235310|NCT02696850|589572711|FG000|Overall Study|Lost to Follow-up|8|||
163235311|NCT02696850|589572712|FG001|Overall Study|Lost to Follow-up|5|||
163235312|NCT00673049|589572715|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
163235313|NCT00673049|589572716|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
163235314|NCT00673049|589572717|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
163235315|NCT00673049|589572718|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
163235316|NCT00673049|589572715|FG000|Before Progression on Erlotinib|Death|235|||
163235317|NCT00673049|589572716|FG001|Before Progression on Erlotinib|Death|167|||
163235318|NCT00673049|589572717|FG002|Before Progression on Erlotinib|Death|1|||
163235319|NCT00673049|589572718|FG003|Before Progression on Erlotinib|Death|0|||
163235320|NCT00673049|589572715|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
163235321|NCT00673049|589572716|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
163235322|NCT00673049|589572717|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
163235323|NCT00673049|589572718|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
163235324|NCT00673049|589572715|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
163235325|NCT00673049|589572716|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
163235326|NCT00673049|589572717|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
163235327|NCT00673049|589572718|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
163235328|NCT00673049|589572715|FG000|Before Progression on Erlotinib|Other|1|||
163235329|NCT00673049|589572716|FG001|Before Progression on Erlotinib|Other|2|||
163235330|NCT00673049|589572717|FG002|Before Progression on Erlotinib|Other|0|||
163235331|NCT00673049|589572718|FG003|Before Progression on Erlotinib|Other|0|||
163235332|NCT00673049|589572715|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
163235333|NCT00673049|589572716|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
163235334|NCT00673049|589572717|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
163235335|NCT00673049|589572718|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
163235336|NCT00673049|589572715|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
163235337|NCT00673049|589572716|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
163235338|NCT00673049|589572717|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
163235339|NCT00673049|589572718|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
163235340|NCT00673049|589572715|FG000|After Progression on Erlotinib|Death|0|||
163235341|NCT00673049|589572716|FG001|After Progression on Erlotinib|Death|0|||
163235342|NCT00673049|589572717|FG002|After Progression on Erlotinib|Death|0|||
163235343|NCT00673049|589572718|FG003|After Progression on Erlotinib|Death|71|||
163235344|NCT00673049|589572715|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
163235345|NCT00673049|589572716|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
163235346|NCT00673049|589572717|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
163235347|NCT00673049|589572718|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
163235348|NCT00673049|589572715|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
163235349|NCT00673049|589572716|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
163235350|NCT00673049|589572717|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
163235351|NCT00673049|589572718|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
163235352|NCT00673049|589572715|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
163235353|NCT00673049|589572716|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
163348535|NCT03193216|589985329|FG000|Overall Study|Physician Decision|4|||
163348536|NCT03193216|589985330|FG001|Overall Study|Physician Decision|0|||
163348537|NCT02490878|589985331|FG000|Overall Study|deemed ineligible|0|||
163348538|NCT02490878|589985332|FG001|Overall Study|deemed ineligible|1|||
163348539|NCT02490878|589985331|FG000|Overall Study|progression prior to treatment|0|||
163348540|NCT02490878|589985332|FG001|Overall Study|progression prior to treatment|1|||
163348541|NCT02490878|589985331|FG000|Overall Study|only submitted baseline QOL|0|||
163348542|NCT02490878|589985332|FG001|Overall Study|only submitted baseline QOL|1|||
163348543|NCT00922441|589985333|FG000|Overall Study|Protocol Violation|0|||
163235354|NCT00673049|589572717|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
163235355|NCT00673049|589572718|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
163235356|NCT01933334|589572722|FG000|Overall Study|Adverse Event|5|||
163235357|NCT01933334|589572723|FG001|Overall Study|Adverse Event|1|||
163235358|NCT01933334|589572722|FG000|Overall Study|Withdrawal by Subject|0|||
163235359|NCT01933334|589572723|FG001|Overall Study|Withdrawal by Subject|1|||
163235360|NCT04265755|589572726|FG000|Overall Study|Withdrawal by Subject|39|||
163235361|NCT04265755|589572726|FG000|Overall Study|Decision by sponsor|2|||
163235362|NCT04265755|589572726|FG000|Overall Study|Lost to Follow-up|11|||
163235363|NCT04265755|589572726|FG000|Overall Study|Death|1|||
163235364|NCT01863446|589572729|FG000|Overall Study|Withdrawal by Subject|1|||
163235365|NCT01863446|589572730|FG001|Overall Study|Withdrawal by Subject|0|||
163235366|NCT01863446|589572731|FG002|Overall Study|Withdrawal by Subject|1|||
163235367|NCT01863446|589572732|FG003|Overall Study|Withdrawal by Subject|2|||
163235368|NCT01863446|589572729|FG000|Overall Study|Physician Decision|0|||
163235369|NCT01863446|589572730|FG001|Overall Study|Physician Decision|0|||
163235370|NCT01863446|589572731|FG002|Overall Study|Physician Decision|1|||
163235371|NCT01863446|589572732|FG003|Overall Study|Physician Decision|0|||
163235372|NCT02554773|589572733|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
163235373|NCT02554773|589572734|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
163235374|NCT02554773|589572733|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
163235375|NCT02554773|589572734|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
163235376|NCT02554773|589572733|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
163235377|NCT02554773|589572734|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
163235378|NCT02554773|589572733|FG000|Original Dose Regimen (SAS 1)|Death|1|||
163235379|NCT02554773|589572734|FG001|Original Dose Regimen (SAS 1)|Death|0|||
163235380|NCT02554773|589572733|FG000|Original Dose Regimen (SAS 1)|Other|4|||
163235381|NCT02554773|589572734|FG001|Original Dose Regimen (SAS 1)|Other|0|||
163235382|NCT02554773|589572733|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
163235383|NCT02554773|589572734|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
163235384|NCT02554773|589572733|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
163235385|NCT02554773|589572734|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
163235386|NCT02554773|589572733|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
163235387|NCT02554773|589572734|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
163235388|NCT02554773|589572733|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
163235389|NCT02554773|589572734|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
163235390|NCT02956629|589572738|FG000|Overall Study|Adverse Event|0|||
163235391|NCT02956629|589572739|FG001|Overall Study|Adverse Event|0|||
163235392|NCT02956629|589572740|FG002|Overall Study|Adverse Event|1|||
163235393|NCT02956629|589572741|FG003|Overall Study|Adverse Event|0|||
163235394|NCT02956629|589572742|FG004|Overall Study|Adverse Event|0|||
163348544|NCT00922441|589985334|FG001|Overall Study|Protocol Violation|0|||
163348545|NCT00922441|589985335|FG002|Overall Study|Protocol Violation|2|||
163348546|NCT00922441|589985333|FG000|Overall Study|Withdrawal by Subject|0|||
163348547|NCT00922441|589985334|FG001|Overall Study|Withdrawal by Subject|0|||
163348548|NCT00922441|589985335|FG002|Overall Study|Withdrawal by Subject|1|||
163348549|NCT00523549|589985338|FG000|Overall Study|Adverse Event|6|||
163348550|NCT00523549|589985339|FG001|Overall Study|Adverse Event|3|||
163348551|NCT00523549|589985338|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163348552|NCT00523549|589985339|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163141330|NCT02219464|589227868|FG000|Overall Study|catheter malfunction|1|||
163141331|NCT02219464|589227869|FG001|Overall Study|catheter malfunction|0|||
163141332|NCT00984256|589227870|FG000|Overall Study|Withdrawal by Subject|0|||
163141333|NCT00984256|589227871|FG001|Overall Study|Withdrawal by Subject|1|||
163141334|NCT02544321|589227877|FG000|Overall Study|Withdrawal by Subject|1|||
163141335|NCT02544321|589227878|FG001|Overall Study|Withdrawal by Subject|2|||
163141336|NCT02544321|589227877|FG000|Overall Study|Adverse Event|1|||
163141337|NCT02544321|589227878|FG001|Overall Study|Adverse Event|1|||
163141338|NCT02544321|589227877|FG000|Overall Study|Protocol Violation|0|||
163141339|NCT02544321|589227878|FG001|Overall Study|Protocol Violation|1|||
163141340|NCT03529110|589227879|FG000|Overall Study|Progressive Disease|66|||
163141341|NCT03529110|589227880|FG001|Overall Study|Progressive Disease|158|||
163141342|NCT03529110|589227879|FG000|Overall Study|Clinical Progression|4|||
163141343|NCT03529110|589227880|FG001|Overall Study|Clinical Progression|12|||
163141344|NCT03529110|589227879|FG000|Overall Study|Adverse Event|35|||
163141345|NCT03529110|589227880|FG001|Overall Study|Adverse Event|17|||
163141346|NCT03529110|589227879|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
163141347|NCT03529110|589227880|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
163141348|NCT03529110|589227879|FG000|Overall Study|Lack of Efficacy|3|||
163141349|NCT03529110|589227880|FG001|Overall Study|Lack of Efficacy|3|||
163141350|NCT03529110|589227879|FG000|Overall Study|Physician Decision|2|||
163141351|NCT03529110|589227880|FG001|Overall Study|Physician Decision|8|||
163141352|NCT03529110|589227879|FG000|Overall Study|Miscellaneous|2|||
163235395|NCT02956629|589572743|FG005|Overall Study|Adverse Event|0|||
163235396|NCT02956629|589572738|FG000|Overall Study|Lost to Follow-up|2|||
163235397|NCT02956629|589572739|FG001|Overall Study|Lost to Follow-up|5|||
163235398|NCT02956629|589572740|FG002|Overall Study|Lost to Follow-up|3|||
163235399|NCT02956629|589572741|FG003|Overall Study|Lost to Follow-up|1|||
163235400|NCT02956629|589572742|FG004|Overall Study|Lost to Follow-up|0|||
163235401|NCT02956629|589572743|FG005|Overall Study|Lost to Follow-up|1|||
163235402|NCT02956629|589572738|FG000|Overall Study|Withdrawal by Subject|3|||
163235403|NCT02956629|589572739|FG001|Overall Study|Withdrawal by Subject|1|||
163235404|NCT02956629|589572740|FG002|Overall Study|Withdrawal by Subject|0|||
163235405|NCT02956629|589572741|FG003|Overall Study|Withdrawal by Subject|0|||
163235406|NCT02956629|589572742|FG004|Overall Study|Withdrawal by Subject|0|||
163235407|NCT02956629|589572743|FG005|Overall Study|Withdrawal by Subject|0|||
163235408|NCT03224468|589572747|FG000|Overall Study|Did not obtain MM card|53|||
163235409|NCT03224468|589572748|FG001|Overall Study|Did not obtain MM card|0|||
163235410|NCT03224468|589572747|FG000|Overall Study|Lost to Follow-up|4|||
163235411|NCT03224468|589572748|FG001|Overall Study|Lost to Follow-up|11|||
163235412|NCT03224468|589572747|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
163235413|NCT03224468|589572748|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
163235414|NCT04713748|589572749|FG000|Overall Study|Not enough kits allocated|35|||
163235415|NCT00406029|589572750|FG000|Overall Study|Adverse Event|12|||
163235416|NCT00406029|589572751|FG001|Overall Study|Adverse Event|2|||
163235417|NCT00406029|589572752|FG002|Overall Study|Adverse Event|5|||
163235418|NCT00406029|589572753|FG003|Overall Study|Adverse Event|10|||
163235419|NCT00406029|589572754|FG004|Overall Study|Adverse Event|7|||
163235420|NCT00406029|589572750|FG000|Overall Study|Withdrawal by Subject|3|||
163235421|NCT00406029|589572751|FG001|Overall Study|Withdrawal by Subject|4|||
163235422|NCT00406029|589572752|FG002|Overall Study|Withdrawal by Subject|2|||
163235423|NCT00406029|589572753|FG003|Overall Study|Withdrawal by Subject|2|||
163235424|NCT00406029|589572754|FG004|Overall Study|Withdrawal by Subject|0|||
163235425|NCT00406029|589572750|FG000|Overall Study|Protocol Violation|1|||
163235426|NCT00406029|589572751|FG001|Overall Study|Protocol Violation|2|||
163235427|NCT00406029|589572752|FG002|Overall Study|Protocol Violation|0|||
163235428|NCT00406029|589572753|FG003|Overall Study|Protocol Violation|2|||
163235429|NCT00406029|589572754|FG004|Overall Study|Protocol Violation|0|||
163235430|NCT00406029|589572750|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
163235431|NCT00406029|589572751|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
163235432|NCT00406029|589572752|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
163235433|NCT00406029|589572753|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
163235434|NCT00406029|589572754|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
163235435|NCT00406029|589572750|FG000|Overall Study|Randomized in Error|0|||
163235436|NCT00406029|589572751|FG001|Overall Study|Randomized in Error|0|||
163235437|NCT00406029|589572752|FG002|Overall Study|Randomized in Error|2|||
163235438|NCT00406029|589572753|FG003|Overall Study|Randomized in Error|3|||
163235439|NCT00406029|589572754|FG004|Overall Study|Randomized in Error|1|||
163235440|NCT01557946|589572755|FG000|Overall Study|Adverse Event|3|||
163235441|NCT01557946|589572756|FG001|Overall Study|Adverse Event|0|||
163235442|NCT04067141|589572757|FG000|First Intervention|Withdrawal by Subject|0|||
163235443|NCT04067141|589572758|FG001|First Intervention|Withdrawal by Subject|1|||
163235444|NCT04067141|589572757|FG000|Second Intervention|Adverse Event|0|||
163235445|NCT04067141|589572758|FG001|Second Intervention|Adverse Event|2|||
163235446|NCT02013765|589572761|FG000|Overall Study|Trial was terminated by sponsor|1|||
163235447|NCT00718042|589572763|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
163235448|NCT00718042|589572764|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
163235449|NCT00718042|589572765|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
163235450|NCT00718042|589572766|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
163235451|NCT00718042|589572767|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
163235452|NCT00718042|589572768|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
163235453|NCT00718042|589572763|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
163235454|NCT00718042|589572764|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
163235455|NCT00718042|589572765|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
163235456|NCT00718042|589572766|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
163235457|NCT00718042|589572767|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
163235458|NCT00718042|589572768|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
163235459|NCT00718042|589572763|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
163235460|NCT00718042|589572764|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
163235461|NCT00718042|589572765|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
163235462|NCT00718042|589572766|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
163235463|NCT00718042|589572767|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
163235464|NCT00718042|589572768|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
163235465|NCT00718042|589572763|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
163235466|NCT00718042|589572764|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
163235467|NCT00718042|589572765|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
163235468|NCT00718042|589572766|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
163409512|NCT05048719|590209394|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163235469|NCT00718042|589572767|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
163348553|NCT00523549|589985338|FG000|Overall Study|Protocol Deviation|3|||
163348554|NCT00523549|589985339|FG001|Overall Study|Protocol Deviation|1|||
163348555|NCT00523549|589985338|FG000|Overall Study|Patient withdrew consent|7|||
163348556|NCT00523549|589985339|FG001|Overall Study|Patient withdrew consent|6|||
163348557|NCT00523549|589985338|FG000|Overall Study|Lost to Follow-up|3|||
163348558|NCT00523549|589985339|FG001|Overall Study|Lost to Follow-up|5|||
163348559|NCT00439647|589985340|FG000|Overall Study|Withdrawal by Subject|25|||
163348560|NCT00439647|589985341|FG001|Overall Study|Withdrawal by Subject|22|||
163348561|NCT00439647|589985340|FG000|Overall Study|Death|15|||
163348562|NCT00439647|589985341|FG001|Overall Study|Death|18|||
163348563|NCT00439647|589985340|FG000|Overall Study|Adverse Event|11|||
163348564|NCT00439647|589985341|FG001|Overall Study|Adverse Event|11|||
163348565|NCT00439647|589985340|FG000|Overall Study|Lost to Follow-up|4|||
163348566|NCT00439647|589985341|FG001|Overall Study|Lost to Follow-up|12|||
163348567|NCT00439647|589985340|FG000|Overall Study|Protocol Violation|3|||
163348568|NCT00439647|589985341|FG001|Overall Study|Protocol Violation|4|||
163348569|NCT00439647|589985340|FG000|Overall Study|Lack of Efficacy|0|||
163348570|NCT00439647|589985341|FG001|Overall Study|Lack of Efficacy|4|||
163348571|NCT02005029|589985342|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
163348572|NCT02005029|589985343|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
163348573|NCT03371485|589985344|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
163348574|NCT03371485|589985344|FG000|2-year Follow-up|Death|5|||
163348575|NCT01264887|589985345|FG000|Overall Study|Adverse Event|5|||
163348576|NCT01264887|589985345|FG000|Overall Study|Death|7|||
163348577|NCT01264887|589985345|FG000|Overall Study|Lack of Efficacy|5|||
163348578|NCT01264887|589985345|FG000|Overall Study|Physician Decision|4|||
163348579|NCT01264887|589985345|FG000|Overall Study|Withdrawal by Subject|6|||
163348580|NCT01264887|589985345|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
163348581|NCT01264887|589985345|FG000|Overall Study|Other|2|||
163348582|NCT02853305|589985349|FG000|Overall Study|Death|287|||
163348583|NCT02853305|589985350|FG001|Overall Study|Death|249|||
163348584|NCT02853305|589985351|FG002|Overall Study|Death|300|||
163348585|NCT02853305|589985349|FG000|Overall Study|Withdrawal by Subject|2|||
163348586|NCT02853305|589985350|FG001|Overall Study|Withdrawal by Subject|8|||
163348587|NCT02853305|589985351|FG002|Overall Study|Withdrawal by Subject|3|||
163348588|NCT02853305|589985349|FG000|Overall Study|Transferred to Extension Study|46|||
163348589|NCT02853305|589985350|FG001|Overall Study|Transferred to Extension Study|30|||
163348590|NCT02853305|589985351|FG002|Overall Study|Transferred to Extension Study|25|||
163348591|NCT02853305|589985349|FG000|Overall Study|Did Not Continue on Extension Study|16|||
163348592|NCT02853305|589985350|FG001|Overall Study|Did Not Continue on Extension Study|20|||
163348593|NCT02853305|589985351|FG002|Overall Study|Did Not Continue on Extension Study|24|||
163348594|NCT00677092|589985354|FG000|Overall Study|Adverse Event|1|||
163348595|NCT00677092|589985354|FG000|Overall Study|Lost to Follow-up|1|||
163141353|NCT03529110|589227880|FG001|Overall Study|Miscellaneous|5|||
163141354|NCT03493945|589227881|FG000|Phase I Dose Escalation|Ineligible|0|||
163141355|NCT03493945|589227882|FG001|Phase I Dose Escalation|Ineligible|0|||
163141356|NCT03493945|589227883|FG002|Phase I Dose Escalation|Ineligible|1|||
163141357|NCT03493945|589227884|FG003|Phase I Dose Escalation|Ineligible|0|||
163141358|NCT03493945|589227885|FG004|Phase I Dose Escalation|Ineligible|0|||
163141359|NCT03493945|589227886|FG005|Phase I Dose Escalation|Ineligible|0|||
163141360|NCT03493945|589227887|FG006|Phase I Dose Escalation|Ineligible|0|||
163141361|NCT03493945|589227881|FG000|Phase I Dose Escalation|New therapy|0|||
163141362|NCT03493945|589227882|FG001|Phase I Dose Escalation|New therapy|1|||
163141363|NCT03493945|589227883|FG002|Phase I Dose Escalation|New therapy|0|||
163141364|NCT03493945|589227884|FG003|Phase I Dose Escalation|New therapy|0|||
163141365|NCT03493945|589227885|FG004|Phase I Dose Escalation|New therapy|0|||
163141366|NCT03493945|589227886|FG005|Phase I Dose Escalation|New therapy|0|||
163141367|NCT03493945|589227887|FG006|Phase I Dose Escalation|New therapy|0|||
163141368|NCT03493945|589227881|FG000|Phase II Dose Expansion|Refused further treatment|0|||
163141369|NCT03493945|589227882|FG001|Phase II Dose Expansion|Refused further treatment|0|||
163141370|NCT03493945|589227883|FG002|Phase II Dose Expansion|Refused further treatment|0|||
163141371|NCT03493945|589227884|FG003|Phase II Dose Expansion|Refused further treatment|0|||
163141372|NCT03493945|589227885|FG004|Phase II Dose Expansion|Refused further treatment|1|||
163348596|NCT00677092|589985354|FG000|Overall Study|Withdrawal by Subject|3|||
163348597|NCT00677092|589985354|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
163141373|NCT03493945|589227886|FG005|Phase II Dose Expansion|Refused further treatment|1|||
163141374|NCT03493945|589227887|FG006|Phase II Dose Expansion|Refused further treatment|0|||
163141375|NCT03493945|589227881|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
163348598|NCT02381652|589985359|FG000|Overall Study|Withdrawal by Subject|0|||
163348599|NCT02381652|589985360|FG001|Overall Study|Withdrawal by Subject|0|||
163348600|NCT02381652|589985361|FG002|Overall Study|Withdrawal by Subject|1|||
163348601|NCT04772313|589985362|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
163348602|NCT04772313|589985362|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
163348603|NCT01836198|589985363|FG000|Part A, Period 2|Protocol Violation|0|||
163348604|NCT01836198|589985364|FG001|Part A, Period 2|Protocol Violation|1|||
163141376|NCT03493945|589227882|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
163141377|NCT03493945|589227883|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
163141378|NCT03493945|589227884|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
163141379|NCT03493945|589227885|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
163141380|NCT03493945|589227886|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
163141381|NCT03493945|589227887|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
163141382|NCT05104450|589227888|FG000|Overall Study|Death|1|||
163141383|NCT05104450|589227889|FG001|Overall Study|Death|2|||
163141384|NCT05104450|589227888|FG000|Overall Study|Withdrawal by Subject|3|||
163141385|NCT05104450|589227889|FG001|Overall Study|Withdrawal by Subject|1|||
163141386|NCT01584232|589227890|FG000|Overall Study|Adverse Event|3|||
163141387|NCT01584232|589227891|FG001|Overall Study|Adverse Event|1|||
163141388|NCT01584232|589227890|FG000|Overall Study|Withdrawal by Subject|2|||
163141389|NCT01584232|589227891|FG001|Overall Study|Withdrawal by Subject|1|||
163141390|NCT01584232|589227890|FG000|Overall Study|Physician Decision|2|||
163141391|NCT01584232|589227891|FG001|Overall Study|Physician Decision|1|||
163141392|NCT01584232|589227890|FG000|Overall Study|Lost to Follow-up|1|||
163141393|NCT01584232|589227891|FG001|Overall Study|Lost to Follow-up|0|||
163141394|NCT01307319|589227892|FG000|Overall Study|Adverse Event|2|||
163141395|NCT01307319|589227893|FG001|Overall Study|Adverse Event|2|||
163141396|NCT01307319|589227894|FG002|Overall Study|Adverse Event|1|||
163141397|NCT01307319|589227892|FG000|Overall Study|Lost to Follow-up|1|||
163141398|NCT01307319|589227893|FG001|Overall Study|Lost to Follow-up|0|||
163141399|NCT01307319|589227894|FG002|Overall Study|Lost to Follow-up|1|||
163141400|NCT01307319|589227892|FG000|Overall Study|Protocol Violation|1|||
163141401|NCT01307319|589227893|FG001|Overall Study|Protocol Violation|1|||
163141402|NCT01307319|589227894|FG002|Overall Study|Protocol Violation|0|||
163141403|NCT01307319|589227892|FG000|Overall Study|Withdrawal by Subject|0|||
163141404|NCT01307319|589227893|FG001|Overall Study|Withdrawal by Subject|1|||
163141405|NCT01307319|589227894|FG002|Overall Study|Withdrawal by Subject|2|||
163141406|NCT01307319|589227892|FG000|Overall Study|Other|0|||
163141407|NCT01307319|589227893|FG001|Overall Study|Other|4|||
163141408|NCT01307319|589227894|FG002|Overall Study|Other|3|||
163141409|NCT02735239|589227896|FG000|Overall Study|Adverse Event|0|||
163141410|NCT02735239|589227897|FG001|Overall Study|Adverse Event|0|||
163141411|NCT02735239|589227898|FG002|Overall Study|Adverse Event|4|||
163141412|NCT02735239|589227899|FG003|Overall Study|Adverse Event|0|||
163141413|NCT02735239|589227900|FG004|Overall Study|Adverse Event|0|||
163141414|NCT02735239|589227901|FG005|Overall Study|Adverse Event|0|||
163141415|NCT02735239|589227896|FG000|Overall Study|Death|1|||
163141416|NCT02735239|589227897|FG001|Overall Study|Death|1|||
163141417|NCT02735239|589227898|FG002|Overall Study|Death|0|||
163141418|NCT02735239|589227899|FG003|Overall Study|Death|0|||
163141419|NCT02735239|589227900|FG004|Overall Study|Death|0|||
163141420|NCT02735239|589227901|FG005|Overall Study|Death|0|||
163141421|NCT02735239|589227896|FG000|Overall Study|Physician Decision|0|||
163141422|NCT02735239|589227897|FG001|Overall Study|Physician Decision|0|||
163141423|NCT02735239|589227898|FG002|Overall Study|Physician Decision|1|||
163141424|NCT02735239|589227899|FG003|Overall Study|Physician Decision|0|||
163141425|NCT02735239|589227900|FG004|Overall Study|Physician Decision|0|||
163141426|NCT02735239|589227901|FG005|Overall Study|Physician Decision|0|||
163141427|NCT02735239|589227896|FG000|Overall Study|Progressive disease|3|||
163141428|NCT02735239|589227897|FG001|Overall Study|Progressive disease|1|||
163141429|NCT02735239|589227898|FG002|Overall Study|Progressive disease|3|||
163141430|NCT02735239|589227899|FG003|Overall Study|Progressive disease|0|||
163141431|NCT02735239|589227900|FG004|Overall Study|Progressive disease|0|||
163141432|NCT02735239|589227901|FG005|Overall Study|Progressive disease|2|||
163141433|NCT02735239|589227896|FG000|Overall Study|Withdrawal by Subject|0|||
163141434|NCT02735239|589227897|FG001|Overall Study|Withdrawal by Subject|1|||
163141435|NCT02735239|589227898|FG002|Overall Study|Withdrawal by Subject|0|||
163141436|NCT02735239|589227899|FG003|Overall Study|Withdrawal by Subject|0|||
163141437|NCT02735239|589227900|FG004|Overall Study|Withdrawal by Subject|0|||
163141438|NCT02735239|589227901|FG005|Overall Study|Withdrawal by Subject|0|||
163141439|NCT02152631|589227907|FG000|Overall Study|Adverse Event|32|||
163141440|NCT02152631|589227908|FG001|Overall Study|Adverse Event|4|||
163141441|NCT02152631|589227907|FG000|Overall Study|Withdrawal by Subject|13|||
163141442|NCT02152631|589227908|FG001|Overall Study|Withdrawal by Subject|16|||
163141443|NCT02152631|589227907|FG000|Overall Study|Noncompliance with study drug|1|||
163141444|NCT02152631|589227908|FG001|Overall Study|Noncompliance with study drug|0|||
163141445|NCT02152631|589227907|FG000|Overall Study|Physician Decision|1|||
163141446|NCT02152631|589227908|FG001|Overall Study|Physician Decision|2|||
163141447|NCT02152631|589227907|FG000|Overall Study|Lost to Follow-up|0|||
163141448|NCT02152631|589227908|FG001|Overall Study|Lost to Follow-up|1|||
163141449|NCT02152631|589227907|FG000|Overall Study|On Treatment|19|||
163141450|NCT02152631|589227908|FG001|Overall Study|On Treatment|3|||
163141451|NCT00527735|589227913|FG000|Overall Study|Disease progression|47|||
163141452|NCT00527735|589227914|FG001|Overall Study|Disease progression|61|||
163141453|NCT00527735|589227915|FG002|Overall Study|Disease progression|53|||
163141454|NCT00527735|589227913|FG000|Overall Study|Death|23|||
163141455|NCT00527735|589227914|FG001|Overall Study|Death|13|||
163141456|NCT00527735|589227915|FG002|Overall Study|Death|15|||
163141457|NCT00527735|589227913|FG000|Overall Study|Completed treatment in treatment phase|14|||
163141458|NCT00527735|589227914|FG001|Overall Study|Completed treatment in treatment phase|13|||
163141459|NCT00527735|589227915|FG002|Overall Study|Completed treatment in treatment phase|18|||
163141460|NCT00527735|589227913|FG000|Overall Study|Adverse Event|10|||
163141461|NCT00527735|589227914|FG001|Overall Study|Adverse Event|6|||
163141462|NCT00527735|589227915|FG002|Overall Study|Adverse Event|7|||
163141463|NCT00527735|589227913|FG000|Overall Study|Not identified|5|||
163141464|NCT00527735|589227914|FG001|Overall Study|Not identified|5|||
163141465|NCT00527735|589227915|FG002|Overall Study|Not identified|5|||
163141466|NCT00527735|589227913|FG000|Overall Study|Withdrawal by Subject|5|||
163141467|NCT00527735|589227914|FG001|Overall Study|Withdrawal by Subject|4|||
163141468|NCT00527735|589227915|FG002|Overall Study|Withdrawal by Subject|3|||
163141469|NCT00527735|589227913|FG000|Overall Study|No longer met study criteria|2|||
163141470|NCT00527735|589227914|FG001|Overall Study|No longer met study criteria|2|||
163141471|NCT00527735|589227915|FG002|Overall Study|No longer met study criteria|1|||
163141472|NCT00527735|589227913|FG000|Overall Study|Lost to Follow-up|0|||
163141473|NCT00527735|589227914|FG001|Overall Study|Lost to Follow-up|0|||
163141474|NCT00527735|589227915|FG002|Overall Study|Lost to Follow-up|3|||
163141475|NCT00527735|589227913|FG000|Overall Study|Poor compliance or noncompliance|0|||
163141476|NCT00527735|589227914|FG001|Overall Study|Poor compliance or noncompliance|1|||
163141477|NCT00527735|589227915|FG002|Overall Study|Poor compliance or noncompliance|1|||
163141478|NCT00527735|589227913|FG000|Overall Study|Completed treatment during maintenance|2|||
163141479|NCT00527735|589227914|FG001|Overall Study|Completed treatment during maintenance|2|||
163141480|NCT00527735|589227915|FG002|Overall Study|Completed treatment during maintenance|1|||
163141481|NCT01080807|589227920|FG000|Overall Study|Adverse Event|9|||
163141482|NCT01080807|589227921|FG001|Overall Study|Adverse Event|1|||
163141483|NCT01080807|589227920|FG000|Overall Study|Lack of Efficacy|0|||
163141484|NCT01080807|589227921|FG001|Overall Study|Lack of Efficacy|1|||
163141485|NCT01080807|589227920|FG000|Overall Study|Withdrawal by Subject|7|||
163141486|NCT01080807|589227921|FG001|Overall Study|Withdrawal by Subject|2|||
163141487|NCT01080807|589227920|FG000|Overall Study|Protocol Violation|7|||
163141488|NCT01080807|589227921|FG001|Overall Study|Protocol Violation|6|||
163141489|NCT01080807|589227920|FG000|Overall Study|Lost to Follow-up|6|||
163141490|NCT01080807|589227921|FG001|Overall Study|Lost to Follow-up|4|||
163141491|NCT01080807|589227920|FG000|Overall Study|Noncompliance with drug administration|1|||
163141492|NCT01080807|589227921|FG001|Overall Study|Noncompliance with drug administration|1|||
163141493|NCT01080807|589227920|FG000|Overall Study|Noncompliance to study procedures|1|||
163141494|NCT01080807|589227921|FG001|Overall Study|Noncompliance to study procedures|1|||
163141495|NCT01080807|589227920|FG000|Overall Study|Began working day shift|0|||
163141496|NCT01080807|589227921|FG001|Overall Study|Began working day shift|2|||
163141497|NCT01080807|589227920|FG000|Overall Study|Laid off or terminated from job|1|||
163141498|NCT01080807|589227921|FG001|Overall Study|Laid off or terminated from job|2|||
163141499|NCT01080807|589227920|FG000|Overall Study|Stopped working consistent night shifts|0|||
163141500|NCT01080807|589227921|FG001|Overall Study|Stopped working consistent night shifts|1|||
163141501|NCT01080807|589227920|FG000|Overall Study|Work schedule changing|1|||
163141502|NCT01080807|589227921|FG001|Overall Study|Work schedule changing|1|||
163141503|NCT01080807|589227920|FG000|Overall Study|Work schedule and travel|0|||
163141504|NCT01080807|589227921|FG001|Overall Study|Work schedule and travel|1|||
163141505|NCT01080807|589227920|FG000|Overall Study|Switched to first shift|1|||
163141506|NCT01080807|589227921|FG001|Overall Study|Switched to first shift|0|||
163141507|NCT01080807|589227920|FG000|Overall Study|Moved away without notifying center|1|||
163141508|NCT01080807|589227921|FG001|Overall Study|Moved away without notifying center|0|||
163141509|NCT03922581|589227929|FG000|Overall Study|Lost to Follow-up|20|||
163141510|NCT03922581|589227930|FG001|Overall Study|Lost to Follow-up|9|||
163141511|NCT03922581|589227929|FG000|Overall Study|Physician Decision|1|||
163141512|NCT03922581|589227930|FG001|Overall Study|Physician Decision|1|||
163141513|NCT03922581|589227929|FG000|Overall Study|Withdrawal by Subject|1|||
163141514|NCT03922581|589227930|FG001|Overall Study|Withdrawal by Subject|0|||
163141515|NCT00764699|589227933|FG000|Overall Study|PI left and study terminated|3|||
163141516|NCT02223715|589227934|FG000|Overall Study|Death|31|||
163141517|NCT02223715|589227934|FG000|Overall Study|Lost to Follow-up|73|||
163141518|NCT01745367|589227935|FG000|Overall Study|Death|1|||
163141519|NCT01745367|589227936|FG001|Overall Study|Death|0|||
163141520|NCT01745367|589227935|FG000|Overall Study|Withdrawal by Subject|1|||
163141521|NCT01745367|589227936|FG001|Overall Study|Withdrawal by Subject|2|||
163235470|NCT00718042|589572768|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
163141522|NCT01745367|589227935|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
163141523|NCT01745367|589227936|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
163141524|NCT01745367|589227935|FG000|Overall Study|Other Reasons Unspecified|0|||
163141525|NCT01745367|589227936|FG001|Overall Study|Other Reasons Unspecified|2|||
163141526|NCT02107703|589227940|FG000|Overall Study|Withdrawal by Subject|46|||
163141527|NCT02107703|589227941|FG001|Overall Study|Withdrawal by Subject|21|||
163235471|NCT00718042|589572763|FG000|Donor Follow-up|Lost to Follow-up|13|||
163348605|NCT01836198|589985365|FG002|Part A, Period 2|Protocol Violation|0|||
163348606|NCT03187353|589985366|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
163348607|NCT03187353|589985367|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
163348608|NCT03187353|589985366|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
163348609|NCT03187353|589985367|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
163348610|NCT03187353|589985366|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
163348611|NCT03187353|589985367|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
163348612|NCT03187353|589985366|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
163141528|NCT02107703|589227940|FG000|Overall Study|Lost to Follow-up|20|||
163141529|NCT02107703|589227941|FG001|Overall Study|Lost to Follow-up|9|||
163141530|NCT02107703|589227940|FG000|Overall Study|On study treatment/follow up|48|||
163141531|NCT02107703|589227941|FG001|Overall Study|On study treatment/follow up|5|||
163141532|NCT02366312|589227942|FG000|Overall Study|Lost to Follow-up|0|||
163141533|NCT02366312|589227943|FG001|Overall Study|Lost to Follow-up|1|||
163141534|NCT00965081|589227944|FG000|Overall Study|Adverse Event|14|||
163141535|NCT00965081|589227945|FG001|Overall Study|Adverse Event|9|||
163141536|NCT00965081|589227944|FG000|Overall Study|Lack of Efficacy|2|||
163141537|NCT00965081|589227945|FG001|Overall Study|Lack of Efficacy|5|||
163141538|NCT00965081|589227944|FG000|Overall Study|Lost to Follow-up|4|||
163141539|NCT00965081|589227945|FG001|Overall Study|Lost to Follow-up|5|||
163141540|NCT00965081|589227944|FG000|Overall Study|Physician Decision|2|||
163141541|NCT00965081|589227945|FG001|Overall Study|Physician Decision|0|||
163141542|NCT00965081|589227944|FG000|Overall Study|Protocol Violation|2|||
163141543|NCT00965081|589227945|FG001|Overall Study|Protocol Violation|5|||
163141544|NCT00965081|589227944|FG000|Overall Study|Sponsor Decision|1|||
163141545|NCT00965081|589227945|FG001|Overall Study|Sponsor Decision|0|||
163141546|NCT00965081|589227944|FG000|Overall Study|Withdrawal by Subject|4|||
163141547|NCT00965081|589227945|FG001|Overall Study|Withdrawal by Subject|7|||
163141548|NCT00965081|589227944|FG000|Overall Study|Switched to Rescue Arm|5|||
163141549|NCT00965081|589227945|FG001|Overall Study|Switched to Rescue Arm|12|||
163141550|NCT01020786|589227950|FG000|Induction Period|Entry Criteria Not Met|2|||
163141551|NCT01020786|589227950|FG000|Induction Period|Adverse Event|10|||
163141552|NCT01020786|589227950|FG000|Induction Period|Progressive Disease|31|||
163141553|NCT01020786|589227950|FG000|Induction Period|Investigator Decision|3|||
163141554|NCT01020786|589227950|FG000|Induction Period|Withdrawal by Subject|3|||
163141555|NCT01020786|589227950|FG000|Maintenance Period|Adverse Event|8|||
163141556|NCT01020786|589227950|FG000|Maintenance Period|Progressive Disease|43|||
163141557|NCT01020786|589227950|FG000|Maintenance Period|Withdrawal by Subject|8|||
163141558|NCT01020786|589227950|FG000|Maintenance Period|Sponsor Decision|1|||
163141559|NCT01338818|589227959|FG000|Overall Study|Adverse Event|8|||
163141560|NCT01338818|589227959|FG000|Overall Study|Lack of Efficacy|5|||
163141561|NCT01338818|589227959|FG000|Overall Study|no longer require study drug|1|||
163141562|NCT01338818|589227959|FG000|Overall Study|Withdrawal by Subject|11|||
163141563|NCT01338818|589227959|FG000|Overall Study|Lost to Follow-up|4|||
163141564|NCT01338818|589227959|FG000|Overall Study|Administrative problems|3|||
163141565|NCT01338818|589227959|FG000|Overall Study|Protocol Deviation|4|||
163141566|NCT05202418|589227960|FG000|Overall Study|Withdrawal by Subject|2|||
163141567|NCT05202418|589227961|FG001|Overall Study|Withdrawal by Subject|1|||
163141568|NCT05202418|589227960|FG000|Overall Study|Lost to Follow-up|1|||
163141569|NCT05202418|589227961|FG001|Overall Study|Lost to Follow-up|1|||
163141570|NCT03901144|589227964|FG000|Overall Study|Lost to Follow-up|1|||
163141571|NCT03901144|589227965|FG001|Overall Study|Lost to Follow-up|1|||
163141572|NCT03901144|589227966|FG002|Overall Study|Lost to Follow-up|1|||
163141573|NCT03901144|589227967|FG003|Overall Study|Lost to Follow-up|1|||
163141574|NCT02491983|589227968|FG000|Overall Study|Physician Decision|1|||
163141575|NCT02491983|589227969|FG001|Overall Study|Physician Decision|0|||
163141576|NCT02491983|589227968|FG000|Overall Study|Not meet selection criteria|1|||
163141577|NCT02491983|589227969|FG001|Overall Study|Not meet selection criteria|0|||
163141578|NCT02491983|589227968|FG000|Overall Study|Withdrawal by Subject|0|||
163141579|NCT02491983|589227969|FG001|Overall Study|Withdrawal by Subject|1|||
163141580|NCT02021565|589227970|FG000|Baseline Through Intervention|Death|0|||
163141581|NCT02021565|589227971|FG001|Baseline Through Intervention|Death|1|||
163141582|NCT02021565|589227970|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
163141583|NCT02021565|589227971|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
163141584|NCT02021565|589227970|FG000|Baseline Through Intervention|Protocol Violation|0|||
163141585|NCT02021565|589227971|FG001|Baseline Through Intervention|Protocol Violation|7|||
163141586|NCT02021565|589227970|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
163141587|NCT02021565|589227971|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
163141588|NCT02021565|589227970|FG000|3-month Follow-up|Death|3|||
163348613|NCT03187353|589985367|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
163141589|NCT02021565|589227971|FG001|3-month Follow-up|Death|0|||
163141590|NCT02021565|589227970|FG000|3-month Follow-up|Withdrawal by Subject|4|||
163348614|NCT03187353|589985366|FG000|Washout (2 Weeks)|Adverse Event|2|||
163141591|NCT02021565|589227971|FG001|3-month Follow-up|Withdrawal by Subject|0|||
163141592|NCT02021565|589227970|FG000|3-month Follow-up|Protocol Violation|3|||
163141593|NCT02021565|589227971|FG001|3-month Follow-up|Protocol Violation|2|||
163235472|NCT00718042|589572764|FG001|Donor Follow-up|Lost to Follow-up|0|||
163235473|NCT00718042|589572765|FG002|Donor Follow-up|Lost to Follow-up|0|||
163235474|NCT00718042|589572766|FG003|Donor Follow-up|Lost to Follow-up|0|||
163235475|NCT00718042|589572767|FG004|Donor Follow-up|Lost to Follow-up|19|||
163235476|NCT00718042|589572768|FG005|Donor Follow-up|Lost to Follow-up|0|||
163235477|NCT02822794|589572769|FG000|Overall Study|Withdrew Consent|1|||
163235478|NCT02822794|589572770|FG001|Overall Study|Withdrew Consent|0|||
163235479|NCT04788147|589572771|FG000|Overall Study|Screen Failure|3|||
163235480|NCT04788147|589572772|FG001|Overall Study|Screen Failure|10|||
163235481|NCT04788147|589572771|FG000|Overall Study|Incomplete RMRS image session|2|||
163235482|NCT04788147|589572772|FG001|Overall Study|Incomplete RMRS image session|0|||
163235483|NCT05101252|589572773|FG000|Overall Study|Unsatisfactory Test Article|1|||
163235484|NCT05101252|589572774|FG001|Overall Study|Unsatisfactory Test Article|0|||
163235485|NCT05101252|589572773|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
163235486|NCT05101252|589572774|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
163235487|NCT05101252|589572773|FG000|Overall Study|Withdrew Consent during study|0|||
163235488|NCT05101252|589572774|FG001|Overall Study|Withdrew Consent during study|1|||
163235489|NCT05101252|589572773|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
163235490|NCT05101252|589572774|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
163235491|NCT02266381|589572775|FG000|Overall Study|Physician Decision|3|||
163235492|NCT02266381|589572776|FG001|Overall Study|Physician Decision|5|||
163235493|NCT02266381|589572777|FG002|Overall Study|Physician Decision|4|||
163235494|NCT02520531|589572784|FG000|Overall Study|Revision of study device components|2|||
163235495|NCT02520531|589572785|FG001|Overall Study|Revision of study device components|2|||
163235496|NCT02520531|589572784|FG000|Overall Study|Death|1|||
163235497|NCT02520531|589572785|FG001|Overall Study|Death|2|||
163235498|NCT02520531|589572784|FG000|Overall Study|Lost to Follow-up|1|||
163235499|NCT02520531|589572785|FG001|Overall Study|Lost to Follow-up|1|||
163235500|NCT02520531|589572784|FG000|Overall Study|Meet exclusion criterion|0|||
163235501|NCT02520531|589572785|FG001|Overall Study|Meet exclusion criterion|1|||
163235502|NCT02520531|589572784|FG000|Overall Study|Withdrawal by Subject|1|||
163235503|NCT02520531|589572785|FG001|Overall Study|Withdrawal by Subject|0|||
163235504|NCT02520531|589572784|FG000|Overall Study|Not study device|1|||
163235505|NCT02520531|589572785|FG001|Overall Study|Not study device|0|||
163235506|NCT02138214|589572789|FG000|Overall Study|Withdrawal by Subject|0|||
163235507|NCT02138214|589572790|FG001|Overall Study|Withdrawal by Subject|1|||
163235508|NCT02138214|589572791|FG002|Overall Study|Withdrawal by Subject|0|||
163235509|NCT02138214|589572789|FG000|Overall Study|Lost to Follow-up|0|||
163235510|NCT02138214|589572790|FG001|Overall Study|Lost to Follow-up|2|||
163235511|NCT02138214|589572791|FG002|Overall Study|Lost to Follow-up|4|||
163235512|NCT02138214|589572789|FG000|Overall Study|Screen Failure|0|||
163235513|NCT02138214|589572790|FG001|Overall Study|Screen Failure|1|||
163235514|NCT02138214|589572791|FG002|Overall Study|Screen Failure|0|||
163235515|NCT02185768|589572792|FG000|Overall Study|Patients were not treated|2|||
163235516|NCT03221257|589572793|FG000|Overall Study|Lost to Follow-up|0|||
163235517|NCT03221257|589572794|FG001|Overall Study|Lost to Follow-up|1|||
163235518|NCT03221257|589572793|FG000|Overall Study|Withdrawal by Subject|1|||
163235519|NCT03221257|589572794|FG001|Overall Study|Withdrawal by Subject|1|||
163235520|NCT01334866|589572795|FG000|Overall Study|Withdrawal by Subject|10|||
163235521|NCT01334866|589572795|FG000|Overall Study|Lost to Follow-up|3|||
163235522|NCT01334866|589572795|FG000|Overall Study|Physician Decision|3|||
163235523|NCT01334866|589572795|FG000|Overall Study|medically necessary prior to procedure|2|||
163235524|NCT01334866|589572795|FG000|Overall Study|medically necessary post-procedure|1|||
163235525|NCT01971346|589572799|FG000|Overall Study|Protocol Violation|3|||
163235526|NCT01971346|589572799|FG000|Overall Study|Lost to Follow-up|2|||
163235527|NCT01971346|589572799|FG000|Overall Study|Withdrawal by Subject|2|||
163235528|NCT01971346|589572799|FG000|Overall Study|Physician Decision|1|||
163235529|NCT04187196|589572802|FG000|Overall Study|Screen Failure|2|||
163235530|NCT04187196|589572803|FG001|Overall Study|Screen Failure|0|||
163235531|NCT01687166|589572804|FG000|Overall Study|Attempt subject|2|||
163235532|NCT01687166|589572805|FG001|Overall Study|Attempt subject|3|||
163235533|NCT01687166|589572806|FG002|Overall Study|Attempt subject|2|||
163235534|NCT01687166|589572807|FG003|Overall Study|Attempt subject|0|||
163235535|NCT01687166|589572804|FG000|Overall Study|Did not meet eligibility criteria|4|||
163235536|NCT01687166|589572805|FG001|Overall Study|Did not meet eligibility criteria|6|||
163235537|NCT01687166|589572806|FG002|Overall Study|Did not meet eligibility criteria|1|||
163235538|NCT01687166|589572807|FG003|Overall Study|Did not meet eligibility criteria|1|||
163235539|NCT01687166|589572804|FG000|Overall Study|Adverse Event|2|||
163235540|NCT01687166|589572805|FG001|Overall Study|Adverse Event|1|||
163235541|NCT01687166|589572806|FG002|Overall Study|Adverse Event|0|||
163235542|NCT01687166|589572807|FG003|Overall Study|Adverse Event|0|||
163235543|NCT01687166|589572804|FG000|Overall Study|Physician Decision|3|||
163235544|NCT01687166|589572805|FG001|Overall Study|Physician Decision|2|||
163235545|NCT01687166|589572806|FG002|Overall Study|Physician Decision|1|||
163235546|NCT01687166|589572807|FG003|Overall Study|Physician Decision|0|||
163235547|NCT01687166|589572804|FG000|Overall Study|Withdrawal by Subject|11|||
163235548|NCT01687166|589572805|FG001|Overall Study|Withdrawal by Subject|4|||
163141594|NCT03575403|589227973|FG000|Overall Study|Adverse Event|1|||
163141595|NCT03575403|589227974|FG001|Overall Study|Adverse Event|0|||
163141596|NCT03575403|589227975|FG002|Overall Study|Adverse Event|0|||
163141597|NCT03575403|589227973|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
163141598|NCT03575403|589227974|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
163141599|NCT03575403|589227975|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
163141600|NCT02292719|589227976|FG000|Overall Study|Withdrawal by Subject|0|||
163141601|NCT02292719|589227977|FG001|Overall Study|Withdrawal by Subject|0|||
163141602|NCT02292719|589227978|FG002|Overall Study|Withdrawal by Subject|0|||
163141603|NCT02292719|589227979|FG003|Overall Study|Withdrawal by Subject|1|||
163141604|NCT02292719|589227980|FG004|Overall Study|Withdrawal by Subject|1|||
163141605|NCT02292719|589227981|FG005|Overall Study|Withdrawal by Subject|0|||
163141606|NCT02292719|589227976|FG000|Overall Study|Subject enrolled in new study.|0|||
163141607|NCT02292719|589227977|FG001|Overall Study|Subject enrolled in new study.|0|||
163141608|NCT02292719|589227978|FG002|Overall Study|Subject enrolled in new study.|1|||
163141609|NCT02292719|589227979|FG003|Overall Study|Subject enrolled in new study.|0|||
163141610|NCT02292719|589227980|FG004|Overall Study|Subject enrolled in new study.|0|||
163141611|NCT02292719|589227981|FG005|Overall Study|Subject enrolled in new study.|0|||
163141612|NCT01332994|589227982|FG000|Overall Study|Adverse Event|34|||
163141613|NCT01332994|589227982|FG000|Overall Study|Death|1|||
163141614|NCT01332994|589227982|FG000|Overall Study|Lack of Efficacy|1|||
163141615|NCT01332994|589227982|FG000|Overall Study|Lost to Follow-up|4|||
163141616|NCT01332994|589227982|FG000|Overall Study|Protocol Violation|6|||
163141617|NCT01332994|589227982|FG000|Overall Study|Withdrawal by Subject|15|||
163141618|NCT01332994|589227982|FG000|Overall Study|Administrative Problem|2|||
163141619|NCT01332994|589227982|FG000|Overall Study|Other|8|||
163141620|NCT00731679|589227984|FG000|Overall Study|Adverse Event|7|||
163141621|NCT00731679|589227985|FG001|Overall Study|Adverse Event|8|||
163141622|NCT00731679|589227984|FG000|Overall Study|Withdrawal by Subject|8|||
163141623|NCT00731679|589227985|FG001|Overall Study|Withdrawal by Subject|8|||
163141624|NCT00731679|589227984|FG000|Overall Study|Lost to Follow-up|7|||
163141625|NCT00731679|589227985|FG001|Overall Study|Lost to Follow-up|8|||
163141626|NCT00731679|589227984|FG000|Overall Study|Noncompliance|0|||
163141627|NCT00731679|589227985|FG001|Overall Study|Noncompliance|1|||
163141628|NCT00731679|589227984|FG000|Overall Study|Pregnancy|0|||
163141629|NCT00731679|589227985|FG001|Overall Study|Pregnancy|1|||
163141630|NCT03089580|589227991|FG000|Overall Study|Lost to Follow-up|2|||
163141631|NCT03087513|589227992|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
163141632|NCT04628780|589227993|FG000|Overall Study|Death|0|||
163141633|NCT04628780|589227994|FG001|Overall Study|Death|1|||
163141634|NCT04628780|589227995|FG002|Overall Study|Death|0|||
163141635|NCT04628780|589227996|FG003|Overall Study|Death|0|||
163141636|NCT04628780|589227997|FG004|Overall Study|Death|1|||
163141637|NCT04628780|589227998|FG005|Overall Study|Death|0|||
163141638|NCT04628780|589227993|FG000|Overall Study|Physician Decision|2|||
163141639|NCT04628780|589227994|FG001|Overall Study|Physician Decision|0|||
163141640|NCT04628780|589227995|FG002|Overall Study|Physician Decision|0|||
163141641|NCT04628780|589227996|FG003|Overall Study|Physician Decision|0|||
163141642|NCT04628780|589227997|FG004|Overall Study|Physician Decision|2|||
163141643|NCT04628780|589227998|FG005|Overall Study|Physician Decision|0|||
163141644|NCT04628780|589227993|FG000|Overall Study|Progressive disease|2|||
163141645|NCT04628780|589227994|FG001|Overall Study|Progressive disease|2|||
163141646|NCT04628780|589227995|FG002|Overall Study|Progressive disease|2|||
163141647|NCT04628780|589227996|FG003|Overall Study|Progressive disease|3|||
163141648|NCT04628780|589227997|FG004|Overall Study|Progressive disease|9|||
163141649|NCT04628780|589227998|FG005|Overall Study|Progressive disease|4|||
163141650|NCT04628780|589227993|FG000|Overall Study|Withdrawal by Subject|0|||
163141651|NCT04628780|589227994|FG001|Overall Study|Withdrawal by Subject|1|||
163141652|NCT04628780|589227995|FG002|Overall Study|Withdrawal by Subject|2|||
163141653|NCT04628780|589227996|FG003|Overall Study|Withdrawal by Subject|0|||
163141654|NCT04628780|589227997|FG004|Overall Study|Withdrawal by Subject|3|||
163141655|NCT04628780|589227998|FG005|Overall Study|Withdrawal by Subject|1|||
163141656|NCT04628780|589227993|FG000|Overall Study|Global deterioration of health status|0|||
163141657|NCT04628780|589227994|FG001|Overall Study|Global deterioration of health status|0|||
163235549|NCT01687166|589572806|FG002|Overall Study|Withdrawal by Subject|3|||
163235550|NCT01687166|589572807|FG003|Overall Study|Withdrawal by Subject|0|||
163141658|NCT04628780|589227995|FG002|Overall Study|Global deterioration of health status|0|||
163141659|NCT04628780|589227996|FG003|Overall Study|Global deterioration of health status|0|||
163141660|NCT04628780|589227997|FG004|Overall Study|Global deterioration of health status|1|||
163141661|NCT04628780|589227998|FG005|Overall Study|Global deterioration of health status|1|||
163141662|NCT03269994|589228000|FG000|Overall Study|Withdrawal by Subject|4|||
163141663|NCT03269994|589228001|FG001|Overall Study|Withdrawal by Subject|5|||
163141664|NCT03269994|589228000|FG000|Overall Study|Unresectable at surgery|39|||
163141665|NCT03269994|589228001|FG001|Overall Study|Unresectable at surgery|58|||
163141666|NCT03269994|589228000|FG000|Overall Study|Patient canceled surgery|5|||
163141667|NCT03269994|589228001|FG001|Overall Study|Patient canceled surgery|14|||
163235551|NCT01687166|589572804|FG000|Overall Study|Lost to Follow-up|2|||
163235552|NCT01687166|589572805|FG001|Overall Study|Lost to Follow-up|5|||
163235553|NCT01687166|589572806|FG002|Overall Study|Lost to Follow-up|1|||
163235554|NCT01687166|589572807|FG003|Overall Study|Lost to Follow-up|0|||
163235555|NCT01687166|589572804|FG000|Overall Study|Equipment/Device Availability|0|||
163235556|NCT01687166|589572805|FG001|Overall Study|Equipment/Device Availability|1|||
163235557|NCT01687166|589572806|FG002|Overall Study|Equipment/Device Availability|0|||
163235558|NCT01687166|589572807|FG003|Overall Study|Equipment/Device Availability|0|||
163235559|NCT01687166|589572804|FG000|Overall Study|Death|1|||
163235560|NCT01687166|589572805|FG001|Overall Study|Death|1|||
163235561|NCT01687166|589572806|FG002|Overall Study|Death|0|||
163235562|NCT01687166|589572807|FG003|Overall Study|Death|0|||
163235563|NCT01687166|589572804|FG000|Overall Study|Protocol Violation|1|||
163235564|NCT01687166|589572805|FG001|Overall Study|Protocol Violation|1|||
163235565|NCT01687166|589572806|FG002|Overall Study|Protocol Violation|1|||
163235566|NCT01687166|589572807|FG003|Overall Study|Protocol Violation|0|||
163235567|NCT01687166|589572804|FG000|Overall Study|Subject moved out of state|0|||
163235568|NCT01687166|589572805|FG001|Overall Study|Subject moved out of state|1|||
163235569|NCT01687166|589572806|FG002|Overall Study|Subject moved out of state|0|||
163235570|NCT01687166|589572807|FG003|Overall Study|Subject moved out of state|0|||
163235571|NCT01687166|589572804|FG000|Overall Study|Patient unable to be compliant|1|||
163235572|NCT01687166|589572805|FG001|Overall Study|Patient unable to be compliant|0|||
163235573|NCT01687166|589572806|FG002|Overall Study|Patient unable to be compliant|0|||
163235574|NCT01687166|589572807|FG003|Overall Study|Patient unable to be compliant|0|||
163235575|NCT01687166|589572804|FG000|Overall Study|Physician choice to use different device|1|||
163235576|NCT01687166|589572805|FG001|Overall Study|Physician choice to use different device|2|||
163235577|NCT01687166|589572806|FG002|Overall Study|Physician choice to use different device|4|||
163235578|NCT01687166|589572807|FG003|Overall Study|Physician choice to use different device|0|||
163235579|NCT01687166|589572804|FG000|Overall Study|Insurance|0|||
163235580|NCT01687166|589572805|FG001|Overall Study|Insurance|0|||
163235581|NCT01687166|589572806|FG002|Overall Study|Insurance|1|||
163235582|NCT01687166|589572807|FG003|Overall Study|Insurance|1|||
163235583|NCT02755831|589572808|FG000|Overall Study|Lost to Follow-up|3|||
163235584|NCT02755831|589572809|FG001|Overall Study|Lost to Follow-up|3|||
163235585|NCT02316717|589572810|FG000|Overall Study|Adverse Event|2|||
163235586|NCT02316717|589572811|FG001|Overall Study|Adverse Event|2|||
163235587|NCT02316717|589572812|FG002|Overall Study|Adverse Event|0|||
163235588|NCT02316717|589572810|FG000|Overall Study|Lost to Follow-up|1|||
163235589|NCT02316717|589572811|FG001|Overall Study|Lost to Follow-up|2|||
163235590|NCT02316717|589572812|FG002|Overall Study|Lost to Follow-up|1|||
163235591|NCT02316717|589572810|FG000|Overall Study|Non compliance|3|||
163235592|NCT02316717|589572811|FG001|Overall Study|Non compliance|1|||
163235593|NCT02316717|589572812|FG002|Overall Study|Non compliance|0|||
163235594|NCT02316717|589572810|FG000|Overall Study|Protocol Violation|2|||
163235595|NCT02316717|589572811|FG001|Overall Study|Protocol Violation|0|||
163235596|NCT02316717|589572812|FG002|Overall Study|Protocol Violation|0|||
163235597|NCT02316717|589572810|FG000|Overall Study|Withdrawal by Subject|2|||
163235598|NCT02316717|589572811|FG001|Overall Study|Withdrawal by Subject|1|||
163235599|NCT02316717|589572812|FG002|Overall Study|Withdrawal by Subject|1|||
163235600|NCT02316717|589572810|FG000|Overall Study|Death|0|||
163235601|NCT02316717|589572811|FG001|Overall Study|Death|0|||
163235602|NCT02316717|589572812|FG002|Overall Study|Death|1|||
163235603|NCT02316717|589572810|FG000|Overall Study|Physician Decision|0|||
163235604|NCT02316717|589572811|FG001|Overall Study|Physician Decision|1|||
163235605|NCT02316717|589572812|FG002|Overall Study|Physician Decision|0|||
163235606|NCT02316717|589572810|FG000|Overall Study|TBC|1|||
163235607|NCT02316717|589572811|FG001|Overall Study|TBC|0|||
163235608|NCT02316717|589572812|FG002|Overall Study|TBC|0|||
163235609|NCT02460198|589572815|FG000|Overall Study|Adverse Event|1|||
163235610|NCT02460198|589572816|FG001|Overall Study|Adverse Event|3|||
163235611|NCT02460198|589572815|FG000|Overall Study|Death|36|||
163235612|NCT02460198|589572816|FG001|Overall Study|Death|28|||
163235613|NCT02460198|589572815|FG000|Overall Study|Lost to Follow-up|1|||
163235614|NCT02460198|589572816|FG001|Overall Study|Lost to Follow-up|1|||
163235615|NCT02460198|589572815|FG000|Overall Study|Transferred to Extension Study|15|||
163235616|NCT02460198|589572816|FG001|Overall Study|Transferred to Extension Study|15|||
163235617|NCT02460198|589572815|FG000|Overall Study|Withdrawal by Subject|2|||
163235618|NCT02460198|589572816|FG001|Overall Study|Withdrawal by Subject|4|||
163235619|NCT02460198|589572815|FG000|Overall Study|Site Terminated By Sponsor|0|||
163235620|NCT02460198|589572816|FG001|Overall Study|Site Terminated By Sponsor|1|||
163235621|NCT02460198|589572815|FG000|Overall Study|Did Not Continue on Extension Study|6|||
163235622|NCT02460198|589572816|FG001|Overall Study|Did Not Continue on Extension Study|11|||
163235623|NCT00931307|589572817|FG000|Overall Study|Lack of Efficacy|12|||
163235624|NCT00931307|589572817|FG000|Overall Study|Biomicroscopy|1|||
163235625|NCT00965848|589572820|FG000|Overall Study|Protocol Violation|3|||
163235626|NCT00965848|589572821|FG001|Overall Study|Protocol Violation|0|||
163235627|NCT00965848|589572822|FG002|Overall Study|Protocol Violation|1|||
163235628|NCT00965848|589572820|FG000|Overall Study|Death|11|||
163235629|NCT00965848|589572821|FG001|Overall Study|Death|1|||
163235630|NCT00965848|589572822|FG002|Overall Study|Death|5|||
163235631|NCT00965848|589572820|FG000|Overall Study|Lost to Follow-up|0|||
163235632|NCT00965848|589572821|FG001|Overall Study|Lost to Follow-up|0|||
163235633|NCT00965848|589572822|FG002|Overall Study|Lost to Follow-up|1|||
163235634|NCT00965848|589572820|FG000|Overall Study|Withdrawal by Subject|1|||
163235635|NCT00965848|589572821|FG001|Overall Study|Withdrawal by Subject|0|||
163235636|NCT00965848|589572822|FG002|Overall Study|Withdrawal by Subject|0|||
163235637|NCT00965848|589572820|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
163235638|NCT00965848|589572821|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
163235639|NCT00965848|589572822|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
163235640|NCT00965848|589572820|FG000|Overall Study|Not Clinically Evaluable|7|||
163235641|NCT00965848|589572821|FG001|Overall Study|Not Clinically Evaluable|1|||
163235642|NCT00965848|589572822|FG002|Overall Study|Not Clinically Evaluable|1|||
163235643|NCT00965848|589572820|FG000|Overall Study|Other|5|||
163235644|NCT00965848|589572821|FG001|Overall Study|Other|0|||
163235645|NCT00965848|589572822|FG002|Overall Study|Other|1|||
163235646|NCT00813761|589572823|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
163235647|NCT00813761|589572824|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
163235648|NCT00813761|589572825|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
163235649|NCT00813761|589572826|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
163235650|NCT00813761|589572823|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
163235651|NCT00813761|589572824|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
163235652|NCT00813761|589572825|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
163235653|NCT00813761|589572826|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
163235654|NCT00813761|589572823|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
163235655|NCT00813761|589572824|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
163235656|NCT00813761|589572825|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
163235657|NCT00813761|589572826|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
163235658|NCT00813761|589572823|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
163235659|NCT00813761|589572824|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
163235660|NCT00813761|589572825|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
163235661|NCT00813761|589572826|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
163235662|NCT00813761|589572823|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
163235663|NCT00813761|589572824|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
163235664|NCT00813761|589572825|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
163235665|NCT00813761|589572826|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
163235666|NCT00813761|589572823|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
163235667|NCT00813761|589572824|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
163235668|NCT00813761|589572825|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
163235669|NCT00813761|589572826|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
163235670|NCT00813761|589572823|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
163235671|NCT00813761|589572824|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
163235672|NCT00813761|589572825|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
163235673|NCT00813761|589572826|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
163235674|NCT00813761|589572823|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
163235675|NCT00813761|589572824|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
163235676|NCT00813761|589572825|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
163235677|NCT00813761|589572826|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
163235678|NCT00813761|589572823|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
163235679|NCT00813761|589572824|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
163235680|NCT00813761|589572825|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
163235681|NCT00813761|589572826|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
163235682|NCT00813761|589572823|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
163235683|NCT00813761|589572824|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
163235684|NCT00813761|589572825|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
163235685|NCT00813761|589572826|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
163235686|NCT00813761|589572823|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
163235687|NCT00813761|589572824|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
163235688|NCT00813761|589572825|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
163235689|NCT00813761|589572826|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
163348615|NCT03187353|589985367|FG001|Washout (2 Weeks)|Adverse Event|0|||
163348616|NCT03187353|589985366|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
163348617|NCT03187353|589985367|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
163348618|NCT02215954|589985368|FG000|Overall Study|Adverse Event|0|||
163348619|NCT02215954|589985369|FG001|Overall Study|Adverse Event|0|||
163348620|NCT02215954|589985370|FG002|Overall Study|Adverse Event|1|||
163348621|NCT02215954|589985368|FG000|Overall Study|Withdrawal by Subject|0|||
163348622|NCT02215954|589985369|FG001|Overall Study|Withdrawal by Subject|0|||
163348623|NCT02215954|589985370|FG002|Overall Study|Withdrawal by Subject|2|||
163235690|NCT00813761|589572823|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
163235691|NCT00813761|589572824|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
163235692|NCT00813761|589572825|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
163348624|NCT02215954|589985368|FG000|Overall Study|Not exposed|1|||
163235693|NCT00813761|589572826|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
163235694|NCT00691210|589572827|FG000|Overall Study|Progression of Disease|0|||
163235695|NCT00691210|589572828|FG001|Overall Study|Progression of Disease|0|||
163235696|NCT00691210|589572829|FG002|Overall Study|Progression of Disease|0|||
163235697|NCT00691210|589572830|FG003|Overall Study|Progression of Disease|2|||
163235698|NCT00691210|589572831|FG004|Overall Study|Progression of Disease|0|||
163235699|NCT00691210|589572832|FG005|Overall Study|Progression of Disease|0|||
163235700|NCT00691210|589572833|FG006|Overall Study|Progression of Disease|0|||
163235701|NCT00691210|589572834|FG007|Overall Study|Progression of Disease|0|||
163235702|NCT00691210|589572827|FG000|Overall Study|Lack of Efficacy|0|||
163235703|NCT00691210|589572828|FG001|Overall Study|Lack of Efficacy|0|||
163235704|NCT00691210|589572829|FG002|Overall Study|Lack of Efficacy|0|||
163235705|NCT00691210|589572830|FG003|Overall Study|Lack of Efficacy|1|||
163235706|NCT00691210|589572831|FG004|Overall Study|Lack of Efficacy|0|||
163235707|NCT00691210|589572832|FG005|Overall Study|Lack of Efficacy|1|||
163235708|NCT00691210|589572833|FG006|Overall Study|Lack of Efficacy|0|||
163235709|NCT00691210|589572834|FG007|Overall Study|Lack of Efficacy|0|||
163235710|NCT02047604|589572837|FG000|Overall Study|Withdrawal by Subject|0|||
163235711|NCT02047604|589572838|FG001|Overall Study|Withdrawal by Subject|0|||
163235712|NCT02047604|589572839|FG002|Overall Study|Withdrawal by Subject|0|||
163235713|NCT02047604|589572840|FG003|Overall Study|Withdrawal by Subject|0|||
163235714|NCT02047604|589572841|FG004|Overall Study|Withdrawal by Subject|1|||
163235715|NCT02047604|589572842|FG005|Overall Study|Withdrawal by Subject|1|||
163235716|NCT00983814|589572843|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
163235717|NCT00983814|589572844|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
163235718|NCT00983814|589572845|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
163235719|NCT00983814|589572843|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
163235720|NCT00983814|589572844|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
163235721|NCT00983814|589572845|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
163235722|NCT00983814|589572843|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
163235723|NCT00983814|589572844|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
163235724|NCT00983814|589572845|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
163235725|NCT00983814|589572843|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
163235726|NCT00983814|589572844|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
163235727|NCT00983814|589572845|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
163235728|NCT00983814|589572843|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
163235729|NCT00983814|589572844|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
163235730|NCT00983814|589572845|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
163235731|NCT01181895|589572846|FG000|Overall Study|Adverse Event|3|||
163235732|NCT01181895|589572847|FG001|Overall Study|Adverse Event|1|||
163235733|NCT01181895|589572848|FG002|Overall Study|Adverse Event|1|||
163235734|NCT01181895|589572846|FG000|Overall Study|Lack of Efficacy|8|||
163235735|NCT01181895|589572847|FG001|Overall Study|Lack of Efficacy|9|||
163235736|NCT01181895|589572848|FG002|Overall Study|Lack of Efficacy|9|||
163235737|NCT01181895|589572846|FG000|Overall Study|Protocol Violation|2|||
163235738|NCT01181895|589572847|FG001|Overall Study|Protocol Violation|1|||
163235739|NCT01181895|589572848|FG002|Overall Study|Protocol Violation|0|||
163235740|NCT01181895|589572846|FG000|Overall Study|Lost to Follow-up|0|||
163235741|NCT01181895|589572847|FG001|Overall Study|Lost to Follow-up|1|||
163235742|NCT01181895|589572848|FG002|Overall Study|Lost to Follow-up|2|||
163235743|NCT01181895|589572846|FG000|Overall Study|Investigator Discretion|1|||
163235744|NCT01181895|589572847|FG001|Overall Study|Investigator Discretion|2|||
163235745|NCT01181895|589572848|FG002|Overall Study|Investigator Discretion|1|||
163235746|NCT01181895|589572846|FG000|Overall Study|Withdrawal by Subject|3|||
163235747|NCT01181895|589572847|FG001|Overall Study|Withdrawal by Subject|0|||
163235748|NCT01181895|589572848|FG002|Overall Study|Withdrawal by Subject|5|||
163235749|NCT00555438|589572849|FG000|10 Days Post-operative|Death|4|||
163235750|NCT00555438|589572849|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
163235751|NCT03136068|589575035|FG000|Overall Study|Lost to Follow-up|1|||
163235752|NCT03136068|589575036|FG001|Overall Study|Lost to Follow-up|1|||
163235753|NCT03136068|589575035|FG000|Overall Study|Protocol Violation|1|||
163235754|NCT03136068|589575036|FG001|Overall Study|Protocol Violation|0|||
163235755|NCT00432380|589575037|FG000|Overall Study|Migrated/moved from study area|3|||
163235756|NCT00432380|589575038|FG001|Overall Study|Migrated/moved from study area|4|||
163235757|NCT00432380|589575039|FG002|Overall Study|Migrated/moved from study area|1|||
163235758|NCT00432380|589575037|FG000|Overall Study|Adverse Event|1|||
163235759|NCT00432380|589575038|FG001|Overall Study|Adverse Event|0|||
163235760|NCT00432380|589575039|FG002|Overall Study|Adverse Event|0|||
163235761|NCT01071395|589575040|FG000|Overall Study|Withdrawal by Subject|2|||
163235762|NCT01071395|589575041|FG001|Overall Study|Withdrawal by Subject|1|||
163235763|NCT01071395|589575040|FG000|Overall Study|Adverse Event|3|||
163235764|NCT01071395|589575041|FG001|Overall Study|Adverse Event|1|||
163235765|NCT04419493|589575042|FG000|Wash-out After Period 1|Adverse Event|1|||
163235766|NCT04419493|589575043|FG001|Wash-out After Period 1|Adverse Event|2|||
163235767|NCT04419493|589575044|FG002|Wash-out After Period 1|Adverse Event|1|||
163235768|NCT04419493|589575045|FG003|Wash-out After Period 1|Adverse Event|0|||
163348625|NCT02215954|589985369|FG001|Overall Study|Not exposed|1|||
163235769|NCT00524134|589575046|FG000|Overall Study|Withdrawal by Subject|1|||
163235770|NCT00524134|589575046|FG000|Overall Study|Physician Decision|1|||
163235771|NCT03794089|589575047|FG000|Overall Study|Lost to Follow-up|4|||
163235772|NCT03794089|589575048|FG001|Overall Study|Lost to Follow-up|1|||
163235773|NCT03794089|589575047|FG000|Overall Study|Withdrawal by Subject|2|||
163235774|NCT03794089|589575048|FG001|Overall Study|Withdrawal by Subject|0|||
163235775|NCT03985423|589575049|FG000|Overall Study|Adverse Event|1|||
163235776|NCT03985423|589575049|FG000|Overall Study|Death|2|||
163235777|NCT03985423|589575049|FG000|Overall Study|Physician Decision|1|||
163235778|NCT03985423|589575049|FG000|Overall Study|Withdrawal by Subject|2|||
163235779|NCT03985423|589575049|FG000|Overall Study|Lack of insurance and citizenship|1|||
163235780|NCT01045447|589575060|FG000|Overall Study|Adverse Event|0|||
163235781|NCT01045447|589575061|FG001|Overall Study|Adverse Event|1|||
163235782|NCT01045447|589575060|FG000|Overall Study|Lack of Efficacy|3|||
163235783|NCT01045447|589575061|FG001|Overall Study|Lack of Efficacy|1|||
163235784|NCT01045447|589575060|FG000|Overall Study|Protocol Violation|6|||
163235785|NCT01045447|589575061|FG001|Overall Study|Protocol Violation|3|||
163235786|NCT01045447|589575060|FG000|Overall Study|Withdrawal Criteria|10|||
163235787|NCT01045447|589575061|FG001|Overall Study|Withdrawal Criteria|10|||
163235788|NCT01045447|589575060|FG000|Overall Study|Unclassified|17|||
163235789|NCT01045447|589575061|FG001|Overall Study|Unclassified|13|||
163235790|NCT01782131|589575065|FG000|Overall Study|Death|93|||
163235791|NCT01782131|589575066|FG001|Overall Study|Death|96|||
163235792|NCT01782131|589575065|FG000|Overall Study|Lost to Follow-up|1|||
163235793|NCT01782131|589575066|FG001|Overall Study|Lost to Follow-up|3|||
163235794|NCT01782131|589575065|FG000|Overall Study|Withdrawal by Subject|10|||
163235795|NCT01782131|589575066|FG001|Overall Study|Withdrawal by Subject|10|||
163235796|NCT01782131|589575065|FG000|Overall Study|Randomized but not treated|5|||
163235797|NCT01782131|589575066|FG001|Overall Study|Randomized but not treated|5|||
163235798|NCT01782131|589575065|FG000|Overall Study|Reason not provided|0|||
163235799|NCT01782131|589575066|FG001|Overall Study|Reason not provided|1|||
163235800|NCT01627249|589575067|FG000|Overall Study|Death|3|||
163235801|NCT01627249|589575068|FG001|Overall Study|Death|5|||
163235802|NCT01627249|589575069|FG002|Overall Study|Death|3|||
163235803|NCT01627249|589575067|FG000|Overall Study|Withdrawal by Subject|12|||
163235804|NCT01627249|589575068|FG001|Overall Study|Withdrawal by Subject|6|||
163235805|NCT01627249|589575069|FG002|Overall Study|Withdrawal by Subject|9|||
163235806|NCT01627249|589575067|FG000|Overall Study|Missed Visit|1|||
163235807|NCT01627249|589575068|FG001|Overall Study|Missed Visit|1|||
163235808|NCT01627249|589575069|FG002|Overall Study|Missed Visit|0|||
163235809|NCT00796718|589575070|FG000|Overall Study|Adverse Event|2|||
163235810|NCT00796718|589575070|FG000|Overall Study|Exclusion Criteria|1|||
163235811|NCT00796718|589575070|FG000|Overall Study|Lost to Follow-up|5|||
163235812|NCT00796718|589575070|FG000|Overall Study|Withdrawal by Informed Consent|1|||
163235813|NCT03266588|589575071|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
163235814|NCT03266588|589575072|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
163235815|NCT03266588|589575073|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
163235816|NCT03266588|589575071|FG000|Observational Period|Withdrawal by Subject|44|||
163235817|NCT03266588|589575072|FG001|Observational Period|Withdrawal by Subject|22|||
163235818|NCT03266588|589575073|FG002|Observational Period|Withdrawal by Subject|13|||
163235819|NCT03266588|589575071|FG000|Observational Period|Non-compliance|18|||
163235820|NCT03266588|589575072|FG001|Observational Period|Non-compliance|12|||
163235821|NCT03266588|589575073|FG002|Observational Period|Non-compliance|10|||
163235822|NCT03266588|589575071|FG000|Observational Period|Lost to Follow-up|8|||
163235823|NCT03266588|589575072|FG001|Observational Period|Lost to Follow-up|12|||
163235824|NCT03266588|589575073|FG002|Observational Period|Lost to Follow-up|4|||
163235825|NCT03266588|589575071|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
163235826|NCT03266588|589575072|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
163235827|NCT03266588|589575073|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
163235828|NCT03266588|589575071|FG000|Observational Period|Protocol Deviation|1|||
163235829|NCT03266588|589575072|FG001|Observational Period|Protocol Deviation|0|||
163235830|NCT03266588|589575073|FG002|Observational Period|Protocol Deviation|0|||
163235831|NCT03266588|589575071|FG000|Observational Period|Other Reasons|3|||
163235832|NCT03266588|589575072|FG001|Observational Period|Other Reasons|0|||
163235833|NCT03266588|589575073|FG002|Observational Period|Other Reasons|1|||
163235834|NCT03266588|589575071|FG000|Long-term Treatment Period|Adverse Event|33|||
163235835|NCT03266588|589575072|FG001|Long-term Treatment Period|Adverse Event|17|||
163235836|NCT03266588|589575073|FG002|Long-term Treatment Period|Adverse Event|8|||
163235837|NCT03266588|589575071|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
163235838|NCT03266588|589575072|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
163235839|NCT03266588|589575073|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
163235840|NCT03266588|589575071|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
163235841|NCT03266588|589575072|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
163235842|NCT03266588|589575073|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
163235843|NCT03266588|589575071|FG000|Long-term Treatment Period|Non-Compliance|126|||
163235844|NCT03266588|589575072|FG001|Long-term Treatment Period|Non-Compliance|57|||
163348626|NCT02215954|589985370|FG002|Overall Study|Not exposed|3|||
163348627|NCT00139659|589985371|FG000|Overall Study|Adverse Event|12|||
163348628|NCT00139659|589985372|FG001|Overall Study|Adverse Event|1|||
163348629|NCT00139659|589985371|FG000|Overall Study|Lack of Efficacy|1|||
163348630|NCT00139659|589985372|FG001|Overall Study|Lack of Efficacy|1|||
163348631|NCT00139659|589985371|FG000|Overall Study|Lost to Follow-up|7|||
163348632|NCT00139659|589985372|FG001|Overall Study|Lost to Follow-up|3|||
163348633|NCT00139659|589985371|FG000|Overall Study|Reason not Specified|6|||
163348634|NCT00139659|589985372|FG001|Overall Study|Reason not Specified|3|||
163348635|NCT00139659|589985371|FG000|Overall Study|Withdrawal by Subject|14|||
163348636|NCT00139659|589985372|FG001|Overall Study|Withdrawal by Subject|10|||
163348637|NCT02625922|589985378|FG000|Overall Study|Non-availability of IMP|1|||
163348638|NCT02625922|589985379|FG001|Overall Study|Non-availability of IMP|1|||
163348639|NCT02625922|589985378|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
163348640|NCT02625922|589985379|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
163348641|NCT00640042|589985380|FG000|Enrollment|Did not receive study drug|83|||
163348642|NCT02359552|589985381|FG000|Overall Study|Lost to Follow-up|3|||
163348643|NCT02359552|589985382|FG001|Overall Study|Lost to Follow-up|4|||
163348644|NCT02391116|589985395|FG000|Treatment|Withdrawal by Subject|1|||
163348645|NCT02391116|589985395|FG000|Treatment|Protocol Violation|1|||
163348646|NCT02391116|589985395|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
163348647|NCT02391116|589985395|FG000|Treatment|AE with Clinical PD|3|||
163348648|NCT02391116|589985395|FG000|Safety Follow-up|Adverse Event|1|||
163348649|NCT02391116|589985395|FG000|Safety Follow-up|Withdrawal by Subject|4|||
163348650|NCT02391116|589985395|FG000|Safety Follow-up|Switching to Other Therapy|4|||
163348651|NCT02391116|589985395|FG000|Safety Follow-up|No Follow Up|1|||
163348652|NCT02391116|589985395|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
163348653|NCT02391116|589985395|FG000|Active Follow-up|Withdrawal by Subject|1|||
163348654|NCT02391116|589985395|FG000|Active Follow-up|Switching to Other Therapy|2|||
163348655|NCT02391116|589985395|FG000|Survival Follow-up|Withdrawal by Subject|3|||
163348656|NCT02391116|589985395|FG000|Survival Follow-up|Switching to Other Therapy|1|||
163348657|NCT02109107|589985396|FG000|Overall Study|Lost to Follow-up|2|||
163348658|NCT01747629|589985398|FG000|Overall Study|Adverse Event|1|||
163348659|NCT01747629|589985399|FG001|Overall Study|Adverse Event|2|||
163348660|NCT01747629|589985398|FG000|Overall Study|Withdrawal by Subject|2|||
163348661|NCT01747629|589985399|FG001|Overall Study|Withdrawal by Subject|2|||
163348662|NCT01747629|589985398|FG000|Overall Study|Noncompliance|1|||
163348663|NCT01747629|589985399|FG001|Overall Study|Noncompliance|1|||
163348664|NCT01747629|589985398|FG000|Overall Study|Inclusion criteria not met|1|||
163348665|NCT01747629|589985399|FG001|Overall Study|Inclusion criteria not met|0|||
163348666|NCT01747629|589985398|FG000|Overall Study|Not treated|1|||
163348667|NCT01747629|589985399|FG001|Overall Study|Not treated|0|||
163348668|NCT01747629|589985398|FG000|Overall Study|Other|2|||
163348669|NCT01747629|589985399|FG001|Overall Study|Other|1|||
163348670|NCT00607789|589985400|FG000|Overall Study|Adverse Event|3|||
163348671|NCT00607789|589985401|FG001|Overall Study|Adverse Event|0|||
163348672|NCT00607789|589985400|FG000|Overall Study|Lack of Efficacy|0|||
163348673|NCT00607789|589985401|FG001|Overall Study|Lack of Efficacy|1|||
163348674|NCT00607789|589985400|FG000|Overall Study|Inadequate adherence|3|||
163348675|NCT00607789|589985401|FG001|Overall Study|Inadequate adherence|0|||
163348676|NCT00607789|589985400|FG000|Overall Study|Lost to Follow-up|0|||
163348677|NCT00607789|589985401|FG001|Overall Study|Lost to Follow-up|5|||
163348678|NCT00607789|589985400|FG000|Overall Study|Withdrawal by Subject|1|||
163348679|NCT00607789|589985401|FG001|Overall Study|Withdrawal by Subject|0|||
163348680|NCT06016127|589985402|FG000|Overall Study|Withdrawal by Subject|4|||
163348681|NCT06016127|589985403|FG001|Overall Study|Withdrawal by Subject|3|||
163348682|NCT03340766|589985404|FG000|Overall Study|Withdrawal by Subject|2|||
163348683|NCT03340766|589985405|FG001|Overall Study|Withdrawal by Subject|1|||
163348684|NCT03340766|589985406|FG002|Overall Study|Withdrawal by Subject|3|||
163348685|NCT03340766|589985404|FG000|Overall Study|Lost to Follow-up|0|||
163348686|NCT03340766|589985405|FG001|Overall Study|Lost to Follow-up|0|||
163348687|NCT03340766|589985406|FG002|Overall Study|Lost to Follow-up|1|||
163141668|NCT03269994|589228000|FG000|Overall Study|Preoperative progression|14|||
163141669|NCT03269994|589228001|FG001|Overall Study|Preoperative progression|9|||
163348688|NCT03340766|589985404|FG000|Overall Study|Death|6|||
163409513|NCT05048719|590209395|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163348689|NCT03340766|589985405|FG001|Overall Study|Death|7|||
163348690|NCT03340766|589985406|FG002|Overall Study|Death|4|||
163348691|NCT00240097|589985407|FG000|Part I|Adverse Event|1|||
163348692|NCT00240097|589985407|FG000|Part I|Death|1|||
163348693|NCT00240097|589985407|FG000|Part I|histology|1|||
163348694|NCT00240097|589985407|FG000|Part I|unevaluable|1|||
163348695|NCT00240097|589985407|FG000|Part II|did not continue from Part I|23|||
163348696|NCT01294358|589985408|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
163348697|NCT01294358|589985409|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
163348698|NCT01294358|589985410|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
163348699|NCT01294358|589985411|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
163235845|NCT03266588|589575073|FG002|Long-term Treatment Period|Non-Compliance|7|||
163235846|NCT03266588|589575071|FG000|Long-term Treatment Period|Pregnancy|11|||
163235847|NCT03266588|589575072|FG001|Long-term Treatment Period|Pregnancy|5|||
163235848|NCT03266588|589575073|FG002|Long-term Treatment Period|Pregnancy|0|||
163235849|NCT03266588|589575071|FG000|Long-term Treatment Period|Protocol Deviation|17|||
163235850|NCT03266588|589575072|FG001|Long-term Treatment Period|Protocol Deviation|10|||
163235851|NCT03266588|589575073|FG002|Long-term Treatment Period|Protocol Deviation|4|||
163235852|NCT03266588|589575071|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
163235853|NCT03266588|589575072|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
163235854|NCT03266588|589575073|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
163235855|NCT03266588|589575071|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
163235856|NCT03266588|589575072|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
163235857|NCT03266588|589575073|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
163235858|NCT03266588|589575071|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
163235859|NCT03266588|589575072|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
163235860|NCT03266588|589575073|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
163235861|NCT03266588|589575071|FG000|Long-term Treatment Period|Other Reasons|5|||
163235862|NCT03266588|589575072|FG001|Long-term Treatment Period|Other Reasons|0|||
163235863|NCT03266588|589575073|FG002|Long-term Treatment Period|Other Reasons|0|||
163235864|NCT03266588|589575071|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
163235865|NCT03266588|589575072|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
163235866|NCT03266588|589575073|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
163235867|NCT01073618|589575076|FG000|Overall Study|Death|208|||
163235868|NCT01073618|589575076|FG000|Overall Study|Adverse Event|19|||
163235869|NCT01073618|589575076|FG000|Overall Study|Other|80|||
163235870|NCT02044510|589575077|FG000|Overall Study|Adverse Event|1|||
163235871|NCT02044510|589575078|FG001|Overall Study|Adverse Event|2|||
163235872|NCT02039505|589575084|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
163235873|NCT02039505|589575085|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
163235874|NCT02039505|589575086|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
163235875|NCT02039505|589575087|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
163235876|NCT02039505|589575088|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
163235877|NCT02039505|589575089|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
163235878|NCT02039505|589575090|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
163235879|NCT02039505|589575084|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
163235880|NCT02039505|589575085|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
163235881|NCT02039505|589575086|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
163235882|NCT02039505|589575087|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
163235883|NCT02039505|589575088|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
163235884|NCT02039505|589575089|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
163235885|NCT02039505|589575090|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
163235886|NCT02039505|589575084|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
163235887|NCT02039505|589575085|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
163235888|NCT02039505|589575086|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
163235889|NCT02039505|589575087|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
163235890|NCT02039505|589575088|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
163235891|NCT02039505|589575089|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
163235892|NCT02039505|589575090|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
163235893|NCT02039505|589575084|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
163235894|NCT02039505|589575085|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
163235895|NCT02039505|589575086|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
163235896|NCT02039505|589575087|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
163235897|NCT02039505|589575088|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
163235898|NCT02039505|589575089|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
163235899|NCT02039505|589575090|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
163235900|NCT02039505|589575084|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
163235901|NCT02039505|589575085|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
163235902|NCT02039505|589575086|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
163235903|NCT02039505|589575087|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
163235904|NCT02039505|589575088|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
163235905|NCT02039505|589575089|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
163348700|NCT01294358|589985412|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
163348701|NCT01294358|589985408|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
163348702|NCT01294358|589985409|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
163348703|NCT01294358|589985410|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
163348704|NCT01294358|589985411|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
163235906|NCT02039505|589575090|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
163235907|NCT02039505|589575084|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
163235908|NCT02039505|589575085|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
163235909|NCT02039505|589575086|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
163235910|NCT02039505|589575087|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
163235911|NCT02039505|589575088|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
163235912|NCT02039505|589575089|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
163235913|NCT02039505|589575090|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
163235914|NCT02039505|589575084|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
163235915|NCT02039505|589575085|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
163235916|NCT02039505|589575086|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
163235917|NCT02039505|589575087|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
163235918|NCT02039505|589575088|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
163235919|NCT02039505|589575089|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
163235920|NCT02039505|589575090|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
163235921|NCT02039505|589575084|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
163235922|NCT02039505|589575085|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
163235923|NCT02039505|589575086|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
163235924|NCT02039505|589575087|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
163235925|NCT02039505|589575088|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
163235926|NCT02039505|589575089|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
163235927|NCT02039505|589575090|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
163235928|NCT02039505|589575084|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
163235929|NCT02039505|589575085|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
163235930|NCT02039505|589575086|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
163235931|NCT02039505|589575087|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
163235932|NCT02039505|589575088|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
163235933|NCT02039505|589575089|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
163348705|NCT01294358|589985412|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
163348706|NCT01294358|589985408|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
163348707|NCT01294358|589985409|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
163348708|NCT01294358|589985410|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
163348709|NCT01294358|589985411|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
163348710|NCT01294358|589985412|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
163348711|NCT01294358|589985408|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
163141670|NCT03269994|589228000|FG000|Overall Study|Preoperative infection|10|||
163141671|NCT03269994|589228001|FG001|Overall Study|Preoperative infection|4|||
163141672|NCT03269994|589228000|FG000|Overall Study|Kidney insufficiency|1|||
163141673|NCT03269994|589228001|FG001|Overall Study|Kidney insufficiency|0|||
163141674|NCT03269994|589228000|FG000|Overall Study|Drug allergy|0|||
163141675|NCT03269994|589228001|FG001|Overall Study|Drug allergy|2|||
163141676|NCT03269994|589228000|FG000|Overall Study|Operation changed to different resection|9|||
163141677|NCT03269994|589228001|FG001|Overall Study|Operation changed to different resection|0|||
163141678|NCT03269994|589228000|FG000|Overall Study|Preoperative steroid|0|||
163141679|NCT03269994|589228001|FG001|Overall Study|Preoperative steroid|3|||
163141680|NCT03269994|589228000|FG000|Overall Study|Accrual Closed|2|||
163141681|NCT03269994|589228001|FG001|Overall Study|Accrual Closed|0|||
163141682|NCT03269994|589228000|FG000|Overall Study|Operation changed to different resection|0|||
163141683|NCT03269994|589228001|FG001|Overall Study|Operation changed to different resection|10|||
163141684|NCT01288989|589228003|FG000|Overall Study|Death|0|||
163141685|NCT01288989|589228004|FG001|Overall Study|Death|0|||
163141686|NCT01288989|589228005|FG002|Overall Study|Death|0|||
163141687|NCT01288989|589228006|FG003|Overall Study|Death|1|||
163141688|NCT01288989|589228007|FG004|Overall Study|Death|0|||
163141689|NCT01288989|589228003|FG000|Overall Study|Dose limiting toxicity|1|||
163141690|NCT01288989|589228004|FG001|Overall Study|Dose limiting toxicity|0|||
163141691|NCT01288989|589228005|FG002|Overall Study|Dose limiting toxicity|0|||
163141692|NCT01288989|589228006|FG003|Overall Study|Dose limiting toxicity|0|||
163141693|NCT01288989|589228007|FG004|Overall Study|Dose limiting toxicity|0|||
163141694|NCT01288989|589228003|FG000|Overall Study|Adverse Event|0|||
163141695|NCT01288989|589228004|FG001|Overall Study|Adverse Event|0|||
163141696|NCT01288989|589228005|FG002|Overall Study|Adverse Event|0|||
163141697|NCT01288989|589228006|FG003|Overall Study|Adverse Event|0|||
163141698|NCT01288989|589228007|FG004|Overall Study|Adverse Event|2|||
163141699|NCT01288989|589228003|FG000|Overall Study|Physician Decision|0|||
163141700|NCT01288989|589228004|FG001|Overall Study|Physician Decision|0|||
163141701|NCT01288989|589228005|FG002|Overall Study|Physician Decision|0|||
163141702|NCT01288989|589228006|FG003|Overall Study|Physician Decision|0|||
163141703|NCT01288989|589228007|FG004|Overall Study|Physician Decision|1|||
163141704|NCT01288989|589228003|FG000|Overall Study|Withdrawal by Subject|0|||
163141705|NCT01288989|589228004|FG001|Overall Study|Withdrawal by Subject|0|||
163141706|NCT01288989|589228005|FG002|Overall Study|Withdrawal by Subject|0|||
163141707|NCT01288989|589228006|FG003|Overall Study|Withdrawal by Subject|0|||
163141708|NCT01288989|589228007|FG004|Overall Study|Withdrawal by Subject|3|||
163141709|NCT01132313|589228008|FG000|Overall Study|Lack of Efficacy|1|||
163141710|NCT01132313|589228009|FG001|Overall Study|Lack of Efficacy|0|||
163141711|NCT01132313|589228010|FG002|Overall Study|Lack of Efficacy|0|||
163141712|NCT01132313|589228011|FG003|Overall Study|Lack of Efficacy|0|||
163141713|NCT01132313|589228012|FG004|Overall Study|Lack of Efficacy|0|||
163141714|NCT01132313|589228013|FG005|Overall Study|Lack of Efficacy|0|||
163141715|NCT01132313|589228014|FG006|Overall Study|Lack of Efficacy|0|||
163141716|NCT01132313|589228015|FG007|Overall Study|Lack of Efficacy|3|||
163141717|NCT01132313|589228016|FG008|Overall Study|Lack of Efficacy|14|||
163141718|NCT01132313|589228017|FG009|Overall Study|Lack of Efficacy|16|||
163141719|NCT01132313|589228018|FG010|Overall Study|Lack of Efficacy|0|||
163141720|NCT01132313|589228019|FG011|Overall Study|Lack of Efficacy|0|||
163141721|NCT01132313|589228008|FG000|Overall Study|Not treated|2|||
163141722|NCT01132313|589228009|FG001|Overall Study|Not treated|0|||
163141723|NCT01132313|589228010|FG002|Overall Study|Not treated|0|||
163141724|NCT01132313|589228011|FG003|Overall Study|Not treated|0|||
163141725|NCT01132313|589228012|FG004|Overall Study|Not treated|2|||
163141726|NCT01132313|589228013|FG005|Overall Study|Not treated|1|||
163141727|NCT01132313|589228014|FG006|Overall Study|Not treated|3|||
163141728|NCT01132313|589228015|FG007|Overall Study|Not treated|0|||
163141729|NCT01132313|589228016|FG008|Overall Study|Not treated|0|||
163141730|NCT01132313|589228017|FG009|Overall Study|Not treated|0|||
163141731|NCT01132313|589228018|FG010|Overall Study|Not treated|0|||
163141732|NCT01132313|589228019|FG011|Overall Study|Not treated|0|||
163141733|NCT01132313|589228008|FG000|Overall Study|Adverse Event|0|||
163141734|NCT01132313|589228009|FG001|Overall Study|Adverse Event|0|||
163141735|NCT01132313|589228010|FG002|Overall Study|Adverse Event|4|||
163141736|NCT01132313|589228011|FG003|Overall Study|Adverse Event|10|||
163141737|NCT01132313|589228012|FG004|Overall Study|Adverse Event|19|||
163141738|NCT01132313|589228013|FG005|Overall Study|Adverse Event|6|||
163141739|NCT01132313|589228014|FG006|Overall Study|Adverse Event|5|||
163141740|NCT01132313|589228015|FG007|Overall Study|Adverse Event|3|||
163141741|NCT01132313|589228016|FG008|Overall Study|Adverse Event|7|||
163141742|NCT01132313|589228017|FG009|Overall Study|Adverse Event|2|||
163141743|NCT01132313|589228018|FG010|Overall Study|Adverse Event|0|||
163141744|NCT01132313|589228019|FG011|Overall Study|Adverse Event|0|||
163141745|NCT01132313|589228008|FG000|Overall Study|Protocol Violation|0|||
163141746|NCT01132313|589228009|FG001|Overall Study|Protocol Violation|0|||
163141747|NCT01132313|589228010|FG002|Overall Study|Protocol Violation|0|||
163141748|NCT01132313|589228011|FG003|Overall Study|Protocol Violation|1|||
163141749|NCT01132313|589228012|FG004|Overall Study|Protocol Violation|0|||
163141750|NCT01132313|589228013|FG005|Overall Study|Protocol Violation|0|||
163141751|NCT01132313|589228014|FG006|Overall Study|Protocol Violation|0|||
163141752|NCT01132313|589228015|FG007|Overall Study|Protocol Violation|0|||
163141753|NCT01132313|589228016|FG008|Overall Study|Protocol Violation|0|||
163141754|NCT01132313|589228017|FG009|Overall Study|Protocol Violation|0|||
163141755|NCT01132313|589228018|FG010|Overall Study|Protocol Violation|0|||
163141756|NCT01132313|589228019|FG011|Overall Study|Protocol Violation|0|||
163235934|NCT02039505|589575090|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
163235935|NCT02039505|589575084|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
163235936|NCT02039505|589575085|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
163235937|NCT02039505|589575086|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
163141757|NCT01132313|589228008|FG000|Overall Study|Lost to Follow-up|0|||
163141758|NCT01132313|589228009|FG001|Overall Study|Lost to Follow-up|0|||
163141759|NCT01132313|589228010|FG002|Overall Study|Lost to Follow-up|1|||
163141760|NCT01132313|589228011|FG003|Overall Study|Lost to Follow-up|0|||
163141761|NCT01132313|589228012|FG004|Overall Study|Lost to Follow-up|0|||
163141762|NCT01132313|589228013|FG005|Overall Study|Lost to Follow-up|0|||
163141763|NCT01132313|589228014|FG006|Overall Study|Lost to Follow-up|0|||
163141764|NCT01132313|589228015|FG007|Overall Study|Lost to Follow-up|1|||
163141765|NCT01132313|589228016|FG008|Overall Study|Lost to Follow-up|0|||
163141766|NCT01132313|589228017|FG009|Overall Study|Lost to Follow-up|0|||
163141767|NCT01132313|589228018|FG010|Overall Study|Lost to Follow-up|0|||
163141768|NCT01132313|589228019|FG011|Overall Study|Lost to Follow-up|0|||
163141769|NCT01132313|589228008|FG000|Overall Study|Withdrawal by Subject|0|||
163141770|NCT01132313|589228009|FG001|Overall Study|Withdrawal by Subject|0|||
163141771|NCT01132313|589228010|FG002|Overall Study|Withdrawal by Subject|3|||
163141772|NCT01132313|589228011|FG003|Overall Study|Withdrawal by Subject|3|||
163141773|NCT01132313|589228012|FG004|Overall Study|Withdrawal by Subject|6|||
163235938|NCT02039505|589575087|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
163235939|NCT02039505|589575088|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
163235940|NCT02039505|589575089|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
163235941|NCT02039505|589575090|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
163235942|NCT02039505|589575084|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
163348712|NCT01294358|589985409|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
163348713|NCT01294358|589985410|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
163348714|NCT01294358|589985411|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
163348715|NCT01294358|589985412|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
163348716|NCT03613454|589985413|FG000|Overall Study|Protocol Violation|1|||
163348717|NCT03613454|589985414|FG001|Overall Study|Protocol Violation|0|||
163348718|NCT03613454|589985413|FG000|Overall Study|Protocol Violation|0|||
163348719|NCT03613454|589985414|FG001|Overall Study|Protocol Violation|1|||
163348720|NCT02963922|589985415|FG000|Overall Study|Adverse Event|15|||
163348721|NCT02963922|589985416|FG001|Overall Study|Adverse Event|6|||
163348722|NCT02963922|589985415|FG000|Overall Study|Protocol deviation|6|||
163348723|NCT02963922|589985416|FG001|Overall Study|Protocol deviation|6|||
163348724|NCT02963922|589985415|FG000|Overall Study|Lack of Efficacy|1|||
163348725|NCT02963922|589985416|FG001|Overall Study|Lack of Efficacy|1|||
163348726|NCT02963922|589985415|FG000|Overall Study|Lost to Follow-up|2|||
163348727|NCT02963922|589985416|FG001|Overall Study|Lost to Follow-up|3|||
163348728|NCT02963922|589985415|FG000|Overall Study|Other|8|||
163348729|NCT02963922|589985416|FG001|Overall Study|Other|14|||
163348730|NCT03873038|589985425|FG000|Part 2|Withdrawal by Subject|0|||
163348731|NCT03873038|589985426|FG001|Part 2|Withdrawal by Subject|0|||
163348732|NCT03873038|589985427|FG002|Part 2|Withdrawal by Subject|0|||
163348733|NCT03873038|589985428|FG003|Part 2|Withdrawal by Subject|0|||
163348734|NCT03873038|589985429|FG004|Part 2|Withdrawal by Subject|0|||
163348735|NCT03873038|589985430|FG005|Part 2|Withdrawal by Subject|1|||
163348736|NCT03873038|589985425|FG000|Part 2|Unknon|0|||
163348737|NCT03873038|589985426|FG001|Part 2|Unknon|0|||
163348738|NCT03873038|589985427|FG002|Part 2|Unknon|0|||
163348739|NCT03873038|589985428|FG003|Part 2|Unknon|0|||
163348740|NCT03873038|589985429|FG004|Part 2|Unknon|1|||
163348741|NCT03873038|589985430|FG005|Part 2|Unknon|0|||
163348742|NCT00595764|589985431|FG000|Overall Study|Protocol Violation|24|||
163348743|NCT00595764|589985432|FG001|Overall Study|Protocol Violation|19|||
163348744|NCT00595764|589985431|FG000|Overall Study|Missed Medication >1 week|10|||
163348745|NCT00595764|589985432|FG001|Overall Study|Missed Medication >1 week|17|||
163348746|NCT00595764|589985431|FG000|Overall Study|Missed 3 PM visits|1|||
163348747|NCT00595764|589985432|FG001|Overall Study|Missed 3 PM visits|7|||
163348748|NCT00595764|589985431|FG000|Overall Study|Withdrawal by Subject|4|||
163348749|NCT00595764|589985432|FG001|Overall Study|Withdrawal by Subject|0|||
163348750|NCT04222088|589985433|FG000|Overall Study|Lost to Follow-up|5|||
163348751|NCT04222088|589985434|FG001|Overall Study|Lost to Follow-up|1|||
163348752|NCT04222088|589985433|FG000|Overall Study|Withdrawal by Subject|4|||
163348753|NCT04222088|589985434|FG001|Overall Study|Withdrawal by Subject|0|||
163348754|NCT00141271|589985435|FG000|Overall Study|Adverse Event|31|||
163348755|NCT00141271|589985436|FG001|Overall Study|Adverse Event|19|||
163348756|NCT00141271|589985437|FG002|Overall Study|Adverse Event|17|||
163348757|NCT00141271|589985435|FG000|Overall Study|Laboratory Abnormality|2|||
163141774|NCT01132313|589228013|FG005|Overall Study|Withdrawal by Subject|0|||
163141775|NCT01132313|589228014|FG006|Overall Study|Withdrawal by Subject|1|||
163141776|NCT01132313|589228015|FG007|Overall Study|Withdrawal by Subject|0|||
163141777|NCT01132313|589228016|FG008|Overall Study|Withdrawal by Subject|0|||
163141778|NCT01132313|589228017|FG009|Overall Study|Withdrawal by Subject|2|||
163141779|NCT01132313|589228018|FG010|Overall Study|Withdrawal by Subject|0|||
163141780|NCT01132313|589228019|FG011|Overall Study|Withdrawal by Subject|0|||
163141781|NCT01132313|589228008|FG000|Overall Study|Lack of antiviral response|0|||
163141782|NCT01132313|589228009|FG001|Overall Study|Lack of antiviral response|0|||
163141783|NCT01132313|589228010|FG002|Overall Study|Lack of antiviral response|12|||
163141784|NCT01132313|589228011|FG003|Overall Study|Lack of antiviral response|18|||
163141785|NCT01132313|589228012|FG004|Overall Study|Lack of antiviral response|18|||
163141786|NCT01132313|589228013|FG005|Overall Study|Lack of antiviral response|18|||
163141787|NCT01132313|589228014|FG006|Overall Study|Lack of antiviral response|21|||
163141788|NCT01132313|589228015|FG007|Overall Study|Lack of antiviral response|0|||
163141789|NCT01132313|589228016|FG008|Overall Study|Lack of antiviral response|0|||
163141790|NCT01132313|589228017|FG009|Overall Study|Lack of antiviral response|0|||
163141791|NCT01132313|589228018|FG010|Overall Study|Lack of antiviral response|1|||
163141792|NCT01132313|589228019|FG011|Overall Study|Lack of antiviral response|0|||
163141793|NCT01132313|589228008|FG000|Overall Study|Other reason not defined above|0|||
163141794|NCT01132313|589228009|FG001|Overall Study|Other reason not defined above|0|||
163141795|NCT01132313|589228010|FG002|Overall Study|Other reason not defined above|0|||
163348758|NCT00141271|589985436|FG001|Overall Study|Laboratory Abnormality|1|||
163348759|NCT00141271|589985437|FG002|Overall Study|Laboratory Abnormality|1|||
163348760|NCT00141271|589985435|FG000|Overall Study|Lack of Efficacy|7|||
163348761|NCT00141271|589985436|FG001|Overall Study|Lack of Efficacy|7|||
163348762|NCT00141271|589985437|FG002|Overall Study|Lack of Efficacy|3|||
163348763|NCT00141271|589985435|FG000|Overall Study|Lost to Follow-up|15|||
163141796|NCT01132313|589228011|FG003|Overall Study|Other reason not defined above|0|||
163141797|NCT01132313|589228012|FG004|Overall Study|Other reason not defined above|0|||
163348764|NCT00141271|589985436|FG001|Overall Study|Lost to Follow-up|15|||
163348765|NCT00141271|589985437|FG002|Overall Study|Lost to Follow-up|21|||
163235943|NCT02039505|589575085|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
163235944|NCT02039505|589575086|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
163235945|NCT02039505|589575087|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
163235946|NCT02039505|589575088|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
163235947|NCT02039505|589575089|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
163235948|NCT02039505|589575090|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
163235949|NCT01722331|589575091|FG000|Part 1|Adverse Event|5|||
163235950|NCT01722331|589575092|FG001|Part 1|Adverse Event|0|||
163235951|NCT01722331|589575093|FG002|Part 1|Adverse Event|0|||
163235952|NCT01722331|589575094|FG003|Part 1|Adverse Event|0|||
163235953|NCT01722331|589575095|FG004|Part 1|Adverse Event|0|||
163235954|NCT01722331|589575096|FG005|Part 1|Adverse Event|0|||
163235955|NCT01722331|589575097|FG006|Part 1|Adverse Event|0|||
163235956|NCT01722331|589575091|FG000|Part 1|Lack of Efficacy|0|||
163235957|NCT01722331|589575092|FG001|Part 1|Lack of Efficacy|0|||
163235958|NCT01722331|589575093|FG002|Part 1|Lack of Efficacy|1|||
163235959|NCT01722331|589575094|FG003|Part 1|Lack of Efficacy|0|||
163235960|NCT01722331|589575095|FG004|Part 1|Lack of Efficacy|2|||
163235961|NCT01722331|589575096|FG005|Part 1|Lack of Efficacy|0|||
163235962|NCT01722331|589575097|FG006|Part 1|Lack of Efficacy|0|||
163235963|NCT01722331|589575091|FG000|Part 1|Lost to Follow-up|1|||
163235964|NCT01722331|589575092|FG001|Part 1|Lost to Follow-up|0|||
163235965|NCT01722331|589575093|FG002|Part 1|Lost to Follow-up|2|||
163235966|NCT01722331|589575094|FG003|Part 1|Lost to Follow-up|0|||
163235967|NCT01722331|589575095|FG004|Part 1|Lost to Follow-up|1|||
163235968|NCT01722331|589575096|FG005|Part 1|Lost to Follow-up|0|||
163235969|NCT01722331|589575097|FG006|Part 1|Lost to Follow-up|0|||
163235970|NCT01722331|589575091|FG000|Part 1|Physician Decision|0|||
163235971|NCT01722331|589575092|FG001|Part 1|Physician Decision|0|||
163235972|NCT01722331|589575093|FG002|Part 1|Physician Decision|3|||
163235973|NCT01722331|589575094|FG003|Part 1|Physician Decision|0|||
163235974|NCT01722331|589575095|FG004|Part 1|Physician Decision|1|||
163235975|NCT01722331|589575096|FG005|Part 1|Physician Decision|0|||
163235976|NCT01722331|589575097|FG006|Part 1|Physician Decision|0|||
163235977|NCT01722331|589575091|FG000|Part 1|Pregnancy|1|||
163235978|NCT01722331|589575092|FG001|Part 1|Pregnancy|0|||
163235979|NCT01722331|589575093|FG002|Part 1|Pregnancy|0|||
163235980|NCT01722331|589575094|FG003|Part 1|Pregnancy|0|||
163235981|NCT01722331|589575095|FG004|Part 1|Pregnancy|0|||
163235982|NCT01722331|589575096|FG005|Part 1|Pregnancy|0|||
163235983|NCT01722331|589575097|FG006|Part 1|Pregnancy|0|||
163235984|NCT01722331|589575091|FG000|Part 1|Progressive Disease|0|||
163235985|NCT01722331|589575092|FG001|Part 1|Progressive Disease|0|||
163235986|NCT01722331|589575093|FG002|Part 1|Progressive Disease|0|||
163235987|NCT01722331|589575094|FG003|Part 1|Progressive Disease|0|||
163235988|NCT01722331|589575095|FG004|Part 1|Progressive Disease|1|||
163235989|NCT01722331|589575096|FG005|Part 1|Progressive Disease|0|||
163235990|NCT01722331|589575097|FG006|Part 1|Progressive Disease|0|||
163235991|NCT01722331|589575091|FG000|Part 1|Protocol Violation|1|||
163235992|NCT01722331|589575092|FG001|Part 1|Protocol Violation|0|||
163235993|NCT01722331|589575093|FG002|Part 1|Protocol Violation|0|||
163235994|NCT01722331|589575094|FG003|Part 1|Protocol Violation|0|||
163235995|NCT01722331|589575095|FG004|Part 1|Protocol Violation|1|||
163235996|NCT01722331|589575096|FG005|Part 1|Protocol Violation|0|||
163235997|NCT01722331|589575097|FG006|Part 1|Protocol Violation|0|||
163235998|NCT01722331|589575091|FG000|Part 1|Withdrawal by Subject|2|||
163235999|NCT01722331|589575092|FG001|Part 1|Withdrawal by Subject|0|||
163236000|NCT01722331|589575093|FG002|Part 1|Withdrawal by Subject|3|||
163236001|NCT01722331|589575094|FG003|Part 1|Withdrawal by Subject|0|||
163236002|NCT01722331|589575095|FG004|Part 1|Withdrawal by Subject|3|||
163236003|NCT01722331|589575096|FG005|Part 1|Withdrawal by Subject|0|||
163236004|NCT01722331|589575097|FG006|Part 1|Withdrawal by Subject|0|||
163236005|NCT01722331|589575091|FG000|Part 2|Adverse Event|3|||
163236006|NCT01722331|589575092|FG001|Part 2|Adverse Event|0|||
163236007|NCT01722331|589575093|FG002|Part 2|Adverse Event|0|||
163236008|NCT01722331|589575094|FG003|Part 2|Adverse Event|0|||
163236009|NCT01722331|589575095|FG004|Part 2|Adverse Event|0|||
163236010|NCT01722331|589575096|FG005|Part 2|Adverse Event|1|||
163236011|NCT01722331|589575097|FG006|Part 2|Adverse Event|0|||
163236012|NCT01722331|589575091|FG000|Part 2|Lack of Efficacy|3|||
163236013|NCT01722331|589575092|FG001|Part 2|Lack of Efficacy|0|||
163236014|NCT01722331|589575093|FG002|Part 2|Lack of Efficacy|11|||
163236015|NCT01722331|589575094|FG003|Part 2|Lack of Efficacy|0|||
163236016|NCT01722331|589575095|FG004|Part 2|Lack of Efficacy|0|||
163236017|NCT01722331|589575096|FG005|Part 2|Lack of Efficacy|3|||
163236018|NCT01722331|589575097|FG006|Part 2|Lack of Efficacy|3|||
163236019|NCT01722331|589575091|FG000|Part 2|Lost to Follow-up|0|||
163236020|NCT01722331|589575092|FG001|Part 2|Lost to Follow-up|0|||
163236021|NCT01722331|589575093|FG002|Part 2|Lost to Follow-up|3|||
163236022|NCT01722331|589575094|FG003|Part 2|Lost to Follow-up|0|||
163236023|NCT01722331|589575095|FG004|Part 2|Lost to Follow-up|0|||
163236024|NCT01722331|589575096|FG005|Part 2|Lost to Follow-up|1|||
163236025|NCT01722331|589575097|FG006|Part 2|Lost to Follow-up|1|||
163236026|NCT01722331|589575091|FG000|Part 2|Non-Compliance with Study Drug|1|||
163236027|NCT01722331|589575092|FG001|Part 2|Non-Compliance with Study Drug|0|||
163348766|NCT00141271|589985435|FG000|Overall Study|Withdrawal by Subject|14|||
163348767|NCT00141271|589985436|FG001|Overall Study|Withdrawal by Subject|9|||
163141798|NCT01132313|589228013|FG005|Overall Study|Other reason not defined above|0|||
163141799|NCT01132313|589228014|FG006|Overall Study|Other reason not defined above|0|||
163141800|NCT01132313|589228015|FG007|Overall Study|Other reason not defined above|1|||
163141801|NCT01132313|589228016|FG008|Overall Study|Other reason not defined above|0|||
163141802|NCT01132313|589228017|FG009|Overall Study|Other reason not defined above|0|||
163141803|NCT01132313|589228018|FG010|Overall Study|Other reason not defined above|0|||
163141804|NCT01132313|589228019|FG011|Overall Study|Other reason not defined above|0|||
163141805|NCT04661150|589228023|FG000|Overall Study|Ongoing in study|19|||
163141806|NCT04661150|589228024|FG001|Overall Study|Ongoing in study|20|||
163141807|NCT04661150|589228023|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
163141808|NCT04661150|589228024|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
163141809|NCT04661150|589228023|FG000|Overall Study|Death|2|||
163141810|NCT04661150|589228024|FG001|Overall Study|Death|0|||
163141811|NCT04965688|589228025|FG000|Overall Study|Withdrawal by Subject|2|||
163141812|NCT00369577|589228026|FG000|Overall Study|Withdrawal by Subject|0|||
163141813|NCT00369577|589228027|FG001|Overall Study|Withdrawal by Subject|0|||
163141814|NCT00369577|589228028|FG002|Overall Study|Withdrawal by Subject|1|||
163141815|NCT04618744|589228029|FG000|Overall Study|Adverse Event|0|||
163141816|NCT04618744|589228030|FG001|Overall Study|Adverse Event|1|||
163141817|NCT04618744|589228029|FG000|Overall Study|Withdrawal by Subject|0|||
163141818|NCT04618744|589228030|FG001|Overall Study|Withdrawal by Subject|1|||
163141819|NCT03553758|589230272|FG000|Overall Study|Lost to Follow-up|1|||
163141820|NCT02807623|589230273|FG000|Overall Study|Lost to Follow-up|23|||
163141821|NCT02807623|589230274|FG001|Overall Study|Lost to Follow-up|18|||
163141822|NCT02807623|589230275|FG002|Overall Study|Lost to Follow-up|22|||
163141823|NCT02807623|589230273|FG000|Overall Study|Drug intolerance|0|||
163141824|NCT02807623|589230274|FG001|Overall Study|Drug intolerance|1|||
163141825|NCT02807623|589230275|FG002|Overall Study|Drug intolerance|0|||
163141826|NCT02807623|589230273|FG000|Overall Study|incomplete blood draw|0|||
163141827|NCT02807623|589230274|FG001|Overall Study|incomplete blood draw|2|||
163141828|NCT02807623|589230275|FG002|Overall Study|incomplete blood draw|1|||
163141829|NCT02614729|589230276|FG000|Overall Study|Withdrawal by Subject|1|||
163141830|NCT02614729|589230277|FG001|Overall Study|Withdrawal by Subject|0|||
163141831|NCT04002960|589230280|FG000|Overall Study|Withdrawn prior to Completion|2|||
163141832|NCT01121146|589230286|FG000|Overall Study|Death|17|||
163141833|NCT01121146|589230287|FG001|Overall Study|Death|15|||
163141834|NCT01121146|589230286|FG000|Overall Study|Adverse Event|2|||
163141835|NCT01121146|589230287|FG001|Overall Study|Adverse Event|11|||
163141836|NCT01121146|589230286|FG000|Overall Study|Lost to Follow-up|7|||
163141837|NCT01121146|589230287|FG001|Overall Study|Lost to Follow-up|16|||
163141838|NCT01276639|589230288|FG000|Week 0 to 16|Death|1|||
163141839|NCT01276639|589230289|FG001|Week 0 to 16|Death|0|||
163141840|NCT01276639|589230290|FG002|Week 0 to 16|Death|0|||
163141841|NCT01276639|589230291|FG003|Week 0 to 16|Death|0|||
163141842|NCT01276639|589230292|FG004|Week 0 to 16|Death|0|||
163141843|NCT01276639|589230288|FG000|Week 0 to 16|Adverse Event|11|||
163141844|NCT01276639|589230289|FG001|Week 0 to 16|Adverse Event|8|||
163141845|NCT01276639|589230290|FG002|Week 0 to 16|Adverse Event|11|||
163141846|NCT01276639|589230291|FG003|Week 0 to 16|Adverse Event|0|||
163141847|NCT01276639|589230292|FG004|Week 0 to 16|Adverse Event|0|||
163141848|NCT01276639|589230288|FG000|Week 0 to 16|Lack of Efficacy|20|||
163141849|NCT01276639|589230289|FG001|Week 0 to 16|Lack of Efficacy|15|||
163141850|NCT01276639|589230290|FG002|Week 0 to 16|Lack of Efficacy|25|||
163141851|NCT01276639|589230291|FG003|Week 0 to 16|Lack of Efficacy|0|||
163141852|NCT01276639|589230292|FG004|Week 0 to 16|Lack of Efficacy|0|||
163141853|NCT01276639|589230288|FG000|Week 0 to 16|Lost to Follow-up|3|||
163141854|NCT01276639|589230289|FG001|Week 0 to 16|Lost to Follow-up|5|||
163141855|NCT01276639|589230290|FG002|Week 0 to 16|Lost to Follow-up|3|||
163141856|NCT01276639|589230291|FG003|Week 0 to 16|Lost to Follow-up|0|||
163141857|NCT01276639|589230292|FG004|Week 0 to 16|Lost to Follow-up|0|||
163141858|NCT01276639|589230288|FG000|Week 0 to 16|Withdrawal by Subject|8|||
163141859|NCT01276639|589230289|FG001|Week 0 to 16|Withdrawal by Subject|5|||
163141860|NCT01276639|589230290|FG002|Week 0 to 16|Withdrawal by Subject|4|||
163141861|NCT01276639|589230291|FG003|Week 0 to 16|Withdrawal by Subject|0|||
163141862|NCT01276639|589230292|FG004|Week 0 to 16|Withdrawal by Subject|0|||
163141863|NCT01276639|589230288|FG000|Week 0 to 16|Other|7|||
163141864|NCT01276639|589230289|FG001|Week 0 to 16|Other|7|||
163141865|NCT01276639|589230290|FG002|Week 0 to 16|Other|2|||
163141866|NCT01276639|589230291|FG003|Week 0 to 16|Other|0|||
163141867|NCT01276639|589230292|FG004|Week 0 to 16|Other|0|||
163141868|NCT01276639|589230288|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
163141869|NCT01276639|589230289|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
163141870|NCT01276639|589230290|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
163141871|NCT01276639|589230291|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
163141872|NCT01276639|589230292|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
163409514|NCT05048719|590209396|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163141873|NCT01276639|589230288|FG000|Week 16 to 52|Death|1|||
163141874|NCT01276639|589230289|FG001|Week 16 to 52|Death|0|||
163141875|NCT01276639|589230290|FG002|Week 16 to 52|Death|0|||
163141876|NCT01276639|589230291|FG003|Week 16 to 52|Death|0|||
163141877|NCT01276639|589230292|FG004|Week 16 to 52|Death|0|||
163141878|NCT01276639|589230288|FG000|Week 16 to 52|Adverse Event|10|||
163141879|NCT01276639|589230289|FG001|Week 16 to 52|Adverse Event|13|||
163141880|NCT01276639|589230290|FG002|Week 16 to 52|Adverse Event|0|||
163141881|NCT01276639|589230291|FG003|Week 16 to 52|Adverse Event|1|||
163141882|NCT01276639|589230292|FG004|Week 16 to 52|Adverse Event|3|||
163141883|NCT01276639|589230288|FG000|Week 16 to 52|Lack of Efficacy|99|||
163141884|NCT01276639|589230289|FG001|Week 16 to 52|Lack of Efficacy|71|||
163141885|NCT01276639|589230290|FG002|Week 16 to 52|Lack of Efficacy|0|||
163141886|NCT01276639|589230291|FG003|Week 16 to 52|Lack of Efficacy|14|||
163141887|NCT01276639|589230292|FG004|Week 16 to 52|Lack of Efficacy|13|||
163141888|NCT01276639|589230288|FG000|Week 16 to 52|Lost to Follow-up|3|||
163141889|NCT01276639|589230289|FG001|Week 16 to 52|Lost to Follow-up|1|||
163141890|NCT01276639|589230290|FG002|Week 16 to 52|Lost to Follow-up|0|||
163141891|NCT01276639|589230291|FG003|Week 16 to 52|Lost to Follow-up|0|||
163141892|NCT01276639|589230292|FG004|Week 16 to 52|Lost to Follow-up|1|||
163141893|NCT01276639|589230288|FG000|Week 16 to 52|Withdrawal by Subject|4|||
163141894|NCT01276639|589230289|FG001|Week 16 to 52|Withdrawal by Subject|4|||
163141895|NCT01276639|589230290|FG002|Week 16 to 52|Withdrawal by Subject|0|||
163141896|NCT01276639|589230291|FG003|Week 16 to 52|Withdrawal by Subject|0|||
163141897|NCT01276639|589230292|FG004|Week 16 to 52|Withdrawal by Subject|1|||
163141898|NCT01276639|589230288|FG000|Week 16 to 52|Other|10|||
163141899|NCT01276639|589230289|FG001|Week 16 to 52|Other|12|||
163141900|NCT01276639|589230290|FG002|Week 16 to 52|Other|0|||
163141901|NCT01276639|589230291|FG003|Week 16 to 52|Other|1|||
163141902|NCT01276639|589230292|FG004|Week 16 to 52|Other|3|||
163141903|NCT01132807|589230297|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
163141904|NCT01132807|589230298|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
163141905|NCT01132807|589230299|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
163141906|NCT01132807|589230297|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
163141907|NCT01132807|589230298|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
163141908|NCT01132807|589230299|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
163141909|NCT01380769|589230300|FG000|Overall Study|Withdrawal by Subject|7|||
163141910|NCT01380769|589230301|FG001|Overall Study|Withdrawal by Subject|11|||
163141911|NCT01380769|589230300|FG000|Overall Study|Physician Decision|1|||
163141912|NCT01380769|589230301|FG001|Overall Study|Physician Decision|1|||
163141913|NCT01380769|589230300|FG000|Overall Study|Adverse Event|1|||
163141914|NCT01380769|589230301|FG001|Overall Study|Adverse Event|1|||
163141915|NCT01380769|589230300|FG000|Overall Study|Protocol Violation|0|||
163141916|NCT01380769|589230301|FG001|Overall Study|Protocol Violation|1|||
163141917|NCT03654690|589230303|FG000|Overall Study|Withdrawal by Subject|1|||
163141918|NCT03654690|589230304|FG001|Overall Study|Withdrawal by Subject|0|||
163141919|NCT03654690|589230305|FG002|Overall Study|Withdrawal by Subject|0|||
163141920|NCT01176058|589230318|FG000|Overall Study|Adverse Event|1|||
163141921|NCT01176058|589230319|FG001|Overall Study|Adverse Event|0|||
163141922|NCT01176058|589230318|FG000|Overall Study|Insufficient clinical response|2|||
163141923|NCT01176058|589230319|FG001|Overall Study|Insufficient clinical response|2|||
163141924|NCT01176058|589230318|FG000|Overall Study|Insufficient mycological response|0|||
163141925|NCT01176058|589230319|FG001|Overall Study|Insufficient mycological response|1|||
163141926|NCT01176058|589230318|FG000|Overall Study|Withdrawal by Subject|1|||
163141927|NCT01176058|589230319|FG001|Overall Study|Withdrawal by Subject|0|||
163141928|NCT00256724|589230322|FG000|Overall Study|Physician Decision|2|||
163141929|NCT00256724|589230323|FG001|Overall Study|Physician Decision|5|||
163141930|NCT00256724|589230322|FG000|Overall Study|Protocol Violation|3|||
163141931|NCT00256724|589230323|FG001|Overall Study|Protocol Violation|3|||
163141932|NCT01217463|589230324|FG000|Overall Study|Adverse Event|8|||
163141933|NCT01217463|589230325|FG001|Overall Study|Adverse Event|5|||
163141934|NCT01217463|589230324|FG000|Overall Study|Physician Decision|0|||
163141935|NCT01217463|589230325|FG001|Overall Study|Physician Decision|1|||
163141936|NCT01217463|589230324|FG000|Overall Study|Withdrawal by Subject|3|||
163141937|NCT01217463|589230325|FG001|Overall Study|Withdrawal by Subject|0|||
163141938|NCT01217463|589230324|FG000|Overall Study|Surgery on the Target Limb|0|||
163141939|NCT01217463|589230325|FG001|Overall Study|Surgery on the Target Limb|1|||
163141940|NCT01217463|589230324|FG000|Overall Study|Patient Non-compliant|1|||
163141941|NCT01217463|589230325|FG001|Overall Study|Patient Non-compliant|0|||
163141942|NCT01217463|589230324|FG000|Overall Study|Other|1|||
163141943|NCT01217463|589230325|FG001|Overall Study|Other|1|||
163141944|NCT01569841|589230326|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
163141945|NCT01569841|589230327|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
163141946|NCT01879683|589230332|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
163141947|NCT00782717|589230335|FG000|Overall Study|Adverse Event|2|||
163141948|NCT00782717|589230336|FG001|Overall Study|Adverse Event|5|||
163141949|NCT00782717|589230335|FG000|Overall Study|Patient decision unrelated to AE|6|||
163409515|NCT05048719|590209397|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163409516|NCT05048719|590209398|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163409517|NCT05048719|590209390|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163409518|NCT05048719|590209391|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
163409519|NCT05048719|590209392|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163409520|NCT05048719|590209393|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163409521|NCT05048719|590209394|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163409522|NCT05048719|590209395|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163409523|NCT05048719|590209396|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163409524|NCT05048719|590209397|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163409525|NCT05048719|590209398|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163409526|NCT05048719|590209390|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
163409527|NCT05048719|590209391|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
163409528|NCT05048719|590209392|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
163409529|NCT05048719|590209393|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
163409530|NCT05048719|590209394|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
163409531|NCT05048719|590209395|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
163141950|NCT00782717|589230336|FG001|Overall Study|Patient decision unrelated to AE|3|||
163141951|NCT00782717|589230335|FG000|Overall Study|Noncompliance|2|||
163141952|NCT00782717|589230336|FG001|Overall Study|Noncompliance|1|||
163141953|NCT00782717|589230335|FG000|Overall Study|Treatment failure|3|||
163141954|NCT00782717|589230336|FG001|Overall Study|Treatment failure|14|||
163141955|NCT00782717|589230335|FG000|Overall Study|Enrollment close prior to surgery|1|||
163141956|NCT00782717|589230336|FG001|Overall Study|Enrollment close prior to surgery|0|||
163141957|NCT00782717|589230335|FG000|Overall Study|Did not meet entrance criteria|1|||
163141958|NCT00782717|589230336|FG001|Overall Study|Did not meet entrance criteria|3|||
163141959|NCT00782717|589230335|FG000|Overall Study|Exited in error|0|||
163141960|NCT00782717|589230336|FG001|Overall Study|Exited in error|2|||
163141961|NCT02446717|589230337|FG000|Overall Study|Adverse Event|0|||
163141962|NCT02446717|589230338|FG001|Overall Study|Adverse Event|0|||
163141963|NCT02446717|589230339|FG002|Overall Study|Adverse Event|1|||
163141964|NCT02446717|589230340|FG003|Overall Study|Adverse Event|0|||
163141965|NCT02446717|589230341|FG004|Overall Study|Adverse Event|0|||
163141966|NCT02446717|589230337|FG000|Overall Study|Lost to Follow-up|0|||
163141967|NCT02446717|589230338|FG001|Overall Study|Lost to Follow-up|1|||
163141968|NCT02446717|589230339|FG002|Overall Study|Lost to Follow-up|1|||
163141969|NCT02446717|589230340|FG003|Overall Study|Lost to Follow-up|0|||
163141970|NCT02446717|589230341|FG004|Overall Study|Lost to Follow-up|1|||
163141971|NCT02446717|589230337|FG000|Overall Study|Withdrew consent|0|||
163141972|NCT02446717|589230338|FG001|Overall Study|Withdrew consent|0|||
163141973|NCT02446717|589230339|FG002|Overall Study|Withdrew consent|0|||
163141974|NCT02446717|589230340|FG003|Overall Study|Withdrew consent|1|||
163141975|NCT02446717|589230341|FG004|Overall Study|Withdrew consent|0|||
163141976|NCT00279916|589230349|FG000|Overall Study|Withdrawal by Subject|4|||
163141977|NCT00279916|589230350|FG001|Overall Study|Withdrawal by Subject|3|||
163141978|NCT00279916|589230349|FG000|Overall Study|Lost to Follow-up|3|||
163141979|NCT00279916|589230350|FG001|Overall Study|Lost to Follow-up|2|||
163141980|NCT02488005|589230355|FG000|Overall Study|Lost to Follow-up|2|||
163141981|NCT00650767|589230360|FG000|Overall Study|Adverse Event|0|||
163141982|NCT00650767|589230361|FG001|Overall Study|Adverse Event|3|||
163141983|NCT00650767|589230362|FG002|Overall Study|Adverse Event|10|||
163141984|NCT00650767|589230363|FG003|Overall Study|Adverse Event|8|||
163141985|NCT00650767|589230360|FG000|Overall Study|Death|1|||
163141986|NCT00650767|589230361|FG001|Overall Study|Death|0|||
163141987|NCT00650767|589230362|FG002|Overall Study|Death|0|||
163141988|NCT00650767|589230363|FG003|Overall Study|Death|0|||
163141989|NCT00650767|589230360|FG000|Overall Study|Withdrawal by Subject|2|||
163141990|NCT00650767|589230361|FG001|Overall Study|Withdrawal by Subject|4|||
163141991|NCT00650767|589230362|FG002|Overall Study|Withdrawal by Subject|3|||
163141992|NCT00650767|589230363|FG003|Overall Study|Withdrawal by Subject|3|||
163141993|NCT00650767|589230360|FG000|Overall Study|Lost to Follow-up|1|||
163141994|NCT00650767|589230361|FG001|Overall Study|Lost to Follow-up|1|||
163141995|NCT00650767|589230362|FG002|Overall Study|Lost to Follow-up|1|||
163141996|NCT00650767|589230363|FG003|Overall Study|Lost to Follow-up|0|||
163141997|NCT00650767|589230360|FG000|Overall Study|Other|1|||
163141998|NCT00650767|589230361|FG001|Overall Study|Other|1|||
163141999|NCT00650767|589230362|FG002|Overall Study|Other|0|||
163142000|NCT00650767|589230363|FG003|Overall Study|Other|0|||
163142001|NCT03384940|589230364|FG000|Overall Study|Progressive disease|36|||
163142002|NCT03384940|589230365|FG001|Overall Study|Progressive disease|11|||
163142003|NCT03384940|589230366|FG002|Overall Study|Progressive disease|13|||
163142004|NCT03384940|589230364|FG000|Overall Study|Clinical progression|4|||
163142005|NCT03384940|589230365|FG001|Overall Study|Clinical progression|0|||
163142006|NCT03384940|589230366|FG002|Overall Study|Clinical progression|3|||
163142007|NCT03384940|589230364|FG000|Overall Study|Adverse Event|7|||
163142008|NCT03384940|589230365|FG001|Overall Study|Adverse Event|1|||
163142009|NCT03384940|589230366|FG002|Overall Study|Adverse Event|1|||
163142010|NCT03384940|589230364|FG000|Overall Study|Withdrawal by Subject|3|||
163142011|NCT03384940|589230365|FG001|Overall Study|Withdrawal by Subject|1|||
163142012|NCT03384940|589230366|FG002|Overall Study|Withdrawal by Subject|0|||
163142013|NCT03384940|589230364|FG000|Overall Study|Physician Decision|1|||
163142014|NCT03384940|589230365|FG001|Overall Study|Physician Decision|1|||
163142015|NCT03384940|589230366|FG002|Overall Study|Physician Decision|0|||
163142016|NCT03384940|589230364|FG000|Overall Study|Death|2|||
163142017|NCT03384940|589230365|FG001|Overall Study|Death|1|||
163142018|NCT03384940|589230366|FG002|Overall Study|Death|0|||
163142019|NCT03384940|589230364|FG000|Overall Study|Other|0|||
163142020|NCT03384940|589230365|FG001|Overall Study|Other|0|||
163142021|NCT03384940|589230366|FG002|Overall Study|Other|1|||
163142022|NCT03649074|589230369|FG000|Overall Study|Lost to Follow-up|2|||
163142023|NCT03649074|589230370|FG001|Overall Study|Lost to Follow-up|1|||
163142024|NCT03649074|589230369|FG000|Overall Study|Adverse Event|1|||
163142025|NCT03649074|589230370|FG001|Overall Study|Adverse Event|0|||
163142026|NCT03649074|589230369|FG000|Overall Study|Physician Decision|1|||
163142027|NCT03649074|589230370|FG001|Overall Study|Physician Decision|0|||
163142028|NCT03649074|589230369|FG000|Overall Study|Withdrawal by Subject|0|||
163142029|NCT03649074|589230370|FG001|Overall Study|Withdrawal by Subject|2|||
163142030|NCT03649074|589230369|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
163142031|NCT03649074|589230370|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
163142032|NCT03649074|589230369|FG000|Overall Study|Other|1|||
163142033|NCT03649074|589230370|FG001|Overall Study|Other|0|||
163142034|NCT04303559|589230371|FG000|Overall Study|Study closed due to poor enrollment.|1|||
163142035|NCT01156714|589230374|FG000|Overall Study|Withdrawal by Subject|9|||
163142036|NCT01156714|589230375|FG001|Overall Study|Withdrawal by Subject|4|||
163142037|NCT01156714|589230376|FG002|Overall Study|Withdrawal by Subject|3|||
163142038|NCT03775486|589230378|FG000|Initial Therapy Phase|Other reason provided|0|||
163142039|NCT03775486|589230379|FG001|Initial Therapy Phase|Other reason provided|15|||
163142040|NCT03775486|589230378|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
163142041|NCT03775486|589230379|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
163142042|NCT03775486|589230378|FG000|Initial Therapy Phase|Protocol Violation|0|||
163142043|NCT03775486|589230379|FG001|Initial Therapy Phase|Protocol Violation|2|||
163142044|NCT03775486|589230378|FG000|Initial Therapy Phase|Adverse Event|0|||
163142045|NCT03775486|589230379|FG001|Initial Therapy Phase|Adverse Event|34|||
163142046|NCT03775486|589230378|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
163142047|NCT03775486|589230379|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
163142048|NCT03775486|589230378|FG000|Maintenance Phase|Withdrawal by Subject|13|||
163142049|NCT03775486|589230379|FG001|Maintenance Phase|Withdrawal by Subject|12|||
163142050|NCT03775486|589230378|FG000|Maintenance Phase|Death|44|||
163142051|NCT03775486|589230379|FG001|Maintenance Phase|Death|45|||
163142052|NCT00801216|589230380|FG000|Overall Study|Screening Failure|2|||
163142053|NCT05907395|589230381|FG000|Period 1|No longer met eligibility criteria|0|||
163142054|NCT05907395|589230382|FG001|Period 1|No longer met eligibility criteria|1|||
163142055|NCT05907395|589230383|FG002|Period 1|No longer met eligibility criteria|0|||
163142056|NCT05907395|589230384|FG003|Period 1|No longer met eligibility criteria|0|||
163142057|NCT05907395|589230385|FG004|Period 1|No longer met eligibility criteria|0|||
163142058|NCT05907395|589230386|FG005|Period 1|No longer met eligibility criteria|1|||
163142059|NCT05907395|589230387|FG006|Period 1|No longer met eligibility criteria|1|||
163142060|NCT05907395|589230388|FG007|Period 1|No longer met eligibility criteria|0|||
163142061|NCT05907395|589230389|FG008|Period 1|No longer met eligibility criteria|0|||
163142062|NCT05907395|589230390|FG009|Period 1|No longer met eligibility criteria|0|||
163142063|NCT05907395|589230391|FG010|Period 1|No longer met eligibility criteria|0|||
163142064|NCT05907395|589230392|FG011|Period 1|No longer met eligibility criteria|0|||
163142065|NCT05907395|589230381|FG000|Period 2|Adverse Event|0|||
163142066|NCT05907395|589230382|FG001|Period 2|Adverse Event|0|||
163142067|NCT05907395|589230383|FG002|Period 2|Adverse Event|0|||
163142068|NCT05907395|589230384|FG003|Period 2|Adverse Event|1|||
163142069|NCT05907395|589230385|FG004|Period 2|Adverse Event|0|||
163142070|NCT05907395|589230386|FG005|Period 2|Adverse Event|0|||
163142071|NCT05907395|589230387|FG006|Period 2|Adverse Event|0|||
163142072|NCT05907395|589230388|FG007|Period 2|Adverse Event|1|||
163142073|NCT05907395|589230389|FG008|Period 2|Adverse Event|0|||
163142074|NCT05907395|589230390|FG009|Period 2|Adverse Event|0|||
163142075|NCT05907395|589230391|FG010|Period 2|Adverse Event|0|||
163236028|NCT01722331|589575093|FG002|Part 2|Non-Compliance with Study Drug|1|||
163142076|NCT05907395|589230392|FG011|Period 2|Adverse Event|0|||
163142077|NCT05907395|589230381|FG000|Period 2|Personal reason|0|||
163142078|NCT05907395|589230382|FG001|Period 2|Personal reason|0|||
163142079|NCT05907395|589230383|FG002|Period 2|Personal reason|0|||
163236029|NCT01722331|589575094|FG003|Part 2|Non-Compliance with Study Drug|0|||
163236030|NCT01722331|589575095|FG004|Part 2|Non-Compliance with Study Drug|0|||
163236031|NCT01722331|589575096|FG005|Part 2|Non-Compliance with Study Drug|0|||
163236032|NCT01722331|589575097|FG006|Part 2|Non-Compliance with Study Drug|0|||
163236033|NCT01722331|589575091|FG000|Part 2|Physician Decision|0|||
163236034|NCT01722331|589575092|FG001|Part 2|Physician Decision|0|||
163236035|NCT01722331|589575093|FG002|Part 2|Physician Decision|2|||
163236036|NCT01722331|589575094|FG003|Part 2|Physician Decision|0|||
163236037|NCT01722331|589575095|FG004|Part 2|Physician Decision|0|||
163236038|NCT01722331|589575096|FG005|Part 2|Physician Decision|0|||
163236039|NCT01722331|589575097|FG006|Part 2|Physician Decision|0|||
163236040|NCT01722331|589575091|FG000|Part 2|Pregnancy|0|||
163236041|NCT01722331|589575092|FG001|Part 2|Pregnancy|0|||
163236042|NCT01722331|589575093|FG002|Part 2|Pregnancy|0|||
163236043|NCT01722331|589575094|FG003|Part 2|Pregnancy|0|||
163236044|NCT01722331|589575095|FG004|Part 2|Pregnancy|0|||
163236045|NCT01722331|589575096|FG005|Part 2|Pregnancy|1|||
163236046|NCT01722331|589575097|FG006|Part 2|Pregnancy|0|||
163236047|NCT01722331|589575091|FG000|Part 2|Progressive Disease|0|||
163236048|NCT01722331|589575092|FG001|Part 2|Progressive Disease|0|||
163236049|NCT01722331|589575093|FG002|Part 2|Progressive Disease|1|||
163236050|NCT01722331|589575094|FG003|Part 2|Progressive Disease|0|||
163236051|NCT01722331|589575095|FG004|Part 2|Progressive Disease|0|||
163236052|NCT01722331|589575096|FG005|Part 2|Progressive Disease|0|||
163236053|NCT01722331|589575097|FG006|Part 2|Progressive Disease|0|||
163236054|NCT01722331|589575091|FG000|Part 2|Protocol Violation|1|||
163236055|NCT01722331|589575092|FG001|Part 2|Protocol Violation|0|||
163236056|NCT01722331|589575093|FG002|Part 2|Protocol Violation|0|||
163236057|NCT01722331|589575094|FG003|Part 2|Protocol Violation|0|||
163236058|NCT01722331|589575095|FG004|Part 2|Protocol Violation|0|||
163236059|NCT01722331|589575096|FG005|Part 2|Protocol Violation|0|||
163348768|NCT00141271|589985437|FG002|Overall Study|Withdrawal by Subject|10|||
163348769|NCT00141271|589985435|FG000|Overall Study|Other|11|||
163348770|NCT00141271|589985436|FG001|Overall Study|Other|12|||
163348771|NCT00141271|589985437|FG002|Overall Study|Other|5|||
163348772|NCT00390806|589985438|FG000|Overall Study|Lost to Follow-up|7|||
163348773|NCT00390806|589985439|FG001|Overall Study|Lost to Follow-up|6|||
163348774|NCT00390806|589985438|FG000|Overall Study|Protocol Violation|2|||
163348775|NCT00390806|589985439|FG001|Overall Study|Protocol Violation|2|||
163348776|NCT00390806|589985438|FG000|Overall Study|Withdrawal by Subject|12|||
163348777|NCT00390806|589985439|FG001|Overall Study|Withdrawal by Subject|15|||
163348778|NCT00390806|589985438|FG000|Overall Study|Investigator Decision|4|||
163348779|NCT00390806|589985439|FG001|Overall Study|Investigator Decision|6|||
163348780|NCT00390806|589985438|FG000|Overall Study|Death|1|||
163348781|NCT00390806|589985439|FG001|Overall Study|Death|0|||
163348782|NCT00390806|589985438|FG000|Overall Study|Physician Decision|0|||
163348783|NCT00390806|589985439|FG001|Overall Study|Physician Decision|1|||
163348784|NCT00390806|589985438|FG000|Overall Study|Ongoing|4|||
163348785|NCT00390806|589985439|FG001|Overall Study|Ongoing|2|||
163348786|NCT00884793|589985442|FG000|Overall Study|Withdrawal by Subject|1|||
163348787|NCT04783519|589985443|FG000|Overall Study|Withdrawal by Subject|2|||
163348788|NCT04783519|589985444|FG001|Overall Study|Withdrawal by Subject|7|||
163348789|NCT04783519|589985445|FG002|Overall Study|Withdrawal by Subject|3|||
163348790|NCT04783519|589985443|FG000|Overall Study|Lost to Follow-up|9|||
163348791|NCT04783519|589985444|FG001|Overall Study|Lost to Follow-up|7|||
163348792|NCT04783519|589985445|FG002|Overall Study|Lost to Follow-up|6|||
163348793|NCT03169530|589985446|FG000|Overall Study|Study ended by NIH|15|||
163348794|NCT03169530|589985447|FG001|Overall Study|Study ended by NIH|17|||
163348795|NCT01032200|589985448|FG000|Overall Study|Death|1|||
163348796|NCT01032200|589985449|FG001|Overall Study|Death|1|||
163348797|NCT01032200|589985448|FG000|Overall Study|Withdrawal by Subject|1|||
163348798|NCT01032200|589985449|FG001|Overall Study|Withdrawal by Subject|3|||
163348799|NCT01032200|589985448|FG000|Overall Study|Toxicity|0|||
163348800|NCT01032200|589985449|FG001|Overall Study|Toxicity|2|||
163348801|NCT01032200|589985448|FG000|Overall Study|Progression|1|||
163348802|NCT01032200|589985449|FG001|Overall Study|Progression|0|||
163348803|NCT01032200|589985448|FG000|Overall Study|Multiple|1|||
163348804|NCT01032200|589985449|FG001|Overall Study|Multiple|1|||
163348805|NCT00746785|589987007|FG000|Overall Study|Lost to Follow-up|29|||
163348806|NCT00746785|589987008|FG001|Overall Study|Lost to Follow-up|25|||
163348807|NCT00746785|589987009|FG002|Overall Study|Lost to Follow-up|27|||
163348808|NCT01231464|589987010|FG000|Overall Study|Adverse Event|0|||
163348809|NCT01231464|589987011|FG001|Overall Study|Adverse Event|1|||
163236060|NCT01722331|589575097|FG006|Part 2|Protocol Violation|0|||
163348810|NCT01231464|589987010|FG000|Overall Study|Protocol Violation|1|||
163348811|NCT01231464|589987011|FG001|Overall Study|Protocol Violation|2|||
163236061|NCT01722331|589575091|FG000|Part 2|Withdrawal by Subject|5|||
163236062|NCT01722331|589575092|FG001|Part 2|Withdrawal by Subject|0|||
163348812|NCT01231464|589987010|FG000|Overall Study|Lost to Follow-up|1|||
163348813|NCT01231464|589987011|FG001|Overall Study|Lost to Follow-up|2|||
163236063|NCT01722331|589575093|FG002|Part 2|Withdrawal by Subject|3|||
163236064|NCT01722331|589575094|FG003|Part 2|Withdrawal by Subject|0|||
163236065|NCT01722331|589575095|FG004|Part 2|Withdrawal by Subject|0|||
163236066|NCT01722331|589575096|FG005|Part 2|Withdrawal by Subject|2|||
163348814|NCT01231464|589987010|FG000|Overall Study|Withdrawal by Subject|3|||
163236067|NCT01722331|589575097|FG006|Part 2|Withdrawal by Subject|2|||
163236068|NCT01722331|589575091|FG000|Part 2|Other Protocol Specified Criteria|6|||
163236069|NCT01722331|589575092|FG001|Part 2|Other Protocol Specified Criteria|0|||
163236070|NCT01722331|589575093|FG002|Part 2|Other Protocol Specified Criteria|10|||
163236071|NCT01722331|589575094|FG003|Part 2|Other Protocol Specified Criteria|0|||
163236072|NCT01722331|589575095|FG004|Part 2|Other Protocol Specified Criteria|0|||
163236073|NCT01722331|589575096|FG005|Part 2|Other Protocol Specified Criteria|2|||
163236074|NCT01722331|589575097|FG006|Part 2|Other Protocol Specified Criteria|1|||
163236075|NCT01722331|589575091|FG000|Part 3|Adverse Event|2|||
163236076|NCT01722331|589575092|FG001|Part 3|Adverse Event|2|||
163236077|NCT01722331|589575093|FG002|Part 3|Adverse Event|0|||
163236078|NCT01722331|589575094|FG003|Part 3|Adverse Event|1|||
163236079|NCT01722331|589575095|FG004|Part 3|Adverse Event|0|||
163236080|NCT01722331|589575096|FG005|Part 3|Adverse Event|0|||
163236081|NCT01722331|589575097|FG006|Part 3|Adverse Event|0|||
163236082|NCT01722331|589575091|FG000|Part 3|Death|1|||
163236083|NCT01722331|589575092|FG001|Part 3|Death|0|||
163236084|NCT01722331|589575093|FG002|Part 3|Death|0|||
163236085|NCT01722331|589575094|FG003|Part 3|Death|0|||
163236086|NCT01722331|589575095|FG004|Part 3|Death|0|||
163348815|NCT01231464|589987011|FG001|Overall Study|Withdrawal by Subject|2|||
163348816|NCT00957996|589987012|FG000|Overall Study|Death|4|||
163348817|NCT00957996|589987013|FG001|Overall Study|Death|10|||
163348818|NCT00957996|589987012|FG000|Overall Study|Lost to Follow-up|4|||
163348819|NCT00957996|589987013|FG001|Overall Study|Lost to Follow-up|7|||
163348820|NCT00957996|589987012|FG000|Overall Study|Withdrawal by Subject|9|||
163348821|NCT00957996|589987013|FG001|Overall Study|Withdrawal by Subject|2|||
163348822|NCT00957996|589987012|FG000|Overall Study|Adverse Event|2|||
163348823|NCT00957996|589987013|FG001|Overall Study|Adverse Event|1|||
163348824|NCT00957996|589987012|FG000|Overall Study|Physician Decision|1|||
163348825|NCT00957996|589987013|FG001|Overall Study|Physician Decision|1|||
163348826|NCT00957996|589987012|FG000|Overall Study|Influenza-related complication|0|||
163348827|NCT00957996|589987013|FG001|Overall Study|Influenza-related complication|1|||
163348828|NCT00957996|589987012|FG000|Overall Study|Missing|1|||
163348829|NCT00957996|589987013|FG001|Overall Study|Missing|0|||
163348830|NCT00957996|589987012|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
163348831|NCT00957996|589987013|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
163348832|NCT00684203|589987020|FG000|Overall Study|Adverse Event|6|||
163348833|NCT00684203|589987021|FG001|Overall Study|Adverse Event|4|||
163348834|NCT00684203|589987022|FG002|Overall Study|Adverse Event|8|||
163348835|NCT00684203|589987023|FG003|Overall Study|Adverse Event|0|||
163348836|NCT00684203|589987024|FG004|Overall Study|Adverse Event|0|||
163348837|NCT00684203|589987025|FG005|Overall Study|Adverse Event|0|||
163348838|NCT00684203|589987020|FG000|Overall Study|Protocol-defined clinical event|3|||
163348839|NCT00684203|589987021|FG001|Overall Study|Protocol-defined clinical event|1|||
163348840|NCT00684203|589987022|FG002|Overall Study|Protocol-defined clinical event|0|||
163348841|NCT00684203|589987023|FG003|Overall Study|Protocol-defined clinical event|0|||
163348842|NCT00684203|589987024|FG004|Overall Study|Protocol-defined clinical event|0|||
163348843|NCT00684203|589987025|FG005|Overall Study|Protocol-defined clinical event|0|||
163348844|NCT00684203|589987020|FG000|Overall Study|Withdrawal by Subject|0|||
163348845|NCT00684203|589987021|FG001|Overall Study|Withdrawal by Subject|2|||
163348846|NCT00684203|589987022|FG002|Overall Study|Withdrawal by Subject|1|||
163348847|NCT00684203|589987023|FG003|Overall Study|Withdrawal by Subject|0|||
163348848|NCT00684203|589987024|FG004|Overall Study|Withdrawal by Subject|0|||
163348849|NCT00684203|589987025|FG005|Overall Study|Withdrawal by Subject|0|||
163348850|NCT00684203|589987020|FG000|Overall Study|Did not meet protocol eligibility|0|||
163348851|NCT00684203|589987021|FG001|Overall Study|Did not meet protocol eligibility|1|||
163348852|NCT00684203|589987022|FG002|Overall Study|Did not meet protocol eligibility|0|||
163348853|NCT00684203|589987023|FG003|Overall Study|Did not meet protocol eligibility|0|||
163348854|NCT00684203|589987024|FG004|Overall Study|Did not meet protocol eligibility|0|||
163348855|NCT00684203|589987025|FG005|Overall Study|Did not meet protocol eligibility|0|||
163348856|NCT00468858|589987033|FG000|Overall Study|Adverse Event|0|||
163348857|NCT00468858|589987034|FG001|Overall Study|Adverse Event|1|||
163348858|NCT00468858|589987035|FG002|Overall Study|Adverse Event|0|||
163348859|NCT00468858|589987033|FG000|Overall Study|Withdrawal by Subject|7|||
163236087|NCT01722331|589575096|FG005|Part 3|Death|0|||
163236088|NCT01722331|589575097|FG006|Part 3|Death|0|||
163236089|NCT01722331|589575091|FG000|Part 3|Lack of Efficacy|1|||
163236090|NCT01722331|589575092|FG001|Part 3|Lack of Efficacy|0|||
163236091|NCT01722331|589575093|FG002|Part 3|Lack of Efficacy|0|||
163348860|NCT00468858|589987034|FG001|Overall Study|Withdrawal by Subject|4|||
163348861|NCT00468858|589987035|FG002|Overall Study|Withdrawal by Subject|5|||
163348862|NCT00468858|589987033|FG000|Overall Study|Relocation|1|||
163236092|NCT01722331|589575094|FG003|Part 3|Lack of Efficacy|0|||
163236093|NCT01722331|589575095|FG004|Part 3|Lack of Efficacy|0|||
163236094|NCT01722331|589575096|FG005|Part 3|Lack of Efficacy|0|||
163236095|NCT01722331|589575097|FG006|Part 3|Lack of Efficacy|0|||
163236096|NCT01722331|589575091|FG000|Part 3|Lost to Follow-up|3|||
163236097|NCT01722331|589575092|FG001|Part 3|Lost to Follow-up|4|||
163236098|NCT01722331|589575093|FG002|Part 3|Lost to Follow-up|0|||
163236099|NCT01722331|589575094|FG003|Part 3|Lost to Follow-up|0|||
163236100|NCT01722331|589575095|FG004|Part 3|Lost to Follow-up|0|||
163236101|NCT01722331|589575096|FG005|Part 3|Lost to Follow-up|1|||
163236102|NCT01722331|589575097|FG006|Part 3|Lost to Follow-up|0|||
163236103|NCT01722331|589575091|FG000|Part 3|Non-Compliance with Study Drug|0|||
163236104|NCT01722331|589575092|FG001|Part 3|Non-Compliance with Study Drug|1|||
163236105|NCT01722331|589575093|FG002|Part 3|Non-Compliance with Study Drug|0|||
163236106|NCT01722331|589575094|FG003|Part 3|Non-Compliance with Study Drug|0|||
163236107|NCT01722331|589575095|FG004|Part 3|Non-Compliance with Study Drug|0|||
163236108|NCT01722331|589575096|FG005|Part 3|Non-Compliance with Study Drug|0|||
163236109|NCT01722331|589575097|FG006|Part 3|Non-Compliance with Study Drug|0|||
163236110|NCT01722331|589575091|FG000|Part 3|Physician Decision|1|||
163236111|NCT01722331|589575092|FG001|Part 3|Physician Decision|1|||
163236112|NCT01722331|589575093|FG002|Part 3|Physician Decision|0|||
163236113|NCT01722331|589575094|FG003|Part 3|Physician Decision|0|||
163236114|NCT01722331|589575095|FG004|Part 3|Physician Decision|0|||
163236115|NCT01722331|589575096|FG005|Part 3|Physician Decision|0|||
163236116|NCT01722331|589575097|FG006|Part 3|Physician Decision|1|||
163236117|NCT01722331|589575091|FG000|Part 3|Protocol Violation|2|||
163236118|NCT01722331|589575092|FG001|Part 3|Protocol Violation|1|||
163236119|NCT01722331|589575093|FG002|Part 3|Protocol Violation|0|||
163236120|NCT01722331|589575094|FG003|Part 3|Protocol Violation|0|||
163236121|NCT01722331|589575095|FG004|Part 3|Protocol Violation|0|||
163236122|NCT01722331|589575096|FG005|Part 3|Protocol Violation|0|||
163236123|NCT01722331|589575097|FG006|Part 3|Protocol Violation|0|||
163236124|NCT01722331|589575091|FG000|Part 3|Withdrawal by Subject|4|||
163236125|NCT01722331|589575092|FG001|Part 3|Withdrawal by Subject|7|||
163236126|NCT01722331|589575093|FG002|Part 3|Withdrawal by Subject|0|||
163236127|NCT01722331|589575094|FG003|Part 3|Withdrawal by Subject|0|||
163236128|NCT01722331|589575095|FG004|Part 3|Withdrawal by Subject|0|||
163236129|NCT01722331|589575096|FG005|Part 3|Withdrawal by Subject|2|||
163236130|NCT01722331|589575097|FG006|Part 3|Withdrawal by Subject|1|||
163236131|NCT01722331|589575091|FG000|Part 3|Other Protocol Specified Criteria|1|||
163236132|NCT01722331|589575092|FG001|Part 3|Other Protocol Specified Criteria|1|||
163236133|NCT01722331|589575093|FG002|Part 3|Other Protocol Specified Criteria|0|||
163236134|NCT01722331|589575094|FG003|Part 3|Other Protocol Specified Criteria|0|||
163236135|NCT01722331|589575095|FG004|Part 3|Other Protocol Specified Criteria|0|||
163236136|NCT01722331|589575096|FG005|Part 3|Other Protocol Specified Criteria|0|||
163236137|NCT01722331|589575097|FG006|Part 3|Other Protocol Specified Criteria|0|||
163236138|NCT00353704|589575102|FG000|Overall Study|Protocol Violation|3|||
163236139|NCT00353704|589575103|FG001|Overall Study|Protocol Violation|1|||
163236140|NCT01154166|589575104|FG000|Overall Study|Adverse Event|14|||
163236141|NCT01154166|589575105|FG001|Overall Study|Adverse Event|9|||
163236142|NCT01154166|589575104|FG000|Overall Study|Lost to Follow-up|1|||
163236143|NCT01154166|589575105|FG001|Overall Study|Lost to Follow-up|1|||
163236144|NCT01154166|589575104|FG000|Overall Study|Protocol Violation|4|||
163236145|NCT01154166|589575105|FG001|Overall Study|Protocol Violation|1|||
163236146|NCT01154166|589575104|FG000|Overall Study|Withdrawal by Subject|10|||
163236147|NCT01154166|589575105|FG001|Overall Study|Withdrawal by Subject|1|||
163236148|NCT01154166|589575104|FG000|Overall Study|Lack of Efficacy|3|||
163236149|NCT01154166|589575105|FG001|Overall Study|Lack of Efficacy|0|||
163236150|NCT01154166|589575104|FG000|Overall Study|Disease Progression|1|||
163236151|NCT01154166|589575105|FG001|Overall Study|Disease Progression|0|||
163236152|NCT01154166|589575104|FG000|Overall Study|Poor Compliance|1|||
163236153|NCT01154166|589575105|FG001|Overall Study|Poor Compliance|0|||
163236154|NCT03614793|589575106|FG000|Overall Study|Lost to Follow-up|1|||
163236155|NCT03614793|589575107|FG001|Overall Study|Lost to Follow-up|2|||
163236156|NCT03614793|589575106|FG000|Overall Study|Lack of Efficacy|0|||
163236157|NCT03614793|589575107|FG001|Overall Study|Lack of Efficacy|5|||
163348863|NCT00468858|589987034|FG001|Overall Study|Relocation|3|||
163348864|NCT00468858|589987035|FG002|Overall Study|Relocation|3|||
163348865|NCT00468858|589987033|FG000|Overall Study|Lost to Follow-up|1|||
163348866|NCT00468858|589987034|FG001|Overall Study|Lost to Follow-up|2|||
163236158|NCT03614793|589575106|FG000|Overall Study|Withdrawal by Subject|0|||
163236159|NCT03614793|589575107|FG001|Overall Study|Withdrawal by Subject|1|||
163236160|NCT03614793|589575106|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
163236161|NCT03614793|589575107|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
163236162|NCT02840877|589575108|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
163236163|NCT02840877|589575108|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
163348867|NCT00468858|589987035|FG002|Overall Study|Lost to Follow-up|5|||
163348868|NCT00468858|589987033|FG000|Overall Study|Other|0|||
163236164|NCT02840877|589575108|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
163236165|NCT02840877|589575108|FG000|Baseline to 12 Weeks|Death|1|||
163236166|NCT02840877|589575108|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
163236167|NCT02840877|589575108|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
163348869|NCT00468858|589987034|FG001|Overall Study|Other|0|||
163236168|NCT02840877|589575108|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
163236169|NCT02840877|589575108|FG000|12 Weeks to 6 Months|Treatment failure|1|||
163348870|NCT00468858|589987035|FG002|Overall Study|Other|1|||
163348871|NCT00797511|589987038|FG000|Overall Study|Withdrawal by Subject|1|||
163142080|NCT05907395|589230384|FG003|Period 2|Personal reason|0|||
163142081|NCT05907395|589230385|FG004|Period 2|Personal reason|0|||
163142082|NCT05907395|589230386|FG005|Period 2|Personal reason|0|||
163142083|NCT05907395|589230387|FG006|Period 2|Personal reason|0|||
163142084|NCT05907395|589230388|FG007|Period 2|Personal reason|0|||
163142085|NCT05907395|589230389|FG008|Period 2|Personal reason|0|||
163142086|NCT05907395|589230390|FG009|Period 2|Personal reason|1|||
163142087|NCT05907395|589230391|FG010|Period 2|Personal reason|0|||
163142088|NCT05907395|589230392|FG011|Period 2|Personal reason|0|||
163142089|NCT05907395|589230381|FG000|Period 3|Adverse Event|0|||
163142090|NCT05907395|589230382|FG001|Period 3|Adverse Event|0|||
163142091|NCT05907395|589230383|FG002|Period 3|Adverse Event|0|||
163142092|NCT05907395|589230384|FG003|Period 3|Adverse Event|0|||
163142093|NCT05907395|589230385|FG004|Period 3|Adverse Event|1|||
163142094|NCT05907395|589230386|FG005|Period 3|Adverse Event|0|||
163142095|NCT05907395|589230387|FG006|Period 3|Adverse Event|0|||
163142096|NCT05907395|589230388|FG007|Period 3|Adverse Event|0|||
163142097|NCT05907395|589230389|FG008|Period 3|Adverse Event|0|||
163142098|NCT05907395|589230390|FG009|Period 3|Adverse Event|0|||
163142099|NCT05907395|589230391|FG010|Period 3|Adverse Event|0|||
163142100|NCT05907395|589230392|FG011|Period 3|Adverse Event|0|||
163142101|NCT05214768|589230393|FG000|Induction Period|Withdrawal by Subject|1|||
163142102|NCT05214768|589230394|FG001|Induction Period|Withdrawal by Subject|0|||
163142103|NCT05214768|589230395|FG002|Induction Period|Withdrawal by Subject|0|||
163142104|NCT05214768|589230396|FG003|Induction Period|Withdrawal by Subject|0|||
163142105|NCT05214768|589230397|FG004|Induction Period|Withdrawal by Subject|0|||
163142106|NCT05214768|589230398|FG005|Induction Period|Withdrawal by Subject|0|||
163142107|NCT05214768|589230393|FG000|Induction Period|Physician Decision|1|||
163142108|NCT05214768|589230394|FG001|Induction Period|Physician Decision|0|||
163142109|NCT05214768|589230395|FG002|Induction Period|Physician Decision|0|||
163142110|NCT05214768|589230396|FG003|Induction Period|Physician Decision|0|||
163142111|NCT05214768|589230397|FG004|Induction Period|Physician Decision|0|||
163142112|NCT05214768|589230398|FG005|Induction Period|Physician Decision|0|||
163142113|NCT05214768|589230393|FG000|Maintenance Period|Other Reasons|0|||
163142114|NCT05214768|589230394|FG001|Maintenance Period|Other Reasons|0|||
163142115|NCT05214768|589230395|FG002|Maintenance Period|Other Reasons|1|||
163142116|NCT05214768|589230396|FG003|Maintenance Period|Other Reasons|1|||
163142117|NCT05214768|589230397|FG004|Maintenance Period|Other Reasons|0|||
163142118|NCT05214768|589230398|FG005|Maintenance Period|Other Reasons|0|||
163142119|NCT05214768|589230393|FG000|Maintenance Period|Withdrawal by Subject|0|||
163142120|NCT05214768|589230394|FG001|Maintenance Period|Withdrawal by Subject|0|||
163142121|NCT05214768|589230395|FG002|Maintenance Period|Withdrawal by Subject|0|||
163142122|NCT05214768|589230396|FG003|Maintenance Period|Withdrawal by Subject|1|||
163142123|NCT05214768|589230397|FG004|Maintenance Period|Withdrawal by Subject|0|||
163142124|NCT05214768|589230398|FG005|Maintenance Period|Withdrawal by Subject|0|||
163142125|NCT05214768|589230393|FG000|Maintenance Period|Lack of Efficacy|0|||
163142126|NCT05214768|589230394|FG001|Maintenance Period|Lack of Efficacy|0|||
163142127|NCT05214768|589230395|FG002|Maintenance Period|Lack of Efficacy|1|||
163142128|NCT05214768|589230396|FG003|Maintenance Period|Lack of Efficacy|0|||
163142129|NCT05214768|589230397|FG004|Maintenance Period|Lack of Efficacy|1|||
163142130|NCT05214768|589230398|FG005|Maintenance Period|Lack of Efficacy|0|||
163142131|NCT05214768|589230393|FG000|Open Label Extension Period|Physician Decision|0|||
163142132|NCT05214768|589230394|FG001|Open Label Extension Period|Physician Decision|0|||
163142133|NCT05214768|589230395|FG002|Open Label Extension Period|Physician Decision|0|||
163142134|NCT05214768|589230396|FG003|Open Label Extension Period|Physician Decision|0|||
163142135|NCT05214768|589230397|FG004|Open Label Extension Period|Physician Decision|0|||
163142136|NCT05214768|589230398|FG005|Open Label Extension Period|Physician Decision|1|||
163142137|NCT05214768|589230393|FG000|Open Label Extension Period|Lack of Efficacy|0|||
163142138|NCT05214768|589230394|FG001|Open Label Extension Period|Lack of Efficacy|0|||
163142139|NCT05214768|589230395|FG002|Open Label Extension Period|Lack of Efficacy|0|||
163142140|NCT05214768|589230396|FG003|Open Label Extension Period|Lack of Efficacy|0|||
163142141|NCT05214768|589230397|FG004|Open Label Extension Period|Lack of Efficacy|0|||
163142142|NCT05214768|589230398|FG005|Open Label Extension Period|Lack of Efficacy|1|||
163142143|NCT05214768|589230393|FG000|Open Label Extension Period|Ongoing Study|0|||
163142144|NCT05214768|589230394|FG001|Open Label Extension Period|Ongoing Study|0|||
163142145|NCT05214768|589230395|FG002|Open Label Extension Period|Ongoing Study|0|||
163142146|NCT05214768|589230396|FG003|Open Label Extension Period|Ongoing Study|0|||
163142147|NCT05214768|589230397|FG004|Open Label Extension Period|Ongoing Study|0|||
163142148|NCT05214768|589230398|FG005|Open Label Extension Period|Ongoing Study|42|||
163142149|NCT05481359|589230399|FG000|Overall Study|Lost to Follow-up|3|||
163142150|NCT05481359|589230399|FG000|Overall Study|Withdrawal by Subject|1|||
163142151|NCT03043872|589230404|FG000|Overall Study|Withdrawal by Subject|6|||
163142152|NCT03043872|589230405|FG001|Overall Study|Withdrawal by Subject|6|||
163142153|NCT03043872|589230406|FG002|Overall Study|Withdrawal by Subject|15|||
163142154|NCT03043872|589230404|FG000|Overall Study|Lost to Follow-up|2|||
163142155|NCT03043872|589230405|FG001|Overall Study|Lost to Follow-up|1|||
163142156|NCT03043872|589230406|FG002|Overall Study|Lost to Follow-up|1|||
163142157|NCT03043872|589230404|FG000|Overall Study|Death|270|||
163236170|NCT02840877|589575108|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
163236171|NCT02840877|589575108|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
163236172|NCT02840877|589575108|FG000|12 Weeks to 6 Months|Death|1|||
163236173|NCT02840877|589575108|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
163236174|NCT02840877|589575108|FG000|6 Months to 18 Months|Treatment failure|7|||
163236175|NCT02840877|589575108|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
163236176|NCT02840877|589575108|FG000|6 Months to 18 Months|Moved/transferred out|6|||
163236177|NCT02840877|589575108|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
163236178|NCT02840877|589575108|FG000|6 Months to 18 Months|Death|4|||
163236179|NCT02840877|589575108|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
163236180|NCT02840877|589575108|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
163236181|NCT02840877|589575108|FG000|6 Months to 18 Months|Still in study.|14|||
163236182|NCT04317586|589575109|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
163236183|NCT04317586|589575109|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
163236184|NCT01276327|589575112|FG000|Overall Study|Adverse Event|1|||
163236185|NCT01276327|589575113|FG001|Overall Study|Adverse Event|3|||
163236186|NCT01276327|589575112|FG000|Overall Study|Withdrawal by Subject|1|||
163236187|NCT01276327|589575113|FG001|Overall Study|Withdrawal by Subject|0|||
163236188|NCT00807092|589575114|FG000|Overall Study|Adverse Event|0|||
163236189|NCT00807092|589575115|FG001|Overall Study|Adverse Event|1|||
163236190|NCT00807092|589575114|FG000|Overall Study|Protocol Violation|0|||
163236191|NCT00807092|589575115|FG001|Overall Study|Protocol Violation|2|||
163236192|NCT00807092|589575114|FG000|Overall Study|Withdrawal by Subject|1|||
163236193|NCT00807092|589575115|FG001|Overall Study|Withdrawal by Subject|0|||
163236194|NCT00807092|589575114|FG000|Overall Study|CGMS data collection failed|0|||
163236195|NCT00807092|589575115|FG001|Overall Study|CGMS data collection failed|1|||
163236196|NCT01794949|589575116|FG000|Overall Study|Lost to Follow-up|1|||
163236197|NCT01794949|589575117|FG001|Overall Study|Lost to Follow-up|0|||
163236198|NCT03003676|589575118|FG000|Overall Study|Lack of Efficacy|5|||
163236199|NCT03003676|589575119|FG001|Overall Study|Lack of Efficacy|7|||
163236200|NCT03003676|589575118|FG000|Overall Study|Withdrawal by Subject|0|||
163236201|NCT03003676|589575119|FG001|Overall Study|Withdrawal by Subject|1|||
163236202|NCT03003676|589575118|FG000|Overall Study|Hepatitis B infection|1|||
163236203|NCT03003676|589575119|FG001|Overall Study|Hepatitis B infection|0|||
163236204|NCT02617589|589575138|FG000|Randomization|Request to Discontinue Study Treatment|1|||
163236205|NCT02617589|589575139|FG001|Randomization|Request to Discontinue Study Treatment|3|||
163236206|NCT02617589|589575138|FG000|Randomization|Participant Withdrew Consent|1|||
163236207|NCT02617589|589575139|FG001|Randomization|Participant Withdrew Consent|2|||
163236208|NCT02617589|589575138|FG000|Treatment|Other Reasons|3|||
163236209|NCT02617589|589575139|FG001|Treatment|Other Reasons|3|||
163236210|NCT02617589|589575138|FG000|Treatment|Poor/Non Compliance|1|||
163236211|NCT02617589|589575139|FG001|Treatment|Poor/Non Compliance|1|||
163236212|NCT02617589|589575138|FG000|Treatment|Maximum Clinical Benefit|0|||
163236213|NCT02617589|589575139|FG001|Treatment|Maximum Clinical Benefit|2|||
163236214|NCT02617589|589575138|FG000|Treatment|Participant Withdrew Consent|2|||
163236215|NCT02617589|589575139|FG001|Treatment|Participant Withdrew Consent|6|||
163236216|NCT02617589|589575138|FG000|Treatment|Participant Request to Discontinue|12|||
163236217|NCT02617589|589575139|FG001|Treatment|Participant Request to Discontinue|21|||
163236218|NCT02617589|589575138|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
163236219|NCT02617589|589575139|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
163236220|NCT02617589|589575138|FG000|Treatment|Death|1|||
163236221|NCT02617589|589575139|FG001|Treatment|Death|1|||
163236222|NCT02617589|589575138|FG000|Treatment|Study Drug Toxicity|27|||
163236223|NCT02617589|589575139|FG001|Treatment|Study Drug Toxicity|20|||
163236224|NCT02617589|589575138|FG000|Treatment|Disease Progression|216|||
163236225|NCT02617589|589575139|FG001|Treatment|Disease Progression|136|||
163236226|NCT03062891|589575140|FG000|Overall Study|Withdrawal by Subject|2|||
163236227|NCT03062891|589575141|FG001|Overall Study|Withdrawal by Subject|0|||
163236228|NCT03062891|589575140|FG000|Overall Study|Lost to Follow-up|50|||
163236229|NCT03062891|589575141|FG001|Overall Study|Lost to Follow-up|38|||
163236230|NCT00958880|589575151|FG000|Overall Study|Lost to Follow-up|2|||
163236231|NCT00958880|589575152|FG001|Overall Study|Lost to Follow-up|2|||
163236232|NCT00298831|589575153|FG000|Overall Study|Adverse Event|1|||
163236233|NCT00298831|589575153|FG000|Overall Study|Lost to Follow-up|3|||
163236234|NCT00298831|589575153|FG000|Overall Study|Withdrawal by Subject|1|||
163236235|NCT00298831|589575153|FG000|Overall Study|Participants did not receive treatment|27|||
163236236|NCT01516879|589575154|FG000|Overall Study|Withdrawal by Subject|9|||
163236237|NCT01516879|589575155|FG001|Overall Study|Withdrawal by Subject|11|||
163236238|NCT01516879|589575154|FG000|Overall Study|Death|0|||
163236239|NCT01516879|589575155|FG001|Overall Study|Death|2|||
163236240|NCT01516879|589575154|FG000|Overall Study|Lost to Follow-up|2|||
163236241|NCT01516879|589575155|FG001|Overall Study|Lost to Follow-up|11|||
163236242|NCT01516879|589575154|FG000|Overall Study|Other|5|||
163236243|NCT01516879|589575155|FG001|Overall Study|Other|10|||
163236244|NCT04568122|589575156|FG000|Overall Study|Lost to Follow-up|48|||
163348872|NCT00317603|589987039|FG000|Overall Study|Progressive Disease|3|||
163348873|NCT00843115|589987040|FG000|Overall Study|Death|4|||
163236245|NCT04568122|589575157|FG001|Overall Study|Lost to Follow-up|44|||
163236246|NCT04568122|589575158|FG002|Overall Study|Lost to Follow-up|4|||
163236247|NCT04568122|589575159|FG003|Overall Study|Lost to Follow-up|0|||
163236248|NCT04568122|589575160|FG004|Overall Study|Lost to Follow-up|0|||
163236249|NCT02460224|589575166|FG000|Overall Study|Adverse Event|0|||
163236250|NCT02460224|589575167|FG001|Overall Study|Adverse Event|0|||
163236251|NCT02460224|589575168|FG002|Overall Study|Adverse Event|0|||
163236252|NCT02460224|589575169|FG003|Overall Study|Adverse Event|0|||
163236253|NCT02460224|589575170|FG004|Overall Study|Adverse Event|0|||
163236254|NCT02460224|589575171|FG005|Overall Study|Adverse Event|0|||
163236255|NCT02460224|589575172|FG006|Overall Study|Adverse Event|1|||
163236256|NCT02460224|589575173|FG007|Overall Study|Adverse Event|0|||
163236257|NCT02460224|589575174|FG008|Overall Study|Adverse Event|0|||
163236258|NCT02460224|589575175|FG009|Overall Study|Adverse Event|0|||
163236259|NCT02460224|589575176|FG010|Overall Study|Adverse Event|0|||
163236260|NCT02460224|589575177|FG011|Overall Study|Adverse Event|0|||
163236261|NCT02460224|589575178|FG012|Overall Study|Adverse Event|1|||
163236262|NCT02460224|589575179|FG013|Overall Study|Adverse Event|0|||
163236263|NCT02460224|589575180|FG014|Overall Study|Adverse Event|0|||
163236264|NCT02460224|589575181|FG015|Overall Study|Adverse Event|0|||
163236265|NCT02460224|589575182|FG016|Overall Study|Adverse Event|1|||
163236266|NCT02460224|589575183|FG017|Overall Study|Adverse Event|0|||
163236267|NCT02460224|589575184|FG018|Overall Study|Adverse Event|1|||
163236268|NCT02460224|589575185|FG019|Overall Study|Adverse Event|0|||
163236269|NCT02460224|589575186|FG020|Overall Study|Adverse Event|1|||
163236270|NCT02460224|589575187|FG021|Overall Study|Adverse Event|1|||
163236271|NCT02460224|589575188|FG022|Overall Study|Adverse Event|1|||
163236272|NCT02460224|589575189|FG023|Overall Study|Adverse Event|0|||
163236273|NCT02460224|589575190|FG024|Overall Study|Adverse Event|0|||
163236274|NCT02460224|589575191|FG025|Overall Study|Adverse Event|0|||
163348874|NCT00843115|589987040|FG000|Overall Study|Adverse Event|30|||
163348875|NCT00843115|589987040|FG000|Overall Study|Lost to Follow-up|4|||
163348876|NCT00843115|589987040|FG000|Overall Study|Withdrawal by Subject|17|||
163348877|NCT00843115|589987040|FG000|Overall Study|Family wanted meds stopped|1|||
163348878|NCT00843115|589987040|FG000|Overall Study|Family does not want continuation|1|||
163348879|NCT00843115|589987040|FG000|Overall Study|Patient forgot to take meds|1|||
163142158|NCT03043872|589230405|FG001|Overall Study|Death|269|||
163142159|NCT03043872|589230406|FG002|Overall Study|Death|296|||
163142160|NCT02777827|589230408|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
163142161|NCT02777827|589230409|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
163142162|NCT02777827|589230410|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
163142163|NCT02777827|589230411|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
163142164|NCT02777827|589230412|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
163142165|NCT02777827|589230413|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
163142166|NCT04551066|589230414|FG000|Overall Study|Death|5|||
163142167|NCT04551066|589230415|FG001|Overall Study|Death|3|||
163142168|NCT04551066|589230414|FG000|Overall Study|Lost to Follow-up|1|||
163142169|NCT04551066|589230415|FG001|Overall Study|Lost to Follow-up|0|||
163142170|NCT04551066|589230414|FG000|Overall Study|Sponsor Decision|104|||
163142171|NCT04551066|589230415|FG001|Overall Study|Sponsor Decision|117|||
163142172|NCT04551066|589230414|FG000|Overall Study|Withdrawal by Subject|8|||
163142173|NCT04551066|589230415|FG001|Overall Study|Withdrawal by Subject|2|||
163142174|NCT04551066|589230414|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
163142175|NCT04551066|589230415|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
163142176|NCT04551066|589230414|FG000|Overall Study|Adverse Event|2|||
163142177|NCT04551066|589230415|FG001|Overall Study|Adverse Event|0|||
163142178|NCT04551066|589230414|FG000|Overall Study|Physician Decision|2|||
163142179|NCT04551066|589230415|FG001|Overall Study|Physician Decision|0|||
163142180|NCT04551066|589230414|FG000|Overall Study|Protocol Violation|1|||
163142181|NCT04551066|589230415|FG001|Overall Study|Protocol Violation|0|||
163142182|NCT04551066|589230414|FG000|Overall Study|Lack of Efficacy|0|||
163142183|NCT04551066|589230415|FG001|Overall Study|Lack of Efficacy|1|||
163142184|NCT04551066|589230414|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
163142185|NCT04551066|589230415|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
163236275|NCT02460224|589575192|FG026|Overall Study|Adverse Event|11|||
163236276|NCT02460224|589575193|FG027|Overall Study|Adverse Event|1|||
163348880|NCT00843115|589987040|FG000|Overall Study|Does not meet entrance criteria|1|||
163142186|NCT04491136|589230416|FG000|Overall Study|Patient withdraw informed consent|9|||
163236277|NCT02460224|589575194|FG028|Overall Study|Adverse Event|6|||
163236278|NCT02460224|589575166|FG000|Overall Study|Death|0|||
163236279|NCT02460224|589575167|FG001|Overall Study|Death|0|||
163142187|NCT04491136|589230416|FG000|Overall Study|Adverse Event|2|||
163142188|NCT04491136|589230416|FG000|Overall Study|Death|3|||
163142189|NCT04491136|589230416|FG000|Overall Study|Lost to Follow-up|3|||
163236280|NCT02460224|589575168|FG002|Overall Study|Death|0|||
163236281|NCT02460224|589575169|FG003|Overall Study|Death|0|||
163348881|NCT00843115|589987040|FG000|Overall Study|Physician Decision|1|||
163142190|NCT04491136|589230416|FG000|Overall Study|Physician Decision|45|||
163142191|NCT04491136|589230416|FG000|Overall Study|sponsor terminated the study early|16|||
163142192|NCT04491136|589230416|FG000|Overall Study|Patient/guardian's decision|1|||
163142193|NCT00319254|589230419|FG000|Overall Study|Withdrawal by Subject|4|||
163142194|NCT00319254|589230419|FG000|Overall Study|Death|46|||
163142195|NCT00319254|589230419|FG000|Overall Study|Lost to Follow-up|2|||
163142196|NCT00319254|589230419|FG000|Overall Study|Enrolled, Not Treated|2|||
163142197|NCT01712204|589230423|FG000|Overall Study|Adverse Event|3|||
163142198|NCT01712204|589230424|FG001|Overall Study|Adverse Event|1|||
163142199|NCT01712204|589230423|FG000|Overall Study|Withdrawal by Subject|3|||
163142200|NCT01712204|589230424|FG001|Overall Study|Withdrawal by Subject|3|||
163142201|NCT01712204|589230423|FG000|Overall Study|Lost to Follow-up|1|||
163142202|NCT01712204|589230424|FG001|Overall Study|Lost to Follow-up|0|||
163142203|NCT01712204|589230423|FG000|Overall Study|Protocol Violation|1|||
163142204|NCT01712204|589230424|FG001|Overall Study|Protocol Violation|1|||
163142205|NCT02452424|589230425|FG000|Overall Study|Death|2|||
163142206|NCT02452424|589230426|FG001|Overall Study|Death|2|||
163142207|NCT02452424|589230427|FG002|Overall Study|Death|2|||
163142208|NCT02452424|589230428|FG003|Overall Study|Death|6|||
163142209|NCT02452424|589230429|FG004|Overall Study|Death|2|||
163142210|NCT02452424|589230430|FG005|Overall Study|Death|0|||
163142211|NCT02452424|589230431|FG006|Overall Study|Death|5|||
163142212|NCT02452424|589230432|FG007|Overall Study|Death|1|||
163142213|NCT02452424|589230433|FG008|Overall Study|Death|3|||
163142214|NCT02452424|589230434|FG009|Overall Study|Death|1|||
163236282|NCT02460224|589575170|FG004|Overall Study|Death|0|||
163236283|NCT02460224|589575171|FG005|Overall Study|Death|2|||
163236284|NCT02460224|589575172|FG006|Overall Study|Death|1|||
163236285|NCT02460224|589575173|FG007|Overall Study|Death|0|||
163236286|NCT02460224|589575174|FG008|Overall Study|Death|0|||
163236287|NCT02460224|589575175|FG009|Overall Study|Death|1|||
163236288|NCT02460224|589575176|FG010|Overall Study|Death|0|||
163236289|NCT02460224|589575177|FG011|Overall Study|Death|0|||
163236290|NCT02460224|589575178|FG012|Overall Study|Death|0|||
163236291|NCT02460224|589575179|FG013|Overall Study|Death|1|||
163236292|NCT02460224|589575180|FG014|Overall Study|Death|0|||
163142215|NCT02452424|589230435|FG010|Overall Study|Death|0|||
163142216|NCT02452424|589230425|FG000|Overall Study|Lost to Follow-up|0|||
163142217|NCT02452424|589230426|FG001|Overall Study|Lost to Follow-up|1|||
163142218|NCT02452424|589230427|FG002|Overall Study|Lost to Follow-up|1|||
163142219|NCT02452424|589230428|FG003|Overall Study|Lost to Follow-up|0|||
163142220|NCT02452424|589230429|FG004|Overall Study|Lost to Follow-up|0|||
163236293|NCT02460224|589575181|FG015|Overall Study|Death|0|||
163236294|NCT02460224|589575182|FG016|Overall Study|Death|2|||
163236295|NCT02460224|589575183|FG017|Overall Study|Death|1|||
163236296|NCT02460224|589575184|FG018|Overall Study|Death|0|||
163236297|NCT02460224|589575185|FG019|Overall Study|Death|2|||
163236298|NCT02460224|589575186|FG020|Overall Study|Death|0|||
163236299|NCT02460224|589575187|FG021|Overall Study|Death|0|||
163236300|NCT02460224|589575188|FG022|Overall Study|Death|0|||
163236301|NCT02460224|589575189|FG023|Overall Study|Death|0|||
163236302|NCT02460224|589575190|FG024|Overall Study|Death|1|||
163236303|NCT02460224|589575191|FG025|Overall Study|Death|1|||
163236304|NCT02460224|589575192|FG026|Overall Study|Death|5|||
163236305|NCT02460224|589575193|FG027|Overall Study|Death|0|||
163236306|NCT02460224|589575194|FG028|Overall Study|Death|1|||
163236307|NCT02460224|589575166|FG000|Overall Study|Lost to Follow-up|0|||
163236308|NCT02460224|589575167|FG001|Overall Study|Lost to Follow-up|0|||
163236309|NCT02460224|589575168|FG002|Overall Study|Lost to Follow-up|0|||
163348882|NCT00843115|589987040|FG000|Overall Study|Family discontinued meds|1|||
163348883|NCT00843115|589987040|FG000|Overall Study|patient took for 2 days then stopped|1|||
163348884|NCT00843115|589987040|FG000|Overall Study|patient never took the medication|1|||
163142221|NCT02452424|589230430|FG005|Overall Study|Lost to Follow-up|0|||
163236310|NCT02460224|589575169|FG003|Overall Study|Lost to Follow-up|0|||
163236311|NCT02460224|589575170|FG004|Overall Study|Lost to Follow-up|0|||
163236312|NCT02460224|589575171|FG005|Overall Study|Lost to Follow-up|0|||
163236313|NCT02460224|589575172|FG006|Overall Study|Lost to Follow-up|0|||
163142222|NCT02452424|589230431|FG006|Overall Study|Lost to Follow-up|0|||
163142223|NCT02452424|589230432|FG007|Overall Study|Lost to Follow-up|0|||
163142224|NCT02452424|589230433|FG008|Overall Study|Lost to Follow-up|0|||
163142225|NCT02452424|589230434|FG009|Overall Study|Lost to Follow-up|0|||
163142226|NCT02452424|589230435|FG010|Overall Study|Lost to Follow-up|0|||
163142227|NCT02452424|589230425|FG000|Overall Study|Withdrawal by Subject|0|||
163142228|NCT02452424|589230426|FG001|Overall Study|Withdrawal by Subject|0|||
163142229|NCT02452424|589230427|FG002|Overall Study|Withdrawal by Subject|3|||
163142230|NCT02452424|589230428|FG003|Overall Study|Withdrawal by Subject|2|||
163236314|NCT02460224|589575173|FG007|Overall Study|Lost to Follow-up|0|||
163236315|NCT02460224|589575174|FG008|Overall Study|Lost to Follow-up|0|||
163236316|NCT02460224|589575175|FG009|Overall Study|Lost to Follow-up|0|||
163236317|NCT02460224|589575176|FG010|Overall Study|Lost to Follow-up|0|||
163236318|NCT02460224|589575177|FG011|Overall Study|Lost to Follow-up|0|||
163236319|NCT02460224|589575178|FG012|Overall Study|Lost to Follow-up|0|||
163236320|NCT02460224|589575179|FG013|Overall Study|Lost to Follow-up|0|||
163236321|NCT02460224|589575180|FG014|Overall Study|Lost to Follow-up|0|||
163236322|NCT02460224|589575181|FG015|Overall Study|Lost to Follow-up|0|||
163236323|NCT02460224|589575182|FG016|Overall Study|Lost to Follow-up|0|||
163236324|NCT02460224|589575183|FG017|Overall Study|Lost to Follow-up|0|||
163236325|NCT02460224|589575184|FG018|Overall Study|Lost to Follow-up|0|||
163236326|NCT02460224|589575185|FG019|Overall Study|Lost to Follow-up|0|||
163236327|NCT02460224|589575186|FG020|Overall Study|Lost to Follow-up|0|||
163236328|NCT02460224|589575187|FG021|Overall Study|Lost to Follow-up|0|||
163236329|NCT02460224|589575188|FG022|Overall Study|Lost to Follow-up|1|||
163236330|NCT02460224|589575189|FG023|Overall Study|Lost to Follow-up|0|||
163236331|NCT02460224|589575190|FG024|Overall Study|Lost to Follow-up|0|||
163236332|NCT02460224|589575191|FG025|Overall Study|Lost to Follow-up|0|||
163236333|NCT02460224|589575192|FG026|Overall Study|Lost to Follow-up|0|||
163236334|NCT02460224|589575193|FG027|Overall Study|Lost to Follow-up|0|||
163236335|NCT02460224|589575194|FG028|Overall Study|Lost to Follow-up|0|||
163236336|NCT02460224|589575166|FG000|Overall Study|Physician Decision|0|||
163236337|NCT02460224|589575167|FG001|Overall Study|Physician Decision|1|||
163236338|NCT02460224|589575168|FG002|Overall Study|Physician Decision|0|||
163236339|NCT02460224|589575169|FG003|Overall Study|Physician Decision|0|||
163236340|NCT02460224|589575170|FG004|Overall Study|Physician Decision|1|||
163236341|NCT02460224|589575171|FG005|Overall Study|Physician Decision|0|||
163236342|NCT02460224|589575172|FG006|Overall Study|Physician Decision|0|||
163236343|NCT02460224|589575173|FG007|Overall Study|Physician Decision|1|||
163236344|NCT02460224|589575174|FG008|Overall Study|Physician Decision|0|||
163236345|NCT02460224|589575175|FG009|Overall Study|Physician Decision|0|||
163236346|NCT02460224|589575176|FG010|Overall Study|Physician Decision|0|||
163236347|NCT02460224|589575177|FG011|Overall Study|Physician Decision|1|||
163236348|NCT02460224|589575178|FG012|Overall Study|Physician Decision|0|||
163236349|NCT02460224|589575179|FG013|Overall Study|Physician Decision|1|||
163236350|NCT02460224|589575180|FG014|Overall Study|Physician Decision|0|||
163236351|NCT02460224|589575181|FG015|Overall Study|Physician Decision|0|||
163236352|NCT02460224|589575182|FG016|Overall Study|Physician Decision|2|||
163236353|NCT02460224|589575183|FG017|Overall Study|Physician Decision|1|||
163236354|NCT02460224|589575184|FG018|Overall Study|Physician Decision|1|||
163236355|NCT02460224|589575185|FG019|Overall Study|Physician Decision|2|||
163236356|NCT02460224|589575186|FG020|Overall Study|Physician Decision|1|||
163236357|NCT02460224|589575187|FG021|Overall Study|Physician Decision|1|||
163236358|NCT02460224|589575188|FG022|Overall Study|Physician Decision|0|||
163236359|NCT02460224|589575189|FG023|Overall Study|Physician Decision|0|||
163236360|NCT02460224|589575190|FG024|Overall Study|Physician Decision|1|||
163236361|NCT02460224|589575191|FG025|Overall Study|Physician Decision|0|||
163236362|NCT02460224|589575192|FG026|Overall Study|Physician Decision|14|||
163236363|NCT02460224|589575193|FG027|Overall Study|Physician Decision|1|||
163142231|NCT02452424|589230429|FG004|Overall Study|Withdrawal by Subject|0|||
163142232|NCT02452424|589230430|FG005|Overall Study|Withdrawal by Subject|0|||
163142233|NCT02452424|589230431|FG006|Overall Study|Withdrawal by Subject|1|||
163142234|NCT02452424|589230432|FG007|Overall Study|Withdrawal by Subject|0|||
163142235|NCT02452424|589230433|FG008|Overall Study|Withdrawal by Subject|1|||
163142236|NCT02452424|589230434|FG009|Overall Study|Withdrawal by Subject|1|||
163142237|NCT02452424|589230435|FG010|Overall Study|Withdrawal by Subject|0|||
163142238|NCT02452424|589230425|FG000|Overall Study|Other|0|||
163142239|NCT02452424|589230426|FG001|Overall Study|Other|0|||
163142240|NCT02452424|589230427|FG002|Overall Study|Other|1|||
163236364|NCT02460224|589575194|FG028|Overall Study|Physician Decision|6|||
163236365|NCT02460224|589575166|FG000|Overall Study|Progressive disease|15|||
163236366|NCT02460224|589575167|FG001|Overall Study|Progressive disease|11|||
163348885|NCT00843115|589987040|FG000|Overall Study|hospitalized due to deterioration|1|||
163142241|NCT02452424|589230428|FG003|Overall Study|Other|0|||
163142242|NCT02452424|589230429|FG004|Overall Study|Other|0|||
163142243|NCT02452424|589230430|FG005|Overall Study|Other|1|||
163142244|NCT02452424|589230431|FG006|Overall Study|Other|4|||
163142245|NCT02452424|589230432|FG007|Overall Study|Other|3|||
163142246|NCT02452424|589230433|FG008|Overall Study|Other|0|||
163142247|NCT02452424|589230434|FG009|Overall Study|Other|0|||
163236367|NCT02460224|589575168|FG002|Overall Study|Progressive disease|5|||
163236368|NCT02460224|589575169|FG003|Overall Study|Progressive disease|6|||
163236369|NCT02460224|589575170|FG004|Overall Study|Progressive disease|3|||
163348886|NCT00843115|589987040|FG000|Overall Study|week 12 not done|1|||
163348887|NCT00843115|589987040|FG000|Overall Study|Syndrome De Glissement|1|||
163142248|NCT02452424|589230435|FG010|Overall Study|Other|1|||
163142249|NCT02452424|589230425|FG000|Overall Study|Progressive disease (per RECIST)|0|||
163142250|NCT02452424|589230426|FG001|Overall Study|Progressive disease (per RECIST)|0|||
163142251|NCT02452424|589230427|FG002|Overall Study|Progressive disease (per RECIST)|0|||
163142252|NCT02452424|589230428|FG003|Overall Study|Progressive disease (per RECIST)|0|||
163236370|NCT02460224|589575171|FG005|Overall Study|Progressive disease|26|||
163236371|NCT02460224|589575172|FG006|Overall Study|Progressive disease|28|||
163236372|NCT02460224|589575173|FG007|Overall Study|Progressive disease|4|||
163236373|NCT02460224|589575174|FG008|Overall Study|Progressive disease|5|||
163236374|NCT02460224|589575175|FG009|Overall Study|Progressive disease|9|||
163236375|NCT02460224|589575176|FG010|Overall Study|Progressive disease|5|||
163348888|NCT02621047|589987041|FG000|Overall Study|Adverse Event|0|||
163236376|NCT02460224|589575177|FG011|Overall Study|Progressive disease|4|||
163236377|NCT02460224|589575178|FG012|Overall Study|Progressive disease|5|||
163236378|NCT02460224|589575179|FG013|Overall Study|Progressive disease|4|||
163236379|NCT02460224|589575180|FG014|Overall Study|Progressive disease|5|||
163236380|NCT02460224|589575181|FG015|Overall Study|Progressive disease|5|||
163236381|NCT02460224|589575182|FG016|Overall Study|Progressive disease|15|||
163236382|NCT02460224|589575183|FG017|Overall Study|Progressive disease|3|||
163142253|NCT02452424|589230429|FG004|Overall Study|Progressive disease (per RECIST)|0|||
163142254|NCT02452424|589230430|FG005|Overall Study|Progressive disease (per RECIST)|0|||
163142255|NCT02452424|589230431|FG006|Overall Study|Progressive disease (per RECIST)|0|||
163142256|NCT02452424|589230432|FG007|Overall Study|Progressive disease (per RECIST)|0|||
163142257|NCT02452424|589230433|FG008|Overall Study|Progressive disease (per RECIST)|2|||
163142258|NCT02452424|589230434|FG009|Overall Study|Progressive disease (per RECIST)|0|||
163142259|NCT02452424|589230435|FG010|Overall Study|Progressive disease (per RECIST)|0|||
163142260|NCT02452424|589230425|FG000|Overall Study|Adverse Event|0|||
163142261|NCT02452424|589230426|FG001|Overall Study|Adverse Event|0|||
163142262|NCT02452424|589230427|FG002|Overall Study|Adverse Event|0|||
163142263|NCT02452424|589230428|FG003|Overall Study|Adverse Event|0|||
163142264|NCT02452424|589230429|FG004|Overall Study|Adverse Event|0|||
163142265|NCT02452424|589230430|FG005|Overall Study|Adverse Event|0|||
163142266|NCT02452424|589230431|FG006|Overall Study|Adverse Event|0|||
163142267|NCT02452424|589230432|FG007|Overall Study|Adverse Event|0|||
163142268|NCT02452424|589230433|FG008|Overall Study|Adverse Event|0|||
163142269|NCT02452424|589230434|FG009|Overall Study|Adverse Event|0|||
163142270|NCT02452424|589230435|FG010|Overall Study|Adverse Event|1|||
163142271|NCT01059318|589230436|FG000|Core Study (26 Week)|Adverse Event|3|||
163142272|NCT01059318|589230436|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
163142273|NCT01059318|589230436|FG000|Extension (36 Week)|Adverse Event|3|||
163142274|NCT03790917|589230437|FG000|Overall Study|Death|1|||
163142275|NCT01223183|589230443|FG000|Imaging Day 1|Physician Decision|0|||
163142276|NCT01223183|589230444|FG001|Imaging Day 1|Physician Decision|1|||
163142277|NCT01223183|589230443|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
163142278|NCT01223183|589230444|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
163142279|NCT01223183|589230443|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
163142280|NCT01223183|589230444|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
163142281|NCT03772665|589230445|FG000|Overall Study|Protocol Violation|1|||
163142282|NCT03772665|589230446|FG001|Overall Study|Protocol Violation|0|||
163142283|NCT02719171|589231670|FG000|Overall Study|Adverse Event|1|||
163142284|NCT02719171|589231671|FG001|Overall Study|Adverse Event|2|||
163142285|NCT02719171|589231672|FG002|Overall Study|Adverse Event|0|||
163142286|NCT02719171|589231673|FG003|Overall Study|Adverse Event|0|||
163142287|NCT02719171|589231674|FG004|Overall Study|Adverse Event|2|||
163142288|NCT02719171|589231670|FG000|Overall Study|Lost to Follow-up|0|||
163142289|NCT02719171|589231671|FG001|Overall Study|Lost to Follow-up|0|||
163142290|NCT02719171|589231672|FG002|Overall Study|Lost to Follow-up|1|||
163142291|NCT02719171|589231673|FG003|Overall Study|Lost to Follow-up|0|||
163142292|NCT02719171|589231674|FG004|Overall Study|Lost to Follow-up|0|||
163142293|NCT02719171|589231670|FG000|Overall Study|Subject Withdrawal|0|||
163142294|NCT02719171|589231671|FG001|Overall Study|Subject Withdrawal|2|||
163142295|NCT02719171|589231672|FG002|Overall Study|Subject Withdrawal|2|||
163142296|NCT02719171|589231673|FG003|Overall Study|Subject Withdrawal|1|||
163142297|NCT02719171|589231674|FG004|Overall Study|Subject Withdrawal|0|||
163142298|NCT02719171|589231670|FG000|Overall Study|Other|0|||
163142299|NCT02719171|589231671|FG001|Overall Study|Other|0|||
163142300|NCT02719171|589231672|FG002|Overall Study|Other|0|||
163142301|NCT02719171|589231673|FG003|Overall Study|Other|1|||
163142302|NCT02719171|589231674|FG004|Overall Study|Other|0|||
163142303|NCT01232868|589231679|FG000|Overall Study|Lost to Follow-up|2|||
163142304|NCT01232868|589231680|FG001|Overall Study|Lost to Follow-up|4|||
163142305|NCT04481243|589231682|FG000|Overall Study|Withdrawal by Subject|4|||
163142306|NCT02796677|589231687|FG000|Overall Study|Adverse Event|11|||
163142307|NCT02796677|589231688|FG001|Overall Study|Adverse Event|22|||
163142308|NCT02796677|589231689|FG002|Overall Study|Adverse Event|14|||
163142309|NCT02796677|589231690|FG003|Overall Study|Adverse Event|14|||
163142310|NCT02796677|589231687|FG000|Overall Study|Protocol Violation|7|||
163142311|NCT02796677|589231688|FG001|Overall Study|Protocol Violation|5|||
163142312|NCT02796677|589231689|FG002|Overall Study|Protocol Violation|4|||
163142313|NCT02796677|589231690|FG003|Overall Study|Protocol Violation|8|||
163142314|NCT02796677|589231687|FG000|Overall Study|Lost to Follow-up|1|||
163142315|NCT02796677|589231688|FG001|Overall Study|Lost to Follow-up|5|||
163142316|NCT02796677|589231689|FG002|Overall Study|Lost to Follow-up|2|||
163142317|NCT02796677|589231690|FG003|Overall Study|Lost to Follow-up|2|||
163142318|NCT02796677|589231687|FG000|Overall Study|Lack of Efficacy|7|||
163142319|NCT02796677|589231688|FG001|Overall Study|Lack of Efficacy|9|||
163142320|NCT02796677|589231689|FG002|Overall Study|Lack of Efficacy|14|||
163142321|NCT02796677|589231690|FG003|Overall Study|Lack of Efficacy|20|||
163142322|NCT02796677|589231687|FG000|Overall Study|Withdrawal by Subject|4|||
163142323|NCT02796677|589231688|FG001|Overall Study|Withdrawal by Subject|14|||
163348889|NCT02621047|589987042|FG001|Overall Study|Adverse Event|0|||
163348890|NCT02621047|589987043|FG002|Overall Study|Adverse Event|1|||
163142324|NCT02796677|589231689|FG002|Overall Study|Withdrawal by Subject|6|||
163142325|NCT02796677|589231690|FG003|Overall Study|Withdrawal by Subject|7|||
163142326|NCT02796677|589231687|FG000|Overall Study|Progressive disease|6|||
163142327|NCT02796677|589231688|FG001|Overall Study|Progressive disease|15|||
163142328|NCT02796677|589231689|FG002|Overall Study|Progressive disease|13|||
163142329|NCT02796677|589231690|FG003|Overall Study|Progressive disease|18|||
163142330|NCT02796677|589231687|FG000|Overall Study|Reason not mentioned|2|||
163142331|NCT02796677|589231688|FG001|Overall Study|Reason not mentioned|3|||
163142332|NCT02796677|589231689|FG002|Overall Study|Reason not mentioned|0|||
163142333|NCT02796677|589231690|FG003|Overall Study|Reason not mentioned|5|||
163142334|NCT00961181|589231693|FG000|Overall Study|Death|2|||
163142335|NCT00961181|589231693|FG000|Overall Study|Withdrawal by Subject|2|||
163142336|NCT00961181|589231693|FG000|Overall Study|Lost to Follow-up|1|||
163142337|NCT01777308|589231694|FG000|Overall Study|Withdrawal by Subject|5|||
163142338|NCT01777308|589231695|FG001|Overall Study|Withdrawal by Subject|1|||
163142339|NCT01777308|589231694|FG000|Overall Study|Migrated/moved from study area|1|||
163142340|NCT01777308|589231695|FG001|Overall Study|Migrated/moved from study area|0|||
163142341|NCT01777308|589231694|FG000|Overall Study|Lost to Follow-up|7|||
163142342|NCT01777308|589231695|FG001|Overall Study|Lost to Follow-up|2|||
163142343|NCT01777308|589231694|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
163142344|NCT01777308|589231695|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
163142345|NCT03212326|589231697|FG000|Overall Study|Physician Decision|4|||
163142346|NCT01131507|589231711|FG000|Overall Study|Adverse Event|1|||
163142347|NCT01131507|589231711|FG000|Overall Study|Lost to Follow-up|1|||
163142348|NCT01131507|589231711|FG000|Overall Study|Withdrawal by Subject|1|||
163142349|NCT01517750|589231712|FG000|Overall Study|Lost to Follow-up|1|||
163142350|NCT01517750|589231713|FG001|Overall Study|Lost to Follow-up|2|||
163142351|NCT01517750|589231714|FG002|Overall Study|Lost to Follow-up|4|||
163142352|NCT01517750|589231715|FG003|Overall Study|Lost to Follow-up|1|||
163142353|NCT01855412|589231717|FG000|Overall Study|Death|77|||
163142354|NCT01855412|589231718|FG001|Overall Study|Death|123|||
163142355|NCT01855412|589231719|FG002|Overall Study|Death|30|||
163142356|NCT01855412|589231717|FG000|Overall Study|Lost to Follow-up|28|||
163142357|NCT01855412|589231718|FG001|Overall Study|Lost to Follow-up|46|||
163142358|NCT01855412|589231719|FG002|Overall Study|Lost to Follow-up|15|||
163142359|NCT01855412|589231717|FG000|Overall Study|Withdrawal by Subject|77|||
163142360|NCT01855412|589231718|FG001|Overall Study|Withdrawal by Subject|123|||
163142361|NCT01855412|589231719|FG002|Overall Study|Withdrawal by Subject|24|||
163142362|NCT01855412|589231717|FG000|Overall Study|Physician Decision|25|||
163142363|NCT01855412|589231718|FG001|Overall Study|Physician Decision|31|||
163142364|NCT01855412|589231719|FG002|Overall Study|Physician Decision|3|||
163142365|NCT01855412|589231717|FG000|Overall Study|Site Closure|4|||
163142366|NCT01855412|589231718|FG001|Overall Study|Site Closure|18|||
163142367|NCT01855412|589231719|FG002|Overall Study|Site Closure|1|||
163142368|NCT01855412|589231717|FG000|Overall Study|Reason not Specified|1|||
163142369|NCT01855412|589231718|FG001|Overall Study|Reason not Specified|2|||
163142370|NCT01855412|589231719|FG002|Overall Study|Reason not Specified|3|||
163142371|NCT05030350|589231725|FG000|Overall Study|Adverse Event|13|||
163142372|NCT05030350|589231725|FG000|Overall Study|Lack of Efficacy|8|||
163142373|NCT05030350|589231725|FG000|Overall Study|Lost to Follow-up|35|||
163142374|NCT05030350|589231725|FG000|Overall Study|Pregnancy|2|||
163142375|NCT05030350|589231725|FG000|Overall Study|Protocol Violation|2|||
163142376|NCT05030350|589231725|FG000|Overall Study|Withdrawal by Subject|60|||
163142377|NCT05030350|589231725|FG000|Overall Study|Study terminated by sponsor|349|||
163142378|NCT05030350|589231725|FG000|Overall Study|Positive Drug Screen|4|||
163142379|NCT05030350|589231725|FG000|Overall Study|Other|8|||
163142380|NCT00742183|589231726|FG000|Overall Study|Adverse Event|2|||
163142381|NCT00742183|589231727|FG001|Overall Study|Adverse Event|2|||
163142382|NCT00742183|589231726|FG000|Overall Study|Death|1|||
163142383|NCT00742183|589231727|FG001|Overall Study|Death|0|||
163142384|NCT00742183|589231726|FG000|Overall Study|Physician Decision|0|||
163142385|NCT00742183|589231727|FG001|Overall Study|Physician Decision|2|||
163142386|NCT00742183|589231726|FG000|Overall Study|Lost to Follow-up|4|||
163142387|NCT00742183|589231727|FG001|Overall Study|Lost to Follow-up|4|||
163142388|NCT00742183|589231726|FG000|Overall Study|Required skin-graft|1|||
163142389|NCT00742183|589231727|FG001|Overall Study|Required skin-graft|1|||
163142390|NCT00742183|589231726|FG000|Overall Study|Withdrawal by Subject|1|||
163142391|NCT00742183|589231727|FG001|Overall Study|Withdrawal by Subject|0|||
163142392|NCT00742183|589231726|FG000|Overall Study|Lack of Efficacy|0|||
163142393|NCT00742183|589231727|FG001|Overall Study|Lack of Efficacy|3|||
163142394|NCT03985761|589231731|FG000|Overall Study|Withdrawal by Subject|2|||
163142395|NCT03985761|589231732|FG001|Overall Study|Withdrawal by Subject|3|||
163142396|NCT01858363|589231735|FG000|Overall Study|Death|35|||
163142397|NCT01858363|589231736|FG001|Overall Study|Death|9|||
163142398|NCT01858363|589231735|FG000|Overall Study|Withdrawal by Subject|28|||
163142399|NCT01858363|589231736|FG001|Overall Study|Withdrawal by Subject|14|||
163142400|NCT01858363|589231735|FG000|Overall Study|Lost to Follow-up|13|||
163409532|NCT05048719|590209396|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
163142401|NCT01858363|589231736|FG001|Overall Study|Lost to Follow-up|3|||
163142402|NCT01859923|589231737|FG000|Overall Study|Adverse Event|0|||
163142403|NCT01859923|589231738|FG001|Overall Study|Adverse Event|0|||
163142404|NCT01859923|589231739|FG002|Overall Study|Adverse Event|1|||
163142405|NCT01859923|589231740|FG003|Overall Study|Adverse Event|1|||
163142406|NCT00764361|589231746|FG000|Overall Study|Withdrawal by Subject|2|||
163142407|NCT00764361|589231747|FG001|Overall Study|Withdrawal by Subject|3|||
163142408|NCT00764361|589231746|FG000|Overall Study|Adverse Event|0|||
163142409|NCT00764361|589231747|FG001|Overall Study|Adverse Event|1|||
163142410|NCT00687401|589231751|FG000|Overall Study|Protocol Violation|7|||
163142411|NCT00687401|589231751|FG000|Overall Study|Adverse Event|6|||
163142412|NCT00687401|589231751|FG000|Overall Study|Lack of Efficacy|6|||
163142413|NCT00687401|589231751|FG000|Overall Study|Withdrawal by Subject|4|||
163142414|NCT00687401|589231751|FG000|Overall Study|Did not return for visit|3|||
163142415|NCT00687401|589231751|FG000|Overall Study|For reasons different from those above|4|||
163142416|NCT02520726|589231752|FG000|Overall Study|Lost to Follow-up|3|||
163142417|NCT02520726|589231753|FG001|Overall Study|Lost to Follow-up|2|||
163142418|NCT00721396|589231754|FG000|Overall Study|Adverse Event|4|||
163142419|NCT00721396|589231755|FG001|Overall Study|Adverse Event|7|||
163142420|NCT00721396|589231756|FG002|Overall Study|Adverse Event|2|||
163142421|NCT00721396|589231757|FG003|Overall Study|Adverse Event|0|||
163142422|NCT00721396|589231754|FG000|Overall Study|Withdrawal by Subject|12|||
163142423|NCT00721396|589231755|FG001|Overall Study|Withdrawal by Subject|15|||
163142424|NCT00721396|589231756|FG002|Overall Study|Withdrawal by Subject|3|||
163142425|NCT00721396|589231757|FG003|Overall Study|Withdrawal by Subject|7|||
163142426|NCT00721396|589231754|FG000|Overall Study|Lost to Follow-up|7|||
163142427|NCT00721396|589231755|FG001|Overall Study|Lost to Follow-up|9|||
163142428|NCT00721396|589231756|FG002|Overall Study|Lost to Follow-up|3|||
163142429|NCT00721396|589231757|FG003|Overall Study|Lost to Follow-up|3|||
163142430|NCT00721396|589231754|FG000|Overall Study|Protocol Violation|4|||
163142431|NCT00721396|589231755|FG001|Overall Study|Protocol Violation|3|||
163142432|NCT00721396|589231756|FG002|Overall Study|Protocol Violation|1|||
163142433|NCT00721396|589231757|FG003|Overall Study|Protocol Violation|0|||
163142434|NCT00721396|589231754|FG000|Overall Study|Inappropriate enrollment|0|||
163142435|NCT00721396|589231755|FG001|Overall Study|Inappropriate enrollment|2|||
163142436|NCT00721396|589231756|FG002|Overall Study|Inappropriate enrollment|0|||
163142437|NCT00721396|589231757|FG003|Overall Study|Inappropriate enrollment|0|||
163142438|NCT00721396|589231754|FG000|Overall Study|Administrative reason|3|||
163142439|NCT00721396|589231755|FG001|Overall Study|Administrative reason|0|||
163142440|NCT00721396|589231756|FG002|Overall Study|Administrative reason|1|||
163142441|NCT00721396|589231757|FG003|Overall Study|Administrative reason|0|||
163142442|NCT00430716|589231759|FG000|Double Blind Phase|Death|1|||
163142443|NCT00430716|589231760|FG001|Double Blind Phase|Death|0|||
163142444|NCT00430716|589231761|FG002|Double Blind Phase|Death|0|||
163142445|NCT00430716|589231759|FG000|Double Blind Phase|No longer willing to participate|2|||
163142446|NCT00430716|589231760|FG001|Double Blind Phase|No longer willing to participate|1|||
163142447|NCT00430716|589231761|FG002|Double Blind Phase|No longer willing to participate|1|||
163142448|NCT00430716|589231759|FG000|Double Blind Phase|Other|0|||
163142449|NCT00430716|589231760|FG001|Double Blind Phase|Other|2|||
163236383|NCT02460224|589575184|FG018|Overall Study|Progressive disease|8|||
163236384|NCT02460224|589575185|FG019|Overall Study|Progressive disease|3|||
163236385|NCT02460224|589575186|FG020|Overall Study|Progressive disease|4|||
163236386|NCT02460224|589575187|FG021|Overall Study|Progressive disease|9|||
163236387|NCT02460224|589575188|FG022|Overall Study|Progressive disease|4|||
163236388|NCT02460224|589575189|FG023|Overall Study|Progressive disease|11|||
163236389|NCT02460224|589575190|FG024|Overall Study|Progressive disease|4|||
163236390|NCT02460224|589575191|FG025|Overall Study|Progressive disease|5|||
163236391|NCT02460224|589575192|FG026|Overall Study|Progressive disease|85|||
163236392|NCT02460224|589575193|FG027|Overall Study|Progressive disease|17|||
163236393|NCT02460224|589575194|FG028|Overall Study|Progressive disease|77|||
163236394|NCT02460224|589575166|FG000|Overall Study|Subject/guardian decision|2|||
163236395|NCT02460224|589575167|FG001|Overall Study|Subject/guardian decision|0|||
163236396|NCT02460224|589575168|FG002|Overall Study|Subject/guardian decision|1|||
163236397|NCT02460224|589575169|FG003|Overall Study|Subject/guardian decision|0|||
163236398|NCT02460224|589575170|FG004|Overall Study|Subject/guardian decision|2|||
163236399|NCT02460224|589575171|FG005|Overall Study|Subject/guardian decision|2|||
163236400|NCT02460224|589575172|FG006|Overall Study|Subject/guardian decision|0|||
163236401|NCT02460224|589575173|FG007|Overall Study|Subject/guardian decision|0|||
163236402|NCT02460224|589575174|FG008|Overall Study|Subject/guardian decision|1|||
163142450|NCT00430716|589231761|FG002|Double Blind Phase|Other|0|||
163142451|NCT00430716|589231759|FG000|Double Blind Phase|Study terminated by sponsor|1|||
163142452|NCT00430716|589231760|FG001|Double Blind Phase|Study terminated by sponsor|1|||
163142453|NCT00430716|589231761|FG002|Double Blind Phase|Study terminated by sponsor|2|||
163142454|NCT00430716|589231759|FG000|Double Blind Phase|Adverse Event|1|||
163142455|NCT00430716|589231760|FG001|Double Blind Phase|Adverse Event|1|||
163236403|NCT02460224|589575175|FG009|Overall Study|Subject/guardian decision|1|||
163142456|NCT00430716|589231761|FG002|Double Blind Phase|Adverse Event|3|||
163142457|NCT00430716|589231759|FG000|Double Blind Phase|Not treated|1|||
163142458|NCT00430716|589231760|FG001|Double Blind Phase|Not treated|0|||
163142459|NCT00430716|589231761|FG002|Double Blind Phase|Not treated|0|||
163142460|NCT00430716|589231759|FG000|Open Label Phase|Lost to Follow-up|1|||
163142461|NCT00430716|589231760|FG001|Open Label Phase|Lost to Follow-up|0|||
163142462|NCT00430716|589231761|FG002|Open Label Phase|Lost to Follow-up|1|||
163142463|NCT00430716|589231759|FG000|Open Label Phase|No longer willing to participate|0|||
163142464|NCT00430716|589231760|FG001|Open Label Phase|No longer willing to participate|1|||
163142465|NCT00430716|589231761|FG002|Open Label Phase|No longer willing to participate|1|||
163142466|NCT00430716|589231759|FG000|Open Label Phase|Other|3|||
163142467|NCT00430716|589231760|FG001|Open Label Phase|Other|1|||
163142468|NCT00430716|589231761|FG002|Open Label Phase|Other|1|||
163142469|NCT00430716|589231759|FG000|Open Label Phase|Protocol Violation|1|||
163142470|NCT00430716|589231760|FG001|Open Label Phase|Protocol Violation|0|||
163142471|NCT00430716|589231761|FG002|Open Label Phase|Protocol Violation|0|||
163142472|NCT00430716|589231759|FG000|Open Label Phase|Study terminated by sponsor|4|||
163142473|NCT00430716|589231760|FG001|Open Label Phase|Study terminated by sponsor|5|||
163142474|NCT00430716|589231761|FG002|Open Label Phase|Study terminated by sponsor|4|||
163142475|NCT05114473|589231764|FG000|Overall Study|Lost to Follow-up|2|||
163142476|NCT05114473|589231765|FG001|Overall Study|Lost to Follow-up|2|||
163142477|NCT05114473|589231766|FG002|Overall Study|Lost to Follow-up|0|||
163142478|NCT00154297|589231769|FG000|Overall Study|Death|5|||
163142479|NCT00154297|589231770|FG001|Overall Study|Death|2|||
163142480|NCT00154297|589231769|FG000|Overall Study|Withdrawal by Subject|0|||
163142481|NCT00154297|589231770|FG001|Overall Study|Withdrawal by Subject|5|||
163142482|NCT00154297|589231769|FG000|Overall Study|Lost to Follow-up|3|||
163142483|NCT00154297|589231770|FG001|Overall Study|Lost to Follow-up|0|||
163142484|NCT03116685|589231773|FG000|Overall Study|Physician Decision|0|||
163142485|NCT03116685|589231774|FG001|Overall Study|Physician Decision|1|||
163142486|NCT00398320|589231776|FG000|Overall Study|Death|1|||
163142487|NCT00398320|589231776|FG000|Overall Study|Adverse Event|4|||
163142488|NCT00398320|589231776|FG000|Overall Study|Physician Decision|1|||
163142489|NCT00064792|589231777|FG000|Overall Study|Withdrawal by Subject|2|||
163142490|NCT00064792|589231778|FG001|Overall Study|Withdrawal by Subject|0|||
163142491|NCT00064792|589231777|FG000|Overall Study|Adverse Event|3|||
163142492|NCT00064792|589231778|FG001|Overall Study|Adverse Event|0|||
163142493|NCT00291486|589231783|FG000|Overall Study|Adverse Event|0|||
163142494|NCT00291486|589231784|FG001|Overall Study|Adverse Event|3|||
163142495|NCT00291486|589231785|FG002|Overall Study|Adverse Event|0|||
163142496|NCT00291486|589231786|FG003|Overall Study|Adverse Event|1|||
163142497|NCT00291486|589231787|FG004|Overall Study|Adverse Event|0|||
163142498|NCT00291486|589231783|FG000|Overall Study|Withdrawal by Subject|0|||
163142499|NCT00291486|589231784|FG001|Overall Study|Withdrawal by Subject|0|||
163142500|NCT00291486|589231785|FG002|Overall Study|Withdrawal by Subject|0|||
163142501|NCT00291486|589231786|FG003|Overall Study|Withdrawal by Subject|0|||
163142502|NCT00291486|589231787|FG004|Overall Study|Withdrawal by Subject|1|||
163142503|NCT00291486|589231783|FG000|Overall Study|Disease progression|1|||
163142504|NCT00291486|589231784|FG001|Overall Study|Disease progression|0|||
163142505|NCT00291486|589231785|FG002|Overall Study|Disease progression|1|||
163142506|NCT00291486|589231786|FG003|Overall Study|Disease progression|0|||
163142507|NCT00291486|589231787|FG004|Overall Study|Disease progression|0|||
163142508|NCT01150097|589231792|FG000|Months 24 to 36 Post-transplantation|Death|2|||
163142509|NCT01150097|589231793|FG001|Months 24 to 36 Post-transplantation|Death|0|||
163142510|NCT01150097|589231794|FG002|Months 24 to 36 Post-transplantation|Death|0|||
163142511|NCT01150097|589231792|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
163142512|NCT01150097|589231793|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
163142513|NCT01150097|589231794|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
163142514|NCT01150097|589231792|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
163142515|NCT01150097|589231793|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
163142516|NCT01150097|589231794|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
163236404|NCT02460224|589575176|FG010|Overall Study|Subject/guardian decision|0|||
163236405|NCT02460224|589575177|FG011|Overall Study|Subject/guardian decision|1|||
163236406|NCT02460224|589575178|FG012|Overall Study|Subject/guardian decision|0|||
163236407|NCT02460224|589575179|FG013|Overall Study|Subject/guardian decision|0|||
163142517|NCT01150097|589231792|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
163236408|NCT02460224|589575180|FG014|Overall Study|Subject/guardian decision|0|||
163236409|NCT02460224|589575181|FG015|Overall Study|Subject/guardian decision|1|||
163236410|NCT02460224|589575182|FG016|Overall Study|Subject/guardian decision|0|||
163236411|NCT02460224|589575183|FG017|Overall Study|Subject/guardian decision|1|||
163236412|NCT02460224|589575184|FG018|Overall Study|Subject/guardian decision|2|||
163142518|NCT01150097|589231793|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
163142519|NCT01150097|589231794|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
163142520|NCT01150097|589231792|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
163142521|NCT01150097|589231793|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
163236413|NCT02460224|589575185|FG019|Overall Study|Subject/guardian decision|0|||
163236414|NCT02460224|589575186|FG020|Overall Study|Subject/guardian decision|0|||
163236415|NCT02460224|589575187|FG021|Overall Study|Subject/guardian decision|1|||
163236416|NCT02460224|589575188|FG022|Overall Study|Subject/guardian decision|0|||
163236417|NCT02460224|589575189|FG023|Overall Study|Subject/guardian decision|0|||
163142522|NCT01150097|589231794|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
163142523|NCT01150097|589231792|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
163142524|NCT01150097|589231793|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
163142525|NCT01150097|589231794|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
163142526|NCT01150097|589231792|FG000|Months 24 to 48 Post-transplantation|Death|2|||
163142527|NCT01150097|589231793|FG001|Months 24 to 48 Post-transplantation|Death|0|||
163142528|NCT01150097|589231794|FG002|Months 24 to 48 Post-transplantation|Death|0|||
163142529|NCT01408459|589231795|FG000|Overall Study|Withdrawal by Subject|1|||
163142530|NCT01408459|589231796|FG001|Overall Study|Withdrawal by Subject|1|||
163236418|NCT02460224|589575190|FG024|Overall Study|Subject/guardian decision|0|||
163236419|NCT02460224|589575191|FG025|Overall Study|Subject/guardian decision|0|||
163236420|NCT02460224|589575192|FG026|Overall Study|Subject/guardian decision|6|||
163236421|NCT02460224|589575193|FG027|Overall Study|Subject/guardian decision|2|||
163236422|NCT02460224|589575194|FG028|Overall Study|Subject/guardian decision|3|||
163236423|NCT01916304|589575195|FG000|Overall Study|Screening failure|17|||
163236424|NCT02774681|589575204|FG000|Treatment on Study|Progressive Disease|7|||
163236425|NCT02774681|589575204|FG000|Follow-Up for 3 Years|Death|11|||
163236426|NCT02774681|589575204|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
163236427|NCT03146650|589575207|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
163236428|NCT03146650|589575207|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
163236429|NCT03146650|589575207|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
163236430|NCT03146650|589575207|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
163236431|NCT03146650|589575207|FG000|2 Year Follow-up|Death|11|||
163236432|NCT03146650|589575207|FG000|2 Year Follow-up|Still in follow-up|7|||
163236433|NCT03146650|589575207|FG000|2 Year Follow-up|Lost to Follow-up|1|||
163236434|NCT04666441|589575208|FG000|Overall Study|Lost to Follow-up|1|||
163236435|NCT04666441|589575209|FG001|Overall Study|Lost to Follow-up|4|||
163236436|NCT04666441|589575210|FG002|Overall Study|Lost to Follow-up|1|||
163236437|NCT04666441|589575211|FG003|Overall Study|Lost to Follow-up|3|||
163236438|NCT04666441|589575212|FG004|Overall Study|Lost to Follow-up|0|||
163236439|NCT04666441|589575213|FG005|Overall Study|Lost to Follow-up|2|||
163236440|NCT04666441|589575214|FG006|Overall Study|Lost to Follow-up|2|||
163236441|NCT04666441|589575215|FG007|Overall Study|Lost to Follow-up|2|||
163236442|NCT04666441|589575208|FG000|Overall Study|Subject Decision|1|||
163236443|NCT04666441|589575209|FG001|Overall Study|Subject Decision|1|||
163236444|NCT04666441|589575210|FG002|Overall Study|Subject Decision|3|||
163236445|NCT04666441|589575211|FG003|Overall Study|Subject Decision|1|||
163236446|NCT04666441|589575212|FG004|Overall Study|Subject Decision|0|||
163236447|NCT04666441|589575213|FG005|Overall Study|Subject Decision|1|||
163236448|NCT04666441|589575214|FG006|Overall Study|Subject Decision|3|||
163236449|NCT04666441|589575215|FG007|Overall Study|Subject Decision|2|||
163236450|NCT00766415|589575226|FG000|Overall Study|Withdrawal by Subject|0|||
163236451|NCT00766415|589575227|FG001|Overall Study|Withdrawal by Subject|1|||
163236452|NCT01114516|589575228|FG000|Overall Study|Lost to Follow-up|2|||
163236453|NCT01114516|589575229|FG001|Overall Study|Lost to Follow-up|1|||
163236454|NCT00132769|589575232|FG000|Overall Study|Withdrawal by Subject|1|||
163236455|NCT00132769|589575233|FG001|Overall Study|Withdrawal by Subject|3|||
163236456|NCT00132769|589575232|FG000|Overall Study|Lack of Efficacy|7|||
163236457|NCT00132769|589575233|FG001|Overall Study|Lack of Efficacy|6|||
163236458|NCT00132769|589575232|FG000|Overall Study|Adverse Event|2|||
163236459|NCT00132769|589575233|FG001|Overall Study|Adverse Event|1|||
163236460|NCT00132769|589575232|FG000|Overall Study|Protocol Violation|1|||
163236461|NCT00132769|589575233|FG001|Overall Study|Protocol Violation|1|||
163236462|NCT01431508|589575234|FG000|Overall Study|Lack of Efficacy|1|||
163236463|NCT01431508|589575234|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
163236464|NCT02758236|589575236|FG000|Overall Study|Investigator discretion|43|||
163236465|NCT00441337|589575239|FG000|Overall Study|Disease Progression|6|||
163236466|NCT00441337|589575240|FG001|Overall Study|Disease Progression|6|||
163236467|NCT00441337|589575241|FG002|Overall Study|Disease Progression|4|||
163236468|NCT00441337|589575242|FG003|Overall Study|Disease Progression|18|||
163236469|NCT00441337|589575239|FG000|Overall Study|Lost to Follow-up|0|||
163236470|NCT00441337|589575240|FG001|Overall Study|Lost to Follow-up|0|||
163236471|NCT00441337|589575241|FG002|Overall Study|Lost to Follow-up|0|||
163236472|NCT00441337|589575242|FG003|Overall Study|Lost to Follow-up|1|||
163236473|NCT00441337|589575239|FG000|Overall Study|Sponsor Decision|0|||
163236474|NCT00441337|589575240|FG001|Overall Study|Sponsor Decision|0|||
163142531|NCT00992459|589231797|FG000|Overall Study|Withdrawal by Subject|0|||
163236475|NCT00441337|589575241|FG002|Overall Study|Sponsor Decision|1|||
163236476|NCT00441337|589575242|FG003|Overall Study|Sponsor Decision|2|||
163236477|NCT00441337|589575239|FG000|Overall Study|Did not meet inclusion criteria|0|||
163236478|NCT00441337|589575240|FG001|Overall Study|Did not meet inclusion criteria|0|||
163236479|NCT00441337|589575241|FG002|Overall Study|Did not meet inclusion criteria|1|||
163236480|NCT00441337|589575242|FG003|Overall Study|Did not meet inclusion criteria|0|||
163142532|NCT00992459|589231798|FG001|Overall Study|Withdrawal by Subject|1|||
163142533|NCT00992459|589231797|FG000|Overall Study|Adverse Event|1|||
163142534|NCT00992459|589231798|FG001|Overall Study|Adverse Event|0|||
163142535|NCT00543387|589231803|FG000|Panel 1 + Panel 2|Adverse Event|0|||
163142536|NCT00543387|589231804|FG001|Panel 1 + Panel 2|Adverse Event|1|||
163142537|NCT00543387|589231805|FG002|Panel 1 + Panel 2|Adverse Event|0|||
163142538|NCT00543387|589231806|FG003|Panel 1 + Panel 2|Adverse Event|0|||
163142539|NCT00543387|589231807|FG004|Panel 1 + Panel 2|Adverse Event|0|||
163142540|NCT00543387|589231808|FG005|Panel 1 + Panel 2|Adverse Event|0|||
163142541|NCT00543387|589231809|FG006|Panel 1 + Panel 2|Adverse Event|0|||
163142542|NCT00543387|589231810|FG007|Panel 1 + Panel 2|Adverse Event|1|||
163142543|NCT00543387|589231811|FG008|Panel 1 + Panel 2|Adverse Event|1|||
163142544|NCT00543387|589231812|FG009|Panel 1 + Panel 2|Adverse Event|0|||
163142545|NCT00543387|589231813|FG010|Panel 1 + Panel 2|Adverse Event|0|||
163142546|NCT00543387|589231803|FG000|Panel 1 + Panel 2|Physician Decision|0|||
163142547|NCT00543387|589231804|FG001|Panel 1 + Panel 2|Physician Decision|0|||
163142548|NCT00543387|589231805|FG002|Panel 1 + Panel 2|Physician Decision|1|||
163142549|NCT00543387|589231806|FG003|Panel 1 + Panel 2|Physician Decision|0|||
163142550|NCT00543387|589231807|FG004|Panel 1 + Panel 2|Physician Decision|0|||
163142551|NCT00543387|589231808|FG005|Panel 1 + Panel 2|Physician Decision|0|||
163142552|NCT00543387|589231809|FG006|Panel 1 + Panel 2|Physician Decision|0|||
163142553|NCT00543387|589231810|FG007|Panel 1 + Panel 2|Physician Decision|1|||
163142554|NCT00543387|589231811|FG008|Panel 1 + Panel 2|Physician Decision|0|||
163142555|NCT00543387|589231812|FG009|Panel 1 + Panel 2|Physician Decision|0|||
163142556|NCT00543387|589231813|FG010|Panel 1 + Panel 2|Physician Decision|0|||
163142557|NCT00543387|589231803|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
163142558|NCT00543387|589231804|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
163142559|NCT00543387|589231805|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
163142560|NCT00543387|589231806|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
163142561|NCT00543387|589231807|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
163142562|NCT00543387|589231808|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
163142563|NCT00543387|589231809|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
163142564|NCT00543387|589231810|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
163142565|NCT00543387|589231811|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
163236481|NCT03655236|589575243|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
163236482|NCT03655236|589575244|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
163236483|NCT03655236|589575245|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
163236484|NCT03655236|589575243|FG000|Subject Disposition in Part 1 Period|Death|1|||
163236485|NCT03655236|589575244|FG001|Subject Disposition in Part 1 Period|Death|0|||
163348891|NCT03772041|589987046|FG000|Overall Study|Adverse Event|8|||
163348892|NCT03772041|589987047|FG001|Overall Study|Adverse Event|3|||
163348893|NCT03772041|589987046|FG000|Overall Study|Withdrawal by Subject|0|||
163348894|NCT03772041|589987047|FG001|Overall Study|Withdrawal by Subject|2|||
163348895|NCT03772041|589987046|FG000|Overall Study|Protocol Violation|4|||
163348896|NCT03772041|589987047|FG001|Overall Study|Protocol Violation|2|||
163142566|NCT00543387|589231812|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
163142567|NCT00543387|589231813|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
163142568|NCT00543387|589231803|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142569|NCT00543387|589231804|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142570|NCT00543387|589231805|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142571|NCT00543387|589231806|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142572|NCT00543387|589231807|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142573|NCT00543387|589231808|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142574|NCT00543387|589231809|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
163142575|NCT00543387|589231810|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142576|NCT00543387|589231811|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142577|NCT00543387|589231812|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142578|NCT00543387|589231813|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142579|NCT00543387|589231803|FG000|Crossover Participants|Progressive Disease|0|||
163142580|NCT00543387|589231804|FG001|Crossover Participants|Progressive Disease|0|||
163142581|NCT00543387|589231805|FG002|Crossover Participants|Progressive Disease|0|||
163236486|NCT03655236|589575245|FG002|Subject Disposition in Part 1 Period|Death|0|||
163236487|NCT03655236|589575243|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
163236488|NCT03655236|589575244|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
163236489|NCT03655236|589575245|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
163348897|NCT03772041|589987046|FG000|Overall Study|Physician Decision|2|||
163348898|NCT03772041|589987047|FG001|Overall Study|Physician Decision|3|||
163142582|NCT00543387|589231806|FG003|Crossover Participants|Progressive Disease|0|||
163142583|NCT00543387|589231807|FG004|Crossover Participants|Progressive Disease|0|||
163142584|NCT00543387|589231808|FG005|Crossover Participants|Progressive Disease|0|||
163142585|NCT00543387|589231809|FG006|Crossover Participants|Progressive Disease|0|||
163348899|NCT03927222|589987051|FG000|Overall Study|Progression|3|||
163142586|NCT00543387|589231810|FG007|Crossover Participants|Progressive Disease|0|||
163142587|NCT00543387|589231811|FG008|Crossover Participants|Progressive Disease|0|||
163142588|NCT00543387|589231812|FG009|Crossover Participants|Progressive Disease|1|||
163142589|NCT00543387|589231813|FG010|Crossover Participants|Progressive Disease|2|||
163142590|NCT00543387|589231803|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
163142591|NCT00543387|589231804|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
163142592|NCT00543387|589231805|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
163142593|NCT00543387|589231806|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
163142594|NCT00543387|589231807|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
163142595|NCT00543387|589231808|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
163142596|NCT00543387|589231809|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
163142597|NCT00543387|589231810|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
163142598|NCT00543387|589231811|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
163142599|NCT00543387|589231812|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
163142600|NCT00543387|589231813|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
163142601|NCT04177212|589231818|FG000|Overall Study|Withdrawal by Subject|9|||
163142602|NCT04177212|589231819|FG001|Overall Study|Withdrawal by Subject|7|||
163142603|NCT04177212|589231818|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
163142604|NCT04177212|589231819|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
163142605|NCT04177212|589231818|FG000|Overall Study|Physician Decision|1|||
163142606|NCT04177212|589231819|FG001|Overall Study|Physician Decision|0|||
163142607|NCT04177212|589231818|FG000|Overall Study|Lost to Follow-up|0|||
163142608|NCT04177212|589231819|FG001|Overall Study|Lost to Follow-up|3|||
163142609|NCT04177212|589231818|FG000|Overall Study|Adverse Event|0|||
163142610|NCT04177212|589231819|FG001|Overall Study|Adverse Event|1|||
163142611|NCT04177212|589231818|FG000|Overall Study|Other|1|||
163142612|NCT04177212|589231819|FG001|Overall Study|Other|2|||
163142613|NCT01792115|589231820|FG000|Overall Study|Lost to Follow-up|0|||
163142614|NCT01792115|589231821|FG001|Overall Study|Lost to Follow-up|1|||
163142615|NCT01792115|589231822|FG002|Overall Study|Lost to Follow-up|0|||
163142616|NCT01279681|589231823|FG000|Overall Study|Disease Progression|9|||
163142617|NCT01279681|589231824|FG001|Overall Study|Disease Progression|6|||
163142618|NCT01279681|589231823|FG000|Overall Study|Withdrawal by Subject|3|||
163142619|NCT01279681|589231824|FG001|Overall Study|Withdrawal by Subject|4|||
163142620|NCT01279681|589231823|FG000|Overall Study|Adverse Event|2|||
163142621|NCT01279681|589231824|FG001|Overall Study|Adverse Event|3|||
163142622|NCT01279681|589231823|FG000|Overall Study|Death|0|||
163142623|NCT01279681|589231824|FG001|Overall Study|Death|1|||
163142624|NCT01279681|589231823|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
163142625|NCT01279681|589231824|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
163142626|NCT01279681|589231823|FG000|Overall Study|Physician Decision|1|||
163142627|NCT01279681|589231824|FG001|Overall Study|Physician Decision|0|||
163142628|NCT01279681|589231823|FG000|Overall Study|Other Reason|0|||
163142629|NCT01279681|589231824|FG001|Overall Study|Other Reason|2|||
163142630|NCT01943591|589231825|FG000|Overall Study|Lost to Follow-up|3|||
163142631|NCT01943591|589231826|FG001|Overall Study|Lost to Follow-up|4|||
163142632|NCT01943591|589231825|FG000|Overall Study|Death|2|||
163142633|NCT01943591|589231826|FG001|Overall Study|Death|7|||
163142634|NCT02539797|589233224|FG000|Overall Study|Lost to Follow-up|0|||
163142635|NCT02539797|589233225|FG001|Overall Study|Lost to Follow-up|1|||
163142636|NCT02539797|589233226|FG002|Overall Study|Lost to Follow-up|0|||
163142637|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
163142638|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
163142639|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
163142640|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
163142641|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
163142642|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
163142643|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
163409533|NCT05048719|590209397|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
163409534|NCT05048719|590209398|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
163409535|NCT05048719|590209390|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163142644|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
163409536|NCT05048719|590209391|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163409537|NCT05048719|590209392|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163409538|NCT05048719|590209393|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163409539|NCT05048719|590209394|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163142645|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
163142646|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
163142647|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
163142648|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
163142649|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
163142650|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
163142651|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
163142652|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
163142653|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
163142654|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
163142655|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
163142656|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
163142657|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
163142658|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
163142659|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
163142660|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
163142661|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
163142662|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
163142663|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
163142664|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
163142665|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
163142666|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
163142667|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
163142668|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
163142669|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
163142670|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
163142671|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
163142672|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
163142673|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
163142674|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
163142675|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
163142676|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
163142677|NCT02831764|589233227|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
163142678|NCT02831764|589233228|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
163142679|NCT02831764|589233229|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
163142680|NCT02831764|589233230|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
163142681|NCT02831764|589233231|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
163142682|NCT02831764|589233227|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
163142683|NCT02831764|589233228|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
163142684|NCT02831764|589233229|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
163142685|NCT02831764|589233230|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
163142686|NCT02831764|589233231|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
163142687|NCT02831764|589233227|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
163142688|NCT02831764|589233228|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
163142689|NCT02831764|589233229|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
163142690|NCT02831764|589233230|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
163142691|NCT02831764|589233231|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
163142692|NCT02831764|589233227|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
163142693|NCT02831764|589233228|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
163142694|NCT02831764|589233229|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
163142695|NCT02831764|589233230|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
163142696|NCT02831764|589233231|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
163142697|NCT02831764|589233227|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
163142698|NCT02831764|589233228|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
163142699|NCT02831764|589233229|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
163142700|NCT02831764|589233230|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
163142701|NCT02831764|589233231|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
163142702|NCT02831764|589233227|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
163142703|NCT02831764|589233228|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
163142704|NCT02831764|589233229|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
163142705|NCT02831764|589233230|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
163142706|NCT02831764|589233231|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
163142707|NCT02831764|589233227|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
163142708|NCT02831764|589233228|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
163142709|NCT02831764|589233229|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
163142710|NCT02831764|589233230|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
163236490|NCT03655236|589575243|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
163142711|NCT02831764|589233231|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
163142712|NCT02831764|589233227|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
163142713|NCT02831764|589233228|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
163142714|NCT02831764|589233229|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
163142715|NCT02831764|589233230|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
163142716|NCT02831764|589233231|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
163142717|NCT02831764|589233227|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
163142718|NCT02831764|589233228|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
163142719|NCT02831764|589233229|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
163142720|NCT02831764|589233230|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
163142721|NCT02831764|589233231|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
163142722|NCT02831764|589233227|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
163142723|NCT02831764|589233228|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
163142724|NCT02831764|589233229|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
163142725|NCT02831764|589233230|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
163142726|NCT02831764|589233231|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
163142727|NCT02831764|589233227|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
163142728|NCT02831764|589233228|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
163142729|NCT02831764|589233229|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
163142730|NCT02831764|589233230|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
163142731|NCT02831764|589233231|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
163142732|NCT01790594|589233235|FG000|Overall Study|Death|1|||
163142733|NCT01790594|589233236|FG001|Overall Study|Death|0|||
163348900|NCT03927222|589987051|FG000|Overall Study|CMV testing results inconclusive|1|||
163142734|NCT01790594|589233237|FG002|Overall Study|Death|0|||
163142735|NCT01790594|589233235|FG000|Overall Study|Physician Decision|2|||
163142736|NCT01790594|589233236|FG001|Overall Study|Physician Decision|1|||
163142737|NCT01790594|589233237|FG002|Overall Study|Physician Decision|0|||
163142738|NCT01790594|589233235|FG000|Overall Study|Withdrawal by Subject|2|||
163142739|NCT01790594|589233236|FG001|Overall Study|Withdrawal by Subject|0|||
163142740|NCT01790594|589233237|FG002|Overall Study|Withdrawal by Subject|0|||
163142741|NCT01790594|589233235|FG000|Overall Study|Transplant was not done|0|||
163142742|NCT01790594|589233236|FG001|Overall Study|Transplant was not done|0|||
163142743|NCT01790594|589233237|FG002|Overall Study|Transplant was not done|3|||
163142744|NCT01790594|589233235|FG000|Overall Study|Terminated prior to week 76|0|||
163142745|NCT01790594|589233236|FG001|Overall Study|Terminated prior to week 76|2|||
163142746|NCT01790594|589233237|FG002|Overall Study|Terminated prior to week 76|0|||
163142747|NCT03347123|589233238|FG000|Overall Study|Death|1|||
163142748|NCT03347123|589233239|FG001|Overall Study|Death|2|||
163142749|NCT03347123|589233240|FG002|Overall Study|Death|0|||
163142750|NCT03347123|589233241|FG003|Overall Study|Death|0|||
163142751|NCT03347123|589233242|FG004|Overall Study|Death|0|||
163142752|NCT03347123|589233243|FG005|Overall Study|Death|0|||
163142753|NCT03347123|589233244|FG006|Overall Study|Death|0|||
163142754|NCT03347123|589233238|FG000|Overall Study|Withdrawal by Subject|1|||
163142755|NCT03347123|589233239|FG001|Overall Study|Withdrawal by Subject|0|||
163142756|NCT03347123|589233240|FG002|Overall Study|Withdrawal by Subject|0|||
163142757|NCT03347123|589233241|FG003|Overall Study|Withdrawal by Subject|0|||
163142758|NCT03347123|589233242|FG004|Overall Study|Withdrawal by Subject|0|||
163142759|NCT03347123|589233243|FG005|Overall Study|Withdrawal by Subject|0|||
163142760|NCT03347123|589233244|FG006|Overall Study|Withdrawal by Subject|0|||
163142761|NCT03347123|589233238|FG000|Overall Study|Reason not Specified|3|||
163142762|NCT03347123|589233239|FG001|Overall Study|Reason not Specified|4|||
163142763|NCT03347123|589233240|FG002|Overall Study|Reason not Specified|0|||
163142764|NCT03347123|589233241|FG003|Overall Study|Reason not Specified|0|||
163142765|NCT03347123|589233242|FG004|Overall Study|Reason not Specified|0|||
163142766|NCT03347123|589233243|FG005|Overall Study|Reason not Specified|0|||
163142767|NCT03347123|589233244|FG006|Overall Study|Reason not Specified|0|||
163142768|NCT00346216|589233249|FG000|Overall Study|Other|181|||
163142769|NCT00346216|589233250|FG001|Overall Study|Other|231|||
163142770|NCT00346216|589233251|FG002|Overall Study|Other|205|||
163142771|NCT00346216|589233249|FG000|Overall Study|No longer willing to participate|600|||
163142772|NCT00346216|589233250|FG001|Overall Study|No longer willing to participate|606|||
163142773|NCT00346216|589233251|FG002|Overall Study|No longer willing to participate|585|||
163142774|NCT00346216|589233249|FG000|Overall Study|Withdrawal by Subject|661|||
163142775|NCT00346216|589233250|FG001|Overall Study|Withdrawal by Subject|692|||
163142776|NCT00346216|589233251|FG002|Overall Study|Withdrawal by Subject|651|||
163142777|NCT00346216|589233249|FG000|Overall Study|Lost to Follow-up|611|||
163142778|NCT00346216|589233250|FG001|Overall Study|Lost to Follow-up|588|||
163142779|NCT00346216|589233251|FG002|Overall Study|Lost to Follow-up|542|||
163142780|NCT00346216|589233249|FG000|Overall Study|Physician Decision|80|||
163142781|NCT00346216|589233250|FG001|Overall Study|Physician Decision|76|||
163348901|NCT03927222|589987051|FG000|Overall Study|Unable to generate enough vaccines|1|||
163142782|NCT00346216|589233251|FG002|Overall Study|Physician Decision|59|||
163142783|NCT00346216|589233249|FG000|Overall Study|Does not meet entrance criteria|13|||
163142784|NCT00346216|589233250|FG001|Overall Study|Does not meet entrance criteria|10|||
163142785|NCT00346216|589233251|FG002|Overall Study|Does not meet entrance criteria|8|||
163142786|NCT00346216|589233249|FG000|Overall Study|Death|189|||
163142787|NCT00346216|589233250|FG001|Overall Study|Death|192|||
163142788|NCT00346216|589233251|FG002|Overall Study|Death|228|||
163142789|NCT00346216|589233249|FG000|Overall Study|Study terminated by sponsor|11|||
163142790|NCT00346216|589233250|FG001|Overall Study|Study terminated by sponsor|4|||
163142791|NCT00346216|589233251|FG002|Overall Study|Study terminated by sponsor|8|||
163142792|NCT00346216|589233249|FG000|Overall Study|Missing Subject Summary Status|62|||
163142793|NCT00346216|589233250|FG001|Overall Study|Missing Subject Summary Status|61|||
163142794|NCT00346216|589233251|FG002|Overall Study|Missing Subject Summary Status|62|||
163142795|NCT03431441|589233252|FG000|Overall Study|Withdrawal by Subject|2|||
163142796|NCT03431441|589233252|FG000|Overall Study|Adverse Event|2|||
163142797|NCT03431441|589233252|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
163142798|NCT01794000|589233258|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
163142799|NCT01794000|589233259|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
163142800|NCT01794000|589233258|FG000|Double-Blind Phase (DBP)|Death|1|||
163142801|NCT01794000|589233259|FG001|Double-Blind Phase (DBP)|Death|2|||
163142802|NCT01794000|589233258|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
163142803|NCT01794000|589233259|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
163142804|NCT01794000|589233258|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
163142805|NCT01794000|589233259|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
163142806|NCT01794000|589233258|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
163142807|NCT01794000|589233259|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
163142808|NCT01794000|589233258|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
163142809|NCT01794000|589233259|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
163142810|NCT01794000|589233258|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
163142811|NCT01794000|589233259|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
163142812|NCT01794000|589233258|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
163142813|NCT01794000|589233259|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
163142814|NCT00796666|589233260|FG000|Overall Study|Death|2|||
163142815|NCT00796666|589233261|FG001|Overall Study|Death|4|||
163142816|NCT00796666|589233260|FG000|Overall Study|Withdrawal by Subject|2|||
163142817|NCT00796666|589233261|FG001|Overall Study|Withdrawal by Subject|0|||
163142818|NCT00796666|589233260|FG000|Overall Study|Adverse Event|7|||
163142819|NCT00796666|589233261|FG001|Overall Study|Adverse Event|5|||
163142820|NCT00796666|589233260|FG000|Overall Study|Protocol Violation|1|||
163142821|NCT00796666|589233261|FG001|Overall Study|Protocol Violation|0|||
163142822|NCT00796666|589233260|FG000|Overall Study|Other|1|||
163142823|NCT00796666|589233261|FG001|Overall Study|Other|0|||
163142824|NCT00796666|589233260|FG000|Overall Study|Terminated by sponsor|53|||
163142825|NCT00796666|589233261|FG001|Overall Study|Terminated by sponsor|55|||
163142826|NCT00796666|589233260|FG000|Overall Study|Randomized and not treated|1|||
163142827|NCT00796666|589233261|FG001|Overall Study|Randomized and not treated|0|||
163142828|NCT01367834|589233262|FG000|Overall Study|Withdrawal by Subject|2|||
163142829|NCT01367834|589233263|FG001|Overall Study|Withdrawal by Subject|2|||
163142830|NCT01367834|589233262|FG000|Overall Study|Study was ended.|0|||
163142831|NCT01367834|589233263|FG001|Overall Study|Study was ended.|1|||
163142832|NCT01156480|589233265|FG000|Overall Study|change in diagnosis|0|||
163142833|NCT01156480|589233266|FG001|Overall Study|change in diagnosis|1|||
163142834|NCT04537793|589233267|FG000|Part B (24 Weeks)|Adverse Event|0|||
163142835|NCT04537793|589233268|FG001|Part B (24 Weeks)|Adverse Event|1|||
163142836|NCT00988598|589233269|FG000|Overall Study|Withdrawal by Subject|2|||
163142837|NCT00988598|589233270|FG001|Overall Study|Withdrawal by Subject|0|||
163142838|NCT03367858|589233271|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
163142839|NCT03367858|589233272|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
163142840|NCT03367858|589233271|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
163142841|NCT03367858|589233272|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
163142842|NCT03367858|589233271|FG000|3 Month Follow Up|Lost to Follow-up|8|||
163142843|NCT03367858|589233272|FG001|3 Month Follow Up|Lost to Follow-up|3|||
163142844|NCT03367858|589233271|FG000|3 Month Follow Up|Moved out of study area|2|||
163142845|NCT03367858|589233272|FG001|3 Month Follow Up|Moved out of study area|6|||
163142846|NCT03367858|589233271|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
163142847|NCT03367858|589233272|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
163142848|NCT03367858|589233271|FG000|3 Month Follow Up|MRI contraindication|2|||
163142849|NCT03367858|589233272|FG001|3 Month Follow Up|MRI contraindication|1|||
163142850|NCT03367858|589233271|FG000|3 Month Follow Up|Incarcerated|0|||
163142851|NCT03367858|589233272|FG001|3 Month Follow Up|Incarcerated|1|||
163142852|NCT03367858|589233271|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
163142853|NCT03367858|589233272|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
163142854|NCT03367858|589233271|FG000|6 Month Follow Up|Lost to Follow-up|5|||
163142855|NCT03367858|589233272|FG001|6 Month Follow Up|Lost to Follow-up|2|||
163142856|NCT03367858|589233271|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
163142857|NCT03367858|589233272|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
163142858|NCT03367858|589233271|FG000|12 Month Follow Up|Lost to Follow-up|3|||
163142859|NCT03367858|589233272|FG001|12 Month Follow Up|Lost to Follow-up|3|||
163142860|NCT03367858|589233271|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
163142861|NCT03367858|589233272|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
163142862|NCT00057863|589233285|FG000|Overall Study|Death|1|||
163142863|NCT00057863|589233285|FG000|Overall Study|Withdrawal by Subject|2|||
163142864|NCT02090426|589233286|FG000|Overall Study|Lost to Follow-up|12|||
163142865|NCT02090426|589233287|FG001|Overall Study|Lost to Follow-up|6|||
163142866|NCT02079038|589233289|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
163142867|NCT02079038|589233290|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
163142868|NCT02079038|589233289|FG000|Modified Intent to Treat Population|Death|1|||
163142869|NCT02079038|589233290|FG001|Modified Intent to Treat Population|Death|0|||
163142870|NCT02079038|589233289|FG000|Completed 6 Months|Lost to Follow-up|2|||
163142871|NCT02079038|589233290|FG001|Completed 6 Months|Lost to Follow-up|1|||
163142872|NCT01141712|589233291|FG000|Overall Study|Disease progression|3|||
163142873|NCT03480152|589233292|FG000|Phase I|Signed consent. Died before treatment.|1|||
163142874|NCT03480152|589233293|FG001|Phase I|Signed consent. Died before treatment.|0|||
163142875|NCT03480152|589233294|FG002|Phase I|Signed consent. Died before treatment.|0|||
163142876|NCT01308736|589233301|FG000|Overall Study|Did not attend a single session|6|||
163142877|NCT01308736|589233302|FG001|Overall Study|Did not attend a single session|5|||
163142878|NCT03634085|589233303|FG000|Overall Study|Adverse Event|1|||
163142879|NCT03634085|589233304|FG001|Overall Study|Adverse Event|0|||
163142880|NCT03634085|589233303|FG000|Overall Study|Withdrawal by Subject|0|||
163142881|NCT03634085|589233304|FG001|Overall Study|Withdrawal by Subject|2|||
163142882|NCT04276233|589233305|FG000|Overall Study|Adverse Event|1|||
163142883|NCT04276233|589233305|FG000|Overall Study|Lost to Follow-up|3|||
163142884|NCT04276233|589233305|FG000|Overall Study|Physician Decision|4|||
163142885|NCT04276233|589233305|FG000|Overall Study|Withdrawal by Subject|2|||
163142886|NCT01946139|589233310|FG000|Overall Study|Withdrawal by Subject|8|||
163142887|NCT01946139|589233310|FG000|Overall Study|ineligible|8|||
163142888|NCT01946139|589233310|FG000|Overall Study|Specimens not available|4|||
163142889|NCT00101686|589233317|FG000|Overall Study|Progressive Disease|37|||
163142890|NCT00101686|589233318|FG001|Overall Study|Progressive Disease|28|||
163142891|NCT00101686|589233319|FG002|Overall Study|Progressive Disease|37|||
163142892|NCT00101686|589233320|FG003|Overall Study|Progressive Disease|38|||
163142893|NCT00101686|589233321|FG004|Overall Study|Progressive Disease|28|||
163142894|NCT00101686|589233322|FG005|Overall Study|Progressive Disease|25|||
163142895|NCT00101686|589233323|FG006|Overall Study|Progressive Disease|5|||
163142896|NCT00101686|589233324|FG007|Overall Study|Progressive Disease|7|||
163142897|NCT00101686|589233325|FG008|Overall Study|Progressive Disease|10|||
163142898|NCT00101686|589233326|FG009|Overall Study|Progressive Disease|8|||
163142899|NCT00101686|589233317|FG000|Overall Study|initiation other anti-cancer treatment|4|||
163142900|NCT00101686|589233318|FG001|Overall Study|initiation other anti-cancer treatment|3|||
163142901|NCT00101686|589233319|FG002|Overall Study|initiation other anti-cancer treatment|4|||
163142902|NCT00101686|589233320|FG003|Overall Study|initiation other anti-cancer treatment|3|||
163142903|NCT00101686|589233321|FG004|Overall Study|initiation other anti-cancer treatment|1|||
163142904|NCT00101686|589233322|FG005|Overall Study|initiation other anti-cancer treatment|1|||
163142905|NCT00101686|589233323|FG006|Overall Study|initiation other anti-cancer treatment|2|||
163142906|NCT00101686|589233324|FG007|Overall Study|initiation other anti-cancer treatment|2|||
163142907|NCT00101686|589233325|FG008|Overall Study|initiation other anti-cancer treatment|3|||
163409540|NCT05048719|590209395|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
163409541|NCT05048719|590209396|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163142908|NCT00101686|589233326|FG009|Overall Study|initiation other anti-cancer treatment|3|||
163142909|NCT00101686|589233317|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
163142910|NCT00101686|589233318|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
163142911|NCT00101686|589233319|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
163142912|NCT00101686|589233320|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
163142913|NCT00101686|589233321|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
163142914|NCT00101686|589233322|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
163142915|NCT00101686|589233323|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
163142916|NCT00101686|589233324|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
163142917|NCT00101686|589233325|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
163142918|NCT00101686|589233326|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
163142919|NCT00101686|589233317|FG000|Overall Study|unacceptable toxicity|3|||
163142920|NCT00101686|589233318|FG001|Overall Study|unacceptable toxicity|9|||
163142921|NCT00101686|589233319|FG002|Overall Study|unacceptable toxicity|10|||
163142922|NCT00101686|589233320|FG003|Overall Study|unacceptable toxicity|6|||
163142923|NCT00101686|589233321|FG004|Overall Study|unacceptable toxicity|16|||
163142924|NCT00101686|589233322|FG005|Overall Study|unacceptable toxicity|10|||
163142925|NCT00101686|589233323|FG006|Overall Study|unacceptable toxicity|4|||
163142926|NCT00101686|589233324|FG007|Overall Study|unacceptable toxicity|2|||
163142927|NCT00101686|589233325|FG008|Overall Study|unacceptable toxicity|1|||
163142928|NCT00101686|589233326|FG009|Overall Study|unacceptable toxicity|4|||
163142929|NCT00101686|589233317|FG000|Overall Study|Randomized but did not receive treament|1|||
163142930|NCT00101686|589233318|FG001|Overall Study|Randomized but did not receive treament|6|||
163142931|NCT00101686|589233319|FG002|Overall Study|Randomized but did not receive treament|2|||
163142932|NCT00101686|589233320|FG003|Overall Study|Randomized but did not receive treament|2|||
163142933|NCT00101686|589233321|FG004|Overall Study|Randomized but did not receive treament|2|||
163142934|NCT00101686|589233322|FG005|Overall Study|Randomized but did not receive treament|2|||
163142935|NCT00101686|589233323|FG006|Overall Study|Randomized but did not receive treament|0|||
163142936|NCT00101686|589233324|FG007|Overall Study|Randomized but did not receive treament|1|||
163142937|NCT00101686|589233325|FG008|Overall Study|Randomized but did not receive treament|0|||
163142938|NCT00101686|589233326|FG009|Overall Study|Randomized but did not receive treament|1|||
163142939|NCT00101686|589233317|FG000|Overall Study|intercurrent non-cancer related illness|0|||
163142940|NCT00101686|589233318|FG001|Overall Study|intercurrent non-cancer related illness|0|||
163142941|NCT00101686|589233319|FG002|Overall Study|intercurrent non-cancer related illness|2|||
163142942|NCT00101686|589233320|FG003|Overall Study|intercurrent non-cancer related illness|0|||
163142943|NCT00101686|589233321|FG004|Overall Study|intercurrent non-cancer related illness|1|||
163142944|NCT00101686|589233322|FG005|Overall Study|intercurrent non-cancer related illness|3|||
163142945|NCT00101686|589233323|FG006|Overall Study|intercurrent non-cancer related illness|1|||
163142946|NCT00101686|589233324|FG007|Overall Study|intercurrent non-cancer related illness|0|||
163142947|NCT00101686|589233325|FG008|Overall Study|intercurrent non-cancer related illness|1|||
163142948|NCT00101686|589233326|FG009|Overall Study|intercurrent non-cancer related illness|1|||
163142949|NCT00101686|589233317|FG000|Overall Study|Physician Decision|10|||
163142950|NCT00101686|589233318|FG001|Overall Study|Physician Decision|13|||
163142951|NCT00101686|589233319|FG002|Overall Study|Physician Decision|6|||
163142952|NCT00101686|589233320|FG003|Overall Study|Physician Decision|7|||
163142953|NCT00101686|589233321|FG004|Overall Study|Physician Decision|8|||
163142954|NCT00101686|589233322|FG005|Overall Study|Physician Decision|9|||
163142955|NCT00101686|589233323|FG006|Overall Study|Physician Decision|5|||
163142956|NCT00101686|589233324|FG007|Overall Study|Physician Decision|5|||
163142957|NCT00101686|589233325|FG008|Overall Study|Physician Decision|1|||
163142958|NCT00101686|589233326|FG009|Overall Study|Physician Decision|1|||
163142959|NCT00101686|589233317|FG000|Overall Study|Other|1|||
163142960|NCT00101686|589233318|FG001|Overall Study|Other|4|||
163142961|NCT00101686|589233319|FG002|Overall Study|Other|1|||
163142962|NCT00101686|589233320|FG003|Overall Study|Other|6|||
163142963|NCT00101686|589233321|FG004|Overall Study|Other|2|||
163142964|NCT00101686|589233322|FG005|Overall Study|Other|12|||
163142965|NCT00101686|589233323|FG006|Overall Study|Other|1|||
163142966|NCT00101686|589233324|FG007|Overall Study|Other|5|||
163142967|NCT00101686|589233325|FG008|Overall Study|Other|3|||
163142968|NCT00101686|589233326|FG009|Overall Study|Other|3|||
163142969|NCT00101686|589233317|FG000|Overall Study|Withdrawal by Subject|9|||
163142970|NCT00101686|589233318|FG001|Overall Study|Withdrawal by Subject|8|||
163142971|NCT00101686|589233319|FG002|Overall Study|Withdrawal by Subject|6|||
163142972|NCT00101686|589233320|FG003|Overall Study|Withdrawal by Subject|8|||
163142973|NCT00101686|589233321|FG004|Overall Study|Withdrawal by Subject|8|||
163142974|NCT00101686|589233322|FG005|Overall Study|Withdrawal by Subject|7|||
163142975|NCT00101686|589233323|FG006|Overall Study|Withdrawal by Subject|7|||
163142976|NCT00101686|589233324|FG007|Overall Study|Withdrawal by Subject|7|||
163142977|NCT00101686|589233325|FG008|Overall Study|Withdrawal by Subject|8|||
163142978|NCT00101686|589233326|FG009|Overall Study|Withdrawal by Subject|9|||
163142979|NCT00296816|589233327|FG000|Overall Study|Disease Progression|37|||
163348902|NCT03927222|589987051|FG000|Overall Study|Early study termination|1|||
163348903|NCT02201771|589987054|FG000|Overall Study|Death|3|||
163348904|NCT02201771|589987055|FG001|Overall Study|Death|2|||
163348905|NCT02201771|589987056|FG002|Overall Study|Death|0|||
163348906|NCT02201771|589987054|FG000|Overall Study|Protocol Violation|10|||
163348907|NCT02201771|589987055|FG001|Overall Study|Protocol Violation|8|||
163142980|NCT00296816|589233327|FG000|Overall Study|Adverse Event|18|||
163142981|NCT00296816|589233327|FG000|Overall Study|Investigator/Participant request|5|||
163142982|NCT00296816|589233327|FG000|Overall Study|Non-compliance|1|||
163142983|NCT00296816|589233327|FG000|Overall Study|Missing for end of treatment|4|||
163142984|NCT00296816|589233327|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
163142985|NCT00296816|589233327|FG000|Overall Study|Poor performance status|1|||
163142986|NCT00296816|589233327|FG000|Overall Study|Relocation to Florida|1|||
163142987|NCT00296816|589233327|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
163142988|NCT00296816|589233327|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
163142989|NCT00296816|589233327|FG000|Overall Study|Neuropathy/patient preference|1|||
163142990|NCT00296816|589233327|FG000|Overall Study|Proteinuria|1|||
163142991|NCT00296816|589233327|FG000|Overall Study|ineligibility due to radiation treatment|1|||
163142992|NCT00985465|589233328|FG000|Overall Study|Withdrawal by Subject|1|||
163142993|NCT00985465|589233329|FG001|Overall Study|Withdrawal by Subject|2|||
163348908|NCT02201771|589987056|FG002|Overall Study|Protocol Violation|10|||
163348909|NCT01287416|589987059|FG000|Pre-post Training|Withdrawal by Subject|17|||
163142994|NCT00985465|589233328|FG000|Overall Study|Considered to be part of the other group|0|||
163142995|NCT00985465|589233329|FG001|Overall Study|Considered to be part of the other group|1|||
163142996|NCT01054456|589233332|FG000|Overall Study|Other|1|||
163142997|NCT04701333|589233333|FG000|Overall Study|Lost to Follow-up|3|||
163142998|NCT04701333|589233334|FG001|Overall Study|Lost to Follow-up|7|||
163142999|NCT04701333|589233333|FG000|Overall Study|Withdrawal by Subject|0|||
163143000|NCT04701333|589233334|FG001|Overall Study|Withdrawal by Subject|1|||
163143001|NCT01012258|589233335|FG000|Overall Study|Death|14|||
163143002|NCT01012258|589233335|FG000|Overall Study|Lost to Follow-up|1|||
163143003|NCT01012258|589233335|FG000|Overall Study|Adverse Event|1|||
163143004|NCT01012258|589233335|FG000|Overall Study|Progressive Disease (PD)|18|||
163143005|NCT01012258|589233335|FG000|Overall Study|Symptomatic Deterioration|1|||
163143006|NCT01012258|589233335|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
163143007|NCT01012258|589233335|FG000|Overall Study|Another Tumor Discovered|1|||
163143008|NCT01012258|589233335|FG000|Overall Study|Ongoing|29|||
163143009|NCT01292187|589233336|FG000|Overall Study|Adverse Event|10|||
163143010|NCT01292187|589233337|FG001|Overall Study|Adverse Event|5|||
163236491|NCT03655236|589575244|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
163236492|NCT03655236|589575245|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
163236493|NCT03655236|589575243|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
163236494|NCT03655236|589575244|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
163236495|NCT03655236|589575245|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
163236496|NCT03655236|589575243|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
163236497|NCT03655236|589575244|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
163236498|NCT03655236|589575245|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
163236499|NCT03655236|589575243|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
163236500|NCT03655236|589575244|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
163236501|NCT03655236|589575245|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
163236502|NCT03655236|589575243|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
163236503|NCT03655236|589575244|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
163236504|NCT03655236|589575245|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
163236505|NCT03655236|589575243|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
163236506|NCT03655236|589575244|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
163236507|NCT03655236|589575245|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
163236508|NCT03655236|589575243|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
163236509|NCT03655236|589575244|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
163236510|NCT03655236|589575245|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
163236511|NCT03655236|589575243|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
163236512|NCT03655236|589575244|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
163236513|NCT03655236|589575245|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
163236514|NCT03655236|589575243|FG000|Subject Disposition in Part 1 Period|Other|0|||
163236515|NCT03655236|589575244|FG001|Subject Disposition in Part 1 Period|Other|2|||
163236516|NCT03655236|589575245|FG002|Subject Disposition in Part 1 Period|Other|2|||
163236517|NCT03655236|589575243|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
163236518|NCT03655236|589575244|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
163236519|NCT03655236|589575245|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
163236520|NCT03655236|589575243|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
163236521|NCT03655236|589575244|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
163236522|NCT03655236|589575245|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
163236523|NCT03655236|589575243|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
163236524|NCT03655236|589575244|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
163236525|NCT03655236|589575245|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
163236526|NCT03655236|589575243|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
163236527|NCT03655236|589575244|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
163236528|NCT03655236|589575245|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
163236529|NCT03655236|589575243|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
163236530|NCT03655236|589575244|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
163236531|NCT03655236|589575245|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
163236532|NCT03655236|589575243|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
163236533|NCT03655236|589575244|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
163236534|NCT03655236|589575245|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
163236535|NCT03655236|589575243|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
163236536|NCT03655236|589575244|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
163236537|NCT03655236|589575245|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
163143011|NCT01292187|589233336|FG000|Overall Study|Withdrawal by Subject|6|||
163143012|NCT01292187|589233337|FG001|Overall Study|Withdrawal by Subject|5|||
163143013|NCT01292187|589233336|FG000|Overall Study|All other reasons|1|||
163143014|NCT01292187|589233337|FG001|Overall Study|All other reasons|3|||
163143015|NCT01814527|589233339|FG000|Overall Study|RTP greater than 30 days|6|||
163143016|NCT01814527|589233340|FG001|Overall Study|RTP greater than 30 days|1|||
163143017|NCT00113841|589233341|FG000|Overall Study|Disease progression|0|||
163143018|NCT00113841|589233342|FG001|Overall Study|Disease progression|2|||
163143019|NCT00113841|589233341|FG000|Overall Study|Non-compliant|1|||
163143020|NCT00113841|589233342|FG001|Overall Study|Non-compliant|0|||
163143021|NCT00148759|589233343|FG000|Overall Study|Withdrawal by Subject|1|||
163143022|NCT00148759|589233344|FG001|Overall Study|Withdrawal by Subject|1|||
163143023|NCT00148759|589233343|FG000|Overall Study|Lost to Follow-up|1|||
163143024|NCT00148759|589233344|FG001|Overall Study|Lost to Follow-up|0|||
163143025|NCT03948334|589233345|FG000|Overall Study|Adverse Event|1|||
163143026|NCT03948334|589233346|FG001|Overall Study|Adverse Event|4|||
163143027|NCT03948334|589233345|FG000|Overall Study|Lack of Efficacy|2|||
163143028|NCT03948334|589233346|FG001|Overall Study|Lack of Efficacy|0|||
163143029|NCT03948334|589233345|FG000|Overall Study|Lost to Follow-up|1|||
163143030|NCT03948334|589233346|FG001|Overall Study|Lost to Follow-up|0|||
163143031|NCT03948334|589233345|FG000|Overall Study|Physician Decision|1|||
163143032|NCT03948334|589233346|FG001|Overall Study|Physician Decision|0|||
163143033|NCT03948334|589233345|FG000|Overall Study|Pregnancy|0|||
163143034|NCT03948334|589233346|FG001|Overall Study|Pregnancy|1|||
163143035|NCT03948334|589233345|FG000|Overall Study|Protocol Deviation|1|||
163143036|NCT03948334|589233346|FG001|Overall Study|Protocol Deviation|0|||
163143037|NCT03948334|589233345|FG000|Overall Study|Study terminated by Sponsor|50|||
163143038|NCT03948334|589233346|FG001|Overall Study|Study terminated by Sponsor|51|||
163143039|NCT03948334|589233345|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
163143040|NCT03948334|589233346|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
163143041|NCT04332107|589233347|FG000|Day 3|Lost to Follow-up|23|||
163143042|NCT04332107|589233348|FG001|Day 3|Lost to Follow-up|14|||
163143043|NCT04332107|589233347|FG000|Day 3|Missing outcome data|3|||
163143044|NCT04332107|589233348|FG001|Day 3|Missing outcome data|6|||
163143045|NCT04332107|589233347|FG000|Day 14|Lost to Follow-up|13|||
163143046|NCT04332107|589233348|FG001|Day 14|Lost to Follow-up|4|||
163143047|NCT04332107|589233347|FG000|Day 14|Missing outcome data|4|||
163143048|NCT04332107|589233348|FG001|Day 14|Missing outcome data|4|||
163143049|NCT04332107|589233347|FG000|Day 21|Lost to Follow-up|10|||
163143050|NCT04332107|589233348|FG001|Day 21|Lost to Follow-up|2|||
163143051|NCT01670721|589233349|FG000|Overall Study|Participant's decision|15|||
163143052|NCT01670721|589233349|FG000|Overall Study|Other than specified above|38|||
163143053|NCT00141102|589233354|FG000|Overall Study|Adverse Event|233|||
163143054|NCT00141102|589233355|FG001|Overall Study|Adverse Event|305|||
163143055|NCT00141102|589233354|FG000|Overall Study|Laboratory Abnormality|9|||
163143056|NCT00141102|589233355|FG001|Overall Study|Laboratory Abnormality|33|||
163143057|NCT00141102|589233354|FG000|Overall Study|Lack of Efficacy|21|||
163143058|NCT00141102|589233355|FG001|Overall Study|Lack of Efficacy|26|||
163143059|NCT00141102|589233354|FG000|Overall Study|Lost to Follow-up|29|||
163143060|NCT00141102|589233355|FG001|Overall Study|Lost to Follow-up|32|||
163143061|NCT00141102|589233354|FG000|Overall Study|Other|87|||
163143062|NCT00141102|589233355|FG001|Overall Study|Other|76|||
163143063|NCT00141102|589233354|FG000|Overall Study|Withdrawal by Subject|112|||
163143064|NCT00141102|589233355|FG001|Overall Study|Withdrawal by Subject|142|||
163143065|NCT00141102|589233354|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
163143066|NCT00141102|589233355|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
163143067|NCT00141102|589233354|FG000|Overall Study|Death|2|||
163143068|NCT00141102|589233355|FG001|Overall Study|Death|2|||
163143069|NCT05477485|589233356|FG000|Overall Study|Lost to Follow-up|0|||
163143070|NCT05477485|589233357|FG001|Overall Study|Lost to Follow-up|4|||
163143071|NCT03061201|589233358|FG000|Overall Study|Participants Terminated at Month 36|0|||
163143072|NCT03061201|589233359|FG001|Overall Study|Participants Terminated at Month 36|1|||
163143073|NCT03061201|589233360|FG002|Overall Study|Participants Terminated at Month 36|0|||
163143074|NCT03061201|589233361|FG003|Overall Study|Participants Terminated at Month 36|1|||
163143075|NCT03061201|589233358|FG000|Overall Study|Lost to Follow-up|1|||
163143076|NCT03061201|589233359|FG001|Overall Study|Lost to Follow-up|0|||
163143077|NCT03061201|589233360|FG002|Overall Study|Lost to Follow-up|0|||
163143078|NCT03061201|589233361|FG003|Overall Study|Lost to Follow-up|0|||
163143079|NCT01572480|589233362|FG000|Participants Enrolled|Withdrawal by Subject|1|||
163143080|NCT01572480|589233362|FG000|Drug Administration|Discontinued drug/Off Study|1|||
163143081|NCT01572480|589233362|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
163143082|NCT01572480|589233362|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
163143083|NCT05081219|589233363|FG000|Overall Study|Withdrawal by Subject|4|||
163143084|NCT05081219|589233364|FG001|Overall Study|Withdrawal by Subject|0|||
163143085|NCT05081219|589233365|FG002|Overall Study|Withdrawal by Subject|0|||
163143086|NCT05081219|589233366|FG003|Overall Study|Withdrawal by Subject|1|||
163143087|NCT03446313|589233367|FG000|Overall Study|Lost to Follow-up|1|||
163143088|NCT03446313|589233368|FG001|Overall Study|Lost to Follow-up|2|||
163143089|NCT03446313|589233367|FG000|Overall Study|Failed primary screening|3|||
163143090|NCT03446313|589233368|FG001|Overall Study|Failed primary screening|0|||
163143091|NCT03446313|589233367|FG000|Overall Study|Diagnosed with terminal cancer|1|||
163143092|NCT03446313|589233368|FG001|Overall Study|Diagnosed with terminal cancer|0|||
163143093|NCT03446313|589233367|FG000|Overall Study|Excluded from analysis|1|||
163143094|NCT03446313|589233368|FG001|Overall Study|Excluded from analysis|1|||
163143095|NCT06235905|589233369|FG000|Overall Study|Adverse Event|1|||
163143096|NCT06235905|589233369|FG000|Overall Study|Non-compliant with protocol procedures|1|||
163143097|NCT00866814|589233371|FG000|Overall Study|Lost to Follow-up|12|||
163143098|NCT00866814|589233371|FG000|Overall Study|Adverse Event|2|||
163143099|NCT00866814|589233371|FG000|Overall Study|Physician Decision|1|||
163143100|NCT00866814|589233371|FG000|Overall Study|Death|1|||
163143101|NCT00866814|589233371|FG000|Overall Study|No longer wished to participate|1|||
163143102|NCT00866814|589233371|FG000|Overall Study|Unable to meet follow-up requirements|2|||
163143103|NCT00866814|589233371|FG000|Overall Study|Moved to area without study site|1|||
163143104|NCT02711137|589235088|FG000|Overall Study|Death|1|||
163143105|NCT02711137|589235089|FG001|Overall Study|Death|4|||
163143106|NCT02711137|589235090|FG002|Overall Study|Death|5|||
163143107|NCT02711137|589235091|FG003|Overall Study|Death|5|||
163143108|NCT02711137|589235092|FG004|Overall Study|Death|3|||
163143109|NCT02711137|589235093|FG005|Overall Study|Death|1|||
163143110|NCT02711137|589235094|FG006|Overall Study|Death|61|||
163348910|NCT01287416|589987060|FG001|Pre-post Training|Withdrawal by Subject|24|||
163348911|NCT01287416|589987059|FG000|Pre-post Training|Lost to Follow-up|5|||
163348912|NCT01287416|589987060|FG001|Pre-post Training|Lost to Follow-up|1|||
163348913|NCT01287416|589987059|FG000|6 Month Follow-up|Lost to Follow-up|3|||
163348914|NCT01287416|589987060|FG001|6 Month Follow-up|Lost to Follow-up|2|||
163348915|NCT00495612|589987065|FG000|Overall Study|Lost to Follow-up|1|||
163348916|NCT00495612|589987066|FG001|Overall Study|Lost to Follow-up|0|||
163348917|NCT00495612|589987065|FG000|Overall Study|Subject's Decision to Withdraw|3|||
163348918|NCT00495612|589987066|FG001|Overall Study|Subject's Decision to Withdraw|0|||
163348919|NCT02383927|589987073|FG000|Overall Study|Disease Progression|8|||
163143111|NCT02711137|589235095|FG007|Overall Study|Death|3|||
163143112|NCT02711137|589235096|FG008|Overall Study|Death|0|||
163143113|NCT02711137|589235097|FG009|Overall Study|Death|1|||
163143114|NCT02711137|589235098|FG010|Overall Study|Death|1|||
163143115|NCT02711137|589235099|FG011|Overall Study|Death|1|||
163143116|NCT02711137|589235100|FG012|Overall Study|Death|0|||
163143117|NCT02711137|589235101|FG013|Overall Study|Death|0|||
163143118|NCT02711137|589235102|FG014|Overall Study|Death|0|||
163143119|NCT02711137|589235088|FG000|Overall Study|Study Terminated by Sponsor|0|||
163348920|NCT02383927|589987074|FG001|Overall Study|Disease Progression|8|||
163348921|NCT02383927|589987075|FG002|Overall Study|Disease Progression|15|||
163348922|NCT02383927|589987076|FG003|Overall Study|Disease Progression|4|||
163348923|NCT02383927|589987073|FG000|Overall Study|Physician Decision|0|||
163348924|NCT02383927|589987074|FG001|Overall Study|Physician Decision|0|||
163348925|NCT02383927|589987075|FG002|Overall Study|Physician Decision|2|||
163348926|NCT02383927|589987076|FG003|Overall Study|Physician Decision|0|||
163348927|NCT02383927|589987073|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
163348928|NCT02383927|589987074|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
163348929|NCT02383927|589987075|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
163348930|NCT02383927|589987076|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
163348931|NCT02383927|589987073|FG000|Overall Study|Adverse Event|4|||
163348932|NCT02383927|589987074|FG001|Overall Study|Adverse Event|1|||
163348933|NCT02383927|589987075|FG002|Overall Study|Adverse Event|3|||
163348934|NCT02383927|589987076|FG003|Overall Study|Adverse Event|5|||
163348935|NCT02383927|589987073|FG000|Overall Study|Miscellaneous|1|||
163143120|NCT02711137|589235089|FG001|Overall Study|Study Terminated by Sponsor|0|||
163143121|NCT02711137|589235090|FG002|Overall Study|Study Terminated by Sponsor|1|||
163143122|NCT02711137|589235091|FG003|Overall Study|Study Terminated by Sponsor|0|||
163143123|NCT02711137|589235092|FG004|Overall Study|Study Terminated by Sponsor|0|||
163143124|NCT02711137|589235093|FG005|Overall Study|Study Terminated by Sponsor|0|||
163143125|NCT02711137|589235094|FG006|Overall Study|Study Terminated by Sponsor|1|||
163143126|NCT02711137|589235095|FG007|Overall Study|Study Terminated by Sponsor|0|||
163143127|NCT02711137|589235096|FG008|Overall Study|Study Terminated by Sponsor|0|||
163143128|NCT02711137|589235097|FG009|Overall Study|Study Terminated by Sponsor|0|||
163143129|NCT02711137|589235098|FG010|Overall Study|Study Terminated by Sponsor|0|||
163424271|NCT00885365|590258214|FG000|4 Weeks ON Treatment|Adverse Event|2|||
163143130|NCT02711137|589235099|FG011|Overall Study|Study Terminated by Sponsor|0|||
163143131|NCT02711137|589235100|FG012|Overall Study|Study Terminated by Sponsor|0|||
163348936|NCT02383927|589987074|FG001|Overall Study|Miscellaneous|0|||
163348937|NCT02383927|589987075|FG002|Overall Study|Miscellaneous|0|||
163348938|NCT02383927|589987076|FG003|Overall Study|Miscellaneous|1|||
163143132|NCT02711137|589235101|FG013|Overall Study|Study Terminated by Sponsor|0|||
163348939|NCT02383927|589987073|FG000|Overall Study|Withdrawal by Subject|0|||
163348940|NCT02383927|589987074|FG001|Overall Study|Withdrawal by Subject|1|||
163348941|NCT02383927|589987075|FG002|Overall Study|Withdrawal by Subject|4|||
163348942|NCT02383927|589987076|FG003|Overall Study|Withdrawal by Subject|0|||
163143133|NCT02711137|589235102|FG014|Overall Study|Study Terminated by Sponsor|0|||
163143134|NCT02711137|589235088|FG000|Overall Study|Physician Decision|1|||
163143135|NCT02711137|589235089|FG001|Overall Study|Physician Decision|0|||
163143136|NCT02711137|589235090|FG002|Overall Study|Physician Decision|2|||
163143137|NCT02711137|589235091|FG003|Overall Study|Physician Decision|1|||
163143138|NCT02711137|589235092|FG004|Overall Study|Physician Decision|1|||
163143139|NCT02711137|589235093|FG005|Overall Study|Physician Decision|0|||
163143140|NCT02711137|589235094|FG006|Overall Study|Physician Decision|12|||
163348943|NCT00734851|589987077|FG000|Overall Study|Withdrawal by Subject|2|||
163348944|NCT00734851|589987077|FG000|Overall Study|Lost to Follow-up|1|||
163348945|NCT00734851|589987077|FG000|Overall Study|Physician Decision|18|||
163348946|NCT00818519|589987078|FG000|Overall Study|Adverse Event|2|||
163348947|NCT00818519|589987079|FG001|Overall Study|Adverse Event|2|||
163348948|NCT00818519|589987078|FG000|Overall Study|Lost to Follow-up|4|||
163348949|NCT00818519|589987079|FG001|Overall Study|Lost to Follow-up|6|||
163348950|NCT00818519|589987078|FG000|Overall Study|Protocol Violation|2|||
163348951|NCT00818519|589987079|FG001|Overall Study|Protocol Violation|1|||
163348952|NCT00818519|589987078|FG000|Overall Study|Pregnancy|0|||
163348953|NCT00818519|589987079|FG001|Overall Study|Pregnancy|1|||
163348954|NCT00818519|589987078|FG000|Overall Study|Withdrawal by Subject|4|||
163348955|NCT00818519|589987079|FG001|Overall Study|Withdrawal by Subject|9|||
163348956|NCT00818519|589987078|FG000|Overall Study|participant recovered completely|1|||
163348957|NCT00818519|589987079|FG001|Overall Study|participant recovered completely|0|||
163348958|NCT00818519|589987078|FG000|Overall Study|participant will leave for long tme|1|||
163348959|NCT00818519|589987079|FG001|Overall Study|participant will leave for long tme|0|||
163348960|NCT00981578|589987083|FG000|Overall Study|Death|1|||
163348961|NCT00981578|589987083|FG000|Overall Study|Withdrawal by Subject|2|||
163348962|NCT01180790|589987089|FG000|Overall Study|Adverse Event|1|||
163348963|NCT01180790|589987090|FG001|Overall Study|Adverse Event|1|||
163348964|NCT01180790|589987091|FG002|Overall Study|Adverse Event|2|||
163348965|NCT01180790|589987092|FG003|Overall Study|Adverse Event|0|||
163348966|NCT01180790|589987093|FG004|Overall Study|Adverse Event|1|||
163348967|NCT01180790|589987094|FG005|Overall Study|Adverse Event|3|||
163348968|NCT01180790|589987095|FG006|Overall Study|Adverse Event|0|||
163348969|NCT01180790|589987089|FG000|Overall Study|Withdrawal by Subject|3|||
163348970|NCT01180790|589987090|FG001|Overall Study|Withdrawal by Subject|0|||
163348971|NCT01180790|589987091|FG002|Overall Study|Withdrawal by Subject|5|||
163348972|NCT01180790|589987092|FG003|Overall Study|Withdrawal by Subject|0|||
163348973|NCT01180790|589987093|FG004|Overall Study|Withdrawal by Subject|2|||
163348974|NCT01180790|589987094|FG005|Overall Study|Withdrawal by Subject|1|||
163348975|NCT01180790|589987095|FG006|Overall Study|Withdrawal by Subject|0|||
163348976|NCT01180790|589987089|FG000|Overall Study|Lost to Follow-up|3|||
163348977|NCT01180790|589987090|FG001|Overall Study|Lost to Follow-up|1|||
163348978|NCT01180790|589987091|FG002|Overall Study|Lost to Follow-up|0|||
163348979|NCT01180790|589987092|FG003|Overall Study|Lost to Follow-up|2|||
163348980|NCT01180790|589987093|FG004|Overall Study|Lost to Follow-up|1|||
163348981|NCT01180790|589987094|FG005|Overall Study|Lost to Follow-up|0|||
163348982|NCT01180790|589987095|FG006|Overall Study|Lost to Follow-up|1|||
163348983|NCT01180790|589987089|FG000|Overall Study|Physician Decision|1|||
163348984|NCT01180790|589987090|FG001|Overall Study|Physician Decision|0|||
163348985|NCT01180790|589987091|FG002|Overall Study|Physician Decision|0|||
163348986|NCT01180790|589987092|FG003|Overall Study|Physician Decision|1|||
163348987|NCT01180790|589987093|FG004|Overall Study|Physician Decision|0|||
163348988|NCT01180790|589987094|FG005|Overall Study|Physician Decision|0|||
163348989|NCT01180790|589987095|FG006|Overall Study|Physician Decision|0|||
163143141|NCT02711137|589235095|FG007|Overall Study|Physician Decision|2|||
163143142|NCT02711137|589235096|FG008|Overall Study|Physician Decision|1|||
163143143|NCT02711137|589235097|FG009|Overall Study|Physician Decision|1|||
163143144|NCT02711137|589235098|FG010|Overall Study|Physician Decision|3|||
163348990|NCT01180790|589987089|FG000|Overall Study|Lack of Efficacy|1|||
163348991|NCT01180790|589987090|FG001|Overall Study|Lack of Efficacy|2|||
163348992|NCT01180790|589987091|FG002|Overall Study|Lack of Efficacy|5|||
163348993|NCT01180790|589987092|FG003|Overall Study|Lack of Efficacy|6|||
163348994|NCT01180790|589987093|FG004|Overall Study|Lack of Efficacy|1|||
163348995|NCT01180790|589987094|FG005|Overall Study|Lack of Efficacy|3|||
163348996|NCT01180790|589987095|FG006|Overall Study|Lack of Efficacy|0|||
163348997|NCT01180790|589987089|FG000|Overall Study|compliance|0|||
163348998|NCT01180790|589987090|FG001|Overall Study|compliance|1|||
163348999|NCT01180790|589987091|FG002|Overall Study|compliance|0|||
163349000|NCT01180790|589987092|FG003|Overall Study|compliance|0|||
163143145|NCT02711137|589235099|FG011|Overall Study|Physician Decision|2|||
163143146|NCT02711137|589235100|FG012|Overall Study|Physician Decision|1|||
163349001|NCT01180790|589987093|FG004|Overall Study|compliance|0|||
163349002|NCT01180790|589987094|FG005|Overall Study|compliance|0|||
163349003|NCT01180790|589987095|FG006|Overall Study|compliance|0|||
163349004|NCT01180790|589987089|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
163349005|NCT01180790|589987090|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
163349006|NCT01180790|589987091|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
163349007|NCT01180790|589987092|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
163409542|NCT05048719|590209397|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163409543|NCT05048719|590209398|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163409544|NCT04541004|590209399|FG000|Overall Study|Adverse Event|2|||
163409545|NCT00605085|590209400|FG000|Overall Study|Withdrawal by Subject|8|||
163409546|NCT00605085|590209401|FG001|Overall Study|Withdrawal by Subject|5|||
163409547|NCT00605085|590209400|FG000|Overall Study|Adverse Event|9|||
163409548|NCT00605085|590209401|FG001|Overall Study|Adverse Event|5|||
163409549|NCT00605085|590209400|FG000|Overall Study|Pregnancy|2|||
163409550|NCT00605085|590209401|FG001|Overall Study|Pregnancy|0|||
163409551|NCT00605085|590209400|FG000|Overall Study|Protocol Violation|3|||
163409552|NCT00605085|590209401|FG001|Overall Study|Protocol Violation|2|||
163409553|NCT00605085|590209400|FG000|Overall Study|Lost to Follow-up|10|||
163409554|NCT00605085|590209401|FG001|Overall Study|Lost to Follow-up|5|||
163409555|NCT00605085|590209400|FG000|Overall Study|administrative reasons|18|||
163409556|NCT00605085|590209401|FG001|Overall Study|administrative reasons|8|||
163409557|NCT00494091|590209404|FG000|Overall Study|Death|5|||
163409558|NCT00494091|590209405|FG001|Overall Study|Death|54|||
163409559|NCT00494091|590209404|FG000|Overall Study|Lost to Follow-up|0|||
163409560|NCT00494091|590209405|FG001|Overall Study|Lost to Follow-up|4|||
163409561|NCT00494091|590209404|FG000|Overall Study|Other|1|||
163409562|NCT00494091|590209405|FG001|Overall Study|Other|11|||
163409563|NCT00494091|590209404|FG000|Overall Study|Withdrawal by Subject|0|||
163409564|NCT00494091|590209405|FG001|Overall Study|Withdrawal by Subject|7|||
163409565|NCT01652287|590209409|FG000|Overall Study|Withdrawal by Subject|2|||
163409566|NCT01652287|590209410|FG001|Overall Study|Withdrawal by Subject|0|||
163409567|NCT01592760|590209412|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
163409568|NCT01592760|590209413|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
163409569|NCT01592760|590209414|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
163409570|NCT04312009|590209415|FG000|Overall Study|Withdrawal by Subject|2|||
163409571|NCT04312009|590209416|FG001|Overall Study|Withdrawal by Subject|1|||
163409572|NCT01637142|590209419|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
163409573|NCT02354703|590209429|FG000|Overall Study|Withdrawal by Subject|1|||
163409574|NCT02354703|590209430|FG001|Overall Study|Withdrawal by Subject|1|||
163409575|NCT02354703|590209431|FG002|Overall Study|Withdrawal by Subject|1|||
163409576|NCT02354703|590209432|FG003|Overall Study|Withdrawal by Subject|1|||
163409577|NCT02354703|590209429|FG000|Overall Study|Lost to Follow-up|2|||
163409578|NCT02354703|590209430|FG001|Overall Study|Lost to Follow-up|7|||
163409579|NCT02354703|590209431|FG002|Overall Study|Lost to Follow-up|9|||
163409580|NCT02354703|590209432|FG003|Overall Study|Lost to Follow-up|2|||
163409581|NCT02354703|590209429|FG000|Overall Study|Adverse Event|0|||
163409582|NCT02354703|590209430|FG001|Overall Study|Adverse Event|0|||
163409583|NCT02354703|590209431|FG002|Overall Study|Adverse Event|1|||
163409584|NCT02354703|590209432|FG003|Overall Study|Adverse Event|0|||
163409585|NCT00699348|590209434|FG000|Overall Study|Death|6|||
163409586|NCT00699348|590209434|FG000|Overall Study|Adverse Event|15|||
163409587|NCT00699348|590209434|FG000|Overall Study|Withdrawal by Subject|11|||
163409588|NCT00699348|590209434|FG000|Overall Study|Protocol Violation|10|||
163409589|NCT00699348|590209434|FG000|Overall Study|Lack of Efficacy|8|||
163409590|NCT00699348|590209434|FG000|Overall Study|Failure to return|1|||
163409591|NCT00699348|590209434|FG000|Overall Study|Blood transfusion|24|||
163409592|NCT00699348|590209434|FG000|Overall Study|Renal transplantation|10|||
163409593|NCT00699348|590209434|FG000|Overall Study|Other|5|||
163409594|NCT00122135|590209435|FG000|Overall Study|Withdrawal by Subject|3|||
163409595|NCT00122135|590209436|FG001|Overall Study|Withdrawal by Subject|0|||
163409596|NCT03269344|590209437|FG000|Overall Study|Protocol Violation|4|||
163409597|NCT03269344|590209438|FG001|Overall Study|Protocol Violation|3|||
163409598|NCT04478708|590209441|FG000|Overall Study|Lost to Follow-up|0|||
163409599|NCT04478708|590209442|FG001|Overall Study|Lost to Follow-up|0|||
163409600|NCT04478708|590209443|FG002|Overall Study|Lost to Follow-up|0|||
163409601|NCT04478708|590209444|FG003|Overall Study|Lost to Follow-up|0|||
163143147|NCT02711137|589235101|FG013|Overall Study|Physician Decision|1|||
163409602|NCT04478708|590209445|FG004|Overall Study|Lost to Follow-up|0|||
163409603|NCT04478708|590209446|FG005|Overall Study|Lost to Follow-up|0|||
163409604|NCT04478708|590209447|FG006|Overall Study|Lost to Follow-up|0|||
163409605|NCT04478708|590209448|FG007|Overall Study|Lost to Follow-up|0|||
163409606|NCT04478708|590209449|FG008|Overall Study|Lost to Follow-up|1|||
163409607|NCT04478708|590209450|FG009|Overall Study|Lost to Follow-up|1|||
163409608|NCT04478708|590209451|FG010|Overall Study|Lost to Follow-up|1|||
163409609|NCT04478708|590209452|FG011|Overall Study|Lost to Follow-up|2|||
163409610|NCT04478708|590209453|FG012|Overall Study|Lost to Follow-up|1|||
163409611|NCT04478708|590209454|FG013|Overall Study|Lost to Follow-up|0|||
163409612|NCT04478708|590209455|FG014|Overall Study|Lost to Follow-up|0|||
163409613|NCT04478708|590209456|FG015|Overall Study|Lost to Follow-up|0|||
163409614|NCT04478708|590209457|FG016|Overall Study|Lost to Follow-up|0|||
163409615|NCT04478708|590209441|FG000|Overall Study|Withdrawal of consent from study|0|||
163409616|NCT04478708|590209442|FG001|Overall Study|Withdrawal of consent from study|1|||
163409617|NCT04478708|590209443|FG002|Overall Study|Withdrawal of consent from study|2|||
163409618|NCT04478708|590209444|FG003|Overall Study|Withdrawal of consent from study|0|||
163143148|NCT02711137|589235102|FG014|Overall Study|Physician Decision|2|||
163143149|NCT02711137|589235088|FG000|Overall Study|Other|0|||
163143150|NCT02711137|589235089|FG001|Overall Study|Other|1|||
163143151|NCT02711137|589235090|FG002|Overall Study|Other|0|||
163143152|NCT02711137|589235091|FG003|Overall Study|Other|0|||
163143153|NCT02711137|589235092|FG004|Overall Study|Other|0|||
163143154|NCT02711137|589235093|FG005|Overall Study|Other|0|||
163143155|NCT02711137|589235094|FG006|Overall Study|Other|3|||
163143156|NCT02711137|589235095|FG007|Overall Study|Other|0|||
163143157|NCT02711137|589235096|FG008|Overall Study|Other|0|||
163143158|NCT02711137|589235097|FG009|Overall Study|Other|0|||
163143159|NCT02711137|589235098|FG010|Overall Study|Other|0|||
163143160|NCT02711137|589235099|FG011|Overall Study|Other|0|||
163143161|NCT02711137|589235100|FG012|Overall Study|Other|0|||
163143162|NCT02711137|589235101|FG013|Overall Study|Other|0|||
163143163|NCT02711137|589235102|FG014|Overall Study|Other|1|||
163143164|NCT02711137|589235088|FG000|Overall Study|Withdrawal by Subject|1|||
163143165|NCT02711137|589235089|FG001|Overall Study|Withdrawal by Subject|0|||
163143166|NCT02711137|589235090|FG002|Overall Study|Withdrawal by Subject|0|||
163143167|NCT02711137|589235091|FG003|Overall Study|Withdrawal by Subject|1|||
163143168|NCT02711137|589235092|FG004|Overall Study|Withdrawal by Subject|1|||
163143169|NCT02711137|589235093|FG005|Overall Study|Withdrawal by Subject|0|||
163143170|NCT02711137|589235094|FG006|Overall Study|Withdrawal by Subject|7|||
163143171|NCT02711137|589235095|FG007|Overall Study|Withdrawal by Subject|0|||
163143172|NCT02711137|589235096|FG008|Overall Study|Withdrawal by Subject|0|||
163143173|NCT02711137|589235097|FG009|Overall Study|Withdrawal by Subject|0|||
163143174|NCT02711137|589235098|FG010|Overall Study|Withdrawal by Subject|0|||
163143175|NCT02711137|589235099|FG011|Overall Study|Withdrawal by Subject|0|||
163143176|NCT02711137|589235100|FG012|Overall Study|Withdrawal by Subject|0|||
163143177|NCT02711137|589235101|FG013|Overall Study|Withdrawal by Subject|1|||
163143178|NCT02711137|589235102|FG014|Overall Study|Withdrawal by Subject|0|||
163143179|NCT02711137|589235088|FG000|Overall Study|Lost to Follow-up|1|||
163143180|NCT02711137|589235089|FG001|Overall Study|Lost to Follow-up|0|||
163143181|NCT02711137|589235090|FG002|Overall Study|Lost to Follow-up|0|||
163143182|NCT02711137|589235091|FG003|Overall Study|Lost to Follow-up|0|||
163143183|NCT02711137|589235092|FG004|Overall Study|Lost to Follow-up|0|||
163143184|NCT02711137|589235093|FG005|Overall Study|Lost to Follow-up|0|||
163143185|NCT02711137|589235094|FG006|Overall Study|Lost to Follow-up|2|||
163143186|NCT02711137|589235095|FG007|Overall Study|Lost to Follow-up|0|||
163143187|NCT02711137|589235096|FG008|Overall Study|Lost to Follow-up|0|||
163143188|NCT02711137|589235097|FG009|Overall Study|Lost to Follow-up|0|||
163143189|NCT02711137|589235098|FG010|Overall Study|Lost to Follow-up|0|||
163143190|NCT02711137|589235099|FG011|Overall Study|Lost to Follow-up|0|||
163143191|NCT02711137|589235100|FG012|Overall Study|Lost to Follow-up|0|||
163143192|NCT02711137|589235101|FG013|Overall Study|Lost to Follow-up|0|||
163143193|NCT02711137|589235102|FG014|Overall Study|Lost to Follow-up|0|||
163143194|NCT03956550|589235103|FG000|Overall Study|Sponsor decision|65|||
163143195|NCT03956550|589235104|FG001|Overall Study|Sponsor decision|66|||
163143196|NCT03956550|589235105|FG002|Overall Study|Sponsor decision|64|||
163143197|NCT03956550|589235103|FG000|Overall Study|Adverse Event|0|||
163143198|NCT03956550|589235104|FG001|Overall Study|Adverse Event|1|||
163143199|NCT03956550|589235105|FG002|Overall Study|Adverse Event|0|||
163143200|NCT03956550|589235103|FG000|Overall Study|Withdrawal by Subject|5|||
163143201|NCT03956550|589235104|FG001|Overall Study|Withdrawal by Subject|5|||
163143202|NCT03956550|589235105|FG002|Overall Study|Withdrawal by Subject|6|||
163143203|NCT03400852|589235106|FG000|Blinded Treatment Period|Physician Decision|0|||
163143204|NCT03400852|589235107|FG001|Blinded Treatment Period|Physician Decision|1|||
163143205|NCT03400852|589235108|FG002|Blinded Treatment Period|Physician Decision|0|||
163143206|NCT03400852|589235106|FG000|Blinded Treatment Period|Adverse Event|1|||
163143207|NCT03400852|589235107|FG001|Blinded Treatment Period|Adverse Event|1|||
163143208|NCT03400852|589235108|FG002|Blinded Treatment Period|Adverse Event|0|||
163143209|NCT03400852|589235106|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
163143210|NCT03400852|589235107|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
163143211|NCT03400852|589235108|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
163143212|NCT03400852|589235106|FG000|Open Label Period|Physician Decision|0|||
163143213|NCT03400852|589235107|FG001|Open Label Period|Physician Decision|0|||
163143214|NCT03400852|589235108|FG002|Open Label Period|Physician Decision|1|||
163143215|NCT03400852|589235106|FG000|Open Label Period|Study terminated by sponsor|0|||
163143216|NCT03400852|589235107|FG001|Open Label Period|Study terminated by sponsor|0|||
163143217|NCT03400852|589235108|FG002|Open Label Period|Study terminated by sponsor|21|||
163143218|NCT00248495|589235109|FG000|Overall Study|Withdrawal by Subject|1|||
163143219|NCT01285401|589235110|FG000|Overall Study|Prematurely withdrawn from the study|17|||
163143220|NCT01285401|589235111|FG001|Overall Study|Prematurely withdrawn from the study|29|||
163143221|NCT03719131|589235115|FG000|Overall Study|Death|1|||
163143222|NCT03719131|589235116|FG001|Overall Study|Death|2|||
163143223|NCT04244253|589235117|FG000|Overall Study|Adverse Event|2|||
163143224|NCT04244253|589235118|FG001|Overall Study|Adverse Event|2|||
163143225|NCT04244253|589235119|FG002|Overall Study|Adverse Event|4|||
163143226|NCT04244253|589235117|FG000|Overall Study|Protocol Violation|1|||
163143227|NCT04244253|589235118|FG001|Overall Study|Protocol Violation|2|||
163143228|NCT04244253|589235119|FG002|Overall Study|Protocol Violation|1|||
163143229|NCT04244253|589235117|FG000|Overall Study|Withdrawal by Subject|0|||
163143230|NCT04244253|589235118|FG001|Overall Study|Withdrawal by Subject|1|||
163143231|NCT04244253|589235119|FG002|Overall Study|Withdrawal by Subject|6|||
163143232|NCT04244253|589235117|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163143233|NCT04244253|589235118|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163143234|NCT04244253|589235119|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163143235|NCT01544920|589235120|FG000|Overall Study|Adverse Event|0|||
163143236|NCT01544920|589235121|FG001|Overall Study|Adverse Event|3|||
163143237|NCT01544920|589235120|FG000|Overall Study|Death|0|||
163143238|NCT01544920|589235121|FG001|Overall Study|Death|1|||
163143239|NCT01544920|589235120|FG000|Overall Study|Lost to Follow-up|11|||
163143240|NCT01544920|589235121|FG001|Overall Study|Lost to Follow-up|12|||
163143241|NCT01544920|589235120|FG000|Overall Study|Protocol Violation|0|||
163143242|NCT01544920|589235121|FG001|Overall Study|Protocol Violation|2|||
163143243|NCT01544920|589235120|FG000|Overall Study|Physician Decision|4|||
163143244|NCT01544920|589235121|FG001|Overall Study|Physician Decision|1|||
163143245|NCT01544920|589235120|FG000|Overall Study|Withdrawal by Subject|4|||
163143246|NCT01544920|589235121|FG001|Overall Study|Withdrawal by Subject|4|||
163143247|NCT03001557|589235125|FG000|Core Phase|Randomized but not treated|0|||
163143248|NCT03001557|589235126|FG001|Core Phase|Randomized but not treated|0|||
163143249|NCT03001557|589235127|FG002|Core Phase|Randomized but not treated|1|||
163143250|NCT03001557|589235128|FG003|Core Phase|Randomized but not treated|0|||
163143251|NCT03001557|589235129|FG004|Core Phase|Randomized but not treated|0|||
163143252|NCT03001557|589235130|FG005|Core Phase|Randomized but not treated|0|||
163143253|NCT03001557|589235131|FG006|Core Phase|Randomized but not treated|0|||
163143254|NCT03001557|589235132|FG007|Core Phase|Randomized but not treated|0|||
163143255|NCT03001557|589235125|FG000|Extension Phase|Adverse Event|0|||
163143256|NCT03001557|589235126|FG001|Extension Phase|Adverse Event|0|||
163143257|NCT03001557|589235127|FG002|Extension Phase|Adverse Event|0|||
163143258|NCT03001557|589235128|FG003|Extension Phase|Adverse Event|0|||
163143259|NCT03001557|589235129|FG004|Extension Phase|Adverse Event|0|||
163143260|NCT03001557|589235130|FG005|Extension Phase|Adverse Event|2|||
163143261|NCT03001557|589235131|FG006|Extension Phase|Adverse Event|0|||
163143262|NCT03001557|589235132|FG007|Extension Phase|Adverse Event|0|||
163143263|NCT03001557|589235125|FG000|Extension Phase|Withdrawal by Subject|0|||
163143264|NCT03001557|589235126|FG001|Extension Phase|Withdrawal by Subject|0|||
163143265|NCT03001557|589235127|FG002|Extension Phase|Withdrawal by Subject|0|||
163143266|NCT03001557|589235128|FG003|Extension Phase|Withdrawal by Subject|0|||
163143267|NCT03001557|589235129|FG004|Extension Phase|Withdrawal by Subject|0|||
163143268|NCT03001557|589235130|FG005|Extension Phase|Withdrawal by Subject|1|||
163143269|NCT03001557|589235131|FG006|Extension Phase|Withdrawal by Subject|5|||
163143270|NCT03001557|589235132|FG007|Extension Phase|Withdrawal by Subject|2|||
163143271|NCT03001557|589235125|FG000|Extension Phase|Lost to Follow-up|0|||
163143272|NCT03001557|589235126|FG001|Extension Phase|Lost to Follow-up|0|||
163143273|NCT03001557|589235127|FG002|Extension Phase|Lost to Follow-up|0|||
163143274|NCT03001557|589235128|FG003|Extension Phase|Lost to Follow-up|0|||
163143275|NCT03001557|589235129|FG004|Extension Phase|Lost to Follow-up|0|||
163143276|NCT03001557|589235130|FG005|Extension Phase|Lost to Follow-up|0|||
163143277|NCT03001557|589235131|FG006|Extension Phase|Lost to Follow-up|2|||
163143278|NCT03001557|589235132|FG007|Extension Phase|Lost to Follow-up|1|||
163143279|NCT03001557|589235125|FG000|Extension Phase|Administrative Reason|0|||
163143280|NCT03001557|589235126|FG001|Extension Phase|Administrative Reason|0|||
163143281|NCT03001557|589235127|FG002|Extension Phase|Administrative Reason|0|||
163143282|NCT03001557|589235128|FG003|Extension Phase|Administrative Reason|0|||
163143283|NCT03001557|589235129|FG004|Extension Phase|Administrative Reason|0|||
163143284|NCT03001557|589235130|FG005|Extension Phase|Administrative Reason|1|||
163143285|NCT03001557|589235131|FG006|Extension Phase|Administrative Reason|3|||
163143286|NCT03001557|589235132|FG007|Extension Phase|Administrative Reason|3|||
163143287|NCT03001557|589235125|FG000|Extension Phase|Loss of caregiver|0|||
163143288|NCT03001557|589235126|FG001|Extension Phase|Loss of caregiver|0|||
163143289|NCT03001557|589235127|FG002|Extension Phase|Loss of caregiver|0|||
163143290|NCT03001557|589235128|FG003|Extension Phase|Loss of caregiver|0|||
163143291|NCT03001557|589235129|FG004|Extension Phase|Loss of caregiver|0|||
163143292|NCT03001557|589235130|FG005|Extension Phase|Loss of caregiver|0|||
163143293|NCT03001557|589235131|FG006|Extension Phase|Loss of caregiver|1|||
163143294|NCT03001557|589235132|FG007|Extension Phase|Loss of caregiver|0|||
163143295|NCT03001557|589235125|FG000|Extension Phase|Others|0|||
163143296|NCT03001557|589235126|FG001|Extension Phase|Others|0|||
163143297|NCT03001557|589235127|FG002|Extension Phase|Others|0|||
163143298|NCT03001557|589235128|FG003|Extension Phase|Others|0|||
163143299|NCT03001557|589235129|FG004|Extension Phase|Others|0|||
163143300|NCT03001557|589235130|FG005|Extension Phase|Others|1|||
163409619|NCT04478708|590209445|FG004|Overall Study|Withdrawal of consent from study|1|||
163143301|NCT03001557|589235131|FG006|Extension Phase|Others|3|||
163143302|NCT03001557|589235132|FG007|Extension Phase|Others|0|||
163143303|NCT01272232|589235133|FG000|Weeks 0-56|Adverse Event|39|||
163236538|NCT03655236|589575243|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
163236539|NCT03655236|589575244|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
163236540|NCT03655236|589575245|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
163143304|NCT01272232|589235134|FG001|Weeks 0-56|Adverse Event|18|||
163143305|NCT01272232|589235135|FG002|Weeks 0-56|Adverse Event|7|||
163143306|NCT01272232|589235133|FG000|Weeks 0-56|Lack of Efficacy|0|||
163143307|NCT01272232|589235134|FG001|Weeks 0-56|Lack of Efficacy|0|||
163143308|NCT01272232|589235135|FG002|Weeks 0-56|Lack of Efficacy|3|||
163143309|NCT01272232|589235133|FG000|Weeks 0-56|Protocol Violation|12|||
163143310|NCT01272232|589235134|FG001|Weeks 0-56|Protocol Violation|8|||
163143311|NCT01272232|589235135|FG002|Weeks 0-56|Protocol Violation|13|||
163143312|NCT01272232|589235133|FG000|Weeks 0-56|Withdrawal criteria|32|||
163143313|NCT01272232|589235134|FG001|Weeks 0-56|Withdrawal criteria|14|||
163143314|NCT01272232|589235135|FG002|Weeks 0-56|Withdrawal criteria|37|||
163143315|NCT01272232|589235133|FG000|Weeks 0-56|Unclassified|16|||
163143316|NCT01272232|589235134|FG001|Weeks 0-56|Unclassified|7|||
163143317|NCT01272232|589235135|FG002|Weeks 0-56|Unclassified|12|||
163143318|NCT01272232|589235133|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
163143319|NCT01272232|589235134|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
163143320|NCT01272232|589235135|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
163143321|NCT01272232|589235133|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
163143322|NCT01272232|589235134|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
163143323|NCT01272232|589235135|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
163143324|NCT01272232|589235133|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
163143325|NCT01272232|589235134|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
163143326|NCT01272232|589235135|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
163143327|NCT01272232|589235133|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
163143328|NCT01272232|589235134|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
163143329|NCT01272232|589235135|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
163143330|NCT01272232|589235133|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
163143331|NCT01272232|589235134|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
163143332|NCT01272232|589235135|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
163143333|NCT02159066|589235136|FG000|Part I|Adverse Event|7|||
163143334|NCT02159066|589235137|FG001|Part I|Adverse Event|5|||
163143335|NCT02159066|589235138|FG002|Part I|Adverse Event|0|||
163143336|NCT02159066|589235139|FG003|Part I|Adverse Event|0|||
163143337|NCT02159066|589235140|FG004|Part I|Adverse Event|0|||
163143338|NCT02159066|589235141|FG005|Part I|Adverse Event|0|||
163143339|NCT02159066|589235136|FG000|Part I|Death|11|||
163143340|NCT02159066|589235137|FG001|Part I|Death|9|||
163143341|NCT02159066|589235138|FG002|Part I|Death|0|||
163143342|NCT02159066|589235139|FG003|Part I|Death|0|||
163143343|NCT02159066|589235140|FG004|Part I|Death|0|||
163143344|NCT02159066|589235141|FG005|Part I|Death|0|||
163143345|NCT02159066|589235136|FG000|Part I|Progressive Disease|37|||
163143346|NCT02159066|589235137|FG001|Part I|Progressive Disease|46|||
163143347|NCT02159066|589235138|FG002|Part I|Progressive Disease|0|||
163143348|NCT02159066|589235139|FG003|Part I|Progressive Disease|0|||
163143349|NCT02159066|589235140|FG004|Part I|Progressive Disease|0|||
163143350|NCT02159066|589235141|FG005|Part I|Progressive Disease|0|||
163143351|NCT02159066|589235136|FG000|Part I|New Therapy for Study Indication|5|||
163143352|NCT02159066|589235137|FG001|Part I|New Therapy for Study Indication|4|||
163143353|NCT02159066|589235138|FG002|Part I|New Therapy for Study Indication|0|||
163143354|NCT02159066|589235139|FG003|Part I|New Therapy for Study Indication|0|||
163143355|NCT02159066|589235140|FG004|Part I|New Therapy for Study Indication|0|||
163143356|NCT02159066|589235141|FG005|Part I|New Therapy for Study Indication|0|||
163143357|NCT02159066|589235136|FG000|Part I|Termination of participants from the study|3|||
163143358|NCT02159066|589235137|FG001|Part I|Termination of participants from the study|3|||
163143359|NCT02159066|589235138|FG002|Part I|Termination of participants from the study|0|||
163143360|NCT02159066|589235139|FG003|Part I|Termination of participants from the study|0|||
163143361|NCT02159066|589235140|FG004|Part I|Termination of participants from the study|0|||
163143362|NCT02159066|589235141|FG005|Part I|Termination of participants from the study|0|||
163143363|NCT02159066|589235136|FG000|Part I|Physician Decision|2|||
163143364|NCT02159066|589235137|FG001|Part I|Physician Decision|9|||
163236541|NCT03655236|589575243|FG000|Subject Disposition in Part 2 Period|Other|1|||
163143365|NCT02159066|589235138|FG002|Part I|Physician Decision|0|||
163143366|NCT02159066|589235139|FG003|Part I|Physician Decision|0|||
163143367|NCT02159066|589235140|FG004|Part I|Physician Decision|0|||
163143368|NCT02159066|589235141|FG005|Part I|Physician Decision|0|||
163143369|NCT02159066|589235136|FG000|Part I|Participant/Guardian Decision|9|||
163143370|NCT02159066|589235137|FG001|Part I|Participant/Guardian Decision|3|||
163143371|NCT02159066|589235138|FG002|Part I|Participant/Guardian Decision|0|||
163143372|NCT02159066|589235139|FG003|Part I|Participant/Guardian Decision|0|||
163143373|NCT02159066|589235140|FG004|Part I|Participant/Guardian Decision|0|||
163236542|NCT03655236|589575244|FG001|Subject Disposition in Part 2 Period|Other|0|||
163236543|NCT03655236|589575245|FG002|Subject Disposition in Part 2 Period|Other|0|||
163236544|NCT06748040|589575246|FG000|Overall Study|Death|3|||
163236545|NCT06748040|589575247|FG001|Overall Study|Death|4|||
163236546|NCT06748040|589575246|FG000|Overall Study|Lost to Follow-up|134|||
163236547|NCT06748040|589575247|FG001|Overall Study|Lost to Follow-up|132|||
163236548|NCT06748040|589575246|FG000|Overall Study|Withdrawal by Subject|3|||
163236549|NCT06748040|589575247|FG001|Overall Study|Withdrawal by Subject|5|||
163236550|NCT02807948|589577462|FG000|Overall Study|Physician Decision|1|||
163236551|NCT02807948|589577463|FG001|Overall Study|Physician Decision|0|||
163236552|NCT03727750|589577464|FG000|Overall Study|Death|45|||
163236553|NCT03727750|589577464|FG000|Overall Study|Withdrawal by Subject|2|||
163236554|NCT03727750|589577464|FG000|Overall Study|Lost to Follow-up|1|||
163236555|NCT03727750|589577464|FG000|Overall Study|Other|1|||
163236556|NCT01375049|589577465|FG000|Overall Study|Adverse Event|2|||
163236557|NCT01375049|589577465|FG000|Overall Study|Lost to Follow-up|1|||
163236558|NCT01375049|589577465|FG000|Overall Study|Withdrawal by Subject|2|||
163236559|NCT01375049|589577465|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
163236560|NCT02082522|589577466|FG000|Overall Study|Sponsor termination|5|||
163349008|NCT01180790|589987093|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
163349009|NCT01180790|589987094|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
163236561|NCT02082522|589577467|FG001|Overall Study|Sponsor termination|3|||
163236562|NCT02082522|589577466|FG000|Overall Study|Withdrawal by Subject|2|||
163236563|NCT02082522|589577467|FG001|Overall Study|Withdrawal by Subject|4|||
163236564|NCT02082522|589577466|FG000|Overall Study|Death|1|||
163236565|NCT02082522|589577467|FG001|Overall Study|Death|0|||
163236566|NCT02082522|589577466|FG000|Overall Study|Lost to Follow-up|1|||
163236567|NCT02082522|589577467|FG001|Overall Study|Lost to Follow-up|0|||
163236568|NCT02082522|589577466|FG000|Overall Study|Physician Decision|3|||
163236569|NCT02082522|589577467|FG001|Overall Study|Physician Decision|1|||
163236570|NCT02082522|589577466|FG000|Overall Study|Disease progression|2|||
163236571|NCT02082522|589577467|FG001|Overall Study|Disease progression|2|||
163236572|NCT02082522|589577466|FG000|Overall Study|Chemotherapy change|1|||
163236573|NCT02082522|589577467|FG001|Overall Study|Chemotherapy change|3|||
163236574|NCT00633984|589577468|FG000|Overall Study|Lost to Follow-up|0|||
163236575|NCT00633984|589577469|FG001|Overall Study|Lost to Follow-up|6|||
163236576|NCT00633984|589577468|FG000|Overall Study|Withdrawal by Subject|8|||
163143374|NCT02159066|589235141|FG005|Part I|Participant/Guardian Decision|0|||
163143375|NCT02159066|589235136|FG000|Part I|Missing Data|1|||
163143376|NCT02159066|589235137|FG001|Part I|Missing Data|0|||
163143377|NCT02159066|589235138|FG002|Part I|Missing Data|0|||
163143378|NCT02159066|589235139|FG003|Part I|Missing Data|0|||
163143379|NCT02159066|589235140|FG004|Part I|Missing Data|0|||
163143380|NCT02159066|589235141|FG005|Part I|Missing Data|0|||
163236577|NCT00633984|589577469|FG001|Overall Study|Withdrawal by Subject|7|||
163349010|NCT01180790|589987095|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
163349011|NCT00655668|589987096|FG000|Overall Study|Adverse Event|6|||
163349012|NCT00655668|589987096|FG000|Overall Study|Death|5|||
163349013|NCT00655668|589987096|FG000|Overall Study|Disease Progression|27|||
163349014|NCT00655668|589987096|FG000|Overall Study|Study Terminated|9|||
163143381|NCT02159066|589235136|FG000|Part II|Adverse Event|0|||
163143382|NCT02159066|589235137|FG001|Part II|Adverse Event|0|||
163143383|NCT02159066|589235138|FG002|Part II|Adverse Event|1|||
163143384|NCT02159066|589235139|FG003|Part II|Adverse Event|0|||
163143385|NCT02159066|589235140|FG004|Part II|Adverse Event|1|||
163143386|NCT02159066|589235141|FG005|Part II|Adverse Event|1|||
163143387|NCT02159066|589235136|FG000|Part II|Death|0|||
163143388|NCT02159066|589235137|FG001|Part II|Death|0|||
163143389|NCT02159066|589235138|FG002|Part II|Death|1|||
163143390|NCT02159066|589235139|FG003|Part II|Death|0|||
163143391|NCT02159066|589235140|FG004|Part II|Death|2|||
163143392|NCT02159066|589235141|FG005|Part II|Death|1|||
163143393|NCT02159066|589235136|FG000|Part II|Progressive Disease|0|||
163143394|NCT02159066|589235137|FG001|Part II|Progressive Disease|0|||
163143395|NCT02159066|589235138|FG002|Part II|Progressive Disease|35|||
163143396|NCT02159066|589235139|FG003|Part II|Progressive Disease|1|||
163143397|NCT02159066|589235140|FG004|Part II|Progressive Disease|7|||
163143398|NCT02159066|589235141|FG005|Part II|Progressive Disease|4|||
163143399|NCT02159066|589235136|FG000|Part II|New Therapy for Study Indication|0|||
163236578|NCT00633984|589577468|FG000|Overall Study|Hospitalized|1|||
163236579|NCT00633984|589577469|FG001|Overall Study|Hospitalized|0|||
163236580|NCT02496884|589577470|FG000|Overall Study|Counted twice as enrolled|2|||
163236581|NCT02496884|589577471|FG001|Overall Study|Counted twice as enrolled|0|||
163236582|NCT02496884|589577472|FG002|Overall Study|Counted twice as enrolled|0|||
163143400|NCT02159066|589235137|FG001|Part II|New Therapy for Study Indication|0|||
163236583|NCT02496884|589577473|FG003|Overall Study|Counted twice as enrolled|0|||
163143401|NCT02159066|589235138|FG002|Part II|New Therapy for Study Indication|0|||
163143402|NCT02159066|589235139|FG003|Part II|New Therapy for Study Indication|0|||
163236584|NCT02496884|589577470|FG000|Overall Study|Withdrawal by Subject|0|||
163236585|NCT02496884|589577471|FG001|Overall Study|Withdrawal by Subject|3|||
163236586|NCT02496884|589577472|FG002|Overall Study|Withdrawal by Subject|0|||
163236587|NCT02496884|589577473|FG003|Overall Study|Withdrawal by Subject|0|||
163349015|NCT00655668|589987096|FG000|Overall Study|Other|1|||
163143403|NCT02159066|589235140|FG004|Part II|New Therapy for Study Indication|1|||
163143404|NCT02159066|589235141|FG005|Part II|New Therapy for Study Indication|0|||
163143405|NCT02159066|589235136|FG000|Part II|Physician Decision|0|||
163143406|NCT02159066|589235137|FG001|Part II|Physician Decision|0|||
163143407|NCT02159066|589235138|FG002|Part II|Physician Decision|1|||
163143408|NCT02159066|589235139|FG003|Part II|Physician Decision|0|||
163143409|NCT02159066|589235140|FG004|Part II|Physician Decision|0|||
163143410|NCT02159066|589235141|FG005|Part II|Physician Decision|0|||
163236588|NCT01168999|589577474|FG000|Overall Study|Lost to Follow-up|2|||
163236589|NCT01168999|589577475|FG001|Overall Study|Lost to Follow-up|1|||
163236590|NCT01168999|589577476|FG002|Overall Study|Lost to Follow-up|0|||
163236591|NCT01168999|589577477|FG003|Overall Study|Lost to Follow-up|0|||
163236592|NCT03766646|589577478|FG000|Overall Study|Withdrawal by Subject|1|||
163236593|NCT03766646|589577479|FG001|Overall Study|Withdrawal by Subject|0|||
163236594|NCT03766646|589577478|FG000|Overall Study|Protocol Violation|0|||
163236595|NCT03766646|589577479|FG001|Overall Study|Protocol Violation|3|||
163236596|NCT02530619|589577489|FG000|Registered for Study|Withdrawal by Subject|2|||
163236597|NCT02530619|589577489|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
163236598|NCT02530619|589577489|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
163236599|NCT02530619|589577489|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
163236600|NCT02530619|589577489|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
163236601|NCT02530619|589577489|FG000|Follow-up Period (6 Months)|Death|4|||
163236602|NCT02530619|589577489|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
163236603|NCT02530619|589577489|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
163236604|NCT01854554|589577493|FG000|Overall Study|Denial of Insurance Coverage|12|||
163236605|NCT01854554|589577494|FG001|Overall Study|Denial of Insurance Coverage|0|||
163236606|NCT01854554|589577493|FG000|Overall Study|Decided to get treatment locally|1|||
163236607|NCT01854554|589577494|FG001|Overall Study|Decided to get treatment locally|5|||
163236608|NCT01854554|589577493|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
163143411|NCT02159066|589235136|FG000|Part II|Participant/Guardian Decision|0|||
163143412|NCT02159066|589235137|FG001|Part II|Participant/Guardian Decision|0|||
163143413|NCT02159066|589235138|FG002|Part II|Participant/Guardian Decision|0|||
163143414|NCT02159066|589235139|FG003|Part II|Participant/Guardian Decision|0|||
163143415|NCT02159066|589235140|FG004|Part II|Participant/Guardian Decision|2|||
163143416|NCT02159066|589235141|FG005|Part II|Participant/Guardian Decision|0|||
163143417|NCT00255190|589235143|FG000|Overall Study|Adverse Event|17|||
163143418|NCT00255190|589235144|FG001|Overall Study|Adverse Event|36|||
163236609|NCT01854554|589577494|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
163236610|NCT01854554|589577493|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
163236611|NCT01854554|589577494|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
163236612|NCT01854554|589577493|FG000|Overall Study|Progression|0|||
163236613|NCT01854554|589577494|FG001|Overall Study|Progression|1|||
163236614|NCT01854554|589577493|FG000|Overall Study|Lost to Follow-up|0|||
163236615|NCT01854554|589577494|FG001|Overall Study|Lost to Follow-up|1|||
163236616|NCT02819726|589577495|FG000|Part A (All Participants)|Lost to Follow-up|0|||
163236617|NCT02819726|589577496|FG001|Part A (All Participants)|Lost to Follow-up|1|||
163236618|NCT02819726|589577497|FG002|Part A (All Participants)|Lost to Follow-up|0|||
163236619|NCT02819726|589577498|FG003|Part A (All Participants)|Lost to Follow-up|0|||
163349016|NCT00655668|589987096|FG000|Overall Study|New Lymphoma Treatment Started|4|||
163349017|NCT00655668|589987096|FG000|Overall Study|Withdrawal by Subject|2|||
163349018|NCT02335242|589987097|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
163349019|NCT02335242|589987098|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
163349020|NCT02335242|589987097|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
163143419|NCT00255190|589235143|FG000|Overall Study|Protocol Violation|2|||
163143420|NCT00255190|589235144|FG001|Overall Study|Protocol Violation|2|||
163143421|NCT00255190|589235143|FG000|Overall Study|Lost to Follow-up|10|||
163349021|NCT02335242|589987098|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163349022|NCT02335242|589987097|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
163349023|NCT02335242|589987098|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
163143422|NCT00255190|589235144|FG001|Overall Study|Lost to Follow-up|27|||
163143423|NCT00255190|589235143|FG000|Overall Study|Withdrew Consent|17|||
163236620|NCT02819726|589577495|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
163236621|NCT02819726|589577496|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
163236622|NCT02819726|589577497|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
163236623|NCT02819726|589577498|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
163236624|NCT02819726|589577495|FG000|Part A (All Participants)|Protocol non-compliance|3|||
163236625|NCT02819726|589577496|FG001|Part A (All Participants)|Protocol non-compliance|4|||
163349024|NCT04167085|589987099|FG000|Baseline|Withdrawal by Subject|2|||
163349025|NCT04167085|589987100|FG001|Baseline|Withdrawal by Subject|1|||
163349026|NCT04167085|589987099|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
163349027|NCT04167085|589987100|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
163349028|NCT03840148|589987101|FG000|Study Drug Disposition|Adverse Event|13|||
163349029|NCT03840148|589987102|FG001|Study Drug Disposition|Adverse Event|2|||
163143424|NCT00255190|589235144|FG001|Overall Study|Withdrew Consent|48|||
163143425|NCT00255190|589235143|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
163143426|NCT00255190|589235144|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
163143427|NCT00255190|589235143|FG000|Overall Study|Erosive esophagitis not healed|0|||
163143428|NCT00255190|589235144|FG001|Overall Study|Erosive esophagitis not healed|20|||
163143429|NCT00255190|589235143|FG000|Overall Study|Various|4|||
163143430|NCT00255190|589235144|FG001|Overall Study|Various|23|||
163143431|NCT00628030|589235145|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
163143432|NCT00628030|589235146|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
163143433|NCT00628030|589235145|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
163143434|NCT00628030|589235146|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
163409620|NCT04478708|590209446|FG005|Overall Study|Withdrawal of consent from study|1|||
163409621|NCT04478708|590209447|FG006|Overall Study|Withdrawal of consent from study|1|||
163409622|NCT04478708|590209448|FG007|Overall Study|Withdrawal of consent from study|0|||
163409623|NCT04478708|590209449|FG008|Overall Study|Withdrawal of consent from study|0|||
163409624|NCT04478708|590209450|FG009|Overall Study|Withdrawal of consent from study|0|||
163409625|NCT04478708|590209451|FG010|Overall Study|Withdrawal of consent from study|4|||
163409626|NCT04478708|590209452|FG011|Overall Study|Withdrawal of consent from study|3|||
163143435|NCT00628030|589235145|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
163143436|NCT00628030|589235146|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
163143437|NCT01255423|589235147|FG000|Overall Study|Abnormal Laboratory value|3|||
163143438|NCT01255423|589235148|FG001|Overall Study|Abnormal Laboratory value|2|||
163143439|NCT01255423|589235147|FG000|Overall Study|Use of prohibited medications|0|||
163236626|NCT02819726|589577497|FG002|Part A (All Participants)|Protocol non-compliance|5|||
163236627|NCT02819726|589577498|FG003|Part A (All Participants)|Protocol non-compliance|0|||
163236628|NCT02819726|589577495|FG000|Part B (All Participants)|Lost to Follow-up|1|||
163236629|NCT02819726|589577496|FG001|Part B (All Participants)|Lost to Follow-up|1|||
163236630|NCT02819726|589577497|FG002|Part B (All Participants)|Lost to Follow-up|2|||
163236631|NCT02819726|589577498|FG003|Part B (All Participants)|Lost to Follow-up|2|||
163236632|NCT02819726|589577495|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
163236633|NCT02819726|589577496|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
163236634|NCT02819726|589577497|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
163236635|NCT02819726|589577498|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
163236636|NCT02819726|589577495|FG000|Part B (All Participants)|Protocol non-compliance|0|||
163236637|NCT02819726|589577496|FG001|Part B (All Participants)|Protocol non-compliance|0|||
163236638|NCT02819726|589577497|FG002|Part B (All Participants)|Protocol non-compliance|1|||
163236639|NCT02819726|589577498|FG003|Part B (All Participants)|Protocol non-compliance|0|||
163236640|NCT00359762|589577499|FG000|Period II|Adverse Event|17|||
163236641|NCT00359762|589577500|FG001|Period II|Adverse Event|0|||
163236642|NCT00359762|589577501|FG002|Period II|Adverse Event|0|||
163409627|NCT04478708|590209453|FG012|Overall Study|Withdrawal of consent from study|0|||
163143440|NCT01255423|589235148|FG001|Overall Study|Use of prohibited medications|1|||
163143441|NCT05470387|589235149|FG000|Overall Study|Protocol Violation|0|||
163143442|NCT05470387|589235150|FG001|Overall Study|Protocol Violation|3|||
163143443|NCT02366195|589235153|FG000|Overall Study|Protocol-specified criteria|3|||
163143444|NCT02366195|589235153|FG000|Overall Study|Withdrawal by Subject|9|||
163143445|NCT02366195|589235153|FG000|Overall Study|Lost to Follow-up|1|||
163143446|NCT02366195|589235153|FG000|Overall Study|Death|41|||
163143447|NCT01894607|589235163|FG000|Overall Study|Ineligible|1|||
163143448|NCT01787461|589235170|FG000|Overall Study|Adverse Event|4|||
163143449|NCT01787461|589235171|FG001|Overall Study|Adverse Event|3|||
163143450|NCT01787461|589235170|FG000|Overall Study|Lost to Follow-up|3|||
163143451|NCT01787461|589235171|FG001|Overall Study|Lost to Follow-up|2|||
163143452|NCT01787461|589235170|FG000|Overall Study|No longer met eligibility criteria|1|||
163143453|NCT01787461|589235171|FG001|Overall Study|No longer met eligibility criteria|0|||
163143454|NCT01787461|589235170|FG000|Overall Study|Withdrawal by Subject|3|||
163143455|NCT01787461|589235171|FG001|Overall Study|Withdrawal by Subject|4|||
163143456|NCT01787461|589235170|FG000|Overall Study|Protocol Violation|3|||
163143457|NCT01787461|589235171|FG001|Overall Study|Protocol Violation|0|||
163143458|NCT03259555|589235172|FG000|Overall Study|Adverse Event|6|||
163143459|NCT03259555|589235173|FG001|Overall Study|Adverse Event|4|||
163143460|NCT03259555|589235172|FG000|Overall Study|Lack of Efficacy|6|||
163143461|NCT03259555|589235173|FG001|Overall Study|Lack of Efficacy|4|||
163143462|NCT03259555|589235172|FG000|Overall Study|Lost to Follow-up|0|||
163143463|NCT03259555|589235173|FG001|Overall Study|Lost to Follow-up|2|||
163409628|NCT04478708|590209454|FG013|Overall Study|Withdrawal of consent from study|0|||
163409629|NCT04478708|590209455|FG014|Overall Study|Withdrawal of consent from study|1|||
163143464|NCT03259555|589235172|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163143465|NCT03259555|589235173|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163143466|NCT03259555|589235172|FG000|Overall Study|Progressive Disease|0|||
163143467|NCT03259555|589235173|FG001|Overall Study|Progressive Disease|2|||
163236643|NCT00359762|589577502|FG003|Period II|Adverse Event|0|||
163143468|NCT03259555|589235172|FG000|Overall Study|Withdrawal by Subject|19|||
163143469|NCT03259555|589235173|FG001|Overall Study|Withdrawal by Subject|16|||
163143470|NCT03259555|589235172|FG000|Overall Study|Physician Decision|1|||
163143471|NCT03259555|589235173|FG001|Overall Study|Physician Decision|2|||
163143472|NCT03259555|589235172|FG000|Overall Study|Other|1|||
163143473|NCT03259555|589235173|FG001|Overall Study|Other|0|||
163143474|NCT02800863|589235174|FG000|Overall Study|Adverse Event|14|||
163143475|NCT02800863|589235174|FG000|Overall Study|Another Device Implanted|1|||
163143476|NCT02800863|589235174|FG000|Overall Study|Device Explanted|1|||
163143477|NCT02800863|589235174|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
163143478|NCT02800863|589235174|FG000|Overall Study|Health Issues|1|||
163143479|NCT02800863|589235174|FG000|Overall Study|Insurance Denial|8|||
163143480|NCT02800863|589235174|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
163143481|NCT02800863|589235174|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
163143482|NCT02800863|589235174|FG000|Overall Study|Screen Failure|1|||
163143483|NCT02800863|589235174|FG000|Overall Study|Sponsor Request|6|||
163143484|NCT02800863|589235174|FG000|Overall Study|Death|3|||
163143485|NCT02800863|589235174|FG000|Overall Study|Subject Implant at Another Facility|1|||
163143486|NCT02800863|589235174|FG000|Overall Study|Lost to Follow-up|26|||
163143487|NCT02800863|589235174|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
163143488|NCT02800863|589235174|FG000|Overall Study|Subject and/or Family Request|64|||
163143489|NCT02800863|589235174|FG000|Overall Study|Trial Failure|81|||
163143490|NCT02800863|589235174|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
163143491|NCT03957551|589235175|FG000|Overall Study|Adverse Event|2|||
163143492|NCT03957551|589235176|FG001|Overall Study|Adverse Event|2|||
163143493|NCT03957551|589235177|FG002|Overall Study|Adverse Event|6|||
163143494|NCT03957551|589235175|FG000|Overall Study|Physician Decision|1|||
163143495|NCT03957551|589235176|FG001|Overall Study|Physician Decision|0|||
163143496|NCT03957551|589235177|FG002|Overall Study|Physician Decision|2|||
163143497|NCT03957551|589235175|FG000|Overall Study|Withdrawal by Subject|1|||
163143498|NCT03957551|589235176|FG001|Overall Study|Withdrawal by Subject|0|||
163143499|NCT03957551|589235177|FG002|Overall Study|Withdrawal by Subject|2|||
163143500|NCT03957551|589235175|FG000|Overall Study|Disease progression|1|||
163143501|NCT03957551|589235176|FG001|Overall Study|Disease progression|0|||
163143502|NCT03957551|589235177|FG002|Overall Study|Disease progression|8|||
163143503|NCT00607087|589235178|FG000|Overall Study|Withdrawal by Subject|9|||
163143504|NCT00607087|589235179|FG001|Overall Study|Withdrawal by Subject|4|||
163143505|NCT00607087|589235180|FG002|Overall Study|Withdrawal by Subject|4|||
163143506|NCT00607087|589235178|FG000|Overall Study|Adverse Event|3|||
163143507|NCT00607087|589235179|FG001|Overall Study|Adverse Event|2|||
163143508|NCT00607087|589235180|FG002|Overall Study|Adverse Event|3|||
163143509|NCT00607087|589235178|FG000|Overall Study|Other reason|1|||
163143510|NCT00607087|589235179|FG001|Overall Study|Other reason|5|||
163143511|NCT00607087|589235180|FG002|Overall Study|Other reason|2|||
163143512|NCT00607087|589235178|FG000|Overall Study|Poor compliance to protocol|1|||
163143513|NCT00607087|589235179|FG001|Overall Study|Poor compliance to protocol|0|||
163143514|NCT00607087|589235180|FG002|Overall Study|Poor compliance to protocol|1|||
163143515|NCT00607087|589235178|FG000|Overall Study|Lost to Follow-up|1|||
163143516|NCT00607087|589235179|FG001|Overall Study|Lost to Follow-up|0|||
163143517|NCT00607087|589235180|FG002|Overall Study|Lost to Follow-up|0|||
163143518|NCT00607087|589235178|FG000|Period 1|Withdrawal by Subject|7|||
163143519|NCT00607087|589235179|FG001|Period 1|Withdrawal by Subject|2|||
163143520|NCT00607087|589235180|FG002|Period 1|Withdrawal by Subject|3|||
163143521|NCT00607087|589235178|FG000|Period 1|Adverse Event|3|||
163143522|NCT00607087|589235179|FG001|Period 1|Adverse Event|0|||
163143523|NCT00607087|589235180|FG002|Period 1|Adverse Event|0|||
163143524|NCT00607087|589235178|FG000|Period 1|Poor compliance to protocol|1|||
163143525|NCT00607087|589235179|FG001|Period 1|Poor compliance to protocol|0|||
163143526|NCT00607087|589235180|FG002|Period 1|Poor compliance to protocol|0|||
163143527|NCT00607087|589235178|FG000|Period 1|Lost to Follow-up|1|||
163143528|NCT00607087|589235179|FG001|Period 1|Lost to Follow-up|0|||
163143529|NCT00607087|589235180|FG002|Period 1|Lost to Follow-up|0|||
163143530|NCT00607087|589235178|FG000|Period 1|Other reason|0|||
163143531|NCT00607087|589235179|FG001|Period 1|Other reason|4|||
163143532|NCT00607087|589235180|FG002|Period 1|Other reason|2|||
163143533|NCT00607087|589235178|FG000|Period 2|Withdrawal by Subject|0|||
163143534|NCT00607087|589235179|FG001|Period 2|Withdrawal by Subject|1|||
163143535|NCT00607087|589235180|FG002|Period 2|Withdrawal by Subject|1|||
163143536|NCT00607087|589235178|FG000|Period 2|Other reason|1|||
163143537|NCT00607087|589235179|FG001|Period 2|Other reason|1|||
163143538|NCT00607087|589235180|FG002|Period 2|Other reason|0|||
163143539|NCT00607087|589235178|FG000|Period 2|Adverse Event|0|||
163143540|NCT00607087|589235179|FG001|Period 2|Adverse Event|1|||
163143541|NCT00607087|589235180|FG002|Period 2|Adverse Event|3|||
163236644|NCT00359762|589577503|FG004|Period II|Adverse Event|49|||
163143542|NCT00607087|589235178|FG000|Period 2|Poor compliance to protocol|0|||
163236645|NCT00359762|589577499|FG000|Period II|Protocol Violation|18|||
163236646|NCT00359762|589577500|FG001|Period II|Protocol Violation|0|||
163236647|NCT00359762|589577501|FG002|Period II|Protocol Violation|0|||
163236648|NCT00359762|589577502|FG003|Period II|Protocol Violation|0|||
163236649|NCT00359762|589577503|FG004|Period II|Protocol Violation|11|||
163236650|NCT00359762|589577499|FG000|Period II|Physician Decision|17|||
163143543|NCT00607087|589235179|FG001|Period 2|Poor compliance to protocol|0|||
163143544|NCT00607087|589235180|FG002|Period 2|Poor compliance to protocol|1|||
163143545|NCT00607087|589235178|FG000|Period 3|Withdrawal by Subject|2|||
163143546|NCT00607087|589235179|FG001|Period 3|Withdrawal by Subject|1|||
163143547|NCT00607087|589235180|FG002|Period 3|Withdrawal by Subject|0|||
163143548|NCT00607087|589235178|FG000|Period 3|Adverse Event|0|||
163143549|NCT00607087|589235179|FG001|Period 3|Adverse Event|1|||
163143550|NCT00607087|589235180|FG002|Period 3|Adverse Event|0|||
163143551|NCT02717494|589235183|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
163143552|NCT02717494|589235184|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
163143553|NCT02717494|589235185|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
163143554|NCT02717494|589235183|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
163143555|NCT02717494|589235184|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
163236651|NCT00359762|589577500|FG001|Period II|Physician Decision|0|||
163236652|NCT00359762|589577501|FG002|Period II|Physician Decision|0|||
163236653|NCT00359762|589577502|FG003|Period II|Physician Decision|0|||
163236654|NCT00359762|589577503|FG004|Period II|Physician Decision|23|||
163236655|NCT00359762|589577499|FG000|Period II|Death|2|||
163236656|NCT00359762|589577500|FG001|Period II|Death|0|||
163236657|NCT00359762|589577501|FG002|Period II|Death|0|||
163236658|NCT00359762|589577502|FG003|Period II|Death|0|||
163236659|NCT00359762|589577503|FG004|Period II|Death|4|||
163236660|NCT00359762|589577499|FG000|Period II|Lack of Efficacy|11|||
163236661|NCT00359762|589577500|FG001|Period II|Lack of Efficacy|0|||
163236662|NCT00359762|589577501|FG002|Period II|Lack of Efficacy|0|||
163236663|NCT00359762|589577502|FG003|Period II|Lack of Efficacy|0|||
163236664|NCT00359762|589577503|FG004|Period II|Lack of Efficacy|8|||
163236665|NCT00359762|589577499|FG000|Period II|Lost to follow up|5|||
163236666|NCT00359762|589577500|FG001|Period II|Lost to follow up|0|||
163236667|NCT00359762|589577501|FG002|Period II|Lost to follow up|0|||
163236668|NCT00359762|589577502|FG003|Period II|Lost to follow up|0|||
163236669|NCT00359762|589577503|FG004|Period II|Lost to follow up|5|||
163236670|NCT00359762|589577499|FG000|Period II|Entry Criteria Not Met|8|||
163236671|NCT00359762|589577500|FG001|Period II|Entry Criteria Not Met|0|||
163236672|NCT00359762|589577501|FG002|Period II|Entry Criteria Not Met|0|||
163236673|NCT00359762|589577502|FG003|Period II|Entry Criteria Not Met|0|||
163236674|NCT00359762|589577503|FG004|Period II|Entry Criteria Not Met|4|||
163236675|NCT00359762|589577499|FG000|Period II|Subject Decision|50|||
163236676|NCT00359762|589577500|FG001|Period II|Subject Decision|0|||
163236677|NCT00359762|589577501|FG002|Period II|Subject Decision|0|||
163236678|NCT00359762|589577502|FG003|Period II|Subject Decision|0|||
163236679|NCT00359762|589577503|FG004|Period II|Subject Decision|70|||
163236680|NCT00359762|589577499|FG000|Period III|Protocol Violation|0|||
163236681|NCT00359762|589577500|FG001|Period III|Protocol Violation|5|||
163236682|NCT00359762|589577501|FG002|Period III|Protocol Violation|3|||
163236683|NCT00359762|589577502|FG003|Period III|Protocol Violation|8|||
163236684|NCT00359762|589577503|FG004|Period III|Protocol Violation|0|||
163236685|NCT00359762|589577499|FG000|Period III|Adverse Event|0|||
163236686|NCT00359762|589577500|FG001|Period III|Adverse Event|3|||
163236687|NCT00359762|589577501|FG002|Period III|Adverse Event|4|||
163236688|NCT00359762|589577502|FG003|Period III|Adverse Event|10|||
163236689|NCT00359762|589577503|FG004|Period III|Adverse Event|0|||
163236690|NCT00359762|589577499|FG000|Period III|Physician Decision|0|||
163236691|NCT00359762|589577500|FG001|Period III|Physician Decision|5|||
163236692|NCT00359762|589577501|FG002|Period III|Physician Decision|9|||
163236693|NCT00359762|589577502|FG003|Period III|Physician Decision|15|||
163236694|NCT00359762|589577503|FG004|Period III|Physician Decision|0|||
163143556|NCT02717494|589235185|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
163143557|NCT02717494|589235183|FG000|First Intervention (Step 1)|Death|0|||
163236695|NCT00359762|589577499|FG000|Period III|Lack of Efficacy|0|||
163236696|NCT00359762|589577500|FG001|Period III|Lack of Efficacy|7|||
163236697|NCT00359762|589577501|FG002|Period III|Lack of Efficacy|5|||
163236698|NCT00359762|589577502|FG003|Period III|Lack of Efficacy|9|||
163236699|NCT00359762|589577503|FG004|Period III|Lack of Efficacy|0|||
163236700|NCT00359762|589577499|FG000|Period III|Lost to follow up|0|||
163236701|NCT00359762|589577500|FG001|Period III|Lost to follow up|1|||
163236702|NCT00359762|589577501|FG002|Period III|Lost to follow up|1|||
163236703|NCT00359762|589577502|FG003|Period III|Lost to follow up|2|||
163236704|NCT00359762|589577503|FG004|Period III|Lost to follow up|0|||
163236705|NCT00359762|589577499|FG000|Period III|Entry Criteria Not Met|0|||
163236706|NCT00359762|589577500|FG001|Period III|Entry Criteria Not Met|1|||
163236707|NCT00359762|589577501|FG002|Period III|Entry Criteria Not Met|0|||
163236708|NCT00359762|589577502|FG003|Period III|Entry Criteria Not Met|1|||
163143558|NCT02717494|589235184|FG001|First Intervention (Step 1)|Death|0|||
163143559|NCT02717494|589235185|FG002|First Intervention (Step 1)|Death|1|||
163143560|NCT02717494|589235183|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
163236709|NCT00359762|589577503|FG004|Period III|Entry Criteria Not Met|0|||
163236710|NCT00359762|589577499|FG000|Period III|Subject Decision|0|||
163236711|NCT00359762|589577500|FG001|Period III|Subject Decision|7|||
163236712|NCT00359762|589577501|FG002|Period III|Subject Decision|8|||
163236713|NCT00359762|589577502|FG003|Period III|Subject Decision|20|||
163236714|NCT00359762|589577503|FG004|Period III|Subject Decision|0|||
163236715|NCT02647658|589577506|FG000|Overall Study|Consent refusal|15|||
163236716|NCT02647658|589577507|FG001|Overall Study|Consent refusal|24|||
163236717|NCT00803023|589577508|FG000|Overall Study|Adverse Event|5|||
163236718|NCT00803023|589577509|FG001|Overall Study|Adverse Event|4|||
163236719|NCT00803023|589577510|FG002|Overall Study|Adverse Event|8|||
163236720|NCT00803023|589577511|FG003|Overall Study|Adverse Event|6|||
163236721|NCT00803023|589577508|FG000|Overall Study|Withdrawal by Subject|0|||
163236722|NCT00803023|589577509|FG001|Overall Study|Withdrawal by Subject|2|||
163236723|NCT00803023|589577510|FG002|Overall Study|Withdrawal by Subject|0|||
163236724|NCT00803023|589577511|FG003|Overall Study|Withdrawal by Subject|0|||
163236725|NCT00803023|589577508|FG000|Overall Study|Lost to Follow-up|0|||
163236726|NCT00803023|589577509|FG001|Overall Study|Lost to Follow-up|1|||
163236727|NCT00803023|589577510|FG002|Overall Study|Lost to Follow-up|2|||
163236728|NCT00803023|589577511|FG003|Overall Study|Lost to Follow-up|1|||
163236729|NCT00803023|589577508|FG000|Overall Study|Lack of Efficacy|0|||
163236730|NCT00803023|589577509|FG001|Overall Study|Lack of Efficacy|1|||
163236731|NCT00803023|589577510|FG002|Overall Study|Lack of Efficacy|1|||
163236732|NCT00803023|589577511|FG003|Overall Study|Lack of Efficacy|1|||
163236733|NCT02461589|589577512|FG000|Overall Study|Withdrawal by Subject|5|||
163236734|NCT02461589|589577513|FG001|Overall Study|Withdrawal by Subject|1|||
163236735|NCT02461589|589577514|FG002|Overall Study|Withdrawal by Subject|3|||
163236736|NCT02461589|589577515|FG003|Overall Study|Withdrawal by Subject|2|||
163236737|NCT02461589|589577516|FG004|Overall Study|Withdrawal by Subject|1|||
163236738|NCT02461589|589577517|FG005|Overall Study|Withdrawal by Subject|2|||
163236739|NCT02461589|589577518|FG006|Overall Study|Withdrawal by Subject|1|||
163236740|NCT02461589|589577519|FG007|Overall Study|Withdrawal by Subject|3|||
163236741|NCT02461589|589577520|FG008|Overall Study|Withdrawal by Subject|3|||
163236742|NCT02461589|589577521|FG009|Overall Study|Withdrawal by Subject|1|||
163236743|NCT02461589|589577512|FG000|Overall Study|Lost to Follow-up|0|||
163236744|NCT02461589|589577513|FG001|Overall Study|Lost to Follow-up|0|||
163236745|NCT02461589|589577514|FG002|Overall Study|Lost to Follow-up|2|||
163236746|NCT02461589|589577515|FG003|Overall Study|Lost to Follow-up|3|||
163236747|NCT02461589|589577516|FG004|Overall Study|Lost to Follow-up|1|||
163236748|NCT02461589|589577517|FG005|Overall Study|Lost to Follow-up|1|||
163236749|NCT02461589|589577518|FG006|Overall Study|Lost to Follow-up|3|||
163236750|NCT02461589|589577519|FG007|Overall Study|Lost to Follow-up|1|||
163236751|NCT02461589|589577520|FG008|Overall Study|Lost to Follow-up|3|||
163236752|NCT02461589|589577521|FG009|Overall Study|Lost to Follow-up|1|||
163236753|NCT02461589|589577512|FG000|Overall Study|Death|0|||
163236754|NCT02461589|589577513|FG001|Overall Study|Death|0|||
163236755|NCT02461589|589577514|FG002|Overall Study|Death|0|||
163236756|NCT02461589|589577515|FG003|Overall Study|Death|0|||
163236757|NCT02461589|589577516|FG004|Overall Study|Death|0|||
163236758|NCT02461589|589577517|FG005|Overall Study|Death|0|||
163236759|NCT02461589|589577518|FG006|Overall Study|Death|0|||
163236760|NCT02461589|589577519|FG007|Overall Study|Death|1|||
163236761|NCT02461589|589577520|FG008|Overall Study|Death|0|||
163236762|NCT02461589|589577521|FG009|Overall Study|Death|0|||
163236763|NCT02461589|589577512|FG000|Overall Study|Unclassified|0|||
163236764|NCT02461589|589577513|FG001|Overall Study|Unclassified|0|||
163236765|NCT02461589|589577514|FG002|Overall Study|Unclassified|0|||
163236766|NCT02461589|589577515|FG003|Overall Study|Unclassified|0|||
163236767|NCT02461589|589577516|FG004|Overall Study|Unclassified|0|||
163236768|NCT02461589|589577517|FG005|Overall Study|Unclassified|0|||
163236769|NCT02461589|589577518|FG006|Overall Study|Unclassified|1|||
163236770|NCT02461589|589577519|FG007|Overall Study|Unclassified|0|||
163236771|NCT02461589|589577520|FG008|Overall Study|Unclassified|0|||
163236772|NCT02461589|589577521|FG009|Overall Study|Unclassified|2|||
163236773|NCT02461589|589577512|FG000|Overall Study|Missing follow-up information|1|||
163236774|NCT02461589|589577513|FG001|Overall Study|Missing follow-up information|1|||
163236775|NCT02461589|589577514|FG002|Overall Study|Missing follow-up information|0|||
163236776|NCT02461589|589577515|FG003|Overall Study|Missing follow-up information|0|||
163236777|NCT02461589|589577516|FG004|Overall Study|Missing follow-up information|0|||
163236778|NCT02461589|589577517|FG005|Overall Study|Missing follow-up information|0|||
163236779|NCT02461589|589577518|FG006|Overall Study|Missing follow-up information|1|||
163236780|NCT02461589|589577519|FG007|Overall Study|Missing follow-up information|0|||
163236781|NCT02461589|589577520|FG008|Overall Study|Missing follow-up information|0|||
163236782|NCT02461589|589577521|FG009|Overall Study|Missing follow-up information|0|||
163236783|NCT02461589|589577512|FG000|Overall Study|Withdrawal from trial before exposure|0|||
163236784|NCT02461589|589577513|FG001|Overall Study|Withdrawal from trial before exposure|0|||
163236785|NCT02461589|589577514|FG002|Overall Study|Withdrawal from trial before exposure|0|||
163236786|NCT02461589|589577515|FG003|Overall Study|Withdrawal from trial before exposure|0|||
163236787|NCT02461589|589577516|FG004|Overall Study|Withdrawal from trial before exposure|0|||
163236788|NCT02461589|589577517|FG005|Overall Study|Withdrawal from trial before exposure|0|||
163236789|NCT02461589|589577518|FG006|Overall Study|Withdrawal from trial before exposure|0|||
163236790|NCT02461589|589577519|FG007|Overall Study|Withdrawal from trial before exposure|0|||
163236791|NCT02461589|589577520|FG008|Overall Study|Withdrawal from trial before exposure|0|||
163236792|NCT02461589|589577521|FG009|Overall Study|Withdrawal from trial before exposure|1|||
163236793|NCT01978119|589577526|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
163236794|NCT01978119|589577527|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
163143561|NCT02717494|589235184|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
163143562|NCT02717494|589235185|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
163143563|NCT01774799|589235191|FG000|Overall Study|Lost to Follow-up|1|||
163143564|NCT01774799|589235192|FG001|Overall Study|Lost to Follow-up|1|||
163143565|NCT01774799|589235193|FG002|Overall Study|Lost to Follow-up|0|||
163143566|NCT01774799|589235194|FG003|Overall Study|Lost to Follow-up|0|||
163143567|NCT01125800|589235196|FG000|Phase I|Protocol Violation|0|||
163236795|NCT01978119|589577526|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
163236796|NCT01978119|589577527|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
163236797|NCT01978119|589577526|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163236798|NCT01978119|589577527|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
163236799|NCT03295201|589577530|FG000|Overall Study|Lost to Follow-up|1|||
163349030|NCT03840148|589987101|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
163349031|NCT03840148|589987102|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
163349032|NCT03840148|589987101|FG000|Study Drug Disposition|Lack of Efficacy|3|||
163349033|NCT03840148|589987102|FG001|Study Drug Disposition|Lack of Efficacy|0|||
163236800|NCT03295201|589577531|FG001|Overall Study|Lost to Follow-up|1|||
163236801|NCT03295201|589577530|FG000|Overall Study|Hospital admission|0|||
163236802|NCT03295201|589577531|FG001|Overall Study|Hospital admission|1|||
163236803|NCT02519504|589577532|FG000|Overall Study|Protocol Violation|6|||
163236804|NCT02519504|589577533|FG001|Overall Study|Protocol Violation|5|||
163236805|NCT02519504|589577532|FG000|Overall Study|Ineligible for direct testing|12|||
163236806|NCT02519504|589577533|FG001|Overall Study|Ineligible for direct testing|12|||
163236807|NCT02519504|589577532|FG000|Overall Study|Did not participate in direct testing|95|||
163236808|NCT02519504|589577533|FG001|Overall Study|Did not participate in direct testing|86|||
163236809|NCT02548962|589577534|FG000|Overall Study|Withdrawal by Subject|1|||
163236810|NCT02548962|589577535|FG001|Overall Study|Withdrawal by Subject|0|||
163236811|NCT01958918|589577539|FG000|Overall Study|Death|1|||
163236812|NCT01958918|589577540|FG001|Overall Study|Death|3|||
163236813|NCT01958918|589577539|FG000|Overall Study|Lost to Follow-up|4|||
163236814|NCT01958918|589577540|FG001|Overall Study|Lost to Follow-up|7|||
163236815|NCT01958918|589577539|FG000|Overall Study|Withdrawal by Subject|13|||
163236816|NCT01958918|589577540|FG001|Overall Study|Withdrawal by Subject|8|||
163236817|NCT01958918|589577539|FG000|Overall Study|Lack of Efficacy|13|||
163236818|NCT01958918|589577540|FG001|Overall Study|Lack of Efficacy|10|||
163236819|NCT01958918|589577539|FG000|Overall Study|Adverse Event|12|||
163236820|NCT01958918|589577540|FG001|Overall Study|Adverse Event|12|||
163236821|NCT01958918|589577539|FG000|Overall Study|administrative problems|0|||
163236822|NCT01958918|589577540|FG001|Overall Study|administrative problems|2|||
163236823|NCT00659269|589577544|FG000|Overall Study|Physician Decision|1|||
163236824|NCT00659269|589577545|FG001|Overall Study|Physician Decision|1|||
163236825|NCT00908960|589577547|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
163236826|NCT00908960|589577548|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
163236827|NCT00908960|589577549|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
163236828|NCT02401672|589577550|FG000|Overall Study|Withdrawal by Subject|1|||
163236829|NCT02401672|589577551|FG001|Overall Study|Withdrawal by Subject|3|||
163236830|NCT03653429|589577554|FG000|Overall Study|Physician Decision|4|||
163236831|NCT03653429|589577555|FG001|Overall Study|Physician Decision|10|||
163236832|NCT00403546|589577556|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
163236833|NCT00403546|589577557|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
163236834|NCT00403546|589577558|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
163236835|NCT00403546|589577556|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
163236836|NCT00403546|589577557|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
163236837|NCT00403546|589577558|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
163236838|NCT00403546|589577556|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
163236839|NCT00403546|589577557|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
163236840|NCT00403546|589577558|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
163349034|NCT03840148|589987101|FG000|Study Drug Disposition|Physician Decision|2|||
163349035|NCT03840148|589987102|FG001|Study Drug Disposition|Physician Decision|0|||
163236841|NCT00403546|589577556|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
163236842|NCT00403546|589577557|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
163236843|NCT00403546|589577558|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
163349036|NCT03840148|589987101|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
163236844|NCT00403546|589577556|FG000|Screening Phase|Screening Failure|22|||
163236845|NCT00403546|589577557|FG001|Screening Phase|Screening Failure|0|||
163143568|NCT01125800|589235197|FG001|Phase I|Protocol Violation|3|||
163143569|NCT01125800|589235198|FG002|Phase I|Protocol Violation|1|||
163236846|NCT00403546|589577558|FG002|Screening Phase|Screening Failure|0|||
163236847|NCT00403546|589577556|FG000|Screening Phase|Adverse Event|1|||
163236848|NCT00403546|589577557|FG001|Screening Phase|Adverse Event|0|||
163236849|NCT00403546|589577558|FG002|Screening Phase|Adverse Event|0|||
163236850|NCT00403546|589577556|FG000|Screening Phase|Terminated Prior to Randomization|5|||
163236851|NCT00403546|589577557|FG001|Screening Phase|Terminated Prior to Randomization|0|||
163236852|NCT00403546|589577558|FG002|Screening Phase|Terminated Prior to Randomization|0|||
163236853|NCT00403546|589577556|FG000|Randomized Trial|Early Terminations|0|||
163236854|NCT00403546|589577557|FG001|Randomized Trial|Early Terminations|17|||
163143570|NCT01125800|589235199|FG003|Phase I|Protocol Violation|1|||
163143571|NCT01125800|589235200|FG004|Phase I|Protocol Violation|0|||
163143572|NCT01125800|589235196|FG000|Phase I|Adverse Event|2|||
163143573|NCT01125800|589235197|FG001|Phase I|Adverse Event|2|||
163143574|NCT01125800|589235198|FG002|Phase I|Adverse Event|1|||
163143575|NCT01125800|589235199|FG003|Phase I|Adverse Event|7|||
163143576|NCT01125800|589235200|FG004|Phase I|Adverse Event|0|||
163143577|NCT01125800|589235196|FG000|Phase I|Administrative problems|1|||
163143578|NCT01125800|589235197|FG001|Phase I|Administrative problems|0|||
163143579|NCT01125800|589235198|FG002|Phase I|Administrative problems|0|||
163143580|NCT01125800|589235199|FG003|Phase I|Administrative problems|0|||
163143581|NCT01125800|589235200|FG004|Phase I|Administrative problems|0|||
163143582|NCT01125800|589235196|FG000|Phase I|Withdrawal by Subject|0|||
163143583|NCT01125800|589235197|FG001|Phase I|Withdrawal by Subject|0|||
163143584|NCT01125800|589235198|FG002|Phase I|Withdrawal by Subject|1|||
163143585|NCT01125800|589235199|FG003|Phase I|Withdrawal by Subject|0|||
163143586|NCT01125800|589235200|FG004|Phase I|Withdrawal by Subject|0|||
163143587|NCT01125800|589235196|FG000|Phase I|Disease progression|5|||
163143588|NCT01125800|589235197|FG001|Phase I|Disease progression|4|||
163143589|NCT01125800|589235198|FG002|Phase I|Disease progression|1|||
163143590|NCT01125800|589235199|FG003|Phase I|Disease progression|3|||
163143591|NCT01125800|589235200|FG004|Phase I|Disease progression|0|||
163143592|NCT01125800|589235196|FG000|Phase II|Protocol Violation|0|||
163143593|NCT01125800|589235197|FG001|Phase II|Protocol Violation|0|||
163143594|NCT01125800|589235198|FG002|Phase II|Protocol Violation|0|||
163143595|NCT01125800|589235199|FG003|Phase II|Protocol Violation|0|||
163143596|NCT01125800|589235200|FG004|Phase II|Protocol Violation|1|||
163143597|NCT01125800|589235196|FG000|Phase II|Adverse Event|0|||
163143598|NCT01125800|589235197|FG001|Phase II|Adverse Event|0|||
163143599|NCT01125800|589235198|FG002|Phase II|Adverse Event|0|||
163143600|NCT01125800|589235199|FG003|Phase II|Adverse Event|0|||
163143601|NCT01125800|589235200|FG004|Phase II|Adverse Event|2|||
163143602|NCT01125800|589235196|FG000|Phase II|Disease progression|0|||
163143603|NCT01125800|589235197|FG001|Phase II|Disease progression|0|||
163143604|NCT01125800|589235198|FG002|Phase II|Disease progression|0|||
163143605|NCT01125800|589235199|FG003|Phase II|Disease progression|1|||
163143606|NCT01125800|589235200|FG004|Phase II|Disease progression|8|||
163143607|NCT05051579|589235201|FG000|Overall Study|Withdrawal by Subject|3|||
163143608|NCT05051579|589235202|FG001|Overall Study|Withdrawal by Subject|5|||
163143609|NCT05051579|589235203|FG002|Overall Study|Withdrawal by Subject|2|||
163143610|NCT05051579|589235204|FG003|Overall Study|Withdrawal by Subject|1|||
163143611|NCT05051579|589235205|FG004|Overall Study|Withdrawal by Subject|4|||
163143612|NCT05051579|589235206|FG005|Overall Study|Withdrawal by Subject|0|||
163143613|NCT05051579|589235207|FG006|Overall Study|Withdrawal by Subject|4|||
163143614|NCT05051579|589235201|FG000|Overall Study|Lost to Follow-up|1|||
163143615|NCT05051579|589235202|FG001|Overall Study|Lost to Follow-up|0|||
163143616|NCT05051579|589235203|FG002|Overall Study|Lost to Follow-up|0|||
163143617|NCT05051579|589235204|FG003|Overall Study|Lost to Follow-up|0|||
163143618|NCT05051579|589235205|FG004|Overall Study|Lost to Follow-up|1|||
163143619|NCT05051579|589235206|FG005|Overall Study|Lost to Follow-up|0|||
163143620|NCT05051579|589235207|FG006|Overall Study|Lost to Follow-up|1|||
163143621|NCT05051579|589235201|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
163143622|NCT05051579|589235202|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
163143623|NCT05051579|589235203|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
163143624|NCT05051579|589235204|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
163143625|NCT05051579|589235205|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
163143626|NCT05051579|589235206|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
163143627|NCT05051579|589235207|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
163143628|NCT05051579|589235201|FG000|Overall Study|Adverse Event|2|||
163143629|NCT05051579|589235202|FG001|Overall Study|Adverse Event|1|||
163143630|NCT05051579|589235203|FG002|Overall Study|Adverse Event|0|||
163143631|NCT05051579|589235204|FG003|Overall Study|Adverse Event|4|||
163143632|NCT05051579|589235205|FG004|Overall Study|Adverse Event|1|||
163143633|NCT05051579|589235206|FG005|Overall Study|Adverse Event|2|||
163143634|NCT05051579|589235207|FG006|Overall Study|Adverse Event|0|||
163143635|NCT05051579|589235201|FG000|Overall Study|Inadvertent Enrollment|0|||
163143636|NCT05051579|589235202|FG001|Overall Study|Inadvertent Enrollment|0|||
163143637|NCT05051579|589235203|FG002|Overall Study|Inadvertent Enrollment|0|||
163236855|NCT00403546|589577558|FG002|Randomized Trial|Early Terminations|16|||
163236856|NCT00793910|589577562|FG000|Overall Study|discarded study pills|0|||
163349037|NCT03840148|589987102|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
163349038|NCT03840148|589987101|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
163349039|NCT03840148|589987102|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
163349040|NCT03840148|589987101|FG000|Study Completion Disposition|Physician Decision|2|||
163349041|NCT03840148|589987102|FG001|Study Completion Disposition|Physician Decision|0|||
163349042|NCT03840148|589987101|FG000|Study Completion Disposition|Covid-19 related|2|||
163349043|NCT03840148|589987102|FG001|Study Completion Disposition|Covid-19 related|0|||
163349044|NCT03840148|589987101|FG000|Study Completion Disposition|Lost to Follow-up|1|||
163143638|NCT05051579|589235204|FG003|Overall Study|Inadvertent Enrollment|0|||
163143639|NCT05051579|589235205|FG004|Overall Study|Inadvertent Enrollment|0|||
163143640|NCT05051579|589235206|FG005|Overall Study|Inadvertent Enrollment|0|||
163143641|NCT05051579|589235207|FG006|Overall Study|Inadvertent Enrollment|1|||
163143642|NCT05051579|589235201|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
163143643|NCT05051579|589235202|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
163143644|NCT05051579|589235203|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
163143645|NCT05051579|589235204|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
163143646|NCT05051579|589235205|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
163143647|NCT05051579|589235206|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
163143648|NCT05051579|589235207|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
163143649|NCT05051579|589235201|FG000|Overall Study|Sponsor Decision|0|||
163143650|NCT05051579|589235202|FG001|Overall Study|Sponsor Decision|0|||
163143651|NCT05051579|589235203|FG002|Overall Study|Sponsor Decision|0|||
163143652|NCT05051579|589235204|FG003|Overall Study|Sponsor Decision|0|||
163143653|NCT05051579|589235205|FG004|Overall Study|Sponsor Decision|1|||
163143654|NCT05051579|589235206|FG005|Overall Study|Sponsor Decision|0|||
163143655|NCT05051579|589235207|FG006|Overall Study|Sponsor Decision|0|||
163143656|NCT05051579|589235201|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
163143657|NCT05051579|589235202|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
163143658|NCT05051579|589235203|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
163143659|NCT05051579|589235204|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
163143660|NCT05051579|589235205|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
163143661|NCT05051579|589235206|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
163143662|NCT05051579|589235207|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
163143663|NCT01808196|589235210|FG000|Overall Study|Lost to Follow-up|1|||
163143664|NCT00479713|589235211|FG000|Overall Study|Adverse Event|8|||
163143665|NCT00479713|589235212|FG001|Overall Study|Adverse Event|6|||
163143666|NCT00479713|589235211|FG000|Overall Study|Death|1|||
163143667|NCT00479713|589235212|FG001|Overall Study|Death|0|||
163143668|NCT00479713|589235211|FG000|Overall Study|Lost to Follow-up|0|||
163143669|NCT00479713|589235212|FG001|Overall Study|Lost to Follow-up|1|||
163143670|NCT00479713|589235211|FG000|Overall Study|Protocol Violation|0|||
163143671|NCT00479713|589235212|FG001|Overall Study|Protocol Violation|1|||
163143672|NCT00479713|589235211|FG000|Overall Study|Withdrawal by Subject|4|||
163143673|NCT00479713|589235212|FG001|Overall Study|Withdrawal by Subject|1|||
163143674|NCT05274958|589235215|FG000|Overall Study|Only completed 1 set of PROMs|22|||
163143675|NCT05274958|589235216|FG001|Overall Study|Only completed 1 set of PROMs|35|||
163143676|NCT01505374|589235217|FG000|Overall Study|Lost to Follow-up|1|||
163143677|NCT01505374|589235218|FG001|Overall Study|Lost to Follow-up|0|||
163143678|NCT00176462|589235224|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
163143679|NCT00176462|589235225|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
163143680|NCT00176462|589235224|FG000|Induction (4 Weeks)|Death|1|||
163143681|NCT00176462|589235225|FG001|Induction (4 Weeks)|Death|2|||
163143682|NCT00176462|589235224|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
163143683|NCT00176462|589235225|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
163143684|NCT00176462|589235224|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
163143685|NCT00176462|589235225|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
163143686|NCT00176462|589235224|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
163143687|NCT00176462|589235225|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
163143688|NCT00176462|589235224|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
163143689|NCT00176462|589235225|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
163143690|NCT00176462|589235224|FG000|Consolidation (12 Weeks)|Not documented|0|||
163143691|NCT00176462|589235225|FG001|Consolidation (12 Weeks)|Not documented|1|||
163143692|NCT00176462|589235224|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
163143693|NCT00176462|589235225|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
163143694|NCT00176462|589235224|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
163143695|NCT00176462|589235225|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
163349045|NCT03840148|589987102|FG001|Study Completion Disposition|Lost to Follow-up|1|||
163349046|NCT03840148|589987101|FG000|Study Completion Disposition|Death|1|||
163409630|NCT04478708|590209456|FG015|Overall Study|Withdrawal of consent from study|0|||
163409631|NCT04478708|590209457|FG016|Overall Study|Withdrawal of consent from study|4|||
163409632|NCT01869114|590209458|FG000|Overall Study|Death|19|||
163409633|NCT01869114|590209459|FG001|Overall Study|Death|18|||
163143696|NCT02679287|589235228|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
163143697|NCT02679287|589235229|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
163143698|NCT02679287|589235228|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
163143699|NCT02679287|589235229|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
163409634|NCT01869114|590209460|FG002|Overall Study|Death|8|||
163409635|NCT01869114|590209458|FG000|Overall Study|Adverse Event/Side Effects/Complications|0|||
163409636|NCT01869114|590209459|FG001|Overall Study|Adverse Event/Side Effects/Complications|1|||
163409637|NCT01869114|590209460|FG002|Overall Study|Adverse Event/Side Effects/Complications|0|||
163409638|NCT01869114|590209458|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
163409639|NCT01869114|590209459|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
163409640|NCT01869114|590209460|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
163409641|NCT01869114|590209458|FG000|Overall Study|Withdrawal by Subject|0|||
163409642|NCT01869114|590209459|FG001|Overall Study|Withdrawal by Subject|3|||
163409643|NCT01869114|590209460|FG002|Overall Study|Withdrawal by Subject|0|||
163143700|NCT02679287|589235228|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
163143701|NCT02679287|589235229|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
163143702|NCT02679287|589235228|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
163143703|NCT02679287|589235229|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
163143704|NCT02679287|589235228|FG000|Period 2|Work/Scheduling Conflict|1|||
163143705|NCT02679287|589235229|FG001|Period 2|Work/Scheduling Conflict|0|||
163143706|NCT02679287|589235228|FG000|Period 2|Disliked Mobile System|2|||
163143707|NCT02679287|589235229|FG001|Period 2|Disliked Mobile System|0|||
163143708|NCT02679287|589235228|FG000|Period 3|Work/Scheduling Conflict|0|||
163143709|NCT02679287|589235229|FG001|Period 3|Work/Scheduling Conflict|1|||
163143710|NCT00320515|589235232|FG000|Overall Study|Death|33|||
163143711|NCT00320515|589235232|FG000|Overall Study|Lost to Follow-up|6|||
163143712|NCT00320515|589235232|FG000|Overall Study|Physician Decision|2|||
163143713|NCT00320515|589235232|FG000|Overall Study|Withdrawal by Subject|8|||
163143714|NCT01114828|589235233|FG000|Overall Study|Adverse Event|1|||
163143715|NCT01114828|589235234|FG001|Overall Study|Adverse Event|1|||
163143716|NCT01114828|589235233|FG000|Overall Study|Lack of Efficacy|0|||
163143717|NCT01114828|589235234|FG001|Overall Study|Lack of Efficacy|2|||
163143718|NCT01114828|589235233|FG000|Overall Study|Protocol Violation|2|||
163143719|NCT01114828|589235234|FG001|Overall Study|Protocol Violation|0|||
163143720|NCT01114828|589235233|FG000|Overall Study|Withdrawal by Subject|0|||
163143721|NCT01114828|589235234|FG001|Overall Study|Withdrawal by Subject|1|||
163143722|NCT00794950|589235235|FG000|BCG Induction|Withdrawal by Subject|2|||
163143723|NCT00794950|589235235|FG000|BCG Induction|ineligible|3|||
163143724|NCT00794950|589235235|FG000|BCG Induction|noncompliant w. BCG|1|||
163143725|NCT00794950|589235235|FG000|BCG Induction|Adverse Event|1|||
163143726|NCT00794950|589235235|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
163143727|NCT00794950|589235235|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
163143728|NCT00794950|589235235|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
163143729|NCT00794950|589235235|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
163143730|NCT02485704|589235236|FG000|Overall Study|Lost to Follow-up|4|||
163143731|NCT02485704|589235237|FG001|Overall Study|Lost to Follow-up|5|||
163143732|NCT02485704|589235236|FG000|Overall Study|Withdrawal by Subject|0|||
163143733|NCT02485704|589235237|FG001|Overall Study|Withdrawal by Subject|3|||
163143734|NCT02485704|589235236|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
163143735|NCT02485704|589235237|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
163143736|NCT00851786|589235240|FG000|Overall Study|Withdrawal by Subject|0|||
163143737|NCT00851786|589235241|FG001|Overall Study|Withdrawal by Subject|1|||
163143738|NCT00851786|589235240|FG000|Overall Study|Protocol Violation|0|||
163143739|NCT00851786|589235241|FG001|Overall Study|Protocol Violation|1|||
163143740|NCT00851786|589235240|FG000|Overall Study|Lost to Follow-up|1|||
163143741|NCT00851786|589235241|FG001|Overall Study|Lost to Follow-up|0|||
163409644|NCT01869114|590209458|FG000|Overall Study|Disease Progression|0|||
163143742|NCT00851786|589235240|FG000|Overall Study|Incarceration|1|||
163143743|NCT00851786|589235241|FG001|Overall Study|Incarceration|0|||
163143744|NCT00851786|589235240|FG000|Overall Study|Site Closure|1|||
163143745|NCT00851786|589235241|FG001|Overall Study|Site Closure|0|||
163143746|NCT00851786|589235240|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
163143747|NCT00851786|589235241|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
163143748|NCT03858049|589237124|FG000|Overall Study|Adverse Event|16|||
163143749|NCT03858049|589237125|FG001|Overall Study|Adverse Event|9|||
163143750|NCT03858049|589237124|FG000|Overall Study|Other|1|||
163409645|NCT01869114|590209459|FG001|Overall Study|Disease Progression|1|||
163409646|NCT01869114|590209460|FG002|Overall Study|Disease Progression|0|||
163409647|NCT00559507|590209461|FG000|Overall Study|Not treated, patient ineligible|3|||
163143751|NCT03858049|589237125|FG001|Overall Study|Other|1|||
163143752|NCT02079740|589237126|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
163143753|NCT02079740|589237127|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
163143754|NCT02079740|589237128|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
163143755|NCT02079740|589237129|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
163143756|NCT02079740|589237130|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
163143757|NCT02079740|589237131|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
163143758|NCT02079740|589237132|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
163143759|NCT02079740|589237133|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
163143760|NCT02079740|589237134|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
163143761|NCT02079740|589237135|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
163143762|NCT02079740|589237136|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
163143763|NCT02079740|589237137|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
163143764|NCT02079740|589237138|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
163143765|NCT02079740|589237126|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
163143766|NCT02079740|589237127|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
163143767|NCT02079740|589237128|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
163143768|NCT02079740|589237129|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
163143769|NCT02079740|589237130|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
163143770|NCT02079740|589237131|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
163143771|NCT02079740|589237132|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
163143772|NCT02079740|589237133|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
163143773|NCT02079740|589237134|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
163143774|NCT02079740|589237135|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
163236857|NCT00793910|589577563|FG001|Overall Study|discarded study pills|1|||
163236858|NCT00793910|589577562|FG000|Overall Study|did not pick up medications|1|||
163236859|NCT00793910|589577563|FG001|Overall Study|did not pick up medications|1|||
163236860|NCT00793910|589577562|FG000|Overall Study|ineligible based on entry criteria|2|||
163143775|NCT02079740|589237136|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
163143776|NCT02079740|589237137|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
163143777|NCT02079740|589237138|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
163143778|NCT02079740|589237126|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143779|NCT02079740|589237127|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143780|NCT02079740|589237128|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143781|NCT02079740|589237129|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143782|NCT02079740|589237130|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143783|NCT02079740|589237131|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143784|NCT02079740|589237132|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143785|NCT02079740|589237133|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
163143786|NCT02079740|589237134|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143787|NCT02079740|589237135|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143788|NCT02079740|589237136|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143789|NCT02079740|589237137|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143790|NCT02079740|589237138|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143791|NCT02079740|589237126|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143792|NCT02079740|589237127|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143793|NCT02079740|589237128|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143794|NCT02079740|589237129|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143795|NCT02079740|589237130|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143796|NCT02079740|589237131|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143797|NCT02079740|589237132|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143798|NCT02079740|589237133|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
163143799|NCT02079740|589237134|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143800|NCT02079740|589237135|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143801|NCT02079740|589237136|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143802|NCT02079740|589237137|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143803|NCT02079740|589237138|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143804|NCT02079740|589237126|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143805|NCT02079740|589237127|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143806|NCT02079740|589237128|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163236861|NCT00793910|589577563|FG001|Overall Study|ineligible based on entry criteria|3|||
163143807|NCT02079740|589237129|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143808|NCT02079740|589237130|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143809|NCT02079740|589237131|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143810|NCT02079740|589237132|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143811|NCT02079740|589237133|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143812|NCT02079740|589237134|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163236862|NCT00793910|589577562|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
163236863|NCT00793910|589577563|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
163143813|NCT02079740|589237135|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
163143814|NCT02079740|589237136|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143815|NCT02079740|589237137|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
163143816|NCT02079740|589237138|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
163143817|NCT01405768|589237143|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
163143818|NCT01405768|589237144|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
163143819|NCT04388111|589237145|FG000|Overall Study|Lost to Follow-up|5|||
163143820|NCT04388111|589237146|FG001|Overall Study|Lost to Follow-up|3|||
163143821|NCT04388111|589237145|FG000|Overall Study|Adverse Event|1|||
163143822|NCT04388111|589237146|FG001|Overall Study|Adverse Event|1|||
163143823|NCT04388111|589237145|FG000|Overall Study|Protocol Violation|2|||
163143824|NCT04388111|589237146|FG001|Overall Study|Protocol Violation|4|||
163143825|NCT04388111|589237145|FG000|Overall Study|Withdrawal by Subject|1|||
163143826|NCT04388111|589237146|FG001|Overall Study|Withdrawal by Subject|0|||
163143827|NCT01474317|589237151|FG000|Overall Study|Adverse Event|1|||
163143828|NCT01474317|589237151|FG000|Overall Study|Subject ineligible for study|1|||
163143829|NCT00387881|589237154|FG000|Overall Study|Lost to Follow-up|23|||
163143830|NCT00387881|589237155|FG001|Overall Study|Lost to Follow-up|23|||
163143831|NCT00387881|589237154|FG000|Overall Study|Protocol Violation|2|||
163143832|NCT00387881|589237155|FG001|Overall Study|Protocol Violation|12|||
163143833|NCT00387881|589237154|FG000|Overall Study|Withdrawal by Subject|15|||
163143834|NCT00387881|589237155|FG001|Overall Study|Withdrawal by Subject|18|||
163143835|NCT00387881|589237154|FG000|Overall Study|Sponsor terminated Study|0|||
163143836|NCT00387881|589237155|FG001|Overall Study|Sponsor terminated Study|1|||
163143837|NCT00387881|589237154|FG000|Overall Study|Not eligible|6|||
163143838|NCT00387881|589237155|FG001|Overall Study|Not eligible|7|||
163143839|NCT00387881|589237154|FG000|Overall Study|No opportunity to treat headache|32|||
163143840|NCT00387881|589237155|FG001|Overall Study|No opportunity to treat headache|34|||
163143841|NCT00387881|589237154|FG000|Overall Study|Not otherwise specified|11|||
163143842|NCT00387881|589237155|FG001|Overall Study|Not otherwise specified|7|||
163143843|NCT00453154|589237156|FG000|Double BIind Maintenance|Adverse Event|0|||
163143844|NCT00453154|589237157|FG001|Double BIind Maintenance|Adverse Event|0|||
163143845|NCT00453154|589237158|FG002|Double BIind Maintenance|Adverse Event|3|||
163143846|NCT00453154|589237159|FG003|Double BIind Maintenance|Adverse Event|12|||
163143847|NCT00453154|589237156|FG000|Double BIind Maintenance|Death|0|||
163143848|NCT00453154|589237157|FG001|Double BIind Maintenance|Death|0|||
163143849|NCT00453154|589237158|FG002|Double BIind Maintenance|Death|2|||
163143850|NCT00453154|589237159|FG003|Double BIind Maintenance|Death|1|||
163143851|NCT00453154|589237156|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
163143852|NCT00453154|589237157|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
163143853|NCT00453154|589237158|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
163236864|NCT00793910|589577562|FG000|Overall Study|Withdrawal by Subject|0|||
163236865|NCT00793910|589577563|FG001|Overall Study|Withdrawal by Subject|1|||
163236866|NCT03634579|589577568|FG000|Overall Study|study termination|9|||
163236867|NCT05061446|589577569|FG000|Overall Study|Adverse Event|2|||
163143854|NCT00453154|589237159|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
163143855|NCT00453154|589237156|FG000|Double BIind Maintenance|Progression|0|||
163143856|NCT00453154|589237157|FG001|Double BIind Maintenance|Progression|0|||
163143857|NCT00453154|589237158|FG002|Double BIind Maintenance|Progression|29|||
163143858|NCT00453154|589237159|FG003|Double BIind Maintenance|Progression|26|||
163143859|NCT00453154|589237156|FG000|Double BIind Maintenance|Medical Issues|0|||
163143860|NCT00453154|589237157|FG001|Double BIind Maintenance|Medical Issues|0|||
163236868|NCT05061446|589577570|FG001|Overall Study|Adverse Event|0|||
163143861|NCT00453154|589237158|FG002|Double BIind Maintenance|Medical Issues|3|||
163143862|NCT00453154|589237159|FG003|Double BIind Maintenance|Medical Issues|1|||
163143863|NCT00453154|589237156|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
163143864|NCT00453154|589237157|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
163143865|NCT00453154|589237158|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
163143866|NCT00453154|589237159|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
163143867|NCT03629886|589237161|FG000|Overall Study|Migrated / moved from the study area|0|||
163143868|NCT03629886|589237162|FG001|Overall Study|Migrated / moved from the study area|55|||
163143869|NCT03629886|589237161|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
163143870|NCT03629886|589237162|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
163143871|NCT03629886|589237161|FG000|Overall Study|Study vaccine not administrated|0|||
163143872|NCT03629886|589237162|FG001|Overall Study|Study vaccine not administrated|3|||
163236869|NCT05061446|589577571|FG002|Overall Study|Adverse Event|0|||
163236870|NCT05061446|589577569|FG000|Overall Study|Participant no longer available due to personal reason|0|||
163236871|NCT05061446|589577570|FG001|Overall Study|Participant no longer available due to personal reason|1|||
163236872|NCT05061446|589577571|FG002|Overall Study|Participant no longer available due to personal reason|0|||
163236873|NCT04111497|589577572|FG000|Overall Study|relapse of primary disease|1|||
163236874|NCT04111497|589577572|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
163236875|NCT01993719|589577575|FG000|First Drug Administration|Not treated|1|||
163236876|NCT01993719|589577576|FG001|First Drug Administration|Not treated|0|||
163143873|NCT03629886|589237161|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
163143874|NCT03629886|589237162|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
163143875|NCT03629886|589237161|FG000|Overall Study|Refused vaccination step of the study|0|||
163143876|NCT03629886|589237162|FG001|Overall Study|Refused vaccination step of the study|44|||
163143877|NCT05473026|589237164|FG000|Overall Study|Lost to Follow-up|5|||
163143878|NCT05473026|589237165|FG001|Overall Study|Lost to Follow-up|2|||
163349047|NCT03840148|589987102|FG001|Study Completion Disposition|Death|0|||
163349048|NCT03840148|589987101|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
163349049|NCT03840148|589987102|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
163349050|NCT03615404|589987103|FG000|Overall Study|Death|1|||
163349051|NCT03615404|589987103|FG000|Overall Study|vaccine did not pass quality assurance|1|||
163349052|NCT00257556|589987104|FG000|Overall Study|Adverse Event|1|||
163349053|NCT00257556|589987105|FG001|Overall Study|Adverse Event|4|||
163349054|NCT00257556|589987104|FG000|Overall Study|Physician Decision|6|||
163143879|NCT02038153|589237166|FG000|Overall Study|Withdrawal by Subject|1|||
163143880|NCT03683173|589237167|FG000|Completed Follow-up|Unavailable|235|||
163143881|NCT03683173|589237168|FG001|Completed Follow-up|Unavailable|217|||
163143882|NCT03683173|589237167|FG000|Completed Follow-up|Refused|69|||
163143883|NCT03683173|589237168|FG001|Completed Follow-up|Refused|59|||
163143884|NCT03683173|589237167|FG000|Completed Follow-up|Disconnected phone|65|||
163143885|NCT03683173|589237168|FG001|Completed Follow-up|Disconnected phone|95|||
163143886|NCT03683173|589237167|FG000|Completed Follow-up|Health issue/deceased|10|||
163143887|NCT03683173|589237168|FG001|Completed Follow-up|Health issue/deceased|4|||
163143888|NCT03683173|589237167|FG000|Completed Follow-up|Moved away|8|||
163143889|NCT03683173|589237168|FG001|Completed Follow-up|Moved away|1|||
163143890|NCT02647281|589237169|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143891|NCT02647281|589237170|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143892|NCT02647281|589237171|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143893|NCT02647281|589237172|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143894|NCT02647281|589237173|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143895|NCT02647281|589237174|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143896|NCT02647281|589237175|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143897|NCT02647281|589237176|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143898|NCT02647281|589237177|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
163143899|NCT01050634|589237178|FG000|Overall Study|Enrolled, but Not Treated|56|||
163143900|NCT01050634|589237178|FG000|Overall Study|Death|2|||
163143901|NCT01050634|589237178|FG000|Overall Study|Adverse Event|42|||
163143902|NCT01050634|589237178|FG000|Overall Study|Lost to Follow-up|2|||
163143903|NCT01050634|589237178|FG000|Overall Study|Other|21|||
163143904|NCT01050634|589237178|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
163143905|NCT00496015|589237179|FG000|Overall Study|Other|1|||
163143906|NCT00496015|589237180|FG001|Overall Study|Other|0|||
163143907|NCT00496015|589237181|FG002|Overall Study|Other|0|||
163143908|NCT00496015|589237182|FG003|Overall Study|Other|1|||
163143909|NCT00496015|589237183|FG004|Overall Study|Other|0|||
163143910|NCT02730728|589237186|FG000|Overall Study|Withdrawal by Subject|0|||
163143911|NCT02730728|589237187|FG001|Overall Study|Withdrawal by Subject|1|||
163349055|NCT00257556|589987105|FG001|Overall Study|Physician Decision|0|||
163349056|NCT00257556|589987104|FG000|Overall Study|Did not meet hCG criterion|3|||
163349057|NCT00257556|589987105|FG001|Overall Study|Did not meet hCG criterion|0|||
163143912|NCT02730728|589237188|FG002|Overall Study|Withdrawal by Subject|0|||
163143913|NCT02730728|589237186|FG000|Overall Study|Lack of Efficacy|0|||
163143914|NCT02730728|589237187|FG001|Overall Study|Lack of Efficacy|1|||
163143915|NCT02730728|589237188|FG002|Overall Study|Lack of Efficacy|1|||
163143916|NCT03360682|589237205|FG000|Overall Study|Adverse Event|3|||
163143917|NCT02420093|589237206|FG000|Overall Study|Withdrawal by Subject|1|||
163143918|NCT02420093|589237207|FG001|Overall Study|Withdrawal by Subject|1|||
163143919|NCT03244917|589237209|FG000|Overall Study|Lost to Follow-up|2|||
163143920|NCT03244917|589237210|FG001|Overall Study|Lost to Follow-up|2|||
163143921|NCT01147666|589237211|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
163143922|NCT01147666|589237212|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
163143923|NCT01147666|589237213|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
163143924|NCT01147666|589237214|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143925|NCT01147666|589237215|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143926|NCT01147666|589237216|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143927|NCT01147666|589237217|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143928|NCT01147666|589237218|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143929|NCT01147666|589237219|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143930|NCT01147666|589237220|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163349058|NCT00257556|589987104|FG000|Overall Study|other reason|4|||
163349059|NCT00257556|589987105|FG001|Overall Study|other reason|6|||
163349060|NCT03849300|589987107|FG000|Overall Study|move out to different area|1|||
163143931|NCT01147666|589237221|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143932|NCT01147666|589237222|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143933|NCT01147666|589237223|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
163143934|NCT01147666|589237224|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163349061|NCT03849300|589987108|FG001|Overall Study|move out to different area|3|||
163143935|NCT01147666|589237225|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143936|NCT01147666|589237211|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
163143937|NCT01147666|589237212|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
163143938|NCT01147666|589237213|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
163143939|NCT01147666|589237214|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
163143940|NCT01147666|589237215|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
163143941|NCT01147666|589237216|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
163143942|NCT01147666|589237217|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
163143943|NCT01147666|589237218|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
163143944|NCT01147666|589237219|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
163143945|NCT01147666|589237220|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
163143946|NCT01147666|589237221|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
163143947|NCT01147666|589237222|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
163143948|NCT01147666|589237223|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
163143949|NCT01147666|589237224|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
163143950|NCT01147666|589237225|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
163143951|NCT01147666|589237211|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
163143952|NCT01147666|589237212|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
163143953|NCT01147666|589237213|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
163143954|NCT01147666|589237214|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
163143955|NCT01147666|589237215|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
163143956|NCT01147666|589237216|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
163143957|NCT01147666|589237217|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
163143958|NCT01147666|589237218|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
163143959|NCT01147666|589237219|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
163143960|NCT01147666|589237220|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
163143961|NCT01147666|589237221|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
163143962|NCT01147666|589237222|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
163143963|NCT01147666|589237223|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
163143964|NCT01147666|589237224|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
163143965|NCT01147666|589237225|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
163143966|NCT01147666|589237211|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
163143967|NCT01147666|589237212|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143968|NCT01147666|589237213|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143969|NCT01147666|589237214|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
163143970|NCT01147666|589237215|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143971|NCT01147666|589237216|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143972|NCT01147666|589237217|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143973|NCT01147666|589237218|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143974|NCT01147666|589237219|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143975|NCT01147666|589237220|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143976|NCT01147666|589237221|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
163143977|NCT01147666|589237222|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143978|NCT01147666|589237223|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143979|NCT01147666|589237224|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143980|NCT01147666|589237225|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143981|NCT01147666|589237211|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143982|NCT01147666|589237212|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143983|NCT01147666|589237213|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143984|NCT01147666|589237214|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143985|NCT01147666|589237215|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
163143986|NCT01147666|589237216|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
163143987|NCT01147666|589237217|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143988|NCT01147666|589237218|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
163143989|NCT01147666|589237219|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143990|NCT01147666|589237220|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
163143991|NCT01147666|589237221|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143992|NCT01147666|589237222|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
163143993|NCT01147666|589237223|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143994|NCT01147666|589237224|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
163143995|NCT01147666|589237225|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143996|NCT01147666|589237211|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163143997|NCT01147666|589237212|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163349062|NCT03849300|589987109|FG002|Overall Study|move out to different area|1|||
163143998|NCT01147666|589237213|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163143999|NCT01147666|589237214|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
163144000|NCT01147666|589237215|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144001|NCT01147666|589237216|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144002|NCT01147666|589237217|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144003|NCT01147666|589237218|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144004|NCT01147666|589237219|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144005|NCT01147666|589237220|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144006|NCT01147666|589237221|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
163144007|NCT01147666|589237222|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144008|NCT01147666|589237223|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144009|NCT01147666|589237224|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144010|NCT01147666|589237225|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144011|NCT01147666|589237211|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144012|NCT01147666|589237212|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144013|NCT01147666|589237213|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144014|NCT01147666|589237214|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144015|NCT01147666|589237215|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144016|NCT01147666|589237216|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144017|NCT01147666|589237217|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144018|NCT01147666|589237218|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144019|NCT01147666|589237219|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163409648|NCT04681170|590209462|FG000|Stratified Enrolment & run-in|Death|1|||
163144020|NCT01147666|589237220|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144021|NCT01147666|589237221|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144022|NCT01147666|589237222|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
163144023|NCT01147666|589237223|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
163144024|NCT01147666|589237224|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144025|NCT01147666|589237225|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
163144026|NCT01147666|589237211|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
163144027|NCT01147666|589237212|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
163144028|NCT01147666|589237213|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
163144029|NCT01147666|589237214|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
163144030|NCT01147666|589237215|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
163144031|NCT01147666|589237216|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
163144032|NCT01147666|589237217|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
163144033|NCT01147666|589237218|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
163144034|NCT01147666|589237219|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
163144035|NCT01147666|589237220|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
163144036|NCT01147666|589237221|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
163144037|NCT01147666|589237222|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
163144038|NCT01147666|589237223|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
163144039|NCT01147666|589237224|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
163144040|NCT01147666|589237225|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
163144041|NCT01147666|589237211|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144042|NCT01147666|589237212|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144043|NCT01147666|589237213|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144044|NCT01147666|589237214|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144045|NCT01147666|589237215|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
163144046|NCT01147666|589237216|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
163144047|NCT01147666|589237217|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
163144048|NCT01147666|589237218|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
163144049|NCT01147666|589237219|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144050|NCT01147666|589237220|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
163144051|NCT01147666|589237221|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144052|NCT01147666|589237222|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144053|NCT01147666|589237223|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
163144054|NCT01147666|589237224|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144055|NCT01147666|589237225|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
163144056|NCT01147666|589237211|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144057|NCT01147666|589237212|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144058|NCT01147666|589237213|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144059|NCT01147666|589237214|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
163144060|NCT01147666|589237215|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144061|NCT01147666|589237216|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163409649|NCT04681170|590209463|FG001|Stratified Enrolment & run-in|Death|0|||
163409650|NCT04681170|590209462|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
163236877|NCT01993719|589577577|FG002|First Drug Administration|Not treated|0|||
163236878|NCT01993719|589577578|FG003|First Drug Administration|Not treated|0|||
163236879|NCT01993719|589577579|FG004|First Drug Administration|Not treated|0|||
163236880|NCT05857527|589577580|FG000|Overall Study|Withdrawal by Subject|0|||
163236881|NCT05857527|589577581|FG001|Overall Study|Withdrawal by Subject|1|||
163236882|NCT02799082|589577583|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
163236883|NCT02799082|589577584|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
163236884|NCT02799082|589577583|FG000|Overall Study|Protocol Violation|0|||
163236885|NCT02799082|589577584|FG001|Overall Study|Protocol Violation|1|||
163236886|NCT01592708|589577585|FG000|Overall Study|Protocol Violation|3|||
163236887|NCT01592708|589577586|FG001|Overall Study|Protocol Violation|0|||
163236888|NCT01723904|589577590|FG000|Overall Study|Noncompliant|3|||
163236889|NCT01723904|589577590|FG000|Overall Study|Adverse Event|5|||
163236890|NCT01723904|589577590|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
163236891|NCT02610140|589577601|FG000|Randomization and Treatment Period|Radiological progression|23|||
163236892|NCT02610140|589577602|FG001|Randomization and Treatment Period|Radiological progression|15|||
163236893|NCT02610140|589577601|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
163236894|NCT02610140|589577602|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
163236895|NCT02610140|589577601|FG000|Randomization and Treatment Period|Protocol Violation|1|||
163236896|NCT02610140|589577602|FG001|Randomization and Treatment Period|Protocol Violation|0|||
163236897|NCT02610140|589577601|FG000|Randomization and Treatment Period|Physician Decision|0|||
163236898|NCT02610140|589577602|FG001|Randomization and Treatment Period|Physician Decision|1|||
163236899|NCT02610140|589577601|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
163236900|NCT02610140|589577602|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
163236901|NCT02610140|589577601|FG000|Randomization and Treatment Period|Death|7|||
163236902|NCT02610140|589577602|FG001|Randomization and Treatment Period|Death|1|||
163236903|NCT02610140|589577601|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
163236904|NCT02610140|589577602|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
163236905|NCT02610140|589577601|FG000|Randomization and Treatment Period|Adverse Event|44|||
163236906|NCT02610140|589577602|FG001|Randomization and Treatment Period|Adverse Event|13|||
163236907|NCT02610140|589577601|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
163236908|NCT02610140|589577602|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
163236909|NCT02610140|589577601|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
163236910|NCT02610140|589577602|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
163236911|NCT02610140|589577601|FG000|Randomization and Treatment Period|Not treated|3|||
163236912|NCT02610140|589577602|FG001|Randomization and Treatment Period|Not treated|10|||
163236913|NCT02610140|589577601|FG000|Safety Follow-up|Other|0|||
163236914|NCT02610140|589577602|FG001|Safety Follow-up|Other|2|||
163236915|NCT02610140|589577601|FG000|Safety Follow-up|Lost to Follow-up|1|||
163236916|NCT02610140|589577602|FG001|Safety Follow-up|Lost to Follow-up|0|||
163236917|NCT02610140|589577601|FG000|Safety Follow-up|No follow-up|5|||
163236918|NCT02610140|589577602|FG001|Safety Follow-up|No follow-up|3|||
163236919|NCT02610140|589577601|FG000|Safety Follow-up|Death|12|||
163236920|NCT02610140|589577602|FG001|Safety Follow-up|Death|2|||
163236921|NCT02610140|589577601|FG000|Safety Follow-up|Deterioration of general conditions|15|||
163236922|NCT02610140|589577602|FG001|Safety Follow-up|Deterioration of general conditions|5|||
163236923|NCT02610140|589577601|FG000|Safety Follow-up|Withdrawal by Subject|12|||
163236924|NCT02610140|589577602|FG001|Safety Follow-up|Withdrawal by Subject|12|||
163236925|NCT02610140|589577601|FG000|Active Follow-up|Progressive disease - radiological|30|||
163236926|NCT02610140|589577602|FG001|Active Follow-up|Progressive disease - radiological|22|||
163236927|NCT02610140|589577601|FG000|Active Follow-up|Death|8|||
163236928|NCT02610140|589577602|FG001|Active Follow-up|Death|1|||
163236929|NCT02610140|589577601|FG000|Active Follow-up|Withdrawal by Subject|4|||
163236930|NCT02610140|589577602|FG001|Active Follow-up|Withdrawal by Subject|0|||
163236931|NCT02610140|589577601|FG000|Active Follow-up|Progressive disease - clinical|1|||
163236932|NCT02610140|589577602|FG001|Active Follow-up|Progressive disease - clinical|2|||
163236933|NCT02610140|589577601|FG000|Active Follow-up|Deterioration of general conditions|1|||
163349063|NCT03849300|589987110|FG003|Overall Study|move out to different area|4|||
163349064|NCT03849300|589987107|FG000|Overall Study|scheduling/transportation conflict|4|||
163349065|NCT03849300|589987108|FG001|Overall Study|scheduling/transportation conflict|4|||
163349066|NCT03849300|589987109|FG002|Overall Study|scheduling/transportation conflict|3|||
163236934|NCT02610140|589577602|FG001|Active Follow-up|Deterioration of general conditions|0|||
163349067|NCT03849300|589987110|FG003|Overall Study|scheduling/transportation conflict|2|||
163236935|NCT02610140|589577601|FG000|Active Follow-up|Ongoing but not completed|4|||
163236936|NCT02610140|589577602|FG001|Active Follow-up|Ongoing but not completed|1|||
163236937|NCT02610140|589577601|FG000|Long-term Follow-up|Death|86|||
163236938|NCT02610140|589577602|FG001|Long-term Follow-up|Death|44|||
163236939|NCT02610140|589577601|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
163236940|NCT02610140|589577602|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
163349068|NCT04839289|589987111|FG000|Overall Study|Withdrawal by Subject|1|||
163349069|NCT04839289|589987112|FG001|Overall Study|Withdrawal by Subject|0|||
163349070|NCT00464737|589987114|FG000|Overall Study|Adverse Event|12|||
163349071|NCT00464737|589987115|FG001|Overall Study|Adverse Event|17|||
163349072|NCT00464737|589987116|FG002|Overall Study|Adverse Event|33|||
163349073|NCT00464737|589987114|FG000|Overall Study|Lack of Efficacy|7|||
163349074|NCT00464737|589987115|FG001|Overall Study|Lack of Efficacy|7|||
163349075|NCT00464737|589987116|FG002|Overall Study|Lack of Efficacy|4|||
163349076|NCT00464737|589987114|FG000|Overall Study|Withdrawal by Subject|5|||
163349077|NCT00464737|589987115|FG001|Overall Study|Withdrawal by Subject|3|||
163349078|NCT00464737|589987116|FG002|Overall Study|Withdrawal by Subject|5|||
163349079|NCT00464737|589987114|FG000|Overall Study|Protocol Violation|1|||
163349080|NCT00464737|589987115|FG001|Overall Study|Protocol Violation|1|||
163349081|NCT00464737|589987116|FG002|Overall Study|Protocol Violation|5|||
163349082|NCT00464737|589987114|FG000|Overall Study|Non-compliance|0|||
163349083|NCT00464737|589987115|FG001|Overall Study|Non-compliance|1|||
163349084|NCT00464737|589987116|FG002|Overall Study|Non-compliance|1|||
163349085|NCT00464737|589987114|FG000|Overall Study|Lost to Follow-up|5|||
163349086|NCT00464737|589987115|FG001|Overall Study|Lost to Follow-up|2|||
163349087|NCT00464737|589987116|FG002|Overall Study|Lost to Follow-up|5|||
163349088|NCT00464737|589987114|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
163349089|NCT00464737|589987115|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
163349090|NCT00464737|589987116|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
163349091|NCT00464737|589987114|FG000|Overall Study|Other: Subject left town; family illness|1|||
163349092|NCT00464737|589987115|FG001|Overall Study|Other: Subject left town; family illness|0|||
163349093|NCT00464737|589987116|FG002|Overall Study|Other: Subject left town; family illness|0|||
163349094|NCT00464737|589987114|FG000|Overall Study|Other: Study demands too great|0|||
163349095|NCT00464737|589987115|FG001|Overall Study|Other: Study demands too great|1|||
163236941|NCT02610140|589577601|FG000|Long-term Follow-up|Lost to Follow-up|1|||
163236942|NCT02610140|589577602|FG001|Long-term Follow-up|Lost to Follow-up|2|||
163236943|NCT02610140|589577601|FG000|Long-term Follow-up|Ongoing but not completed|30|||
163236944|NCT02610140|589577602|FG001|Long-term Follow-up|Ongoing but not completed|17|||
163236945|NCT00887341|589577603|FG000|Overall Study|Refused treatment|1|||
163236946|NCT00887341|589577604|FG001|Overall Study|Refused treatment|0|||
163236947|NCT00887341|589577603|FG000|Overall Study|Withdrawal by Subject|1|||
163236948|NCT00887341|589577604|FG001|Overall Study|Withdrawal by Subject|1|||
163236949|NCT00887341|589577603|FG000|Overall Study|Adverse Event|0|||
163236950|NCT00887341|589577604|FG001|Overall Study|Adverse Event|1|||
163236951|NCT00887341|589577603|FG000|Overall Study|Lost to Follow-up|0|||
163236952|NCT00887341|589577604|FG001|Overall Study|Lost to Follow-up|1|||
163236953|NCT01752933|589577607|FG000|Treatment|Disease Progression|3|||
163236954|NCT01752933|589577608|FG001|Treatment|Disease Progression|29|||
163236955|NCT01752933|589577607|FG000|Treatment|Withdrawal by Subject|0|||
163236956|NCT01752933|589577608|FG001|Treatment|Withdrawal by Subject|5|||
163236957|NCT01752933|589577607|FG000|Treatment|Adverse Event|1|||
163236958|NCT01752933|589577608|FG001|Treatment|Adverse Event|4|||
163236959|NCT01752933|589577607|FG000|Treatment|Physician Decision|0|||
163236960|NCT01752933|589577608|FG001|Treatment|Physician Decision|3|||
163236961|NCT01752933|589577607|FG000|Treatment|Death|0|||
163236962|NCT01752933|589577608|FG001|Treatment|Death|2|||
163236963|NCT01752933|589577607|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
163236964|NCT01752933|589577608|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
163236965|NCT01752933|589577607|FG000|Treatment|Patient noncompliant|0|||
163236966|NCT01752933|589577608|FG001|Treatment|Patient noncompliant|1|||
163236967|NCT01752933|589577607|FG000|Treatment|Patient unable to travel to appointments|0|||
163236968|NCT01752933|589577608|FG001|Treatment|Patient unable to travel to appointments|1|||
163236969|NCT01752933|589577607|FG000|Overall Study and Follow-up|Death|4|||
163236970|NCT01752933|589577608|FG001|Overall Study and Follow-up|Death|34|||
163236971|NCT01752933|589577607|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
163236972|NCT01752933|589577608|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
163236973|NCT01752933|589577607|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
163236974|NCT01752933|589577608|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
163236975|NCT01752933|589577607|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
163236976|NCT01752933|589577608|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
163236977|NCT01591681|589577609|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
163236978|NCT01591681|589577609|FG000|Overall Study|Failed to use system during run-in|1|||
163236979|NCT01312961|589577611|FG000|Overall Study|Adverse Event|3|||
163236980|NCT01312961|589577612|FG001|Overall Study|Adverse Event|3|||
163236981|NCT01312961|589577611|FG000|Overall Study|Lack of Efficacy|11|||
163349096|NCT00464737|589987116|FG002|Overall Study|Other: Study demands too great|0|||
163349097|NCT00464737|589987114|FG000|Overall Study|Other: Personal family reasons|0|||
163349098|NCT00464737|589987115|FG001|Overall Study|Other: Personal family reasons|0|||
163349099|NCT00464737|589987116|FG002|Overall Study|Other: Personal family reasons|1|||
163349100|NCT00464737|589987114|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
163349101|NCT00464737|589987115|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
163349102|NCT00464737|589987116|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
163236982|NCT01312961|589577612|FG001|Overall Study|Lack of Efficacy|1|||
163349103|NCT00580047|589987119|FG000|Overall Study|Lost to Follow-up|1|||
163409651|NCT04681170|590209463|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
163144062|NCT01147666|589237217|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144063|NCT01147666|589237218|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144064|NCT01147666|589237219|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144065|NCT01147666|589237220|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144066|NCT01147666|589237221|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144067|NCT01147666|589237222|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144068|NCT01147666|589237223|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144069|NCT01147666|589237224|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144070|NCT01147666|589237225|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144071|NCT01147666|589237211|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144072|NCT01147666|589237212|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144073|NCT01147666|589237213|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144074|NCT01147666|589237214|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144075|NCT01147666|589237215|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
163144076|NCT01147666|589237216|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
163144077|NCT01147666|589237217|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144078|NCT01147666|589237218|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
163144079|NCT01147666|589237219|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144080|NCT01147666|589237220|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
163144081|NCT01147666|589237221|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144082|NCT01147666|589237222|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144083|NCT01147666|589237223|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144084|NCT01147666|589237224|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
163144085|NCT01147666|589237225|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144086|NCT01147666|589237211|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144087|NCT01147666|589237212|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144088|NCT01147666|589237213|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144089|NCT01147666|589237214|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
163144090|NCT01147666|589237215|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144091|NCT01147666|589237216|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144092|NCT01147666|589237217|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144093|NCT01147666|589237218|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144094|NCT01147666|589237219|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144095|NCT01147666|589237220|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144096|NCT01147666|589237221|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
163144097|NCT01147666|589237222|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144098|NCT01147666|589237223|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144099|NCT01147666|589237224|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144100|NCT01147666|589237225|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144101|NCT01147666|589237211|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144102|NCT01147666|589237212|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144103|NCT01147666|589237213|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144104|NCT01147666|589237214|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144105|NCT01147666|589237215|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144106|NCT01147666|589237216|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144107|NCT01147666|589237217|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144108|NCT01147666|589237218|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144109|NCT01147666|589237219|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144110|NCT01147666|589237220|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144111|NCT01147666|589237221|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144112|NCT01147666|589237222|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144113|NCT01147666|589237223|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
163144114|NCT01147666|589237224|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144115|NCT01147666|589237225|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144116|NCT01147666|589237211|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144117|NCT01147666|589237212|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144118|NCT01147666|589237213|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144119|NCT01147666|589237214|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144120|NCT01147666|589237215|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144121|NCT01147666|589237216|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144122|NCT01147666|589237217|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144123|NCT01147666|589237218|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144124|NCT01147666|589237219|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144125|NCT01147666|589237220|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144126|NCT01147666|589237221|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163349104|NCT00580047|589987120|FG001|Overall Study|Lost to Follow-up|1|||
163349105|NCT00580047|589987121|FG002|Overall Study|Lost to Follow-up|0|||
163349106|NCT00580047|589987119|FG000|Overall Study|Withdrawal by Subject|1|||
163349107|NCT00580047|589987120|FG001|Overall Study|Withdrawal by Subject|1|||
163349108|NCT00580047|589987121|FG002|Overall Study|Withdrawal by Subject|2|||
163349109|NCT00580047|589987119|FG000|Overall Study|Withdrawal by Subject|1|||
163349110|NCT00580047|589987120|FG001|Overall Study|Withdrawal by Subject|0|||
163349111|NCT00580047|589987121|FG002|Overall Study|Withdrawal by Subject|0|||
163349112|NCT01780584|589987124|FG000|Overall Study|Death|1|||
163349113|NCT01780584|589987125|FG001|Overall Study|Death|0|||
163349114|NCT01780584|589987126|FG002|Overall Study|Death|1|||
163349115|NCT01780584|589987124|FG000|Overall Study|Adverse Event|0|||
163349116|NCT01780584|589987125|FG001|Overall Study|Adverse Event|1|||
163409652|NCT04681170|590209462|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
163409653|NCT04681170|590209463|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
163409654|NCT04681170|590209462|FG000|Open Label Efficacy Phase|Adverse Event|0|||
163409655|NCT04681170|590209463|FG001|Open Label Efficacy Phase|Adverse Event|2|||
163409656|NCT04681170|590209462|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
163409657|NCT04681170|590209463|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
163409658|NCT04681170|590209462|FG000|Open Label Safety Phase|AEs and none compliance|0|||
163144127|NCT01147666|589237222|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144128|NCT01147666|589237223|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
163144129|NCT01147666|589237224|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144130|NCT01147666|589237225|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
163144131|NCT02748863|589237226|FG000|Treatment Period 1|Adverse Event|0|||
163144132|NCT02748863|589237227|FG001|Treatment Period 1|Adverse Event|1|||
163144133|NCT02748863|589237228|FG002|Treatment Period 1|Adverse Event|0|||
163144134|NCT02748863|589237229|FG003|Treatment Period 1|Adverse Event|0|||
163144135|NCT02748863|589237230|FG004|Treatment Period 1|Adverse Event|0|||
163144136|NCT02748863|589237226|FG000|Treatment Period 1|Lack of Efficacy|0|||
163144137|NCT02748863|589237227|FG001|Treatment Period 1|Lack of Efficacy|0|||
163144138|NCT02748863|589237228|FG002|Treatment Period 1|Lack of Efficacy|1|||
163144139|NCT02748863|589237229|FG003|Treatment Period 1|Lack of Efficacy|0|||
163144140|NCT02748863|589237230|FG004|Treatment Period 1|Lack of Efficacy|0|||
163144141|NCT02748863|589237226|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163144142|NCT02748863|589237227|FG001|Treatment Period 1|Withdrawal by Subject|1|||
163144143|NCT02748863|589237228|FG002|Treatment Period 1|Withdrawal by Subject|1|||
163144144|NCT02748863|589237229|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163144145|NCT02748863|589237230|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163144146|NCT02748863|589237226|FG000|Treatment Period 2|Lost to Follow-up|2|||
163144147|NCT02748863|589237227|FG001|Treatment Period 2|Lost to Follow-up|0|||
163144148|NCT02748863|589237228|FG002|Treatment Period 2|Lost to Follow-up|0|||
163144149|NCT02748863|589237229|FG003|Treatment Period 2|Lost to Follow-up|0|||
163144150|NCT02748863|589237230|FG004|Treatment Period 2|Lost to Follow-up|0|||
163144151|NCT02748863|589237226|FG000|Treatment Period 2|Adverse Event|3|||
163144152|NCT02748863|589237227|FG001|Treatment Period 2|Adverse Event|2|||
163144153|NCT02748863|589237228|FG002|Treatment Period 2|Adverse Event|0|||
163144154|NCT02748863|589237229|FG003|Treatment Period 2|Adverse Event|2|||
163144155|NCT02748863|589237230|FG004|Treatment Period 2|Adverse Event|0|||
163144156|NCT02748863|589237226|FG000|Treatment Period 2|Lack of Efficacy|0|||
163144157|NCT02748863|589237227|FG001|Treatment Period 2|Lack of Efficacy|1|||
163144158|NCT02748863|589237228|FG002|Treatment Period 2|Lack of Efficacy|0|||
163144159|NCT02748863|589237229|FG003|Treatment Period 2|Lack of Efficacy|0|||
163144160|NCT02748863|589237230|FG004|Treatment Period 2|Lack of Efficacy|0|||
163144161|NCT02748863|589237226|FG000|Treatment Period 2|Pregnancy|0|||
163144162|NCT02748863|589237227|FG001|Treatment Period 2|Pregnancy|0|||
163144163|NCT02748863|589237228|FG002|Treatment Period 2|Pregnancy|0|||
163144164|NCT02748863|589237229|FG003|Treatment Period 2|Pregnancy|0|||
163144165|NCT02748863|589237230|FG004|Treatment Period 2|Pregnancy|1|||
163144166|NCT02576639|589237231|FG000|Overall Study|Withdrawal by Subject|1|||
163144167|NCT02576639|589237232|FG001|Overall Study|Withdrawal by Subject|2|||
163144168|NCT02576639|589237233|FG002|Overall Study|Withdrawal by Subject|1|||
163144169|NCT02576639|589237234|FG003|Overall Study|Withdrawal by Subject|0|||
163144170|NCT02576639|589237235|FG004|Overall Study|Withdrawal by Subject|1|||
163144171|NCT02576639|589237231|FG000|Overall Study|Adverse Event|1|||
163144172|NCT02576639|589237232|FG001|Overall Study|Adverse Event|0|||
163144173|NCT02576639|589237233|FG002|Overall Study|Adverse Event|1|||
163144174|NCT02576639|589237234|FG003|Overall Study|Adverse Event|1|||
163144175|NCT02576639|589237235|FG004|Overall Study|Adverse Event|2|||
163144176|NCT02576639|589237231|FG000|Overall Study|Physician Decision|0|||
163144177|NCT02576639|589237232|FG001|Overall Study|Physician Decision|0|||
163144178|NCT02576639|589237233|FG002|Overall Study|Physician Decision|0|||
163144179|NCT02576639|589237234|FG003|Overall Study|Physician Decision|0|||
163144180|NCT02576639|589237235|FG004|Overall Study|Physician Decision|1|||
163144181|NCT01135134|589237236|FG000|Overall Study|Adverse Event|1|||
163144182|NCT01135134|589237237|FG001|Overall Study|Adverse Event|1|||
163349117|NCT01780584|589987126|FG002|Overall Study|Adverse Event|0|||
163236983|NCT01312961|589577611|FG000|Overall Study|Poor compliance to protocol|1|||
163236984|NCT01312961|589577612|FG001|Overall Study|Poor compliance to protocol|0|||
163236985|NCT01312961|589577611|FG000|Overall Study|Other than specified above|2|||
163236986|NCT01312961|589577612|FG001|Overall Study|Other than specified above|3|||
163236987|NCT05402995|589577613|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
163236988|NCT05402995|589577614|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
163236989|NCT05402995|589577615|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
163236990|NCT05402995|589577616|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
163236991|NCT01337297|589577619|FG000|Overall Study|They entered to single anodal tDCS|4|||
163236992|NCT01337297|589577620|FG001|Overall Study|They entered to single anodal tDCS|3|||
163236993|NCT01337297|589577619|FG000|Overall Study|Lost to Follow-up|1|||
163236994|NCT01337297|589577620|FG001|Overall Study|Lost to Follow-up|3|||
163236995|NCT01800903|589577621|FG000|Second Test Period|unable to catheterise|1|||
163236996|NCT01800903|589577622|FG001|Second Test Period|unable to catheterise|0|||
163236997|NCT01800903|589577623|FG002|Second Test Period|unable to catheterise|0|||
163236998|NCT01800903|589577624|FG003|Second Test Period|unable to catheterise|0|||
163236999|NCT01800903|589577625|FG004|Second Test Period|unable to catheterise|0|||
163237000|NCT01800903|589577626|FG005|Second Test Period|unable to catheterise|0|||
163237001|NCT01306617|589577628|FG000|Overall Study|Adverse Event|1|||
163237002|NCT01306617|589577629|FG001|Overall Study|Adverse Event|0|||
163237003|NCT01306617|589577630|FG002|Overall Study|Adverse Event|0|||
163237004|NCT01306617|589577628|FG000|Overall Study|Virologic Failure|0|||
163237005|NCT01306617|589577629|FG001|Overall Study|Virologic Failure|0|||
163237006|NCT01306617|589577630|FG002|Overall Study|Virologic Failure|5|||
163237007|NCT01306617|589577628|FG000|Overall Study|Non-compliance|0|||
163237008|NCT01306617|589577629|FG001|Overall Study|Non-compliance|1|||
163237009|NCT01306617|589577630|FG002|Overall Study|Non-compliance|0|||
163237010|NCT01208233|589577632|FG000|Overall Study|Adverse Event|0|||
163144183|NCT01135134|589237236|FG000|Overall Study|Did not meet protocol eligibility|1|||
163144184|NCT01135134|589237237|FG001|Overall Study|Did not meet protocol eligibility|0|||
163144185|NCT01329978|589237262|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
163144186|NCT01329978|589237263|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
163144187|NCT01329978|589237264|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
163144188|NCT01329978|589237265|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
163144189|NCT01329978|589237266|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
163144190|NCT01329978|589237262|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
163144191|NCT01329978|589237263|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
163144192|NCT01329978|589237264|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
163144193|NCT01329978|589237265|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
163144194|NCT01329978|589237266|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
163144195|NCT01329978|589237262|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
163144196|NCT01329978|589237263|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
163144197|NCT01329978|589237264|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
163144198|NCT01329978|589237265|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
163144199|NCT01329978|589237266|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
163144200|NCT01329978|589237262|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
163144201|NCT01329978|589237263|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
163144202|NCT01329978|589237264|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
163144203|NCT01329978|589237265|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
163144204|NCT01329978|589237266|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
163144205|NCT01329978|589237262|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
163144206|NCT01329978|589237263|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
163144207|NCT01329978|589237264|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
163144208|NCT01329978|589237265|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
163144209|NCT01329978|589237266|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
163144210|NCT01329978|589237262|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
163144211|NCT01329978|589237263|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
163144212|NCT01329978|589237264|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
163144213|NCT01329978|589237265|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
163144214|NCT01329978|589237266|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
163144215|NCT01329978|589237262|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
163349118|NCT01780584|589987124|FG000|Overall Study|Protocol Violation|0|||
163349119|NCT01780584|589987125|FG001|Overall Study|Protocol Violation|0|||
163349120|NCT01780584|589987126|FG002|Overall Study|Protocol Violation|1|||
163237011|NCT01208233|589577633|FG001|Overall Study|Adverse Event|1|||
163237012|NCT01208233|589577634|FG002|Overall Study|Adverse Event|2|||
163237013|NCT01208233|589577635|FG003|Overall Study|Adverse Event|0|||
163237014|NCT01208233|589577636|FG004|Overall Study|Adverse Event|3|||
163237015|NCT01208233|589577637|FG005|Overall Study|Adverse Event|5|||
163237016|NCT01208233|589577632|FG000|Overall Study|Death|0|||
163237017|NCT01208233|589577633|FG001|Overall Study|Death|0|||
163237018|NCT01208233|589577634|FG002|Overall Study|Death|0|||
163237019|NCT01208233|589577635|FG003|Overall Study|Death|0|||
163237020|NCT01208233|589577636|FG004|Overall Study|Death|3|||
163237021|NCT01208233|589577637|FG005|Overall Study|Death|5|||
163237022|NCT01208233|589577632|FG000|Overall Study|Did not meet entrance criteria|2|||
163237023|NCT01208233|589577633|FG001|Overall Study|Did not meet entrance criteria|1|||
163237024|NCT01208233|589577634|FG002|Overall Study|Did not meet entrance criteria|1|||
163237025|NCT01208233|589577635|FG003|Overall Study|Did not meet entrance criteria|0|||
163237026|NCT01208233|589577636|FG004|Overall Study|Did not meet entrance criteria|1|||
163237027|NCT01208233|589577637|FG005|Overall Study|Did not meet entrance criteria|0|||
163237028|NCT01208233|589577632|FG000|Overall Study|Medication error without adverse event|0|||
163237029|NCT01208233|589577633|FG001|Overall Study|Medication error without adverse event|0|||
163237030|NCT01208233|589577634|FG002|Overall Study|Medication error without adverse event|0|||
163237031|NCT01208233|589577635|FG003|Overall Study|Medication error without adverse event|0|||
163237032|NCT01208233|589577636|FG004|Overall Study|Medication error without adverse event|0|||
163237033|NCT01208233|589577637|FG005|Overall Study|Medication error without adverse event|1|||
163237034|NCT01208233|589577632|FG000|Overall Study|Study terminated by sponsor|0|||
163237035|NCT01208233|589577633|FG001|Overall Study|Study terminated by sponsor|0|||
163237036|NCT01208233|589577634|FG002|Overall Study|Study terminated by sponsor|0|||
163237037|NCT01208233|589577635|FG003|Overall Study|Study terminated by sponsor|0|||
163237038|NCT01208233|589577636|FG004|Overall Study|Study terminated by sponsor|10|||
163237039|NCT01208233|589577637|FG005|Overall Study|Study terminated by sponsor|7|||
163237040|NCT01208233|589577632|FG000|Overall Study|Protocol Violation|0|||
163237041|NCT01208233|589577633|FG001|Overall Study|Protocol Violation|0|||
163237042|NCT01208233|589577634|FG002|Overall Study|Protocol Violation|0|||
163237043|NCT01208233|589577635|FG003|Overall Study|Protocol Violation|0|||
163237044|NCT01208233|589577636|FG004|Overall Study|Protocol Violation|3|||
163237045|NCT01208233|589577637|FG005|Overall Study|Protocol Violation|0|||
163237046|NCT01208233|589577632|FG000|Overall Study|Other|2|||
163237047|NCT01208233|589577633|FG001|Overall Study|Other|1|||
163237048|NCT01208233|589577634|FG002|Overall Study|Other|0|||
163237049|NCT01208233|589577635|FG003|Overall Study|Other|0|||
163237050|NCT01208233|589577636|FG004|Overall Study|Other|0|||
163237051|NCT01208233|589577637|FG005|Overall Study|Other|1|||
163237052|NCT01208233|589577632|FG000|Overall Study|Withdrawal by Subject|1|||
163237053|NCT01208233|589577633|FG001|Overall Study|Withdrawal by Subject|0|||
163237054|NCT01208233|589577634|FG002|Overall Study|Withdrawal by Subject|1|||
163237055|NCT01208233|589577635|FG003|Overall Study|Withdrawal by Subject|1|||
163237056|NCT01208233|589577636|FG004|Overall Study|Withdrawal by Subject|4|||
163237057|NCT01208233|589577637|FG005|Overall Study|Withdrawal by Subject|2|||
163237058|NCT04028388|589577641|FG000|Overall Study|Evaluations missing|3|||
163237059|NCT04028388|589577642|FG001|Overall Study|Evaluations missing|6|||
163237060|NCT04028388|589577641|FG000|Overall Study|Not started|2|||
163237061|NCT04028388|589577642|FG001|Overall Study|Not started|0|||
163237062|NCT00129259|589577649|FG000|Overall Study|Lost to Follow-up|1|||
163237063|NCT00129259|589577650|FG001|Overall Study|Lost to Follow-up|1|||
163237064|NCT00129259|589577649|FG000|Overall Study|Withdrawal by Subject|2|||
163237065|NCT00129259|589577650|FG001|Overall Study|Withdrawal by Subject|1|||
163237066|NCT00129259|589577649|FG000|Overall Study|Only available minimal phone assessments|0|||
163237067|NCT00129259|589577650|FG001|Overall Study|Only available minimal phone assessments|1|||
163237068|NCT01609556|589577651|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
163237069|NCT01609556|589577652|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
163237070|NCT01609556|589577653|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
163237071|NCT01609556|589577654|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
163237072|NCT01609556|589577655|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
163237073|NCT01609556|589577656|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
163237074|NCT01609556|589577657|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
163237075|NCT01609556|589577658|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
163237076|NCT01609556|589577659|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
163237077|NCT01609556|589577660|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
163237078|NCT01609556|589577661|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
163237079|NCT01609556|589577662|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
163237080|NCT01609556|589577663|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
163237081|NCT01609556|589577664|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
163349121|NCT01544153|589987131|FG000|Overall Study|Under 18|0|||
163349122|NCT01544153|589987132|FG001|Overall Study|Under 18|1|||
163349123|NCT01544153|589987133|FG002|Overall Study|Under 18|0|||
163349124|NCT01544153|589987134|FG003|Overall Study|Under 18|0|||
163237082|NCT01609556|589577665|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
163237083|NCT01609556|589577666|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
163237084|NCT01609556|589577651|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
163237085|NCT01609556|589577652|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
163349125|NCT01544153|589987131|FG000|Overall Study|Non-smoker|0|||
163237086|NCT01609556|589577653|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
163237087|NCT01609556|589577654|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
163237088|NCT01609556|589577655|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
163237089|NCT01609556|589577656|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
163237090|NCT01609556|589577657|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
163237091|NCT01609556|589577658|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
163237092|NCT01609556|589577659|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
163237093|NCT01609556|589577660|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
163237094|NCT01609556|589577661|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
163237095|NCT01609556|589577662|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
163237096|NCT01609556|589577663|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
163237097|NCT01609556|589577664|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
163237098|NCT01609556|589577665|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
163237099|NCT01609556|589577666|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
163237100|NCT01609556|589577651|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
163237101|NCT01609556|589577652|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
163237102|NCT01609556|589577653|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
163237103|NCT01609556|589577654|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
163237104|NCT01609556|589577655|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
163237105|NCT01609556|589577656|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
163237106|NCT01609556|589577657|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
163237107|NCT01609556|589577658|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
163237108|NCT01609556|589577659|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
163237109|NCT01609556|589577660|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
163237110|NCT01609556|589577661|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
163237111|NCT01609556|589577662|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
163237112|NCT01609556|589577663|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
163237113|NCT01609556|589577664|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
163237114|NCT01609556|589577665|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
163237115|NCT01609556|589577666|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
163237116|NCT01609556|589577651|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
163237117|NCT01609556|589577652|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
163237118|NCT01609556|589577653|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
163237119|NCT01609556|589577654|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
163237120|NCT01609556|589577655|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
163237121|NCT01609556|589577656|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
163237122|NCT01609556|589577657|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
163237123|NCT01609556|589577658|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
163237124|NCT01609556|589577659|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
163237125|NCT01609556|589577660|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
163237126|NCT01609556|589577661|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
163237127|NCT01609556|589577662|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
163237128|NCT01609556|589577663|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
163237129|NCT01609556|589577664|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
163237130|NCT01609556|589577665|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
163237131|NCT01609556|589577666|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
163237132|NCT01609556|589577651|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
163237133|NCT01609556|589577652|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
163237134|NCT01609556|589577653|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
163237135|NCT01609556|589577654|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
163237136|NCT01609556|589577655|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
163237137|NCT01609556|589577656|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
163237138|NCT01609556|589577657|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
163237139|NCT01609556|589577658|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
163237140|NCT01609556|589577659|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
163237141|NCT01609556|589577660|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
163237142|NCT01609556|589577661|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
163237143|NCT01609556|589577662|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
163237144|NCT01609556|589577663|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
163237145|NCT01609556|589577664|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
163237146|NCT01609556|589577665|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
163237147|NCT01609556|589577666|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
163237148|NCT01609556|589577651|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
163237149|NCT01609556|589577652|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
163237150|NCT01609556|589577653|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
163237151|NCT01609556|589577654|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
163237152|NCT01609556|589577655|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
163237153|NCT01609556|589577656|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
163237154|NCT01609556|589577657|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
163237155|NCT01609556|589577658|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
163237156|NCT01609556|589577659|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
163237157|NCT01609556|589577660|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
163237158|NCT01609556|589577661|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
163237159|NCT01609556|589577662|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
163237160|NCT01609556|589577663|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
163237161|NCT01609556|589577664|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
163237162|NCT01609556|589577665|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
163237163|NCT01609556|589577666|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
163237164|NCT01609556|589577651|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
163237165|NCT01609556|589577652|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
163237166|NCT01609556|589577653|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
163237167|NCT01609556|589577654|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
163237168|NCT01609556|589577655|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
163237169|NCT01609556|589577656|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
163237170|NCT01609556|589577657|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
163237171|NCT01609556|589577658|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
163237172|NCT01609556|589577659|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
163237173|NCT01609556|589577660|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
163237174|NCT01609556|589577661|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
163237175|NCT01609556|589577662|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
163237176|NCT01609556|589577663|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
163237177|NCT01609556|589577664|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
163237178|NCT01609556|589577665|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
163237179|NCT01609556|589577666|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
163237180|NCT01609556|589577651|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
163237181|NCT01609556|589577652|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
163237182|NCT01609556|589577653|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
163237183|NCT01609556|589577654|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
163237184|NCT01609556|589577655|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
163237185|NCT01609556|589577656|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
163237186|NCT01609556|589577657|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
163237187|NCT01609556|589577658|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
163237188|NCT01609556|589577659|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
163237189|NCT01609556|589577660|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
163237190|NCT01609556|589577661|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
163237191|NCT01609556|589577662|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
163237192|NCT01609556|589577663|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
163237193|NCT01609556|589577664|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
163237194|NCT01609556|589577665|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
163237195|NCT01609556|589577666|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
163237196|NCT01609556|589577651|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
163237197|NCT01609556|589577652|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
163237198|NCT01609556|589577653|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
163237199|NCT01609556|589577654|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
163237200|NCT01609556|589577655|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
163237201|NCT01609556|589577656|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
163237202|NCT01609556|589577657|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
163237203|NCT01609556|589577658|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
163237204|NCT01609556|589577659|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
163237205|NCT01609556|589577660|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
163237206|NCT01609556|589577661|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
163237207|NCT01609556|589577662|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
163237208|NCT01609556|589577663|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
163237209|NCT01609556|589577664|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
163237210|NCT01609556|589577665|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
163237211|NCT01609556|589577666|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
163237212|NCT01609556|589577651|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
163237213|NCT01609556|589577652|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
163237214|NCT01609556|589577653|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
163349126|NCT01544153|589987132|FG001|Overall Study|Non-smoker|0|||
163237215|NCT01609556|589577654|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
163237216|NCT01609556|589577655|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
163237217|NCT01609556|589577656|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
163237218|NCT01609556|589577657|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
163237219|NCT01609556|589577658|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
163237220|NCT01609556|589577659|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
163237221|NCT01609556|589577660|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
163237222|NCT01609556|589577661|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
163237223|NCT01609556|589577662|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
163237224|NCT01609556|589577663|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
163237225|NCT01609556|589577664|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
163237226|NCT01609556|589577665|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
163237227|NCT01609556|589577666|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
163237228|NCT01609556|589577651|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163237229|NCT01609556|589577652|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163237230|NCT01609556|589577653|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163237231|NCT01609556|589577654|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163237232|NCT01609556|589577655|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163237233|NCT01609556|589577656|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163237234|NCT01609556|589577657|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163237235|NCT01609556|589577658|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163237236|NCT01609556|589577659|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163237237|NCT01609556|589577660|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163237238|NCT01609556|589577661|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163237239|NCT01609556|589577662|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163237240|NCT01609556|589577663|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
163237241|NCT01609556|589577664|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163237242|NCT01609556|589577665|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163237243|NCT01609556|589577666|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163237244|NCT01609556|589577651|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
163237245|NCT01609556|589577652|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
163237246|NCT01609556|589577653|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
163237247|NCT01609556|589577654|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
163237248|NCT01609556|589577655|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
163237249|NCT01609556|589577656|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
163237250|NCT01609556|589577657|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
163237251|NCT01609556|589577658|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
163237252|NCT01609556|589577659|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
163237253|NCT01609556|589577660|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
163237254|NCT01609556|589577661|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
163237255|NCT01609556|589577662|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
163237256|NCT01609556|589577663|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
163237257|NCT01609556|589577664|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
163237258|NCT01609556|589577665|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
163237259|NCT01609556|589577666|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
163237260|NCT01609556|589577651|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163237261|NCT01609556|589577652|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163237262|NCT01609556|589577653|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163237263|NCT01609556|589577654|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163237264|NCT01609556|589577655|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163237265|NCT01609556|589577656|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163237266|NCT01609556|589577657|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163237267|NCT01609556|589577658|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163237268|NCT01609556|589577659|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163237269|NCT01609556|589577660|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163237270|NCT01609556|589577661|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163237271|NCT01609556|589577662|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163237272|NCT01609556|589577663|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163349127|NCT01544153|589987133|FG002|Overall Study|Non-smoker|1|||
163349128|NCT01544153|589987134|FG003|Overall Study|Non-smoker|0|||
163349129|NCT00727259|589987139|FG000|Overall Study|Not all questionnaires completed|1055|||
163349130|NCT01021683|589987140|FG000|Overall Study|Lack of Efficacy|12|||
163349131|NCT01021683|589987140|FG000|Overall Study|Recovery of neutrophil count|51|||
163349132|NCT01021683|589987140|FG000|Overall Study|Other|8|||
163349133|NCT01374971|589987141|FG000|Overall Study|Withdrawal by Subject|1|||
163349134|NCT02273180|589987142|FG000|Overall Study|Adverse Event|2|||
163237273|NCT01609556|589577664|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163237274|NCT01609556|589577665|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163237275|NCT01609556|589577666|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
163237276|NCT01609556|589577651|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
163237277|NCT01609556|589577652|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
163237278|NCT01609556|589577653|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
163237279|NCT01609556|589577654|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
163237280|NCT01609556|589577655|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
163237281|NCT01609556|589577656|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
163237282|NCT01609556|589577657|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
163237283|NCT01609556|589577658|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
163237284|NCT01609556|589577659|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
163237285|NCT01609556|589577660|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
163237286|NCT01609556|589577661|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
163237287|NCT01609556|589577662|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
163237288|NCT01609556|589577663|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
163237289|NCT01609556|589577664|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
163237290|NCT01609556|589577665|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
163237291|NCT01609556|589577666|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
163237292|NCT01609556|589577651|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
163237293|NCT01609556|589577652|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
163237294|NCT01609556|589577653|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
163237295|NCT01609556|589577654|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
163237296|NCT01609556|589577655|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
163237297|NCT01609556|589577656|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
163237298|NCT01609556|589577657|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
163237299|NCT01609556|589577658|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
163237300|NCT01609556|589577659|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
163237301|NCT01609556|589577660|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
163237302|NCT01609556|589577661|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
163237303|NCT01609556|589577662|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
163237304|NCT01609556|589577663|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
163237305|NCT01609556|589577664|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
163237306|NCT01609556|589577665|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
163237307|NCT01609556|589577666|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
163237308|NCT01632579|589577669|FG000|Washout Period|Adverse Event|1|||
163237309|NCT01632579|589577670|FG001|Washout Period|Adverse Event|0|||
163237310|NCT01632579|589577671|FG002|Washout Period|Adverse Event|0|||
163237311|NCT01632579|589577672|FG003|Washout Period|Adverse Event|0|||
163237312|NCT01632579|589577673|FG004|Washout Period|Adverse Event|0|||
163237313|NCT01632579|589577674|FG005|Washout Period|Adverse Event|0|||
163237314|NCT01632579|589577675|FG006|Washout Period|Adverse Event|0|||
163237315|NCT01632579|589577676|FG007|Washout Period|Adverse Event|0|||
163237316|NCT01632579|589577677|FG008|Washout Period|Adverse Event|0|||
163237317|NCT01632579|589577669|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
163237318|NCT01632579|589577670|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
163237319|NCT01632579|589577671|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
163237320|NCT01632579|589577672|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
163237321|NCT01632579|589577673|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
163237322|NCT01632579|589577674|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
163237323|NCT01632579|589577675|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
163237324|NCT01632579|589577676|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
163237325|NCT01632579|589577677|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
163237326|NCT01539291|589579527|FG000|Study GS-US-312-0116|Adverse Event|9|||
163237327|NCT01539291|589579528|FG001|Study GS-US-312-0116|Adverse Event|0|||
163237328|NCT01539291|589579529|FG002|Study GS-US-312-0116|Adverse Event|0|||
163237329|NCT01539291|589579530|FG003|Study GS-US-312-0116|Adverse Event|0|||
163237330|NCT01539291|589579527|FG000|Study GS-US-312-0116|Physician Decision|1|||
163237331|NCT01539291|589579528|FG001|Study GS-US-312-0116|Physician Decision|0|||
163237332|NCT01539291|589579529|FG002|Study GS-US-312-0116|Physician Decision|0|||
163237333|NCT01539291|589579530|FG003|Study GS-US-312-0116|Physician Decision|0|||
163237334|NCT01539291|589579527|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
163237335|NCT01539291|589579528|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
163237336|NCT01539291|589579529|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
163237337|NCT01539291|589579530|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
163237338|NCT01539291|589579527|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
163237339|NCT01539291|589579528|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
163237340|NCT01539291|589579529|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
163237341|NCT01539291|589579530|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
163237342|NCT01539291|589579527|FG000|Study GS-US-312-0116|Other|1|||
163349135|NCT02273180|589987143|FG001|Overall Study|Adverse Event|2|||
163349136|NCT02273180|589987142|FG000|Overall Study|Lack of Efficacy|1|||
163237343|NCT01539291|589579528|FG001|Study GS-US-312-0116|Other|0|||
163237344|NCT01539291|589579529|FG002|Study GS-US-312-0116|Other|0|||
163237345|NCT01539291|589579530|FG003|Study GS-US-312-0116|Other|0|||
163237346|NCT01539291|589579527|FG000|Study GS-US-312-0117|Adverse Event|22|||
163237347|NCT01539291|589579528|FG001|Study GS-US-312-0117|Adverse Event|1|||
163237348|NCT01539291|589579529|FG002|Study GS-US-312-0117|Adverse Event|9|||
163237349|NCT01539291|589579530|FG003|Study GS-US-312-0117|Adverse Event|12|||
163237350|NCT01539291|589579527|FG000|Study GS-US-312-0117|Physician Decision|9|||
163237351|NCT01539291|589579528|FG001|Study GS-US-312-0117|Physician Decision|0|||
163237352|NCT01539291|589579529|FG002|Study GS-US-312-0117|Physician Decision|6|||
163237353|NCT01539291|589579530|FG003|Study GS-US-312-0117|Physician Decision|4|||
163237354|NCT01539291|589579527|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
163237355|NCT01539291|589579528|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
163237356|NCT01539291|589579529|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
163237357|NCT01539291|589579530|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
163237358|NCT01539291|589579527|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
163237359|NCT01539291|589579528|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
163237360|NCT01539291|589579529|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
163237361|NCT01539291|589579530|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
163237362|NCT01539291|589579527|FG000|Study GS-US-312-0117|Other|2|||
163237363|NCT01539291|589579528|FG001|Study GS-US-312-0117|Other|1|||
163237364|NCT01539291|589579529|FG002|Study GS-US-312-0117|Other|1|||
163237365|NCT01539291|589579530|FG003|Study GS-US-312-0117|Other|1|||
163237366|NCT00129987|589579535|FG000|1st Educational Session|Withdrawal by Subject|141|||
163237367|NCT00129987|589579536|FG001|1st Educational Session|Withdrawal by Subject|109|||
163237368|NCT00129987|589579535|FG000|1 Year|Withdrawal by Subject|32|||
163237369|NCT00129987|589579536|FG001|1 Year|Withdrawal by Subject|21|||
163237370|NCT00116805|589579537|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
163237371|NCT00116805|589579538|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
163237372|NCT00116805|589579537|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
163237373|NCT00116805|589579538|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
163237374|NCT00116805|589579537|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
163237375|NCT00116805|589579538|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
163237376|NCT00116805|589579537|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
163237377|NCT00116805|589579538|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
163237378|NCT00116805|589579537|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
163237379|NCT00116805|589579538|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
163237380|NCT00116805|589579537|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
163237381|NCT00116805|589579538|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
163237382|NCT00116805|589579537|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
163237383|NCT00116805|589579538|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
163237384|NCT00116805|589579537|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
163237385|NCT00116805|589579538|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
163237386|NCT00116805|589579537|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
163237387|NCT00116805|589579538|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
163237388|NCT00116805|589579537|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
163237389|NCT00116805|589579538|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
163237390|NCT00116805|589579537|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
163237391|NCT00116805|589579538|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
163237392|NCT00116805|589579537|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
163237393|NCT00116805|589579538|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
163237394|NCT00116805|589579537|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
163237395|NCT00116805|589579538|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
163237396|NCT00116805|589579537|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
163237397|NCT00116805|589579538|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
163237398|NCT00116805|589579537|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
163237399|NCT00116805|589579538|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
163237400|NCT00116805|589579537|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
163237401|NCT00116805|589579538|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
163237402|NCT00116805|589579537|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
163237403|NCT00116805|589579538|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
163237404|NCT00116805|589579537|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
163237405|NCT00116805|589579538|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
163237406|NCT00116805|589579537|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
163237407|NCT00116805|589579538|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
163237408|NCT00116805|589579537|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
163237409|NCT00116805|589579538|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
163349137|NCT02273180|589987143|FG001|Overall Study|Lack of Efficacy|0|||
163349138|NCT02273180|589987142|FG000|Overall Study|Protocol Violation|1|||
163237410|NCT00116805|589579537|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
163237411|NCT00116805|589579538|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
163237412|NCT00116805|589579537|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
163237413|NCT00116805|589579538|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
163237414|NCT00116805|589579537|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
163237415|NCT00116805|589579538|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
163237416|NCT00116805|589579537|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
163237417|NCT00116805|589579538|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
163237418|NCT00116805|589579537|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
163237419|NCT00116805|589579538|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
163237420|NCT00116805|589579537|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
163237421|NCT00116805|589579538|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
163237422|NCT00116805|589579537|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
163237423|NCT00116805|589579538|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
163237424|NCT00116805|589579537|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
163237425|NCT00116805|589579538|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
163237426|NCT00116805|589579537|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
163237427|NCT00116805|589579538|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
163237428|NCT00116805|589579537|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
163237429|NCT00116805|589579538|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
163237430|NCT00116805|589579537|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
163237431|NCT00116805|589579538|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
163237432|NCT00116805|589579537|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
163237433|NCT00116805|589579538|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
163237434|NCT00116805|589579537|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
163237435|NCT00116805|589579538|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
163237436|NCT00116805|589579537|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
163237437|NCT00116805|589579538|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
163237438|NCT00116805|589579537|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
163237439|NCT00116805|589579538|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
163237440|NCT00116805|589579537|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
163237441|NCT00116805|589579538|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
163237442|NCT00116805|589579537|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
163237443|NCT00116805|589579538|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
163237444|NCT00116805|589579537|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
163237445|NCT00116805|589579538|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
163237446|NCT00116805|589579537|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
163237447|NCT00116805|589579538|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
163237448|NCT00116805|589579537|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
163237449|NCT00116805|589579538|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
163237450|NCT00116805|589579537|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
163237451|NCT00116805|589579538|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
163237452|NCT00116805|589579537|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
163237453|NCT00116805|589579538|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
163237454|NCT00116805|589579537|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
163237455|NCT00116805|589579538|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
163237456|NCT00116805|589579537|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
163237457|NCT00116805|589579538|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
163237458|NCT00116805|589579537|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
163237459|NCT00116805|589579538|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
163237460|NCT01159938|589579539|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
163237461|NCT01159938|589579540|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
163237462|NCT01159938|589579541|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
163237463|NCT01159938|589579542|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
163237464|NCT01159938|589579543|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
163237465|NCT02105116|589579545|FG000|Overall Study|not eligible for step 2 of trial|5|||
163237466|NCT02105116|589579545|FG000|Overall Study|Death|1|||
163237467|NCT02318329|589579547|FG000|Overall Study|Progressive Disease|2|||
163237468|NCT02318329|589579548|FG001|Overall Study|Progressive Disease|3|||
163349139|NCT02273180|589987143|FG001|Overall Study|Protocol Violation|7|||
163349140|NCT02273180|589987142|FG000|Overall Study|Randomized but not treated|1|||
163349141|NCT02273180|589987143|FG001|Overall Study|Randomized but not treated|0|||
163349142|NCT02273180|589987142|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
163349143|NCT02273180|589987143|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
163349144|NCT02273180|589987142|FG000|Overall Study|Other than specified above|21|||
163349145|NCT02273180|589987143|FG001|Overall Study|Other than specified above|10|||
163237469|NCT02318329|589579549|FG002|Overall Study|Progressive Disease|2|||
163237470|NCT02318329|589579550|FG003|Overall Study|Progressive Disease|3|||
163237471|NCT02318329|589579551|FG004|Overall Study|Progressive Disease|3|||
163237472|NCT02318329|589579552|FG005|Overall Study|Progressive Disease|3|||
163237473|NCT02318329|589579553|FG006|Overall Study|Progressive Disease|1|||
163237474|NCT02318329|589579554|FG007|Overall Study|Progressive Disease|1|||
163237475|NCT02318329|589579555|FG008|Overall Study|Progressive Disease|5|||
163237476|NCT02318329|589579556|FG009|Overall Study|Progressive Disease|39|||
163237477|NCT02318329|589579547|FG000|Overall Study|Death|0|||
163237478|NCT02318329|589579548|FG001|Overall Study|Death|0|||
163237479|NCT02318329|589579549|FG002|Overall Study|Death|0|||
163237480|NCT02318329|589579550|FG003|Overall Study|Death|0|||
163237481|NCT02318329|589579551|FG004|Overall Study|Death|0|||
163237482|NCT02318329|589579552|FG005|Overall Study|Death|0|||
163237483|NCT02318329|589579553|FG006|Overall Study|Death|0|||
163237484|NCT02318329|589579554|FG007|Overall Study|Death|0|||
163237485|NCT02318329|589579555|FG008|Overall Study|Death|0|||
163237486|NCT02318329|589579556|FG009|Overall Study|Death|5|||
163237487|NCT02318329|589579547|FG000|Overall Study|Lost to Follow-up|0|||
163237488|NCT02318329|589579548|FG001|Overall Study|Lost to Follow-up|0|||
163237489|NCT02318329|589579549|FG002|Overall Study|Lost to Follow-up|0|||
163237490|NCT02318329|589579550|FG003|Overall Study|Lost to Follow-up|0|||
163237491|NCT02318329|589579551|FG004|Overall Study|Lost to Follow-up|0|||
163237492|NCT02318329|589579552|FG005|Overall Study|Lost to Follow-up|0|||
163237493|NCT02318329|589579553|FG006|Overall Study|Lost to Follow-up|0|||
163237494|NCT02318329|589579554|FG007|Overall Study|Lost to Follow-up|0|||
163237495|NCT02318329|589579555|FG008|Overall Study|Lost to Follow-up|0|||
163237496|NCT02318329|589579556|FG009|Overall Study|Lost to Follow-up|1|||
163237497|NCT02318329|589579547|FG000|Overall Study|Withdrawal by Subject|0|||
163237498|NCT02318329|589579548|FG001|Overall Study|Withdrawal by Subject|0|||
163237499|NCT02318329|589579549|FG002|Overall Study|Withdrawal by Subject|0|||
163237500|NCT02318329|589579550|FG003|Overall Study|Withdrawal by Subject|0|||
163237501|NCT02318329|589579551|FG004|Overall Study|Withdrawal by Subject|0|||
163237502|NCT02318329|589579552|FG005|Overall Study|Withdrawal by Subject|0|||
163237503|NCT02318329|589579553|FG006|Overall Study|Withdrawal by Subject|0|||
163237504|NCT02318329|589579554|FG007|Overall Study|Withdrawal by Subject|0|||
163237505|NCT02318329|589579555|FG008|Overall Study|Withdrawal by Subject|0|||
163237506|NCT02318329|589579556|FG009|Overall Study|Withdrawal by Subject|6|||
163237507|NCT02318329|589579547|FG000|Overall Study|Other|1|||
163237508|NCT02318329|589579548|FG001|Overall Study|Other|1|||
163237509|NCT02318329|589579549|FG002|Overall Study|Other|1|||
163237510|NCT02318329|589579550|FG003|Overall Study|Other|0|||
163237511|NCT02318329|589579551|FG004|Overall Study|Other|0|||
163237512|NCT02318329|589579552|FG005|Overall Study|Other|0|||
163237513|NCT02318329|589579553|FG006|Overall Study|Other|0|||
163237514|NCT02318329|589579554|FG007|Overall Study|Other|0|||
163237515|NCT02318329|589579555|FG008|Overall Study|Other|1|||
163237516|NCT02318329|589579556|FG009|Overall Study|Other|1|||
163237517|NCT04837482|589579557|FG000|Period 2|Withdrawal by Subject|0|||
163237518|NCT04837482|589579558|FG001|Period 2|Withdrawal by Subject|1|||
163237519|NCT00581945|589579559|FG000|Overall Study|Adverse Event|4|||
163237520|NCT00581945|589579560|FG001|Overall Study|Adverse Event|4|||
163237521|NCT00581945|589579559|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163237522|NCT00581945|589579560|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163237523|NCT00581945|589579559|FG000|Overall Study|Withdrawal by Subject|2|||
163237524|NCT00581945|589579560|FG001|Overall Study|Withdrawal by Subject|6|||
163237525|NCT00581945|589579559|FG000|Overall Study|Death|1|||
163237526|NCT00581945|589579560|FG001|Overall Study|Death|0|||
163237527|NCT02979535|589579561|FG000|Overall Study|Non compliance with the protocol|78|||
163237528|NCT02979535|589579562|FG001|Overall Study|Non compliance with the protocol|82|||
163349146|NCT04531813|589987144|FG000|Overall Study|Protocol Violation|1|||
163237529|NCT02979535|589579561|FG000|Overall Study|Consent withdrawn by participant|11|||
163349147|NCT04531813|589987144|FG000|Overall Study|Withdrawal by Subject|1|||
163349148|NCT04341584|589987147|FG000|Overall Study|Withdrew consent|0|||
163349149|NCT04341584|589987148|FG001|Overall Study|Withdrew consent|2|||
163349150|NCT04341584|589987149|FG002|Overall Study|Withdrew consent|2|||
163237530|NCT02979535|589579562|FG001|Overall Study|Consent withdrawn by participant|18|||
163237531|NCT02979535|589579561|FG000|Overall Study|Lost to Follow-up|6|||
163237532|NCT02979535|589579562|FG001|Overall Study|Lost to Follow-up|1|||
163237533|NCT04820673|589579563|FG000|Overall Study|Adverse Event|6|||
163349151|NCT04341584|589987150|FG003|Overall Study|Withdrew consent|1|||
163237534|NCT04820673|589579563|FG000|Overall Study|Due to Lack of Effectiveness|1|||
163237535|NCT04820673|589579563|FG000|Overall Study|Pregnancy|1|||
163237536|NCT04820673|589579563|FG000|Overall Study|Voluntary Withdrawal|20|||
163237537|NCT04820673|589579563|FG000|Overall Study|Lost to Follow-up|10|||
163349152|NCT00381797|589988428|FG000|Overall Study|Withdrawal by Subject|1|||
163237538|NCT00587587|589579566|FG000|Overall Study|Lost to Follow-up|6|||
163237539|NCT00587587|589579567|FG001|Overall Study|Lost to Follow-up|1|||
163237540|NCT02032901|589579570|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
163237541|NCT02032901|589579571|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
163237542|NCT02032901|589579570|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
163237543|NCT02032901|589579571|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
163237544|NCT00466193|589579572|FG000|Overall Study|Adverse Event|0|||
163237545|NCT00466193|589579573|FG001|Overall Study|Adverse Event|1|||
163237546|NCT00466193|589579572|FG000|Overall Study|Lost to Follow-up|2|||
163237547|NCT00466193|589579573|FG001|Overall Study|Lost to Follow-up|4|||
163237548|NCT00466193|589579572|FG000|Overall Study|Physician Decision|1|||
163237549|NCT00466193|589579573|FG001|Overall Study|Physician Decision|0|||
163237550|NCT00466193|589579572|FG000|Overall Study|Protocol Violation|1|||
163237551|NCT00466193|589579573|FG001|Overall Study|Protocol Violation|1|||
163237552|NCT00466193|589579572|FG000|Overall Study|Withdrawal by Subject|7|||
163237553|NCT00466193|589579573|FG001|Overall Study|Withdrawal by Subject|2|||
163237554|NCT00466193|589579572|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
163237555|NCT00466193|589579573|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
163237556|NCT00086346|589579580|FG000|Randomization|Did not receive test article|4|||
163237557|NCT00086346|589579581|FG001|Randomization|Did not receive test article|4|||
163237558|NCT00086346|589579580|FG000|Patients Dosed With Test Article|Adverse Event|94|||
163237559|NCT00086346|589579581|FG001|Patients Dosed With Test Article|Adverse Event|11|||
163237560|NCT00086346|589579580|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
163237561|NCT00086346|589579581|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
163237562|NCT00086346|589579580|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
163237563|NCT00086346|589579581|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
163237564|NCT00086346|589579580|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
163237565|NCT00086346|589579581|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
163237566|NCT00086346|589579580|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
163237567|NCT00086346|589579581|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
163237568|NCT00086346|589579580|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
163237569|NCT00086346|589579581|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
163237570|NCT04495374|589579582|FG000|Overall Study|Protocol Violation|2|||
163237571|NCT04495374|589579583|FG001|Overall Study|Protocol Violation|1|||
163237572|NCT02473614|589579584|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
163237573|NCT02473614|589579585|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
163237574|NCT02525133|589579586|FG000|Overall Study|Adverse Event|0|||
163237575|NCT02525133|589579587|FG001|Overall Study|Adverse Event|1|||
163237576|NCT02525133|589579586|FG000|Overall Study|Death|0|||
163237577|NCT02525133|589579587|FG001|Overall Study|Death|1|||
163237578|NCT02525133|589579586|FG000|Overall Study|did not meet randomization criteria|1|||
163237579|NCT02525133|589579587|FG001|Overall Study|did not meet randomization criteria|0|||
163237580|NCT02525133|589579586|FG000|Overall Study|Lost to Follow-up|5|||
163237581|NCT02525133|589579587|FG001|Overall Study|Lost to Follow-up|1|||
163237582|NCT02525133|589579586|FG000|Overall Study|randomized not enrolled|3|||
163237583|NCT02525133|589579587|FG001|Overall Study|randomized not enrolled|0|||
163237584|NCT02525133|589579586|FG000|Overall Study|Withdrawal by Subject|1|||
163237585|NCT02525133|589579587|FG001|Overall Study|Withdrawal by Subject|0|||
163237586|NCT01343082|589579588|FG000|The run-in Period|Not meeting criteria|3|||
163237587|NCT01343082|589579589|FG001|The run-in Period|Not meeting criteria|4|||
163237588|NCT01343082|589579590|FG002|The run-in Period|Not meeting criteria|5|||
163237589|NCT01343082|589579588|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
163237590|NCT01343082|589579589|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
163237591|NCT01343082|589579590|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
163237592|NCT01343082|589579588|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
163237593|NCT01343082|589579589|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
163237594|NCT01343082|589579590|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
163237595|NCT01343082|589579588|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
163237596|NCT01343082|589579589|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
163237597|NCT01343082|589579590|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
163237598|NCT01343082|589579588|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
163237599|NCT01343082|589579589|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
163237600|NCT01343082|589579590|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
163237601|NCT01075074|589579591|FG000|Overall Study|Surgeon changed to open incisional case|1|||
163237602|NCT01075074|589579592|FG001|Overall Study|Surgeon changed to open incisional case|2|||
163349153|NCT00381797|589988429|FG001|Overall Study|Withdrawal by Subject|1|||
163349154|NCT00381797|589988430|FG002|Overall Study|Withdrawal by Subject|0|||
163237603|NCT01075074|589579593|FG002|Overall Study|Surgeon changed to open incisional case|2|||
163237604|NCT01575561|589579595|FG000|Overall Study|Adverse Event|9|||
163237605|NCT01575561|589579595|FG000|Overall Study|Lack of Efficacy|8|||
163237606|NCT01575561|589579595|FG000|Overall Study|Lost to Follow-up|6|||
163237607|NCT01575561|589579595|FG000|Overall Study|Protocol Violation|4|||
163237608|NCT01575561|589579595|FG000|Overall Study|Withdrawal by Subject|11|||
163237609|NCT01575561|589579595|FG000|Overall Study|administration|1|||
163237610|NCT01172938|589579597|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
163237611|NCT01172938|589579598|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
163237612|NCT01172938|589579599|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
163237613|NCT01172938|589579600|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163237614|NCT01172938|589579601|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163237615|NCT01172938|589579602|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163237616|NCT01172938|589579603|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163237617|NCT01172938|589579604|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163237618|NCT01172938|589579605|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163237619|NCT01172938|589579597|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
163237620|NCT01172938|589579598|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
163237621|NCT01172938|589579599|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
163237622|NCT01172938|589579600|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163237623|NCT01172938|589579601|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163237624|NCT01172938|589579602|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163237625|NCT01172938|589579603|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163237626|NCT01172938|589579604|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163237627|NCT01172938|589579605|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163237628|NCT01172938|589579597|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163237629|NCT01172938|589579598|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
163237630|NCT01172938|589579599|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
163237631|NCT01172938|589579600|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163237632|NCT01172938|589579601|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163237633|NCT01172938|589579602|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163237634|NCT01172938|589579603|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163237635|NCT01172938|589579604|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163237636|NCT01172938|589579605|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163237637|NCT01172938|589579597|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
163237638|NCT01172938|589579598|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
163237639|NCT01172938|589579599|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
163237640|NCT01172938|589579600|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163237641|NCT01172938|589579601|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163237642|NCT01172938|589579602|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163237643|NCT01172938|589579603|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163237644|NCT01172938|589579604|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163237645|NCT01172938|589579605|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163237646|NCT01172938|589579597|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
163237647|NCT01172938|589579598|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
163237648|NCT01172938|589579599|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
163237649|NCT01172938|589579600|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
163237650|NCT01172938|589579601|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
163237651|NCT01172938|589579602|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
163237652|NCT01172938|589579603|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
163237653|NCT01172938|589579604|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
163237654|NCT01172938|589579605|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
163237655|NCT01172938|589579597|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
163237656|NCT01172938|589579598|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163237657|NCT01172938|589579599|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163237658|NCT01172938|589579600|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163237659|NCT01172938|589579601|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163237660|NCT01172938|589579602|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163349155|NCT00381797|589988431|FG003|Overall Study|Withdrawal by Subject|0|||
163349156|NCT00381797|589988432|FG004|Overall Study|Withdrawal by Subject|2|||
163237661|NCT01172938|589579603|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163349157|NCT00381797|589988428|FG000|Overall Study|Ineligible|0|||
163349158|NCT00381797|589988429|FG001|Overall Study|Ineligible|0|||
163349159|NCT00381797|589988430|FG002|Overall Study|Ineligible|0|||
163349160|NCT00381797|589988431|FG003|Overall Study|Ineligible|1|||
163349161|NCT00381797|589988432|FG004|Overall Study|Ineligible|0|||
163349162|NCT01990313|589988436|FG000|Overall Study|Lost to Follow-up|1|||
163349163|NCT00837096|589988438|FG000|Overall Study|Physician Decision|1|||
163349164|NCT00837096|589988439|FG001|Overall Study|Physician Decision|1|||
163349165|NCT00837096|589988438|FG000|Overall Study|Not reported|9|||
163349166|NCT00837096|589988439|FG001|Overall Study|Not reported|8|||
163349167|NCT00721214|589988440|FG000|Overall Study|Chose another center for transplant|1|||
163349168|NCT00721214|589988440|FG000|Overall Study|Death|3|||
163349169|NCT00983905|589988441|FG000|Theophylline Alone|Adverse Event|1|||
163349170|NCT00983905|589988441|FG000|Colchicine Alone|Adverse Event|2|||
163349171|NCT01169636|589988442|FG000|Overall Study|Adverse Event|0|||
163349172|NCT01169636|589988443|FG001|Overall Study|Adverse Event|0|||
163349173|NCT01169636|589988444|FG002|Overall Study|Adverse Event|1|||
163349174|NCT01169636|589988445|FG003|Overall Study|Adverse Event|1|||
163349175|NCT01169636|589988446|FG004|Overall Study|Adverse Event|0|||
163237662|NCT01172938|589579604|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163237663|NCT01172938|589579605|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163237664|NCT01172938|589579597|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
163237665|NCT01172938|589579598|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
163237666|NCT01172938|589579599|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
163237667|NCT01172938|589579600|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
163237668|NCT01172938|589579601|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
163237669|NCT01172938|589579602|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
163237670|NCT01172938|589579603|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
163237671|NCT01172938|589579604|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
163237672|NCT01172938|589579605|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
163237673|NCT01172938|589579597|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
163237674|NCT01172938|589579598|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
163237675|NCT01172938|589579599|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
163237676|NCT01172938|589579600|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
163237677|NCT01172938|589579601|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
163237678|NCT01172938|589579602|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
163237679|NCT01172938|589579603|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
163237680|NCT01172938|589579604|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
163237681|NCT01172938|589579605|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
163237682|NCT01172938|589579597|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
163237683|NCT01172938|589579598|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
163237684|NCT01172938|589579599|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
163237685|NCT01172938|589579600|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
163237686|NCT01172938|589579601|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
163237687|NCT01172938|589579602|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
163237688|NCT01172938|589579603|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
163237689|NCT01172938|589579604|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
163237690|NCT01172938|589579605|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
163237691|NCT01172938|589579597|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
163237692|NCT01172938|589579598|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
163237693|NCT01172938|589579599|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
163237694|NCT01172938|589579600|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
163237695|NCT01172938|589579601|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
163237696|NCT01172938|589579602|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
163237697|NCT01172938|589579603|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
163237698|NCT01172938|589579604|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
163237699|NCT01172938|589579605|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
163237700|NCT01172938|589579597|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
163237701|NCT01172938|589579598|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
163237702|NCT01172938|589579599|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
163237703|NCT01172938|589579600|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
163237704|NCT01172938|589579601|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
163237705|NCT01172938|589579602|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
163237706|NCT01172938|589579603|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
163237707|NCT01172938|589579604|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
163237708|NCT01172938|589579605|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
163237709|NCT01172938|589579597|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
163237710|NCT01172938|589579598|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
163237711|NCT01172938|589579599|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
163237712|NCT01172938|589579600|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
163237713|NCT01172938|589579601|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
163237714|NCT01172938|589579602|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
163237715|NCT01172938|589579603|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
163237716|NCT01172938|589579604|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
163237717|NCT01172938|589579605|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
163237718|NCT01172938|589579597|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
163349176|NCT01169636|589988442|FG000|Overall Study|Screen failure|0|||
163349177|NCT01169636|589988443|FG001|Overall Study|Screen failure|0|||
163349178|NCT01169636|589988444|FG002|Overall Study|Screen failure|2|||
163349179|NCT01169636|589988445|FG003|Overall Study|Screen failure|0|||
163349180|NCT01169636|589988446|FG004|Overall Study|Screen failure|0|||
163349181|NCT01169636|589988442|FG000|Overall Study|Withdrawal by Subject|0|||
163349182|NCT01169636|589988443|FG001|Overall Study|Withdrawal by Subject|0|||
163349183|NCT01169636|589988444|FG002|Overall Study|Withdrawal by Subject|0|||
163349184|NCT01169636|589988445|FG003|Overall Study|Withdrawal by Subject|0|||
163349185|NCT01169636|589988446|FG004|Overall Study|Withdrawal by Subject|3|||
163349186|NCT02396953|589988447|FG000|Overall Study|Withdrawal by Subject|0|||
163349187|NCT02396953|589988448|FG001|Overall Study|Withdrawal by Subject|0|||
163349188|NCT02396953|589988449|FG002|Overall Study|Withdrawal by Subject|1|||
163349189|NCT02396953|589988447|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
163144216|NCT01329978|589237263|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
163144217|NCT01329978|589237264|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
163144218|NCT01329978|589237265|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
163144219|NCT01329978|589237266|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
163144220|NCT01188772|589237268|FG000|Overall Study|Randomized but Not Treated|0|||
163144221|NCT01188772|589237269|FG001|Overall Study|Randomized but Not Treated|1|||
163144222|NCT01188772|589237270|FG002|Overall Study|Randomized but Not Treated|0|||
163144223|NCT01188772|589237271|FG003|Overall Study|Randomized but Not Treated|0|||
163144224|NCT01188772|589237268|FG000|Overall Study|Adverse Event|0|||
163144225|NCT01188772|589237269|FG001|Overall Study|Adverse Event|1|||
163144226|NCT01188772|589237270|FG002|Overall Study|Adverse Event|2|||
163144227|NCT01188772|589237271|FG003|Overall Study|Adverse Event|0|||
163144228|NCT01188772|589237268|FG000|Overall Study|Lost to Follow-up|4|||
163144229|NCT01188772|589237269|FG001|Overall Study|Lost to Follow-up|1|||
163144230|NCT01188772|589237270|FG002|Overall Study|Lost to Follow-up|1|||
163144231|NCT01188772|589237271|FG003|Overall Study|Lost to Follow-up|1|||
163144232|NCT01188772|589237268|FG000|Overall Study|Non-responder|0|||
163144233|NCT01188772|589237269|FG001|Overall Study|Non-responder|0|||
163144234|NCT01188772|589237270|FG002|Overall Study|Non-responder|3|||
163144235|NCT01188772|589237271|FG003|Overall Study|Non-responder|0|||
163144236|NCT01188772|589237268|FG000|Overall Study|Physician Decision|0|||
163144237|NCT01188772|589237269|FG001|Overall Study|Physician Decision|0|||
163144238|NCT01188772|589237270|FG002|Overall Study|Physician Decision|1|||
163144239|NCT01188772|589237271|FG003|Overall Study|Physician Decision|0|||
163144240|NCT01188772|589237268|FG000|Overall Study|Terminated by Sponsor|0|||
163144241|NCT01188772|589237269|FG001|Overall Study|Terminated by Sponsor|0|||
163144242|NCT01188772|589237270|FG002|Overall Study|Terminated by Sponsor|1|||
163144243|NCT01188772|589237271|FG003|Overall Study|Terminated by Sponsor|0|||
163144244|NCT01188772|589237268|FG000|Overall Study|Treatment Failure|0|||
163144245|NCT01188772|589237269|FG001|Overall Study|Treatment Failure|0|||
163144246|NCT01188772|589237270|FG002|Overall Study|Treatment Failure|1|||
163144247|NCT01188772|589237271|FG003|Overall Study|Treatment Failure|0|||
163144248|NCT01188772|589237268|FG000|Overall Study|Virologic Failure|1|||
163144249|NCT01188772|589237269|FG001|Overall Study|Virologic Failure|0|||
163144250|NCT01188772|589237270|FG002|Overall Study|Virologic Failure|0|||
163144251|NCT01188772|589237271|FG003|Overall Study|Virologic Failure|0|||
163144252|NCT01188772|589237268|FG000|Overall Study|Withdrawal by Subject|0|||
163144253|NCT01188772|589237269|FG001|Overall Study|Withdrawal by Subject|0|||
163144254|NCT01188772|589237270|FG002|Overall Study|Withdrawal by Subject|2|||
163144255|NCT01188772|589237271|FG003|Overall Study|Withdrawal by Subject|0|||
163144256|NCT03081884|589237275|FG000|Overall Study|deferred prostate cancer treatment|1|||
163144257|NCT03081884|589237275|FG000|Overall Study|metastasis managed with systemic therapy|3|||
163144258|NCT02294058|589237276|FG000|Overall Study|Adverse Event|16|||
163144259|NCT02294058|589237277|FG001|Overall Study|Adverse Event|7|||
163144260|NCT02294058|589237278|FG002|Overall Study|Adverse Event|13|||
163144261|NCT02294058|589237276|FG000|Overall Study|Lack of Efficacy|3|||
163144262|NCT02294058|589237277|FG001|Overall Study|Lack of Efficacy|3|||
163144263|NCT02294058|589237278|FG002|Overall Study|Lack of Efficacy|0|||
163144264|NCT02294058|589237276|FG000|Overall Study|Lost to Follow-up|1|||
163144265|NCT02294058|589237277|FG001|Overall Study|Lost to Follow-up|0|||
163144266|NCT02294058|589237278|FG002|Overall Study|Lost to Follow-up|2|||
163144267|NCT02294058|589237276|FG000|Overall Study|Withdrawal by Subject|10|||
163144268|NCT02294058|589237277|FG001|Overall Study|Withdrawal by Subject|14|||
163144269|NCT02294058|589237278|FG002|Overall Study|Withdrawal by Subject|13|||
163144270|NCT02294058|589237276|FG000|Overall Study|Physician Decision|2|||
163144271|NCT02294058|589237277|FG001|Overall Study|Physician Decision|1|||
163144272|NCT02294058|589237278|FG002|Overall Study|Physician Decision|0|||
163144273|NCT02294058|589237276|FG000|Overall Study|Miscellaneous|4|||
163144274|NCT02294058|589237277|FG001|Overall Study|Miscellaneous|1|||
163144275|NCT02294058|589237278|FG002|Overall Study|Miscellaneous|1|||
163144276|NCT00152503|589237289|FG000|Overall Study|Adverse Event|4|||
163144277|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
163144278|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
163144279|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
163144280|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
163144281|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
163144282|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
163144283|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
163144284|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
163237719|NCT01172938|589579598|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
163237720|NCT01172938|589579599|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
163237721|NCT01172938|589579600|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
163237722|NCT01172938|589579601|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
163237723|NCT01172938|589579602|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
163237724|NCT01172938|589579603|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
163237725|NCT01172938|589579604|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
163237726|NCT01172938|589579605|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
163237727|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
163237728|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
163237729|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
163237730|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
163237731|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
163237732|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
163237733|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
163237734|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
163237735|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
163237736|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
163237737|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
163237738|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
163237739|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
163237740|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
163237741|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
163237742|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
163237743|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
163237744|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
163237745|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
163237746|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
163237747|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
163237748|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
163237749|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
163237750|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
163237751|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
163237752|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
163237753|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
163237754|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
163237755|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
163237756|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
163237757|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
163237758|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
163237759|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
163237760|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
163237761|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
163237762|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
163237763|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
163237764|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
163237765|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
163237766|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
163237767|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
163237768|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
163237769|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
163237770|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
163349190|NCT02396953|589988448|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
163349191|NCT02396953|589988449|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
163349192|NCT02396953|589988447|FG000|Overall Study|Personal Reasons|1|||
163349193|NCT02396953|589988448|FG001|Overall Study|Personal Reasons|1|||
163349194|NCT02396953|589988449|FG002|Overall Study|Personal Reasons|0|||
163349195|NCT00510198|589988450|FG000|Overall Study|Withdrawal by Subject|5|||
163237771|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
163237772|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
163237773|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
163237774|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
163237775|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
163349196|NCT00510198|589988451|FG001|Overall Study|Withdrawal by Subject|4|||
163349197|NCT00494026|589988453|FG000|Overall Study|Sponsor Decision|4|||
163349198|NCT02466243|589988454|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
163409659|NCT04681170|590209463|FG001|Open Label Safety Phase|AEs and none compliance|1|||
163409660|NCT01407926|590209468|FG000|Overall Study|Lost to Follow-up|55|||
163409661|NCT02468648|590209469|FG000|Overall Study|Death|1|||
163409662|NCT02118792|590209470|FG000|Overall Study|Withdrawal by Subject|6|||
163409663|NCT02118792|590209471|FG001|Overall Study|Withdrawal by Subject|3|||
163409664|NCT02118792|590209470|FG000|Overall Study|Lost to Follow-up|4|||
163409665|NCT02118792|590209471|FG001|Overall Study|Lost to Follow-up|4|||
163409666|NCT02118792|590209470|FG000|Overall Study|Adverse Event|5|||
163409667|NCT02118792|590209471|FG001|Overall Study|Adverse Event|4|||
163409668|NCT02118792|590209470|FG000|Overall Study|Withdrawal by parent/guardian|14|||
163237776|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
163237777|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
163237778|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
163237779|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
163237780|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
163237781|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
163237782|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
163237783|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
163237784|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
163237785|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
163237786|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
163349199|NCT02466243|589988455|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
163349200|NCT02466243|589988454|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
163349201|NCT02466243|589988455|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
163349202|NCT02466243|589988454|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
163349203|NCT02466243|589988455|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
163349204|NCT02466243|589988454|FG000|Part B Open-label Treatment Period|Missing|2|||
163349205|NCT02466243|589988455|FG001|Part B Open-label Treatment Period|Missing|2|||
163349206|NCT00307164|589988458|FG000|Overall Study|Death|1|||
163349207|NCT00307164|589988459|FG001|Overall Study|Death|0|||
163349208|NCT00307164|589988458|FG000|Overall Study|Severe debilitation, unable to continue|1|||
163349209|NCT00307164|589988459|FG001|Overall Study|Severe debilitation, unable to continue|0|||
163349210|NCT00307164|589988458|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
163349211|NCT00307164|589988459|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
163349212|NCT00307164|589988458|FG000|Overall Study|Withdrawal by Subject|1|||
163349213|NCT00307164|589988459|FG001|Overall Study|Withdrawal by Subject|8|||
163349214|NCT00307164|589988458|FG000|Overall Study|Not compliant with requirements|4|||
163349215|NCT00307164|589988459|FG001|Overall Study|Not compliant with requirements|4|||
163349216|NCT00307164|589988458|FG000|Overall Study|Lost to Follow-up|6|||
163349217|NCT00307164|589988459|FG001|Overall Study|Lost to Follow-up|1|||
163349218|NCT03712449|589988461|FG000|Overall Study|Withdraw Consent|0|||
163349219|NCT03712449|589988462|FG001|Overall Study|Withdraw Consent|1|||
163349220|NCT03972137|589988466|FG000|Overall Study|Lost to Follow-up|2|||
163349221|NCT03972137|589988466|FG000|Overall Study|Withdrawal by Subject|4|||
163349222|NCT03226353|589988467|FG000|Overall Study|Withdrawal by Subject|1|||
163349223|NCT03226353|589988467|FG000|Overall Study|Screen Failure|5|||
163349224|NCT03168425|589988468|FG000|Overall Study|Lost to Follow-up|5|||
163349225|NCT03168425|589988469|FG001|Overall Study|Lost to Follow-up|8|||
163349226|NCT03168425|589988468|FG000|Overall Study|unable to confirm post op opioids|2|||
163349227|NCT03168425|589988469|FG001|Overall Study|unable to confirm post op opioids|3|||
163349228|NCT03029234|589988472|FG000|Overall Study|Sponsor Decision|1|||
163349229|NCT03029234|589988472|FG000|Overall Study|Withdrawal by Subject|5|||
163349230|NCT03029234|589988472|FG000|Overall Study|Death|91|||
163349231|NCT03029234|589988472|FG000|Overall Study|Lost to Follow-up|2|||
163349232|NCT00498433|589988473|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
163349233|NCT00498433|589988474|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
163349234|NCT00498433|589988475|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
163349235|NCT00498433|589988473|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
163349236|NCT00498433|589988474|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
163349237|NCT00498433|589988475|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
163349238|NCT00498433|589988473|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
163409669|NCT02118792|590209471|FG001|Overall Study|Withdrawal by parent/guardian|20|||
163349239|NCT00498433|589988474|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
163349240|NCT00498433|589988475|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
163349241|NCT00498433|589988473|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
163409670|NCT02118792|590209470|FG000|Overall Study|Other|1|||
163237787|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
163349242|NCT00498433|589988474|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
163349243|NCT00498433|589988475|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
163349244|NCT01885936|589988482|FG000|Overall Study|Withdrawal by Subject|1|||
163409671|NCT02118792|590209471|FG001|Overall Study|Other|6|||
163409672|NCT02118792|590209470|FG000|Overall Study|Randomised but not treated|1|||
163349245|NCT01885936|589988483|FG001|Overall Study|Withdrawal by Subject|0|||
163349246|NCT03214250|589988484|FG000|Overall Study|Death|5|||
163349247|NCT03214250|589988485|FG001|Overall Study|Death|5|||
163349248|NCT03214250|589988486|FG002|Overall Study|Death|7|||
163349249|NCT03214250|589988487|FG003|Overall Study|Death|4|||
163349250|NCT03214250|589988488|FG004|Overall Study|Death|23|||
163349251|NCT03214250|589988489|FG005|Overall Study|Death|23|||
163349252|NCT03214250|589988490|FG006|Overall Study|Death|24|||
163349253|NCT03214250|589988484|FG000|Overall Study|Lost to Follow-up|0|||
163349254|NCT03214250|589988485|FG001|Overall Study|Lost to Follow-up|0|||
163349255|NCT03214250|589988486|FG002|Overall Study|Lost to Follow-up|0|||
163349256|NCT03214250|589988487|FG003|Overall Study|Lost to Follow-up|1|||
163349257|NCT03214250|589988488|FG004|Overall Study|Lost to Follow-up|1|||
163349258|NCT03214250|589988489|FG005|Overall Study|Lost to Follow-up|2|||
163144285|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
163144286|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
163144287|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
163144288|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
163144289|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
163144290|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
163144291|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
163144292|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
163144293|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
163144294|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
163144295|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
163144296|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
163144297|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
163144298|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
163144299|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
163144300|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
163144301|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
163144302|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
163144303|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
163144304|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
163144305|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
163144306|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
163144307|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
163144308|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
163144309|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
163144310|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
163144311|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
163144312|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
163144313|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
163144314|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
163144315|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
163144316|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
163144317|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
163144318|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
163144319|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
163144320|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
163144321|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
163144322|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
163144323|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
163144324|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
163144325|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
163144326|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
163144327|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
163144328|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
163144329|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
163144330|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
163144331|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
163144332|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
163144333|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
163144334|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
163144335|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
163144336|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
163349259|NCT03214250|589988490|FG006|Overall Study|Lost to Follow-up|0|||
163349260|NCT03214250|589988484|FG000|Overall Study|Other|0|||
163349261|NCT03214250|589988485|FG001|Overall Study|Other|0|||
163349262|NCT03214250|589988486|FG002|Overall Study|Other|0|||
163349263|NCT03214250|589988487|FG003|Overall Study|Other|0|||
163237788|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
163237789|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
163237790|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
163237791|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
163237792|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
163237793|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
163237794|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
163237795|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
163237796|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
163237797|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
163237798|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
163237799|NCT01172938|589579597|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
163237800|NCT01172938|589579598|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
163237801|NCT01172938|589579599|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
163237802|NCT01172938|589579600|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
163237803|NCT01172938|589579601|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
163237804|NCT01172938|589579602|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
163237805|NCT01172938|589579603|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
163237806|NCT01172938|589579604|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
163237807|NCT01172938|589579605|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
163237808|NCT01172938|589579597|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
163237809|NCT01172938|589579598|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
163237810|NCT01172938|589579599|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
163237811|NCT01172938|589579600|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
163237812|NCT01172938|589579601|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
163237813|NCT01172938|589579602|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
163237814|NCT01172938|589579603|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
163237815|NCT01172938|589579604|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
163237816|NCT01172938|589579605|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
163237817|NCT01172938|589579597|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
163237818|NCT01172938|589579598|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
163237819|NCT01172938|589579599|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
163237820|NCT01172938|589579600|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
163237821|NCT01172938|589579601|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
163237822|NCT01172938|589579602|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
163237823|NCT01172938|589579603|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
163237824|NCT01172938|589579604|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
163237825|NCT01172938|589579605|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
163237826|NCT01172938|589579597|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
163237827|NCT01172938|589579598|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
163237828|NCT01172938|589579599|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
163237829|NCT01172938|589579600|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
163237830|NCT01172938|589579601|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
163237831|NCT01172938|589579602|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
163237832|NCT01172938|589579603|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
163237833|NCT01172938|589579604|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
163237834|NCT01172938|589579605|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
163237835|NCT01172938|589579597|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
163237836|NCT01172938|589579598|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
163237837|NCT01172938|589579599|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
163237838|NCT01172938|589579600|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
163237839|NCT01172938|589579601|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
163237840|NCT01172938|589579602|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
163237841|NCT01172938|589579603|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
163237842|NCT01172938|589579604|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
163237843|NCT01172938|589579605|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
163237844|NCT01172938|589579597|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
163237845|NCT01172938|589579598|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
163237846|NCT01172938|589579599|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
163237847|NCT01172938|589579600|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
163237848|NCT01172938|589579601|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
163237849|NCT01172938|589579602|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
163237850|NCT01172938|589579603|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
163237851|NCT01172938|589579604|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
163237852|NCT01172938|589579605|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
163237853|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
163349264|NCT03214250|589988488|FG004|Overall Study|Other|1|||
163349265|NCT03214250|589988489|FG005|Overall Study|Other|1|||
163349266|NCT03214250|589988490|FG006|Overall Study|Other|2|||
163349267|NCT03214250|589988484|FG000|Overall Study|Remains on Study|2|||
163349268|NCT03214250|589988485|FG001|Overall Study|Remains on Study|2|||
163349269|NCT03214250|589988486|FG002|Overall Study|Remains on Study|0|||
163349270|NCT03214250|589988487|FG003|Overall Study|Remains on Study|1|||
163349271|NCT03214250|589988488|FG004|Overall Study|Remains on Study|7|||
163349272|NCT03214250|589988489|FG005|Overall Study|Remains on Study|5|||
163349273|NCT03214250|589988490|FG006|Overall Study|Remains on Study|3|||
163144337|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
163144338|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
163144339|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
163144340|NCT04393493|589237295|FG000|First 4 Days of Intervention|Early improvement|5|||
163144341|NCT04393493|589237296|FG001|First 4 Days of Intervention|Early improvement|7|||
163144342|NCT02910466|589237297|FG000|Overall Study|Adverse Event|1|||
163144343|NCT02910466|589237297|FG000|Overall Study|Withdrawal by Subject|3|||
163144344|NCT02910466|589237297|FG000|Overall Study|Lost to Follow-up|5|||
163144345|NCT02910466|589237297|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
163144346|NCT02910466|589237297|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
163144347|NCT00717249|589237301|FG000|Overall Study|Lens Discomfort|4|||
163144348|NCT00717249|589237302|FG001|Overall Study|Lens Discomfort|1|||
163144349|NCT00717249|589237301|FG000|Overall Study|Unsatisfactory visual Response|0|||
163144350|NCT00717249|589237302|FG001|Overall Study|Unsatisfactory visual Response|2|||
163144351|NCT00717249|589237301|FG000|Overall Study|Adverse Event|4|||
163144352|NCT00717249|589237302|FG001|Overall Study|Adverse Event|2|||
163144353|NCT00717249|589237301|FG000|Overall Study|Lost to Follow-up|2|||
163144354|NCT00717249|589237302|FG001|Overall Study|Lost to Follow-up|0|||
163144355|NCT00717249|589237301|FG000|Overall Study|Withdrawal by Subject|1|||
163144356|NCT00717249|589237302|FG001|Overall Study|Withdrawal by Subject|2|||
163144357|NCT00717249|589237301|FG000|Overall Study|Pregnancy|6|||
163144358|NCT00717249|589237302|FG001|Overall Study|Pregnancy|3|||
163144359|NCT00717249|589237301|FG000|Overall Study|Protocol Violation|0|||
163144360|NCT00717249|589237302|FG001|Overall Study|Protocol Violation|2|||
163144361|NCT00717249|589237301|FG000|Overall Study|Subject became Ineligible|1|||
163144362|NCT00717249|589237302|FG001|Overall Study|Subject became Ineligible|1|||
163144363|NCT00717249|589237301|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
163144364|NCT00717249|589237302|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
163144365|NCT00717249|589237301|FG000|Overall Study|Gastric Surgery|0|||
163144366|NCT00717249|589237302|FG001|Overall Study|Gastric Surgery|1|||
163144367|NCT00717249|589237301|FG000|Overall Study|Diagnosed with Diabetes|1|||
163144368|NCT00717249|589237302|FG001|Overall Study|Diagnosed with Diabetes|0|||
163144369|NCT00717249|589237301|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
163144370|NCT00717249|589237302|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
163144371|NCT00717249|589237301|FG000|Overall Study|Subject relocated|1|||
163144372|NCT00717249|589237302|FG001|Overall Study|Subject relocated|0|||
163144373|NCT00717249|589237301|FG000|Overall Study|Headaches|1|||
163144374|NCT00717249|589237302|FG001|Overall Study|Headaches|0|||
163144375|NCT03370718|589237306|FG000|Overall Study|Withdrawal by Subject|1|||
163144376|NCT06172348|589237307|FG000|Treatment Period 2|Adverse Event|0|||
163144377|NCT06172348|589237308|FG001|Treatment Period 2|Adverse Event|0|||
163144378|NCT06172348|589237309|FG002|Treatment Period 2|Adverse Event|1|||
163144379|NCT06172348|589237310|FG003|Treatment Period 2|Adverse Event|0|||
163144380|NCT06172348|589237311|FG004|Treatment Period 2|Adverse Event|0|||
163144381|NCT06172348|589237312|FG005|Treatment Period 2|Adverse Event|0|||
163144382|NCT04539938|589237313|FG000|Overall Study|Death|30|||
163144383|NCT04539938|589237313|FG000|Overall Study|Withdrawal by Subject|4|||
163144384|NCT04037891|589237314|FG000|Open-label Period|Withdrawal by Subject|1|||
163144385|NCT04037891|589237315|FG001|Open-label Period|Withdrawal by Subject|0|||
163144386|NCT04037891|589237316|FG002|Open-label Period|Withdrawal by Subject|0|||
163144387|NCT04037891|589237314|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
163144388|NCT04037891|589237315|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
163144389|NCT04037891|589237316|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
163144390|NCT00990106|589237317|FG000|Overall Study|"too busy to continue"|1|||
163144391|NCT00990106|589237318|FG001|Overall Study|"too busy to continue"|2|||
163144392|NCT00990106|589237317|FG000|Overall Study|Lost to Follow-up|1|||
163144393|NCT00990106|589237318|FG001|Overall Study|Lost to Follow-up|3|||
163144394|NCT00990106|589237317|FG000|Overall Study|Withdrawal by Subject|2|||
163144395|NCT00990106|589237318|FG001|Overall Study|Withdrawal by Subject|1|||
163144396|NCT00990106|589237317|FG000|Overall Study|opted for open label prazosin|1|||
163349274|NCT03214250|589988484|FG000|Overall Study|Withdrawal by Subject|0|||
163144397|NCT00990106|589237318|FG001|Overall Study|opted for open label prazosin|1|||
163144398|NCT00990106|589237317|FG000|Overall Study|relocation/deployment|4|||
163144399|NCT00990106|589237318|FG001|Overall Study|relocation/deployment|1|||
163349275|NCT03214250|589988485|FG001|Overall Study|Withdrawal by Subject|0|||
163349276|NCT03214250|589988486|FG002|Overall Study|Withdrawal by Subject|1|||
163349277|NCT03214250|589988487|FG003|Overall Study|Withdrawal by Subject|2|||
163349278|NCT03214250|589988488|FG004|Overall Study|Withdrawal by Subject|5|||
163349279|NCT03214250|589988489|FG005|Overall Study|Withdrawal by Subject|0|||
163349280|NCT03214250|589988490|FG006|Overall Study|Withdrawal by Subject|2|||
163349281|NCT02845375|589988496|FG000|Overall Study|upper airway obstruction|1|||
163349282|NCT02845375|589988497|FG001|Overall Study|upper airway obstruction|2|||
163349283|NCT02845375|589988498|FG002|Overall Study|upper airway obstruction|1|||
163349284|NCT02171130|589988501|FG000|Overall Study|Death|1|||
163349285|NCT02171130|589988501|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
163349286|NCT02171130|589988501|FG000|Overall Study|Discontinued; Site Termination|5|||
163349287|NCT02171130|589988501|FG000|Overall Study|Withdrawal by Subject|3|||
163349288|NCT02171130|589988501|FG000|Overall Study|Physician Decision|1|||
163349289|NCT02171130|589988501|FG000|Overall Study|Lost to Follow-up|1|||
163349290|NCT02171130|589988501|FG000|Overall Study|Met Exclusion Criteria|1|||
163349291|NCT01951261|589988502|FG000|Overall Study|Death|1|||
163349292|NCT01951261|589988503|FG001|Overall Study|Death|0|||
163349293|NCT01951261|589988502|FG000|Overall Study|Lost to Follow-up|4|||
163237854|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
163237855|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
163237856|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
163237857|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
163237858|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
163237859|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
163237860|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
163237861|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
163237862|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
163237863|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
163237864|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
163237865|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
163237866|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
163237867|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
163237868|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
163237869|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
163237870|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
163237871|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
163237872|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
163237873|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
163237874|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
163237875|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
163237876|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
163237877|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
163237878|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
163237879|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
163349294|NCT01951261|589988503|FG001|Overall Study|Lost to Follow-up|3|||
163349295|NCT01951261|589988502|FG000|Overall Study|Protocol Violation|4|||
163349296|NCT01951261|589988503|FG001|Overall Study|Protocol Violation|3|||
163349297|NCT03723915|589988510|FG000|Screening|Failed to meet screening requirements.|2|||
163349298|NCT03723915|589988510|FG000|On Treatment|Failed to meet treatment requirements|2|||
163349299|NCT03569475|589988511|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
163349300|NCT03569475|589988512|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
163349301|NCT03569475|589988513|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
163349302|NCT03569475|589988511|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
163349303|NCT03569475|589988512|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
163349304|NCT03569475|589988513|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
163349305|NCT03569475|589988511|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
163349306|NCT03569475|589988512|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
163349307|NCT03569475|589988513|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
163349308|NCT03569475|589988511|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
163349309|NCT03569475|589988512|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
163349310|NCT03569475|589988513|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
163349311|NCT03569475|589988511|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
163349312|NCT03569475|589988512|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
163349313|NCT03569475|589988513|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
163349314|NCT03569475|589988511|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
163237880|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
163237881|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
163237882|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
163349315|NCT03569475|589988512|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
163349316|NCT03569475|589988513|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
163349317|NCT03569475|589988511|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
163144400|NCT00990106|589237317|FG000|Overall Study|started exclusionary medication|0|||
163144401|NCT00990106|589237318|FG001|Overall Study|started exclusionary medication|1|||
163144402|NCT00990106|589237317|FG000|Overall Study|planned major surgery|0|||
163144403|NCT00990106|589237318|FG001|Overall Study|planned major surgery|1|||
163144404|NCT00990106|589237317|FG000|Overall Study|scheduling conflicts|0|||
163144405|NCT00990106|589237318|FG001|Overall Study|scheduling conflicts|2|||
163144406|NCT04194944|589237319|FG000|Overall Study|Lost to Follow-up|3|||
163144407|NCT04194944|589237320|FG001|Overall Study|Lost to Follow-up|0|||
163144408|NCT04194944|589237319|FG000|Overall Study|Withdrawal by Subject|2|||
163144409|NCT04194944|589237320|FG001|Overall Study|Withdrawal by Subject|2|||
163144410|NCT04194944|589237319|FG000|Overall Study|On Treatment|93|||
163144411|NCT04194944|589237320|FG001|Overall Study|On Treatment|30|||
163144412|NCT00348673|589237323|FG000|Stage 1|Randomized but not Treated|0|||
163144413|NCT00348673|589237324|FG001|Stage 1|Randomized but not Treated|0|||
163144414|NCT00348673|589237325|FG002|Stage 1|Randomized but not Treated|1|||
163144415|NCT00348673|589237326|FG003|Stage 1|Randomized but not Treated|0|||
163144416|NCT00348673|589237327|FG004|Stage 1|Randomized but not Treated|0|||
163144417|NCT00348673|589237328|FG005|Stage 1|Randomized but not Treated|0|||
163144418|NCT00348673|589237329|FG006|Stage 1|Randomized but not Treated|0|||
163144419|NCT00348673|589237330|FG007|Stage 1|Randomized but not Treated|0|||
163144420|NCT00348673|589237331|FG008|Stage 1|Randomized but not Treated|0|||
163144421|NCT03798717|589239387|FG000|Overall Study|Failed Screening|0|||
163144422|NCT03798717|589239388|FG001|Overall Study|Failed Screening|0|||
163144423|NCT03798717|589239389|FG002|Overall Study|Failed Screening|0|||
163144424|NCT03798717|589239390|FG003|Overall Study|Failed Screening|0|||
163144425|NCT03798717|589239391|FG004|Overall Study|Failed Screening|0|||
163144426|NCT03798717|589239392|FG005|Overall Study|Failed Screening|1|||
163144427|NCT03798717|589239387|FG000|Overall Study|Physician Decision|1|||
163144428|NCT03798717|589239388|FG001|Overall Study|Physician Decision|0|||
163144429|NCT03798717|589239389|FG002|Overall Study|Physician Decision|1|||
163144430|NCT03798717|589239390|FG003|Overall Study|Physician Decision|0|||
163144431|NCT03798717|589239391|FG004|Overall Study|Physician Decision|0|||
163144432|NCT03798717|589239392|FG005|Overall Study|Physician Decision|0|||
163144433|NCT03798717|589239387|FG000|Overall Study|Withdrawal by Subject|0|||
163144434|NCT03798717|589239388|FG001|Overall Study|Withdrawal by Subject|0|||
163144435|NCT03798717|589239389|FG002|Overall Study|Withdrawal by Subject|0|||
163144436|NCT03798717|589239390|FG003|Overall Study|Withdrawal by Subject|1|||
163144437|NCT03798717|589239391|FG004|Overall Study|Withdrawal by Subject|0|||
163144438|NCT03798717|589239392|FG005|Overall Study|Withdrawal by Subject|0|||
163144439|NCT03798717|589239387|FG000|Overall Study|Lost to Follow-up|1|||
163144440|NCT03798717|589239388|FG001|Overall Study|Lost to Follow-up|0|||
163144441|NCT03798717|589239389|FG002|Overall Study|Lost to Follow-up|0|||
163144442|NCT03798717|589239390|FG003|Overall Study|Lost to Follow-up|1|||
163144443|NCT03798717|589239391|FG004|Overall Study|Lost to Follow-up|0|||
163144444|NCT03798717|589239392|FG005|Overall Study|Lost to Follow-up|0|||
163144445|NCT03798717|589239387|FG000|Overall Study|Adverse Event|0|||
163144446|NCT03798717|589239388|FG001|Overall Study|Adverse Event|1|||
163144447|NCT03798717|589239389|FG002|Overall Study|Adverse Event|0|||
163144448|NCT03798717|589239390|FG003|Overall Study|Adverse Event|0|||
163144449|NCT03798717|589239391|FG004|Overall Study|Adverse Event|0|||
163144450|NCT03798717|589239392|FG005|Overall Study|Adverse Event|0|||
163144451|NCT03798717|589239387|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
163144452|NCT03798717|589239388|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
163144453|NCT03798717|589239389|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
163144454|NCT03798717|589239390|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
163144455|NCT03798717|589239391|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
163144456|NCT03798717|589239392|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
163144457|NCT00445549|589239393|FG000|Overall Study|progressive disease|12|||
163144458|NCT03096834|589239406|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
163144459|NCT03096834|589239407|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
163144460|NCT03096834|589239408|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
163144461|NCT03096834|589239409|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
163144462|NCT03096834|589239406|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
163144463|NCT03096834|589239407|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
163144464|NCT03096834|589239408|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
163349318|NCT03569475|589988512|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
163144465|NCT03096834|589239409|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
163144466|NCT03096834|589239406|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
163144467|NCT03096834|589239407|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
163144468|NCT03096834|589239408|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
163144469|NCT03096834|589239409|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
163237883|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
163237884|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
163237885|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
163237886|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
163237887|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
163237888|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
163237889|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
163237890|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
163409673|NCT02118792|590209471|FG001|Overall Study|Randomised but not treated|0|||
163237891|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
163237892|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
163237893|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
163237894|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
163237895|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
163237896|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
163237897|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
163237898|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
163237899|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
163237900|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
163237901|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
163237902|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
163237903|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
163237904|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
163237905|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
163237906|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
163237907|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
163237908|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
163237909|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
163237910|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
163237911|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
163237912|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
163237913|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
163237914|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
163237915|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
163237916|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
163237917|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
163237918|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
163237919|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
163237920|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
163237921|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
163237922|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
163237923|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
163237924|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
163237925|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
163237926|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
163237927|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
163237928|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
163237929|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
163237930|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
163237931|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
163237932|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
163237933|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
163237934|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
163237935|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
163237936|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
163237937|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
163237938|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
163237939|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
163237940|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
163237941|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
163237942|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
163237943|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
163237944|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
163237945|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
163349319|NCT03569475|589988513|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
163349320|NCT03569475|589988511|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
163349321|NCT03569475|589988512|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
163349322|NCT03569475|589988513|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
163349323|NCT03569475|589988511|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
163349324|NCT03569475|589988512|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
163349325|NCT03569475|589988513|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
163349326|NCT02630706|589988514|FG000|Overall Study|Adverse Event|2|||
163349327|NCT02630706|589988515|FG001|Overall Study|Adverse Event|1|||
163349328|NCT02630706|589988516|FG002|Overall Study|Adverse Event|1|||
163349329|NCT02630706|589988514|FG000|Overall Study|Lost to Follow-up|0|||
163349330|NCT02630706|589988515|FG001|Overall Study|Lost to Follow-up|1|||
163349331|NCT02630706|589988516|FG002|Overall Study|Lost to Follow-up|2|||
163349332|NCT02630706|589988514|FG000|Overall Study|Physician Decision|1|||
163237946|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
163237947|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
163237948|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
163237949|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
163237950|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
163237951|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
163237952|NCT01172938|589579597|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
163237953|NCT01172938|589579598|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
163237954|NCT01172938|589579599|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
163237955|NCT01172938|589579600|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
163237956|NCT01172938|589579601|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
163237957|NCT01172938|589579602|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
163237958|NCT01172938|589579603|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
163237959|NCT01172938|589579604|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
163237960|NCT01172938|589579605|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
163237961|NCT01033747|589579606|FG000|Overall Study|Adverse Event|9|||
163237962|NCT01033747|589579607|FG001|Overall Study|Adverse Event|4|||
163237963|NCT01033747|589579606|FG000|Overall Study|Abnormal Laboratory Value|1|||
163237964|NCT01033747|589579607|FG001|Overall Study|Abnormal Laboratory Value|0|||
163237965|NCT01033747|589579606|FG000|Overall Study|Abnormal test procedure|0|||
163237966|NCT01033747|589579607|FG001|Overall Study|Abnormal test procedure|1|||
163237967|NCT01033747|589579606|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
163237968|NCT01033747|589579607|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
163237969|NCT01033747|589579606|FG000|Overall Study|Protocol Violation|1|||
163237970|NCT01033747|589579607|FG001|Overall Study|Protocol Violation|0|||
163237971|NCT01033747|589579606|FG000|Overall Study|Withdrawal by Subject|9|||
163237972|NCT01033747|589579607|FG001|Overall Study|Withdrawal by Subject|6|||
163237973|NCT01033747|589579606|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
163237974|NCT01033747|589579607|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
163237975|NCT01033747|589579606|FG000|Overall Study|Stopped at end of Extension 1|2|||
163237976|NCT01033747|589579607|FG001|Overall Study|Stopped at end of Extension 1|0|||
163237977|NCT02613481|589579608|FG000|Overall Study|Lost to Follow-up|7|||
163237978|NCT02613481|589579608|FG000|Overall Study|Withdrawal by Subject|2|||
163237979|NCT00844194|589579609|FG000|Overall Study|Adverse Event|17|||
163237980|NCT00844194|589579610|FG001|Overall Study|Adverse Event|5|||
163237981|NCT00844194|589579609|FG000|Overall Study|Protocol Violation|1|||
163237982|NCT00844194|589579610|FG001|Overall Study|Protocol Violation|1|||
163237983|NCT00844194|589579609|FG000|Overall Study|Lost to Follow-up|1|||
163237984|NCT00844194|589579610|FG001|Overall Study|Lost to Follow-up|1|||
163237985|NCT00844194|589579609|FG000|Overall Study|Withdrawal by Subject|2|||
163237986|NCT00844194|589579610|FG001|Overall Study|Withdrawal by Subject|1|||
163237987|NCT00844194|589579609|FG000|Overall Study|Lack of Efficacy|3|||
163349333|NCT02630706|589988515|FG001|Overall Study|Physician Decision|1|||
163349334|NCT02630706|589988516|FG002|Overall Study|Physician Decision|0|||
163349335|NCT02630706|589988514|FG000|Overall Study|Pregnancy|0|||
163237988|NCT00844194|589579610|FG001|Overall Study|Lack of Efficacy|0|||
163349336|NCT02630706|589988515|FG001|Overall Study|Pregnancy|1|||
163349337|NCT02630706|589988516|FG002|Overall Study|Pregnancy|0|||
163349338|NCT02630706|589988514|FG000|Overall Study|Withdrawal by Subject|4|||
163349339|NCT02630706|589988515|FG001|Overall Study|Withdrawal by Subject|5|||
163349340|NCT02630706|589988516|FG002|Overall Study|Withdrawal by Subject|7|||
163237989|NCT00844194|589579609|FG000|Overall Study|Other reason (not specified)|1|||
163237990|NCT00844194|589579610|FG001|Overall Study|Other reason (not specified)|0|||
163349341|NCT02820298|589988526|FG000|Overall Study|Withdrawal by Subject|0|||
163349342|NCT02820298|589988527|FG001|Overall Study|Withdrawal by Subject|1|||
163349343|NCT02820298|589988526|FG000|Overall Study|Physician Decision|1|||
163349344|NCT02820298|589988527|FG001|Overall Study|Physician Decision|0|||
163237991|NCT01542528|589579615|FG000|Overall Study|Lost to Follow-up|2|||
163237992|NCT01542528|589579616|FG001|Overall Study|Lost to Follow-up|1|||
163237993|NCT01542528|589579615|FG000|Overall Study|Physician Decision|1|||
163237994|NCT01542528|589579616|FG001|Overall Study|Physician Decision|0|||
163237995|NCT01542528|589579615|FG000|Overall Study|Withdrawal by Subject|9|||
163237996|NCT01542528|589579616|FG001|Overall Study|Withdrawal by Subject|6|||
163237997|NCT05282004|589579617|FG000|Overall Study|Adverse Event|2|||
163237998|NCT04808609|589579618|FG000|Overall Study|Lost to Follow-up|0|||
163237999|NCT04808609|589579619|FG001|Overall Study|Lost to Follow-up|2|||
163238000|NCT04808609|589579618|FG000|Overall Study|Administrative Withdrawal|0|||
163238001|NCT04808609|589579619|FG001|Overall Study|Administrative Withdrawal|1|||
163238002|NCT00562159|589579621|FG000|Overall Study|Adverse Event|11|||
163238003|NCT00562159|589579622|FG001|Overall Study|Adverse Event|8|||
163238004|NCT00562159|589579621|FG000|Overall Study|Lost to Follow-up|5|||
163238005|NCT00562159|589579622|FG001|Overall Study|Lost to Follow-up|4|||
163238006|NCT00562159|589579621|FG000|Overall Study|Withdrawal by Subject|9|||
163238007|NCT00562159|589579622|FG001|Overall Study|Withdrawal by Subject|8|||
163238008|NCT00562159|589579621|FG000|Overall Study|Protocol Violation|12|||
163238009|NCT00562159|589579622|FG001|Overall Study|Protocol Violation|12|||
163238010|NCT00562159|589579621|FG000|Overall Study|Did not meet protocol eligibility|1|||
163238011|NCT00562159|589579622|FG001|Overall Study|Did not meet protocol eligibility|1|||
163238012|NCT04382326|589579625|FG000|Overall Study|Adverse Event, not serious|1|||
163238013|NCT04382326|589579626|FG001|Overall Study|Adverse Event, not serious|2|||
163238014|NCT04382326|589579625|FG000|Overall Study|Other|1|||
163238015|NCT04382326|589579626|FG001|Overall Study|Other|0|||
163238016|NCT04382326|589579625|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
163238017|NCT04382326|589579626|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
163238018|NCT04382326|589579625|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
163238019|NCT04382326|589579626|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
163238020|NCT04382326|589579625|FG000|Overall Study|Protocol Violation|29|||
163238021|NCT04382326|589579626|FG001|Overall Study|Protocol Violation|23|||
163238022|NCT04382326|589579625|FG000|Overall Study|Physician Decision|0|||
163238023|NCT04382326|589579626|FG001|Overall Study|Physician Decision|1|||
163238024|NCT04382326|589579625|FG000|Overall Study|Lost to Follow-up|48|||
163238025|NCT04382326|589579626|FG001|Overall Study|Lost to Follow-up|63|||
163238026|NCT04382326|589579625|FG000|Overall Study|Adverse Event, non-fatal|1|||
163238027|NCT04382326|589579626|FG001|Overall Study|Adverse Event, non-fatal|1|||
163238028|NCT01181921|589579629|FG000|Overall Study|Lost to Follow-up|1|||
163238029|NCT01038921|589579635|FG000|Overall Study|Withdrawal by Subject|1|||
163238030|NCT01038921|589579636|FG001|Overall Study|Withdrawal by Subject|0|||
163238031|NCT01038921|589579635|FG000|Overall Study|Physician Decision|1|||
163238032|NCT01038921|589579636|FG001|Overall Study|Physician Decision|0|||
163238033|NCT00572572|589579637|FG000|Overall Study|Withdrawal by Subject|3|||
163238034|NCT00572572|589579638|FG001|Overall Study|Withdrawal by Subject|6|||
163238035|NCT02480621|589579650|FG000|Randomization|Withdrawal by Subject|1|||
163238036|NCT02480621|589579651|FG001|Randomization|Withdrawal by Subject|0|||
163238037|NCT02480621|589579650|FG000|Randomization|Surgeon did not give intervention|0|||
163238038|NCT02480621|589579651|FG001|Randomization|Surgeon did not give intervention|1|||
163238039|NCT02480621|589579650|FG000|Follow Up|Lost to Follow-up|4|||
163238040|NCT02480621|589579651|FG001|Follow Up|Lost to Follow-up|2|||
163238041|NCT01748994|589579652|FG000|Overall Study|Lost to Follow-up|8|||
163238042|NCT01748994|589579653|FG001|Overall Study|Lost to Follow-up|6|||
163238043|NCT03105362|589579654|FG000|Overall Study|Withdrawal by Subject|1|||
163238044|NCT03105362|589579654|FG000|Overall Study|Lost to Follow-up|1|||
163238045|NCT00861341|589579656|FG000|Overall Study|Withdrawal by Subject|2|||
163238046|NCT01440946|589579657|FG000|Overall Study|Lost to Follow-up|1|||
163238047|NCT01440946|589579658|FG001|Overall Study|Lost to Follow-up|1|||
163238048|NCT01440946|589579657|FG000|Overall Study|Physician Decision|1|||
163238049|NCT01440946|589579658|FG001|Overall Study|Physician Decision|0|||
163238050|NCT01975389|589579659|FG000|Overall Study|Adverse Event|10|||
163349345|NCT02820298|589988526|FG000|Overall Study|Protocol Violation|0|||
163349346|NCT02820298|589988527|FG001|Overall Study|Protocol Violation|1|||
163349347|NCT01894256|589988528|FG000|Part A|Adverse Event|0|||
163349348|NCT01894256|589988529|FG001|Part A|Adverse Event|1|||
163349349|NCT01894256|589988530|FG002|Part A|Adverse Event|0|||
163238051|NCT01975389|589579660|FG001|Overall Study|Adverse Event|6|||
163238052|NCT01975389|589579659|FG000|Overall Study|Death|61|||
163238053|NCT01975389|589579660|FG001|Overall Study|Death|54|||
163238054|NCT01975389|589579659|FG000|Overall Study|Lost to Follow-up|81|||
163238055|NCT01975389|589579660|FG001|Overall Study|Lost to Follow-up|86|||
163238056|NCT01975389|589579659|FG000|Overall Study|Withdrawal by Subject|90|||
163238057|NCT01975389|589579660|FG001|Overall Study|Withdrawal by Subject|76|||
163238058|NCT01975389|589579659|FG000|Overall Study|Other|6|||
163238059|NCT01975389|589579660|FG001|Overall Study|Other|9|||
163238060|NCT01975389|589579659|FG000|Overall Study|Randomized, not treated|4|||
163238061|NCT01975389|589579660|FG001|Overall Study|Randomized, not treated|5|||
163238062|NCT02296112|589579667|FG000|Overall Study|Disease progression|7|||
163238063|NCT02296112|589579667|FG000|Overall Study|Toxicity|1|||
163238064|NCT02296112|589579667|FG000|Overall Study|Began an alternate therapy|1|||
163238065|NCT02778204|589579668|FG000|Overall Study|Adverse Event|1|||
163349350|NCT01894256|589988528|FG000|Part B|Death|0|||
163349351|NCT01894256|589988529|FG001|Part B|Death|1|||
163349352|NCT01894256|589988530|FG002|Part B|Death|1|||
163349353|NCT01894256|589988528|FG000|Part B|Withdrawal by Subject|0|||
163349354|NCT01894256|589988529|FG001|Part B|Withdrawal by Subject|1|||
163349355|NCT01894256|589988530|FG002|Part B|Withdrawal by Subject|0|||
163349356|NCT01894256|589988528|FG000|Part B|Lack of Efficacy|15|||
163349357|NCT01894256|589988529|FG001|Part B|Lack of Efficacy|12|||
163144470|NCT03096834|589239406|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
163144471|NCT03096834|589239407|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
163144472|NCT03096834|589239408|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
163144473|NCT03096834|589239409|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
163144474|NCT03096834|589239406|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
163144475|NCT03096834|589239407|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
163349358|NCT01894256|589988530|FG002|Part B|Lack of Efficacy|13|||
163349359|NCT00645099|589988536|FG000|Overall Study|Lack of Efficacy|15|||
163144476|NCT03096834|589239408|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
163144477|NCT03096834|589239409|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
163144478|NCT03096834|589239406|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
163144479|NCT03096834|589239407|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
163144480|NCT03096834|589239408|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
163144481|NCT03096834|589239409|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
163144482|NCT03096834|589239406|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
163144483|NCT03096834|589239407|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
163144484|NCT03096834|589239408|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
163144485|NCT03096834|589239409|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
163144486|NCT03096834|589239406|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
163144487|NCT03096834|589239407|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
163144488|NCT03096834|589239408|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
163144489|NCT03096834|589239409|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
163144490|NCT03096834|589239406|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
163144491|NCT03096834|589239407|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
163144492|NCT03096834|589239408|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
163144493|NCT03096834|589239409|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
163144494|NCT03096834|589239406|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
163144495|NCT03096834|589239407|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
163144496|NCT03096834|589239408|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
163144497|NCT03096834|589239409|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
163144498|NCT03096834|589239406|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
163144499|NCT03096834|589239407|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
163144500|NCT03096834|589239408|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
163144501|NCT03096834|589239409|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
163144502|NCT03096834|589239406|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
163144503|NCT03096834|589239407|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
163144504|NCT03096834|589239408|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
163144505|NCT03096834|589239409|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
163144506|NCT01600326|589239412|FG000|Overall Study|Lost to Follow-up|1|||
163144507|NCT01600326|589239413|FG001|Overall Study|Lost to Follow-up|1|||
163144508|NCT04617782|589239414|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
163144509|NCT04617782|589239414|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
163144510|NCT04617782|589239414|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
163144511|NCT04617782|589239414|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
163144512|NCT04617782|589239414|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
163144513|NCT04617782|589239414|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
163144514|NCT01169103|589239430|FG000|Overall Study|Lost to Follow-up|3|||
163144515|NCT01169103|589239431|FG001|Overall Study|Lost to Follow-up|3|||
163144516|NCT01169103|589239430|FG000|Overall Study|Withdrawal by Subject|3|||
163144517|NCT01169103|589239431|FG001|Overall Study|Withdrawal by Subject|1|||
163144518|NCT02634333|589239436|FG000|Overall Study|Completed out of Window|3|||
163144519|NCT02634333|589239437|FG001|Overall Study|Completed out of Window|2|||
163144520|NCT02634333|589239436|FG000|Overall Study|Missed Visit|5|||
163144521|NCT02634333|589239437|FG001|Overall Study|Missed Visit|2|||
163144522|NCT02634333|589239436|FG000|Overall Study|Lost to Follow-up|12|||
163144523|NCT02634333|589239437|FG001|Overall Study|Lost to Follow-up|7|||
163144524|NCT02634333|589239436|FG000|Overall Study|Withdrawal by Subject|9|||
163144525|NCT02634333|589239437|FG001|Overall Study|Withdrawal by Subject|13|||
163144526|NCT02634333|589239436|FG000|Overall Study|Death|11|||
163144527|NCT02634333|589239437|FG001|Overall Study|Death|8|||
163144528|NCT00657046|589239438|FG000|Overall Study|Adverse Event|1|||
163144529|NCT00657046|589239439|FG001|Overall Study|Adverse Event|1|||
163144530|NCT00657046|589239440|FG002|Overall Study|Adverse Event|0|||
163144531|NCT00657046|589239438|FG000|Overall Study|Protocol Violation|2|||
163144532|NCT00657046|589239439|FG001|Overall Study|Protocol Violation|2|||
163349360|NCT00645099|589988537|FG001|Overall Study|Lack of Efficacy|6|||
163349361|NCT00645099|589988536|FG000|Overall Study|Withdrawal by Subject|30|||
163238066|NCT02778204|589579669|FG001|Overall Study|Adverse Event|0|||
163238067|NCT02778204|589579670|FG002|Overall Study|Adverse Event|0|||
163238068|NCT02778204|589579671|FG003|Overall Study|Adverse Event|0|||
163238069|NCT02778204|589579668|FG000|Overall Study|Withdrawal by Subject|0|||
163238070|NCT02778204|589579669|FG001|Overall Study|Withdrawal by Subject|0|||
163238071|NCT02778204|589579670|FG002|Overall Study|Withdrawal by Subject|1|||
163238072|NCT02778204|589579671|FG003|Overall Study|Withdrawal by Subject|2|||
163238073|NCT02778204|589579668|FG000|Overall Study|Lost to Follow-up|1|||
163238074|NCT02778204|589579669|FG001|Overall Study|Lost to Follow-up|0|||
163238075|NCT02778204|589579670|FG002|Overall Study|Lost to Follow-up|2|||
163238076|NCT02778204|589579671|FG003|Overall Study|Lost to Follow-up|1|||
163238077|NCT02778204|589579668|FG000|Overall Study|Protocol Violation|0|||
163238078|NCT02778204|589579669|FG001|Overall Study|Protocol Violation|0|||
163238079|NCT02778204|589579670|FG002|Overall Study|Protocol Violation|1|||
163238080|NCT02778204|589579671|FG003|Overall Study|Protocol Violation|0|||
163238081|NCT02778204|589579668|FG000|Overall Study|Eligibility Violation|0|||
163238082|NCT02778204|589579669|FG001|Overall Study|Eligibility Violation|0|||
163238083|NCT02778204|589579670|FG002|Overall Study|Eligibility Violation|0|||
163238084|NCT02778204|589579671|FG003|Overall Study|Eligibility Violation|1|||
163238085|NCT01720069|589579672|FG000|Overall Study|Could not use e-diary correctly|0|||
163238086|NCT01720069|589579673|FG001|Overall Study|Could not use e-diary correctly|1|||
163238087|NCT01720069|589579674|FG002|Overall Study|Could not use e-diary correctly|1|||
163238088|NCT01720069|589579672|FG000|Overall Study|Randomised without baseline values|0|||
163238089|NCT01720069|589579673|FG001|Overall Study|Randomised without baseline values|0|||
163238090|NCT01720069|589579674|FG002|Overall Study|Randomised without baseline values|1|||
163238091|NCT01720069|589579672|FG000|Overall Study|Adverse Event|0|||
163238092|NCT01720069|589579673|FG001|Overall Study|Adverse Event|0|||
163238093|NCT01720069|589579674|FG002|Overall Study|Adverse Event|1|||
163238094|NCT01720069|589579672|FG000|Overall Study|Lack of Efficacy|0|||
163238095|NCT01720069|589579673|FG001|Overall Study|Lack of Efficacy|4|||
163238096|NCT01720069|589579674|FG002|Overall Study|Lack of Efficacy|0|||
163238097|NCT01720069|589579672|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
163238098|NCT01720069|589579673|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
163238099|NCT01720069|589579674|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
163238100|NCT01720069|589579672|FG000|Overall Study|Withdrawal by Subject|0|||
163238101|NCT01720069|589579673|FG001|Overall Study|Withdrawal by Subject|2|||
163238102|NCT01720069|589579674|FG002|Overall Study|Withdrawal by Subject|1|||
163238103|NCT01720069|589579672|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
163238104|NCT01720069|589579673|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
163238105|NCT01720069|589579674|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
163238106|NCT01720069|589579672|FG000|Overall Study|Non-compliance on using e-diary|0|||
163238107|NCT01720069|589579673|FG001|Overall Study|Non-compliance on using e-diary|0|||
163238108|NCT01720069|589579674|FG002|Overall Study|Non-compliance on using e-diary|1|||
163238109|NCT01720069|589579672|FG000|Overall Study|Lost to Follow-up|0|||
163238110|NCT01720069|589579673|FG001|Overall Study|Lost to Follow-up|0|||
163238111|NCT01720069|589579674|FG002|Overall Study|Lost to Follow-up|1|||
163238112|NCT00360334|589579675|FG000|Overall Study|Adverse Event|7|||
163238113|NCT00360334|589579676|FG001|Overall Study|Adverse Event|4|||
163238114|NCT00360334|589579675|FG000|Overall Study|Protocol Violation|1|||
163238115|NCT00360334|589579676|FG001|Overall Study|Protocol Violation|1|||
163238116|NCT00360334|589579675|FG000|Overall Study|Physician Decision|2|||
163238117|NCT00360334|589579676|FG001|Overall Study|Physician Decision|3|||
163238118|NCT00360334|589579675|FG000|Overall Study|Lack of Efficacy|0|||
163238119|NCT00360334|589579676|FG001|Overall Study|Lack of Efficacy|1|||
163238120|NCT00360334|589579675|FG000|Overall Study|Entry criterion not met|1|||
163238121|NCT00360334|589579676|FG001|Overall Study|Entry criterion not met|2|||
163238122|NCT00360334|589579675|FG000|Overall Study|Subject decision|8|||
163238123|NCT00360334|589579676|FG001|Overall Study|Subject decision|2|||
163238124|NCT01898793|589579677|FG000|Overall Study|Death|2|||
163238125|NCT01898793|589579678|FG001|Overall Study|Death|1|||
163238126|NCT01898793|589579679|FG002|Overall Study|Death|4|||
163238127|NCT01898793|589579680|FG003|Overall Study|Death|0|||
163238128|NCT01898793|589579681|FG004|Overall Study|Death|0|||
163238129|NCT01898793|589579682|FG005|Overall Study|Death|0|||
163238130|NCT01898793|589579683|FG006|Overall Study|Death|0|||
163238131|NCT00162136|589579687|FG000|Overall Study|Adverse Event|1|||
163238132|NCT00162136|589579687|FG000|Overall Study|Death|1|||
163238133|NCT00162136|589579687|FG000|Overall Study|Disease Progression/Relapse|23|||
163238134|NCT00162136|589579687|FG000|Overall Study|Investigator Request|5|||
163238135|NCT00162136|589579687|FG000|Overall Study|Study Drug Toxicity|4|||
163238136|NCT00162136|589579687|FG000|Overall Study|Withdrawal by Subject|1|||
163238137|NCT04450264|589581300|FG000|Overall Study|Incomplete survey|13|||
163238138|NCT04450264|589581301|FG001|Overall Study|Incomplete survey|19|||
163238139|NCT01992536|589581307|FG000|Overall Study|Administrative Reason|0|||
163238140|NCT01992536|589581308|FG001|Overall Study|Administrative Reason|0|||
163238141|NCT01992536|589581309|FG002|Overall Study|Administrative Reason|0|||
163238142|NCT01992536|589581310|FG003|Overall Study|Administrative Reason|0|||
163238143|NCT01992536|589581311|FG004|Overall Study|Administrative Reason|0|||
163238144|NCT01992536|589581312|FG005|Overall Study|Administrative Reason|0|||
163238145|NCT01992536|589581313|FG006|Overall Study|Administrative Reason|7|||
163238146|NCT01992536|589581314|FG007|Overall Study|Administrative Reason|0|||
163238147|NCT01992536|589581315|FG008|Overall Study|Administrative Reason|0|||
163238148|NCT01992536|589581316|FG009|Overall Study|Administrative Reason|0|||
163238149|NCT01992536|589581307|FG000|Overall Study|Lost to Follow-up|4|||
163238150|NCT01992536|589581308|FG001|Overall Study|Lost to Follow-up|2|||
163238151|NCT01992536|589581309|FG002|Overall Study|Lost to Follow-up|1|||
163238152|NCT01992536|589581310|FG003|Overall Study|Lost to Follow-up|0|||
163238153|NCT01992536|589581311|FG004|Overall Study|Lost to Follow-up|0|||
163238154|NCT01992536|589581312|FG005|Overall Study|Lost to Follow-up|1|||
163238155|NCT01992536|589581313|FG006|Overall Study|Lost to Follow-up|0|||
163238156|NCT01992536|589581314|FG007|Overall Study|Lost to Follow-up|0|||
163238157|NCT01992536|589581315|FG008|Overall Study|Lost to Follow-up|1|||
163238158|NCT01992536|589581316|FG009|Overall Study|Lost to Follow-up|1|||
163238159|NCT01992536|589581307|FG000|Overall Study|Withdrawal by Subject|0|||
163238160|NCT01992536|589581308|FG001|Overall Study|Withdrawal by Subject|1|||
163238161|NCT01992536|589581309|FG002|Overall Study|Withdrawal by Subject|0|||
163238162|NCT01992536|589581310|FG003|Overall Study|Withdrawal by Subject|2|||
163238163|NCT01992536|589581311|FG004|Overall Study|Withdrawal by Subject|0|||
163238164|NCT01992536|589581312|FG005|Overall Study|Withdrawal by Subject|0|||
163238165|NCT01992536|589581313|FG006|Overall Study|Withdrawal by Subject|0|||
163238166|NCT01992536|589581314|FG007|Overall Study|Withdrawal by Subject|0|||
163238167|NCT01992536|589581315|FG008|Overall Study|Withdrawal by Subject|0|||
163238168|NCT01992536|589581316|FG009|Overall Study|Withdrawal by Subject|0|||
163238169|NCT02162810|589581319|FG000|Overall Study|Protocol Violation|1|||
163238170|NCT02162810|589581320|FG001|Overall Study|Protocol Violation|0|||
163238171|NCT02162810|589581319|FG000|Overall Study|patients did not report compliance|4|||
163238172|NCT02162810|589581320|FG001|Overall Study|patients did not report compliance|1|||
163238173|NCT00389324|589581321|FG000|Run-In Phase|Adverse Event|1|||
163238174|NCT00389324|589581321|FG000|Run-In Phase|Lost to Follow-up|1|||
163238175|NCT00389324|589581321|FG000|Run-In Phase|Withdrawal by Subject|1|||
163238176|NCT00389324|589581321|FG000|Subcutaneous Phase|Adverse Event|2|||
163238177|NCT00389324|589581321|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
163238178|NCT00389324|589581321|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
163238179|NCT00389324|589581321|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
163238180|NCT01831089|589581322|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
163238181|NCT01831089|589581323|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
163238182|NCT01831089|589581324|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
163238183|NCT01831089|589581325|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
163238184|NCT01831089|589581326|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
163238185|NCT01831089|589581327|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
163238186|NCT01831089|589581322|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
163238187|NCT01831089|589581323|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
163238188|NCT01831089|589581324|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
163238189|NCT01831089|589581325|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
163238190|NCT01831089|589581326|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
163238191|NCT01831089|589581327|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
163238192|NCT01831089|589581322|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
163238193|NCT01831089|589581323|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
163238194|NCT01831089|589581324|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
163238195|NCT01831089|589581325|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
163238196|NCT01831089|589581326|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
163238197|NCT01831089|589581327|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
163238198|NCT01831089|589581322|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
163238199|NCT01831089|589581323|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
163238200|NCT01831089|589581324|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
163238201|NCT01831089|589581325|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
163238202|NCT01831089|589581326|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
163238203|NCT01831089|589581327|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
163238204|NCT01831089|589581322|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
163349362|NCT00645099|589988537|FG001|Overall Study|Withdrawal by Subject|22|||
163349363|NCT00645099|589988536|FG000|Overall Study|Lost to Follow-up|6|||
163349364|NCT00645099|589988537|FG001|Overall Study|Lost to Follow-up|4|||
163349365|NCT00645099|589988536|FG000|Overall Study|Adverse Event|11|||
163238205|NCT01831089|589581323|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
163238206|NCT01831089|589581324|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
163238207|NCT01831089|589581325|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
163238208|NCT01831089|589581326|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
163238209|NCT01831089|589581327|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
163238210|NCT01831089|589581322|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
163349366|NCT00645099|589988537|FG001|Overall Study|Adverse Event|5|||
163349367|NCT00645099|589988536|FG000|Overall Study|Other|9|||
163238211|NCT01831089|589581323|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
163238212|NCT01831089|589581324|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
163238213|NCT01831089|589581325|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
163238214|NCT01831089|589581326|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
163238215|NCT01831089|589581327|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
163238216|NCT01831089|589581322|FG000|Cohort III: Dose Level 3|Global end of study|0|||
163238217|NCT01831089|589581323|FG001|Cohort III: Dose Level 3|Global end of study|0|||
163238218|NCT01831089|589581324|FG002|Cohort III: Dose Level 3|Global end of study|1|||
163238219|NCT01831089|589581325|FG003|Cohort III: Dose Level 3|Global end of study|0|||
163238220|NCT01831089|589581326|FG004|Cohort III: Dose Level 3|Global end of study|0|||
163238221|NCT01831089|589581327|FG005|Cohort III: Dose Level 3|Global end of study|0|||
163238222|NCT01831089|589581322|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
163238223|NCT01831089|589581323|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
163238224|NCT01831089|589581324|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
163238225|NCT01831089|589581325|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
163238226|NCT01831089|589581326|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
163238227|NCT01831089|589581327|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
163238228|NCT01831089|589581322|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
163238229|NCT01831089|589581323|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
163238230|NCT01831089|589581324|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
163238231|NCT01831089|589581325|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
163238232|NCT01831089|589581326|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
163238233|NCT01831089|589581327|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
163238234|NCT01831089|589581322|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
163238235|NCT01831089|589581323|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
163238236|NCT01831089|589581324|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
163238237|NCT01831089|589581325|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
163238238|NCT01831089|589581326|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
163238239|NCT01831089|589581327|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
163238240|NCT01831089|589581322|FG000|Cohort V: Dose Level 5|Death|0|||
163238241|NCT01831089|589581323|FG001|Cohort V: Dose Level 5|Death|0|||
163238242|NCT01831089|589581324|FG002|Cohort V: Dose Level 5|Death|0|||
163238243|NCT01831089|589581325|FG003|Cohort V: Dose Level 5|Death|0|||
163238244|NCT01831089|589581326|FG004|Cohort V: Dose Level 5|Death|1|||
163238245|NCT01831089|589581327|FG005|Cohort V: Dose Level 5|Death|0|||
163238246|NCT01831089|589581322|FG000|Cohort V: Dose Level 5|Global end of study|0|||
163238247|NCT01831089|589581323|FG001|Cohort V: Dose Level 5|Global end of study|0|||
163238248|NCT01831089|589581324|FG002|Cohort V: Dose Level 5|Global end of study|0|||
163238249|NCT01831089|589581325|FG003|Cohort V: Dose Level 5|Global end of study|0|||
163238250|NCT01831089|589581326|FG004|Cohort V: Dose Level 5|Global end of study|2|||
163238251|NCT01831089|589581327|FG005|Cohort V: Dose Level 5|Global end of study|0|||
163238252|NCT01831089|589581322|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
163238253|NCT01831089|589581323|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
163238254|NCT01831089|589581324|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
163238255|NCT01831089|589581325|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
163238256|NCT01831089|589581326|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
163238257|NCT01831089|589581327|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
163238258|NCT01831089|589581322|FG000|Cohort B: Arm B|Progressive disease|0|||
163238259|NCT01831089|589581323|FG001|Cohort B: Arm B|Progressive disease|0|||
163238260|NCT01831089|589581324|FG002|Cohort B: Arm B|Progressive disease|0|||
163238261|NCT01831089|589581325|FG003|Cohort B: Arm B|Progressive disease|0|||
163238262|NCT01831089|589581326|FG004|Cohort B: Arm B|Progressive disease|0|||
163238263|NCT01831089|589581327|FG005|Cohort B: Arm B|Progressive disease|8|||
163238264|NCT01831089|589581322|FG000|Cohort B: Arm B|Physician Decision|0|||
163238265|NCT01831089|589581323|FG001|Cohort B: Arm B|Physician Decision|0|||
163238266|NCT01831089|589581324|FG002|Cohort B: Arm B|Physician Decision|0|||
163238267|NCT01831089|589581325|FG003|Cohort B: Arm B|Physician Decision|0|||
163238268|NCT01831089|589581326|FG004|Cohort B: Arm B|Physician Decision|0|||
163238269|NCT01831089|589581327|FG005|Cohort B: Arm B|Physician Decision|2|||
163238270|NCT01831089|589581322|FG000|Cohort B: Arm B|Never treated|0|||
163238271|NCT01831089|589581323|FG001|Cohort B: Arm B|Never treated|0|||
163238272|NCT01831089|589581324|FG002|Cohort B: Arm B|Never treated|0|||
163238273|NCT01831089|589581325|FG003|Cohort B: Arm B|Never treated|0|||
163238274|NCT01831089|589581326|FG004|Cohort B: Arm B|Never treated|0|||
163238275|NCT01831089|589581327|FG005|Cohort B: Arm B|Never treated|2|||
163238276|NCT01831089|589581322|FG000|Cohort B: Arm B|Adverse Event|0|||
163238277|NCT01831089|589581323|FG001|Cohort B: Arm B|Adverse Event|0|||
163238278|NCT01831089|589581324|FG002|Cohort B: Arm B|Adverse Event|0|||
163238279|NCT01831089|589581325|FG003|Cohort B: Arm B|Adverse Event|0|||
163238280|NCT01831089|589581326|FG004|Cohort B: Arm B|Adverse Event|0|||
163238281|NCT01831089|589581327|FG005|Cohort B: Arm B|Adverse Event|1|||
163238282|NCT01831089|589581322|FG000|Cohort B: Arm B|Global end of study|0|||
163238283|NCT01831089|589581323|FG001|Cohort B: Arm B|Global end of study|0|||
163238284|NCT01831089|589581324|FG002|Cohort B: Arm B|Global end of study|0|||
163349368|NCT00645099|589988537|FG001|Overall Study|Other|5|||
163349369|NCT01201915|589988538|FG000|Overall Study|Adverse Event|2|||
163144533|NCT00657046|589239440|FG002|Overall Study|Protocol Violation|0|||
163144534|NCT00657046|589239438|FG000|Overall Study|Withdrawal by Subject|1|||
163144535|NCT00657046|589239439|FG001|Overall Study|Withdrawal by Subject|0|||
163144536|NCT00657046|589239440|FG002|Overall Study|Withdrawal by Subject|0|||
163144537|NCT00657046|589239438|FG000|Overall Study|Death|0|||
163144538|NCT00657046|589239439|FG001|Overall Study|Death|0|||
163144539|NCT00657046|589239440|FG002|Overall Study|Death|1|||
163144540|NCT00657046|589239438|FG000|Overall Study|Surgery|0|||
163144541|NCT00657046|589239439|FG001|Overall Study|Surgery|0|||
163144542|NCT00657046|589239440|FG002|Overall Study|Surgery|1|||
163144543|NCT03827655|589239441|FG000|Overall Study|Death|0|||
163144544|NCT03827655|589239442|FG001|Overall Study|Death|0|||
163144545|NCT03827655|589239443|FG002|Overall Study|Death|0|||
163144546|NCT03827655|589239444|FG003|Overall Study|Death|0|||
163144547|NCT03827655|589239445|FG004|Overall Study|Death|1|||
163144548|NCT03827655|589239441|FG000|Overall Study|Protocol Deviation|1|||
163144549|NCT03827655|589239442|FG001|Overall Study|Protocol Deviation|0|||
163144550|NCT03827655|589239443|FG002|Overall Study|Protocol Deviation|1|||
163144551|NCT03827655|589239444|FG003|Overall Study|Protocol Deviation|1|||
163144552|NCT03827655|589239445|FG004|Overall Study|Protocol Deviation|0|||
163144553|NCT03827655|589239441|FG000|Overall Study|Withdrawal by Subject|3|||
163144554|NCT03827655|589239442|FG001|Overall Study|Withdrawal by Subject|2|||
163144555|NCT03827655|589239443|FG002|Overall Study|Withdrawal by Subject|2|||
163144556|NCT03827655|589239444|FG003|Overall Study|Withdrawal by Subject|0|||
163144557|NCT03827655|589239445|FG004|Overall Study|Withdrawal by Subject|1|||
163144558|NCT03827655|589239441|FG000|Overall Study|Reason not Specified|3|||
163144559|NCT03827655|589239442|FG001|Overall Study|Reason not Specified|1|||
163144560|NCT03827655|589239443|FG002|Overall Study|Reason not Specified|1|||
163144561|NCT03827655|589239444|FG003|Overall Study|Reason not Specified|1|||
163144562|NCT03827655|589239445|FG004|Overall Study|Reason not Specified|1|||
163144563|NCT03935126|589239448|FG000|Overall Study|Study termination by sponsor|3|||
163144564|NCT01092728|589239449|FG000|Overall Study|Withdrawal by Subject|2|||
163144565|NCT01092728|589239450|FG001|Overall Study|Withdrawal by Subject|0|||
163144566|NCT01092728|589239449|FG000|Overall Study|Adverse Event|0|||
163144567|NCT01092728|589239450|FG001|Overall Study|Adverse Event|1|||
163144568|NCT01092728|589239449|FG000|Overall Study|Disease Progression|1|||
163144569|NCT01092728|589239450|FG001|Overall Study|Disease Progression|13|||
163144570|NCT01092728|589239449|FG000|Overall Study|Prohibited Concomitant Medications|1|||
163144571|NCT01092728|589239450|FG001|Overall Study|Prohibited Concomitant Medications|0|||
163144572|NCT01454596|589239452|FG000|Overall Study|Death|0|||
163144573|NCT01454596|589239453|FG001|Overall Study|Death|0|||
163144574|NCT01454596|589239454|FG002|Overall Study|Death|0|||
163144575|NCT01454596|589239455|FG003|Overall Study|Death|0|||
163144576|NCT01454596|589239456|FG004|Overall Study|Death|0|||
163144577|NCT01454596|589239457|FG005|Overall Study|Death|0|||
163144578|NCT01454596|589239458|FG006|Overall Study|Death|0|||
163144579|NCT01454596|589239459|FG007|Overall Study|Death|0|||
163144580|NCT01454596|589239460|FG008|Overall Study|Death|0|||
163144581|NCT01454596|589239461|FG009|Overall Study|Death|1|||
163144582|NCT01454596|589239462|FG010|Overall Study|Death|1|||
163144583|NCT01454596|589239463|FG011|Overall Study|Death|0|||
163144584|NCT03318549|589239473|FG000|Overall Study|Withdrawal by Subject|5|||
163144585|NCT03318549|589239474|FG001|Overall Study|Withdrawal by Subject|19|||
163144586|NCT03318549|589239475|FG002|Overall Study|Withdrawal by Subject|2|||
163144587|NCT03318549|589239476|FG003|Overall Study|Withdrawal by Subject|0|||
163144588|NCT03318549|589239477|FG004|Overall Study|Withdrawal by Subject|0|||
163144589|NCT03318549|589239478|FG005|Overall Study|Withdrawal by Subject|0|||
163144590|NCT03318549|589239479|FG006|Overall Study|Withdrawal by Subject|0|||
163144591|NCT03318549|589239473|FG000|Overall Study|Physician Decision|0|||
163144592|NCT03318549|589239474|FG001|Overall Study|Physician Decision|4|||
163144593|NCT03318549|589239475|FG002|Overall Study|Physician Decision|1|||
163144594|NCT03318549|589239476|FG003|Overall Study|Physician Decision|0|||
163349370|NCT01201915|589988539|FG001|Overall Study|Adverse Event|1|||
163349371|NCT01201915|589988540|FG002|Overall Study|Adverse Event|1|||
163349372|NCT01201915|589988538|FG000|Overall Study|Lost to Follow-up|0|||
163349373|NCT01201915|589988539|FG001|Overall Study|Lost to Follow-up|4|||
163144595|NCT03318549|589239477|FG004|Overall Study|Physician Decision|0|||
163144596|NCT03318549|589239478|FG005|Overall Study|Physician Decision|0|||
163144597|NCT03318549|589239479|FG006|Overall Study|Physician Decision|0|||
163144598|NCT03318549|589239473|FG000|Overall Study|Lost to Follow-up|0|||
163144599|NCT03318549|589239474|FG001|Overall Study|Lost to Follow-up|3|||
163144600|NCT03318549|589239475|FG002|Overall Study|Lost to Follow-up|3|||
163349374|NCT01201915|589988540|FG002|Overall Study|Lost to Follow-up|0|||
163144601|NCT03318549|589239476|FG003|Overall Study|Lost to Follow-up|0|||
163144602|NCT03318549|589239477|FG004|Overall Study|Lost to Follow-up|0|||
163144603|NCT03318549|589239478|FG005|Overall Study|Lost to Follow-up|0|||
163144604|NCT03318549|589239479|FG006|Overall Study|Lost to Follow-up|0|||
163144605|NCT01433172|589239480|FG000|Overall Study|Withdrawal by Subject|0|||
163349375|NCT01201915|589988538|FG000|Overall Study|Physician Decision|3|||
163238285|NCT01831089|589581325|FG003|Cohort B: Arm B|Global end of study|0|||
163238286|NCT01831089|589581326|FG004|Cohort B: Arm B|Global end of study|0|||
163238287|NCT01831089|589581327|FG005|Cohort B: Arm B|Global end of study|1|||
163238288|NCT00889421|589581328|FG000|Overall Study|Lack of Efficacy|3|||
163238289|NCT03936244|589581334|FG000|Overall Study|Lost to Follow-up|5|||
163238290|NCT03936244|589581335|FG001|Overall Study|Lost to Follow-up|1|||
163238291|NCT03936244|589581334|FG000|Overall Study|Physician Decision|7|||
163238292|NCT03936244|589581335|FG001|Overall Study|Physician Decision|3|||
163238293|NCT03551938|589581336|FG000|3-Month Follow Up|Lost to Follow-up|39|||
163238294|NCT03551938|589581337|FG001|3-Month Follow Up|Lost to Follow-up|38|||
163238295|NCT03551938|589581336|FG000|6-Month Follow Up|Lost to Follow-up|46|||
163238296|NCT03551938|589581337|FG001|6-Month Follow Up|Lost to Follow-up|42|||
163238297|NCT03551938|589581336|FG000|9-Month Follow Up|Lost to Follow-up|44|||
163238298|NCT03551938|589581337|FG001|9-Month Follow Up|Lost to Follow-up|43|||
163238299|NCT01925183|589581338|FG000|Overall Study|Adverse Event|1|||
163238300|NCT01925183|589581339|FG001|Overall Study|Adverse Event|0|||
163238301|NCT01046110|589581340|FG000|Overall Study|Adverse Event|9|||
163238302|NCT01046110|589581341|FG001|Overall Study|Adverse Event|2|||
163238303|NCT01046110|589581340|FG000|Overall Study|Lack of Efficacy|0|||
163238304|NCT01046110|589581341|FG001|Overall Study|Lack of Efficacy|1|||
163238305|NCT01046110|589581340|FG000|Overall Study|Protocol Violation|7|||
163238306|NCT01046110|589581341|FG001|Overall Study|Protocol Violation|12|||
163238307|NCT01046110|589581340|FG000|Overall Study|Withdrawal Criteria|3|||
163238308|NCT01046110|589581341|FG001|Overall Study|Withdrawal Criteria|5|||
163238309|NCT01046110|589581340|FG000|Overall Study|Unclassified|36|||
163238310|NCT01046110|589581341|FG001|Overall Study|Unclassified|35|||
163238311|NCT01114646|589581342|FG000|Overall Study|Withdrawal by Subject|3|||
163238312|NCT01114646|589581343|FG001|Overall Study|Withdrawal by Subject|2|||
163238313|NCT02667912|589581353|FG000|Overall Study|Death|3|||
163238314|NCT02667912|589581354|FG001|Overall Study|Death|1|||
163144606|NCT01433172|589239481|FG001|Overall Study|Withdrawal by Subject|1|||
163144607|NCT01433172|589239482|FG002|Overall Study|Withdrawal by Subject|0|||
163144608|NCT01433172|589239480|FG000|Overall Study|Disease Progression|0|||
163144609|NCT01433172|589239481|FG001|Overall Study|Disease Progression|0|||
163144610|NCT01433172|589239482|FG002|Overall Study|Disease Progression|1|||
163144611|NCT01433172|589239480|FG000|Overall Study|Death|0|||
163144612|NCT01433172|589239481|FG001|Overall Study|Death|2|||
163144613|NCT01433172|589239482|FG002|Overall Study|Death|0|||
163144614|NCT00104650|589239483|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
163144615|NCT00104650|589239484|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
163144616|NCT00104650|589239485|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
163144617|NCT00104650|589239483|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
163349376|NCT01201915|589988539|FG001|Overall Study|Physician Decision|0|||
163144618|NCT00104650|589239484|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
163144619|NCT00104650|589239485|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
163144620|NCT00104650|589239483|FG000|Treatment Period (25 Weeks)|Death|7|||
163144621|NCT00104650|589239484|FG001|Treatment Period (25 Weeks)|Death|5|||
163144622|NCT00104650|589239485|FG002|Treatment Period (25 Weeks)|Death|6|||
163144623|NCT00104650|589239483|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
163144624|NCT00104650|589239484|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
163144625|NCT00104650|589239485|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
163144626|NCT00104650|589239483|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
163238315|NCT02667912|589581353|FG000|Overall Study|Withdrawal by Subject|1|||
163238316|NCT02667912|589581354|FG001|Overall Study|Withdrawal by Subject|2|||
163238317|NCT02667912|589581353|FG000|Overall Study|Withdrawal by Subject|1|||
163238318|NCT02667912|589581354|FG001|Overall Study|Withdrawal by Subject|0|||
163238319|NCT04443218|589581355|FG000|Overall Study|Exited study for other reasons|9|||
163238320|NCT04443218|589581355|FG000|Overall Study|Withdrawal by Subject|1|||
163238321|NCT04443218|589581355|FG000|Overall Study|Lost to Follow-up|4|||
163238322|NCT04443218|589581355|FG000|Overall Study|Death|19|||
163238323|NCT01047683|589581356|FG000|Overall Study|Adverse Event|3|||
163238324|NCT01047683|589581357|FG001|Overall Study|Adverse Event|1|||
163238325|NCT01047683|589581358|FG002|Overall Study|Adverse Event|0|||
163238326|NCT01047683|589581356|FG000|Overall Study|Withdrew Consent|1|||
163238327|NCT01047683|589581357|FG001|Overall Study|Withdrew Consent|4|||
163238328|NCT01047683|589581358|FG002|Overall Study|Withdrew Consent|2|||
163238329|NCT01047683|589581356|FG000|Overall Study|Lost to Follow-up|0|||
163238330|NCT01047683|589581357|FG001|Overall Study|Lost to Follow-up|1|||
163349377|NCT01201915|589988540|FG002|Overall Study|Physician Decision|0|||
163349378|NCT01201915|589988538|FG000|Overall Study|Subject Decision|3|||
163238331|NCT01047683|589581358|FG002|Overall Study|Lost to Follow-up|0|||
163238332|NCT01047683|589581356|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
163238333|NCT01047683|589581357|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
163144627|NCT00104650|589239484|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
163238334|NCT01047683|589581358|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
163238335|NCT03447769|589581359|FG000|Overall Study|Progressive disease|138|||
163144628|NCT00104650|589239485|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
163238336|NCT03447769|589581360|FG001|Overall Study|Progressive disease|148|||
163238337|NCT03447769|589581359|FG000|Overall Study|Study terminated by Sponsor|60|||
163238338|NCT03447769|589581360|FG001|Overall Study|Study terminated by Sponsor|44|||
163238339|NCT03447769|589581359|FG000|Overall Study|Adverse Event|34|||
163238340|NCT03447769|589581360|FG001|Overall Study|Adverse Event|31|||
163238341|NCT03447769|589581359|FG000|Overall Study|Patient decision|27|||
163238342|NCT03447769|589581360|FG001|Overall Study|Patient decision|27|||
163238343|NCT03447769|589581359|FG000|Overall Study|Protocol deviation|4|||
163238344|NCT03447769|589581360|FG001|Overall Study|Protocol deviation|6|||
163238345|NCT03447769|589581359|FG000|Overall Study|Death|2|||
163238346|NCT03447769|589581360|FG001|Overall Study|Death|7|||
163238347|NCT03447769|589581359|FG000|Overall Study|Technical problems|1|||
163238348|NCT03447769|589581360|FG001|Overall Study|Technical problems|0|||
163238349|NCT03447769|589581359|FG000|Overall Study|Lost to Follow-up|0|||
163238350|NCT03447769|589581360|FG001|Overall Study|Lost to Follow-up|1|||
163238351|NCT03447769|589581359|FG000|Overall Study|Physician Decision|13|||
163238352|NCT03447769|589581360|FG001|Overall Study|Physician Decision|5|||
163238353|NCT00781326|589581363|FG000|Phase I|Adverse Event|1|||
163238354|NCT00781326|589581363|FG000|Phase I|Withdrawal by Subject|1|||
163238355|NCT00781326|589581363|FG000|Phase I|Physician Decision|2|||
163238356|NCT00096941|589581364|FG000|Overall Study|disease progression|3|||
163238357|NCT01525082|589581372|FG000|Overall Study|Death|1|||
163238358|NCT00022516|589581382|FG000|Overall Study|Adverse Event|0|||
163238359|NCT00022516|589581383|FG001|Overall Study|Adverse Event|59|||
163238360|NCT00022516|589581382|FG000|Overall Study|Lack of Efficacy|0|||
163238361|NCT00022516|589581383|FG001|Overall Study|Lack of Efficacy|27|||
163238362|NCT00022516|589581382|FG000|Overall Study|Physician Decision|0|||
163238363|NCT00022516|589581383|FG001|Overall Study|Physician Decision|1|||
163238364|NCT00022516|589581382|FG000|Overall Study|Protocol Violation|1|||
163238365|NCT00022516|589581383|FG001|Overall Study|Protocol Violation|3|||
163238366|NCT00022516|589581382|FG000|Overall Study|Withdrawal by Subject|2|||
163238367|NCT00022516|589581383|FG001|Overall Study|Withdrawal by Subject|113|||
163238368|NCT00022516|589581382|FG000|Overall Study|Incomplete documentation|0|||
163238369|NCT00022516|589581383|FG001|Overall Study|Incomplete documentation|27|||
163238370|NCT01568047|589581386|FG000|Overall Study|Ineligibility|1|||
163238371|NCT01568047|589581387|FG001|Overall Study|Ineligibility|0|||
163238372|NCT01568047|589581388|FG002|Overall Study|Ineligibility|0|||
163238373|NCT01568047|589581389|FG003|Overall Study|Ineligibility|0|||
163238374|NCT01568047|589581386|FG000|Overall Study|Withdrawal by Subject|0|||
163238375|NCT01568047|589581387|FG001|Overall Study|Withdrawal by Subject|1|||
163238376|NCT01568047|589581388|FG002|Overall Study|Withdrawal by Subject|0|||
163238377|NCT01568047|589581389|FG003|Overall Study|Withdrawal by Subject|0|||
163238378|NCT01568047|589581386|FG000|Overall Study|Adverse Event|0|||
163238379|NCT01568047|589581387|FG001|Overall Study|Adverse Event|0|||
163238380|NCT01568047|589581388|FG002|Overall Study|Adverse Event|1|||
163238381|NCT01568047|589581389|FG003|Overall Study|Adverse Event|1|||
163238382|NCT03783923|589581390|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
163238383|NCT03783923|589581391|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
163238384|NCT03783923|589581390|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
163238385|NCT03783923|589581391|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
163238386|NCT03783923|589581390|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
163238387|NCT03783923|589581391|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
163238388|NCT03783923|589581390|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
163238389|NCT03783923|589581391|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
163238390|NCT03783923|589581390|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
163238391|NCT03783923|589581391|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
163238392|NCT02328326|589581396|FG000|Overall Study|Withdrawal by Subject|10|||
163238393|NCT02328326|589581397|FG001|Overall Study|Withdrawal by Subject|3|||
163238394|NCT02328326|589581396|FG000|Overall Study|Death|2|||
163238395|NCT02328326|589581397|FG001|Overall Study|Death|1|||
163238396|NCT02328326|589581396|FG000|Overall Study|Lost to Follow-up|10|||
163238397|NCT02328326|589581397|FG001|Overall Study|Lost to Follow-up|4|||
163238398|NCT02543346|589581398|FG000|Second Priming Visit|Withdrawal by Subject|0|||
163238399|NCT02543346|589581399|FG001|Second Priming Visit|Withdrawal by Subject|2|||
163238400|NCT02543346|589581400|FG002|Second Priming Visit|Withdrawal by Subject|2|||
163238401|NCT02543346|589581401|FG003|Second Priming Visit|Withdrawal by Subject|2|||
163238402|NCT02543346|589581398|FG000|Second Priming Visit|Adverse Event|1|||
163238403|NCT02543346|589581399|FG001|Second Priming Visit|Adverse Event|0|||
163238404|NCT02543346|589581400|FG002|Second Priming Visit|Adverse Event|0|||
163238405|NCT02543346|589581401|FG003|Second Priming Visit|Adverse Event|0|||
163238406|NCT02209324|589581404|FG000|Overall Study|Adverse Event|2|||
163238407|NCT02209324|589581404|FG000|Overall Study|Lack of Efficacy|1|||
163409674|NCT04232696|590209473|FG000|Overall Study|Implant attempted but not completed|5|||
163238408|NCT02209324|589581404|FG000|Overall Study|Lost to Follow-up|1|||
163238409|NCT02209324|589581404|FG000|Overall Study|Physician Decision|3|||
163238410|NCT02209324|589581404|FG000|Overall Study|Protocol Violation|14|||
163238411|NCT02209324|589581404|FG000|Overall Study|Withdrawal by Subject|8|||
163238412|NCT02209324|589581404|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
163238413|NCT02209324|589581404|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
163238414|NCT02209324|589581404|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
163238415|NCT01985126|589581405|FG000|Overall Study|Death|15|||
163238416|NCT01985126|589581406|FG001|Overall Study|Death|69|||
163238417|NCT01985126|589581405|FG000|Overall Study|Lost to Follow-up|0|||
163238418|NCT01985126|589581406|FG001|Overall Study|Lost to Follow-up|8|||
163238419|NCT01985126|589581405|FG000|Overall Study|Study Terminated By Sponsor|1|||
163238420|NCT01985126|589581406|FG001|Overall Study|Study Terminated By Sponsor|22|||
163238421|NCT01985126|589581405|FG000|Overall Study|Withdrawal by Subject|2|||
163238422|NCT01985126|589581406|FG001|Overall Study|Withdrawal by Subject|7|||
163238423|NCT03433456|589581409|FG000|Overall Study|Death|1|||
163238424|NCT03433456|589581410|FG001|Overall Study|Death|1|||
163238425|NCT03433456|589581409|FG000|Overall Study|Lost to Follow-up|14|||
163238426|NCT03433456|589581410|FG001|Overall Study|Lost to Follow-up|11|||
163238427|NCT03433456|589581409|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
163238428|NCT03433456|589581410|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
163238429|NCT01198600|589581415|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
163238430|NCT01198600|589581416|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
163238431|NCT01198600|589581417|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
163238432|NCT01198600|589581418|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
163238433|NCT01198600|589581415|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
163238434|NCT01198600|589581416|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
163238435|NCT01198600|589581417|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
163238436|NCT01198600|589581418|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
163238437|NCT01198600|589581415|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
163238438|NCT01198600|589581416|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
163238439|NCT01198600|589581417|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
163238440|NCT01198600|589581418|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
163238441|NCT01198600|589581415|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
163238442|NCT01198600|589581416|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
163238443|NCT01198600|589581417|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
163238444|NCT01198600|589581418|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
163238445|NCT01198600|589581415|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
163238446|NCT01198600|589581416|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
163238447|NCT01198600|589581417|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
163238448|NCT01198600|589581418|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
163238449|NCT01198600|589581415|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
163238450|NCT01198600|589581416|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
163238451|NCT01198600|589581417|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
163238452|NCT01198600|589581418|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
163238453|NCT01198600|589581415|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
163238454|NCT01198600|589581416|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
163238455|NCT01198600|589581417|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
163238456|NCT01198600|589581418|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
163238457|NCT01785602|589581419|FG000|Overall Study|Withdrawal by Subject|2|||
163238458|NCT01785602|589581420|FG001|Overall Study|Withdrawal by Subject|0|||
163238459|NCT01785602|589581419|FG000|Overall Study|Lost to Follow-up|1|||
163238460|NCT01785602|589581420|FG001|Overall Study|Lost to Follow-up|1|||
163238461|NCT01785602|589581419|FG000|Overall Study|Adverse Event|3|||
163238462|NCT01785602|589581420|FG001|Overall Study|Adverse Event|5|||
163238463|NCT01785602|589581419|FG000|Overall Study|Administrative problems|7|||
163238464|NCT01785602|589581420|FG001|Overall Study|Administrative problems|3|||
163238465|NCT02141516|589581423|FG000|Overall Study|Adverse Event|0|||
163238466|NCT02141516|589581424|FG001|Overall Study|Adverse Event|1|||
163238467|NCT02141516|589581425|FG002|Overall Study|Adverse Event|0|||
163238468|NCT02141516|589581423|FG000|Overall Study|Lost to Follow-up|0|||
163238469|NCT02141516|589581424|FG001|Overall Study|Lost to Follow-up|1|||
163238470|NCT02141516|589581425|FG002|Overall Study|Lost to Follow-up|0|||
163238471|NCT02141516|589581423|FG000|Overall Study|Other|0|||
163238472|NCT02141516|589581424|FG001|Overall Study|Other|3|||
163238473|NCT02141516|589581425|FG002|Overall Study|Other|0|||
163238474|NCT03251924|589581427|FG000|Overall Study|Disease Progression|6|||
163238475|NCT03251924|589581428|FG001|Overall Study|Disease Progression|6|||
163349379|NCT01201915|589988539|FG001|Overall Study|Subject Decision|3|||
163238476|NCT03251924|589581429|FG002|Overall Study|Disease Progression|7|||
163238477|NCT03251924|589581430|FG003|Overall Study|Disease Progression|8|||
163238478|NCT03251924|589581431|FG004|Overall Study|Disease Progression|8|||
163238479|NCT03251924|589581432|FG005|Overall Study|Disease Progression|7|||
163238480|NCT03251924|589581433|FG006|Overall Study|Disease Progression|6|||
163349380|NCT01201915|589988540|FG002|Overall Study|Subject Decision|5|||
163349381|NCT01201915|589988538|FG000|Overall Study|Target Lesion Progression|0|||
163349382|NCT01201915|589988539|FG001|Overall Study|Target Lesion Progression|3|||
163349383|NCT01201915|589988540|FG002|Overall Study|Target Lesion Progression|0|||
163144629|NCT00104650|589239483|FG000|Treatment Period (25 Weeks)|Other|1|||
163144630|NCT00104650|589239484|FG001|Treatment Period (25 Weeks)|Other|0|||
163144631|NCT00104650|589239485|FG002|Treatment Period (25 Weeks)|Other|0|||
163144632|NCT00104650|589239483|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
163144633|NCT00104650|589239484|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
163144634|NCT00104650|589239485|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
163144635|NCT00104650|589239483|FG000|Follow-up Period|Physician Decision|1|||
163144636|NCT00104650|589239484|FG001|Follow-up Period|Physician Decision|1|||
163144637|NCT00104650|589239485|FG002|Follow-up Period|Physician Decision|0|||
163144638|NCT00104650|589239483|FG000|Follow-up Period|Adverse Event|1|||
163144639|NCT00104650|589239484|FG001|Follow-up Period|Adverse Event|0|||
163144640|NCT00104650|589239485|FG002|Follow-up Period|Adverse Event|1|||
163144641|NCT00104650|589239483|FG000|Follow-up Period|Withdrawal by Subject|0|||
163144642|NCT00104650|589239484|FG001|Follow-up Period|Withdrawal by Subject|3|||
163144643|NCT00104650|589239485|FG002|Follow-up Period|Withdrawal by Subject|3|||
163144644|NCT00104650|589239483|FG000|Follow-up Period|Death|6|||
163144645|NCT00104650|589239484|FG001|Follow-up Period|Death|6|||
163144646|NCT00104650|589239485|FG002|Follow-up Period|Death|4|||
163144647|NCT00104650|589239483|FG000|Follow-up Period|Disease progression|3|||
163144648|NCT00104650|589239484|FG001|Follow-up Period|Disease progression|1|||
163144649|NCT00104650|589239485|FG002|Follow-up Period|Disease progression|0|||
163144650|NCT00104650|589239483|FG000|Follow-up Period|Lost to Follow-up|0|||
163144651|NCT00104650|589239484|FG001|Follow-up Period|Lost to Follow-up|1|||
163144652|NCT00104650|589239485|FG002|Follow-up Period|Lost to Follow-up|2|||
163144653|NCT00104650|589239483|FG000|Follow-up Period|Other|0|||
163144654|NCT00104650|589239484|FG001|Follow-up Period|Other|1|||
163144655|NCT00104650|589239485|FG002|Follow-up Period|Other|0|||
163144656|NCT01391663|589239486|FG000|Overall Study|Withdrawal by Subject|0|||
163144657|NCT01391663|589239487|FG001|Overall Study|Withdrawal by Subject|0|||
163144658|NCT01391663|589239488|FG002|Overall Study|Withdrawal by Subject|1|||
163144659|NCT01391663|589239489|FG003|Overall Study|Withdrawal by Subject|0|||
163144660|NCT03515824|589239490|FG000|Overall Study|Death|3|||
163144661|NCT03515824|589239491|FG001|Overall Study|Death|2|||
163144662|NCT03515824|589239492|FG002|Overall Study|Death|6|||
163144663|NCT03515824|589239493|FG003|Overall Study|Death|0|||
163144664|NCT03515824|589239490|FG000|Overall Study|Lost to Follow-up|0|||
163144665|NCT03515824|589239491|FG001|Overall Study|Lost to Follow-up|1|||
163144666|NCT03515824|589239492|FG002|Overall Study|Lost to Follow-up|1|||
163144667|NCT03515824|589239493|FG003|Overall Study|Lost to Follow-up|0|||
163144668|NCT03515824|589239490|FG000|Overall Study|Study terminated by sponsor|0|||
163144669|NCT03515824|589239491|FG001|Overall Study|Study terminated by sponsor|1|||
163144670|NCT03515824|589239492|FG002|Overall Study|Study terminated by sponsor|6|||
163144671|NCT03515824|589239493|FG003|Overall Study|Study terminated by sponsor|0|||
163144672|NCT03515824|589239490|FG000|Overall Study|Status not recorded|0|||
163144673|NCT03515824|589239491|FG001|Overall Study|Status not recorded|0|||
163144674|NCT03515824|589239492|FG002|Overall Study|Status not recorded|2|||
163144675|NCT03515824|589239493|FG003|Overall Study|Status not recorded|0|||
163144676|NCT00510835|589239495|FG000|Overall Study|Withdrawal by Subject|6|||
163144677|NCT00510835|589239496|FG001|Overall Study|Withdrawal by Subject|2|||
163144678|NCT00510835|589239497|FG002|Overall Study|Withdrawal by Subject|2|||
163144679|NCT03084796|589239498|FG000|Overall Study|Adverse Event|4|||
163144680|NCT03084796|589239499|FG001|Overall Study|Adverse Event|5|||
163144681|NCT03084796|589239500|FG002|Overall Study|Adverse Event|6|||
163144682|NCT03084796|589239501|FG003|Overall Study|Adverse Event|2|||
163144683|NCT03084796|589239502|FG004|Overall Study|Adverse Event|3|||
163144684|NCT03084796|589239503|FG005|Overall Study|Adverse Event|5|||
163144685|NCT03084796|589239498|FG000|Overall Study|Withdrawal by Subject|3|||
163144686|NCT03084796|589239499|FG001|Overall Study|Withdrawal by Subject|5|||
163144687|NCT03084796|589239500|FG002|Overall Study|Withdrawal by Subject|2|||
163144688|NCT03084796|589239501|FG003|Overall Study|Withdrawal by Subject|1|||
163144689|NCT03084796|589239502|FG004|Overall Study|Withdrawal by Subject|3|||
163144690|NCT03084796|589239503|FG005|Overall Study|Withdrawal by Subject|0|||
163144691|NCT03084796|589239498|FG000|Overall Study|Protocol Violation|0|||
163144692|NCT03084796|589239499|FG001|Overall Study|Protocol Violation|0|||
163144693|NCT03084796|589239500|FG002|Overall Study|Protocol Violation|1|||
163144694|NCT03084796|589239501|FG003|Overall Study|Protocol Violation|0|||
163144695|NCT03084796|589239502|FG004|Overall Study|Protocol Violation|1|||
163144696|NCT03084796|589239503|FG005|Overall Study|Protocol Violation|1|||
163144697|NCT03084796|589239498|FG000|Overall Study|Lack of Efficacy|0|||
163144698|NCT03084796|589239499|FG001|Overall Study|Lack of Efficacy|0|||
163144699|NCT03084796|589239500|FG002|Overall Study|Lack of Efficacy|1|||
163144700|NCT03084796|589239501|FG003|Overall Study|Lack of Efficacy|0|||
163144701|NCT03084796|589239502|FG004|Overall Study|Lack of Efficacy|1|||
163144702|NCT03084796|589239503|FG005|Overall Study|Lack of Efficacy|0|||
163144703|NCT03084796|589239498|FG000|Overall Study|Lost to Follow-up|0|||
163144704|NCT03084796|589239499|FG001|Overall Study|Lost to Follow-up|0|||
163144705|NCT03084796|589239500|FG002|Overall Study|Lost to Follow-up|1|||
163144706|NCT03084796|589239501|FG003|Overall Study|Lost to Follow-up|1|||
163144707|NCT03084796|589239502|FG004|Overall Study|Lost to Follow-up|3|||
163144708|NCT03084796|589239503|FG005|Overall Study|Lost to Follow-up|1|||
163144709|NCT03084796|589239498|FG000|Overall Study|Randomization error|0|||
163144710|NCT03084796|589239499|FG001|Overall Study|Randomization error|0|||
163144711|NCT03084796|589239500|FG002|Overall Study|Randomization error|1|||
163144712|NCT03084796|589239501|FG003|Overall Study|Randomization error|0|||
163144713|NCT03084796|589239502|FG004|Overall Study|Randomization error|0|||
163144714|NCT03084796|589239503|FG005|Overall Study|Randomization error|0|||
163144715|NCT05470985|589239504|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
163144716|NCT05470985|589239505|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
163144717|NCT05470985|589239504|FG000|Double Blind Treatment Period|Physician Decision|0|||
163144718|NCT05470985|589239505|FG001|Double Blind Treatment Period|Physician Decision|1|||
163144719|NCT05470985|589239504|FG000|Long Term Extension|Adverse Event|0|||
163144720|NCT05470985|589239505|FG001|Long Term Extension|Adverse Event|1|||
163144721|NCT05470985|589239504|FG000|Long Term Extension|Study terminated by sponsor|2|||
163144722|NCT05470985|589239505|FG001|Long Term Extension|Study terminated by sponsor|0|||
163144723|NCT01917747|589239506|FG000|Overall Study|Withdrawal by Subject|1|||
163144724|NCT01917747|589239507|FG001|Overall Study|Withdrawal by Subject|2|||
163144725|NCT01917747|589239506|FG000|Overall Study|Lost to Follow-up|18|||
163144726|NCT01917747|589239507|FG001|Overall Study|Lost to Follow-up|9|||
163144727|NCT02741245|589239516|FG000|Overall Study|Adverse Event|0|||
163144728|NCT02741245|589239517|FG001|Overall Study|Adverse Event|0|||
163144729|NCT02741245|589239518|FG002|Overall Study|Adverse Event|0|||
163144730|NCT02741245|589239519|FG003|Overall Study|Adverse Event|2|||
163144731|NCT02741245|589239520|FG004|Overall Study|Adverse Event|2|||
163144732|NCT02741245|589239516|FG000|Overall Study|Protocol Violation|0|||
163144733|NCT02741245|589239517|FG001|Overall Study|Protocol Violation|1|||
163144734|NCT02741245|589239518|FG002|Overall Study|Protocol Violation|0|||
163144735|NCT02741245|589239519|FG003|Overall Study|Protocol Violation|1|||
163144736|NCT02741245|589239520|FG004|Overall Study|Protocol Violation|0|||
163144737|NCT02741245|589239516|FG000|Overall Study|Withdrawal by Subject|0|||
163144738|NCT02741245|589239517|FG001|Overall Study|Withdrawal by Subject|0|||
163144739|NCT02741245|589239518|FG002|Overall Study|Withdrawal by Subject|0|||
163144740|NCT02741245|589239519|FG003|Overall Study|Withdrawal by Subject|1|||
163144741|NCT02741245|589239520|FG004|Overall Study|Withdrawal by Subject|0|||
163144742|NCT03799341|589239523|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
163144743|NCT03799341|589239524|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
163144744|NCT03799341|589239525|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
163144745|NCT03799341|589239523|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
163144746|NCT03799341|589239524|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
163144747|NCT03799341|589239525|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
163144748|NCT03799341|589239523|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
163144749|NCT03799341|589239524|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
163144750|NCT03799341|589239525|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
163144751|NCT03799341|589239523|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
163144752|NCT03799341|589239524|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
163144753|NCT03799341|589239525|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
163144754|NCT03799341|589239523|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
163144755|NCT03799341|589239524|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
163144756|NCT03799341|589239525|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
163144757|NCT03799341|589239523|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
163144758|NCT03799341|589239524|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
163144759|NCT03799341|589239525|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
163144760|NCT01116648|589239526|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
163144761|NCT01116648|589239527|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
163144762|NCT01116648|589239528|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
163144763|NCT01116648|589239529|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
163144764|NCT01116648|589239530|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
163144765|NCT01116648|589239531|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
163144766|NCT01116648|589239532|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
163144767|NCT01116648|589239533|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
163144768|NCT01116648|589239534|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
163144769|NCT01116648|589239535|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
163144770|NCT01116648|589239536|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
163144771|NCT01116648|589239537|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
163144772|NCT01116648|589239538|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
163144773|NCT01116648|589239539|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
163144774|NCT01116648|589239540|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
163144775|NCT03064490|589239541|FG000|Overall Study|Physician Decision|5|||
163144776|NCT05579977|589239546|FG000|Treatment Phase|Other|0|||
163144777|NCT05579977|589239547|FG001|Treatment Phase|Other|0|||
163144778|NCT05579977|589239548|FG002|Treatment Phase|Other|0|||
163144779|NCT05579977|589239549|FG003|Treatment Phase|Other|2|||
163144780|NCT05579977|589239550|FG004|Treatment Phase|Other|1|||
163144781|NCT05579977|589239551|FG005|Treatment Phase|Other|2|||
163144782|NCT05579977|589239552|FG006|Treatment Phase|Other|1|||
163144783|NCT05579977|589239553|FG007|Treatment Phase|Other|2|||
163144784|NCT05579977|589239554|FG008|Treatment Phase|Other|2|||
163144785|NCT05579977|589239555|FG009|Treatment Phase|Other|1|||
163144786|NCT05579977|589239556|FG010|Treatment Phase|Other|0|||
163144787|NCT05579977|589239557|FG011|Treatment Phase|Other|0|||
163144788|NCT05579977|589239558|FG012|Treatment Phase|Other|3|||
163144789|NCT05579977|589239546|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
163144790|NCT05579977|589239547|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
163144791|NCT05579977|589239548|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
163144792|NCT05579977|589239549|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
163144793|NCT05579977|589239550|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
163144794|NCT05579977|589239551|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
163144795|NCT05579977|589239552|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
163144796|NCT05579977|589239553|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
163144797|NCT05579977|589239554|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
163144798|NCT05579977|589239555|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
163144799|NCT05579977|589239556|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
163144800|NCT05579977|589239557|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
163144801|NCT05579977|589239558|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
163144802|NCT05579977|589239546|FG000|Treatment Phase|Withdrawal by Subject|2|||
163144803|NCT05579977|589239547|FG001|Treatment Phase|Withdrawal by Subject|0|||
163144804|NCT05579977|589239548|FG002|Treatment Phase|Withdrawal by Subject|0|||
163144805|NCT05579977|589239549|FG003|Treatment Phase|Withdrawal by Subject|1|||
163144806|NCT05579977|589239550|FG004|Treatment Phase|Withdrawal by Subject|2|||
163144807|NCT05579977|589239551|FG005|Treatment Phase|Withdrawal by Subject|0|||
163144808|NCT05579977|589239552|FG006|Treatment Phase|Withdrawal by Subject|1|||
163144809|NCT05579977|589239553|FG007|Treatment Phase|Withdrawal by Subject|8|||
163144810|NCT05579977|589239554|FG008|Treatment Phase|Withdrawal by Subject|3|||
163144811|NCT05579977|589239555|FG009|Treatment Phase|Withdrawal by Subject|3|||
163144812|NCT05579977|589239556|FG010|Treatment Phase|Withdrawal by Subject|5|||
163144813|NCT05579977|589239557|FG011|Treatment Phase|Withdrawal by Subject|1|||
163144814|NCT05579977|589239558|FG012|Treatment Phase|Withdrawal by Subject|3|||
163144815|NCT05579977|589239546|FG000|Treatment Phase|Study terminated by sponsor|70|||
163144816|NCT05579977|589239547|FG001|Treatment Phase|Study terminated by sponsor|70|||
163144817|NCT05579977|589239548|FG002|Treatment Phase|Study terminated by sponsor|61|||
163144818|NCT05579977|589239549|FG003|Treatment Phase|Study terminated by sponsor|59|||
163144819|NCT05579977|589239550|FG004|Treatment Phase|Study terminated by sponsor|63|||
163144820|NCT05579977|589239551|FG005|Treatment Phase|Study terminated by sponsor|53|||
163144821|NCT05579977|589239552|FG006|Treatment Phase|Study terminated by sponsor|66|||
163144822|NCT05579977|589239553|FG007|Treatment Phase|Study terminated by sponsor|48|||
163144823|NCT05579977|589239554|FG008|Treatment Phase|Study terminated by sponsor|47|||
163144824|NCT05579977|589239555|FG009|Treatment Phase|Study terminated by sponsor|37|||
163144825|NCT05579977|589239556|FG010|Treatment Phase|Study terminated by sponsor|44|||
163144826|NCT05579977|589239557|FG011|Treatment Phase|Study terminated by sponsor|36|||
163144827|NCT05579977|589239558|FG012|Treatment Phase|Study terminated by sponsor|32|||
163144828|NCT05579977|589239546|FG000|Treatment Phase|Pregnancy|0|||
163144829|NCT05579977|589239547|FG001|Treatment Phase|Pregnancy|0|||
163144830|NCT05579977|589239548|FG002|Treatment Phase|Pregnancy|0|||
163144831|NCT05579977|589239549|FG003|Treatment Phase|Pregnancy|0|||
163144832|NCT05579977|589239550|FG004|Treatment Phase|Pregnancy|0|||
163144833|NCT05579977|589239551|FG005|Treatment Phase|Pregnancy|0|||
163144834|NCT05579977|589239552|FG006|Treatment Phase|Pregnancy|0|||
163144835|NCT05579977|589239553|FG007|Treatment Phase|Pregnancy|0|||
163144836|NCT05579977|589239554|FG008|Treatment Phase|Pregnancy|0|||
163144837|NCT05579977|589239555|FG009|Treatment Phase|Pregnancy|1|||
163144838|NCT05579977|589239556|FG010|Treatment Phase|Pregnancy|0|||
163144839|NCT05579977|589239557|FG011|Treatment Phase|Pregnancy|0|||
163144840|NCT05579977|589239558|FG012|Treatment Phase|Pregnancy|0|||
163144841|NCT05579977|589239546|FG000|Treatment Phase|Physician Decision|0|||
163144842|NCT05579977|589239547|FG001|Treatment Phase|Physician Decision|0|||
163144843|NCT05579977|589239548|FG002|Treatment Phase|Physician Decision|0|||
163144844|NCT05579977|589239549|FG003|Treatment Phase|Physician Decision|0|||
163144845|NCT05579977|589239550|FG004|Treatment Phase|Physician Decision|0|||
163144846|NCT05579977|589239551|FG005|Treatment Phase|Physician Decision|0|||
163144847|NCT05579977|589239552|FG006|Treatment Phase|Physician Decision|0|||
163144848|NCT05579977|589239553|FG007|Treatment Phase|Physician Decision|0|||
163144849|NCT05579977|589239554|FG008|Treatment Phase|Physician Decision|0|||
163144850|NCT05579977|589239555|FG009|Treatment Phase|Physician Decision|0|||
163144851|NCT05579977|589239556|FG010|Treatment Phase|Physician Decision|0|||
163144852|NCT05579977|589239557|FG011|Treatment Phase|Physician Decision|1|||
163144853|NCT05579977|589239558|FG012|Treatment Phase|Physician Decision|0|||
163144854|NCT05579977|589239546|FG000|Treatment Phase|Lost to Follow-up|0|||
163238481|NCT03251924|589581434|FG007|Overall Study|Disease Progression|10|||
163238482|NCT03251924|589581435|FG008|Overall Study|Disease Progression|6|||
163238483|NCT03251924|589581427|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
163238484|NCT03251924|589581428|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
163238485|NCT03251924|589581429|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
163238486|NCT03251924|589581430|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
163238487|NCT03251924|589581431|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
163238488|NCT03251924|589581432|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
163238489|NCT03251924|589581433|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
163238490|NCT03251924|589581434|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
163238491|NCT03251924|589581435|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
163238492|NCT03251924|589581427|FG000|Overall Study|Death|0|||
163238493|NCT03251924|589581428|FG001|Overall Study|Death|1|||
163238494|NCT03251924|589581429|FG002|Overall Study|Death|0|||
163238495|NCT03251924|589581430|FG003|Overall Study|Death|1|||
163238496|NCT03251924|589581431|FG004|Overall Study|Death|1|||
163238497|NCT03251924|589581432|FG005|Overall Study|Death|1|||
163238498|NCT03251924|589581433|FG006|Overall Study|Death|0|||
163238499|NCT03251924|589581434|FG007|Overall Study|Death|0|||
163238500|NCT03251924|589581435|FG008|Overall Study|Death|0|||
163238501|NCT03251924|589581427|FG000|Overall Study|Study Drug Toxicity|0|||
163238502|NCT03251924|589581428|FG001|Overall Study|Study Drug Toxicity|0|||
163238503|NCT03251924|589581429|FG002|Overall Study|Study Drug Toxicity|0|||
163238504|NCT03251924|589581430|FG003|Overall Study|Study Drug Toxicity|1|||
163238505|NCT03251924|589581431|FG004|Overall Study|Study Drug Toxicity|0|||
163238506|NCT03251924|589581432|FG005|Overall Study|Study Drug Toxicity|0|||
163238507|NCT03251924|589581433|FG006|Overall Study|Study Drug Toxicity|0|||
163238508|NCT03251924|589581434|FG007|Overall Study|Study Drug Toxicity|0|||
163238509|NCT03251924|589581435|FG008|Overall Study|Study Drug Toxicity|1|||
163238510|NCT03251924|589581427|FG000|Overall Study|Other Reasons|0|||
163238511|NCT03251924|589581428|FG001|Overall Study|Other Reasons|0|||
163238512|NCT03251924|589581429|FG002|Overall Study|Other Reasons|0|||
163238513|NCT03251924|589581430|FG003|Overall Study|Other Reasons|0|||
163238514|NCT03251924|589581431|FG004|Overall Study|Other Reasons|0|||
163238515|NCT03251924|589581432|FG005|Overall Study|Other Reasons|0|||
163238516|NCT03251924|589581433|FG006|Overall Study|Other Reasons|0|||
163238517|NCT03251924|589581434|FG007|Overall Study|Other Reasons|0|||
163238518|NCT03251924|589581435|FG008|Overall Study|Other Reasons|1|||
163238519|NCT03251924|589581427|FG000|Overall Study|Participant request to discontinue study treatment|0|||
163238520|NCT03251924|589581428|FG001|Overall Study|Participant request to discontinue study treatment|0|||
163238521|NCT03251924|589581429|FG002|Overall Study|Participant request to discontinue study treatment|0|||
163238522|NCT03251924|589581430|FG003|Overall Study|Participant request to discontinue study treatment|0|||
163238523|NCT03251924|589581431|FG004|Overall Study|Participant request to discontinue study treatment|0|||
163238524|NCT03251924|589581432|FG005|Overall Study|Participant request to discontinue study treatment|0|||
163238525|NCT03251924|589581433|FG006|Overall Study|Participant request to discontinue study treatment|0|||
163238526|NCT03251924|589581434|FG007|Overall Study|Participant request to discontinue study treatment|1|||
163238527|NCT03251924|589581435|FG008|Overall Study|Participant request to discontinue study treatment|0|||
163238528|NCT02127307|589581438|FG000|Overall Study|Protocol Violation|36|||
163238529|NCT02127307|589581438|FG000|Overall Study|Lost to Follow-up|2|||
163238530|NCT02127307|589581438|FG000|Overall Study|Death|101|||
163238531|NCT02127307|589581438|FG000|Overall Study|Other than specified above|169|||
163238532|NCT00766376|589581439|FG000|Overall Study|Withdrawal by Subject|27|||
163238533|NCT00235989|589581440|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
163238534|NCT00235989|589581441|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
163238535|NCT00235989|589581442|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
163238536|NCT00235989|589581443|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
163238537|NCT00235989|589581444|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
163238538|NCT00235989|589581445|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
163238539|NCT00235989|589581440|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
163238540|NCT00235989|589581441|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
163238541|NCT00235989|589581442|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
163238542|NCT00235989|589581443|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
163238543|NCT00235989|589581444|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
163238544|NCT00235989|589581445|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
163349384|NCT02154516|589988541|FG000|Overall Study|Withdrawal by Subject|0|||
163349385|NCT02154516|589988542|FG001|Overall Study|Withdrawal by Subject|1|||
163238545|NCT00235989|589581440|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
163349386|NCT02154516|589988541|FG000|Overall Study|Lost to Follow-up|1|||
163238546|NCT00235989|589581441|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
163238547|NCT00235989|589581442|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
163238548|NCT00235989|589581443|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
163238549|NCT00235989|589581444|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
163238550|NCT00235989|589581445|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
163349387|NCT02154516|589988542|FG001|Overall Study|Lost to Follow-up|0|||
163238551|NCT00235989|589581440|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
163238552|NCT00235989|589581441|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
163238553|NCT00235989|589581442|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
163238554|NCT00235989|589581443|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
163238555|NCT00235989|589581444|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
163238556|NCT00235989|589581445|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
163238557|NCT00235989|589581440|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
163238558|NCT00235989|589581441|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
163238559|NCT00235989|589581442|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
163238560|NCT00235989|589581443|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
163238561|NCT00235989|589581444|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
163238562|NCT00235989|589581445|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
163238563|NCT00983580|589581450|FG000|Overall Study|Cancel Prior to treatment|1|||
163238564|NCT00983580|589581451|FG001|Overall Study|Cancel Prior to treatment|3|||
163238565|NCT00983580|589581450|FG000|Overall Study|Protocol Violation|1|||
163238566|NCT00983580|589581451|FG001|Overall Study|Protocol Violation|1|||
163238567|NCT00983580|589581450|FG000|Overall Study|Ineligible|3|||
163238568|NCT00983580|589581451|FG001|Overall Study|Ineligible|0|||
163238569|NCT04382612|589581452|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
163238570|NCT01328002|589581453|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
163238571|NCT01328002|589581454|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
163238572|NCT01328002|589581453|FG000|Open-Label Period|Adverse Event|8|||
163238573|NCT01328002|589581454|FG001|Open-Label Period|Adverse Event|0|||
163238574|NCT01328002|589581453|FG000|Open-Label Period|Lack of Efficacy|3|||
163238575|NCT01328002|589581454|FG001|Open-Label Period|Lack of Efficacy|0|||
163238576|NCT01328002|589581453|FG000|Open-Label Period|Protocol Violation|2|||
163238577|NCT01328002|589581454|FG001|Open-Label Period|Protocol Violation|0|||
163238578|NCT01328002|589581453|FG000|Open-Label Period|Withdrawal by Subject|9|||
163238579|NCT01328002|589581454|FG001|Open-Label Period|Withdrawal by Subject|0|||
163238580|NCT01328002|589581453|FG000|Open-Label Period|Lost to Follow-up|6|||
163238581|NCT01328002|589581454|FG001|Open-Label Period|Lost to Follow-up|0|||
163238582|NCT01328002|589581453|FG000|Open-Label Period|Other Reason|2|||
163238583|NCT01328002|589581454|FG001|Open-Label Period|Other Reason|0|||
163238584|NCT01328002|589581453|FG000|Double-Blind Period|Adverse Event|1|||
163238585|NCT01328002|589581454|FG001|Double-Blind Period|Adverse Event|0|||
163238586|NCT01328002|589581453|FG000|Double-Blind Period|Lack of Efficacy|1|||
163238587|NCT01328002|589581454|FG001|Double-Blind Period|Lack of Efficacy|0|||
163238588|NCT00852397|589581455|FG000|Overall Study|Adverse Event|4|||
163238589|NCT00852397|589581456|FG001|Overall Study|Adverse Event|6|||
163238590|NCT00852397|589581457|FG002|Overall Study|Adverse Event|4|||
163238591|NCT00852397|589581455|FG000|Overall Study|Death|0|||
163238592|NCT00852397|589581456|FG001|Overall Study|Death|0|||
163238593|NCT00852397|589581457|FG002|Overall Study|Death|1|||
163238594|NCT00852397|589581455|FG000|Overall Study|Withdrawal by Subject|4|||
163238595|NCT00852397|589581456|FG001|Overall Study|Withdrawal by Subject|1|||
163238596|NCT00852397|589581457|FG002|Overall Study|Withdrawal by Subject|2|||
163238597|NCT00852397|589581455|FG000|Overall Study|Study terminated by sponsor|2|||
163238598|NCT00852397|589581456|FG001|Overall Study|Study terminated by sponsor|1|||
163238599|NCT00852397|589581457|FG002|Overall Study|Study terminated by sponsor|6|||
163238600|NCT00852397|589581455|FG000|Overall Study|Difficulty in study site visit|1|||
163238601|NCT00852397|589581456|FG001|Overall Study|Difficulty in study site visit|0|||
163238602|NCT00852397|589581457|FG002|Overall Study|Difficulty in study site visit|0|||
163238603|NCT00852397|589581455|FG000|Overall Study|Protocol Violation|0|||
163238604|NCT00852397|589581456|FG001|Overall Study|Protocol Violation|0|||
163238605|NCT00852397|589581457|FG002|Overall Study|Protocol Violation|1|||
163238606|NCT00836875|589581460|FG000|Overall Study|Death|3|||
163238607|NCT00836875|589581461|FG001|Overall Study|Death|2|||
163238608|NCT00836875|589581460|FG000|Overall Study|Withdrawal by Subject|0|||
163238609|NCT00836875|589581461|FG001|Overall Study|Withdrawal by Subject|1|||
163238610|NCT03964454|589581471|FG000|Overall Study|Lost to Follow-up|13|||
163238611|NCT03964454|589581472|FG001|Overall Study|Lost to Follow-up|7|||
163238612|NCT03964454|589581471|FG000|Overall Study|Withdrawal by Subject|4|||
163238613|NCT03964454|589581472|FG001|Overall Study|Withdrawal by Subject|11|||
163238614|NCT00074282|589583294|FG000|Step 1|Adverse Event|32|||
163238615|NCT00074282|589583295|FG001|Step 1|Adverse Event|0|||
163238616|NCT00074282|589583296|FG002|Step 1|Adverse Event|0|||
163238617|NCT00074282|589583294|FG000|Step 1|Death|6|||
163238618|NCT00074282|589583295|FG001|Step 1|Death|0|||
163238619|NCT00074282|589583296|FG002|Step 1|Death|0|||
163238620|NCT00074282|589583294|FG000|Step 1|Withdrawal by Subject|7|||
163238621|NCT00074282|589583295|FG001|Step 1|Withdrawal by Subject|0|||
163238622|NCT00074282|589583296|FG002|Step 1|Withdrawal by Subject|0|||
163238623|NCT00074282|589583294|FG000|Step 1|Disease progression|2|||
163238624|NCT00074282|589583295|FG001|Step 1|Disease progression|0|||
163238625|NCT00074282|589583296|FG002|Step 1|Disease progression|0|||
163238626|NCT00074282|589583294|FG000|Step 1|Alternative therapy|2|||
163349388|NCT02154516|589988541|FG000|Overall Study|Removal/revision of device|1|||
163349389|NCT02154516|589988542|FG001|Overall Study|Removal/revision of device|0|||
163349390|NCT02154516|589988541|FG000|Overall Study|Death|2|||
163349391|NCT02154516|589988542|FG001|Overall Study|Death|1|||
163349392|NCT03406507|589988543|FG000|Extension Period|Lack of Efficacy|0|||
163349393|NCT03406507|589988544|FG001|Extension Period|Lack of Efficacy|1|||
163349394|NCT00663923|589988545|FG000|Overall Study|Lost to Follow-up|2|||
163349395|NCT02316171|589988550|FG000|Overall Study|difficulties with urinary catheter|1|||
163349396|NCT02316171|589988551|FG001|Overall Study|difficulties with urinary catheter|0|||
163349397|NCT02316171|589988552|FG002|Overall Study|difficulties with urinary catheter|0|||
163349398|NCT02316171|589988553|FG003|Overall Study|difficulties with urinary catheter|0|||
163349399|NCT01804140|589988554|FG000|Overall Study|No sampling or biopsy procedures done|114|||
163349400|NCT02785900|589988557|FG000|Overall Study|Study Termination by Sponsor|64|||
163349401|NCT02785900|589988558|FG001|Overall Study|Study Termination by Sponsor|81|||
163349402|NCT02785900|589988557|FG000|Overall Study|Death|46|||
163349403|NCT02785900|589988558|FG001|Overall Study|Death|32|||
163349404|NCT02785900|589988557|FG000|Overall Study|Withdrawal by Subject|4|||
163349405|NCT02785900|589988558|FG001|Overall Study|Withdrawal by Subject|8|||
163349406|NCT02785900|589988557|FG000|Overall Study|Physician Decision|3|||
163349407|NCT02785900|589988558|FG001|Overall Study|Physician Decision|2|||
163349408|NCT00547300|589988559|FG000|Overall Study|Study was Administratively Terminated|25|||
163349409|NCT00547300|589988560|FG001|Overall Study|Study was Administratively Terminated|24|||
163349410|NCT00547300|589988559|FG000|Overall Study|Did not Meet Entry Criteria|0|||
163349411|NCT00547300|589988560|FG001|Overall Study|Did not Meet Entry Criteria|2|||
163349412|NCT04435522|589988561|FG000|Overall Study|Withdrawal by Subject|2|||
163349413|NCT00092521|589990777|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
163349414|NCT00092521|589990778|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
163349415|NCT00092521|589990779|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
163349416|NCT00092521|589990780|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
163144855|NCT05579977|589239547|FG001|Treatment Phase|Lost to Follow-up|0|||
163144856|NCT05579977|589239548|FG002|Treatment Phase|Lost to Follow-up|0|||
163144857|NCT05579977|589239549|FG003|Treatment Phase|Lost to Follow-up|1|||
163144858|NCT05579977|589239550|FG004|Treatment Phase|Lost to Follow-up|1|||
163144859|NCT05579977|589239551|FG005|Treatment Phase|Lost to Follow-up|1|||
163144860|NCT05579977|589239552|FG006|Treatment Phase|Lost to Follow-up|0|||
163144861|NCT05579977|589239553|FG007|Treatment Phase|Lost to Follow-up|1|||
163144862|NCT05579977|589239554|FG008|Treatment Phase|Lost to Follow-up|2|||
163144863|NCT05579977|589239555|FG009|Treatment Phase|Lost to Follow-up|2|||
163144864|NCT05579977|589239556|FG010|Treatment Phase|Lost to Follow-up|1|||
163144865|NCT05579977|589239557|FG011|Treatment Phase|Lost to Follow-up|4|||
163144866|NCT05579977|589239558|FG012|Treatment Phase|Lost to Follow-up|3|||
163144867|NCT05579977|589239546|FG000|Treatment Phase|Death|1|||
163144868|NCT05579977|589239547|FG001|Treatment Phase|Death|0|||
163144869|NCT05579977|589239548|FG002|Treatment Phase|Death|0|||
163144870|NCT05579977|589239549|FG003|Treatment Phase|Death|0|||
163144871|NCT05579977|589239550|FG004|Treatment Phase|Death|0|||
163144872|NCT05579977|589239551|FG005|Treatment Phase|Death|0|||
163144873|NCT05579977|589239552|FG006|Treatment Phase|Death|0|||
163144874|NCT05579977|589239553|FG007|Treatment Phase|Death|0|||
163144875|NCT05579977|589239554|FG008|Treatment Phase|Death|0|||
163144876|NCT05579977|589239555|FG009|Treatment Phase|Death|0|||
163144877|NCT05579977|589239556|FG010|Treatment Phase|Death|0|||
163144878|NCT05579977|589239557|FG011|Treatment Phase|Death|0|||
163144879|NCT05579977|589239558|FG012|Treatment Phase|Death|0|||
163144880|NCT05579977|589239546|FG000|Treatment Phase|Adverse Event|0|||
163144881|NCT05579977|589239547|FG001|Treatment Phase|Adverse Event|3|||
163144882|NCT05579977|589239548|FG002|Treatment Phase|Adverse Event|11|||
163144883|NCT05579977|589239549|FG003|Treatment Phase|Adverse Event|10|||
163144884|NCT05579977|589239550|FG004|Treatment Phase|Adverse Event|5|||
163144885|NCT05579977|589239551|FG005|Treatment Phase|Adverse Event|17|||
163144886|NCT05579977|589239552|FG006|Treatment Phase|Adverse Event|5|||
163144887|NCT05579977|589239553|FG007|Treatment Phase|Adverse Event|5|||
163144888|NCT05579977|589239554|FG008|Treatment Phase|Adverse Event|12|||
163144889|NCT05579977|589239555|FG009|Treatment Phase|Adverse Event|20|||
163144890|NCT05579977|589239556|FG010|Treatment Phase|Adverse Event|15|||
163144891|NCT05579977|589239557|FG011|Treatment Phase|Adverse Event|24|||
163144892|NCT05579977|589239558|FG012|Treatment Phase|Adverse Event|23|||
163144893|NCT05579977|589239546|FG000|Treatment Phase|Randomized not treated|0|||
163144894|NCT05579977|589239547|FG001|Treatment Phase|Randomized not treated|0|||
163144895|NCT05579977|589239548|FG002|Treatment Phase|Randomized not treated|0|||
163349417|NCT00092521|589990777|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
163349418|NCT00092521|589990778|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
163349419|NCT00092521|589990779|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
163349420|NCT00092521|589990780|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
163349421|NCT00092521|589990777|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
163144896|NCT05579977|589239549|FG003|Treatment Phase|Randomized not treated|0|||
163144897|NCT05579977|589239550|FG004|Treatment Phase|Randomized not treated|1|||
163144898|NCT05579977|589239551|FG005|Treatment Phase|Randomized not treated|0|||
163349422|NCT00092521|589990778|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
163349423|NCT00092521|589990779|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
163349424|NCT00092521|589990780|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
163349425|NCT00092521|589990777|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
163349426|NCT00092521|589990778|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
163238627|NCT00074282|589583295|FG001|Step 1|Alternative therapy|0|||
163238628|NCT00074282|589583296|FG002|Step 1|Alternative therapy|0|||
163238629|NCT00074282|589583294|FG000|Step 1|Other complicating disease|2|||
163238630|NCT00074282|589583295|FG001|Step 1|Other complicating disease|0|||
163238631|NCT00074282|589583296|FG002|Step 1|Other complicating disease|0|||
163238632|NCT00074282|589583294|FG000|Step 1|Physician Decision|1|||
163238633|NCT00074282|589583295|FG001|Step 1|Physician Decision|0|||
163238634|NCT00074282|589583296|FG002|Step 1|Physician Decision|0|||
163238635|NCT00074282|589583294|FG000|Step 1|Ineligible|4|||
163238636|NCT00074282|589583295|FG001|Step 1|Ineligible|0|||
163238637|NCT00074282|589583296|FG002|Step 1|Ineligible|0|||
163238638|NCT00074282|589583294|FG000|Step 1|Never started treatment|2|||
163238639|NCT00074282|589583295|FG001|Step 1|Never started treatment|0|||
163238640|NCT00074282|589583296|FG002|Step 1|Never started treatment|0|||
163349427|NCT00092521|589990779|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
163238641|NCT00074282|589583294|FG000|Step 2|Adverse Event|0|||
163238642|NCT00074282|589583295|FG001|Step 2|Adverse Event|2|||
163238643|NCT00074282|589583296|FG002|Step 2|Adverse Event|12|||
163238644|NCT00074282|589583294|FG000|Step 2|Disease progression|0|||
163238645|NCT00074282|589583295|FG001|Step 2|Disease progression|0|||
163238646|NCT00074282|589583296|FG002|Step 2|Disease progression|5|||
163238647|NCT00074282|589583294|FG000|Step 2|Death|0|||
163238648|NCT00074282|589583295|FG001|Step 2|Death|0|||
163238649|NCT00074282|589583296|FG002|Step 2|Death|3|||
163238650|NCT00074282|589583294|FG000|Step 2|Withdrawal by Subject|0|||
163238651|NCT00074282|589583295|FG001|Step 2|Withdrawal by Subject|0|||
163238652|NCT00074282|589583296|FG002|Step 2|Withdrawal by Subject|2|||
163238653|NCT00074282|589583294|FG000|Step 2|Physician Decision|0|||
163238654|NCT00074282|589583295|FG001|Step 2|Physician Decision|0|||
163238655|NCT00074282|589583296|FG002|Step 2|Physician Decision|1|||
163238656|NCT00074282|589583294|FG000|Step 2|Ineligible|0|||
163238657|NCT00074282|589583295|FG001|Step 2|Ineligible|0|||
163238658|NCT00074282|589583296|FG002|Step 2|Ineligible|1|||
163238659|NCT00464542|589583297|FG000|Pre-treatment|Withdrawal by Subject|2|||
163238660|NCT04745169|589583299|FG000|Overall Study|Kidney transplantation|1|||
163238661|NCT04745169|589583299|FG000|Overall Study|Participant health problems|3|||
163238662|NCT04745169|589583299|FG000|Overall Study|Physician Decision|2|||
163238663|NCT02055352|589583300|FG000|Overall Study|Adverse Event|0|||
163238664|NCT02055352|589583301|FG001|Overall Study|Adverse Event|1|||
163238665|NCT02055352|589583300|FG000|Overall Study|Non-eligible|0|||
163238666|NCT02055352|589583301|FG001|Overall Study|Non-eligible|1|||
163238667|NCT02055352|589583300|FG000|Overall Study|Poor compliance|1|||
163238668|NCT02055352|589583301|FG001|Overall Study|Poor compliance|1|||
163238669|NCT02055352|589583300|FG000|Overall Study|Death|1|||
163238670|NCT02055352|589583301|FG001|Overall Study|Death|2|||
163238671|NCT02055352|589583300|FG000|Overall Study|Patient decision|1|||
163238672|NCT02055352|589583301|FG001|Overall Study|Patient decision|1|||
163238673|NCT02055352|589583300|FG000|Overall Study|Use of prohibited treatment|0|||
163238674|NCT02055352|589583301|FG001|Overall Study|Use of prohibited treatment|3|||
163238675|NCT02055352|589583300|FG000|Overall Study|AE, study drug would be detrimental|1|||
163238676|NCT02055352|589583301|FG001|Overall Study|AE, study drug would be detrimental|3|||
163238677|NCT02055352|589583300|FG000|Overall Study|Withdrawal of informed consent|1|||
163238678|NCT02055352|589583301|FG001|Overall Study|Withdrawal of informed consent|0|||
163238679|NCT02055352|589583300|FG000|Overall Study|Reason unknown|1|||
163238680|NCT02055352|589583301|FG001|Overall Study|Reason unknown|5|||
163349428|NCT00092521|589990780|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
163349429|NCT00092521|589990777|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
163349430|NCT00092521|589990778|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
163349431|NCT00092521|589990779|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
163349432|NCT00092521|589990780|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
163349433|NCT00092521|589990777|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
163238681|NCT01760954|589583302|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
163238682|NCT01760954|589583303|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
163238683|NCT01760954|589583304|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
163238684|NCT01760954|589583305|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
163238685|NCT01760954|589583302|FG000|Treatment Period (6 Months)|Adverse Event|5|||
163238686|NCT01760954|589583303|FG001|Treatment Period (6 Months)|Adverse Event|3|||
163238687|NCT01760954|589583304|FG002|Treatment Period (6 Months)|Adverse Event|4|||
163238688|NCT01760954|589583305|FG003|Treatment Period (6 Months)|Adverse Event|10|||
163349434|NCT00092521|589990778|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
163238689|NCT01760954|589583302|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
163238690|NCT01760954|589583303|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
163238691|NCT01760954|589583304|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
163238692|NCT01760954|589583305|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
163238693|NCT01760954|589583302|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
163238694|NCT01760954|589583303|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
163238695|NCT01760954|589583304|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
163238696|NCT01760954|589583305|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
163238697|NCT01760954|589583302|FG000|Treatment Period (6 Months)|Pregnancy|5|||
163238698|NCT01760954|589583303|FG001|Treatment Period (6 Months)|Pregnancy|0|||
163238699|NCT01760954|589583304|FG002|Treatment Period (6 Months)|Pregnancy|3|||
163238700|NCT01760954|589583305|FG003|Treatment Period (6 Months)|Pregnancy|2|||
163238701|NCT01760954|589583302|FG000|Treatment Period (6 Months)|Non-compliance|1|||
163238702|NCT01760954|589583303|FG001|Treatment Period (6 Months)|Non-compliance|4|||
163238703|NCT01760954|589583304|FG002|Treatment Period (6 Months)|Non-compliance|0|||
163238704|NCT01760954|589583305|FG003|Treatment Period (6 Months)|Non-compliance|3|||
163349435|NCT00092521|589990779|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
163349436|NCT00092521|589990780|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
163349437|NCT00092521|589990777|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
163349438|NCT00092521|589990778|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
163349439|NCT00092521|589990779|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
163349440|NCT00092521|589990780|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
163349441|NCT00092521|589990777|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
163349442|NCT00092521|589990778|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
163409675|NCT04232696|590209474|FG001|Overall Study|Implant attempted but not completed|2|||
163409676|NCT04232696|590209473|FG000|Overall Study|Not satisfied with therapy outcome|0|||
163409677|NCT04232696|590209474|FG001|Overall Study|Not satisfied with therapy outcome|8|||
163238705|NCT01760954|589583302|FG000|Treatment Period (6 Months)|Other|0|||
163238706|NCT01760954|589583303|FG001|Treatment Period (6 Months)|Other|3|||
163238707|NCT01760954|589583304|FG002|Treatment Period (6 Months)|Other|3|||
163238708|NCT01760954|589583305|FG003|Treatment Period (6 Months)|Other|1|||
163238709|NCT01760954|589583302|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
163238710|NCT01760954|589583303|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
163238711|NCT01760954|589583304|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
163238712|NCT01760954|589583305|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
163238713|NCT01760954|589583302|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
163238714|NCT01760954|589583303|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
163238715|NCT01760954|589583304|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
163238716|NCT01760954|589583305|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
163238717|NCT01760954|589583302|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
163238718|NCT01760954|589583303|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
163238719|NCT01760954|589583304|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
163238720|NCT01760954|589583305|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
163238721|NCT01760954|589583302|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
163238722|NCT01760954|589583303|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
163238723|NCT01760954|589583304|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
163238724|NCT01760954|589583305|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
163238725|NCT01760954|589583302|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
163238726|NCT01760954|589583303|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
163238727|NCT01760954|589583304|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
163238728|NCT01760954|589583305|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
163238729|NCT01760954|589583302|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
163238730|NCT01760954|589583303|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
163238731|NCT01760954|589583304|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
163238732|NCT01760954|589583305|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
163238733|NCT01760954|589583302|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
163238734|NCT01760954|589583303|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
163238735|NCT01760954|589583304|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
163349443|NCT00092521|589990779|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
163349444|NCT00092521|589990780|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
163349445|NCT00092521|589990777|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
163349446|NCT00092521|589990778|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
163349447|NCT00092521|589990779|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
163409678|NCT04232696|590209473|FG000|Overall Study|Adverse Event|0|||
163409679|NCT04232696|590209474|FG001|Overall Study|Adverse Event|3|||
163409680|NCT04232696|590209473|FG000|Overall Study|Withdrawal by Subject|0|||
163349448|NCT00092521|589990780|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
163349449|NCT00092521|589990777|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
163349450|NCT00092521|589990778|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
163349451|NCT00092521|589990779|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
163349452|NCT00092521|589990780|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
163349453|NCT00092521|589990777|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
163349454|NCT00092521|589990778|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
163144899|NCT05579977|589239552|FG006|Treatment Phase|Randomized not treated|0|||
163144900|NCT05579977|589239553|FG007|Treatment Phase|Randomized not treated|0|||
163144901|NCT05579977|589239554|FG008|Treatment Phase|Randomized not treated|0|||
163144902|NCT05579977|589239555|FG009|Treatment Phase|Randomized not treated|0|||
163144903|NCT05579977|589239556|FG010|Treatment Phase|Randomized not treated|0|||
163144904|NCT05579977|589239557|FG011|Treatment Phase|Randomized not treated|0|||
163144905|NCT05579977|589239558|FG012|Treatment Phase|Randomized not treated|0|||
163144906|NCT05579977|589239546|FG000|Follow up|Death|1|||
163144907|NCT05579977|589239547|FG001|Follow up|Death|0|||
163144908|NCT05579977|589239548|FG002|Follow up|Death|0|||
163144909|NCT05579977|589239549|FG003|Follow up|Death|0|||
163144910|NCT05579977|589239550|FG004|Follow up|Death|0|||
163144911|NCT05579977|589239551|FG005|Follow up|Death|0|||
163144912|NCT05579977|589239552|FG006|Follow up|Death|0|||
163144913|NCT05579977|589239553|FG007|Follow up|Death|0|||
163144914|NCT05579977|589239554|FG008|Follow up|Death|0|||
163144915|NCT05579977|589239555|FG009|Follow up|Death|0|||
163144916|NCT05579977|589239556|FG010|Follow up|Death|0|||
163144917|NCT05579977|589239557|FG011|Follow up|Death|0|||
163144918|NCT05579977|589239558|FG012|Follow up|Death|0|||
163144919|NCT05579977|589239546|FG000|Follow up|Lost to Follow-up|0|||
163144920|NCT05579977|589239547|FG001|Follow up|Lost to Follow-up|0|||
163144921|NCT05579977|589239548|FG002|Follow up|Lost to Follow-up|0|||
163144922|NCT05579977|589239549|FG003|Follow up|Lost to Follow-up|1|||
163144923|NCT05579977|589239550|FG004|Follow up|Lost to Follow-up|1|||
163144924|NCT05579977|589239551|FG005|Follow up|Lost to Follow-up|2|||
163144925|NCT05579977|589239552|FG006|Follow up|Lost to Follow-up|1|||
163144926|NCT05579977|589239553|FG007|Follow up|Lost to Follow-up|1|||
163144927|NCT05579977|589239554|FG008|Follow up|Lost to Follow-up|3|||
163144928|NCT05579977|589239555|FG009|Follow up|Lost to Follow-up|2|||
163144929|NCT05579977|589239556|FG010|Follow up|Lost to Follow-up|2|||
163144930|NCT05579977|589239557|FG011|Follow up|Lost to Follow-up|4|||
163144931|NCT05579977|589239558|FG012|Follow up|Lost to Follow-up|4|||
163144932|NCT05579977|589239546|FG000|Follow up|Withdrawal by Subject|2|||
163144933|NCT05579977|589239547|FG001|Follow up|Withdrawal by Subject|0|||
163144934|NCT05579977|589239548|FG002|Follow up|Withdrawal by Subject|0|||
163144935|NCT05579977|589239549|FG003|Follow up|Withdrawal by Subject|0|||
163144936|NCT05579977|589239550|FG004|Follow up|Withdrawal by Subject|1|||
163144937|NCT05579977|589239551|FG005|Follow up|Withdrawal by Subject|0|||
163144938|NCT05579977|589239552|FG006|Follow up|Withdrawal by Subject|1|||
163144939|NCT05579977|589239553|FG007|Follow up|Withdrawal by Subject|4|||
163144940|NCT05579977|589239554|FG008|Follow up|Withdrawal by Subject|2|||
163144941|NCT05579977|589239555|FG009|Follow up|Withdrawal by Subject|3|||
163144942|NCT05579977|589239556|FG010|Follow up|Withdrawal by Subject|3|||
163144943|NCT05579977|589239557|FG011|Follow up|Withdrawal by Subject|1|||
163144944|NCT05579977|589239558|FG012|Follow up|Withdrawal by Subject|3|||
163144945|NCT01777776|589239560|FG000|Overall Study|Adverse Event|2|||
163144946|NCT01777776|589239561|FG001|Overall Study|Adverse Event|4|||
163144947|NCT01777776|589239562|FG002|Overall Study|Adverse Event|0|||
163144948|NCT01777776|589239563|FG003|Overall Study|Adverse Event|0|||
163144949|NCT01777776|589239560|FG000|Overall Study|Disease Progression|4|||
163144950|NCT01777776|589239561|FG001|Overall Study|Disease Progression|8|||
163144951|NCT01777776|589239562|FG002|Overall Study|Disease Progression|6|||
163144952|NCT01777776|589239563|FG003|Overall Study|Disease Progression|3|||
163144953|NCT01777776|589239560|FG000|Overall Study|Withdrawal by Subject|0|||
163144954|NCT01777776|589239561|FG001|Overall Study|Withdrawal by Subject|0|||
163144955|NCT01777776|589239562|FG002|Overall Study|Withdrawal by Subject|0|||
163144956|NCT01777776|589239563|FG003|Overall Study|Withdrawal by Subject|1|||
163144957|NCT01420926|589239566|FG000|Overall Study|Adverse Event|6|||
163144958|NCT01420926|589239567|FG001|Overall Study|Adverse Event|4|||
163144959|NCT01420926|589239566|FG000|Overall Study|Death|18|||
163144960|NCT01420926|589239567|FG001|Overall Study|Death|17|||
163144961|NCT01420926|589239566|FG000|Overall Study|Withdrawal by Subject|11|||
163144962|NCT01420926|589239567|FG001|Overall Study|Withdrawal by Subject|17|||
163144963|NCT01420926|589239566|FG000|Overall Study|Non-protocol treatment|17|||
163144964|NCT01420926|589239567|FG001|Overall Study|Non-protocol treatment|20|||
163144965|NCT01420926|589239566|FG000|Overall Study|Physician Decision|8|||
163144966|NCT01420926|589239567|FG001|Overall Study|Physician Decision|5|||
163144967|NCT04564846|589241545|FG000|Overall Study|Withdrawal by Subject|2|||
163144968|NCT04564846|589241546|FG001|Overall Study|Withdrawal by Subject|1|||
163144969|NCT04564846|589241545|FG000|Overall Study|Physician Decision|0|||
163144970|NCT04564846|589241546|FG001|Overall Study|Physician Decision|1|||
163144971|NCT04564846|589241545|FG000|Overall Study|Lost to Follow-up|0|||
163349455|NCT00092521|589990779|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
163349456|NCT00092521|589990780|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
163144972|NCT04564846|589241546|FG001|Overall Study|Lost to Follow-up|1|||
163144973|NCT04564846|589241545|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
163144974|NCT04564846|589241546|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
163144975|NCT04564846|589241545|FG000|Overall Study|Subject non-compliance|1|||
163144976|NCT04564846|589241546|FG001|Overall Study|Subject non-compliance|0|||
163144977|NCT03737123|589241547|FG000|Study Treatment|Adverse Event|2|||
163144978|NCT03737123|589241548|FG001|Study Treatment|Adverse Event|0|||
163144979|NCT03737123|589241547|FG000|Study Treatment|Disease Progression|2|||
163144980|NCT03737123|589241548|FG001|Study Treatment|Disease Progression|0|||
163144981|NCT03737123|589241547|FG000|Study Treatment|Withdrawal by Subject|2|||
163144982|NCT03737123|589241548|FG001|Study Treatment|Withdrawal by Subject|0|||
163144983|NCT03737123|589241547|FG000|Follow up|Death|1|||
163144984|NCT03737123|589241548|FG001|Follow up|Death|0|||
163144985|NCT03737123|589241547|FG000|Follow up|Withdrawal by Subject|1|||
163144986|NCT03737123|589241548|FG001|Follow up|Withdrawal by Subject|0|||
163144987|NCT03737123|589241547|FG000|Follow up|Termination of study|4|||
163144988|NCT03737123|589241548|FG001|Follow up|Termination of study|0|||
163144989|NCT01519323|589241549|FG000|Overall Study|Death|3|||
163144990|NCT01519323|589241550|FG001|Overall Study|Death|2|||
163144991|NCT01519323|589241549|FG000|Overall Study|Study terminated by sponsor|0|||
163144992|NCT01519323|589241550|FG001|Overall Study|Study terminated by sponsor|1|||
163144993|NCT00762359|589241551|FG000|Overall Study|Adverse Event|20|||
163144994|NCT00762359|589241552|FG001|Overall Study|Adverse Event|23|||
163144995|NCT00762359|589241551|FG000|Overall Study|Protocol Violation|21|||
163144996|NCT00762359|589241552|FG001|Overall Study|Protocol Violation|13|||
163144997|NCT00762359|589241551|FG000|Overall Study|Withdrawal by Subject|13|||
163144998|NCT00762359|589241552|FG001|Overall Study|Withdrawal by Subject|10|||
163144999|NCT00762359|589241551|FG000|Overall Study|Lack of Efficacy|0|||
163145000|NCT00762359|589241552|FG001|Overall Study|Lack of Efficacy|4|||
163145001|NCT00762359|589241551|FG000|Overall Study|Institution closed|2|||
163145002|NCT00762359|589241552|FG001|Overall Study|Institution closed|3|||
163145003|NCT00762359|589241551|FG000|Overall Study|Physician Decision|2|||
163145004|NCT00762359|589241552|FG001|Overall Study|Physician Decision|3|||
163145005|NCT00762359|589241551|FG000|Overall Study|Removal|0|||
163145006|NCT00762359|589241552|FG001|Overall Study|Removal|1|||
163145007|NCT00762359|589241551|FG000|Overall Study|Withdrew consent|1|||
163145008|NCT00762359|589241552|FG001|Overall Study|Withdrew consent|0|||
163145009|NCT01421017|589241557|FG000|Overall Study|Withdrawal by Subject|2|||
163145010|NCT01421017|589241558|FG001|Overall Study|Withdrawal by Subject|0|||
163145011|NCT01421017|589241559|FG002|Overall Study|Withdrawal by Subject|0|||
163145012|NCT01421017|589241557|FG000|Overall Study|POD|0|||
163145013|NCT01421017|589241558|FG001|Overall Study|POD|6|||
163145014|NCT01421017|589241559|FG002|Overall Study|POD|3|||
163145015|NCT02313766|589241560|FG000|Overall Study|surgery cancelled|1|||
163145016|NCT02313766|589241561|FG001|Overall Study|surgery cancelled|0|||
163145017|NCT02313766|589241562|FG002|Overall Study|surgery cancelled|0|||
163145018|NCT02313766|589241560|FG000|Overall Study|Lost to Follow-up|0|||
163145019|NCT02313766|589241561|FG001|Overall Study|Lost to Follow-up|2|||
163145020|NCT02313766|589241562|FG002|Overall Study|Lost to Follow-up|0|||
163145021|NCT02313766|589241560|FG000|Overall Study|Adverse Event|0|||
163145022|NCT02313766|589241561|FG001|Overall Study|Adverse Event|1|||
163145023|NCT02313766|589241562|FG002|Overall Study|Adverse Event|0|||
163145024|NCT00416624|589241565|FG000|Overall Study|Withdrawal by Subject|1|||
163145025|NCT00416624|589241566|FG001|Overall Study|Withdrawal by Subject|6|||
163145026|NCT00416624|589241567|FG002|Overall Study|Withdrawal by Subject|4|||
163145027|NCT00416624|589241568|FG003|Overall Study|Withdrawal by Subject|9|||
163145028|NCT00416624|589241565|FG000|Overall Study|Death|4|||
163145029|NCT00416624|589241566|FG001|Overall Study|Death|7|||
163145030|NCT00416624|589241567|FG002|Overall Study|Death|7|||
163145031|NCT00416624|589241568|FG003|Overall Study|Death|1|||
163145032|NCT00416624|589241565|FG000|Overall Study|Adverse Event|8|||
163145033|NCT00416624|589241566|FG001|Overall Study|Adverse Event|3|||
163145034|NCT00416624|589241567|FG002|Overall Study|Adverse Event|2|||
163145035|NCT00416624|589241568|FG003|Overall Study|Adverse Event|2|||
163145036|NCT00416624|589241565|FG000|Overall Study|Other|8|||
163145037|NCT00416624|589241566|FG001|Overall Study|Other|11|||
163145038|NCT00416624|589241567|FG002|Overall Study|Other|5|||
163145039|NCT00416624|589241568|FG003|Overall Study|Other|5|||
163145040|NCT00416624|589241565|FG000|Overall Study|Cancel|1|||
163145041|NCT00416624|589241566|FG001|Overall Study|Cancel|0|||
163145042|NCT00416624|589241567|FG002|Overall Study|Cancel|0|||
163145043|NCT00416624|589241568|FG003|Overall Study|Cancel|0|||
163145044|NCT01005251|589241569|FG000|Overall Study|Withdrawal by Subject|2|||
163145045|NCT01005251|589241570|FG001|Overall Study|Withdrawal by Subject|5|||
163145046|NCT01005251|589241571|FG002|Overall Study|Withdrawal by Subject|3|||
163145047|NCT01005251|589241572|FG003|Overall Study|Withdrawal by Subject|4|||
163145048|NCT01005251|589241573|FG004|Overall Study|Withdrawal by Subject|9|||
163145049|NCT01005251|589241569|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
163145050|NCT01005251|589241570|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
163145051|NCT01005251|589241571|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
163145052|NCT01005251|589241572|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
163145053|NCT01005251|589241573|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
163238736|NCT01760954|589583305|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
163238737|NCT01760954|589583302|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
163238738|NCT01760954|589583303|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
163238739|NCT01760954|589583304|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
163238740|NCT01760954|589583305|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
163238741|NCT00982020|589583306|FG000|Overall Study|Adverse Event|19|||
163238742|NCT00982020|589583307|FG001|Overall Study|Adverse Event|15|||
163238743|NCT00982020|589583306|FG000|Overall Study|Withdrawal by Subject|11|||
163238744|NCT00982020|589583307|FG001|Overall Study|Withdrawal by Subject|14|||
163238745|NCT00982020|589583306|FG000|Overall Study|Lost to Follow-up|5|||
163238746|NCT00982020|589583307|FG001|Overall Study|Lost to Follow-up|11|||
163238747|NCT00982020|589583306|FG000|Overall Study|Lack of Efficacy|10|||
163238748|NCT00982020|589583307|FG001|Overall Study|Lack of Efficacy|4|||
163238749|NCT00982020|589583306|FG000|Overall Study|Parent/Caregiver Decision|5|||
163238750|NCT00982020|589583307|FG001|Overall Study|Parent/Caregiver Decision|5|||
163238751|NCT00982020|589583306|FG000|Overall Study|Treatment Non-compliance|3|||
163238752|NCT00982020|589583307|FG001|Overall Study|Treatment Non-compliance|6|||
163238753|NCT00982020|589583306|FG000|Overall Study|Physician Decision|2|||
163238754|NCT00982020|589583307|FG001|Overall Study|Physician Decision|5|||
163238755|NCT00982020|589583306|FG000|Overall Study|Entry Criteria Not Met|2|||
163238756|NCT00982020|589583307|FG001|Overall Study|Entry Criteria Not Met|1|||
163238757|NCT00982020|589583306|FG000|Overall Study|Protocol Violation|0|||
163238758|NCT00982020|589583307|FG001|Overall Study|Protocol Violation|2|||
163238759|NCT00982020|589583306|FG000|Overall Study|Clinical Relapse|0|||
163238760|NCT00982020|589583307|FG001|Overall Study|Clinical Relapse|1|||
163238761|NCT01762761|589583308|FG000|Overall Study|Adverse Event|15|||
163238762|NCT01762761|589583309|FG001|Overall Study|Adverse Event|17|||
163238763|NCT01762761|589583308|FG000|Overall Study|Lack of Efficacy|9|||
163238764|NCT01762761|589583309|FG001|Overall Study|Lack of Efficacy|25|||
163238765|NCT01762761|589583308|FG000|Overall Study|Protocol Violation|1|||
163238766|NCT01762761|589583309|FG001|Overall Study|Protocol Violation|1|||
163238767|NCT01762761|589583308|FG000|Overall Study|Study closed/terminated|0|||
163238768|NCT01762761|589583309|FG001|Overall Study|Study closed/terminated|2|||
163238769|NCT01762761|589583308|FG000|Overall Study|Lost to Follow-up|3|||
163238770|NCT01762761|589583309|FG001|Overall Study|Lost to Follow-up|6|||
163238771|NCT01762761|589583308|FG000|Overall Study|Physician Decision|4|||
163238772|NCT01762761|589583309|FG001|Overall Study|Physician Decision|6|||
163238773|NCT01762761|589583308|FG000|Overall Study|Withdrawal by Subject|7|||
163238774|NCT01762761|589583309|FG001|Overall Study|Withdrawal by Subject|8|||
163238775|NCT02352493|589583310|FG000|Overall Study|Pregnancy|0|||
163238776|NCT02352493|589583311|FG001|Overall Study|Pregnancy|0|||
163238777|NCT02352493|589583312|FG002|Overall Study|Pregnancy|0|||
163238778|NCT02352493|589583313|FG003|Overall Study|Pregnancy|0|||
163349457|NCT00092521|589990777|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
163349458|NCT00092521|589990778|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
163349459|NCT00092521|589990779|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
163349460|NCT00092521|589990780|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
163349461|NCT00092521|589990777|FG000|Follow-Up (After Month 7)|Death|2|||
163349462|NCT00092521|589990778|FG001|Follow-Up (After Month 7)|Death|0|||
163349463|NCT00092521|589990779|FG002|Follow-Up (After Month 7)|Death|1|||
163349464|NCT00092521|589990780|FG003|Follow-Up (After Month 7)|Death|0|||
163349465|NCT00092521|589990777|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
163349466|NCT00092521|589990778|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
163349467|NCT00092521|589990779|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
163349468|NCT00092521|589990780|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
163349469|NCT00092521|589990777|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
163349470|NCT00092521|589990778|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
163349471|NCT00092521|589990779|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
163349472|NCT00092521|589990780|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
163349473|NCT00092521|589990777|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
163349474|NCT00092521|589990778|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
163349475|NCT00092521|589990779|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
163349476|NCT00092521|589990780|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
163349477|NCT00092521|589990777|FG000|Follow-Up (After Month 7)|Moved|32|||
163349478|NCT00092521|589990778|FG001|Follow-Up (After Month 7)|Moved|2|||
163349479|NCT00092521|589990779|FG002|Follow-Up (After Month 7)|Moved|28|||
163238779|NCT02352493|589583314|FG004|Overall Study|Pregnancy|0|||
163238780|NCT02352493|589583315|FG005|Overall Study|Pregnancy|0|||
163238781|NCT02352493|589583316|FG006|Overall Study|Pregnancy|1|||
163238782|NCT02352493|589583317|FG007|Overall Study|Pregnancy|0|||
163238783|NCT02352493|589583318|FG008|Overall Study|Pregnancy|1|||
163238784|NCT02352493|589583319|FG009|Overall Study|Pregnancy|0|||
163238785|NCT02352493|589583320|FG010|Overall Study|Pregnancy|0|||
163238786|NCT02352493|589583321|FG011|Overall Study|Pregnancy|0|||
163238787|NCT02352493|589583322|FG012|Overall Study|Pregnancy|0|||
163349480|NCT00092521|589990780|FG003|Follow-Up (After Month 7)|Moved|0|||
163349481|NCT00092521|589990777|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
163349482|NCT00092521|589990778|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
163238788|NCT02352493|589583323|FG013|Overall Study|Pregnancy|0|||
163238789|NCT02352493|589583324|FG014|Overall Study|Pregnancy|0|||
163238790|NCT02352493|589583325|FG015|Overall Study|Pregnancy|0|||
163238791|NCT02352493|589583326|FG016|Overall Study|Pregnancy|0|||
163238792|NCT02352493|589583327|FG017|Overall Study|Pregnancy|0|||
163349483|NCT00092521|589990779|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
163349484|NCT00092521|589990780|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
163349485|NCT00092521|589990777|FG000|Follow-Up (After Month 7)|Travel|2|||
163349486|NCT00092521|589990778|FG001|Follow-Up (After Month 7)|Travel|0|||
163349487|NCT00092521|589990779|FG002|Follow-Up (After Month 7)|Travel|0|||
163349488|NCT00092521|589990780|FG003|Follow-Up (After Month 7)|Travel|0|||
163349489|NCT00092521|589990777|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
163349490|NCT00092521|589990778|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
163349491|NCT00092521|589990779|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
163349492|NCT00092521|589990780|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
163349493|NCT00092521|589990777|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
163349494|NCT00092521|589990778|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
163349495|NCT00092521|589990779|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
163349496|NCT00092521|589990780|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
163349497|NCT00092521|589990777|FG000|Extension Study (Group 4)|Adverse Event|0|||
163145054|NCT01005251|589241569|FG000|Overall Study|Adverse Event|2|||
163145055|NCT01005251|589241570|FG001|Overall Study|Adverse Event|6|||
163145056|NCT01005251|589241571|FG002|Overall Study|Adverse Event|8|||
163145057|NCT01005251|589241572|FG003|Overall Study|Adverse Event|5|||
163145058|NCT01005251|589241573|FG004|Overall Study|Adverse Event|4|||
163145059|NCT01005251|589241569|FG000|Overall Study|Protocol Violation|1|||
163145060|NCT01005251|589241570|FG001|Overall Study|Protocol Violation|0|||
163145061|NCT01005251|589241571|FG002|Overall Study|Protocol Violation|0|||
163145062|NCT01005251|589241572|FG003|Overall Study|Protocol Violation|0|||
163145063|NCT01005251|589241573|FG004|Overall Study|Protocol Violation|2|||
163145064|NCT01005251|589241569|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
163145065|NCT01005251|589241570|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
163238793|NCT02352493|589583310|FG000|Overall Study|Withdrawal by Subject|0|||
163238794|NCT02352493|589583311|FG001|Overall Study|Withdrawal by Subject|0|||
163238795|NCT02352493|589583312|FG002|Overall Study|Withdrawal by Subject|0|||
163349498|NCT00092521|589990778|FG001|Extension Study (Group 4)|Adverse Event|0|||
163349499|NCT00092521|589990779|FG002|Extension Study (Group 4)|Adverse Event|0|||
163349500|NCT00092521|589990780|FG003|Extension Study (Group 4)|Adverse Event|2|||
163349501|NCT00092521|589990777|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
163349502|NCT00092521|589990778|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
163349503|NCT00092521|589990779|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
163349504|NCT00092521|589990780|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
163349505|NCT00092521|589990777|FG000|Extension Study (Group 4)|Pregnancy|0|||
163349506|NCT00092521|589990778|FG001|Extension Study (Group 4)|Pregnancy|0|||
163349507|NCT00092521|589990779|FG002|Extension Study (Group 4)|Pregnancy|0|||
163349508|NCT00092521|589990780|FG003|Extension Study (Group 4)|Pregnancy|4|||
163349509|NCT00092521|589990777|FG000|Extension Study (Group 4)|Protocol Violation|0|||
163349510|NCT00092521|589990778|FG001|Extension Study (Group 4)|Protocol Violation|0|||
163349511|NCT00092521|589990779|FG002|Extension Study (Group 4)|Protocol Violation|0|||
163349512|NCT00092521|589990780|FG003|Extension Study (Group 4)|Protocol Violation|2|||
163349513|NCT00092521|589990777|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
163349514|NCT00092521|589990778|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
163349515|NCT00092521|589990779|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
163349516|NCT00092521|589990780|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
163349517|NCT00092521|589990777|FG000|Extension Study (Group 4)|Moved|0|||
163349518|NCT00092521|589990778|FG001|Extension Study (Group 4)|Moved|0|||
163349519|NCT00092521|589990779|FG002|Extension Study (Group 4)|Moved|0|||
163349520|NCT00092521|589990780|FG003|Extension Study (Group 4)|Moved|16|||
163349521|NCT00092521|589990777|FG000|Extension Study (Group 4)|Site Terminated|0|||
163349522|NCT00092521|589990778|FG001|Extension Study (Group 4)|Site Terminated|0|||
163349523|NCT00092521|589990779|FG002|Extension Study (Group 4)|Site Terminated|0|||
163349524|NCT00092521|589990780|FG003|Extension Study (Group 4)|Site Terminated|4|||
163349525|NCT00092521|589990777|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
163349526|NCT00092521|589990778|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
163409681|NCT04232696|590209474|FG001|Overall Study|Withdrawal by Subject|3|||
163145066|NCT01005251|589241571|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
163145067|NCT01005251|589241572|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
163238796|NCT02352493|589583313|FG003|Overall Study|Withdrawal by Subject|0|||
163349527|NCT00092521|589990779|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
163349528|NCT00092521|589990780|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
163349529|NCT01878383|589990781|FG000|Overall Study|Lost to Follow-up|0|||
163349530|NCT01878383|589990782|FG001|Overall Study|Lost to Follow-up|1499|||
163349531|NCT03464383|589990783|FG000|Overall Study|Lost to Follow-up|1|||
163349532|NCT03464383|589990784|FG001|Overall Study|Lost to Follow-up|0|||
163238797|NCT02352493|589583314|FG004|Overall Study|Withdrawal by Subject|0|||
163238798|NCT02352493|589583315|FG005|Overall Study|Withdrawal by Subject|0|||
163238799|NCT02352493|589583316|FG006|Overall Study|Withdrawal by Subject|0|||
163238800|NCT02352493|589583317|FG007|Overall Study|Withdrawal by Subject|0|||
163238801|NCT02352493|589583318|FG008|Overall Study|Withdrawal by Subject|1|||
163238802|NCT02352493|589583319|FG009|Overall Study|Withdrawal by Subject|0|||
163238803|NCT02352493|589583320|FG010|Overall Study|Withdrawal by Subject|0|||
163238804|NCT02352493|589583321|FG011|Overall Study|Withdrawal by Subject|0|||
163238805|NCT02352493|589583322|FG012|Overall Study|Withdrawal by Subject|0|||
163238806|NCT02352493|589583323|FG013|Overall Study|Withdrawal by Subject|0|||
163238807|NCT02352493|589583324|FG014|Overall Study|Withdrawal by Subject|1|||
163238808|NCT02352493|589583325|FG015|Overall Study|Withdrawal by Subject|0|||
163238809|NCT02352493|589583326|FG016|Overall Study|Withdrawal by Subject|0|||
163238810|NCT02352493|589583327|FG017|Overall Study|Withdrawal by Subject|0|||
163238811|NCT02352493|589583310|FG000|Overall Study|Lost to Follow-up|0|||
163238812|NCT02352493|589583311|FG001|Overall Study|Lost to Follow-up|0|||
163238813|NCT02352493|589583312|FG002|Overall Study|Lost to Follow-up|0|||
163238814|NCT02352493|589583313|FG003|Overall Study|Lost to Follow-up|0|||
163238815|NCT02352493|589583314|FG004|Overall Study|Lost to Follow-up|0|||
163238816|NCT02352493|589583315|FG005|Overall Study|Lost to Follow-up|0|||
163238817|NCT02352493|589583316|FG006|Overall Study|Lost to Follow-up|0|||
163238818|NCT02352493|589583317|FG007|Overall Study|Lost to Follow-up|0|||
163238819|NCT02352493|589583318|FG008|Overall Study|Lost to Follow-up|0|||
163238820|NCT02352493|589583319|FG009|Overall Study|Lost to Follow-up|1|||
163238821|NCT02352493|589583320|FG010|Overall Study|Lost to Follow-up|0|||
163238822|NCT02352493|589583321|FG011|Overall Study|Lost to Follow-up|0|||
163238823|NCT02352493|589583322|FG012|Overall Study|Lost to Follow-up|1|||
163238824|NCT02352493|589583323|FG013|Overall Study|Lost to Follow-up|2|||
163238825|NCT02352493|589583324|FG014|Overall Study|Lost to Follow-up|0|||
163238826|NCT02352493|589583325|FG015|Overall Study|Lost to Follow-up|0|||
163238827|NCT02352493|589583326|FG016|Overall Study|Lost to Follow-up|0|||
163238828|NCT02352493|589583327|FG017|Overall Study|Lost to Follow-up|0|||
163238829|NCT02317575|589583328|FG000|Period 1|Difficulty with venous cannulation|0|||
163238830|NCT02317575|589583329|FG001|Period 1|Difficulty with venous cannulation|1|||
163238831|NCT02317575|589583330|FG002|Period 1|Difficulty with venous cannulation|0|||
163238832|NCT02317575|589583331|FG003|Period 1|Difficulty with venous cannulation|0|||
163238833|NCT02317575|589583332|FG004|Period 1|Difficulty with venous cannulation|0|||
163238834|NCT02317575|589583328|FG000|Period 1|Withdrawal by Subject|1|||
163238835|NCT02317575|589583329|FG001|Period 1|Withdrawal by Subject|0|||
163238836|NCT02317575|589583330|FG002|Period 1|Withdrawal by Subject|0|||
163238837|NCT02317575|589583331|FG003|Period 1|Withdrawal by Subject|0|||
163238838|NCT02317575|589583332|FG004|Period 1|Withdrawal by Subject|0|||
163238839|NCT01465334|589583333|FG000|Overall Study|Disease Progression|1|||
163238840|NCT01465334|589583334|FG001|Overall Study|Disease Progression|0|||
163238841|NCT01465334|589583333|FG000|Overall Study|Adverse Event|1|||
163238842|NCT01465334|589583334|FG001|Overall Study|Adverse Event|0|||
163238843|NCT01465334|589583333|FG000|Overall Study|Richter's transformation|0|||
163238844|NCT01465334|589583334|FG001|Overall Study|Richter's transformation|3|||
163238845|NCT01465334|589583333|FG000|Overall Study|Refractory Disease|0|||
163238846|NCT01465334|589583334|FG001|Overall Study|Refractory Disease|3|||
163238847|NCT02159482|589583335|FG000|Overall Study|Withdrawal by Subject|2|||
163238848|NCT02159482|589583335|FG000|Overall Study|Physician Decision|3|||
163238849|NCT04479618|589583336|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
163238850|NCT04479618|589583337|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
163238851|NCT04479618|589583338|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
163238852|NCT04479618|589583336|FG000|Overall Study|Lack of Efficacy|1|||
163238853|NCT04479618|589583337|FG001|Overall Study|Lack of Efficacy|0|||
163238854|NCT04479618|589583338|FG002|Overall Study|Lack of Efficacy|0|||
163238855|NCT04479618|589583336|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
163238856|NCT04479618|589583337|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
163238857|NCT04479618|589583338|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
163238858|NCT04479618|589583336|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
163238859|NCT04479618|589583337|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
163238860|NCT04479618|589583338|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
163238861|NCT04479618|589583336|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
163238862|NCT04479618|589583337|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
163238863|NCT04479618|589583338|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
163238864|NCT04479618|589583336|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
163238865|NCT04479618|589583337|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
163238866|NCT04479618|589583338|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
163238867|NCT01430130|589583339|FG000|Overall Study|Lost to Follow-up|1|||
163238868|NCT01430130|589583339|FG000|Overall Study|Infection on Control Side of Incision|1|||
163238869|NCT00797667|589583340|FG000|Overall Study|Lack of Efficacy|0|||
163238870|NCT00797667|589583341|FG001|Overall Study|Lack of Efficacy|1|||
163238871|NCT00797667|589583342|FG002|Overall Study|Lack of Efficacy|0|||
163238872|NCT00797667|589583340|FG000|Overall Study|Lost to Follow-up|8|||
163238873|NCT00797667|589583341|FG001|Overall Study|Lost to Follow-up|12|||
163238874|NCT00797667|589583342|FG002|Overall Study|Lost to Follow-up|2|||
163238875|NCT00797667|589583340|FG000|Overall Study|Physician Decision|3|||
163238876|NCT00797667|589583341|FG001|Overall Study|Physician Decision|1|||
163238877|NCT00797667|589583342|FG002|Overall Study|Physician Decision|0|||
163238878|NCT00797667|589583340|FG000|Overall Study|Pregnancy|2|||
163238879|NCT00797667|589583341|FG001|Overall Study|Pregnancy|0|||
163238880|NCT00797667|589583342|FG002|Overall Study|Pregnancy|0|||
163238881|NCT00797667|589583340|FG000|Overall Study|Protocol Violation|2|||
163238882|NCT00797667|589583341|FG001|Overall Study|Protocol Violation|7|||
163238883|NCT00797667|589583342|FG002|Overall Study|Protocol Violation|0|||
163238884|NCT00797667|589583340|FG000|Overall Study|Study Terminated by Sponsor|217|||
163238885|NCT00797667|589583341|FG001|Overall Study|Study Terminated by Sponsor|216|||
163238886|NCT00797667|589583342|FG002|Overall Study|Study Terminated by Sponsor|115|||
163238887|NCT00797667|589583340|FG000|Overall Study|Withdrawal by Subject|9|||
163238888|NCT00797667|589583341|FG001|Overall Study|Withdrawal by Subject|14|||
163238889|NCT00797667|589583342|FG002|Overall Study|Withdrawal by Subject|2|||
163238890|NCT00797667|589583340|FG000|Overall Study|Adverse Event|19|||
163238891|NCT00797667|589583341|FG001|Overall Study|Adverse Event|8|||
163238892|NCT00797667|589583342|FG002|Overall Study|Adverse Event|8|||
163238893|NCT01485861|589583343|FG000|Phase Ib|Death|1|||
163238894|NCT01485861|589583344|FG001|Phase Ib|Death|0|||
163238895|NCT01485861|589583345|FG002|Phase Ib|Death|0|||
163238896|NCT01485861|589583346|FG003|Phase Ib|Death|0|||
163238897|NCT01485861|589583347|FG004|Phase Ib|Death|0|||
163238898|NCT01485861|589583348|FG005|Phase Ib|Death|0|||
163238899|NCT01485861|589583343|FG000|Phase Ib|Physician Decision|1|||
163238900|NCT01485861|589583344|FG001|Phase Ib|Physician Decision|1|||
163238901|NCT01485861|589583345|FG002|Phase Ib|Physician Decision|0|||
163238902|NCT01485861|589583346|FG003|Phase Ib|Physician Decision|0|||
163238903|NCT01485861|589583347|FG004|Phase Ib|Physician Decision|0|||
163238904|NCT01485861|589583348|FG005|Phase Ib|Physician Decision|0|||
163238905|NCT01485861|589583343|FG000|Phase Ib|Adverse Event|0|||
163238906|NCT01485861|589583344|FG001|Phase Ib|Adverse Event|4|||
163238907|NCT01485861|589583345|FG002|Phase Ib|Adverse Event|0|||
163238908|NCT01485861|589583346|FG003|Phase Ib|Adverse Event|0|||
163238909|NCT01485861|589583347|FG004|Phase Ib|Adverse Event|0|||
163238910|NCT01485861|589583348|FG005|Phase Ib|Adverse Event|0|||
163238911|NCT01485861|589583343|FG000|Phase Ib|Progression of disease|5|||
163238912|NCT01485861|589583344|FG001|Phase Ib|Progression of disease|0|||
163238913|NCT01485861|589583345|FG002|Phase Ib|Progression of disease|0|||
163238914|NCT01485861|589583346|FG003|Phase Ib|Progression of disease|0|||
163349533|NCT03464383|589990785|FG002|Overall Study|Lost to Follow-up|0|||
163349534|NCT03464383|589990783|FG000|Overall Study|Withdrawal by Subject|0|||
163349535|NCT03464383|589990784|FG001|Overall Study|Withdrawal by Subject|1|||
163349536|NCT03464383|589990785|FG002|Overall Study|Withdrawal by Subject|0|||
163349537|NCT00560313|589990786|FG000|Overall Study|Adverse Events or Death|2|||
163349538|NCT00560313|589990786|FG000|Overall Study|Withdrawal by Subject|2|||
163349539|NCT00560313|589990786|FG000|Overall Study|Lost to Follow-up|1|||
163349540|NCT00560313|589990786|FG000|Overall Study|Protocol Violation|1|||
163349541|NCT00605566|589990787|FG000|Overall Study|Adverse Event|1|||
163349542|NCT00605566|589990787|FG000|Overall Study|Clinical deterioration|1|||
163349543|NCT00605566|589990787|FG000|Overall Study|Poor compliance in run-in period|1|||
163349544|NCT03449134|589990788|FG000|52-Week Treatment Period|Death|2|||
163349545|NCT03449134|589990789|FG001|52-Week Treatment Period|Death|1|||
163349546|NCT03449134|589990790|FG002|52-Week Treatment Period|Death|0|||
163349547|NCT03449134|589990788|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
163238915|NCT01485861|589583347|FG004|Phase Ib|Progression of disease|0|||
163238916|NCT01485861|589583348|FG005|Phase Ib|Progression of disease|0|||
163238917|NCT01485861|589583343|FG000|Phase Ib|Other|3|||
163238918|NCT01485861|589583344|FG001|Phase Ib|Other|0|||
163238919|NCT01485861|589583345|FG002|Phase Ib|Other|0|||
163238920|NCT01485861|589583346|FG003|Phase Ib|Other|0|||
163238921|NCT01485861|589583347|FG004|Phase Ib|Other|0|||
163238922|NCT01485861|589583348|FG005|Phase Ib|Other|0|||
163238923|NCT01485861|589583343|FG000|Phase Ib|Withdrawal by Subject|4|||
163238924|NCT01485861|589583344|FG001|Phase Ib|Withdrawal by Subject|1|||
163238925|NCT01485861|589583345|FG002|Phase Ib|Withdrawal by Subject|0|||
163238926|NCT01485861|589583346|FG003|Phase Ib|Withdrawal by Subject|0|||
163238927|NCT01485861|589583347|FG004|Phase Ib|Withdrawal by Subject|0|||
163238928|NCT01485861|589583348|FG005|Phase Ib|Withdrawal by Subject|0|||
163238929|NCT01485861|589583343|FG000|Phase II|Death|0|||
163238930|NCT01485861|589583344|FG001|Phase II|Death|0|||
163238931|NCT01485861|589583345|FG002|Phase II|Death|67|||
163349548|NCT03449134|589990789|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
163349549|NCT03449134|589990790|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
163238932|NCT01485861|589583346|FG003|Phase II|Death|71|||
163238933|NCT01485861|589583347|FG004|Phase II|Death|68|||
163238934|NCT01485861|589583348|FG005|Phase II|Death|0|||
163238935|NCT01485861|589583343|FG000|Phase II|Progression of Disease|0|||
163238936|NCT01485861|589583344|FG001|Phase II|Progression of Disease|0|||
163238937|NCT01485861|589583345|FG002|Phase II|Progression of Disease|1|||
163238938|NCT01485861|589583346|FG003|Phase II|Progression of Disease|0|||
163238939|NCT01485861|589583347|FG004|Phase II|Progression of Disease|0|||
163238940|NCT01485861|589583348|FG005|Phase II|Progression of Disease|0|||
163238941|NCT01485861|589583343|FG000|Phase II|Other|0|||
163238942|NCT01485861|589583344|FG001|Phase II|Other|0|||
163238943|NCT01485861|589583345|FG002|Phase II|Other|0|||
163238944|NCT01485861|589583346|FG003|Phase II|Other|1|||
163238945|NCT01485861|589583347|FG004|Phase II|Other|0|||
163238946|NCT01485861|589583348|FG005|Phase II|Other|0|||
163238947|NCT01485861|589583343|FG000|Phase II|Withdrawal by Subject|0|||
163238948|NCT01485861|589583344|FG001|Phase II|Withdrawal by Subject|0|||
163238949|NCT01485861|589583345|FG002|Phase II|Withdrawal by Subject|6|||
163238950|NCT01485861|589583346|FG003|Phase II|Withdrawal by Subject|3|||
163238951|NCT01485861|589583347|FG004|Phase II|Withdrawal by Subject|4|||
163238952|NCT01485861|589583348|FG005|Phase II|Withdrawal by Subject|0|||
163238953|NCT01485861|589583343|FG000|Phase II|Lost to Follow-up|0|||
163238954|NCT01485861|589583344|FG001|Phase II|Lost to Follow-up|0|||
163238955|NCT01485861|589583345|FG002|Phase II|Lost to Follow-up|2|||
163238956|NCT01485861|589583346|FG003|Phase II|Lost to Follow-up|3|||
163238957|NCT01485861|589583347|FG004|Phase II|Lost to Follow-up|5|||
163238958|NCT01485861|589583348|FG005|Phase II|Lost to Follow-up|0|||
163238959|NCT01485861|589583343|FG000|Phase II|Study Ended|0|||
163238960|NCT01485861|589583344|FG001|Phase II|Study Ended|0|||
163238961|NCT01485861|589583345|FG002|Phase II|Study Ended|7|||
163238962|NCT01485861|589583346|FG003|Phase II|Study Ended|8|||
163238963|NCT01485861|589583347|FG004|Phase II|Study Ended|6|||
163238964|NCT01485861|589583348|FG005|Phase II|Study Ended|0|||
163238965|NCT01485861|589583343|FG000|Safety Phase|Death|0|||
163238966|NCT01485861|589583344|FG001|Safety Phase|Death|0|||
163238967|NCT01485861|589583345|FG002|Safety Phase|Death|0|||
163238968|NCT01485861|589583346|FG003|Safety Phase|Death|0|||
163238969|NCT01485861|589583347|FG004|Safety Phase|Death|0|||
163238970|NCT01485861|589583348|FG005|Safety Phase|Death|2|||
163238971|NCT01485861|589583343|FG000|Safety Phase|Adverse Event|0|||
163238972|NCT01485861|589583344|FG001|Safety Phase|Adverse Event|0|||
163238973|NCT01485861|589583345|FG002|Safety Phase|Adverse Event|0|||
163238974|NCT01485861|589583346|FG003|Safety Phase|Adverse Event|0|||
163238975|NCT01485861|589583347|FG004|Safety Phase|Adverse Event|0|||
163238976|NCT01485861|589583348|FG005|Safety Phase|Adverse Event|1|||
163238977|NCT01485861|589583343|FG000|Safety Phase|Other|0|||
163238978|NCT01485861|589583344|FG001|Safety Phase|Other|0|||
163238979|NCT01485861|589583345|FG002|Safety Phase|Other|0|||
163238980|NCT01485861|589583346|FG003|Safety Phase|Other|0|||
163238981|NCT01485861|589583347|FG004|Safety Phase|Other|0|||
163238982|NCT01485861|589583348|FG005|Safety Phase|Other|5|||
163238983|NCT01485861|589583343|FG000|Safety Phase|Progression of Disease|0|||
163238984|NCT01485861|589583344|FG001|Safety Phase|Progression of Disease|0|||
163238985|NCT01485861|589583345|FG002|Safety Phase|Progression of Disease|0|||
163238986|NCT01485861|589583346|FG003|Safety Phase|Progression of Disease|0|||
163238987|NCT01485861|589583347|FG004|Safety Phase|Progression of Disease|0|||
163238988|NCT01485861|589583348|FG005|Safety Phase|Progression of Disease|9|||
163238989|NCT01485861|589583343|FG000|Safety Phase|Withdrawal by Subject|0|||
163238990|NCT01485861|589583344|FG001|Safety Phase|Withdrawal by Subject|0|||
163238991|NCT01485861|589583345|FG002|Safety Phase|Withdrawal by Subject|0|||
163238992|NCT01485861|589583346|FG003|Safety Phase|Withdrawal by Subject|0|||
163238993|NCT01485861|589583347|FG004|Safety Phase|Withdrawal by Subject|0|||
163238994|NCT01485861|589583348|FG005|Safety Phase|Withdrawal by Subject|6|||
163238995|NCT01485861|589583343|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
163238996|NCT01485861|589583344|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
163349550|NCT03449134|589990788|FG000|52-Week Treatment Period|Physician Decision|2|||
163349551|NCT03449134|589990789|FG001|52-Week Treatment Period|Physician Decision|3|||
163349552|NCT03449134|589990790|FG002|52-Week Treatment Period|Physician Decision|3|||
163238997|NCT01485861|589583345|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
163238998|NCT01485861|589583346|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
163238999|NCT01485861|589583347|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
163239000|NCT01485861|589583348|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
163239001|NCT01986829|589583353|FG000|Overall Study|Death|1|||
163239002|NCT03795922|589583354|FG000|Overall Study|Adverse Event|2|||
163239003|NCT03795922|589583355|FG001|Overall Study|Adverse Event|1|||
163239004|NCT03795922|589583354|FG000|Overall Study|Withdrawal by Subject|5|||
163239005|NCT03795922|589583355|FG001|Overall Study|Withdrawal by Subject|13|||
163349553|NCT03449134|589990788|FG000|52-Week Treatment Period|Screen Failure|1|||
163239006|NCT03795922|589583354|FG000|Overall Study|Lost to Follow-up|2|||
163239007|NCT03795922|589583355|FG001|Overall Study|Lost to Follow-up|3|||
163239008|NCT03795922|589583354|FG000|Overall Study|Pregnancy|0|||
163239009|NCT03795922|589583355|FG001|Overall Study|Pregnancy|1|||
163239010|NCT03795922|589583354|FG000|Overall Study|Physician Decision|1|||
163239011|NCT03795922|589583355|FG001|Overall Study|Physician Decision|2|||
163239012|NCT03795922|589583354|FG000|Overall Study|Protocol Violation|0|||
163239013|NCT03795922|589583355|FG001|Overall Study|Protocol Violation|1|||
163239014|NCT03795922|589583354|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
163239015|NCT03795922|589583355|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
163239016|NCT00701051|589583358|FG000|Screening|Failed Screening|40|||
163239017|NCT00701051|589583359|FG001|Screening|Failed Screening|0|||
163239018|NCT00701051|589583360|FG002|Screening|Failed Screening|0|||
163239019|NCT00701051|589583358|FG000|Screening|Time conflicts|19|||
163239020|NCT00701051|589583359|FG001|Screening|Time conflicts|0|||
163239021|NCT00701051|589583360|FG002|Screening|Time conflicts|0|||
163239022|NCT00701051|589583358|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
163239023|NCT00701051|589583359|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
163239024|NCT00701051|589583360|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
163239025|NCT01243944|589583361|FG000|Overall Study|Adverse Event|15|||
163239026|NCT01243944|589583362|FG001|Overall Study|Adverse Event|13|||
163239027|NCT01243944|589583361|FG000|Overall Study|Lost to Follow-up|2|||
163239028|NCT01243944|589583362|FG001|Overall Study|Lost to Follow-up|1|||
163239029|NCT01243944|589583361|FG000|Overall Study|Physician Decision|2|||
163239030|NCT01243944|589583362|FG001|Overall Study|Physician Decision|7|||
163239031|NCT01243944|589583361|FG000|Overall Study|Disease progression|12|||
163239032|NCT01243944|589583362|FG001|Overall Study|Disease progression|11|||
163239033|NCT01243944|589583361|FG000|Overall Study|Protocol deviation|1|||
163239034|NCT01243944|589583362|FG001|Overall Study|Protocol deviation|1|||
163239035|NCT01243944|589583361|FG000|Overall Study|Participant decision|10|||
163239036|NCT01243944|589583362|FG001|Overall Study|Participant decision|15|||
163239037|NCT01243944|589583361|FG000|Overall Study|Death|2|||
163239038|NCT01243944|589583362|FG001|Overall Study|Death|3|||
163239039|NCT01243944|589583361|FG000|Overall Study|Non-compliance with study treatment|1|||
163239040|NCT01243944|589583362|FG001|Overall Study|Non-compliance with study treatment|0|||
163239041|NCT03029208|589583365|FG000|Overall Study|Withdrawal by Subject|2|||
163239042|NCT03029208|589583366|FG001|Overall Study|Withdrawal by Subject|3|||
163239043|NCT03029208|589583365|FG000|Overall Study|Lost to Follow-up|0|||
163239044|NCT03029208|589583366|FG001|Overall Study|Lost to Follow-up|1|||
163239045|NCT02673697|589583371|FG000|Overall Study|Adverse Event|2|||
163239046|NCT02673697|589583372|FG001|Overall Study|Adverse Event|0|||
163239047|NCT02673697|589583371|FG000|Overall Study|Death|32|||
163239048|NCT02673697|589583372|FG001|Overall Study|Death|24|||
163239049|NCT02673697|589583371|FG000|Overall Study|Lost to Follow-up|5|||
163239050|NCT02673697|589583372|FG001|Overall Study|Lost to Follow-up|2|||
163239051|NCT02673697|589583371|FG000|Overall Study|Physician Decision|2|||
163239052|NCT02673697|589583372|FG001|Overall Study|Physician Decision|1|||
163239053|NCT02673697|589583371|FG000|Overall Study|Withdrawal by Subject|10|||
163239054|NCT02673697|589583372|FG001|Overall Study|Withdrawal by Subject|7|||
163239055|NCT02673697|589583371|FG000|Overall Study|Change subj medical status|1|||
163239056|NCT02673697|589583372|FG001|Overall Study|Change subj medical status|2|||
163239057|NCT02673697|589583371|FG000|Overall Study|Explant|10|||
163239058|NCT02673697|589583372|FG001|Overall Study|Explant|5|||
163239059|NCT02673697|589583371|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
163239060|NCT02673697|589583372|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
163239061|NCT00437489|589583373|FG000|Overall Study|Study terminated by sponsor|23|||
163239062|NCT00437489|589583374|FG001|Overall Study|Study terminated by sponsor|21|||
163239063|NCT00437489|589583373|FG000|Overall Study|Lost to Follow-up|0|||
163239064|NCT00437489|589583374|FG001|Overall Study|Lost to Follow-up|1|||
163239065|NCT03893448|589583377|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
163239066|NCT03893448|589583378|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
163239067|NCT03893448|589583377|FG000|Overall Study|Physician Decision|8|||
163239068|NCT03893448|589583378|FG001|Overall Study|Physician Decision|14|||
163239069|NCT03893448|589583377|FG000|Overall Study|Lost to Follow-up|34|||
163239070|NCT03893448|589583378|FG001|Overall Study|Lost to Follow-up|27|||
163239071|NCT03893448|589583377|FG000|Overall Study|Death|1|||
163239072|NCT03893448|589583378|FG001|Overall Study|Death|0|||
163239073|NCT03321981|589583380|FG000|Overall Study|Progressive Disease (PD)|15|||
163239074|NCT03321981|589583381|FG001|Overall Study|Progressive Disease (PD)|30|||
163239075|NCT03321981|589583382|FG002|Overall Study|Progressive Disease (PD)|47|||
163239076|NCT03321981|589583380|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
163239077|NCT03321981|589583381|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
163239078|NCT03321981|589583382|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
163239079|NCT03321981|589583380|FG000|Overall Study|Adverse Event|0|||
163239080|NCT03321981|589583381|FG001|Overall Study|Adverse Event|0|||
163349554|NCT03449134|589990789|FG001|52-Week Treatment Period|Screen Failure|0|||
163239081|NCT03321981|589583382|FG002|Overall Study|Adverse Event|2|||
163239082|NCT03321981|589583380|FG000|Overall Study|symptomatic deterioration|0|||
163239083|NCT03321981|589583381|FG001|Overall Study|symptomatic deterioration|1|||
163409682|NCT04232696|590209473|FG000|Overall Study|Missed Visit|0|||
163409683|NCT04232696|590209474|FG001|Overall Study|Missed Visit|2|||
163409684|NCT04232696|590209473|FG000|Overall Study|Other reason|0|||
163239084|NCT03321981|589583382|FG002|Overall Study|symptomatic deterioration|1|||
163239085|NCT03321981|589583380|FG000|Overall Study|Lack of compliance|0|||
163239086|NCT03321981|589583381|FG001|Overall Study|Lack of compliance|1|||
163239087|NCT03321981|589583382|FG002|Overall Study|Lack of compliance|0|||
163239088|NCT03321981|589583380|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
163239089|NCT03321981|589583381|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
163239090|NCT03321981|589583382|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
163239091|NCT03321981|589583380|FG000|Overall Study|Death|0|||
163239092|NCT03321981|589583381|FG001|Overall Study|Death|1|||
163239093|NCT03321981|589583382|FG002|Overall Study|Death|0|||
163239094|NCT03321981|589583380|FG000|Overall Study|Subject withdrawal of investigational product|0|||
163239095|NCT03321981|589583381|FG001|Overall Study|Subject withdrawal of investigational product|1|||
163239096|NCT03321981|589583382|FG002|Overall Study|Subject withdrawal of investigational product|0|||
163239097|NCT03321981|589583380|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
163239098|NCT03321981|589583381|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
163239099|NCT03321981|589583382|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
163239100|NCT03321981|589583380|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
163239101|NCT03321981|589583381|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
163239102|NCT03321981|589583382|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
163239103|NCT03321019|589583384|FG000|Overall Study|Withdrawal by Subject|0|||
163239104|NCT03321019|589583385|FG001|Overall Study|Withdrawal by Subject|6|||
163239105|NCT03321019|589583384|FG000|Overall Study|Lost to Follow-up|0|||
163239106|NCT03321019|589583385|FG001|Overall Study|Lost to Follow-up|22|||
163239107|NCT03880578|589583386|FG000|Overall Study|Withdrawal by Subject|0|||
163239108|NCT03880578|589583387|FG001|Overall Study|Withdrawal by Subject|3|||
163239109|NCT03880578|589583388|FG002|Overall Study|Withdrawal by Subject|1|||
163239110|NCT03880578|589583386|FG000|Overall Study|Death|0|||
163239111|NCT03880578|589583387|FG001|Overall Study|Death|1|||
163239112|NCT03880578|589583388|FG002|Overall Study|Death|0|||
163239113|NCT04934670|589583389|FG000|Overall Study|Death|4|||
163239114|NCT04934670|589583390|FG001|Overall Study|Death|0|||
163239115|NCT04934670|589583389|FG000|Overall Study|Lost to Follow-up|1|||
163239116|NCT04934670|589583390|FG001|Overall Study|Lost to Follow-up|4|||
163239117|NCT03056690|589583392|FG000|Overall Study|Adverse Event|3|||
163239118|NCT03056690|589583393|FG001|Overall Study|Adverse Event|2|||
163239119|NCT03056690|589583392|FG000|Overall Study|Lack of Efficacy|1|||
163239120|NCT03056690|589583393|FG001|Overall Study|Lack of Efficacy|2|||
163239121|NCT03056690|589583392|FG000|Overall Study|Lost to Follow-up|3|||
163239122|NCT03056690|589583393|FG001|Overall Study|Lost to Follow-up|2|||
163239123|NCT03056690|589583392|FG000|Overall Study|Protocol Violation|2|||
163239124|NCT03056690|589583393|FG001|Overall Study|Protocol Violation|2|||
163239125|NCT03056690|589583392|FG000|Overall Study|Withdrawal by Subject|3|||
163239126|NCT03056690|589583393|FG001|Overall Study|Withdrawal by Subject|6|||
163239127|NCT03056690|589583392|FG000|Overall Study|Non-compliance with Study Drug|1|||
163239128|NCT03056690|589583393|FG001|Overall Study|Non-compliance with Study Drug|0|||
163239129|NCT03056690|589583392|FG000|Overall Study|Miscellaneous|1|||
163239130|NCT03056690|589583393|FG001|Overall Study|Miscellaneous|2|||
163239131|NCT01944046|589583399|FG000|Randomized to DB|Adverse Event|5|||
163239132|NCT01944046|589583400|FG001|Randomized to DB|Adverse Event|2|||
163239133|NCT01944046|589583399|FG000|Randomized to DB|Clinical Worsening|3|||
163239134|NCT01944046|589583400|FG001|Randomized to DB|Clinical Worsening|2|||
163239135|NCT01944046|589583399|FG000|Randomized to DB|Lost to Follow-up|3|||
163239136|NCT01944046|589583400|FG001|Randomized to DB|Lost to Follow-up|3|||
163239137|NCT01944046|589583399|FG000|Randomized to DB|Withdrawal by Subject|2|||
163239138|NCT01944046|589583400|FG001|Randomized to DB|Withdrawal by Subject|4|||
163239139|NCT01944046|589583399|FG000|Randomized to DB|Physician Decision|1|||
163239140|NCT01944046|589583400|FG001|Randomized to DB|Physician Decision|2|||
163239141|NCT01944046|589583399|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
163239142|NCT01944046|589583400|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
163239143|NCT01944046|589583399|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
163239144|NCT01944046|589583400|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
163239145|NCT01944046|589583399|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
163239146|NCT01944046|589583400|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
163239147|NCT01944046|589583399|FG000|Open Label Eligible and Consented|Adverse Event|6|||
163239148|NCT01944046|589583400|FG001|Open Label Eligible and Consented|Adverse Event|1|||
163239149|NCT01944046|589583399|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
163239150|NCT01944046|589583400|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
163239151|NCT01944046|589583399|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
163349555|NCT03449134|589990790|FG002|52-Week Treatment Period|Screen Failure|1|||
163349556|NCT03449134|589990788|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
163349557|NCT03449134|589990789|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
163349558|NCT03449134|589990790|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
163349559|NCT03449134|589990788|FG000|52-Week Treatment Period|Site Closure|1|||
163349560|NCT03449134|589990789|FG001|52-Week Treatment Period|Site Closure|0|||
163349561|NCT03449134|589990790|FG002|52-Week Treatment Period|Site Closure|0|||
163349562|NCT03475056|589990791|FG000|Overall Study|Lost to Follow-up|0|||
163409685|NCT04232696|590209474|FG001|Overall Study|Other reason|1|||
163145068|NCT01005251|589241573|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
163145069|NCT01005251|589241569|FG000|Overall Study|Lost to Follow-up|1|||
163145070|NCT01005251|589241570|FG001|Overall Study|Lost to Follow-up|4|||
163145071|NCT01005251|589241571|FG002|Overall Study|Lost to Follow-up|2|||
163145072|NCT01005251|589241572|FG003|Overall Study|Lost to Follow-up|0|||
163145073|NCT01005251|589241573|FG004|Overall Study|Lost to Follow-up|0|||
163145074|NCT01005251|589241569|FG000|Overall Study|Physician Decision|0|||
163145075|NCT01005251|589241570|FG001|Overall Study|Physician Decision|0|||
163145076|NCT01005251|589241571|FG002|Overall Study|Physician Decision|0|||
163145077|NCT01005251|589241572|FG003|Overall Study|Physician Decision|0|||
163145078|NCT01005251|589241573|FG004|Overall Study|Physician Decision|2|||
163145079|NCT01005251|589241569|FG000|Overall Study|Patient moved|1|||
163145080|NCT01005251|589241570|FG001|Overall Study|Patient moved|0|||
163145081|NCT01005251|589241571|FG002|Overall Study|Patient moved|0|||
163145082|NCT01005251|589241572|FG003|Overall Study|Patient moved|0|||
163145083|NCT01005251|589241573|FG004|Overall Study|Patient moved|0|||
163145084|NCT01005251|589241569|FG000|Overall Study|Wrong drug dispensed|0|||
163145085|NCT01005251|589241570|FG001|Overall Study|Wrong drug dispensed|1|||
163145086|NCT01005251|589241571|FG002|Overall Study|Wrong drug dispensed|0|||
163145087|NCT01005251|589241572|FG003|Overall Study|Wrong drug dispensed|0|||
163145088|NCT01005251|589241573|FG004|Overall Study|Wrong drug dispensed|0|||
163145089|NCT01005251|589241569|FG000|Overall Study|Randomized in error|0|||
163145090|NCT01005251|589241570|FG001|Overall Study|Randomized in error|0|||
163145091|NCT01005251|589241571|FG002|Overall Study|Randomized in error|1|||
163145092|NCT01005251|589241572|FG003|Overall Study|Randomized in error|1|||
163145093|NCT01005251|589241573|FG004|Overall Study|Randomized in error|0|||
163145094|NCT01005251|589241569|FG000|Overall Study|Lack of Efficacy|0|||
163145095|NCT01005251|589241570|FG001|Overall Study|Lack of Efficacy|0|||
163145096|NCT01005251|589241571|FG002|Overall Study|Lack of Efficacy|1|||
163145097|NCT01005251|589241572|FG003|Overall Study|Lack of Efficacy|1|||
163145098|NCT01005251|589241573|FG004|Overall Study|Lack of Efficacy|0|||
163145099|NCT01702844|589241574|FG000|Overall Study|Adverse Event|9|||
163145100|NCT01702844|589241574|FG000|Overall Study|Death|1|||
163145101|NCT01702844|589241574|FG000|Overall Study|Withdrawal by Subject|3|||
163145102|NCT01702844|589241574|FG000|Overall Study|Physician Decision|6|||
163145103|NCT02193776|589241575|FG000|Overall Study|Consent withdrawn|1|||
163145104|NCT02193776|589241576|FG001|Overall Study|Consent withdrawn|0|||
163145105|NCT02193776|589241577|FG002|Overall Study|Consent withdrawn|0|||
163145106|NCT02193776|589241578|FG003|Overall Study|Consent withdrawn|0|||
163145107|NCT02193776|589241575|FG000|Overall Study|Failure to comply with protocol|0|||
163145108|NCT02193776|589241576|FG001|Overall Study|Failure to comply with protocol|1|||
163145109|NCT02193776|589241577|FG002|Overall Study|Failure to comply with protocol|0|||
163145110|NCT02193776|589241578|FG003|Overall Study|Failure to comply with protocol|0|||
163145111|NCT02193776|589241575|FG000|Overall Study|Investigator/Sponsor decision|1|||
163145112|NCT02193776|589241576|FG001|Overall Study|Investigator/Sponsor decision|1|||
163145113|NCT02193776|589241577|FG002|Overall Study|Investigator/Sponsor decision|0|||
163145114|NCT02193776|589241578|FG003|Overall Study|Investigator/Sponsor decision|0|||
163145115|NCT02193776|589241575|FG000|Overall Study|Death|1|||
163145116|NCT02193776|589241576|FG001|Overall Study|Death|0|||
163145117|NCT02193776|589241577|FG002|Overall Study|Death|0|||
163145118|NCT02193776|589241578|FG003|Overall Study|Death|0|||
163145119|NCT02193776|589241575|FG000|Overall Study|Adverse event/Specific toxicity|5|||
163145120|NCT02193776|589241576|FG001|Overall Study|Adverse event/Specific toxicity|5|||
163145121|NCT02193776|589241577|FG002|Overall Study|Adverse event/Specific toxicity|2|||
163145122|NCT02193776|589241578|FG003|Overall Study|Adverse event/Specific toxicity|2|||
163145123|NCT02995980|589241579|FG000|Overall Study|Lost to Follow-up|14|||
163145124|NCT01458639|589241581|FG000|Overall Study|Physician Decision|4|||
163145125|NCT01458639|589241581|FG000|Overall Study|Equipment issue|1|||
163145126|NCT01458639|589241581|FG000|Overall Study|Inability to obtain subject blood sample|1|||
163145127|NCT04245111|589241582|FG000|Overall Study|Lost to Follow-up|5|||
163145128|NCT04245111|589241583|FG001|Overall Study|Lost to Follow-up|1|||
163145129|NCT04245111|589241584|FG002|Overall Study|Lost to Follow-up|1|||
163145130|NCT06039579|589241585|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
163145131|NCT06039579|589241586|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
163145132|NCT06039579|589241587|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
163145133|NCT06039579|589241588|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
163349563|NCT03475056|589990792|FG001|Overall Study|Lost to Follow-up|1|||
163349564|NCT03475056|589990791|FG000|Overall Study|Moved from Area|0|||
163239152|NCT01944046|589583400|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
163239153|NCT04496258|589583404|FG000|Overall Study|Withdrawal by Subject|2|||
163239154|NCT04496258|589583405|FG001|Overall Study|Withdrawal by Subject|1|||
163239155|NCT02041429|589583406|FG000|Overall Study|Progressive Disease|2|||
163239156|NCT02041429|589583407|FG001|Overall Study|Progressive Disease|2|||
163239157|NCT02041429|589583408|FG002|Overall Study|Progressive Disease|3|||
163239158|NCT02041429|589583409|FG003|Overall Study|Progressive Disease|2|||
163239159|NCT02041429|589583406|FG000|Overall Study|Toxicity|0|||
163239160|NCT02041429|589583407|FG001|Overall Study|Toxicity|1|||
163239161|NCT02041429|589583408|FG002|Overall Study|Toxicity|4|||
163239162|NCT02041429|589583409|FG003|Overall Study|Toxicity|2|||
163239163|NCT02041429|589583406|FG000|Overall Study|Withdrawal by Subject|0|||
163239164|NCT02041429|589583407|FG001|Overall Study|Withdrawal by Subject|1|||
163239165|NCT02041429|589583408|FG002|Overall Study|Withdrawal by Subject|0|||
163239166|NCT02041429|589583409|FG003|Overall Study|Withdrawal by Subject|0|||
163239167|NCT02041429|589583406|FG000|Overall Study|On Maintenance Therapy|1|||
163239168|NCT02041429|589583407|FG001|Overall Study|On Maintenance Therapy|0|||
163239169|NCT02041429|589583408|FG002|Overall Study|On Maintenance Therapy|0|||
163239170|NCT02041429|589583409|FG003|Overall Study|On Maintenance Therapy|2|||
163239171|NCT01427712|589583410|FG000|Overall Study|Transfer to a different hospital|2|||
163239172|NCT01427712|589583410|FG000|Overall Study|Lost to Follow-up|1|||
163239173|NCT01427712|589583410|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
163239174|NCT01427712|589583410|FG000|Overall Study|Failure to visit|1|||
163239175|NCT00153101|589583411|FG000|Overall Study|Lost to Follow-up|14|||
163239176|NCT00153101|589583412|FG001|Overall Study|Lost to Follow-up|14|||
163239177|NCT00153101|589583413|FG002|Overall Study|Lost to Follow-up|12|||
163239178|NCT00153101|589583414|FG003|Overall Study|Lost to Follow-up|5|||
163239179|NCT00153101|589583415|FG004|Overall Study|Lost to Follow-up|5|||
163239180|NCT00153101|589583411|FG000|Overall Study|Withdrawal by Subject|3|||
163239181|NCT00153101|589583412|FG001|Overall Study|Withdrawal by Subject|4|||
163239182|NCT00153101|589583413|FG002|Overall Study|Withdrawal by Subject|3|||
163239183|NCT00153101|589583414|FG003|Overall Study|Withdrawal by Subject|3|||
163239184|NCT00153101|589583415|FG004|Overall Study|Withdrawal by Subject|5|||
163239185|NCT03169153|589583416|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
163239186|NCT03169153|589583417|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
163239187|NCT03169153|589583416|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
163239188|NCT03169153|589583417|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
163239189|NCT03169153|589583416|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
163239190|NCT03169153|589583417|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
163239191|NCT03169153|589583416|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
163239192|NCT03169153|589583417|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
163239193|NCT00439777|589583418|FG000|Treatment Period|Death|29|||
163239194|NCT00439777|589583419|FG001|Treatment Period|Death|21|||
163239195|NCT00439777|589583418|FG000|Treatment Period|Study terminated by sponsor|125|||
163239196|NCT00439777|589583419|FG001|Treatment Period|Study terminated by sponsor|132|||
163239197|NCT00439777|589583418|FG000|Treatment Period|Site closed by investigator|0|||
163239198|NCT00439777|589583419|FG001|Treatment Period|Site closed by investigator|1|||
163239199|NCT00439777|589583418|FG000|Treatment Period|Did not take study treatment|7|||
163239200|NCT00439777|589583419|FG001|Treatment Period|Did not take study treatment|8|||
163239201|NCT00439777|589583418|FG000|Treatment Period|Adverse Event|111|||
163239202|NCT00439777|589583419|FG001|Treatment Period|Adverse Event|92|||
163239203|NCT00439777|589583418|FG000|Treatment Period|Protocol Violation|23|||
163239204|NCT00439777|589583419|FG001|Treatment Period|Protocol Violation|30|||
163239205|NCT00439777|589583418|FG000|Treatment Period|Withdrawal by Subject|66|||
163239206|NCT00439777|589583419|FG001|Treatment Period|Withdrawal by Subject|118|||
163239207|NCT00439777|589583418|FG000|Treatment Period|Lack of Efficacy|1|||
163239208|NCT00439777|589583419|FG001|Treatment Period|Lack of Efficacy|4|||
163239209|NCT00439777|589583418|FG000|Treatment Period|Lost to Follow-up|8|||
163239210|NCT00439777|589583419|FG001|Treatment Period|Lost to Follow-up|10|||
163239211|NCT00439777|589583418|FG000|Treatment Period|Protocol driven decision point|1|||
163239212|NCT00439777|589583419|FG001|Treatment Period|Protocol driven decision point|3|||
163239213|NCT00439777|589583418|FG000|Treatment Period|Physician Decision|7|||
163239214|NCT00439777|589583419|FG001|Treatment Period|Physician Decision|18|||
163239215|NCT00439777|589583418|FG000|Treatment Period|Clinical endpoint reached|26|||
163239216|NCT00439777|589583419|FG001|Treatment Period|Clinical endpoint reached|13|||
163239217|NCT00439777|589583418|FG000|Treatment Period|Technical problems|3|||
163239218|NCT00439777|589583419|FG001|Treatment Period|Technical problems|1|||
163239219|NCT00439777|589583418|FG000|Treatment Period|Participant convenience|12|||
163409686|NCT00488982|590209475|FG000|Course 1|Physician Decision|0|||
163239220|NCT00439777|589583419|FG001|Treatment Period|Participant convenience|8|||
163239221|NCT00439777|589583418|FG000|Observational Period|Protocol Violation|0|||
163239222|NCT00439777|589583419|FG001|Observational Period|Protocol Violation|2|||
163239223|NCT00439777|589583418|FG000|Observational Period|Withdrawal by Subject|9|||
163239224|NCT00439777|589583419|FG001|Observational Period|Withdrawal by Subject|5|||
163239225|NCT00439777|589583418|FG000|Observational Period|Lost to Follow-up|1|||
163239226|NCT00439777|589583419|FG001|Observational Period|Lost to Follow-up|11|||
163239227|NCT00439777|589583418|FG000|Observational Period|Death|27|||
163239228|NCT00439777|589583419|FG001|Observational Period|Death|20|||
163239229|NCT00439777|589583418|FG000|Observational Period|Study terminated by sponsor|3|||
163239230|NCT00439777|589583419|FG001|Observational Period|Study terminated by sponsor|1|||
163239231|NCT00439777|589583418|FG000|Observational Period|Protocol driven decision point|0|||
163239232|NCT00439777|589583419|FG001|Observational Period|Protocol driven decision point|1|||
163239233|NCT00439777|589583418|FG000|Observational Period|Lack of Efficacy|1|||
163239234|NCT00439777|589583419|FG001|Observational Period|Lack of Efficacy|0|||
163239235|NCT00439777|589583418|FG000|Observational Period|Technical problems|0|||
163239236|NCT00439777|589583419|FG001|Observational Period|Technical problems|1|||
163239237|NCT00661492|589583420|FG000|Overall Study|Adverse Event|16|||
163239238|NCT00661492|589583421|FG001|Overall Study|Adverse Event|13|||
163239239|NCT00661492|589583420|FG000|Overall Study|Disease Progression|44|||
163239240|NCT00661492|589583421|FG001|Overall Study|Disease Progression|14|||
163239241|NCT00661492|589583420|FG000|Overall Study|Patient Request|6|||
163239242|NCT00661492|589583421|FG001|Overall Study|Patient Request|1|||
163239243|NCT00661492|589583420|FG000|Overall Study|Investigator Request|1|||
163239244|NCT00661492|589583421|FG001|Overall Study|Investigator Request|0|||
163239245|NCT00661492|589583420|FG000|Overall Study|Lost to Follow-up|0|||
163239246|NCT00661492|589583421|FG001|Overall Study|Lost to Follow-up|1|||
163239247|NCT00661492|589583420|FG000|Overall Study|Other|1|||
163239248|NCT00661492|589583421|FG001|Overall Study|Other|0|||
163239249|NCT00784043|589583422|FG000|Overall Study|Withdrawal by Subject|8|||
163239250|NCT00784043|589583423|FG001|Overall Study|Withdrawal by Subject|5|||
163239251|NCT00784043|589583422|FG000|Overall Study|Protocol Terminated|23|||
163239252|NCT00784043|589583423|FG001|Overall Study|Protocol Terminated|1|||
163239253|NCT00803634|589583424|FG000|Overall Study|Withdrew Consent|1|||
163239254|NCT00803634|589583425|FG001|Overall Study|Withdrew Consent|0|||
163239255|NCT00803634|589583424|FG000|Overall Study|Lost to Follow-up|2|||
163239256|NCT00803634|589583425|FG001|Overall Study|Lost to Follow-up|3|||
163239257|NCT00803634|589583424|FG000|Overall Study|Death|3|||
163239258|NCT00803634|589583425|FG001|Overall Study|Death|2|||
163239259|NCT03791398|589583432|FG000|Overall Study|Progression of Disease Under Study|2|||
163239260|NCT03791398|589583433|FG001|Overall Study|Progression of Disease Under Study|0|||
163239261|NCT03791398|589583434|FG002|Overall Study|Progression of Disease Under Study|0|||
163239262|NCT01072201|589583436|FG000|Overall Study|Lost to Follow-up|0|||
163239263|NCT01072201|589583437|FG001|Overall Study|Lost to Follow-up|1|||
163239264|NCT01578551|589583439|FG000|Overall Study|Adverse Event|1|||
163239265|NCT01578551|589583440|FG001|Overall Study|Adverse Event|0|||
163239266|NCT00061048|589583442|FG000|Overall Study|Adverse Event|2|||
163239267|NCT00061048|589583442|FG000|Overall Study|disease progression|20|||
163239268|NCT02752048|589583443|FG000|Overall Study|Withdrawal by Subject|0|||
163239269|NCT02752048|589583444|FG001|Overall Study|Withdrawal by Subject|0|||
163239270|NCT02752048|589583445|FG002|Overall Study|Withdrawal by Subject|3|||
163239271|NCT00818441|589583449|FG000|Overall Study|Death|69|||
163239272|NCT00818441|589583450|FG001|Overall Study|Death|26|||
163239273|NCT00818441|589583449|FG000|Overall Study|Other|5|||
163239274|NCT00818441|589583450|FG001|Overall Study|Other|0|||
163239275|NCT00818441|589583449|FG000|Overall Study|Lost to Follow-up|2|||
163239276|NCT00818441|589583450|FG001|Overall Study|Lost to Follow-up|1|||
163239277|NCT00818441|589583449|FG000|Overall Study|Withdrawal by Subject|2|||
163239278|NCT00818441|589583450|FG001|Overall Study|Withdrawal by Subject|0|||
163239279|NCT00818441|589583449|FG000|Overall Study|Adverse Event|0|||
163239280|NCT00818441|589583450|FG001|Overall Study|Adverse Event|1|||
163239281|NCT00818441|589583449|FG000|Overall Study|Study terminated by sponsor|11|||
163239282|NCT00818441|589583450|FG001|Overall Study|Study terminated by sponsor|2|||
163239283|NCT00898677|589583453|FG000|Overall Study|Adverse Event|0|||
163239284|NCT00898677|589583454|FG001|Overall Study|Adverse Event|0|||
163239285|NCT00898677|589583455|FG002|Overall Study|Adverse Event|1|||
163239286|NCT00898677|589583456|FG003|Overall Study|Adverse Event|0|||
163239287|NCT00898677|589583453|FG000|Overall Study|Lost to Follow-up|0|||
163239288|NCT00898677|589583454|FG001|Overall Study|Lost to Follow-up|0|||
163239289|NCT00898677|589583455|FG002|Overall Study|Lost to Follow-up|2|||
163239290|NCT00898677|589583456|FG003|Overall Study|Lost to Follow-up|0|||
163239291|NCT00898677|589583453|FG000|Overall Study|Protocol Violation|1|||
163239292|NCT00898677|589583454|FG001|Overall Study|Protocol Violation|1|||
163239293|NCT00898677|589583455|FG002|Overall Study|Protocol Violation|2|||
163349565|NCT03475056|589990792|FG001|Overall Study|Moved from Area|2|||
163239294|NCT00898677|589583456|FG003|Overall Study|Protocol Violation|0|||
163239295|NCT00898677|589583453|FG000|Overall Study|Withdrawal by Subject|0|||
163239296|NCT00898677|589583454|FG001|Overall Study|Withdrawal by Subject|0|||
163239297|NCT00898677|589583455|FG002|Overall Study|Withdrawal by Subject|0|||
163239298|NCT00898677|589583456|FG003|Overall Study|Withdrawal by Subject|1|||
163239299|NCT00898677|589583453|FG000|Overall Study|Not Treated: Adverse Event|0|||
163239300|NCT00898677|589583454|FG001|Overall Study|Not Treated: Adverse Event|2|||
163239301|NCT00898677|589583455|FG002|Overall Study|Not Treated: Adverse Event|1|||
163239302|NCT00898677|589583456|FG003|Overall Study|Not Treated: Adverse Event|0|||
163409687|NCT00488982|590209476|FG001|Course 1|Physician Decision|2|||
163349566|NCT00113269|589990795|FG000|Overall Study|Not transplanted, donor issues|4|||
163239303|NCT00898677|589583453|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
163239304|NCT00898677|589583454|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
163239305|NCT00898677|589583455|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
163239306|NCT00898677|589583456|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
163239307|NCT00898677|589583453|FG000|Overall Study|Not Treated: Pregnancy|0|||
163239308|NCT00898677|589583454|FG001|Overall Study|Not Treated: Pregnancy|0|||
163239309|NCT00898677|589583455|FG002|Overall Study|Not Treated: Pregnancy|1|||
163239310|NCT00898677|589583456|FG003|Overall Study|Not Treated: Pregnancy|0|||
163239311|NCT00898677|589583453|FG000|Overall Study|Not Treated: Protocol Violation|2|||
163239312|NCT00898677|589583454|FG001|Overall Study|Not Treated: Protocol Violation|0|||
163239313|NCT00898677|589583455|FG002|Overall Study|Not Treated: Protocol Violation|2|||
163239314|NCT00898677|589583456|FG003|Overall Study|Not Treated: Protocol Violation|0|||
163239315|NCT00898677|589583453|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
163239316|NCT00898677|589583454|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
163239317|NCT00898677|589583455|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
163239318|NCT00898677|589583456|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
163239319|NCT00898677|589583453|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
163239320|NCT00898677|589583454|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
163239321|NCT00898677|589583455|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
163239322|NCT00898677|589583456|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
163239323|NCT00898677|589583453|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
163239324|NCT00898677|589583454|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
163239325|NCT00898677|589583455|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
163239326|NCT00898677|589583456|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
163239327|NCT00898677|589583453|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
163239328|NCT00898677|589583454|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
163239329|NCT00898677|589583455|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
163239330|NCT00898677|589583456|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
163239331|NCT00898677|589583453|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
163239332|NCT00898677|589583454|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
163239333|NCT00898677|589583455|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
163239334|NCT00898677|589583456|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
163239335|NCT00898677|589583453|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
163239336|NCT00898677|589583454|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
163239337|NCT00898677|589583455|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
163239338|NCT00898677|589583456|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
163239339|NCT00898677|589583453|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
163239340|NCT00898677|589583454|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
163239341|NCT00898677|589583455|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
163239342|NCT00898677|589583456|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
163239343|NCT00774995|589583460|FG000|Overall Study|Protocol Violation|0|||
163239344|NCT00774995|589583461|FG001|Overall Study|Protocol Violation|0|||
163239345|NCT00774995|589583462|FG002|Overall Study|Protocol Violation|1|||
163239346|NCT00774995|589583463|FG003|Overall Study|Protocol Violation|0|||
163239347|NCT02239510|589585150|FG000|Overall Study|Lost to Follow-up|2|||
163239348|NCT02239510|589585151|FG001|Overall Study|Lost to Follow-up|1|||
163239349|NCT00993447|589585152|FG000|Overall Study|Withdrawal by Subject|23|||
163239350|NCT00993447|589585153|FG001|Overall Study|Withdrawal by Subject|8|||
163239351|NCT00993447|589585152|FG000|Overall Study|Protocol Violation|12|||
163239352|NCT00993447|589585153|FG001|Overall Study|Protocol Violation|8|||
163239353|NCT00993447|589585152|FG000|Overall Study|Lost to Follow-up|1|||
163239354|NCT00993447|589585153|FG001|Overall Study|Lost to Follow-up|3|||
163239355|NCT00993447|589585152|FG000|Overall Study|Adverse Event|1|||
163239356|NCT00993447|589585153|FG001|Overall Study|Adverse Event|0|||
163239357|NCT02707055|589585154|FG000|Phase 1|Withdrawal by Subject|1|||
163239358|NCT02707055|589585155|FG001|Phase 1|Withdrawal by Subject|2|||
163239359|NCT02707055|589585154|FG000|Phase 1|Physician Decision|0|||
163239360|NCT02707055|589585155|FG001|Phase 1|Physician Decision|1|||
163239361|NCT02707055|589585154|FG000|Phase 2|Adverse Event|1|||
163239362|NCT02707055|589585155|FG001|Phase 2|Adverse Event|2|||
163239363|NCT01880424|589585156|FG000|Overall Study|Adverse Event|7|||
163239364|NCT01880424|589585157|FG001|Overall Study|Adverse Event|6|||
163239365|NCT01880424|589585156|FG000|Overall Study|Lack of Efficacy|1|||
163239366|NCT01880424|589585157|FG001|Overall Study|Lack of Efficacy|4|||
163239367|NCT01880424|589585156|FG000|Overall Study|Lost to Follow-up|3|||
163239368|NCT01880424|589585157|FG001|Overall Study|Lost to Follow-up|2|||
163239369|NCT01880424|589585156|FG000|Overall Study|Protocol Violation|11|||
163239370|NCT01880424|589585157|FG001|Overall Study|Protocol Violation|13|||
163239371|NCT01880424|589585156|FG000|Overall Study|Withdrawal by Subject|10|||
163239372|NCT01880424|589585157|FG001|Overall Study|Withdrawal by Subject|30|||
163239373|NCT01880424|589585156|FG000|Overall Study|Other|1|||
163239374|NCT01880424|589585157|FG001|Overall Study|Other|0|||
163239375|NCT02280044|589585160|FG000|Overall Study|Planned alternate|0|||
163349567|NCT00113269|589990796|FG001|Overall Study|Not transplanted, donor issues|0|||
163349568|NCT00113269|589990797|FG002|Overall Study|Not transplanted, donor issues|2|||
163239376|NCT02280044|589585161|FG001|Overall Study|Planned alternate|2|||
163239377|NCT05706506|589585162|FG000|Overall Study|Adverse Event|1|||
163239378|NCT05706506|589585162|FG000|Overall Study|Withdrawal by Subject|4|||
163239379|NCT05706506|589585162|FG000|Overall Study|Lost to Follow-up|2|||
163239380|NCT05706506|589585162|FG000|Overall Study|Inadvertent Enrolment|12|||
163239381|NCT05706506|589585162|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
163239382|NCT05706506|589585162|FG000|Overall Study|Participant Moved Out of State|1|||
163239383|NCT02246998|589585163|FG000|Overall Study|Adverse Event|0|||
163239384|NCT02246998|589585164|FG001|Overall Study|Adverse Event|1|||
163239385|NCT02246998|589585165|FG002|Overall Study|Adverse Event|1|||
163239386|NCT02246998|589585166|FG003|Overall Study|Adverse Event|0|||
163239387|NCT02246998|589585163|FG000|Overall Study|Lost to Follow-up|1|||
163239388|NCT02246998|589585164|FG001|Overall Study|Lost to Follow-up|0|||
163239389|NCT02246998|589585165|FG002|Overall Study|Lost to Follow-up|0|||
163239390|NCT02246998|589585166|FG003|Overall Study|Lost to Follow-up|1|||
163239391|NCT02246998|589585163|FG000|Overall Study|Randomized but Never Dosed|1|||
163239392|NCT02246998|589585164|FG001|Overall Study|Randomized but Never Dosed|2|||
163239393|NCT02246998|589585165|FG002|Overall Study|Randomized but Never Dosed|2|||
163239394|NCT02246998|589585166|FG003|Overall Study|Randomized but Never Dosed|1|||
163239395|NCT01303627|589585170|FG000|Overall Study|the failure while performing URS|0|||
163239396|NCT01303627|589585171|FG001|Overall Study|the failure while performing URS|1|||
163239397|NCT02590354|589585173|FG000|Phase 1|Active hepatitis B or C infection|1|||
163239398|NCT02590354|589585173|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
163239399|NCT02590354|589585173|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
163239400|NCT02590354|589585173|FG000|Phase 1|Subject does not want to participate|20|||
163239401|NCT02590354|589585173|FG000|Phase 1|Lost to Follow-up|1|||
163239402|NCT02590354|589585173|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
163239403|NCT00996996|589585174|FG000|Overall Study|Progressive Disease|10|||
163239404|NCT00996996|589585174|FG000|Overall Study|Non-compliance|8|||
163239405|NCT00996996|589585174|FG000|Overall Study|Lost to Follow-up|9|||
163239406|NCT00996996|589585174|FG000|Overall Study|Death|5|||
163239407|NCT00996996|589585174|FG000|Overall Study|Did Not Receive Study Medications|1|||
163239408|NCT01227889|589585175|FG000|Randomized Phase (RP)|Adverse Event|13|||
163239409|NCT01227889|589585176|FG001|Randomized Phase (RP)|Adverse Event|0|||
163239410|NCT01227889|589585175|FG000|Randomized Phase (RP)|Physician Decision|13|||
163239411|NCT01227889|589585176|FG001|Randomized Phase (RP)|Physician Decision|5|||
163239412|NCT01227889|589585175|FG000|Randomized Phase (RP)|Progressive Disease|135|||
163239413|NCT01227889|589585176|FG001|Randomized Phase (RP)|Progressive Disease|52|||
163239414|NCT01227889|589585175|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
163239415|NCT01227889|589585176|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
163239416|NCT01227889|589585175|FG000|Randomized Phase (RP)|Missing|1|||
163239417|NCT01227889|589585176|FG001|Randomized Phase (RP)|Missing|3|||
163239418|NCT01227889|589585175|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
163239419|NCT01227889|589585176|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
163239420|NCT01227889|589585175|FG000|Crossover Phase|Adverse Event|0|||
163239421|NCT01227889|589585176|FG001|Crossover Phase|Adverse Event|1|||
163239422|NCT01227889|589585175|FG000|Crossover Phase|Physician Decision|0|||
163239423|NCT01227889|589585176|FG001|Crossover Phase|Physician Decision|3|||
163239424|NCT01227889|589585175|FG000|Crossover Phase|Progressive Disease|0|||
163239425|NCT01227889|589585176|FG001|Crossover Phase|Progressive Disease|31|||
163239426|NCT01227889|589585175|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
163239427|NCT01227889|589585176|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
163239428|NCT01227889|589585175|FG000|Crossover Phase|Withdrawal by Subject|0|||
163239429|NCT01227889|589585176|FG001|Crossover Phase|Withdrawal by Subject|1|||
163239430|NCT01709227|589585180|FG000|Overall Study|Physician Decision|1|||
163239431|NCT01709227|589585181|FG001|Overall Study|Physician Decision|0|||
163239432|NCT01709227|589585180|FG000|Overall Study|Pleural Peritoneal communication|0|||
163239433|NCT01709227|589585181|FG001|Overall Study|Pleural Peritoneal communication|9|||
163239434|NCT04831736|589585184|FG000|Overall Study|Withdrawal by Subject|0|||
163239435|NCT04831736|589585185|FG001|Overall Study|Withdrawal by Subject|1|||
163239436|NCT00795600|589585186|FG000|Overall Study|Adverse Event|1|||
163239437|NCT00795600|589585187|FG001|Overall Study|Adverse Event|1|||
163239438|NCT00795600|589585186|FG000|Overall Study|Protocol Violation|1|||
163239439|NCT00795600|589585187|FG001|Overall Study|Protocol Violation|2|||
163239440|NCT00795600|589585186|FG000|Overall Study|Withdrawal by Subject|1|||
163239441|NCT00795600|589585187|FG001|Overall Study|Withdrawal by Subject|0|||
163239442|NCT00795600|589585186|FG000|Overall Study|Unclassified|1|||
163239443|NCT00795600|589585187|FG001|Overall Study|Unclassified|1|||
163239444|NCT01659021|589585188|FG000|Main Study|Adverse Event|2|||
163239445|NCT01659021|589585189|FG001|Main Study|Adverse Event|3|||
163239446|NCT01659021|589585188|FG000|Main Study|Lost to Follow-up|1|||
163239447|NCT01659021|589585189|FG001|Main Study|Lost to Follow-up|0|||
163239448|NCT01659021|589585188|FG000|Main Study|Unknown Reasons|2|||
163239449|NCT01659021|589585189|FG001|Main Study|Unknown Reasons|1|||
163239450|NCT01659021|589585188|FG000|Main Study|Physician Decision|34|||
163239451|NCT01659021|589585189|FG001|Main Study|Physician Decision|16|||
163239452|NCT01659021|589585188|FG000|Main Study|Withdrawal by Subject|19|||
163239453|NCT01659021|589585189|FG001|Main Study|Withdrawal by Subject|16|||
163239454|NCT01659021|589585188|FG000|Main Study|Study Terminated by Sponsor|16|||
163239455|NCT01659021|589585189|FG001|Main Study|Study Terminated by Sponsor|1|||
163239456|NCT01659021|589585188|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
163239457|NCT01659021|589585189|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
163239458|NCT01659021|589585188|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
163239459|NCT01659021|589585189|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
163239460|NCT01233817|589585190|FG000|Overall Study|Lost to Follow-up|1|||
163239461|NCT01233817|589585190|FG000|Overall Study|Withdrawal by Subject|2|||
163239462|NCT01248884|589585191|FG000|Overall Study|Withdrawal by Subject|1|||
163239463|NCT01248884|589585192|FG001|Overall Study|Withdrawal by Subject|3|||
163239464|NCT01248884|589585193|FG002|Overall Study|Withdrawal by Subject|1|||
163239465|NCT01248884|589585191|FG000|Overall Study|Adverse Event|1|||
163239466|NCT01248884|589585192|FG001|Overall Study|Adverse Event|0|||
163239467|NCT01248884|589585193|FG002|Overall Study|Adverse Event|0|||
163239468|NCT00840970|589585196|FG000|Overall Study|Adverse Event|0|||
163239469|NCT00840970|589585197|FG001|Overall Study|Adverse Event|0|||
163239470|NCT00840970|589585198|FG002|Overall Study|Adverse Event|1|||
163239471|NCT03465540|589585199|FG000|Overall Study|Withdrawal by Subject|0|||
163239472|NCT03465540|589585200|FG001|Overall Study|Withdrawal by Subject|0|||
163239473|NCT03465540|589585201|FG002|Overall Study|Withdrawal by Subject|1|||
163239474|NCT03465540|589585202|FG003|Overall Study|Withdrawal by Subject|1|||
163239475|NCT03465540|589585203|FG004|Overall Study|Withdrawal by Subject|1|||
163239476|NCT03465540|589585204|FG005|Overall Study|Withdrawal by Subject|0|||
163239477|NCT03465540|589585199|FG000|Overall Study|Lost to Follow-up|0|||
163239478|NCT03465540|589585200|FG001|Overall Study|Lost to Follow-up|1|||
163239479|NCT03465540|589585201|FG002|Overall Study|Lost to Follow-up|0|||
163349569|NCT00113269|589990798|FG003|Overall Study|Not transplanted, donor issues|2|||
163349570|NCT00113269|589990795|FG000|Overall Study|Not transplanted, recipient issues|2|||
163349571|NCT00113269|589990796|FG001|Overall Study|Not transplanted, recipient issues|1|||
163349572|NCT00113269|589990797|FG002|Overall Study|Not transplanted, recipient issues|7|||
163349573|NCT00113269|589990798|FG003|Overall Study|Not transplanted, recipient issues|4|||
163349574|NCT00113269|589990795|FG000|Overall Study|Early graft loss, technical|0|||
163349575|NCT00113269|589990796|FG001|Overall Study|Early graft loss, technical|0|||
163349576|NCT00113269|589990797|FG002|Overall Study|Early graft loss, technical|2|||
163349577|NCT00113269|589990798|FG003|Overall Study|Early graft loss, technical|0|||
163349578|NCT00113269|589990795|FG000|Overall Study|Death in operating room|0|||
163349579|NCT00113269|589990796|FG001|Overall Study|Death in operating room|0|||
163349580|NCT00113269|589990797|FG002|Overall Study|Death in operating room|0|||
163349581|NCT00113269|589990798|FG003|Overall Study|Death in operating room|1|||
163349582|NCT00113269|589990795|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
163349583|NCT00113269|589990796|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
163349584|NCT00113269|589990797|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
163349585|NCT00113269|589990798|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
163349586|NCT00113269|589990795|FG000|Overall Study|Adverse Event|2|||
163349587|NCT00113269|589990796|FG001|Overall Study|Adverse Event|7|||
163349588|NCT00113269|589990797|FG002|Overall Study|Adverse Event|11|||
163349589|NCT00113269|589990798|FG003|Overall Study|Adverse Event|7|||
163349590|NCT00113269|589990795|FG000|Overall Study|Withdrawal by Subject|4|||
163349591|NCT00113269|589990796|FG001|Overall Study|Withdrawal by Subject|3|||
163349592|NCT00113269|589990797|FG002|Overall Study|Withdrawal by Subject|4|||
163349593|NCT00113269|589990798|FG003|Overall Study|Withdrawal by Subject|2|||
163349594|NCT00113269|589990795|FG000|Overall Study|Graft loss|6|||
163349595|NCT00113269|589990796|FG001|Overall Study|Graft loss|6|||
163349596|NCT00113269|589990797|FG002|Overall Study|Graft loss|4|||
163349597|NCT00113269|589990798|FG003|Overall Study|Graft loss|9|||
163349598|NCT00113269|589990795|FG000|Overall Study|Protocol Violation|1|||
163349599|NCT00113269|589990796|FG001|Overall Study|Protocol Violation|0|||
163349600|NCT00113269|589990797|FG002|Overall Study|Protocol Violation|4|||
163349601|NCT00113269|589990798|FG003|Overall Study|Protocol Violation|2|||
163349602|NCT00113269|589990795|FG000|Overall Study|Lost to Follow-up|2|||
163349603|NCT00113269|589990796|FG001|Overall Study|Lost to Follow-up|3|||
163239480|NCT03465540|589585202|FG003|Overall Study|Lost to Follow-up|0|||
163239481|NCT03465540|589585203|FG004|Overall Study|Lost to Follow-up|1|||
163239482|NCT03465540|589585204|FG005|Overall Study|Lost to Follow-up|0|||
163239483|NCT03465540|589585199|FG000|Overall Study|Death|1|||
163239484|NCT03465540|589585200|FG001|Overall Study|Death|1|||
163239485|NCT03465540|589585201|FG002|Overall Study|Death|0|||
163239486|NCT03465540|589585202|FG003|Overall Study|Death|2|||
163349604|NCT00113269|589990797|FG002|Overall Study|Lost to Follow-up|6|||
163349605|NCT00113269|589990798|FG003|Overall Study|Lost to Follow-up|3|||
163239487|NCT03465540|589585203|FG004|Overall Study|Death|0|||
163239488|NCT03465540|589585204|FG005|Overall Study|Death|2|||
163349606|NCT00113269|589990795|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
163349607|NCT00113269|589990796|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
163239489|NCT03465540|589585199|FG000|Overall Study|Protocol specified criteria|0|||
163239490|NCT03465540|589585200|FG001|Overall Study|Protocol specified criteria|2|||
163239491|NCT03465540|589585201|FG002|Overall Study|Protocol specified criteria|2|||
163239492|NCT03465540|589585202|FG003|Overall Study|Protocol specified criteria|0|||
163239493|NCT03465540|589585203|FG004|Overall Study|Protocol specified criteria|2|||
163239494|NCT03465540|589585204|FG005|Overall Study|Protocol specified criteria|0|||
163239495|NCT00504829|589585205|FG000|Overall Study|Protocol Violation|6|||
163239496|NCT00504829|589585206|FG001|Overall Study|Protocol Violation|4|||
163239497|NCT00504829|589585207|FG002|Overall Study|Protocol Violation|10|||
163239498|NCT01854827|589585208|FG000|Overall Study|Death|1|||
163239499|NCT00736996|589585209|FG000|Overall Study|Lost to Follow-up|1|||
163239500|NCT00736996|589585210|FG001|Overall Study|Lost to Follow-up|9|||
163239501|NCT00736996|589585211|FG002|Overall Study|Lost to Follow-up|2|||
163239502|NCT00462384|589585212|FG000|Overall Study|Adverse Event|2|||
163239503|NCT00462384|589585212|FG000|Overall Study|Death|2|||
163239504|NCT00462384|589585212|FG000|Overall Study|Withdrawal by Subject|1|||
163239505|NCT00462384|589585212|FG000|Overall Study|Other|4|||
163239506|NCT04000165|589585213|FG000|Overall Study|Physician Decision|1|||
163239507|NCT04000165|589585213|FG000|Overall Study|Withdrawal by Subject|1|||
163239508|NCT01751568|589585218|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
163239509|NCT01751568|589585219|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
163239510|NCT01751568|589585220|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
163239511|NCT02660944|589585229|FG000|Overall Study|Adverse Event|3|||
163239512|NCT02660944|589585230|FG001|Overall Study|Adverse Event|4|||
163239513|NCT02660944|589585229|FG000|Overall Study|Physician Decision|3|||
163239514|NCT02660944|589585230|FG001|Overall Study|Physician Decision|1|||
163239515|NCT02660944|589585229|FG000|Overall Study|Withdrawal by Subject|5|||
163239516|NCT02660944|589585230|FG001|Overall Study|Withdrawal by Subject|3|||
163239517|NCT02660944|589585229|FG000|Overall Study|Lost to Follow-up|4|||
163239518|NCT02660944|589585230|FG001|Overall Study|Lost to Follow-up|1|||
163239519|NCT02660944|589585229|FG000|Overall Study|Subject schedule|0|||
163239520|NCT02660944|589585230|FG001|Overall Study|Subject schedule|1|||
163239521|NCT02660944|589585229|FG000|Overall Study|Exclusion criteria met|2|||
163239522|NCT02660944|589585230|FG001|Overall Study|Exclusion criteria met|0|||
163239523|NCT02843568|589585231|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
163239524|NCT02843568|589585232|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
163239525|NCT02843568|589585231|FG000|Overall Study|Death|3|||
163239526|NCT02843568|589585232|FG001|Overall Study|Death|3|||
163239527|NCT02843568|589585231|FG000|Overall Study|Withdrawal by Subject|1|||
163239528|NCT02843568|589585232|FG001|Overall Study|Withdrawal by Subject|1|||
163239529|NCT02843568|589585231|FG000|Overall Study|Lost to Follow-up|2|||
163239530|NCT02843568|589585232|FG001|Overall Study|Lost to Follow-up|0|||
163239531|NCT03586999|589585233|FG000|Overall Study|Lack of Efficacy|2|||
163239532|NCT04096560|589585234|FG000|Overall Study|Reason not Specified|1|||
163239533|NCT04096560|589585235|FG001|Overall Study|Reason not Specified|0|||
163239534|NCT04096560|589585236|FG002|Overall Study|Reason not Specified|0|||
163239535|NCT04096560|589585237|FG003|Overall Study|Reason not Specified|0|||
163239536|NCT04096560|589585238|FG004|Overall Study|Reason not Specified|1|||
163239537|NCT04096560|589585239|FG005|Overall Study|Reason not Specified|1|||
163239538|NCT04096560|589585240|FG006|Overall Study|Reason not Specified|1|||
163239539|NCT04096560|589585241|FG007|Overall Study|Reason not Specified|0|||
163239540|NCT04096560|589585234|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
163239541|NCT04096560|589585235|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
163239542|NCT04096560|589585236|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
163239543|NCT04096560|589585237|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
163239544|NCT04096560|589585238|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
163239545|NCT04096560|589585239|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
163239546|NCT04096560|589585240|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
163239547|NCT04096560|589585241|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
163239548|NCT04096560|589585234|FG000|Overall Study|Study Terminated by Sponsor|0|||
163239549|NCT04096560|589585235|FG001|Overall Study|Study Terminated by Sponsor|0|||
163239550|NCT04096560|589585236|FG002|Overall Study|Study Terminated by Sponsor|0|||
163239551|NCT04096560|589585237|FG003|Overall Study|Study Terminated by Sponsor|5|||
163239552|NCT04096560|589585238|FG004|Overall Study|Study Terminated by Sponsor|6|||
163239553|NCT04096560|589585239|FG005|Overall Study|Study Terminated by Sponsor|4|||
163239554|NCT04096560|589585240|FG006|Overall Study|Study Terminated by Sponsor|6|||
163239555|NCT04096560|589585241|FG007|Overall Study|Study Terminated by Sponsor|1|||
163239556|NCT04096560|589585234|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
163239557|NCT04096560|589585235|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
163239558|NCT04096560|589585236|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
163239559|NCT04096560|589585237|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
163239560|NCT04096560|589585238|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
163239561|NCT04096560|589585239|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
163239562|NCT04096560|589585240|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
163239563|NCT04096560|589585241|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
163239564|NCT00534352|589585244|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
163239565|NCT00534352|589585244|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
163239566|NCT00534352|589585244|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
163239567|NCT00534352|589585244|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
163239568|NCT00534352|589585244|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
163239569|NCT00534352|589585244|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
163239570|NCT03264989|589585247|FG000|Overall Study|Lost to Follow-up|1|||
163239571|NCT03264989|589585248|FG001|Overall Study|Lost to Follow-up|0|||
163239572|NCT03264989|589585247|FG000|Overall Study|New Therapy for study Indication|1|||
163239573|NCT03264989|589585248|FG001|Overall Study|New Therapy for study Indication|0|||
163239574|NCT03264989|589585247|FG000|Overall Study|Protocol Violation|0|||
163239575|NCT03264989|589585248|FG001|Overall Study|Protocol Violation|1|||
163239576|NCT03264989|589585247|FG000|Overall Study|Patient decision|13|||
163239577|NCT03264989|589585248|FG001|Overall Study|Patient decision|0|||
163239578|NCT03264989|589585247|FG000|Overall Study|Physician Decision|6|||
163239579|NCT03264989|589585248|FG001|Overall Study|Physician Decision|4|||
163239580|NCT03264989|589585247|FG000|Overall Study|Adverse Event|2|||
163239581|NCT03264989|589585248|FG001|Overall Study|Adverse Event|1|||
163349608|NCT00113269|589990797|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
163349609|NCT00113269|589990798|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
163349610|NCT00113269|589990795|FG000|Overall Study|Discontinued due to rejection|0|||
163409688|NCT00488982|590209477|FG002|Course 1|Physician Decision|4|||
163409689|NCT00488982|590209475|FG000|Course 1|Withdrawal by Subject|0|||
163409690|NCT00488982|590209476|FG001|Course 1|Withdrawal by Subject|8|||
163409691|NCT00488982|590209477|FG002|Course 1|Withdrawal by Subject|2|||
163409692|NCT00488982|590209475|FG000|Course 1|nonprotocol therapy|0|||
163409693|NCT00488982|590209476|FG001|Course 1|nonprotocol therapy|2|||
163409694|NCT00488982|590209477|FG002|Course 1|nonprotocol therapy|2|||
163409695|NCT00488982|590209475|FG000|Course 1|Adverse Event|0|||
163409696|NCT00488982|590209476|FG001|Course 1|Adverse Event|0|||
163409697|NCT00488982|590209477|FG002|Course 1|Adverse Event|6|||
163409698|NCT01368835|590209478|FG000|Overall Study|Inclusion criteria/photography quality|22|||
163409699|NCT01368835|590209478|FG000|Overall Study|Lost to Follow-up|11|||
163349611|NCT00113269|589990796|FG001|Overall Study|Discontinued due to rejection|0|||
163409700|NCT02754726|590209479|FG000|Overall Study|Progressive Disease by RECIST|13|||
163409701|NCT02754726|590209479|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
163409702|NCT02754726|590209479|FG000|Overall Study|Clinical Disease Progression|5|||
163409703|NCT02754726|590209479|FG000|Overall Study|Adverse Event|3|||
163349612|NCT00113269|589990797|FG002|Overall Study|Discontinued due to rejection|1|||
163349613|NCT00113269|589990798|FG003|Overall Study|Discontinued due to rejection|0|||
163349614|NCT00113269|589990795|FG000|Overall Study|Moved|0|||
163349615|NCT00113269|589990796|FG001|Overall Study|Moved|1|||
163349616|NCT00113269|589990797|FG002|Overall Study|Moved|0|||
163349617|NCT00113269|589990798|FG003|Overall Study|Moved|3|||
163349618|NCT00113269|589990795|FG000|Overall Study|Received pancreas transplant|0|||
163349619|NCT00113269|589990796|FG001|Overall Study|Received pancreas transplant|0|||
163349620|NCT00113269|589990797|FG002|Overall Study|Received pancreas transplant|0|||
163349621|NCT00113269|589990798|FG003|Overall Study|Received pancreas transplant|2|||
163349622|NCT00113269|589990795|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
163349623|NCT00113269|589990796|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
163349624|NCT00113269|589990797|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
163349625|NCT00113269|589990798|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
163349626|NCT00113269|589990795|FG000|Overall Study|Did not meet eligibility criteria|1|||
163349627|NCT00113269|589990796|FG001|Overall Study|Did not meet eligibility criteria|0|||
163349628|NCT00113269|589990797|FG002|Overall Study|Did not meet eligibility criteria|0|||
163349629|NCT00113269|589990798|FG003|Overall Study|Did not meet eligibility criteria|1|||
163349630|NCT00113269|589990795|FG000|Overall Study|Unable to return for follow up|2|||
163349631|NCT00113269|589990796|FG001|Overall Study|Unable to return for follow up|1|||
163409704|NCT02754726|590209479|FG000|Overall Study|Withdrawal by Subject|1|||
163409705|NCT02754726|590209479|FG000|Overall Study|Tolerability|1|||
163239582|NCT03264989|589585247|FG000|Overall Study|Death|1|||
163349632|NCT00113269|589990797|FG002|Overall Study|Unable to return for follow up|0|||
163349633|NCT00113269|589990798|FG003|Overall Study|Unable to return for follow up|0|||
163409706|NCT02872311|590209489|FG000|Overall Study|Death|2|||
163409707|NCT02872311|590209490|FG001|Overall Study|Death|0|||
163349634|NCT03864341|589990805|FG000|Overall Study|Withdrawal by Subject|1|||
163409708|NCT02872311|590209491|FG002|Overall Study|Death|0|||
163409709|NCT02872311|590209492|FG003|Overall Study|Death|0|||
163239583|NCT03264989|589585248|FG001|Overall Study|Death|1|||
163409710|NCT02872311|590209493|FG004|Overall Study|Death|0|||
163239584|NCT03264989|589585247|FG000|Overall Study|Pregnancy|2|||
163239585|NCT03264989|589585248|FG001|Overall Study|Pregnancy|0|||
163239586|NCT03264989|589585247|FG000|Overall Study|End of Study|19|||
163239587|NCT03264989|589585248|FG001|Overall Study|End of Study|5|||
163239588|NCT00833924|589585254|FG000|Overall Study|Death|21|||
163239589|NCT00833924|589585254|FG000|Overall Study|Conversion|2|||
163239590|NCT00833924|589585254|FG000|Overall Study|Lost to Follow-up|2|||
163239591|NCT00833924|589585254|FG000|Overall Study|Withdrawal by Subject|13|||
163239592|NCT00833924|589585254|FG000|Overall Study|In study follow-up|71|||
163239593|NCT02504866|589585255|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
163239594|NCT02504866|589585256|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
163239595|NCT02504866|589585257|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
163239596|NCT01229436|589585258|FG000|Overall Study|Withdrawal by Subject|2|||
163239597|NCT01229436|589585258|FG000|Overall Study|Lost to Follow-up|3|||
163239598|NCT01775137|589585261|FG000|Overall Study|Death|1|||
163239599|NCT01775137|589585261|FG000|Overall Study|Protocol deviation|2|||
163239600|NCT01775137|589585261|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163239601|NCT01775137|589585261|FG000|Overall Study|Adverse Event|1|||
163239602|NCT01775137|589585261|FG000|Overall Study|Withdrawal by participants|5|||
163239603|NCT04796610|589585262|FG000|Overall Study|Withdrawal by Subject|1|||
163239604|NCT04796610|589585263|FG001|Overall Study|Withdrawal by Subject|0|||
163239605|NCT04796610|589585264|FG002|Overall Study|Withdrawal by Subject|0|||
163239606|NCT04796610|589585265|FG003|Overall Study|Withdrawal by Subject|0|||
163239607|NCT04796610|589585262|FG000|Overall Study|Lost to Follow-up|2|||
163239608|NCT04796610|589585263|FG001|Overall Study|Lost to Follow-up|0|||
163239609|NCT04796610|589585264|FG002|Overall Study|Lost to Follow-up|1|||
163239610|NCT04796610|589585265|FG003|Overall Study|Lost to Follow-up|1|||
163239611|NCT00733824|589585266|FG000|Phase I|Withdrawal by Subject|1|||
163239612|NCT00733824|589585267|FG001|Phase I|Withdrawal by Subject|0|||
163239613|NCT00733824|589585268|FG002|Phase I|Withdrawal by Subject|0|||
163239614|NCT00733824|589585269|FG003|Phase I|Withdrawal by Subject|0|||
163239615|NCT00733824|589585270|FG004|Phase I|Withdrawal by Subject|0|||
163239616|NCT01459796|589585271|FG000|Overall Study|Non compliance with protocol|2|||
163239617|NCT01459796|589585272|FG001|Overall Study|Non compliance with protocol|4|||
163239618|NCT01459796|589585271|FG000|Overall Study|Adverse Event|5|||
163239619|NCT01459796|589585272|FG001|Overall Study|Adverse Event|5|||
163239620|NCT01459796|589585271|FG000|Overall Study|Withdrawal by Subject|6|||
163239621|NCT01459796|589585272|FG001|Overall Study|Withdrawal by Subject|3|||
163239622|NCT01459796|589585271|FG000|Overall Study|Lost to Follow-up|5|||
163239623|NCT01459796|589585272|FG001|Overall Study|Lost to Follow-up|4|||
163239624|NCT01459796|589585271|FG000|Overall Study|Reason unspecified|1|||
163239625|NCT01459796|589585272|FG001|Overall Study|Reason unspecified|2|||
163239626|NCT01459796|589585271|FG000|Overall Study|Decision by the sponsor|75|||
163239627|NCT01459796|589585272|FG001|Overall Study|Decision by the sponsor|108|||
163239628|NCT01343056|589585273|FG000|Overall Study|Lost to Follow-up|7|||
163239629|NCT01343056|589585274|FG001|Overall Study|Lost to Follow-up|5|||
163239630|NCT01343056|589585275|FG002|Overall Study|Lost to Follow-up|3|||
163239631|NCT01343056|589585276|FG003|Overall Study|Lost to Follow-up|9|||
163239632|NCT02059148|589585277|FG000|Treatment 1|Protocol Violation|0|||
163239633|NCT02059148|589585278|FG001|Treatment 1|Protocol Violation|0|||
163239634|NCT02059148|589585279|FG002|Treatment 1|Protocol Violation|0|||
163239635|NCT02059148|589585280|FG003|Treatment 1|Protocol Violation|0|||
163239636|NCT02059148|589585281|FG004|Treatment 1|Protocol Violation|0|||
163239637|NCT02059148|589585282|FG005|Treatment 1|Protocol Violation|1|||
163239638|NCT03231371|589585284|FG000|Overall Study|Withdrawal by Subject|1|||
163239639|NCT03231371|589585284|FG000|Overall Study|chose or were ineligible to have MRI|12|||
163239640|NCT03067441|589585288|FG000|Overall Study|Withdrawal by Subject|16|||
163239641|NCT03067441|589585289|FG001|Overall Study|Withdrawal by Subject|34|||
163239642|NCT03067441|589585288|FG000|Overall Study|Lost to Follow-up|7|||
163239643|NCT03067441|589585289|FG001|Overall Study|Lost to Follow-up|5|||
163239644|NCT03067441|589585288|FG000|Overall Study|Adverse Event|7|||
163239645|NCT03067441|589585289|FG001|Overall Study|Adverse Event|14|||
163239646|NCT03067441|589585288|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
163239647|NCT03067441|589585289|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
163349635|NCT01066936|589990806|FG000|Overall Study|Death|2|||
163349636|NCT01066936|589990806|FG000|Overall Study|Device revised/removed|1|||
163239648|NCT03067441|589585288|FG000|Overall Study|Physician Decision|1|||
163239649|NCT03067441|589585289|FG001|Overall Study|Physician Decision|3|||
163239650|NCT03067441|589585288|FG000|Overall Study|Other|1|||
163239651|NCT03067441|589585289|FG001|Overall Study|Other|1|||
163239652|NCT00856583|589585290|FG000|Overall Study|Lack of Efficacy|389|||
163239653|NCT00856583|589585291|FG001|Overall Study|Lack of Efficacy|377|||
163239654|NCT00856583|589585290|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
163239655|NCT00856583|589585291|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
163239656|NCT00856583|589585290|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
163239657|NCT00856583|589585291|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
163239658|NCT00856583|589585290|FG000|Overall Study|Non-compliance|305|||
163239659|NCT00856583|589585291|FG001|Overall Study|Non-compliance|262|||
163239660|NCT00856583|589585290|FG000|Overall Study|Withdrawal by Subject|1092|||
163239661|NCT00856583|589585291|FG001|Overall Study|Withdrawal by Subject|919|||
163239662|NCT00856583|589585290|FG000|Overall Study|Physician Decision|59|||
163239663|NCT00856583|589585291|FG001|Overall Study|Physician Decision|82|||
163239664|NCT00856583|589585290|FG000|Overall Study|Pregnancy|14|||
163239665|NCT00856583|589585291|FG001|Overall Study|Pregnancy|5|||
163239666|NCT00856583|589585290|FG000|Overall Study|Other|92|||
163239667|NCT00856583|589585291|FG001|Overall Study|Other|104|||
163239668|NCT00856583|589585290|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
163239669|NCT00856583|589585291|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
163239670|NCT02056301|589585295|FG000|Overall Study|Protocol Violation|1|||
163239671|NCT02056301|589585296|FG001|Overall Study|Protocol Violation|2|||
163239672|NCT02056301|589585295|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
163239673|NCT02056301|589585296|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
163239674|NCT02056301|589585295|FG000|Overall Study|Withdrawal by Subject|0|||
163239675|NCT02056301|589585296|FG001|Overall Study|Withdrawal by Subject|1|||
163239676|NCT02056301|589585295|FG000|Overall Study|Issues with epidural|0|||
163239677|NCT02056301|589585296|FG001|Overall Study|Issues with epidural|3|||
163239678|NCT00499889|589585302|FG000|Overall Study|Infection prior to treatment|1|||
163239679|NCT03299192|589585303|FG000|Overall Study|Fell before classes started|1|||
163239680|NCT03299192|589585304|FG001|Overall Study|Fell before classes started|0|||
163239681|NCT03299192|589585305|FG002|Overall Study|Fell before classes started|0|||
163239682|NCT03299192|589585303|FG000|Overall Study|Other|0|||
163239683|NCT03299192|589585304|FG001|Overall Study|Other|2|||
163239684|NCT03299192|589585305|FG002|Overall Study|Other|1|||
163239685|NCT01418209|589585311|FG000|Overall Study|Withdrawal by Subject|1|||
163239686|NCT01418209|589585312|FG001|Overall Study|Withdrawal by Subject|0|||
163239687|NCT01418209|589585313|FG002|Overall Study|Withdrawal by Subject|1|||
163239688|NCT01418209|589585311|FG000|Overall Study|Did not provide hot flash diary data|1|||
163239689|NCT01418209|589585312|FG001|Overall Study|Did not provide hot flash diary data|3|||
163239690|NCT01418209|589585313|FG002|Overall Study|Did not provide hot flash diary data|3|||
163239691|NCT03779841|589585314|FG000|Randomized Population|Did Not Receive Treatment|3|||
163239692|NCT03779841|589585315|FG001|Randomized Population|Did Not Receive Treatment|1|||
163239693|NCT03779841|589585316|FG002|Randomized Population|Did Not Receive Treatment|0|||
163239694|NCT03779841|589585314|FG000|Treated (Safety) Population|Adverse Event|1|||
163239695|NCT03779841|589585315|FG001|Treated (Safety) Population|Adverse Event|1|||
163239696|NCT03779841|589585316|FG002|Treated (Safety) Population|Adverse Event|0|||
163239697|NCT03779841|589585314|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
163239698|NCT03779841|589585315|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
163239699|NCT03779841|589585316|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
163239700|NCT03779841|589585314|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
163239701|NCT03779841|589585315|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
163239702|NCT03779841|589585316|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
163239703|NCT03779841|589585314|FG000|Treated (Safety) Population|Death|1|||
163239704|NCT03779841|589585315|FG001|Treated (Safety) Population|Death|0|||
163239705|NCT03779841|589585316|FG002|Treated (Safety) Population|Death|2|||
163239706|NCT02788175|589585317|FG000|Overall Study|Protocol Violation|3|||
163239707|NCT02788175|589585317|FG000|Overall Study|Withdrawal by Subject|4|||
163239708|NCT02788175|589585317|FG000|Overall Study|Ineligible prior to study agent|6|||
163239709|NCT05349617|589588024|FG000|Overall Study|Death|1|||
163239710|NCT05349617|589588025|FG001|Overall Study|Death|1|||
163239711|NCT05349617|589588024|FG000|Overall Study|Lost to Follow-up|3|||
163239712|NCT05349617|589588025|FG001|Overall Study|Lost to Follow-up|8|||
163239713|NCT05349617|589588024|FG000|Overall Study|Withdrawal by Subject|2|||
163239714|NCT05349617|589588025|FG001|Overall Study|Withdrawal by Subject|10|||
163239715|NCT04401579|589588030|FG000|Overall Study|Death|23|||
163239716|NCT04401579|589588031|FG001|Overall Study|Death|36|||
163239717|NCT04401579|589588030|FG000|Overall Study|Lost to Follow-up|40|||
163239718|NCT04401579|589588031|FG001|Overall Study|Lost to Follow-up|41|||
163239719|NCT04401579|589588030|FG000|Overall Study|Withdrawal by Subject|8|||
163409711|NCT02872311|590209489|FG000|Overall Study|Lost to Follow-up|2|||
163409712|NCT02872311|590209490|FG001|Overall Study|Lost to Follow-up|0|||
163145134|NCT06039579|589241589|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
163145135|NCT06039579|589241590|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
163145136|NCT06039579|589241591|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
163145137|NCT06039579|589241592|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
163145138|NCT02792231|589241593|FG000|Overall Study|Patient/guardian decision|32|||
163145139|NCT02792231|589241594|FG001|Overall Study|Patient/guardian decision|42|||
163145140|NCT02792231|589241593|FG000|Overall Study|Adverse Event|15|||
163145141|NCT02792231|589241594|FG001|Overall Study|Adverse Event|11|||
163145142|NCT02792231|589241593|FG000|Overall Study|Physician Decision|14|||
163145143|NCT02792231|589241594|FG001|Overall Study|Physician Decision|12|||
163145144|NCT02792231|589241593|FG000|Overall Study|Lack of Efficacy|7|||
163145145|NCT02792231|589241594|FG001|Overall Study|Lack of Efficacy|9|||
163239720|NCT04401579|589588031|FG001|Overall Study|Withdrawal by Subject|16|||
163145146|NCT02792231|589241593|FG000|Overall Study|Lost to Follow-up|9|||
163145147|NCT02792231|589241594|FG001|Overall Study|Lost to Follow-up|5|||
163145148|NCT02792231|589241593|FG000|Overall Study|Pregnancy|1|||
163239721|NCT04401579|589588030|FG000|Overall Study|Physician Decision|1|||
163239722|NCT04401579|589588031|FG001|Overall Study|Physician Decision|2|||
163239723|NCT04401579|589588030|FG000|Overall Study|Became ineligible after enrollment|1|||
163409713|NCT02872311|590209491|FG002|Overall Study|Lost to Follow-up|0|||
163409714|NCT02872311|590209492|FG003|Overall Study|Lost to Follow-up|0|||
163409715|NCT02872311|590209493|FG004|Overall Study|Lost to Follow-up|0|||
163409716|NCT02872311|590209489|FG000|Overall Study|Protocol Violation|0|||
163409717|NCT02872311|590209490|FG001|Overall Study|Protocol Violation|2|||
163409718|NCT02872311|590209491|FG002|Overall Study|Protocol Violation|1|||
163409719|NCT02872311|590209492|FG003|Overall Study|Protocol Violation|0|||
163409720|NCT02872311|590209493|FG004|Overall Study|Protocol Violation|0|||
163239724|NCT04401579|589588031|FG001|Overall Study|Became ineligible after enrollment|1|||
163239725|NCT04401579|589588030|FG000|Overall Study|Enrolled but treatment not administered|7|||
163239726|NCT04401579|589588031|FG001|Overall Study|Enrolled but treatment not administered|9|||
163239727|NCT04401579|589588030|FG000|Overall Study|Adverse Event|2|||
163239728|NCT04401579|589588031|FG001|Overall Study|Adverse Event|1|||
163239729|NCT04401579|589588030|FG000|Overall Study|Scheduling error|1|||
163239730|NCT04401579|589588031|FG001|Overall Study|Scheduling error|2|||
163239731|NCT04401579|589588030|FG000|Overall Study|Transferred to another hospital|1|||
163239732|NCT04401579|589588031|FG001|Overall Study|Transferred to another hospital|2|||
163239733|NCT00489970|589588032|FG000|Persistence Year 9|Lost to Follow-up|2|||
163239734|NCT00489970|589588033|FG001|Persistence Year 9|Lost to Follow-up|2|||
163239735|NCT00489970|589588034|FG002|Persistence Year 9|Lost to Follow-up|3|||
163239736|NCT00489970|589588032|FG000|Persistence Year 9|Other|1|||
163239737|NCT00489970|589588033|FG001|Persistence Year 9|Other|0|||
163239738|NCT00489970|589588034|FG002|Persistence Year 9|Other|2|||
163239739|NCT00896168|589588037|FG000|Overall Study|Adverse Event|4|||
163239740|NCT00896168|589588038|FG001|Overall Study|Adverse Event|7|||
163239741|NCT00896168|589588037|FG000|Overall Study|Treatment failure|8|||
163239742|NCT00896168|589588038|FG001|Overall Study|Treatment failure|10|||
163239743|NCT00896168|589588037|FG000|Overall Study|Lost to Follow-up|1|||
163239744|NCT00896168|589588038|FG001|Overall Study|Lost to Follow-up|1|||
163239745|NCT00896168|589588037|FG000|Overall Study|Other|1|||
163409721|NCT05617911|590209494|FG000|Overall Study|Withdrawal by Subject|1|||
163409722|NCT05617911|590209495|FG001|Overall Study|Withdrawal by Subject|0|||
163409723|NCT03557359|590209496|FG000|Dose 1: 240 mg|Adverse Event|1|||
163409724|NCT03557359|590209497|FG001|Dose 1: 240 mg|Adverse Event|0|||
163409725|NCT04868903|590209498|FG000|Overall Study|Adverse Event|0|||
163145149|NCT02792231|589241594|FG001|Overall Study|Pregnancy|3|||
163145150|NCT02792231|589241593|FG000|Overall Study|Non-compliance with study treatment|2|||
163145151|NCT02792231|589241594|FG001|Overall Study|Non-compliance with study treatment|1|||
163145152|NCT02792231|589241593|FG000|Overall Study|Protocol deviation|2|||
163145153|NCT02792231|589241594|FG001|Overall Study|Protocol deviation|0|||
163145154|NCT02792231|589241593|FG000|Overall Study|Technical problems|0|||
163145155|NCT02792231|589241594|FG001|Overall Study|Technical problems|1|||
163145156|NCT03309878|589241595|FG000|Overall Study|Adverse Event|1|||
163145157|NCT03309878|589241596|FG001|Overall Study|Adverse Event|0|||
163145158|NCT03309878|589241597|FG002|Overall Study|Adverse Event|0|||
163145159|NCT03309878|589241598|FG003|Overall Study|Adverse Event|0|||
163145160|NCT03309878|589241595|FG000|Overall Study|Did not maintain eligibility|2|||
163145161|NCT03309878|589241596|FG001|Overall Study|Did not maintain eligibility|1|||
163145162|NCT03309878|589241597|FG002|Overall Study|Did not maintain eligibility|0|||
163145163|NCT03309878|589241598|FG003|Overall Study|Did not maintain eligibility|0|||
163145164|NCT03309878|589241595|FG000|Overall Study|Withdrawal by Subject|0|||
163145165|NCT03309878|589241596|FG001|Overall Study|Withdrawal by Subject|1|||
163145166|NCT03309878|589241597|FG002|Overall Study|Withdrawal by Subject|0|||
163145167|NCT03309878|589241598|FG003|Overall Study|Withdrawal by Subject|0|||
163145168|NCT01884077|589241599|FG000|Overall Study|screen fail|0|||
163145169|NCT01884077|589241600|FG001|Overall Study|screen fail|2|||
163145170|NCT01884077|589241599|FG000|Overall Study|canceled surgery|2|||
163145171|NCT01884077|589241600|FG001|Overall Study|canceled surgery|0|||
163145172|NCT01884077|589241599|FG000|Overall Study|Lost to Follow-up|0|||
163145173|NCT01884077|589241600|FG001|Overall Study|Lost to Follow-up|4|||
163145174|NCT01884077|589241599|FG000|Overall Study|study closed|6|||
163145175|NCT01884077|589241600|FG001|Overall Study|study closed|4|||
163145176|NCT00981149|589241602|FG000|Overall Study|Lost to Follow-up|1|||
163145177|NCT00981149|589241603|FG001|Overall Study|Lost to Follow-up|2|||
163145178|NCT00981149|589241602|FG000|Overall Study|Withdrawal by Subject|1|||
163145179|NCT00981149|589241603|FG001|Overall Study|Withdrawal by Subject|1|||
163145180|NCT01220167|589241607|FG000|Period 3|Urine positive for substance abuse|0|||
163145181|NCT01220167|589241608|FG001|Period 3|Urine positive for substance abuse|1|||
163145182|NCT01220167|589241609|FG002|Period 3|Urine positive for substance abuse|0|||
163239746|NCT00896168|589588038|FG001|Overall Study|Other|1|||
163239747|NCT01075321|589588042|FG000|Overall Study|Withdrawal by Subject|0|||
163239748|NCT01075321|589588043|FG001|Overall Study|Withdrawal by Subject|0|||
163409726|NCT04868903|590209499|FG001|Overall Study|Adverse Event|0|||
163145183|NCT01008943|589241610|FG000|Overall Study|Withdrawal by Subject|1|||
163145184|NCT00861705|589241611|FG000|Overall Study|Never Began Treatment|7|||
163145185|NCT00861705|589241612|FG001|Overall Study|Never Began Treatment|3|||
163145186|NCT00861705|589241613|FG002|Overall Study|Never Began Treatment|0|||
163145187|NCT00861705|589241614|FG003|Overall Study|Never Began Treatment|1|||
163145188|NCT06237049|589241623|FG000|Overall Study|Death|0|||
163145189|NCT06237049|589241624|FG001|Overall Study|Death|0|||
163145190|NCT06237049|589241625|FG002|Overall Study|Death|0|||
163145191|NCT06237049|589241626|FG003|Overall Study|Death|1|||
163145192|NCT06237049|589241623|FG000|Overall Study|Lost to Follow-up|11|||
163145193|NCT06237049|589241624|FG001|Overall Study|Lost to Follow-up|5|||
163145194|NCT06237049|589241625|FG002|Overall Study|Lost to Follow-up|8|||
163145195|NCT06237049|589241626|FG003|Overall Study|Lost to Follow-up|8|||
163145196|NCT06237049|589241623|FG000|Overall Study|Protocol Violation|0|||
163145197|NCT06237049|589241624|FG001|Overall Study|Protocol Violation|1|||
163145198|NCT06237049|589241625|FG002|Overall Study|Protocol Violation|0|||
163145199|NCT06237049|589241626|FG003|Overall Study|Protocol Violation|1|||
163145200|NCT06237049|589241623|FG000|Overall Study|Withdrawal by Subject|4|||
163145201|NCT06237049|589241624|FG001|Overall Study|Withdrawal by Subject|2|||
163145202|NCT06237049|589241625|FG002|Overall Study|Withdrawal by Subject|1|||
163145203|NCT06237049|589241626|FG003|Overall Study|Withdrawal by Subject|0|||
163145204|NCT04678115|589241627|FG000|Overall Study|Lost to Follow-up|1|||
163145205|NCT04678115|589241628|FG001|Overall Study|Lost to Follow-up|0|||
163145206|NCT02336607|589241629|FG000|Overall Study|Physician Decision|1|||
163145207|NCT02336607|589241630|FG001|Overall Study|Physician Decision|4|||
163145208|NCT02336607|589241631|FG002|Overall Study|Physician Decision|3|||
163145209|NCT02336607|589241632|FG003|Overall Study|Physician Decision|15|||
163145210|NCT02336607|589241629|FG000|Overall Study|Lack of Efficacy|1|||
163145211|NCT02336607|589241630|FG001|Overall Study|Lack of Efficacy|0|||
163145212|NCT02336607|589241631|FG002|Overall Study|Lack of Efficacy|0|||
163145213|NCT02336607|589241632|FG003|Overall Study|Lack of Efficacy|2|||
163145214|NCT02336607|589241629|FG000|Overall Study|Lost to Follow-up|2|||
163145215|NCT02336607|589241630|FG001|Overall Study|Lost to Follow-up|1|||
163145216|NCT02336607|589241631|FG002|Overall Study|Lost to Follow-up|0|||
163145217|NCT02336607|589241632|FG003|Overall Study|Lost to Follow-up|21|||
163145218|NCT02336607|589241629|FG000|Overall Study|Protocol Violation|0|||
163145219|NCT02336607|589241630|FG001|Overall Study|Protocol Violation|1|||
163145220|NCT02336607|589241631|FG002|Overall Study|Protocol Violation|1|||
163145221|NCT02336607|589241632|FG003|Overall Study|Protocol Violation|3|||
163145222|NCT02336607|589241629|FG000|Overall Study|Adverse Event|0|||
163145223|NCT02336607|589241630|FG001|Overall Study|Adverse Event|2|||
163145224|NCT02336607|589241631|FG002|Overall Study|Adverse Event|2|||
163145225|NCT02336607|589241632|FG003|Overall Study|Adverse Event|26|||
163145226|NCT02336607|589241629|FG000|Overall Study|Withdrawal by Subject|0|||
163145227|NCT02336607|589241630|FG001|Overall Study|Withdrawal by Subject|2|||
163145228|NCT02336607|589241631|FG002|Overall Study|Withdrawal by Subject|0|||
163145229|NCT02336607|589241632|FG003|Overall Study|Withdrawal by Subject|20|||
163145230|NCT02552966|589241633|FG000|Overall Study|Lost to Follow-up|2|||
163145231|NCT02552966|589241633|FG000|Overall Study|Withdrawal by Subject|3|||
163145232|NCT01091675|589241641|FG000|Overall Study|Adverse Event|7|||
163145233|NCT01091675|589241641|FG000|Overall Study|Lack of Efficacy|27|||
163145234|NCT02365649|589241649|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145235|NCT02365649|589241650|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145236|NCT02365649|589241651|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145237|NCT02365649|589241652|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
163145238|NCT02365649|589241653|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145239|NCT02365649|589241654|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145240|NCT02365649|589241655|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145241|NCT02365649|589241656|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145242|NCT02365649|589241657|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145243|NCT02365649|589241658|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145244|NCT02365649|589241649|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
163145245|NCT02365649|589241650|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
163145246|NCT02365649|589241651|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
163145247|NCT02365649|589241652|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
163145248|NCT02365649|589241653|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
163145249|NCT02365649|589241654|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
163145250|NCT02365649|589241655|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
163145251|NCT02365649|589241656|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
163145252|NCT02365649|589241657|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
163145253|NCT02365649|589241658|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
163145254|NCT02365649|589241649|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
163145255|NCT02365649|589241650|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
163145256|NCT02365649|589241651|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
163145257|NCT02365649|589241652|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
163145258|NCT02365649|589241653|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
163349637|NCT01066936|589990806|FG000|Overall Study|Lost to Follow-up|3|||
163349638|NCT01066936|589990806|FG000|Overall Study|Withdrawal by Subject|4|||
163349639|NCT01904136|589990807|FG000|Overall Study|Physician Decision|0|||
163349640|NCT01904136|589990808|FG001|Overall Study|Physician Decision|0|||
163349641|NCT01904136|589990809|FG002|Overall Study|Physician Decision|0|||
163349642|NCT01904136|589990810|FG003|Overall Study|Physician Decision|0|||
163349643|NCT01904136|589990811|FG004|Overall Study|Physician Decision|0|||
163145259|NCT02365649|589241654|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
163145260|NCT02365649|589241655|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
163145261|NCT02365649|589241656|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
163145262|NCT02365649|589241657|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
163145263|NCT02365649|589241658|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
163145264|NCT02365649|589241649|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
163145265|NCT02365649|589241650|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
163145266|NCT02365649|589241651|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
163145267|NCT02365649|589241652|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
163145268|NCT02365649|589241653|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
163145269|NCT02365649|589241654|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
163145270|NCT02365649|589241655|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
163145271|NCT02365649|589241656|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
163145272|NCT02365649|589241657|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
163145273|NCT02365649|589241658|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
163145274|NCT02365649|589241649|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
163145275|NCT02365649|589241650|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
163145276|NCT02365649|589241651|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
163145277|NCT02365649|589241652|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
163145278|NCT02365649|589241653|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
163145279|NCT02365649|589241654|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
163145280|NCT02365649|589241655|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
163145281|NCT02365649|589241656|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
163145282|NCT02365649|589241657|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
163145283|NCT02365649|589241658|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
163145284|NCT02365649|589241649|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
163145285|NCT02365649|589241650|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
163145286|NCT02365649|589241651|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
163145287|NCT02365649|589241652|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
163145288|NCT02365649|589241653|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
163145289|NCT02365649|589241654|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
163145290|NCT02365649|589241655|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
163145291|NCT02365649|589241656|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
163145292|NCT02365649|589241657|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
163145293|NCT02365649|589241658|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
163145294|NCT02365649|589241649|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145295|NCT02365649|589241650|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145296|NCT02365649|589241651|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
163145297|NCT02365649|589241652|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145298|NCT02365649|589241653|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145299|NCT02365649|589241654|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145300|NCT02365649|589241655|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145301|NCT02365649|589241656|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145302|NCT02365649|589241657|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145303|NCT02365649|589241658|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145304|NCT02365649|589241649|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145305|NCT02365649|589241650|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145306|NCT02365649|589241651|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145307|NCT02365649|589241652|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145308|NCT02365649|589241653|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145309|NCT02365649|589241654|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145310|NCT02365649|589241655|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
163145311|NCT02365649|589241656|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145312|NCT02365649|589241657|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145313|NCT02365649|589241658|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145314|NCT02365649|589241649|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
163145315|NCT02365649|589241650|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
163145316|NCT02365649|589241651|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
163145317|NCT02365649|589241652|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
163349644|NCT01904136|589990812|FG005|Overall Study|Physician Decision|1|||
163349645|NCT01904136|589990813|FG006|Overall Study|Physician Decision|0|||
163239749|NCT01075321|589588044|FG002|Overall Study|Withdrawal by Subject|1|||
163239750|NCT01075321|589588045|FG003|Overall Study|Withdrawal by Subject|1|||
163239751|NCT01075321|589588042|FG000|Overall Study|Protocol Violation|0|||
163239752|NCT01075321|589588043|FG001|Overall Study|Protocol Violation|0|||
163239753|NCT01075321|589588044|FG002|Overall Study|Protocol Violation|1|||
163239754|NCT01075321|589588045|FG003|Overall Study|Protocol Violation|0|||
163239755|NCT01075321|589588042|FG000|Overall Study|Treatment Incomplete due to progression|1|||
163239756|NCT01075321|589588043|FG001|Overall Study|Treatment Incomplete due to progression|0|||
163239757|NCT01075321|589588044|FG002|Overall Study|Treatment Incomplete due to progression|0|||
163239758|NCT01075321|589588045|FG003|Overall Study|Treatment Incomplete due to progression|0|||
163239759|NCT01075321|589588042|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
163239760|NCT01075321|589588043|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
163239761|NCT01075321|589588044|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
163239762|NCT01075321|589588045|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
163239763|NCT02646423|589588046|FG000|Overall Study|Adverse Event|5|||
163239764|NCT02646423|589588047|FG001|Overall Study|Adverse Event|7|||
163239765|NCT02646423|589588046|FG000|Overall Study|Ineligible|2|||
163239766|NCT02646423|589588047|FG001|Overall Study|Ineligible|1|||
163239767|NCT00003457|589588048|FG000|Overall Study|Not evaluable|9|||
163239768|NCT01054729|589588052|FG000|Overall Study|Randomized but Not Treated|0|||
163239769|NCT01054729|589588053|FG001|Overall Study|Randomized but Not Treated|1|||
163239770|NCT01054729|589588054|FG002|Overall Study|Randomized but Not Treated|0|||
163239771|NCT01054729|589588055|FG003|Overall Study|Randomized but Not Treated|0|||
163239772|NCT01054729|589588052|FG000|Overall Study|Adverse Event|1|||
163239773|NCT01054729|589588053|FG001|Overall Study|Adverse Event|1|||
163239774|NCT01054729|589588054|FG002|Overall Study|Adverse Event|2|||
163239775|NCT01054729|589588055|FG003|Overall Study|Adverse Event|1|||
163239776|NCT01054729|589588052|FG000|Overall Study|Withdrawal by Subject|1|||
163239777|NCT01054729|589588053|FG001|Overall Study|Withdrawal by Subject|0|||
163239778|NCT01054729|589588054|FG002|Overall Study|Withdrawal by Subject|1|||
163239779|NCT01054729|589588055|FG003|Overall Study|Withdrawal by Subject|0|||
163239780|NCT01054729|589588052|FG000|Overall Study|Lost to Follow-up|0|||
163239781|NCT01054729|589588053|FG001|Overall Study|Lost to Follow-up|1|||
163239782|NCT01054729|589588054|FG002|Overall Study|Lost to Follow-up|0|||
163239783|NCT01054729|589588055|FG003|Overall Study|Lost to Follow-up|0|||
163239784|NCT01054729|589588052|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
163239785|NCT01054729|589588053|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
163239786|NCT01054729|589588054|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
163239787|NCT01054729|589588055|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
163239788|NCT01054729|589588052|FG000|Overall Study|Non-responder|1|||
163239789|NCT01054729|589588053|FG001|Overall Study|Non-responder|0|||
163239790|NCT01054729|589588054|FG002|Overall Study|Non-responder|1|||
163239791|NCT01054729|589588055|FG003|Overall Study|Non-responder|1|||
163239792|NCT01054729|589588052|FG000|Overall Study|PEG/RBV Non-responder|1|||
163239793|NCT01054729|589588053|FG001|Overall Study|PEG/RBV Non-responder|0|||
163239794|NCT01054729|589588054|FG002|Overall Study|PEG/RBV Non-responder|1|||
163239795|NCT01054729|589588055|FG003|Overall Study|PEG/RBV Non-responder|0|||
163239796|NCT01054729|589588052|FG000|Overall Study|Personal/Obligations|0|||
163239797|NCT01054729|589588053|FG001|Overall Study|Personal/Obligations|1|||
163239798|NCT01054729|589588054|FG002|Overall Study|Personal/Obligations|0|||
163239799|NCT01054729|589588055|FG003|Overall Study|Personal/Obligations|0|||
163239800|NCT01054729|589588052|FG000|Overall Study|Subject moved|0|||
163239801|NCT01054729|589588053|FG001|Overall Study|Subject moved|0|||
163239802|NCT01054729|589588054|FG002|Overall Study|Subject moved|1|||
163239803|NCT01054729|589588055|FG003|Overall Study|Subject moved|0|||
163239804|NCT01054729|589588052|FG000|Overall Study|Lack of Efficacy|0|||
163239805|NCT01054729|589588053|FG001|Overall Study|Lack of Efficacy|0|||
163409727|NCT04868903|590209500|FG002|Overall Study|Adverse Event|0|||
163239806|NCT01054729|589588054|FG002|Overall Study|Lack of Efficacy|0|||
163239807|NCT01054729|589588055|FG003|Overall Study|Lack of Efficacy|1|||
163239808|NCT03489304|589588056|FG000|Overall Study|Lost to Follow-up|4|||
163239809|NCT00321919|589588057|FG000|Overall Study|Adverse Event|17|||
163239810|NCT00321919|589588058|FG001|Overall Study|Adverse Event|10|||
163239811|NCT00321919|589588057|FG000|Overall Study|Death|21|||
163239812|NCT00321919|589588058|FG001|Overall Study|Death|17|||
163239813|NCT00321919|589588057|FG000|Overall Study|Insufficient Therapeutic Response|1|||
163239814|NCT00321919|589588058|FG001|Overall Study|Insufficient Therapeutic Response|0|||
163239815|NCT00321919|589588057|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
163239816|NCT00321919|589588058|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
163239817|NCT00321919|589588057|FG000|Overall Study|Refused Treatment|23|||
163239818|NCT00321919|589588058|FG001|Overall Study|Refused Treatment|14|||
163239819|NCT00321919|589588057|FG000|Overall Study|Other Protocol Violation|2|||
163239820|NCT00321919|589588058|FG001|Overall Study|Other Protocol Violation|3|||
163239821|NCT00321919|589588057|FG000|Overall Study|Failure to Return|3|||
163239822|NCT00321919|589588058|FG001|Overall Study|Failure to Return|1|||
163239823|NCT00321919|589588057|FG000|Overall Study|Other withdrawal reason|7|||
163349646|NCT01904136|589990814|FG007|Overall Study|Physician Decision|0|||
163349647|NCT01904136|589990815|FG008|Overall Study|Physician Decision|0|||
163349648|NCT01960348|589990820|FG000|Overall Study|Adverse event, not serious|2|||
163349649|NCT01960348|589990821|FG001|Overall Study|Adverse event, not serious|2|||
163349650|NCT01960348|589990820|FG000|Overall Study|Adverse event, serious fatal|6|||
163349651|NCT01960348|589990821|FG001|Overall Study|Adverse event, serious fatal|5|||
163145318|NCT02365649|589241653|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
163145319|NCT02365649|589241654|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
163145320|NCT02365649|589241655|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
163145321|NCT02365649|589241656|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
163145322|NCT02365649|589241657|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
163145323|NCT02365649|589241658|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
163145324|NCT02365649|589241649|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
163145325|NCT02365649|589241650|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
163145326|NCT02365649|589241651|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
163145327|NCT02365649|589241652|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
163145328|NCT02365649|589241653|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
163145329|NCT02365649|589241654|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
163145330|NCT02365649|589241655|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
163145331|NCT02365649|589241656|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
163145332|NCT02365649|589241657|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
163145333|NCT02365649|589241658|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
163145334|NCT02365649|589241649|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
163145335|NCT02365649|589241650|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
163145336|NCT02365649|589241651|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
163145337|NCT02365649|589241652|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
163145338|NCT02365649|589241653|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
163145339|NCT02365649|589241654|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
163145340|NCT02365649|589241655|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
163145341|NCT02365649|589241656|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
163145342|NCT02365649|589241657|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
163145343|NCT02365649|589241658|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
163145344|NCT02365649|589241649|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145345|NCT02365649|589241650|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145346|NCT02365649|589241651|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145347|NCT02365649|589241652|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145348|NCT02365649|589241653|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145349|NCT02365649|589241654|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145350|NCT02365649|589241655|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
163145351|NCT02365649|589241656|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145352|NCT02365649|589241657|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
163145353|NCT02365649|589241658|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145354|NCT01506271|589241659|FG000|Overall Study|Progressive disease|0|||
163145355|NCT01506271|589241660|FG001|Overall Study|Progressive disease|1|||
163145356|NCT01506271|589241661|FG002|Overall Study|Progressive disease|0|||
163145357|NCT01506271|589241659|FG000|Overall Study|Protocol Violation|3|||
163145358|NCT01506271|589241660|FG001|Overall Study|Protocol Violation|1|||
163145359|NCT01506271|589241661|FG002|Overall Study|Protocol Violation|0|||
163145360|NCT01506271|589241659|FG000|Overall Study|Death|0|||
163145361|NCT01506271|589241660|FG001|Overall Study|Death|1|||
163145362|NCT01506271|589241661|FG002|Overall Study|Death|0|||
163145363|NCT01506271|589241659|FG000|Overall Study|Adverse Event|0|||
163145364|NCT01506271|589241660|FG001|Overall Study|Adverse Event|2|||
163145365|NCT01506271|589241661|FG002|Overall Study|Adverse Event|0|||
163145366|NCT01506271|589241659|FG000|Overall Study|Insufficient supply of study drug|1|||
163145367|NCT01506271|589241660|FG001|Overall Study|Insufficient supply of study drug|0|||
163145368|NCT01506271|589241661|FG002|Overall Study|Insufficient supply of study drug|0|||
163145369|NCT01506271|589241659|FG000|Overall Study|Withdrawal by Subject|0|||
163145370|NCT01506271|589241660|FG001|Overall Study|Withdrawal by Subject|1|||
163145371|NCT01506271|589241661|FG002|Overall Study|Withdrawal by Subject|1|||
163145372|NCT01506271|589241659|FG000|Overall Study|Lost to Follow-up|0|||
163145373|NCT01506271|589241660|FG001|Overall Study|Lost to Follow-up|1|||
163145374|NCT01506271|589241661|FG002|Overall Study|Lost to Follow-up|2|||
163145375|NCT00689390|589241662|FG000|Overall Study|Adverse Event|19|||
163145376|NCT00689390|589241663|FG001|Overall Study|Adverse Event|0|||
163145377|NCT00689390|589241662|FG000|Overall Study|Lost to Follow-up|179|||
163145378|NCT00689390|589241663|FG001|Overall Study|Lost to Follow-up|7|||
163349652|NCT01960348|589990820|FG000|Overall Study|Adverse event, serious non-fatal|0|||
163349653|NCT01960348|589990821|FG001|Overall Study|Adverse event, serious non-fatal|3|||
163349654|NCT01960348|589990820|FG000|Overall Study|Withdrawal by Subject|1|||
163239824|NCT00321919|589588058|FG001|Overall Study|Other withdrawal reason|6|||
163239825|NCT02624804|589588059|FG000|Overall Study|Screen Failure|5|||
163239826|NCT01148810|589588060|FG000|Overall Study|Adverse Event|0|||
163239827|NCT01148810|589588061|FG001|Overall Study|Adverse Event|2|||
163239828|NCT01148810|589588060|FG000|Overall Study|Lack of Efficacy|0|||
163239829|NCT01148810|589588061|FG001|Overall Study|Lack of Efficacy|1|||
163239830|NCT01148810|589588060|FG000|Overall Study|Withdrawal by Subject|0|||
163239831|NCT01148810|589588061|FG001|Overall Study|Withdrawal by Subject|2|||
163239832|NCT01148810|589588060|FG000|Overall Study|Protocol Violation|1|||
163239833|NCT01148810|589588061|FG001|Overall Study|Protocol Violation|0|||
163239834|NCT02731131|589588068|FG000|Overall Study|Psychiatric Disorder|0|||
163239835|NCT02731131|589588069|FG001|Overall Study|Psychiatric Disorder|1|||
163239836|NCT02731131|589588068|FG000|Overall Study|Refused Therapy|0|||
163239837|NCT02731131|589588069|FG001|Overall Study|Refused Therapy|1|||
163239838|NCT02348216|589588075|FG000|Overall Study|Death|5|||
163239839|NCT02348216|589588076|FG001|Overall Study|Death|53|||
163239840|NCT02348216|589588077|FG002|Overall Study|Death|11|||
163239841|NCT02348216|589588078|FG003|Overall Study|Death|20|||
163239842|NCT02348216|589588079|FG004|Overall Study|Death|16|||
163239843|NCT02348216|589588080|FG005|Overall Study|Death|32|||
163239844|NCT02348216|589588081|FG006|Overall Study|Death|17|||
163239845|NCT02348216|589588075|FG000|Overall Study|Full consent withdrawal|0|||
163239846|NCT02348216|589588076|FG001|Overall Study|Full consent withdrawal|0|||
163239847|NCT02348216|589588077|FG002|Overall Study|Full consent withdrawal|0|||
163239848|NCT02348216|589588078|FG003|Overall Study|Full consent withdrawal|1|||
163239849|NCT02348216|589588079|FG004|Overall Study|Full consent withdrawal|3|||
163239850|NCT02348216|589588080|FG005|Overall Study|Full consent withdrawal|0|||
163239851|NCT02348216|589588081|FG006|Overall Study|Full consent withdrawal|3|||
163239852|NCT02348216|589588075|FG000|Overall Study|Lost to Follow-up|0|||
163239853|NCT02348216|589588076|FG001|Overall Study|Lost to Follow-up|5|||
163239854|NCT02348216|589588077|FG002|Overall Study|Lost to Follow-up|2|||
163239855|NCT02348216|589588078|FG003|Overall Study|Lost to Follow-up|0|||
163239856|NCT02348216|589588079|FG004|Overall Study|Lost to Follow-up|1|||
163239857|NCT02348216|589588080|FG005|Overall Study|Lost to Follow-up|1|||
163239858|NCT02348216|589588081|FG006|Overall Study|Lost to Follow-up|1|||
163239859|NCT02348216|589588075|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
163239860|NCT02348216|589588076|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
163239861|NCT02348216|589588077|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
163239862|NCT02348216|589588078|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
163239863|NCT02348216|589588079|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
163239864|NCT02348216|589588080|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
163239865|NCT02348216|589588081|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
163239866|NCT02348216|589588075|FG000|Overall Study|Reason not specified|2|||
163239867|NCT02348216|589588076|FG001|Overall Study|Reason not specified|19|||
163239868|NCT02348216|589588077|FG002|Overall Study|Reason not specified|11|||
163239869|NCT02348216|589588078|FG003|Overall Study|Reason not specified|17|||
163239870|NCT02348216|589588079|FG004|Overall Study|Reason not specified|21|||
163239871|NCT02348216|589588080|FG005|Overall Study|Reason not specified|17|||
163239872|NCT02348216|589588081|FG006|Overall Study|Reason not specified|19|||
163239873|NCT01055639|589588082|FG000|Overall Study|Adverse Event|0|||
163239874|NCT01055639|589588083|FG001|Overall Study|Adverse Event|1|||
163239875|NCT01055639|589588082|FG000|Overall Study|Lack of Efficacy|0|||
163239876|NCT01055639|589588083|FG001|Overall Study|Lack of Efficacy|1|||
163239877|NCT01055639|589588082|FG000|Overall Study|Lost to Follow-up|8|||
163239878|NCT01055639|589588083|FG001|Overall Study|Lost to Follow-up|11|||
163239879|NCT01055639|589588082|FG000|Overall Study|Protocol Violation|5|||
163239880|NCT01055639|589588083|FG001|Overall Study|Protocol Violation|5|||
163239881|NCT01055639|589588082|FG000|Overall Study|Withdrawal by Subject|8|||
163239882|NCT01055639|589588083|FG001|Overall Study|Withdrawal by Subject|11|||
163239883|NCT01202773|589588085|FG000|Overall Study|Adverse Event|4|||
163239884|NCT01202773|589588086|FG001|Overall Study|Adverse Event|5|||
163409728|NCT04868903|590209501|FG003|Overall Study|Adverse Event|1|||
163239885|NCT01202773|589588087|FG002|Overall Study|Adverse Event|5|||
163239886|NCT01202773|589588085|FG000|Overall Study|Lack of Efficacy|5|||
163239887|NCT01202773|589588086|FG001|Overall Study|Lack of Efficacy|4|||
163409729|NCT04868903|590209498|FG000|Overall Study|Withdrawal by Subject|29|||
163239888|NCT01202773|589588087|FG002|Overall Study|Lack of Efficacy|9|||
163239889|NCT01202773|589588085|FG000|Overall Study|Entry Criteria Not Met|2|||
163239890|NCT01202773|589588086|FG001|Overall Study|Entry Criteria Not Met|0|||
163239891|NCT01202773|589588087|FG002|Overall Study|Entry Criteria Not Met|1|||
163239892|NCT01202773|589588085|FG000|Overall Study|Lost to Follow-up|1|||
163239893|NCT01202773|589588086|FG001|Overall Study|Lost to Follow-up|2|||
163409730|NCT04868903|590209499|FG001|Overall Study|Withdrawal by Subject|44|||
163239894|NCT01202773|589588087|FG002|Overall Study|Lost to Follow-up|2|||
163239895|NCT01202773|589588085|FG000|Overall Study|Withdrawal by Subject|13|||
163239896|NCT01202773|589588086|FG001|Overall Study|Withdrawal by Subject|6|||
163239897|NCT01202773|589588087|FG002|Overall Study|Withdrawal by Subject|5|||
163409731|NCT04868903|590209500|FG002|Overall Study|Withdrawal by Subject|17|||
163409732|NCT04868903|590209501|FG003|Overall Study|Withdrawal by Subject|12|||
163409733|NCT04868903|590209498|FG000|Overall Study|Hyperparathyroidism|3|||
163409734|NCT04868903|590209499|FG001|Overall Study|Hyperparathyroidism|5|||
163409735|NCT04868903|590209500|FG002|Overall Study|Hyperparathyroidism|2|||
163409736|NCT04868903|590209501|FG003|Overall Study|Hyperparathyroidism|3|||
163409737|NCT03975647|590209502|FG000|Overall Study|Death|71|||
163409738|NCT03975647|590209503|FG001|Overall Study|Death|63|||
163409739|NCT03975647|590209502|FG000|Overall Study|Lost to Follow-up|2|||
163409740|NCT03975647|590209503|FG001|Overall Study|Lost to Follow-up|2|||
163409741|NCT03975647|590209502|FG000|Overall Study|Subject withdrawal of consent|7|||
163409742|NCT03975647|590209503|FG001|Overall Study|Subject withdrawal of consent|11|||
163409743|NCT03735667|590209504|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
163409744|NCT03735667|590209505|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
163145379|NCT00689390|589241662|FG000|Overall Study|Withdrawal by Subject|117|||
163145380|NCT00689390|589241663|FG001|Overall Study|Withdrawal by Subject|3|||
163145381|NCT00689390|589241662|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
163145382|NCT00689390|589241663|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
163145383|NCT00689390|589241662|FG000|Overall Study|Non-Compliance With Protocol|21|||
163145384|NCT00689390|589241663|FG001|Overall Study|Non-Compliance With Protocol|0|||
163145385|NCT00689390|589241662|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
163145386|NCT00689390|589241663|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
163145387|NCT00689390|589241662|FG000|Overall Study|Administrative|37|||
163145388|NCT00689390|589241663|FG001|Overall Study|Administrative|0|||
163145389|NCT00920855|589241665|FG000|Overall Study|Adverse Event|1|||
163145390|NCT00920855|589241666|FG001|Overall Study|Adverse Event|1|||
163145391|NCT00920855|589241667|FG002|Overall Study|Adverse Event|4|||
163145392|NCT00920855|589241665|FG000|Overall Study|Withdrawal by Subject|2|||
163145393|NCT00920855|589241666|FG001|Overall Study|Withdrawal by Subject|1|||
163145394|NCT00920855|589241667|FG002|Overall Study|Withdrawal by Subject|6|||
163145395|NCT00920855|589241665|FG000|Overall Study|Disease progression|2|||
163145396|NCT00920855|589241666|FG001|Overall Study|Disease progression|1|||
163145397|NCT00920855|589241667|FG002|Overall Study|Disease progression|10|||
163145398|NCT00920855|589241665|FG000|Overall Study|Noncompliance to study medication|0|||
163145399|NCT00920855|589241666|FG001|Overall Study|Noncompliance to study medication|0|||
163145400|NCT00920855|589241667|FG002|Overall Study|Noncompliance to study medication|1|||
163145401|NCT00920855|589241665|FG000|Overall Study|Response plateau; started maintenance|0|||
163145402|NCT00920855|589241666|FG001|Overall Study|Response plateau; started maintenance|0|||
163145403|NCT00920855|589241667|FG002|Overall Study|Response plateau; started maintenance|1|||
163145404|NCT00539994|589241668|FG000|Overall Study|Lost to Follow-up|2|||
163145405|NCT00539994|589241669|FG001|Overall Study|Lost to Follow-up|1|||
163145406|NCT00539994|589241670|FG002|Overall Study|Lost to Follow-up|0|||
163145407|NCT00539994|589241668|FG000|Overall Study|Withdrawal by Subject|1|||
163145408|NCT00539994|589241669|FG001|Overall Study|Withdrawal by Subject|0|||
163145409|NCT00539994|589241670|FG002|Overall Study|Withdrawal by Subject|1|||
163145410|NCT00539994|589241668|FG000|Overall Study|Physician Decision|0|||
163145411|NCT00539994|589241669|FG001|Overall Study|Physician Decision|0|||
163145412|NCT00539994|589241670|FG002|Overall Study|Physician Decision|1|||
163145413|NCT01611194|589241674|FG000|Overall Study|Lost to Follow-up|0|||
163145414|NCT01611194|589241675|FG001|Overall Study|Lost to Follow-up|1|||
163145415|NCT01611194|589241674|FG000|Overall Study|Withdrawal by Subject|0|||
163145416|NCT01611194|589241675|FG001|Overall Study|Withdrawal by Subject|1|||
163145417|NCT01611194|589241674|FG000|Overall Study|drug use|0|||
163145418|NCT01611194|589241675|FG001|Overall Study|drug use|1|||
163145419|NCT02464410|589241687|FG000|Overall Study|Death|3|||
163145420|NCT02464410|589241688|FG001|Overall Study|Death|4|||
163145421|NCT02464410|589241687|FG000|Overall Study|Lost to Follow-up|7|||
163145422|NCT02464410|589241688|FG001|Overall Study|Lost to Follow-up|9|||
163145423|NCT02464410|589241687|FG000|Overall Study|Withdrawal by Subject|12|||
163145424|NCT02464410|589241688|FG001|Overall Study|Withdrawal by Subject|3|||
163145425|NCT01928927|589241689|FG000|Overall Study|Lost to Follow-up|1|||
163145426|NCT01928927|589241690|FG001|Overall Study|Lost to Follow-up|0|||
163145427|NCT01928927|589241689|FG000|Overall Study|Withdrawal by Subject|1|||
163145428|NCT01928927|589241690|FG001|Overall Study|Withdrawal by Subject|1|||
163145429|NCT01871519|589241695|FG000|Overall Study|Death|26|||
163145430|NCT01871519|589241695|FG000|Overall Study|Lost to Follow-up|15|||
163145431|NCT01871519|589241695|FG000|Overall Study|Withdrawal by Subject|49|||
163145432|NCT00350844|589241696|FG000|Overall Study|Lost to Follow-up|1|||
163145433|NCT02775916|589241697|FG000|Overall Study|Adverse Event|1|||
163145434|NCT02775916|589241698|FG001|Overall Study|Adverse Event|0|||
163145435|NCT02775916|589241697|FG000|Overall Study|Subject/Guardian Decision|2|||
163145436|NCT02775916|589241698|FG001|Overall Study|Subject/Guardian Decision|0|||
163145437|NCT00179621|589243036|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
163145438|NCT00179621|589243037|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
163145439|NCT00179621|589243038|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
163409745|NCT03735667|590209506|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
163239898|NCT01202773|589588085|FG000|Overall Study|Physician Decision|2|||
163239899|NCT01202773|589588086|FG001|Overall Study|Physician Decision|0|||
163239900|NCT01202773|589588087|FG002|Overall Study|Physician Decision|0|||
163239901|NCT01202773|589588085|FG000|Overall Study|Protocol Violation|11|||
163239902|NCT01202773|589588086|FG001|Overall Study|Protocol Violation|6|||
163239903|NCT01202773|589588087|FG002|Overall Study|Protocol Violation|10|||
163239904|NCT01202773|589588085|FG000|Overall Study|Sponsor Decision|19|||
163239905|NCT01202773|589588086|FG001|Overall Study|Sponsor Decision|20|||
163239906|NCT01202773|589588087|FG002|Overall Study|Sponsor Decision|23|||
163239907|NCT03058679|589588088|FG000|Baseline to Week 6|Lost to Follow-up|3|||
163239908|NCT03058679|589588089|FG001|Baseline to Week 6|Lost to Follow-up|2|||
163239909|NCT03058679|589588088|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
163239910|NCT03058679|589588089|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
163239911|NCT03058679|589588088|FG000|Baseline to Week 6|Adverse Event|6|||
163239912|NCT03058679|589588089|FG001|Baseline to Week 6|Adverse Event|6|||
163239913|NCT03058679|589588088|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
163239914|NCT03058679|589588089|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
163239915|NCT03058679|589588088|FG000|Baseline to Week 6|Difficulty following the diet|0|||
163239916|NCT03058679|589588089|FG001|Baseline to Week 6|Difficulty following the diet|2|||
163239917|NCT03058679|589588088|FG000|Baseline to Week 6|Physician Decision|1|||
163239918|NCT03058679|589588089|FG001|Baseline to Week 6|Physician Decision|0|||
163239919|NCT03058679|589588088|FG000|Week 6 to Week 12|Change in medication|5|||
163239920|NCT03058679|589588089|FG001|Week 6 to Week 12|Change in medication|7|||
163239921|NCT03058679|589588088|FG000|Week 6 to Week 12|Adverse Event|4|||
163239922|NCT03058679|589588089|FG001|Week 6 to Week 12|Adverse Event|3|||
163239923|NCT03058679|589588088|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
163239924|NCT03058679|589588089|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
163239925|NCT03058679|589588088|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
163239926|NCT03058679|589588089|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
163239927|NCT04137380|589588094|FG000|Overall Study|Physician Decision|0|||
163239928|NCT04137380|589588095|FG001|Overall Study|Physician Decision|0|||
163239929|NCT04137380|589588096|FG002|Overall Study|Physician Decision|0|||
163239930|NCT04137380|589588097|FG003|Overall Study|Physician Decision|1|||
163239931|NCT04137380|589588098|FG004|Overall Study|Physician Decision|0|||
163239932|NCT04137380|589588099|FG005|Overall Study|Physician Decision|0|||
163239933|NCT04137380|589588100|FG006|Overall Study|Physician Decision|0|||
163239934|NCT00575588|589588106|FG000|Overall Study|Adverse Event|11|||
163239935|NCT00575588|589588107|FG001|Overall Study|Adverse Event|13|||
163239936|NCT00575588|589588106|FG000|Overall Study|Withdrawal by Subject|27|||
163239937|NCT00575588|589588107|FG001|Overall Study|Withdrawal by Subject|31|||
163239938|NCT00575588|589588106|FG000|Overall Study|Lost to Follow-up|1|||
163239939|NCT00575588|589588107|FG001|Overall Study|Lost to Follow-up|3|||
163239940|NCT00575588|589588106|FG000|Overall Study|Death|4|||
163239941|NCT00575588|589588107|FG001|Overall Study|Death|2|||
163239942|NCT00575588|589588106|FG000|Overall Study|Incorrect enrollment|8|||
163239943|NCT00575588|589588107|FG001|Overall Study|Incorrect enrollment|4|||
163239944|NCT00575588|589588106|FG000|Overall Study|Study specific discontinuation criteria|203|||
163239945|NCT00575588|589588107|FG001|Overall Study|Study specific discontinuation criteria|218|||
163239946|NCT00575588|589588106|FG000|Overall Study|Severe non-compliance to protocol|5|||
163239947|NCT00575588|589588107|FG001|Overall Study|Severe non-compliance to protocol|7|||
163239948|NCT00575588|589588106|FG000|Overall Study|Safety reasons|2|||
163239949|NCT00575588|589588107|FG001|Overall Study|Safety reasons|1|||
163239950|NCT00575588|589588106|FG000|Overall Study|Elevated triglyceride|1|||
163239951|NCT00575588|589588107|FG001|Overall Study|Elevated triglyceride|0|||
163239952|NCT00575588|589588106|FG000|Overall Study|Patient moved|1|||
163239953|NCT00575588|589588107|FG001|Overall Study|Patient moved|3|||
163239954|NCT00575588|589588106|FG000|Overall Study|Impossible to determine HbA1c|0|||
163349655|NCT01960348|589990821|FG001|Overall Study|Withdrawal by Subject|11|||
163349656|NCT01960348|589990820|FG000|Overall Study|Physician Decision|0|||
163349657|NCT01960348|589990821|FG001|Overall Study|Physician Decision|1|||
163349658|NCT01960348|589990820|FG000|Overall Study|Protocol Violation|1|||
163239955|NCT00575588|589588107|FG001|Overall Study|Impossible to determine HbA1c|1|||
163349659|NCT01960348|589990821|FG001|Overall Study|Protocol Violation|0|||
163349660|NCT00853372|589990822|FG000|Overall Study|Death|30|||
163349661|NCT00853372|589990823|FG001|Overall Study|Death|26|||
163239956|NCT02265705|589588108|FG000|Treatment Period Week 0-24|Adverse Event|3|||
163239957|NCT02265705|589588109|FG001|Treatment Period Week 0-24|Adverse Event|2|||
163239958|NCT02265705|589588110|FG002|Treatment Period Week 0-24|Adverse Event|0|||
163239959|NCT02265705|589588111|FG003|Treatment Period Week 0-24|Adverse Event|0|||
163239960|NCT02265705|589588112|FG004|Treatment Period Week 0-24|Adverse Event|0|||
163239961|NCT02265705|589588113|FG005|Treatment Period Week 0-24|Adverse Event|0|||
163239962|NCT02265705|589588114|FG006|Treatment Period Week 0-24|Adverse Event|0|||
163239963|NCT02265705|589588108|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
163239964|NCT02265705|589588109|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
163239965|NCT02265705|589588110|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
163239966|NCT02265705|589588111|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
163349662|NCT00853372|589990822|FG000|Overall Study|Lost to Follow-up|1|||
163145440|NCT00179621|589243039|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
163145441|NCT00179621|589243036|FG000|Double-Blind Period|Adverse Event|2|||
163145442|NCT00179621|589243037|FG001|Double-Blind Period|Adverse Event|7|||
163145443|NCT00179621|589243038|FG002|Double-Blind Period|Adverse Event|4|||
163145444|NCT00179621|589243039|FG003|Double-Blind Period|Adverse Event|0|||
163145445|NCT00179621|589243036|FG000|Double-Blind Period|Withdrawal by Subject|2|||
163145446|NCT00179621|589243037|FG001|Double-Blind Period|Withdrawal by Subject|1|||
163145447|NCT00179621|589243038|FG002|Double-Blind Period|Withdrawal by Subject|3|||
163145448|NCT00179621|589243039|FG003|Double-Blind Period|Withdrawal by Subject|0|||
163145449|NCT00179621|589243036|FG000|Double-Blind Period|Death|0|||
163145450|NCT00179621|589243037|FG001|Double-Blind Period|Death|1|||
163145451|NCT00179621|589243038|FG002|Double-Blind Period|Death|2|||
163145452|NCT00179621|589243039|FG003|Double-Blind Period|Death|0|||
163145453|NCT00179621|589243036|FG000|Double-Blind Period|Protocol Violation|1|||
163145454|NCT00179621|589243037|FG001|Double-Blind Period|Protocol Violation|0|||
163145455|NCT00179621|589243038|FG002|Double-Blind Period|Protocol Violation|0|||
163145456|NCT00179621|589243039|FG003|Double-Blind Period|Protocol Violation|0|||
163145457|NCT00179621|589243036|FG000|Double-Blind Period|Other|0|||
163145458|NCT00179621|589243037|FG001|Double-Blind Period|Other|2|||
163145459|NCT00179621|589243038|FG002|Double-Blind Period|Other|2|||
163145460|NCT00179621|589243039|FG003|Double-Blind Period|Other|0|||
163145461|NCT00179621|589243036|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
163145462|NCT00179621|589243037|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
163145463|NCT00179621|589243038|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
163145464|NCT00179621|589243039|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
163145465|NCT00179621|589243036|FG000|Open-Label Period|Adverse Event|0|||
163145466|NCT00179621|589243037|FG001|Open-Label Period|Adverse Event|6|||
163145467|NCT00179621|589243038|FG002|Open-Label Period|Adverse Event|5|||
163145468|NCT00179621|589243039|FG003|Open-Label Period|Adverse Event|6|||
163145469|NCT00179621|589243036|FG000|Open-Label Period|Withdrawal by Subject|0|||
163145470|NCT00179621|589243037|FG001|Open-Label Period|Withdrawal by Subject|2|||
163145471|NCT00179621|589243038|FG002|Open-Label Period|Withdrawal by Subject|2|||
163145472|NCT00179621|589243039|FG003|Open-Label Period|Withdrawal by Subject|2|||
163145473|NCT00179621|589243036|FG000|Open-Label Period|Death|0|||
163145474|NCT00179621|589243037|FG001|Open-Label Period|Death|0|||
163145475|NCT00179621|589243038|FG002|Open-Label Period|Death|1|||
163145476|NCT00179621|589243039|FG003|Open-Label Period|Death|2|||
163145477|NCT00179621|589243036|FG000|Open-Label Period|Other|0|||
163145478|NCT00179621|589243037|FG001|Open-Label Period|Other|1|||
163145479|NCT00179621|589243038|FG002|Open-Label Period|Other|1|||
163145480|NCT00179621|589243039|FG003|Open-Label Period|Other|2|||
163145481|NCT00865345|589243041|FG000|Overall Study|Withdrawal by Subject|2|||
163145482|NCT00966654|589243046|FG000|Overall Study|Study was terminated,PI left institution|12|||
163145483|NCT00882440|589243049|FG000|Overall Study|Adverse Event|2|||
163145484|NCT00882440|589243050|FG001|Overall Study|Adverse Event|2|||
163145485|NCT00882440|589243051|FG002|Overall Study|Adverse Event|2|||
163145486|NCT00882440|589243052|FG003|Overall Study|Adverse Event|1|||
163145487|NCT00882440|589243053|FG004|Overall Study|Adverse Event|1|||
163145488|NCT00882440|589243054|FG005|Overall Study|Adverse Event|4|||
163145489|NCT00882440|589243055|FG006|Overall Study|Adverse Event|2|||
163145490|NCT00882440|589243049|FG000|Overall Study|Lack of Efficacy|3|||
163145491|NCT00882440|589243050|FG001|Overall Study|Lack of Efficacy|5|||
163145492|NCT00882440|589243051|FG002|Overall Study|Lack of Efficacy|2|||
163145493|NCT00882440|589243052|FG003|Overall Study|Lack of Efficacy|0|||
163145494|NCT00882440|589243053|FG004|Overall Study|Lack of Efficacy|0|||
163145495|NCT00882440|589243054|FG005|Overall Study|Lack of Efficacy|3|||
163145496|NCT00882440|589243055|FG006|Overall Study|Lack of Efficacy|0|||
163145497|NCT00882440|589243049|FG000|Overall Study|Lost to Follow-up|2|||
163145498|NCT00882440|589243050|FG001|Overall Study|Lost to Follow-up|0|||
163239967|NCT02265705|589588112|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
163239968|NCT02265705|589588113|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
163239969|NCT02265705|589588114|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
163239970|NCT02265705|589588108|FG000|Treatment Period Week 0-24|Physician Decision|1|||
163239971|NCT02265705|589588109|FG001|Treatment Period Week 0-24|Physician Decision|0|||
163239972|NCT02265705|589588110|FG002|Treatment Period Week 0-24|Physician Decision|0|||
163239973|NCT02265705|589588111|FG003|Treatment Period Week 0-24|Physician Decision|0|||
163239974|NCT02265705|589588112|FG004|Treatment Period Week 0-24|Physician Decision|0|||
163239975|NCT02265705|589588113|FG005|Treatment Period Week 0-24|Physician Decision|0|||
163239976|NCT02265705|589588114|FG006|Treatment Period Week 0-24|Physician Decision|0|||
163239977|NCT02265705|589588108|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
163239978|NCT02265705|589588109|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
163239979|NCT02265705|589588110|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
163239980|NCT02265705|589588111|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
163239981|NCT02265705|589588112|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
163239982|NCT02265705|589588113|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
163239983|NCT02265705|589588114|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
163239984|NCT02265705|589588108|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
163349663|NCT00853372|589990823|FG001|Overall Study|Lost to Follow-up|2|||
163409746|NCT03735667|590209504|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
163409747|NCT03735667|590209505|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
163409748|NCT03735667|590209506|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
163409749|NCT03735667|590209504|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
163409750|NCT03735667|590209505|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
163409751|NCT03735667|590209506|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
163409752|NCT03735667|590209504|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
163409753|NCT03735667|590209505|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
163409754|NCT03735667|590209506|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
163409755|NCT03735667|590209504|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
163409756|NCT03735667|590209505|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
163409757|NCT03735667|590209506|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
163409758|NCT03735667|590209504|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
163409759|NCT03735667|590209505|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
163409760|NCT03735667|590209506|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
163409761|NCT03735667|590209504|FG000|4D-CT Substudy (subset of Main RCT)|Death|8|||
163409762|NCT03735667|590209505|FG001|4D-CT Substudy (subset of Main RCT)|Death|5|||
163409763|NCT03735667|590209506|FG002|4D-CT Substudy (subset of Main RCT)|Death|0|||
163409764|NCT03735667|590209504|FG000|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
163409765|NCT03735667|590209505|FG001|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
163409766|NCT03735667|590209506|FG002|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|0|||
163409767|NCT03735667|590209504|FG000|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|1|||
163409768|NCT03735667|590209505|FG001|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
163409769|NCT03735667|590209506|FG002|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
163409770|NCT03735667|590209504|FG000|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
163409771|NCT03735667|590209505|FG001|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
163409772|NCT03735667|590209506|FG002|4D-CT Substudy (subset of Main RCT)|Physician Decision|0|||
163409773|NCT03735667|590209504|FG000|4D-CT Substudy (subset of Main RCT)|Other|0|||
163409774|NCT03735667|590209505|FG001|4D-CT Substudy (subset of Main RCT)|Other|1|||
163409775|NCT03735667|590209506|FG002|4D-CT Substudy (subset of Main RCT)|Other|0|||
163409776|NCT03735667|590209504|FG000|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
163409777|NCT03735667|590209505|FG001|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
163409778|NCT03735667|590209506|FG002|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|0|||
163409779|NCT03092726|590209507|FG000|Overall Study|Adverse Event|3|||
163409780|NCT03092726|590209508|FG001|Overall Study|Adverse Event|10|||
163409781|NCT03092726|590209507|FG000|Overall Study|Lack of Efficacy|0|||
163409782|NCT03092726|590209508|FG001|Overall Study|Lack of Efficacy|1|||
163409783|NCT03092726|590209507|FG000|Overall Study|Lost to Follow-up|1|||
163409784|NCT03092726|590209508|FG001|Overall Study|Lost to Follow-up|0|||
163409785|NCT03092726|590209507|FG000|Overall Study|Withdrawal by Subject|5|||
163409786|NCT03092726|590209508|FG001|Overall Study|Withdrawal by Subject|3|||
163409787|NCT05048342|590209515|FG000|Overall Study|Adverse Event|1|||
163409788|NCT05048342|590209515|FG000|Overall Study|Subject decision|2|||
163409789|NCT04418765|590209516|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
163409790|NCT04418765|590209517|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
163409791|NCT04418765|590209518|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
163409792|NCT04418765|590209516|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
163409793|NCT04418765|590209517|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
163409794|NCT04418765|590209518|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
163409795|NCT04418765|590209516|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
163409796|NCT04418765|590209517|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
163409797|NCT04418765|590209518|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
163409798|NCT04418765|590209516|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
163409799|NCT04418765|590209517|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
163409800|NCT04418765|590209518|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
163409801|NCT04418765|590209516|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
163409802|NCT04418765|590209517|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
163409803|NCT04418765|590209518|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
163409804|NCT04418765|590209516|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
163409805|NCT04418765|590209517|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
163409806|NCT04418765|590209518|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
163409807|NCT04418765|590209516|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
163409808|NCT04418765|590209517|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
163409809|NCT04418765|590209518|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
163409810|NCT04418765|590209516|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
163409811|NCT04418765|590209517|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
163409812|NCT04418765|590209518|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
163409813|NCT04418765|590209516|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
163239985|NCT02265705|589588109|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
163239986|NCT02265705|589588110|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
163239987|NCT02265705|589588111|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
163239988|NCT02265705|589588112|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
163239989|NCT02265705|589588113|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
163239990|NCT02265705|589588114|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
163239991|NCT02265705|589588108|FG000|Rescue Period|Withdrawal by Subject|0|||
163239992|NCT02265705|589588109|FG001|Rescue Period|Withdrawal by Subject|0|||
163239993|NCT02265705|589588110|FG002|Rescue Period|Withdrawal by Subject|1|||
163239994|NCT02265705|589588111|FG003|Rescue Period|Withdrawal by Subject|0|||
163239995|NCT02265705|589588112|FG004|Rescue Period|Withdrawal by Subject|0|||
163239996|NCT02265705|589588113|FG005|Rescue Period|Withdrawal by Subject|0|||
163239997|NCT02265705|589588114|FG006|Rescue Period|Withdrawal by Subject|0|||
163239998|NCT02265705|589588108|FG000|Rescue Period|Death|0|||
163239999|NCT02265705|589588109|FG001|Rescue Period|Death|0|||
163240000|NCT02265705|589588110|FG002|Rescue Period|Death|1|||
163240001|NCT02265705|589588111|FG003|Rescue Period|Death|0|||
163240002|NCT02265705|589588112|FG004|Rescue Period|Death|0|||
163240003|NCT02265705|589588113|FG005|Rescue Period|Death|0|||
163240004|NCT02265705|589588114|FG006|Rescue Period|Death|0|||
163240005|NCT02265705|589588108|FG000|Rescue Period|Lack of Efficacy|0|||
163240006|NCT02265705|589588109|FG001|Rescue Period|Lack of Efficacy|0|||
163240007|NCT02265705|589588110|FG002|Rescue Period|Lack of Efficacy|1|||
163240008|NCT02265705|589588111|FG003|Rescue Period|Lack of Efficacy|0|||
163240009|NCT02265705|589588112|FG004|Rescue Period|Lack of Efficacy|0|||
163349664|NCT00853372|589990822|FG000|Overall Study|Full Consent Withdrawn|1|||
163349665|NCT00853372|589990823|FG001|Overall Study|Full Consent Withdrawn|1|||
163349666|NCT01580995|589990824|FG000|Overall Study|Lost to Follow-up|2|||
163349667|NCT01580995|589990825|FG001|Overall Study|Lost to Follow-up|2|||
163349668|NCT01821729|589990826|FG000|Overall Study|Withdrawal by Subject|1|||
163349669|NCT02517528|589990828|FG000|Overall Study|Withdrawal by Subject|1|||
163349670|NCT02202109|589990832|FG000|Overall Study|Lost to Follow-up|88|||
163349671|NCT02202109|589990833|FG001|Overall Study|Lost to Follow-up|87|||
163349672|NCT02202109|589990832|FG000|Overall Study|Withdrawal by Subject|2|||
163349673|NCT02202109|589990833|FG001|Overall Study|Withdrawal by Subject|0|||
163349674|NCT01268098|589990836|FG000|Overall Study|Adverse Event|1|||
163349675|NCT01268098|589990837|FG001|Overall Study|Adverse Event|0|||
163349676|NCT04156399|589990845|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
163349677|NCT04156399|589990845|FG000|Overall Study|study suspension due to COVID pandemic|3|||
163349678|NCT01093599|589990848|FG000|Overall Study|Lost to Follow-up|32|||
163349679|NCT01093599|589990849|FG001|Overall Study|Lost to Follow-up|46|||
163349680|NCT01703845|589990850|FG000|Overall Study|Adverse Event|1|||
163349681|NCT01703845|589990851|FG001|Overall Study|Adverse Event|0|||
163349682|NCT01703845|589990850|FG000|Overall Study|Protocol Violation|1|||
163349683|NCT01703845|589990851|FG001|Overall Study|Protocol Violation|0|||
163349684|NCT01703845|589990850|FG000|Overall Study|other than stated above|1|||
163349685|NCT01703845|589990851|FG001|Overall Study|other than stated above|0|||
163349686|NCT01644188|589990852|FG000|Overall Study|Adverse Event|44|||
163349687|NCT01644188|589990853|FG001|Overall Study|Adverse Event|20|||
163349688|NCT01644188|589990852|FG000|Overall Study|Poor compliance to protocol|26|||
163349689|NCT01644188|589990853|FG001|Overall Study|Poor compliance to protocol|14|||
163349690|NCT01644188|589990852|FG000|Overall Study|Physician Decision|1|||
163349691|NCT01644188|589990853|FG001|Overall Study|Physician Decision|3|||
163349692|NCT01644188|589990852|FG000|Overall Study|Participant moved|7|||
163349693|NCT01644188|589990853|FG001|Overall Study|Participant moved|2|||
163349694|NCT01644188|589990852|FG000|Overall Study|Related to auto-injector administration|2|||
163349695|NCT01644188|589990853|FG001|Overall Study|Related to auto-injector administration|2|||
163349696|NCT01644188|589990852|FG000|Overall Study|Consent withdrawn by participant|14|||
163349697|NCT01644188|589990853|FG001|Overall Study|Consent withdrawn by participant|7|||
163240010|NCT02265705|589588113|FG005|Rescue Period|Lack of Efficacy|0|||
163240011|NCT02265705|589588114|FG006|Rescue Period|Lack of Efficacy|0|||
163240012|NCT02265705|589588108|FG000|Open Label Period|Adverse Event|0|||
163240013|NCT02265705|589588109|FG001|Open Label Period|Adverse Event|0|||
163240014|NCT02265705|589588110|FG002|Open Label Period|Adverse Event|0|||
163240015|NCT02265705|589588111|FG003|Open Label Period|Adverse Event|2|||
163240016|NCT02265705|589588112|FG004|Open Label Period|Adverse Event|2|||
163240017|NCT02265705|589588113|FG005|Open Label Period|Adverse Event|0|||
163349698|NCT01644188|589990852|FG000|Overall Study|Selection criteria finally not met|2|||
163349699|NCT01644188|589990853|FG001|Overall Study|Selection criteria finally not met|0|||
163349700|NCT01644188|589990852|FG000|Overall Study|Lost to Follow-up|1|||
163349701|NCT01644188|589990853|FG001|Overall Study|Lost to Follow-up|0|||
163349702|NCT01644188|589990852|FG000|Overall Study|Death|4|||
163349703|NCT01644188|589990853|FG001|Overall Study|Death|3|||
163349704|NCT01644188|589990852|FG000|Overall Study|Last visit outside protocol visit window|14|||
163349705|NCT01644188|589990853|FG001|Overall Study|Last visit outside protocol visit window|16|||
163240018|NCT02265705|589588114|FG006|Open Label Period|Adverse Event|0|||
163240019|NCT02265705|589588108|FG000|Open Label Period|Physician Decision|0|||
163240020|NCT02265705|589588109|FG001|Open Label Period|Physician Decision|0|||
163240021|NCT02265705|589588110|FG002|Open Label Period|Physician Decision|0|||
163240022|NCT02265705|589588111|FG003|Open Label Period|Physician Decision|0|||
163240023|NCT02265705|589588112|FG004|Open Label Period|Physician Decision|1|||
163240024|NCT02265705|589588113|FG005|Open Label Period|Physician Decision|0|||
163240025|NCT02265705|589588114|FG006|Open Label Period|Physician Decision|0|||
163240026|NCT02265705|589588108|FG000|Open Label Period|Withdrawal by Subject|0|||
163240027|NCT02265705|589588109|FG001|Open Label Period|Withdrawal by Subject|0|||
163240028|NCT02265705|589588110|FG002|Open Label Period|Withdrawal by Subject|0|||
163240029|NCT02265705|589588111|FG003|Open Label Period|Withdrawal by Subject|0|||
163240030|NCT02265705|589588112|FG004|Open Label Period|Withdrawal by Subject|2|||
163240031|NCT02265705|589588113|FG005|Open Label Period|Withdrawal by Subject|0|||
163240032|NCT02265705|589588114|FG006|Open Label Period|Withdrawal by Subject|0|||
163240033|NCT02265705|589588108|FG000|Follow-up Period|Sponsor Decision|0|||
163240034|NCT02265705|589588109|FG001|Follow-up Period|Sponsor Decision|0|||
163240035|NCT02265705|589588110|FG002|Follow-up Period|Sponsor Decision|0|||
163240036|NCT02265705|589588111|FG003|Follow-up Period|Sponsor Decision|0|||
163240037|NCT02265705|589588112|FG004|Follow-up Period|Sponsor Decision|0|||
163240038|NCT02265705|589588113|FG005|Follow-up Period|Sponsor Decision|1|||
163240039|NCT02265705|589588114|FG006|Follow-up Period|Sponsor Decision|6|||
163240040|NCT02265705|589588108|FG000|Follow-up Period|Adverse Event|0|||
163240041|NCT02265705|589588109|FG001|Follow-up Period|Adverse Event|0|||
163240042|NCT02265705|589588110|FG002|Follow-up Period|Adverse Event|0|||
163240043|NCT02265705|589588111|FG003|Follow-up Period|Adverse Event|0|||
163240044|NCT02265705|589588112|FG004|Follow-up Period|Adverse Event|0|||
163240045|NCT02265705|589588113|FG005|Follow-up Period|Adverse Event|0|||
163240046|NCT02265705|589588114|FG006|Follow-up Period|Adverse Event|3|||
163240047|NCT02265705|589588108|FG000|Follow-up Period|Physician Decision|0|||
163240048|NCT02265705|589588109|FG001|Follow-up Period|Physician Decision|0|||
163240049|NCT02265705|589588110|FG002|Follow-up Period|Physician Decision|0|||
163240050|NCT02265705|589588111|FG003|Follow-up Period|Physician Decision|0|||
163240051|NCT02265705|589588112|FG004|Follow-up Period|Physician Decision|0|||
163240052|NCT02265705|589588113|FG005|Follow-up Period|Physician Decision|0|||
163240053|NCT02265705|589588114|FG006|Follow-up Period|Physician Decision|1|||
163240054|NCT02265705|589588108|FG000|Follow-up Period|Withdrawal by Subject|0|||
163240055|NCT02265705|589588109|FG001|Follow-up Period|Withdrawal by Subject|0|||
163240056|NCT02265705|589588110|FG002|Follow-up Period|Withdrawal by Subject|0|||
163240057|NCT02265705|589588111|FG003|Follow-up Period|Withdrawal by Subject|0|||
163240058|NCT02265705|589588112|FG004|Follow-up Period|Withdrawal by Subject|0|||
163240059|NCT02265705|589588113|FG005|Follow-up Period|Withdrawal by Subject|0|||
163240060|NCT02265705|589588114|FG006|Follow-up Period|Withdrawal by Subject|1|||
163240061|NCT02828111|589588119|FG000|Overall Study|Withdrawal by Subject|0|||
163240062|NCT02828111|589588120|FG001|Overall Study|Withdrawal by Subject|0|||
163240063|NCT02828111|589588121|FG002|Overall Study|Withdrawal by Subject|2|||
163240064|NCT02828111|589588122|FG003|Overall Study|Withdrawal by Subject|0|||
163240065|NCT02828111|589588123|FG004|Overall Study|Withdrawal by Subject|0|||
163240066|NCT02828111|589588119|FG000|Overall Study|Lost to Follow-up|0|||
163240067|NCT02828111|589588120|FG001|Overall Study|Lost to Follow-up|0|||
163240068|NCT02828111|589588121|FG002|Overall Study|Lost to Follow-up|0|||
163240069|NCT02828111|589588122|FG003|Overall Study|Lost to Follow-up|1|||
163240070|NCT02828111|589588123|FG004|Overall Study|Lost to Follow-up|1|||
163240071|NCT00614939|589588124|FG000|Overall Study|Withdrawal by Subject|10|||
163240072|NCT00614939|589588125|FG001|Overall Study|Withdrawal by Subject|17|||
163240073|NCT00614939|589588124|FG000|Overall Study|Study specific discontinuation criteris|13|||
163240074|NCT00614939|589588125|FG001|Overall Study|Study specific discontinuation criteris|16|||
163240075|NCT00614939|589588124|FG000|Overall Study|Adverse Event|2|||
163240076|NCT00614939|589588125|FG001|Overall Study|Adverse Event|5|||
163240077|NCT00614939|589588124|FG000|Overall Study|Incorrect enrollment|1|||
163240078|NCT00614939|589588125|FG001|Overall Study|Incorrect enrollment|2|||
163240079|NCT00614939|589588124|FG000|Overall Study|Death|4|||
163240080|NCT00614939|589588125|FG001|Overall Study|Death|3|||
163240081|NCT00614939|589588124|FG000|Overall Study|Poor/non-compliance|4|||
163240082|NCT00614939|589588125|FG001|Overall Study|Poor/non-compliance|0|||
163240083|NCT00614939|589588124|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
163240084|NCT00614939|589588125|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
163240085|NCT02079805|589588129|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
163240086|NCT02079805|589588130|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
163240087|NCT02079805|589588129|FG000|Overall Study|Voluntary Withdrawal|0|||
163240088|NCT02079805|589588130|FG001|Overall Study|Voluntary Withdrawal|1|||
163240089|NCT01753193|589588131|FG000|Overall Study|Withdrawal by Subject|23|||
163240090|NCT01753193|589588131|FG000|Overall Study|Lost to Follow-up|6|||
163240091|NCT01753193|589588131|FG000|Overall Study|Death|1|||
163240092|NCT01753193|589588131|FG000|Overall Study|Other|16|||
163240093|NCT00383435|589588132|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
163240094|NCT00383435|589588133|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
163240095|NCT00383435|589588134|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
163145499|NCT00882440|589243051|FG002|Overall Study|Lost to Follow-up|1|||
163145500|NCT00882440|589243052|FG003|Overall Study|Lost to Follow-up|1|||
163145501|NCT00882440|589243053|FG004|Overall Study|Lost to Follow-up|1|||
163145502|NCT00882440|589243054|FG005|Overall Study|Lost to Follow-up|0|||
163145503|NCT00882440|589243055|FG006|Overall Study|Lost to Follow-up|1|||
163145504|NCT00882440|589243049|FG000|Overall Study|Protocol Violation|0|||
163145505|NCT00882440|589243050|FG001|Overall Study|Protocol Violation|0|||
163145506|NCT00882440|589243051|FG002|Overall Study|Protocol Violation|1|||
163145507|NCT00882440|589243052|FG003|Overall Study|Protocol Violation|1|||
163145508|NCT00882440|589243053|FG004|Overall Study|Protocol Violation|1|||
163145509|NCT00882440|589243054|FG005|Overall Study|Protocol Violation|0|||
163145510|NCT00882440|589243055|FG006|Overall Study|Protocol Violation|0|||
163145511|NCT00882440|589243049|FG000|Overall Study|Withdrawal by Subject|2|||
163145512|NCT00882440|589243050|FG001|Overall Study|Withdrawal by Subject|1|||
163145513|NCT00882440|589243051|FG002|Overall Study|Withdrawal by Subject|1|||
163145514|NCT00882440|589243052|FG003|Overall Study|Withdrawal by Subject|0|||
163145515|NCT00882440|589243053|FG004|Overall Study|Withdrawal by Subject|6|||
163145516|NCT00882440|589243054|FG005|Overall Study|Withdrawal by Subject|0|||
163145517|NCT00882440|589243055|FG006|Overall Study|Withdrawal by Subject|1|||
163145518|NCT00882440|589243049|FG000|Overall Study|Patient Uncooperative|2|||
163145519|NCT00882440|589243050|FG001|Overall Study|Patient Uncooperative|0|||
163145520|NCT00882440|589243051|FG002|Overall Study|Patient Uncooperative|0|||
163145521|NCT00882440|589243052|FG003|Overall Study|Patient Uncooperative|0|||
163145522|NCT00882440|589243053|FG004|Overall Study|Patient Uncooperative|1|||
163145523|NCT00882440|589243054|FG005|Overall Study|Patient Uncooperative|0|||
163145524|NCT00882440|589243055|FG006|Overall Study|Patient Uncooperative|0|||
163145525|NCT05482308|589243059|FG000|Overall Study|Withdrawal by Subject|1|||
163145526|NCT05482308|589243060|FG001|Overall Study|Withdrawal by Subject|0|||
163145527|NCT05482308|589243059|FG000|Overall Study|No longer meets eligibility criteria|0|||
163145528|NCT05482308|589243060|FG001|Overall Study|No longer meets eligibility criteria|1|||
163145529|NCT01693029|589243069|FG000|Overall Study|Withdrawal by Subject|15|||
163145530|NCT01693029|589243070|FG001|Overall Study|Withdrawal by Subject|22|||
163145531|NCT01693029|589243069|FG000|Overall Study|Kidney transplantation|7|||
163145532|NCT01693029|589243070|FG001|Overall Study|Kidney transplantation|7|||
163145533|NCT01693029|589243069|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
163145534|NCT01693029|589243070|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
163145535|NCT01693029|589243069|FG000|Overall Study|Protocol Violation|6|||
163145536|NCT01693029|589243070|FG001|Overall Study|Protocol Violation|7|||
163145537|NCT01693029|589243069|FG000|Overall Study|Change in dialysis modality|2|||
163145538|NCT01693029|589243070|FG001|Overall Study|Change in dialysis modality|1|||
163145539|NCT01693029|589243069|FG000|Overall Study|Physician Decision|0|||
163145540|NCT01693029|589243070|FG001|Overall Study|Physician Decision|2|||
163145541|NCT01693029|589243069|FG000|Overall Study|Lost to Follow-up|0|||
163145542|NCT01693029|589243070|FG001|Overall Study|Lost to Follow-up|1|||
163145543|NCT01693029|589243069|FG000|Overall Study|Adverse Event|1|||
163145544|NCT01693029|589243070|FG001|Overall Study|Adverse Event|6|||
163145545|NCT01693029|589243069|FG000|Overall Study|Death|5|||
163145546|NCT01693029|589243070|FG001|Overall Study|Death|8|||
163145547|NCT01693029|589243069|FG000|Overall Study|Non-compliance|2|||
163145548|NCT01693029|589243070|FG001|Overall Study|Non-compliance|1|||
163145549|NCT01535807|589243071|FG000|Overall Study|Withdrawal by Subject|1|||
163145550|NCT01535807|589243072|FG001|Overall Study|Withdrawal by Subject|1|||
163145551|NCT01535807|589243071|FG000|Overall Study|Data collection error|1|||
163145552|NCT01535807|589243072|FG001|Overall Study|Data collection error|1|||
163145553|NCT01329263|589243073|FG000|Overall Study|Lost to Follow-up|4|||
163145554|NCT01329263|589243074|FG001|Overall Study|Lost to Follow-up|21|||
163145555|NCT01329263|589243073|FG000|Overall Study|Withdrawal by Subject|1|||
163145556|NCT01329263|589243074|FG001|Overall Study|Withdrawal by Subject|2|||
163145557|NCT01631435|589243075|FG000|Overall Study|Adverse Event|2|||
163145558|NCT01631435|589243075|FG000|Overall Study|Withdrawal by Subject|2|||
163145559|NCT01631435|589243075|FG000|Overall Study|incomplete study procedure|5|||
163145560|NCT02123134|589243076|FG000|Overall Study|Withdrawal of consent|3|||
163145561|NCT02123134|589243077|FG001|Overall Study|Withdrawal of consent|2|||
163145562|NCT02123134|589243076|FG000|Overall Study|Administrative decision|0|||
163349706|NCT01644188|589990852|FG000|Overall Study|Site closure|1|||
163349707|NCT01644188|589990853|FG001|Overall Study|Site closure|1|||
163349708|NCT01644188|589990852|FG000|Overall Study|Other than specified above|6|||
163349709|NCT01644188|589990853|FG001|Overall Study|Other than specified above|7|||
163349710|NCT01845649|589990857|FG000|Overall Study|Adverse Event|7|||
163145563|NCT02123134|589243077|FG001|Overall Study|Administrative decision|1|||
163145564|NCT00657540|589243078|FG000|Overall Study|Lost to Follow-up|1|||
163145565|NCT00657540|589243079|FG001|Overall Study|Lost to Follow-up|4|||
163145566|NCT00141453|589243080|FG000|Overall Study|Protocol Violation|6|||
163145567|NCT00141453|589243081|FG001|Overall Study|Protocol Violation|5|||
163145568|NCT02656017|589243084|FG000|Overall Study|Study burden|3|||
163145569|NCT02656017|589243085|FG001|Overall Study|Study burden|3|||
163145570|NCT02656017|589243084|FG000|Overall Study|Adverse Event|2|||
163145571|NCT02656017|589243085|FG001|Overall Study|Adverse Event|1|||
163240096|NCT00383435|589588135|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
163240097|NCT00383435|589588136|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
163240098|NCT00383435|589588132|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
163240099|NCT00383435|589588133|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
163240100|NCT00383435|589588134|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
163240101|NCT00383435|589588135|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
163240102|NCT00383435|589588136|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
163349711|NCT01845649|589990858|FG001|Overall Study|Adverse Event|10|||
163349712|NCT01845649|589990857|FG000|Overall Study|Lack of Efficacy|1|||
163349713|NCT01845649|589990858|FG001|Overall Study|Lack of Efficacy|1|||
163349714|NCT01845649|589990857|FG000|Overall Study|Lost to Follow-up|2|||
163349715|NCT01845649|589990858|FG001|Overall Study|Lost to Follow-up|2|||
163349716|NCT01845649|589990857|FG000|Overall Study|Withdrew Consent|12|||
163349717|NCT01845649|589990858|FG001|Overall Study|Withdrew Consent|4|||
163349718|NCT01845649|589990857|FG000|Overall Study|Protocol Deviation|7|||
163349719|NCT01845649|589990858|FG001|Overall Study|Protocol Deviation|4|||
163349720|NCT01845649|589990857|FG000|Overall Study|Reason not Specified|2|||
163349721|NCT01845649|589990858|FG001|Overall Study|Reason not Specified|1|||
163349722|NCT03418493|589990861|FG000|Overall Study|Adverse Event|1|||
163349723|NCT03418493|589990862|FG001|Overall Study|Adverse Event|0|||
163240103|NCT00383435|589588132|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
163240104|NCT00383435|589588133|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
163240105|NCT00383435|589588134|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
163240106|NCT00383435|589588135|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
163240107|NCT00383435|589588136|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
163240108|NCT00383435|589588132|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
163240109|NCT00383435|589588133|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
163240110|NCT00383435|589588134|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
163240111|NCT00383435|589588135|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
163240112|NCT00383435|589588136|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
163240113|NCT00383435|589588132|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
163240114|NCT00383435|589588133|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
163240115|NCT00383435|589588134|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
163240116|NCT00383435|589588135|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
163240117|NCT00383435|589588136|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
163240118|NCT00383435|589588132|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
163240119|NCT00383435|589588133|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
163240120|NCT00383435|589588134|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
163240121|NCT00383435|589588135|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
163240122|NCT00383435|589588136|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
163240123|NCT00383435|589588132|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
163240124|NCT00383435|589588133|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
163240125|NCT00383435|589588134|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
163240126|NCT00383435|589588135|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
163240127|NCT00383435|589588136|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
163240128|NCT00383435|589588132|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
163240129|NCT00383435|589588133|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
163240130|NCT00383435|589588134|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
163240131|NCT00383435|589588135|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
163240132|NCT00383435|589588136|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
163240133|NCT00383435|589588132|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
163240134|NCT00383435|589588133|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
163240135|NCT00383435|589588134|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
163240136|NCT00383435|589588135|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
163240137|NCT00383435|589588136|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
163349724|NCT03418493|589990863|FG002|Overall Study|Adverse Event|0|||
163349725|NCT03418493|589990864|FG003|Overall Study|Adverse Event|0|||
163349726|NCT03418493|589990865|FG004|Overall Study|Adverse Event|0|||
163349727|NCT03418493|589990866|FG005|Overall Study|Adverse Event|0|||
163349728|NCT03418493|589990867|FG006|Overall Study|Adverse Event|0|||
163349729|NCT03418493|589990868|FG007|Overall Study|Adverse Event|0|||
163349730|NCT03418493|589990869|FG008|Overall Study|Adverse Event|0|||
163349731|NCT03418493|589990870|FG009|Overall Study|Adverse Event|0|||
163349732|NCT03418493|589990871|FG010|Overall Study|Adverse Event|0|||
163349733|NCT03418493|589990861|FG000|Overall Study|Protocol Violation|0|||
163349734|NCT03418493|589990862|FG001|Overall Study|Protocol Violation|0|||
163349735|NCT03418493|589990863|FG002|Overall Study|Protocol Violation|0|||
163349736|NCT03418493|589990864|FG003|Overall Study|Protocol Violation|0|||
163240138|NCT00383435|589588132|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
163240139|NCT00383435|589588133|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
163240140|NCT00383435|589588134|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
163240141|NCT00383435|589588135|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
163240142|NCT00383435|589588136|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
163240143|NCT00383435|589588132|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
163240144|NCT00383435|589588133|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
163240145|NCT00383435|589588134|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
163240146|NCT00383435|589588135|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
163240147|NCT00383435|589588136|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
163240148|NCT00383435|589588132|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
163240149|NCT00383435|589588133|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
163240150|NCT00383435|589588134|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
163240151|NCT00383435|589588135|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
163240152|NCT00383435|589588136|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
163240153|NCT00383435|589588132|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
163240154|NCT00383435|589588133|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
163240155|NCT00383435|589588134|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
163240156|NCT00383435|589588135|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
163240157|NCT00383435|589588136|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
163240158|NCT00383435|589588132|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
163240159|NCT00383435|589588133|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
163240160|NCT00383435|589588134|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
163240161|NCT00383435|589588135|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
163240162|NCT00383435|589588136|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
163240163|NCT00383435|589588132|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
163240164|NCT00383435|589588133|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
163240165|NCT00383435|589588134|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
163240166|NCT00383435|589588135|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
163240167|NCT00383435|589588136|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
163240168|NCT00383435|589588132|FG000|26-Week Treatment Safety Extension|Administrative|1|||
163240169|NCT00383435|589588133|FG001|26-Week Treatment Safety Extension|Administrative|1|||
163240170|NCT00383435|589588134|FG002|26-Week Treatment Safety Extension|Administrative|0|||
163240171|NCT00383435|589588135|FG003|26-Week Treatment Safety Extension|Administrative|1|||
163240172|NCT00383435|589588136|FG004|26-Week Treatment Safety Extension|Administrative|0|||
163240173|NCT00583557|589588137|FG000|Overall Study|Withdrawal by Subject|18|||
163240174|NCT00583557|589588137|FG000|Overall Study|Adverse Event|9|||
163240175|NCT00583557|589588137|FG000|Overall Study|Lack of Efficacy|31|||
163240176|NCT00583557|589588137|FG000|Overall Study|Lack of Compliance|5|||
163240177|NCT00583557|589588137|FG000|Overall Study|Other|5|||
163240178|NCT00583557|589588137|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
163240179|NCT02682264|589588138|FG000|Overall Study|Withdrawal by Subject|56|||
163240180|NCT02682264|589588139|FG001|Overall Study|Withdrawal by Subject|45|||
163240181|NCT02682264|589588138|FG000|Overall Study|Lost to Follow-up|49|||
163240182|NCT02682264|589588139|FG001|Overall Study|Lost to Follow-up|41|||
163240183|NCT02682264|589588138|FG000|Overall Study|Lack of Efficacy|14|||
163240184|NCT02682264|589588139|FG001|Overall Study|Lack of Efficacy|16|||
163240185|NCT02682264|589588138|FG000|Overall Study|Withdrawal by Parent|6|||
163240186|NCT02682264|589588139|FG001|Overall Study|Withdrawal by Parent|7|||
163240187|NCT02682264|589588138|FG000|Overall Study|Adverse Event|9|||
163240188|NCT02682264|589588139|FG001|Overall Study|Adverse Event|0|||
163240189|NCT02682264|589588138|FG000|Overall Study|Noncompliance with study drug|1|||
163240190|NCT02682264|589588139|FG001|Overall Study|Noncompliance with study drug|4|||
163240191|NCT02682264|589588138|FG000|Overall Study|Pregnancy|1|||
163240192|NCT02682264|589588139|FG001|Overall Study|Pregnancy|2|||
163240193|NCT02682264|589588138|FG000|Overall Study|Recovery|1|||
163240194|NCT02682264|589588139|FG001|Overall Study|Recovery|2|||
163349737|NCT03418493|589990865|FG004|Overall Study|Protocol Violation|0|||
163349738|NCT03418493|589990866|FG005|Overall Study|Protocol Violation|0|||
163349739|NCT03418493|589990867|FG006|Overall Study|Protocol Violation|0|||
163240195|NCT02682264|589588138|FG000|Overall Study|Progressive Disease|1|||
163240196|NCT02682264|589588139|FG001|Overall Study|Progressive Disease|0|||
163240197|NCT02682264|589588138|FG000|Overall Study|Technical Problems|0|||
163240198|NCT02682264|589588139|FG001|Overall Study|Technical Problems|1|||
163240199|NCT02682264|589588138|FG000|Overall Study|Moved abroad and unable to continue|0|||
163240200|NCT02682264|589588139|FG001|Overall Study|Moved abroad and unable to continue|3|||
163240201|NCT02682264|589588138|FG000|Overall Study|Stopped test article application|0|||
163240202|NCT02682264|589588139|FG001|Overall Study|Stopped test article application|1|||
163240203|NCT01131312|589588140|FG000|Overall Study|Lost to Follow-up|425|||
163349740|NCT03418493|589990868|FG007|Overall Study|Protocol Violation|0|||
163240204|NCT01131312|589588141|FG001|Overall Study|Lost to Follow-up|229|||
163240205|NCT01131312|589588142|FG002|Overall Study|Lost to Follow-up|351|||
163240206|NCT02347761|589588143|FG000|All Collected|Death|1|||
163240207|NCT02347761|589588144|FG001|All Collected|Death|0|||
163240208|NCT02347761|589588145|FG002|All Collected|Death|0|||
163240209|NCT02347761|589588143|FG000|All Collected|Lost to Follow-up|3|||
163240210|NCT02347761|589588144|FG001|All Collected|Lost to Follow-up|2|||
163240211|NCT02347761|589588145|FG002|All Collected|Lost to Follow-up|3|||
163240212|NCT02347761|589588143|FG000|All Collected|Withdrawal by Subject|11|||
163240213|NCT02347761|589588144|FG001|All Collected|Withdrawal by Subject|11|||
163240214|NCT02347761|589588145|FG002|All Collected|Withdrawal by Subject|22|||
163240215|NCT02347761|589588143|FG000|All Collected|invetigator disretion|2|||
163240216|NCT02347761|589588144|FG001|All Collected|invetigator disretion|0|||
163240217|NCT02347761|589588145|FG002|All Collected|invetigator disretion|0|||
163240218|NCT02347761|589588143|FG000|All Collected|instillation site pain|0|||
163240219|NCT02347761|589588144|FG001|All Collected|instillation site pain|0|||
163240220|NCT02347761|589588145|FG002|All Collected|instillation site pain|1|||
163240221|NCT02347761|589588143|FG000|All Collected|exacerbation of COPD|0|||
163240222|NCT02347761|589588144|FG001|All Collected|exacerbation of COPD|0|||
163240223|NCT02347761|589588145|FG002|All Collected|exacerbation of COPD|1|||
163240224|NCT02347761|589588143|FG000|All Collected|moved/travel|0|||
163240225|NCT02347761|589588144|FG001|All Collected|moved/travel|1|||
163240226|NCT02347761|589588145|FG002|All Collected|moved/travel|0|||
163240227|NCT02347761|589588143|FG000|On Study Treatment|Lack of Efficacy|2|||
163240228|NCT02347761|589588144|FG001|On Study Treatment|Lack of Efficacy|3|||
163240229|NCT02347761|589588145|FG002|On Study Treatment|Lack of Efficacy|4|||
163240230|NCT02347761|589588143|FG000|On Study Treatment|non-compliance with study medication|0|||
163240231|NCT02347761|589588144|FG001|On Study Treatment|non-compliance with study medication|0|||
163240232|NCT02347761|589588145|FG002|On Study Treatment|non-compliance with study medication|2|||
163240233|NCT02347761|589588143|FG000|On Study Treatment|Withdrawal by Subject|7|||
163240234|NCT02347761|589588144|FG001|On Study Treatment|Withdrawal by Subject|3|||
163240235|NCT02347761|589588145|FG002|On Study Treatment|Withdrawal by Subject|5|||
163240236|NCT02347761|589588143|FG000|On Study Treatment|move/travel|2|||
163240237|NCT02347761|589588144|FG001|On Study Treatment|move/travel|6|||
163240238|NCT02347761|589588145|FG002|On Study Treatment|move/travel|5|||
163240239|NCT02347761|589588143|FG000|On Study Treatment|dissastisfaction with device|2|||
163240240|NCT02347761|589588144|FG001|On Study Treatment|dissastisfaction with device|1|||
163240241|NCT02347761|589588145|FG002|On Study Treatment|dissastisfaction with device|4|||
163240242|NCT02347761|589588143|FG000|On Study Treatment|Lost to Follow-up|2|||
163240243|NCT02347761|589588144|FG001|On Study Treatment|Lost to Follow-up|1|||
163240244|NCT02347761|589588145|FG002|On Study Treatment|Lost to Follow-up|1|||
163240245|NCT02347761|589588143|FG000|On Study Treatment|investigator discretion|2|||
163240246|NCT02347761|589588144|FG001|On Study Treatment|investigator discretion|0|||
163240247|NCT02347761|589588145|FG002|On Study Treatment|investigator discretion|0|||
163240248|NCT02347761|589588143|FG000|On Study Treatment|durg not working|0|||
163240249|NCT02347761|589588144|FG001|On Study Treatment|durg not working|1|||
163240250|NCT02347761|589588145|FG002|On Study Treatment|durg not working|1|||
163240251|NCT02347761|589588143|FG000|On Study Treatment|Adverse Event|10|||
163240252|NCT02347761|589588144|FG001|On Study Treatment|Adverse Event|8|||
163240253|NCT02347761|589588145|FG002|On Study Treatment|Adverse Event|20|||
163240254|NCT01255358|589588146|FG000|Overall Study|Adverse Event|2|||
163240255|NCT01255358|589588146|FG000|Overall Study|Protocol Violation|2|||
163240256|NCT04079933|589588149|FG000|Overall Study|Withdrawal by Subject|3|||
163240257|NCT04079933|589588150|FG001|Overall Study|Withdrawal by Subject|4|||
163240258|NCT04079933|589588149|FG000|Overall Study|Lost to Follow-up|0|||
163240259|NCT04079933|589588150|FG001|Overall Study|Lost to Follow-up|1|||
163240260|NCT03207750|589588151|FG000|Overall Study|Adverse Event|3|||
163240261|NCT03207750|589588152|FG001|Overall Study|Adverse Event|2|||
163240262|NCT03207750|589588151|FG000|Overall Study|Lost to Follow-up|21|||
163240263|NCT03207750|589588152|FG001|Overall Study|Lost to Follow-up|29|||
163240264|NCT03207750|589588151|FG000|Overall Study|Protocol Violation|0|||
163240265|NCT03207750|589588152|FG001|Overall Study|Protocol Violation|1|||
163240266|NCT03207750|589588151|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
163240267|NCT03207750|589588152|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
163240268|NCT03207750|589588151|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
163240269|NCT03207750|589588152|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
163240270|NCT03207750|589588151|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
163240271|NCT03207750|589588152|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
163240272|NCT03207750|589588151|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
163240273|NCT03207750|589588152|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
163240274|NCT03207750|589588151|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
163240275|NCT03207750|589588152|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
163240276|NCT02493361|589588153|FG000|Overall Study|Withdrawal by Subject|3|||
163349741|NCT03418493|589990869|FG008|Overall Study|Protocol Violation|0|||
163349742|NCT03418493|589990870|FG009|Overall Study|Protocol Violation|1|||
163349743|NCT03418493|589990871|FG010|Overall Study|Protocol Violation|0|||
163240277|NCT02937545|589588157|FG000|Overall Study|Withdrawal by Subject|1|||
163240278|NCT02937545|589588158|FG001|Overall Study|Withdrawal by Subject|2|||
163240279|NCT02937545|589588159|FG002|Overall Study|Withdrawal by Subject|6|||
163240280|NCT02937545|589588160|FG003|Overall Study|Withdrawal by Subject|7|||
163240281|NCT02937545|589588157|FG000|Overall Study|Lost to Follow-up|1|||
163240282|NCT02937545|589588158|FG001|Overall Study|Lost to Follow-up|0|||
163240283|NCT02937545|589588159|FG002|Overall Study|Lost to Follow-up|0|||
163240284|NCT02937545|589588160|FG003|Overall Study|Lost to Follow-up|0|||
163240285|NCT02504294|589588163|FG000|Overall Study|Adverse Event|15|||
163240286|NCT02504294|589588164|FG001|Overall Study|Adverse Event|12|||
163240287|NCT02504294|589588163|FG000|Overall Study|Withdrawal by Subject|7|||
163240288|NCT02504294|589588164|FG001|Overall Study|Withdrawal by Subject|1|||
163240289|NCT02504294|589588163|FG000|Overall Study|Protocol Violation|27|||
163240290|NCT02504294|589588164|FG001|Overall Study|Protocol Violation|26|||
163240291|NCT02504294|589588163|FG000|Overall Study|Physician Decision|1|||
163240292|NCT02504294|589588164|FG001|Overall Study|Physician Decision|2|||
163240293|NCT02504294|589588163|FG000|Overall Study|Lost to Follow-up|6|||
163240294|NCT02504294|589588164|FG001|Overall Study|Lost to Follow-up|7|||
163240295|NCT02252211|589588167|FG000|Overall Study|Adverse Event|0|||
163240296|NCT02252211|589588168|FG001|Overall Study|Adverse Event|1|||
163240297|NCT02252211|589588169|FG002|Overall Study|Adverse Event|0|||
163240298|NCT02252211|589588167|FG000|Overall Study|Progressive disease|3|||
163240299|NCT02252211|589588168|FG001|Overall Study|Progressive disease|2|||
163240300|NCT02252211|589588169|FG002|Overall Study|Progressive disease|0|||
163240301|NCT02252211|589588167|FG000|Overall Study|Withdrawal by Subject|1|||
163240302|NCT02252211|589588168|FG001|Overall Study|Withdrawal by Subject|0|||
163240303|NCT02252211|589588169|FG002|Overall Study|Withdrawal by Subject|0|||
163145572|NCT02656017|589243084|FG000|Overall Study|Unable/unwilling to take study medication|2|||
163145573|NCT02656017|589243085|FG001|Overall Study|Unable/unwilling to take study medication|1|||
163145574|NCT02656017|589243084|FG000|Overall Study|Began Tolvaptan|1|||
163145575|NCT02656017|589243085|FG001|Overall Study|Began Tolvaptan|1|||
163145576|NCT02656017|589243084|FG000|Overall Study|Withdrawal by Subject|1|||
163145577|NCT02656017|589243085|FG001|Overall Study|Withdrawal by Subject|0|||
163145578|NCT02611479|589243090|FG000|Baseline Enrollment|Exited study|13|||
163145579|NCT02611479|589243090|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
163145580|NCT02611479|589243090|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
163145581|NCT02611479|589243090|FG000|Data Cleaning|No baseline function or pain metrics|2|||
163145582|NCT00743249|589243091|FG000|Overall Study|Adverse Event|0|||
163145583|NCT00743249|589243092|FG001|Overall Study|Adverse Event|4|||
163145584|NCT00743249|589243091|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
163145585|NCT00743249|589243092|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
163145586|NCT00743249|589243091|FG000|Overall Study|Unsuccessful insertion of stent|2|||
163145587|NCT00743249|589243092|FG001|Overall Study|Unsuccessful insertion of stent|1|||
163145588|NCT02314052|589243093|FG000|Cycle One|Adverse Event|0|||
163145589|NCT02314052|589243094|FG001|Cycle One|Adverse Event|0|||
163145590|NCT02314052|589243095|FG002|Cycle One|Adverse Event|0|||
163145591|NCT02314052|589243096|FG003|Cycle One|Adverse Event|1|||
163145592|NCT02314052|589243097|FG004|Cycle One|Adverse Event|0|||
163145593|NCT02314052|589243098|FG005|Cycle One|Adverse Event|0|||
163145594|NCT00474955|589243099|FG000|Overall Study|Adverse Event|2|||
163145595|NCT00474955|589243099|FG000|Overall Study|Drug unavailability|1|||
163145596|NCT00474955|589243099|FG000|Overall Study|Personal reasons|5|||
163145597|NCT02422498|589243100|FG000|Overall Study|Inevaluable|4|||
163145598|NCT02653326|589243101|FG000|Overall Study|Lost to Follow-up|10|||
163145599|NCT02653326|589243102|FG001|Overall Study|Lost to Follow-up|7|||
163145600|NCT01620060|589243103|FG000|Overall Study|Adverse Event|9|||
163145601|NCT01620060|589243103|FG000|Overall Study|Protocol Violation|1|||
163145602|NCT01620060|589243103|FG000|Overall Study|Withdrawal by Subject|1|||
163145603|NCT01620060|589243103|FG000|Overall Study|Did not comply with Study Produre|1|||
163145604|NCT01620060|589243103|FG000|Overall Study|Family emergency|1|||
163145605|NCT01620060|589243103|FG000|Overall Study|Per Sponsor Decision|2|||
163145606|NCT01960140|589243104|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
163240304|NCT02252211|589588167|FG000|Overall Study|Serious Adverse Event During Screening|1|||
163240305|NCT02252211|589588168|FG001|Overall Study|Serious Adverse Event During Screening|0|||
163240306|NCT02252211|589588169|FG002|Overall Study|Serious Adverse Event During Screening|1|||
163240307|NCT05799495|589588174|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
163240308|NCT05799495|589588175|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
163240309|NCT05799495|589588176|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
163240310|NCT05799495|589588177|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
163240311|NCT05799495|589588174|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
163240312|NCT05799495|589588175|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
163240313|NCT05799495|589588176|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
163349744|NCT00719212|589990872|FG000|Overall Study|Death|41|||
163145607|NCT03452540|589243105|FG000|Overall Study|Adverse Event|1|||
163145608|NCT03452540|589243105|FG000|Overall Study|Withdrawal by Subject|1|||
163145609|NCT03452540|589243105|FG000|Overall Study|Other SAE and AE|2|||
163145610|NCT04551989|589243117|FG000|Overall Study|Adverse Event|4|||
163240314|NCT05799495|589588177|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
163240315|NCT05799495|589588174|FG000|Treatment (Up to 5 Days)|Other|0|||
163240316|NCT05799495|589588175|FG001|Treatment (Up to 5 Days)|Other|1|||
163240317|NCT05799495|589588176|FG002|Treatment (Up to 5 Days)|Other|0|||
163240318|NCT05799495|589588177|FG003|Treatment (Up to 5 Days)|Other|0|||
163240319|NCT05799495|589588174|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
163240320|NCT05799495|589588175|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
163240321|NCT05799495|589588176|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
163240322|NCT05799495|589588177|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
163240323|NCT05799495|589588174|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
163240324|NCT05799495|589588175|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
163240325|NCT05799495|589588176|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
163240326|NCT05799495|589588177|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
163240327|NCT05799495|589588174|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
163240328|NCT05799495|589588175|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
163240329|NCT05799495|589588176|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
163240330|NCT05799495|589588177|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
163240331|NCT03694548|589588181|FG000|Part A Survey|Protocol Violation|3|||
163240332|NCT03694548|589588182|FG001|Part A Survey|Protocol Violation|3|||
163240333|NCT03694548|589588183|FG002|Part A Survey|Protocol Violation|0|||
163240334|NCT03694548|589588181|FG000|Part B Yoga Program|Protocol Violation|0|||
163240335|NCT03694548|589588182|FG001|Part B Yoga Program|Protocol Violation|0|||
163240336|NCT03694548|589588183|FG002|Part B Yoga Program|Protocol Violation|3|||
163240337|NCT03694548|589588181|FG000|Part B Yoga Program|Did not attend intervention|0|||
163240338|NCT03694548|589588182|FG001|Part B Yoga Program|Did not attend intervention|0|||
163240339|NCT03694548|589588183|FG002|Part B Yoga Program|Did not attend intervention|8|||
163240340|NCT04177108|589588184|FG000|Overall Study|Withdrawal by Subject|4|||
163240341|NCT04177108|589588185|FG001|Overall Study|Withdrawal by Subject|8|||
163240342|NCT04177108|589588186|FG002|Overall Study|Withdrawal by Subject|9|||
163240343|NCT04177108|589588187|FG003|Overall Study|Withdrawal by Subject|11|||
163240344|NCT04177108|589588188|FG004|Overall Study|Withdrawal by Subject|13|||
163240345|NCT04177108|589588184|FG000|Overall Study|Physician Decision|23|||
163240346|NCT04177108|589588185|FG001|Overall Study|Physician Decision|15|||
163240347|NCT04177108|589588186|FG002|Overall Study|Physician Decision|18|||
163240348|NCT04177108|589588187|FG003|Overall Study|Physician Decision|29|||
163240349|NCT04177108|589588188|FG004|Overall Study|Physician Decision|23|||
163240350|NCT04177108|589588184|FG000|Overall Study|Reason Not Specified|0|||
163240351|NCT04177108|589588185|FG001|Overall Study|Reason Not Specified|1|||
163240352|NCT04177108|589588186|FG002|Overall Study|Reason Not Specified|0|||
163240353|NCT04177108|589588187|FG003|Overall Study|Reason Not Specified|0|||
163240354|NCT04177108|589588188|FG004|Overall Study|Reason Not Specified|2|||
163240355|NCT04177108|589588184|FG000|Overall Study|Lost to Follow-up|0|||
163240356|NCT04177108|589588185|FG001|Overall Study|Lost to Follow-up|0|||
163240357|NCT04177108|589588186|FG002|Overall Study|Lost to Follow-up|1|||
163240358|NCT04177108|589588187|FG003|Overall Study|Lost to Follow-up|1|||
163240359|NCT04177108|589588188|FG004|Overall Study|Lost to Follow-up|1|||
163240360|NCT04177108|589588184|FG000|Overall Study|Death|16|||
163240361|NCT04177108|589588185|FG001|Overall Study|Death|19|||
163240362|NCT04177108|589588186|FG002|Overall Study|Death|13|||
163240363|NCT04177108|589588187|FG003|Overall Study|Death|17|||
163240364|NCT04177108|589588188|FG004|Overall Study|Death|18|||
163240365|NCT00101101|589588189|FG000|Overall Study|never received vaccine|20|||
163240366|NCT01603875|589588190|FG000|Overall Study|Preexisting rabies antibody|3|||
163240367|NCT01603875|589588191|FG001|Overall Study|Preexisting rabies antibody|4|||
163240368|NCT01603875|589588192|FG002|Overall Study|Preexisting rabies antibody|3|||
163240369|NCT01603875|589588190|FG000|Overall Study|Lost to Follow-up|4|||
163349745|NCT00719212|589990872|FG000|Overall Study|Lost to Follow-up|2|||
163240370|NCT01603875|589588191|FG001|Overall Study|Lost to Follow-up|3|||
163240371|NCT01603875|589588192|FG002|Overall Study|Lost to Follow-up|6|||
163240372|NCT01603875|589588190|FG000|Overall Study|Protocol Violation|0|||
163240373|NCT01603875|589588191|FG001|Overall Study|Protocol Violation|1|||
163240374|NCT01603875|589588192|FG002|Overall Study|Protocol Violation|0|||
163240375|NCT01652716|589588196|FG000|Overall Study|Loss of glucose control|1|||
163240376|NCT01652716|589588197|FG001|Overall Study|Loss of glucose control|0|||
163240377|NCT01652716|589588196|FG000|Overall Study|Administrative|0|||
163240378|NCT01652716|589588197|FG001|Overall Study|Administrative|2|||
163240379|NCT01652716|589588196|FG000|Overall Study|Investigator decision|1|||
163240380|NCT01652716|589588197|FG001|Overall Study|Investigator decision|4|||
163240381|NCT01652716|589588196|FG000|Overall Study|Lost to Follow-up|12|||
163240382|NCT01652716|589588197|FG001|Overall Study|Lost to Follow-up|11|||
163240383|NCT01652716|589588196|FG000|Overall Study|Protocol Violation|2|||
163240384|NCT01652716|589588197|FG001|Overall Study|Protocol Violation|1|||
163240385|NCT01652716|589588196|FG000|Overall Study|Adverse Event|7|||
163240386|NCT01652716|589588197|FG001|Overall Study|Adverse Event|10|||
163240387|NCT01652716|589588196|FG000|Overall Study|Withdrawal by Subject|33|||
163240388|NCT01652716|589588197|FG001|Overall Study|Withdrawal by Subject|18|||
163240389|NCT04122443|589588200|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
163145611|NCT04551989|589243117|FG000|Overall Study|Protocol Violation|3|||
163145612|NCT04551989|589243117|FG000|Overall Study|Lost to Follow-up|1|||
163145613|NCT04551989|589243117|FG000|Overall Study|Physician Decision|3|||
163145614|NCT04201431|589243118|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
163145615|NCT04201431|589243119|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
163145616|NCT04201431|589243120|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
163145617|NCT00088530|589243125|FG000|Overall Study|Progressive/Relapsed Disease|28|||
163145618|NCT00088530|589243126|FG001|Overall Study|Progressive/Relapsed Disease|39|||
163145619|NCT00088530|589243125|FG000|Overall Study|Adverse Event|15|||
163145620|NCT00088530|589243126|FG001|Overall Study|Adverse Event|9|||
163145621|NCT00088530|589243125|FG000|Overall Study|Withdrawal by Subject|2|||
163145622|NCT00088530|589243126|FG001|Overall Study|Withdrawal by Subject|5|||
163145623|NCT00088530|589243125|FG000|Overall Study|Lost to Follow-up|2|||
163145624|NCT00088530|589243126|FG001|Overall Study|Lost to Follow-up|0|||
163145625|NCT00088530|589243125|FG000|Overall Study|Physician Decision|2|||
163145626|NCT00088530|589243126|FG001|Overall Study|Physician Decision|0|||
163145627|NCT00088530|589243125|FG000|Overall Study|Sponsor decision|0|||
163145628|NCT00088530|589243126|FG001|Overall Study|Sponsor decision|1|||
163145629|NCT00088530|589243125|FG000|Overall Study|Patient never treated|1|||
163145630|NCT00088530|589243126|FG001|Overall Study|Patient never treated|0|||
163145631|NCT00300755|589243127|FG000|Overall Study|Adverse Event|1|||
163145632|NCT00300755|589243128|FG001|Overall Study|Adverse Event|2|||
163145633|NCT00300755|589243129|FG002|Overall Study|Adverse Event|1|||
163145634|NCT00300755|589243127|FG000|Overall Study|Withdrawal by Subject|0|||
163145635|NCT00300755|589243128|FG001|Overall Study|Withdrawal by Subject|2|||
163145636|NCT00300755|589243129|FG002|Overall Study|Withdrawal by Subject|0|||
163145637|NCT00300755|589243127|FG000|Overall Study|Protocol Violation|0|||
163145638|NCT00300755|589243128|FG001|Overall Study|Protocol Violation|0|||
163145639|NCT00300755|589243129|FG002|Overall Study|Protocol Violation|1|||
163145640|NCT04571944|589243130|FG000|Overall Study|Death|1|||
163145641|NCT04571944|589243131|FG001|Overall Study|Death|0|||
163145642|NCT04571944|589243130|FG000|Overall Study|Withdrawal by Subject|3|||
163145643|NCT04571944|589243131|FG001|Overall Study|Withdrawal by Subject|0|||
163145644|NCT04571944|589243130|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
163145645|NCT04571944|589243131|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
163145646|NCT02694744|589243135|FG000|Overall Study|Adverse Event|2|||
163145647|NCT02694744|589243136|FG001|Overall Study|Adverse Event|1|||
163145648|NCT02694744|589243135|FG000|Overall Study|Withdrawal by Subject|2|||
163145649|NCT02694744|589243136|FG001|Overall Study|Withdrawal by Subject|1|||
163145650|NCT02694744|589243135|FG000|Overall Study|Physician Decision|1|||
163145651|NCT02694744|589243136|FG001|Overall Study|Physician Decision|2|||
163145652|NCT02694744|589243135|FG000|Overall Study|Lost to Follow-up|1|||
163145653|NCT02694744|589243136|FG001|Overall Study|Lost to Follow-up|0|||
163145654|NCT02694744|589243135|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
163145655|NCT02694744|589243136|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
163145656|NCT00686777|589243139|FG000|Overall Study|Adverse Event|2|||
163145657|NCT00686777|589243139|FG000|Overall Study|Pregnancy|1|||
163145658|NCT00686777|589243139|FG000|Overall Study|Withdrawal by Subject|2|||
163145659|NCT00686777|589243139|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
163145660|NCT00686777|589243139|FG000|Overall Study|No Visit|1|||
163145661|NCT00667888|589243140|FG000|Overall Study|Death|1|||
163145662|NCT00667888|589243141|FG001|Overall Study|Death|1|||
163145663|NCT00667888|589243140|FG000|Overall Study|Withdrawal by Subject|6|||
163145664|NCT00667888|589243141|FG001|Overall Study|Withdrawal by Subject|3|||
163145665|NCT00667888|589243140|FG000|Overall Study|Proceed with other treatment|3|||
163145666|NCT00667888|589243141|FG001|Overall Study|Proceed with other treatment|3|||
163145667|NCT00667888|589243140|FG000|Overall Study|Ineligible after SIM|0|||
163145668|NCT00667888|589243141|FG001|Overall Study|Ineligible after SIM|2|||
163145669|NCT00883779|589243142|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
163145670|NCT00883779|589243143|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
163145671|NCT00883779|589243142|FG000|Primary Study Treatment Phase|Disease progression|75|||
163145672|NCT00883779|589243143|FG001|Primary Study Treatment Phase|Disease progression|59|||
163145673|NCT00883779|589243142|FG000|Primary Study Treatment Phase|Adverse Event|16|||
163145674|NCT00883779|589243143|FG001|Primary Study Treatment Phase|Adverse Event|16|||
163145675|NCT00883779|589243142|FG000|Primary Study Treatment Phase|Death|2|||
163145676|NCT00883779|589243143|FG001|Primary Study Treatment Phase|Death|3|||
163145677|NCT00883779|589243142|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
163145678|NCT00883779|589243143|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
163145679|NCT00883779|589243142|FG000|Primary Study Treatment Phase|Other|3|||
163145680|NCT00883779|589243143|FG001|Primary Study Treatment Phase|Other|0|||
163145681|NCT00883779|589243142|FG000|Post-Study Treatment Phase|Adverse Event|2|||
163145682|NCT00883779|589243143|FG001|Post-Study Treatment Phase|Adverse Event|3|||
163145683|NCT00883779|589243142|FG000|Post-Study Treatment Phase|Death|1|||
163145684|NCT00883779|589243143|FG001|Post-Study Treatment Phase|Death|3|||
163240390|NCT04122443|589588201|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
163240391|NCT04122443|589588202|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
163240392|NCT04122443|589588200|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
163240393|NCT04122443|589588201|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
163240394|NCT04122443|589588202|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
163240395|NCT05204134|589588203|FG000|Overall Study|Withdrawal by Subject|3|||
163240396|NCT05204134|589588203|FG000|Overall Study|Physician Decision|1|||
163240397|NCT01312467|589588207|FG000|Overall Study|Adverse Event|4|||
163240398|NCT01312467|589588207|FG000|Overall Study|Lost to Follow-up|1|||
163240399|NCT01312467|589588207|FG000|Overall Study|Withdrawal by Subject|2|||
163240400|NCT01312467|589588207|FG000|Overall Study|Deported to country of origin|1|||
163240401|NCT01312467|589588207|FG000|Overall Study|Another medical condition|1|||
163240402|NCT01312467|589588207|FG000|Overall Study|Ineligible|4|||
163240403|NCT01059617|589588208|FG000|Overall Study|Other|7|||
163240404|NCT01059617|589588209|FG001|Overall Study|Other|1|||
163240405|NCT01059617|589588210|FG002|Overall Study|Other|8|||
163240406|NCT01059617|589588211|FG003|Overall Study|Other|6|||
163240407|NCT01968434|589588214|FG000|Overall Study|Lost to Follow-up|3|||
163240408|NCT01968434|589588215|FG001|Overall Study|Lost to Follow-up|6|||
163240409|NCT02199691|589588216|FG000|Overall Study|Protocol Violation|3|||
163240410|NCT02199691|589588217|FG001|Overall Study|Protocol Violation|3|||
163240411|NCT02199691|589588218|FG002|Overall Study|Protocol Violation|6|||
163240412|NCT02199691|589588219|FG003|Overall Study|Protocol Violation|7|||
163240413|NCT02199691|589588216|FG000|Overall Study|Withdrawal by Subject|5|||
163240414|NCT02199691|589588217|FG001|Overall Study|Withdrawal by Subject|3|||
163240415|NCT02199691|589588218|FG002|Overall Study|Withdrawal by Subject|12|||
163240416|NCT02199691|589588219|FG003|Overall Study|Withdrawal by Subject|13|||
163240417|NCT02199691|589588216|FG000|Overall Study|Lost to Follow-up|2|||
163240418|NCT02199691|589588217|FG001|Overall Study|Lost to Follow-up|1|||
163240419|NCT02199691|589588218|FG002|Overall Study|Lost to Follow-up|9|||
163240420|NCT02199691|589588219|FG003|Overall Study|Lost to Follow-up|10|||
163240421|NCT00612313|589588222|FG000|Overall Study|Withdrawal by Subject|6|||
163240422|NCT00612313|589588223|FG001|Overall Study|Withdrawal by Subject|9|||
163240423|NCT00612313|589588222|FG000|Overall Study|Lost to Follow-up|11|||
163240424|NCT00612313|589588223|FG001|Overall Study|Lost to Follow-up|4|||
163240425|NCT00136955|589590168|FG000|Overall Study|Adverse Event|8|||
163240426|NCT00136955|589590168|FG000|Overall Study|Lost to Follow-up|1|||
163240427|NCT00136955|589590168|FG000|Overall Study|Withdrawal by Subject|2|||
163240428|NCT00136955|589590168|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
163240429|NCT04827576|589590169|FG000|Overall Study|Death|5|||
163240430|NCT04827576|589590170|FG001|Overall Study|Death|17|||
163240431|NCT04827576|589590171|FG002|Overall Study|Death|17|||
163240432|NCT04827576|589590172|FG003|Overall Study|Death|32|||
163240433|NCT04827576|589590169|FG000|Overall Study|Study Terminated by Sponsor|2|||
163349746|NCT00719212|589990872|FG000|Overall Study|Withdrawal by Subject|1|||
163349747|NCT00526097|589990877|FG000|Overall Study|Adverse Event|6|||
163349748|NCT00526097|589990878|FG001|Overall Study|Adverse Event|44|||
163349749|NCT00526097|589990877|FG000|Overall Study|Protocol Violation|4|||
163349750|NCT00526097|589990878|FG001|Overall Study|Protocol Violation|10|||
163349751|NCT00526097|589990877|FG000|Overall Study|Withdrawal by Subject|3|||
163349752|NCT00526097|589990878|FG001|Overall Study|Withdrawal by Subject|1|||
163349753|NCT00526097|589990877|FG000|Overall Study|Other|2|||
163349754|NCT00526097|589990878|FG001|Overall Study|Other|1|||
163349755|NCT00966979|589990879|FG000|Overall Study|Death|1|||
163349756|NCT00966979|589990879|FG000|Overall Study|Lost to Follow-up|6|||
163349757|NCT00966979|589990879|FG000|Overall Study|Withdrawal by Subject|14|||
163349758|NCT00966979|589990879|FG000|Overall Study|Adverse Event|5|||
163349759|NCT00966979|589990879|FG000|Overall Study|Sponsor terminated early|49|||
163349760|NCT00966979|589990879|FG000|Overall Study|Censored because surgery not done|2|||
163349761|NCT00966979|589990879|FG000|Overall Study|Censored because study device was not implanted|14|||
163349762|NCT00966979|589990879|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
163349763|NCT04140266|589990880|FG000|Overall Study|Physician Decision|2|||
163349764|NCT04140266|589990881|FG001|Overall Study|Physician Decision|0|||
163349765|NCT04140266|589990880|FG000|Overall Study|Withdrawal by Subject|4|||
163349766|NCT04140266|589990881|FG001|Overall Study|Withdrawal by Subject|2|||
163240434|NCT04827576|589590170|FG001|Overall Study|Study Terminated by Sponsor|9|||
163240435|NCT04827576|589590171|FG002|Overall Study|Study Terminated by Sponsor|7|||
163240436|NCT04827576|589590172|FG003|Overall Study|Study Terminated by Sponsor|5|||
163349767|NCT00943618|589990882|FG000|Overall Study|Lost to Follow-up|38|||
163240437|NCT04827576|589590169|FG000|Overall Study|Investigator's Discretion|1|||
163240438|NCT04827576|589590170|FG001|Overall Study|Investigator's Discretion|0|||
163240439|NCT04827576|589590171|FG002|Overall Study|Investigator's Discretion|2|||
163240440|NCT04827576|589590172|FG003|Overall Study|Investigator's Discretion|5|||
163240441|NCT04827576|589590169|FG000|Overall Study|Withdrew Consent|0|||
163240442|NCT04827576|589590170|FG001|Overall Study|Withdrew Consent|3|||
163349768|NCT00943618|589990883|FG001|Overall Study|Lost to Follow-up|48|||
163349769|NCT00943618|589990884|FG002|Overall Study|Lost to Follow-up|20|||
163240443|NCT04827576|589590171|FG002|Overall Study|Withdrew Consent|0|||
163240444|NCT04827576|589590172|FG003|Overall Study|Withdrew Consent|0|||
163240445|NCT04827576|589590169|FG000|Overall Study|Lost to Follow-up|1|||
163240446|NCT04827576|589590170|FG001|Overall Study|Lost to Follow-up|0|||
163240447|NCT04827576|589590171|FG002|Overall Study|Lost to Follow-up|0|||
163240448|NCT04827576|589590172|FG003|Overall Study|Lost to Follow-up|0|||
163240449|NCT01773226|589590173|FG000|Overall Study|Withdrawal by Subject|1|||
163240450|NCT00724282|589590176|FG000|Overall Study|Withdrawal by Subject|3|||
163240451|NCT00724282|589590176|FG000|Overall Study|Physician Decision|1|||
163240452|NCT00970502|589590177|FG000|Overall Study|Withdrawal by Subject|1|||
163240453|NCT01438411|589590178|FG000|Overall Study|Adverse Event|8|||
163240454|NCT01438411|589590178|FG000|Overall Study|Lost to Follow-up|1|||
163240455|NCT01438411|589590178|FG000|Overall Study|Lack of Efficacy|1|||
163240456|NCT01438411|589590178|FG000|Overall Study|Withdrawal by Subject|3|||
163240457|NCT01863680|589590179|FG000|Overall Study|Adverse Event|17|||
163240458|NCT01863680|589590179|FG000|Overall Study|Risk of OHSS|17|||
163240459|NCT01863680|589590179|FG000|Overall Study|Spontaneous pregnancy|2|||
163240460|NCT01863680|589590179|FG000|Overall Study|Withdrawal by Subject|1|||
163240461|NCT01863680|589590179|FG000|Overall Study|Did not undergo IVF/ET|14|||
163240462|NCT01863680|589590179|FG000|Overall Study|Other|6|||
163240463|NCT00618514|589590180|FG000|Overall Study|Lost to Follow-up|11|||
163240464|NCT00618514|589590181|FG001|Overall Study|Lost to Follow-up|12|||
163240465|NCT00618514|589590182|FG002|Overall Study|Lost to Follow-up|4|||
163240466|NCT00566228|589590189|FG000|Overall Study|Withdrawal by Subject|1|||
163240467|NCT00566228|589590190|FG001|Overall Study|Withdrawal by Subject|0|||
163240468|NCT00566228|589590189|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
163240469|NCT00566228|589590190|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
163240470|NCT00566228|589590189|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
163240471|NCT00566228|589590190|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
163240472|NCT00566228|589590189|FG000|Overall Study|progressed before infusion could occur|0|||
163240473|NCT00566228|589590190|FG001|Overall Study|progressed before infusion could occur|1|||
163240474|NCT03320070|589590193|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
163240475|NCT03320070|589590194|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
163240476|NCT03320070|589590193|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
163240477|NCT03320070|589590194|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
163240478|NCT03320070|589590193|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
163240479|NCT03320070|589590194|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
163240480|NCT03320070|589590193|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
163240481|NCT03320070|589590194|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
163240482|NCT03320070|589590193|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
163240483|NCT03320070|589590194|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
163240484|NCT03320070|589590193|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
163240485|NCT03320070|589590194|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
163240486|NCT03586648|589590195|FG000|Period 1|Withdrawal by Subject|0|||
163240487|NCT03586648|589590196|FG001|Period 1|Withdrawal by Subject|1|||
163240488|NCT03586648|589590195|FG000|Period 1|Lost to Follow-up|1|||
163240489|NCT03586648|589590196|FG001|Period 1|Lost to Follow-up|1|||
163240490|NCT03586648|589590195|FG000|Period 1|Adverse Event|1|||
163240491|NCT03586648|589590196|FG001|Period 1|Adverse Event|0|||
163240492|NCT03586648|589590195|FG000|Period 1|Study related symptoms or complaints|2|||
163240493|NCT03586648|589590196|FG001|Period 1|Study related symptoms or complaints|1|||
163240494|NCT03586648|589590195|FG000|Period 1|Physician Decision|0|||
163240495|NCT03586648|589590196|FG001|Period 1|Physician Decision|1|||
163240496|NCT03586648|589590195|FG000|Period 2|Adverse Event|1|||
163240497|NCT03586648|589590196|FG001|Period 2|Adverse Event|0|||
163240498|NCT02041195|589590197|FG000|Overall Study|Adverse Event|1|||
163240499|NCT02041195|589590198|FG001|Overall Study|Adverse Event|2|||
163240500|NCT02041195|589590199|FG002|Overall Study|Adverse Event|0|||
163240501|NCT02041195|589590200|FG003|Overall Study|Adverse Event|0|||
163240502|NCT02041195|589590201|FG004|Overall Study|Adverse Event|0|||
163240503|NCT02041195|589590202|FG005|Overall Study|Adverse Event|0|||
163240504|NCT02041195|589590203|FG006|Overall Study|Adverse Event|3|||
163240505|NCT02041195|589590204|FG007|Overall Study|Adverse Event|0|||
163240506|NCT02041195|589590197|FG000|Overall Study|Withdrawal by Subject|1|||
163240507|NCT02041195|589590198|FG001|Overall Study|Withdrawal by Subject|0|||
163240508|NCT02041195|589590199|FG002|Overall Study|Withdrawal by Subject|0|||
163240509|NCT02041195|589590200|FG003|Overall Study|Withdrawal by Subject|0|||
163240510|NCT02041195|589590201|FG004|Overall Study|Withdrawal by Subject|0|||
163240511|NCT02041195|589590202|FG005|Overall Study|Withdrawal by Subject|0|||
163240512|NCT02041195|589590203|FG006|Overall Study|Withdrawal by Subject|4|||
163240513|NCT02041195|589590204|FG007|Overall Study|Withdrawal by Subject|3|||
163240514|NCT02041195|589590197|FG000|Overall Study|Unable to comply with study visits|0|||
163240515|NCT02041195|589590198|FG001|Overall Study|Unable to comply with study visits|1|||
163240516|NCT02041195|589590199|FG002|Overall Study|Unable to comply with study visits|0|||
163240517|NCT02041195|589590200|FG003|Overall Study|Unable to comply with study visits|0|||
163349770|NCT00943618|589990882|FG000|Overall Study|Discontinued Medication|17|||
163349771|NCT00943618|589990883|FG001|Overall Study|Discontinued Medication|29|||
163349772|NCT00943618|589990884|FG002|Overall Study|Discontinued Medication|11|||
163349773|NCT03713281|589990889|FG000|Overall Study|Lens handling difficuluties|2|||
163349774|NCT03713281|589990889|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
163349775|NCT02412111|589990890|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
163349776|NCT02412111|589990891|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
163349777|NCT02412111|589990892|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
163349778|NCT02412111|589990890|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
163349779|NCT02412111|589990891|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
163349780|NCT02412111|589990892|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
163349781|NCT02412111|589990890|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
163349782|NCT02412111|589990891|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
163349783|NCT02412111|589990892|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
163349784|NCT02412111|589990890|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
163349785|NCT02412111|589990891|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
163349786|NCT02412111|589990892|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
163349787|NCT02412111|589990890|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
163349788|NCT02412111|589990891|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
163349789|NCT02412111|589990892|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
163240518|NCT02041195|589590201|FG004|Overall Study|Unable to comply with study visits|1|||
163240519|NCT02041195|589590202|FG005|Overall Study|Unable to comply with study visits|0|||
163240520|NCT02041195|589590203|FG006|Overall Study|Unable to comply with study visits|0|||
163240521|NCT02041195|589590204|FG007|Overall Study|Unable to comply with study visits|0|||
163240522|NCT02367911|589590207|FG000|Overall Study|Withdrawal by Subject|3|||
163240523|NCT02367911|589590208|FG001|Overall Study|Withdrawal by Subject|2|||
163240524|NCT02367911|589590207|FG000|Overall Study|Lost to Follow-up|2|||
163240525|NCT02367911|589590208|FG001|Overall Study|Lost to Follow-up|2|||
163240526|NCT00263666|589590209|FG000|Overall Study|Adverse Event|6|||
163240527|NCT00263666|589590210|FG001|Overall Study|Adverse Event|8|||
163240528|NCT00263666|589590209|FG000|Overall Study|Lost to Follow-up|1|||
163240529|NCT00263666|589590210|FG001|Overall Study|Lost to Follow-up|2|||
163240530|NCT00263666|589590209|FG000|Overall Study|Withdrawal by Subject|0|||
163240531|NCT00263666|589590210|FG001|Overall Study|Withdrawal by Subject|1|||
163240532|NCT00902304|589590211|FG000|Overall Study|Adverse Event|4|||
163240533|NCT00902304|589590212|FG001|Overall Study|Adverse Event|10|||
163240534|NCT00902304|589590213|FG002|Overall Study|Adverse Event|25|||
163240535|NCT00902304|589590211|FG000|Overall Study|Investigator discretion|3|||
163240536|NCT00902304|589590212|FG001|Overall Study|Investigator discretion|5|||
163240537|NCT00902304|589590213|FG002|Overall Study|Investigator discretion|13|||
163240538|NCT00902304|589590211|FG000|Overall Study|Lost to Follow-up|7|||
163240539|NCT00902304|589590212|FG001|Overall Study|Lost to Follow-up|7|||
163240540|NCT00902304|589590213|FG002|Overall Study|Lost to Follow-up|7|||
163240541|NCT00902304|589590211|FG000|Overall Study|Protocol Violation|9|||
163240542|NCT00902304|589590212|FG001|Overall Study|Protocol Violation|18|||
163240543|NCT00902304|589590213|FG002|Overall Study|Protocol Violation|20|||
163240544|NCT00902304|589590211|FG000|Overall Study|Withdrawal by Subject|32|||
163240545|NCT00902304|589590212|FG001|Overall Study|Withdrawal by Subject|22|||
163240546|NCT00902304|589590213|FG002|Overall Study|Withdrawal by Subject|43|||
163240547|NCT00902304|589590211|FG000|Overall Study|includes pregnancy|3|||
163240548|NCT00902304|589590212|FG001|Overall Study|includes pregnancy|9|||
163240549|NCT00902304|589590213|FG002|Overall Study|includes pregnancy|2|||
163240550|NCT02492100|589590214|FG000|Overall Study|Death|1|||
163240551|NCT03832010|589590215|FG000|Overall Study|Withdrawal by Subject|2|||
163240552|NCT03832010|589590216|FG001|Overall Study|Withdrawal by Subject|1|||
163240553|NCT03832010|589590217|FG002|Overall Study|Withdrawal by Subject|0|||
163240554|NCT03832010|589590215|FG000|Overall Study|Lost to Follow-up|2|||
163349790|NCT02412111|589990890|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
163349791|NCT02412111|589990891|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
163349792|NCT02412111|589990892|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
163349793|NCT02412111|589990890|FG000|Active Comparator Period (8 Weeks)|Other|0|||
163349794|NCT02412111|589990891|FG001|Active Comparator Period (8 Weeks)|Other|0|||
163349795|NCT02412111|589990892|FG002|Active Comparator Period (8 Weeks)|Other|2|||
163349796|NCT02624869|589990893|FG000|Overall Study|Lost to Follow-up|0|||
163349797|NCT02624869|589990894|FG001|Overall Study|Lost to Follow-up|0|||
163409814|NCT04418765|590209517|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
163409815|NCT04418765|590209518|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
163240555|NCT03832010|589590216|FG001|Overall Study|Lost to Follow-up|1|||
163240556|NCT03832010|589590217|FG002|Overall Study|Lost to Follow-up|1|||
163240557|NCT04969783|589590218|FG000|Overall Study|Lost to Follow-up|2|||
163240558|NCT04969783|589590219|FG001|Overall Study|Lost to Follow-up|0|||
163240559|NCT04969783|589590218|FG000|Overall Study|Withdrawal by Subject|4|||
163240560|NCT04969783|589590219|FG001|Overall Study|Withdrawal by Subject|0|||
163240561|NCT04969783|589590218|FG000|Overall Study|Physician Decision|6|||
163240562|NCT04969783|589590219|FG001|Overall Study|Physician Decision|0|||
163240563|NCT02489500|589590220|FG000|Overall Study|Death|1|||
163240564|NCT02489500|589590221|FG001|Overall Study|Death|1|||
163240565|NCT00987467|589590226|FG000|Overall Study|Lost to Follow-up|2|||
163240566|NCT00512135|589590227|FG000|Overall Study|Not Treated|5|||
163240567|NCT00512135|589590227|FG000|Overall Study|Lack of Efficacy|2|||
163240568|NCT00512135|589590227|FG000|Overall Study|Adverse Event|6|||
163240569|NCT00512135|589590227|FG000|Overall Study|Withdrawal by Subject|22|||
163240570|NCT00512135|589590227|FG000|Overall Study|Lost to Follow-up|27|||
163240571|NCT00512135|589590227|FG000|Overall Study|Other|22|||
163240572|NCT00262834|589590228|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
163240573|NCT00262834|589590229|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
163240574|NCT03422250|589590230|FG000|Intervention|Adverse Event|0|||
163240575|NCT03422250|589590231|FG001|Intervention|Adverse Event|1|||
163240576|NCT03422250|589590232|FG002|Intervention|Adverse Event|0|||
163240577|NCT03422250|589590233|FG003|Intervention|Adverse Event|1|||
163240578|NCT03422250|589590230|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
163240579|NCT03422250|589590231|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
163240580|NCT03422250|589590232|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
163240581|NCT03422250|589590233|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
163240582|NCT03422250|589590230|FG000|Follow-up|Withdrawal by Subject|0|||
163240583|NCT03422250|589590231|FG001|Follow-up|Withdrawal by Subject|0|||
163240584|NCT03422250|589590232|FG002|Follow-up|Withdrawal by Subject|0|||
163240585|NCT03422250|589590233|FG003|Follow-up|Withdrawal by Subject|1|||
163240586|NCT03422250|589590230|FG000|Follow-up|Adverse Event|0|||
163240587|NCT03422250|589590231|FG001|Follow-up|Adverse Event|0|||
163240588|NCT03422250|589590232|FG002|Follow-up|Adverse Event|0|||
163240589|NCT03422250|589590233|FG003|Follow-up|Adverse Event|1|||
163240590|NCT00377819|589590236|FG000|Overall Study|Adverse Event|2|||
163240591|NCT00377819|589590237|FG001|Overall Study|Adverse Event|3|||
163240592|NCT00377819|589590236|FG000|Overall Study|Withdrawal by Subject|10|||
163240593|NCT00377819|589590237|FG001|Overall Study|Withdrawal by Subject|4|||
163240594|NCT00377819|589590236|FG000|Overall Study|Death|0|||
163240595|NCT00377819|589590237|FG001|Overall Study|Death|1|||
163240596|NCT00377819|589590236|FG000|Overall Study|Lost to Follow-up|0|||
163240597|NCT00377819|589590237|FG001|Overall Study|Lost to Follow-up|1|||
163240598|NCT00377819|589590236|FG000|Overall Study|Protocol Violation|1|||
163240599|NCT00377819|589590237|FG001|Overall Study|Protocol Violation|1|||
163240600|NCT02416791|589590238|FG000|6 Months|Lost to Follow-up|0|||
163240601|NCT02416791|589590239|FG001|6 Months|Lost to Follow-up|0|||
163240602|NCT02416791|589590240|FG002|6 Months|Lost to Follow-up|1|||
163240603|NCT01054820|589590241|FG000|Overall Study|Withdrawal by Subject|2|||
163240604|NCT00467870|589590248|FG000|Overall Study|Adverse Event|13|||
163240605|NCT00467870|589590249|FG001|Overall Study|Adverse Event|9|||
163240606|NCT00467870|589590250|FG002|Overall Study|Adverse Event|1|||
163240607|NCT00467870|589590251|FG003|Overall Study|Adverse Event|15|||
163240608|NCT00467870|589590252|FG004|Overall Study|Adverse Event|15|||
163240609|NCT00467870|589590253|FG005|Overall Study|Adverse Event|1|||
163240610|NCT00467870|589590248|FG000|Overall Study|Protocol Violation|2|||
163240611|NCT00467870|589590249|FG001|Overall Study|Protocol Violation|1|||
163240612|NCT00467870|589590250|FG002|Overall Study|Protocol Violation|1|||
163240613|NCT00467870|589590251|FG003|Overall Study|Protocol Violation|2|||
163240614|NCT00467870|589590252|FG004|Overall Study|Protocol Violation|0|||
163240615|NCT00467870|589590253|FG005|Overall Study|Protocol Violation|0|||
163240616|NCT00467870|589590248|FG000|Overall Study|Withdrawal by Subject|14|||
163240617|NCT00467870|589590249|FG001|Overall Study|Withdrawal by Subject|21|||
163240618|NCT00467870|589590250|FG002|Overall Study|Withdrawal by Subject|0|||
163240619|NCT00467870|589590251|FG003|Overall Study|Withdrawal by Subject|9|||
163240620|NCT00467870|589590252|FG004|Overall Study|Withdrawal by Subject|10|||
163240621|NCT00467870|589590253|FG005|Overall Study|Withdrawal by Subject|1|||
163240622|NCT00467870|589590248|FG000|Overall Study|Lost to Follow-up|5|||
163240623|NCT00467870|589590249|FG001|Overall Study|Lost to Follow-up|3|||
163240624|NCT00467870|589590250|FG002|Overall Study|Lost to Follow-up|1|||
163240625|NCT00467870|589590251|FG003|Overall Study|Lost to Follow-up|1|||
163240626|NCT00467870|589590252|FG004|Overall Study|Lost to Follow-up|3|||
163240627|NCT00467870|589590253|FG005|Overall Study|Lost to Follow-up|0|||
163240628|NCT00467870|589590248|FG000|Overall Study|Subject Non-compliance|3|||
163349798|NCT02624869|589990895|FG002|Overall Study|Lost to Follow-up|1|||
163349799|NCT02624869|589990893|FG000|Overall Study|Withdrawal by Subject|1|||
163349800|NCT02624869|589990894|FG001|Overall Study|Withdrawal by Subject|3|||
163349801|NCT02624869|589990895|FG002|Overall Study|Withdrawal by Subject|1|||
163240629|NCT00467870|589590249|FG001|Overall Study|Subject Non-compliance|4|||
163240630|NCT00467870|589590250|FG002|Overall Study|Subject Non-compliance|0|||
163240631|NCT00467870|589590251|FG003|Overall Study|Subject Non-compliance|1|||
163240632|NCT00467870|589590252|FG004|Overall Study|Subject Non-compliance|5|||
163240633|NCT00467870|589590253|FG005|Overall Study|Subject Non-compliance|0|||
163240634|NCT00467870|589590248|FG000|Overall Study|Other/Unknown|8|||
163240635|NCT00467870|589590249|FG001|Overall Study|Other/Unknown|5|||
163145685|NCT00883779|589243142|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
163145686|NCT00883779|589243143|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
163145687|NCT00883779|589243142|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
163145688|NCT00883779|589243143|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
163145689|NCT00883779|589243142|FG000|Post-Study Treatment Phase|Disease progression|103|||
163145690|NCT00883779|589243143|FG001|Post-Study Treatment Phase|Disease progression|122|||
163145691|NCT00883779|589243142|FG000|Post-Study Treatment Phase|Other|3|||
163145692|NCT00883779|589243143|FG001|Post-Study Treatment Phase|Other|0|||
163145693|NCT00883779|589243142|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
163145694|NCT00883779|589243143|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
163145695|NCT00883779|589243142|FG000|Off-study Phase|Death|185|||
163145696|NCT00883779|589243143|FG001|Off-study Phase|Death|174|||
163145697|NCT00883779|589243142|FG000|Off-study Phase|Refused treatment|1|||
163145698|NCT00883779|589243143|FG001|Off-study Phase|Refused treatment|1|||
163145699|NCT00883779|589243142|FG000|Off-study Phase|Failure to return|5|||
163145700|NCT00883779|589243143|FG001|Off-study Phase|Failure to return|6|||
163145701|NCT00883779|589243142|FG000|Off-study Phase|Other|18|||
163145702|NCT00883779|589243143|FG001|Off-study Phase|Other|21|||
163145703|NCT00499681|589243144|FG000|Overall Study|toxicity|0|||
163145704|NCT00499681|589243145|FG001|Overall Study|toxicity|1|||
163145705|NCT00499681|589243144|FG000|Overall Study|disease progression|0|||
163145706|NCT00499681|589243145|FG001|Overall Study|disease progression|1|||
163145707|NCT00739401|589243146|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
163145708|NCT00739401|589243146|FG000|Overall Study|Death|3|||
163145709|NCT00739401|589243146|FG000|Overall Study|Withdrawal by Subject|4|||
163145710|NCT04575155|589243147|FG000|2 Month|Withdrawal by Subject|1|||
163145711|NCT04575155|589243148|FG001|2 Month|Withdrawal by Subject|1|||
163145712|NCT04575155|589243147|FG000|2 Month|Lost to Follow-up|5|||
163145713|NCT04575155|589243148|FG001|2 Month|Lost to Follow-up|3|||
163145714|NCT04575155|589243147|FG000|2 Month|Ineligible|1|||
163145715|NCT04575155|589243148|FG001|2 Month|Ineligible|0|||
163145716|NCT01239381|589243150|FG000|Overall Study|Protocol Violation|1|||
163145717|NCT01239381|589243150|FG000|Overall Study|Withdrawal by Subject|1|||
163145718|NCT03748823|589243151|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
163145719|NCT03748823|589243152|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
163145720|NCT03748823|589243151|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
163145721|NCT03748823|589243152|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
163145722|NCT03748823|589243151|FG000|Extension Period|Withdrawal by Subject|9|||
163145723|NCT03748823|589243152|FG001|Extension Period|Withdrawal by Subject|12|||
163145724|NCT03748823|589243151|FG000|Extension Period|Death|2|||
163145725|NCT03748823|589243152|FG001|Extension Period|Death|2|||
163145726|NCT03748823|589243151|FG000|Extension Period|Other than Specified|0|||
163145727|NCT03748823|589243152|FG001|Extension Period|Other than Specified|1|||
163145728|NCT03748823|589243151|FG000|Extension Period|Protocol Violation|1|||
163145729|NCT03748823|589243152|FG001|Extension Period|Protocol Violation|0|||
163145730|NCT03748823|589243151|FG000|Extension Period|Lost to Follow-up|0|||
163145731|NCT03748823|589243152|FG001|Extension Period|Lost to Follow-up|1|||
163145732|NCT03748823|589243151|FG000|Extension Period|Lack of Efficacy|0|||
163145733|NCT03748823|589243152|FG001|Extension Period|Lack of Efficacy|1|||
163145734|NCT03748823|589243151|FG000|Extension Period|Physician Decision|1|||
163145735|NCT03748823|589243152|FG001|Extension Period|Physician Decision|2|||
163145736|NCT00890825|589243153|FG000|Overall Study|Withdrawal by Subject|1|||
163145737|NCT00890825|589243154|FG001|Overall Study|Withdrawal by Subject|0|||
163145738|NCT00890825|589243153|FG000|Overall Study|Alive at data cut off (DCO)|13|||
163145739|NCT00890825|589243154|FG001|Overall Study|Alive at data cut off (DCO)|14|||
163145740|NCT01363700|589243155|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
163145741|NCT01363700|589243156|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
163145742|NCT01363700|589243157|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
163145743|NCT01363700|589243158|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
163145744|NCT01363700|589243159|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
163145745|NCT02920892|589243160|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
163145746|NCT02920892|589243161|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
163145747|NCT02920892|589243162|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
163145748|NCT02920892|589243160|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
163145749|NCT02920892|589243161|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
163145750|NCT02920892|589243162|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
163145751|NCT02920892|589243160|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
163145752|NCT02920892|589243161|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
163145753|NCT02920892|589243162|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
163145754|NCT02920892|589243160|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
163145755|NCT02920892|589243161|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
163145756|NCT02920892|589243162|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
163145757|NCT02920892|589243160|FG000|Placebo-Controlled Period|Physician Decision|0|||
163145758|NCT02920892|589243161|FG001|Placebo-Controlled Period|Physician Decision|0|||
163145759|NCT02920892|589243162|FG002|Placebo-Controlled Period|Physician Decision|1|||
163240636|NCT00467870|589590250|FG002|Overall Study|Other/Unknown|1|||
163240637|NCT00467870|589590251|FG003|Overall Study|Other/Unknown|5|||
163240638|NCT00467870|589590252|FG004|Overall Study|Other/Unknown|4|||
163240639|NCT00467870|589590253|FG005|Overall Study|Other/Unknown|0|||
163240640|NCT02239679|589590254|FG000|Overall Study|Lost to Follow-up|1|||
163240641|NCT02239679|589590255|FG001|Overall Study|Lost to Follow-up|0|||
163349802|NCT00329550|589990896|FG000|Overall Study|Adverse Event|3|||
163349803|NCT00329550|589990897|FG001|Overall Study|Adverse Event|4|||
163349804|NCT00329550|589990898|FG002|Overall Study|Adverse Event|2|||
163349805|NCT00329550|589990896|FG000|Overall Study|Withdrawal of Consent|1|||
163349806|NCT00329550|589990897|FG001|Overall Study|Withdrawal of Consent|0|||
163349807|NCT00329550|589990898|FG002|Overall Study|Withdrawal of Consent|1|||
163349808|NCT00329550|589990896|FG000|Overall Study|Due to Relocation|0|||
163349809|NCT00329550|589990897|FG001|Overall Study|Due to Relocation|0|||
163349810|NCT00329550|589990898|FG002|Overall Study|Due to Relocation|1|||
163349811|NCT02994784|589990899|FG000|6 Months Follow-up|Lost to Follow-up|3|||
163349812|NCT02637856|589990903|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
163349813|NCT02637856|589990904|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
163349814|NCT02637856|589990903|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
163349815|NCT02637856|589990904|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
163349816|NCT02637856|589990903|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
163349817|NCT02637856|589990904|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
163349818|NCT02637856|589990903|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
163349819|NCT02637856|589990904|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
163349820|NCT02637856|589990903|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
163349821|NCT02637856|589990904|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
163349822|NCT02637856|589990903|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
163349823|NCT02637856|589990904|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
163349824|NCT02637856|589990903|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
163349825|NCT02637856|589990904|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
163349826|NCT02637856|589990903|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
163349827|NCT02637856|589990904|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
163349828|NCT02637856|589990903|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
163349829|NCT02637856|589990904|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
163349830|NCT02637856|589990903|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
163349831|NCT02637856|589990904|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
163349832|NCT02637856|589990903|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
163409816|NCT04418765|590209516|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
163409817|NCT04418765|590209517|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
163409818|NCT04418765|590209518|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
163240642|NCT02239679|589590256|FG002|Overall Study|Lost to Follow-up|0|||
163240643|NCT02239679|589590254|FG000|Overall Study|Withdrawal by Subject|2|||
163240644|NCT02239679|589590255|FG001|Overall Study|Withdrawal by Subject|3|||
163240645|NCT02239679|589590256|FG002|Overall Study|Withdrawal by Subject|1|||
163240646|NCT01917526|589590257|FG000|Overall Study|Protocol Violation|1|||
163240647|NCT01917526|589590258|FG001|Overall Study|Protocol Violation|1|||
163240648|NCT00760929|589590262|FG000|Overall Study|Adverse Event|2|||
163240649|NCT00760929|589590263|FG001|Overall Study|Adverse Event|0|||
163240650|NCT00760929|589590264|FG002|Overall Study|Adverse Event|6|||
163240651|NCT00760929|589590265|FG003|Overall Study|Adverse Event|10|||
163240652|NCT00760929|589590262|FG000|Overall Study|Lack of Efficacy|0|||
163240653|NCT00760929|589590263|FG001|Overall Study|Lack of Efficacy|2|||
163240654|NCT00760929|589590264|FG002|Overall Study|Lack of Efficacy|1|||
163240655|NCT00760929|589590265|FG003|Overall Study|Lack of Efficacy|0|||
163240656|NCT00760929|589590262|FG000|Overall Study|Withdrawal by Subject|1|||
163240657|NCT00760929|589590263|FG001|Overall Study|Withdrawal by Subject|0|||
163240658|NCT00760929|589590264|FG002|Overall Study|Withdrawal by Subject|9|||
163240659|NCT00760929|589590265|FG003|Overall Study|Withdrawal by Subject|1|||
163240660|NCT00760929|589590262|FG000|Overall Study|Lost to Follow-up|0|||
163240661|NCT00760929|589590263|FG001|Overall Study|Lost to Follow-up|0|||
163349833|NCT02637856|589990904|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
163349834|NCT02637856|589990903|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
163349835|NCT02637856|589990904|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
163349836|NCT02637856|589990903|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
163349837|NCT02637856|589990904|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
163409819|NCT04418765|590209516|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
163349838|NCT01649557|589990905|FG000|Overall Study|Lost to Follow-up|5|||
163409820|NCT04418765|590209517|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
163409821|NCT04418765|590209518|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
163240662|NCT00760929|589590264|FG002|Overall Study|Lost to Follow-up|1|||
163240663|NCT00760929|589590265|FG003|Overall Study|Lost to Follow-up|0|||
163240664|NCT00760929|589590262|FG000|Overall Study|Progression of Disease|21|||
163240665|NCT00760929|589590263|FG001|Overall Study|Progression of Disease|26|||
163349839|NCT01649557|589990906|FG001|Overall Study|Lost to Follow-up|0|||
163349840|NCT01649557|589990907|FG002|Overall Study|Lost to Follow-up|3|||
163349841|NCT01649557|589990905|FG000|Overall Study|Adverse Event|7|||
163349842|NCT01649557|589990906|FG001|Overall Study|Adverse Event|5|||
163349843|NCT01649557|589990907|FG002|Overall Study|Adverse Event|1|||
163349844|NCT01649557|589990905|FG000|Overall Study|Met withdrawal criteria|4|||
163349845|NCT01649557|589990906|FG001|Overall Study|Met withdrawal criteria|0|||
163145760|NCT02920892|589243160|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
163145761|NCT02920892|589243161|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
163145762|NCT02920892|589243162|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
163145763|NCT02920892|589243160|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163145764|NCT02920892|589243161|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
163145765|NCT02920892|589243162|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
163145766|NCT02920892|589243160|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
163145767|NCT02920892|589243161|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
163145768|NCT02920892|589243162|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
163145769|NCT03649217|589243163|FG000|Overall Study|subject had severe ataxia not initially found|1|||
163145770|NCT03649217|589243163|FG000|Overall Study|subject had cognitive issues not initially found|1|||
163145771|NCT01721161|589243164|FG000|Overall Study|Adverse Event|2|||
163145772|NCT01721161|589243165|FG001|Overall Study|Adverse Event|3|||
163145773|NCT01721161|589243164|FG000|Overall Study|Lost to Follow-up|1|||
163145774|NCT01721161|589243165|FG001|Overall Study|Lost to Follow-up|2|||
163145775|NCT01721161|589243164|FG000|Overall Study|Withdrawal by Subject|1|||
163145776|NCT01721161|589243165|FG001|Overall Study|Withdrawal by Subject|1|||
163145777|NCT01721161|589243164|FG000|Overall Study|Other|0|||
163145778|NCT01721161|589243165|FG001|Overall Study|Other|1|||
163145779|NCT01216202|589243166|FG000|Overall Study|Withdrawal by Subject|8|||
163145780|NCT01216202|589243167|FG001|Overall Study|Withdrawal by Subject|0|||
163145781|NCT01216202|589243166|FG000|Overall Study|Death|0|||
163145782|NCT01216202|589243167|FG001|Overall Study|Death|2|||
163145783|NCT01216202|589243166|FG000|Overall Study|Lost to Follow-up|14|||
163145784|NCT01216202|589243167|FG001|Overall Study|Lost to Follow-up|0|||
163145785|NCT00614380|589243170|FG000|Overall Study|Adverse Event|14|||
163145786|NCT00614380|589243171|FG001|Overall Study|Adverse Event|4|||
163145787|NCT00614380|589243172|FG002|Overall Study|Adverse Event|0|||
163145788|NCT00614380|589243173|FG003|Overall Study|Adverse Event|0|||
163145789|NCT00614380|589243170|FG000|Overall Study|Lost to Follow-up|6|||
163145790|NCT00614380|589243171|FG001|Overall Study|Lost to Follow-up|1|||
163145791|NCT00614380|589243172|FG002|Overall Study|Lost to Follow-up|0|||
163145792|NCT00614380|589243173|FG003|Overall Study|Lost to Follow-up|0|||
163145793|NCT00614380|589243170|FG000|Overall Study|Non compliant with the protocol|12|||
163145794|NCT00614380|589243171|FG001|Overall Study|Non compliant with the protocol|2|||
163145795|NCT00614380|589243172|FG002|Overall Study|Non compliant with the protocol|1|||
163145796|NCT00614380|589243173|FG003|Overall Study|Non compliant with the protocol|2|||
163145797|NCT00614380|589243170|FG000|Overall Study|Consent withdrawn|3|||
163145798|NCT00614380|589243171|FG001|Overall Study|Consent withdrawn|1|||
163145799|NCT00614380|589243172|FG002|Overall Study|Consent withdrawn|0|||
163145800|NCT00614380|589243173|FG003|Overall Study|Consent withdrawn|0|||
163145801|NCT04908397|589243178|FG000|Overall Study|Withdrawal by Subject|2|||
163145802|NCT00462306|589243179|FG000|Overall Study|insufficient data|0|||
163145803|NCT00462306|589243180|FG001|Overall Study|insufficient data|13|||
163145804|NCT00191334|589243186|FG000|Overall Study|Adverse Event|4|||
163145805|NCT00191334|589243186|FG000|Overall Study|Disease Progression or Relapse|8|||
163145806|NCT00191334|589243186|FG000|Overall Study|Physician Decision|1|||
163145807|NCT00191334|589243186|FG000|Overall Study|Withdrawal by Subject|4|||
163145808|NCT00452790|589243187|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
163145809|NCT00452790|589243188|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
163145810|NCT00452790|589243187|FG000|Infant Series|Parent/legal guardian request|8|||
163145811|NCT00452790|589243188|FG001|Infant Series|Parent/legal guardian request|6|||
163145812|NCT00452790|589243187|FG000|Infant Series|Failed to return|4|||
163145813|NCT00452790|589243188|FG001|Infant Series|Failed to return|1|||
163145814|NCT00452790|589243187|FG000|Infant Series|Protocol Violation|1|||
163145815|NCT00452790|589243188|FG001|Infant Series|Protocol Violation|3|||
163145816|NCT00452790|589243187|FG000|Infant Series|Lost to Follow-up|2|||
163145817|NCT00452790|589243188|FG001|Infant Series|Lost to Follow-up|2|||
163145818|NCT00452790|589243187|FG000|Infant Series|Adverse Event|1|||
163145819|NCT00452790|589243188|FG001|Infant Series|Adverse Event|2|||
163145820|NCT00452790|589243187|FG000|Infant Series|Other reasons|1|||
163145821|NCT00452790|589243188|FG001|Infant Series|Other reasons|2|||
163145822|NCT00452790|589243187|FG000|Infant Series|Investigator request|0|||
163145823|NCT00452790|589243188|FG001|Infant Series|Investigator request|1|||
163145824|NCT00452790|589243187|FG000|Infant Series|Death|0|||
163145825|NCT00452790|589243188|FG001|Infant Series|Death|1|||
163145826|NCT00452790|589243187|FG000|After Infant Series|Investigator request|10|||
163145827|NCT00452790|589243188|FG001|After Infant Series|Investigator request|10|||
163145828|NCT00452790|589243187|FG000|After Infant Series|Adverse Event|4|||
163349846|NCT01649557|589990907|FG002|Overall Study|Met withdrawal criteria|0|||
163240666|NCT00760929|589590264|FG002|Overall Study|Progression of Disease|38|||
163240667|NCT00760929|589590265|FG003|Overall Study|Progression of Disease|42|||
163240668|NCT00760929|589590262|FG000|Overall Study|Other|2|||
163240669|NCT00760929|589590263|FG001|Overall Study|Other|0|||
163240670|NCT00760929|589590264|FG002|Overall Study|Other|2|||
163240671|NCT00760929|589590265|FG003|Overall Study|Other|1|||
163240672|NCT00760929|589590262|FG000|Overall Study|Death|0|||
163240673|NCT00760929|589590263|FG001|Overall Study|Death|0|||
163240674|NCT00760929|589590264|FG002|Overall Study|Death|1|||
163240675|NCT00760929|589590265|FG003|Overall Study|Death|0|||
163240676|NCT00760929|589590262|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
163240677|NCT00760929|589590263|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
163240678|NCT00760929|589590264|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
163240679|NCT00760929|589590265|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
163240680|NCT04408469|589590272|FG000|Overall Study|Lost to Follow-up|6|||
163240681|NCT04408469|589590273|FG001|Overall Study|Lost to Follow-up|9|||
163240682|NCT04408469|589590272|FG000|Overall Study|Withdrawal by Subject|6|||
163240683|NCT04408469|589590273|FG001|Overall Study|Withdrawal by Subject|1|||
163240684|NCT04408469|589590272|FG000|Overall Study|Dismissal due to ineligibility|0|||
163240685|NCT04408469|589590273|FG001|Overall Study|Dismissal due to ineligibility|1|||
163240686|NCT04321460|589590274|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
163240687|NCT04321460|589590275|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
163240688|NCT03669081|589590278|FG000|Overall Study|Data could not be validated|1|||
163240689|NCT03669081|589590279|FG001|Overall Study|Data could not be validated|1|||
163240690|NCT01308749|589590284|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
163240691|NCT01308749|589590285|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
163240692|NCT01308749|589590284|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
163240693|NCT01308749|589590285|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
163240694|NCT01308749|589590284|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
163240695|NCT01308749|589590285|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
163240696|NCT02546544|589590286|FG000|Overall Study|Disease Progression|14|||
163240697|NCT02546544|589590286|FG000|Overall Study|Adverse Event|1|||
163240698|NCT02546544|589590286|FG000|Overall Study|Withdrawal by Subject|1|||
163240699|NCT02223390|589590287|FG000|Overall Study|Lost to Follow-up|9|||
163240700|NCT02223390|589590288|FG001|Overall Study|Lost to Follow-up|4|||
163240701|NCT01197950|589590292|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
163240702|NCT01197950|589590293|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
163240703|NCT01197950|589590294|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
163240704|NCT02553330|589590295|FG000|Overall Study|Study Terminated by Sponsor|2|||
163240705|NCT02553330|589590296|FG001|Overall Study|Study Terminated by Sponsor|13|||
163240706|NCT02553330|589590297|FG002|Overall Study|Study Terminated by Sponsor|12|||
163240707|NCT02553330|589590295|FG000|Overall Study|Withdrawal by Subject|3|||
163240708|NCT02553330|589590296|FG001|Overall Study|Withdrawal by Subject|19|||
163240709|NCT02553330|589590297|FG002|Overall Study|Withdrawal by Subject|21|||
163240710|NCT02553330|589590295|FG000|Overall Study|Other|0|||
163240711|NCT02553330|589590296|FG001|Overall Study|Other|1|||
163240712|NCT02553330|589590297|FG002|Overall Study|Other|0|||
163240713|NCT02553330|589590295|FG000|Overall Study|Non compliance to study treatment|0|||
163240714|NCT02553330|589590296|FG001|Overall Study|Non compliance to study treatment|1|||
163240715|NCT02553330|589590297|FG002|Overall Study|Non compliance to study treatment|0|||
163240716|NCT02553330|589590295|FG000|Overall Study|Adverse Event|0|||
163240717|NCT02553330|589590296|FG001|Overall Study|Adverse Event|1|||
163240718|NCT02553330|589590297|FG002|Overall Study|Adverse Event|0|||
163240719|NCT02553330|589590295|FG000|Overall Study|Lost to Follow-up|0|||
163240720|NCT02553330|589590296|FG001|Overall Study|Lost to Follow-up|4|||
163240721|NCT02553330|589590297|FG002|Overall Study|Lost to Follow-up|4|||
163240722|NCT01666002|589590298|FG000|Overall Study|Lost to Follow-up|5|||
163240723|NCT01666002|589590299|FG001|Overall Study|Lost to Follow-up|0|||
163240724|NCT02511431|589590300|FG000|Treatment|Lost to Follow-up|0|||
163240725|NCT02511431|589590301|FG001|Treatment|Lost to Follow-up|0|||
163240726|NCT02511431|589590302|FG002|Treatment|Lost to Follow-up|1|||
163349847|NCT01649557|589990905|FG000|Overall Study|Physician Decision|8|||
163240727|NCT02511431|589590303|FG003|Treatment|Lost to Follow-up|0|||
163240728|NCT02511431|589590304|FG004|Treatment|Lost to Follow-up|0|||
163240729|NCT02511431|589590305|FG005|Treatment|Lost to Follow-up|1|||
163240730|NCT00346034|589590322|FG000|Overall Study|Adverse Event|34|||
163240731|NCT00346034|589590322|FG000|Overall Study|Lack of Efficacy|8|||
163240732|NCT00346034|589590322|FG000|Overall Study|Withdrawal by Subject|13|||
163240733|NCT00346034|589590322|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
163349848|NCT01649557|589990906|FG001|Overall Study|Physician Decision|2|||
163240734|NCT00346034|589590322|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
163240735|NCT00099983|589590324|FG000|Overall Study|Lost to Follow-up|2|||
163240736|NCT00099983|589590325|FG001|Overall Study|Lost to Follow-up|3|||
163240737|NCT00099983|589590324|FG000|Overall Study|Missing Source Documents|14|||
163349849|NCT01649557|589990907|FG002|Overall Study|Physician Decision|1|||
163145829|NCT00452790|589243188|FG001|After Infant Series|Adverse Event|1|||
163145830|NCT00452790|589243187|FG000|After Infant Series|Parent/legal guardian request|1|||
163145831|NCT00452790|589243188|FG001|After Infant Series|Parent/legal guardian request|3|||
163145832|NCT00452790|589243187|FG000|After Infant Series|Lost to Follow-up|4|||
163145833|NCT00452790|589243188|FG001|After Infant Series|Lost to Follow-up|0|||
163145834|NCT00452790|589243187|FG000|After Infant Series|Failed to return|1|||
163145835|NCT00452790|589243188|FG001|After Infant Series|Failed to return|0|||
163145836|NCT00452790|589243187|FG000|After Infant Series|Other reasons|1|||
163145837|NCT00452790|589243188|FG001|After Infant Series|Other reasons|0|||
163145838|NCT00452790|589243187|FG000|Toddler Dose|Failed to return|0|||
163145839|NCT00452790|589243188|FG001|Toddler Dose|Failed to return|1|||
163145840|NCT00452790|589243187|FG000|Toddler Dose|Parent/legal guardian request|0|||
163145841|NCT00452790|589243188|FG001|Toddler Dose|Parent/legal guardian request|1|||
163145842|NCT02926638|589243192|FG000|Overall Study|Progression|2|||
163145843|NCT02926638|589243193|FG001|Overall Study|Progression|5|||
163145844|NCT02926638|589243192|FG000|Overall Study|Ineligible|1|||
163145845|NCT02926638|589243193|FG001|Overall Study|Ineligible|0|||
163145846|NCT02926638|589243192|FG000|Overall Study|Not protocol specified|1|||
163145847|NCT02926638|589243193|FG001|Overall Study|Not protocol specified|0|||
163145848|NCT02360228|589243196|FG000|Overall Study|Withdrawal by Subject|1|||
163145849|NCT02360228|589243197|FG001|Overall Study|Withdrawal by Subject|0|||
163145850|NCT02360228|589243198|FG002|Overall Study|Withdrawal by Subject|0|||
163145851|NCT02360228|589243196|FG000|Overall Study|Self-discontinued medication|0|||
163145852|NCT02360228|589243197|FG001|Overall Study|Self-discontinued medication|1|||
163145853|NCT02360228|589243198|FG002|Overall Study|Self-discontinued medication|0|||
163145854|NCT02360228|589243196|FG000|Overall Study|Unstable symptoms during screening|0|||
163145855|NCT02360228|589243197|FG001|Overall Study|Unstable symptoms during screening|0|||
163145856|NCT02360228|589243198|FG002|Overall Study|Unstable symptoms during screening|1|||
163145857|NCT01063153|589243199|FG000|Overall Study|Found Ineligible During Screening|2|||
163145858|NCT01063153|589243200|FG001|Overall Study|Found Ineligible During Screening|0|||
163145859|NCT01063153|589243199|FG000|Overall Study|Lost to Follow-up|0|||
163145860|NCT01063153|589243200|FG001|Overall Study|Lost to Follow-up|7|||
163145861|NCT01063153|589243199|FG000|Overall Study|Withdrawal by Subject|0|||
163145862|NCT01063153|589243200|FG001|Overall Study|Withdrawal by Subject|1|||
163145863|NCT01063153|589243199|FG000|Overall Study|Physician Decision|0|||
163145864|NCT01063153|589243200|FG001|Overall Study|Physician Decision|4|||
163145865|NCT02426580|589244454|FG000|Overall Study|Death|2|||
163145866|NCT02426580|589244455|FG001|Overall Study|Death|2|||
163145867|NCT02426580|589244454|FG000|Overall Study|Lost to Follow-up|0|||
163145868|NCT02426580|589244455|FG001|Overall Study|Lost to Follow-up|9|||
163145869|NCT02426580|589244454|FG000|Overall Study|transfer to hemodialysis|5|||
163145870|NCT02426580|589244455|FG001|Overall Study|transfer to hemodialysis|5|||
163145871|NCT02426580|589244454|FG000|Overall Study|Kidney transplant|3|||
163145872|NCT02426580|589244455|FG001|Overall Study|Kidney transplant|0|||
163145873|NCT02426580|589244454|FG000|Overall Study|Allergic to egg white|1|||
163145874|NCT02426580|589244455|FG001|Overall Study|Allergic to egg white|0|||
163145875|NCT00383552|589244456|FG000|Overall Study|Adverse Event|7|||
163145876|NCT00383552|589244457|FG001|Overall Study|Adverse Event|6|||
163145877|NCT00383552|589244458|FG002|Overall Study|Adverse Event|9|||
163145878|NCT00383552|589244459|FG003|Overall Study|Adverse Event|6|||
163145879|NCT00383552|589244456|FG000|Overall Study|Lack of Efficacy|4|||
163145880|NCT00383552|589244457|FG001|Overall Study|Lack of Efficacy|13|||
163145881|NCT00383552|589244458|FG002|Overall Study|Lack of Efficacy|29|||
163145882|NCT00383552|589244459|FG003|Overall Study|Lack of Efficacy|42|||
163145883|NCT00383552|589244456|FG000|Overall Study|Lost to Follow-up|0|||
163145884|NCT00383552|589244457|FG001|Overall Study|Lost to Follow-up|1|||
163145885|NCT00383552|589244458|FG002|Overall Study|Lost to Follow-up|5|||
163145886|NCT00383552|589244459|FG003|Overall Study|Lost to Follow-up|1|||
163145887|NCT00383552|589244456|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
163145888|NCT00383552|589244457|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
163145889|NCT00383552|589244458|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
163145890|NCT00383552|589244459|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
163145891|NCT00383552|589244456|FG000|Overall Study|Did not wish to continue (related)|1|||
163145892|NCT00383552|589244457|FG001|Overall Study|Did not wish to continue (related)|0|||
163145893|NCT00383552|589244458|FG002|Overall Study|Did not wish to continue (related)|2|||
163145894|NCT00383552|589244459|FG003|Overall Study|Did not wish to continue (related)|3|||
163145895|NCT00383552|589244456|FG000|Overall Study|Noncompliance with the protocol|11|||
163145896|NCT00383552|589244457|FG001|Overall Study|Noncompliance with the protocol|6|||
163145897|NCT00383552|589244458|FG002|Overall Study|Noncompliance with the protocol|8|||
163145898|NCT00383552|589244459|FG003|Overall Study|Noncompliance with the protocol|10|||
163145899|NCT00383552|589244456|FG000|Overall Study|Did not meet protocol eligibility|8|||
163145900|NCT00383552|589244457|FG001|Overall Study|Did not meet protocol eligibility|6|||
163145901|NCT00383552|589244458|FG002|Overall Study|Did not meet protocol eligibility|2|||
163145902|NCT00383552|589244459|FG003|Overall Study|Did not meet protocol eligibility|3|||
163145903|NCT00383552|589244456|FG000|Overall Study|Administrative|1|||
163349850|NCT01649557|589990905|FG000|Overall Study|Withdrawal by Subject|15|||
163240738|NCT00099983|589590325|FG001|Overall Study|Missing Source Documents|15|||
163240739|NCT00099983|589590324|FG000|Overall Study|Withdrawal by Subject|3|||
163240740|NCT00099983|589590325|FG001|Overall Study|Withdrawal by Subject|2|||
163240741|NCT00099983|589590324|FG000|Overall Study|Adverse Event|1|||
163240742|NCT00099983|589590325|FG001|Overall Study|Adverse Event|1|||
163240743|NCT00099983|589590324|FG000|Overall Study|Lack of Efficacy|0|||
163240744|NCT00099983|589590325|FG001|Overall Study|Lack of Efficacy|1|||
163240745|NCT00099983|589590324|FG000|Overall Study|Unable to return for appointments|1|||
163240746|NCT00099983|589590325|FG001|Overall Study|Unable to return for appointments|1|||
163240747|NCT00099983|589590324|FG000|Overall Study|Moved|1|||
163240748|NCT00099983|589590325|FG001|Overall Study|Moved|0|||
163240749|NCT00099983|589590324|FG000|Overall Study|Other psychiatric problem|1|||
163240750|NCT00099983|589590325|FG001|Overall Study|Other psychiatric problem|0|||
163240751|NCT00099983|589590324|FG000|Overall Study|Incarcerated|0|||
163240752|NCT00099983|589590325|FG001|Overall Study|Incarcerated|1|||
163240753|NCT00099983|589590324|FG000|Overall Study|Intolerant of burden of visits|0|||
163240754|NCT00099983|589590325|FG001|Overall Study|Intolerant of burden of visits|1|||
163240755|NCT00099983|589590324|FG000|Overall Study|Other issue|1|||
163240756|NCT00099983|589590325|FG001|Overall Study|Other issue|0|||
163240757|NCT02641080|589590326|FG000|Overall Study|Physician Decision|2|||
163240758|NCT02641080|589590327|FG001|Overall Study|Physician Decision|0|||
163240759|NCT02641080|589590326|FG000|Overall Study|Withdrawal by Subject|0|||
163240760|NCT02641080|589590327|FG001|Overall Study|Withdrawal by Subject|1|||
163240761|NCT02641080|589590326|FG000|Overall Study|Rehab Center denied use of pumps|0|||
163240762|NCT02641080|589590327|FG001|Overall Study|Rehab Center denied use of pumps|3|||
163240763|NCT02641080|589590326|FG000|Overall Study|Lost to Follow-up|0|||
163240764|NCT02641080|589590327|FG001|Overall Study|Lost to Follow-up|3|||
163240765|NCT06281548|589590328|FG000|Overall Study|Lost to Follow-up|3|||
163240766|NCT03835533|589590329|FG000|Overall Study|Death|5|||
163240767|NCT03835533|589590330|FG001|Overall Study|Death|10|||
163240768|NCT03835533|589590331|FG002|Overall Study|Death|9|||
163240769|NCT03835533|589590329|FG000|Overall Study|Withdrawal by Subject|2|||
163240770|NCT03835533|589590330|FG001|Overall Study|Withdrawal by Subject|2|||
163240771|NCT03835533|589590331|FG002|Overall Study|Withdrawal by Subject|2|||
163240772|NCT03835533|589590329|FG000|Overall Study|Lost to Follow-up|1|||
163240773|NCT03835533|589590330|FG001|Overall Study|Lost to Follow-up|0|||
163240774|NCT03835533|589590331|FG002|Overall Study|Lost to Follow-up|0|||
163240775|NCT01866709|589590335|FG000|Overall Study|Adverse Event|1|||
163240776|NCT01866709|589590336|FG001|Overall Study|Adverse Event|0|||
163240777|NCT02207829|589590338|FG000|Overall Study|Adverse Event|10|||
163240778|NCT02207829|589590339|FG001|Overall Study|Adverse Event|9|||
163240779|NCT02207829|589590338|FG000|Overall Study|Lack of Efficacy|7|||
163240780|NCT02207829|589590339|FG001|Overall Study|Lack of Efficacy|5|||
163240781|NCT02207829|589590338|FG000|Overall Study|Lost to Follow-up|2|||
163240782|NCT02207829|589590339|FG001|Overall Study|Lost to Follow-up|2|||
163240783|NCT02207829|589590338|FG000|Overall Study|Protocol deviation|5|||
163240784|NCT02207829|589590339|FG001|Overall Study|Protocol deviation|4|||
163240785|NCT02207829|589590338|FG000|Overall Study|Withdrew consent|18|||
163240786|NCT02207829|589590339|FG001|Overall Study|Withdrew consent|14|||
163240787|NCT03285477|589590341|FG000|Treatment and Response Assessment Period|Death|1|||
163240788|NCT03285477|589590342|FG001|Treatment and Response Assessment Period|Death|0|||
163240789|NCT03285477|589590341|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
163349851|NCT01649557|589990906|FG001|Overall Study|Withdrawal by Subject|5|||
163349852|NCT01649557|589990907|FG002|Overall Study|Withdrawal by Subject|4|||
163349853|NCT01649557|589990905|FG000|Overall Study|Protocol deviation|0|||
163349854|NCT01649557|589990906|FG001|Overall Study|Protocol deviation|2|||
163349855|NCT01649557|589990907|FG002|Overall Study|Protocol deviation|0|||
163349856|NCT01649557|589990905|FG000|Overall Study|Lack of Efficacy|5|||
163349857|NCT01649557|589990906|FG001|Overall Study|Lack of Efficacy|0|||
163240790|NCT03285477|589590342|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
163240791|NCT03285477|589590341|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
163240792|NCT03285477|589590342|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
163240793|NCT03285477|589590341|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
163240794|NCT03285477|589590342|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
163240795|NCT03285477|589590341|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
163240796|NCT03285477|589590342|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
163349858|NCT01649557|589990907|FG002|Overall Study|Lack of Efficacy|0|||
163349859|NCT01011049|589990908|FG000|Overall Study|Protocol Violation|0|||
163349860|NCT01011049|589990909|FG001|Overall Study|Protocol Violation|0|||
163240797|NCT00560833|589590355|FG000|Overall Study|Adverse Event|16|||
163240798|NCT00560833|589590356|FG001|Overall Study|Adverse Event|10|||
163240799|NCT00560833|589590357|FG002|Overall Study|Adverse Event|25|||
163240800|NCT00560833|589590358|FG003|Overall Study|Adverse Event|23|||
163240801|NCT00560833|589590359|FG004|Overall Study|Adverse Event|35|||
163240802|NCT00560833|589590355|FG000|Overall Study|Lost to Follow-up|0|||
163349861|NCT01011049|589990910|FG002|Overall Study|Protocol Violation|2|||
163349862|NCT01011049|589990911|FG003|Overall Study|Protocol Violation|0|||
163349863|NCT01011049|589990908|FG000|Overall Study|Lost to Follow-up|1|||
163349864|NCT01011049|589990909|FG001|Overall Study|Lost to Follow-up|2|||
163349865|NCT01011049|589990910|FG002|Overall Study|Lost to Follow-up|1|||
163349866|NCT01011049|589990911|FG003|Overall Study|Lost to Follow-up|0|||
163349867|NCT01011049|589990908|FG000|Overall Study|Withdrawal by Subject|0|||
163349868|NCT01011049|589990909|FG001|Overall Study|Withdrawal by Subject|0|||
163349869|NCT01011049|589990910|FG002|Overall Study|Withdrawal by Subject|1|||
163349870|NCT01011049|589990911|FG003|Overall Study|Withdrawal by Subject|0|||
163349871|NCT02815735|589990912|FG000|First Intervention (4 Weeks)|Discomfort|1|||
163349872|NCT02815735|589990913|FG001|First Intervention (4 Weeks)|Discomfort|0|||
163349873|NCT02815735|589990912|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
163349874|NCT02815735|589990913|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
163349875|NCT02815735|589990912|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
163349876|NCT02815735|589990913|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
163349877|NCT02815735|589990912|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
163349878|NCT02815735|589990913|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
163349879|NCT00352053|589990914|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
163349880|NCT00352053|589990915|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
163349881|NCT00352053|589990914|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
163349882|NCT00352053|589990915|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
163349883|NCT00352053|589990914|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
163349884|NCT00352053|589990915|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
163349885|NCT00352053|589990914|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
163349886|NCT00352053|589990915|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
163349887|NCT00352053|589990914|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
163349888|NCT00352053|589990915|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
163349889|NCT00352053|589990914|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
163349890|NCT00352053|589990915|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
163349891|NCT00352053|589990914|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
163349892|NCT00352053|589990915|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
163349893|NCT00352053|589990914|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
163349894|NCT00352053|589990915|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
163349895|NCT00352053|589990914|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
163349896|NCT00352053|589990915|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
163349897|NCT00352053|589990914|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
163349898|NCT00352053|589990915|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
163349899|NCT00352053|589990914|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
163349900|NCT00352053|589990915|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
163349901|NCT00352053|589990914|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
163349902|NCT00352053|589990915|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
163409822|NCT04418765|590209516|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
163240803|NCT00560833|589590356|FG001|Overall Study|Lost to Follow-up|0|||
163240804|NCT00560833|589590357|FG002|Overall Study|Lost to Follow-up|1|||
163240805|NCT00560833|589590358|FG003|Overall Study|Lost to Follow-up|0|||
163240806|NCT00560833|589590359|FG004|Overall Study|Lost to Follow-up|0|||
163240807|NCT00560833|589590355|FG000|Overall Study|Lack of Efficacy|22|||
163240808|NCT00560833|589590356|FG001|Overall Study|Lack of Efficacy|9|||
163240809|NCT00560833|589590357|FG002|Overall Study|Lack of Efficacy|6|||
163240810|NCT00560833|589590358|FG003|Overall Study|Lack of Efficacy|4|||
163240811|NCT00560833|589590359|FG004|Overall Study|Lack of Efficacy|4|||
163240812|NCT00560833|589590355|FG000|Overall Study|Participant uncooperative|5|||
163240813|NCT00560833|589590356|FG001|Overall Study|Participant uncooperative|5|||
163240814|NCT00560833|589590357|FG002|Overall Study|Participant uncooperative|4|||
163240815|NCT00560833|589590358|FG003|Overall Study|Participant uncooperative|4|||
163240816|NCT00560833|589590359|FG004|Overall Study|Participant uncooperative|2|||
163240817|NCT00560833|589590355|FG000|Overall Study|Other|1|||
163240818|NCT00560833|589590356|FG001|Overall Study|Other|1|||
163240819|NCT00560833|589590357|FG002|Overall Study|Other|3|||
163240820|NCT00560833|589590358|FG003|Overall Study|Other|0|||
163240821|NCT00560833|589590359|FG004|Overall Study|Other|0|||
163349903|NCT00352053|589990914|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
163240822|NCT00560833|589590355|FG000|Overall Study|Never received drug|0|||
163240823|NCT00560833|589590356|FG001|Overall Study|Never received drug|1|||
163240824|NCT00560833|589590357|FG002|Overall Study|Never received drug|0|||
163349904|NCT00352053|589990915|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
163349905|NCT02435381|589990916|FG000|Overall Study|Lost to Follow-up|2|||
163349906|NCT02435381|589990917|FG001|Overall Study|Lost to Follow-up|1|||
163349907|NCT04150341|589990920|FG000|Overall Study|Physician Decision|0|||
163349908|NCT04150341|589990921|FG001|Overall Study|Physician Decision|0|||
163349909|NCT04150341|589990922|FG002|Overall Study|Physician Decision|1|||
163240825|NCT00560833|589590358|FG003|Overall Study|Never received drug|0|||
163240826|NCT00560833|589590359|FG004|Overall Study|Never received drug|1|||
163240827|NCT03283670|589590360|FG000|Placebo Gas|Withdrawal by Subject|2|||
163240828|NCT03283670|589590360|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
163240829|NCT03283670|589590360|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
163240830|NCT01307501|589590363|FG000|Overall Study|Treatment Failure|1|||
163240831|NCT01307501|589590363|FG000|Overall Study|Death|20|||
163240832|NCT01307501|589590363|FG000|Overall Study|Lost to Follow-up|1|||
163240833|NCT01307501|589590363|FG000|Overall Study|Starting Hospice|1|||
163240834|NCT01209624|589590367|FG000|Overall Study|Death|2|||
163240835|NCT01209624|589590367|FG000|Overall Study|Adverse Event|13|||
163240836|NCT01209624|589590367|FG000|Overall Study|Lack of Efficacy|17|||
163240837|NCT01209624|589590367|FG000|Overall Study|Lost to Follow-up|290|||
163240838|NCT01209624|589590367|FG000|Overall Study|Other|4|||
163240839|NCT03564496|589590368|FG000|Overall Study|Withdrawal by Subject|1|||
163240840|NCT03564496|589590369|FG001|Overall Study|Withdrawal by Subject|1|||
163240841|NCT03564496|589590370|FG002|Overall Study|Withdrawal by Subject|0|||
163240842|NCT03564496|589590368|FG000|Overall Study|Screen failure|0|||
163240843|NCT03564496|589590369|FG001|Overall Study|Screen failure|3|||
163240844|NCT03564496|589590370|FG002|Overall Study|Screen failure|0|||
163240845|NCT00428610|589590371|FG000|Overall Study|Death Due to Adverse Event|3|||
163240846|NCT00428610|589590372|FG001|Overall Study|Death Due to Adverse Event|0|||
163240847|NCT00428610|589590373|FG002|Overall Study|Death Due to Adverse Event|5|||
163240848|NCT00428610|589590371|FG000|Overall Study|Death Due to Progressive Disease|0|||
163240849|NCT00428610|589590372|FG001|Overall Study|Death Due to Progressive Disease|0|||
163240850|NCT00428610|589590373|FG002|Overall Study|Death Due to Progressive Disease|2|||
163240851|NCT00428610|589590371|FG000|Overall Study|Adverse Event|2|||
163240852|NCT00428610|589590372|FG001|Overall Study|Adverse Event|3|||
163240853|NCT00428610|589590373|FG002|Overall Study|Adverse Event|2|||
163240854|NCT00428610|589590371|FG000|Overall Study|Investigator Decision|2|||
163240855|NCT00428610|589590372|FG001|Overall Study|Investigator Decision|1|||
163240856|NCT00428610|589590373|FG002|Overall Study|Investigator Decision|1|||
163240857|NCT00428610|589590371|FG000|Overall Study|Progressive Disease|42|||
163240858|NCT00428610|589590372|FG001|Overall Study|Progressive Disease|14|||
163240859|NCT00428610|589590373|FG002|Overall Study|Progressive Disease|22|||
163240860|NCT00428610|589590371|FG000|Overall Study|Withdrawal by Subject|4|||
163240861|NCT00428610|589590372|FG001|Overall Study|Withdrawal by Subject|0|||
163240862|NCT00428610|589590373|FG002|Overall Study|Withdrawal by Subject|0|||
163240863|NCT00791765|589592467|FG000|Weeks 1 to 12|Adverse Event|0|||
163240864|NCT00791765|589592468|FG001|Weeks 1 to 12|Adverse Event|1|||
163240865|NCT00791765|589592467|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
163240866|NCT00791765|589592468|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
163240867|NCT00791765|589592467|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
163240868|NCT00791765|589592468|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
163240869|NCT00791765|589592467|FG000|Weeks 1 to 12|Physician Decision|1|||
163240870|NCT00791765|589592468|FG001|Weeks 1 to 12|Physician Decision|0|||
163240871|NCT00791765|589592467|FG000|Weeks 1 to 12|Disease progression|3|||
163240872|NCT00791765|589592468|FG001|Weeks 1 to 12|Disease progression|0|||
163240873|NCT00791765|589592467|FG000|Weeks 1 to 12|Ineligibility determined|0|||
163240874|NCT00791765|589592468|FG001|Weeks 1 to 12|Ineligibility determined|3|||
163240875|NCT00791765|589592467|FG000|Weeks 13 to 24|Protocol deviation|2|||
163240876|NCT00791765|589592468|FG001|Weeks 13 to 24|Protocol deviation|0|||
163240877|NCT00791765|589592467|FG000|Weeks 13 to 24|Adverse Event|0|||
163240878|NCT00791765|589592468|FG001|Weeks 13 to 24|Adverse Event|3|||
163240879|NCT00791765|589592467|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
163240880|NCT00791765|589592468|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
163240881|NCT00791765|589592467|FG000|Weeks 13 to 24|Disease progression|0|||
163240882|NCT00791765|589592468|FG001|Weeks 13 to 24|Disease progression|1|||
163240883|NCT00791765|589592467|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
163349910|NCT04150341|589990923|FG003|Overall Study|Physician Decision|0|||
163349911|NCT04150341|589990924|FG004|Overall Study|Physician Decision|0|||
163349912|NCT04150341|589990925|FG005|Overall Study|Physician Decision|0|||
163349913|NCT04150341|589990920|FG000|Overall Study|Adverse Event|0|||
163349914|NCT04150341|589990921|FG001|Overall Study|Adverse Event|0|||
163349915|NCT04150341|589990922|FG002|Overall Study|Adverse Event|0|||
163349916|NCT04150341|589990923|FG003|Overall Study|Adverse Event|0|||
163349917|NCT04150341|589990924|FG004|Overall Study|Adverse Event|1|||
163145904|NCT00383552|589244457|FG001|Overall Study|Administrative|0|||
163145905|NCT00383552|589244458|FG002|Overall Study|Administrative|1|||
163145906|NCT00383552|589244459|FG003|Overall Study|Administrative|1|||
163145907|NCT01381016|589244461|FG000|Overall Study|Lost to Follow-up|1|||
163145908|NCT01381016|589244462|FG001|Overall Study|Lost to Follow-up|1|||
163145909|NCT01381016|589244461|FG000|Overall Study|Screen Failure|2|||
163145910|NCT01381016|589244462|FG001|Overall Study|Screen Failure|2|||
163145911|NCT01381016|589244461|FG000|Overall Study|Withdrawal by Subject|0|||
163145912|NCT01381016|589244462|FG001|Overall Study|Withdrawal by Subject|1|||
163145913|NCT01381016|589244461|FG000|Overall Study|Physician Decision|0|||
163145914|NCT01381016|589244462|FG001|Overall Study|Physician Decision|2|||
163349918|NCT04150341|589990925|FG005|Overall Study|Adverse Event|0|||
163145915|NCT03598036|589244468|FG000|Overall Study|Withdrawal by Subject|1|||
163145916|NCT03598036|589244469|FG001|Overall Study|Withdrawal by Subject|0|||
163145917|NCT05801991|589244473|FG000|Overall Study|Lost to Follow-up|1|||
163145918|NCT05801991|589244474|FG001|Overall Study|Lost to Follow-up|0|||
163145919|NCT01838694|589244475|FG000|Overall Study|Adverse Event|0|||
163145920|NCT01838694|589244476|FG001|Overall Study|Adverse Event|1|||
163145921|NCT04235140|589244477|FG000|Overall Study|Adverse Event|2|||
163145922|NCT04235140|589244477|FG000|Overall Study|Lost to Follow-up|1|||
163145923|NCT04235140|589244477|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
163145924|NCT04235140|589244477|FG000|Overall Study|Commercial drug is available for participants|7|||
163145925|NCT03016312|589244478|FG000|Overall Study|discontinued before the treatment started|0|||
163145926|NCT03016312|589244479|FG001|Overall Study|discontinued before the treatment started|1|||
163145927|NCT03016312|589244478|FG000|Overall Study|Withdrawal by Subject|37|||
163145928|NCT03016312|589244479|FG001|Overall Study|Withdrawal by Subject|44|||
163145929|NCT03016312|589244478|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
163145930|NCT03016312|589244479|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
163145931|NCT03016312|589244478|FG000|Overall Study|Physician Decision|1|||
163145932|NCT03016312|589244479|FG001|Overall Study|Physician Decision|3|||
163145933|NCT03016312|589244478|FG000|Overall Study|Lost to Follow-up|12|||
163145934|NCT03016312|589244479|FG001|Overall Study|Lost to Follow-up|12|||
163145935|NCT03016312|589244478|FG000|Overall Study|Death|210|||
163145936|NCT03016312|589244479|FG001|Overall Study|Death|184|||
163145937|NCT03016312|589244478|FG000|Overall Study|loss to contact|1|||
163145938|NCT03016312|589244479|FG001|Overall Study|loss to contact|0|||
163145939|NCT03016312|589244478|FG000|Overall Study|started a new cancer therapy|1|||
163145940|NCT03016312|589244479|FG001|Overall Study|started a new cancer therapy|0|||
163145941|NCT01451723|589244481|FG000|Overall Study|study halted|6|||
163145942|NCT01451723|589244482|FG001|Overall Study|study halted|5|||
163145943|NCT02210000|589244483|FG000|Overall Study|Study Terminated|11|||
163145944|NCT02210000|589244484|FG001|Overall Study|Study Terminated|12|||
163145945|NCT02210000|589244483|FG000|Overall Study|Withdrawal by Subject|7|||
163145946|NCT02210000|589244484|FG001|Overall Study|Withdrawal by Subject|1|||
163145947|NCT02210000|589244483|FG000|Overall Study|Adverse Event|1|||
163145948|NCT02210000|589244484|FG001|Overall Study|Adverse Event|5|||
163145949|NCT02210000|589244483|FG000|Overall Study|Lost to Follow-up|0|||
163145950|NCT02210000|589244484|FG001|Overall Study|Lost to Follow-up|2|||
163145951|NCT02210000|589244483|FG000|Overall Study|Physician Decision|0|||
163145952|NCT02210000|589244484|FG001|Overall Study|Physician Decision|1|||
163145953|NCT00833040|589244485|FG000|Overall Study|Adverse Event|0|||
163145954|NCT00833040|589244486|FG001|Overall Study|Adverse Event|0|||
163145955|NCT00833040|589244487|FG002|Overall Study|Adverse Event|0|||
163145956|NCT00833040|589244488|FG003|Overall Study|Adverse Event|0|||
163145957|NCT00833040|589244489|FG004|Overall Study|Adverse Event|0|||
163145958|NCT00833040|589244490|FG005|Overall Study|Adverse Event|1|||
163240884|NCT00791765|589592468|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
163240885|NCT00791765|589592467|FG000|Weeks 13 to 24|Other|0|||
163240886|NCT00791765|589592468|FG001|Weeks 13 to 24|Other|1|||
163240887|NCT04295564|589592469|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
163240888|NCT04295564|589592470|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
163240889|NCT04537923|589592471|FG000|Overall Study|Adverse Event|2|||
163240890|NCT04537923|589592472|FG001|Overall Study|Adverse Event|1|||
163240891|NCT04537923|589592473|FG002|Overall Study|Adverse Event|2|||
163240892|NCT04537923|589592474|FG003|Overall Study|Adverse Event|4|||
163240893|NCT04537923|589592471|FG000|Overall Study|Death|3|||
163240894|NCT04537923|589592472|FG001|Overall Study|Death|3|||
163240895|NCT04537923|589592473|FG002|Overall Study|Death|1|||
163240896|NCT04537923|589592474|FG003|Overall Study|Death|11|||
163240897|NCT04537923|589592471|FG000|Overall Study|Lost to Follow-up|1|||
163240898|NCT04537923|589592472|FG001|Overall Study|Lost to Follow-up|2|||
163240899|NCT04537923|589592473|FG002|Overall Study|Lost to Follow-up|1|||
163240900|NCT04537923|589592474|FG003|Overall Study|Lost to Follow-up|6|||
163240901|NCT04537923|589592471|FG000|Overall Study|Physician Decision|1|||
163240902|NCT04537923|589592472|FG001|Overall Study|Physician Decision|0|||
163240903|NCT04537923|589592473|FG002|Overall Study|Physician Decision|2|||
163240904|NCT04537923|589592474|FG003|Overall Study|Physician Decision|5|||
163240905|NCT04537923|589592471|FG000|Overall Study|Pregnancy|1|||
163240906|NCT04537923|589592472|FG001|Overall Study|Pregnancy|0|||
163240907|NCT04537923|589592473|FG002|Overall Study|Pregnancy|0|||
163240908|NCT04537923|589592474|FG003|Overall Study|Pregnancy|0|||
163240909|NCT04537923|589592471|FG000|Overall Study|Withdrawal by Subject|4|||
163240910|NCT04537923|589592472|FG001|Overall Study|Withdrawal by Subject|4|||
163240911|NCT04537923|589592473|FG002|Overall Study|Withdrawal by Subject|4|||
163240912|NCT04537923|589592474|FG003|Overall Study|Withdrawal by Subject|58|||
163240913|NCT04537923|589592471|FG000|Overall Study|Missed study visits|2|||
163240914|NCT04537923|589592472|FG001|Overall Study|Missed study visits|0|||
163240915|NCT04537923|589592473|FG002|Overall Study|Missed study visits|0|||
163240916|NCT04537923|589592474|FG003|Overall Study|Missed study visits|3|||
163240917|NCT04537923|589592471|FG000|Overall Study|Sponsor's decision|0|||
163240918|NCT04537923|589592472|FG001|Overall Study|Sponsor's decision|0|||
163349919|NCT00875615|589990926|FG000|Overall Study|Withdrawal by Subject|1|||
163349920|NCT00405912|589990928|FG000|Overall Study|Withdrawal by Subject|12|||
163349921|NCT00405912|589990929|FG001|Overall Study|Withdrawal by Subject|11|||
163349922|NCT00405912|589990930|FG002|Overall Study|Withdrawal by Subject|12|||
163349923|NCT00405912|589990928|FG000|Overall Study|Lost to Follow-up|4|||
163039240|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
163039241|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
163039242|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
163039243|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
163039244|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
163039245|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
163039246|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
163039247|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
163039248|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
163039249|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
163039250|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
163039251|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
163039252|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
163039253|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
163039254|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
163039255|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
163145959|NCT01731912|589244501|FG000|Overall Study|noncompliance|2|||
163145960|NCT02043938|589244502|FG000|Overall Study|Withdrawal by Subject|7|||
163145961|NCT02043938|589244502|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
163145962|NCT02043938|589244502|FG000|Overall Study|No show by subject|1|||
163145963|NCT02043938|589244502|FG000|Overall Study|Investigator decision|1|||
163145964|NCT00443040|589244505|FG000|Overall Study|Withdrawal by Subject|1|||
163145965|NCT00443040|589244506|FG001|Overall Study|Withdrawal by Subject|0|||
163145966|NCT00443040|589244507|FG002|Overall Study|Withdrawal by Subject|0|||
163145967|NCT00443040|589244505|FG000|Overall Study|Converted to an open laparotomy|3|||
163145968|NCT00443040|589244506|FG001|Overall Study|Converted to an open laparotomy|0|||
163145969|NCT00443040|589244507|FG002|Overall Study|Converted to an open laparotomy|1|||
163145970|NCT01755234|589244510|FG000|Overall Study|Lost to Follow-up|11|||
163145971|NCT01755234|589244511|FG001|Overall Study|Lost to Follow-up|6|||
163145972|NCT01755234|589244510|FG000|Overall Study|Change in surgical case|2|||
163145973|NCT01755234|589244511|FG001|Overall Study|Change in surgical case|1|||
163145974|NCT01755234|589244510|FG000|Overall Study|case cancelled|1|||
163145975|NCT01755234|589244511|FG001|Overall Study|case cancelled|0|||
163145976|NCT01755234|589244510|FG000|Overall Study|Withdrawal by Subject|0|||
163145977|NCT01755234|589244511|FG001|Overall Study|Withdrawal by Subject|1|||
163145978|NCT01755234|589244510|FG000|Overall Study|unblinded|1|||
163145979|NCT01755234|589244511|FG001|Overall Study|unblinded|0|||
163145980|NCT02836652|589244512|FG000|Overall Study|Death|3|||
163145981|NCT02836652|589244513|FG001|Overall Study|Death|3|||
163145982|NCT02836652|589244512|FG000|Overall Study|Transplant/Explant|3|||
163145983|NCT02836652|589244513|FG001|Overall Study|Transplant/Explant|4|||
163145984|NCT02836652|589244512|FG000|Overall Study|Withdrawn|9|||
163145985|NCT02836652|589244513|FG001|Overall Study|Withdrawn|9|||
163145986|NCT02836652|589244512|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
163145987|NCT02836652|589244513|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
163145988|NCT03812380|589244514|FG000|Overall Study|Protocol Violation|3|||
163145989|NCT03812380|589244515|FG001|Overall Study|Protocol Violation|3|||
163145990|NCT03812380|589244514|FG000|Overall Study|Withdrawal by Subject|5|||
163145991|NCT03812380|589244515|FG001|Overall Study|Withdrawal by Subject|4|||
163145992|NCT03812380|589244514|FG000|Overall Study|Early termination of study|14|||
163145993|NCT03812380|589244515|FG001|Overall Study|Early termination of study|14|||
163145994|NCT02349633|589244517|FG000|Overall Study|Death|0|||
163145995|NCT02349633|589244518|FG001|Overall Study|Death|1|||
163145996|NCT02349633|589244519|FG002|Overall Study|Death|0|||
163145997|NCT02349633|589244520|FG003|Overall Study|Death|0|||
163145998|NCT02349633|589244521|FG004|Overall Study|Death|0|||
163145999|NCT02349633|589244522|FG005|Overall Study|Death|1|||
163146000|NCT02349633|589244523|FG006|Overall Study|Death|1|||
163146001|NCT02349633|589244524|FG007|Overall Study|Death|1|||
163146002|NCT02349633|589244525|FG008|Overall Study|Death|0|||
163146003|NCT02349633|589244526|FG009|Overall Study|Death|1|||
163146004|NCT02349633|589244527|FG010|Overall Study|Death|0|||
163146005|NCT02349633|589244528|FG011|Overall Study|Death|0|||
163146006|NCT02349633|589244529|FG012|Overall Study|Death|0|||
163146007|NCT02349633|589244530|FG013|Overall Study|Death|0|||
163146008|NCT02349633|589244517|FG000|Overall Study|Withdrawal by Subject|0|||
163146009|NCT02349633|589244518|FG001|Overall Study|Withdrawal by Subject|0|||
163146010|NCT02349633|589244519|FG002|Overall Study|Withdrawal by Subject|0|||
163240919|NCT04537923|589592473|FG002|Overall Study|Sponsor's decision|1|||
163240920|NCT04537923|589592474|FG003|Overall Study|Sponsor's decision|1|||
163240921|NCT04537923|589592471|FG000|Overall Study|Safety reasons|1|||
163409823|NCT04418765|590209517|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
163409824|NCT04418765|590209518|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
163240922|NCT04537923|589592472|FG001|Overall Study|Safety reasons|0|||
163240923|NCT04537923|589592473|FG002|Overall Study|Safety reasons|0|||
163240924|NCT04537923|589592474|FG003|Overall Study|Safety reasons|0|||
163240925|NCT01261611|589592475|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
163240926|NCT01261611|589592476|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
163240927|NCT01261611|589592477|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
163039256|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
163039257|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
163039258|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
163039259|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
163409825|NCT04418765|590209516|FG000|Extension Period (48 Weeks)|Other than specified|0|||
163409826|NCT04418765|590209517|FG001|Extension Period (48 Weeks)|Other than specified|5|||
163409827|NCT04418765|590209518|FG002|Extension Period (48 Weeks)|Other than specified|2|||
163146011|NCT02349633|589244520|FG003|Overall Study|Withdrawal by Subject|1|||
163146012|NCT02349633|589244521|FG004|Overall Study|Withdrawal by Subject|0|||
163146013|NCT02349633|589244522|FG005|Overall Study|Withdrawal by Subject|0|||
163146014|NCT02349633|589244523|FG006|Overall Study|Withdrawal by Subject|0|||
163146015|NCT02349633|589244524|FG007|Overall Study|Withdrawal by Subject|2|||
163146016|NCT02349633|589244525|FG008|Overall Study|Withdrawal by Subject|2|||
163146017|NCT02349633|589244526|FG009|Overall Study|Withdrawal by Subject|1|||
163146018|NCT02349633|589244527|FG010|Overall Study|Withdrawal by Subject|0|||
163146019|NCT02349633|589244528|FG011|Overall Study|Withdrawal by Subject|0|||
163146020|NCT02349633|589244529|FG012|Overall Study|Withdrawal by Subject|0|||
163146021|NCT02349633|589244530|FG013|Overall Study|Withdrawal by Subject|0|||
163146022|NCT02349633|589244517|FG000|Overall Study|Withdrawal of informed consent|0|||
163146023|NCT02349633|589244518|FG001|Overall Study|Withdrawal of informed consent|0|||
163146024|NCT02349633|589244519|FG002|Overall Study|Withdrawal of informed consent|0|||
163146025|NCT02349633|589244520|FG003|Overall Study|Withdrawal of informed consent|1|||
163146026|NCT02349633|589244521|FG004|Overall Study|Withdrawal of informed consent|1|||
163146027|NCT02349633|589244522|FG005|Overall Study|Withdrawal of informed consent|0|||
163146028|NCT02349633|589244523|FG006|Overall Study|Withdrawal of informed consent|0|||
163146029|NCT02349633|589244524|FG007|Overall Study|Withdrawal of informed consent|3|||
163146030|NCT02349633|589244525|FG008|Overall Study|Withdrawal of informed consent|0|||
163146031|NCT02349633|589244526|FG009|Overall Study|Withdrawal of informed consent|0|||
163146032|NCT02349633|589244527|FG010|Overall Study|Withdrawal of informed consent|0|||
163146033|NCT02349633|589244528|FG011|Overall Study|Withdrawal of informed consent|0|||
163146034|NCT02349633|589244529|FG012|Overall Study|Withdrawal of informed consent|0|||
163146035|NCT02349633|589244530|FG013|Overall Study|Withdrawal of informed consent|0|||
163146036|NCT02349633|589244517|FG000|Overall Study|Transition to compassionate use|0|||
163146037|NCT02349633|589244518|FG001|Overall Study|Transition to compassionate use|0|||
163146038|NCT02349633|589244519|FG002|Overall Study|Transition to compassionate use|0|||
163146039|NCT02349633|589244520|FG003|Overall Study|Transition to compassionate use|0|||
163146040|NCT02349633|589244521|FG004|Overall Study|Transition to compassionate use|1|||
163146041|NCT02349633|589244522|FG005|Overall Study|Transition to compassionate use|0|||
163146042|NCT02349633|589244523|FG006|Overall Study|Transition to compassionate use|0|||
163146043|NCT02349633|589244524|FG007|Overall Study|Transition to compassionate use|3|||
163146044|NCT02349633|589244525|FG008|Overall Study|Transition to compassionate use|0|||
163146045|NCT02349633|589244526|FG009|Overall Study|Transition to compassionate use|1|||
163146046|NCT02349633|589244527|FG010|Overall Study|Transition to compassionate use|0|||
163146047|NCT02349633|589244528|FG011|Overall Study|Transition to compassionate use|0|||
163146048|NCT02349633|589244529|FG012|Overall Study|Transition to compassionate use|0|||
163146049|NCT02349633|589244530|FG013|Overall Study|Transition to compassionate use|0|||
163146050|NCT02349633|589244517|FG000|Overall Study|Early termination of survival follow-up|0|||
163146051|NCT02349633|589244518|FG001|Overall Study|Early termination of survival follow-up|0|||
163146052|NCT02349633|589244519|FG002|Overall Study|Early termination of survival follow-up|0|||
163146053|NCT02349633|589244520|FG003|Overall Study|Early termination of survival follow-up|0|||
163146054|NCT02349633|589244521|FG004|Overall Study|Early termination of survival follow-up|0|||
163146055|NCT02349633|589244522|FG005|Overall Study|Early termination of survival follow-up|0|||
163146056|NCT02349633|589244523|FG006|Overall Study|Early termination of survival follow-up|0|||
163146057|NCT02349633|589244524|FG007|Overall Study|Early termination of survival follow-up|4|||
163146058|NCT02349633|589244525|FG008|Overall Study|Early termination of survival follow-up|0|||
163146059|NCT02349633|589244526|FG009|Overall Study|Early termination of survival follow-up|0|||
163240928|NCT01261611|589592475|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
163039260|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
163039261|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
163349924|NCT00405912|589990929|FG001|Overall Study|Lost to Follow-up|8|||
163349925|NCT00405912|589990930|FG002|Overall Study|Lost to Follow-up|4|||
163146060|NCT02349633|589244527|FG010|Overall Study|Early termination of survival follow-up|0|||
163146061|NCT02349633|589244528|FG011|Overall Study|Early termination of survival follow-up|0|||
163146062|NCT02349633|589244529|FG012|Overall Study|Early termination of survival follow-up|0|||
163146063|NCT02349633|589244530|FG013|Overall Study|Early termination of survival follow-up|0|||
163146064|NCT02349633|589244517|FG000|Overall Study|Termination by sponsor|0|||
163146065|NCT02349633|589244518|FG001|Overall Study|Termination by sponsor|0|||
163146066|NCT02349633|589244519|FG002|Overall Study|Termination by sponsor|0|||
163146067|NCT02349633|589244520|FG003|Overall Study|Termination by sponsor|0|||
163146068|NCT02349633|589244521|FG004|Overall Study|Termination by sponsor|0|||
163146069|NCT02349633|589244522|FG005|Overall Study|Termination by sponsor|0|||
163146070|NCT02349633|589244523|FG006|Overall Study|Termination by sponsor|0|||
163146071|NCT02349633|589244524|FG007|Overall Study|Termination by sponsor|1|||
163146072|NCT02349633|589244525|FG008|Overall Study|Termination by sponsor|0|||
163146073|NCT02349633|589244526|FG009|Overall Study|Termination by sponsor|2|||
163146074|NCT02349633|589244527|FG010|Overall Study|Termination by sponsor|0|||
163146075|NCT02349633|589244528|FG011|Overall Study|Termination by sponsor|0|||
163146076|NCT02349633|589244529|FG012|Overall Study|Termination by sponsor|0|||
163146077|NCT02349633|589244530|FG013|Overall Study|Termination by sponsor|0|||
163146078|NCT02349633|589244517|FG000|Overall Study|Other|0|||
163146079|NCT02349633|589244518|FG001|Overall Study|Other|0|||
163146080|NCT02349633|589244519|FG002|Overall Study|Other|0|||
163146081|NCT02349633|589244520|FG003|Overall Study|Other|0|||
163146082|NCT02349633|589244521|FG004|Overall Study|Other|0|||
163146083|NCT02349633|589244522|FG005|Overall Study|Other|0|||
163146084|NCT02349633|589244523|FG006|Overall Study|Other|0|||
163146085|NCT02349633|589244524|FG007|Overall Study|Other|2|||
163146086|NCT02349633|589244525|FG008|Overall Study|Other|0|||
163146087|NCT02349633|589244526|FG009|Overall Study|Other|0|||
163146088|NCT02349633|589244527|FG010|Overall Study|Other|0|||
163146089|NCT02349633|589244528|FG011|Overall Study|Other|0|||
163146090|NCT02349633|589244529|FG012|Overall Study|Other|0|||
163146091|NCT02349633|589244530|FG013|Overall Study|Other|0|||
163146092|NCT00667628|589244531|FG000|Overall Study|Lost to Follow-up|1|||
163146093|NCT00667628|589244532|FG001|Overall Study|Lost to Follow-up|0|||
163146094|NCT00667628|589244531|FG000|Overall Study|Death|6|||
163146095|NCT00667628|589244532|FG001|Overall Study|Death|6|||
163146096|NCT00667628|589244531|FG000|Overall Study|Investigator Considers in Best Interest|1|||
163146097|NCT00667628|589244532|FG001|Overall Study|Investigator Considers in Best Interest|0|||
163146098|NCT00667628|589244531|FG000|Overall Study|Sponsor Terminated Study|17|||
163146099|NCT00667628|589244532|FG001|Overall Study|Sponsor Terminated Study|21|||
163146100|NCT05789745|589244533|FG000|Overall Study|Withdrawal by Subject|0|||
163146101|NCT05789745|589244534|FG001|Overall Study|Withdrawal by Subject|0|||
163146102|NCT05789745|589244535|FG002|Overall Study|Withdrawal by Subject|0|||
163146103|NCT05789745|589244536|FG003|Overall Study|Withdrawal by Subject|0|||
163146104|NCT05789745|589244537|FG004|Overall Study|Withdrawal by Subject|1|||
163146105|NCT04663321|589244538|FG000|Overall Study|Study terminated by Sponsor|2|||
163146106|NCT04663321|589244539|FG001|Overall Study|Study terminated by Sponsor|1|||
163146107|NCT04663321|589244540|FG002|Overall Study|Study terminated by Sponsor|2|||
163146108|NCT04663321|589244538|FG000|Overall Study|Withdrawal by Subject|10|||
163146109|NCT04663321|589244539|FG001|Overall Study|Withdrawal by Subject|3|||
163146110|NCT04663321|589244540|FG002|Overall Study|Withdrawal by Subject|2|||
163146111|NCT04663321|589244538|FG000|Overall Study|Not provided|0|||
163146112|NCT04663321|589244539|FG001|Overall Study|Not provided|0|||
163146113|NCT04663321|589244540|FG002|Overall Study|Not provided|1|||
163146114|NCT00622505|589244543|FG000|Overall Study|Adverse Event|9|||
163146115|NCT00622505|589244544|FG001|Overall Study|Adverse Event|7|||
163146116|NCT00622505|589244543|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
163146117|NCT00622505|589244544|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
163146118|NCT00622505|589244543|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
163146119|NCT00622505|589244544|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
163146120|NCT00622505|589244543|FG000|Overall Study|Withdrawal by Subject|12|||
163146121|NCT00622505|589244544|FG001|Overall Study|Withdrawal by Subject|5|||
163146122|NCT00622505|589244543|FG000|Overall Study|Administrative Problems|2|||
163146123|NCT00622505|589244544|FG001|Overall Study|Administrative Problems|4|||
163146124|NCT00622505|589244543|FG000|Overall Study|Death|2|||
163146125|NCT00622505|589244544|FG001|Overall Study|Death|2|||
163146126|NCT00619515|589244545|FG000|Overall Study|Study Termination by IRB|73|||
163146127|NCT03294590|589244548|FG000|Overall Study|Lost to Follow-up|105|||
163146128|NCT03294590|589244549|FG001|Overall Study|Lost to Follow-up|107|||
163146129|NCT01962441|589244552|FG000|Randomized Period|Randomized but Never Treated|4|||
163146130|NCT01962441|589244553|FG001|Randomized Period|Randomized but Never Treated|2|||
163146131|NCT01962441|589244554|FG002|Randomized Period|Randomized but Never Treated|3|||
163146132|NCT01962441|589244552|FG000|Randomized Period|Lost to Follow-up|2|||
163146133|NCT01962441|589244553|FG001|Randomized Period|Lost to Follow-up|4|||
163349926|NCT03730662|589990931|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
163349927|NCT03730662|589990932|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
163349928|NCT03730662|589990933|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
163349929|NCT03730662|589990934|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
163349930|NCT03730662|589990931|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
163349931|NCT03730662|589990932|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
163349932|NCT03730662|589990933|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
163349933|NCT03730662|589990934|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
163349934|NCT03730662|589990931|FG000|Treatment Period (52 Weeks)|Death|6|||
163349935|NCT03730662|589990932|FG001|Treatment Period (52 Weeks)|Death|2|||
163349936|NCT03730662|589990933|FG002|Treatment Period (52 Weeks)|Death|2|||
163349937|NCT03730662|589990934|FG003|Treatment Period (52 Weeks)|Death|9|||
163349938|NCT03730662|589990931|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
163349939|NCT03730662|589990932|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
163349940|NCT03730662|589990933|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
163349941|NCT03730662|589990934|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
163349942|NCT03730662|589990931|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
163349943|NCT03730662|589990932|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
163349944|NCT03730662|589990933|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
163349945|NCT03730662|589990934|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
163349946|NCT03730662|589990931|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
163349947|NCT03730662|589990932|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
163349948|NCT03730662|589990933|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
163349949|NCT03730662|589990934|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
163349950|NCT03730662|589990931|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
163349951|NCT03730662|589990932|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
163349952|NCT03730662|589990933|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
163349953|NCT03730662|589990934|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
163146134|NCT01962441|589244554|FG002|Randomized Period|Lost to Follow-up|4|||
163146135|NCT01962441|589244552|FG000|Randomized Period|Withdrew Consent|3|||
163146136|NCT01962441|589244553|FG001|Randomized Period|Withdrew Consent|3|||
163146137|NCT01962441|589244554|FG002|Randomized Period|Withdrew Consent|2|||
163146138|NCT01962441|589244552|FG000|Randomized Period|Adverse Event|1|||
163146139|NCT01962441|589244553|FG001|Randomized Period|Adverse Event|1|||
163146140|NCT01962441|589244554|FG002|Randomized Period|Adverse Event|0|||
163146141|NCT01962441|589244552|FG000|Randomized Period|Death|0|||
163146142|NCT01962441|589244553|FG001|Randomized Period|Death|0|||
163146143|NCT01962441|589244554|FG002|Randomized Period|Death|2|||
163146144|NCT01962441|589244552|FG000|Randomized Period|Protocol Violation|0|||
163146145|NCT01962441|589244553|FG001|Randomized Period|Protocol Violation|1|||
163146146|NCT01962441|589244554|FG002|Randomized Period|Protocol Violation|0|||
163146147|NCT01962441|589244552|FG000|Retreatment Substudy|Lack of Efficacy|1|||
163146148|NCT01962441|589244553|FG001|Retreatment Substudy|Lack of Efficacy|0|||
163146149|NCT01962441|589244554|FG002|Retreatment Substudy|Lack of Efficacy|0|||
163146150|NCT01962441|589244552|FG000|Retreatment Substudy|Lost to Follow-up|1|||
163146151|NCT01962441|589244553|FG001|Retreatment Substudy|Lost to Follow-up|0|||
163146152|NCT01962441|589244554|FG002|Retreatment Substudy|Lost to Follow-up|0|||
163146153|NCT04862065|589244555|FG000|Screening|Protocol Violation|54|||
163146154|NCT04862065|589244556|FG001|Screening|Protocol Violation|0|||
163146155|NCT04862065|589244557|FG002|Screening|Protocol Violation|0|||
163146156|NCT04862065|589244555|FG000|Screening|Insufficient Sample|1|||
163146157|NCT04862065|589244556|FG001|Screening|Insufficient Sample|0|||
163146158|NCT04862065|589244557|FG002|Screening|Insufficient Sample|0|||
163146159|NCT04862065|589244555|FG000|Follow-Up|Lost to Follow-up|3|||
163146160|NCT04862065|589244556|FG001|Follow-Up|Lost to Follow-up|0|||
163146161|NCT04862065|589244557|FG002|Follow-Up|Lost to Follow-up|0|||
163146162|NCT01453140|589244558|FG000|Overall Study|Adverse Event|3|||
163146163|NCT00718510|589244559|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
163146164|NCT00718510|589244560|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
163146165|NCT00718510|589244559|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
163146166|NCT00718510|589244560|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
163146167|NCT00423657|589244562|FG000|Overall Study|Withdrew consent|10|||
163146168|NCT00423657|589244563|FG001|Overall Study|Withdrew consent|8|||
163146169|NCT00423657|589244562|FG000|Overall Study|Non-compliance|0|||
163146170|NCT00423657|589244563|FG001|Overall Study|Non-compliance|1|||
163146171|NCT00423657|589244562|FG000|Overall Study|Other|15|||
163146172|NCT00423657|589244563|FG001|Overall Study|Other|16|||
163146173|NCT00423657|589244562|FG000|Overall Study|Request of sponsor/investigator|1|||
163146174|NCT00423657|589244563|FG001|Overall Study|Request of sponsor/investigator|0|||
163146175|NCT02269124|589244565|FG000|Overall Study|Lost to Follow-up|1|||
163146176|NCT02269124|589244566|FG001|Overall Study|Lost to Follow-up|0|||
163146177|NCT02269124|589244565|FG000|Overall Study|Withdrawal by Subject|0|||
163146178|NCT02269124|589244566|FG001|Overall Study|Withdrawal by Subject|2|||
163349954|NCT03730662|589990931|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
163349955|NCT03730662|589990932|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
163349956|NCT03730662|589990933|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
163349957|NCT03730662|589990934|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
163349958|NCT03730662|589990931|FG000|Variable Treatment Period|Adverse Event|1|||
163349959|NCT03730662|589990932|FG001|Variable Treatment Period|Adverse Event|2|||
163349960|NCT03730662|589990933|FG002|Variable Treatment Period|Adverse Event|0|||
163349961|NCT03730662|589990934|FG003|Variable Treatment Period|Adverse Event|7|||
163349962|NCT03730662|589990931|FG000|Variable Treatment Period|Death|9|||
163349963|NCT03730662|589990932|FG001|Variable Treatment Period|Death|0|||
163349964|NCT03730662|589990933|FG002|Variable Treatment Period|Death|6|||
163349965|NCT03730662|589990934|FG003|Variable Treatment Period|Death|26|||
163349966|NCT03730662|589990931|FG000|Variable Treatment Period|Lost to Follow-up|2|||
163349967|NCT03730662|589990932|FG001|Variable Treatment Period|Lost to Follow-up|1|||
163349968|NCT03730662|589990933|FG002|Variable Treatment Period|Lost to Follow-up|4|||
163349969|NCT03730662|589990934|FG003|Variable Treatment Period|Lost to Follow-up|11|||
163349970|NCT03730662|589990931|FG000|Variable Treatment Period|Personal Reason|0|||
163349971|NCT03730662|589990932|FG001|Variable Treatment Period|Personal Reason|2|||
163349972|NCT03730662|589990933|FG002|Variable Treatment Period|Personal Reason|1|||
163349973|NCT03730662|589990934|FG003|Variable Treatment Period|Personal Reason|6|||
163349974|NCT03730662|589990931|FG000|Variable Treatment Period|Physician Decision|0|||
163349975|NCT03730662|589990932|FG001|Variable Treatment Period|Physician Decision|0|||
163349976|NCT03730662|589990933|FG002|Variable Treatment Period|Physician Decision|0|||
163349977|NCT03730662|589990934|FG003|Variable Treatment Period|Physician Decision|3|||
163349978|NCT03730662|589990931|FG000|Variable Treatment Period|Protocol Violation|0|||
163349979|NCT03730662|589990932|FG001|Variable Treatment Period|Protocol Violation|1|||
163349980|NCT03730662|589990933|FG002|Variable Treatment Period|Protocol Violation|1|||
163349981|NCT03730662|589990934|FG003|Variable Treatment Period|Protocol Violation|1|||
163349982|NCT03730662|589990931|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
163349983|NCT03730662|589990932|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
163349984|NCT03730662|589990933|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
163349985|NCT03730662|589990934|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
163349986|NCT00833898|589990935|FG000|Overall Study|Withdrawal by Subject|33|||
163349987|NCT00833898|589990936|FG001|Overall Study|Withdrawal by Subject|27|||
163146179|NCT04664153|589244569|FG000|Overall Study|Lack of Efficacy|0|||
163146180|NCT04664153|589244570|FG001|Overall Study|Lack of Efficacy|0|||
163146181|NCT04664153|589244571|FG002|Overall Study|Lack of Efficacy|1|||
163146182|NCT04664153|589244572|FG003|Overall Study|Lack of Efficacy|0|||
163146183|NCT04664153|589244569|FG000|Overall Study|Physician Decision|0|||
163146184|NCT04664153|589244570|FG001|Overall Study|Physician Decision|0|||
163146185|NCT04664153|589244571|FG002|Overall Study|Physician Decision|1|||
163146186|NCT04664153|589244572|FG003|Overall Study|Physician Decision|0|||
163146187|NCT04664153|589244569|FG000|Overall Study|Withdrawal by Subject|3|||
163146188|NCT04664153|589244570|FG001|Overall Study|Withdrawal by Subject|2|||
163146189|NCT04664153|589244571|FG002|Overall Study|Withdrawal by Subject|1|||
163146190|NCT04664153|589244572|FG003|Overall Study|Withdrawal by Subject|2|||
163146191|NCT04664153|589244569|FG000|Overall Study|Other|0|||
163146192|NCT04664153|589244570|FG001|Overall Study|Other|1|||
163146193|NCT04664153|589244571|FG002|Overall Study|Other|0|||
163146194|NCT04664153|589244572|FG003|Overall Study|Other|0|||
163146195|NCT04664153|589244569|FG000|Overall Study|Adverse Event|4|||
163146196|NCT04664153|589244570|FG001|Overall Study|Adverse Event|0|||
163146197|NCT04664153|589244571|FG002|Overall Study|Adverse Event|1|||
163146198|NCT04664153|589244572|FG003|Overall Study|Adverse Event|0|||
163146199|NCT00231777|589244573|FG000|Overall Study|Lost to Follow-up|3|||
163146200|NCT00231777|589244574|FG001|Overall Study|Lost to Follow-up|0|||
163146201|NCT00231777|589244573|FG000|Overall Study|Other|3|||
163146202|NCT00231777|589244574|FG001|Overall Study|Other|2|||
163146203|NCT00524485|589244575|FG000|Overall Study|Withdrawal by Subject|5|||
163146204|NCT01600885|589244576|FG000|First Period|Adverse Event|1|||
163146205|NCT01600885|589244577|FG001|First Period|Adverse Event|1|||
163146206|NCT01600885|589244576|FG000|First Period|moved out of area|1|||
163146207|NCT01600885|589244577|FG001|First Period|moved out of area|0|||
163146208|NCT00642356|589244583|FG000|Overall Study|Adverse Event|1|||
163146209|NCT00642356|589244584|FG001|Overall Study|Adverse Event|0|||
163146210|NCT00642356|589244583|FG000|Overall Study|Protocol Violation|0|||
163146211|NCT00642356|589244584|FG001|Overall Study|Protocol Violation|3|||
163146212|NCT00642356|589244583|FG000|Overall Study|Lack of Efficacy|1|||
163146213|NCT00642356|589244584|FG001|Overall Study|Lack of Efficacy|0|||
163146214|NCT01009060|589244585|FG000|Overall Study|Adverse Event|1|||
163146215|NCT01009060|589244586|FG001|Overall Study|Adverse Event|2|||
163146216|NCT01009060|589244585|FG000|Overall Study|Protocol Violation|0|||
163146217|NCT01009060|589244586|FG001|Overall Study|Protocol Violation|1|||
163146218|NCT01009060|589244585|FG000|Overall Study|Lost to Follow-up|1|||
163146219|NCT01009060|589244586|FG001|Overall Study|Lost to Follow-up|0|||
163146220|NCT01009060|589244585|FG000|Overall Study|Physician Decision|1|||
163146221|NCT01009060|589244586|FG001|Overall Study|Physician Decision|1|||
163146222|NCT01009060|589244585|FG000|Overall Study|Withdrawal by Subject|1|||
163349988|NCT00833898|589990935|FG000|Overall Study|Lost to Follow-up|7|||
163349989|NCT00833898|589990936|FG001|Overall Study|Lost to Follow-up|7|||
163349990|NCT00833898|589990935|FG000|Overall Study|Patient did not receive transplant|0|||
163409828|NCT03345472|590209522|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
163409829|NCT03345472|590209522|FG000|Implant to 3 Months|Physician Decision|1|||
163409830|NCT03345472|590209522|FG000|Implant to 3 Months|Adverse Event|1|||
163409831|NCT03345472|590209522|FG000|3 Months to 12 Months|Physician Decision|3|||
163409832|NCT03345472|590209522|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
163409833|NCT03345472|590209522|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
163409834|NCT03345472|590209522|FG000|3 Months to 12 Months|Adverse Event|1|||
163409835|NCT03345472|590209522|FG000|3 Months to 12 Months|Death|1|||
163409836|NCT01926782|590209523|FG000|Overall Study|Participant moved|2|||
163409837|NCT01926782|590209524|FG001|Overall Study|Participant moved|0|||
163409838|NCT01926782|590209525|FG002|Overall Study|Participant moved|1|||
163409839|NCT01926782|590209526|FG003|Overall Study|Participant moved|1|||
163409840|NCT01926782|590209527|FG004|Overall Study|Participant moved|0|||
163409841|NCT01926782|590209528|FG005|Overall Study|Participant moved|3|||
163409842|NCT01926782|590209523|FG000|Overall Study|Physician Decision|0|||
163409843|NCT01926782|590209524|FG001|Overall Study|Physician Decision|2|||
163409844|NCT01926782|590209525|FG002|Overall Study|Physician Decision|1|||
163409845|NCT01926782|590209526|FG003|Overall Study|Physician Decision|1|||
163409846|NCT01926782|590209527|FG004|Overall Study|Physician Decision|0|||
163409847|NCT01926782|590209528|FG005|Overall Study|Physician Decision|0|||
163409848|NCT01926782|590209523|FG000|Overall Study|Other than specified|2|||
163409849|NCT01926782|590209524|FG001|Overall Study|Other than specified|3|||
163409850|NCT01926782|590209525|FG002|Overall Study|Other than specified|5|||
163409851|NCT01926782|590209526|FG003|Overall Study|Other than specified|12|||
163409852|NCT01926782|590209527|FG004|Overall Study|Other than specified|4|||
163039262|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
163039263|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
163039264|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
163039265|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
163039266|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
163039267|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
163146223|NCT01009060|589244586|FG001|Overall Study|Withdrawal by Subject|1|||
163146224|NCT00005906|589244587|FG000|Overall Study|Lack of Efficacy|3|||
163146225|NCT01945021|589244588|FG000|Overall Study|Adverse Event|1|||
163409853|NCT01926782|590209528|FG005|Overall Study|Other than specified|11|||
163409854|NCT01926782|590209523|FG000|Overall Study|Adverse Event|13|||
163409855|NCT01926782|590209524|FG001|Overall Study|Adverse Event|4|||
163409856|NCT01926782|590209525|FG002|Overall Study|Adverse Event|17|||
163146226|NCT01945021|589244588|FG000|Overall Study|Withdrawal of consent|12|||
163146227|NCT01945021|589244588|FG000|Overall Study|Lost to Follow-up|5|||
163146228|NCT01945021|589244588|FG000|Overall Study|Death|65|||
163146229|NCT03409796|589246153|FG000|Overall Study|Adverse Event|2|||
163146230|NCT03409796|589246154|FG001|Overall Study|Adverse Event|0|||
163146231|NCT03409796|589246153|FG000|Overall Study|Other|0|||
163146232|NCT03409796|589246154|FG001|Overall Study|Other|1|||
163146233|NCT00740220|589246155|FG000|Overall Study|screen failures (non-COPD patients)|9|||
163146234|NCT00770653|589246159|FG000|Overall Study|Adverse Event|13|||
163146235|NCT00770653|589246160|FG001|Overall Study|Adverse Event|5|||
163146236|NCT00770653|589246159|FG000|Overall Study|Protocol Violation|8|||
163146237|NCT00770653|589246160|FG001|Overall Study|Protocol Violation|6|||
163146238|NCT00770653|589246159|FG000|Overall Study|Withdrawal by Subject|4|||
163146239|NCT00770653|589246160|FG001|Overall Study|Withdrawal by Subject|7|||
163146240|NCT00770653|589246159|FG000|Overall Study|Lack of Compliance|1|||
163146241|NCT00770653|589246160|FG001|Overall Study|Lack of Compliance|4|||
163146242|NCT00770653|589246159|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
163146243|NCT00770653|589246160|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
163146244|NCT00770653|589246159|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
163146245|NCT00770653|589246160|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
163146246|NCT00770653|589246159|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
163146247|NCT00770653|589246160|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
163146248|NCT00770653|589246159|FG000|Overall Study|Lost to Follow-up|1|||
163146249|NCT00770653|589246160|FG001|Overall Study|Lost to Follow-up|2|||
163146250|NCT00770653|589246159|FG000|Overall Study|Physician Decision|1|||
163146251|NCT00770653|589246160|FG001|Overall Study|Physician Decision|0|||
163146252|NCT01908426|589246162|FG000|Overall Study|Adverse Event|98|||
163146253|NCT01908426|589246163|FG001|Overall Study|Adverse Event|11|||
163146254|NCT01908426|589246162|FG000|Overall Study|Clinical Deterioration|72|||
163146255|NCT01908426|589246163|FG001|Overall Study|Clinical Deterioration|38|||
163146256|NCT01908426|589246162|FG000|Overall Study|Lack of Efficacy|3|||
163146257|NCT01908426|589246163|FG001|Overall Study|Lack of Efficacy|0|||
163146258|NCT01908426|589246162|FG000|Overall Study|Lost to Follow-up|0|||
163146259|NCT01908426|589246163|FG001|Overall Study|Lost to Follow-up|1|||
163146260|NCT01908426|589246162|FG000|Overall Study|Physician Decision|3|||
163146261|NCT01908426|589246163|FG001|Overall Study|Physician Decision|3|||
163146262|NCT01908426|589246162|FG000|Overall Study|Withdrawal by Subject|11|||
163409857|NCT01926782|590209526|FG003|Overall Study|Adverse Event|4|||
163409858|NCT01926782|590209527|FG004|Overall Study|Adverse Event|3|||
163039268|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
163039269|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
163039270|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
163039271|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
163039272|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
163039273|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
163039274|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
163039275|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
163240929|NCT01261611|589592476|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
163240930|NCT01261611|589592477|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
163039276|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
163039277|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
163039278|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
163039279|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
163039280|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
163039281|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
163039282|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
163039283|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
163240931|NCT01261611|589592475|FG000|Treatment Cycle 1|Adverse Event|0|||
163039284|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
163039285|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
163039286|NCT01289574|588850692|FG000|Overall Study|Lack of Efficacy|4|||
163039287|NCT01289574|588850693|FG001|Overall Study|Lack of Efficacy|0|||
163039288|NCT01289574|588850694|FG002|Overall Study|Lack of Efficacy|1|||
163039289|NCT01289574|588850692|FG000|Overall Study|Lost to Follow-up|2|||
163240932|NCT01261611|589592476|FG001|Treatment Cycle 1|Adverse Event|1|||
163240933|NCT01261611|589592477|FG002|Treatment Cycle 1|Adverse Event|0|||
163240934|NCT01261611|589592475|FG000|Treatment Cycle 1|Protocol Violation|0|||
163240935|NCT01261611|589592476|FG001|Treatment Cycle 1|Protocol Violation|0|||
163240936|NCT01261611|589592477|FG002|Treatment Cycle 1|Protocol Violation|2|||
163240937|NCT01261611|589592475|FG000|Treatment Cycle 2|Completed study|4|||
163240938|NCT01261611|589592476|FG001|Treatment Cycle 2|Completed study|0|||
163240939|NCT01261611|589592477|FG002|Treatment Cycle 2|Completed study|0|||
163240940|NCT01261611|589592475|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
163240941|NCT01261611|589592476|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
163240942|NCT01261611|589592477|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
163240943|NCT01261611|589592475|FG000|Treatment Cycle 2|Adverse Event|1|||
163240944|NCT01261611|589592476|FG001|Treatment Cycle 2|Adverse Event|0|||
163240945|NCT01261611|589592477|FG002|Treatment Cycle 2|Adverse Event|0|||
163240946|NCT01261611|589592475|FG000|Treatment Cycle 2|Protocol Violation|2|||
163240947|NCT01261611|589592476|FG001|Treatment Cycle 2|Protocol Violation|0|||
163240948|NCT01261611|589592477|FG002|Treatment Cycle 2|Protocol Violation|0|||
163240949|NCT01261611|589592475|FG000|Treatment Cycle 2|Not otherwise specified|2|||
163039290|NCT01289574|588850693|FG001|Overall Study|Lost to Follow-up|0|||
163039291|NCT01289574|588850694|FG002|Overall Study|Lost to Follow-up|1|||
163039292|NCT01289574|588850692|FG000|Overall Study|Withdrawal by Subject|1|||
163039293|NCT01289574|588850693|FG001|Overall Study|Withdrawal by Subject|1|||
163240950|NCT01261611|589592476|FG001|Treatment Cycle 2|Not otherwise specified|0|||
163240951|NCT01261611|589592477|FG002|Treatment Cycle 2|Not otherwise specified|0|||
163240952|NCT01261611|589592475|FG000|Treatment Cycle 3|Completed study|24|||
163240953|NCT01261611|589592476|FG001|Treatment Cycle 3|Completed study|0|||
163039294|NCT01289574|588850694|FG002|Overall Study|Withdrawal by Subject|1|||
163039295|NCT01289574|588850692|FG000|Overall Study|Adverse Event|0|||
163039296|NCT01289574|588850693|FG001|Overall Study|Adverse Event|1|||
163039297|NCT01289574|588850694|FG002|Overall Study|Adverse Event|0|||
163039298|NCT01289574|588850692|FG000|Overall Study|Subject wanted alternate treatment|0|||
163039299|NCT01289574|588850693|FG001|Overall Study|Subject wanted alternate treatment|1|||
163039300|NCT01289574|588850694|FG002|Overall Study|Subject wanted alternate treatment|0|||
163039301|NCT02432144|588850696|FG000|Overall Study|Participant Non-Compliance|1|||
163039302|NCT00262002|588850697|FG000|Overall Study|Adverse Event|2|||
163039303|NCT00262002|588850698|FG001|Overall Study|Adverse Event|1|||
163039304|NCT00262002|588850699|FG002|Overall Study|Adverse Event|0|||
163039305|NCT00262002|588850700|FG003|Overall Study|Adverse Event|0|||
163349991|NCT00833898|589990936|FG001|Overall Study|Patient did not receive transplant|2|||
163349992|NCT02895360|589990945|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
163349993|NCT02895360|589990946|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
163039306|NCT00262002|588850701|FG004|Overall Study|Adverse Event|0|||
163039307|NCT00262002|588850702|FG005|Overall Study|Adverse Event|1|||
163240954|NCT01261611|589592477|FG002|Treatment Cycle 3|Completed study|0|||
163349994|NCT02895360|589990947|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
163240955|NCT01261611|589592475|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
163240956|NCT01261611|589592476|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
163349995|NCT02895360|589990948|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
163146263|NCT01908426|589246163|FG001|Overall Study|Withdrawal by Subject|6|||
163146264|NCT01908426|589246162|FG000|Overall Study|Progressive Disease|206|||
163146265|NCT01908426|589246163|FG001|Overall Study|Progressive Disease|152|||
163146266|NCT01908426|589246162|FG000|Overall Study|Protocol Violation|1|||
163146267|NCT01908426|589246163|FG001|Overall Study|Protocol Violation|0|||
163146268|NCT01908426|589246162|FG000|Overall Study|No Study Treatment Given|3|||
163146269|NCT01908426|589246163|FG001|Overall Study|No Study Treatment Given|0|||
163146270|NCT02973100|589246168|FG000|Overall Study|Adverse Event|1|||
163146271|NCT02973100|589246169|FG001|Overall Study|Adverse Event|2|||
163146272|NCT02973100|589246170|FG002|Overall Study|Adverse Event|1|||
163146273|NCT02973100|589246171|FG003|Overall Study|Adverse Event|2|||
163146274|NCT02973100|589246168|FG000|Overall Study|Lost to Follow-up|3|||
163146275|NCT02973100|589246169|FG001|Overall Study|Lost to Follow-up|1|||
163146276|NCT02973100|589246170|FG002|Overall Study|Lost to Follow-up|1|||
163146277|NCT02973100|589246171|FG003|Overall Study|Lost to Follow-up|0|||
163146278|NCT02973100|589246168|FG000|Overall Study|Withdrawal by Subject|3|||
163146279|NCT02973100|589246169|FG001|Overall Study|Withdrawal by Subject|5|||
163146280|NCT02973100|589246170|FG002|Overall Study|Withdrawal by Subject|1|||
163146281|NCT02973100|589246171|FG003|Overall Study|Withdrawal by Subject|4|||
163146282|NCT02973100|589246168|FG000|Overall Study|Notification of change in address|0|||
163146283|NCT02973100|589246169|FG001|Overall Study|Notification of change in address|0|||
163146284|NCT02973100|589246170|FG002|Overall Study|Notification of change in address|0|||
163146285|NCT02973100|589246171|FG003|Overall Study|Notification of change in address|1|||
163146286|NCT02973100|589246168|FG000|Overall Study|Failed to attend Safety followup period|0|||
163146287|NCT02973100|589246169|FG001|Overall Study|Failed to attend Safety followup period|0|||
163146288|NCT02973100|589246170|FG002|Overall Study|Failed to attend Safety followup period|1|||
163146289|NCT02973100|589246171|FG003|Overall Study|Failed to attend Safety followup period|0|||
163146290|NCT01419236|589246178|FG000|Overall Study|Adverse Event|1|||
163146291|NCT01419236|589246179|FG001|Overall Study|Adverse Event|0|||
163146292|NCT01419236|589246178|FG000|Overall Study|Lack of Efficacy|0|||
163146293|NCT01419236|589246179|FG001|Overall Study|Lack of Efficacy|1|||
163146294|NCT01419236|589246178|FG000|Overall Study|Lost to Follow-up|1|||
163146295|NCT01419236|589246179|FG001|Overall Study|Lost to Follow-up|0|||
163146296|NCT01419236|589246178|FG000|Overall Study|Physician Decision|1|||
163146297|NCT01419236|589246179|FG001|Overall Study|Physician Decision|0|||
163146298|NCT01419236|589246178|FG000|Overall Study|Withdrawal by Subject|1|||
163146299|NCT01419236|589246179|FG001|Overall Study|Withdrawal by Subject|4|||
163146300|NCT01419236|589246178|FG000|Overall Study|Entry Criteria Not Met|1|||
163146301|NCT01419236|589246179|FG001|Overall Study|Entry Criteria Not Met|0|||
163146302|NCT04456504|589246180|FG000|Overall Study|Lost to Follow-up|2|||
163146303|NCT01342913|589246183|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
163146304|NCT01342913|589246184|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163146305|NCT01342913|589246185|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163146306|NCT01342913|589246183|FG000|2-week Run-in Period|Physician Decision|6|||
163146307|NCT01342913|589246184|FG001|2-week Run-in Period|Physician Decision|0|||
163146308|NCT01342913|589246185|FG002|2-week Run-in Period|Physician Decision|0|||
163146309|NCT01342913|589246183|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
163146310|NCT01342913|589246184|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
163146311|NCT01342913|589246185|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
163146312|NCT01342913|589246183|FG000|2-week Run-in Period|Adverse Event|2|||
163146313|NCT01342913|589246184|FG001|2-week Run-in Period|Adverse Event|0|||
163146314|NCT01342913|589246185|FG002|2-week Run-in Period|Adverse Event|0|||
163146315|NCT01342913|589246183|FG000|2-week Run-in Period|Protocol Violation|5|||
163146316|NCT01342913|589246184|FG001|2-week Run-in Period|Protocol Violation|0|||
163146317|NCT01342913|589246185|FG002|2-week Run-in Period|Protocol Violation|0|||
163146318|NCT01342913|589246183|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
163146319|NCT01342913|589246184|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
163146320|NCT01342913|589246185|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
163146321|NCT01342913|589246183|FG000|Double-Blind Treatment Period|Adverse Event|0|||
163146322|NCT01342913|589246184|FG001|Double-Blind Treatment Period|Adverse Event|3|||
163146323|NCT01342913|589246185|FG002|Double-Blind Treatment Period|Adverse Event|6|||
163146324|NCT01342913|589246183|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
163146325|NCT01342913|589246184|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
163146326|NCT01342913|589246185|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
163146327|NCT01342913|589246183|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
163146328|NCT01342913|589246184|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
163146329|NCT01342913|589246185|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
163146330|NCT01342913|589246183|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163146331|NCT01342913|589246184|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
163146332|NCT01342913|589246185|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
163409859|NCT01926782|590209528|FG005|Overall Study|Adverse Event|14|||
163146333|NCT01342913|589246183|FG000|Double-Blind Treatment Period|Physician Decision|0|||
163146334|NCT01342913|589246184|FG001|Double-Blind Treatment Period|Physician Decision|2|||
163146335|NCT01342913|589246185|FG002|Double-Blind Treatment Period|Physician Decision|0|||
163240957|NCT01261611|589592477|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
163240958|NCT01261611|589592475|FG000|Treatment Cycle 3|Adverse Event|1|||
163240959|NCT01261611|589592476|FG001|Treatment Cycle 3|Adverse Event|0|||
163240960|NCT01261611|589592477|FG002|Treatment Cycle 3|Adverse Event|0|||
163349996|NCT02895360|589990949|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
163349997|NCT02895360|589990950|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
163349998|NCT02895360|589990945|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
163349999|NCT02895360|589990946|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
163350000|NCT02895360|589990947|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
163350001|NCT02895360|589990948|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
163350002|NCT02895360|589990949|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
163350003|NCT02895360|589990950|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
163350004|NCT02895360|589990945|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
163350005|NCT02895360|589990946|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
163350006|NCT02895360|589990947|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
163350007|NCT02895360|589990948|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
163350008|NCT02895360|589990949|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
163350009|NCT02895360|589990950|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
163350010|NCT02895360|589990945|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
163350011|NCT02895360|589990946|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
163350012|NCT02895360|589990947|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
163350013|NCT02895360|589990948|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
163350014|NCT02895360|589990949|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
163350015|NCT02895360|589990950|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
163350016|NCT02895360|589990945|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
163350017|NCT02895360|589990946|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
163240961|NCT01261611|589592475|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
163240962|NCT01261611|589592476|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
163240963|NCT01261611|589592477|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
163240964|NCT01261611|589592475|FG000|Treatment Cycle 4|Completed study|87|||
163240965|NCT01261611|589592476|FG001|Treatment Cycle 4|Completed study|0|||
163240966|NCT01261611|589592477|FG002|Treatment Cycle 4|Completed study|0|||
163240967|NCT01261611|589592475|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
163240968|NCT01261611|589592476|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
163240969|NCT01261611|589592477|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
163240970|NCT01261611|589592475|FG000|Treatment Cycle 4|Adverse Event|1|||
163240971|NCT01261611|589592476|FG001|Treatment Cycle 4|Adverse Event|0|||
163240972|NCT01261611|589592477|FG002|Treatment Cycle 4|Adverse Event|0|||
163240973|NCT01261611|589592475|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
163240974|NCT01261611|589592476|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
163240975|NCT01261611|589592477|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
163240976|NCT01261611|589592475|FG000|Treatment Cycle 4|Not otherwise specified|3|||
163240977|NCT01261611|589592476|FG001|Treatment Cycle 4|Not otherwise specified|0|||
163240978|NCT01261611|589592477|FG002|Treatment Cycle 4|Not otherwise specified|0|||
163240979|NCT01261611|589592475|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
163240980|NCT01261611|589592476|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
163240981|NCT01261611|589592477|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
163240982|NCT01261611|589592475|FG000|Treatment Cycle 5|Adverse Event|1|||
163240983|NCT01261611|589592476|FG001|Treatment Cycle 5|Adverse Event|0|||
163240984|NCT01261611|589592477|FG002|Treatment Cycle 5|Adverse Event|0|||
163039308|NCT00262002|588850703|FG006|Overall Study|Adverse Event|0|||
163039309|NCT00262002|588850697|FG000|Overall Study|Withdrawal by Subject|4|||
163039310|NCT00262002|588850698|FG001|Overall Study|Withdrawal by Subject|2|||
163039311|NCT00262002|588850699|FG002|Overall Study|Withdrawal by Subject|0|||
163039312|NCT00262002|588850700|FG003|Overall Study|Withdrawal by Subject|1|||
163039313|NCT00262002|588850701|FG004|Overall Study|Withdrawal by Subject|2|||
163039314|NCT00262002|588850702|FG005|Overall Study|Withdrawal by Subject|2|||
163039315|NCT00262002|588850703|FG006|Overall Study|Withdrawal by Subject|2|||
163350018|NCT02895360|589990947|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
163350019|NCT02895360|589990948|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
163350020|NCT02895360|589990949|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
163350021|NCT02895360|589990950|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
163350022|NCT02895360|589990945|FG000|Phase 2a|Adverse Event|0|||
163350023|NCT02895360|589990946|FG001|Phase 2a|Adverse Event|0|||
163350024|NCT02895360|589990947|FG002|Phase 2a|Adverse Event|0|||
163350025|NCT02895360|589990948|FG003|Phase 2a|Adverse Event|0|||
163039316|NCT00262002|588850697|FG000|Overall Study|Lost to Follow-up|2|||
163039317|NCT00262002|588850698|FG001|Overall Study|Lost to Follow-up|0|||
163039318|NCT00262002|588850699|FG002|Overall Study|Lost to Follow-up|0|||
163350026|NCT02895360|589990949|FG004|Phase 2a|Adverse Event|0|||
163350027|NCT02895360|589990950|FG005|Phase 2a|Adverse Event|1|||
163350028|NCT02895360|589990945|FG000|Phase 2a|Progressive disease|0|||
163350029|NCT02895360|589990946|FG001|Phase 2a|Progressive disease|0|||
163350030|NCT02895360|589990947|FG002|Phase 2a|Progressive disease|0|||
163039319|NCT00262002|588850700|FG003|Overall Study|Lost to Follow-up|2|||
163039320|NCT00262002|588850701|FG004|Overall Study|Lost to Follow-up|0|||
163039321|NCT00262002|588850702|FG005|Overall Study|Lost to Follow-up|1|||
163240985|NCT01261611|589592475|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
163240986|NCT01261611|589592476|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
163240987|NCT01261611|589592477|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
163240988|NCT02527798|589592478|FG000|Overall Study|Physician Decision|1|||
163240989|NCT02527798|589592479|FG001|Overall Study|Physician Decision|0|||
163240990|NCT02527798|589592480|FG002|Overall Study|Physician Decision|1|||
163240991|NCT02527798|589592481|FG003|Overall Study|Physician Decision|1|||
163240992|NCT02527798|589592482|FG004|Overall Study|Physician Decision|0|||
163039322|NCT00262002|588850703|FG006|Overall Study|Lost to Follow-up|0|||
163039323|NCT00262002|588850697|FG000|Overall Study|Inapropriate enrollment|0|||
163039324|NCT00262002|588850698|FG001|Overall Study|Inapropriate enrollment|1|||
163039325|NCT00262002|588850699|FG002|Overall Study|Inapropriate enrollment|0|||
163039326|NCT00262002|588850700|FG003|Overall Study|Inapropriate enrollment|0|||
163039327|NCT00262002|588850701|FG004|Overall Study|Inapropriate enrollment|0|||
163039328|NCT00262002|588850702|FG005|Overall Study|Inapropriate enrollment|0|||
163039329|NCT00262002|588850703|FG006|Overall Study|Inapropriate enrollment|0|||
163039330|NCT00262002|588850697|FG000|Overall Study|Protocol Violation|3|||
163039331|NCT00262002|588850698|FG001|Overall Study|Protocol Violation|2|||
163039332|NCT00262002|588850699|FG002|Overall Study|Protocol Violation|0|||
163039333|NCT00262002|588850700|FG003|Overall Study|Protocol Violation|2|||
163039334|NCT00262002|588850701|FG004|Overall Study|Protocol Violation|5|||
163039335|NCT00262002|588850702|FG005|Overall Study|Protocol Violation|3|||
163039336|NCT00262002|588850703|FG006|Overall Study|Protocol Violation|2|||
163039337|NCT00262002|588850697|FG000|Overall Study|Unable to classify|0|||
163039338|NCT00262002|588850698|FG001|Overall Study|Unable to classify|0|||
163039339|NCT00262002|588850699|FG002|Overall Study|Unable to classify|0|||
163039340|NCT00262002|588850700|FG003|Overall Study|Unable to classify|0|||
163039341|NCT00262002|588850701|FG004|Overall Study|Unable to classify|0|||
163039342|NCT00262002|588850702|FG005|Overall Study|Unable to classify|0|||
163039343|NCT00262002|588850703|FG006|Overall Study|Unable to classify|2|||
163039344|NCT00958412|588850706|FG000|Overall Study|Study prematurely terminated|18|||
163039345|NCT02552888|588850709|FG000|Overall Study|Lost to Follow-up|1|||
163039346|NCT02552888|588850710|FG001|Overall Study|Lost to Follow-up|1|||
163039347|NCT00398216|588852710|FG000|Overall Study|Adverse Event|4|||
163039348|NCT00398216|588852711|FG001|Overall Study|Adverse Event|2|||
163039349|NCT00398216|588852712|FG002|Overall Study|Adverse Event|5|||
163350031|NCT02895360|589990948|FG003|Phase 2a|Progressive disease|0|||
163350032|NCT02895360|589990949|FG004|Phase 2a|Progressive disease|11|||
163350033|NCT02895360|589990950|FG005|Phase 2a|Progressive disease|11|||
163350034|NCT00666198|589990951|FG000|Overall Study|Protocol Violation|10|||
163350035|NCT00666198|589990951|FG000|Overall Study|No Visit After First Day of Treatment|13|||
163350036|NCT00666198|589990951|FG000|Overall Study|Safety Not Assessable|6|||
163350037|NCT00666198|589990951|FG000|Overall Study|No Drug Administration|4|||
163350038|NCT05153499|589990952|FG000|Overall Study|Withdrawal by Subject|1|||
163350039|NCT05153499|589990953|FG001|Overall Study|Withdrawal by Subject|0|||
163350040|NCT05153499|589990952|FG000|Overall Study|Clinical Hold|1|||
163350041|NCT05153499|589990953|FG001|Overall Study|Clinical Hold|0|||
163350042|NCT05153499|589990952|FG000|Overall Study|Study Termination|6|||
163350043|NCT05153499|589990953|FG001|Overall Study|Study Termination|5|||
163350044|NCT01960114|589990955|FG000|Overall Study|Adverse Event|1|||
163350045|NCT01960114|589990956|FG001|Overall Study|Adverse Event|0|||
163039350|NCT00398216|588852713|FG003|Overall Study|Adverse Event|7|||
163039351|NCT00398216|588852714|FG004|Overall Study|Adverse Event|2|||
163039352|NCT00398216|588852710|FG000|Overall Study|Protocol Violation|2|||
163039353|NCT00398216|588852711|FG001|Overall Study|Protocol Violation|4|||
163039354|NCT00398216|588852712|FG002|Overall Study|Protocol Violation|5|||
163039355|NCT00398216|588852713|FG003|Overall Study|Protocol Violation|7|||
163039356|NCT00398216|588852714|FG004|Overall Study|Protocol Violation|5|||
163039357|NCT00398216|588852710|FG000|Overall Study|Lost to Follow-up|1|||
163039358|NCT00398216|588852711|FG001|Overall Study|Lost to Follow-up|6|||
163039359|NCT00398216|588852712|FG002|Overall Study|Lost to Follow-up|4|||
163039360|NCT00398216|588852713|FG003|Overall Study|Lost to Follow-up|4|||
163039361|NCT00398216|588852714|FG004|Overall Study|Lost to Follow-up|1|||
163039362|NCT00398216|588852710|FG000|Overall Study|Death|0|||
163039363|NCT00398216|588852711|FG001|Overall Study|Death|3|||
163039364|NCT00398216|588852712|FG002|Overall Study|Death|0|||
163039365|NCT00398216|588852713|FG003|Overall Study|Death|0|||
163350046|NCT01960114|589990955|FG000|Overall Study|Could not swallow study medication|0|||
163350047|NCT01960114|589990956|FG001|Overall Study|Could not swallow study medication|1|||
163350048|NCT00427778|589990957|FG000|First Intervention (4 Weeks)|no longer interested|1|||
163350049|NCT00427778|589990958|FG001|First Intervention (4 Weeks)|no longer interested|0|||
163350050|NCT00427778|589990957|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
163350051|NCT00427778|589990958|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
163350052|NCT00427778|589990957|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
163350053|NCT00427778|589990958|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
163350054|NCT00427778|589990957|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
163039366|NCT00398216|588852714|FG004|Overall Study|Death|0|||
163039367|NCT00398216|588852710|FG000|Overall Study|Withdrawal by Subject|1|||
163039368|NCT00398216|588852711|FG001|Overall Study|Withdrawal by Subject|0|||
163039369|NCT00398216|588852712|FG002|Overall Study|Withdrawal by Subject|3|||
163039370|NCT00398216|588852713|FG003|Overall Study|Withdrawal by Subject|1|||
163039371|NCT00398216|588852714|FG004|Overall Study|Withdrawal by Subject|2|||
163039372|NCT00398216|588852710|FG000|Overall Study|administrative reasons|3|||
163039373|NCT00398216|588852711|FG001|Overall Study|administrative reasons|4|||
163039374|NCT00398216|588852712|FG002|Overall Study|administrative reasons|4|||
163039375|NCT00398216|588852713|FG003|Overall Study|administrative reasons|3|||
163039376|NCT00398216|588852714|FG004|Overall Study|administrative reasons|3|||
163039377|NCT00398216|588852710|FG000|Overall Study|entrance criteria|0|||
163039378|NCT00398216|588852711|FG001|Overall Study|entrance criteria|0|||
163039379|NCT00398216|588852712|FG002|Overall Study|entrance criteria|0|||
163039380|NCT00398216|588852713|FG003|Overall Study|entrance criteria|0|||
163039381|NCT00398216|588852714|FG004|Overall Study|entrance criteria|2|||
163039382|NCT01048944|588852715|FG000|Overall Study|Protocol Violation|8|||
163039383|NCT01048944|588852716|FG001|Overall Study|Protocol Violation|10|||
163039384|NCT01048944|588852717|FG002|Overall Study|Protocol Violation|10|||
163039385|NCT01048944|588852718|FG003|Overall Study|Protocol Violation|2|||
163039386|NCT01962948|588852719|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
163039387|NCT01962948|588852720|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
163039388|NCT01962948|588852721|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
163039389|NCT01962948|588852722|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
163240993|NCT02527798|589592483|FG005|Overall Study|Physician Decision|0|||
163240994|NCT02527798|589592478|FG000|Overall Study|Death|0|||
163240995|NCT02527798|589592479|FG001|Overall Study|Death|0|||
163240996|NCT02527798|589592480|FG002|Overall Study|Death|1|||
163240997|NCT02527798|589592481|FG003|Overall Study|Death|0|||
163240998|NCT02527798|589592482|FG004|Overall Study|Death|0|||
163240999|NCT02527798|589592483|FG005|Overall Study|Death|0|||
163241000|NCT02527798|589592478|FG000|Overall Study|Withdrawal by Subject|0|||
163241001|NCT02527798|589592479|FG001|Overall Study|Withdrawal by Subject|1|||
163241002|NCT02527798|589592480|FG002|Overall Study|Withdrawal by Subject|2|||
163039390|NCT00376532|588852723|FG000|Overall Study|Lack sufficient blood sample|6|||
163039391|NCT00376532|588852724|FG001|Overall Study|Lack sufficient blood sample|6|||
163039392|NCT01133704|588852725|FG000|Overall Study|Death|44|||
163039393|NCT01133704|588852726|FG001|Overall Study|Death|26|||
163039394|NCT01133704|588852725|FG000|Overall Study|Patient refused to continue|4|||
163039395|NCT01133704|588852726|FG001|Overall Study|Patient refused to continue|0|||
163039396|NCT01133704|588852725|FG000|Overall Study|Study Closure|1|||
163039397|NCT01133704|588852726|FG001|Overall Study|Study Closure|0|||
163039398|NCT02207400|588852727|FG000|Overall Study|Adverse Event|1|||
163039399|NCT02207400|588852728|FG001|Overall Study|Adverse Event|1|||
163039400|NCT02207400|588852727|FG000|Overall Study|Lost to Follow-up|6|||
163039401|NCT02207400|588852728|FG001|Overall Study|Lost to Follow-up|7|||
163039402|NCT02207400|588852727|FG000|Overall Study|Protocol Violation|1|||
163039403|NCT02207400|588852728|FG001|Overall Study|Protocol Violation|1|||
163039404|NCT02207400|588852727|FG000|Overall Study|Withdrawal by Subject|8|||
163039405|NCT02207400|588852728|FG001|Overall Study|Withdrawal by Subject|4|||
163039406|NCT02207400|588852727|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
163039407|NCT02207400|588852728|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
163039408|NCT02849704|588852729|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
163350055|NCT00427778|589990958|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
163039409|NCT02849704|588852730|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
163039410|NCT02849704|588852729|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
163039411|NCT02849704|588852730|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
163039412|NCT02849704|588852729|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
163039413|NCT02849704|588852730|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
163241003|NCT02527798|589592481|FG003|Overall Study|Withdrawal by Subject|0|||
163241004|NCT02527798|589592482|FG004|Overall Study|Withdrawal by Subject|0|||
163241005|NCT02527798|589592483|FG005|Overall Study|Withdrawal by Subject|0|||
163350056|NCT00225277|589990959|FG000|Overall Study|Adverse Event|30|||
163241006|NCT02527798|589592478|FG000|Overall Study|Reason undisclosed|1|||
163241007|NCT02527798|589592479|FG001|Overall Study|Reason undisclosed|0|||
163241008|NCT02527798|589592480|FG002|Overall Study|Reason undisclosed|1|||
163241009|NCT02527798|589592481|FG003|Overall Study|Reason undisclosed|0|||
163241010|NCT02527798|589592482|FG004|Overall Study|Reason undisclosed|0|||
163241011|NCT02527798|589592483|FG005|Overall Study|Reason undisclosed|0|||
163241012|NCT02527798|589592478|FG000|Overall Study|Did not receive intervention|1|||
163241013|NCT02527798|589592479|FG001|Overall Study|Did not receive intervention|1|||
163350057|NCT00225277|589990960|FG001|Overall Study|Adverse Event|34|||
163039414|NCT00314808|588852738|FG000|Overall Study|Disease Progression without AE|4|||
163039415|NCT00314808|588852738|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
163039416|NCT04304508|588852739|FG000|Overall Study|Subject Decision|29|||
163039417|NCT04304508|588852740|FG001|Overall Study|Subject Decision|39|||
163039418|NCT04304508|588852741|FG002|Overall Study|Subject Decision|37|||
163039419|NCT04304508|588852742|FG003|Overall Study|Subject Decision|48|||
163039420|NCT04304508|588852739|FG000|Overall Study|Death|6|||
163039421|NCT04304508|588852740|FG001|Overall Study|Death|1|||
163039422|NCT04304508|588852741|FG002|Overall Study|Death|8|||
163241014|NCT02527798|589592480|FG002|Overall Study|Did not receive intervention|0|||
163241015|NCT02527798|589592481|FG003|Overall Study|Did not receive intervention|0|||
163039423|NCT04304508|588852742|FG003|Overall Study|Death|5|||
163039424|NCT04304508|588852739|FG000|Overall Study|Non-compliance With Study Drug|3|||
163039425|NCT04304508|588852740|FG001|Overall Study|Non-compliance With Study Drug|1|||
163039426|NCT04304508|588852741|FG002|Overall Study|Non-compliance With Study Drug|2|||
163039427|NCT04304508|588852742|FG003|Overall Study|Non-compliance With Study Drug|0|||
163039428|NCT04304508|588852739|FG000|Overall Study|Switching To Other Therapy|1|||
163039429|NCT04304508|588852740|FG001|Overall Study|Switching To Other Therapy|1|||
163039430|NCT04304508|588852741|FG002|Overall Study|Switching To Other Therapy|1|||
163039431|NCT04304508|588852742|FG003|Overall Study|Switching To Other Therapy|2|||
163039432|NCT04304508|588852739|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
163039433|NCT04304508|588852740|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
163039434|NCT04304508|588852741|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
163039435|NCT04304508|588852742|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
163039436|NCT04304508|588852739|FG000|Overall Study|Withdrawal by Subject|7|||
163039437|NCT04304508|588852740|FG001|Overall Study|Withdrawal by Subject|5|||
163039438|NCT04304508|588852741|FG002|Overall Study|Withdrawal by Subject|11|||
163039439|NCT04304508|588852742|FG003|Overall Study|Withdrawal by Subject|6|||
163039440|NCT04304508|588852739|FG000|Overall Study|Logistical Difficulties|2|||
163039441|NCT04304508|588852740|FG001|Overall Study|Logistical Difficulties|2|||
163039442|NCT04304508|588852741|FG002|Overall Study|Logistical Difficulties|3|||
163039443|NCT04304508|588852742|FG003|Overall Study|Logistical Difficulties|2|||
163039444|NCT04304508|588852739|FG000|Overall Study|Missing Information|1|||
163039445|NCT04304508|588852740|FG001|Overall Study|Missing Information|2|||
163039446|NCT04304508|588852741|FG002|Overall Study|Missing Information|1|||
163039447|NCT04304508|588852742|FG003|Overall Study|Missing Information|3|||
163039448|NCT04304508|588852739|FG000|Overall Study|Other|7|||
163039449|NCT04304508|588852740|FG001|Overall Study|Other|6|||
163039450|NCT04304508|588852741|FG002|Overall Study|Other|5|||
163039451|NCT04304508|588852742|FG003|Overall Study|Other|4|||
163039452|NCT04304508|588852739|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
163039453|NCT04304508|588852740|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
163039454|NCT04304508|588852741|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
163039455|NCT04304508|588852742|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
163039456|NCT04304508|588852739|FG000|Overall Study|Physician Decision|3|||
163039457|NCT04304508|588852740|FG001|Overall Study|Physician Decision|4|||
163039458|NCT04304508|588852741|FG002|Overall Study|Physician Decision|9|||
163039459|NCT04304508|588852742|FG003|Overall Study|Physician Decision|7|||
163039460|NCT04304508|588852739|FG000|Overall Study|Study drug never administered|10|||
163039461|NCT04304508|588852740|FG001|Overall Study|Study drug never administered|4|||
163039462|NCT04304508|588852741|FG002|Overall Study|Study drug never administered|4|||
163039463|NCT04304508|588852742|FG003|Overall Study|Study drug never administered|4|||
163039464|NCT04304508|588852739|FG000|Overall Study|Adverse Event|49|||
163039465|NCT04304508|588852740|FG001|Overall Study|Adverse Event|50|||
163039466|NCT04304508|588852741|FG002|Overall Study|Adverse Event|51|||
163039467|NCT04304508|588852742|FG003|Overall Study|Adverse Event|56|||
163039468|NCT04304508|588852739|FG000|Overall Study|Lost to Follow-up|1|||
163039469|NCT04304508|588852740|FG001|Overall Study|Lost to Follow-up|5|||
163039470|NCT04304508|588852741|FG002|Overall Study|Lost to Follow-up|2|||
163039471|NCT04304508|588852742|FG003|Overall Study|Lost to Follow-up|3|||
163039472|NCT02113007|588852743|FG000|Overall Study|Progressive disease|2|||
163039473|NCT00885378|588852744|FG000|Overall Study|Lack of Efficacy|2|||
163039474|NCT00885378|588852745|FG001|Overall Study|Lack of Efficacy|2|||
163039475|NCT00885378|588852744|FG000|Overall Study|Withdrawal by Subject|1|||
163039476|NCT00885378|588852745|FG001|Overall Study|Withdrawal by Subject|2|||
163039477|NCT00885378|588852744|FG000|Overall Study|Lost to Follow-up|1|||
163039478|NCT00885378|588852745|FG001|Overall Study|Lost to Follow-up|2|||
163039479|NCT00885378|588852744|FG000|Overall Study|Poor/Noncompliance|2|||
163039480|NCT00885378|588852745|FG001|Overall Study|Poor/Noncompliance|2|||
163039481|NCT00885378|588852744|FG000|Overall Study|Protocol Violation|2|||
163039482|NCT00885378|588852745|FG001|Overall Study|Protocol Violation|0|||
163039483|NCT03091738|588852746|FG000|Overall Study|Adverse Event|1|||
163039484|NCT03091738|588852746|FG000|Overall Study|Lost to Follow-up|1|||
163241016|NCT02527798|589592482|FG004|Overall Study|Did not receive intervention|0|||
163241017|NCT02527798|589592483|FG005|Overall Study|Did not receive intervention|0|||
163241018|NCT03859323|589592485|FG000|Overall Study|Lost to Follow-up|0|||
163241019|NCT03859323|589592486|FG001|Overall Study|Lost to Follow-up|0|||
163241020|NCT03859323|589592487|FG002|Overall Study|Lost to Follow-up|0|||
163241021|NCT03859323|589592488|FG003|Overall Study|Lost to Follow-up|0|||
163146336|NCT01342913|589246183|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163146337|NCT01342913|589246184|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
163146338|NCT01342913|589246185|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
163146339|NCT02869633|589246189|FG000|Overall Study|Death|2|||
163146340|NCT02869633|589246190|FG001|Overall Study|Death|1|||
163146341|NCT02869633|589246189|FG000|Overall Study|Patient refused follow-up|1|||
163146342|NCT02869633|589246190|FG001|Overall Study|Patient refused follow-up|0|||
163146343|NCT02869633|589246189|FG000|Overall Study|Provider discretion|1|||
163146344|NCT02869633|589246190|FG001|Overall Study|Provider discretion|0|||
163146345|NCT02869633|589246189|FG000|Overall Study|Investigator decision|1|||
163146346|NCT02869633|589246190|FG001|Overall Study|Investigator decision|0|||
163146347|NCT02869633|589246189|FG000|Overall Study|Lost to Follow-up|0|||
163146348|NCT02869633|589246190|FG001|Overall Study|Lost to Follow-up|1|||
163146349|NCT02869633|589246189|FG000|Overall Study|Not eligible|6|||
163146350|NCT02869633|589246190|FG001|Overall Study|Not eligible|1|||
163146351|NCT02869633|589246189|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
163146352|NCT02869633|589246190|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
163146353|NCT02869633|589246189|FG000|Overall Study|Withdrawal by Subject|0|||
163146354|NCT02869633|589246190|FG001|Overall Study|Withdrawal by Subject|1|||
163146355|NCT03287791|589246191|FG000|Overall Study|Insufficient Therapeutic Response|0|||
163146356|NCT03287791|589246192|FG001|Overall Study|Insufficient Therapeutic Response|0|||
163146357|NCT03287791|589246193|FG002|Overall Study|Insufficient Therapeutic Response|1|||
163146358|NCT03287791|589246191|FG000|Overall Study|Adverse Event|0|||
163146359|NCT03287791|589246192|FG001|Overall Study|Adverse Event|4|||
163146360|NCT03287791|589246193|FG002|Overall Study|Adverse Event|3|||
163146361|NCT03287791|589246191|FG000|Overall Study|Withdrawal by Subject|12|||
163146362|NCT03287791|589246192|FG001|Overall Study|Withdrawal by Subject|12|||
163146363|NCT03287791|589246193|FG002|Overall Study|Withdrawal by Subject|17|||
163146364|NCT03287791|589246191|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
163146365|NCT03287791|589246192|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
163146366|NCT03287791|589246193|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
163146367|NCT03287791|589246191|FG000|Overall Study|Lost to Follow-up|8|||
163146368|NCT03287791|589246192|FG001|Overall Study|Lost to Follow-up|14|||
163146369|NCT03287791|589246193|FG002|Overall Study|Lost to Follow-up|11|||
163146370|NCT03287791|589246191|FG000|Overall Study|Protocol Violation|7|||
163146371|NCT03287791|589246192|FG001|Overall Study|Protocol Violation|2|||
163146372|NCT03287791|589246193|FG002|Overall Study|Protocol Violation|1|||
163146373|NCT03287791|589246191|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
163146374|NCT03287791|589246192|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
163146375|NCT03287791|589246193|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
163146376|NCT03287791|589246191|FG000|Overall Study|Too much time between 2 visits|0|||
163146377|NCT03287791|589246192|FG001|Overall Study|Too much time between 2 visits|1|||
163146378|NCT03287791|589246193|FG002|Overall Study|Too much time between 2 visits|0|||
163146379|NCT03287791|589246191|FG000|Overall Study|Non-compliance|0|||
163146380|NCT03287791|589246192|FG001|Overall Study|Non-compliance|1|||
163146381|NCT03287791|589246193|FG002|Overall Study|Non-compliance|0|||
163146382|NCT03287791|589246191|FG000|Overall Study|Did not meet inclusion criteria|1|||
163146383|NCT03287791|589246192|FG001|Overall Study|Did not meet inclusion criteria|0|||
163146384|NCT03287791|589246193|FG002|Overall Study|Did not meet inclusion criteria|0|||
163146385|NCT02891174|589246195|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
163146386|NCT02891174|589246196|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
163146387|NCT02891174|589246195|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
163146388|NCT02891174|589246196|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
163146389|NCT02891174|589246195|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
163146390|NCT02891174|589246196|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
163146391|NCT02891174|589246195|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
163146392|NCT02891174|589246196|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
163146393|NCT02891174|589246195|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
163146394|NCT02891174|589246196|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
163146395|NCT02891174|589246195|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
163146396|NCT02891174|589246196|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
163146397|NCT02891174|589246195|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
163146398|NCT02891174|589246196|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
163146399|NCT04319198|589246199|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
163350058|NCT00225277|589990959|FG000|Overall Study|Lack of Efficacy|4|||
163350059|NCT00225277|589990960|FG001|Overall Study|Lack of Efficacy|1|||
163146400|NCT04319198|589246200|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
163146401|NCT04319198|589246201|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
163146402|NCT04319198|589246199|FG000|Overall Study|Death|0|||
163146403|NCT04319198|589246200|FG001|Overall Study|Death|3|||
163146404|NCT04319198|589246201|FG002|Overall Study|Death|3|||
163146405|NCT04319198|589246199|FG000|Overall Study|Reason Not Specified|0|||
163039485|NCT03746405|588852749|FG000|Overall Study|Withdrawal by Subject|3|||
163039486|NCT03746405|588852750|FG001|Overall Study|Withdrawal by Subject|0|||
163039487|NCT03746405|588852749|FG000|Overall Study|technical difficulties|0|||
163039488|NCT03746405|588852750|FG001|Overall Study|technical difficulties|2|||
163039489|NCT03479008|588852751|FG000|Overall Study|Withdrawal by Subject|3|||
163039490|NCT00412932|588852752|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
163039491|NCT00412932|588852752|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
163039492|NCT00412932|588852752|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
163039493|NCT00412932|588852752|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
163039494|NCT00412932|588852752|FG000|Olmesartan (Olm) 20 mg|Other|1|||
163039495|NCT00412932|588852752|FG000|Olmesartan 40 mg|Adverse Event|4|||
163039496|NCT00412932|588852752|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
163039497|NCT00412932|588852752|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
163039498|NCT00412932|588852752|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
163039499|NCT00412932|588852752|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
163039500|NCT00412932|588852752|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
163039501|NCT00412932|588852752|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
163039502|NCT02630563|588852753|FG000|Overall Study|Administrative|1|||
163039503|NCT00929994|588852754|FG000|Overall Study|Withdrawal by Subject|1|||
163039504|NCT00929994|588852754|FG000|Overall Study|medical issue unrelated to intervention|4|||
163039505|NCT00929994|588852754|FG000|Overall Study|employment|1|||
163039506|NCT02061813|588852756|FG000|Overall Study|Withdrawal by Subject|1|||
163039507|NCT02061813|588852756|FG000|Overall Study|Protocol Violation|2|||
163039508|NCT01705080|588852757|FG000|Overall Study|Missed visit|10|||
163039509|NCT01705080|588852758|FG001|Overall Study|Missed visit|4|||
163039510|NCT01705080|588852759|FG002|Overall Study|Missed visit|1|||
163039511|NCT01705080|588852757|FG000|Overall Study|Death|4|||
163039512|NCT01705080|588852758|FG001|Overall Study|Death|4|||
163039513|NCT01705080|588852759|FG002|Overall Study|Death|6|||
163039514|NCT01705080|588852757|FG000|Overall Study|Withdrawal by Subject|61|||
163039515|NCT01705080|588852758|FG001|Overall Study|Withdrawal by Subject|44|||
163039516|NCT01705080|588852759|FG002|Overall Study|Withdrawal by Subject|9|||
163039517|NCT00667563|588852761|FG000|Overall Study|Protocol Violation|24|||
163039518|NCT03130959|588852764|FG000|Overall Study|Disease progression|19|||
163039519|NCT03130959|588852765|FG001|Overall Study|Disease progression|7|||
163039520|NCT03130959|588852766|FG002|Overall Study|Disease progression|12|||
163039521|NCT03130959|588852767|FG003|Overall Study|Disease progression|7|||
163039522|NCT03130959|588852768|FG004|Overall Study|Disease progression|12|||
163039523|NCT03130959|588852769|FG005|Overall Study|Disease progression|3|||
163039524|NCT03130959|588852770|FG006|Overall Study|Disease progression|6|||
163039525|NCT03130959|588852771|FG007|Overall Study|Disease progression|3|||
163039526|NCT03130959|588852772|FG008|Overall Study|Disease progression|15|||
163039527|NCT03130959|588852773|FG009|Overall Study|Disease progression|8|||
163039528|NCT03130959|588852764|FG000|Overall Study|Study drug toxicity|2|||
163039529|NCT03130959|588852765|FG001|Overall Study|Study drug toxicity|2|||
163039530|NCT03130959|588852766|FG002|Overall Study|Study drug toxicity|1|||
163039531|NCT03130959|588852767|FG003|Overall Study|Study drug toxicity|2|||
163039532|NCT03130959|588852768|FG004|Overall Study|Study drug toxicity|1|||
163350060|NCT00225277|589990959|FG000|Overall Study|Lost to Follow-up|4|||
163350061|NCT00225277|589990960|FG001|Overall Study|Lost to Follow-up|6|||
163350062|NCT00225277|589990959|FG000|Overall Study|Physician Decision|6|||
163350063|NCT00225277|589990960|FG001|Overall Study|Physician Decision|8|||
163350064|NCT00225277|589990959|FG000|Overall Study|Protocol Violation|6|||
163350065|NCT00225277|589990960|FG001|Overall Study|Protocol Violation|3|||
163350066|NCT00225277|589990959|FG000|Overall Study|Withdrawal by Subject|40|||
163350067|NCT00225277|589990960|FG001|Overall Study|Withdrawal by Subject|34|||
163350068|NCT00225277|589990959|FG000|Overall Study|Other|7|||
163350069|NCT00225277|589990960|FG001|Overall Study|Other|9|||
163350070|NCT00591409|589990966|FG000|Overall Study|Not Treated|0|||
163350071|NCT00591409|589990967|FG001|Overall Study|Not Treated|0|||
163350072|NCT00591409|589990968|FG002|Overall Study|Not Treated|0|||
163350073|NCT00591409|589990969|FG003|Overall Study|Not Treated|0|||
163350074|NCT00591409|589990970|FG004|Overall Study|Not Treated|1|||
163350075|NCT00591409|589990971|FG005|Overall Study|Not Treated|0|||
163350076|NCT00591409|589990972|FG006|Overall Study|Not Treated|0|||
163350077|NCT00591409|589990973|FG007|Overall Study|Not Treated|0|||
163409860|NCT01926782|590209523|FG000|Overall Study|Poor compliance to protocol|5|||
163409861|NCT01926782|590209524|FG001|Overall Study|Poor compliance to protocol|3|||
163039533|NCT03130959|588852769|FG005|Overall Study|Study drug toxicity|1|||
163039534|NCT03130959|588852770|FG006|Overall Study|Study drug toxicity|3|||
163039535|NCT03130959|588852771|FG007|Overall Study|Study drug toxicity|0|||
163039536|NCT03130959|588852772|FG008|Overall Study|Study drug toxicity|3|||
163039537|NCT03130959|588852773|FG009|Overall Study|Study drug toxicity|3|||
163039538|NCT03130959|588852764|FG000|Overall Study|Other reasons|0|||
163039539|NCT03130959|588852765|FG001|Overall Study|Other reasons|0|||
163039540|NCT03130959|588852766|FG002|Overall Study|Other reasons|0|||
163039541|NCT03130959|588852767|FG003|Overall Study|Other reasons|0|||
163039542|NCT03130959|588852768|FG004|Overall Study|Other reasons|0|||
163039543|NCT03130959|588852769|FG005|Overall Study|Other reasons|1|||
163039544|NCT03130959|588852770|FG006|Overall Study|Other reasons|1|||
163039545|NCT03130959|588852771|FG007|Overall Study|Other reasons|0|||
163039546|NCT03130959|588852772|FG008|Overall Study|Other reasons|0|||
163039547|NCT03130959|588852773|FG009|Overall Study|Other reasons|0|||
163039548|NCT03130959|588852764|FG000|Overall Study|Subject request to discontinue therapy|0|||
163039549|NCT03130959|588852765|FG001|Overall Study|Subject request to discontinue therapy|0|||
163039550|NCT03130959|588852766|FG002|Overall Study|Subject request to discontinue therapy|1|||
163039551|NCT03130959|588852767|FG003|Overall Study|Subject request to discontinue therapy|1|||
163039552|NCT03130959|588852768|FG004|Overall Study|Subject request to discontinue therapy|0|||
163039553|NCT03130959|588852769|FG005|Overall Study|Subject request to discontinue therapy|0|||
163039554|NCT03130959|588852770|FG006|Overall Study|Subject request to discontinue therapy|1|||
163039555|NCT03130959|588852771|FG007|Overall Study|Subject request to discontinue therapy|1|||
163039556|NCT03130959|588852772|FG008|Overall Study|Subject request to discontinue therapy|0|||
163039557|NCT03130959|588852773|FG009|Overall Study|Subject request to discontinue therapy|0|||
163039558|NCT03130959|588852764|FG000|Overall Study|Not reported|0|||
163039559|NCT03130959|588852765|FG001|Overall Study|Not reported|0|||
163039560|NCT03130959|588852766|FG002|Overall Study|Not reported|0|||
163039561|NCT03130959|588852767|FG003|Overall Study|Not reported|1|||
163039562|NCT03130959|588852768|FG004|Overall Study|Not reported|0|||
163039563|NCT03130959|588852769|FG005|Overall Study|Not reported|1|||
163039564|NCT03130959|588852770|FG006|Overall Study|Not reported|0|||
163039565|NCT03130959|588852771|FG007|Overall Study|Not reported|0|||
163039566|NCT03130959|588852772|FG008|Overall Study|Not reported|0|||
163039567|NCT03130959|588852773|FG009|Overall Study|Not reported|1|||
163039568|NCT03130959|588852764|FG000|Overall Study|Adverse Event unrelated to drug|0|||
163039569|NCT03130959|588852765|FG001|Overall Study|Adverse Event unrelated to drug|0|||
163039570|NCT03130959|588852766|FG002|Overall Study|Adverse Event unrelated to drug|1|||
163039571|NCT03130959|588852767|FG003|Overall Study|Adverse Event unrelated to drug|1|||
163039572|NCT03130959|588852768|FG004|Overall Study|Adverse Event unrelated to drug|1|||
163039573|NCT03130959|588852769|FG005|Overall Study|Adverse Event unrelated to drug|0|||
163039574|NCT03130959|588852770|FG006|Overall Study|Adverse Event unrelated to drug|1|||
163039575|NCT03130959|588852771|FG007|Overall Study|Adverse Event unrelated to drug|0|||
163039576|NCT03130959|588852772|FG008|Overall Study|Adverse Event unrelated to drug|1|||
163039577|NCT03130959|588852773|FG009|Overall Study|Adverse Event unrelated to drug|1|||
163039578|NCT03130959|588852764|FG000|Overall Study|Participant withdrew consent|0|||
163039579|NCT03130959|588852765|FG001|Overall Study|Participant withdrew consent|1|||
163039580|NCT03130959|588852766|FG002|Overall Study|Participant withdrew consent|0|||
163039581|NCT03130959|588852767|FG003|Overall Study|Participant withdrew consent|2|||
163039582|NCT03130959|588852768|FG004|Overall Study|Participant withdrew consent|1|||
163039583|NCT03130959|588852769|FG005|Overall Study|Participant withdrew consent|0|||
163039584|NCT03130959|588852770|FG006|Overall Study|Participant withdrew consent|0|||
163039585|NCT03130959|588852771|FG007|Overall Study|Participant withdrew consent|0|||
163039586|NCT03130959|588852772|FG008|Overall Study|Participant withdrew consent|0|||
163039587|NCT03130959|588852773|FG009|Overall Study|Participant withdrew consent|2|||
163039588|NCT03130959|588852764|FG000|Overall Study|Administrative reason by sponsor|1|||
163039589|NCT03130959|588852765|FG001|Overall Study|Administrative reason by sponsor|0|||
163039590|NCT03130959|588852766|FG002|Overall Study|Administrative reason by sponsor|1|||
163039591|NCT03130959|588852767|FG003|Overall Study|Administrative reason by sponsor|0|||
163039592|NCT03130959|588852768|FG004|Overall Study|Administrative reason by sponsor|0|||
163039593|NCT03130959|588852769|FG005|Overall Study|Administrative reason by sponsor|0|||
163039594|NCT03130959|588852770|FG006|Overall Study|Administrative reason by sponsor|0|||
163039595|NCT03130959|588852771|FG007|Overall Study|Administrative reason by sponsor|0|||
163039596|NCT03130959|588852772|FG008|Overall Study|Administrative reason by sponsor|0|||
163039597|NCT03130959|588852773|FG009|Overall Study|Administrative reason by sponsor|0|||
163039598|NCT03130959|588852764|FG000|Overall Study|Lost to Follow-up|1|||
163039599|NCT03130959|588852765|FG001|Overall Study|Lost to Follow-up|0|||
163039600|NCT03130959|588852766|FG002|Overall Study|Lost to Follow-up|0|||
163039601|NCT03130959|588852767|FG003|Overall Study|Lost to Follow-up|0|||
163039602|NCT03130959|588852768|FG004|Overall Study|Lost to Follow-up|0|||
163039603|NCT03130959|588852769|FG005|Overall Study|Lost to Follow-up|0|||
163039604|NCT03130959|588852770|FG006|Overall Study|Lost to Follow-up|0|||
163039605|NCT03130959|588852771|FG007|Overall Study|Lost to Follow-up|0|||
163039606|NCT03130959|588852772|FG008|Overall Study|Lost to Follow-up|0|||
163039607|NCT03130959|588852773|FG009|Overall Study|Lost to Follow-up|0|||
163039608|NCT02384538|588852788|FG000|Overall Study|Adverse Event|1|||
163039609|NCT02384538|588852789|FG001|Overall Study|Adverse Event|4|||
163039610|NCT02384538|588852788|FG000|Overall Study|Lack of Efficacy|4|||
163039611|NCT02384538|588852789|FG001|Overall Study|Lack of Efficacy|4|||
163039612|NCT02384538|588852788|FG000|Overall Study|Withdrew Consent|0|||
163039613|NCT02384538|588852789|FG001|Overall Study|Withdrew Consent|4|||
163039614|NCT02384538|588852788|FG000|Overall Study|Other|1|||
163039615|NCT02384538|588852789|FG001|Overall Study|Other|3|||
163039616|NCT03042910|588852792|FG000|Overall Study|Adverse Event|1|||
163039617|NCT03042910|588852792|FG000|Overall Study|Disease Progression|2|||
163039618|NCT03042910|588852792|FG000|Overall Study|Withdrawal by Subject|3|||
163039619|NCT03042910|588852792|FG000|Overall Study|Enrolled but not treated|1|||
163039620|NCT02187861|588852793|FG000|Overall Study|Adverse Event|2|||
163039621|NCT02187861|588852794|FG001|Overall Study|Adverse Event|1|||
163039622|NCT02187861|588852795|FG002|Overall Study|Adverse Event|2|||
163039623|NCT02187861|588852796|FG003|Overall Study|Adverse Event|1|||
163039624|NCT02187861|588852793|FG000|Overall Study|Death|0|||
163039625|NCT02187861|588852794|FG001|Overall Study|Death|3|||
163039626|NCT02187861|588852795|FG002|Overall Study|Death|1|||
163039627|NCT02187861|588852796|FG003|Overall Study|Death|2|||
163039628|NCT02187861|588852793|FG000|Overall Study|Physician Decision|0|||
163039629|NCT02187861|588852794|FG001|Overall Study|Physician Decision|1|||
163039630|NCT02187861|588852795|FG002|Overall Study|Physician Decision|0|||
163039631|NCT02187861|588852796|FG003|Overall Study|Physician Decision|3|||
163039632|NCT02187861|588852793|FG000|Overall Study|Progressive Disease|4|||
163039633|NCT02187861|588852794|FG001|Overall Study|Progressive Disease|42|||
163039634|NCT02187861|588852795|FG002|Overall Study|Progressive Disease|19|||
163039635|NCT02187861|588852796|FG003|Overall Study|Progressive Disease|22|||
163039636|NCT02187861|588852793|FG000|Overall Study|Withdrawal by Subject|0|||
163039637|NCT02187861|588852794|FG001|Overall Study|Withdrawal by Subject|0|||
163039638|NCT02187861|588852795|FG002|Overall Study|Withdrawal by Subject|3|||
163039639|NCT02187861|588852796|FG003|Overall Study|Withdrawal by Subject|3|||
163039640|NCT02187861|588852793|FG000|Overall Study|Other|0|||
163039641|NCT02187861|588852794|FG001|Overall Study|Other|1|||
163039642|NCT02187861|588852795|FG002|Overall Study|Other|7|||
163039643|NCT02187861|588852796|FG003|Overall Study|Other|1|||
163039644|NCT01491841|588852798|FG000|Overall Study|Screen Failure|10|||
163039645|NCT01491841|588852798|FG000|Overall Study|Withdrawal by Subject|1|||
163039646|NCT01301079|588852799|FG000|Overall Study|Lost to Follow-up|2|||
163039647|NCT01301079|588852800|FG001|Overall Study|Lost to Follow-up|2|||
163039648|NCT00313586|588852801|FG000|Overall Study|Disease progression|14|||
163039649|NCT00313586|588852802|FG001|Overall Study|Disease progression|19|||
163039650|NCT00313586|588852803|FG002|Overall Study|Disease progression|10|||
163039651|NCT00313586|588852804|FG003|Overall Study|Disease progression|3|||
163039652|NCT00313586|588852801|FG000|Overall Study|Adverse Event|12|||
163039653|NCT00313586|588852802|FG001|Overall Study|Adverse Event|18|||
163039654|NCT00313586|588852803|FG002|Overall Study|Adverse Event|3|||
163039655|NCT00313586|588852804|FG003|Overall Study|Adverse Event|10|||
163039656|NCT00313586|588852801|FG000|Overall Study|Death|11|||
163039657|NCT00313586|588852802|FG001|Overall Study|Death|8|||
163039658|NCT00313586|588852803|FG002|Overall Study|Death|1|||
163039659|NCT00313586|588852804|FG003|Overall Study|Death|7|||
163039660|NCT00313586|588852801|FG000|Overall Study|Withdrawal by Subject|13|||
163039661|NCT00313586|588852802|FG001|Overall Study|Withdrawal by Subject|6|||
163039662|NCT00313586|588852803|FG002|Overall Study|Withdrawal by Subject|6|||
163039663|NCT00313586|588852804|FG003|Overall Study|Withdrawal by Subject|2|||
163039664|NCT00313586|588852801|FG000|Overall Study|Alternative therapy|3|||
163039665|NCT00313586|588852802|FG001|Overall Study|Alternative therapy|6|||
163039666|NCT00313586|588852803|FG002|Overall Study|Alternative therapy|2|||
163039667|NCT00313586|588852804|FG003|Overall Study|Alternative therapy|0|||
163039668|NCT00313586|588852801|FG000|Overall Study|Other complicating disease|2|||
163350078|NCT00591409|589990974|FG008|Overall Study|Not Treated|0|||
163350079|NCT00591409|589990975|FG009|Overall Study|Not Treated|1|||
163350080|NCT01340300|589990976|FG000|Overall Study|Lost to Follow-up|3|||
163350081|NCT01340300|589990977|FG001|Overall Study|Lost to Follow-up|0|||
163350082|NCT01340300|589990978|FG002|Overall Study|Lost to Follow-up|5|||
163350083|NCT01340300|589990979|FG003|Overall Study|Lost to Follow-up|10|||
163350084|NCT01340300|589990976|FG000|Overall Study|Withdrawal by Subject|5|||
163350085|NCT01340300|589990977|FG001|Overall Study|Withdrawal by Subject|6|||
163039669|NCT00313586|588852802|FG001|Overall Study|Other complicating disease|2|||
163039670|NCT00313586|588852803|FG002|Overall Study|Other complicating disease|0|||
163039671|NCT00313586|588852804|FG003|Overall Study|Other complicating disease|0|||
163039672|NCT00313586|588852801|FG000|Overall Study|Did not achieve HI-major/better response|10|||
163039673|NCT00313586|588852802|FG001|Overall Study|Did not achieve HI-major/better response|7|||
163039674|NCT00313586|588852803|FG002|Overall Study|Did not achieve HI-major/better response|2|||
163039675|NCT00313586|588852804|FG003|Overall Study|Did not achieve HI-major/better response|1|||
163039676|NCT00313586|588852801|FG000|Overall Study|Physician Decision|2|||
163039677|NCT00313586|588852802|FG001|Overall Study|Physician Decision|1|||
163039678|NCT00313586|588852803|FG002|Overall Study|Physician Decision|0|||
163039679|NCT00313586|588852804|FG003|Overall Study|Physician Decision|0|||
163039680|NCT00313586|588852801|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
163039681|NCT00313586|588852802|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
163039682|NCT00313586|588852803|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
163039683|NCT00313586|588852804|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
163039684|NCT00313586|588852801|FG000|Overall Study|Lost insurance|0|||
163039685|NCT00313586|588852802|FG001|Overall Study|Lost insurance|1|||
163039686|NCT00313586|588852803|FG002|Overall Study|Lost insurance|0|||
163039687|NCT00313586|588852804|FG003|Overall Study|Lost insurance|0|||
163039688|NCT00313586|588852801|FG000|Overall Study|Moved|0|||
163039689|NCT00313586|588852802|FG001|Overall Study|Moved|1|||
163350086|NCT01340300|589990978|FG002|Overall Study|Withdrawal by Subject|6|||
163350087|NCT01340300|589990979|FG003|Overall Study|Withdrawal by Subject|3|||
163350088|NCT01340300|589990976|FG000|Overall Study|Adverse Event|1|||
163350089|NCT01340300|589990977|FG001|Overall Study|Adverse Event|0|||
163350090|NCT01340300|589990978|FG002|Overall Study|Adverse Event|4|||
163350091|NCT01340300|589990979|FG003|Overall Study|Adverse Event|0|||
163350092|NCT01340300|589990976|FG000|Overall Study|Physician Decision|0|||
163350093|NCT01340300|589990977|FG001|Overall Study|Physician Decision|1|||
163350094|NCT01340300|589990978|FG002|Overall Study|Physician Decision|0|||
163409862|NCT01926782|590209525|FG002|Overall Study|Poor compliance to protocol|8|||
163146406|NCT04319198|589246200|FG001|Overall Study|Reason Not Specified|2|||
163241022|NCT03859323|589592489|FG004|Overall Study|Lost to Follow-up|0|||
163241023|NCT03859323|589592490|FG005|Overall Study|Lost to Follow-up|0|||
163241024|NCT03859323|589592491|FG006|Overall Study|Lost to Follow-up|1|||
163241025|NCT03859323|589592492|FG007|Overall Study|Lost to Follow-up|0|||
163241026|NCT03859323|589592493|FG008|Overall Study|Lost to Follow-up|0|||
163241027|NCT03859323|589592494|FG009|Overall Study|Lost to Follow-up|0|||
163241028|NCT03859323|589592495|FG010|Overall Study|Lost to Follow-up|0|||
163241029|NCT03859323|589592496|FG011|Overall Study|Lost to Follow-up|0|||
163241030|NCT03859323|589592497|FG012|Overall Study|Lost to Follow-up|0|||
163241031|NCT03859323|589592485|FG000|Overall Study|Withdrawal by Subject|0|||
163241032|NCT03859323|589592486|FG001|Overall Study|Withdrawal by Subject|0|||
163241033|NCT03859323|589592487|FG002|Overall Study|Withdrawal by Subject|1|||
163241034|NCT03859323|589592488|FG003|Overall Study|Withdrawal by Subject|0|||
163241035|NCT03859323|589592489|FG004|Overall Study|Withdrawal by Subject|0|||
163241036|NCT03859323|589592490|FG005|Overall Study|Withdrawal by Subject|1|||
163241037|NCT03859323|589592491|FG006|Overall Study|Withdrawal by Subject|0|||
163241038|NCT03859323|589592492|FG007|Overall Study|Withdrawal by Subject|0|||
163241039|NCT03859323|589592493|FG008|Overall Study|Withdrawal by Subject|0|||
163241040|NCT03859323|589592494|FG009|Overall Study|Withdrawal by Subject|1|||
163241041|NCT03859323|589592495|FG010|Overall Study|Withdrawal by Subject|1|||
163241042|NCT03859323|589592496|FG011|Overall Study|Withdrawal by Subject|2|||
163241043|NCT03859323|589592497|FG012|Overall Study|Withdrawal by Subject|1|||
163241044|NCT03859323|589592485|FG000|Overall Study|Pregnancy|0|||
163241045|NCT03859323|589592486|FG001|Overall Study|Pregnancy|0|||
163241046|NCT03859323|589592487|FG002|Overall Study|Pregnancy|0|||
163241047|NCT03859323|589592488|FG003|Overall Study|Pregnancy|0|||
163241048|NCT03859323|589592489|FG004|Overall Study|Pregnancy|0|||
163241049|NCT03859323|589592490|FG005|Overall Study|Pregnancy|0|||
163241050|NCT03859323|589592491|FG006|Overall Study|Pregnancy|0|||
163241051|NCT03859323|589592492|FG007|Overall Study|Pregnancy|0|||
163241052|NCT03859323|589592493|FG008|Overall Study|Pregnancy|0|||
163241053|NCT03859323|589592494|FG009|Overall Study|Pregnancy|1|||
163241054|NCT03859323|589592495|FG010|Overall Study|Pregnancy|0|||
163241055|NCT03859323|589592496|FG011|Overall Study|Pregnancy|0|||
163241056|NCT03859323|589592497|FG012|Overall Study|Pregnancy|0|||
163241057|NCT01682460|589592499|FG000|Overall Study|Withdrawal by Subject|2|||
163241058|NCT01682460|589592499|FG000|Overall Study|Did not meet inclusion criteria|2|||
163241059|NCT01808690|589592503|FG000|Overall Study|Withdrawal by Subject|1|||
163241060|NCT01808690|589592504|FG001|Overall Study|Withdrawal by Subject|2|||
163241061|NCT03811912|589592505|FG000|Overall Study|Withdrew Consent|4|||
163241062|NCT03811912|589592506|FG001|Overall Study|Withdrew Consent|2|||
163241063|NCT02891187|589592507|FG000|Overall Study|Lost to Follow-up|1|||
163241064|NCT02891187|589592508|FG001|Overall Study|Lost to Follow-up|2|||
163241065|NCT00674986|589592509|FG000|Overall Study|Adverse Event|2|||
163241066|NCT00674986|589592510|FG001|Overall Study|Adverse Event|1|||
163241067|NCT00674986|589592509|FG000|Overall Study|Subject withdrew consent|12|||
163241068|NCT00674986|589592510|FG001|Overall Study|Subject withdrew consent|19|||
163241069|NCT00674986|589592509|FG000|Overall Study|Lost to Follow-up|25|||
163241070|NCT00674986|589592510|FG001|Overall Study|Lost to Follow-up|53|||
163241071|NCT00674986|589592509|FG000|Overall Study|Other reasons|4|||
163241072|NCT00674986|589592510|FG001|Overall Study|Other reasons|8|||
163241073|NCT00377234|589592511|FG000|Overall Study|Adverse Event|14|||
163241074|NCT00377234|589592512|FG001|Overall Study|Adverse Event|17|||
163241075|NCT00377234|589592511|FG000|Overall Study|Withdrawal by Subject|11|||
163241076|NCT00377234|589592512|FG001|Overall Study|Withdrawal by Subject|9|||
163241077|NCT00377234|589592511|FG000|Overall Study|Lost to Follow-up|4|||
163241078|NCT00377234|589592512|FG001|Overall Study|Lost to Follow-up|2|||
163241079|NCT00377234|589592511|FG000|Overall Study|Administrative|2|||
163241080|NCT00377234|589592512|FG001|Overall Study|Administrative|1|||
163241081|NCT00377234|589592511|FG000|Overall Study|Not assigned|3|||
163241082|NCT00377234|589592512|FG001|Overall Study|Not assigned|2|||
163241083|NCT02053350|589592519|FG000|Overall Study|Withdrawal by Subject|1|||
163241084|NCT02053350|589592519|FG000|Overall Study|Adverse Event|4|||
163241085|NCT01275625|589592520|FG000|Overall Study|Death|1|||
163241086|NCT01275625|589592520|FG000|Overall Study|Lack of Efficacy|2|||
163241087|NCT01275625|589592520|FG000|Overall Study|Lost to Follow-up|1|||
163350095|NCT01340300|589990979|FG003|Overall Study|Physician Decision|0|||
163350096|NCT01340300|589990976|FG000|Overall Study|Unrelated sickness|0|||
163350097|NCT01340300|589990977|FG001|Overall Study|Unrelated sickness|2|||
163350098|NCT01340300|589990978|FG002|Overall Study|Unrelated sickness|0|||
163350099|NCT01340300|589990979|FG003|Overall Study|Unrelated sickness|1|||
163350100|NCT01222533|589992733|FG000|Overall Study|Adverse Event|5|||
163350101|NCT01222533|589992733|FG000|Overall Study|Withdrawal by Subject|5|||
163350102|NCT01222533|589992733|FG000|Overall Study|Other|4|||
163039690|NCT00313586|588852803|FG002|Overall Study|Moved|0|||
163039691|NCT00313586|588852804|FG003|Overall Study|Moved|0|||
163039692|NCT00313586|588852801|FG000|Overall Study|Death before starting treatment|1|||
163039693|NCT00313586|588852802|FG001|Overall Study|Death before starting treatment|0|||
163039694|NCT00313586|588852803|FG002|Overall Study|Death before starting treatment|0|||
163039695|NCT00313586|588852804|FG003|Overall Study|Death before starting treatment|0|||
163039696|NCT00264290|588852805|FG000|Intervention (8 Weeks)|Adverse Event|1|||
163039697|NCT00264290|588852806|FG001|Intervention (8 Weeks)|Adverse Event|0|||
163039698|NCT04472494|588852807|FG000|Pre-treatment|Other reasons|2|||
163039699|NCT04472494|588852808|FG001|Pre-treatment|Other reasons|0|||
163039700|NCT04472494|588852807|FG000|Treatment|Death|5|||
163039701|NCT04472494|588852808|FG001|Treatment|Death|2|||
163039702|NCT04472494|588852807|FG000|Treatment|Hospital discharge|1|||
163039703|NCT04472494|588852808|FG001|Treatment|Hospital discharge|1|||
163039704|NCT03519919|588852810|FG000|Overall Study|Withdrawal by Subject|1|||
163039705|NCT03519919|588852810|FG000|Overall Study|Lack of Efficacy|1|||
163039706|NCT03519919|588852810|FG000|Overall Study|Screen Failure|1|||
163039707|NCT03076996|588852811|FG000|Overall Study|Withdrawal by Subject|2|||
163039708|NCT03076996|588852811|FG000|Overall Study|Lost to Follow-up|3|||
163039709|NCT03076996|588852811|FG000|Overall Study|Literacy precluded participation|1|||
163039710|NCT00587795|588852816|FG000|Overall Study|Withdrawal by Subject|1|||
163039711|NCT00587795|588852817|FG001|Overall Study|Withdrawal by Subject|0|||
163039712|NCT02144077|588852818|FG000|Overall Study|Withdrawal by Subject|3|||
163039713|NCT02144077|588852819|FG001|Overall Study|Withdrawal by Subject|3|||
163039714|NCT02144077|588852818|FG000|Overall Study|Adverse Event|2|||
163039715|NCT02144077|588852819|FG001|Overall Study|Adverse Event|3|||
163039716|NCT02144077|588852818|FG000|Overall Study|Lost to Follow-up|2|||
163039717|NCT02144077|588852819|FG001|Overall Study|Lost to Follow-up|2|||
163039718|NCT02144077|588852818|FG000|Overall Study|Protocol Violation|1|||
163039719|NCT02144077|588852819|FG001|Overall Study|Protocol Violation|2|||
163039720|NCT02144077|588852818|FG000|Overall Study|Death|0|||
163039721|NCT02144077|588852819|FG001|Overall Study|Death|1|||
163039722|NCT02144077|588852818|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
163039723|NCT02144077|588852819|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
163039724|NCT00943592|588852820|FG000|Overall Study|Death|3|||
163039725|NCT01909973|588852821|FG000|Overall Study|Lost to Follow-up|1|||
163039726|NCT01909973|588852822|FG001|Overall Study|Lost to Follow-up|0|||
163039727|NCT00460239|588852823|FG000|Overall Study|Physician Decision|0|||
163039728|NCT00460239|588852824|FG001|Overall Study|Physician Decision|1|||
163039729|NCT00460239|588852825|FG002|Overall Study|Physician Decision|0|||
163039730|NCT00460239|588852826|FG003|Overall Study|Physician Decision|0|||
163039731|NCT00460239|588852827|FG004|Overall Study|Physician Decision|0|||
163039732|NCT00460239|588852828|FG005|Overall Study|Physician Decision|2|||
163039733|NCT00460239|588852829|FG006|Overall Study|Physician Decision|0|||
163039734|NCT00460239|588852830|FG007|Overall Study|Physician Decision|0|||
163039735|NCT00460239|588852831|FG008|Overall Study|Physician Decision|0|||
163039736|NCT00460239|588852823|FG000|Overall Study|Withdrawal by Subject|0|||
163039737|NCT00460239|588852824|FG001|Overall Study|Withdrawal by Subject|0|||
163039738|NCT00460239|588852825|FG002|Overall Study|Withdrawal by Subject|0|||
163039739|NCT00460239|588852826|FG003|Overall Study|Withdrawal by Subject|0|||
163039740|NCT00460239|588852827|FG004|Overall Study|Withdrawal by Subject|0|||
163039741|NCT00460239|588852828|FG005|Overall Study|Withdrawal by Subject|1|||
163039742|NCT00460239|588852829|FG006|Overall Study|Withdrawal by Subject|0|||
163039743|NCT00460239|588852830|FG007|Overall Study|Withdrawal by Subject|0|||
163350103|NCT03834623|589992734|FG000|Overall Study|Progression|0|||
163350104|NCT03834623|589992735|FG001|Overall Study|Progression|1|||
163350105|NCT01947517|589992736|FG000|Overall Study|Withdrawal by Subject|1|||
163350106|NCT01947517|589992737|FG001|Overall Study|Withdrawal by Subject|1|||
163350107|NCT00460564|589992738|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
163350108|NCT00460564|589992739|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
163350109|NCT00460564|589992740|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163350110|NCT00460564|589992741|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163350111|NCT00460564|589992742|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163350112|NCT00460564|589992743|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163350113|NCT00460564|589992744|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163350114|NCT00460564|589992745|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163350115|NCT00460564|589992738|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
163350116|NCT00460564|589992739|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163350117|NCT00460564|589992740|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163039744|NCT00460239|588852831|FG008|Overall Study|Withdrawal by Subject|0|||
163039745|NCT02438280|588852837|FG000|Overall Study|Physician Decision|1|||
163039746|NCT02438280|588852838|FG001|Overall Study|Physician Decision|0|||
163039747|NCT02087943|588852839|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
163039748|NCT02087943|588852840|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
163241088|NCT01275625|589592520|FG000|Overall Study|Withdrawal by Subject|3|||
163241089|NCT01275625|589592520|FG000|Overall Study|Protocol Violation|1|||
163241090|NCT01275625|589592520|FG000|Overall Study|Adverse Event|4|||
163241091|NCT01275625|589592520|FG000|Overall Study|Other|1|||
163241092|NCT01585103|589592522|FG000|Overall Study|Unable to swallow Cytosponge|6|||
163241093|NCT03521635|589592523|FG000|Overall Study|Adverse Event|1|||
163241094|NCT03521635|589592524|FG001|Overall Study|Adverse Event|1|||
163241095|NCT03521635|589592523|FG000|Overall Study|Refused to complete study visit|1|||
163039749|NCT02087943|588852841|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
163039750|NCT02087943|588852842|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
163241096|NCT03521635|589592524|FG001|Overall Study|Refused to complete study visit|0|||
163241097|NCT03521635|589592523|FG000|Overall Study|Refused to continue trial medication|2|||
163241098|NCT03521635|589592524|FG001|Overall Study|Refused to continue trial medication|2|||
163241099|NCT03521635|589592523|FG000|Overall Study|Lost to Follow-up|0|||
163241100|NCT03521635|589592524|FG001|Overall Study|Lost to Follow-up|1|||
163241101|NCT03521635|589592523|FG000|Overall Study|Meet exclusion criteria|0|||
163241102|NCT03521635|589592524|FG001|Overall Study|Meet exclusion criteria|1|||
163241103|NCT03521635|589592523|FG000|Overall Study|Patient not taken study medicine|0|||
163241104|NCT03521635|589592524|FG001|Overall Study|Patient not taken study medicine|1|||
163241105|NCT01349569|589592525|FG000|Overall Study|Lack of Efficacy|4|||
163241106|NCT03581305|589592526|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
163241107|NCT03581305|589592527|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
163241108|NCT03581305|589592526|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
163241109|NCT03581305|589592527|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
163241110|NCT03581305|589592526|FG000|Serotonergic Study|Withdrawal by Subject|5|||
163241111|NCT03581305|589592527|FG001|Serotonergic Study|Withdrawal by Subject|1|||
163241112|NCT02244944|589592528|FG000|Overall Study|Withdrawal by Subject|1|||
163241113|NCT02244944|589592528|FG000|Overall Study|Study Terminated|1|||
163241114|NCT01747772|589592529|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
163241115|NCT00626522|589592532|FG000|Overall Study|Protocol Violation|0|||
163241116|NCT00626522|589592533|FG001|Overall Study|Protocol Violation|0|||
163241117|NCT00626522|589592534|FG002|Overall Study|Protocol Violation|0|||
163241118|NCT00626522|589592535|FG003|Overall Study|Protocol Violation|0|||
163241119|NCT00626522|589592536|FG004|Overall Study|Protocol Violation|1|||
163241120|NCT00626522|589592537|FG005|Overall Study|Protocol Violation|0|||
163241121|NCT00626522|589592532|FG000|Overall Study|Adverse Event|2|||
163241122|NCT00626522|589592533|FG001|Overall Study|Adverse Event|1|||
163241123|NCT00626522|589592534|FG002|Overall Study|Adverse Event|2|||
163241124|NCT00626522|589592535|FG003|Overall Study|Adverse Event|0|||
163241125|NCT00626522|589592536|FG004|Overall Study|Adverse Event|1|||
163241126|NCT00626522|589592537|FG005|Overall Study|Adverse Event|1|||
163241127|NCT00626522|589592532|FG000|Overall Study|Withdrawal by Subject|2|||
163241128|NCT00626522|589592533|FG001|Overall Study|Withdrawal by Subject|5|||
163241129|NCT00626522|589592534|FG002|Overall Study|Withdrawal by Subject|5|||
163241130|NCT00626522|589592535|FG003|Overall Study|Withdrawal by Subject|0|||
163241131|NCT00626522|589592536|FG004|Overall Study|Withdrawal by Subject|4|||
163241132|NCT00626522|589592537|FG005|Overall Study|Withdrawal by Subject|1|||
163241133|NCT00626522|589592532|FG000|Overall Study|COPD exacerbation|0|||
163241134|NCT00626522|589592533|FG001|Overall Study|COPD exacerbation|0|||
163241135|NCT00626522|589592534|FG002|Overall Study|COPD exacerbation|0|||
163241136|NCT00626522|589592535|FG003|Overall Study|COPD exacerbation|1|||
163241137|NCT00626522|589592536|FG004|Overall Study|COPD exacerbation|1|||
163241138|NCT00626522|589592537|FG005|Overall Study|COPD exacerbation|0|||
163241139|NCT00626522|589592532|FG000|Overall Study|Lost to Follow-up|0|||
163241140|NCT00626522|589592533|FG001|Overall Study|Lost to Follow-up|1|||
163241141|NCT00626522|589592534|FG002|Overall Study|Lost to Follow-up|0|||
163241142|NCT00626522|589592535|FG003|Overall Study|Lost to Follow-up|0|||
163241143|NCT00626522|589592536|FG004|Overall Study|Lost to Follow-up|0|||
163241144|NCT00626522|589592537|FG005|Overall Study|Lost to Follow-up|0|||
163241145|NCT00626522|589592532|FG000|Overall Study|Inconsistent reason reported|1|||
163241146|NCT00626522|589592533|FG001|Overall Study|Inconsistent reason reported|0|||
163241147|NCT00626522|589592534|FG002|Overall Study|Inconsistent reason reported|0|||
163241148|NCT00626522|589592535|FG003|Overall Study|Inconsistent reason reported|0|||
163241149|NCT00626522|589592536|FG004|Overall Study|Inconsistent reason reported|0|||
163241150|NCT00626522|589592537|FG005|Overall Study|Inconsistent reason reported|0|||
163241151|NCT00626522|589592532|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
163241152|NCT00626522|589592533|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
163241153|NCT00626522|589592534|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
163039751|NCT02087943|588852843|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
163039752|NCT02087943|588852839|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
163241154|NCT00626522|589592535|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
163241155|NCT00626522|589592536|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
163241156|NCT00626522|589592537|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
163241157|NCT01928719|589592538|FG000|Overall Study|Lost to Follow-up|26|||
163241158|NCT01928719|589592539|FG001|Overall Study|Lost to Follow-up|11|||
163241159|NCT01928719|589592538|FG000|Overall Study|Withdrawal by Subject|22|||
163241160|NCT01928719|589592539|FG001|Overall Study|Withdrawal by Subject|7|||
163241161|NCT01928719|589592538|FG000|Overall Study|Protocol Violation|3|||
163241162|NCT01928719|589592539|FG001|Overall Study|Protocol Violation|1|||
163241163|NCT01928719|589592538|FG000|Overall Study|Adverse Event|1|||
163241164|NCT01928719|589592539|FG001|Overall Study|Adverse Event|0|||
163241165|NCT01490632|589592540|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
163241166|NCT01490632|589592541|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
163241167|NCT01490632|589592542|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
163241168|NCT01490632|589592543|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
163241169|NCT01490632|589592544|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
163241170|NCT01490632|589592545|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
163241171|NCT01490632|589592546|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
163241172|NCT01490632|589592547|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
163241173|NCT01490632|589592548|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
163241174|NCT01490632|589592549|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
163241175|NCT01490632|589592550|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
163241176|NCT01490632|589592551|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
163241177|NCT01490632|589592552|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
163241178|NCT01490632|589592553|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
163241179|NCT01490632|589592554|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
163241180|NCT01490632|589592555|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
163241181|NCT01490632|589592556|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
163241182|NCT01490632|589592557|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
163241183|NCT01490632|589592558|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
163241184|NCT01490632|589592559|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
163241185|NCT01490632|589592540|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
163241186|NCT01490632|589592541|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
163241187|NCT01490632|589592542|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
163241188|NCT01490632|589592543|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
163241189|NCT01490632|589592544|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241190|NCT01490632|589592545|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241191|NCT01490632|589592546|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241192|NCT01490632|589592547|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241193|NCT01490632|589592548|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241194|NCT01490632|589592549|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241195|NCT01490632|589592550|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241196|NCT01490632|589592551|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241197|NCT01490632|589592552|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241198|NCT01490632|589592553|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241199|NCT01490632|589592554|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241200|NCT01490632|589592555|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241201|NCT01490632|589592556|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241202|NCT01490632|589592557|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241203|NCT01490632|589592558|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241204|NCT01490632|589592559|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
163241205|NCT01490632|589592540|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241206|NCT01490632|589592541|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241207|NCT01490632|589592542|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
163241208|NCT01490632|589592543|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
163241209|NCT01490632|589592544|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
163241210|NCT01490632|589592545|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241211|NCT01490632|589592546|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241212|NCT01490632|589592547|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241213|NCT01490632|589592548|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241214|NCT01490632|589592549|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241215|NCT01490632|589592550|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241216|NCT01490632|589592551|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241217|NCT01490632|589592552|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241218|NCT01490632|589592553|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241219|NCT01490632|589592554|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241220|NCT01490632|589592555|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241221|NCT01490632|589592556|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241222|NCT01490632|589592557|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241223|NCT01490632|589592558|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241224|NCT01490632|589592559|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
163241225|NCT01490632|589592540|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
163241226|NCT01490632|589592541|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
163241227|NCT01490632|589592542|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
163241228|NCT01490632|589592543|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
163241229|NCT01490632|589592544|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
163241230|NCT01490632|589592545|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
163241231|NCT01490632|589592546|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
163241232|NCT01490632|589592547|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
163241233|NCT01490632|589592548|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
163241234|NCT01490632|589592549|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
163241235|NCT01490632|589592550|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
163241236|NCT01490632|589592551|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
163241237|NCT01490632|589592552|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
163241238|NCT01490632|589592553|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
163241239|NCT01490632|589592554|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
163241240|NCT01490632|589592555|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
163241241|NCT01490632|589592556|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
163241242|NCT01490632|589592557|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
163241243|NCT01490632|589592558|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
163241244|NCT01490632|589592559|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
163241245|NCT01490632|589592540|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
163241246|NCT01490632|589592541|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241247|NCT01490632|589592542|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241248|NCT01490632|589592543|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241249|NCT01490632|589592544|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241250|NCT01490632|589592545|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241251|NCT01490632|589592546|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241252|NCT01490632|589592547|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241253|NCT01490632|589592548|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241254|NCT01490632|589592549|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241255|NCT01490632|589592550|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241256|NCT01490632|589592551|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241257|NCT01490632|589592552|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241258|NCT01490632|589592553|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241259|NCT01490632|589592554|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241260|NCT01490632|589592555|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241261|NCT01490632|589592556|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241262|NCT01490632|589592557|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241263|NCT01490632|589592558|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241264|NCT01490632|589592559|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
163241265|NCT01490632|589592540|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
163241266|NCT01490632|589592541|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
163241267|NCT01490632|589592542|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241268|NCT01490632|589592543|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
163241269|NCT01490632|589592544|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
163241270|NCT01490632|589592545|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241271|NCT01490632|589592546|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241272|NCT01490632|589592547|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241273|NCT01490632|589592548|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241274|NCT01490632|589592549|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241275|NCT01490632|589592550|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241276|NCT01490632|589592551|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241277|NCT01490632|589592552|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241278|NCT01490632|589592553|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241279|NCT01490632|589592554|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241280|NCT01490632|589592555|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241281|NCT01490632|589592556|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241282|NCT01490632|589592557|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241283|NCT01490632|589592558|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241284|NCT01490632|589592559|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
163241285|NCT01490632|589592540|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241286|NCT01490632|589592541|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163350118|NCT00460564|589992741|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163350119|NCT00460564|589992742|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163350120|NCT00460564|589992743|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163350121|NCT00460564|589992744|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163350122|NCT00460564|589992745|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163350123|NCT00460564|589992738|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
163350124|NCT00460564|589992739|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
163350125|NCT00460564|589992740|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
163350126|NCT00460564|589992741|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
163350127|NCT00460564|589992742|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
163350128|NCT00460564|589992743|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
163350129|NCT00460564|589992744|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
163350130|NCT00460564|589992745|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
163350131|NCT00460564|589992738|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163350132|NCT00460564|589992739|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163350133|NCT00460564|589992740|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163350134|NCT00460564|589992741|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163350135|NCT00460564|589992742|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
163350136|NCT00460564|589992743|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
163350137|NCT00460564|589992744|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163350138|NCT00460564|589992745|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163350139|NCT00460564|589992738|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
163350140|NCT00460564|589992739|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
163350141|NCT00460564|589992740|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
163350142|NCT00460564|589992741|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
163350143|NCT00460564|589992742|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
163350144|NCT00460564|589992743|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
163350145|NCT00460564|589992744|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
163350146|NCT00460564|589992745|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
163350147|NCT03226106|589992752|FG000|Overall Study|Withdrawal by Subject|2|||
163350148|NCT03226106|589992753|FG001|Overall Study|Withdrawal by Subject|0|||
163350149|NCT03226106|589992752|FG000|Overall Study|Adverse Event|1|||
163350150|NCT03226106|589992753|FG001|Overall Study|Adverse Event|0|||
163350151|NCT03226106|589992752|FG000|Overall Study|Lost to Follow-up|2|||
163350152|NCT03226106|589992753|FG001|Overall Study|Lost to Follow-up|0|||
163350153|NCT04349644|589992754|FG000|Allocation/Pretest|Lost to pretest|0|||
163350154|NCT04349644|589992755|FG001|Allocation/Pretest|Lost to pretest|3|||
163350155|NCT04349644|589992754|FG000|Posttest|Lost to posttest|0|||
163350156|NCT04349644|589992755|FG001|Posttest|Lost to posttest|8|||
163350157|NCT04349644|589992754|FG000|Posttest|Discontinued intervention|6|||
163350158|NCT04349644|589992755|FG001|Posttest|Discontinued intervention|0|||
163350159|NCT04349644|589992754|FG000|Follow-up|Lost to Follow-up|0|||
163350160|NCT04349644|589992755|FG001|Follow-up|Lost to Follow-up|2|||
163350161|NCT00702650|589992756|FG000|Overall Study|Withdrawal by Subject|9|||
163350162|NCT00702650|589992756|FG000|Overall Study|Non-Compliance of Study Drug|3|||
163146407|NCT04319198|589246201|FG002|Overall Study|Reason Not Specified|4|||
163146408|NCT04319198|589246199|FG000|Overall Study|Withdrawal of Consent|0|||
163350163|NCT00702650|589992756|FG000|Overall Study|Lost to Follow-up|2|||
163350164|NCT00702650|589992756|FG000|Overall Study|Non-Compliance with Site Directives|1|||
163350165|NCT00702650|589992756|FG000|Overall Study|Sponsor Request|1|||
163350166|NCT00702650|589992756|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
163350167|NCT00702650|589992756|FG000|Overall Study|Adverse Event|3|||
163350168|NCT01309243|589992757|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
163350169|NCT01309243|589992758|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
163350170|NCT01309243|589992757|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
163350171|NCT01309243|589992758|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
163350172|NCT01309243|589992757|FG000|Randomized Phase Through Week 96|Death|0|||
163350173|NCT01309243|589992758|FG001|Randomized Phase Through Week 96|Death|1|||
163350174|NCT01309243|589992757|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
163350175|NCT01309243|589992758|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
163350176|NCT01309243|589992757|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
163350177|NCT01309243|589992758|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
163146409|NCT04319198|589246200|FG001|Overall Study|Withdrawal of Consent|0|||
163146410|NCT04319198|589246201|FG002|Overall Study|Withdrawal of Consent|5|||
163146411|NCT04319198|589246199|FG000|Overall Study|Site Terminated by Sponsor|0|||
163146412|NCT04319198|589246200|FG001|Overall Study|Site Terminated by Sponsor|1|||
163146413|NCT04319198|589246201|FG002|Overall Study|Site Terminated by Sponsor|0|||
163146414|NCT04607668|589246203|FG000|Overall Study|Death|49|||
163146415|NCT04607668|589246204|FG001|Overall Study|Death|26|||
163146416|NCT04607668|589246203|FG000|Overall Study|Lost to Follow-up|3|||
163146417|NCT04607668|589246204|FG001|Overall Study|Lost to Follow-up|4|||
163146418|NCT04607668|589246203|FG000|Overall Study|Study terminated by Sponsor|92|||
163241287|NCT01490632|589592542|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241288|NCT01490632|589592543|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241289|NCT01490632|589592544|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
163241290|NCT01490632|589592545|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241291|NCT01490632|589592546|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241292|NCT01490632|589592547|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241293|NCT01490632|589592548|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241294|NCT01490632|589592549|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241295|NCT01490632|589592550|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241296|NCT01490632|589592551|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241297|NCT01490632|589592552|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241298|NCT01490632|589592553|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241299|NCT01490632|589592554|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241300|NCT01490632|589592555|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241301|NCT01490632|589592556|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241302|NCT01490632|589592557|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241303|NCT01490632|589592558|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241304|NCT01490632|589592559|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163241305|NCT01490632|589592540|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
163241306|NCT01490632|589592541|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
163241307|NCT01490632|589592542|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
163241308|NCT01490632|589592543|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
163241309|NCT01490632|589592544|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
163241310|NCT01490632|589592545|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
163241311|NCT01490632|589592546|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
163241312|NCT01490632|589592547|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
163241313|NCT01490632|589592548|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
163241314|NCT01490632|589592549|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
163039753|NCT02087943|588852840|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
163039754|NCT02087943|588852841|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
163039755|NCT02087943|588852842|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
163039756|NCT02087943|588852843|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
163039757|NCT02087943|588852839|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
163039758|NCT02087943|588852840|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
163039759|NCT02087943|588852841|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
163039760|NCT02087943|588852842|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
163039761|NCT02087943|588852843|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
163039762|NCT02087943|588852839|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
163039763|NCT02087943|588852840|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
163039764|NCT02087943|588852841|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
163039765|NCT02087943|588852842|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
163039766|NCT02087943|588852843|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
163039767|NCT02087943|588852839|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
163039768|NCT02087943|588852840|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
163039769|NCT02087943|588852841|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
163039770|NCT02087943|588852842|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
163039771|NCT02087943|588852843|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
163241315|NCT01490632|589592550|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
163241316|NCT01490632|589592551|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
163241317|NCT01490632|589592552|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
163241318|NCT01490632|589592553|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
163241319|NCT01490632|589592554|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
163350178|NCT01309243|589992757|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
163350179|NCT01309243|589992758|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
163350180|NCT01309243|589992757|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
163350181|NCT01309243|589992758|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
163350182|NCT01309243|589992757|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
163350183|NCT01309243|589992758|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
163350184|NCT01309243|589992757|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
163350185|NCT01309243|589992758|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
163039772|NCT02087943|588852839|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
163039773|NCT02087943|588852840|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
163039774|NCT02087943|588852841|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
163039775|NCT02087943|588852842|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
163409863|NCT01926782|590209526|FG003|Overall Study|Poor compliance to protocol|0|||
163039776|NCT02087943|588852843|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
163039777|NCT02087943|588852839|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
163039778|NCT02087943|588852840|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
163039779|NCT02087943|588852841|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
163039780|NCT02087943|588852842|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
163039781|NCT02087943|588852843|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
163039782|NCT02087943|588852839|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
163039783|NCT02087943|588852840|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
163039784|NCT02087943|588852841|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
163039785|NCT02087943|588852842|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
163039786|NCT02087943|588852843|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
163039787|NCT02087943|588852839|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
163039788|NCT02087943|588852840|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
163039789|NCT02087943|588852841|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
163039790|NCT02087943|588852842|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
163039791|NCT02087943|588852843|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
163039792|NCT02087943|588852839|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
163039793|NCT02087943|588852840|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
163039794|NCT02087943|588852841|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
163039795|NCT02087943|588852842|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
163039796|NCT02087943|588852843|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
163039797|NCT01690299|588852844|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
163039798|NCT01690299|588852845|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
163039799|NCT01690299|588852846|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
163039800|NCT01690299|588852847|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
163039801|NCT01690299|588852848|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
163039802|NCT01690299|588852849|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
163039803|NCT01690299|588852844|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
163039804|NCT01690299|588852845|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163039805|NCT01690299|588852846|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163241320|NCT01490632|589592555|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
163241321|NCT01490632|589592556|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
163241322|NCT01490632|589592557|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
163241323|NCT01490632|589592558|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
163241324|NCT01490632|589592559|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
163241325|NCT01490632|589592540|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241326|NCT01490632|589592541|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241327|NCT01490632|589592542|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241328|NCT01490632|589592543|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241329|NCT01490632|589592544|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241330|NCT01490632|589592545|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241331|NCT01490632|589592546|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
163241332|NCT01490632|589592547|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241333|NCT01490632|589592548|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
163241334|NCT01490632|589592549|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
163241335|NCT01490632|589592550|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
163241336|NCT01490632|589592551|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241337|NCT01490632|589592552|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241338|NCT01490632|589592553|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241339|NCT01490632|589592554|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241340|NCT01490632|589592555|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241341|NCT01490632|589592556|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241342|NCT01490632|589592557|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241343|NCT01490632|589592558|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241344|NCT01490632|589592559|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
163241345|NCT01490632|589592540|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241346|NCT01490632|589592541|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241347|NCT01490632|589592542|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241348|NCT01490632|589592543|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241349|NCT01490632|589592544|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241350|NCT01490632|589592545|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241351|NCT01490632|589592546|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
163241352|NCT01490632|589592547|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241353|NCT01490632|589592548|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241354|NCT01490632|589592549|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
163350186|NCT01309243|589992757|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
163350187|NCT01309243|589992758|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
163350188|NCT01309243|589992757|FG000|Extension Phase|Lost to Follow-up|6|||
163350189|NCT01309243|589992758|FG001|Extension Phase|Lost to Follow-up|0|||
163350190|NCT00943722|589992760|FG000|Base Study|Adverse Event|0|||
163350191|NCT00943722|589992761|FG001|Base Study|Adverse Event|0|||
163350192|NCT00943722|589992762|FG002|Base Study|Adverse Event|0|||
163350193|NCT00943722|589992763|FG003|Base Study|Adverse Event|1|||
163350194|NCT00943722|589992764|FG004|Base Study|Adverse Event|0|||
163350195|NCT00943722|589992765|FG005|Base Study|Adverse Event|0|||
163350196|NCT00943722|589992766|FG006|Base Study|Adverse Event|0|||
163350197|NCT00943722|589992760|FG000|Base Study|Lost to Follow-up|12|||
163350198|NCT00943722|589992761|FG001|Base Study|Lost to Follow-up|8|||
163350199|NCT00943722|589992762|FG002|Base Study|Lost to Follow-up|10|||
163350200|NCT00943722|589992763|FG003|Base Study|Lost to Follow-up|8|||
163350201|NCT00943722|589992764|FG004|Base Study|Lost to Follow-up|11|||
163350202|NCT00943722|589992765|FG005|Base Study|Lost to Follow-up|0|||
163350203|NCT00943722|589992766|FG006|Base Study|Lost to Follow-up|0|||
163350204|NCT00943722|589992760|FG000|Base Study|Physician Decision|1|||
163350205|NCT00943722|589992761|FG001|Base Study|Physician Decision|0|||
163350206|NCT00943722|589992762|FG002|Base Study|Physician Decision|0|||
163350207|NCT00943722|589992763|FG003|Base Study|Physician Decision|0|||
163350208|NCT00943722|589992764|FG004|Base Study|Physician Decision|1|||
163350209|NCT00943722|589992765|FG005|Base Study|Physician Decision|0|||
163350210|NCT00943722|589992766|FG006|Base Study|Physician Decision|0|||
163350211|NCT00943722|589992760|FG000|Base Study|Pregnancy|0|||
163350212|NCT00943722|589992761|FG001|Base Study|Pregnancy|0|||
163350213|NCT00943722|589992762|FG002|Base Study|Pregnancy|1|||
163350214|NCT00943722|589992763|FG003|Base Study|Pregnancy|0|||
163350215|NCT00943722|589992764|FG004|Base Study|Pregnancy|2|||
163350216|NCT00943722|589992765|FG005|Base Study|Pregnancy|0|||
163350217|NCT00943722|589992766|FG006|Base Study|Pregnancy|0|||
163350218|NCT00943722|589992760|FG000|Base Study|Protocol Violation|0|||
163350219|NCT00943722|589992761|FG001|Base Study|Protocol Violation|1|||
163350220|NCT00943722|589992762|FG002|Base Study|Protocol Violation|0|||
163350221|NCT00943722|589992763|FG003|Base Study|Protocol Violation|0|||
163350222|NCT00943722|589992764|FG004|Base Study|Protocol Violation|2|||
163350223|NCT00943722|589992765|FG005|Base Study|Protocol Violation|0|||
163350224|NCT00943722|589992766|FG006|Base Study|Protocol Violation|0|||
163350225|NCT00943722|589992760|FG000|Base Study|Withdrawal by Subject|12|||
163350226|NCT00943722|589992761|FG001|Base Study|Withdrawal by Subject|13|||
163350227|NCT00943722|589992762|FG002|Base Study|Withdrawal by Subject|2|||
163350228|NCT00943722|589992763|FG003|Base Study|Withdrawal by Subject|13|||
163350229|NCT00943722|589992764|FG004|Base Study|Withdrawal by Subject|8|||
163350230|NCT00943722|589992765|FG005|Base Study|Withdrawal by Subject|0|||
163350231|NCT00943722|589992766|FG006|Base Study|Withdrawal by Subject|0|||
163350232|NCT00943722|589992760|FG000|Base Study|Month 12 visit not completed|0|||
163350233|NCT00943722|589992761|FG001|Base Study|Month 12 visit not completed|0|||
163350234|NCT00943722|589992762|FG002|Base Study|Month 12 visit not completed|0|||
163350235|NCT00943722|589992763|FG003|Base Study|Month 12 visit not completed|0|||
163350236|NCT00943722|589992764|FG004|Base Study|Month 12 visit not completed|2|||
163350237|NCT00943722|589992765|FG005|Base Study|Month 12 visit not completed|0|||
163350238|NCT00943722|589992766|FG006|Base Study|Month 12 visit not completed|0|||
163350239|NCT00943722|589992760|FG000|First Extension Study: EXT 1|Adverse Event|0|||
163350240|NCT00943722|589992761|FG001|First Extension Study: EXT 1|Adverse Event|0|||
163350241|NCT00943722|589992762|FG002|First Extension Study: EXT 1|Adverse Event|0|||
163350242|NCT00943722|589992763|FG003|First Extension Study: EXT 1|Adverse Event|0|||
163350243|NCT00943722|589992764|FG004|First Extension Study: EXT 1|Adverse Event|0|||
163350244|NCT00943722|589992765|FG005|First Extension Study: EXT 1|Adverse Event|1|||
163350245|NCT00943722|589992766|FG006|First Extension Study: EXT 1|Adverse Event|0|||
163350246|NCT00943722|589992760|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
163409864|NCT01926782|590209527|FG004|Overall Study|Poor compliance to protocol|1|||
163350247|NCT00943722|589992761|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
163350248|NCT00943722|589992762|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
163350249|NCT00943722|589992763|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
163350250|NCT00943722|589992764|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
163350251|NCT00943722|589992765|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
163350252|NCT00943722|589992766|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
163350253|NCT00943722|589992760|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
163350254|NCT00943722|589992761|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
163350255|NCT00943722|589992762|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
163350256|NCT00943722|589992763|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
163350257|NCT00943722|589992764|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
163350258|NCT00943722|589992765|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
163350259|NCT00943722|589992766|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
163350260|NCT00943722|589992760|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
163350261|NCT00943722|589992761|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
163350262|NCT00943722|589992762|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
163350263|NCT00943722|589992763|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
163350264|NCT00943722|589992764|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
163350265|NCT00943722|589992765|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
163350266|NCT00943722|589992766|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
163350267|NCT00943722|589992760|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
163350268|NCT00943722|589992761|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
163350269|NCT00943722|589992762|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
163350270|NCT00943722|589992763|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
163350271|NCT00943722|589992764|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
163350272|NCT00943722|589992765|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
163350273|NCT00943722|589992766|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
163350274|NCT00943722|589992760|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
163350275|NCT00943722|589992761|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
163350276|NCT00943722|589992762|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
163350277|NCT00943722|589992763|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
163350278|NCT00943722|589992764|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
163350279|NCT00943722|589992765|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
163350280|NCT00943722|589992766|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
163350281|NCT00943722|589992760|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
163350282|NCT00943722|589992761|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
163350283|NCT00943722|589992762|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
163350284|NCT00943722|589992763|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
163350285|NCT00943722|589992764|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
163350286|NCT00943722|589992765|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
163350287|NCT00943722|589992766|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
163350288|NCT00943722|589992760|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
163350289|NCT00943722|589992761|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
163350290|NCT00943722|589992762|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
163350291|NCT00943722|589992763|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
163350292|NCT00943722|589992764|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
163350293|NCT00943722|589992765|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
163350294|NCT00943722|589992766|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
163350295|NCT00943722|589992760|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
163350296|NCT00943722|589992761|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
163409865|NCT01926782|590209528|FG005|Overall Study|Poor compliance to protocol|6|||
163409866|NCT01926782|590209523|FG000|Overall Study|Randomized and not treated|0|||
163409867|NCT01926782|590209524|FG001|Overall Study|Randomized and not treated|0|||
163409868|NCT01926782|590209525|FG002|Overall Study|Randomized and not treated|0|||
163409869|NCT01926782|590209526|FG003|Overall Study|Randomized and not treated|1|||
163409870|NCT01926782|590209527|FG004|Overall Study|Randomized and not treated|0|||
163409871|NCT01926782|590209528|FG005|Overall Study|Randomized and not treated|0|||
163409872|NCT01926782|590209523|FG000|Overall Study|Withdrawal by Subject|6|||
163409873|NCT01926782|590209524|FG001|Overall Study|Withdrawal by Subject|1|||
163409874|NCT01926782|590209525|FG002|Overall Study|Withdrawal by Subject|8|||
163409875|NCT01926782|590209526|FG003|Overall Study|Withdrawal by Subject|1|||
163409876|NCT01926782|590209527|FG004|Overall Study|Withdrawal by Subject|0|||
163409877|NCT01926782|590209528|FG005|Overall Study|Withdrawal by Subject|5|||
163409878|NCT01926782|590209523|FG000|Overall Study|Related to study drug administration|0|||
163409879|NCT01926782|590209524|FG001|Overall Study|Related to study drug administration|0|||
163409880|NCT01926782|590209525|FG002|Overall Study|Related to study drug administration|0|||
163409881|NCT01926782|590209526|FG003|Overall Study|Related to study drug administration|0|||
163409882|NCT01926782|590209527|FG004|Overall Study|Related to study drug administration|0|||
163409883|NCT01926782|590209528|FG005|Overall Study|Related to study drug administration|2|||
163409884|NCT04607733|590209531|FG000|Overall Study|Lost to Follow-up|1|||
163409885|NCT04607733|590209532|FG001|Overall Study|Lost to Follow-up|0|||
163409886|NCT04607733|590209533|FG002|Overall Study|Lost to Follow-up|0|||
163409887|NCT04607733|590209534|FG003|Overall Study|Lost to Follow-up|1|||
163409888|NCT04607733|590209535|FG004|Overall Study|Lost to Follow-up|1|||
163409889|NCT04607733|590209536|FG005|Overall Study|Lost to Follow-up|0|||
163409890|NCT04607733|590209531|FG000|Overall Study|Withdrawal by Subject|0|||
163409891|NCT04607733|590209532|FG001|Overall Study|Withdrawal by Subject|0|||
163409892|NCT04607733|590209533|FG002|Overall Study|Withdrawal by Subject|0|||
163409893|NCT04607733|590209534|FG003|Overall Study|Withdrawal by Subject|0|||
163409894|NCT04607733|590209535|FG004|Overall Study|Withdrawal by Subject|1|||
163409895|NCT04607733|590209536|FG005|Overall Study|Withdrawal by Subject|0|||
163409896|NCT02296242|590209537|FG000|Overall Study|Death|1|||
163409897|NCT02296242|590209538|FG001|Overall Study|Death|1|||
163409898|NCT02296242|590209539|FG002|Overall Study|Death|1|||
163409899|NCT02296242|590209540|FG003|Overall Study|Death|1|||
163409900|NCT02296242|590209541|FG004|Overall Study|Death|1|||
163409901|NCT02296242|590209537|FG000|Overall Study|Withdrawal by Subject|0|||
163409902|NCT02296242|590209538|FG001|Overall Study|Withdrawal by Subject|0|||
163350297|NCT00943722|589992762|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
163350298|NCT00943722|589992763|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
163350299|NCT00943722|589992764|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
163350300|NCT00943722|589992765|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
163350301|NCT00943722|589992766|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
163350302|NCT01772823|589992767|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
163350303|NCT01772823|589992768|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
163350304|NCT01772823|589992767|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
163350305|NCT01772823|589992768|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
163350306|NCT01772823|589992767|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
163350307|NCT01772823|589992768|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
163350308|NCT01772823|589992767|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
163350309|NCT01772823|589992768|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
163350310|NCT01772823|589992767|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
163350311|NCT01772823|589992768|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
163350312|NCT01772823|589992767|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
163350313|NCT01772823|589992768|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
163350314|NCT01772823|589992767|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
163350315|NCT01772823|589992768|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
163350316|NCT01772823|589992767|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
163350317|NCT01772823|589992768|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
163350318|NCT01772823|589992767|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
163350319|NCT01772823|589992768|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
163350320|NCT01772823|589992767|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
163350321|NCT01772823|589992768|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
163350322|NCT01772823|589992767|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
163350323|NCT01772823|589992768|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
163350324|NCT01772823|589992767|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
163350325|NCT01772823|589992768|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
163350326|NCT01772823|589992767|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
163350327|NCT01772823|589992768|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
163350328|NCT01772823|589992767|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
163350329|NCT01772823|589992768|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
163350330|NCT01772823|589992767|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
163350331|NCT01772823|589992768|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
163350332|NCT01772823|589992767|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
163350333|NCT01772823|589992768|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
163350334|NCT01402063|589992771|FG000|Overall Study|Withdrawal by Subject|3|||
163350335|NCT01402063|589992772|FG001|Overall Study|Withdrawal by Subject|3|||
163350336|NCT05109117|589992775|FG000|Overall Study|Lost to Follow-up|1|||
163350337|NCT05109117|589992775|FG000|Overall Study|Discontinued for non-compliance|1|||
163350338|NCT03220776|589992776|FG000|Overall Study|Claustrophobia|0|||
163350339|NCT03220776|589992777|FG001|Overall Study|Claustrophobia|1|||
163350340|NCT03220776|589992778|FG002|Overall Study|Claustrophobia|1|||
163350341|NCT03220776|589992779|FG003|Overall Study|Claustrophobia|0|||
163350342|NCT03220776|589992780|FG004|Overall Study|Claustrophobia|1|||
163350343|NCT03220776|589992781|FG005|Overall Study|Claustrophobia|0|||
163350344|NCT03220776|589992776|FG000|Overall Study|MRI Equipment Failure|1|||
163350345|NCT03220776|589992777|FG001|Overall Study|MRI Equipment Failure|0|||
163350346|NCT03220776|589992778|FG002|Overall Study|MRI Equipment Failure|0|||
163350347|NCT03220776|589992779|FG003|Overall Study|MRI Equipment Failure|0|||
163350348|NCT03220776|589992780|FG004|Overall Study|MRI Equipment Failure|0|||
163350349|NCT03220776|589992781|FG005|Overall Study|MRI Equipment Failure|0|||
163350350|NCT03220776|589992776|FG000|Overall Study|Inclimate Weather|0|||
163350351|NCT03220776|589992777|FG001|Overall Study|Inclimate Weather|0|||
163350352|NCT03220776|589992778|FG002|Overall Study|Inclimate Weather|0|||
163350353|NCT03220776|589992779|FG003|Overall Study|Inclimate Weather|0|||
163350354|NCT03220776|589992780|FG004|Overall Study|Inclimate Weather|0|||
163350355|NCT03220776|589992781|FG005|Overall Study|Inclimate Weather|1|||
163350356|NCT03220776|589992776|FG000|Overall Study|Physician Decision|0|||
163350357|NCT03220776|589992777|FG001|Overall Study|Physician Decision|0|||
163350358|NCT03220776|589992778|FG002|Overall Study|Physician Decision|0|||
163350359|NCT03220776|589992779|FG003|Overall Study|Physician Decision|1|||
163350360|NCT03220776|589992780|FG004|Overall Study|Physician Decision|0|||
163350361|NCT03220776|589992781|FG005|Overall Study|Physician Decision|0|||
163350362|NCT03220776|589992776|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
163350363|NCT03220776|589992777|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
163350364|NCT03220776|589992778|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
163039806|NCT01690299|588852847|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163039807|NCT01690299|588852848|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163039808|NCT01690299|588852849|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163039809|NCT01690299|588852844|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
163039810|NCT01690299|588852845|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
163039811|NCT01690299|588852846|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163039812|NCT01690299|588852847|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163039813|NCT01690299|588852848|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163039814|NCT01690299|588852849|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163039815|NCT01690299|588852844|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
163039816|NCT01690299|588852845|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
163039817|NCT01690299|588852846|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
163039818|NCT01690299|588852847|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
163039819|NCT01690299|588852848|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
163039820|NCT01690299|588852849|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
163039821|NCT01690299|588852844|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
163039822|NCT01690299|588852845|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
163039823|NCT01690299|588852846|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
163039824|NCT01690299|588852847|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
163039825|NCT01690299|588852848|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
163039826|NCT01690299|588852849|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
163039827|NCT01690299|588852844|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
163039828|NCT01690299|588852845|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
163039829|NCT01690299|588852846|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
163039830|NCT01690299|588852847|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
163039831|NCT01690299|588852848|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
163039832|NCT01690299|588852849|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
163039833|NCT01690299|588852844|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
163039834|NCT01690299|588852845|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
163039835|NCT01690299|588852846|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
163039836|NCT01690299|588852847|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
163039837|NCT01690299|588852848|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
163039838|NCT01690299|588852849|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
163039839|NCT01690299|588852844|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
163039840|NCT01690299|588852845|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
163039841|NCT01690299|588852846|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
163039842|NCT01690299|588852847|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
163039843|NCT01690299|588852848|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
163039844|NCT01690299|588852849|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
163039845|NCT01690299|588852844|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
163039846|NCT01690299|588852845|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
163039847|NCT01690299|588852846|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
163039848|NCT01690299|588852847|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
163039849|NCT01690299|588852848|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
163039850|NCT01690299|588852849|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
163039851|NCT01690299|588852844|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
163039852|NCT01690299|588852845|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
163039853|NCT01690299|588852846|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
163039854|NCT01690299|588852847|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
163039855|NCT01690299|588852848|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
163039856|NCT01690299|588852849|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
163039857|NCT01882803|588852854|FG000|Overall Study|Disease Progression|1|||
163039858|NCT01882803|588852854|FG000|Overall Study|Withdrawal by Subject|9|||
163039859|NCT01882803|588852854|FG000|Overall Study|Death|68|||
163039860|NCT01882803|588852854|FG000|Overall Study|Physician Decision|3|||
163039861|NCT01882803|588852854|FG000|Overall Study|Lost to Follow-up|3|||
163039862|NCT01882803|588852854|FG000|Overall Study|Follow-up Completed|39|||
163039863|NCT01882803|588852854|FG000|Overall Study|Study Terminated by the Sponsor|6|||
163039864|NCT02869893|588852855|FG000|Overall Study|participant aversion to IV|5|||
163039865|NCT02869893|588852855|FG000|Overall Study|participant fear of MRI scanner|2|||
163039866|NCT01563913|588852856|FG000|Overall Study|Physician Decision|1|||
163039867|NCT01563913|588852857|FG001|Overall Study|Physician Decision|0|||
163039868|NCT01563913|588852856|FG000|Overall Study|Spouse Passed Away|1|||
163039869|NCT01563913|588852857|FG001|Overall Study|Spouse Passed Away|0|||
163039870|NCT03066778|588852858|FG000|Overall Study|Death|195|||
163039871|NCT03066778|588852859|FG001|Overall Study|Death|205|||
163039872|NCT03066778|588852858|FG000|Overall Study|Withdrawal by Subject|5|||
163039873|NCT03066778|588852859|FG001|Overall Study|Withdrawal by Subject|7|||
163039874|NCT00551525|588852860|FG000|Overall Study|Protocol Violation|5|||
163039875|NCT02912455|588852862|FG000|Overall Study|Withdrawal by Subject|0|||
163039876|NCT02912455|588852863|FG001|Overall Study|Withdrawal by Subject|1|||
163039877|NCT02912455|588852862|FG000|Overall Study|Lack of Efficacy|0|||
163039878|NCT02912455|588852863|FG001|Overall Study|Lack of Efficacy|1|||
163039879|NCT02912455|588852862|FG000|Overall Study|Lost to Follow-up|2|||
163039880|NCT02912455|588852863|FG001|Overall Study|Lost to Follow-up|1|||
163039881|NCT00073008|588852864|FG000|Overall Study|Missing|6|||
163039882|NCT00073008|588852865|FG001|Overall Study|Missing|6|||
163039883|NCT00073008|588852864|FG000|Overall Study|Withdrawal by Subject|2|||
163039884|NCT00073008|588852865|FG001|Overall Study|Withdrawal by Subject|2|||
163039885|NCT00073008|588852864|FG000|Overall Study|Lost to Follow-up|1|||
163039886|NCT00073008|588852865|FG001|Overall Study|Lost to Follow-up|3|||
163039887|NCT00073008|588852864|FG000|Overall Study|Death|46|||
163241355|NCT01490632|589592550|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241356|NCT01490632|589592551|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241357|NCT01490632|589592552|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241358|NCT01490632|589592553|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241359|NCT01490632|589592554|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241360|NCT01490632|589592555|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241361|NCT01490632|589592556|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241362|NCT01490632|589592557|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241363|NCT01490632|589592558|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241364|NCT01490632|589592559|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163241365|NCT01490632|589592540|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241366|NCT01490632|589592541|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241367|NCT01490632|589592542|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241368|NCT01490632|589592543|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241369|NCT01490632|589592544|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241370|NCT01490632|589592545|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241371|NCT01490632|589592546|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
163241372|NCT01490632|589592547|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241373|NCT01490632|589592548|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241374|NCT01490632|589592549|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
163350365|NCT03220776|589992779|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
163350366|NCT03220776|589992780|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
163039888|NCT00073008|588852865|FG001|Overall Study|Death|47|||
163039889|NCT00073008|588852864|FG000|Overall Study|"Other selected on Case Report Form"|7|||
163039890|NCT00073008|588852865|FG001|Overall Study|"Other selected on Case Report Form"|5|||
163039891|NCT01778751|588852875|FG000|Overall Study|Lost to Follow-up|1|||
163039892|NCT01778751|588852876|FG001|Overall Study|Lost to Follow-up|0|||
163039893|NCT01778751|588852875|FG000|Overall Study|Withdrawal by Subject|0|||
163039894|NCT01778751|588852876|FG001|Overall Study|Withdrawal by Subject|2|||
163039895|NCT01778751|588852875|FG000|Overall Study|Transfered care|1|||
163039896|NCT01778751|588852876|FG001|Overall Study|Transfered care|0|||
163039897|NCT03337048|588852877|FG000|Overall Study|Withdrawal by Subject|2|||
163039898|NCT03337048|588852878|FG001|Overall Study|Withdrawal by Subject|0|||
163039899|NCT03337048|588852879|FG002|Overall Study|Withdrawal by Subject|0|||
163039900|NCT02669667|588852880|FG000|Overall Study|Lost to Follow-up|0|||
163350367|NCT03220776|589992781|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
163350368|NCT03220776|589992776|FG000|Overall Study|Protocol Violation|0|||
163146419|NCT04607668|589246204|FG001|Overall Study|Study terminated by Sponsor|114|||
163146420|NCT04607668|589246203|FG000|Overall Study|Withdrawal by Subject|12|||
163146421|NCT04607668|589246204|FG001|Overall Study|Withdrawal by Subject|11|||
163146422|NCT04607668|589246203|FG000|Overall Study|Other, unspecified|8|||
163146423|NCT04607668|589246204|FG001|Overall Study|Other, unspecified|7|||
163146424|NCT02250326|589246205|FG000|Treatment|Death|1|||
163146425|NCT02250326|589246206|FG001|Treatment|Death|13|||
163146426|NCT02250326|589246207|FG002|Treatment|Death|2|||
163146427|NCT02250326|589246205|FG000|Treatment|Adverse Event|8|||
163146428|NCT02250326|589246206|FG001|Treatment|Adverse Event|8|||
163146429|NCT02250326|589246207|FG002|Treatment|Adverse Event|9|||
163146430|NCT02250326|589246205|FG000|Treatment|Progressive Disease|42|||
163039901|NCT02669667|588852881|FG001|Overall Study|Lost to Follow-up|0|||
163039902|NCT02669667|588852882|FG002|Overall Study|Lost to Follow-up|0|||
163039903|NCT02669667|588852883|FG003|Overall Study|Lost to Follow-up|0|||
163039904|NCT02669667|588852884|FG004|Overall Study|Lost to Follow-up|0|||
163039905|NCT02669667|588852885|FG005|Overall Study|Lost to Follow-up|1|||
163039906|NCT02669667|588852886|FG006|Overall Study|Lost to Follow-up|0|||
163146431|NCT02250326|589246206|FG001|Treatment|Progressive Disease|40|||
163146432|NCT02250326|589246207|FG002|Treatment|Progressive Disease|47|||
163146433|NCT02250326|589246205|FG000|Treatment|Symptomatic Deterioration|9|||
163146434|NCT02250326|589246206|FG001|Treatment|Symptomatic Deterioration|4|||
163350369|NCT03220776|589992777|FG001|Overall Study|Protocol Violation|0|||
163350370|NCT03220776|589992778|FG002|Overall Study|Protocol Violation|0|||
163350371|NCT03220776|589992779|FG003|Overall Study|Protocol Violation|2|||
163146435|NCT02250326|589246207|FG002|Treatment|Symptomatic Deterioration|10|||
163146436|NCT02250326|589246205|FG000|Treatment|Withdrawal by Subject|11|||
163146437|NCT02250326|589246206|FG001|Treatment|Withdrawal by Subject|6|||
163146438|NCT02250326|589246207|FG002|Treatment|Withdrawal by Subject|4|||
163146439|NCT02250326|589246205|FG000|Treatment|Other reasons|8|||
163146440|NCT02250326|589246206|FG001|Treatment|Other reasons|7|||
163146441|NCT02250326|589246207|FG002|Treatment|Other reasons|7|||
163146442|NCT02250326|589246205|FG000|Extension Period|Progressive Disease|0|||
163350372|NCT03220776|589992780|FG004|Overall Study|Protocol Violation|0|||
163350373|NCT03220776|589992781|FG005|Overall Study|Protocol Violation|1|||
163350374|NCT03220776|589992776|FG000|Overall Study|Withdrawal by Subject|1|||
163350375|NCT03220776|589992777|FG001|Overall Study|Withdrawal by Subject|0|||
163350376|NCT03220776|589992778|FG002|Overall Study|Withdrawal by Subject|0|||
163350377|NCT03220776|589992779|FG003|Overall Study|Withdrawal by Subject|0|||
163350378|NCT03220776|589992780|FG004|Overall Study|Withdrawal by Subject|0|||
163039907|NCT00636961|588852894|FG000|Period 1|Administrative problems|1|||
163039908|NCT00636961|588852895|FG001|Period 1|Administrative problems|1|||
163039909|NCT00636961|588852894|FG000|Period 2|Adverse Event|1|||
163039910|NCT00636961|588852895|FG001|Period 2|Adverse Event|0|||
163146443|NCT02250326|589246206|FG001|Extension Period|Progressive Disease|2|||
163146444|NCT02250326|589246207|FG002|Extension Period|Progressive Disease|0|||
163146445|NCT02250326|589246205|FG000|Extension Period|Withdrawal by Subject|0|||
163146446|NCT02250326|589246206|FG001|Extension Period|Withdrawal by Subject|1|||
163146447|NCT02250326|589246207|FG002|Extension Period|Withdrawal by Subject|0|||
163146448|NCT02250326|589246205|FG000|Extension Period|Withdrawal by investigator|0|||
163241375|NCT01490632|589592550|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241376|NCT01490632|589592551|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241377|NCT01490632|589592552|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241378|NCT01490632|589592553|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241379|NCT01490632|589592554|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241380|NCT01490632|589592555|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241381|NCT01490632|589592556|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241382|NCT01490632|589592557|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241383|NCT01490632|589592558|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
163350379|NCT03220776|589992781|FG005|Overall Study|Withdrawal by Subject|0|||
163350380|NCT04491006|589992782|FG000|Overall Study|Adverse Event|0|||
163039911|NCT01428115|588852899|FG000|Overall Study|Lack of Efficacy|3|||
163039912|NCT01428115|588852899|FG000|Overall Study|Lost to Follow-up|10|||
163039913|NCT01428115|588852899|FG000|Overall Study|Pregnancy|1|||
163039914|NCT01428115|588852899|FG000|Overall Study|Protocol Violation|3|||
163039915|NCT01428115|588852899|FG000|Overall Study|Withdrawal by Subject|4|||
163039916|NCT03755518|588852900|FG000|Overall Study|Lack of Efficacy|10|||
163039917|NCT03755518|588852900|FG000|Overall Study|Adverse Event|7|||
163039918|NCT03755518|588852900|FG000|Overall Study|Study Terminated by Sponsor|5|||
163039919|NCT03755518|588852900|FG000|Overall Study|Death|1|||
163039920|NCT03755518|588852900|FG000|Overall Study|Withdrawal by Subject|3|||
163039921|NCT03755518|588852900|FG000|Overall Study|Progressive Disease|4|||
163039922|NCT03755518|588852900|FG000|Overall Study|Bone Marrow Transplant|4|||
163039923|NCT03755518|588852900|FG000|Overall Study|Physicians Decision|1|||
163039924|NCT03755518|588852900|FG000|Overall Study|Relapse|1|||
163039925|NCT03755518|588852900|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
163039926|NCT03755518|588852900|FG000|Overall Study|Withdrawal by PI|1|||
163039927|NCT01714609|588852901|FG000|Overall Study|Protocol Violation|1|||
163039928|NCT01714609|588852902|FG001|Overall Study|Protocol Violation|0|||
163039929|NCT03403621|588852903|FG000|Overall Study|Withdrawal by Subject|2|||
163039930|NCT03403621|588852904|FG001|Overall Study|Withdrawal by Subject|2|||
163039931|NCT00395642|588852905|FG000|Overall Study|Death|4|||
163039932|NCT00395642|588852905|FG000|Overall Study|Lost to Follow-up|1|||
163039933|NCT00395642|588852905|FG000|Overall Study|Physician Decision|7|||
163039934|NCT00395642|588852905|FG000|Overall Study|Withdrawal by Subject|1|||
163039935|NCT00659776|588852910|FG000|Overall Study|Withdrawal by Subject|12|||
163039936|NCT00659776|588852911|FG001|Overall Study|Withdrawal by Subject|2|||
163039937|NCT00659776|588852912|FG002|Overall Study|Withdrawal by Subject|0|||
163039938|NCT01738191|588852915|FG000|Overall Study|Withdrawal by Subject|4|||
163039939|NCT01738191|588852916|FG001|Overall Study|Withdrawal by Subject|1|||
163039940|NCT02483572|588852917|FG000|Overall Study|Withdrawal by Subject|1|||
163039941|NCT02483572|588852918|FG001|Overall Study|Withdrawal by Subject|0|||
163039942|NCT02483572|588852917|FG000|Overall Study|Lost to Follow-up|1|||
163039943|NCT02483572|588852918|FG001|Overall Study|Lost to Follow-up|0|||
163039944|NCT02483572|588852917|FG000|Overall Study|Physician Decision|0|||
163039945|NCT02483572|588852918|FG001|Overall Study|Physician Decision|1|||
163039946|NCT01451554|588852919|FG000|Overall Study|Withdrawal by Subject|14|||
163039947|NCT01451554|588852920|FG001|Overall Study|Withdrawal by Subject|9|||
163350381|NCT04491006|589992783|FG001|Overall Study|Adverse Event|3|||
163350382|NCT04491006|589992784|FG002|Overall Study|Adverse Event|5|||
163350383|NCT04491006|589992782|FG000|Overall Study|Withdrawal by Subject|1|||
163350384|NCT04491006|589992783|FG001|Overall Study|Withdrawal by Subject|0|||
163350385|NCT04491006|589992784|FG002|Overall Study|Withdrawal by Subject|2|||
163350386|NCT02166047|589992785|FG000|Overall Study|Withdrawal by Participant|0|||
163350387|NCT02166047|589992786|FG001|Overall Study|Withdrawal by Participant|1|||
163350388|NCT02166047|589992787|FG002|Overall Study|Withdrawal by Participant|2|||
163350389|NCT02166047|589992788|FG003|Overall Study|Withdrawal by Participant|0|||
163350390|NCT02166047|589992789|FG004|Overall Study|Withdrawal by Participant|0|||
163350391|NCT02166047|589992790|FG005|Overall Study|Withdrawal by Participant|0|||
163350392|NCT02166047|589992791|FG006|Overall Study|Withdrawal by Participant|1|||
163350393|NCT02166047|589992792|FG007|Overall Study|Withdrawal by Participant|0|||
163350394|NCT02166047|589992793|FG008|Overall Study|Withdrawal by Participant|0|||
163350395|NCT02166047|589992794|FG009|Overall Study|Withdrawal by Participant|0|||
163350396|NCT02166047|589992795|FG010|Overall Study|Withdrawal by Participant|0|||
163350397|NCT02166047|589992796|FG011|Overall Study|Withdrawal by Participant|0|||
163350398|NCT02166047|589992785|FG000|Overall Study|Adverse Event|0|||
163350399|NCT02166047|589992786|FG001|Overall Study|Adverse Event|0|||
163350400|NCT02166047|589992787|FG002|Overall Study|Adverse Event|0|||
163350401|NCT02166047|589992788|FG003|Overall Study|Adverse Event|0|||
163350402|NCT02166047|589992789|FG004|Overall Study|Adverse Event|1|||
163350403|NCT02166047|589992790|FG005|Overall Study|Adverse Event|0|||
163350404|NCT02166047|589992791|FG006|Overall Study|Adverse Event|1|||
163350405|NCT02166047|589992792|FG007|Overall Study|Adverse Event|0|||
163350406|NCT02166047|589992793|FG008|Overall Study|Adverse Event|0|||
163350407|NCT02166047|589992794|FG009|Overall Study|Adverse Event|0|||
163350408|NCT02166047|589992795|FG010|Overall Study|Adverse Event|2|||
163350409|NCT02166047|589992796|FG011|Overall Study|Adverse Event|0|||
163350410|NCT00451555|589992802|FG000|Overall Study|Protocol Violation|2|||
163350411|NCT00451555|589992803|FG001|Overall Study|Protocol Violation|2|||
163350412|NCT00451555|589992802|FG000|Overall Study|Adverse Event|3|||
163350413|NCT00451555|589992803|FG001|Overall Study|Adverse Event|1|||
163350414|NCT00451555|589992802|FG000|Overall Study|Withdrawal by Subject|6|||
163350415|NCT00451555|589992803|FG001|Overall Study|Withdrawal by Subject|0|||
163350416|NCT00451555|589992802|FG000|Overall Study|Physician Decision|2|||
163350417|NCT00451555|589992803|FG001|Overall Study|Physician Decision|1|||
163350418|NCT01004185|589992806|FG000|Overall Study|Adverse Event|1|||
163350419|NCT01004185|589992807|FG001|Overall Study|Adverse Event|1|||
163350420|NCT01004185|589992806|FG000|Overall Study|Lost to Follow-up|0|||
163350421|NCT01004185|589992807|FG001|Overall Study|Lost to Follow-up|1|||
163350422|NCT01004185|589992806|FG000|Overall Study|Lack of Efficacy|2|||
163350423|NCT01004185|589992807|FG001|Overall Study|Lack of Efficacy|1|||
163350424|NCT01004185|589992806|FG000|Overall Study|Sponsor Terminated Study|4|||
163350425|NCT01004185|589992807|FG001|Overall Study|Sponsor Terminated Study|5|||
163350426|NCT01004185|589992806|FG000|Overall Study|Withdrawal by Subject|2|||
163350427|NCT01004185|589992807|FG001|Overall Study|Withdrawal by Subject|1|||
163350428|NCT01388478|589992812|FG000|Overall Study|Adverse Event|4|||
163350429|NCT01388478|589992812|FG000|Overall Study|Withdrawal by Subject|1|||
163350430|NCT01037413|589992813|FG000|Part A: Skin Testing|Adverse Event|1|||
163350431|NCT01037413|589992814|FG001|Part A: Skin Testing|Adverse Event|0|||
163350432|NCT01037413|589992813|FG000|Part A: Skin Testing|Protocol Violation|1|||
163350433|NCT01037413|589992814|FG001|Part A: Skin Testing|Protocol Violation|0|||
163350434|NCT01037413|589992813|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
163350435|NCT01037413|589992814|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
163350436|NCT01037413|589992813|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
163350437|NCT01037413|589992814|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
163350438|NCT01990664|589992815|FG000|Overall Study|Lost to Follow-up|2|||
163350439|NCT01990664|589992816|FG001|Overall Study|Lost to Follow-up|6|||
163350440|NCT01990664|589992815|FG000|Overall Study|Withdrawal by Subject|2|||
163350441|NCT01990664|589992816|FG001|Overall Study|Withdrawal by Subject|3|||
163350442|NCT01990664|589992815|FG000|Overall Study|Protocol Violation|1|||
163350443|NCT01990664|589992816|FG001|Overall Study|Protocol Violation|0|||
163350444|NCT01990664|589992815|FG000|Overall Study|Lens Discomfort|1|||
163350445|NCT01990664|589992816|FG001|Overall Study|Lens Discomfort|1|||
163350446|NCT01990664|589992815|FG000|Overall Study|Lens Handling Difficulties|1|||
163350447|NCT01990664|589992816|FG001|Overall Study|Lens Handling Difficulties|0|||
163350448|NCT01990664|589992815|FG000|Overall Study|Unsatisfactory Visual Response|0|||
163350449|NCT01990664|589992816|FG001|Overall Study|Unsatisfactory Visual Response|1|||
163350450|NCT00619983|589992817|FG000|Test Drug Alone|Withdrawal by Subject|1|||
163350451|NCT00619983|589992818|FG001|Test Drug Alone|Withdrawal by Subject|0|||
163350452|NCT00619983|589992819|FG002|Test Drug Alone|Withdrawal by Subject|0|||
163350453|NCT00619983|589992820|FG003|Test Drug Alone|Withdrawal by Subject|1|||
163350454|NCT00619983|589992817|FG000|Test Drug Alone|Failure of daily diary device|1|||
163350455|NCT00619983|589992818|FG001|Test Drug Alone|Failure of daily diary device|1|||
163350456|NCT00619983|589992819|FG002|Test Drug Alone|Failure of daily diary device|2|||
163350457|NCT00619983|589992820|FG003|Test Drug Alone|Failure of daily diary device|2|||
163350458|NCT01177137|589992822|FG000|Overall Study|Withdrawal by Subject|10|||
163350459|NCT01177137|589992823|FG001|Overall Study|Withdrawal by Subject|10|||
163350460|NCT01177137|589992824|FG002|Overall Study|Withdrawal by Subject|2|||
163350461|NCT02560389|589992829|FG000|Overall Study|Lost to Follow-up|1|||
163350462|NCT02560389|589992830|FG001|Overall Study|Lost to Follow-up|2|||
163350463|NCT02560389|589992831|FG002|Overall Study|Lost to Follow-up|2|||
163350464|NCT02560389|589992829|FG000|Overall Study|Tested positive for illicit substance|0|||
163350465|NCT02560389|589992830|FG001|Overall Study|Tested positive for illicit substance|1|||
163350466|NCT02560389|589992831|FG002|Overall Study|Tested positive for illicit substance|0|||
163350467|NCT02716298|589992832|FG000|First Intervention (1 Month)|Lens discomfort|1|||
163350468|NCT02716298|589992833|FG001|First Intervention (1 Month)|Lens discomfort|1|||
163350469|NCT00713206|589992834|FG000|Overall Study|Lost to Follow-up|4|||
163350470|NCT00713206|589992835|FG001|Overall Study|Lost to Follow-up|4|||
163350471|NCT00713206|589992834|FG000|Overall Study|Death|1|||
163350472|NCT00713206|589992835|FG001|Overall Study|Death|0|||
163350473|NCT01114672|589992838|FG000|Overall Study|Death|0|||
163350474|NCT01114672|589992839|FG001|Overall Study|Death|1|||
163350475|NCT01114672|589992838|FG000|Overall Study|Withdrawal by Subject|2|||
163350476|NCT01114672|589992839|FG001|Overall Study|Withdrawal by Subject|1|||
163350477|NCT01114672|589992838|FG000|Overall Study|Lost to Follow-up|1|||
163350478|NCT01114672|589992839|FG001|Overall Study|Lost to Follow-up|0|||
163350479|NCT01114672|589992838|FG000|Overall Study|transplanted|1|||
163350480|NCT01114672|589992839|FG001|Overall Study|transplanted|0|||
163350481|NCT00827775|589992840|FG000|Overall Study|Withdrawal by Subject|0|||
163350482|NCT00827775|589992841|FG001|Overall Study|Withdrawal by Subject|5|||
163350483|NCT03041701|589992842|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
163350484|NCT03041701|589992843|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
163350485|NCT03041701|589992844|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
163350486|NCT03041701|589992842|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
163350487|NCT03041701|589992843|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
163350488|NCT03041701|589992844|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
163350489|NCT00297778|589992855|FG000|Overall Study|Adverse Event|16|||
163350490|NCT00297778|589992856|FG001|Overall Study|Adverse Event|10|||
163350491|NCT00297778|589992855|FG000|Overall Study|Withdrawal by Subject|1|||
163350492|NCT00297778|589992856|FG001|Overall Study|Withdrawal by Subject|5|||
163350493|NCT00297778|589992855|FG000|Overall Study|Lack of Efficacy|2|||
163350494|NCT00297778|589992856|FG001|Overall Study|Lack of Efficacy|1|||
163350495|NCT00297778|589992855|FG000|Overall Study|Non-compliant with trial protocol|0|||
163350496|NCT00297778|589992856|FG001|Overall Study|Non-compliant with trial protocol|3|||
163350497|NCT00297778|589992855|FG000|Overall Study|Other|0|||
163350498|NCT00297778|589992856|FG001|Overall Study|Other|1|||
163350499|NCT00583115|589992857|FG000|Overall Study|Death|1|||
163350500|NCT01678898|589992861|FG000|PB-102-F01|Adverse Event|0|||
163350501|NCT01678898|589992862|FG001|PB-102-F01|Adverse Event|1|||
163350502|NCT01678898|589992863|FG002|PB-102-F01|Adverse Event|0|||
163350503|NCT01678898|589992861|FG000|PB-102-F01|Physician Decision|0|||
163350504|NCT01678898|589992862|FG001|PB-102-F01|Physician Decision|1|||
163350505|NCT01678898|589992863|FG002|PB-102-F01|Physician Decision|0|||
163350506|NCT02551692|589992868|FG000|Overall Study|Lost to Follow-up|0|||
163350507|NCT02551692|589992869|FG001|Overall Study|Lost to Follow-up|1|||
163350508|NCT02551692|589992870|FG002|Overall Study|Lost to Follow-up|4|||
163350509|NCT02551692|589992868|FG000|Overall Study|Withdrawal by Subject|1|||
163350510|NCT02551692|589992869|FG001|Overall Study|Withdrawal by Subject|0|||
163350511|NCT02551692|589992870|FG002|Overall Study|Withdrawal by Subject|1|||
163350512|NCT02965599|589992871|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
163350513|NCT02965599|589992872|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
163350514|NCT00230971|589992874|FG000|Randomization|No study drug administered|3|||
163350515|NCT00230971|589992875|FG001|Randomization|No study drug administered|3|||
163350516|NCT00230971|589992874|FG000|Baseline Participants|Lost to Follow-up|5|||
163350517|NCT00230971|589992875|FG001|Baseline Participants|Lost to Follow-up|12|||
163350518|NCT00230971|589992874|FG000|Baseline Participants|Death|6|||
163350519|NCT00230971|589992875|FG001|Baseline Participants|Death|5|||
163350520|NCT00230971|589992874|FG000|Baseline Participants|Withdrawal by Subject|7|||
163350521|NCT00230971|589992875|FG001|Baseline Participants|Withdrawal by Subject|1|||
163350522|NCT00230971|589992874|FG000|Baseline Participants|Adverse Event|1|||
163350523|NCT00230971|589992875|FG001|Baseline Participants|Adverse Event|0|||
163350524|NCT00230971|589992874|FG000|Baseline Participants|No bacteria observed|1|||
163350525|NCT00230971|589992875|FG001|Baseline Participants|No bacteria observed|0|||
163350526|NCT00230971|589992874|FG000|Baseline Participants|Failure to return|1|||
163350527|NCT00230971|589992875|FG001|Baseline Participants|Failure to return|1|||
163350528|NCT00230971|589992874|FG000|Baseline Participants|Reintervention|1|||
163350529|NCT00230971|589992875|FG001|Baseline Participants|Reintervention|0|||
163350530|NCT04130061|589992877|FG000|Overall Study|OR team forgot to request membrane|1|||
163350531|NCT04130061|589992878|FG001|Overall Study|OR team forgot to request membrane|0|||
163350532|NCT04267393|589992881|FG000|Randomization|Adverse Event|1|||
163146449|NCT02250326|589246206|FG001|Extension Period|Withdrawal by investigator|1|||
163146450|NCT02250326|589246207|FG002|Extension Period|Withdrawal by investigator|0|||
163146451|NCT00962208|589246208|FG000|Overall Study|Could not achieve good vision|9|||
163146452|NCT00962208|589246209|FG001|Overall Study|Could not achieve good vision|0|||
163146453|NCT00962208|589246208|FG000|Overall Study|Contraindicated to continue study|5|||
163146454|NCT00962208|589246209|FG001|Overall Study|Contraindicated to continue study|1|||
163146455|NCT00962208|589246208|FG000|Overall Study|Lost to Follow-up|0|||
163146456|NCT00962208|589246209|FG001|Overall Study|Lost to Follow-up|9|||
163146457|NCT03010527|589246211|FG000|Overall Study|Death|0|||
163146458|NCT03010527|589246212|FG001|Overall Study|Death|0|||
163146459|NCT03010527|589246213|FG002|Overall Study|Death|1|||
163146460|NCT03010527|589246211|FG000|Overall Study|Adverse Event|0|||
163146461|NCT03010527|589246212|FG001|Overall Study|Adverse Event|4|||
163146462|NCT03010527|589246213|FG002|Overall Study|Adverse Event|2|||
163146463|NCT03010527|589246211|FG000|Overall Study|Protocol Violation|0|||
163146464|NCT03010527|589246212|FG001|Overall Study|Protocol Violation|1|||
163146465|NCT03010527|589246213|FG002|Overall Study|Protocol Violation|0|||
163146466|NCT03010527|589246211|FG000|Overall Study|Lost to Follow-up|0|||
163146467|NCT03010527|589246212|FG001|Overall Study|Lost to Follow-up|2|||
163146468|NCT03010527|589246213|FG002|Overall Study|Lost to Follow-up|1|||
163146469|NCT03010527|589246211|FG000|Overall Study|Withdrawal by Subject|0|||
163146470|NCT03010527|589246212|FG001|Overall Study|Withdrawal by Subject|3|||
163146471|NCT03010527|589246213|FG002|Overall Study|Withdrawal by Subject|4|||
163146472|NCT03010527|589246211|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
163146473|NCT03010527|589246212|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
163146474|NCT03010527|589246213|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
163146475|NCT03010527|589246211|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
163146476|NCT03010527|589246212|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
163146477|NCT03010527|589246213|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
163146478|NCT03010527|589246211|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
163146479|NCT03010527|589246212|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
163146480|NCT03010527|589246213|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
163146481|NCT02469623|589246214|FG000|Overall Study|Not consented for long-term follow-up|4|||
163146482|NCT02469623|589246214|FG000|Overall Study|Lost to Follow-up|4|||
163146483|NCT02469623|589246214|FG000|Overall Study|Withdrawal by Subject|2|||
163146484|NCT02469623|589246214|FG000|Overall Study|Death|3|||
163146485|NCT04073186|589246215|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
163146486|NCT04073186|589246215|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
163146487|NCT04073186|589246215|FG000|First Wearing Cycle|Protocol Violation|1|||
163146488|NCT04073186|589246215|FG000|First Wearing Cycle|Lens Discomfort|2|||
163146489|NCT04073186|589246215|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
163146490|NCT04073186|589246215|FG000|Second Wearing Cycle|Adverse Event|1|||
163146491|NCT01096316|589246216|FG000|Overall Study|Lost to Follow-up|15|||
163146492|NCT01096316|589246217|FG001|Overall Study|Lost to Follow-up|9|||
163146493|NCT00473434|589246218|FG000|Overall Study|Physician Decision|3|||
163146494|NCT00473434|589246218|FG000|Overall Study|Withdrawal by Subject|9|||
163146495|NCT00473434|589246218|FG000|Overall Study|Compliance|3|||
163146496|NCT00473434|589246218|FG000|Overall Study|Lack of Efficacy|3|||
163146497|NCT00473434|589246218|FG000|Overall Study|Adverse Event|3|||
163146498|NCT00473434|589246218|FG000|Overall Study|Patient was selling medication to others|1|||
163146499|NCT00473434|589246218|FG000|Overall Study|Safety evaluation|1|||
163146500|NCT00473434|589246218|FG000|Overall Study|Reason not specified|6|||
163146501|NCT00473434|589246218|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
163350533|NCT04267393|589992882|FG001|Randomization|Adverse Event|0|||
163350534|NCT04267393|589992883|FG002|Randomization|Adverse Event|0|||
163350535|NCT04267393|589992881|FG000|Randomization|Administrative Reasons by Sponsor|0|||
163350536|NCT04267393|589992882|FG001|Randomization|Administrative Reasons by Sponsor|1|||
163350537|NCT04267393|589992883|FG002|Randomization|Administrative Reasons by Sponsor|0|||
163350538|NCT04267393|589992881|FG000|Treatment Period|Adverse Event|0|||
163350539|NCT04267393|589992882|FG001|Treatment Period|Adverse Event|2|||
163350540|NCT04267393|589992883|FG002|Treatment Period|Adverse Event|3|||
163350541|NCT04267393|589992881|FG000|Treatment Period|Participant Withdrew Consent|0|||
163146502|NCT00473434|589246218|FG000|Overall Study|Switching to trial medication|1|||
163146503|NCT00473434|589246218|FG000|Overall Study|No longer required|1|||
163146504|NCT06418152|589246220|FG000|Overall Study|Frequent DBS setting changes|1|||
163146505|NCT06418152|589246220|FG000|Overall Study|Withdrawal by Subject|2|||
163146506|NCT02529852|589246223|FG000|Overall Study|Withdrawal by Subject|2|||
163146507|NCT02055898|589246224|FG000|First Intervention (5 Days)|Physician Decision|2|||
163146508|NCT02055898|589246225|FG001|First Intervention (5 Days)|Physician Decision|0|||
163146509|NCT02055898|589246224|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
163146510|NCT02055898|589246225|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
163146511|NCT02201524|589246227|FG000|Overall Study|Adverse Event|0|||
163146512|NCT02201524|589246228|FG001|Overall Study|Adverse Event|2|||
163146513|NCT02201524|589246229|FG002|Overall Study|Adverse Event|1|||
163350542|NCT04267393|589992882|FG001|Treatment Period|Participant Withdrew Consent|0|||
163350543|NCT04267393|589992883|FG002|Treatment Period|Participant Withdrew Consent|1|||
163350544|NCT04267393|589992881|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
163350545|NCT04267393|589992882|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
163350546|NCT04267393|589992883|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
163350547|NCT01932762|589994247|FG000|Overall Study|Withdrawal by Subject|1|||
163350548|NCT01932762|589994248|FG001|Overall Study|Withdrawal by Subject|2|||
163350549|NCT01932762|589994249|FG002|Overall Study|Withdrawal by Subject|0|||
163350550|NCT01932762|589994250|FG003|Overall Study|Withdrawal by Subject|0|||
163350551|NCT01932762|589994247|FG000|Overall Study|Lost to Follow-up|4|||
163350552|NCT01932762|589994248|FG001|Overall Study|Lost to Follow-up|0|||
163350553|NCT01932762|589994249|FG002|Overall Study|Lost to Follow-up|0|||
163350554|NCT01932762|589994250|FG003|Overall Study|Lost to Follow-up|1|||
163350555|NCT01932762|589994247|FG000|Overall Study|Physician Decision|1|||
163350556|NCT01932762|589994248|FG001|Overall Study|Physician Decision|0|||
163350557|NCT01932762|589994249|FG002|Overall Study|Physician Decision|0|||
163350558|NCT01932762|589994250|FG003|Overall Study|Physician Decision|0|||
163350559|NCT01726049|589994252|FG000|Overall Study|Death|1|||
163350560|NCT01726049|589994253|FG001|Overall Study|Death|1|||
163350561|NCT01726049|589994252|FG000|Overall Study|Adverse Event|4|||
163350562|NCT01726049|589994253|FG001|Overall Study|Adverse Event|1|||
163350563|NCT01726049|589994252|FG000|Overall Study|refused second HC|0|||
163350564|NCT01726049|589994253|FG001|Overall Study|refused second HC|2|||
163350565|NCT02161406|589994254|FG000|Overall Study|Death|2|||
163350566|NCT02161406|589994255|FG001|Overall Study|Death|1|||
163350567|NCT02161406|589994254|FG000|Overall Study|Lost to Follow-up|2|||
163350568|NCT02161406|589994255|FG001|Overall Study|Lost to Follow-up|1|||
163350569|NCT02161406|589994254|FG000|Overall Study|Withdrawal by Subject|2|||
163350570|NCT02161406|589994255|FG001|Overall Study|Withdrawal by Subject|4|||
163350571|NCT02161406|589994254|FG000|Overall Study|investigator withdrew subject|3|||
163350572|NCT02161406|589994255|FG001|Overall Study|investigator withdrew subject|1|||
163350573|NCT02161406|589994254|FG000|Overall Study|Lack of Efficacy|1|||
163350574|NCT02161406|589994255|FG001|Overall Study|Lack of Efficacy|1|||
163350575|NCT02161406|589994254|FG000|Overall Study|relocation|0|||
163350576|NCT02161406|589994255|FG001|Overall Study|relocation|1|||
163350577|NCT00320398|589994267|FG000|Overall Study|Adverse Event|1|||
163350578|NCT00320398|589994268|FG001|Overall Study|Adverse Event|4|||
163350579|NCT00320398|589994267|FG000|Overall Study|Other|1|||
163350580|NCT00320398|589994268|FG001|Overall Study|Other|0|||
163350581|NCT00784147|589994280|FG000|Overall Study|Lost to Follow-up|2|||
163350582|NCT00784147|589994281|FG001|Overall Study|Lost to Follow-up|4|||
163350583|NCT00784147|589994280|FG000|Overall Study|Withdrawal by Subject|1|||
163350584|NCT00784147|589994281|FG001|Overall Study|Withdrawal by Subject|3|||
163350585|NCT00784147|589994280|FG000|Overall Study|Physician Decision|2|||
163350586|NCT00784147|589994281|FG001|Overall Study|Physician Decision|1|||
163350587|NCT00784147|589994280|FG000|Overall Study|Protocol Violation|1|||
163350588|NCT00784147|589994281|FG001|Overall Study|Protocol Violation|1|||
163350589|NCT00784147|589994280|FG000|Overall Study|Death|2|||
163350590|NCT00784147|589994281|FG001|Overall Study|Death|0|||
163350591|NCT03596242|589994283|FG000|Overall Study|Lost to Follow-up|2|||
163350592|NCT03596242|589994284|FG001|Overall Study|Lost to Follow-up|2|||
163350593|NCT02973802|589994290|FG000|Overall Study|Lost to Follow-up|1|||
163350594|NCT02973802|589994290|FG000|Overall Study|Withdrawal by Subject|1|||
163350595|NCT00706914|589994291|FG000|Overall Study|Lack of Efficacy|0|||
163350596|NCT00706914|589994292|FG001|Overall Study|Lack of Efficacy|1|||
163350597|NCT00706914|589994293|FG002|Overall Study|Lack of Efficacy|0|||
163350598|NCT00706914|589994291|FG000|Overall Study|Lost to Follow-up|1|||
163350599|NCT00706914|589994292|FG001|Overall Study|Lost to Follow-up|0|||
163350600|NCT00706914|589994293|FG002|Overall Study|Lost to Follow-up|0|||
163350601|NCT00706914|589994291|FG000|Overall Study|Adverse Event|2|||
163350602|NCT00706914|589994292|FG001|Overall Study|Adverse Event|2|||
163350603|NCT00706914|589994293|FG002|Overall Study|Adverse Event|0|||
163350604|NCT00706914|589994291|FG000|Overall Study|Protocol Violation|3|||
163350605|NCT00706914|589994292|FG001|Overall Study|Protocol Violation|1|||
163350606|NCT00706914|589994293|FG002|Overall Study|Protocol Violation|1|||
163350607|NCT01850823|589994294|FG000|Overall Study|Early Visit Window|0|||
163350608|NCT01850823|589994295|FG001|Overall Study|Early Visit Window|1|||
163350609|NCT01850823|589994296|FG002|Overall Study|Early Visit Window|4|||
163350610|NCT01850823|589994294|FG000|Overall Study|Enrolled in Error|0|||
163350611|NCT01850823|589994295|FG001|Overall Study|Enrolled in Error|1|||
163350612|NCT01850823|589994296|FG002|Overall Study|Enrolled in Error|2|||
163350613|NCT01850823|589994294|FG000|Overall Study|Lack of Efficacy|1|||
163350614|NCT01850823|589994295|FG001|Overall Study|Lack of Efficacy|0|||
163350615|NCT01850823|589994296|FG002|Overall Study|Lack of Efficacy|0|||
163350616|NCT01850823|589994294|FG000|Overall Study|Lost to Follow-up|0|||
163350617|NCT01850823|589994295|FG001|Overall Study|Lost to Follow-up|0|||
163350618|NCT01850823|589994296|FG002|Overall Study|Lost to Follow-up|1|||
163350619|NCT01850823|589994294|FG000|Overall Study|Restricted Medication|0|||
163350620|NCT01850823|589994295|FG001|Overall Study|Restricted Medication|0|||
163350621|NCT01850823|589994296|FG002|Overall Study|Restricted Medication|2|||
163350622|NCT01850823|589994294|FG000|Overall Study|Significant worstening of SAR|0|||
163241384|NCT01490632|589592559|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
163241385|NCT01490632|589592540|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241386|NCT01490632|589592541|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241387|NCT01490632|589592542|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241388|NCT01490632|589592543|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241389|NCT01490632|589592544|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241390|NCT01490632|589592545|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
163241391|NCT01490632|589592546|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241392|NCT01490632|589592547|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241393|NCT01490632|589592548|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241394|NCT01490632|589592549|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241395|NCT01490632|589592550|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241396|NCT01490632|589592551|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241397|NCT01490632|589592552|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241398|NCT01490632|589592553|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241399|NCT01490632|589592554|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241400|NCT01490632|589592555|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241401|NCT01490632|589592556|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241402|NCT01490632|589592557|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241403|NCT01490632|589592558|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241404|NCT01490632|589592559|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163241405|NCT01490632|589592540|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241406|NCT01490632|589592541|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241407|NCT01490632|589592542|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241408|NCT01490632|589592543|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241409|NCT01490632|589592544|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241410|NCT01490632|589592545|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241411|NCT01490632|589592546|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
163241412|NCT01490632|589592547|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241413|NCT01490632|589592548|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
163241414|NCT01490632|589592549|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241415|NCT01490632|589592550|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
163241416|NCT01490632|589592551|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
163241417|NCT01490632|589592552|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241418|NCT01490632|589592553|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241419|NCT01490632|589592554|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241420|NCT01490632|589592555|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241421|NCT01490632|589592556|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241422|NCT01490632|589592557|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241423|NCT01490632|589592558|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241424|NCT01490632|589592559|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
163241425|NCT01490632|589592540|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
163241426|NCT01490632|589592541|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
163241427|NCT01490632|589592542|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
163241428|NCT01490632|589592543|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
163241429|NCT01490632|589592544|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
163241430|NCT01490632|589592545|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
163241431|NCT01490632|589592546|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
163241432|NCT01490632|589592547|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
163241433|NCT01490632|589592548|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
163241434|NCT01490632|589592549|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
163241435|NCT01490632|589592550|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
163241436|NCT01490632|589592551|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
163241437|NCT01490632|589592552|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
163241438|NCT01490632|589592553|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
163241439|NCT01490632|589592554|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
163241440|NCT01490632|589592555|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
163241441|NCT01490632|589592556|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
163241442|NCT01490632|589592557|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
163241443|NCT01490632|589592558|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
163241444|NCT01490632|589592559|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
163241445|NCT01490632|589592540|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
163350623|NCT01850823|589994295|FG001|Overall Study|Significant worstening of SAR|1|||
163350624|NCT01850823|589994296|FG002|Overall Study|Significant worstening of SAR|0|||
163350625|NCT01850823|589994294|FG000|Overall Study|Withdrawal by Subject|2|||
163350626|NCT01850823|589994295|FG001|Overall Study|Withdrawal by Subject|0|||
163350627|NCT01850823|589994296|FG002|Overall Study|Withdrawal by Subject|1|||
163350628|NCT00053352|589994298|FG000|Overall Study|Lost to Follow-up|0|||
163350629|NCT00053352|589994299|FG001|Overall Study|Lost to Follow-up|1|||
163350630|NCT00053352|589994298|FG000|Overall Study|Physician Decision|11|||
163350631|NCT00053352|589994299|FG001|Overall Study|Physician Decision|1|||
163350632|NCT00053352|589994298|FG000|Overall Study|Withdrawal by Subject|1|||
163350633|NCT00053352|589994299|FG001|Overall Study|Withdrawal by Subject|0|||
163350634|NCT00053352|589994298|FG000|Overall Study|Ineligible|8|||
163350635|NCT00053352|589994299|FG001|Overall Study|Ineligible|8|||
163350636|NCT00053352|589994298|FG000|Overall Study|Disease at new site|1|||
163350637|NCT00053352|589994299|FG001|Overall Study|Disease at new site|0|||
163350638|NCT00931918|589994302|FG000|Overall Study|Adverse Event|4|||
163350639|NCT00931918|589994303|FG001|Overall Study|Adverse Event|6|||
163350640|NCT00931918|589994302|FG000|Overall Study|Progressive Disease|2|||
163350641|NCT00931918|589994303|FG001|Overall Study|Progressive Disease|1|||
163350642|NCT00931918|589994302|FG000|Overall Study|Symptomatic Deterioration|1|||
163350643|NCT00931918|589994303|FG001|Overall Study|Symptomatic Deterioration|0|||
163350644|NCT00931918|589994302|FG000|Overall Study|Withdrawal by Patient|3|||
163350645|NCT00931918|589994303|FG001|Overall Study|Withdrawal by Patient|4|||
163350646|NCT00931918|589994302|FG000|Overall Study|Other Reason not Specified|4|||
163350647|NCT00931918|589994303|FG001|Overall Study|Other Reason not Specified|4|||
163350648|NCT00931918|589994302|FG000|Overall Study|Did not receive study drug|3|||
163350649|NCT00931918|589994303|FG001|Overall Study|Did not receive study drug|2|||
163350650|NCT00809341|589994304|FG000|Overall Study|Physician Decision|0|||
163350651|NCT00809341|589994305|FG001|Overall Study|Physician Decision|1|||
163350652|NCT04081389|589994310|FG000|Overall Study|Withdrawal by Subject|0|||
163350653|NCT04081389|589994311|FG001|Overall Study|Withdrawal by Subject|0|||
163350654|NCT04081389|589994312|FG002|Overall Study|Withdrawal by Subject|1|||
163350655|NCT04081389|589994313|FG003|Overall Study|Withdrawal by Subject|0|||
163350656|NCT00866918|589994314|FG000|Overall Study|Death|1|||
163350657|NCT00866918|589994315|FG001|Overall Study|Death|5|||
163350658|NCT00866918|589994314|FG000|Overall Study|Lack of Efficacy|1|||
163350659|NCT00866918|589994315|FG001|Overall Study|Lack of Efficacy|1|||
163350660|NCT00866918|589994314|FG000|Overall Study|Physician Decision|10|||
163350661|NCT00866918|589994315|FG001|Overall Study|Physician Decision|2|||
163350662|NCT00866918|589994314|FG000|Overall Study|Ineligible|2|||
163350663|NCT00866918|589994315|FG001|Overall Study|Ineligible|4|||
163350664|NCT00866918|589994314|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
163350665|NCT00866918|589994315|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
163350666|NCT00866918|589994314|FG000|Overall Study|Secondary malignancy|1|||
163350667|NCT00866918|589994315|FG001|Overall Study|Secondary malignancy|0|||
163350668|NCT00527514|589994316|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
163350669|NCT00527514|589994316|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
163350670|NCT00527514|589994316|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
163350671|NCT00527514|589994316|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
163350672|NCT00527514|589994316|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
163350673|NCT00527514|589994316|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
163350674|NCT00527514|589994316|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
163350675|NCT00920699|589994322|FG000|Overall Study|Withdrawal by Subject|2|||
163350676|NCT00920699|589994323|FG001|Overall Study|Withdrawal by Subject|0|||
163350677|NCT00920699|589994324|FG002|Overall Study|Withdrawal by Subject|2|||
163350678|NCT00920699|589994322|FG000|Overall Study|no longer met eligibility|0|||
163350679|NCT00920699|589994323|FG001|Overall Study|no longer met eligibility|1|||
163350680|NCT00920699|589994324|FG002|Overall Study|no longer met eligibility|0|||
163350681|NCT00920699|589994322|FG000|Overall Study|Lost to Follow-up|0|||
163350682|NCT00920699|589994323|FG001|Overall Study|Lost to Follow-up|0|||
163350683|NCT00920699|589994324|FG002|Overall Study|Lost to Follow-up|2|||
163350684|NCT02287883|589994325|FG000|Overall Study|Death|8|||
163350685|NCT02287883|589994326|FG001|Overall Study|Death|7|||
163350686|NCT02287883|589994325|FG000|Overall Study|No longer eligible|222|||
163350687|NCT02287883|589994326|FG001|Overall Study|No longer eligible|182|||
163350688|NCT02287883|589994325|FG000|Overall Study|Non-response to survey|229|||
163350689|NCT02287883|589994326|FG001|Overall Study|Non-response to survey|237|||
163350690|NCT01281917|589994332|FG000|Overall Study|Withdrawal by Subject|1|||
163350691|NCT00802438|589994333|FG000|Overall Study|Screen Failure|20|||
163350692|NCT00802438|589994333|FG000|Overall Study|Withdrawal by Subject|7|||
163350693|NCT00802438|589994333|FG000|Overall Study|Physician Decision|1|||
163350694|NCT04016805|589994335|FG000|Overall Study|Sponsor's Discretion|30|||
163350695|NCT04016805|589994336|FG001|Overall Study|Sponsor's Discretion|6|||
163350696|NCT04016805|589994337|FG002|Overall Study|Sponsor's Discretion|5|||
163350697|NCT02101268|589994340|FG000|Randomized Treatment Phase|Subject Decision|8|||
163350698|NCT02101268|589994341|FG001|Randomized Treatment Phase|Subject Decision|4|||
163350699|NCT02101268|589994342|FG002|Randomized Treatment Phase|Subject Decision|0|||
163350700|NCT02101268|589994343|FG003|Randomized Treatment Phase|Subject Decision|0|||
163350701|NCT02101268|589994340|FG000|Randomized Treatment Phase|Physician Decision|4|||
163350702|NCT02101268|589994341|FG001|Randomized Treatment Phase|Physician Decision|1|||
163350703|NCT02101268|589994342|FG002|Randomized Treatment Phase|Physician Decision|0|||
163350704|NCT02101268|589994343|FG003|Randomized Treatment Phase|Physician Decision|0|||
163350705|NCT02101268|589994340|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
163350706|NCT02101268|589994341|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
163350707|NCT02101268|589994342|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
163350708|NCT02101268|589994343|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
163350709|NCT02101268|589994340|FG000|Randomized Treatment Phase|Adverse Event|6|||
163350710|NCT02101268|589994341|FG001|Randomized Treatment Phase|Adverse Event|0|||
163350711|NCT02101268|589994342|FG002|Randomized Treatment Phase|Adverse Event|0|||
163350712|NCT02101268|589994343|FG003|Randomized Treatment Phase|Adverse Event|0|||
163350713|NCT02101268|589994340|FG000|Randomized Treatment Phase|Death|5|||
163350714|NCT02101268|589994341|FG001|Randomized Treatment Phase|Death|4|||
163350715|NCT02101268|589994342|FG002|Randomized Treatment Phase|Death|0|||
163350716|NCT02101268|589994343|FG003|Randomized Treatment Phase|Death|0|||
163350717|NCT02101268|589994340|FG000|Randomized Treatment Phase|Disease Progression|4|||
163350718|NCT02101268|589994341|FG001|Randomized Treatment Phase|Disease Progression|1|||
163350719|NCT02101268|589994342|FG002|Randomized Treatment Phase|Disease Progression|0|||
163409903|NCT02296242|590209539|FG002|Overall Study|Withdrawal by Subject|1|||
163409904|NCT02296242|590209540|FG003|Overall Study|Withdrawal by Subject|1|||
163409905|NCT02296242|590209541|FG004|Overall Study|Withdrawal by Subject|3|||
163409906|NCT02296242|590209537|FG000|Overall Study|Disease Progression|1|||
163409907|NCT02296242|590209538|FG001|Overall Study|Disease Progression|3|||
163409908|NCT02296242|590209539|FG002|Overall Study|Disease Progression|2|||
163409909|NCT02296242|590209540|FG003|Overall Study|Disease Progression|8|||
163409910|NCT02296242|590209541|FG004|Overall Study|Disease Progression|11|||
163409911|NCT02296242|590209537|FG000|Overall Study|Unacceptable Toxicity|0|||
163409912|NCT02296242|590209538|FG001|Overall Study|Unacceptable Toxicity|0|||
163409913|NCT02296242|590209539|FG002|Overall Study|Unacceptable Toxicity|0|||
163409914|NCT02296242|590209540|FG003|Overall Study|Unacceptable Toxicity|0|||
163409915|NCT02296242|590209541|FG004|Overall Study|Unacceptable Toxicity|1|||
163409916|NCT02296242|590209537|FG000|Overall Study|Patient Condition Changed|0|||
163409917|NCT02296242|590209538|FG001|Overall Study|Patient Condition Changed|0|||
163409918|NCT02296242|590209539|FG002|Overall Study|Patient Condition Changed|2|||
163409919|NCT02296242|590209540|FG003|Overall Study|Patient Condition Changed|0|||
163409920|NCT02296242|590209541|FG004|Overall Study|Patient Condition Changed|1|||
163409921|NCT02296242|590209537|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
163409922|NCT02296242|590209538|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
163409923|NCT02296242|590209539|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
163409924|NCT02296242|590209540|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
163409925|NCT02296242|590209541|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
163409926|NCT02296242|590209537|FG000|Overall Study|Lost to Follow-up|1|||
163409927|NCT02296242|590209538|FG001|Overall Study|Lost to Follow-up|0|||
163409928|NCT02296242|590209539|FG002|Overall Study|Lost to Follow-up|0|||
163409929|NCT02296242|590209540|FG003|Overall Study|Lost to Follow-up|0|||
163409930|NCT02296242|590209541|FG004|Overall Study|Lost to Follow-up|0|||
163409931|NCT02296242|590209537|FG000|Overall Study|Need for Hydroxyurea|2|||
163409932|NCT02296242|590209538|FG001|Overall Study|Need for Hydroxyurea|0|||
163409933|NCT02296242|590209539|FG002|Overall Study|Need for Hydroxyurea|0|||
163409934|NCT02296242|590209540|FG003|Overall Study|Need for Hydroxyurea|0|||
163409935|NCT02296242|590209541|FG004|Overall Study|Need for Hydroxyurea|0|||
163409936|NCT02296242|590209537|FG000|Overall Study|Screened for Other Protocol|0|||
163409937|NCT02296242|590209538|FG001|Overall Study|Screened for Other Protocol|1|||
163409938|NCT02296242|590209539|FG002|Overall Study|Screened for Other Protocol|0|||
163409939|NCT02296242|590209540|FG003|Overall Study|Screened for Other Protocol|0|||
163409940|NCT02296242|590209541|FG004|Overall Study|Screened for Other Protocol|0|||
163409941|NCT02296242|590209537|FG000|Overall Study|Physician Decision|0|||
163409942|NCT02296242|590209538|FG001|Overall Study|Physician Decision|1|||
163409943|NCT02296242|590209539|FG002|Overall Study|Physician Decision|0|||
163409944|NCT02296242|590209540|FG003|Overall Study|Physician Decision|1|||
163409945|NCT02296242|590209541|FG004|Overall Study|Physician Decision|0|||
163409946|NCT02296242|590209537|FG000|Overall Study|Alternative Treatment|0|||
163409947|NCT02296242|590209538|FG001|Overall Study|Alternative Treatment|0|||
163409948|NCT02296242|590209539|FG002|Overall Study|Alternative Treatment|0|||
163350720|NCT02101268|589994343|FG003|Randomized Treatment Phase|Disease Progression|0|||
163350721|NCT02101268|589994340|FG000|Extended Treatment Phase|Subject Decision|0|||
163350722|NCT02101268|589994341|FG001|Extended Treatment Phase|Subject Decision|0|||
163350723|NCT02101268|589994342|FG002|Extended Treatment Phase|Subject Decision|3|||
163409949|NCT02296242|590209540|FG003|Overall Study|Alternative Treatment|1|||
163350724|NCT02101268|589994343|FG003|Extended Treatment Phase|Subject Decision|2|||
163350725|NCT02101268|589994340|FG000|Extended Treatment Phase|Physician Decision|0|||
163350726|NCT02101268|589994341|FG001|Extended Treatment Phase|Physician Decision|0|||
163350727|NCT02101268|589994342|FG002|Extended Treatment Phase|Physician Decision|5|||
163350728|NCT02101268|589994343|FG003|Extended Treatment Phase|Physician Decision|2|||
163350729|NCT02101268|589994340|FG000|Extended Treatment Phase|Adverse Event|0|||
163350730|NCT02101268|589994341|FG001|Extended Treatment Phase|Adverse Event|0|||
163350731|NCT02101268|589994342|FG002|Extended Treatment Phase|Adverse Event|14|||
163409950|NCT02296242|590209541|FG004|Overall Study|Alternative Treatment|0|||
163409951|NCT02296242|590209537|FG000|Overall Study|Adverse Event|0|||
163409952|NCT02296242|590209538|FG001|Overall Study|Adverse Event|0|||
163409953|NCT02296242|590209539|FG002|Overall Study|Adverse Event|0|||
163409954|NCT02296242|590209540|FG003|Overall Study|Adverse Event|1|||
163409955|NCT02296242|590209541|FG004|Overall Study|Adverse Event|0|||
163409956|NCT02296242|590209537|FG000|Overall Study|Lack of Efficacy|0|||
163409957|NCT02296242|590209538|FG001|Overall Study|Lack of Efficacy|0|||
163409958|NCT02296242|590209539|FG002|Overall Study|Lack of Efficacy|0|||
163409959|NCT02296242|590209540|FG003|Overall Study|Lack of Efficacy|0|||
163409960|NCT02296242|590209541|FG004|Overall Study|Lack of Efficacy|3|||
163409961|NCT03504397|590209547|FG000|Overall Study|Progressive Disease|151|||
163409962|NCT03504397|590209548|FG001|Overall Study|Progressive Disease|199|||
163409963|NCT03504397|590209547|FG000|Overall Study|Withdrawal by Subject|29|||
163409964|NCT03504397|590209548|FG001|Overall Study|Withdrawal by Subject|17|||
163409965|NCT03504397|590209547|FG000|Overall Study|Lost to Follow-up|1|||
163409966|NCT03504397|590209548|FG001|Overall Study|Lost to Follow-up|0|||
163409967|NCT03504397|590209547|FG000|Overall Study|Death|14|||
163409968|NCT03504397|590209548|FG001|Overall Study|Death|16|||
163409969|NCT03504397|590209547|FG000|Overall Study|Adverse Event|40|||
163409970|NCT03504397|590209548|FG001|Overall Study|Adverse Event|14|||
163409971|NCT03504397|590209547|FG000|Overall Study|miscellaneous|17|||
163409972|NCT03504397|590209548|FG001|Overall Study|miscellaneous|15|||
163409973|NCT03504397|590209547|FG000|Overall Study|Protocol deviation|1|||
163409974|NCT03504397|590209548|FG001|Overall Study|Protocol deviation|0|||
163409975|NCT03504397|590209547|FG000|Overall Study|Participants who did not take the study drug|4|||
163409976|NCT03504397|590209548|FG001|Overall Study|Participants who did not take the study drug|4|||
163409977|NCT00070941|590209549|FG000|Overall Study|Adverse Event|10|||
163409978|NCT00070941|590209550|FG001|Overall Study|Adverse Event|8|||
163409979|NCT00070941|590209551|FG002|Overall Study|Adverse Event|4|||
163409980|NCT02443883|590209552|FG000|Overall Study|Adverse Event|0|||
163409981|NCT02443883|590209553|FG001|Overall Study|Adverse Event|1|||
163350732|NCT02101268|589994343|FG003|Extended Treatment Phase|Adverse Event|18|||
163350733|NCT02101268|589994340|FG000|Extended Treatment Phase|Death|0|||
163350734|NCT02101268|589994341|FG001|Extended Treatment Phase|Death|0|||
163350735|NCT02101268|589994342|FG002|Extended Treatment Phase|Death|5|||
163350736|NCT02101268|589994343|FG003|Extended Treatment Phase|Death|1|||
163350737|NCT02101268|589994340|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
163350738|NCT02101268|589994341|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
163350739|NCT02101268|589994342|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
163350740|NCT02101268|589994343|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
163350741|NCT02101268|589994340|FG000|Extended Treatment Phase|Disease Progression|0|||
163350742|NCT02101268|589994341|FG001|Extended Treatment Phase|Disease Progression|0|||
163350743|NCT02101268|589994342|FG002|Extended Treatment Phase|Disease Progression|13|||
163350744|NCT02101268|589994343|FG003|Extended Treatment Phase|Disease Progression|6|||
163350745|NCT02101268|589994340|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
163350746|NCT02101268|589994341|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
163350747|NCT02101268|589994342|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
163350748|NCT02101268|589994343|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
163350749|NCT00740870|589994344|FG000|Overall Study|Not Catheterized|4|||
163350750|NCT00740870|589994344|FG000|Overall Study|Further testing contraindicated implant|17|||
163350751|NCT00819013|589994346|FG000|Overall Study|Not meeting continuing study eligibility|2|||
163350752|NCT00819013|589994347|FG001|Overall Study|Not meeting continuing study eligibility|1|||
163350753|NCT00819013|589994348|FG002|Overall Study|Not meeting continuing study eligibility|2|||
163350754|NCT00819013|589994349|FG003|Overall Study|Not meeting continuing study eligibility|1|||
163350755|NCT00819013|589994346|FG000|Overall Study|Adverse Event|0|||
163350756|NCT00819013|589994347|FG001|Overall Study|Adverse Event|0|||
163350757|NCT00819013|589994348|FG002|Overall Study|Adverse Event|1|||
163350758|NCT00819013|589994349|FG003|Overall Study|Adverse Event|0|||
163350759|NCT00819013|589994346|FG000|Overall Study|Withdrawal by Subject|1|||
163350760|NCT00819013|589994347|FG001|Overall Study|Withdrawal by Subject|0|||
163350761|NCT00819013|589994348|FG002|Overall Study|Withdrawal by Subject|1|||
163350762|NCT00819013|589994349|FG003|Overall Study|Withdrawal by Subject|0|||
163350763|NCT00819013|589994346|FG000|Overall Study|Lost to Follow-up|0|||
163350764|NCT00819013|589994347|FG001|Overall Study|Lost to Follow-up|0|||
163350765|NCT00819013|589994348|FG002|Overall Study|Lost to Follow-up|1|||
163350766|NCT00819013|589994349|FG003|Overall Study|Lost to Follow-up|2|||
163409982|NCT02443883|590209554|FG002|Overall Study|Adverse Event|0|||
163409983|NCT02443883|590209555|FG003|Overall Study|Adverse Event|0|||
163409984|NCT02443883|590209552|FG000|Overall Study|Lost to Follow-up|3|||
163409985|NCT02443883|590209553|FG001|Overall Study|Lost to Follow-up|2|||
163146514|NCT02201524|589246230|FG003|Overall Study|Adverse Event|0|||
163146515|NCT02201524|589246227|FG000|Overall Study|Insufficient clinical response|1|||
163146516|NCT02201524|589246228|FG001|Overall Study|Insufficient clinical response|0|||
163146517|NCT02201524|589246229|FG002|Overall Study|Insufficient clinical response|0|||
163146518|NCT02201524|589246230|FG003|Overall Study|Insufficient clinical response|0|||
163146519|NCT02201524|589246227|FG000|Overall Study|Lost to Follow-up|0|||
163146520|NCT02201524|589246228|FG001|Overall Study|Lost to Follow-up|0|||
163146521|NCT02201524|589246229|FG002|Overall Study|Lost to Follow-up|2|||
163146522|NCT02201524|589246230|FG003|Overall Study|Lost to Follow-up|0|||
163146523|NCT02201524|589246227|FG000|Overall Study|No longer meets eligibility criteria|0|||
163146524|NCT02201524|589246228|FG001|Overall Study|No longer meets eligibility criteria|0|||
163146525|NCT02201524|589246229|FG002|Overall Study|No longer meets eligibility criteria|0|||
163146526|NCT02201524|589246230|FG003|Overall Study|No longer meets eligibility criteria|2|||
163146527|NCT02201524|589246227|FG000|Overall Study|Protocol Violation|0|||
163146528|NCT02201524|589246228|FG001|Overall Study|Protocol Violation|0|||
163146529|NCT02201524|589246229|FG002|Overall Study|Protocol Violation|0|||
163146530|NCT02201524|589246230|FG003|Overall Study|Protocol Violation|1|||
163146531|NCT02201524|589246227|FG000|Overall Study|Withdrawal by Subject|0|||
163146532|NCT02201524|589246228|FG001|Overall Study|Withdrawal by Subject|0|||
163146533|NCT02201524|589246229|FG002|Overall Study|Withdrawal by Subject|1|||
163146534|NCT02201524|589246230|FG003|Overall Study|Withdrawal by Subject|1|||
163146535|NCT02201524|589246227|FG000|Overall Study|Other|1|||
163146536|NCT02201524|589246228|FG001|Overall Study|Other|1|||
163146537|NCT02201524|589246229|FG002|Overall Study|Other|0|||
163146538|NCT02201524|589246230|FG003|Overall Study|Other|0|||
163146539|NCT03206216|589246235|FG000|Overall Study|Withdrawal by Subject|0|||
163146540|NCT03206216|589246236|FG001|Overall Study|Withdrawal by Subject|1|||
163146541|NCT00097500|589246239|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
163146542|NCT00097500|589246240|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
163146543|NCT00097500|589246239|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
163146544|NCT00097500|589246240|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
163146545|NCT00097500|589246239|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
163146546|NCT00097500|589246240|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
163146547|NCT00097500|589246239|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
163146548|NCT00097500|589246240|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
163146549|NCT00097500|589246239|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
163146550|NCT00097500|589246240|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
163146551|NCT00097500|589246239|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
163146552|NCT00097500|589246240|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
163146553|NCT00097500|589246239|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
163146554|NCT00097500|589246240|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
163146555|NCT01553084|589246245|FG000|Overall Study|Withdrawal by Subject|15|||
163146556|NCT01553084|589246246|FG001|Overall Study|Withdrawal by Subject|13|||
163146557|NCT01553084|589246247|FG002|Overall Study|Withdrawal by Subject|35|||
163146558|NCT03119259|589246249|FG000|Overall Study|Withdrawn as no longer eligible|1|||
163146559|NCT03119259|589246250|FG001|Overall Study|Withdrawn as no longer eligible|0|||
163146560|NCT03119259|589246249|FG000|Overall Study|Withdrawal by Subject|4|||
163146561|NCT03119259|589246250|FG001|Overall Study|Withdrawal by Subject|2|||
163146562|NCT03119259|589246249|FG000|Overall Study|Lost to Follow-up|0|||
163146563|NCT03119259|589246250|FG001|Overall Study|Lost to Follow-up|1|||
163146564|NCT00647296|589246257|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
163146565|NCT00647296|589246258|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
163146566|NCT00647296|589246259|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
163146567|NCT00647296|589246260|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
163146568|NCT00647296|589246257|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
163146569|NCT00647296|589246258|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
163146570|NCT00647296|589246259|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
163146571|NCT00647296|589246260|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
163146572|NCT00647296|589246257|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
163146573|NCT00647296|589246258|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
163146574|NCT00647296|589246259|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
163146575|NCT00647296|589246260|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
163241446|NCT01490632|589592541|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
163241447|NCT01490632|589592542|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
163241448|NCT01490632|589592543|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
163241449|NCT01490632|589592544|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
163241450|NCT01490632|589592545|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
163241451|NCT01490632|589592546|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
163241452|NCT01490632|589592547|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
163350767|NCT00819013|589994346|FG000|Overall Study|Death|0|||
163146576|NCT00647296|589246257|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
163350768|NCT00819013|589994347|FG001|Overall Study|Death|0|||
163350769|NCT00819013|589994348|FG002|Overall Study|Death|0|||
163350770|NCT00819013|589994349|FG003|Overall Study|Death|1|||
163350771|NCT00576823|589994350|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
163350772|NCT00576823|589994351|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
163350773|NCT00576823|589994352|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
163350774|NCT00576823|589994350|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
163350775|NCT00576823|589994351|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
163350776|NCT00576823|589994352|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
163350777|NCT00839332|589994353|FG000|Phase 1|Disease Progression|38|||
163350778|NCT00839332|589994354|FG001|Phase 1|Disease Progression|0|||
163350779|NCT00839332|589994355|FG002|Phase 1|Disease Progression|0|||
163350780|NCT00839332|589994353|FG000|Phase 1|Adverse Event|6|||
163350781|NCT00839332|589994354|FG001|Phase 1|Adverse Event|0|||
163350782|NCT00839332|589994355|FG002|Phase 1|Adverse Event|0|||
163350783|NCT00839332|589994353|FG000|Phase 1|Withdrawal by Subject|4|||
163350784|NCT00839332|589994354|FG001|Phase 1|Withdrawal by Subject|0|||
163350785|NCT00839332|589994355|FG002|Phase 1|Withdrawal by Subject|0|||
163350786|NCT00839332|589994353|FG000|Phase 1|Physician Decision|2|||
163350787|NCT00839332|589994354|FG001|Phase 1|Physician Decision|0|||
163350788|NCT00839332|589994355|FG002|Phase 1|Physician Decision|0|||
163350789|NCT00839332|589994353|FG000|Phase 2|Protocol Violation|0|||
163350790|NCT00839332|589994354|FG001|Phase 2|Protocol Violation|1|||
163350791|NCT00839332|589994355|FG002|Phase 2|Protocol Violation|0|||
163350792|NCT00839332|589994353|FG000|Phase 2|Disease Progression|0|||
163350793|NCT00839332|589994354|FG001|Phase 2|Disease Progression|46|||
163350794|NCT00839332|589994355|FG002|Phase 2|Disease Progression|21|||
163350795|NCT00839332|589994353|FG000|Phase 2|Adverse Event|0|||
163350796|NCT00839332|589994354|FG001|Phase 2|Adverse Event|8|||
163350797|NCT00839332|589994355|FG002|Phase 2|Adverse Event|6|||
163350798|NCT00839332|589994353|FG000|Phase 2|Death|0|||
163350799|NCT00839332|589994354|FG001|Phase 2|Death|4|||
163350800|NCT00839332|589994355|FG002|Phase 2|Death|2|||
163350801|NCT00839332|589994353|FG000|Phase 2|Withdrawal by Subject|0|||
163350802|NCT00839332|589994354|FG001|Phase 2|Withdrawal by Subject|5|||
163350803|NCT00839332|589994355|FG002|Phase 2|Withdrawal by Subject|8|||
163350804|NCT00839332|589994353|FG000|Phase 2|Physician Decision|0|||
163350805|NCT00839332|589994354|FG001|Phase 2|Physician Decision|4|||
163350806|NCT00839332|589994355|FG002|Phase 2|Physician Decision|1|||
163350807|NCT00839332|589994353|FG000|Phase 2|Lost to Follow-up|0|||
163350808|NCT00839332|589994354|FG001|Phase 2|Lost to Follow-up|0|||
163350809|NCT00839332|589994355|FG002|Phase 2|Lost to Follow-up|1|||
163350810|NCT01200485|589994356|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
163350811|NCT01200485|589994357|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
163350812|NCT01200485|589994358|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
163350813|NCT01200485|589994356|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
163350814|NCT01200485|589994357|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
163350815|NCT01200485|589994358|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
163350816|NCT02132117|589994360|FG000|Overall Study|Adverse Event|6|||
163350817|NCT02132117|589994361|FG001|Overall Study|Adverse Event|1|||
163350818|NCT02132117|589994360|FG000|Overall Study|Lost to Follow-up|2|||
163350819|NCT02132117|589994361|FG001|Overall Study|Lost to Follow-up|2|||
163350820|NCT02132117|589994360|FG000|Overall Study|Personal Reasons|1|||
163350821|NCT02132117|589994361|FG001|Overall Study|Personal Reasons|2|||
163350822|NCT02132117|589994360|FG000|Overall Study|Other Miscellaneous Reasons|2|||
163350823|NCT02132117|589994361|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163350824|NCT04947436|589994363|FG000|Overall Study|Lost to Follow-up|3|||
163350825|NCT04947436|589994364|FG001|Overall Study|Lost to Follow-up|7|||
163350826|NCT04947436|589994365|FG002|Overall Study|Lost to Follow-up|5|||
163350827|NCT04947436|589994363|FG000|Overall Study|Death|1|||
163350828|NCT04947436|589994364|FG001|Overall Study|Death|1|||
163350829|NCT04947436|589994365|FG002|Overall Study|Death|1|||
163350830|NCT01544309|589994369|FG000|Overall Study|Withdrawal by Subject|12|||
163350831|NCT01544309|589994370|FG001|Overall Study|Withdrawal by Subject|7|||
163350832|NCT01544309|589994369|FG000|Overall Study|Protocol Violation|2|||
163350833|NCT01544309|589994370|FG001|Overall Study|Protocol Violation|1|||
163350834|NCT01544309|589994369|FG000|Overall Study|Physician Decision|4|||
163350835|NCT01544309|589994370|FG001|Overall Study|Physician Decision|1|||
163350836|NCT01544309|589994369|FG000|Overall Study|Not performed pre-dose examination|1|||
163350837|NCT01544309|589994370|FG001|Overall Study|Not performed pre-dose examination|2|||
163350838|NCT01544309|589994369|FG000|Overall Study|Administered prohibit prior medication|1|||
163350839|NCT01544309|589994370|FG001|Overall Study|Administered prohibit prior medication|0|||
163350840|NCT03078751|589994371|FG000|Overall Study|Adverse Event|4|||
163350841|NCT03078751|589994372|FG001|Overall Study|Adverse Event|0|||
163350842|NCT03078751|589994371|FG000|Overall Study|Physician Decision|1|||
163350843|NCT03078751|589994372|FG001|Overall Study|Physician Decision|0|||
163350844|NCT03078751|589994371|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
163350845|NCT03078751|589994372|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
163350846|NCT03078751|589994371|FG000|Overall Study|Subject/guardian decision|8|||
163350847|NCT03078751|589994372|FG001|Overall Study|Subject/guardian decision|1|||
163350848|NCT03078751|589994371|FG000|Overall Study|Untreated|0|||
163350849|NCT03078751|589994372|FG001|Overall Study|Untreated|4|||
163350850|NCT02515097|589994378|FG000|Overall Study|Lost to Follow-up|4|||
163350851|NCT02515097|589994379|FG001|Overall Study|Lost to Follow-up|2|||
163350852|NCT02515097|589994378|FG000|Overall Study|Withdrawal by Subject|1|||
163350853|NCT02515097|589994379|FG001|Overall Study|Withdrawal by Subject|3|||
163350854|NCT02515097|589994378|FG000|Overall Study|Adverse Event|2|||
163350855|NCT02515097|589994379|FG001|Overall Study|Adverse Event|1|||
163350856|NCT01196741|589994380|FG000|Overall Study|Disease progression|34|||
163350857|NCT01196741|589994381|FG001|Overall Study|Disease progression|14|||
163350858|NCT01196741|589994380|FG000|Overall Study|Adverse Event|10|||
163350859|NCT01196741|589994381|FG001|Overall Study|Adverse Event|6|||
163350860|NCT01196741|589994380|FG000|Overall Study|Serious Adverse Event|3|||
163350861|NCT01196741|589994381|FG001|Overall Study|Serious Adverse Event|1|||
163350862|NCT01196741|589994380|FG000|Overall Study|Dose limiting Adverse Event|2|||
163350863|NCT01196741|589994381|FG001|Overall Study|Dose limiting Adverse Event|1|||
163350864|NCT01196741|589994380|FG000|Overall Study|Withdrawal by Subject|3|||
163350865|NCT01196741|589994381|FG001|Overall Study|Withdrawal by Subject|0|||
163350866|NCT01196741|589994380|FG000|Overall Study|Other reason|3|||
163350867|NCT01196741|589994381|FG001|Overall Study|Other reason|3|||
163350868|NCT01196741|589994380|FG000|Overall Study|Other|3|||
163350869|NCT01196741|589994381|FG001|Overall Study|Other|2|||
163350870|NCT01196741|589994380|FG000|Overall Study|Protocol Violation|2|||
163350871|NCT01196741|589994381|FG001|Overall Study|Protocol Violation|1|||
163350872|NCT03030599|589994382|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
163350873|NCT03030599|589994383|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
163350874|NCT03030599|589994384|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
163350875|NCT03030599|589994382|FG000|Open Label Treatment and Titration|Other|1|||
163350876|NCT03030599|589994383|FG001|Open Label Treatment and Titration|Other|0|||
163350877|NCT03030599|589994384|FG002|Open Label Treatment and Titration|Other|0|||
163350878|NCT03030599|589994382|FG000|Open Label Treatment and Titration|Physician Decision|3|||
163350879|NCT03030599|589994383|FG001|Open Label Treatment and Titration|Physician Decision|0|||
163350880|NCT03030599|589994384|FG002|Open Label Treatment and Titration|Physician Decision|0|||
163350881|NCT03030599|589994382|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
163350882|NCT03030599|589994383|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
163350883|NCT03030599|589994384|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
163350884|NCT03030599|589994382|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
163350885|NCT03030599|589994383|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
163350886|NCT03030599|589994384|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
163350887|NCT03030599|589994382|FG000|Open Label Treatment and Titration|Adverse Event|18|||
163350888|NCT03030599|589994383|FG001|Open Label Treatment and Titration|Adverse Event|0|||
163350889|NCT03030599|589994384|FG002|Open Label Treatment and Titration|Adverse Event|0|||
163350890|NCT03030599|589994382|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
163350891|NCT03030599|589994383|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
163350892|NCT03030599|589994384|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
163350893|NCT03030599|589994382|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
163350894|NCT03030599|589994383|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
163350895|NCT03030599|589994384|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
163350896|NCT03030599|589994382|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
163350897|NCT03030599|589994383|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
163350898|NCT03030599|589994384|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
163350899|NCT03030599|589994382|FG000|Stable Dose|Protocol deviation|3|||
163350900|NCT03030599|589994383|FG001|Stable Dose|Protocol deviation|0|||
163350901|NCT03030599|589994384|FG002|Stable Dose|Protocol deviation|0|||
163350902|NCT03030599|589994382|FG000|Stable Dose|Adverse Event|1|||
163350903|NCT03030599|589994383|FG001|Stable Dose|Adverse Event|0|||
163350904|NCT03030599|589994384|FG002|Stable Dose|Adverse Event|0|||
163350905|NCT03030599|589994382|FG000|Stable Dose|Lost to Follow-up|1|||
163350906|NCT03030599|589994383|FG001|Stable Dose|Lost to Follow-up|0|||
163409986|NCT02443883|590209554|FG002|Overall Study|Lost to Follow-up|1|||
163409987|NCT02443883|590209555|FG003|Overall Study|Lost to Follow-up|0|||
163350907|NCT03030599|589994384|FG002|Stable Dose|Lost to Follow-up|0|||
163350908|NCT03030599|589994382|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
163350909|NCT03030599|589994383|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
163350910|NCT03030599|589994384|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
163350911|NCT03030599|589994382|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
163350912|NCT03030599|589994383|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
163350913|NCT03030599|589994384|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
163350914|NCT03030599|589994382|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
163350915|NCT03030599|589994383|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
163350916|NCT03030599|589994384|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
163146577|NCT00647296|589246258|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
163146578|NCT00647296|589246259|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
163146579|NCT00647296|589246260|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
163146580|NCT00647296|589246257|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
163146581|NCT00647296|589246258|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
163146582|NCT00647296|589246259|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
163146583|NCT00647296|589246260|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
163146584|NCT00647296|589246257|FG000|Part 2: 4-week Placebo Washout|Death|3|||
163146585|NCT00647296|589246258|FG001|Part 2: 4-week Placebo Washout|Death|0|||
163146586|NCT00647296|589246259|FG002|Part 2: 4-week Placebo Washout|Death|0|||
163146587|NCT00647296|589246260|FG003|Part 2: 4-week Placebo Washout|Death|0|||
163146588|NCT00647296|589246257|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
163146589|NCT00647296|589246258|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
163146590|NCT00647296|589246259|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
163146591|NCT00647296|589246260|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
163146592|NCT00647296|589246257|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
163146593|NCT00647296|589246258|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
163146594|NCT00647296|589246259|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
163146595|NCT00647296|589246260|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
163146596|NCT00647296|589246257|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
163146597|NCT00647296|589246258|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
163146598|NCT00647296|589246259|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
163146599|NCT00647296|589246260|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
163146600|NCT00647296|589246257|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
163146601|NCT00647296|589246258|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
163146602|NCT00647296|589246259|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
163146603|NCT00647296|589246260|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
163350917|NCT03030599|589994382|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
163146604|NCT00647296|589246257|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
163146605|NCT00647296|589246258|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
163146606|NCT00647296|589246259|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
163146607|NCT00647296|589246260|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
163146608|NCT01300234|589246261|FG000|Overall Study|Adverse Event|1|||
163146609|NCT01300234|589246262|FG001|Overall Study|Adverse Event|1|||
163146610|NCT01300234|589246261|FG000|Overall Study|Protocol Violation|2|||
163146611|NCT01300234|589246262|FG001|Overall Study|Protocol Violation|3|||
163146612|NCT01300234|589246261|FG000|Overall Study|Withdrawal by Subject|5|||
163146613|NCT01300234|589246262|FG001|Overall Study|Withdrawal by Subject|9|||
163146614|NCT01300234|589246261|FG000|Overall Study|Lost to Follow-up|14|||
163146615|NCT01300234|589246262|FG001|Overall Study|Lost to Follow-up|12|||
163146616|NCT01300234|589246261|FG000|Overall Study|Pregnancy|2|||
163146617|NCT01300234|589246262|FG001|Overall Study|Pregnancy|1|||
163146618|NCT01300234|589246261|FG000|Overall Study|Participant reached stopping critera|2|||
163146619|NCT01300234|589246262|FG001|Overall Study|Participant reached stopping critera|0|||
163146620|NCT01300234|589246261|FG000|Overall Study|Participant stopped medication|1|||
163146621|NCT01300234|589246262|FG001|Overall Study|Participant stopped medication|1|||
163146622|NCT01300234|589246261|FG000|Overall Study|Participant refused return to hospital|1|||
163146623|NCT01300234|589246262|FG001|Overall Study|Participant refused return to hospital|0|||
163146624|NCT03253679|589246263|FG000|Overall Study|Screen Failure|1|||
163146625|NCT04816214|589246264|FG000|Overall Study|Progressive Disease|4|||
163146626|NCT04816214|589246265|FG001|Overall Study|Progressive Disease|0|||
163146627|NCT04816214|589246266|FG002|Overall Study|Progressive Disease|0|||
163146628|NCT04816214|589246264|FG000|Overall Study|Death|1|||
163146629|NCT04816214|589246265|FG001|Overall Study|Death|0|||
163146630|NCT04816214|589246266|FG002|Overall Study|Death|0|||
163146631|NCT04816214|589246264|FG000|Overall Study|Study Terminated by Sponsor|1|||
163146632|NCT04816214|589246265|FG001|Overall Study|Study Terminated by Sponsor|0|||
163146633|NCT04816214|589246266|FG002|Overall Study|Study Terminated by Sponsor|0|||
163146634|NCT04879628|589246267|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
163146635|NCT04879628|589246268|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
163146636|NCT04879628|589246269|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
163350918|NCT03030599|589994383|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
163350919|NCT03030599|589994384|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
163146637|NCT04879628|589246270|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
163146638|NCT04879628|589246267|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
163350920|NCT03030599|589994382|FG000|Open-label Extension|Adverse Event|3|||
163350921|NCT03030599|589994383|FG001|Open-label Extension|Adverse Event|0|||
163146639|NCT04879628|589246268|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
163350922|NCT03030599|589994384|FG002|Open-label Extension|Adverse Event|0|||
163146640|NCT04879628|589246269|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
163146641|NCT04879628|589246270|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
163146642|NCT04879628|589246267|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
163146643|NCT04879628|589246268|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
163146644|NCT04879628|589246269|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
163146645|NCT04879628|589246270|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
163146646|NCT04879628|589246267|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
163146647|NCT04879628|589246268|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
163146648|NCT04879628|589246269|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
163146649|NCT04879628|589246270|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
163146650|NCT00360412|589246276|FG000|Overall Study|Adverse Event|37|||
163146651|NCT00360412|589246277|FG001|Overall Study|Adverse Event|65|||
163146652|NCT00360412|589246276|FG000|Overall Study|Protocol Violation|2|||
163146653|NCT00360412|589246277|FG001|Overall Study|Protocol Violation|5|||
163146654|NCT00360412|589246276|FG000|Overall Study|Patient withdrew consent|27|||
163146655|NCT00360412|589246277|FG001|Overall Study|Patient withdrew consent|52|||
163146656|NCT00360412|589246276|FG000|Overall Study|Lack of therapeutic efficacy|46|||
163146657|NCT00360412|589246277|FG001|Overall Study|Lack of therapeutic efficacy|61|||
163146658|NCT00360412|589246276|FG000|Overall Study|Physician Decision|2|||
163146659|NCT00360412|589246277|FG001|Overall Study|Physician Decision|4|||
163146660|NCT00360412|589246276|FG000|Overall Study|Other|5|||
163146661|NCT00360412|589246277|FG001|Overall Study|Other|6|||
163146662|NCT00360412|589246276|FG000|Overall Study|Study termination by Sponsor|214|||
163146663|NCT00360412|589246277|FG001|Overall Study|Study termination by Sponsor|469|||
163146664|NCT00871871|589246278|FG000|Part I|Adverse Event|0|||
163146665|NCT00871871|589246279|FG001|Part I|Adverse Event|2|||
163146666|NCT00871871|589246280|FG002|Part I|Adverse Event|0|||
163146667|NCT00871871|589246281|FG003|Part I|Adverse Event|0|||
163146668|NCT00871871|589246278|FG000|Part I|Withdrawal by Subject|3|||
163146669|NCT00871871|589246279|FG001|Part I|Withdrawal by Subject|0|||
163146670|NCT00871871|589246280|FG002|Part I|Withdrawal by Subject|0|||
163146671|NCT00871871|589246281|FG003|Part I|Withdrawal by Subject|0|||
163146672|NCT00871871|589246278|FG000|Part I|Laboratory abnormality|0|||
163146673|NCT00871871|589246279|FG001|Part I|Laboratory abnormality|1|||
163146674|NCT00871871|589246280|FG002|Part I|Laboratory abnormality|0|||
163146675|NCT00871871|589246281|FG003|Part I|Laboratory abnormality|0|||
163146676|NCT00871871|589246278|FG000|Part II|Lack of Efficacy|0|||
163146677|NCT00871871|589246279|FG001|Part II|Lack of Efficacy|0|||
163146678|NCT00871871|589246280|FG002|Part II|Lack of Efficacy|1|||
163146679|NCT00871871|589246281|FG003|Part II|Lack of Efficacy|0|||
163146680|NCT00871871|589246278|FG000|Part II|Withdrawal by Subject|0|||
163146681|NCT00871871|589246279|FG001|Part II|Withdrawal by Subject|0|||
163146682|NCT00871871|589246280|FG002|Part II|Withdrawal by Subject|2|||
163146683|NCT00871871|589246281|FG003|Part II|Withdrawal by Subject|1|||
163146684|NCT00871871|589246278|FG000|Part II|Adverse Event|0|||
163146685|NCT00871871|589246279|FG001|Part II|Adverse Event|0|||
163146686|NCT00871871|589246280|FG002|Part II|Adverse Event|1|||
163146687|NCT00871871|589246281|FG003|Part II|Adverse Event|2|||
163146688|NCT00871871|589246278|FG000|Part II|Protocol Violation|0|||
163146689|NCT00871871|589246279|FG001|Part II|Protocol Violation|0|||
163146690|NCT00871871|589246280|FG002|Part II|Protocol Violation|0|||
163146691|NCT00871871|589246281|FG003|Part II|Protocol Violation|1|||
163146692|NCT04612725|589246282|FG000|Overall Study|Adverse Event|1|||
163146693|NCT04612725|589246283|FG001|Overall Study|Adverse Event|3|||
163146694|NCT04612725|589246284|FG002|Overall Study|Adverse Event|1|||
163146695|NCT04612725|589246285|FG003|Overall Study|Adverse Event|0|||
163146696|NCT04612725|589246286|FG004|Overall Study|Adverse Event|1|||
163146697|NCT04612725|589246282|FG000|Overall Study|Lost to Follow-up|0|||
163146698|NCT04612725|589246283|FG001|Overall Study|Lost to Follow-up|1|||
163146699|NCT04612725|589246284|FG002|Overall Study|Lost to Follow-up|0|||
163146700|NCT04612725|589246285|FG003|Overall Study|Lost to Follow-up|0|||
163146701|NCT04612725|589246286|FG004|Overall Study|Lost to Follow-up|0|||
163146702|NCT04612725|589246282|FG000|Overall Study|Physician Decision|2|||
163146703|NCT04612725|589246283|FG001|Overall Study|Physician Decision|0|||
163146704|NCT04612725|589246284|FG002|Overall Study|Physician Decision|0|||
163146705|NCT04612725|589246285|FG003|Overall Study|Physician Decision|0|||
163146706|NCT04612725|589246286|FG004|Overall Study|Physician Decision|0|||
163146707|NCT04612725|589246282|FG000|Overall Study|Study terminated by sponsor|3|||
163146708|NCT04612725|589246283|FG001|Overall Study|Study terminated by sponsor|1|||
163146709|NCT04612725|589246284|FG002|Overall Study|Study terminated by sponsor|2|||
163146710|NCT04612725|589246285|FG003|Overall Study|Study terminated by sponsor|4|||
163146711|NCT04612725|589246286|FG004|Overall Study|Study terminated by sponsor|5|||
163146712|NCT04612725|589246282|FG000|Overall Study|Withdrawal by Subject|8|||
163146713|NCT04612725|589246283|FG001|Overall Study|Withdrawal by Subject|3|||
163146714|NCT04612725|589246284|FG002|Overall Study|Withdrawal by Subject|5|||
163146715|NCT04612725|589246285|FG003|Overall Study|Withdrawal by Subject|1|||
163146716|NCT04612725|589246286|FG004|Overall Study|Withdrawal by Subject|9|||
163350923|NCT03030599|589994382|FG000|Open-label Extension|Lost to Follow-up|2|||
163350924|NCT03030599|589994383|FG001|Open-label Extension|Lost to Follow-up|0|||
163350925|NCT03030599|589994384|FG002|Open-label Extension|Lost to Follow-up|0|||
163350926|NCT03030599|589994382|FG000|Open-label Extension|Lack of Efficacy|1|||
163350927|NCT03030599|589994383|FG001|Open-label Extension|Lack of Efficacy|0|||
163350928|NCT03030599|589994384|FG002|Open-label Extension|Lack of Efficacy|0|||
163350929|NCT03030599|589994382|FG000|Open-label Extension|Other Reason|1|||
163350930|NCT03030599|589994383|FG001|Open-label Extension|Other Reason|0|||
163350931|NCT03030599|589994384|FG002|Open-label Extension|Other Reason|0|||
163350932|NCT01592383|589994385|FG000|Overall Study|Adverse Event|1|||
163350933|NCT04582864|589994386|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
163350934|NCT04582864|589994386|FG000|Overall Study|Death|1|||
163350935|NCT01064856|589994387|FG000|Double-blind (DB) Period|Adverse Event|1|||
163350936|NCT01064856|589994388|FG001|Double-blind (DB) Period|Adverse Event|0|||
163350937|NCT01064856|589994389|FG002|Double-blind (DB) Period|Adverse Event|0|||
163350938|NCT01064856|589994390|FG003|Double-blind (DB) Period|Adverse Event|0|||
163350939|NCT01064856|589994387|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
163350940|NCT01064856|589994388|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
163350941|NCT01064856|589994389|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
163350942|NCT01064856|589994390|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
163350943|NCT01064856|589994387|FG000|Open-label (OL) Period|Adverse Event|0|||
163350944|NCT01064856|589994388|FG001|Open-label (OL) Period|Adverse Event|0|||
163350945|NCT01064856|589994389|FG002|Open-label (OL) Period|Adverse Event|12|||
163350946|NCT01064856|589994390|FG003|Open-label (OL) Period|Adverse Event|6|||
163350947|NCT01064856|589994387|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
163350948|NCT01064856|589994388|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
163350949|NCT01064856|589994389|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
163350950|NCT01064856|589994390|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
163350951|NCT01064856|589994387|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
163350952|NCT01064856|589994388|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
163350953|NCT01064856|589994389|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
163350954|NCT01064856|589994390|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
163350955|NCT01064856|589994387|FG000|Open-label (OL) Period|Other|0|||
163350956|NCT01064856|589994388|FG001|Open-label (OL) Period|Other|0|||
163350957|NCT01064856|589994389|FG002|Open-label (OL) Period|Other|7|||
163350958|NCT01064856|589994390|FG003|Open-label (OL) Period|Other|7|||
163350959|NCT02133131|589994391|FG000|Overall Study|Adverse Event|0|||
163350960|NCT02133131|589994392|FG001|Overall Study|Adverse Event|0|||
163350961|NCT02133131|589994393|FG002|Overall Study|Adverse Event|0|||
163350962|NCT02133131|589994394|FG003|Overall Study|Adverse Event|1|||
163350963|NCT02133131|589994395|FG004|Overall Study|Adverse Event|0|||
163350964|NCT02133131|589994396|FG005|Overall Study|Adverse Event|0|||
163350965|NCT02133131|589994397|FG006|Overall Study|Adverse Event|0|||
163350966|NCT02133131|589994391|FG000|Overall Study|Lost to Follow-up|1|||
163350967|NCT02133131|589994392|FG001|Overall Study|Lost to Follow-up|0|||
163350968|NCT02133131|589994393|FG002|Overall Study|Lost to Follow-up|0|||
163350969|NCT02133131|589994394|FG003|Overall Study|Lost to Follow-up|1|||
163350970|NCT02133131|589994395|FG004|Overall Study|Lost to Follow-up|0|||
163350971|NCT02133131|589994396|FG005|Overall Study|Lost to Follow-up|0|||
163350972|NCT02133131|589994397|FG006|Overall Study|Lost to Follow-up|0|||
163350973|NCT02133131|589994391|FG000|Overall Study|Status not recorded|4|||
163350974|NCT02133131|589994392|FG001|Overall Study|Status not recorded|5|||
163350975|NCT02133131|589994393|FG002|Overall Study|Status not recorded|1|||
163146717|NCT04612725|589246282|FG000|Overall Study|Other|0|||
163146718|NCT04612725|589246283|FG001|Overall Study|Other|0|||
163146719|NCT04612725|589246284|FG002|Overall Study|Other|0|||
163146720|NCT04612725|589246285|FG003|Overall Study|Other|0|||
163146721|NCT04612725|589246286|FG004|Overall Study|Other|1|||
163146722|NCT03863509|589246287|FG000|Overall Study|COVID-19 shutdown period|0|||
163350976|NCT02133131|589994394|FG003|Overall Study|Status not recorded|4|||
163350977|NCT02133131|589994395|FG004|Overall Study|Status not recorded|0|||
163350978|NCT02133131|589994396|FG005|Overall Study|Status not recorded|0|||
163350979|NCT02133131|589994397|FG006|Overall Study|Status not recorded|0|||
163146723|NCT03863509|589246288|FG001|Overall Study|COVID-19 shutdown period|4|||
163146724|NCT03863509|589246289|FG002|Overall Study|COVID-19 shutdown period|0|||
163350980|NCT02133131|589994391|FG000|Overall Study|Ongoing in study|0|||
163350981|NCT02133131|589994392|FG001|Overall Study|Ongoing in study|0|||
163350982|NCT02133131|589994393|FG002|Overall Study|Ongoing in study|0|||
163350983|NCT02133131|589994394|FG003|Overall Study|Ongoing in study|0|||
163350984|NCT02133131|589994395|FG004|Overall Study|Ongoing in study|15|||
163350985|NCT02133131|589994396|FG005|Overall Study|Ongoing in study|14|||
163350986|NCT02133131|589994397|FG006|Overall Study|Ongoing in study|11|||
163350987|NCT02133131|589994391|FG000|Overall Study|Protocol Violation|0|||
163350988|NCT02133131|589994392|FG001|Overall Study|Protocol Violation|0|||
163350989|NCT02133131|589994393|FG002|Overall Study|Protocol Violation|0|||
163350990|NCT02133131|589994394|FG003|Overall Study|Protocol Violation|0|||
163350991|NCT02133131|589994395|FG004|Overall Study|Protocol Violation|0|||
163350992|NCT02133131|589994396|FG005|Overall Study|Protocol Violation|0|||
163146725|NCT03863509|589246287|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
163146726|NCT03863509|589246288|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
163146727|NCT03863509|589246289|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
163146728|NCT03863509|589246287|FG000|Overall Study|Lost to Follow-up|8|||
163146729|NCT03863509|589246288|FG001|Overall Study|Lost to Follow-up|0|||
163146730|NCT03863509|589246289|FG002|Overall Study|Lost to Follow-up|2|||
163146731|NCT03863509|589246287|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
163146732|NCT03863509|589246288|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
163146733|NCT03863509|589246289|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
163146734|NCT03863509|589246287|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
163146735|NCT03863509|589246288|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
163146736|NCT03863509|589246289|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
163146737|NCT03861273|589246290|FG000|Screening Phase (3 Weeks)|Other|1|||
163146738|NCT03861273|589246290|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
163146739|NCT03861273|589246290|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
163146740|NCT03861273|589246290|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
163146741|NCT03861273|589246290|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
163146742|NCT00948064|589248428|FG000|Phase I|No treatment received|1|||
163146743|NCT00948064|589248429|FG001|Phase I|No treatment received|0|||
163146744|NCT00948064|589248430|FG002|Phase I|No treatment received|0|||
163146745|NCT00948064|589248428|FG000|Phase II|Physician Decision|0|||
163146746|NCT00948064|589248429|FG001|Phase II|Physician Decision|0|||
163146747|NCT00948064|589248430|FG002|Phase II|Physician Decision|1|||
163146748|NCT00948064|589248428|FG000|Phase II|Withdrawal by Subject|0|||
163146749|NCT00948064|589248429|FG001|Phase II|Withdrawal by Subject|1|||
163146750|NCT00948064|589248430|FG002|Phase II|Withdrawal by Subject|0|||
163146751|NCT04416204|589248440|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
163146752|NCT04416204|589248441|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
163146753|NCT04416204|589248442|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
163146754|NCT04416204|589248443|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
163146755|NCT01959503|589248444|FG000|Overall Study|Death|2|||
163146756|NCT01959503|589248445|FG001|Overall Study|Death|1|||
163146757|NCT01959503|589248444|FG000|Overall Study|Randomized but not treated|1|||
163146758|NCT01959503|589248445|FG001|Overall Study|Randomized but not treated|1|||
163146759|NCT01393158|589248447|FG000|Overall Study|Adverse Event|1|||
163146760|NCT01393158|589248448|FG001|Overall Study|Adverse Event|0|||
163146761|NCT04233801|589248450|FG000|Overall Study|Other than listed|0|||
163146762|NCT04233801|589248451|FG001|Overall Study|Other than listed|0|||
163146763|NCT04233801|589248452|FG002|Overall Study|Other than listed|1|||
163146764|NCT04233801|589248450|FG000|Overall Study|Withdrawal by Subject|0|||
163146765|NCT04233801|589248451|FG001|Overall Study|Withdrawal by Subject|2|||
163146766|NCT04233801|589248452|FG002|Overall Study|Withdrawal by Subject|3|||
163146767|NCT02173769|589248453|FG000|Overall Study|Protocol Violation|4|||
163146768|NCT00683878|589248464|FG000|Overall Study|Lack of Efficacy|3|||
163146769|NCT00683878|589248465|FG001|Overall Study|Lack of Efficacy|0|||
163146770|NCT00683878|589248466|FG002|Overall Study|Lack of Efficacy|1|||
163146771|NCT00683878|589248464|FG000|Overall Study|Adverse Event|4|||
163146772|NCT00683878|589248465|FG001|Overall Study|Adverse Event|3|||
163146773|NCT00683878|589248466|FG002|Overall Study|Adverse Event|3|||
163146774|NCT00683878|589248464|FG000|Overall Study|Withdrawal by Subject|9|||
163146775|NCT00683878|589248465|FG001|Overall Study|Withdrawal by Subject|8|||
163146776|NCT00683878|589248466|FG002|Overall Study|Withdrawal by Subject|6|||
163146777|NCT00683878|589248464|FG000|Overall Study|Death|0|||
163146778|NCT00683878|589248465|FG001|Overall Study|Death|1|||
163146779|NCT00683878|589248466|FG002|Overall Study|Death|0|||
163146780|NCT00683878|589248464|FG000|Overall Study|Lost to Follow-up|4|||
163146781|NCT00683878|589248465|FG001|Overall Study|Lost to Follow-up|2|||
163146782|NCT00683878|589248466|FG002|Overall Study|Lost to Follow-up|4|||
163146783|NCT00683878|589248464|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
163146784|NCT00683878|589248465|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
163146785|NCT00683878|589248466|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
163146786|NCT04024891|589248467|FG000|Overall Study|Pregnancy|0|||
163146787|NCT04024891|589248468|FG001|Overall Study|Pregnancy|1|||
163146788|NCT03095651|589248476|FG000|Overall Study|Lost to Follow-up|1|||
163146789|NCT03095651|589248477|FG001|Overall Study|Lost to Follow-up|1|||
163146790|NCT03095651|589248478|FG002|Overall Study|Lost to Follow-up|0|||
163146791|NCT03095651|589248479|FG003|Overall Study|Lost to Follow-up|1|||
163146792|NCT03095651|589248480|FG004|Overall Study|Lost to Follow-up|0|||
163146793|NCT03095651|589248481|FG005|Overall Study|Lost to Follow-up|0|||
163146794|NCT03095651|589248482|FG006|Overall Study|Lost to Follow-up|0|||
163146795|NCT03095651|589248483|FG007|Overall Study|Lost to Follow-up|0|||
163146796|NCT03095651|589248476|FG000|Overall Study|Withdrawal by Subject|0|||
163146797|NCT03095651|589248477|FG001|Overall Study|Withdrawal by Subject|0|||
163146798|NCT03095651|589248478|FG002|Overall Study|Withdrawal by Subject|0|||
163146799|NCT03095651|589248479|FG003|Overall Study|Withdrawal by Subject|0|||
163146800|NCT03095651|589248480|FG004|Overall Study|Withdrawal by Subject|0|||
163146801|NCT03095651|589248481|FG005|Overall Study|Withdrawal by Subject|1|||
163146802|NCT03095651|589248482|FG006|Overall Study|Withdrawal by Subject|0|||
163146803|NCT03095651|589248483|FG007|Overall Study|Withdrawal by Subject|0|||
163146804|NCT04124939|589248489|FG000|Overall Study|Lost to Follow-up|1|||
163146805|NCT04124939|589248490|FG001|Overall Study|Lost to Follow-up|3|||
163350993|NCT02133131|589994397|FG006|Overall Study|Protocol Violation|1|||
163350994|NCT01679613|589994400|FG000|Overall Study|other than stated above|0|||
163350995|NCT01679613|589994401|FG001|Overall Study|other than stated above|1|||
163350996|NCT01679613|589994402|FG002|Overall Study|other than stated above|2|||
163350997|NCT01679613|589994403|FG003|Overall Study|other than stated above|2|||
163350998|NCT00509925|589994405|FG000|Overall Study|Personal reasons|0|||
163350999|NCT00509925|589994406|FG001|Overall Study|Personal reasons|1|||
163351000|NCT00951171|589994407|FG000|Overall Study|Adverse Event|2|||
163351001|NCT00951171|589994408|FG001|Overall Study|Adverse Event|0|||
163351002|NCT02799745|589994411|FG000|Overall Study|Participant moved out of state|1|||
163351003|NCT02799745|589994412|FG001|Overall Study|Participant moved out of state|0|||
163351004|NCT02799745|589994411|FG000|Overall Study|Discontinued due to planned surgery|1|||
163351005|NCT02799745|589994412|FG001|Overall Study|Discontinued due to planned surgery|0|||
163351006|NCT02799745|589994411|FG000|Overall Study|Withdrawal by Subject|16|||
163351007|NCT02799745|589994412|FG001|Overall Study|Withdrawal by Subject|25|||
163351008|NCT02799745|589994411|FG000|Overall Study|Protocol Deviation|4|||
163351009|NCT02799745|589994412|FG001|Overall Study|Protocol Deviation|5|||
163351010|NCT02799745|589994411|FG000|Overall Study|Progressive Disease|28|||
163351011|NCT02799745|589994412|FG001|Overall Study|Progressive Disease|38|||
163351012|NCT02799745|589994411|FG000|Overall Study|Lost to Follow-up|3|||
163351013|NCT02799745|589994412|FG001|Overall Study|Lost to Follow-up|2|||
163351014|NCT02799745|589994411|FG000|Overall Study|Death|3|||
163351015|NCT02799745|589994412|FG001|Overall Study|Death|0|||
163351016|NCT02799745|589994411|FG000|Overall Study|Adverse Event|0|||
163351017|NCT02799745|589994412|FG001|Overall Study|Adverse Event|1|||
163351018|NCT02210208|589996079|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
163351019|NCT02210208|589996079|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
163351020|NCT02210208|589996079|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
163351021|NCT00695136|589996080|FG000|Overall Study|Withdrawal by Subject|1|||
163351022|NCT00695136|589996080|FG000|Overall Study|unrelated adverse event|1|||
163351023|NCT01333111|589996081|FG000|Overall Study|patient undergoing major surgery|0|||
163351024|NCT01333111|589996082|FG001|Overall Study|patient undergoing major surgery|2|||
163351025|NCT01333111|589996083|FG002|Overall Study|patient undergoing major surgery|0|||
163351026|NCT01333111|589996081|FG000|Overall Study|personal reasons|0|||
163351027|NCT01333111|589996082|FG001|Overall Study|personal reasons|0|||
163351028|NCT01333111|589996083|FG002|Overall Study|personal reasons|1|||
163351029|NCT01333111|589996081|FG000|Overall Study|unclassified|1|||
163351030|NCT01333111|589996082|FG001|Overall Study|unclassified|0|||
163351031|NCT01333111|589996083|FG002|Overall Study|unclassified|0|||
163351032|NCT01333111|589996081|FG000|Overall Study|withdrawal criteria|0|||
163351033|NCT01333111|589996082|FG001|Overall Study|withdrawal criteria|1|||
163351034|NCT01333111|589996083|FG002|Overall Study|withdrawal criteria|0|||
163351035|NCT01333111|589996081|FG000|Overall Study|Non-compliance|1|||
163351036|NCT01333111|589996082|FG001|Overall Study|Non-compliance|0|||
163351037|NCT01333111|589996083|FG002|Overall Study|Non-compliance|0|||
163351038|NCT01333111|589996081|FG000|Overall Study|Ineffective therapy|0|||
163351039|NCT01333111|589996082|FG001|Overall Study|Ineffective therapy|0|||
163351040|NCT01333111|589996083|FG002|Overall Study|Ineffective therapy|1|||
163351041|NCT01929876|589996084|FG000|Period 2|Non-Compliance|1|||
163351042|NCT01468077|589996085|FG000|Overall Study|Adverse Event|2|||
163351043|NCT01468077|589996086|FG001|Overall Study|Adverse Event|2|||
163351044|NCT01468077|589996085|FG000|Overall Study|Lack of Efficacy|1|||
163351045|NCT01468077|589996086|FG001|Overall Study|Lack of Efficacy|1|||
163351046|NCT01468077|589996085|FG000|Overall Study|Physician Decision|1|||
163351047|NCT01468077|589996086|FG001|Overall Study|Physician Decision|0|||
163351048|NCT05446714|589996087|FG000|Overall Study|Lost to Follow-up|1|||
163351049|NCT05446714|589996088|FG001|Overall Study|Lost to Follow-up|3|||
163351050|NCT05446714|589996089|FG002|Overall Study|Lost to Follow-up|2|||
163351051|NCT05446714|589996087|FG000|Overall Study|Protocol Violation|2|||
163351052|NCT05446714|589996088|FG001|Overall Study|Protocol Violation|0|||
163351053|NCT05446714|589996089|FG002|Overall Study|Protocol Violation|0|||
163351054|NCT03024996|589996090|FG000|Overall Study|Death|57|||
163351055|NCT03024996|589996091|FG001|Overall Study|Death|55|||
163351056|NCT03024996|589996090|FG000|Overall Study|Disease relapse|1|||
163351057|NCT03024996|589996091|FG001|Overall Study|Disease relapse|0|||
163351058|NCT03024996|589996090|FG000|Overall Study|Lost to Follow-up|5|||
163351059|NCT03024996|589996091|FG001|Overall Study|Lost to Follow-up|10|||
163351060|NCT03024996|589996090|FG000|Overall Study|Other|3|||
163351061|NCT03024996|589996091|FG001|Overall Study|Other|3|||
163351062|NCT03024996|589996090|FG000|Overall Study|Physician Decision|0|||
163351063|NCT03024996|589996091|FG001|Overall Study|Physician Decision|1|||
163351064|NCT03024996|589996090|FG000|Overall Study|Study terminated by sponsor|303|||
163146806|NCT00308139|589248493|FG000|Overall Study|Adverse Event|20|||
163146807|NCT00308139|589248494|FG001|Overall Study|Adverse Event|14|||
163146808|NCT00308139|589248493|FG000|Overall Study|Lost to Follow-up|13|||
163146809|NCT00308139|589248494|FG001|Overall Study|Lost to Follow-up|8|||
163146810|NCT00308139|589248493|FG000|Overall Study|Protocol Violation|3|||
163146811|NCT00308139|589248494|FG001|Overall Study|Protocol Violation|2|||
163146812|NCT00308139|589248493|FG000|Overall Study|Withdrawal of Consent|40|||
163146813|NCT00308139|589248494|FG001|Overall Study|Withdrawal of Consent|42|||
163146814|NCT00308139|589248493|FG000|Overall Study|Investigator Decision|11|||
163146815|NCT00308139|589248494|FG001|Overall Study|Investigator Decision|10|||
163146816|NCT00308139|589248493|FG000|Overall Study|Loss of Glucose Control|5|||
163146817|NCT00308139|589248494|FG001|Overall Study|Loss of Glucose Control|7|||
163146818|NCT00308139|589248493|FG000|Overall Study|Administrative|1|||
163146819|NCT00308139|589248494|FG001|Overall Study|Administrative|4|||
163146820|NCT00308139|589248493|FG000|Overall Study|Other|1|||
163146821|NCT00308139|589248494|FG001|Overall Study|Other|0|||
163146822|NCT00791388|589248499|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
163146823|NCT00791388|589248500|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
163146824|NCT00791388|589248501|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
163146825|NCT00791388|589248502|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
163146826|NCT00791388|589248503|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
163146827|NCT00791388|589248499|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
163146828|NCT00791388|589248500|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
163146829|NCT00791388|589248501|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
163146830|NCT00791388|589248502|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
163146831|NCT00791388|589248503|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
163146832|NCT00791388|589248499|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
163146833|NCT00791388|589248500|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
163146834|NCT00791388|589248501|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
163146835|NCT00791388|589248502|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
163146836|NCT00791388|589248503|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
163146837|NCT00435409|589248512|FG000|Overall Study|Protocol Violation|1|||
163146838|NCT00435409|589248513|FG001|Overall Study|Protocol Violation|2|||
163146839|NCT00435409|589248514|FG002|Overall Study|Protocol Violation|0|||
163146840|NCT00435409|589248512|FG000|Overall Study|Lost to Follow-up|1|||
163146841|NCT00435409|589248513|FG001|Overall Study|Lost to Follow-up|2|||
163146842|NCT00435409|589248514|FG002|Overall Study|Lost to Follow-up|0|||
163146843|NCT00435409|589248512|FG000|Overall Study|Death|8|||
163146844|NCT00435409|589248513|FG001|Overall Study|Death|6|||
163146845|NCT00435409|589248514|FG002|Overall Study|Death|6|||
163146846|NCT00435409|589248512|FG000|Overall Study|Objective progression or relapse|158|||
163146847|NCT00435409|589248513|FG001|Overall Study|Objective progression or relapse|93|||
163146848|NCT00435409|589248514|FG002|Overall Study|Objective progression or relapse|58|||
163146849|NCT00435409|589248512|FG000|Overall Study|Global deterioration of health status|0|||
163146850|NCT00435409|589248513|FG001|Overall Study|Global deterioration of health status|0|||
163146851|NCT00435409|589248514|FG002|Overall Study|Global deterioration of health status|4|||
163146852|NCT00435409|589248512|FG000|Overall Study|Withdrawal by Subject|8|||
163146853|NCT00435409|589248513|FG001|Overall Study|Withdrawal by Subject|7|||
163146854|NCT00435409|589248514|FG002|Overall Study|Withdrawal by Subject|1|||
163146855|NCT00435409|589248512|FG000|Overall Study|Other|45|||
163146856|NCT00435409|589248513|FG001|Overall Study|Other|30|||
163146857|NCT00435409|589248514|FG002|Overall Study|Other|1|||
163146858|NCT00435409|589248512|FG000|Overall Study|Adverse Event|0|||
163146859|NCT00435409|589248513|FG001|Overall Study|Adverse Event|0|||
163146860|NCT00435409|589248514|FG002|Overall Study|Adverse Event|8|||
163146861|NCT00435409|589248512|FG000|Overall Study|Sponsor decision|0|||
163146862|NCT00435409|589248513|FG001|Overall Study|Sponsor decision|3|||
163146863|NCT00435409|589248514|FG002|Overall Study|Sponsor decision|0|||
163146864|NCT04750824|589248515|FG000|Overall Study|Toxicity/intolerability|3|||
163146865|NCT04750824|589248516|FG001|Overall Study|Toxicity/intolerability|1|||
163351065|NCT03024996|589996091|FG001|Overall Study|Study terminated by sponsor|283|||
163351066|NCT03024996|589996090|FG000|Overall Study|Withdrawal by Subject|21|||
163351067|NCT03024996|589996091|FG001|Overall Study|Withdrawal by Subject|36|||
163351068|NCT02418845|589996094|FG000|Overall Study|Lost to Follow-up|7|||
163351069|NCT02418845|589996095|FG001|Overall Study|Lost to Follow-up|2|||
163146866|NCT04750824|589248515|FG000|Overall Study|Death|1|||
163146867|NCT04750824|589248516|FG001|Overall Study|Death|3|||
163146868|NCT04750824|589248515|FG000|Overall Study|Scheduled duration of therapy complete|1|||
163146869|NCT04750824|589248516|FG001|Overall Study|Scheduled duration of therapy complete|9|||
163146870|NCT04750824|589248515|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
163146871|NCT04750824|589248516|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
163146872|NCT05196828|589248517|FG000|Overall Study|Withdrawal by Subject|2|||
163146873|NCT05196828|589248518|FG001|Overall Study|Withdrawal by Subject|0|||
163146874|NCT05196828|589248517|FG000|Overall Study|Lost to Follow-up|0|||
163351070|NCT02418845|589996094|FG000|Overall Study|Lack of Efficacy|0|||
163146875|NCT05196828|589248518|FG001|Overall Study|Lost to Follow-up|4|||
163146876|NCT05196828|589248517|FG000|Overall Study|Adverse Event|1|||
163146877|NCT05196828|589248518|FG001|Overall Study|Adverse Event|0|||
163146878|NCT02763644|589248519|FG000|Overall Study|Patient/guardian decision|1|||
163146879|NCT02763644|589248520|FG001|Overall Study|Patient/guardian decision|0|||
163146880|NCT02763644|589248519|FG000|Overall Study|Death|1|||
163146881|NCT02763644|589248520|FG001|Overall Study|Death|1|||
163146882|NCT02763644|589248519|FG000|Overall Study|Adverse Event|1|||
163146883|NCT02763644|589248520|FG001|Overall Study|Adverse Event|1|||
163146884|NCT02356159|589248521|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
163146885|NCT02356159|589248522|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
163146886|NCT02356159|589248523|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
163146887|NCT02356159|589248524|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
163146888|NCT02356159|589248525|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
163146889|NCT02356159|589248526|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
163146890|NCT03192176|589248527|FG000|Overall Study|Adverse Event|1|||
163146891|NCT03192176|589248528|FG001|Overall Study|Adverse Event|0|||
163146892|NCT03192176|589248529|FG002|Overall Study|Adverse Event|4|||
163146893|NCT03192176|589248530|FG003|Overall Study|Adverse Event|5|||
163146894|NCT03192176|589248531|FG004|Overall Study|Adverse Event|3|||
163146895|NCT03192176|589248532|FG005|Overall Study|Adverse Event|2|||
163146896|NCT03192176|589248533|FG006|Overall Study|Adverse Event|3|||
163146897|NCT03192176|589248534|FG007|Overall Study|Adverse Event|3|||
163146898|NCT03192176|589248527|FG000|Overall Study|Lost to Follow-up|0|||
163146899|NCT03192176|589248528|FG001|Overall Study|Lost to Follow-up|0|||
163146900|NCT03192176|589248529|FG002|Overall Study|Lost to Follow-up|1|||
163146901|NCT03192176|589248530|FG003|Overall Study|Lost to Follow-up|2|||
163146902|NCT03192176|589248531|FG004|Overall Study|Lost to Follow-up|3|||
163146903|NCT03192176|589248532|FG005|Overall Study|Lost to Follow-up|1|||
163146904|NCT03192176|589248533|FG006|Overall Study|Lost to Follow-up|1|||
163146905|NCT03192176|589248534|FG007|Overall Study|Lost to Follow-up|1|||
163146906|NCT03192176|589248527|FG000|Overall Study|Physician Decision|1|||
163146907|NCT03192176|589248528|FG001|Overall Study|Physician Decision|0|||
163146908|NCT03192176|589248529|FG002|Overall Study|Physician Decision|0|||
163146909|NCT03192176|589248530|FG003|Overall Study|Physician Decision|0|||
163146910|NCT03192176|589248531|FG004|Overall Study|Physician Decision|0|||
163146911|NCT03192176|589248532|FG005|Overall Study|Physician Decision|2|||
163146912|NCT03192176|589248533|FG006|Overall Study|Physician Decision|1|||
163146913|NCT03192176|589248534|FG007|Overall Study|Physician Decision|0|||
163146914|NCT03192176|589248527|FG000|Overall Study|Protocol Deviation|1|||
163146915|NCT03192176|589248528|FG001|Overall Study|Protocol Deviation|1|||
163146916|NCT03192176|589248529|FG002|Overall Study|Protocol Deviation|0|||
163146917|NCT03192176|589248530|FG003|Overall Study|Protocol Deviation|0|||
163146918|NCT03192176|589248531|FG004|Overall Study|Protocol Deviation|2|||
163146919|NCT03192176|589248532|FG005|Overall Study|Protocol Deviation|0|||
163146920|NCT03192176|589248533|FG006|Overall Study|Protocol Deviation|0|||
163146921|NCT03192176|589248534|FG007|Overall Study|Protocol Deviation|0|||
163146922|NCT03192176|589248527|FG000|Overall Study|Withdrawal by Subject|3|||
163146923|NCT03192176|589248528|FG001|Overall Study|Withdrawal by Subject|4|||
163146924|NCT03192176|589248529|FG002|Overall Study|Withdrawal by Subject|0|||
163146925|NCT03192176|589248530|FG003|Overall Study|Withdrawal by Subject|4|||
163146926|NCT03192176|589248531|FG004|Overall Study|Withdrawal by Subject|3|||
163146927|NCT03192176|589248532|FG005|Overall Study|Withdrawal by Subject|4|||
163146928|NCT03192176|589248533|FG006|Overall Study|Withdrawal by Subject|4|||
163146929|NCT03192176|589248534|FG007|Overall Study|Withdrawal by Subject|2|||
163146930|NCT03192176|589248527|FG000|Overall Study|Miscellaneous|1|||
163146931|NCT03192176|589248528|FG001|Overall Study|Miscellaneous|0|||
163146932|NCT03192176|589248529|FG002|Overall Study|Miscellaneous|1|||
163146933|NCT03192176|589248530|FG003|Overall Study|Miscellaneous|1|||
163146934|NCT03192176|589248531|FG004|Overall Study|Miscellaneous|1|||
163146935|NCT03192176|589248532|FG005|Overall Study|Miscellaneous|2|||
163146936|NCT03192176|589248533|FG006|Overall Study|Miscellaneous|0|||
163146937|NCT03192176|589248534|FG007|Overall Study|Miscellaneous|1|||
163146938|NCT00836589|589248539|FG000|Overall Study|Lost to Follow-up|246|||
163146939|NCT00836589|589248539|FG000|Overall Study|Death|429|||
163146940|NCT00836589|589248539|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
163146941|NCT00117637|589248540|FG000|First Intervention (Period 1)|Adverse Event|11|||
163146942|NCT00117637|589248541|FG001|First Intervention (Period 1)|Adverse Event|16|||
163241453|NCT01490632|589592548|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
163241454|NCT01490632|589592549|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
163146943|NCT00117637|589248540|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
163146944|NCT00117637|589248541|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
163146945|NCT00117637|589248540|FG000|First Intervention (Period 1)|Protocol Violation|1|||
163146946|NCT00117637|589248541|FG001|First Intervention (Period 1)|Protocol Violation|0|||
163146947|NCT00117637|589248540|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
163241455|NCT01490632|589592550|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
163241456|NCT01490632|589592551|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
163146948|NCT00117637|589248541|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
163146949|NCT00117637|589248540|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
163146950|NCT00117637|589248541|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
163146951|NCT00117637|589248540|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
163146952|NCT00117637|589248541|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
163146953|NCT00117637|589248540|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
163146954|NCT00117637|589248541|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
163146955|NCT00117637|589248540|FG000|First Intervention (Period 1)|reason not reported|0|||
163146956|NCT00117637|589248541|FG001|First Intervention (Period 1)|reason not reported|1|||
163146957|NCT00117637|589248540|FG000|Second Intervention (Period 2)|Adverse Event|0|||
163146958|NCT00117637|589248541|FG001|Second Intervention (Period 2)|Adverse Event|9|||
163146959|NCT00117637|589248540|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
163146960|NCT00117637|589248541|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
163146961|NCT00117637|589248540|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
163146962|NCT00117637|589248541|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
163146963|NCT00117637|589248540|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
163146964|NCT00117637|589248541|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
163146965|NCT00117637|589248540|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
163146966|NCT00117637|589248541|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
163146967|NCT00117637|589248540|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
163146968|NCT00117637|589248541|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
163146969|NCT00117637|589248540|FG000|Second Intervention (Period 2)|reason not reported|1|||
163146970|NCT00117637|589248541|FG001|Second Intervention (Period 2)|reason not reported|0|||
163146971|NCT02914639|589248544|FG000|Overall Study|Withdrawal by Subject|0|||
163146972|NCT02914639|589248545|FG001|Overall Study|Withdrawal by Subject|2|||
163146973|NCT01582061|589248546|FG000|Overall Study|Lack of Efficacy|3|||
163146974|NCT01582061|589248547|FG001|Overall Study|Lack of Efficacy|23|||
163146975|NCT01582061|589248546|FG000|Overall Study|Adverse Event|12|||
163146976|NCT01582061|589248547|FG001|Overall Study|Adverse Event|8|||
163146977|NCT01582061|589248546|FG000|Overall Study|Withdrawal by Subject|10|||
163146978|NCT01582061|589248547|FG001|Overall Study|Withdrawal by Subject|4|||
163146979|NCT01582061|589248546|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163146980|NCT01582061|589248547|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163146981|NCT01582061|589248546|FG000|Overall Study|Death|0|||
163146982|NCT01582061|589248547|FG001|Overall Study|Death|1|||
163146983|NCT01582061|589248546|FG000|Overall Study|condition no longer requires study drug|1|||
163146984|NCT01582061|589248547|FG001|Overall Study|condition no longer requires study drug|0|||
163146985|NCT01582061|589248546|FG000|Overall Study|Lost to Follow-up|1|||
163146986|NCT01582061|589248547|FG001|Overall Study|Lost to Follow-up|0|||
163146987|NCT01045460|589248551|FG000|Overall Study|Physician Decision|3|||
163146988|NCT01045460|589248552|FG001|Overall Study|Physician Decision|2|||
163146989|NCT01045460|589248551|FG000|Overall Study|Lost to Follow-up|0|||
163146990|NCT01045460|589248552|FG001|Overall Study|Lost to Follow-up|1|||
163146991|NCT01045460|589248551|FG000|Overall Study|Lack of Efficacy|3|||
163146992|NCT01045460|589248552|FG001|Overall Study|Lack of Efficacy|0|||
163146993|NCT00436332|589248555|FG000|Overall Study|Adverse Event|9|||
163146994|NCT00436332|589248555|FG000|Overall Study|Withdrawal by Subject|2|||
163146995|NCT00436332|589248555|FG000|Overall Study|Progression|59|||
163146996|NCT00436332|589248555|FG000|Overall Study|Death|2|||
163146997|NCT00436332|589248555|FG000|Overall Study|Not Protocol Specified|6|||
163146998|NCT00436332|589248555|FG000|Overall Study|Ineligible|2|||
163146999|NCT00436332|589248555|FG000|Overall Study|Never Received Treatment|3|||
163147000|NCT00062439|589248556|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
163147001|NCT00062439|589248556|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
163147002|NCT00062439|589248556|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
163147003|NCT00062439|589248556|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
163147004|NCT00062439|589248556|FG000|Post Chemoradiation Assessment|Death|1|||
163147005|NCT00062439|589248556|FG000|Post Chemoradiation Assessment|Disease progression|2|||
163147006|NCT00062439|589248556|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
163147007|NCT00062439|589248556|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
163147008|NCT00062439|589248556|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
163241457|NCT01490632|589592552|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
163241458|NCT01490632|589592553|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
163241459|NCT01490632|589592554|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
163147009|NCT00062439|589248556|FG000|Surgery|Physician Decision|4|||
163147010|NCT00062439|589248556|FG000|Surgery|Death|1|||
163147011|NCT00062439|589248556|FG000|Surgery|Adverse Event|2|||
163147012|NCT00062439|589248556|FG000|Consolidation Chemotherapy|Adverse Event|2|||
163147013|NCT01924845|589248557|FG000|Overall Study|Adverse Event|3|||
163351071|NCT02418845|589996095|FG001|Overall Study|Lack of Efficacy|3|||
163351072|NCT02418845|589996094|FG000|Overall Study|Physician Decision|5|||
163351073|NCT02418845|589996095|FG001|Overall Study|Physician Decision|5|||
163351074|NCT02418845|589996094|FG000|Overall Study|Protocol Violation|1|||
163351075|NCT02418845|589996095|FG001|Overall Study|Protocol Violation|0|||
163351076|NCT02418845|589996094|FG000|Overall Study|Withdrawal by Subject|3|||
163351077|NCT02418845|589996095|FG001|Overall Study|Withdrawal by Subject|2|||
163351078|NCT00478647|589996096|FG000|Overall Study|Adverse Event|1|||
163351079|NCT00478647|589996096|FG000|Overall Study|Withdrawal by Subject|1|||
163351080|NCT04333147|589996097|FG000|Overall Study|Adverse Event|43|||
163351081|NCT04333147|589996098|FG001|Overall Study|Adverse Event|40|||
163351082|NCT04333147|589996097|FG000|Overall Study|Lack of Efficacy|49|||
163351083|NCT04333147|589996098|FG001|Overall Study|Lack of Efficacy|48|||
163351084|NCT04333147|589996097|FG000|Overall Study|Lost to Follow-up|19|||
163351085|NCT04333147|589996098|FG001|Overall Study|Lost to Follow-up|16|||
163351086|NCT04333147|589996097|FG000|Overall Study|Physician Decision|17|||
163351087|NCT04333147|589996098|FG001|Overall Study|Physician Decision|20|||
163351088|NCT04333147|589996097|FG000|Overall Study|Withdrawal by Subject|65|||
163351089|NCT04333147|589996098|FG001|Overall Study|Withdrawal by Subject|68|||
163351090|NCT04333147|589996097|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
163351091|NCT04333147|589996098|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
163351092|NCT04333147|589996097|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
163351093|NCT04333147|589996098|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
163351094|NCT04333147|589996097|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
163351095|NCT04333147|589996098|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
163351096|NCT00487552|589996099|FG000|Overall Study|Unsuccessful magnet placements|3|||
163351097|NCT00487552|589996099|FG000|Overall Study|Death due to progressive malignancy|2|||
163351098|NCT00487552|589996099|FG000|Overall Study|Stent not placed|1|||
163351099|NCT03119688|589996100|FG000|Overall Study|Adverse Event|4|||
163351100|NCT00630552|589996101|FG000|Overall Study|Adverse Event|0|||
163351101|NCT00630552|589996102|FG001|Overall Study|Adverse Event|1|||
163351102|NCT00630552|589996103|FG002|Overall Study|Adverse Event|5|||
163351103|NCT00630552|589996104|FG003|Overall Study|Adverse Event|4|||
163351104|NCT00630552|589996105|FG004|Overall Study|Adverse Event|2|||
163351105|NCT00630552|589996101|FG000|Overall Study|Disease progression|5|||
163147014|NCT01924845|589248557|FG000|Overall Study|Withdrawal by Subject|2|||
163147015|NCT01924845|589248557|FG000|Overall Study|Protocol Violation|1|||
163147016|NCT03780452|589248558|FG000|Overall Study|Screening failure|2|||
163147017|NCT02388269|589248559|FG000|Overall Study|Adverse Event|2|||
163147018|NCT02388269|589248560|FG001|Overall Study|Adverse Event|0|||
163147019|NCT02388269|589248561|FG002|Overall Study|Adverse Event|0|||
163147020|NCT02388269|589248559|FG000|Overall Study|Withdrawal by Subject|1|||
163147021|NCT02388269|589248560|FG001|Overall Study|Withdrawal by Subject|2|||
163147022|NCT02388269|589248561|FG002|Overall Study|Withdrawal by Subject|0|||
163147023|NCT02388269|589248559|FG000|Overall Study|less than 50% stimulations|1|||
163147024|NCT02388269|589248560|FG001|Overall Study|less than 50% stimulations|0|||
163147025|NCT02388269|589248561|FG002|Overall Study|less than 50% stimulations|0|||
163147026|NCT02388269|589248559|FG000|Overall Study|no diary data|3|||
163147027|NCT02388269|589248560|FG001|Overall Study|no diary data|0|||
163147028|NCT02388269|589248561|FG002|Overall Study|no diary data|0|||
163147029|NCT02388269|589248559|FG000|Overall Study|Protocol Violation|2|||
163147030|NCT02388269|589248560|FG001|Overall Study|Protocol Violation|0|||
163147031|NCT02388269|589248561|FG002|Overall Study|Protocol Violation|0|||
163147032|NCT02388269|589248559|FG000|Overall Study|Screen Failure|0|||
163147033|NCT02388269|589248560|FG001|Overall Study|Screen Failure|0|||
163147034|NCT02388269|589248561|FG002|Overall Study|Screen Failure|10|||
163147035|NCT00265564|589248564|FG000|Overall Study|Lost to Follow-up|5|||
163147036|NCT00265564|589248565|FG001|Overall Study|Lost to Follow-up|7|||
163147037|NCT00265564|589248564|FG000|Overall Study|met exclusion criteria|5|||
163147038|NCT00265564|589248565|FG001|Overall Study|met exclusion criteria|2|||
163147039|NCT04698343|589248566|FG000|Overall Study|Withdrawal by Subject|6|||
163147040|NCT04698343|589248566|FG000|Overall Study|Physician Decision|2|||
163147041|NCT04698343|589248566|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
163147042|NCT04698343|589248566|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
163147043|NCT04698343|589248566|FG000|Overall Study|Personal reasons|3|||
163147044|NCT04698343|589248566|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
163351106|NCT00630552|589996102|FG001|Overall Study|Disease progression|6|||
163351107|NCT00630552|589996103|FG002|Overall Study|Disease progression|27|||
163351108|NCT00630552|589996104|FG003|Overall Study|Disease progression|22|||
163147045|NCT02163902|589248569|FG000|Overall Study|Subject's Request|3|||
163351109|NCT00630552|589996105|FG004|Overall Study|Disease progression|31|||
163351110|NCT00630552|589996101|FG000|Overall Study|Never received IP|0|||
163351111|NCT00630552|589996102|FG001|Overall Study|Never received IP|0|||
163147046|NCT02163902|589248570|FG001|Overall Study|Subject's Request|4|||
163147047|NCT02163902|589248569|FG000|Overall Study|Lost to Follow-up|6|||
163147048|NCT02163902|589248570|FG001|Overall Study|Lost to Follow-up|7|||
163147049|NCT02163902|589248569|FG000|Overall Study|Administrative Decision|2|||
163147050|NCT02163902|589248570|FG001|Overall Study|Administrative Decision|2|||
163351112|NCT00630552|589996103|FG002|Overall Study|Never received IP|0|||
163351113|NCT00630552|589996104|FG003|Overall Study|Never received IP|2|||
163147051|NCT00325897|589248573|FG000|Overall Study|Lost to Follow-up|12|||
163147052|NCT00325897|589248574|FG001|Overall Study|Lost to Follow-up|13|||
163147053|NCT00467740|589248575|FG000|Overall Study|Adverse Event|0|||
163147054|NCT00467740|589248576|FG001|Overall Study|Adverse Event|0|||
163147055|NCT00467740|589248577|FG002|Overall Study|Adverse Event|1|||
163147056|NCT00467740|589248578|FG003|Overall Study|Adverse Event|0|||
163147057|NCT00467740|589248579|FG004|Overall Study|Adverse Event|0|||
163147058|NCT00467740|589248575|FG000|Overall Study|Protocol Violation|0|||
163147059|NCT00467740|589248576|FG001|Overall Study|Protocol Violation|0|||
163147060|NCT00467740|589248577|FG002|Overall Study|Protocol Violation|1|||
163147061|NCT00467740|589248578|FG003|Overall Study|Protocol Violation|0|||
163147062|NCT00467740|589248579|FG004|Overall Study|Protocol Violation|0|||
163147063|NCT00467740|589248575|FG000|Overall Study|Lost to Follow-up|0|||
163147064|NCT00467740|589248576|FG001|Overall Study|Lost to Follow-up|1|||
163147065|NCT00467740|589248577|FG002|Overall Study|Lost to Follow-up|0|||
163147066|NCT00467740|589248578|FG003|Overall Study|Lost to Follow-up|0|||
163147067|NCT00467740|589248579|FG004|Overall Study|Lost to Follow-up|0|||
163147068|NCT00467740|589248575|FG000|Overall Study|Withdrawal by Subject|1|||
163147069|NCT00467740|589248576|FG001|Overall Study|Withdrawal by Subject|1|||
163147070|NCT00467740|589248577|FG002|Overall Study|Withdrawal by Subject|0|||
163147071|NCT00467740|589248578|FG003|Overall Study|Withdrawal by Subject|1|||
163147072|NCT00467740|589248579|FG004|Overall Study|Withdrawal by Subject|0|||
163147073|NCT00467740|589248575|FG000|Overall Study|Lack of Efficacy|0|||
163147074|NCT00467740|589248576|FG001|Overall Study|Lack of Efficacy|1|||
163147075|NCT00467740|589248577|FG002|Overall Study|Lack of Efficacy|0|||
163147076|NCT00467740|589248578|FG003|Overall Study|Lack of Efficacy|0|||
163351114|NCT00630552|589996105|FG004|Overall Study|Never received IP|2|||
163351115|NCT00630552|589996101|FG000|Overall Study|Ineligibility determined|0|||
163351116|NCT00630552|589996102|FG001|Overall Study|Ineligibility determined|0|||
163351117|NCT00630552|589996103|FG002|Overall Study|Ineligibility determined|0|||
163351118|NCT00630552|589996104|FG003|Overall Study|Ineligibility determined|0|||
163351119|NCT00630552|589996105|FG004|Overall Study|Ineligibility determined|1|||
163351120|NCT00630552|589996101|FG000|Overall Study|Protocol Violation|0|||
163351121|NCT00630552|589996102|FG001|Overall Study|Protocol Violation|0|||
163351122|NCT00630552|589996103|FG002|Overall Study|Protocol Violation|0|||
163351123|NCT00630552|589996104|FG003|Overall Study|Protocol Violation|1|||
163351124|NCT00630552|589996105|FG004|Overall Study|Protocol Violation|0|||
163351125|NCT00630552|589996101|FG000|Overall Study|Physician Decision|0|||
163351126|NCT00630552|589996102|FG001|Overall Study|Physician Decision|0|||
163351127|NCT00630552|589996103|FG002|Overall Study|Physician Decision|0|||
163351128|NCT00630552|589996104|FG003|Overall Study|Physician Decision|0|||
163351129|NCT00630552|589996105|FG004|Overall Study|Physician Decision|1|||
163351130|NCT00630552|589996101|FG000|Overall Study|Death|0|||
163351131|NCT00630552|589996102|FG001|Overall Study|Death|0|||
163351132|NCT00630552|589996103|FG002|Overall Study|Death|1|||
163351133|NCT00630552|589996104|FG003|Overall Study|Death|2|||
163351134|NCT00630552|589996105|FG004|Overall Study|Death|2|||
163351135|NCT00630552|589996101|FG000|Overall Study|Withdrawal by Subject|0|||
163351136|NCT00630552|589996102|FG001|Overall Study|Withdrawal by Subject|0|||
163351137|NCT00630552|589996103|FG002|Overall Study|Withdrawal by Subject|0|||
163351138|NCT00630552|589996104|FG003|Overall Study|Withdrawal by Subject|1|||
163351139|NCT00630552|589996105|FG004|Overall Study|Withdrawal by Subject|0|||
163351140|NCT00630552|589996101|FG000|Overall Study|Other|0|||
163351141|NCT00630552|589996102|FG001|Overall Study|Other|0|||
163351142|NCT00630552|589996103|FG002|Overall Study|Other|4|||
163351143|NCT00630552|589996104|FG003|Overall Study|Other|2|||
163351144|NCT00630552|589996105|FG004|Overall Study|Other|0|||
163351145|NCT01084239|589996106|FG000|28-Day Follow-up|Lost to Follow-up|4|||
163351146|NCT01084239|589996107|FG001|28-Day Follow-up|Lost to Follow-up|9|||
163351147|NCT05006417|589996108|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
163351148|NCT02705625|589996109|FG000|Overall Study|Protocol Violation|1|||
163351149|NCT02705625|589996110|FG001|Overall Study|Protocol Violation|0|||
163351150|NCT02705625|589996111|FG002|Overall Study|Protocol Violation|0|||
163351151|NCT02705625|589996109|FG000|Overall Study|Adverse Event|6|||
163351152|NCT02705625|589996110|FG001|Overall Study|Adverse Event|5|||
163351153|NCT02705625|589996111|FG002|Overall Study|Adverse Event|2|||
163351154|NCT02705625|589996109|FG000|Overall Study|Death|0|||
163351155|NCT02705625|589996110|FG001|Overall Study|Death|0|||
163147077|NCT00467740|589248579|FG004|Overall Study|Lack of Efficacy|0|||
163147078|NCT02903160|589248580|FG000|Overall Study|Adverse Event|2|||
163147079|NCT02903160|589248580|FG000|Overall Study|Death|1|||
163147080|NCT02903160|589248580|FG000|Overall Study|Lost to Follow-up|2|||
163147081|NCT02903160|589248580|FG000|Overall Study|Withdrawal by Subject|1|||
163351156|NCT02705625|589996111|FG002|Overall Study|Death|1|||
163351157|NCT02705625|589996109|FG000|Overall Study|Withdrawal by Subject|1|||
163351158|NCT02705625|589996110|FG001|Overall Study|Withdrawal by Subject|4|||
163351159|NCT02705625|589996111|FG002|Overall Study|Withdrawal by Subject|5|||
163351160|NCT02705625|589996109|FG000|Overall Study|Lost to Follow-up|0|||
163351161|NCT02705625|589996110|FG001|Overall Study|Lost to Follow-up|0|||
163351162|NCT02705625|589996111|FG002|Overall Study|Lost to Follow-up|1|||
163147082|NCT02903160|589248580|FG000|Overall Study|Medical Insurance Barriers|1|||
163147083|NCT01664910|589248583|FG000|Overall Study|Adverse Event|0|||
163147084|NCT01664910|589248584|FG001|Overall Study|Adverse Event|0|||
163147085|NCT01664910|589248585|FG002|Overall Study|Adverse Event|1|||
163147086|NCT02240485|589248586|FG000|3 Months Post-admission|Lost to Follow-up|1|||
163147087|NCT02240485|589248587|FG001|3 Months Post-admission|Lost to Follow-up|5|||
163147088|NCT02240485|589248586|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
163147089|NCT02240485|589248587|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
163147090|NCT02240485|589248586|FG000|9 Months Post-admission|Lost to Follow-up|3|||
163147091|NCT02240485|589248587|FG001|9 Months Post-admission|Lost to Follow-up|1|||
163147092|NCT02240485|589248586|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
163147093|NCT02240485|589248587|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
163147094|NCT02240485|589248586|FG000|18 Months Post-admission|Lost to Follow-up|1|||
163147095|NCT02240485|589248587|FG001|18 Months Post-admission|Lost to Follow-up|1|||
163147096|NCT02240485|589248586|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
163147097|NCT02240485|589248587|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
163147098|NCT02525471|589248588|FG000|Overall Study|Screen Failure|6|||
163147099|NCT02525471|589248588|FG000|Overall Study|Withdrawal by Subject|4|||
163147100|NCT02525471|589248588|FG000|Overall Study|Death|1|||
163147101|NCT00844376|589248592|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
163147102|NCT00844376|589248593|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
163147103|NCT00539981|589248596|FG000|Overall Study|Adverse events (AE)|3|||
163147104|NCT00539981|589248597|FG001|Overall Study|Adverse events (AE)|3|||
163147105|NCT00539981|589248596|FG000|Overall Study|Lost to Follow-up|260|||
163147106|NCT00539981|589248597|FG001|Overall Study|Lost to Follow-up|251|||
163147107|NCT00539981|589248596|FG000|Overall Study|Withdrew consent|22|||
163147108|NCT00539981|589248597|FG001|Overall Study|Withdrew consent|14|||
163147109|NCT00539981|589248596|FG000|Overall Study|Death|1|||
163147110|NCT00539981|589248597|FG001|Overall Study|Death|1|||
163147111|NCT00539981|589248596|FG000|Overall Study|Other reason-unspecified|9|||
163147112|NCT00539981|589248597|FG001|Overall Study|Other reason-unspecified|13|||
163147113|NCT01759420|589248598|FG000|Overall Study|Screen failure|5|||
163147114|NCT01759420|589248598|FG000|Overall Study|Inaccurate EKG machine readings|1|||
163147115|NCT01129622|589248599|FG000|Overall Study|Withdrawal by Subject|2|||
163147116|NCT03069352|589248603|FG000|Overall Study|Ongoing|12|||
163147117|NCT03069352|589248604|FG001|Overall Study|Ongoing|40|||
163147118|NCT02621424|589248605|FG000|Overall Study|Withdrawal by Subject|1|||
163147119|NCT02621424|589248606|FG001|Overall Study|Withdrawal by Subject|2|||
163147120|NCT00633477|589251150|FG000|Overall Study|Death|1|||
163147121|NCT00633477|589251151|FG001|Overall Study|Death|0|||
163147122|NCT00633477|589251150|FG000|Overall Study|Randomized but not treated|1|||
163147123|NCT00633477|589251151|FG001|Overall Study|Randomized but not treated|0|||
163147124|NCT04906499|589251153|FG000|Overall Study|Lack of time|1|||
163147125|NCT03346434|589251154|FG000|Overall Study|Randomized in Error|0|||
163147126|NCT03346434|589251155|FG001|Overall Study|Randomized in Error|0|||
163147127|NCT03346434|589251156|FG002|Overall Study|Randomized in Error|0|||
163147128|NCT03346434|589251157|FG003|Overall Study|Randomized in Error|0|||
163147129|NCT03346434|589251158|FG004|Overall Study|Randomized in Error|1|||
163147130|NCT03346434|589251159|FG005|Overall Study|Randomized in Error|0|||
163147131|NCT03346434|589251154|FG000|Overall Study|Withdrawal by Subject|0|||
163147132|NCT03346434|589251155|FG001|Overall Study|Withdrawal by Subject|0|||
163147133|NCT03346434|589251156|FG002|Overall Study|Withdrawal by Subject|1|||
163147134|NCT03346434|589251157|FG003|Overall Study|Withdrawal by Subject|0|||
163147135|NCT03346434|589251158|FG004|Overall Study|Withdrawal by Subject|1|||
163147136|NCT03346434|589251159|FG005|Overall Study|Withdrawal by Subject|0|||
163147137|NCT03346434|589251154|FG000|Overall Study|Lost to Follow-up|0|||
163147138|NCT03346434|589251155|FG001|Overall Study|Lost to Follow-up|0|||
163147139|NCT03346434|589251156|FG002|Overall Study|Lost to Follow-up|0|||
163147140|NCT03346434|589251157|FG003|Overall Study|Lost to Follow-up|0|||
163147141|NCT03346434|589251158|FG004|Overall Study|Lost to Follow-up|1|||
163147142|NCT03346434|589251159|FG005|Overall Study|Lost to Follow-up|1|||
163147143|NCT03346434|589251154|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
163147144|NCT03346434|589251155|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
163147145|NCT03346434|589251156|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
163147146|NCT03346434|589251157|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
163147147|NCT03346434|589251158|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
163147148|NCT03346434|589251159|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
163147149|NCT02081677|589251160|FG000|Overall Study|Adverse Event|0|||
163147150|NCT02081677|589251161|FG001|Overall Study|Adverse Event|0|||
163241460|NCT01490632|589592555|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
163241461|NCT01490632|589592556|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
163241462|NCT01490632|589592557|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
163147151|NCT02081677|589251162|FG002|Overall Study|Adverse Event|1|||
163147152|NCT02081677|589251163|FG003|Overall Study|Adverse Event|0|||
163241463|NCT01490632|589592558|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
163241464|NCT01490632|589592559|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
163147153|NCT02081677|589251160|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
163147154|NCT02081677|589251161|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
163147155|NCT02081677|589251162|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
163147156|NCT02081677|589251163|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
163147157|NCT02081677|589251160|FG000|Overall Study|Not comfortable with lens care system|1|||
163147158|NCT02081677|589251161|FG001|Overall Study|Not comfortable with lens care system|0|||
163147159|NCT02081677|589251162|FG002|Overall Study|Not comfortable with lens care system|0|||
163147160|NCT02081677|589251163|FG003|Overall Study|Not comfortable with lens care system|0|||
163147161|NCT02081677|589251160|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
163147162|NCT02081677|589251161|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
163147163|NCT02081677|589251162|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
163147164|NCT02081677|589251163|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
163147165|NCT01751061|589251174|FG000|Overall Study|Death|1|||
163147166|NCT01751061|589251175|FG001|Overall Study|Death|0|||
163147167|NCT01751061|589251174|FG000|Overall Study|patient death|5|||
163147168|NCT01751061|589251175|FG001|Overall Study|patient death|0|||
163147169|NCT01751061|589251174|FG000|Overall Study|Lost to Follow-up|40|||
163147170|NCT01751061|589251175|FG001|Overall Study|Lost to Follow-up|25|||
163147171|NCT01751061|589251174|FG000|Overall Study|patient regained decisional capacity|4|||
163147172|NCT01751061|589251175|FG001|Overall Study|patient regained decisional capacity|8|||
163147173|NCT01751061|589251174|FG000|Overall Study|Withdrawal by Subject|4|||
163147174|NCT01751061|589251175|FG001|Overall Study|Withdrawal by Subject|1|||
163147175|NCT01751061|589251174|FG000|Overall Study|Physician Decision|2|||
163147176|NCT01751061|589251175|FG001|Overall Study|Physician Decision|0|||
163147177|NCT02412306|589251176|FG000|Overall Study|Lost to Follow-up|0|||
163147178|NCT02412306|589251177|FG001|Overall Study|Lost to Follow-up|1|||
163147179|NCT02412306|589251178|FG002|Overall Study|Lost to Follow-up|0|||
163147180|NCT02412306|589251179|FG003|Overall Study|Lost to Follow-up|0|||
163147181|NCT02412306|589251180|FG004|Overall Study|Lost to Follow-up|0|||
163147182|NCT02412306|589251176|FG000|Overall Study|Withdrawal by Subject|0|||
163147183|NCT02412306|589251177|FG001|Overall Study|Withdrawal by Subject|0|||
163147184|NCT02412306|589251178|FG002|Overall Study|Withdrawal by Subject|1|||
163147185|NCT02412306|589251179|FG003|Overall Study|Withdrawal by Subject|0|||
163147186|NCT02412306|589251180|FG004|Overall Study|Withdrawal by Subject|0|||
163147187|NCT02412306|589251176|FG000|Overall Study|Death|5|||
163147188|NCT02412306|589251177|FG001|Overall Study|Death|7|||
163147189|NCT02412306|589251178|FG002|Overall Study|Death|15|||
163147190|NCT02412306|589251179|FG003|Overall Study|Death|0|||
163147191|NCT02412306|589251180|FG004|Overall Study|Death|2|||
163147192|NCT05635461|589251181|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
163147193|NCT05635461|589251182|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
163147194|NCT05635461|589251183|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
163147195|NCT05635461|589251184|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
163147196|NCT05635461|589251185|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
163147197|NCT05635461|589251186|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
163147198|NCT05635461|589251181|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
163147199|NCT05635461|589251182|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
163147200|NCT05635461|589251183|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
163147201|NCT05635461|589251184|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
163147202|NCT05635461|589251185|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
163147203|NCT05635461|589251186|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
163147204|NCT05635461|589251181|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
163147205|NCT05635461|589251182|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
163147206|NCT05635461|589251183|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
163147207|NCT05635461|589251184|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
163147208|NCT05635461|589251185|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
163147209|NCT05635461|589251186|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
163147210|NCT00614575|589251187|FG000|Overall Study|Adverse Event|106|||
163147211|NCT00614575|589251187|FG000|Overall Study|Lost to Follow-up|55|||
163147212|NCT00614575|589251187|FG000|Overall Study|Lack of Efficacy|14|||
163147213|NCT00614575|589251187|FG000|Overall Study|Withdrawal by Subject|6|||
163147214|NCT00614575|589251187|FG000|Overall Study|Death|3|||
163147215|NCT00614575|589251187|FG000|Overall Study|Physician Decision|2|||
163147216|NCT00614575|589251187|FG000|Overall Study|No data were collected.|18|||
163147217|NCT00614575|589251187|FG000|Overall Study|Irregularly enrolled patients|23|||
163409988|NCT02443883|590209552|FG000|Overall Study|Physician Decision|1|||
163409989|NCT02443883|590209553|FG001|Overall Study|Physician Decision|1|||
163147218|NCT00614575|589251187|FG000|Overall Study|No treatment|1|||
163147219|NCT00189540|589251188|FG000|Overall Study|Withdrawal by Subject|3|||
163147220|NCT00189540|589251189|FG001|Overall Study|Withdrawal by Subject|0|||
163147221|NCT00189540|589251188|FG000|Overall Study|Death|4|||
163147222|NCT00189540|589251189|FG001|Overall Study|Death|1|||
163147223|NCT00472108|589251190|FG000|Overall Study|Lost to Follow-up|0|||
163147224|NCT00472108|589251191|FG001|Overall Study|Lost to Follow-up|1|||
163147225|NCT03882021|589251192|FG000|Enrollment|Procedure aborted/cancelled|2|||
163147226|NCT03882021|589251192|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
163147227|NCT03882021|589251192|FG000|Enrollment to 3-Month|Death|1|||
163147228|NCT03882021|589251192|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
163147229|NCT03882021|589251192|FG000|Enrollment to 3-Month|Missed Visit|4|||
163147230|NCT03882021|589251192|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
163147231|NCT03882021|589251192|FG000|6-Month to 12-Month Visit|Death|1|||
163147232|NCT03882021|589251192|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
163147233|NCT00286442|589251193|FG000|Overall Study|Hyperglycemic Rescue|19|||
163147234|NCT00286442|589251194|FG001|Overall Study|Hyperglycemic Rescue|17|||
163147235|NCT00286442|589251195|FG002|Overall Study|Hyperglycemic Rescue|25|||
163147236|NCT00286442|589251193|FG000|Overall Study|Adverse Event|7|||
163147237|NCT00286442|589251194|FG001|Overall Study|Adverse Event|6|||
163147238|NCT00286442|589251195|FG002|Overall Study|Adverse Event|1|||
163147239|NCT00286442|589251193|FG000|Overall Study|Protocol Violation|2|||
163147240|NCT00286442|589251194|FG001|Overall Study|Protocol Violation|4|||
163147241|NCT00286442|589251195|FG002|Overall Study|Protocol Violation|2|||
163147242|NCT00286442|589251193|FG000|Overall Study|Lost to Follow-up|5|||
163147243|NCT00286442|589251194|FG001|Overall Study|Lost to Follow-up|2|||
163147244|NCT00286442|589251195|FG002|Overall Study|Lost to Follow-up|1|||
163147245|NCT00286442|589251193|FG000|Overall Study|Physician Decision|1|||
163147246|NCT00286442|589251194|FG001|Overall Study|Physician Decision|1|||
163147247|NCT00286442|589251195|FG002|Overall Study|Physician Decision|1|||
163147248|NCT00286442|589251193|FG000|Overall Study|Administrative Error|1|||
163147249|NCT00286442|589251194|FG001|Overall Study|Administrative Error|1|||
163147250|NCT00286442|589251195|FG002|Overall Study|Administrative Error|0|||
163147251|NCT00286442|589251193|FG000|Overall Study|Withdrawal by Subject|2|||
163147252|NCT00286442|589251194|FG001|Overall Study|Withdrawal by Subject|14|||
163147253|NCT00286442|589251195|FG002|Overall Study|Withdrawal by Subject|2|||
163147254|NCT03582215|589251198|FG000|Overall Study|Adverse Event|1|||
163147255|NCT03582215|589251199|FG001|Overall Study|Adverse Event|0|||
163147256|NCT03582215|589251200|FG002|Overall Study|Adverse Event|0|||
163147257|NCT03582215|589251201|FG003|Overall Study|Adverse Event|0|||
163147258|NCT03582215|589251202|FG004|Overall Study|Adverse Event|0|||
163147259|NCT03582215|589251203|FG005|Overall Study|Adverse Event|0|||
163147260|NCT03582215|589251204|FG006|Overall Study|Adverse Event|2|||
163147261|NCT03582215|589251205|FG007|Overall Study|Adverse Event|2|||
163147262|NCT02174731|589251206|FG000|Overall Study|Participant decision|67|||
163147263|NCT02174731|589251207|FG001|Overall Study|Participant decision|64|||
163147264|NCT02174731|589251206|FG000|Overall Study|Incorrect enrolment before randomization|0|||
163147265|NCT02174731|589251207|FG001|Overall Study|Incorrect enrolment before randomization|1|||
163147266|NCT02174731|589251206|FG000|Overall Study|Missing|2|||
163147267|NCT02174731|589251207|FG001|Overall Study|Missing|0|||
163147268|NCT00079040|589251208|FG000|Overall Study|Withdrew before treatment|1|||
163147269|NCT00079040|589251208|FG000|Overall Study|Ineligible|1|||
163147270|NCT03915717|589251213|FG000|Overall Study|EchoMark Not Implanted|6|||
163147271|NCT04079296|589251216|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
163147272|NCT04079296|589251217|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
163147273|NCT04079296|589251218|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
163147274|NCT04079296|589251219|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
163147275|NCT04079296|589251220|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
163147276|NCT04079296|589251216|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
163147277|NCT04079296|589251217|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
163147278|NCT04079296|589251218|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
163147279|NCT04079296|589251219|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
163147280|NCT04079296|589251220|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
163147281|NCT04079296|589251216|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
163147282|NCT04079296|589251217|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
163147283|NCT04079296|589251218|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
163147284|NCT04079296|589251219|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
163351163|NCT02705625|589996109|FG000|Overall Study|Non-compliance|0|||
163351164|NCT02705625|589996110|FG001|Overall Study|Non-compliance|1|||
163351165|NCT02705625|589996111|FG002|Overall Study|Non-compliance|1|||
163351166|NCT02705625|589996109|FG000|Overall Study|Overdosing|0|||
163351167|NCT02705625|589996110|FG001|Overall Study|Overdosing|0|||
163351168|NCT02705625|589996111|FG002|Overall Study|Overdosing|1|||
163351169|NCT00863798|589996112|FG000|Overall Study|Adverse Event|5|||
163351170|NCT00863798|589996113|FG001|Overall Study|Adverse Event|2|||
163351171|NCT00863798|589996114|FG002|Overall Study|Adverse Event|4|||
163351172|NCT00863798|589996112|FG000|Overall Study|Participant failed to return|2|||
163147285|NCT04079296|589251220|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
163147286|NCT04079296|589251216|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
163147287|NCT04079296|589251217|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
163351173|NCT00863798|589996113|FG001|Overall Study|Participant failed to return|1|||
163351174|NCT00863798|589996114|FG002|Overall Study|Participant failed to return|0|||
163351175|NCT00863798|589996112|FG000|Overall Study|Investigator request|1|||
163351176|NCT00863798|589996113|FG001|Overall Study|Investigator request|2|||
163147288|NCT04079296|589251218|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
163147289|NCT04079296|589251219|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
163147290|NCT04079296|589251220|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
163147291|NCT04079296|589251216|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
163147292|NCT04079296|589251217|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
163147293|NCT04079296|589251218|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
163147294|NCT04079296|589251219|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
163147295|NCT04079296|589251220|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
163147296|NCT04079296|589251216|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
163147297|NCT04079296|589251217|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
163147298|NCT04079296|589251218|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
163147299|NCT04079296|589251219|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
163147300|NCT04079296|589251220|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
163147301|NCT04079296|589251216|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
163147302|NCT04079296|589251217|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
163147303|NCT04079296|589251218|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
163147304|NCT04079296|589251219|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
163147305|NCT04079296|589251220|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
163147306|NCT04079296|589251216|FG000|Dose Expansion Phase (168 Days)|Death|0|||
163147307|NCT04079296|589251217|FG001|Dose Expansion Phase (168 Days)|Death|0|||
163147308|NCT04079296|589251218|FG002|Dose Expansion Phase (168 Days)|Death|0|||
163147309|NCT04079296|589251219|FG003|Dose Expansion Phase (168 Days)|Death|1|||
163147310|NCT04079296|589251220|FG004|Dose Expansion Phase (168 Days)|Death|0|||
163147311|NCT00867165|589251233|FG000|Overall Study|Adverse Event|3|||
163147312|NCT00867165|589251234|FG001|Overall Study|Adverse Event|0|||
163147313|NCT00867165|589251233|FG000|Overall Study|Withdrawal by Subject|1|||
163147314|NCT00867165|589251234|FG001|Overall Study|Withdrawal by Subject|0|||
163147315|NCT03275740|589251235|FG000|Overall Study|Adverse Event|0|||
163147316|NCT03275740|589251236|FG001|Overall Study|Adverse Event|0|||
163147317|NCT03275740|589251237|FG002|Overall Study|Adverse Event|0|||
163147318|NCT03275740|589251238|FG003|Overall Study|Adverse Event|0|||
163147319|NCT03275740|589251239|FG004|Overall Study|Adverse Event|1|||
163147320|NCT03275740|589251240|FG005|Overall Study|Adverse Event|0|||
163147321|NCT03275740|589251241|FG006|Overall Study|Adverse Event|0|||
163147322|NCT03275740|589251242|FG007|Overall Study|Adverse Event|0|||
163147323|NCT03275740|589251243|FG008|Overall Study|Adverse Event|0|||
163147324|NCT03275740|589251244|FG009|Overall Study|Adverse Event|0|||
163147325|NCT03275740|589251245|FG010|Overall Study|Adverse Event|0|||
163147326|NCT03275740|589251246|FG011|Overall Study|Adverse Event|0|||
163147327|NCT03275740|589251235|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147328|NCT03275740|589251236|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147329|NCT03275740|589251237|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147330|NCT03275740|589251238|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147331|NCT03275740|589251239|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147332|NCT03275740|589251240|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
163147333|NCT03275740|589251241|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147334|NCT03275740|589251242|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147335|NCT03275740|589251243|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147336|NCT03275740|589251244|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147337|NCT03275740|589251245|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147338|NCT03275740|589251246|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147339|NCT03275740|589251235|FG000|Overall Study|Withdrawal by Subject|0|||
163147340|NCT03275740|589251236|FG001|Overall Study|Withdrawal by Subject|0|||
163147341|NCT03275740|589251237|FG002|Overall Study|Withdrawal by Subject|0|||
163147342|NCT03275740|589251238|FG003|Overall Study|Withdrawal by Subject|0|||
163147343|NCT03275740|589251239|FG004|Overall Study|Withdrawal by Subject|0|||
163147344|NCT03275740|589251240|FG005|Overall Study|Withdrawal by Subject|0|||
163147345|NCT03275740|589251241|FG006|Overall Study|Withdrawal by Subject|0|||
163147346|NCT03275740|589251242|FG007|Overall Study|Withdrawal by Subject|0|||
163241465|NCT01490632|589592540|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241466|NCT01490632|589592541|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241467|NCT01490632|589592542|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163147347|NCT03275740|589251243|FG008|Overall Study|Withdrawal by Subject|1|||
163147348|NCT03275740|589251244|FG009|Overall Study|Withdrawal by Subject|1|||
163147349|NCT03275740|589251245|FG010|Overall Study|Withdrawal by Subject|0|||
163147350|NCT03275740|589251246|FG011|Overall Study|Withdrawal by Subject|0|||
163147351|NCT00988884|589251248|FG000|Overall Study|Adverse Event|0|||
163147352|NCT00988884|589251249|FG001|Overall Study|Adverse Event|1|||
163147353|NCT00988884|589251248|FG000|Overall Study|Lost to Follow-up|20|||
163147354|NCT00988884|589251249|FG001|Overall Study|Lost to Follow-up|16|||
163241468|NCT01490632|589592543|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163147355|NCT00988884|589251248|FG000|Overall Study|Protocol Violation|0|||
163147356|NCT00988884|589251249|FG001|Overall Study|Protocol Violation|1|||
163147357|NCT00988884|589251248|FG000|Overall Study|Withdrawal by Subject|15|||
163147358|NCT00988884|589251249|FG001|Overall Study|Withdrawal by Subject|18|||
163147359|NCT04621448|589251251|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
163147360|NCT04621448|589251252|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
163147361|NCT04621448|589251253|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
163147362|NCT04621448|589251254|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
163147363|NCT04621448|589251251|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
163147364|NCT04621448|589251252|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
163147365|NCT04621448|589251253|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
163147366|NCT04621448|589251254|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
163147367|NCT04621448|589251251|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
163147368|NCT04621448|589251252|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
163147369|NCT04621448|589251253|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
163147370|NCT04621448|589251254|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
163147371|NCT04621448|589251251|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
163147372|NCT04621448|589251252|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
163147373|NCT04621448|589251253|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
163241469|NCT01490632|589592544|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241470|NCT01490632|589592545|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241471|NCT01490632|589592546|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241472|NCT01490632|589592547|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241473|NCT01490632|589592548|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241474|NCT01490632|589592549|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241475|NCT01490632|589592550|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241476|NCT01490632|589592551|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241477|NCT01490632|589592552|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241478|NCT01490632|589592553|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
163241479|NCT01490632|589592554|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241480|NCT01490632|589592555|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241481|NCT01490632|589592556|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241482|NCT01490632|589592557|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241483|NCT01490632|589592558|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241484|NCT01490632|589592559|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163241485|NCT01490632|589592540|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241486|NCT01490632|589592541|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241487|NCT01490632|589592542|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241488|NCT01490632|589592543|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241489|NCT01490632|589592544|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241490|NCT01490632|589592545|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241491|NCT01490632|589592546|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241492|NCT01490632|589592547|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241493|NCT01490632|589592548|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241494|NCT01490632|589592549|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241495|NCT01490632|589592550|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241496|NCT01490632|589592551|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241497|NCT01490632|589592552|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241498|NCT01490632|589592553|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241499|NCT01490632|589592554|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
163241500|NCT01490632|589592555|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
163241501|NCT01490632|589592556|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241502|NCT01490632|589592557|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241503|NCT01490632|589592558|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241504|NCT01490632|589592559|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163241505|NCT01490632|589592540|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163241506|NCT01490632|589592541|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163241507|NCT01490632|589592542|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163241508|NCT01490632|589592543|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163241509|NCT01490632|589592544|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163409990|NCT02443883|590209554|FG002|Overall Study|Physician Decision|0|||
163409991|NCT02443883|590209555|FG003|Overall Study|Physician Decision|3|||
163409992|NCT02443883|590209552|FG000|Overall Study|Withdrawal by Subject|1|||
163409993|NCT02443883|590209553|FG001|Overall Study|Withdrawal by Subject|0|||
163147374|NCT04621448|589251254|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
163147375|NCT00549640|589251255|FG000|Overall Study|Withdrawal by Subject|6|||
163147376|NCT00549640|589251256|FG001|Overall Study|Withdrawal by Subject|12|||
163147377|NCT00549640|589251255|FG000|Overall Study|Adverse Event|5|||
163241510|NCT01490632|589592545|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163241511|NCT01490632|589592546|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163241512|NCT01490632|589592547|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163241513|NCT01490632|589592548|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163241514|NCT01490632|589592549|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163241515|NCT01490632|589592550|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163351177|NCT00863798|589996114|FG002|Overall Study|Investigator request|1|||
163351178|NCT00863798|589996112|FG000|Overall Study|Lack of Efficacy|4|||
163147378|NCT00549640|589251256|FG001|Overall Study|Adverse Event|0|||
163147379|NCT00549640|589251255|FG000|Overall Study|Lost to Follow-up|7|||
163147380|NCT00549640|589251256|FG001|Overall Study|Lost to Follow-up|4|||
163147381|NCT03550378|589251257|FG000|Overall Study|Death|0|||
163147382|NCT03550378|589251258|FG001|Overall Study|Death|1|||
163147383|NCT04486235|589251259|FG000|Overall Study|Pregnancy|1|||
163147384|NCT04486235|589251260|FG001|Overall Study|Pregnancy|0|||
163147385|NCT04486235|589251259|FG000|Overall Study|Lost to Follow-up|1|||
163147386|NCT04486235|589251260|FG001|Overall Study|Lost to Follow-up|0|||
163147387|NCT00626275|589251261|FG000|Part A - Treatment Period 1|Adverse Event|1|||
163147388|NCT00626275|589251262|FG001|Part A - Treatment Period 1|Adverse Event|0|||
163147389|NCT00626275|589251263|FG002|Part A - Treatment Period 1|Adverse Event|0|||
163147390|NCT00626275|589251264|FG003|Part A - Treatment Period 1|Adverse Event|0|||
163147391|NCT00626275|589251265|FG004|Part A - Treatment Period 1|Adverse Event|0|||
163147392|NCT00626275|589251266|FG005|Part A - Treatment Period 1|Adverse Event|0|||
163147393|NCT00626275|589251267|FG006|Part A - Treatment Period 1|Adverse Event|0|||
163147394|NCT00626275|589251268|FG007|Part A - Treatment Period 1|Adverse Event|0|||
163147395|NCT00626275|589251261|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
163147396|NCT00626275|589251262|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
163147397|NCT00626275|589251263|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
163147398|NCT00626275|589251264|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
163147399|NCT00626275|589251265|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
163147400|NCT00626275|589251266|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
163147401|NCT00626275|589251267|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
163147402|NCT00626275|589251268|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
163147403|NCT00626275|589251261|FG000|Part B|Lost to Follow-up|0|||
163147404|NCT00626275|589251262|FG001|Part B|Lost to Follow-up|0|||
163147405|NCT00626275|589251263|FG002|Part B|Lost to Follow-up|0|||
163147406|NCT00626275|589251264|FG003|Part B|Lost to Follow-up|0|||
163147407|NCT00626275|589251265|FG004|Part B|Lost to Follow-up|0|||
163147408|NCT00626275|589251266|FG005|Part B|Lost to Follow-up|0|||
163147409|NCT00626275|589251267|FG006|Part B|Lost to Follow-up|1|||
163147410|NCT00626275|589251268|FG007|Part B|Lost to Follow-up|0|||
163147411|NCT00626275|589251261|FG000|Part B|Withdrawal by Subject|0|||
163147412|NCT00626275|589251262|FG001|Part B|Withdrawal by Subject|0|||
163147413|NCT00626275|589251263|FG002|Part B|Withdrawal by Subject|0|||
163147414|NCT00626275|589251264|FG003|Part B|Withdrawal by Subject|0|||
163147415|NCT00626275|589251265|FG004|Part B|Withdrawal by Subject|0|||
163147416|NCT00626275|589251266|FG005|Part B|Withdrawal by Subject|0|||
163147417|NCT00626275|589251267|FG006|Part B|Withdrawal by Subject|0|||
163147418|NCT00626275|589251268|FG007|Part B|Withdrawal by Subject|1|||
163147419|NCT04999839|589251269|FG000|Overall Study|Adverse Event|1|||
163147420|NCT04999839|589251270|FG001|Overall Study|Adverse Event|1|||
163147421|NCT04999839|589251271|FG002|Overall Study|Adverse Event|1|||
163147422|NCT04999839|589251272|FG003|Overall Study|Adverse Event|1|||
163147423|NCT04999839|589251273|FG004|Overall Study|Adverse Event|1|||
163147424|NCT04999839|589251269|FG000|Overall Study|Lost to Follow-up|2|||
163147425|NCT04999839|589251270|FG001|Overall Study|Lost to Follow-up|0|||
163147426|NCT04999839|589251271|FG002|Overall Study|Lost to Follow-up|2|||
163147427|NCT04999839|589251272|FG003|Overall Study|Lost to Follow-up|4|||
163147428|NCT04999839|589251273|FG004|Overall Study|Lost to Follow-up|1|||
163147429|NCT04999839|589251269|FG000|Overall Study|Withdrawal by Subject|6|||
163147430|NCT04999839|589251270|FG001|Overall Study|Withdrawal by Subject|5|||
163147431|NCT04999839|589251271|FG002|Overall Study|Withdrawal by Subject|3|||
163147432|NCT04999839|589251272|FG003|Overall Study|Withdrawal by Subject|2|||
163147433|NCT04999839|589251273|FG004|Overall Study|Withdrawal by Subject|2|||
163147434|NCT04999839|589251269|FG000|Overall Study|Lack of Efficacy|0|||
163147435|NCT04999839|589251270|FG001|Overall Study|Lack of Efficacy|1|||
163147436|NCT04999839|589251271|FG002|Overall Study|Lack of Efficacy|0|||
163147437|NCT04999839|589251272|FG003|Overall Study|Lack of Efficacy|0|||
163147438|NCT04999839|589251273|FG004|Overall Study|Lack of Efficacy|0|||
163147439|NCT04999839|589251269|FG000|Overall Study|Physician Decision|0|||
163147440|NCT04999839|589251270|FG001|Overall Study|Physician Decision|0|||
163147441|NCT04999839|589251271|FG002|Overall Study|Physician Decision|0|||
163147442|NCT04999839|589251272|FG003|Overall Study|Physician Decision|0|||
163147443|NCT04999839|589251273|FG004|Overall Study|Physician Decision|1|||
163241516|NCT01490632|589592551|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163241517|NCT01490632|589592552|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
163241518|NCT01490632|589592553|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
163241519|NCT01490632|589592554|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
163241520|NCT01490632|589592555|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
163241521|NCT01490632|589592556|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163241522|NCT01490632|589592557|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163241523|NCT01490632|589592558|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163241524|NCT01490632|589592559|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
163241525|NCT01490632|589592540|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
163241526|NCT01490632|589592541|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
163241527|NCT01490632|589592542|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
163241528|NCT01490632|589592543|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
163241529|NCT01490632|589592544|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
163241530|NCT01490632|589592545|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
163241531|NCT01490632|589592546|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
163241532|NCT01490632|589592547|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
163241533|NCT01490632|589592548|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
163241534|NCT01490632|589592549|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
163241535|NCT01490632|589592550|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
163241536|NCT01490632|589592551|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
163241537|NCT01490632|589592552|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
163241538|NCT01490632|589592553|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
163241539|NCT01490632|589592554|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
163241540|NCT01490632|589592555|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
163241541|NCT01490632|589592556|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
163241542|NCT01490632|589592557|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
163241543|NCT01490632|589592558|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
163241544|NCT01490632|589592559|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
163241545|NCT01490632|589592540|FG000|Part D: Re-Treatment Period|Death|0|||
163241546|NCT01490632|589592541|FG001|Part D: Re-Treatment Period|Death|0|||
163241547|NCT01490632|589592542|FG002|Part D: Re-Treatment Period|Death|0|||
163241548|NCT01490632|589592543|FG003|Part D: Re-Treatment Period|Death|0|||
163241549|NCT01490632|589592544|FG004|Part D: Re-Treatment Period|Death|0|||
163241550|NCT01490632|589592545|FG005|Part D: Re-Treatment Period|Death|0|||
163241551|NCT01490632|589592546|FG006|Part D: Re-Treatment Period|Death|0|||
163241552|NCT01490632|589592547|FG007|Part D: Re-Treatment Period|Death|0|||
163241553|NCT01490632|589592548|FG008|Part D: Re-Treatment Period|Death|0|||
163241554|NCT01490632|589592549|FG009|Part D: Re-Treatment Period|Death|0|||
163241555|NCT01490632|589592550|FG010|Part D: Re-Treatment Period|Death|0|||
163241556|NCT01490632|589592551|FG011|Part D: Re-Treatment Period|Death|0|||
163241557|NCT01490632|589592552|FG012|Part D: Re-Treatment Period|Death|0|||
163241558|NCT01490632|589592553|FG013|Part D: Re-Treatment Period|Death|0|||
163241559|NCT01490632|589592554|FG014|Part D: Re-Treatment Period|Death|0|||
163241560|NCT01490632|589592555|FG015|Part D: Re-Treatment Period|Death|0|||
163241561|NCT01490632|589592556|FG016|Part D: Re-Treatment Period|Death|0|||
163241562|NCT01490632|589592557|FG017|Part D: Re-Treatment Period|Death|0|||
163241563|NCT01490632|589592558|FG018|Part D: Re-Treatment Period|Death|1|||
163241564|NCT01490632|589592559|FG019|Part D: Re-Treatment Period|Death|0|||
163241565|NCT01490632|589592540|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241566|NCT01490632|589592541|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241567|NCT01490632|589592542|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241568|NCT01490632|589592543|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241569|NCT01490632|589592544|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241570|NCT01490632|589592545|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241571|NCT01490632|589592546|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241572|NCT01490632|589592547|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241573|NCT01490632|589592548|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241574|NCT01490632|589592549|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241575|NCT01490632|589592550|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241576|NCT01490632|589592551|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241577|NCT01490632|589592552|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163351179|NCT00863798|589996113|FG001|Overall Study|Lack of Efficacy|3|||
163351180|NCT00863798|589996114|FG002|Overall Study|Lack of Efficacy|6|||
163241578|NCT01490632|589592553|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241579|NCT01490632|589592554|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241580|NCT01490632|589592555|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241581|NCT01490632|589592556|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
163241582|NCT01490632|589592557|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
163351181|NCT00863798|589996112|FG000|Overall Study|Lost to Follow-up|6|||
163241583|NCT01490632|589592558|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
163351182|NCT00863798|589996113|FG001|Overall Study|Lost to Follow-up|9|||
163351183|NCT00863798|589996114|FG002|Overall Study|Lost to Follow-up|5|||
163147444|NCT04999839|589251269|FG000|Overall Study|Sponsor request|0|||
163147445|NCT04999839|589251270|FG001|Overall Study|Sponsor request|1|||
163147446|NCT04999839|589251271|FG002|Overall Study|Sponsor request|0|||
163147447|NCT04999839|589251272|FG003|Overall Study|Sponsor request|0|||
163147448|NCT04999839|589251273|FG004|Overall Study|Sponsor request|0|||
163147449|NCT04999839|589251269|FG000|Overall Study|Other|0|||
163147450|NCT04999839|589251270|FG001|Overall Study|Other|0|||
163147451|NCT04999839|589251271|FG002|Overall Study|Other|1|||
163147452|NCT04999839|589251272|FG003|Overall Study|Other|0|||
163147453|NCT04999839|589251273|FG004|Overall Study|Other|0|||
163147454|NCT01362348|589251274|FG000|Overall Study|Protocol-defined stopping criteria|9|||
163147455|NCT01362348|589251274|FG000|Overall Study|Study closed/terminated|5|||
163147456|NCT00399516|589251275|FG000|Overall Study|Lost to Follow-up|2|||
163147457|NCT01046565|589251276|FG000|Overall Study|Adverse Event|2|||
163147458|NCT01046565|589251276|FG000|Overall Study|Withdrawal by Subject|7|||
163147459|NCT03546621|589251277|FG000|Overall Study|Withdrawal by Subject|0|||
163147460|NCT03546621|589251278|FG001|Overall Study|Withdrawal by Subject|1|||
163147461|NCT03546621|589251279|FG002|Overall Study|Withdrawal by Subject|2|||
163147462|NCT03546621|589251280|FG003|Overall Study|Withdrawal by Subject|1|||
163147463|NCT03546621|589251277|FG000|Overall Study|Lost to Follow-up|0|||
163147464|NCT03546621|589251278|FG001|Overall Study|Lost to Follow-up|1|||
163147465|NCT03546621|589251279|FG002|Overall Study|Lost to Follow-up|0|||
163147466|NCT03546621|589251280|FG003|Overall Study|Lost to Follow-up|0|||
163147467|NCT03546621|589251277|FG000|Overall Study|Adverse Event|0|||
163147468|NCT03546621|589251278|FG001|Overall Study|Adverse Event|1|||
163147469|NCT03546621|589251279|FG002|Overall Study|Adverse Event|0|||
163147470|NCT03546621|589251280|FG003|Overall Study|Adverse Event|1|||
163147471|NCT03546621|589251277|FG000|Overall Study|Progressive disease|0|||
163147472|NCT03546621|589251278|FG001|Overall Study|Progressive disease|0|||
163147473|NCT03546621|589251279|FG002|Overall Study|Progressive disease|0|||
163147474|NCT03546621|589251280|FG003|Overall Study|Progressive disease|1|||
163147475|NCT00660192|589251281|FG000|Overall Study|Lost to Follow-up|2|||
163147476|NCT00660192|589251282|FG001|Overall Study|Lost to Follow-up|3|||
163147477|NCT00377520|589251283|FG000|Overall Study|Ineligible (Prior radiation)|1|||
163147478|NCT00982735|589251284|FG000|Overall Study|Lost to Follow-up|6|||
163147479|NCT00982735|589251284|FG000|Overall Study|Patient ineligible for trial|224|||
163147480|NCT03740048|589251285|FG000|Overall Study|Withdrawal by Subject|1|||
163147481|NCT03740048|589251286|FG001|Overall Study|Withdrawal by Subject|1|||
163147482|NCT03740048|589251285|FG000|Overall Study|Death|1|||
163147483|NCT03740048|589251286|FG001|Overall Study|Death|6|||
163147484|NCT03740048|589251285|FG000|Overall Study|Switched to thrice-weekly HD|2|||
163147485|NCT03740048|589251286|FG001|Overall Study|Switched to thrice-weekly HD|0|||
163147486|NCT03740048|589251285|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
163147487|NCT03740048|589251286|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
163147488|NCT03740048|589251285|FG000|Overall Study|Lost to Follow-up|0|||
163147489|NCT03740048|589251286|FG001|Overall Study|Lost to Follow-up|1|||
163147490|NCT03740048|589251285|FG000|Overall Study|Non-compliance with HD|0|||
163147491|NCT03740048|589251286|FG001|Overall Study|Non-compliance with HD|1|||
163147492|NCT03261336|589251287|FG000|Overall Study|Adverse Event|1|||
163147493|NCT01069484|589251288|FG000|Overall Study|Death-in-near-family|1|||
163147494|NCT01069484|589251289|FG001|Overall Study|Death-in-near-family|0|||
163147495|NCT01069484|589251288|FG000|Overall Study|No specific reason|8|||
163147496|NCT01069484|589251289|FG001|Overall Study|No specific reason|2|||
163147497|NCT01069484|589251288|FG000|Overall Study|Illness mother or child|3|||
163147498|NCT01069484|589251289|FG001|Overall Study|Illness mother or child|1|||
163147499|NCT00292942|589251290|FG000|Overall Study|Withdrawal by Subject|0|||
163147500|NCT00292942|589251291|FG001|Overall Study|Withdrawal by Subject|0|||
163147501|NCT00292942|589251292|FG002|Overall Study|Withdrawal by Subject|1|||
163147502|NCT00292942|589251293|FG003|Overall Study|Withdrawal by Subject|0|||
163147503|NCT00292942|589251290|FG000|Overall Study|Adverse Event|0|||
163147504|NCT00292942|589251291|FG001|Overall Study|Adverse Event|0|||
163147505|NCT00292942|589251292|FG002|Overall Study|Adverse Event|0|||
163147506|NCT00292942|589251293|FG003|Overall Study|Adverse Event|1|||
163147507|NCT00644358|589251294|FG000|Overall Study|Adverse Event|124|||
163147508|NCT00644358|589251294|FG000|Overall Study|Lost to Follow-up|105|||
163147509|NCT00644358|589251294|FG000|Overall Study|Consent Withdrawal|64|||
163147510|NCT00644358|589251294|FG000|Overall Study|Lack of Effectiveness|39|||
163147511|NCT00644358|589251294|FG000|Overall Study|Protocol Violation|5|||
163147512|NCT00644358|589251294|FG000|Overall Study|Noncompliance|14|||
163147513|NCT00644358|589251294|FG000|Overall Study|Other Unspecified|11|||
163147514|NCT00651924|589251299|FG000|Overall Study|Withdrawal by PI|0|||
163147515|NCT00651924|589251300|FG001|Overall Study|Withdrawal by PI|2|||
163147516|NCT00651924|589251299|FG000|Overall Study|Withdrawal by Subject|0|||
163147517|NCT00651924|589251300|FG001|Overall Study|Withdrawal by Subject|5|||
163147518|NCT00758771|589251301|FG000|Overall Study|Withdrawal by Subject|1|||
163147519|NCT00758771|589251302|FG001|Overall Study|Withdrawal by Subject|1|||
163147520|NCT00758771|589251301|FG000|Overall Study|Did not meet eligibility criteria|2|||
163351184|NCT00863798|589996112|FG000|Overall Study|Other|2|||
163241584|NCT01490632|589592559|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
163241585|NCT01490632|589592540|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241586|NCT01490632|589592541|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241587|NCT01490632|589592542|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241588|NCT01490632|589592543|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241589|NCT01490632|589592544|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241590|NCT01490632|589592545|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241591|NCT01490632|589592546|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241592|NCT01490632|589592547|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241593|NCT01490632|589592548|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241594|NCT01490632|589592549|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241595|NCT01490632|589592550|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241596|NCT01490632|589592551|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241597|NCT01490632|589592552|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241598|NCT01490632|589592553|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241599|NCT01490632|589592554|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241600|NCT01490632|589592555|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241601|NCT01490632|589592556|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241602|NCT01490632|589592557|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241603|NCT01490632|589592558|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
163241604|NCT01490632|589592559|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
163241605|NCT01490632|589592540|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
163241606|NCT01490632|589592541|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
163241607|NCT01490632|589592542|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
163241608|NCT01490632|589592543|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
163241609|NCT01490632|589592544|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
163241610|NCT01490632|589592545|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
163241611|NCT01490632|589592546|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
163241612|NCT01490632|589592547|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
163241613|NCT01490632|589592548|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
163241614|NCT01490632|589592549|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
163241615|NCT01490632|589592550|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
163241616|NCT01490632|589592551|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
163241617|NCT01490632|589592552|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
163241618|NCT01490632|589592553|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
163241619|NCT01490632|589592554|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
163241620|NCT01490632|589592555|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
163241621|NCT01490632|589592556|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
163241622|NCT01490632|589592557|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
163241623|NCT01490632|589592558|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
163241624|NCT01490632|589592559|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
163241625|NCT01490632|589592540|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
163241626|NCT01490632|589592541|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
163241627|NCT01490632|589592542|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
163241628|NCT01490632|589592543|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
163241629|NCT01490632|589592544|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
163241630|NCT01490632|589592545|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
163241631|NCT01490632|589592546|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
163241632|NCT01490632|589592547|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
163241633|NCT01490632|589592548|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
163241634|NCT01490632|589592549|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
163241635|NCT01490632|589592550|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
163241636|NCT01490632|589592551|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
163241637|NCT01490632|589592552|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
163241638|NCT01490632|589592553|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
163241639|NCT01490632|589592554|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
163241640|NCT01490632|589592555|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
163241641|NCT01490632|589592556|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
163241642|NCT01490632|589592557|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
163241643|NCT01490632|589592558|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
163241644|NCT01490632|589592559|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
163241645|NCT01490632|589592540|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241646|NCT01490632|589592541|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241647|NCT01490632|589592542|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241648|NCT01490632|589592543|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241649|NCT01490632|589592544|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241650|NCT01490632|589592545|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241651|NCT01490632|589592546|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241652|NCT01490632|589592547|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241653|NCT01490632|589592548|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163351185|NCT00863798|589996113|FG001|Overall Study|Other|3|||
163351186|NCT00863798|589996114|FG002|Overall Study|Other|1|||
163147521|NCT00758771|589251302|FG001|Overall Study|Did not meet eligibility criteria|4|||
163147522|NCT00960063|589251303|FG000|Overall Study|Adverse Event|1|||
163147523|NCT00960063|589251304|FG001|Overall Study|Adverse Event|0|||
163147524|NCT00960063|589251305|FG002|Overall Study|Adverse Event|0|||
163147525|NCT00960063|589251303|FG000|Overall Study|Progression of Disease|0|||
163147526|NCT00960063|589251304|FG001|Overall Study|Progression of Disease|0|||
163147527|NCT00960063|589251305|FG002|Overall Study|Progression of Disease|3|||
163147528|NCT02051764|589251310|FG000|Overall Study|Study terminated by sponsor|0|||
163147529|NCT02051764|589251311|FG001|Overall Study|Study terminated by sponsor|7|||
163147530|NCT00591006|589251312|FG000|Overall Study|Withdrawal by Subject|0|||
163147531|NCT00591006|589251313|FG001|Overall Study|Withdrawal by Subject|0|||
163147532|NCT00591006|589251314|FG002|Overall Study|Withdrawal by Subject|0|||
163147533|NCT00591006|589251315|FG003|Overall Study|Withdrawal by Subject|0|||
163147534|NCT00591006|589251316|FG004|Overall Study|Withdrawal by Subject|0|||
163147535|NCT00591006|589251317|FG005|Overall Study|Withdrawal by Subject|0|||
163147536|NCT00591006|589251318|FG006|Overall Study|Withdrawal by Subject|0|||
163147537|NCT00591006|589251319|FG007|Overall Study|Withdrawal by Subject|0|||
163147538|NCT00591006|589251320|FG008|Overall Study|Withdrawal by Subject|0|||
163147539|NCT00591006|589251321|FG009|Overall Study|Withdrawal by Subject|0|||
163147540|NCT00591006|589251322|FG010|Overall Study|Withdrawal by Subject|0|||
163147541|NCT00591006|589251323|FG011|Overall Study|Withdrawal by Subject|0|||
163147542|NCT00591006|589251324|FG012|Overall Study|Withdrawal by Subject|0|||
163147543|NCT00591006|589251325|FG013|Overall Study|Withdrawal by Subject|0|||
163147544|NCT00591006|589251326|FG014|Overall Study|Withdrawal by Subject|0|||
163147545|NCT00591006|589251327|FG015|Overall Study|Withdrawal by Subject|1|||
163147546|NCT00591006|589251328|FG016|Overall Study|Withdrawal by Subject|0|||
163147547|NCT00591006|589251329|FG017|Overall Study|Withdrawal by Subject|0|||
163147548|NCT00591006|589251330|FG018|Overall Study|Withdrawal by Subject|0|||
163147549|NCT00591006|589251331|FG019|Overall Study|Withdrawal by Subject|0|||
163147550|NCT00591006|589251332|FG020|Overall Study|Withdrawal by Subject|0|||
163147551|NCT00591006|589251333|FG021|Overall Study|Withdrawal by Subject|0|||
163147552|NCT00591006|589251334|FG022|Overall Study|Withdrawal by Subject|0|||
163147553|NCT00591006|589251335|FG023|Overall Study|Withdrawal by Subject|1|||
163147554|NCT00591006|589251312|FG000|Overall Study|Adverse Event|0|||
163147555|NCT00591006|589251313|FG001|Overall Study|Adverse Event|0|||
163147556|NCT00591006|589251314|FG002|Overall Study|Adverse Event|0|||
163147557|NCT00591006|589251315|FG003|Overall Study|Adverse Event|0|||
163147558|NCT00591006|589251316|FG004|Overall Study|Adverse Event|0|||
163147559|NCT00591006|589251317|FG005|Overall Study|Adverse Event|0|||
163147560|NCT00591006|589251318|FG006|Overall Study|Adverse Event|0|||
163147561|NCT00591006|589251319|FG007|Overall Study|Adverse Event|0|||
163147562|NCT00591006|589251320|FG008|Overall Study|Adverse Event|0|||
163147563|NCT00591006|589251321|FG009|Overall Study|Adverse Event|0|||
163147564|NCT00591006|589251322|FG010|Overall Study|Adverse Event|0|||
163147565|NCT00591006|589251323|FG011|Overall Study|Adverse Event|0|||
163147566|NCT00591006|589251324|FG012|Overall Study|Adverse Event|0|||
163147567|NCT00591006|589251325|FG013|Overall Study|Adverse Event|0|||
163147568|NCT00591006|589251326|FG014|Overall Study|Adverse Event|0|||
163147569|NCT00591006|589251327|FG015|Overall Study|Adverse Event|0|||
163147570|NCT00591006|589251328|FG016|Overall Study|Adverse Event|0|||
163147571|NCT00591006|589251329|FG017|Overall Study|Adverse Event|0|||
163147572|NCT00591006|589251330|FG018|Overall Study|Adverse Event|0|||
163147573|NCT00591006|589251331|FG019|Overall Study|Adverse Event|0|||
163147574|NCT00591006|589251332|FG020|Overall Study|Adverse Event|0|||
163147575|NCT00591006|589251333|FG021|Overall Study|Adverse Event|0|||
163147576|NCT00591006|589251334|FG022|Overall Study|Adverse Event|1|||
163147577|NCT00591006|589251335|FG023|Overall Study|Adverse Event|0|||
163147578|NCT02898454|589251336|FG000|Overall Study|Adverse Event|4|||
163147579|NCT02898454|589251337|FG001|Overall Study|Adverse Event|1|||
163147580|NCT02898454|589251338|FG002|Overall Study|Adverse Event|2|||
163147581|NCT02898454|589251336|FG000|Overall Study|Protocol Violation|1|||
163147582|NCT02898454|589251337|FG001|Overall Study|Protocol Violation|0|||
163147583|NCT02898454|589251338|FG002|Overall Study|Protocol Violation|1|||
163147584|NCT02898454|589251336|FG000|Overall Study|Lack of Efficacy|4|||
163147585|NCT02898454|589251337|FG001|Overall Study|Lack of Efficacy|1|||
163147586|NCT02898454|589251338|FG002|Overall Study|Lack of Efficacy|0|||
163147587|NCT02898454|589251336|FG000|Overall Study|Withdrawal by Subject|6|||
163147588|NCT02898454|589251337|FG001|Overall Study|Withdrawal by Subject|3|||
163147589|NCT02898454|589251338|FG002|Overall Study|Withdrawal by Subject|3|||
163147590|NCT02898454|589251336|FG000|Overall Study|Lost to Follow-up|1|||
163351187|NCT00863798|589996112|FG000|Overall Study|Protocol Violation|0|||
163147591|NCT02898454|589251337|FG001|Overall Study|Lost to Follow-up|0|||
163147592|NCT02898454|589251338|FG002|Overall Study|Lost to Follow-up|0|||
163147593|NCT02898454|589251336|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
163147594|NCT02898454|589251337|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
163351188|NCT00863798|589996113|FG001|Overall Study|Protocol Violation|1|||
163241654|NCT01490632|589592549|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241655|NCT01490632|589592550|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241656|NCT01490632|589592551|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241657|NCT01490632|589592552|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241658|NCT01490632|589592553|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241659|NCT01490632|589592554|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241660|NCT01490632|589592555|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241661|NCT01490632|589592556|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
163241662|NCT01490632|589592557|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
163241663|NCT01490632|589592558|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
163241664|NCT01490632|589592559|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
163241665|NCT03725982|589592560|FG000|First Intervention|Withdrawal by Subject|0|||
163241666|NCT03725982|589592561|FG001|First Intervention|Withdrawal by Subject|1|||
163241667|NCT03725982|589592560|FG000|First Intervention|Physician Decision|1|||
163241668|NCT03725982|589592561|FG001|First Intervention|Physician Decision|1|||
163241669|NCT01003899|589592562|FG000|Overall Study|Other Adverse Event|8|||
163241670|NCT01003899|589592562|FG000|Overall Study|Not entered|4|||
163241671|NCT01003899|589592562|FG000|Overall Study|Not treated|1|||
163241672|NCT01003899|589592562|FG000|Overall Study|Progressive disease|34|||
163241673|NCT02099838|589592565|FG000|Overall Study|Death|1|||
163241674|NCT02099838|589592566|FG001|Overall Study|Death|0|||
163241675|NCT02099838|589592565|FG000|Overall Study|Lost to Follow-up|3|||
163241676|NCT02099838|589592566|FG001|Overall Study|Lost to Follow-up|1|||
163241677|NCT02099838|589592565|FG000|Overall Study|Withdrawal by Subject|0|||
163241678|NCT02099838|589592566|FG001|Overall Study|Withdrawal by Subject|1|||
163241679|NCT04121962|589592569|FG000|Overall Study|Lost to Follow-up|42|||
163241680|NCT04121962|589592570|FG001|Overall Study|Lost to Follow-up|39|||
163241681|NCT01175382|589592571|FG000|Overall Study|Lost to Follow-up|4|||
163241682|NCT01175382|589592572|FG001|Overall Study|Lost to Follow-up|3|||
163241683|NCT01175382|589592573|FG002|Overall Study|Lost to Follow-up|1|||
163241684|NCT01175382|589592571|FG000|Overall Study|Physician Decision|0|||
163241685|NCT01175382|589592572|FG001|Overall Study|Physician Decision|1|||
163241686|NCT01175382|589592573|FG002|Overall Study|Physician Decision|0|||
163147595|NCT02898454|589251338|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
163147596|NCT03040141|589251339|FG000|Overall Study|Death|1|||
163147597|NCT03040141|589251340|FG001|Overall Study|Death|2|||
163147598|NCT03040141|589251341|FG002|Overall Study|Death|3|||
163147599|NCT03040141|589251339|FG000|Overall Study|Withdrawal by Subject|3|||
163147600|NCT03040141|589251340|FG001|Overall Study|Withdrawal by Subject|1|||
163147601|NCT03040141|589251341|FG002|Overall Study|Withdrawal by Subject|1|||
163147602|NCT03040141|589251339|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
163147603|NCT03040141|589251340|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
163147604|NCT03040141|589251341|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
163147605|NCT03040141|589251339|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
163147606|NCT03040141|589251340|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
163147607|NCT03040141|589251341|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
163147608|NCT01384734|589251343|FG000|Overall Study|Adverse Event|0|||
163147609|NCT01384734|589251344|FG001|Overall Study|Adverse Event|3|||
163147610|NCT01384734|589251345|FG002|Overall Study|Adverse Event|0|||
163147611|NCT01384734|589251346|FG003|Overall Study|Adverse Event|2|||
163147612|NCT01384734|589251347|FG004|Overall Study|Adverse Event|7|||
163147613|NCT01384734|589251343|FG000|Overall Study|Death|1|||
163147614|NCT01384734|589251344|FG001|Overall Study|Death|0|||
163147615|NCT01384734|589251345|FG002|Overall Study|Death|1|||
163147616|NCT01384734|589251346|FG003|Overall Study|Death|0|||
163147617|NCT01384734|589251347|FG004|Overall Study|Death|0|||
163147618|NCT01384734|589251343|FG000|Overall Study|Continuation criteria not met|0|||
163147619|NCT01384734|589251344|FG001|Overall Study|Continuation criteria not met|0|||
163147620|NCT01384734|589251345|FG002|Overall Study|Continuation criteria not met|1|||
163147621|NCT01384734|589251346|FG003|Overall Study|Continuation criteria not met|1|||
163147622|NCT01384734|589251347|FG004|Overall Study|Continuation criteria not met|0|||
163147623|NCT01384734|589251343|FG000|Overall Study|Lack of Efficacy|3|||
163147624|NCT01384734|589251344|FG001|Overall Study|Lack of Efficacy|7|||
163147625|NCT01384734|589251345|FG002|Overall Study|Lack of Efficacy|4|||
163147626|NCT01384734|589251346|FG003|Overall Study|Lack of Efficacy|4|||
163147627|NCT01384734|589251347|FG004|Overall Study|Lack of Efficacy|2|||
163147628|NCT01384734|589251343|FG000|Overall Study|Lost to Follow-up|5|||
163147629|NCT01384734|589251344|FG001|Overall Study|Lost to Follow-up|3|||
163147630|NCT01384734|589251345|FG002|Overall Study|Lost to Follow-up|3|||
163147631|NCT01384734|589251346|FG003|Overall Study|Lost to Follow-up|8|||
163147632|NCT01384734|589251347|FG004|Overall Study|Lost to Follow-up|5|||
163147633|NCT01384734|589251343|FG000|Overall Study|Non-compliance with study drug|1|||
163147634|NCT01384734|589251344|FG001|Overall Study|Non-compliance with study drug|2|||
163147635|NCT01384734|589251345|FG002|Overall Study|Non-compliance with study drug|6|||
163147636|NCT01384734|589251346|FG003|Overall Study|Non-compliance with study drug|0|||
163241687|NCT01175382|589592571|FG000|Overall Study|Withdrawal by Subject|0|||
163241688|NCT01175382|589592572|FG001|Overall Study|Withdrawal by Subject|0|||
163241689|NCT01175382|589592573|FG002|Overall Study|Withdrawal by Subject|1|||
163241690|NCT01175382|589592571|FG000|Overall Study|No longer having problem|1|||
163241691|NCT01175382|589592572|FG001|Overall Study|No longer having problem|0|||
163241692|NCT01175382|589592573|FG002|Overall Study|No longer having problem|1|||
163241693|NCT01175382|589592571|FG000|Overall Study|Unable/unwilling to attend visits|3|||
163241694|NCT01175382|589592572|FG001|Overall Study|Unable/unwilling to attend visits|1|||
163241695|NCT01175382|589592573|FG002|Overall Study|Unable/unwilling to attend visits|2|||
163241696|NCT01175382|589592571|FG000|Overall Study|Unwilling to follow protocol|0|||
163241697|NCT01175382|589592572|FG001|Overall Study|Unwilling to follow protocol|1|||
163241698|NCT01175382|589592573|FG002|Overall Study|Unwilling to follow protocol|0|||
163241699|NCT01175382|589592571|FG000|Overall Study|Unable to tolerate study meds|0|||
163241700|NCT01175382|589592572|FG001|Overall Study|Unable to tolerate study meds|1|||
163241701|NCT01175382|589592573|FG002|Overall Study|Unable to tolerate study meds|1|||
163241702|NCT00774787|589592574|FG000|Overall Study|Lost to Follow-up|1|||
163241703|NCT02019719|589592575|FG000|Overall Study|Adverse Event|1|||
163241704|NCT02019719|589592576|FG001|Overall Study|Adverse Event|0|||
163241705|NCT02019719|589592577|FG002|Overall Study|Adverse Event|0|||
163241706|NCT02019719|589592578|FG003|Overall Study|Adverse Event|1|||
163241707|NCT02019719|589592579|FG004|Overall Study|Adverse Event|1|||
163241708|NCT02019719|589592575|FG000|Overall Study|Protocol Violation|1|||
163241709|NCT02019719|589592576|FG001|Overall Study|Protocol Violation|1|||
163241710|NCT02019719|589592577|FG002|Overall Study|Protocol Violation|0|||
163241711|NCT02019719|589592578|FG003|Overall Study|Protocol Violation|0|||
163241712|NCT02019719|589592579|FG004|Overall Study|Protocol Violation|0|||
163241713|NCT02019719|589592575|FG000|Overall Study|Protocol defined stopping criteria|2|||
163241714|NCT02019719|589592576|FG001|Overall Study|Protocol defined stopping criteria|0|||
163241715|NCT02019719|589592577|FG002|Overall Study|Protocol defined stopping criteria|0|||
163241716|NCT02019719|589592578|FG003|Overall Study|Protocol defined stopping criteria|1|||
163241717|NCT02019719|589592579|FG004|Overall Study|Protocol defined stopping criteria|1|||
163241718|NCT02019719|589592575|FG000|Overall Study|Physician Decision|2|||
163241719|NCT02019719|589592576|FG001|Overall Study|Physician Decision|0|||
163241720|NCT02019719|589592577|FG002|Overall Study|Physician Decision|0|||
163241721|NCT02019719|589592578|FG003|Overall Study|Physician Decision|0|||
163241722|NCT02019719|589592579|FG004|Overall Study|Physician Decision|0|||
163241723|NCT04535037|589592580|FG000|Overall Study|Protocol Violation|1|||
163241724|NCT04535037|589592581|FG001|Overall Study|Protocol Violation|0|||
163241725|NCT04535037|589592580|FG000|Overall Study|Withdrawal by Subject|8|||
163241726|NCT04535037|589592581|FG001|Overall Study|Withdrawal by Subject|9|||
163241727|NCT04535037|589592580|FG000|Overall Study|Migrated / moved from the study area|1|||
163241728|NCT04535037|589592581|FG001|Overall Study|Migrated / moved from the study area|4|||
163241729|NCT04535037|589592580|FG000|Overall Study|Other|2|||
163241730|NCT04535037|589592581|FG001|Overall Study|Other|5|||
163241731|NCT02031276|589592582|FG000|Period 1 Double-blind IV|Adverse Event|6|||
163241732|NCT02031276|589592583|FG001|Period 1 Double-blind IV|Adverse Event|5|||
163241733|NCT02031276|589592584|FG002|Period 1 Double-blind IV|Adverse Event|1|||
163241734|NCT02031276|589592582|FG000|Period 1 Double-blind IV|Other|0|||
163241735|NCT02031276|589592583|FG001|Period 1 Double-blind IV|Other|1|||
163241736|NCT02031276|589592584|FG002|Period 1 Double-blind IV|Other|0|||
163241737|NCT02031276|589592582|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
163241738|NCT02031276|589592583|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
163241739|NCT02031276|589592584|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
163241740|NCT02031276|589592582|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
163241741|NCT02031276|589592583|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
163409994|NCT02443883|590209554|FG002|Overall Study|Withdrawal by Subject|0|||
163409995|NCT02443883|590209555|FG003|Overall Study|Withdrawal by Subject|2|||
163241742|NCT02031276|589592584|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
163241743|NCT02031276|589592582|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
163241744|NCT02031276|589592583|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
163241745|NCT02031276|589592584|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
163241746|NCT02031276|589592582|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
163241747|NCT02031276|589592583|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
163241748|NCT02031276|589592584|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
163241749|NCT02031276|589592582|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
163241750|NCT02031276|589592583|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
163241751|NCT02031276|589592584|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
163241752|NCT02031276|589592582|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
163241753|NCT02031276|589592583|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
163241754|NCT02031276|589592584|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
163241755|NCT02031276|589592582|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
163409996|NCT02443883|590209552|FG000|Overall Study|Randomized, but never treated|1|||
163241756|NCT02031276|589592583|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
163241757|NCT02031276|589592584|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
163241758|NCT00765245|589592585|FG000|Overall Study|disease progression|3|||
163241759|NCT00765245|589592586|FG001|Overall Study|disease progression|2|||
163241760|NCT00765245|589592585|FG000|Overall Study|Withdrawal by Subject|3|||
163241761|NCT00765245|589592586|FG001|Overall Study|Withdrawal by Subject|0|||
163241762|NCT00765245|589592585|FG000|Overall Study|Adverse Event|5|||
163241763|NCT00765245|589592586|FG001|Overall Study|Adverse Event|0|||
163241764|NCT00765245|589592585|FG000|Overall Study|Physician Decision|1|||
163241765|NCT00765245|589592586|FG001|Overall Study|Physician Decision|0|||
163241766|NCT00765245|589592585|FG000|Overall Study|Death|1|||
163241767|NCT00765245|589592586|FG001|Overall Study|Death|0|||
163241768|NCT02417246|589592587|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
163241769|NCT02417246|589592588|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
163241770|NCT02417246|589592587|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
163241771|NCT02417246|589592588|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
163241772|NCT02417246|589592587|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
163241773|NCT02417246|589592588|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
163241774|NCT02417246|589592587|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
163241775|NCT02417246|589592588|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
163241776|NCT01921348|589592593|FG000|Overall Study|Withdrawal by Subject|1|||
163241777|NCT01921348|589592594|FG001|Overall Study|Withdrawal by Subject|0|||
163241778|NCT01921348|589592593|FG000|Overall Study|Lost to Follow-up|0|||
163241779|NCT01921348|589592594|FG001|Overall Study|Lost to Follow-up|2|||
163241780|NCT02896855|589592597|FG000|Overall Study|Death|50|||
163241781|NCT02896855|589592598|FG001|Overall Study|Death|40|||
163241782|NCT02896855|589592597|FG000|Overall Study|Lost to Follow-up|15|||
163241783|NCT02896855|589592598|FG001|Overall Study|Lost to Follow-up|9|||
163241784|NCT02896855|589592597|FG000|Overall Study|Withdrawal by Subject|7|||
163241785|NCT02896855|589592598|FG001|Overall Study|Withdrawal by Subject|4|||
163241786|NCT01205685|589592599|FG000|Overall Study|Disease Progression|10|||
163241787|NCT01205685|589592599|FG000|Overall Study|Withdrawal by Subject|1|||
163241788|NCT02169674|589592600|FG000|Overall Study|Withdrawal by Subject|2|||
163241789|NCT02169674|589592601|FG001|Overall Study|Withdrawal by Subject|1|||
163241790|NCT02169674|589592600|FG000|Overall Study|Seroprotected|30|||
163241791|NCT02169674|589592601|FG001|Overall Study|Seroprotected|76|||
163241792|NCT02169674|589592600|FG000|Overall Study|Lost to Follow-up|0|||
163241793|NCT02169674|589592601|FG001|Overall Study|Lost to Follow-up|1|||
163241794|NCT03525834|589592604|FG000|Overall Study|Progressive disease|1|||
163241795|NCT00941603|589592607|FG000|Overall Study|Adverse Event|10|||
163241796|NCT00941603|589592608|FG001|Overall Study|Adverse Event|15|||
163241797|NCT00941603|589592609|FG002|Overall Study|Adverse Event|5|||
163241798|NCT00941603|589592610|FG003|Overall Study|Adverse Event|1|||
163241799|NCT00941603|589592611|FG004|Overall Study|Adverse Event|4|||
163241800|NCT00941603|589592612|FG005|Overall Study|Adverse Event|0|||
163241801|NCT00941603|589592607|FG000|Overall Study|Lost to Follow-up|0|||
163241802|NCT00941603|589592608|FG001|Overall Study|Lost to Follow-up|0|||
163241803|NCT00941603|589592609|FG002|Overall Study|Lost to Follow-up|0|||
163241804|NCT00941603|589592610|FG003|Overall Study|Lost to Follow-up|1|||
163241805|NCT00941603|589592611|FG004|Overall Study|Lost to Follow-up|0|||
163241806|NCT00941603|589592612|FG005|Overall Study|Lost to Follow-up|2|||
163241807|NCT00941603|589592607|FG000|Overall Study|Withdrawal by Subject|0|||
163241808|NCT00941603|589592608|FG001|Overall Study|Withdrawal by Subject|0|||
163241809|NCT00941603|589592609|FG002|Overall Study|Withdrawal by Subject|0|||
163241810|NCT00941603|589592610|FG003|Overall Study|Withdrawal by Subject|2|||
163241811|NCT00941603|589592611|FG004|Overall Study|Withdrawal by Subject|0|||
163241812|NCT00941603|589592612|FG005|Overall Study|Withdrawal by Subject|1|||
163241813|NCT00941603|589592607|FG000|Overall Study|Protocol Violation|0|||
163241814|NCT00941603|589592608|FG001|Overall Study|Protocol Violation|1|||
163241815|NCT00941603|589592609|FG002|Overall Study|Protocol Violation|0|||
163241816|NCT00941603|589592610|FG003|Overall Study|Protocol Violation|0|||
163241817|NCT00941603|589592611|FG004|Overall Study|Protocol Violation|0|||
163241818|NCT00941603|589592612|FG005|Overall Study|Protocol Violation|0|||
163241819|NCT00941603|589592607|FG000|Overall Study|Did not meet protocol eligibility|1|||
163241820|NCT00941603|589592608|FG001|Overall Study|Did not meet protocol eligibility|0|||
163241821|NCT00941603|589592609|FG002|Overall Study|Did not meet protocol eligibility|0|||
163241822|NCT00941603|589592610|FG003|Overall Study|Did not meet protocol eligibility|0|||
163241823|NCT00941603|589592611|FG004|Overall Study|Did not meet protocol eligibility|0|||
163241824|NCT00941603|589592612|FG005|Overall Study|Did not meet protocol eligibility|0|||
163241825|NCT03879798|589592615|FG000|Overall Study|Adverse Event|0|||
163351189|NCT00863798|589996114|FG002|Overall Study|Protocol Violation|1|||
163241826|NCT03879798|589592616|FG001|Overall Study|Adverse Event|0|||
163241827|NCT03879798|589592617|FG002|Overall Study|Adverse Event|0|||
163241828|NCT03879798|589592618|FG003|Overall Study|Adverse Event|0|||
163241829|NCT03879798|589592619|FG004|Overall Study|Adverse Event|0|||
163241830|NCT03879798|589592620|FG005|Overall Study|Adverse Event|1|||
163241831|NCT03879798|589592615|FG000|Overall Study|Lack of Efficacy|0|||
163241832|NCT03879798|589592616|FG001|Overall Study|Lack of Efficacy|0|||
163241833|NCT03879798|589592617|FG002|Overall Study|Lack of Efficacy|0|||
163241834|NCT03879798|589592618|FG003|Overall Study|Lack of Efficacy|0|||
163241835|NCT03879798|589592619|FG004|Overall Study|Lack of Efficacy|0|||
163241836|NCT03879798|589592620|FG005|Overall Study|Lack of Efficacy|1|||
163241837|NCT03879798|589592615|FG000|Overall Study|Withdrawal by Subject|0|||
163241838|NCT03879798|589592616|FG001|Overall Study|Withdrawal by Subject|0|||
163241839|NCT03879798|589592617|FG002|Overall Study|Withdrawal by Subject|0|||
163241840|NCT03879798|589592618|FG003|Overall Study|Withdrawal by Subject|0|||
163241841|NCT03879798|589592619|FG004|Overall Study|Withdrawal by Subject|0|||
163241842|NCT03879798|589592620|FG005|Overall Study|Withdrawal by Subject|1|||
163241843|NCT01343407|589592621|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
163241844|NCT01343407|589592622|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
163241845|NCT01343407|589592623|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
163241846|NCT01343407|589592624|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
163241847|NCT01343407|589592625|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
163241848|NCT01343407|589592626|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
163241849|NCT01343407|589592621|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
163241850|NCT01343407|589592622|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
163241851|NCT01343407|589592623|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
163241852|NCT01343407|589592624|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
163241853|NCT01343407|589592625|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
163241854|NCT01343407|589592626|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
163241855|NCT06027216|589592627|FG000|Overall Study|Did not qualify|8|||
163241856|NCT01732835|589592631|FG000|6-month Primary Endpoint|Did not receive device|19|||
163241857|NCT01732835|589592631|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
163241858|NCT01732835|589592631|FG000|6-month Primary Endpoint|Adverse Event|3|||
163241859|NCT01732835|589592631|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
163241860|NCT01732835|589592631|FG000|2-year Extended Follow-up|Adverse Event|3|||
163241861|NCT01732835|589592631|FG000|2-year Extended Follow-up|Death|1|||
163241862|NCT00874029|589592636|FG000|Overall Study|Withdrawal by Subject|10|||
163241863|NCT00874029|589592636|FG000|Overall Study|Pregnancy|4|||
163241864|NCT00874029|589592636|FG000|Overall Study|Physician Decision|1|||
163241865|NCT00874029|589592636|FG000|Overall Study|Adverse Event|1|||
163241866|NCT00874029|589592636|FG000|Overall Study|Lost to Follow-up|5|||
163241867|NCT01767116|589592637|FG000|Overall Study|Lost to Follow-up|2|||
163241868|NCT01767116|589592638|FG001|Overall Study|Lost to Follow-up|2|||
163241869|NCT00968669|589592639|FG000|Overall Study|Lost to Follow-up|5|||
163241870|NCT00968669|589592640|FG001|Overall Study|Lost to Follow-up|2|||
163241871|NCT00968669|589592641|FG002|Overall Study|Lost to Follow-up|1|||
163241872|NCT00968669|589592642|FG003|Overall Study|Lost to Follow-up|4|||
163241873|NCT00968669|589592639|FG000|Overall Study|Withdrawal by Subject|9|||
163241874|NCT00968669|589592640|FG001|Overall Study|Withdrawal by Subject|7|||
163241875|NCT00968669|589592641|FG002|Overall Study|Withdrawal by Subject|5|||
163241876|NCT00968669|589592642|FG003|Overall Study|Withdrawal by Subject|3|||
163241877|NCT00968669|589592639|FG000|Overall Study|Pregnancy|0|||
163241878|NCT00968669|589592640|FG001|Overall Study|Pregnancy|0|||
163241879|NCT00968669|589592641|FG002|Overall Study|Pregnancy|2|||
163241880|NCT00968669|589592642|FG003|Overall Study|Pregnancy|0|||
163241881|NCT00968669|589592639|FG000|Overall Study|AE|1|||
163241882|NCT00968669|589592640|FG001|Overall Study|AE|0|||
163241883|NCT00968669|589592641|FG002|Overall Study|AE|0|||
163241884|NCT00968669|589592642|FG003|Overall Study|AE|0|||
163241885|NCT00968669|589592639|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
163241886|NCT00968669|589592640|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
163241887|NCT00968669|589592641|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
163241888|NCT00968669|589592642|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
163241889|NCT00968669|589592639|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
163241890|NCT00968669|589592640|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
163241891|NCT00968669|589592641|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
163241892|NCT00968669|589592642|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
163241893|NCT00968669|589592639|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
163241894|NCT00968669|589592640|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
163241895|NCT00968669|589592641|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
163241896|NCT00968669|589592642|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
163409997|NCT02443883|590209553|FG001|Overall Study|Randomized, but never treated|0|||
163409998|NCT02443883|590209554|FG002|Overall Study|Randomized, but never treated|0|||
163409999|NCT02443883|590209555|FG003|Overall Study|Randomized, but never treated|0|||
163410000|NCT02199080|590209556|FG000|Overall Study|Protocol Violation|12|||
163241897|NCT00968669|589592639|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
163241898|NCT00968669|589592640|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
163241899|NCT00968669|589592641|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
163241900|NCT00968669|589592642|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
163241901|NCT00968669|589592639|FG000|Overall Study|EARLY WITHDRAWAL|0|||
163241902|NCT00968669|589592640|FG001|Overall Study|EARLY WITHDRAWAL|1|||
163241903|NCT00968669|589592641|FG002|Overall Study|EARLY WITHDRAWAL|0|||
163241904|NCT00968669|589592642|FG003|Overall Study|EARLY WITHDRAWAL|0|||
163147637|NCT01384734|589251347|FG004|Overall Study|Non-compliance with study drug|2|||
163147638|NCT01384734|589251343|FG000|Overall Study|Pregnancy|0|||
163147639|NCT01384734|589251344|FG001|Overall Study|Pregnancy|1|||
163147640|NCT01384734|589251345|FG002|Overall Study|Pregnancy|0|||
163147641|NCT01384734|589251346|FG003|Overall Study|Pregnancy|0|||
163147642|NCT01384734|589251347|FG004|Overall Study|Pregnancy|1|||
163147643|NCT01384734|589251343|FG000|Overall Study|Sponsor terminated|0|||
163147644|NCT01384734|589251344|FG001|Overall Study|Sponsor terminated|0|||
163147645|NCT01384734|589251345|FG002|Overall Study|Sponsor terminated|0|||
163147646|NCT01384734|589251346|FG003|Overall Study|Sponsor terminated|0|||
163147647|NCT01384734|589251347|FG004|Overall Study|Sponsor terminated|1|||
163147648|NCT01384734|589251343|FG000|Overall Study|Withdrawal by Subject|5|||
163147649|NCT01384734|589251344|FG001|Overall Study|Withdrawal by Subject|5|||
163147650|NCT01384734|589251345|FG002|Overall Study|Withdrawal by Subject|6|||
163147651|NCT01384734|589251346|FG003|Overall Study|Withdrawal by Subject|7|||
163147652|NCT01384734|589251347|FG004|Overall Study|Withdrawal by Subject|9|||
163147653|NCT01384734|589251343|FG000|Overall Study|Investigator relocating|0|||
163147654|NCT01384734|589251344|FG001|Overall Study|Investigator relocating|2|||
163147655|NCT01384734|589251345|FG002|Overall Study|Investigator relocating|0|||
163147656|NCT01384734|589251346|FG003|Overall Study|Investigator relocating|3|||
163147657|NCT01384734|589251347|FG004|Overall Study|Investigator relocating|1|||
163147658|NCT01384734|589251343|FG000|Overall Study|Unable to come back for visit|1|||
163147659|NCT01384734|589251344|FG001|Overall Study|Unable to come back for visit|0|||
163147660|NCT01384734|589251345|FG002|Overall Study|Unable to come back for visit|1|||
163147661|NCT01384734|589251346|FG003|Overall Study|Unable to come back for visit|1|||
163147662|NCT01384734|589251347|FG004|Overall Study|Unable to come back for visit|0|||
163147663|NCT01384734|589251343|FG000|Overall Study|Prison|0|||
163147664|NCT01384734|589251344|FG001|Overall Study|Prison|0|||
163147665|NCT01384734|589251345|FG002|Overall Study|Prison|1|||
163147666|NCT01384734|589251346|FG003|Overall Study|Prison|0|||
163147667|NCT01384734|589251347|FG004|Overall Study|Prison|0|||
163147668|NCT01384734|589251343|FG000|Overall Study|As per Exclusion criteria|0|||
163147669|NCT01384734|589251344|FG001|Overall Study|As per Exclusion criteria|1|||
163147670|NCT01384734|589251345|FG002|Overall Study|As per Exclusion criteria|0|||
163147671|NCT01384734|589251346|FG003|Overall Study|As per Exclusion criteria|0|||
163147672|NCT01384734|589251347|FG004|Overall Study|As per Exclusion criteria|0|||
163147673|NCT01384734|589251343|FG000|Overall Study|Missed End of treatment visit|0|||
163147674|NCT01384734|589251344|FG001|Overall Study|Missed End of treatment visit|0|||
163147675|NCT01384734|589251345|FG002|Overall Study|Missed End of treatment visit|0|||
163147676|NCT01384734|589251346|FG003|Overall Study|Missed End of treatment visit|1|||
163147677|NCT01384734|589251347|FG004|Overall Study|Missed End of treatment visit|0|||
163147678|NCT01384734|589251343|FG000|Overall Study|Adhesion problem|0|||
163147679|NCT01384734|589251344|FG001|Overall Study|Adhesion problem|0|||
163147680|NCT01384734|589251345|FG002|Overall Study|Adhesion problem|0|||
163147681|NCT01384734|589251346|FG003|Overall Study|Adhesion problem|1|||
163147682|NCT01384734|589251347|FG004|Overall Study|Adhesion problem|0|||
163147683|NCT01384734|589251343|FG000|Overall Study|Early termination|0|||
163147684|NCT01384734|589251344|FG001|Overall Study|Early termination|0|||
163147685|NCT01384734|589251345|FG002|Overall Study|Early termination|0|||
163147686|NCT01384734|589251346|FG003|Overall Study|Early termination|0|||
163147687|NCT01384734|589251347|FG004|Overall Study|Early termination|1|||
163147688|NCT01384734|589251343|FG000|Overall Study|Physician Decision|1|||
163147689|NCT01384734|589251344|FG001|Overall Study|Physician Decision|0|||
163147690|NCT01384734|589251345|FG002|Overall Study|Physician Decision|0|||
163147691|NCT01384734|589251346|FG003|Overall Study|Physician Decision|0|||
163147692|NCT01384734|589251347|FG004|Overall Study|Physician Decision|0|||
163147693|NCT01290523|589251348|FG000|Overall Study|Death|3|||
163147694|NCT03071263|589251349|FG000|Overall Study|Adverse Event|1|||
163147695|NCT03071263|589251350|FG001|Overall Study|Adverse Event|3|||
163147696|NCT03071263|589251349|FG000|Overall Study|Withdrawal by Subject|1|||
163147697|NCT03071263|589251350|FG001|Overall Study|Withdrawal by Subject|3|||
163147698|NCT03071263|589251349|FG000|Overall Study|Physician Decision|1|||
163147699|NCT03071263|589251350|FG001|Overall Study|Physician Decision|0|||
163147700|NCT03071263|589251349|FG000|Overall Study|Participant moved to another city|0|||
163147701|NCT03071263|589251350|FG001|Overall Study|Participant moved to another city|1|||
163147702|NCT02922725|589251352|FG000|Overall Study|Withdrawal by Subject|1|||
163147703|NCT02922725|589251353|FG001|Overall Study|Withdrawal by Subject|0|||
163147704|NCT02922725|589251354|FG002|Overall Study|Withdrawal by Subject|0|||
163147705|NCT05148234|589251358|FG000|Phase I|Ineligible|0|||
163147706|NCT05148234|589251359|FG001|Phase I|Ineligible|0|||
163147707|NCT05148234|589251360|FG002|Phase I|Ineligible|0|||
163147708|NCT05148234|589251361|FG003|Phase I|Ineligible|0|||
163147709|NCT05148234|589251362|FG004|Phase I|Ineligible|0|||
163147710|NCT05148234|589251363|FG005|Phase I|Ineligible|0|||
163147711|NCT05148234|589251364|FG006|Phase I|Ineligible|0|||
163147712|NCT05148234|589251365|FG007|Phase I|Ineligible|1|||
163147713|NCT05148234|589251358|FG000|Phase I|Company closed the trial.|0|||
163147714|NCT05148234|589251359|FG001|Phase I|Company closed the trial.|1|||
163147715|NCT05148234|589251360|FG002|Phase I|Company closed the trial.|0|||
163241905|NCT00968669|589592639|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
163241906|NCT00968669|589592640|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
163241907|NCT00968669|589592641|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
163241908|NCT00968669|589592642|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
163241909|NCT00968669|589592639|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
163241910|NCT00968669|589592640|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
163241911|NCT00968669|589592641|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
163241912|NCT00968669|589592642|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
163241913|NCT00968669|589592639|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
163241914|NCT00968669|589592640|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
163241915|NCT00968669|589592641|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
163241916|NCT00968669|589592642|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
163241917|NCT00968669|589592639|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
163241918|NCT00968669|589592640|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
163241919|NCT00968669|589592641|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
163241920|NCT00968669|589592642|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
163241921|NCT00968669|589592639|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
163241922|NCT00968669|589592640|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
163241923|NCT00968669|589592641|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
163241924|NCT00968669|589592642|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
163241925|NCT00968669|589592639|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
163241926|NCT00968669|589592640|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
163241927|NCT00968669|589592641|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
163241928|NCT00968669|589592642|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
163241929|NCT00968669|589592639|FG000|Overall Study|SPONSOR DECISION|0|||
163241930|NCT00968669|589592640|FG001|Overall Study|SPONSOR DECISION|1|||
163241931|NCT00968669|589592641|FG002|Overall Study|SPONSOR DECISION|0|||
163351190|NCT00863798|589996112|FG000|Overall Study|Withdrawal by Subject|8|||
163147716|NCT05148234|589251361|FG003|Phase I|Company closed the trial.|0|||
163147717|NCT05148234|589251362|FG004|Phase I|Company closed the trial.|0|||
163147718|NCT05148234|589251363|FG005|Phase I|Company closed the trial.|0|||
163147719|NCT05148234|589251364|FG006|Phase I|Company closed the trial.|0|||
163147720|NCT05148234|589251365|FG007|Phase I|Company closed the trial.|0|||
163147721|NCT01400698|589251366|FG000|Overall Study|Lost to Follow-up|2|||
163147722|NCT01400698|589251367|FG001|Overall Study|Lost to Follow-up|5|||
163147723|NCT01400698|589251368|FG002|Overall Study|Lost to Follow-up|2|||
163147724|NCT01400698|589251369|FG003|Overall Study|Lost to Follow-up|1|||
163147725|NCT01400698|589251370|FG004|Overall Study|Lost to Follow-up|4|||
163147726|NCT01400698|589251371|FG005|Overall Study|Lost to Follow-up|3|||
163147727|NCT01400698|589251366|FG000|Overall Study|Withdrawal by Subject|8|||
163147728|NCT01400698|589251367|FG001|Overall Study|Withdrawal by Subject|2|||
163147729|NCT01400698|589251368|FG002|Overall Study|Withdrawal by Subject|0|||
163147730|NCT01400698|589251369|FG003|Overall Study|Withdrawal by Subject|4|||
163147731|NCT01400698|589251370|FG004|Overall Study|Withdrawal by Subject|1|||
163147732|NCT01400698|589251371|FG005|Overall Study|Withdrawal by Subject|3|||
163147733|NCT01400698|589251366|FG000|Overall Study|Protocol Violation|0|||
163147734|NCT01400698|589251367|FG001|Overall Study|Protocol Violation|1|||
163147735|NCT01400698|589251368|FG002|Overall Study|Protocol Violation|0|||
163147736|NCT01400698|589251369|FG003|Overall Study|Protocol Violation|0|||
163147737|NCT01400698|589251370|FG004|Overall Study|Protocol Violation|1|||
163147738|NCT01400698|589251371|FG005|Overall Study|Protocol Violation|0|||
163147739|NCT01400698|589251366|FG000|Overall Study|Non-compliance|0|||
163147740|NCT01400698|589251367|FG001|Overall Study|Non-compliance|1|||
163147741|NCT01400698|589251368|FG002|Overall Study|Non-compliance|0|||
163147742|NCT01400698|589251369|FG003|Overall Study|Non-compliance|1|||
163147743|NCT01400698|589251370|FG004|Overall Study|Non-compliance|0|||
163147744|NCT01400698|589251371|FG005|Overall Study|Non-compliance|0|||
163147745|NCT01400698|589251366|FG000|Overall Study|Adverse Event|1|||
163241932|NCT00968669|589592642|FG003|Overall Study|SPONSOR DECISION|0|||
163241933|NCT00968669|589592639|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
163241934|NCT00968669|589592640|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
163241935|NCT00968669|589592641|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
163241936|NCT00968669|589592642|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
163241937|NCT00968669|589592639|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
163241938|NCT00968669|589592640|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
163241939|NCT00968669|589592641|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
163241940|NCT00968669|589592642|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
163147746|NCT01400698|589251367|FG001|Overall Study|Adverse Event|0|||
163147747|NCT01400698|589251368|FG002|Overall Study|Adverse Event|0|||
163147748|NCT01400698|589251369|FG003|Overall Study|Adverse Event|0|||
163147749|NCT01400698|589251370|FG004|Overall Study|Adverse Event|0|||
163147750|NCT01400698|589251371|FG005|Overall Study|Adverse Event|0|||
163147751|NCT01400698|589251366|FG000|Overall Study|Other|4|||
163147752|NCT01400698|589251367|FG001|Overall Study|Other|2|||
163147753|NCT01400698|589251368|FG002|Overall Study|Other|0|||
163147754|NCT01400698|589251369|FG003|Overall Study|Other|2|||
163147755|NCT01400698|589251370|FG004|Overall Study|Other|1|||
163147756|NCT01400698|589251371|FG005|Overall Study|Other|0|||
163147757|NCT04750642|589251372|FG000|Overall Study|Adverse Event|1|||
163147758|NCT04750642|589251373|FG001|Overall Study|Adverse Event|0|||
163147759|NCT04750642|589251372|FG000|Overall Study|Withdrawal by Subject|0|||
163147760|NCT04750642|589251373|FG001|Overall Study|Withdrawal by Subject|1|||
163147761|NCT04750642|589251372|FG000|Overall Study|Protocol Violation|0|||
163147762|NCT04750642|589251373|FG001|Overall Study|Protocol Violation|1|||
163147763|NCT01650194|589251374|FG000|Overall Study|Progressive Disease (PD)|35|||
163147764|NCT01650194|589251374|FG000|Overall Study|Withdrawal by Subject|2|||
163147765|NCT01650194|589251374|FG000|Overall Study|Miscellaneous|10|||
163147766|NCT01602224|589252932|FG000|Overall Study|Adverse Event|0|||
163147767|NCT01602224|589252933|FG001|Overall Study|Adverse Event|1|||
163147768|NCT01602224|589252934|FG002|Overall Study|Adverse Event|0|||
163147769|NCT01602224|589252932|FG000|Overall Study|Investigator Decison|1|||
163147770|NCT01602224|589252933|FG001|Overall Study|Investigator Decison|0|||
163147771|NCT01602224|589252934|FG002|Overall Study|Investigator Decison|0|||
163147772|NCT01602224|589252932|FG000|Overall Study|Lost to Follow-up|0|||
163147773|NCT01602224|589252933|FG001|Overall Study|Lost to Follow-up|0|||
163147774|NCT01602224|589252934|FG002|Overall Study|Lost to Follow-up|1|||
163147775|NCT01602224|589252932|FG000|Overall Study|Protocol Violation|0|||
163147776|NCT01602224|589252933|FG001|Overall Study|Protocol Violation|1|||
163147777|NCT01602224|589252934|FG002|Overall Study|Protocol Violation|0|||
163147778|NCT01602224|589252932|FG000|Overall Study|Sponsor Decision|2|||
163147779|NCT01602224|589252933|FG001|Overall Study|Sponsor Decision|3|||
163147780|NCT01602224|589252934|FG002|Overall Study|Sponsor Decision|2|||
163147781|NCT01602224|589252932|FG000|Overall Study|Withdrawal by Subject|5|||
163147782|NCT01602224|589252933|FG001|Overall Study|Withdrawal by Subject|3|||
163147783|NCT01602224|589252934|FG002|Overall Study|Withdrawal by Subject|3|||
163147784|NCT01352117|589252935|FG000|Overall Study|Death|15|||
163147785|NCT01352117|589252936|FG001|Overall Study|Death|16|||
163147786|NCT01352117|589252935|FG000|Overall Study|Withdrawal by Subject|1|||
163147787|NCT01352117|589252936|FG001|Overall Study|Withdrawal by Subject|0|||
163147788|NCT01352117|589252935|FG000|Overall Study|Lost to Follow-up|2|||
163147789|NCT01352117|589252936|FG001|Overall Study|Lost to Follow-up|7|||
163147790|NCT01352117|589252935|FG000|Overall Study|Non-adherent to study requirements|1|||
163147791|NCT01352117|589252936|FG001|Overall Study|Non-adherent to study requirements|1|||
163147792|NCT01352117|589252935|FG000|Overall Study|Did not initiate study treatment|1|||
163147793|NCT01352117|589252936|FG001|Overall Study|Did not initiate study treatment|0|||
163147794|NCT01352117|589252935|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
163147795|NCT01352117|589252936|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
163147796|NCT00644423|589252937|FG000|Overall Study|Lost to Follow-up|1|||
163147797|NCT00644423|589252938|FG001|Overall Study|Lost to Follow-up|1|||
163147798|NCT03525444|589252939|FG000|Overall Study|Adverse Event|0|||
163147799|NCT03525444|589252940|FG001|Overall Study|Adverse Event|1|||
163147800|NCT03525444|589252939|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
163147801|NCT03525444|589252940|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
163147802|NCT03525444|589252939|FG000|Overall Study|Other|0|||
163147803|NCT03525444|589252940|FG001|Overall Study|Other|1|||
163147804|NCT00262860|589252942|FG000|Overall Study|Adverse Event|2|||
163147805|NCT02741128|589252943|FG000|Overall Study|Protocol Violation|4|||
163147806|NCT02741128|589252944|FG001|Overall Study|Protocol Violation|1|||
163147807|NCT02741128|589252943|FG000|Overall Study|Withdrawal by Subject|2|||
163147808|NCT02741128|589252944|FG001|Overall Study|Withdrawal by Subject|0|||
163147809|NCT02741128|589252943|FG000|Overall Study|Lost to Follow-up|1|||
163147810|NCT02741128|589252944|FG001|Overall Study|Lost to Follow-up|0|||
163147811|NCT01419769|589252945|FG000|Overall Study|Did not receive the AXIOS stent|3|||
163147812|NCT01419769|589252945|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
163147813|NCT00878501|589252946|FG000|Overall Study|Adverse Event|11|||
163147814|NCT00878501|589252947|FG001|Overall Study|Adverse Event|3|||
163147815|NCT00878501|589252948|FG002|Overall Study|Adverse Event|3|||
163147816|NCT00878501|589252946|FG000|Overall Study|Lack of Efficacy|2|||
163147817|NCT00878501|589252947|FG001|Overall Study|Lack of Efficacy|1|||
163147818|NCT00878501|589252948|FG002|Overall Study|Lack of Efficacy|0|||
163147819|NCT00878501|589252946|FG000|Overall Study|Withdrawal by Subject|2|||
163147820|NCT00878501|589252947|FG001|Overall Study|Withdrawal by Subject|1|||
163147821|NCT00878501|589252948|FG002|Overall Study|Withdrawal by Subject|2|||
163147822|NCT00878501|589252946|FG000|Overall Study|Protocol Violation|0|||
163147823|NCT00878501|589252947|FG001|Overall Study|Protocol Violation|0|||
163147824|NCT00878501|589252948|FG002|Overall Study|Protocol Violation|1|||
163147825|NCT00878501|589252946|FG000|Overall Study|Incorrect enrolment|1|||
163147826|NCT00878501|589252947|FG001|Overall Study|Incorrect enrolment|2|||
163147827|NCT00878501|589252948|FG002|Overall Study|Incorrect enrolment|0|||
163147828|NCT00878501|589252946|FG000|Overall Study|Intake of prohibited concom. medication|0|||
163147829|NCT00878501|589252947|FG001|Overall Study|Intake of prohibited concom. medication|0|||
163147830|NCT00878501|589252948|FG002|Overall Study|Intake of prohibited concom. medication|1|||
163147831|NCT00878501|589252946|FG000|Overall Study|Mis-randomisation of patient|1|||
163241941|NCT00968669|589592639|FG000|Overall Study|SUBJECT INCARCERATED|0|||
163241942|NCT00968669|589592640|FG001|Overall Study|SUBJECT INCARCERATED|1|||
163241943|NCT00968669|589592641|FG002|Overall Study|SUBJECT INCARCERATED|0|||
163241944|NCT00968669|589592642|FG003|Overall Study|SUBJECT INCARCERATED|0|||
163241945|NCT00968669|589592639|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
163241946|NCT00968669|589592640|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
163241947|NCT00968669|589592641|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
163241948|NCT00968669|589592642|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
163241949|NCT00968669|589592639|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
163241950|NCT00968669|589592640|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
163241951|NCT00968669|589592641|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
163241952|NCT00968669|589592642|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
163241953|NCT01669343|589592645|FG000|Part A: All Patients|Withdrawal by Subject|7|||
163241954|NCT01669343|589592645|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
163241955|NCT01669343|589592645|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
163241956|NCT01669343|589592645|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
163241957|NCT01669343|589592645|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
163241958|NCT02371369|589592650|FG000|Part 1|Physician Decision|0|||
163241959|NCT02371369|589592651|FG001|Part 1|Physician Decision|3|||
163241960|NCT02371369|589592650|FG000|Part 1|Adverse Event|8|||
163241961|NCT02371369|589592651|FG001|Part 1|Adverse Event|0|||
163241962|NCT02371369|589592650|FG000|Part 1|Withdrawal by Subject|1|||
163241963|NCT02371369|589592651|FG001|Part 1|Withdrawal by Subject|6|||
163241964|NCT02371369|589592650|FG000|Part 1|Disease progression|0|||
163241965|NCT02371369|589592651|FG001|Part 1|Disease progression|1|||
163241966|NCT02371369|589592650|FG000|Part 1|Protocol Violation|0|||
163241967|NCT02371369|589592651|FG001|Part 1|Protocol Violation|1|||
163241968|NCT02371369|589592650|FG000|Part 2|Adverse Event|6|||
163241969|NCT02371369|589592651|FG001|Part 2|Adverse Event|5|||
163241970|NCT02371369|589592650|FG000|Part 2|Withdrawal by Subject|16|||
163241971|NCT02371369|589592651|FG001|Part 2|Withdrawal by Subject|6|||
163241972|NCT02371369|589592650|FG000|Part 2|Investigator decision|1|||
163241973|NCT02371369|589592651|FG001|Part 2|Investigator decision|2|||
163241974|NCT02371369|589592650|FG000|Part 2|Death|0|||
163241975|NCT02371369|589592651|FG001|Part 2|Death|1|||
163241976|NCT02371369|589592650|FG000|Part 2|Disease progression|1|||
163351191|NCT00863798|589996113|FG001|Overall Study|Withdrawal by Subject|7|||
163351192|NCT00863798|589996114|FG002|Overall Study|Withdrawal by Subject|4|||
163351193|NCT00863798|589996112|FG000|Overall Study|Randomized not treated|4|||
163351194|NCT00863798|589996113|FG001|Overall Study|Randomized not treated|2|||
163351195|NCT00863798|589996114|FG002|Overall Study|Randomized not treated|3|||
163351196|NCT04238520|589996115|FG000|Overall Study|Withdrawal by Subject|1|||
163351197|NCT04238520|589996116|FG001|Overall Study|Withdrawal by Subject|1|||
163351198|NCT04238520|589996115|FG000|Overall Study|Lost to Follow-up|1|||
163351199|NCT04238520|589996116|FG001|Overall Study|Lost to Follow-up|2|||
163351200|NCT04238520|589996115|FG000|Overall Study|Death|0|||
163351201|NCT04238520|589996116|FG001|Overall Study|Death|2|||
163351202|NCT04238520|589996115|FG000|Overall Study|Unsafe home environment for research staff|0|||
163351203|NCT04238520|589996116|FG001|Overall Study|Unsafe home environment for research staff|1|||
163351204|NCT01470599|589996117|FG000|Overall Study|Did not meet entrance criteria|1|||
163351205|NCT01470599|589996118|FG001|Overall Study|Did not meet entrance criteria|0|||
163351206|NCT01470599|589996117|FG000|Overall Study|Lost to Follow-up|2|||
163351207|NCT01470599|589996118|FG001|Overall Study|Lost to Follow-up|1|||
163351208|NCT01470599|589996117|FG000|Overall Study|Withdrawal by Subject|3|||
163351209|NCT01470599|589996118|FG001|Overall Study|Withdrawal by Subject|4|||
163351210|NCT01470599|589996117|FG000|Overall Study|Other|1|||
163351211|NCT01470599|589996118|FG001|Overall Study|Other|0|||
163351212|NCT01470599|589996117|FG000|Overall Study|Protocol Violation|3|||
163241977|NCT02371369|589592651|FG001|Part 2|Disease progression|0|||
163241978|NCT02371369|589592650|FG000|Part 2|Subject Noncompliance|1|||
163241979|NCT02371369|589592651|FG001|Part 2|Subject Noncompliance|0|||
163241980|NCT02371369|589592650|FG000|Part 2|Lost to Follow-up|1|||
163241981|NCT02371369|589592651|FG001|Part 2|Lost to Follow-up|1|||
163241982|NCT02371369|589592650|FG000|Part 2|Subject transitioned to commercial supply|6|||
163241983|NCT02371369|589592651|FG001|Part 2|Subject transitioned to commercial supply|4|||
163241984|NCT02371369|589592650|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
163241985|NCT02371369|589592651|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
163241986|NCT02371369|589592650|FG000|Part 2|Surgical resection of tumor|1|||
163241987|NCT02371369|589592651|FG001|Part 2|Surgical resection of tumor|1|||
163241988|NCT02371369|589592650|FG000|Part 2|Other|0|||
163241989|NCT02371369|589592651|FG001|Part 2|Other|1|||
163241990|NCT01024387|589592652|FG000|Overall Study|Radiographic Progression|29|||
163241991|NCT01024387|589592652|FG000|Overall Study|Symptomatic Progression|10|||
163241992|NCT01024387|589592652|FG000|Overall Study|Physician Decision|5|||
163351213|NCT01470599|589996118|FG001|Overall Study|Protocol Violation|1|||
163351214|NCT01470599|589996117|FG000|Overall Study|Adverse event related to study drug|2|||
163351215|NCT01470599|589996118|FG001|Overall Study|Adverse event related to study drug|5|||
163241993|NCT01024387|589592652|FG000|Overall Study|Withdrawal by Subject|5|||
163241994|NCT01024387|589592652|FG000|Overall Study|Death|2|||
163241995|NCT01024387|589592652|FG000|Overall Study|Prolonged Treatment Delay|1|||
163241996|NCT01024387|589592652|FG000|Overall Study|Adverse Event|3|||
163241997|NCT01024387|589592652|FG000|Overall Study|Other|5|||
163241998|NCT03855189|589592653|FG000|Overall Study|Adverse Event|5|||
163241999|NCT03855189|589592654|FG001|Overall Study|Adverse Event|2|||
163242000|NCT03855189|589592655|FG002|Overall Study|Adverse Event|4|||
163242001|NCT03855189|589592653|FG000|Overall Study|Treatment Failure|1|||
163242002|NCT03855189|589592654|FG001|Overall Study|Treatment Failure|1|||
163242003|NCT03855189|589592655|FG002|Overall Study|Treatment Failure|2|||
163242004|NCT03855189|589592653|FG000|Overall Study|Noncompliance with Protocol|0|||
163242005|NCT03855189|589592654|FG001|Overall Study|Noncompliance with Protocol|1|||
163242006|NCT03855189|589592655|FG002|Overall Study|Noncompliance with Protocol|0|||
163242007|NCT03855189|589592653|FG000|Overall Study|Did Not Return|4|||
163242008|NCT03855189|589592654|FG001|Overall Study|Did Not Return|3|||
163242009|NCT03855189|589592655|FG002|Overall Study|Did Not Return|0|||
163242010|NCT01143259|589592656|FG000|Overall Study|Withdrawal by Subject|3|||
163242011|NCT01143259|589592657|FG001|Overall Study|Withdrawal by Subject|2|||
163242012|NCT01143259|589592656|FG000|Overall Study|Protocol Violation|13|||
163242013|NCT01143259|589592657|FG001|Overall Study|Protocol Violation|9|||
163242014|NCT01143259|589592656|FG000|Overall Study|Screen Failure|7|||
163242015|NCT01143259|589592657|FG001|Overall Study|Screen Failure|9|||
163242016|NCT04307186|589592660|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
163242017|NCT04307186|589592660|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
163242018|NCT04307186|589592660|FG000|Washout 3-14 Days|Progressive disease|1|||
163242019|NCT04307186|589592660|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
163242020|NCT04307186|589592660|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
163242021|NCT01618838|589592663|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
163242022|NCT01434602|589592664|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
163242023|NCT01434602|589592665|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
163242024|NCT01434602|589592666|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
163242025|NCT01434602|589592667|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
163242026|NCT01434602|589592668|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
163242027|NCT01434602|589592664|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
163242028|NCT01434602|589592665|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
163242029|NCT01434602|589592666|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
163242030|NCT01434602|589592667|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
163242031|NCT01434602|589592668|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
163242032|NCT01434602|589592664|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
163242033|NCT01434602|589592665|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
163242034|NCT01434602|589592666|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
163242035|NCT01434602|589592667|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
163242036|NCT01434602|589592668|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
163242037|NCT01434602|589592664|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
163242038|NCT01434602|589592665|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
163242039|NCT01434602|589592666|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
163242040|NCT01434602|589592667|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
163242041|NCT01434602|589592668|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
163242042|NCT01434602|589592664|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
163242043|NCT01434602|589592665|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
163242044|NCT01434602|589592666|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
163351216|NCT01470599|589996117|FG000|Overall Study|Insufficient clinical response|6|||
163351217|NCT01470599|589996118|FG001|Overall Study|Insufficient clinical response|27|||
163351218|NCT01470599|589996117|FG000|Overall Study|Adverse event not related to study drug|1|||
163351219|NCT01470599|589996118|FG001|Overall Study|Adverse event not related to study drug|5|||
163351220|NCT00195442|589996119|FG000|Overall Study|Less than expected therapeutic effect|38|||
163351221|NCT00195442|589996119|FG000|Overall Study|Lost to Follow-up|27|||
163242045|NCT01434602|589592667|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
163242046|NCT01434602|589592668|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
163242047|NCT01434602|589592664|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
163242048|NCT01434602|589592665|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
163351222|NCT00195442|589996119|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
163351223|NCT00195442|589996119|FG000|Overall Study|Intermittent product shortage|21|||
163242049|NCT01434602|589592666|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
163242050|NCT01434602|589592667|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
163242051|NCT01434602|589592668|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
163242052|NCT01434602|589592664|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
163242053|NCT01434602|589592665|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
163242054|NCT01434602|589592666|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
163242055|NCT01434602|589592667|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
163242056|NCT01434602|589592668|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
163242057|NCT01434602|589592664|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
163242058|NCT01434602|589592665|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
163242059|NCT01434602|589592666|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
163242060|NCT01434602|589592667|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
163242061|NCT01434602|589592668|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
163242062|NCT01434602|589592664|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
163242063|NCT01434602|589592665|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
163242064|NCT01434602|589592666|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
163242065|NCT01434602|589592667|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
163242066|NCT01434602|589592668|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
163242067|NCT01434602|589592664|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
163242068|NCT01434602|589592665|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
163242069|NCT01434602|589592666|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
163242070|NCT01434602|589592667|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
163242071|NCT01434602|589592668|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
163242072|NCT01587651|589592673|FG000|Overall Study|Adverse Event|0|||
163242073|NCT01587651|589592674|FG001|Overall Study|Adverse Event|1|||
163242074|NCT01587651|589592675|FG002|Overall Study|Adverse Event|0|||
163242075|NCT01587651|589592673|FG000|Overall Study|Protocol Violation|0|||
163242076|NCT01587651|589592674|FG001|Overall Study|Protocol Violation|1|||
163242077|NCT01587651|589592675|FG002|Overall Study|Protocol Violation|1|||
163242078|NCT01587651|589592673|FG000|Overall Study|Withdrawal by Subject|0|||
163242079|NCT01587651|589592674|FG001|Overall Study|Withdrawal by Subject|1|||
163242080|NCT01587651|589592675|FG002|Overall Study|Withdrawal by Subject|0|||
163242081|NCT03864900|589592678|FG000|Overall Study|Withdrawal by Subject|1|||
163242082|NCT03864900|589592679|FG001|Overall Study|Withdrawal by Subject|1|||
163242083|NCT03864900|589592678|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
163242084|NCT03864900|589592679|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
163242085|NCT03238001|589592682|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
163242086|NCT03238001|589592682|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
163242087|NCT03238001|589592682|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
163242088|NCT03238001|589592682|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
163242089|NCT03238001|589592682|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
163242090|NCT03238001|589592682|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
163242091|NCT03238001|589592682|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
163242092|NCT03238001|589592682|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
163242093|NCT00759109|589592683|FG000|Overall Study|Adverse Event|17|||
163242094|NCT00759109|589592684|FG001|Overall Study|Adverse Event|12|||
163242095|NCT00759109|589592683|FG000|Overall Study|Inability to comply|1|||
163242096|NCT00759109|589592684|FG001|Overall Study|Inability to comply|1|||
163242097|NCT00759109|589592683|FG000|Overall Study|Withdrawal by Subject|9|||
163242098|NCT00759109|589592684|FG001|Overall Study|Withdrawal by Subject|5|||
163242099|NCT00759109|589592683|FG000|Overall Study|Death|4|||
163242100|NCT00759109|589592684|FG001|Overall Study|Death|3|||
163242101|NCT00759109|589592683|FG000|Overall Study|Lost to Follow-up|4|||
163242102|NCT00759109|589592684|FG001|Overall Study|Lost to Follow-up|6|||
163242103|NCT00759109|589592683|FG000|Overall Study|Started new therapy|2|||
163242104|NCT00759109|589592684|FG001|Overall Study|Started new therapy|6|||
163242105|NCT00759109|589592683|FG000|Overall Study|HCV RNA negative|1|||
163242106|NCT00759109|589592684|FG001|Overall Study|HCV RNA negative|0|||
163242107|NCT00759109|589592683|FG000|Overall Study|Participant moved to a different city|0|||
163242108|NCT00759109|589592684|FG001|Overall Study|Participant moved to a different city|1|||
163242109|NCT00759109|589592683|FG000|Overall Study|Participant had a liver transplant|0|||
163242110|NCT00759109|589592684|FG001|Overall Study|Participant had a liver transplant|1|||
163242111|NCT00759109|589592683|FG000|Overall Study|Lost during study|1|||
163242112|NCT00759109|589592684|FG001|Overall Study|Lost during study|0|||
163351224|NCT00195442|589996119|FG000|Overall Study|Death|7|||
163351225|NCT00195442|589996119|FG000|Overall Study|No reason specified|4|||
163351226|NCT00195442|589996119|FG000|Overall Study|Poor cooperation|2|||
163351227|NCT00195442|589996119|FG000|Overall Study|Other|14|||
163351228|NCT01917006|589996120|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
163351229|NCT01917006|589996121|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
163242113|NCT02332720|589594461|FG000|Part A and Part B|Lost to Follow-up|1|||
163242114|NCT02332720|589594462|FG001|Part A and Part B|Lost to Follow-up|0|||
163242115|NCT02332720|589594463|FG002|Part A and Part B|Lost to Follow-up|0|||
163242116|NCT02332720|589594464|FG003|Part A and Part B|Lost to Follow-up|0|||
163242117|NCT02332720|589594465|FG004|Part A and Part B|Lost to Follow-up|0|||
163242118|NCT02332720|589594466|FG005|Part A and Part B|Lost to Follow-up|2|||
163242119|NCT02332720|589594467|FG006|Part A and Part B|Lost to Follow-up|1|||
163242120|NCT02332720|589594468|FG007|Part A and Part B|Lost to Follow-up|1|||
163242121|NCT02332720|589594469|FG008|Part A and Part B|Lost to Follow-up|0|||
163242122|NCT02332720|589594470|FG009|Part A and Part B|Lost to Follow-up|0|||
163242123|NCT02332720|589594471|FG010|Part A and Part B|Lost to Follow-up|0|||
163242124|NCT02332720|589594472|FG011|Part A and Part B|Lost to Follow-up|0|||
163242125|NCT02332720|589594473|FG012|Part A and Part B|Lost to Follow-up|0|||
163242126|NCT02332720|589594474|FG013|Part A and Part B|Lost to Follow-up|0|||
163242127|NCT02332720|589594475|FG014|Part A and Part B|Lost to Follow-up|0|||
163242128|NCT02332720|589594476|FG015|Part A and Part B|Lost to Follow-up|1|||
163242129|NCT02332720|589594477|FG016|Part A and Part B|Lost to Follow-up|0|||
163242130|NCT02332720|589594478|FG017|Part A and Part B|Lost to Follow-up|0|||
163242131|NCT02332720|589594479|FG018|Part A and Part B|Lost to Follow-up|0|||
163242132|NCT02332720|589594480|FG019|Part A and Part B|Lost to Follow-up|0|||
163242133|NCT02332720|589594481|FG020|Part A and Part B|Lost to Follow-up|0|||
163242134|NCT02332720|589594482|FG021|Part A and Part B|Lost to Follow-up|0|||
163242135|NCT02332720|589594483|FG022|Part A and Part B|Lost to Follow-up|0|||
163242136|NCT02332720|589594461|FG000|Part A and Part B|Adverse Event|0|||
163242137|NCT02332720|589594462|FG001|Part A and Part B|Adverse Event|0|||
163242138|NCT02332720|589594463|FG002|Part A and Part B|Adverse Event|0|||
163242139|NCT02332720|589594464|FG003|Part A and Part B|Adverse Event|0|||
163242140|NCT02332720|589594465|FG004|Part A and Part B|Adverse Event|0|||
163242141|NCT02332720|589594466|FG005|Part A and Part B|Adverse Event|0|||
163242142|NCT02332720|589594467|FG006|Part A and Part B|Adverse Event|0|||
163242143|NCT02332720|589594468|FG007|Part A and Part B|Adverse Event|0|||
163242144|NCT02332720|589594469|FG008|Part A and Part B|Adverse Event|0|||
163242145|NCT02332720|589594470|FG009|Part A and Part B|Adverse Event|0|||
163242146|NCT02332720|589594471|FG010|Part A and Part B|Adverse Event|0|||
163242147|NCT02332720|589594472|FG011|Part A and Part B|Adverse Event|0|||
163242148|NCT02332720|589594473|FG012|Part A and Part B|Adverse Event|0|||
163242149|NCT02332720|589594474|FG013|Part A and Part B|Adverse Event|0|||
163242150|NCT02332720|589594475|FG014|Part A and Part B|Adverse Event|0|||
163242151|NCT02332720|589594476|FG015|Part A and Part B|Adverse Event|0|||
163242152|NCT02332720|589594477|FG016|Part A and Part B|Adverse Event|0|||
163242153|NCT02332720|589594478|FG017|Part A and Part B|Adverse Event|1|||
163242154|NCT02332720|589594479|FG018|Part A and Part B|Adverse Event|0|||
163242155|NCT02332720|589594480|FG019|Part A and Part B|Adverse Event|0|||
163242156|NCT02332720|589594481|FG020|Part A and Part B|Adverse Event|0|||
163242157|NCT02332720|589594482|FG021|Part A and Part B|Adverse Event|0|||
163242158|NCT02332720|589594483|FG022|Part A and Part B|Adverse Event|0|||
163242159|NCT02332720|589594461|FG000|Part A and Part B|Physician Decision|0|||
163242160|NCT02332720|589594462|FG001|Part A and Part B|Physician Decision|0|||
163242161|NCT02332720|589594463|FG002|Part A and Part B|Physician Decision|0|||
163242162|NCT02332720|589594464|FG003|Part A and Part B|Physician Decision|0|||
163242163|NCT02332720|589594465|FG004|Part A and Part B|Physician Decision|0|||
163242164|NCT02332720|589594466|FG005|Part A and Part B|Physician Decision|0|||
163242165|NCT02332720|589594467|FG006|Part A and Part B|Physician Decision|0|||
163242166|NCT02332720|589594468|FG007|Part A and Part B|Physician Decision|0|||
163242167|NCT02332720|589594469|FG008|Part A and Part B|Physician Decision|0|||
163242168|NCT02332720|589594470|FG009|Part A and Part B|Physician Decision|0|||
163242169|NCT02332720|589594471|FG010|Part A and Part B|Physician Decision|0|||
163242170|NCT02332720|589594472|FG011|Part A and Part B|Physician Decision|0|||
163242171|NCT02332720|589594473|FG012|Part A and Part B|Physician Decision|0|||
163242172|NCT02332720|589594474|FG013|Part A and Part B|Physician Decision|0|||
163242173|NCT02332720|589594475|FG014|Part A and Part B|Physician Decision|0|||
163242174|NCT02332720|589594476|FG015|Part A and Part B|Physician Decision|0|||
163242175|NCT02332720|589594477|FG016|Part A and Part B|Physician Decision|0|||
163242176|NCT02332720|589594478|FG017|Part A and Part B|Physician Decision|0|||
163242177|NCT02332720|589594479|FG018|Part A and Part B|Physician Decision|1|||
163242178|NCT02332720|589594480|FG019|Part A and Part B|Physician Decision|0|||
163351230|NCT01917006|589996122|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
163351231|NCT01917006|589996123|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
163351232|NCT01917006|589996124|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
163351233|NCT01917006|589996125|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
163351234|NCT01917006|589996126|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
163351235|NCT01917006|589996127|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
163351236|NCT01917006|589996120|FG000|Randomized-treatment Period|Personal Reasons|0|||
163242179|NCT02332720|589594481|FG020|Part A and Part B|Physician Decision|0|||
163242180|NCT02332720|589594482|FG021|Part A and Part B|Physician Decision|0|||
163242181|NCT02332720|589594483|FG022|Part A and Part B|Physician Decision|0|||
163242182|NCT02332720|589594461|FG000|Part A and Part B|Withdrawal by Subject|0|||
163242183|NCT02332720|589594462|FG001|Part A and Part B|Withdrawal by Subject|0|||
163242184|NCT02332720|589594463|FG002|Part A and Part B|Withdrawal by Subject|0|||
163242185|NCT02332720|589594464|FG003|Part A and Part B|Withdrawal by Subject|0|||
163242186|NCT02332720|589594465|FG004|Part A and Part B|Withdrawal by Subject|0|||
163242187|NCT02332720|589594466|FG005|Part A and Part B|Withdrawal by Subject|1|||
163242188|NCT02332720|589594467|FG006|Part A and Part B|Withdrawal by Subject|0|||
163242189|NCT02332720|589594468|FG007|Part A and Part B|Withdrawal by Subject|0|||
163242190|NCT02332720|589594469|FG008|Part A and Part B|Withdrawal by Subject|0|||
163242191|NCT02332720|589594470|FG009|Part A and Part B|Withdrawal by Subject|0|||
163242192|NCT02332720|589594471|FG010|Part A and Part B|Withdrawal by Subject|0|||
163242193|NCT02332720|589594472|FG011|Part A and Part B|Withdrawal by Subject|0|||
163242194|NCT02332720|589594473|FG012|Part A and Part B|Withdrawal by Subject|0|||
163242195|NCT02332720|589594474|FG013|Part A and Part B|Withdrawal by Subject|0|||
163242196|NCT02332720|589594475|FG014|Part A and Part B|Withdrawal by Subject|0|||
163242197|NCT02332720|589594476|FG015|Part A and Part B|Withdrawal by Subject|0|||
163242198|NCT02332720|589594477|FG016|Part A and Part B|Withdrawal by Subject|0|||
163242199|NCT02332720|589594478|FG017|Part A and Part B|Withdrawal by Subject|0|||
163242200|NCT02332720|589594479|FG018|Part A and Part B|Withdrawal by Subject|0|||
163242201|NCT02332720|589594480|FG019|Part A and Part B|Withdrawal by Subject|1|||
163242202|NCT02332720|589594481|FG020|Part A and Part B|Withdrawal by Subject|0|||
163242203|NCT02332720|589594482|FG021|Part A and Part B|Withdrawal by Subject|0|||
163242204|NCT02332720|589594483|FG022|Part A and Part B|Withdrawal by Subject|0|||
163242205|NCT05732454|589594484|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
163242206|NCT05732454|589594485|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
163242207|NCT05732454|589594484|FG000|Part 1: DB Period|Adverse Event|1|||
163242208|NCT05732454|589594485|FG001|Part 1: DB Period|Adverse Event|0|||
163242209|NCT05732454|589594484|FG000|Part 1: DB Period|Lost to Follow-up|1|||
163242210|NCT05732454|589594485|FG001|Part 1: DB Period|Lost to Follow-up|0|||
163242211|NCT05732454|589594484|FG000|Part 1: DB Period|Protocol Violation|0|||
163242212|NCT05732454|589594485|FG001|Part 1: DB Period|Protocol Violation|1|||
163242213|NCT05732454|589594484|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
163242214|NCT05732454|589594485|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
163242215|NCT05732454|589594484|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
163242216|NCT05732454|589594485|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
163242217|NCT05732454|589594484|FG000|Part 1: OLE Period|Adverse Event|0|||
163242218|NCT05732454|589594485|FG001|Part 1: OLE Period|Adverse Event|1|||
163242219|NCT05732454|589594484|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
163242220|NCT05732454|589594485|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
163242221|NCT00838110|589594488|FG000|Overall Study|Death|0|||
163242222|NCT00838110|589594489|FG001|Overall Study|Death|0|||
163242223|NCT00838110|589594490|FG002|Overall Study|Death|1|||
163242224|NCT00838110|589594491|FG003|Overall Study|Death|2|||
163242225|NCT00838110|589594488|FG000|Overall Study|Adverse Event|11|||
163242226|NCT00838110|589594489|FG001|Overall Study|Adverse Event|10|||
163242227|NCT00838110|589594490|FG002|Overall Study|Adverse Event|8|||
163242228|NCT00838110|589594491|FG003|Overall Study|Adverse Event|7|||
163242229|NCT00838110|589594488|FG000|Overall Study|Withdrawal by Subject|5|||
163242230|NCT00838110|589594489|FG001|Overall Study|Withdrawal by Subject|6|||
163242231|NCT00838110|589594490|FG002|Overall Study|Withdrawal by Subject|3|||
163242232|NCT00838110|589594491|FG003|Overall Study|Withdrawal by Subject|4|||
163242233|NCT00838110|589594488|FG000|Overall Study|Other|3|||
163242234|NCT00838110|589594489|FG001|Overall Study|Other|3|||
163242235|NCT00838110|589594490|FG002|Overall Study|Other|3|||
163242236|NCT00838110|589594491|FG003|Overall Study|Other|2|||
163242237|NCT00838110|589594488|FG000|Overall Study|Protocol Violation|0|||
163242238|NCT00838110|589594489|FG001|Overall Study|Protocol Violation|2|||
163242239|NCT00838110|589594490|FG002|Overall Study|Protocol Violation|1|||
163242240|NCT00838110|589594491|FG003|Overall Study|Protocol Violation|1|||
163242241|NCT00838110|589594488|FG000|Overall Study|Lost to Follow-up|3|||
163242242|NCT00838110|589594489|FG001|Overall Study|Lost to Follow-up|0|||
163242243|NCT00838110|589594490|FG002|Overall Study|Lost to Follow-up|0|||
163242244|NCT00838110|589594491|FG003|Overall Study|Lost to Follow-up|0|||
163242245|NCT00838110|589594488|FG000|Overall Study|Did not meet eligibility criteria|0|||
163242246|NCT00838110|589594489|FG001|Overall Study|Did not meet eligibility criteria|0|||
163242247|NCT00838110|589594490|FG002|Overall Study|Did not meet eligibility criteria|1|||
163242248|NCT00838110|589594491|FG003|Overall Study|Did not meet eligibility criteria|2|||
163242249|NCT00838110|589594488|FG000|Overall Study|Randomized but not treated|0|||
163242250|NCT00838110|589594489|FG001|Overall Study|Randomized but not treated|1|||
163242251|NCT00838110|589594490|FG002|Overall Study|Randomized but not treated|0|||
163242252|NCT00838110|589594491|FG003|Overall Study|Randomized but not treated|0|||
163242253|NCT00352365|589594492|FG000|Induction Therapy|Adverse Event|7|||
163242254|NCT00352365|589594492|FG000|Induction Therapy|Progression/Relapse|8|||
163242255|NCT00352365|589594492|FG000|Induction Therapy|Death|7|||
163242256|NCT00352365|589594492|FG000|Induction Therapy|Not protocol specified|1|||
163242257|NCT00352365|589594492|FG000|Induction Therapy|Not eligible|3|||
163242258|NCT00352365|589594492|FG000|Induction Therapy|Death before starting protocol therapy|1|||
163242259|NCT00352365|589594492|FG000|Maintenance Therapy|Progression/Relapse|3|||
163242260|NCT00352365|589594492|FG000|Maintenance Therapy|Death|2|||
163242261|NCT00352365|589594492|FG000|Maintenance Therapy|Not protocol specified|3|||
163242262|NCT00352365|589594492|FG000|Maintenance Therapy|Not eligible|4|||
163242263|NCT01262651|589594493|FG000|Overall Study|Adverse Event|40|||
163242264|NCT01262651|589594494|FG001|Overall Study|Adverse Event|35|||
163242265|NCT01262651|589594493|FG000|Overall Study|Withdrawal by Subject|15|||
163242266|NCT01262651|589594494|FG001|Overall Study|Withdrawal by Subject|11|||
163242267|NCT01262651|589594493|FG000|Overall Study|Withdrawal by Investigator|2|||
163242268|NCT01262651|589594494|FG001|Overall Study|Withdrawal by Investigator|2|||
163242269|NCT01262651|589594493|FG000|Overall Study|Met Withdrawal Criteria|1|||
163242270|NCT01262651|589594494|FG001|Overall Study|Met Withdrawal Criteria|0|||
163242271|NCT04743908|589594495|FG000|Overall Study|Death|1|||
163242272|NCT04743908|589594496|FG001|Overall Study|Death|0|||
163242273|NCT04743908|589594495|FG000|Overall Study|Lost to Follow-up|181|||
163242274|NCT04743908|589594496|FG001|Overall Study|Lost to Follow-up|180|||
163242275|NCT04743908|589594495|FG000|Overall Study|Withdrawal by Subject|1|||
163242276|NCT04743908|589594496|FG001|Overall Study|Withdrawal by Subject|2|||
163242277|NCT03822533|589594497|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
163242278|NCT03822533|589594498|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
163242279|NCT03822533|589594497|FG000|3 Month Follow-up|Lost to Follow-up|2|||
163242280|NCT03822533|589594498|FG001|3 Month Follow-up|Lost to Follow-up|2|||
163242281|NCT03822533|589594497|FG000|6 Month Follow-up|Lost to Follow-up|3|||
163242282|NCT03822533|589594498|FG001|6 Month Follow-up|Lost to Follow-up|0|||
163242283|NCT03822533|589594497|FG000|12 Month Follow-up|Lost to Follow-up|2|||
163242284|NCT03822533|589594498|FG001|12 Month Follow-up|Lost to Follow-up|3|||
163242285|NCT03822533|589594497|FG000|12 Month Follow-up|Pregnancy|0|||
163242286|NCT03822533|589594498|FG001|12 Month Follow-up|Pregnancy|1|||
163242287|NCT03822533|589594497|FG000|12 Month Follow-up|Surgery|2|||
163242288|NCT03822533|589594498|FG001|12 Month Follow-up|Surgery|0|||
163242289|NCT03822533|589594497|FG000|12 Month Follow-up|Wrong address|1|||
163242290|NCT03822533|589594498|FG001|12 Month Follow-up|Wrong address|0|||
163242291|NCT03822533|589594497|FG000|12 Month Follow-up|No symptoms|1|||
163242292|NCT03822533|589594498|FG001|12 Month Follow-up|No symptoms|0|||
163242293|NCT03822533|589594497|FG000|12 Month Follow-up|Changed primary care center|0|||
163242294|NCT03822533|589594498|FG001|12 Month Follow-up|Changed primary care center|1|||
163242295|NCT01412944|589594499|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
163242296|NCT01412944|589594500|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
163242297|NCT01412944|589594501|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
163242298|NCT01412944|589594502|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
163242299|NCT01412944|589594503|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
163242300|NCT01412944|589594504|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
163242301|NCT01412944|589594499|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
163242302|NCT01412944|589594500|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
163242303|NCT01412944|589594501|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
163242304|NCT01412944|589594502|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
163242305|NCT01412944|589594503|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
163242306|NCT01412944|589594504|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
163242307|NCT01412944|589594499|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
163242308|NCT01412944|589594500|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
163242309|NCT01412944|589594501|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
163242310|NCT01412944|589594502|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
163242311|NCT01412944|589594503|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
163242312|NCT01412944|589594504|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
163242313|NCT01412944|589594499|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
163242314|NCT01412944|589594500|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
163242315|NCT01412944|589594501|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
163242316|NCT01412944|589594502|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
163242317|NCT01412944|589594503|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
163242318|NCT01412944|589594504|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
163242319|NCT01412944|589594499|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
163242320|NCT01412944|589594500|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
163242321|NCT01412944|589594501|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
163242322|NCT01412944|589594502|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
163242323|NCT01412944|589594503|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
163242324|NCT01412944|589594504|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
163410001|NCT00999908|590209557|FG000|Treatment Period 1|Subject withdrew consent|2|||
163242325|NCT01412944|589594499|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
163242326|NCT01412944|589594500|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
163242327|NCT01412944|589594501|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
163242328|NCT01412944|589594502|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
163242329|NCT01412944|589594503|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
163242330|NCT01412944|589594504|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
163242331|NCT01412944|589594499|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
163242332|NCT01412944|589594500|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
163242333|NCT01412944|589594501|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
163242334|NCT01412944|589594502|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
163242335|NCT01412944|589594503|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
163242336|NCT01412944|589594504|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
163242337|NCT01412944|589594499|FG000|Entire: IV + Maintenance|Adverse Event|0|||
163242338|NCT01412944|589594500|FG001|Entire: IV + Maintenance|Adverse Event|0|||
163242339|NCT01412944|589594501|FG002|Entire: IV + Maintenance|Adverse Event|0|||
163242340|NCT01412944|589594502|FG003|Entire: IV + Maintenance|Adverse Event|0|||
163242341|NCT01412944|589594503|FG004|Entire: IV + Maintenance|Adverse Event|1|||
163242342|NCT01412944|589594504|FG005|Entire: IV + Maintenance|Adverse Event|0|||
163242343|NCT01412944|589594499|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
163242344|NCT01412944|589594500|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
163242345|NCT01412944|589594501|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
163242346|NCT01412944|589594502|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
163242347|NCT01412944|589594503|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
163242348|NCT01412944|589594504|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
163242349|NCT01412944|589594499|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
163242350|NCT01412944|589594500|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
163242351|NCT01412944|589594501|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
163242352|NCT01412944|589594502|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
163242353|NCT01412944|589594503|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
163242354|NCT01412944|589594504|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
163242355|NCT01412944|589594499|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
163242356|NCT01412944|589594500|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
163242357|NCT01412944|589594501|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
163242358|NCT01412944|589594502|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
163242359|NCT01412944|589594503|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
163242360|NCT01412944|589594504|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
163242361|NCT01412944|589594499|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
163242362|NCT01412944|589594500|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
163242363|NCT01412944|589594501|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
163242364|NCT01412944|589594502|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
163242365|NCT01412944|589594503|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
163242366|NCT01412944|589594504|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
163242367|NCT01412944|589594499|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
163242368|NCT01412944|589594500|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
163242369|NCT01412944|589594501|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
163242370|NCT01412944|589594502|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
163242371|NCT01412944|589594503|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
163242372|NCT01412944|589594504|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
163242373|NCT01412944|589594499|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
163242374|NCT01412944|589594500|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
163242375|NCT01412944|589594501|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
163242376|NCT01412944|589594502|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
163242377|NCT01412944|589594503|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
163242378|NCT01412944|589594504|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
163242379|NCT01412944|589594499|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
163242380|NCT01412944|589594500|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
163242381|NCT01412944|589594501|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
163242382|NCT01412944|589594502|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
163242383|NCT01412944|589594503|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
163242384|NCT01412944|589594504|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
163242385|NCT01412944|589594499|FG000|Entire: IV + Maintenance|Adverse Event|0|||
163242386|NCT01412944|589594500|FG001|Entire: IV + Maintenance|Adverse Event|1|||
163242387|NCT01412944|589594501|FG002|Entire: IV + Maintenance|Adverse Event|0|||
163242388|NCT01412944|589594502|FG003|Entire: IV + Maintenance|Adverse Event|0|||
163351237|NCT01917006|589996121|FG001|Randomized-treatment Period|Personal Reasons|0|||
163351238|NCT01917006|589996122|FG002|Randomized-treatment Period|Personal Reasons|0|||
163242389|NCT01412944|589594503|FG004|Entire: IV + Maintenance|Adverse Event|0|||
163242390|NCT01412944|589594504|FG005|Entire: IV + Maintenance|Adverse Event|0|||
163242391|NCT01990950|589594505|FG000|Overall Study|Death|3|||
163242392|NCT01990950|589594505|FG000|Overall Study|Lost to Follow-up|2|||
163242393|NCT01990950|589594505|FG000|Overall Study|Withdrawal by Subject|6|||
163242394|NCT02863926|589594506|FG000|Overall Study|Physician Decision|1|||
163242395|NCT02863926|589594507|FG001|Overall Study|Physician Decision|0|||
163242396|NCT02863926|589594506|FG000|Overall Study|Lost to Follow-up|1|||
163242397|NCT02863926|589594507|FG001|Overall Study|Lost to Follow-up|1|||
163242398|NCT00455195|589594511|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
163242399|NCT00455195|589594512|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
163242400|NCT00455195|589594511|FG000|Double-blind Study AGLU02704|Death|1|||
163410002|NCT00999908|590209558|FG001|Treatment Period 1|Subject withdrew consent|0|||
163410003|NCT00999908|590209559|FG002|Treatment Period 1|Subject withdrew consent|0|||
163147832|NCT00878501|589252947|FG001|Overall Study|Mis-randomisation of patient|0|||
163147833|NCT00878501|589252948|FG002|Overall Study|Mis-randomisation of patient|0|||
163147834|NCT00878501|589252946|FG000|Overall Study|Administrative|0|||
163147835|NCT00878501|589252947|FG001|Overall Study|Administrative|0|||
163147836|NCT00878501|589252948|FG002|Overall Study|Administrative|1|||
163147837|NCT01690052|589252955|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
163147838|NCT01690052|589252956|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
163147839|NCT01194830|589252960|FG000|Overall Study|Adverse Event|3|||
163147840|NCT01194830|589252961|FG001|Overall Study|Adverse Event|2|||
163147841|NCT01194830|589252960|FG000|Overall Study|Protocol Violation|5|||
163147842|NCT01194830|589252961|FG001|Overall Study|Protocol Violation|4|||
163147843|NCT01194830|589252960|FG000|Overall Study|Lost to Follow-up|9|||
163147844|NCT01194830|589252961|FG001|Overall Study|Lost to Follow-up|7|||
163147845|NCT01194830|589252960|FG000|Overall Study|Withdrawal by Subject|2|||
163147846|NCT01194830|589252961|FG001|Overall Study|Withdrawal by Subject|1|||
163147847|NCT01194830|589252960|FG000|Overall Study|Lack of Efficacy|1|||
163147848|NCT01194830|589252961|FG001|Overall Study|Lack of Efficacy|1|||
163147849|NCT01194830|589252960|FG000|Overall Study|Non-compliance issues|4|||
163147850|NCT01194830|589252961|FG001|Overall Study|Non-compliance issues|4|||
163147851|NCT01194830|589252960|FG000|Overall Study|Other Reason|12|||
163147852|NCT01194830|589252961|FG001|Overall Study|Other Reason|8|||
163147853|NCT01317472|589252964|FG000|Overall Study|Withdrawal by Subject|1|||
163147854|NCT01317472|589252965|FG001|Overall Study|Withdrawal by Subject|0|||
163147855|NCT01317472|589252964|FG000|Overall Study|Unrelated hospitalization|1|||
163147856|NCT01317472|589252965|FG001|Overall Study|Unrelated hospitalization|0|||
163147857|NCT01815918|589252966|FG000|Overall Study|Patient samples not analyzable|3|||
163147858|NCT01815918|589252967|FG001|Overall Study|Patient samples not analyzable|4|||
163147859|NCT01815918|589252966|FG000|Overall Study|Lack of Efficacy|15|||
163147860|NCT01815918|589252967|FG001|Overall Study|Lack of Efficacy|15|||
163147861|NCT00866177|589252970|FG000|Overall Study|Withdrawal by Subject|1|||
163147862|NCT00866177|589252970|FG000|Overall Study|Not Treated|151|||
163147863|NCT00807911|589252979|FG000|Overall Study|Withdrawal by Subject|12|||
163147864|NCT00807911|589252980|FG001|Overall Study|Withdrawal by Subject|10|||
163147865|NCT00807911|589252979|FG000|Overall Study|Ineligible|0|||
163147866|NCT00807911|589252980|FG001|Overall Study|Ineligible|4|||
163147867|NCT02648204|589252985|FG000|Overall Study|Withdrawal by Subject|12|||
163147868|NCT02648204|589252986|FG001|Overall Study|Withdrawal by Subject|8|||
163147869|NCT02648204|589252987|FG002|Overall Study|Withdrawal by Subject|2|||
163147870|NCT02648204|589252988|FG003|Overall Study|Withdrawal by Subject|6|||
163147871|NCT02648204|589252985|FG000|Overall Study|Lost to Follow-up|5|||
163147872|NCT02648204|589252986|FG001|Overall Study|Lost to Follow-up|8|||
163147873|NCT02648204|589252987|FG002|Overall Study|Lost to Follow-up|4|||
163147874|NCT02648204|589252988|FG003|Overall Study|Lost to Follow-up|6|||
163147875|NCT02648204|589252985|FG000|Overall Study|Missing follow-up information|4|||
163147876|NCT02648204|589252986|FG001|Overall Study|Missing follow-up information|4|||
163147877|NCT02648204|589252987|FG002|Overall Study|Missing follow-up information|4|||
163147878|NCT02648204|589252988|FG003|Overall Study|Missing follow-up information|2|||
163147879|NCT02648204|589252985|FG000|Overall Study|Death|1|||
163147880|NCT02648204|589252986|FG001|Overall Study|Death|1|||
163147881|NCT02648204|589252987|FG002|Overall Study|Death|2|||
163147882|NCT02648204|589252988|FG003|Overall Study|Death|2|||
163147883|NCT02648204|589252985|FG000|Overall Study|Adverse Event|0|||
163147884|NCT02648204|589252986|FG001|Overall Study|Adverse Event|0|||
163147885|NCT02648204|589252987|FG002|Overall Study|Adverse Event|1|||
163147886|NCT02648204|589252988|FG003|Overall Study|Adverse Event|0|||
163147887|NCT04349891|589252989|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
163147888|NCT04349891|589252990|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
163147889|NCT04349891|589252989|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
163147890|NCT04349891|589252990|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
163147891|NCT04349891|589252989|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
163147892|NCT04349891|589252990|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
163147893|NCT04349891|589252989|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
163147894|NCT04349891|589252990|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
163410004|NCT00999908|590209557|FG000|Treatment Period 2|Protocol Violation|1|||
163410005|NCT00999908|590209558|FG001|Treatment Period 2|Protocol Violation|0|||
163147895|NCT03532542|589252993|FG000|Overall Study|Death|1|||
163147896|NCT03532542|589252994|FG001|Overall Study|Death|0|||
163147897|NCT03532542|589252993|FG000|Overall Study|Study Terminated by Sponsor|41|||
163147898|NCT03532542|589252994|FG001|Overall Study|Study Terminated by Sponsor|65|||
163147899|NCT03532542|589252993|FG000|Overall Study|Withdrawal by Subject|6|||
163147900|NCT03532542|589252994|FG001|Overall Study|Withdrawal by Subject|5|||
163147901|NCT01018030|589252995|FG000|Overall Study|Adverse Event|10|||
163147902|NCT01018030|589252996|FG001|Overall Study|Adverse Event|5|||
163147903|NCT01018030|589252997|FG002|Overall Study|Adverse Event|5|||
163147904|NCT01018030|589252995|FG000|Overall Study|Withdrawal by Subject|2|||
163242401|NCT00455195|589594512|FG001|Double-blind Study AGLU02704|Death|0|||
163242402|NCT00455195|589594511|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
163147905|NCT01018030|589252996|FG001|Overall Study|Withdrawal by Subject|2|||
163147906|NCT01018030|589252997|FG002|Overall Study|Withdrawal by Subject|4|||
163147907|NCT01018030|589252995|FG000|Overall Study|Lost to Follow-up|2|||
163147908|NCT01018030|589252996|FG001|Overall Study|Lost to Follow-up|0|||
163147909|NCT01018030|589252997|FG002|Overall Study|Lost to Follow-up|3|||
163147910|NCT01018030|589252995|FG000|Overall Study|Protocol Violation|2|||
163147911|NCT01018030|589252996|FG001|Overall Study|Protocol Violation|1|||
163147912|NCT01018030|589252997|FG002|Overall Study|Protocol Violation|0|||
163147913|NCT01018030|589252995|FG000|Overall Study|Physician Decision|1|||
163147914|NCT01018030|589252996|FG001|Overall Study|Physician Decision|0|||
163147915|NCT01018030|589252997|FG002|Overall Study|Physician Decision|1|||
163147916|NCT01018030|589252995|FG000|Overall Study|Lack of Efficacy|1|||
163147917|NCT01018030|589252996|FG001|Overall Study|Lack of Efficacy|0|||
163147918|NCT01018030|589252997|FG002|Overall Study|Lack of Efficacy|0|||
163147919|NCT01018030|589252995|FG000|Overall Study|Did Not Receive Study Drug|1|||
163147920|NCT01018030|589252996|FG001|Overall Study|Did Not Receive Study Drug|3|||
163147921|NCT01018030|589252997|FG002|Overall Study|Did Not Receive Study Drug|0|||
163147922|NCT04590014|589253013|FG000|Overall Study|Withdrawal by Subject|1|||
163147923|NCT04590014|589253014|FG001|Overall Study|Withdrawal by Subject|0|||
163147924|NCT00468299|589253015|FG000|Overall Study|Withdrawal by Subject|0|||
163147925|NCT00468299|589253016|FG001|Overall Study|Withdrawal by Subject|1|||
163147926|NCT00625131|589253017|FG000|Overall Study|Lost to Follow-up|3|||
163147927|NCT00625131|589253018|FG001|Overall Study|Lost to Follow-up|2|||
163147928|NCT00625131|589253019|FG002|Overall Study|Lost to Follow-up|0|||
163147929|NCT00625131|589253017|FG000|Overall Study|Withdrawal by Subject|1|||
163147930|NCT00625131|589253018|FG001|Overall Study|Withdrawal by Subject|0|||
163147931|NCT00625131|589253019|FG002|Overall Study|Withdrawal by Subject|5|||
163147932|NCT05083351|589253025|FG000|Overall Study|Adverse Event|3|||
163147933|NCT05083351|589253025|FG000|Overall Study|Did not meet data inclusion criteria|8|||
163147934|NCT05083351|589253025|FG000|Overall Study|Did not meet eligibility criteria|19|||
163147935|NCT05083351|589253025|FG000|Overall Study|Study Staff Decision|19|||
163147936|NCT02343263|589253032|FG000|Overall Study|Physician Decision|5|||
163147937|NCT02343263|589253033|FG001|Overall Study|Physician Decision|3|||
163147938|NCT02343263|589253034|FG002|Overall Study|Physician Decision|1|||
163147939|NCT00849940|589253037|FG000|Overall Study|Physician Decision|4|||
163147940|NCT03353675|589253041|FG000|Overall Study|Adverse Event|4|||
163147941|NCT00402168|589253042|FG000|Randomized|Lost to Follow-up|1|||
163147942|NCT00402168|589253043|FG001|Randomized|Lost to Follow-up|0|||
163147943|NCT00402168|589253042|FG000|Randomized|Withdrawal by Subject|0|||
163147944|NCT00402168|589253043|FG001|Randomized|Withdrawal by Subject|1|||
163147945|NCT00402168|589253042|FG000|Treatment (up to 12 Months)|Death|0|||
163147946|NCT00402168|589253043|FG001|Treatment (up to 12 Months)|Death|1|||
163147947|NCT00402168|589253042|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
163147948|NCT00402168|589253043|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
163147949|NCT00402168|589253042|FG000|Treatment (up to 12 Months)|non-specified|0|||
163147950|NCT00402168|589253043|FG001|Treatment (up to 12 Months)|non-specified|1|||
163147951|NCT00402168|589253042|FG000|Long Term (LT)|Adverse Event|1|||
163147952|NCT00402168|589253043|FG001|Long Term (LT)|Adverse Event|5|||
163147953|NCT00402168|589253042|FG000|Long Term (LT)|Withdrawal by Subject|4|||
163147954|NCT00402168|589253043|FG001|Long Term (LT)|Withdrawal by Subject|7|||
163147955|NCT00402168|589253042|FG000|Long Term (LT)|Pregnancy|0|||
163147956|NCT00402168|589253043|FG001|Long Term (LT)|Pregnancy|1|||
163147957|NCT00402168|589253042|FG000|Long Term (LT)|Lost to Follow-up|1|||
163147958|NCT00402168|589253043|FG001|Long Term (LT)|Lost to Follow-up|0|||
163147959|NCT00402168|589253042|FG000|Long Term (LT)|Death|4|||
163147960|NCT00402168|589253043|FG001|Long Term (LT)|Death|0|||
163147961|NCT00402168|589253042|FG000|Long Term (LT)|Lack of Efficacy|0|||
163147962|NCT00402168|589253043|FG001|Long Term (LT)|Lack of Efficacy|2|||
163147963|NCT00402168|589253042|FG000|Long Term (LT)|non-specified|1|||
163147964|NCT00402168|589253043|FG001|Long Term (LT)|non-specified|2|||
163147965|NCT00402168|589253042|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
163147966|NCT00402168|589253043|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
163147967|NCT00402168|589253042|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
163147968|NCT00402168|589253043|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
163147969|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
163147970|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
163147971|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
163147972|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
163147973|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
163147974|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
163147975|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
163242403|NCT00455195|589594512|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
163242404|NCT00455195|589594511|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
163242405|NCT00455195|589594512|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
163242406|NCT01286779|589594513|FG000|Overall Study|Withdrawal by Subject|9|||
163242407|NCT01286779|589594513|FG000|Overall Study|Protocol Violation|5|||
163242408|NCT01286779|589594513|FG000|Overall Study|Physician Decision|2|||
163242409|NCT01286779|589594513|FG000|Overall Study|Participant had scheduled surgery|1|||
163242410|NCT01286779|589594513|FG000|Overall Study|Participant moved to another country|1|||
163242411|NCT01286779|589594513|FG000|Overall Study|Discontinued by sponsor|1|||
163242412|NCT00304070|589594514|FG000|Overall Study|Death|0|||
163242413|NCT00304070|589594515|FG001|Overall Study|Death|0|||
163242414|NCT00304070|589594516|FG002|Overall Study|Death|3|||
163242415|NCT00304070|589594514|FG000|Overall Study|Lost to Follow-up|0|||
163242416|NCT00304070|589594515|FG001|Overall Study|Lost to Follow-up|0|||
163242417|NCT00304070|589594516|FG002|Overall Study|Lost to Follow-up|1|||
163242418|NCT00304070|589594514|FG000|Overall Study|Physician Decision|0|||
163242419|NCT00304070|589594515|FG001|Overall Study|Physician Decision|0|||
163242420|NCT00304070|589594516|FG002|Overall Study|Physician Decision|3|||
163242421|NCT00304070|589594514|FG000|Overall Study|Withdrawal by Subject|0|||
163242422|NCT00304070|589594515|FG001|Overall Study|Withdrawal by Subject|0|||
163242423|NCT00304070|589594516|FG002|Overall Study|Withdrawal by Subject|1|||
163242424|NCT00304070|589594514|FG000|Overall Study|Progressive Disease|3|||
163242425|NCT00304070|589594515|FG001|Overall Study|Progressive Disease|7|||
163242426|NCT00304070|589594516|FG002|Overall Study|Progressive Disease|4|||
163242427|NCT00779246|589594525|FG000|Overall Study|Missing sufficient data for analysis|33|||
163242428|NCT00779246|589594526|FG001|Overall Study|Missing sufficient data for analysis|53|||
163242429|NCT02844946|589594527|FG000|Overall Study|Lost to Follow-up|7|||
163242430|NCT02844946|589594528|FG001|Overall Study|Lost to Follow-up|0|||
163242431|NCT02806986|589594529|FG000|Treatment Stage 1|Adverse Event|1|||
163242432|NCT02806986|589594529|FG000|Treatment Stage 2|Adverse Event|3|||
163242433|NCT02806986|589594529|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
163242434|NCT03646513|589594531|FG000|Overall Study|Premature study termination|4|||
163242435|NCT02334748|589594532|FG000|Overall Study|Adverse Event|1|||
163242436|NCT02334748|589594532|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
163242437|NCT02334748|589594532|FG000|Overall Study|Patient no longer required study drug|2|||
163242438|NCT02334748|589594532|FG000|Overall Study|Lack of Efficacy|4|||
163242439|NCT01046643|589594533|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
163242440|NCT01046643|589594534|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
163242441|NCT01046643|589594535|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
163242442|NCT01046643|589594536|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
163242443|NCT00093145|589594537|FG000|Overall Study|Unacceptable Toxicity Only|2|||
163242444|NCT00093145|589594537|FG000|Overall Study|Physician Decision|5|||
163242445|NCT00093145|589594537|FG000|Overall Study|Withdrawal by Subject|9|||
163242446|NCT00093145|589594537|FG000|Overall Study|Other|1|||
163242447|NCT01310036|589594538|FG000|Overall Study|Administrative/other|10|||
163242448|NCT01310036|589594538|FG000|Overall Study|Withdrew Consent|11|||
163242449|NCT01310036|589594538|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
163242450|NCT01310036|589594538|FG000|Overall Study|Progression of Disease|164|||
163242451|NCT01310036|589594538|FG000|Overall Study|Death|1|||
163242452|NCT01310036|589594538|FG000|Overall Study|Adverse event or intercurrent illness|12|||
163242453|NCT01175668|589594539|FG000|Overall Study|Withdrawal by Subject|2|||
163242454|NCT01175668|589594540|FG001|Overall Study|Withdrawal by Subject|0|||
163242455|NCT00817089|589594541|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
163242456|NCT00817089|589594542|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
163351239|NCT01917006|589996123|FG003|Randomized-treatment Period|Personal Reasons|0|||
163351240|NCT01917006|589996124|FG004|Randomized-treatment Period|Personal Reasons|0|||
163351241|NCT01917006|589996125|FG005|Randomized-treatment Period|Personal Reasons|1|||
163351242|NCT01917006|589996126|FG006|Randomized-treatment Period|Personal Reasons|0|||
163351243|NCT01917006|589996127|FG007|Randomized-treatment Period|Personal Reasons|0|||
163351244|NCT01917006|589996120|FG000|Randomized-treatment Period|Protocol Violation|1|||
163242457|NCT00817089|589594543|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
163242458|NCT00817089|589594544|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
163242459|NCT00817089|589594541|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
163242460|NCT00817089|589594542|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
163242461|NCT00817089|589594543|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
163242462|NCT00817089|589594544|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
163242463|NCT02043782|589594545|FG000|Period 1|Adverse Event|0|||
163242464|NCT02043782|589594546|FG001|Period 1|Adverse Event|0|||
163242465|NCT02043782|589594547|FG002|Period 1|Adverse Event|1|||
163242466|NCT02043782|589594548|FG003|Period 1|Adverse Event|0|||
163242467|NCT02043782|589594549|FG004|Period 1|Adverse Event|0|||
163242468|NCT02043782|589594550|FG005|Period 1|Adverse Event|0|||
163242469|NCT00709722|589594551|FG000|Overall Study|Adverse Event|1|||
163242470|NCT04667117|589594552|FG000|Investigational Period|Lost to Follow-up|0|||
163242471|NCT04667117|589594553|FG001|Investigational Period|Lost to Follow-up|0|||
163242472|NCT04667117|589594554|FG002|Investigational Period|Lost to Follow-up|1|||
163242473|NCT04667117|589594552|FG000|Investigational Period|Protocol Deviation|0|||
163351245|NCT01917006|589996121|FG001|Randomized-treatment Period|Protocol Violation|0|||
163242474|NCT04667117|589594553|FG001|Investigational Period|Protocol Deviation|1|||
163242475|NCT04667117|589594554|FG002|Investigational Period|Protocol Deviation|0|||
163242476|NCT04667117|589594552|FG000|Extension Period|Lost to Follow-up|1|||
163242477|NCT04667117|589594553|FG001|Extension Period|Lost to Follow-up|0|||
163242478|NCT04667117|589594554|FG002|Extension Period|Lost to Follow-up|0|||
163242479|NCT03359096|589594555|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
163242480|NCT03359096|589594556|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
163242481|NCT03359096|589594555|FG000|First Intervention (4 Weeks)|Death|1|||
163242482|NCT03359096|589594556|FG001|First Intervention (4 Weeks)|Death|0|||
163147976|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
163147977|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
163147978|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
163147979|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
163147980|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
163147981|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
163147982|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
163147983|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
163147984|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
163147985|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
163147986|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
163147987|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
163147988|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
163147989|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
163147990|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
163147991|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
163147992|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
163147993|NCT00550407|589253046|FG000|26-Week Randomized Phase|Adverse Event|0|||
163242483|NCT03359096|589594555|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
163242484|NCT03359096|589594556|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
163242485|NCT02007577|589594567|FG000|Overall Study|Adverse Event|1|||
163242486|NCT02007577|589594568|FG001|Overall Study|Adverse Event|0|||
163242487|NCT02007577|589594567|FG000|Overall Study|Withdrawal by Subject|0|||
163242488|NCT02007577|589594568|FG001|Overall Study|Withdrawal by Subject|1|||
163242489|NCT01953926|589594569|FG000|Overall Study|Withdrawal by Subject|23|||
163242490|NCT01953926|589594570|FG001|Overall Study|Withdrawal by Subject|3|||
163242491|NCT01953926|589594571|FG002|Overall Study|Withdrawal by Subject|3|||
163242492|NCT01953926|589594572|FG003|Overall Study|Withdrawal by Subject|5|||
163242493|NCT01953926|589594573|FG004|Overall Study|Withdrawal by Subject|6|||
163242494|NCT01953926|589594574|FG005|Overall Study|Withdrawal by Subject|0|||
163242495|NCT01953926|589594575|FG006|Overall Study|Withdrawal by Subject|1|||
163242496|NCT01953926|589594569|FG000|Overall Study|Physician Decision|1|||
163242497|NCT01953926|589594570|FG001|Overall Study|Physician Decision|0|||
163242498|NCT01953926|589594571|FG002|Overall Study|Physician Decision|0|||
163242499|NCT01953926|589594572|FG003|Overall Study|Physician Decision|0|||
163242500|NCT01953926|589594573|FG004|Overall Study|Physician Decision|2|||
163242501|NCT01953926|589594574|FG005|Overall Study|Physician Decision|0|||
163242502|NCT01953926|589594575|FG006|Overall Study|Physician Decision|0|||
163242503|NCT01953926|589594569|FG000|Overall Study|Lost to Follow-up|18|||
163242504|NCT01953926|589594570|FG001|Overall Study|Lost to Follow-up|3|||
163242505|NCT01953926|589594571|FG002|Overall Study|Lost to Follow-up|0|||
163242506|NCT01953926|589594572|FG003|Overall Study|Lost to Follow-up|5|||
163242507|NCT01953926|589594573|FG004|Overall Study|Lost to Follow-up|3|||
163242508|NCT01953926|589594574|FG005|Overall Study|Lost to Follow-up|0|||
163410006|NCT00999908|590209559|FG002|Treatment Period 2|Protocol Violation|0|||
163410007|NCT01097863|590209560|FG000|Overall Study|Discomfort|1|||
163410008|NCT01097863|590209561|FG001|Overall Study|Discomfort|0|||
163147994|NCT00550407|589253047|FG001|26-Week Randomized Phase|Adverse Event|5|||
163147995|NCT00550407|589253048|FG002|26-Week Randomized Phase|Adverse Event|2|||
163242509|NCT01953926|589594575|FG006|Overall Study|Lost to Follow-up|0|||
163242510|NCT01953926|589594569|FG000|Overall Study|Protocol Violation|1|||
163242511|NCT01953926|589594570|FG001|Overall Study|Protocol Violation|0|||
163242512|NCT01953926|589594571|FG002|Overall Study|Protocol Violation|0|||
163242513|NCT01953926|589594572|FG003|Overall Study|Protocol Violation|0|||
163242514|NCT01953926|589594573|FG004|Overall Study|Protocol Violation|0|||
163242515|NCT01953926|589594574|FG005|Overall Study|Protocol Violation|0|||
163242516|NCT01953926|589594575|FG006|Overall Study|Protocol Violation|0|||
163242517|NCT01953926|589594569|FG000|Overall Study|Other, Disease progression|2|||
163242518|NCT01953926|589594570|FG001|Overall Study|Other, Disease progression|1|||
163242519|NCT01953926|589594571|FG002|Overall Study|Other, Disease progression|0|||
163242520|NCT01953926|589594572|FG003|Overall Study|Other, Disease progression|0|||
163242521|NCT01953926|589594573|FG004|Overall Study|Other, Disease progression|1|||
163242522|NCT01953926|589594574|FG005|Overall Study|Other, Disease progression|0|||
163410009|NCT01097863|590209562|FG002|Overall Study|Discomfort|1|||
163147996|NCT00550407|589253046|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
163147997|NCT00550407|589253047|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
163147998|NCT00550407|589253048|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
163147999|NCT00550407|589253046|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
163148000|NCT00550407|589253047|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
163148001|NCT00550407|589253048|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
163148002|NCT00550407|589253046|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
163148003|NCT00550407|589253047|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
163148004|NCT00550407|589253048|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
163148005|NCT00584415|589253049|FG000|Overall Study|Adverse Event|7|||
163148006|NCT02370420|589253050|FG000|Overall Study|Physician Decision|3|||
163148007|NCT02370420|589253051|FG001|Overall Study|Physician Decision|3|||
163148008|NCT02370420|589253050|FG000|Overall Study|Lost to Follow-up|11|||
163148009|NCT02370420|589253051|FG001|Overall Study|Lost to Follow-up|9|||
163148010|NCT00556894|589253052|FG000|Overall Study|Adverse Event|2|||
163148011|NCT00556894|589253053|FG001|Overall Study|Adverse Event|3|||
163148012|NCT00556894|589253054|FG002|Overall Study|Adverse Event|3|||
163148013|NCT00556894|589253052|FG000|Overall Study|Death|1|||
163148014|NCT00556894|589253053|FG001|Overall Study|Death|0|||
163148015|NCT00556894|589253054|FG002|Overall Study|Death|0|||
163148016|NCT00556894|589253052|FG000|Overall Study|regulatory decision in Bulgaria|10|||
163148017|NCT00556894|589253053|FG001|Overall Study|regulatory decision in Bulgaria|14|||
163148018|NCT00556894|589253054|FG002|Overall Study|regulatory decision in Bulgaria|13|||
163148019|NCT00556894|589253052|FG000|Overall Study|Change in therapy|2|||
163148020|NCT00556894|589253053|FG001|Overall Study|Change in therapy|1|||
163148021|NCT00556894|589253054|FG002|Overall Study|Change in therapy|2|||
163148022|NCT00556894|589253052|FG000|Overall Study|Withdrawal by Subject|1|||
163148023|NCT00556894|589253053|FG001|Overall Study|Withdrawal by Subject|1|||
163148024|NCT00556894|589253054|FG002|Overall Study|Withdrawal by Subject|1|||
163148025|NCT03883581|589253055|FG000|Overall Study|Withdrawal by Subject|4|||
163148026|NCT03224130|589255347|FG000|Overall Study|consent issue|0|||
163148027|NCT03224130|589255348|FG001|Overall Study|consent issue|1|||
163148028|NCT01453049|589255349|FG000|Overall Study|Protocol Violation|2|||
163148029|NCT01453049|589255350|FG001|Overall Study|Protocol Violation|5|||
163148030|NCT01453049|589255349|FG000|Overall Study|Lost to Follow-up|2|||
163148031|NCT01453049|589255350|FG001|Overall Study|Lost to Follow-up|1|||
163148032|NCT01453049|589255349|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
163148033|NCT01453049|589255350|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
163148034|NCT01453049|589255349|FG000|Overall Study|Withdrawal by Subject|1|||
163148035|NCT01453049|589255350|FG001|Overall Study|Withdrawal by Subject|0|||
163148036|NCT01453049|589255349|FG000|Overall Study|Randomized in Error|1|||
163148037|NCT01453049|589255350|FG001|Overall Study|Randomized in Error|0|||
163148038|NCT00768989|589255353|FG000|Prior to Week 24|Withdrawal by Subject|1|||
163148039|NCT00768989|589255354|FG001|Prior to Week 24|Withdrawal by Subject|0|||
163148040|NCT00768989|589255353|FG000|Prior to Week 24|Adverse Event|3|||
163148041|NCT00768989|589255354|FG001|Prior to Week 24|Adverse Event|0|||
163148042|NCT00768989|589255353|FG000|Prior to Week 24|Lost to Follow-up|0|||
163148043|NCT00768989|589255354|FG001|Prior to Week 24|Lost to Follow-up|1|||
163148044|NCT00768989|589255353|FG000|Prior to Week 24|Protocol Violation|0|||
163148045|NCT00768989|589255354|FG001|Prior to Week 24|Protocol Violation|2|||
163148046|NCT00768989|589255353|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
163148047|NCT00768989|589255354|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
163148048|NCT00768989|589255353|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
163148049|NCT00768989|589255354|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
163148050|NCT00768989|589255353|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
163148051|NCT00768989|589255354|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
163148052|NCT00768989|589255353|FG000|On or After Week 36|Lack of Efficacy|1|||
163148053|NCT00768989|589255354|FG001|On or After Week 36|Lack of Efficacy|0|||
163148054|NCT00768989|589255353|FG000|On or After Week 36|Adverse Event|0|||
163148055|NCT00768989|589255354|FG001|On or After Week 36|Adverse Event|1|||
163148056|NCT00768989|589255353|FG000|On or After Week 36|Lost to Follow-up|1|||
163148057|NCT00768989|589255354|FG001|On or After Week 36|Lost to Follow-up|0|||
163148058|NCT00768989|589255353|FG000|On or After Week 36|Poor Compliance|1|||
163148059|NCT00768989|589255354|FG001|On or After Week 36|Poor Compliance|0|||
163148060|NCT00768989|589255353|FG000|On or After Week 36|Protocol Violation|1|||
163148061|NCT00768989|589255354|FG001|On or After Week 36|Protocol Violation|0|||
163148062|NCT00768989|589255353|FG000|On or After Week 36|Did not attend termination visit|2|||
163148063|NCT00768989|589255354|FG001|On or After Week 36|Did not attend termination visit|0|||
163148064|NCT00768989|589255353|FG000|On or After Week 36|Sponsor Termination|45|||
163148065|NCT00768989|589255354|FG001|On or After Week 36|Sponsor Termination|26|||
163148066|NCT02153086|589255355|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
163148067|NCT02153086|589255355|FG000|Overall Study|Other|2|||
163148068|NCT03115359|589255356|FG000|Overall Study|Withdrawal by Subject|29|||
163148069|NCT03115359|589255357|FG001|Overall Study|Withdrawal by Subject|39|||
163148070|NCT03115359|589255356|FG000|Overall Study|Scheduling conflict|25|||
163148071|NCT03115359|589255357|FG001|Overall Study|Scheduling conflict|23|||
163242523|NCT01953926|589594575|FG006|Overall Study|Other, Disease progression|0|||
163242524|NCT01953926|589594569|FG000|Overall Study|Discontinuation of study by sponsor|41|||
163242525|NCT01953926|589594570|FG001|Overall Study|Discontinuation of study by sponsor|7|||
163242526|NCT01953926|589594571|FG002|Overall Study|Discontinuation of study by sponsor|5|||
163242527|NCT01953926|589594572|FG003|Overall Study|Discontinuation of study by sponsor|12|||
163242528|NCT01953926|589594573|FG004|Overall Study|Discontinuation of study by sponsor|46|||
163242529|NCT01953926|589594574|FG005|Overall Study|Discontinuation of study by sponsor|5|||
163242530|NCT01953926|589594575|FG006|Overall Study|Discontinuation of study by sponsor|6|||
163242531|NCT01953926|589594569|FG000|Overall Study|Not Treated|1|||
163242532|NCT01953926|589594570|FG001|Overall Study|Not Treated|0|||
163242533|NCT01953926|589594571|FG002|Overall Study|Not Treated|1|||
163242534|NCT01953926|589594572|FG003|Overall Study|Not Treated|0|||
163242535|NCT01953926|589594573|FG004|Overall Study|Not Treated|0|||
163242536|NCT01953926|589594574|FG005|Overall Study|Not Treated|0|||
163242537|NCT01953926|589594575|FG006|Overall Study|Not Treated|0|||
163242538|NCT04102501|589594579|FG000|Overall Study|Withdrawal by Subject|7|||
163242539|NCT04102501|589594580|FG001|Overall Study|Withdrawal by Subject|9|||
163242540|NCT04102501|589594579|FG000|Overall Study|Adverse Event|1|||
163242541|NCT04102501|589594580|FG001|Overall Study|Adverse Event|3|||
163242542|NCT02338362|589594582|FG000|Overall Study|Withdrawal by Subject|1|||
163242543|NCT02338362|589594583|FG001|Overall Study|Withdrawal by Subject|1|||
163242544|NCT04798586|589594585|FG000|Overall Study|Death|2|||
163242545|NCT00968617|589594586|FG000|Overall Study|Study terminated by sponsor|6|||
163242546|NCT04433767|589594587|FG000|Overall Study|Adverse Event|1|||
163242547|NCT03325712|589594595|FG000|Overall Study|Protocol Violation|0|||
163242548|NCT03325712|589594596|FG001|Overall Study|Protocol Violation|0|||
163242549|NCT03325712|589594597|FG002|Overall Study|Protocol Violation|0|||
163242550|NCT03325712|589594598|FG003|Overall Study|Protocol Violation|0|||
163242551|NCT03325712|589594599|FG004|Overall Study|Protocol Violation|1|||
163242552|NCT03325712|589594600|FG005|Overall Study|Protocol Violation|0|||
163242553|NCT03325712|589594601|FG006|Overall Study|Protocol Violation|0|||
163242554|NCT03325712|589594602|FG007|Overall Study|Protocol Violation|0|||
163242555|NCT03325712|589594595|FG000|Overall Study|Adverse Event|0|||
163242556|NCT03325712|589594596|FG001|Overall Study|Adverse Event|0|||
163242557|NCT03325712|589594597|FG002|Overall Study|Adverse Event|0|||
163242558|NCT03325712|589594598|FG003|Overall Study|Adverse Event|0|||
163242559|NCT03325712|589594599|FG004|Overall Study|Adverse Event|1|||
163242560|NCT03325712|589594600|FG005|Overall Study|Adverse Event|0|||
163242561|NCT03325712|589594601|FG006|Overall Study|Adverse Event|0|||
163242562|NCT03325712|589594602|FG007|Overall Study|Adverse Event|0|||
163242563|NCT02265237|589594603|FG000|As Treated (Overall Study)|Adverse Event|1|||
163242564|NCT02265237|589594604|FG001|As Treated (Overall Study)|Adverse Event|1|||
163242565|NCT02265237|589594605|FG002|As Treated (Overall Study)|Adverse Event|0|||
163242566|NCT02265237|589594606|FG003|As Treated (Overall Study)|Adverse Event|0|||
163242567|NCT02265237|589594603|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
163242568|NCT02265237|589594604|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
163242569|NCT02265237|589594605|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
163242570|NCT02265237|589594606|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
163242571|NCT02265237|589594603|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
163242572|NCT02265237|589594604|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
163242573|NCT02265237|589594605|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
163242574|NCT02265237|589594606|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
163242575|NCT02265237|589594603|FG000|As Treated (Overall Study)|Other|2|||
163242576|NCT02265237|589594604|FG001|As Treated (Overall Study)|Other|0|||
163242577|NCT02265237|589594605|FG002|As Treated (Overall Study)|Other|3|||
163242578|NCT02265237|589594606|FG003|As Treated (Overall Study)|Other|1|||
163242579|NCT01178853|589594608|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
163242580|NCT01178853|589594609|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
163242581|NCT01178853|589594608|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
163242582|NCT01178853|589594609|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
163242583|NCT01178853|589594608|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
163242584|NCT01178853|589594609|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
163242585|NCT01178853|589594608|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
163242586|NCT01178853|589594609|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
163242587|NCT01178853|589594608|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
163242588|NCT01178853|589594609|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
163242589|NCT03550313|589594610|FG000|Overall Study|Adverse Event|0|||
163242590|NCT03550313|589594611|FG001|Overall Study|Adverse Event|1|||
163242591|NCT03550313|589594612|FG002|Overall Study|Adverse Event|0|||
163242592|NCT03550313|589594610|FG000|Overall Study|Lost to Follow-up|5|||
163242593|NCT03550313|589594611|FG001|Overall Study|Lost to Follow-up|7|||
163242594|NCT03550313|589594612|FG002|Overall Study|Lost to Follow-up|12|||
163242595|NCT03550313|589594610|FG000|Overall Study|Study terminated by sponsor|44|||
163242596|NCT03550313|589594611|FG001|Overall Study|Study terminated by sponsor|37|||
163242597|NCT03550313|589594612|FG002|Overall Study|Study terminated by sponsor|48|||
163242598|NCT03550313|589594610|FG000|Overall Study|No longer met eligibility criteria|3|||
163242599|NCT03550313|589594611|FG001|Overall Study|No longer met eligibility criteria|5|||
163242600|NCT03550313|589594612|FG002|Overall Study|No longer met eligibility criteria|6|||
163242601|NCT03550313|589594610|FG000|Overall Study|Withdrawal by parent/guardian|20|||
163242602|NCT03550313|589594611|FG001|Overall Study|Withdrawal by parent/guardian|18|||
163242603|NCT03550313|589594612|FG002|Overall Study|Withdrawal by parent/guardian|26|||
163242604|NCT03550313|589594610|FG000|Overall Study|Other|4|||
163242605|NCT03550313|589594611|FG001|Overall Study|Other|2|||
163242606|NCT03550313|589594612|FG002|Overall Study|Other|2|||
163242607|NCT03550313|589594610|FG000|Overall Study|Randomized but not vaccinated|3|||
163242608|NCT03550313|589594611|FG001|Overall Study|Randomized but not vaccinated|23|||
163242609|NCT03550313|589594612|FG002|Overall Study|Randomized but not vaccinated|2|||
163242610|NCT03550313|589594610|FG000|Overall Study|Sites terminated due to quality issues|18|||
163242611|NCT03550313|589594611|FG001|Overall Study|Sites terminated due to quality issues|17|||
163242612|NCT03550313|589594612|FG002|Overall Study|Sites terminated due to quality issues|18|||
163242613|NCT00839072|589594613|FG000|First Intervention Period|Withdrawal by Subject|1|||
163242614|NCT00839072|589594614|FG001|First Intervention Period|Withdrawal by Subject|0|||
163242615|NCT00839072|589594613|FG000|First Intervention Period|Adverse Event|1|||
163242616|NCT00839072|589594614|FG001|First Intervention Period|Adverse Event|1|||
163242617|NCT00839072|589594613|FG000|Second Intervention Period|Withdrawal by Subject|1|||
163242618|NCT00839072|589594614|FG001|Second Intervention Period|Withdrawal by Subject|0|||
163242619|NCT00380068|589594615|FG000|Overall Study|Adverse Event|40|||
163242620|NCT00380068|589594615|FG000|Overall Study|Withdrawal by Subject|10|||
163242621|NCT00380068|589594615|FG000|Overall Study|Not compliant|6|||
163242622|NCT00380068|589594615|FG000|Overall Study|Lost to Follow-up|1|||
163242623|NCT00380068|589594615|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
163242624|NCT00380068|589594615|FG000|Overall Study|Lung transplant|3|||
163242625|NCT00380068|589594615|FG000|Overall Study|Physician Decision|2|||
163242626|NCT00380068|589594615|FG000|Overall Study|Partipant moved away|1|||
163242627|NCT00380068|589594615|FG000|Overall Study|Lack of Efficacy|5|||
163242628|NCT01297062|589594616|FG000|Overall Study|Adverse Event|2|||
163242629|NCT01297062|589594617|FG001|Overall Study|Adverse Event|0|||
163242630|NCT01297062|589594618|FG002|Overall Study|Adverse Event|1|||
163242631|NCT01297062|589594619|FG003|Overall Study|Adverse Event|0|||
163242632|NCT01297062|589594620|FG004|Overall Study|Adverse Event|0|||
163242633|NCT01297062|589594621|FG005|Overall Study|Adverse Event|0|||
163242634|NCT01297062|589594622|FG006|Overall Study|Adverse Event|0|||
163242635|NCT01297062|589594616|FG000|Overall Study|Physician Decision|1|||
163242636|NCT01297062|589594617|FG001|Overall Study|Physician Decision|0|||
163242637|NCT01297062|589594618|FG002|Overall Study|Physician Decision|1|||
163242638|NCT01297062|589594619|FG003|Overall Study|Physician Decision|0|||
163242639|NCT01297062|589594620|FG004|Overall Study|Physician Decision|0|||
163242640|NCT01297062|589594621|FG005|Overall Study|Physician Decision|0|||
163242641|NCT01297062|589594622|FG006|Overall Study|Physician Decision|6|||
163242642|NCT01297062|589594616|FG000|Overall Study|Protocol Violation|0|||
163242643|NCT01297062|589594617|FG001|Overall Study|Protocol Violation|0|||
163242644|NCT01297062|589594618|FG002|Overall Study|Protocol Violation|0|||
163242645|NCT01297062|589594619|FG003|Overall Study|Protocol Violation|0|||
163242646|NCT01297062|589594620|FG004|Overall Study|Protocol Violation|1|||
163242647|NCT01297062|589594621|FG005|Overall Study|Protocol Violation|0|||
163242648|NCT01297062|589594622|FG006|Overall Study|Protocol Violation|0|||
163242649|NCT01297062|589594616|FG000|Overall Study|Subject Decision|1|||
163242650|NCT01297062|589594617|FG001|Overall Study|Subject Decision|1|||
163242651|NCT01297062|589594618|FG002|Overall Study|Subject Decision|0|||
163351246|NCT01917006|589996122|FG002|Randomized-treatment Period|Protocol Violation|0|||
163351247|NCT01917006|589996123|FG003|Randomized-treatment Period|Protocol Violation|0|||
163351248|NCT01917006|589996124|FG004|Randomized-treatment Period|Protocol Violation|0|||
163351249|NCT01917006|589996125|FG005|Randomized-treatment Period|Protocol Violation|0|||
163351250|NCT01917006|589996126|FG006|Randomized-treatment Period|Protocol Violation|0|||
163351251|NCT01917006|589996127|FG007|Randomized-treatment Period|Protocol Violation|0|||
163351252|NCT01917006|589996120|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
163351253|NCT01917006|589996121|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
163351254|NCT01917006|589996122|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
163242652|NCT01297062|589594619|FG003|Overall Study|Subject Decision|1|||
163242653|NCT01297062|589594620|FG004|Overall Study|Subject Decision|1|||
163242654|NCT01297062|589594621|FG005|Overall Study|Subject Decision|1|||
163242655|NCT01297062|589594622|FG006|Overall Study|Subject Decision|2|||
163242656|NCT03191903|589594623|FG000|Overall Study|Withdrawal by Subject|6|||
163242657|NCT03191903|589594624|FG001|Overall Study|Withdrawal by Subject|5|||
163242658|NCT03191903|589594625|FG002|Overall Study|Withdrawal by Subject|4|||
163242659|NCT03191903|589594623|FG000|Overall Study|Adverse Event|1|||
163242660|NCT03191903|589594624|FG001|Overall Study|Adverse Event|0|||
163242661|NCT03191903|589594625|FG002|Overall Study|Adverse Event|0|||
163242662|NCT03149328|589594626|FG000|Overall Study|Withdrawal by Subject|30|||
163242663|NCT03149328|589594627|FG001|Overall Study|Withdrawal by Subject|26|||
163351255|NCT01917006|589996123|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
163351256|NCT01917006|589996124|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
163242664|NCT03149328|589594626|FG000|Overall Study|Changed Dialysis Modality|18|||
163242665|NCT03149328|589594627|FG001|Overall Study|Changed Dialysis Modality|1|||
163242666|NCT03149328|589594626|FG000|Overall Study|Transplant|9|||
163242667|NCT03149328|589594627|FG001|Overall Study|Transplant|1|||
163242668|NCT03149328|589594626|FG000|Overall Study|Lost to Follow-up|25|||
163242669|NCT03149328|589594627|FG001|Overall Study|Lost to Follow-up|16|||
163242670|NCT03149328|589594626|FG000|Overall Study|Left Study Site|1|||
163242671|NCT03149328|589594627|FG001|Overall Study|Left Study Site|2|||
163242672|NCT03149328|589594626|FG000|Overall Study|Language Barrier|1|||
163242673|NCT03149328|589594627|FG001|Overall Study|Language Barrier|0|||
163242674|NCT00503685|589594631|FG000|Overall Study|Adverse Event|0|||
163242675|NCT00503685|589594632|FG001|Overall Study|Adverse Event|0|||
163242676|NCT00503685|589594633|FG002|Overall Study|Adverse Event|2|||
163242677|NCT00503685|589594631|FG000|Overall Study|Withdrawal by Subject|0|||
163242678|NCT00503685|589594632|FG001|Overall Study|Withdrawal by Subject|1|||
163242679|NCT00503685|589594633|FG002|Overall Study|Withdrawal by Subject|0|||
163242680|NCT00503685|589594631|FG000|Overall Study|Protocol Violation|0|||
163242681|NCT00503685|589594632|FG001|Overall Study|Protocol Violation|1|||
163242682|NCT00503685|589594633|FG002|Overall Study|Protocol Violation|0|||
163242683|NCT00503685|589594631|FG000|Overall Study|Eligibility Criteria Not Met|0|||
163242684|NCT00503685|589594632|FG001|Overall Study|Eligibility Criteria Not Met|1|||
163242685|NCT00503685|589594633|FG002|Overall Study|Eligibility Criteria Not Met|0|||
163242686|NCT00927927|589594634|FG000|Overall Study|Withdrawal by Subject|0|||
163242687|NCT00927927|589594635|FG001|Overall Study|Withdrawal by Subject|0|||
163242688|NCT00927927|589594636|FG002|Overall Study|Withdrawal by Subject|0|||
163242689|NCT00927927|589594637|FG003|Overall Study|Withdrawal by Subject|0|||
163242690|NCT00927927|589594638|FG004|Overall Study|Withdrawal by Subject|0|||
163242691|NCT00927927|589594639|FG005|Overall Study|Withdrawal by Subject|0|||
163242692|NCT00927927|589594640|FG006|Overall Study|Withdrawal by Subject|0|||
163242693|NCT00927927|589594641|FG007|Overall Study|Withdrawal by Subject|2|||
163242694|NCT00927927|589594642|FG008|Overall Study|Withdrawal by Subject|0|||
163242695|NCT00927927|589594643|FG009|Overall Study|Withdrawal by Subject|0|||
163242696|NCT00927927|589594644|FG010|Overall Study|Withdrawal by Subject|0|||
163242697|NCT00927927|589594645|FG011|Overall Study|Withdrawal by Subject|2|||
163242698|NCT00927927|589594646|FG012|Overall Study|Withdrawal by Subject|0|||
163242699|NCT00927927|589594647|FG013|Overall Study|Withdrawal by Subject|0|||
163242700|NCT00927927|589594648|FG014|Overall Study|Withdrawal by Subject|0|||
163242701|NCT01110239|589594655|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
163242702|NCT01110239|589594656|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
163242703|NCT01110239|589594657|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
163242704|NCT01110239|589594658|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
163242705|NCT01110239|589594655|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
163242706|NCT01110239|589594656|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
163242707|NCT01110239|589594657|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
163242708|NCT01110239|589594658|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
163242709|NCT00080223|589594663|FG000|Overall Study|Adverse Event|23|||
163242710|NCT00080223|589594663|FG000|Overall Study|Death|21|||
163242711|NCT00080223|589594663|FG000|Overall Study|Withdrawal by Subject|13|||
163242712|NCT00080223|589594663|FG000|Overall Study|Lung Transplantation|9|||
163242713|NCT00080223|589594663|FG000|Overall Study|Non-compliance With Study Treatment|7|||
163242714|NCT00080223|589594663|FG000|Overall Study|Participant unwilling to continue|2|||
163242715|NCT00080223|589594663|FG000|Overall Study|Physician Decision|1|||
163242716|NCT00924287|589596580|FG000|Overall Study|Death|1|||
163242717|NCT00156065|589596587|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
163242718|NCT00156065|589596588|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
163242719|NCT00156065|589596589|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
163242720|NCT00156065|589596587|FG000|Overall Study|Adverse Event|8|||
163242721|NCT00156065|589596588|FG001|Overall Study|Adverse Event|11|||
163242722|NCT00156065|589596589|FG002|Overall Study|Adverse Event|4|||
163242723|NCT00156065|589596587|FG000|Overall Study|Lack of Efficacy|2|||
163242724|NCT00156065|589596588|FG001|Overall Study|Lack of Efficacy|9|||
163242725|NCT00156065|589596589|FG002|Overall Study|Lack of Efficacy|3|||
163242726|NCT00156065|589596587|FG000|Overall Study|Withdrawal by Subject|13|||
163242727|NCT00156065|589596588|FG001|Overall Study|Withdrawal by Subject|26|||
163351257|NCT01917006|589996125|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
163351258|NCT01917006|589996126|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
163242728|NCT00156065|589596589|FG002|Overall Study|Withdrawal by Subject|16|||
163242729|NCT00156065|589596587|FG000|Overall Study|Lost to Follow-up|5|||
163242730|NCT00156065|589596588|FG001|Overall Study|Lost to Follow-up|7|||
163242731|NCT00156065|589596589|FG002|Overall Study|Lost to Follow-up|1|||
163242732|NCT00156065|589596587|FG000|Overall Study|Other|2|||
163242733|NCT00156065|589596588|FG001|Overall Study|Other|9|||
163242734|NCT00156065|589596589|FG002|Overall Study|Other|3|||
163242735|NCT01432366|589596590|FG000|Overall Study|Non-Responder|7|||
163242736|NCT01432366|589596590|FG000|Overall Study|Adverse Event|8|||
163242737|NCT01432366|589596590|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
163242738|NCT01432366|589596590|FG000|Overall Study|Pregnancy|1|||
163242739|NCT01432366|589596590|FG000|Overall Study|Lost to Follow-up|13|||
163242740|NCT01432366|589596590|FG000|Overall Study|Lack of Efficacy|1|||
163242741|NCT01432366|589596590|FG000|Overall Study|Site Closed|20|||
163242742|NCT01432366|589596590|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
163242743|NCT01432366|589596590|FG000|Overall Study|Other|14|||
163242744|NCT02395120|589596591|FG000|Overall Study|Missed follow-up dental exam|57|||
163242745|NCT02395120|589596592|FG001|Overall Study|Missed follow-up dental exam|62|||
163242746|NCT02395120|589596593|FG002|Overall Study|Missed follow-up dental exam|6|||
163242747|NCT02395120|589596594|FG003|Overall Study|Missed follow-up dental exam|6|||
163242748|NCT02395120|589596595|FG004|Overall Study|Missed follow-up dental exam|51|||
163242749|NCT04546581|589596597|FG000|Overall Study|Adverse Event|9|||
163242750|NCT04546581|589596598|FG001|Overall Study|Adverse Event|3|||
163242751|NCT04546581|589596597|FG000|Overall Study|Physician Decision|0|||
163242752|NCT04546581|589596598|FG001|Overall Study|Physician Decision|1|||
163242753|NCT04546581|589596597|FG000|Overall Study|Protocol Violation|1|||
163242754|NCT04546581|589596598|FG001|Overall Study|Protocol Violation|2|||
163242755|NCT04546581|589596597|FG000|Overall Study|Withdrawal by Subject|3|||
163242756|NCT04546581|589596598|FG001|Overall Study|Withdrawal by Subject|7|||
163242757|NCT02526693|589596599|FG000|Overall Study|Physician Decision|3|||
163242758|NCT02526693|589596600|FG001|Overall Study|Physician Decision|1|||
163242759|NCT01798927|589596601|FG000|Overall Study|Withdrawal by Subject|1|||
163242760|NCT01159691|589596602|FG000|Overall Study|Lost to Follow-up|2|||
163242761|NCT01159691|589596602|FG000|Overall Study|Unknown reasons|1|||
163242762|NCT01159691|589596602|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
163242763|NCT01159691|589596602|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
163242764|NCT01159691|589596602|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
163242765|NCT01159691|589596602|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
163242766|NCT01159691|589596602|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
163242767|NCT01159691|589596602|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
163242768|NCT04579757|589596613|FG000|Overall Study|Adverse Event|0|||
163242769|NCT04579757|589596614|FG001|Overall Study|Adverse Event|0|||
163242770|NCT04579757|589596615|FG002|Overall Study|Adverse Event|0|||
163242771|NCT04579757|589596616|FG003|Overall Study|Adverse Event|2|||
163242772|NCT04579757|589596617|FG004|Overall Study|Adverse Event|1|||
163242773|NCT04579757|589596618|FG005|Overall Study|Adverse Event|1|||
163242774|NCT04579757|589596619|FG006|Overall Study|Adverse Event|0|||
163242775|NCT04579757|589596620|FG007|Overall Study|Adverse Event|0|||
163242776|NCT04579757|589596621|FG008|Overall Study|Adverse Event|0|||
163242777|NCT04579757|589596613|FG000|Overall Study|Death|4|||
163242778|NCT04579757|589596614|FG001|Overall Study|Death|1|||
163242779|NCT04579757|589596615|FG002|Overall Study|Death|14|||
163242780|NCT04579757|589596616|FG003|Overall Study|Death|3|||
163242781|NCT04579757|589596617|FG004|Overall Study|Death|2|||
163242782|NCT04579757|589596618|FG005|Overall Study|Death|7|||
163242783|NCT04579757|589596619|FG006|Overall Study|Death|0|||
163242784|NCT04579757|589596620|FG007|Overall Study|Death|1|||
163242785|NCT04579757|589596621|FG008|Overall Study|Death|3|||
163242786|NCT04579757|589596613|FG000|Overall Study|Physician Decision|0|||
163242787|NCT04579757|589596614|FG001|Overall Study|Physician Decision|0|||
163242788|NCT04579757|589596615|FG002|Overall Study|Physician Decision|0|||
163242789|NCT04579757|589596616|FG003|Overall Study|Physician Decision|2|||
163242790|NCT04579757|589596617|FG004|Overall Study|Physician Decision|1|||
163242791|NCT04579757|589596618|FG005|Overall Study|Physician Decision|1|||
163242792|NCT04579757|589596619|FG006|Overall Study|Physician Decision|1|||
163242793|NCT04579757|589596620|FG007|Overall Study|Physician Decision|0|||
163242794|NCT04579757|589596621|FG008|Overall Study|Physician Decision|0|||
163242795|NCT04579757|589596613|FG000|Overall Study|Study Terminated By Sponsor|0|||
163410010|NCT01097863|590209560|FG000|Overall Study|Did not return for final visit|0|||
163242796|NCT04579757|589596614|FG001|Overall Study|Study Terminated By Sponsor|0|||
163242797|NCT04579757|589596615|FG002|Overall Study|Study Terminated By Sponsor|0|||
163242798|NCT04579757|589596616|FG003|Overall Study|Study Terminated By Sponsor|0|||
163242799|NCT04579757|589596617|FG004|Overall Study|Study Terminated By Sponsor|2|||
163242800|NCT04579757|589596618|FG005|Overall Study|Study Terminated By Sponsor|0|||
163242801|NCT04579757|589596619|FG006|Overall Study|Study Terminated By Sponsor|0|||
163242802|NCT04579757|589596620|FG007|Overall Study|Study Terminated By Sponsor|2|||
163242803|NCT04579757|589596621|FG008|Overall Study|Study Terminated By Sponsor|0|||
163242804|NCT04579757|589596613|FG000|Overall Study|Withdrawal by Subject|1|||
163242805|NCT04579757|589596614|FG001|Overall Study|Withdrawal by Subject|1|||
163410011|NCT01097863|590209561|FG001|Overall Study|Did not return for final visit|0|||
163242806|NCT04579757|589596615|FG002|Overall Study|Withdrawal by Subject|0|||
163242807|NCT04579757|589596616|FG003|Overall Study|Withdrawal by Subject|0|||
163242808|NCT04579757|589596617|FG004|Overall Study|Withdrawal by Subject|2|||
163242809|NCT04579757|589596618|FG005|Overall Study|Withdrawal by Subject|1|||
163242810|NCT04579757|589596619|FG006|Overall Study|Withdrawal by Subject|0|||
163242811|NCT04579757|589596620|FG007|Overall Study|Withdrawal by Subject|3|||
163242812|NCT04579757|589596621|FG008|Overall Study|Withdrawal by Subject|0|||
163242813|NCT04579757|589596613|FG000|Overall Study|Radiological or Clinical PD|1|||
163242814|NCT04579757|589596614|FG001|Overall Study|Radiological or Clinical PD|4|||
163242815|NCT04579757|589596615|FG002|Overall Study|Radiological or Clinical PD|1|||
163242816|NCT04579757|589596616|FG003|Overall Study|Radiological or Clinical PD|3|||
163242817|NCT04579757|589596617|FG004|Overall Study|Radiological or Clinical PD|9|||
163242818|NCT04579757|589596618|FG005|Overall Study|Radiological or Clinical PD|4|||
163242819|NCT04579757|589596619|FG006|Overall Study|Radiological or Clinical PD|2|||
163242820|NCT04579757|589596620|FG007|Overall Study|Radiological or Clinical PD|2|||
163242821|NCT04579757|589596621|FG008|Overall Study|Radiological or Clinical PD|0|||
163242822|NCT04579757|589596613|FG000|Overall Study|Start of New Therapy|0|||
163242823|NCT04579757|589596614|FG001|Overall Study|Start of New Therapy|0|||
163242824|NCT04579757|589596615|FG002|Overall Study|Start of New Therapy|0|||
163242825|NCT04579757|589596616|FG003|Overall Study|Start of New Therapy|0|||
163242826|NCT04579757|589596617|FG004|Overall Study|Start of New Therapy|2|||
163242827|NCT04579757|589596618|FG005|Overall Study|Start of New Therapy|1|||
163242828|NCT04579757|589596619|FG006|Overall Study|Start of New Therapy|0|||
163242829|NCT04579757|589596620|FG007|Overall Study|Start of New Therapy|0|||
163242830|NCT04579757|589596621|FG008|Overall Study|Start of New Therapy|0|||
163242831|NCT01153633|589596622|FG000|Overall Study|Protocol Violation|1|||
163242832|NCT01153633|589596623|FG001|Overall Study|Protocol Violation|1|||
163242833|NCT01153633|589596622|FG000|Overall Study|Therapeutic failure|3|||
163242834|NCT01153633|589596623|FG001|Overall Study|Therapeutic failure|3|||
163242835|NCT00384085|589596624|FG000|Overall Study|Adverse Event|5|||
163242836|NCT00384085|589596625|FG001|Overall Study|Adverse Event|5|||
163242837|NCT00384085|589596626|FG002|Overall Study|Adverse Event|4|||
163242838|NCT00384085|589596624|FG000|Overall Study|Lack of Efficacy|0|||
163242839|NCT00384085|589596625|FG001|Overall Study|Lack of Efficacy|3|||
163242840|NCT00384085|589596626|FG002|Overall Study|Lack of Efficacy|2|||
163242841|NCT00384085|589596624|FG000|Overall Study|No longer Requires Study Treatment|1|||
163242842|NCT00384085|589596625|FG001|Overall Study|No longer Requires Study Treatment|0|||
163242843|NCT00384085|589596626|FG002|Overall Study|No longer Requires Study Treatment|1|||
163242844|NCT00384085|589596624|FG000|Overall Study|Protocol Violation|2|||
163242845|NCT00384085|589596625|FG001|Overall Study|Protocol Violation|2|||
163242846|NCT00384085|589596626|FG002|Overall Study|Protocol Violation|2|||
163242847|NCT00384085|589596624|FG000|Overall Study|Lost to Follow-up|9|||
163242848|NCT00384085|589596625|FG001|Overall Study|Lost to Follow-up|9|||
163242849|NCT00384085|589596626|FG002|Overall Study|Lost to Follow-up|10|||
163242850|NCT00384085|589596624|FG000|Overall Study|Progressive Disease|0|||
163242851|NCT00384085|589596625|FG001|Overall Study|Progressive Disease|1|||
163242852|NCT00384085|589596626|FG002|Overall Study|Progressive Disease|0|||
163242853|NCT00384085|589596624|FG000|Overall Study|Withdrawal by Subject|14|||
163242854|NCT00384085|589596625|FG001|Overall Study|Withdrawal by Subject|19|||
163242855|NCT00384085|589596626|FG002|Overall Study|Withdrawal by Subject|29|||
163242856|NCT00384085|589596624|FG000|Overall Study|Patient non-compliant|4|||
163242857|NCT00384085|589596625|FG001|Overall Study|Patient non-compliant|4|||
163242858|NCT00384085|589596626|FG002|Overall Study|Patient non-compliant|5|||
163242859|NCT00384085|589596624|FG000|Overall Study|Physician Decision|1|||
163242860|NCT00384085|589596625|FG001|Overall Study|Physician Decision|0|||
163242861|NCT00384085|589596626|FG002|Overall Study|Physician Decision|0|||
163242862|NCT00384085|589596624|FG000|Overall Study|Loss of site personnel|1|||
163242863|NCT00384085|589596625|FG001|Overall Study|Loss of site personnel|0|||
163242864|NCT00384085|589596626|FG002|Overall Study|Loss of site personnel|1|||
163242865|NCT00384085|589596624|FG000|Overall Study|Sponsor decision|1|||
163242866|NCT00384085|589596625|FG001|Overall Study|Sponsor decision|2|||
163242867|NCT00384085|589596626|FG002|Overall Study|Sponsor decision|1|||
163242868|NCT00384085|589596624|FG000|Overall Study|Patient moved|1|||
163242869|NCT00384085|589596625|FG001|Overall Study|Patient moved|0|||
163242870|NCT00384085|589596626|FG002|Overall Study|Patient moved|1|||
163242871|NCT00384085|589596624|FG000|Overall Study|Patient required surgery|0|||
163242872|NCT00384085|589596625|FG001|Overall Study|Patient required surgery|1|||
163242873|NCT00384085|589596626|FG002|Overall Study|Patient required surgery|0|||
163242874|NCT05912400|589596627|FG000|Overall Study|Lost to Follow-up|1|||
163242875|NCT05912400|589596628|FG001|Overall Study|Lost to Follow-up|0|||
163351259|NCT01917006|589996127|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
163351260|NCT01917006|589996120|FG000|Open-label Period|Adverse Event|0|||
163351261|NCT01917006|589996121|FG001|Open-label Period|Adverse Event|0|||
163242876|NCT05912400|589596627|FG000|Overall Study|Physician Decision|6|||
163242877|NCT05912400|589596628|FG001|Overall Study|Physician Decision|0|||
163242878|NCT05912400|589596627|FG000|Overall Study|Withdrawal by Subject|1|||
163242879|NCT05912400|589596628|FG001|Overall Study|Withdrawal by Subject|0|||
163242880|NCT01944631|589596632|FG000|Overall Study|Adverse Event|1|||
163242881|NCT01944631|589596633|FG001|Overall Study|Adverse Event|0|||
163242882|NCT01944631|589596632|FG000|Overall Study|Lost to Follow-up|3|||
163242883|NCT01944631|589596633|FG001|Overall Study|Lost to Follow-up|1|||
163242884|NCT01944631|589596632|FG000|Overall Study|Withdrawal by Subject|0|||
163242885|NCT01944631|589596633|FG001|Overall Study|Withdrawal by Subject|1|||
163242886|NCT01843192|589596634|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
163242887|NCT01843192|589596635|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
163410012|NCT01097863|590209562|FG002|Overall Study|Did not return for final visit|1|||
163148072|NCT03115359|589255356|FG000|Overall Study|Personal reasons including health|12|||
163148073|NCT03115359|589255357|FG001|Overall Study|Personal reasons including health|9|||
163148074|NCT03115359|589255356|FG000|Overall Study|Transportation barriers|3|||
163148075|NCT03115359|589255357|FG001|Overall Study|Transportation barriers|0|||
163148076|NCT03115359|589255356|FG000|Overall Study|No longer interested|5|||
163148077|NCT03115359|589255357|FG001|Overall Study|No longer interested|4|||
163148078|NCT03115359|589255356|FG000|Overall Study|No reason provided|45|||
163148079|NCT03115359|589255357|FG001|Overall Study|No reason provided|47|||
163148080|NCT05546476|589255361|FG000|Period 1: Part A|Adverse Event|2|||
163148081|NCT05546476|589255362|FG001|Period 1: Part A|Adverse Event|0|||
163148082|NCT05546476|589255363|FG002|Period 1: Part A|Adverse Event|0|||
163148083|NCT05546476|589255364|FG003|Period 1: Part A|Adverse Event|1|||
163148084|NCT05546476|589255361|FG000|Period 1: Part A|Death|4|||
163148085|NCT05546476|589255362|FG001|Period 1: Part A|Death|4|||
163148086|NCT05546476|589255363|FG002|Period 1: Part A|Death|5|||
163148087|NCT05546476|589255364|FG003|Period 1: Part A|Death|6|||
163148088|NCT05546476|589255361|FG000|Period 1: Part A|Lack of Efficacy|0|||
163148089|NCT05546476|589255362|FG001|Period 1: Part A|Lack of Efficacy|0|||
163148090|NCT05546476|589255363|FG002|Period 1: Part A|Lack of Efficacy|0|||
163148091|NCT05546476|589255364|FG003|Period 1: Part A|Lack of Efficacy|1|||
163148092|NCT05546476|589255361|FG000|Period 1: Part A|Lost to Follow-up|0|||
163148093|NCT05546476|589255362|FG001|Period 1: Part A|Lost to Follow-up|0|||
163148094|NCT05546476|589255363|FG002|Period 1: Part A|Lost to Follow-up|0|||
163148095|NCT05546476|589255364|FG003|Period 1: Part A|Lost to Follow-up|1|||
163148096|NCT05546476|589255361|FG000|Period 1: Part A|Physician Decision|1|||
163148097|NCT05546476|589255362|FG001|Period 1: Part A|Physician Decision|0|||
163148098|NCT05546476|589255363|FG002|Period 1: Part A|Physician Decision|0|||
163148099|NCT05546476|589255364|FG003|Period 1: Part A|Physician Decision|0|||
163148100|NCT05546476|589255361|FG000|Period 1: Part A|Progressive disease|3|||
163148101|NCT05546476|589255362|FG001|Period 1: Part A|Progressive disease|5|||
163148102|NCT05546476|589255363|FG002|Period 1: Part A|Progressive disease|0|||
163148103|NCT05546476|589255364|FG003|Period 1: Part A|Progressive disease|1|||
163148104|NCT05546476|589255361|FG000|Period 1: Part A|Withdrawal by Subject|1|||
163148105|NCT05546476|589255362|FG001|Period 1: Part A|Withdrawal by Subject|1|||
163148106|NCT05546476|589255363|FG002|Period 1: Part A|Withdrawal by Subject|1|||
163148107|NCT05546476|589255364|FG003|Period 1: Part A|Withdrawal by Subject|2|||
163148108|NCT05546476|589255361|FG000|Period 1: Part A|Global deterioration of health status|2|||
163148109|NCT05546476|589255362|FG001|Period 1: Part A|Global deterioration of health status|2|||
163148110|NCT05546476|589255363|FG002|Period 1: Part A|Global deterioration of health status|1|||
163148111|NCT05546476|589255364|FG003|Period 1: Part A|Global deterioration of health status|4|||
163148112|NCT05546476|589255361|FG000|Period 1: Part A|Other: Unspecified|0|||
163148113|NCT05546476|589255362|FG001|Period 1: Part A|Other: Unspecified|2|||
163148114|NCT05546476|589255363|FG002|Period 1: Part A|Other: Unspecified|0|||
163148115|NCT05546476|589255364|FG003|Period 1: Part A|Other: Unspecified|0|||
163148116|NCT05546476|589255361|FG000|Period 2: Part B|Ongoing|26|||
163148117|NCT05546476|589255362|FG001|Period 2: Part B|Ongoing|27|||
163148118|NCT05546476|589255363|FG002|Period 2: Part B|Ongoing|35|||
163148119|NCT05546476|589255364|FG003|Period 2: Part B|Ongoing|29|||
163148120|NCT03585660|589255373|FG000|Overall Study|operator error|1|||
163148121|NCT03585660|589255373|FG000|Overall Study|technical error|2|||
163148122|NCT03585660|589255373|FG000|Overall Study|hip prosthesis|2|||
163148123|NCT03585660|589255373|FG000|Overall Study|did not undergo biopsy|8|||
163148124|NCT03585660|589255373|FG000|Overall Study|scanner problem|2|||
163148125|NCT03661723|589255380|FG000|Overall Study|Disease Progression|4|||
163148126|NCT03661723|589255381|FG001|Overall Study|Disease Progression|24|||
163148127|NCT03661723|589255382|FG002|Overall Study|Disease Progression|4|||
163148128|NCT03661723|589255383|FG003|Overall Study|Disease Progression|19|||
163148129|NCT03661723|589255380|FG000|Overall Study|Withdrawal by Subject|1|||
163148130|NCT03661723|589255381|FG001|Overall Study|Withdrawal by Subject|0|||
163148131|NCT03661723|589255382|FG002|Overall Study|Withdrawal by Subject|2|||
163148132|NCT03661723|589255383|FG003|Overall Study|Withdrawal by Subject|4|||
163148133|NCT03661723|589255380|FG000|Overall Study|Physician Decision|1|||
163148134|NCT03661723|589255381|FG001|Overall Study|Physician Decision|0|||
163148135|NCT03661723|589255382|FG002|Overall Study|Physician Decision|0|||
163148136|NCT03661723|589255383|FG003|Overall Study|Physician Decision|0|||
163148137|NCT03661723|589255380|FG000|Overall Study|Clinical Deterioration|0|||
163148138|NCT03661723|589255381|FG001|Overall Study|Clinical Deterioration|0|||
163148139|NCT03661723|589255382|FG002|Overall Study|Clinical Deterioration|0|||
163148140|NCT03661723|589255383|FG003|Overall Study|Clinical Deterioration|1|||
163148141|NCT03760029|589255384|FG000|Overall Study|Death|1|||
163148142|NCT03760029|589255385|FG001|Overall Study|Death|0|||
163148143|NCT03760029|589255386|FG002|Overall Study|Death|0|||
163148144|NCT03760029|589255384|FG000|Overall Study|Lost to Follow-up|0|||
163148145|NCT03760029|589255385|FG001|Overall Study|Lost to Follow-up|2|||
163148146|NCT03760029|589255386|FG002|Overall Study|Lost to Follow-up|1|||
163148147|NCT03760029|589255384|FG000|Overall Study|Withdrawal by Subject|1|||
163148148|NCT03760029|589255385|FG001|Overall Study|Withdrawal by Subject|4|||
163242888|NCT01843192|589596636|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
163242889|NCT00328510|589596639|FG000|Overall Study|Gag disorder, could not use frame|4|||
163242890|NCT00328510|589596640|FG001|Overall Study|Gag disorder, could not use frame|0|||
163242891|NCT00328510|589596639|FG000|Overall Study|Dentition problems, could not use frame|1|||
163242892|NCT00328510|589596640|FG001|Overall Study|Dentition problems, could not use frame|0|||
163242893|NCT00328510|589596639|FG000|Overall Study|Withdrawal by Subject|4|||
163242894|NCT00328510|589596640|FG001|Overall Study|Withdrawal by Subject|2|||
163242895|NCT00328510|589596639|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
163242896|NCT00328510|589596640|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
163148149|NCT03760029|589255386|FG002|Overall Study|Withdrawal by Subject|1|||
163148150|NCT03760029|589255384|FG000|Overall Study|Withdrawal by parent/guardian|4|||
163148151|NCT03760029|589255385|FG001|Overall Study|Withdrawal by parent/guardian|4|||
163148152|NCT03760029|589255386|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163148153|NCT03760029|589255384|FG000|Overall Study|Other|2|||
163148154|NCT03760029|589255385|FG001|Overall Study|Other|1|||
163148155|NCT03760029|589255386|FG002|Overall Study|Other|0|||
163148156|NCT04890652|589255392|FG000|Overall Study|Withdrawal by Subject|2|||
163148157|NCT02399215|589255401|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
163148158|NCT02399215|589255401|FG000|Overall Study|Withdrawal by Subject|1|||
163148159|NCT00772538|589255402|FG000|Overall Study|Adverse Event|6|||
163148160|NCT00772538|589255403|FG001|Overall Study|Adverse Event|6|||
163148161|NCT00772538|589255402|FG000|Overall Study|Protocol Violation|3|||
163148162|NCT00772538|589255403|FG001|Overall Study|Protocol Violation|3|||
163148163|NCT00772538|589255402|FG000|Overall Study|Lost to Follow-up|1|||
163148164|NCT00772538|589255403|FG001|Overall Study|Lost to Follow-up|1|||
163148165|NCT00772538|589255402|FG000|Overall Study|Withdrawal by Subject|3|||
163148166|NCT00772538|589255403|FG001|Overall Study|Withdrawal by Subject|8|||
163148167|NCT00772538|589255402|FG000|Overall Study|Lack of Efficacy|0|||
163148168|NCT00772538|589255403|FG001|Overall Study|Lack of Efficacy|1|||
163148169|NCT00772538|589255402|FG000|Overall Study|Other|7|||
163148170|NCT00772538|589255403|FG001|Overall Study|Other|7|||
163148171|NCT01089504|589255406|FG000|Overall Study|Lost to Follow-up|1|||
163148172|NCT01089504|589255407|FG001|Overall Study|Lost to Follow-up|1|||
163148173|NCT01089504|589255406|FG000|Overall Study|Withdrawal by Subject|2|||
163148174|NCT01089504|589255407|FG001|Overall Study|Withdrawal by Subject|0|||
163148175|NCT00001832|589255408|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
163148176|NCT00001832|589255409|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
163148177|NCT00001832|589255410|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
163148178|NCT00001832|589255411|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
163148179|NCT00001832|589255412|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
163148180|NCT00001832|589255413|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
163148181|NCT00001832|589255414|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
163148182|NCT00001832|589255415|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
163148183|NCT00001832|589255416|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
163148184|NCT00001832|589255417|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
163148185|NCT00001832|589255418|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
163148186|NCT00001832|589255419|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
163148187|NCT00001832|589255420|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
163148188|NCT00001832|589255421|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
163148189|NCT00001832|589255422|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
163148190|NCT00001832|589255408|FG000|Treatment Period|Death during treatment|0|||
163148191|NCT00001832|589255409|FG001|Treatment Period|Death during treatment|0|||
163148192|NCT00001832|589255410|FG002|Treatment Period|Death during treatment|0|||
163148193|NCT00001832|589255411|FG003|Treatment Period|Death during treatment|0|||
163148194|NCT00001832|589255412|FG004|Treatment Period|Death during treatment|0|||
163148195|NCT00001832|589255413|FG005|Treatment Period|Death during treatment|1|||
163148196|NCT00001832|589255414|FG006|Treatment Period|Death during treatment|0|||
163148197|NCT00001832|589255415|FG007|Treatment Period|Death during treatment|0|||
163148198|NCT00001832|589255416|FG008|Treatment Period|Death during treatment|0|||
163148199|NCT00001832|589255417|FG009|Treatment Period|Death during treatment|0|||
163148200|NCT00001832|589255418|FG010|Treatment Period|Death during treatment|0|||
163148201|NCT00001832|589255419|FG011|Treatment Period|Death during treatment|0|||
163148202|NCT00001832|589255420|FG012|Treatment Period|Death during treatment|0|||
163148203|NCT00001832|589255421|FG013|Treatment Period|Death during treatment|0|||
163148204|NCT00001832|589255422|FG014|Treatment Period|Death during treatment|0|||
163148205|NCT00001832|589255408|FG000|Treatment Period|Not treated|0|||
163148206|NCT00001832|589255409|FG001|Treatment Period|Not treated|0|||
163148207|NCT00001832|589255410|FG002|Treatment Period|Not treated|0|||
163148208|NCT00001832|589255411|FG003|Treatment Period|Not treated|0|||
163148209|NCT00001832|589255412|FG004|Treatment Period|Not treated|0|||
163148210|NCT00001832|589255413|FG005|Treatment Period|Not treated|0|||
163148211|NCT00001832|589255414|FG006|Treatment Period|Not treated|0|||
163148212|NCT00001832|589255415|FG007|Treatment Period|Not treated|1|||
163148213|NCT00001832|589255416|FG008|Treatment Period|Not treated|0|||
163242897|NCT00328510|589596639|FG000|Overall Study|Treatment changed to a single fraction|1|||
163242898|NCT00328510|589596640|FG001|Overall Study|Treatment changed to a single fraction|1|||
163242899|NCT02261363|589596642|FG000|Overall Study|Lost to Follow-up|21|||
163242900|NCT01517802|589596643|FG000|Overall Study|Death|1|||
163242901|NCT02605954|589596644|FG000|Overall Study|Adverse Event|5|||
163242902|NCT02605954|589596645|FG001|Overall Study|Adverse Event|1|||
163242903|NCT02605954|589596644|FG000|Overall Study|Investigator's Discretion|1|||
163242904|NCT02605954|589596645|FG001|Overall Study|Investigator's Discretion|0|||
163242905|NCT02605954|589596644|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163242906|NCT02605954|589596645|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163242907|NCT02605954|589596644|FG000|Overall Study|Withdrew Consent|2|||
163242908|NCT02605954|589596645|FG001|Overall Study|Withdrew Consent|2|||
163242909|NCT02605954|589596644|FG000|Overall Study|Lost to Follow-up|3|||
163242910|NCT02605954|589596645|FG001|Overall Study|Lost to Follow-up|0|||
163242911|NCT02605954|589596644|FG000|Overall Study|Randomized but not treated|0|||
163242912|NCT02605954|589596645|FG001|Overall Study|Randomized but not treated|1|||
163242913|NCT02301143|589596646|FG000|Induction Period|Enrolled But Not Treated|1|||
163242914|NCT02301143|589596647|FG001|Induction Period|Enrolled But Not Treated|0|||
163242915|NCT02301143|589596646|FG000|Induction Period|Death|1|||
163242916|NCT02301143|589596647|FG001|Induction Period|Death|0|||
163242917|NCT02301143|589596646|FG000|Induction Period|Adverse Event|22|||
163242918|NCT02301143|589596647|FG001|Induction Period|Adverse Event|0|||
163242919|NCT02301143|589596646|FG000|Induction Period|Progressive Disease|8|||
163242920|NCT02301143|589596647|FG001|Induction Period|Progressive Disease|0|||
163242921|NCT02301143|589596646|FG000|Induction Period|Withdrawal by Subject|3|||
163242922|NCT02301143|589596647|FG001|Induction Period|Withdrawal by Subject|0|||
163242923|NCT02301143|589596646|FG000|Induction Period|Noncompliance with Study Drug|1|||
163242924|NCT02301143|589596647|FG001|Induction Period|Noncompliance with Study Drug|0|||
163242925|NCT02301143|589596646|FG000|Induction Period|Physician Decision|4|||
163242926|NCT02301143|589596647|FG001|Induction Period|Physician Decision|0|||
163242927|NCT02301143|589596646|FG000|Induction Period|Symptomatic Deterioration|2|||
163242928|NCT02301143|589596647|FG001|Induction Period|Symptomatic Deterioration|0|||
163242929|NCT02301143|589596646|FG000|Induction Period|Protocol Violation|2|||
163242930|NCT02301143|589596647|FG001|Induction Period|Protocol Violation|0|||
163242931|NCT02301143|589596646|FG000|Induction Period|Other|1|||
163242932|NCT02301143|589596647|FG001|Induction Period|Other|0|||
163242933|NCT02301143|589596646|FG000|Investigator's Choice|Adverse Event|0|||
163242934|NCT02301143|589596647|FG001|Investigator's Choice|Adverse Event|3|||
163242935|NCT02301143|589596646|FG000|Investigator's Choice|Progressive Disease|0|||
163242936|NCT02301143|589596647|FG001|Investigator's Choice|Progressive Disease|3|||
163242937|NCT02301143|589596646|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
163242938|NCT02301143|589596647|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
163242939|NCT02301143|589596646|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
163242940|NCT02301143|589596647|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
163242941|NCT02301143|589596646|FG000|Investigator's Choice|Other|0|||
163242942|NCT02301143|589596647|FG001|Investigator's Choice|Other|1|||
163242943|NCT02301143|589596646|FG000|Investigator's Choice|Unresectable Surgery|0|||
163242944|NCT02301143|589596647|FG001|Investigator's Choice|Unresectable Surgery|1|||
163242945|NCT03214367|589596650|FG000|Lead-in Period|Withdrawal by Subject|50|||
163242946|NCT03214367|589596651|FG001|Lead-in Period|Withdrawal by Subject|0|||
163242947|NCT03214367|589596652|FG002|Lead-in Period|Withdrawal by Subject|0|||
163242948|NCT03214367|589596653|FG003|Lead-in Period|Withdrawal by Subject|0|||
163242949|NCT03214367|589596654|FG004|Lead-in Period|Withdrawal by Subject|2|||
163242950|NCT03214367|589596655|FG005|Lead-in Period|Withdrawal by Subject|0|||
163242951|NCT03214367|589596656|FG006|Lead-in Period|Withdrawal by Subject|0|||
163242952|NCT03214367|589596657|FG007|Lead-in Period|Withdrawal by Subject|0|||
163242953|NCT03214367|589596650|FG000|Lead-in Period|Adverse Event|3|||
163242954|NCT03214367|589596651|FG001|Lead-in Period|Adverse Event|0|||
163242955|NCT03214367|589596652|FG002|Lead-in Period|Adverse Event|0|||
163242956|NCT03214367|589596653|FG003|Lead-in Period|Adverse Event|0|||
163242957|NCT03214367|589596654|FG004|Lead-in Period|Adverse Event|0|||
163242958|NCT03214367|589596655|FG005|Lead-in Period|Adverse Event|0|||
163242959|NCT03214367|589596656|FG006|Lead-in Period|Adverse Event|0|||
163242960|NCT03214367|589596657|FG007|Lead-in Period|Adverse Event|0|||
163242961|NCT03214367|589596650|FG000|Lead-in Period|Lost to Follow-up|12|||
163242962|NCT03214367|589596651|FG001|Lead-in Period|Lost to Follow-up|0|||
163242963|NCT03214367|589596652|FG002|Lead-in Period|Lost to Follow-up|0|||
163242964|NCT03214367|589596653|FG003|Lead-in Period|Lost to Follow-up|0|||
163242965|NCT03214367|589596654|FG004|Lead-in Period|Lost to Follow-up|0|||
163242966|NCT03214367|589596655|FG005|Lead-in Period|Lost to Follow-up|0|||
163242967|NCT03214367|589596656|FG006|Lead-in Period|Lost to Follow-up|0|||
163242968|NCT03214367|589596657|FG007|Lead-in Period|Lost to Follow-up|0|||
163242969|NCT03214367|589596650|FG000|Lead-in Period|Sponsor Decision|11|||
163242970|NCT03214367|589596651|FG001|Lead-in Period|Sponsor Decision|0|||
163242971|NCT03214367|589596652|FG002|Lead-in Period|Sponsor Decision|0|||
163242972|NCT03214367|589596653|FG003|Lead-in Period|Sponsor Decision|0|||
163242973|NCT03214367|589596654|FG004|Lead-in Period|Sponsor Decision|0|||
163242974|NCT03214367|589596655|FG005|Lead-in Period|Sponsor Decision|0|||
163242975|NCT03214367|589596656|FG006|Lead-in Period|Sponsor Decision|0|||
163242976|NCT03214367|589596657|FG007|Lead-in Period|Sponsor Decision|0|||
163242977|NCT03214367|589596650|FG000|Lead-in Period|Physician Decision|12|||
163242978|NCT03214367|589596651|FG001|Lead-in Period|Physician Decision|0|||
163242979|NCT03214367|589596652|FG002|Lead-in Period|Physician Decision|0|||
163242980|NCT03214367|589596653|FG003|Lead-in Period|Physician Decision|0|||
163242981|NCT03214367|589596654|FG004|Lead-in Period|Physician Decision|0|||
163242982|NCT03214367|589596655|FG005|Lead-in Period|Physician Decision|0|||
163242983|NCT03214367|589596656|FG006|Lead-in Period|Physician Decision|0|||
163242984|NCT03214367|589596657|FG007|Lead-in Period|Physician Decision|0|||
163242985|NCT03214367|589596650|FG000|Lead-in Period|Protocol Violation|5|||
163242986|NCT03214367|589596651|FG001|Lead-in Period|Protocol Violation|0|||
163242987|NCT03214367|589596652|FG002|Lead-in Period|Protocol Violation|0|||
163242988|NCT03214367|589596653|FG003|Lead-in Period|Protocol Violation|0|||
163242989|NCT03214367|589596654|FG004|Lead-in Period|Protocol Violation|0|||
163242990|NCT03214367|589596655|FG005|Lead-in Period|Protocol Violation|0|||
163242991|NCT03214367|589596656|FG006|Lead-in Period|Protocol Violation|0|||
163242992|NCT03214367|589596657|FG007|Lead-in Period|Protocol Violation|0|||
163242993|NCT03214367|589596650|FG000|Lead-in Period|Treatment Interruption|1|||
163242994|NCT03214367|589596651|FG001|Lead-in Period|Treatment Interruption|0|||
163242995|NCT03214367|589596652|FG002|Lead-in Period|Treatment Interruption|0|||
163242996|NCT03214367|589596653|FG003|Lead-in Period|Treatment Interruption|0|||
163242997|NCT03214367|589596654|FG004|Lead-in Period|Treatment Interruption|0|||
163242998|NCT03214367|589596655|FG005|Lead-in Period|Treatment Interruption|0|||
163242999|NCT03214367|589596656|FG006|Lead-in Period|Treatment Interruption|0|||
163243000|NCT03214367|589596657|FG007|Lead-in Period|Treatment Interruption|0|||
163243001|NCT03214367|589596650|FG000|Treatment Period|Adverse Event|0|||
163243002|NCT03214367|589596651|FG001|Treatment Period|Adverse Event|1|||
163243003|NCT03214367|589596652|FG002|Treatment Period|Adverse Event|4|||
163243004|NCT03214367|589596653|FG003|Treatment Period|Adverse Event|2|||
163243005|NCT03214367|589596654|FG004|Treatment Period|Adverse Event|0|||
163243006|NCT03214367|589596655|FG005|Treatment Period|Adverse Event|0|||
163243007|NCT03214367|589596656|FG006|Treatment Period|Adverse Event|0|||
163243008|NCT03214367|589596657|FG007|Treatment Period|Adverse Event|0|||
163243009|NCT03214367|589596650|FG000|Treatment Period|Death|0|||
163243010|NCT03214367|589596651|FG001|Treatment Period|Death|1|||
163243011|NCT03214367|589596652|FG002|Treatment Period|Death|1|||
163243012|NCT03214367|589596653|FG003|Treatment Period|Death|1|||
163243013|NCT03214367|589596654|FG004|Treatment Period|Death|0|||
163243014|NCT03214367|589596655|FG005|Treatment Period|Death|0|||
163243015|NCT03214367|589596656|FG006|Treatment Period|Death|0|||
163243016|NCT03214367|589596657|FG007|Treatment Period|Death|0|||
163243017|NCT03214367|589596650|FG000|Treatment Period|Lost to Follow-up|0|||
163243018|NCT03214367|589596651|FG001|Treatment Period|Lost to Follow-up|5|||
163243019|NCT03214367|589596652|FG002|Treatment Period|Lost to Follow-up|3|||
163243020|NCT03214367|589596653|FG003|Treatment Period|Lost to Follow-up|2|||
163243021|NCT03214367|589596654|FG004|Treatment Period|Lost to Follow-up|0|||
163243022|NCT03214367|589596655|FG005|Treatment Period|Lost to Follow-up|2|||
163243023|NCT03214367|589596656|FG006|Treatment Period|Lost to Follow-up|1|||
163243024|NCT03214367|589596657|FG007|Treatment Period|Lost to Follow-up|0|||
163243025|NCT03214367|589596650|FG000|Treatment Period|Sponsor Decision|0|||
163243026|NCT03214367|589596651|FG001|Treatment Period|Sponsor Decision|3|||
163243027|NCT03214367|589596652|FG002|Treatment Period|Sponsor Decision|0|||
163243028|NCT03214367|589596653|FG003|Treatment Period|Sponsor Decision|0|||
163243029|NCT03214367|589596654|FG004|Treatment Period|Sponsor Decision|0|||
163243030|NCT03214367|589596655|FG005|Treatment Period|Sponsor Decision|0|||
163243031|NCT03214367|589596656|FG006|Treatment Period|Sponsor Decision|0|||
163351262|NCT01917006|589996122|FG002|Open-label Period|Adverse Event|0|||
163351263|NCT01917006|589996123|FG003|Open-label Period|Adverse Event|0|||
163351264|NCT01917006|589996124|FG004|Open-label Period|Adverse Event|0|||
163351265|NCT01917006|589996125|FG005|Open-label Period|Adverse Event|0|||
163351266|NCT01917006|589996126|FG006|Open-label Period|Adverse Event|0|||
163243032|NCT03214367|589596657|FG007|Treatment Period|Sponsor Decision|0|||
163243033|NCT03214367|589596650|FG000|Treatment Period|Physician Decision|0|||
163243034|NCT03214367|589596651|FG001|Treatment Period|Physician Decision|1|||
163243035|NCT03214367|589596652|FG002|Treatment Period|Physician Decision|2|||
163243036|NCT03214367|589596653|FG003|Treatment Period|Physician Decision|0|||
163243037|NCT03214367|589596654|FG004|Treatment Period|Physician Decision|0|||
163243038|NCT03214367|589596655|FG005|Treatment Period|Physician Decision|0|||
163243039|NCT03214367|589596656|FG006|Treatment Period|Physician Decision|0|||
163243040|NCT03214367|589596657|FG007|Treatment Period|Physician Decision|0|||
163243041|NCT03214367|589596650|FG000|Treatment Period|Protocol Violation|0|||
163243042|NCT03214367|589596651|FG001|Treatment Period|Protocol Violation|3|||
163243043|NCT03214367|589596652|FG002|Treatment Period|Protocol Violation|0|||
163243044|NCT03214367|589596653|FG003|Treatment Period|Protocol Violation|0|||
163243045|NCT03214367|589596654|FG004|Treatment Period|Protocol Violation|0|||
163243046|NCT03214367|589596655|FG005|Treatment Period|Protocol Violation|0|||
163351267|NCT01917006|589996127|FG007|Open-label Period|Adverse Event|1|||
163243047|NCT03214367|589596656|FG006|Treatment Period|Protocol Violation|0|||
163243048|NCT03214367|589596657|FG007|Treatment Period|Protocol Violation|0|||
163243049|NCT03214367|589596650|FG000|Treatment Period|Withdrawal by Subject|0|||
163243050|NCT03214367|589596651|FG001|Treatment Period|Withdrawal by Subject|20|||
163243051|NCT03214367|589596652|FG002|Treatment Period|Withdrawal by Subject|23|||
163243052|NCT03214367|589596653|FG003|Treatment Period|Withdrawal by Subject|14|||
163243053|NCT03214367|589596654|FG004|Treatment Period|Withdrawal by Subject|0|||
163243054|NCT03214367|589596655|FG005|Treatment Period|Withdrawal by Subject|1|||
163243055|NCT03214367|589596656|FG006|Treatment Period|Withdrawal by Subject|1|||
163243056|NCT03214367|589596657|FG007|Treatment Period|Withdrawal by Subject|1|||
163243057|NCT03268811|589596660|FG000|Overall Study|Adverse Event|0|||
163243058|NCT03268811|589596661|FG001|Overall Study|Adverse Event|1|||
163243059|NCT04726709|589596662|FG000|Overall Study|Withdrawal by Subject|2|||
163243060|NCT04726709|589596663|FG001|Overall Study|Withdrawal by Subject|2|||
163243061|NCT02117570|589596666|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
163243062|NCT02117570|589596667|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
163243063|NCT02117570|589596668|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
163243064|NCT02117570|589596666|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
163243065|NCT02117570|589596667|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
163243066|NCT02117570|589596668|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
163243067|NCT02117570|589596666|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
163243068|NCT02117570|589596667|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
163243069|NCT02117570|589596668|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
163243070|NCT02117570|589596666|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
163243071|NCT02117570|589596667|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
163243072|NCT02117570|589596668|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
163243073|NCT02117570|589596666|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
163243074|NCT02117570|589596667|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
163243075|NCT02117570|589596668|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
163243076|NCT02117570|589596666|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
163243077|NCT02117570|589596667|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
163243078|NCT02117570|589596668|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
163243079|NCT02117570|589596666|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
163243080|NCT02117570|589596667|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
163243081|NCT02117570|589596668|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
163243082|NCT02148250|589596669|FG000|Screening|Withdrawal by Subject|5|||
163243083|NCT02148250|589596670|FG001|Screening|Withdrawal by Subject|0|||
163243084|NCT04447404|589596671|FG000|Overall Study|Death|2|||
163243085|NCT04447404|589596672|FG001|Overall Study|Death|0|||
163243086|NCT00563784|589596673|FG000|Overall Study|Withdrawal by Subject|2|||
163243087|NCT00563784|589596673|FG000|Overall Study|Screen Failures|20|||
163243088|NCT04004611|589596675|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
163243089|NCT04004611|589596676|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
163243090|NCT04004611|589596677|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
163243091|NCT04004611|589596678|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
163243092|NCT04004611|589596679|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
163351268|NCT01917006|589996120|FG000|Open-label Period|Lost to Follow-up|0|||
163351269|NCT01917006|589996121|FG001|Open-label Period|Lost to Follow-up|0|||
163351270|NCT01917006|589996122|FG002|Open-label Period|Lost to Follow-up|0|||
163351271|NCT01917006|589996123|FG003|Open-label Period|Lost to Follow-up|0|||
163351272|NCT01917006|589996124|FG004|Open-label Period|Lost to Follow-up|0|||
163148214|NCT00001832|589255417|FG009|Treatment Period|Not treated|0|||
163148215|NCT00001832|589255418|FG010|Treatment Period|Not treated|0|||
163148216|NCT00001832|589255419|FG011|Treatment Period|Not treated|0|||
163148217|NCT00001832|589255420|FG012|Treatment Period|Not treated|0|||
163148218|NCT00001832|589255421|FG013|Treatment Period|Not treated|0|||
163148219|NCT00001832|589255422|FG014|Treatment Period|Not treated|0|||
163148220|NCT00713609|589255423|FG000|Overall Study|Adverse Event|2|||
163148221|NCT00713609|589255424|FG001|Overall Study|Adverse Event|0|||
163148222|NCT00713609|589255425|FG002|Overall Study|Adverse Event|2|||
163148223|NCT00713609|589255426|FG003|Overall Study|Adverse Event|2|||
163148224|NCT00713609|589255427|FG004|Overall Study|Adverse Event|3|||
163148225|NCT00713609|589255428|FG005|Overall Study|Adverse Event|1|||
163148226|NCT00713609|589255423|FG000|Overall Study|Lost to Follow-up|5|||
163148227|NCT00713609|589255424|FG001|Overall Study|Lost to Follow-up|7|||
163148228|NCT00713609|589255425|FG002|Overall Study|Lost to Follow-up|5|||
163243093|NCT04004611|589596680|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
163351273|NCT01917006|589996125|FG005|Open-label Period|Lost to Follow-up|0|||
163148229|NCT00713609|589255426|FG003|Overall Study|Lost to Follow-up|5|||
163148230|NCT00713609|589255427|FG004|Overall Study|Lost to Follow-up|7|||
163148231|NCT00713609|589255428|FG005|Overall Study|Lost to Follow-up|0|||
163351274|NCT01917006|589996126|FG006|Open-label Period|Lost to Follow-up|0|||
163243094|NCT04004611|589596681|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
163243095|NCT04004611|589596682|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
163243096|NCT04004611|589596683|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
163243097|NCT04004611|589596675|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
163243098|NCT04004611|589596676|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
163243099|NCT04004611|589596677|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
163243100|NCT04004611|589596678|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
163243101|NCT04004611|589596679|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
163243102|NCT04004611|589596680|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
163243103|NCT04004611|589596681|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
163243104|NCT04004611|589596682|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
163243105|NCT04004611|589596683|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
163243106|NCT04004611|589596675|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
163243107|NCT04004611|589596676|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
163243108|NCT04004611|589596677|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
163243109|NCT04004611|589596678|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
163243110|NCT04004611|589596679|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
163243111|NCT04004611|589596680|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
163243112|NCT04004611|589596681|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
163243113|NCT04004611|589596682|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
163243114|NCT04004611|589596683|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
163243115|NCT04004611|589596675|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
163243116|NCT04004611|589596676|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
163243117|NCT04004611|589596677|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
163243118|NCT04004611|589596678|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
163243119|NCT04004611|589596679|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
163243120|NCT04004611|589596680|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
163243121|NCT04004611|589596681|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
163243122|NCT04004611|589596682|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
163243123|NCT04004611|589596683|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
163243124|NCT04004611|589596675|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
163243125|NCT04004611|589596676|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
163243126|NCT04004611|589596677|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
163243127|NCT04004611|589596678|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
163243128|NCT04004611|589596679|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
163243129|NCT04004611|589596680|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
163243130|NCT04004611|589596681|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
163243131|NCT04004611|589596682|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
163243132|NCT04004611|589596683|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
163243133|NCT04004611|589596675|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
163243134|NCT04004611|589596676|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
163243135|NCT04004611|589596677|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
163243136|NCT04004611|589596678|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
163243137|NCT04004611|589596679|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
163243138|NCT04004611|589596680|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
163243139|NCT04004611|589596681|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
163243140|NCT04004611|589596682|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
163243141|NCT04004611|589596683|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
163243142|NCT00320216|589596684|FG000|Overall Study|Adverse Event|0|||
163243143|NCT00320216|589596685|FG001|Overall Study|Adverse Event|6|||
163243144|NCT00320216|589596686|FG002|Overall Study|Adverse Event|0|||
163243145|NCT00320216|589596687|FG003|Overall Study|Adverse Event|2|||
163351275|NCT01917006|589996127|FG007|Open-label Period|Lost to Follow-up|1|||
163351276|NCT02158247|589996128|FG000|Overall Study|Invisible vocal cords|5|||
163351277|NCT01057251|589996130|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
163351278|NCT01057251|589996131|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
163351279|NCT01057251|589996130|FG000|Overall Study|Adverse Event|4|||
163351280|NCT01057251|589996131|FG001|Overall Study|Adverse Event|2|||
163351281|NCT01057251|589996130|FG000|Overall Study|Lack of Efficacy|2|||
163351282|NCT01057251|589996131|FG001|Overall Study|Lack of Efficacy|11|||
163351283|NCT01057251|589996130|FG000|Overall Study|Protocol Violation|6|||
163351284|NCT01057251|589996131|FG001|Overall Study|Protocol Violation|2|||
163351285|NCT01057251|589996130|FG000|Overall Study|Withdrawal by Subject|4|||
163243146|NCT00320216|589596688|FG004|Overall Study|Adverse Event|2|||
163243147|NCT00320216|589596684|FG000|Overall Study|Lack of Efficacy|6|||
163243148|NCT00320216|589596685|FG001|Overall Study|Lack of Efficacy|2|||
163351286|NCT01057251|589996131|FG001|Overall Study|Withdrawal by Subject|5|||
163351287|NCT01057251|589996130|FG000|Overall Study|Lost to Follow-up|7|||
163243149|NCT00320216|589596686|FG002|Overall Study|Lack of Efficacy|1|||
163243150|NCT00320216|589596687|FG003|Overall Study|Lack of Efficacy|0|||
163243151|NCT00320216|589596688|FG004|Overall Study|Lack of Efficacy|1|||
163243152|NCT00320216|589596684|FG000|Overall Study|Lost to Follow-up|3|||
163243153|NCT00320216|589596685|FG001|Overall Study|Lost to Follow-up|0|||
163243154|NCT00320216|589596686|FG002|Overall Study|Lost to Follow-up|0|||
163243155|NCT00320216|589596687|FG003|Overall Study|Lost to Follow-up|0|||
163243156|NCT00320216|589596688|FG004|Overall Study|Lost to Follow-up|0|||
163243157|NCT00320216|589596684|FG000|Overall Study|Other|7|||
163243158|NCT00320216|589596685|FG001|Overall Study|Other|2|||
163243159|NCT00320216|589596686|FG002|Overall Study|Other|5|||
163243160|NCT00320216|589596687|FG003|Overall Study|Other|1|||
163243161|NCT00320216|589596688|FG004|Overall Study|Other|3|||
163243162|NCT02384759|589596694|FG000|Overall Study|Patients not treated|3|||
163243163|NCT02384759|589596695|FG001|Overall Study|Patients not treated|2|||
163243164|NCT01605617|589596696|FG000|First Intervention|Adverse Event|0|||
163243165|NCT01605617|589596697|FG001|First Intervention|Adverse Event|1|||
163243166|NCT01605617|589596696|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
163243167|NCT01605617|589596697|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
163243168|NCT03950739|589596698|FG000|Treatment Phase|Adverse Event|2|||
163243169|NCT03950739|589596698|FG000|Optional Extension Phase|Death|1|||
163243170|NCT03950739|589596698|FG000|Optional Extension Phase|Progressive Disease|5|||
163243171|NCT03950739|589596698|FG000|Optional Extension Phase|Adverse Event|7|||
163243172|NCT03950739|589596698|FG000|Optional Extension Phase|Lost to Follow-up|2|||
163243173|NCT03950739|589596698|FG000|Optional Extension Phase|Site Closure|2|||
163243174|NCT03950739|589596698|FG000|Optional Extension Phase|Pregnancy|1|||
163243175|NCT03625570|589596699|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
163243176|NCT03625570|589596700|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
163243177|NCT03625570|589596699|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
163243178|NCT03625570|589596700|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
163243179|NCT03625570|589596699|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
163243180|NCT03625570|589596700|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
163243181|NCT00345579|589596701|FG000|Overall Study|Adverse Event|9|||
163243182|NCT00345579|589596702|FG001|Overall Study|Adverse Event|6|||
163243183|NCT00345579|589596701|FG000|Overall Study|Protocol Violation|14|||
163243184|NCT00345579|589596702|FG001|Overall Study|Protocol Violation|5|||
163243185|NCT00345579|589596701|FG000|Overall Study|Withdrawal by Subject|50|||
163243186|NCT00345579|589596702|FG001|Overall Study|Withdrawal by Subject|17|||
163243187|NCT00345579|589596701|FG000|Overall Study|Lost to Follow-up|82|||
163243188|NCT00345579|589596702|FG001|Overall Study|Lost to Follow-up|36|||
163243189|NCT00345579|589596701|FG000|Overall Study|Other|9|||
163243190|NCT00345579|589596702|FG001|Overall Study|Other|1|||
163243191|NCT01949480|589596703|FG000|Overall Study|Physician Decision|5|||
163243192|NCT01949480|589596704|FG001|Overall Study|Physician Decision|8|||
163243193|NCT00144339|589596705|FG000|Overall Study|Adverse Event|746|||
163243194|NCT00144339|589596706|FG001|Overall Study|Adverse Event|627|||
163243195|NCT00144339|589596705|FG000|Overall Study|Protocol Violation|75|||
163243196|NCT00144339|589596706|FG001|Overall Study|Protocol Violation|48|||
163243197|NCT00144339|589596705|FG000|Overall Study|Withdrawal by Subject|403|||
163243198|NCT00144339|589596706|FG001|Overall Study|Withdrawal by Subject|300|||
163243199|NCT00144339|589596705|FG000|Overall Study|Lost to Follow-up|76|||
163243200|NCT00144339|589596706|FG001|Overall Study|Lost to Follow-up|64|||
163243201|NCT00144339|589596705|FG000|Overall Study|Other|58|||
163243202|NCT00144339|589596706|FG001|Overall Study|Other|60|||
163243203|NCT00305058|589596707|FG000|Overall Study|Participant too young|1|||
163243204|NCT00305058|589596708|FG001|Overall Study|Participant too young|0|||
163243205|NCT00305058|589596707|FG000|Overall Study|Missing data collection instrument|3|||
163243206|NCT00305058|589596708|FG001|Overall Study|Missing data collection instrument|2|||
163243207|NCT00305058|589596707|FG000|Overall Study|Missing outcome data|3|||
163243208|NCT00305058|589596708|FG001|Overall Study|Missing outcome data|2|||
163243209|NCT03538626|589596709|FG000|Overall Study|Withdrawal by Subject|0|||
163351288|NCT01057251|589996131|FG001|Overall Study|Lost to Follow-up|6|||
163351289|NCT01057251|589996130|FG000|Overall Study|Other Reason|1|||
163351290|NCT01057251|589996131|FG001|Overall Study|Other Reason|1|||
163351291|NCT02509312|589996132|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
163351292|NCT02509312|589996133|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
163351293|NCT02509312|589996132|FG000|Overall Study|Obstetrician refusal|0|||
163243210|NCT03538626|589596710|FG001|Overall Study|Withdrawal by Subject|1|||
163243211|NCT03538626|589596711|FG002|Overall Study|Withdrawal by Subject|0|||
163243212|NCT03538626|589596712|FG003|Overall Study|Withdrawal by Subject|0|||
163243213|NCT03538626|589596713|FG004|Overall Study|Withdrawal by Subject|0|||
163243214|NCT03538626|589596714|FG005|Overall Study|Withdrawal by Subject|0|||
163243215|NCT03538626|589596715|FG006|Overall Study|Withdrawal by Subject|0|||
163243216|NCT03538626|589596716|FG007|Overall Study|Withdrawal by Subject|0|||
163351294|NCT02509312|589996133|FG001|Overall Study|Obstetrician refusal|1|||
163351295|NCT02509312|589996132|FG000|Overall Study|Patient elected for TOLAC|1|||
163243217|NCT03538626|589596709|FG000|Overall Study|Lost to Follow-up|0|||
163243218|NCT03538626|589596710|FG001|Overall Study|Lost to Follow-up|0|||
163243219|NCT03538626|589596711|FG002|Overall Study|Lost to Follow-up|0|||
163243220|NCT03538626|589596712|FG003|Overall Study|Lost to Follow-up|0|||
163243221|NCT03538626|589596713|FG004|Overall Study|Lost to Follow-up|0|||
163243222|NCT03538626|589596714|FG005|Overall Study|Lost to Follow-up|0|||
163243223|NCT03538626|589596715|FG006|Overall Study|Lost to Follow-up|1|||
163243224|NCT03538626|589596716|FG007|Overall Study|Lost to Follow-up|0|||
163243225|NCT00288587|589596717|FG000|Overall Study|Death|4|||
163243226|NCT00288587|589596718|FG001|Overall Study|Death|4|||
163243227|NCT00288587|589596717|FG000|Overall Study|Transplant|0|||
163243228|NCT00288587|589596718|FG001|Overall Study|Transplant|3|||
163243229|NCT00288587|589596717|FG000|Overall Study|Adverse Event|0|||
163243230|NCT00288587|589596718|FG001|Overall Study|Adverse Event|1|||
163243231|NCT00288587|589596717|FG000|Overall Study|Physician Decision|0|||
163243232|NCT00288587|589596718|FG001|Overall Study|Physician Decision|2|||
163243233|NCT00288587|589596717|FG000|Overall Study|Severe Aortic Stenosis|1|||
163243234|NCT00288587|589596718|FG001|Overall Study|Severe Aortic Stenosis|0|||
163243235|NCT02232893|589596724|FG000|Overall Study|Withdrawal by Subject|4|||
163243236|NCT02232893|589596725|FG001|Overall Study|Withdrawal by Subject|1|||
163243237|NCT02232893|589596724|FG000|Overall Study|Adverse Event|0|||
163243238|NCT02232893|589596725|FG001|Overall Study|Adverse Event|1|||
163243239|NCT02232893|589596724|FG000|Overall Study|Sponsor request early termination|0|||
163243240|NCT02232893|589596725|FG001|Overall Study|Sponsor request early termination|1|||
163243241|NCT02232893|589596724|FG000|Overall Study|Developed exclusion criteria|0|||
163243242|NCT02232893|589596725|FG001|Overall Study|Developed exclusion criteria|1|||
163243243|NCT02232893|589596724|FG000|Overall Study|Other|0|||
163243244|NCT02232893|589596725|FG001|Overall Study|Other|3|||
163243245|NCT01764945|589596726|FG000|Overall Study|Adverse Event|0|||
163243246|NCT01764945|589596727|FG001|Overall Study|Adverse Event|1|||
163243247|NCT01764945|589596728|FG002|Overall Study|Adverse Event|0|||
163243248|NCT01764945|589596729|FG003|Overall Study|Adverse Event|0|||
163243249|NCT01764945|589596730|FG004|Overall Study|Adverse Event|0|||
163243250|NCT01764945|589596731|FG005|Overall Study|Adverse Event|0|||
163243251|NCT01764945|589596732|FG006|Overall Study|Adverse Event|1|||
163243252|NCT01764945|589596733|FG007|Overall Study|Adverse Event|0|||
163243253|NCT05077267|589596736|FG000|Treatment Period|Lost to Follow-up|0|||
163243254|NCT05077267|589596737|FG001|Treatment Period|Lost to Follow-up|1|||
163243255|NCT05077267|589596738|FG002|Treatment Period|Lost to Follow-up|0|||
163243256|NCT05077267|589596736|FG000|Treatment Period|Withdrawal by Subject|0|||
163243257|NCT05077267|589596737|FG001|Treatment Period|Withdrawal by Subject|1|||
163243258|NCT05077267|589596738|FG002|Treatment Period|Withdrawal by Subject|0|||
163243259|NCT05077267|589596736|FG000|Follow-up Period|Lost to Follow-up|0|||
163243260|NCT05077267|589596737|FG001|Follow-up Period|Lost to Follow-up|5|||
163243261|NCT05077267|589596738|FG002|Follow-up Period|Lost to Follow-up|7|||
163243262|NCT05077267|589596736|FG000|Follow-up Period|Withdrawal by Subject|0|||
163243263|NCT05077267|589596737|FG001|Follow-up Period|Withdrawal by Subject|2|||
163243264|NCT05077267|589596738|FG002|Follow-up Period|Withdrawal by Subject|5|||
163243265|NCT05077267|589596736|FG000|Follow-up Period|Study terminated by sponsor|0|||
163243266|NCT05077267|589596737|FG001|Follow-up Period|Study terminated by sponsor|27|||
163243267|NCT05077267|589596738|FG002|Follow-up Period|Study terminated by sponsor|23|||
163243268|NCT05077267|589596736|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
163243269|NCT05077267|589596737|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
163243270|NCT05077267|589596738|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
163243271|NCT05077267|589596736|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
163243272|NCT05077267|589596737|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
163243273|NCT05077267|589596738|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
163243274|NCT02911948|589596739|FG000|Overall Study|Protocol Violation|0|||
163243275|NCT02911948|589596740|FG001|Overall Study|Protocol Violation|1|||
163243276|NCT02911948|589596739|FG000|Overall Study|Withdrawal by Subject|0|||
163243277|NCT02911948|589596740|FG001|Overall Study|Withdrawal by Subject|2|||
163243278|NCT02911948|589596739|FG000|Overall Study|Lack of Efficacy|0|||
163351296|NCT02509312|589996133|FG001|Overall Study|Patient elected for TOLAC|0|||
163243279|NCT02911948|589596740|FG001|Overall Study|Lack of Efficacy|1|||
163243280|NCT02911948|589596739|FG000|Overall Study|Unclassified|0|||
163243281|NCT02911948|589596740|FG001|Overall Study|Unclassified|3|||
163243282|NCT00586105|589596747|FG000|Overall Study|Adverse Event|4|||
163243283|NCT00586105|589596747|FG000|Overall Study|Death|2|||
163243284|NCT00586105|589596747|FG000|Overall Study|Protocol Violation|1|||
163243285|NCT00586105|589596747|FG000|Overall Study|Withdrawal by Subject|3|||
163243286|NCT00586105|589596747|FG000|Overall Study|Disease progression|19|||
163243287|NCT00586105|589596747|FG000|Overall Study|Switched to commercial drug|9|||
163243288|NCT00586105|589596747|FG000|Overall Study|Reason not reported|1|||
163243289|NCT01136291|589596751|FG000|Overall Study|Lost to Follow-up|1|||
163243290|NCT01136291|589596752|FG001|Overall Study|Lost to Follow-up|1|||
163243291|NCT03965052|589596753|FG000|Overall Study|Protocol Violation|1|||
163243292|NCT03965052|589596754|FG001|Overall Study|Protocol Violation|0|||
163243293|NCT02308033|589596764|FG000|Overall Study|Normal Gram stain at Baseline|13|||
163243294|NCT02308033|589596765|FG001|Overall Study|Normal Gram stain at Baseline|10|||
163243295|NCT02308033|589596764|FG000|Overall Study|Positive for STD at Baseline|7|||
163243296|NCT02308033|589596765|FG001|Overall Study|Positive for STD at Baseline|4|||
163243297|NCT02308033|589596764|FG000|Overall Study|Lost to Follow-up|6|||
163243298|NCT02308033|589596765|FG001|Overall Study|Lost to Follow-up|5|||
163243299|NCT03165045|589596766|FG000|Visit 1|No registration after visit 1|9|||
163243300|NCT03165045|589596766|FG000|Visit 1|No treatment documented|10|||
163243301|NCT03165045|589596766|FG000|Visit 1|No visit 1|10|||
163243302|NCT03165045|589596766|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
163243303|NCT03165045|589596766|FG000|Visit 2|No available total CCQ score at all|29|||
163243304|NCT03165045|589596766|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
163243305|NCT04964089|589596769|FG000|Overall Study|Adverse Event|8|||
163243306|NCT04964089|589596770|FG001|Overall Study|Adverse Event|6|||
163243307|NCT04964089|589596769|FG000|Overall Study|Non-compliance with study schedule|1|||
163243308|NCT04964089|589596770|FG001|Overall Study|Non-compliance with study schedule|0|||
163243309|NCT04964089|589596769|FG000|Overall Study|Withdrawal by Subject|6|||
163243310|NCT04964089|589596770|FG001|Overall Study|Withdrawal by Subject|5|||
163243311|NCT04964089|589596769|FG000|Overall Study|Lost to Follow-up|1|||
163243312|NCT04964089|589596770|FG001|Overall Study|Lost to Follow-up|1|||
163243313|NCT04964089|589596769|FG000|Overall Study|Progressive disease|4|||
163243314|NCT04964089|589596770|FG001|Overall Study|Progressive disease|0|||
163243315|NCT04964089|589596769|FG000|Overall Study|Physician Decision|1|||
163243316|NCT04964089|589596770|FG001|Overall Study|Physician Decision|0|||
163243317|NCT04964089|589596769|FG000|Overall Study|Participant did not want to continue study treatment|1|||
163243318|NCT04964089|589596770|FG001|Overall Study|Participant did not want to continue study treatment|0|||
163243319|NCT04964089|589596769|FG000|Overall Study|Participant moved to different state|1|||
163243320|NCT04964089|589596770|FG001|Overall Study|Participant moved to different state|0|||
163410013|NCT00419380|590209563|FG000|Overall Study|Lack of Efficacy|1|||
163410014|NCT00419380|590209564|FG001|Overall Study|Lack of Efficacy|7|||
163410015|NCT00419380|590209563|FG000|Overall Study|Physician Decision|0|||
163410016|NCT00419380|590209564|FG001|Overall Study|Physician Decision|1|||
163410017|NCT00419380|590209563|FG000|Overall Study|Lost to Follow-up|0|||
163410018|NCT00419380|590209564|FG001|Overall Study|Lost to Follow-up|1|||
163410019|NCT00419380|590209563|FG000|Overall Study|Withdrawal by Subject|0|||
163410020|NCT00419380|590209564|FG001|Overall Study|Withdrawal by Subject|1|||
163410021|NCT03099707|590209565|FG000|Overall Study|Withdrawal by Subject|0|||
163148232|NCT00713609|589255423|FG000|Overall Study|Lack of Efficacy|1|||
163148233|NCT00713609|589255424|FG001|Overall Study|Lack of Efficacy|3|||
163148234|NCT00713609|589255425|FG002|Overall Study|Lack of Efficacy|0|||
163148235|NCT00713609|589255426|FG003|Overall Study|Lack of Efficacy|0|||
163148236|NCT00713609|589255427|FG004|Overall Study|Lack of Efficacy|1|||
163148237|NCT00713609|589255428|FG005|Overall Study|Lack of Efficacy|0|||
163148238|NCT00713609|589255423|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
163148239|NCT00713609|589255424|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
163148240|NCT00713609|589255425|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
163148241|NCT00713609|589255426|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
163148242|NCT00713609|589255427|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
163148243|NCT00713609|589255428|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
163148244|NCT00713609|589255423|FG000|Overall Study|Withdrawal by Subject|6|||
163148245|NCT00713609|589255424|FG001|Overall Study|Withdrawal by Subject|1|||
163148246|NCT00713609|589255425|FG002|Overall Study|Withdrawal by Subject|5|||
163148247|NCT00713609|589255426|FG003|Overall Study|Withdrawal by Subject|1|||
163148248|NCT00713609|589255427|FG004|Overall Study|Withdrawal by Subject|5|||
163148249|NCT00713609|589255428|FG005|Overall Study|Withdrawal by Subject|7|||
163148250|NCT00713609|589255423|FG000|Overall Study|Protocol Violation|6|||
163148251|NCT00713609|589255424|FG001|Overall Study|Protocol Violation|3|||
163148252|NCT00713609|589255425|FG002|Overall Study|Protocol Violation|1|||
163148253|NCT00713609|589255426|FG003|Overall Study|Protocol Violation|1|||
163148254|NCT00713609|589255427|FG004|Overall Study|Protocol Violation|2|||
163148255|NCT00713609|589255428|FG005|Overall Study|Protocol Violation|0|||
163148256|NCT01903356|589255429|FG000|Overall Study|Lost to Follow-up|7|||
163148257|NCT01903356|589255429|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
163148258|NCT01903356|589255429|FG000|Overall Study|Violated the dosage and administration|3|||
163148259|NCT04529083|589255430|FG000|Overall Study|Withdrawal by Subject|3|||
163148260|NCT03305666|589255435|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
163148261|NCT03305666|589255436|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
163148262|NCT04196686|589255437|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
163148263|NCT04196686|589255438|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
163148264|NCT00914849|589255444|FG000|Overall Study|Withdrawal by Subject|1|||
163148265|NCT00914849|589255445|FG001|Overall Study|Withdrawal by Subject|0|||
163243321|NCT04964089|589596769|FG000|Overall Study|Participant decided to discontinue|0|||
163410022|NCT03099707|590209566|FG001|Overall Study|Withdrawal by Subject|3|||
163410023|NCT03099707|590209565|FG000|Overall Study|Lost to Follow-up|0|||
163243322|NCT04964089|589596770|FG001|Overall Study|Participant decided to discontinue|1|||
163243323|NCT00574080|589598445|FG000|Overall Study|Death|10|||
163243324|NCT00574080|589598446|FG001|Overall Study|Death|10|||
163243325|NCT01221597|589598447|FG000|Overall Study|Adverse Event|4|||
163243326|NCT01221597|589598448|FG001|Overall Study|Adverse Event|1|||
163243327|NCT01221597|589598447|FG000|Overall Study|Withdrawal by Subject|20|||
163243328|NCT01221597|589598448|FG001|Overall Study|Withdrawal by Subject|6|||
163243329|NCT01221597|589598447|FG000|Overall Study|Lost to Follow-up|6|||
163243330|NCT01221597|589598448|FG001|Overall Study|Lost to Follow-up|5|||
163243331|NCT01221597|589598447|FG000|Overall Study|Protocol Violation|1|||
163243332|NCT01221597|589598448|FG001|Overall Study|Protocol Violation|0|||
163243333|NCT01221597|589598447|FG000|Overall Study|Other|3|||
163243334|NCT01221597|589598448|FG001|Overall Study|Other|4|||
163243335|NCT01221597|589598447|FG000|Overall Study|Death|2|||
163243336|NCT01221597|589598448|FG001|Overall Study|Death|0|||
163243337|NCT00148343|589598451|FG000|Overall Study|Withdrawal by Subject|12|||
163243338|NCT00148343|589598452|FG001|Overall Study|Withdrawal by Subject|7|||
163243339|NCT00148343|589598451|FG000|Overall Study|Physician Decision|3|||
163243340|NCT00148343|589598452|FG001|Overall Study|Physician Decision|4|||
163243341|NCT00121238|589598459|FG000|Overall Study|disease progression before intervention|1|||
163243342|NCT00121238|589598459|FG000|Overall Study|Protocol Violation|2|||
163243343|NCT01380327|589598460|FG000|Overall Study|Lost to Follow-up|0|||
163243344|NCT01380327|589598461|FG001|Overall Study|Lost to Follow-up|1|||
163243345|NCT01380327|589598462|FG002|Overall Study|Lost to Follow-up|1|||
163243346|NCT01380327|589598460|FG000|Overall Study|Protocol Violation|3|||
163243347|NCT01380327|589598461|FG001|Overall Study|Protocol Violation|2|||
163243348|NCT01380327|589598462|FG002|Overall Study|Protocol Violation|3|||
163243349|NCT01380327|589598460|FG000|Overall Study|Withdrawal by Subject|0|||
163243350|NCT01380327|589598461|FG001|Overall Study|Withdrawal by Subject|0|||
163243351|NCT01380327|589598462|FG002|Overall Study|Withdrawal by Subject|1|||
163243352|NCT01380327|589598460|FG000|Overall Study|Housing situation precluded ability to k|0|||
163243353|NCT01380327|589598461|FG001|Overall Study|Housing situation precluded ability to k|0|||
163243354|NCT01380327|589598462|FG002|Overall Study|Housing situation precluded ability to k|1|||
163243355|NCT01380327|589598460|FG000|Overall Study|Questionable onset of epilepsy|0|||
163243356|NCT01380327|589598461|FG001|Overall Study|Questionable onset of epilepsy|0|||
163243357|NCT01380327|589598462|FG002|Overall Study|Questionable onset of epilepsy|1|||
163243358|NCT03043664|589598463|FG000|Overall Study|Lost to Follow-up|1|||
163243359|NCT01540851|589598464|FG000|Overall Study|Lost to Follow-up|14|||
163243360|NCT01540851|589598465|FG001|Overall Study|Lost to Follow-up|15|||
163243361|NCT01540851|589598464|FG000|Overall Study|Withdrawal by Subject|7|||
163243362|NCT01540851|589598465|FG001|Overall Study|Withdrawal by Subject|3|||
163243363|NCT00325468|589598466|FG000|Overall Study|Adverse Event|1|||
163243364|NCT00325468|589598467|FG001|Overall Study|Adverse Event|1|||
163243365|NCT00325468|589598468|FG002|Overall Study|Adverse Event|0|||
163243366|NCT00325468|589598469|FG003|Overall Study|Adverse Event|5|||
163243367|NCT00325468|589598470|FG004|Overall Study|Adverse Event|1|||
163243368|NCT00325468|589598466|FG000|Overall Study|Death|2|||
163243369|NCT00325468|589598467|FG001|Overall Study|Death|0|||
163243370|NCT00325468|589598468|FG002|Overall Study|Death|2|||
163243371|NCT00325468|589598469|FG003|Overall Study|Death|4|||
163243372|NCT00325468|589598470|FG004|Overall Study|Death|0|||
163243373|NCT00325468|589598466|FG000|Overall Study|Lost to Follow-up|0|||
163243374|NCT00325468|589598467|FG001|Overall Study|Lost to Follow-up|0|||
163243375|NCT00325468|589598468|FG002|Overall Study|Lost to Follow-up|1|||
163243376|NCT00325468|589598469|FG003|Overall Study|Lost to Follow-up|2|||
163243377|NCT00325468|589598470|FG004|Overall Study|Lost to Follow-up|2|||
163243378|NCT00325468|589598466|FG000|Overall Study|Physician Decision|1|||
163243379|NCT00325468|589598467|FG001|Overall Study|Physician Decision|1|||
163243380|NCT00325468|589598468|FG002|Overall Study|Physician Decision|0|||
163243381|NCT00325468|589598469|FG003|Overall Study|Physician Decision|1|||
163243382|NCT00325468|589598470|FG004|Overall Study|Physician Decision|0|||
163243383|NCT00325468|589598466|FG000|Overall Study|Withdrawal by Subject|3|||
163243384|NCT00325468|589598467|FG001|Overall Study|Withdrawal by Subject|1|||
163243385|NCT00325468|589598468|FG002|Overall Study|Withdrawal by Subject|0|||
163243386|NCT00325468|589598469|FG003|Overall Study|Withdrawal by Subject|14|||
163243387|NCT00325468|589598470|FG004|Overall Study|Withdrawal by Subject|4|||
163243388|NCT00325468|589598466|FG000|Overall Study|site closure etc|4|||
163243389|NCT00325468|589598467|FG001|Overall Study|site closure etc|2|||
163243390|NCT00325468|589598468|FG002|Overall Study|site closure etc|1|||
163243391|NCT00325468|589598469|FG003|Overall Study|site closure etc|8|||
163243392|NCT00325468|589598470|FG004|Overall Study|site closure etc|1|||
163243393|NCT03732209|589598471|FG000|Overall Study|Lost to Follow-up|4|||
163243394|NCT03732209|589598472|FG001|Overall Study|Lost to Follow-up|4|||
163243395|NCT03732209|589598471|FG000|Overall Study|Withdrawal by Subject|8|||
163243396|NCT03732209|589598472|FG001|Overall Study|Withdrawal by Subject|9|||
163243397|NCT05046795|589598473|FG000|Overall Study|Adverse Event|13|||
163243398|NCT05046795|589598474|FG001|Overall Study|Adverse Event|15|||
163243399|NCT05046795|589598473|FG000|Overall Study|Withdrawal by Subject|4|||
163243400|NCT05046795|589598474|FG001|Overall Study|Withdrawal by Subject|7|||
163351297|NCT02509312|589996132|FG000|Overall Study|Cesarean deemed stat|1|||
163351298|NCT02509312|589996133|FG001|Overall Study|Cesarean deemed stat|0|||
163351299|NCT02509312|589996132|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
163351300|NCT02509312|589996133|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
163351301|NCT04544865|589996134|FG000|Overall Study|Death|0|||
163351302|NCT04544865|589996135|FG001|Overall Study|Death|2|||
163351303|NCT04544865|589996134|FG000|Overall Study|Lost to Follow-up|11|||
163351304|NCT04544865|589996135|FG001|Overall Study|Lost to Follow-up|7|||
163148266|NCT00914849|589255444|FG000|Overall Study|Not eligible|0|||
163148267|NCT00914849|589255445|FG001|Overall Study|Not eligible|1|||
163148268|NCT01001221|589255446|FG000|Overall Study|Adverse Event|1|||
163148269|NCT01001221|589255447|FG001|Overall Study|Adverse Event|2|||
163148270|NCT01001221|589255448|FG002|Overall Study|Adverse Event|0|||
163148271|NCT01001221|589255449|FG003|Overall Study|Adverse Event|2|||
163148272|NCT01001221|589255450|FG004|Overall Study|Adverse Event|0|||
163148273|NCT01001221|589255446|FG000|Overall Study|Disease progression|3|||
163148274|NCT01001221|589255447|FG001|Overall Study|Disease progression|2|||
163148275|NCT01001221|589255448|FG002|Overall Study|Disease progression|2|||
163148276|NCT01001221|589255449|FG003|Overall Study|Disease progression|4|||
163148277|NCT01001221|589255450|FG004|Overall Study|Disease progression|0|||
163148278|NCT01001221|589255446|FG000|Overall Study|Other|1|||
163148279|NCT01001221|589255447|FG001|Overall Study|Other|1|||
163148280|NCT01001221|589255448|FG002|Overall Study|Other|0|||
163148281|NCT01001221|589255449|FG003|Overall Study|Other|0|||
163148282|NCT01001221|589255450|FG004|Overall Study|Other|0|||
163148283|NCT01001221|589255446|FG000|Overall Study|Not treated; protocol exclusion|0|||
163148284|NCT01001221|589255447|FG001|Overall Study|Not treated; protocol exclusion|0|||
163148285|NCT01001221|589255448|FG002|Overall Study|Not treated; protocol exclusion|1|||
163148286|NCT01001221|589255449|FG003|Overall Study|Not treated; protocol exclusion|0|||
163148287|NCT01001221|589255450|FG004|Overall Study|Not treated; protocol exclusion|0|||
163148288|NCT05106959|589255451|FG000|Overall Study|Lost to Follow-up|1|||
163148289|NCT03448406|589255452|FG000|Overall Study|Noncompliance of scheduled visits|1|||
163148290|NCT03448406|589255453|FG001|Overall Study|Noncompliance of scheduled visits|2|||
163148291|NCT03448406|589255452|FG000|Overall Study|Withdrawal by Subject|1|||
163148292|NCT03448406|589255453|FG001|Overall Study|Withdrawal by Subject|2|||
163148293|NCT03448406|589255452|FG000|Overall Study|Protocol Violation|1|||
163148294|NCT03448406|589255453|FG001|Overall Study|Protocol Violation|0|||
163148295|NCT03448406|589255452|FG000|Overall Study|Adverse Event|8|||
163148296|NCT03448406|589255453|FG001|Overall Study|Adverse Event|9|||
163148297|NCT01292486|589255454|FG000|Overall Study|Protocol Violation|2|||
163148298|NCT01292486|589255454|FG000|Overall Study|Did not meet screening criteria|2|||
163148299|NCT01292486|589255454|FG000|Overall Study|Adverse Event|1|||
163148300|NCT01292486|589255454|FG000|Overall Study|Physician Decision|1|||
163148301|NCT00087152|589255455|FG000|Overall Study|Ineligible|6|||
163148302|NCT04602390|589255462|FG000|Overall Study|Withdrawal by Subject|0|||
163148303|NCT04602390|589255463|FG001|Overall Study|Withdrawal by Subject|0|||
163148304|NCT04602390|589255464|FG002|Overall Study|Withdrawal by Subject|0|||
163148305|NCT04602390|589255465|FG003|Overall Study|Withdrawal by Subject|0|||
163148306|NCT04602390|589255466|FG004|Overall Study|Withdrawal by Subject|1|||
163148307|NCT04602390|589255467|FG005|Overall Study|Withdrawal by Subject|0|||
163148308|NCT04602390|589255462|FG000|Overall Study|Adverse Event|0|||
163148309|NCT04602390|589255463|FG001|Overall Study|Adverse Event|0|||
163148310|NCT04602390|589255464|FG002|Overall Study|Adverse Event|0|||
163148311|NCT04602390|589255465|FG003|Overall Study|Adverse Event|0|||
163148312|NCT04602390|589255466|FG004|Overall Study|Adverse Event|0|||
163148313|NCT04602390|589255467|FG005|Overall Study|Adverse Event|1|||
163148314|NCT01277744|589255472|FG000|Overall Study|Physician Decision|2|||
163148315|NCT01791244|589255473|FG000|Overall Study|Adverse Event|5|||
163148316|NCT01791244|589255474|FG001|Overall Study|Adverse Event|7|||
163148317|NCT01791244|589255473|FG000|Overall Study|Insufficient clinical response|10|||
163148318|NCT01791244|589255474|FG001|Overall Study|Insufficient clinical response|10|||
163148319|NCT01791244|589255473|FG000|Overall Study|Laboratory Abnormality|0|||
163148320|NCT01791244|589255474|FG001|Overall Study|Laboratory Abnormality|1|||
163148321|NCT02358473|589255476|FG000|Overall Study|Disease Progession|6|||
163148322|NCT02358473|589255476|FG000|Overall Study|Adverse Event|3|||
163148323|NCT02358473|589255476|FG000|Overall Study|Withdrawal by Subject|2|||
163148324|NCT02358473|589255476|FG000|Overall Study|Physician Decision|2|||
163148325|NCT00703014|589255479|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
163148326|NCT00703014|589255480|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
163148327|NCT00703014|589255481|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
163148328|NCT00703014|589255482|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
163148329|NCT00703014|589255479|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
163148330|NCT00703014|589255480|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
163148331|NCT00703014|589255481|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
163148332|NCT00703014|589255482|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
163148333|NCT04949191|589255483|FG000|Overall Study|Non-compliance with Study Drug|1|||
163148334|NCT04949191|589255484|FG001|Overall Study|Non-compliance with Study Drug|0|||
163148335|NCT04949191|589255485|FG002|Overall Study|Non-compliance with Study Drug|0|||
163148336|NCT04949191|589255486|FG003|Overall Study|Non-compliance with Study Drug|0|||
163148337|NCT04949191|589255483|FG000|Overall Study|Progressive Disease|0|||
163148338|NCT04949191|589255484|FG001|Overall Study|Progressive Disease|1|||
163148339|NCT04949191|589255485|FG002|Overall Study|Progressive Disease|0|||
163148340|NCT04949191|589255486|FG003|Overall Study|Progressive Disease|0|||
163148341|NCT04949191|589255483|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
163148342|NCT04949191|589255484|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
163148343|NCT04949191|589255485|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
163148344|NCT04949191|589255486|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
163148345|NCT04949191|589255483|FG000|Overall Study|Sponsor Terminated Study|0|||
163148346|NCT04949191|589255484|FG001|Overall Study|Sponsor Terminated Study|0|||
163148347|NCT04949191|589255485|FG002|Overall Study|Sponsor Terminated Study|1|||
163148348|NCT04949191|589255486|FG003|Overall Study|Sponsor Terminated Study|1|||
163148349|NCT00730158|589255487|FG000|Overall Study|Withdrawal by Subject|1|||
163148350|NCT00730158|589255488|FG001|Overall Study|Withdrawal by Subject|1|||
163148351|NCT03535974|589255490|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
163148352|NCT03535974|589255491|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
163148353|NCT03535974|589255492|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
163148354|NCT03535974|589255490|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
163148355|NCT03535974|589255491|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
163148356|NCT03535974|589255492|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
163148357|NCT04059549|589255493|FG000|Overall Study|Withdrawal by Subject|2|||
163148358|NCT04059549|589255494|FG001|Overall Study|Withdrawal by Subject|0|||
163148359|NCT02678351|589255495|FG000|Overall Study|Withdrawal by Subject|1|||
163148360|NCT03259230|589255496|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
163148361|NCT03259230|589255497|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
163148362|NCT02913482|589255498|FG000|Overall Study|Death|0|||
163148363|NCT02913482|589255499|FG001|Overall Study|Death|2|||
163148364|NCT02913482|589255500|FG002|Overall Study|Death|2|||
163148365|NCT02913482|589255498|FG000|Overall Study|Progressive Disease|1|||
163148366|NCT02913482|589255499|FG001|Overall Study|Progressive Disease|1|||
163148367|NCT02913482|589255500|FG002|Overall Study|Progressive Disease|1|||
163148368|NCT02913482|589255498|FG000|Overall Study|Reason not specified|0|||
163148369|NCT02913482|589255499|FG001|Overall Study|Reason not specified|0|||
163148370|NCT02913482|589255500|FG002|Overall Study|Reason not specified|1|||
163148371|NCT02913482|589255498|FG000|Overall Study|Withdrawal by Subject|0|||
163148372|NCT02913482|589255499|FG001|Overall Study|Withdrawal by Subject|1|||
163148373|NCT02913482|589255500|FG002|Overall Study|Withdrawal by Subject|1|||
163148374|NCT01919229|589255501|FG000|Overall Study|Subject/guardian decision|0|||
163148375|NCT01919229|589255502|FG001|Overall Study|Subject/guardian decision|0|||
163148376|NCT01919229|589255503|FG002|Overall Study|Subject/guardian decision|1|||
163148377|NCT01011673|589255504|FG000|Randomized|Secondary headache|2|||
163148378|NCT01011673|589255505|FG001|Randomized|Secondary headache|1|||
163148379|NCT01011673|589255504|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
163148380|NCT01011673|589255505|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
163148381|NCT05468814|589255506|FG000|Overall Study|Lost to Follow-up|5|||
163148382|NCT05468814|589255507|FG001|Overall Study|Lost to Follow-up|6|||
163148383|NCT04716426|589255512|FG000|Overall Study|Vaccination|1|||
163148384|NCT04716426|589255513|FG001|Overall Study|Vaccination|1|||
163148385|NCT04716426|589255512|FG000|Overall Study|Contamination|1|||
163148386|NCT04716426|589255513|FG001|Overall Study|Contamination|0|||
163148387|NCT01650558|589255516|FG000|Overall Study|Migration out of study area|61|||
163148388|NCT01650558|589255517|FG001|Overall Study|Migration out of study area|71|||
163148389|NCT01650558|589255518|FG002|Overall Study|Migration out of study area|56|||
163148390|NCT01650558|589255516|FG000|Overall Study|Lost to Follow-up|10|||
163148391|NCT01650558|589255517|FG001|Overall Study|Lost to Follow-up|13|||
163148392|NCT01650558|589255518|FG002|Overall Study|Lost to Follow-up|6|||
163148393|NCT01650558|589255516|FG000|Overall Study|Death|10|||
163148394|NCT01650558|589255517|FG001|Overall Study|Death|6|||
163148395|NCT01650558|589255518|FG002|Overall Study|Death|8|||
163148396|NCT01650558|589255516|FG000|Overall Study|Withdrawal by Subject|1|||
163148397|NCT01650558|589255517|FG001|Overall Study|Withdrawal by Subject|1|||
163148398|NCT01650558|589255518|FG002|Overall Study|Withdrawal by Subject|3|||
163148399|NCT01650558|589255516|FG000|Overall Study|Non-compliant participant|1|||
163243401|NCT05046795|589598473|FG000|Overall Study|Physician Decision|1|||
163148400|NCT01650558|589255517|FG001|Overall Study|Non-compliant participant|0|||
163148401|NCT01650558|589255518|FG002|Overall Study|Non-compliant participant|2|||
163148402|NCT01650558|589255516|FG000|Overall Study|Physician Decision|0|||
163148403|NCT01650558|589255517|FG001|Overall Study|Physician Decision|1|||
163148404|NCT01650558|589255518|FG002|Overall Study|Physician Decision|0|||
163243402|NCT05046795|589598474|FG001|Overall Study|Physician Decision|2|||
163243403|NCT05046795|589598473|FG000|Overall Study|Protocol Violation|1|||
163243404|NCT05046795|589598474|FG001|Overall Study|Protocol Violation|2|||
163243405|NCT05046795|589598473|FG000|Overall Study|Death|1|||
163243406|NCT05046795|589598474|FG001|Overall Study|Death|0|||
163243407|NCT05046795|589598473|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
163243408|NCT05046795|589598474|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
163243409|NCT01127178|589598475|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
163243410|NCT01127178|589598476|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
163243411|NCT01127178|589598475|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
163243412|NCT01127178|589598476|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
163243413|NCT01127178|589598475|FG000|Dose Escalation: Treatment Phase|Other|2|||
163243414|NCT01127178|589598476|FG001|Dose Escalation: Treatment Phase|Other|0|||
163243415|NCT01127178|589598475|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
163243416|NCT01127178|589598476|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
163243417|NCT01127178|589598475|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
163243418|NCT01127178|589598476|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
163243419|NCT01127178|589598475|FG000|Dose Escalation: Extension Phase|Other|1|||
163243420|NCT01127178|589598476|FG001|Dose Escalation: Extension Phase|Other|0|||
163243421|NCT04139317|589598477|FG000|Overall Study|Adverse Event|10|||
163243422|NCT04139317|589598478|FG001|Overall Study|Adverse Event|2|||
163243423|NCT04139317|589598477|FG000|Overall Study|Death|6|||
163243424|NCT04139317|589598478|FG001|Overall Study|Death|4|||
163243425|NCT04139317|589598477|FG000|Overall Study|Lost to Follow-up|1|||
163243426|NCT04139317|589598478|FG001|Overall Study|Lost to Follow-up|0|||
163243427|NCT04139317|589598477|FG000|Overall Study|Physician Decision|3|||
163243428|NCT04139317|589598478|FG001|Overall Study|Physician Decision|1|||
163243429|NCT04139317|589598477|FG000|Overall Study|Progressive Disease|19|||
163243430|NCT04139317|589598478|FG001|Overall Study|Progressive Disease|9|||
163243431|NCT04139317|589598477|FG000|Overall Study|Subject Decision|2|||
163243432|NCT04139317|589598478|FG001|Overall Study|Subject Decision|2|||
163243433|NCT00782340|589598481|FG000|Open Label Titration|Adverse Event|12|||
163243434|NCT00782340|589598482|FG001|Open Label Titration|Adverse Event|0|||
163243435|NCT00782340|589598483|FG002|Open Label Titration|Adverse Event|0|||
163243436|NCT00782340|589598481|FG000|Open Label Titration|Treatment failure|50|||
163243437|NCT00782340|589598482|FG001|Open Label Titration|Treatment failure|0|||
163243438|NCT00782340|589598483|FG002|Open Label Titration|Treatment failure|0|||
163243439|NCT00782340|589598481|FG000|Open Label Titration|Protocol Violation|5|||
163243440|NCT00782340|589598482|FG001|Open Label Titration|Protocol Violation|0|||
163243441|NCT00782340|589598483|FG002|Open Label Titration|Protocol Violation|0|||
163243442|NCT00782340|589598481|FG000|Open Label Titration|Withdrawal by Subject|5|||
163243443|NCT00782340|589598482|FG001|Open Label Titration|Withdrawal by Subject|0|||
163243444|NCT00782340|589598483|FG002|Open Label Titration|Withdrawal by Subject|0|||
163243445|NCT00782340|589598481|FG000|Open Label Titration|Enrollment capped|16|||
163243446|NCT00782340|589598482|FG001|Open Label Titration|Enrollment capped|0|||
163243447|NCT00782340|589598483|FG002|Open Label Titration|Enrollment capped|0|||
163243448|NCT00782340|589598481|FG000|Open Label Titration|Did not meet responder criteria|2|||
163243449|NCT00782340|589598482|FG001|Open Label Titration|Did not meet responder criteria|0|||
163243450|NCT00782340|589598483|FG002|Open Label Titration|Did not meet responder criteria|0|||
163243451|NCT00782340|589598481|FG000|Open Label Titration|Lost to Follow-up|5|||
163243452|NCT00782340|589598482|FG001|Open Label Titration|Lost to Follow-up|0|||
163243453|NCT00782340|589598483|FG002|Open Label Titration|Lost to Follow-up|0|||
163243454|NCT00782340|589598481|FG000|Open Label Titration|Randomized in error|6|||
163243455|NCT00782340|589598482|FG001|Open Label Titration|Randomized in error|0|||
163243456|NCT00782340|589598483|FG002|Open Label Titration|Randomized in error|0|||
163243457|NCT02365467|589598484|FG000|Overall Study|Death|3|||
163243458|NCT01306162|589598485|FG000|Period 1|Adverse Event|0|||
163243459|NCT01306162|589598486|FG001|Period 1|Adverse Event|0|||
163243460|NCT01306162|589598487|FG002|Period 1|Adverse Event|0|||
163243461|NCT01306162|589598488|FG003|Period 1|Adverse Event|1|||
163243462|NCT01306162|589598485|FG000|Washout 1|Non-compliance to protocol|0|||
163243463|NCT01306162|589598486|FG001|Washout 1|Non-compliance to protocol|1|||
163243464|NCT01306162|589598487|FG002|Washout 1|Non-compliance to protocol|0|||
163243465|NCT01306162|589598488|FG003|Washout 1|Non-compliance to protocol|0|||
163243466|NCT01109992|589598489|FG000|Overall Study|Withdrawal by Subject|0|||
163243467|NCT01109992|589598490|FG001|Overall Study|Withdrawal by Subject|1|||
163243468|NCT01109992|589598489|FG000|Overall Study|Movement during rest scan.|0|||
163243469|NCT01109992|589598490|FG001|Overall Study|Movement during rest scan.|1|||
163243470|NCT00690755|589598491|FG000|Overall Study|Physician Decision|2|||
163243471|NCT00690755|589598492|FG001|Overall Study|Physician Decision|0|||
163243472|NCT00690755|589598493|FG002|Overall Study|Physician Decision|46|||
163243473|NCT00690755|589598494|FG003|Overall Study|Physician Decision|5|||
163243474|NCT00690755|589598495|FG004|Overall Study|Physician Decision|0|||
163243475|NCT00690755|589598496|FG005|Overall Study|Physician Decision|4|||
163243476|NCT00690755|589598497|FG006|Overall Study|Physician Decision|0|||
163243477|NCT04287920|589598501|FG000|Overall Study|Lost to Follow-up|1|||
163410024|NCT03099707|590209566|FG001|Overall Study|Lost to Follow-up|1|||
163148405|NCT02960217|589255519|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
163148406|NCT02960217|589255520|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
163148407|NCT02960217|589255519|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
163148408|NCT02960217|589255520|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
163148409|NCT02960217|589255519|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
163148410|NCT02960217|589255520|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
163148411|NCT02960217|589255519|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
163148412|NCT02960217|589255520|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
163148413|NCT02960217|589255519|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
163148414|NCT02960217|589255520|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
163148415|NCT02960217|589255519|FG000|Open-Label Extension Phase|Adverse Event|1|||
163148416|NCT02960217|589255520|FG001|Open-Label Extension Phase|Adverse Event|0|||
163148417|NCT02960217|589255519|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
163148418|NCT02960217|589255520|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
163148419|NCT02960217|589255519|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
163148420|NCT02960217|589255520|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
163148421|NCT02960217|589255519|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
163148422|NCT02960217|589255520|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
163148423|NCT02734693|589255521|FG000|Overall Study|Adverse Event|1|||
163148424|NCT02734693|589255522|FG001|Overall Study|Adverse Event|3|||
163148425|NCT02734693|589255523|FG002|Overall Study|Adverse Event|3|||
163148426|NCT02734693|589255521|FG000|Overall Study|Lack of Efficacy|1|||
163148427|NCT02734693|589255522|FG001|Overall Study|Lack of Efficacy|0|||
163148428|NCT02734693|589255523|FG002|Overall Study|Lack of Efficacy|0|||
163148429|NCT02734693|589255521|FG000|Overall Study|Lost to Follow-up|2|||
163148430|NCT02734693|589255522|FG001|Overall Study|Lost to Follow-up|0|||
163148431|NCT02734693|589255523|FG002|Overall Study|Lost to Follow-up|0|||
163148432|NCT02734693|589255521|FG000|Overall Study|Protocol Violation|1|||
163148433|NCT02734693|589255522|FG001|Overall Study|Protocol Violation|0|||
163148434|NCT02734693|589255523|FG002|Overall Study|Protocol Violation|0|||
163148435|NCT02734693|589255521|FG000|Overall Study|Withdrawal by Subject|1|||
163148436|NCT02734693|589255522|FG001|Overall Study|Withdrawal by Subject|0|||
163148437|NCT02734693|589255523|FG002|Overall Study|Withdrawal by Subject|0|||
163148438|NCT04158583|589255527|FG000|Overall Study|Withdrawal by Subject|1|||
163148439|NCT04158583|589255528|FG001|Overall Study|Withdrawal by Subject|1|||
163148440|NCT04158583|589255529|FG002|Overall Study|Withdrawal by Subject|0|||
163148441|NCT04158583|589255530|FG003|Overall Study|Withdrawal by Subject|0|||
163148442|NCT04158583|589255531|FG004|Overall Study|Withdrawal by Subject|1|||
163148443|NCT04158583|589255532|FG005|Overall Study|Withdrawal by Subject|0|||
163148444|NCT04158583|589255533|FG006|Overall Study|Withdrawal by Subject|0|||
163148445|NCT04158583|589255534|FG007|Overall Study|Withdrawal by Subject|0|||
163148446|NCT04158583|589255535|FG008|Overall Study|Withdrawal by Subject|2|||
163148447|NCT04158583|589255536|FG009|Overall Study|Withdrawal by Subject|0|||
163148448|NCT04158583|589255527|FG000|Overall Study|Study Terminated by Sponsor|0|||
163148449|NCT04158583|589255528|FG001|Overall Study|Study Terminated by Sponsor|0|||
163148450|NCT04158583|589255529|FG002|Overall Study|Study Terminated by Sponsor|0|||
163148451|NCT04158583|589255530|FG003|Overall Study|Study Terminated by Sponsor|1|||
163148452|NCT04158583|589255531|FG004|Overall Study|Study Terminated by Sponsor|0|||
163148453|NCT04158583|589255532|FG005|Overall Study|Study Terminated by Sponsor|0|||
163148454|NCT04158583|589255533|FG006|Overall Study|Study Terminated by Sponsor|0|||
163148455|NCT04158583|589255534|FG007|Overall Study|Study Terminated by Sponsor|0|||
163148456|NCT04158583|589255535|FG008|Overall Study|Study Terminated by Sponsor|0|||
163148457|NCT04158583|589255536|FG009|Overall Study|Study Terminated by Sponsor|0|||
163148458|NCT04158583|589255527|FG000|Overall Study|Progressive Disease|1|||
163148459|NCT04158583|589255528|FG001|Overall Study|Progressive Disease|0|||
163148460|NCT04158583|589255529|FG002|Overall Study|Progressive Disease|3|||
163148461|NCT04158583|589255530|FG003|Overall Study|Progressive Disease|5|||
163148462|NCT04158583|589255531|FG004|Overall Study|Progressive Disease|0|||
163148463|NCT04158583|589255532|FG005|Overall Study|Progressive Disease|1|||
163148464|NCT04158583|589255533|FG006|Overall Study|Progressive Disease|6|||
163148465|NCT04158583|589255534|FG007|Overall Study|Progressive Disease|2|||
163148466|NCT04158583|589255535|FG008|Overall Study|Progressive Disease|1|||
163148467|NCT04158583|589255536|FG009|Overall Study|Progressive Disease|2|||
163148468|NCT04158583|589255527|FG000|Overall Study|Lost to Follow-up|0|||
163148469|NCT04158583|589255528|FG001|Overall Study|Lost to Follow-up|0|||
163148470|NCT04158583|589255529|FG002|Overall Study|Lost to Follow-up|1|||
163148471|NCT04158583|589255530|FG003|Overall Study|Lost to Follow-up|1|||
163148472|NCT04158583|589255531|FG004|Overall Study|Lost to Follow-up|1|||
163148473|NCT04158583|589255532|FG005|Overall Study|Lost to Follow-up|0|||
163148474|NCT04158583|589255533|FG006|Overall Study|Lost to Follow-up|0|||
163148475|NCT04158583|589255534|FG007|Overall Study|Lost to Follow-up|0|||
163148476|NCT04158583|589255535|FG008|Overall Study|Lost to Follow-up|0|||
163148477|NCT04158583|589255536|FG009|Overall Study|Lost to Follow-up|0|||
163243478|NCT04287920|589598502|FG001|Overall Study|Lost to Follow-up|1|||
163410025|NCT03167073|590209567|FG000|Overall Study|Stillbirth|1|||
163243479|NCT04287920|589598501|FG000|Overall Study|Withdrawal by Subject|0|||
163243480|NCT04287920|589598502|FG001|Overall Study|Withdrawal by Subject|3|||
163243481|NCT02952924|589598507|FG000|Overall Study|Protocol Violation|0|||
163243482|NCT02952924|589598508|FG001|Overall Study|Protocol Violation|0|||
163243483|NCT02952924|589598509|FG002|Overall Study|Protocol Violation|0|||
163243484|NCT02952924|589598510|FG003|Overall Study|Protocol Violation|0|||
163243485|NCT02952924|589598511|FG004|Overall Study|Protocol Violation|0|||
163243486|NCT02952924|589598512|FG005|Overall Study|Protocol Violation|0|||
163243487|NCT02952924|589598513|FG006|Overall Study|Protocol Violation|0|||
163243488|NCT02952924|589598514|FG007|Overall Study|Protocol Violation|0|||
163243489|NCT02952924|589598515|FG008|Overall Study|Protocol Violation|0|||
163243490|NCT02952924|589598516|FG009|Overall Study|Protocol Violation|0|||
163243491|NCT02952924|589598517|FG010|Overall Study|Protocol Violation|0|||
163243492|NCT02952924|589598518|FG011|Overall Study|Protocol Violation|0|||
163243493|NCT02952924|589598519|FG012|Overall Study|Protocol Violation|0|||
163243494|NCT02952924|589598520|FG013|Overall Study|Protocol Violation|0|||
163243495|NCT02952924|589598521|FG014|Overall Study|Protocol Violation|0|||
163243496|NCT02952924|589598522|FG015|Overall Study|Protocol Violation|0|||
163243497|NCT02952924|589598523|FG016|Overall Study|Protocol Violation|0|||
163243498|NCT02952924|589598524|FG017|Overall Study|Protocol Violation|0|||
163243499|NCT02952924|589598525|FG018|Overall Study|Protocol Violation|0|||
163243500|NCT02952924|589598526|FG019|Overall Study|Protocol Violation|1|||
163243501|NCT02952924|589598527|FG020|Overall Study|Protocol Violation|0|||
163243502|NCT02952924|589598528|FG021|Overall Study|Protocol Violation|0|||
163243503|NCT02952924|589598507|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
163243504|NCT02952924|589598508|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
163243505|NCT02952924|589598509|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
163243506|NCT02952924|589598510|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
163243507|NCT02952924|589598511|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
163243508|NCT02952924|589598512|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
163243509|NCT02952924|589598513|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
163243510|NCT02952924|589598514|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
163243511|NCT02952924|589598515|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
163243512|NCT02952924|589598516|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
163243513|NCT02952924|589598517|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
163243514|NCT02952924|589598518|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
163243515|NCT02952924|589598519|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
163243516|NCT02952924|589598520|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
163243517|NCT02952924|589598521|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
163243518|NCT02952924|589598522|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
163243519|NCT02952924|589598523|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
163243520|NCT02952924|589598524|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
163243521|NCT02952924|589598525|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
163243522|NCT02952924|589598526|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
163243523|NCT02952924|589598527|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
163243524|NCT02952924|589598528|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
163243525|NCT02952924|589598507|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243526|NCT02952924|589598508|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243527|NCT02952924|589598509|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243528|NCT02952924|589598510|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243529|NCT02952924|589598511|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243530|NCT02952924|589598512|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243531|NCT02952924|589598513|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243532|NCT02952924|589598514|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243533|NCT02952924|589598515|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243534|NCT02952924|589598516|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243535|NCT02952924|589598517|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243536|NCT02952924|589598518|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243537|NCT02952924|589598519|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243538|NCT02952924|589598520|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243539|NCT02952924|589598521|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243540|NCT02952924|589598522|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243541|NCT02952924|589598523|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243542|NCT02952924|589598524|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243543|NCT02952924|589598525|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243544|NCT02952924|589598526|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243545|NCT02952924|589598527|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
163243546|NCT02952924|589598528|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
163243547|NCT02952924|589598507|FG000|Overall Study|Noncompliance with study drug|0|||
163243548|NCT02952924|589598508|FG001|Overall Study|Noncompliance with study drug|0|||
163243549|NCT02952924|589598509|FG002|Overall Study|Noncompliance with study drug|0|||
163243550|NCT02952924|589598510|FG003|Overall Study|Noncompliance with study drug|0|||
163243551|NCT02952924|589598511|FG004|Overall Study|Noncompliance with study drug|0|||
163243552|NCT02952924|589598512|FG005|Overall Study|Noncompliance with study drug|0|||
163243553|NCT02952924|589598513|FG006|Overall Study|Noncompliance with study drug|0|||
163243554|NCT02952924|589598514|FG007|Overall Study|Noncompliance with study drug|0|||
163243555|NCT02952924|589598515|FG008|Overall Study|Noncompliance with study drug|0|||
163243556|NCT02952924|589598516|FG009|Overall Study|Noncompliance with study drug|0|||
163243557|NCT02952924|589598517|FG010|Overall Study|Noncompliance with study drug|0|||
163243558|NCT02952924|589598518|FG011|Overall Study|Noncompliance with study drug|0|||
163243559|NCT02952924|589598519|FG012|Overall Study|Noncompliance with study drug|0|||
163243560|NCT02952924|589598520|FG013|Overall Study|Noncompliance with study drug|0|||
163243561|NCT02952924|589598521|FG014|Overall Study|Noncompliance with study drug|0|||
163243562|NCT02952924|589598522|FG015|Overall Study|Noncompliance with study drug|0|||
163243563|NCT02952924|589598523|FG016|Overall Study|Noncompliance with study drug|0|||
163243564|NCT02952924|589598524|FG017|Overall Study|Noncompliance with study drug|0|||
163243565|NCT02952924|589598525|FG018|Overall Study|Noncompliance with study drug|0|||
163243566|NCT02952924|589598526|FG019|Overall Study|Noncompliance with study drug|0|||
163243567|NCT02952924|589598527|FG020|Overall Study|Noncompliance with study drug|0|||
163243568|NCT02952924|589598528|FG021|Overall Study|Noncompliance with study drug|1|||
163243569|NCT01435577|589598529|FG000|Overall Study|Adverse Event|10|||
163243570|NCT01435577|589598530|FG001|Overall Study|Adverse Event|0|||
163243571|NCT01435577|589598529|FG000|Overall Study|Lack of Efficacy|7|||
163243572|NCT01435577|589598530|FG001|Overall Study|Lack of Efficacy|51|||
163243573|NCT01435577|589598529|FG000|Overall Study|Alternative treatment started|0|||
163243574|NCT01435577|589598530|FG001|Overall Study|Alternative treatment started|1|||
163243575|NCT01934218|589598532|FG000|Double-blind Phase|Adverse Event|8|||
163243576|NCT01934218|589598533|FG001|Double-blind Phase|Adverse Event|8|||
163243577|NCT01934218|589598532|FG000|Double-blind Phase|Lack of Efficacy|6|||
163243578|NCT01934218|589598533|FG001|Double-blind Phase|Lack of Efficacy|7|||
163243579|NCT01934218|589598532|FG000|Double-blind Phase|Lost to Follow-up|7|||
163243580|NCT01934218|589598533|FG001|Double-blind Phase|Lost to Follow-up|14|||
163243581|NCT01934218|589598532|FG000|Double-blind Phase|Physician Decision|1|||
163243582|NCT01934218|589598533|FG001|Double-blind Phase|Physician Decision|2|||
163243583|NCT01934218|589598532|FG000|Double-blind Phase|Protocol Violation|4|||
163243584|NCT01934218|589598533|FG001|Double-blind Phase|Protocol Violation|0|||
163243585|NCT01934218|589598532|FG000|Double-blind Phase|Withdrawal by Subject|16|||
163243586|NCT01934218|589598533|FG001|Double-blind Phase|Withdrawal by Subject|13|||
163243587|NCT01934218|589598532|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
163243588|NCT01934218|589598533|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
163243589|NCT01934218|589598532|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
163243590|NCT01934218|589598533|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
163243591|NCT01934218|589598532|FG000|Open-Label Phase|Adverse Event|2|||
163243592|NCT01934218|589598533|FG001|Open-Label Phase|Adverse Event|4|||
163243593|NCT01934218|589598532|FG000|Open-Label Phase|Lack of Efficacy|1|||
163243594|NCT01934218|589598533|FG001|Open-Label Phase|Lack of Efficacy|4|||
163243595|NCT01934218|589598532|FG000|Open-Label Phase|Lost to Follow-up|4|||
163243596|NCT01934218|589598533|FG001|Open-Label Phase|Lost to Follow-up|2|||
163243597|NCT01934218|589598532|FG000|Open-Label Phase|Physician Decision|1|||
163243598|NCT01934218|589598533|FG001|Open-Label Phase|Physician Decision|0|||
163243599|NCT01934218|589598532|FG000|Open-Label Phase|Protocol Violation|1|||
163243600|NCT01934218|589598533|FG001|Open-Label Phase|Protocol Violation|0|||
163243601|NCT01934218|589598532|FG000|Open-Label Phase|Withdrawal by Subject|13|||
163243602|NCT01934218|589598533|FG001|Open-Label Phase|Withdrawal by Subject|11|||
163243603|NCT01934218|589598532|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
163243604|NCT01934218|589598533|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
163243605|NCT01934218|589598532|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
163243606|NCT01934218|589598533|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
163243607|NCT03273946|589598537|FG000|Overall Study|Withdrawal by Subject|5|||
163243608|NCT03273946|589598537|FG000|Overall Study|Unwillingness of the guardian|1|||
163351305|NCT04544865|589996134|FG000|Overall Study|Withdrawal by Subject|0|||
163351306|NCT04544865|589996135|FG001|Overall Study|Withdrawal by Subject|1|||
163243609|NCT03273946|589598537|FG000|Overall Study|Participant refused to use the drug|2|||
163351307|NCT04544865|589996134|FG000|Overall Study|Other|0|||
163243610|NCT03273946|589598537|FG000|Overall Study|Participant relative refused to use drug|1|||
163243611|NCT01220557|589598538|FG000|Overall Study|Lost to Follow-up|5|||
163243612|NCT01220557|589598539|FG001|Overall Study|Lost to Follow-up|3|||
163243613|NCT01220557|589598538|FG000|Overall Study|attended less than 6 lessons|1|||
163148478|NCT04158583|589255527|FG000|Overall Study|Due To Patient Status|0|||
163148479|NCT04158583|589255528|FG001|Overall Study|Due To Patient Status|0|||
163148480|NCT04158583|589255529|FG002|Overall Study|Due To Patient Status|0|||
163148481|NCT04158583|589255530|FG003|Overall Study|Due To Patient Status|0|||
163148482|NCT04158583|589255531|FG004|Overall Study|Due To Patient Status|0|||
163148483|NCT04158583|589255532|FG005|Overall Study|Due To Patient Status|0|||
163148484|NCT04158583|589255533|FG006|Overall Study|Due To Patient Status|0|||
163148485|NCT04158583|589255534|FG007|Overall Study|Due To Patient Status|0|||
163148486|NCT04158583|589255535|FG008|Overall Study|Due To Patient Status|1|||
163148487|NCT04158583|589255536|FG009|Overall Study|Due To Patient Status|0|||
163148488|NCT04158583|589255527|FG000|Overall Study|Death|3|||
163148489|NCT04158583|589255528|FG001|Overall Study|Death|4|||
163148490|NCT04158583|589255529|FG002|Overall Study|Death|2|||
163148491|NCT04158583|589255530|FG003|Overall Study|Death|2|||
163148492|NCT04158583|589255531|FG004|Overall Study|Death|4|||
163148493|NCT04158583|589255532|FG005|Overall Study|Death|3|||
163148494|NCT04158583|589255533|FG006|Overall Study|Death|5|||
163148495|NCT04158583|589255534|FG007|Overall Study|Death|2|||
163148496|NCT04158583|589255535|FG008|Overall Study|Death|0|||
163148497|NCT04158583|589255536|FG009|Overall Study|Death|1|||
163148498|NCT04158583|589255527|FG000|Overall Study|Clinical Progression Disease|0|||
163148499|NCT04158583|589255528|FG001|Overall Study|Clinical Progression Disease|0|||
163148500|NCT04158583|589255529|FG002|Overall Study|Clinical Progression Disease|0|||
163148501|NCT04158583|589255530|FG003|Overall Study|Clinical Progression Disease|1|||
163148502|NCT04158583|589255531|FG004|Overall Study|Clinical Progression Disease|0|||
163148503|NCT04158583|589255532|FG005|Overall Study|Clinical Progression Disease|0|||
163148504|NCT04158583|589255533|FG006|Overall Study|Clinical Progression Disease|0|||
163148505|NCT04158583|589255534|FG007|Overall Study|Clinical Progression Disease|0|||
163148506|NCT04158583|589255535|FG008|Overall Study|Clinical Progression Disease|0|||
163148507|NCT04158583|589255536|FG009|Overall Study|Clinical Progression Disease|0|||
163148508|NCT04158583|589255527|FG000|Overall Study|Clinical Progression|0|||
163148509|NCT04158583|589255528|FG001|Overall Study|Clinical Progression|0|||
163148510|NCT04158583|589255529|FG002|Overall Study|Clinical Progression|0|||
163148511|NCT04158583|589255530|FG003|Overall Study|Clinical Progression|0|||
163148512|NCT04158583|589255531|FG004|Overall Study|Clinical Progression|1|||
163148513|NCT04158583|589255532|FG005|Overall Study|Clinical Progression|0|||
163148514|NCT04158583|589255533|FG006|Overall Study|Clinical Progression|2|||
163148515|NCT04158583|589255534|FG007|Overall Study|Clinical Progression|0|||
163148516|NCT04158583|589255535|FG008|Overall Study|Clinical Progression|0|||
163148517|NCT04158583|589255536|FG009|Overall Study|Clinical Progression|0|||
163148518|NCT04158583|589255527|FG000|Overall Study|Clinical Deterioration|0|||
163148519|NCT04158583|589255528|FG001|Overall Study|Clinical Deterioration|0|||
163148520|NCT04158583|589255529|FG002|Overall Study|Clinical Deterioration|0|||
163148521|NCT04158583|589255530|FG003|Overall Study|Clinical Deterioration|1|||
163148522|NCT04158583|589255531|FG004|Overall Study|Clinical Deterioration|0|||
163148523|NCT04158583|589255532|FG005|Overall Study|Clinical Deterioration|0|||
163148524|NCT04158583|589255533|FG006|Overall Study|Clinical Deterioration|0|||
163148525|NCT04158583|589255534|FG007|Overall Study|Clinical Deterioration|0|||
163148526|NCT04158583|589255535|FG008|Overall Study|Clinical Deterioration|0|||
163148527|NCT04158583|589255536|FG009|Overall Study|Clinical Deterioration|1|||
163148528|NCT01766050|589257277|FG000|Overall Study|Adverse Event|1|||
163148529|NCT01766050|589257277|FG000|Overall Study|Lost to Follow-up|1|||
163148530|NCT01766050|589257277|FG000|Overall Study|Withdrawal by Subject|2|||
163148531|NCT01097668|589257278|FG000|Overall Study|Withdrawal by Subject|1|||
163148532|NCT01097668|589257279|FG001|Overall Study|Withdrawal by Subject|2|||
163148533|NCT01097668|589257278|FG000|Overall Study|Lost to Follow-up|1|||
163148534|NCT01097668|589257279|FG001|Overall Study|Lost to Follow-up|0|||
163148535|NCT00812708|589257280|FG000|Overall Study|Device could not be implanted|2|||
163148536|NCT00812708|589257280|FG000|Overall Study|Lack of medical insurance|1|||
163148537|NCT00812708|589257280|FG000|Overall Study|Switched to another study|1|||
163148538|NCT00812708|589257280|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
163148539|NCT00812708|589257280|FG000|Overall Study|Signed consent but later withdrew|3|||
163148540|NCT02421172|589257281|FG000|Period 1|Adverse Event|1|||
163148541|NCT02421172|589257282|FG001|Period 1|Adverse Event|0|||
163148542|NCT02421172|589257283|FG002|Period 1|Adverse Event|0|||
163148543|NCT02421172|589257284|FG003|Period 1|Adverse Event|0|||
163148544|NCT02421172|589257285|FG004|Period 1|Adverse Event|0|||
163148545|NCT02421172|589257281|FG000|Period 1|Lost to Follow-up|3|||
163148546|NCT02421172|589257282|FG001|Period 1|Lost to Follow-up|1|||
163148547|NCT02421172|589257283|FG002|Period 1|Lost to Follow-up|0|||
163148548|NCT02421172|589257284|FG003|Period 1|Lost to Follow-up|0|||
163148549|NCT02421172|589257285|FG004|Period 1|Lost to Follow-up|0|||
163148550|NCT02421172|589257281|FG000|Period 1|Patient/guardian decision|0|||
163148551|NCT02421172|589257282|FG001|Period 1|Patient/guardian decision|1|||
163148552|NCT02421172|589257283|FG002|Period 1|Patient/guardian decision|0|||
163148553|NCT02421172|589257284|FG003|Period 1|Patient/guardian decision|0|||
163148554|NCT02421172|589257285|FG004|Period 1|Patient/guardian decision|0|||
163243614|NCT01220557|589598539|FG001|Overall Study|attended less than 6 lessons|2|||
163243615|NCT04323436|589598542|FG000|Overall Study|Adverse Event|7|||
163243616|NCT04323436|589598543|FG001|Overall Study|Adverse Event|0|||
163243617|NCT04323436|589598544|FG002|Overall Study|Adverse Event|0|||
163243618|NCT04323436|589598542|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
163243619|NCT04323436|589598543|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
163243620|NCT04323436|589598544|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
163243621|NCT04323436|589598542|FG000|Overall Study|Death|1|||
163243622|NCT04323436|589598543|FG001|Overall Study|Death|0|||
163243623|NCT04323436|589598544|FG002|Overall Study|Death|0|||
163243624|NCT04323436|589598542|FG000|Overall Study|Physician Decision|2|||
163243625|NCT04323436|589598543|FG001|Overall Study|Physician Decision|0|||
163243626|NCT04323436|589598544|FG002|Overall Study|Physician Decision|0|||
163243627|NCT04323436|589598542|FG000|Overall Study|Progressive disease|10|||
163243628|NCT04323436|589598543|FG001|Overall Study|Progressive disease|0|||
163243629|NCT04323436|589598544|FG002|Overall Study|Progressive disease|0|||
163243630|NCT04323436|589598542|FG000|Overall Study|Subject decision|3|||
163243631|NCT04323436|589598543|FG001|Overall Study|Subject decision|0|||
163243632|NCT04323436|589598544|FG002|Overall Study|Subject decision|0|||
163351308|NCT04544865|589996135|FG001|Overall Study|Other|1|||
163351309|NCT03357471|589996136|FG000|Overall Study|Adverse Event|1|||
163351310|NCT03357471|589996137|FG001|Overall Study|Adverse Event|0|||
163351311|NCT03357471|589996136|FG000|Overall Study|Lost to Follow-up|1|||
163351312|NCT03357471|589996137|FG001|Overall Study|Lost to Follow-up|0|||
163351313|NCT01202409|589996138|FG000|Overall Study|Adverse Event|1|||
163351314|NCT01202409|589996138|FG000|Overall Study|Ineligible - KRAS mutants|7|||
163351315|NCT01732926|589996141|FG000|Overall Study|Study Terminated by Sponsor|168|||
163351316|NCT01732926|589996142|FG001|Overall Study|Study Terminated by Sponsor|80|||
163351317|NCT01732926|589996141|FG000|Overall Study|Withdrawal by Subject|46|||
163148555|NCT02421172|589257281|FG000|Period 2|Adverse Event|0|||
163148556|NCT02421172|589257282|FG001|Period 2|Adverse Event|0|||
163148557|NCT02421172|589257283|FG002|Period 2|Adverse Event|4|||
163148558|NCT02421172|589257284|FG003|Period 2|Adverse Event|0|||
163148559|NCT02421172|589257285|FG004|Period 2|Adverse Event|0|||
163148560|NCT02421172|589257281|FG000|Period 2|Lost to Follow-up|0|||
163148561|NCT02421172|589257282|FG001|Period 2|Lost to Follow-up|0|||
163148562|NCT02421172|589257283|FG002|Period 2|Lost to Follow-up|0|||
163148563|NCT02421172|589257284|FG003|Period 2|Lost to Follow-up|1|||
163148564|NCT02421172|589257285|FG004|Period 2|Lost to Follow-up|0|||
163148565|NCT02421172|589257281|FG000|Period 2|Patient/guardian decision|0|||
163148566|NCT02421172|589257282|FG001|Period 2|Patient/guardian decision|0|||
163148567|NCT02421172|589257283|FG002|Period 2|Patient/guardian decision|3|||
163148568|NCT02421172|589257284|FG003|Period 2|Patient/guardian decision|2|||
163148569|NCT02421172|589257285|FG004|Period 2|Patient/guardian decision|1|||
163148570|NCT00928486|589257286|FG000|Overall Study|Adverse Event|2|||
163148571|NCT00928486|589257286|FG000|Overall Study|Disease Progression|7|||
163148572|NCT00928486|589257286|FG000|Overall Study|Withdrawal by Subject|1|||
163148573|NCT01021020|589257287|FG000|Period I|Protocol Violation|1|||
163148574|NCT01021020|589257287|FG000|Period I|Withdrawal by Subject|1|||
163148575|NCT01021020|589257287|FG000|14 Day Washout Period A|Physician Decision|1|||
163148576|NCT00755183|589257288|FG000|Overall Study|Adverse Event|5|||
163148577|NCT00755183|589257289|FG001|Overall Study|Adverse Event|2|||
163148578|NCT00755183|589257288|FG000|Overall Study|Protocol Violation|0|||
163148579|NCT00755183|589257289|FG001|Overall Study|Protocol Violation|1|||
163148580|NCT00755183|589257288|FG000|Overall Study|Withdrawal by Subject|0|||
163148581|NCT00755183|589257289|FG001|Overall Study|Withdrawal by Subject|2|||
163148582|NCT00755183|589257288|FG000|Overall Study|Administrative|2|||
163148583|NCT00755183|589257289|FG001|Overall Study|Administrative|1|||
163148584|NCT02587520|589257292|FG000|Overall Study|Protocol Violation|2|||
163148585|NCT02587520|589257293|FG001|Overall Study|Protocol Violation|0|||
163148586|NCT02587520|589257294|FG002|Overall Study|Protocol Violation|0|||
163148587|NCT02587520|589257295|FG003|Overall Study|Protocol Violation|2|||
163148588|NCT02587520|589257296|FG004|Overall Study|Protocol Violation|0|||
163148589|NCT02587520|589257297|FG005|Overall Study|Protocol Violation|1|||
163148590|NCT02587520|589257298|FG006|Overall Study|Protocol Violation|1|||
163148591|NCT02587520|589257299|FG007|Overall Study|Protocol Violation|1|||
163148592|NCT02587520|589257300|FG008|Overall Study|Protocol Violation|3|||
163243633|NCT01682837|589598547|FG000|Baseline|Withdrawal by Subject|5|||
163243634|NCT01664078|589598548|FG000|Overall Study|Death|9|||
163148593|NCT02587520|589257301|FG009|Overall Study|Protocol Violation|3|||
163243635|NCT01664078|589598548|FG000|Overall Study|Withdrawal by Subject|4|||
163243636|NCT01664078|589598548|FG000|Overall Study|Lost to Follow-up|2|||
163243637|NCT01664078|589598548|FG000|Overall Study|missed 5 year visit|1|||
163148594|NCT02587520|589257302|FG010|Overall Study|Protocol Violation|1|||
163148595|NCT02587520|589257303|FG011|Overall Study|Protocol Violation|2|||
163351318|NCT01732926|589996142|FG001|Overall Study|Withdrawal by Subject|8|||
163351319|NCT01732926|589996141|FG000|Overall Study|Physician Decision|24|||
163351320|NCT01732926|589996142|FG001|Overall Study|Physician Decision|11|||
163351321|NCT01732926|589996141|FG000|Overall Study|Other Reason|21|||
163410026|NCT03167073|590209568|FG001|Overall Study|Stillbirth|0|||
163410027|NCT01079182|590209571|FG000|Overall Study|Lost to Follow-up|1634|||
163410028|NCT01079182|590209571|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
163410029|NCT01079182|590209571|FG000|Overall Study|Lack of Efficacy|514|||
163410030|NCT01079182|590209571|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
163410031|NCT01079182|590209571|FG000|Overall Study|Reasons not Evaluated|271|||
163410032|NCT01026831|590209572|FG000|Overall Study|Adverse Event|4|||
163410033|NCT01026831|590209573|FG001|Overall Study|Adverse Event|3|||
163410034|NCT01026831|590209572|FG000|Overall Study|Lost to Follow-up|2|||
163410035|NCT01026831|590209573|FG001|Overall Study|Lost to Follow-up|0|||
163410036|NCT01026831|590209572|FG000|Overall Study|Physician Decision|1|||
163410037|NCT01026831|590209573|FG001|Overall Study|Physician Decision|1|||
163410038|NCT01026831|590209572|FG000|Overall Study|Protocol Violation|0|||
163410039|NCT01026831|590209573|FG001|Overall Study|Protocol Violation|2|||
163410040|NCT01026831|590209572|FG000|Overall Study|Withdrawal by Subject|7|||
163410041|NCT01026831|590209573|FG001|Overall Study|Withdrawal by Subject|5|||
163351322|NCT01732926|589996142|FG001|Overall Study|Other Reason|4|||
163351323|NCT01732926|589996141|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
163351324|NCT01732926|589996142|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
163351325|NCT01732926|589996141|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
163351326|NCT01732926|589996142|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
163351327|NCT02482935|589996147|FG000|Period 1|Withdrawal by Subject|1|||
163351328|NCT02482935|589996148|FG001|Period 1|Withdrawal by Subject|0|||
163351329|NCT03503162|589996149|FG000|Overall Study|did not meet eligibility|1|||
163351330|NCT02835092|589996150|FG000|Overall Study|Withdrawal by Subject|3|||
163351331|NCT02835092|589996151|FG001|Overall Study|Withdrawal by Subject|6|||
163351332|NCT02835092|589996152|FG002|Overall Study|Withdrawal by Subject|3|||
163351333|NCT02835092|589996150|FG000|Overall Study|Lost to Follow-up|0|||
163351334|NCT02835092|589996151|FG001|Overall Study|Lost to Follow-up|2|||
163351335|NCT02835092|589996152|FG002|Overall Study|Lost to Follow-up|0|||
163351336|NCT00025506|589996153|FG000|Overall Study|Ineligible: clerical error|1|||
163351337|NCT00025506|589996153|FG000|Overall Study|Ineligible: wrong cell type|5|||
163351338|NCT00025506|589996153|FG000|Overall Study|Ineligible: inadequate pathology|2|||
163351339|NCT00025506|589996153|FG000|Overall Study|Never Treated|2|||
163351340|NCT00394589|589996158|FG000|Overall Study|Adverse Event|2|||
163351341|NCT00394589|589996159|FG001|Overall Study|Adverse Event|1|||
163351342|NCT00394589|589996160|FG002|Overall Study|Adverse Event|2|||
163351343|NCT00394589|589996158|FG000|Overall Study|Lack of Efficacy|2|||
163351344|NCT00394589|589996159|FG001|Overall Study|Lack of Efficacy|2|||
163351345|NCT00394589|589996160|FG002|Overall Study|Lack of Efficacy|3|||
163351346|NCT00394589|589996158|FG000|Overall Study|Protocol Violation|4|||
163351347|NCT00394589|589996159|FG001|Overall Study|Protocol Violation|0|||
163351348|NCT00394589|589996160|FG002|Overall Study|Protocol Violation|2|||
163351349|NCT01710800|589996168|FG000|Overall Study|Withdrawal by Subject|21|||
163351350|NCT01710800|589996168|FG000|Overall Study|Protocol Violation|1|||
163351351|NCT03891641|589996172|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
163351352|NCT03891641|589996173|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
163351353|NCT01585298|589996174|FG000|Overall Study|Study completion was not documented.|1|||
163351354|NCT01585298|589996174|FG000|Overall Study|Protocol deviation|1|||
163351355|NCT01585298|589996174|FG000|Overall Study|Administrative problems|4|||
163351356|NCT01585298|589996174|FG000|Overall Study|Lost to Follow-up|2|||
163351357|NCT01585298|589996174|FG000|Overall Study|Withdrawal by Subject|4|||
163351358|NCT01585298|589996174|FG000|Overall Study|Abnormal test procedure results|1|||
163351359|NCT01585298|589996174|FG000|Overall Study|Adverse Event|24|||
163351360|NCT01670188|589996175|FG000|Overall Study|Death|0|||
163351361|NCT01670188|589996176|FG001|Overall Study|Death|1|||
163351362|NCT02212301|589996177|FG000|Period 1|Lost to Follow-up|0|||
163351363|NCT02212301|589996178|FG001|Period 1|Lost to Follow-up|1|||
163351364|NCT02427958|589996183|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
163351365|NCT02427958|589996183|FG000|Overall Study|Lost to Follow-up|6|||
163351366|NCT02427958|589996183|FG000|Overall Study|Withdrawal by Subject|14|||
163351367|NCT02427958|589996183|FG000|Overall Study|Lack of Efficacy|1|||
163351368|NCT00578318|589996184|FG000|Overall Study|Lost to Follow-up|2|||
163351369|NCT00578318|589996185|FG001|Overall Study|Lost to Follow-up|0|||
163351370|NCT00578318|589996184|FG000|Overall Study|Physician Decision|1|||
163410042|NCT00984204|590211241|FG000|Overall Study|Death|1|||
163410043|NCT00984204|590211241|FG000|Overall Study|Lost to Follow-up|4|||
163351371|NCT00578318|589996185|FG001|Overall Study|Physician Decision|0|||
163351372|NCT02025985|589996186|FG000|Overall Study|Consent withdrawn|0|||
163351373|NCT02025985|589996187|FG001|Overall Study|Consent withdrawn|0|||
163351374|NCT02025985|589996188|FG002|Overall Study|Consent withdrawn|1|||
163351375|NCT02025985|589996189|FG003|Overall Study|Consent withdrawn|0|||
163351376|NCT02025985|589996190|FG004|Overall Study|Consent withdrawn|0|||
163351377|NCT02025985|589996186|FG000|Overall Study|Termination of study by Sponsor|4|||
163351378|NCT02025985|589996187|FG001|Overall Study|Termination of study by Sponsor|3|||
163410044|NCT00984204|590211241|FG000|Overall Study|Lack of Efficacy|10|||
163410045|NCT01678144|590211242|FG000|Stage 1: MAR Classic|Adverse Event|1|||
163410046|NCT01885000|590211243|FG000|Overall Study|Adverse Event|1|||
163351379|NCT02025985|589996188|FG002|Overall Study|Termination of study by Sponsor|1|||
163351380|NCT02025985|589996189|FG003|Overall Study|Termination of study by Sponsor|1|||
163351381|NCT02025985|589996190|FG004|Overall Study|Termination of study by Sponsor|3|||
163351382|NCT02025985|589996186|FG000|Overall Study|Death|21|||
163351383|NCT02025985|589996187|FG001|Overall Study|Death|20|||
163351384|NCT02025985|589996188|FG002|Overall Study|Death|23|||
163351385|NCT02025985|589996189|FG003|Overall Study|Death|20|||
163351386|NCT02025985|589996190|FG004|Overall Study|Death|17|||
163351387|NCT00001941|589996193|FG000|Overall Study|not treated- rapidly progressing disease|0|||
163351388|NCT00001941|589996194|FG001|Overall Study|not treated- rapidly progressing disease|0|||
163351389|NCT00001941|589996195|FG002|Overall Study|not treated- rapidly progressing disease|0|||
163351390|NCT00001941|589996196|FG003|Overall Study|not treated- rapidly progressing disease|0|||
163351391|NCT00001941|589996197|FG004|Overall Study|not treated- rapidly progressing disease|1|||
163351392|NCT03175198|589996198|FG000|Overall Study|Adverse Event|480|||
163351393|NCT03175198|589996198|FG000|Overall Study|No actual visit|120|||
163351394|NCT03175198|589996198|FG000|Overall Study|Registration rule not followed|4|||
163351395|NCT03175198|589996198|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
163351396|NCT03175198|589996198|FG000|Overall Study|Other personal reason|509|||
163351397|NCT03175198|589996198|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
163351398|NCT03175198|589996198|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
163351399|NCT03175198|589996198|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
163351400|NCT03175198|589996198|FG000|Overall Study|To conduct invasive treatment of operation|53|||
163351401|NCT03175198|589996198|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
163351402|NCT00545571|589996199|FG000|Overall Study|Administrative Reasons|1|||
163351403|NCT00545571|589996199|FG000|Overall Study|Adverse Event|2|||
163351404|NCT00545571|589996199|FG000|Overall Study|Death|5|||
163351405|NCT00545571|589996199|FG000|Overall Study|Lack of Efficacy|1|||
163351406|NCT00545571|589996199|FG000|Overall Study|Protocol Violation|2|||
163351407|NCT00545571|589996199|FG000|Overall Study|Refused Treatment|1|||
163351408|NCT00545571|589996199|FG000|Overall Study|Screen Failure|16|||
163351409|NCT00545571|589996199|FG000|Overall Study|Transfusion|12|||
163351410|NCT00545571|589996199|FG000|Overall Study|Early Termination of Study|24|||
163351411|NCT00545571|589996199|FG000|Overall Study|Kidney Transplantation|3|||
163351412|NCT00874497|589996200|FG000|Overall Study|Lost to Follow-up|2|||
163351413|NCT00874497|589996201|FG001|Overall Study|Lost to Follow-up|4|||
163351414|NCT00874497|589996200|FG000|Overall Study|Adverse Event|9|||
163351415|NCT00874497|589996201|FG001|Overall Study|Adverse Event|4|||
163351416|NCT00874497|589996200|FG000|Overall Study|Sponsor Discontinued Trial|7|||
163351417|NCT00874497|589996201|FG001|Overall Study|Sponsor Discontinued Trial|3|||
163351418|NCT00874497|589996200|FG000|Overall Study|Met Withdrawal Criteria|4|||
163351419|NCT00874497|589996201|FG001|Overall Study|Met Withdrawal Criteria|2|||
163351420|NCT00874497|589996200|FG000|Overall Study|Physician Decision|1|||
163351421|NCT00874497|589996201|FG001|Overall Study|Physician Decision|1|||
163351422|NCT00874497|589996200|FG000|Overall Study|Withdrawal by Subject|5|||
163351423|NCT00874497|589996201|FG001|Overall Study|Withdrawal by Subject|4|||
163351424|NCT01013740|589996202|FG000|Overall Study|Lost to Follow-up|3|||
163351425|NCT01013740|589996203|FG001|Overall Study|Lost to Follow-up|5|||
163351426|NCT01013740|589996202|FG000|Overall Study|Physician Decision|2|||
163351427|NCT01013740|589996203|FG001|Overall Study|Physician Decision|0|||
163351428|NCT01013740|589996202|FG000|Overall Study|Withdrawal by Subject|2|||
163351429|NCT01013740|589996203|FG001|Overall Study|Withdrawal by Subject|10|||
163351430|NCT01013740|589996202|FG000|Overall Study|study close / terminated : done in error|2|||
163351431|NCT01013740|589996203|FG001|Overall Study|study close / terminated : done in error|1|||
163351432|NCT01013740|589996202|FG000|Overall Study|Missing|2|||
163351433|NCT01013740|589996203|FG001|Overall Study|Missing|1|||
163351434|NCT01013740|589996202|FG000|Overall Study|Ongoing: Study records not completed|0|||
163351435|NCT01013740|589996203|FG001|Overall Study|Ongoing: Study records not completed|2|||
163351436|NCT00607997|589996204|FG000|Overall Study|Lack of Efficacy|6|||
163351437|NCT00607997|589996205|FG001|Overall Study|Lack of Efficacy|20|||
163148596|NCT02587520|589257304|FG012|Overall Study|Protocol Violation|0|||
163148597|NCT02587520|589257305|FG013|Overall Study|Protocol Violation|0|||
163148598|NCT02587520|589257306|FG014|Overall Study|Protocol Violation|0|||
163351438|NCT00607997|589996206|FG002|Overall Study|Lack of Efficacy|14|||
163351439|NCT00607997|589996207|FG003|Overall Study|Lack of Efficacy|10|||
163351440|NCT00607997|589996204|FG000|Overall Study|Death|8|||
163148599|NCT02587520|589257307|FG015|Overall Study|Protocol Violation|0|||
163351441|NCT00607997|589996205|FG001|Overall Study|Death|5|||
163351442|NCT00607997|589996206|FG002|Overall Study|Death|2|||
163351443|NCT00607997|589996207|FG003|Overall Study|Death|5|||
163351444|NCT00607997|589996204|FG000|Overall Study|Adverse Event|3|||
163351445|NCT00607997|589996205|FG001|Overall Study|Adverse Event|1|||
163351446|NCT00607997|589996206|FG002|Overall Study|Adverse Event|2|||
163351447|NCT00607997|589996207|FG003|Overall Study|Adverse Event|0|||
163351448|NCT00607997|589996204|FG000|Overall Study|Physician Decision|4|||
163351449|NCT00607997|589996205|FG001|Overall Study|Physician Decision|1|||
163351450|NCT00607997|589996206|FG002|Overall Study|Physician Decision|0|||
163351451|NCT00607997|589996207|FG003|Overall Study|Physician Decision|0|||
163351452|NCT00607997|589996204|FG000|Overall Study|Relapse, recurrent illness|4|||
163351453|NCT00607997|589996205|FG001|Overall Study|Relapse, recurrent illness|0|||
163351454|NCT00607997|589996206|FG002|Overall Study|Relapse, recurrent illness|2|||
163351455|NCT00607997|589996207|FG003|Overall Study|Relapse, recurrent illness|0|||
163351456|NCT00607997|589996204|FG000|Overall Study|Other without explanation|2|||
163351457|NCT00607997|589996205|FG001|Overall Study|Other without explanation|0|||
163351458|NCT00607997|589996206|FG002|Overall Study|Other without explanation|4|||
163351459|NCT00607997|589996207|FG003|Overall Study|Other without explanation|1|||
163351460|NCT03811834|589996208|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
163351461|NCT00372255|589996209|FG000|Overall Study|Withdrawn for other reasons|2|||
163351462|NCT00372255|589996210|FG001|Overall Study|Withdrawn for other reasons|1|||
163351463|NCT00776984|589996214|FG000|Overall Study|Adverse Event|8|||
163351464|NCT00776984|589996215|FG001|Overall Study|Adverse Event|2|||
163351465|NCT00776984|589996214|FG000|Overall Study|Protocol Violation|4|||
163351466|NCT00776984|589996215|FG001|Overall Study|Protocol Violation|2|||
163351467|NCT00776984|589996214|FG000|Overall Study|Lost to Follow-up|2|||
163351468|NCT00776984|589996215|FG001|Overall Study|Lost to Follow-up|0|||
163351469|NCT00776984|589996214|FG000|Overall Study|Withdrawal by Subject|12|||
163351470|NCT00776984|589996215|FG001|Overall Study|Withdrawal by Subject|7|||
163351471|NCT00776984|589996214|FG000|Overall Study|Lack of Efficacy|0|||
163351472|NCT00776984|589996215|FG001|Overall Study|Lack of Efficacy|1|||
163351473|NCT00776984|589996214|FG000|Overall Study|Other|5|||
163351474|NCT00776984|589996215|FG001|Overall Study|Other|9|||
163351475|NCT04414397|589996218|FG000|Control Period|Withdrawal by Subject|2|||
163351476|NCT04414397|589996219|FG001|Control Period|Withdrawal by Subject|2|||
163351477|NCT04414397|589996218|FG000|Control Period|Lost to Follow-up|0|||
163351478|NCT04414397|589996219|FG001|Control Period|Lost to Follow-up|4|||
163351479|NCT04414397|589996218|FG000|Control Period|Protocol deviation|0|||
163351480|NCT04414397|589996219|FG001|Control Period|Protocol deviation|1|||
163351481|NCT04414397|589996218|FG000|Post-Control Period|Withdrawal by Subject|3|||
163351482|NCT04414397|589996219|FG001|Post-Control Period|Withdrawal by Subject|6|||
163351483|NCT04414397|589996218|FG000|Post-Control Period|Lost to Follow-up|4|||
163351484|NCT04414397|589996219|FG001|Post-Control Period|Lost to Follow-up|9|||
163351485|NCT04414397|589996218|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
163351486|NCT04414397|589996219|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
163351487|NCT04414397|589996218|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
163351488|NCT04414397|589996219|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
163351489|NCT00356759|589996220|FG000|Overall Study|Death|5|||
163351490|NCT00356759|589996221|FG001|Overall Study|Death|2|||
163351491|NCT00356759|589996220|FG000|Overall Study|Withdrawal by Subject|2|||
163351492|NCT00356759|589996221|FG001|Overall Study|Withdrawal by Subject|2|||
163351493|NCT00356759|589996220|FG000|Overall Study|Adverse Event|1|||
163351494|NCT00356759|589996221|FG001|Overall Study|Adverse Event|3|||
163351495|NCT00356759|589996220|FG000|Overall Study|Lost to Follow-up|1|||
163351496|NCT00356759|589996221|FG001|Overall Study|Lost to Follow-up|1|||
163351497|NCT00356759|589996220|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
163148600|NCT02587520|589257308|FG016|Overall Study|Protocol Violation|0|||
163148601|NCT02587520|589257309|FG017|Overall Study|Protocol Violation|0|||
163148602|NCT02587520|589257292|FG000|Overall Study|Adverse Event|0|||
163148603|NCT02587520|589257293|FG001|Overall Study|Adverse Event|0|||
163148604|NCT02587520|589257294|FG002|Overall Study|Adverse Event|0|||
163148605|NCT02587520|589257295|FG003|Overall Study|Adverse Event|0|||
163148606|NCT02587520|589257296|FG004|Overall Study|Adverse Event|0|||
163148607|NCT02587520|589257297|FG005|Overall Study|Adverse Event|0|||
163148608|NCT02587520|589257298|FG006|Overall Study|Adverse Event|0|||
163148609|NCT02587520|589257299|FG007|Overall Study|Adverse Event|0|||
163148610|NCT02587520|589257300|FG008|Overall Study|Adverse Event|0|||
163148611|NCT02587520|589257301|FG009|Overall Study|Adverse Event|0|||
163148612|NCT02587520|589257302|FG010|Overall Study|Adverse Event|0|||
163148613|NCT02587520|589257303|FG011|Overall Study|Adverse Event|1|||
163148614|NCT02587520|589257304|FG012|Overall Study|Adverse Event|0|||
163148615|NCT02587520|589257305|FG013|Overall Study|Adverse Event|0|||
163148616|NCT02587520|589257306|FG014|Overall Study|Adverse Event|0|||
163148617|NCT02587520|589257307|FG015|Overall Study|Adverse Event|0|||
163148618|NCT02587520|589257308|FG016|Overall Study|Adverse Event|0|||
163148619|NCT02587520|589257309|FG017|Overall Study|Adverse Event|0|||
163148620|NCT02587520|589257292|FG000|Overall Study|Withdrawal by Subject|0|||
163148621|NCT02587520|589257293|FG001|Overall Study|Withdrawal by Subject|0|||
163148622|NCT02587520|589257294|FG002|Overall Study|Withdrawal by Subject|1|||
163148623|NCT02587520|589257295|FG003|Overall Study|Withdrawal by Subject|1|||
163148624|NCT02587520|589257296|FG004|Overall Study|Withdrawal by Subject|0|||
163148625|NCT02587520|589257297|FG005|Overall Study|Withdrawal by Subject|1|||
163148626|NCT02587520|589257298|FG006|Overall Study|Withdrawal by Subject|1|||
163148627|NCT02587520|589257299|FG007|Overall Study|Withdrawal by Subject|0|||
163148628|NCT02587520|589257300|FG008|Overall Study|Withdrawal by Subject|0|||
163148629|NCT02587520|589257301|FG009|Overall Study|Withdrawal by Subject|0|||
163148630|NCT02587520|589257302|FG010|Overall Study|Withdrawal by Subject|0|||
163410047|NCT01885000|590211244|FG001|Overall Study|Adverse Event|0|||
163410048|NCT01885000|590211243|FG000|Overall Study|Withdrawal by Subject|1|||
163410049|NCT01885000|590211244|FG001|Overall Study|Withdrawal by Subject|1|||
163410050|NCT01885000|590211243|FG000|Overall Study|Protocol Violation|0|||
163410051|NCT01885000|590211244|FG001|Overall Study|Protocol Violation|1|||
163410052|NCT02792842|590211245|FG000|Overall Study|Adverse Event|4|||
163410053|NCT02792842|590211246|FG001|Overall Study|Adverse Event|2|||
163410054|NCT02792842|590211247|FG002|Overall Study|Adverse Event|3|||
163410055|NCT02792842|590211245|FG000|Overall Study|Withdrawal by Subject|0|||
163148631|NCT02587520|589257303|FG011|Overall Study|Withdrawal by Subject|0|||
163148632|NCT02587520|589257304|FG012|Overall Study|Withdrawal by Subject|0|||
163148633|NCT02587520|589257305|FG013|Overall Study|Withdrawal by Subject|1|||
163148634|NCT02587520|589257306|FG014|Overall Study|Withdrawal by Subject|0|||
163148635|NCT02587520|589257307|FG015|Overall Study|Withdrawal by Subject|0|||
163148636|NCT02587520|589257308|FG016|Overall Study|Withdrawal by Subject|0|||
163148637|NCT02587520|589257309|FG017|Overall Study|Withdrawal by Subject|0|||
163148638|NCT02587520|589257292|FG000|Overall Study|Lost to Follow-up|0|||
163148639|NCT02587520|589257293|FG001|Overall Study|Lost to Follow-up|2|||
163148640|NCT02587520|589257294|FG002|Overall Study|Lost to Follow-up|0|||
163148641|NCT02587520|589257295|FG003|Overall Study|Lost to Follow-up|2|||
163148642|NCT02587520|589257296|FG004|Overall Study|Lost to Follow-up|0|||
163148643|NCT02587520|589257297|FG005|Overall Study|Lost to Follow-up|1|||
163148644|NCT02587520|589257298|FG006|Overall Study|Lost to Follow-up|1|||
163148645|NCT02587520|589257299|FG007|Overall Study|Lost to Follow-up|1|||
163148646|NCT02587520|589257300|FG008|Overall Study|Lost to Follow-up|0|||
163148647|NCT02587520|589257301|FG009|Overall Study|Lost to Follow-up|2|||
163148648|NCT02587520|589257302|FG010|Overall Study|Lost to Follow-up|2|||
163148649|NCT02587520|589257303|FG011|Overall Study|Lost to Follow-up|1|||
163148650|NCT02587520|589257304|FG012|Overall Study|Lost to Follow-up|0|||
163148651|NCT02587520|589257305|FG013|Overall Study|Lost to Follow-up|0|||
163148652|NCT02587520|589257306|FG014|Overall Study|Lost to Follow-up|0|||
163148653|NCT02587520|589257307|FG015|Overall Study|Lost to Follow-up|0|||
163148654|NCT02587520|589257308|FG016|Overall Study|Lost to Follow-up|0|||
163148655|NCT02587520|589257309|FG017|Overall Study|Lost to Follow-up|0|||
163148656|NCT00672555|589257310|FG000|Overall Study|Lost to Follow-up|4|||
163148657|NCT00672555|589257310|FG000|Overall Study|Did not want to answer questionnaire|2|||
163148658|NCT04516746|589257313|FG000|Overall Study|Randomized but not Treated|51|||
163148659|NCT04516746|589257314|FG001|Overall Study|Randomized but not Treated|19|||
163148660|NCT04516746|589257313|FG000|Overall Study|Adverse Event|0|||
163148661|NCT04516746|589257314|FG001|Overall Study|Adverse Event|1|||
163148662|NCT04516746|589257313|FG000|Overall Study|Death|62|||
163148663|NCT04516746|589257314|FG001|Overall Study|Death|32|||
163148664|NCT04516746|589257313|FG000|Overall Study|Lost to Follow-up|3431|||
163243638|NCT01664078|589598548|FG000|Overall Study|Other|53|||
163243639|NCT04782323|589598549|FG000|Overall Study|Death|1|||
163243640|NCT04782323|589598550|FG001|Overall Study|Death|0|||
163243641|NCT04782323|589598551|FG002|Overall Study|Death|0|||
163243642|NCT04782323|589598552|FG003|Overall Study|Death|0|||
163243643|NCT04782323|589598553|FG004|Overall Study|Death|1|||
163243644|NCT04782323|589598554|FG005|Overall Study|Death|1|||
163243645|NCT04782323|589598555|FG006|Overall Study|Death|1|||
163243646|NCT04782323|589598556|FG007|Overall Study|Death|0|||
163243647|NCT04782323|589598549|FG000|Overall Study|Withdrawal by Subject|0|||
163243648|NCT04782323|589598550|FG001|Overall Study|Withdrawal by Subject|0|||
163243649|NCT04782323|589598551|FG002|Overall Study|Withdrawal by Subject|1|||
163243650|NCT04782323|589598552|FG003|Overall Study|Withdrawal by Subject|0|||
163243651|NCT04782323|589598553|FG004|Overall Study|Withdrawal by Subject|0|||
163243652|NCT04782323|589598554|FG005|Overall Study|Withdrawal by Subject|1|||
163243653|NCT04782323|589598555|FG006|Overall Study|Withdrawal by Subject|0|||
163243654|NCT04782323|589598556|FG007|Overall Study|Withdrawal by Subject|1|||
163243655|NCT04782323|589598549|FG000|Overall Study|Lost to Follow-up|0|||
163243656|NCT04782323|589598550|FG001|Overall Study|Lost to Follow-up|1|||
163243657|NCT04782323|589598551|FG002|Overall Study|Lost to Follow-up|1|||
163243658|NCT04782323|589598552|FG003|Overall Study|Lost to Follow-up|0|||
163243659|NCT04782323|589598553|FG004|Overall Study|Lost to Follow-up|0|||
163243660|NCT04782323|589598554|FG005|Overall Study|Lost to Follow-up|1|||
163243661|NCT04782323|589598555|FG006|Overall Study|Lost to Follow-up|1|||
163243662|NCT04782323|589598556|FG007|Overall Study|Lost to Follow-up|2|||
163243663|NCT04782323|589598549|FG000|Overall Study|randomization in error|1|||
163243664|NCT04782323|589598550|FG001|Overall Study|randomization in error|0|||
163243665|NCT04782323|589598551|FG002|Overall Study|randomization in error|0|||
163243666|NCT04782323|589598552|FG003|Overall Study|randomization in error|0|||
163243667|NCT04782323|589598553|FG004|Overall Study|randomization in error|0|||
163243668|NCT04782323|589598554|FG005|Overall Study|randomization in error|0|||
163243669|NCT04782323|589598555|FG006|Overall Study|randomization in error|0|||
163243670|NCT04782323|589598556|FG007|Overall Study|randomization in error|0|||
163243671|NCT04369469|589598559|FG000|Overall Study|Lost to Follow-up|2|||
163243672|NCT04369469|589598560|FG001|Overall Study|Lost to Follow-up|4|||
163243673|NCT04369469|589598559|FG000|Overall Study|Physician Decision|2|||
163410056|NCT02792842|590211246|FG001|Overall Study|Withdrawal by Subject|1|||
163243674|NCT04369469|589598560|FG001|Overall Study|Physician Decision|1|||
163243675|NCT04369469|589598559|FG000|Overall Study|Withdrawal by Subject|2|||
163243676|NCT04369469|589598560|FG001|Overall Study|Withdrawal by Subject|3|||
163243677|NCT04369469|589598559|FG000|Overall Study|Adverse Event|1|||
163243678|NCT04369469|589598560|FG001|Overall Study|Adverse Event|0|||
163243679|NCT04369469|589598559|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
163243680|NCT04369469|589598560|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
163243681|NCT04369469|589598559|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
163243682|NCT04369469|589598560|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
163243683|NCT04369469|589598559|FG000|Overall Study|Unable to Provide Consent|0|||
163243684|NCT04369469|589598560|FG001|Overall Study|Unable to Provide Consent|1|||
163243685|NCT03135522|589598561|FG000|Overall Study|Adverse Event|1|||
163243686|NCT03135522|589598562|FG001|Overall Study|Adverse Event|0|||
163243687|NCT03832192|589598565|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
163243688|NCT03832192|589598566|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
163243689|NCT00499369|589598569|FG000|Overall Study|Adverse Event|2|||
163243690|NCT00499369|589598570|FG001|Overall Study|Adverse Event|2|||
163243691|NCT00499369|589598571|FG002|Overall Study|Adverse Event|3|||
163243692|NCT00499369|589598572|FG003|Overall Study|Adverse Event|1|||
163243693|NCT00499369|589598573|FG004|Overall Study|Adverse Event|2|||
163243694|NCT00499369|589598569|FG000|Overall Study|Withdrawal by Subject|0|||
163243695|NCT00499369|589598570|FG001|Overall Study|Withdrawal by Subject|1|||
163243696|NCT00499369|589598571|FG002|Overall Study|Withdrawal by Subject|1|||
163243697|NCT00499369|589598572|FG003|Overall Study|Withdrawal by Subject|0|||
163243698|NCT00499369|589598573|FG004|Overall Study|Withdrawal by Subject|0|||
163243699|NCT00499369|589598569|FG000|Overall Study|Progression|10|||
163243700|NCT00499369|589598570|FG001|Overall Study|Progression|12|||
163243701|NCT00499369|589598571|FG002|Overall Study|Progression|9|||
163243702|NCT00499369|589598572|FG003|Overall Study|Progression|6|||
163243703|NCT00499369|589598573|FG004|Overall Study|Progression|10|||
163243704|NCT00499369|589598569|FG000|Overall Study|Death|0|||
163243705|NCT00499369|589598570|FG001|Overall Study|Death|1|||
163243706|NCT00499369|589598571|FG002|Overall Study|Death|0|||
163243707|NCT00499369|589598572|FG003|Overall Study|Death|0|||
163243708|NCT00499369|589598573|FG004|Overall Study|Death|0|||
163243709|NCT00499369|589598569|FG000|Overall Study|Not protocol specified|2|||
163243710|NCT00499369|589598570|FG001|Overall Study|Not protocol specified|0|||
163243711|NCT00499369|589598571|FG002|Overall Study|Not protocol specified|3|||
163243712|NCT00499369|589598572|FG003|Overall Study|Not protocol specified|1|||
163243713|NCT00499369|589598573|FG004|Overall Study|Not protocol specified|0|||
163243714|NCT00499369|589598569|FG000|Overall Study|Ineligible|2|||
163243715|NCT00499369|589598570|FG001|Overall Study|Ineligible|2|||
163243716|NCT00499369|589598571|FG002|Overall Study|Ineligible|1|||
163243717|NCT00499369|589598572|FG003|Overall Study|Ineligible|1|||
163243718|NCT00499369|589598573|FG004|Overall Study|Ineligible|0|||
163243719|NCT01898195|589598574|FG000|Smoking Abstinence|Did not have good measurements|35|||
163243720|NCT01898195|589598575|FG001|Smoking Abstinence|Did not have good measurements|38|||
163243721|NCT01898195|589598576|FG002|Smoking Abstinence|Did not have good measurements|36|||
163243722|NCT01337245|589598577|FG000|Overall Study|Lost to Follow-up|1|||
163243723|NCT04095858|589598578|FG000|Overall Study|Death|1|||
163243724|NCT04095858|589598579|FG001|Overall Study|Death|0|||
163243725|NCT04095858|589598578|FG000|Overall Study|Study terminated by Sponsor|2|||
163243726|NCT04095858|589598579|FG001|Overall Study|Study terminated by Sponsor|4|||
163243727|NCT01344460|589598580|FG000|Overall Study|Withdrawal by Subject|1|||
163243728|NCT01344460|589598580|FG000|Overall Study|Lost to Follow-up|2|||
163243729|NCT02838017|589598582|FG000|Overall Study|Lost to Follow-up|14|||
163243730|NCT02838017|589598583|FG001|Overall Study|Lost to Follow-up|11|||
163243731|NCT01692197|589598584|FG000|Overall Study|Failed Screening|3|||
163243732|NCT02120924|589598585|FG000|Overall Study|Lack of Efficacy|1|||
163243733|NCT02120924|589598586|FG001|Overall Study|Lack of Efficacy|2|||
163243734|NCT02120924|589598587|FG002|Overall Study|Lack of Efficacy|3|||
163243735|NCT02120924|589598585|FG000|Overall Study|Adverse Event|0|||
163243736|NCT02120924|589598586|FG001|Overall Study|Adverse Event|1|||
163243737|NCT02120924|589598587|FG002|Overall Study|Adverse Event|3|||
163243738|NCT02120924|589598585|FG000|Overall Study|Withdrawal by Subject|16|||
163243739|NCT02120924|589598586|FG001|Overall Study|Withdrawal by Subject|20|||
163243740|NCT02120924|589598587|FG002|Overall Study|Withdrawal by Subject|8|||
163243741|NCT02120924|589598585|FG000|Overall Study|Lost to Follow-up|14|||
163243742|NCT02120924|589598586|FG001|Overall Study|Lost to Follow-up|14|||
163243743|NCT02120924|589598587|FG002|Overall Study|Lost to Follow-up|11|||
163243744|NCT02120924|589598585|FG000|Overall Study|Pregnancy|2|||
163410057|NCT02792842|590211247|FG002|Overall Study|Withdrawal by Subject|2|||
163243745|NCT02120924|589598586|FG001|Overall Study|Pregnancy|0|||
163243746|NCT02120924|589598587|FG002|Overall Study|Pregnancy|0|||
163243747|NCT02120924|589598585|FG000|Overall Study|Protocol Violation|3|||
163243748|NCT02120924|589598586|FG001|Overall Study|Protocol Violation|7|||
163243749|NCT02120924|589598587|FG002|Overall Study|Protocol Violation|2|||
163243750|NCT02120924|589598585|FG000|Overall Study|Physician Decision|0|||
163243751|NCT02120924|589598586|FG001|Overall Study|Physician Decision|1|||
163243752|NCT02120924|589598587|FG002|Overall Study|Physician Decision|1|||
163243753|NCT02120924|589598585|FG000|Overall Study|Death|1|||
163243754|NCT02120924|589598586|FG001|Overall Study|Death|0|||
163243755|NCT02120924|589598587|FG002|Overall Study|Death|0|||
163243756|NCT02120924|589598585|FG000|Overall Study|Compliance with IP|5|||
163243757|NCT02120924|589598586|FG001|Overall Study|Compliance with IP|1|||
163243758|NCT02120924|589598587|FG002|Overall Study|Compliance with IP|1|||
163243759|NCT03483623|589598588|FG000|Overall Study|43 complete sets achieved|1|||
163243760|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
163243761|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
163243762|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
163243763|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
163243764|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
163243765|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
163243766|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
163243767|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
163243768|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
163243769|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
163243770|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
163243771|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
163243772|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
163243773|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
163243774|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
163243775|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
163243776|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
163243777|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
163243778|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
163243779|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
163243780|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
163243781|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
163243782|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
163243783|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
163243784|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
163243785|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
163243786|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
163243787|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
163243788|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
163243789|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
163243790|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
163243791|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
163243792|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
163243793|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
163243794|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
163243795|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
163243796|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
163243797|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
163243798|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
163243799|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
163243800|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
163243801|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
163243802|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
163243803|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
163243804|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
163243805|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
163243806|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
163243807|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
163243808|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
163243809|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
163243810|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
163243811|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
163243812|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
163243813|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
163410058|NCT02792842|590211245|FG000|Overall Study|Lost to Follow-up|0|||
163410059|NCT02792842|590211246|FG001|Overall Study|Lost to Follow-up|0|||
163243814|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
163243815|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
163243816|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
163243817|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
163243818|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
163243819|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
163243820|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
163243821|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
163243822|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
163243823|NCT01884350|589598589|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
163243824|NCT01884350|589598590|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
163243825|NCT01884350|589598591|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
163243826|NCT02730819|589598604|FG000|Overall Study|Lost to Follow-up|9|||
163243827|NCT03403634|589598605|FG000|Overall Study|Disease progression|3|||
163243828|NCT03403634|589598605|FG000|Overall Study|Did not meet eligibility criteria|4|||
163243829|NCT01850004|589598606|FG000|Overall Study|Poor/Non-compliance|1|||
163243830|NCT01850004|589598606|FG000|Overall Study|Participant Withdrew Consent|9|||
163243831|NCT01850004|589598606|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
163243832|NCT01850004|589598606|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
163243833|NCT01850004|589598606|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
163243834|NCT01850004|589598606|FG000|Overall Study|Other Reasons|2|||
163243835|NCT01850004|589598606|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
163243836|NCT01850004|589598606|FG000|Overall Study|Maximum Clinical Benefit|4|||
163243837|NCT02536508|589600430|FG000|Overall Study|Withdrawal by Subject|18|||
163243838|NCT02536508|589600431|FG001|Overall Study|Withdrawal by Subject|13|||
163243839|NCT02536508|589600432|FG002|Overall Study|Withdrawal by Subject|7|||
163243840|NCT02536508|589600430|FG000|Overall Study|Adverse Event|14|||
163243841|NCT02536508|589600431|FG001|Overall Study|Adverse Event|13|||
163243842|NCT02536508|589600432|FG002|Overall Study|Adverse Event|6|||
163243843|NCT02536508|589600430|FG000|Overall Study|Lost to Follow-up|12|||
163243844|NCT02536508|589600431|FG001|Overall Study|Lost to Follow-up|4|||
163243845|NCT02536508|589600432|FG002|Overall Study|Lost to Follow-up|0|||
163243846|NCT02536508|589600430|FG000|Overall Study|Lack of Efficacy|3|||
163243847|NCT02536508|589600431|FG001|Overall Study|Lack of Efficacy|5|||
163243848|NCT02536508|589600432|FG002|Overall Study|Lack of Efficacy|4|||
163243849|NCT02536508|589600430|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
163243850|NCT02536508|589600431|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
163243851|NCT02536508|589600432|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
163243852|NCT02536508|589600430|FG000|Overall Study|Physician Decision|0|||
163243853|NCT02536508|589600431|FG001|Overall Study|Physician Decision|4|||
163243854|NCT02536508|589600432|FG002|Overall Study|Physician Decision|2|||
163243855|NCT02536508|589600430|FG000|Overall Study|Major Protocol Deviation|2|||
163243856|NCT02536508|589600431|FG001|Overall Study|Major Protocol Deviation|2|||
163243857|NCT02536508|589600432|FG002|Overall Study|Major Protocol Deviation|2|||
163410060|NCT02792842|590211247|FG002|Overall Study|Lost to Follow-up|1|||
163410061|NCT02792842|590211245|FG000|Overall Study|Schedule delay|0|||
163410062|NCT02792842|590211246|FG001|Overall Study|Schedule delay|1|||
163410063|NCT02792842|590211247|FG002|Overall Study|Schedule delay|1|||
163148665|NCT04516746|589257314|FG001|Overall Study|Lost to Follow-up|1831|||
163148666|NCT04516746|589257313|FG000|Overall Study|Withdrawal by Subject|1946|||
163148667|NCT04516746|589257314|FG001|Overall Study|Withdrawal by Subject|1696|||
163148668|NCT04516746|589257313|FG000|Overall Study|Physician Decision|10|||
163148669|NCT04516746|589257314|FG001|Overall Study|Physician Decision|8|||
163148670|NCT04516746|589257313|FG000|Overall Study|Other|35|||
163148671|NCT04516746|589257314|FG001|Overall Study|Other|16|||
163148672|NCT03489863|589257315|FG000|Overall Study|Withdrawal by Subject|0|||
163148673|NCT03489863|589257316|FG001|Overall Study|Withdrawal by Subject|1|||
163148674|NCT00446849|589257318|FG000|Acute Phase|Lack of Efficacy|64|||
163148675|NCT00446849|589257318|FG000|Acute Phase|Protocol Violation|10|||
163148676|NCT00446849|589257318|FG000|Acute Phase|Consent withdrawn|4|||
163148677|NCT00446849|589257318|FG000|Acute Phase|Lost to Follow-up|2|||
163148678|NCT00446849|589257318|FG000|Acute Phase|Physician Decision|1|||
163148679|NCT00446849|589257318|FG000|Acute Phase|noncompliance|1|||
163148680|NCT00446849|589257318|FG000|Maintenance Phase|Lack of Efficacy|40|||
163148681|NCT00446849|589257318|FG000|Maintenance Phase|Protocol Violation|7|||
163148682|NCT00446849|589257318|FG000|Maintenance Phase|Adverse Event|6|||
163148683|NCT00446849|589257318|FG000|Maintenance Phase|Consent withdrawn|5|||
163148684|NCT00446849|589257318|FG000|Maintenance Phase|Lost to Follow-up|3|||
163148685|NCT00446849|589257318|FG000|Maintenance Phase|Pregnancy|1|||
163148686|NCT00446849|589257318|FG000|Maintenance Phase|noncompliance|2|||
163243858|NCT02536508|589600430|FG000|Overall Study|Administrative Reasons|0|||
163243859|NCT02536508|589600431|FG001|Overall Study|Administrative Reasons|1|||
163148687|NCT00446849|589257318|FG000|Maintenance Phase|prohibited medication use|2|||
163148688|NCT00446849|589257318|FG000|Maintenance Phase|antibiotic use|1|||
163351498|NCT00356759|589996221|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
163351499|NCT03640754|589996222|FG000|Overall Study|Withdrawal by Subject|1|||
163351500|NCT03640754|589996223|FG001|Overall Study|Withdrawal by Subject|0|||
163351501|NCT03640754|589996222|FG000|Overall Study|Lost to Follow-up|0|||
163351502|NCT03640754|589996223|FG001|Overall Study|Lost to Follow-up|1|||
163351503|NCT01204775|589996224|FG000|Overall Study|Poor/non-compliance|0|||
163351504|NCT01204775|589996225|FG001|Overall Study|Poor/non-compliance|1|||
163351505|NCT01204775|589996224|FG000|Overall Study|Withdrawal by Subject|1|||
163351506|NCT01204775|589996225|FG001|Overall Study|Withdrawal by Subject|0|||
163351507|NCT00276016|589996226|FG000|Intervention 1|Withdrawal by Subject|0|||
163351508|NCT00276016|589996227|FG001|Intervention 1|Withdrawal by Subject|1|||
163351509|NCT00276016|589996228|FG002|Intervention 1|Withdrawal by Subject|0|||
163351510|NCT00276016|589996229|FG003|Intervention 1|Withdrawal by Subject|0|||
163351511|NCT00276016|589996230|FG004|Intervention 1|Withdrawal by Subject|0|||
163351512|NCT00276016|589996231|FG005|Intervention 1|Withdrawal by Subject|0|||
163351513|NCT04380688|589996232|FG000|Overall Study|Death|2|||
163351514|NCT04380688|589996233|FG001|Overall Study|Death|2|||
163351515|NCT04380688|589996232|FG000|Overall Study|Lost to Follow-up|2|||
163410064|NCT05289830|590211256|FG000|Overall Study|Lost to Follow-up|1|||
163410065|NCT05289830|590211257|FG001|Overall Study|Lost to Follow-up|1|||
163410066|NCT05289830|590211256|FG000|Overall Study|Physician Decision|0|||
163410067|NCT05289830|590211257|FG001|Overall Study|Physician Decision|1|||
163410068|NCT01046825|590211258|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
163410069|NCT01046825|590211259|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
163410070|NCT01046825|590211260|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
163410071|NCT01046825|590211261|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
163410072|NCT01046825|590211262|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
163410073|NCT01046825|590211258|FG000|Overall Study|Physician Decision|0|||
163410074|NCT01046825|590211259|FG001|Overall Study|Physician Decision|1|||
163410075|NCT01046825|590211260|FG002|Overall Study|Physician Decision|2|||
163410076|NCT01046825|590211261|FG003|Overall Study|Physician Decision|0|||
163410077|NCT01046825|590211262|FG004|Overall Study|Physician Decision|0|||
163410078|NCT01046825|590211258|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
163410079|NCT01046825|590211259|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
163410080|NCT01046825|590211260|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
163410081|NCT01046825|590211261|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
163410082|NCT01046825|590211262|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
163410083|NCT01046825|590211258|FG000|Overall Study|Found to be ineligible|0|||
163410084|NCT01046825|590211259|FG001|Overall Study|Found to be ineligible|1|||
163410085|NCT01046825|590211260|FG002|Overall Study|Found to be ineligible|0|||
163410086|NCT01046825|590211261|FG003|Overall Study|Found to be ineligible|0|||
163410087|NCT01046825|590211262|FG004|Overall Study|Found to be ineligible|0|||
163410088|NCT01046825|590211258|FG000|Overall Study|Death|0|||
163410089|NCT01046825|590211259|FG001|Overall Study|Death|0|||
163410090|NCT01046825|590211260|FG002|Overall Study|Death|0|||
163410091|NCT01046825|590211261|FG003|Overall Study|Death|1|||
163410092|NCT01046825|590211262|FG004|Overall Study|Death|0|||
163148689|NCT00446849|589257318|FG000|Maintenance Phase|study closure|1|||
163148690|NCT00446849|589257318|FG000|Maintenance Phase|hydrocodone use|1|||
163148691|NCT00446849|589257318|FG000|Maintenance Phase|concomitant medication use|1|||
163148692|NCT01706458|589257319|FG000|Overall Study|Physician Decision|3|||
163148693|NCT01706458|589257320|FG001|Overall Study|Physician Decision|4|||
163148694|NCT03547518|589257321|FG000|Overall Study|Lost to Follow-up|2|||
163148695|NCT03547518|589257322|FG001|Overall Study|Lost to Follow-up|0|||
163148696|NCT03035032|589257326|FG000|Overall Study|Adverse Event|2|||
163148697|NCT03035032|589257326|FG000|Overall Study|Death|9|||
163148698|NCT03035032|589257326|FG000|Overall Study|Lost to Follow-up|1|||
163148699|NCT03035032|589257326|FG000|Overall Study|Progressive Disease|22|||
163148700|NCT03035032|589257326|FG000|Overall Study|Protocol Violation|2|||
163148701|NCT03035032|589257326|FG000|Overall Study|Withdrawal by Subject|2|||
163148702|NCT03035032|589257326|FG000|Overall Study|Physician Decision|5|||
163148703|NCT01546857|589257330|FG000|Overall Study|Withdrawal by Subject|2|||
163148704|NCT01546857|589257331|FG001|Overall Study|Withdrawal by Subject|3|||
163148705|NCT02542865|589257332|FG000|Overall Study|Identified as screen failure|1|||
163148706|NCT02542865|589257333|FG001|Overall Study|Identified as screen failure|0|||
163148707|NCT02542865|589257332|FG000|Overall Study|Withdrawal by Subject|16|||
163148708|NCT02542865|589257333|FG001|Overall Study|Withdrawal by Subject|0|||
163148709|NCT01339689|589257334|FG000|Overall Study|Adverse Event|1|||
163148710|NCT01339689|589257335|FG001|Overall Study|Adverse Event|2|||
163148711|NCT01339689|589257334|FG000|Overall Study|Lost to Follow-up|9|||
163148712|NCT01339689|589257335|FG001|Overall Study|Lost to Follow-up|3|||
163148713|NCT01339689|589257334|FG000|Overall Study|Withdrawal by Subject|3|||
163148714|NCT01339689|589257335|FG001|Overall Study|Withdrawal by Subject|0|||
163148715|NCT01339689|589257334|FG000|Overall Study|Noncompliance|1|||
163148716|NCT01339689|589257335|FG001|Overall Study|Noncompliance|0|||
163351516|NCT04380688|589996233|FG001|Overall Study|Lost to Follow-up|4|||
163351517|NCT04380688|589996232|FG000|Overall Study|Withdrawal by Subject|3|||
163351518|NCT04380688|589996233|FG001|Overall Study|Withdrawal by Subject|3|||
163351519|NCT00664105|589998074|FG000|Overall Study|Death|3|||
163351520|NCT00664105|589998074|FG000|Overall Study|Withdrawal by Subject|5|||
163351521|NCT00664105|589998074|FG000|Overall Study|Adverse Event|9|||
163351522|NCT00664105|589998074|FG000|Overall Study|Disease progression|7|||
163351523|NCT00847132|589998078|FG000|Overall Study|Death|1|||
163351524|NCT00847132|589998079|FG001|Overall Study|Death|1|||
163351525|NCT00988533|589998081|FG000|Overall Study|Lost to Follow-up|3|||
163351526|NCT00913523|589998084|FG000|Overall Study|Withdrawal by Subject|3|||
163351527|NCT00913523|589998085|FG001|Overall Study|Withdrawal by Subject|2|||
163351528|NCT00913523|589998086|FG002|Overall Study|Withdrawal by Subject|2|||
163351529|NCT00913523|589998084|FG000|Overall Study|Lost to Follow-up|1|||
163351530|NCT00913523|589998085|FG001|Overall Study|Lost to Follow-up|1|||
163351531|NCT00913523|589998086|FG002|Overall Study|Lost to Follow-up|1|||
163351532|NCT00913523|589998084|FG000|Overall Study|Adverse Event|1|||
163351533|NCT00913523|589998085|FG001|Overall Study|Adverse Event|0|||
163351534|NCT00913523|589998086|FG002|Overall Study|Adverse Event|0|||
163351535|NCT00913523|589998084|FG000|Overall Study|Protocol Violation|5|||
163351536|NCT00913523|589998085|FG001|Overall Study|Protocol Violation|8|||
163351537|NCT00913523|589998086|FG002|Overall Study|Protocol Violation|8|||
163351538|NCT00913523|589998084|FG000|Overall Study|Pregnancy|1|||
163351539|NCT00913523|589998085|FG001|Overall Study|Pregnancy|3|||
163410093|NCT01046825|590211258|FG000|Overall Study|Did not submit biology samples|0|||
163410094|NCT01046825|590211259|FG001|Overall Study|Did not submit biology samples|0|||
163410095|NCT01046825|590211260|FG002|Overall Study|Did not submit biology samples|0|||
163410096|NCT01046825|590211261|FG003|Overall Study|Did not submit biology samples|0|||
163410097|NCT01046825|590211262|FG004|Overall Study|Did not submit biology samples|13|||
163410098|NCT00577993|590211264|FG000|Overall Study|Adverse Event|1|||
163410099|NCT00577993|590211265|FG001|Overall Study|Adverse Event|0|||
163410100|NCT00577993|590211266|FG002|Overall Study|Adverse Event|0|||
163410101|NCT00577993|590211264|FG000|Overall Study|Death|0|||
163410102|NCT00577993|590211265|FG001|Overall Study|Death|1|||
163410103|NCT00577993|590211266|FG002|Overall Study|Death|1|||
163410104|NCT00577993|590211264|FG000|Overall Study|Lack of Efficacy|0|||
163410105|NCT00577993|590211265|FG001|Overall Study|Lack of Efficacy|1|||
163410106|NCT00577993|590211266|FG002|Overall Study|Lack of Efficacy|0|||
163410107|NCT00577993|590211264|FG000|Overall Study|Protocol Violation|2|||
163410108|NCT00577993|590211265|FG001|Overall Study|Protocol Violation|3|||
163410109|NCT00577993|590211266|FG002|Overall Study|Protocol Violation|0|||
163410110|NCT00577993|590211264|FG000|Overall Study|Withdrawal by Subject|1|||
163410111|NCT00577993|590211265|FG001|Overall Study|Withdrawal by Subject|0|||
163410112|NCT00577993|590211266|FG002|Overall Study|Withdrawal by Subject|2|||
163410113|NCT00577993|590211264|FG000|Overall Study|Conversion|2|||
163410114|NCT00577993|590211265|FG001|Overall Study|Conversion|5|||
163410115|NCT00577993|590211266|FG002|Overall Study|Conversion|0|||
163410116|NCT00577993|590211264|FG000|Overall Study|Uninsured|1|||
163410117|NCT00577993|590211265|FG001|Overall Study|Uninsured|0|||
163410118|NCT00577993|590211266|FG002|Overall Study|Uninsured|0|||
163410119|NCT02217566|590211267|FG000|Overall Study|Lost to Follow-up|2|||
163410120|NCT02217566|590211267|FG000|Overall Study|Death|3|||
163410121|NCT02217566|590211267|FG000|Overall Study|Early study termination|6|||
163410122|NCT02064387|590211272|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163410123|NCT02064387|590211273|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163410124|NCT02064387|590211274|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163410125|NCT02064387|590211275|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163410126|NCT02064387|590211276|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163410127|NCT02064387|590211277|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163410128|NCT02064387|590211278|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163148717|NCT01339689|589257334|FG000|Overall Study|Relocated out of area|0|||
163351540|NCT00913523|589998086|FG002|Overall Study|Pregnancy|0|||
163351541|NCT00913523|589998084|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
163351542|NCT00913523|589998085|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
163351543|NCT00913523|589998086|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
163351544|NCT01649297|589998088|FG000|Overall Study|Adverse Event|5|||
163351545|NCT01649297|589998089|FG001|Overall Study|Adverse Event|5|||
163351546|NCT01649297|589998090|FG002|Overall Study|Adverse Event|4|||
163351547|NCT01649297|589998091|FG003|Overall Study|Adverse Event|13|||
163351548|NCT01649297|589998092|FG004|Overall Study|Adverse Event|1|||
163351549|NCT01649297|589998088|FG000|Overall Study|Lack of Efficacy|0|||
163351550|NCT01649297|589998089|FG001|Overall Study|Lack of Efficacy|0|||
163351551|NCT01649297|589998090|FG002|Overall Study|Lack of Efficacy|0|||
163410129|NCT02064387|590211279|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
163410130|NCT02064387|590211280|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163410131|NCT02064387|590211281|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
163410132|NCT02064387|590211282|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163410133|NCT02064387|590211283|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163351552|NCT01649297|589998091|FG003|Overall Study|Lack of Efficacy|0|||
163351553|NCT01649297|589998092|FG004|Overall Study|Lack of Efficacy|1|||
163351554|NCT01649297|589998088|FG000|Overall Study|Non compliant with Protocol|1|||
163351555|NCT01649297|589998089|FG001|Overall Study|Non compliant with Protocol|0|||
163351556|NCT01649297|589998090|FG002|Overall Study|Non compliant with Protocol|3|||
163351557|NCT01649297|589998091|FG003|Overall Study|Non compliant with Protocol|2|||
163351558|NCT01649297|589998092|FG004|Overall Study|Non compliant with Protocol|1|||
163351559|NCT01649297|589998088|FG000|Overall Study|Lost to Follow-up|1|||
163351560|NCT01649297|589998089|FG001|Overall Study|Lost to Follow-up|1|||
163351561|NCT01649297|589998090|FG002|Overall Study|Lost to Follow-up|4|||
163351562|NCT01649297|589998091|FG003|Overall Study|Lost to Follow-up|3|||
163351563|NCT01649297|589998092|FG004|Overall Study|Lost to Follow-up|0|||
163351564|NCT01649297|589998088|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
163351565|NCT01649297|589998089|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
163351566|NCT01649297|589998090|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
163351567|NCT01649297|589998091|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
163351568|NCT01649297|589998092|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
163351569|NCT01649297|589998088|FG000|Overall Study|For other reason|4|||
163351570|NCT01649297|589998089|FG001|Overall Study|For other reason|1|||
163351571|NCT01649297|589998090|FG002|Overall Study|For other reason|2|||
163351572|NCT01649297|589998091|FG003|Overall Study|For other reason|0|||
163351573|NCT01649297|589998092|FG004|Overall Study|For other reason|0|||
163351574|NCT01685047|589998093|FG000|Overall Study|Withdrawal by Subject|20|||
163351575|NCT01685047|589998093|FG000|Overall Study|Death|26|||
163351576|NCT01685047|589998093|FG000|Overall Study|Lost to Follow-up|8|||
163351577|NCT01685047|589998093|FG000|Overall Study|Physician Decision|25|||
163351578|NCT01685047|589998093|FG000|Overall Study|Adverse Event|5|||
163351579|NCT01685047|589998093|FG000|Overall Study|patient withdrawn by sponsor|1|||
163351580|NCT02544113|589998094|FG000|Overall Study|Death|3|||
163351581|NCT02544113|589998095|FG001|Overall Study|Death|4|||
163351582|NCT02847637|589998099|FG000|Overall Study|Withdrawal by Subject|0|||
163351583|NCT02847637|589998100|FG001|Overall Study|Withdrawal by Subject|1|||
163351584|NCT02847637|589998101|FG002|Overall Study|Withdrawal by Subject|1|||
163351585|NCT02847637|589998102|FG003|Overall Study|Withdrawal by Subject|0|||
163351586|NCT02847637|589998099|FG000|Overall Study|Lost to Follow-up|1|||
163351587|NCT02847637|589998100|FG001|Overall Study|Lost to Follow-up|1|||
163351588|NCT02847637|589998101|FG002|Overall Study|Lost to Follow-up|0|||
163351589|NCT02847637|589998102|FG003|Overall Study|Lost to Follow-up|0|||
163351590|NCT01746108|589998103|FG000|Overall Study|Migrated /moved from study area|0|||
163351591|NCT01746108|589998104|FG001|Overall Study|Migrated /moved from study area|1|||
163351592|NCT01746108|589998105|FG002|Overall Study|Migrated /moved from study area|0|||
163351593|NCT01746108|589998103|FG000|Overall Study|Adverse event, non-fatal|0|||
163351594|NCT01746108|589998104|FG001|Overall Study|Adverse event, non-fatal|1|||
163351595|NCT01746108|589998105|FG002|Overall Study|Adverse event, non-fatal|0|||
163351596|NCT01746108|589998103|FG000|Overall Study|Withdrawal by Subject|0|||
163351597|NCT01746108|589998104|FG001|Overall Study|Withdrawal by Subject|1|||
163351598|NCT01746108|589998105|FG002|Overall Study|Withdrawal by Subject|0|||
163351599|NCT01746108|589998103|FG000|Overall Study|Lost to Follow-up|0|||
163351600|NCT01746108|589998104|FG001|Overall Study|Lost to Follow-up|1|||
163351601|NCT01746108|589998105|FG002|Overall Study|Lost to Follow-up|0|||
163351602|NCT03036150|589998106|FG000|Overall Study|Withdrawal by Subject|8|||
163351603|NCT03036150|589998107|FG001|Overall Study|Withdrawal by Subject|3|||
163351604|NCT03036150|589998106|FG000|Overall Study|Lost to Follow-up|2|||
163351605|NCT03036150|589998107|FG001|Overall Study|Lost to Follow-up|2|||
163351606|NCT02741713|589998114|FG000|Overall Study|Surgery type changed intra-operatively|2|||
163351607|NCT02741713|589998115|FG001|Overall Study|Surgery type changed intra-operatively|1|||
163351608|NCT00496626|589998116|FG000|Overall Study|Lost to Follow-up|0|||
163351609|NCT00496626|589998117|FG001|Overall Study|Lost to Follow-up|1|||
163351610|NCT00496626|589998116|FG000|Overall Study|Protocol Violation|1|||
163351611|NCT00496626|589998117|FG001|Overall Study|Protocol Violation|0|||
163351612|NCT00496626|589998116|FG000|Overall Study|Withdrawal by Subject|5|||
163351613|NCT00496626|589998117|FG001|Overall Study|Withdrawal by Subject|4|||
163351614|NCT00496626|589998116|FG000|Overall Study|Relocated|0|||
163351615|NCT00496626|589998117|FG001|Overall Study|Relocated|1|||
163351616|NCT00570921|589998118|FG000|Overall Study|Protocol Violation|1|||
163351617|NCT00570921|589998118|FG000|Overall Study|Physician Decision|1|||
163351618|NCT04191148|589998119|FG000|Overall Study|Withdrawal by Subject|1|||
163351619|NCT04191148|589998120|FG001|Overall Study|Withdrawal by Subject|0|||
163351620|NCT04191148|589998119|FG000|Overall Study|Adverse Event|1|||
163351621|NCT04191148|589998120|FG001|Overall Study|Adverse Event|0|||
163351622|NCT02647788|589998121|FG000|Overall Study|Lost to Follow-up|13|||
163351623|NCT02647788|589998122|FG001|Overall Study|Lost to Follow-up|11|||
163351624|NCT02647788|589998121|FG000|Overall Study|Did not want opiate|0|||
163351625|NCT02647788|589998122|FG001|Overall Study|Did not want opiate|1|||
163351626|NCT02647788|589998121|FG000|Overall Study|Withdrawal by Subject|1|||
163351627|NCT02647788|589998122|FG001|Overall Study|Withdrawal by Subject|0|||
163351628|NCT02647788|589998121|FG000|Overall Study|Felt itchy with assigned medication|1|||
163351629|NCT02647788|589998122|FG001|Overall Study|Felt itchy with assigned medication|0|||
163351630|NCT02647788|589998121|FG000|Overall Study|Felt nauseous with assigned medication|1|||
163351631|NCT02647788|589998122|FG001|Overall Study|Felt nauseous with assigned medication|1|||
163351632|NCT02447432|589998123|FG000|Epoch 001|Adverse Event|1|||
163351633|NCT02447432|589998124|FG001|Epoch 001|Adverse Event|1|||
163351634|NCT02447432|589998123|FG000|Epoch 001|Withdrawal by Subject|0|||
163351635|NCT02447432|589998124|FG001|Epoch 001|Withdrawal by Subject|4|||
163351636|NCT02447432|589998123|FG000|Epoch 001|Migrated/moved from study area|3|||
163351637|NCT02447432|589998124|FG001|Epoch 001|Migrated/moved from study area|5|||
163351638|NCT02447432|589998123|FG000|Epoch 001|Lost to Follow-up|1|||
163148718|NCT01339689|589257335|FG001|Overall Study|Relocated out of area|1|||
163148719|NCT01339689|589257334|FG000|Overall Study|Other|2|||
163148720|NCT01339689|589257335|FG001|Overall Study|Other|2|||
163351639|NCT02447432|589998124|FG001|Epoch 001|Lost to Follow-up|3|||
163351640|NCT01274559|589998127|FG000|Overall Study|Adverse Event|57|||
163351641|NCT01274559|589998128|FG001|Overall Study|Adverse Event|13|||
163351642|NCT01274559|589998127|FG000|Overall Study|Death|1|||
163351643|NCT01274559|589998128|FG001|Overall Study|Death|1|||
163351644|NCT01274559|589998127|FG000|Overall Study|Lost to Follow-up|3|||
163351645|NCT01274559|589998128|FG001|Overall Study|Lost to Follow-up|3|||
163351646|NCT01274559|589998127|FG000|Overall Study|Non-compliance with Study Drug|2|||
163351647|NCT01274559|589998128|FG001|Overall Study|Non-compliance with Study Drug|4|||
163351648|NCT01274559|589998127|FG000|Overall Study|Physician Decision|2|||
163351649|NCT01274559|589998128|FG001|Overall Study|Physician Decision|1|||
163351650|NCT01274559|589998127|FG000|Overall Study|Protocol Violation|28|||
163351651|NCT01274559|589998128|FG001|Overall Study|Protocol Violation|23|||
163351652|NCT01274559|589998127|FG000|Overall Study|Study Terminated by Sponsor|79|||
163351653|NCT01274559|589998128|FG001|Overall Study|Study Terminated by Sponsor|87|||
163351654|NCT01274559|589998127|FG000|Overall Study|Withdrawal by Subject|25|||
163351655|NCT01274559|589998128|FG001|Overall Study|Withdrawal by Subject|13|||
163351656|NCT02561806|589998142|FG000|Induction Period|Adverse Event|0|||
163351657|NCT02561806|589998143|FG001|Induction Period|Adverse Event|2|||
163351658|NCT02561806|589998142|FG000|Induction Period|Lack of Efficacy|1|||
163351659|NCT02561806|589998143|FG001|Induction Period|Lack of Efficacy|0|||
163351660|NCT02561806|589998142|FG000|Induction Period|Withdrawal by Subject|0|||
163351661|NCT02561806|589998143|FG001|Induction Period|Withdrawal by Subject|2|||
163351662|NCT02561806|589998142|FG000|Induction Period|Site staff became unblinded|1|||
163351663|NCT02561806|589998143|FG001|Induction Period|Site staff became unblinded|0|||
163351664|NCT02561806|589998142|FG000|Induction Period|Randomized but not treated|0|||
163351665|NCT02561806|589998143|FG001|Induction Period|Randomized but not treated|1|||
163351666|NCT02561806|589998142|FG000|Maintenance Period|Adverse Event|2|||
163351667|NCT02561806|589998143|FG001|Maintenance Period|Adverse Event|1|||
163351668|NCT02561806|589998142|FG000|Maintenance Period|Lack of Efficacy|3|||
163351669|NCT02561806|589998143|FG001|Maintenance Period|Lack of Efficacy|1|||
163351670|NCT02561806|589998142|FG000|Maintenance Period|Lost to Follow-up|2|||
163351671|NCT02561806|589998143|FG001|Maintenance Period|Lost to Follow-up|2|||
163351672|NCT02561806|589998142|FG000|Maintenance Period|Protocol Violation|1|||
163351673|NCT02561806|589998143|FG001|Maintenance Period|Protocol Violation|0|||
163351674|NCT02561806|589998142|FG000|Maintenance Period|Withdrawal by Subject|5|||
163351675|NCT02561806|589998143|FG001|Maintenance Period|Withdrawal by Subject|3|||
163351676|NCT02561806|589998142|FG000|Maintenance Period|Site staff became unblinded|0|||
163351677|NCT02561806|589998143|FG001|Maintenance Period|Site staff became unblinded|1|||
163351678|NCT02561806|589998142|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
163351679|NCT02561806|589998143|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
163351680|NCT02561806|589998142|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
163351681|NCT02561806|589998143|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
163351682|NCT00591591|589998149|FG000|Overall Study|Withdrawal by Subject|1|||
163351683|NCT00591591|589998150|FG001|Overall Study|Withdrawal by Subject|37|||
163351684|NCT00591591|589998149|FG000|Overall Study|Lack of Efficacy|10|||
163351685|NCT00591591|589998150|FG001|Overall Study|Lack of Efficacy|2|||
163351686|NCT00002597|589998151|FG000|Overall Study|Protocol Violation|19|||
163351687|NCT00002597|589998152|FG001|Overall Study|Protocol Violation|17|||
163351688|NCT00002597|589998151|FG000|Overall Study|Withdrawal by Subject|7|||
163351689|NCT00002597|589998152|FG001|Overall Study|Withdrawal by Subject|6|||
163351690|NCT00912223|589998153|FG000|Overall Study|Withdrawal by Subject|1|||
163351691|NCT00912223|589998153|FG000|Overall Study|Not transplanted|1|||
163351692|NCT00912223|589998153|FG000|Overall Study|Transformed disease|1|||
163351693|NCT01242371|589998157|FG000|Overall Study|Withdrawal by Subject|2|||
163351694|NCT01242371|589998158|FG001|Overall Study|Withdrawal by Subject|2|||
163351695|NCT01242371|589998157|FG000|Overall Study|Protocol Violation|0|||
163351696|NCT01242371|589998158|FG001|Overall Study|Protocol Violation|3|||
163351697|NCT00510146|589998161|FG000|Double-Blind Treatment|Adverse Event|30|||
163351698|NCT00510146|589998162|FG001|Double-Blind Treatment|Adverse Event|13|||
163351699|NCT00510146|589998161|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
163351700|NCT00510146|589998162|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
163351701|NCT00510146|589998161|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
163148721|NCT01339689|589257334|FG000|Overall Study|multiple reasons|1|||
163243860|NCT02536508|589600432|FG002|Overall Study|Administrative Reasons|0|||
163243861|NCT00434057|589600434|FG000|Overall Study|Withdrawal by Subject|1|||
163243862|NCT00823719|589600439|FG000|Overall Study|Adverse Event|1|||
163243863|NCT00823719|589600440|FG001|Overall Study|Adverse Event|2|||
163243864|NCT00823719|589600439|FG000|Overall Study|Physician Decision|1|||
163243865|NCT00823719|589600440|FG001|Overall Study|Physician Decision|4|||
163243866|NCT00823719|589600439|FG000|Overall Study|Withdrawal by Subject|0|||
163243867|NCT00823719|589600440|FG001|Overall Study|Withdrawal by Subject|1|||
163243868|NCT00823719|589600439|FG000|Overall Study|Disease Progression|4|||
163243869|NCT00823719|589600440|FG001|Overall Study|Disease Progression|4|||
163243870|NCT02103439|589600441|FG000|Overall Study|Adverse Event|0|||
163243871|NCT02103439|589600442|FG001|Overall Study|Adverse Event|2|||
163243872|NCT02103439|589600441|FG000|Overall Study|Withdrawal by Subject|3|||
163243873|NCT02103439|589600442|FG001|Overall Study|Withdrawal by Subject|1|||
163243874|NCT02370602|589600443|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
163243875|NCT02370602|589600444|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
163243876|NCT02370602|589600445|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
163243877|NCT02370602|589600446|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
163243878|NCT02370602|589600447|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
163243879|NCT02370602|589600448|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
163243880|NCT00784810|589600450|FG000|Overall Study|Adverse Event|32|||
163243881|NCT00784810|589600451|FG001|Overall Study|Adverse Event|20|||
163243882|NCT00784810|589600450|FG000|Overall Study|Lack of Efficacy|14|||
163243883|NCT00784810|589600451|FG001|Overall Study|Lack of Efficacy|11|||
163243884|NCT00784810|589600450|FG000|Overall Study|Withdrawal by Subject|11|||
163243885|NCT00784810|589600451|FG001|Overall Study|Withdrawal by Subject|9|||
163243886|NCT00784810|589600450|FG000|Overall Study|Administrative|5|||
163243887|NCT00784810|589600451|FG001|Overall Study|Administrative|8|||
163243888|NCT00784810|589600450|FG000|Overall Study|Lost to Follow-up|1|||
163243889|NCT00784810|589600451|FG001|Overall Study|Lost to Follow-up|1|||
163243890|NCT03305016|589600454|FG000|Overall Study|Withdrawal by Subject|2|||
163243891|NCT02119416|589600455|FG000|Overall Study|Protocol Violation|1|||
163243892|NCT02119416|589600456|FG001|Overall Study|Protocol Violation|1|||
163243893|NCT02119416|589600457|FG002|Overall Study|Protocol Violation|1|||
163243894|NCT02119416|589600455|FG000|Overall Study|wrong pubertal stage|1|||
163243895|NCT02119416|589600456|FG001|Overall Study|wrong pubertal stage|0|||
163243896|NCT02119416|589600457|FG002|Overall Study|wrong pubertal stage|1|||
163243897|NCT04420689|589600458|FG000|Overall Study|COVID-19 related hospitalization|0|||
163243898|NCT04420689|589600459|FG001|Overall Study|COVID-19 related hospitalization|0|||
163243899|NCT04420689|589600460|FG002|Overall Study|COVID-19 related hospitalization|0|||
163243900|NCT04420689|589600461|FG003|Overall Study|COVID-19 related hospitalization|0|||
163243901|NCT04420689|589600462|FG004|Overall Study|COVID-19 related hospitalization|1|||
163243902|NCT04420689|589600463|FG005|Overall Study|COVID-19 related hospitalization|0|||
163243903|NCT04420689|589600464|FG006|Overall Study|COVID-19 related hospitalization|0|||
163243904|NCT04420689|589600458|FG000|Overall Study|Physician Decision|0|||
163243905|NCT04420689|589600459|FG001|Overall Study|Physician Decision|0|||
163243906|NCT04420689|589600460|FG002|Overall Study|Physician Decision|0|||
163243907|NCT04420689|589600461|FG003|Overall Study|Physician Decision|0|||
163243908|NCT04420689|589600462|FG004|Overall Study|Physician Decision|0|||
163243909|NCT04420689|589600463|FG005|Overall Study|Physician Decision|1|||
163243910|NCT04420689|589600464|FG006|Overall Study|Physician Decision|0|||
163243911|NCT03434119|589600465|FG000|Overall Study|Randomized but not treated|1|||
163243912|NCT03434119|589600466|FG001|Overall Study|Randomized but not treated|0|||
163243913|NCT03434119|589600465|FG000|Overall Study|Adverse Event|1|||
163243914|NCT03434119|589600466|FG001|Overall Study|Adverse Event|0|||
163243915|NCT03434119|589600465|FG000|Overall Study|Poor Compliance to Protocol|0|||
163243916|NCT03434119|589600466|FG001|Overall Study|Poor Compliance to Protocol|1|||
163243917|NCT03434119|589600465|FG000|Overall Study|Study Terminated by Sponsor|91|||
163243918|NCT03434119|589600466|FG001|Overall Study|Study Terminated by Sponsor|102|||
163243919|NCT03434119|589600465|FG000|Overall Study|Withdrawal by Subject|7|||
163351702|NCT00510146|589998162|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
163351703|NCT00510146|589998161|FG000|Double-Blind Treatment|Physician Decision|6|||
163351704|NCT00510146|589998162|FG001|Double-Blind Treatment|Physician Decision|0|||
163351705|NCT00510146|589998161|FG000|Double-Blind Treatment|Protocol Violation|1|||
163243920|NCT03434119|589600466|FG001|Overall Study|Withdrawal by Subject|5|||
163243921|NCT03434119|589600465|FG000|Overall Study|Other than specified|7|||
163243922|NCT03434119|589600466|FG001|Overall Study|Other than specified|5|||
163243923|NCT04360824|589600469|FG000|Overall Study|Withdrawal by Subject|2|||
163243924|NCT04360824|589600470|FG001|Overall Study|Withdrawal by Subject|1|||
163243925|NCT04360824|589600469|FG000|Overall Study|Did not receive assigned treatment|1|||
163351706|NCT00510146|589998162|FG001|Double-Blind Treatment|Protocol Violation|2|||
163351707|NCT00510146|589998161|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
163351708|NCT00510146|589998162|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
163243926|NCT04360824|589600470|FG001|Overall Study|Did not receive assigned treatment|3|||
163243927|NCT02278328|589600474|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
163243928|NCT02278328|589600475|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
163351709|NCT00510146|589998161|FG000|Double-Blind Treatment|Clinical Relapse|0|||
163351710|NCT00510146|589998162|FG001|Double-Blind Treatment|Clinical Relapse|1|||
163351711|NCT00510146|589998161|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
163351712|NCT00510146|589998162|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
163351713|NCT00510146|589998161|FG000|Open-Label Treatment|Adverse Event|22|||
163351714|NCT00510146|589998162|FG001|Open-Label Treatment|Adverse Event|8|||
163351715|NCT00510146|589998161|FG000|Open-Label Treatment|Death|1|||
163351716|NCT00510146|589998162|FG001|Open-Label Treatment|Death|1|||
163351717|NCT00510146|589998161|FG000|Open-Label Treatment|Lack of Efficacy|4|||
163351718|NCT00510146|589998162|FG001|Open-Label Treatment|Lack of Efficacy|0|||
163351719|NCT00510146|589998161|FG000|Open-Label Treatment|Lost to Follow-up|10|||
163351720|NCT00510146|589998162|FG001|Open-Label Treatment|Lost to Follow-up|1|||
163351721|NCT00510146|589998161|FG000|Open-Label Treatment|Physician Decision|3|||
163351722|NCT00510146|589998162|FG001|Open-Label Treatment|Physician Decision|1|||
163351723|NCT00510146|589998161|FG000|Open-Label Treatment|Protocol Violation|4|||
163351724|NCT00510146|589998162|FG001|Open-Label Treatment|Protocol Violation|2|||
163351725|NCT00510146|589998161|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
163351726|NCT00510146|589998162|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
163351727|NCT00510146|589998161|FG000|Open-Label Treatment|Clinical Relapse|1|||
163351728|NCT00510146|589998162|FG001|Open-Label Treatment|Clinical Relapse|1|||
163351729|NCT00510146|589998161|FG000|Open-Label Treatment|Sponsor Decision|2|||
163351730|NCT00510146|589998162|FG001|Open-Label Treatment|Sponsor Decision|0|||
163351731|NCT06080438|589998163|FG000|Overall Study|Lost to Follow-up|2|||
163351732|NCT00025662|589998164|FG000|Overall Study|Withdrawal by Subject|2|||
163351733|NCT00025662|589998164|FG000|Overall Study|Technical failure of manipulation|1|||
163351734|NCT03589300|589998165|FG000|Overall Study|Adverse Event|2|||
163351735|NCT03589300|589998165|FG000|Overall Study|Death|4|||
163351736|NCT03589300|589998165|FG000|Overall Study|Lost to Follow-up|12|||
163351737|NCT03589300|589998165|FG000|Overall Study|Withdrawal by Subject|5|||
163351738|NCT02161185|589998166|FG000|Treatment Phase|Administrative/Other|7|||
163351739|NCT01527500|589998168|FG000|Part A|Administrative|11|||
163351740|NCT01527500|589998169|FG001|Part A|Administrative|7|||
163351741|NCT01527500|589998168|FG000|Part A|Adverse Event|4|||
163351742|NCT01527500|589998169|FG001|Part A|Adverse Event|2|||
163351743|NCT01527500|589998168|FG000|Part A|Death|4|||
163351744|NCT01527500|589998169|FG001|Part A|Death|1|||
163351745|NCT01527500|589998168|FG000|Part A|Lost to Follow-up|0|||
163351746|NCT01527500|589998169|FG001|Part A|Lost to Follow-up|1|||
163351747|NCT01527500|589998168|FG000|Part A|Protocol Deviation|9|||
163351748|NCT01527500|589998169|FG001|Part A|Protocol Deviation|2|||
163351749|NCT01527500|589998168|FG000|Part A|Withdrawal by Subject|2|||
163351750|NCT01527500|589998169|FG001|Part A|Withdrawal by Subject|0|||
163351751|NCT01527500|589998168|FG000|Part B|Adverse Event|1|||
163351752|NCT01527500|589998169|FG001|Part B|Adverse Event|0|||
163351753|NCT02573883|589998170|FG000|Six Month Follow Up|Lost to Follow-up|1|||
163351754|NCT02573883|589998171|FG001|Six Month Follow Up|Lost to Follow-up|0|||
163351755|NCT02573883|589998172|FG002|Six Month Follow Up|Lost to Follow-up|0|||
163351756|NCT02573883|589998173|FG003|Six Month Follow Up|Lost to Follow-up|0|||
163351757|NCT02573883|589998170|FG000|One Year Follow Up|Lost to Follow-up|2|||
163351758|NCT02573883|589998171|FG001|One Year Follow Up|Lost to Follow-up|1|||
163351759|NCT02573883|589998172|FG002|One Year Follow Up|Lost to Follow-up|0|||
163351760|NCT02573883|589998173|FG003|One Year Follow Up|Lost to Follow-up|0|||
163351761|NCT00582114|589998174|FG000|Overall Study|Death|4|||
163351762|NCT00582114|589998175|FG001|Overall Study|Death|4|||
163351763|NCT00582114|589998174|FG000|Overall Study|Kidney Transplant|3|||
163351764|NCT00582114|589998175|FG001|Overall Study|Kidney Transplant|1|||
163351765|NCT00582114|589998174|FG000|Overall Study|Lost to Follow-up|7|||
163351766|NCT00582114|589998175|FG001|Overall Study|Lost to Follow-up|6|||
163351767|NCT00582114|589998174|FG000|Overall Study|Withdrawal by Subject|8|||
163351768|NCT00582114|589998175|FG001|Overall Study|Withdrawal by Subject|16|||
163351769|NCT00582114|589998174|FG000|Overall Study|Adverse Event|1|||
163351770|NCT00582114|589998175|FG001|Overall Study|Adverse Event|1|||
163351771|NCT00582114|589998174|FG000|Overall Study|Physician Decision|0|||
163351772|NCT00582114|589998175|FG001|Overall Study|Physician Decision|6|||
163351773|NCT00582114|589998174|FG000|Overall Study|Stopped by data safety monitoring board|19|||
163351774|NCT00582114|589998175|FG001|Overall Study|Stopped by data safety monitoring board|20|||
163351775|NCT00130728|589998183|FG000|Overall Study|Death|258|||
163351776|NCT00130728|589998184|FG001|Overall Study|Death|258|||
163351777|NCT00130728|589998183|FG000|Overall Study|Lost to Follow-up|4|||
163351778|NCT00130728|589998184|FG001|Overall Study|Lost to Follow-up|0|||
163351779|NCT00130728|589998183|FG000|Overall Study|Withdrawal by Subject|0|||
163351780|NCT00130728|589998184|FG001|Overall Study|Withdrawal by Subject|2|||
163351781|NCT00519285|589998191|FG000|Overall Study|Adverse Event|127|||
163351782|NCT00519285|589998192|FG001|Overall Study|Adverse Event|266|||
163351783|NCT00519285|589998191|FG000|Overall Study|Disease progression|334|||
163351784|NCT00519285|589998192|FG001|Overall Study|Disease progression|186|||
163351785|NCT00519285|589998191|FG000|Overall Study|Physician Decision|75|||
163148722|NCT01339689|589257335|FG001|Overall Study|multiple reasons|1|||
163351786|NCT00519285|589998192|FG001|Overall Study|Physician Decision|47|||
163243929|NCT02278328|589600476|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
163243930|NCT02278328|589600474|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
163243931|NCT02278328|589600475|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
163243932|NCT02278328|589600476|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
163243933|NCT02278328|589600474|FG000|Neuropsych Screening|incomplete consent|0|||
163243934|NCT02278328|589600475|FG001|Neuropsych Screening|incomplete consent|0|||
163243935|NCT02278328|589600476|FG002|Neuropsych Screening|incomplete consent|2|||
163243936|NCT00377676|589600477|FG000|Overall Study|Adverse Event|498|||
163243937|NCT00377676|589600478|FG001|Overall Study|Adverse Event|107|||
163243938|NCT00377676|589600477|FG000|Overall Study|Protocol Violation|33|||
163243939|NCT00377676|589600478|FG001|Overall Study|Protocol Violation|27|||
163243940|NCT00377676|589600477|FG000|Overall Study|Death|5|||
163243941|NCT00377676|589600478|FG001|Overall Study|Death|2|||
163243942|NCT00377676|589600477|FG000|Overall Study|Withdrawal by Subject|187|||
163243943|NCT00377676|589600478|FG001|Overall Study|Withdrawal by Subject|72|||
163243944|NCT00377676|589600477|FG000|Overall Study|Lost to Follow-up|120|||
163243945|NCT00377676|589600478|FG001|Overall Study|Lost to Follow-up|56|||
163243946|NCT00377676|589600477|FG000|Overall Study|Other|118|||
163243947|NCT00377676|589600478|FG001|Overall Study|Other|58|||
163243948|NCT03834779|589600484|FG000|Overall Study|Death|1|||
163243949|NCT03834779|589600485|FG001|Overall Study|Death|2|||
163243950|NCT03834779|589600484|FG000|Overall Study|Lost to Follow-up|6|||
163243951|NCT03834779|589600485|FG001|Overall Study|Lost to Follow-up|4|||
163243952|NCT03579459|589600486|FG000|Overall Study|Adverse Event|7|||
163243953|NCT03579459|589600487|FG001|Overall Study|Adverse Event|6|||
163243954|NCT03579459|589600488|FG002|Overall Study|Adverse Event|2|||
163243955|NCT03579459|589600489|FG003|Overall Study|Adverse Event|6|||
163243956|NCT03579459|589600486|FG000|Overall Study|Death|1|||
163243957|NCT03579459|589600487|FG001|Overall Study|Death|0|||
163243958|NCT03579459|589600488|FG002|Overall Study|Death|1|||
163243959|NCT03579459|589600489|FG003|Overall Study|Death|2|||
163243960|NCT03579459|589600486|FG000|Overall Study|Lost to Follow-up|6|||
163243961|NCT03579459|589600487|FG001|Overall Study|Lost to Follow-up|2|||
163243962|NCT03579459|589600488|FG002|Overall Study|Lost to Follow-up|4|||
163243963|NCT03579459|589600489|FG003|Overall Study|Lost to Follow-up|1|||
163243964|NCT03579459|589600486|FG000|Overall Study|Physician Decision|0|||
163243965|NCT03579459|589600487|FG001|Overall Study|Physician Decision|1|||
163243966|NCT03579459|589600488|FG002|Overall Study|Physician Decision|0|||
163243967|NCT03579459|589600489|FG003|Overall Study|Physician Decision|1|||
163243968|NCT03579459|589600486|FG000|Overall Study|Protocol Violation|1|||
163243969|NCT03579459|589600487|FG001|Overall Study|Protocol Violation|2|||
163243970|NCT03579459|589600488|FG002|Overall Study|Protocol Violation|3|||
163243971|NCT03579459|589600489|FG003|Overall Study|Protocol Violation|5|||
163243972|NCT03579459|589600486|FG000|Overall Study|Withdrawal by Subject|12|||
163243973|NCT03579459|589600487|FG001|Overall Study|Withdrawal by Subject|8|||
163243974|NCT03579459|589600488|FG002|Overall Study|Withdrawal by Subject|11|||
163243975|NCT03579459|589600489|FG003|Overall Study|Withdrawal by Subject|8|||
163243976|NCT03579459|589600486|FG000|Overall Study|Medication error without associated adverse event|2|||
163243977|NCT03579459|589600487|FG001|Overall Study|Medication error without associated adverse event|1|||
163243978|NCT03579459|589600488|FG002|Overall Study|Medication error without associated adverse event|1|||
163243979|NCT03579459|589600489|FG003|Overall Study|Medication error without associated adverse event|0|||
163243980|NCT03579459|589600486|FG000|Overall Study|Other|0|||
163243981|NCT03579459|589600487|FG001|Overall Study|Other|1|||
163243982|NCT03579459|589600488|FG002|Overall Study|Other|1|||
163243983|NCT03579459|589600489|FG003|Overall Study|Other|0|||
163243984|NCT03579459|589600486|FG000|Overall Study|Randomized not vaccinated|0|||
163243985|NCT03579459|589600487|FG001|Overall Study|Randomized not vaccinated|2|||
163243986|NCT03579459|589600488|FG002|Overall Study|Randomized not vaccinated|0|||
163243987|NCT03579459|589600489|FG003|Overall Study|Randomized not vaccinated|1|||
163243988|NCT02528214|589600490|FG000|Overall Study|Protocol Violation|0|||
163243989|NCT02528214|589600491|FG001|Overall Study|Protocol Violation|1|||
163243990|NCT02528214|589600490|FG000|Overall Study|Adverse Event|0|||
163351787|NCT00519285|589998191|FG000|Overall Study|Participant's request|53|||
163351788|NCT00519285|589998192|FG001|Overall Study|Participant's request|84|||
163351789|NCT00519285|589998191|FG000|Overall Study|Consent withdrawn|4|||
163351790|NCT00519285|589998192|FG001|Overall Study|Consent withdrawn|5|||
163351791|NCT00519285|589998191|FG000|Overall Study|Poor compliance to protocol|5|||
163243991|NCT02528214|589600491|FG001|Overall Study|Adverse Event|1|||
163243992|NCT02528214|589600490|FG000|Overall Study|Other than specified above|0|||
163243993|NCT02528214|589600491|FG001|Overall Study|Other than specified above|1|||
163243994|NCT00407537|589600492|FG000|Overall Study|Death|5|||
163351792|NCT00519285|589998192|FG001|Overall Study|Poor compliance to protocol|7|||
163351793|NCT00519285|589998191|FG000|Overall Study|Reason unspecified|5|||
163243995|NCT00407537|589600493|FG001|Overall Study|Death|2|||
163243996|NCT00407537|589600492|FG000|Overall Study|Adverse Event|36|||
163243997|NCT00407537|589600493|FG001|Overall Study|Adverse Event|0|||
163243998|NCT00407537|589600492|FG000|Overall Study|Lost to Follow-up|12|||
163243999|NCT00407537|589600493|FG001|Overall Study|Lost to Follow-up|19|||
163244000|NCT00407537|589600492|FG000|Overall Study|Other|6|||
163410134|NCT02064387|590211272|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163410135|NCT02064387|590211273|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163410136|NCT02064387|590211274|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163410137|NCT02064387|590211275|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163410138|NCT02064387|590211276|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163410139|NCT02064387|590211277|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163410140|NCT02064387|590211278|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163410141|NCT02064387|590211279|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
163410142|NCT02064387|590211280|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163410143|NCT02064387|590211281|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163410144|NCT02064387|590211282|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163410145|NCT02064387|590211283|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163410146|NCT02064387|590211272|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163410147|NCT02064387|590211273|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163410148|NCT02064387|590211274|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163410149|NCT02064387|590211275|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163410150|NCT02064387|590211276|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163410151|NCT02064387|590211277|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163410152|NCT02064387|590211278|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163410153|NCT02064387|590211279|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163410154|NCT02064387|590211280|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
163148723|NCT01469221|589257336|FG000|Double Blind Phase|Protocol Violation|1|||
163351794|NCT00519285|589998192|FG001|Overall Study|Reason unspecified|8|||
163351795|NCT00519285|589998191|FG000|Overall Study|Not treated|8|||
163351796|NCT00519285|589998192|FG001|Overall Study|Not treated|7|||
163351797|NCT00519285|589998191|FG000|Overall Study|Treatment ongoing|1|||
163351798|NCT00519285|589998192|FG001|Overall Study|Treatment ongoing|2|||
163351799|NCT02970305|589998193|FG000|Overall Study|Adverse Event|10|||
163351800|NCT02970305|589998194|FG001|Overall Study|Adverse Event|6|||
163351801|NCT02970305|589998193|FG000|Overall Study|Lack of Efficacy|1|||
163351802|NCT02970305|589998194|FG001|Overall Study|Lack of Efficacy|1|||
163351803|NCT02970305|589998193|FG000|Overall Study|Noncompliance with study drug|2|||
163351804|NCT02970305|589998194|FG001|Overall Study|Noncompliance with study drug|4|||
163351805|NCT02970305|589998193|FG000|Overall Study|Protocol Violation|2|||
163351806|NCT02970305|589998194|FG001|Overall Study|Protocol Violation|2|||
163410155|NCT02064387|590211281|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163410156|NCT02064387|590211282|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163148724|NCT01469221|589257337|FG001|Double Blind Phase|Protocol Violation|0|||
163148725|NCT01469221|589257338|FG002|Double Blind Phase|Protocol Violation|0|||
163148726|NCT01469221|589257336|FG000|Double Blind Phase|Physician Decision|1|||
163148727|NCT01469221|589257337|FG001|Double Blind Phase|Physician Decision|1|||
163148728|NCT01469221|589257338|FG002|Double Blind Phase|Physician Decision|0|||
163148729|NCT01469221|589257336|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
163148730|NCT01469221|589257337|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
163148731|NCT01469221|589257338|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
163148732|NCT05121766|589257346|FG000|Overall Study|Covid reinfection|3|||
163148733|NCT05121766|589257347|FG001|Overall Study|Covid reinfection|0|||
163148734|NCT05121766|589257346|FG000|Overall Study|Withdrawal by Subject|3|||
163148735|NCT05121766|589257347|FG001|Overall Study|Withdrawal by Subject|1|||
163148736|NCT05121766|589257346|FG000|Overall Study|Adverse Event|2|||
163148737|NCT05121766|589257347|FG001|Overall Study|Adverse Event|4|||
163148738|NCT05121766|589257346|FG000|Overall Study|Lost to Follow-up|0|||
163148739|NCT05121766|589257347|FG001|Overall Study|Lost to Follow-up|1|||
163148740|NCT01632020|589257348|FG000|Overall Study|Withdrawal by Subject|1|||
163148741|NCT01632020|589257349|FG001|Overall Study|Withdrawal by Subject|0|||
163148742|NCT01632020|589257348|FG000|Overall Study|Adverse Event|1|||
163148743|NCT01632020|589257349|FG001|Overall Study|Adverse Event|0|||
163148744|NCT00528957|589257350|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
163148745|NCT00528957|589257351|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
163148746|NCT00528957|589257350|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
163148747|NCT00528957|589257351|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
163148748|NCT00528957|589257350|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
163148749|NCT00528957|589257351|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
163148750|NCT00528957|589257350|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
163148751|NCT00528957|589257351|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
163148752|NCT00528957|589257350|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
163148753|NCT00528957|589257351|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
163351807|NCT02970305|589998193|FG000|Overall Study|Withdrawal by Subject|12|||
163351808|NCT02970305|589998194|FG001|Overall Study|Withdrawal by Subject|11|||
163351809|NCT02970305|589998193|FG000|Overall Study|Not further specified|1|||
163351810|NCT02970305|589998194|FG001|Overall Study|Not further specified|2|||
163351811|NCT02970305|589998193|FG000|Overall Study|Lost to Follow-up|1|||
163351812|NCT02970305|589998194|FG001|Overall Study|Lost to Follow-up|2|||
163351813|NCT02175745|589998195|FG000|Overall Study|Not Eligible|1|||
163351814|NCT00808899|589998197|FG000|Overall Study|Death|1|||
163351815|NCT00808899|589998197|FG000|Overall Study|Physician Decision|3|||
163351816|NCT04088500|589998198|FG000|Overall Study|Reason unknown|1|||
163351817|NCT04088500|589998198|FG000|Overall Study|Participant withdrew consent|1|||
163351818|NCT04088500|589998198|FG000|Overall Study|Disease progression|3|||
163351819|NCT02212197|589998199|FG000|Overall Study|Need for radiotherapy|1|||
163351820|NCT02212197|589998200|FG001|Overall Study|Need for radiotherapy|0|||
163351821|NCT02212197|589998201|FG002|Overall Study|Need for radiotherapy|0|||
163351822|NCT01078584|589998202|FG000|Overall Study|Final Status Unknown|1073|||
163244001|NCT00407537|589600493|FG001|Overall Study|Other|7|||
163244002|NCT00407537|589600492|FG000|Overall Study|Withdrawal by Subject|34|||
163244003|NCT00407537|589600493|FG001|Overall Study|Withdrawal by Subject|16|||
163244004|NCT03593655|589600495|FG000|First Product Use Period|Withdrawal by Subject|1|||
163244005|NCT03593655|589600496|FG001|First Product Use Period|Withdrawal by Subject|1|||
163244006|NCT03593655|589600495|FG000|First Product Use Period|Lost to Follow-up|1|||
163244007|NCT03593655|589600496|FG001|First Product Use Period|Lost to Follow-up|3|||
163244008|NCT03593655|589600495|FG000|Second Product Use Period|Withdrawal by Subject|1|||
163244009|NCT03593655|589600496|FG001|Second Product Use Period|Withdrawal by Subject|1|||
163244010|NCT03593655|589600495|FG000|Second Product Use Period|Lost to Follow-up|1|||
163244011|NCT03593655|589600496|FG001|Second Product Use Period|Lost to Follow-up|0|||
163244012|NCT03593655|589600495|FG000|Third Product Use Period|Lost to Follow-up|1|||
163244013|NCT03593655|589600496|FG001|Third Product Use Period|Lost to Follow-up|2|||
163244014|NCT03593655|589600495|FG000|Third Product Use Period|Physician Decision|0|||
163244015|NCT03593655|589600496|FG001|Third Product Use Period|Physician Decision|1|||
163244016|NCT03593655|589600495|FG000|Third Product Use Period|Withdrawal by Subject|0|||
163244017|NCT03593655|589600496|FG001|Third Product Use Period|Withdrawal by Subject|1|||
163244018|NCT01090453|589600498|FG000|Overall Study|Withdrawal by Subject|1|||
163244019|NCT01090453|589600499|FG001|Overall Study|Withdrawal by Subject|2|||
163244020|NCT01090453|589600498|FG000|Overall Study|Lost to Follow-up|7|||
163244021|NCT01090453|589600499|FG001|Overall Study|Lost to Follow-up|7|||
163244022|NCT01090453|589600498|FG000|Overall Study|Non serious AEs|1|||
163244023|NCT01090453|589600499|FG001|Overall Study|Non serious AEs|0|||
163244024|NCT01090453|589600498|FG000|Overall Study|Protocol Violation|2|||
163244025|NCT01090453|589600499|FG001|Overall Study|Protocol Violation|0|||
163244026|NCT01090453|589600498|FG000|Overall Study|Other|2|||
163244027|NCT01090453|589600499|FG001|Overall Study|Other|4|||
163244028|NCT01090453|589600498|FG000|Overall Study|Eligibility Criteria|0|||
163244029|NCT01090453|589600499|FG001|Overall Study|Eligibility Criteria|1|||
163244030|NCT00142909|589600505|FG000|Randomization|Various Reasons|7|||
163244031|NCT00142909|589600506|FG001|Randomization|Various Reasons|10|||
163244032|NCT00142909|589600505|FG000|Medications Begin|Protocol Violation|2|||
163244033|NCT00142909|589600506|FG001|Medications Begin|Protocol Violation|0|||
163244034|NCT00142909|589600505|FG000|Medications Begin|Withdrawal by Subject|5|||
163244035|NCT00142909|589600506|FG001|Medications Begin|Withdrawal by Subject|3|||
163244036|NCT00142909|589600505|FG000|Medications Begin|Withdrawal by Subject|2|||
163244037|NCT00142909|589600506|FG001|Medications Begin|Withdrawal by Subject|0|||
163244038|NCT01660763|589600510|FG000|Overall Study|Lack of Efficacy|45|||
163244039|NCT01660763|589600511|FG001|Overall Study|Lack of Efficacy|50|||
163244040|NCT01660763|589600510|FG000|Overall Study|Adverse Event|22|||
163244041|NCT01660763|589600511|FG001|Overall Study|Adverse Event|7|||
163244042|NCT01660763|589600510|FG000|Overall Study|Protocol Violation|1|||
163244043|NCT01660763|589600511|FG001|Overall Study|Protocol Violation|0|||
163244044|NCT01660763|589600510|FG000|Overall Study|Withdrawal by Subject|4|||
163244045|NCT01660763|589600511|FG001|Overall Study|Withdrawal by Subject|0|||
163244046|NCT01660763|589600510|FG000|Overall Study|Patient ready for early discharge|28|||
163244047|NCT01660763|589600511|FG001|Overall Study|Patient ready for early discharge|4|||
163244048|NCT01870843|589600512|FG000|Overall Study|Adverse Event|10|||
163244049|NCT01870843|589600512|FG000|Overall Study|Lost to Follow-up|24|||
163244050|NCT01870843|589600512|FG000|Overall Study|Death|1|||
163244051|NCT01870843|589600512|FG000|Overall Study|Withdrawal by Subject|18|||
163244052|NCT00345397|589600513|FG000|Overall Study|Death|1|||
163244053|NCT01365494|589600517|FG000|Overall Study|Adverse Event|1|||
163244054|NCT01365494|589600518|FG001|Overall Study|Adverse Event|0|||
163244055|NCT01365494|589600517|FG000|Overall Study|Withdrawal by Subject|0|||
163244056|NCT01365494|589600518|FG001|Overall Study|Withdrawal by Subject|1|||
163244057|NCT01365494|589600517|FG000|Overall Study|Lost to Follow-up|1|||
163244058|NCT01365494|589600518|FG001|Overall Study|Lost to Follow-up|2|||
163244059|NCT03021187|589600519|FG000|Overall Study|Death|0|||
163244060|NCT03021187|589600520|FG001|Overall Study|Death|0|||
163244061|NCT03021187|589600521|FG002|Overall Study|Death|3|||
163351823|NCT01078584|589998202|FG000|Overall Study|Lost to Follow-up|670|||
163351824|NCT01078584|589998202|FG000|Overall Study|Non-serious Adverse Event|577|||
163410157|NCT02064387|590211283|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163410158|NCT02064387|590211272|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
163410159|NCT02064387|590211273|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
163148754|NCT00528957|589257350|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
163244062|NCT03021187|589600522|FG003|Overall Study|Death|0|||
163244063|NCT03021187|589600519|FG000|Overall Study|Withdrawal by Subject|0|||
163244064|NCT03021187|589600520|FG001|Overall Study|Withdrawal by Subject|6|||
163244065|NCT03021187|589600521|FG002|Overall Study|Withdrawal by Subject|2|||
163244066|NCT03021187|589600522|FG003|Overall Study|Withdrawal by Subject|5|||
163244067|NCT03021187|589600519|FG000|Overall Study|Lost to Follow-up|10|||
163244068|NCT03021187|589600520|FG001|Overall Study|Lost to Follow-up|3|||
163244069|NCT03021187|589600521|FG002|Overall Study|Lost to Follow-up|1|||
163244070|NCT03021187|589600522|FG003|Overall Study|Lost to Follow-up|4|||
163244071|NCT03351049|589600523|FG000|Overall Study|Withdrawal|26|||
163244072|NCT03351049|589600524|FG001|Overall Study|Withdrawal|22|||
163244073|NCT00718718|589600525|FG000|Prior to Week 12|Adverse Event|0|||
163244074|NCT00718718|589600526|FG001|Prior to Week 12|Adverse Event|0|||
163244075|NCT00718718|589600527|FG002|Prior to Week 12|Adverse Event|0|||
163244076|NCT00718718|589600528|FG003|Prior to Week 12|Adverse Event|0|||
163244077|NCT00718718|589600529|FG004|Prior to Week 12|Adverse Event|0|||
163244078|NCT00718718|589600530|FG005|Prior to Week 12|Adverse Event|0|||
163244079|NCT00718718|589600531|FG006|Prior to Week 12|Adverse Event|0|||
163244080|NCT00718718|589600532|FG007|Prior to Week 12|Adverse Event|1|||
163244081|NCT00718718|589600533|FG008|Prior to Week 12|Adverse Event|1|||
163244082|NCT00718718|589600534|FG009|Prior to Week 12|Adverse Event|0|||
163244083|NCT00718718|589600525|FG000|Prior to Week 12|Withdrawal by Subject|0|||
163244084|NCT00718718|589600526|FG001|Prior to Week 12|Withdrawal by Subject|0|||
163244085|NCT00718718|589600527|FG002|Prior to Week 12|Withdrawal by Subject|0|||
163244086|NCT00718718|589600528|FG003|Prior to Week 12|Withdrawal by Subject|0|||
163244087|NCT00718718|589600529|FG004|Prior to Week 12|Withdrawal by Subject|3|||
163244088|NCT00718718|589600530|FG005|Prior to Week 12|Withdrawal by Subject|0|||
163244089|NCT00718718|589600531|FG006|Prior to Week 12|Withdrawal by Subject|1|||
163244090|NCT00718718|589600532|FG007|Prior to Week 12|Withdrawal by Subject|1|||
163244091|NCT00718718|589600533|FG008|Prior to Week 12|Withdrawal by Subject|1|||
163244092|NCT00718718|589600534|FG009|Prior to Week 12|Withdrawal by Subject|0|||
163244093|NCT00718718|589600525|FG000|Prior to Week 12|Other|1|||
163244094|NCT00718718|589600526|FG001|Prior to Week 12|Other|0|||
163244095|NCT00718718|589600527|FG002|Prior to Week 12|Other|1|||
163244096|NCT00718718|589600528|FG003|Prior to Week 12|Other|0|||
163244097|NCT00718718|589600529|FG004|Prior to Week 12|Other|0|||
163244098|NCT00718718|589600530|FG005|Prior to Week 12|Other|0|||
163244099|NCT00718718|589600531|FG006|Prior to Week 12|Other|0|||
163244100|NCT00718718|589600532|FG007|Prior to Week 12|Other|0|||
163244101|NCT00718718|589600533|FG008|Prior to Week 12|Other|0|||
163244102|NCT00718718|589600534|FG009|Prior to Week 12|Other|0|||
163244103|NCT00718718|589600525|FG000|Week 12 to End of Study|Adverse Event|0|||
163244104|NCT00718718|589600526|FG001|Week 12 to End of Study|Adverse Event|0|||
163244105|NCT00718718|589600527|FG002|Week 12 to End of Study|Adverse Event|0|||
163244106|NCT00718718|589600528|FG003|Week 12 to End of Study|Adverse Event|0|||
163244107|NCT00718718|589600529|FG004|Week 12 to End of Study|Adverse Event|0|||
163244108|NCT00718718|589600530|FG005|Week 12 to End of Study|Adverse Event|0|||
163244109|NCT00718718|589600531|FG006|Week 12 to End of Study|Adverse Event|0|||
163244110|NCT00718718|589600532|FG007|Week 12 to End of Study|Adverse Event|1|||
163244111|NCT00718718|589600533|FG008|Week 12 to End of Study|Adverse Event|0|||
163244112|NCT00718718|589600534|FG009|Week 12 to End of Study|Adverse Event|0|||
163244113|NCT00718718|589600525|FG000|Week 12 to End of Study|Death|0|||
163244114|NCT00718718|589600526|FG001|Week 12 to End of Study|Death|0|||
163244115|NCT00718718|589600527|FG002|Week 12 to End of Study|Death|0|||
163244116|NCT00718718|589600528|FG003|Week 12 to End of Study|Death|0|||
163244117|NCT00718718|589600529|FG004|Week 12 to End of Study|Death|0|||
163244118|NCT00718718|589600530|FG005|Week 12 to End of Study|Death|1|||
163244119|NCT00718718|589600531|FG006|Week 12 to End of Study|Death|0|||
163244120|NCT00718718|589600532|FG007|Week 12 to End of Study|Death|0|||
163244121|NCT00718718|589600533|FG008|Week 12 to End of Study|Death|0|||
163244122|NCT00718718|589600534|FG009|Week 12 to End of Study|Death|0|||
163244123|NCT00718718|589600525|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
163244124|NCT00718718|589600526|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
163244125|NCT00718718|589600527|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
163244126|NCT00718718|589600528|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
163244127|NCT00718718|589600529|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
163244128|NCT00718718|589600530|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
163244129|NCT00718718|589600531|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
163244130|NCT00718718|589600532|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
163244131|NCT00718718|589600533|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
163244132|NCT00718718|589600534|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
163351825|NCT01078584|589998202|FG000|Overall Study|Withdrawal of Consent|244|||
163351826|NCT01078584|589998202|FG000|Overall Study|Physician Withdrew from Study|90|||
163351827|NCT01078584|589998202|FG000|Overall Study|Non-compliance|67|||
163351828|NCT01078584|589998202|FG000|Overall Study|Blood Pressure Controlled|49|||
163351829|NCT01078584|589998202|FG000|Overall Study|Physician Switched Medication|26|||
163351830|NCT01078584|589998202|FG000|Overall Study|Physician Discontinued Patient|12|||
163351831|NCT01078584|589998202|FG000|Overall Study|Lack of Efficacy|98|||
163351832|NCT01078584|589998202|FG000|Overall Study|Protocol Violation|75|||
163351833|NCT01078584|589998202|FG000|Overall Study|Serious Adverse Event|27|||
163351834|NCT01078584|589998202|FG000|Overall Study|Multiple Reasons|2|||
163351835|NCT01208870|589998205|FG000|Overall Study|Lost to Follow-up|2|||
163351836|NCT01208870|589998206|FG001|Overall Study|Lost to Follow-up|8|||
163351837|NCT02979613|589998207|FG000|Double-Blind Phase|Withdrew Consent|2|||
163351838|NCT02979613|589998208|FG001|Double-Blind Phase|Withdrew Consent|4|||
163351839|NCT02979613|589998207|FG000|Double-Blind Phase|Pregnancy|2|||
163351840|NCT02979613|589998208|FG001|Double-Blind Phase|Pregnancy|2|||
163351841|NCT02979613|589998207|FG000|Double-Blind Phase|Adverse Event|2|||
163351842|NCT02979613|589998208|FG001|Double-Blind Phase|Adverse Event|0|||
163351843|NCT02979613|589998207|FG000|Double-Blind Phase|Lost to Follow-up|1|||
163351844|NCT02979613|589998208|FG001|Double-Blind Phase|Lost to Follow-up|1|||
163351845|NCT02979613|589998207|FG000|Double-Blind Phase|Protocol Violation|1|||
163351846|NCT02979613|589998208|FG001|Double-Blind Phase|Protocol Violation|1|||
163351847|NCT02979613|589998207|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
163351848|NCT02979613|589998208|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
163351849|NCT02979613|589998207|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
163351850|NCT02979613|589998208|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
163351851|NCT02979613|589998207|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
163351852|NCT02979613|589998208|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
163351853|NCT02979613|589998207|FG000|Open-Label Extension (OLE) Phase|Death|0|||
163351854|NCT02979613|589998208|FG001|Open-Label Extension (OLE) Phase|Death|1|||
163351855|NCT02979613|589998207|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
163351856|NCT02979613|589998208|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
163351857|NCT00919061|589998211|FG000|Overall Study|Adverse Event|1|||
163244133|NCT00718718|589600525|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
163244134|NCT00718718|589600526|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
163244135|NCT00718718|589600527|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
163244136|NCT00718718|589600528|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
163244137|NCT00718718|589600529|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
163244138|NCT00718718|589600530|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
163244139|NCT00718718|589600531|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
163244140|NCT00718718|589600532|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
163244141|NCT00718718|589600533|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
163244142|NCT00718718|589600534|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
163244143|NCT00718718|589600525|FG000|Week 12 to End of Study|Other|0|||
163244144|NCT00718718|589600526|FG001|Week 12 to End of Study|Other|1|||
163244145|NCT00718718|589600527|FG002|Week 12 to End of Study|Other|0|||
163244146|NCT00718718|589600528|FG003|Week 12 to End of Study|Other|1|||
163244147|NCT00718718|589600529|FG004|Week 12 to End of Study|Other|0|||
163244148|NCT00718718|589600530|FG005|Week 12 to End of Study|Other|0|||
163244149|NCT00718718|589600531|FG006|Week 12 to End of Study|Other|1|||
163244150|NCT00718718|589600532|FG007|Week 12 to End of Study|Other|0|||
163244151|NCT00718718|589600533|FG008|Week 12 to End of Study|Other|0|||
163244152|NCT00718718|589600534|FG009|Week 12 to End of Study|Other|0|||
163244153|NCT03099382|589600535|FG000|Overall Study|Protocol Violation|2|||
163244154|NCT03099382|589600536|FG001|Overall Study|Protocol Violation|3|||
163244155|NCT01802411|589600539|FG000|Overall Study|Death|2|||
163351858|NCT00919061|589998211|FG000|Overall Study|Withdrawal by Subject|1|||
163351859|NCT05294328|589998212|FG000|Overall Study|Adverse Event|1|||
163351860|NCT05294328|589998213|FG001|Overall Study|Adverse Event|0|||
163351861|NCT05294328|589998214|FG002|Overall Study|Adverse Event|0|||
163351862|NCT05294328|589998212|FG000|Overall Study|Physician Decision|1|||
163351863|NCT05294328|589998213|FG001|Overall Study|Physician Decision|1|||
163244156|NCT01802411|589600540|FG001|Overall Study|Death|1|||
163244157|NCT01802411|589600539|FG000|Overall Study|Adverse Event|2|||
163244158|NCT01802411|589600540|FG001|Overall Study|Adverse Event|7|||
163351864|NCT05294328|589998214|FG002|Overall Study|Physician Decision|0|||
163351865|NCT05294328|589998212|FG000|Overall Study|Withdrawal by Subject|0|||
163351866|NCT05294328|589998213|FG001|Overall Study|Withdrawal by Subject|2|||
163351867|NCT05294328|589998214|FG002|Overall Study|Withdrawal by Subject|1|||
163244159|NCT01802411|589600539|FG000|Overall Study|Lack of Efficacy|8|||
163244160|NCT01802411|589600540|FG001|Overall Study|Lack of Efficacy|10|||
163244161|NCT01802411|589600539|FG000|Overall Study|Withdrawal by Subject|0|||
163351868|NCT05294328|589998212|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
163351869|NCT05294328|589998213|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
163351870|NCT05294328|589998214|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
163351871|NCT02056873|589998215|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
163244162|NCT01802411|589600540|FG001|Overall Study|Withdrawal by Subject|2|||
163244163|NCT01802411|589600539|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
163244164|NCT01802411|589600540|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
163244165|NCT01802411|589600539|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
163244166|NCT01802411|589600540|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
163244167|NCT01802411|589600539|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
163244168|NCT01802411|589600540|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
163244169|NCT03930745|589600546|FG000|Overall Study|Lost to Follow-up|10|||
163244170|NCT03930745|589600547|FG001|Overall Study|Lost to Follow-up|5|||
163244171|NCT03930745|589600546|FG000|Overall Study|Withdrawal by Subject|1|||
163244172|NCT03930745|589600547|FG001|Overall Study|Withdrawal by Subject|2|||
163244173|NCT03930745|589600546|FG000|Overall Study|Protocol Violation|2|||
163244174|NCT03930745|589600547|FG001|Overall Study|Protocol Violation|2|||
163244175|NCT03930745|589600546|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
163244176|NCT03930745|589600547|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
163244177|NCT03930745|589600546|FG000|Overall Study|Adverse Event|0|||
163244178|NCT03930745|589600547|FG001|Overall Study|Adverse Event|1|||
163244179|NCT03930745|589600546|FG000|Overall Study|Pregnancy|0|||
163244180|NCT03930745|589600547|FG001|Overall Study|Pregnancy|1|||
163244181|NCT02715765|589600550|FG000|Overall Study|Study Termination|3|||
163244182|NCT02715765|589600551|FG001|Overall Study|Study Termination|0|||
163244183|NCT02715765|589600552|FG002|Overall Study|Study Termination|0|||
163244184|NCT03588572|589600553|FG000|Visitation 1|Lack of Efficacy|1|||
163244185|NCT03588572|589600554|FG001|Visitation 1|Lack of Efficacy|1|||
163244186|NCT03588572|589600553|FG000|Visitation 2|Lost to Follow-up|1|||
163244187|NCT03588572|589600554|FG001|Visitation 2|Lost to Follow-up|1|||
163244188|NCT03588572|589600553|FG000|Visitation 2|Lack of Efficacy|0|||
163244189|NCT03588572|589600554|FG001|Visitation 2|Lack of Efficacy|1|||
163244190|NCT03588572|589600553|FG000|Visitation 2|Withdrawal by Subject|1|||
163244191|NCT03588572|589600554|FG001|Visitation 2|Withdrawal by Subject|0|||
163244192|NCT03588572|589600553|FG000|Visitation 3|Lost to Follow-up|1|||
163244193|NCT03588572|589600554|FG001|Visitation 3|Lost to Follow-up|1|||
163244194|NCT03588572|589600553|FG000|Visitation 3|Physician Decision|1|||
163244195|NCT03588572|589600554|FG001|Visitation 3|Physician Decision|1|||
163244196|NCT03588572|589600553|FG000|Visitation 3|Withdrawal by Subject|1|||
163244197|NCT03588572|589600554|FG001|Visitation 3|Withdrawal by Subject|0|||
163244198|NCT01165281|589600560|FG000|Overall Study|Adverse Event|12|||
163244199|NCT01165281|589600561|FG001|Overall Study|Adverse Event|14|||
163244200|NCT01165281|589600560|FG000|Overall Study|Death|3|||
163244201|NCT01165281|589600561|FG001|Overall Study|Death|4|||
163244202|NCT01165281|589600560|FG000|Overall Study|Lack of Efficacy|4|||
163244203|NCT01165281|589600561|FG001|Overall Study|Lack of Efficacy|1|||
163244204|NCT01165281|589600560|FG000|Overall Study|Lost to Follow-up|0|||
163244205|NCT01165281|589600561|FG001|Overall Study|Lost to Follow-up|1|||
163244206|NCT01165281|589600560|FG000|Overall Study|Physician Decision|8|||
163244207|NCT01165281|589600561|FG001|Overall Study|Physician Decision|1|||
163244208|NCT01165281|589600560|FG000|Overall Study|Protocol Violation|6|||
163244209|NCT01165281|589600561|FG001|Overall Study|Protocol Violation|5|||
163244210|NCT01165281|589600560|FG000|Overall Study|Withdrawal by Subject|8|||
163244211|NCT01165281|589600561|FG001|Overall Study|Withdrawal by Subject|7|||
163244212|NCT01165281|589600560|FG000|Overall Study|Noncompliance with Study Drug|1|||
163244213|NCT01165281|589600561|FG001|Overall Study|Noncompliance with Study Drug|4|||
163244214|NCT01165281|589600560|FG000|Overall Study|Progressive Disease|10|||
163244215|NCT01165281|589600561|FG001|Overall Study|Progressive Disease|14|||
163244216|NCT01165281|589600560|FG000|Overall Study|Other|6|||
163244217|NCT01165281|589600561|FG001|Overall Study|Other|0|||
163244218|NCT03277313|589600564|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
163244219|NCT03277313|589600565|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
163244220|NCT03277313|589600564|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
163244221|NCT03277313|589600565|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
163244222|NCT03277313|589600564|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
163244223|NCT03277313|589600565|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
163244224|NCT03277313|589600564|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
163244225|NCT03277313|589600565|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
163244226|NCT03277313|589600564|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
163244227|NCT03277313|589600565|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
163244228|NCT02863991|589600566|FG000|Overall Study|Death|0|||
163244229|NCT02863991|589600567|FG001|Overall Study|Death|3|||
163351872|NCT01181609|590000281|FG000|Overall Study|Adverse Event|1|||
163244230|NCT02863991|589600566|FG000|Overall Study|Lack of Efficacy|0|||
163244231|NCT02863991|589600567|FG001|Overall Study|Lack of Efficacy|1|||
163351873|NCT01181609|590000281|FG000|Overall Study|Withdrawal by Subject|1|||
163351874|NCT01181609|590000281|FG000|Overall Study|Lost to Follow-up|1|||
163244232|NCT02863991|589600566|FG000|Overall Study|Study Terminated|2|||
163244233|NCT02863991|589600567|FG001|Overall Study|Study Terminated|8|||
163244234|NCT00364858|589600568|FG000|Overall Study|Adverse Event|1|||
163244235|NCT00364858|589600569|FG001|Overall Study|Adverse Event|5|||
163244236|NCT00364858|589600568|FG000|Overall Study|Withdrawal by Subject|1|||
163244237|NCT00364858|589600569|FG001|Overall Study|Withdrawal by Subject|1|||
163244238|NCT00364858|589600568|FG000|Overall Study|Pregnancy|1|||
163244239|NCT00364858|589600569|FG001|Overall Study|Pregnancy|1|||
163244240|NCT00364858|589600568|FG000|Overall Study|Clinical failure|2|||
163244241|NCT00364858|589600569|FG001|Overall Study|Clinical failure|13|||
163244242|NCT00364858|589600568|FG000|Overall Study|Discontinuation at baseline|1|||
163244243|NCT00364858|589600569|FG001|Overall Study|Discontinuation at baseline|0|||
163244244|NCT00364858|589600568|FG000|Overall Study|Non-compliant|1|||
163244245|NCT00364858|589600569|FG001|Overall Study|Non-compliant|0|||
163244246|NCT00364858|589600568|FG000|Overall Study|Return to Q2 regimen|0|||
163244247|NCT00364858|589600569|FG001|Overall Study|Return to Q2 regimen|1|||
163244248|NCT00364858|589600568|FG000|Overall Study|Clinical baseline issue|0|||
163351875|NCT01181609|590000281|FG000|Overall Study|Death|50|||
163351876|NCT03991988|590000285|FG000|Overall Study|Withdrawal by Subject|2|||
163351877|NCT03991988|590000286|FG001|Overall Study|Withdrawal by Subject|2|||
163351878|NCT01751165|590000291|FG000|Overall Study|Adverse event, serious fatal|1|||
163351879|NCT01751165|590000292|FG001|Overall Study|Adverse event, serious fatal|0|||
163351880|NCT01751165|590000293|FG002|Overall Study|Adverse event, serious fatal|1|||
163351881|NCT01751165|590000291|FG000|Overall Study|Withdrawal by Subject|0|||
163351882|NCT01751165|590000292|FG001|Overall Study|Withdrawal by Subject|0|||
163351883|NCT01751165|590000293|FG002|Overall Study|Withdrawal by Subject|1|||
163351884|NCT01751165|590000291|FG000|Overall Study|Serious adverse event|0|||
163351885|NCT01751165|590000292|FG001|Overall Study|Serious adverse event|2|||
163351886|NCT01751165|590000293|FG002|Overall Study|Serious adverse event|0|||
163351887|NCT01751165|590000291|FG000|Overall Study|Lost to Follow-up|1|||
163351888|NCT01751165|590000292|FG001|Overall Study|Lost to Follow-up|1|||
163351889|NCT01751165|590000293|FG002|Overall Study|Lost to Follow-up|1|||
163351890|NCT01036165|590000294|FG000|Overall Study|Adverse Event|6|||
163351891|NCT01036165|590000294|FG000|Overall Study|Lost to Follow-up|2|||
163351892|NCT01036165|590000294|FG000|Overall Study|Withdrawal by Subject|3|||
163351893|NCT01036165|590000294|FG000|Overall Study|Device Related Issues|3|||
163351894|NCT01036165|590000294|FG000|Overall Study|Problems finding proper area to inject|1|||
163148755|NCT00528957|589257351|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
163148756|NCT00528957|589257350|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
163148757|NCT00528957|589257351|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
163148758|NCT00528957|589257350|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
163148759|NCT00528957|589257351|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
163148760|NCT00528957|589257350|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
163148761|NCT00528957|589257351|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
163148762|NCT00528957|589257350|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
163148763|NCT00528957|589257351|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
163148764|NCT00528957|589257350|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
163148765|NCT00528957|589257351|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
163148766|NCT00528957|589257350|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
163148767|NCT00528957|589257351|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
163148768|NCT00528957|589257350|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
163148769|NCT00528957|589257351|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
163148770|NCT00528957|589257350|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
163148771|NCT00528957|589257351|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
163148772|NCT00528957|589257350|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
163148773|NCT00528957|589257351|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
163148774|NCT00528957|589257350|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
163148775|NCT00528957|589257351|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
163148776|NCT02675907|589257356|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
163148777|NCT02675907|589257357|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
163148778|NCT02675907|589257356|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
163148779|NCT02675907|589257357|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
163148780|NCT02675907|589257356|FG000|Study Overall|Lack of Efficacy|1|||
163148781|NCT02675907|589257357|FG001|Study Overall|Lack of Efficacy|0|||
163148782|NCT02675907|589257356|FG000|Study Overall|Withdrawal by Subject|2|||
163148783|NCT02675907|589257357|FG001|Study Overall|Withdrawal by Subject|2|||
163148784|NCT02675907|589257356|FG000|Study Overall|Lost to Follow-up|0|||
163148785|NCT02675907|589257357|FG001|Study Overall|Lost to Follow-up|2|||
163244249|NCT00364858|589600569|FG001|Overall Study|Clinical baseline issue|1|||
163244250|NCT00363766|589600570|FG000|Overall Study|Progressive Disease|15|||
163244251|NCT00363766|589600571|FG001|Overall Study|Progressive Disease|9|||
163351895|NCT01475461|590000295|FG000|Run-in Period|Not meet eligibility criteria|16|||
163351896|NCT01475461|590000296|FG001|Run-in Period|Not meet eligibility criteria|0|||
163351897|NCT01475461|590000297|FG002|Run-in Period|Not meet eligibility criteria|0|||
163148786|NCT01611792|589257358|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
163148787|NCT01611792|589257359|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
163148788|NCT01611792|589257358|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
163148789|NCT01611792|589257359|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
163148790|NCT03416868|589257360|FG000|Overall Study|Withdrawal by Subject|2|||
163148791|NCT03416868|589257360|FG000|Overall Study|Lost to Follow-up|1|||
163148792|NCT00960375|589257363|FG000|Overall Study|Lost to Follow-up|20|||
163148793|NCT00960375|589257364|FG001|Overall Study|Lost to Follow-up|22|||
163148794|NCT00083889|589257365|FG000|Overall Study|Adverse Event|76|||
163148795|NCT00083889|589257366|FG001|Overall Study|Adverse Event|86|||
163148796|NCT00083889|589257365|FG000|Overall Study|Protocol Violation|2|||
163148797|NCT00083889|589257366|FG001|Overall Study|Protocol Violation|2|||
163148798|NCT00083889|589257365|FG000|Overall Study|Withdrawal by Subject|22|||
163148799|NCT00083889|589257366|FG001|Overall Study|Withdrawal by Subject|24|||
163148800|NCT00083889|589257365|FG000|Overall Study|Lack of Efficacy|240|||
163148801|NCT00083889|589257366|FG001|Overall Study|Lack of Efficacy|219|||
163148802|NCT00083889|589257365|FG000|Overall Study|Decision of sponsor|32|||
163148803|NCT00083889|589257366|FG001|Overall Study|Decision of sponsor|4|||
163148804|NCT00083889|589257365|FG000|Overall Study|Randomized: did not take study drug|0|||
163148805|NCT00083889|589257366|FG001|Overall Study|Randomized: did not take study drug|15|||
163148806|NCT00083889|589257365|FG000|Overall Study|Completed on marketed sunitinub|3|||
163148807|NCT00083889|589257366|FG001|Overall Study|Completed on marketed sunitinub|0|||
163148808|NCT00083889|589257365|FG000|Overall Study|Crossover to SU011248|0|||
163148809|NCT00083889|589257366|FG001|Overall Study|Crossover to SU011248|25|||
163148810|NCT03624881|589257367|FG000|Overall Study|Screen Failure|14|||
163148811|NCT03624881|589257368|FG001|Overall Study|Screen Failure|0|||
163148812|NCT03624881|589257367|FG000|Overall Study|No Catheter Inserted|6|||
163148813|NCT03624881|589257368|FG001|Overall Study|No Catheter Inserted|1|||
163148814|NCT03624881|589257367|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
163148815|NCT03624881|589257368|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
163148816|NCT03624881|589257367|FG000|Overall Study|Death|2|||
163148817|NCT03624881|589257368|FG001|Overall Study|Death|0|||
163148818|NCT03624881|589257367|FG000|Overall Study|Lost to Follow-up|10|||
163148819|NCT03624881|589257368|FG001|Overall Study|Lost to Follow-up|4|||
163148820|NCT03624881|589257367|FG000|Overall Study|Withdrawal by Subject|12|||
163148821|NCT03624881|589257368|FG001|Overall Study|Withdrawal by Subject|1|||
163148822|NCT00168844|589257369|FG000|Overall Study|Adverse Event|31|||
163148823|NCT00168844|589257370|FG001|Overall Study|Adverse Event|32|||
163148824|NCT00168844|589257371|FG002|Overall Study|Adverse Event|48|||
163148825|NCT00168844|589257369|FG000|Overall Study|Lost to Follow-up|4|||
163148826|NCT00168844|589257370|FG001|Overall Study|Lost to Follow-up|5|||
163148827|NCT00168844|589257371|FG002|Overall Study|Lost to Follow-up|11|||
163148828|NCT00168844|589257369|FG000|Overall Study|Withdrawal by Subject|12|||
163148829|NCT00168844|589257370|FG001|Overall Study|Withdrawal by Subject|9|||
163148830|NCT00168844|589257371|FG002|Overall Study|Withdrawal by Subject|19|||
163148831|NCT00168844|589257369|FG000|Overall Study|Protocol Violation|2|||
163148832|NCT00168844|589257370|FG001|Overall Study|Protocol Violation|2|||
163148833|NCT00168844|589257371|FG002|Overall Study|Protocol Violation|4|||
163148834|NCT00168844|589257369|FG000|Overall Study|Other|6|||
163148835|NCT00168844|589257370|FG001|Overall Study|Other|7|||
163148836|NCT00168844|589257371|FG002|Overall Study|Other|9|||
163148837|NCT03473236|589257373|FG000|Overall Study|Withdrawal by Subject|0|||
163148838|NCT03473236|589257374|FG001|Overall Study|Withdrawal by Subject|0|||
163148839|NCT03473236|589257375|FG002|Overall Study|Withdrawal by Subject|0|||
163148840|NCT03473236|589257376|FG003|Overall Study|Withdrawal by Subject|0|||
163148841|NCT03473236|589257377|FG004|Overall Study|Withdrawal by Subject|0|||
163148842|NCT03473236|589257378|FG005|Overall Study|Withdrawal by Subject|1|||
163148843|NCT03473236|589257379|FG006|Overall Study|Withdrawal by Subject|0|||
163148844|NCT03473236|589257380|FG007|Overall Study|Withdrawal by Subject|0|||
163148845|NCT03473236|589257381|FG008|Overall Study|Withdrawal by Subject|1|||
163148846|NCT03473236|589257382|FG009|Overall Study|Withdrawal by Subject|0|||
163148847|NCT04264442|589257383|FG000|Overall Study|Lack of Efficacy|6|||
163148848|NCT04264442|589257383|FG000|Overall Study|Lost to Follow-up|2|||
163148849|NCT04264442|589257383|FG000|Overall Study|Sponsor Decision|23|||
163148850|NCT04264442|589257383|FG000|Overall Study|Withdrawal by Subject|11|||
163351898|NCT01475461|590000298|FG003|Run-in Period|Not meet eligibility criteria|0|||
163148851|NCT04264442|589257383|FG000|Overall Study|Study Termination|5|||
163148852|NCT03309020|589257386|FG000|Overall Study|Death|1|||
163148853|NCT03309020|589257387|FG001|Overall Study|Death|0|||
163148854|NCT03309020|589257386|FG000|Overall Study|Did not undergo surgery|2|||
163148855|NCT03309020|589257387|FG001|Overall Study|Did not undergo surgery|1|||
163148856|NCT02362724|589257394|FG000|Overall Study|Withdrawal by Subject|3|||
163148857|NCT02362724|589257395|FG001|Overall Study|Withdrawal by Subject|1|||
163148858|NCT02362724|589257394|FG000|Overall Study|Adverse Event|3|||
163148859|NCT02362724|589257395|FG001|Overall Study|Adverse Event|0|||
163148860|NCT05190120|589257401|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
163244252|NCT00363766|589600570|FG000|Overall Study|Adverse Event|10|||
163244253|NCT00363766|589600571|FG001|Overall Study|Adverse Event|2|||
163244254|NCT00363766|589600570|FG000|Overall Study|Disease Related Death|1|||
163244255|NCT00363766|589600571|FG001|Overall Study|Disease Related Death|3|||
163244256|NCT00363766|589600570|FG000|Overall Study|Not Disease Related Death|3|||
163244257|NCT00363766|589600571|FG001|Overall Study|Not Disease Related Death|4|||
163244258|NCT00363766|589600570|FG000|Overall Study|Withdrawal by Subject|2|||
163351899|NCT01475461|590000299|FG004|Run-in Period|Not meet eligibility criteria|0|||
163351900|NCT01475461|590000300|FG005|Run-in Period|Not meet eligibility criteria|0|||
163351901|NCT01475461|590000301|FG006|Run-in Period|Not meet eligibility criteria|0|||
163351902|NCT01475461|590000295|FG000|Run-in Period|Lost to Follow-up|7|||
163351903|NCT01475461|590000296|FG001|Run-in Period|Lost to Follow-up|0|||
163351904|NCT01475461|590000297|FG002|Run-in Period|Lost to Follow-up|0|||
163351905|NCT01475461|590000298|FG003|Run-in Period|Lost to Follow-up|0|||
163351906|NCT01475461|590000299|FG004|Run-in Period|Lost to Follow-up|0|||
163351907|NCT01475461|590000300|FG005|Run-in Period|Lost to Follow-up|0|||
163351908|NCT01475461|590000301|FG006|Run-in Period|Lost to Follow-up|0|||
163351909|NCT01475461|590000295|FG000|Run-in Period|Withdrawal by Subject|11|||
163351910|NCT01475461|590000296|FG001|Run-in Period|Withdrawal by Subject|0|||
163351911|NCT01475461|590000297|FG002|Run-in Period|Withdrawal by Subject|0|||
163351912|NCT01475461|590000298|FG003|Run-in Period|Withdrawal by Subject|0|||
163351913|NCT01475461|590000299|FG004|Run-in Period|Withdrawal by Subject|0|||
163351914|NCT01475461|590000300|FG005|Run-in Period|Withdrawal by Subject|0|||
163351915|NCT01475461|590000301|FG006|Run-in Period|Withdrawal by Subject|0|||
163351916|NCT01475461|590000295|FG000|Run-in Period|Other|3|||
163351917|NCT01475461|590000296|FG001|Run-in Period|Other|0|||
163351918|NCT01475461|590000297|FG002|Run-in Period|Other|0|||
163351919|NCT01475461|590000298|FG003|Run-in Period|Other|0|||
163351920|NCT01475461|590000299|FG004|Run-in Period|Other|0|||
163351921|NCT01475461|590000300|FG005|Run-in Period|Other|0|||
163351922|NCT01475461|590000301|FG006|Run-in Period|Other|0|||
163351923|NCT01475461|590000295|FG000|Run-in Period|Protocol Violation|4|||
163351924|NCT01475461|590000296|FG001|Run-in Period|Protocol Violation|0|||
163351925|NCT01475461|590000297|FG002|Run-in Period|Protocol Violation|0|||
163351926|NCT01475461|590000298|FG003|Run-in Period|Protocol Violation|0|||
163351927|NCT01475461|590000299|FG004|Run-in Period|Protocol Violation|0|||
163351928|NCT01475461|590000300|FG005|Run-in Period|Protocol Violation|0|||
163351929|NCT01475461|590000301|FG006|Run-in Period|Protocol Violation|0|||
163351930|NCT01475461|590000295|FG000|Treatment Period|Death|0|||
163351931|NCT01475461|590000296|FG001|Treatment Period|Death|0|||
163351932|NCT01475461|590000297|FG002|Treatment Period|Death|0|||
163351933|NCT01475461|590000298|FG003|Treatment Period|Death|1|||
163351934|NCT01475461|590000299|FG004|Treatment Period|Death|0|||
163351935|NCT01475461|590000300|FG005|Treatment Period|Death|0|||
163351936|NCT01475461|590000301|FG006|Treatment Period|Death|0|||
163351937|NCT01475461|590000295|FG000|Treatment Period|Lost to Follow-up|0|||
163351938|NCT01475461|590000296|FG001|Treatment Period|Lost to Follow-up|3|||
163351939|NCT01475461|590000297|FG002|Treatment Period|Lost to Follow-up|2|||
163351940|NCT01475461|590000298|FG003|Treatment Period|Lost to Follow-up|3|||
163351941|NCT01475461|590000299|FG004|Treatment Period|Lost to Follow-up|1|||
163351942|NCT01475461|590000300|FG005|Treatment Period|Lost to Follow-up|2|||
163351943|NCT01475461|590000301|FG006|Treatment Period|Lost to Follow-up|1|||
163351944|NCT01475461|590000295|FG000|Treatment Period|Withdrawal by Subject|0|||
163351945|NCT01475461|590000296|FG001|Treatment Period|Withdrawal by Subject|2|||
163351946|NCT01475461|590000297|FG002|Treatment Period|Withdrawal by Subject|2|||
163351947|NCT01475461|590000298|FG003|Treatment Period|Withdrawal by Subject|0|||
163244259|NCT00363766|589600571|FG001|Overall Study|Withdrawal by Subject|0|||
163244260|NCT00363766|589600570|FG000|Overall Study|Physician Decision|1|||
163244261|NCT00363766|589600571|FG001|Overall Study|Physician Decision|2|||
163244262|NCT00558285|589600572|FG000|Overall Study|Adverse Event|1|||
163244263|NCT00558285|589600573|FG001|Overall Study|Adverse Event|1|||
163244264|NCT00558285|589600574|FG002|Overall Study|Adverse Event|4|||
163244265|NCT00558285|589600575|FG003|Overall Study|Adverse Event|1|||
163351948|NCT01475461|590000299|FG004|Treatment Period|Withdrawal by Subject|2|||
163351949|NCT01475461|590000300|FG005|Treatment Period|Withdrawal by Subject|2|||
163351950|NCT01475461|590000301|FG006|Treatment Period|Withdrawal by Subject|0|||
163351951|NCT01475461|590000295|FG000|Treatment Period|Other|0|||
163351952|NCT01475461|590000296|FG001|Treatment Period|Other|1|||
163244266|NCT00558285|589600576|FG004|Overall Study|Adverse Event|2|||
163244267|NCT00558285|589600572|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163244268|NCT00558285|589600573|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163351953|NCT01475461|590000297|FG002|Treatment Period|Other|0|||
163351954|NCT01475461|590000298|FG003|Treatment Period|Other|0|||
163351955|NCT01475461|590000299|FG004|Treatment Period|Other|0|||
163351956|NCT01475461|590000300|FG005|Treatment Period|Other|0|||
163351957|NCT01475461|590000301|FG006|Treatment Period|Other|0|||
163351958|NCT01475461|590000295|FG000|Treatment Period|Protocol Violation|0|||
163351959|NCT01475461|590000296|FG001|Treatment Period|Protocol Violation|1|||
163351960|NCT01475461|590000297|FG002|Treatment Period|Protocol Violation|0|||
163351961|NCT01475461|590000298|FG003|Treatment Period|Protocol Violation|0|||
163244269|NCT00558285|589600574|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163244270|NCT00558285|589600575|FG003|Overall Study|Abnormal test procedure result(s)|0|||
163244271|NCT00558285|589600576|FG004|Overall Study|Abnormal test procedure result(s)|0|||
163244272|NCT00558285|589600572|FG000|Overall Study|Subject withdrew consent|2|||
163244273|NCT00558285|589600573|FG001|Overall Study|Subject withdrew consent|0|||
163244274|NCT00558285|589600574|FG002|Overall Study|Subject withdrew consent|1|||
163244275|NCT00558285|589600575|FG003|Overall Study|Subject withdrew consent|1|||
163244276|NCT00558285|589600576|FG004|Overall Study|Subject withdrew consent|1|||
163244277|NCT00558285|589600572|FG000|Overall Study|Lost to Follow-up|1|||
163244278|NCT00558285|589600573|FG001|Overall Study|Lost to Follow-up|1|||
163244279|NCT00558285|589600574|FG002|Overall Study|Lost to Follow-up|0|||
163244280|NCT00558285|589600575|FG003|Overall Study|Lost to Follow-up|0|||
163244281|NCT00558285|589600576|FG004|Overall Study|Lost to Follow-up|0|||
163244282|NCT00558285|589600572|FG000|Overall Study|Administrative problems|0|||
163244283|NCT00558285|589600573|FG001|Overall Study|Administrative problems|0|||
163244284|NCT00558285|589600574|FG002|Overall Study|Administrative problems|0|||
163244285|NCT00558285|589600575|FG003|Overall Study|Administrative problems|1|||
163244286|NCT00558285|589600576|FG004|Overall Study|Administrative problems|1|||
163244287|NCT00558285|589600572|FG000|Overall Study|Protocol deviation|1|||
163244288|NCT00558285|589600573|FG001|Overall Study|Protocol deviation|1|||
163244289|NCT00558285|589600574|FG002|Overall Study|Protocol deviation|0|||
163244290|NCT00558285|589600575|FG003|Overall Study|Protocol deviation|1|||
163244291|NCT00558285|589600576|FG004|Overall Study|Protocol deviation|0|||
163244292|NCT02345512|589600577|FG000|Overall Study|Adverse Event|1|||
163244293|NCT02345512|589600577|FG000|Overall Study|Withdrawal by Subject|1|||
163244294|NCT02121847|589600578|FG000|Overall Study|Administrative Reasons|1|||
163244295|NCT02121847|589600578|FG000|Overall Study|Adverse Event|2|||
163244296|NCT01660906|589600579|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
163244297|NCT03478891|589600587|FG000|Overall Study|Enrolled, but product never administered|0|||
163244298|NCT03478891|589600588|FG001|Overall Study|Enrolled, but product never administered|0|||
163244299|NCT03478891|589600589|FG002|Overall Study|Enrolled, but product never administered|1|||
163244300|NCT03478891|589600587|FG000|Overall Study|Moved from area|0|||
163244301|NCT03478891|589600588|FG001|Overall Study|Moved from area|0|||
163244302|NCT03478891|589600589|FG002|Overall Study|Moved from area|1|||
163244303|NCT03478891|589600587|FG000|Overall Study|Lost to Follow-up|1|||
163244304|NCT03478891|589600588|FG001|Overall Study|Lost to Follow-up|0|||
163244305|NCT03478891|589600589|FG002|Overall Study|Lost to Follow-up|1|||
163244306|NCT01308580|589600591|FG000|Overall Study|Lost to Follow-up|12|||
163244307|NCT01308580|589600592|FG001|Overall Study|Lost to Follow-up|7|||
163244308|NCT03823651|589600597|FG000|Overall Study|Death|5|||
163244309|NCT03823651|589600598|FG001|Overall Study|Death|0|||
163244310|NCT03823651|589600597|FG000|Overall Study|Physician Decision|1|||
163244311|NCT03823651|589600598|FG001|Overall Study|Physician Decision|0|||
163244312|NCT03823651|589600597|FG000|Overall Study|Caregiver to patient who died|0|||
163244313|NCT03823651|589600598|FG001|Overall Study|Caregiver to patient who died|5|||
163244314|NCT03823651|589600597|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
163244315|NCT03823651|589600598|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
163244316|NCT03864614|589600602|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
163244317|NCT03864614|589600603|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
163244318|NCT03864614|589600604|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
163244319|NCT03864614|589600605|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
163244320|NCT03864614|589600602|FG000|Overall Study|Withdrawal by Subject|72|||
163244321|NCT03864614|589600603|FG001|Overall Study|Withdrawal by Subject|100|||
163244322|NCT03864614|589600604|FG002|Overall Study|Withdrawal by Subject|1|||
163244323|NCT03864614|589600605|FG003|Overall Study|Withdrawal by Subject|21|||
163244324|NCT03864614|589600602|FG000|Overall Study|Lost to Follow-up|45|||
163244325|NCT03864614|589600603|FG001|Overall Study|Lost to Follow-up|54|||
163244326|NCT03864614|589600604|FG002|Overall Study|Lost to Follow-up|0|||
163244327|NCT03864614|589600605|FG003|Overall Study|Lost to Follow-up|9|||
163244328|NCT03864614|589600602|FG000|Overall Study|Adverse Event|42|||
163244329|NCT03864614|589600603|FG001|Overall Study|Adverse Event|30|||
163244330|NCT03864614|589600604|FG002|Overall Study|Adverse Event|1|||
163244331|NCT03864614|589600605|FG003|Overall Study|Adverse Event|9|||
163244332|NCT03864614|589600602|FG000|Overall Study|Protocol Deviation|6|||
163244333|NCT03864614|589600603|FG001|Overall Study|Protocol Deviation|26|||
163244334|NCT03864614|589600604|FG002|Overall Study|Protocol Deviation|0|||
163244335|NCT03864614|589600605|FG003|Overall Study|Protocol Deviation|1|||
163244336|NCT03864614|589600602|FG000|Overall Study|Physician Decision|7|||
163244337|NCT03864614|589600603|FG001|Overall Study|Physician Decision|10|||
163244338|NCT03864614|589600604|FG002|Overall Study|Physician Decision|1|||
163244339|NCT03864614|589600605|FG003|Overall Study|Physician Decision|5|||
163244340|NCT03864614|589600602|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
163244341|NCT03864614|589600603|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
163244342|NCT03864614|589600604|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
163244343|NCT03864614|589600605|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
163351962|NCT01475461|590000299|FG004|Treatment Period|Protocol Violation|0|||
163351963|NCT01475461|590000300|FG005|Treatment Period|Protocol Violation|0|||
163351964|NCT01475461|590000301|FG006|Treatment Period|Protocol Violation|1|||
163351965|NCT01475461|590000295|FG000|Treatment Period|Lack of Efficacy|0|||
163351966|NCT01475461|590000296|FG001|Treatment Period|Lack of Efficacy|2|||
163351967|NCT01475461|590000297|FG002|Treatment Period|Lack of Efficacy|0|||
163351968|NCT01475461|590000298|FG003|Treatment Period|Lack of Efficacy|2|||
163351969|NCT01475461|590000299|FG004|Treatment Period|Lack of Efficacy|1|||
163351970|NCT01475461|590000300|FG005|Treatment Period|Lack of Efficacy|1|||
163351971|NCT01475461|590000301|FG006|Treatment Period|Lack of Efficacy|0|||
163351972|NCT01475461|590000295|FG000|Treatment Period|Medication Error|0|||
163351973|NCT01475461|590000296|FG001|Treatment Period|Medication Error|0|||
163351974|NCT01475461|590000297|FG002|Treatment Period|Medication Error|0|||
163351975|NCT01475461|590000298|FG003|Treatment Period|Medication Error|1|||
163351976|NCT01475461|590000299|FG004|Treatment Period|Medication Error|0|||
163351977|NCT01475461|590000300|FG005|Treatment Period|Medication Error|0|||
163351978|NCT01475461|590000301|FG006|Treatment Period|Medication Error|0|||
163351979|NCT01475461|590000295|FG000|Treatment Period|Adverse Event|0|||
163351980|NCT01475461|590000296|FG001|Treatment Period|Adverse Event|0|||
163351981|NCT01475461|590000297|FG002|Treatment Period|Adverse Event|0|||
163351982|NCT01475461|590000298|FG003|Treatment Period|Adverse Event|1|||
163351983|NCT01475461|590000299|FG004|Treatment Period|Adverse Event|0|||
163351984|NCT01475461|590000300|FG005|Treatment Period|Adverse Event|0|||
163351985|NCT01475461|590000301|FG006|Treatment Period|Adverse Event|0|||
163351986|NCT04051242|590000302|FG000|Overall Study|Withdrawal by Subject|1|||
163351987|NCT04051242|590000302|FG000|Overall Study|Physician Decision|1|||
163351988|NCT02262364|590000305|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
163351989|NCT01049984|590000306|FG000|Overall Study|Withdrawal by Subject|1|||
163410160|NCT02064387|590211274|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
163410161|NCT02064387|590211275|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
163410162|NCT02064387|590211276|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
163410163|NCT02064387|590211277|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
163410164|NCT02064387|590211278|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
163410165|NCT02064387|590211279|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
163410166|NCT02064387|590211280|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
163410167|NCT02064387|590211281|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
163410168|NCT02064387|590211282|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
163410169|NCT02064387|590211283|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
163410170|NCT02064387|590211272|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163410171|NCT02064387|590211273|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163410172|NCT02064387|590211274|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163410173|NCT02064387|590211275|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163410174|NCT02064387|590211276|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163410175|NCT02064387|590211277|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163410176|NCT02064387|590211278|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163410177|NCT02064387|590211279|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163410178|NCT02064387|590211280|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163410179|NCT02064387|590211281|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163410180|NCT02064387|590211282|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
163410181|NCT02064387|590211283|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163410182|NCT02436876|590211287|FG000|Overall Study|Lost to Follow-up|0|||
163410183|NCT02436876|590211288|FG001|Overall Study|Lost to Follow-up|1|||
163410184|NCT02436876|590211289|FG002|Overall Study|Lost to Follow-up|1|||
163410185|NCT02436876|590211290|FG003|Overall Study|Lost to Follow-up|1|||
163410186|NCT02436876|590211287|FG000|Overall Study|Withdrawal by Subject|1|||
163410187|NCT02436876|590211288|FG001|Overall Study|Withdrawal by Subject|0|||
163410188|NCT02436876|590211289|FG002|Overall Study|Withdrawal by Subject|0|||
163410189|NCT02436876|590211290|FG003|Overall Study|Withdrawal by Subject|1|||
163410190|NCT02436876|590211287|FG000|Overall Study|Physician Decision|0|||
163410191|NCT02436876|590211288|FG001|Overall Study|Physician Decision|2|||
163148861|NCT05190120|589257402|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
163351990|NCT01049984|590000307|FG001|Overall Study|Withdrawal by Subject|5|||
163351991|NCT01049984|590000306|FG000|Overall Study|Protocol Violation|3|||
163410192|NCT02436876|590211289|FG002|Overall Study|Physician Decision|1|||
163410193|NCT02436876|590211290|FG003|Overall Study|Physician Decision|0|||
163410194|NCT02436876|590211287|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
163410195|NCT02436876|590211288|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
163351992|NCT01049984|590000307|FG001|Overall Study|Protocol Violation|4|||
163351993|NCT01049984|590000306|FG000|Overall Study|Lost to Follow-up|2|||
163351994|NCT01049984|590000307|FG001|Overall Study|Lost to Follow-up|1|||
163351995|NCT01049984|590000306|FG000|Overall Study|Adverse Event|13|||
163410196|NCT02436876|590211289|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
163351996|NCT01049984|590000307|FG001|Overall Study|Adverse Event|7|||
163351997|NCT01049984|590000306|FG000|Overall Study|Treatment failure|0|||
163351998|NCT01049984|590000307|FG001|Overall Study|Treatment failure|2|||
163351999|NCT00337285|590000308|FG000|Overall Study|Withdrawal by Subject|42|||
163352000|NCT00337285|590000308|FG000|Overall Study|Lost to Follow-up|41|||
163352001|NCT00337285|590000308|FG000|Overall Study|Adverse Event|28|||
163352002|NCT00337285|590000308|FG000|Overall Study|Protocol Violation|27|||
163352003|NCT00337285|590000308|FG000|Overall Study|Lack of Efficacy|11|||
163352004|NCT00337285|590000308|FG000|Overall Study|Death|1|||
163352005|NCT00337285|590000308|FG000|Overall Study|Physician Decision|1|||
163352006|NCT00337285|590000308|FG000|Overall Study|Lack of protocol compliance|7|||
163352007|NCT00553605|590000309|FG000|Overall Study|Did not meet entrance criteria|1|||
163352008|NCT00553605|590000310|FG001|Overall Study|Did not meet entrance criteria|3|||
163352009|NCT00553605|590000309|FG000|Overall Study|Did not receive full dose|1|||
163352010|NCT00553605|590000310|FG001|Overall Study|Did not receive full dose|0|||
163352011|NCT00553605|590000309|FG000|Overall Study|Randomized but not treated|2|||
163352012|NCT00553605|590000310|FG001|Overall Study|Randomized but not treated|0|||
163352013|NCT01040403|590000314|FG000|Overall Study|Adverse Event|10|||
163352014|NCT01040403|590000314|FG000|Overall Study|Protocol Violation|2|||
163352015|NCT01040403|590000314|FG000|Overall Study|Lost to Follow-up|1|||
163352016|NCT01040403|590000314|FG000|Overall Study|Not treated|1|||
163352017|NCT01040403|590000314|FG000|Overall Study|Other reason not defined above|6|||
163352018|NCT01085812|590000316|FG000|Open-Label Period|Adverse Event|0|||
163352019|NCT01085812|590000317|FG001|Open-Label Period|Adverse Event|80|||
163352020|NCT01085812|590000316|FG000|Open-Label Period|Lack of Efficacy|0|||
163352021|NCT01085812|590000317|FG001|Open-Label Period|Lack of Efficacy|26|||
163352022|NCT01085812|590000316|FG000|Open-Label Period|Protocol Violation|0|||
163352023|NCT01085812|590000317|FG001|Open-Label Period|Protocol Violation|39|||
163352024|NCT01085812|590000316|FG000|Open-Label Period|Withdrawal by Subject|0|||
163352025|NCT01085812|590000317|FG001|Open-Label Period|Withdrawal by Subject|53|||
163352026|NCT01085812|590000316|FG000|Open-Label Period|Lost to Follow-up|0|||
163352027|NCT01085812|590000317|FG001|Open-Label Period|Lost to Follow-up|42|||
163352028|NCT01085812|590000316|FG000|Double-Blind Period|Adverse Event|3|||
163352029|NCT01085812|590000317|FG001|Double-Blind Period|Adverse Event|8|||
163352030|NCT01085812|590000316|FG000|Double-Blind Period|Protocol Violation|2|||
163352031|NCT01085812|590000317|FG001|Double-Blind Period|Protocol Violation|7|||
163352032|NCT01085812|590000316|FG000|Double-Blind Period|Withdrawal by Subject|11|||
163352033|NCT01085812|590000317|FG001|Double-Blind Period|Withdrawal by Subject|24|||
163352034|NCT01085812|590000316|FG000|Double-Blind Period|Lost to Follow-up|5|||
163352035|NCT01085812|590000317|FG001|Double-Blind Period|Lost to Follow-up|17|||
163352036|NCT01085812|590000316|FG000|Double-Blind Period|Other Reasons|0|||
163352037|NCT01085812|590000317|FG001|Double-Blind Period|Other Reasons|2|||
163352038|NCT01085812|590000316|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
163244344|NCT03864614|589600602|FG000|Overall Study|Sponsor Decision|1|||
163244345|NCT03864614|589600603|FG001|Overall Study|Sponsor Decision|2|||
163244346|NCT03864614|589600604|FG002|Overall Study|Sponsor Decision|0|||
163244347|NCT03864614|589600605|FG003|Overall Study|Sponsor Decision|0|||
163244348|NCT03864614|589600602|FG000|Overall Study|Pregnancy|0|||
163244349|NCT03864614|589600603|FG001|Overall Study|Pregnancy|1|||
163244350|NCT03864614|589600604|FG002|Overall Study|Pregnancy|0|||
163244351|NCT03864614|589600605|FG003|Overall Study|Pregnancy|0|||
163244352|NCT03864614|589600602|FG000|Overall Study|Other|7|||
163244353|NCT03864614|589600603|FG001|Overall Study|Other|9|||
163244354|NCT03864614|589600604|FG002|Overall Study|Other|1|||
163244355|NCT03864614|589600605|FG003|Overall Study|Other|4|||
163244356|NCT03864614|589600602|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
163244357|NCT03864614|589600603|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
163244358|NCT03864614|589600604|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
163244359|NCT03864614|589600605|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
163244360|NCT00932893|589600606|FG000|Overall Study|Death|115|||
163244361|NCT00932893|589600607|FG001|Overall Study|Death|24|||
163352039|NCT01085812|590000317|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
163352040|NCT01085812|590000316|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
163352041|NCT01085812|590000317|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
163352042|NCT01085812|590000316|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
163352043|NCT01085812|590000317|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
163352044|NCT01085812|590000316|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
163352045|NCT01085812|590000317|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
163352046|NCT01085812|590000316|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
163352047|NCT01085812|590000317|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
163244362|NCT00932893|589600606|FG000|Overall Study|Lost to Follow-up|8|||
163244363|NCT00932893|589600607|FG001|Overall Study|Lost to Follow-up|0|||
163352048|NCT01874665|590000321|FG000|Overall Study|Adverse Event|6|||
163352049|NCT01874665|590000322|FG001|Overall Study|Adverse Event|2|||
163244364|NCT00932893|589600606|FG000|Overall Study|Withdrawal by Subject|5|||
163244365|NCT00932893|589600607|FG001|Overall Study|Withdrawal by Subject|2|||
163148862|NCT05190120|589257403|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
163244366|NCT00932893|589600606|FG000|Overall Study|Other|5|||
163244367|NCT00932893|589600607|FG001|Overall Study|Other|144|||
163244368|NCT01983293|589602673|FG000|Overall Study|Withdrawal by Subject|29|||
163244369|NCT01983293|589602674|FG001|Overall Study|Withdrawal by Subject|15|||
163244370|NCT01983293|589602673|FG000|Overall Study|Missing 12-month visit|3|||
163244371|NCT01983293|589602674|FG001|Overall Study|Missing 12-month visit|3|||
163244372|NCT01983293|589602673|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
163244373|NCT01983293|589602674|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
163244374|NCT03147248|589602675|FG000|Overall Study|Adverse Event|0|||
163244375|NCT03147248|589602676|FG001|Overall Study|Adverse Event|2|||
163244376|NCT03147248|589602677|FG002|Overall Study|Adverse Event|2|||
163244377|NCT03147248|589602678|FG003|Overall Study|Adverse Event|2|||
163244378|NCT03147248|589602679|FG004|Overall Study|Adverse Event|6|||
163244379|NCT03147248|589602680|FG005|Overall Study|Adverse Event|11|||
163244380|NCT03147248|589602675|FG000|Overall Study|Disease progression|1|||
163244381|NCT03147248|589602676|FG001|Overall Study|Disease progression|0|||
163244382|NCT03147248|589602677|FG002|Overall Study|Disease progression|0|||
163244383|NCT03147248|589602678|FG003|Overall Study|Disease progression|0|||
163244384|NCT03147248|589602679|FG004|Overall Study|Disease progression|0|||
163244385|NCT03147248|589602680|FG005|Overall Study|Disease progression|2|||
163244386|NCT03147248|589602675|FG000|Overall Study|Withdrawal by Subject|0|||
163244387|NCT03147248|589602676|FG001|Overall Study|Withdrawal by Subject|0|||
163244388|NCT03147248|589602677|FG002|Overall Study|Withdrawal by Subject|0|||
163244389|NCT03147248|589602678|FG003|Overall Study|Withdrawal by Subject|0|||
163244390|NCT03147248|589602679|FG004|Overall Study|Withdrawal by Subject|12|||
163244391|NCT03147248|589602680|FG005|Overall Study|Withdrawal by Subject|9|||
163244392|NCT03147248|589602675|FG000|Overall Study|Protocol Violation|0|||
163244393|NCT03147248|589602676|FG001|Overall Study|Protocol Violation|0|||
163244394|NCT03147248|589602677|FG002|Overall Study|Protocol Violation|0|||
163244395|NCT03147248|589602678|FG003|Overall Study|Protocol Violation|0|||
163244396|NCT03147248|589602679|FG004|Overall Study|Protocol Violation|2|||
163244397|NCT03147248|589602680|FG005|Overall Study|Protocol Violation|0|||
163244398|NCT03147248|589602675|FG000|Overall Study|Lost to Follow-up|0|||
163244399|NCT03147248|589602676|FG001|Overall Study|Lost to Follow-up|0|||
163244400|NCT03147248|589602677|FG002|Overall Study|Lost to Follow-up|0|||
163244401|NCT03147248|589602678|FG003|Overall Study|Lost to Follow-up|0|||
163244402|NCT03147248|589602679|FG004|Overall Study|Lost to Follow-up|2|||
163244403|NCT03147248|589602680|FG005|Overall Study|Lost to Follow-up|0|||
163244404|NCT03147248|589602675|FG000|Overall Study|Pregnancy|0|||
163244405|NCT03147248|589602676|FG001|Overall Study|Pregnancy|0|||
163244406|NCT03147248|589602677|FG002|Overall Study|Pregnancy|0|||
163244407|NCT03147248|589602678|FG003|Overall Study|Pregnancy|0|||
163244408|NCT03147248|589602679|FG004|Overall Study|Pregnancy|1|||
163244409|NCT03147248|589602680|FG005|Overall Study|Pregnancy|0|||
163244410|NCT03147248|589602675|FG000|Overall Study|Death|0|||
163244411|NCT03147248|589602676|FG001|Overall Study|Death|0|||
163244412|NCT03147248|589602677|FG002|Overall Study|Death|0|||
163244413|NCT03147248|589602678|FG003|Overall Study|Death|0|||
163244414|NCT03147248|589602679|FG004|Overall Study|Death|0|||
163244415|NCT03147248|589602680|FG005|Overall Study|Death|4|||
163244416|NCT03147248|589602675|FG000|Overall Study|Physician Decision|0|||
163244417|NCT03147248|589602676|FG001|Overall Study|Physician Decision|0|||
163244418|NCT03147248|589602677|FG002|Overall Study|Physician Decision|0|||
163244419|NCT03147248|589602678|FG003|Overall Study|Physician Decision|0|||
163244420|NCT03147248|589602679|FG004|Overall Study|Physician Decision|2|||
163244421|NCT03147248|589602680|FG005|Overall Study|Physician Decision|4|||
163244422|NCT03147248|589602675|FG000|Overall Study|Prolonged Dosing Interval|0|||
163244423|NCT03147248|589602676|FG001|Overall Study|Prolonged Dosing Interval|0|||
163244424|NCT03147248|589602677|FG002|Overall Study|Prolonged Dosing Interval|0|||
163244425|NCT03147248|589602678|FG003|Overall Study|Prolonged Dosing Interval|0|||
163244426|NCT03147248|589602679|FG004|Overall Study|Prolonged Dosing Interval|1|||
163244427|NCT03147248|589602680|FG005|Overall Study|Prolonged Dosing Interval|1|||
163244428|NCT01914926|589602683|FG000|Overall Study|Adverse Event|1|||
163244429|NCT01914926|589602684|FG001|Overall Study|Adverse Event|0|||
163244430|NCT01914926|589602683|FG000|Overall Study|uncooperative, agitated and removed|0|||
163244431|NCT01914926|589602684|FG001|Overall Study|uncooperative, agitated and removed|1|||
163244432|NCT00856856|589602691|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
163244433|NCT00856856|589602691|FG000|4-year Clinical Follow-up|Missed visit|1|||
163244434|NCT03073603|589602693|FG000|Overall Study|Noncompliance|3|||
163244435|NCT03073603|589602694|FG001|Overall Study|Noncompliance|1|||
163244436|NCT03073603|589602693|FG000|Overall Study|Adverse Event|5|||
163244437|NCT03073603|589602694|FG001|Overall Study|Adverse Event|3|||
163244438|NCT03073603|589602693|FG000|Overall Study|Physician Decision|1|||
163244439|NCT03073603|589602694|FG001|Overall Study|Physician Decision|2|||
163244440|NCT03073603|589602693|FG000|Overall Study|Required treatment not allowed by protocol|1|||
163410197|NCT02436876|590211290|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
163244441|NCT03073603|589602694|FG001|Overall Study|Required treatment not allowed by protocol|0|||
163244442|NCT03073603|589602693|FG000|Overall Study|Financial or insurance-related|8|||
163244443|NCT03073603|589602694|FG001|Overall Study|Financial or insurance-related|0|||
163244444|NCT03073603|589602693|FG000|Overall Study|Withdrawal by Subject|0|||
163244445|NCT03073603|589602694|FG001|Overall Study|Withdrawal by Subject|1|||
163244446|NCT03073603|589602693|FG000|Overall Study|Discontinued DMT|4|||
163244447|NCT03073603|589602694|FG001|Overall Study|Discontinued DMT|0|||
163244448|NCT03073603|589602693|FG000|Overall Study|Restarted DMT|0|||
163244449|NCT03073603|589602694|FG001|Overall Study|Restarted DMT|1|||
163244450|NCT02473952|589602695|FG000|Overall Study|Adverse Event|2|||
163244451|NCT02473952|589602696|FG001|Overall Study|Adverse Event|2|||
163244452|NCT02473952|589602695|FG000|Overall Study|Withdrawal by Subject|0|||
163244453|NCT02473952|589602696|FG001|Overall Study|Withdrawal by Subject|6|||
163244454|NCT00922428|589602697|FG000|Overall Study|retrospective/extremely implausible data|2|||
163244455|NCT00922428|589602697|FG000|Overall Study|no medication use or questionable use|13|||
163244456|NCT04757649|589602698|FG000|Overall Study|Withdrawal by Subject|1|||
163244457|NCT04757649|589602698|FG000|Overall Study|Adverse Event|1|||
163244458|NCT02508311|589602706|FG000|Overall Study|Withdrawal by Subject|1|||
163244459|NCT02508311|589602707|FG001|Overall Study|Withdrawal by Subject|0|||
163244460|NCT04862143|589602708|FG000|Overall Study|Adverse Event|1|||
163244461|NCT04862143|589602708|FG000|Overall Study|Study terminated by sponsor|1|||
163244462|NCT04955639|589602709|FG000|Overall Study|Withdrawal by Subject|2|||
163244463|NCT04955639|589602710|FG001|Overall Study|Withdrawal by Subject|2|||
163244464|NCT04955639|589602709|FG000|Overall Study|Week 26 survey not completed|2|||
163244465|NCT04955639|589602710|FG001|Overall Study|Week 26 survey not completed|2|||
163244466|NCT00413153|589602711|FG000|Overall Study|Withdrawal by Subject|1|||
163244467|NCT00413153|589602712|FG001|Overall Study|Withdrawal by Subject|1|||
163244468|NCT00413153|589602711|FG000|Overall Study|Adverse Event|1|||
163244469|NCT00413153|589602712|FG001|Overall Study|Adverse Event|0|||
163244470|NCT00599326|589602715|FG000|Overall Study|Lost to Follow-up|1|||
163244471|NCT00599326|589602715|FG000|Overall Study|Noncompliant|1|||
163244472|NCT02862106|589602718|FG000|Overall Study|Adverse Event|4|||
163244473|NCT02862106|589602719|FG001|Overall Study|Adverse Event|0|||
163244474|NCT02862106|589602718|FG000|Overall Study|Protocol Violation|16|||
163244475|NCT02862106|589602719|FG001|Overall Study|Protocol Violation|1|||
163244476|NCT02862106|589602718|FG000|Overall Study|Lost to Follow-up|15|||
163244477|NCT02862106|589602719|FG001|Overall Study|Lost to Follow-up|5|||
163244478|NCT02862106|589602718|FG000|Overall Study|Withdrawal by Subject|2|||
163244479|NCT02862106|589602719|FG001|Overall Study|Withdrawal by Subject|0|||
163244480|NCT02862106|589602718|FG000|Overall Study|Subjects moved to other city|1|||
163244481|NCT02862106|589602719|FG001|Overall Study|Subjects moved to other city|0|||
163244482|NCT03966157|589602722|FG000|Overall Study|Physician Decision|1|||
163244483|NCT03966157|589602723|FG001|Overall Study|Physician Decision|0|||
163244484|NCT04969250|589602724|FG000|Overall Study|Protocol Violation|0|||
163244485|NCT04969250|589602725|FG001|Overall Study|Protocol Violation|2|||
163244486|NCT04969250|589602726|FG002|Overall Study|Protocol Violation|3|||
163244487|NCT04969250|589602727|FG003|Overall Study|Protocol Violation|8|||
163244488|NCT04969250|589602724|FG000|Overall Study|Withdrawal by Subject|0|||
163244489|NCT04969250|589602725|FG001|Overall Study|Withdrawal by Subject|1|||
163244490|NCT04969250|589602726|FG002|Overall Study|Withdrawal by Subject|0|||
163244491|NCT04969250|589602727|FG003|Overall Study|Withdrawal by Subject|0|||
163244492|NCT03526250|589602728|FG000|Overall Study|Adverse Event|4|||
163244493|NCT03526250|589602728|FG000|Overall Study|Progressive Disease|16|||
163244494|NCT03526250|589602728|FG000|Overall Study|No Treatment|3|||
163244495|NCT04420221|589602729|FG000|Overall Study|Withdrawal by Subject|0|||
163244496|NCT04420221|589602730|FG001|Overall Study|Withdrawal by Subject|0|||
163244497|NCT04420221|589602731|FG002|Overall Study|Withdrawal by Subject|0|||
163244498|NCT04420221|589602732|FG003|Overall Study|Withdrawal by Subject|0|||
163244499|NCT04420221|589602733|FG004|Overall Study|Withdrawal by Subject|0|||
163244500|NCT04420221|589602734|FG005|Overall Study|Withdrawal by Subject|20|||
163244501|NCT04420221|589602735|FG006|Overall Study|Withdrawal by Subject|5|||
163244502|NCT04420221|589602729|FG000|Overall Study|Other|0|||
163244503|NCT04420221|589602730|FG001|Overall Study|Other|0|||
163244504|NCT04420221|589602731|FG002|Overall Study|Other|0|||
163244505|NCT04420221|589602732|FG003|Overall Study|Other|0|||
163244506|NCT04420221|589602733|FG004|Overall Study|Other|0|||
163244507|NCT04420221|589602734|FG005|Overall Study|Other|1|||
163244508|NCT04420221|589602735|FG006|Overall Study|Other|1|||
163244509|NCT04420221|589602729|FG000|Overall Study|Lost to Follow-up|0|||
163244510|NCT04420221|589602730|FG001|Overall Study|Lost to Follow-up|0|||
163244511|NCT04420221|589602731|FG002|Overall Study|Lost to Follow-up|0|||
163244512|NCT04420221|589602732|FG003|Overall Study|Lost to Follow-up|0|||
163244513|NCT04420221|589602733|FG004|Overall Study|Lost to Follow-up|0|||
163244514|NCT04420221|589602734|FG005|Overall Study|Lost to Follow-up|3|||
163244515|NCT04420221|589602735|FG006|Overall Study|Lost to Follow-up|2|||
163244516|NCT04420221|589602729|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
163352050|NCT01874665|590000321|FG000|Overall Study|Withdrawal by Subject|4|||
163352051|NCT01874665|590000322|FG001|Overall Study|Withdrawal by Subject|1|||
163352052|NCT01874665|590000321|FG000|Overall Study|Physician Decision|3|||
163352053|NCT01874665|590000322|FG001|Overall Study|Physician Decision|0|||
163352054|NCT01874665|590000321|FG000|Overall Study|Clinical Progressive Disease|4|||
163352055|NCT01874665|590000322|FG001|Overall Study|Clinical Progressive Disease|3|||
163352056|NCT01874665|590000321|FG000|Overall Study|Study Terminated by Sponsor|0|||
163352057|NCT01874665|590000322|FG001|Overall Study|Study Terminated by Sponsor|2|||
163352058|NCT01874665|590000321|FG000|Overall Study|Documented Progressive Disease|11|||
163352059|NCT01874665|590000322|FG001|Overall Study|Documented Progressive Disease|7|||
163352060|NCT01874665|590000321|FG000|Overall Study|Other|2|||
163352061|NCT01874665|590000322|FG001|Overall Study|Other|0|||
163352062|NCT04582669|590000323|FG000|Overall Study|Subject missed appointment(s).|1|||
163352063|NCT04582669|590000324|FG001|Overall Study|Subject missed appointment(s).|0|||
163352064|NCT04582669|590000325|FG002|Overall Study|Subject missed appointment(s).|1|||
163352065|NCT04582669|590000326|FG003|Overall Study|Subject missed appointment(s).|2|||
163352066|NCT04582669|590000323|FG000|Overall Study|Protocol Violation|0|||
163352067|NCT04582669|590000324|FG001|Overall Study|Protocol Violation|1|||
163352068|NCT04582669|590000325|FG002|Overall Study|Protocol Violation|1|||
163352069|NCT04582669|590000326|FG003|Overall Study|Protocol Violation|0|||
163352070|NCT03201900|590000327|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
163352071|NCT03201900|590000327|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
163352072|NCT03201900|590000327|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
163352073|NCT03201900|590000327|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
163352074|NCT03201900|590000327|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
163352075|NCT03201900|590000327|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
163352076|NCT03201900|590000327|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
163352077|NCT03201900|590000327|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
163352078|NCT03201900|590000327|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
163352079|NCT03201900|590000327|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
163352080|NCT03201900|590000327|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
163352081|NCT03201900|590000327|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
163352082|NCT03201900|590000327|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
163352083|NCT01233999|590000328|FG000|Overall Study|Withdrawal by Subject|1|||
163352084|NCT01233999|590000328|FG000|Overall Study|Lost to Follow-up|1|||
163352085|NCT00550446|590000329|FG000|Up To Week 12|Adverse Event|2|||
163352086|NCT00550446|590000330|FG001|Up To Week 12|Adverse Event|2|||
163352087|NCT00550446|590000331|FG002|Up To Week 12|Adverse Event|0|||
163352088|NCT00550446|590000332|FG003|Up To Week 12|Adverse Event|0|||
163352089|NCT00550446|590000333|FG004|Up To Week 12|Adverse Event|2|||
163352090|NCT00550446|590000334|FG005|Up To Week 12|Adverse Event|2|||
163352091|NCT00550446|590000335|FG006|Up To Week 12|Adverse Event|1|||
163352092|NCT00550446|590000336|FG007|Up To Week 12|Adverse Event|0|||
163352093|NCT00550446|590000337|FG008|Up To Week 12|Adverse Event|0|||
163352094|NCT00550446|590000338|FG009|Up To Week 12|Adverse Event|0|||
163352095|NCT00550446|590000339|FG010|Up To Week 12|Adverse Event|0|||
163352096|NCT00550446|590000329|FG000|Up To Week 12|Lack of Efficacy|3|||
163352097|NCT00550446|590000330|FG001|Up To Week 12|Lack of Efficacy|1|||
163352098|NCT00550446|590000331|FG002|Up To Week 12|Lack of Efficacy|0|||
163352099|NCT00550446|590000332|FG003|Up To Week 12|Lack of Efficacy|1|||
163352100|NCT00550446|590000333|FG004|Up To Week 12|Lack of Efficacy|0|||
163352101|NCT00550446|590000334|FG005|Up To Week 12|Lack of Efficacy|3|||
163352102|NCT00550446|590000335|FG006|Up To Week 12|Lack of Efficacy|3|||
163352103|NCT00550446|590000336|FG007|Up To Week 12|Lack of Efficacy|0|||
163352104|NCT00550446|590000337|FG008|Up To Week 12|Lack of Efficacy|0|||
163352105|NCT00550446|590000338|FG009|Up To Week 12|Lack of Efficacy|0|||
163352106|NCT00550446|590000339|FG010|Up To Week 12|Lack of Efficacy|0|||
163352107|NCT00550446|590000329|FG000|Up To Week 12|Lost to Follow-up|0|||
163352108|NCT00550446|590000330|FG001|Up To Week 12|Lost to Follow-up|1|||
163352109|NCT00550446|590000331|FG002|Up To Week 12|Lost to Follow-up|0|||
163352110|NCT00550446|590000332|FG003|Up To Week 12|Lost to Follow-up|0|||
163352111|NCT00550446|590000333|FG004|Up To Week 12|Lost to Follow-up|1|||
163352112|NCT00550446|590000334|FG005|Up To Week 12|Lost to Follow-up|1|||
163352113|NCT00550446|590000335|FG006|Up To Week 12|Lost to Follow-up|2|||
163352114|NCT00550446|590000336|FG007|Up To Week 12|Lost to Follow-up|0|||
163352115|NCT00550446|590000337|FG008|Up To Week 12|Lost to Follow-up|0|||
163352116|NCT00550446|590000338|FG009|Up To Week 12|Lost to Follow-up|0|||
163352117|NCT00550446|590000339|FG010|Up To Week 12|Lost to Follow-up|0|||
163352118|NCT00550446|590000329|FG000|Up To Week 12|Withdrawal by Subject|2|||
163352119|NCT00550446|590000330|FG001|Up To Week 12|Withdrawal by Subject|0|||
163352120|NCT00550446|590000331|FG002|Up To Week 12|Withdrawal by Subject|3|||
163352121|NCT00550446|590000332|FG003|Up To Week 12|Withdrawal by Subject|2|||
163352122|NCT00550446|590000333|FG004|Up To Week 12|Withdrawal by Subject|0|||
163352123|NCT00550446|590000334|FG005|Up To Week 12|Withdrawal by Subject|1|||
163352124|NCT00550446|590000335|FG006|Up To Week 12|Withdrawal by Subject|3|||
163352125|NCT00550446|590000336|FG007|Up To Week 12|Withdrawal by Subject|0|||
163352126|NCT00550446|590000337|FG008|Up To Week 12|Withdrawal by Subject|0|||
163352127|NCT00550446|590000338|FG009|Up To Week 12|Withdrawal by Subject|0|||
163352128|NCT00550446|590000339|FG010|Up To Week 12|Withdrawal by Subject|0|||
163352129|NCT00550446|590000329|FG000|Up To Week 12|Other|3|||
163352130|NCT00550446|590000330|FG001|Up To Week 12|Other|0|||
163352131|NCT00550446|590000331|FG002|Up To Week 12|Other|0|||
163352132|NCT00550446|590000332|FG003|Up To Week 12|Other|0|||
163352133|NCT00550446|590000333|FG004|Up To Week 12|Other|0|||
163352134|NCT00550446|590000334|FG005|Up To Week 12|Other|1|||
163352135|NCT00550446|590000335|FG006|Up To Week 12|Other|4|||
163352136|NCT00550446|590000336|FG007|Up To Week 12|Other|0|||
163352137|NCT00550446|590000337|FG008|Up To Week 12|Other|0|||
163410198|NCT00075504|590211291|FG000|Overall Study|Withdrawal by Subject|9|||
163410199|NCT00075504|590211292|FG001|Overall Study|Withdrawal by Subject|7|||
163244517|NCT04420221|589602730|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
163244518|NCT04420221|589602731|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
163244519|NCT04420221|589602732|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
163244520|NCT04420221|589602733|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
163244521|NCT04420221|589602734|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
163244522|NCT04420221|589602735|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
163244523|NCT05348681|589602736|FG000|Overall Study|Study terminated by Sponsor|8|||
163244524|NCT05348681|589602737|FG001|Overall Study|Study terminated by Sponsor|3|||
163244525|NCT05348681|589602736|FG000|Overall Study|Withdrawal by Subject|1|||
163244526|NCT05348681|589602737|FG001|Overall Study|Withdrawal by Subject|1|||
163244527|NCT05348681|589602736|FG000|Overall Study|Lost to Follow-up|1|||
163244528|NCT05348681|589602737|FG001|Overall Study|Lost to Follow-up|1|||
163244529|NCT05348681|589602736|FG000|Overall Study|Adverse Event|1|||
163244530|NCT05348681|589602737|FG001|Overall Study|Adverse Event|0|||
163244531|NCT05348681|589602736|FG000|Overall Study|Other|2|||
163244532|NCT05348681|589602737|FG001|Overall Study|Other|1|||
163244533|NCT01040130|589602738|FG000|Overall Study|Adverse Event|1|||
163244534|NCT01040130|589602739|FG001|Overall Study|Adverse Event|1|||
163244535|NCT01040130|589602740|FG002|Overall Study|Adverse Event|0|||
163244536|NCT01040130|589602741|FG003|Overall Study|Adverse Event|5|||
163244537|NCT01040130|589602742|FG004|Overall Study|Adverse Event|0|||
163244538|NCT01040130|589602743|FG005|Overall Study|Adverse Event|3|||
163244539|NCT01040130|589602738|FG000|Overall Study|Protocol Violation|0|||
163244540|NCT01040130|589602739|FG001|Overall Study|Protocol Violation|0|||
163244541|NCT01040130|589602740|FG002|Overall Study|Protocol Violation|2|||
163244542|NCT01040130|589602741|FG003|Overall Study|Protocol Violation|0|||
163244543|NCT01040130|589602742|FG004|Overall Study|Protocol Violation|0|||
163244544|NCT01040130|589602743|FG005|Overall Study|Protocol Violation|0|||
163244545|NCT01040130|589602738|FG000|Overall Study|Withdrawal by Subject|0|||
163244546|NCT01040130|589602739|FG001|Overall Study|Withdrawal by Subject|2|||
163244547|NCT01040130|589602740|FG002|Overall Study|Withdrawal by Subject|0|||
163244548|NCT01040130|589602741|FG003|Overall Study|Withdrawal by Subject|0|||
163244549|NCT01040130|589602742|FG004|Overall Study|Withdrawal by Subject|0|||
163244550|NCT01040130|589602743|FG005|Overall Study|Withdrawal by Subject|1|||
163244551|NCT01040130|589602738|FG000|Overall Study|Other reasons not listed above|2|||
163244552|NCT01040130|589602739|FG001|Overall Study|Other reasons not listed above|0|||
163244553|NCT01040130|589602740|FG002|Overall Study|Other reasons not listed above|0|||
163244554|NCT01040130|589602741|FG003|Overall Study|Other reasons not listed above|0|||
163244555|NCT01040130|589602742|FG004|Overall Study|Other reasons not listed above|0|||
163244556|NCT01040130|589602743|FG005|Overall Study|Other reasons not listed above|0|||
163244557|NCT00553267|589602748|FG000|Overall Study|Adverse Event|8|||
163244558|NCT00553267|589602749|FG001|Overall Study|Adverse Event|10|||
163244559|NCT00553267|589602750|FG002|Overall Study|Adverse Event|5|||
163244560|NCT00553267|589602748|FG000|Overall Study|Non compliant with protocol|3|||
163244561|NCT00553267|589602749|FG001|Overall Study|Non compliant with protocol|3|||
163244562|NCT00553267|589602750|FG002|Overall Study|Non compliant with protocol|2|||
163244563|NCT00553267|589602748|FG000|Overall Study|Lost to Follow-up|0|||
163244564|NCT00553267|589602749|FG001|Overall Study|Lost to Follow-up|0|||
163244565|NCT00553267|589602750|FG002|Overall Study|Lost to Follow-up|1|||
163244566|NCT00553267|589602748|FG000|Overall Study|Consent withdrawn|2|||
163244567|NCT00553267|589602749|FG001|Overall Study|Consent withdrawn|3|||
163244568|NCT00553267|589602750|FG002|Overall Study|Consent withdrawn|1|||
163244569|NCT00553267|589602748|FG000|Overall Study|Specified category|1|||
163244570|NCT00553267|589602749|FG001|Overall Study|Specified category|2|||
163244571|NCT00553267|589602750|FG002|Overall Study|Specified category|1|||
163244572|NCT04389840|589602751|FG000|Overall Study|Adverse Event|0|||
163244573|NCT04389840|589602752|FG001|Overall Study|Adverse Event|0|||
163244574|NCT04389840|589602753|FG002|Overall Study|Adverse Event|0|||
163244575|NCT04389840|589602754|FG003|Overall Study|Adverse Event|1|||
163244576|NCT04389840|589602755|FG004|Overall Study|Adverse Event|0|||
163244577|NCT04389840|589602756|FG005|Overall Study|Adverse Event|0|||
163352138|NCT00550446|590000338|FG009|Up To Week 12|Other|0|||
163352139|NCT00550446|590000339|FG010|Up To Week 12|Other|0|||
163352140|NCT00550446|590000329|FG000|Up To Week 12|Randomized not treated|0|||
163244578|NCT04389840|589602751|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
163244579|NCT04389840|589602752|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
163244580|NCT04389840|589602753|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
163244581|NCT04389840|589602754|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
163244582|NCT04389840|589602755|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
163244583|NCT04389840|589602756|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
163244584|NCT04389840|589602751|FG000|Overall Study|Death|0|||
163244585|NCT04389840|589602752|FG001|Overall Study|Death|1|||
163244586|NCT04389840|589602753|FG002|Overall Study|Death|0|||
163244587|NCT04389840|589602754|FG003|Overall Study|Death|0|||
163244588|NCT04389840|589602755|FG004|Overall Study|Death|0|||
163244589|NCT04389840|589602756|FG005|Overall Study|Death|0|||
163244590|NCT01618864|589602757|FG000|Overall Study|Withdrawal by Subject|2|||
163244591|NCT01618864|589602757|FG000|Overall Study|Lost to Follow-up|2|||
163244592|NCT00096135|589602763|FG000|Overall Study|Physician Decision|20|||
163244593|NCT00096135|589602764|FG001|Overall Study|Physician Decision|4|||
163244594|NCT00096135|589602763|FG000|Overall Study|Refusal of further protocol therapy|4|||
163244595|NCT00096135|589602764|FG001|Overall Study|Refusal of further protocol therapy|1|||
163244596|NCT00096135|589602763|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
163244597|NCT00096135|589602764|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
163244598|NCT00096135|589602763|FG000|Overall Study|Other, specify|15|||
163244599|NCT00096135|589602764|FG001|Overall Study|Other, specify|3|||
163244600|NCT00096135|589602763|FG000|Overall Study|Ineligible|2|||
163244601|NCT00096135|589602764|FG001|Overall Study|Ineligible|0|||
163244602|NCT00833989|589602773|FG000|Overall Study|Physician Decision|0|||
163244603|NCT00833989|589602774|FG001|Overall Study|Physician Decision|0|||
163244604|NCT00833989|589602775|FG002|Overall Study|Physician Decision|0|||
163244605|NCT00833989|589602776|FG003|Overall Study|Physician Decision|1|||
163244606|NCT00833989|589602773|FG000|Overall Study|Withdrawal by Subject|3|||
163244607|NCT00833989|589602774|FG001|Overall Study|Withdrawal by Subject|0|||
163244608|NCT00833989|589602775|FG002|Overall Study|Withdrawal by Subject|1|||
163244609|NCT00833989|589602776|FG003|Overall Study|Withdrawal by Subject|1|||
163244610|NCT02310750|589602779|FG000|HP Period 1|Lost to Follow-up|0|||
163244611|NCT02310750|589602780|FG001|HP Period 1|Lost to Follow-up|0|||
163244612|NCT02310750|589602781|FG002|HP Period 1|Lost to Follow-up|0|||
163244613|NCT02310750|589602782|FG003|HP Period 1|Lost to Follow-up|0|||
163244614|NCT02310750|589602783|FG004|HP Period 1|Lost to Follow-up|0|||
163244615|NCT02310750|589602784|FG005|HP Period 1|Lost to Follow-up|0|||
163244616|NCT02310750|589602785|FG006|HP Period 1|Lost to Follow-up|1|||
163244617|NCT02310750|589602786|FG007|HP Period 1|Lost to Follow-up|0|||
163244618|NCT02310750|589602787|FG008|HP Period 1|Lost to Follow-up|0|||
163244619|NCT02310750|589602788|FG009|HP Period 1|Lost to Follow-up|0|||
163244620|NCT02310750|589602789|FG010|HP Period 1|Lost to Follow-up|0|||
163244621|NCT02310750|589602790|FG011|HP Period 1|Lost to Follow-up|0|||
163244622|NCT02310750|589602791|FG012|HP Period 1|Lost to Follow-up|0|||
163244623|NCT02310750|589602792|FG013|HP Period 1|Lost to Follow-up|0|||
163244624|NCT02310750|589602793|FG014|HP Period 1|Lost to Follow-up|0|||
163244625|NCT02310750|589602794|FG015|HP Period 1|Lost to Follow-up|0|||
163244626|NCT02310750|589602779|FG000|HP Period 1|Withdrawal by Subject|1|||
163244627|NCT02310750|589602780|FG001|HP Period 1|Withdrawal by Subject|0|||
163244628|NCT02310750|589602781|FG002|HP Period 1|Withdrawal by Subject|0|||
163244629|NCT02310750|589602782|FG003|HP Period 1|Withdrawal by Subject|1|||
163244630|NCT02310750|589602783|FG004|HP Period 1|Withdrawal by Subject|0|||
163244631|NCT02310750|589602784|FG005|HP Period 1|Withdrawal by Subject|0|||
163244632|NCT02310750|589602785|FG006|HP Period 1|Withdrawal by Subject|0|||
163244633|NCT02310750|589602786|FG007|HP Period 1|Withdrawal by Subject|0|||
163244634|NCT02310750|589602787|FG008|HP Period 1|Withdrawal by Subject|0|||
163244635|NCT02310750|589602788|FG009|HP Period 1|Withdrawal by Subject|0|||
163244636|NCT02310750|589602789|FG010|HP Period 1|Withdrawal by Subject|0|||
163244637|NCT02310750|589602790|FG011|HP Period 1|Withdrawal by Subject|0|||
163244638|NCT02310750|589602791|FG012|HP Period 1|Withdrawal by Subject|0|||
163244639|NCT02310750|589602792|FG013|HP Period 1|Withdrawal by Subject|0|||
163244640|NCT02310750|589602793|FG014|HP Period 1|Withdrawal by Subject|0|||
163244641|NCT02310750|589602794|FG015|HP Period 1|Withdrawal by Subject|0|||
163244642|NCT02310750|589602779|FG000|HP Washout 1|Lost to Follow-up|0|||
163244643|NCT02310750|589602780|FG001|HP Washout 1|Lost to Follow-up|0|||
163244644|NCT02310750|589602781|FG002|HP Washout 1|Lost to Follow-up|1|||
163244645|NCT02310750|589602782|FG003|HP Washout 1|Lost to Follow-up|1|||
163244646|NCT02310750|589602783|FG004|HP Washout 1|Lost to Follow-up|2|||
163244647|NCT02310750|589602784|FG005|HP Washout 1|Lost to Follow-up|2|||
163244648|NCT02310750|589602785|FG006|HP Washout 1|Lost to Follow-up|3|||
163244649|NCT02310750|589602786|FG007|HP Washout 1|Lost to Follow-up|0|||
163244650|NCT02310750|589602787|FG008|HP Washout 1|Lost to Follow-up|0|||
163244651|NCT02310750|589602788|FG009|HP Washout 1|Lost to Follow-up|0|||
163244652|NCT02310750|589602789|FG010|HP Washout 1|Lost to Follow-up|0|||
163244653|NCT02310750|589602790|FG011|HP Washout 1|Lost to Follow-up|0|||
163244654|NCT02310750|589602791|FG012|HP Washout 1|Lost to Follow-up|0|||
163244655|NCT02310750|589602792|FG013|HP Washout 1|Lost to Follow-up|0|||
163352141|NCT00550446|590000330|FG001|Up To Week 12|Randomized not treated|1|||
163352142|NCT00550446|590000331|FG002|Up To Week 12|Randomized not treated|1|||
163352143|NCT00550446|590000332|FG003|Up To Week 12|Randomized not treated|0|||
163352144|NCT00550446|590000333|FG004|Up To Week 12|Randomized not treated|0|||
163352145|NCT00550446|590000334|FG005|Up To Week 12|Randomized not treated|0|||
163352146|NCT00550446|590000335|FG006|Up To Week 12|Randomized not treated|0|||
163352147|NCT00550446|590000336|FG007|Up To Week 12|Randomized not treated|0|||
163352148|NCT00550446|590000337|FG008|Up To Week 12|Randomized not treated|0|||
163352149|NCT00550446|590000338|FG009|Up To Week 12|Randomized not treated|0|||
163352150|NCT00550446|590000339|FG010|Up To Week 12|Randomized not treated|0|||
163352151|NCT00550446|590000329|FG000|Post Week 12|Adverse Event|2|||
163352152|NCT00550446|590000330|FG001|Post Week 12|Adverse Event|1|||
163352153|NCT00550446|590000331|FG002|Post Week 12|Adverse Event|1|||
163352154|NCT00550446|590000332|FG003|Post Week 12|Adverse Event|1|||
163352155|NCT00550446|590000333|FG004|Post Week 12|Adverse Event|1|||
163352156|NCT00550446|590000334|FG005|Post Week 12|Adverse Event|1|||
163352157|NCT00550446|590000335|FG006|Post Week 12|Adverse Event|0|||
163352158|NCT00550446|590000336|FG007|Post Week 12|Adverse Event|0|||
163352159|NCT00550446|590000337|FG008|Post Week 12|Adverse Event|0|||
163352160|NCT00550446|590000338|FG009|Post Week 12|Adverse Event|4|||
163352161|NCT00550446|590000339|FG010|Post Week 12|Adverse Event|0|||
163352162|NCT00550446|590000329|FG000|Post Week 12|Lack of Efficacy|0|||
163352163|NCT00550446|590000330|FG001|Post Week 12|Lack of Efficacy|0|||
163352164|NCT00550446|590000331|FG002|Post Week 12|Lack of Efficacy|1|||
163352165|NCT00550446|590000332|FG003|Post Week 12|Lack of Efficacy|0|||
163352166|NCT00550446|590000333|FG004|Post Week 12|Lack of Efficacy|0|||
163352167|NCT00550446|590000334|FG005|Post Week 12|Lack of Efficacy|0|||
163352168|NCT00550446|590000335|FG006|Post Week 12|Lack of Efficacy|0|||
163352169|NCT00550446|590000336|FG007|Post Week 12|Lack of Efficacy|1|||
163352170|NCT00550446|590000337|FG008|Post Week 12|Lack of Efficacy|1|||
163352171|NCT00550446|590000338|FG009|Post Week 12|Lack of Efficacy|2|||
163352172|NCT00550446|590000339|FG010|Post Week 12|Lack of Efficacy|1|||
163352173|NCT00550446|590000329|FG000|Post Week 12|Lost to Follow-up|0|||
163352174|NCT00550446|590000330|FG001|Post Week 12|Lost to Follow-up|0|||
163352175|NCT00550446|590000331|FG002|Post Week 12|Lost to Follow-up|1|||
163352176|NCT00550446|590000332|FG003|Post Week 12|Lost to Follow-up|1|||
163352177|NCT00550446|590000333|FG004|Post Week 12|Lost to Follow-up|0|||
163352178|NCT00550446|590000334|FG005|Post Week 12|Lost to Follow-up|0|||
163352179|NCT00550446|590000335|FG006|Post Week 12|Lost to Follow-up|1|||
163352180|NCT00550446|590000336|FG007|Post Week 12|Lost to Follow-up|0|||
163352181|NCT00550446|590000337|FG008|Post Week 12|Lost to Follow-up|0|||
163352182|NCT00550446|590000338|FG009|Post Week 12|Lost to Follow-up|0|||
163352183|NCT00550446|590000339|FG010|Post Week 12|Lost to Follow-up|0|||
163352184|NCT00550446|590000329|FG000|Post Week 12|Withdrawal by Subject|0|||
163352185|NCT00550446|590000330|FG001|Post Week 12|Withdrawal by Subject|0|||
163352186|NCT00550446|590000331|FG002|Post Week 12|Withdrawal by Subject|0|||
163352187|NCT00550446|590000332|FG003|Post Week 12|Withdrawal by Subject|0|||
163352188|NCT00550446|590000333|FG004|Post Week 12|Withdrawal by Subject|1|||
163352189|NCT00550446|590000334|FG005|Post Week 12|Withdrawal by Subject|0|||
163352190|NCT00550446|590000335|FG006|Post Week 12|Withdrawal by Subject|0|||
163352191|NCT00550446|590000336|FG007|Post Week 12|Withdrawal by Subject|0|||
163352192|NCT00550446|590000337|FG008|Post Week 12|Withdrawal by Subject|0|||
163352193|NCT00550446|590000338|FG009|Post Week 12|Withdrawal by Subject|0|||
163352194|NCT00550446|590000339|FG010|Post Week 12|Withdrawal by Subject|0|||
163352195|NCT00550446|590000329|FG000|Post Week 12|Other|1|||
163352196|NCT00550446|590000330|FG001|Post Week 12|Other|1|||
163352197|NCT00550446|590000331|FG002|Post Week 12|Other|0|||
163352198|NCT00550446|590000332|FG003|Post Week 12|Other|1|||
163352199|NCT00550446|590000333|FG004|Post Week 12|Other|0|||
163352200|NCT00550446|590000334|FG005|Post Week 12|Other|0|||
163352201|NCT00550446|590000335|FG006|Post Week 12|Other|1|||
163148863|NCT05190120|589257404|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
163148864|NCT05190120|589257401|FG000|Overall Study|Lost to Follow-up|5|||
163148865|NCT05190120|589257402|FG001|Overall Study|Lost to Follow-up|0|||
163148866|NCT05190120|589257403|FG002|Overall Study|Lost to Follow-up|2|||
163148867|NCT05190120|589257404|FG003|Overall Study|Lost to Follow-up|3|||
163352202|NCT00550446|590000336|FG007|Post Week 12|Other|0|||
163352203|NCT00550446|590000337|FG008|Post Week 12|Other|1|||
163352204|NCT00550446|590000338|FG009|Post Week 12|Other|1|||
163352205|NCT00550446|590000339|FG010|Post Week 12|Other|0|||
163410200|NCT01290692|590211293|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
163148868|NCT03062358|589257405|FG000|Overall Study|Death|269|||
163352206|NCT01321723|590000340|FG000|Overall Study|Adverse Event|3|||
163352207|NCT01321723|590000341|FG001|Overall Study|Adverse Event|5|||
163352208|NCT01321723|590000342|FG002|Overall Study|Adverse Event|2|||
163352209|NCT01321723|590000340|FG000|Overall Study|Withdrawal by Subject|2|||
163352210|NCT01321723|590000341|FG001|Overall Study|Withdrawal by Subject|0|||
163352211|NCT01321723|590000342|FG002|Overall Study|Withdrawal by Subject|2|||
163352212|NCT02246218|590000343|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163352213|NCT02246218|590000344|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163352214|NCT02246218|590000343|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
163352215|NCT02246218|590000344|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
163148869|NCT03062358|589257406|FG001|Overall Study|Death|145|||
163148870|NCT03062358|589257405|FG000|Overall Study|Withdrawal by Subject|2|||
163148871|NCT03062358|589257406|FG001|Overall Study|Withdrawal by Subject|1|||
163148872|NCT03062358|589257405|FG000|Overall Study|Sponsor Decision|29|||
163148873|NCT03062358|589257406|FG001|Overall Study|Sponsor Decision|7|||
163148874|NCT05893862|589257407|FG000|Overall Study|Physician Decision|0|||
163148875|NCT05893862|589257408|FG001|Overall Study|Physician Decision|1|||
163148876|NCT05893862|589257409|FG002|Overall Study|Physician Decision|0|||
163148877|NCT05893862|589257410|FG003|Overall Study|Physician Decision|0|||
163148878|NCT05893862|589257411|FG004|Overall Study|Physician Decision|1|||
163148879|NCT05893862|589257412|FG005|Overall Study|Physician Decision|0|||
163148880|NCT05893862|589257407|FG000|Overall Study|Withdrawal by Subject|1|||
163148881|NCT05893862|589257408|FG001|Overall Study|Withdrawal by Subject|7|||
163148882|NCT05893862|589257409|FG002|Overall Study|Withdrawal by Subject|1|||
163148883|NCT05893862|589257410|FG003|Overall Study|Withdrawal by Subject|3|||
163148884|NCT05893862|589257411|FG004|Overall Study|Withdrawal by Subject|3|||
163148885|NCT05893862|589257412|FG005|Overall Study|Withdrawal by Subject|2|||
163148886|NCT05893862|589257407|FG000|Overall Study|Adverse Event|1|||
163148887|NCT05893862|589257408|FG001|Overall Study|Adverse Event|4|||
163148888|NCT05893862|589257409|FG002|Overall Study|Adverse Event|2|||
163148889|NCT05893862|589257410|FG003|Overall Study|Adverse Event|2|||
163148890|NCT05893862|589257411|FG004|Overall Study|Adverse Event|1|||
163148891|NCT05893862|589257412|FG005|Overall Study|Adverse Event|0|||
163148892|NCT00410956|589257413|FG000|Overall Study|Adverse Event|1|||
163148893|NCT00410956|589257413|FG000|Overall Study|Death|2|||
163148894|NCT00410956|589257413|FG000|Overall Study|Lack of Efficacy|10|||
163148895|NCT00410956|589257413|FG000|Overall Study|Physician Decision|6|||
163148896|NCT00880698|589257414|FG000|Overall Study|Death|0|||
163148897|NCT00880698|589257415|FG001|Overall Study|Death|0|||
163148898|NCT00880698|589257416|FG002|Overall Study|Death|1|||
163148899|NCT00880698|589257417|FG003|Overall Study|Death|2|||
163148900|NCT00880698|589257414|FG000|Overall Study|Lost to Follow-up|1|||
163148901|NCT00880698|589257415|FG001|Overall Study|Lost to Follow-up|3|||
163148902|NCT00880698|589257416|FG002|Overall Study|Lost to Follow-up|0|||
163148903|NCT00880698|589257417|FG003|Overall Study|Lost to Follow-up|1|||
163148904|NCT00089297|589259348|FG000|Overall Study|Adverse Event|9|||
163148905|NCT00089297|589259348|FG000|Overall Study|Death|1|||
163148906|NCT00089297|589259348|FG000|Overall Study|Withdrawal by Subject|12|||
163148907|NCT00089297|589259348|FG000|Overall Study|Disease progression|2|||
163148908|NCT00089297|589259348|FG000|Overall Study|Ineligible|11|||
163148909|NCT00089297|589259348|FG000|Overall Study|Secondary malignancy|1|||
163148910|NCT00089297|589259348|FG000|Overall Study|IRB approval not ready|1|||
163148911|NCT00089297|589259348|FG000|Overall Study|Non-compliance|1|||
163148912|NCT04199351|589259351|FG000|Overall Study|Decision by sponsor|0|||
163148913|NCT04199351|589259352|FG001|Overall Study|Decision by sponsor|0|||
163148914|NCT04199351|589259353|FG002|Overall Study|Decision by sponsor|0|||
163148915|NCT04199351|589259354|FG003|Overall Study|Decision by sponsor|2|||
163148916|NCT04199351|589259355|FG004|Overall Study|Decision by sponsor|0|||
163148917|NCT04199351|589259356|FG005|Overall Study|Decision by sponsor|0|||
163148918|NCT04199351|589259357|FG006|Overall Study|Decision by sponsor|0|||
163148919|NCT04199351|589259358|FG007|Overall Study|Decision by sponsor|0|||
163352216|NCT02246218|590000343|FG000|Overall Study|Adverse Event|1|||
163352217|NCT02246218|590000344|FG001|Overall Study|Adverse Event|1|||
163148920|NCT04199351|589259359|FG008|Overall Study|Decision by sponsor|0|||
163148921|NCT04199351|589259360|FG009|Overall Study|Decision by sponsor|6|||
163148922|NCT04199351|589259351|FG000|Overall Study|Lost to Follow-up|0|||
163148923|NCT04199351|589259352|FG001|Overall Study|Lost to Follow-up|0|||
163148924|NCT04199351|589259353|FG002|Overall Study|Lost to Follow-up|1|||
163148925|NCT04199351|589259354|FG003|Overall Study|Lost to Follow-up|0|||
163148926|NCT04199351|589259355|FG004|Overall Study|Lost to Follow-up|0|||
163148927|NCT04199351|589259356|FG005|Overall Study|Lost to Follow-up|1|||
163148928|NCT04199351|589259357|FG006|Overall Study|Lost to Follow-up|0|||
163148929|NCT04199351|589259358|FG007|Overall Study|Lost to Follow-up|0|||
163148930|NCT04199351|589259359|FG008|Overall Study|Lost to Follow-up|0|||
163148931|NCT04199351|589259360|FG009|Overall Study|Lost to Follow-up|0|||
163148932|NCT04199351|589259351|FG000|Overall Study|Withdrawal by Subject|0|||
163148933|NCT04199351|589259352|FG001|Overall Study|Withdrawal by Subject|1|||
163148934|NCT04199351|589259353|FG002|Overall Study|Withdrawal by Subject|0|||
163148935|NCT04199351|589259354|FG003|Overall Study|Withdrawal by Subject|0|||
163148936|NCT04199351|589259355|FG004|Overall Study|Withdrawal by Subject|1|||
163148937|NCT04199351|589259356|FG005|Overall Study|Withdrawal by Subject|4|||
163148938|NCT04199351|589259357|FG006|Overall Study|Withdrawal by Subject|2|||
163148939|NCT04199351|589259358|FG007|Overall Study|Withdrawal by Subject|0|||
163148940|NCT04199351|589259359|FG008|Overall Study|Withdrawal by Subject|3|||
163148941|NCT04199351|589259360|FG009|Overall Study|Withdrawal by Subject|0|||
163148942|NCT00979901|589259361|FG000|Overall Study|Adverse Event|1|||
163148943|NCT00979901|589259362|FG001|Overall Study|Adverse Event|3|||
163352218|NCT02246218|590000343|FG000|Overall Study|Lost to Follow-up|1|||
163148944|NCT00979901|589259363|FG002|Overall Study|Adverse Event|9|||
163148945|NCT00979901|589259364|FG003|Overall Study|Adverse Event|2|||
163148946|NCT00979901|589259361|FG000|Overall Study|Lack of Efficacy|8|||
163148947|NCT00979901|589259362|FG001|Overall Study|Lack of Efficacy|4|||
163148948|NCT00979901|589259363|FG002|Overall Study|Lack of Efficacy|9|||
163148949|NCT00979901|589259364|FG003|Overall Study|Lack of Efficacy|0|||
163148950|NCT00979901|589259361|FG000|Overall Study|Lost to Follow-up|1|||
163148951|NCT00979901|589259362|FG001|Overall Study|Lost to Follow-up|1|||
163148952|NCT00979901|589259363|FG002|Overall Study|Lost to Follow-up|2|||
163148953|NCT00979901|589259364|FG003|Overall Study|Lost to Follow-up|0|||
163148954|NCT00979901|589259361|FG000|Overall Study|Protocol Violation|2|||
163148955|NCT00979901|589259362|FG001|Overall Study|Protocol Violation|2|||
163148956|NCT00979901|589259363|FG002|Overall Study|Protocol Violation|7|||
163148957|NCT00979901|589259364|FG003|Overall Study|Protocol Violation|1|||
163148958|NCT00979901|589259361|FG000|Overall Study|Withdrawal by Subject|2|||
163148959|NCT00979901|589259362|FG001|Overall Study|Withdrawal by Subject|1|||
163148960|NCT00979901|589259363|FG002|Overall Study|Withdrawal by Subject|1|||
163148961|NCT00979901|589259364|FG003|Overall Study|Withdrawal by Subject|1|||
163148962|NCT00979901|589259361|FG000|Overall Study|Noncompliance|1|||
163148963|NCT00979901|589259362|FG001|Overall Study|Noncompliance|0|||
163148964|NCT00979901|589259363|FG002|Overall Study|Noncompliance|0|||
163148965|NCT00979901|589259364|FG003|Overall Study|Noncompliance|0|||
163148966|NCT00979901|589259361|FG000|Overall Study|out-of-state|1|||
163148967|NCT00979901|589259362|FG001|Overall Study|out-of-state|0|||
163148968|NCT00979901|589259363|FG002|Overall Study|out-of-state|0|||
163148969|NCT00979901|589259364|FG003|Overall Study|out-of-state|0|||
163148970|NCT00979901|589259361|FG000|Overall Study|vacation|1|||
163148971|NCT00979901|589259362|FG001|Overall Study|vacation|0|||
163148972|NCT00979901|589259363|FG002|Overall Study|vacation|0|||
163148973|NCT00979901|589259364|FG003|Overall Study|vacation|0|||
163148974|NCT00979901|589259361|FG000|Overall Study|elevated lab values pre-randomization|1|||
163148975|NCT00979901|589259362|FG001|Overall Study|elevated lab values pre-randomization|0|||
163148976|NCT00979901|589259363|FG002|Overall Study|elevated lab values pre-randomization|0|||
163148977|NCT00979901|589259364|FG003|Overall Study|elevated lab values pre-randomization|0|||
163148978|NCT00979901|589259361|FG000|Overall Study|Discontinued in Error|0|||
163148979|NCT00979901|589259362|FG001|Overall Study|Discontinued in Error|1|||
163148980|NCT00979901|589259363|FG002|Overall Study|Discontinued in Error|0|||
163148981|NCT00979901|589259364|FG003|Overall Study|Discontinued in Error|0|||
163148982|NCT00979901|589259361|FG000|Overall Study|Left Country|0|||
163148983|NCT00979901|589259362|FG001|Overall Study|Left Country|0|||
163148984|NCT00979901|589259363|FG002|Overall Study|Left Country|1|||
163148985|NCT00979901|589259364|FG003|Overall Study|Left Country|0|||
163148986|NCT00979901|589259361|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
163148987|NCT00979901|589259362|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
163148988|NCT00979901|589259363|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
163148989|NCT00979901|589259364|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
163148990|NCT02814916|589259368|FG000|Overall Study|Withdrawal of consent|0|||
163148991|NCT02814916|589259369|FG001|Overall Study|Withdrawal of consent|2|||
163148992|NCT02814916|589259370|FG002|Overall Study|Withdrawal of consent|0|||
163148993|NCT02814916|589259368|FG000|Overall Study|Lost to Follow-up|0|||
163148994|NCT02814916|589259369|FG001|Overall Study|Lost to Follow-up|1|||
163148995|NCT02814916|589259370|FG002|Overall Study|Lost to Follow-up|0|||
163148996|NCT02814916|589259368|FG000|Overall Study|Other, not specified|0|||
163148997|NCT02814916|589259369|FG001|Overall Study|Other, not specified|1|||
163148998|NCT02814916|589259370|FG002|Overall Study|Other, not specified|0|||
163148999|NCT05316597|589259375|FG000|First Session|Withdrawal by Subject|0|||
163149000|NCT05316597|589259376|FG001|First Session|Withdrawal by Subject|1|||
163149001|NCT05316597|589259375|FG000|Washout Period|Lost to Follow-up|1|||
163149002|NCT05316597|589259376|FG001|Washout Period|Lost to Follow-up|2|||
163352219|NCT02246218|590000344|FG001|Overall Study|Lost to Follow-up|0|||
163149003|NCT05316597|589259375|FG000|Washout Period|Physician Decision|1|||
163149004|NCT05316597|589259376|FG001|Washout Period|Physician Decision|1|||
163149005|NCT05316597|589259375|FG000|Washout Period|Excluded before second session|1|||
163149006|NCT05316597|589259376|FG001|Washout Period|Excluded before second session|1|||
163149007|NCT05316597|589259375|FG000|Washout Period|Withdrawal by Subject|0|||
163149008|NCT05316597|589259376|FG001|Washout Period|Withdrawal by Subject|4|||
163149009|NCT02766023|589259381|FG000|Overall Study|Lost to Follow-up|23|||
163149010|NCT02766023|589259382|FG001|Overall Study|Lost to Follow-up|11|||
163149011|NCT02766023|589259381|FG000|Overall Study|Pregnancy|1|||
163149012|NCT02766023|589259382|FG001|Overall Study|Pregnancy|0|||
163149013|NCT02766023|589259381|FG000|Overall Study|Adverse Event|1|||
163149014|NCT02766023|589259382|FG001|Overall Study|Adverse Event|0|||
163149015|NCT02766023|589259381|FG000|Overall Study|Withdrawal by Subject|4|||
163149016|NCT02766023|589259382|FG001|Overall Study|Withdrawal by Subject|5|||
163149017|NCT02766023|589259381|FG000|Overall Study|Physician Decision|1|||
163149018|NCT02766023|589259382|FG001|Overall Study|Physician Decision|0|||
163149019|NCT02766023|589259381|FG000|Overall Study|Not Eligible at Enrollment|0|||
163352220|NCT00905034|590000345|FG000|Overall Study|Withdrawal by Subject|1|||
163352221|NCT03409731|590000347|FG000|Overall Study|Withdrawal by Subject|17|||
163352222|NCT03409731|590000347|FG000|Overall Study|Death|4|||
163352223|NCT00505414|590000349|FG000|Titration Phase|Adverse Event|0|||
163352224|NCT00505414|590000350|FG001|Titration Phase|Adverse Event|0|||
163352225|NCT00505414|590000351|FG002|Titration Phase|Adverse Event|0|||
163352226|NCT00505414|590000352|FG003|Titration Phase|Adverse Event|8|||
163352227|NCT00505414|590000353|FG004|Titration Phase|Adverse Event|3|||
163352228|NCT00505414|590000349|FG000|Titration Phase|Death|0|||
163352229|NCT00505414|590000350|FG001|Titration Phase|Death|0|||
163352230|NCT00505414|590000351|FG002|Titration Phase|Death|0|||
163352231|NCT00505414|590000352|FG003|Titration Phase|Death|2|||
163352232|NCT00505414|590000353|FG004|Titration Phase|Death|0|||
163410201|NCT02780648|590211294|FG000|Overall Study|Disease Progression|1|||
163149020|NCT02766023|589259382|FG001|Overall Study|Not Eligible at Enrollment|1|||
163149021|NCT00286468|589259383|FG000|Overall Study|Hyperglycemic Rescue|28|||
163149022|NCT00286468|589259384|FG001|Overall Study|Hyperglycemic Rescue|30|||
163149023|NCT00286468|589259385|FG002|Overall Study|Hyperglycemic Rescue|31|||
163149024|NCT00286468|589259383|FG000|Overall Study|Adverse Event|2|||
163149025|NCT00286468|589259384|FG001|Overall Study|Adverse Event|6|||
163149026|NCT00286468|589259385|FG002|Overall Study|Adverse Event|4|||
163149027|NCT00286468|589259383|FG000|Overall Study|Protocol Violation|0|||
163149028|NCT00286468|589259384|FG001|Overall Study|Protocol Violation|3|||
163149029|NCT00286468|589259385|FG002|Overall Study|Protocol Violation|1|||
163149030|NCT00286468|589259383|FG000|Overall Study|Lost to Follow-up|1|||
163149031|NCT00286468|589259384|FG001|Overall Study|Lost to Follow-up|1|||
163149032|NCT00286468|589259385|FG002|Overall Study|Lost to Follow-up|2|||
163149033|NCT00286468|589259383|FG000|Overall Study|Withdrawal by Subject|3|||
163149034|NCT00286468|589259384|FG001|Overall Study|Withdrawal by Subject|8|||
163149035|NCT00286468|589259385|FG002|Overall Study|Withdrawal by Subject|11|||
163149036|NCT00286468|589259383|FG000|Overall Study|Physician Decision|3|||
163149037|NCT00286468|589259384|FG001|Overall Study|Physician Decision|2|||
163244656|NCT02310750|589602793|FG014|HP Washout 1|Lost to Follow-up|0|||
163244657|NCT02310750|589602794|FG015|HP Washout 1|Lost to Follow-up|0|||
163244658|NCT02310750|589602779|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
163244659|NCT02310750|589602780|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
163244660|NCT02310750|589602781|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
163244661|NCT02310750|589602782|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
163244662|NCT02310750|589602783|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
163244663|NCT02310750|589602784|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
163244664|NCT02310750|589602785|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
163244665|NCT02310750|589602786|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
163244666|NCT02310750|589602787|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
163244667|NCT02310750|589602788|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
163244668|NCT02310750|589602789|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
163244669|NCT02310750|589602790|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
163244670|NCT02310750|589602791|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
163244671|NCT02310750|589602792|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
163244672|NCT02310750|589602793|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
163244673|NCT02310750|589602794|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
163244674|NCT02310750|589602779|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
163244675|NCT02310750|589602780|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
163244676|NCT02310750|589602781|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
163244677|NCT02310750|589602782|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
163244678|NCT02310750|589602783|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
163244679|NCT02310750|589602784|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
163244680|NCT02310750|589602785|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
163244681|NCT02310750|589602786|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
163244682|NCT02310750|589602787|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
163244683|NCT02310750|589602788|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
163244684|NCT02310750|589602789|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
163244685|NCT02310750|589602790|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
163244686|NCT02310750|589602791|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
163244687|NCT02310750|589602792|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
163244688|NCT02310750|589602793|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
163244689|NCT02310750|589602794|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
163244690|NCT02310750|589602779|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
163244691|NCT02310750|589602780|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
163244692|NCT02310750|589602781|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
163244693|NCT02310750|589602782|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
163244694|NCT02310750|589602783|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
163244695|NCT02310750|589602784|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
163352233|NCT00505414|590000349|FG000|Titration Phase|Lack of Efficacy|0|||
163352234|NCT00505414|590000350|FG001|Titration Phase|Lack of Efficacy|0|||
163352235|NCT00505414|590000351|FG002|Titration Phase|Lack of Efficacy|0|||
163352236|NCT00505414|590000352|FG003|Titration Phase|Lack of Efficacy|10|||
163352237|NCT00505414|590000353|FG004|Titration Phase|Lack of Efficacy|1|||
163352238|NCT00505414|590000349|FG000|Titration Phase|Protocol Violation|0|||
163352239|NCT00505414|590000350|FG001|Titration Phase|Protocol Violation|0|||
163352240|NCT00505414|590000351|FG002|Titration Phase|Protocol Violation|0|||
163352241|NCT00505414|590000352|FG003|Titration Phase|Protocol Violation|0|||
163352242|NCT00505414|590000353|FG004|Titration Phase|Protocol Violation|1|||
163352243|NCT00505414|590000349|FG000|Titration Phase|Withdrawal by Subject|0|||
163352244|NCT00505414|590000350|FG001|Titration Phase|Withdrawal by Subject|0|||
163352245|NCT00505414|590000351|FG002|Titration Phase|Withdrawal by Subject|0|||
163352246|NCT00505414|590000352|FG003|Titration Phase|Withdrawal by Subject|3|||
163352247|NCT00505414|590000353|FG004|Titration Phase|Withdrawal by Subject|4|||
163352248|NCT00505414|590000349|FG000|Titration Phase|Underlying disease and therapy required|0|||
163352249|NCT00505414|590000350|FG001|Titration Phase|Underlying disease and therapy required|0|||
163352250|NCT00505414|590000351|FG002|Titration Phase|Underlying disease and therapy required|0|||
163352251|NCT00505414|590000352|FG003|Titration Phase|Underlying disease and therapy required|7|||
163352252|NCT00505414|590000353|FG004|Titration Phase|Underlying disease and therapy required|3|||
163352253|NCT00505414|590000349|FG000|Maintenance Phase|Adverse Event|2|||
163352254|NCT00505414|590000350|FG001|Maintenance Phase|Adverse Event|2|||
163352255|NCT00505414|590000351|FG002|Maintenance Phase|Adverse Event|3|||
163352256|NCT00505414|590000352|FG003|Maintenance Phase|Adverse Event|0|||
163352257|NCT00505414|590000353|FG004|Maintenance Phase|Adverse Event|0|||
163352258|NCT00505414|590000349|FG000|Maintenance Phase|Death|2|||
163352259|NCT00505414|590000350|FG001|Maintenance Phase|Death|0|||
163352260|NCT00505414|590000351|FG002|Maintenance Phase|Death|1|||
163352261|NCT00505414|590000352|FG003|Maintenance Phase|Death|0|||
163352262|NCT00505414|590000353|FG004|Maintenance Phase|Death|0|||
163352263|NCT00505414|590000349|FG000|Maintenance Phase|Lack of Efficacy|2|||
163352264|NCT00505414|590000350|FG001|Maintenance Phase|Lack of Efficacy|1|||
163352265|NCT00505414|590000351|FG002|Maintenance Phase|Lack of Efficacy|1|||
163352266|NCT00505414|590000352|FG003|Maintenance Phase|Lack of Efficacy|0|||
163352267|NCT00505414|590000353|FG004|Maintenance Phase|Lack of Efficacy|0|||
163352268|NCT00505414|590000349|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163352269|NCT00505414|590000350|FG001|Maintenance Phase|Withdrawal by Subject|0|||
163352270|NCT00505414|590000351|FG002|Maintenance Phase|Withdrawal by Subject|1|||
163352271|NCT00505414|590000352|FG003|Maintenance Phase|Withdrawal by Subject|0|||
163352272|NCT00505414|590000353|FG004|Maintenance Phase|Withdrawal by Subject|0|||
163352273|NCT00505414|590000349|FG000|Maintenance Phase|underlying disease and therapy required|0|||
163352274|NCT00505414|590000350|FG001|Maintenance Phase|underlying disease and therapy required|2|||
163352275|NCT00505414|590000351|FG002|Maintenance Phase|underlying disease and therapy required|2|||
163410202|NCT02780648|590211295|FG001|Overall Study|Disease Progression|0|||
163149038|NCT00286468|589259385|FG002|Overall Study|Physician Decision|1|||
163149039|NCT03103542|589259386|FG000|Overall Study|Physician Decision|2|||
163149040|NCT03103542|589259386|FG000|Overall Study|Adverse Event|2|||
163149041|NCT03103542|589259386|FG000|Overall Study|Other|2|||
163149042|NCT03103542|589259386|FG000|Overall Study|Withdrawal by Subject|1|||
163149043|NCT02953652|589259387|FG000|Overall Study|Adverse Event|18|||
163149044|NCT02953652|589259387|FG000|Overall Study|Withdrawal by Subject|6|||
163149045|NCT02953652|589259387|FG000|Overall Study|Protocol Violation|1|||
163149046|NCT02953652|589259387|FG000|Overall Study|Disease Progression|27|||
163149047|NCT02384551|589259390|FG000|Overall Study|Lost to Follow-up|13|||
163149048|NCT02384551|589259391|FG001|Overall Study|Lost to Follow-up|14|||
163149049|NCT02384551|589259392|FG002|Overall Study|Lost to Follow-up|14|||
163149050|NCT02384551|589259393|FG003|Overall Study|Lost to Follow-up|14|||
163149051|NCT02927301|589259397|FG000|Overall Study|Death|39|||
163149052|NCT02927301|589259397|FG000|Overall Study|Lost to Follow-up|8|||
163149053|NCT02927301|589259397|FG000|Overall Study|Physician Decision|2|||
163149054|NCT02927301|589259397|FG000|Overall Study|Withdrawal by Subject|12|||
163149055|NCT02927301|589259397|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
163149056|NCT04742556|589259398|FG000|Overall Study|Withdrawal by Subject|0|||
163149057|NCT04742556|589259399|FG001|Overall Study|Withdrawal by Subject|1|||
163149058|NCT04742556|589259400|FG002|Overall Study|Withdrawal by Subject|0|||
163149059|NCT04742556|589259398|FG000|Overall Study|Adverse Event|0|||
163149060|NCT04742556|589259399|FG001|Overall Study|Adverse Event|0|||
163149061|NCT04742556|589259400|FG002|Overall Study|Adverse Event|2|||
163149062|NCT04742556|589259398|FG000|Overall Study|Clinical disease progression|0|||
163149063|NCT04742556|589259399|FG001|Overall Study|Clinical disease progression|1|||
163149064|NCT04742556|589259400|FG002|Overall Study|Clinical disease progression|2|||
163149065|NCT04742556|589259398|FG000|Overall Study|Objective disease progression|3|||
163149066|NCT04742556|589259399|FG001|Overall Study|Objective disease progression|2|||
163352276|NCT00505414|590000352|FG003|Maintenance Phase|underlying disease and therapy required|0|||
163352277|NCT00505414|590000353|FG004|Maintenance Phase|underlying disease and therapy required|0|||
163352278|NCT04358068|590000354|FG000|Overall Study|Did not initiate study treatment|2|||
163410203|NCT03127384|590211307|FG000|Overall Study|Lost to Follow-up|4|||
163352279|NCT04358068|590000355|FG001|Overall Study|Did not initiate study treatment|2|||
163352280|NCT01193218|590000356|FG000|0-12 Weeks|Adverse Event|6|||
163352281|NCT01193218|590000357|FG001|0-12 Weeks|Adverse Event|0|||
163352282|NCT01193218|590000358|FG002|0-12 Weeks|Adverse Event|1|||
163352283|NCT01193218|590000359|FG003|0-12 Weeks|Adverse Event|0|||
163352284|NCT01193218|590000360|FG004|0-12 Weeks|Adverse Event|0|||
163352285|NCT01193218|590000361|FG005|0-12 Weeks|Adverse Event|2|||
163352286|NCT01193218|590000362|FG006|0-12 Weeks|Adverse Event|2|||
163352287|NCT01193218|590000363|FG007|0-12 Weeks|Adverse Event|0|||
163352288|NCT01193218|590000356|FG000|0-12 Weeks|Protocol Violation|0|||
163352289|NCT01193218|590000357|FG001|0-12 Weeks|Protocol Violation|0|||
163352290|NCT01193218|590000358|FG002|0-12 Weeks|Protocol Violation|0|||
163352291|NCT01193218|590000359|FG003|0-12 Weeks|Protocol Violation|0|||
163352292|NCT01193218|590000360|FG004|0-12 Weeks|Protocol Violation|1|||
163410204|NCT03127384|590211307|FG000|Overall Study|Subject request|2|||
163149067|NCT04742556|589259400|FG002|Overall Study|Objective disease progression|4|||
163149068|NCT02903771|589259401|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
163149069|NCT02903771|589259402|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
163244696|NCT02310750|589602785|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
163244697|NCT02310750|589602786|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
163244698|NCT02310750|589602787|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
163244699|NCT02310750|589602788|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
163244700|NCT02310750|589602789|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
163244701|NCT02310750|589602790|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
163244702|NCT02310750|589602791|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
163244703|NCT02310750|589602792|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
163244704|NCT02310750|589602793|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
163244705|NCT02310750|589602794|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
163244706|NCT02310750|589602779|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
163244707|NCT02310750|589602780|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
163244708|NCT02310750|589602781|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
163244709|NCT02310750|589602782|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
163244710|NCT02310750|589602783|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
163244711|NCT02310750|589602784|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
163244712|NCT02310750|589602785|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
163244713|NCT02310750|589602786|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
163244714|NCT02310750|589602787|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
163244715|NCT02310750|589602788|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
163244716|NCT02310750|589602789|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
163244717|NCT02310750|589602790|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
163244718|NCT02310750|589602791|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
163244719|NCT02310750|589602792|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
163244720|NCT02310750|589602793|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
163244721|NCT02310750|589602794|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
163244722|NCT02310750|589602779|FG000|HP Washout 2|Lost to Follow-up|0|||
163244723|NCT02310750|589602780|FG001|HP Washout 2|Lost to Follow-up|0|||
163244724|NCT02310750|589602781|FG002|HP Washout 2|Lost to Follow-up|0|||
163244725|NCT02310750|589602782|FG003|HP Washout 2|Lost to Follow-up|0|||
163244726|NCT02310750|589602783|FG004|HP Washout 2|Lost to Follow-up|1|||
163244727|NCT02310750|589602784|FG005|HP Washout 2|Lost to Follow-up|0|||
163244728|NCT02310750|589602785|FG006|HP Washout 2|Lost to Follow-up|7|||
163244729|NCT02310750|589602786|FG007|HP Washout 2|Lost to Follow-up|0|||
163244730|NCT02310750|589602787|FG008|HP Washout 2|Lost to Follow-up|0|||
163244731|NCT02310750|589602788|FG009|HP Washout 2|Lost to Follow-up|0|||
163244732|NCT02310750|589602789|FG010|HP Washout 2|Lost to Follow-up|0|||
163244733|NCT02310750|589602790|FG011|HP Washout 2|Lost to Follow-up|0|||
163352293|NCT01193218|590000361|FG005|0-12 Weeks|Protocol Violation|1|||
163352294|NCT01193218|590000362|FG006|0-12 Weeks|Protocol Violation|0|||
163149070|NCT02903771|589259403|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
163149071|NCT02903771|589259404|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
163149072|NCT02903771|589259405|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
163149073|NCT02903771|589259406|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
163149074|NCT02903771|589259407|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
163149075|NCT02903771|589259401|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
163149076|NCT02903771|589259402|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
163149077|NCT02903771|589259403|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
163149078|NCT02903771|589259404|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
163149079|NCT02903771|589259405|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
163352295|NCT01193218|590000363|FG007|0-12 Weeks|Protocol Violation|0|||
163352296|NCT01193218|590000356|FG000|0-12 Weeks|Withdrawal by Subject|3|||
163352297|NCT01193218|590000357|FG001|0-12 Weeks|Withdrawal by Subject|0|||
163352298|NCT01193218|590000358|FG002|0-12 Weeks|Withdrawal by Subject|2|||
163352299|NCT01193218|590000359|FG003|0-12 Weeks|Withdrawal by Subject|0|||
163352300|NCT01193218|590000360|FG004|0-12 Weeks|Withdrawal by Subject|0|||
163352301|NCT01193218|590000361|FG005|0-12 Weeks|Withdrawal by Subject|0|||
163352302|NCT01193218|590000362|FG006|0-12 Weeks|Withdrawal by Subject|1|||
163352303|NCT01193218|590000363|FG007|0-12 Weeks|Withdrawal by Subject|0|||
163352304|NCT01193218|590000356|FG000|12-52 Weeks|Adverse Event|1|||
163352305|NCT01193218|590000357|FG001|12-52 Weeks|Adverse Event|0|||
163352306|NCT01193218|590000358|FG002|12-52 Weeks|Adverse Event|1|||
163352307|NCT01193218|590000359|FG003|12-52 Weeks|Adverse Event|2|||
163352308|NCT01193218|590000360|FG004|12-52 Weeks|Adverse Event|3|||
163352309|NCT01193218|590000361|FG005|12-52 Weeks|Adverse Event|3|||
163352310|NCT01193218|590000362|FG006|12-52 Weeks|Adverse Event|1|||
163352311|NCT01193218|590000363|FG007|12-52 Weeks|Adverse Event|2|||
163352312|NCT01193218|590000356|FG000|12-52 Weeks|Lack of Efficacy|0|||
163352313|NCT01193218|590000357|FG001|12-52 Weeks|Lack of Efficacy|0|||
163352314|NCT01193218|590000358|FG002|12-52 Weeks|Lack of Efficacy|0|||
163352315|NCT01193218|590000359|FG003|12-52 Weeks|Lack of Efficacy|0|||
163352316|NCT01193218|590000360|FG004|12-52 Weeks|Lack of Efficacy|0|||
163352317|NCT01193218|590000361|FG005|12-52 Weeks|Lack of Efficacy|0|||
163352318|NCT01193218|590000362|FG006|12-52 Weeks|Lack of Efficacy|1|||
163352319|NCT01193218|590000363|FG007|12-52 Weeks|Lack of Efficacy|0|||
163352320|NCT01193218|590000356|FG000|12-52 Weeks|Withdrawal by Subject|3|||
163352321|NCT01193218|590000357|FG001|12-52 Weeks|Withdrawal by Subject|0|||
163352322|NCT01193218|590000358|FG002|12-52 Weeks|Withdrawal by Subject|3|||
163352323|NCT01193218|590000359|FG003|12-52 Weeks|Withdrawal by Subject|0|||
163352324|NCT01193218|590000360|FG004|12-52 Weeks|Withdrawal by Subject|0|||
163352325|NCT01193218|590000361|FG005|12-52 Weeks|Withdrawal by Subject|2|||
163352326|NCT01193218|590000362|FG006|12-52 Weeks|Withdrawal by Subject|1|||
163352327|NCT01193218|590000363|FG007|12-52 Weeks|Withdrawal by Subject|2|||
163352328|NCT01193218|590000356|FG000|12-52 Weeks|Other reason than above|1|||
163352329|NCT01193218|590000357|FG001|12-52 Weeks|Other reason than above|0|||
163352330|NCT01193218|590000358|FG002|12-52 Weeks|Other reason than above|0|||
163352331|NCT01193218|590000359|FG003|12-52 Weeks|Other reason than above|1|||
163352332|NCT01193218|590000360|FG004|12-52 Weeks|Other reason than above|1|||
163352333|NCT01193218|590000361|FG005|12-52 Weeks|Other reason than above|0|||
163352334|NCT01193218|590000362|FG006|12-52 Weeks|Other reason than above|0|||
163352335|NCT01193218|590000363|FG007|12-52 Weeks|Other reason than above|0|||
163352336|NCT00665223|590000366|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
163352337|NCT00665223|590000367|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
163352338|NCT00665223|590000368|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
163352339|NCT00665223|590000366|FG000|Randomized Phase (26 Weeks)|Death|0|||
163352340|NCT00665223|590000367|FG001|Randomized Phase (26 Weeks)|Death|0|||
163352341|NCT00665223|590000368|FG002|Randomized Phase (26 Weeks)|Death|1|||
163352342|NCT00665223|590000366|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
163352343|NCT00665223|590000367|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
163352344|NCT00665223|590000368|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
163352345|NCT00665223|590000366|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
163352346|NCT00665223|590000367|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
163352347|NCT00665223|590000368|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
163352348|NCT00665223|590000366|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
163352349|NCT00665223|590000367|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
163352350|NCT00665223|590000368|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
163352351|NCT00665223|590000366|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
163352352|NCT00665223|590000367|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
163352353|NCT00665223|590000368|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
163352354|NCT00665223|590000366|FG000|Open-Label Period (26 Weeks)|Death|0|||
163352355|NCT00665223|590000367|FG001|Open-Label Period (26 Weeks)|Death|1|||
163352356|NCT00665223|590000368|FG002|Open-Label Period (26 Weeks)|Death|0|||
163352357|NCT00665223|590000366|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
163352358|NCT00665223|590000367|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
163352359|NCT00665223|590000368|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
163352360|NCT00665223|590000366|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
163352361|NCT00665223|590000367|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
163352362|NCT00665223|590000368|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
163352363|NCT00665223|590000366|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
163352364|NCT00665223|590000367|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
163352365|NCT00665223|590000368|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
163352366|NCT00665223|590000366|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
163352367|NCT00665223|590000367|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
163352368|NCT00665223|590000368|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
163352369|NCT00363649|590000369|FG000|Overall Study|Withdrawal by Subject|1|||
163352370|NCT00363649|590000370|FG001|Overall Study|Withdrawal by Subject|1|||
163352371|NCT00363649|590000369|FG000|Overall Study|Adverse Event|6|||
163352372|NCT00363649|590000370|FG001|Overall Study|Adverse Event|0|||
163352373|NCT01349036|590000371|FG000|Overall Study|Disease progression|13|||
163352374|NCT01349036|590000372|FG001|Overall Study|Disease progression|22|||
163352375|NCT01349036|590000371|FG000|Overall Study|Other|1|||
163352376|NCT01349036|590000372|FG001|Overall Study|Other|0|||
163149080|NCT02903771|589259406|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
163244734|NCT02310750|589602791|FG012|HP Washout 2|Lost to Follow-up|0|||
163244735|NCT02310750|589602792|FG013|HP Washout 2|Lost to Follow-up|0|||
163244736|NCT02310750|589602793|FG014|HP Washout 2|Lost to Follow-up|0|||
163244737|NCT02310750|589602794|FG015|HP Washout 2|Lost to Follow-up|0|||
163244738|NCT03585244|589602795|FG000|Overall Study|Withdrawal by Subject|15|||
163244739|NCT02199028|589602800|FG000|Week 1|Adverse Event|1|||
163244740|NCT02199028|589602801|FG001|Week 1|Adverse Event|0|||
163244741|NCT02199028|589602800|FG000|Week 3|Adverse Event|1|||
163244742|NCT02199028|589602801|FG001|Week 3|Adverse Event|0|||
163244743|NCT01881126|589602804|FG000|Overall Study|Non-compliance|1|||
163244744|NCT01881126|589602805|FG001|Overall Study|Non-compliance|1|||
163244745|NCT01881126|589602804|FG000|Overall Study|Adverse Event|0|||
163244746|NCT01881126|589602805|FG001|Overall Study|Adverse Event|1|||
163244747|NCT05045625|589602806|FG000|Overall Study|Lost to Follow-up|3|||
163244748|NCT01617629|589602810|FG000|Overall Study|Death|2|||
163244749|NCT01617629|589602810|FG000|Overall Study|Investigator's Clinical Judgement|1|||
163244750|NCT01617629|589602810|FG000|Overall Study|Reason Not Specified|1|||
163244751|NCT01617629|589602810|FG000|Overall Study|Participant Withdrew Consent|2|||
163244752|NCT01663636|589602811|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
163244753|NCT01663636|589602812|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
163244754|NCT02663817|589602815|FG000|Overall Study|Screen failure|2|||
163244755|NCT05350449|589602816|FG000|Overall Study|Withdrawal by Subject|4|||
163244756|NCT05350449|589602817|FG001|Overall Study|Withdrawal by Subject|8|||
163244757|NCT01912612|589605364|FG000|Overall Study|Adverse Event|4|||
163244758|NCT01912612|589605365|FG001|Overall Study|Adverse Event|0|||
163244759|NCT01912612|589605366|FG002|Overall Study|Adverse Event|0|||
163244760|NCT01912612|589605364|FG000|Overall Study|Withdrew consent|1|||
163244761|NCT01912612|589605365|FG001|Overall Study|Withdrew consent|0|||
163244762|NCT01912612|589605366|FG002|Overall Study|Withdrew consent|0|||
163244763|NCT01912612|589605364|FG000|Overall Study|Study design change|0|||
163244764|NCT01912612|589605365|FG001|Overall Study|Study design change|0|||
163244765|NCT01912612|589605366|FG002|Overall Study|Study design change|3|||
163244766|NCT01588184|589605367|FG000|Overall Study|Death|1|||
163244767|NCT01588184|589605368|FG001|Overall Study|Death|0|||
163244768|NCT01588184|589605369|FG002|Overall Study|Death|0|||
163244769|NCT01588184|589605370|FG003|Overall Study|Death|1|||
163244770|NCT01588184|589605371|FG004|Overall Study|Death|1|||
163244771|NCT01588184|589605372|FG005|Overall Study|Death|1|||
163244772|NCT01588184|589605367|FG000|Overall Study|Withdrawal by Subject|2|||
163244773|NCT01588184|589605368|FG001|Overall Study|Withdrawal by Subject|4|||
163244774|NCT01588184|589605369|FG002|Overall Study|Withdrawal by Subject|0|||
163244775|NCT01588184|589605370|FG003|Overall Study|Withdrawal by Subject|1|||
163244776|NCT01588184|589605371|FG004|Overall Study|Withdrawal by Subject|0|||
163244777|NCT01588184|589605372|FG005|Overall Study|Withdrawal by Subject|0|||
163244778|NCT01588184|589605367|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
163244779|NCT01588184|589605368|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
163244780|NCT01588184|589605369|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
163244781|NCT01588184|589605370|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
163244782|NCT01588184|589605371|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
163244783|NCT01588184|589605372|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
163244784|NCT01588184|589605367|FG000|Overall Study|multiple reasons|0|||
163244785|NCT01588184|589605368|FG001|Overall Study|multiple reasons|3|||
163244786|NCT01588184|589605369|FG002|Overall Study|multiple reasons|0|||
163244787|NCT01588184|589605370|FG003|Overall Study|multiple reasons|1|||
163244788|NCT01588184|589605371|FG004|Overall Study|multiple reasons|0|||
163244789|NCT01588184|589605372|FG005|Overall Study|multiple reasons|0|||
163244790|NCT03750552|589605373|FG000|Overall Study|Adverse Event|5|||
163244791|NCT03750552|589605374|FG001|Overall Study|Adverse Event|1|||
163244792|NCT03750552|589605373|FG000|Overall Study|Withdrawal by Subject|1|||
163244793|NCT03750552|589605374|FG001|Overall Study|Withdrawal by Subject|1|||
163244794|NCT03750552|589605373|FG000|Overall Study|Other|2|||
163244795|NCT03750552|589605374|FG001|Overall Study|Other|0|||
163244796|NCT02062632|589605375|FG000|Overall Study|No treatment data|1|||
163244797|NCT00773968|589605378|FG000|Overall Study|Adverse Event|2|||
163244798|NCT00773968|589605378|FG000|Overall Study|Death|1|||
163244799|NCT00773968|589605378|FG000|Overall Study|Failure to Return|2|||
163244800|NCT00773968|589605378|FG000|Overall Study|Lack of Efficacy|3|||
163244801|NCT00773968|589605378|FG000|Overall Study|Protocol Violation|1|||
163244802|NCT00773968|589605378|FG000|Overall Study|Withdrawal by Subject|11|||
163244803|NCT00773968|589605378|FG000|Overall Study|Screen Failure|17|||
163244804|NCT00773968|589605378|FG000|Overall Study|Other|8|||
163244805|NCT02008890|589605381|FG000|Period 1|Withdrawal by Subject|7|||
163244806|NCT02008890|589605382|FG001|Period 1|Withdrawal by Subject|7|||
163244807|NCT02008890|589605383|FG002|Period 1|Withdrawal by Subject|5|||
163244808|NCT02008890|589605384|FG003|Period 1|Withdrawal by Subject|0|||
163352377|NCT01349036|590000371|FG000|Overall Study|Withdrawal by Subject|0|||
163352378|NCT01349036|590000372|FG001|Overall Study|Withdrawal by Subject|2|||
163352379|NCT03796208|590000373|FG000|Overall Study|Withdrawal by Subject|3|||
163352380|NCT03796208|590000374|FG001|Overall Study|Withdrawal by Subject|0|||
163352381|NCT03796208|590000373|FG000|Overall Study|Loss of pregnancy|1|||
163352382|NCT03796208|590000374|FG001|Overall Study|Loss of pregnancy|1|||
163352383|NCT03796208|590000373|FG000|Overall Study|Changed prenatal clinics|0|||
163352384|NCT03796208|590000374|FG001|Overall Study|Changed prenatal clinics|5|||
163352385|NCT03796208|590000373|FG000|Overall Study|Lost to Follow-up|20|||
163149081|NCT02903771|589259407|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
163149082|NCT02903771|589259401|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
163149083|NCT02903771|589259402|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
163149084|NCT02903771|589259403|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
163149085|NCT02903771|589259404|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
163149086|NCT02903771|589259405|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
163149087|NCT02903771|589259406|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
163149088|NCT02903771|589259407|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
163149089|NCT02903771|589259401|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
163149090|NCT02903771|589259402|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
163149091|NCT02903771|589259403|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
163149092|NCT02903771|589259404|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
163149093|NCT02903771|589259405|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
163149094|NCT02903771|589259406|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
163149095|NCT02903771|589259407|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
163149096|NCT02903771|589259401|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
163149097|NCT02903771|589259402|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
163149098|NCT02903771|589259403|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
163149099|NCT02903771|589259404|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
163149100|NCT02903771|589259405|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
163149101|NCT02903771|589259406|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
163149102|NCT02903771|589259407|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
163149103|NCT02903771|589259401|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
163149104|NCT02903771|589259402|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
163149105|NCT02903771|589259403|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
163149106|NCT02903771|589259404|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
163149107|NCT02903771|589259405|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
163149108|NCT02903771|589259406|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
163149109|NCT02903771|589259407|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
163149110|NCT02903771|589259401|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
163149111|NCT02903771|589259402|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
163149112|NCT02903771|589259403|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
163149113|NCT02903771|589259404|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
163149114|NCT02903771|589259405|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
163149115|NCT02903771|589259406|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
163149116|NCT02903771|589259407|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
163149117|NCT02903771|589259401|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
163149118|NCT02903771|589259402|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
163149119|NCT02903771|589259403|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
163149120|NCT02903771|589259404|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
163149121|NCT02903771|589259405|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
163149122|NCT02903771|589259406|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
163149123|NCT02903771|589259407|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
163149124|NCT02903771|589259401|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
163149125|NCT02903771|589259402|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
163149126|NCT02903771|589259403|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
163149127|NCT02903771|589259404|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
163149128|NCT02903771|589259405|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
163149129|NCT02903771|589259406|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
163149130|NCT02903771|589259407|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
163149131|NCT02903771|589259401|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
163149132|NCT02903771|589259402|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
163149133|NCT02903771|589259403|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
163149134|NCT02903771|589259404|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
163149135|NCT02903771|589259405|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
163149136|NCT02903771|589259406|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
163149137|NCT02903771|589259407|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
163149138|NCT02903771|589259401|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
163352386|NCT03796208|590000374|FG001|Overall Study|Lost to Follow-up|16|||
163410205|NCT00689871|590211308|FG000|Overall Study|Lost to Follow-up|123|||
163410206|NCT00689871|590211309|FG001|Overall Study|Lost to Follow-up|13|||
163410207|NCT00689871|590211310|FG002|Overall Study|Lost to Follow-up|37|||
163410208|NCT00689871|590211311|FG003|Overall Study|Lost to Follow-up|1|||
163410209|NCT00689871|590211308|FG000|Overall Study|Explanted of All Study Devices|36|||
163244809|NCT02008890|589605385|FG004|Period 1|Withdrawal by Subject|0|||
163244810|NCT02008890|589605381|FG000|Period 1|Pregnancy|1|||
163244811|NCT02008890|589605382|FG001|Period 1|Pregnancy|0|||
163244812|NCT02008890|589605383|FG002|Period 1|Pregnancy|0|||
163244813|NCT02008890|589605384|FG003|Period 1|Pregnancy|0|||
163244814|NCT02008890|589605385|FG004|Period 1|Pregnancy|0|||
163244815|NCT02008890|589605381|FG000|Period 1|Physician Decision|1|||
163244816|NCT02008890|589605382|FG001|Period 1|Physician Decision|0|||
163244817|NCT02008890|589605383|FG002|Period 1|Physician Decision|1|||
163244818|NCT02008890|589605384|FG003|Period 1|Physician Decision|0|||
163244819|NCT02008890|589605385|FG004|Period 1|Physician Decision|0|||
163244820|NCT02008890|589605381|FG000|Period 1|Adverse Event|6|||
163244821|NCT02008890|589605382|FG001|Period 1|Adverse Event|8|||
163244822|NCT02008890|589605383|FG002|Period 1|Adverse Event|6|||
163244823|NCT02008890|589605384|FG003|Period 1|Adverse Event|0|||
163244824|NCT02008890|589605385|FG004|Period 1|Adverse Event|0|||
163244825|NCT02008890|589605381|FG000|Period 2|Adverse Event|12|||
163244826|NCT02008890|589605382|FG001|Period 2|Adverse Event|7|||
163244827|NCT02008890|589605383|FG002|Period 2|Adverse Event|0|||
163244828|NCT02008890|589605384|FG003|Period 2|Adverse Event|5|||
163244829|NCT02008890|589605385|FG004|Period 2|Adverse Event|5|||
163244830|NCT02008890|589605381|FG000|Period 2|Withdrawal by Subject|11|||
163244831|NCT02008890|589605382|FG001|Period 2|Withdrawal by Subject|8|||
163244832|NCT02008890|589605383|FG002|Period 2|Withdrawal by Subject|0|||
163244833|NCT02008890|589605384|FG003|Period 2|Withdrawal by Subject|7|||
163244834|NCT02008890|589605385|FG004|Period 2|Withdrawal by Subject|2|||
163244835|NCT02008890|589605381|FG000|Period 2|Physician Decision|4|||
163244836|NCT02008890|589605382|FG001|Period 2|Physician Decision|0|||
163244837|NCT02008890|589605383|FG002|Period 2|Physician Decision|0|||
163244838|NCT02008890|589605384|FG003|Period 2|Physician Decision|2|||
163244839|NCT02008890|589605385|FG004|Period 2|Physician Decision|1|||
163244840|NCT02008890|589605381|FG000|Period 2|Lost to Follow-up|0|||
163244841|NCT02008890|589605382|FG001|Period 2|Lost to Follow-up|0|||
163244842|NCT02008890|589605383|FG002|Period 2|Lost to Follow-up|1|||
163244843|NCT02008890|589605384|FG003|Period 2|Lost to Follow-up|0|||
163244844|NCT02008890|589605385|FG004|Period 2|Lost to Follow-up|0|||
163244845|NCT02008890|589605381|FG000|Extension Period|Withdrawal by Subject|3|||
163244846|NCT02008890|589605382|FG001|Extension Period|Withdrawal by Subject|2|||
163244847|NCT02008890|589605383|FG002|Extension Period|Withdrawal by Subject|0|||
163244848|NCT02008890|589605384|FG003|Extension Period|Withdrawal by Subject|4|||
163244849|NCT02008890|589605385|FG004|Extension Period|Withdrawal by Subject|2|||
163244850|NCT02008890|589605381|FG000|Extension Period|Lost to Follow-up|1|||
163244851|NCT02008890|589605382|FG001|Extension Period|Lost to Follow-up|0|||
163244852|NCT02008890|589605383|FG002|Extension Period|Lost to Follow-up|0|||
163244853|NCT02008890|589605384|FG003|Extension Period|Lost to Follow-up|0|||
163244854|NCT02008890|589605385|FG004|Extension Period|Lost to Follow-up|0|||
163244855|NCT02008890|589605381|FG000|Extension Period|Adverse Event|1|||
163244856|NCT02008890|589605382|FG001|Extension Period|Adverse Event|3|||
163244857|NCT02008890|589605383|FG002|Extension Period|Adverse Event|0|||
163244858|NCT02008890|589605384|FG003|Extension Period|Adverse Event|0|||
163244859|NCT02008890|589605385|FG004|Extension Period|Adverse Event|2|||
163244860|NCT02207816|589605386|FG000|Overall Study|Serious Adverse Event|0|||
163244861|NCT02207816|589605387|FG001|Overall Study|Serious Adverse Event|5|||
163244862|NCT02207816|589605388|FG002|Overall Study|Serious Adverse Event|2|||
163244863|NCT02207816|589605386|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
163244864|NCT02207816|589605387|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
163244865|NCT02207816|589605388|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
163244866|NCT02207816|589605386|FG000|Overall Study|Withdrawal by Subject|4|||
163244867|NCT02207816|589605387|FG001|Overall Study|Withdrawal by Subject|9|||
163244868|NCT02207816|589605388|FG002|Overall Study|Withdrawal by Subject|7|||
163244869|NCT02207816|589605386|FG000|Overall Study|Migrated/Moved From Study Area|41|||
163244870|NCT02207816|589605387|FG001|Overall Study|Migrated/Moved From Study Area|60|||
163244871|NCT02207816|589605388|FG002|Overall Study|Migrated/Moved From Study Area|51|||
163244872|NCT02207816|589605386|FG000|Overall Study|Lost to Follow-up|3|||
163244873|NCT02207816|589605387|FG001|Overall Study|Lost to Follow-up|9|||
163244874|NCT02207816|589605388|FG002|Overall Study|Lost to Follow-up|1|||
163244875|NCT02207816|589605386|FG000|Overall Study|Other|1|||
163244876|NCT02207816|589605387|FG001|Overall Study|Other|2|||
163244877|NCT02207816|589605388|FG002|Overall Study|Other|4|||
163244878|NCT02522494|589605389|FG000|Overall Study|Lost to Follow-up|6|||
163244879|NCT02522494|589605390|FG001|Overall Study|Lost to Follow-up|2|||
163244880|NCT02522494|589605389|FG000|Overall Study|Withdrawal by Subject|1|||
163352387|NCT01161628|590000375|FG000|Overall Study|Death|6|||
163352388|NCT01161628|590000375|FG000|Overall Study|Lack of Efficacy|2|||
163352389|NCT01125566|590000377|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
163352390|NCT01125566|590000378|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
163352391|NCT01125566|590000379|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
163352392|NCT01125566|590000377|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
163352393|NCT01125566|590000378|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
163352394|NCT01125566|590000379|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
163352395|NCT01125566|590000377|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
163352396|NCT01125566|590000378|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
163352397|NCT01125566|590000379|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
163352398|NCT01125566|590000377|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
163352399|NCT01125566|590000378|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
163352400|NCT01125566|590000379|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
163352401|NCT01125566|590000377|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
163352402|NCT01125566|590000378|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
163352403|NCT01125566|590000379|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
163352404|NCT01125566|590000377|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
163352405|NCT01125566|590000378|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
163352406|NCT01125566|590000379|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
163352407|NCT01125566|590000377|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
163352408|NCT01125566|590000378|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
163352409|NCT01125566|590000379|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
163352410|NCT01125566|590000377|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
163352411|NCT01125566|590000378|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
163352412|NCT01125566|590000379|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
163352413|NCT01125566|590000377|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
163352414|NCT01125566|590000378|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
163352415|NCT01125566|590000379|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
163352416|NCT01125566|590000377|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
163352417|NCT01125566|590000378|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
163352418|NCT01125566|590000379|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
163352419|NCT01125566|590000377|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
163352420|NCT01125566|590000378|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
163352421|NCT01125566|590000379|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
163352422|NCT01125566|590000377|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
163352423|NCT01125566|590000378|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
163352424|NCT01125566|590000379|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
163352425|NCT01726517|590000380|FG000|Overall Study|Withdrawal by Subject|0|||
163352426|NCT01726517|590000381|FG001|Overall Study|Withdrawal by Subject|0|||
163352427|NCT01726517|590000382|FG002|Overall Study|Withdrawal by Subject|1|||
163352428|NCT01726517|590000383|FG003|Overall Study|Withdrawal by Subject|0|||
163352429|NCT01726517|590000384|FG004|Overall Study|Withdrawal by Subject|0|||
163352430|NCT01424189|590000389|FG000|Overall Study|Adverse Event|1|||
163352431|NCT01424189|590000390|FG001|Overall Study|Adverse Event|0|||
163352432|NCT01424189|590000389|FG000|Overall Study|Lost to Follow-up|4|||
163352433|NCT01424189|590000390|FG001|Overall Study|Lost to Follow-up|1|||
163352434|NCT01424189|590000389|FG000|Overall Study|Withdrawal by Subject|4|||
163352435|NCT01424189|590000390|FG001|Overall Study|Withdrawal by Subject|4|||
163352436|NCT01424189|590000389|FG000|Overall Study|Subject moved|1|||
163352437|NCT01424189|590000390|FG001|Overall Study|Subject moved|0|||
163352438|NCT01424189|590000389|FG000|Overall Study|Death|3|||
163352439|NCT01424189|590000390|FG001|Overall Study|Death|1|||
163352440|NCT01203956|590000391|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
163352441|NCT01203956|590000392|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
163352442|NCT02230306|590000395|FG000|Overall Study|Did not receive study treatment|1|||
163352443|NCT00312845|590000396|FG000|Overall Study|Adverse Event|19|||
163352444|NCT00312845|590000397|FG001|Overall Study|Adverse Event|5|||
163352445|NCT00312845|590000396|FG000|Overall Study|Death|2|||
163352446|NCT00312845|590000397|FG001|Overall Study|Death|2|||
163352447|NCT00312845|590000396|FG000|Overall Study|Withdrawal by Subject|14|||
163352448|NCT00312845|590000397|FG001|Overall Study|Withdrawal by Subject|6|||
163352449|NCT00312845|590000396|FG000|Overall Study|Disease Progression|56|||
163352450|NCT00312845|590000397|FG001|Overall Study|Disease Progression|77|||
163352451|NCT00312845|590000396|FG000|Overall Study|Lost to Follow-up|2|||
163352452|NCT00312845|590000397|FG001|Overall Study|Lost to Follow-up|0|||
163352453|NCT00312845|590000396|FG000|Overall Study|Other|6|||
163244881|NCT02522494|589605390|FG001|Overall Study|Withdrawal by Subject|0|||
163244882|NCT02522494|589605389|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
163244883|NCT02522494|589605390|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
163244884|NCT02522494|589605389|FG000|Overall Study|Participant did not watch the video|1|||
163244885|NCT02522494|589605390|FG001|Overall Study|Participant did not watch the video|0|||
163244886|NCT02522494|589605389|FG000|Overall Study|Death|0|||
163244887|NCT02522494|589605390|FG001|Overall Study|Death|1|||
163244888|NCT02349295|589605393|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
163244889|NCT02349295|589605394|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
163244890|NCT02349295|589605395|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
163244891|NCT02349295|589605396|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
163244892|NCT02349295|589605397|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
163244893|NCT02349295|589605398|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
163244894|NCT02349295|589605399|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
163244895|NCT02349295|589605400|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
163244896|NCT02349295|589605401|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
163244897|NCT02349295|589605402|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
163244898|NCT02349295|589605403|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
163244899|NCT02349295|589605404|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
163244900|NCT02349295|589605405|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
163244901|NCT02349295|589605406|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
163244902|NCT02349295|589605393|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
163244903|NCT02349295|589605394|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
163244904|NCT02349295|589605395|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
163244905|NCT02349295|589605396|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
163244906|NCT02349295|589605397|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
163244907|NCT02349295|589605398|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
163244908|NCT02349295|589605399|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
163244909|NCT02349295|589605400|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
163244910|NCT02349295|589605401|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
163244911|NCT02349295|589605402|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
163244912|NCT02349295|589605403|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
163244913|NCT02349295|589605404|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
163244914|NCT02349295|589605405|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
163244915|NCT02349295|589605406|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
163244916|NCT02349295|589605393|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
163244917|NCT02349295|589605394|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
163244918|NCT02349295|589605395|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
163244919|NCT02349295|589605396|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
163244920|NCT02349295|589605397|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
163244921|NCT02349295|589605398|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
163244922|NCT02349295|589605399|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
163244923|NCT02349295|589605400|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
163244924|NCT02349295|589605401|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
163244925|NCT02349295|589605402|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
163244926|NCT02349295|589605403|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
163244927|NCT02349295|589605404|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
163244928|NCT02349295|589605405|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
163244929|NCT02349295|589605406|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
163244930|NCT02349295|589605393|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
163244931|NCT02349295|589605394|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
163244932|NCT02349295|589605395|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
163244933|NCT02349295|589605396|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
163244934|NCT02349295|589605397|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
163244935|NCT02349295|589605398|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
163244936|NCT02349295|589605399|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
163244937|NCT02349295|589605400|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
163244938|NCT02349295|589605401|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
163244939|NCT02349295|589605402|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
163244940|NCT02349295|589605403|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
163244941|NCT02349295|589605404|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
163244942|NCT02349295|589605405|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
163244943|NCT02349295|589605406|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
163244944|NCT02349295|589605393|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
163244945|NCT02349295|589605394|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
163244946|NCT02349295|589605395|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
163244947|NCT02349295|589605396|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
163244948|NCT02349295|589605397|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
163244949|NCT02349295|589605398|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
163244950|NCT02349295|589605399|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
163244951|NCT02349295|589605400|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
163244952|NCT02349295|589605401|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
163244953|NCT02349295|589605402|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
163244954|NCT02349295|589605403|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
163244955|NCT02349295|589605404|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
163244956|NCT02349295|589605405|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
163244957|NCT02349295|589605406|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
163244958|NCT02349295|589605393|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
163244959|NCT02349295|589605394|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
163244960|NCT02349295|589605395|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
163244961|NCT02349295|589605396|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
163244962|NCT02349295|589605397|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
163244963|NCT02349295|589605398|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
163244964|NCT02349295|589605399|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
163244965|NCT02349295|589605400|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
163244966|NCT02349295|589605401|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
163244967|NCT02349295|589605402|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
163244968|NCT02349295|589605403|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
163244969|NCT02349295|589605404|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
163244970|NCT02349295|589605405|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
163244971|NCT02349295|589605406|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
163244972|NCT02349295|589605393|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
163244973|NCT02349295|589605394|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
163244974|NCT02349295|589605395|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
163244975|NCT02349295|589605396|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
163244976|NCT02349295|589605397|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
163244977|NCT02349295|589605398|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
163244978|NCT02349295|589605399|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
163244979|NCT02349295|589605400|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
163244980|NCT02349295|589605401|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
163244981|NCT02349295|589605402|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
163244982|NCT02349295|589605403|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
163244983|NCT02349295|589605404|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
163244984|NCT02349295|589605405|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
163244985|NCT02349295|589605406|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
163244986|NCT02349295|589605393|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
163244987|NCT02349295|589605394|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
163244988|NCT02349295|589605395|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
163244989|NCT02349295|589605396|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
163244990|NCT02349295|589605397|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
163244991|NCT02349295|589605398|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
163244992|NCT02349295|589605399|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
163244993|NCT02349295|589605400|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
163244994|NCT02349295|589605401|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
163244995|NCT02349295|589605402|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
163244996|NCT02349295|589605403|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
163244997|NCT02349295|589605404|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
163244998|NCT02349295|589605405|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
163244999|NCT02349295|589605406|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
163245000|NCT02349295|589605393|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
163245001|NCT02349295|589605394|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
163245002|NCT02349295|589605395|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
163245003|NCT02349295|589605396|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
163245004|NCT02349295|589605397|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
163245005|NCT02349295|589605398|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
163245006|NCT02349295|589605399|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
163245007|NCT02349295|589605400|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
163245008|NCT02349295|589605401|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
163245009|NCT02349295|589605402|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
163245010|NCT02349295|589605403|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
163245011|NCT02349295|589605404|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
163245012|NCT02349295|589605405|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
163245013|NCT02349295|589605406|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
163245014|NCT02349295|589605393|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
163245015|NCT02349295|589605394|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
163352454|NCT00312845|590000397|FG001|Overall Study|Other|5|||
163352455|NCT04206384|590000398|FG000|Overall Study|Withdrawal by Subject|8|||
163352456|NCT04206384|590000398|FG000|Overall Study|Adverse Event|2|||
163352457|NCT01121185|590000400|FG000|Overall Study|Not infused|0|||
163352458|NCT01121185|590000401|FG001|Overall Study|Not infused|1|||
163352459|NCT01121185|590000400|FG000|Overall Study|Not transplanted|1|||
163352460|NCT01121185|590000401|FG001|Overall Study|Not transplanted|0|||
163352461|NCT01260142|590000403|FG000|Treatment Period 1|Study on hold|1|||
163352462|NCT01260142|590000404|FG001|Treatment Period 1|Study on hold|1|||
163352463|NCT01260142|590000405|FG002|Treatment Period 1|Study on hold|0|||
163352464|NCT01260142|590000406|FG003|Treatment Period 1|Study on hold|0|||
163352465|NCT01260142|590000407|FG004|Treatment Period 1|Study on hold|1|||
163352466|NCT01260142|590000408|FG005|Treatment Period 1|Study on hold|2|||
163352467|NCT01260142|590000403|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
163352468|NCT01260142|590000404|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
163352469|NCT01260142|590000405|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
163352470|NCT01260142|590000406|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
163352471|NCT01260142|590000407|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
163352472|NCT01260142|590000408|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
163352473|NCT01260142|590000403|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163352474|NCT01260142|590000404|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163352475|NCT01260142|590000405|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163352476|NCT01260142|590000406|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163352477|NCT01260142|590000407|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163352478|NCT01260142|590000408|FG005|Treatment Period 1|Withdrawal by Subject|1|||
163352479|NCT00496834|590000416|FG000|Overall Study|Withdrawal by Subject|4|||
163352480|NCT00496834|590000417|FG001|Overall Study|Withdrawal by Subject|6|||
163352481|NCT00496834|590000416|FG000|Overall Study|Contraindicated medication administered|0|||
163352482|NCT00496834|590000417|FG001|Overall Study|Contraindicated medication administered|1|||
163352483|NCT00496834|590000416|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
163352484|NCT00496834|590000417|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
163352485|NCT00496834|590000416|FG000|Overall Study|Adverse Event|5|||
163352486|NCT00496834|590000417|FG001|Overall Study|Adverse Event|3|||
163352487|NCT00496834|590000416|FG000|Overall Study|IP administration violation|2|||
163352488|NCT00496834|590000417|FG001|Overall Study|IP administration violation|0|||
163352489|NCT00496834|590000416|FG000|Overall Study|Lost to Follow-up|2|||
163352490|NCT00496834|590000417|FG001|Overall Study|Lost to Follow-up|0|||
163352491|NCT00496834|590000416|FG000|Overall Study|Blood Pressure control failure|2|||
163352492|NCT00496834|590000417|FG001|Overall Study|Blood Pressure control failure|1|||
163352493|NCT01503164|590000418|FG000|Overall Study|Withdrawal by Subject|2|||
163352494|NCT01503164|590000419|FG001|Overall Study|Withdrawal by Subject|1|||
163352495|NCT01227928|590000420|FG000|Overall Study|Lost to Follow-up|4|||
163352496|NCT01227928|590000421|FG001|Overall Study|Lost to Follow-up|2|||
163352497|NCT01227928|590000420|FG000|Overall Study|Withdrawal by Subject|4|||
163352498|NCT01227928|590000421|FG001|Overall Study|Withdrawal by Subject|3|||
163352499|NCT01227928|590000420|FG000|Overall Study|Death|14|||
163352500|NCT01227928|590000421|FG001|Overall Study|Death|12|||
163352501|NCT04088136|590000424|FG000|Overall Study|Withdrawal by Subject|5|||
163352502|NCT04088136|590000425|FG001|Overall Study|Withdrawal by Subject|0|||
163352503|NCT04088136|590000424|FG000|Overall Study|Lack of Efficacy|0|||
163352504|NCT04088136|590000425|FG001|Overall Study|Lack of Efficacy|1|||
163352505|NCT01494298|590000426|FG000|Overall Study|Protocol Violation|2|||
163352506|NCT01494298|590000427|FG001|Overall Study|Protocol Violation|8|||
163352507|NCT04159805|590000428|FG000|Overall Study|Withdrawal by Subject|0|||
163352508|NCT04159805|590000429|FG001|Overall Study|Withdrawal by Subject|2|||
163352509|NCT04159805|590000430|FG002|Overall Study|Withdrawal by Subject|2|||
163352510|NCT02930837|590000431|FG000|Overall Study|Adverse Event|6|||
163352511|NCT02930837|590000431|FG000|Overall Study|Lost to Follow-up|5|||
163352512|NCT02930837|590000431|FG000|Overall Study|Withdrawal by Subject|1|||
163352513|NCT01393613|590000432|FG000|Overall Study|Adverse Event|11|||
163352514|NCT01393613|590000433|FG001|Overall Study|Adverse Event|11|||
163352515|NCT01393613|590000434|FG002|Overall Study|Adverse Event|13|||
163352516|NCT01393613|590000435|FG003|Overall Study|Adverse Event|22|||
163352517|NCT01393613|590000432|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
163352518|NCT01393613|590000433|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
163352519|NCT01393613|590000434|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
163352520|NCT01393613|590000435|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
163352521|NCT01393613|590000432|FG000|Overall Study|Physician Decision|2|||
163352522|NCT01393613|590000433|FG001|Overall Study|Physician Decision|0|||
163352523|NCT01393613|590000434|FG002|Overall Study|Physician Decision|0|||
163352524|NCT01393613|590000435|FG003|Overall Study|Physician Decision|1|||
163352525|NCT01393613|590000432|FG000|Overall Study|Withdrawal by Subject|15|||
163352526|NCT01393613|590000433|FG001|Overall Study|Withdrawal by Subject|25|||
163352527|NCT01393613|590000434|FG002|Overall Study|Withdrawal by Subject|23|||
163352528|NCT01393613|590000435|FG003|Overall Study|Withdrawal by Subject|21|||
163352529|NCT01393613|590000432|FG000|Overall Study|Protocol Deviation|2|||
163352530|NCT01393613|590000433|FG001|Overall Study|Protocol Deviation|1|||
163352531|NCT01393613|590000434|FG002|Overall Study|Protocol Deviation|0|||
163352532|NCT01393613|590000435|FG003|Overall Study|Protocol Deviation|0|||
163352533|NCT01393613|590000432|FG000|Overall Study|Lack of Efficacy|9|||
163352534|NCT01393613|590000433|FG001|Overall Study|Lack of Efficacy|20|||
163352535|NCT01393613|590000434|FG002|Overall Study|Lack of Efficacy|16|||
163352536|NCT01393613|590000435|FG003|Overall Study|Lack of Efficacy|21|||
163352537|NCT02998918|590000439|FG000|Overall Study|Withdrawal by Subject|1|||
163352538|NCT02998918|590000440|FG001|Overall Study|Withdrawal by Subject|0|||
163352539|NCT01071317|590000441|FG000|Overall Study|Lost to Follow-up|2|||
163352540|NCT01071317|590000442|FG001|Overall Study|Lost to Follow-up|2|||
163352541|NCT05041439|590000445|FG000|Overall Study|Withdrawal by Subject|1|||
163352542|NCT05041439|590000446|FG001|Overall Study|Withdrawal by Subject|1|||
163352543|NCT05041439|590000445|FG000|Overall Study|Death|1|||
163352544|NCT05041439|590000446|FG001|Overall Study|Death|0|||
163352545|NCT02388347|590002428|FG000|Overall Study|Withdrawal by Subject|0|||
163352546|NCT02388347|590002429|FG001|Overall Study|Withdrawal by Subject|0|||
163352547|NCT02388347|590002430|FG002|Overall Study|Withdrawal by Subject|1|||
163352548|NCT02388347|590002431|FG003|Overall Study|Withdrawal by Subject|0|||
163352549|NCT02388347|590002432|FG004|Overall Study|Withdrawal by Subject|0|||
163352550|NCT00497874|590002433|FG000|Overall Study|Withdrawal by Subject|48|||
163352551|NCT00497874|590002434|FG001|Overall Study|Withdrawal by Subject|17|||
163352552|NCT00497874|590002433|FG000|Overall Study|Illness|8|||
163352553|NCT00497874|590002434|FG001|Overall Study|Illness|4|||
163352554|NCT00497874|590002433|FG000|Overall Study|Death|2|||
163352555|NCT00497874|590002434|FG001|Overall Study|Death|4|||
163352556|NCT00497874|590002433|FG000|Overall Study|Unable to contact|52|||
163352557|NCT00497874|590002434|FG001|Overall Study|Unable to contact|67|||
163352558|NCT00497874|590002433|FG000|Overall Study|Unable to schedule|37|||
163352559|NCT00497874|590002434|FG001|Overall Study|Unable to schedule|24|||
163352560|NCT01101334|590002435|FG000|Overall Study|Adverse Event|9|||
163352561|NCT01101334|590002436|FG001|Overall Study|Adverse Event|4|||
163352562|NCT01101334|590002435|FG000|Overall Study|Death|7|||
163352563|NCT01101334|590002436|FG001|Overall Study|Death|1|||
163352564|NCT01101334|590002435|FG000|Overall Study|Withdrawal by Subject|4|||
163352565|NCT01101334|590002436|FG001|Overall Study|Withdrawal by Subject|3|||
163352566|NCT01101334|590002435|FG000|Overall Study|Withdrawal by Sponsor|1|||
163352567|NCT01101334|590002436|FG001|Overall Study|Withdrawal by Sponsor|1|||
163352568|NCT01101334|590002435|FG000|Overall Study|Progressive Disease|22|||
163352569|NCT01101334|590002436|FG001|Overall Study|Progressive Disease|35|||
163352570|NCT01101334|590002435|FG000|Overall Study|Other|2|||
163352571|NCT01101334|590002436|FG001|Overall Study|Other|1|||
163352572|NCT00612352|590002437|FG000|Overall Study|Adverse Event|1|||
163352573|NCT00612352|590002438|FG001|Overall Study|Adverse Event|0|||
163352574|NCT00612352|590002437|FG000|Overall Study|Withdrawal by Subject|3|||
163352575|NCT00612352|590002438|FG001|Overall Study|Withdrawal by Subject|5|||
163352576|NCT00612352|590002437|FG000|Overall Study|moved out of state|1|||
163352577|NCT00612352|590002438|FG001|Overall Study|moved out of state|0|||
163352578|NCT00612352|590002437|FG000|Overall Study|didn't return calls/show up on test date|4|||
163352579|NCT00612352|590002438|FG001|Overall Study|didn't return calls/show up on test date|1|||
163352580|NCT00263211|590002439|FG000|Overall Study|Death|1|||
163352581|NCT00263211|590002440|FG001|Overall Study|Death|0|||
163352582|NCT00263211|590002439|FG000|Overall Study|Withdrawal by Subject|3|||
163352583|NCT00263211|590002440|FG001|Overall Study|Withdrawal by Subject|0|||
163352584|NCT00263211|590002439|FG000|Overall Study|Protocol Violation|1|||
163352585|NCT00263211|590002440|FG001|Overall Study|Protocol Violation|0|||
163352586|NCT00263211|590002439|FG000|Overall Study|Disease Progression|0|||
163352587|NCT00263211|590002440|FG001|Overall Study|Disease Progression|1|||
163352588|NCT02820597|590002441|FG000|Overall Study|Lost to Follow-up|12|||
163352589|NCT04606199|590002442|FG000|Overall Study|Withdrawal by Subject|2|||
163352590|NCT00408928|590002443|FG000|Overall Study|Withdrawal by Subject|1|||
163352591|NCT00408928|590002443|FG000|Overall Study|Death|1|||
163352592|NCT00408928|590002443|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
163352593|NCT02512861|590002449|FG000|Overall Study|Protocol Violation|3|||
163352594|NCT02512861|590002450|FG001|Overall Study|Protocol Violation|7|||
163352595|NCT02512861|590002449|FG000|Overall Study|Physician Decision|3|||
163352596|NCT02512861|590002450|FG001|Overall Study|Physician Decision|1|||
163352597|NCT02512861|590002449|FG000|Overall Study|Withdrawal by Subject|0|||
163352598|NCT02512861|590002450|FG001|Overall Study|Withdrawal by Subject|1|||
163352599|NCT01774019|590002451|FG000|Overall Study|No longer meets protocol criteria|2|||
163352600|NCT01774019|590002452|FG001|Overall Study|No longer meets protocol criteria|0|||
163352601|NCT01774019|590002451|FG000|Overall Study|Withdrawal by Subject|1|||
163352602|NCT01774019|590002452|FG001|Overall Study|Withdrawal by Subject|0|||
163352603|NCT01774019|590002451|FG000|Overall Study|Surgery delayed > 120 days|1|||
163352604|NCT01774019|590002452|FG001|Overall Study|Surgery delayed > 120 days|0|||
163352605|NCT01774019|590002451|FG000|Overall Study|Patient refused surgery|1|||
163352606|NCT01774019|590002452|FG001|Overall Study|Patient refused surgery|1|||
163352607|NCT01774019|590002451|FG000|Overall Study|Unable to implant study device|1|||
163352608|NCT01774019|590002452|FG001|Overall Study|Unable to implant study device|0|||
163352609|NCT01774019|590002451|FG000|Overall Study|Lost to Follow-up|0|||
163352610|NCT01774019|590002452|FG001|Overall Study|Lost to Follow-up|3|||
163352611|NCT00292981|590002453|FG000|Overall Study|Adverse Event|1|||
163352612|NCT00292981|590002453|FG000|Overall Study|Lost to Follow-up|13|||
163352613|NCT00292981|590002453|FG000|Overall Study|Withdrawal by Subject|22|||
163352614|NCT00292981|590002453|FG000|Overall Study|Other|3|||
163352615|NCT00594178|590002456|FG000|Overall Study|Physician Decision|5|||
163352616|NCT03245619|590002468|FG000|Part A (Up to Day 22)|Physician Decision|4|||
163352617|NCT03245619|590002469|FG001|Part A (Up to Day 22)|Physician Decision|6|||
163352618|NCT03245619|590002470|FG002|Part A (Up to Day 22)|Physician Decision|6|||
163352619|NCT03245619|590002471|FG003|Part A (Up to Day 22)|Physician Decision|0|||
163352620|NCT03245619|590002472|FG004|Part A (Up to Day 22)|Physician Decision|0|||
163352621|NCT03245619|590002473|FG005|Part A (Up to Day 22)|Physician Decision|0|||
163352622|NCT03245619|590002474|FG006|Part A (Up to Day 22)|Physician Decision|0|||
163352623|NCT03245619|590002475|FG007|Part A (Up to Day 22)|Physician Decision|0|||
163352624|NCT03245619|590002476|FG008|Part A (Up to Day 22)|Physician Decision|0|||
163352625|NCT03245619|590002477|FG009|Part A (Up to Day 22)|Physician Decision|0|||
163352626|NCT03245619|590002478|FG010|Part A (Up to Day 22)|Physician Decision|0|||
163352627|NCT03245619|590002479|FG011|Part A (Up to Day 22)|Physician Decision|0|||
163352628|NCT03245619|590002480|FG012|Part A (Up to Day 22)|Physician Decision|0|||
163352629|NCT03245619|590002481|FG013|Part A (Up to Day 22)|Physician Decision|0|||
163352630|NCT03245619|590002482|FG014|Part A (Up to Day 22)|Physician Decision|0|||
163352631|NCT03245619|590002483|FG015|Part A (Up to Day 22)|Physician Decision|0|||
163352632|NCT03245619|590002484|FG016|Part A (Up to Day 22)|Physician Decision|0|||
163352633|NCT03470545|590002486|FG000|Overall Study|Death|0|||
163352634|NCT03470545|590002487|FG001|Overall Study|Death|1|||
163352635|NCT03470545|590002486|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
163352636|NCT03470545|590002487|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
163352637|NCT03470545|590002486|FG000|Overall Study|Adverse Event|2|||
163352638|NCT03470545|590002487|FG001|Overall Study|Adverse Event|0|||
163352639|NCT03470545|590002486|FG000|Overall Study|Withdrawal by Subject|1|||
163352640|NCT03470545|590002487|FG001|Overall Study|Withdrawal by Subject|1|||
163352641|NCT03470545|590002486|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
163352642|NCT03470545|590002487|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
163352643|NCT00776659|590002503|FG000|Overall Study|Lost to Follow-up|15|||
163352644|NCT00776659|590002503|FG000|Overall Study|Withdrawal by Subject|10|||
163352645|NCT00776659|590002503|FG000|Overall Study|Study Terminated by Sponsor|1|||
163352646|NCT02971228|590002504|FG000|Overall Study|Withdrawal by Subject|1|||
163352647|NCT02971228|590002505|FG001|Overall Study|Withdrawal by Subject|1|||
163352648|NCT02971228|590002506|FG002|Overall Study|Withdrawal by Subject|0|||
163352649|NCT02971228|590002507|FG003|Overall Study|Withdrawal by Subject|0|||
163352650|NCT02971228|590002508|FG004|Overall Study|Withdrawal by Subject|0|||
163352651|NCT02971228|590002504|FG000|Overall Study|Logistical challenges|0|||
163352652|NCT02971228|590002505|FG001|Overall Study|Logistical challenges|1|||
163352653|NCT02971228|590002506|FG002|Overall Study|Logistical challenges|0|||
163352654|NCT02971228|590002507|FG003|Overall Study|Logistical challenges|0|||
163352655|NCT02971228|590002508|FG004|Overall Study|Logistical challenges|0|||
163352656|NCT01664923|590002509|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
163352657|NCT01664923|590002510|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
163352658|NCT01664923|590002509|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
163352659|NCT01664923|590002510|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
163352660|NCT01664923|590002509|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
163352661|NCT01664923|590002510|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
163352662|NCT01664923|590002509|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
163410210|NCT00689871|590211309|FG001|Overall Study|Explanted of All Study Devices|25|||
163352663|NCT01664923|590002510|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
163352664|NCT01664923|590002509|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
163352665|NCT01664923|590002510|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
163352666|NCT01664923|590002509|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
163352667|NCT01664923|590002510|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
163352668|NCT01664923|590002509|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
163352669|NCT01664923|590002510|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
163352670|NCT01664923|590002509|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
163352671|NCT01664923|590002510|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
163352672|NCT01664923|590002509|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
163352673|NCT01664923|590002510|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
163352674|NCT01664923|590002509|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
163352675|NCT01664923|590002510|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
163352676|NCT01664923|590002509|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
163352677|NCT01664923|590002510|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
163352678|NCT01664923|590002509|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
163352679|NCT01664923|590002510|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
163352680|NCT01664923|590002509|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
163352681|NCT01664923|590002510|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
163352682|NCT01664923|590002509|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
163352683|NCT01664923|590002510|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
163352684|NCT01167192|590002513|FG000|Overall Study|Adverse Event|1|||
163352685|NCT01167192|590002513|FG000|Overall Study|Death|1|||
163352686|NCT01167192|590002513|FG000|Overall Study|Withdrawal by Subject|1|||
163352687|NCT01167192|590002513|FG000|Overall Study|Insurance denial|1|||
163352688|NCT01336205|590002514|FG000|Overall Study|Other|22|||
163352689|NCT01336205|590002515|FG001|Overall Study|Other|9|||
163352690|NCT01336205|590002514|FG000|Overall Study|Lost to Follow-up|40|||
163352691|NCT01336205|590002515|FG001|Overall Study|Lost to Follow-up|20|||
163352692|NCT01336205|590002514|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
163352693|NCT01336205|590002515|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
163352694|NCT01336205|590002514|FG000|Overall Study|Lack of Efficacy|4|||
163352695|NCT01336205|590002515|FG001|Overall Study|Lack of Efficacy|0|||
163352696|NCT01336205|590002514|FG000|Overall Study|Severe noncompliance with protocol|9|||
163352697|NCT01336205|590002515|FG001|Overall Study|Severe noncompliance with protocol|2|||
163352698|NCT01336205|590002514|FG000|Overall Study|Adverse Event|56|||
163352699|NCT01336205|590002515|FG001|Overall Study|Adverse Event|6|||
163352700|NCT01336205|590002514|FG000|Overall Study|Death|1|||
163352701|NCT01336205|590002515|FG001|Overall Study|Death|1|||
163352702|NCT01336205|590002514|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
163352703|NCT01336205|590002515|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
163352704|NCT01336205|590002514|FG000|Overall Study|Withdrawal by Subject|72|||
163352705|NCT01336205|590002515|FG001|Overall Study|Withdrawal by Subject|38|||
163352706|NCT01336205|590002514|FG000|Overall Study|Did not receive treatment|4|||
163352707|NCT01336205|590002515|FG001|Overall Study|Did not receive treatment|0|||
163352708|NCT00129649|590002516|FG000|Overall Study|Withdrawal by Subject|76|||
163352709|NCT00129649|590002517|FG001|Overall Study|Withdrawal by Subject|65|||
163352710|NCT04952701|590002518|FG000|Control Lens|Physician Decision|4|||
163352711|NCT04952701|590002518|FG000|Test Lens|Physician Decision|1|||
163352712|NCT02547441|590002519|FG000|Double-Blind Study Period|Adverse Event|4|||
163352713|NCT02547441|590002520|FG001|Double-Blind Study Period|Adverse Event|9|||
163352714|NCT02547441|590002519|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
163352715|NCT02547441|590002520|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
163352716|NCT02547441|590002519|FG000|Double-Blind Study Period|Physician Decision|1|||
163352717|NCT02547441|590002520|FG001|Double-Blind Study Period|Physician Decision|0|||
163352718|NCT02547441|590002519|FG000|Double-Blind Study Period|Protocol Violation|1|||
163352719|NCT02547441|590002520|FG001|Double-Blind Study Period|Protocol Violation|2|||
163352720|NCT02547441|590002519|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
163352721|NCT02547441|590002520|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
163352722|NCT02547441|590002519|FG000|Double-Blind Study Period|Sponsor Decision|1|||
163352723|NCT02547441|590002520|FG001|Double-Blind Study Period|Sponsor Decision|0|||
163352724|NCT02547441|590002519|FG000|Open-Label Study Period|Adverse Event|10|||
163352725|NCT02547441|590002520|FG001|Open-Label Study Period|Adverse Event|11|||
163352726|NCT02547441|590002519|FG000|Open-Label Study Period|Lack of Efficacy|3|||
163352727|NCT02547441|590002520|FG001|Open-Label Study Period|Lack of Efficacy|2|||
163352728|NCT02547441|590002519|FG000|Open-Label Study Period|Lost to Follow-up|7|||
163352729|NCT02547441|590002520|FG001|Open-Label Study Period|Lost to Follow-up|8|||
163352730|NCT02547441|590002519|FG000|Open-Label Study Period|Physician Decision|1|||
163352731|NCT02547441|590002520|FG001|Open-Label Study Period|Physician Decision|0|||
163352732|NCT02547441|590002519|FG000|Open-Label Study Period|Protocol Violation|2|||
163352733|NCT02547441|590002520|FG001|Open-Label Study Period|Protocol Violation|0|||
163352734|NCT02547441|590002519|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
163352735|NCT02547441|590002520|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
163352736|NCT02547441|590002519|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
163352737|NCT02547441|590002520|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
163352738|NCT01322009|590002521|FG000|Overall Study|Death|0|||
163352739|NCT01322009|590002522|FG001|Overall Study|Death|1|||
163352740|NCT01322009|590002521|FG000|Overall Study|Adverse Event|0|||
163352741|NCT01322009|590002522|FG001|Overall Study|Adverse Event|1|||
163245016|NCT02349295|589605395|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
163245017|NCT02349295|589605396|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
163245018|NCT02349295|589605397|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
163245019|NCT02349295|589605398|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
163245020|NCT02349295|589605399|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
163245021|NCT02349295|589605400|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
163245022|NCT02349295|589605401|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
163245023|NCT02349295|589605402|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
163245024|NCT02349295|589605403|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
163245025|NCT02349295|589605404|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
163245026|NCT02349295|589605405|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
163245027|NCT02349295|589605406|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
163245028|NCT02349295|589605393|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
163245029|NCT02349295|589605394|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
163245030|NCT02349295|589605395|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
163245031|NCT02349295|589605396|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
163245032|NCT02349295|589605397|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
163245033|NCT02349295|589605398|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
163245034|NCT02349295|589605399|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
163245035|NCT02349295|589605400|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
163245036|NCT02349295|589605401|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
163245037|NCT02349295|589605402|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
163245038|NCT02349295|589605403|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
163245039|NCT02349295|589605404|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
163245040|NCT02349295|589605405|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
163245041|NCT02349295|589605406|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
163245042|NCT02349295|589605393|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
163245043|NCT02349295|589605394|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
163245044|NCT02349295|589605395|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
163245045|NCT02349295|589605396|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
163245046|NCT02349295|589605397|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
163245047|NCT02349295|589605398|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
163245048|NCT02349295|589605399|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
163245049|NCT02349295|589605400|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
163245050|NCT02349295|589605401|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
163245051|NCT02349295|589605402|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
163245052|NCT02349295|589605403|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
163245053|NCT02349295|589605404|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
163245054|NCT02349295|589605405|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
163245055|NCT02349295|589605406|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
163245056|NCT02349295|589605393|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
163245057|NCT02349295|589605394|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
163245058|NCT02349295|589605395|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
163245059|NCT02349295|589605396|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
163245060|NCT02349295|589605397|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
163245061|NCT02349295|589605398|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
163245062|NCT02349295|589605399|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
163245063|NCT02349295|589605400|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
163245064|NCT02349295|589605401|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
163245065|NCT02349295|589605402|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
163245066|NCT02349295|589605403|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
163245067|NCT02349295|589605404|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
163245068|NCT02349295|589605405|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
163245069|NCT02349295|589605406|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
163245070|NCT02349295|589605393|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
163245071|NCT02349295|589605394|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
163245072|NCT02349295|589605395|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
163245073|NCT02349295|589605396|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
163245074|NCT02349295|589605397|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
163245075|NCT02349295|589605398|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
163245076|NCT02349295|589605399|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
163245077|NCT02349295|589605400|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
163245078|NCT02349295|589605401|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
163245079|NCT02349295|589605402|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
163245080|NCT02349295|589605403|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
163245081|NCT02349295|589605404|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
163245082|NCT02349295|589605405|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
163245083|NCT02349295|589605406|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
163245084|NCT02349295|589605393|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
163245085|NCT02349295|589605394|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
163245086|NCT02349295|589605395|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
163245087|NCT02349295|589605396|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
163245088|NCT02349295|589605397|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
163245089|NCT02349295|589605398|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
163352742|NCT01322009|590002521|FG000|Overall Study|ng tube discontinued|0|||
163352743|NCT01322009|590002522|FG001|Overall Study|ng tube discontinued|1|||
163352744|NCT01657877|590002523|FG000|Overall Study|Withdrawal by Subject|4|||
163352745|NCT01657877|590002523|FG000|Overall Study|Protocol Violation|6|||
163352746|NCT01657877|590002523|FG000|Overall Study|Adverse Event|2|||
163352747|NCT01657877|590002523|FG000|Overall Study|Other Reason|2|||
163352748|NCT04545476|590002524|FG000|Overall Study|Lost to Follow-up|1|||
163352749|NCT04545476|590002525|FG001|Overall Study|Lost to Follow-up|1|||
163352750|NCT04545476|590002526|FG002|Overall Study|Lost to Follow-up|0|||
163352751|NCT04545476|590002527|FG003|Overall Study|Lost to Follow-up|0|||
163352752|NCT00937521|590002532|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
163352753|NCT00937521|590002533|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
163352754|NCT00937521|590002534|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
163352755|NCT00937521|590002535|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
163352756|NCT00937521|590002536|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
163352757|NCT00937521|590002537|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
163352758|NCT00937521|590002538|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
163352759|NCT00937521|590002539|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
163352760|NCT00937521|590002532|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
163352761|NCT00937521|590002533|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
163352762|NCT00937521|590002534|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
163352763|NCT00937521|590002535|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
163352764|NCT00937521|590002536|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
163352765|NCT00937521|590002537|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
163352766|NCT00937521|590002538|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
163352767|NCT00937521|590002539|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
163352768|NCT00937521|590002532|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
163352769|NCT00937521|590002533|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
163352770|NCT00937521|590002534|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
163352771|NCT00937521|590002535|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
163352772|NCT00937521|590002536|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
163352773|NCT00937521|590002537|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
163352774|NCT00937521|590002538|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
163352775|NCT00937521|590002539|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
163352776|NCT00937521|590002532|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
163352777|NCT00937521|590002533|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
163352778|NCT00937521|590002534|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
163352779|NCT00937521|590002535|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
163352780|NCT00937521|590002536|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
163352781|NCT00937521|590002537|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
163352782|NCT00937521|590002538|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
163352783|NCT00937521|590002539|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
163352784|NCT00937521|590002532|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
163352785|NCT00937521|590002533|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
163352786|NCT00937521|590002534|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
163352787|NCT00937521|590002535|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
163352788|NCT00937521|590002536|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
163352789|NCT00937521|590002537|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
163352790|NCT00937521|590002538|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
163352791|NCT00937521|590002539|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
163352792|NCT00937521|590002532|FG000|Booster Phase|Adverse Event|0|||
163352793|NCT00937521|590002533|FG001|Booster Phase|Adverse Event|0|||
163352794|NCT00937521|590002534|FG002|Booster Phase|Adverse Event|0|||
163149139|NCT02903771|589259402|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
163149140|NCT02903771|589259403|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
163149141|NCT02903771|589259404|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
163149142|NCT02903771|589259405|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
163149143|NCT02903771|589259406|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
163149144|NCT02903771|589259407|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
163352795|NCT00937521|590002535|FG003|Booster Phase|Adverse Event|0|||
163352796|NCT00937521|590002536|FG004|Booster Phase|Adverse Event|0|||
163352797|NCT00937521|590002537|FG005|Booster Phase|Adverse Event|0|||
163352798|NCT00937521|590002538|FG006|Booster Phase|Adverse Event|1|||
163410211|NCT00689871|590211310|FG002|Overall Study|Explanted of All Study Devices|29|||
163352799|NCT00937521|590002539|FG007|Booster Phase|Adverse Event|0|||
163410212|NCT00689871|590211311|FG003|Overall Study|Explanted of All Study Devices|3|||
163410213|NCT00689871|590211308|FG000|Overall Study|Withdrawal by Subject|13|||
163245090|NCT02349295|589605399|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
163245091|NCT02349295|589605400|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
163245092|NCT02349295|589605401|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
163245093|NCT02349295|589605402|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
163245094|NCT02349295|589605403|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
163245095|NCT02349295|589605404|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
163245096|NCT02349295|589605405|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
163245097|NCT02349295|589605406|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
163245098|NCT02349295|589605393|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
163245099|NCT02349295|589605394|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
163245100|NCT02349295|589605395|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
163245101|NCT02349295|589605396|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
163245102|NCT02349295|589605397|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
163245103|NCT02349295|589605398|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
163245104|NCT02349295|589605399|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
163245105|NCT02349295|589605400|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
163245106|NCT02349295|589605401|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
163245107|NCT02349295|589605402|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
163245108|NCT02349295|589605403|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
163245109|NCT02349295|589605404|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
163245110|NCT02349295|589605405|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
163245111|NCT02349295|589605406|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
163245112|NCT02349295|589605393|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
163245113|NCT02349295|589605394|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
163245114|NCT02349295|589605395|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
163245115|NCT02349295|589605396|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
163245116|NCT02349295|589605397|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
163245117|NCT02349295|589605398|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
163245118|NCT02349295|589605399|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
163245119|NCT02349295|589605400|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
163245120|NCT02349295|589605401|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
163245121|NCT02349295|589605402|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
163245122|NCT02349295|589605403|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
163245123|NCT02349295|589605404|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
163245124|NCT02349295|589605405|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
163245125|NCT02349295|589605406|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
163245126|NCT02349295|589605393|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
163245127|NCT02349295|589605394|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
163245128|NCT02349295|589605395|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
163245129|NCT02349295|589605396|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
163245130|NCT02349295|589605397|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
163245131|NCT02349295|589605398|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
163245132|NCT02349295|589605399|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
163245133|NCT02349295|589605400|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
163245134|NCT02349295|589605401|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
163245135|NCT02349295|589605402|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
163245136|NCT02349295|589605403|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
163245137|NCT02349295|589605404|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
163245138|NCT02349295|589605405|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
163245139|NCT02349295|589605406|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
163245140|NCT03240588|589605407|FG000|Overall Study|Death|3|||
163245141|NCT03240588|589605408|FG001|Overall Study|Death|0|||
163245142|NCT03240588|589605409|FG002|Overall Study|Death|0|||
163245143|NCT03240588|589605407|FG000|Overall Study|Adverse Event|5|||
163352800|NCT00937521|590002532|FG000|Booster Phase|Withdrawal by Subject|1|||
163352801|NCT00937521|590002533|FG001|Booster Phase|Withdrawal by Subject|0|||
163352802|NCT00937521|590002534|FG002|Booster Phase|Withdrawal by Subject|0|||
163352803|NCT00937521|590002535|FG003|Booster Phase|Withdrawal by Subject|1|||
163352804|NCT00937521|590002536|FG004|Booster Phase|Withdrawal by Subject|0|||
163352805|NCT00937521|590002537|FG005|Booster Phase|Withdrawal by Subject|0|||
163352806|NCT00937521|590002538|FG006|Booster Phase|Withdrawal by Subject|0|||
163352807|NCT00937521|590002539|FG007|Booster Phase|Withdrawal by Subject|2|||
163352808|NCT00937521|590002532|FG000|Booster Phase|Lost to Follow-up|2|||
163352809|NCT00937521|590002533|FG001|Booster Phase|Lost to Follow-up|2|||
163352810|NCT00937521|590002534|FG002|Booster Phase|Lost to Follow-up|4|||
163352811|NCT00937521|590002535|FG003|Booster Phase|Lost to Follow-up|2|||
163352812|NCT00937521|590002536|FG004|Booster Phase|Lost to Follow-up|4|||
163352813|NCT00937521|590002537|FG005|Booster Phase|Lost to Follow-up|4|||
163352814|NCT00937521|590002538|FG006|Booster Phase|Lost to Follow-up|3|||
163149145|NCT04247347|589259408|FG000|Overall Study|Withdrawal by Subject|2|||
163149146|NCT04247347|589259409|FG001|Overall Study|Withdrawal by Subject|3|||
163352815|NCT00937521|590002539|FG007|Booster Phase|Lost to Follow-up|0|||
163352816|NCT00937521|590002532|FG000|Booster Phase|Administrative Reason|0|||
163352817|NCT00937521|590002533|FG001|Booster Phase|Administrative Reason|0|||
163352818|NCT00937521|590002534|FG002|Booster Phase|Administrative Reason|1|||
163352819|NCT00937521|590002535|FG003|Booster Phase|Administrative Reason|0|||
163352820|NCT00937521|590002536|FG004|Booster Phase|Administrative Reason|1|||
163352821|NCT00937521|590002537|FG005|Booster Phase|Administrative Reason|1|||
163352822|NCT00937521|590002538|FG006|Booster Phase|Administrative Reason|0|||
163352823|NCT00937521|590002539|FG007|Booster Phase|Administrative Reason|0|||
163352824|NCT00937521|590002532|FG000|Booster Phase|Protocol Deviation|0|||
163352825|NCT00937521|590002533|FG001|Booster Phase|Protocol Deviation|0|||
163352826|NCT00937521|590002534|FG002|Booster Phase|Protocol Deviation|0|||
163352827|NCT00937521|590002535|FG003|Booster Phase|Protocol Deviation|0|||
163352828|NCT00937521|590002536|FG004|Booster Phase|Protocol Deviation|0|||
163352829|NCT00937521|590002537|FG005|Booster Phase|Protocol Deviation|0|||
163352830|NCT00937521|590002538|FG006|Booster Phase|Protocol Deviation|1|||
163352831|NCT00937521|590002539|FG007|Booster Phase|Protocol Deviation|0|||
163352832|NCT01978236|590002540|FG000|Overall Study|Discontinued due to study close|2|||
163352833|NCT04035577|590002541|FG000|Overall Study|Lost to Follow-up|1|||
163352834|NCT04035577|590002541|FG000|Overall Study|Withdrawal by Subject|1|||
163352835|NCT00846768|590002543|FG000|Overall Study|Adverse Event|0|||
163352836|NCT00846768|590002544|FG001|Overall Study|Adverse Event|1|||
163352837|NCT00846768|590002545|FG002|Overall Study|Adverse Event|0|||
163352838|NCT00846768|590002546|FG003|Overall Study|Adverse Event|0|||
163352839|NCT00634920|590002548|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
163352840|NCT00634920|590002549|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
163352841|NCT00634920|590002550|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
163352842|NCT00634920|590002548|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
163352843|NCT00634920|590002549|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
163352844|NCT00634920|590002550|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
163352845|NCT00634920|590002548|FG000|Period 1 - Pre-Randomization|Rejections|0|||
163352846|NCT00634920|590002549|FG001|Period 1 - Pre-Randomization|Rejections|0|||
163352847|NCT00634920|590002550|FG002|Period 1 - Pre-Randomization|Rejections|55|||
163352848|NCT00634920|590002548|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
163352849|NCT00634920|590002549|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
163352850|NCT00634920|590002550|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
163149147|NCT04247347|589259410|FG002|Overall Study|Withdrawal by Subject|3|||
163149148|NCT04247347|589259408|FG000|Overall Study|Lost to Follow-up|1|||
163149149|NCT04247347|589259409|FG001|Overall Study|Lost to Follow-up|1|||
163149150|NCT04247347|589259410|FG002|Overall Study|Lost to Follow-up|1|||
163149151|NCT03562195|589259411|FG000|Overall Study|Adverse Event|0|||
163149152|NCT03562195|589259412|FG001|Overall Study|Adverse Event|6|||
163149153|NCT03562195|589259411|FG000|Overall Study|Lack of Efficacy|0|||
163149154|NCT03562195|589259412|FG001|Overall Study|Lack of Efficacy|5|||
163149155|NCT03562195|589259411|FG000|Overall Study|Protocol Violation|0|||
163149156|NCT03562195|589259412|FG001|Overall Study|Protocol Violation|1|||
163149157|NCT03562195|589259411|FG000|Overall Study|Lost to Follow-up|0|||
163149158|NCT03562195|589259412|FG001|Overall Study|Lost to Follow-up|1|||
163149159|NCT03562195|589259411|FG000|Overall Study|Physician Decision|1|||
163149160|NCT03562195|589259412|FG001|Overall Study|Physician Decision|0|||
163149161|NCT03562195|589259411|FG000|Overall Study|Withdrawal by Subject|3|||
163149162|NCT03562195|589259412|FG001|Overall Study|Withdrawal by Subject|0|||
163149163|NCT02218372|589259413|FG000|Overall Study|Adverse Event|1|||
163149164|NCT02218372|589259414|FG001|Overall Study|Adverse Event|1|||
163149165|NCT02218372|589259413|FG000|Overall Study|Miscellaneous|2|||
163352851|NCT00634920|590002548|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
163352852|NCT00634920|590002549|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
163352853|NCT00634920|590002550|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
163352854|NCT00634920|590002548|FG000|Period 1 - Pre-Randomization|Other issues|0|||
163352855|NCT00634920|590002549|FG001|Period 1 - Pre-Randomization|Other issues|0|||
163352856|NCT00634920|590002550|FG002|Period 1 - Pre-Randomization|Other issues|6|||
163352857|NCT00634920|590002548|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
163352858|NCT00634920|590002549|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
163352859|NCT00634920|590002550|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
163352860|NCT00634920|590002548|FG000|Period 2 - Post-Randomization|Rejection|11|||
163352861|NCT00634920|590002549|FG001|Period 2 - Post-Randomization|Rejection|5|||
163149166|NCT02218372|589259414|FG001|Overall Study|Miscellaneous|1|||
163149167|NCT02218372|589259413|FG000|Overall Study|Randomized but did not receive treatment|2|||
163149168|NCT02218372|589259414|FG001|Overall Study|Randomized but did not receive treatment|3|||
163352862|NCT00634920|590002550|FG002|Period 2 - Post-Randomization|Rejection|0|||
163352863|NCT00634920|590002548|FG000|Period 2 - Post-Randomization|Death|2|||
163352864|NCT00634920|590002549|FG001|Period 2 - Post-Randomization|Death|5|||
163352865|NCT00634920|590002550|FG002|Period 2 - Post-Randomization|Death|0|||
163410214|NCT00689871|590211309|FG001|Overall Study|Withdrawal by Subject|3|||
163410215|NCT00689871|590211310|FG002|Overall Study|Withdrawal by Subject|4|||
163410216|NCT00689871|590211311|FG003|Overall Study|Withdrawal by Subject|1|||
163410217|NCT00689871|590211308|FG000|Overall Study|Death|1|||
163410218|NCT00689871|590211309|FG001|Overall Study|Death|10|||
163410219|NCT00689871|590211310|FG002|Overall Study|Death|2|||
163410220|NCT00689871|590211311|FG003|Overall Study|Death|2|||
163149169|NCT02218372|589259413|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163149170|NCT02218372|589259414|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163149171|NCT02923726|589259415|FG000|Overall Study|Death|196|||
163149172|NCT02923726|589259416|FG001|Overall Study|Death|175|||
163149173|NCT02923726|589259415|FG000|Overall Study|Withdrawal by Subject|337|||
163149174|NCT02923726|589259416|FG001|Overall Study|Withdrawal by Subject|307|||
163149175|NCT03406780|589259421|FG000|Overall Study|Withdrawal by Subject|1|||
163149176|NCT03406780|589259422|FG001|Overall Study|Withdrawal by Subject|1|||
163149177|NCT03406780|589259421|FG000|Overall Study|Other|0|||
163149178|NCT03406780|589259422|FG001|Overall Study|Other|2|||
163149179|NCT02546609|589259434|FG000|Overall Study|Withdrawal by Subject|0|||
163149180|NCT02546609|589259435|FG001|Overall Study|Withdrawal by Subject|1|||
163149181|NCT02546609|589259436|FG002|Overall Study|Withdrawal by Subject|2|||
163149182|NCT02546609|589259434|FG000|Overall Study|Adverse Event|0|||
163149183|NCT02546609|589259435|FG001|Overall Study|Adverse Event|6|||
163149184|NCT02546609|589259436|FG002|Overall Study|Adverse Event|1|||
163149185|NCT02546609|589259434|FG000|Overall Study|Protocol Violation|0|||
163149186|NCT02546609|589259435|FG001|Overall Study|Protocol Violation|1|||
163149187|NCT02546609|589259436|FG002|Overall Study|Protocol Violation|1|||
163149188|NCT02546609|589259434|FG000|Overall Study|Lost to Follow-up|2|||
163149189|NCT02546609|589259435|FG001|Overall Study|Lost to Follow-up|3|||
163149190|NCT02546609|589259436|FG002|Overall Study|Lost to Follow-up|1|||
163149191|NCT02546609|589259434|FG000|Overall Study|travel or work schedule restriction|0|||
163149192|NCT02546609|589259435|FG001|Overall Study|travel or work schedule restriction|0|||
163149193|NCT02546609|589259436|FG002|Overall Study|travel or work schedule restriction|2|||
163149194|NCT02756338|589259438|FG000|Overall Study|Withdrawn by Investigator|1|||
163149195|NCT02756338|589259438|FG000|Overall Study|Device Replaced with Pacemaker|4|||
163149196|NCT01176032|589259439|FG000|Overall Study|Adverse Event|1|||
163149197|NCT01176032|589259440|FG001|Overall Study|Adverse Event|0|||
163149198|NCT01176032|589259439|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163149199|NCT01176032|589259440|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163149200|NCT01176032|589259439|FG000|Overall Study|Protocol Violation|1|||
163149201|NCT01176032|589259440|FG001|Overall Study|Protocol Violation|0|||
163149202|NCT01176032|589259439|FG000|Overall Study|Informed consent withdrawn|3|||
163149203|NCT01176032|589259440|FG001|Overall Study|Informed consent withdrawn|0|||
163149204|NCT01176032|589259439|FG000|Overall Study|Other|1|||
163149205|NCT01176032|589259440|FG001|Overall Study|Other|0|||
163149206|NCT00659061|589259441|FG000|Overall Study|Migration due to political unrest|21|||
163149207|NCT00659061|589259442|FG001|Overall Study|Migration due to political unrest|15|||
163149208|NCT04038359|589259445|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
163149209|NCT04038359|589259446|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
163149210|NCT04038359|589259445|FG000|Overall Study|Death|8|||
163149211|NCT04038359|589259446|FG001|Overall Study|Death|7|||
163149212|NCT04038359|589259445|FG000|Overall Study|Lost to Follow-up|3|||
163149213|NCT04038359|589259446|FG001|Overall Study|Lost to Follow-up|0|||
163149214|NCT04038359|589259445|FG000|Overall Study|Participant Moved|1|||
163149215|NCT04038359|589259446|FG001|Overall Study|Participant Moved|0|||
163149216|NCT04038359|589259445|FG000|Overall Study|Withdrawal by Subject|4|||
163149217|NCT04038359|589259446|FG001|Overall Study|Withdrawal by Subject|3|||
163149218|NCT04038359|589259445|FG000|Overall Study|Physician Decision|3|||
163149219|NCT04038359|589259446|FG001|Overall Study|Physician Decision|2|||
163149220|NCT04038359|589259445|FG000|Overall Study|Adverse Event|0|||
163149221|NCT04038359|589259446|FG001|Overall Study|Adverse Event|2|||
163149222|NCT04038359|589259445|FG000|Overall Study|Progressive Disease|0|||
163149223|NCT04038359|589259446|FG001|Overall Study|Progressive Disease|1|||
163149224|NCT00475670|589259447|FG000|Overall Study|Death|0|||
163149225|NCT00475670|589259448|FG001|Overall Study|Death|1|||
163149226|NCT00475670|589259447|FG000|Overall Study|Lack of Efficacy|3|||
163149227|NCT00475670|589259448|FG001|Overall Study|Lack of Efficacy|34|||
163149228|NCT00475670|589259447|FG000|Overall Study|Refused treatment|0|||
163149229|NCT00475670|589259448|FG001|Overall Study|Refused treatment|2|||
163149230|NCT00475670|589259447|FG000|Overall Study|Failure to Return|0|||
163245144|NCT03240588|589605408|FG001|Overall Study|Adverse Event|4|||
163245145|NCT03240588|589605409|FG002|Overall Study|Adverse Event|0|||
163149231|NCT00475670|589259448|FG001|Overall Study|Failure to Return|1|||
163149232|NCT00475670|589259447|FG000|Overall Study|Other|0|||
163149233|NCT00475670|589259448|FG001|Overall Study|Other|3|||
163149234|NCT02004236|589259451|FG000|Overall Study|Lack of Efficacy|0|||
163149235|NCT02004236|589259452|FG001|Overall Study|Lack of Efficacy|0|||
163149236|NCT02004236|589259453|FG002|Overall Study|Lack of Efficacy|16|||
163149237|NCT01168349|589259455|FG000|Overall Study|Death|157|||
163410221|NCT00689871|590211308|FG000|Overall Study|Physician Decision|2|||
163352866|NCT00634920|590002548|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
163352867|NCT00634920|590002549|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
163352868|NCT00634920|590002550|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
163352869|NCT00634920|590002548|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
163352870|NCT00634920|590002549|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
163352871|NCT00634920|590002550|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
163352872|NCT00644878|590002551|FG000|Overall Study|Adverse Event|2|||
163352873|NCT00644878|590002551|FG000|Overall Study|Abnormal laboratory value|3|||
163352874|NCT00644878|590002551|FG000|Overall Study|Protocol deviation|2|||
163352875|NCT00644878|590002551|FG000|Overall Study|Treatment duration completed as per protocol|11|||
163352876|NCT04353817|590002552|FG000|Overall Study|Adverse Event|0|||
163352877|NCT04353817|590002553|FG001|Overall Study|Adverse Event|1|||
163352878|NCT02143063|590002556|FG000|Overall Study|Lost to Follow-up|16|||
163352879|NCT02143063|590002557|FG001|Overall Study|Lost to Follow-up|28|||
163352880|NCT02143063|590002558|FG002|Overall Study|Lost to Follow-up|29|||
163352881|NCT02143063|590002556|FG000|Overall Study|Withdrawal by Subject|0|||
163352882|NCT02143063|590002557|FG001|Overall Study|Withdrawal by Subject|1|||
163352883|NCT02143063|590002558|FG002|Overall Study|Withdrawal by Subject|0|||
163352884|NCT02143063|590002556|FG000|Overall Study|Death|0|||
163352885|NCT02143063|590002557|FG001|Overall Study|Death|1|||
163352886|NCT02143063|590002558|FG002|Overall Study|Death|1|||
163352887|NCT00878553|590002559|FG000|Sleep Study|Withdrawal by Subject|2|||
163352888|NCT00878553|590002560|FG001|Sleep Study|Withdrawal by Subject|0|||
163352889|NCT00878553|590002561|FG002|Sleep Study|Withdrawal by Subject|0|||
163352890|NCT00878553|590002562|FG003|Sleep Study|Withdrawal by Subject|0|||
163352891|NCT00878553|590002563|FG004|Sleep Study|Withdrawal by Subject|0|||
163352892|NCT00878553|590002559|FG000|Sleep Study|Lost to Follow-up|1|||
163352893|NCT00878553|590002560|FG001|Sleep Study|Lost to Follow-up|0|||
163352894|NCT00878553|590002561|FG002|Sleep Study|Lost to Follow-up|0|||
163352895|NCT00878553|590002562|FG003|Sleep Study|Lost to Follow-up|0|||
163352896|NCT00878553|590002563|FG004|Sleep Study|Lost to Follow-up|0|||
163352897|NCT00878553|590002559|FG000|Sleep Study|car accident|1|||
163352898|NCT00878553|590002560|FG001|Sleep Study|car accident|0|||
163352899|NCT00878553|590002561|FG002|Sleep Study|car accident|0|||
163352900|NCT00878553|590002562|FG003|Sleep Study|car accident|0|||
163352901|NCT00878553|590002563|FG004|Sleep Study|car accident|0|||
163352902|NCT00878553|590002559|FG000|Sleep Study|family emergency|1|||
163352903|NCT00878553|590002560|FG001|Sleep Study|family emergency|0|||
163352904|NCT00878553|590002561|FG002|Sleep Study|family emergency|0|||
163352905|NCT00878553|590002562|FG003|Sleep Study|family emergency|0|||
163352906|NCT00878553|590002563|FG004|Sleep Study|family emergency|0|||
163352907|NCT00878553|590002559|FG000|PK Study|Withdrawal by Subject|0|||
163352908|NCT00878553|590002560|FG001|PK Study|Withdrawal by Subject|0|||
163352909|NCT00878553|590002561|FG002|PK Study|Withdrawal by Subject|0|||
163352910|NCT00878553|590002562|FG003|PK Study|Withdrawal by Subject|1|||
163352911|NCT00878553|590002563|FG004|PK Study|Withdrawal by Subject|0|||
163352912|NCT03517111|590002566|FG000|Enrolled|Withdrawal by Subject|0|||
163352913|NCT03517111|590002567|FG001|Enrolled|Withdrawal by Subject|1|||
163352914|NCT03517111|590002568|FG002|Enrolled|Withdrawal by Subject|0|||
163352915|NCT03517111|590002566|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
163352916|NCT03517111|590002567|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
163352917|NCT03517111|590002568|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
163352918|NCT03517111|590002566|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
163352919|NCT03517111|590002567|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
163352920|NCT03517111|590002568|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
163352921|NCT03517111|590002566|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
163352922|NCT03517111|590002567|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
163352923|NCT03517111|590002568|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
163352924|NCT03517111|590002566|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
163352925|NCT03517111|590002567|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
163352926|NCT03517111|590002568|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
163352927|NCT00909532|590002569|FG000|Overall Study|Adverse Event|4|||
163352928|NCT00909532|590002570|FG001|Overall Study|Adverse Event|1|||
163352929|NCT00909532|590002569|FG000|Overall Study|Pregnancy|0|||
163352930|NCT00909532|590002570|FG001|Overall Study|Pregnancy|1|||
163352931|NCT00909532|590002569|FG000|Overall Study|Prohibited Medication|2|||
163352932|NCT00909532|590002570|FG001|Overall Study|Prohibited Medication|1|||
163352933|NCT00909532|590002569|FG000|Overall Study|Withdrawal of Consent|1|||
163352934|NCT00909532|590002570|FG001|Overall Study|Withdrawal of Consent|1|||
163352935|NCT00909532|590002569|FG000|Overall Study|Noncompliance with Study Requirements|0|||
163352936|NCT00909532|590002570|FG001|Overall Study|Noncompliance with Study Requirements|2|||
163352937|NCT00909532|590002569|FG000|Overall Study|Physician Decision|1|||
163352938|NCT00909532|590002570|FG001|Overall Study|Physician Decision|0|||
163352939|NCT00909532|590002569|FG000|Overall Study|Wrong Genotype|1|||
163352940|NCT00909532|590002570|FG001|Overall Study|Wrong Genotype|0|||
163352941|NCT00909532|590002569|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
163245146|NCT03240588|589605407|FG000|Overall Study|Lost to Follow-up|9|||
163245147|NCT03240588|589605408|FG001|Overall Study|Lost to Follow-up|4|||
163245148|NCT03240588|589605409|FG002|Overall Study|Lost to Follow-up|0|||
163245149|NCT03240588|589605407|FG000|Overall Study|Physician Decision|3|||
163245150|NCT03240588|589605408|FG001|Overall Study|Physician Decision|2|||
163245151|NCT03240588|589605409|FG002|Overall Study|Physician Decision|0|||
163245152|NCT03240588|589605407|FG000|Overall Study|Did not meet eligibility criteria|0|||
163245153|NCT03240588|589605408|FG001|Overall Study|Did not meet eligibility criteria|6|||
163245154|NCT03240588|589605409|FG002|Overall Study|Did not meet eligibility criteria|0|||
163245155|NCT03240588|589605407|FG000|Overall Study|No longer meets protocol criteria|12|||
163245156|NCT03240588|589605408|FG001|Overall Study|No longer meets protocol criteria|7|||
163245157|NCT03240588|589605409|FG002|Overall Study|No longer meets protocol criteria|0|||
163245158|NCT03240588|589605407|FG000|Overall Study|Withdrawal by Subject|60|||
163245159|NCT03240588|589605408|FG001|Overall Study|Withdrawal by Subject|52|||
163245160|NCT03240588|589605409|FG002|Overall Study|Withdrawal by Subject|7|||
163245161|NCT03240588|589605407|FG000|Overall Study|Other, additional details not available.|0|||
163245162|NCT03240588|589605408|FG001|Overall Study|Other, additional details not available.|12|||
163245163|NCT03240588|589605409|FG002|Overall Study|Other, additional details not available.|1|||
163245164|NCT03240588|589605407|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
163245165|NCT03240588|589605408|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
163245166|NCT03240588|589605409|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
163245167|NCT03240588|589605407|FG000|Overall Study|Closure of study|55|||
163245168|NCT03240588|589605408|FG001|Overall Study|Closure of study|3|||
163245169|NCT03240588|589605409|FG002|Overall Study|Closure of study|0|||
163245170|NCT03240588|589605407|FG000|Overall Study|Subject non-compliance|23|||
163245171|NCT03240588|589605408|FG001|Overall Study|Subject non-compliance|2|||
163245172|NCT03240588|589605409|FG002|Overall Study|Subject non-compliance|1|||
163245173|NCT03240588|589605407|FG000|Overall Study|Device Deficiency|1|||
163245174|NCT03240588|589605408|FG001|Overall Study|Device Deficiency|0|||
163245175|NCT03240588|589605409|FG002|Overall Study|Device Deficiency|0|||
163245176|NCT03240588|589605407|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
163245177|NCT03240588|589605408|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
163245178|NCT03240588|589605409|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
163245179|NCT01259713|589605411|FG000|Overall Study|Adverse Event|54|||
163245180|NCT01259713|589605412|FG001|Overall Study|Adverse Event|23|||
163245181|NCT01259713|589605411|FG000|Overall Study|Death Not Related to IFI|8|||
163245182|NCT01259713|589605412|FG001|Overall Study|Death Not Related to IFI|1|||
163245183|NCT01259713|589605411|FG000|Overall Study|Investigators Discretion|14|||
163245184|NCT01259713|589605412|FG001|Overall Study|Investigators Discretion|6|||
163245185|NCT01259713|589605411|FG000|Overall Study|Lack of Efficacy|2|||
163245186|NCT01259713|589605412|FG001|Overall Study|Lack of Efficacy|0|||
163245187|NCT01259713|589605411|FG000|Overall Study|Protocol Violation|5|||
163245188|NCT01259713|589605412|FG001|Overall Study|Protocol Violation|4|||
163245189|NCT01259713|589605411|FG000|Overall Study|Subject Withdrew Consent|12|||
163245190|NCT01259713|589605412|FG001|Overall Study|Subject Withdrew Consent|7|||
163245191|NCT02091726|589605413|FG000|Overall Study|Lost to Follow-up|6|||
163245192|NCT06111742|589605420|FG000|Overall Study|Did not receive intervention|1|||
163245193|NCT06111742|589605421|FG001|Overall Study|Did not receive intervention|0|||
163245194|NCT06111742|589605422|FG002|Overall Study|Did not receive intervention|0|||
163245195|NCT06111742|589605420|FG000|Overall Study|Withdrawal by Subject|2|||
163245196|NCT06111742|589605421|FG001|Overall Study|Withdrawal by Subject|0|||
163245197|NCT06111742|589605422|FG002|Overall Study|Withdrawal by Subject|0|||
163245198|NCT03461003|589605423|FG000|Overall Study|Lost to Follow-up|2|||
163245199|NCT03461003|589605424|FG001|Overall Study|Lost to Follow-up|2|||
163245200|NCT03461003|589605423|FG000|Overall Study|Withdrawal by Subject|3|||
163245201|NCT03461003|589605424|FG001|Overall Study|Withdrawal by Subject|1|||
163245202|NCT00620750|589605428|FG000|Overall Study|Lost to Follow-up|25|||
163245203|NCT04477187|589605429|FG000|Overall Study|Lost to Follow-up|2|||
163245204|NCT03508843|589605431|FG000|Overall Study|Withdrawal by Subject|1|||
163245205|NCT03508843|589605431|FG000|Overall Study|technical difficulties|2|||
163245206|NCT04717596|589605432|FG000|Overall Study|Withdrawal by Subject|4|||
163245207|NCT00765843|589605433|FG000|Overall Study|Lost to Follow-up|1|||
163245208|NCT00765843|589605434|FG001|Overall Study|Lost to Follow-up|3|||
163245209|NCT00765843|589605435|FG002|Overall Study|Lost to Follow-up|2|||
163245210|NCT00765843|589605433|FG000|Overall Study|did not return to receive intervention|0|||
163245211|NCT00765843|589605434|FG001|Overall Study|did not return to receive intervention|1|||
163245212|NCT00765843|589605435|FG002|Overall Study|did not return to receive intervention|0|||
163245213|NCT00765843|589605433|FG000|Overall Study|Adverse Event|0|||
163245214|NCT00765843|589605434|FG001|Overall Study|Adverse Event|0|||
163245215|NCT00765843|589605435|FG002|Overall Study|Adverse Event|1|||
163245216|NCT03555396|589605436|FG000|Overall Study|Death|3|||
163352942|NCT00909532|590002570|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
163352943|NCT03188536|590002572|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
163352944|NCT03188536|590002572|FG000|Overall Study|Not participated/met inclusion criteria|1|||
163352945|NCT02062645|590002575|FG000|Overall Study|Adverse Event|2|||
163352946|NCT02062645|590002575|FG000|Overall Study|Protocol Violation|8|||
163352947|NCT02062645|590002575|FG000|Overall Study|Lost to Follow-up|5|||
163352948|NCT02864342|590002577|FG000|Overall Study|Eligibility Criteria Deviation|2|||
163352949|NCT02864342|590002578|FG001|Overall Study|Eligibility Criteria Deviation|3|||
163352950|NCT02864342|590002577|FG000|Overall Study|Withdrawal by Subject|4|||
163352951|NCT02864342|590002578|FG001|Overall Study|Withdrawal by Subject|2|||
163352952|NCT02864342|590002577|FG000|Overall Study|Device Technology Issue|6|||
163352953|NCT02864342|590002578|FG001|Overall Study|Device Technology Issue|7|||
163352954|NCT02864342|590002577|FG000|Overall Study|Death|0|||
163352955|NCT02864342|590002578|FG001|Overall Study|Death|1|||
163352956|NCT02864342|590002577|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
163352957|NCT02864342|590002578|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
163352958|NCT02864342|590002577|FG000|Overall Study|Lost to Follow-up|1|||
163352959|NCT02864342|590002578|FG001|Overall Study|Lost to Follow-up|5|||
163352960|NCT02864342|590002577|FG000|Overall Study|Lost Device|1|||
163352961|NCT02864342|590002578|FG001|Overall Study|Lost Device|0|||
163352962|NCT02864342|590002577|FG000|Overall Study|Adverse Event|1|||
163352963|NCT02864342|590002578|FG001|Overall Study|Adverse Event|0|||
163352964|NCT00118703|590002581|FG000|Overall Study|Protocol Violation|1|||
163352965|NCT00118703|590002582|FG001|Overall Study|Protocol Violation|0|||
163352966|NCT00118703|590002581|FG000|Overall Study|Adverse Event|1|||
163352967|NCT00118703|590002582|FG001|Overall Study|Adverse Event|1|||
163352968|NCT00118703|590002581|FG000|Overall Study|Participant took two different treatment|0|||
163352969|NCT00118703|590002582|FG001|Overall Study|Participant took two different treatment|1|||
163352970|NCT00118703|590002581|FG000|Overall Study|Withdrawal by Subject|2|||
163245217|NCT03555396|589605437|FG001|Overall Study|Death|1|||
163245218|NCT03555396|589605436|FG000|Overall Study|Lost to Follow-up|0|||
163245219|NCT03555396|589605437|FG001|Overall Study|Lost to Follow-up|2|||
163245220|NCT02460991|589605438|FG000|Overall Study|Withdrawal by Subject|0|||
163245221|NCT02460991|589605439|FG001|Overall Study|Withdrawal by Subject|2|||
163245222|NCT02564523|589605440|FG000|Overall Study|Withdrawal by Subject|3|||
163245223|NCT02564523|589605441|FG001|Overall Study|Withdrawal by Subject|0|||
163245224|NCT02564523|589605442|FG002|Overall Study|Withdrawal by Subject|1|||
163245225|NCT02564523|589605443|FG003|Overall Study|Withdrawal by Subject|0|||
163245226|NCT02564523|589605444|FG004|Overall Study|Withdrawal by Subject|1|||
163245227|NCT02564523|589605445|FG005|Overall Study|Withdrawal by Subject|0|||
163245228|NCT02564523|589605446|FG006|Overall Study|Withdrawal by Subject|1|||
163245229|NCT02564523|589605447|FG007|Overall Study|Withdrawal by Subject|0|||
163245230|NCT02564523|589605448|FG008|Overall Study|Withdrawal by Subject|0|||
163245231|NCT02564523|589605449|FG009|Overall Study|Withdrawal by Subject|0|||
163245232|NCT02564523|589605450|FG010|Overall Study|Withdrawal by Subject|1|||
163245233|NCT02564523|589605451|FG011|Overall Study|Withdrawal by Subject|0|||
163245234|NCT02564523|589605452|FG012|Overall Study|Withdrawal by Subject|1|||
163245235|NCT02564523|589605453|FG013|Overall Study|Withdrawal by Subject|0|||
163245236|NCT02564523|589605454|FG014|Overall Study|Withdrawal by Subject|0|||
163245237|NCT02564523|589605455|FG015|Overall Study|Withdrawal by Subject|0|||
163245238|NCT02564523|589605456|FG016|Overall Study|Withdrawal by Subject|0|||
163245239|NCT02564523|589605457|FG017|Overall Study|Withdrawal by Subject|0|||
163245240|NCT02564523|589605440|FG000|Overall Study|Adverse Event|0|||
163245241|NCT02564523|589605441|FG001|Overall Study|Adverse Event|0|||
163245242|NCT02564523|589605442|FG002|Overall Study|Adverse Event|0|||
163245243|NCT02564523|589605443|FG003|Overall Study|Adverse Event|0|||
163245244|NCT02564523|589605444|FG004|Overall Study|Adverse Event|0|||
163245245|NCT02564523|589605445|FG005|Overall Study|Adverse Event|0|||
163245246|NCT02564523|589605446|FG006|Overall Study|Adverse Event|0|||
163245247|NCT02564523|589605447|FG007|Overall Study|Adverse Event|0|||
163245248|NCT02564523|589605448|FG008|Overall Study|Adverse Event|0|||
163245249|NCT02564523|589605449|FG009|Overall Study|Adverse Event|0|||
163245250|NCT02564523|589605450|FG010|Overall Study|Adverse Event|0|||
163245251|NCT02564523|589605451|FG011|Overall Study|Adverse Event|0|||
163245252|NCT02564523|589605452|FG012|Overall Study|Adverse Event|0|||
163245253|NCT02564523|589605453|FG013|Overall Study|Adverse Event|0|||
163245254|NCT02564523|589605454|FG014|Overall Study|Adverse Event|0|||
163245255|NCT02564523|589605455|FG015|Overall Study|Adverse Event|0|||
163245256|NCT02564523|589605456|FG016|Overall Study|Adverse Event|0|||
163245257|NCT02564523|589605457|FG017|Overall Study|Adverse Event|1|||
163245258|NCT02564523|589605440|FG000|Overall Study|Death|0|||
163245259|NCT02564523|589605441|FG001|Overall Study|Death|0|||
163245260|NCT02564523|589605442|FG002|Overall Study|Death|0|||
163245261|NCT02564523|589605443|FG003|Overall Study|Death|0|||
163245262|NCT02564523|589605444|FG004|Overall Study|Death|0|||
163245263|NCT02564523|589605445|FG005|Overall Study|Death|0|||
163245264|NCT02564523|589605446|FG006|Overall Study|Death|1|||
163245265|NCT02564523|589605447|FG007|Overall Study|Death|0|||
163245266|NCT02564523|589605448|FG008|Overall Study|Death|0|||
163245267|NCT02564523|589605449|FG009|Overall Study|Death|0|||
163245268|NCT02564523|589605450|FG010|Overall Study|Death|1|||
163245269|NCT02564523|589605451|FG011|Overall Study|Death|0|||
163245270|NCT02564523|589605452|FG012|Overall Study|Death|0|||
163245271|NCT02564523|589605453|FG013|Overall Study|Death|0|||
163245272|NCT02564523|589605454|FG014|Overall Study|Death|0|||
163245273|NCT02564523|589605455|FG015|Overall Study|Death|0|||
163245274|NCT02564523|589605456|FG016|Overall Study|Death|0|||
163245275|NCT02564523|589605457|FG017|Overall Study|Death|0|||
163245276|NCT02564523|589605440|FG000|Overall Study|Lost to Follow-up|2|||
163245277|NCT02564523|589605441|FG001|Overall Study|Lost to Follow-up|1|||
163245278|NCT02564523|589605442|FG002|Overall Study|Lost to Follow-up|4|||
163245279|NCT02564523|589605443|FG003|Overall Study|Lost to Follow-up|0|||
163245280|NCT02564523|589605444|FG004|Overall Study|Lost to Follow-up|1|||
163245281|NCT02564523|589605445|FG005|Overall Study|Lost to Follow-up|0|||
163245282|NCT02564523|589605446|FG006|Overall Study|Lost to Follow-up|1|||
163245283|NCT02564523|589605447|FG007|Overall Study|Lost to Follow-up|0|||
163245284|NCT02564523|589605448|FG008|Overall Study|Lost to Follow-up|0|||
163245285|NCT02564523|589605449|FG009|Overall Study|Lost to Follow-up|0|||
163245286|NCT02564523|589605450|FG010|Overall Study|Lost to Follow-up|0|||
163245287|NCT02564523|589605451|FG011|Overall Study|Lost to Follow-up|1|||
163245288|NCT02564523|589605452|FG012|Overall Study|Lost to Follow-up|1|||
163245289|NCT02564523|589605453|FG013|Overall Study|Lost to Follow-up|0|||
163245290|NCT02564523|589605454|FG014|Overall Study|Lost to Follow-up|0|||
163245291|NCT02564523|589605455|FG015|Overall Study|Lost to Follow-up|0|||
163245292|NCT02564523|589605456|FG016|Overall Study|Lost to Follow-up|0|||
163245293|NCT02564523|589605457|FG017|Overall Study|Lost to Follow-up|0|||
163245294|NCT02564523|589605440|FG000|Overall Study|Physician Decision|0|||
163245295|NCT02564523|589605441|FG001|Overall Study|Physician Decision|0|||
163245296|NCT02564523|589605442|FG002|Overall Study|Physician Decision|0|||
163245297|NCT02564523|589605443|FG003|Overall Study|Physician Decision|0|||
163245298|NCT02564523|589605444|FG004|Overall Study|Physician Decision|1|||
163245299|NCT02564523|589605445|FG005|Overall Study|Physician Decision|0|||
163245300|NCT02564523|589605446|FG006|Overall Study|Physician Decision|0|||
163245301|NCT02564523|589605447|FG007|Overall Study|Physician Decision|0|||
163245302|NCT02564523|589605448|FG008|Overall Study|Physician Decision|0|||
163245303|NCT02564523|589605449|FG009|Overall Study|Physician Decision|0|||
163245304|NCT02564523|589605450|FG010|Overall Study|Physician Decision|1|||
163245305|NCT02564523|589605451|FG011|Overall Study|Physician Decision|0|||
163245306|NCT02564523|589605452|FG012|Overall Study|Physician Decision|0|||
163245307|NCT02564523|589605453|FG013|Overall Study|Physician Decision|0|||
163245308|NCT02564523|589605454|FG014|Overall Study|Physician Decision|0|||
163245309|NCT02564523|589605455|FG015|Overall Study|Physician Decision|0|||
163245310|NCT02564523|589605456|FG016|Overall Study|Physician Decision|0|||
163245311|NCT02564523|589605457|FG017|Overall Study|Physician Decision|0|||
163245312|NCT02564523|589605440|FG000|Overall Study|Protocol Violation|2|||
163245313|NCT02564523|589605441|FG001|Overall Study|Protocol Violation|2|||
163245314|NCT02564523|589605442|FG002|Overall Study|Protocol Violation|5|||
163245315|NCT02564523|589605443|FG003|Overall Study|Protocol Violation|0|||
163245316|NCT02564523|589605444|FG004|Overall Study|Protocol Violation|1|||
163245317|NCT02564523|589605445|FG005|Overall Study|Protocol Violation|0|||
163245318|NCT02564523|589605446|FG006|Overall Study|Protocol Violation|0|||
163245319|NCT02564523|589605447|FG007|Overall Study|Protocol Violation|0|||
163245320|NCT02564523|589605448|FG008|Overall Study|Protocol Violation|0|||
163245321|NCT02564523|589605449|FG009|Overall Study|Protocol Violation|0|||
163245322|NCT02564523|589605450|FG010|Overall Study|Protocol Violation|0|||
163245323|NCT02564523|589605451|FG011|Overall Study|Protocol Violation|0|||
163245324|NCT02564523|589605452|FG012|Overall Study|Protocol Violation|0|||
163245325|NCT02564523|589605453|FG013|Overall Study|Protocol Violation|0|||
163245326|NCT02564523|589605454|FG014|Overall Study|Protocol Violation|0|||
163245327|NCT02564523|589605455|FG015|Overall Study|Protocol Violation|0|||
163352971|NCT00118703|590002582|FG001|Overall Study|Withdrawal by Subject|5|||
163352972|NCT00118703|590002581|FG000|Overall Study|Lost to Follow-up|1|||
163352973|NCT00118703|590002582|FG001|Overall Study|Lost to Follow-up|2|||
163352974|NCT00461123|590002583|FG000|Overall Study|Adverse Event|1|||
163352975|NCT00461123|590002584|FG001|Overall Study|Adverse Event|0|||
163352976|NCT00461123|590002583|FG000|Overall Study|Lost to Follow-up|1|||
163352977|NCT00461123|590002584|FG001|Overall Study|Lost to Follow-up|1|||
163245328|NCT02564523|589605456|FG016|Overall Study|Protocol Violation|0|||
163245329|NCT02564523|589605457|FG017|Overall Study|Protocol Violation|0|||
163245330|NCT02564523|589605440|FG000|Overall Study|Other|3|||
163245331|NCT02564523|589605441|FG001|Overall Study|Other|0|||
163245332|NCT02564523|589605442|FG002|Overall Study|Other|0|||
163245333|NCT02564523|589605443|FG003|Overall Study|Other|1|||
163245334|NCT02564523|589605444|FG004|Overall Study|Other|0|||
163245335|NCT02564523|589605445|FG005|Overall Study|Other|0|||
163245336|NCT02564523|589605446|FG006|Overall Study|Other|0|||
163245337|NCT02564523|589605447|FG007|Overall Study|Other|0|||
163352978|NCT00461123|590002583|FG000|Overall Study|Protocol Violation|3|||
163245338|NCT02564523|589605448|FG008|Overall Study|Other|0|||
163245339|NCT02564523|589605449|FG009|Overall Study|Other|0|||
163245340|NCT02564523|589605450|FG010|Overall Study|Other|0|||
163245341|NCT02564523|589605451|FG011|Overall Study|Other|0|||
163245342|NCT02564523|589605452|FG012|Overall Study|Other|0|||
163352979|NCT00461123|590002584|FG001|Overall Study|Protocol Violation|2|||
163352980|NCT00461123|590002583|FG000|Overall Study|Withdrawal by Subject|1|||
163352981|NCT00461123|590002584|FG001|Overall Study|Withdrawal by Subject|3|||
163352982|NCT00927901|590002585|FG000|Treatment Period 1|Subject withdrew consent|0|||
163352983|NCT00927901|590002586|FG001|Treatment Period 1|Subject withdrew consent|0|||
163352984|NCT00927901|590002587|FG002|Treatment Period 1|Subject withdrew consent|1|||
163352985|NCT00927901|590002588|FG003|Treatment Period 1|Subject withdrew consent|0|||
163352986|NCT00927901|590002585|FG000|Treatment Period 4|Adverse Event|0|||
163352987|NCT00927901|590002586|FG001|Treatment Period 4|Adverse Event|0|||
163352988|NCT00927901|590002587|FG002|Treatment Period 4|Adverse Event|0|||
163352989|NCT00927901|590002588|FG003|Treatment Period 4|Adverse Event|1|||
163352990|NCT00927901|590002585|FG000|Treatment Period 4|Subject withdrew consent|0|||
163352991|NCT00927901|590002586|FG001|Treatment Period 4|Subject withdrew consent|0|||
163352992|NCT00927901|590002587|FG002|Treatment Period 4|Subject withdrew consent|1|||
163352993|NCT00927901|590002588|FG003|Treatment Period 4|Subject withdrew consent|0|||
163352994|NCT02344173|590002589|FG000|Procedure|Ablation Procedure Not Performed|7|||
163352995|NCT02344173|590002589|FG000|12-month Visit|Death|8|||
163352996|NCT02344173|590002589|FG000|12-month Visit|Withdrawal by Subject|30|||
163352997|NCT02344173|590002589|FG000|12-month Visit|Lost to Follow-up|58|||
163352998|NCT00746356|590002594|FG000|Overall Study|Withdrawal by Subject|2|||
163352999|NCT00746356|590002595|FG001|Overall Study|Withdrawal by Subject|3|||
163353000|NCT00746356|590002594|FG000|Overall Study|Death|7|||
163353001|NCT00746356|590002595|FG001|Overall Study|Death|3|||
163353002|NCT00746356|590002594|FG000|Overall Study|Lost to Follow-up|1|||
163353003|NCT00746356|590002595|FG001|Overall Study|Lost to Follow-up|0|||
163353004|NCT00746356|590002594|FG000|Overall Study|Removal of Device|0|||
163353005|NCT00746356|590002595|FG001|Overall Study|Removal of Device|1|||
163353006|NCT00746356|590002594|FG000|Overall Study|Patient relocated|1|||
163353007|NCT00746356|590002595|FG001|Overall Study|Patient relocated|0|||
163353008|NCT01263925|590002596|FG000|Overall Study|Protocol Violation|1|||
163353009|NCT01263925|590002597|FG001|Overall Study|Protocol Violation|0|||
163353010|NCT01263925|590002596|FG000|Overall Study|Lack of Efficacy|0|||
163353011|NCT01263925|590002597|FG001|Overall Study|Lack of Efficacy|1|||
163353012|NCT01263925|590002596|FG000|Overall Study|Adverse Event|23|||
163353013|NCT01263925|590002597|FG001|Overall Study|Adverse Event|22|||
163353014|NCT01263925|590002596|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
163353015|NCT01263925|590002597|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
163353016|NCT01263925|590002596|FG000|Overall Study|Withdrawal by Subject|6|||
163353017|NCT01263925|590002597|FG001|Overall Study|Withdrawal by Subject|8|||
163353018|NCT01263925|590002596|FG000|Overall Study|Other|4|||
163353019|NCT01263925|590002597|FG001|Overall Study|Other|4|||
163353020|NCT01263925|590002596|FG000|Overall Study|Lost to Follow-up|3|||
163353021|NCT01263925|590002597|FG001|Overall Study|Lost to Follow-up|1|||
163353022|NCT01263925|590002596|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
163353023|NCT01263925|590002597|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
163353024|NCT01263925|590002596|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
163353025|NCT01263925|590002597|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
163353026|NCT01263925|590002596|FG000|Overall Study|AE/ Withdrawal|1|||
163353027|NCT01263925|590002597|FG001|Overall Study|AE/ Withdrawal|4|||
163353028|NCT01263925|590002596|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
163353029|NCT01263925|590002597|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
163353030|NCT01263925|590002596|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
163353031|NCT01263925|590002597|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
163353032|NCT01263925|590002596|FG000|Overall Study|Withdrawal/ Not specified|0|||
163353033|NCT01263925|590002597|FG001|Overall Study|Withdrawal/ Not specified|1|||
163353034|NCT01560585|590002602|FG000|Overall Study|Physician Decision|3|||
163353035|NCT03028012|590002603|FG000|Overall Study|Lost to Follow-up|2|||
163353036|NCT03028012|590002604|FG001|Overall Study|Lost to Follow-up|3|||
163353037|NCT03028012|590002605|FG002|Overall Study|Lost to Follow-up|3|||
163353038|NCT00770588|590002607|FG000|Overall Study|Adverse Event|9|||
163353039|NCT00770588|590002608|FG001|Overall Study|Adverse Event|2|||
163353040|NCT00770588|590002607|FG000|Overall Study|Death caused by progression of disease|70|||
163410222|NCT00689871|590211309|FG001|Overall Study|Physician Decision|1|||
163353041|NCT00770588|590002608|FG001|Overall Study|Death caused by progression of disease|91|||
163353042|NCT00770588|590002607|FG000|Overall Study|Lost to Follow-up|1|||
163353043|NCT00770588|590002608|FG001|Overall Study|Lost to Follow-up|1|||
163353044|NCT00770588|590002607|FG000|Overall Study|Withdrawal by Subject|1|||
163353045|NCT00770588|590002608|FG001|Overall Study|Withdrawal by Subject|1|||
163353046|NCT01053247|590004580|FG000|Overall Study|Withdrawal by Subject|9|||
163353047|NCT01053247|590004581|FG001|Overall Study|Withdrawal by Subject|4|||
163353048|NCT01053247|590004582|FG002|Overall Study|Withdrawal by Subject|15|||
163353049|NCT01053247|590004580|FG000|Overall Study|Lack of Efficacy|1|||
163353050|NCT01053247|590004581|FG001|Overall Study|Lack of Efficacy|0|||
163353051|NCT01053247|590004582|FG002|Overall Study|Lack of Efficacy|1|||
163353052|NCT01053247|590004580|FG000|Overall Study|Protocol Violation|2|||
163353053|NCT01053247|590004581|FG001|Overall Study|Protocol Violation|1|||
163245343|NCT02564523|589605453|FG013|Overall Study|Other|0|||
163245344|NCT02564523|589605454|FG014|Overall Study|Other|0|||
163245345|NCT02564523|589605455|FG015|Overall Study|Other|0|||
163245346|NCT02564523|589605456|FG016|Overall Study|Other|0|||
163245347|NCT02564523|589605457|FG017|Overall Study|Other|0|||
163245348|NCT03701555|589605463|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
163245349|NCT03701555|589605464|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
163245350|NCT03701555|589605465|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
163245351|NCT03701555|589605466|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
163245352|NCT03701555|589605467|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
163245353|NCT03701555|589605468|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
163245354|NCT03701555|589605469|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
163245355|NCT03701555|589605470|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
163245356|NCT03701555|589605471|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
163245357|NCT03701555|589605472|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
163245358|NCT03701555|589605473|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
163245359|NCT03701555|589605474|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
163245360|NCT03701555|589605475|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
163245361|NCT03701555|589605476|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
163245362|NCT03701555|589605477|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
163245363|NCT03701555|589605478|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
163245364|NCT03701555|589605479|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
163245365|NCT03701555|589605480|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
163245366|NCT03701555|589605481|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
163245367|NCT03701555|589605482|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
163245368|NCT03701555|589605483|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
163245369|NCT03701555|589605484|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
163245370|NCT03701555|589605485|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
163245371|NCT03701555|589605486|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
163245372|NCT03701555|589605487|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
163245373|NCT03701555|589605488|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
163245374|NCT03701555|589605489|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
163245375|NCT03701555|589605490|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
163245376|NCT03701555|589605491|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
163245377|NCT03701555|589605492|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
163245378|NCT03701555|589605493|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
163245379|NCT03701555|589605494|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
163245380|NCT03701555|589605495|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
163245381|NCT03701555|589605496|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
163245382|NCT03701555|589605497|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
163245383|NCT03701555|589605498|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
163245384|NCT03701555|589605463|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
163245385|NCT03701555|589605464|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
163245386|NCT03701555|589605465|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
163245387|NCT03701555|589605466|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
163245388|NCT03701555|589605467|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
163245389|NCT03701555|589605468|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
163245390|NCT03701555|589605469|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
163245391|NCT03701555|589605470|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
163245392|NCT03701555|589605471|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
163245393|NCT03701555|589605472|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
163245394|NCT03701555|589605473|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
163245395|NCT03701555|589605474|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
163245396|NCT03701555|589605475|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
163245397|NCT03701555|589605476|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
163245398|NCT03701555|589605477|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
163245399|NCT03701555|589605478|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
163245400|NCT03701555|589605479|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
163245401|NCT03701555|589605480|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
163245402|NCT03701555|589605481|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
163245403|NCT03701555|589605482|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
163410223|NCT00689871|590211310|FG002|Overall Study|Physician Decision|1|||
163410224|NCT00689871|590211311|FG003|Overall Study|Physician Decision|0|||
163245404|NCT03701555|589605483|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
163245405|NCT03701555|589605484|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
163245406|NCT03701555|589605485|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
163245407|NCT03701555|589605486|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
163245408|NCT03701555|589605487|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
163245409|NCT03701555|589605488|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
163245410|NCT03701555|589605489|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
163245411|NCT03701555|589605490|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
163245412|NCT03701555|589605491|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
163245413|NCT03701555|589605492|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
163245414|NCT03701555|589605493|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
163245415|NCT03701555|589605494|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
163245416|NCT03701555|589605495|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
163245417|NCT03701555|589605496|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
163245418|NCT03701555|589605497|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
163410225|NCT04417894|590211321|FG000|Overall Study|Lost to Follow-up|3|||
163353054|NCT01053247|590004582|FG002|Overall Study|Protocol Violation|2|||
163353055|NCT01053247|590004580|FG000|Overall Study|Lost to Follow-up|8|||
163353056|NCT01053247|590004581|FG001|Overall Study|Lost to Follow-up|5|||
163353057|NCT01053247|590004582|FG002|Overall Study|Lost to Follow-up|7|||
163353058|NCT01053247|590004580|FG000|Overall Study|Adverse Event|0|||
163353059|NCT01053247|590004581|FG001|Overall Study|Adverse Event|9|||
163353060|NCT01053247|590004582|FG002|Overall Study|Adverse Event|3|||
163353061|NCT03458728|590004583|FG000|Overall Study|Adverse Event|1|||
163353062|NCT03458728|590004584|FG001|Overall Study|Adverse Event|0|||
163353063|NCT03458728|590004583|FG000|Overall Study|Physician Decision|1|||
163353064|NCT03458728|590004584|FG001|Overall Study|Physician Decision|0|||
163353065|NCT03458728|590004583|FG000|Overall Study|Progressive disease - clinical assessment|1|||
163353066|NCT03458728|590004584|FG001|Overall Study|Progressive disease - clinical assessment|0|||
163353067|NCT03458728|590004583|FG000|Overall Study|Progressive disease - radiological progression|21|||
163353068|NCT03458728|590004584|FG001|Overall Study|Progressive disease - radiological progression|6|||
163353069|NCT03458728|590004583|FG000|Overall Study|Withdrawal by Subject|0|||
163353070|NCT03458728|590004584|FG001|Overall Study|Withdrawal by Subject|1|||
163353071|NCT00908349|590004587|FG000|Overall Study|Adverse Event|10|||
163353072|NCT00908349|590004587|FG000|Overall Study|Withdrawal by Subject|9|||
163353073|NCT00908349|590004587|FG000|Overall Study|Physician Decision|5|||
163353074|NCT00908349|590004587|FG000|Overall Study|Lost to Follow-up|5|||
163353075|NCT00908349|590004587|FG000|Overall Study|Various|6|||
163353076|NCT01114139|590004589|FG000|Overall Study|Adverse Event|3|||
163353077|NCT01114139|590004590|FG001|Overall Study|Adverse Event|2|||
163353078|NCT01114139|590004589|FG000|Overall Study|Lost to Follow-up|15|||
163353079|NCT01114139|590004590|FG001|Overall Study|Lost to Follow-up|3|||
163353080|NCT01114139|590004589|FG000|Overall Study|Withdrawal by Subject|17|||
163353081|NCT01114139|590004590|FG001|Overall Study|Withdrawal by Subject|6|||
163353082|NCT01114139|590004589|FG000|Overall Study|Other-Missed 1 visit|1|||
163353083|NCT01114139|590004590|FG001|Overall Study|Other-Missed 1 visit|0|||
163353084|NCT01114139|590004589|FG000|Overall Study|Other-Protocol Violation|1|||
163353085|NCT01114139|590004590|FG001|Overall Study|Other-Protocol Violation|0|||
163353086|NCT01114139|590004589|FG000|Overall Study|Other-Out of window for study drug dose|1|||
163353087|NCT01114139|590004590|FG001|Overall Study|Other-Out of window for study drug dose|0|||
163353088|NCT01114139|590004589|FG000|Overall Study|Other-Participant falsified records|0|||
163353089|NCT01114139|590004590|FG001|Overall Study|Other-Participant falsified records|1|||
163353090|NCT01114139|590004589|FG000|Overall Study|Other-Participant went on hospice|0|||
163353091|NCT01114139|590004590|FG001|Overall Study|Other-Participant went on hospice|1|||
163353092|NCT01114139|590004589|FG000|Overall Study|Other-Physician changed treatment|1|||
163353093|NCT01114139|590004590|FG001|Overall Study|Other-Physician changed treatment|0|||
163353094|NCT01114139|590004589|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
163353095|NCT01114139|590004590|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
163353096|NCT01951378|590004591|FG000|Overall Study|Study Terminated-Not completed|23|||
163353097|NCT01951378|590004592|FG001|Overall Study|Study Terminated-Not completed|17|||
163353098|NCT00477464|590004594|FG000|Overall Study|Lost to Follow-up|1|||
163353099|NCT00477464|590004594|FG000|Overall Study|Death|36|||
163353100|NCT00477464|590004594|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
163353101|NCT03568812|590004595|FG000|Overall Study|Physician Decision|0|||
163353102|NCT03568812|590004596|FG001|Overall Study|Physician Decision|1|||
163353103|NCT00639769|590004598|FG000|Overall Study|Death|2|||
163353104|NCT00639769|590004598|FG000|Overall Study|Adverse Event|7|||
163353105|NCT00639769|590004598|FG000|Overall Study|Lack of Efficacy|1|||
163353106|NCT00639769|590004598|FG000|Overall Study|Disease progression|26|||
163353107|NCT00639769|590004598|FG000|Overall Study|Withdrawal by Subject|4|||
163353108|NCT00634842|590004599|FG000|Overall Study|Adverse Event|2|||
163353109|NCT00634842|590004600|FG001|Overall Study|Adverse Event|3|||
163353110|NCT00634842|590004599|FG000|Overall Study|Protocol Violation|8|||
163353111|NCT00634842|590004600|FG001|Overall Study|Protocol Violation|4|||
163353112|NCT00634842|590004599|FG000|Overall Study|Move to another state|1|||
163353113|NCT00634842|590004600|FG001|Overall Study|Move to another state|0|||
163353114|NCT00634842|590004599|FG000|Overall Study|Inclusion criteria were not met|1|||
163353115|NCT00634842|590004600|FG001|Overall Study|Inclusion criteria were not met|0|||
163353116|NCT00634842|590004599|FG000|Overall Study|Lost to Follow-up|1|||
163353117|NCT00634842|590004600|FG001|Overall Study|Lost to Follow-up|2|||
163353118|NCT00634842|590004599|FG000|Overall Study|Physician Decision|1|||
163353119|NCT00634842|590004600|FG001|Overall Study|Physician Decision|0|||
163353120|NCT00634842|590004599|FG000|Overall Study|Withdrawal by Subject|1|||
163353121|NCT00634842|590004600|FG001|Overall Study|Withdrawal by Subject|3|||
163353122|NCT00634842|590004599|FG000|Overall Study|Lack of time and intolerance to drug|0|||
163353123|NCT00634842|590004600|FG001|Overall Study|Lack of time and intolerance to drug|1|||
163353124|NCT00634842|590004599|FG000|Overall Study|Discontinued due to injection|0|||
163353125|NCT00634842|590004600|FG001|Overall Study|Discontinued due to injection|2|||
163353126|NCT00634842|590004599|FG000|Overall Study|No need of study drug to treat diabetes|0|||
163353127|NCT00634842|590004600|FG001|Overall Study|No need of study drug to treat diabetes|1|||
163149238|NCT01168349|589259455|FG000|Overall Study|Lost to Follow-up|34|||
163245419|NCT03701555|589605498|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
163245420|NCT03701555|589605463|FG000|Part 2 (Day 1)|Other|0|||
163245421|NCT03701555|589605464|FG001|Part 2 (Day 1)|Other|0|||
163353128|NCT00634842|590004599|FG000|Overall Study|No wish to keep taking Avandia|0|||
163353129|NCT00634842|590004600|FG001|Overall Study|No wish to keep taking Avandia|1|||
163353130|NCT00634842|590004599|FG000|Overall Study|Subject off study drug for too long|0|||
163353131|NCT00634842|590004600|FG001|Overall Study|Subject off study drug for too long|1|||
163353132|NCT00832000|590004601|FG000|Overall Study|Adverse Event|2|||
163353133|NCT00832000|590004602|FG001|Overall Study|Adverse Event|0|||
163353134|NCT00832000|590004601|FG000|Overall Study|Withdrawal by Subject|1|||
163353135|NCT00832000|590004602|FG001|Overall Study|Withdrawal by Subject|0|||
163353136|NCT00832000|590004601|FG000|Overall Study|No calls to IVR in either period|1|||
163353137|NCT00832000|590004602|FG001|Overall Study|No calls to IVR in either period|1|||
163353138|NCT00832000|590004601|FG000|Overall Study|No calls to IVR in period 2|2|||
163353139|NCT00832000|590004602|FG001|Overall Study|No calls to IVR in period 2|0|||
163353140|NCT03974100|590004603|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
163353141|NCT03974100|590004604|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
163353142|NCT03974100|590004605|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
163353143|NCT03974100|590004606|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
163353144|NCT03974100|590004607|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
163353145|NCT03974100|590004603|FG000|TP1 - Day 1 to Week 52|Death|1|||
163353146|NCT03974100|590004604|FG001|TP1 - Day 1 to Week 52|Death|0|||
163353147|NCT03974100|590004605|FG002|TP1 - Day 1 to Week 52|Death|0|||
163353148|NCT03974100|590004606|FG003|TP1 - Day 1 to Week 52|Death|0|||
163353149|NCT03974100|590004607|FG004|TP1 - Day 1 to Week 52|Death|0|||
163353150|NCT03974100|590004603|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
163353151|NCT03974100|590004604|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
163353152|NCT03974100|590004605|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
163353153|NCT03974100|590004606|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
163353154|NCT03974100|590004607|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
163353155|NCT03974100|590004603|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
163353156|NCT03974100|590004604|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
163353157|NCT03974100|590004605|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
163353158|NCT03974100|590004606|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
163353159|NCT03974100|590004607|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
163353160|NCT03974100|590004603|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
163353161|NCT03974100|590004604|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
163353162|NCT03974100|590004605|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
163353163|NCT03974100|590004606|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
163353164|NCT03974100|590004607|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
163353165|NCT03974100|590004603|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
163353166|NCT03974100|590004604|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
163353167|NCT03974100|590004605|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
163353168|NCT03974100|590004606|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
163353169|NCT03974100|590004607|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
163353170|NCT03974100|590004603|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
163245422|NCT03701555|589605465|FG002|Part 2 (Day 1)|Other|0|||
163245423|NCT03701555|589605466|FG003|Part 2 (Day 1)|Other|0|||
163245424|NCT03701555|589605467|FG004|Part 2 (Day 1)|Other|0|||
163245425|NCT03701555|589605468|FG005|Part 2 (Day 1)|Other|0|||
163245426|NCT03701555|589605469|FG006|Part 2 (Day 1)|Other|0|||
163245427|NCT03701555|589605470|FG007|Part 2 (Day 1)|Other|0|||
163245428|NCT03701555|589605471|FG008|Part 2 (Day 1)|Other|0|||
163245429|NCT03701555|589605472|FG009|Part 2 (Day 1)|Other|0|||
163245430|NCT03701555|589605473|FG010|Part 2 (Day 1)|Other|3|||
163245431|NCT03701555|589605474|FG011|Part 2 (Day 1)|Other|1|||
163245432|NCT03701555|589605475|FG012|Part 2 (Day 1)|Other|0|||
163245433|NCT03701555|589605476|FG013|Part 2 (Day 1)|Other|1|||
163245434|NCT03701555|589605477|FG014|Part 2 (Day 1)|Other|0|||
163245435|NCT03701555|589605478|FG015|Part 2 (Day 1)|Other|2|||
163245436|NCT03701555|589605479|FG016|Part 2 (Day 1)|Other|2|||
163245437|NCT03701555|589605480|FG017|Part 2 (Day 1)|Other|0|||
163245438|NCT03701555|589605481|FG018|Part 2 (Day 1)|Other|0|||
163245439|NCT03701555|589605482|FG019|Part 2 (Day 1)|Other|0|||
163245440|NCT03701555|589605483|FG020|Part 2 (Day 1)|Other|0|||
163353171|NCT03974100|590004604|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
163353172|NCT03974100|590004605|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
163353173|NCT03974100|590004606|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
163353174|NCT03974100|590004607|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
163353175|NCT03318783|590004608|FG000|Overall Study|Withdrawal by Subject|0|||
163353176|NCT03318783|590004609|FG001|Overall Study|Withdrawal by Subject|1|||
163353177|NCT03318783|590004608|FG000|Overall Study|Death|0|||
163245441|NCT03701555|589605484|FG021|Part 2 (Day 1)|Other|0|||
163245442|NCT03701555|589605485|FG022|Part 2 (Day 1)|Other|0|||
163245443|NCT03701555|589605486|FG023|Part 2 (Day 1)|Other|0|||
163245444|NCT03701555|589605487|FG024|Part 2 (Day 1)|Other|0|||
163245445|NCT03701555|589605488|FG025|Part 2 (Day 1)|Other|0|||
163245446|NCT03701555|589605489|FG026|Part 2 (Day 1)|Other|0|||
163245447|NCT03701555|589605490|FG027|Part 2 (Day 1)|Other|0|||
163245448|NCT03701555|589605491|FG028|Part 2 (Day 1)|Other|0|||
163245449|NCT03701555|589605492|FG029|Part 2 (Day 1)|Other|0|||
163245450|NCT03701555|589605493|FG030|Part 2 (Day 1)|Other|0|||
163245451|NCT03701555|589605494|FG031|Part 2 (Day 1)|Other|0|||
163245452|NCT03701555|589605495|FG032|Part 2 (Day 1)|Other|0|||
163245453|NCT03701555|589605496|FG033|Part 2 (Day 1)|Other|0|||
163245454|NCT03701555|589605497|FG034|Part 2 (Day 1)|Other|0|||
163245455|NCT03701555|589605498|FG035|Part 2 (Day 1)|Other|0|||
163245456|NCT03701555|589605463|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
163245457|NCT03701555|589605464|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
163245458|NCT03701555|589605465|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
163245459|NCT03701555|589605466|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
163245460|NCT03701555|589605467|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
163245461|NCT03701555|589605468|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
163245462|NCT03701555|589605469|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
163245463|NCT03701555|589605470|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
163245464|NCT03701555|589605471|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
163245465|NCT03701555|589605472|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
163245466|NCT03701555|589605473|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
163245467|NCT03701555|589605474|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
163245468|NCT03701555|589605475|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
163245469|NCT03701555|589605476|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
163245470|NCT03701555|589605477|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
163245471|NCT03701555|589605478|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
163245472|NCT03701555|589605479|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
163245473|NCT03701555|589605480|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
163245474|NCT03701555|589605481|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
163245475|NCT03701555|589605482|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
163245476|NCT03701555|589605483|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
163245477|NCT03701555|589605484|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
163245478|NCT03701555|589605485|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
163245479|NCT03701555|589605486|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
163245480|NCT03701555|589605487|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
163245481|NCT03701555|589605488|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
163245482|NCT03701555|589605489|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
163245483|NCT03701555|589605490|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
163245484|NCT03701555|589605491|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
163245485|NCT03701555|589605492|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
163245486|NCT03701555|589605493|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
163245487|NCT03701555|589605494|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
163245488|NCT03701555|589605495|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
163245489|NCT03701555|589605496|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
163245490|NCT03701555|589605497|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
163245491|NCT03701555|589605498|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
163245492|NCT03701555|589605463|FG000|Part 3 (Day 1)|Subject Decision|0|||
163245493|NCT03701555|589605464|FG001|Part 3 (Day 1)|Subject Decision|0|||
163245494|NCT03701555|589605465|FG002|Part 3 (Day 1)|Subject Decision|0|||
163245495|NCT03701555|589605466|FG003|Part 3 (Day 1)|Subject Decision|0|||
163245496|NCT03701555|589605467|FG004|Part 3 (Day 1)|Subject Decision|0|||
163245497|NCT03701555|589605468|FG005|Part 3 (Day 1)|Subject Decision|0|||
163245498|NCT03701555|589605469|FG006|Part 3 (Day 1)|Subject Decision|0|||
163245499|NCT03701555|589605470|FG007|Part 3 (Day 1)|Subject Decision|0|||
163245500|NCT03701555|589605471|FG008|Part 3 (Day 1)|Subject Decision|0|||
163353178|NCT03318783|590004609|FG001|Overall Study|Death|1|||
163353179|NCT03856047|590004610|FG000|Overall Study|Withdrawal by Subject|0|||
163353180|NCT03856047|590004611|FG001|Overall Study|Withdrawal by Subject|1|||
163353181|NCT03856047|590004612|FG002|Overall Study|Withdrawal by Subject|1|||
163353182|NCT03856047|590004613|FG003|Overall Study|Withdrawal by Subject|0|||
163353183|NCT03856047|590004614|FG004|Overall Study|Withdrawal by Subject|3|||
163353184|NCT03856047|590004615|FG005|Overall Study|Withdrawal by Subject|0|||
163353185|NCT03856047|590004616|FG006|Overall Study|Withdrawal by Subject|2|||
163353186|NCT03856047|590004610|FG000|Overall Study|Lost to Follow-up|4|||
163410226|NCT04417894|590211322|FG001|Overall Study|Lost to Follow-up|0|||
163245501|NCT03701555|589605472|FG009|Part 3 (Day 1)|Subject Decision|0|||
163245502|NCT03701555|589605473|FG010|Part 3 (Day 1)|Subject Decision|0|||
163245503|NCT03701555|589605474|FG011|Part 3 (Day 1)|Subject Decision|0|||
163245504|NCT03701555|589605475|FG012|Part 3 (Day 1)|Subject Decision|0|||
163245505|NCT03701555|589605476|FG013|Part 3 (Day 1)|Subject Decision|0|||
163245506|NCT03701555|589605477|FG014|Part 3 (Day 1)|Subject Decision|0|||
163245507|NCT03701555|589605478|FG015|Part 3 (Day 1)|Subject Decision|0|||
163245508|NCT03701555|589605479|FG016|Part 3 (Day 1)|Subject Decision|0|||
163245509|NCT03701555|589605480|FG017|Part 3 (Day 1)|Subject Decision|0|||
163245510|NCT03701555|589605481|FG018|Part 3 (Day 1)|Subject Decision|0|||
163245511|NCT03701555|589605482|FG019|Part 3 (Day 1)|Subject Decision|0|||
163245512|NCT03701555|589605483|FG020|Part 3 (Day 1)|Subject Decision|0|||
163245513|NCT03701555|589605484|FG021|Part 3 (Day 1)|Subject Decision|0|||
163245514|NCT03701555|589605485|FG022|Part 3 (Day 1)|Subject Decision|0|||
163245515|NCT03701555|589605486|FG023|Part 3 (Day 1)|Subject Decision|0|||
163353187|NCT03856047|590004611|FG001|Overall Study|Lost to Follow-up|2|||
163245516|NCT03701555|589605487|FG024|Part 3 (Day 1)|Subject Decision|0|||
163149239|NCT01168349|589259455|FG000|Overall Study|Withdrawal by Subject|9|||
163149240|NCT01168349|589259455|FG000|Overall Study|Kidney transplantation|3|||
163149241|NCT01168349|589259455|FG000|Overall Study|Other|22|||
163149242|NCT01168349|589259455|FG000|Overall Study|Protocol Violation|76|||
163149243|NCT01033240|589259456|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
163149244|NCT01033240|589259457|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
163149245|NCT01033240|589259458|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
163149246|NCT01033240|589259456|FG000|Overall Study|Death|2|||
163149247|NCT01033240|589259457|FG001|Overall Study|Death|0|||
163149248|NCT01033240|589259458|FG002|Overall Study|Death|0|||
163149249|NCT01033240|589259456|FG000|Overall Study|Withdrew Consent|2|||
163149250|NCT01033240|589259457|FG001|Overall Study|Withdrew Consent|9|||
163149251|NCT01033240|589259458|FG002|Overall Study|Withdrew Consent|2|||
163149252|NCT01033240|589259456|FG000|Overall Study|Disease Progression|35|||
163149253|NCT01033240|589259457|FG001|Overall Study|Disease Progression|32|||
163149254|NCT01033240|589259458|FG002|Overall Study|Disease Progression|41|||
163149255|NCT01033240|589259456|FG000|Overall Study|Investigator Discretion|0|||
163149256|NCT01033240|589259457|FG001|Overall Study|Investigator Discretion|0|||
163149257|NCT01033240|589259458|FG002|Overall Study|Investigator Discretion|2|||
163149258|NCT01033240|589259456|FG000|Overall Study|Other|0|||
163149259|NCT01033240|589259457|FG001|Overall Study|Other|1|||
163149260|NCT01033240|589259458|FG002|Overall Study|Other|2|||
163149261|NCT00918385|589259462|FG000|Monotherapy|Adverse Event|1|||
163149262|NCT00918385|589259463|FG001|Monotherapy|Adverse Event|6|||
163149263|NCT00918385|589259462|FG000|Monotherapy|Complicating illness|1|||
163149264|NCT00918385|589259463|FG001|Monotherapy|Complicating illness|0|||
163149265|NCT00918385|589259462|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
163149266|NCT00918385|589259463|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
163149267|NCT00918385|589259462|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
163149268|NCT00918385|589259463|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
163149269|NCT00918385|589259462|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
163149270|NCT00918385|589259463|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
163149271|NCT00918385|589259462|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
163149272|NCT00918385|589259463|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
163149273|NCT01476722|589259466|FG000|Overall Study|Adverse Event|1|||
163149274|NCT00918281|589259471|FG000|Overall Study|Physician Decision|29|||
163149275|NCT02978417|589259472|FG000|Overall Study|Lost to Follow-up|2|||
163149276|NCT02978417|589259473|FG001|Overall Study|Lost to Follow-up|2|||
163149277|NCT01323582|589259474|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
163149278|NCT01323582|589259475|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
163149279|NCT01323582|589259474|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
163149280|NCT01323582|589259475|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
163149281|NCT01323582|589259474|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
163149282|NCT01323582|589259475|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
163149283|NCT03557970|589259480|FG000|Overall Study|Study closure|1|||
163149284|NCT03557970|589259481|FG001|Overall Study|Study closure|0|||
163149285|NCT03557970|589259480|FG000|Overall Study|Physician Decision|0|||
163149286|NCT03557970|589259481|FG001|Overall Study|Physician Decision|1|||
163149287|NCT03557970|589259480|FG000|Overall Study|Death|0|||
163149288|NCT03557970|589259481|FG001|Overall Study|Death|1|||
163149289|NCT00525512|589259487|FG000|Double-Blind Phase|Adverse Event|48|||
163149290|NCT00525512|589259488|FG001|Double-Blind Phase|Adverse Event|28|||
163149291|NCT00525512|589259489|FG002|Double-Blind Phase|Adverse Event|0|||
163149292|NCT00525512|589259490|FG003|Double-Blind Phase|Adverse Event|0|||
163149293|NCT00525512|589259487|FG000|Double-Blind Phase|Protocol Violation|3|||
163149294|NCT00525512|589259488|FG001|Double-Blind Phase|Protocol Violation|1|||
163149295|NCT00525512|589259489|FG002|Double-Blind Phase|Protocol Violation|0|||
163149296|NCT00525512|589259490|FG003|Double-Blind Phase|Protocol Violation|0|||
163149297|NCT00525512|589259487|FG000|Double-Blind Phase|Lost to Follow-up|3|||
163149298|NCT00525512|589259488|FG001|Double-Blind Phase|Lost to Follow-up|7|||
163149299|NCT00525512|589259489|FG002|Double-Blind Phase|Lost to Follow-up|0|||
163245517|NCT03701555|589605488|FG025|Part 3 (Day 1)|Subject Decision|0|||
163245518|NCT03701555|589605489|FG026|Part 3 (Day 1)|Subject Decision|1|||
163245519|NCT03701555|589605490|FG027|Part 3 (Day 1)|Subject Decision|0|||
163245520|NCT03701555|589605491|FG028|Part 3 (Day 1)|Subject Decision|0|||
163245521|NCT03701555|589605492|FG029|Part 3 (Day 1)|Subject Decision|0|||
163245522|NCT03701555|589605493|FG030|Part 3 (Day 1)|Subject Decision|0|||
163245523|NCT03701555|589605494|FG031|Part 3 (Day 1)|Subject Decision|2|||
163245524|NCT03701555|589605495|FG032|Part 3 (Day 1)|Subject Decision|1|||
163245525|NCT03701555|589605496|FG033|Part 3 (Day 1)|Subject Decision|1|||
163245526|NCT03701555|589605497|FG034|Part 3 (Day 1)|Subject Decision|0|||
163245527|NCT03701555|589605498|FG035|Part 3 (Day 1)|Subject Decision|0|||
163245528|NCT03701555|589605463|FG000|Part 3 (Day 1)|Other|0|||
163245529|NCT03701555|589605464|FG001|Part 3 (Day 1)|Other|0|||
163245530|NCT03701555|589605465|FG002|Part 3 (Day 1)|Other|0|||
163245531|NCT03701555|589605466|FG003|Part 3 (Day 1)|Other|0|||
163245532|NCT03701555|589605467|FG004|Part 3 (Day 1)|Other|0|||
163353188|NCT03856047|590004612|FG002|Overall Study|Lost to Follow-up|3|||
163353189|NCT03856047|590004613|FG003|Overall Study|Lost to Follow-up|1|||
163353190|NCT03856047|590004614|FG004|Overall Study|Lost to Follow-up|4|||
163353191|NCT03856047|590004615|FG005|Overall Study|Lost to Follow-up|4|||
163353192|NCT03856047|590004616|FG006|Overall Study|Lost to Follow-up|4|||
163353193|NCT01426113|590004621|FG000|Overall Study|Study Discontinued|1|||
163353194|NCT01426113|590004622|FG001|Overall Study|Study Discontinued|1|||
163353195|NCT01426113|590004621|FG000|Overall Study|Adverse Event|0|||
163353196|NCT01426113|590004622|FG001|Overall Study|Adverse Event|1|||
163353197|NCT00338949|590004623|FG000|Subject Screening|Screen failures|11|||
163353198|NCT00338949|590004624|FG001|Subject Screening|Screen failures|11|||
163353199|NCT00338949|590004623|FG000|Randomization|Withdrawal by Subject|1|||
163353200|NCT00338949|590004624|FG001|Randomization|Withdrawal by Subject|0|||
163353201|NCT00338949|590004623|FG000|Randomization|Adverse Event|0|||
163353202|NCT00338949|590004624|FG001|Randomization|Adverse Event|5|||
163353203|NCT00436956|590004627|FG000|Overall Study|Not evaluable|1|||
163353204|NCT00436956|590004628|FG001|Overall Study|Not evaluable|0|||
163353205|NCT02719743|590004634|FG000|Overall Study|Consent withdrawal|0|||
163353206|NCT02719743|590004635|FG001|Overall Study|Consent withdrawal|2|||
163353207|NCT02719743|590004636|FG002|Overall Study|Consent withdrawal|0|||
163353208|NCT02719743|590004637|FG003|Overall Study|Consent withdrawal|1|||
163353209|NCT02719743|590004638|FG004|Overall Study|Consent withdrawal|0|||
163353210|NCT02719743|590004634|FG000|Overall Study|Migrated/moved from study area|0|||
163353211|NCT02719743|590004635|FG001|Overall Study|Migrated/moved from study area|0|||
163353212|NCT02719743|590004636|FG002|Overall Study|Migrated/moved from study area|0|||
163353213|NCT02719743|590004637|FG003|Overall Study|Migrated/moved from study area|0|||
163353214|NCT02719743|590004638|FG004|Overall Study|Migrated/moved from study area|2|||
163353215|NCT02719743|590004634|FG000|Overall Study|Lost to Follow-up|1|||
163353216|NCT02719743|590004635|FG001|Overall Study|Lost to Follow-up|1|||
163353217|NCT02719743|590004636|FG002|Overall Study|Lost to Follow-up|0|||
163353218|NCT02719743|590004637|FG003|Overall Study|Lost to Follow-up|0|||
163353219|NCT02719743|590004638|FG004|Overall Study|Lost to Follow-up|0|||
163353220|NCT01930214|590004639|FG000|Overall Study|Death|4|||
163353221|NCT01930214|590004640|FG001|Overall Study|Death|4|||
163353222|NCT01930214|590004641|FG002|Overall Study|Death|11|||
163353223|NCT01930214|590004639|FG000|Overall Study|Lost to Follow-up|12|||
163353224|NCT01930214|590004640|FG001|Overall Study|Lost to Follow-up|13|||
163353225|NCT01930214|590004641|FG002|Overall Study|Lost to Follow-up|12|||
163353226|NCT01930214|590004639|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
163353227|NCT01930214|590004640|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
163353228|NCT01930214|590004641|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
163353229|NCT01930214|590004639|FG000|Overall Study|Physician Decision|2|||
163353230|NCT01930214|590004640|FG001|Overall Study|Physician Decision|0|||
163353231|NCT01930214|590004641|FG002|Overall Study|Physician Decision|0|||
163353232|NCT02601209|590004642|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
163353233|NCT02601209|590004643|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
163353234|NCT02601209|590004644|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
163353235|NCT02601209|590004645|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
163353236|NCT02601209|590004646|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
163353237|NCT02601209|590004647|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
163353238|NCT02601209|590004648|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
163353239|NCT02601209|590004649|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
163353240|NCT02601209|590004650|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
163353241|NCT02601209|590004642|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
163353242|NCT02601209|590004643|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
163353243|NCT02601209|590004644|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
163353244|NCT02601209|590004645|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
163353245|NCT02601209|590004646|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
163353246|NCT02601209|590004647|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
163353247|NCT02601209|590004648|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
163353248|NCT02601209|590004649|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
163353249|NCT02601209|590004650|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
163353250|NCT02024750|590004652|FG000|Overall Study|Withdrawal by Subject|2|||
163353251|NCT02024750|590004653|FG001|Overall Study|Withdrawal by Subject|1|||
163353252|NCT02261285|590004654|FG000|Overall Study|Disease progression|0|||
163353253|NCT02261285|590004655|FG001|Overall Study|Disease progression|0|||
163353254|NCT02261285|590004656|FG002|Overall Study|Disease progression|1|||
163353255|NCT01215032|590004657|FG000|Overall Study|Adverse Event|3|||
163353256|NCT01215032|590004657|FG000|Overall Study|Lack of Efficacy|17|||
163353257|NCT00983892|590004658|FG000|Overall Study|Withdrawal by Subject|10|||
163353258|NCT00983892|590004659|FG001|Overall Study|Withdrawal by Subject|12|||
163353259|NCT02484547|590004663|FG000|Placebo-Controlled Period|Adverse Event|10|||
163353260|NCT02484547|590004664|FG001|Placebo-Controlled Period|Adverse Event|13|||
163353261|NCT02484547|590004665|FG002|Placebo-Controlled Period|Adverse Event|20|||
163353262|NCT02484547|590004666|FG003|Placebo-Controlled Period|Adverse Event|0|||
163353263|NCT02484547|590004667|FG004|Placebo-Controlled Period|Adverse Event|0|||
163353264|NCT02484547|590004668|FG005|Placebo-Controlled Period|Adverse Event|0|||
163149300|NCT00525512|589259490|FG003|Double-Blind Phase|Lost to Follow-up|0|||
163149301|NCT00525512|589259487|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
163149302|NCT00525512|589259488|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
163149303|NCT00525512|589259489|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
163149304|NCT00525512|589259490|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
163149305|NCT00525512|589259487|FG000|Double-Blind Phase|Lack of Efficacy|13|||
163149306|NCT00525512|589259488|FG001|Double-Blind Phase|Lack of Efficacy|5|||
163149307|NCT00525512|589259489|FG002|Double-Blind Phase|Lack of Efficacy|0|||
163149308|NCT00525512|589259490|FG003|Double-Blind Phase|Lack of Efficacy|0|||
163149309|NCT00525512|589259487|FG000|Double-Blind Phase|Other reason (not specified)|12|||
163149310|NCT00525512|589259488|FG001|Double-Blind Phase|Other reason (not specified)|13|||
163149311|NCT00525512|589259489|FG002|Double-Blind Phase|Other reason (not specified)|0|||
163149312|NCT00525512|589259490|FG003|Double-Blind Phase|Other reason (not specified)|0|||
163149313|NCT00525512|589259487|FG000|Open-Label Phase|Adverse Event|0|||
163149314|NCT00525512|589259488|FG001|Open-Label Phase|Adverse Event|0|||
163149315|NCT00525512|589259489|FG002|Open-Label Phase|Adverse Event|1|||
163149316|NCT00525512|589259490|FG003|Open-Label Phase|Adverse Event|0|||
163149317|NCT00525512|589259487|FG000|Open-Label Phase|Lost to Follow-up|0|||
163149318|NCT00525512|589259488|FG001|Open-Label Phase|Lost to Follow-up|0|||
163149319|NCT00525512|589259489|FG002|Open-Label Phase|Lost to Follow-up|1|||
163149320|NCT00525512|589259490|FG003|Open-Label Phase|Lost to Follow-up|0|||
163149321|NCT00525512|589259487|FG000|Open-Label Phase|Other reason (not specified)|0|||
163149322|NCT00525512|589259488|FG001|Open-Label Phase|Other reason (not specified)|0|||
163149323|NCT00525512|589259489|FG002|Open-Label Phase|Other reason (not specified)|4|||
163149324|NCT00525512|589259490|FG003|Open-Label Phase|Other reason (not specified)|5|||
163149325|NCT01601535|589259495|FG000|Phase 1|Adverse Event|1|||
163149326|NCT01601535|589259496|FG001|Phase 1|Adverse Event|0|||
163149327|NCT01601535|589259497|FG002|Phase 1|Adverse Event|2|||
163149328|NCT01601535|589259498|FG003|Phase 1|Adverse Event|1|||
163149329|NCT01601535|589259499|FG004|Phase 1|Adverse Event|0|||
163149330|NCT01601535|589259500|FG005|Phase 1|Adverse Event|0|||
163149331|NCT01601535|589259495|FG000|Phase 1|Withdrawal by Subject|2|||
163149332|NCT01601535|589259496|FG001|Phase 1|Withdrawal by Subject|1|||
163149333|NCT01601535|589259497|FG002|Phase 1|Withdrawal by Subject|1|||
163149334|NCT01601535|589259498|FG003|Phase 1|Withdrawal by Subject|2|||
163149335|NCT01601535|589259499|FG004|Phase 1|Withdrawal by Subject|0|||
163149336|NCT01601535|589259500|FG005|Phase 1|Withdrawal by Subject|0|||
163149337|NCT01601535|589259495|FG000|Phase 1|Progressive Disease|2|||
163149338|NCT01601535|589259496|FG001|Phase 1|Progressive Disease|3|||
163149339|NCT01601535|589259497|FG002|Phase 1|Progressive Disease|2|||
163149340|NCT01601535|589259498|FG003|Phase 1|Progressive Disease|1|||
163149341|NCT01601535|589259499|FG004|Phase 1|Progressive Disease|0|||
163149342|NCT01601535|589259500|FG005|Phase 1|Progressive Disease|0|||
163149343|NCT01601535|589259495|FG000|Phase 1|Started Another Treatment|1|||
163149344|NCT01601535|589259496|FG001|Phase 1|Started Another Treatment|2|||
163149345|NCT01601535|589259497|FG002|Phase 1|Started Another Treatment|0|||
163149346|NCT01601535|589259498|FG003|Phase 1|Started Another Treatment|0|||
163149347|NCT01601535|589259499|FG004|Phase 1|Started Another Treatment|0|||
163149348|NCT01601535|589259500|FG005|Phase 1|Started Another Treatment|0|||
163149349|NCT01601535|589259495|FG000|Phase 2|Adverse Event|0|||
163149350|NCT01601535|589259496|FG001|Phase 2|Adverse Event|0|||
163149351|NCT01601535|589259497|FG002|Phase 2|Adverse Event|0|||
163149352|NCT01601535|589259498|FG003|Phase 2|Adverse Event|0|||
163149353|NCT01601535|589259499|FG004|Phase 2|Adverse Event|5|||
163149354|NCT01601535|589259500|FG005|Phase 2|Adverse Event|1|||
163149355|NCT01601535|589259495|FG000|Phase 2|Withdrawal by Subject|0|||
163149356|NCT01601535|589259496|FG001|Phase 2|Withdrawal by Subject|0|||
163149357|NCT01601535|589259497|FG002|Phase 2|Withdrawal by Subject|0|||
163149358|NCT01601535|589259498|FG003|Phase 2|Withdrawal by Subject|0|||
163149359|NCT01601535|589259499|FG004|Phase 2|Withdrawal by Subject|8|||
163245533|NCT03701555|589605468|FG005|Part 3 (Day 1)|Other|0|||
163149360|NCT01601535|589259500|FG005|Phase 2|Withdrawal by Subject|2|||
163245534|NCT03701555|589605469|FG006|Part 3 (Day 1)|Other|0|||
163245535|NCT03701555|589605470|FG007|Part 3 (Day 1)|Other|0|||
163245536|NCT03701555|589605471|FG008|Part 3 (Day 1)|Other|0|||
163245537|NCT03701555|589605472|FG009|Part 3 (Day 1)|Other|0|||
163245538|NCT03701555|589605473|FG010|Part 3 (Day 1)|Other|0|||
163245539|NCT03701555|589605474|FG011|Part 3 (Day 1)|Other|0|||
163245540|NCT03701555|589605475|FG012|Part 3 (Day 1)|Other|0|||
163245541|NCT03701555|589605476|FG013|Part 3 (Day 1)|Other|0|||
163245542|NCT03701555|589605477|FG014|Part 3 (Day 1)|Other|0|||
163245543|NCT03701555|589605478|FG015|Part 3 (Day 1)|Other|0|||
163245544|NCT03701555|589605479|FG016|Part 3 (Day 1)|Other|0|||
163245545|NCT03701555|589605480|FG017|Part 3 (Day 1)|Other|0|||
163245546|NCT03701555|589605481|FG018|Part 3 (Day 1)|Other|0|||
163245547|NCT03701555|589605482|FG019|Part 3 (Day 1)|Other|0|||
163149361|NCT01601535|589259495|FG000|Phase 2|Progressive Disease|0|||
163149362|NCT01601535|589259496|FG001|Phase 2|Progressive Disease|0|||
163149363|NCT01601535|589259497|FG002|Phase 2|Progressive Disease|0|||
163149364|NCT01601535|589259498|FG003|Phase 2|Progressive Disease|0|||
163149365|NCT01601535|589259499|FG004|Phase 2|Progressive Disease|5|||
163149366|NCT01601535|589259500|FG005|Phase 2|Progressive Disease|7|||
163149367|NCT01601535|589259495|FG000|Phase 2|Started Another Treatment|0|||
163149368|NCT01601535|589259496|FG001|Phase 2|Started Another Treatment|0|||
163149369|NCT01601535|589259497|FG002|Phase 2|Started Another Treatment|0|||
163149370|NCT01601535|589259498|FG003|Phase 2|Started Another Treatment|0|||
163149371|NCT01601535|589259499|FG004|Phase 2|Started Another Treatment|1|||
163149372|NCT01601535|589259500|FG005|Phase 2|Started Another Treatment|2|||
163149373|NCT03600909|589259503|FG000|Overall Study|Not treated|0|||
163149374|NCT03600909|589259504|FG001|Overall Study|Not treated|3|||
163149375|NCT03600909|589259505|FG002|Overall Study|Not treated|0|||
163149376|NCT04576988|589259506|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
163149377|NCT04576988|589259507|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
163149378|NCT04576988|589259506|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
163149379|NCT04576988|589259507|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
163149380|NCT04576988|589259506|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
163149381|NCT04576988|589259507|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
163149382|NCT04576988|589259506|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
163149383|NCT04576988|589259507|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
163149384|NCT04576988|589259506|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
163149385|NCT04576988|589259507|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
163149386|NCT04576988|589259506|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
163149387|NCT04576988|589259507|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
163149388|NCT04576988|589259506|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
163149389|NCT04576988|589259507|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
163149390|NCT04576988|589259506|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
163149391|NCT04576988|589259507|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
163149392|NCT04576988|589259506|FG000|Long Term Double Blind (LTDB)|Death|2|||
163149393|NCT04576988|589259507|FG001|Long Term Double Blind (LTDB)|Death|1|||
163149394|NCT04576988|589259506|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
163149395|NCT04576988|589259507|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
163149396|NCT02919761|589259515|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
163149397|NCT02919761|589259516|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
163149398|NCT02919761|589259517|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
163149399|NCT02919761|589259515|FG000|Part 1: Open Label|Adverse Event|1|||
163149400|NCT02919761|589259516|FG001|Part 1: Open Label|Adverse Event|0|||
163149401|NCT02919761|589259517|FG002|Part 1: Open Label|Adverse Event|0|||
163149402|NCT02919761|589259515|FG000|Part 1: Open Label|Lost to Follow-up|1|||
163149403|NCT02919761|589259516|FG001|Part 1: Open Label|Lost to Follow-up|0|||
163149404|NCT02919761|589259517|FG002|Part 1: Open Label|Lost to Follow-up|0|||
163149405|NCT02919761|589259515|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
163149406|NCT02919761|589259516|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
163149407|NCT02919761|589259517|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
163149408|NCT02919761|589259515|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
163149409|NCT02919761|589259516|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
163149410|NCT02919761|589259517|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
163149411|NCT02919761|589259515|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
163149412|NCT02919761|589259516|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
163149413|NCT02919761|589259517|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
163149414|NCT02919761|589259515|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
163149415|NCT02919761|589259516|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
163149416|NCT02919761|589259517|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
163149417|NCT02919761|589259515|FG000|Part 1: Open Label|Termination by Sponsor|1|||
163149418|NCT02919761|589259516|FG001|Part 1: Open Label|Termination by Sponsor|0|||
163149419|NCT02919761|589259517|FG002|Part 1: Open Label|Termination by Sponsor|0|||
163149420|NCT02919761|589259515|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
163149421|NCT02919761|589259516|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
163149422|NCT02919761|589259517|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
163149423|NCT02919761|589259515|FG000|Part 2: Double-blind|Adverse Event|0|||
163149424|NCT02919761|589259516|FG001|Part 2: Double-blind|Adverse Event|1|||
163149425|NCT02919761|589259517|FG002|Part 2: Double-blind|Adverse Event|0|||
163149426|NCT02919761|589259515|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
163149427|NCT02919761|589259516|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
163149428|NCT02919761|589259517|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
163149429|NCT02919761|589259515|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
163149430|NCT02919761|589259516|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
163149431|NCT02919761|589259517|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
163149432|NCT02919761|589259515|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
163245548|NCT03701555|589605483|FG020|Part 3 (Day 1)|Other|0|||
163353265|NCT02484547|590004669|FG006|Placebo-Controlled Period|Adverse Event|0|||
163353266|NCT02484547|590004663|FG000|Placebo-Controlled Period|Change of Treatment|0|||
163353267|NCT02484547|590004664|FG001|Placebo-Controlled Period|Change of Treatment|0|||
163353268|NCT02484547|590004665|FG002|Placebo-Controlled Period|Change of Treatment|1|||
163353269|NCT02484547|590004666|FG003|Placebo-Controlled Period|Change of Treatment|0|||
163353270|NCT02484547|590004667|FG004|Placebo-Controlled Period|Change of Treatment|0|||
163353271|NCT02484547|590004668|FG005|Placebo-Controlled Period|Change of Treatment|0|||
163149433|NCT02919761|589259516|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
163149434|NCT02919761|589259517|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
163149435|NCT02919761|589259515|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
163149436|NCT02919761|589259516|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
163149437|NCT02919761|589259517|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
163149438|NCT02919761|589259515|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
163149439|NCT02919761|589259516|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
163149440|NCT02919761|589259517|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
163149441|NCT02919761|589259515|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
163149442|NCT02919761|589259516|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
163149443|NCT02919761|589259517|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
163149444|NCT03724942|589259518|FG000|Overall Study|Adverse Event|20|||
163149445|NCT03724942|589259519|FG001|Overall Study|Adverse Event|14|||
163149446|NCT03724942|589259518|FG000|Overall Study|Lack of Efficacy|0|||
163149447|NCT03724942|589259519|FG001|Overall Study|Lack of Efficacy|1|||
163149448|NCT03724942|589259518|FG000|Overall Study|Physician Decision|5|||
163149449|NCT03724942|589259519|FG001|Overall Study|Physician Decision|2|||
163149450|NCT03724942|589259518|FG000|Overall Study|Protocol Violation|1|||
163149451|NCT03724942|589259519|FG001|Overall Study|Protocol Violation|0|||
163149452|NCT03724942|589259518|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
163149453|NCT03724942|589259519|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
163149454|NCT03724942|589259518|FG000|Overall Study|Withdrawal by Legal Representative|3|||
163149455|NCT03724942|589259519|FG001|Overall Study|Withdrawal by Legal Representative|0|||
163149456|NCT02994108|589261414|FG000|Intervention Messages|Withdrawal by Subject|2|||
163149457|NCT02994108|589261415|FG001|Intervention Messages|Withdrawal by Subject|0|||
163149458|NCT02994108|589261414|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
163149459|NCT02994108|589261415|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
163149460|NCT02994108|589261414|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
163149461|NCT02994108|589261415|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
163149462|NCT02994108|589261414|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
163149463|NCT02994108|589261415|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
163149464|NCT00904969|589261416|FG000|Overall Study|Lost to Follow-up|4|||
163149465|NCT00904969|589261416|FG000|Overall Study|Withdrawal by Subject|3|||
163149466|NCT00904969|589261416|FG000|Overall Study|Additional Treatments|11|||
163149467|NCT00904969|589261416|FG000|Overall Study|Case Aborted; Subject Exited|1|||
163245549|NCT03701555|589605484|FG021|Part 3 (Day 1)|Other|0|||
163245550|NCT03701555|589605485|FG022|Part 3 (Day 1)|Other|0|||
163245551|NCT03701555|589605486|FG023|Part 3 (Day 1)|Other|0|||
163245552|NCT03701555|589605487|FG024|Part 3 (Day 1)|Other|1|||
163245553|NCT03701555|589605488|FG025|Part 3 (Day 1)|Other|1|||
163245554|NCT03701555|589605489|FG026|Part 3 (Day 1)|Other|0|||
163245555|NCT03701555|589605490|FG027|Part 3 (Day 1)|Other|0|||
163245556|NCT03701555|589605491|FG028|Part 3 (Day 1)|Other|0|||
163245557|NCT03701555|589605492|FG029|Part 3 (Day 1)|Other|1|||
163245558|NCT03701555|589605493|FG030|Part 3 (Day 1)|Other|1|||
163245559|NCT03701555|589605494|FG031|Part 3 (Day 1)|Other|0|||
163245560|NCT03701555|589605495|FG032|Part 3 (Day 1)|Other|1|||
163245561|NCT03701555|589605496|FG033|Part 3 (Day 1)|Other|1|||
163245562|NCT03701555|589605497|FG034|Part 3 (Day 1)|Other|0|||
163245563|NCT03701555|589605498|FG035|Part 3 (Day 1)|Other|0|||
163245564|NCT00448539|589605499|FG000|Overall Study|Medication non-compliance|4|||
163245565|NCT00448539|589605500|FG001|Overall Study|Medication non-compliance|1|||
163245566|NCT00448539|589605499|FG000|Overall Study|Protocol Violation|1|||
163245567|NCT00448539|589605500|FG001|Overall Study|Protocol Violation|0|||
163245568|NCT00448539|589605499|FG000|Overall Study|Request of the investigator or sponsor|67|||
163245569|NCT00448539|589605500|FG001|Overall Study|Request of the investigator or sponsor|54|||
163245570|NCT00448539|589605499|FG000|Overall Study|Withdrawal by Subject|20|||
163245571|NCT00448539|589605500|FG001|Overall Study|Withdrawal by Subject|24|||
163245572|NCT00448539|589605499|FG000|Overall Study|Diary non-compliance|1|||
163245573|NCT00448539|589605500|FG001|Overall Study|Diary non-compliance|0|||
163245574|NCT00448539|589605499|FG000|Overall Study|Adverse Event|9|||
163245575|NCT00448539|589605500|FG001|Overall Study|Adverse Event|26|||
163353272|NCT02484547|590004669|FG006|Placebo-Controlled Period|Change of Treatment|0|||
163353273|NCT02484547|590004663|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
163353274|NCT02484547|590004664|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
163353275|NCT02484547|590004665|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
163353276|NCT02484547|590004666|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
163353277|NCT02484547|590004667|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
163353278|NCT02484547|590004668|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
163353279|NCT02484547|590004669|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
163353280|NCT02484547|590004663|FG000|Placebo-Controlled Period|Death|5|||
163353281|NCT02484547|590004664|FG001|Placebo-Controlled Period|Death|0|||
163353282|NCT02484547|590004665|FG002|Placebo-Controlled Period|Death|6|||
163353283|NCT02484547|590004666|FG003|Placebo-Controlled Period|Death|0|||
163353284|NCT02484547|590004667|FG004|Placebo-Controlled Period|Death|0|||
163353285|NCT02484547|590004668|FG005|Placebo-Controlled Period|Death|0|||
163353286|NCT02484547|590004669|FG006|Placebo-Controlled Period|Death|0|||
163353287|NCT02484547|590004663|FG000|Placebo-Controlled Period|Disease Progression|2|||
163353288|NCT02484547|590004664|FG001|Placebo-Controlled Period|Disease Progression|0|||
163353289|NCT02484547|590004665|FG002|Placebo-Controlled Period|Disease Progression|1|||
163353290|NCT02484547|590004666|FG003|Placebo-Controlled Period|Disease Progression|0|||
163353291|NCT02484547|590004667|FG004|Placebo-Controlled Period|Disease Progression|0|||
163353292|NCT02484547|590004668|FG005|Placebo-Controlled Period|Disease Progression|0|||
163353293|NCT02484547|590004669|FG006|Placebo-Controlled Period|Disease Progression|0|||
163353294|NCT02484547|590004663|FG000|Placebo-Controlled Period|Investigator Decision|2|||
163353295|NCT02484547|590004664|FG001|Placebo-Controlled Period|Investigator Decision|2|||
163353296|NCT02484547|590004665|FG002|Placebo-Controlled Period|Investigator Decision|5|||
163353297|NCT02484547|590004666|FG003|Placebo-Controlled Period|Investigator Decision|0|||
163353298|NCT02484547|590004667|FG004|Placebo-Controlled Period|Investigator Decision|0|||
163353299|NCT02484547|590004668|FG005|Placebo-Controlled Period|Investigator Decision|0|||
163353300|NCT02484547|590004669|FG006|Placebo-Controlled Period|Investigator Decision|0|||
163353301|NCT02484547|590004663|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
163353302|NCT02484547|590004664|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
163353303|NCT02484547|590004665|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
163353304|NCT02484547|590004666|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
163353305|NCT02484547|590004667|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
163353306|NCT02484547|590004668|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
163353307|NCT02484547|590004669|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
163353308|NCT02484547|590004663|FG000|Placebo-Controlled Period|Relocation|1|||
163353309|NCT02484547|590004664|FG001|Placebo-Controlled Period|Relocation|1|||
163353310|NCT02484547|590004665|FG002|Placebo-Controlled Period|Relocation|1|||
163353311|NCT02484547|590004666|FG003|Placebo-Controlled Period|Relocation|0|||
163353312|NCT02484547|590004667|FG004|Placebo-Controlled Period|Relocation|0|||
163353313|NCT02484547|590004668|FG005|Placebo-Controlled Period|Relocation|0|||
163353314|NCT02484547|590004669|FG006|Placebo-Controlled Period|Relocation|0|||
163353315|NCT02484547|590004663|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
163353316|NCT02484547|590004664|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
163353317|NCT02484547|590004665|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
163353318|NCT02484547|590004666|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
163353319|NCT02484547|590004667|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
163353320|NCT02484547|590004668|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
163353321|NCT02484547|590004669|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
163353322|NCT02484547|590004663|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
163353323|NCT02484547|590004664|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
163353324|NCT02484547|590004665|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
163353325|NCT02484547|590004666|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
163353326|NCT02484547|590004667|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
163353327|NCT02484547|590004668|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
163353328|NCT02484547|590004669|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
163353329|NCT02484547|590004663|FG000|Placebo-Controlled Period|Reason not Specified|216|||
163353330|NCT02484547|590004664|FG001|Placebo-Controlled Period|Reason not Specified|194|||
163353331|NCT02484547|590004665|FG002|Placebo-Controlled Period|Reason not Specified|183|||
163353332|NCT02484547|590004666|FG003|Placebo-Controlled Period|Reason not Specified|0|||
163353333|NCT02484547|590004667|FG004|Placebo-Controlled Period|Reason not Specified|0|||
163353334|NCT02484547|590004668|FG005|Placebo-Controlled Period|Reason not Specified|0|||
163353335|NCT02484547|590004669|FG006|Placebo-Controlled Period|Reason not Specified|0|||
163410227|NCT04417894|590211321|FG000|Overall Study|Withdrawal by Subject|7|||
163410228|NCT04417894|590211322|FG001|Overall Study|Withdrawal by Subject|6|||
163410229|NCT04417894|590211321|FG000|Overall Study|Lack of Efficacy|3|||
163410230|NCT04417894|590211322|FG001|Overall Study|Lack of Efficacy|1|||
163410231|NCT00262873|590211323|FG000|Overall Study|Adverse Event|3|||
163353336|NCT02484547|590004663|FG000|Long-Term Extension Period|Adverse Event|0|||
163353337|NCT02484547|590004664|FG001|Long-Term Extension Period|Adverse Event|0|||
163353338|NCT02484547|590004665|FG002|Long-Term Extension Period|Adverse Event|0|||
163353339|NCT02484547|590004666|FG003|Long-Term Extension Period|Adverse Event|0|||
163353340|NCT02484547|590004667|FG004|Long-Term Extension Period|Adverse Event|1|||
163353341|NCT02484547|590004668|FG005|Long-Term Extension Period|Adverse Event|3|||
163410232|NCT00262873|590211323|FG000|Overall Study|Withdrawal by Subject|5|||
163410233|NCT00844753|590211324|FG000|Overall Study|Lack of Efficacy|1|||
163353342|NCT02484547|590004669|FG006|Long-Term Extension Period|Adverse Event|2|||
163353343|NCT02484547|590004663|FG000|Long-Term Extension Period|Death|0|||
163353344|NCT02484547|590004664|FG001|Long-Term Extension Period|Death|0|||
163353345|NCT02484547|590004665|FG002|Long-Term Extension Period|Death|0|||
163353346|NCT02484547|590004666|FG003|Long-Term Extension Period|Death|0|||
163353347|NCT02484547|590004667|FG004|Long-Term Extension Period|Death|0|||
163353348|NCT02484547|590004668|FG005|Long-Term Extension Period|Death|3|||
163353349|NCT02484547|590004669|FG006|Long-Term Extension Period|Death|0|||
163353350|NCT02484547|590004663|FG000|Long-Term Extension Period|Disease Progression|0|||
163353351|NCT02484547|590004664|FG001|Long-Term Extension Period|Disease Progression|0|||
163353352|NCT02484547|590004665|FG002|Long-Term Extension Period|Disease Progression|0|||
163353353|NCT02484547|590004666|FG003|Long-Term Extension Period|Disease Progression|0|||
163353354|NCT02484547|590004667|FG004|Long-Term Extension Period|Disease Progression|2|||
163353355|NCT02484547|590004668|FG005|Long-Term Extension Period|Disease Progression|4|||
163353356|NCT02484547|590004669|FG006|Long-Term Extension Period|Disease Progression|0|||
163353357|NCT02484547|590004663|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
163353358|NCT02484547|590004664|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
163353359|NCT02484547|590004665|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
163353360|NCT02484547|590004666|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
163353361|NCT02484547|590004667|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
163353362|NCT02484547|590004668|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
163353363|NCT02484547|590004669|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
163353364|NCT02484547|590004663|FG000|Long-Term Extension Period|Loss of Capacity|0|||
163353365|NCT02484547|590004664|FG001|Long-Term Extension Period|Loss of Capacity|0|||
163353366|NCT02484547|590004665|FG002|Long-Term Extension Period|Loss of Capacity|0|||
163353367|NCT02484547|590004666|FG003|Long-Term Extension Period|Loss of Capacity|0|||
163353368|NCT02484547|590004667|FG004|Long-Term Extension Period|Loss of Capacity|1|||
163353369|NCT02484547|590004668|FG005|Long-Term Extension Period|Loss of Capacity|0|||
163353370|NCT02484547|590004669|FG006|Long-Term Extension Period|Loss of Capacity|0|||
163353371|NCT02484547|590004663|FG000|Long-Term Extension Period|Change of Treatment|0|||
163353372|NCT02484547|590004664|FG001|Long-Term Extension Period|Change of Treatment|0|||
163353373|NCT02484547|590004665|FG002|Long-Term Extension Period|Change of Treatment|0|||
163353374|NCT02484547|590004666|FG003|Long-Term Extension Period|Change of Treatment|0|||
163353375|NCT02484547|590004667|FG004|Long-Term Extension Period|Change of Treatment|0|||
163353376|NCT02484547|590004668|FG005|Long-Term Extension Period|Change of Treatment|0|||
163353377|NCT02484547|590004669|FG006|Long-Term Extension Period|Change of Treatment|1|||
163353378|NCT02484547|590004663|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
163353379|NCT02484547|590004664|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
163353380|NCT02484547|590004665|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
163353381|NCT02484547|590004666|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
163353382|NCT02484547|590004667|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
163353383|NCT02484547|590004668|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
163353384|NCT02484547|590004669|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
163353385|NCT02484547|590004663|FG000|Long-Term Extension Period|Investigator Decision|0|||
163353386|NCT02484547|590004664|FG001|Long-Term Extension Period|Investigator Decision|0|||
163353387|NCT02484547|590004665|FG002|Long-Term Extension Period|Investigator Decision|0|||
163353388|NCT02484547|590004666|FG003|Long-Term Extension Period|Investigator Decision|2|||
163353389|NCT02484547|590004667|FG004|Long-Term Extension Period|Investigator Decision|1|||
163353390|NCT02484547|590004668|FG005|Long-Term Extension Period|Investigator Decision|0|||
163353391|NCT02484547|590004669|FG006|Long-Term Extension Period|Investigator Decision|1|||
163353392|NCT02484547|590004663|FG000|Long-Term Extension Period|Relocation|0|||
163353393|NCT02484547|590004664|FG001|Long-Term Extension Period|Relocation|0|||
163353394|NCT02484547|590004665|FG002|Long-Term Extension Period|Relocation|0|||
163353395|NCT02484547|590004666|FG003|Long-Term Extension Period|Relocation|1|||
163353396|NCT02484547|590004667|FG004|Long-Term Extension Period|Relocation|1|||
163353397|NCT02484547|590004668|FG005|Long-Term Extension Period|Relocation|0|||
163353398|NCT02484547|590004669|FG006|Long-Term Extension Period|Relocation|0|||
163353399|NCT02484547|590004663|FG000|Long-Term Extension Period|Study Visit Burden|0|||
163353400|NCT02484547|590004664|FG001|Long-Term Extension Period|Study Visit Burden|0|||
163353401|NCT02484547|590004665|FG002|Long-Term Extension Period|Study Visit Burden|0|||
163353402|NCT02484547|590004666|FG003|Long-Term Extension Period|Study Visit Burden|2|||
163353403|NCT02484547|590004667|FG004|Long-Term Extension Period|Study Visit Burden|0|||
163353404|NCT02484547|590004668|FG005|Long-Term Extension Period|Study Visit Burden|0|||
163353405|NCT02484547|590004669|FG006|Long-Term Extension Period|Study Visit Burden|3|||
163353406|NCT02484547|590004663|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
163353407|NCT02484547|590004664|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
163353408|NCT02484547|590004665|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
163353409|NCT02484547|590004666|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
163353410|NCT02484547|590004667|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
163353411|NCT02484547|590004668|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
163353412|NCT02484547|590004669|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
163353413|NCT02484547|590004663|FG000|Long-Term Extension Period|Reason not Specified|0|||
163353414|NCT02484547|590004664|FG001|Long-Term Extension Period|Reason not Specified|0|||
163353415|NCT02484547|590004665|FG002|Long-Term Extension Period|Reason not Specified|0|||
163353416|NCT02484547|590004666|FG003|Long-Term Extension Period|Reason not Specified|119|||
163353417|NCT02484547|590004667|FG004|Long-Term Extension Period|Reason not Specified|117|||
163353418|NCT02484547|590004668|FG005|Long-Term Extension Period|Reason not Specified|223|||
163353419|NCT02484547|590004669|FG006|Long-Term Extension Period|Reason not Specified|231|||
163353420|NCT03765164|590004670|FG000|Pre-intervention|Withdrawal by Subject|5|||
163353421|NCT03765164|590004671|FG001|Pre-intervention|Withdrawal by Subject|6|||
163353422|NCT01813305|590004672|FG000|Overall Study|Withdrawal by Subject|12|||
163353423|NCT01813305|590004673|FG001|Overall Study|Withdrawal by Subject|5|||
163353424|NCT01813305|590004672|FG000|Overall Study|Safety Concern|4|||
163353425|NCT01813305|590004673|FG001|Overall Study|Safety Concern|0|||
163353426|NCT01813305|590004672|FG000|Overall Study|Ulcer became worse|4|||
163353427|NCT01813305|590004673|FG001|Overall Study|Ulcer became worse|0|||
163353428|NCT01813305|590004672|FG000|Overall Study|Physician Decision|4|||
163353429|NCT01813305|590004673|FG001|Overall Study|Physician Decision|0|||
163353430|NCT01813305|590004672|FG000|Overall Study|Lost to Follow-up|3|||
163353431|NCT01813305|590004673|FG001|Overall Study|Lost to Follow-up|1|||
163353432|NCT01813305|590004672|FG000|Overall Study|Protocol Violation|1|||
163353433|NCT01813305|590004673|FG001|Overall Study|Protocol Violation|0|||
163353434|NCT01813305|590004672|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
163353435|NCT01813305|590004673|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
163353436|NCT03448536|590004674|FG000|Overall Study|Protocol Violation|2|||
163353437|NCT03448536|590004675|FG001|Overall Study|Protocol Violation|0|||
163353438|NCT03448536|590004674|FG000|Overall Study|Pregnancy|1|||
163353439|NCT03448536|590004675|FG001|Overall Study|Pregnancy|0|||
163353440|NCT03448536|590004674|FG000|Overall Study|Withdrawal by Subject|1|||
163353441|NCT03448536|590004675|FG001|Overall Study|Withdrawal by Subject|2|||
163353442|NCT03448536|590004674|FG000|Overall Study|Lost to Follow-up|3|||
163353443|NCT03448536|590004675|FG001|Overall Study|Lost to Follow-up|2|||
163353444|NCT03448536|590004674|FG000|Overall Study|Inadequate pain reporter|1|||
163353445|NCT03448536|590004675|FG001|Overall Study|Inadequate pain reporter|0|||
163353446|NCT03448536|590004674|FG000|Overall Study|Other|3|||
163353447|NCT03448536|590004675|FG001|Overall Study|Other|0|||
163353448|NCT03448536|590004674|FG000|Overall Study|Physician Decision|1|||
163353449|NCT03448536|590004675|FG001|Overall Study|Physician Decision|0|||
163149468|NCT01295814|589261423|FG000|Overall Study|Lack of Efficacy|0|||
163149469|NCT01295814|589261424|FG001|Overall Study|Lack of Efficacy|2|||
163149470|NCT01295814|589261423|FG000|Overall Study|Withdrawal by Subject|2|||
163149471|NCT01295814|589261424|FG001|Overall Study|Withdrawal by Subject|0|||
163149472|NCT03414983|589261425|FG000|Pre-Treatment|Other reasons|1|||
163149473|NCT03414983|589261426|FG001|Pre-Treatment|Other reasons|0|||
163149474|NCT03414983|589261425|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
163149475|NCT03414983|589261426|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
163149476|NCT03414983|589261425|FG000|Pre-Treatment|Participant withdrew consent|1|||
163149477|NCT03414983|589261426|FG001|Pre-Treatment|Participant withdrew consent|3|||
163149478|NCT03414983|589261425|FG000|Treatment|Participant withdrew consent|4|||
163149479|NCT03414983|589261426|FG001|Treatment|Participant withdrew consent|3|||
163149480|NCT03414983|589261425|FG000|Treatment|Participant request to discontinue study treatment|8|||
163149481|NCT03414983|589261426|FG001|Treatment|Participant request to discontinue study treatment|10|||
163149482|NCT03414983|589261425|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
163149483|NCT03414983|589261426|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
163149484|NCT03414983|589261425|FG000|Treatment|Death|0|||
163149485|NCT03414983|589261426|FG001|Treatment|Death|1|||
163149486|NCT03414983|589261425|FG000|Treatment|Study Drug Toxicity|10|||
163149487|NCT03414983|589261426|FG001|Treatment|Study Drug Toxicity|5|||
163149488|NCT03414983|589261425|FG000|Treatment|Disease Progression|75|||
163149489|NCT03414983|589261426|FG001|Treatment|Disease Progression|29|||
163149490|NCT03414983|589261425|FG000|Treatment|Not reported|1|||
163149491|NCT03414983|589261426|FG001|Treatment|Not reported|0|||
163149492|NCT03414983|589261425|FG000|Treatment|Other reasons|3|||
163149493|NCT03414983|589261426|FG001|Treatment|Other reasons|2|||
163149494|NCT03414983|589261425|FG000|Treatment|Poor/non-compliance|2|||
163149495|NCT03414983|589261426|FG001|Treatment|Poor/non-compliance|0|||
163149496|NCT03414983|589261425|FG000|Treatment|Maximum clinical benefit|5|||
163149497|NCT03414983|589261426|FG001|Treatment|Maximum clinical benefit|9|||
163149498|NCT03414983|589261425|FG000|Treatment|Lost to Follow-up|0|||
163353450|NCT01665599|590004676|FG000|Overall Study|Adverse Event|1|||
163353451|NCT01665599|590004676|FG000|Overall Study|Consent Withdrawn|1|||
163353452|NCT01665599|590004676|FG000|Overall Study|Investigator/Sponsor decision|1|||
163353453|NCT01665599|590004676|FG000|Overall Study|Death|1|||
163353454|NCT01665599|590004676|FG000|Overall Study|Lost to Follow-up|2|||
163353455|NCT01665599|590004676|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
163353456|NCT01665599|590004676|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
163353457|NCT03120949|590004677|FG000|Overall Study|randomized in error|1|||
163353458|NCT03120949|590004678|FG001|Overall Study|randomized in error|0|||
163245576|NCT00448539|589605499|FG000|Overall Study|Lack of Efficacy|27|||
163353459|NCT03120949|590004677|FG000|Overall Study|Death|13|||
163353460|NCT03120949|590004678|FG001|Overall Study|Death|13|||
163353461|NCT03120949|590004677|FG000|Overall Study|Lost to Follow-up|23|||
163353462|NCT03120949|590004678|FG001|Overall Study|Lost to Follow-up|13|||
163353463|NCT03120949|590004677|FG000|Overall Study|Withdrawal by Subject|139|||
163353464|NCT03120949|590004678|FG001|Overall Study|Withdrawal by Subject|124|||
163353465|NCT03120949|590004677|FG000|Overall Study|Covid-19|43|||
163353466|NCT03120949|590004678|FG001|Overall Study|Covid-19|34|||
163353467|NCT03120949|590004677|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
163353468|NCT03120949|590004678|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
163353469|NCT03120949|590004677|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
163353470|NCT03120949|590004678|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
163353471|NCT03120949|590004677|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
163353472|NCT03120949|590004678|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
163353473|NCT03120949|590004677|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
163353474|NCT03120949|590004678|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
163353475|NCT03120949|590004677|FG000|Overall Study|Site was closed|2|||
163353476|NCT03120949|590004678|FG001|Overall Study|Site was closed|3|||
163245577|NCT00448539|589605500|FG001|Overall Study|Lack of Efficacy|40|||
163245578|NCT00448539|589605499|FG000|Overall Study|Miscellaneous|2|||
163245579|NCT00448539|589605500|FG001|Overall Study|Miscellaneous|1|||
163245580|NCT00448539|589605499|FG000|Overall Study|Change of meds|2|||
163245581|NCT00448539|589605500|FG001|Overall Study|Change of meds|3|||
163245582|NCT00448539|589605499|FG000|Overall Study|Lost to Follow-up|1|||
163245583|NCT00448539|589605500|FG001|Overall Study|Lost to Follow-up|3|||
163245584|NCT03349710|589605501|FG000|Treatment Period|Death|0|||
163245585|NCT03349710|589605502|FG001|Treatment Period|Death|0|||
163245586|NCT03349710|589605503|FG002|Treatment Period|Death|1|||
163245587|NCT03349710|589605504|FG003|Treatment Period|Death|0|||
163245588|NCT03349710|589605501|FG000|Treatment Period|Disease Progression|0|||
163245589|NCT03349710|589605502|FG001|Treatment Period|Disease Progression|2|||
163245590|NCT03349710|589605503|FG002|Treatment Period|Disease Progression|0|||
163245591|NCT03349710|589605504|FG003|Treatment Period|Disease Progression|1|||
163245592|NCT03349710|589605501|FG000|Treatment Period|Study Drug Toxicity|1|||
163245593|NCT03349710|589605502|FG001|Treatment Period|Study Drug Toxicity|0|||
163245594|NCT03349710|589605503|FG002|Treatment Period|Study Drug Toxicity|1|||
163245595|NCT03349710|589605504|FG003|Treatment Period|Study Drug Toxicity|1|||
163245596|NCT03349710|589605501|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
163245597|NCT03349710|589605502|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
163245598|NCT03349710|589605503|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
163245599|NCT03349710|589605504|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
163245600|NCT03349710|589605501|FG000|Treatment Period|admin reason by sponsor|0|||
163245601|NCT03349710|589605502|FG001|Treatment Period|admin reason by sponsor|7|||
163245602|NCT03349710|589605503|FG002|Treatment Period|admin reason by sponsor|0|||
163245603|NCT03349710|589605504|FG003|Treatment Period|admin reason by sponsor|19|||
163245604|NCT03349710|589605501|FG000|Treatment Period|Other Reason|2|||
163245605|NCT03349710|589605502|FG001|Treatment Period|Other Reason|0|||
163245606|NCT03349710|589605503|FG002|Treatment Period|Other Reason|2|||
163245607|NCT03349710|589605504|FG003|Treatment Period|Other Reason|1|||
163245608|NCT03349710|589605501|FG000|Treatment Period|completed|6|||
163245609|NCT03349710|589605502|FG001|Treatment Period|completed|0|||
163245610|NCT03349710|589605503|FG002|Treatment Period|completed|18|||
163245611|NCT03349710|589605504|FG003|Treatment Period|completed|1|||
163245612|NCT03349710|589605501|FG000|Treatment Period|participant request to discontinue|0|||
163245613|NCT03349710|589605502|FG001|Treatment Period|participant request to discontinue|0|||
163245614|NCT03349710|589605503|FG002|Treatment Period|participant request to discontinue|4|||
163245615|NCT03349710|589605504|FG003|Treatment Period|participant request to discontinue|0|||
163245616|NCT03349710|589605501|FG000|Treatment Period|participant withdrew consent|1|||
163245617|NCT03349710|589605502|FG001|Treatment Period|participant withdrew consent|0|||
163245618|NCT03349710|589605503|FG002|Treatment Period|participant withdrew consent|0|||
163245619|NCT03349710|589605504|FG003|Treatment Period|participant withdrew consent|0|||
163245620|NCT00695903|589605505|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
163245621|NCT00695903|589605506|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
163245622|NCT00695903|589605505|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
163245623|NCT00695903|589605506|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
163245624|NCT00695903|589605505|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
163245625|NCT00695903|589605506|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
163245626|NCT00695903|589605505|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
163245627|NCT00695903|589605506|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
163384898|NCT00427895|590119257|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
163245628|NCT00695903|589605505|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
163245629|NCT00695903|589605506|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
163245630|NCT00695903|589605505|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
163245631|NCT00695903|589605506|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
163245632|NCT00695903|589605505|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
163245633|NCT00695903|589605506|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
163245634|NCT00695903|589605505|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
163245635|NCT00695903|589605506|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
163245636|NCT00695903|589605505|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
163245637|NCT00695903|589605506|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
163245638|NCT01296568|589605509|FG000|Continued Access Phase|Lost to Follow-up|1|||
163245639|NCT01296568|589605509|FG000|Continued Access Phase|Withdrawal by Subject|1|||
163245640|NCT01296568|589605509|FG000|Continued Access Phase|Disease Progression|1|||
163245641|NCT01369342|589605515|FG000|Overall Study|Withdrawal by Subject|7|||
163245642|NCT01369342|589605516|FG001|Overall Study|Withdrawal by Subject|7|||
163245643|NCT01369342|589605517|FG002|Overall Study|Withdrawal by Subject|2|||
163245644|NCT01369342|589605515|FG000|Overall Study|Lost to Follow-up|5|||
163245645|NCT01369342|589605516|FG001|Overall Study|Lost to Follow-up|2|||
163245646|NCT01369342|589605517|FG002|Overall Study|Lost to Follow-up|1|||
163245647|NCT01369342|589605515|FG000|Overall Study|Not Treated|1|||
163245648|NCT01369342|589605516|FG001|Overall Study|Not Treated|0|||
163245649|NCT01369342|589605517|FG002|Overall Study|Not Treated|0|||
163245650|NCT00321854|589605518|FG000|Overall Study|Adverse Event|41|||
163245651|NCT00321854|589605519|FG001|Overall Study|Adverse Event|43|||
163245652|NCT00321854|589605518|FG000|Overall Study|Lack of Efficacy|9|||
163245653|NCT00321854|589605519|FG001|Overall Study|Lack of Efficacy|14|||
163245654|NCT00321854|589605518|FG000|Overall Study|Protocol Violation|6|||
163245655|NCT00321854|589605519|FG001|Overall Study|Protocol Violation|5|||
163245656|NCT00321854|589605518|FG000|Overall Study|Lost to Follow-up|0|||
163245657|NCT00321854|589605519|FG001|Overall Study|Lost to Follow-up|2|||
163245658|NCT00321854|589605518|FG000|Overall Study|Withdrawal by Subject|6|||
163245659|NCT00321854|589605519|FG001|Overall Study|Withdrawal by Subject|17|||
163245660|NCT00321854|589605518|FG000|Overall Study|Other|1|||
163245661|NCT00321854|589605519|FG001|Overall Study|Other|1|||
163245662|NCT01816594|589605520|FG000|Overall Study|Local Progress|0|||
163245663|NCT01816594|589605521|FG001|Overall Study|Local Progress|2|||
163245664|NCT01816594|589605520|FG000|Overall Study|Adverse Event|9|||
163245665|NCT01816594|589605521|FG001|Overall Study|Adverse Event|0|||
163245666|NCT01816594|589605520|FG000|Overall Study|Withdrawal by Subject|1|||
163245667|NCT01816594|589605521|FG001|Overall Study|Withdrawal by Subject|0|||
163245668|NCT01816594|589605520|FG000|Overall Study|Physician Decision|1|||
163245669|NCT01816594|589605521|FG001|Overall Study|Physician Decision|0|||
163245670|NCT03905655|589605522|FG000|Overall Study|Adverse Event|1|||
163245671|NCT03905655|589605523|FG001|Overall Study|Adverse Event|0|||
163245672|NCT03905655|589605524|FG002|Overall Study|Adverse Event|1|||
163245673|NCT03905655|589605525|FG003|Overall Study|Adverse Event|1|||
163245674|NCT04723576|589605526|FG000|Overall Study|Withdrawal by Subject|2133|||
163245675|NCT04723576|589605527|FG001|Overall Study|Withdrawal by Subject|3234|||
163245676|NCT03204279|589605531|FG000|Overall Study|Withdrawal by Subject|0|||
163245677|NCT03204279|589605532|FG001|Overall Study|Withdrawal by Subject|1|||
163245678|NCT04827212|589605533|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
163245679|NCT04827212|589605534|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
163245680|NCT04827212|589605533|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
163245681|NCT04827212|589605534|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
163245682|NCT03927950|589605540|FG000|Overall Study|Adverse Event|9|||
163245683|NCT03263429|589605541|FG000|Overall Study|Withdrawal by Subject|0|||
163245684|NCT03263429|589605542|FG001|Overall Study|Withdrawal by Subject|1|||
163245685|NCT03263429|589605543|FG002|Overall Study|Withdrawal by Subject|0|||
163245686|NCT03263429|589605541|FG000|Overall Study|Follow-Up Period Completed|0|||
163245687|NCT03263429|589605542|FG001|Overall Study|Follow-Up Period Completed|2|||
163245688|NCT03263429|589605543|FG002|Overall Study|Follow-Up Period Completed|0|||
163245689|NCT03263429|589605541|FG000|Overall Study|Death|3|||
163245690|NCT03263429|589605542|FG001|Overall Study|Death|5|||
163245691|NCT03263429|589605543|FG002|Overall Study|Death|16|||
163245692|NCT03263429|589605541|FG000|Overall Study|Participant unable to return|0|||
163245693|NCT03263429|589605542|FG001|Overall Study|Participant unable to return|0|||
163245694|NCT03263429|589605543|FG002|Overall Study|Participant unable to return|1|||
163245695|NCT03263429|589605541|FG000|Overall Study|Study Closed|0|||
163245696|NCT03263429|589605542|FG001|Overall Study|Study Closed|0|||
163245697|NCT03263429|589605543|FG002|Overall Study|Study Closed|1|||
163245698|NCT04530448|589605544|FG000|Overall Study|Physician Decision|3|||
163245699|NCT04530448|589605545|FG001|Overall Study|Physician Decision|0|||
163245700|NCT01519206|589605546|FG000|Overall Study|Lost to Follow-up|3|||
163245701|NCT01519206|589605546|FG000|Overall Study|Missed Visit|2|||
163245702|NCT02014116|589605547|FG000|Overall Study|Progressive Disease|3|||
163245703|NCT02014116|589605548|FG001|Overall Study|Progressive Disease|4|||
163245704|NCT02014116|589605549|FG002|Overall Study|Progressive Disease|2|||
163353477|NCT03120949|590004677|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
163353478|NCT03120949|590004678|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
163353479|NCT03120949|590004677|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
163353480|NCT03120949|590004678|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
163353481|NCT03120949|590004677|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
163353482|NCT03120949|590004678|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
163353483|NCT03120949|590004677|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
163353484|NCT03120949|590004678|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
163353485|NCT03120949|590004677|FG000|Overall Study|Other: Adverse Event|0|||
163353486|NCT03120949|590004678|FG001|Overall Study|Other: Adverse Event|1|||
163353487|NCT03120949|590004677|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
163353488|NCT03120949|590004678|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
163353489|NCT03120949|590004677|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
163353490|NCT03120949|590004678|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
163353491|NCT03120949|590004677|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
163353492|NCT03120949|590004678|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
163353493|NCT03120949|590004677|FG000|Overall Study|Personal Reasons|0|||
163353494|NCT03120949|590004678|FG001|Overall Study|Personal Reasons|1|||
163353495|NCT03120949|590004677|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
163353496|NCT03120949|590004678|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
163353497|NCT03120949|590004677|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
163353498|NCT03120949|590004678|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
163353499|NCT03120949|590004677|FG000|Overall Study|Compliance With Medication|0|||
163353500|NCT03120949|590004678|FG001|Overall Study|Compliance With Medication|1|||
163353501|NCT03120949|590004677|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
163353502|NCT03120949|590004678|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
163353503|NCT03120949|590004677|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
163353504|NCT03120949|590004678|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
163353505|NCT03120949|590004677|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
163353506|NCT03120949|590004678|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
163353507|NCT01705145|590004679|FG000|Part B|Adverse Event|1|||
163353508|NCT00988117|590004680|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
163353509|NCT00988117|590004680|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
163353510|NCT03015181|590004682|FG000|Overall Study|Enrolled, but product never administered|1|||
163353511|NCT03015181|590004683|FG001|Overall Study|Enrolled, but product never administered|0|||
163353512|NCT03015181|590004684|FG002|Overall Study|Enrolled, but product never administered|0|||
163353513|NCT03015181|590004685|FG003|Overall Study|Enrolled, but product never administered|0|||
163353514|NCT03015181|590004686|FG004|Overall Study|Enrolled, but product never administered|0|||
163353515|NCT03015181|590004687|FG005|Overall Study|Enrolled, but product never administered|0|||
163353516|NCT03015181|590004688|FG006|Overall Study|Enrolled, but product never administered|0|||
163353517|NCT03015181|590004682|FG000|Overall Study|Withdrawal by Subject|0|||
163353518|NCT03015181|590004683|FG001|Overall Study|Withdrawal by Subject|0|||
163353519|NCT03015181|590004684|FG002|Overall Study|Withdrawal by Subject|0|||
163353520|NCT03015181|590004685|FG003|Overall Study|Withdrawal by Subject|0|||
163353521|NCT03015181|590004686|FG004|Overall Study|Withdrawal by Subject|0|||
163353522|NCT03015181|590004687|FG005|Overall Study|Withdrawal by Subject|1|||
163353523|NCT03015181|590004688|FG006|Overall Study|Withdrawal by Subject|0|||
163353524|NCT03015181|590004682|FG000|Overall Study|Physician Decision|0|||
163353525|NCT03015181|590004683|FG001|Overall Study|Physician Decision|0|||
163353526|NCT03015181|590004684|FG002|Overall Study|Physician Decision|0|||
163353527|NCT03015181|590004685|FG003|Overall Study|Physician Decision|0|||
163353528|NCT03015181|590004686|FG004|Overall Study|Physician Decision|0|||
163353529|NCT03015181|590004687|FG005|Overall Study|Physician Decision|0|||
163353530|NCT03015181|590004688|FG006|Overall Study|Physician Decision|1|||
163353531|NCT01077622|590004689|FG000|Overall Study|Physician Decision|2|||
163353532|NCT01077622|590004689|FG000|Overall Study|Withdrawal by Subject|1|||
163353533|NCT00424177|590004690|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
163353534|NCT00424177|590004690|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
163353535|NCT00424177|590004690|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
163353536|NCT00424177|590004690|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
163353537|NCT00424177|590004690|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
163353538|NCT00424177|590004690|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
163410234|NCT00844753|590211325|FG001|Overall Study|Lack of Efficacy|0|||
163410235|NCT00844753|590211326|FG002|Overall Study|Lack of Efficacy|2|||
163410236|NCT00844753|590211327|FG003|Overall Study|Lack of Efficacy|2|||
163410237|NCT00844753|590211324|FG000|Overall Study|Adverse Event|3|||
163245705|NCT02014116|589605550|FG003|Overall Study|Progressive Disease|6|||
163245706|NCT02014116|589605551|FG004|Overall Study|Progressive Disease|1|||
163245707|NCT02014116|589605552|FG005|Overall Study|Progressive Disease|13|||
163245708|NCT02014116|589605553|FG006|Overall Study|Progressive Disease|1|||
163245709|NCT02014116|589605554|FG007|Overall Study|Progressive Disease|3|||
163245710|NCT02014116|589605555|FG008|Overall Study|Progressive Disease|7|||
163245711|NCT02014116|589605547|FG000|Overall Study|Adverse Event|0|||
163245712|NCT02014116|589605548|FG001|Overall Study|Adverse Event|0|||
163245713|NCT02014116|589605549|FG002|Overall Study|Adverse Event|0|||
163245714|NCT02014116|589605550|FG003|Overall Study|Adverse Event|0|||
163245715|NCT02014116|589605551|FG004|Overall Study|Adverse Event|1|||
163245716|NCT02014116|589605552|FG005|Overall Study|Adverse Event|0|||
163245717|NCT02014116|589605553|FG006|Overall Study|Adverse Event|0|||
163245718|NCT02014116|589605554|FG007|Overall Study|Adverse Event|1|||
163245719|NCT02014116|589605555|FG008|Overall Study|Adverse Event|0|||
163245720|NCT02014116|589605547|FG000|Overall Study|Lost to Follow-up|0|||
163149499|NCT03414983|589261426|FG001|Treatment|Lost to Follow-up|1|||
163149500|NCT03414983|589261425|FG000|Treatment|Administrative reasons by sponsor|1|||
163149501|NCT03414983|589261426|FG001|Treatment|Administrative reasons by sponsor|0|||
163149502|NCT04515771|589261431|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
163149503|NCT04515771|589261432|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
163149504|NCT04515771|589261431|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
163149505|NCT04515771|589261432|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
163149506|NCT04515771|589261431|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
163149507|NCT04515771|589261432|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
163149508|NCT00948246|589261436|FG000|Overall Study|Lost to Follow-up|11|||
163149509|NCT00948246|589261436|FG000|Overall Study|Adverse Event|11|||
163149510|NCT00948246|589261436|FG000|Overall Study|Death|1|||
163149511|NCT00948246|589261436|FG000|Overall Study|Withdrawal by Subject|1|||
163149512|NCT00148317|589261437|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
163149513|NCT00148317|589261437|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
163245721|NCT02014116|589605548|FG001|Overall Study|Lost to Follow-up|0|||
163245722|NCT02014116|589605549|FG002|Overall Study|Lost to Follow-up|0|||
163245723|NCT02014116|589605550|FG003|Overall Study|Lost to Follow-up|0|||
163245724|NCT02014116|589605551|FG004|Overall Study|Lost to Follow-up|0|||
163245725|NCT02014116|589605552|FG005|Overall Study|Lost to Follow-up|1|||
163245726|NCT02014116|589605553|FG006|Overall Study|Lost to Follow-up|0|||
163245727|NCT02014116|589605554|FG007|Overall Study|Lost to Follow-up|0|||
163245728|NCT02014116|589605555|FG008|Overall Study|Lost to Follow-up|1|||
163245729|NCT02014116|589605547|FG000|Overall Study|Death|0|||
163245730|NCT02014116|589605548|FG001|Overall Study|Death|0|||
163245731|NCT02014116|589605549|FG002|Overall Study|Death|0|||
163245732|NCT02014116|589605550|FG003|Overall Study|Death|0|||
163245733|NCT02014116|589605551|FG004|Overall Study|Death|0|||
163245734|NCT02014116|589605552|FG005|Overall Study|Death|0|||
163245735|NCT02014116|589605553|FG006|Overall Study|Death|0|||
163245736|NCT02014116|589605554|FG007|Overall Study|Death|1|||
163245737|NCT02014116|589605555|FG008|Overall Study|Death|1|||
163245738|NCT02014116|589605547|FG000|Overall Study|Withdrawal by Subject|0|||
163245739|NCT02014116|589605548|FG001|Overall Study|Withdrawal by Subject|0|||
163245740|NCT02014116|589605549|FG002|Overall Study|Withdrawal by Subject|1|||
163245741|NCT02014116|589605550|FG003|Overall Study|Withdrawal by Subject|1|||
163245742|NCT02014116|589605551|FG004|Overall Study|Withdrawal by Subject|0|||
163245743|NCT02014116|589605552|FG005|Overall Study|Withdrawal by Subject|1|||
163245744|NCT02014116|589605553|FG006|Overall Study|Withdrawal by Subject|0|||
163245745|NCT02014116|589605554|FG007|Overall Study|Withdrawal by Subject|0|||
163245746|NCT02014116|589605555|FG008|Overall Study|Withdrawal by Subject|0|||
163245747|NCT02014116|589605547|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
163245748|NCT02014116|589605548|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
163245749|NCT02014116|589605549|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
163245750|NCT02014116|589605550|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
163245751|NCT02014116|589605551|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
163245752|NCT02014116|589605552|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
163245753|NCT02014116|589605553|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
163245754|NCT02014116|589605554|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
163245755|NCT02014116|589605555|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
163245756|NCT02014116|589605547|FG000|Overall Study|Physician Decision|0|||
163245757|NCT02014116|589605548|FG001|Overall Study|Physician Decision|0|||
163245758|NCT02014116|589605549|FG002|Overall Study|Physician Decision|0|||
163245759|NCT02014116|589605550|FG003|Overall Study|Physician Decision|0|||
163245760|NCT02014116|589605551|FG004|Overall Study|Physician Decision|0|||
163245761|NCT02014116|589605552|FG005|Overall Study|Physician Decision|0|||
163245762|NCT02014116|589605553|FG006|Overall Study|Physician Decision|0|||
163353539|NCT00424177|590004690|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
163353540|NCT00424177|590004690|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
163353541|NCT00424177|590004690|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
163353542|NCT00424177|590004690|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
163353543|NCT01091519|590004696|FG000|Overall Study|Adverse Event|12|||
163353544|NCT01091519|590004697|FG001|Overall Study|Adverse Event|16|||
163353545|NCT01091519|590004696|FG000|Overall Study|Death|1|||
163353546|NCT01091519|590004697|FG001|Overall Study|Death|0|||
163353547|NCT01091519|590004696|FG000|Overall Study|Lack of Efficacy|16|||
163353548|NCT01091519|590004697|FG001|Overall Study|Lack of Efficacy|19|||
163353549|NCT01091519|590004696|FG000|Overall Study|Lost to Follow-up|14|||
163353550|NCT01091519|590004697|FG001|Overall Study|Lost to Follow-up|24|||
163353551|NCT01091519|590004696|FG000|Overall Study|Withdrawal by Subject|2|||
163353552|NCT01091519|590004697|FG001|Overall Study|Withdrawal by Subject|2|||
163353553|NCT01091519|590004696|FG000|Overall Study|Other|6|||
163353554|NCT01091519|590004697|FG001|Overall Study|Other|8|||
163353555|NCT01091519|590004696|FG000|Overall Study|Randomized not treated|4|||
163353556|NCT01091519|590004697|FG001|Overall Study|Randomized not treated|4|||
163353557|NCT01177228|590004702|FG000|Overall Study|Positive tuberculosis test|0|||
163353558|NCT01177228|590004703|FG001|Overall Study|Positive tuberculosis test|1|||
163353559|NCT01177228|590004704|FG002|Overall Study|Positive tuberculosis test|0|||
163353560|NCT01177228|590004705|FG003|Overall Study|Positive tuberculosis test|0|||
163353561|NCT01177228|590004702|FG000|Overall Study|Worsening disease activity|1|||
163353562|NCT01177228|590004703|FG001|Overall Study|Worsening disease activity|0|||
163353563|NCT01177228|590004704|FG002|Overall Study|Worsening disease activity|0|||
163353564|NCT01177228|590004705|FG003|Overall Study|Worsening disease activity|0|||
163353565|NCT01177228|590004702|FG000|Overall Study|Withdrawal by Subject|0|||
163353566|NCT01177228|590004703|FG001|Overall Study|Withdrawal by Subject|1|||
163353567|NCT01177228|590004704|FG002|Overall Study|Withdrawal by Subject|0|||
163353568|NCT01177228|590004705|FG003|Overall Study|Withdrawal by Subject|0|||
163353569|NCT01251887|590004706|FG000|Overall Study|Scheduling conflict|1|||
163353570|NCT01251887|590004707|FG001|Overall Study|Scheduling conflict|2|||
163353571|NCT01251887|590004708|FG002|Overall Study|Scheduling conflict|2|||
163353572|NCT01251887|590004706|FG000|Overall Study|Physician Decision|0|||
163353573|NCT01251887|590004707|FG001|Overall Study|Physician Decision|1|||
163353574|NCT01251887|590004708|FG002|Overall Study|Physician Decision|0|||
163353575|NCT00316589|590004711|FG000|Overall Study|Withdrawal by Subject|0|||
163353576|NCT00316589|590004712|FG001|Overall Study|Withdrawal by Subject|5|||
163353577|NCT00316589|590004713|FG002|Overall Study|Withdrawal by Subject|0|||
163353578|NCT00316589|590004714|FG003|Overall Study|Withdrawal by Subject|1|||
163353579|NCT00316589|590004711|FG000|Overall Study|Subject unwilling/unable to comply|0|||
163353580|NCT00316589|590004712|FG001|Overall Study|Subject unwilling/unable to comply|6|||
163353581|NCT00316589|590004713|FG002|Overall Study|Subject unwilling/unable to comply|0|||
163353582|NCT00316589|590004714|FG003|Overall Study|Subject unwilling/unable to comply|2|||
163353583|NCT00316589|590004711|FG000|Overall Study|Adverse Event|1|||
163353584|NCT00316589|590004712|FG001|Overall Study|Adverse Event|0|||
163353585|NCT00316589|590004713|FG002|Overall Study|Adverse Event|0|||
163353586|NCT00316589|590004714|FG003|Overall Study|Adverse Event|1|||
163353587|NCT00316589|590004711|FG000|Overall Study|Physician Decision|0|||
163353588|NCT00316589|590004712|FG001|Overall Study|Physician Decision|1|||
163353589|NCT00316589|590004713|FG002|Overall Study|Physician Decision|0|||
163353590|NCT00316589|590004714|FG003|Overall Study|Physician Decision|0|||
163353591|NCT00316589|590004711|FG000|Overall Study|Other reason|0|||
163353592|NCT00316589|590004712|FG001|Overall Study|Other reason|12|||
163353593|NCT00316589|590004713|FG002|Overall Study|Other reason|1|||
163353594|NCT00316589|590004714|FG003|Overall Study|Other reason|1|||
163353595|NCT01283971|590004717|FG000|Overall Study|Adverse Event|3|||
163353596|NCT01283971|590004718|FG001|Overall Study|Adverse Event|5|||
163353597|NCT01283971|590004717|FG000|Overall Study|Insufficient therapeutic responses|3|||
163353598|NCT01283971|590004718|FG001|Overall Study|Insufficient therapeutic responses|3|||
163353599|NCT01283971|590004717|FG000|Overall Study|Protocol Violation|5|||
163353600|NCT01283971|590004718|FG001|Overall Study|Protocol Violation|1|||
163353601|NCT01283971|590004717|FG000|Overall Study|Refused treatment|3|||
163353602|NCT01283971|590004718|FG001|Overall Study|Refused treatment|1|||
163353603|NCT01283971|590004717|FG000|Overall Study|Failure to return|0|||
163353604|NCT01283971|590004718|FG001|Overall Study|Failure to return|1|||
163149514|NCT00148317|589261437|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
163149515|NCT03623243|589261442|FG000|Overall Study|Adverse Event|15|||
163149516|NCT03623243|589261442|FG000|Overall Study|Guardian Decision|1|||
163353605|NCT01283971|590004717|FG000|Overall Study|Administrative reasons|1|||
163353606|NCT01283971|590004718|FG001|Overall Study|Administrative reasons|1|||
163353607|NCT00562484|590004727|FG000|Overall Study|Adverse Event|6|||
163353608|NCT00562484|590004728|FG001|Overall Study|Adverse Event|1|||
163353609|NCT00562484|590004727|FG000|Overall Study|Protocol Violation|11|||
163353610|NCT00562484|590004728|FG001|Overall Study|Protocol Violation|2|||
163353611|NCT00562484|590004727|FG000|Overall Study|Withdrawal by Subject|12|||
163353612|NCT00562484|590004728|FG001|Overall Study|Withdrawal by Subject|9|||
163410238|NCT00844753|590211325|FG001|Overall Study|Adverse Event|2|||
163353613|NCT00562484|590004727|FG000|Overall Study|Moved away from the study area|20|||
163353614|NCT00562484|590004728|FG001|Overall Study|Moved away from the study area|9|||
163353615|NCT00562484|590004727|FG000|Overall Study|Lost to Follow-up|132|||
163353616|NCT00562484|590004728|FG001|Overall Study|Lost to Follow-up|71|||
163353617|NCT00562484|590004727|FG000|Overall Study|Reason not provided or not specified|25|||
163353618|NCT00562484|590004728|FG001|Overall Study|Reason not provided or not specified|12|||
163353619|NCT02598934|590004730|FG000|Overall Study|Adverse Event|11|||
163353620|NCT02598934|590004731|FG001|Overall Study|Adverse Event|13|||
163353621|NCT02598934|590004730|FG000|Overall Study|Failure to Return|3|||
163353622|NCT02598934|590004731|FG001|Overall Study|Failure to Return|3|||
163353623|NCT02598934|590004730|FG000|Overall Study|Withdrawal by Subject|2|||
163353624|NCT02598934|590004731|FG001|Overall Study|Withdrawal by Subject|3|||
163353625|NCT02598934|590004730|FG000|Overall Study|Administrative|2|||
163353626|NCT02598934|590004731|FG001|Overall Study|Administrative|1|||
163353627|NCT02598934|590004730|FG000|Overall Study|Protocol Violation|1|||
163353628|NCT02598934|590004731|FG001|Overall Study|Protocol Violation|2|||
163353629|NCT00702520|590004732|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
163353630|NCT00702520|590004733|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
163353631|NCT00702520|590004734|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
163353632|NCT00702520|590004735|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
163353633|NCT00702520|590004732|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
163353634|NCT00702520|590004733|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
163353635|NCT00702520|590004734|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
163353636|NCT00702520|590004735|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
163353637|NCT00702520|590004732|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
163353638|NCT00702520|590004733|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
163353639|NCT00702520|590004734|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
163353640|NCT00702520|590004735|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
163353641|NCT02154347|590004736|FG000|Double-blind Period|Adverse Event|1|||
163353642|NCT02154347|590004737|FG001|Double-blind Period|Adverse Event|2|||
163353643|NCT02154347|590004736|FG000|Double-blind Period|Lack of Efficacy|1|||
163353644|NCT02154347|590004737|FG001|Double-blind Period|Lack of Efficacy|0|||
163353645|NCT02154347|590004736|FG000|Double-blind Period|Physician Decision|0|||
163353646|NCT02154347|590004737|FG001|Double-blind Period|Physician Decision|1|||
163353647|NCT02154347|590004736|FG000|Double-blind Period|Withdrawal by Subject|1|||
163353648|NCT02154347|590004737|FG001|Double-blind Period|Withdrawal by Subject|1|||
163353649|NCT02154347|590004736|FG000|Open-label Period|Adverse Event|3|||
163353650|NCT02154347|590004737|FG001|Open-label Period|Adverse Event|4|||
163353651|NCT02154347|590004736|FG000|Open-label Period|Lack of Efficacy|4|||
163353652|NCT02154347|590004737|FG001|Open-label Period|Lack of Efficacy|19|||
163353653|NCT02154347|590004736|FG000|Open-label Period|Protocol Violation|0|||
163353654|NCT02154347|590004737|FG001|Open-label Period|Protocol Violation|1|||
163353655|NCT02154347|590004736|FG000|Open-label Period|Withdrawal by Subject|0|||
163353656|NCT02154347|590004737|FG001|Open-label Period|Withdrawal by Subject|1|||
163353657|NCT02481934|590004738|FG000|Overall Study|Death|2|||
163353658|NCT02473913|590004739|FG000|Overall Study|Lost to Follow-up|3|||
163353659|NCT02473913|590004740|FG001|Overall Study|Lost to Follow-up|3|||
163353660|NCT02250183|590004748|FG000|Overall Study|Withdrawal by Subject|2|||
163353661|NCT02250183|590004748|FG000|Overall Study|Adverse Event|5|||
163353662|NCT02250183|590004748|FG000|Overall Study|Lost to Follow-up|1|||
163353663|NCT03282799|590004749|FG000|Overall Study|Pregnancy|1|||
163353664|NCT03282799|590004750|FG001|Overall Study|Pregnancy|0|||
163353665|NCT03282799|590004749|FG000|Overall Study|Physician Decision|1|||
163353666|NCT03282799|590004750|FG001|Overall Study|Physician Decision|0|||
163353667|NCT03749616|590004754|FG000|Overall Study|Lost to Follow-up|4|||
163353668|NCT03749616|590004755|FG001|Overall Study|Lost to Follow-up|7|||
163353669|NCT03749616|590004754|FG000|Overall Study|Screen Failure|1|||
163353670|NCT03749616|590004755|FG001|Overall Study|Screen Failure|1|||
163353671|NCT03749616|590004754|FG000|Overall Study|Withdrawal by Subject|2|||
163353672|NCT03749616|590004755|FG001|Overall Study|Withdrawal by Subject|0|||
163353673|NCT03302559|590004756|FG000|Overall Study|Adverse Event|2|||
163353674|NCT03302559|590004756|FG000|Overall Study|Lost to Follow-up|1|||
163353675|NCT03302559|590004756|FG000|Overall Study|Withdrew Consent|3|||
163353676|NCT02080403|590006132|FG000|Overall Study|Adverse Event|5|||
163353677|NCT02080403|590006133|FG001|Overall Study|Adverse Event|1|||
163353678|NCT02080403|590006132|FG000|Overall Study|Death|0|||
163353679|NCT02080403|590006133|FG001|Overall Study|Death|2|||
163353680|NCT02080403|590006132|FG000|Overall Study|Lost to Follow-up|2|||
163353681|NCT02080403|590006133|FG001|Overall Study|Lost to Follow-up|0|||
163149517|NCT03623243|589261442|FG000|Overall Study|New Therapy for Study Indication|1|||
163149518|NCT03623243|589261442|FG000|Overall Study|Protocol Deviation|3|||
163149519|NCT03623243|589261442|FG000|Overall Study|Physician Decision|4|||
163149520|NCT03623243|589261442|FG000|Overall Study|Patient Decision|15|||
163149521|NCT03007966|589261443|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
163149522|NCT03007966|589261444|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
163245763|NCT02014116|589605554|FG007|Overall Study|Physician Decision|0|||
163245764|NCT02014116|589605555|FG008|Overall Study|Physician Decision|1|||
163245765|NCT01491854|589605556|FG000|Overall Study|mainly due to premature termination|93|||
163245766|NCT01491854|589605556|FG000|Overall Study|Death|1|||
163245767|NCT01491854|589605556|FG000|Overall Study|Withdrawal by Subject|3|||
163245768|NCT01491854|589605556|FG000|Overall Study|Lost to Follow-up|33|||
163245769|NCT05545072|589605565|FG000|Overall Study|Lost to Follow-up|1|||
163245770|NCT05545072|589605566|FG001|Overall Study|Lost to Follow-up|0|||
163245771|NCT05545072|589605565|FG000|Overall Study|Study ended prematurely due to funding|2|||
163245772|NCT05545072|589605566|FG001|Overall Study|Study ended prematurely due to funding|2|||
163245773|NCT02395042|589605567|FG000|Treatment 1 Period|Adverse Event|1|||
163245774|NCT02395042|589605568|FG001|Treatment 1 Period|Adverse Event|3|||
163245775|NCT02395042|589605569|FG002|Treatment 1 Period|Adverse Event|1|||
163245776|NCT02395042|589605567|FG000|Treatment 1 Period|Lack of Efficacy|1|||
163245777|NCT02395042|589605568|FG001|Treatment 1 Period|Lack of Efficacy|1|||
163245778|NCT02395042|589605569|FG002|Treatment 1 Period|Lack of Efficacy|0|||
163245779|NCT02395042|589605567|FG000|Treatment 1 Period|Lost to Follow-up|1|||
163245780|NCT02395042|589605568|FG001|Treatment 1 Period|Lost to Follow-up|0|||
163245781|NCT02395042|589605569|FG002|Treatment 1 Period|Lost to Follow-up|0|||
163245782|NCT02395042|589605567|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
163245783|NCT02395042|589605568|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
163245784|NCT02395042|589605569|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
163245785|NCT02395042|589605567|FG000|Treatment 2 Period|Lack of Efficacy|1|||
163245786|NCT02395042|589605568|FG001|Treatment 2 Period|Lack of Efficacy|1|||
163245787|NCT02395042|589605569|FG002|Treatment 2 Period|Lack of Efficacy|0|||
163245788|NCT03638141|589605570|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
163245789|NCT03996473|589605571|FG000|Treatment Assignment|Withdrawal by Subject|1|||
163245790|NCT03996473|589605571|FG000|Treatment Assignment|Progressive disease|6|||
163245791|NCT03996473|589605571|FG000|Treatment Assignment|Study drug never administered|1|||
163245792|NCT03996473|589605571|FG000|Active Follow-up|Death|1|||
163245793|NCT03996473|589605571|FG000|Long-term Follow-up|Death|5|||
163245794|NCT03759873|589605572|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
163245795|NCT03759873|589605573|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
163245796|NCT03759873|589605574|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
163245797|NCT03759873|589605575|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
163245798|NCT03759873|589605572|FG000|Overall Study|Moved outside eligible area|0|||
163245799|NCT03759873|589605573|FG001|Overall Study|Moved outside eligible area|2|||
163245800|NCT03759873|589605574|FG002|Overall Study|Moved outside eligible area|0|||
163245801|NCT03759873|589605575|FG003|Overall Study|Moved outside eligible area|0|||
163245802|NCT03759873|589605572|FG000|Overall Study|Withdrawal by Subject|0|||
163245803|NCT03759873|589605573|FG001|Overall Study|Withdrawal by Subject|0|||
163245804|NCT03759873|589605574|FG002|Overall Study|Withdrawal by Subject|1|||
163245805|NCT03759873|589605575|FG003|Overall Study|Withdrawal by Subject|0|||
163245806|NCT03579563|589605578|FG000|Overall Study|Lost to Follow-up|0|||
163245807|NCT03579563|589605579|FG001|Overall Study|Lost to Follow-up|0|||
163245808|NCT03579563|589605580|FG002|Overall Study|Lost to Follow-up|0|||
163245809|NCT03579563|589605581|FG003|Overall Study|Lost to Follow-up|0|||
163245810|NCT03579563|589605582|FG004|Overall Study|Lost to Follow-up|1|||
163245811|NCT03579563|589605583|FG005|Overall Study|Lost to Follow-up|0|||
163245812|NCT03579563|589605578|FG000|Overall Study|Lack of Efficacy|1|||
163245813|NCT03579563|589605579|FG001|Overall Study|Lack of Efficacy|1|||
163245814|NCT03579563|589605580|FG002|Overall Study|Lack of Efficacy|4|||
163245815|NCT03579563|589605581|FG003|Overall Study|Lack of Efficacy|1|||
163245816|NCT03579563|589605582|FG004|Overall Study|Lack of Efficacy|2|||
163245817|NCT03579563|589605583|FG005|Overall Study|Lack of Efficacy|3|||
163245818|NCT03579563|589605578|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
163245819|NCT03579563|589605579|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
163245820|NCT03579563|589605580|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
163245821|NCT03579563|589605581|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
163245822|NCT03579563|589605582|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
163245823|NCT03579563|589605583|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
163245824|NCT03579563|589605578|FG000|Overall Study|Time/distance concern|0|||
163245825|NCT03579563|589605579|FG001|Overall Study|Time/distance concern|0|||
163245826|NCT03579563|589605580|FG002|Overall Study|Time/distance concern|1|||
163245827|NCT03579563|589605581|FG003|Overall Study|Time/distance concern|0|||
163245828|NCT03579563|589605582|FG004|Overall Study|Time/distance concern|0|||
163245829|NCT03579563|589605583|FG005|Overall Study|Time/distance concern|1|||
163245830|NCT03579563|589605578|FG000|Overall Study|COVID shutdown|2|||
163245831|NCT03579563|589605579|FG001|Overall Study|COVID shutdown|3|||
163245832|NCT03579563|589605580|FG002|Overall Study|COVID shutdown|4|||
163245833|NCT03579563|589605581|FG003|Overall Study|COVID shutdown|3|||
163245834|NCT03579563|589605582|FG004|Overall Study|COVID shutdown|1|||
163245835|NCT03579563|589605583|FG005|Overall Study|COVID shutdown|2|||
163245836|NCT03579563|589605578|FG000|Overall Study|Protocol administration error|1|||
163353682|NCT02080403|590006132|FG000|Overall Study|Pregnancy|0|||
163353683|NCT02080403|590006133|FG001|Overall Study|Pregnancy|1|||
163353684|NCT02080403|590006132|FG000|Overall Study|Protocol Violation|3|||
163353685|NCT02080403|590006133|FG001|Overall Study|Protocol Violation|7|||
163353686|NCT02080403|590006132|FG000|Overall Study|Withdrawal by Subject|5|||
163353687|NCT02080403|590006133|FG001|Overall Study|Withdrawal by Subject|1|||
163353688|NCT01999972|590006134|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
163353689|NCT01999972|590006135|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
163353690|NCT01999972|590006136|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
163353691|NCT01999972|590006137|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
163353692|NCT01999972|590006138|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
163353693|NCT01999972|590006139|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
163353694|NCT01999972|590006134|FG000|Dose Escalation Part|Death|0|||
163353695|NCT01999972|590006135|FG001|Dose Escalation Part|Death|1|||
163353696|NCT01999972|590006136|FG002|Dose Escalation Part|Death|0|||
163353697|NCT01999972|590006137|FG003|Dose Escalation Part|Death|0|||
163353698|NCT01999972|590006138|FG004|Dose Escalation Part|Death|0|||
163353699|NCT01999972|590006139|FG005|Dose Escalation Part|Death|0|||
163353700|NCT01999972|590006134|FG000|Dose Escalation Part|Enrolled but not treated|0|||
163353701|NCT01999972|590006135|FG001|Dose Escalation Part|Enrolled but not treated|0|||
163353702|NCT01999972|590006136|FG002|Dose Escalation Part|Enrolled but not treated|1|||
163353703|NCT01999972|590006137|FG003|Dose Escalation Part|Enrolled but not treated|1|||
163353704|NCT01999972|590006138|FG004|Dose Escalation Part|Enrolled but not treated|0|||
163410239|NCT00844753|590211326|FG002|Overall Study|Adverse Event|5|||
163245837|NCT03579563|589605579|FG001|Overall Study|Protocol administration error|0|||
163245838|NCT03579563|589605580|FG002|Overall Study|Protocol administration error|1|||
163245839|NCT03579563|589605581|FG003|Overall Study|Protocol administration error|0|||
163245840|NCT03579563|589605582|FG004|Overall Study|Protocol administration error|1|||
163245841|NCT03579563|589605583|FG005|Overall Study|Protocol administration error|5|||
163245842|NCT03621696|589605584|FG000|Overall Study|Not eligible|0|||
163245843|NCT03621696|589605585|FG001|Overall Study|Not eligible|0|||
163245844|NCT03621696|589605586|FG002|Overall Study|Not eligible|0|||
163245845|NCT03621696|589605587|FG003|Overall Study|Not eligible|5|||
163245846|NCT03621696|589605584|FG000|Overall Study|Withdrawal by Subject|1|||
163245847|NCT03621696|589605585|FG001|Overall Study|Withdrawal by Subject|1|||
163245848|NCT03621696|589605586|FG002|Overall Study|Withdrawal by Subject|1|||
163245849|NCT03621696|589605587|FG003|Overall Study|Withdrawal by Subject|0|||
163245850|NCT03621696|589605584|FG000|Overall Study|Physician Decision|0|||
163245851|NCT03621696|589605585|FG001|Overall Study|Physician Decision|0|||
163245852|NCT03621696|589605586|FG002|Overall Study|Physician Decision|1|||
163245853|NCT03621696|589605587|FG003|Overall Study|Physician Decision|0|||
163245854|NCT03867734|589605588|FG000|Overall Study|Lost to Follow-up|2|||
163245855|NCT01827904|589605589|FG000|Main Study|Withdrawal by Subject|1|||
163245856|NCT01827904|589605590|FG001|Main Study|Withdrawal by Subject|0|||
163245857|NCT01827904|589605591|FG002|Main Study|Withdrawal by Subject|0|||
163245858|NCT01827904|589605589|FG000|Main Study|Adverse Event|1|||
163245859|NCT01827904|589605590|FG001|Main Study|Adverse Event|0|||
163245860|NCT01827904|589605591|FG002|Main Study|Adverse Event|0|||
163245861|NCT01827904|589605589|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
163245862|NCT01827904|589605590|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
163245863|NCT01827904|589605591|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
163245864|NCT01827904|589605589|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
163245865|NCT01827904|589605590|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
163245866|NCT01827904|589605591|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
163245867|NCT01827904|589605589|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
163245868|NCT01827904|589605590|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
163245869|NCT01827904|589605591|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
163245870|NCT01827904|589605589|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
163245871|NCT01827904|589605590|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
163245872|NCT01827904|589605591|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
163245873|NCT01827904|589605589|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
163245874|NCT01827904|589605590|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
163353705|NCT01999972|590006139|FG005|Dose Escalation Part|Enrolled but not treated|0|||
163245875|NCT01827904|589605591|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
163245876|NCT01827904|589605589|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
163245877|NCT01827904|589605590|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
163245878|NCT01827904|589605591|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
163353706|NCT01999972|590006134|FG000|Dose Escalation Part|Disease progression|3|||
163353707|NCT01999972|590006135|FG001|Dose Escalation Part|Disease progression|2|||
163353708|NCT01999972|590006136|FG002|Dose Escalation Part|Disease progression|3|||
163410240|NCT00844753|590211327|FG003|Overall Study|Adverse Event|5|||
163245879|NCT01827904|589605589|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
163245880|NCT01827904|589605590|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
163410241|NCT00844753|590211324|FG000|Overall Study|Lost to Follow-up|1|||
163410242|NCT00844753|590211325|FG001|Overall Study|Lost to Follow-up|1|||
163410243|NCT00844753|590211326|FG002|Overall Study|Lost to Follow-up|0|||
163410244|NCT00844753|590211327|FG003|Overall Study|Lost to Follow-up|1|||
163245881|NCT01827904|589605591|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
163245882|NCT01827904|589605589|FG000|Long-term Annual Follow-up|Physician Decision|1|||
163245883|NCT01827904|589605590|FG001|Long-term Annual Follow-up|Physician Decision|0|||
163245884|NCT01827904|589605591|FG002|Long-term Annual Follow-up|Physician Decision|0|||
163245885|NCT01827904|589605589|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
163245886|NCT01827904|589605590|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
163245887|NCT01827904|589605591|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
163245888|NCT01827904|589605589|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
163245889|NCT01827904|589605590|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
163245890|NCT01827904|589605591|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
163245891|NCT01910519|589605592|FG000|Overall Study|Withdrawal by Subject|2|||
163245892|NCT01910519|589605593|FG001|Overall Study|Withdrawal by Subject|0|||
163245893|NCT01910519|589605592|FG000|Overall Study|Adverse Event|2|||
163245894|NCT01910519|589605593|FG001|Overall Study|Adverse Event|0|||
163245895|NCT04266028|589605594|FG000|Overall Study|Adverse Event|0|||
163245896|NCT04266028|589605595|FG001|Overall Study|Adverse Event|0|||
163245897|NCT04266028|589605596|FG002|Overall Study|Adverse Event|1|||
163245898|NCT04266028|589605597|FG003|Overall Study|Adverse Event|0|||
163245899|NCT04266028|589605598|FG004|Overall Study|Adverse Event|1|||
163245900|NCT04266028|589605599|FG005|Overall Study|Adverse Event|0|||
163245901|NCT04266028|589605600|FG006|Overall Study|Adverse Event|2|||
163245902|NCT04266028|589605601|FG007|Overall Study|Adverse Event|0|||
163245903|NCT04266028|589605594|FG000|Overall Study|temporary halt of the study|0|||
163245904|NCT04266028|589605595|FG001|Overall Study|temporary halt of the study|0|||
163245905|NCT04266028|589605596|FG002|Overall Study|temporary halt of the study|0|||
163245906|NCT04266028|589605597|FG003|Overall Study|temporary halt of the study|0|||
163245907|NCT04266028|589605598|FG004|Overall Study|temporary halt of the study|0|||
163245908|NCT04266028|589605599|FG005|Overall Study|temporary halt of the study|0|||
163245909|NCT04266028|589605600|FG006|Overall Study|temporary halt of the study|2|||
163245910|NCT04266028|589605601|FG007|Overall Study|temporary halt of the study|1|||
163245911|NCT04266028|589605594|FG000|Overall Study|Onset of birch pollen season|0|||
163245912|NCT04266028|589605595|FG001|Overall Study|Onset of birch pollen season|0|||
163245913|NCT04266028|589605596|FG002|Overall Study|Onset of birch pollen season|0|||
163245914|NCT04266028|589605597|FG003|Overall Study|Onset of birch pollen season|0|||
163245915|NCT04266028|589605598|FG004|Overall Study|Onset of birch pollen season|1|||
163245916|NCT04266028|589605599|FG005|Overall Study|Onset of birch pollen season|0|||
163245917|NCT04266028|589605600|FG006|Overall Study|Onset of birch pollen season|0|||
163245918|NCT04266028|589605601|FG007|Overall Study|Onset of birch pollen season|0|||
163245919|NCT01458574|589605602|FG000|Overall Study|Adverse Event|5|||
163245920|NCT01458574|589605603|FG001|Overall Study|Adverse Event|9|||
163245921|NCT01458574|589605604|FG002|Overall Study|Adverse Event|7|||
163245922|NCT01458574|589605602|FG000|Overall Study|Lack of Efficacy|70|||
163245923|NCT01458574|589605603|FG001|Overall Study|Lack of Efficacy|53|||
163245924|NCT01458574|589605604|FG002|Overall Study|Lack of Efficacy|132|||
163245925|NCT01458574|589605602|FG000|Overall Study|Lost to Follow-up|3|||
163245926|NCT01458574|589605603|FG001|Overall Study|Lost to Follow-up|2|||
163245927|NCT01458574|589605604|FG002|Overall Study|Lost to Follow-up|1|||
163245928|NCT01458574|589605602|FG000|Overall Study|Pregnancy|1|||
163245929|NCT01458574|589605603|FG001|Overall Study|Pregnancy|1|||
163245930|NCT01458574|589605604|FG002|Overall Study|Pregnancy|0|||
163245931|NCT01458574|589605602|FG000|Overall Study|Protocol Violation|0|||
163245932|NCT01458574|589605603|FG001|Overall Study|Protocol Violation|1|||
163245933|NCT01458574|589605604|FG002|Overall Study|Protocol Violation|0|||
163245934|NCT01458574|589605602|FG000|Overall Study|Withdrawal by Subject|6|||
163245935|NCT01458574|589605603|FG001|Overall Study|Withdrawal by Subject|3|||
163245936|NCT01458574|589605604|FG002|Overall Study|Withdrawal by Subject|5|||
163245937|NCT01458574|589605602|FG000|Overall Study|Other|2|||
163245938|NCT01458574|589605603|FG001|Overall Study|Other|1|||
163245939|NCT01458574|589605604|FG002|Overall Study|Other|0|||
163245940|NCT01458574|589605602|FG000|Overall Study|Randomized but not treated|0|||
163245941|NCT01458574|589605603|FG001|Overall Study|Randomized but not treated|1|||
163245942|NCT01458574|589605604|FG002|Overall Study|Randomized but not treated|0|||
163245943|NCT02125786|589605605|FG000|Overall Study|Still in Follow-up|3|||
163245944|NCT02125786|589605605|FG000|Overall Study|Screen Failure|2|||
163245945|NCT02125786|589605605|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
163245946|NCT02125786|589605605|FG000|Overall Study|Progressive Disease|44|||
163245947|NCT02125786|589605605|FG000|Overall Study|Death|8|||
163245948|NCT02663128|589605606|FG000|Period 2|Physician Decision|0|||
163245949|NCT02663128|589605607|FG001|Period 2|Physician Decision|0|||
163245950|NCT02663128|589605608|FG002|Period 2|Physician Decision|0|||
163245951|NCT02663128|589605609|FG003|Period 2|Physician Decision|0|||
163245952|NCT02663128|589605610|FG004|Period 2|Physician Decision|1|||
163245953|NCT02663128|589605611|FG005|Period 2|Physician Decision|0|||
163353709|NCT01999972|590006137|FG003|Dose Escalation Part|Disease progression|6|||
163353710|NCT01999972|590006138|FG004|Dose Escalation Part|Disease progression|0|||
163353711|NCT01999972|590006139|FG005|Dose Escalation Part|Disease progression|0|||
163353712|NCT01999972|590006134|FG000|Dose Escalation Part|Adverse Event|0|||
163353713|NCT01999972|590006135|FG001|Dose Escalation Part|Adverse Event|0|||
163353714|NCT01999972|590006136|FG002|Dose Escalation Part|Adverse Event|0|||
163353715|NCT01999972|590006137|FG003|Dose Escalation Part|Adverse Event|2|||
163353716|NCT01999972|590006138|FG004|Dose Escalation Part|Adverse Event|0|||
163353717|NCT01999972|590006139|FG005|Dose Escalation Part|Adverse Event|0|||
163353718|NCT01999972|590006134|FG000|Dose Escalation Part|Global deterioration of health status|1|||
163353719|NCT01999972|590006135|FG001|Dose Escalation Part|Global deterioration of health status|0|||
163353720|NCT01999972|590006136|FG002|Dose Escalation Part|Global deterioration of health status|0|||
163353721|NCT01999972|590006137|FG003|Dose Escalation Part|Global deterioration of health status|1|||
163353722|NCT01999972|590006138|FG004|Dose Escalation Part|Global deterioration of health status|0|||
163353723|NCT01999972|590006139|FG005|Dose Escalation Part|Global deterioration of health status|0|||
163353724|NCT01999972|590006134|FG000|Dose Expansion Part|Death|0|||
163353725|NCT01999972|590006135|FG001|Dose Expansion Part|Death|0|||
163353726|NCT01999972|590006136|FG002|Dose Expansion Part|Death|0|||
163353727|NCT01999972|590006137|FG003|Dose Expansion Part|Death|0|||
163353728|NCT01999972|590006138|FG004|Dose Expansion Part|Death|2|||
163353729|NCT01999972|590006139|FG005|Dose Expansion Part|Death|1|||
163353730|NCT01999972|590006134|FG000|Dose Expansion Part|Disease progression|0|||
163353731|NCT01999972|590006135|FG001|Dose Expansion Part|Disease progression|0|||
163353732|NCT01999972|590006136|FG002|Dose Expansion Part|Disease progression|0|||
163353733|NCT01999972|590006137|FG003|Dose Expansion Part|Disease progression|0|||
163353734|NCT01999972|590006138|FG004|Dose Expansion Part|Disease progression|9|||
163353735|NCT01999972|590006139|FG005|Dose Expansion Part|Disease progression|3|||
163353736|NCT01999972|590006134|FG000|Dose Expansion Part|Sponsor decision|0|||
163353737|NCT01999972|590006135|FG001|Dose Expansion Part|Sponsor decision|0|||
163353738|NCT01999972|590006136|FG002|Dose Expansion Part|Sponsor decision|0|||
163353739|NCT01999972|590006137|FG003|Dose Expansion Part|Sponsor decision|0|||
163353740|NCT01999972|590006138|FG004|Dose Expansion Part|Sponsor decision|1|||
163353741|NCT01999972|590006139|FG005|Dose Expansion Part|Sponsor decision|0|||
163353742|NCT01999972|590006134|FG000|Dose Expansion Part|Adverse Event|0|||
163353743|NCT01999972|590006135|FG001|Dose Expansion Part|Adverse Event|0|||
163353744|NCT01999972|590006136|FG002|Dose Expansion Part|Adverse Event|0|||
163353745|NCT01999972|590006137|FG003|Dose Expansion Part|Adverse Event|0|||
163353746|NCT01999972|590006138|FG004|Dose Expansion Part|Adverse Event|4|||
163353747|NCT01999972|590006139|FG005|Dose Expansion Part|Adverse Event|2|||
163353748|NCT01999972|590006134|FG000|Dose Expansion Part|Participant's non-compliance|0|||
163353749|NCT01999972|590006135|FG001|Dose Expansion Part|Participant's non-compliance|0|||
163353750|NCT01999972|590006136|FG002|Dose Expansion Part|Participant's non-compliance|0|||
163353751|NCT01999972|590006137|FG003|Dose Expansion Part|Participant's non-compliance|0|||
163353752|NCT01999972|590006138|FG004|Dose Expansion Part|Participant's non-compliance|0|||
163353753|NCT01999972|590006139|FG005|Dose Expansion Part|Participant's non-compliance|1|||
163353754|NCT01999972|590006134|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
163353755|NCT01999972|590006135|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
163353756|NCT01999972|590006136|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
163353757|NCT01999972|590006137|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
163353758|NCT01999972|590006138|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
163353759|NCT01999972|590006139|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
163353760|NCT01999972|590006134|FG000|Dose Expansion Part|Changed to standard of care|0|||
163353761|NCT01999972|590006135|FG001|Dose Expansion Part|Changed to standard of care|0|||
163353762|NCT01999972|590006136|FG002|Dose Expansion Part|Changed to standard of care|0|||
163353763|NCT01999972|590006137|FG003|Dose Expansion Part|Changed to standard of care|0|||
163353764|NCT01999972|590006138|FG004|Dose Expansion Part|Changed to standard of care|1|||
163353765|NCT01999972|590006139|FG005|Dose Expansion Part|Changed to standard of care|0|||
163353766|NCT01171183|590006140|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
163353767|NCT01171183|590006141|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
163353768|NCT01171183|590006140|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
163353769|NCT01171183|590006141|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
163353770|NCT01171183|590006140|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
163353771|NCT01171183|590006141|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
163353772|NCT01171183|590006140|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
163353773|NCT01171183|590006141|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
163353774|NCT01171183|590006140|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
163353775|NCT01171183|590006141|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
163353776|NCT01171183|590006140|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
163353777|NCT01171183|590006141|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
163353778|NCT02826798|590006148|FG000|Overall Study|Withdrawal by Subject|0|||
163353779|NCT02826798|590006149|FG001|Overall Study|Withdrawal by Subject|1|||
163245954|NCT02720484|589605612|FG000|Treatment on Study|Adverse Event|1|||
163245955|NCT02720484|589605612|FG000|Treatment on Study|Withdrawal by Subject|1|||
163245956|NCT02720484|589605612|FG000|Treatment on Study|Progressive Disease|4|||
163245957|NCT02720484|589605612|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
163245958|NCT02720484|589605612|FG000|Follow Up for 2 Years|Death|3|||
163245959|NCT02720484|589605612|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
163245960|NCT05070897|589605613|FG000|Overall Study|Protocol Violation|123|||
163245961|NCT05070897|589605614|FG001|Overall Study|Protocol Violation|68|||
163245962|NCT03832946|589605617|FG000|Overall Study|Adverse Event|3|||
163245963|NCT03832946|589605618|FG001|Overall Study|Adverse Event|1|||
163245964|NCT03832946|589605617|FG000|Overall Study|Lost to Follow-up|1|||
163245965|NCT03832946|589605618|FG001|Overall Study|Lost to Follow-up|0|||
163245966|NCT03832946|589605617|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
163245967|NCT03832946|589605618|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
163245968|NCT03832946|589605617|FG000|Overall Study|Lack of Efficacy|1|||
163245969|NCT03832946|589605618|FG001|Overall Study|Lack of Efficacy|0|||
163245970|NCT03832946|589605617|FG000|Overall Study|Withdrawal by Subject|12|||
163245971|NCT03832946|589605618|FG001|Overall Study|Withdrawal by Subject|9|||
163245972|NCT01003249|589605621|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163245973|NCT01003249|589605622|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163245974|NCT01003249|589605621|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
163245975|NCT01003249|589605622|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
163245976|NCT01003249|589605621|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
163245977|NCT01003249|589605622|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
163245978|NCT01003249|589605621|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
163245979|NCT01003249|589605622|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
163245980|NCT03394924|589605623|FG000|Overall Study|Adverse Event|0|||
163245981|NCT03394924|589605624|FG001|Overall Study|Adverse Event|5|||
163245982|NCT03394924|589605625|FG002|Overall Study|Adverse Event|0|||
163245983|NCT03394924|589605623|FG000|Overall Study|Withdrawal by Subject|2|||
163245984|NCT03394924|589605624|FG001|Overall Study|Withdrawal by Subject|0|||
163245985|NCT03394924|589605625|FG002|Overall Study|Withdrawal by Subject|0|||
163245986|NCT03394924|589605623|FG000|Overall Study|Lost to Follow-up|0|||
163245987|NCT03394924|589605624|FG001|Overall Study|Lost to Follow-up|1|||
163245988|NCT03394924|589605625|FG002|Overall Study|Lost to Follow-up|0|||
163245989|NCT03394924|589605623|FG000|Overall Study|Did not meet all inclusion criteria|1|||
163245990|NCT03394924|589605624|FG001|Overall Study|Did not meet all inclusion criteria|0|||
163245991|NCT03394924|589605625|FG002|Overall Study|Did not meet all inclusion criteria|0|||
163245992|NCT00110617|589605626|FG000|Overall Study|Adverse Event|2|||
163245993|NCT00110617|589605627|FG001|Overall Study|Adverse Event|4|||
163245994|NCT00110617|589605626|FG000|Overall Study|Abnormal Laboratory Value|4|||
163245995|NCT00110617|589605627|FG001|Overall Study|Abnormal Laboratory Value|2|||
163245996|NCT00110617|589605626|FG000|Overall Study|Lack of Efficacy|1|||
163245997|NCT00110617|589605627|FG001|Overall Study|Lack of Efficacy|0|||
163245998|NCT00110617|589605626|FG000|Overall Study|Patient no longer requires study drug|1|||
163245999|NCT00110617|589605627|FG001|Overall Study|Patient no longer requires study drug|0|||
163246000|NCT00110617|589605626|FG000|Overall Study|Protocol Violation|5|||
163246001|NCT00110617|589605627|FG001|Overall Study|Protocol Violation|0|||
163246002|NCT00110617|589605626|FG000|Overall Study|Withdrawal by Subject|10|||
163246003|NCT00110617|589605627|FG001|Overall Study|Withdrawal by Subject|4|||
163246004|NCT00110617|589605626|FG000|Overall Study|Lost to Follow-up|9|||
163246005|NCT00110617|589605627|FG001|Overall Study|Lost to Follow-up|1|||
163246006|NCT00110617|589605626|FG000|Overall Study|Administrative problems|6|||
163246007|NCT00110617|589605627|FG001|Overall Study|Administrative problems|5|||
163246008|NCT00110617|589605626|FG000|Overall Study|Death|1|||
163246009|NCT00110617|589605627|FG001|Overall Study|Death|1|||
163246010|NCT00110617|589605626|FG000|Overall Study|Did not receive study drug|0|||
163246011|NCT00110617|589605627|FG001|Overall Study|Did not receive study drug|12|||
163353780|NCT02826798|590006150|FG002|Overall Study|Withdrawal by Subject|0|||
163353781|NCT02826798|590006151|FG003|Overall Study|Withdrawal by Subject|1|||
163353782|NCT02826798|590006152|FG004|Overall Study|Withdrawal by Subject|0|||
163353783|NCT02806505|590006154|FG000|Overall Study|Adverse event/intercurrent illness|1|||
163246012|NCT01949311|589608350|FG000|Overall Study|Lost to Follow-up|73|||
163246013|NCT01949311|589608350|FG000|Overall Study|Terminated by Sponsor|708|||
163246014|NCT01949311|589608350|FG000|Overall Study|Withdrawal by Subject|375|||
163246015|NCT01949311|589608350|FG000|Overall Study|Lack of Efficacy|50|||
163246016|NCT01949311|589608350|FG000|Overall Study|Protocol Deviation|34|||
163246017|NCT01949311|589608350|FG000|Overall Study|Pregnancy|20|||
163353784|NCT02806505|590006155|FG001|Overall Study|Adverse event/intercurrent illness|3|||
163353785|NCT02806505|590006154|FG000|Overall Study|Death|4|||
163353786|NCT02806505|590006155|FG001|Overall Study|Death|0|||
163246018|NCT01949311|589608350|FG000|Overall Study|Physician Decision|9|||
163246019|NCT01949311|589608350|FG000|Overall Study|Other|4|||
163246020|NCT01949311|589608350|FG000|Overall Study|Adverse Event|107|||
163353787|NCT02806505|590006154|FG000|Overall Study|Did not cooperate/refused treatment|3|||
163353788|NCT02806505|590006155|FG001|Overall Study|Did not cooperate/refused treatment|3|||
163410245|NCT00844753|590211324|FG000|Overall Study|could not swallow medication|2|||
163410246|NCT00844753|590211325|FG001|Overall Study|could not swallow medication|0|||
163410247|NCT00844753|590211326|FG002|Overall Study|could not swallow medication|0|||
163246021|NCT00951041|589608355|FG000|Overall Study|Withdrawal by Subject|1|||
163246022|NCT00951041|589608356|FG001|Overall Study|Withdrawal by Subject|1|||
163246023|NCT00951041|589608355|FG000|Overall Study|Lost to Follow-up|1|||
163246024|NCT00951041|589608356|FG001|Overall Study|Lost to Follow-up|0|||
163246025|NCT00951041|589608355|FG000|Overall Study|Other|3|||
163246026|NCT00951041|589608356|FG001|Overall Study|Other|0|||
163246027|NCT02388724|589608357|FG000|Overall Study|Reason not Specified|0|||
163246028|NCT02388724|589608358|FG001|Overall Study|Reason not Specified|1|||
163246029|NCT02388724|589608357|FG000|Overall Study|Major Protocol Deviation|3|||
163246030|NCT02388724|589608358|FG001|Overall Study|Major Protocol Deviation|3|||
163246031|NCT02388724|589608357|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
163246032|NCT02388724|589608358|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
163246033|NCT02388724|589608357|FG000|Overall Study|Voluntary Withdrawal|6|||
163246034|NCT02388724|589608358|FG001|Overall Study|Voluntary Withdrawal|5|||
163246035|NCT02388724|589608357|FG000|Overall Study|Randomized but not Treated|0|||
163246036|NCT02388724|589608358|FG001|Overall Study|Randomized but not Treated|2|||
163246037|NCT01925950|589608359|FG000|Part 2|Withdrawal by Subject|1|||
163246038|NCT01925950|589608360|FG001|Part 2|Withdrawal by Subject|0|||
163246039|NCT02047045|589608364|FG000|Baseline|Withdrawal by Subject|3|||
163246040|NCT02047045|589608365|FG001|Baseline|Withdrawal by Subject|2|||
163246041|NCT02047045|589608364|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
163246042|NCT02047045|589608365|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
163246043|NCT02047045|589608364|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
163246044|NCT02047045|589608365|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
163246045|NCT02047045|589608364|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
163246046|NCT02047045|589608365|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
163246047|NCT02047045|589608364|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
163246048|NCT02047045|589608365|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
163246049|NCT02047045|589608364|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
163246050|NCT02047045|589608365|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
163246051|NCT02047045|589608364|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
163246052|NCT02047045|589608365|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
163246053|NCT02047045|589608364|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
163246054|NCT02047045|589608365|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
163246055|NCT02047045|589608364|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
163246056|NCT02047045|589608365|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
163246057|NCT04066114|589608366|FG000|Overall Study|Adverse Event|1|||
163246058|NCT04066114|589608367|FG001|Overall Study|Adverse Event|0|||
163246059|NCT04066114|589608368|FG002|Overall Study|Adverse Event|0|||
163246060|NCT04066114|589608366|FG000|Overall Study|Withdrawal by Subject|1|||
163246061|NCT04066114|589608367|FG001|Overall Study|Withdrawal by Subject|0|||
163246062|NCT04066114|589608368|FG002|Overall Study|Withdrawal by Subject|0|||
163246063|NCT04066114|589608366|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
163246064|NCT04066114|589608367|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
163246065|NCT04066114|589608368|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
163246066|NCT02277106|589608369|FG000|Stage 2|Adverse Event|0|||
163246067|NCT02277106|589608370|FG001|Stage 2|Adverse Event|0|||
163246068|NCT02277106|589608371|FG002|Stage 2|Adverse Event|1|||
163246069|NCT01064739|589608372|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
163246070|NCT02479412|589608373|FG000|Overall Study|Adverse Event|0|||
163246071|NCT02479412|589608374|FG001|Overall Study|Adverse Event|0|||
163246072|NCT02479412|589608375|FG002|Overall Study|Adverse Event|1|||
163246073|NCT02479412|589608376|FG003|Overall Study|Adverse Event|0|||
163246074|NCT02479412|589608377|FG004|Overall Study|Adverse Event|0|||
163246075|NCT02479412|589608378|FG005|Overall Study|Adverse Event|0|||
163246076|NCT02479412|589608379|FG006|Overall Study|Adverse Event|0|||
163246077|NCT02479412|589608380|FG007|Overall Study|Adverse Event|0|||
163246078|NCT02479412|589608381|FG008|Overall Study|Adverse Event|0|||
163246079|NCT02479412|589608373|FG000|Overall Study|Study-specific withdrawal criteria|0|||
163246080|NCT02479412|589608374|FG001|Overall Study|Study-specific withdrawal criteria|0|||
163246081|NCT02479412|589608375|FG002|Overall Study|Study-specific withdrawal criteria|1|||
163246082|NCT02479412|589608376|FG003|Overall Study|Study-specific withdrawal criteria|1|||
163246083|NCT02479412|589608377|FG004|Overall Study|Study-specific withdrawal criteria|0|||
163246084|NCT02479412|589608378|FG005|Overall Study|Study-specific withdrawal criteria|0|||
163246085|NCT02479412|589608379|FG006|Overall Study|Study-specific withdrawal criteria|0|||
163246086|NCT02479412|589608380|FG007|Overall Study|Study-specific withdrawal criteria|1|||
163246087|NCT02479412|589608381|FG008|Overall Study|Study-specific withdrawal criteria|1|||
163246088|NCT02479412|589608373|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
163246089|NCT02479412|589608374|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
163246090|NCT02479412|589608375|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
163246091|NCT02479412|589608376|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
163246092|NCT02479412|589608377|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
163246093|NCT02479412|589608378|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
163246094|NCT02479412|589608379|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
163246095|NCT02479412|589608380|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
163246096|NCT02479412|589608381|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
163246097|NCT00454051|589608382|FG000|Overall Study|Adverse Event|1|||
163246098|NCT00454051|589608383|FG001|Overall Study|Adverse Event|2|||
163246099|NCT00454051|589608382|FG000|Overall Study|Withdrawal by Subject|1|||
163246100|NCT00454051|589608383|FG001|Overall Study|Withdrawal by Subject|0|||
163246101|NCT00454051|589608382|FG000|Overall Study|Protocol Violation|1|||
163246102|NCT00454051|589608383|FG001|Overall Study|Protocol Violation|1|||
163246103|NCT01571362|589608384|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
163246104|NCT01571362|589608385|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
163246105|NCT01571362|589608386|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
163246106|NCT01571362|589608384|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
163246107|NCT01571362|589608385|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
163246108|NCT01571362|589608386|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
163246109|NCT01571362|589608384|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
163246110|NCT01571362|589608385|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
163246111|NCT01571362|589608386|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
163246112|NCT01571362|589608384|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
163246113|NCT01571362|589608385|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
163246114|NCT01571362|589608386|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
163246115|NCT01571362|589608384|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
163246116|NCT01571362|589608385|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
163246117|NCT01571362|589608386|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
163246118|NCT01571362|589608384|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
163246119|NCT01571362|589608385|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
163246120|NCT01571362|589608386|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
163246121|NCT01571362|589608384|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163246122|NCT01571362|589608385|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
163246123|NCT01571362|589608386|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
163246124|NCT01571362|589608384|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
163246125|NCT01571362|589608385|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
163246126|NCT01571362|589608386|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
163246127|NCT01571362|589608384|FG000|Double-Blind Treatment Period|Adverse Event|0|||
163246128|NCT01571362|589608385|FG001|Double-Blind Treatment Period|Adverse Event|9|||
163246129|NCT01571362|589608386|FG002|Double-Blind Treatment Period|Adverse Event|14|||
163246130|NCT01571362|589608384|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163246131|NCT01571362|589608385|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
163246132|NCT01571362|589608386|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
163246133|NCT01571362|589608384|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
163246134|NCT01571362|589608385|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
163246135|NCT01571362|589608386|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
163246136|NCT01571362|589608384|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
163246137|NCT01571362|589608385|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
163246138|NCT01571362|589608386|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
163246139|NCT04258020|589608387|FG000|Overall Study|Withdrawal by Subject|1|||
163246140|NCT04258020|589608388|FG001|Overall Study|Withdrawal by Subject|0|||
163246141|NCT02097472|589608391|FG000|Received Vaccination 2|Adverse Event|0|||
163246142|NCT02097472|589608392|FG001|Received Vaccination 2|Adverse Event|0|||
163246143|NCT02097472|589608393|FG002|Received Vaccination 2|Adverse Event|0|||
163246144|NCT02097472|589608394|FG003|Received Vaccination 2|Adverse Event|0|||
163246145|NCT02097472|589608395|FG004|Received Vaccination 2|Adverse Event|0|||
163246146|NCT02097472|589608396|FG005|Received Vaccination 2|Adverse Event|0|||
163246147|NCT02097472|589608397|FG006|Received Vaccination 2|Adverse Event|1|||
163353789|NCT02806505|590006154|FG000|Overall Study|Failure to return|0|||
163353790|NCT02806505|590006155|FG001|Overall Study|Failure to return|1|||
163246148|NCT02097472|589608398|FG007|Received Vaccination 2|Adverse Event|0|||
163246149|NCT01669629|589608399|FG000|Period 1|protocol deviation|1|||
163246150|NCT01669629|589608400|FG001|Period 1|protocol deviation|2|||
163246151|NCT04402866|589608403|FG000|Overall Study|Discontinued Prior to Treatment|0|||
163246152|NCT04402866|589608404|FG001|Overall Study|Discontinued Prior to Treatment|0|||
163246153|NCT04402866|589608405|FG002|Overall Study|Discontinued Prior to Treatment|0|||
163246154|NCT04402866|589608406|FG003|Overall Study|Discontinued Prior to Treatment|0|||
163353791|NCT02806505|590006154|FG000|Overall Study|Insufficient therapeutic response|2|||
163353792|NCT02806505|590006155|FG001|Overall Study|Insufficient therapeutic response|4|||
163353793|NCT03440047|590006157|FG000|Overall Study|Withdrawal by Subject|2|||
163353794|NCT01722045|590006158|FG000|Overall Study|Adverse Event|8|||
163353795|NCT01722045|590006158|FG000|Overall Study|Death|3|||
163353796|NCT01722045|590006158|FG000|Overall Study|Withdrawal by Subject|8|||
163353797|NCT01722045|590006158|FG000|Overall Study|Lost to Follow-up|4|||
163353798|NCT01722045|590006158|FG000|Overall Study|Protocol Deviation|1|||
163353799|NCT01722045|590006158|FG000|Overall Study|Physician Decision|3|||
163353800|NCT01722045|590006158|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
163353801|NCT03898700|590006160|FG000|Overall Study|Withdrawal by Subject|2|||
163353802|NCT00701909|590006164|FG000|Overall Study|Withdrawal by Subject|0|||
163353803|NCT00701909|590006165|FG001|Overall Study|Withdrawal by Subject|1|||
163353804|NCT00971997|590006168|FG000|Overall Study|Adverse Event|2|||
163353805|NCT00971997|590006168|FG000|Overall Study|Death|1|||
163353806|NCT00971997|590006168|FG000|Overall Study|Protocol Violation|4|||
163353807|NCT00971997|590006168|FG000|Overall Study|Withdrawal by Subject|5|||
163353808|NCT00971997|590006168|FG000|Overall Study|Physician Decision|7|||
163353809|NCT04843579|590006172|FG000|Overall Study|Adverse Event|1|||
163353810|NCT04843579|590006172|FG000|Overall Study|Disease Progression|1|||
163353811|NCT04009629|590006173|FG000|Overall Study|Withdrawal by Subject|2|||
163353812|NCT04009629|590006174|FG001|Overall Study|Withdrawal by Subject|0|||
163353813|NCT00761956|590006179|FG000|Overall Study|Lost to Follow-up|6|||
163353814|NCT00761956|590006180|FG001|Overall Study|Lost to Follow-up|11|||
163353815|NCT00761956|590006179|FG000|Overall Study|Withdrawal by Subject|3|||
163353816|NCT00761956|590006180|FG001|Overall Study|Withdrawal by Subject|8|||
163353817|NCT00761956|590006179|FG000|Overall Study|Death|0|||
163353818|NCT00761956|590006180|FG001|Overall Study|Death|1|||
163353819|NCT00761956|590006179|FG000|Overall Study|Adverse Event|26|||
163353820|NCT00761956|590006180|FG001|Overall Study|Adverse Event|34|||
163353821|NCT04398368|590006183|FG000|Overall Study|Withdrawal by Subject|2|||
163353822|NCT03602586|590006184|FG000|Overall Study|Withdrawal by Subject|3|||
163353823|NCT01755546|590006187|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
163353824|NCT01755546|590006187|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
163353825|NCT01755546|590006187|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
163353826|NCT01755546|590006187|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
163353827|NCT01755546|590006187|FG000|Titration Phase|Adverse Event|11|||
163353828|NCT01755546|590006187|FG000|Titration Phase|Lack of Efficacy|18|||
163353829|NCT01755546|590006187|FG000|Titration Phase|Protocol Violation|9|||
163353830|NCT01755546|590006187|FG000|Titration Phase|Lost to Follow-up|2|||
163353831|NCT01755546|590006187|FG000|Titration Phase|Other and Continuing|22|||
163353832|NCT01755546|590006187|FG000|Titration Phase|Withdrawal by Subject|8|||
163353833|NCT01755546|590006187|FG000|Long Term Treatment|Adverse Event|12|||
163353834|NCT01755546|590006187|FG000|Long Term Treatment|Lack of Efficacy|6|||
163353835|NCT01755546|590006187|FG000|Long Term Treatment|Protocol Violation|10|||
163353836|NCT01755546|590006187|FG000|Long Term Treatment|Withdrawal by Subject|35|||
163353837|NCT01755546|590006187|FG000|Long Term Treatment|Lost to Follow-up|17|||
163353838|NCT01755546|590006187|FG000|Long Term Treatment|other and ongoing|41|||
163353839|NCT04702893|590006188|FG000|Overall Study|Other reasons than listed|11|||
163353840|NCT04702893|590006188|FG000|Overall Study|Withdrawal by Subject|3|||
163353841|NCT04702893|590006188|FG000|Overall Study|Lost to Follow-up|7|||
163353842|NCT04702893|590006188|FG000|Overall Study|Death|10|||
163353843|NCT04702893|590006188|FG000|Overall Study|Not treated|6|||
163353844|NCT03294941|590006189|FG000|Overall Study|Withdrawal by Subject|0|||
163353845|NCT03294941|590006190|FG001|Overall Study|Withdrawal by Subject|2|||
163353846|NCT04629443|590006191|FG000|Overall Study|Adverse Event|2|||
163353847|NCT04629443|590006192|FG001|Overall Study|Adverse Event|1|||
163353848|NCT04629443|590006193|FG002|Overall Study|Adverse Event|2|||
163353849|NCT04629443|590006191|FG000|Overall Study|Progressive Disease|2|||
163353850|NCT04629443|590006192|FG001|Overall Study|Progressive Disease|3|||
163353851|NCT04629443|590006193|FG002|Overall Study|Progressive Disease|3|||
163353852|NCT04629443|590006191|FG000|Overall Study|Physician Decision|1|||
163353853|NCT04629443|590006192|FG001|Overall Study|Physician Decision|3|||
163353854|NCT04629443|590006193|FG002|Overall Study|Physician Decision|0|||
163353855|NCT01172639|590006199|FG000|Overall Study|Death|1|||
163353856|NCT01172639|590006200|FG001|Overall Study|Death|1|||
163353857|NCT01172639|590006201|FG002|Overall Study|Death|0|||
163353858|NCT01172639|590006202|FG003|Overall Study|Death|0|||
163353859|NCT01172639|590006203|FG004|Overall Study|Death|0|||
163353860|NCT01172639|590006199|FG000|Overall Study|Lost to Follow-up|9|||
163353861|NCT01172639|590006200|FG001|Overall Study|Lost to Follow-up|7|||
163353862|NCT01172639|590006201|FG002|Overall Study|Lost to Follow-up|11|||
163353863|NCT01172639|590006202|FG003|Overall Study|Lost to Follow-up|6|||
163353864|NCT01172639|590006203|FG004|Overall Study|Lost to Follow-up|6|||
163353865|NCT01172639|590006199|FG000|Overall Study|Withdrawal by Subject|3|||
163353866|NCT01172639|590006200|FG001|Overall Study|Withdrawal by Subject|3|||
163353867|NCT01172639|590006201|FG002|Overall Study|Withdrawal by Subject|5|||
163353868|NCT01172639|590006202|FG003|Overall Study|Withdrawal by Subject|5|||
163353869|NCT01172639|590006203|FG004|Overall Study|Withdrawal by Subject|0|||
163353870|NCT01316887|590006204|FG000|Overall Study|Adverse Event|13|||
163353871|NCT01316887|590006205|FG001|Overall Study|Adverse Event|21|||
163353872|NCT01316887|590006206|FG002|Overall Study|Adverse Event|17|||
163353873|NCT01316887|590006204|FG000|Overall Study|Lack of Efficacy|9|||
163353874|NCT01316887|590006205|FG001|Overall Study|Lack of Efficacy|3|||
163353875|NCT01316887|590006206|FG002|Overall Study|Lack of Efficacy|1|||
163353876|NCT01316887|590006204|FG000|Overall Study|Protocol Violation|2|||
163353877|NCT01316887|590006205|FG001|Overall Study|Protocol Violation|6|||
163353878|NCT01316887|590006206|FG002|Overall Study|Protocol Violation|6|||
163353879|NCT01316887|590006204|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
163353880|NCT01316887|590006205|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
163353881|NCT01316887|590006206|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
163353882|NCT01316887|590006204|FG000|Overall Study|Study Closed/Terminated|2|||
163353883|NCT01316887|590006205|FG001|Overall Study|Study Closed/Terminated|4|||
163353884|NCT01316887|590006206|FG002|Overall Study|Study Closed/Terminated|3|||
163353885|NCT01316887|590006204|FG000|Overall Study|Lost to Follow-up|1|||
163353886|NCT01316887|590006205|FG001|Overall Study|Lost to Follow-up|7|||
163353887|NCT01316887|590006206|FG002|Overall Study|Lost to Follow-up|5|||
163246155|NCT04402866|589608407|FG004|Overall Study|Discontinued Prior to Treatment|2|||
163246156|NCT04402866|589608408|FG005|Overall Study|Discontinued Prior to Treatment|3|||
163246157|NCT04402866|589608403|FG000|Overall Study|Adverse Event|2|||
163246158|NCT04402866|589608404|FG001|Overall Study|Adverse Event|1|||
163246159|NCT04402866|589608405|FG002|Overall Study|Adverse Event|0|||
163246160|NCT04402866|589608406|FG003|Overall Study|Adverse Event|0|||
163246161|NCT04402866|589608407|FG004|Overall Study|Adverse Event|13|||
163246162|NCT04402866|589608408|FG005|Overall Study|Adverse Event|8|||
163246163|NCT04402866|589608403|FG000|Overall Study|Miscellaneous|0|||
163246164|NCT04402866|589608404|FG001|Overall Study|Miscellaneous|0|||
163246165|NCT04402866|589608405|FG002|Overall Study|Miscellaneous|1|||
163246166|NCT04402866|589608406|FG003|Overall Study|Miscellaneous|0|||
163246167|NCT04402866|589608407|FG004|Overall Study|Miscellaneous|0|||
163246168|NCT04402866|589608408|FG005|Overall Study|Miscellaneous|0|||
163246169|NCT04402866|589608403|FG000|Overall Study|Lost to Follow-up|0|||
163246170|NCT04402866|589608404|FG001|Overall Study|Lost to Follow-up|0|||
163246171|NCT04402866|589608405|FG002|Overall Study|Lost to Follow-up|0|||
163246172|NCT04402866|589608406|FG003|Overall Study|Lost to Follow-up|0|||
163246173|NCT04402866|589608407|FG004|Overall Study|Lost to Follow-up|0|||
163246174|NCT04402866|589608408|FG005|Overall Study|Lost to Follow-up|1|||
163246175|NCT04402866|589608403|FG000|Overall Study|Withdrawal by Subject|0|||
163246176|NCT04402866|589608404|FG001|Overall Study|Withdrawal by Subject|0|||
163246177|NCT04402866|589608405|FG002|Overall Study|Withdrawal by Subject|0|||
163246178|NCT04402866|589608406|FG003|Overall Study|Withdrawal by Subject|0|||
163246179|NCT04402866|589608407|FG004|Overall Study|Withdrawal by Subject|0|||
163246180|NCT04402866|589608408|FG005|Overall Study|Withdrawal by Subject|2|||
163246181|NCT03667053|589608409|FG000|Overall Study|Withdrawal by Subject|1|||
163246182|NCT03667053|589608410|FG001|Overall Study|Withdrawal by Subject|0|||
163246183|NCT03667053|589608411|FG002|Overall Study|Withdrawal by Subject|0|||
163246184|NCT01292928|589608413|FG000|Overall Study|Death|8|||
163246185|NCT01292928|589608413|FG000|Overall Study|Withdrawal by Subject|8|||
163246186|NCT01292928|589608413|FG000|Overall Study|Lost to Follow-up|6|||
163246187|NCT01292928|589608413|FG000|Overall Study|Physician Decision|2|||
163246188|NCT00130533|589608414|FG000|Overall Study|Withdrawal by Subject|33|||
163246189|NCT00130533|589608415|FG001|Overall Study|Withdrawal by Subject|6|||
163246190|NCT00130533|589608414|FG000|Overall Study|Adverse Event|34|||
163246191|NCT00130533|589608415|FG001|Overall Study|Adverse Event|1|||
163246192|NCT00130533|589608414|FG000|Overall Study|Disease relapse|9|||
163246193|NCT00130533|589608415|FG001|Overall Study|Disease relapse|13|||
163246194|NCT00130533|589608414|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
163246195|NCT00130533|589608415|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
163353888|NCT01316887|590006204|FG000|Overall Study|Withdrawal by Subject|8|||
163353889|NCT01316887|590006205|FG001|Overall Study|Withdrawal by Subject|16|||
163353890|NCT01316887|590006206|FG002|Overall Study|Withdrawal by Subject|15|||
163353891|NCT02172950|590006207|FG000|Overall Study|Physician Decision|3|||
163246196|NCT00130533|589608414|FG000|Overall Study|Death|4|||
163246197|NCT00130533|589608415|FG001|Overall Study|Death|2|||
163246198|NCT00130533|589608414|FG000|Overall Study|Protocol Violation|5|||
163246199|NCT00130533|589608415|FG001|Overall Study|Protocol Violation|1|||
163246200|NCT00130533|589608414|FG000|Overall Study|Lost to Follow-up|1|||
163353892|NCT02172950|590006208|FG001|Overall Study|Physician Decision|3|||
163353893|NCT02172950|590006207|FG000|Overall Study|Lack of Efficacy|1|||
163246201|NCT00130533|589608415|FG001|Overall Study|Lost to Follow-up|1|||
163246202|NCT00130533|589608414|FG000|Overall Study|Sponsor´s decision|2|||
163246203|NCT00130533|589608415|FG001|Overall Study|Sponsor´s decision|0|||
163353894|NCT02172950|590006208|FG001|Overall Study|Lack of Efficacy|0|||
163246204|NCT00130533|589608414|FG000|Overall Study|Second Primary Malignancy|0|||
163246205|NCT00130533|589608415|FG001|Overall Study|Second Primary Malignancy|1|||
163353895|NCT02172950|590006207|FG000|Overall Study|Adverse Event|4|||
163353896|NCT02172950|590006208|FG001|Overall Study|Adverse Event|1|||
163353897|NCT02172950|590006207|FG000|Overall Study|Withdrawal by Subject|10|||
163246206|NCT00130533|589608414|FG000|Overall Study|Other|12|||
163246207|NCT00130533|589608415|FG001|Overall Study|Other|5|||
163246208|NCT01059565|589608416|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
163353898|NCT02172950|590006208|FG001|Overall Study|Withdrawal by Subject|0|||
163353899|NCT02172950|590006207|FG000|Overall Study|Protocol Violation|1|||
163353900|NCT02172950|590006208|FG001|Overall Study|Protocol Violation|0|||
163353901|NCT02172950|590006207|FG000|Overall Study|Lost to Follow-up|1|||
163353902|NCT02172950|590006208|FG001|Overall Study|Lost to Follow-up|0|||
163353903|NCT02172950|590006207|FG000|Overall Study|Death|1|||
163353904|NCT02172950|590006208|FG001|Overall Study|Death|0|||
163353905|NCT02172950|590006207|FG000|Overall Study|Patient traveling|1|||
163353906|NCT02172950|590006208|FG001|Overall Study|Patient traveling|0|||
163353907|NCT02172950|590006207|FG000|Overall Study|Patient went to other country|1|||
163353908|NCT02172950|590006208|FG001|Overall Study|Patient went to other country|0|||
163353909|NCT02172950|590006207|FG000|Overall Study|Patient relocated overseas|1|||
163353910|NCT02172950|590006208|FG001|Overall Study|Patient relocated overseas|1|||
163353911|NCT02172950|590006207|FG000|Overall Study|Patient moving|1|||
163353912|NCT02172950|590006208|FG001|Overall Study|Patient moving|0|||
163353913|NCT00469456|590006209|FG000|Overall Study|Adverse Event|4|||
163353914|NCT00469456|590006210|FG001|Overall Study|Adverse Event|3|||
163353915|NCT00469456|590006209|FG000|Overall Study|Protocol Violation|1|||
163353916|NCT00469456|590006210|FG001|Overall Study|Protocol Violation|0|||
163353917|NCT00469456|590006209|FG000|Overall Study|Withdrawal by Subject|4|||
163353918|NCT00469456|590006210|FG001|Overall Study|Withdrawal by Subject|1|||
163353919|NCT00704171|590006215|FG000|Overall Study|Withdrawal by Subject|1|||
163353920|NCT00704171|590006216|FG001|Overall Study|Withdrawal by Subject|0|||
163353921|NCT00813098|590006221|FG000|Overall Study|Adverse Event|2|||
163353922|NCT00813098|590006222|FG001|Overall Study|Adverse Event|4|||
163353923|NCT00813098|590006223|FG002|Overall Study|Adverse Event|1|||
163353924|NCT00813098|590006221|FG000|Overall Study|Withdrawal by Subject|0|||
163353925|NCT00813098|590006222|FG001|Overall Study|Withdrawal by Subject|1|||
163353926|NCT00813098|590006223|FG002|Overall Study|Withdrawal by Subject|0|||
163353927|NCT00813098|590006221|FG000|Overall Study|Inability to complete study procedures|1|||
163353928|NCT00813098|590006222|FG001|Overall Study|Inability to complete study procedures|0|||
163353929|NCT00813098|590006223|FG002|Overall Study|Inability to complete study procedures|0|||
163353930|NCT00813098|590006221|FG000|Overall Study|Lost to Follow-up|0|||
163353931|NCT00813098|590006222|FG001|Overall Study|Lost to Follow-up|1|||
163353932|NCT00813098|590006223|FG002|Overall Study|Lost to Follow-up|0|||
163353933|NCT00813098|590006221|FG000|Overall Study|Protocol Violation|0|||
163353934|NCT00813098|590006222|FG001|Overall Study|Protocol Violation|0|||
163353935|NCT00813098|590006223|FG002|Overall Study|Protocol Violation|1|||
163353936|NCT00813098|590006221|FG000|Overall Study|Principal Investigator decision|0|||
163353937|NCT00813098|590006222|FG001|Overall Study|Principal Investigator decision|1|||
163353938|NCT00813098|590006223|FG002|Overall Study|Principal Investigator decision|0|||
163353939|NCT00813098|590006221|FG000|Overall Study|Withdrew Consent|0|||
163353940|NCT00813098|590006222|FG001|Overall Study|Withdrew Consent|1|||
163353941|NCT00813098|590006223|FG002|Overall Study|Withdrew Consent|0|||
163353942|NCT01086384|590006226|FG000|2-week Run-in Period|Adverse Event|1|||
163353943|NCT01086384|590006227|FG001|2-week Run-in Period|Adverse Event|0|||
163353944|NCT01086384|590006228|FG002|2-week Run-in Period|Adverse Event|0|||
163353945|NCT01086384|590006226|FG000|2-week Run-in Period|Protocol Violation|1|||
163353946|NCT01086384|590006227|FG001|2-week Run-in Period|Protocol Violation|0|||
163353947|NCT01086384|590006228|FG002|2-week Run-in Period|Protocol Violation|0|||
163353948|NCT01086384|590006226|FG000|2-week Run-in Period|Lost to Follow-up|1|||
163353949|NCT01086384|590006227|FG001|2-week Run-in Period|Lost to Follow-up|0|||
163353950|NCT01086384|590006228|FG002|2-week Run-in Period|Lost to Follow-up|0|||
163353951|NCT01086384|590006226|FG000|2-week Run-in Period|Physician Decision|6|||
163353952|NCT01086384|590006227|FG001|2-week Run-in Period|Physician Decision|0|||
163353953|NCT01086384|590006228|FG002|2-week Run-in Period|Physician Decision|0|||
163353954|NCT01086384|590006226|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
163353955|NCT01086384|590006227|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
163353956|NCT01086384|590006228|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
163353957|NCT01086384|590006226|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
163353958|NCT01086384|590006227|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
163353959|NCT01086384|590006228|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
163353960|NCT01086384|590006226|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
163353961|NCT01086384|590006227|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
163353962|NCT01086384|590006228|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
163353963|NCT01086384|590006226|FG000|2-week Run-in Period|Randomized in Error|1|||
163353964|NCT01086384|590006227|FG001|2-week Run-in Period|Randomized in Error|0|||
163353965|NCT01086384|590006228|FG002|2-week Run-in Period|Randomized in Error|0|||
163353966|NCT01086384|590006226|FG000|Treatment Period|Withdrawal by Subject|0|||
163353967|NCT01086384|590006227|FG001|Treatment Period|Withdrawal by Subject|53|||
163353968|NCT01086384|590006228|FG002|Treatment Period|Withdrawal by Subject|55|||
163353969|NCT01086384|590006226|FG000|Treatment Period|Protocol Violation|0|||
163353970|NCT01086384|590006227|FG001|Treatment Period|Protocol Violation|26|||
163353971|NCT01086384|590006228|FG002|Treatment Period|Protocol Violation|17|||
163353972|NCT01086384|590006226|FG000|Treatment Period|Lack of Efficacy|0|||
163353973|NCT01086384|590006227|FG001|Treatment Period|Lack of Efficacy|22|||
163353974|NCT01086384|590006228|FG002|Treatment Period|Lack of Efficacy|13|||
163353975|NCT01086384|590006226|FG000|Treatment Period|Adverse Event|0|||
163353976|NCT01086384|590006227|FG001|Treatment Period|Adverse Event|19|||
163353977|NCT01086384|590006228|FG002|Treatment Period|Adverse Event|15|||
163353978|NCT01086384|590006226|FG000|Treatment Period|Lost to Follow-up|0|||
163353979|NCT01086384|590006227|FG001|Treatment Period|Lost to Follow-up|11|||
163353980|NCT01086384|590006228|FG002|Treatment Period|Lost to Follow-up|9|||
163353981|NCT01086384|590006226|FG000|Treatment Period|Physician Decision|0|||
163353982|NCT01086384|590006227|FG001|Treatment Period|Physician Decision|9|||
163353983|NCT01086384|590006228|FG002|Treatment Period|Physician Decision|6|||
163353984|NCT01086384|590006226|FG000|Treatment Period|Study Closed/Terminated|0|||
163353985|NCT01086384|590006227|FG001|Treatment Period|Study Closed/Terminated|7|||
163353986|NCT01086384|590006228|FG002|Treatment Period|Study Closed/Terminated|8|||
163353987|NCT01086384|590006226|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
163353988|NCT01086384|590006227|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
163353989|NCT01086384|590006228|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
163353990|NCT01086384|590006226|FG000|Treatment Period|Received Treatment in Error|0|||
163353991|NCT01086384|590006227|FG001|Treatment Period|Received Treatment in Error|1|||
163353992|NCT01086384|590006228|FG002|Treatment Period|Received Treatment in Error|0|||
163353993|NCT02586415|590006233|FG000|Overall Study|Death|13|||
163353994|NCT02586415|590006234|FG001|Overall Study|Death|23|||
163353995|NCT02586415|590006233|FG000|Overall Study|Lost to Follow-up|1|||
163353996|NCT02586415|590006234|FG001|Overall Study|Lost to Follow-up|2|||
163353997|NCT01209286|590006241|FG000|Overall Study|Adverse Event|4|||
163353998|NCT01209286|590006242|FG001|Overall Study|Adverse Event|3|||
163353999|NCT01209286|590006243|FG002|Overall Study|Adverse Event|1|||
163354000|NCT01209286|590006241|FG000|Overall Study|Hematological Relapse After Remission|0|||
163354001|NCT01209286|590006242|FG001|Overall Study|Hematological Relapse After Remission|1|||
163354002|NCT01209286|590006243|FG002|Overall Study|Hematological Relapse After Remission|1|||
163354003|NCT01209286|590006241|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
163354004|NCT01209286|590006242|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
163354005|NCT01209286|590006243|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
163354006|NCT01209286|590006241|FG000|Overall Study|Physician Decision|0|||
163354007|NCT01209286|590006242|FG001|Overall Study|Physician Decision|2|||
163354008|NCT01209286|590006243|FG002|Overall Study|Physician Decision|0|||
163354009|NCT01209286|590006241|FG000|Overall Study|Other|0|||
163354010|NCT01209286|590006242|FG001|Overall Study|Other|1|||
163354011|NCT01209286|590006243|FG002|Overall Study|Other|0|||
163354012|NCT01891890|590006244|FG000|Overall Study|Lost to Follow-up|0|||
163354013|NCT01891890|590006245|FG001|Overall Study|Lost to Follow-up|0|||
163354014|NCT01891890|590006246|FG002|Overall Study|Lost to Follow-up|1|||
163354015|NCT01891890|590006244|FG000|Overall Study|Study ended before endpoint reached|7|||
163354016|NCT01891890|590006245|FG001|Overall Study|Study ended before endpoint reached|3|||
163354017|NCT01891890|590006246|FG002|Overall Study|Study ended before endpoint reached|6|||
163354018|NCT03029819|590006247|FG000|Overall Study|Lost to Follow-up|3|||
163354019|NCT03029819|590006248|FG001|Overall Study|Lost to Follow-up|5|||
163354020|NCT03029819|590006247|FG000|Overall Study|Removed due to disruptive behavior|0|||
163354021|NCT03029819|590006248|FG001|Overall Study|Removed due to disruptive behavior|1|||
163354022|NCT03605368|590006250|FG000|Overall Study|Lost to Follow-up|2|||
163354023|NCT03605368|590006251|FG001|Overall Study|Lost to Follow-up|1|||
163354024|NCT03605368|590006252|FG002|Overall Study|Lost to Follow-up|3|||
163354025|NCT03605368|590006253|FG003|Overall Study|Lost to Follow-up|2|||
163354026|NCT03605368|590006250|FG000|Overall Study|Withdrawal by Subject|0|||
163354027|NCT03605368|590006251|FG001|Overall Study|Withdrawal by Subject|0|||
163354028|NCT03605368|590006252|FG002|Overall Study|Withdrawal by Subject|4|||
163354029|NCT03605368|590006253|FG003|Overall Study|Withdrawal by Subject|3|||
163354030|NCT01020747|590006254|FG000|Overall Study|Withdrawal by Subject|1|||
163354031|NCT02881047|590006259|FG000|Overall Study|Adverse Event|1|||
163354032|NCT02881047|590006259|FG000|Overall Study|Withdrawal by Subject|1|||
163354033|NCT01329419|590006265|FG000|Overall Study|Protocol Violation|235|||
163354034|NCT00514813|590006270|FG000|Overall Study|Study terminated|14|||
163354035|NCT00514813|590006271|FG001|Overall Study|Study terminated|74|||
163354036|NCT00514813|590006272|FG002|Overall Study|Study terminated|40|||
163354037|NCT00514813|590006273|FG003|Overall Study|Study terminated|2|||
163354038|NCT00514813|590006270|FG000|Overall Study|Adverse Event|0|||
163354039|NCT00514813|590006271|FG001|Overall Study|Adverse Event|2|||
163354040|NCT00514813|590006272|FG002|Overall Study|Adverse Event|2|||
163354041|NCT00514813|590006273|FG003|Overall Study|Adverse Event|0|||
163354042|NCT00514813|590006270|FG000|Overall Study|Protocol Violation|1|||
163354043|NCT00514813|590006271|FG001|Overall Study|Protocol Violation|0|||
163354044|NCT00514813|590006272|FG002|Overall Study|Protocol Violation|0|||
163354045|NCT00514813|590006273|FG003|Overall Study|Protocol Violation|0|||
163354046|NCT00514813|590006270|FG000|Overall Study|Withdrawal by Subject|0|||
163354047|NCT00514813|590006271|FG001|Overall Study|Withdrawal by Subject|1|||
163354048|NCT00514813|590006272|FG002|Overall Study|Withdrawal by Subject|0|||
163354049|NCT00514813|590006273|FG003|Overall Study|Withdrawal by Subject|0|||
163354050|NCT00514813|590006270|FG000|Overall Study|Lack of Efficacy|0|||
163246209|NCT01059565|589608417|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
163246210|NCT01059565|589608416|FG000|24-Week Randomized Phase|Adverse Event|5|||
163246211|NCT01059565|589608417|FG001|24-Week Randomized Phase|Adverse Event|0|||
163246212|NCT01059565|589608416|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
163246213|NCT01059565|589608417|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
163246214|NCT01059565|589608416|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
163246215|NCT01059565|589608417|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
163246216|NCT01059565|589608416|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
163246217|NCT01059565|589608417|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
163246218|NCT01059565|589608416|FG000|24-Week Open-Label Phase|Adverse Event|2|||
163246219|NCT01059565|589608417|FG001|24-Week Open-Label Phase|Adverse Event|0|||
163246220|NCT01059565|589608416|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
163246221|NCT01059565|589608417|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
163246222|NCT01059565|589608416|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
163246223|NCT01059565|589608417|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
163246224|NCT01059565|589608416|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
163246225|NCT01059565|589608417|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
163246226|NCT01059565|589608416|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
163246227|NCT01059565|589608417|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
163246228|NCT01059565|589608416|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
163246229|NCT01059565|589608417|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
163246230|NCT02732938|589608418|FG000|Overall Study|Death|0|||
163246231|NCT02732938|589608419|FG001|Overall Study|Death|11|||
163246232|NCT02732938|589608420|FG002|Overall Study|Death|0|||
163246233|NCT02732938|589608418|FG000|Overall Study|Randomized but did not receive treatment|0|||
163246234|NCT02732938|589608419|FG001|Overall Study|Randomized but did not receive treatment|1|||
163246235|NCT02732938|589608420|FG002|Overall Study|Randomized but did not receive treatment|0|||
163246236|NCT02732938|589608418|FG000|Overall Study|Refused further follow-up|1|||
163246237|NCT02732938|589608419|FG001|Overall Study|Refused further follow-up|0|||
163246238|NCT02732938|589608420|FG002|Overall Study|Refused further follow-up|0|||
163246239|NCT02732938|589608418|FG000|Overall Study|Study terminated by sponsor|3|||
163246240|NCT02732938|589608419|FG001|Overall Study|Study terminated by sponsor|6|||
163246241|NCT02732938|589608420|FG002|Overall Study|Study terminated by sponsor|0|||
163246242|NCT01026974|589608431|FG000|Overall Study|Withdrawal by Subject|0|||
163246243|NCT01026974|589608432|FG001|Overall Study|Withdrawal by Subject|1|||
163246244|NCT01026974|589608433|FG002|Overall Study|Withdrawal by Subject|7|||
163246245|NCT01026974|589608434|FG003|Overall Study|Withdrawal by Subject|2|||
163246246|NCT01026974|589608431|FG000|Overall Study|Lost to Follow-up|1|||
163246247|NCT01026974|589608432|FG001|Overall Study|Lost to Follow-up|1|||
163246248|NCT01026974|589608433|FG002|Overall Study|Lost to Follow-up|4|||
163246249|NCT01026974|589608434|FG003|Overall Study|Lost to Follow-up|0|||
163246250|NCT01026974|589608431|FG000|Overall Study|Adverse Event|0|||
163246251|NCT01026974|589608432|FG001|Overall Study|Adverse Event|0|||
163246252|NCT01026974|589608433|FG002|Overall Study|Adverse Event|0|||
163246253|NCT01026974|589608434|FG003|Overall Study|Adverse Event|1|||
163246254|NCT01026974|589608431|FG000|Overall Study|Inappropriate enrollment|0|||
163246255|NCT01026974|589608432|FG001|Overall Study|Inappropriate enrollment|0|||
163246256|NCT01026974|589608433|FG002|Overall Study|Inappropriate enrollment|1|||
163246257|NCT01026974|589608434|FG003|Overall Study|Inappropriate enrollment|0|||
163246258|NCT02864082|589608441|FG000|Overall Study|Adverse Event|1|||
163246259|NCT02864082|589608442|FG001|Overall Study|Adverse Event|1|||
163246260|NCT02864082|589608441|FG000|Overall Study|Lost to Follow-up|0|||
163246261|NCT02864082|589608442|FG001|Overall Study|Lost to Follow-up|1|||
163246262|NCT02864082|589608441|FG000|Overall Study|Withdrawal by Subject|2|||
163246263|NCT02864082|589608442|FG001|Overall Study|Withdrawal by Subject|2|||
163246264|NCT04349553|589608443|FG000|Overall Study|Withdrawal by Subject|1|||
163246265|NCT04349553|589608444|FG001|Overall Study|Withdrawal by Subject|0|||
163246266|NCT04349553|589608445|FG002|Overall Study|Withdrawal by Subject|1|||
163246267|NCT04349553|589608446|FG003|Overall Study|Withdrawal by Subject|0|||
163246268|NCT01869491|589608449|FG000|Overall Study|Adverse Event|3|||
163246269|NCT01869491|589608450|FG001|Overall Study|Adverse Event|5|||
163246270|NCT01869491|589608449|FG000|Overall Study|Lack of Efficacy|0|||
163246271|NCT01869491|589608450|FG001|Overall Study|Lack of Efficacy|3|||
163246272|NCT01869491|589608449|FG000|Overall Study|Withdrawal by Subject|6|||
163246273|NCT01869491|589608450|FG001|Overall Study|Withdrawal by Subject|7|||
163246274|NCT01869491|589608449|FG000|Overall Study|Lost to Follow-up|11|||
163246275|NCT01869491|589608450|FG001|Overall Study|Lost to Follow-up|9|||
163246276|NCT01869491|589608449|FG000|Overall Study|No further need of investigational product|1|||
163246277|NCT01869491|589608450|FG001|Overall Study|No further need of investigational product|0|||
163246278|NCT05177770|589608451|FG000|Overall Study|Death|4|||
163246279|NCT05177770|589608451|FG000|Overall Study|Withdrawal by Subject|1|||
163246280|NCT05177770|589608451|FG000|Overall Study|Adverse Event prior to dosing|1|||
163246281|NCT01272934|589608455|FG000|Overall Study|Adverse Event|0|||
163246282|NCT01272934|589608456|FG001|Overall Study|Adverse Event|1|||
163246283|NCT01272934|589608455|FG000|Overall Study|Abnormal Laboratory Value|0|||
163246284|NCT01272934|589608456|FG001|Overall Study|Abnormal Laboratory Value|1|||
163246285|NCT02105948|589608457|FG000|Overall Study|Adverse Event|10|||
163246286|NCT02105948|589608458|FG001|Overall Study|Adverse Event|7|||
163246287|NCT02105948|589608459|FG002|Overall Study|Adverse Event|11|||
163246288|NCT02105948|589608460|FG003|Overall Study|Adverse Event|11|||
163246289|NCT02105948|589608457|FG000|Overall Study|Lack of Efficacy|0|||
163246290|NCT02105948|589608458|FG001|Overall Study|Lack of Efficacy|1|||
163246291|NCT02105948|589608459|FG002|Overall Study|Lack of Efficacy|3|||
163246292|NCT02105948|589608460|FG003|Overall Study|Lack of Efficacy|2|||
163246293|NCT02105948|589608457|FG000|Overall Study|Lost to Follow-up|0|||
163246294|NCT02105948|589608458|FG001|Overall Study|Lost to Follow-up|0|||
163246295|NCT02105948|589608459|FG002|Overall Study|Lost to Follow-up|2|||
163246296|NCT02105948|589608460|FG003|Overall Study|Lost to Follow-up|1|||
163246297|NCT02105948|589608457|FG000|Overall Study|Physician Decision|2|||
163246298|NCT02105948|589608458|FG001|Overall Study|Physician Decision|2|||
163246299|NCT02105948|589608459|FG002|Overall Study|Physician Decision|2|||
163246300|NCT02105948|589608460|FG003|Overall Study|Physician Decision|2|||
163246301|NCT02105948|589608457|FG000|Overall Study|Withdrawal by Subject|15|||
163246302|NCT02105948|589608458|FG001|Overall Study|Withdrawal by Subject|10|||
163246303|NCT02105948|589608459|FG002|Overall Study|Withdrawal by Subject|10|||
163246304|NCT02105948|589608460|FG003|Overall Study|Withdrawal by Subject|11|||
163246305|NCT04558346|589608461|FG000|Overall Study|Withdrawal by Subject|2|||
163246306|NCT04558346|589608462|FG001|Overall Study|Withdrawal by Subject|0|||
163246307|NCT04558346|589608461|FG000|Overall Study|Lost to Follow-up|0|||
163246308|NCT04558346|589608462|FG001|Overall Study|Lost to Follow-up|1|||
163246309|NCT04558346|589608461|FG000|Overall Study|Adverse Event|0|||
163246310|NCT04558346|589608462|FG001|Overall Study|Adverse Event|1|||
163246311|NCT00724971|589608465|FG000|Overall Study|Adverse Event|5|||
163246312|NCT00724971|589608465|FG000|Overall Study|Withdrawal by Subject|1|||
163246313|NCT01962974|589608466|FG000|Overall Study|Study termination|7|||
163246314|NCT02276482|589608469|FG000|Overall Study|Adverse Event|1|||
163246315|NCT02276482|589608470|FG001|Overall Study|Adverse Event|0|||
163246316|NCT02276482|589608469|FG000|Overall Study|Withdrawal by Subject|1|||
163246317|NCT02276482|589608470|FG001|Overall Study|Withdrawal by Subject|0|||
163246318|NCT02276482|589608469|FG000|Overall Study|Gram-negative infection|1|||
163246319|NCT02276482|589608470|FG001|Overall Study|Gram-negative infection|0|||
163246320|NCT02276482|589608469|FG000|Overall Study|Reason not specified|0|||
163246321|NCT02276482|589608470|FG001|Overall Study|Reason not specified|1|||
163246322|NCT02005471|589608477|FG000|Main Study|Adverse Event|0|||
163246323|NCT02005471|589608478|FG001|Main Study|Adverse Event|1|||
163246324|NCT02005471|589608479|FG002|Main Study|Adverse Event|0|||
163246325|NCT02005471|589608480|FG003|Main Study|Adverse Event|0|||
163246326|NCT02005471|589608477|FG000|Main Study|Death|83|||
163246327|NCT02005471|589608478|FG001|Main Study|Death|52|||
163246328|NCT02005471|589608479|FG002|Main Study|Death|0|||
163246329|NCT02005471|589608480|FG003|Main Study|Death|0|||
163246330|NCT02005471|589608477|FG000|Main Study|Lost to Follow-up|4|||
163246331|NCT02005471|589608478|FG001|Main Study|Lost to Follow-up|5|||
163246332|NCT02005471|589608479|FG002|Main Study|Lost to Follow-up|0|||
163246333|NCT02005471|589608480|FG003|Main Study|Lost to Follow-up|0|||
163246334|NCT02005471|589608477|FG000|Main Study|Physician Decision|3|||
163246335|NCT02005471|589608478|FG001|Main Study|Physician Decision|1|||
163246336|NCT02005471|589608479|FG002|Main Study|Physician Decision|0|||
163246337|NCT02005471|589608480|FG003|Main Study|Physician Decision|0|||
163246338|NCT02005471|589608477|FG000|Main Study|Withdrawal by Subject|26|||
163246339|NCT02005471|589608478|FG001|Main Study|Withdrawal by Subject|11|||
163246340|NCT02005471|589608479|FG002|Main Study|Withdrawal by Subject|0|||
163246341|NCT02005471|589608480|FG003|Main Study|Withdrawal by Subject|0|||
163246342|NCT02005471|589608477|FG000|Main Study|Reason not Specified|0|||
163246343|NCT02005471|589608478|FG001|Main Study|Reason not Specified|6|||
163246344|NCT02005471|589608479|FG002|Main Study|Reason not Specified|0|||
163246345|NCT02005471|589608480|FG003|Main Study|Reason not Specified|0|||
163246346|NCT02005471|589608477|FG000|Main Study|Randomized but not Dosed|8|||
163246347|NCT02005471|589608478|FG001|Main Study|Randomized but not Dosed|0|||
163246348|NCT02005471|589608479|FG002|Main Study|Randomized but not Dosed|0|||
163246349|NCT02005471|589608480|FG003|Main Study|Randomized but not Dosed|0|||
163246350|NCT02005471|589608477|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
163246351|NCT02005471|589608478|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
163246352|NCT02005471|589608479|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
163246353|NCT02005471|589608480|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
163246354|NCT02005471|589608477|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
163246355|NCT02005471|589608478|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
163246356|NCT02005471|589608479|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
163246357|NCT02005471|589608480|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
163246358|NCT02005471|589608477|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
163246359|NCT02005471|589608478|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
163246360|NCT02005471|589608479|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
163149523|NCT00474487|589261448|FG000|Overall Study|Withdrawal by Subject|6|||
163149524|NCT00474487|589261449|FG001|Overall Study|Withdrawal by Subject|0|||
163149525|NCT00474487|589261450|FG002|Overall Study|Withdrawal by Subject|0|||
163149526|NCT00474487|589261451|FG003|Overall Study|Withdrawal by Subject|0|||
163149527|NCT00474487|589261448|FG000|Overall Study|Lost to Follow-up|20|||
163149528|NCT00474487|589261449|FG001|Overall Study|Lost to Follow-up|1|||
163149529|NCT00474487|589261450|FG002|Overall Study|Lost to Follow-up|7|||
163149530|NCT00474487|589261451|FG003|Overall Study|Lost to Follow-up|0|||
163149531|NCT00474487|589261448|FG000|Overall Study|Inappropriate enrollment|4|||
163149532|NCT00474487|589261449|FG001|Overall Study|Inappropriate enrollment|0|||
163149533|NCT00474487|589261450|FG002|Overall Study|Inappropriate enrollment|7|||
163149534|NCT00474487|589261451|FG003|Overall Study|Inappropriate enrollment|0|||
163149535|NCT00474487|589261448|FG000|Overall Study|Death|0|||
163149536|NCT00474487|589261449|FG001|Overall Study|Death|1|||
163149537|NCT00474487|589261450|FG002|Overall Study|Death|0|||
163149538|NCT00474487|589261451|FG003|Overall Study|Death|0|||
163149539|NCT03924622|589261452|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
163149540|NCT03924622|589261453|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
163149541|NCT03924622|589261454|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
163149542|NCT03924622|589261455|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
163149543|NCT03924622|589261456|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
163149544|NCT03924622|589261457|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
163149545|NCT00248625|589261458|FG000|Overall Study|Withdrawal by Subject|0|||
163149546|NCT00248625|589261459|FG001|Overall Study|Withdrawal by Subject|2|||
163149547|NCT03085095|589261462|FG000|Overall Study|Adverse Event|23|||
163149548|NCT03085095|589261463|FG001|Overall Study|Adverse Event|8|||
163149549|NCT03085095|589261462|FG000|Overall Study|Protocol Violation|0|||
163149550|NCT03085095|589261463|FG001|Overall Study|Protocol Violation|1|||
163149551|NCT03085095|589261462|FG000|Overall Study|Lost to Follow-up|2|||
163149552|NCT03085095|589261463|FG001|Overall Study|Lost to Follow-up|1|||
163149553|NCT03085095|589261462|FG000|Overall Study|Withdrawal by Subject|17|||
163149554|NCT03085095|589261463|FG001|Overall Study|Withdrawal by Subject|6|||
163149555|NCT03085095|589261462|FG000|Overall Study|Physician Decision|9|||
163149556|NCT03085095|589261463|FG001|Overall Study|Physician Decision|3|||
163149557|NCT03085095|589261462|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
163149558|NCT03085095|589261463|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
163149559|NCT03085095|589261462|FG000|Overall Study|Did not Receive Study Drug|2|||
163149560|NCT03085095|589261463|FG001|Overall Study|Did not Receive Study Drug|2|||
163149561|NCT03085095|589261462|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
163149562|NCT03085095|589261463|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
163149563|NCT03284710|589261464|FG000|Overall Study|Withdrawal by Subject|1|||
163149564|NCT03284710|589261465|FG001|Overall Study|Withdrawal by Subject|0|||
163149565|NCT03284710|589261466|FG002|Overall Study|Withdrawal by Subject|1|||
163149566|NCT03284710|589261467|FG003|Overall Study|Withdrawal by Subject|6|||
163149567|NCT03284710|589261464|FG000|Overall Study|Lost to Follow-up|3|||
163149568|NCT03284710|589261465|FG001|Overall Study|Lost to Follow-up|3|||
163149569|NCT03284710|589261466|FG002|Overall Study|Lost to Follow-up|1|||
163149570|NCT03284710|589261467|FG003|Overall Study|Lost to Follow-up|0|||
163149571|NCT03284710|589261464|FG000|Overall Study|Physician Decision|1|||
163149572|NCT03284710|589261465|FG001|Overall Study|Physician Decision|0|||
163149573|NCT03284710|589261466|FG002|Overall Study|Physician Decision|0|||
163149574|NCT03284710|589261467|FG003|Overall Study|Physician Decision|0|||
163149575|NCT03284710|589261464|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
163149576|NCT03284710|589261465|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
163149577|NCT03284710|589261466|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
163149578|NCT03284710|589261467|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
163149579|NCT03284710|589261464|FG000|Overall Study|HIV Infection|0|||
163149580|NCT03284710|589261465|FG001|Overall Study|HIV Infection|2|||
163354051|NCT00514813|590006271|FG001|Overall Study|Lack of Efficacy|1|||
163149581|NCT03284710|589261466|FG002|Overall Study|HIV Infection|2|||
163149582|NCT03284710|589261467|FG003|Overall Study|HIV Infection|1|||
163149583|NCT05176314|589261470|FG000|Overall Study|Lost to Follow-up|2|||
163149584|NCT05176314|589261470|FG000|Overall Study|Physician Decision|1|||
163149585|NCT05176314|589261470|FG000|Overall Study|Adverse Event|1|||
163149586|NCT05543265|589261472|FG000|Overall Study|Lost to Follow-up|3|||
163149587|NCT05543265|589261473|FG001|Overall Study|Lost to Follow-up|3|||
163149588|NCT05543265|589261472|FG000|Overall Study|Withdrawal by Subject|0|||
163149589|NCT05543265|589261473|FG001|Overall Study|Withdrawal by Subject|1|||
163149590|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
163149591|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
163149592|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
163149593|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Death|9|||
163149594|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Death|0|||
163149595|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Death|0|||
163354052|NCT00514813|590006272|FG002|Overall Study|Lack of Efficacy|0|||
163354053|NCT00514813|590006273|FG003|Overall Study|Lack of Efficacy|0|||
163354054|NCT00514813|590006270|FG000|Overall Study|Kidney transplant|0|||
163354055|NCT00514813|590006271|FG001|Overall Study|Kidney transplant|6|||
163354056|NCT00514813|590006272|FG002|Overall Study|Kidney transplant|2|||
163354057|NCT00514813|590006273|FG003|Overall Study|Kidney transplant|0|||
163354058|NCT00514813|590006270|FG000|Overall Study|Death|0|||
163354059|NCT00514813|590006271|FG001|Overall Study|Death|2|||
163354060|NCT00514813|590006272|FG002|Overall Study|Death|3|||
163354061|NCT00514813|590006273|FG003|Overall Study|Death|2|||
163354062|NCT01075100|590006276|FG000|Overall Study|Adverse Event|15|||
163354063|NCT01075100|590006277|FG001|Overall Study|Adverse Event|18|||
163354064|NCT01075100|590006276|FG000|Overall Study|Patient Request|4|||
163354065|NCT01075100|590006277|FG001|Overall Study|Patient Request|4|||
163354066|NCT01075100|590006276|FG000|Overall Study|Investigator Request|2|||
163354067|NCT01075100|590006277|FG001|Overall Study|Investigator Request|1|||
163354068|NCT01075100|590006276|FG000|Overall Study|Disease Progression|25|||
163354069|NCT01075100|590006277|FG001|Overall Study|Disease Progression|29|||
163354070|NCT01075100|590006276|FG000|Overall Study|Other|3|||
163354071|NCT01075100|590006277|FG001|Overall Study|Other|1|||
163354072|NCT00511836|590007262|FG000|Double-blind Period|Lost to Follow-up|1|||
163354073|NCT00511836|590007263|FG001|Double-blind Period|Lost to Follow-up|0|||
163354074|NCT00030823|590007264|FG000|Overall Study|Withdrawal by Subject|1|||
163354075|NCT00891046|590007270|FG000|Overall Study|Protocol Violation|1|||
163354076|NCT00891046|590007271|FG001|Overall Study|Protocol Violation|1|||
163354077|NCT00891046|590007272|FG002|Overall Study|Protocol Violation|0|||
163354078|NCT00891046|590007273|FG003|Overall Study|Protocol Violation|0|||
163354079|NCT00891046|590007274|FG004|Overall Study|Protocol Violation|1|||
163354080|NCT00891046|590007270|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
163354081|NCT00891046|590007271|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163354082|NCT00891046|590007272|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
163354083|NCT00891046|590007273|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
163354084|NCT00891046|590007274|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
163354085|NCT00891046|590007270|FG000|Overall Study|Administrative problems|0|||
163354086|NCT00891046|590007271|FG001|Overall Study|Administrative problems|0|||
163354087|NCT00891046|590007272|FG002|Overall Study|Administrative problems|0|||
163354088|NCT00891046|590007273|FG003|Overall Study|Administrative problems|0|||
163354089|NCT00891046|590007274|FG004|Overall Study|Administrative problems|1|||
163354090|NCT00891046|590007270|FG000|Overall Study|Participant no longer required drug|0|||
163354091|NCT00891046|590007271|FG001|Overall Study|Participant no longer required drug|2|||
163354092|NCT00891046|590007272|FG002|Overall Study|Participant no longer required drug|0|||
163354093|NCT00891046|590007273|FG003|Overall Study|Participant no longer required drug|0|||
163354094|NCT00891046|590007274|FG004|Overall Study|Participant no longer required drug|1|||
163354095|NCT00891046|590007270|FG000|Overall Study|Adverse Event|4|||
163410248|NCT00844753|590211327|FG003|Overall Study|could not swallow medication|0|||
163410249|NCT00844753|590211324|FG000|Overall Study|Withdrawal by Subject|1|||
163410250|NCT00844753|590211325|FG001|Overall Study|Withdrawal by Subject|0|||
163410251|NCT00844753|590211326|FG002|Overall Study|Withdrawal by Subject|0|||
163410252|NCT00844753|590211327|FG003|Overall Study|Withdrawal by Subject|3|||
163410253|NCT01110200|590211329|FG000|Overall Study|Adverse Event|28|||
163410254|NCT01110200|590211330|FG001|Overall Study|Adverse Event|28|||
163410255|NCT01110200|590211329|FG000|Overall Study|Withdrawal by Subject|25|||
163410256|NCT01110200|590211330|FG001|Overall Study|Withdrawal by Subject|32|||
163410257|NCT01110200|590211329|FG000|Overall Study|Lack of Efficacy|16|||
163410258|NCT01110200|590211330|FG001|Overall Study|Lack of Efficacy|25|||
163410259|NCT01110200|590211329|FG000|Overall Study|Protocol Violation|14|||
163410260|NCT01110200|590211330|FG001|Overall Study|Protocol Violation|12|||
163410261|NCT01110200|590211329|FG000|Overall Study|Physician Decision|13|||
163410262|NCT01110200|590211330|FG001|Overall Study|Physician Decision|17|||
163410263|NCT01110200|590211329|FG000|Overall Study|Lost to Follow-up|10|||
163410264|NCT01110200|590211330|FG001|Overall Study|Lost to Follow-up|7|||
163410265|NCT00903175|590211331|FG000|Period 1 - First Line|Adverse Event|36|||
163410266|NCT00903175|590211332|FG001|Period 1 - First Line|Adverse Event|50|||
163410267|NCT00903175|590211331|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
163410268|NCT00903175|590211332|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
163410269|NCT00903175|590211331|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
163410270|NCT00903175|590211332|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
163410271|NCT00903175|590211331|FG000|Period 1 - First Line|Protocol Violation|3|||
163410272|NCT00903175|590211332|FG001|Period 1 - First Line|Protocol Violation|3|||
163410273|NCT00903175|590211331|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
163410274|NCT00903175|590211332|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
163410275|NCT00903175|590211331|FG000|Period 1 - First Line|Administrative problems|12|||
163410276|NCT00903175|590211332|FG001|Period 1 - First Line|Administrative problems|13|||
163410277|NCT00903175|590211331|FG000|Period 1 - First Line|Death|17|||
163410278|NCT00903175|590211332|FG001|Period 1 - First Line|Death|10|||
163410279|NCT00903175|590211331|FG000|Period 2 - Second Line|Missing|1|||
163410280|NCT00903175|590211332|FG001|Period 2 - Second Line|Missing|0|||
163354096|NCT00891046|590007271|FG001|Overall Study|Adverse Event|3|||
163354097|NCT00891046|590007272|FG002|Overall Study|Adverse Event|2|||
163354098|NCT00891046|590007273|FG003|Overall Study|Adverse Event|0|||
163354099|NCT00891046|590007274|FG004|Overall Study|Adverse Event|14|||
163354100|NCT00891046|590007270|FG000|Overall Study|Withdrawal by Subject|2|||
163354101|NCT00891046|590007271|FG001|Overall Study|Withdrawal by Subject|1|||
163354102|NCT00891046|590007272|FG002|Overall Study|Withdrawal by Subject|2|||
163354103|NCT00891046|590007273|FG003|Overall Study|Withdrawal by Subject|1|||
163354104|NCT00891046|590007274|FG004|Overall Study|Withdrawal by Subject|1|||
163354105|NCT00891046|590007270|FG000|Overall Study|Lost to Follow-up|0|||
163354106|NCT00891046|590007271|FG001|Overall Study|Lost to Follow-up|0|||
163354107|NCT00891046|590007272|FG002|Overall Study|Lost to Follow-up|0|||
163354108|NCT00891046|590007273|FG003|Overall Study|Lost to Follow-up|0|||
163354109|NCT00891046|590007274|FG004|Overall Study|Lost to Follow-up|1|||
163354110|NCT00362375|590007275|FG000|Overall Study|Lost to Follow-up|40|||
163354111|NCT00362375|590007276|FG001|Overall Study|Lost to Follow-up|35|||
163354112|NCT02106195|590007277|FG000|Overall Study|Adverse Event|2|||
163354113|NCT02106195|590007277|FG000|Overall Study|Protocol Violation|1|||
163354114|NCT04984239|590007278|FG000|Overall Study|Lost to Follow-up|1|||
163354115|NCT02438371|590007281|FG000|Overall Study|Lost to Follow-up|3|||
163354116|NCT02438371|590007282|FG001|Overall Study|Lost to Follow-up|2|||
163354117|NCT02438371|590007281|FG000|Overall Study|Withdrawal by Subject|1|||
163354118|NCT02438371|590007282|FG001|Overall Study|Withdrawal by Subject|1|||
163410281|NCT00903175|590211331|FG000|Period 2 - Second Line|Adverse Event|16|||
163410282|NCT00903175|590211332|FG001|Period 2 - Second Line|Adverse Event|20|||
163410283|NCT00903175|590211331|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
163410284|NCT00903175|590211332|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
163410285|NCT00903175|590211331|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
163354119|NCT03065933|590007283|FG000|Overall Study|study terminated|5|||
163354120|NCT01513330|590007284|FG000|SenSura Mio First,|Adverse Event|2|||
163354121|NCT01513330|590007285|FG001|SenSura Mio First,|Adverse Event|0|||
163354122|NCT01513330|590007284|FG000|SenSura Mio First,|Lack of Efficacy|0|||
163354123|NCT01513330|590007285|FG001|SenSura Mio First,|Lack of Efficacy|1|||
163354124|NCT01513330|590007284|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
163354125|NCT01513330|590007285|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
163354126|NCT01513330|590007284|FG000|SenSura Mio First,|Other|1|||
163354127|NCT01513330|590007285|FG001|SenSura Mio First,|Other|0|||
163354128|NCT01513330|590007284|FG000|Standard Care First,|Lack of Efficacy|2|||
163354129|NCT01513330|590007285|FG001|Standard Care First,|Lack of Efficacy|2|||
163354130|NCT01513330|590007284|FG000|Standard Care First,|Withdrawal by Subject|1|||
163354131|NCT01513330|590007285|FG001|Standard Care First,|Withdrawal by Subject|2|||
163354132|NCT01513330|590007284|FG000|Standard Care First,|Other|1|||
163354133|NCT01513330|590007285|FG001|Standard Care First,|Other|0|||
163410286|NCT00903175|590211332|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
163149596|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
163149597|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
163149598|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
163149599|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
163149600|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
163149601|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
163149602|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Other|135|||
163149603|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Other|0|||
163149604|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Other|0|||
163149605|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
163149606|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
163149607|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
163149608|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
163149609|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
163149610|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
163149611|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
163149612|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
163149613|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
163149614|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Other|3|||
163149615|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Other|0|||
163149616|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Other|0|||
163149617|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
163149618|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
163354134|NCT00916305|590007288|FG000|Overall Study|Lost to Follow-up|21|||
163354135|NCT00916305|590007289|FG001|Overall Study|Lost to Follow-up|27|||
163354136|NCT00916305|590007288|FG000|Overall Study|Withdrawal by Subject|0|||
163354137|NCT00916305|590007289|FG001|Overall Study|Withdrawal by Subject|1|||
163354138|NCT01379703|590007290|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
163410287|NCT00903175|590211331|FG000|Period 2 - Second Line|Administrative problems|19|||
163410288|NCT00903175|590211332|FG001|Period 2 - Second Line|Administrative problems|9|||
163354139|NCT01379703|590007291|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
163354140|NCT01379703|590007292|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
163354141|NCT01379703|590007290|FG000|Study Start Through 9 Months|Adverse Event|0|||
163354142|NCT01379703|590007291|FG001|Study Start Through 9 Months|Adverse Event|14|||
163354143|NCT01379703|590007292|FG002|Study Start Through 9 Months|Adverse Event|10|||
163354144|NCT01379703|590007290|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
163354145|NCT01379703|590007291|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
163354146|NCT01379703|590007292|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
163354147|NCT01379703|590007290|FG000|Study Start Through 9 Months|Treatment Failure|0|||
163246361|NCT02005471|589608480|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
163246362|NCT00627705|589608482|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
163354148|NCT01379703|590007291|FG001|Study Start Through 9 Months|Treatment Failure|2|||
163354149|NCT01379703|590007292|FG002|Study Start Through 9 Months|Treatment Failure|2|||
163354150|NCT01379703|590007290|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
163354151|NCT01379703|590007291|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
163354152|NCT01379703|590007292|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
163354153|NCT01379703|590007290|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
163354154|NCT01379703|590007291|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
163354155|NCT01379703|590007292|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
163354156|NCT01379703|590007290|FG000|Study Start Through 9 Months|Medication not available|0|||
163354157|NCT01379703|590007291|FG001|Study Start Through 9 Months|Medication not available|2|||
163246363|NCT00627705|589608483|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
163246364|NCT00627705|589608482|FG000|Overall Study|Adverse Event|1|||
163246365|NCT00627705|589608483|FG001|Overall Study|Adverse Event|0|||
163246366|NCT00627705|589608482|FG000|Overall Study|Withdrawal by Subject|0|||
163246367|NCT00627705|589608483|FG001|Overall Study|Withdrawal by Subject|2|||
163246368|NCT00627705|589608482|FG000|Overall Study|Lost to Follow-up|0|||
163246369|NCT00627705|589608483|FG001|Overall Study|Lost to Follow-up|1|||
163246370|NCT01410448|589608489|FG000|Overall Study|No conversion to everolimus|0|||
163246371|NCT01410448|589608490|FG001|Overall Study|No conversion to everolimus|24|||
163246372|NCT01410448|589608489|FG000|Overall Study|Graft loss|4|||
163246373|NCT01410448|589608490|FG001|Overall Study|Graft loss|1|||
163246374|NCT01410448|589608489|FG000|Overall Study|Administrative issues|2|||
163246375|NCT01410448|589608490|FG001|Overall Study|Administrative issues|1|||
163246376|NCT01410448|589608489|FG000|Overall Study|Lost to Follow-up|1|||
163246377|NCT01410448|589608490|FG001|Overall Study|Lost to Follow-up|0|||
163246378|NCT01410448|589608489|FG000|Overall Study|Withdrawal by Subject|3|||
163246379|NCT01410448|589608490|FG001|Overall Study|Withdrawal by Subject|2|||
163246380|NCT01410448|589608489|FG000|Overall Study|Protocol Violation|0|||
163246381|NCT01410448|589608490|FG001|Overall Study|Protocol Violation|4|||
163246382|NCT01410448|589608489|FG000|Overall Study|Death|2|||
163246383|NCT01410448|589608490|FG001|Overall Study|Death|3|||
163246384|NCT02535065|589608491|FG000|Overall Study|Death|13|||
163246385|NCT02535065|589608491|FG000|Overall Study|Lost to Follow-up|1|||
163246386|NCT02535065|589608491|FG000|Overall Study|Withdrawal by Subject|6|||
163246387|NCT03712917|589608493|FG000|Overall Study|Pregnancy|0|||
163246388|NCT03712917|589608494|FG001|Overall Study|Pregnancy|0|||
163246389|NCT03712917|589608495|FG002|Overall Study|Pregnancy|1|||
163246390|NCT03712917|589608493|FG000|Overall Study|Adverse Event|0|||
163246391|NCT03712917|589608494|FG001|Overall Study|Adverse Event|4|||
163246392|NCT03712917|589608495|FG002|Overall Study|Adverse Event|3|||
163246393|NCT03712917|589608493|FG000|Overall Study|Lost to Follow-up|9|||
163246394|NCT03712917|589608494|FG001|Overall Study|Lost to Follow-up|4|||
163354158|NCT01379703|590007292|FG002|Study Start Through 9 Months|Medication not available|1|||
163354159|NCT01379703|590007290|FG000|Study Start Through 9 Months|Poor general condition|0|||
163354160|NCT01379703|590007291|FG001|Study Start Through 9 Months|Poor general condition|1|||
163354161|NCT01379703|590007292|FG002|Study Start Through 9 Months|Poor general condition|0|||
163354162|NCT01379703|590007290|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
163354163|NCT01379703|590007291|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
163246395|NCT03712917|589608495|FG002|Overall Study|Lost to Follow-up|5|||
163354164|NCT01379703|590007292|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
163354165|NCT01379703|590007290|FG000|Study Start Through 9 Months|Reason unknown|2|||
163246396|NCT04764396|589608496|FG000|Overall Study|Physician Decision|1|||
163246397|NCT04764396|589608497|FG001|Overall Study|Physician Decision|0|||
163246398|NCT03230916|589608498|FG000|Overall Study|Withdrawal by Subject|0|||
163246399|NCT03230916|589608499|FG001|Overall Study|Withdrawal by Subject|0|||
163246400|NCT03230916|589608500|FG002|Overall Study|Withdrawal by Subject|0|||
163246401|NCT03230916|589608501|FG003|Overall Study|Withdrawal by Subject|0|||
163246402|NCT03230916|589608502|FG004|Overall Study|Withdrawal by Subject|0|||
163246403|NCT03230916|589608503|FG005|Overall Study|Withdrawal by Subject|1|||
163246404|NCT03230916|589608504|FG006|Overall Study|Withdrawal by Subject|0|||
163246405|NCT03230916|589608505|FG007|Overall Study|Withdrawal by Subject|0|||
163246406|NCT03230916|589608506|FG008|Overall Study|Withdrawal by Subject|0|||
163246407|NCT03230916|589608507|FG009|Overall Study|Withdrawal by Subject|0|||
163354166|NCT01379703|590007291|FG001|Study Start Through 9 Months|Reason unknown|31|||
163354167|NCT01379703|590007292|FG002|Study Start Through 9 Months|Reason unknown|24|||
163354168|NCT01379703|590007290|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
163354169|NCT01379703|590007291|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
163354170|NCT01379703|590007292|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
163354171|NCT01379703|590007290|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
163354172|NCT01379703|590007291|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
163354173|NCT01379703|590007292|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
163354174|NCT01379703|590007290|FG000|9 Months Through 18 Months|Adverse Event|0|||
163354175|NCT01379703|590007291|FG001|9 Months Through 18 Months|Adverse Event|6|||
163354176|NCT01379703|590007292|FG002|9 Months Through 18 Months|Adverse Event|0|||
163354177|NCT01379703|590007290|FG000|9 Months Through 18 Months|Treatment failure|0|||
163354178|NCT01379703|590007291|FG001|9 Months Through 18 Months|Treatment failure|5|||
163354179|NCT01379703|590007292|FG002|9 Months Through 18 Months|Treatment failure|0|||
163354180|NCT01379703|590007290|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
163354181|NCT01379703|590007291|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
163354182|NCT01379703|590007292|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
163354183|NCT01379703|590007290|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
163354184|NCT01379703|590007291|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
163354185|NCT01379703|590007292|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
163354186|NCT01379703|590007290|FG000|9 Months Through 18 Months|Fatigue|0|||
163354187|NCT01379703|590007291|FG001|9 Months Through 18 Months|Fatigue|1|||
163354188|NCT01379703|590007292|FG002|9 Months Through 18 Months|Fatigue|0|||
163354189|NCT01379703|590007290|FG000|9 Months Through 18 Months|Reason Unknown|0|||
163354190|NCT01379703|590007291|FG001|9 Months Through 18 Months|Reason Unknown|23|||
163354191|NCT01379703|590007292|FG002|9 Months Through 18 Months|Reason Unknown|0|||
163354192|NCT03481556|590007293|FG000|Overall Study|Adverse Event|1|||
163354193|NCT03481556|590007294|FG001|Overall Study|Adverse Event|0|||
163354194|NCT03481556|590007295|FG002|Overall Study|Adverse Event|0|||
163354195|NCT03481556|590007296|FG003|Overall Study|Adverse Event|0|||
163354196|NCT03481556|590007293|FG000|Overall Study|Death|4|||
163354197|NCT03481556|590007294|FG001|Overall Study|Death|2|||
163354198|NCT03481556|590007295|FG002|Overall Study|Death|3|||
163354199|NCT03481556|590007296|FG003|Overall Study|Death|16|||
163354200|NCT03481556|590007293|FG000|Overall Study|Study Terminated by Sponsor|10|||
163354201|NCT03481556|590007294|FG001|Overall Study|Study Terminated by Sponsor|5|||
163354202|NCT03481556|590007295|FG002|Overall Study|Study Terminated by Sponsor|2|||
163354203|NCT03481556|590007296|FG003|Overall Study|Study Terminated by Sponsor|9|||
163354204|NCT03463577|590007297|FG000|Overall Study|Lost to Follow-up|238|||
163354205|NCT03463577|590007298|FG001|Overall Study|Lost to Follow-up|435|||
163354206|NCT03463577|590007299|FG002|Overall Study|Lost to Follow-up|0|||
163354207|NCT03463577|590007300|FG003|Overall Study|Lost to Follow-up|0|||
163354208|NCT03463577|590007301|FG004|Overall Study|Lost to Follow-up|0|||
163354209|NCT03463577|590007302|FG005|Overall Study|Lost to Follow-up|0|||
163354210|NCT03463577|590007297|FG000|Overall Study|With unknown pregnancy outcome|0|||
163354211|NCT03463577|590007298|FG001|Overall Study|With unknown pregnancy outcome|5|||
163354212|NCT03463577|590007299|FG002|Overall Study|With unknown pregnancy outcome|0|||
163354213|NCT03463577|590007300|FG003|Overall Study|With unknown pregnancy outcome|0|||
163354214|NCT03463577|590007301|FG004|Overall Study|With unknown pregnancy outcome|0|||
163354215|NCT03463577|590007302|FG005|Overall Study|With unknown pregnancy outcome|0|||
163354216|NCT03463577|590007297|FG000|Overall Study|Maternal death|2|||
163354217|NCT03463577|590007298|FG001|Overall Study|Maternal death|0|||
163354218|NCT03463577|590007299|FG002|Overall Study|Maternal death|0|||
163354219|NCT03463577|590007300|FG003|Overall Study|Maternal death|0|||
163354220|NCT03463577|590007301|FG004|Overall Study|Maternal death|0|||
163354221|NCT03463577|590007302|FG005|Overall Study|Maternal death|0|||
163354222|NCT03463577|590007297|FG000|Overall Study|Neonatal death|0|||
163354223|NCT03463577|590007298|FG001|Overall Study|Neonatal death|0|||
163354224|NCT03463577|590007299|FG002|Overall Study|Neonatal death|0|||
163354225|NCT03463577|590007300|FG003|Overall Study|Neonatal death|15|||
163354226|NCT03463577|590007301|FG004|Overall Study|Neonatal death|17|||
163354227|NCT03463577|590007302|FG005|Overall Study|Neonatal death|0|||
163149619|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
163354228|NCT00236184|590007303|FG000|Overall Study|Adverse Event|5|||
163354229|NCT00236184|590007304|FG001|Overall Study|Adverse Event|2|||
163354230|NCT00236184|590007303|FG000|Overall Study|Lack of Efficacy|0|||
163354231|NCT00236184|590007304|FG001|Overall Study|Lack of Efficacy|1|||
163354232|NCT00236184|590007303|FG000|Overall Study|Lost to Follow-up|3|||
163354233|NCT00236184|590007304|FG001|Overall Study|Lost to Follow-up|4|||
163354234|NCT00236184|590007303|FG000|Overall Study|Physician Decision|1|||
163354235|NCT00236184|590007304|FG001|Overall Study|Physician Decision|1|||
163354236|NCT00236184|590007303|FG000|Overall Study|Withdrawal by Subject|3|||
163354237|NCT00236184|590007304|FG001|Overall Study|Withdrawal by Subject|0|||
163354238|NCT00236184|590007303|FG000|Overall Study|Protocol Violation|3|||
163354239|NCT00236184|590007304|FG001|Overall Study|Protocol Violation|0|||
163354240|NCT00236184|590007303|FG000|Overall Study|non-compliance with study drug|2|||
163354241|NCT00236184|590007304|FG001|Overall Study|non-compliance with study drug|1|||
163354242|NCT00236184|590007303|FG000|Overall Study|other|1|||
163354243|NCT00236184|590007304|FG001|Overall Study|other|2|||
163354244|NCT01101997|590007305|FG000|Overall Study|Withdrawal by Subject|2|||
163354245|NCT01841697|590007306|FG000|Overall Study|Death|0|||
163354246|NCT01841697|590007307|FG001|Overall Study|Death|1|||
163354247|NCT01841697|590007306|FG000|Overall Study|Lost to Follow-up|4|||
163354248|NCT01841697|590007307|FG001|Overall Study|Lost to Follow-up|1|||
163354249|NCT01841697|590007306|FG000|Overall Study|Withdrawal by Subject|16|||
163354250|NCT01841697|590007307|FG001|Overall Study|Withdrawal by Subject|16|||
163354251|NCT01777490|590007308|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
163354252|NCT01777490|590007309|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
163354253|NCT01777490|590007310|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
163354254|NCT01777490|590007311|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
163354255|NCT01772563|590007312|FG000|Cycle 1|Dose limiting toxicity|2|||
163354256|NCT01772563|590007312|FG000|Cycle 1|Progressive disease|2|||
163354257|NCT01772563|590007312|FG000|Cycle 2 and Beyond|Progressive disease|17|||
163354258|NCT01772563|590007312|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
163354259|NCT01772563|590007312|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
163354260|NCT00255944|590007315|FG000|Overall Study|Lost to Follow-up|797|||
163354261|NCT00255944|590007316|FG001|Overall Study|Lost to Follow-up|834|||
163354262|NCT00935259|590007323|FG000|Period 1|Administrative (scheduling conflict)|1|||
163246408|NCT03230916|589608508|FG010|Overall Study|Withdrawal by Subject|0|||
163246409|NCT01438541|589608513|FG000|Overall Study|Physician Decision|1|||
163246410|NCT01438541|589608513|FG000|Overall Study|Withdrawal by Subject|1|||
163246411|NCT01438541|589608513|FG000|Overall Study|discharge from the hospital|5|||
163246412|NCT02091167|589608514|FG000|Overall Study|Lost to Follow-up|0|||
163246413|NCT02091167|589608515|FG001|Overall Study|Lost to Follow-up|2|||
163246414|NCT01218646|589608516|FG000|Overall Study|Adverse Event|0|||
163246415|NCT01218646|589608517|FG001|Overall Study|Adverse Event|0|||
163246416|NCT01218646|589608518|FG002|Overall Study|Adverse Event|1|||
163246417|NCT01218646|589608519|FG003|Overall Study|Adverse Event|0|||
163246418|NCT01218646|589608516|FG000|Overall Study|Lost to Follow-up|1|||
163246419|NCT01218646|589608517|FG001|Overall Study|Lost to Follow-up|0|||
163246420|NCT01218646|589608518|FG002|Overall Study|Lost to Follow-up|0|||
163246421|NCT01218646|589608519|FG003|Overall Study|Lost to Follow-up|0|||
163246422|NCT01218646|589608516|FG000|Overall Study|Protocol Violation|0|||
163246423|NCT01218646|589608517|FG001|Overall Study|Protocol Violation|0|||
163246424|NCT01218646|589608518|FG002|Overall Study|Protocol Violation|1|||
163246425|NCT01218646|589608519|FG003|Overall Study|Protocol Violation|1|||
163246426|NCT00722761|589608520|FG000|Overall Study|Lost to Follow-up|1|||
163246427|NCT00722761|589608521|FG001|Overall Study|Lost to Follow-up|4|||
163246428|NCT00722761|589608520|FG000|Overall Study|Withdrawal by Subject|5|||
163246429|NCT00722761|589608521|FG001|Overall Study|Withdrawal by Subject|2|||
163246430|NCT02693665|589608525|FG000|Overall Study|Death|3|||
163246431|NCT02693665|589608526|FG001|Overall Study|Death|2|||
163246432|NCT02693665|589608525|FG000|Overall Study|Lost to Follow-up|7|||
163246433|NCT02693665|589608526|FG001|Overall Study|Lost to Follow-up|3|||
163246434|NCT02693665|589608525|FG000|Overall Study|Protocol Violation|1|||
163246435|NCT02693665|589608526|FG001|Overall Study|Protocol Violation|0|||
163246436|NCT02693665|589608525|FG000|Overall Study|Withdrawal by Subject|2|||
163246437|NCT02693665|589608526|FG001|Overall Study|Withdrawal by Subject|0|||
163246438|NCT02693665|589608525|FG000|Overall Study|patient wanted to leave it behind|1|||
163246439|NCT02693665|589608526|FG001|Overall Study|patient wanted to leave it behind|0|||
163246440|NCT02693665|589608525|FG000|Overall Study|anxiety|1|||
163246441|NCT02693665|589608526|FG001|Overall Study|anxiety|0|||
163246442|NCT02693665|589608525|FG000|Overall Study|family issues|1|||
163246443|NCT02693665|589608526|FG001|Overall Study|family issues|0|||
163246444|NCT02693665|589608525|FG000|Overall Study|no reason given|1|||
163246445|NCT02693665|589608526|FG001|Overall Study|no reason given|0|||
163354263|NCT00935259|590007324|FG001|Period 1|Administrative (scheduling conflict)|1|||
163246446|NCT03096782|589608527|FG000|Overall Study|Death|1|||
163354264|NCT02980705|590007327|FG000|Overall Study|Adverse Event|0|||
163354265|NCT02980705|590007328|FG001|Overall Study|Adverse Event|1|||
163354266|NCT02980705|590007327|FG000|Overall Study|Withdrawal by Subject|6|||
163354267|NCT02980705|590007328|FG001|Overall Study|Withdrawal by Subject|9|||
163354268|NCT02980705|590007327|FG000|Overall Study|withdrew participation|0|||
163354269|NCT02980705|590007328|FG001|Overall Study|withdrew participation|1|||
163354270|NCT02980705|590007327|FG000|Overall Study|Lost to Follow-up|2|||
163246447|NCT03096782|589608527|FG000|Overall Study|Participant Relapsed|1|||
163246448|NCT02075593|589608528|FG000|Overall Study|Withdrawal by Subject|1|||
163246449|NCT03156023|589608529|FG000|Overall Study|Withdrawal by Subject|1|||
163246450|NCT03156023|589608530|FG001|Overall Study|Withdrawal by Subject|0|||
163246451|NCT03156023|589608531|FG002|Overall Study|Withdrawal by Subject|2|||
163246452|NCT03156023|589608532|FG003|Overall Study|Withdrawal by Subject|1|||
163246453|NCT03156023|589608533|FG004|Overall Study|Withdrawal by Subject|1|||
163246454|NCT03156023|589608529|FG000|Overall Study|Lost to Follow-up|0|||
163246455|NCT03156023|589608530|FG001|Overall Study|Lost to Follow-up|0|||
163354271|NCT02980705|590007328|FG001|Overall Study|Lost to Follow-up|0|||
163354272|NCT01721746|590007329|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
163354273|NCT01721746|590007330|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
163354274|NCT01721746|590007329|FG000|Pre-Treatment|Withdrawal by Subject|1|||
163354275|NCT01721746|590007330|FG001|Pre-Treatment|Withdrawal by Subject|16|||
163354276|NCT01721746|590007329|FG000|Pre-Treatment|Poor/Non-compliance|1|||
163354277|NCT01721746|590007330|FG001|Pre-Treatment|Poor/Non-compliance|0|||
163354278|NCT01721746|590007329|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
163354279|NCT01721746|590007330|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
163354280|NCT01721746|590007329|FG000|Treatment|Disease Progression|192|||
163354281|NCT01721746|590007330|FG001|Treatment|Disease Progression|74|||
163354282|NCT01721746|590007329|FG000|Treatment|Study Drug Toxicity|19|||
163354283|NCT01721746|590007330|FG001|Treatment|Study Drug Toxicity|11|||
163354284|NCT01721746|590007329|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
163354285|NCT01721746|590007330|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
163354286|NCT01721746|590007329|FG000|Treatment|Participant request to discontinue Study treatment|26|||
163354287|NCT01721746|590007330|FG001|Treatment|Participant request to discontinue Study treatment|7|||
163354288|NCT01721746|590007329|FG000|Treatment|Participant withdrew consent|4|||
163354289|NCT01721746|590007330|FG001|Treatment|Participant withdrew consent|2|||
163354290|NCT01721746|590007329|FG000|Treatment|Maximum Clinical Benefit|9|||
163354291|NCT01721746|590007330|FG001|Treatment|Maximum Clinical Benefit|3|||
163354292|NCT01721746|590007329|FG000|Treatment|Poor/Non-compliance|2|||
163354293|NCT01721746|590007330|FG001|Treatment|Poor/Non-compliance|0|||
163354294|NCT01721746|590007329|FG000|Treatment|Participant no longer met Study criteria|4|||
163354295|NCT01721746|590007330|FG001|Treatment|Participant no longer met Study criteria|0|||
163354296|NCT01721746|590007329|FG000|Treatment|Other reasons|6|||
163354297|NCT01721746|590007330|FG001|Treatment|Other reasons|2|||
163354298|NCT00263575|590007331|FG000|Titration Period|Adverse Event|14|||
163354299|NCT00263575|590007331|FG000|Titration Period|Withdrawal by Subject|10|||
163354300|NCT00263575|590007331|FG000|Titration Period|Protocol Violation|9|||
163354301|NCT00263575|590007331|FG000|Titration Period|Sponsor Decision|2|||
163354302|NCT00263575|590007331|FG000|Titration Period|Other|2|||
163354303|NCT00263575|590007331|FG000|Titration Period|Lack of Efficacy|6|||
163354304|NCT00263575|590007331|FG000|Maintence Period|Adverse Event|23|||
163354305|NCT00263575|590007331|FG000|Maintence Period|Withdrawal by Subject|8|||
163354306|NCT00263575|590007331|FG000|Maintence Period|Protocol Violation|4|||
163354307|NCT00263575|590007331|FG000|Maintence Period|Lack of Efficacy|4|||
163354308|NCT00263575|590007331|FG000|Maintence Period|Physician Decision|6|||
163354309|NCT00263575|590007331|FG000|Maintence Period|Lost to Follow-up|1|||
163354310|NCT00263575|590007331|FG000|Maintence Period|Sponsor Decision|24|||
163354311|NCT00263575|590007331|FG000|Maintence Period|Other|7|||
163354312|NCT01841112|590007335|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
163354313|NCT01841112|590007336|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
163354314|NCT01841112|590007337|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
163354315|NCT01841112|590007338|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
163354316|NCT01841112|590007339|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
163354317|NCT01880437|590007343|FG000|Overall Study|Death|12|||
163354318|NCT01880437|590007344|FG001|Overall Study|Death|4|||
163354319|NCT01880437|590007345|FG002|Overall Study|Death|17|||
163354320|NCT01880437|590007343|FG000|Overall Study|Study terminated by Sponsor|3|||
163354321|NCT01880437|590007344|FG001|Overall Study|Study terminated by Sponsor|0|||
163354322|NCT01880437|590007345|FG002|Overall Study|Study terminated by Sponsor|2|||
163354323|NCT01209598|590007346|FG000|Overall Study|Withdrawal by Subject|1|||
163354324|NCT01209598|590007347|FG001|Overall Study|Withdrawal by Subject|0|||
163354325|NCT01438840|590007348|FG000|Core Study|Adverse Event|0|||
163354326|NCT01438840|590007349|FG001|Core Study|Adverse Event|3|||
163354327|NCT01438840|590007350|FG002|Core Study|Adverse Event|0|||
163354328|NCT01438840|590007348|FG000|Core Study|Lack of Efficacy|15|||
163354329|NCT01438840|590007349|FG001|Core Study|Lack of Efficacy|7|||
163354330|NCT01438840|590007350|FG002|Core Study|Lack of Efficacy|0|||
163354331|NCT01438840|590007348|FG000|Core Study|Withdrawal of consent|1|||
163354332|NCT01438840|590007349|FG001|Core Study|Withdrawal of consent|0|||
163354333|NCT01438840|590007350|FG002|Core Study|Withdrawal of consent|0|||
163354334|NCT01438840|590007348|FG000|Extension Phase|Adverse Event|0|||
163354335|NCT01438840|590007349|FG001|Extension Phase|Adverse Event|0|||
163354336|NCT01438840|590007350|FG002|Extension Phase|Adverse Event|3|||
163354337|NCT01438840|590007348|FG000|Extension Phase|Lost to Follow-up|0|||
163354338|NCT01438840|590007349|FG001|Extension Phase|Lost to Follow-up|0|||
163354339|NCT01438840|590007350|FG002|Extension Phase|Lost to Follow-up|1|||
163354340|NCT01438840|590007348|FG000|Extension Phase|Withdrawal by Subject|0|||
163354341|NCT01438840|590007349|FG001|Extension Phase|Withdrawal by Subject|0|||
163354342|NCT01438840|590007350|FG002|Extension Phase|Withdrawal by Subject|3|||
163354343|NCT01438840|590007348|FG000|Extension Phase|Lack of Efficacy|0|||
163354344|NCT01438840|590007349|FG001|Extension Phase|Lack of Efficacy|0|||
163354345|NCT01438840|590007350|FG002|Extension Phase|Lack of Efficacy|2|||
163354346|NCT01438840|590007348|FG000|Extension Phase|Other|0|||
163354347|NCT01438840|590007349|FG001|Extension Phase|Other|0|||
163354348|NCT01438840|590007350|FG002|Extension Phase|Other|1|||
163354349|NCT00085566|590007352|FG000|Overall Study|Adverse Event|0|||
163354350|NCT00085566|590007353|FG001|Overall Study|Adverse Event|0|||
163354351|NCT00085566|590007354|FG002|Overall Study|Adverse Event|10|||
163354352|NCT00085566|590007352|FG000|Overall Study|Patient Not treated|0|||
163354353|NCT00085566|590007353|FG001|Overall Study|Patient Not treated|0|||
163354354|NCT00085566|590007354|FG002|Overall Study|Patient Not treated|3|||
163354355|NCT00085566|590007352|FG000|Overall Study|Clinical progression|0|||
163354356|NCT00085566|590007353|FG001|Overall Study|Clinical progression|0|||
163354357|NCT00085566|590007354|FG002|Overall Study|Clinical progression|1|||
163354358|NCT02604342|590007357|FG000|Overall Study|Death|32|||
163354359|NCT02604342|590007358|FG001|Overall Study|Death|16|||
163354360|NCT02604342|590007357|FG000|Overall Study|Progression of disease|1|||
163354361|NCT02604342|590007358|FG001|Overall Study|Progression of disease|0|||
163354362|NCT02604342|590007357|FG000|Overall Study|Withdrawal by Subject|5|||
163354363|NCT02604342|590007358|FG001|Overall Study|Withdrawal by Subject|6|||
163354364|NCT02604342|590007357|FG000|Overall Study|Other|1|||
163354365|NCT02604342|590007358|FG001|Overall Study|Other|0|||
163354366|NCT02604342|590007357|FG000|Overall Study|Study Termination by Sponsor|1|||
163354367|NCT02604342|590007358|FG001|Overall Study|Study Termination by Sponsor|0|||
163354368|NCT02604342|590007357|FG000|Overall Study|Lost to Follow-up|1|||
163354369|NCT02604342|590007358|FG001|Overall Study|Lost to Follow-up|1|||
163354370|NCT02604342|590007357|FG000|Overall Study|Physician Decision|2|||
163354371|NCT02604342|590007358|FG001|Overall Study|Physician Decision|0|||
163354372|NCT01702519|590007359|FG000|Washout Period|Lost to Follow-up|1|||
163354373|NCT01702519|590007360|FG001|Washout Period|Lost to Follow-up|0|||
163354374|NCT01702519|590007359|FG000|Washout Period|Withdrawal by Subject|0|||
163354375|NCT01702519|590007360|FG001|Washout Period|Withdrawal by Subject|2|||
163354376|NCT04688086|590007363|FG000|Overall Study|Lost to Follow-up|164|||
163354377|NCT04688086|590007363|FG000|Overall Study|Imaging error;|64|||
163354378|NCT00966264|590009507|FG000|Overall Study|Lost to Follow-up|4|||
163354379|NCT00966264|590009508|FG001|Overall Study|Lost to Follow-up|3|||
163354380|NCT03614676|590009509|FG000|Overall Study|Delivery before planned visit|2|||
163354381|NCT03614676|590009510|FG001|Overall Study|Delivery before planned visit|0|||
163354382|NCT03614676|590009509|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
163354383|NCT03614676|590009510|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
163354384|NCT03614676|590009509|FG000|Overall Study|Migrated / moved from the study area|30|||
163354385|NCT03614676|590009510|FG001|Overall Study|Migrated / moved from the study area|22|||
163354386|NCT03614676|590009509|FG000|Overall Study|Lost to Follow-up|17|||
163354387|NCT03614676|590009510|FG001|Overall Study|Lost to Follow-up|42|||
163354388|NCT03614676|590009509|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
163354389|NCT03614676|590009510|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
163354390|NCT03614676|590009509|FG000|Overall Study|Other|16|||
163354391|NCT03614676|590009510|FG001|Overall Study|Other|47|||
163354392|NCT03614676|590009509|FG000|Overall Study|Protocol Violation|0|||
163354393|NCT03614676|590009510|FG001|Overall Study|Protocol Violation|2|||
163354394|NCT03614676|590009509|FG000|Overall Study|Neonatal event of interest|0|||
163354395|NCT03614676|590009510|FG001|Overall Study|Neonatal event of interest|6|||
163354396|NCT03614676|590009509|FG000|Overall Study|Death in infant greater than 28 days old|0|||
163354397|NCT03614676|590009510|FG001|Overall Study|Death in infant greater than 28 days old|12|||
163354398|NCT03614676|590009509|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
163354399|NCT03614676|590009510|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
163354400|NCT00416598|590009511|FG000|Induction & Intensification|Adverse Event|38|||
163354401|NCT00416598|590009511|FG000|Induction & Intensification|Death|32|||
163354402|NCT00416598|590009511|FG000|Induction & Intensification|Withdrawal by Subject|46|||
163354403|NCT00416598|590009511|FG000|Induction & Intensification|Alternative Treatment|135|||
163354404|NCT00416598|590009511|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
163354405|NCT00416598|590009511|FG000|Induction & Intensification|Relapse/progression|29|||
163354406|NCT00416598|590009511|FG000|Induction & Intensification|Failed induction|87|||
163354407|NCT00416598|590009511|FG000|Decitabine Maintenance|Adverse Event|5|||
163354408|NCT00416598|590009511|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
163354409|NCT00416598|590009511|FG000|Decitabine Maintenance|Progression/relapse|38|||
163354410|NCT00416598|590009511|FG000|Decitabine Maintenance|Alternative treatment|2|||
163354411|NCT00416598|590009511|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
163354412|NCT02166476|590009518|FG000|Overall Study|Withdrawal by Subject|5|||
163354413|NCT02166476|590009519|FG001|Overall Study|Withdrawal by Subject|7|||
163354414|NCT02166476|590009518|FG000|Overall Study|Adverse Event|3|||
163354415|NCT02166476|590009519|FG001|Overall Study|Adverse Event|3|||
163149620|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
163149621|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
163149622|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
163149623|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
163149624|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
163246456|NCT03156023|589608531|FG002|Overall Study|Lost to Follow-up|0|||
163246457|NCT03156023|589608532|FG003|Overall Study|Lost to Follow-up|0|||
163246458|NCT03156023|589608533|FG004|Overall Study|Lost to Follow-up|1|||
163246459|NCT05819749|589608538|FG000|Overall Study|Lost to Follow-up|1|||
163246460|NCT00844857|589610840|FG000|Overall Study|Adverse Event|24|||
163246461|NCT00844857|589610841|FG001|Overall Study|Adverse Event|5|||
163246462|NCT00844857|589610840|FG000|Overall Study|Sponsor Decision|1|||
163246463|NCT00844857|589610841|FG001|Overall Study|Sponsor Decision|1|||
163246464|NCT00844857|589610840|FG000|Overall Study|Physician Decision|2|||
163246465|NCT00844857|589610841|FG001|Overall Study|Physician Decision|0|||
163246466|NCT00844857|589610840|FG000|Overall Study|Parent/Caregiver Decision|6|||
163246467|NCT00844857|589610841|FG001|Overall Study|Parent/Caregiver Decision|2|||
163246468|NCT00844857|589610840|FG000|Overall Study|Withdrawal by Subject|8|||
163246469|NCT00844857|589610841|FG001|Overall Study|Withdrawal by Subject|7|||
163246470|NCT00844857|589610840|FG000|Overall Study|Protocol Violation|6|||
163246471|NCT00844857|589610841|FG001|Overall Study|Protocol Violation|0|||
163246472|NCT00844857|589610840|FG000|Overall Study|Lack of Efficacy|5|||
163246473|NCT00844857|589610841|FG001|Overall Study|Lack of Efficacy|5|||
163246474|NCT00844857|589610840|FG000|Overall Study|Clinical Relapse|0|||
163246475|NCT00844857|589610841|FG001|Overall Study|Clinical Relapse|1|||
163246476|NCT00844857|589610840|FG000|Overall Study|Entry Criteria Not Met|0|||
163246477|NCT00844857|589610841|FG001|Overall Study|Entry Criteria Not Met|1|||
163246478|NCT00844857|589610840|FG000|Overall Study|Lost to Follow-up|2|||
163246479|NCT00844857|589610841|FG001|Overall Study|Lost to Follow-up|3|||
163246480|NCT00844857|589610840|FG000|Overall Study|Did Not Take Study Drug|3|||
163246481|NCT00844857|589610841|FG001|Overall Study|Did Not Take Study Drug|1|||
163246482|NCT00844857|589610840|FG000|Overall Study|Good Clinical Practice Violations|21|||
163246483|NCT00844857|589610841|FG001|Overall Study|Good Clinical Practice Violations|11|||
163246484|NCT00570674|589610842|FG000|Overall Study|Withdrawal by Subject|0|||
163246485|NCT00570674|589610843|FG001|Overall Study|Withdrawal by Subject|0|||
163246486|NCT00570674|589610844|FG002|Overall Study|Withdrawal by Subject|1|||
163246487|NCT00570674|589610845|FG003|Overall Study|Withdrawal by Subject|0|||
163246488|NCT00570674|589610846|FG004|Overall Study|Withdrawal by Subject|0|||
163246489|NCT00570674|589610847|FG005|Overall Study|Withdrawal by Subject|0|||
163246490|NCT00570674|589610848|FG006|Overall Study|Withdrawal by Subject|0|||
163246491|NCT03069482|589610849|FG000|Overall Study|Lost to Follow-up|0|||
163246492|NCT03069482|589610850|FG001|Overall Study|Lost to Follow-up|1|||
163246493|NCT03069482|589610849|FG000|Overall Study|Physician Decision|1|||
163246494|NCT03069482|589610850|FG001|Overall Study|Physician Decision|0|||
163246495|NCT02338154|589610862|FG000|Overall Study|Death|46|||
163246496|NCT02338154|589610862|FG000|Overall Study|Valve Implant Failure|17|||
163246497|NCT02338154|589610862|FG000|Overall Study|Valve Explant|11|||
163246498|NCT02338154|589610862|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
163246499|NCT02338154|589610862|FG000|Overall Study|Lost to Follow-up|8|||
163246500|NCT02338154|589610862|FG000|Overall Study|Other Reason|3|||
163246501|NCT02338154|589610862|FG000|Overall Study|Patients Without Exit Form|47|||
163246502|NCT02338154|589610862|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
163246503|NCT03393000|589610865|FG000|Overall Study|Death|11|||
163246504|NCT03393000|589610865|FG000|Overall Study|Withdrawal by Subject|2|||
163246505|NCT03393000|589610865|FG000|Overall Study|Physician Decision|1|||
163246506|NCT01773070|589610866|FG000|Overall Study|Withdrawal by Subject|24|||
163246507|NCT01773070|589610866|FG000|Overall Study|Lost to Follow-up|39|||
163246508|NCT01773070|589610866|FG000|Overall Study|Other|15|||
163246509|NCT01773070|589610866|FG000|Overall Study|Death (unrelated to study procedures)|3|||
163246510|NCT01559844|589610867|FG000|Overall Study|Consent Withdrawn|7|||
163246511|NCT01559844|589610867|FG000|Overall Study|Death|5|||
163246512|NCT01559844|589610867|FG000|Overall Study|Efficacy Failure|10|||
163246513|NCT01559844|589610867|FG000|Overall Study|No Longer A Transplant Candidate|3|||
163246514|NCT02181803|589610868|FG000|Overall Study|Withdrawal by Subject|0|||
163246515|NCT02181803|589610869|FG001|Overall Study|Withdrawal by Subject|2|||
163246516|NCT02181803|589610870|FG002|Overall Study|Withdrawal by Subject|0|||
163246517|NCT02181803|589610871|FG003|Overall Study|Withdrawal by Subject|0|||
163410289|NCT00903175|590211331|FG000|Period 2 - Second Line|Death|5|||
163410290|NCT00903175|590211332|FG001|Period 2 - Second Line|Death|2|||
163246518|NCT02181803|589610872|FG004|Overall Study|Withdrawal by Subject|0|||
163246519|NCT02181803|589610873|FG005|Overall Study|Withdrawal by Subject|0|||
163246520|NCT02181803|589610874|FG006|Overall Study|Withdrawal by Subject|0|||
163246521|NCT02181803|589610875|FG007|Overall Study|Withdrawal by Subject|0|||
163246522|NCT02181803|589610876|FG008|Overall Study|Withdrawal by Subject|0|||
163246523|NCT02181803|589610868|FG000|Overall Study|Physician Decision|0|||
163246524|NCT02181803|589610869|FG001|Overall Study|Physician Decision|0|||
163246525|NCT02181803|589610870|FG002|Overall Study|Physician Decision|0|||
163246526|NCT02181803|589610871|FG003|Overall Study|Physician Decision|1|||
163246527|NCT02181803|589610872|FG004|Overall Study|Physician Decision|0|||
163246528|NCT02181803|589610873|FG005|Overall Study|Physician Decision|0|||
163246529|NCT02181803|589610874|FG006|Overall Study|Physician Decision|0|||
163246530|NCT02181803|589610875|FG007|Overall Study|Physician Decision|1|||
163246531|NCT02181803|589610876|FG008|Overall Study|Physician Decision|0|||
163149625|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
163149626|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
163149627|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
163149628|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
163149629|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
163149630|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
163149631|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
163149632|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
163149633|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
163246532|NCT02181803|589610868|FG000|Overall Study|Adverse Event|0|||
163246533|NCT02181803|589610869|FG001|Overall Study|Adverse Event|2|||
163246534|NCT02181803|589610870|FG002|Overall Study|Adverse Event|0|||
163246535|NCT02181803|589610871|FG003|Overall Study|Adverse Event|1|||
163246536|NCT02181803|589610872|FG004|Overall Study|Adverse Event|0|||
163246537|NCT02181803|589610873|FG005|Overall Study|Adverse Event|0|||
163246538|NCT02181803|589610874|FG006|Overall Study|Adverse Event|1|||
163246539|NCT02181803|589610875|FG007|Overall Study|Adverse Event|0|||
163246540|NCT02181803|589610876|FG008|Overall Study|Adverse Event|0|||
163246541|NCT04786444|589610881|FG000|Overall Study|Withdrawal by Subject|4|||
163246542|NCT04786444|589610882|FG001|Overall Study|Withdrawal by Subject|7|||
163246543|NCT04786444|589610883|FG002|Overall Study|Withdrawal by Subject|2|||
163246544|NCT04786444|589610881|FG000|Overall Study|Lost to Follow-up|11|||
163246545|NCT04786444|589610882|FG001|Overall Study|Lost to Follow-up|9|||
163246546|NCT04786444|589610883|FG002|Overall Study|Lost to Follow-up|10|||
163246547|NCT04786444|589610881|FG000|Overall Study|Subject would like to become pregnant|0|||
163246548|NCT04786444|589610882|FG001|Overall Study|Subject would like to become pregnant|1|||
163246549|NCT04786444|589610883|FG002|Overall Study|Subject would like to become pregnant|0|||
163246550|NCT03166618|589610884|FG000|Overall Study|Study was Terminated|0|||
163246551|NCT03166618|589610885|FG001|Overall Study|Study was Terminated|1|||
163246552|NCT03137303|589610886|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
163246553|NCT03137303|589610887|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
163246554|NCT03137303|589610886|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
163246555|NCT03137303|589610887|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
163246556|NCT03137303|589610886|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
163246557|NCT03137303|589610887|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
163246558|NCT03137303|589610886|FG000|T3: 9-month Follow-up|Death|1|||
163246559|NCT03137303|589610887|FG001|T3: 9-month Follow-up|Death|0|||
163246560|NCT03137303|589610886|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
163246561|NCT03137303|589610887|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
163246562|NCT03137303|589610886|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
163246563|NCT03137303|589610887|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
163246564|NCT03137303|589610886|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
163246565|NCT03137303|589610887|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
163246566|NCT01217073|589610888|FG000|Base Period|Adverse Event|1|||
163246567|NCT01217073|589610889|FG001|Base Period|Adverse Event|0|||
163246568|NCT01217073|589610890|FG002|Base Period|Adverse Event|1|||
163246569|NCT01217073|589610891|FG003|Base Period|Adverse Event|0|||
163246570|NCT01217073|589610892|FG004|Base Period|Adverse Event|4|||
163246571|NCT01217073|589610893|FG005|Base Period|Adverse Event|1|||
163246572|NCT01217073|589610894|FG006|Base Period|Adverse Event|0|||
163246573|NCT01217073|589610895|FG007|Base Period|Adverse Event|0|||
163246574|NCT01217073|589610888|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
163246575|NCT01217073|589610889|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
163246576|NCT01217073|589610890|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
163246577|NCT01217073|589610891|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
163246578|NCT01217073|589610892|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
163246579|NCT01217073|589610893|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
163246580|NCT01217073|589610894|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
163246581|NCT01217073|589610895|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
163246582|NCT01217073|589610888|FG000|Base Period|Excluded medication|0|||
163246583|NCT01217073|589610889|FG001|Base Period|Excluded medication|0|||
163246584|NCT01217073|589610890|FG002|Base Period|Excluded medication|0|||
163246585|NCT01217073|589610891|FG003|Base Period|Excluded medication|0|||
163246586|NCT01217073|589610892|FG004|Base Period|Excluded medication|1|||
163246587|NCT01217073|589610893|FG005|Base Period|Excluded medication|0|||
163246588|NCT01217073|589610894|FG006|Base Period|Excluded medication|0|||
163246589|NCT01217073|589610895|FG007|Base Period|Excluded medication|0|||
163246590|NCT01217073|589610888|FG000|Base Period|Lack of Efficacy|0|||
163246591|NCT01217073|589610889|FG001|Base Period|Lack of Efficacy|0|||
163246592|NCT01217073|589610890|FG002|Base Period|Lack of Efficacy|0|||
163246593|NCT01217073|589610891|FG003|Base Period|Lack of Efficacy|0|||
163246594|NCT01217073|589610892|FG004|Base Period|Lack of Efficacy|0|||
163246595|NCT01217073|589610893|FG005|Base Period|Lack of Efficacy|1|||
163246596|NCT01217073|589610894|FG006|Base Period|Lack of Efficacy|0|||
163246597|NCT01217073|589610895|FG007|Base Period|Lack of Efficacy|0|||
163246598|NCT01217073|589610888|FG000|Base Period|Lost to Follow-up|0|||
163246599|NCT01217073|589610889|FG001|Base Period|Lost to Follow-up|0|||
163246600|NCT01217073|589610890|FG002|Base Period|Lost to Follow-up|1|||
163246601|NCT01217073|589610891|FG003|Base Period|Lost to Follow-up|1|||
163246602|NCT01217073|589610892|FG004|Base Period|Lost to Follow-up|3|||
163246603|NCT01217073|589610893|FG005|Base Period|Lost to Follow-up|0|||
163246604|NCT01217073|589610894|FG006|Base Period|Lost to Follow-up|0|||
163246605|NCT01217073|589610895|FG007|Base Period|Lost to Follow-up|0|||
163246606|NCT01217073|589610888|FG000|Base Period|Physician Decision|0|||
163246607|NCT01217073|589610889|FG001|Base Period|Physician Decision|0|||
163246608|NCT01217073|589610890|FG002|Base Period|Physician Decision|0|||
163246609|NCT01217073|589610891|FG003|Base Period|Physician Decision|0|||
163246610|NCT01217073|589610892|FG004|Base Period|Physician Decision|1|||
163246611|NCT01217073|589610893|FG005|Base Period|Physician Decision|0|||
163246612|NCT01217073|589610894|FG006|Base Period|Physician Decision|0|||
163246613|NCT01217073|589610895|FG007|Base Period|Physician Decision|0|||
163246614|NCT01217073|589610888|FG000|Base Period|Protocol Violation|1|||
163246615|NCT01217073|589610889|FG001|Base Period|Protocol Violation|0|||
163246616|NCT01217073|589610890|FG002|Base Period|Protocol Violation|0|||
163246617|NCT01217073|589610891|FG003|Base Period|Protocol Violation|0|||
163246618|NCT01217073|589610892|FG004|Base Period|Protocol Violation|1|||
163246619|NCT01217073|589610893|FG005|Base Period|Protocol Violation|2|||
163246620|NCT01217073|589610894|FG006|Base Period|Protocol Violation|0|||
163246621|NCT01217073|589610895|FG007|Base Period|Protocol Violation|0|||
163246622|NCT01217073|589610888|FG000|Base Period|Withdrawal by Subject|4|||
163246623|NCT01217073|589610889|FG001|Base Period|Withdrawal by Subject|5|||
163246624|NCT01217073|589610890|FG002|Base Period|Withdrawal by Subject|5|||
163246625|NCT01217073|589610891|FG003|Base Period|Withdrawal by Subject|1|||
163246626|NCT01217073|589610892|FG004|Base Period|Withdrawal by Subject|5|||
163246627|NCT01217073|589610893|FG005|Base Period|Withdrawal by Subject|5|||
163246628|NCT01217073|589610894|FG006|Base Period|Withdrawal by Subject|0|||
163246629|NCT01217073|589610895|FG007|Base Period|Withdrawal by Subject|0|||
163246630|NCT01217073|589610888|FG000|Extension Period|Adverse Event|0|||
163246631|NCT01217073|589610889|FG001|Extension Period|Adverse Event|0|||
163246632|NCT01217073|589610890|FG002|Extension Period|Adverse Event|0|||
163246633|NCT01217073|589610891|FG003|Extension Period|Adverse Event|0|||
163246634|NCT01217073|589610892|FG004|Extension Period|Adverse Event|0|||
163246635|NCT01217073|589610893|FG005|Extension Period|Adverse Event|0|||
163246636|NCT01217073|589610894|FG006|Extension Period|Adverse Event|19|||
163246637|NCT01217073|589610895|FG007|Extension Period|Adverse Event|5|||
163246638|NCT01217073|589610888|FG000|Extension Period|ALT/AST|0|||
163246639|NCT01217073|589610889|FG001|Extension Period|ALT/AST|0|||
163246640|NCT01217073|589610890|FG002|Extension Period|ALT/AST|0|||
163246641|NCT01217073|589610891|FG003|Extension Period|ALT/AST|0|||
163246642|NCT01217073|589610892|FG004|Extension Period|ALT/AST|0|||
163246643|NCT01217073|589610893|FG005|Extension Period|ALT/AST|0|||
163246644|NCT01217073|589610894|FG006|Extension Period|ALT/AST|2|||
163246645|NCT01217073|589610895|FG007|Extension Period|ALT/AST|0|||
163246646|NCT01217073|589610888|FG000|Extension Period|Contraindication to study medication|0|||
163246647|NCT01217073|589610889|FG001|Extension Period|Contraindication to study medication|0|||
163246648|NCT01217073|589610890|FG002|Extension Period|Contraindication to study medication|0|||
163246649|NCT01217073|589610891|FG003|Extension Period|Contraindication to study medication|0|||
163354416|NCT02166476|590009518|FG000|Overall Study|Lost to Follow-up|5|||
163354417|NCT02166476|590009519|FG001|Overall Study|Lost to Follow-up|10|||
163354418|NCT02166476|590009518|FG000|Overall Study|Physician Decision|1|||
163354419|NCT02166476|590009519|FG001|Overall Study|Physician Decision|0|||
163354420|NCT02166476|590009518|FG000|Overall Study|Unable to Come for Visit|0|||
163354421|NCT02166476|590009519|FG001|Overall Study|Unable to Come for Visit|3|||
163354422|NCT04523207|590009522|FG000|Overall Study|Adverse Event|5|||
163354423|NCT04523207|590009523|FG001|Overall Study|Adverse Event|1|||
163354424|NCT04523207|590009522|FG000|Overall Study|Lost to Follow-up|2|||
163354425|NCT04523207|590009523|FG001|Overall Study|Lost to Follow-up|0|||
163246650|NCT01217073|589610892|FG004|Extension Period|Contraindication to study medication|0|||
163246651|NCT01217073|589610893|FG005|Extension Period|Contraindication to study medication|0|||
163246652|NCT01217073|589610894|FG006|Extension Period|Contraindication to study medication|1|||
163246653|NCT01217073|589610895|FG007|Extension Period|Contraindication to study medication|0|||
163246654|NCT01217073|589610888|FG000|Extension Period|Creatinine/eGFR|0|||
163246655|NCT01217073|589610889|FG001|Extension Period|Creatinine/eGFR|0|||
163246656|NCT01217073|589610890|FG002|Extension Period|Creatinine/eGFR|0|||
163246657|NCT01217073|589610891|FG003|Extension Period|Creatinine/eGFR|0|||
163246658|NCT01217073|589610892|FG004|Extension Period|Creatinine/eGFR|0|||
163246659|NCT01217073|589610893|FG005|Extension Period|Creatinine/eGFR|0|||
163246660|NCT01217073|589610894|FG006|Extension Period|Creatinine/eGFR|11|||
163246661|NCT01217073|589610895|FG007|Extension Period|Creatinine/eGFR|1|||
163246662|NCT01217073|589610888|FG000|Extension Period|Death|0|||
163246663|NCT01217073|589610889|FG001|Extension Period|Death|0|||
163246664|NCT01217073|589610890|FG002|Extension Period|Death|0|||
163246665|NCT01217073|589610891|FG003|Extension Period|Death|0|||
163354426|NCT04523207|590009522|FG000|Overall Study|Withdrawal by Subject|2|||
163246666|NCT01217073|589610892|FG004|Extension Period|Death|0|||
163246667|NCT01217073|589610893|FG005|Extension Period|Death|0|||
163246668|NCT01217073|589610894|FG006|Extension Period|Death|1|||
163246669|NCT01217073|589610895|FG007|Extension Period|Death|0|||
163246670|NCT01217073|589610888|FG000|Extension Period|Excluded medication|0|||
163246671|NCT01217073|589610889|FG001|Extension Period|Excluded medication|0|||
163246672|NCT01217073|589610890|FG002|Extension Period|Excluded medication|0|||
163246673|NCT01217073|589610891|FG003|Extension Period|Excluded medication|0|||
163246674|NCT01217073|589610892|FG004|Extension Period|Excluded medication|0|||
163246675|NCT01217073|589610893|FG005|Extension Period|Excluded medication|0|||
163246676|NCT01217073|589610894|FG006|Extension Period|Excluded medication|2|||
163246677|NCT01217073|589610895|FG007|Extension Period|Excluded medication|0|||
163246678|NCT01217073|589610888|FG000|Extension Period|Lack of Efficacy|0|||
163246679|NCT01217073|589610889|FG001|Extension Period|Lack of Efficacy|0|||
163246680|NCT01217073|589610890|FG002|Extension Period|Lack of Efficacy|0|||
163246681|NCT01217073|589610891|FG003|Extension Period|Lack of Efficacy|0|||
163246682|NCT01217073|589610892|FG004|Extension Period|Lack of Efficacy|0|||
163246683|NCT01217073|589610893|FG005|Extension Period|Lack of Efficacy|0|||
163246684|NCT01217073|589610894|FG006|Extension Period|Lack of Efficacy|3|||
163246685|NCT01217073|589610895|FG007|Extension Period|Lack of Efficacy|0|||
163246686|NCT01217073|589610888|FG000|Extension Period|Lost to Follow-up|0|||
163246687|NCT01217073|589610889|FG001|Extension Period|Lost to Follow-up|0|||
163246688|NCT01217073|589610890|FG002|Extension Period|Lost to Follow-up|0|||
163246689|NCT01217073|589610891|FG003|Extension Period|Lost to Follow-up|0|||
163246690|NCT01217073|589610892|FG004|Extension Period|Lost to Follow-up|0|||
163246691|NCT01217073|589610893|FG005|Extension Period|Lost to Follow-up|0|||
163246692|NCT01217073|589610894|FG006|Extension Period|Lost to Follow-up|9|||
163246693|NCT01217073|589610895|FG007|Extension Period|Lost to Follow-up|1|||
163246694|NCT01217073|589610888|FG000|Extension Period|Non-compliance with study drug|0|||
163246695|NCT01217073|589610889|FG001|Extension Period|Non-compliance with study drug|0|||
163246696|NCT01217073|589610890|FG002|Extension Period|Non-compliance with study drug|0|||
163246697|NCT01217073|589610891|FG003|Extension Period|Non-compliance with study drug|0|||
163246698|NCT01217073|589610892|FG004|Extension Period|Non-compliance with study drug|0|||
163246699|NCT01217073|589610893|FG005|Extension Period|Non-compliance with study drug|0|||
163246700|NCT01217073|589610894|FG006|Extension Period|Non-compliance with study drug|0|||
163246701|NCT01217073|589610895|FG007|Extension Period|Non-compliance with study drug|1|||
163246702|NCT01217073|589610888|FG000|Extension Period|Physician Decision|0|||
163246703|NCT01217073|589610889|FG001|Extension Period|Physician Decision|0|||
163246704|NCT01217073|589610890|FG002|Extension Period|Physician Decision|0|||
163246705|NCT01217073|589610891|FG003|Extension Period|Physician Decision|0|||
163246706|NCT01217073|589610892|FG004|Extension Period|Physician Decision|0|||
163246707|NCT01217073|589610893|FG005|Extension Period|Physician Decision|0|||
163246708|NCT01217073|589610894|FG006|Extension Period|Physician Decision|4|||
163246709|NCT01217073|589610895|FG007|Extension Period|Physician Decision|1|||
163246710|NCT01217073|589610888|FG000|Extension Period|Protocol Violation|0|||
163246711|NCT01217073|589610889|FG001|Extension Period|Protocol Violation|0|||
163246712|NCT01217073|589610890|FG002|Extension Period|Protocol Violation|0|||
163246713|NCT01217073|589610891|FG003|Extension Period|Protocol Violation|0|||
163246714|NCT01217073|589610892|FG004|Extension Period|Protocol Violation|0|||
163246715|NCT01217073|589610893|FG005|Extension Period|Protocol Violation|0|||
163246716|NCT01217073|589610894|FG006|Extension Period|Protocol Violation|2|||
163246717|NCT01217073|589610895|FG007|Extension Period|Protocol Violation|1|||
163246718|NCT01217073|589610888|FG000|Extension Period|Site discontinued study participation|0|||
163246719|NCT01217073|589610889|FG001|Extension Period|Site discontinued study participation|0|||
163246720|NCT01217073|589610890|FG002|Extension Period|Site discontinued study participation|0|||
163246721|NCT01217073|589610891|FG003|Extension Period|Site discontinued study participation|0|||
163246722|NCT01217073|589610892|FG004|Extension Period|Site discontinued study participation|0|||
163246723|NCT01217073|589610893|FG005|Extension Period|Site discontinued study participation|0|||
163246724|NCT01217073|589610894|FG006|Extension Period|Site discontinued study participation|7|||
163246725|NCT01217073|589610895|FG007|Extension Period|Site discontinued study participation|2|||
163246726|NCT01217073|589610888|FG000|Extension Period|Withdrawal by Subject|0|||
163246727|NCT01217073|589610889|FG001|Extension Period|Withdrawal by Subject|0|||
163354427|NCT04523207|590009523|FG001|Overall Study|Withdrawal by Subject|0|||
163354428|NCT04523207|590009522|FG000|Overall Study|Progressive Disease|2|||
163246728|NCT01217073|589610890|FG002|Extension Period|Withdrawal by Subject|0|||
163246729|NCT01217073|589610891|FG003|Extension Period|Withdrawal by Subject|0|||
163246730|NCT01217073|589610892|FG004|Extension Period|Withdrawal by Subject|0|||
163246731|NCT01217073|589610893|FG005|Extension Period|Withdrawal by Subject|0|||
163246732|NCT01217073|589610894|FG006|Extension Period|Withdrawal by Subject|30|||
163246733|NCT01217073|589610895|FG007|Extension Period|Withdrawal by Subject|8|||
163246734|NCT03561090|589610896|FG000|Overall Study|Adverse Event|11|||
163246735|NCT03561090|589610897|FG001|Overall Study|Adverse Event|7|||
163246736|NCT03561090|589610896|FG000|Overall Study|Non-Compliance With Study Drug|2|||
163246737|NCT03561090|589610897|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163246738|NCT03561090|589610896|FG000|Overall Study|Protocol Violation|2|||
163354429|NCT04523207|590009523|FG001|Overall Study|Progressive Disease|1|||
163354430|NCT04523207|590009522|FG000|Overall Study|Other|7|||
163354431|NCT04523207|590009523|FG001|Overall Study|Other|1|||
163354432|NCT03113383|590009524|FG000|Overall Study|Death|4|||
163354433|NCT03113383|590009525|FG001|Overall Study|Death|0|||
163354434|NCT04469465|590009526|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
163354435|NCT04469465|590009527|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
163354436|NCT04469465|590009526|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
163354437|NCT04469465|590009527|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
163354438|NCT04469465|590009526|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
163354439|NCT04469465|590009527|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
163354440|NCT04469465|590009526|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
163354441|NCT04469465|590009527|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
163354442|NCT04469465|590009526|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
163354443|NCT04469465|590009527|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
163354444|NCT04469465|590009526|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
163354445|NCT04469465|590009527|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
163354446|NCT04469465|590009526|FG000|Long-Term Extension (LTE)|Death|0|||
163354447|NCT04469465|590009527|FG001|Long-Term Extension (LTE)|Death|1|||
163354448|NCT04469465|590009526|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
163354449|NCT04469465|590009527|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
163354450|NCT02641587|590009528|FG000|Confinement Period|Adverse Event|1|||
163354451|NCT02641587|590009529|FG001|Confinement Period|Adverse Event|0|||
163354452|NCT02641587|590009528|FG000|Confinement Period|Withdrawal by Subject|2|||
163354453|NCT02641587|590009529|FG001|Confinement Period|Withdrawal by Subject|1|||
163354454|NCT02641587|590009528|FG000|Ambulatory Period|Withdrawal by Subject|1|||
163354455|NCT02641587|590009529|FG001|Ambulatory Period|Withdrawal by Subject|0|||
163354456|NCT01150045|590009533|FG000|Overall Study|Protocol Violation|0|||
163354457|NCT01150045|590009534|FG001|Overall Study|Protocol Violation|1|||
163354458|NCT01150045|590009535|FG002|Overall Study|Protocol Violation|0|||
163354459|NCT01150045|590009536|FG003|Overall Study|Protocol Violation|1|||
163354460|NCT03194867|590009537|FG000|Overall Study|Incorrect completion of end of study form|0|||
163354461|NCT03194867|590009538|FG001|Overall Study|Incorrect completion of end of study form|0|||
163354462|NCT03194867|590009539|FG002|Overall Study|Incorrect completion of end of study form|1|||
163354463|NCT03194867|590009540|FG003|Overall Study|Incorrect completion of end of study form|0|||
163354464|NCT00464945|590009541|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
163354465|NCT00464945|590009542|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
163354466|NCT00464945|590009541|FG000|Infant Series|Protocol Violation|1|||
163354467|NCT00464945|590009542|FG001|Infant Series|Protocol Violation|0|||
163354468|NCT00464945|590009541|FG000|Infant Series|Lost to Follow-up|1|||
163354469|NCT00464945|590009542|FG001|Infant Series|Lost to Follow-up|0|||
163354470|NCT00464945|590009541|FG000|After Infant Series|Withdrawal by Subject|0|||
163354471|NCT00464945|590009542|FG001|After Infant Series|Withdrawal by Subject|2|||
163354472|NCT00464945|590009541|FG000|Toddler Dose|Lost to Follow-up|0|||
163354473|NCT00464945|590009542|FG001|Toddler Dose|Lost to Follow-up|1|||
163354474|NCT02094898|590009546|FG000|Overall Study|Clinical Worsening|2|||
163354475|NCT02094898|590009546|FG000|Overall Study|Adverse Event|2|||
163354476|NCT02094898|590009546|FG000|Overall Study|Lack of Efficacy|1|||
163354477|NCT03520075|590009547|FG000|Phase 1 (Dose Escalation)|Death|2|||
163354478|NCT03520075|590009548|FG001|Phase 1 (Dose Escalation)|Death|2|||
163354479|NCT03520075|590009549|FG002|Phase 1 (Dose Escalation)|Death|3|||
163354480|NCT03520075|590009550|FG003|Phase 1 (Dose Escalation)|Death|2|||
163354481|NCT03520075|590009551|FG004|Phase 1 (Dose Escalation)|Death|6|||
163354482|NCT03520075|590009552|FG005|Phase 1 (Dose Escalation)|Death|5|||
163354483|NCT03520075|590009553|FG006|Phase 1 (Dose Escalation)|Death|3|||
163246739|NCT03561090|589610897|FG001|Overall Study|Protocol Violation|2|||
163246740|NCT03561090|589610896|FG000|Overall Study|Withdrawal by Subject|7|||
163246741|NCT03561090|589610897|FG001|Overall Study|Withdrawal by Subject|7|||
163246742|NCT03561090|589610896|FG000|Overall Study|Lost to Follow-up|7|||
163246743|NCT03561090|589610897|FG001|Overall Study|Lost to Follow-up|2|||
163246744|NCT03561090|589610896|FG000|Overall Study|Study Terminated by Sponsor|10|||
163246745|NCT03561090|589610897|FG001|Overall Study|Study Terminated by Sponsor|15|||
163246746|NCT03561090|589610896|FG000|Overall Study|Randomized by Mistake|1|||
163246747|NCT03561090|589610897|FG001|Overall Study|Randomized by Mistake|1|||
163246748|NCT03561090|589610896|FG000|Overall Study|Other Not Specified|0|||
163246749|NCT03561090|589610897|FG001|Overall Study|Other Not Specified|2|||
163246750|NCT00725452|589610904|FG000|Overall Study|Adverse Event|3|||
163246751|NCT00725452|589610904|FG000|Overall Study|Lack of Efficacy|2|||
163246752|NCT00725452|589610904|FG000|Overall Study|Reason not specified|1|||
163246753|NCT00725452|589610904|FG000|Overall Study|Physician Decision|1|||
163246754|NCT00725452|589610904|FG000|Overall Study|Withdrawal by Subject|3|||
163246755|NCT00725452|589610904|FG000|Overall Study|Lost to Follow-up|1|||
163246756|NCT00713648|589610906|FG000|Overall Study|Adverse Event|1|||
163246757|NCT00713648|589610906|FG000|Overall Study|Unclassified|2|||
163246758|NCT00713648|589610906|FG000|Overall Study|According to Protocol|2|||
163246759|NCT00713648|589610906|FG000|Overall Study|Development of antibodies|3|||
163246760|NCT02696317|589610909|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
163246761|NCT02696317|589610910|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
163246762|NCT02696317|589610909|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
163246763|NCT02696317|589610910|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
163246764|NCT01343368|589610911|FG000|Overall Study|Death|1|||
163246765|NCT01343368|589610912|FG001|Overall Study|Death|0|||
163246766|NCT01343368|589610911|FG000|Overall Study|Lost to Follow-up|1|||
163246767|NCT01343368|589610912|FG001|Overall Study|Lost to Follow-up|0|||
163246768|NCT00237744|589610913|FG000|Overall Study|Withdrawal by Subject|3|||
163246769|NCT00237744|589610914|FG001|Overall Study|Withdrawal by Subject|1|||
163246770|NCT00237744|589610915|FG002|Overall Study|Withdrawal by Subject|0|||
163246771|NCT03117738|589610916|FG000|Overall Study|Withdrawal by Subject|3|||
163246772|NCT03117738|589610917|FG001|Overall Study|Withdrawal by Subject|1|||
163246773|NCT03117738|589610916|FG000|Overall Study|Lost to Follow-up|1|||
163246774|NCT03117738|589610917|FG001|Overall Study|Lost to Follow-up|4|||
163246775|NCT02015676|589610918|FG000|Overall Study|Adverse Event|2|||
163246776|NCT02015676|589610919|FG001|Overall Study|Adverse Event|18|||
163246777|NCT02015676|589610920|FG002|Overall Study|Adverse Event|0|||
163246778|NCT02015676|589610918|FG000|Overall Study|Lack of Efficacy|2|||
163246779|NCT02015676|589610919|FG001|Overall Study|Lack of Efficacy|4|||
163246780|NCT02015676|589610920|FG002|Overall Study|Lack of Efficacy|0|||
163246781|NCT02015676|589610918|FG000|Overall Study|Protocol Violation|1|||
163246782|NCT02015676|589610919|FG001|Overall Study|Protocol Violation|0|||
163246783|NCT02015676|589610920|FG002|Overall Study|Protocol Violation|0|||
163246784|NCT02015676|589610918|FG000|Overall Study|Withdrawal by Subject|1|||
163246785|NCT02015676|589610919|FG001|Overall Study|Withdrawal by Subject|7|||
163246786|NCT02015676|589610920|FG002|Overall Study|Withdrawal by Subject|1|||
163246787|NCT02015676|589610918|FG000|Overall Study|Administrative reasons|0|||
163246788|NCT02015676|589610919|FG001|Overall Study|Administrative reasons|3|||
163246789|NCT02015676|589610920|FG002|Overall Study|Administrative reasons|1|||
163246790|NCT02015676|589610918|FG000|Overall Study|Death|0|||
163246791|NCT02015676|589610919|FG001|Overall Study|Death|1|||
163246792|NCT02015676|589610920|FG002|Overall Study|Death|0|||
163246793|NCT02015676|589610918|FG000|Overall Study|Disease progression|3|||
163246794|NCT02015676|589610919|FG001|Overall Study|Disease progression|1|||
163246795|NCT02015676|589610920|FG002|Overall Study|Disease progression|1|||
163246796|NCT00476476|589610922|FG000|Overall Study|Adverse Event|2|||
163246797|NCT00476476|589610923|FG001|Overall Study|Adverse Event|7|||
163246798|NCT00476476|589610922|FG000|Overall Study|Progressive Disease|0|||
163246799|NCT00476476|589610923|FG001|Overall Study|Progressive Disease|17|||
163246800|NCT00971048|589610927|FG000|Overall Study|Protocol Violation|1|||
163246801|NCT00971048|589610928|FG001|Overall Study|Protocol Violation|2|||
163246802|NCT00971048|589610929|FG002|Overall Study|Protocol Violation|0|||
163246803|NCT00971048|589610930|FG003|Overall Study|Protocol Violation|1|||
163246804|NCT00971048|589610927|FG000|Overall Study|Adverse Event|0|||
163246805|NCT00971048|589610928|FG001|Overall Study|Adverse Event|0|||
163246806|NCT00971048|589610929|FG002|Overall Study|Adverse Event|1|||
163246807|NCT00971048|589610930|FG003|Overall Study|Adverse Event|0|||
163246808|NCT00971048|589610927|FG000|Overall Study|Physician Decision|0|||
163246809|NCT00971048|589610928|FG001|Overall Study|Physician Decision|0|||
163246810|NCT00971048|589610929|FG002|Overall Study|Physician Decision|0|||
163246811|NCT00971048|589610930|FG003|Overall Study|Physician Decision|1|||
163246812|NCT01715805|589610934|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
163246813|NCT01715805|589610935|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
163246814|NCT01715805|589610936|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
163246815|NCT01715805|589610937|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
163246816|NCT01715805|589610934|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
163246817|NCT01715805|589610935|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
163246818|NCT01715805|589610936|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
163246819|NCT01715805|589610937|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
163246820|NCT01715805|589610934|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
163246821|NCT01715805|589610935|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
163246822|NCT01715805|589610936|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
163246823|NCT01715805|589610937|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
163246824|NCT01715805|589610934|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
163246825|NCT01715805|589610935|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
163246826|NCT01715805|589610936|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
163246827|NCT01715805|589610937|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
163246828|NCT01715805|589610934|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
163246829|NCT01715805|589610935|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
163246830|NCT01715805|589610936|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
163246831|NCT01715805|589610937|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
163246832|NCT01715805|589610934|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
163246833|NCT01715805|589610935|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
163246834|NCT01715805|589610936|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
163246835|NCT01715805|589610937|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
163246836|NCT01715805|589610934|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
163246837|NCT01715805|589610935|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
163246838|NCT01715805|589610936|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
163246839|NCT01715805|589610937|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
163246840|NCT01715805|589610934|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
163246841|NCT01715805|589610935|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
163246842|NCT01715805|589610936|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
163246843|NCT01715805|589610937|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
163246844|NCT01715805|589610934|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
163246845|NCT01715805|589610935|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
163246846|NCT01715805|589610936|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
163246847|NCT01715805|589610937|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
163246848|NCT01715805|589610934|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
163246849|NCT01715805|589610935|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
163246850|NCT01715805|589610936|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
163246851|NCT01715805|589610937|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
163246852|NCT01715805|589610934|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
163246853|NCT01715805|589610935|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
163246854|NCT01715805|589610936|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
163246855|NCT01715805|589610937|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
163246856|NCT01715805|589610934|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
163246857|NCT01715805|589610935|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
163246858|NCT01715805|589610936|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
163246859|NCT01715805|589610937|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
163246860|NCT01715805|589610934|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
163246861|NCT01715805|589610935|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
163246862|NCT01715805|589610936|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
163246863|NCT01715805|589610937|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
163246864|NCT01715805|589610934|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
163246865|NCT01715805|589610935|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
163246866|NCT01715805|589610936|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
163246867|NCT01715805|589610937|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
163246868|NCT00413413|589610940|FG000|Single-Blind|Adverse Event|0|||
163246869|NCT00413413|589610941|FG001|Single-Blind|Adverse Event|9|||
163246870|NCT00413413|589610942|FG002|Single-Blind|Adverse Event|0|||
163246871|NCT00413413|589610940|FG000|Single-Blind|Lack of Efficacy|0|||
163246872|NCT00413413|589610941|FG001|Single-Blind|Lack of Efficacy|5|||
163246873|NCT00413413|589610942|FG002|Single-Blind|Lack of Efficacy|0|||
163246874|NCT00413413|589610940|FG000|Single-Blind|Subject no longer requires study drug|0|||
163246875|NCT00413413|589610941|FG001|Single-Blind|Subject no longer requires study drug|151|||
163246876|NCT00413413|589610942|FG002|Single-Blind|Subject no longer requires study drug|0|||
163246877|NCT00413413|589610940|FG000|Single-Blind|Protocol Violation|0|||
163246878|NCT00413413|589610941|FG001|Single-Blind|Protocol Violation|16|||
163246879|NCT00413413|589610942|FG002|Single-Blind|Protocol Violation|0|||
163246880|NCT00413413|589610940|FG000|Single-Blind|Withdrawal by Subject|0|||
163246881|NCT00413413|589610941|FG001|Single-Blind|Withdrawal by Subject|27|||
163246882|NCT00413413|589610942|FG002|Single-Blind|Withdrawal by Subject|0|||
163246883|NCT00413413|589610940|FG000|Single-Blind|Lost to Follow-up|0|||
163246884|NCT00413413|589610941|FG001|Single-Blind|Lost to Follow-up|8|||
163246885|NCT00413413|589610942|FG002|Single-Blind|Lost to Follow-up|0|||
163246886|NCT00413413|589610940|FG000|Double-Blind|Adverse Event|6|||
163246887|NCT00413413|589610941|FG001|Double-Blind|Adverse Event|0|||
163246888|NCT00413413|589610942|FG002|Double-Blind|Adverse Event|5|||
163246889|NCT00413413|589610940|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
163246890|NCT00413413|589610941|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
163246891|NCT00413413|589610942|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
163246892|NCT00413413|589610940|FG000|Double-Blind|Protocol deviation|1|||
163246893|NCT00413413|589610941|FG001|Double-Blind|Protocol deviation|2|||
163246894|NCT00413413|589610942|FG002|Double-Blind|Protocol deviation|1|||
163246895|NCT00413413|589610940|FG000|Double-Blind|Subject withdrew consent|4|||
163246896|NCT00413413|589610941|FG001|Double-Blind|Subject withdrew consent|6|||
163246897|NCT00413413|589610942|FG002|Double-Blind|Subject withdrew consent|9|||
163246898|NCT00413413|589610940|FG000|Double-Blind|Lost to Follow-up|3|||
163246899|NCT00413413|589610941|FG001|Double-Blind|Lost to Follow-up|4|||
163246900|NCT00413413|589610942|FG002|Double-Blind|Lost to Follow-up|2|||
163246901|NCT00214136|589610944|FG000|Overall Study|Death|5|||
163246902|NCT04313634|589610945|FG000|Overall Study|Adverse Event|2|||
163246903|NCT04313634|589610946|FG001|Overall Study|Adverse Event|2|||
163246904|NCT04313634|589610947|FG002|Overall Study|Adverse Event|0|||
163246905|NCT04313634|589610945|FG000|Overall Study|Withdrawal by Subject|1|||
163354484|NCT03520075|590009554|FG007|Phase 1 (Dose Escalation)|Death|2|||
163354485|NCT03520075|590009555|FG008|Phase 1 (Dose Escalation)|Death|3|||
163354486|NCT03520075|590009556|FG009|Phase 1 (Dose Escalation)|Death|1|||
163354487|NCT03520075|590009557|FG010|Phase 1 (Dose Escalation)|Death|5|||
163354488|NCT03520075|590009558|FG011|Phase 1 (Dose Escalation)|Death|7|||
163354489|NCT03520075|590009559|FG012|Phase 1 (Dose Escalation)|Death|11|||
163354490|NCT03520075|590009560|FG013|Phase 1 (Dose Escalation)|Death|0|||
163354491|NCT03520075|590009561|FG014|Phase 1 (Dose Escalation)|Death|0|||
163354492|NCT03520075|590009562|FG015|Phase 1 (Dose Escalation)|Death|0|||
163354493|NCT03520075|590009563|FG016|Phase 1 (Dose Escalation)|Death|0|||
163354494|NCT03520075|590009564|FG017|Phase 1 (Dose Escalation)|Death|0|||
163354495|NCT03520075|590009565|FG018|Phase 1 (Dose Escalation)|Death|0|||
163354496|NCT03520075|590009547|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
163354497|NCT03520075|590009548|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163354498|NCT03520075|590009549|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163354499|NCT03520075|590009550|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
163354500|NCT03520075|590009551|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
163354501|NCT03520075|590009552|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
163354502|NCT03520075|590009553|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163354503|NCT03520075|590009554|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
163354504|NCT03520075|590009555|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163354505|NCT03520075|590009556|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
163354506|NCT03520075|590009557|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163354507|NCT03520075|590009558|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163354508|NCT03520075|590009559|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
163354509|NCT03520075|590009560|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163354510|NCT03520075|590009561|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163354511|NCT03520075|590009562|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163354512|NCT03520075|590009563|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163354513|NCT03520075|590009564|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163354514|NCT03520075|590009565|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163354515|NCT03520075|590009547|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163354516|NCT03520075|590009548|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
163354517|NCT03520075|590009549|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163354518|NCT03520075|590009550|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
163354519|NCT03520075|590009551|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
163354520|NCT03520075|590009552|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163354521|NCT03520075|590009553|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163354522|NCT03520075|590009554|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163354523|NCT03520075|590009555|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163354524|NCT03520075|590009556|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163246906|NCT04313634|589610946|FG001|Overall Study|Withdrawal by Subject|0|||
163246907|NCT04313634|589610947|FG002|Overall Study|Withdrawal by Subject|1|||
163246908|NCT04313634|589610945|FG000|Overall Study|Protocol Violation|0|||
163246909|NCT04313634|589610946|FG001|Overall Study|Protocol Violation|0|||
163246910|NCT04313634|589610947|FG002|Overall Study|Protocol Violation|1|||
163246911|NCT00319098|589610950|FG000|Overall Study|Serious adverse event|3|||
163246912|NCT00319098|589610951|FG001|Overall Study|Serious adverse event|0|||
163246913|NCT00319098|589610950|FG000|Overall Study|Adverse Event|20|||
163246914|NCT00319098|589610951|FG001|Overall Study|Adverse Event|1|||
163246915|NCT00319098|589610950|FG000|Overall Study|Withdrawal by Subject|37|||
163246916|NCT00319098|589610951|FG001|Overall Study|Withdrawal by Subject|8|||
163246917|NCT00319098|589610950|FG000|Overall Study|Migrated/moved from study area|2|||
163246918|NCT00319098|589610951|FG001|Overall Study|Migrated/moved from study area|1|||
163246919|NCT00319098|589610950|FG000|Overall Study|Lost to Follow-up|37|||
163246920|NCT00319098|589610951|FG001|Overall Study|Lost to Follow-up|13|||
163246921|NCT00319098|589610950|FG000|Overall Study|Others|33|||
163246922|NCT00319098|589610951|FG001|Overall Study|Others|8|||
163246923|NCT00319098|589610950|FG000|Overall Study|Protocol Violation|3|||
163246924|NCT00319098|589610951|FG001|Overall Study|Protocol Violation|1|||
163246925|NCT03449030|589610952|FG000|Overall Study|Withdrawal by Subject|0|||
163246926|NCT03449030|589610953|FG001|Overall Study|Withdrawal by Subject|0|||
163246927|NCT03449030|589610954|FG002|Overall Study|Withdrawal by Subject|0|||
163246928|NCT03449030|589610955|FG003|Overall Study|Withdrawal by Subject|1|||
163246929|NCT03449030|589610956|FG004|Overall Study|Withdrawal by Subject|1|||
163354525|NCT03520075|590009557|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
163354526|NCT03520075|590009558|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163354527|NCT03520075|590009559|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
163246930|NCT03449030|589610957|FG005|Overall Study|Withdrawal by Subject|1|||
163246931|NCT03449030|589610958|FG006|Overall Study|Withdrawal by Subject|1|||
163246932|NCT03449030|589610959|FG007|Overall Study|Withdrawal by Subject|2|||
163246933|NCT03449030|589610960|FG008|Overall Study|Withdrawal by Subject|0|||
163246934|NCT03449030|589610961|FG009|Overall Study|Withdrawal by Subject|0|||
163246935|NCT03449030|589610952|FG000|Overall Study|Symptomatic Deterioration|0|||
163246936|NCT03449030|589610953|FG001|Overall Study|Symptomatic Deterioration|1|||
163246937|NCT03449030|589610954|FG002|Overall Study|Symptomatic Deterioration|0|||
163246938|NCT03449030|589610955|FG003|Overall Study|Symptomatic Deterioration|0|||
163246939|NCT03449030|589610956|FG004|Overall Study|Symptomatic Deterioration|0|||
163246940|NCT03449030|589610957|FG005|Overall Study|Symptomatic Deterioration|1|||
163246941|NCT03449030|589610958|FG006|Overall Study|Symptomatic Deterioration|1|||
163246942|NCT03449030|589610959|FG007|Overall Study|Symptomatic Deterioration|0|||
163246943|NCT03449030|589610960|FG008|Overall Study|Symptomatic Deterioration|2|||
163246944|NCT03449030|589610961|FG009|Overall Study|Symptomatic Deterioration|0|||
163246945|NCT03449030|589610952|FG000|Overall Study|Progressive Disease|1|||
163246946|NCT03449030|589610953|FG001|Overall Study|Progressive Disease|0|||
163246947|NCT03449030|589610954|FG002|Overall Study|Progressive Disease|1|||
163246948|NCT03449030|589610955|FG003|Overall Study|Progressive Disease|4|||
163246949|NCT03449030|589610956|FG004|Overall Study|Progressive Disease|5|||
163246950|NCT03449030|589610957|FG005|Overall Study|Progressive Disease|3|||
163246951|NCT03449030|589610958|FG006|Overall Study|Progressive Disease|0|||
163246952|NCT03449030|589610959|FG007|Overall Study|Progressive Disease|1|||
163246953|NCT03449030|589610960|FG008|Overall Study|Progressive Disease|1|||
163246954|NCT03449030|589610961|FG009|Overall Study|Progressive Disease|1|||
163246955|NCT03449030|589610952|FG000|Overall Study|Adverse Event|0|||
163246956|NCT03449030|589610953|FG001|Overall Study|Adverse Event|0|||
163246957|NCT03449030|589610954|FG002|Overall Study|Adverse Event|0|||
163246958|NCT03449030|589610955|FG003|Overall Study|Adverse Event|0|||
163246959|NCT03449030|589610956|FG004|Overall Study|Adverse Event|0|||
163246960|NCT03449030|589610957|FG005|Overall Study|Adverse Event|2|||
163246961|NCT03449030|589610958|FG006|Overall Study|Adverse Event|0|||
163246962|NCT03449030|589610959|FG007|Overall Study|Adverse Event|0|||
163246963|NCT03449030|589610960|FG008|Overall Study|Adverse Event|0|||
163246964|NCT03449030|589610961|FG009|Overall Study|Adverse Event|0|||
163246965|NCT03449030|589610952|FG000|Overall Study|Death|0|||
163246966|NCT03449030|589610953|FG001|Overall Study|Death|0|||
163246967|NCT03449030|589610954|FG002|Overall Study|Death|0|||
163246968|NCT03449030|589610955|FG003|Overall Study|Death|0|||
163246969|NCT03449030|589610956|FG004|Overall Study|Death|1|||
163246970|NCT03449030|589610957|FG005|Overall Study|Death|0|||
163246971|NCT03449030|589610958|FG006|Overall Study|Death|0|||
163246972|NCT03449030|589610959|FG007|Overall Study|Death|0|||
163246973|NCT03449030|589610960|FG008|Overall Study|Death|0|||
163246974|NCT03449030|589610961|FG009|Overall Study|Death|0|||
163246975|NCT03595904|589610964|FG000|Overall Study|Protocol Violation|3|||
163246976|NCT03595904|589610965|FG001|Overall Study|Protocol Violation|1|||
163246977|NCT03595904|589610964|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
163246978|NCT03595904|589610965|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
163246979|NCT03595904|589610964|FG000|Overall Study|Insurance complications|1|||
163246980|NCT03595904|589610965|FG001|Overall Study|Insurance complications|0|||
163246981|NCT03595904|589610964|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
163246982|NCT03595904|589610965|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
163246983|NCT02187991|589610966|FG000|Overall Study|Adverse Event|13|||
163246984|NCT02187991|589610967|FG001|Overall Study|Adverse Event|14|||
163246985|NCT02187991|589610968|FG002|Overall Study|Adverse Event|3|||
163246986|NCT02187991|589610969|FG003|Overall Study|Adverse Event|2|||
163246987|NCT02187991|589610966|FG000|Overall Study|Withdrawal by Subject|9|||
163246988|NCT02187991|589610967|FG001|Overall Study|Withdrawal by Subject|6|||
163246989|NCT02187991|589610968|FG002|Overall Study|Withdrawal by Subject|3|||
163246990|NCT02187991|589610969|FG003|Overall Study|Withdrawal by Subject|2|||
163246991|NCT02187991|589610966|FG000|Overall Study|Physician Decision|4|||
163246992|NCT02187991|589610967|FG001|Overall Study|Physician Decision|4|||
163246993|NCT02187991|589610968|FG002|Overall Study|Physician Decision|0|||
163246994|NCT02187991|589610969|FG003|Overall Study|Physician Decision|2|||
163246995|NCT02187991|589610966|FG000|Overall Study|Other, unrelated complication|7|||
163246996|NCT02187991|589610967|FG001|Overall Study|Other, unrelated complication|1|||
163246997|NCT02187991|589610968|FG002|Overall Study|Other, unrelated complication|1|||
163246998|NCT02187991|589610969|FG003|Overall Study|Other, unrelated complication|2|||
163246999|NCT02187991|589610966|FG000|Overall Study|Death|1|||
163247000|NCT02187991|589610967|FG001|Overall Study|Death|3|||
163247001|NCT02187991|589610968|FG002|Overall Study|Death|0|||
163247002|NCT02187991|589610969|FG003|Overall Study|Death|0|||
163247003|NCT01392560|589610970|FG000|Overall Study|Adverse Event|2|||
163247004|NCT01392560|589610970|FG000|Overall Study|not entered|8|||
163247005|NCT01392560|589610970|FG000|Overall Study|discontinued during placebo run-in|2|||
163410291|NCT03074474|590211335|FG000|Overall Study|Lost to Follow-up|10|||
163410292|NCT03074474|590211335|FG000|Overall Study|Withdrawal by Subject|10|||
163247006|NCT00522275|589610976|FG000|Overall Study|Adverse Event|35|||
163247007|NCT00522275|589610976|FG000|Overall Study|Lack of Efficacy|80|||
163247008|NCT00522275|589610976|FG000|Overall Study|Subject withdrew consent|16|||
163247009|NCT00522275|589610976|FG000|Overall Study|Protocol deviation|1|||
163247010|NCT00522275|589610976|FG000|Overall Study|Unsatisfactory compliance|11|||
163247011|NCT00522275|589610976|FG000|Overall Study|Lost to Follow-up|8|||
163354528|NCT03520075|590009560|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163354529|NCT03520075|590009561|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163354530|NCT03520075|590009562|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163354531|NCT03520075|590009563|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163354532|NCT03520075|590009564|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163354533|NCT03520075|590009565|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163354534|NCT03520075|590009547|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354535|NCT03520075|590009548|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354536|NCT03520075|590009549|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354537|NCT03520075|590009550|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354538|NCT03520075|590009551|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354539|NCT03520075|590009552|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354540|NCT03520075|590009553|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354541|NCT03520075|590009554|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354542|NCT03520075|590009555|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354543|NCT03520075|590009556|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
163354544|NCT03520075|590009557|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354545|NCT03520075|590009558|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354546|NCT03520075|590009559|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
163354547|NCT03520075|590009560|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354548|NCT03520075|590009561|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354549|NCT03520075|590009562|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354550|NCT03520075|590009563|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354551|NCT03520075|590009564|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354552|NCT03520075|590009565|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163354553|NCT03520075|590009547|FG000|Phase 2 (Dose Expansion)|Death|0|||
163354554|NCT03520075|590009548|FG001|Phase 2 (Dose Expansion)|Death|0|||
163354555|NCT03520075|590009549|FG002|Phase 2 (Dose Expansion)|Death|0|||
163354556|NCT03520075|590009550|FG003|Phase 2 (Dose Expansion)|Death|0|||
163354557|NCT03520075|590009551|FG004|Phase 2 (Dose Expansion)|Death|0|||
163354558|NCT03520075|590009552|FG005|Phase 2 (Dose Expansion)|Death|0|||
163354559|NCT03520075|590009553|FG006|Phase 2 (Dose Expansion)|Death|0|||
163354560|NCT03520075|590009554|FG007|Phase 2 (Dose Expansion)|Death|0|||
163354561|NCT03520075|590009555|FG008|Phase 2 (Dose Expansion)|Death|0|||
163354562|NCT03520075|590009556|FG009|Phase 2 (Dose Expansion)|Death|0|||
163354563|NCT03520075|590009557|FG010|Phase 2 (Dose Expansion)|Death|0|||
163354564|NCT03520075|590009558|FG011|Phase 2 (Dose Expansion)|Death|0|||
163354565|NCT03520075|590009559|FG012|Phase 2 (Dose Expansion)|Death|0|||
163354566|NCT03520075|590009560|FG013|Phase 2 (Dose Expansion)|Death|20|||
163354567|NCT03520075|590009561|FG014|Phase 2 (Dose Expansion)|Death|13|||
163354568|NCT03520075|590009562|FG015|Phase 2 (Dose Expansion)|Death|9|||
163354569|NCT03520075|590009563|FG016|Phase 2 (Dose Expansion)|Death|5|||
163354570|NCT03520075|590009564|FG017|Phase 2 (Dose Expansion)|Death|14|||
163354571|NCT03520075|590009565|FG018|Phase 2 (Dose Expansion)|Death|12|||
163354572|NCT03520075|590009547|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163354573|NCT03520075|590009548|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163354574|NCT03520075|590009549|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163354575|NCT03520075|590009550|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163354576|NCT03520075|590009551|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163354577|NCT03520075|590009552|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163354578|NCT03520075|590009553|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163354579|NCT03520075|590009554|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163354580|NCT03520075|590009555|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163354581|NCT03520075|590009556|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163354582|NCT03520075|590009557|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163354583|NCT03520075|590009558|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163354584|NCT03520075|590009559|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163354585|NCT03520075|590009560|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163354586|NCT03520075|590009561|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
163354587|NCT03520075|590009562|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
163354588|NCT03520075|590009563|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
163354589|NCT03520075|590009564|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
163354590|NCT03520075|590009565|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
163354591|NCT03520075|590009547|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163354592|NCT03520075|590009548|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163354593|NCT03520075|590009549|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163354594|NCT03520075|590009550|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163354595|NCT03520075|590009551|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163354596|NCT03520075|590009552|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163354597|NCT03520075|590009553|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163354598|NCT03520075|590009554|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163354599|NCT03520075|590009555|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163354600|NCT03520075|590009556|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163354601|NCT03520075|590009557|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163354602|NCT03520075|590009558|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163354603|NCT03520075|590009559|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163354604|NCT03520075|590009560|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163354605|NCT03520075|590009561|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
163354606|NCT03520075|590009562|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
163354607|NCT03520075|590009563|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163354608|NCT03520075|590009564|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163247012|NCT00522275|589610976|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
163247013|NCT00522275|589610976|FG000|Overall Study|Other: Subject is pregnant|2|||
163247014|NCT00522275|589610976|FG000|Overall Study|Other: Subject relocated|2|||
163247015|NCT00522275|589610976|FG000|Overall Study|Other: Subject arrested|1|||
163247016|NCT00522275|589610976|FG000|Overall Study|Other: Site / clinic closed|4|||
163247017|NCT00522275|589610976|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
163247018|NCT00522275|589610976|FG000|Overall Study|Other: Sponsor request|2|||
163247019|NCT00522275|589610976|FG000|Overall Study|Other: Subject ran out of medication|1|||
163247020|NCT00522275|589610976|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
163247021|NCT04656847|589610978|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
163247022|NCT03301051|589610979|FG000|Overall Study|Adverse Event|0|||
163247023|NCT03301051|589610980|FG001|Overall Study|Adverse Event|4|||
163247024|NCT03301051|589610979|FG000|Overall Study|Withdrawal by Subject|59|||
163247025|NCT03301051|589610980|FG001|Overall Study|Withdrawal by Subject|65|||
163247026|NCT03301051|589610979|FG000|Overall Study|Lost to Follow-up|263|||
163247027|NCT03301051|589610980|FG001|Overall Study|Lost to Follow-up|282|||
163247028|NCT03301051|589610979|FG000|Overall Study|Protocol Violation|1|||
163247029|NCT03301051|589610980|FG001|Overall Study|Protocol Violation|3|||
163247030|NCT03301051|589610979|FG000|Overall Study|Physician Decision|1|||
163247031|NCT03301051|589610980|FG001|Overall Study|Physician Decision|3|||
163247032|NCT03301051|589610979|FG000|Overall Study|Death|1|||
163247033|NCT03301051|589610980|FG001|Overall Study|Death|1|||
163247034|NCT03301051|589610979|FG000|Overall Study|Miscellaneous|8|||
163247035|NCT03301051|589610980|FG001|Overall Study|Miscellaneous|4|||
163247036|NCT03301051|589610979|FG000|Overall Study|Randomized, not vaccinated|13|||
163247037|NCT03301051|589610980|FG001|Overall Study|Randomized, not vaccinated|10|||
163247038|NCT00047879|589610981|FG000|Overall Study|Progressive disease|4|||
163247039|NCT00047879|589610982|FG001|Overall Study|Progressive disease|3|||
163247040|NCT01196975|589610983|FG000|Overall Study|Adverse Event|2|||
163247041|NCT01196975|589610984|FG001|Overall Study|Adverse Event|2|||
163247042|NCT01196975|589610985|FG002|Overall Study|Adverse Event|0|||
163247043|NCT01196975|589610986|FG003|Overall Study|Adverse Event|0|||
163247044|NCT01196975|589610987|FG004|Overall Study|Adverse Event|2|||
163247045|NCT01196975|589610983|FG000|Overall Study|Withdrawal by Subject|2|||
163247046|NCT01196975|589610984|FG001|Overall Study|Withdrawal by Subject|1|||
163247047|NCT01196975|589610985|FG002|Overall Study|Withdrawal by Subject|0|||
163247048|NCT01196975|589610986|FG003|Overall Study|Withdrawal by Subject|1|||
163247049|NCT01196975|589610987|FG004|Overall Study|Withdrawal by Subject|0|||
163247050|NCT01196975|589610983|FG000|Overall Study|Lost to Follow-up|11|||
163247051|NCT01196975|589610984|FG001|Overall Study|Lost to Follow-up|6|||
163247052|NCT01196975|589610985|FG002|Overall Study|Lost to Follow-up|5|||
163247053|NCT01196975|589610986|FG003|Overall Study|Lost to Follow-up|5|||
163247054|NCT01196975|589610987|FG004|Overall Study|Lost to Follow-up|11|||
163247055|NCT01358526|589610999|FG000|Open-label Titration Period|Adverse Event|95|||
163354609|NCT03520075|590009565|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
163247056|NCT01358526|589611000|FG001|Open-label Titration Period|Adverse Event|0|||
163247057|NCT01358526|589611001|FG002|Open-label Titration Period|Adverse Event|0|||
163247058|NCT01358526|589610999|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
163247059|NCT01358526|589611000|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
163354610|NCT03520075|590009547|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163354611|NCT03520075|590009548|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163354612|NCT03520075|590009549|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163354613|NCT03520075|590009550|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163354614|NCT03520075|590009551|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163354615|NCT03520075|590009552|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163410293|NCT03074474|590211335|FG000|Overall Study|Death|4|||
163247060|NCT01358526|589611001|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
163247061|NCT01358526|589610999|FG000|Open-label Titration Period|Lost to Follow-up|25|||
163247062|NCT01358526|589611000|FG001|Open-label Titration Period|Lost to Follow-up|0|||
163247063|NCT01358526|589611001|FG002|Open-label Titration Period|Lost to Follow-up|0|||
163247064|NCT01358526|589610999|FG000|Open-label Titration Period|Lack of Efficacy|107|||
163247065|NCT01358526|589611000|FG001|Open-label Titration Period|Lack of Efficacy|0|||
163247066|NCT01358526|589611001|FG002|Open-label Titration Period|Lack of Efficacy|0|||
163247067|NCT01358526|589610999|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
163247068|NCT01358526|589611000|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
163247069|NCT01358526|589611001|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
163247070|NCT01358526|589610999|FG000|Open-label Titration Period|Administrative|8|||
163247071|NCT01358526|589611000|FG001|Open-label Titration Period|Administrative|0|||
163247072|NCT01358526|589611001|FG002|Open-label Titration Period|Administrative|0|||
163247073|NCT01358526|589610999|FG000|Open-label Titration Period|Did not qualify|178|||
163247074|NCT01358526|589611000|FG001|Open-label Titration Period|Did not qualify|0|||
163247075|NCT01358526|589611001|FG002|Open-label Titration Period|Did not qualify|0|||
163247076|NCT01358526|589610999|FG000|Double-blind Phase|Adverse Event|0|||
163247077|NCT01358526|589611000|FG001|Double-blind Phase|Adverse Event|24|||
163247078|NCT01358526|589611001|FG002|Double-blind Phase|Adverse Event|23|||
163247079|NCT01358526|589610999|FG000|Double-blind Phase|Withdrawal by Subject|0|||
163247080|NCT01358526|589611000|FG001|Double-blind Phase|Withdrawal by Subject|10|||
163247081|NCT01358526|589611001|FG002|Double-blind Phase|Withdrawal by Subject|8|||
163247082|NCT01358526|589610999|FG000|Double-blind Phase|Lost to Follow-up|0|||
163247083|NCT01358526|589611000|FG001|Double-blind Phase|Lost to Follow-up|4|||
163247084|NCT01358526|589611001|FG002|Double-blind Phase|Lost to Follow-up|1|||
163247085|NCT01358526|589610999|FG000|Double-blind Phase|Lack of Efficacy|0|||
163247086|NCT01358526|589611000|FG001|Double-blind Phase|Lack of Efficacy|31|||
163247087|NCT01358526|589611001|FG002|Double-blind Phase|Lack of Efficacy|73|||
163247088|NCT01358526|589610999|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
163247089|NCT01358526|589611000|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
163247090|NCT01358526|589611001|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
163247091|NCT01358526|589610999|FG000|Double-blind Phase|Administrative|0|||
163247092|NCT01358526|589611000|FG001|Double-blind Phase|Administrative|6|||
163247093|NCT01358526|589611001|FG002|Double-blind Phase|Administrative|10|||
163247094|NCT01462344|589611002|FG000|Overall Study|Withdrawal by Subject|245|||
163247095|NCT01462344|589611003|FG001|Overall Study|Withdrawal by Subject|226|||
163247096|NCT01462344|589611002|FG000|Overall Study|Adverse Event|24|||
163247097|NCT01462344|589611003|FG001|Overall Study|Adverse Event|23|||
163247098|NCT01462344|589611002|FG000|Overall Study|Asthma Exacerbation|34|||
163247099|NCT01462344|589611003|FG001|Overall Study|Asthma Exacerbation|35|||
163247100|NCT01462344|589611002|FG000|Overall Study|Lack of Efficacy|5|||
163247101|NCT01462344|589611003|FG001|Overall Study|Lack of Efficacy|6|||
163247102|NCT01462344|589611002|FG000|Overall Study|Protocol Violation|68|||
163247103|NCT01462344|589611003|FG001|Overall Study|Protocol Violation|53|||
163247104|NCT01462344|589611002|FG000|Overall Study|Lost to Follow-up|7|||
163247105|NCT01462344|589611003|FG001|Overall Study|Lost to Follow-up|7|||
163247106|NCT00360529|589611004|FG000|Overall Study|Adverse Event|10|||
163247107|NCT00360529|589611005|FG001|Overall Study|Adverse Event|23|||
163247108|NCT00360529|589611006|FG002|Overall Study|Adverse Event|33|||
163247109|NCT00360529|589611004|FG000|Overall Study|Protocol Violation|3|||
163247110|NCT00360529|589611005|FG001|Overall Study|Protocol Violation|3|||
163247111|NCT00360529|589611006|FG002|Overall Study|Protocol Violation|11|||
163247112|NCT00360529|589611004|FG000|Overall Study|Lost to Follow-up|14|||
163247113|NCT00360529|589611005|FG001|Overall Study|Lost to Follow-up|10|||
163247114|NCT00360529|589611006|FG002|Overall Study|Lost to Follow-up|13|||
163247115|NCT00360529|589611004|FG000|Overall Study|Withdrawal by Subject|22|||
163247116|NCT00360529|589611005|FG001|Overall Study|Withdrawal by Subject|14|||
163247117|NCT00360529|589611006|FG002|Overall Study|Withdrawal by Subject|18|||
163247118|NCT00360529|589611004|FG000|Overall Study|Lack of Efficacy|8|||
163247119|NCT00360529|589611005|FG001|Overall Study|Lack of Efficacy|6|||
163247120|NCT00360529|589611006|FG002|Overall Study|Lack of Efficacy|5|||
163247121|NCT00360529|589611004|FG000|Overall Study|Reason discontinued not explained above|4|||
163247122|NCT00360529|589611005|FG001|Overall Study|Reason discontinued not explained above|9|||
163247123|NCT00360529|589611006|FG002|Overall Study|Reason discontinued not explained above|11|||
163247124|NCT01781572|589611011|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
163247125|NCT01781572|589611012|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
163247126|NCT01781572|589611013|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
163247127|NCT01781572|589611011|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
163247128|NCT01781572|589611012|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
163247129|NCT01781572|589611013|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
163247130|NCT01781572|589611011|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
163247131|NCT01781572|589611012|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
163247132|NCT01781572|589611013|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
163247133|NCT01781572|589611011|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
163247134|NCT01781572|589611012|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
163247135|NCT01781572|589611013|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
163247136|NCT01781572|589611011|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
163247137|NCT01781572|589611012|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
163247138|NCT01781572|589611013|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
163247139|NCT01781572|589611011|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
163354616|NCT03520075|590009553|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163354617|NCT03520075|590009554|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163354618|NCT03520075|590009555|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163354619|NCT03520075|590009556|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163354620|NCT03520075|590009557|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163354621|NCT03520075|590009558|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163354622|NCT03520075|590009559|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163354623|NCT03520075|590009560|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
163354624|NCT03520075|590009561|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163354625|NCT03520075|590009562|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163354626|NCT03520075|590009563|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
163354627|NCT03520075|590009564|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
163354628|NCT03520075|590009565|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163354629|NCT01432626|590009568|FG000|Overall Study|LV function recovered|2|||
163354630|NCT01432626|590009568|FG000|Overall Study|Withdrawal by Subject|2|||
163354631|NCT01432626|590009568|FG000|Overall Study|Only 1 image competed|2|||
163354632|NCT01432626|590009568|FG000|Overall Study|Imaging agent not available|1|||
163354633|NCT03305809|590009569|FG000|Overall Study|Adverse Event|2|||
163354634|NCT03305809|590009570|FG001|Overall Study|Adverse Event|2|||
163354635|NCT03305809|590009571|FG002|Overall Study|Adverse Event|6|||
163354636|NCT03305809|590009572|FG003|Overall Study|Adverse Event|6|||
163354637|NCT03305809|590009569|FG000|Overall Study|Death|0|||
163354638|NCT03305809|590009570|FG001|Overall Study|Death|0|||
163354639|NCT03305809|590009571|FG002|Overall Study|Death|1|||
163354640|NCT03305809|590009572|FG003|Overall Study|Death|1|||
163354641|NCT03305809|590009569|FG000|Overall Study|Lost to Follow-up|1|||
163354642|NCT03305809|590009570|FG001|Overall Study|Lost to Follow-up|2|||
163354643|NCT03305809|590009571|FG002|Overall Study|Lost to Follow-up|0|||
163354644|NCT03305809|590009572|FG003|Overall Study|Lost to Follow-up|0|||
163247140|NCT01781572|589611012|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
163247141|NCT01781572|589611013|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
163247142|NCT01781572|589611011|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
163247143|NCT01781572|589611012|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
163247144|NCT01781572|589611013|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
163247145|NCT01781572|589611011|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
163247146|NCT01781572|589611012|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
163247147|NCT01781572|589611013|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
163247148|NCT01781572|589611011|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
163247149|NCT01781572|589611012|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
163247150|NCT01781572|589611013|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
163247151|NCT01781572|589611011|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
163247152|NCT01781572|589611012|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
163247153|NCT01781572|589611013|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
163247154|NCT01781572|589611011|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
163247155|NCT01781572|589611012|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
163247156|NCT01781572|589611013|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
163247157|NCT01781572|589611011|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
163247158|NCT01781572|589611012|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
163247159|NCT01781572|589611013|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
163247160|NCT01781572|589611011|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
163247161|NCT01781572|589611012|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
163247162|NCT01781572|589611013|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
163247163|NCT01781572|589611011|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
163247164|NCT01781572|589611012|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
163247165|NCT01781572|589611013|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
163247166|NCT01781572|589611011|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
163247167|NCT01781572|589611012|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
163247168|NCT01781572|589611013|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
163247169|NCT01781572|589611011|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
163247170|NCT01781572|589611012|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
163247171|NCT01781572|589611013|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
163247172|NCT01781572|589611011|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
163247173|NCT01781572|589611012|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
163247174|NCT01781572|589611013|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
163247175|NCT01781572|589611011|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
163247176|NCT01781572|589611012|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
163247177|NCT01781572|589611013|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
163354645|NCT03305809|590009569|FG000|Overall Study|Sponsor Decision|1|||
163354646|NCT03305809|590009570|FG001|Overall Study|Sponsor Decision|0|||
163354647|NCT03305809|590009571|FG002|Overall Study|Sponsor Decision|1|||
163354648|NCT03305809|590009572|FG003|Overall Study|Sponsor Decision|8|||
163247178|NCT01218438|589611014|FG000|Epoch 1|Physician Decision|2|||
163247179|NCT01218438|589611014|FG000|Epoch 1|Adverse Event|1|||
163247180|NCT01218438|589611014|FG000|Epoch 3|Withdrawal by Subject|3|||
163149634|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
163149635|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
163149636|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
163149637|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
163149638|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
163149639|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
163149640|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
163149641|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
163149642|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
163149643|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
163149644|NCT02182895|589261477|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
163149645|NCT02182895|589261478|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
163149646|NCT01488045|589261488|FG000|Overall Study|Withdrawal by Subject|6|||
163149647|NCT01488045|589261489|FG001|Overall Study|Withdrawal by Subject|11|||
163149648|NCT01488045|589261488|FG000|Overall Study|Failure to present for colonoscopy|3|||
163149649|NCT01488045|589261489|FG001|Overall Study|Failure to present for colonoscopy|6|||
163149650|NCT01488045|589261488|FG000|Overall Study|Failure to report exclusion criteria|0|||
163149651|NCT01488045|589261489|FG001|Overall Study|Failure to report exclusion criteria|1|||
163149652|NCT00671658|589261491|FG000|Overall Study|Physician Decision|5|||
163149653|NCT03617172|589261494|FG000|Overall Study|Lost to Follow-up|1|||
163149654|NCT03617172|589261495|FG001|Overall Study|Lost to Follow-up|0|||
163149655|NCT01680341|589261496|FG000|Overall Study|Adverse Event|3|||
163149656|NCT01680341|589261497|FG001|Overall Study|Adverse Event|2|||
163149657|NCT01680341|589261496|FG000|Overall Study|Unclassified|18|||
163149658|NCT01680341|589261497|FG001|Overall Study|Unclassified|15|||
163149659|NCT02587221|589261499|FG000|Overall Study|Adverse Event|3|||
163149660|NCT02587221|589261500|FG001|Overall Study|Adverse Event|3|||
163149661|NCT02587221|589261499|FG000|Overall Study|Death|33|||
163149662|NCT02587221|589261500|FG001|Overall Study|Death|34|||
163149663|NCT02587221|589261499|FG000|Overall Study|Withdrawal by Subject|66|||
163149664|NCT02587221|589261500|FG001|Overall Study|Withdrawal by Subject|61|||
163149665|NCT02587221|589261499|FG000|Overall Study|Lost to Follow-up|21|||
163149666|NCT02587221|589261500|FG001|Overall Study|Lost to Follow-up|19|||
163149667|NCT02587221|589261499|FG000|Overall Study|Protocol Violation|6|||
163149668|NCT02587221|589261500|FG001|Overall Study|Protocol Violation|5|||
163149669|NCT02587221|589261499|FG000|Overall Study|Other Reason or Unspecified|2|||
163149670|NCT02587221|589261500|FG001|Overall Study|Other Reason or Unspecified|1|||
163149671|NCT03988400|589261501|FG000|Overall Study|Adverse Event|1|||
163149672|NCT03988400|589261502|FG001|Overall Study|Adverse Event|0|||
163149673|NCT03988400|589261501|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
163149674|NCT03988400|589261502|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
163149675|NCT03988400|589261501|FG000|Overall Study|Lost to Follow-up|0|||
163149676|NCT03988400|589261502|FG001|Overall Study|Lost to Follow-up|1|||
163149677|NCT04913610|589261503|FG000|Randomized Participants|Did Not Receive Treatment|0|||
163149678|NCT04913610|589261504|FG001|Randomized Participants|Did Not Receive Treatment|0|||
163149679|NCT04913610|589261505|FG002|Randomized Participants|Did Not Receive Treatment|1|||
163149680|NCT04913610|589261506|FG003|Randomized Participants|Did Not Receive Treatment|1|||
163149681|NCT04913610|589261507|FG004|Randomized Participants|Did Not Receive Treatment|0|||
163149682|NCT04913610|589261503|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
163149683|NCT04913610|589261504|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
163149684|NCT04913610|589261505|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
163149685|NCT04913610|589261506|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
163149686|NCT04913610|589261507|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
163149687|NCT03186209|589261508|FG000|Overall Study|Withdrawal by Subject|11|||
163149688|NCT03186209|589261509|FG001|Overall Study|Withdrawal by Subject|22|||
163149689|NCT03186209|589261508|FG000|Overall Study|Pregnancy|1|||
163149690|NCT03186209|589261509|FG001|Overall Study|Pregnancy|0|||
163149691|NCT03186209|589261508|FG000|Overall Study|Adverse Event|4|||
163149692|NCT03186209|589261509|FG001|Overall Study|Adverse Event|0|||
163149693|NCT03186209|589261508|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
163149694|NCT03186209|589261509|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
163149695|NCT03186209|589261508|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
163149696|NCT03186209|589261509|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
163149697|NCT03186209|589261508|FG000|Overall Study|Fail to meet randomization criteria|0|||
163149698|NCT03186209|589261509|FG001|Overall Study|Fail to meet randomization criteria|1|||
163149699|NCT03186209|589261508|FG000|Overall Study|Lost to Follow-up|0|||
163149700|NCT03186209|589261509|FG001|Overall Study|Lost to Follow-up|1|||
163149701|NCT00953667|589261515|FG000|Overall Study|Lost to Follow-up|11|||
163149702|NCT00953667|589261515|FG000|Overall Study|Physician Decision|35|||
163149703|NCT00953667|589261515|FG000|Overall Study|Withdrawal by Subject|63|||
163149704|NCT00953667|589261515|FG000|Overall Study|Adverse Event|10|||
163149705|NCT00953667|589261515|FG000|Overall Study|poor venous access,unable to draw blood|4|||
163247181|NCT01218438|589611014|FG000|Epoch 3|Adverse Event|1|||
163247182|NCT01218438|589611014|FG000|Epoch 4|Physician Decision|1|||
163247183|NCT01218438|589611014|FG000|Epoch 4|Withdrawal by Subject|2|||
163247184|NCT06167031|589611017|FG000|Overall Study|Lost to Follow-up|5|||
163247185|NCT06167031|589611018|FG001|Overall Study|Lost to Follow-up|1|||
163247186|NCT00907153|589613171|FG000|Overall Study|Lost to Follow-up|1|||
163247187|NCT00907153|589613172|FG001|Overall Study|Lost to Follow-up|1|||
163247188|NCT00907153|589613171|FG000|Overall Study|Withdrawal by Subject|1|||
163247189|NCT00907153|589613172|FG001|Overall Study|Withdrawal by Subject|3|||
163247190|NCT02566031|589613178|FG000|Overall Study|Patient/guardian decision|14|||
163247191|NCT02566031|589613179|FG001|Overall Study|Patient/guardian decision|7|||
163247192|NCT02566031|589613178|FG000|Overall Study|Protocol deviation|2|||
163247193|NCT02566031|589613179|FG001|Overall Study|Protocol deviation|3|||
163247194|NCT02566031|589613178|FG000|Overall Study|Adverse Event|3|||
163247195|NCT02566031|589613179|FG001|Overall Study|Adverse Event|1|||
163247196|NCT02566031|589613178|FG000|Overall Study|Lost to Follow-up|1|||
163247197|NCT02566031|589613179|FG001|Overall Study|Lost to Follow-up|1|||
163247198|NCT03031938|589613180|FG000|Overall Study|Death|1|||
163247199|NCT03031938|589613181|FG001|Overall Study|Death|0|||
163247200|NCT02647359|589613188|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
163247201|NCT02647359|589613189|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
163247202|NCT02647359|589613188|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
163247203|NCT02647359|589613189|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
163247204|NCT02647359|589613188|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
163247205|NCT02647359|589613189|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
163247206|NCT02647359|589613188|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
163247207|NCT02647359|589613189|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
163247208|NCT02647359|589613188|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
163247209|NCT02647359|589613189|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
163247210|NCT02647359|589613188|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
163247211|NCT02647359|589613189|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
163247212|NCT02219932|589613196|FG000|Overall Study|Other|5|||
163247213|NCT02219932|589613197|FG001|Overall Study|Other|11|||
163247214|NCT02219932|589613196|FG000|Overall Study|Death|1|||
163247215|NCT02219932|589613197|FG001|Overall Study|Death|1|||
163247216|NCT02219932|589613196|FG000|Overall Study|Investigator Decision|0|||
163247217|NCT02219932|589613197|FG001|Overall Study|Investigator Decision|1|||
163247218|NCT02219932|589613196|FG000|Overall Study|Consent Withdrawn|11|||
163247219|NCT02219932|589613197|FG001|Overall Study|Consent Withdrawn|7|||
163247220|NCT02219932|589613196|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
163247221|NCT02219932|589613197|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
163247222|NCT02219932|589613196|FG000|Overall Study|Protocol Violation|10|||
163247223|NCT02219932|589613197|FG001|Overall Study|Protocol Violation|6|||
163247224|NCT02219932|589613196|FG000|Overall Study|Pregnancy|1|||
163247225|NCT02219932|589613197|FG001|Overall Study|Pregnancy|0|||
163247226|NCT02219932|589613196|FG000|Overall Study|Lost to Follow-up|4|||
163247227|NCT02219932|589613197|FG001|Overall Study|Lost to Follow-up|2|||
163247228|NCT02219932|589613196|FG000|Overall Study|Adverse Event|23|||
163247229|NCT02219932|589613197|FG001|Overall Study|Adverse Event|21|||
163247230|NCT04642638|589613200|FG000|Overall Study|Withdrawal by Subject|23|||
163247231|NCT04642638|589613201|FG001|Overall Study|Withdrawal by Subject|29|||
163247232|NCT04642638|589613202|FG002|Overall Study|Withdrawal by Subject|9|||
163247233|NCT04642638|589613203|FG003|Overall Study|Withdrawal by Subject|7|||
163247234|NCT04642638|589613204|FG004|Overall Study|Withdrawal by Subject|61|||
163247235|NCT04642638|589613205|FG005|Overall Study|Withdrawal by Subject|27|||
163247236|NCT04642638|589613200|FG000|Overall Study|Lost to Follow-up|17|||
163247237|NCT04642638|589613201|FG001|Overall Study|Lost to Follow-up|18|||
163247238|NCT04642638|589613202|FG002|Overall Study|Lost to Follow-up|5|||
163247239|NCT04642638|589613203|FG003|Overall Study|Lost to Follow-up|5|||
163247240|NCT04642638|589613204|FG004|Overall Study|Lost to Follow-up|6|||
163247241|NCT04642638|589613205|FG005|Overall Study|Lost to Follow-up|3|||
163247242|NCT04642638|589613200|FG000|Overall Study|Adverse Event|0|||
163247243|NCT04642638|589613201|FG001|Overall Study|Adverse Event|0|||
163247244|NCT04642638|589613202|FG002|Overall Study|Adverse Event|1|||
163247245|NCT04642638|589613203|FG003|Overall Study|Adverse Event|0|||
163247246|NCT04642638|589613204|FG004|Overall Study|Adverse Event|10|||
163354649|NCT03305809|590009569|FG000|Overall Study|Physician Decision|0|||
163247247|NCT04642638|589613205|FG005|Overall Study|Adverse Event|3|||
163247248|NCT04642638|589613200|FG000|Overall Study|Reason Not Specified|1|||
163247249|NCT04642638|589613201|FG001|Overall Study|Reason Not Specified|4|||
163247250|NCT04642638|589613202|FG002|Overall Study|Reason Not Specified|0|||
163247251|NCT04642638|589613203|FG003|Overall Study|Reason Not Specified|0|||
163247252|NCT04642638|589613204|FG004|Overall Study|Reason Not Specified|38|||
163247253|NCT04642638|589613205|FG005|Overall Study|Reason Not Specified|16|||
163247254|NCT04642638|589613200|FG000|Overall Study|Physician Decision|0|||
163247255|NCT04642638|589613201|FG001|Overall Study|Physician Decision|0|||
163247256|NCT04642638|589613202|FG002|Overall Study|Physician Decision|0|||
163247257|NCT04642638|589613203|FG003|Overall Study|Physician Decision|0|||
163247258|NCT04642638|589613204|FG004|Overall Study|Physician Decision|2|||
163247259|NCT04642638|589613205|FG005|Overall Study|Physician Decision|1|||
163247260|NCT04642638|589613200|FG000|Overall Study|Protocol Deviation|0|||
163247261|NCT04642638|589613201|FG001|Overall Study|Protocol Deviation|0|||
163247262|NCT04642638|589613202|FG002|Overall Study|Protocol Deviation|0|||
163247263|NCT04642638|589613203|FG003|Overall Study|Protocol Deviation|0|||
163247264|NCT04642638|589613204|FG004|Overall Study|Protocol Deviation|1|||
163247265|NCT04642638|589613205|FG005|Overall Study|Protocol Deviation|3|||
163247266|NCT04642638|589613200|FG000|Overall Study|Study Terminated|0|||
163247267|NCT04642638|589613201|FG001|Overall Study|Study Terminated|0|||
163247268|NCT04642638|589613202|FG002|Overall Study|Study Terminated|0|||
163247269|NCT04642638|589613203|FG003|Overall Study|Study Terminated|0|||
163247270|NCT04642638|589613204|FG004|Overall Study|Study Terminated|484|||
163247271|NCT04642638|589613205|FG005|Overall Study|Study Terminated|250|||
163247272|NCT04642638|589613200|FG000|Overall Study|Pregnancy|0|||
163247273|NCT04642638|589613201|FG001|Overall Study|Pregnancy|0|||
163247274|NCT04642638|589613202|FG002|Overall Study|Pregnancy|0|||
163247275|NCT04642638|589613203|FG003|Overall Study|Pregnancy|0|||
163247276|NCT04642638|589613204|FG004|Overall Study|Pregnancy|1|||
163247277|NCT04642638|589613205|FG005|Overall Study|Pregnancy|0|||
163247278|NCT00511004|589613206|FG000|Overall Study|Lost to Follow-up|0|||
163247279|NCT00511004|589613207|FG001|Overall Study|Lost to Follow-up|0|||
163247280|NCT00511004|589613208|FG002|Overall Study|Lost to Follow-up|4|||
163247281|NCT00990652|589613209|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
163247282|NCT00990652|589613209|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
163247283|NCT01672801|589613211|FG000|Overall Study|Screen Failure|0|||
163247284|NCT01672801|589613212|FG001|Overall Study|Screen Failure|1|||
163247285|NCT06476366|589613213|FG000|Overall Study|Lost to Follow-up|1|||
163247286|NCT06476366|589613214|FG001|Overall Study|Lost to Follow-up|3|||
163247287|NCT06476366|589613213|FG000|Overall Study|Adverse Event|1|||
163247288|NCT06476366|589613214|FG001|Overall Study|Adverse Event|0|||
163247289|NCT04313881|589613218|FG000|Overall Study|Death|138|||
163247290|NCT04313881|589613219|FG001|Overall Study|Death|126|||
163247291|NCT04313881|589613218|FG000|Overall Study|Study terminated by sponsor|108|||
163247292|NCT04313881|589613219|FG001|Overall Study|Study terminated by sponsor|129|||
163247293|NCT04313881|589613218|FG000|Overall Study|Consent withdrawn|19|||
163247294|NCT04313881|589613219|FG001|Overall Study|Consent withdrawn|15|||
163247295|NCT04313881|589613218|FG000|Overall Study|Reason not Specified|3|||
163247296|NCT04313881|589613219|FG001|Overall Study|Reason not Specified|1|||
163247297|NCT00727272|589613220|FG000|Washout Period A|Adverse Event|0|||
163247298|NCT00727272|589613221|FG001|Washout Period A|Adverse Event|0|||
163247299|NCT00727272|589613222|FG002|Washout Period A|Adverse Event|1|||
163247300|NCT00727272|589613220|FG000|Washout Period B|Withdrawal by Subject|0|||
163247301|NCT00727272|589613221|FG001|Washout Period B|Withdrawal by Subject|0|||
163247302|NCT00727272|589613222|FG002|Washout Period B|Withdrawal by Subject|1|||
163247303|NCT00651664|589613223|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
163247304|NCT00651664|589613224|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
163247305|NCT00651664|589613225|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
163247306|NCT00651664|589613226|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
163247307|NCT00651664|589613227|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
163247308|NCT00651664|589613228|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
163247309|NCT00651664|589613229|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
163247310|NCT00651664|589613230|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
163410294|NCT03074474|590211335|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
163247311|NCT00651664|589613231|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
163247312|NCT00651664|589613232|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
163247313|NCT00651664|589613223|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
163247314|NCT00651664|589613224|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
163247315|NCT00651664|589613225|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
163247316|NCT00651664|589613226|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
163247317|NCT00651664|589613227|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
163410295|NCT00371865|590211338|FG000|Overall Study|Lack of Efficacy|0|||
163410296|NCT00371865|590211339|FG001|Overall Study|Lack of Efficacy|2|||
163410297|NCT00371865|590211338|FG000|Overall Study|Protocol Violation|3|||
163247318|NCT00651664|589613228|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
163247319|NCT00651664|589613229|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
163247320|NCT00651664|589613230|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
163247321|NCT00651664|589613231|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
163247322|NCT00651664|589613232|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
163247323|NCT00651664|589613223|FG000|Overall Study|Progressive Disease|3|||
163247324|NCT00651664|589613224|FG001|Overall Study|Progressive Disease|3|||
163247325|NCT00651664|589613225|FG002|Overall Study|Progressive Disease|3|||
163247326|NCT00651664|589613226|FG003|Overall Study|Progressive Disease|12|||
163247327|NCT00651664|589613227|FG004|Overall Study|Progressive Disease|4|||
163247328|NCT00651664|589613228|FG005|Overall Study|Progressive Disease|1|||
163247329|NCT00651664|589613229|FG006|Overall Study|Progressive Disease|3|||
163247330|NCT00651664|589613230|FG007|Overall Study|Progressive Disease|6|||
163247331|NCT00651664|589613231|FG008|Overall Study|Progressive Disease|5|||
163247332|NCT00651664|589613232|FG009|Overall Study|Progressive Disease|5|||
163247333|NCT00651664|589613223|FG000|Overall Study|Patient Declined Further Treatment|0|||
163247334|NCT00651664|589613224|FG001|Overall Study|Patient Declined Further Treatment|0|||
163247335|NCT00651664|589613225|FG002|Overall Study|Patient Declined Further Treatment|0|||
163247336|NCT00651664|589613226|FG003|Overall Study|Patient Declined Further Treatment|1|||
163247337|NCT00651664|589613227|FG004|Overall Study|Patient Declined Further Treatment|1|||
163247338|NCT00651664|589613228|FG005|Overall Study|Patient Declined Further Treatment|1|||
163247339|NCT00651664|589613229|FG006|Overall Study|Patient Declined Further Treatment|0|||
163247340|NCT00651664|589613230|FG007|Overall Study|Patient Declined Further Treatment|0|||
163247341|NCT00651664|589613231|FG008|Overall Study|Patient Declined Further Treatment|0|||
163247342|NCT00651664|589613232|FG009|Overall Study|Patient Declined Further Treatment|1|||
163247343|NCT00651664|589613223|FG000|Overall Study|Symptomatic Deterioration|0|||
163247344|NCT00651664|589613224|FG001|Overall Study|Symptomatic Deterioration|0|||
163247345|NCT00651664|589613225|FG002|Overall Study|Symptomatic Deterioration|0|||
163247346|NCT00651664|589613226|FG003|Overall Study|Symptomatic Deterioration|1|||
163247347|NCT00651664|589613227|FG004|Overall Study|Symptomatic Deterioration|0|||
163247348|NCT00651664|589613228|FG005|Overall Study|Symptomatic Deterioration|0|||
163247349|NCT00651664|589613229|FG006|Overall Study|Symptomatic Deterioration|1|||
163247350|NCT00651664|589613230|FG007|Overall Study|Symptomatic Deterioration|0|||
163247351|NCT00651664|589613231|FG008|Overall Study|Symptomatic Deterioration|1|||
163247352|NCT00651664|589613232|FG009|Overall Study|Symptomatic Deterioration|0|||
163247353|NCT00651664|589613223|FG000|Overall Study|Reason not Specified|0|||
163247354|NCT00651664|589613224|FG001|Overall Study|Reason not Specified|0|||
163247355|NCT00651664|589613225|FG002|Overall Study|Reason not Specified|0|||
163247356|NCT00651664|589613226|FG003|Overall Study|Reason not Specified|0|||
163247357|NCT00651664|589613227|FG004|Overall Study|Reason not Specified|0|||
163247358|NCT00651664|589613228|FG005|Overall Study|Reason not Specified|0|||
163247359|NCT00651664|589613229|FG006|Overall Study|Reason not Specified|1|||
163247360|NCT00651664|589613230|FG007|Overall Study|Reason not Specified|0|||
163247361|NCT00651664|589613231|FG008|Overall Study|Reason not Specified|0|||
163247362|NCT00651664|589613232|FG009|Overall Study|Reason not Specified|0|||
163247363|NCT01910129|589613237|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
163247364|NCT01910129|589613238|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
163247365|NCT01910129|589613239|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
163247366|NCT01910129|589613237|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
163247367|NCT01910129|589613238|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
163247368|NCT01910129|589613239|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
163247369|NCT00965523|589613241|FG000|Study 221|Progressive Disease|4|||
163247370|NCT00965523|589613241|FG000|Study 221|Physician Decision|3|||
163247371|NCT00965523|589613241|FG000|Study 224|Progressive Disease|5|||
163247372|NCT00965523|589613241|FG000|Study 224|Physician Decision|1|||
163247373|NCT02415400|589613244|FG000|Overall Study|Adverse Event|0|||
163247374|NCT02415400|589613245|FG001|Overall Study|Adverse Event|1|||
163247375|NCT02415400|589613246|FG002|Overall Study|Adverse Event|1|||
163247376|NCT02415400|589613247|FG003|Overall Study|Adverse Event|2|||
163247377|NCT02415400|589613244|FG000|Overall Study|Participant request to stop therapy|4|||
163247378|NCT02415400|589613245|FG001|Overall Study|Participant request to stop therapy|3|||
163247379|NCT02415400|589613246|FG002|Overall Study|Participant request to stop therapy|8|||
163247380|NCT02415400|589613247|FG003|Overall Study|Participant request to stop therapy|6|||
163247381|NCT02415400|589613244|FG000|Overall Study|Participant withdrew consent|14|||
163247382|NCT02415400|589613245|FG001|Overall Study|Participant withdrew consent|12|||
163247383|NCT02415400|589613246|FG002|Overall Study|Participant withdrew consent|30|||
163247384|NCT02415400|589613247|FG003|Overall Study|Participant withdrew consent|21|||
163247385|NCT02415400|589613244|FG000|Overall Study|Death|39|||
163247386|NCT02415400|589613245|FG001|Overall Study|Death|41|||
163247387|NCT02415400|589613246|FG002|Overall Study|Death|35|||
163247388|NCT02415400|589613247|FG003|Overall Study|Death|42|||
163247389|NCT02415400|589613244|FG000|Overall Study|Lost to Follow-up|3|||
163247390|NCT02415400|589613245|FG001|Overall Study|Lost to Follow-up|3|||
163247391|NCT02415400|589613246|FG002|Overall Study|Lost to Follow-up|2|||
163247392|NCT02415400|589613247|FG003|Overall Study|Lost to Follow-up|5|||
163354650|NCT03305809|590009570|FG001|Overall Study|Physician Decision|0|||
163354651|NCT03305809|590009571|FG002|Overall Study|Physician Decision|2|||
163354652|NCT03305809|590009572|FG003|Overall Study|Physician Decision|4|||
163247393|NCT02415400|589613244|FG000|Overall Study|Poor/Non-Compliance|0|||
163247394|NCT02415400|589613245|FG001|Overall Study|Poor/Non-Compliance|1|||
163247395|NCT02415400|589613246|FG002|Overall Study|Poor/Non-Compliance|3|||
163247396|NCT02415400|589613247|FG003|Overall Study|Poor/Non-Compliance|4|||
163247397|NCT02415400|589613244|FG000|Overall Study|Participant no longer meets criteria|2|||
163247398|NCT02415400|589613245|FG001|Overall Study|Participant no longer meets criteria|0|||
163247399|NCT02415400|589613246|FG002|Overall Study|Participant no longer meets criteria|0|||
163247400|NCT02415400|589613247|FG003|Overall Study|Participant no longer meets criteria|1|||
163247401|NCT02415400|589613244|FG000|Overall Study|Participant doesn't answer phone|1|||
163247402|NCT02415400|589613245|FG001|Overall Study|Participant doesn't answer phone|0|||
163247403|NCT02415400|589613246|FG002|Overall Study|Participant doesn't answer phone|0|||
163247404|NCT02415400|589613247|FG003|Overall Study|Participant doesn't answer phone|0|||
163247405|NCT02415400|589613244|FG000|Overall Study|Participant wanted home visits|1|||
163247406|NCT02415400|589613245|FG001|Overall Study|Participant wanted home visits|0|||
163247407|NCT02415400|589613246|FG002|Overall Study|Participant wanted home visits|0|||
163247408|NCT02415400|589613247|FG003|Overall Study|Participant wanted home visits|0|||
163247409|NCT02415400|589613244|FG000|Overall Study|Randomized in error|2|||
163247410|NCT02415400|589613245|FG001|Overall Study|Randomized in error|0|||
163247411|NCT02415400|589613246|FG002|Overall Study|Randomized in error|0|||
163247412|NCT02415400|589613247|FG003|Overall Study|Randomized in error|0|||
163247413|NCT02415400|589613244|FG000|Overall Study|No study drug on site|0|||
163247414|NCT02415400|589613245|FG001|Overall Study|No study drug on site|1|||
163247415|NCT02415400|589613246|FG002|Overall Study|No study drug on site|0|||
163247416|NCT02415400|589613247|FG003|Overall Study|No study drug on site|0|||
163247417|NCT02415400|589613244|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
163247418|NCT02415400|589613245|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
163247419|NCT02415400|589613246|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
163247420|NCT02415400|589613247|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
163247421|NCT02415400|589613244|FG000|Overall Study|Coagulation values cannot be set|0|||
163247422|NCT02415400|589613245|FG001|Overall Study|Coagulation values cannot be set|0|||
163247423|NCT02415400|589613246|FG002|Overall Study|Coagulation values cannot be set|1|||
163247424|NCT02415400|589613247|FG003|Overall Study|Coagulation values cannot be set|0|||
163247425|NCT02415400|589613244|FG000|Overall Study|State regulations prevent participation|0|||
163247426|NCT02415400|589613245|FG001|Overall Study|State regulations prevent participation|0|||
163247427|NCT02415400|589613246|FG002|Overall Study|State regulations prevent participation|1|||
163247428|NCT02415400|589613247|FG003|Overall Study|State regulations prevent participation|0|||
163247429|NCT02415400|589613244|FG000|Overall Study|Poor treatment monitoring|0|||
163247430|NCT02415400|589613245|FG001|Overall Study|Poor treatment monitoring|0|||
163247431|NCT02415400|589613246|FG002|Overall Study|Poor treatment monitoring|1|||
163247432|NCT02415400|589613247|FG003|Overall Study|Poor treatment monitoring|0|||
163247433|NCT02415400|589613244|FG000|Overall Study|Participant in jail|0|||
163247434|NCT02415400|589613245|FG001|Overall Study|Participant in jail|0|||
163247435|NCT02415400|589613246|FG002|Overall Study|Participant in jail|1|||
163247436|NCT02415400|589613247|FG003|Overall Study|Participant in jail|0|||
163247437|NCT02415400|589613244|FG000|Overall Study|Investigator decision|0|||
163247438|NCT02415400|589613245|FG001|Overall Study|Investigator decision|0|||
163247439|NCT02415400|589613246|FG002|Overall Study|Investigator decision|1|||
163247440|NCT02415400|589613247|FG003|Overall Study|Investigator decision|1|||
163247441|NCT02415400|589613244|FG000|Overall Study|Site closure; participant won't transfer|0|||
163247442|NCT02415400|589613245|FG001|Overall Study|Site closure; participant won't transfer|0|||
163247443|NCT02415400|589613246|FG002|Overall Study|Site closure; participant won't transfer|0|||
163247444|NCT02415400|589613247|FG003|Overall Study|Site closure; participant won't transfer|1|||
163247445|NCT01226745|589613248|FG000|Overall Study|Did not complete schedule of assessments|8|||
163247446|NCT01226745|589613249|FG001|Overall Study|Did not complete schedule of assessments|3|||
163247447|NCT01226745|589613250|FG002|Overall Study|Did not complete schedule of assessments|6|||
163247448|NCT01226745|589613251|FG003|Overall Study|Did not complete schedule of assessments|0|||
163247449|NCT01226745|589613252|FG004|Overall Study|Did not complete schedule of assessments|0|||
163247450|NCT01226745|589613253|FG005|Overall Study|Did not complete schedule of assessments|1|||
163247451|NCT01226745|589613248|FG000|Overall Study|Lost to Follow-up|2|||
163247452|NCT01226745|589613249|FG001|Overall Study|Lost to Follow-up|6|||
163247453|NCT01226745|589613250|FG002|Overall Study|Lost to Follow-up|6|||
163247454|NCT01226745|589613251|FG003|Overall Study|Lost to Follow-up|1|||
163247455|NCT01226745|589613252|FG004|Overall Study|Lost to Follow-up|1|||
163247456|NCT01226745|589613253|FG005|Overall Study|Lost to Follow-up|2|||
163247457|NCT01226745|589613248|FG000|Overall Study|Death|1|||
163247458|NCT01226745|589613249|FG001|Overall Study|Death|0|||
163247459|NCT01226745|589613250|FG002|Overall Study|Death|0|||
163247460|NCT01226745|589613251|FG003|Overall Study|Death|0|||
163247461|NCT01226745|589613252|FG004|Overall Study|Death|0|||
163247462|NCT01226745|589613253|FG005|Overall Study|Death|1|||
163410298|NCT00371865|590211339|FG001|Overall Study|Protocol Violation|2|||
163410299|NCT00371865|590211338|FG000|Overall Study|Withdrawal by Subject|12|||
163247463|NCT01226745|589613248|FG000|Overall Study|Other|6|||
163247464|NCT01226745|589613249|FG001|Overall Study|Other|7|||
163247465|NCT01226745|589613250|FG002|Overall Study|Other|8|||
163247466|NCT01226745|589613251|FG003|Overall Study|Other|4|||
163247467|NCT01226745|589613252|FG004|Overall Study|Other|3|||
163247468|NCT01226745|589613253|FG005|Overall Study|Other|1|||
163247469|NCT02270450|589613258|FG000|Overall Study|Refusal unrelated to adverse event|3|||
163247470|NCT02270450|589613259|FG001|Overall Study|Refusal unrelated to adverse event|1|||
163247471|NCT02270450|589613260|FG002|Overall Study|Refusal unrelated to adverse event|5|||
163247472|NCT02270450|589613261|FG003|Overall Study|Refusal unrelated to adverse event|14|||
163410300|NCT00371865|590211339|FG001|Overall Study|Withdrawal by Subject|10|||
163410301|NCT05073458|590211346|FG000|24-week Double-blind Period|Adverse Event|1|||
163247473|NCT02270450|589613258|FG000|Overall Study|Progression/relapse|1|||
163247474|NCT02270450|589613259|FG001|Overall Study|Progression/relapse|2|||
163247475|NCT02270450|589613260|FG002|Overall Study|Progression/relapse|4|||
163247476|NCT02270450|589613261|FG003|Overall Study|Progression/relapse|9|||
163247477|NCT02270450|589613258|FG000|Overall Study|Death|19|||
163247478|NCT02270450|589613259|FG001|Overall Study|Death|19|||
163247479|NCT02270450|589613260|FG002|Overall Study|Death|31|||
163247480|NCT02270450|589613261|FG003|Overall Study|Death|59|||
163247481|NCT01581281|589613270|FG000|Overall Study|Early Study Closure|15|||
163247482|NCT01581281|589613271|FG001|Overall Study|Early Study Closure|6|||
163247483|NCT01581281|589613272|FG002|Overall Study|Early Study Closure|12|||
163247484|NCT02081846|589613275|FG000|Overall Study|Withdrawal by Subject|1|||
163247485|NCT02081846|589613276|FG001|Overall Study|Withdrawal by Subject|0|||
163247486|NCT02081846|589613275|FG000|Overall Study|invalid consent|1|||
163247487|NCT02081846|589613276|FG001|Overall Study|invalid consent|0|||
163247488|NCT00535730|589613277|FG000|Overall Study|Adverse Event|1|||
163247489|NCT00535730|589613278|FG001|Overall Study|Adverse Event|1|||
163247490|NCT00535730|589613277|FG000|Overall Study|Lost to Follow-up|0|||
163247491|NCT00535730|589613278|FG001|Overall Study|Lost to Follow-up|1|||
163247492|NCT00535730|589613277|FG000|Overall Study|Physician Decision|0|||
163247493|NCT00535730|589613278|FG001|Overall Study|Physician Decision|1|||
163247494|NCT00535730|589613277|FG000|Overall Study|Protocol Violation|1|||
163247495|NCT00535730|589613278|FG001|Overall Study|Protocol Violation|0|||
163247496|NCT00535730|589613277|FG000|Overall Study|Withdrawal by Subject|0|||
163247497|NCT00535730|589613278|FG001|Overall Study|Withdrawal by Subject|4|||
163247498|NCT00295750|589613279|FG000|Overall Study|Adverse Event|19|||
163247499|NCT00295750|589613280|FG001|Overall Study|Adverse Event|15|||
163247500|NCT00295750|589613281|FG002|Overall Study|Adverse Event|12|||
163247501|NCT00295750|589613279|FG000|Overall Study|Lack of Efficacy|1|||
163247502|NCT00295750|589613280|FG001|Overall Study|Lack of Efficacy|1|||
163247503|NCT00295750|589613281|FG002|Overall Study|Lack of Efficacy|0|||
163247504|NCT00295750|589613279|FG000|Overall Study|Lost to Follow-up|1|||
163247505|NCT00295750|589613280|FG001|Overall Study|Lost to Follow-up|4|||
163247506|NCT00295750|589613281|FG002|Overall Study|Lost to Follow-up|1|||
163247507|NCT00295750|589613279|FG000|Overall Study|Taking prohibited therapy|2|||
163247508|NCT00295750|589613280|FG001|Overall Study|Taking prohibited therapy|3|||
163247509|NCT00295750|589613281|FG002|Overall Study|Taking prohibited therapy|2|||
163247510|NCT00295750|589613279|FG000|Overall Study|Administrative errors|2|||
163247511|NCT00295750|589613280|FG001|Overall Study|Administrative errors|4|||
163247512|NCT00295750|589613281|FG002|Overall Study|Administrative errors|5|||
163247513|NCT00295750|589613279|FG000|Overall Study|Trial drug errors|1|||
163247514|NCT00295750|589613280|FG001|Overall Study|Trial drug errors|1|||
163247515|NCT00295750|589613281|FG002|Overall Study|Trial drug errors|0|||
163247516|NCT00295750|589613279|FG000|Overall Study|Disease progression|2|||
163247517|NCT00295750|589613280|FG001|Overall Study|Disease progression|1|||
163247518|NCT00295750|589613281|FG002|Overall Study|Disease progression|0|||
163247519|NCT00295750|589613279|FG000|Overall Study|Personal reasons|0|||
163247520|NCT00295750|589613280|FG001|Overall Study|Personal reasons|1|||
163247521|NCT00295750|589613281|FG002|Overall Study|Personal reasons|0|||
163247522|NCT00295750|589613279|FG000|Overall Study|Randomized but never received trial drug|4|||
163247523|NCT00295750|589613280|FG001|Overall Study|Randomized but never received trial drug|3|||
163247524|NCT00295750|589613281|FG002|Overall Study|Randomized but never received trial drug|3|||
163247525|NCT00295750|589613279|FG000|Overall Study|Withdrawal by Subject|9|||
163247526|NCT00295750|589613280|FG001|Overall Study|Withdrawal by Subject|4|||
163247527|NCT00295750|589613281|FG002|Overall Study|Withdrawal by Subject|7|||
163247528|NCT00295750|589613279|FG000|Overall Study|Protocol Violation|2|||
163247529|NCT00295750|589613280|FG001|Overall Study|Protocol Violation|4|||
163247530|NCT00295750|589613281|FG002|Overall Study|Protocol Violation|2|||
163247531|NCT01650259|589613282|FG000|Overall Study|Improvement|105|||
163247532|NCT01650259|589613283|FG001|Overall Study|Improvement|0|||
163247533|NCT01650259|589613282|FG000|Overall Study|Adverse Event|127|||
163247534|NCT01650259|589613283|FG001|Overall Study|Adverse Event|0|||
163247535|NCT01650259|589613282|FG000|Overall Study|Lack of Efficacy|143|||
163247536|NCT01650259|589613283|FG001|Overall Study|Lack of Efficacy|0|||
163247537|NCT01650259|589613282|FG000|Overall Study|Lost to Follow-up|435|||
163247538|NCT01650259|589613283|FG001|Overall Study|Lost to Follow-up|0|||
163247539|NCT01650259|589613282|FG000|Overall Study|Patients had no visit after entry|70|||
163247540|NCT01650259|589613283|FG001|Overall Study|Patients had no visit after entry|0|||
163247541|NCT01650259|589613282|FG000|Overall Study|CRF not collected|98|||
163247542|NCT01650259|589613283|FG001|Overall Study|CRF not collected|82|||
163247543|NCT01650259|589613282|FG000|Overall Study|Not treated|1|||
163247544|NCT01650259|589613283|FG001|Overall Study|Not treated|7|||
163247545|NCT01650259|589613282|FG000|Overall Study|Other than listed|64|||
163247546|NCT01650259|589613283|FG001|Overall Study|Other than listed|146|||
163247547|NCT00936858|589613284|FG000|Overall Study|Death|3|||
163247548|NCT00936858|589613284|FG000|Overall Study|Progression|29|||
163247549|NCT00936858|589613284|FG000|Overall Study|Withdrawal by Subject|5|||
163247550|NCT00936858|589613284|FG000|Overall Study|Adverse Event|1|||
163247551|NCT00936858|589613284|FG000|Overall Study|Physician Decision|7|||
163354653|NCT03305809|590009569|FG000|Overall Study|Progressive Disease|0|||
163149706|NCT00551759|589261516|FG000|Overall Study|Adverse Event|7|||
163149707|NCT00551759|589261516|FG000|Overall Study|Death|5|||
163149708|NCT00551759|589261516|FG000|Overall Study|Ineligible|1|||
163149709|NCT03521570|589261517|FG000|Overall Study|Not eligible|11|||
163149710|NCT00322881|589261519|FG000|Overall Study|Death|2|||
163149711|NCT00322881|589261519|FG000|Overall Study|Adverse Event|1|||
163149712|NCT00322881|589261519|FG000|Overall Study|Disease Progression|2|||
163149713|NCT00112736|589261526|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
163149714|NCT00112736|589261527|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
163149715|NCT02138890|589261528|FG000|Overall Study|Adverse Event|1|||
163149716|NCT02138890|589261529|FG001|Overall Study|Adverse Event|0|||
163149717|NCT05435339|589261530|FG000|Overall Study|Death|1|||
163149718|NCT05435339|589261531|FG001|Overall Study|Death|0|||
163149719|NCT05435339|589261532|FG002|Overall Study|Death|3|||
163149720|NCT05435339|589261533|FG003|Overall Study|Death|1|||
163149721|NCT05435339|589261534|FG004|Overall Study|Death|3|||
163149722|NCT05435339|589261535|FG005|Overall Study|Death|2|||
163149723|NCT05435339|589261536|FG006|Overall Study|Death|4|||
163149724|NCT05435339|589261537|FG007|Overall Study|Death|6|||
163149725|NCT05435339|589261530|FG000|Overall Study|Sponsor Decision|0|||
163149726|NCT05435339|589261531|FG001|Overall Study|Sponsor Decision|1|||
163149727|NCT05435339|589261532|FG002|Overall Study|Sponsor Decision|0|||
163149728|NCT05435339|589261533|FG003|Overall Study|Sponsor Decision|0|||
163149729|NCT05435339|589261534|FG004|Overall Study|Sponsor Decision|2|||
163149730|NCT05435339|589261535|FG005|Overall Study|Sponsor Decision|1|||
163149731|NCT05435339|589261536|FG006|Overall Study|Sponsor Decision|2|||
163149732|NCT05435339|589261537|FG007|Overall Study|Sponsor Decision|2|||
163149733|NCT05435339|589261530|FG000|Overall Study|Withdrawal by Subject|0|||
163149734|NCT05435339|589261531|FG001|Overall Study|Withdrawal by Subject|0|||
163149735|NCT05435339|589261532|FG002|Overall Study|Withdrawal by Subject|0|||
163149736|NCT05435339|589261533|FG003|Overall Study|Withdrawal by Subject|0|||
163149737|NCT05435339|589261534|FG004|Overall Study|Withdrawal by Subject|1|||
163149738|NCT05435339|589261535|FG005|Overall Study|Withdrawal by Subject|0|||
163149739|NCT05435339|589261536|FG006|Overall Study|Withdrawal by Subject|1|||
163149740|NCT05435339|589261537|FG007|Overall Study|Withdrawal by Subject|1|||
163149741|NCT01446159|589261539|FG000|Overall Study|Withdrawal by Subject|1|||
163149742|NCT01446159|589261540|FG001|Overall Study|Withdrawal by Subject|0|||
163149743|NCT01446159|589261541|FG002|Overall Study|Withdrawal by Subject|14|||
163149744|NCT01446159|589261542|FG003|Overall Study|Withdrawal by Subject|11|||
163149745|NCT01446159|589261539|FG000|Overall Study|Lost to Follow-up|0|||
163149746|NCT01446159|589261540|FG001|Overall Study|Lost to Follow-up|0|||
163149747|NCT01446159|589261541|FG002|Overall Study|Lost to Follow-up|1|||
163149748|NCT01446159|589261542|FG003|Overall Study|Lost to Follow-up|2|||
163149749|NCT01446159|589261539|FG000|Overall Study|Death|2|||
163149750|NCT01446159|589261540|FG001|Overall Study|Death|3|||
163149751|NCT01446159|589261541|FG002|Overall Study|Death|43|||
163149752|NCT01446159|589261542|FG003|Overall Study|Death|36|||
163149753|NCT01446159|589261539|FG000|Overall Study|Other|0|||
163149754|NCT01446159|589261540|FG001|Overall Study|Other|0|||
163149755|NCT01446159|589261541|FG002|Overall Study|Other|13|||
163149756|NCT01446159|589261542|FG003|Overall Study|Other|13|||
163149757|NCT05135871|589261551|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
163149758|NCT05135871|589261552|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
163149759|NCT05135871|589261553|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
163149760|NCT05135871|589261554|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
163149761|NCT04258423|589261555|FG000|Overall Study|Study Closure|2|||
163149762|NCT04258423|589261556|FG001|Overall Study|Study Closure|2|||
163149763|NCT03980730|589261557|FG000|Overall Study|Study Terminated by Sponsor|0|||
163149764|NCT03980730|589261558|FG001|Overall Study|Study Terminated by Sponsor|3|||
163149765|NCT03980730|589261557|FG000|Overall Study|Adverse Event|2|||
163149766|NCT03980730|589261558|FG001|Overall Study|Adverse Event|0|||
163149767|NCT03980730|589261557|FG000|Overall Study|Sponsor Request|0|||
163149768|NCT03980730|589261558|FG001|Overall Study|Sponsor Request|1|||
163149769|NCT00880620|589261559|FG000|Overall Study|Adverse Event|4|||
163149770|NCT00880620|589261560|FG001|Overall Study|Adverse Event|5|||
163149771|NCT00880620|589261561|FG002|Overall Study|Adverse Event|15|||
163149772|NCT00880620|589261562|FG003|Overall Study|Adverse Event|15|||
163149773|NCT00880620|589261559|FG000|Overall Study|Death|0|||
163149774|NCT00880620|589261560|FG001|Overall Study|Death|0|||
163149775|NCT00880620|589261561|FG002|Overall Study|Death|1|||
163149776|NCT00880620|589261562|FG003|Overall Study|Death|0|||
163149777|NCT00880620|589261559|FG000|Overall Study|Lack of Efficacy|12|||
163149778|NCT00880620|589261560|FG001|Overall Study|Lack of Efficacy|4|||
163149779|NCT00880620|589261561|FG002|Overall Study|Lack of Efficacy|0|||
163149780|NCT00880620|589261562|FG003|Overall Study|Lack of Efficacy|1|||
163247552|NCT00936858|589613284|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
163149781|NCT00880620|589261559|FG000|Overall Study|Lost to Follow-up|0|||
163149782|NCT00880620|589261560|FG001|Overall Study|Lost to Follow-up|1|||
163247553|NCT00936858|589613284|FG000|Overall Study|Lost to Follow-up|1|||
163247554|NCT00584727|589613295|FG000|First Intervention|Discontinuation|0|||
163247555|NCT00584727|589613296|FG001|First Intervention|Discontinuation|0|||
163247556|NCT00584727|589613297|FG002|First Intervention|Discontinuation|1|||
163247557|NCT00584727|589613298|FG003|First Intervention|Discontinuation|0|||
163247558|NCT00584727|589613299|FG004|First Intervention|Discontinuation|0|||
163247559|NCT00584727|589613300|FG005|First Intervention|Discontinuation|0|||
163247560|NCT00584727|589613295|FG000|Third Intervention|Protocol Violation|0|||
163247561|NCT00584727|589613296|FG001|Third Intervention|Protocol Violation|0|||
163247562|NCT00584727|589613297|FG002|Third Intervention|Protocol Violation|1|||
163247563|NCT00584727|589613298|FG003|Third Intervention|Protocol Violation|0|||
163247564|NCT00584727|589613299|FG004|Third Intervention|Protocol Violation|4|||
163247565|NCT00584727|589613300|FG005|Third Intervention|Protocol Violation|2|||
163247566|NCT04072159|589613301|FG000|Overall Study|Lost to Follow-up|6|||
163247567|NCT04072159|589613302|FG001|Overall Study|Lost to Follow-up|6|||
163247568|NCT04072159|589613301|FG000|Overall Study|Withdrawal by Subject|2|||
163247569|NCT04072159|589613302|FG001|Overall Study|Withdrawal by Subject|0|||
163247570|NCT00989287|589613306|FG000|Overall Study|Adverse Event|1|||
163247571|NCT00989287|589613307|FG001|Overall Study|Adverse Event|0|||
163247572|NCT00989287|589613306|FG000|Overall Study|Lost to Follow-up|0|||
163247573|NCT00989287|589613307|FG001|Overall Study|Lost to Follow-up|1|||
163247574|NCT00695669|589613308|FG000|Overall Study|Adverse Event|0|||
163247575|NCT00695669|589613309|FG001|Overall Study|Adverse Event|0|||
163247576|NCT00695669|589613310|FG002|Overall Study|Adverse Event|2|||
163247577|NCT00695669|589613311|FG003|Overall Study|Adverse Event|0|||
163247578|NCT00695669|589613308|FG000|Overall Study|Lost to Follow-up|4|||
163247579|NCT00695669|589613309|FG001|Overall Study|Lost to Follow-up|4|||
163247580|NCT00695669|589613310|FG002|Overall Study|Lost to Follow-up|1|||
163247581|NCT00695669|589613311|FG003|Overall Study|Lost to Follow-up|4|||
163247582|NCT00092131|589613312|FG000|Treatment Period I|Adverse Event|1|||
163247583|NCT00092131|589613313|FG001|Treatment Period I|Adverse Event|0|||
163247584|NCT00092131|589613312|FG000|Treatment Period II|Adverse Event|0|||
163247585|NCT00092131|589613313|FG001|Treatment Period II|Adverse Event|1|||
163247586|NCT02341417|589613314|FG000|Overall Study|Withdrawal by Subject|0|||
163247587|NCT02341417|589613315|FG001|Overall Study|Withdrawal by Subject|2|||
163247588|NCT02341417|589613316|FG002|Overall Study|Withdrawal by Subject|0|||
163354654|NCT03305809|590009570|FG001|Overall Study|Progressive Disease|0|||
163354655|NCT03305809|590009571|FG002|Overall Study|Progressive Disease|1|||
163354656|NCT03305809|590009572|FG003|Overall Study|Progressive Disease|0|||
163354657|NCT03305809|590009569|FG000|Overall Study|Protocol Violation|1|||
163354658|NCT03305809|590009570|FG001|Overall Study|Protocol Violation|0|||
163354659|NCT03305809|590009571|FG002|Overall Study|Protocol Violation|2|||
163354660|NCT03305809|590009572|FG003|Overall Study|Protocol Violation|3|||
163354661|NCT03305809|590009569|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
163354662|NCT03305809|590009570|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
163354663|NCT03305809|590009571|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
163354664|NCT03305809|590009572|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
163354665|NCT03305809|590009569|FG000|Overall Study|Withdrawal by Subject|2|||
163354666|NCT03305809|590009570|FG001|Overall Study|Withdrawal by Subject|4|||
163354667|NCT03305809|590009571|FG002|Overall Study|Withdrawal by Subject|5|||
163354668|NCT03305809|590009572|FG003|Overall Study|Withdrawal by Subject|2|||
163354669|NCT03305809|590009569|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
163354670|NCT03305809|590009570|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
163354671|NCT03305809|590009571|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
163354672|NCT03305809|590009572|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
163354673|NCT00816556|590009575|FG000|Overall Study|Adverse Event|1|||
163354674|NCT00816556|590009576|FG001|Overall Study|Adverse Event|1|||
163354675|NCT00816556|590009577|FG002|Overall Study|Adverse Event|1|||
163354676|NCT00816556|590009575|FG000|Overall Study|Withdrawal by Subject|1|||
163410302|NCT05073458|590211347|FG001|24-week Double-blind Period|Adverse Event|0|||
163410303|NCT05073458|590211346|FG000|24-week Double-blind Period|Physician Decision|1|||
163354677|NCT00816556|590009576|FG001|Overall Study|Withdrawal by Subject|1|||
163354678|NCT00816556|590009577|FG002|Overall Study|Withdrawal by Subject|1|||
163354679|NCT00816556|590009575|FG000|Overall Study|Lost to Follow-up|0|||
163354680|NCT00816556|590009576|FG001|Overall Study|Lost to Follow-up|0|||
163354681|NCT00816556|590009577|FG002|Overall Study|Lost to Follow-up|1|||
163354682|NCT02536742|590009581|FG000|Overall Study|Did not start protocol therapy|1|||
163354683|NCT02536742|590009581|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
163354684|NCT01010204|590009582|FG000|Overall Study|Lost to Follow-up|2|||
163354685|NCT01010204|590009583|FG001|Overall Study|Lost to Follow-up|2|||
163410304|NCT05073458|590211347|FG001|24-week Double-blind Period|Physician Decision|0|||
163410305|NCT05073458|590211346|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
163247589|NCT02341417|589613314|FG000|Overall Study|Decision by sponsor|2|||
163247590|NCT02341417|589613315|FG001|Overall Study|Decision by sponsor|0|||
163354686|NCT01010204|590009582|FG000|Overall Study|Adverse Event|1|||
163247591|NCT02341417|589613316|FG002|Overall Study|Decision by sponsor|0|||
163247592|NCT02341417|589613314|FG000|Overall Study|Death|0|||
163247593|NCT02341417|589613315|FG001|Overall Study|Death|0|||
163247594|NCT02341417|589613316|FG002|Overall Study|Death|1|||
163247595|NCT03570619|589613332|FG000|Overall Study|Adverse Event|2|||
163247596|NCT03570619|589613333|FG001|Overall Study|Adverse Event|0|||
163247597|NCT03570619|589613334|FG002|Overall Study|Adverse Event|1|||
163247598|NCT03570619|589613332|FG000|Overall Study|new diagnosis of new malignancy|1|||
163247599|NCT03570619|589613333|FG001|Overall Study|new diagnosis of new malignancy|0|||
163247600|NCT03570619|589613334|FG002|Overall Study|new diagnosis of new malignancy|0|||
163247601|NCT03570619|589613332|FG000|Overall Study|Physician Decision|1|||
163247602|NCT03570619|589613333|FG001|Overall Study|Physician Decision|1|||
163247603|NCT03570619|589613334|FG002|Overall Study|Physician Decision|0|||
163247604|NCT03570619|589613332|FG000|Overall Study|Withdrawal by Subject|0|||
163247605|NCT03570619|589613333|FG001|Overall Study|Withdrawal by Subject|2|||
163247606|NCT03570619|589613334|FG002|Overall Study|Withdrawal by Subject|0|||
163247607|NCT04773587|589613335|FG000|Overall Study|Lost to Follow-up|11|||
163247608|NCT04773587|589613336|FG001|Overall Study|Lost to Follow-up|3|||
163247609|NCT04773587|589613335|FG000|Overall Study|Adverse Event|6|||
163247610|NCT04773587|589613336|FG001|Overall Study|Adverse Event|3|||
163247611|NCT04773587|589613335|FG000|Overall Study|Lack of Efficacy|5|||
163247612|NCT04773587|589613336|FG001|Overall Study|Lack of Efficacy|2|||
163247613|NCT04773587|589613335|FG000|Overall Study|Withdrawal by Subject|4|||
163247614|NCT04773587|589613336|FG001|Overall Study|Withdrawal by Subject|5|||
163247615|NCT04773587|589613335|FG000|Overall Study|Noncompliance|1|||
163247616|NCT04773587|589613336|FG001|Overall Study|Noncompliance|0|||
163247617|NCT04773587|589613335|FG000|Overall Study|Protocol Violation|1|||
163247618|NCT04773587|589613336|FG001|Overall Study|Protocol Violation|0|||
163247619|NCT04773587|589613335|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
163247620|NCT04773587|589613336|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
163247621|NCT00659334|589613343|FG000|Overall Study|Screen Failure|8|||
163247622|NCT00659334|589613344|FG001|Overall Study|Screen Failure|5|||
163247623|NCT00659334|589613345|FG002|Overall Study|Screen Failure|0|||
163247624|NCT00659334|589613346|FG003|Overall Study|Screen Failure|0|||
163247625|NCT00659334|589613347|FG004|Overall Study|Screen Failure|0|||
163247626|NCT00659334|589613348|FG005|Overall Study|Screen Failure|0|||
163247627|NCT00659334|589613349|FG006|Overall Study|Screen Failure|1|||
163247628|NCT03034577|589613350|FG000|Overall Study|Withdrawal by Subject|6|||
163247629|NCT03034577|589613351|FG001|Overall Study|Withdrawal by Subject|9|||
163247630|NCT03034577|589613350|FG000|Overall Study|Lost to Follow-up|25|||
163247631|NCT03034577|589613351|FG001|Overall Study|Lost to Follow-up|26|||
163247632|NCT01174342|589613352|FG000|Overall Study|Conversion to cesarean section|4|||
163247633|NCT02625623|589613353|FG000|Overall Study|Participants randomized but not treated|9|||
163247634|NCT02625623|589613354|FG001|Overall Study|Participants randomized but not treated|1|||
163247635|NCT02298192|589613360|FG000|Overall Study|Unclassified|3|||
163247636|NCT02298192|589613361|FG001|Overall Study|Unclassified|2|||
163247637|NCT02298192|589613360|FG000|Overall Study|Withdrawal criteria|2|||
163247638|NCT02298192|589613361|FG001|Overall Study|Withdrawal criteria|0|||
163247639|NCT02298192|589613360|FG000|Overall Study|Withdrawal by Subject|6|||
163247640|NCT02298192|589613361|FG001|Overall Study|Withdrawal by Subject|1|||
163247641|NCT02298192|589613360|FG000|Overall Study|Lost to Follow-up|2|||
163247642|NCT02298192|589613361|FG001|Overall Study|Lost to Follow-up|1|||
163247643|NCT02298192|589613360|FG000|Overall Study|Adverse Event|6|||
163247644|NCT02298192|589613361|FG001|Overall Study|Adverse Event|2|||
163247645|NCT02352948|589613366|FG000|Overall Study|Death|47|||
163247646|NCT02352948|589613367|FG001|Overall Study|Death|48|||
163247647|NCT02352948|589613368|FG002|Overall Study|Death|114|||
163247648|NCT02352948|589613369|FG003|Overall Study|Death|74|||
163247649|NCT02352948|589613370|FG004|Overall Study|Death|77|||
163247650|NCT02352948|589613371|FG005|Overall Study|Death|44|||
163247651|NCT02352948|589613366|FG000|Overall Study|Lost to Follow-up|1|||
163247652|NCT02352948|589613367|FG001|Overall Study|Lost to Follow-up|0|||
163247653|NCT02352948|589613368|FG002|Overall Study|Lost to Follow-up|2|||
163247654|NCT02352948|589613369|FG003|Overall Study|Lost to Follow-up|1|||
163247655|NCT02352948|589613370|FG004|Overall Study|Lost to Follow-up|2|||
163247656|NCT02352948|589613371|FG005|Overall Study|Lost to Follow-up|1|||
163247657|NCT02352948|589613366|FG000|Overall Study|Withdrawal by Subject|1|||
163247658|NCT02352948|589613367|FG001|Overall Study|Withdrawal by Subject|10|||
163410306|NCT05073458|590211347|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
163247659|NCT02352948|589613368|FG002|Overall Study|Withdrawal by Subject|11|||
163410307|NCT05073458|590211346|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
163410308|NCT05073458|590211347|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
163247660|NCT02352948|589613369|FG003|Overall Study|Withdrawal by Subject|23|||
163247661|NCT02352948|589613370|FG004|Overall Study|Withdrawal by Subject|9|||
163247662|NCT02352948|589613371|FG005|Overall Study|Withdrawal by Subject|4|||
163247663|NCT02352948|589613366|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163247664|NCT02352948|589613367|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163247665|NCT02352948|589613368|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
163247666|NCT02352948|589613369|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
163247667|NCT02352948|589613370|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
163247668|NCT02352948|589613371|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
163247669|NCT02352948|589613366|FG000|Overall Study|Other|0|||
163247670|NCT02352948|589613367|FG001|Overall Study|Other|0|||
163247671|NCT02352948|589613368|FG002|Overall Study|Other|2|||
163247672|NCT02352948|589613369|FG003|Overall Study|Other|0|||
163247673|NCT02352948|589613370|FG004|Overall Study|Other|0|||
163247674|NCT02352948|589613371|FG005|Overall Study|Other|0|||
163247675|NCT01453595|589613375|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
163247676|NCT01453595|589613376|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
163247677|NCT01453595|589613377|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
163247678|NCT01128413|589613378|FG000|Overall Study|Withdrawal by Subject|1|||
163247679|NCT01128413|589613379|FG001|Overall Study|Withdrawal by Subject|0|||
163247680|NCT01128413|589613378|FG000|Overall Study|NICOM Monitor Problems|2|||
163247681|NCT01128413|589613379|FG001|Overall Study|NICOM Monitor Problems|1|||
163247682|NCT01128413|589613378|FG000|Overall Study|Pt made DNR|1|||
163247683|NCT01128413|589613379|FG001|Overall Study|Pt made DNR|0|||
163247684|NCT03762473|589613380|FG000|Overall Study|Death|1|||
163247685|NCT03762473|589613381|FG001|Overall Study|Death|0|||
163247686|NCT00045110|589613382|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
163247687|NCT00045110|589613383|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
163247688|NCT00045110|589613384|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
163247689|NCT00045110|589613382|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
163247690|NCT00045110|589613383|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
163247691|NCT00045110|589613384|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
163247692|NCT00045110|589613382|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
163247693|NCT00045110|589613383|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
163247694|NCT00045110|589613384|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
163247695|NCT03662750|589613386|FG000|Overall Study|Withdrawal by Subject|1|||
163247696|NCT02010060|589613387|FG000|Overall Study|Lost to Follow-up|1|||
163247697|NCT02010060|589613388|FG001|Overall Study|Lost to Follow-up|2|||
163247698|NCT02010060|589613389|FG002|Overall Study|Lost to Follow-up|2|||
163247699|NCT02010060|589613387|FG000|Overall Study|Injury|0|||
163247700|NCT02010060|589613388|FG001|Overall Study|Injury|1|||
163247701|NCT02010060|589613389|FG002|Overall Study|Injury|0|||
163247702|NCT00660010|589613390|FG000|Overall Study|Withdrawal by Subject|2|||
163247703|NCT00660010|589613390|FG000|Overall Study|Lost to Follow-up|3|||
163247704|NCT00660010|589613390|FG000|Overall Study|Adverse Event|1|||
163247705|NCT00660010|589613390|FG000|Overall Study|Noncompliance with visit schedule|3|||
163247706|NCT00726752|589613391|FG000|Overall Study|Lack of Efficacy|6|||
163247707|NCT01292603|589615452|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
163247708|NCT01292603|589615453|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
163247709|NCT01292603|589615454|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
163247710|NCT01292603|589615455|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
163247711|NCT01292603|589615456|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
163247712|NCT01292603|589615457|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
163247713|NCT01292603|589615452|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
163247714|NCT01292603|589615453|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
163247715|NCT01292603|589615454|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
163247716|NCT01292603|589615455|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
163247717|NCT01292603|589615456|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
163247718|NCT01292603|589615457|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
163247719|NCT01292603|589615452|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
163247720|NCT01292603|589615453|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
163247721|NCT01292603|589615454|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
163247722|NCT01292603|589615455|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
163247723|NCT01292603|589615456|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
163247724|NCT01292603|589615457|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
163247725|NCT01292603|589615452|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
163247726|NCT01292603|589615453|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
163247727|NCT01292603|589615454|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
163247728|NCT01292603|589615455|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
163247729|NCT01292603|589615456|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
163247730|NCT01292603|589615457|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
163247731|NCT01292603|589615452|FG000|Part 1: Regular Follow-Up Period|Death|3|||
163247732|NCT01292603|589615453|FG001|Part 1: Regular Follow-Up Period|Death|1|||
163247733|NCT01292603|589615454|FG002|Part 1: Regular Follow-Up Period|Death|3|||
163247734|NCT01292603|589615455|FG003|Part 1: Regular Follow-Up Period|Death|1|||
163247735|NCT01292603|589615456|FG004|Part 1: Regular Follow-Up Period|Death|0|||
163247736|NCT01292603|589615457|FG005|Part 1: Regular Follow-Up Period|Death|0|||
163247737|NCT01292603|589615452|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
163247738|NCT01292603|589615453|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
163247739|NCT01292603|589615454|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
163247740|NCT01292603|589615455|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
163247741|NCT01292603|589615456|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
163247742|NCT01292603|589615457|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
163247743|NCT01292603|589615452|FG000|Part 2: Dose Confirmation Period|Death|0|||
163247744|NCT01292603|589615453|FG001|Part 2: Dose Confirmation Period|Death|0|||
163247745|NCT01292603|589615454|FG002|Part 2: Dose Confirmation Period|Death|0|||
163247746|NCT01292603|589615455|FG003|Part 2: Dose Confirmation Period|Death|0|||
163247747|NCT01292603|589615456|FG004|Part 2: Dose Confirmation Period|Death|1|||
163247748|NCT01292603|589615457|FG005|Part 2: Dose Confirmation Period|Death|0|||
163247749|NCT01292603|589615452|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
163247750|NCT01292603|589615453|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
163247751|NCT01292603|589615454|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
163247752|NCT01292603|589615455|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
163247753|NCT01292603|589615456|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
163247754|NCT01292603|589615457|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
163247755|NCT01292603|589615452|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
163247756|NCT01292603|589615453|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
163247757|NCT01292603|589615454|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
163247758|NCT01292603|589615455|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
163247759|NCT01292603|589615456|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
163247760|NCT01292603|589615457|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
163247761|NCT01292603|589615452|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
163247762|NCT01292603|589615453|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
163247763|NCT01292603|589615454|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
163247764|NCT01292603|589615455|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
163247765|NCT01292603|589615456|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
163247766|NCT01292603|589615457|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
163247767|NCT01292603|589615452|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
163247768|NCT01292603|589615453|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
163247769|NCT01292603|589615454|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
163247770|NCT01292603|589615455|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
163247771|NCT01292603|589615456|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
163247772|NCT01292603|589615457|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
163247773|NCT01292603|589615452|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
163247774|NCT01292603|589615453|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
163247775|NCT01292603|589615454|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
163247776|NCT01292603|589615455|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
163247777|NCT01292603|589615456|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
163247778|NCT01292603|589615457|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
163247779|NCT01292603|589615452|FG000|Part 2: Regular Follow-Up|Death|0|||
163247780|NCT01292603|589615453|FG001|Part 2: Regular Follow-Up|Death|0|||
163247781|NCT01292603|589615454|FG002|Part 2: Regular Follow-Up|Death|0|||
163247782|NCT01292603|589615455|FG003|Part 2: Regular Follow-Up|Death|0|||
163247783|NCT01292603|589615456|FG004|Part 2: Regular Follow-Up|Death|6|||
163247784|NCT01292603|589615457|FG005|Part 2: Regular Follow-Up|Death|3|||
163247785|NCT01292603|589615452|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
163247786|NCT01292603|589615453|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
163247787|NCT01292603|589615454|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
163247788|NCT01292603|589615455|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
163247789|NCT01292603|589615456|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
163247790|NCT01292603|589615457|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
163247791|NCT01292603|589615452|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
163247792|NCT01292603|589615453|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
163247793|NCT01292603|589615454|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
163247794|NCT01292603|589615455|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
163247795|NCT01292603|589615456|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
163247796|NCT01292603|589615457|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
163247797|NCT01292603|589615452|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
163247798|NCT01292603|589615453|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
163247799|NCT01292603|589615454|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
163247800|NCT01292603|589615455|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
163247801|NCT01292603|589615456|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
163247802|NCT01292603|589615457|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
163247803|NCT01292603|589615452|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
163247804|NCT01292603|589615453|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
163247805|NCT01292603|589615454|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
163410309|NCT05073458|590211346|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
163247806|NCT01292603|589615455|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
163247807|NCT01292603|589615456|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
163247808|NCT01292603|589615457|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
163247809|NCT01292603|589615452|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
163247810|NCT01292603|589615453|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
163247811|NCT01292603|589615454|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
163247812|NCT01292603|589615455|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
163247813|NCT01292603|589615456|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
163247814|NCT01292603|589615457|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
163247815|NCT01292603|589615452|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
163247816|NCT01292603|589615453|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
163247817|NCT01292603|589615454|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
163247818|NCT01292603|589615455|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
163247819|NCT01292603|589615456|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
163247820|NCT01292603|589615457|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
163247821|NCT01292603|589615452|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
163247822|NCT01292603|589615453|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
163247823|NCT01292603|589615454|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
163247824|NCT01292603|589615455|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
163247825|NCT01292603|589615456|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
163247826|NCT01292603|589615457|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
163247827|NCT01292603|589615452|FG000|Overall Survival Status|Death|3|||
163247828|NCT01292603|589615453|FG001|Overall Survival Status|Death|1|||
163247829|NCT01292603|589615454|FG002|Overall Survival Status|Death|3|||
163247830|NCT01292603|589615455|FG003|Overall Survival Status|Death|1|||
163247831|NCT01292603|589615456|FG004|Overall Survival Status|Death|16|||
163247832|NCT01292603|589615457|FG005|Overall Survival Status|Death|10|||
163247833|NCT04307004|589615462|FG000|Randomization 1|Withdrawal by Subject|25|||
163247834|NCT04307004|589615463|FG001|Randomization 1|Withdrawal by Subject|26|||
163247835|NCT04307004|589615464|FG002|Randomization 1|Withdrawal by Subject|0|||
163247836|NCT04307004|589615465|FG003|Randomization 1|Withdrawal by Subject|0|||
163247837|NCT04307004|589615462|FG000|Randomization 2|Withdrawal by Subject|0|||
163247838|NCT04307004|589615463|FG001|Randomization 2|Withdrawal by Subject|0|||
163247839|NCT04307004|589615464|FG002|Randomization 2|Withdrawal by Subject|28|||
163247840|NCT04307004|589615465|FG003|Randomization 2|Withdrawal by Subject|23|||
163247841|NCT02807558|589615466|FG000|Overall Study|Consent withdrawn by participant|4|||
163247842|NCT02807558|589615467|FG001|Overall Study|Consent withdrawn by participant|0|||
163247843|NCT02807558|589615468|FG002|Overall Study|Consent withdrawn by participant|4|||
163247844|NCT02807558|589615469|FG003|Overall Study|Consent withdrawn by participant|2|||
163247845|NCT02807558|589615470|FG004|Overall Study|Consent withdrawn by participant|1|||
163247846|NCT02807558|589615471|FG005|Overall Study|Consent withdrawn by participant|0|||
163247847|NCT02807558|589615466|FG000|Overall Study|Non-compliance with Study Drug|0|||
163247848|NCT02807558|589615467|FG001|Overall Study|Non-compliance with Study Drug|0|||
163247849|NCT02807558|589615468|FG002|Overall Study|Non-compliance with Study Drug|1|||
163247850|NCT02807558|589615469|FG003|Overall Study|Non-compliance with Study Drug|0|||
163247851|NCT02807558|589615470|FG004|Overall Study|Non-compliance with Study Drug|0|||
163247852|NCT02807558|589615471|FG005|Overall Study|Non-compliance with Study Drug|0|||
163247853|NCT02807558|589615466|FG000|Overall Study|Adverse Event|0|||
163247854|NCT02807558|589615467|FG001|Overall Study|Adverse Event|0|||
163247855|NCT02807558|589615468|FG002|Overall Study|Adverse Event|9|||
163247856|NCT02807558|589615469|FG003|Overall Study|Adverse Event|0|||
163247857|NCT02807558|589615470|FG004|Overall Study|Adverse Event|0|||
163247858|NCT02807558|589615471|FG005|Overall Study|Adverse Event|0|||
163247859|NCT02807558|589615466|FG000|Overall Study|Death|23|||
163247860|NCT02807558|589615467|FG001|Overall Study|Death|2|||
163247861|NCT02807558|589615468|FG002|Overall Study|Death|3|||
163247862|NCT02807558|589615469|FG003|Overall Study|Death|43|||
163247863|NCT02807558|589615470|FG004|Overall Study|Death|24|||
163247864|NCT02807558|589615471|FG005|Overall Study|Death|15|||
163247865|NCT02807558|589615466|FG000|Overall Study|Progressive Disease|0|||
163247866|NCT02807558|589615467|FG001|Overall Study|Progressive Disease|0|||
163247867|NCT02807558|589615468|FG002|Overall Study|Progressive Disease|1|||
163354687|NCT01010204|590009583|FG001|Overall Study|Adverse Event|3|||
163354688|NCT01010204|590009582|FG000|Overall Study|Withdrawal by Subject|2|||
163247868|NCT02807558|589615469|FG003|Overall Study|Progressive Disease|0|||
163247869|NCT02807558|589615470|FG004|Overall Study|Progressive Disease|0|||
163247870|NCT02807558|589615471|FG005|Overall Study|Progressive Disease|0|||
163247871|NCT02807558|589615466|FG000|Overall Study|Other than specified|1|||
163247872|NCT02807558|589615467|FG001|Overall Study|Other than specified|0|||
163247873|NCT02807558|589615468|FG002|Overall Study|Other than specified|2|||
163247874|NCT02807558|589615469|FG003|Overall Study|Other than specified|0|||
163247875|NCT02807558|589615470|FG004|Overall Study|Other than specified|1|||
163247876|NCT02807558|589615471|FG005|Overall Study|Other than specified|1|||
163247877|NCT02807558|589615466|FG000|Overall Study|Lack of Efficacy|0|||
163354689|NCT01010204|590009583|FG001|Overall Study|Withdrawal by Subject|3|||
163354690|NCT01010204|590009582|FG000|Overall Study|psychiatric hospitalization|2|||
163247878|NCT02807558|589615467|FG001|Overall Study|Lack of Efficacy|0|||
163247879|NCT02807558|589615468|FG002|Overall Study|Lack of Efficacy|9|||
163247880|NCT02807558|589615469|FG003|Overall Study|Lack of Efficacy|0|||
163247881|NCT02807558|589615470|FG004|Overall Study|Lack of Efficacy|0|||
163247882|NCT02807558|589615471|FG005|Overall Study|Lack of Efficacy|0|||
163247883|NCT01972841|589615472|FG000|Overall Study|Randomized but Never Received Treatment|2|||
163247884|NCT01972841|589615473|FG001|Overall Study|Randomized but Never Received Treatment|5|||
163247885|NCT01972841|589615474|FG002|Overall Study|Randomized but Never Received Treatment|4|||
163247886|NCT01972841|589615475|FG003|Overall Study|Randomized but Never Received Treatment|2|||
163247887|NCT01972841|589615476|FG004|Overall Study|Randomized but Never Received Treatment|6|||
163247888|NCT01972841|589615477|FG005|Overall Study|Randomized but Never Received Treatment|13|||
163247889|NCT01972841|589615472|FG000|Overall Study|Adverse Event|13|||
163247890|NCT01972841|589615473|FG001|Overall Study|Adverse Event|8|||
163247891|NCT01972841|589615474|FG002|Overall Study|Adverse Event|12|||
163247892|NCT01972841|589615475|FG003|Overall Study|Adverse Event|9|||
163247893|NCT01972841|589615476|FG004|Overall Study|Adverse Event|21|||
163247894|NCT01972841|589615477|FG005|Overall Study|Adverse Event|26|||
163247895|NCT01972841|589615472|FG000|Overall Study|Lack of Efficacy|1|||
163247896|NCT01972841|589615473|FG001|Overall Study|Lack of Efficacy|0|||
163247897|NCT01972841|589615474|FG002|Overall Study|Lack of Efficacy|0|||
163247898|NCT01972841|589615475|FG003|Overall Study|Lack of Efficacy|2|||
163247899|NCT01972841|589615476|FG004|Overall Study|Lack of Efficacy|4|||
163247900|NCT01972841|589615477|FG005|Overall Study|Lack of Efficacy|1|||
163247901|NCT01972841|589615472|FG000|Overall Study|Lost to Follow-up|4|||
163247902|NCT01972841|589615473|FG001|Overall Study|Lost to Follow-up|2|||
163247903|NCT01972841|589615474|FG002|Overall Study|Lost to Follow-up|4|||
163247904|NCT01972841|589615475|FG003|Overall Study|Lost to Follow-up|2|||
163247905|NCT01972841|589615476|FG004|Overall Study|Lost to Follow-up|9|||
163247906|NCT01972841|589615477|FG005|Overall Study|Lost to Follow-up|3|||
163247907|NCT01972841|589615472|FG000|Overall Study|Protocol Violation|2|||
163247908|NCT01972841|589615473|FG001|Overall Study|Protocol Violation|2|||
163247909|NCT01972841|589615474|FG002|Overall Study|Protocol Violation|3|||
163247910|NCT01972841|589615475|FG003|Overall Study|Protocol Violation|5|||
163247911|NCT01972841|589615476|FG004|Overall Study|Protocol Violation|9|||
163247912|NCT01972841|589615477|FG005|Overall Study|Protocol Violation|4|||
163247913|NCT01972841|589615472|FG000|Overall Study|Withdrawal by participants|21|||
163247914|NCT01972841|589615473|FG001|Overall Study|Withdrawal by participants|27|||
163247915|NCT01972841|589615474|FG002|Overall Study|Withdrawal by participants|23|||
163247916|NCT01972841|589615475|FG003|Overall Study|Withdrawal by participants|16|||
163247917|NCT01972841|589615476|FG004|Overall Study|Withdrawal by participants|33|||
163247918|NCT01972841|589615477|FG005|Overall Study|Withdrawal by participants|34|||
163247919|NCT01972841|589615472|FG000|Overall Study|Miscellaneous|0|||
163247920|NCT01972841|589615473|FG001|Overall Study|Miscellaneous|0|||
163247921|NCT01972841|589615474|FG002|Overall Study|Miscellaneous|4|||
163247922|NCT01972841|589615475|FG003|Overall Study|Miscellaneous|1|||
163247923|NCT01972841|589615476|FG004|Overall Study|Miscellaneous|0|||
163247924|NCT01972841|589615477|FG005|Overall Study|Miscellaneous|4|||
163247925|NCT01972841|589615472|FG000|Overall Study|Did not have end of treatment page|0|||
163247926|NCT01972841|589615473|FG001|Overall Study|Did not have end of treatment page|0|||
163247927|NCT01972841|589615474|FG002|Overall Study|Did not have end of treatment page|0|||
163247928|NCT01972841|589615475|FG003|Overall Study|Did not have end of treatment page|0|||
163247929|NCT01972841|589615476|FG004|Overall Study|Did not have end of treatment page|1|||
163247930|NCT01972841|589615477|FG005|Overall Study|Did not have end of treatment page|0|||
163247931|NCT00688636|589615482|FG000|Overall Study|Adverse Event|2|||
163247932|NCT00688636|589615483|FG001|Overall Study|Adverse Event|1|||
163247933|NCT01572727|589615484|FG000|Overall Study|Adverse Event|43|||
163247934|NCT01572727|589615485|FG001|Overall Study|Adverse Event|15|||
163247935|NCT01572727|589615484|FG000|Overall Study|Lost to Follow-up|1|||
163247936|NCT01572727|589615485|FG001|Overall Study|Lost to Follow-up|1|||
163247937|NCT01572727|589615484|FG000|Overall Study|Physician Decision|23|||
163247938|NCT01572727|589615485|FG001|Overall Study|Physician Decision|9|||
163247939|NCT01572727|589615484|FG000|Overall Study|Progressive disease|59|||
163247940|NCT01572727|589615485|FG001|Overall Study|Progressive disease|82|||
163247941|NCT01572727|589615484|FG000|Overall Study|Protocol Violation|0|||
163247942|NCT01572727|589615485|FG001|Overall Study|Protocol Violation|1|||
163247943|NCT01572727|589615484|FG000|Overall Study|Study terminated by sponsor|61|||
163247944|NCT01572727|589615485|FG001|Overall Study|Study terminated by sponsor|83|||
163247945|NCT01572727|589615484|FG000|Overall Study|Parent/guardian decision|14|||
163247946|NCT01572727|589615485|FG001|Overall Study|Parent/guardian decision|9|||
163247947|NCT01572727|589615484|FG000|Overall Study|Death|2|||
163247948|NCT01572727|589615485|FG001|Overall Study|Death|2|||
163247949|NCT01572727|589615484|FG000|Overall Study|Untreated|4|||
163247950|NCT01572727|589615485|FG001|Overall Study|Untreated|7|||
163247951|NCT04053764|589615486|FG000|Overall Study|Withdrawal by Subject|6|||
163247952|NCT04053764|589615487|FG001|Overall Study|Withdrawal by Subject|2|||
163247953|NCT04053764|589615486|FG000|Overall Study|Physician Decision|2|||
163247954|NCT04053764|589615487|FG001|Overall Study|Physician Decision|1|||
163247955|NCT04053764|589615486|FG000|Overall Study|Adverse Event|1|||
163247956|NCT04053764|589615487|FG001|Overall Study|Adverse Event|0|||
163247957|NCT04053764|589615486|FG000|Overall Study|Pregnancy|1|||
163247958|NCT04053764|589615487|FG001|Overall Study|Pregnancy|0|||
163247959|NCT02384954|589615491|FG000|Phase 1|Progressive Disease|2|||
163247960|NCT02384954|589615492|FG001|Phase 1|Progressive Disease|0|||
163247961|NCT02384954|589615493|FG002|Phase 1|Progressive Disease|1|||
163247962|NCT02384954|589615494|FG003|Phase 1|Progressive Disease|1|||
163247963|NCT02384954|589615495|FG004|Phase 1|Progressive Disease|0|||
163247964|NCT02384954|589615496|FG005|Phase 1|Progressive Disease|0|||
163247965|NCT02384954|589615497|FG006|Phase 1|Progressive Disease|0|||
163247966|NCT02384954|589615498|FG007|Phase 1|Progressive Disease|0|||
163247967|NCT02384954|589615499|FG008|Phase 1|Progressive Disease|0|||
163247968|NCT02384954|589615491|FG000|Phase 1|Adverse Event|0|||
163247969|NCT02384954|589615492|FG001|Phase 1|Adverse Event|0|||
163247970|NCT02384954|589615493|FG002|Phase 1|Adverse Event|1|||
163247971|NCT02384954|589615494|FG003|Phase 1|Adverse Event|0|||
163247972|NCT02384954|589615495|FG004|Phase 1|Adverse Event|0|||
163247973|NCT02384954|589615496|FG005|Phase 1|Adverse Event|0|||
163247974|NCT02384954|589615497|FG006|Phase 1|Adverse Event|0|||
163247975|NCT02384954|589615498|FG007|Phase 1|Adverse Event|0|||
163247976|NCT02384954|589615499|FG008|Phase 1|Adverse Event|0|||
163247977|NCT02384954|589615491|FG000|Phase 2|Progressive Disease|0|||
163247978|NCT02384954|589615492|FG001|Phase 2|Progressive Disease|0|||
163247979|NCT02384954|589615493|FG002|Phase 2|Progressive Disease|0|||
163247980|NCT02384954|589615494|FG003|Phase 2|Progressive Disease|0|||
163247981|NCT02384954|589615495|FG004|Phase 2|Progressive Disease|0|||
163247982|NCT02384954|589615496|FG005|Phase 2|Progressive Disease|0|||
163247983|NCT02384954|589615497|FG006|Phase 2|Progressive Disease|0|||
163247984|NCT02384954|589615498|FG007|Phase 2|Progressive Disease|1|||
163247985|NCT02384954|589615499|FG008|Phase 2|Progressive Disease|2|||
163247986|NCT02384954|589615491|FG000|Phase 2|Adverse Event|0|||
163247987|NCT02384954|589615492|FG001|Phase 2|Adverse Event|0|||
163247988|NCT02384954|589615493|FG002|Phase 2|Adverse Event|0|||
163247989|NCT02384954|589615494|FG003|Phase 2|Adverse Event|0|||
163247990|NCT02384954|589615495|FG004|Phase 2|Adverse Event|0|||
163247991|NCT02384954|589615496|FG005|Phase 2|Adverse Event|0|||
163247992|NCT02384954|589615497|FG006|Phase 2|Adverse Event|0|||
163247993|NCT02384954|589615498|FG007|Phase 2|Adverse Event|1|||
163247994|NCT02384954|589615499|FG008|Phase 2|Adverse Event|1|||
163247995|NCT02384954|589615491|FG000|Phase 2|Failure to meet continuation criteria|0|||
163247996|NCT02384954|589615492|FG001|Phase 2|Failure to meet continuation criteria|0|||
163247997|NCT02384954|589615493|FG002|Phase 2|Failure to meet continuation criteria|0|||
163247998|NCT02384954|589615494|FG003|Phase 2|Failure to meet continuation criteria|0|||
163247999|NCT02384954|589615495|FG004|Phase 2|Failure to meet continuation criteria|0|||
163248000|NCT02384954|589615496|FG005|Phase 2|Failure to meet continuation criteria|0|||
163248001|NCT02384954|589615497|FG006|Phase 2|Failure to meet continuation criteria|0|||
163248002|NCT02384954|589615498|FG007|Phase 2|Failure to meet continuation criteria|1|||
163248003|NCT02384954|589615499|FG008|Phase 2|Failure to meet continuation criteria|0|||
163248004|NCT04732286|589615500|FG000|Overall Study|Progressive Disease|2|||
163248005|NCT04732286|589615500|FG000|Overall Study|Physician Decision|1|||
163248006|NCT04732286|589615500|FG000|Overall Study|Study Terminated by Sponsor|31|||
163248007|NCT04732286|589615500|FG000|Overall Study|Withdrawal by Subject|10|||
163248008|NCT04732286|589615500|FG000|Overall Study|Non-compliance With Study Drug|1|||
163248009|NCT04732286|589615500|FG000|Overall Study|Lost to Follow-up|4|||
163248010|NCT04732286|589615500|FG000|Overall Study|Death|51|||
163248011|NCT01474681|589615504|FG000|Overall Study|Death|0|||
163248012|NCT01474681|589615505|FG001|Overall Study|Death|3|||
163248013|NCT01474681|589615506|FG002|Overall Study|Death|2|||
163248014|NCT01474681|589615507|FG003|Overall Study|Death|6|||
163248015|NCT02372396|589615513|FG000|Overall Study|Lost to Follow-up|7|||
163248016|NCT02372396|589615514|FG001|Overall Study|Lost to Follow-up|9|||
163248017|NCT01483924|589615515|FG000|Overall Study|Withdrawal by Subject|2|||
163248018|NCT01483924|589615516|FG001|Overall Study|Withdrawal by Subject|0|||
163248019|NCT01483924|589615517|FG002|Overall Study|Withdrawal by Subject|0|||
163248020|NCT01483924|589615518|FG003|Overall Study|Withdrawal by Subject|1|||
163248021|NCT01483924|589615519|FG004|Overall Study|Withdrawal by Subject|1|||
163248022|NCT01483924|589615515|FG000|Overall Study|Adverse Event|0|||
163248023|NCT01483924|589615516|FG001|Overall Study|Adverse Event|0|||
163248024|NCT01483924|589615517|FG002|Overall Study|Adverse Event|1|||
163248025|NCT01483924|589615518|FG003|Overall Study|Adverse Event|1|||
163248026|NCT01483924|589615519|FG004|Overall Study|Adverse Event|0|||
163248027|NCT01483924|589615515|FG000|Overall Study|Non-compliance|0|||
163248028|NCT01483924|589615516|FG001|Overall Study|Non-compliance|0|||
163248029|NCT01483924|589615517|FG002|Overall Study|Non-compliance|0|||
163248030|NCT01483924|589615518|FG003|Overall Study|Non-compliance|1|||
163248031|NCT01483924|589615519|FG004|Overall Study|Non-compliance|1|||
163248032|NCT01483924|589615515|FG000|Overall Study|Sponsor concern over ECG result|0|||
163248033|NCT01483924|589615516|FG001|Overall Study|Sponsor concern over ECG result|0|||
163248034|NCT01483924|589615517|FG002|Overall Study|Sponsor concern over ECG result|0|||
163248035|NCT01483924|589615518|FG003|Overall Study|Sponsor concern over ECG result|1|||
163248036|NCT01483924|589615519|FG004|Overall Study|Sponsor concern over ECG result|0|||
163149783|NCT00880620|589261561|FG002|Overall Study|Lost to Follow-up|1|||
163149784|NCT00880620|589261562|FG003|Overall Study|Lost to Follow-up|0|||
163149785|NCT00880620|589261559|FG000|Overall Study|Protocol Violation|0|||
163149786|NCT00880620|589261560|FG001|Overall Study|Protocol Violation|1|||
163149787|NCT00880620|589261561|FG002|Overall Study|Protocol Violation|0|||
163149788|NCT00880620|589261562|FG003|Overall Study|Protocol Violation|2|||
163149789|NCT00880620|589261559|FG000|Overall Study|Withdrawal by Subject|4|||
163149790|NCT00880620|589261560|FG001|Overall Study|Withdrawal by Subject|3|||
163149791|NCT00880620|589261561|FG002|Overall Study|Withdrawal by Subject|1|||
163149792|NCT00880620|589261562|FG003|Overall Study|Withdrawal by Subject|3|||
163149793|NCT00880620|589261559|FG000|Overall Study|Noncompliance|0|||
163149794|NCT00880620|589261560|FG001|Overall Study|Noncompliance|0|||
163149795|NCT00880620|589261561|FG002|Overall Study|Noncompliance|1|||
163149796|NCT00880620|589261562|FG003|Overall Study|Noncompliance|1|||
163149797|NCT00880620|589261559|FG000|Overall Study|Other|1|||
163149798|NCT00880620|589261560|FG001|Overall Study|Other|1|||
163149799|NCT00880620|589261561|FG002|Overall Study|Other|2|||
163149800|NCT00880620|589261562|FG003|Overall Study|Other|2|||
163149801|NCT01775501|589263496|FG000|Overall Study|Discontinued prior to treatment|1|||
163149802|NCT03037385|589263497|FG000|Overall Study|Adverse Event|0|||
163149803|NCT03037385|589263498|FG001|Overall Study|Adverse Event|0|||
163149804|NCT03037385|589263499|FG002|Overall Study|Adverse Event|1|||
163149805|NCT03037385|589263500|FG003|Overall Study|Adverse Event|0|||
163149806|NCT03037385|589263501|FG004|Overall Study|Adverse Event|0|||
163149807|NCT03037385|589263502|FG005|Overall Study|Adverse Event|0|||
163149808|NCT03037385|589263503|FG006|Overall Study|Adverse Event|0|||
163149809|NCT03037385|589263504|FG007|Overall Study|Adverse Event|0|||
163149810|NCT03037385|589263505|FG008|Overall Study|Adverse Event|0|||
163149811|NCT03037385|589263506|FG009|Overall Study|Adverse Event|6|||
163149812|NCT03037385|589263497|FG000|Overall Study|Death|1|||
163149813|NCT03037385|589263498|FG001|Overall Study|Death|4|||
163149814|NCT03037385|589263499|FG002|Overall Study|Death|2|||
163149815|NCT03037385|589263500|FG003|Overall Study|Death|2|||
163149816|NCT03037385|589263501|FG004|Overall Study|Death|5|||
163149817|NCT03037385|589263502|FG005|Overall Study|Death|2|||
163149818|NCT03037385|589263503|FG006|Overall Study|Death|1|||
163149819|NCT03037385|589263504|FG007|Overall Study|Death|4|||
163149820|NCT03037385|589263505|FG008|Overall Study|Death|3|||
163149821|NCT03037385|589263506|FG009|Overall Study|Death|240|||
163149822|NCT03037385|589263497|FG000|Overall Study|Initiation of Another Therapy|1|||
163149823|NCT03037385|589263498|FG001|Overall Study|Initiation of Another Therapy|0|||
163149824|NCT03037385|589263499|FG002|Overall Study|Initiation of Another Therapy|0|||
163149825|NCT03037385|589263500|FG003|Overall Study|Initiation of Another Therapy|0|||
163149826|NCT03037385|589263501|FG004|Overall Study|Initiation of Another Therapy|0|||
163149827|NCT03037385|589263502|FG005|Overall Study|Initiation of Another Therapy|0|||
163149828|NCT03037385|589263503|FG006|Overall Study|Initiation of Another Therapy|0|||
163149829|NCT03037385|589263504|FG007|Overall Study|Initiation of Another Therapy|1|||
163149830|NCT03037385|589263505|FG008|Overall Study|Initiation of Another Therapy|0|||
163149831|NCT03037385|589263506|FG009|Overall Study|Initiation of Another Therapy|2|||
163149832|NCT03037385|589263497|FG000|Overall Study|Lost to Follow-up|0|||
163149833|NCT03037385|589263498|FG001|Overall Study|Lost to Follow-up|0|||
163149834|NCT03037385|589263499|FG002|Overall Study|Lost to Follow-up|0|||
163149835|NCT03037385|589263500|FG003|Overall Study|Lost to Follow-up|0|||
163149836|NCT03037385|589263501|FG004|Overall Study|Lost to Follow-up|0|||
163149837|NCT03037385|589263502|FG005|Overall Study|Lost to Follow-up|1|||
163149838|NCT03037385|589263503|FG006|Overall Study|Lost to Follow-up|0|||
163149839|NCT03037385|589263504|FG007|Overall Study|Lost to Follow-up|0|||
163149840|NCT03037385|589263505|FG008|Overall Study|Lost to Follow-up|0|||
163149841|NCT03037385|589263506|FG009|Overall Study|Lost to Follow-up|16|||
163149842|NCT03037385|589263497|FG000|Overall Study|Physician Decision|0|||
163149843|NCT03037385|589263498|FG001|Overall Study|Physician Decision|0|||
163149844|NCT03037385|589263499|FG002|Overall Study|Physician Decision|0|||
163149845|NCT03037385|589263500|FG003|Overall Study|Physician Decision|0|||
163149846|NCT03037385|589263501|FG004|Overall Study|Physician Decision|0|||
163149847|NCT03037385|589263502|FG005|Overall Study|Physician Decision|0|||
163149848|NCT03037385|589263503|FG006|Overall Study|Physician Decision|0|||
163149849|NCT03037385|589263504|FG007|Overall Study|Physician Decision|0|||
163149850|NCT03037385|589263505|FG008|Overall Study|Physician Decision|0|||
163149851|NCT03037385|589263506|FG009|Overall Study|Physician Decision|1|||
163149852|NCT03037385|589263497|FG000|Overall Study|Progressive Disease|0|||
163149853|NCT03037385|589263498|FG001|Overall Study|Progressive Disease|1|||
163149854|NCT03037385|589263499|FG002|Overall Study|Progressive Disease|1|||
163149855|NCT03037385|589263500|FG003|Overall Study|Progressive Disease|5|||
163149856|NCT03037385|589263501|FG004|Overall Study|Progressive Disease|2|||
163149857|NCT03037385|589263502|FG005|Overall Study|Progressive Disease|0|||
163149858|NCT03037385|589263503|FG006|Overall Study|Progressive Disease|1|||
163149859|NCT03037385|589263504|FG007|Overall Study|Progressive Disease|0|||
163149860|NCT03037385|589263505|FG008|Overall Study|Progressive Disease|0|||
163149861|NCT03037385|589263506|FG009|Overall Study|Progressive Disease|30|||
163248037|NCT00003298|589615522|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
163248038|NCT00003298|589615522|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
163248039|NCT00003298|589615522|FG000|Surgery|Unresectable at surgery|3|||
163248040|NCT00003298|589615522|FG000|Surgery|Progression before surgery|2|||
163248041|NCT00003298|589615522|FG000|Surgery|Unevaluable and off study|2|||
163248042|NCT00003298|589615522|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
163248043|NCT00003298|589615522|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
163248044|NCT00003298|589615522|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
163248045|NCT00003298|589615522|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
163248046|NCT00003298|589615522|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
163248047|NCT00003298|589615522|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
163248048|NCT00003298|589615522|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
163248049|NCT00003298|589615522|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
163248050|NCT00003298|589615522|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
163248051|NCT00003298|589615522|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
163248052|NCT00335322|589615526|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
163248053|NCT00335322|589615527|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
163248054|NCT00335322|589615528|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
163248055|NCT02195986|589615529|FG000|Overall Study|Adverse Event|3|||
163248056|NCT02195986|589615530|FG001|Overall Study|Adverse Event|0|||
163248057|NCT02195986|589615531|FG002|Overall Study|Adverse Event|0|||
163248058|NCT02195986|589615529|FG000|Overall Study|Withdrawal by Subject|0|||
163248059|NCT02195986|589615530|FG001|Overall Study|Withdrawal by Subject|3|||
163248060|NCT02195986|589615531|FG002|Overall Study|Withdrawal by Subject|0|||
163248061|NCT02195986|589615529|FG000|Overall Study|Family Emergency|0|||
163248062|NCT02195986|589615530|FG001|Overall Study|Family Emergency|0|||
163248063|NCT02195986|589615531|FG002|Overall Study|Family Emergency|1|||
163248064|NCT02195986|589615529|FG000|Overall Study|Protocol Violation|0|||
163248065|NCT02195986|589615530|FG001|Overall Study|Protocol Violation|1|||
163248066|NCT02195986|589615531|FG002|Overall Study|Protocol Violation|1|||
163248067|NCT02195986|589615529|FG000|Overall Study|Non-compliance|0|||
163248068|NCT02195986|589615530|FG001|Overall Study|Non-compliance|1|||
163248069|NCT02195986|589615531|FG002|Overall Study|Non-compliance|0|||
163248070|NCT02834780|589615534|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
163248071|NCT02834780|589615535|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
163248072|NCT02834780|589615536|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
163248073|NCT02834780|589615537|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
163248074|NCT02834780|589615538|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
163248075|NCT02834780|589615539|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
163248076|NCT02834780|589615540|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
163248077|NCT02834780|589615541|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
163248078|NCT02834780|589615542|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
163248079|NCT02834780|589615543|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
163248080|NCT02834780|589615544|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
163248081|NCT02834780|589615545|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
163248082|NCT02834780|589615546|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
163248083|NCT02834780|589615534|FG000|Overall Study|Withdrawal by Subject|0|||
163248084|NCT02834780|589615535|FG001|Overall Study|Withdrawal by Subject|0|||
163248085|NCT02834780|589615536|FG002|Overall Study|Withdrawal by Subject|1|||
163248086|NCT02834780|589615537|FG003|Overall Study|Withdrawal by Subject|0|||
163248087|NCT02834780|589615538|FG004|Overall Study|Withdrawal by Subject|0|||
163248088|NCT02834780|589615539|FG005|Overall Study|Withdrawal by Subject|0|||
163248089|NCT02834780|589615540|FG006|Overall Study|Withdrawal by Subject|0|||
163248090|NCT02834780|589615541|FG007|Overall Study|Withdrawal by Subject|0|||
163248091|NCT02834780|589615542|FG008|Overall Study|Withdrawal by Subject|0|||
163248092|NCT02834780|589615543|FG009|Overall Study|Withdrawal by Subject|0|||
163248093|NCT02834780|589615544|FG010|Overall Study|Withdrawal by Subject|1|||
163248094|NCT02834780|589615545|FG011|Overall Study|Withdrawal by Subject|0|||
163248095|NCT02834780|589615546|FG012|Overall Study|Withdrawal by Subject|0|||
163248096|NCT02834780|589615534|FG000|Overall Study|Adverse Event|0|||
163248097|NCT02834780|589615535|FG001|Overall Study|Adverse Event|0|||
163248098|NCT02834780|589615536|FG002|Overall Study|Adverse Event|0|||
163248099|NCT02834780|589615537|FG003|Overall Study|Adverse Event|0|||
163248100|NCT02834780|589615538|FG004|Overall Study|Adverse Event|1|||
163248101|NCT02834780|589615539|FG005|Overall Study|Adverse Event|0|||
163248102|NCT02834780|589615540|FG006|Overall Study|Adverse Event|1|||
163248103|NCT02834780|589615541|FG007|Overall Study|Adverse Event|1|||
163248104|NCT02834780|589615542|FG008|Overall Study|Adverse Event|0|||
163248105|NCT02834780|589615543|FG009|Overall Study|Adverse Event|2|||
163248106|NCT02834780|589615544|FG010|Overall Study|Adverse Event|0|||
163248107|NCT02834780|589615545|FG011|Overall Study|Adverse Event|3|||
163248108|NCT02834780|589615546|FG012|Overall Study|Adverse Event|2|||
163248109|NCT02834780|589615534|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
163248110|NCT02834780|589615535|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
163248111|NCT02834780|589615536|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
163248112|NCT02834780|589615537|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
163248113|NCT02834780|589615538|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
163248114|NCT02834780|589615539|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
163248115|NCT02834780|589615540|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
163248116|NCT02834780|589615541|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
163248117|NCT02834780|589615542|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
163248118|NCT02834780|589615543|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
163248119|NCT02834780|589615544|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
163248120|NCT02834780|589615545|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
163248121|NCT02834780|589615546|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
163248122|NCT02834780|589615534|FG000|Overall Study|Other|1|||
163248123|NCT02834780|589615535|FG001|Overall Study|Other|0|||
163248124|NCT02834780|589615536|FG002|Overall Study|Other|1|||
163248125|NCT02834780|589615537|FG003|Overall Study|Other|2|||
163248126|NCT02834780|589615538|FG004|Overall Study|Other|0|||
163248127|NCT02834780|589615539|FG005|Overall Study|Other|0|||
163248128|NCT02834780|589615540|FG006|Overall Study|Other|0|||
163248129|NCT02834780|589615541|FG007|Overall Study|Other|0|||
163248130|NCT02834780|589615542|FG008|Overall Study|Other|0|||
163248131|NCT02834780|589615543|FG009|Overall Study|Other|0|||
163248132|NCT02834780|589615544|FG010|Overall Study|Other|0|||
163248133|NCT02834780|589615545|FG011|Overall Study|Other|0|||
163248134|NCT02834780|589615546|FG012|Overall Study|Other|1|||
163248135|NCT03150056|589615547|FG000|Overall Study|Withdrawal by Subject|0|||
163248136|NCT03150056|589615548|FG001|Overall Study|Withdrawal by Subject|0|||
163248137|NCT03150056|589615549|FG002|Overall Study|Withdrawal by Subject|0|||
163248138|NCT03150056|589615550|FG003|Overall Study|Withdrawal by Subject|0|||
163248139|NCT03150056|589615551|FG004|Overall Study|Withdrawal by Subject|0|||
163248140|NCT03150056|589615552|FG005|Overall Study|Withdrawal by Subject|2|||
163248141|NCT03150056|589615547|FG000|Overall Study|Study terminated by Sponsor|1|||
163248142|NCT03150056|589615548|FG001|Overall Study|Study terminated by Sponsor|3|||
163248143|NCT03150056|589615549|FG002|Overall Study|Study terminated by Sponsor|1|||
163248144|NCT03150056|589615550|FG003|Overall Study|Study terminated by Sponsor|1|||
163248145|NCT03150056|589615551|FG004|Overall Study|Study terminated by Sponsor|5|||
163248146|NCT03150056|589615552|FG005|Overall Study|Study terminated by Sponsor|6|||
163248147|NCT03150056|589615547|FG000|Overall Study|Death|9|||
163248148|NCT03150056|589615548|FG001|Overall Study|Death|2|||
163248149|NCT03150056|589615549|FG002|Overall Study|Death|2|||
163248150|NCT03150056|589615550|FG003|Overall Study|Death|7|||
163248151|NCT03150056|589615551|FG004|Overall Study|Death|8|||
163248152|NCT03150056|589615552|FG005|Overall Study|Death|10|||
163248153|NCT02363738|589615555|FG000|Overall Study|Adverse Event|5|||
163248154|NCT02363738|589615556|FG001|Overall Study|Adverse Event|2|||
163248155|NCT02363738|589615555|FG000|Overall Study|Lack of Efficacy|1|||
163248156|NCT02363738|589615556|FG001|Overall Study|Lack of Efficacy|2|||
163248157|NCT02363738|589615555|FG000|Overall Study|Lost to Follow-up|2|||
163248158|NCT02363738|589615556|FG001|Overall Study|Lost to Follow-up|1|||
163248159|NCT03265600|589615557|FG000|Overall Study|Lost to Follow-up|17|||
163248160|NCT03265600|589615558|FG001|Overall Study|Lost to Follow-up|5|||
163248161|NCT03265600|589615557|FG000|Overall Study|Withdrawal by Subject|4|||
163248162|NCT03265600|589615558|FG001|Overall Study|Withdrawal by Subject|2|||
163248163|NCT03265600|589615557|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
163248164|NCT03265600|589615558|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
163248165|NCT02372409|589615559|FG000|Overall Study|Lost to Follow-up|1|||
163248166|NCT02372409|589615560|FG001|Overall Study|Lost to Follow-up|0|||
163248167|NCT02372409|589615559|FG000|Overall Study|Disease progression|1|||
163248168|NCT02372409|589615560|FG001|Overall Study|Disease progression|1|||
163248169|NCT01808313|589615563|FG000|Overall Study|Adverse Event|5|||
163248170|NCT01808313|589615563|FG000|Overall Study|Protocol Violation|2|||
163248171|NCT01808313|589615563|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
163248172|NCT01808313|589615563|FG000|Overall Study|Lost to Follow-up|1|||
163248173|NCT01808313|589615563|FG000|Overall Study|Physician Decision|1|||
163248174|NCT03086447|589615573|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
163248175|NCT03086447|589615574|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
163248176|NCT03086447|589615573|FG000|Overall Study|Lost Lens|2|||
163248177|NCT03086447|589615574|FG001|Overall Study|Lost Lens|5|||
163248178|NCT03086447|589615573|FG000|Overall Study|Product quality complaint|0|||
163248179|NCT03086447|589615574|FG001|Overall Study|Product quality complaint|1|||
163248180|NCT03086447|589615573|FG000|Overall Study|Lens Damage|1|||
163248181|NCT03086447|589615574|FG001|Overall Study|Lens Damage|6|||
163248182|NCT03086447|589615573|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
163248183|NCT03086447|589615574|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
163248184|NCT03086447|589615573|FG000|Overall Study|Test Article No Longer Available|1|||
163248185|NCT03086447|589615574|FG001|Overall Study|Test Article No Longer Available|0|||
163248186|NCT03086447|589615573|FG000|Overall Study|Protocol Violation|2|||
163248187|NCT03086447|589615574|FG001|Overall Study|Protocol Violation|4|||
163248188|NCT03086447|589615573|FG000|Overall Study|Lost to Follow-up|0|||
163248189|NCT03086447|589615574|FG001|Overall Study|Lost to Follow-up|1|||
163248190|NCT03086447|589615573|FG000|Overall Study|Adverse Event|3|||
163248191|NCT03086447|589615574|FG001|Overall Study|Adverse Event|0|||
163248192|NCT03086447|589615573|FG000|Overall Study|Lens Discomfort|2|||
163248193|NCT03086447|589615574|FG001|Overall Study|Lens Discomfort|1|||
163248194|NCT00435370|589615578|FG000|Overall Study|Adverse Event|8|||
163248195|NCT00435370|589615579|FG001|Overall Study|Adverse Event|8|||
163248196|NCT00435370|589615578|FG000|Overall Study|Withdrawal by Subject|10|||
163248197|NCT00435370|589615579|FG001|Overall Study|Withdrawal by Subject|10|||
163248198|NCT00435370|589615578|FG000|Overall Study|Antipsychotic medication changed|4|||
163248199|NCT00435370|589615579|FG001|Overall Study|Antipsychotic medication changed|2|||
163248200|NCT02132611|589615580|FG000|Overall Study|Death|2|||
163410310|NCT05073458|590211347|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
163410311|NCT05073458|590211346|FG000|24-week Open-label Period|Adverse Event|1|||
163248201|NCT01965834|589615582|FG000|Overall Study|Lack of Efficacy|4|||
163248202|NCT03674177|589615585|FG000|Overall Study|Lost to Follow-up|2|||
163248203|NCT03674177|589615586|FG001|Overall Study|Lost to Follow-up|1|||
163248204|NCT03674177|589615587|FG002|Overall Study|Lost to Follow-up|0|||
163248205|NCT03674177|589615588|FG003|Overall Study|Lost to Follow-up|2|||
163248206|NCT03387852|589615589|FG000|Overall Study|Adverse event (AE)|3|||
163248207|NCT03387852|589615590|FG001|Overall Study|Adverse event (AE)|0|||
163248208|NCT03387852|589615591|FG002|Overall Study|Adverse event (AE)|2|||
163248209|NCT03387852|589615592|FG003|Overall Study|Adverse event (AE)|0|||
163248210|NCT03387852|589615589|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
163248211|NCT03387852|589615590|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
163248212|NCT03387852|589615591|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
163248213|NCT03387852|589615592|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
163248214|NCT03387852|589615589|FG000|Overall Study|Withdrawal by participant|1|||
163248215|NCT03387852|589615590|FG001|Overall Study|Withdrawal by participant|1|||
163248216|NCT03387852|589615591|FG002|Overall Study|Withdrawal by participant|3|||
163248217|NCT03387852|589615592|FG003|Overall Study|Withdrawal by participant|2|||
163248218|NCT03387852|589615589|FG000|Overall Study|Other- Unspecified|1|||
163248219|NCT03387852|589615590|FG001|Overall Study|Other- Unspecified|1|||
163248220|NCT03387852|589615591|FG002|Overall Study|Other- Unspecified|2|||
163248221|NCT03387852|589615592|FG003|Overall Study|Other- Unspecified|1|||
163248222|NCT03387852|589615589|FG000|Overall Study|Poor compliance to protocol|0|||
163248223|NCT03387852|589615590|FG001|Overall Study|Poor compliance to protocol|0|||
163248224|NCT03387852|589615591|FG002|Overall Study|Poor compliance to protocol|0|||
163248225|NCT03387852|589615592|FG003|Overall Study|Poor compliance to protocol|1|||
163248226|NCT03387852|589615589|FG000|Overall Study|Randomized and not treated|0|||
163248227|NCT03387852|589615590|FG001|Overall Study|Randomized and not treated|0|||
163248228|NCT03387852|589615591|FG002|Overall Study|Randomized and not treated|0|||
163248229|NCT03387852|589615592|FG003|Overall Study|Randomized and not treated|1|||
163248230|NCT02493127|589615593|FG000|Overall Study|Lost to Follow-up|1|||
163248231|NCT02493127|589615594|FG001|Overall Study|Lost to Follow-up|1|||
163248232|NCT00714168|589615595|FG000|Overall Study|Pregnancy|5|||
163248233|NCT00714168|589615596|FG001|Overall Study|Pregnancy|4|||
163248234|NCT00714168|589615595|FG000|Overall Study|Lost to Follow-up|32|||
163248235|NCT00714168|589615596|FG001|Overall Study|Lost to Follow-up|50|||
163248236|NCT00714168|589615595|FG000|Overall Study|Relocation|4|||
163248237|NCT00714168|589615596|FG001|Overall Study|Relocation|3|||
163248238|NCT00714168|589615595|FG000|Overall Study|Non-study medical condition|3|||
163248239|NCT00714168|589615596|FG001|Overall Study|Non-study medical condition|2|||
163248240|NCT00809757|589615597|FG000|Overall Study|Adverse Event|2|||
163248241|NCT00809757|589615598|FG001|Overall Study|Adverse Event|3|||
163248242|NCT00809757|589615599|FG002|Overall Study|Adverse Event|3|||
163248243|NCT00809757|589615597|FG000|Overall Study|Lost to Follow-up|0|||
163248244|NCT00809757|589615598|FG001|Overall Study|Lost to Follow-up|0|||
163248245|NCT00809757|589615599|FG002|Overall Study|Lost to Follow-up|1|||
163248246|NCT00809757|589615597|FG000|Overall Study|Protocol Violation|1|||
163248247|NCT00809757|589615598|FG001|Overall Study|Protocol Violation|1|||
163248248|NCT00809757|589615599|FG002|Overall Study|Protocol Violation|1|||
163248249|NCT00809757|589615597|FG000|Overall Study|Withdrawal by Subject|2|||
163248250|NCT00809757|589615598|FG001|Overall Study|Withdrawal by Subject|1|||
163248251|NCT00809757|589615599|FG002|Overall Study|Withdrawal by Subject|3|||
163248252|NCT00809757|589615597|FG000|Overall Study|Subject Uncooperative|1|||
163248253|NCT00809757|589615598|FG001|Overall Study|Subject Uncooperative|0|||
163248254|NCT00809757|589615599|FG002|Overall Study|Subject Uncooperative|2|||
163248255|NCT00809757|589615597|FG000|Overall Study|Noncompliance with Medication|0|||
163248256|NCT00809757|589615598|FG001|Overall Study|Noncompliance with Medication|0|||
163248257|NCT00809757|589615599|FG002|Overall Study|Noncompliance with Medication|1|||
163248258|NCT00253864|589615600|FG000|Overall Study|Lost to Follow-up|5|||
163248259|NCT00253864|589615601|FG001|Overall Study|Lost to Follow-up|8|||
163248260|NCT00744653|589615602|FG000|Overall Study|antineoplastic treatment|11|||
163248261|NCT00744653|589615602|FG000|Overall Study|Death|1|||
163248262|NCT00744653|589615602|FG000|Overall Study|Lost to Follow-up|1|||
163248263|NCT00744653|589615602|FG000|Overall Study|Physician Decision|3|||
163248264|NCT03826667|589615603|FG000|Overall Study|Protocol deviation|21|||
163248265|NCT00808808|589615604|FG000|Overall Study|Vaccinated; survey not completed|131|||
163248266|NCT00808808|589615605|FG001|Overall Study|Vaccinated; survey not completed|169|||
163248267|NCT00808808|589615606|FG002|Overall Study|Vaccinated; survey not completed|302|||
163248268|NCT00808808|589615604|FG000|Overall Study|Employee was not vaccinated.|2686|||
163248269|NCT00808808|589615605|FG001|Overall Study|Employee was not vaccinated.|2268|||
163248270|NCT00808808|589615606|FG002|Overall Study|Employee was not vaccinated.|2255|||
163248271|NCT01864564|589615613|FG000|Overall Study|Lost to Follow-up|17|||
163248272|NCT01864564|589615614|FG001|Overall Study|Lost to Follow-up|23|||
163248273|NCT01864564|589615613|FG000|Overall Study|Withdrawal by Subject|20|||
163248274|NCT01864564|589615614|FG001|Overall Study|Withdrawal by Subject|11|||
163248275|NCT01864564|589615613|FG000|Overall Study|Protocol Violation|0|||
163248276|NCT01864564|589615614|FG001|Overall Study|Protocol Violation|27|||
163248277|NCT01864564|589615613|FG000|Overall Study|not reported|0|||
163248278|NCT01864564|589615614|FG001|Overall Study|not reported|34|||
163248279|NCT03077724|589615615|FG000|Overall Study|Lost to Follow-up|5|||
163248280|NCT03077724|589615616|FG001|Overall Study|Lost to Follow-up|1|||
163248281|NCT03077724|589615615|FG000|Overall Study|Withdrawal by Subject|3|||
163248282|NCT03077724|589615616|FG001|Overall Study|Withdrawal by Subject|1|||
163248283|NCT02269670|589615617|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
163248284|NCT00234065|589615618|FG000|Overall Study|Adverse Event|268|||
163248285|NCT00234065|589615619|FG001|Overall Study|Adverse Event|166|||
163248286|NCT00234065|589615618|FG000|Overall Study|Withdrawal by Subject|73|||
163248287|NCT00234065|589615619|FG001|Overall Study|Withdrawal by Subject|56|||
163248288|NCT00234065|589615618|FG000|Overall Study|Physician Decision|23|||
163248289|NCT00234065|589615619|FG001|Overall Study|Physician Decision|22|||
163248290|NCT00234065|589615618|FG000|Overall Study|Not Classified|111|||
163248291|NCT00234065|589615619|FG001|Overall Study|Not Classified|112|||
163248292|NCT00126438|589615620|FG000|Overall Study|Withdrawal due to adverse event|1|||
163248293|NCT00126438|589615621|FG001|Overall Study|Withdrawal due to adverse event|0|||
163248294|NCT00126438|589615620|FG000|Overall Study|Lost to Follow-up|22|||
163248295|NCT00126438|589615621|FG001|Overall Study|Lost to Follow-up|0|||
163248296|NCT00126438|589615620|FG000|Overall Study|Protocol Violation|8|||
163248297|NCT00126438|589615621|FG001|Overall Study|Protocol Violation|8|||
163248298|NCT00126438|589615620|FG000|Overall Study|Withdrawal by Subject|3|||
163248299|NCT00126438|589615621|FG001|Overall Study|Withdrawal by Subject|2|||
163248300|NCT02313428|589615622|FG000|Overall Study|Lost to Follow-up|1|||
163248301|NCT02313428|589615623|FG001|Overall Study|Lost to Follow-up|1|||
163248302|NCT04414696|589615625|FG000|3-month Follow up|Withdrawal by Subject|1|||
163248303|NCT04414696|589615626|FG001|3-month Follow up|Withdrawal by Subject|0|||
163248304|NCT04414696|589615625|FG000|3-month Follow up|Lost to Follow-up|22|||
163248305|NCT04414696|589615626|FG001|3-month Follow up|Lost to Follow-up|23|||
163248306|NCT04414696|589615625|FG000|6-month Follow up|Withdrawal by Subject|1|||
163248307|NCT04414696|589615626|FG001|6-month Follow up|Withdrawal by Subject|2|||
163248308|NCT04414696|589615625|FG000|6-month Follow up|Lost to Follow-up|5|||
163248309|NCT04414696|589615626|FG001|6-month Follow up|Lost to Follow-up|2|||
163248310|NCT02160314|589617433|FG000|Overall Study|Adverse Event|0|||
163248311|NCT02160314|589617434|FG001|Overall Study|Adverse Event|6|||
163248312|NCT02160314|589617433|FG000|Overall Study|Protocol Violation|0|||
163248313|NCT02160314|589617434|FG001|Overall Study|Protocol Violation|4|||
163248314|NCT02160314|589617433|FG000|Overall Study|Withdrawal by Subject|1|||
163248315|NCT02160314|589617434|FG001|Overall Study|Withdrawal by Subject|2|||
163248316|NCT02160314|589617433|FG000|Overall Study|Lost to Follow-up|0|||
163248317|NCT02160314|589617434|FG001|Overall Study|Lost to Follow-up|1|||
163248318|NCT00593567|589617435|FG000|Overall Study|Adverse Event|2|||
163248319|NCT00593567|589617436|FG001|Overall Study|Adverse Event|0|||
163248320|NCT00593567|589617435|FG000|Overall Study|Physician Decision|2|||
163248321|NCT00593567|589617436|FG001|Overall Study|Physician Decision|0|||
163248322|NCT00593567|589617435|FG000|Overall Study|Protocol Violation|13|||
163248323|NCT00593567|589617436|FG001|Overall Study|Protocol Violation|7|||
163248324|NCT00593567|589617435|FG000|Overall Study|Lack of Efficacy|2|||
163248325|NCT00593567|589617436|FG001|Overall Study|Lack of Efficacy|1|||
163248326|NCT00593567|589617435|FG000|Overall Study|Withdrawal by Subject|1|||
163248327|NCT00593567|589617436|FG001|Overall Study|Withdrawal by Subject|2|||
163248328|NCT00785291|589617441|FG000|Overall Study|Never began treatment|8|||
163354691|NCT01010204|590009583|FG001|Overall Study|psychiatric hospitalization|1|||
163248329|NCT00785291|589617442|FG001|Overall Study|Never began treatment|4|||
163248330|NCT00785291|589617443|FG002|Overall Study|Never began treatment|4|||
163248331|NCT00785291|589617441|FG000|Overall Study|Adverse Event|39|||
163248332|NCT00785291|589617442|FG001|Overall Study|Adverse Event|70|||
163248333|NCT00785291|589617443|FG002|Overall Study|Adverse Event|56|||
163248334|NCT00785291|589617441|FG000|Overall Study|Death|7|||
163248335|NCT00785291|589617442|FG001|Overall Study|Death|4|||
163248336|NCT00785291|589617443|FG002|Overall Study|Death|3|||
163248337|NCT00785291|589617441|FG000|Overall Study|Withdrawal by Subject|35|||
163354692|NCT01519778|590009584|FG000|Overall Study|Withdrawal by Subject|3|||
163248338|NCT00785291|589617442|FG001|Overall Study|Withdrawal by Subject|36|||
163248339|NCT00785291|589617443|FG002|Overall Study|Withdrawal by Subject|17|||
163248340|NCT00785291|589617441|FG000|Overall Study|Alternative Therapy|12|||
163248341|NCT00785291|589617442|FG001|Overall Study|Alternative Therapy|6|||
163248342|NCT00785291|589617443|FG002|Overall Study|Alternative Therapy|7|||
163248343|NCT00785291|589617441|FG000|Overall Study|Complicating illness|6|||
163248344|NCT00785291|589617442|FG001|Overall Study|Complicating illness|4|||
163248345|NCT00785291|589617443|FG002|Overall Study|Complicating illness|4|||
163248346|NCT00785291|589617441|FG000|Overall Study|Other Medical Reasons|29|||
163248347|NCT00785291|589617442|FG001|Overall Study|Other Medical Reasons|25|||
163248348|NCT00785291|589617443|FG002|Overall Study|Other Medical Reasons|15|||
163248349|NCT02119260|589617444|FG000|Overall Study|Adverse Event|1|||
163248350|NCT02119260|589617445|FG001|Overall Study|Adverse Event|0|||
163248351|NCT02119260|589617446|FG002|Overall Study|Adverse Event|0|||
163248352|NCT02119260|589617447|FG003|Overall Study|Adverse Event|0|||
163248353|NCT02119260|589617448|FG004|Overall Study|Adverse Event|0|||
163248354|NCT02119260|589617449|FG005|Overall Study|Adverse Event|0|||
163248355|NCT02119260|589617450|FG006|Overall Study|Adverse Event|0|||
163248356|NCT02119260|589617444|FG000|Overall Study|Withdrew consent|0|||
163248357|NCT02119260|589617445|FG001|Overall Study|Withdrew consent|1|||
163248358|NCT02119260|589617446|FG002|Overall Study|Withdrew consent|1|||
163248359|NCT02119260|589617447|FG003|Overall Study|Withdrew consent|0|||
163248360|NCT02119260|589617448|FG004|Overall Study|Withdrew consent|0|||
163248361|NCT02119260|589617449|FG005|Overall Study|Withdrew consent|0|||
163248362|NCT02119260|589617450|FG006|Overall Study|Withdrew consent|0|||
163248363|NCT01877408|589617455|FG000|Overall Study|Lost to Follow-up|0|||
163248364|NCT01877408|589617456|FG001|Overall Study|Lost to Follow-up|2|||
163248365|NCT03870763|589617459|FG000|Overall Study|Study terminated by sponsor|0|||
163248366|NCT03870763|589617460|FG001|Overall Study|Study terminated by sponsor|2|||
163248367|NCT03870763|589617461|FG002|Overall Study|Study terminated by sponsor|0|||
163248368|NCT03870763|589617459|FG000|Overall Study|Withdrawal by Subject|0|||
163248369|NCT03870763|589617460|FG001|Overall Study|Withdrawal by Subject|1|||
163248370|NCT03870763|589617461|FG002|Overall Study|Withdrawal by Subject|0|||
163248371|NCT03870763|589617459|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
163248372|NCT03870763|589617460|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
163248373|NCT03870763|589617461|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
163248374|NCT04279314|589617462|FG000|Overall Study|Adverse Event|55|||
163248375|NCT04279314|589617462|FG000|Overall Study|Withdrawal by Subject|5|||
163248376|NCT04279314|589617462|FG000|Overall Study|Lack of Efficacy|5|||
163248377|NCT04279314|589617462|FG000|Overall Study|Protocol Violation|3|||
163248378|NCT04279314|589617462|FG000|Overall Study|Other (not COVID-19 related)|2|||
163248379|NCT02120027|589617463|FG000|Overall Study|Adverse Event|4|||
163248380|NCT02120027|589617464|FG001|Overall Study|Adverse Event|5|||
163248381|NCT02120027|589617463|FG000|Overall Study|Lack of Efficacy|3|||
163248382|NCT02120027|589617464|FG001|Overall Study|Lack of Efficacy|5|||
163248383|NCT02120027|589617463|FG000|Overall Study|Lost to Follow-up|5|||
163248384|NCT02120027|589617464|FG001|Overall Study|Lost to Follow-up|13|||
163248385|NCT02120027|589617463|FG000|Overall Study|Other|4|||
163248386|NCT02120027|589617464|FG001|Overall Study|Other|0|||
163248387|NCT02120027|589617463|FG000|Overall Study|Physician Decision|4|||
163248388|NCT02120027|589617464|FG001|Overall Study|Physician Decision|3|||
163248389|NCT02120027|589617463|FG000|Overall Study|Protocol Violation|18|||
163248390|NCT02120027|589617464|FG001|Overall Study|Protocol Violation|21|||
163248391|NCT02120027|589617463|FG000|Overall Study|Study terminated by Sponsor|45|||
163248392|NCT02120027|589617464|FG001|Overall Study|Study terminated by Sponsor|47|||
163248393|NCT02120027|589617463|FG000|Overall Study|Withdrawal by Subject|33|||
163248394|NCT02120027|589617464|FG001|Overall Study|Withdrawal by Subject|25|||
163248395|NCT01471054|589617469|FG000|Overall Study|Study terminated prematurely|4|||
163248396|NCT01471054|589617470|FG001|Overall Study|Study terminated prematurely|0|||
163248397|NCT00985725|589617471|FG000|Overall Study|Adverse Event|4|||
163410312|NCT05073458|590211347|FG001|24-week Open-label Period|Adverse Event|2|||
163248398|NCT00985725|589617472|FG001|Overall Study|Adverse Event|1|||
163248399|NCT00985725|589617471|FG000|Overall Study|Protocol Violation|1|||
163410313|NCT05913232|590211355|FG000|Overall Study|Adverse Event|0|||
163410314|NCT05913232|590211356|FG001|Overall Study|Adverse Event|2|||
163248400|NCT00985725|589617472|FG001|Overall Study|Protocol Violation|3|||
163248401|NCT00985725|589617471|FG000|Overall Study|Withdrawal by Subject|4|||
163248402|NCT00985725|589617472|FG001|Overall Study|Withdrawal by Subject|4|||
163248403|NCT00985725|589617471|FG000|Overall Study|Lost to Follow-up|1|||
163248404|NCT00985725|589617472|FG001|Overall Study|Lost to Follow-up|1|||
163248405|NCT00985725|589617471|FG000|Overall Study|Lack of Efficacy|0|||
163248406|NCT00985725|589617472|FG001|Overall Study|Lack of Efficacy|1|||
163248407|NCT00985725|589617471|FG000|Overall Study|Non-compliance|1|||
163248408|NCT00985725|589617472|FG001|Overall Study|Non-compliance|2|||
163248409|NCT00985725|589617471|FG000|Overall Study|Out-of-window visits|0|||
163248410|NCT00985725|589617472|FG001|Overall Study|Out-of-window visits|1|||
163248411|NCT03151005|589617476|FG000|Overall Study|Lost to Follow-up|5|||
163248412|NCT03151005|589617477|FG001|Overall Study|Lost to Follow-up|5|||
163248413|NCT03912259|589617478|FG000|Overall Study|Adverse Event (AE)|2|||
163248414|NCT03912259|589617479|FG001|Overall Study|Adverse Event (AE)|4|||
163248415|NCT03912259|589617478|FG000|Overall Study|Lack of Efficacy|4|||
163248416|NCT03912259|589617479|FG001|Overall Study|Lack of Efficacy|1|||
163248417|NCT03912259|589617478|FG000|Overall Study|Withdrawal by Subject|11|||
163248418|NCT03912259|589617479|FG001|Overall Study|Withdrawal by Subject|1|||
163248419|NCT00360308|589617482|FG000|Overall Study|Adverse Event|15|||
163248420|NCT00360308|589617483|FG001|Overall Study|Adverse Event|14|||
163248421|NCT00360308|589617484|FG002|Overall Study|Adverse Event|25|||
163248422|NCT00360308|589617482|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
163248423|NCT00360308|589617483|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
163248424|NCT00360308|589617484|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
163248425|NCT00360308|589617482|FG000|Overall Study|Protocol Violation|2|||
163248426|NCT00360308|589617483|FG001|Overall Study|Protocol Violation|1|||
163248427|NCT00360308|589617484|FG002|Overall Study|Protocol Violation|2|||
163248428|NCT00360308|589617482|FG000|Overall Study|Withdrawal by Subject|11|||
163248429|NCT00360308|589617483|FG001|Overall Study|Withdrawal by Subject|7|||
163248430|NCT00360308|589617484|FG002|Overall Study|Withdrawal by Subject|14|||
163248431|NCT00360308|589617482|FG000|Overall Study|Lack of Efficacy|3|||
163248432|NCT00360308|589617483|FG001|Overall Study|Lack of Efficacy|0|||
163248433|NCT00360308|589617484|FG002|Overall Study|Lack of Efficacy|2|||
163248434|NCT00360308|589617482|FG000|Overall Study|Other|2|||
163248435|NCT00360308|589617483|FG001|Overall Study|Other|1|||
163248436|NCT00360308|589617484|FG002|Overall Study|Other|1|||
163248437|NCT00360308|589617482|FG000|Overall Study|Study termination by sponsor|43|||
163248438|NCT00360308|589617483|FG001|Overall Study|Study termination by sponsor|55|||
163248439|NCT00360308|589617484|FG002|Overall Study|Study termination by sponsor|44|||
163248440|NCT01549613|589617485|FG000|Overall Study|Lost to Follow-up|11|||
163248441|NCT01549613|589617486|FG001|Overall Study|Lost to Follow-up|11|||
163248442|NCT02131272|589617487|FG000|Overall Study|Withdrawal by parent|0|||
163248443|NCT02131272|589617488|FG001|Overall Study|Withdrawal by parent|1|||
163248444|NCT02131272|589617487|FG000|Overall Study|Withdrawal by Subject|0|||
163248445|NCT02131272|589617488|FG001|Overall Study|Withdrawal by Subject|1|||
163248446|NCT02131272|589617487|FG000|Overall Study|Withdrawal Criteria|1|||
163248447|NCT02131272|589617488|FG001|Overall Study|Withdrawal Criteria|0|||
163248448|NCT00381940|589617489|FG000|Overall Study|Lack of Efficacy|3|||
163248449|NCT00381940|589617489|FG000|Overall Study|Protocol Violation|1|||
163248450|NCT00381940|589617489|FG000|Overall Study|Ineligible|1|||
163248451|NCT03162224|589617490|FG000|Overall Study|Death|4|||
163248452|NCT03162224|589617491|FG001|Overall Study|Death|5|||
163248453|NCT03162224|589617492|FG002|Overall Study|Death|8|||
163248454|NCT03162224|589617490|FG000|Overall Study|Withdrawal by Subject|1|||
163248455|NCT03162224|589617491|FG001|Overall Study|Withdrawal by Subject|0|||
163248456|NCT03162224|589617492|FG002|Overall Study|Withdrawal by Subject|1|||
163248457|NCT03162224|589617490|FG000|Overall Study|Lost to Follow-up|0|||
163248458|NCT03162224|589617491|FG001|Overall Study|Lost to Follow-up|1|||
163248459|NCT03162224|589617492|FG002|Overall Study|Lost to Follow-up|0|||
163248460|NCT03162224|589617490|FG000|Overall Study|Other|6|||
163248461|NCT03162224|589617491|FG001|Overall Study|Other|2|||
163248462|NCT03162224|589617492|FG002|Overall Study|Other|1|||
163248463|NCT04162769|589617493|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
163248464|NCT04162769|589617494|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
163248465|NCT04162769|589617495|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
163248466|NCT04162769|589617496|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
163248467|NCT04162769|589617493|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
163248468|NCT04162769|589617494|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
163248469|NCT04162769|589617495|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
163248470|NCT04162769|589617496|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
163248471|NCT04162769|589617493|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
163248472|NCT04162769|589617494|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
163248473|NCT04162769|589617495|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
163248474|NCT04162769|589617496|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
163248475|NCT04162769|589617493|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
163248476|NCT04162769|589617494|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
163248477|NCT04162769|589617495|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
163248478|NCT04162769|589617496|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
163248479|NCT04162769|589617493|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
163248480|NCT04162769|589617494|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
163248481|NCT04162769|589617495|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
163248482|NCT04162769|589617496|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
163248483|NCT04162769|589617493|FG000|Double-blind Treatment (12-Week)|Other|0|||
163248484|NCT04162769|589617494|FG001|Double-blind Treatment (12-Week)|Other|1|||
163248485|NCT04162769|589617495|FG002|Double-blind Treatment (12-Week)|Other|1|||
163248486|NCT04162769|589617496|FG003|Double-blind Treatment (12-Week)|Other|0|||
163248487|NCT04162769|589617493|FG000|OLE Period (52-Week)|Adverse Event|0|||
163248488|NCT04162769|589617494|FG001|OLE Period (52-Week)|Adverse Event|0|||
163248489|NCT04162769|589617495|FG002|OLE Period (52-Week)|Adverse Event|0|||
163248490|NCT04162769|589617496|FG003|OLE Period (52-Week)|Adverse Event|5|||
163248491|NCT04162769|589617493|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
163248492|NCT04162769|589617494|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
163248493|NCT04162769|589617495|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
163248494|NCT04162769|589617496|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
163248495|NCT04162769|589617493|FG000|OLE Period (52-Week)|Physician Decision|0|||
163248496|NCT04162769|589617494|FG001|OLE Period (52-Week)|Physician Decision|0|||
163248497|NCT04162769|589617495|FG002|OLE Period (52-Week)|Physician Decision|0|||
163248498|NCT04162769|589617496|FG003|OLE Period (52-Week)|Physician Decision|1|||
163248499|NCT04162769|589617493|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
163248500|NCT04162769|589617494|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
163248501|NCT04162769|589617495|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
163248502|NCT04162769|589617496|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
163248503|NCT04162769|589617493|FG000|OLE Period (52-Week)|Protocol deviation|0|||
163248504|NCT04162769|589617494|FG001|OLE Period (52-Week)|Protocol deviation|0|||
163248505|NCT04162769|589617495|FG002|OLE Period (52-Week)|Protocol deviation|0|||
163248506|NCT04162769|589617496|FG003|OLE Period (52-Week)|Protocol deviation|2|||
163248507|NCT00082173|589617497|FG000|Overall Study|Withdrawal by Subject|3|||
163248508|NCT00082173|589617498|FG001|Overall Study|Withdrawal by Subject|5|||
163248509|NCT00082173|589617497|FG000|Overall Study|Lost to Follow-up|1|||
163248510|NCT00082173|589617498|FG001|Overall Study|Lost to Follow-up|0|||
163248511|NCT00082173|589617497|FG000|Overall Study|Adverse Event|1|||
163248512|NCT00082173|589617498|FG001|Overall Study|Adverse Event|0|||
163248513|NCT00082173|589617497|FG000|Overall Study|Culture negative or resistant at baselin|5|||
163248514|NCT00082173|589617498|FG001|Overall Study|Culture negative or resistant at baselin|6|||
163248515|NCT01733732|589617499|FG000|Overall Study|Adverse Event|1|||
163248516|NCT01733732|589617500|FG001|Overall Study|Adverse Event|0|||
163248517|NCT01733732|589617499|FG000|Overall Study|Did not attend all study visits|1|||
163248518|NCT01733732|589617500|FG001|Overall Study|Did not attend all study visits|0|||
163248519|NCT03280121|589617506|FG000|Overall Study|Physician Decision|1|||
163248520|NCT03280121|589617506|FG000|Overall Study|Lost to Follow-up|1|||
163248521|NCT03280121|589617506|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
163248522|NCT02633137|589617519|FG000|Overall Study|Adverse Event|1|||
163248523|NCT02633137|589617519|FG000|Overall Study|Lack of Efficacy|2|||
163248524|NCT02633137|589617519|FG000|Overall Study|Withdrawal by Subject|1|||
163248525|NCT01324271|589617520|FG000|Overall Study|Lost to Follow-up|3|||
163248526|NCT01324271|589617521|FG001|Overall Study|Lost to Follow-up|0|||
163248527|NCT01324271|589617520|FG000|Overall Study|Physician Decision|1|||
163248528|NCT01324271|589617521|FG001|Overall Study|Physician Decision|0|||
163248529|NCT06116591|589617522|FG000|Overall Study|No longer met eligibility criteria|0|||
163248530|NCT06116591|589617523|FG001|Overall Study|No longer met eligibility criteria|1|||
163248531|NCT06116591|589617522|FG000|Overall Study|Other: Change in life situation|0|||
163248532|NCT06116591|589617523|FG001|Overall Study|Other: Change in life situation|1|||
163248533|NCT05585307|589617524|FG000|Overall Study|Lost to Follow-up|0|||
163248534|NCT05585307|589617525|FG001|Overall Study|Lost to Follow-up|0|||
163248535|NCT05585307|589617526|FG002|Overall Study|Lost to Follow-up|0|||
163248536|NCT05585307|589617527|FG003|Overall Study|Lost to Follow-up|0|||
163248537|NCT05585307|589617528|FG004|Overall Study|Lost to Follow-up|0|||
163248538|NCT05585307|589617529|FG005|Overall Study|Lost to Follow-up|0|||
163248539|NCT05585307|589617530|FG006|Overall Study|Lost to Follow-up|1|||
163248540|NCT05585307|589617531|FG007|Overall Study|Lost to Follow-up|0|||
163248541|NCT04391023|589617532|FG000|Overall Study|Withdrawal by Subject|2|||
163248542|NCT04391023|589617533|FG001|Overall Study|Withdrawal by Subject|2|||
163248543|NCT01270347|589617535|FG000|Core Phase|Adverse Event|1|||
163248544|NCT01270347|589617536|FG001|Core Phase|Adverse Event|6|||
163248545|NCT01270347|589617535|FG000|Core Phase|Withdrawal by Subject|1|||
163248546|NCT01270347|589617536|FG001|Core Phase|Withdrawal by Subject|2|||
163248547|NCT01270347|589617535|FG000|Core Phase|Lost to Follow-up|0|||
163248548|NCT01270347|589617536|FG001|Core Phase|Lost to Follow-up|1|||
163248549|NCT01270347|589617535|FG000|Core Phase|Miscellaneous|8|||
163248550|NCT01270347|589617536|FG001|Core Phase|Miscellaneous|14|||
163248551|NCT01270347|589617535|FG000|Extension Phase|Adverse Event|1|||
163248552|NCT01270347|589617536|FG001|Extension Phase|Adverse Event|3|||
163248553|NCT01270347|589617535|FG000|Extension Phase|Withdrawal by Subject|3|||
163248554|NCT01270347|589617536|FG001|Extension Phase|Withdrawal by Subject|4|||
163248555|NCT01270347|589617535|FG000|Extension Phase|Miscellaneous|2|||
163248556|NCT01270347|589617536|FG001|Extension Phase|Miscellaneous|2|||
163248557|NCT02085408|589617537|FG000|Step 1: Induction|Disease Progression|19|||
163248558|NCT02085408|589617538|FG001|Step 1: Induction|Disease Progression|19|||
163248559|NCT02085408|589617537|FG000|Step 1: Induction|Adverse Event|18|||
163248560|NCT02085408|589617538|FG001|Step 1: Induction|Adverse Event|17|||
163248561|NCT02085408|589617537|FG000|Step 1: Induction|Death|33|||
163248562|NCT02085408|589617538|FG001|Step 1: Induction|Death|30|||
163248563|NCT02085408|589617537|FG000|Step 1: Induction|Withdrawal by Subject|16|||
163248564|NCT02085408|589617538|FG001|Step 1: Induction|Withdrawal by Subject|8|||
163248565|NCT02085408|589617537|FG000|Step 1: Induction|Alternative Therapy|15|||
163248566|NCT02085408|589617538|FG001|Step 1: Induction|Alternative Therapy|19|||
163248567|NCT02085408|589617537|FG000|Step 1: Induction|Complicating Disease|2|||
163248568|NCT02085408|589617538|FG001|Step 1: Induction|Complicating Disease|3|||
163248569|NCT02085408|589617537|FG000|Step 1: Induction|Other|27|||
163248570|NCT02085408|589617538|FG001|Step 1: Induction|Other|39|||
163248571|NCT02085408|589617537|FG000|Step 1: Induction|Never started treatment|6|||
163248572|NCT02085408|589617538|FG001|Step 1: Induction|Never started treatment|4|||
163248573|NCT02085408|589617537|FG000|Step 2: Consolidation|Disease Progression|5|||
163248574|NCT02085408|589617538|FG001|Step 2: Consolidation|Disease Progression|20|||
163248575|NCT02085408|589617537|FG000|Step 2: Consolidation|Adverse Event|9|||
163248576|NCT02085408|589617538|FG001|Step 2: Consolidation|Adverse Event|8|||
163248577|NCT02085408|589617537|FG000|Step 2: Consolidation|Death|4|||
163248578|NCT02085408|589617538|FG001|Step 2: Consolidation|Death|3|||
163248579|NCT02085408|589617537|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
163248580|NCT02085408|589617538|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
163248581|NCT02085408|589617537|FG000|Step 2: Consolidation|Alternative Therapy|9|||
163248582|NCT02085408|589617538|FG001|Step 2: Consolidation|Alternative Therapy|3|||
163248583|NCT02085408|589617537|FG000|Step 2: Consolidation|Complicating Disease|0|||
163248584|NCT02085408|589617538|FG001|Step 2: Consolidation|Complicating Disease|2|||
163248585|NCT02085408|589617537|FG000|Step 2: Consolidation|Other|6|||
163248586|NCT02085408|589617538|FG001|Step 2: Consolidation|Other|6|||
163248587|NCT02085408|589617537|FG000|Step 2: Consolidation|Never started treatment|4|||
163248588|NCT02085408|589617538|FG001|Step 2: Consolidation|Never started treatment|3|||
163248589|NCT02085408|589617537|FG000|Step 3: Maintenance|Disease Progression|13|||
163248590|NCT02085408|589617538|FG001|Step 3: Maintenance|Disease Progression|11|||
163248591|NCT02085408|589617537|FG000|Step 3: Maintenance|Adverse Event|2|||
163248592|NCT02085408|589617538|FG001|Step 3: Maintenance|Adverse Event|4|||
163248593|NCT02085408|589617537|FG000|Step 3: Maintenance|Death|1|||
163248594|NCT02085408|589617538|FG001|Step 3: Maintenance|Death|2|||
163248595|NCT02085408|589617537|FG000|Step 3: Maintenance|Alternative Therapy|1|||
163248596|NCT02085408|589617538|FG001|Step 3: Maintenance|Alternative Therapy|1|||
163248597|NCT02085408|589617537|FG000|Step 3: Maintenance|Complicating Disease|0|||
163248598|NCT02085408|589617538|FG001|Step 3: Maintenance|Complicating Disease|1|||
163248599|NCT02085408|589617537|FG000|Step 3: Maintenance|Other|3|||
163248600|NCT02085408|589617538|FG001|Step 3: Maintenance|Other|2|||
163248601|NCT02085408|589617537|FG000|Step 3: Maintenance|Never started treatment|5|||
163248602|NCT02085408|589617538|FG001|Step 3: Maintenance|Never started treatment|1|||
163248603|NCT00492284|589617539|FG000|Overall Study|Adverse Event|0|||
163248604|NCT00492284|589617540|FG001|Overall Study|Adverse Event|1|||
163248605|NCT00492284|589617541|FG002|Overall Study|Adverse Event|1|||
163248606|NCT00492284|589617542|FG003|Overall Study|Adverse Event|2|||
163248607|NCT00492284|589617539|FG000|Overall Study|Lost to Follow-up|0|||
163248608|NCT00492284|589617540|FG001|Overall Study|Lost to Follow-up|0|||
163248609|NCT00492284|589617541|FG002|Overall Study|Lost to Follow-up|3|||
163248610|NCT00492284|589617542|FG003|Overall Study|Lost to Follow-up|1|||
163248611|NCT00492284|589617539|FG000|Overall Study|Death|0|||
163248612|NCT00492284|589617540|FG001|Overall Study|Death|3|||
163248613|NCT00492284|589617541|FG002|Overall Study|Death|2|||
163248614|NCT00492284|589617542|FG003|Overall Study|Death|5|||
163248615|NCT00492284|589617539|FG000|Overall Study|Withdrawal by Subject|1|||
163248616|NCT00492284|589617540|FG001|Overall Study|Withdrawal by Subject|0|||
163248617|NCT00492284|589617541|FG002|Overall Study|Withdrawal by Subject|0|||
163248618|NCT00492284|589617542|FG003|Overall Study|Withdrawal by Subject|2|||
163248619|NCT02734212|589617545|FG000|Overall Study|Lost to Follow-up|5|||
163248620|NCT02734212|589617546|FG001|Overall Study|Lost to Follow-up|10|||
163248621|NCT01939028|589617549|FG000|Overall Study|Withdrawal by Subject|5|||
163248622|NCT01939028|589617549|FG000|Overall Study|Physician Decision|7|||
163248623|NCT03282227|589617550|FG000|Overall Study|Exposure Goals Achieved|60|||
163248624|NCT03282227|589617550|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
163248625|NCT03282227|589617550|FG000|Overall Study|Adverse Event|15|||
163248626|NCT03282227|589617550|FG000|Overall Study|Lost to Follow-up|21|||
163248627|NCT03282227|589617550|FG000|Overall Study|Withdrawal by Subject|20|||
163248628|NCT03282227|589617550|FG000|Overall Study|Lack of Efficacy|12|||
163248629|NCT03282227|589617550|FG000|Overall Study|Sponsor decision|3|||
163248630|NCT03282227|589617550|FG000|Overall Study|Physician Decision|2|||
163248631|NCT03282227|589617550|FG000|Overall Study|Pregnancy|2|||
163248632|NCT03282227|589617550|FG000|Overall Study|Other|1|||
163248633|NCT02576678|589617551|FG000|Overall Study|Adverse Event|0|||
163248634|NCT02576678|589617552|FG001|Overall Study|Adverse Event|0|||
163248635|NCT02576678|589617553|FG002|Overall Study|Adverse Event|2|||
163248636|NCT02576678|589617551|FG000|Overall Study|Withdrawal by Subject|3|||
163248637|NCT02576678|589617552|FG001|Overall Study|Withdrawal by Subject|1|||
163248638|NCT02576678|589617553|FG002|Overall Study|Withdrawal by Subject|2|||
163248639|NCT02576678|589617551|FG000|Overall Study|Lost to Follow-up|0|||
163248640|NCT02576678|589617552|FG001|Overall Study|Lost to Follow-up|0|||
163248641|NCT02576678|589617553|FG002|Overall Study|Lost to Follow-up|1|||
163248642|NCT02576678|589617551|FG000|Overall Study|Miscellaneous|2|||
163248643|NCT02576678|589617552|FG001|Overall Study|Miscellaneous|0|||
163248644|NCT02576678|589617553|FG002|Overall Study|Miscellaneous|0|||
163248645|NCT00700401|589617564|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
163248646|NCT00700401|589617564|FG000|Overall Study|Adverse Event|5|||
163248647|NCT00700401|589617564|FG000|Overall Study|Refused Treatment|2|||
163248648|NCT00700401|589617564|FG000|Overall Study|Lost to Follow-up|1|||
163248649|NCT00700401|589617564|FG000|Overall Study|Treatment never started|1|||
163248650|NCT00700401|589617564|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
163248651|NCT00700401|589617564|FG000|Overall Study|Withdrawal by Subject|2|||
163248652|NCT02491671|589617565|FG000|Overall Study|Adverse Event|6|||
163248653|NCT02491671|589617566|FG001|Overall Study|Adverse Event|8|||
163248654|NCT02491671|589617565|FG000|Overall Study|Death|0|||
163248655|NCT02491671|589617566|FG001|Overall Study|Death|2|||
163248656|NCT02491671|589617565|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
163248657|NCT02491671|589617566|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
163248658|NCT02251990|589617570|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
163248659|NCT02251990|589617571|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
163248660|NCT02251990|589617570|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
163248661|NCT02251990|589617571|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
163248662|NCT02251990|589617570|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
163248663|NCT02251990|589617571|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
163248664|NCT02251990|589617570|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
163248665|NCT02251990|589617571|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
163248666|NCT02251990|589617570|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
163248667|NCT02251990|589617571|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
163248668|NCT02251990|589617570|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
163248669|NCT02251990|589617571|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
163248670|NCT02293538|589617572|FG000|Overall Study|Adverse Event|0|||
163248671|NCT02293538|589617573|FG001|Overall Study|Adverse Event|1|||
163248672|NCT02293538|589617572|FG000|Overall Study|Lost to Follow-up|1|||
163248673|NCT02293538|589617573|FG001|Overall Study|Lost to Follow-up|0|||
163248674|NCT02293538|589617572|FG000|Overall Study|Withdrawal by Subject|0|||
163410315|NCT05913232|590211357|FG002|Overall Study|Adverse Event|1|||
163410316|NCT05913232|590211358|FG003|Overall Study|Adverse Event|1|||
163410317|NCT05103332|590211359|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410318|NCT05103332|590211360|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
163410319|NCT05103332|590211361|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
163410320|NCT05103332|590211362|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410321|NCT05103332|590211363|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410322|NCT05103332|590211364|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
163410323|NCT05103332|590211365|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410324|NCT05103332|590211366|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410325|NCT05103332|590211367|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410326|NCT05103332|590211368|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410327|NCT05103332|590211369|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163354693|NCT01519778|590009584|FG000|Overall Study|Lost to Follow-up|10|||
163354694|NCT01519778|590009584|FG000|Overall Study|Physician Decision|1|||
163248675|NCT02293538|589617573|FG001|Overall Study|Withdrawal by Subject|1|||
163248676|NCT00322348|589617574|FG000|Overall Study|Adverse Event|0|||
163248677|NCT00322348|589617575|FG001|Overall Study|Adverse Event|1|||
163248678|NCT00322348|589617574|FG000|Overall Study|Withdrawal by Subject|1|||
163248679|NCT00322348|589617575|FG001|Overall Study|Withdrawal by Subject|4|||
163248680|NCT00322348|589617574|FG000|Overall Study|Lost to Follow-up|1|||
163248681|NCT00322348|589617575|FG001|Overall Study|Lost to Follow-up|0|||
163248682|NCT00322348|589617574|FG000|Overall Study|Death|0|||
163248683|NCT00322348|589617575|FG001|Overall Study|Death|2|||
163354695|NCT01547117|590009590|FG000|Overall Study|Physician Decision|0|||
163354696|NCT01547117|590009591|FG001|Overall Study|Physician Decision|1|||
163354697|NCT01547117|590009592|FG002|Overall Study|Physician Decision|1|||
163354698|NCT01547117|590009593|FG003|Overall Study|Physician Decision|3|||
163354699|NCT01547117|590009590|FG000|Overall Study|Withdrawal by Subject|1|||
163354700|NCT01547117|590009591|FG001|Overall Study|Withdrawal by Subject|2|||
163354701|NCT01547117|590009592|FG002|Overall Study|Withdrawal by Subject|1|||
163354702|NCT01547117|590009593|FG003|Overall Study|Withdrawal by Subject|2|||
163354703|NCT01844726|590009594|FG000|Overall Study|Withdrawal by Subject|0|||
163354704|NCT01844726|590009595|FG001|Overall Study|Withdrawal by Subject|1|||
163354705|NCT01844726|590009594|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
163354706|NCT01844726|590009595|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
163354707|NCT02229578|590009596|FG000|Overall Study|Withdrawal by Subject|1|||
163354708|NCT02229578|590009597|FG001|Overall Study|Withdrawal by Subject|3|||
163354709|NCT02229578|590009596|FG000|Overall Study|Protocol Violation|2|||
163354710|NCT02229578|590009597|FG001|Overall Study|Protocol Violation|0|||
163354711|NCT01288209|590009598|FG000|Overall Study|Withdrawal by Subject|1|||
163354712|NCT01288209|590009599|FG001|Overall Study|Withdrawal by Subject|3|||
163354713|NCT01288209|590009598|FG000|Overall Study|Other|1|||
163354714|NCT01288209|590009599|FG001|Overall Study|Other|0|||
163354715|NCT01496365|590009600|FG000|Overall Study|Adverse Event|2|||
163354716|NCT01496365|590009601|FG001|Overall Study|Adverse Event|3|||
163354717|NCT01496365|590009602|FG002|Overall Study|Adverse Event|3|||
163354718|NCT01496365|590009603|FG003|Overall Study|Adverse Event|2|||
163354719|NCT01496365|590009604|FG004|Overall Study|Adverse Event|5|||
163354720|NCT01496365|590009605|FG005|Overall Study|Adverse Event|6|||
163354721|NCT01496365|590009606|FG006|Overall Study|Adverse Event|4|||
163354722|NCT01496365|590009600|FG000|Overall Study|Withdrawal by Subject|6|||
163354723|NCT01496365|590009601|FG001|Overall Study|Withdrawal by Subject|6|||
163354724|NCT01496365|590009602|FG002|Overall Study|Withdrawal by Subject|0|||
163354725|NCT01496365|590009603|FG003|Overall Study|Withdrawal by Subject|1|||
163354726|NCT01496365|590009604|FG004|Overall Study|Withdrawal by Subject|3|||
163354727|NCT01496365|590009605|FG005|Overall Study|Withdrawal by Subject|2|||
163354728|NCT01496365|590009606|FG006|Overall Study|Withdrawal by Subject|1|||
163354729|NCT01496365|590009600|FG000|Overall Study|Protocol Violation|2|||
163354730|NCT01496365|590009601|FG001|Overall Study|Protocol Violation|1|||
163354731|NCT01496365|590009602|FG002|Overall Study|Protocol Violation|1|||
163354732|NCT01496365|590009603|FG003|Overall Study|Protocol Violation|0|||
163354733|NCT01496365|590009604|FG004|Overall Study|Protocol Violation|0|||
163354734|NCT01496365|590009605|FG005|Overall Study|Protocol Violation|1|||
163354735|NCT01496365|590009606|FG006|Overall Study|Protocol Violation|0|||
163354736|NCT01496365|590009600|FG000|Overall Study|Lack of Efficacy|1|||
163354737|NCT01496365|590009601|FG001|Overall Study|Lack of Efficacy|0|||
163354738|NCT01496365|590009602|FG002|Overall Study|Lack of Efficacy|0|||
163354739|NCT01496365|590009603|FG003|Overall Study|Lack of Efficacy|0|||
163354740|NCT01496365|590009604|FG004|Overall Study|Lack of Efficacy|0|||
163354741|NCT01496365|590009605|FG005|Overall Study|Lack of Efficacy|1|||
163248684|NCT00322348|589617574|FG000|Overall Study|Disease Progression|30|||
163248685|NCT00322348|589617575|FG001|Overall Study|Disease Progression|25|||
163248686|NCT00322348|589617574|FG000|Overall Study|Reasons not specified|5|||
163248687|NCT00322348|589617575|FG001|Overall Study|Reasons not specified|1|||
163248688|NCT01041638|589617577|FG000|Overall Study|Adverse Event|4|||
163248689|NCT01041638|589617577|FG000|Overall Study|Death|1|||
163248690|NCT01041638|589617577|FG000|Overall Study|Lack of Efficacy|7|||
163248691|NCT01041638|589617577|FG000|Overall Study|Physician Decision|4|||
163248692|NCT01041638|589617577|FG000|Overall Study|Withdrawal by Subject|11|||
163248693|NCT03152552|589617578|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
163248694|NCT03152552|589617579|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
163248695|NCT03152552|589617580|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
163248696|NCT03152552|589617581|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
163248697|NCT03152552|589617582|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
163248698|NCT03152552|589617578|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
163248699|NCT03152552|589617579|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
163248700|NCT03152552|589617580|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
163248701|NCT03152552|589617581|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
163248702|NCT03152552|589617582|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
163248703|NCT03152552|589617578|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
163248704|NCT03152552|589617579|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
163248705|NCT03152552|589617580|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
163248706|NCT03152552|589617581|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
163248707|NCT03152552|589617582|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
163248708|NCT03152552|589617578|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163248709|NCT03152552|589617579|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163248710|NCT03152552|589617580|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
163248711|NCT03152552|589617581|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163248712|NCT03152552|589617582|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163248713|NCT03152552|589617578|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
163248714|NCT03152552|589617579|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
163248715|NCT03152552|589617580|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
163248716|NCT03152552|589617581|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
163248717|NCT03152552|589617582|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
163248718|NCT03152552|589617578|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
163354742|NCT01496365|590009606|FG006|Overall Study|Lack of Efficacy|0|||
163354743|NCT01496365|590009600|FG000|Overall Study|Lost to Follow-up|0|||
163354744|NCT01496365|590009601|FG001|Overall Study|Lost to Follow-up|1|||
163354745|NCT01496365|590009602|FG002|Overall Study|Lost to Follow-up|0|||
163354746|NCT01496365|590009603|FG003|Overall Study|Lost to Follow-up|0|||
163354747|NCT01496365|590009604|FG004|Overall Study|Lost to Follow-up|2|||
163354748|NCT01496365|590009605|FG005|Overall Study|Lost to Follow-up|0|||
163354749|NCT01496365|590009606|FG006|Overall Study|Lost to Follow-up|0|||
163354750|NCT01496365|590009600|FG000|Overall Study|Other|4|||
163354751|NCT01496365|590009601|FG001|Overall Study|Other|4|||
163354752|NCT01496365|590009602|FG002|Overall Study|Other|2|||
163354753|NCT01496365|590009603|FG003|Overall Study|Other|1|||
163354754|NCT01496365|590009604|FG004|Overall Study|Other|3|||
163248719|NCT03152552|589617579|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
163248720|NCT03152552|589617580|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
163248721|NCT03152552|589617581|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
163248722|NCT03152552|589617582|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
163248723|NCT03152552|589617578|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
163248724|NCT03152552|589617579|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
163248725|NCT03152552|589617580|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
163248726|NCT03152552|589617581|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
163248727|NCT03152552|589617582|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
163248728|NCT03240692|589617588|FG000|Overall Study|Physician Decision|1|||
163248729|NCT03240692|589617588|FG000|Overall Study|Withdrawal by Subject|1|||
163248730|NCT00683644|589617589|FG000|Overall Study|Withdrawal by Subject|4|||
163248731|NCT00683644|589617590|FG001|Overall Study|Withdrawal by Subject|2|||
163248732|NCT00683644|589617589|FG000|Overall Study|Lost to Follow-up|1|||
163248733|NCT00683644|589617590|FG001|Overall Study|Lost to Follow-up|4|||
163248734|NCT00683644|589617589|FG000|Overall Study|Adverse Event|1|||
163248735|NCT00683644|589617590|FG001|Overall Study|Adverse Event|2|||
163248736|NCT00683644|589617589|FG000|Overall Study|Low copper, other health problems,|7|||
163248737|NCT00683644|589617590|FG001|Overall Study|Low copper, other health problems,|6|||
163248738|NCT01857531|589617591|FG000|Overall Study|Withdrawal by Subject|4|||
163248739|NCT00355082|589617592|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
163248740|NCT00355082|589617593|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
163248741|NCT00355082|589617594|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
163248742|NCT00355082|589617592|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
163248743|NCT00355082|589617593|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
163248744|NCT00355082|589617594|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
163248745|NCT00355082|589617592|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
163248746|NCT00355082|589617593|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
163248747|NCT00355082|589617594|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
163248748|NCT00355082|589617592|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
163248749|NCT00355082|589617593|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
163248750|NCT00355082|589617594|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
163248751|NCT00355082|589617592|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
163248752|NCT00355082|589617593|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
163248753|NCT00355082|589617594|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
163248754|NCT00355082|589617592|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
163248755|NCT00355082|589617593|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
163248756|NCT00355082|589617594|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
163248757|NCT00355082|589617592|FG000|Continuation Phase|Adverse Event|2|||
163248758|NCT00355082|589617593|FG001|Continuation Phase|Adverse Event|0|||
163248759|NCT00355082|589617594|FG002|Continuation Phase|Adverse Event|1|||
163248760|NCT00355082|589617592|FG000|Continuation Phase|Lost to Follow-up|2|||
163248761|NCT00355082|589617593|FG001|Continuation Phase|Lost to Follow-up|0|||
163248762|NCT00355082|589617594|FG002|Continuation Phase|Lost to Follow-up|1|||
163248763|NCT00355082|589617592|FG000|Continuation Phase|Protocol Violation|1|||
163248764|NCT00355082|589617593|FG001|Continuation Phase|Protocol Violation|0|||
163248765|NCT00355082|589617594|FG002|Continuation Phase|Protocol Violation|1|||
163248766|NCT00355082|589617592|FG000|Continuation Phase|Withdrawal by Subject|4|||
163248767|NCT00355082|589617593|FG001|Continuation Phase|Withdrawal by Subject|0|||
163248768|NCT00355082|589617594|FG002|Continuation Phase|Withdrawal by Subject|0|||
163248769|NCT00355082|589617592|FG000|Continuation Phase|Lack of Efficacy|5|||
163248770|NCT00355082|589617593|FG001|Continuation Phase|Lack of Efficacy|0|||
163248771|NCT00355082|589617594|FG002|Continuation Phase|Lack of Efficacy|0|||
163248772|NCT00355082|589617592|FG000|Continuation Phase|Site Closed by Sponsor|8|||
163248773|NCT00355082|589617593|FG001|Continuation Phase|Site Closed by Sponsor|0|||
163248774|NCT00355082|589617594|FG002|Continuation Phase|Site Closed by Sponsor|0|||
163248775|NCT00355082|589617592|FG000|Continuation Phase|Scheduling Error|1|||
163248776|NCT00355082|589617593|FG001|Continuation Phase|Scheduling Error|0|||
163248777|NCT00355082|589617594|FG002|Continuation Phase|Scheduling Error|0|||
163248778|NCT00355082|589617592|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
163248779|NCT00355082|589617593|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
163248780|NCT00355082|589617594|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
163248781|NCT02576067|589617595|FG000|Overall Study|Death|0|||
163248782|NCT02576067|589617596|FG001|Overall Study|Death|1|||
163248783|NCT02576067|589617595|FG000|Overall Study|Lack of Efficacy|1|||
163248784|NCT02576067|589617596|FG001|Overall Study|Lack of Efficacy|0|||
163248785|NCT02576067|589617595|FG000|Overall Study|Lost to Follow-up|11|||
163248786|NCT02576067|589617596|FG001|Overall Study|Lost to Follow-up|0|||
163248787|NCT02576067|589617595|FG000|Overall Study|Withdrawal by Subject|11|||
163248788|NCT02576067|589617596|FG001|Overall Study|Withdrawal by Subject|2|||
163248789|NCT02576067|589617595|FG000|Overall Study|study closure of main CIRT trial)|0|||
163248790|NCT02576067|589617596|FG001|Overall Study|study closure of main CIRT trial)|8|||
163248791|NCT02576067|589617595|FG000|Overall Study|not randomized, failed run-in|7|||
163248792|NCT02576067|589617596|FG001|Overall Study|not randomized, failed run-in|0|||
163248793|NCT02576067|589617595|FG000|Overall Study|screen failure/ re-enrolled|0|||
163248794|NCT02576067|589617596|FG001|Overall Study|screen failure/ re-enrolled|25|||
163248795|NCT02576067|589617595|FG000|Overall Study|Physician Decision|4|||
163248796|NCT02576067|589617596|FG001|Overall Study|Physician Decision|0|||
163248797|NCT04084314|589617597|FG000|Overall Study|Subject/guardian decision|91|||
163248798|NCT04084314|589617597|FG000|Overall Study|Adverse Event|24|||
163248799|NCT04084314|589617597|FG000|Overall Study|Lost to Follow-up|19|||
163248800|NCT04084314|589617597|FG000|Overall Study|New therapy for study indication|9|||
163248801|NCT04084314|589617597|FG000|Overall Study|Pregnancy|9|||
163248802|NCT04084314|589617597|FG000|Overall Study|Withdrawal of informed consent|8|||
163248803|NCT04084314|589617597|FG000|Overall Study|Physician Decision|4|||
163248804|NCT04084314|589617597|FG000|Overall Study|Protocol Deviation|3|||
163248805|NCT00622167|589617598|FG000|Overall Study|Did not meet angiographic criteria|20|||
163248806|NCT02194621|589617612|FG000|Overall Study|6 withdrew prior to randomization|2|||
163248807|NCT02194621|589617613|FG001|Overall Study|6 withdrew prior to randomization|2|||
163248808|NCT02194621|589617614|FG002|Overall Study|6 withdrew prior to randomization|2|||
163248809|NCT02194621|589617612|FG000|Overall Study|Withdrawal by Subject|4|||
163248810|NCT02194621|589617613|FG001|Overall Study|Withdrawal by Subject|4|||
163248811|NCT02194621|589617614|FG002|Overall Study|Withdrawal by Subject|7|||
163248812|NCT05374421|589617615|FG000|Overall Study|Withdrawal by Subject|3|||
163248813|NCT05374421|589617616|FG001|Overall Study|Withdrawal by Subject|4|||
163248814|NCT00003508|589619443|FG000|Overall Study|Not evaluable|5|||
163248815|NCT03576768|589619445|FG000|Overall Study|Lost to Follow-up|3|||
163248816|NCT03576768|589619446|FG001|Overall Study|Lost to Follow-up|3|||
163248817|NCT03576768|589619447|FG002|Overall Study|Lost to Follow-up|0|||
163248818|NCT03576768|589619448|FG003|Overall Study|Lost to Follow-up|0|||
163248819|NCT00590902|589619449|FG000|Overall Study|Death|1|||
163248820|NCT02057874|589619450|FG000|Overall Study|participant did not return for scan|1|||
163248821|NCT02979639|589619451|FG000|Overall Study|Withdrawal based on medical judgement|1|||
163248822|NCT02979639|589619451|FG000|Overall Study|Lost to Follow-up|8|||
163248823|NCT02979639|589619451|FG000|Overall Study|Withdrawal by Subject|3|||
163248824|NCT02979639|589619451|FG000|Overall Study|Adverse Event|2|||
163248825|NCT01738984|589619454|FG000|Overall Study|Pregnancy|4|||
163248826|NCT01738984|589619455|FG001|Overall Study|Pregnancy|0|||
163248827|NCT01738984|589619454|FG000|Overall Study|Withdrawal by Subject|1|||
163248828|NCT01738984|589619455|FG001|Overall Study|Withdrawal by Subject|0|||
163248829|NCT01738984|589619454|FG000|Overall Study|Lost to Follow-up|59|||
163248830|NCT01738984|589619455|FG001|Overall Study|Lost to Follow-up|39|||
163248831|NCT02621931|589619460|FG000|Overall Study|Death|0|||
163248832|NCT02621931|589619461|FG001|Overall Study|Death|1|||
163248833|NCT02621931|589619462|FG002|Overall Study|Death|0|||
163248834|NCT02621931|589619460|FG000|Overall Study|Adverse Event|8|||
163248835|NCT02621931|589619461|FG001|Overall Study|Adverse Event|5|||
163248836|NCT02621931|589619462|FG002|Overall Study|Adverse Event|7|||
163248837|NCT02621931|589619460|FG000|Overall Study|Withdrawal by Subject|12|||
163248838|NCT02621931|589619461|FG001|Overall Study|Withdrawal by Subject|10|||
163248839|NCT02621931|589619462|FG002|Overall Study|Withdrawal by Subject|11|||
163248840|NCT02621931|589619460|FG000|Overall Study|Protocol Violation|2|||
163248841|NCT02621931|589619461|FG001|Overall Study|Protocol Violation|2|||
163248842|NCT02621931|589619462|FG002|Overall Study|Protocol Violation|2|||
163248843|NCT02621931|589619460|FG000|Overall Study|Pregnancy|2|||
163248844|NCT02621931|589619461|FG001|Overall Study|Pregnancy|0|||
163248845|NCT02621931|589619462|FG002|Overall Study|Pregnancy|0|||
163248846|NCT02621931|589619460|FG000|Overall Study|Noncompliance to study procedures|0|||
163248847|NCT02621931|589619461|FG001|Overall Study|Noncompliance to study procedures|1|||
163248848|NCT02621931|589619462|FG002|Overall Study|Noncompliance to study procedures|2|||
163248849|NCT02621931|589619460|FG000|Overall Study|Lost to Follow-up|8|||
163248850|NCT02621931|589619461|FG001|Overall Study|Lost to Follow-up|7|||
163248851|NCT02621931|589619462|FG002|Overall Study|Lost to Follow-up|10|||
163248852|NCT02621931|589619460|FG000|Overall Study|Lack of Efficacy|0|||
163248853|NCT02621931|589619461|FG001|Overall Study|Lack of Efficacy|0|||
163248854|NCT02621931|589619462|FG002|Overall Study|Lack of Efficacy|1|||
163248855|NCT02621931|589619460|FG000|Overall Study|Other|1|||
163248856|NCT02621931|589619461|FG001|Overall Study|Other|1|||
163248857|NCT02621931|589619462|FG002|Overall Study|Other|3|||
163248858|NCT00920426|589619463|FG000|ITZ111451|Adverse Event|1|||
163248859|NCT00920426|589619464|FG001|ITZ111451|Adverse Event|0|||
163248860|NCT00920426|589619465|FG002|ITZ111451|Adverse Event|0|||
163248861|NCT00920426|589619466|FG003|ITZ111451|Adverse Event|0|||
163248862|NCT00955357|589619471|FG000|Titration Phase|Adverse Event|9|||
163248863|NCT00955357|589619472|FG001|Titration Phase|Adverse Event|46|||
163248864|NCT00955357|589619471|FG000|Titration Phase|Lack of Efficacy|0|||
163248865|NCT00955357|589619472|FG001|Titration Phase|Lack of Efficacy|2|||
163248866|NCT00955357|589619471|FG000|Titration Phase|Protocol Violation|3|||
163248867|NCT00955357|589619472|FG001|Titration Phase|Protocol Violation|7|||
163248868|NCT00955357|589619471|FG000|Titration Phase|Lost to Follow-up|1|||
163248869|NCT00955357|589619472|FG001|Titration Phase|Lost to Follow-up|3|||
163248870|NCT00955357|589619471|FG000|Titration Phase|Withdrawal by Subject|3|||
163248871|NCT00955357|589619472|FG001|Titration Phase|Withdrawal by Subject|5|||
163248872|NCT00955357|589619471|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
163248873|NCT00955357|589619472|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
163248874|NCT00955357|589619471|FG000|Titration Phase|Study medication not tolerated|0|||
163248875|NCT00955357|589619472|FG001|Titration Phase|Study medication not tolerated|1|||
163248876|NCT00955357|589619471|FG000|Titration Phase|Non compliance to study procedures|0|||
163248877|NCT00955357|589619472|FG001|Titration Phase|Non compliance to study procedures|1|||
163248878|NCT00955357|589619471|FG000|Maintenance Phase|Adverse Event|3|||
163248879|NCT00955357|589619472|FG001|Maintenance Phase|Adverse Event|23|||
163248880|NCT00955357|589619471|FG000|Maintenance Phase|Lack of Efficacy|0|||
163248881|NCT00955357|589619472|FG001|Maintenance Phase|Lack of Efficacy|4|||
163248882|NCT00955357|589619471|FG000|Maintenance Phase|Protocol Violation|2|||
163248883|NCT00955357|589619472|FG001|Maintenance Phase|Protocol Violation|6|||
163248884|NCT00955357|589619471|FG000|Maintenance Phase|Lost to Follow-up|2|||
163248885|NCT00955357|589619472|FG001|Maintenance Phase|Lost to Follow-up|7|||
163248886|NCT00955357|589619471|FG000|Maintenance Phase|Withdrawal by Subject|4|||
163248887|NCT00955357|589619472|FG001|Maintenance Phase|Withdrawal by Subject|4|||
163248888|NCT00955357|589619471|FG000|Maintenance Phase|Patient moving out of area|0|||
163248889|NCT00955357|589619472|FG001|Maintenance Phase|Patient moving out of area|1|||
163248890|NCT00955357|589619471|FG000|Maintenance Phase|Non compliance to study procedures|1|||
163248891|NCT00955357|589619472|FG001|Maintenance Phase|Non compliance to study procedures|0|||
163248892|NCT00886340|589619473|FG000|Overall Study|Withdrawal by Subject|0|||
163248893|NCT00886340|589619474|FG001|Overall Study|Withdrawal by Subject|7|||
163248894|NCT02985866|589619475|FG000|Overall Study|Poor CGM data|1|||
163248895|NCT02985866|589619476|FG001|Overall Study|Poor CGM data|1|||
163248896|NCT03224182|589619477|FG000|Overall Study|Study Drug Not Instilled|6|||
163248897|NCT03224182|589619478|FG001|Overall Study|Study Drug Not Instilled|1|||
163248898|NCT03224182|589619477|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
163248899|NCT03224182|589619478|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
163248900|NCT03224182|589619477|FG000|Overall Study|Withdrew of Consent|4|||
163248901|NCT03224182|589619478|FG001|Overall Study|Withdrew of Consent|2|||
163248902|NCT03224182|589619477|FG000|Overall Study|Investigator Decision|3|||
163248903|NCT03224182|589619478|FG001|Overall Study|Investigator Decision|1|||
163248904|NCT03224182|589619477|FG000|Overall Study|Sponsor Decision|26|||
163248905|NCT03224182|589619478|FG001|Overall Study|Sponsor Decision|12|||
163248906|NCT03224182|589619477|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
163248907|NCT03224182|589619478|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
163248908|NCT03224182|589619477|FG000|Overall Study|Lost to Follow-up|1|||
163248909|NCT03224182|589619478|FG001|Overall Study|Lost to Follow-up|0|||
163248910|NCT03224182|589619477|FG000|Overall Study|Participant Had Recurrence|11|||
163248911|NCT03224182|589619478|FG001|Overall Study|Participant Had Recurrence|5|||
163248912|NCT03224182|589619477|FG000|Overall Study|Death|0|||
163248913|NCT03224182|589619478|FG001|Overall Study|Death|1|||
163248914|NCT03224182|589619477|FG000|Overall Study|Reason not Specified|3|||
163248915|NCT03224182|589619478|FG001|Overall Study|Reason not Specified|3|||
163248916|NCT03224182|589619477|FG000|Overall Study|Other|1|||
163248917|NCT03224182|589619478|FG001|Overall Study|Other|0|||
163248918|NCT02925455|589619482|FG000|Overall Study|Withdrawal by Subject|2|||
163248919|NCT02925455|589619483|FG001|Overall Study|Withdrawal by Subject|0|||
163248920|NCT00686166|589619487|FG000|Overall Study|Adverse Event|7|||
163248921|NCT00686166|589619487|FG000|Overall Study|Withdrawal by Subject|1|||
163248922|NCT00686166|589619487|FG000|Overall Study|Progression/Relapse|1|||
163248923|NCT00686166|589619487|FG000|Overall Study|Death|1|||
163248924|NCT00686166|589619487|FG000|Overall Study|Not Protocol Specified|1|||
163248925|NCT00686166|589619487|FG000|Overall Study|Ineligible|5|||
163248926|NCT00686166|589619487|FG000|Overall Study|Did not begin protocol therapy|4|||
163248927|NCT02314624|589619488|FG000|Overall Study|No participating patient|16|||
163248928|NCT02314624|589619489|FG001|Overall Study|No participating patient|13|||
163248929|NCT02314624|589619488|FG000|Overall Study|Participant withdrew|7|||
163248930|NCT02314624|589619489|FG001|Overall Study|Participant withdrew|2|||
163248931|NCT02314624|589619488|FG000|Overall Study|Lost to Follow-up|2|||
163248932|NCT02314624|589619489|FG001|Overall Study|Lost to Follow-up|5|||
163248933|NCT02314624|589619488|FG000|Overall Study|Dropped/Excluded by PI|6|||
163248934|NCT02314624|589619489|FG001|Overall Study|Dropped/Excluded by PI|6|||
163248935|NCT00464815|589619490|FG000|Overall Study|Withdrawal by Subject|6|||
163248936|NCT00464815|589619491|FG001|Overall Study|Withdrawal by Subject|3|||
163248937|NCT03643952|589619495|FG000|Overall Study|Lack of Efficacy|1|||
163248938|NCT01358968|589619496|FG000|Period 2|Adverse Event|0|||
163248939|NCT01358968|589619497|FG001|Period 2|Adverse Event|1|||
163248940|NCT01358968|589619498|FG002|Period 2|Adverse Event|0|||
163248941|NCT01358968|589619499|FG003|Period 2|Adverse Event|0|||
163248942|NCT01358968|589619496|FG000|Continued Access Phase|Progression of Disease|0|||
163248943|NCT01358968|589619497|FG001|Continued Access Phase|Progression of Disease|0|||
163248944|NCT01358968|589619498|FG002|Continued Access Phase|Progression of Disease|8|||
163354755|NCT01496365|590009605|FG005|Overall Study|Other|0|||
163354756|NCT01496365|590009606|FG006|Overall Study|Other|1|||
163354757|NCT01015677|590009607|FG000|Overall Study|Adverse Event|0|||
163354758|NCT01015677|590009608|FG001|Overall Study|Adverse Event|1|||
163354759|NCT01015677|590009609|FG002|Overall Study|Adverse Event|0|||
163354760|NCT01015677|590009607|FG000|Overall Study|Lack of Efficacy|0|||
163354761|NCT01015677|590009608|FG001|Overall Study|Lack of Efficacy|1|||
163354762|NCT01015677|590009609|FG002|Overall Study|Lack of Efficacy|0|||
163354763|NCT01015677|590009607|FG000|Overall Study|Protocol Violation|0|||
163354764|NCT01015677|590009608|FG001|Overall Study|Protocol Violation|1|||
163354765|NCT01015677|590009609|FG002|Overall Study|Protocol Violation|0|||
163354766|NCT01015677|590009607|FG000|Overall Study|Withdrawal by Subject|1|||
163354767|NCT01015677|590009608|FG001|Overall Study|Withdrawal by Subject|1|||
163354768|NCT01015677|590009609|FG002|Overall Study|Withdrawal by Subject|0|||
163354769|NCT01660256|590009610|FG000|Overall Study|Adverse Event|4|||
163354770|NCT01660256|590009611|FG001|Overall Study|Adverse Event|0|||
163354771|NCT01660256|590009612|FG002|Overall Study|Adverse Event|2|||
163354772|NCT01660256|590009610|FG000|Overall Study|Withdrawal by Subject|1|||
163354773|NCT01660256|590009611|FG001|Overall Study|Withdrawal by Subject|0|||
163354774|NCT01660256|590009612|FG002|Overall Study|Withdrawal by Subject|2|||
163354775|NCT01646385|590009614|FG000|Overall Study|Death|202|||
163354776|NCT01646385|590009615|FG001|Overall Study|Death|222|||
163354777|NCT01646385|590009614|FG000|Overall Study|Switched to alternate biologic|636|||
163354778|NCT01646385|590009615|FG001|Overall Study|Switched to alternate biologic|649|||
163354779|NCT03603639|590009619|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
163354780|NCT03603639|590009620|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
163354781|NCT03603639|590009621|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
163354782|NCT03603639|590009622|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
163354783|NCT03603639|590009623|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
163354784|NCT03603639|590009624|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
163354785|NCT03603639|590009619|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
163354786|NCT03603639|590009620|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
163149862|NCT03037385|589263497|FG000|Overall Study|Withdrawal by Subject|0|||
163149863|NCT03037385|589263498|FG001|Overall Study|Withdrawal by Subject|0|||
163149864|NCT03037385|589263499|FG002|Overall Study|Withdrawal by Subject|1|||
163149865|NCT03037385|589263500|FG003|Overall Study|Withdrawal by Subject|2|||
163149866|NCT03037385|589263501|FG004|Overall Study|Withdrawal by Subject|1|||
163149867|NCT03037385|589263502|FG005|Overall Study|Withdrawal by Subject|3|||
163149868|NCT03037385|589263503|FG006|Overall Study|Withdrawal by Subject|0|||
163149869|NCT03037385|589263504|FG007|Overall Study|Withdrawal by Subject|0|||
163149870|NCT03037385|589263505|FG008|Overall Study|Withdrawal by Subject|0|||
163149871|NCT03037385|589263506|FG009|Overall Study|Withdrawal by Subject|52|||
163149872|NCT03037385|589263497|FG000|Overall Study|Reason Not Specified|0|||
163149873|NCT03037385|589263498|FG001|Overall Study|Reason Not Specified|1|||
163149874|NCT03037385|589263499|FG002|Overall Study|Reason Not Specified|0|||
163149875|NCT03037385|589263500|FG003|Overall Study|Reason Not Specified|4|||
163149876|NCT03037385|589263501|FG004|Overall Study|Reason Not Specified|3|||
163149877|NCT03037385|589263502|FG005|Overall Study|Reason Not Specified|6|||
163149878|NCT03037385|589263503|FG006|Overall Study|Reason Not Specified|2|||
163149879|NCT03037385|589263504|FG007|Overall Study|Reason Not Specified|0|||
163149880|NCT03037385|589263505|FG008|Overall Study|Reason Not Specified|1|||
163149881|NCT03037385|589263506|FG009|Overall Study|Reason Not Specified|181|||
163149882|NCT02318706|589263507|FG000|Double-blind Phase|Adverse Event|7|||
163149883|NCT02318706|589263508|FG001|Double-blind Phase|Adverse Event|4|||
163149884|NCT02318706|589263509|FG002|Double-blind Phase|Adverse Event|3|||
163149885|NCT02318706|589263510|FG003|Double-blind Phase|Adverse Event|10|||
163149886|NCT02318706|589263511|FG004|Double-blind Phase|Adverse Event|0|||
163149887|NCT02318706|589263507|FG000|Double-blind Phase|Lost to Follow-up|1|||
163149888|NCT02318706|589263508|FG001|Double-blind Phase|Lost to Follow-up|0|||
163149889|NCT02318706|589263509|FG002|Double-blind Phase|Lost to Follow-up|0|||
163149890|NCT02318706|589263510|FG003|Double-blind Phase|Lost to Follow-up|0|||
163149891|NCT02318706|589263511|FG004|Double-blind Phase|Lost to Follow-up|0|||
163149892|NCT02318706|589263507|FG000|Double-blind Phase|Protocol Violation|4|||
163149893|NCT02318706|589263508|FG001|Double-blind Phase|Protocol Violation|2|||
163149894|NCT02318706|589263509|FG002|Double-blind Phase|Protocol Violation|4|||
163149895|NCT02318706|589263510|FG003|Double-blind Phase|Protocol Violation|3|||
163149896|NCT02318706|589263511|FG004|Double-blind Phase|Protocol Violation|0|||
163149897|NCT02318706|589263507|FG000|Double-blind Phase|Withdrawal by Subject|9|||
163149898|NCT02318706|589263508|FG001|Double-blind Phase|Withdrawal by Subject|5|||
163149899|NCT02318706|589263509|FG002|Double-blind Phase|Withdrawal by Subject|7|||
163149900|NCT02318706|589263510|FG003|Double-blind Phase|Withdrawal by Subject|10|||
163149901|NCT02318706|589263511|FG004|Double-blind Phase|Withdrawal by Subject|0|||
163354787|NCT03603639|590009621|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
163354788|NCT03603639|590009622|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
163354789|NCT03603639|590009623|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
163354790|NCT03603639|590009624|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
163354791|NCT00858247|590009628|FG000|Baseline Assessment|Withdrawal by Subject|1|||
163354792|NCT00858247|590009629|FG001|Baseline Assessment|Withdrawal by Subject|1|||
163354793|NCT00858247|590009628|FG000|Baseline Assessment|Poor IV access|1|||
163354794|NCT00858247|590009629|FG001|Baseline Assessment|Poor IV access|0|||
163354795|NCT00858247|590009628|FG000|Baseline Assessment|Protocol Violation|0|||
163354796|NCT00858247|590009629|FG001|Baseline Assessment|Protocol Violation|1|||
163354797|NCT00858247|590009628|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
163354798|NCT00858247|590009629|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
163354799|NCT02165397|590009630|FG000|Overall Study|Death|7|||
163354800|NCT02165397|590009631|FG001|Overall Study|Death|10|||
163354801|NCT02165397|590009632|FG002|Overall Study|Death|8|||
163354802|NCT02165397|590009630|FG000|Overall Study|Lost to Follow-up|1|||
163354803|NCT02165397|590009631|FG001|Overall Study|Lost to Follow-up|3|||
163354804|NCT02165397|590009632|FG002|Overall Study|Lost to Follow-up|0|||
163354805|NCT02165397|590009630|FG000|Overall Study|Withdrawal by Subject|6|||
163354806|NCT02165397|590009631|FG001|Overall Study|Withdrawal by Subject|6|||
163354807|NCT02165397|590009632|FG002|Overall Study|Withdrawal by Subject|1|||
163354808|NCT02165397|590009630|FG000|Overall Study|Other, Not Specified|0|||
163354809|NCT02165397|590009631|FG001|Overall Study|Other, Not Specified|0|||
163354810|NCT02165397|590009632|FG002|Overall Study|Other, Not Specified|1|||
163354811|NCT03898960|590009635|FG000|Overall Study|Death|10|||
163354812|NCT01898442|590009638|FG000|Overall Study|Hemolysis/technical problems|1|||
163354813|NCT01898442|590009639|FG001|Overall Study|Hemolysis/technical problems|2|||
163354814|NCT01898442|590009640|FG002|Overall Study|Hemolysis/technical problems|2|||
163354815|NCT01898442|590009638|FG000|Overall Study|Patient vomited pills|0|||
163354816|NCT01898442|590009639|FG001|Overall Study|Patient vomited pills|0|||
163354817|NCT01898442|590009640|FG002|Overall Study|Patient vomited pills|1|||
163354818|NCT02725008|590009642|FG000|Overall Study|Lost to Follow-up|7|||
163354819|NCT02725008|590009643|FG001|Overall Study|Lost to Follow-up|9|||
163354820|NCT02725008|590009642|FG000|Overall Study|Withdrawal by Subject|2|||
163354821|NCT02725008|590009643|FG001|Overall Study|Withdrawal by Subject|2|||
163354822|NCT02725008|590009642|FG000|Overall Study|Admitted to hospital|0|||
163354823|NCT02725008|590009643|FG001|Overall Study|Admitted to hospital|1|||
163354824|NCT01837797|590009648|FG000|Period 1|Adverse Event|9|||
163354825|NCT01837797|590009649|FG001|Period 1|Adverse Event|0|||
163354826|NCT01837797|590009650|FG002|Period 1|Adverse Event|0|||
163354827|NCT01837797|590009651|FG003|Period 1|Adverse Event|0|||
163354828|NCT01837797|590009652|FG004|Period 1|Adverse Event|0|||
163354829|NCT01837797|590009648|FG000|Period 1|Withdrawal by Subject|6|||
163354830|NCT01837797|590009649|FG001|Period 1|Withdrawal by Subject|0|||
163354831|NCT01837797|590009650|FG002|Period 1|Withdrawal by Subject|0|||
163354832|NCT01837797|590009651|FG003|Period 1|Withdrawal by Subject|0|||
163354833|NCT01837797|590009652|FG004|Period 1|Withdrawal by Subject|0|||
163354834|NCT01837797|590009648|FG000|Period 1|Administrative reasons|76|||
163354835|NCT01837797|590009649|FG001|Period 1|Administrative reasons|0|||
163354836|NCT01837797|590009650|FG002|Period 1|Administrative reasons|0|||
163354837|NCT01837797|590009651|FG003|Period 1|Administrative reasons|0|||
163354838|NCT01837797|590009652|FG004|Period 1|Administrative reasons|0|||
163354839|NCT01837797|590009648|FG000|Period 1|Withdrawal of consent before treatment|1|||
163354840|NCT01837797|590009649|FG001|Period 1|Withdrawal of consent before treatment|0|||
163354841|NCT01837797|590009650|FG002|Period 1|Withdrawal of consent before treatment|0|||
163354842|NCT01837797|590009651|FG003|Period 1|Withdrawal of consent before treatment|0|||
163354843|NCT01837797|590009652|FG004|Period 1|Withdrawal of consent before treatment|0|||
163354844|NCT01837797|590009648|FG000|Period 1|Other|10|||
163354845|NCT01837797|590009649|FG001|Period 1|Other|0|||
163354846|NCT01837797|590009650|FG002|Period 1|Other|0|||
163354847|NCT01837797|590009651|FG003|Period 1|Other|0|||
163354848|NCT01837797|590009652|FG004|Period 1|Other|0|||
163354849|NCT01837797|590009648|FG000|Period 2|Administrative or other reasons|0|||
163410328|NCT05103332|590211370|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410329|NCT05103332|590211371|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410330|NCT05103332|590211372|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163354850|NCT01837797|590009649|FG001|Period 2|Administrative or other reasons|5|||
163354851|NCT01837797|590009650|FG002|Period 2|Administrative or other reasons|2|||
163354852|NCT01837797|590009651|FG003|Period 2|Administrative or other reasons|4|||
163354853|NCT01837797|590009652|FG004|Period 2|Administrative or other reasons|0|||
163354854|NCT01837797|590009648|FG000|Period 2|Adverse Event|0|||
163354855|NCT01837797|590009649|FG001|Period 2|Adverse Event|0|||
163354856|NCT01837797|590009650|FG002|Period 2|Adverse Event|0|||
163354857|NCT01837797|590009651|FG003|Period 2|Adverse Event|1|||
163354858|NCT01837797|590009652|FG004|Period 2|Adverse Event|0|||
163354859|NCT01837797|590009648|FG000|Period 3|Adverse Event|0|||
163354860|NCT01837797|590009649|FG001|Period 3|Adverse Event|0|||
163354861|NCT01837797|590009650|FG002|Period 3|Adverse Event|0|||
163354862|NCT01837797|590009651|FG003|Period 3|Adverse Event|0|||
163354863|NCT01837797|590009652|FG004|Period 3|Adverse Event|1|||
163354864|NCT01837797|590009648|FG000|Period 3|Administrative reasons|0|||
163354865|NCT01837797|590009649|FG001|Period 3|Administrative reasons|0|||
163354866|NCT01837797|590009650|FG002|Period 3|Administrative reasons|0|||
163354867|NCT01837797|590009651|FG003|Period 3|Administrative reasons|0|||
163354868|NCT01837797|590009652|FG004|Period 3|Administrative reasons|20|||
163354869|NCT01837797|590009648|FG000|Period 3|Other|0|||
163354870|NCT01837797|590009649|FG001|Period 3|Other|0|||
163354871|NCT01837797|590009650|FG002|Period 3|Other|0|||
163354872|NCT01837797|590009651|FG003|Period 3|Other|0|||
163354873|NCT01837797|590009652|FG004|Period 3|Other|2|||
163354874|NCT03797989|590009673|FG000|VAC069A|Withdrawal by Subject|0|||
163354875|NCT03797989|590009674|FG001|VAC069A|Withdrawal by Subject|0|||
163354876|NCT03797989|590009675|FG002|VAC069A|Withdrawal by Subject|1|||
163354877|NCT03797989|590009676|FG003|VAC069A|Withdrawal by Subject|0|||
163354878|NCT03797989|590009677|FG004|VAC069A|Withdrawal by Subject|0|||
163354879|NCT03797989|590009678|FG005|VAC069A|Withdrawal by Subject|0|||
163354880|NCT03797989|590009679|FG006|VAC069A|Withdrawal by Subject|0|||
163354881|NCT03797989|590009680|FG007|VAC069A|Withdrawal by Subject|0|||
163354882|NCT03797989|590009681|FG008|VAC069A|Withdrawal by Subject|0|||
163354883|NCT03797989|590009682|FG009|VAC069A|Withdrawal by Subject|0|||
163354884|NCT03797989|590009683|FG010|VAC069A|Withdrawal by Subject|0|||
163354885|NCT03797989|590009684|FG011|VAC069A|Withdrawal by Subject|0|||
163354886|NCT04522778|590009686|FG000|Overall Study|Patient did not want to wear the device|1|||
163354887|NCT04522778|590009687|FG001|Overall Study|Patient did not want to wear the device|0|||
163354888|NCT04522778|590009686|FG000|Overall Study|Lost to Follow-up|0|||
163354889|NCT04522778|590009687|FG001|Overall Study|Lost to Follow-up|1|||
163354890|NCT04052997|590009688|FG000|Overall Study|Withdrawal by Subject|17|||
163354891|NCT04052997|590009688|FG000|Overall Study|Physician Decision|50|||
163354892|NCT04052997|590009688|FG000|Overall Study|Death|43|||
163354893|NCT04052997|590009688|FG000|Overall Study|Lost to Follow-up|5|||
163354894|NCT04052997|590009688|FG000|Overall Study|Progression of Disease|1|||
163354895|NCT00069277|590009689|FG000|Overall Study|Adverse Event|3|||
163354896|NCT00069277|590009689|FG000|Overall Study|Withdrawal by Subject|1|||
163354897|NCT00069277|590009689|FG000|Overall Study|Progressive Disease|15|||
163354898|NCT00069277|590009689|FG000|Overall Study|Physician Decision|2|||
163354899|NCT04594733|590009690|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
163354900|NCT04594733|590009691|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
163354901|NCT04594733|590009690|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
163354902|NCT04594733|590009691|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
163354903|NCT04594733|590009690|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
163354904|NCT04594733|590009691|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
163354905|NCT01024036|590009696|FG000|Blinded Treatment|Adverse Event|1|||
163354906|NCT01024036|590009697|FG001|Blinded Treatment|Adverse Event|1|||
163354907|NCT01024036|590009696|FG000|Blinded Treatment|Lack of Efficacy|16|||
163354908|NCT01024036|590009697|FG001|Blinded Treatment|Lack of Efficacy|14|||
163354909|NCT01024036|590009696|FG000|Blinded Treatment|Physician Decision|1|||
163354910|NCT01024036|590009697|FG001|Blinded Treatment|Physician Decision|0|||
163354911|NCT01024036|590009696|FG000|Blinded Treatment|Death|0|||
163354912|NCT01024036|590009697|FG001|Blinded Treatment|Death|2|||
163354913|NCT01024036|590009696|FG000|Blinded Treatment|Withdrawal by Subject|4|||
163354914|NCT01024036|590009697|FG001|Blinded Treatment|Withdrawal by Subject|3|||
163354915|NCT01024036|590009696|FG000|Unblinded Treatment|Adverse Event|0|||
163354916|NCT01024036|590009697|FG001|Unblinded Treatment|Adverse Event|1|||
163354917|NCT01024036|590009696|FG000|Unblinded Treatment|Lack of Efficacy|0|||
163354918|NCT01024036|590009697|FG001|Unblinded Treatment|Lack of Efficacy|2|||
163354919|NCT01024036|590009696|FG000|Follow-Up Period|Lost to Follow-up|1|||
163354920|NCT01024036|590009697|FG001|Follow-Up Period|Lost to Follow-up|1|||
163354921|NCT01024036|590009696|FG000|Follow-Up Period|Withdrawal by Subject|0|||
163354922|NCT01024036|590009697|FG001|Follow-Up Period|Withdrawal by Subject|1|||
163354923|NCT01024036|590009696|FG000|Follow-Up Period|Adverse Event|4|||
163354924|NCT01024036|590009697|FG001|Follow-Up Period|Adverse Event|1|||
163354925|NCT00361842|590009698|FG000|Overall Study|Withdrawal by Subject|2|||
163354926|NCT00361842|590009699|FG001|Overall Study|Withdrawal by Subject|3|||
163354927|NCT00361842|590009698|FG000|Overall Study|Death|2|||
163410331|NCT05103332|590211373|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410332|NCT05103332|590211374|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410333|NCT05103332|590211375|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410334|NCT05103332|590211376|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410335|NCT05103332|590211359|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
163354928|NCT00361842|590009699|FG001|Overall Study|Death|1|||
163354929|NCT00361842|590009698|FG000|Overall Study|Disease progression|19|||
163354930|NCT00361842|590009699|FG001|Overall Study|Disease progression|20|||
163354931|NCT00361842|590009698|FG000|Overall Study|Adverse Event|2|||
163354932|NCT00361842|590009699|FG001|Overall Study|Adverse Event|3|||
163354933|NCT00361842|590009698|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
163354934|NCT00361842|590009699|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
163354935|NCT00361842|590009698|FG000|Overall Study|Other|1|||
163354936|NCT00361842|590009699|FG001|Overall Study|Other|0|||
163354937|NCT00361842|590009698|FG000|Overall Study|Other|0|||
163354938|NCT00361842|590009699|FG001|Overall Study|Other|2|||
163354939|NCT03512288|590009704|FG000|Overall Study|Adverse Event|1|||
163354940|NCT03512288|590009705|FG001|Overall Study|Adverse Event|0|||
163354941|NCT03512288|590009704|FG000|Overall Study|Lost to Follow-up|12|||
163354942|NCT03512288|590009705|FG001|Overall Study|Lost to Follow-up|15|||
163354943|NCT03512288|590009704|FG000|Overall Study|Physician Decision|0|||
163354944|NCT03512288|590009705|FG001|Overall Study|Physician Decision|2|||
163248945|NCT01358968|589619499|FG003|Continued Access Phase|Progression of Disease|4|||
163248946|NCT01358968|589619496|FG000|Continued Access Phase|Protocol Violation|0|||
163248947|NCT01358968|589619497|FG001|Continued Access Phase|Protocol Violation|0|||
163248948|NCT01358968|589619498|FG002|Continued Access Phase|Protocol Violation|0|||
163248949|NCT01358968|589619499|FG003|Continued Access Phase|Protocol Violation|2|||
163248950|NCT01358968|589619496|FG000|Continued Access Phase|Withdrawal by Subject|0|||
163248951|NCT01358968|589619497|FG001|Continued Access Phase|Withdrawal by Subject|0|||
163248952|NCT01358968|589619498|FG002|Continued Access Phase|Withdrawal by Subject|3|||
163248953|NCT01358968|589619499|FG003|Continued Access Phase|Withdrawal by Subject|0|||
163248954|NCT01358968|589619496|FG000|Continued Access Phase|Death|0|||
163248955|NCT01358968|589619497|FG001|Continued Access Phase|Death|0|||
163248956|NCT01358968|589619498|FG002|Continued Access Phase|Death|1|||
163248957|NCT01358968|589619499|FG003|Continued Access Phase|Death|1|||
163248958|NCT01597050|589619500|FG000|Overall Study|Withdrawal by Subject|1|||
163248959|NCT01597050|589619501|FG001|Overall Study|Withdrawal by Subject|0|||
163248960|NCT00483184|589619502|FG000|Overall Study|Withdrawal by Subject|2|||
163248961|NCT00483184|589619503|FG001|Overall Study|Withdrawal by Subject|2|||
163248962|NCT00483184|589619504|FG002|Overall Study|Withdrawal by Subject|0|||
163248963|NCT00483184|589619502|FG000|Overall Study|Lost to Follow-up|1|||
163248964|NCT00483184|589619503|FG001|Overall Study|Lost to Follow-up|0|||
163248965|NCT00483184|589619504|FG002|Overall Study|Lost to Follow-up|0|||
163248966|NCT00483184|589619502|FG000|Overall Study|Adverse Event|1|||
163248967|NCT00483184|589619503|FG001|Overall Study|Adverse Event|2|||
163248968|NCT00483184|589619504|FG002|Overall Study|Adverse Event|2|||
163248969|NCT00483184|589619502|FG000|Overall Study|Protocol Violation|1|||
163248970|NCT00483184|589619503|FG001|Overall Study|Protocol Violation|0|||
163248971|NCT00483184|589619504|FG002|Overall Study|Protocol Violation|1|||
163248972|NCT00515502|589619512|FG000|Treatment Period 1|Adverse Event|0|||
163248973|NCT00515502|589619513|FG001|Treatment Period 1|Adverse Event|0|||
163248974|NCT00515502|589619514|FG002|Treatment Period 1|Adverse Event|0|||
163248975|NCT00515502|589619515|FG003|Treatment Period 1|Adverse Event|0|||
163248976|NCT00515502|589619516|FG004|Treatment Period 1|Adverse Event|0|||
163248977|NCT00515502|589619517|FG005|Treatment Period 1|Adverse Event|0|||
163248978|NCT00515502|589619518|FG006|Treatment Period 1|Adverse Event|1|||
163248979|NCT00515502|589619519|FG007|Treatment Period 1|Adverse Event|0|||
163248980|NCT00515502|589619520|FG008|Treatment Period 1|Adverse Event|1|||
163248981|NCT00515502|589619521|FG009|Treatment Period 1|Adverse Event|0|||
163248982|NCT00515502|589619522|FG010|Treatment Period 1|Adverse Event|0|||
163248983|NCT00515502|589619523|FG011|Treatment Period 1|Adverse Event|1|||
163248984|NCT00515502|589619512|FG000|Treatment Period 2|Adverse Event|0|||
163248985|NCT00515502|589619513|FG001|Treatment Period 2|Adverse Event|1|||
163248986|NCT00515502|589619514|FG002|Treatment Period 2|Adverse Event|0|||
163248987|NCT00515502|589619515|FG003|Treatment Period 2|Adverse Event|0|||
163248988|NCT00515502|589619516|FG004|Treatment Period 2|Adverse Event|0|||
163248989|NCT00515502|589619517|FG005|Treatment Period 2|Adverse Event|0|||
163248990|NCT00515502|589619518|FG006|Treatment Period 2|Adverse Event|0|||
163248991|NCT00515502|589619519|FG007|Treatment Period 2|Adverse Event|0|||
163248992|NCT00515502|589619520|FG008|Treatment Period 2|Adverse Event|0|||
163248993|NCT00515502|589619521|FG009|Treatment Period 2|Adverse Event|0|||
163248994|NCT00515502|589619522|FG010|Treatment Period 2|Adverse Event|0|||
163248995|NCT00515502|589619523|FG011|Treatment Period 2|Adverse Event|0|||
163248996|NCT03252587|589619526|FG000|Overall Study|Adverse Event|3|||
163248997|NCT03252587|589619527|FG001|Overall Study|Adverse Event|8|||
163248998|NCT03252587|589619528|FG002|Overall Study|Adverse Event|6|||
163248999|NCT03252587|589619529|FG003|Overall Study|Adverse Event|12|||
163249000|NCT03252587|589619526|FG000|Overall Study|Lack of Efficacy|7|||
163249001|NCT03252587|589619527|FG001|Overall Study|Lack of Efficacy|2|||
163249002|NCT03252587|589619528|FG002|Overall Study|Lack of Efficacy|2|||
163249003|NCT03252587|589619529|FG003|Overall Study|Lack of Efficacy|4|||
163249004|NCT03252587|589619526|FG000|Overall Study|Lost to Follow-up|2|||
163249005|NCT03252587|589619527|FG001|Overall Study|Lost to Follow-up|0|||
163249006|NCT03252587|589619528|FG002|Overall Study|Lost to Follow-up|0|||
163249007|NCT03252587|589619529|FG003|Overall Study|Lost to Follow-up|2|||
163249008|NCT03252587|589619526|FG000|Overall Study|Pregnancy|2|||
163249009|NCT03252587|589619527|FG001|Overall Study|Pregnancy|1|||
163249010|NCT03252587|589619528|FG002|Overall Study|Pregnancy|0|||
163249011|NCT03252587|589619529|FG003|Overall Study|Pregnancy|1|||
163249012|NCT03252587|589619526|FG000|Overall Study|Withdrawal by Subject|8|||
163249013|NCT03252587|589619527|FG001|Overall Study|Withdrawal by Subject|4|||
163249014|NCT03252587|589619528|FG002|Overall Study|Withdrawal by Subject|4|||
163249015|NCT03252587|589619529|FG003|Overall Study|Withdrawal by Subject|4|||
163249016|NCT03252587|589619526|FG000|Overall Study|Other Reasons|2|||
163354945|NCT03512288|590009704|FG000|Overall Study|Protocol Violation|6|||
163354946|NCT03512288|590009705|FG001|Overall Study|Protocol Violation|4|||
163354947|NCT03512288|590009704|FG000|Overall Study|Medication error without associated adverse event|1|||
163354948|NCT03512288|590009705|FG001|Overall Study|Medication error without associated adverse event|0|||
163354949|NCT03512288|590009704|FG000|Overall Study|No longer met eligibility criteria|5|||
163354950|NCT03512288|590009705|FG001|Overall Study|No longer met eligibility criteria|2|||
163354951|NCT03512288|590009704|FG000|Overall Study|Withdrawal by parent/guardian|14|||
163354952|NCT03512288|590009705|FG001|Overall Study|Withdrawal by parent/guardian|18|||
163354953|NCT03512288|590009704|FG000|Overall Study|Other|1|||
163354954|NCT03512288|590009705|FG001|Overall Study|Other|1|||
163354955|NCT03512288|590009704|FG000|Overall Study|Randomized but not treated|1|||
163354956|NCT03512288|590009705|FG001|Overall Study|Randomized but not treated|1|||
163354957|NCT00934700|590009708|FG000|Overall Study|missing scan|5|||
163354958|NCT00934700|590009709|FG001|Overall Study|missing scan|9|||
163354959|NCT00934700|590009708|FG000|Overall Study|Death|8|||
163354960|NCT00934700|590009709|FG001|Overall Study|Death|3|||
163354961|NCT01831726|590009710|FG000|Overall Study|Adverse Event|16|||
163354962|NCT01831726|590009710|FG000|Overall Study|Death|7|||
163354963|NCT01831726|590009710|FG000|Overall Study|Disease Progression|49|||
163354964|NCT01831726|590009710|FG000|Overall Study|Physician Decision|1|||
163354965|NCT01831726|590009710|FG000|Overall Study|Subject/guardian decision|7|||
163354966|NCT03821064|590009711|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
163354967|NCT00474383|590009712|FG000|Main Study|Adverse Event|11|||
163354968|NCT00474383|590009713|FG001|Main Study|Adverse Event|0|||
163354969|NCT00474383|590009712|FG000|Main Study|Symptomatic Deterioration|1|||
163354970|NCT00474383|590009713|FG001|Main Study|Symptomatic Deterioration|0|||
163354971|NCT00474383|590009712|FG000|Main Study|Progressive Disease|23|||
163354972|NCT00474383|590009713|FG001|Main Study|Progressive Disease|0|||
163354973|NCT00474383|590009712|FG000|Main Study|Other|1|||
163354974|NCT00474383|590009713|FG001|Main Study|Other|0|||
163354975|NCT00474383|590009712|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
163354976|NCT00474383|590009713|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
163354977|NCT00474383|590009712|FG000|Extension|Progressive Disease|0|||
163354978|NCT00474383|590009713|FG001|Extension|Progressive Disease|5|||
163354979|NCT01482819|590009717|FG000|Overall Study|Lost to Follow-up|2|||
163354980|NCT00942188|590009720|FG000|Overall Study|Adverse Event|0|||
163354981|NCT00942188|590009721|FG001|Overall Study|Adverse Event|3|||
163354982|NCT00942188|590009722|FG002|Overall Study|Adverse Event|2|||
163354983|NCT00942188|590009723|FG003|Overall Study|Adverse Event|0|||
163354984|NCT00942188|590009720|FG000|Overall Study|Lack of Efficacy|0|||
163354985|NCT00942188|590009721|FG001|Overall Study|Lack of Efficacy|0|||
163354986|NCT00942188|590009722|FG002|Overall Study|Lack of Efficacy|0|||
163354987|NCT00942188|590009723|FG003|Overall Study|Lack of Efficacy|1|||
163354988|NCT00942188|590009720|FG000|Overall Study|Protocol Violation|1|||
163354989|NCT00942188|590009721|FG001|Overall Study|Protocol Violation|1|||
163354990|NCT00942188|590009722|FG002|Overall Study|Protocol Violation|0|||
163354991|NCT00942188|590009723|FG003|Overall Study|Protocol Violation|0|||
163354992|NCT00942188|590009720|FG000|Overall Study|Lost to Follow-up|2|||
163354993|NCT00942188|590009721|FG001|Overall Study|Lost to Follow-up|1|||
163354994|NCT00942188|590009722|FG002|Overall Study|Lost to Follow-up|2|||
163354995|NCT00942188|590009723|FG003|Overall Study|Lost to Follow-up|0|||
163354996|NCT00942188|590009720|FG000|Overall Study|Withdrawal by Subject|1|||
163354997|NCT00942188|590009721|FG001|Overall Study|Withdrawal by Subject|3|||
163354998|NCT00942188|590009722|FG002|Overall Study|Withdrawal by Subject|4|||
163354999|NCT00942188|590009723|FG003|Overall Study|Withdrawal by Subject|2|||
163355000|NCT00942188|590009720|FG000|Overall Study|Physician Decision|0|||
163355001|NCT00942188|590009721|FG001|Overall Study|Physician Decision|0|||
163355002|NCT00942188|590009722|FG002|Overall Study|Physician Decision|1|||
163355003|NCT00942188|590009723|FG003|Overall Study|Physician Decision|0|||
163355004|NCT00942188|590009720|FG000|Overall Study|Sponsor Decision|0|||
163355005|NCT00942188|590009721|FG001|Overall Study|Sponsor Decision|2|||
163355006|NCT00942188|590009722|FG002|Overall Study|Sponsor Decision|0|||
163355007|NCT00942188|590009723|FG003|Overall Study|Sponsor Decision|1|||
163355008|NCT04811339|590009725|FG000|Overall Study|lack of transportation not wanting to return|4|||
163355009|NCT04811339|590009726|FG001|Overall Study|lack of transportation not wanting to return|8|||
163355010|NCT04811339|590009727|FG002|Overall Study|lack of transportation not wanting to return|0|||
163355011|NCT04811339|590009725|FG000|Overall Study|Adverse Event|3|||
163355012|NCT04811339|590009726|FG001|Overall Study|Adverse Event|0|||
163355013|NCT04811339|590009727|FG002|Overall Study|Adverse Event|0|||
163355014|NCT04811339|590009725|FG000|Overall Study|Lost to Follow-up|1|||
163355015|NCT04811339|590009726|FG001|Overall Study|Lost to Follow-up|0|||
163355016|NCT04811339|590009727|FG002|Overall Study|Lost to Follow-up|0|||
163355017|NCT04811339|590009725|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
163355018|NCT04811339|590009726|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
163355019|NCT04811339|590009727|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
163355020|NCT04811339|590009725|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
163355021|NCT04811339|590009726|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
163355022|NCT04811339|590009727|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
163249017|NCT03252587|589619527|FG001|Overall Study|Other Reasons|5|||
163249018|NCT03252587|589619528|FG002|Overall Study|Other Reasons|5|||
163249019|NCT03252587|589619529|FG003|Overall Study|Other Reasons|4|||
163249020|NCT04052204|589619530|FG000|Overall Study|Death|1|||
163249021|NCT04052204|589619531|FG001|Overall Study|Death|0|||
163249022|NCT04052204|589619532|FG002|Overall Study|Death|0|||
163249023|NCT04052204|589619530|FG000|Overall Study|Progressive disease|1|||
163249024|NCT04052204|589619531|FG001|Overall Study|Progressive disease|0|||
163249025|NCT04052204|589619532|FG002|Overall Study|Progressive disease|0|||
163249026|NCT04052204|589619530|FG000|Overall Study|Other|1|||
163249027|NCT04052204|589619531|FG001|Overall Study|Other|0|||
163249028|NCT04052204|589619532|FG002|Overall Study|Other|0|||
163249029|NCT01613248|589619533|FG000|Overall Study|Adverse Event|0|||
163249030|NCT01613248|589619534|FG001|Overall Study|Adverse Event|0|||
163249031|NCT01613248|589619535|FG002|Overall Study|Adverse Event|0|||
163249032|NCT01613248|589619536|FG003|Overall Study|Adverse Event|1|||
163249033|NCT01613248|589619537|FG004|Overall Study|Adverse Event|0|||
163249034|NCT01613248|589619538|FG005|Overall Study|Adverse Event|0|||
163249035|NCT01613248|589619533|FG000|Overall Study|Withdrawal by Subject|3|||
163249036|NCT01613248|589619534|FG001|Overall Study|Withdrawal by Subject|2|||
163249037|NCT01613248|589619535|FG002|Overall Study|Withdrawal by Subject|2|||
163249038|NCT01613248|589619536|FG003|Overall Study|Withdrawal by Subject|5|||
163249039|NCT01613248|589619537|FG004|Overall Study|Withdrawal by Subject|0|||
163249040|NCT01613248|589619538|FG005|Overall Study|Withdrawal by Subject|1|||
163249041|NCT01613248|589619533|FG000|Overall Study|Lost to Follow-up|5|||
163249042|NCT01613248|589619534|FG001|Overall Study|Lost to Follow-up|7|||
163249043|NCT01613248|589619535|FG002|Overall Study|Lost to Follow-up|4|||
163249044|NCT01613248|589619536|FG003|Overall Study|Lost to Follow-up|8|||
163249045|NCT01613248|589619537|FG004|Overall Study|Lost to Follow-up|4|||
163249046|NCT01613248|589619538|FG005|Overall Study|Lost to Follow-up|2|||
163249047|NCT01613248|589619533|FG000|Overall Study|Study Terminated by Sponsor|4|||
163249048|NCT01613248|589619534|FG001|Overall Study|Study Terminated by Sponsor|6|||
163249049|NCT01613248|589619535|FG002|Overall Study|Study Terminated by Sponsor|8|||
163249050|NCT01613248|589619536|FG003|Overall Study|Study Terminated by Sponsor|8|||
163249051|NCT01613248|589619537|FG004|Overall Study|Study Terminated by Sponsor|9|||
163249052|NCT01613248|589619538|FG005|Overall Study|Study Terminated by Sponsor|11|||
163249053|NCT01613248|589619533|FG000|Overall Study|Physician Decision|8|||
163249054|NCT01613248|589619534|FG001|Overall Study|Physician Decision|8|||
163249055|NCT01613248|589619535|FG002|Overall Study|Physician Decision|9|||
163249056|NCT01613248|589619536|FG003|Overall Study|Physician Decision|4|||
163249057|NCT01613248|589619537|FG004|Overall Study|Physician Decision|7|||
163249058|NCT01613248|589619538|FG005|Overall Study|Physician Decision|6|||
163249059|NCT01613248|589619533|FG000|Overall Study|Lack of Qualifying Event|9|||
163249060|NCT01613248|589619534|FG001|Overall Study|Lack of Qualifying Event|11|||
163249061|NCT01613248|589619535|FG002|Overall Study|Lack of Qualifying Event|10|||
163249062|NCT01613248|589619536|FG003|Overall Study|Lack of Qualifying Event|11|||
163249063|NCT01613248|589619537|FG004|Overall Study|Lack of Qualifying Event|15|||
163249064|NCT01613248|589619538|FG005|Overall Study|Lack of Qualifying Event|18|||
163249065|NCT01613248|589619533|FG000|Overall Study|Pregnancy|0|||
163249066|NCT01613248|589619534|FG001|Overall Study|Pregnancy|0|||
163249067|NCT01613248|589619535|FG002|Overall Study|Pregnancy|0|||
163249068|NCT01613248|589619536|FG003|Overall Study|Pregnancy|1|||
163249069|NCT01613248|589619537|FG004|Overall Study|Pregnancy|0|||
163249070|NCT01613248|589619538|FG005|Overall Study|Pregnancy|0|||
163249071|NCT01433354|589619539|FG000|Overall Study|Adverse Event|6|||
163249072|NCT01433354|589619539|FG000|Overall Study|Lost to Follow-up|1|||
163249073|NCT01433354|589619539|FG000|Overall Study|Administrative problems|90|||
163249074|NCT01433354|589619539|FG000|Overall Study|Protocol Violation|2|||
163249075|NCT01433354|589619539|FG000|Overall Study|Lack of Efficacy|17|||
163249076|NCT01433354|589619539|FG000|Overall Study|Subject Withdrew Consent|3|||
163249077|NCT04124926|589619552|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
163249078|NCT04124926|589619553|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
163355023|NCT04811339|590009725|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
163249079|NCT04124926|589619554|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
163249080|NCT04124926|589619555|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
163249081|NCT04124926|589619556|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
163249082|NCT04124926|589619552|FG000|Healing Phase|Protocol Violation|0|||
163249083|NCT04124926|589619553|FG001|Healing Phase|Protocol Violation|1|||
163249084|NCT04124926|589619554|FG002|Healing Phase|Protocol Violation|0|||
163249085|NCT04124926|589619555|FG003|Healing Phase|Protocol Violation|0|||
163249086|NCT04124926|589619556|FG004|Healing Phase|Protocol Violation|0|||
163249087|NCT04124926|589619552|FG000|Healing Phase|Lost to Follow-up|5|||
163249088|NCT04124926|589619553|FG001|Healing Phase|Lost to Follow-up|4|||
163249089|NCT04124926|589619554|FG002|Healing Phase|Lost to Follow-up|0|||
163249090|NCT04124926|589619555|FG003|Healing Phase|Lost to Follow-up|0|||
163249091|NCT04124926|589619556|FG004|Healing Phase|Lost to Follow-up|0|||
163249092|NCT04124926|589619552|FG000|Healing Phase|Voluntary Withdrawal|10|||
163355024|NCT04811339|590009726|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
163355025|NCT04811339|590009727|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
163355026|NCT04811339|590009725|FG000|Overall Study|Withdrawal by Subject|0|||
163355027|NCT04811339|590009726|FG001|Overall Study|Withdrawal by Subject|3|||
163355028|NCT04811339|590009727|FG002|Overall Study|Withdrawal by Subject|0|||
163355029|NCT04811339|590009725|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
163355030|NCT04811339|590009726|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
163355031|NCT04811339|590009727|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
163355032|NCT04811339|590009725|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
163355033|NCT04811339|590009726|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
163355034|NCT04811339|590009727|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
163355035|NCT00143598|590009728|FG000|Overall Study|Lost to Follow-up|23|||
163355036|NCT00143598|590009729|FG001|Overall Study|Lost to Follow-up|21|||
163355037|NCT00143598|590009728|FG000|Overall Study|Withdrawal by Subject|33|||
163355038|NCT00143598|590009729|FG001|Overall Study|Withdrawal by Subject|37|||
163355039|NCT00143598|590009728|FG000|Overall Study|Death|36|||
163249093|NCT04124926|589619553|FG001|Healing Phase|Voluntary Withdrawal|7|||
163249094|NCT04124926|589619554|FG002|Healing Phase|Voluntary Withdrawal|0|||
163249095|NCT04124926|589619555|FG003|Healing Phase|Voluntary Withdrawal|0|||
163249096|NCT04124926|589619556|FG004|Healing Phase|Voluntary Withdrawal|0|||
163249097|NCT04124926|589619552|FG000|Healing Phase|Withdrawal of Consent|5|||
163249098|NCT04124926|589619553|FG001|Healing Phase|Withdrawal of Consent|3|||
163249099|NCT04124926|589619554|FG002|Healing Phase|Withdrawal of Consent|0|||
163249100|NCT04124926|589619555|FG003|Healing Phase|Withdrawal of Consent|0|||
163249101|NCT04124926|589619556|FG004|Healing Phase|Withdrawal of Consent|0|||
163249102|NCT04124926|589619552|FG000|Healing Phase|Miscellaneous|8|||
163249103|NCT04124926|589619553|FG001|Healing Phase|Miscellaneous|7|||
163249104|NCT04124926|589619554|FG002|Healing Phase|Miscellaneous|0|||
163249105|NCT04124926|589619555|FG003|Healing Phase|Miscellaneous|0|||
163249106|NCT04124926|589619556|FG004|Healing Phase|Miscellaneous|0|||
163249107|NCT04124926|589619552|FG000|Healing Phase|Randomized but not Treated|0|||
163249108|NCT04124926|589619553|FG001|Healing Phase|Randomized but not Treated|3|||
163249109|NCT04124926|589619554|FG002|Healing Phase|Randomized but not Treated|0|||
163249110|NCT04124926|589619555|FG003|Healing Phase|Randomized but not Treated|0|||
163249111|NCT04124926|589619556|FG004|Healing Phase|Randomized but not Treated|0|||
163249112|NCT04124926|589619552|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
163249113|NCT04124926|589619553|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
163249114|NCT04124926|589619554|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
163249115|NCT04124926|589619555|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
163249116|NCT04124926|589619556|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
163249117|NCT04124926|589619552|FG000|Maintenance Phase|Protocol Violation|0|||
163249118|NCT04124926|589619553|FG001|Maintenance Phase|Protocol Violation|0|||
163249119|NCT04124926|589619554|FG002|Maintenance Phase|Protocol Violation|3|||
163249120|NCT04124926|589619555|FG003|Maintenance Phase|Protocol Violation|0|||
163249121|NCT04124926|589619556|FG004|Maintenance Phase|Protocol Violation|0|||
163249122|NCT04124926|589619552|FG000|Maintenance Phase|Lost to Follow-up|0|||
163249123|NCT04124926|589619553|FG001|Maintenance Phase|Lost to Follow-up|0|||
163249124|NCT04124926|589619554|FG002|Maintenance Phase|Lost to Follow-up|7|||
163249125|NCT04124926|589619555|FG003|Maintenance Phase|Lost to Follow-up|8|||
163249126|NCT04124926|589619556|FG004|Maintenance Phase|Lost to Follow-up|9|||
163249127|NCT04124926|589619552|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
163249128|NCT04124926|589619553|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
163249129|NCT04124926|589619554|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
163249130|NCT04124926|589619555|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
163249131|NCT04124926|589619556|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
163249132|NCT04124926|589619552|FG000|Maintenance Phase|Pregnancy|0|||
163249133|NCT04124926|589619553|FG001|Maintenance Phase|Pregnancy|0|||
163249134|NCT04124926|589619554|FG002|Maintenance Phase|Pregnancy|0|||
163355040|NCT00143598|590009729|FG001|Overall Study|Death|36|||
163355041|NCT04944784|590009730|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
163355042|NCT04944784|590009731|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
163410336|NCT05103332|590211360|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
163249135|NCT04124926|589619555|FG003|Maintenance Phase|Pregnancy|1|||
163355043|NCT04944784|590009732|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
163355044|NCT04944784|590009733|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
163355045|NCT04944784|590009730|FG000|Double-blind Period|Adverse Event|20|||
163249136|NCT04124926|589619556|FG004|Maintenance Phase|Pregnancy|0|||
163249137|NCT04124926|589619552|FG000|Maintenance Phase|Lack of Efficacy|0|||
163249138|NCT04124926|589619553|FG001|Maintenance Phase|Lack of Efficacy|0|||
163249139|NCT04124926|589619554|FG002|Maintenance Phase|Lack of Efficacy|0|||
163249140|NCT04124926|589619555|FG003|Maintenance Phase|Lack of Efficacy|0|||
163249141|NCT04124926|589619556|FG004|Maintenance Phase|Lack of Efficacy|1|||
163355046|NCT04944784|590009731|FG001|Double-blind Period|Adverse Event|4|||
163355047|NCT04944784|590009732|FG002|Double-blind Period|Adverse Event|0|||
163355048|NCT04944784|590009733|FG003|Double-blind Period|Adverse Event|0|||
163355049|NCT04944784|590009730|FG000|Double-blind Period|Withdrawal by Subject|15|||
163355050|NCT04944784|590009731|FG001|Double-blind Period|Withdrawal by Subject|4|||
163355051|NCT04944784|590009732|FG002|Double-blind Period|Withdrawal by Subject|0|||
163355052|NCT04944784|590009733|FG003|Double-blind Period|Withdrawal by Subject|0|||
163355053|NCT04944784|590009730|FG000|Double-blind Period|Death|7|||
163355054|NCT04944784|590009731|FG001|Double-blind Period|Death|2|||
163355055|NCT04944784|590009732|FG002|Double-blind Period|Death|0|||
163355056|NCT04944784|590009733|FG003|Double-blind Period|Death|0|||
163355057|NCT04944784|590009730|FG000|Double-blind Period|Physician Decision|2|||
163355058|NCT04944784|590009731|FG001|Double-blind Period|Physician Decision|1|||
163355059|NCT04944784|590009732|FG002|Double-blind Period|Physician Decision|0|||
163355060|NCT04944784|590009733|FG003|Double-blind Period|Physician Decision|0|||
163355061|NCT04944784|590009730|FG000|Double-blind Period|Lack of Efficacy|0|||
163355062|NCT04944784|590009731|FG001|Double-blind Period|Lack of Efficacy|1|||
163355063|NCT04944784|590009732|FG002|Double-blind Period|Lack of Efficacy|0|||
163355064|NCT04944784|590009733|FG003|Double-blind Period|Lack of Efficacy|0|||
163355065|NCT04944784|590009730|FG000|Double-blind Period|Sponsor Request|2|||
163355066|NCT04944784|590009731|FG001|Double-blind Period|Sponsor Request|1|||
163355067|NCT04944784|590009732|FG002|Double-blind Period|Sponsor Request|0|||
163355068|NCT04944784|590009733|FG003|Double-blind Period|Sponsor Request|0|||
163355069|NCT04944784|590009730|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
163355070|NCT04944784|590009731|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
163355071|NCT04944784|590009732|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
163355072|NCT04944784|590009733|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
163355073|NCT04944784|590009730|FG000|Double-blind Period|Participant Choice|1|||
163355074|NCT04944784|590009731|FG001|Double-blind Period|Participant Choice|1|||
163355075|NCT04944784|590009732|FG002|Double-blind Period|Participant Choice|0|||
163355076|NCT04944784|590009733|FG003|Double-blind Period|Participant Choice|0|||
163355077|NCT04944784|590009730|FG000|Double-blind Period|Progressive Disease|2|||
163355078|NCT04944784|590009731|FG001|Double-blind Period|Progressive Disease|2|||
163355079|NCT04944784|590009732|FG002|Double-blind Period|Progressive Disease|0|||
163355080|NCT04944784|590009733|FG003|Double-blind Period|Progressive Disease|0|||
163355081|NCT04944784|590009730|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
163355082|NCT04944784|590009731|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
163355083|NCT04944784|590009732|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
163355084|NCT04944784|590009733|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
163355085|NCT04944784|590009730|FG000|Active Drug Period|Adverse Event|0|||
163355086|NCT04944784|590009731|FG001|Active Drug Period|Adverse Event|0|||
163355087|NCT04944784|590009732|FG002|Active Drug Period|Adverse Event|3|||
163355088|NCT04944784|590009733|FG003|Active Drug Period|Adverse Event|6|||
163355089|NCT04944784|590009730|FG000|Active Drug Period|Withdrawal by Subject|0|||
163355090|NCT04944784|590009731|FG001|Active Drug Period|Withdrawal by Subject|0|||
163355091|NCT04944784|590009732|FG002|Active Drug Period|Withdrawal by Subject|4|||
163355092|NCT04944784|590009733|FG003|Active Drug Period|Withdrawal by Subject|7|||
163355093|NCT04944784|590009730|FG000|Active Drug Period|Death|0|||
163355094|NCT04944784|590009731|FG001|Active Drug Period|Death|0|||
163355095|NCT04944784|590009732|FG002|Active Drug Period|Death|3|||
163355096|NCT04944784|590009733|FG003|Active Drug Period|Death|4|||
163355097|NCT04944784|590009730|FG000|Active Drug Period|Lack of Efficacy|0|||
163355098|NCT04944784|590009731|FG001|Active Drug Period|Lack of Efficacy|0|||
163355099|NCT04944784|590009732|FG002|Active Drug Period|Lack of Efficacy|2|||
163355100|NCT04944784|590009733|FG003|Active Drug Period|Lack of Efficacy|2|||
163355101|NCT04944784|590009730|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
163355102|NCT04944784|590009731|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
163355103|NCT04944784|590009732|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
163355104|NCT04944784|590009733|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
163355105|NCT04944784|590009730|FG000|Active Drug Period|Participant Choice|0|||
163355106|NCT04944784|590009731|FG001|Active Drug Period|Participant Choice|0|||
163355107|NCT04944784|590009732|FG002|Active Drug Period|Participant Choice|0|||
163355108|NCT04944784|590009733|FG003|Active Drug Period|Participant Choice|1|||
163355109|NCT04944784|590009730|FG000|Active Drug Period|Progressive Disease|0|||
163355110|NCT04944784|590009731|FG001|Active Drug Period|Progressive Disease|0|||
163355111|NCT04944784|590009732|FG002|Active Drug Period|Progressive Disease|4|||
163355112|NCT04944784|590009733|FG003|Active Drug Period|Progressive Disease|4|||
163355113|NCT04944784|590009730|FG000|Active Drug Period|Lost to Follow-up|0|||
163355114|NCT04944784|590009731|FG001|Active Drug Period|Lost to Follow-up|0|||
163355115|NCT04944784|590009732|FG002|Active Drug Period|Lost to Follow-up|0|||
163355116|NCT04944784|590009733|FG003|Active Drug Period|Lost to Follow-up|1|||
163355117|NCT03900715|590009734|FG000|Overall Study|Protocol Deviation|1|||
163355118|NCT03900715|590009734|FG000|Overall Study|Lack of Efficacy|1|||
163355119|NCT03900715|590009734|FG000|Overall Study|Progressive Disease|6|||
163355120|NCT03900715|590009734|FG000|Overall Study|Adverse Event|2|||
163355121|NCT03900715|590009734|FG000|Overall Study|Other reasons|11|||
163355122|NCT02034162|590011345|FG000|Double-blind|Lost to Follow-up|3|||
163355123|NCT02034162|590011346|FG001|Double-blind|Lost to Follow-up|0|||
163355124|NCT02034162|590011347|FG002|Double-blind|Lost to Follow-up|0|||
163355125|NCT02034162|590011345|FG000|Double-blind|Physician Decision|1|||
163355126|NCT02034162|590011346|FG001|Double-blind|Physician Decision|0|||
163249142|NCT04124926|589619552|FG000|Maintenance Phase|Withdrawal of Consent|0|||
163249143|NCT04124926|589619553|FG001|Maintenance Phase|Withdrawal of Consent|0|||
163249144|NCT04124926|589619554|FG002|Maintenance Phase|Withdrawal of Consent|5|||
163249145|NCT04124926|589619555|FG003|Maintenance Phase|Withdrawal of Consent|5|||
163249146|NCT04124926|589619556|FG004|Maintenance Phase|Withdrawal of Consent|5|||
163249147|NCT04124926|589619552|FG000|Maintenance Phase|Miscellaneous|0|||
163249148|NCT04124926|589619553|FG001|Maintenance Phase|Miscellaneous|0|||
163249149|NCT04124926|589619554|FG002|Maintenance Phase|Miscellaneous|1|||
163249150|NCT04124926|589619555|FG003|Maintenance Phase|Miscellaneous|2|||
163249151|NCT04124926|589619556|FG004|Maintenance Phase|Miscellaneous|4|||
163249152|NCT04124926|589619552|FG000|Maintenance Phase|Randomized but not Treated|0|||
163249153|NCT04124926|589619553|FG001|Maintenance Phase|Randomized but not Treated|0|||
163249154|NCT04124926|589619554|FG002|Maintenance Phase|Randomized but not Treated|2|||
163249155|NCT04124926|589619555|FG003|Maintenance Phase|Randomized but not Treated|2|||
163249156|NCT04124926|589619556|FG004|Maintenance Phase|Randomized but not Treated|0|||
163249157|NCT03321396|589619561|FG000|Overall Study|Physician Decision|1|||
163249158|NCT00937924|589619565|FG000|Overall Study|Lost to Follow-up|44|||
163249159|NCT00937924|589619566|FG001|Overall Study|Lost to Follow-up|44|||
163249160|NCT00937924|589619567|FG002|Overall Study|Lost to Follow-up|41|||
163249161|NCT04009291|589619568|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
163249162|NCT04009291|589619569|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
163249163|NCT04009291|589619570|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
163249164|NCT04009291|589619571|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
163249165|NCT04009291|589619572|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
163249166|NCT04009291|589619568|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
163249167|NCT04009291|589619569|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
163249168|NCT04009291|589619570|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
163249169|NCT04009291|589619571|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
163249170|NCT04009291|589619572|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
163249171|NCT00729833|589619577|FG000|Overall Study|Death|5|||
163249172|NCT00729833|589619578|FG001|Overall Study|Death|1|||
163249173|NCT00729833|589619579|FG002|Overall Study|Death|3|||
163249174|NCT00729833|589619580|FG003|Overall Study|Death|5|||
163249175|NCT00729833|589619577|FG000|Overall Study|Study Terminated by Sponsor|0|||
163249176|NCT00729833|589619578|FG001|Overall Study|Study Terminated by Sponsor|0|||
163249177|NCT00729833|589619579|FG002|Overall Study|Study Terminated by Sponsor|1|||
163249178|NCT00729833|589619580|FG003|Overall Study|Study Terminated by Sponsor|0|||
163249179|NCT00729833|589619577|FG000|Overall Study|Lost to Follow-up|1|||
163249180|NCT00729833|589619578|FG001|Overall Study|Lost to Follow-up|0|||
163249181|NCT00729833|589619579|FG002|Overall Study|Lost to Follow-up|0|||
163249182|NCT00729833|589619580|FG003|Overall Study|Lost to Follow-up|0|||
163249183|NCT00729833|589619577|FG000|Overall Study|Withdrawal by Subject|3|||
163249184|NCT00729833|589619578|FG001|Overall Study|Withdrawal by Subject|1|||
163249185|NCT00729833|589619579|FG002|Overall Study|Withdrawal by Subject|3|||
163249186|NCT00729833|589619580|FG003|Overall Study|Withdrawal by Subject|0|||
163249187|NCT00729833|589619577|FG000|Overall Study|Unspecified Reasons|11|||
163249188|NCT00729833|589619578|FG001|Overall Study|Unspecified Reasons|5|||
163249189|NCT00729833|589619579|FG002|Overall Study|Unspecified Reasons|5|||
163249190|NCT00729833|589619580|FG003|Overall Study|Unspecified Reasons|1|||
163249191|NCT01922076|589619582|FG000|Overall Study|Adverse Event|0|||
163249192|NCT01922076|589619583|FG001|Overall Study|Adverse Event|0|||
163249193|NCT01922076|589619584|FG002|Overall Study|Adverse Event|0|||
163249194|NCT01922076|589619585|FG003|Overall Study|Adverse Event|0|||
163355127|NCT02034162|590011347|FG002|Double-blind|Physician Decision|0|||
163355128|NCT02034162|590011345|FG000|Double-blind|Protocol Violation|0|||
163355129|NCT02034162|590011346|FG001|Double-blind|Protocol Violation|1|||
163249195|NCT01922076|589619586|FG004|Overall Study|Adverse Event|1|||
163249196|NCT01922076|589619587|FG005|Overall Study|Adverse Event|0|||
163249197|NCT01922076|589619588|FG006|Overall Study|Adverse Event|0|||
163249198|NCT01922076|589619582|FG000|Overall Study|Physician Decision|0|||
163249199|NCT01922076|589619583|FG001|Overall Study|Physician Decision|0|||
163249200|NCT01922076|589619584|FG002|Overall Study|Physician Decision|1|||
163249201|NCT01922076|589619585|FG003|Overall Study|Physician Decision|0|||
163249202|NCT01922076|589619586|FG004|Overall Study|Physician Decision|0|||
163249203|NCT01922076|589619587|FG005|Overall Study|Physician Decision|0|||
163249204|NCT01922076|589619588|FG006|Overall Study|Physician Decision|0|||
163249205|NCT01922076|589619582|FG000|Overall Study|Withdrawal by Subject|0|||
163249206|NCT01922076|589619583|FG001|Overall Study|Withdrawal by Subject|0|||
163249207|NCT01922076|589619584|FG002|Overall Study|Withdrawal by Subject|0|||
163249208|NCT01922076|589619585|FG003|Overall Study|Withdrawal by Subject|1|||
163249209|NCT01922076|589619586|FG004|Overall Study|Withdrawal by Subject|0|||
163355130|NCT02034162|590011347|FG002|Double-blind|Protocol Violation|0|||
163355131|NCT02034162|590011345|FG000|Double-blind|Withdrawal by Subject|5|||
163249210|NCT01922076|589619587|FG005|Overall Study|Withdrawal by Subject|1|||
163249211|NCT01922076|589619588|FG006|Overall Study|Withdrawal by Subject|1|||
163249212|NCT03738150|589619595|FG000|Base Study|Withdrawal by Subject|1|||
163249213|NCT03738150|589619595|FG000|Extension Study|Withdrawal by Subject|1|||
163249214|NCT04598152|589619598|FG000|Overall Study|Lost to Follow-up|0|||
163249215|NCT04598152|589619599|FG001|Overall Study|Lost to Follow-up|1|||
163249216|NCT03346759|589619604|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
163249217|NCT03346759|589619605|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
163249218|NCT03346759|589619604|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
163249219|NCT03346759|589619605|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
163249220|NCT03346759|589619604|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
163249221|NCT03346759|589619605|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
163249222|NCT03943095|589619606|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
163249223|NCT03943095|589619607|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
163249224|NCT03943095|589619606|FG000|Overall Study|Withdrawal by Subject|1|||
163249225|NCT03943095|589619607|FG001|Overall Study|Withdrawal by Subject|0|||
163249226|NCT04988308|589619608|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
163249227|NCT04988308|589619609|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
163249228|NCT04988308|589619610|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
163249229|NCT04988308|589619611|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
163249230|NCT04988308|589619612|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
163249231|NCT04988308|589619613|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
163249232|NCT04988308|589619608|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
163249233|NCT04988308|589619609|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
163249234|NCT04988308|589619610|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
163249235|NCT04988308|589619611|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
163249236|NCT04988308|589619612|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
163249237|NCT04988308|589619613|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
163249238|NCT04988308|589619608|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
163249239|NCT04988308|589619609|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
163249240|NCT04988308|589619610|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
163249241|NCT04988308|589619611|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
163249242|NCT04988308|589619612|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
163249243|NCT04988308|589619613|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
163249244|NCT04988308|589619608|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
163249245|NCT04988308|589619609|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
163249246|NCT04988308|589619610|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
163249247|NCT04988308|589619611|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
163249248|NCT04988308|589619612|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
163249249|NCT04988308|589619613|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
163249250|NCT04988308|589619608|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
163249251|NCT04988308|589619609|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
163249252|NCT04988308|589619610|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
163249253|NCT04988308|589619611|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
163249254|NCT04988308|589619612|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
163249255|NCT04988308|589619613|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
163249256|NCT04988308|589619608|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
163249257|NCT04988308|589619609|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
163249258|NCT04988308|589619610|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
163249259|NCT04988308|589619611|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
163249260|NCT04988308|589619612|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
163249261|NCT04988308|589619613|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
163249262|NCT04988308|589619608|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
163249263|NCT04988308|589619609|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
163249264|NCT04988308|589619610|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
163249265|NCT04988308|589619611|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
163249266|NCT04988308|589619612|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
163249267|NCT04988308|589619613|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
163249268|NCT04988308|589619608|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
163249269|NCT04988308|589619609|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
163355132|NCT02034162|590011346|FG001|Double-blind|Withdrawal by Subject|7|||
163355133|NCT02034162|590011347|FG002|Double-blind|Withdrawal by Subject|0|||
163355134|NCT00760513|590011348|FG000|Overall Study|Withdrawal by Subject|5|||
163249270|NCT04988308|589619610|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
163249271|NCT04988308|589619611|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
163355135|NCT00760513|590011349|FG001|Overall Study|Withdrawal by Subject|7|||
163355136|NCT02808975|590011354|FG000|Overall Study|Adverse Event|3|||
163149902|NCT02318706|589263507|FG000|Double-blind Phase|Other|4|||
163149903|NCT02318706|589263508|FG001|Double-blind Phase|Other|1|||
163149904|NCT02318706|589263509|FG002|Double-blind Phase|Other|2|||
163149905|NCT02318706|589263510|FG003|Double-blind Phase|Other|1|||
163149906|NCT02318706|589263511|FG004|Double-blind Phase|Other|0|||
163149907|NCT02318706|589263507|FG000|Double-blind Phase|Death|0|||
163149908|NCT02318706|589263508|FG001|Double-blind Phase|Death|0|||
163149909|NCT02318706|589263509|FG002|Double-blind Phase|Death|2|||
163149910|NCT02318706|589263510|FG003|Double-blind Phase|Death|0|||
163149911|NCT02318706|589263511|FG004|Double-blind Phase|Death|0|||
163149912|NCT02318706|589263507|FG000|Open-label Extension Phase|Adverse Event|0|||
163149913|NCT02318706|589263508|FG001|Open-label Extension Phase|Adverse Event|0|||
163149914|NCT02318706|589263509|FG002|Open-label Extension Phase|Adverse Event|0|||
163149915|NCT02318706|589263510|FG003|Open-label Extension Phase|Adverse Event|0|||
163149916|NCT02318706|589263511|FG004|Open-label Extension Phase|Adverse Event|21|||
163149917|NCT02318706|589263507|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
163149918|NCT02318706|589263508|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
163149919|NCT02318706|589263509|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
163149920|NCT02318706|589263510|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
163149921|NCT02318706|589263511|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
163149922|NCT02318706|589263507|FG000|Open-label Extension Phase|Death|0|||
163149923|NCT02318706|589263508|FG001|Open-label Extension Phase|Death|0|||
163149924|NCT02318706|589263509|FG002|Open-label Extension Phase|Death|0|||
163149925|NCT02318706|589263510|FG003|Open-label Extension Phase|Death|0|||
163149926|NCT02318706|589263511|FG004|Open-label Extension Phase|Death|1|||
163149927|NCT02318706|589263507|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
163149928|NCT02318706|589263508|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
163149929|NCT02318706|589263509|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
163149930|NCT02318706|589263510|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
163149931|NCT02318706|589263511|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
163149932|NCT04328077|589263512|FG000|Overall Study|Lost to Follow-up|0|||
163149933|NCT04328077|589263513|FG001|Overall Study|Lost to Follow-up|1|||
163149934|NCT04328077|589263514|FG002|Overall Study|Lost to Follow-up|0|||
163149935|NCT04328077|589263515|FG003|Overall Study|Lost to Follow-up|0|||
163149936|NCT04328077|589263512|FG000|Overall Study|Withdrawal by Subject|0|||
163149937|NCT04328077|589263513|FG001|Overall Study|Withdrawal by Subject|1|||
163149938|NCT04328077|589263514|FG002|Overall Study|Withdrawal by Subject|1|||
163149939|NCT04328077|589263515|FG003|Overall Study|Withdrawal by Subject|3|||
163149940|NCT02326155|589263521|FG000|Overall Study|Adverse Event|21|||
163149941|NCT02326155|589263522|FG001|Overall Study|Adverse Event|5|||
163149942|NCT02326155|589263521|FG000|Overall Study|Death|3|||
163149943|NCT02326155|589263522|FG001|Overall Study|Death|0|||
163149944|NCT02326155|589263521|FG000|Overall Study|Lack of Efficacy|49|||
163149945|NCT02326155|589263522|FG001|Overall Study|Lack of Efficacy|5|||
163149946|NCT02326155|589263521|FG000|Overall Study|Lost to Follow-up|14|||
163149947|NCT02326155|589263522|FG001|Overall Study|Lost to Follow-up|3|||
163149948|NCT02326155|589263521|FG000|Overall Study|Protocol Violation|2|||
163149949|NCT02326155|589263522|FG001|Overall Study|Protocol Violation|0|||
163149950|NCT02326155|589263521|FG000|Overall Study|Withdrawal by Subject|34|||
163149951|NCT02326155|589263522|FG001|Overall Study|Withdrawal by Subject|11|||
163149952|NCT02326155|589263521|FG000|Overall Study|Disease progression|37|||
163149953|NCT02326155|589263522|FG001|Overall Study|Disease progression|4|||
163149954|NCT02326155|589263521|FG000|Overall Study|Study close|188|||
163149955|NCT02326155|589263522|FG001|Overall Study|Study close|21|||
163149956|NCT02326155|589263521|FG000|Overall Study|except for study close|46|||
163149957|NCT02326155|589263522|FG001|Overall Study|except for study close|13|||
163149958|NCT01499940|589263528|FG000|Overall Study|Study was withdrawn before completion.|9|||
163149959|NCT04739982|589263530|FG000|Overall Study|Lost to Follow-up|176|||
163149960|NCT04739982|589263531|FG001|Overall Study|Lost to Follow-up|65|||
163149961|NCT04739982|589263530|FG000|Overall Study|Withdrawal by Subject|19|||
163149962|NCT04739982|589263531|FG001|Overall Study|Withdrawal by Subject|0|||
163149963|NCT04739982|589263530|FG000|Overall Study|Protocol Violation|0|||
163149964|NCT04739982|589263531|FG001|Overall Study|Protocol Violation|5|||
163149965|NCT04914364|589263533|FG000|Overall Study|No longer eligible for study|1|||
163149966|NCT04914364|589263533|FG000|Overall Study|Lost to Follow-up|2|||
163149967|NCT00537394|589263534|FG000|First Year of Follow-up|Death|7|||
163149968|NCT00537394|589263535|FG001|First Year of Follow-up|Death|0|||
163149969|NCT00537394|589263536|FG002|First Year of Follow-up|Death|0|||
163149970|NCT00537394|589263534|FG000|First Year of Follow-up|Severe debilitation|1|||
163149971|NCT00537394|589263535|FG001|First Year of Follow-up|Severe debilitation|0|||
163149972|NCT00537394|589263536|FG002|First Year of Follow-up|Severe debilitation|1|||
163149973|NCT00537394|589263534|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
163149974|NCT00537394|589263535|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
163149975|NCT00537394|589263536|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
163149976|NCT00537394|589263534|FG000|First Year of Follow-up|Lost to Follow-up|1|||
163149977|NCT00537394|589263535|FG001|First Year of Follow-up|Lost to Follow-up|5|||
163149978|NCT00537394|589263536|FG002|First Year of Follow-up|Lost to Follow-up|1|||
163149979|NCT00537394|589263534|FG000|2nd Year of Follow-up|Death|4|||
163249272|NCT04988308|589619612|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
163249273|NCT04988308|589619613|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
163249274|NCT04988308|589619608|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
163249275|NCT04988308|589619609|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
163249276|NCT04988308|589619610|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
163249277|NCT04988308|589619611|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
163249278|NCT04988308|589619612|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
163249279|NCT04988308|589619613|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
163249280|NCT04177758|589619623|FG000|Overall Study|Lost to Follow-up|19|||
163249281|NCT04177758|589619624|FG001|Overall Study|Lost to Follow-up|11|||
163249282|NCT00679939|589619625|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
163249283|NCT00679939|589619626|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
163249284|NCT00679939|589619625|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
163249285|NCT00679939|589619626|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
163249286|NCT00679939|589619625|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
163249287|NCT00679939|589619626|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
163249288|NCT00679939|589619625|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
163249289|NCT00679939|589619626|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
163249290|NCT00679939|589619625|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
163249291|NCT00679939|589619626|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
163249292|NCT00679939|589619625|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
163249293|NCT00679939|589619626|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
163249294|NCT00679939|589619625|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
163249295|NCT00679939|589619626|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
163249296|NCT00679939|589619625|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
163249297|NCT00679939|589619626|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
163249298|NCT00679939|589619625|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
163249299|NCT00679939|589619626|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
163249300|NCT00679939|589619625|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
163249301|NCT00679939|589619626|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
163249302|NCT02763384|589619627|FG000|Overall Study|Physician Decision|1|||
163249303|NCT02763384|589619627|FG000|Overall Study|Rapid decline - went on hospice|1|||
163249304|NCT04657211|589619628|FG000|Overall Study|Withdrawal by Subject|21|||
163249305|NCT04657211|589619628|FG000|Overall Study|Lost to Follow-up|113|||
163249306|NCT04657211|589619628|FG000|Overall Study|Death|47|||
163249307|NCT04657211|589619628|FG000|Overall Study|Transfer to another institution|21|||
163249308|NCT04657211|589619628|FG000|Overall Study|Other|29|||
163249309|NCT02943408|589621274|FG000|Overall Study|Lost to Follow-up|7|||
163249310|NCT02943408|589621275|FG001|Overall Study|Lost to Follow-up|1|||
163249311|NCT02943408|589621274|FG000|Overall Study|Withdrawal by Subject|0|||
163249312|NCT02943408|589621275|FG001|Overall Study|Withdrawal by Subject|1|||
163249313|NCT01621126|589621278|FG000|Overall Study|Physician Decision|6|||
163249314|NCT03751631|589621279|FG000|Overall Study|Withdrawal by Subject|0|||
163249315|NCT03751631|589621280|FG001|Overall Study|Withdrawal by Subject|0|||
163249316|NCT03751631|589621281|FG002|Overall Study|Withdrawal by Subject|1|||
163249317|NCT03751631|589621282|FG003|Overall Study|Withdrawal by Subject|1|||
163249318|NCT03751631|589621283|FG004|Overall Study|Withdrawal by Subject|0|||
163249319|NCT03751631|589621284|FG005|Overall Study|Withdrawal by Subject|0|||
163249320|NCT02481310|589621285|FG000|Follow up|Still in follow up|0|||
163249321|NCT02481310|589621286|FG001|Follow up|Still in follow up|3|||
163249322|NCT02481310|589621287|FG002|Follow up|Still in follow up|0|||
163249323|NCT00643916|589621289|FG000|Overall Study|Protocol Violation|0|||
163249324|NCT00643916|589621290|FG001|Overall Study|Protocol Violation|1|||
163249325|NCT00643916|589621291|FG002|Overall Study|Protocol Violation|1|||
163249326|NCT00643916|589621292|FG003|Overall Study|Protocol Violation|1|||
163249327|NCT00643916|589621293|FG004|Overall Study|Protocol Violation|0|||
163355137|NCT02808975|590011355|FG001|Overall Study|Adverse Event|4|||
163355138|NCT02808975|590011354|FG000|Overall Study|Withdrew consent|9|||
163355139|NCT02808975|590011355|FG001|Overall Study|Withdrew consent|8|||
163355140|NCT02808975|590011354|FG000|Overall Study|Lost to Follow-up|4|||
163355141|NCT02808975|590011355|FG001|Overall Study|Lost to Follow-up|6|||
163355142|NCT02808975|590011354|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
163410337|NCT05103332|590211361|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
163249328|NCT00643916|589621294|FG005|Overall Study|Protocol Violation|0|||
163249329|NCT00643916|589621289|FG000|Overall Study|Lost to Follow-up|0|||
163249330|NCT00643916|589621290|FG001|Overall Study|Lost to Follow-up|1|||
163249331|NCT00643916|589621291|FG002|Overall Study|Lost to Follow-up|0|||
163249332|NCT00643916|589621292|FG003|Overall Study|Lost to Follow-up|0|||
163249333|NCT00643916|589621293|FG004|Overall Study|Lost to Follow-up|0|||
163249334|NCT00643916|589621294|FG005|Overall Study|Lost to Follow-up|0|||
163249335|NCT00643916|589621289|FG000|Overall Study|Withdrawal by Subject|2|||
163355143|NCT02808975|590011355|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
163355144|NCT02808975|590011354|FG000|Overall Study|Other, not specified|5|||
163249336|NCT00643916|589621290|FG001|Overall Study|Withdrawal by Subject|2|||
163249337|NCT00643916|589621291|FG002|Overall Study|Withdrawal by Subject|2|||
163249338|NCT00643916|589621292|FG003|Overall Study|Withdrawal by Subject|1|||
163249339|NCT00643916|589621293|FG004|Overall Study|Withdrawal by Subject|0|||
163249340|NCT00643916|589621294|FG005|Overall Study|Withdrawal by Subject|1|||
163249341|NCT00643916|589621289|FG000|Overall Study|Not Vaccinated|2|||
163249342|NCT00643916|589621290|FG001|Overall Study|Not Vaccinated|2|||
163249343|NCT00643916|589621291|FG002|Overall Study|Not Vaccinated|3|||
163249344|NCT00643916|589621292|FG003|Overall Study|Not Vaccinated|0|||
163249345|NCT00643916|589621293|FG004|Overall Study|Not Vaccinated|2|||
163249346|NCT00643916|589621294|FG005|Overall Study|Not Vaccinated|0|||
163249347|NCT00677833|589621296|FG000|Overall Study|Withdrawal by Subject|4|||
163249348|NCT00677833|589621297|FG001|Overall Study|Withdrawal by Subject|0|||
163249349|NCT00677833|589621298|FG002|Overall Study|Withdrawal by Subject|1|||
163249350|NCT00677833|589621299|FG003|Overall Study|Withdrawal by Subject|3|||
163249351|NCT00677833|589621296|FG000|Overall Study|Lost to Follow-up|0|||
163249352|NCT00677833|589621297|FG001|Overall Study|Lost to Follow-up|0|||
163249353|NCT00677833|589621298|FG002|Overall Study|Lost to Follow-up|1|||
163249354|NCT00677833|589621299|FG003|Overall Study|Lost to Follow-up|0|||
163249355|NCT02606279|589621300|FG000|Overall Study|Lost to Follow-up|0|||
163249356|NCT02606279|589621301|FG001|Overall Study|Lost to Follow-up|1|||
163249357|NCT02184611|589621302|FG000|Overall Study|Lack of Efficacy|11|||
163249358|NCT02184611|589621303|FG001|Overall Study|Lack of Efficacy|15|||
163249359|NCT02184611|589621302|FG000|Overall Study|Withdrawal by Subject|5|||
163249360|NCT02184611|589621303|FG001|Overall Study|Withdrawal by Subject|6|||
163249361|NCT02184611|589621302|FG000|Overall Study|Adverse Event|4|||
163249362|NCT02184611|589621303|FG001|Overall Study|Adverse Event|5|||
163249363|NCT02184611|589621302|FG000|Overall Study|Protocol Violation|1|||
163249364|NCT02184611|589621303|FG001|Overall Study|Protocol Violation|1|||
163249365|NCT02184611|589621302|FG000|Overall Study|Protocol defined stopping criteria|0|||
163249366|NCT02184611|589621303|FG001|Overall Study|Protocol defined stopping criteria|1|||
163249367|NCT01514448|589621306|FG000|Overall Study|Death|7|||
163249368|NCT01514448|589621307|FG001|Overall Study|Death|8|||
163249369|NCT01514448|589621306|FG000|Overall Study|Withdrawal by Subject|2|||
163249370|NCT01514448|589621307|FG001|Overall Study|Withdrawal by Subject|0|||
163249371|NCT01514448|589621306|FG000|Overall Study|Lost to Follow-up|2|||
163249372|NCT01514448|589621307|FG001|Overall Study|Lost to Follow-up|0|||
163249373|NCT01514448|589621306|FG000|Overall Study|New Cancer Therapy|1|||
163249374|NCT01514448|589621307|FG001|Overall Study|New Cancer Therapy|0|||
163249375|NCT01690130|589621308|FG000|Overall Study|Subject have cancelled visit.|1|||
163249376|NCT01690130|589621309|FG001|Overall Study|Subject have cancelled visit.|0|||
163249377|NCT05159622|589621310|FG000|Overall Study|Lost to Follow-up|4|||
163249378|NCT05159622|589621311|FG001|Overall Study|Lost to Follow-up|5|||
163249379|NCT02723864|589621312|FG000|Overall Study|Refused further treatment|1|||
163249380|NCT02723864|589621313|FG001|Overall Study|Refused further treatment|0|||
163249381|NCT02723864|589621314|FG002|Overall Study|Refused further treatment|0|||
163249382|NCT02723864|589621315|FG003|Overall Study|Refused further treatment|0|||
163249383|NCT02723864|589621316|FG004|Overall Study|Refused further treatment|1|||
163249384|NCT02723864|589621317|FG005|Overall Study|Refused further treatment|2|||
163249385|NCT02723864|589621318|FG006|Overall Study|Refused further treatment|0|||
163249386|NCT02723864|589621312|FG000|Overall Study|Exceed treatment hold time|0|||
163249387|NCT02723864|589621313|FG001|Overall Study|Exceed treatment hold time|1|||
163249388|NCT02723864|589621314|FG002|Overall Study|Exceed treatment hold time|0|||
163249389|NCT02723864|589621315|FG003|Overall Study|Exceed treatment hold time|0|||
163249390|NCT02723864|589621316|FG004|Overall Study|Exceed treatment hold time|0|||
163249391|NCT02723864|589621317|FG005|Overall Study|Exceed treatment hold time|0|||
163249392|NCT02723864|589621318|FG006|Overall Study|Exceed treatment hold time|0|||
163249393|NCT02723864|589621312|FG000|Overall Study|Clinical progression|0|||
163249394|NCT02723864|589621313|FG001|Overall Study|Clinical progression|0|||
163249395|NCT02723864|589621314|FG002|Overall Study|Clinical progression|1|||
163249396|NCT02723864|589621315|FG003|Overall Study|Clinical progression|0|||
163249397|NCT02723864|589621316|FG004|Overall Study|Clinical progression|0|||
163355145|NCT02808975|590011355|FG001|Overall Study|Other, not specified|1|||
163355146|NCT04367480|590011360|FG000|Overall Study|Adverse Event|1|||
163355147|NCT04367480|590011361|FG001|Overall Study|Adverse Event|1|||
163249398|NCT02723864|589621317|FG005|Overall Study|Clinical progression|3|||
163249399|NCT02723864|589621318|FG006|Overall Study|Clinical progression|1|||
163249400|NCT02723864|589621312|FG000|Overall Study|Physician Decision|0|||
163249401|NCT02723864|589621313|FG001|Overall Study|Physician Decision|0|||
163249402|NCT02723864|589621314|FG002|Overall Study|Physician Decision|0|||
163249403|NCT02723864|589621315|FG003|Overall Study|Physician Decision|0|||
163249404|NCT02723864|589621316|FG004|Overall Study|Physician Decision|0|||
163249405|NCT02723864|589621317|FG005|Overall Study|Physician Decision|0|||
163249406|NCT02723864|589621318|FG006|Overall Study|Physician Decision|1|||
163249407|NCT02723864|589621312|FG000|Overall Study|Changes in patient condition|0|||
163249408|NCT02723864|589621313|FG001|Overall Study|Changes in patient condition|0|||
163355148|NCT04367480|590011360|FG000|Overall Study|Death|1|||
163355149|NCT04367480|590011361|FG001|Overall Study|Death|0|||
163249409|NCT02723864|589621314|FG002|Overall Study|Changes in patient condition|0|||
163249410|NCT02723864|589621315|FG003|Overall Study|Changes in patient condition|0|||
163249411|NCT02723864|589621316|FG004|Overall Study|Changes in patient condition|0|||
163249412|NCT02723864|589621317|FG005|Overall Study|Changes in patient condition|1|||
163249413|NCT02723864|589621318|FG006|Overall Study|Changes in patient condition|0|||
163249414|NCT02723864|589621312|FG000|Overall Study|Patient choice|0|||
163249415|NCT02723864|589621313|FG001|Overall Study|Patient choice|0|||
163249416|NCT02723864|589621314|FG002|Overall Study|Patient choice|0|||
163249417|NCT02723864|589621315|FG003|Overall Study|Patient choice|0|||
163249418|NCT02723864|589621316|FG004|Overall Study|Patient choice|0|||
163249419|NCT02723864|589621317|FG005|Overall Study|Patient choice|1|||
163249420|NCT02723864|589621318|FG006|Overall Study|Patient choice|0|||
163249421|NCT02723864|589621312|FG000|Overall Study|Adverse Event|0|||
163249422|NCT02723864|589621313|FG001|Overall Study|Adverse Event|0|||
163249423|NCT02723864|589621314|FG002|Overall Study|Adverse Event|0|||
163249424|NCT02723864|589621315|FG003|Overall Study|Adverse Event|0|||
163249425|NCT02723864|589621316|FG004|Overall Study|Adverse Event|0|||
163249426|NCT02723864|589621317|FG005|Overall Study|Adverse Event|1|||
163249427|NCT02723864|589621318|FG006|Overall Study|Adverse Event|0|||
163249428|NCT02723864|589621312|FG000|Overall Study|Started new treatment|0|||
163249429|NCT02723864|589621313|FG001|Overall Study|Started new treatment|0|||
163249430|NCT02723864|589621314|FG002|Overall Study|Started new treatment|0|||
163249431|NCT02723864|589621315|FG003|Overall Study|Started new treatment|0|||
163249432|NCT02723864|589621316|FG004|Overall Study|Started new treatment|0|||
163249433|NCT02723864|589621317|FG005|Overall Study|Started new treatment|1|||
163249434|NCT02723864|589621318|FG006|Overall Study|Started new treatment|0|||
163249435|NCT02723864|589621312|FG000|Overall Study|Switched to alternative treatment|0|||
163249436|NCT02723864|589621313|FG001|Overall Study|Switched to alternative treatment|0|||
163249437|NCT02723864|589621314|FG002|Overall Study|Switched to alternative treatment|0|||
163249438|NCT02723864|589621315|FG003|Overall Study|Switched to alternative treatment|0|||
163249439|NCT02723864|589621316|FG004|Overall Study|Switched to alternative treatment|0|||
163249440|NCT02723864|589621317|FG005|Overall Study|Switched to alternative treatment|1|||
163249441|NCT02723864|589621318|FG006|Overall Study|Switched to alternative treatment|0|||
163249442|NCT02723864|589621312|FG000|Overall Study|Late determination of ineligibility|0|||
163249443|NCT02723864|589621313|FG001|Overall Study|Late determination of ineligibility|0|||
163249444|NCT02723864|589621314|FG002|Overall Study|Late determination of ineligibility|0|||
163249445|NCT02723864|589621315|FG003|Overall Study|Late determination of ineligibility|0|||
163249446|NCT02723864|589621316|FG004|Overall Study|Late determination of ineligibility|0|||
163249447|NCT02723864|589621317|FG005|Overall Study|Late determination of ineligibility|1|||
163249448|NCT02723864|589621318|FG006|Overall Study|Late determination of ineligibility|0|||
163249449|NCT03232983|589621319|FG000|Period 1|Physician Decision|0|||
163249450|NCT03232983|589621320|FG001|Period 1|Physician Decision|0|||
163249451|NCT03232983|589621321|FG002|Period 1|Physician Decision|1|||
163249452|NCT03232983|589621322|FG003|Period 1|Physician Decision|0|||
163249453|NCT03232983|589621319|FG000|Washout Period 2|Physician Decision|0|||
163249454|NCT03232983|589621320|FG001|Washout Period 2|Physician Decision|0|||
163249455|NCT03232983|589621321|FG002|Washout Period 2|Physician Decision|1|||
163249456|NCT03232983|589621322|FG003|Washout Period 2|Physician Decision|0|||
163249457|NCT03232983|589621319|FG000|Washout Period 2|Withdrawal by Subject|0|||
163249458|NCT03232983|589621320|FG001|Washout Period 2|Withdrawal by Subject|0|||
163249459|NCT03232983|589621321|FG002|Washout Period 2|Withdrawal by Subject|0|||
163249460|NCT03232983|589621322|FG003|Washout Period 2|Withdrawal by Subject|1|||
163249461|NCT03232983|589621319|FG000|Period 4|Withdrawal by Subject|1|||
163249462|NCT03232983|589621320|FG001|Period 4|Withdrawal by Subject|0|||
163249463|NCT03232983|589621321|FG002|Period 4|Withdrawal by Subject|0|||
163249464|NCT03232983|589621322|FG003|Period 4|Withdrawal by Subject|0|||
163249465|NCT00746590|589621323|FG000|Overall Study|Death|1|||
163249466|NCT02633800|589621324|FG000|Overall Study|Death|3|||
163249467|NCT02633800|589621325|FG001|Overall Study|Death|3|||
163249468|NCT02633800|589621324|FG000|Overall Study|Reason not provided|1|||
163249469|NCT02633800|589621325|FG001|Overall Study|Reason not provided|0|||
163249470|NCT02633800|589621324|FG000|Overall Study|Radiologic(al) progression|23|||
163249471|NCT02633800|589621325|FG001|Overall Study|Radiologic(al) progression|23|||
163249472|NCT02633800|589621324|FG000|Overall Study|Clinical progression|3|||
163355150|NCT04367480|590011360|FG000|Overall Study|Lost to Follow-up|1|||
163249473|NCT02633800|589621325|FG001|Overall Study|Clinical progression|6|||
163249474|NCT02633800|589621324|FG000|Overall Study|Study terminated by sponsor|6|||
163249475|NCT02633800|589621325|FG001|Overall Study|Study terminated by sponsor|5|||
163249476|NCT02633800|589621324|FG000|Overall Study|Adverse event, non-fatal|7|||
163249477|NCT02633800|589621325|FG001|Overall Study|Adverse event, non-fatal|2|||
163249478|NCT02633800|589621324|FG000|Overall Study|Withdrawal by Subject|0|||
163249479|NCT02633800|589621325|FG001|Overall Study|Withdrawal by Subject|3|||
163249480|NCT02633800|589621324|FG000|Overall Study|Patient Request|1|||
163249481|NCT02633800|589621325|FG001|Overall Study|Patient Request|1|||
163249482|NCT00815295|589621329|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
163249483|NCT00815295|589621330|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
163249484|NCT00815295|589621331|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
163249485|NCT03647501|589621332|FG000|Overall Study|Lost to Follow-up|1|||
163249486|NCT03647501|589621333|FG001|Overall Study|Lost to Follow-up|1|||
163249487|NCT03647501|589621332|FG000|Overall Study|Withdrawal by Subject|0|||
163249488|NCT03647501|589621333|FG001|Overall Study|Withdrawal by Subject|1|||
163249489|NCT03945188|589621334|FG000|Overall Study|Protocol Violation|1|||
163249490|NCT03945188|589621335|FG001|Overall Study|Protocol Violation|0|||
163249491|NCT03945188|589621334|FG000|Overall Study|Disease worsening|79|||
163249492|NCT03945188|589621335|FG001|Overall Study|Disease worsening|73|||
163249493|NCT03945188|589621334|FG000|Overall Study|Physician Decision|2|||
163249494|NCT03945188|589621335|FG001|Overall Study|Physician Decision|2|||
163249495|NCT03945188|589621334|FG000|Overall Study|Lack of Efficacy|7|||
163249496|NCT03945188|589621335|FG001|Overall Study|Lack of Efficacy|4|||
163249497|NCT03945188|589621334|FG000|Overall Study|Pregnancy|2|||
163249498|NCT03945188|589621335|FG001|Overall Study|Pregnancy|0|||
163249499|NCT03945188|589621334|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
163249500|NCT03945188|589621335|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
163249501|NCT03945188|589621334|FG000|Overall Study|Adverse Event|10|||
163249502|NCT03945188|589621335|FG001|Overall Study|Adverse Event|5|||
163249503|NCT03945188|589621334|FG000|Overall Study|Other|2|||
163249504|NCT03945188|589621335|FG001|Overall Study|Other|2|||
163249505|NCT03945188|589621334|FG000|Overall Study|Lost to Follow-up|1|||
163249506|NCT03945188|589621335|FG001|Overall Study|Lost to Follow-up|2|||
163249507|NCT04794803|589621336|FG000|Overall Study|Death|1|||
163249508|NCT04794803|589621337|FG001|Overall Study|Death|3|||
163249509|NCT04794803|589621336|FG000|Overall Study|Lost to Follow-up|2|||
163249510|NCT04794803|589621337|FG001|Overall Study|Lost to Follow-up|2|||
163249511|NCT04794803|589621336|FG000|Overall Study|Withdrawal by Subject|1|||
163249512|NCT04794803|589621337|FG001|Overall Study|Withdrawal by Subject|0|||
163249513|NCT04794803|589621336|FG000|Overall Study|Physician Decision|1|||
163249514|NCT04794803|589621337|FG001|Overall Study|Physician Decision|1|||
163249515|NCT04794803|589621336|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
163355151|NCT04367480|590011361|FG001|Overall Study|Lost to Follow-up|1|||
163355152|NCT04367480|590011360|FG000|Overall Study|Withdrawal by Subject|0|||
163355153|NCT04367480|590011361|FG001|Overall Study|Withdrawal by Subject|3|||
163355154|NCT04367480|590011360|FG000|Overall Study|App glitch during the study|1|||
163355155|NCT04367480|590011361|FG001|Overall Study|App glitch during the study|0|||
163355156|NCT04367480|590011360|FG000|Overall Study|Device Distribution Error|0|||
163355157|NCT04367480|590011361|FG001|Overall Study|Device Distribution Error|2|||
163355158|NCT04367480|590011360|FG000|Overall Study|Ineligible after Randomization|0|||
163355159|NCT04367480|590011361|FG001|Overall Study|Ineligible after Randomization|1|||
163355160|NCT04367480|590011360|FG000|Overall Study|Other Medical Reasons|0|||
163355161|NCT04367480|590011361|FG001|Overall Study|Other Medical Reasons|2|||
163355162|NCT03382561|590011362|FG000|Overall Study|Disease progression|47|||
163355163|NCT03382561|590011363|FG001|Overall Study|Disease progression|6|||
163355164|NCT03382561|590011362|FG000|Overall Study|Adverse Event|10|||
163355165|NCT03382561|590011363|FG001|Overall Study|Adverse Event|2|||
163355166|NCT03382561|590011362|FG000|Overall Study|Death|8|||
163355167|NCT03382561|590011363|FG001|Overall Study|Death|3|||
163355168|NCT03382561|590011362|FG000|Overall Study|Withdrawal by Subject|6|||
163355169|NCT03382561|590011363|FG001|Overall Study|Withdrawal by Subject|5|||
163355170|NCT03382561|590011362|FG000|Overall Study|Alternative therapy|2|||
163355171|NCT03382561|590011363|FG001|Overall Study|Alternative therapy|8|||
163355172|NCT03382561|590011362|FG000|Overall Study|Never started treatment|3|||
163355173|NCT03382561|590011363|FG001|Overall Study|Never started treatment|6|||
163410338|NCT05103332|590211362|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
163410339|NCT05103332|590211363|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
163249516|NCT04794803|589621337|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
163249517|NCT04794803|589621336|FG000|Overall Study|Refused to continue the treatment|1|||
163249518|NCT04794803|589621337|FG001|Overall Study|Refused to continue the treatment|0|||
163249519|NCT04794803|589621336|FG000|Overall Study|Patient admitted to ICU|0|||
163249520|NCT04794803|589621337|FG001|Overall Study|Patient admitted to ICU|1|||
163355174|NCT03382561|590011362|FG000|Overall Study|Lack of Efficacy|0|||
163410340|NCT05103332|590211364|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
163410341|NCT05103332|590211365|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
163410342|NCT05103332|590211366|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
163249521|NCT01618162|589621338|FG000|Overall Study|Protocol Violation|13|||
163249522|NCT01618162|589621339|FG001|Overall Study|Protocol Violation|10|||
163355175|NCT03382561|590011363|FG001|Overall Study|Lack of Efficacy|1|||
163249523|NCT01618162|589621338|FG000|Overall Study|Adverse Event|9|||
163249524|NCT01618162|589621339|FG001|Overall Study|Adverse Event|2|||
163249525|NCT01618162|589621338|FG000|Overall Study|Withdrawal Criteria|2|||
163249526|NCT01618162|589621339|FG001|Overall Study|Withdrawal Criteria|10|||
163355176|NCT03382561|590011362|FG000|Overall Study|Physician Decision|0|||
163355177|NCT03382561|590011363|FG001|Overall Study|Physician Decision|1|||
163355178|NCT03382561|590011362|FG000|Overall Study|Other complicating disease|0|||
163355179|NCT03382561|590011363|FG001|Overall Study|Other complicating disease|1|||
163355180|NCT01131104|590011364|FG000|Overall Study|Withdrawal by Subject|3|||
163355181|NCT01131104|590011364|FG000|Overall Study|Physician Decision|4|||
163355182|NCT01131104|590011364|FG000|Overall Study|Information Not Available|5|||
163355183|NCT01131104|590011364|FG000|Overall Study|No Information on Index Date of Onset|1|||
163355184|NCT02370251|590011366|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
163355185|NCT02370251|590011366|FG000|Overall Study|Death|4|||
163355186|NCT05499130|590011367|FG000|Overall Study|Adverse Event|2|||
163410343|NCT05103332|590211367|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
163355187|NCT05499130|590011368|FG001|Overall Study|Adverse Event|0|||
163355188|NCT05499130|590011369|FG002|Overall Study|Adverse Event|1|||
163410344|NCT05103332|590211368|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
163410345|NCT05103332|590211369|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
163410346|NCT05103332|590211370|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
163410347|NCT05103332|590211371|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
163410348|NCT05103332|590211372|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
163149980|NCT00537394|589263535|FG001|2nd Year of Follow-up|Death|1|||
163149981|NCT00537394|589263536|FG002|2nd Year of Follow-up|Death|2|||
163149982|NCT00537394|589263534|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
163149983|NCT00537394|589263535|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
163149984|NCT00537394|589263536|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
163149985|NCT00537394|589263534|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
163149986|NCT00537394|589263535|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
163149987|NCT00537394|589263536|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
163149988|NCT00537394|589263534|FG000|2nd Year of Follow-up|Clinic site closure|1|||
163149989|NCT00537394|589263535|FG001|2nd Year of Follow-up|Clinic site closure|0|||
163149990|NCT00537394|589263536|FG002|2nd Year of Follow-up|Clinic site closure|0|||
163149991|NCT01283139|589263537|FG000|Overall Study|Lost to Follow-up|5|||
163149992|NCT01283139|589263538|FG001|Overall Study|Lost to Follow-up|2|||
163149993|NCT01283139|589263539|FG002|Overall Study|Lost to Follow-up|3|||
163149994|NCT01283139|589263540|FG003|Overall Study|Lost to Follow-up|1|||
163149995|NCT01283139|589263537|FG000|Overall Study|Withdrawal by Subject|8|||
163149996|NCT01283139|589263538|FG001|Overall Study|Withdrawal by Subject|8|||
163149997|NCT01283139|589263539|FG002|Overall Study|Withdrawal by Subject|6|||
163149998|NCT01283139|589263540|FG003|Overall Study|Withdrawal by Subject|8|||
163149999|NCT01283139|589263537|FG000|Overall Study|Death|2|||
163150000|NCT01283139|589263538|FG001|Overall Study|Death|0|||
163150001|NCT01283139|589263539|FG002|Overall Study|Death|2|||
163150002|NCT01283139|589263540|FG003|Overall Study|Death|2|||
163150003|NCT01283139|589263537|FG000|Overall Study|Lack of Efficacy|1|||
163150004|NCT01283139|589263538|FG001|Overall Study|Lack of Efficacy|2|||
163150005|NCT01283139|589263539|FG002|Overall Study|Lack of Efficacy|2|||
163150006|NCT01283139|589263540|FG003|Overall Study|Lack of Efficacy|1|||
163150007|NCT01283139|589263537|FG000|Overall Study|Early termination due to AE/SAE|1|||
163150008|NCT01283139|589263538|FG001|Overall Study|Early termination due to AE/SAE|1|||
163150009|NCT01283139|589263539|FG002|Overall Study|Early termination due to AE/SAE|0|||
163150010|NCT01283139|589263540|FG003|Overall Study|Early termination due to AE/SAE|0|||
163150011|NCT01283139|589263537|FG000|Overall Study|Participant's refusal to continue|0|||
163150012|NCT01283139|589263538|FG001|Overall Study|Participant's refusal to continue|3|||
163150013|NCT01283139|589263539|FG002|Overall Study|Participant's refusal to continue|1|||
163150014|NCT01283139|589263540|FG003|Overall Study|Participant's refusal to continue|1|||
163150015|NCT01283139|589263537|FG000|Overall Study|Pregnancy|0|||
163150016|NCT01283139|589263538|FG001|Overall Study|Pregnancy|1|||
163150017|NCT01283139|589263539|FG002|Overall Study|Pregnancy|1|||
163150018|NCT01283139|589263540|FG003|Overall Study|Pregnancy|0|||
163150019|NCT01283139|589263537|FG000|Overall Study|Missed follow-up visit|0|||
163150020|NCT01283139|589263538|FG001|Overall Study|Missed follow-up visit|1|||
163150021|NCT01283139|589263539|FG002|Overall Study|Missed follow-up visit|2|||
163150022|NCT01283139|589263540|FG003|Overall Study|Missed follow-up visit|2|||
163150023|NCT01283139|589263537|FG000|Overall Study|Participant randomized in error|0|||
163150024|NCT01283139|589263538|FG001|Overall Study|Participant randomized in error|0|||
163150025|NCT01283139|589263539|FG002|Overall Study|Participant randomized in error|1|||
163150026|NCT01283139|589263540|FG003|Overall Study|Participant randomized in error|0|||
163150027|NCT00004563|589263545|FG000|Overall Study|Withdrawal by Subject|20|||
163150028|NCT00004563|589263546|FG001|Overall Study|Withdrawal by Subject|16|||
163150029|NCT00004563|589263545|FG000|Overall Study|Lack of Efficacy|3|||
163150030|NCT00004563|589263546|FG001|Overall Study|Lack of Efficacy|5|||
163150031|NCT00004563|589263545|FG000|Overall Study|Death|2|||
163150032|NCT00004563|589263546|FG001|Overall Study|Death|3|||
163150033|NCT01056822|589263547|FG000|Overall Study|Adverse Event|0|||
163150034|NCT01056822|589263548|FG001|Overall Study|Adverse Event|1|||
163150035|NCT01056822|589263547|FG000|Overall Study|Protocol Violation|6|||
163150036|NCT01056822|589263548|FG001|Overall Study|Protocol Violation|5|||
163150037|NCT01056822|589263547|FG000|Overall Study|Withdrawal by Subject|1|||
163150038|NCT01056822|589263548|FG001|Overall Study|Withdrawal by Subject|1|||
163355189|NCT05499130|590011370|FG003|Overall Study|Adverse Event|0|||
163355190|NCT05499130|590011371|FG004|Overall Study|Adverse Event|1|||
163249527|NCT01618162|589621338|FG000|Overall Study|Unclassified|14|||
163249528|NCT01618162|589621339|FG001|Overall Study|Unclassified|13|||
163249529|NCT02013622|589621340|FG000|Overall Study|Lost to Follow-up|10|||
163249530|NCT02013622|589621340|FG000|Overall Study|Adverse Event|3|||
163249531|NCT02013622|589621340|FG000|Overall Study|Met Withdrawal Criteria|3|||
163249532|NCT02013622|589621340|FG000|Overall Study|Withdrawal by Subject|6|||
163249533|NCT02013622|589621340|FG000|Overall Study|Protocol Deviation|1|||
163249534|NCT02013622|589621340|FG000|Overall Study|Lack of Efficacy|1|||
163249535|NCT00224874|589621341|FG000|Overall Study|Withdrawal by Subject|0|||
163249536|NCT00224874|589621342|FG001|Overall Study|Withdrawal by Subject|0|||
163249537|NCT00224874|589621343|FG002|Overall Study|Withdrawal by Subject|1|||
163249538|NCT00224874|589621344|FG003|Overall Study|Withdrawal by Subject|0|||
163249539|NCT02355002|589621347|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
163249540|NCT02355002|589621348|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
163249541|NCT02355002|589621347|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
163249542|NCT02355002|589621348|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
163249543|NCT02355002|589621347|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
163249544|NCT02355002|589621348|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
163249545|NCT02355002|589621347|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
163249546|NCT02355002|589621348|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
163249547|NCT02355002|589621347|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
163249548|NCT02355002|589621348|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
163249549|NCT02355002|589621347|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
163249550|NCT02355002|589621348|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
163249551|NCT02355002|589621347|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
163249552|NCT02355002|589621348|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
163249553|NCT03644186|589621349|FG000|Overall Study|Withdrawal by Subject|1|||
163249554|NCT03644186|589621350|FG001|Overall Study|Withdrawal by Subject|1|||
163249555|NCT01640808|589621352|FG000|Overall Study|Unable to continue dynamic CT|14|||
163249556|NCT01640808|589621353|FG001|Overall Study|Unable to continue dynamic CT|4|||
163249557|NCT01640808|589621352|FG000|Overall Study|Withdrawal by Subject|12|||
163249558|NCT01640808|589621353|FG001|Overall Study|Withdrawal by Subject|4|||
163249559|NCT01640808|589621352|FG000|Overall Study|Lost to Follow-up|4|||
163249560|NCT01640808|589621353|FG001|Overall Study|Lost to Follow-up|0|||
163249561|NCT01640808|589621352|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
163249562|NCT01640808|589621353|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
163249563|NCT01640808|589621352|FG000|Overall Study|Administration of anticancer drugs|2|||
163249564|NCT01640808|589621353|FG001|Overall Study|Administration of anticancer drugs|1|||
163249565|NCT01640808|589621352|FG000|Overall Study|Physician Decision|19|||
163249566|NCT01640808|589621353|FG001|Overall Study|Physician Decision|5|||
163249567|NCT01640808|589621352|FG000|Overall Study|Randomized but not treated|4|||
163249568|NCT01640808|589621353|FG001|Overall Study|Randomized but not treated|2|||
163249569|NCT02477111|589621354|FG000|Overall Study|Death|28|||
163249570|NCT02477111|589621354|FG000|Overall Study|Withdrawal by Subject|19|||
163249571|NCT02477111|589621354|FG000|Overall Study|Lost to Follow-up|4|||
163249572|NCT02192502|589621355|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
163249573|NCT02192502|589621356|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
163249574|NCT02192502|589621355|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
163249575|NCT02192502|589621356|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
163249576|NCT02192502|589621355|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
163249577|NCT02192502|589621356|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
163249578|NCT01381692|589621357|FG000|Overall Study|Adverse Event|1|||
163249579|NCT01381692|589621358|FG001|Overall Study|Adverse Event|0|||
163249580|NCT01381692|589621359|FG002|Overall Study|Adverse Event|0|||
163249581|NCT01381692|589621360|FG003|Overall Study|Adverse Event|0|||
163249582|NCT01381692|589621361|FG004|Overall Study|Adverse Event|0|||
163249583|NCT01381692|589621362|FG005|Overall Study|Adverse Event|0|||
163249584|NCT02189798|589621363|FG000|Extended Use Phase|Withdrawal by Subject|0|||
163249585|NCT02189798|589621364|FG001|Extended Use Phase|Withdrawal by Subject|4|||
163249586|NCT02189798|589621363|FG000|Extended Use Phase|Physician Decision|1|||
163249587|NCT02189798|589621364|FG001|Extended Use Phase|Physician Decision|0|||
163249588|NCT02189798|589621363|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
163249589|NCT02189798|589621364|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
163249590|NCT02189798|589621363|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
163249591|NCT02189798|589621364|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
163249592|NCT02189798|589621363|FG000|Extended Use Phase|Travel Issues|2|||
163249593|NCT02189798|589621364|FG001|Extended Use Phase|Travel Issues|1|||
163249594|NCT02189798|589621363|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
163355191|NCT05499130|590011372|FG005|Overall Study|Adverse Event|4|||
163249595|NCT02189798|589621364|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
163249596|NCT04818346|589621368|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
163249597|NCT04818346|589621369|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
163249598|NCT04818346|589621370|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
163249599|NCT04818346|589621371|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
163249600|NCT04818346|589621368|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
163249601|NCT04818346|589621369|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
163249602|NCT04818346|589621370|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
163249603|NCT04818346|589621371|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
163249604|NCT04818346|589621368|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
163249605|NCT04818346|589621369|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
163249606|NCT04818346|589621370|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
163249607|NCT04818346|589621371|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
163249608|NCT04818346|589621368|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
163249609|NCT04818346|589621369|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
163249610|NCT04818346|589621370|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
163249611|NCT04818346|589621371|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
163249612|NCT04818346|589621368|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
163249613|NCT04818346|589621369|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
163249614|NCT04818346|589621370|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
163249615|NCT04818346|589621371|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
163249616|NCT04818346|589621368|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
163249617|NCT04818346|589621369|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
163249618|NCT04818346|589621370|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
163249619|NCT04818346|589621371|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
163249620|NCT04818346|589621368|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
163249621|NCT04818346|589621369|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
163249622|NCT04818346|589621370|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
163249623|NCT04818346|589621371|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
163249624|NCT04818346|589621368|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
163249625|NCT04818346|589621369|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
163249626|NCT04818346|589621370|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
163249627|NCT04818346|589621371|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
163249628|NCT04818346|589621368|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
163249629|NCT04818346|589621369|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
163249630|NCT04818346|589621370|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
163249631|NCT04818346|589621371|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
163249632|NCT04818346|589621368|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
163249633|NCT04818346|589621369|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
163249634|NCT04818346|589621370|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
163249635|NCT04818346|589621371|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
163249636|NCT04818346|589621368|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
163249637|NCT04818346|589621369|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
163249638|NCT04818346|589621370|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
163249639|NCT04818346|589621371|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
163249640|NCT04818346|589621368|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
163249641|NCT04818346|589621369|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
163249642|NCT04818346|589621370|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
163249643|NCT04818346|589621371|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
163249644|NCT04818346|589621368|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
163249645|NCT04818346|589621369|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
163249646|NCT04818346|589621370|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
163249647|NCT04818346|589621371|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
163249648|NCT04818346|589621368|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
163249649|NCT04818346|589621369|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
163249650|NCT04818346|589621370|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
163249651|NCT04818346|589621371|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
163249652|NCT04818346|589621368|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
163249653|NCT04818346|589621369|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
163249654|NCT04818346|589621370|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
163355192|NCT05499130|590011373|FG006|Overall Study|Adverse Event|1|||
163355193|NCT05499130|590011374|FG007|Overall Study|Adverse Event|0|||
163150039|NCT01056822|589263547|FG000|Overall Study|Lost to Follow-up|1|||
163150040|NCT01056822|589263548|FG001|Overall Study|Lost to Follow-up|0|||
163150041|NCT01844765|589263551|FG000|Overall Study|Adverse Event|6|||
163150042|NCT01844765|589263552|FG001|Overall Study|Adverse Event|8|||
163150043|NCT01844765|589263551|FG000|Overall Study|Withdrawal by Subject|2|||
163150044|NCT01844765|589263552|FG001|Overall Study|Withdrawal by Subject|3|||
163150045|NCT01844765|589263551|FG000|Overall Study|Disease progression|1|||
163150046|NCT01844765|589263552|FG001|Overall Study|Disease progression|0|||
163150047|NCT01844765|589263551|FG000|Overall Study|Administrative problems|3|||
163150048|NCT01844765|589263552|FG001|Overall Study|Administrative problems|4|||
163150049|NCT01844765|589263551|FG000|Overall Study|Protocol deviation|2|||
163150050|NCT01844765|589263552|FG001|Overall Study|Protocol deviation|0|||
163150051|NCT01844765|589263551|FG000|Overall Study|Untreated|1|||
163150052|NCT01844765|589263552|FG001|Overall Study|Untreated|0|||
163150053|NCT02025179|589263553|FG000|Overall Study|Lost to Follow-up|0|||
163150054|NCT02025179|589263554|FG001|Overall Study|Lost to Follow-up|0|||
163150055|NCT02025179|589263555|FG002|Overall Study|Lost to Follow-up|1|||
163150056|NCT00556075|589263556|FG000|Overall Study|Lost to Follow-up|3|||
163150057|NCT00556075|589263557|FG001|Overall Study|Lost to Follow-up|0|||
163150058|NCT00556075|589263558|FG002|Overall Study|Lost to Follow-up|3|||
163150059|NCT00556075|589263556|FG000|Overall Study|Withdrawal by Subject|3|||
163150060|NCT00556075|589263557|FG001|Overall Study|Withdrawal by Subject|3|||
163150061|NCT00556075|589263558|FG002|Overall Study|Withdrawal by Subject|0|||
163150062|NCT00556075|589263556|FG000|Overall Study|Protocol Violation|1|||
163150063|NCT00556075|589263557|FG001|Overall Study|Protocol Violation|1|||
163150064|NCT00556075|589263558|FG002|Overall Study|Protocol Violation|3|||
163150065|NCT00556075|589263556|FG000|Overall Study|Not eligible|1|||
163150066|NCT00556075|589263557|FG001|Overall Study|Not eligible|1|||
163150067|NCT00556075|589263558|FG002|Overall Study|Not eligible|2|||
163150068|NCT00556075|589263556|FG000|Overall Study|Adverse Event|1|||
163150069|NCT00556075|589263557|FG001|Overall Study|Adverse Event|2|||
163150070|NCT00556075|589263558|FG002|Overall Study|Adverse Event|0|||
163150071|NCT00556075|589263556|FG000|Overall Study|Personal issues|4|||
163150072|NCT00556075|589263557|FG001|Overall Study|Personal issues|1|||
163150073|NCT00556075|589263558|FG002|Overall Study|Personal issues|0|||
163150074|NCT00556075|589263556|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
163150075|NCT00556075|589263557|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
163150076|NCT00556075|589263558|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
163150077|NCT00601835|589263559|FG000|Overall Study|Withdrawal by Subject|9|||
163150078|NCT00601835|589263560|FG001|Overall Study|Withdrawal by Subject|6|||
163150079|NCT00601835|589263559|FG000|Overall Study|Physician Decision|1|||
163150080|NCT00601835|589263560|FG001|Overall Study|Physician Decision|0|||
163150081|NCT00601835|589263559|FG000|Overall Study|Lost to Follow-up|37|||
163150082|NCT00601835|589263560|FG001|Overall Study|Lost to Follow-up|5|||
163150083|NCT00601835|589263559|FG000|Overall Study|Adverse Event|1|||
163150084|NCT00601835|589263560|FG001|Overall Study|Adverse Event|1|||
163150085|NCT00601835|589263559|FG000|Overall Study|Relocate|12|||
163150086|NCT00601835|589263560|FG001|Overall Study|Relocate|2|||
163150087|NCT01927497|589263561|FG000|Overall Study|Death|0|||
163150088|NCT01927497|589263562|FG001|Overall Study|Death|1|||
163150089|NCT01927497|589263561|FG000|Overall Study|Protocol Violation|2|||
163150090|NCT01927497|589263562|FG001|Overall Study|Protocol Violation|0|||
163150091|NCT00395746|589263563|FG000|Overall Study|Adverse Event|5|||
163150092|NCT00395746|589263564|FG001|Overall Study|Adverse Event|2|||
163150093|NCT00395746|589263565|FG002|Overall Study|Adverse Event|2|||
163150094|NCT00395746|589263563|FG000|Overall Study|Protocol Violation|0|||
163150095|NCT00395746|589263564|FG001|Overall Study|Protocol Violation|1|||
163150096|NCT00395746|589263565|FG002|Overall Study|Protocol Violation|0|||
163150097|NCT00395746|589263563|FG000|Overall Study|Lack of Efficacy|2|||
163150098|NCT00395746|589263564|FG001|Overall Study|Lack of Efficacy|0|||
163150099|NCT00395746|589263565|FG002|Overall Study|Lack of Efficacy|17|||
163150100|NCT00395746|589263563|FG000|Overall Study|Hypoglycaemia|2|||
163150101|NCT00395746|589263564|FG001|Overall Study|Hypoglycaemia|1|||
163150102|NCT00395746|589263565|FG002|Overall Study|Hypoglycaemia|0|||
163150103|NCT00395746|589263563|FG000|Overall Study|Subject decision|0|||
163150104|NCT00395746|589263564|FG001|Overall Study|Subject decision|0|||
163150105|NCT00395746|589263565|FG002|Overall Study|Subject decision|1|||
163150106|NCT00395746|589263563|FG000|Overall Study|Withdrawal of consent|0|||
163150107|NCT00395746|589263564|FG001|Overall Study|Withdrawal of consent|0|||
163150108|NCT00395746|589263565|FG002|Overall Study|Withdrawal of consent|1|||
163150109|NCT00395746|589263563|FG000|Overall Study|Difficultulty in use of device|0|||
163150110|NCT00395746|589263564|FG001|Overall Study|Difficultulty in use of device|0|||
163150111|NCT00395746|589263565|FG002|Overall Study|Difficultulty in use of device|1|||
163150112|NCT00395746|589263563|FG000|Overall Study|Unable to visit site on schedule|1|||
163150113|NCT00395746|589263564|FG001|Overall Study|Unable to visit site on schedule|0|||
163150114|NCT00395746|589263565|FG002|Overall Study|Unable to visit site on schedule|0|||
163150115|NCT04528641|589263566|FG000|Overall Study|Withdrawal by Subject|0|||
163150116|NCT04528641|589263567|FG001|Overall Study|Withdrawal by Subject|0|||
163249655|NCT04818346|589621371|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
163249656|NCT05553808|589621372|FG000|Overall Study|Death|25|||
163249657|NCT05553808|589621373|FG001|Overall Study|Death|62|||
163249658|NCT05553808|589621372|FG000|Overall Study|Site Closed|6|||
163249659|NCT05553808|589621373|FG001|Overall Study|Site Closed|6|||
163249660|NCT05553808|589621372|FG000|Overall Study|Lost to Follow-up|1|||
163249661|NCT05553808|589621373|FG001|Overall Study|Lost to Follow-up|0|||
163249662|NCT05553808|589621372|FG000|Overall Study|Withdrawal by Subject|3|||
163355194|NCT05499130|590011367|FG000|Overall Study|Lack of Efficacy|1|||
163355195|NCT05499130|590011368|FG001|Overall Study|Lack of Efficacy|0|||
163355196|NCT05499130|590011369|FG002|Overall Study|Lack of Efficacy|0|||
163355197|NCT05499130|590011370|FG003|Overall Study|Lack of Efficacy|0|||
163355198|NCT05499130|590011371|FG004|Overall Study|Lack of Efficacy|5|||
163355199|NCT05499130|590011372|FG005|Overall Study|Lack of Efficacy|0|||
163355200|NCT05499130|590011373|FG006|Overall Study|Lack of Efficacy|1|||
163355201|NCT05499130|590011374|FG007|Overall Study|Lack of Efficacy|0|||
163355202|NCT05499130|590011367|FG000|Overall Study|Withdrawal by Subject|2|||
163355203|NCT05499130|590011368|FG001|Overall Study|Withdrawal by Subject|0|||
163355204|NCT05499130|590011369|FG002|Overall Study|Withdrawal by Subject|0|||
163355205|NCT05499130|590011370|FG003|Overall Study|Withdrawal by Subject|0|||
163355206|NCT05499130|590011371|FG004|Overall Study|Withdrawal by Subject|1|||
163355207|NCT05499130|590011372|FG005|Overall Study|Withdrawal by Subject|2|||
163355208|NCT05499130|590011373|FG006|Overall Study|Withdrawal by Subject|0|||
163355209|NCT05499130|590011374|FG007|Overall Study|Withdrawal by Subject|0|||
163355210|NCT05499130|590011367|FG000|Overall Study|Lost to Follow-up|0|||
163355211|NCT05499130|590011368|FG001|Overall Study|Lost to Follow-up|0|||
163355212|NCT05499130|590011369|FG002|Overall Study|Lost to Follow-up|0|||
163249663|NCT05553808|589621373|FG001|Overall Study|Withdrawal by Subject|2|||
163249664|NCT02273141|589621374|FG000|Overall Study|Adverse Event|0|||
163249665|NCT02273141|589621375|FG001|Overall Study|Adverse Event|1|||
163249666|NCT02273141|589621374|FG000|Overall Study|Lost to Follow-up|1|||
163249667|NCT02273141|589621375|FG001|Overall Study|Lost to Follow-up|3|||
163249668|NCT02273141|589621374|FG000|Overall Study|Withdrawal by Subject|10|||
163249669|NCT02273141|589621375|FG001|Overall Study|Withdrawal by Subject|15|||
163249670|NCT02273141|589621374|FG000|Overall Study|Various|6|||
163249671|NCT02273141|589621375|FG001|Overall Study|Various|6|||
163249672|NCT00529399|589621378|FG000|Overall Study|Lost to Follow-up|1|||
163249673|NCT00529399|589621379|FG001|Overall Study|Lost to Follow-up|0|||
163249674|NCT00529399|589621380|FG002|Overall Study|Lost to Follow-up|1|||
163249675|NCT00529399|589621378|FG000|Overall Study|Withdrawal by Subject|1|||
163249676|NCT00529399|589621379|FG001|Overall Study|Withdrawal by Subject|0|||
163249677|NCT00529399|589621380|FG002|Overall Study|Withdrawal by Subject|1|||
163249678|NCT00529399|589621378|FG000|Overall Study|Non-compliant|0|||
163249679|NCT00529399|589621379|FG001|Overall Study|Non-compliant|1|||
163249680|NCT00529399|589621380|FG002|Overall Study|Non-compliant|0|||
163249681|NCT03695172|589621381|FG000|Overall Study|Withdrawal by Subject|1|||
163249682|NCT03695172|589621382|FG001|Overall Study|Withdrawal by Subject|1|||
163249683|NCT03695172|589621383|FG002|Overall Study|Withdrawal by Subject|0|||
163249684|NCT01506193|589621384|FG000|Overall Study|Protocol Violation|1|||
163249685|NCT01506193|589621385|FG001|Overall Study|Protocol Violation|0|||
163249686|NCT01506193|589621386|FG002|Overall Study|Protocol Violation|1|||
163249687|NCT01506193|589621384|FG000|Overall Study|Migrated/moved from study area|0|||
163249688|NCT01506193|589621385|FG001|Overall Study|Migrated/moved from study area|0|||
163249689|NCT01506193|589621386|FG002|Overall Study|Migrated/moved from study area|1|||
163249690|NCT01506193|589621384|FG000|Overall Study|Adverse event, non-fatal|0|||
163249691|NCT01506193|589621385|FG001|Overall Study|Adverse event, non-fatal|0|||
163249692|NCT01506193|589621386|FG002|Overall Study|Adverse event, non-fatal|1|||
163249693|NCT01506193|589621384|FG000|Overall Study|Withdrawal by Subject|5|||
163355213|NCT05499130|590011370|FG003|Overall Study|Lost to Follow-up|0|||
163355214|NCT05499130|590011371|FG004|Overall Study|Lost to Follow-up|0|||
163355215|NCT05499130|590011372|FG005|Overall Study|Lost to Follow-up|2|||
163355216|NCT05499130|590011373|FG006|Overall Study|Lost to Follow-up|0|||
163355217|NCT05499130|590011374|FG007|Overall Study|Lost to Follow-up|0|||
163355218|NCT05499130|590011367|FG000|Overall Study|Other Than Specified|0|||
163249694|NCT01506193|589621385|FG001|Overall Study|Withdrawal by Subject|1|||
163249695|NCT01506193|589621386|FG002|Overall Study|Withdrawal by Subject|8|||
163249696|NCT01506193|589621384|FG000|Overall Study|Lost to Follow-up|8|||
163249697|NCT01506193|589621385|FG001|Overall Study|Lost to Follow-up|3|||
163249698|NCT01506193|589621386|FG002|Overall Study|Lost to Follow-up|3|||
163249699|NCT04575467|589621403|FG000|Overall Study|Adverse Event|0|||
163249700|NCT04575467|589621404|FG001|Overall Study|Adverse Event|1|||
163249701|NCT04575467|589621405|FG002|Overall Study|Adverse Event|0|||
163249702|NCT04575467|589621406|FG003|Overall Study|Adverse Event|0|||
163249703|NCT01328574|589621407|FG000|Overall Study|Refused further treatment|1|||
163355219|NCT05499130|590011368|FG001|Overall Study|Other Than Specified|0|||
163355220|NCT05499130|590011369|FG002|Overall Study|Other Than Specified|0|||
163355221|NCT05499130|590011370|FG003|Overall Study|Other Than Specified|0|||
163355222|NCT05499130|590011371|FG004|Overall Study|Other Than Specified|1|||
163150117|NCT04528641|589263568|FG002|Overall Study|Withdrawal by Subject|0|||
163150118|NCT04528641|589263569|FG003|Overall Study|Withdrawal by Subject|1|||
163150119|NCT04528641|589263570|FG004|Overall Study|Withdrawal by Subject|0|||
163150120|NCT04528641|589263571|FG005|Overall Study|Withdrawal by Subject|1|||
163150121|NCT03914417|589263572|FG000|Overall Study|Withdrawal by Subject|2|||
163150122|NCT00517296|589263577|FG000|Overall Study|Withdrawal by Subject|1|||
163150123|NCT00517296|589263578|FG001|Overall Study|Withdrawal by Subject|0|||
163150124|NCT04764162|589263581|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
163150125|NCT04764162|589263582|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
163150126|NCT00795704|589263583|FG000|Overall Study|Withdrawal by Subject|3|||
163150127|NCT00795704|589263584|FG001|Overall Study|Withdrawal by Subject|2|||
163150128|NCT00795704|589263583|FG000|Overall Study|Adverse Event|1|||
163150129|NCT00795704|589263584|FG001|Overall Study|Adverse Event|1|||
163150130|NCT01300728|589263585|FG000|Overall Study|Withdrawal by Subject|1|||
163150131|NCT01300728|589263586|FG001|Overall Study|Withdrawal by Subject|1|||
163150132|NCT01300728|589263585|FG000|Overall Study|Physician Decision|1|||
163150133|NCT01300728|589263586|FG001|Overall Study|Physician Decision|0|||
163150134|NCT01247324|589263587|FG000|Overall Study|Death|6|||
163150135|NCT01247324|589263588|FG001|Overall Study|Death|10|||
163150136|NCT01247324|589263587|FG000|Overall Study|Physician Decision|2|||
163150137|NCT01247324|589263588|FG001|Overall Study|Physician Decision|3|||
163150138|NCT01247324|589263587|FG000|Overall Study|Non-compliance with study drug|3|||
163150139|NCT01247324|589263588|FG001|Overall Study|Non-compliance with study drug|0|||
163150140|NCT01247324|589263587|FG000|Overall Study|Lack of Efficacy|24|||
163150141|NCT01247324|589263588|FG001|Overall Study|Lack of Efficacy|14|||
163150142|NCT01247324|589263587|FG000|Overall Study|Non-compliance|3|||
163150143|NCT01247324|589263588|FG001|Overall Study|Non-compliance|2|||
163150144|NCT01247324|589263587|FG000|Overall Study|Pregnancy|5|||
163150145|NCT01247324|589263588|FG001|Overall Study|Pregnancy|10|||
163150146|NCT01247324|589263587|FG000|Overall Study|Protocol Violation|1|||
163150147|NCT01247324|589263588|FG001|Overall Study|Protocol Violation|1|||
163150148|NCT01247324|589263587|FG000|Overall Study|Reason not specified|42|||
163150149|NCT01247324|589263588|FG001|Overall Study|Reason not specified|32|||
163150150|NCT01247324|589263587|FG000|Overall Study|Consent withdrawn by participant|41|||
163150151|NCT01247324|589263588|FG001|Overall Study|Consent withdrawn by participant|56|||
163150152|NCT01247324|589263587|FG000|Overall Study|Adverse Event|49|||
163150153|NCT01247324|589263588|FG001|Overall Study|Adverse Event|35|||
163150154|NCT01247324|589263587|FG000|Overall Study|Lost to Follow-up|3|||
163150155|NCT01247324|589263588|FG001|Overall Study|Lost to Follow-up|6|||
163150156|NCT01247324|589263587|FG000|Overall Study|Study Terminated by Sponsor|4|||
163150157|NCT01247324|589263588|FG001|Overall Study|Study Terminated by Sponsor|1|||
163150158|NCT01247324|589263587|FG000|Overall Study|Missing|2|||
163150159|NCT01247324|589263588|FG001|Overall Study|Missing|1|||
163150160|NCT00506350|589263589|FG000|Overall Study|Serious Adverse Event|1|||
163150161|NCT00506350|589263590|FG001|Overall Study|Serious Adverse Event|0|||
163150162|NCT00506350|589263591|FG002|Overall Study|Serious Adverse Event|0|||
163150163|NCT00506350|589263592|FG003|Overall Study|Serious Adverse Event|0|||
163150164|NCT00506350|589263593|FG004|Overall Study|Serious Adverse Event|0|||
163150165|NCT00506350|589263594|FG005|Overall Study|Serious Adverse Event|0|||
163150166|NCT00506350|589263595|FG006|Overall Study|Serious Adverse Event|0|||
163150167|NCT00506350|589263596|FG007|Overall Study|Serious Adverse Event|0|||
163150168|NCT00506350|589263597|FG008|Overall Study|Serious Adverse Event|0|||
163150169|NCT00506350|589263589|FG000|Overall Study|Adverse Event|0|||
163150170|NCT00506350|589263590|FG001|Overall Study|Adverse Event|0|||
163150171|NCT00506350|589263591|FG002|Overall Study|Adverse Event|0|||
163150172|NCT00506350|589263592|FG003|Overall Study|Adverse Event|0|||
163150173|NCT00506350|589263593|FG004|Overall Study|Adverse Event|0|||
163150174|NCT00506350|589263594|FG005|Overall Study|Adverse Event|0|||
163150175|NCT00506350|589263595|FG006|Overall Study|Adverse Event|0|||
163150176|NCT00506350|589263596|FG007|Overall Study|Adverse Event|1|||
163150177|NCT00506350|589263597|FG008|Overall Study|Adverse Event|1|||
163150178|NCT00506350|589263589|FG000|Overall Study|Protocol Violation|0|||
163150179|NCT00506350|589263590|FG001|Overall Study|Protocol Violation|0|||
163150180|NCT00506350|589263591|FG002|Overall Study|Protocol Violation|1|||
163150181|NCT00506350|589263592|FG003|Overall Study|Protocol Violation|0|||
163150182|NCT00506350|589263593|FG004|Overall Study|Protocol Violation|0|||
163249704|NCT01687257|589621411|FG000|Overall Study|Efficacy Failure|6|||
163249705|NCT01687257|589621412|FG001|Overall Study|Efficacy Failure|0|||
163150183|NCT00506350|589263594|FG005|Overall Study|Protocol Violation|0|||
163150184|NCT00506350|589263595|FG006|Overall Study|Protocol Violation|1|||
163150185|NCT00506350|589263596|FG007|Overall Study|Protocol Violation|0|||
163150186|NCT00506350|589263597|FG008|Overall Study|Protocol Violation|0|||
163150187|NCT00506350|589263589|FG000|Overall Study|Withdrawal by Subject|0|||
163150188|NCT00506350|589263590|FG001|Overall Study|Withdrawal by Subject|1|||
163150189|NCT00506350|589263591|FG002|Overall Study|Withdrawal by Subject|1|||
163150190|NCT00506350|589263592|FG003|Overall Study|Withdrawal by Subject|1|||
163150191|NCT00506350|589263593|FG004|Overall Study|Withdrawal by Subject|4|||
163249706|NCT01687257|589621413|FG002|Overall Study|Efficacy Failure|5|||
163249707|NCT01687257|589621411|FG000|Overall Study|Subject Withdrew Consent|1|||
163249708|NCT01687257|589621412|FG001|Overall Study|Subject Withdrew Consent|1|||
163249709|NCT01687257|589621413|FG002|Overall Study|Subject Withdrew Consent|1|||
163249710|NCT01687257|589621411|FG000|Overall Study|Adverse Event|1|||
163249711|NCT01687257|589621412|FG001|Overall Study|Adverse Event|0|||
163249712|NCT01687257|589621413|FG002|Overall Study|Adverse Event|0|||
163249713|NCT01687257|589621411|FG000|Overall Study|Investigator's Discretion|0|||
163249714|NCT01687257|589621412|FG001|Overall Study|Investigator's Discretion|3|||
163249715|NCT01687257|589621413|FG002|Overall Study|Investigator's Discretion|0|||
163249716|NCT04899349|589621414|FG000|Overall Study|Study terminated by Sponsor|2|||
163249717|NCT04899349|589621415|FG001|Overall Study|Study terminated by Sponsor|0|||
163249718|NCT03336619|589621417|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
163249719|NCT03336619|589621418|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
163249720|NCT03336619|589621417|FG000|Overall Study|Withdrawal by Subject|17|||
163249721|NCT03336619|589621418|FG001|Overall Study|Withdrawal by Subject|16|||
163249722|NCT03336619|589621417|FG000|Overall Study|Adverse Event|2|||
163249723|NCT03336619|589621418|FG001|Overall Study|Adverse Event|5|||
163249724|NCT03336619|589621417|FG000|Overall Study|Physician Decision|3|||
163249725|NCT03336619|589621418|FG001|Overall Study|Physician Decision|0|||
163249726|NCT01300546|589621419|FG000|Overall Study|Withdrawal by Subject|1|||
163249727|NCT01300546|589621420|FG001|Overall Study|Withdrawal by Subject|0|||
163249728|NCT01300546|589621419|FG000|Overall Study|Lost to Follow-up|0|||
163249729|NCT01300546|589621420|FG001|Overall Study|Lost to Follow-up|2|||
163249730|NCT01300546|589621419|FG000|Overall Study|Lack of Efficacy|0|||
163249731|NCT01300546|589621420|FG001|Overall Study|Lack of Efficacy|3|||
163249732|NCT01300546|589621419|FG000|Overall Study|Adverse Event|0|||
163249733|NCT01300546|589621420|FG001|Overall Study|Adverse Event|1|||
163249734|NCT02820623|589621421|FG000|Overall Study|Withdrawal by Subject|1|||
163249735|NCT02820623|589621422|FG001|Overall Study|Withdrawal by Subject|3|||
163249736|NCT02820623|589621423|FG002|Overall Study|Withdrawal by Subject|3|||
163249737|NCT02820623|589621421|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
163249738|NCT02820623|589621422|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
163249739|NCT02820623|589621423|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
163249740|NCT02820623|589621421|FG000|Overall Study|Therapist unable to enroll clients|1|||
163249741|NCT02820623|589621422|FG001|Overall Study|Therapist unable to enroll clients|1|||
163249742|NCT02820623|589621423|FG002|Overall Study|Therapist unable to enroll clients|3|||
163249743|NCT02820623|589621421|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
163249744|NCT02820623|589621422|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
163249745|NCT02820623|589621423|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
163249746|NCT05207813|589621426|FG000|Overall Study|Lost to Follow-up|2|||
163249747|NCT01954017|589621427|FG000|Overall Study|Adverse Event|0|||
163249748|NCT01954017|589621428|FG001|Overall Study|Adverse Event|0|||
163249749|NCT01954017|589621429|FG002|Overall Study|Adverse Event|1|||
163249750|NCT01954017|589621427|FG000|Overall Study|Death|2|||
163249751|NCT01954017|589621428|FG001|Overall Study|Death|1|||
163249752|NCT01954017|589621429|FG002|Overall Study|Death|1|||
163249753|NCT01954017|589621427|FG000|Overall Study|Withdrawal by Subject|0|||
163249754|NCT01954017|589621428|FG001|Overall Study|Withdrawal by Subject|1|||
163249755|NCT01954017|589621429|FG002|Overall Study|Withdrawal by Subject|0|||
163249756|NCT01954017|589621427|FG000|Overall Study|Protocol Violation|0|||
163249757|NCT01954017|589621428|FG001|Overall Study|Protocol Violation|3|||
163249758|NCT01954017|589621429|FG002|Overall Study|Protocol Violation|2|||
163249759|NCT01954017|589621427|FG000|Overall Study|Necrotizing enterocolitis|1|||
163249760|NCT01954017|589621428|FG001|Overall Study|Necrotizing enterocolitis|0|||
163249761|NCT01954017|589621429|FG002|Overall Study|Necrotizing enterocolitis|1|||
163249762|NCT01954017|589621427|FG000|Overall Study|Enteral intake stopped >7 days|0|||
163249763|NCT01954017|589621428|FG001|Overall Study|Enteral intake stopped >7 days|1|||
163249764|NCT01954017|589621429|FG002|Overall Study|Enteral intake stopped >7 days|1|||
163249765|NCT01954017|589621427|FG000|Overall Study|All other reasons|2|||
163249766|NCT01954017|589621428|FG001|Overall Study|All other reasons|2|||
163249767|NCT01954017|589621429|FG002|Overall Study|All other reasons|7|||
163249768|NCT02653482|589621432|FG000|Overall Study|Death|1|||
163249769|NCT02653482|589621433|FG001|Overall Study|Death|1|||
163249770|NCT05132699|589621435|FG000|Overall Study|Withdrawal by Subject|3|||
163249771|NCT05132699|589621436|FG001|Overall Study|Withdrawal by Subject|0|||
163249772|NCT04370054|589621437|FG000|Treatment Phase|Lost to Follow-up|1|||
163249773|NCT04370054|589621437|FG000|Treatment Phase|Withdrawal by Subject|1|||
163249774|NCT04370054|589621437|FG000|Follow-Up Phase|Ongoing|75|||
163249775|NCT02096900|589621438|FG000|Overall Study|Did not receive medication|3|||
163249776|NCT02096900|589621439|FG001|Overall Study|Did not receive medication|1|||
163249777|NCT02096900|589621438|FG000|Overall Study|Surgery cancelled- medication received|1|||
163249778|NCT02096900|589621439|FG001|Overall Study|Surgery cancelled- medication received|1|||
163249779|NCT00710424|589621442|FG000|Overall Study|Adverse Event|30|||
163249780|NCT00710424|589621443|FG001|Overall Study|Adverse Event|12|||
163249781|NCT00710424|589621442|FG000|Overall Study|Lack of Efficacy|4|||
163249782|NCT00710424|589621443|FG001|Overall Study|Lack of Efficacy|5|||
163249783|NCT00710424|589621442|FG000|Overall Study|Withdrawal by Subject|5|||
163249784|NCT00710424|589621443|FG001|Overall Study|Withdrawal by Subject|3|||
163249785|NCT00710424|589621442|FG000|Overall Study|Lost to Follow-up|0|||
163249786|NCT00710424|589621443|FG001|Overall Study|Lost to Follow-up|1|||
163249787|NCT00710424|589621442|FG000|Overall Study|Refused medication, no side effects|1|||
163249788|NCT00710424|589621443|FG001|Overall Study|Refused medication, no side effects|0|||
163249789|NCT00710424|589621442|FG000|Overall Study|Non-compliance with stable analgesia|1|||
163249790|NCT00710424|589621443|FG001|Overall Study|Non-compliance with stable analgesia|0|||
163249791|NCT00710424|589621442|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
163249792|NCT00710424|589621443|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
163249793|NCT00710424|589621442|FG000|Overall Study|Subject thought medication changed|1|||
163249794|NCT00710424|589621443|FG001|Overall Study|Subject thought medication changed|0|||
163249795|NCT00710424|589621442|FG000|Overall Study|Ceased treatment due to travel|1|||
163249796|NCT00710424|589621443|FG001|Overall Study|Ceased treatment due to travel|0|||
163249797|NCT00710424|589621442|FG000|Overall Study|Subject preferred paracetamol|0|||
163249798|NCT00710424|589621443|FG001|Overall Study|Subject preferred paracetamol|1|||
163249799|NCT00710424|589621442|FG000|Overall Study|Felt good so stopped treatment|0|||
163249800|NCT00710424|589621443|FG001|Overall Study|Felt good so stopped treatment|1|||
163249801|NCT06273774|589621444|FG000|Overall Study|Participant was out of state.|0|||
163249802|NCT06273774|589621445|FG001|Overall Study|Participant was out of state.|0|||
163249803|NCT06273774|589621446|FG002|Overall Study|Participant was out of state.|0|||
163249804|NCT06273774|589621447|FG003|Overall Study|Participant was out of state.|0|||
163249805|NCT06273774|589621448|FG004|Overall Study|Participant was out of state.|0|||
163249806|NCT06273774|589621449|FG005|Overall Study|Participant was out of state.|1|||
163249807|NCT06273774|589621444|FG000|Overall Study|Lost to Follow-up|0|||
163249808|NCT06273774|589621445|FG001|Overall Study|Lost to Follow-up|0|||
163249809|NCT06273774|589621446|FG002|Overall Study|Lost to Follow-up|0|||
163249810|NCT06273774|589621447|FG003|Overall Study|Lost to Follow-up|0|||
163249811|NCT06273774|589621448|FG004|Overall Study|Lost to Follow-up|1|||
163249812|NCT06273774|589621449|FG005|Overall Study|Lost to Follow-up|0|||
163249813|NCT04918784|589623821|FG000|Overall Study|Amputation - no longer eligible|1|||
163249814|NCT04918784|589623822|FG001|Overall Study|Amputation - no longer eligible|2|||
163249815|NCT04918784|589623821|FG000|Overall Study|Death|1|||
163249816|NCT04918784|589623822|FG001|Overall Study|Death|0|||
163249817|NCT04918784|589623821|FG000|Overall Study|patient non-compliance|3|||
163249818|NCT04918784|589623822|FG001|Overall Study|patient non-compliance|1|||
163249819|NCT04918784|589623821|FG000|Overall Study|Adverse Event|1|||
163249820|NCT04918784|589623822|FG001|Overall Study|Adverse Event|0|||
163249821|NCT01712009|589623823|FG000|Overall Study|Withdrawal by Subject|24|||
163249822|NCT01712009|589623824|FG001|Overall Study|Withdrawal by Subject|15|||
163249823|NCT01712009|589623825|FG002|Overall Study|Withdrawal by Subject|8|||
163249824|NCT01712009|589623823|FG000|Overall Study|Lost to Follow-up|2|||
163249825|NCT01712009|589623824|FG001|Overall Study|Lost to Follow-up|0|||
163249826|NCT01712009|589623825|FG002|Overall Study|Lost to Follow-up|1|||
163249827|NCT01712009|589623823|FG000|Overall Study|Decision by Sponsor|12|||
163249828|NCT01712009|589623824|FG001|Overall Study|Decision by Sponsor|14|||
163249829|NCT01712009|589623825|FG002|Overall Study|Decision by Sponsor|12|||
163249830|NCT01111123|589623827|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
163249831|NCT01111123|589623828|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
163249832|NCT01111123|589623827|FG000|Maintenance Phase|Lost to Follow-up|0|||
163249833|NCT01111123|589623828|FG001|Maintenance Phase|Lost to Follow-up|2|||
163249834|NCT01986881|589623829|FG000|Overall Study|Death|228|||
163249835|NCT01986881|589623830|FG001|Overall Study|Death|233|||
163249836|NCT01986881|589623831|FG002|Overall Study|Death|247|||
163249837|NCT01986881|589623829|FG000|Overall Study|Lost to Follow-up|51|||
163249838|NCT01986881|589623830|FG001|Overall Study|Lost to Follow-up|44|||
163249839|NCT01986881|589623831|FG002|Overall Study|Lost to Follow-up|55|||
163249840|NCT01986881|589623829|FG000|Overall Study|Physician Decision|7|||
163249841|NCT01986881|589623830|FG001|Overall Study|Physician Decision|4|||
163249842|NCT01986881|589623831|FG002|Overall Study|Physician Decision|6|||
163249843|NCT01986881|589623829|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
163249844|NCT01986881|589623830|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
163249845|NCT01986881|589623831|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
163249846|NCT01986881|589623829|FG000|Overall Study|Withdrawal by Subject|41|||
163249847|NCT01986881|589623830|FG001|Overall Study|Withdrawal by Subject|60|||
163249848|NCT01986881|589623831|FG002|Overall Study|Withdrawal by Subject|45|||
163249849|NCT01986881|589623829|FG000|Overall Study|Subject Moved|0|||
163249850|NCT01986881|589623830|FG001|Overall Study|Subject Moved|1|||
163249851|NCT01986881|589623831|FG002|Overall Study|Subject Moved|0|||
163249852|NCT01986881|589623829|FG000|Overall Study|Other|1|||
163249853|NCT01986881|589623830|FG001|Overall Study|Other|2|||
163249854|NCT01986881|589623831|FG002|Overall Study|Other|2|||
163249855|NCT04050865|589623837|FG000|Overall Study|Adverse Event|1|||
163410349|NCT05103332|590211373|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
163249856|NCT04050865|589623838|FG001|Overall Study|Adverse Event|0|||
163249857|NCT04050865|589623837|FG000|Overall Study|no insert|1|||
163249858|NCT04050865|589623838|FG001|Overall Study|no insert|0|||
163249859|NCT04050865|589623837|FG000|Overall Study|Only 1 insert|2|||
163249860|NCT04050865|589623838|FG001|Overall Study|Only 1 insert|3|||
163249861|NCT04050865|589623837|FG000|Overall Study|Physician Decision|0|||
163249862|NCT04050865|589623838|FG001|Overall Study|Physician Decision|1|||
163249863|NCT04050865|589623837|FG000|Overall Study|Withdrawal by Subject|0|||
163249864|NCT04050865|589623838|FG001|Overall Study|Withdrawal by Subject|1|||
163249865|NCT02035332|589623839|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
163249866|NCT01258608|589623840|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
163249867|NCT01258608|589623841|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
163249868|NCT01258608|589623840|FG000|Overall Study|Clinical progression|1|||
163249869|NCT01258608|589623841|FG001|Overall Study|Clinical progression|0|||
163249870|NCT01258608|589623840|FG000|Overall Study|Sponsor decision|0|||
163249871|NCT01258608|589623841|FG001|Overall Study|Sponsor decision|1|||
163249872|NCT01258608|589623840|FG000|Overall Study|Physician Decision|6|||
163249873|NCT01258608|589623841|FG001|Overall Study|Physician Decision|1|||
163249874|NCT01258608|589623840|FG000|Overall Study|Lost to Follow-up|0|||
163249875|NCT01258608|589623841|FG001|Overall Study|Lost to Follow-up|1|||
163249876|NCT01258608|589623840|FG000|Overall Study|Lack of compliance|1|||
163249877|NCT01258608|589623841|FG001|Overall Study|Lack of compliance|0|||
163249878|NCT01258608|589623840|FG000|Overall Study|Lack of Efficacy|0|||
163249879|NCT01258608|589623841|FG001|Overall Study|Lack of Efficacy|1|||
163249880|NCT01258608|589623840|FG000|Overall Study|Adverse Event|6|||
163249881|NCT01258608|589623841|FG001|Overall Study|Adverse Event|10|||
163249882|NCT01258608|589623840|FG000|Overall Study|Withdrawal by Subject|6|||
163249883|NCT01258608|589623841|FG001|Overall Study|Withdrawal by Subject|5|||
163249884|NCT04205630|589623842|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
163249885|NCT04205630|589623842|FG000|Overall Study|Disease clinical progression|7|||
163249886|NCT04205630|589623842|FG000|Overall Study|Withdrawal by Subject|2|||
163249887|NCT04205630|589623842|FG000|Overall Study|Adverse Event|17|||
163249888|NCT04205630|589623842|FG000|Overall Study|Other|1|||
163249889|NCT00447057|589623849|FG000|Overall Study|Adverse Event|4|||
163249890|NCT00447057|589623850|FG001|Overall Study|Adverse Event|10|||
163249891|NCT00447057|589623851|FG002|Overall Study|Adverse Event|0|||
163249892|NCT00447057|589623852|FG003|Overall Study|Adverse Event|3|||
163249893|NCT00447057|589623849|FG000|Overall Study|Death due to study disease|6|||
163249894|NCT00447057|589623850|FG001|Overall Study|Death due to study disease|4|||
163249895|NCT00447057|589623851|FG002|Overall Study|Death due to study disease|1|||
163249896|NCT00447057|589623852|FG003|Overall Study|Death due to study disease|1|||
163249897|NCT00447057|589623849|FG000|Overall Study|Lost to Follow-up|0|||
163249898|NCT00447057|589623850|FG001|Overall Study|Lost to Follow-up|1|||
163249899|NCT00447057|589623851|FG002|Overall Study|Lost to Follow-up|0|||
163249900|NCT00447057|589623852|FG003|Overall Study|Lost to Follow-up|0|||
163249901|NCT00447057|589623849|FG000|Overall Study|Entry criteria not met|1|||
163249902|NCT00447057|589623850|FG001|Overall Study|Entry criteria not met|1|||
163249903|NCT00447057|589623851|FG002|Overall Study|Entry criteria not met|0|||
163249904|NCT00447057|589623852|FG003|Overall Study|Entry criteria not met|0|||
163249905|NCT00447057|589623849|FG000|Overall Study|Protocol Violation|0|||
163249906|NCT00447057|589623850|FG001|Overall Study|Protocol Violation|1|||
163249907|NCT00447057|589623851|FG002|Overall Study|Protocol Violation|0|||
163249908|NCT00447057|589623852|FG003|Overall Study|Protocol Violation|0|||
163249909|NCT00447057|589623849|FG000|Overall Study|Withdrawal by Subject|4|||
163249910|NCT00447057|589623850|FG001|Overall Study|Withdrawal by Subject|5|||
163249911|NCT00447057|589623851|FG002|Overall Study|Withdrawal by Subject|1|||
163249912|NCT00447057|589623852|FG003|Overall Study|Withdrawal by Subject|1|||
163249913|NCT00447057|589623849|FG000|Overall Study|Physician Decision|9|||
163249914|NCT00447057|589623850|FG001|Overall Study|Physician Decision|6|||
163249915|NCT00447057|589623851|FG002|Overall Study|Physician Decision|3|||
163249916|NCT00447057|589623852|FG003|Overall Study|Physician Decision|1|||
163249917|NCT00447057|589623849|FG000|Overall Study|Sponsor decision|1|||
163249918|NCT00447057|589623850|FG001|Overall Study|Sponsor decision|1|||
163249919|NCT00447057|589623851|FG002|Overall Study|Sponsor decision|0|||
163249920|NCT00447057|589623852|FG003|Overall Study|Sponsor decision|0|||
163249921|NCT00447057|589623849|FG000|Overall Study|Progressive disease|58|||
163249922|NCT00447057|589623850|FG001|Overall Study|Progressive disease|43|||
163249923|NCT00447057|589623851|FG002|Overall Study|Progressive disease|13|||
163249924|NCT00447057|589623852|FG003|Overall Study|Progressive disease|18|||
163249925|NCT00447057|589623849|FG000|Overall Study|Death due to adverse event|0|||
163249926|NCT00447057|589623850|FG001|Overall Study|Death due to adverse event|0|||
163249927|NCT00447057|589623851|FG002|Overall Study|Death due to adverse event|1|||
163249928|NCT00447057|589623852|FG003|Overall Study|Death due to adverse event|2|||
163249929|NCT00447057|589623849|FG000|Overall Study|Death, study drug related|0|||
163249930|NCT00447057|589623850|FG001|Overall Study|Death, study drug related|1|||
163249931|NCT00447057|589623851|FG002|Overall Study|Death, study drug related|0|||
163249932|NCT00447057|589623852|FG003|Overall Study|Death, study drug related|0|||
163249933|NCT04493216|589623857|FG000|Overall Study|Study terminated by sponsor|30|||
163249934|NCT04493216|589623858|FG001|Overall Study|Study terminated by sponsor|33|||
163249935|NCT04493216|589623859|FG002|Overall Study|Study terminated by sponsor|28|||
163249936|NCT04493216|589623860|FG003|Overall Study|Study terminated by sponsor|27|||
163249937|NCT04493216|589623857|FG000|Overall Study|Withdrawal by Subject|2|||
163249938|NCT04493216|589623858|FG001|Overall Study|Withdrawal by Subject|1|||
163249939|NCT04493216|589623859|FG002|Overall Study|Withdrawal by Subject|1|||
163249940|NCT04493216|589623860|FG003|Overall Study|Withdrawal by Subject|2|||
163249941|NCT04493216|589623857|FG000|Overall Study|Protocol Violation|1|||
163249942|NCT04493216|589623858|FG001|Overall Study|Protocol Violation|2|||
163249943|NCT04493216|589623859|FG002|Overall Study|Protocol Violation|0|||
163249944|NCT04493216|589623860|FG003|Overall Study|Protocol Violation|2|||
163249945|NCT04493216|589623857|FG000|Overall Study|Physician Decision|0|||
163249946|NCT04493216|589623858|FG001|Overall Study|Physician Decision|0|||
163249947|NCT04493216|589623859|FG002|Overall Study|Physician Decision|1|||
163249948|NCT04493216|589623860|FG003|Overall Study|Physician Decision|0|||
163249949|NCT04493216|589623857|FG000|Overall Study|Lost to Follow-up|2|||
163249950|NCT04493216|589623858|FG001|Overall Study|Lost to Follow-up|1|||
163249951|NCT04493216|589623859|FG002|Overall Study|Lost to Follow-up|0|||
163249952|NCT04493216|589623860|FG003|Overall Study|Lost to Follow-up|1|||
163249953|NCT04493216|589623857|FG000|Overall Study|Adverse Event|1|||
163249954|NCT04493216|589623858|FG001|Overall Study|Adverse Event|4|||
163249955|NCT04493216|589623859|FG002|Overall Study|Adverse Event|5|||
163249956|NCT04493216|589623860|FG003|Overall Study|Adverse Event|2|||
163249957|NCT04493216|589623857|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
163249958|NCT04493216|589623858|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
163249959|NCT04493216|589623859|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
163249960|NCT04493216|589623860|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
163249961|NCT04605978|589623863|FG000|Overall Study|Adverse Event|2|||
163249962|NCT04605978|589623864|FG001|Overall Study|Adverse Event|1|||
163249963|NCT04605978|589623863|FG000|Overall Study|Withdrawal nonmedical reason|1|||
163249964|NCT04605978|589623864|FG001|Overall Study|Withdrawal nonmedical reason|1|||
163249965|NCT02216123|589623865|FG000|Overall Study|Lost to Follow-up|4|||
163355223|NCT05499130|590011372|FG005|Overall Study|Other Than Specified|1|||
163355224|NCT05499130|590011373|FG006|Overall Study|Other Than Specified|2|||
163355225|NCT05499130|590011374|FG007|Overall Study|Other Than Specified|0|||
163355226|NCT05499130|590011367|FG000|Overall Study|Protocol Violation|0|||
163355227|NCT05499130|590011368|FG001|Overall Study|Protocol Violation|0|||
163355228|NCT05499130|590011369|FG002|Overall Study|Protocol Violation|0|||
163355229|NCT05499130|590011370|FG003|Overall Study|Protocol Violation|0|||
163355230|NCT05499130|590011371|FG004|Overall Study|Protocol Violation|1|||
163355231|NCT05499130|590011372|FG005|Overall Study|Protocol Violation|0|||
163355232|NCT05499130|590011373|FG006|Overall Study|Protocol Violation|0|||
163355233|NCT05499130|590011374|FG007|Overall Study|Protocol Violation|0|||
163249966|NCT02216123|589623866|FG001|Overall Study|Lost to Follow-up|2|||
163249967|NCT02216123|589623865|FG000|Overall Study|Withdrawal by Subject|2|||
163249968|NCT02216123|589623866|FG001|Overall Study|Withdrawal by Subject|0|||
163249969|NCT03318523|589623869|FG000|PC Period: Up to Year 1|Adverse Event|1|||
163249970|NCT03318523|589623870|FG001|PC Period: Up to Year 1|Adverse Event|0|||
163249971|NCT03318523|589623871|FG002|PC Period: Up to Year 1|Adverse Event|2|||
163355234|NCT00013611|590011376|FG000|Overall Study|Lost to Follow-up|91|||
163355235|NCT00013611|590011377|FG001|Overall Study|Lost to Follow-up|100|||
163355236|NCT01663506|590011378|FG000|Overall Study|Lack of Efficacy|3|||
163355237|NCT01663506|590011378|FG000|Overall Study|Consent Withdrawal by Subject|1|||
163355238|NCT01663506|590011378|FG000|Overall Study|Lost to Follow-up|1|||
163355239|NCT01663506|590011378|FG000|Overall Study|Adverse Event|1|||
163355240|NCT01663506|590011378|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
163355241|NCT00810342|590011379|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
163355242|NCT00810342|590011380|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
163355243|NCT00810342|590011379|FG000|Month 1 Follow-up|Pregnancy|1|||
163355244|NCT00810342|590011380|FG001|Month 1 Follow-up|Pregnancy|0|||
163355245|NCT00810342|590011379|FG000|6-month Follow-up|Lost to Follow-up|18|||
163355246|NCT00810342|590011380|FG001|6-month Follow-up|Lost to Follow-up|6|||
163355247|NCT00810342|590011379|FG000|6-month Follow-up|Pregnancy|6|||
163355248|NCT00810342|590011380|FG001|6-month Follow-up|Pregnancy|2|||
163249972|NCT03318523|589623872|FG003|PC Period: Up to Year 1|Adverse Event|0|||
163249973|NCT03318523|589623873|FG004|PC Period: Up to Year 1|Adverse Event|0|||
163249974|NCT03318523|589623874|FG005|PC Period: Up to Year 1|Adverse Event|0|||
163249975|NCT03318523|589623875|FG006|PC Period: Up to Year 1|Adverse Event|0|||
163355249|NCT00810342|590011379|FG000|12-month Followup|Pregnancy|9|||
163355250|NCT00810342|590011380|FG001|12-month Followup|Pregnancy|10|||
163355251|NCT00810342|590011379|FG000|12-month Followup|Lost to Follow-up|3|||
163355252|NCT00810342|590011380|FG001|12-month Followup|Lost to Follow-up|1|||
163355253|NCT02330562|590011381|FG000|Overall Study|Adverse Event|0|||
163355254|NCT02330562|590011382|FG001|Overall Study|Adverse Event|0|||
163355255|NCT02330562|590011383|FG002|Overall Study|Adverse Event|3|||
163355256|NCT02330562|590011384|FG003|Overall Study|Adverse Event|0|||
163355257|NCT02330562|590011385|FG004|Overall Study|Adverse Event|3|||
163249976|NCT03318523|589623876|FG007|PC Period: Up to Year 1|Adverse Event|0|||
163249977|NCT03318523|589623877|FG008|PC Period: Up to Year 1|Adverse Event|0|||
163249978|NCT03318523|589623878|FG009|PC Period: Up to Year 1|Adverse Event|0|||
163249979|NCT03318523|589623869|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
163249980|NCT03318523|589623870|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
163249981|NCT03318523|589623871|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
163249982|NCT03318523|589623872|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
163249983|NCT03318523|589623873|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
163249984|NCT03318523|589623874|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
163249985|NCT03318523|589623875|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
163249986|NCT03318523|589623876|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
163249987|NCT03318523|589623877|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
163249988|NCT03318523|589623878|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
163249989|NCT03318523|589623869|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
163249990|NCT03318523|589623870|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
163249991|NCT03318523|589623871|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
163249992|NCT03318523|589623872|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
163249993|NCT03318523|589623873|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
163249994|NCT03318523|589623874|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
163249995|NCT03318523|589623875|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
163249996|NCT03318523|589623876|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
163249997|NCT03318523|589623877|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
163249998|NCT03318523|589623878|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
163249999|NCT03318523|589623869|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
163250000|NCT03318523|589623870|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
163250001|NCT03318523|589623871|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
163250002|NCT03318523|589623872|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
163250003|NCT03318523|589623873|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
163250004|NCT03318523|589623874|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
163250005|NCT03318523|589623875|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
163250006|NCT03318523|589623876|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
163250007|NCT03318523|589623877|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
163355258|NCT02330562|590011386|FG005|Overall Study|Adverse Event|1|||
163355259|NCT02330562|590011387|FG006|Overall Study|Adverse Event|0|||
163355260|NCT02330562|590011388|FG007|Overall Study|Adverse Event|0|||
163355261|NCT02330562|590011389|FG008|Overall Study|Adverse Event|0|||
163355262|NCT02330562|590011390|FG009|Overall Study|Adverse Event|1|||
163355263|NCT02330562|590011391|FG010|Overall Study|Adverse Event|1|||
163355264|NCT02330562|590011381|FG000|Overall Study|Participant decision|1|||
163355265|NCT02330562|590011382|FG001|Overall Study|Participant decision|0|||
163355266|NCT02330562|590011383|FG002|Overall Study|Participant decision|4|||
163355267|NCT02330562|590011384|FG003|Overall Study|Participant decision|1|||
163355268|NCT02330562|590011385|FG004|Overall Study|Participant decision|5|||
163355269|NCT02330562|590011386|FG005|Overall Study|Participant decision|2|||
163355270|NCT02330562|590011387|FG006|Overall Study|Participant decision|0|||
163355271|NCT02330562|590011388|FG007|Overall Study|Participant decision|0|||
163355272|NCT02330562|590011389|FG008|Overall Study|Participant decision|0|||
163355273|NCT02330562|590011390|FG009|Overall Study|Participant decision|3|||
163355274|NCT02330562|590011391|FG010|Overall Study|Participant decision|0|||
163355275|NCT02330562|590011381|FG000|Overall Study|Disease progression|5|||
163355276|NCT02330562|590011382|FG001|Overall Study|Disease progression|3|||
163355277|NCT02330562|590011383|FG002|Overall Study|Disease progression|20|||
163355278|NCT02330562|590011384|FG003|Overall Study|Disease progression|28|||
163355279|NCT02330562|590011385|FG004|Overall Study|Disease progression|23|||
163355280|NCT02330562|590011386|FG005|Overall Study|Disease progression|7|||
163355281|NCT02330562|590011387|FG006|Overall Study|Disease progression|1|||
163355282|NCT02330562|590011388|FG007|Overall Study|Disease progression|1|||
163355283|NCT02330562|590011389|FG008|Overall Study|Disease progression|1|||
163355284|NCT02330562|590011390|FG009|Overall Study|Disease progression|0|||
163355285|NCT02330562|590011391|FG010|Overall Study|Disease progression|5|||
163355286|NCT02330562|590011381|FG000|Overall Study|Other reasons|0|||
163355287|NCT02330562|590011382|FG001|Overall Study|Other reasons|0|||
163355288|NCT02330562|590011383|FG002|Overall Study|Other reasons|0|||
163355289|NCT02330562|590011384|FG003|Overall Study|Other reasons|1|||
163355290|NCT02330562|590011385|FG004|Overall Study|Other reasons|0|||
163355291|NCT02330562|590011386|FG005|Overall Study|Other reasons|0|||
163355292|NCT02330562|590011387|FG006|Overall Study|Other reasons|0|||
163355293|NCT02330562|590011388|FG007|Overall Study|Other reasons|0|||
163355294|NCT02330562|590011389|FG008|Overall Study|Other reasons|0|||
163355295|NCT02330562|590011390|FG009|Overall Study|Other reasons|0|||
163355296|NCT02330562|590011391|FG010|Overall Study|Other reasons|0|||
163355297|NCT02330562|590011381|FG000|Overall Study|Withdrawal by Subject|0|||
163355298|NCT02330562|590011382|FG001|Overall Study|Withdrawal by Subject|0|||
163410350|NCT05103332|590211374|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
163250008|NCT03318523|589623878|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
163250009|NCT03318523|589623869|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
163250010|NCT03318523|589623870|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
163250011|NCT03318523|589623871|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
163250012|NCT03318523|589623872|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
163250013|NCT03318523|589623873|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
163250014|NCT03318523|589623874|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
163250015|NCT03318523|589623875|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
163250016|NCT03318523|589623876|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
163250017|NCT03318523|589623877|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
163250018|NCT03318523|589623878|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
163250019|NCT03318523|589623869|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
163250020|NCT03318523|589623870|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
163250021|NCT03318523|589623871|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
163250022|NCT03318523|589623872|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
163250023|NCT03318523|589623873|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
163250024|NCT03318523|589623874|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
163250025|NCT03318523|589623875|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
163250026|NCT03318523|589623876|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
163250027|NCT03318523|589623877|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
163250028|NCT03318523|589623878|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
163250029|NCT03318523|589623869|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
163250030|NCT03318523|589623870|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
163250031|NCT03318523|589623871|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
163355299|NCT02330562|590011383|FG002|Overall Study|Withdrawal by Subject|0|||
163355300|NCT02330562|590011384|FG003|Overall Study|Withdrawal by Subject|0|||
163355301|NCT02330562|590011385|FG004|Overall Study|Withdrawal by Subject|0|||
163355302|NCT02330562|590011386|FG005|Overall Study|Withdrawal by Subject|0|||
163355303|NCT02330562|590011387|FG006|Overall Study|Withdrawal by Subject|0|||
163355304|NCT02330562|590011388|FG007|Overall Study|Withdrawal by Subject|0|||
163355305|NCT02330562|590011389|FG008|Overall Study|Withdrawal by Subject|0|||
163355306|NCT02330562|590011390|FG009|Overall Study|Withdrawal by Subject|1|||
163355307|NCT02330562|590011391|FG010|Overall Study|Withdrawal by Subject|0|||
163355308|NCT01657799|590011393|FG000|Overall Study|Adverse Event Related to progression|6|||
163355309|NCT01657799|590011394|FG001|Overall Study|Adverse Event Related to progression|8|||
163355310|NCT01657799|590011395|FG002|Overall Study|Adverse Event Related to progression|12|||
163355311|NCT01657799|590011393|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
163355312|NCT01657799|590011394|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
163355313|NCT01657799|590011395|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
163355314|NCT01657799|590011393|FG000|Overall Study|Withdrawal by Subject|13|||
163355315|NCT01657799|590011394|FG001|Overall Study|Withdrawal by Subject|10|||
163355316|NCT01657799|590011395|FG002|Overall Study|Withdrawal by Subject|10|||
163355317|NCT01657799|590011393|FG000|Overall Study|Lost to Follow-up|1|||
163355318|NCT01657799|590011394|FG001|Overall Study|Lost to Follow-up|0|||
163355319|NCT01657799|590011395|FG002|Overall Study|Lost to Follow-up|1|||
163355320|NCT01657799|590011393|FG000|Overall Study|Disease Progression|2|||
163355321|NCT01657799|590011394|FG001|Overall Study|Disease Progression|4|||
163355322|NCT01657799|590011395|FG002|Overall Study|Disease Progression|4|||
163355323|NCT01657799|590011393|FG000|Overall Study|Progressive Disease Clinical|7|||
163355324|NCT01657799|590011394|FG001|Overall Study|Progressive Disease Clinical|4|||
163355325|NCT01657799|590011395|FG002|Overall Study|Progressive Disease Clinical|7|||
163355326|NCT01657799|590011393|FG000|Overall Study|Radiographic & Clinical Progression|16|||
163355327|NCT01657799|590011394|FG001|Overall Study|Radiographic & Clinical Progression|11|||
163355328|NCT01657799|590011395|FG002|Overall Study|Radiographic & Clinical Progression|15|||
163355329|NCT01657799|590011393|FG000|Overall Study|Other|52|||
163355330|NCT01657799|590011394|FG001|Overall Study|Other|62|||
163355331|NCT01657799|590011395|FG002|Overall Study|Other|49|||
163355332|NCT04599855|590011400|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
163355333|NCT04599855|590011401|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
163355334|NCT04599855|590011402|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
163355335|NCT04599855|590011400|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
163355336|NCT04599855|590011401|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
163355337|NCT04599855|590011402|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
163355338|NCT04599855|590011400|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
163355339|NCT04599855|590011401|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
163355340|NCT04599855|590011402|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
163355341|NCT04599855|590011400|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
163355342|NCT04599855|590011401|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
163355343|NCT04599855|590011402|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
163250032|NCT03318523|589623872|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
163250033|NCT03318523|589623873|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
163250034|NCT03318523|589623874|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
163250035|NCT03318523|589623875|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
163250036|NCT03318523|589623876|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
163250037|NCT03318523|589623877|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
163250038|NCT03318523|589623878|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
163250039|NCT03318523|589623869|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
163250040|NCT03318523|589623870|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
163250041|NCT03318523|589623871|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
163250042|NCT03318523|589623872|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
163250043|NCT03318523|589623873|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
163250044|NCT03318523|589623874|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
163250045|NCT03318523|589623875|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
163250046|NCT03318523|589623876|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
163250047|NCT03318523|589623877|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
163250048|NCT03318523|589623878|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
163250049|NCT02163733|589623879|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
163250050|NCT02163733|589623880|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
163250051|NCT02163733|589623881|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
163250052|NCT02163733|589623879|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
163250053|NCT02163733|589623880|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
163250054|NCT02163733|589623881|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
163250055|NCT00487162|589623885|FG000|Overall Study|Adverse Event|0|||
163250056|NCT00487162|589623886|FG001|Overall Study|Adverse Event|1|||
163250057|NCT00487162|589623885|FG000|Overall Study|Physician Decision|0|||
163250058|NCT00487162|589623886|FG001|Overall Study|Physician Decision|1|||
163250059|NCT00487162|589623885|FG000|Overall Study|Withdrawal by Subject|2|||
163250060|NCT00487162|589623886|FG001|Overall Study|Withdrawal by Subject|3|||
163250061|NCT00530855|589623887|FG000|Overall Study|Lack of Efficacy|20|||
163250062|NCT00530855|589623887|FG000|Overall Study|Withdrawal by Subject|30|||
163250063|NCT00530855|589623887|FG000|Overall Study|Fatal Serious AE|3|||
163250064|NCT00530855|589623887|FG000|Overall Study|Non Fatal Serious AE|7|||
163250065|NCT00530855|589623887|FG000|Overall Study|Non Fatal Non Serious AE|12|||
163250066|NCT00530855|589623887|FG000|Overall Study|Protocol Violation|3|||
163250067|NCT00530855|589623887|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
163250068|NCT00530855|589623887|FG000|Overall Study|Lost to Follow-up|9|||
163250069|NCT00530855|589623887|FG000|Overall Study|Other reason for premature termination|17|||
163250070|NCT01654549|589623906|FG000|Overall Study|H.pylori eradication not successful|0|||
163250071|NCT01654549|589623907|FG001|Overall Study|H.pylori eradication not successful|1|||
163250072|NCT03152526|589623908|FG000|Overall Study|Withdrawal by Subject|0|||
163250073|NCT03152526|589623909|FG001|Overall Study|Withdrawal by Subject|1|||
163250074|NCT05554237|589623910|FG000|Part 2 (7 Days)|Adverse Event|0|||
163250075|NCT05554237|589623911|FG001|Part 2 (7 Days)|Adverse Event|0|||
163250076|NCT05554237|589623912|FG002|Part 2 (7 Days)|Adverse Event|0|||
163250077|NCT05554237|589623913|FG003|Part 2 (7 Days)|Adverse Event|0|||
163250078|NCT05554237|589623914|FG004|Part 2 (7 Days)|Adverse Event|2|||
163250079|NCT05554237|589623915|FG005|Part 2 (7 Days)|Adverse Event|0|||
163250080|NCT05554237|589623916|FG006|Part 2 (7 Days)|Adverse Event|0|||
163250081|NCT05554237|589623917|FG007|Part 2 (7 Days)|Adverse Event|0|||
163250082|NCT05554237|589623918|FG008|Part 2 (7 Days)|Adverse Event|0|||
163250083|NCT05554237|589623919|FG009|Part 2 (7 Days)|Adverse Event|1|||
163250084|NCT05554237|589623920|FG010|Part 2 (7 Days)|Adverse Event|0|||
163250085|NCT05554237|589623921|FG011|Part 2 (7 Days)|Adverse Event|0|||
163250086|NCT05554237|589623922|FG012|Part 2 (7 Days)|Adverse Event|1|||
163250087|NCT05554237|589623923|FG013|Part 2 (7 Days)|Adverse Event|0|||
163250088|NCT05130970|589623924|FG000|Overall Study|Adverse Event|1|||
163250089|NCT05130970|589623925|FG001|Overall Study|Adverse Event|1|||
163250090|NCT05130970|589623924|FG000|Overall Study|Death|0|||
163250091|NCT05130970|589623925|FG001|Overall Study|Death|1|||
163250092|NCT05130970|589623924|FG000|Overall Study|Lost to Follow-up|0|||
163250093|NCT05130970|589623925|FG001|Overall Study|Lost to Follow-up|1|||
163250094|NCT05130970|589623924|FG000|Overall Study|Physician Decision|0|||
163250095|NCT05130970|589623925|FG001|Overall Study|Physician Decision|1|||
163250096|NCT05130970|589623924|FG000|Overall Study|Withdrawal by Subject|1|||
163250097|NCT05130970|589623925|FG001|Overall Study|Withdrawal by Subject|1|||
163250098|NCT04969198|589623926|FG000|Overall Study|Withdrawal by Subject|20|||
163250099|NCT04969198|589623926|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
163250100|NCT04969198|589623926|FG000|Overall Study|Lost to Follow-up|20|||
163250101|NCT02701985|589623927|FG000|Overall Study|Withdrawal by Subject|1|||
163250102|NCT02701985|589623928|FG001|Overall Study|Withdrawal by Subject|1|||
163250103|NCT02701985|589623927|FG000|Overall Study|Lost to Follow-up|1|||
163410351|NCT05103332|590211375|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
163250104|NCT02701985|589623928|FG001|Overall Study|Lost to Follow-up|0|||
163250105|NCT02701985|589623927|FG000|Overall Study|Death|1|||
163250106|NCT02701985|589623928|FG001|Overall Study|Death|0|||
163250107|NCT02701985|589623927|FG000|Overall Study|Adverse Event|0|||
163250108|NCT02701985|589623928|FG001|Overall Study|Adverse Event|5|||
163250109|NCT01362140|589623930|FG000|Overall Study|Noncompliance|1|||
163250110|NCT01362140|589623931|FG001|Overall Study|Noncompliance|0|||
163250111|NCT01362140|589623930|FG000|Overall Study|Adverse Event|2|||
163250112|NCT01362140|589623931|FG001|Overall Study|Adverse Event|2|||
163250113|NCT01362140|589623930|FG000|Overall Study|Withdrawal by Subject|3|||
163250114|NCT01362140|589623931|FG001|Overall Study|Withdrawal by Subject|3|||
163250115|NCT01362140|589623930|FG000|Overall Study|Administrative Decision|0|||
163250116|NCT01362140|589623931|FG001|Overall Study|Administrative Decision|1|||
163250117|NCT01362140|589623930|FG000|Overall Study|Death|2|||
163250118|NCT01362140|589623931|FG001|Overall Study|Death|1|||
163250119|NCT01362140|589623930|FG000|Overall Study|Other|1|||
163250120|NCT01362140|589623931|FG001|Overall Study|Other|1|||
163250121|NCT01362140|589623930|FG000|Overall Study|Protocol-specified Criteria|1|||
163250122|NCT01362140|589623931|FG001|Overall Study|Protocol-specified Criteria|2|||
163250123|NCT01362140|589623930|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
163250124|NCT01362140|589623931|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
163250125|NCT01556438|589623932|FG000|Overall Study|Adverse Event|4|||
163250126|NCT01556438|589623933|FG001|Overall Study|Adverse Event|2|||
163250127|NCT01556438|589623932|FG000|Overall Study|Sponsor Decision|0|||
163250128|NCT01556438|589623933|FG001|Overall Study|Sponsor Decision|2|||
163250129|NCT01556438|589623932|FG000|Overall Study|Progressive Disease|0|||
163250130|NCT01556438|589623933|FG001|Overall Study|Progressive Disease|6|||
163250131|NCT01556438|589623932|FG000|Overall Study|Death|0|||
163250132|NCT01556438|589623933|FG001|Overall Study|Death|1|||
163250133|NCT01388816|589623934|FG000|Overall Study|Adverse Event|0|||
163250134|NCT01388816|589623935|FG001|Overall Study|Adverse Event|2|||
163250135|NCT01388816|589623936|FG002|Overall Study|Adverse Event|0|||
163250136|NCT01388816|589623937|FG003|Overall Study|Adverse Event|0|||
163250137|NCT01388816|589623934|FG000|Overall Study|Lost to Follow-up|0|||
163250138|NCT01388816|589623935|FG001|Overall Study|Lost to Follow-up|1|||
163250139|NCT01388816|589623936|FG002|Overall Study|Lost to Follow-up|0|||
163250140|NCT01388816|589623937|FG003|Overall Study|Lost to Follow-up|0|||
163250141|NCT01388816|589623934|FG000|Overall Study|Withdrawal by Subject|2|||
163250142|NCT01388816|589623935|FG001|Overall Study|Withdrawal by Subject|1|||
163250143|NCT01388816|589623936|FG002|Overall Study|Withdrawal by Subject|1|||
163250144|NCT01388816|589623937|FG003|Overall Study|Withdrawal by Subject|0|||
163250145|NCT01388816|589623934|FG000|Overall Study|Protocol Violation|0|||
163250146|NCT01388816|589623935|FG001|Overall Study|Protocol Violation|0|||
163250147|NCT01388816|589623936|FG002|Overall Study|Protocol Violation|2|||
163250148|NCT01388816|589623937|FG003|Overall Study|Protocol Violation|0|||
163250149|NCT00743366|589623938|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
163250150|NCT00743366|589623939|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
163250151|NCT03206203|589623940|FG000|Treatment|Death|38|||
163250152|NCT03206203|589623941|FG001|Treatment|Death|26|||
163250153|NCT03206203|589623942|FG002|Treatment|Death|0|||
163250154|NCT03206203|589623940|FG000|Treatment|Withdrawal by Subject|1|||
163250155|NCT03206203|589623941|FG001|Treatment|Withdrawal by Subject|0|||
163250156|NCT03206203|589623942|FG002|Treatment|Withdrawal by Subject|0|||
163250157|NCT03206203|589623940|FG000|Treatment|Lost to Follow-up|4|||
163250158|NCT03206203|589623941|FG001|Treatment|Lost to Follow-up|0|||
163355344|NCT04599855|590011400|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
163250159|NCT03206203|589623942|FG002|Treatment|Lost to Follow-up|0|||
163250160|NCT03206203|589623940|FG000|Treatment|N/A in Follow-Up|8|||
163250161|NCT03206203|589623941|FG001|Treatment|N/A in Follow-Up|1|||
163355345|NCT04599855|590011401|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
163355346|NCT04599855|590011402|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
163250162|NCT03206203|589623942|FG002|Treatment|N/A in Follow-Up|0|||
163250163|NCT03206203|589623940|FG000|Treatment|Disease progression|0|||
163250164|NCT03206203|589623941|FG001|Treatment|Disease progression|1|||
163355347|NCT04599855|590011400|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
163355348|NCT04599855|590011401|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
163250165|NCT03206203|589623942|FG002|Treatment|Disease progression|0|||
163250166|NCT03206203|589623940|FG000|Treatment|Refused follow-up|0|||
163250167|NCT03206203|589623941|FG001|Treatment|Refused follow-up|1|||
163250168|NCT03206203|589623942|FG002|Treatment|Refused follow-up|0|||
163250169|NCT03206203|589623940|FG000|Treatment|Cross over to Arm 1|0|||
163250170|NCT03206203|589623941|FG001|Treatment|Cross over to Arm 1|19|||
163250171|NCT03206203|589623942|FG002|Treatment|Cross over to Arm 1|0|||
163250172|NCT03206203|589623940|FG000|Optional Cross-Over|Death|0|||
163250173|NCT03206203|589623941|FG001|Optional Cross-Over|Death|0|||
163250174|NCT03206203|589623942|FG002|Optional Cross-Over|Death|14|||
163250175|NCT03206203|589623940|FG000|Optional Cross-Over|Refused follow-up|0|||
163250176|NCT03206203|589623941|FG001|Optional Cross-Over|Refused follow-up|0|||
163250177|NCT03206203|589623942|FG002|Optional Cross-Over|Refused follow-up|2|||
163250178|NCT03998618|589623945|FG000|Overall Study|Death|7|||
163250179|NCT03998618|589623946|FG001|Overall Study|Death|11|||
163250180|NCT03998618|589623945|FG000|Overall Study|hospice enrollment|3|||
163250181|NCT03998618|589623946|FG001|Overall Study|hospice enrollment|3|||
163250182|NCT03998618|589623945|FG000|Overall Study|Not feeling well/health problems|3|||
163250183|NCT03998618|589623946|FG001|Overall Study|Not feeling well/health problems|5|||
163250184|NCT03998618|589623945|FG000|Overall Study|Lost to Follow-up|6|||
163250185|NCT03998618|589623946|FG001|Overall Study|Lost to Follow-up|6|||
163250186|NCT03998618|589623945|FG000|Overall Study|Withdrawal by Subject|0|||
163250187|NCT03998618|589623946|FG001|Overall Study|Withdrawal by Subject|4|||
163250188|NCT01152580|589623951|FG000|Overall Study|Withdrawal by Subject|0|||
163250189|NCT01152580|589623952|FG001|Overall Study|Withdrawal by Subject|1|||
163250190|NCT02308748|589623953|FG000|Period 1|Withdrawal by Subject|0|||
163250191|NCT02308748|589623954|FG001|Period 1|Withdrawal by Subject|0|||
163250192|NCT02308748|589623955|FG002|Period 1|Withdrawal by Subject|1|||
163250193|NCT02308748|589623956|FG003|Period 1|Withdrawal by Subject|0|||
163250194|NCT02308748|589623957|FG004|Period 1|Withdrawal by Subject|0|||
163250195|NCT02308748|589623958|FG005|Period 1|Withdrawal by Subject|0|||
163250196|NCT02308748|589623959|FG006|Period 1|Withdrawal by Subject|0|||
163250197|NCT02308748|589623960|FG007|Period 1|Withdrawal by Subject|0|||
163250198|NCT02308748|589623961|FG008|Period 1|Withdrawal by Subject|0|||
163250199|NCT02308748|589623962|FG009|Period 1|Withdrawal by Subject|0|||
163250200|NCT02308748|589623953|FG000|Period 2|Adverse Event|0|||
163250201|NCT02308748|589623954|FG001|Period 2|Adverse Event|0|||
163250202|NCT02308748|589623955|FG002|Period 2|Adverse Event|0|||
163250203|NCT02308748|589623956|FG003|Period 2|Adverse Event|0|||
163250204|NCT02308748|589623957|FG004|Period 2|Adverse Event|0|||
163250205|NCT02308748|589623958|FG005|Period 2|Adverse Event|0|||
163250206|NCT02308748|589623959|FG006|Period 2|Adverse Event|0|||
163250207|NCT02308748|589623960|FG007|Period 2|Adverse Event|1|||
163250208|NCT02308748|589623961|FG008|Period 2|Adverse Event|0|||
163250209|NCT02308748|589623962|FG009|Period 2|Adverse Event|0|||
163250210|NCT02308748|589623953|FG000|Period 3|Protocol Violation|0|||
163250211|NCT02308748|589623954|FG001|Period 3|Protocol Violation|0|||
163250212|NCT02308748|589623955|FG002|Period 3|Protocol Violation|0|||
163250213|NCT02308748|589623956|FG003|Period 3|Protocol Violation|0|||
163250214|NCT02308748|589623957|FG004|Period 3|Protocol Violation|0|||
163250215|NCT02308748|589623958|FG005|Period 3|Protocol Violation|0|||
163250216|NCT02308748|589623959|FG006|Period 3|Protocol Violation|0|||
163250217|NCT02308748|589623960|FG007|Period 3|Protocol Violation|0|||
163250218|NCT02308748|589623961|FG008|Period 3|Protocol Violation|0|||
163250219|NCT02308748|589623962|FG009|Period 3|Protocol Violation|1|||
163250220|NCT02308748|589623953|FG000|Period 5|Adverse Event|1|||
163250221|NCT02308748|589623954|FG001|Period 5|Adverse Event|0|||
163250222|NCT02308748|589623955|FG002|Period 5|Adverse Event|0|||
163250223|NCT02308748|589623956|FG003|Period 5|Adverse Event|0|||
163250224|NCT02308748|589623957|FG004|Period 5|Adverse Event|0|||
163250225|NCT02308748|589623958|FG005|Period 5|Adverse Event|0|||
163250226|NCT02308748|589623959|FG006|Period 5|Adverse Event|0|||
163250227|NCT02308748|589623960|FG007|Period 5|Adverse Event|0|||
163250228|NCT02308748|589623961|FG008|Period 5|Adverse Event|1|||
163250229|NCT02308748|589623962|FG009|Period 5|Adverse Event|0|||
163250230|NCT01994954|589623963|FG000|Overall Study|Death|1|||
163250231|NCT01994954|589623964|FG001|Overall Study|Death|0|||
163250232|NCT01994954|589623963|FG000|Overall Study|Withdrawal by Subject|9|||
163250233|NCT01994954|589623964|FG001|Overall Study|Withdrawal by Subject|14|||
163250234|NCT01994954|589623963|FG000|Overall Study|Physician Decision|2|||
163250235|NCT01994954|589623964|FG001|Overall Study|Physician Decision|2|||
163250236|NCT01994954|589623963|FG000|Overall Study|Lost to Follow-up|8|||
163250237|NCT01994954|589623964|FG001|Overall Study|Lost to Follow-up|10|||
163250238|NCT01994954|589623963|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
163250239|NCT01994954|589623964|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
163250240|NCT00449176|589623966|FG000|Overall Study|Withdrawal by Subject|39|||
163250241|NCT00449176|589623967|FG001|Overall Study|Withdrawal by Subject|43|||
163250242|NCT00449176|589623968|FG002|Overall Study|Withdrawal by Subject|59|||
163250243|NCT00449176|589623966|FG000|Overall Study|Lost to Follow-up|13|||
163250244|NCT00449176|589623967|FG001|Overall Study|Lost to Follow-up|8|||
163355349|NCT04599855|590011402|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
163250245|NCT00449176|589623968|FG002|Overall Study|Lost to Follow-up|12|||
163250246|NCT00449176|589623966|FG000|Overall Study|Adverse Event|51|||
163250247|NCT00449176|589623967|FG001|Overall Study|Adverse Event|107|||
163250248|NCT00449176|589623968|FG002|Overall Study|Adverse Event|15|||
163250249|NCT00449176|589623966|FG000|Overall Study|Lack of Efficacy|13|||
163250250|NCT00449176|589623967|FG001|Overall Study|Lack of Efficacy|7|||
163250251|NCT00449176|589623968|FG002|Overall Study|Lack of Efficacy|50|||
163250252|NCT00449176|589623966|FG000|Overall Study|Study drug non-compliant|14|||
163250253|NCT00449176|589623967|FG001|Overall Study|Study drug non-compliant|11|||
163250254|NCT00449176|589623968|FG002|Overall Study|Study drug non-compliant|11|||
163250255|NCT00449176|589623966|FG000|Overall Study|all other|22|||
163250256|NCT00449176|589623967|FG001|Overall Study|all other|19|||
163250257|NCT00449176|589623968|FG002|Overall Study|all other|20|||
163250258|NCT02472964|589623969|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
163250259|NCT02472964|589623970|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
163250260|NCT02472964|589623969|FG000|Part 1 (up to Week 24)|disease progression|58|||
163250261|NCT02472964|589623970|FG001|Part 1 (up to Week 24)|disease progression|47|||
163250262|NCT02472964|589623969|FG000|Part 1 (up to Week 24)|Death|3|||
163250263|NCT02472964|589623970|FG001|Part 1 (up to Week 24)|Death|6|||
163250264|NCT02472964|589623969|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
163250265|NCT02472964|589623970|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
163250266|NCT02472964|589623969|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
163250267|NCT02472964|589623970|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
163250268|NCT02472964|589623969|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
163250269|NCT02472964|589623970|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
163250270|NCT02472964|589623969|FG000|Part 1 (up to Week 24)|Other|2|||
163250271|NCT02472964|589623970|FG001|Part 1 (up to Week 24)|Other|1|||
163250272|NCT02472964|589623969|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
163250273|NCT02472964|589623970|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
163250274|NCT02472964|589623969|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
163250275|NCT02472964|589623970|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
163250276|NCT02472964|589623969|FG000|Part 2 (Week 24-week 48)|Death|0|||
163250277|NCT02472964|589623970|FG001|Part 2 (Week 24-week 48)|Death|1|||
163250278|NCT02472964|589623969|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
163250279|NCT02472964|589623970|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
163250280|NCT02472964|589623969|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
163250281|NCT02472964|589623970|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
163250282|NCT02472964|589623969|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
163250283|NCT02472964|589623970|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
163250284|NCT02472964|589623969|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
163250285|NCT02472964|589623970|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
163250286|NCT01454583|589623971|FG000|1st Year|Lost to Follow-up|1057|||
163250287|NCT01454583|589623972|FG001|1st Year|Lost to Follow-up|318|||
163250288|NCT01454583|589623973|FG002|1st Year|Lost to Follow-up|180|||
163250289|NCT01454583|589623971|FG000|2nd Year|Lost to Follow-up|3965|||
163250290|NCT01454583|589623972|FG001|2nd Year|Lost to Follow-up|1049|||
163250291|NCT01454583|589623973|FG002|2nd Year|Lost to Follow-up|737|||
163250292|NCT01454583|589623971|FG000|3rd Year|Lost to Follow-up|1959|||
163250293|NCT01454583|589623972|FG001|3rd Year|Lost to Follow-up|512|||
163250294|NCT01454583|589623973|FG002|3rd Year|Lost to Follow-up|297|||
163250295|NCT04330638|589623976|FG000|Overall Study|Adverse Event|9|||
163250296|NCT04330638|589623977|FG001|Overall Study|Adverse Event|10|||
163250297|NCT04330638|589623978|FG002|Overall Study|Adverse Event|15|||
163250298|NCT04330638|589623979|FG003|Overall Study|Adverse Event|6|||
163250299|NCT04330638|589623980|FG004|Overall Study|Adverse Event|10|||
163250300|NCT04330638|589623981|FG005|Overall Study|Adverse Event|5|||
163250301|NCT04330638|589623976|FG000|Overall Study|Other|2|||
163250302|NCT04330638|589623977|FG001|Overall Study|Other|2|||
163250303|NCT04330638|589623978|FG002|Overall Study|Other|5|||
163250304|NCT04330638|589623979|FG003|Overall Study|Other|1|||
163250305|NCT04330638|589623980|FG004|Overall Study|Other|3|||
163250306|NCT04330638|589623981|FG005|Overall Study|Other|2|||
163250307|NCT04330638|589623976|FG000|Overall Study|Withdrawal by Subject|4|||
163250308|NCT04330638|589623977|FG001|Overall Study|Withdrawal by Subject|0|||
163250309|NCT04330638|589623978|FG002|Overall Study|Withdrawal by Subject|0|||
163250310|NCT04330638|589623979|FG003|Overall Study|Withdrawal by Subject|0|||
163250311|NCT04330638|589623980|FG004|Overall Study|Withdrawal by Subject|0|||
163250312|NCT04330638|589623981|FG005|Overall Study|Withdrawal by Subject|0|||
163250313|NCT04330638|589623976|FG000|Overall Study|Lost to Follow-up|3|||
163250314|NCT04330638|589623977|FG001|Overall Study|Lost to Follow-up|2|||
163250315|NCT04330638|589623978|FG002|Overall Study|Lost to Follow-up|3|||
163250316|NCT04330638|589623979|FG003|Overall Study|Lost to Follow-up|2|||
163250317|NCT04330638|589623980|FG004|Overall Study|Lost to Follow-up|3|||
163250318|NCT04330638|589623981|FG005|Overall Study|Lost to Follow-up|0|||
163250319|NCT01967732|589623983|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
163250320|NCT01967732|589623984|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
163250321|NCT01967732|589623985|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
163410352|NCT05103332|590211376|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
163410353|NCT05103332|590211359|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
163250322|NCT01967732|589623986|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
163250323|NCT01967732|589623983|FG000|First Intervention (Day 1)|Poor venous access|0|||
163250324|NCT01967732|589623984|FG001|First Intervention (Day 1)|Poor venous access|1|||
163250325|NCT01967732|589623985|FG002|First Intervention (Day 1)|Poor venous access|0|||
163250326|NCT01967732|589623986|FG003|First Intervention (Day 1)|Poor venous access|0|||
163250327|NCT01988779|589623995|FG000|Overall Study|Withdrawal by Subject|2|||
163250328|NCT01988779|589623996|FG001|Overall Study|Withdrawal by Subject|2|||
163250329|NCT01988779|589623995|FG000|Overall Study|Protocol Violation|1|||
163410354|NCT05103332|590211360|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
163250330|NCT01988779|589623996|FG001|Overall Study|Protocol Violation|0|||
163250331|NCT02275065|589623997|FG000|Overall Study|Randomized but not treated|1|||
163250332|NCT02275065|589623998|FG001|Overall Study|Randomized but not treated|0|||
163250333|NCT02275065|589623999|FG002|Overall Study|Randomized but not treated|1|||
163250334|NCT02275065|589624000|FG003|Overall Study|Randomized but not treated|1|||
163250335|NCT02275065|589624001|FG004|Overall Study|Randomized but not treated|0|||
163250336|NCT00377403|589624002|FG000|Overall Study|Unable to contact for telephone intervie|4|||
163250337|NCT00377403|589624003|FG001|Overall Study|Unable to contact for telephone intervie|7|||
163250338|NCT00417079|589624005|FG000|Overall Study|Disease progression|267|||
163250339|NCT00417079|589624006|FG001|Overall Study|Disease progression|180|||
163250340|NCT00417079|589624005|FG000|Overall Study|Adverse Event|32|||
163250341|NCT00417079|589624006|FG001|Overall Study|Adverse Event|67|||
163250342|NCT00417079|589624005|FG000|Overall Study|Non-compliance to protocol|0|||
163250343|NCT00417079|589624006|FG001|Overall Study|Non-compliance to protocol|1|||
163250344|NCT00417079|589624005|FG000|Overall Study|Lost to Follow-up|2|||
163250345|NCT00417079|589624006|FG001|Overall Study|Lost to Follow-up|0|||
163250346|NCT00417079|589624005|FG000|Overall Study|Withdrawal by Subject|17|||
163250347|NCT00417079|589624006|FG001|Overall Study|Withdrawal by Subject|8|||
163250348|NCT00417079|589624005|FG000|Overall Study|Not treated|6|||
163250349|NCT00417079|589624006|FG001|Overall Study|Not treated|7|||
163250350|NCT00417079|589624005|FG000|Overall Study|Screened failure|2|||
163250351|NCT00417079|589624006|FG001|Overall Study|Screened failure|1|||
163250352|NCT00417079|589624005|FG000|Overall Study|Investigator's decision|1|||
163250353|NCT00417079|589624006|FG001|Overall Study|Investigator's decision|4|||
163250354|NCT00417079|589624005|FG000|Overall Study|Non-confirmed Disease progression|1|||
163250355|NCT00417079|589624006|FG001|Overall Study|Non-confirmed Disease progression|1|||
163250356|NCT00417079|589624005|FG000|Overall Study|Clinical deterioration|1|||
163250357|NCT00417079|589624006|FG001|Overall Study|Clinical deterioration|0|||
163250358|NCT00417079|589624005|FG000|Overall Study|Screening error|2|||
163250359|NCT00417079|589624006|FG001|Overall Study|Screening error|1|||
163250360|NCT00417079|589624005|FG000|Overall Study|Withdrawal by subject's family|0|||
163250361|NCT00417079|589624006|FG001|Overall Study|Withdrawal by subject's family|1|||
163250362|NCT00417079|589624005|FG000|Overall Study|Patient unable to come to the clinic|0|||
163250363|NCT00417079|589624006|FG001|Overall Study|Patient unable to come to the clinic|1|||
163250364|NCT00417079|589624005|FG000|Overall Study|abnormal liver function tests|0|||
163250365|NCT00417079|589624006|FG001|Overall Study|abnormal liver function tests|1|||
163250366|NCT00833638|589624007|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
163250367|NCT00833638|589624008|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
163250368|NCT00833638|589624009|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
163250369|NCT00833638|589624007|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
163250370|NCT00833638|589624008|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
163250371|NCT00833638|589624009|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
163250372|NCT00833638|589624007|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
163250373|NCT00833638|589624008|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
163250374|NCT00833638|589624009|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
163250375|NCT00833638|589624007|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
163250376|NCT00833638|589624008|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
163250377|NCT00833638|589624009|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
163250378|NCT00833638|589624007|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
163250379|NCT00833638|589624008|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
163250380|NCT00833638|589624009|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
163250381|NCT00833638|589624007|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
163250382|NCT00833638|589624008|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
163250383|NCT00833638|589624009|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
163250384|NCT00833638|589624007|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
163250385|NCT00833638|589624008|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
163250386|NCT00833638|589624009|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
163250387|NCT00833638|589624007|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
163250388|NCT00833638|589624008|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
163250389|NCT00833638|589624009|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
163250390|NCT00833638|589624007|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
163250391|NCT00833638|589624008|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
163250392|NCT00833638|589624009|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
163250393|NCT01178086|589624010|FG000|Overall Study|Participant refusal|7|||
163250394|NCT01178086|589624010|FG000|Overall Study|Physician Decision|44|||
163250395|NCT01178086|589624010|FG000|Overall Study|Switch to other CLL therapy|113|||
163250396|NCT01178086|589624010|FG000|Overall Study|Death|59|||
163355350|NCT04599855|590011400|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
163250397|NCT01178086|589624010|FG000|Overall Study|Other unspecified|89|||
163250398|NCT01178086|589624010|FG000|Overall Study|Excluded from EAS|20|||
163250399|NCT02097108|589624011|FG000|Overall Study|Adverse Event|1|||
163250400|NCT02097108|589624011|FG000|Overall Study|patient was abroad for 6 months|1|||
163250401|NCT00127608|589624014|FG000|Overall Study|VZV DNA negative|1|||
163250402|NCT00160680|589625313|FG000|Overall Study|Adverse Event|0|||
163250403|NCT00160680|589625314|FG001|Overall Study|Adverse Event|1|||
163250404|NCT00160680|589625313|FG000|Overall Study|Lack of Efficacy|2|||
163250405|NCT00160680|589625314|FG001|Overall Study|Lack of Efficacy|1|||
163250406|NCT00160680|589625313|FG000|Overall Study|Lost to Follow-up|3|||
163250407|NCT00160680|589625314|FG001|Overall Study|Lost to Follow-up|2|||
163250408|NCT00160680|589625313|FG000|Overall Study|Withdrawal by Subject|4|||
163250409|NCT00160680|589625314|FG001|Overall Study|Withdrawal by Subject|9|||
163250410|NCT02583425|589625325|FG000|Screening|Did not meet entry criteria|12|||
163250411|NCT02583425|589625325|FG000|Baseline|Did not meet continued criteria|5|||
163250412|NCT02583425|589625325|FG000|Treatment Period|Adverse Event|1|||
163250413|NCT01644734|589625326|FG000|Overall Study|Adverse Event|4|||
163250414|NCT01644734|589625326|FG000|Overall Study|Lost to Follow-up|17|||
163250415|NCT01644734|589625326|FG000|Overall Study|Reasons other than stated above|7|||
163250416|NCT01644734|589625326|FG000|Overall Study|Missing documentation|238|||
163250417|NCT01615328|589625331|FG000|Overall Study|Lost to Follow-up|3|||
163250418|NCT01615328|589625332|FG001|Overall Study|Lost to Follow-up|5|||
163250419|NCT02157779|589625333|FG000|Overall Study|Logistical|9|||
163250420|NCT02157779|589625334|FG001|Overall Study|Logistical|3|||
163250421|NCT02157779|589625333|FG000|Overall Study|Stopped attending, reason unknown|11|||
163250422|NCT02157779|589625334|FG001|Overall Study|Stopped attending, reason unknown|7|||
163250423|NCT02157779|589625333|FG000|Overall Study|No response to outreach after Baseline|1|||
163250424|NCT02157779|589625334|FG001|Overall Study|No response to outreach after Baseline|1|||
163250425|NCT02157779|589625333|FG000|Overall Study|Moved|1|||
163250426|NCT02157779|589625334|FG001|Overall Study|Moved|0|||
163250427|NCT02157779|589625333|FG000|Overall Study|Medical|1|||
163250428|NCT02157779|589625334|FG001|Overall Study|Medical|0|||
163250429|NCT02157779|589625333|FG000|Overall Study|Legal issue|1|||
163250430|NCT02157779|589625334|FG001|Overall Study|Legal issue|0|||
163250431|NCT02548455|589625335|FG000|Overall Study|Withdrawal by Subject|27|||
163250432|NCT02548455|589625335|FG000|Overall Study|Death|26|||
163250433|NCT02548455|589625335|FG000|Overall Study|Lost to Follow-up|14|||
163250434|NCT02548455|589625335|FG000|Overall Study|Visit not completed|173|||
163250435|NCT02525874|589625338|FG000|Overall Study|Other|1|||
163250436|NCT02525874|589625338|FG000|Overall Study|Investigator Decision|1|||
163250437|NCT02525874|589625338|FG000|Overall Study|Consent withdrawn|22|||
163250438|NCT02525874|589625338|FG000|Overall Study|Non-compliance with study drug|3|||
163250439|NCT02525874|589625338|FG000|Overall Study|Adverse Event|17|||
163250440|NCT02525874|589625338|FG000|Overall Study|Lost to Follow-up|7|||
163250441|NCT02525874|589625338|FG000|Overall Study|Disease progression, defined by protocol|2|||
163250442|NCT02525874|589625338|FG000|Overall Study|Disease relapse|4|||
163250443|NCT02525874|589625338|FG000|Overall Study|Alternative Treatment for MS|2|||
163250444|NCT02525874|589625338|FG000|Overall Study|New lesions in Brain|1|||
163250445|NCT02794285|589625341|FG000|Overall Study|Adverse Event|11|||
163250446|NCT02794285|589625342|FG001|Overall Study|Adverse Event|4|||
163250447|NCT02794285|589625343|FG002|Overall Study|Adverse Event|5|||
163250448|NCT02794285|589625344|FG003|Overall Study|Adverse Event|8|||
163250449|NCT02794285|589625341|FG000|Overall Study|Condition Under Investigation Improved|1|||
163250450|NCT02794285|589625342|FG001|Overall Study|Condition Under Investigation Improved|0|||
163250451|NCT02794285|589625343|FG002|Overall Study|Condition Under Investigation Improved|0|||
163250452|NCT02794285|589625344|FG003|Overall Study|Condition Under Investigation Improved|0|||
163250453|NCT02794285|589625341|FG000|Overall Study|Condition Under Investigation Worsened|0|||
163250454|NCT02794285|589625342|FG001|Overall Study|Condition Under Investigation Worsened|2|||
163250455|NCT02794285|589625343|FG002|Overall Study|Condition Under Investigation Worsened|1|||
163250456|NCT02794285|589625344|FG003|Overall Study|Condition Under Investigation Worsened|0|||
163250457|NCT02794285|589625341|FG000|Overall Study|Death|2|||
163355351|NCT04599855|590011401|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
163355352|NCT04599855|590011402|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
163355353|NCT04599855|590011400|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
163355354|NCT04599855|590011401|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
163355355|NCT04599855|590011402|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
163355356|NCT04599855|590011400|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
163250458|NCT02794285|589625342|FG001|Overall Study|Death|1|||
163250459|NCT02794285|589625343|FG002|Overall Study|Death|2|||
163250460|NCT02794285|589625344|FG003|Overall Study|Death|0|||
163250461|NCT02794285|589625341|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
163250462|NCT02794285|589625342|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
163250463|NCT02794285|589625343|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
163250464|NCT02794285|589625344|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
163250465|NCT02794285|589625341|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
163250466|NCT02794285|589625342|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
163250467|NCT02794285|589625343|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
163250468|NCT02794285|589625344|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
163355357|NCT04599855|590011401|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
163355358|NCT04599855|590011402|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
163355359|NCT04599855|590011400|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
163355360|NCT04599855|590011401|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
163355361|NCT04599855|590011402|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
163355362|NCT04599855|590011400|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
163355363|NCT04599855|590011401|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
163355364|NCT04599855|590011402|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
163355365|NCT04599855|590011400|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
163355366|NCT04599855|590011401|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
163355367|NCT04599855|590011402|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
163355368|NCT04599855|590011400|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
163355369|NCT04599855|590011401|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
163355370|NCT04599855|590011402|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
163355371|NCT04599855|590011400|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
163355372|NCT04599855|590011401|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
163355373|NCT04599855|590011402|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
163355374|NCT01588366|590011405|FG000|Overall Study|Adverse Event|0|||
163355375|NCT01588366|590011406|FG001|Overall Study|Adverse Event|1|||
163355376|NCT01588366|590011407|FG002|Overall Study|Adverse Event|0|||
163355377|NCT01588366|590011408|FG003|Overall Study|Adverse Event|1|||
163355378|NCT01588366|590011409|FG004|Overall Study|Adverse Event|0|||
163355379|NCT01588366|590011410|FG005|Overall Study|Adverse Event|2|||
163355380|NCT04962698|590011411|FG000|Motor Imagery|Technical difficulty|1|||
163355381|NCT04962698|590011412|FG001|Motor Imagery|Technical difficulty|0|||
163355382|NCT04962698|590011411|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
163355383|NCT04962698|590011412|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
163355384|NCT04962698|590011411|FG000|Kinesthetic MI|Technical difficulty|1|||
163355385|NCT04962698|590011412|FG001|Kinesthetic MI|Technical difficulty|0|||
163355386|NCT04962698|590011411|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
163355387|NCT04962698|590011412|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
163355388|NCT04962698|590011411|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
163355389|NCT04962698|590011412|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
163355390|NCT04962698|590011411|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
163355391|NCT04962698|590011412|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
163355392|NCT04962698|590011411|FG000|Virtual-hand Interaction|Technical difficulty|1|||
163355393|NCT04962698|590011412|FG001|Virtual-hand Interaction|Technical difficulty|0|||
163355394|NCT04962698|590011411|FG000|Robotic Action Observation|Technical difficulty|1|||
163355395|NCT04962698|590011412|FG001|Robotic Action Observation|Technical difficulty|0|||
163355396|NCT04962698|590011411|FG000|Rest|Technical difficulty|1|||
163150192|NCT00506350|589263594|FG005|Overall Study|Withdrawal by Subject|1|||
163150193|NCT00506350|589263595|FG006|Overall Study|Withdrawal by Subject|1|||
163150194|NCT00506350|589263596|FG007|Overall Study|Withdrawal by Subject|2|||
163150195|NCT00506350|589263597|FG008|Overall Study|Withdrawal by Subject|0|||
163150196|NCT00506350|589263589|FG000|Overall Study|Lost to Follow-up|1|||
163150197|NCT00506350|589263590|FG001|Overall Study|Lost to Follow-up|1|||
163150198|NCT00506350|589263591|FG002|Overall Study|Lost to Follow-up|1|||
163150199|NCT00506350|589263592|FG003|Overall Study|Lost to Follow-up|1|||
163150200|NCT00506350|589263593|FG004|Overall Study|Lost to Follow-up|2|||
163150201|NCT00506350|589263594|FG005|Overall Study|Lost to Follow-up|1|||
163150202|NCT00506350|589263595|FG006|Overall Study|Lost to Follow-up|0|||
163150203|NCT00506350|589263596|FG007|Overall Study|Lost to Follow-up|0|||
163150204|NCT00506350|589263597|FG008|Overall Study|Lost to Follow-up|2|||
163150205|NCT00506350|589263589|FG000|Overall Study|Medical Reason|0|||
163150206|NCT00506350|589263590|FG001|Overall Study|Medical Reason|0|||
163150207|NCT00506350|589263591|FG002|Overall Study|Medical Reason|0|||
163150208|NCT00506350|589263592|FG003|Overall Study|Medical Reason|0|||
163150209|NCT00506350|589263593|FG004|Overall Study|Medical Reason|1|||
163150210|NCT00506350|589263594|FG005|Overall Study|Medical Reason|0|||
163150211|NCT00506350|589263595|FG006|Overall Study|Medical Reason|0|||
163150212|NCT00506350|589263596|FG007|Overall Study|Medical Reason|0|||
163150213|NCT00506350|589263597|FG008|Overall Study|Medical Reason|0|||
163150214|NCT00506350|589263589|FG000|Overall Study|Other|1|||
163150215|NCT00506350|589263590|FG001|Overall Study|Other|1|||
163150216|NCT00506350|589263591|FG002|Overall Study|Other|3|||
163410355|NCT05103332|590211361|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
163150217|NCT00506350|589263592|FG003|Overall Study|Other|0|||
163150218|NCT00506350|589263593|FG004|Overall Study|Other|3|||
163150219|NCT00506350|589263594|FG005|Overall Study|Other|0|||
163150220|NCT00506350|589263595|FG006|Overall Study|Other|0|||
163150221|NCT00506350|589263596|FG007|Overall Study|Other|2|||
163150222|NCT00506350|589263597|FG008|Overall Study|Other|2|||
163150223|NCT03474588|589263598|FG000|Overall Study|Withdrawal by Subject|4|||
163150224|NCT03474588|589263599|FG001|Overall Study|Withdrawal by Subject|3|||
163250469|NCT02794285|589625341|FG000|Overall Study|Lack of Efficacy|10|||
163250470|NCT02794285|589625342|FG001|Overall Study|Lack of Efficacy|6|||
163250471|NCT02794285|589625343|FG002|Overall Study|Lack of Efficacy|3|||
163250472|NCT02794285|589625344|FG003|Overall Study|Lack of Efficacy|3|||
163250473|NCT02794285|589625341|FG000|Overall Study|Lost to Follow-up|5|||
163250474|NCT02794285|589625342|FG001|Overall Study|Lost to Follow-up|6|||
163250475|NCT02794285|589625343|FG002|Overall Study|Lost to Follow-up|3|||
163250476|NCT02794285|589625344|FG003|Overall Study|Lost to Follow-up|1|||
163250477|NCT02794285|589625341|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
163250478|NCT02794285|589625342|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
163250479|NCT02794285|589625343|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
163250480|NCT02794285|589625344|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
163250481|NCT02794285|589625341|FG000|Overall Study|Withdrawal by Subject|38|||
163250482|NCT02794285|589625342|FG001|Overall Study|Withdrawal by Subject|29|||
163250483|NCT02794285|589625343|FG002|Overall Study|Withdrawal by Subject|20|||
163250484|NCT02794285|589625344|FG003|Overall Study|Withdrawal by Subject|12|||
163250485|NCT02794285|589625341|FG000|Overall Study|Missing|1|||
163250486|NCT02794285|589625342|FG001|Overall Study|Missing|0|||
163250487|NCT02794285|589625343|FG002|Overall Study|Missing|0|||
163250488|NCT02794285|589625344|FG003|Overall Study|Missing|0|||
163250489|NCT02794285|589625341|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
163250490|NCT02794285|589625342|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
163250491|NCT02794285|589625343|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
163250492|NCT02794285|589625344|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
163250493|NCT02794285|589625341|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
163250494|NCT02794285|589625342|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
163250495|NCT02794285|589625343|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
163250496|NCT02794285|589625344|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
163250497|NCT00423176|589625345|FG000|Overall Study|Adverse Event|4|||
163250498|NCT00423176|589625346|FG001|Overall Study|Adverse Event|6|||
163250499|NCT00423176|589625345|FG000|Overall Study|Treatment Failure|1|||
163250500|NCT00423176|589625346|FG001|Overall Study|Treatment Failure|6|||
163250501|NCT00423176|589625345|FG000|Overall Study|Lost to Follow-up|4|||
163250502|NCT00423176|589625346|FG001|Overall Study|Lost to Follow-up|7|||
163250503|NCT00423176|589625345|FG000|Overall Study|Withdrawal by Subject|4|||
163250504|NCT00423176|589625346|FG001|Overall Study|Withdrawal by Subject|3|||
163250505|NCT00423176|589625345|FG000|Overall Study|Protocol Violation|1|||
163250506|NCT00423176|589625346|FG001|Overall Study|Protocol Violation|3|||
163250507|NCT00423176|589625345|FG000|Overall Study|Did not meet protocol eligibility|2|||
163250508|NCT00423176|589625346|FG001|Overall Study|Did not meet protocol eligibility|4|||
163250509|NCT04535947|589625347|FG000|Overall Study|Adverse Event|1|||
163250510|NCT04535947|589625348|FG001|Overall Study|Adverse Event|4|||
163250511|NCT04535947|589625347|FG000|Overall Study|Other reasons not specified|2|||
163250512|NCT04535947|589625348|FG001|Overall Study|Other reasons not specified|0|||
163250513|NCT04535947|589625347|FG000|Overall Study|Withdrawal by Subject|1|||
163250514|NCT04535947|589625348|FG001|Overall Study|Withdrawal by Subject|1|||
163250515|NCT04867369|589625354|FG000|Overall Study|Withdrawal by Subject|1|||
163250516|NCT04867369|589625355|FG001|Overall Study|Withdrawal by Subject|0|||
163250517|NCT03896035|589625361|FG000|Overall Study|Lost to Follow-up|2|||
163250518|NCT03896035|589625362|FG001|Overall Study|Lost to Follow-up|6|||
163250519|NCT03896035|589625361|FG000|Overall Study|Withdrawal by Subject|0|||
163250520|NCT03896035|589625362|FG001|Overall Study|Withdrawal by Subject|1|||
163250521|NCT03896035|589625361|FG000|Overall Study|Health/family health issues during COVID|0|||
163250522|NCT03896035|589625362|FG001|Overall Study|Health/family health issues during COVID|4|||
163250523|NCT00675766|589625372|FG000|Overall Study|Lost to Follow-up|6|||
163250524|NCT00675766|589625373|FG001|Overall Study|Lost to Follow-up|5|||
163250525|NCT00675766|589625374|FG002|Overall Study|Lost to Follow-up|21|||
163250526|NCT00675766|589625375|FG003|Overall Study|Lost to Follow-up|26|||
163250527|NCT01749982|589625378|FG000|Overall Study|Physician Decision|0|||
163355397|NCT04962698|590011412|FG001|Rest|Technical difficulty|0|||
163355398|NCT04962698|590011411|FG000|Rest|Exclusion criteria met after enrollment|0|||
163355399|NCT04962698|590011412|FG001|Rest|Exclusion criteria met after enrollment|2|||
163250528|NCT01749982|589625379|FG001|Overall Study|Physician Decision|0|||
163250529|NCT01749982|589625380|FG002|Overall Study|Physician Decision|0|||
163250530|NCT01749982|589625381|FG003|Overall Study|Physician Decision|1|||
163250531|NCT01749982|589625378|FG000|Overall Study|Lost to Follow-up|0|||
163250532|NCT01749982|589625379|FG001|Overall Study|Lost to Follow-up|0|||
163250533|NCT01749982|589625380|FG002|Overall Study|Lost to Follow-up|0|||
163250534|NCT01749982|589625381|FG003|Overall Study|Lost to Follow-up|1|||
163250535|NCT01749982|589625378|FG000|Overall Study|Withdrawal by Subject|0|||
163250536|NCT01749982|589625379|FG001|Overall Study|Withdrawal by Subject|0|||
163250537|NCT01749982|589625380|FG002|Overall Study|Withdrawal by Subject|0|||
163250538|NCT01749982|589625381|FG003|Overall Study|Withdrawal by Subject|1|||
163250539|NCT02677116|589625382|FG000|Overall Study|Adverse Event|0|||
163250540|NCT02677116|589625383|FG001|Overall Study|Adverse Event|1|||
163250541|NCT02677116|589625384|FG002|Overall Study|Adverse Event|0|||
163250542|NCT02677116|589625385|FG003|Overall Study|Adverse Event|0|||
163355400|NCT00853229|590011413|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
163355401|NCT00853229|590011414|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
163355402|NCT00585975|590011418|FG000|Overall Study|Withdrawal by Subject|3|||
163355403|NCT00585975|590011419|FG001|Overall Study|Withdrawal by Subject|3|||
163355404|NCT00585975|590011418|FG000|Overall Study|Lost to Follow-up|2|||
163355405|NCT00585975|590011419|FG001|Overall Study|Lost to Follow-up|1|||
163355406|NCT00585975|590011418|FG000|Overall Study|Enrollment met/over-enrolled|10|||
163355407|NCT00585975|590011419|FG001|Overall Study|Enrollment met/over-enrolled|9|||
163355408|NCT03414047|590011426|FG000|Overall Study|Adverse Event|0|||
163355409|NCT03414047|590011427|FG001|Overall Study|Adverse Event|0|||
163355410|NCT03414047|590011428|FG002|Overall Study|Adverse Event|1|||
163355411|NCT03414047|590011429|FG003|Overall Study|Adverse Event|1|||
163355412|NCT03414047|590011426|FG000|Overall Study|Physician Decision|1|||
163355413|NCT03414047|590011427|FG001|Overall Study|Physician Decision|0|||
163355414|NCT03414047|590011428|FG002|Overall Study|Physician Decision|0|||
163355415|NCT03414047|590011429|FG003|Overall Study|Physician Decision|1|||
163355416|NCT03414047|590011426|FG000|Overall Study|Withdrawal by Subject|1|||
163355417|NCT03414047|590011427|FG001|Overall Study|Withdrawal by Subject|0|||
163150225|NCT03474588|589263598|FG000|Overall Study|Death|0|||
163150226|NCT03474588|589263599|FG001|Overall Study|Death|1|||
163150227|NCT01607957|589263600|FG000|Overall Study|Not treated|1|||
163150228|NCT01607957|589263601|FG001|Overall Study|Not treated|1|||
163150229|NCT01607957|589263600|FG000|Overall Study|Death|367|||
163150230|NCT01607957|589263601|FG001|Overall Study|Death|211|||
163150231|NCT01607957|589263600|FG000|Overall Study|Lost to Follow-up|3|||
163150232|NCT01607957|589263601|FG001|Overall Study|Lost to Follow-up|3|||
163150233|NCT01607957|589263600|FG000|Overall Study|Participant refusal|1|||
163150234|NCT01607957|589263601|FG001|Overall Study|Participant refusal|0|||
163150235|NCT01691794|589263602|FG000|Overall Study|Poor/Non-Compliance|1|||
163150236|NCT01691794|589263603|FG001|Overall Study|Poor/Non-Compliance|4|||
163150237|NCT01691794|589263604|FG002|Overall Study|Poor/Non-Compliance|1|||
163150238|NCT01691794|589263602|FG000|Overall Study|Death|0|||
163150239|NCT01691794|589263603|FG001|Overall Study|Death|0|||
163150240|NCT01691794|589263604|FG002|Overall Study|Death|1|||
163150241|NCT01691794|589263602|FG000|Overall Study|Lack of Efficacy|0|||
163150242|NCT01691794|589263603|FG001|Overall Study|Lack of Efficacy|7|||
163150243|NCT01691794|589263604|FG002|Overall Study|Lack of Efficacy|1|||
163150244|NCT01691794|589263602|FG000|Overall Study|Participant request to discontinue|0|||
163150245|NCT01691794|589263603|FG001|Overall Study|Participant request to discontinue|1|||
163150246|NCT01691794|589263604|FG002|Overall Study|Participant request to discontinue|0|||
163150247|NCT01691794|589263602|FG000|Overall Study|Adverse Event|0|||
163150248|NCT01691794|589263603|FG001|Overall Study|Adverse Event|1|||
163150249|NCT01691794|589263604|FG002|Overall Study|Adverse Event|1|||
163150250|NCT01691794|589263602|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
163150251|NCT01691794|589263603|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
163150252|NCT01691794|589263604|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
163150253|NCT01691794|589263602|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
163150254|NCT01691794|589263603|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
163150255|NCT01691794|589263604|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
163150256|NCT04972786|589263605|FG000|First Intervention (1 Day)|Adverse Event|1|||
163150257|NCT04972786|589263606|FG001|First Intervention (1 Day)|Adverse Event|0|||
163150258|NCT03905096|589263607|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
163150259|NCT03905096|589263608|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
163150260|NCT02016781|589263610|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
163150261|NCT02016781|589263611|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
163150262|NCT02016781|589263610|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
163150263|NCT02016781|589263611|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
163150264|NCT02016781|589263610|FG000|Final Database Lock|Withdrawal by Subject|2|||
163150265|NCT02016781|589263611|FG001|Final Database Lock|Withdrawal by Subject|1|||
163150266|NCT02016781|589263610|FG000|Final Database Lock|Lost to Follow-up|11|||
163150267|NCT02016781|589263611|FG001|Final Database Lock|Lost to Follow-up|4|||
163150268|NCT02016781|589263610|FG000|Final Database Lock|Missing data|0|||
163150269|NCT02016781|589263611|FG001|Final Database Lock|Missing data|3|||
163150270|NCT00945009|589263612|FG000|Overall Study|Lack of Efficacy|10|||
163150271|NCT00945009|589263613|FG001|Overall Study|Lack of Efficacy|0|||
163150272|NCT00945009|589263614|FG002|Overall Study|Lack of Efficacy|0|||
163150273|NCT00945009|589263612|FG000|Overall Study|Physician Decision|21|||
163150274|NCT00945009|589263613|FG001|Overall Study|Physician Decision|4|||
163150275|NCT00945009|589263614|FG002|Overall Study|Physician Decision|3|||
163150276|NCT00945009|589263612|FG000|Overall Study|Protocol Violation|6|||
163150277|NCT00945009|589263613|FG001|Overall Study|Protocol Violation|1|||
163150278|NCT00945009|589263614|FG002|Overall Study|Protocol Violation|0|||
163150279|NCT00945009|589263612|FG000|Overall Study|Withdrawal by Subject|1|||
163355418|NCT03414047|590011428|FG002|Overall Study|Withdrawal by Subject|2|||
163150280|NCT00945009|589263613|FG001|Overall Study|Withdrawal by Subject|0|||
163150281|NCT00945009|589263614|FG002|Overall Study|Withdrawal by Subject|0|||
163250543|NCT02677116|589625386|FG004|Overall Study|Adverse Event|0|||
163250544|NCT02677116|589625387|FG005|Overall Study|Adverse Event|1|||
163250545|NCT02677116|589625388|FG006|Overall Study|Adverse Event|1|||
163250546|NCT02677116|589625389|FG007|Overall Study|Adverse Event|0|||
163250547|NCT02677116|589625390|FG008|Overall Study|Adverse Event|0|||
163250548|NCT02677116|589625382|FG000|Overall Study|Physician Decision|0|||
163250549|NCT02677116|589625383|FG001|Overall Study|Physician Decision|2|||
163250550|NCT02677116|589625384|FG002|Overall Study|Physician Decision|3|||
163250551|NCT02677116|589625385|FG003|Overall Study|Physician Decision|2|||
163250552|NCT02677116|589625386|FG004|Overall Study|Physician Decision|1|||
163250553|NCT02677116|589625387|FG005|Overall Study|Physician Decision|3|||
163250554|NCT02677116|589625388|FG006|Overall Study|Physician Decision|1|||
163250555|NCT02677116|589625389|FG007|Overall Study|Physician Decision|1|||
163250556|NCT02677116|589625390|FG008|Overall Study|Physician Decision|2|||
163250557|NCT02677116|589625382|FG000|Overall Study|Withdrawal by parent or guardian|2|||
163250558|NCT02677116|589625383|FG001|Overall Study|Withdrawal by parent or guardian|1|||
163250559|NCT02677116|589625384|FG002|Overall Study|Withdrawal by parent or guardian|0|||
163250560|NCT02677116|589625385|FG003|Overall Study|Withdrawal by parent or guardian|1|||
163250561|NCT02677116|589625386|FG004|Overall Study|Withdrawal by parent or guardian|0|||
163250562|NCT02677116|589625387|FG005|Overall Study|Withdrawal by parent or guardian|0|||
163250563|NCT02677116|589625388|FG006|Overall Study|Withdrawal by parent or guardian|2|||
163250564|NCT02677116|589625389|FG007|Overall Study|Withdrawal by parent or guardian|1|||
163250565|NCT02677116|589625390|FG008|Overall Study|Withdrawal by parent or guardian|0|||
163250566|NCT02677116|589625382|FG000|Overall Study|Withdrawal by Subject|1|||
163355419|NCT03414047|590011429|FG003|Overall Study|Withdrawal by Subject|0|||
163355420|NCT01129115|590011434|FG000|Overall Study|Adverse Event|1|||
163355421|NCT01129115|590011435|FG001|Overall Study|Adverse Event|2|||
163355422|NCT01129115|590011436|FG002|Overall Study|Adverse Event|3|||
163355423|NCT01129115|590011437|FG003|Overall Study|Adverse Event|3|||
163355424|NCT01129115|590011434|FG000|Overall Study|Withdrawal by Subject|1|||
163355425|NCT01129115|590011435|FG001|Overall Study|Withdrawal by Subject|3|||
163355426|NCT01129115|590011436|FG002|Overall Study|Withdrawal by Subject|1|||
163355427|NCT01129115|590011437|FG003|Overall Study|Withdrawal by Subject|4|||
163355428|NCT01129115|590011434|FG000|Overall Study|Protocol Violation|0|||
163355429|NCT01129115|590011435|FG001|Overall Study|Protocol Violation|2|||
163355430|NCT01129115|590011436|FG002|Overall Study|Protocol Violation|2|||
163355431|NCT01129115|590011437|FG003|Overall Study|Protocol Violation|2|||
163355432|NCT01747837|590011438|FG000|Overall Study|Lost to Follow-up|5|||
163355433|NCT01747837|590011439|FG001|Overall Study|Lost to Follow-up|2|||
163355434|NCT01747837|590011438|FG000|Overall Study|Death|4|||
163355435|NCT01747837|590011439|FG001|Overall Study|Death|4|||
163355436|NCT01121913|590011440|FG000|First Intervention Period|Adverse Event|0|||
163355437|NCT01121913|590011441|FG001|First Intervention Period|Adverse Event|0|||
163355438|NCT01121913|590011442|FG002|First Intervention Period|Adverse Event|1|||
163355439|NCT01121913|590011443|FG003|First Intervention Period|Adverse Event|0|||
163355440|NCT01121913|590011440|FG000|First Washout Period|Withdrawal by Subject|1|||
163355441|NCT01121913|590011441|FG001|First Washout Period|Withdrawal by Subject|0|||
163355442|NCT01121913|590011442|FG002|First Washout Period|Withdrawal by Subject|0|||
163355443|NCT01121913|590011443|FG003|First Washout Period|Withdrawal by Subject|0|||
163355444|NCT01121913|590011440|FG000|Second Intervention Period|Adverse Event|0|||
163355445|NCT01121913|590011441|FG001|Second Intervention Period|Adverse Event|0|||
163355446|NCT01121913|590011442|FG002|Second Intervention Period|Adverse Event|1|||
163355447|NCT01121913|590011443|FG003|Second Intervention Period|Adverse Event|0|||
163355448|NCT01121913|590011440|FG000|Second Washout Period|Withdrawal by Subject|0|||
163355449|NCT01121913|590011441|FG001|Second Washout Period|Withdrawal by Subject|0|||
163355450|NCT01121913|590011442|FG002|Second Washout Period|Withdrawal by Subject|1|||
163355451|NCT01121913|590011443|FG003|Second Washout Period|Withdrawal by Subject|0|||
163355452|NCT01121913|590011440|FG000|Third Washout Period|Adverse Event|1|||
163355453|NCT01121913|590011441|FG001|Third Washout Period|Adverse Event|0|||
163355454|NCT01121913|590011442|FG002|Third Washout Period|Adverse Event|0|||
163355455|NCT01121913|590011443|FG003|Third Washout Period|Adverse Event|0|||
163355456|NCT00690378|590011444|FG000|Overall Study|Adverse Event|1|||
163355457|NCT00690378|590011445|FG001|Overall Study|Adverse Event|0|||
163355458|NCT00690378|590011444|FG000|Overall Study|Withdrawal by Subject|2|||
163355459|NCT00690378|590011445|FG001|Overall Study|Withdrawal by Subject|0|||
163355460|NCT00690378|590011444|FG000|Overall Study|Protocol Violation|1|||
163355461|NCT00690378|590011445|FG001|Overall Study|Protocol Violation|0|||
163355462|NCT00690378|590011444|FG000|Overall Study|Lost to Follow-up|2|||
163355463|NCT00690378|590011445|FG001|Overall Study|Lost to Follow-up|3|||
163355464|NCT00690378|590011444|FG000|Overall Study|Did not meet inc/exc criteria|13|||
163250567|NCT02677116|589625383|FG001|Overall Study|Withdrawal by Subject|0|||
163250568|NCT02677116|589625384|FG002|Overall Study|Withdrawal by Subject|0|||
163355465|NCT00690378|590011445|FG001|Overall Study|Did not meet inc/exc criteria|11|||
163250569|NCT02677116|589625385|FG003|Overall Study|Withdrawal by Subject|0|||
163250570|NCT02677116|589625386|FG004|Overall Study|Withdrawal by Subject|0|||
163250571|NCT02677116|589625387|FG005|Overall Study|Withdrawal by Subject|0|||
163410356|NCT05103332|590211362|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
163410357|NCT05103332|590211363|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
163424272|NCT00885365|590258215|FG001|4 Weeks ON Treatment|Adverse Event|4|||
163150282|NCT00945009|589263612|FG000|Overall Study|Ineligible|6|||
163355466|NCT00690378|590011444|FG000|Overall Study|Social problem|1|||
163355467|NCT00690378|590011445|FG001|Overall Study|Social problem|0|||
163355468|NCT02019641|590011449|FG000|10-Week Follow up|Withdrawal by investigator|2|||
163355469|NCT02019641|590011450|FG001|10-Week Follow up|Withdrawal by investigator|0|||
163355470|NCT02019641|590011451|FG002|10-Week Follow up|Withdrawal by investigator|0|||
163355471|NCT02019641|590011449|FG000|10-Week Follow up|Withdrawal by Subject|1|||
163355472|NCT02019641|590011450|FG001|10-Week Follow up|Withdrawal by Subject|1|||
163355473|NCT02019641|590011451|FG002|10-Week Follow up|Withdrawal by Subject|0|||
163355474|NCT02019641|590011449|FG000|20-Week Follow up|Withdrawal by investigator|0|||
163355475|NCT02019641|590011450|FG001|20-Week Follow up|Withdrawal by investigator|0|||
163355476|NCT02019641|590011451|FG002|20-Week Follow up|Withdrawal by investigator|1|||
163355477|NCT03269695|590011455|FG000|Overall Study|Adverse Event|2|||
163355478|NCT03269695|590011456|FG001|Overall Study|Adverse Event|1|||
163355479|NCT03269695|590011455|FG000|Overall Study|Lack of Efficacy|0|||
163355480|NCT03269695|590011456|FG001|Overall Study|Lack of Efficacy|1|||
163355481|NCT03269695|590011455|FG000|Overall Study|Withdrawal by Subject|0|||
163355482|NCT03269695|590011456|FG001|Overall Study|Withdrawal by Subject|1|||
163355483|NCT01017263|590011457|FG000|Overall Study|not eligible|12|||
163355484|NCT05043883|590011458|FG000|Overall Study|Minimum required measurements could not be taken|4|||
163355485|NCT00239681|590011461|FG000|Overall Study|Adverse Event|100|||
163355486|NCT00239681|590011462|FG001|Overall Study|Adverse Event|99|||
163355487|NCT00239681|590011461|FG000|Overall Study|Withdrawal by Subject|458|||
163355488|NCT00239681|590011462|FG001|Overall Study|Withdrawal by Subject|489|||
163355489|NCT00239681|590011461|FG000|Overall Study|Lost to Follow-up|28|||
163355490|NCT00239681|590011462|FG001|Overall Study|Lost to Follow-up|22|||
163355491|NCT00239681|590011461|FG000|Overall Study|Protocol Violation|4|||
163355492|NCT00239681|590011462|FG001|Overall Study|Protocol Violation|4|||
163355493|NCT00239681|590011461|FG000|Overall Study|Physician Decision|13|||
163355494|NCT00239681|590011462|FG001|Overall Study|Physician Decision|17|||
163355495|NCT00239681|590011461|FG000|Overall Study|No information chacked on CaseReportForm|90|||
163355496|NCT00239681|590011462|FG001|Overall Study|No information chacked on CaseReportForm|84|||
163355497|NCT02447718|590011463|FG000|Overall Study|Lost to Follow-up|8|||
163355498|NCT02447718|590011464|FG001|Overall Study|Lost to Follow-up|0|||
163355499|NCT02447718|590011463|FG000|Overall Study|Withdrawal by Subject|3|||
163355500|NCT02447718|590011464|FG001|Overall Study|Withdrawal by Subject|0|||
163355501|NCT02447718|590011463|FG000|Overall Study|Screen Failure|1|||
163355502|NCT02447718|590011464|FG001|Overall Study|Screen Failure|0|||
163355503|NCT00905359|590011469|FG000|Overall Study|Lost to Follow-up|17|||
163355504|NCT00905359|590011470|FG001|Overall Study|Lost to Follow-up|10|||
163355505|NCT00905359|590011469|FG000|Overall Study|Death|2|||
163355506|NCT00905359|590011470|FG001|Overall Study|Death|0|||
163355507|NCT00905359|590011469|FG000|Overall Study|Withdrawal consent|5|||
163355508|NCT00905359|590011470|FG001|Overall Study|Withdrawal consent|6|||
163355509|NCT00468130|590011471|FG000|Overall Study|Adverse Event|2|||
163355510|NCT00468130|590011472|FG001|Overall Study|Adverse Event|1|||
163355511|NCT00468130|590011471|FG000|Overall Study|Withdrawal by Subject|0|||
163150283|NCT00945009|589263613|FG001|Overall Study|Ineligible|1|||
163150284|NCT00945009|589263614|FG002|Overall Study|Ineligible|0|||
163150285|NCT00945009|589263612|FG000|Overall Study|Inevaluable|0|||
163150286|NCT00945009|589263613|FG001|Overall Study|Inevaluable|1|||
163150287|NCT00945009|589263614|FG002|Overall Study|Inevaluable|0|||
163150288|NCT00945009|589263612|FG000|Overall Study|Refusal of further protocol|1|||
163150289|NCT00945009|589263613|FG001|Overall Study|Refusal of further protocol|0|||
163150290|NCT00945009|589263614|FG002|Overall Study|Refusal of further protocol|0|||
163150291|NCT04886154|589263615|FG000|Overall Study|Adverse Event|0|||
163150292|NCT04886154|589263616|FG001|Overall Study|Adverse Event|0|||
163150293|NCT04886154|589263617|FG002|Overall Study|Adverse Event|0|||
163150294|NCT04886154|589263618|FG003|Overall Study|Adverse Event|0|||
163150295|NCT04886154|589263619|FG004|Overall Study|Adverse Event|1|||
163150296|NCT04886154|589263620|FG005|Overall Study|Adverse Event|0|||
163150297|NCT04886154|589263621|FG006|Overall Study|Adverse Event|0|||
163150298|NCT04886154|589263622|FG007|Overall Study|Adverse Event|1|||
163150299|NCT04886154|589263623|FG008|Overall Study|Adverse Event|1|||
163150300|NCT04886154|589263624|FG009|Overall Study|Adverse Event|0|||
163150301|NCT04886154|589263625|FG010|Overall Study|Adverse Event|0|||
163150302|NCT04886154|589263626|FG011|Overall Study|Adverse Event|1|||
163150303|NCT04886154|589263627|FG012|Overall Study|Adverse Event|0|||
163150304|NCT04886154|589263628|FG013|Overall Study|Adverse Event|0|||
163150305|NCT04886154|589263629|FG014|Overall Study|Adverse Event|3|||
163355512|NCT00468130|590011472|FG001|Overall Study|Withdrawal by Subject|1|||
163355513|NCT03713320|590011473|FG000|Randomized Period|Adverse Event|1|||
163355514|NCT03713320|590011474|FG001|Randomized Period|Adverse Event|5|||
163355515|NCT03713320|590011475|FG002|Randomized Period|Adverse Event|0|||
163355516|NCT03713320|590011473|FG000|Randomized Period|Physician Decision|1|||
163355517|NCT03713320|590011474|FG001|Randomized Period|Physician Decision|1|||
163355518|NCT03713320|590011475|FG002|Randomized Period|Physician Decision|0|||
163355519|NCT03713320|590011473|FG000|Randomized Period|Withdrawal by Subject|4|||
163355520|NCT03713320|590011474|FG001|Randomized Period|Withdrawal by Subject|0|||
163355521|NCT03713320|590011475|FG002|Randomized Period|Withdrawal by Subject|0|||
163355522|NCT03713320|590011473|FG000|Randomized Period|Participant decision|3|||
163355523|NCT03713320|590011474|FG001|Randomized Period|Participant decision|1|||
163355524|NCT03713320|590011475|FG002|Randomized Period|Participant decision|0|||
163355525|NCT03713320|590011473|FG000|Randomized Period|Study terminated by sponsor|6|||
163355526|NCT03713320|590011474|FG001|Randomized Period|Study terminated by sponsor|3|||
163355527|NCT03713320|590011475|FG002|Randomized Period|Study terminated by sponsor|0|||
163410358|NCT05103332|590211364|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
163410359|NCT05103332|590211365|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163150306|NCT04886154|589263615|FG000|Overall Study|Lost to Follow-up|1|||
163150307|NCT04886154|589263616|FG001|Overall Study|Lost to Follow-up|0|||
163150308|NCT04886154|589263617|FG002|Overall Study|Lost to Follow-up|2|||
163150309|NCT04886154|589263618|FG003|Overall Study|Lost to Follow-up|0|||
163150310|NCT04886154|589263619|FG004|Overall Study|Lost to Follow-up|17|||
163150311|NCT04886154|589263620|FG005|Overall Study|Lost to Follow-up|7|||
163150312|NCT04886154|589263621|FG006|Overall Study|Lost to Follow-up|8|||
163150313|NCT04886154|589263622|FG007|Overall Study|Lost to Follow-up|7|||
163150314|NCT04886154|589263623|FG008|Overall Study|Lost to Follow-up|8|||
163150315|NCT04886154|589263624|FG009|Overall Study|Lost to Follow-up|0|||
163150316|NCT04886154|589263625|FG010|Overall Study|Lost to Follow-up|2|||
163150317|NCT04886154|589263626|FG011|Overall Study|Lost to Follow-up|0|||
163150318|NCT04886154|589263627|FG012|Overall Study|Lost to Follow-up|0|||
163150319|NCT04886154|589263628|FG013|Overall Study|Lost to Follow-up|0|||
163150320|NCT04886154|589263629|FG014|Overall Study|Lost to Follow-up|0|||
163150321|NCT04886154|589263615|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150322|NCT04886154|589263616|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150323|NCT04886154|589263617|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150324|NCT04886154|589263618|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150325|NCT04886154|589263619|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150326|NCT04886154|589263620|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150327|NCT04886154|589263621|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
163150328|NCT04886154|589263622|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150329|NCT04886154|589263623|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150330|NCT04886154|589263624|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150331|NCT04886154|589263625|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150332|NCT04886154|589263626|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150333|NCT04886154|589263627|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150334|NCT04886154|589263628|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150335|NCT04886154|589263629|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150336|NCT04886154|589263615|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150337|NCT04886154|589263616|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150338|NCT04886154|589263617|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150339|NCT04886154|589263618|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150340|NCT04886154|589263619|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163150341|NCT04886154|589263620|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150342|NCT04886154|589263621|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
163150343|NCT04886154|589263622|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163150344|NCT04886154|589263623|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150345|NCT04886154|589263624|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150346|NCT04886154|589263625|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150347|NCT04886154|589263626|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150348|NCT04886154|589263627|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150349|NCT04886154|589263628|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150350|NCT04886154|589263629|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163150351|NCT04886154|589263615|FG000|Overall Study|Other, Not Specified|0|||
163150352|NCT04886154|589263616|FG001|Overall Study|Other, Not Specified|0|||
163150353|NCT04886154|589263617|FG002|Overall Study|Other, Not Specified|0|||
163150354|NCT04886154|589263618|FG003|Overall Study|Other, Not Specified|0|||
163150355|NCT04886154|589263619|FG004|Overall Study|Other, Not Specified|11|||
163150356|NCT04886154|589263620|FG005|Overall Study|Other, Not Specified|8|||
163150357|NCT04886154|589263621|FG006|Overall Study|Other, Not Specified|9|||
163150358|NCT04886154|589263622|FG007|Overall Study|Other, Not Specified|10|||
163355528|NCT03713320|590011473|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
163150359|NCT04886154|589263623|FG008|Overall Study|Other, Not Specified|6|||
163150360|NCT04886154|589263624|FG009|Overall Study|Other, Not Specified|1|||
163150361|NCT04886154|589263625|FG010|Overall Study|Other, Not Specified|1|||
163150362|NCT04886154|589263626|FG011|Overall Study|Other, Not Specified|2|||
163250572|NCT02677116|589625388|FG006|Overall Study|Withdrawal by Subject|0|||
163250573|NCT02677116|589625389|FG007|Overall Study|Withdrawal by Subject|0|||
163250574|NCT02677116|589625390|FG008|Overall Study|Withdrawal by Subject|0|||
163250575|NCT01207102|589625395|FG000|Overall Study|Withdrawal by Subject|5|||
163410360|NCT05103332|590211366|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410361|NCT05103332|590211367|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410362|NCT05103332|590211368|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410363|NCT05103332|590211369|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410364|NCT05103332|590211370|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410365|NCT05103332|590211371|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410366|NCT05103332|590211372|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410367|NCT05103332|590211373|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410368|NCT05103332|590211374|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163250576|NCT01207102|589625395|FG000|Overall Study|Adverse Event|2|||
163250577|NCT01207102|589625395|FG000|Overall Study|progression|2|||
163250578|NCT01207102|589625395|FG000|Overall Study|Withdrawal by Treating Physician|1|||
163250579|NCT01018394|589625396|FG000|Overall Study|Withdrawal by Subject|5|||
163250580|NCT01018394|589625397|FG001|Overall Study|Withdrawal by Subject|5|||
163250581|NCT01018394|589625396|FG000|Overall Study|Lost to Follow-up|4|||
163250582|NCT01018394|589625397|FG001|Overall Study|Lost to Follow-up|3|||
163250583|NCT03792126|589625398|FG000|Overall Study|Adverse Event|1|||
163250584|NCT03792126|589625399|FG001|Overall Study|Adverse Event|2|||
163250585|NCT03792126|589625398|FG000|Overall Study|Death|0|||
163250586|NCT03792126|589625399|FG001|Overall Study|Death|1|||
163250587|NCT03792126|589625398|FG000|Overall Study|Lost to Follow-up|1|||
163250588|NCT03792126|589625399|FG001|Overall Study|Lost to Follow-up|0|||
163250589|NCT03792126|589625398|FG000|Overall Study|Withdrawal by Subject|0|||
163250590|NCT03792126|589625399|FG001|Overall Study|Withdrawal by Subject|1|||
163250591|NCT03792126|589625398|FG000|Overall Study|COVID-19 Restrictions|1|||
163250592|NCT03792126|589625399|FG001|Overall Study|COVID-19 Restrictions|3|||
163250593|NCT03792126|589625398|FG000|Overall Study|Symptoms resolved|0|||
163250594|NCT03792126|589625399|FG001|Overall Study|Symptoms resolved|3|||
163250595|NCT00490646|589625400|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
163250596|NCT00490646|589625401|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
163250597|NCT00490646|589625400|FG000|Overall Study|Never Treated (had an adverse event)|1|||
163250598|NCT00490646|589625401|FG001|Overall Study|Never Treated (had an adverse event)|0|||
163250599|NCT00490646|589625400|FG000|Overall Study|Never Treated (withdrew consent)|0|||
163250600|NCT00490646|589625401|FG001|Overall Study|Never Treated (withdrew consent)|1|||
163250601|NCT01400503|589625403|FG000|Overall Study|Withdrawal by Subject|1|||
163250602|NCT01400503|589625403|FG000|Overall Study|Study Terminated by Sponsor|58|||
163250603|NCT01400503|589625403|FG000|Overall Study|Other|1|||
163250604|NCT00983073|589625404|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
163250605|NCT00983073|589625404|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
163250606|NCT00983073|589625404|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
163250607|NCT00983073|589625404|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
163250608|NCT00983073|589625404|FG000|Titration and Optimal Dose Period|Other reason|4|||
163355529|NCT03713320|590011474|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
163355530|NCT03713320|590011475|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
163355531|NCT03713320|590011473|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
163355532|NCT03713320|590011474|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
163355533|NCT03713320|590011475|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
163355534|NCT02725528|590011476|FG000|Overall Study|Lost to Follow-up|1|||
163355535|NCT02725528|590011477|FG001|Overall Study|Lost to Follow-up|4|||
163355536|NCT02725528|590011476|FG000|Overall Study|Withdrawal by Subject|0|||
163355537|NCT02725528|590011477|FG001|Overall Study|Withdrawal by Subject|1|||
163355538|NCT02706847|590011478|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
163355539|NCT02706847|590011479|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
163355540|NCT02706847|590011480|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
163355541|NCT02706847|590011481|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
163355542|NCT02706847|590011478|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
163355543|NCT02706847|590011479|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
163355544|NCT02706847|590011480|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
163355545|NCT02706847|590011481|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
163355546|NCT02706847|590011478|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
163355547|NCT02706847|590011479|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
163250609|NCT00983073|589625404|FG000|Maintenance Period|Adverse Event|5|||
163250610|NCT00983073|589625404|FG000|Maintenance Period|Withdrawal by Subject|2|||
163250611|NCT00983073|589625404|FG000|Maintenance Period|Lack of Efficacy|2|||
163355548|NCT02706847|590011480|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
163355549|NCT02706847|590011481|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
163250612|NCT00983073|589625404|FG000|Maintenance Period|Other Reason|7|||
163250613|NCT01669122|589625407|FG000|Period I|Lost to Follow-up|1|||
163250614|NCT01669122|589625407|FG000|Washout Period II|Protocol Violation|2|||
163250615|NCT02962908|589625408|FG000|Overall Study|Lost to Follow-up|0|||
163250616|NCT02962908|589625409|FG001|Overall Study|Lost to Follow-up|3|||
163250617|NCT02962908|589625410|FG002|Overall Study|Lost to Follow-up|0|||
163250618|NCT02962908|589625411|FG003|Overall Study|Lost to Follow-up|1|||
163250619|NCT02962908|589625408|FG000|Overall Study|Withdrawal by Subject|0|||
163250620|NCT02962908|589625409|FG001|Overall Study|Withdrawal by Subject|3|||
163250621|NCT02962908|589625410|FG002|Overall Study|Withdrawal by Subject|0|||
163250622|NCT02962908|589625411|FG003|Overall Study|Withdrawal by Subject|2|||
163250623|NCT02962908|589625408|FG000|Overall Study|Protocol Violation|0|||
163250624|NCT02962908|589625409|FG001|Overall Study|Protocol Violation|1|||
163250625|NCT02962908|589625410|FG002|Overall Study|Protocol Violation|0|||
163250626|NCT02962908|589625411|FG003|Overall Study|Protocol Violation|0|||
163250627|NCT02962908|589625408|FG000|Overall Study|Physician Decision|0|||
163250628|NCT02962908|589625409|FG001|Overall Study|Physician Decision|1|||
163250629|NCT02962908|589625410|FG002|Overall Study|Physician Decision|0|||
163250630|NCT02962908|589625411|FG003|Overall Study|Physician Decision|0|||
163250631|NCT03543254|589625412|FG000|Overall Study|Lost to Follow-up|1|||
163250632|NCT02077166|589625413|FG000|Overall Study|Death|6|||
163250633|NCT02077166|589625414|FG001|Overall Study|Death|7|||
163355550|NCT02706847|590011478|FG000|Period 1: Day 1 to Week 12|Other|4|||
163355551|NCT02706847|590011479|FG001|Period 1: Day 1 to Week 12|Other|4|||
163355552|NCT02706847|590011480|FG002|Period 1: Day 1 to Week 12|Other|2|||
163355553|NCT02706847|590011481|FG003|Period 1: Day 1 to Week 12|Other|2|||
163355554|NCT02706847|590011478|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
163355555|NCT02706847|590011479|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
163355556|NCT02706847|590011480|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
163355557|NCT02706847|590011481|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
163355558|NCT02706847|590011478|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
163355559|NCT02706847|590011479|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
163355560|NCT02706847|590011480|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
163355561|NCT02706847|590011481|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
163355562|NCT02706847|590011478|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
163355563|NCT02706847|590011479|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
163355564|NCT02706847|590011480|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
163355565|NCT02706847|590011481|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
163355566|NCT02706847|590011478|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
163355567|NCT02706847|590011479|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
163355568|NCT02706847|590011480|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
163355569|NCT02706847|590011481|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
163355570|NCT02706847|590011478|FG000|Period 1: Week 12 to Week 24|Other|1|||
163355571|NCT02706847|590011479|FG001|Period 1: Week 12 to Week 24|Other|0|||
163355572|NCT02706847|590011480|FG002|Period 1: Week 12 to Week 24|Other|1|||
163355573|NCT02706847|590011481|FG003|Period 1: Week 12 to Week 24|Other|4|||
163355574|NCT02706847|590011478|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
163355575|NCT02706847|590011479|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
163355576|NCT02706847|590011480|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
163355577|NCT02706847|590011481|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
163355578|NCT02706847|590011478|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
163355579|NCT02706847|590011479|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
163355580|NCT02706847|590011480|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
163355581|NCT02706847|590011481|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
163355582|NCT02706847|590011478|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
163355583|NCT02706847|590011479|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
163355584|NCT02706847|590011480|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
163355585|NCT02706847|590011481|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
163355586|NCT02706847|590011478|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
163355587|NCT02706847|590011479|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
163355588|NCT02706847|590011480|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
163355589|NCT02706847|590011481|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
163355590|NCT02706847|590011478|FG000|Period 2: Week 24 to Week 260|Other|8|||
163355591|NCT02706847|590011479|FG001|Period 2: Week 24 to Week 260|Other|5|||
163355592|NCT02706847|590011480|FG002|Period 2: Week 24 to Week 260|Other|15|||
163355593|NCT02706847|590011481|FG003|Period 2: Week 24 to Week 260|Other|15|||
163355594|NCT01174264|590011482|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
163355595|NCT01174264|590011483|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
163250634|NCT02077166|589625415|FG002|Overall Study|Death|5|||
163250635|NCT02077166|589625416|FG003|Overall Study|Death|6|||
163250636|NCT02077166|589625417|FG004|Overall Study|Death|4|||
163250637|NCT02077166|589625418|FG005|Overall Study|Death|32|||
163250638|NCT02077166|589625419|FG006|Overall Study|Death|22|||
163355596|NCT01174264|590011484|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
163355597|NCT01174264|590011482|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
163250639|NCT02077166|589625413|FG000|Overall Study|Study Closure by Sponsor|3|||
163250640|NCT02077166|589625414|FG001|Overall Study|Study Closure by Sponsor|0|||
163250641|NCT02077166|589625415|FG002|Overall Study|Study Closure by Sponsor|2|||
163250642|NCT02077166|589625416|FG003|Overall Study|Study Closure by Sponsor|2|||
163250643|NCT02077166|589625417|FG004|Overall Study|Study Closure by Sponsor|2|||
163250644|NCT02077166|589625418|FG005|Overall Study|Study Closure by Sponsor|12|||
163250645|NCT02077166|589625419|FG006|Overall Study|Study Closure by Sponsor|4|||
163250646|NCT02077166|589625413|FG000|Overall Study|Lost to Follow-up|0|||
163250647|NCT02077166|589625414|FG001|Overall Study|Lost to Follow-up|0|||
163250648|NCT02077166|589625415|FG002|Overall Study|Lost to Follow-up|0|||
163250649|NCT02077166|589625416|FG003|Overall Study|Lost to Follow-up|0|||
163250650|NCT02077166|589625417|FG004|Overall Study|Lost to Follow-up|0|||
163250651|NCT02077166|589625418|FG005|Overall Study|Lost to Follow-up|1|||
163250652|NCT02077166|589625419|FG006|Overall Study|Lost to Follow-up|0|||
163250653|NCT02077166|589625413|FG000|Overall Study|Withdrawal by Subject|3|||
163250654|NCT02077166|589625414|FG001|Overall Study|Withdrawal by Subject|0|||
163250655|NCT02077166|589625415|FG002|Overall Study|Withdrawal by Subject|1|||
163250656|NCT02077166|589625416|FG003|Overall Study|Withdrawal by Subject|1|||
163250657|NCT02077166|589625417|FG004|Overall Study|Withdrawal by Subject|1|||
163250658|NCT02077166|589625418|FG005|Overall Study|Withdrawal by Subject|3|||
163250659|NCT02077166|589625419|FG006|Overall Study|Withdrawal by Subject|0|||
163250660|NCT02077166|589625413|FG000|Overall Study|Other, Not Specified|0|||
163250661|NCT02077166|589625414|FG001|Overall Study|Other, Not Specified|0|||
163250662|NCT02077166|589625415|FG002|Overall Study|Other, Not Specified|1|||
163250663|NCT02077166|589625416|FG003|Overall Study|Other, Not Specified|0|||
163250664|NCT02077166|589625417|FG004|Overall Study|Other, Not Specified|1|||
163250665|NCT02077166|589625418|FG005|Overall Study|Other, Not Specified|7|||
163250666|NCT02077166|589625419|FG006|Overall Study|Other, Not Specified|8|||
163250667|NCT01261338|589625420|FG000|Overall Study|Withdrawal by Subject|3|||
163250668|NCT01261338|589625421|FG001|Overall Study|Withdrawal by Subject|2|||
163250669|NCT02899728|589625427|FG000|Overall Study|Withdrawal by Subject|1|||
163250670|NCT02899728|589625428|FG001|Overall Study|Withdrawal by Subject|1|||
163250671|NCT05557942|589625429|FG000|Overall Study|Death|0|||
163250672|NCT05557942|589625430|FG001|Overall Study|Death|0|||
163250673|NCT05557942|589625431|FG002|Overall Study|Death|0|||
163250674|NCT05557942|589625432|FG003|Overall Study|Death|2|||
163250675|NCT05557942|589625433|FG004|Overall Study|Death|1|||
163250676|NCT05557942|589625434|FG005|Overall Study|Death|1|||
163250677|NCT05557942|589625429|FG000|Overall Study|Physician Decision|1|||
163250678|NCT05557942|589625430|FG001|Overall Study|Physician Decision|1|||
163250679|NCT05557942|589625431|FG002|Overall Study|Physician Decision|2|||
163250680|NCT05557942|589625432|FG003|Overall Study|Physician Decision|3|||
163250681|NCT05557942|589625433|FG004|Overall Study|Physician Decision|0|||
163250682|NCT05557942|589625434|FG005|Overall Study|Physician Decision|2|||
163150363|NCT04886154|589263627|FG012|Overall Study|Other, Not Specified|1|||
163150364|NCT04886154|589263628|FG013|Overall Study|Other, Not Specified|2|||
163150365|NCT04886154|589263629|FG014|Overall Study|Other, Not Specified|3|||
163150366|NCT03919773|589263630|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
163150367|NCT03919773|589263631|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
163150368|NCT03919773|589263630|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
163150369|NCT03919773|589263631|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
163150370|NCT02702492|589263632|FG000|Overall Study|Disease progression|3|||
163150371|NCT02702492|589263633|FG001|Overall Study|Disease progression|3|||
163150372|NCT02702492|589263634|FG002|Overall Study|Disease progression|2|||
163150373|NCT02702492|589263635|FG003|Overall Study|Disease progression|4|||
163150374|NCT02702492|589263636|FG004|Overall Study|Disease progression|4|||
163150375|NCT02702492|589263637|FG005|Overall Study|Disease progression|1|||
163150376|NCT02702492|589263638|FG006|Overall Study|Disease progression|2|||
163150377|NCT02702492|589263639|FG007|Overall Study|Disease progression|8|||
163150378|NCT02702492|589263640|FG008|Overall Study|Disease progression|5|||
163150379|NCT02702492|589263641|FG009|Overall Study|Disease progression|1|||
163150380|NCT02702492|589263642|FG010|Overall Study|Disease progression|0|||
163150381|NCT02702492|589263643|FG011|Overall Study|Disease progression|3|||
163150382|NCT02702492|589263644|FG012|Overall Study|Disease progression|2|||
163150383|NCT02702492|589263632|FG000|Overall Study|Clinical progression|0|||
163150384|NCT02702492|589263633|FG001|Overall Study|Clinical progression|0|||
163150385|NCT02702492|589263634|FG002|Overall Study|Clinical progression|2|||
163150386|NCT02702492|589263635|FG003|Overall Study|Clinical progression|1|||
163150387|NCT02702492|589263636|FG004|Overall Study|Clinical progression|0|||
163150388|NCT02702492|589263637|FG005|Overall Study|Clinical progression|2|||
163150389|NCT02702492|589263638|FG006|Overall Study|Clinical progression|1|||
163250683|NCT05557942|589625429|FG000|Overall Study|Study terminated by sponsor|17|||
163250684|NCT05557942|589625430|FG001|Overall Study|Study terminated by sponsor|17|||
163250685|NCT05557942|589625431|FG002|Overall Study|Study terminated by sponsor|14|||
163250686|NCT05557942|589625432|FG003|Overall Study|Study terminated by sponsor|40|||
163250687|NCT05557942|589625433|FG004|Overall Study|Study terminated by sponsor|45|||
163250688|NCT05557942|589625434|FG005|Overall Study|Study terminated by sponsor|37|||
163250689|NCT05557942|589625429|FG000|Overall Study|Protocol Violation|0|||
163250690|NCT05557942|589625430|FG001|Overall Study|Protocol Violation|0|||
163250691|NCT05557942|589625431|FG002|Overall Study|Protocol Violation|0|||
163250692|NCT05557942|589625432|FG003|Overall Study|Protocol Violation|0|||
163250693|NCT05557942|589625433|FG004|Overall Study|Protocol Violation|0|||
163250694|NCT05557942|589625434|FG005|Overall Study|Protocol Violation|1|||
163250695|NCT05557942|589625429|FG000|Overall Study|Withdrawal by Subject|0|||
163250696|NCT05557942|589625430|FG001|Overall Study|Withdrawal by Subject|0|||
163250697|NCT05557942|589625431|FG002|Overall Study|Withdrawal by Subject|0|||
163250698|NCT05557942|589625432|FG003|Overall Study|Withdrawal by Subject|0|||
163250699|NCT05557942|589625433|FG004|Overall Study|Withdrawal by Subject|2|||
163250700|NCT05557942|589625434|FG005|Overall Study|Withdrawal by Subject|0|||
163250701|NCT01962493|589625435|FG000|Overall Study|Adverse Event|1|||
163250702|NCT01962493|589625436|FG001|Overall Study|Adverse Event|2|||
163250703|NCT01962493|589625435|FG000|Overall Study|Protocol Violation|0|||
163250704|NCT01962493|589625436|FG001|Overall Study|Protocol Violation|1|||
163250705|NCT01962493|589625435|FG000|Overall Study|Withdrawal by Subject|4|||
163250706|NCT01962493|589625436|FG001|Overall Study|Withdrawal by Subject|2|||
163250707|NCT01951625|589625437|FG000|Treatment Period|Protocol Violation|2|||
163250708|NCT01951625|589625438|FG001|Treatment Period|Protocol Violation|0|||
163250709|NCT01951625|589625439|FG002|Treatment Period|Protocol Violation|1|||
163250710|NCT01951625|589625440|FG003|Treatment Period|Protocol Violation|3|||
163250711|NCT01951625|589625441|FG004|Treatment Period|Protocol Violation|2|||
163250712|NCT01951625|589625437|FG000|Treatment Period|Physician Decision|0|||
163250713|NCT01951625|589625438|FG001|Treatment Period|Physician Decision|0|||
163250714|NCT01951625|589625439|FG002|Treatment Period|Physician Decision|0|||
163250715|NCT01951625|589625440|FG003|Treatment Period|Physician Decision|0|||
163250716|NCT01951625|589625441|FG004|Treatment Period|Physician Decision|1|||
163250717|NCT01951625|589625437|FG000|Treatment Period|Protocol driven decision point|0|||
163250718|NCT01951625|589625438|FG001|Treatment Period|Protocol driven decision point|5|||
163250719|NCT01951625|589625439|FG002|Treatment Period|Protocol driven decision point|0|||
163250720|NCT01951625|589625440|FG003|Treatment Period|Protocol driven decision point|2|||
163250721|NCT01951625|589625441|FG004|Treatment Period|Protocol driven decision point|1|||
163250722|NCT01951625|589625437|FG000|Treatment Period|Non compliance with study drug|1|||
163250723|NCT01951625|589625438|FG001|Treatment Period|Non compliance with study drug|2|||
163250724|NCT01951625|589625439|FG002|Treatment Period|Non compliance with study drug|2|||
163250725|NCT01951625|589625440|FG003|Treatment Period|Non compliance with study drug|0|||
163250726|NCT01951625|589625441|FG004|Treatment Period|Non compliance with study drug|0|||
163250727|NCT01951625|589625437|FG000|Treatment Period|Death|3|||
163250728|NCT01951625|589625438|FG001|Treatment Period|Death|2|||
163250729|NCT01951625|589625439|FG002|Treatment Period|Death|2|||
163250730|NCT01951625|589625440|FG003|Treatment Period|Death|1|||
163250731|NCT01951625|589625441|FG004|Treatment Period|Death|2|||
163250732|NCT01951625|589625437|FG000|Treatment Period|Adverse Event|7|||
163250733|NCT01951625|589625438|FG001|Treatment Period|Adverse Event|10|||
163250734|NCT01951625|589625439|FG002|Treatment Period|Adverse Event|9|||
163250735|NCT01951625|589625440|FG003|Treatment Period|Adverse Event|8|||
163250736|NCT01951625|589625441|FG004|Treatment Period|Adverse Event|8|||
163250737|NCT01951625|589625437|FG000|Treatment Period|Withdrawal by Subject|5|||
163250738|NCT01951625|589625438|FG001|Treatment Period|Withdrawal by Subject|2|||
163250739|NCT01951625|589625439|FG002|Treatment Period|Withdrawal by Subject|1|||
163250740|NCT01951625|589625440|FG003|Treatment Period|Withdrawal by Subject|7|||
163250741|NCT01951625|589625441|FG004|Treatment Period|Withdrawal by Subject|3|||
163250742|NCT01951625|589625437|FG000|Treatment Period|Lost to Follow-up|1|||
163250743|NCT01951625|589625438|FG001|Treatment Period|Lost to Follow-up|0|||
163250744|NCT01951625|589625439|FG002|Treatment Period|Lost to Follow-up|0|||
163250745|NCT01951625|589625440|FG003|Treatment Period|Lost to Follow-up|1|||
163250746|NCT01951625|589625441|FG004|Treatment Period|Lost to Follow-up|0|||
163250747|NCT01951625|589625437|FG000|Follow Up Period|Non-compliance with study drug|1|||
163250748|NCT01951625|589625438|FG001|Follow Up Period|Non-compliance with study drug|0|||
163250749|NCT01951625|589625439|FG002|Follow Up Period|Non-compliance with study drug|0|||
163250750|NCT01951625|589625440|FG003|Follow Up Period|Non-compliance with study drug|0|||
163250751|NCT01951625|589625441|FG004|Follow Up Period|Non-compliance with study drug|0|||
163250752|NCT01951625|589625437|FG000|Follow Up Period|Death|1|||
163250753|NCT01951625|589625438|FG001|Follow Up Period|Death|3|||
163250754|NCT01951625|589625439|FG002|Follow Up Period|Death|2|||
163250755|NCT01951625|589625440|FG003|Follow Up Period|Death|2|||
163250756|NCT01951625|589625441|FG004|Follow Up Period|Death|1|||
163250757|NCT01951625|589625437|FG000|Follow Up Period|Logistical difficulties|1|||
163250758|NCT01951625|589625438|FG001|Follow Up Period|Logistical difficulties|2|||
163250759|NCT01951625|589625439|FG002|Follow Up Period|Logistical difficulties|0|||
163250760|NCT01951625|589625440|FG003|Follow Up Period|Logistical difficulties|0|||
163250761|NCT01951625|589625441|FG004|Follow Up Period|Logistical difficulties|0|||
163250762|NCT01951625|589625437|FG000|Follow Up Period|Adverse Event|0|||
163250763|NCT01951625|589625438|FG001|Follow Up Period|Adverse Event|3|||
163250764|NCT01951625|589625439|FG002|Follow Up Period|Adverse Event|2|||
163250765|NCT01951625|589625440|FG003|Follow Up Period|Adverse Event|3|||
163250766|NCT01951625|589625441|FG004|Follow Up Period|Adverse Event|5|||
163250767|NCT01951625|589625437|FG000|Follow Up Period|Withdrawal by Subject|4|||
163250768|NCT01951625|589625438|FG001|Follow Up Period|Withdrawal by Subject|1|||
163250769|NCT01951625|589625439|FG002|Follow Up Period|Withdrawal by Subject|0|||
163250770|NCT01951625|589625440|FG003|Follow Up Period|Withdrawal by Subject|5|||
163250771|NCT01951625|589625441|FG004|Follow Up Period|Withdrawal by Subject|3|||
163250772|NCT01951625|589625437|FG000|Follow Up Period|Lost to Follow-up|1|||
163250773|NCT01951625|589625438|FG001|Follow Up Period|Lost to Follow-up|0|||
163250774|NCT01951625|589625439|FG002|Follow Up Period|Lost to Follow-up|0|||
163250775|NCT01951625|589625440|FG003|Follow Up Period|Lost to Follow-up|1|||
163250776|NCT01951625|589625441|FG004|Follow Up Period|Lost to Follow-up|1|||
163250777|NCT03754803|589625444|FG000|Overall Study|Withdrawal by Subject|2|||
163250778|NCT05338333|589625445|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
163250779|NCT05338333|589625446|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
163250780|NCT04348604|589625449|FG000|Week 8|Withdrawal by Subject|1|||
163250781|NCT04348604|589625450|FG001|Week 8|Withdrawal by Subject|1|||
163250782|NCT04348604|589625449|FG000|Week 8|Lost to Follow-up|1|||
163250783|NCT04348604|589625450|FG001|Week 8|Lost to Follow-up|2|||
163250784|NCT04348604|589625449|FG000|Week 8|Suspended|0|||
163250785|NCT04348604|589625450|FG001|Week 8|Suspended|1|||
163250786|NCT04348604|589625449|FG000|Week 12|Lost to Follow-up|1|||
163250787|NCT04348604|589625450|FG001|Week 12|Lost to Follow-up|2|||
163250788|NCT04348604|589625449|FG000|Week 12|Withdrawal by Subject|1|||
163250789|NCT04348604|589625450|FG001|Week 12|Withdrawal by Subject|0|||
163250790|NCT04348604|589625449|FG000|Week 24|Lost to Follow-up|2|||
163250791|NCT04348604|589625450|FG001|Week 24|Lost to Follow-up|1|||
163250792|NCT02822222|589626616|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
163250793|NCT02822222|589626617|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
163250794|NCT00833560|589626618|FG000|Overall Study|Toxicity|13|||
163250795|NCT00833560|589626618|FG000|Overall Study|Adverse Event|11|||
163250796|NCT00833560|589626618|FG000|Overall Study|Protocol Violation|6|||
163250797|NCT00833560|589626618|FG000|Overall Study|Lack of Efficacy|4|||
163250798|NCT00833560|589626618|FG000|Overall Study|Death|2|||
163250799|NCT00833560|589626618|FG000|Overall Study|Pregression of other disease|1|||
163250800|NCT00833560|589626618|FG000|Overall Study|Other|5|||
163250801|NCT03382782|589626621|FG000|Cohort 1|Withdrawal by Subject|11|||
163250802|NCT03382782|589626622|FG001|Cohort 1|Withdrawal by Subject|5|||
163250803|NCT03382782|589626623|FG002|Cohort 1|Withdrawal by Subject|0|||
163250804|NCT03382782|589626621|FG000|Cohort 2|Withdrawal by Subject|1|||
163250805|NCT03382782|589626622|FG001|Cohort 2|Withdrawal by Subject|1|||
163250806|NCT03382782|589626623|FG002|Cohort 2|Withdrawal by Subject|0|||
163250807|NCT03382782|589626621|FG000|Cohort 3|Withdrawal by Subject|1|||
163250808|NCT03382782|589626622|FG001|Cohort 3|Withdrawal by Subject|2|||
163250809|NCT03382782|589626623|FG002|Cohort 3|Withdrawal by Subject|0|||
163250810|NCT00440531|589626625|FG000|Overall Study|Adverse Event|1|||
163250811|NCT00440531|589626626|FG001|Overall Study|Adverse Event|0|||
163250812|NCT00440531|589626627|FG002|Overall Study|Adverse Event|2|||
163250813|NCT00440531|589626625|FG000|Overall Study|Withdrawal by Subject|2|||
163250814|NCT00440531|589626626|FG001|Overall Study|Withdrawal by Subject|0|||
163250815|NCT00440531|589626627|FG002|Overall Study|Withdrawal by Subject|0|||
163250816|NCT00440531|589626625|FG000|Overall Study|Protocol Violation|1|||
163250817|NCT00440531|589626626|FG001|Overall Study|Protocol Violation|2|||
163250818|NCT00440531|589626627|FG002|Overall Study|Protocol Violation|0|||
163250819|NCT00440531|589626625|FG000|Overall Study|Lost to Follow-up|4|||
163250820|NCT00440531|589626626|FG001|Overall Study|Lost to Follow-up|3|||
163250821|NCT00440531|589626627|FG002|Overall Study|Lost to Follow-up|5|||
163250822|NCT00440531|589626625|FG000|Overall Study|see pre-assignment details|2|||
163250823|NCT00440531|589626626|FG001|Overall Study|see pre-assignment details|0|||
163250824|NCT00440531|589626627|FG002|Overall Study|see pre-assignment details|0|||
163355598|NCT01174264|590011483|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
163250825|NCT01791725|589626628|FG000|Overall Study|Withdrawal by Subject|0|||
163250826|NCT01791725|589626629|FG001|Overall Study|Withdrawal by Subject|1|||
163250827|NCT01791725|589626630|FG002|Overall Study|Withdrawal by Subject|0|||
163250828|NCT00512148|589626631|FG000|Primay Study Period|Withdrawal by Subject|1|||
163250829|NCT02690974|589626634|FG000|Overall Study|Adverse Event|16|||
163250830|NCT02690974|589626634|FG000|Overall Study|Death|9|||
163250831|NCT02690974|589626634|FG000|Overall Study|Subject/guardian decision|4|||
163250832|NCT02690974|589626634|FG000|Overall Study|Lost to Follow-up|3|||
163250833|NCT02690974|589626634|FG000|Overall Study|Withdrawal of Informed Consent|3|||
163250834|NCT02690974|589626634|FG000|Overall Study|Physician Decision|2|||
163250835|NCT02690974|589626634|FG000|Overall Study|Non-compliance with study treatment|1|||
163250836|NCT02690974|589626634|FG000|Overall Study|Protocol-defined stopping criteria|1|||
163250837|NCT02690974|589626634|FG000|Overall Study|Protocol Deviation|1|||
163250838|NCT01666951|589626637|FG000|Overall Study|Not dosed|1|||
163250839|NCT01666951|589626638|FG001|Overall Study|Not dosed|1|||
163250840|NCT00254982|589626656|FG000|Overall Study|Other|2|||
163250841|NCT00254982|589626657|FG001|Overall Study|Other|1|||
163250842|NCT00254982|589626656|FG000|Overall Study|Lack of Efficacy|5|||
163250843|NCT00254982|589626657|FG001|Overall Study|Lack of Efficacy|3|||
163355599|NCT01174264|590011484|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
163250844|NCT00254982|589626656|FG000|Overall Study|Lost to Follow-up|5|||
163250845|NCT00254982|589626657|FG001|Overall Study|Lost to Follow-up|3|||
163250846|NCT00254982|589626656|FG000|Overall Study|Adverse Event|18|||
163250847|NCT00254982|589626657|FG001|Overall Study|Adverse Event|16|||
163250848|NCT00254982|589626656|FG000|Overall Study|Withdrawal by Subject|1|||
163250849|NCT00254982|589626657|FG001|Overall Study|Withdrawal by Subject|1|||
163250850|NCT00254982|589626656|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
163250851|NCT00254982|589626657|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
163250852|NCT00254982|589626656|FG000|Overall Study|Protocol deviation|1|||
163355600|NCT01174264|590011482|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
163355601|NCT01174264|590011483|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
163355602|NCT01174264|590011484|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
163355603|NCT03432390|590011485|FG000|Apnea Period|Protocol Violation|2|||
163355604|NCT03432390|590011486|FG001|Apnea Period|Protocol Violation|2|||
163355605|NCT01774305|590011489|FG000|Overall Study|Physician Decision|1|||
163355606|NCT01774305|590011490|FG001|Overall Study|Physician Decision|0|||
163355607|NCT03772613|590011497|FG000|Overall Study|Lost to Follow-up|0|||
163355608|NCT03772613|590011498|FG001|Overall Study|Lost to Follow-up|1|||
163355609|NCT03772613|590011499|FG002|Overall Study|Lost to Follow-up|1|||
163355610|NCT01185171|590011502|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
163355611|NCT01185171|590011502|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
163355612|NCT01185171|590011502|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
163355613|NCT01185171|590011502|FG000|Maintenance|Elevated liver transaminases|3|||
163355614|NCT01185171|590011502|FG000|Maintenance|Rush|2|||
163355615|NCT01185171|590011502|FG000|Maintenance|Diarrhea|1|||
163355616|NCT01185171|590011502|FG000|Maintenance|Xerostomia|1|||
163355617|NCT01185171|590011502|FG000|Maintenance|Nausea|1|||
163355618|NCT01185171|590011502|FG000|Maintenance|Comorbid Illness|2|||
163355619|NCT01185171|590011502|FG000|Maintenance|Withdrawal by Subject|1|||
163355620|NCT01185171|590011502|FG000|Maintenance|Disease Recurrence|1|||
163355621|NCT01482429|590011504|FG000|Care Usual|Protocol Violation|0|||
163355622|NCT01482429|590011505|FG001|Care Usual|Protocol Violation|172|||
163355623|NCT01482429|590011504|FG000|Care Usual|Lost to Follow-up|0|||
163355624|NCT01482429|590011505|FG001|Care Usual|Lost to Follow-up|1|||
163355625|NCT01482429|590011504|FG000|Protocol|Protocol Violation|275|||
163355626|NCT01482429|590011505|FG001|Protocol|Protocol Violation|0|||
163355627|NCT01502371|590011513|FG000|Overall Study|Withdrawal by Subject|1|||
163355628|NCT01502371|590011514|FG001|Overall Study|Withdrawal by Subject|2|||
163355629|NCT01502371|590011515|FG002|Overall Study|Withdrawal by Subject|1|||
163355630|NCT01502371|590011516|FG003|Overall Study|Withdrawal by Subject|1|||
163355631|NCT01502371|590011517|FG004|Overall Study|Withdrawal by Subject|1|||
163355632|NCT01502371|590011513|FG000|Overall Study|Adverse Event|2|||
163355633|NCT01502371|590011514|FG001|Overall Study|Adverse Event|1|||
163355634|NCT01502371|590011515|FG002|Overall Study|Adverse Event|0|||
163355635|NCT01502371|590011516|FG003|Overall Study|Adverse Event|4|||
163355636|NCT01502371|590011517|FG004|Overall Study|Adverse Event|3|||
163355637|NCT01502371|590011513|FG000|Overall Study|Treatment Failure|22|||
163355638|NCT01502371|590011514|FG001|Overall Study|Treatment Failure|20|||
163355639|NCT01502371|590011515|FG002|Overall Study|Treatment Failure|12|||
163355640|NCT01502371|590011516|FG003|Overall Study|Treatment Failure|19|||
163355641|NCT01502371|590011517|FG004|Overall Study|Treatment Failure|30|||
163355642|NCT01502371|590011513|FG000|Overall Study|Lack of Efficacy|3|||
163355643|NCT01502371|590011514|FG001|Overall Study|Lack of Efficacy|3|||
163355644|NCT01502371|590011515|FG002|Overall Study|Lack of Efficacy|2|||
163355645|NCT01502371|590011516|FG003|Overall Study|Lack of Efficacy|2|||
163355646|NCT01502371|590011517|FG004|Overall Study|Lack of Efficacy|4|||
163355647|NCT01502371|590011513|FG000|Overall Study|Physician Decision|3|||
163355648|NCT01502371|590011514|FG001|Overall Study|Physician Decision|0|||
163355649|NCT01502371|590011515|FG002|Overall Study|Physician Decision|0|||
163355650|NCT01502371|590011516|FG003|Overall Study|Physician Decision|0|||
163355651|NCT01502371|590011517|FG004|Overall Study|Physician Decision|1|||
163355652|NCT01502371|590011513|FG000|Overall Study|Noncompliance with Study Drug|0|||
163355653|NCT01502371|590011514|FG001|Overall Study|Noncompliance with Study Drug|0|||
163355654|NCT01502371|590011515|FG002|Overall Study|Noncompliance with Study Drug|1|||
163355655|NCT01502371|590011516|FG003|Overall Study|Noncompliance with Study Drug|2|||
163410369|NCT05103332|590211375|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410370|NCT05103332|590211376|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163355656|NCT01502371|590011517|FG004|Overall Study|Noncompliance with Study Drug|1|||
163250853|NCT00254982|589626657|FG001|Overall Study|Protocol deviation|1|||
163355657|NCT01502371|590011513|FG000|Overall Study|Technical Problems|1|||
163355658|NCT01502371|590011514|FG001|Overall Study|Technical Problems|0|||
163355659|NCT01502371|590011515|FG002|Overall Study|Technical Problems|2|||
163355660|NCT01502371|590011516|FG003|Overall Study|Technical Problems|4|||
163355661|NCT01502371|590011517|FG004|Overall Study|Technical Problems|1|||
163355662|NCT01502371|590011513|FG000|Overall Study|Protocol Violation|9|||
163355663|NCT01502371|590011514|FG001|Overall Study|Protocol Violation|5|||
163355664|NCT01502371|590011515|FG002|Overall Study|Protocol Violation|6|||
163355665|NCT01502371|590011516|FG003|Overall Study|Protocol Violation|5|||
163250854|NCT00254982|589626656|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
163250855|NCT00254982|589626657|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
163250856|NCT00254982|589626656|FG000|Overall Study|Malignancy|0|||
163250857|NCT00254982|589626657|FG001|Overall Study|Malignancy|2|||
163250858|NCT00254982|589626656|FG000|Overall Study|Opportunistic infection|1|||
163250859|NCT00254982|589626657|FG001|Overall Study|Opportunistic infection|0|||
163250860|NCT00254982|589626656|FG000|Overall Study|Abnormal liver function tests|2|||
163250861|NCT00254982|589626657|FG001|Overall Study|Abnormal liver function tests|1|||
163250862|NCT02570126|589626658|FG000|Overall Study|Lost to Follow-up|2|||
163250863|NCT02570126|589626659|FG001|Overall Study|Lost to Follow-up|0|||
163250864|NCT02570126|589626658|FG000|Overall Study|Unable To Arrange Visit 3|1|||
163250865|NCT02570126|589626659|FG001|Overall Study|Unable To Arrange Visit 3|0|||
163250866|NCT02570126|589626658|FG000|Overall Study|Violation Of Procedures GSK|0|||
163250867|NCT02570126|589626659|FG001|Overall Study|Violation Of Procedures GSK|1|||
163250868|NCT02570126|589626658|FG000|Overall Study|Protocol Violation|0|||
163250869|NCT02570126|589626659|FG001|Overall Study|Protocol Violation|1|||
163250870|NCT02570126|589626658|FG000|Overall Study|Withdrawal by Subject|3|||
163250871|NCT02570126|589626659|FG001|Overall Study|Withdrawal by Subject|7|||
163250872|NCT00626028|589626660|FG000|Overall Study|Adverse Event|1|||
163250873|NCT00626028|589626661|FG001|Overall Study|Adverse Event|1|||
163250874|NCT00626028|589626660|FG000|Overall Study|Device Failure|0|||
163250875|NCT00626028|589626661|FG001|Overall Study|Device Failure|1|||
163250876|NCT00626028|589626660|FG000|Overall Study|Physician Decision|2|||
163250877|NCT00626028|589626661|FG001|Overall Study|Physician Decision|1|||
163250878|NCT00626028|589626660|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
163250879|NCT00626028|589626661|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
163250880|NCT05224050|589626662|FG000|Overall Study|Withdrawal by Subject|9|||
163250881|NCT05224050|589626662|FG000|Overall Study|Lost to Follow-up|3|||
163250882|NCT01292876|589626664|FG000|Overall Study|Physician Decision|4|||
163250883|NCT01627327|589626665|FG000|Overall Study|Adverse Event|6|||
163250884|NCT01627327|589626666|FG001|Overall Study|Adverse Event|12|||
163250885|NCT01627327|589626665|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
163250886|NCT01627327|589626666|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
163250887|NCT01627327|589626665|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
163250888|NCT01627327|589626666|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
163250889|NCT01627327|589626665|FG000|Overall Study|Protocol Violation|4|||
163250890|NCT01627327|589626666|FG001|Overall Study|Protocol Violation|10|||
163250891|NCT01627327|589626665|FG000|Overall Study|Lost to Follow-up|1|||
163250892|NCT01627327|589626666|FG001|Overall Study|Lost to Follow-up|3|||
163250893|NCT01627327|589626665|FG000|Overall Study|Physician Decision|1|||
163250894|NCT01627327|589626666|FG001|Overall Study|Physician Decision|0|||
163250895|NCT01627327|589626665|FG000|Overall Study|Withdrawal by Subject|3|||
163250896|NCT01627327|589626666|FG001|Overall Study|Withdrawal by Subject|3|||
163250897|NCT00917579|589626667|FG000|Washout >= 2 Weeks|Adverse Event|1|||
163250898|NCT00917579|589626668|FG001|Washout >= 2 Weeks|Adverse Event|0|||
163250899|NCT00917579|589626667|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
163250900|NCT00917579|589626668|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
163250901|NCT05763628|589626674|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
163250902|NCT05763628|589626675|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
163250903|NCT05763628|589626674|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
163250904|NCT05763628|589626675|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
163250905|NCT05763628|589626674|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
163250906|NCT05763628|589626675|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
163250907|NCT01137474|589626676|FG000|Overall Study|Adverse Event|3|||
163250908|NCT01137474|589626677|FG001|Overall Study|Adverse Event|5|||
163250909|NCT01137474|589626678|FG002|Overall Study|Adverse Event|1|||
163250910|NCT01137474|589626679|FG003|Overall Study|Adverse Event|3|||
163250911|NCT01137474|589626676|FG000|Overall Study|Withdrawal by Subject|7|||
163250912|NCT01137474|589626677|FG001|Overall Study|Withdrawal by Subject|2|||
163250913|NCT01137474|589626678|FG002|Overall Study|Withdrawal by Subject|6|||
163250914|NCT01137474|589626679|FG003|Overall Study|Withdrawal by Subject|9|||
163250915|NCT01137474|589626676|FG000|Overall Study|No longer met study criteria|6|||
163250916|NCT01137474|589626677|FG001|Overall Study|No longer met study criteria|1|||
163250917|NCT01137474|589626678|FG002|Overall Study|No longer met study criteria|0|||
163250918|NCT01137474|589626679|FG003|Overall Study|No longer met study criteria|5|||
163250919|NCT01137474|589626676|FG000|Overall Study|Lost to Follow-up|5|||
163250920|NCT01137474|589626677|FG001|Overall Study|Lost to Follow-up|1|||
163250921|NCT01137474|589626678|FG002|Overall Study|Lost to Follow-up|0|||
163250922|NCT01137474|589626679|FG003|Overall Study|Lost to Follow-up|2|||
163250923|NCT01137474|589626676|FG000|Overall Study|Lack of Efficacy|0|||
163250924|NCT01137474|589626677|FG001|Overall Study|Lack of Efficacy|0|||
163250925|NCT01137474|589626678|FG002|Overall Study|Lack of Efficacy|0|||
163250926|NCT01137474|589626679|FG003|Overall Study|Lack of Efficacy|2|||
163250927|NCT01137474|589626676|FG000|Overall Study|Other|3|||
163250928|NCT01137474|589626677|FG001|Overall Study|Other|1|||
163250929|NCT01137474|589626678|FG002|Overall Study|Other|0|||
163250930|NCT01137474|589626679|FG003|Overall Study|Other|0|||
163250931|NCT01137474|589626676|FG000|Overall Study|Pregnancy|0|||
163410371|NCT05103332|590211359|FG000|DB Period (6 Months=168 Days)|Other|0|||
163410372|NCT05103332|590211360|FG001|DB Period (6 Months=168 Days)|Other|0|||
163250932|NCT01137474|589626677|FG001|Overall Study|Pregnancy|1|||
163250933|NCT01137474|589626678|FG002|Overall Study|Pregnancy|0|||
163250934|NCT01137474|589626679|FG003|Overall Study|Pregnancy|0|||
163250935|NCT01137474|589626676|FG000|Overall Study|Administrative reason by sponsor|0|||
163250936|NCT01137474|589626677|FG001|Overall Study|Administrative reason by sponsor|1|||
163250937|NCT01137474|589626678|FG002|Overall Study|Administrative reason by sponsor|0|||
163250938|NCT01137474|589626679|FG003|Overall Study|Administrative reason by sponsor|0|||
163250939|NCT00868439|589626685|FG000|Overall Study|Adverse Event|4|||
163250940|NCT00868439|589626686|FG001|Overall Study|Adverse Event|3|||
163250941|NCT00868439|589626685|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
163250942|NCT00868439|589626686|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
163250943|NCT00868439|589626685|FG000|Overall Study|Death|0|||
163250944|NCT00868439|589626686|FG001|Overall Study|Death|1|||
163250945|NCT00868439|589626685|FG000|Overall Study|Protocol Violation|1|||
163250946|NCT00868439|589626686|FG001|Overall Study|Protocol Violation|1|||
163250947|NCT00868439|589626685|FG000|Overall Study|Physician Decision|1|||
163250948|NCT00868439|589626686|FG001|Overall Study|Physician Decision|0|||
163250949|NCT00868439|589626685|FG000|Overall Study|Withdrawal by Subject|0|||
163250950|NCT00868439|589626686|FG001|Overall Study|Withdrawal by Subject|1|||
163250951|NCT01132326|589626687|FG000|Overall Study|Lack of Efficacy|25|||
163250952|NCT01132326|589626687|FG000|Overall Study|Adverse Event|37|||
163250953|NCT01132326|589626687|FG000|Overall Study|Protocol Violation|1|||
163250954|NCT01132326|589626687|FG000|Overall Study|Lost to Follow-up|16|||
163250955|NCT01132326|589626687|FG000|Overall Study|Withdrawal by Subject|40|||
163250956|NCT01132326|589626687|FG000|Overall Study|Physician Decision|10|||
163250957|NCT01132326|589626687|FG000|Overall Study|Study Termination|80|||
163250958|NCT01132326|589626687|FG000|Overall Study|Declining Health|1|||
163250959|NCT01132326|589626687|FG000|Overall Study|Pregnancy|1|||
163250960|NCT01132326|589626687|FG000|Overall Study|Caregiver Withdrew Consent|1|||
163250961|NCT01132326|589626687|FG000|Overall Study|Death|5|||
163250962|NCT01132326|589626687|FG000|Overall Study|Subject Unable to Come To Visits|1|||
163250963|NCT00338884|589626690|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
163250964|NCT00338884|589626690|FG000|Overall Study|Adverse Event|14|||
163250965|NCT00338884|589626690|FG000|Overall Study|Death|8|||
163250966|NCT00338884|589626690|FG000|Overall Study|Other|4|||
163250967|NCT00338884|589626690|FG000|Overall Study|Global Deterioration of Health Status|3|||
163250968|NCT00338884|589626690|FG000|Overall Study|Withdrawal by Subject|3|||
163250969|NCT00338884|589626690|FG000|Overall Study|Lost to Follow-up|1|||
163250970|NCT00338884|589626690|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
163250971|NCT00911534|589626691|FG000|Overall Study|Adverse Event|4|||
163250972|NCT00911534|589626692|FG001|Overall Study|Adverse Event|4|||
163250973|NCT00911534|589626691|FG000|Overall Study|Lost to Follow-up|2|||
163250974|NCT00911534|589626692|FG001|Overall Study|Lost to Follow-up|4|||
163250975|NCT00911534|589626691|FG000|Overall Study|Withdrawal by Subject|2|||
163250976|NCT00911534|589626692|FG001|Overall Study|Withdrawal by Subject|1|||
163250977|NCT00911534|589626691|FG000|Overall Study|Lack of Efficacy|4|||
163250978|NCT00911534|589626692|FG001|Overall Study|Lack of Efficacy|1|||
163250979|NCT00911534|589626691|FG000|Overall Study|Withdrawal of consent|1|||
163250980|NCT00911534|589626692|FG001|Overall Study|Withdrawal of consent|4|||
163250981|NCT00911534|589626691|FG000|Overall Study|Other|2|||
163250982|NCT00911534|589626692|FG001|Overall Study|Other|2|||
163250983|NCT03492281|589626694|FG000|Overall Study|Withdrawal by Subject|21|||
163250984|NCT03492281|589626695|FG001|Overall Study|Withdrawal by Subject|14|||
163250985|NCT03492281|589626696|FG002|Overall Study|Withdrawal by Subject|13|||
163250986|NCT03492281|589626694|FG000|Overall Study|Lost to Follow-up|14|||
163250987|NCT03492281|589626695|FG001|Overall Study|Lost to Follow-up|15|||
163250988|NCT03492281|589626696|FG002|Overall Study|Lost to Follow-up|10|||
163250989|NCT03492281|589626694|FG000|Overall Study|Adverse Event|6|||
163250990|NCT03492281|589626695|FG001|Overall Study|Adverse Event|8|||
163250991|NCT03492281|589626696|FG002|Overall Study|Adverse Event|13|||
163250992|NCT03492281|589626694|FG000|Overall Study|Lack of Efficacy|3|||
163250993|NCT03492281|589626695|FG001|Overall Study|Lack of Efficacy|0|||
163250994|NCT03492281|589626696|FG002|Overall Study|Lack of Efficacy|1|||
163250995|NCT03492281|589626694|FG000|Overall Study|Physician Decision|1|||
163250996|NCT03492281|589626695|FG001|Overall Study|Physician Decision|0|||
163250997|NCT03492281|589626696|FG002|Overall Study|Physician Decision|3|||
163250998|NCT03492281|589626694|FG000|Overall Study|Protocol Violation|0|||
163250999|NCT03492281|589626695|FG001|Overall Study|Protocol Violation|2|||
163251000|NCT03492281|589626696|FG002|Overall Study|Protocol Violation|1|||
163251001|NCT03492281|589626694|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
163251002|NCT03492281|589626695|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
163251003|NCT03492281|589626696|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
163251004|NCT03492281|589626694|FG000|Overall Study|Death|0|||
163251005|NCT03492281|589626695|FG001|Overall Study|Death|0|||
163251006|NCT03492281|589626696|FG002|Overall Study|Death|1|||
163410373|NCT05103332|590211361|FG002|DB Period (6 Months=168 Days)|Other|0|||
163410374|NCT05103332|590211362|FG003|DB Period (6 Months=168 Days)|Other|1|||
163355666|NCT01502371|590011517|FG004|Overall Study|Protocol Violation|10|||
163355667|NCT01502371|590011513|FG000|Overall Study|Excluded Medication|0|||
163355668|NCT01502371|590011514|FG001|Overall Study|Excluded Medication|1|||
163410375|NCT05103332|590211363|FG004|DB Period (6 Months=168 Days)|Other|0|||
163410376|NCT05103332|590211364|FG005|DB Period (6 Months=168 Days)|Other|0|||
163410377|NCT05103332|590211365|FG006|DB Period (6 Months=168 Days)|Other|0|||
163410378|NCT05103332|590211366|FG007|DB Period (6 Months=168 Days)|Other|0|||
163410379|NCT05103332|590211367|FG008|DB Period (6 Months=168 Days)|Other|0|||
163410380|NCT05103332|590211368|FG009|DB Period (6 Months=168 Days)|Other|0|||
163410381|NCT05103332|590211369|FG010|DB Period (6 Months=168 Days)|Other|0|||
163355669|NCT01502371|590011515|FG002|Overall Study|Excluded Medication|1|||
163355670|NCT01502371|590011516|FG003|Overall Study|Excluded Medication|0|||
163355671|NCT01502371|590011517|FG004|Overall Study|Excluded Medication|1|||
163355672|NCT03325608|590011518|FG000|Overall Study|Lost to Follow-up|23|||
163355673|NCT03325608|590011519|FG001|Overall Study|Lost to Follow-up|23|||
163355674|NCT03325608|590011520|FG002|Overall Study|Lost to Follow-up|30|||
163355675|NCT03325608|590011521|FG003|Overall Study|Lost to Follow-up|30|||
163355676|NCT03325608|590011518|FG000|Overall Study|Death of Caregiver|0|||
163410382|NCT05103332|590211370|FG011|DB Period (6 Months=168 Days)|Other|0|||
163410383|NCT05103332|590211371|FG012|DB Period (6 Months=168 Days)|Other|0|||
163410384|NCT05103332|590211372|FG013|DB Period (6 Months=168 Days)|Other|0|||
163150390|NCT02702492|589263639|FG007|Overall Study|Clinical progression|4|||
163150391|NCT02702492|589263640|FG008|Overall Study|Clinical progression|0|||
163150392|NCT02702492|589263641|FG009|Overall Study|Clinical progression|0|||
163150393|NCT02702492|589263642|FG010|Overall Study|Clinical progression|1|||
163150394|NCT02702492|589263643|FG011|Overall Study|Clinical progression|2|||
163150395|NCT02702492|589263644|FG012|Overall Study|Clinical progression|0|||
163150396|NCT02702492|589263632|FG000|Overall Study|Adverse Event|0|||
163150397|NCT02702492|589263633|FG001|Overall Study|Adverse Event|0|||
163150398|NCT02702492|589263634|FG002|Overall Study|Adverse Event|1|||
163150399|NCT02702492|589263635|FG003|Overall Study|Adverse Event|2|||
163150400|NCT02702492|589263636|FG004|Overall Study|Adverse Event|1|||
163150401|NCT02702492|589263637|FG005|Overall Study|Adverse Event|0|||
163150402|NCT02702492|589263638|FG006|Overall Study|Adverse Event|1|||
163150403|NCT02702492|589263639|FG007|Overall Study|Adverse Event|0|||
163150404|NCT02702492|589263640|FG008|Overall Study|Adverse Event|2|||
163150405|NCT02702492|589263641|FG009|Overall Study|Adverse Event|0|||
163150406|NCT02702492|589263642|FG010|Overall Study|Adverse Event|0|||
163150407|NCT02702492|589263643|FG011|Overall Study|Adverse Event|0|||
163150408|NCT02702492|589263644|FG012|Overall Study|Adverse Event|1|||
163150409|NCT02702492|589263632|FG000|Overall Study|Other|0|||
163150410|NCT02702492|589263633|FG001|Overall Study|Other|0|||
163150411|NCT02702492|589263634|FG002|Overall Study|Other|0|||
163150412|NCT02702492|589263635|FG003|Overall Study|Other|0|||
163150413|NCT02702492|589263636|FG004|Overall Study|Other|0|||
163150414|NCT02702492|589263637|FG005|Overall Study|Other|0|||
163150415|NCT02702492|589263638|FG006|Overall Study|Other|0|||
163150416|NCT02702492|589263639|FG007|Overall Study|Other|0|||
163150417|NCT02702492|589263640|FG008|Overall Study|Other|0|||
163150418|NCT02702492|589263641|FG009|Overall Study|Other|0|||
163150419|NCT02702492|589263642|FG010|Overall Study|Other|0|||
163150420|NCT02702492|589263643|FG011|Overall Study|Other|0|||
163150421|NCT02702492|589263644|FG012|Overall Study|Other|1|||
163150422|NCT04972162|589263649|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
163150423|NCT04972162|589263650|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
163150424|NCT02429830|589263651|FG000|Overall Study|Lost to Follow-up|1|||
163150425|NCT02429830|589263651|FG000|Overall Study|Device Explant|2|||
163150426|NCT00199381|589265269|FG000|Overall Study|Withdrawal by Subject|38|||
163355677|NCT03325608|590011519|FG001|Overall Study|Death of Caregiver|0|||
163355678|NCT03325608|590011520|FG002|Overall Study|Death of Caregiver|2|||
163355679|NCT03325608|590011521|FG003|Overall Study|Death of Caregiver|2|||
163355680|NCT03325608|590011518|FG000|Overall Study|Death of Care Recipient|34|||
163355681|NCT03325608|590011519|FG001|Overall Study|Death of Care Recipient|34|||
163410385|NCT05103332|590211373|FG014|DB Period (6 Months=168 Days)|Other|0|||
163410386|NCT05103332|590211374|FG015|DB Period (6 Months=168 Days)|Other|0|||
163410387|NCT05103332|590211375|FG016|DB Period (6 Months=168 Days)|Other|0|||
163150427|NCT00199381|589265269|FG000|Overall Study|Adverse Event|73|||
163150428|NCT00199381|589265269|FG000|Overall Study|Protocol Violation|6|||
163150429|NCT00199381|589265269|FG000|Overall Study|Lack of Efficacy|27|||
163150430|NCT00199381|589265269|FG000|Overall Study|Not including due to early termination|37|||
163150431|NCT00199381|589265269|FG000|Overall Study|Study termination by Sponsor|323|||
163150432|NCT00385671|589265271|FG000|Overall Study|Adverse Event|14|||
163150433|NCT00385671|589265272|FG001|Overall Study|Adverse Event|27|||
163150434|NCT00385671|589265273|FG002|Overall Study|Adverse Event|18|||
163150435|NCT00385671|589265271|FG000|Overall Study|Lack of Efficacy|5|||
163150436|NCT00385671|589265272|FG001|Overall Study|Lack of Efficacy|9|||
163355682|NCT03325608|590011520|FG002|Overall Study|Death of Care Recipient|28|||
163251007|NCT03492281|589626694|FG000|Overall Study|Captured as Other in Database|8|||
163251008|NCT03492281|589626695|FG001|Overall Study|Captured as Other in Database|6|||
163251009|NCT03492281|589626696|FG002|Overall Study|Captured as Other in Database|3|||
163251010|NCT03342638|589626697|FG000|Overall Study|Withdrawal by Subject|1|||
163251011|NCT03342638|589626698|FG001|Overall Study|Withdrawal by Subject|0|||
163251012|NCT03342638|589626697|FG000|Overall Study|Physician Decision|0|||
163251013|NCT03342638|589626698|FG001|Overall Study|Physician Decision|1|||
163251014|NCT00113568|589626710|FG000|Overall Study|Adverse Event|97|||
163251015|NCT00113568|589626710|FG000|Overall Study|Death|1|||
163251016|NCT00113568|589626710|FG000|Overall Study|Lack of Efficacy|30|||
163251017|NCT00113568|589626710|FG000|Overall Study|Lost to Follow-up|156|||
163251018|NCT00113568|589626710|FG000|Overall Study|Protocol Violation|32|||
163251019|NCT00113568|589626710|FG000|Overall Study|Withdrawal by Subject|117|||
163251020|NCT00113568|589626710|FG000|Overall Study|Other|112|||
163251021|NCT02191267|589626712|FG000|Overall Study|Withdrawal by Subject|1|||
163251022|NCT02191267|589626713|FG001|Overall Study|Withdrawal by Subject|0|||
163251023|NCT02191267|589626714|FG002|Overall Study|Withdrawal by Subject|0|||
163251024|NCT03213158|589626717|FG000|Overall Study|Withdrawal by Subject|1|||
163251025|NCT03213158|589626717|FG000|Overall Study|Physician Decision|2|||
163251026|NCT00587964|589626718|FG000|Overall Study|Withdrawal by Subject|1|||
163251027|NCT00587964|589626718|FG000|Overall Study|Lost to Follow-up|1|||
163251028|NCT00587964|589626718|FG000|Overall Study|Patient found to be ineligible|1|||
163251029|NCT00587964|589626718|FG000|Overall Study|Patient did not receive intervention|5|||
163251030|NCT00587964|589626718|FG000|Overall Study|Progression of Disease|4|||
163251031|NCT01569438|589626720|FG000|Overall Study|Lack of Efficacy|1|||
163251032|NCT01569438|589626721|FG001|Overall Study|Lack of Efficacy|2|||
163251033|NCT01569438|589626720|FG000|Overall Study|Withdrawal by Subject|0|||
163251034|NCT01569438|589626721|FG001|Overall Study|Withdrawal by Subject|3|||
163251035|NCT01569438|589626720|FG000|Overall Study|Adverse Event|2|||
163251036|NCT01569438|589626721|FG001|Overall Study|Adverse Event|15|||
163251037|NCT01569438|589626720|FG000|Overall Study|Protocol Violation|2|||
163251038|NCT01569438|589626721|FG001|Overall Study|Protocol Violation|0|||
163251039|NCT01569438|589626720|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
163251040|NCT01569438|589626721|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
163251041|NCT01569438|589626720|FG000|Overall Study|Sponsor/Physician decision|1|||
163251042|NCT01569438|589626721|FG001|Overall Study|Sponsor/Physician decision|1|||
163251043|NCT01569438|589626720|FG000|Overall Study|Unable to adhere to study schedule|0|||
163251044|NCT01569438|589626721|FG001|Overall Study|Unable to adhere to study schedule|1|||
163251045|NCT03649230|589626722|FG000|Overall Study|Adverse Event|12|||
163251046|NCT03649230|589626722|FG000|Overall Study|Death|8|||
163251047|NCT03649230|589626722|FG000|Overall Study|Withdrawal by Subject|6|||
163251048|NCT03649230|589626722|FG000|Overall Study|Physician Decision|5|||
163251049|NCT03649230|589626722|FG000|Overall Study|Disease progression|5|||
163251050|NCT03649230|589626722|FG000|Overall Study|Switched to non-HEC|5|||
163251051|NCT03649230|589626722|FG000|Overall Study|Chemotherapy discontinued|4|||
163251052|NCT03649230|589626722|FG000|Overall Study|Received only 3 HEC cycles|4|||
163251053|NCT03649230|589626722|FG000|Overall Study|Screen Failure|3|||
163251054|NCT03649230|589626722|FG000|Overall Study|Patient stopped treatment|2|||
163251055|NCT03649230|589626722|FG000|Overall Study|Protocol Violation|1|||
163251056|NCT03649230|589626722|FG000|Overall Study|Non-compliance|1|||
163251057|NCT03649230|589626722|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
163251058|NCT01693068|589626724|FG000|Randomization Period|On-study|2|||
163251059|NCT01693068|589626725|FG001|Randomization Period|On-study|5|||
163251060|NCT01693068|589626726|FG002|Randomization Period|On-study|0|||
163251061|NCT01693068|589626724|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
163251062|NCT01693068|589626725|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
163251063|NCT01693068|589626726|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
163251064|NCT04302350|589626732|FG000|Overall Study|Physician Decision|1|||
163251065|NCT04302350|589626733|FG001|Overall Study|Physician Decision|1|||
163251066|NCT04302350|589626734|FG002|Overall Study|Physician Decision|2|||
163251067|NCT04302350|589626732|FG000|Overall Study|Lack of Efficacy|1|||
163251068|NCT04302350|589626733|FG001|Overall Study|Lack of Efficacy|1|||
163251069|NCT04302350|589626734|FG002|Overall Study|Lack of Efficacy|4|||
163251070|NCT04302350|589626732|FG000|Overall Study|Adverse Event|0|||
163251071|NCT04302350|589626733|FG001|Overall Study|Adverse Event|1|||
163251072|NCT04302350|589626734|FG002|Overall Study|Adverse Event|2|||
163251073|NCT00617344|589626736|FG000|Overall Study|Serious adverse event|1|||
163251074|NCT00617344|589626737|FG001|Overall Study|Serious adverse event|0|||
163251075|NCT00617344|589626738|FG002|Overall Study|Serious adverse event|0|||
163251076|NCT00617344|589626736|FG000|Overall Study|Other Adverse Event|1|||
163251077|NCT00617344|589626737|FG001|Overall Study|Other Adverse Event|1|||
163251078|NCT00617344|589626738|FG002|Overall Study|Other Adverse Event|0|||
163251079|NCT00617344|589626736|FG000|Overall Study|Protocol Violation|10|||
163251080|NCT00617344|589626737|FG001|Overall Study|Protocol Violation|8|||
163251081|NCT00617344|589626738|FG002|Overall Study|Protocol Violation|5|||
163251082|NCT00617344|589626736|FG000|Overall Study|Lost to Follow-up|5|||
163251083|NCT00617344|589626737|FG001|Overall Study|Lost to Follow-up|4|||
163251084|NCT00617344|589626738|FG002|Overall Study|Lost to Follow-up|1|||
163251085|NCT00617344|589626736|FG000|Overall Study|Withdrawal by Subject|8|||
163251086|NCT00617344|589626737|FG001|Overall Study|Withdrawal by Subject|9|||
163251087|NCT00617344|589626738|FG002|Overall Study|Withdrawal by Subject|2|||
163251088|NCT02747238|589626739|FG000|Overall Study|Lack of Efficacy|0|||
163251089|NCT02747238|589626740|FG001|Overall Study|Lack of Efficacy|1|||
163251090|NCT02747238|589626739|FG000|Overall Study|Data lost|3|||
163251091|NCT02747238|589626740|FG001|Overall Study|Data lost|5|||
163251092|NCT05245864|589626745|FG000|Overall Study|Withdrawal by Subject|1|||
163251093|NCT05245864|589626746|FG001|Overall Study|Withdrawal by Subject|1|||
163251094|NCT01475136|589626747|FG000|Overall Study|Sponsor Decision|0|||
163251095|NCT01475136|589626748|FG001|Overall Study|Sponsor Decision|1|||
163251096|NCT01475136|589626749|FG002|Overall Study|Sponsor Decision|0|||
163251097|NCT01475136|589626750|FG003|Overall Study|Sponsor Decision|0|||
163251098|NCT01475136|589626747|FG000|Overall Study|Entry Criteria Not Met|0|||
163251099|NCT01475136|589626748|FG001|Overall Study|Entry Criteria Not Met|2|||
163251100|NCT01475136|589626749|FG002|Overall Study|Entry Criteria Not Met|3|||
163251101|NCT01475136|589626750|FG003|Overall Study|Entry Criteria Not Met|1|||
163251102|NCT01475136|589626747|FG000|Overall Study|Withdrawal by Subject|0|||
163251103|NCT01475136|589626748|FG001|Overall Study|Withdrawal by Subject|0|||
163251104|NCT01475136|589626749|FG002|Overall Study|Withdrawal by Subject|0|||
163251105|NCT01475136|589626750|FG003|Overall Study|Withdrawal by Subject|2|||
163251106|NCT01475136|589626747|FG000|Overall Study|Adverse Event|1|||
163251107|NCT01475136|589626748|FG001|Overall Study|Adverse Event|0|||
163251108|NCT01475136|589626749|FG002|Overall Study|Adverse Event|0|||
163251109|NCT01475136|589626750|FG003|Overall Study|Adverse Event|1|||
163251110|NCT01475136|589626747|FG000|Overall Study|Death|0|||
163251111|NCT01475136|589626748|FG001|Overall Study|Death|0|||
163251112|NCT01475136|589626749|FG002|Overall Study|Death|0|||
163251113|NCT01475136|589626750|FG003|Overall Study|Death|1|||
163251114|NCT01323530|589628995|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
163251115|NCT01323530|589628996|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163251116|NCT01323530|589628997|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163251117|NCT01323530|589628998|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163251118|NCT01323530|589628999|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163251119|NCT01323530|589629000|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
163251120|NCT01323530|589629001|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163251121|NCT01323530|589628995|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
163251122|NCT01323530|589628996|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
163251123|NCT01323530|589628997|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
163251124|NCT01323530|589628998|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163251125|NCT01323530|589628999|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
163251126|NCT01323530|589629000|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163251127|NCT01323530|589629001|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163251128|NCT01323530|589628995|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
163251129|NCT01323530|589628996|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
163251130|NCT01323530|589628997|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
163251131|NCT01323530|589628998|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
163251132|NCT01323530|589628999|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
163251133|NCT01323530|589629000|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
163251134|NCT01323530|589629001|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
163251135|NCT01323530|589628995|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
163251136|NCT01323530|589628996|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
163251137|NCT01323530|589628997|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
163251138|NCT01323530|589628998|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
163251139|NCT01323530|589628999|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
163251140|NCT01323530|589629000|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
163355683|NCT03325608|590011521|FG003|Overall Study|Death of Care Recipient|28|||
163251141|NCT01323530|589629001|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
163251142|NCT01323530|589628995|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
163251143|NCT01323530|589628996|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
163251144|NCT01323530|589628997|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
163251145|NCT01323530|589628998|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
163251146|NCT01323530|589628999|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
163251147|NCT01323530|589629000|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
163251148|NCT01323530|589629001|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
163251149|NCT01323530|589628995|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
163251150|NCT01323530|589628996|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
163355684|NCT03325608|590011518|FG000|Overall Study|Withdrawal by Subject|49|||
163355685|NCT03325608|590011519|FG001|Overall Study|Withdrawal by Subject|49|||
163251151|NCT01323530|589628997|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
163251152|NCT01323530|589628998|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
163251153|NCT01323530|589628999|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
163251154|NCT01323530|589629000|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
163251155|NCT01323530|589629001|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
163251156|NCT01323530|589628995|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
163251157|NCT01323530|589628996|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
163251158|NCT01323530|589628997|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
163251159|NCT01323530|589628998|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
163251160|NCT01323530|589628999|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
163251161|NCT01323530|589629000|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
163251162|NCT01323530|589629001|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
163251163|NCT01323530|589628995|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
163251164|NCT01323530|589628996|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
163251165|NCT01323530|589628997|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
163251166|NCT01323530|589628998|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
163251167|NCT01323530|589628999|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
163251168|NCT01323530|589629000|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
163251169|NCT01323530|589629001|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
163251170|NCT01194570|589629004|FG000|Overall Study|Adverse Event|22|||
163251171|NCT01194570|589629005|FG001|Overall Study|Adverse Event|40|||
163251172|NCT01194570|589629004|FG000|Overall Study|Death|6|||
163251173|NCT01194570|589629005|FG001|Overall Study|Death|20|||
163251174|NCT01194570|589629004|FG000|Overall Study|Lack of Efficacy|32|||
163251175|NCT01194570|589629005|FG001|Overall Study|Lack of Efficacy|33|||
163251176|NCT01194570|589629004|FG000|Overall Study|Lost to Follow-up|4|||
163251177|NCT01194570|589629005|FG001|Overall Study|Lost to Follow-up|15|||
163251178|NCT01194570|589629004|FG000|Overall Study|Non-Compliance|2|||
163251179|NCT01194570|589629005|FG001|Overall Study|Non-Compliance|2|||
163251180|NCT01194570|589629004|FG000|Overall Study|Non-Compliance With Study Drug|2|||
163251181|NCT01194570|589629005|FG001|Overall Study|Non-Compliance With Study Drug|2|||
163251182|NCT01194570|589629004|FG000|Overall Study|Other|18|||
163251183|NCT01194570|589629005|FG001|Overall Study|Other|47|||
163251184|NCT01194570|589629004|FG000|Overall Study|Physician Decision|10|||
163251185|NCT01194570|589629005|FG001|Overall Study|Physician Decision|25|||
163251186|NCT01194570|589629004|FG000|Overall Study|Protocol Violation|1|||
163251187|NCT01194570|589629005|FG001|Overall Study|Protocol Violation|2|||
163251188|NCT01194570|589629004|FG000|Overall Study|Study Terminated By Sponsor|0|||
163251189|NCT01194570|589629005|FG001|Overall Study|Study Terminated By Sponsor|1|||
163251190|NCT01194570|589629004|FG000|Overall Study|Withdrawal by Subject|57|||
163251191|NCT01194570|589629005|FG001|Overall Study|Withdrawal by Subject|82|||
163251192|NCT01194570|589629004|FG000|Overall Study|Pregnancy|1|||
163251193|NCT01194570|589629005|FG001|Overall Study|Pregnancy|1|||
163251194|NCT01377480|589629012|FG000|Overall Study|Protocol Violation|0|||
163251195|NCT01377480|589629013|FG001|Overall Study|Protocol Violation|0|||
163251196|NCT01377480|589629014|FG002|Overall Study|Protocol Violation|0|||
163251197|NCT01377480|589629015|FG003|Overall Study|Protocol Violation|4|||
163251198|NCT01377480|589629012|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
163251199|NCT01377480|589629013|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
163251200|NCT01377480|589629014|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
163251201|NCT01377480|589629015|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
163251202|NCT01377480|589629012|FG000|Overall Study|Withdrawal by Subject|0|||
163251203|NCT01377480|589629013|FG001|Overall Study|Withdrawal by Subject|0|||
163251204|NCT01377480|589629014|FG002|Overall Study|Withdrawal by Subject|1|||
163251205|NCT01377480|589629015|FG003|Overall Study|Withdrawal by Subject|0|||
163251206|NCT01377480|589629012|FG000|Overall Study|Serious adverse event|0|||
163251207|NCT01377480|589629013|FG001|Overall Study|Serious adverse event|0|||
163251208|NCT01377480|589629014|FG002|Overall Study|Serious adverse event|1|||
163251209|NCT01377480|589629015|FG003|Overall Study|Serious adverse event|1|||
163251210|NCT01377480|589629012|FG000|Overall Study|Other|0|||
163251211|NCT01377480|589629013|FG001|Overall Study|Other|0|||
163251212|NCT01377480|589629014|FG002|Overall Study|Other|7|||
163251213|NCT01377480|589629015|FG003|Overall Study|Other|6|||
163251214|NCT01735201|589629022|FG000|Overall Study|Adverse Event|1|||
163251215|NCT01735201|589629023|FG001|Overall Study|Adverse Event|1|||
163251216|NCT01735201|589629024|FG002|Overall Study|Adverse Event|0|||
163251217|NCT01735201|589629025|FG003|Overall Study|Adverse Event|1|||
163251218|NCT01735201|589629026|FG004|Overall Study|Adverse Event|1|||
163251219|NCT01735201|589629027|FG005|Overall Study|Adverse Event|3|||
163251220|NCT01735201|589629028|FG006|Overall Study|Adverse Event|2|||
163251221|NCT01735201|589629029|FG007|Overall Study|Adverse Event|1|||
163251222|NCT01735201|589629022|FG000|Overall Study|Personal Reasons|1|||
163251223|NCT01735201|589629023|FG001|Overall Study|Personal Reasons|0|||
163251224|NCT01735201|589629024|FG002|Overall Study|Personal Reasons|0|||
163251225|NCT01735201|589629025|FG003|Overall Study|Personal Reasons|0|||
163251226|NCT01735201|589629026|FG004|Overall Study|Personal Reasons|0|||
163251227|NCT01735201|589629027|FG005|Overall Study|Personal Reasons|0|||
163355686|NCT03325608|590011520|FG002|Overall Study|Withdrawal by Subject|35|||
163355687|NCT03325608|590011521|FG003|Overall Study|Withdrawal by Subject|35|||
163355688|NCT03325608|590011518|FG000|Overall Study|Ineligible|7|||
163355689|NCT03325608|590011519|FG001|Overall Study|Ineligible|7|||
163355690|NCT03325608|590011520|FG002|Overall Study|Ineligible|5|||
163355691|NCT03325608|590011521|FG003|Overall Study|Ineligible|5|||
163355692|NCT01266018|590013513|FG000|Overall Study|Physician Decision|1|||
163355693|NCT01266018|590013514|FG001|Overall Study|Physician Decision|0|||
163355694|NCT01266018|590013513|FG000|Overall Study|Progressive disease|0|||
163355695|NCT01266018|590013514|FG001|Overall Study|Progressive disease|1|||
163355696|NCT03167151|590013515|FG000|Overall Study|Withdrawal by Subject|1|||
163355697|NCT03167151|590013516|FG001|Overall Study|Withdrawal by Subject|0|||
163355698|NCT03167151|590013517|FG002|Overall Study|Withdrawal by Subject|0|||
163355699|NCT03167151|590013515|FG000|Overall Study|No evidence of tumour at surgery|0|||
163355700|NCT03167151|590013516|FG001|Overall Study|No evidence of tumour at surgery|1|||
163355701|NCT03167151|590013517|FG002|Overall Study|No evidence of tumour at surgery|1|||
163355702|NCT01458522|590013518|FG000|Overall Study|Withdrawal by Subject|2|||
163355703|NCT01458522|590013519|FG001|Overall Study|Withdrawal by Subject|2|||
163355704|NCT01458522|590013518|FG000|Overall Study|Physician Decision|1|||
163355705|NCT01458522|590013519|FG001|Overall Study|Physician Decision|9|||
163355706|NCT00516139|590013520|FG000|Overall Study|Adverse Event|27|||
163355707|NCT00516139|590013520|FG000|Overall Study|Lost to Follow-up|1|||
163355708|NCT00516139|590013520|FG000|Overall Study|Protocol Violation|1|||
163355709|NCT00516139|590013520|FG000|Overall Study|Withdrawal by Subject|8|||
163355710|NCT00516139|590013520|FG000|Overall Study|Lack of Efficacy|1|||
163355711|NCT00589303|590013521|FG000|Overall Study|Withdrawal by Subject|2|||
163355712|NCT00589303|590013522|FG001|Overall Study|Withdrawal by Subject|1|||
163355713|NCT00730015|590013523|FG000|Overall Study|Adverse Event|11|||
163355714|NCT00730015|590013524|FG001|Overall Study|Adverse Event|10|||
163355715|NCT00730015|590013525|FG002|Overall Study|Adverse Event|8|||
163355716|NCT00730015|590013523|FG000|Overall Study|Protocol Violation|2|||
163355717|NCT00730015|590013524|FG001|Overall Study|Protocol Violation|6|||
163355718|NCT00730015|590013525|FG002|Overall Study|Protocol Violation|4|||
163355719|NCT00730015|590013523|FG000|Overall Study|Withdrawal by Subject|12|||
163355720|NCT00730015|590013524|FG001|Overall Study|Withdrawal by Subject|12|||
163355721|NCT00730015|590013525|FG002|Overall Study|Withdrawal by Subject|8|||
163355722|NCT00730015|590013523|FG000|Overall Study|Lost to Follow-up|4|||
163355723|NCT00730015|590013524|FG001|Overall Study|Lost to Follow-up|10|||
163355724|NCT00730015|590013525|FG002|Overall Study|Lost to Follow-up|3|||
163355725|NCT00730015|590013523|FG000|Overall Study|Lack of Efficacy|1|||
163355726|NCT00730015|590013524|FG001|Overall Study|Lack of Efficacy|2|||
163355727|NCT00730015|590013525|FG002|Overall Study|Lack of Efficacy|8|||
163355728|NCT00730015|590013523|FG000|Overall Study|Other Reason|1|||
163355729|NCT00730015|590013524|FG001|Overall Study|Other Reason|0|||
163355730|NCT00730015|590013525|FG002|Overall Study|Other Reason|1|||
163355731|NCT03062449|590013527|FG000|Overall Study|Withdrawal by Subject|7|||
163355732|NCT03062449|590013528|FG001|Overall Study|Withdrawal by Subject|1|||
163355733|NCT04120376|590013530|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
163355734|NCT04120376|590013531|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
163355735|NCT02053610|590013532|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
163355736|NCT02053610|590013533|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
163355737|NCT02053610|590013532|FG000|Overall Study|Withdrew Consent|2|||
163355738|NCT02053610|590013533|FG001|Overall Study|Withdrew Consent|9|||
163355739|NCT02053610|590013532|FG000|Overall Study|Death|5|||
163355740|NCT02053610|590013533|FG001|Overall Study|Death|5|||
163355741|NCT02053610|590013532|FG000|Overall Study|Administrative/Other|1|||
163355742|NCT02053610|590013533|FG001|Overall Study|Administrative/Other|1|||
163355743|NCT02053610|590013532|FG000|Overall Study|Disease Progression|2|||
163355744|NCT02053610|590013533|FG001|Overall Study|Disease Progression|3|||
163355745|NCT02053610|590013532|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
163355746|NCT02053610|590013533|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
163355747|NCT02053610|590013532|FG000|Overall Study|Did not Receive Treatment|4|||
163355748|NCT02053610|590013533|FG001|Overall Study|Did not Receive Treatment|2|||
163355749|NCT02053610|590013532|FG000|Overall Study|Insufficient Therapeutic Response|1|||
163355750|NCT02053610|590013533|FG001|Overall Study|Insufficient Therapeutic Response|1|||
163355751|NCT02053610|590013532|FG000|Overall Study|Violation of Selection Criteria|1|||
163355752|NCT02053610|590013533|FG001|Overall Study|Violation of Selection Criteria|0|||
163355753|NCT01165177|590013534|FG000|Overall Study|Serious Adverse Event|227|||
163355754|NCT01165177|590013535|FG001|Overall Study|Serious Adverse Event|235|||
163355755|NCT01165177|590013534|FG000|Overall Study|Withdrawal by Subject|368|||
163355756|NCT01165177|590013535|FG001|Overall Study|Withdrawal by Subject|354|||
163355757|NCT01165177|590013534|FG000|Overall Study|Protocol Violation|19|||
163355758|NCT01165177|590013535|FG001|Overall Study|Protocol Violation|21|||
163355759|NCT01165177|590013534|FG000|Overall Study|Non-serious adverse event|30|||
163355760|NCT01165177|590013535|FG001|Overall Study|Non-serious adverse event|18|||
163355761|NCT01165177|590013534|FG000|Overall Study|Other unspecified reasons|47|||
163355762|NCT01165177|590013535|FG001|Overall Study|Other unspecified reasons|35|||
163251228|NCT01735201|589629028|FG006|Overall Study|Personal Reasons|0|||
163251229|NCT01735201|589629029|FG007|Overall Study|Personal Reasons|0|||
163251230|NCT01735201|589629022|FG000|Overall Study|Protocol Violation|1|||
163251231|NCT01735201|589629023|FG001|Overall Study|Protocol Violation|0|||
163251232|NCT01735201|589629024|FG002|Overall Study|Protocol Violation|0|||
163251233|NCT01735201|589629025|FG003|Overall Study|Protocol Violation|0|||
163251234|NCT01735201|589629026|FG004|Overall Study|Protocol Violation|0|||
163251235|NCT01735201|589629027|FG005|Overall Study|Protocol Violation|0|||
163251236|NCT01735201|589629028|FG006|Overall Study|Protocol Violation|0|||
163251237|NCT01735201|589629029|FG007|Overall Study|Protocol Violation|0|||
163251238|NCT01735201|589629022|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163251239|NCT01735201|589629023|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163251240|NCT01735201|589629024|FG002|Overall Study|Other Miscellaneous Reasons|0|||
163251241|NCT01735201|589629025|FG003|Overall Study|Other Miscellaneous Reasons|1|||
163251242|NCT01735201|589629026|FG004|Overall Study|Other Miscellaneous Reasons|0|||
163251243|NCT01735201|589629027|FG005|Overall Study|Other Miscellaneous Reasons|2|||
163251244|NCT01735201|589629028|FG006|Overall Study|Other Miscellaneous Reasons|1|||
163251245|NCT01735201|589629029|FG007|Overall Study|Other Miscellaneous Reasons|1|||
163251246|NCT01203930|589629035|FG000|Overall Study|Disease Progression|0|||
163251247|NCT01203930|589629036|FG001|Overall Study|Disease Progression|4|||
163251248|NCT01203930|589629035|FG000|Overall Study|Death|3|||
163251249|NCT01203930|589629036|FG001|Overall Study|Death|1|||
163251250|NCT01203930|589629035|FG000|Overall Study|Withdrew Consent|1|||
163251251|NCT01203930|589629036|FG001|Overall Study|Withdrew Consent|10|||
163251252|NCT01203930|589629035|FG000|Overall Study|Investigator Request|0|||
163251253|NCT01203930|589629036|FG001|Overall Study|Investigator Request|8|||
163251254|NCT01203930|589629035|FG000|Overall Study|Study Terminated by Sponsor|0|||
163251255|NCT01203930|589629036|FG001|Overall Study|Study Terminated by Sponsor|12|||
163251256|NCT01203930|589629035|FG000|Overall Study|Poor tolerance of study drug|0|||
163251257|NCT01203930|589629036|FG001|Overall Study|Poor tolerance of study drug|1|||
163251258|NCT01203930|589629035|FG000|Overall Study|Adverse Event|17|||
163251259|NCT01203930|589629036|FG001|Overall Study|Adverse Event|5|||
163251260|NCT02178059|589629037|FG000|Washout|Physician Decision|1|||
163251261|NCT02178059|589629038|FG001|Washout|Physician Decision|0|||
163251262|NCT01266850|589629041|FG000|Overall Study|Lost to Follow-up|19|||
163251263|NCT01266850|589629042|FG001|Overall Study|Lost to Follow-up|19|||
163251264|NCT01266850|589629043|FG002|Overall Study|Lost to Follow-up|13|||
163251265|NCT01266850|589629044|FG003|Overall Study|Lost to Follow-up|13|||
163251266|NCT01266850|589629045|FG004|Overall Study|Lost to Follow-up|12|||
163251267|NCT01266850|589629041|FG000|Overall Study|Withdrawal by Subject|8|||
163251268|NCT01266850|589629042|FG001|Overall Study|Withdrawal by Subject|9|||
163251269|NCT01266850|589629043|FG002|Overall Study|Withdrawal by Subject|6|||
163251270|NCT01266850|589629044|FG003|Overall Study|Withdrawal by Subject|9|||
163251271|NCT01266850|589629045|FG004|Overall Study|Withdrawal by Subject|12|||
163251272|NCT01266850|589629041|FG000|Overall Study|Physician Decision|3|||
163251273|NCT01266850|589629042|FG001|Overall Study|Physician Decision|6|||
163251274|NCT01266850|589629043|FG002|Overall Study|Physician Decision|4|||
163251275|NCT01266850|589629044|FG003|Overall Study|Physician Decision|4|||
163251276|NCT01266850|589629045|FG004|Overall Study|Physician Decision|3|||
163251277|NCT01266850|589629041|FG000|Overall Study|Protocol Violation|0|||
163251278|NCT01266850|589629042|FG001|Overall Study|Protocol Violation|1|||
163251279|NCT01266850|589629043|FG002|Overall Study|Protocol Violation|0|||
163251280|NCT01266850|589629044|FG003|Overall Study|Protocol Violation|1|||
163251281|NCT01266850|589629045|FG004|Overall Study|Protocol Violation|2|||
163251282|NCT01266850|589629041|FG000|Overall Study|Adverse Event|0|||
163251283|NCT01266850|589629042|FG001|Overall Study|Adverse Event|0|||
163251284|NCT01266850|589629043|FG002|Overall Study|Adverse Event|0|||
163251285|NCT01266850|589629044|FG003|Overall Study|Adverse Event|0|||
163251286|NCT01266850|589629045|FG004|Overall Study|Adverse Event|1|||
163251287|NCT01266850|589629041|FG000|Overall Study|Site Closure|0|||
163251288|NCT01266850|589629042|FG001|Overall Study|Site Closure|1|||
163251289|NCT01266850|589629043|FG002|Overall Study|Site Closure|1|||
163251290|NCT01266850|589629044|FG003|Overall Study|Site Closure|1|||
163251291|NCT01266850|589629045|FG004|Overall Study|Site Closure|0|||
163251292|NCT00857207|589629049|FG000|Overall Study|Withdrawal by Subject|13|||
163251293|NCT00857207|589629050|FG001|Overall Study|Withdrawal by Subject|0|||
163251294|NCT00857207|589629049|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
163251295|NCT00857207|589629050|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
163251296|NCT00857207|589629049|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
163251297|NCT00857207|589629050|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
163251298|NCT02030015|589629051|FG000|Overall Study|Withdrawal by Subject|3|||
163251299|NCT02030015|589629051|FG000|Overall Study|Death|13|||
163251300|NCT04098406|589629052|FG000|Overall Study|Adverse Event|2|||
163251301|NCT04098406|589629053|FG001|Overall Study|Adverse Event|1|||
163251302|NCT04098406|589629052|FG000|Overall Study|Withdrawal by Subject|1|||
163251303|NCT04098406|589629053|FG001|Overall Study|Withdrawal by Subject|0|||
163251304|NCT03014674|589629054|FG000|Overall Study|Withdrawal by Subject|1|||
163355763|NCT01165177|590013534|FG000|Overall Study|Suspected HZ episode|0|||
163355764|NCT01165177|590013535|FG001|Overall Study|Suspected HZ episode|2|||
163355765|NCT01165177|590013534|FG000|Overall Study|Lost to Follow-up|183|||
163355766|NCT01165177|590013535|FG001|Overall Study|Lost to Follow-up|194|||
163355767|NCT01165177|590013534|FG000|Overall Study|Migrated/ moved from study area|48|||
163355768|NCT01165177|590013535|FG001|Overall Study|Migrated/ moved from study area|43|||
163355769|NCT00781937|590013536|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
163355770|NCT00781937|590013537|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
163355771|NCT00781937|590013536|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
163355772|NCT00781937|590013537|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
163355773|NCT00781937|590013536|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
163355774|NCT00781937|590013537|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
163355775|NCT00781937|590013536|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
163355776|NCT00781937|590013537|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
163355777|NCT00781937|590013536|FG000|Main Trial Period Through Week 56|Unclassified|10|||
163355778|NCT00781937|590013537|FG001|Main Trial Period Through Week 56|Unclassified|15|||
163355779|NCT00781937|590013536|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
163355780|NCT00781937|590013537|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
163355781|NCT00781937|590013536|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
163355782|NCT00781937|590013537|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
163355783|NCT00543062|590013538|FG000|Overall Study|Withdrawal by Subject|1|||
163355784|NCT00543062|590013539|FG001|Overall Study|Withdrawal by Subject|0|||
163355785|NCT00543062|590013540|FG002|Overall Study|Withdrawal by Subject|2|||
163355786|NCT00543062|590013541|FG003|Overall Study|Withdrawal by Subject|0|||
163355787|NCT00543062|590013538|FG000|Overall Study|Adverse Event|0|||
163355788|NCT00543062|590013539|FG001|Overall Study|Adverse Event|1|||
163355789|NCT00543062|590013540|FG002|Overall Study|Adverse Event|1|||
163355790|NCT00543062|590013541|FG003|Overall Study|Adverse Event|1|||
163355791|NCT00543062|590013538|FG000|Overall Study|Protocol Violation|1|||
163355792|NCT00543062|590013539|FG001|Overall Study|Protocol Violation|0|||
163355793|NCT00543062|590013540|FG002|Overall Study|Protocol Violation|0|||
163355794|NCT00543062|590013541|FG003|Overall Study|Protocol Violation|0|||
163355795|NCT00328562|590013547|FG000|Overall Study|Disease progression|1|||
163355796|NCT04014790|590013548|FG000|Overall Study|Death|4|||
163355797|NCT04014790|590013548|FG000|Overall Study|Adverse Event|1|||
163355798|NCT04014790|590013548|FG000|Overall Study|Withdrawal by Subject|1|||
163355799|NCT03546816|590013549|FG000|Overall Study|Adverse Event|5|||
163355800|NCT03546816|590013550|FG001|Overall Study|Adverse Event|3|||
163355801|NCT03546816|590013549|FG000|Overall Study|Lack of Efficacy|2|||
163355802|NCT03546816|590013550|FG001|Overall Study|Lack of Efficacy|4|||
163355803|NCT03546816|590013549|FG000|Overall Study|Pregnancy|1|||
163355804|NCT03546816|590013550|FG001|Overall Study|Pregnancy|0|||
163355805|NCT03546816|590013549|FG000|Overall Study|Physician Decision|2|||
163355806|NCT03546816|590013550|FG001|Overall Study|Physician Decision|0|||
163355807|NCT03546816|590013549|FG000|Overall Study|Withdrawal by Subject|8|||
163355808|NCT03546816|590013550|FG001|Overall Study|Withdrawal by Subject|10|||
163355809|NCT03546816|590013549|FG000|Overall Study|Lost to Follow-up|3|||
163355810|NCT03546816|590013550|FG001|Overall Study|Lost to Follow-up|2|||
163355811|NCT01161446|590013551|FG000|Overall Study|Lost to Follow-up|18|||
163355812|NCT01161446|590013552|FG001|Overall Study|Lost to Follow-up|14|||
163355813|NCT01161446|590013551|FG000|Overall Study|Withdrawal by Subject|0|||
163355814|NCT01161446|590013552|FG001|Overall Study|Withdrawal by Subject|1|||
163355815|NCT02270671|590013553|FG000|Overall Study|Withdrawal by Subject|1|||
163355816|NCT02270671|590013554|FG001|Overall Study|Withdrawal by Subject|1|||
163355817|NCT02270671|590013553|FG000|Overall Study|Protocol Violation|0|||
163355818|NCT02270671|590013554|FG001|Overall Study|Protocol Violation|1|||
163150437|NCT00385671|589265273|FG002|Overall Study|Lack of Efficacy|5|||
163150438|NCT00385671|589265271|FG000|Overall Study|Lost to Follow-up|6|||
163150439|NCT00385671|589265272|FG001|Overall Study|Lost to Follow-up|6|||
163150440|NCT00385671|589265273|FG002|Overall Study|Lost to Follow-up|5|||
163150441|NCT00385671|589265271|FG000|Overall Study|Physician Decision|2|||
163150442|NCT00385671|589265272|FG001|Overall Study|Physician Decision|1|||
163150443|NCT00385671|589265273|FG002|Overall Study|Physician Decision|2|||
163355819|NCT02270671|590013553|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
163150444|NCT00385671|589265271|FG000|Overall Study|Protocol Violation|5|||
163150445|NCT00385671|589265272|FG001|Overall Study|Protocol Violation|2|||
163150446|NCT00385671|589265273|FG002|Overall Study|Protocol Violation|1|||
163150447|NCT00385671|589265271|FG000|Overall Study|Sponsor Decision|2|||
163355820|NCT02270671|590013554|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
163355821|NCT02270671|590013553|FG000|Overall Study|Lost to Follow-up|2|||
163355822|NCT02270671|590013554|FG001|Overall Study|Lost to Follow-up|1|||
163355823|NCT03927690|590013557|FG000|Overall Study|Withdrawal by Subject|3|||
163355824|NCT03927690|590013558|FG001|Overall Study|Withdrawal by Subject|1|||
163355825|NCT03927690|590013559|FG002|Overall Study|Withdrawal by Subject|1|||
163355826|NCT03927690|590013557|FG000|Overall Study|Adverse Event|1|||
163355827|NCT03927690|590013558|FG001|Overall Study|Adverse Event|0|||
163355828|NCT03927690|590013559|FG002|Overall Study|Adverse Event|0|||
163355829|NCT03927690|590013557|FG000|Overall Study|Death|1|||
163355830|NCT03927690|590013558|FG001|Overall Study|Death|0|||
163355831|NCT03927690|590013559|FG002|Overall Study|Death|0|||
163355832|NCT03927690|590013557|FG000|Overall Study|Lost to Follow-up|2|||
163355833|NCT03927690|590013558|FG001|Overall Study|Lost to Follow-up|2|||
163355834|NCT03927690|590013559|FG002|Overall Study|Lost to Follow-up|1|||
163355835|NCT00126659|590013562|FG000|Overall Study|Adverse Event|0|||
163355836|NCT00126659|590013563|FG001|Overall Study|Adverse Event|0|||
163355837|NCT00126659|590013564|FG002|Overall Study|Adverse Event|2|||
163355838|NCT00174447|590013567|FG000|Overall Study|Adverse Event|19|||
163355839|NCT00174447|590013567|FG000|Overall Study|Withdrawal by Subject|15|||
163355840|NCT00174447|590013567|FG000|Overall Study|Protocol Violation|1|||
163355841|NCT00174447|590013567|FG000|Overall Study|Lack of Efficacy|1|||
163355842|NCT00174447|590013567|FG000|Overall Study|Administrative reason/Other|2|||
163355843|NCT00551135|590013577|FG000|Overall Study|Adverse Event|1|||
163355844|NCT00551135|590013578|FG001|Overall Study|Adverse Event|0|||
163355845|NCT00551135|590013579|FG002|Overall Study|Adverse Event|1|||
163355846|NCT00551135|590013580|FG003|Overall Study|Adverse Event|1|||
163355847|NCT00551135|590013577|FG000|Overall Study|Lost to Follow-up|0|||
163355848|NCT00551135|590013578|FG001|Overall Study|Lost to Follow-up|0|||
163355849|NCT00551135|590013579|FG002|Overall Study|Lost to Follow-up|0|||
163355850|NCT00551135|590013580|FG003|Overall Study|Lost to Follow-up|1|||
163355851|NCT00551135|590013577|FG000|Overall Study|Other|3|||
163355852|NCT00551135|590013578|FG001|Overall Study|Other|2|||
163355853|NCT00551135|590013579|FG002|Overall Study|Other|1|||
163355854|NCT00551135|590013580|FG003|Overall Study|Other|2|||
163355855|NCT00551135|590013577|FG000|Overall Study|Withdrawal by Subject|1|||
163355856|NCT00551135|590013578|FG001|Overall Study|Withdrawal by Subject|0|||
163355857|NCT00551135|590013579|FG002|Overall Study|Withdrawal by Subject|3|||
163355858|NCT00551135|590013580|FG003|Overall Study|Withdrawal by Subject|1|||
163355859|NCT04294667|590013581|FG000|Overall Study|Lack of Efficacy|4|||
163355860|NCT04294667|590013582|FG001|Overall Study|Lack of Efficacy|4|||
163355861|NCT04294667|590013581|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
163355862|NCT04294667|590013582|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
163355863|NCT04294667|590013581|FG000|Overall Study|Patient has a Renal Flare|1|||
163355864|NCT04294667|590013582|FG001|Overall Study|Patient has a Renal Flare|0|||
163355865|NCT04294667|590013581|FG000|Overall Study|SLE Worsening|0|||
163355866|NCT04294667|590013582|FG001|Overall Study|SLE Worsening|1|||
163355867|NCT04294667|590013581|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
163355868|NCT04294667|590013582|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
163355869|NCT04294667|590013581|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
163355870|NCT04294667|590013582|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
163355871|NCT04294667|590013581|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
163355872|NCT04294667|590013582|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
163150448|NCT00385671|589265272|FG001|Overall Study|Sponsor Decision|2|||
163150449|NCT00385671|589265273|FG002|Overall Study|Sponsor Decision|1|||
163150450|NCT00385671|589265271|FG000|Overall Study|Withdrawal by Subject|4|||
163150451|NCT00385671|589265272|FG001|Overall Study|Withdrawal by Subject|4|||
163150452|NCT00385671|589265273|FG002|Overall Study|Withdrawal by Subject|4|||
163150453|NCT02608684|589265274|FG000|Overall Study|Physician Decision|2|||
163150454|NCT02608684|589265274|FG000|Overall Study|Withdrawal by Subject|1|||
163150455|NCT00751296|589265275|FG000|Overall Study|Adverse Event|2|||
163150456|NCT01972217|589265276|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
163355873|NCT04294667|590013581|FG000|Overall Study|Subject Moved to Another State|0|||
163355874|NCT04294667|590013582|FG001|Overall Study|Subject Moved to Another State|1|||
163355875|NCT04294667|590013581|FG000|Overall Study|Adverse event, serious fatal|0|||
163355876|NCT04294667|590013582|FG001|Overall Study|Adverse event, serious fatal|1|||
163150457|NCT01972217|589265277|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
163150458|NCT01972217|589265278|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
163150459|NCT01972217|589265279|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
163150460|NCT01972217|589265276|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
163150461|NCT01972217|589265277|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
163150462|NCT01972217|589265278|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
163150463|NCT01972217|589265279|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
163150464|NCT01972217|589265276|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
163150465|NCT01972217|589265277|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
163150466|NCT01972217|589265278|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
163150467|NCT01972217|589265279|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
163150468|NCT01972217|589265276|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
163150469|NCT01972217|589265277|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
163150470|NCT01972217|589265278|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
163355877|NCT04294667|590013581|FG000|Overall Study|Adverse event, non-fatal|3|||
163355878|NCT04294667|590013582|FG001|Overall Study|Adverse event, non-fatal|4|||
163251305|NCT03014674|589629055|FG001|Overall Study|Withdrawal by Subject|0|||
163251306|NCT03014674|589629056|FG002|Overall Study|Withdrawal by Subject|0|||
163251307|NCT01332227|589629057|FG000|Overall Study|Adverse Event|4|||
163355879|NCT00548847|590013583|FG000|Overall Study|Disease progression|7|||
163355880|NCT00727415|590013584|FG000|Phase I|Dose Limiting Toxicity|2|||
163355881|NCT03634839|590013585|FG000|First Intervention (2 Hours)|Adverse Event|0|||
163355882|NCT03634839|590013586|FG001|First Intervention (2 Hours)|Adverse Event|2|||
163251308|NCT01332227|589629058|FG001|Overall Study|Adverse Event|1|||
163251309|NCT01332227|589629057|FG000|Overall Study|Withdrawal by Subject|5|||
163251310|NCT01332227|589629058|FG001|Overall Study|Withdrawal by Subject|1|||
163251311|NCT01332227|589629057|FG000|Overall Study|Lost to Follow-up|2|||
163251312|NCT01332227|589629058|FG001|Overall Study|Lost to Follow-up|0|||
163251313|NCT01332227|589629057|FG000|Overall Study|Lack of Efficacy|3|||
163251314|NCT01332227|589629058|FG001|Overall Study|Lack of Efficacy|1|||
163251315|NCT01332227|589629057|FG000|Overall Study|Poor compliance/noncompliance|1|||
163251316|NCT01332227|589629058|FG001|Overall Study|Poor compliance/noncompliance|1|||
163251317|NCT01332227|589629057|FG000|Overall Study|Patient moved from area|1|||
163251318|NCT01332227|589629058|FG001|Overall Study|Patient moved from area|0|||
163251319|NCT01332227|589629057|FG000|Overall Study|Patient began prohibited medication|0|||
163251320|NCT01332227|589629058|FG001|Overall Study|Patient began prohibited medication|1|||
163251321|NCT00428090|589629067|FG000|Overall Study|Adverse Event|10|||
163251322|NCT00428090|589629068|FG001|Overall Study|Adverse Event|8|||
163251323|NCT00428090|589629069|FG002|Overall Study|Adverse Event|10|||
163251324|NCT00428090|589629070|FG003|Overall Study|Adverse Event|11|||
163251325|NCT00428090|589629067|FG000|Overall Study|Lost to Follow-up|3|||
163251326|NCT00428090|589629068|FG001|Overall Study|Lost to Follow-up|6|||
163251327|NCT00428090|589629069|FG002|Overall Study|Lost to Follow-up|1|||
163251328|NCT00428090|589629070|FG003|Overall Study|Lost to Follow-up|4|||
163251329|NCT00428090|589629067|FG000|Overall Study|Protocol Violation|3|||
163251330|NCT00428090|589629068|FG001|Overall Study|Protocol Violation|1|||
163251331|NCT00428090|589629069|FG002|Overall Study|Protocol Violation|3|||
163251332|NCT00428090|589629070|FG003|Overall Study|Protocol Violation|3|||
163251333|NCT00428090|589629067|FG000|Overall Study|Withdrawal by Subject|10|||
163251334|NCT00428090|589629068|FG001|Overall Study|Withdrawal by Subject|12|||
163251335|NCT00428090|589629069|FG002|Overall Study|Withdrawal by Subject|15|||
163251336|NCT00428090|589629070|FG003|Overall Study|Withdrawal by Subject|5|||
163251337|NCT00428090|589629067|FG000|Overall Study|Sponsor terminated study|0|||
163251338|NCT00428090|589629068|FG001|Overall Study|Sponsor terminated study|1|||
163251339|NCT00428090|589629069|FG002|Overall Study|Sponsor terminated study|0|||
163251340|NCT00428090|589629070|FG003|Overall Study|Sponsor terminated study|0|||
163251341|NCT00428090|589629067|FG000|Overall Study|Non-compliance|4|||
163251342|NCT00428090|589629068|FG001|Overall Study|Non-compliance|0|||
163251343|NCT00428090|589629069|FG002|Overall Study|Non-compliance|1|||
163251344|NCT00428090|589629070|FG003|Overall Study|Non-compliance|3|||
163251345|NCT00428090|589629067|FG000|Overall Study|Par. did not returned to visit|1|||
163251346|NCT00428090|589629068|FG001|Overall Study|Par. did not returned to visit|0|||
163251347|NCT00428090|589629069|FG002|Overall Study|Par. did not returned to visit|0|||
163251348|NCT00428090|589629070|FG003|Overall Study|Par. did not returned to visit|1|||
163251349|NCT00428090|589629067|FG000|Overall Study|Follow-Up visit not possible|1|||
163251350|NCT00428090|589629068|FG001|Overall Study|Follow-Up visit not possible|0|||
163251351|NCT00428090|589629069|FG002|Overall Study|Follow-Up visit not possible|0|||
163251352|NCT00428090|589629070|FG003|Overall Study|Follow-Up visit not possible|0|||
163251353|NCT00428090|589629067|FG000|Overall Study|Prohibited medication used for SAE|1|||
163251354|NCT00428090|589629068|FG001|Overall Study|Prohibited medication used for SAE|0|||
163251355|NCT00428090|589629069|FG002|Overall Study|Prohibited medication used for SAE|0|||
163251356|NCT00428090|589629070|FG003|Overall Study|Prohibited medication used for SAE|0|||
163251357|NCT00428090|589629067|FG000|Overall Study|Death of par.|1|||
163251358|NCT00428090|589629068|FG001|Overall Study|Death of par.|0|||
163355883|NCT00302159|590013589|FG000|Overall Study|pt declined before treatment started|1|||
163355884|NCT00302159|590013589|FG000|Overall Study|pt started Avastin|1|||
163355885|NCT02312206|590013595|FG000|Overall Study|Adverse Event|3|||
163251359|NCT00428090|589629069|FG002|Overall Study|Death of par.|1|||
163251360|NCT00428090|589629070|FG003|Overall Study|Death of par.|0|||
163251361|NCT00428090|589629067|FG000|Overall Study|Visit 7 exceed the visit window|0|||
163355886|NCT02312206|590013596|FG001|Overall Study|Adverse Event|6|||
163355887|NCT02312206|590013595|FG000|Overall Study|Withdrawal by Subject|6|||
163355888|NCT02312206|590013596|FG001|Overall Study|Withdrawal by Subject|6|||
163355889|NCT02312206|590013595|FG000|Overall Study|Physician Decision|7|||
163410388|NCT05103332|590211376|FG017|DB Period (6 Months=168 Days)|Other|0|||
163251362|NCT00428090|589629068|FG001|Overall Study|Visit 7 exceed the visit window|1|||
163251363|NCT00428090|589629069|FG002|Overall Study|Visit 7 exceed the visit window|0|||
163251364|NCT00428090|589629070|FG003|Overall Study|Visit 7 exceed the visit window|0|||
163251365|NCT00428090|589629067|FG000|Overall Study|Medical monitor terminated par.|0|||
163251366|NCT00428090|589629068|FG001|Overall Study|Medical monitor terminated par.|1|||
163355890|NCT02312206|590013596|FG001|Overall Study|Physician Decision|6|||
163355891|NCT02312206|590013595|FG000|Overall Study|Death|31|||
163251367|NCT00428090|589629069|FG002|Overall Study|Medical monitor terminated par.|0|||
163251368|NCT00428090|589629070|FG003|Overall Study|Medical monitor terminated par.|0|||
163251369|NCT00428090|589629067|FG000|Overall Study|Mental status of par. was|0|||
163251370|NCT00428090|589629068|FG001|Overall Study|Mental status of par. was|1|||
163251371|NCT00428090|589629069|FG002|Overall Study|Mental status of par. was|0|||
163251372|NCT00428090|589629070|FG003|Overall Study|Mental status of par. was|0|||
163251373|NCT00428090|589629067|FG000|Overall Study|Worsening of AD|0|||
163251374|NCT00428090|589629068|FG001|Overall Study|Worsening of AD|0|||
163251375|NCT00428090|589629069|FG002|Overall Study|Worsening of AD|1|||
163251376|NCT00428090|589629070|FG003|Overall Study|Worsening of AD|0|||
163251377|NCT00428090|589629067|FG000|Overall Study|Excluded for concerning QTc value|0|||
163251378|NCT00428090|589629068|FG001|Overall Study|Excluded for concerning QTc value|0|||
163251379|NCT00428090|589629069|FG002|Overall Study|Excluded for concerning QTc value|1|||
163251380|NCT00428090|589629070|FG003|Overall Study|Excluded for concerning QTc value|0|||
163251381|NCT00428090|589629067|FG000|Overall Study|Insufficient AD documentation|0|||
163251382|NCT00428090|589629068|FG001|Overall Study|Insufficient AD documentation|0|||
163251383|NCT00428090|589629069|FG002|Overall Study|Insufficient AD documentation|1|||
163251384|NCT00428090|589629070|FG003|Overall Study|Insufficient AD documentation|0|||
163251385|NCT00428090|589629067|FG000|Overall Study|High MMSE scores|0|||
163251386|NCT00428090|589629068|FG001|Overall Study|High MMSE scores|0|||
163251387|NCT00428090|589629069|FG002|Overall Study|High MMSE scores|1|||
163251388|NCT00428090|589629070|FG003|Overall Study|High MMSE scores|0|||
163251389|NCT00428090|589629067|FG000|Overall Study|Deterioration of cognitive status|0|||
163251390|NCT00428090|589629068|FG001|Overall Study|Deterioration of cognitive status|0|||
163251391|NCT00428090|589629069|FG002|Overall Study|Deterioration of cognitive status|1|||
163251392|NCT00428090|589629070|FG003|Overall Study|Deterioration of cognitive status|0|||
163251393|NCT00428090|589629067|FG000|Overall Study|Serious adverse event|0|||
163251394|NCT00428090|589629068|FG001|Overall Study|Serious adverse event|0|||
163251395|NCT00428090|589629069|FG002|Overall Study|Serious adverse event|1|||
163251396|NCT00428090|589629070|FG003|Overall Study|Serious adverse event|0|||
163251397|NCT00428090|589629067|FG000|Overall Study|Excluded for heart insufficiency|0|||
163251398|NCT00428090|589629068|FG001|Overall Study|Excluded for heart insufficiency|0|||
163251399|NCT00428090|589629069|FG002|Overall Study|Excluded for heart insufficiency|1|||
163251400|NCT00428090|589629070|FG003|Overall Study|Excluded for heart insufficiency|0|||
163251401|NCT00428090|589629067|FG000|Overall Study|Raised Creatinine Value|0|||
163251402|NCT00428090|589629068|FG001|Overall Study|Raised Creatinine Value|0|||
163251403|NCT00428090|589629069|FG002|Overall Study|Raised Creatinine Value|0|||
163251404|NCT00428090|589629070|FG003|Overall Study|Raised Creatinine Value|1|||
163251405|NCT03409666|589629071|FG000|Overall Study|Physician Decision|0|||
163251406|NCT03409666|589629072|FG001|Overall Study|Physician Decision|1|||
163251407|NCT03409666|589629071|FG000|Overall Study|Protocol Violation|0|||
163251408|NCT03409666|589629072|FG001|Overall Study|Protocol Violation|3|||
163251409|NCT02623322|589629076|FG000|Overall Study|Lost to Follow-up|2|||
163251410|NCT02623322|589629077|FG001|Overall Study|Lost to Follow-up|1|||
163251411|NCT02623322|589629078|FG002|Overall Study|Lost to Follow-up|0|||
163251412|NCT03104699|589629079|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
163251413|NCT03104699|589629080|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
163251414|NCT03104699|589629081|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
163251415|NCT03104699|589629082|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
163251416|NCT03104699|589629083|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
163251417|NCT03104699|589629084|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
163251418|NCT03104699|589629079|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
163251419|NCT03104699|589629080|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
163251420|NCT03104699|589629081|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
163251421|NCT03104699|589629082|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
163251422|NCT03104699|589629083|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
163251423|NCT03104699|589629084|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
163251424|NCT03104699|589629079|FG000|Phase 1: Dose Escalation|Death|6|||
163251425|NCT03104699|589629080|FG001|Phase 1: Dose Escalation|Death|3|||
163251426|NCT03104699|589629081|FG002|Phase 1: Dose Escalation|Death|0|||
163251427|NCT03104699|589629082|FG003|Phase 1: Dose Escalation|Death|1|||
163251428|NCT03104699|589629083|FG004|Phase 1: Dose Escalation|Death|1|||
163251429|NCT03104699|589629084|FG005|Phase 1: Dose Escalation|Death|0|||
163410389|NCT05103332|590211359|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163410390|NCT05103332|590211360|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163251430|NCT03104699|589629079|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
163251431|NCT03104699|589629080|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
163251432|NCT03104699|589629081|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
163251433|NCT03104699|589629082|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
163251434|NCT03104699|589629083|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
163251435|NCT03104699|589629084|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
163251436|NCT03104699|589629079|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
163251437|NCT03104699|589629080|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
163251438|NCT03104699|589629081|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
163251439|NCT03104699|589629082|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
163251440|NCT03104699|589629083|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
163251441|NCT03104699|589629084|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
163251442|NCT03104699|589629079|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
163251443|NCT03104699|589629080|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
163251444|NCT03104699|589629081|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
163251445|NCT03104699|589629082|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
163251446|NCT03104699|589629083|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
163251447|NCT03104699|589629084|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
163251448|NCT03104699|589629079|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
163251449|NCT03104699|589629080|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
163251450|NCT03104699|589629081|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
163251451|NCT03104699|589629082|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
163251452|NCT03104699|589629083|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
163251453|NCT03104699|589629084|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
163251454|NCT03104699|589629079|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
163251455|NCT03104699|589629080|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
163251456|NCT03104699|589629081|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
163251457|NCT03104699|589629082|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
163251458|NCT03104699|589629083|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
163251459|NCT03104699|589629084|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
163251460|NCT03104699|589629079|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
163251461|NCT03104699|589629080|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
163251462|NCT03104699|589629081|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
163251463|NCT03104699|589629082|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
163251464|NCT03104699|589629083|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
163251465|NCT03104699|589629084|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
163251466|NCT03104699|589629079|FG000|Phase 2: Dose Expansion|Death|0|||
163251467|NCT03104699|589629080|FG001|Phase 2: Dose Expansion|Death|0|||
163251468|NCT03104699|589629081|FG002|Phase 2: Dose Expansion|Death|0|||
163251469|NCT03104699|589629082|FG003|Phase 2: Dose Expansion|Death|0|||
163251470|NCT03104699|589629083|FG004|Phase 2: Dose Expansion|Death|0|||
163251471|NCT03104699|589629084|FG005|Phase 2: Dose Expansion|Death|107|||
163251472|NCT03104699|589629079|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
163251473|NCT03104699|589629080|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
163251474|NCT03104699|589629081|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
163251475|NCT03104699|589629082|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
163251476|NCT03104699|589629083|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
163251477|NCT03104699|589629084|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
163251478|NCT03104699|589629079|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
163251479|NCT03104699|589629080|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
163251480|NCT03104699|589629081|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
163251481|NCT03104699|589629082|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
163251482|NCT03104699|589629083|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
163251483|NCT03104699|589629084|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
163251484|NCT03104699|589629079|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163251485|NCT03104699|589629080|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163251486|NCT03104699|589629081|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163251487|NCT03104699|589629082|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163251488|NCT03104699|589629083|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163251489|NCT03104699|589629084|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
163251490|NCT03104699|589629079|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
163251491|NCT03104699|589629080|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
163251492|NCT03104699|589629081|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
163251493|NCT03104699|589629082|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
163251494|NCT03104699|589629083|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
163251495|NCT03104699|589629084|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
163251496|NCT02450331|589629085|FG000|Overall Study|Death|162|||
163251497|NCT02450331|589629086|FG001|Overall Study|Death|171|||
163251498|NCT02450331|589629085|FG000|Overall Study|Lost to Follow-up|14|||
163251499|NCT02450331|589629086|FG001|Overall Study|Lost to Follow-up|12|||
163251500|NCT02450331|589629085|FG000|Overall Study|Withdrawal by Subject|55|||
163355892|NCT02312206|590013596|FG001|Overall Study|Death|36|||
163355893|NCT02312206|590013595|FG000|Overall Study|Study Terminated by Sponsor|81|||
163355894|NCT02312206|590013596|FG001|Overall Study|Study Terminated by Sponsor|74|||
163251501|NCT02450331|589629086|FG001|Overall Study|Withdrawal by Subject|44|||
163251502|NCT02450331|589629085|FG000|Overall Study|Non-specified other|1|||
163251503|NCT02450331|589629086|FG001|Overall Study|Non-specified other|1|||
163251504|NCT02080871|589629087|FG000|Overall Study|Death|1|||
163251505|NCT02080871|589629087|FG000|Overall Study|Lost to Follow-up|1|||
163251506|NCT00234052|589629088|FG000|Treatment|Withdrawal by Subject|3|||
163355895|NCT02312206|590013595|FG000|Overall Study|Patient transferred to hospice|0|||
163355896|NCT02312206|590013596|FG001|Overall Study|Patient transferred to hospice|1|||
163355897|NCT02312206|590013595|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
163355898|NCT02312206|590013596|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
163355899|NCT02312206|590013595|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
163355900|NCT02312206|590013596|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
163355901|NCT02312206|590013595|FG000|Overall Study|Disease Progression|1|||
163355902|NCT02312206|590013596|FG001|Overall Study|Disease Progression|0|||
163355903|NCT03082612|590013597|FG000|Overall Study|Lost to Follow-up|2|||
163355904|NCT03082612|590013598|FG001|Overall Study|Lost to Follow-up|0|||
163355905|NCT01006616|590013599|FG000|Period 1 (6 Months)|Adverse Event|10|||
163150471|NCT01972217|589265279|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
163150472|NCT01972217|589265276|FG000|Part B Double-blind, Randomised Period|Death|0|||
163150473|NCT01972217|589265277|FG001|Part B Double-blind, Randomised Period|Death|0|||
163150474|NCT01972217|589265278|FG002|Part B Double-blind, Randomised Period|Death|43|||
163150475|NCT01972217|589265279|FG003|Part B Double-blind, Randomised Period|Death|44|||
163150476|NCT01972217|589265276|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
163150477|NCT01972217|589265277|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
163150478|NCT01972217|589265278|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
163150479|NCT01972217|589265279|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
163150480|NCT01972217|589265276|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
163150481|NCT01972217|589265277|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
163150482|NCT01972217|589265278|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
163150483|NCT01972217|589265279|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
163150484|NCT01972217|589265276|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
163150485|NCT01972217|589265277|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
163150486|NCT01972217|589265278|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
163150487|NCT01972217|589265279|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
163150488|NCT01972217|589265276|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
163150489|NCT01972217|589265277|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
163150490|NCT01972217|589265278|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
163150491|NCT01972217|589265279|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
163150492|NCT01456039|589265280|FG000|Phase 1 (First Step)|Disease Progression|1|||
163150493|NCT01456039|589265281|FG001|Phase 1 (First Step)|Disease Progression|1|||
163150494|NCT01456039|589265282|FG002|Phase 1 (First Step)|Disease Progression|0|||
163150495|NCT01456039|589265280|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
163150496|NCT01456039|589265281|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
163150497|NCT01456039|589265282|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
163150498|NCT01456039|589265280|FG000|Phase 1 (First Step)|Adverse Event|0|||
163150499|NCT01456039|589265281|FG001|Phase 1 (First Step)|Adverse Event|3|||
163150500|NCT01456039|589265282|FG002|Phase 1 (First Step)|Adverse Event|0|||
163150501|NCT01456039|589265280|FG000|Phase 1 (First Step)|Other|0|||
163150502|NCT01456039|589265281|FG001|Phase 1 (First Step)|Other|1|||
163150503|NCT01456039|589265282|FG002|Phase 1 (First Step)|Other|0|||
163150504|NCT01456039|589265280|FG000|Phase 2 (Second Step)|Disease Progression|0|||
163150505|NCT01456039|589265281|FG001|Phase 2 (Second Step)|Disease Progression|0|||
163150506|NCT01456039|589265282|FG002|Phase 2 (Second Step)|Disease Progression|17|||
163150507|NCT01456039|589265280|FG000|Phase 2 (Second Step)|Adverse Event|0|||
163150508|NCT01456039|589265281|FG001|Phase 2 (Second Step)|Adverse Event|0|||
163150509|NCT01456039|589265282|FG002|Phase 2 (Second Step)|Adverse Event|10|||
163150510|NCT01456039|589265280|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
163150511|NCT01456039|589265281|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
163150512|NCT01456039|589265282|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
163150513|NCT01456039|589265280|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
163150514|NCT01456039|589265281|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
163150515|NCT01456039|589265282|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
163150516|NCT01456039|589265280|FG000|Phase 2 (Second Step)|Other|0|||
163150517|NCT01456039|589265281|FG001|Phase 2 (Second Step)|Other|0|||
163150518|NCT01456039|589265282|FG002|Phase 2 (Second Step)|Other|1|||
163150519|NCT01702311|589265286|FG000|Overall Study|Withdrawal by Subject|3|||
163150520|NCT01702311|589265287|FG001|Overall Study|Withdrawal by Subject|2|||
163150521|NCT01702311|589265286|FG000|Overall Study|Discharge less than 24 hours|10|||
163150522|NCT01702311|589265287|FG001|Overall Study|Discharge less than 24 hours|7|||
163150523|NCT01702311|589265286|FG000|Overall Study|Physician Decision|3|||
163150524|NCT01702311|589265287|FG001|Overall Study|Physician Decision|4|||
163150525|NCT04106557|589265289|FG000|Overall Study|Physician Decision|0|||
163150526|NCT04106557|589265290|FG001|Overall Study|Physician Decision|1|||
163150527|NCT04106557|589265291|FG002|Overall Study|Physician Decision|0|||
163150528|NCT04106557|589265289|FG000|Overall Study|Protocol Violation|0|||
163355906|NCT01006616|590013600|FG001|Period 1 (6 Months)|Adverse Event|31|||
163150529|NCT04106557|589265290|FG001|Overall Study|Protocol Violation|1|||
163251507|NCT00234052|589629088|FG000|Treatment|Adverse Event|5|||
163251508|NCT00234052|589629088|FG000|Treatment|Death|2|||
163251509|NCT00234052|589629088|FG000|Treatment|Progressive Disease|11|||
163251510|NCT00234052|589629088|FG000|Follow-up for 5 Years|Death|41|||
163251511|NCT00234052|589629088|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
163251512|NCT00234052|589629088|FG000|Follow-up for 5 Years|Other|7|||
163251513|NCT01410474|589629089|FG000|Overall Study|Withdrawal by Subject|0|||
163251514|NCT01410474|589629090|FG001|Overall Study|Withdrawal by Subject|1|||
163251515|NCT02428296|589629091|FG000|Overall Study|Adverse Event|7|||
163251516|NCT02428296|589629091|FG000|Overall Study|Withdrawal by Subject|2|||
163251517|NCT04493931|589629093|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
163251518|NCT04493931|589629094|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
163251519|NCT04493931|589629095|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
163251520|NCT04493931|589629096|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
163251521|NCT04493931|589629097|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
163251522|NCT04493931|589629098|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
163251523|NCT04493931|589629099|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
163251524|NCT04493931|589629093|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
163251525|NCT04493931|589629094|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
163251526|NCT04493931|589629095|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
163251527|NCT04493931|589629096|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
163251528|NCT04493931|589629097|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
163251529|NCT04493931|589629098|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
163251530|NCT04493931|589629099|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
163251531|NCT04493931|589629093|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
163251532|NCT04493931|589629094|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
163251533|NCT04493931|589629095|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
163251534|NCT04493931|589629096|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
163251535|NCT04493931|589629097|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
163251536|NCT04493931|589629098|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
163251537|NCT04493931|589629099|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
163251538|NCT04493931|589629093|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
163251539|NCT04493931|589629094|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
163251540|NCT04493931|589629095|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
163251541|NCT04493931|589629096|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
163251542|NCT04493931|589629097|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
163251543|NCT04493931|589629098|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
163251544|NCT04493931|589629099|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
163251545|NCT03338894|589629100|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
163251546|NCT00420199|589629102|FG000|Overall Study|Participant no longer met study criteria|1|||
163251547|NCT00420199|589629103|FG001|Overall Study|Participant no longer met study criteria|0|||
163251548|NCT02261493|589629104|FG000|Overall Study|Noncompliance|0|||
163251549|NCT02261493|589629105|FG001|Overall Study|Noncompliance|0|||
163251550|NCT02261493|589629106|FG002|Overall Study|Noncompliance|2|||
163251551|NCT02261493|589629104|FG000|Overall Study|Physician Decision|0|||
163251552|NCT02261493|589629105|FG001|Overall Study|Physician Decision|1|||
163251553|NCT02261493|589629106|FG002|Overall Study|Physician Decision|0|||
163251554|NCT02261493|589629104|FG000|Overall Study|Undisclosed alcohol abuse|0|||
163251555|NCT02261493|589629105|FG001|Overall Study|Undisclosed alcohol abuse|1|||
163251556|NCT02261493|589629106|FG002|Overall Study|Undisclosed alcohol abuse|0|||
163251557|NCT02261493|589629104|FG000|Overall Study|Protocol Violation|1|||
163251558|NCT02261493|589629105|FG001|Overall Study|Protocol Violation|0|||
163251559|NCT02261493|589629106|FG002|Overall Study|Protocol Violation|0|||
163251560|NCT02261493|589629104|FG000|Overall Study|Personal Reasons|14|||
163251561|NCT02261493|589629105|FG001|Overall Study|Personal Reasons|14|||
163251562|NCT02261493|589629106|FG002|Overall Study|Personal Reasons|16|||
163251563|NCT02261493|589629104|FG000|Overall Study|Lost to Follow-up|14|||
163251564|NCT02261493|589629105|FG001|Overall Study|Lost to Follow-up|27|||
163251565|NCT02261493|589629106|FG002|Overall Study|Lost to Follow-up|8|||
163251566|NCT02261493|589629104|FG000|Overall Study|Pregnancy|1|||
163251567|NCT02261493|589629105|FG001|Overall Study|Pregnancy|2|||
163251568|NCT02261493|589629106|FG002|Overall Study|Pregnancy|0|||
163251569|NCT02261493|589629104|FG000|Overall Study|Lack of Efficacy|0|||
163355907|NCT01006616|590013601|FG002|Period 1 (6 Months)|Adverse Event|37|||
163355908|NCT01006616|590013602|FG003|Period 1 (6 Months)|Adverse Event|9|||
163355909|NCT01006616|590013599|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
163251570|NCT02261493|589629105|FG001|Overall Study|Lack of Efficacy|1|||
163251571|NCT02261493|589629106|FG002|Overall Study|Lack of Efficacy|0|||
163251572|NCT02261493|589629104|FG000|Overall Study|Adverse Event|0|||
163251573|NCT02261493|589629105|FG001|Overall Study|Adverse Event|1|||
163251574|NCT02261493|589629106|FG002|Overall Study|Adverse Event|0|||
163251575|NCT00558428|589629107|FG000|Overall Study|Adverse Event|6|||
163251576|NCT00558428|589629108|FG001|Overall Study|Adverse Event|22|||
163251577|NCT00558428|589629109|FG002|Overall Study|Adverse Event|3|||
163251578|NCT00558428|589629110|FG003|Overall Study|Adverse Event|4|||
163251579|NCT00558428|589629107|FG000|Overall Study|Lost to Follow-up|0|||
163251580|NCT00558428|589629108|FG001|Overall Study|Lost to Follow-up|1|||
163251581|NCT00558428|589629109|FG002|Overall Study|Lost to Follow-up|0|||
163251582|NCT00558428|589629110|FG003|Overall Study|Lost to Follow-up|0|||
163251583|NCT00558428|589629107|FG000|Overall Study|Lack of Efficacy|0|||
163251584|NCT00558428|589629108|FG001|Overall Study|Lack of Efficacy|0|||
163251585|NCT00558428|589629109|FG002|Overall Study|Lack of Efficacy|1|||
163251586|NCT00558428|589629110|FG003|Overall Study|Lack of Efficacy|2|||
163251587|NCT00558428|589629107|FG000|Overall Study|Non compliant with protocol|1|||
163251588|NCT00558428|589629108|FG001|Overall Study|Non compliant with protocol|0|||
163251589|NCT00558428|589629109|FG002|Overall Study|Non compliant with protocol|0|||
163251590|NCT00558428|589629110|FG003|Overall Study|Non compliant with protocol|3|||
163251591|NCT00558428|589629107|FG000|Overall Study|Consent withdrawn|2|||
163251592|NCT00558428|589629108|FG001|Overall Study|Consent withdrawn|1|||
163251593|NCT00558428|589629109|FG002|Overall Study|Consent withdrawn|0|||
163251594|NCT00558428|589629110|FG003|Overall Study|Consent withdrawn|1|||
163251595|NCT00558428|589629107|FG000|Overall Study|Other|3|||
163251596|NCT00558428|589629108|FG001|Overall Study|Other|0|||
163251597|NCT00558428|589629109|FG002|Overall Study|Other|0|||
163251598|NCT00558428|589629110|FG003|Overall Study|Other|1|||
163251599|NCT00754338|589629111|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
163251600|NCT00754338|589629112|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
163251601|NCT00754338|589629113|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
163251602|NCT00754338|589629114|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
163251603|NCT00754338|589629111|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
163251604|NCT00754338|589629112|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
163251605|NCT00754338|589629113|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
163251606|NCT00754338|589629114|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
163251607|NCT00831779|589629117|FG000|Overall Study|Lost to Follow-up|1|||
163251608|NCT00831779|589629118|FG001|Overall Study|Lost to Follow-up|0|||
163251609|NCT00831779|589629117|FG000|Overall Study|No longer met criteria|0|||
163251610|NCT00831779|589629118|FG001|Overall Study|No longer met criteria|1|||
163251611|NCT04020341|589629119|FG000|Overall Study|Adverse Event|8|||
163251612|NCT04020341|589629120|FG001|Overall Study|Adverse Event|6|||
163251613|NCT04020341|589629119|FG000|Overall Study|Lost to Follow-up|8|||
163251614|NCT04020341|589629120|FG001|Overall Study|Lost to Follow-up|2|||
163251615|NCT04020341|589629119|FG000|Overall Study|Withdrawal by Subject|16|||
163251616|NCT04020341|589629120|FG001|Overall Study|Withdrawal by Subject|16|||
163251617|NCT04020341|589629119|FG000|Overall Study|Participant not able to swallow the tablet|1|||
163251618|NCT04020341|589629120|FG001|Overall Study|Participant not able to swallow the tablet|0|||
163251619|NCT04020341|589629119|FG000|Overall Study|Physician Decision|0|||
163251620|NCT04020341|589629120|FG001|Overall Study|Physician Decision|2|||
163251621|NCT04020341|589629119|FG000|Overall Study|Protocol Deviation|0|||
163251622|NCT04020341|589629120|FG001|Overall Study|Protocol Deviation|2|||
163251623|NCT04528069|589629121|FG000|Overall Study|Adverse Event|1|||
163251624|NCT04528069|589629121|FG000|Overall Study|Lost to Follow-up|1|||
163251625|NCT04528069|589629121|FG000|Overall Study|Patient Unable to Come|1|||
163251626|NCT04528069|589629121|FG000|Overall Study|Patient Unable to Attend|1|||
163251627|NCT01814371|589629123|FG000|Overall Study|Lost to Follow-up|30|||
163251628|NCT01814371|589629124|FG001|Overall Study|Lost to Follow-up|27|||
163251629|NCT04683926|589629125|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
163251630|NCT04683926|589629126|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
163251631|NCT04683926|589629127|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
163251632|NCT04683926|589629128|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
163251633|NCT01692782|589629130|FG000|Overall Study|Adverse Event|12|||
163251634|NCT01692782|589629131|FG001|Overall Study|Adverse Event|32|||
163251635|NCT01692782|589629132|FG002|Overall Study|Adverse Event|2|||
163251636|NCT01692782|589629130|FG000|Overall Study|Lack of Efficacy|1|||
163251637|NCT01692782|589629131|FG001|Overall Study|Lack of Efficacy|2|||
163251638|NCT01692782|589629132|FG002|Overall Study|Lack of Efficacy|0|||
163251639|NCT01692782|589629130|FG000|Overall Study|Lost to Follow-up|2|||
163251640|NCT01692782|589629131|FG001|Overall Study|Lost to Follow-up|7|||
163251641|NCT01692782|589629132|FG002|Overall Study|Lost to Follow-up|1|||
163251642|NCT01692782|589629130|FG000|Overall Study|Pregnancy|1|||
163251643|NCT01692782|589629131|FG001|Overall Study|Pregnancy|0|||
163251644|NCT01692782|589629132|FG002|Overall Study|Pregnancy|0|||
163251645|NCT01692782|589629130|FG000|Overall Study|Protocol Violation|1|||
163251646|NCT01692782|589629131|FG001|Overall Study|Protocol Violation|0|||
163251647|NCT01692782|589629132|FG002|Overall Study|Protocol Violation|2|||
163251648|NCT01692782|589629130|FG000|Overall Study|Non-complance with study drug|0|||
163251649|NCT01692782|589629131|FG001|Overall Study|Non-complance with study drug|4|||
163251650|NCT01692782|589629132|FG002|Overall Study|Non-complance with study drug|1|||
163251651|NCT01692782|589629130|FG000|Overall Study|Non-compliant with study visits|0|||
163251652|NCT01692782|589629131|FG001|Overall Study|Non-compliant with study visits|0|||
163251653|NCT01692782|589629132|FG002|Overall Study|Non-compliant with study visits|1|||
163251654|NCT01692782|589629130|FG000|Overall Study|SAE not related to study drug|0|||
163251655|NCT01692782|589629131|FG001|Overall Study|SAE not related to study drug|1|||
163251656|NCT01692782|589629132|FG002|Overall Study|SAE not related to study drug|0|||
163251657|NCT01692782|589629130|FG000|Overall Study|Withdrawal by Subject|3|||
163251658|NCT01692782|589629131|FG001|Overall Study|Withdrawal by Subject|10|||
163251659|NCT01692782|589629132|FG002|Overall Study|Withdrawal by Subject|3|||
163251660|NCT00952367|589629141|FG000|Overall Study|Withdrawal by Subject|2|||
163251661|NCT00952367|589629141|FG000|Overall Study|Noncoordination|1|||
163251662|NCT00952367|589629141|FG000|Overall Study|Protocol Violation|3|||
163251663|NCT05072080|589629144|FG000|Overall Study|Death|0|||
163251664|NCT05072080|589629145|FG001|Overall Study|Death|0|||
163251665|NCT05072080|589629146|FG002|Overall Study|Death|1|||
163251666|NCT05072080|589629147|FG003|Overall Study|Death|0|||
163251667|NCT05072080|589629144|FG000|Overall Study|Lost to Follow-up|65|||
163251668|NCT05072080|589629145|FG001|Overall Study|Lost to Follow-up|70|||
163251669|NCT05072080|589629146|FG002|Overall Study|Lost to Follow-up|58|||
163251670|NCT05072080|589629147|FG003|Overall Study|Lost to Follow-up|23|||
163251671|NCT05072080|589629144|FG000|Overall Study|Physician Decision|2|||
163251672|NCT05072080|589629145|FG001|Overall Study|Physician Decision|1|||
163251673|NCT05072080|589629146|FG002|Overall Study|Physician Decision|1|||
163251674|NCT05072080|589629147|FG003|Overall Study|Physician Decision|0|||
163251675|NCT05072080|589629144|FG000|Overall Study|Withdrawal by Subject|45|||
163251676|NCT05072080|589629145|FG001|Overall Study|Withdrawal by Subject|30|||
163251677|NCT05072080|589629146|FG002|Overall Study|Withdrawal by Subject|27|||
163251678|NCT05072080|589629147|FG003|Overall Study|Withdrawal by Subject|7|||
163251679|NCT05072080|589629144|FG000|Overall Study|Sponsor Decision|0|||
163251680|NCT05072080|589629145|FG001|Overall Study|Sponsor Decision|1|||
163251681|NCT05072080|589629146|FG002|Overall Study|Sponsor Decision|0|||
163251682|NCT05072080|589629147|FG003|Overall Study|Sponsor Decision|0|||
163251683|NCT05072080|589629144|FG000|Overall Study|Subject moved|1|||
163251684|NCT05072080|589629145|FG001|Overall Study|Subject moved|3|||
163251685|NCT05072080|589629146|FG002|Overall Study|Subject moved|5|||
163251686|NCT05072080|589629147|FG003|Overall Study|Subject moved|2|||
163251687|NCT05072080|589629144|FG000|Overall Study|Withdrawal by parent|0|||
163251688|NCT05072080|589629145|FG001|Overall Study|Withdrawal by parent|0|||
163251689|NCT05072080|589629146|FG002|Overall Study|Withdrawal by parent|1|||
163251690|NCT05072080|589629147|FG003|Overall Study|Withdrawal by parent|0|||
163251691|NCT05072080|589629144|FG000|Overall Study|Subject was deployed|0|||
163251692|NCT05072080|589629145|FG001|Overall Study|Subject was deployed|1|||
163251693|NCT05072080|589629146|FG002|Overall Study|Subject was deployed|0|||
163251694|NCT05072080|589629147|FG003|Overall Study|Subject was deployed|0|||
163251695|NCT05072080|589629144|FG000|Overall Study|Subject left site without receiving dose|0|||
163251696|NCT05072080|589629145|FG001|Overall Study|Subject left site without receiving dose|1|||
163251697|NCT05072080|589629146|FG002|Overall Study|Subject left site without receiving dose|0|||
163251698|NCT05072080|589629147|FG003|Overall Study|Subject left site without receiving dose|0|||
163251699|NCT05072080|589629144|FG000|Overall Study|Subject incarcerated|0|||
163251700|NCT05072080|589629145|FG001|Overall Study|Subject incarcerated|1|||
163251701|NCT05072080|589629146|FG002|Overall Study|Subject incarcerated|0|||
163251702|NCT05072080|589629147|FG003|Overall Study|Subject incarcerated|1|||
163251703|NCT05072080|589629144|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
163251704|NCT05072080|589629145|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
163251705|NCT05072080|589629146|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
163251706|NCT05072080|589629147|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
163251707|NCT05072080|589629144|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
163251708|NCT05072080|589629145|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
163355910|NCT01006616|590013600|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
163355911|NCT01006616|590013601|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
163355912|NCT01006616|590013602|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
163355913|NCT01006616|590013599|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
163355914|NCT01006616|590013600|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
163355915|NCT01006616|590013601|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
163355916|NCT01006616|590013602|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
163251709|NCT05072080|589629146|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
163251710|NCT05072080|589629147|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
163251711|NCT00736645|589629156|FG000|Overall Study|Adverse Event|0|||
163355917|NCT01006616|590013599|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
163251712|NCT00736645|589629157|FG001|Overall Study|Adverse Event|2|||
163251713|NCT00736645|589629158|FG002|Overall Study|Adverse Event|0|||
163251714|NCT00736645|589629159|FG003|Overall Study|Adverse Event|0|||
163251715|NCT02300220|589629163|FG000|Overall Study|Lost to Follow-up|1|||
163251716|NCT02300220|589629164|FG001|Overall Study|Lost to Follow-up|2|||
163251717|NCT02300220|589629163|FG000|Overall Study|Death|1|||
163251718|NCT02300220|589629164|FG001|Overall Study|Death|1|||
163251719|NCT02300220|589629163|FG000|Overall Study|Adverse Event|1|||
163251720|NCT02300220|589629164|FG001|Overall Study|Adverse Event|1|||
163251721|NCT02300220|589629163|FG000|Overall Study|Protocol Violation|1|||
163251722|NCT02300220|589629164|FG001|Overall Study|Protocol Violation|0|||
163251723|NCT02300220|589629163|FG000|Overall Study|Withdrawal by Subject|0|||
163251724|NCT02300220|589629164|FG001|Overall Study|Withdrawal by Subject|2|||
163251725|NCT02300220|589629163|FG000|Overall Study|Did not tolerate IMP|0|||
163251726|NCT02300220|589629164|FG001|Overall Study|Did not tolerate IMP|1|||
163251727|NCT04322682|589629165|FG000|Overall Study|Withdrawal by Subject|33|||
163251728|NCT04322682|589629166|FG001|Overall Study|Withdrawal by Subject|47|||
163251729|NCT04322682|589629165|FG000|Overall Study|Death|5|||
163251730|NCT04322682|589629166|FG001|Overall Study|Death|9|||
163251731|NCT04322682|589629165|FG000|Overall Study|Lost to Follow-up|4|||
163251732|NCT04322682|589629166|FG001|Overall Study|Lost to Follow-up|8|||
163251733|NCT04322682|589629165|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
163251734|NCT04322682|589629166|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
163251735|NCT02238379|589629167|FG000|Overall Study|Lost to Follow-up|1|||
163251736|NCT02238379|589629168|FG001|Overall Study|Lost to Follow-up|0|||
163251737|NCT04123067|589629169|FG000|Overall Study|Lost to Follow-up|0|||
163251738|NCT04123067|589629170|FG001|Overall Study|Lost to Follow-up|1|||
163251739|NCT03085485|589629171|FG000|Overall Study|Death|1|||
163251740|NCT03085485|589629172|FG001|Overall Study|Death|0|||
163251741|NCT03085485|589629171|FG000|Overall Study|Lost to Follow-up|1|||
163251742|NCT03085485|589629172|FG001|Overall Study|Lost to Follow-up|0|||
163251743|NCT00605280|589629173|FG000|Year 1|Protocol Violation|0|||
163251744|NCT00605280|589629174|FG001|Year 1|Protocol Violation|0|||
163251745|NCT00605280|589629175|FG002|Year 1|Protocol Violation|0|||
163251746|NCT00605280|589629176|FG003|Year 1|Protocol Violation|1|||
163251747|NCT00605280|589629173|FG000|Year 1|Adverse Event|3|||
163251748|NCT00605280|589629174|FG001|Year 1|Adverse Event|1|||
163251749|NCT00605280|589629175|FG002|Year 1|Adverse Event|1|||
163251750|NCT00605280|589629176|FG003|Year 1|Adverse Event|5|||
163251751|NCT00605280|589629173|FG000|Year 1|Physician Decision|7|||
163251752|NCT00605280|589629174|FG001|Year 1|Physician Decision|4|||
163251753|NCT00605280|589629175|FG002|Year 1|Physician Decision|0|||
163251754|NCT00605280|589629176|FG003|Year 1|Physician Decision|6|||
163251755|NCT00605280|589629173|FG000|Year 1|Withdrawal by Subject|2|||
163251756|NCT00605280|589629174|FG001|Year 1|Withdrawal by Subject|4|||
163251757|NCT00605280|589629175|FG002|Year 1|Withdrawal by Subject|0|||
163251758|NCT00605280|589629176|FG003|Year 1|Withdrawal by Subject|4|||
163251759|NCT00605280|589629173|FG000|Year 1|Other|2|||
163251760|NCT00605280|589629174|FG001|Year 1|Other|1|||
163251761|NCT00605280|589629175|FG002|Year 1|Other|0|||
163251762|NCT00605280|589629176|FG003|Year 1|Other|1|||
163251763|NCT00605280|589629173|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
163251764|NCT00605280|589629174|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
163251765|NCT00605280|589629175|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
163251766|NCT00605280|589629176|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
163251767|NCT00605280|589629173|FG000|Year 2|Adverse Event|4|||
163251768|NCT00605280|589629174|FG001|Year 2|Adverse Event|0|||
163251769|NCT00605280|589629175|FG002|Year 2|Adverse Event|2|||
163251770|NCT00605280|589629176|FG003|Year 2|Adverse Event|4|||
163251771|NCT00605280|589629173|FG000|Year 2|Physician Decision|11|||
163410391|NCT05103332|590211361|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163410392|NCT05103332|590211362|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163410393|NCT05103332|590211363|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163410394|NCT05103332|590211364|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163251772|NCT00605280|589629174|FG001|Year 2|Physician Decision|6|||
163251773|NCT00605280|589629175|FG002|Year 2|Physician Decision|4|||
163251774|NCT00605280|589629176|FG003|Year 2|Physician Decision|11|||
163251775|NCT00605280|589629173|FG000|Year 2|Withdrawal by Subject|4|||
163251776|NCT00605280|589629174|FG001|Year 2|Withdrawal by Subject|0|||
163251777|NCT00605280|589629175|FG002|Year 2|Withdrawal by Subject|0|||
163251778|NCT00605280|589629176|FG003|Year 2|Withdrawal by Subject|4|||
163251779|NCT00605280|589629173|FG000|Year 2|Other|1|||
163251780|NCT00605280|589629174|FG001|Year 2|Other|0|||
163251781|NCT00605280|589629175|FG002|Year 2|Other|0|||
163251782|NCT00605280|589629176|FG003|Year 2|Other|1|||
163251783|NCT00605280|589629173|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
163251784|NCT00605280|589629174|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
163251785|NCT00605280|589629175|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
163251786|NCT00605280|589629176|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
163251787|NCT00605280|589629173|FG000|Year 3 Extension|Adverse Event|2|||
163251788|NCT00605280|589629174|FG001|Year 3 Extension|Adverse Event|0|||
163251789|NCT00605280|589629175|FG002|Year 3 Extension|Adverse Event|0|||
163251790|NCT00605280|589629176|FG003|Year 3 Extension|Adverse Event|2|||
163251791|NCT00605280|589629173|FG000|Year 3 Extension|Physician Decision|0|||
163251792|NCT00605280|589629174|FG001|Year 3 Extension|Physician Decision|0|||
163251793|NCT00605280|589629175|FG002|Year 3 Extension|Physician Decision|0|||
163251794|NCT00605280|589629176|FG003|Year 3 Extension|Physician Decision|2|||
163251795|NCT00605280|589629173|FG000|Year 3 Extension|Withdrawal by Subject|2|||
163355918|NCT01006616|590013600|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
163355919|NCT01006616|590013601|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
163355920|NCT01006616|590013602|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
163355921|NCT01006616|590013599|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
163355922|NCT01006616|590013600|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
163355923|NCT01006616|590013601|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
163355924|NCT01006616|590013602|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
163355925|NCT01006616|590013599|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
163355926|NCT01006616|590013600|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
163355927|NCT01006616|590013601|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
163355928|NCT01006616|590013602|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
163150530|NCT04106557|589265291|FG002|Overall Study|Protocol Violation|0|||
163150531|NCT00313014|589265292|FG000|Overall Study|Withdrawal by Subject|11|||
163150532|NCT00313014|589265293|FG001|Overall Study|Withdrawal by Subject|7|||
163150533|NCT00313014|589265294|FG002|Overall Study|Withdrawal by Subject|5|||
163150534|NCT00313014|589265292|FG000|Overall Study|Adverse Event|14|||
163150535|NCT00313014|589265293|FG001|Overall Study|Adverse Event|29|||
163150536|NCT00313014|589265294|FG002|Overall Study|Adverse Event|16|||
163150537|NCT00313014|589265292|FG000|Overall Study|Lost to Follow-up|7|||
163150538|NCT00313014|589265293|FG001|Overall Study|Lost to Follow-up|6|||
163150539|NCT00313014|589265294|FG002|Overall Study|Lost to Follow-up|10|||
163150540|NCT00313014|589265292|FG000|Overall Study|Administrative|9|||
163150541|NCT00313014|589265293|FG001|Overall Study|Administrative|6|||
163150542|NCT00313014|589265294|FG002|Overall Study|Administrative|14|||
163150543|NCT00313014|589265292|FG000|Overall Study|Lack of Efficacy|52|||
163150544|NCT00313014|589265293|FG001|Overall Study|Lack of Efficacy|25|||
163150545|NCT00313014|589265294|FG002|Overall Study|Lack of Efficacy|16|||
163150546|NCT03714672|589265295|FG000|Overall Study|Adverse Event|0|||
163150547|NCT03714672|589265296|FG001|Overall Study|Adverse Event|0|||
163150548|NCT03714672|589265297|FG002|Overall Study|Adverse Event|3|||
163150549|NCT03714672|589265298|FG003|Overall Study|Adverse Event|0|||
163150550|NCT03714672|589265295|FG000|Overall Study|Physician Decision|0|||
163150551|NCT03714672|589265296|FG001|Overall Study|Physician Decision|1|||
163150552|NCT03714672|589265297|FG002|Overall Study|Physician Decision|0|||
163150553|NCT03714672|589265298|FG003|Overall Study|Physician Decision|0|||
163150554|NCT03714672|589265295|FG000|Overall Study|Other Reason|1|||
163150555|NCT03714672|589265296|FG001|Overall Study|Other Reason|2|||
163150556|NCT03714672|589265297|FG002|Overall Study|Other Reason|1|||
163150557|NCT03714672|589265298|FG003|Overall Study|Other Reason|1|||
163150558|NCT03714672|589265295|FG000|Overall Study|Lost to Follow-up|1|||
163150559|NCT03714672|589265296|FG001|Overall Study|Lost to Follow-up|1|||
163150560|NCT03714672|589265297|FG002|Overall Study|Lost to Follow-up|0|||
163150561|NCT03714672|589265298|FG003|Overall Study|Lost to Follow-up|0|||
163150562|NCT00419393|589265303|FG000|Overall Study|Adverse Event|5|||
163150563|NCT00419393|589265303|FG000|Overall Study|Protocol Violation|5|||
163150564|NCT00419393|589265303|FG000|Overall Study|Withdrawal by Subject|7|||
163150565|NCT00419393|589265303|FG000|Overall Study|Other: Sponsor request|3|||
163150566|NCT00419393|589265303|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
163150567|NCT00419393|589265303|FG000|Overall Study|Other: Site closure|1|||
163150568|NCT00419393|589265303|FG000|Overall Study|Other: Other health problems|1|||
163150569|NCT00419393|589265303|FG000|Overall Study|Other: Investigator decision|1|||
163150570|NCT01231984|589265306|FG000|Study Period 1|Withdrawal by Subject|0|||
163150571|NCT01231984|589265307|FG001|Study Period 1|Withdrawal by Subject|0|||
163150572|NCT01231984|589265308|FG002|Study Period 1|Withdrawal by Subject|0|||
163150573|NCT01231984|589265309|FG003|Study Period 1|Withdrawal by Subject|1|||
163355929|NCT01006616|590013599|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
163355930|NCT01006616|590013600|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
163410395|NCT05103332|590211365|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163150574|NCT01231984|589265306|FG000|Study Period 1|Lost to Follow-up|1|||
163150575|NCT01231984|589265307|FG001|Study Period 1|Lost to Follow-up|1|||
163150576|NCT01231984|589265308|FG002|Study Period 1|Lost to Follow-up|1|||
163150577|NCT01231984|589265309|FG003|Study Period 1|Lost to Follow-up|0|||
163150578|NCT01231984|589265306|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
163150579|NCT01231984|589265307|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
163150580|NCT01231984|589265308|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
163150581|NCT01231984|589265309|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
163150582|NCT01231984|589265306|FG000|Study Period 1|Screen Failure|0|||
163150583|NCT01231984|589265307|FG001|Study Period 1|Screen Failure|0|||
163150584|NCT01231984|589265308|FG002|Study Period 1|Screen Failure|0|||
163150585|NCT01231984|589265309|FG003|Study Period 1|Screen Failure|1|||
163150586|NCT01231984|589265306|FG000|Study Period 1|Non-compliance with study requirements|5|||
163150587|NCT01231984|589265307|FG001|Study Period 1|Non-compliance with study requirements|0|||
163150588|NCT01231984|589265308|FG002|Study Period 1|Non-compliance with study requirements|2|||
163150589|NCT01231984|589265309|FG003|Study Period 1|Non-compliance with study requirements|1|||
163150590|NCT01231984|589265306|FG000|Study Period 1|Protocol Violation|3|||
163150591|NCT01231984|589265307|FG001|Study Period 1|Protocol Violation|4|||
163150592|NCT01231984|589265308|FG002|Study Period 1|Protocol Violation|2|||
163150593|NCT01231984|589265309|FG003|Study Period 1|Protocol Violation|3|||
163150594|NCT01231984|589265306|FG000|Study Period 1|Adverse Event|1|||
163150595|NCT01231984|589265307|FG001|Study Period 1|Adverse Event|0|||
163150596|NCT01231984|589265308|FG002|Study Period 1|Adverse Event|0|||
163150597|NCT01231984|589265309|FG003|Study Period 1|Adverse Event|0|||
163150598|NCT01231984|589265306|FG000|Study Period 1|Other|0|||
163150599|NCT01231984|589265307|FG001|Study Period 1|Other|0|||
163150600|NCT01231984|589265308|FG002|Study Period 1|Other|0|||
163150601|NCT01231984|589265309|FG003|Study Period 1|Other|1|||
163150602|NCT01231984|589265306|FG000|Study Period 2|Withdrawal by Subject|1|||
163150603|NCT01231984|589265307|FG001|Study Period 2|Withdrawal by Subject|1|||
163150604|NCT01231984|589265308|FG002|Study Period 2|Withdrawal by Subject|0|||
163150605|NCT01231984|589265309|FG003|Study Period 2|Withdrawal by Subject|0|||
163150606|NCT01231984|589265306|FG000|Study Period 2|Lost to Follow-up|1|||
163150607|NCT01231984|589265307|FG001|Study Period 2|Lost to Follow-up|0|||
163150608|NCT01231984|589265308|FG002|Study Period 2|Lost to Follow-up|0|||
163150609|NCT01231984|589265309|FG003|Study Period 2|Lost to Follow-up|3|||
163150610|NCT01231984|589265306|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
163150611|NCT01231984|589265307|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
163150612|NCT01231984|589265308|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
163150613|NCT01231984|589265309|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
163150614|NCT02939287|589265310|FG000|Overall Study|met exclusion criteria|1|||
163150615|NCT02939287|589265311|FG001|Overall Study|met exclusion criteria|1|||
163150616|NCT02939287|589265312|FG002|Overall Study|met exclusion criteria|1|||
163150617|NCT02939287|589265310|FG000|Overall Study|Did not complete survey|2|||
163150618|NCT02939287|589265311|FG001|Overall Study|Did not complete survey|2|||
163150619|NCT02939287|589265312|FG002|Overall Study|Did not complete survey|0|||
163150620|NCT02939287|589265310|FG000|Overall Study|Withdrawal by Subject|1|||
163150621|NCT02939287|589265311|FG001|Overall Study|Withdrawal by Subject|1|||
163150622|NCT02939287|589265312|FG002|Overall Study|Withdrawal by Subject|0|||
163150623|NCT05236270|589265314|FG000|Overall Study|Lost to Follow-up|3|||
163150624|NCT05236270|589265315|FG001|Overall Study|Lost to Follow-up|2|||
163150625|NCT05236270|589265316|FG002|Overall Study|Lost to Follow-up|0|||
163150626|NCT05236270|589265317|FG003|Overall Study|Lost to Follow-up|0|||
163150627|NCT05236270|589265318|FG004|Overall Study|Lost to Follow-up|2|||
163150628|NCT05236270|589265319|FG005|Overall Study|Lost to Follow-up|0|||
163150629|NCT05236270|589265320|FG006|Overall Study|Lost to Follow-up|1|||
163150630|NCT05236270|589265321|FG007|Overall Study|Lost to Follow-up|3|||
163150631|NCT02476617|589265322|FG000|Overall Study|Adverse Event|1|||
163150632|NCT02476617|589265322|FG000|Overall Study|Lost to Follow-up|1|||
163150633|NCT01383928|589265323|FG000|Overall Study|Initiation of ASCT|2|||
163150634|NCT01383928|589265324|FG001|Overall Study|Initiation of ASCT|1|||
163150635|NCT01383928|589265325|FG002|Overall Study|Initiation of ASCT|18|||
163150636|NCT01383928|589265323|FG000|Overall Study|Adverse Event|1|||
163150637|NCT01383928|589265324|FG001|Overall Study|Adverse Event|2|||
163150638|NCT01383928|589265325|FG002|Overall Study|Adverse Event|8|||
163150639|NCT01383928|589265323|FG000|Overall Study|Other|1|||
163150640|NCT01383928|589265324|FG001|Overall Study|Other|3|||
163150641|NCT01383928|589265325|FG002|Overall Study|Other|4|||
163150642|NCT01383928|589265323|FG000|Overall Study|Progressive Disease|1|||
163150643|NCT01383928|589265324|FG001|Overall Study|Progressive Disease|1|||
163150644|NCT01383928|589265325|FG002|Overall Study|Progressive Disease|5|||
163150645|NCT01383928|589265323|FG000|Overall Study|Withdrawal by Subject|0|||
163150646|NCT01383928|589265324|FG001|Overall Study|Withdrawal by Subject|0|||
163150647|NCT01383928|589265325|FG002|Overall Study|Withdrawal by Subject|4|||
163150648|NCT01383928|589265323|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
163150649|NCT01383928|589265324|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
163150650|NCT01383928|589265325|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
163150651|NCT03486912|589265326|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
163150652|NCT03486912|589265327|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
163150653|NCT03486912|589265328|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
163150654|NCT03486912|589265329|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
163150655|NCT03486912|589265326|FG000|Treatment Period|Withdrawal by Subject|3|||
163150656|NCT03486912|589265327|FG001|Treatment Period|Withdrawal by Subject|3|||
163150657|NCT03486912|589265328|FG002|Treatment Period|Withdrawal by Subject|3|||
163150658|NCT03486912|589265329|FG003|Treatment Period|Withdrawal by Subject|2|||
163150659|NCT03486912|589265326|FG000|Treatment Period|Other Reasons|0|||
163150660|NCT03486912|589265327|FG001|Treatment Period|Other Reasons|2|||
163150661|NCT03486912|589265328|FG002|Treatment Period|Other Reasons|1|||
163150662|NCT03486912|589265329|FG003|Treatment Period|Other Reasons|1|||
163150663|NCT03486912|589265326|FG000|Treatment Period|Adverse Event|0|||
163150664|NCT03486912|589265327|FG001|Treatment Period|Adverse Event|1|||
163150665|NCT03486912|589265328|FG002|Treatment Period|Adverse Event|1|||
163150666|NCT03486912|589265329|FG003|Treatment Period|Adverse Event|0|||
163410396|NCT05103332|590211366|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163150667|NCT03486912|589265326|FG000|Treatment Period|Lost to Follow-up|1|||
163251796|NCT00605280|589629174|FG001|Year 3 Extension|Withdrawal by Subject|0|||
163251797|NCT00605280|589629175|FG002|Year 3 Extension|Withdrawal by Subject|0|||
163251798|NCT00605280|589629176|FG003|Year 3 Extension|Withdrawal by Subject|5|||
163251799|NCT00605280|589629173|FG000|Year 3 Extension|Other|2|||
163251800|NCT00605280|589629174|FG001|Year 3 Extension|Other|0|||
163251801|NCT00605280|589629175|FG002|Year 3 Extension|Other|0|||
163251802|NCT00605280|589629176|FG003|Year 3 Extension|Other|0|||
163251803|NCT00605280|589629173|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
163251804|NCT00605280|589629174|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
163251805|NCT00605280|589629175|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
163251806|NCT00605280|589629176|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
163251807|NCT02137369|589629182|FG000|Overall Study|Withdrawal by Subject|3|||
163251808|NCT02137369|589629183|FG001|Overall Study|Withdrawal by Subject|2|||
163251809|NCT02137369|589629182|FG000|Overall Study|Adverse Event|2|||
163251810|NCT02137369|589629183|FG001|Overall Study|Adverse Event|0|||
163251811|NCT02137369|589629182|FG000|Overall Study|Lost to Follow-up|1|||
163251812|NCT02137369|589629183|FG001|Overall Study|Lost to Follow-up|0|||
163251813|NCT02137369|589629182|FG000|Overall Study|Moved away|2|||
163251814|NCT02137369|589629183|FG001|Overall Study|Moved away|0|||
163251815|NCT01329029|589629196|FG000|Overall Study|Withdrawal by Subject|117|||
163251816|NCT01329029|589629197|FG001|Overall Study|Withdrawal by Subject|87|||
163251817|NCT01329029|589629196|FG000|Overall Study|Adverse Event|82|||
163251818|NCT01329029|589629197|FG001|Overall Study|Adverse Event|29|||
163251819|NCT01329029|589629196|FG000|Overall Study|Death|16|||
163251820|NCT01329029|589629197|FG001|Overall Study|Death|19|||
163251821|NCT01329029|589629196|FG000|Overall Study|Other|14|||
163251822|NCT01329029|589629197|FG001|Overall Study|Other|20|||
163251823|NCT01329029|589629196|FG000|Overall Study|COPD Exacerbation|11|||
163251824|NCT01329029|589629197|FG001|Overall Study|COPD Exacerbation|18|||
163251825|NCT01329029|589629196|FG000|Overall Study|Physician Decision|16|||
163251826|NCT01329029|589629197|FG001|Overall Study|Physician Decision|13|||
163251827|NCT01329029|589629196|FG000|Overall Study|Lost to Follow-up|8|||
163251828|NCT01329029|589629197|FG001|Overall Study|Lost to Follow-up|5|||
163251829|NCT01329029|589629196|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
163251830|NCT01329029|589629197|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
163251831|NCT04128293|589631908|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
163251832|NCT04128293|589631909|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
163251833|NCT04128293|589631910|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
163251834|NCT04128293|589631911|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
163251835|NCT00514943|589631914|FG000|Stage 1|Progressive disease|4|||
163251836|NCT00514943|589631915|FG001|Stage 1|Progressive disease|8|||
163251837|NCT00514943|589631914|FG000|Stage 1|Other Adverse Event|16|||
163251838|NCT00514943|589631915|FG001|Stage 1|Other Adverse Event|6|||
163251839|NCT00514943|589631914|FG000|Stage 1|Not treated|1|||
163251840|NCT00514943|589631915|FG001|Stage 1|Not treated|2|||
163251841|NCT00514943|589631914|FG000|Stage 1|Patient refused to continue study meds|8|||
163251842|NCT00514943|589631915|FG001|Stage 1|Patient refused to continue study meds|3|||
163251843|NCT00514943|589631914|FG000|Stage 1|Other than stated above|1|||
163251844|NCT00514943|589631915|FG001|Stage 1|Other than stated above|7|||
163251845|NCT00514943|589631914|FG000|Stage 2|Progressive disease|27|||
163251846|NCT00514943|589631915|FG001|Stage 2|Progressive disease|24|||
163251847|NCT00514943|589631914|FG000|Stage 2|Other Adverse Event|3|||
163251848|NCT00514943|589631915|FG001|Stage 2|Other Adverse Event|10|||
163251849|NCT00514943|589631914|FG000|Stage 2|Patient refused to continue study meds|2|||
163251850|NCT00514943|589631915|FG001|Stage 2|Patient refused to continue study meds|0|||
163251851|NCT00514943|589631914|FG000|Stage 2|Other than stated above|0|||
163251852|NCT00514943|589631915|FG001|Stage 2|Other than stated above|2|||
163251853|NCT00499031|589631916|FG000|Overall Study|Improper pre-protocol treatment|1|||
163251854|NCT00499031|589631916|FG000|Overall Study|Required test not done|1|||
163251855|NCT00499031|589631916|FG000|Overall Study|Never treated|1|||
163251856|NCT02001194|589631918|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
163251857|NCT02001194|589631919|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
163410397|NCT05103332|590211367|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163410398|NCT05103332|590211368|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163410399|NCT05103332|590211369|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
163410400|NCT05103332|590211370|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163251858|NCT02001194|589631920|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
163410401|NCT05103332|590211371|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163410402|NCT05103332|590211372|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163251859|NCT02001194|589631921|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
163251860|NCT02001194|589631918|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
163251861|NCT02001194|589631919|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
163251862|NCT02001194|589631920|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
163251863|NCT02001194|589631921|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
163251864|NCT02366910|589631926|FG000|Overall Study|Withdrawal by Subject|2|||
163410403|NCT05103332|590211373|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163251865|NCT02366910|589631926|FG000|Overall Study|Screen Failure|3|||
163251866|NCT01699022|589631927|FG000|Overall Study|Early discontinuation from the study|3|||
163251867|NCT03284788|589631928|FG000|Overall Study|Withdrawal by Subject|2|||
163251868|NCT02462876|589631929|FG000|Overall Study|Death|3|||
163251869|NCT02462876|589631929|FG000|Overall Study|Lost to Follow-up|7|||
163251870|NCT02462876|589631929|FG000|Overall Study|Surgical Bypass|9|||
163251871|NCT02462876|589631929|FG000|Overall Study|Amputation Above the Metatarsals|1|||
163251872|NCT02462876|589631929|FG000|Overall Study|36 months follow-up visit missed|1|||
163251873|NCT02462876|589631929|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
163251874|NCT02462876|589631929|FG000|Overall Study|Patient did not come back to the vascular department|1|||
163251875|NCT02462876|589631929|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
163251876|NCT02462876|589631929|FG000|Overall Study|Patient refused to come back|1|||
163251877|NCT02462876|589631929|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
163251878|NCT02462876|589631929|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
163251879|NCT01786512|589631930|FG000|Overall Study|Lost to Follow-up|0|||
163251880|NCT01786512|589631931|FG001|Overall Study|Lost to Follow-up|0|||
163251881|NCT01786512|589631932|FG002|Overall Study|Lost to Follow-up|0|||
163251882|NCT01786512|589631933|FG003|Overall Study|Lost to Follow-up|0|||
163251883|NCT01786512|589631934|FG004|Overall Study|Lost to Follow-up|0|||
163251884|NCT01786512|589631935|FG005|Overall Study|Lost to Follow-up|0|||
163251885|NCT01786512|589631936|FG006|Overall Study|Lost to Follow-up|0|||
163251886|NCT01786512|589631937|FG007|Overall Study|Lost to Follow-up|0|||
163251887|NCT01786512|589631938|FG008|Overall Study|Lost to Follow-up|0|||
163251888|NCT01786512|589631939|FG009|Overall Study|Lost to Follow-up|1|||
163251889|NCT01786512|589631940|FG010|Overall Study|Lost to Follow-up|0|||
163251890|NCT01786512|589631930|FG000|Overall Study|Decision by sponsor|0|||
163251891|NCT01786512|589631931|FG001|Overall Study|Decision by sponsor|0|||
163251892|NCT01786512|589631932|FG002|Overall Study|Decision by sponsor|0|||
163251893|NCT01786512|589631933|FG003|Overall Study|Decision by sponsor|0|||
163251894|NCT01786512|589631934|FG004|Overall Study|Decision by sponsor|0|||
163251895|NCT01786512|589631935|FG005|Overall Study|Decision by sponsor|0|||
163251896|NCT01786512|589631936|FG006|Overall Study|Decision by sponsor|0|||
163251897|NCT01786512|589631937|FG007|Overall Study|Decision by sponsor|0|||
163251898|NCT01786512|589631938|FG008|Overall Study|Decision by sponsor|0|||
163251899|NCT01786512|589631939|FG009|Overall Study|Decision by sponsor|0|||
163251900|NCT01786512|589631940|FG010|Overall Study|Decision by sponsor|2|||
163251901|NCT01786512|589631930|FG000|Overall Study|Withdrawal by Subject|0|||
163251902|NCT01786512|589631931|FG001|Overall Study|Withdrawal by Subject|1|||
163251903|NCT01786512|589631932|FG002|Overall Study|Withdrawal by Subject|0|||
163251904|NCT01786512|589631933|FG003|Overall Study|Withdrawal by Subject|0|||
163251905|NCT01786512|589631934|FG004|Overall Study|Withdrawal by Subject|0|||
163251906|NCT01786512|589631935|FG005|Overall Study|Withdrawal by Subject|0|||
163251907|NCT01786512|589631936|FG006|Overall Study|Withdrawal by Subject|1|||
163251908|NCT01786512|589631937|FG007|Overall Study|Withdrawal by Subject|0|||
163251909|NCT01786512|589631938|FG008|Overall Study|Withdrawal by Subject|0|||
163251910|NCT01786512|589631939|FG009|Overall Study|Withdrawal by Subject|3|||
163251911|NCT01786512|589631940|FG010|Overall Study|Withdrawal by Subject|7|||
163251912|NCT01786512|589631930|FG000|Overall Study|Death|0|||
163251913|NCT01786512|589631931|FG001|Overall Study|Death|0|||
163251914|NCT01786512|589631932|FG002|Overall Study|Death|0|||
163251915|NCT01786512|589631933|FG003|Overall Study|Death|0|||
163251916|NCT01786512|589631934|FG004|Overall Study|Death|0|||
163355931|NCT01006616|590013601|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
163355932|NCT01006616|590013602|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
163355933|NCT01006616|590013599|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
163355934|NCT01006616|590013600|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
163355935|NCT01006616|590013601|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
163355936|NCT01006616|590013602|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
163251917|NCT01786512|589631935|FG005|Overall Study|Death|0|||
163355937|NCT01006616|590013599|FG000|Period 1 (6 Months)|Not Treated|0|||
163355938|NCT01006616|590013600|FG001|Period 1 (6 Months)|Not Treated|0|||
163355939|NCT01006616|590013601|FG002|Period 1 (6 Months)|Not Treated|1|||
163355940|NCT01006616|590013602|FG003|Period 1 (6 Months)|Not Treated|1|||
163251918|NCT01786512|589631936|FG006|Overall Study|Death|0|||
163251919|NCT01786512|589631937|FG007|Overall Study|Death|0|||
163251920|NCT01786512|589631938|FG008|Overall Study|Death|4|||
163251921|NCT01786512|589631939|FG009|Overall Study|Death|1|||
163251922|NCT01786512|589631940|FG010|Overall Study|Death|3|||
163251923|NCT00605293|589631941|FG000|Overall Study|Death|2|||
163251924|NCT00605293|589631942|FG001|Overall Study|Death|1|||
163251925|NCT00605293|589631941|FG000|Overall Study|Insufficient Therapeutic Response|2|||
163251926|NCT00605293|589631942|FG001|Overall Study|Insufficient Therapeutic Response|0|||
163251927|NCT00605293|589631941|FG000|Overall Study|Adverse Event|1|||
163251928|NCT00605293|589631942|FG001|Overall Study|Adverse Event|0|||
163355941|NCT01006616|590013599|FG000|Period 2 (18 Months)|Adverse Event|6|||
163251929|NCT00605293|589631941|FG000|Overall Study|Holidays Dialysis Out|1|||
163251930|NCT00605293|589631942|FG001|Overall Study|Holidays Dialysis Out|0|||
163251931|NCT00605293|589631941|FG000|Overall Study|Blood Transfusion|7|||
163251932|NCT00605293|589631942|FG001|Overall Study|Blood Transfusion|1|||
163251933|NCT00605293|589631941|FG000|Overall Study|Renal Transplantation|3|||
163251934|NCT00605293|589631942|FG001|Overall Study|Renal Transplantation|1|||
163251935|NCT00605293|589631941|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
163251936|NCT00605293|589631942|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
163251937|NCT00605293|589631941|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
163251938|NCT00605293|589631942|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
163251939|NCT00605293|589631941|FG000|Overall Study|Principal Investigator Decision|0|||
163251940|NCT00605293|589631942|FG001|Overall Study|Principal Investigator Decision|1|||
163251941|NCT03581981|589631943|FG000|Overall Study|Withdrawal by Subject|12|||
163251942|NCT03581981|589631944|FG001|Overall Study|Withdrawal by Subject|13|||
163251943|NCT03581981|589631943|FG000|Overall Study|Physician Decision|1|||
163251944|NCT03581981|589631944|FG001|Overall Study|Physician Decision|2|||
163251945|NCT03581981|589631943|FG000|Overall Study|Lost to Follow-up|0|||
163251946|NCT03581981|589631944|FG001|Overall Study|Lost to Follow-up|4|||
163251947|NCT00781391|589631947|FG000|Overall Study|never received study drug|24|||
163251948|NCT00781391|589631948|FG001|Overall Study|never received study drug|23|||
163251949|NCT00781391|589631949|FG002|Overall Study|never received study drug|32|||
163251950|NCT00781391|589631947|FG000|Overall Study|Protocol Violation|19|||
163251951|NCT00781391|589631948|FG001|Overall Study|Protocol Violation|17|||
163251952|NCT00781391|589631949|FG002|Overall Study|Protocol Violation|20|||
163251953|NCT00781391|589631947|FG000|Overall Study|Death|789|||
163251954|NCT00781391|589631948|FG001|Overall Study|Death|730|||
163251955|NCT00781391|589631949|FG002|Overall Study|Death|706|||
163251956|NCT00781391|589631947|FG000|Overall Study|Withdrawal by Subject|47|||
163251957|NCT00781391|589631948|FG001|Overall Study|Withdrawal by Subject|37|||
163251958|NCT00781391|589631949|FG002|Overall Study|Withdrawal by Subject|25|||
163251959|NCT00781391|589631947|FG000|Overall Study|Lost to Follow-up|0|||
163251960|NCT00781391|589631948|FG001|Overall Study|Lost to Follow-up|0|||
163251961|NCT00781391|589631949|FG002|Overall Study|Lost to Follow-up|1|||
163251962|NCT01984684|589631950|FG000|Overall Study|Lost to Follow-up|25|||
163251963|NCT01984684|589631951|FG001|Overall Study|Lost to Follow-up|24|||
163251964|NCT01984684|589631950|FG000|Overall Study|Adverse Event|8|||
163251965|NCT01984684|589631951|FG001|Overall Study|Adverse Event|12|||
163251966|NCT01984684|589631950|FG000|Overall Study|Withdrawal by Subject|9|||
163251967|NCT01984684|589631951|FG001|Overall Study|Withdrawal by Subject|9|||
163251968|NCT01984684|589631950|FG000|Overall Study|Lack of Efficacy|3|||
163251969|NCT01984684|589631951|FG001|Overall Study|Lack of Efficacy|6|||
163251970|NCT01984684|589631950|FG000|Overall Study|Physician Decision|4|||
163251971|NCT01984684|589631951|FG001|Overall Study|Physician Decision|2|||
163251972|NCT01984684|589631950|FG000|Overall Study|Protocol Violation|4|||
163251973|NCT01984684|589631951|FG001|Overall Study|Protocol Violation|2|||
163251974|NCT01984684|589631950|FG000|Overall Study|Death|0|||
163251975|NCT01984684|589631951|FG001|Overall Study|Death|1|||
163251976|NCT01984684|589631950|FG000|Overall Study|Noncompliance with study drug|2|||
163251977|NCT01984684|589631951|FG001|Overall Study|Noncompliance with study drug|1|||
163251978|NCT01984684|589631950|FG000|Overall Study|Subject incarcerated|1|||
163251979|NCT01984684|589631951|FG001|Overall Study|Subject incarcerated|0|||
163251980|NCT01984684|589631950|FG000|Overall Study|Study drug not available at site|1|||
163355942|NCT01006616|590013600|FG001|Period 2 (18 Months)|Adverse Event|6|||
163355943|NCT01006616|590013601|FG002|Period 2 (18 Months)|Adverse Event|6|||
163355944|NCT01006616|590013602|FG003|Period 2 (18 Months)|Adverse Event|4|||
163251981|NCT01984684|589631951|FG001|Overall Study|Study drug not available at site|1|||
163251982|NCT01984684|589631950|FG000|Overall Study|Subject had inadequate IV access|0|||
163251983|NCT01984684|589631951|FG001|Overall Study|Subject had inadequate IV access|1|||
163251984|NCT03205371|589631961|FG000|Overall Study|Withdrawal by Subject|4|||
163251985|NCT03205371|589631962|FG001|Overall Study|Withdrawal by Subject|1|||
163251986|NCT03205371|589631963|FG002|Overall Study|Withdrawal by Subject|0|||
163251987|NCT03205371|589631964|FG003|Overall Study|Withdrawal by Subject|0|||
163251988|NCT03205371|589631965|FG004|Overall Study|Withdrawal by Subject|0|||
163251989|NCT03205371|589631966|FG005|Overall Study|Withdrawal by Subject|0|||
163251990|NCT03205371|589631967|FG006|Overall Study|Withdrawal by Subject|4|||
163251991|NCT03205371|589631968|FG007|Overall Study|Withdrawal by Subject|0|||
163251992|NCT03205371|589631969|FG008|Overall Study|Withdrawal by Subject|2|||
163251993|NCT03205371|589631970|FG009|Overall Study|Withdrawal by Subject|0|||
163251994|NCT03205371|589631971|FG010|Overall Study|Withdrawal by Subject|0|||
163251995|NCT03205371|589631972|FG011|Overall Study|Withdrawal by Subject|1|||
163251996|NCT03205371|589631961|FG000|Overall Study|Lost to Follow-up|0|||
163251997|NCT03205371|589631962|FG001|Overall Study|Lost to Follow-up|0|||
163251998|NCT03205371|589631963|FG002|Overall Study|Lost to Follow-up|0|||
163251999|NCT03205371|589631964|FG003|Overall Study|Lost to Follow-up|0|||
163252000|NCT03205371|589631965|FG004|Overall Study|Lost to Follow-up|0|||
163252001|NCT03205371|589631966|FG005|Overall Study|Lost to Follow-up|0|||
163252002|NCT03205371|589631967|FG006|Overall Study|Lost to Follow-up|5|||
163252003|NCT03205371|589631968|FG007|Overall Study|Lost to Follow-up|2|||
163252004|NCT03205371|589631969|FG008|Overall Study|Lost to Follow-up|3|||
163410404|NCT05103332|590211374|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163410405|NCT05103332|590211375|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163410406|NCT05103332|590211376|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163410407|NCT05103332|590211359|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410408|NCT05103332|590211360|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410409|NCT05103332|590211361|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410410|NCT05103332|590211362|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410411|NCT05103332|590211363|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410412|NCT05103332|590211364|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410413|NCT05103332|590211365|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410414|NCT05103332|590211366|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410415|NCT05103332|590211367|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
163410416|NCT05103332|590211368|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410417|NCT05103332|590211369|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410418|NCT05103332|590211370|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410419|NCT05103332|590211371|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410420|NCT05103332|590211372|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410421|NCT05103332|590211373|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410422|NCT05103332|590211374|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410423|NCT05103332|590211375|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410424|NCT05103332|590211376|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163410425|NCT05103332|590211359|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163410426|NCT05103332|590211360|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163410427|NCT05103332|590211361|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163410428|NCT05103332|590211362|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163410429|NCT05103332|590211363|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163355945|NCT01006616|590013599|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
163355946|NCT01006616|590013600|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
163355947|NCT01006616|590013601|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
163355948|NCT01006616|590013602|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
163355949|NCT01006616|590013599|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
163355950|NCT01006616|590013600|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
163355951|NCT01006616|590013601|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
163355952|NCT01006616|590013602|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
163355953|NCT01006616|590013599|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
163355954|NCT01006616|590013600|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
163355955|NCT01006616|590013601|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
163355956|NCT01006616|590013602|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
163355957|NCT01006616|590013599|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
163355958|NCT01006616|590013600|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
163355959|NCT01006616|590013601|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
163355960|NCT01006616|590013602|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
163355961|NCT01006616|590013599|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
163355962|NCT01006616|590013600|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
163355963|NCT01006616|590013601|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
163355964|NCT01006616|590013602|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
163355965|NCT01006616|590013599|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
163355966|NCT01006616|590013600|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
163355967|NCT01006616|590013601|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
163355968|NCT01006616|590013602|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
163355969|NCT01006616|590013599|FG000|Period 2 (18 Months)|Study Terminated|63|||
163355970|NCT01006616|590013600|FG001|Period 2 (18 Months)|Study Terminated|46|||
163355971|NCT01006616|590013601|FG002|Period 2 (18 Months)|Study Terminated|44|||
163355972|NCT01006616|590013602|FG003|Period 2 (18 Months)|Study Terminated|70|||
163355973|NCT03672175|590013603|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
163355974|NCT03672175|590013604|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
163355975|NCT03672175|590013605|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
163355976|NCT03672175|590013603|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
163355977|NCT03672175|590013604|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
163355978|NCT03672175|590013605|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
163355979|NCT03672175|590013603|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
163355980|NCT03672175|590013604|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
163410430|NCT05103332|590211364|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163355981|NCT03672175|590013605|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
163410431|NCT05103332|590211365|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163410432|NCT05103332|590211366|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163410433|NCT05103332|590211367|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163355982|NCT03672175|590013603|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
163410434|NCT05103332|590211368|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163410435|NCT05103332|590211369|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163410436|NCT05103332|590211370|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
163410437|NCT05103332|590211371|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163252005|NCT03205371|589631970|FG009|Overall Study|Lost to Follow-up|0|||
163252006|NCT03205371|589631971|FG010|Overall Study|Lost to Follow-up|0|||
163252007|NCT03205371|589631972|FG011|Overall Study|Lost to Follow-up|0|||
163252008|NCT03205371|589631961|FG000|Overall Study|Protocol Violation|0|||
163252009|NCT03205371|589631962|FG001|Overall Study|Protocol Violation|0|||
163252010|NCT03205371|589631963|FG002|Overall Study|Protocol Violation|0|||
163252011|NCT03205371|589631964|FG003|Overall Study|Protocol Violation|0|||
163252012|NCT03205371|589631965|FG004|Overall Study|Protocol Violation|0|||
163252013|NCT03205371|589631966|FG005|Overall Study|Protocol Violation|0|||
163252014|NCT03205371|589631967|FG006|Overall Study|Protocol Violation|1|||
163252015|NCT03205371|589631968|FG007|Overall Study|Protocol Violation|0|||
163252016|NCT03205371|589631969|FG008|Overall Study|Protocol Violation|0|||
163252017|NCT03205371|589631970|FG009|Overall Study|Protocol Violation|0|||
163252018|NCT03205371|589631971|FG010|Overall Study|Protocol Violation|0|||
163252019|NCT03205371|589631972|FG011|Overall Study|Protocol Violation|0|||
163252020|NCT03205371|589631961|FG000|Overall Study|Adverse Event|0|||
163252021|NCT03205371|589631962|FG001|Overall Study|Adverse Event|0|||
163252022|NCT03205371|589631963|FG002|Overall Study|Adverse Event|0|||
163252023|NCT03205371|589631964|FG003|Overall Study|Adverse Event|0|||
163252024|NCT03205371|589631965|FG004|Overall Study|Adverse Event|0|||
163252025|NCT03205371|589631966|FG005|Overall Study|Adverse Event|0|||
163252026|NCT03205371|589631967|FG006|Overall Study|Adverse Event|0|||
163252027|NCT03205371|589631968|FG007|Overall Study|Adverse Event|1|||
163252028|NCT03205371|589631969|FG008|Overall Study|Adverse Event|0|||
163252029|NCT03205371|589631970|FG009|Overall Study|Adverse Event|0|||
163252030|NCT03205371|589631971|FG010|Overall Study|Adverse Event|0|||
163252031|NCT03205371|589631972|FG011|Overall Study|Adverse Event|0|||
163252032|NCT02835339|589631973|FG000|Overall Study|Did not receive allocated intervention|13|||
163252033|NCT02835339|589631974|FG001|Overall Study|Did not receive allocated intervention|16|||
163252034|NCT01077544|589631975|FG000|Overall Study|New Cancer Therapy|3|||
163252035|NCT01077544|589631976|FG001|Overall Study|New Cancer Therapy|3|||
163252036|NCT01077544|589631975|FG000|Overall Study|Adverse Event|0|||
163252037|NCT01077544|589631976|FG001|Overall Study|Adverse Event|1|||
163252038|NCT01077544|589631975|FG000|Overall Study|Disease Progression|0|||
163252039|NCT01077544|589631976|FG001|Overall Study|Disease Progression|1|||
163252040|NCT00295022|589631978|FG000|Overall Study|Adverse Event|1|||
163252041|NCT00295022|589631979|FG001|Overall Study|Adverse Event|1|||
163252042|NCT00295022|589631980|FG002|Overall Study|Adverse Event|2|||
163252043|NCT00295022|589631978|FG000|Overall Study|Lost to Follow-up|0|||
163252044|NCT00295022|589631979|FG001|Overall Study|Lost to Follow-up|0|||
163252045|NCT00295022|589631980|FG002|Overall Study|Lost to Follow-up|1|||
163252046|NCT00295022|589631978|FG000|Overall Study|Withdrawal by Subject|0|||
163252047|NCT00295022|589631979|FG001|Overall Study|Withdrawal by Subject|0|||
163252048|NCT00295022|589631980|FG002|Overall Study|Withdrawal by Subject|2|||
163252049|NCT00734630|589631982|FG000|Overall Study|Lack of Efficacy|4|||
163252050|NCT00734630|589631983|FG001|Overall Study|Lack of Efficacy|4|||
163252051|NCT00734630|589631982|FG000|Overall Study|Withdrawal by Subject|7|||
163252052|NCT00734630|589631983|FG001|Overall Study|Withdrawal by Subject|9|||
163252053|NCT00734630|589631982|FG000|Overall Study|Lost to Follow-up|13|||
163252054|NCT00734630|589631983|FG001|Overall Study|Lost to Follow-up|7|||
163252055|NCT00734630|589631982|FG000|Overall Study|Protocol Violation|0|||
163252056|NCT00734630|589631983|FG001|Overall Study|Protocol Violation|3|||
163252057|NCT00734630|589631982|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
163252058|NCT00734630|589631983|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
163252059|NCT00734630|589631982|FG000|Overall Study|Adverse Event|3|||
163252060|NCT00734630|589631983|FG001|Overall Study|Adverse Event|6|||
163252061|NCT00734630|589631982|FG000|Overall Study|Randomized in Error|0|||
163252062|NCT00734630|589631983|FG001|Overall Study|Randomized in Error|1|||
163410438|NCT05103332|590211372|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163252063|NCT00734630|589631982|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
163252064|NCT00734630|589631983|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
163252065|NCT00734630|589631982|FG000|Overall Study|Poor Compliance|1|||
163252066|NCT00734630|589631983|FG001|Overall Study|Poor Compliance|1|||
163252067|NCT01239030|589631984|FG000|Double Blind|Adverse Event|0|||
163252068|NCT01239030|589631985|FG001|Double Blind|Adverse Event|1|||
163252069|NCT01239030|589631986|FG002|Double Blind|Adverse Event|0|||
163252070|NCT01239030|589631987|FG003|Double Blind|Adverse Event|2|||
163252071|NCT01239030|589631988|FG004|Double Blind|Adverse Event|0|||
163252072|NCT01239030|589631984|FG000|Double Blind|Withdrawal by Subject|0|||
163252073|NCT01239030|589631985|FG001|Double Blind|Withdrawal by Subject|1|||
163252074|NCT01239030|589631986|FG002|Double Blind|Withdrawal by Subject|1|||
163252075|NCT01239030|589631987|FG003|Double Blind|Withdrawal by Subject|0|||
163252076|NCT01239030|589631988|FG004|Double Blind|Withdrawal by Subject|1|||
163410439|NCT05103332|590211373|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163355983|NCT03672175|590013604|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
163355984|NCT03672175|590013605|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
163355985|NCT03672175|590013603|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
163355986|NCT03672175|590013604|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
163355987|NCT03672175|590013605|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
163355988|NCT03672175|590013603|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
163355989|NCT03672175|590013604|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
163355990|NCT03672175|590013605|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
163355991|NCT03672175|590013603|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
163355992|NCT03672175|590013604|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
163355993|NCT03672175|590013605|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
163355994|NCT03672175|590013603|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
163355995|NCT03672175|590013604|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
163355996|NCT03672175|590013605|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
163355997|NCT03672175|590013603|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
163355998|NCT03672175|590013604|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
163252077|NCT01239030|589631984|FG000|Double Blind|Lost to Follow-up|1|||
163252078|NCT01239030|589631985|FG001|Double Blind|Lost to Follow-up|1|||
163252079|NCT01239030|589631986|FG002|Double Blind|Lost to Follow-up|0|||
163252080|NCT01239030|589631987|FG003|Double Blind|Lost to Follow-up|0|||
163252081|NCT01239030|589631988|FG004|Double Blind|Lost to Follow-up|0|||
163252082|NCT01239030|589631984|FG000|Double Blind|Physician Decision|0|||
163252083|NCT01239030|589631985|FG001|Double Blind|Physician Decision|1|||
163252084|NCT01239030|589631986|FG002|Double Blind|Physician Decision|0|||
163252085|NCT01239030|589631987|FG003|Double Blind|Physician Decision|0|||
163252086|NCT01239030|589631988|FG004|Double Blind|Physician Decision|0|||
163252087|NCT01239030|589631984|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
163252088|NCT01239030|589631985|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
163252089|NCT01239030|589631986|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
163252090|NCT01239030|589631987|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
163252091|NCT01239030|589631988|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
163252092|NCT01239030|589631984|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
163252093|NCT01239030|589631985|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
163252094|NCT01239030|589631986|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
163252095|NCT01239030|589631987|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
163252096|NCT01239030|589631988|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
163252097|NCT01239030|589631984|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
163252098|NCT01239030|589631985|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
163252099|NCT01239030|589631986|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
163252100|NCT01239030|589631987|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
163252101|NCT01239030|589631988|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
163252102|NCT01239030|589631984|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
163252103|NCT01239030|589631985|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
163252104|NCT01239030|589631986|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
163252105|NCT01239030|589631987|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
163252106|NCT01239030|589631988|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
163252107|NCT04403698|589631989|FG000|Overall Study|Adverse Event|1|||
163252108|NCT04403698|589631990|FG001|Overall Study|Adverse Event|1|||
163252109|NCT04403698|589631989|FG000|Overall Study|Lost to Follow-up|1|||
163252110|NCT04403698|589631990|FG001|Overall Study|Lost to Follow-up|0|||
163252111|NCT04403698|589631989|FG000|Overall Study|Protocol Violation|0|||
163252112|NCT04403698|589631990|FG001|Overall Study|Protocol Violation|1|||
163252113|NCT00977665|589631991|FG000|Overall Study|Withdrawal by Subject|1|||
163252114|NCT00977665|589631992|FG001|Overall Study|Withdrawal by Subject|3|||
163252115|NCT00977665|589631991|FG000|Overall Study|Physician Decision|2|||
163252116|NCT00977665|589631992|FG001|Overall Study|Physician Decision|1|||
163252117|NCT00977665|589631991|FG000|Overall Study|Sponsor requested withdrawal|0|||
163252118|NCT00977665|589631992|FG001|Overall Study|Sponsor requested withdrawal|1|||
163252119|NCT00977665|589631991|FG000|Overall Study|Lost to Follow-up|1|||
163252120|NCT00977665|589631992|FG001|Overall Study|Lost to Follow-up|0|||
163355999|NCT03672175|590013605|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
163252121|NCT00977665|589631991|FG000|Overall Study|Death|3|||
163356000|NCT03672175|590013603|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
163252122|NCT00977665|589631992|FG001|Overall Study|Death|2|||
163252123|NCT00977665|589631991|FG000|Overall Study|Adverse Event|14|||
163356001|NCT03672175|590013604|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
163356002|NCT03672175|590013605|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
163356003|NCT03672175|590013603|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
163252124|NCT00977665|589631992|FG001|Overall Study|Adverse Event|7|||
163252125|NCT00977665|589631991|FG000|Overall Study|Treatment failure|0|||
163252126|NCT00977665|589631992|FG001|Overall Study|Treatment failure|1|||
163252127|NCT01330433|589631993|FG000|Overall Study|Death|1|||
163252128|NCT01330433|589631994|FG001|Overall Study|Death|3|||
163252129|NCT01330433|589631993|FG000|Overall Study|Lost to Follow-up|1|||
163252130|NCT01330433|589631994|FG001|Overall Study|Lost to Follow-up|0|||
163252131|NCT00441090|589631997|FG000|Overall Study|Adverse Event|0|||
163252132|NCT00441090|589631998|FG001|Overall Study|Adverse Event|1|||
163252133|NCT00441090|589631999|FG002|Overall Study|Adverse Event|1|||
163252134|NCT00441090|589632000|FG003|Overall Study|Adverse Event|0|||
163252135|NCT00441090|589632001|FG004|Overall Study|Adverse Event|0|||
163252136|NCT00441090|589631997|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
163252137|NCT00441090|589631998|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
163252138|NCT00441090|589631999|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
163252139|NCT00441090|589632000|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
163252140|NCT00441090|589632001|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
163252141|NCT00441090|589631997|FG000|Overall Study|Withdrawal by Subject|1|||
163252142|NCT00441090|589631998|FG001|Overall Study|Withdrawal by Subject|0|||
163252143|NCT00441090|589631999|FG002|Overall Study|Withdrawal by Subject|1|||
163252144|NCT00441090|589632000|FG003|Overall Study|Withdrawal by Subject|0|||
163252145|NCT00441090|589632001|FG004|Overall Study|Withdrawal by Subject|0|||
163252146|NCT00441090|589631997|FG000|Overall Study|Lack of Efficacy|1|||
163252147|NCT00441090|589631998|FG001|Overall Study|Lack of Efficacy|0|||
163252148|NCT00441090|589631999|FG002|Overall Study|Lack of Efficacy|0|||
163252149|NCT00441090|589632000|FG003|Overall Study|Lack of Efficacy|0|||
163252150|NCT00441090|589632001|FG004|Overall Study|Lack of Efficacy|0|||
163252151|NCT01441102|589632002|FG000|Overall Study|Adverse Event|1|||
163252152|NCT01441102|589632002|FG000|Overall Study|Withdrawal by Subject|2|||
163252153|NCT00518115|589632006|FG000|Overall Study|Adverse Event|6|||
163252154|NCT00518115|589632007|FG001|Overall Study|Adverse Event|1|||
163252155|NCT00518115|589632008|FG002|Overall Study|Adverse Event|5|||
163252156|NCT00518115|589632009|FG003|Overall Study|Adverse Event|6|||
163252157|NCT00518115|589632010|FG004|Overall Study|Adverse Event|5|||
163252158|NCT00518115|589632011|FG005|Overall Study|Adverse Event|5|||
163252159|NCT00518115|589632012|FG006|Overall Study|Adverse Event|5|||
163252160|NCT00518115|589632013|FG007|Overall Study|Adverse Event|10|||
163252161|NCT00518115|589632014|FG008|Overall Study|Adverse Event|2|||
163252162|NCT00518115|589632015|FG009|Overall Study|Adverse Event|9|||
163252163|NCT00518115|589632006|FG000|Overall Study|Lost to Follow-up|0|||
163252164|NCT00518115|589632007|FG001|Overall Study|Lost to Follow-up|0|||
163252165|NCT00518115|589632008|FG002|Overall Study|Lost to Follow-up|2|||
163252166|NCT00518115|589632009|FG003|Overall Study|Lost to Follow-up|3|||
163252167|NCT00518115|589632010|FG004|Overall Study|Lost to Follow-up|1|||
163252168|NCT00518115|589632011|FG005|Overall Study|Lost to Follow-up|3|||
163252169|NCT00518115|589632012|FG006|Overall Study|Lost to Follow-up|0|||
163252170|NCT00518115|589632013|FG007|Overall Study|Lost to Follow-up|1|||
163252171|NCT00518115|589632014|FG008|Overall Study|Lost to Follow-up|1|||
163252172|NCT00518115|589632015|FG009|Overall Study|Lost to Follow-up|1|||
163252173|NCT00518115|589632006|FG000|Overall Study|Protocol Violation|1|||
163252174|NCT00518115|589632007|FG001|Overall Study|Protocol Violation|3|||
163252175|NCT00518115|589632008|FG002|Overall Study|Protocol Violation|1|||
163252176|NCT00518115|589632009|FG003|Overall Study|Protocol Violation|0|||
163252177|NCT00518115|589632010|FG004|Overall Study|Protocol Violation|0|||
163252178|NCT00518115|589632011|FG005|Overall Study|Protocol Violation|0|||
163252179|NCT00518115|589632012|FG006|Overall Study|Protocol Violation|0|||
163252180|NCT00518115|589632013|FG007|Overall Study|Protocol Violation|0|||
163252181|NCT00518115|589632014|FG008|Overall Study|Protocol Violation|0|||
163252182|NCT00518115|589632015|FG009|Overall Study|Protocol Violation|0|||
163252183|NCT00518115|589632006|FG000|Overall Study|Withdrawal by Subject|1|||
163252184|NCT00518115|589632007|FG001|Overall Study|Withdrawal by Subject|1|||
163252185|NCT00518115|589632008|FG002|Overall Study|Withdrawal by Subject|5|||
163252186|NCT00518115|589632009|FG003|Overall Study|Withdrawal by Subject|0|||
163252187|NCT00518115|589632010|FG004|Overall Study|Withdrawal by Subject|2|||
163252188|NCT00518115|589632011|FG005|Overall Study|Withdrawal by Subject|1|||
163252189|NCT00518115|589632012|FG006|Overall Study|Withdrawal by Subject|0|||
163252190|NCT00518115|589632013|FG007|Overall Study|Withdrawal by Subject|2|||
163252191|NCT00518115|589632014|FG008|Overall Study|Withdrawal by Subject|1|||
163252192|NCT00518115|589632015|FG009|Overall Study|Withdrawal by Subject|3|||
163252193|NCT00518115|589632006|FG000|Overall Study|Lack of Efficacy|1|||
163252194|NCT00518115|589632007|FG001|Overall Study|Lack of Efficacy|0|||
163252195|NCT00518115|589632008|FG002|Overall Study|Lack of Efficacy|1|||
163252196|NCT00518115|589632009|FG003|Overall Study|Lack of Efficacy|1|||
163252197|NCT00518115|589632010|FG004|Overall Study|Lack of Efficacy|0|||
163252198|NCT00518115|589632011|FG005|Overall Study|Lack of Efficacy|0|||
163252199|NCT00518115|589632012|FG006|Overall Study|Lack of Efficacy|0|||
163252200|NCT00518115|589632013|FG007|Overall Study|Lack of Efficacy|1|||
163356004|NCT03672175|590013604|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
163252201|NCT00518115|589632014|FG008|Overall Study|Lack of Efficacy|0|||
163252202|NCT00518115|589632015|FG009|Overall Study|Lack of Efficacy|0|||
163252203|NCT00518115|589632006|FG000|Overall Study|Non-Compliance|1|||
163252204|NCT00518115|589632007|FG001|Overall Study|Non-Compliance|0|||
163252205|NCT00518115|589632008|FG002|Overall Study|Non-Compliance|1|||
163356005|NCT03672175|590013605|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
163356006|NCT03672175|590013603|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
163356007|NCT03672175|590013604|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
163356008|NCT03672175|590013605|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
163356009|NCT03410108|590013607|FG000|Overall Study|Ongoing|41|||
163356010|NCT03410108|590013607|FG000|Overall Study|Adverse Event|4|||
163356011|NCT03410108|590013607|FG000|Overall Study|Progressive Disease|58|||
163356012|NCT03410108|590013607|FG000|Overall Study|Withdrawal by Subject|1|||
163356013|NCT01313624|590013608|FG000|Double-Blind Phase|Adverse Event|27|||
163356014|NCT01313624|590013609|FG001|Double-Blind Phase|Adverse Event|4|||
163356015|NCT01313624|590013608|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
163356016|NCT01313624|590013609|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
163356017|NCT01313624|590013608|FG000|Double-Blind Phase|Lost to Follow-up|0|||
163356018|NCT01313624|590013609|FG001|Double-Blind Phase|Lost to Follow-up|2|||
163356019|NCT01313624|590013608|FG000|Double-Blind Phase|Physician Decision|1|||
163356020|NCT01313624|590013609|FG001|Double-Blind Phase|Physician Decision|0|||
163356021|NCT01313624|590013608|FG000|Double-Blind Phase|Lack of Efficacy|1|||
163356022|NCT01313624|590013609|FG001|Double-Blind Phase|Lack of Efficacy|0|||
163356023|NCT01313624|590013608|FG000|Open-Label Phase|Adverse Event|1|||
163356024|NCT01313624|590013609|FG001|Open-Label Phase|Adverse Event|10|||
163356025|NCT01313624|590013608|FG000|Open-Label Phase|Withdrawal by Subject|2|||
163356026|NCT01313624|590013609|FG001|Open-Label Phase|Withdrawal by Subject|2|||
163356027|NCT01313624|590013608|FG000|Open-Label Phase|Lost to Follow-up|1|||
163356028|NCT01313624|590013609|FG001|Open-Label Phase|Lost to Follow-up|1|||
163356029|NCT03599622|590013610|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
163356030|NCT03599622|590013611|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
163356031|NCT03599622|590013612|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
163356032|NCT03599622|590013613|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
163356033|NCT03599622|590013610|FG000|Pre-Treatment Period|Other reasons|1|||
163356034|NCT03599622|590013611|FG001|Pre-Treatment Period|Other reasons|1|||
163356035|NCT03599622|590013612|FG002|Pre-Treatment Period|Other reasons|1|||
163356036|NCT03599622|590013613|FG003|Pre-Treatment Period|Other reasons|0|||
163356037|NCT03599622|590013610|FG000|Treatment Period|Adverse Event|11|||
163356038|NCT03599622|590013611|FG001|Treatment Period|Adverse Event|20|||
163356039|NCT03599622|590013612|FG002|Treatment Period|Adverse Event|18|||
163356040|NCT03599622|590013613|FG003|Treatment Period|Adverse Event|2|||
163356041|NCT03599622|590013610|FG000|Treatment Period|Lack of Efficacy|18|||
163356042|NCT03599622|590013611|FG001|Treatment Period|Lack of Efficacy|12|||
163356043|NCT03599622|590013612|FG002|Treatment Period|Lack of Efficacy|13|||
163356044|NCT03599622|590013613|FG003|Treatment Period|Lack of Efficacy|2|||
163356045|NCT03599622|590013610|FG000|Treatment Period|Withdrawal by Subject|5|||
163356046|NCT03599622|590013611|FG001|Treatment Period|Withdrawal by Subject|11|||
163356047|NCT03599622|590013612|FG002|Treatment Period|Withdrawal by Subject|16|||
163356048|NCT03599622|590013613|FG003|Treatment Period|Withdrawal by Subject|1|||
163356049|NCT03599622|590013610|FG000|Treatment Period|Other reasons|4|||
163356050|NCT03599622|590013611|FG001|Treatment Period|Other reasons|6|||
163356051|NCT03599622|590013612|FG002|Treatment Period|Other reasons|7|||
163356052|NCT03599622|590013613|FG003|Treatment Period|Other reasons|0|||
163356053|NCT03599622|590013610|FG000|Treatment Period|Lost to Follow-up|1|||
163356054|NCT03599622|590013611|FG001|Treatment Period|Lost to Follow-up|0|||
163356055|NCT03599622|590013612|FG002|Treatment Period|Lost to Follow-up|0|||
163356056|NCT03599622|590013613|FG003|Treatment Period|Lost to Follow-up|0|||
163356057|NCT03599622|590013610|FG000|Treatment Period|Study terminated by sponsor|7|||
163356058|NCT03599622|590013611|FG001|Treatment Period|Study terminated by sponsor|20|||
163356059|NCT03599622|590013612|FG002|Treatment Period|Study terminated by sponsor|15|||
163356060|NCT03599622|590013613|FG003|Treatment Period|Study terminated by sponsor|0|||
163356061|NCT03599622|590013610|FG000|Treatment Period|Site terminated by sponsor|0|||
163356062|NCT03599622|590013611|FG001|Treatment Period|Site terminated by sponsor|1|||
163356063|NCT03599622|590013612|FG002|Treatment Period|Site terminated by sponsor|0|||
163356064|NCT03599622|590013613|FG003|Treatment Period|Site terminated by sponsor|0|||
163356065|NCT02654132|590013614|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
163356066|NCT02654132|590013615|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
163356067|NCT02654132|590013614|FG000|Treatment Period|Disease progression|43|||
163356068|NCT02654132|590013615|FG001|Treatment Period|Disease progression|38|||
163356069|NCT02654132|590013614|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
163356070|NCT02654132|590013615|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
163356071|NCT02654132|590013614|FG000|Treatment Period|Other reasons|4|||
163356072|NCT02654132|590013615|FG001|Treatment Period|Other reasons|2|||
163356073|NCT02654132|590013614|FG000|Treatment Period|Study drug toxicity|2|||
163356074|NCT02654132|590013615|FG001|Treatment Period|Study drug toxicity|2|||
163356075|NCT02654132|590013614|FG000|Treatment Period|Withdrawal by Subject|2|||
163356076|NCT02654132|590013615|FG001|Treatment Period|Withdrawal by Subject|1|||
163356077|NCT02654132|590013614|FG000|Treatment Period|Maximum Clinical Benefit|0|||
163356078|NCT02654132|590013615|FG001|Treatment Period|Maximum Clinical Benefit|2|||
163356079|NCT02654132|590013614|FG000|Treatment Period|Participant request to discontinue|2|||
163252206|NCT00518115|589632009|FG003|Overall Study|Non-Compliance|0|||
163252207|NCT00518115|589632010|FG004|Overall Study|Non-Compliance|1|||
163252208|NCT00518115|589632011|FG005|Overall Study|Non-Compliance|1|||
163252209|NCT00518115|589632012|FG006|Overall Study|Non-Compliance|1|||
163252210|NCT00518115|589632013|FG007|Overall Study|Non-Compliance|1|||
163252211|NCT00518115|589632014|FG008|Overall Study|Non-Compliance|0|||
163252212|NCT00518115|589632015|FG009|Overall Study|Non-Compliance|1|||
163252213|NCT00518115|589632006|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
163252214|NCT00518115|589632007|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
163252215|NCT00518115|589632008|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
163252216|NCT00518115|589632009|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
163252217|NCT00518115|589632010|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
163252218|NCT00518115|589632011|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
163252219|NCT00518115|589632012|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
163252220|NCT00518115|589632013|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
163252221|NCT00518115|589632014|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
163252222|NCT00518115|589632015|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
163252223|NCT00518115|589632006|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
163252224|NCT00518115|589632007|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163252225|NCT00518115|589632008|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163252226|NCT00518115|589632009|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163252227|NCT00518115|589632010|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163252228|NCT00518115|589632011|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163252229|NCT00518115|589632012|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163252230|NCT00518115|589632013|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163252231|NCT00518115|589632014|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163252232|NCT00518115|589632015|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163252233|NCT00518115|589632006|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
163252234|NCT00518115|589632007|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
163252235|NCT00518115|589632008|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
163252236|NCT00518115|589632009|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
163252237|NCT00518115|589632010|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
163252238|NCT00518115|589632011|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
163252239|NCT00518115|589632012|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
163252240|NCT00518115|589632013|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
163252241|NCT00518115|589632014|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
163252242|NCT00518115|589632015|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
163252243|NCT00518115|589632006|FG000|Overall Study|Wrong Monotherapy Administered|0|||
163252244|NCT00518115|589632007|FG001|Overall Study|Wrong Monotherapy Administered|0|||
163252245|NCT00518115|589632008|FG002|Overall Study|Wrong Monotherapy Administered|1|||
163252246|NCT00518115|589632009|FG003|Overall Study|Wrong Monotherapy Administered|0|||
163252247|NCT00518115|589632010|FG004|Overall Study|Wrong Monotherapy Administered|0|||
163252248|NCT00518115|589632011|FG005|Overall Study|Wrong Monotherapy Administered|0|||
163252249|NCT00518115|589632012|FG006|Overall Study|Wrong Monotherapy Administered|1|||
163252250|NCT00518115|589632013|FG007|Overall Study|Wrong Monotherapy Administered|0|||
163252251|NCT00518115|589632014|FG008|Overall Study|Wrong Monotherapy Administered|0|||
163252252|NCT00518115|589632015|FG009|Overall Study|Wrong Monotherapy Administered|0|||
163252253|NCT00518115|589632006|FG000|Overall Study|Violation of Exclusion Criteria|0|||
163252254|NCT00518115|589632007|FG001|Overall Study|Violation of Exclusion Criteria|0|||
163252255|NCT00518115|589632008|FG002|Overall Study|Violation of Exclusion Criteria|0|||
163252256|NCT00518115|589632009|FG003|Overall Study|Violation of Exclusion Criteria|1|||
163252257|NCT00518115|589632010|FG004|Overall Study|Violation of Exclusion Criteria|0|||
163252258|NCT00518115|589632011|FG005|Overall Study|Violation of Exclusion Criteria|0|||
163252259|NCT00518115|589632012|FG006|Overall Study|Violation of Exclusion Criteria|1|||
163252260|NCT00518115|589632013|FG007|Overall Study|Violation of Exclusion Criteria|0|||
163252261|NCT00518115|589632014|FG008|Overall Study|Violation of Exclusion Criteria|0|||
163252262|NCT00518115|589632015|FG009|Overall Study|Violation of Exclusion Criteria|0|||
163252263|NCT00518115|589632006|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
163252264|NCT00518115|589632007|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
163252265|NCT00518115|589632008|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
163252266|NCT00518115|589632009|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
163252267|NCT00518115|589632010|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
163252268|NCT00518115|589632011|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
163252269|NCT00518115|589632012|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
163252270|NCT00518115|589632013|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
163252271|NCT00518115|589632014|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
163252272|NCT00518115|589632015|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
163356080|NCT02654132|590013615|FG001|Treatment Period|Participant request to discontinue|0|||
163356081|NCT02654132|590013614|FG000|Treatment Period|Administrative reasons by sponsor|0|||
163252273|NCT00518115|589632006|FG000|Overall Study|Withdrew Consent|0|||
163252274|NCT00518115|589632007|FG001|Overall Study|Withdrew Consent|0|||
163252275|NCT00518115|589632008|FG002|Overall Study|Withdrew Consent|0|||
163252276|NCT00518115|589632009|FG003|Overall Study|Withdrew Consent|0|||
163252277|NCT00518115|589632010|FG004|Overall Study|Withdrew Consent|0|||
163252278|NCT00518115|589632011|FG005|Overall Study|Withdrew Consent|1|||
163252279|NCT00518115|589632012|FG006|Overall Study|Withdrew Consent|0|||
163252280|NCT00518115|589632013|FG007|Overall Study|Withdrew Consent|0|||
163252281|NCT00518115|589632014|FG008|Overall Study|Withdrew Consent|0|||
163252282|NCT00518115|589632015|FG009|Overall Study|Withdrew Consent|0|||
163252283|NCT00518115|589632006|FG000|Overall Study|Moved Out of State|0|||
163252284|NCT00518115|589632007|FG001|Overall Study|Moved Out of State|0|||
163252285|NCT00518115|589632008|FG002|Overall Study|Moved Out of State|0|||
163252286|NCT00518115|589632009|FG003|Overall Study|Moved Out of State|0|||
163252287|NCT00518115|589632010|FG004|Overall Study|Moved Out of State|0|||
163252288|NCT00518115|589632011|FG005|Overall Study|Moved Out of State|0|||
163252289|NCT00518115|589632012|FG006|Overall Study|Moved Out of State|0|||
163252290|NCT00518115|589632013|FG007|Overall Study|Moved Out of State|0|||
163252291|NCT00518115|589632014|FG008|Overall Study|Moved Out of State|0|||
163252292|NCT00518115|589632015|FG009|Overall Study|Moved Out of State|1|||
163252293|NCT04891419|589632016|FG000|Overall Study|Withdrawal by Subject|4|||
163252294|NCT04891419|589632017|FG001|Overall Study|Withdrawal by Subject|0|||
163252295|NCT04891419|589632016|FG000|Overall Study|Lost to Follow-up|1|||
163252296|NCT04891419|589632017|FG001|Overall Study|Lost to Follow-up|3|||
163252297|NCT00802074|589632021|FG000|Overall Study|Adverse Event|1|||
163252298|NCT00802074|589632022|FG001|Overall Study|Adverse Event|1|||
163252299|NCT00802074|589632023|FG002|Overall Study|Adverse Event|1|||
163252300|NCT00802074|589632024|FG003|Overall Study|Adverse Event|0|||
163252301|NCT00802074|589632025|FG004|Overall Study|Adverse Event|0|||
163252302|NCT00802074|589632026|FG005|Overall Study|Adverse Event|0|||
163252303|NCT00802074|589632021|FG000|Overall Study|Withdrawal by Subject|1|||
163252304|NCT00802074|589632022|FG001|Overall Study|Withdrawal by Subject|0|||
163252305|NCT00802074|589632023|FG002|Overall Study|Withdrawal by Subject|0|||
163252306|NCT00802074|589632024|FG003|Overall Study|Withdrawal by Subject|0|||
163252307|NCT00802074|589632025|FG004|Overall Study|Withdrawal by Subject|0|||
163252308|NCT00802074|589632026|FG005|Overall Study|Withdrawal by Subject|0|||
163252309|NCT00827918|589632027|FG000|Overall Study|Adverse Event|4|||
163252310|NCT00827918|589632028|FG001|Overall Study|Adverse Event|0|||
163252311|NCT00827918|589632029|FG002|Overall Study|Adverse Event|0|||
163252312|NCT00827918|589632027|FG000|Overall Study|Lack of Efficacy|16|||
163252313|NCT00827918|589632028|FG001|Overall Study|Lack of Efficacy|4|||
163252314|NCT00827918|589632029|FG002|Overall Study|Lack of Efficacy|15|||
163252315|NCT00827918|589632027|FG000|Overall Study|Physician Decision|1|||
163252316|NCT00827918|589632028|FG001|Overall Study|Physician Decision|0|||
163252317|NCT00827918|589632029|FG002|Overall Study|Physician Decision|0|||
163252318|NCT00827918|589632027|FG000|Overall Study|Pregnancy|0|||
163252319|NCT00827918|589632028|FG001|Overall Study|Pregnancy|1|||
163252320|NCT00827918|589632029|FG002|Overall Study|Pregnancy|0|||
163252321|NCT00827918|589632027|FG000|Overall Study|Progressive Disease|1|||
163252322|NCT00827918|589632028|FG001|Overall Study|Progressive Disease|1|||
163252323|NCT00827918|589632029|FG002|Overall Study|Progressive Disease|0|||
163252324|NCT00827918|589632027|FG000|Overall Study|Protocol Violation|0|||
163252325|NCT00827918|589632028|FG001|Overall Study|Protocol Violation|1|||
163252326|NCT00827918|589632029|FG002|Overall Study|Protocol Violation|0|||
163252327|NCT00827918|589632027|FG000|Overall Study|Withdrawal by Subject|6|||
163252328|NCT00827918|589632028|FG001|Overall Study|Withdrawal by Subject|2|||
163252329|NCT00827918|589632029|FG002|Overall Study|Withdrawal by Subject|6|||
163252330|NCT00843167|589632032|FG000|Treatment Period|Adverse Event|1|||
163252331|NCT00843167|589632033|FG001|Treatment Period|Adverse Event|5|||
163252332|NCT00843167|589632032|FG000|Treatment Period|Withdrawal by Subject|2|||
163252333|NCT00843167|589632033|FG001|Treatment Period|Withdrawal by Subject|3|||
163252334|NCT02291614|589632034|FG000|Overall Study|Lost to Follow-up|0|||
163252335|NCT02291614|589632035|FG001|Overall Study|Lost to Follow-up|0|||
163252336|NCT02291614|589632036|FG002|Overall Study|Lost to Follow-up|0|||
163252337|NCT02291614|589632037|FG003|Overall Study|Lost to Follow-up|0|||
163356082|NCT02654132|590013615|FG001|Treatment Period|Administrative reasons by sponsor|1|||
163252338|NCT02291614|589632038|FG004|Overall Study|Lost to Follow-up|0|||
163252339|NCT02291614|589632039|FG005|Overall Study|Lost to Follow-up|0|||
163252340|NCT02291614|589632040|FG006|Overall Study|Lost to Follow-up|0|||
163356083|NCT02654132|590013614|FG000|Treatment Period|Death|1|||
163356084|NCT02654132|590013615|FG001|Treatment Period|Death|0|||
163252341|NCT02291614|589632041|FG007|Overall Study|Lost to Follow-up|1|||
163252342|NCT02291614|589632042|FG008|Overall Study|Lost to Follow-up|0|||
163252343|NCT02291614|589632043|FG009|Overall Study|Lost to Follow-up|0|||
163252344|NCT02291614|589632044|FG010|Overall Study|Lost to Follow-up|0|||
163252345|NCT02291614|589632034|FG000|Overall Study|Withdrawal by Subject|0|||
163252346|NCT02291614|589632035|FG001|Overall Study|Withdrawal by Subject|1|||
163252347|NCT02291614|589632036|FG002|Overall Study|Withdrawal by Subject|0|||
163252348|NCT02291614|589632037|FG003|Overall Study|Withdrawal by Subject|0|||
163356085|NCT02485899|590013616|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
163252349|NCT02291614|589632038|FG004|Overall Study|Withdrawal by Subject|0|||
163252350|NCT02291614|589632039|FG005|Overall Study|Withdrawal by Subject|0|||
163252351|NCT02291614|589632040|FG006|Overall Study|Withdrawal by Subject|0|||
163252352|NCT02291614|589632041|FG007|Overall Study|Withdrawal by Subject|0|||
163252353|NCT02291614|589632042|FG008|Overall Study|Withdrawal by Subject|0|||
163252354|NCT02291614|589632043|FG009|Overall Study|Withdrawal by Subject|2|||
163252355|NCT02291614|589632044|FG010|Overall Study|Withdrawal by Subject|2|||
163252356|NCT02291614|589632034|FG000|Overall Study|Decision by sponsor|0|||
163252357|NCT02291614|589632035|FG001|Overall Study|Decision by sponsor|0|||
163252358|NCT02291614|589632036|FG002|Overall Study|Decision by sponsor|0|||
163252359|NCT02291614|589632037|FG003|Overall Study|Decision by sponsor|1|||
163252360|NCT02291614|589632038|FG004|Overall Study|Decision by sponsor|0|||
163252361|NCT02291614|589632039|FG005|Overall Study|Decision by sponsor|0|||
163252362|NCT02291614|589632040|FG006|Overall Study|Decision by sponsor|0|||
163252363|NCT02291614|589632041|FG007|Overall Study|Decision by sponsor|0|||
163252364|NCT02291614|589632042|FG008|Overall Study|Decision by sponsor|0|||
163252365|NCT02291614|589632043|FG009|Overall Study|Decision by sponsor|0|||
163252366|NCT02291614|589632044|FG010|Overall Study|Decision by sponsor|0|||
163252367|NCT02291614|589632034|FG000|Overall Study|Death|0|||
163252368|NCT02291614|589632035|FG001|Overall Study|Death|0|||
163252369|NCT02291614|589632036|FG002|Overall Study|Death|1|||
163252370|NCT02291614|589632037|FG003|Overall Study|Death|0|||
163252371|NCT02291614|589632038|FG004|Overall Study|Death|1|||
163252372|NCT02291614|589632039|FG005|Overall Study|Death|1|||
163252373|NCT02291614|589632040|FG006|Overall Study|Death|1|||
163252374|NCT02291614|589632041|FG007|Overall Study|Death|0|||
163252375|NCT02291614|589632042|FG008|Overall Study|Death|0|||
163252376|NCT02291614|589632043|FG009|Overall Study|Death|0|||
163252377|NCT02291614|589632044|FG010|Overall Study|Death|0|||
163252378|NCT00127101|589632045|FG000|Base Protocol|Adverse Event|0|||
163252379|NCT00127101|589632046|FG001|Base Protocol|Adverse Event|2|||
163252380|NCT00127101|589632047|FG002|Base Protocol|Adverse Event|1|||
163252381|NCT00127101|589632048|FG003|Base Protocol|Adverse Event|0|||
163252382|NCT00127101|589632049|FG004|Base Protocol|Adverse Event|0|||
163252383|NCT00127101|589632050|FG005|Base Protocol|Adverse Event|0|||
163252384|NCT00127101|589632045|FG000|Base Protocol|Lack of Efficacy|1|||
163252385|NCT00127101|589632046|FG001|Base Protocol|Lack of Efficacy|0|||
163252386|NCT00127101|589632047|FG002|Base Protocol|Lack of Efficacy|0|||
163252387|NCT00127101|589632048|FG003|Base Protocol|Lack of Efficacy|0|||
163252388|NCT00127101|589632049|FG004|Base Protocol|Lack of Efficacy|2|||
163252389|NCT00127101|589632050|FG005|Base Protocol|Lack of Efficacy|0|||
163252390|NCT00127101|589632045|FG000|Base Protocol|Withdrawal by Subject|1|||
163252391|NCT00127101|589632046|FG001|Base Protocol|Withdrawal by Subject|2|||
163252392|NCT00127101|589632047|FG002|Base Protocol|Withdrawal by Subject|1|||
163252393|NCT00127101|589632048|FG003|Base Protocol|Withdrawal by Subject|0|||
163252394|NCT00127101|589632049|FG004|Base Protocol|Withdrawal by Subject|0|||
163252395|NCT00127101|589632050|FG005|Base Protocol|Withdrawal by Subject|1|||
163252396|NCT00127101|589632045|FG000|Continuation Phase|Adverse Event|0|||
163252397|NCT00127101|589632046|FG001|Continuation Phase|Adverse Event|0|||
163252398|NCT00127101|589632047|FG002|Continuation Phase|Adverse Event|0|||
163252399|NCT00127101|589632048|FG003|Continuation Phase|Adverse Event|0|||
163252400|NCT00127101|589632049|FG004|Continuation Phase|Adverse Event|1|||
163252401|NCT00127101|589632050|FG005|Continuation Phase|Adverse Event|1|||
163252402|NCT00127101|589632045|FG000|Continuation Phase|Lack of Efficacy|0|||
163252403|NCT00127101|589632046|FG001|Continuation Phase|Lack of Efficacy|0|||
163252404|NCT00127101|589632047|FG002|Continuation Phase|Lack of Efficacy|0|||
163252405|NCT00127101|589632048|FG003|Continuation Phase|Lack of Efficacy|0|||
163252406|NCT00127101|589632049|FG004|Continuation Phase|Lack of Efficacy|0|||
163252407|NCT00127101|589632050|FG005|Continuation Phase|Lack of Efficacy|1|||
163252408|NCT00127101|589632045|FG000|Continuation Phase|Withdrawal by Subject|0|||
163252409|NCT00127101|589632046|FG001|Continuation Phase|Withdrawal by Subject|0|||
163252410|NCT00127101|589632047|FG002|Continuation Phase|Withdrawal by Subject|1|||
163356086|NCT02485899|590013617|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163356087|NCT02485899|590013616|FG000|Overall Study|Withdrawal by Subject|1|||
163356088|NCT02485899|590013617|FG001|Overall Study|Withdrawal by Subject|0|||
163356089|NCT02485899|590013616|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
163252411|NCT00127101|589632048|FG003|Continuation Phase|Withdrawal by Subject|0|||
163252412|NCT00127101|589632049|FG004|Continuation Phase|Withdrawal by Subject|2|||
163252413|NCT00127101|589632050|FG005|Continuation Phase|Withdrawal by Subject|1|||
163252414|NCT03743038|589632051|FG000|Overall Study|Physician Decision|1|||
163252415|NCT01830127|589632052|FG000|Overall Study|Adverse Event|1|||
163252416|NCT01830127|589632053|FG001|Overall Study|Adverse Event|6|||
163356090|NCT02485899|590013617|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
163356091|NCT01006889|590013618|FG000|Overall Study|Withdrawal by Subject|3|||
163252417|NCT01830127|589632052|FG000|Overall Study|Lack of Efficacy|3|||
163252418|NCT01830127|589632053|FG001|Overall Study|Lack of Efficacy|0|||
163252419|NCT01830127|589632052|FG000|Overall Study|Withdrawal by Subject|1|||
163252420|NCT01830127|589632053|FG001|Overall Study|Withdrawal by Subject|1|||
163252421|NCT01830127|589632052|FG000|Overall Study|Other reason not defined above|0|||
163356092|NCT00623363|590013619|FG000|Overall Study|Adverse Event|2|||
163356093|NCT00623363|590013620|FG001|Overall Study|Adverse Event|2|||
163356094|NCT04706793|590013621|FG000|Treatment|Disease worsening|10|||
163356095|NCT04706793|590013622|FG001|Treatment|Disease worsening|10|||
163356096|NCT04706793|590013621|FG000|Follow-up|Lack of Efficacy|1|||
163356097|NCT04706793|590013622|FG001|Follow-up|Lack of Efficacy|0|||
163356098|NCT04706793|590013621|FG000|Follow-up|Disease worsening|8|||
163356099|NCT04706793|590013622|FG001|Follow-up|Disease worsening|10|||
163356100|NCT04706793|590013621|FG000|Follow-up|Adverse Event|1|||
163356101|NCT04706793|590013622|FG001|Follow-up|Adverse Event|0|||
163356102|NCT00823836|590013623|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
163356103|NCT00823836|590013624|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
163356104|NCT00823836|590013623|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
163356105|NCT00823836|590013624|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
163356106|NCT00823836|590013623|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
163356107|NCT00823836|590013624|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
163356108|NCT00823836|590013623|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
163356109|NCT00823836|590013624|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
163356110|NCT00823836|590013623|FG000|Long-term Phase|Adverse Event|3|||
163356111|NCT00823836|590013624|FG001|Long-term Phase|Adverse Event|2|||
163356112|NCT00823836|590013623|FG000|Long-term Phase|Physician Decision|1|||
163356113|NCT00823836|590013624|FG001|Long-term Phase|Physician Decision|2|||
163356114|NCT00823836|590013623|FG000|Long-term Phase|Withdrawal by Subject|1|||
163356115|NCT00823836|590013624|FG001|Long-term Phase|Withdrawal by Subject|1|||
163356116|NCT01130168|590013625|FG000|Period 1|Withdrawal by Subject|0|||
163356117|NCT01130168|590013626|FG001|Period 1|Withdrawal by Subject|1|||
163356118|NCT01130168|590013627|FG002|Period 1|Withdrawal by Subject|0|||
163356119|NCT01130168|590013628|FG003|Period 1|Withdrawal by Subject|1|||
163356120|NCT01130168|590013629|FG004|Period 1|Withdrawal by Subject|0|||
163356121|NCT01130168|590013630|FG005|Period 1|Withdrawal by Subject|0|||
163356122|NCT01130168|590013625|FG000|Period 1|Discontinued For Other Reason|0|||
163356123|NCT01130168|590013626|FG001|Period 1|Discontinued For Other Reason|0|||
163356124|NCT01130168|590013627|FG002|Period 1|Discontinued For Other Reason|1|||
163356125|NCT01130168|590013628|FG003|Period 1|Discontinued For Other Reason|1|||
163356126|NCT01130168|590013629|FG004|Period 1|Discontinued For Other Reason|0|||
163356127|NCT01130168|590013630|FG005|Period 1|Discontinued For Other Reason|0|||
163356128|NCT01130168|590013625|FG000|Period 1|Adverse Event|0|||
163356129|NCT01130168|590013626|FG001|Period 1|Adverse Event|0|||
163356130|NCT01130168|590013627|FG002|Period 1|Adverse Event|0|||
163356131|NCT01130168|590013628|FG003|Period 1|Adverse Event|1|||
163356132|NCT01130168|590013629|FG004|Period 1|Adverse Event|0|||
163356133|NCT01130168|590013630|FG005|Period 1|Adverse Event|0|||
163356134|NCT04354168|590013631|FG000|Overall Study|Lost to Follow-up|22|||
163356135|NCT01781832|590013632|FG000|Overall Study|Withdrawal by Subject|1|||
163356136|NCT02287233|590013633|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
163356137|NCT02287233|590013634|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
163356138|NCT02287233|590013635|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
163356139|NCT02287233|590013633|FG000|Overall Study|Adverse Event Related to Progression|0|||
163356140|NCT02287233|590013634|FG001|Overall Study|Adverse Event Related to Progression|2|||
163356141|NCT02287233|590013635|FG002|Overall Study|Adverse Event Related to Progression|8|||
163356142|NCT02287233|590013633|FG000|Overall Study|Physician Decision|1|||
163356143|NCT02287233|590013634|FG001|Overall Study|Physician Decision|2|||
163356144|NCT02287233|590013635|FG002|Overall Study|Physician Decision|4|||
163356145|NCT02287233|590013633|FG000|Overall Study|Progressive Disease with Death|0|||
163356146|NCT02287233|590013634|FG001|Overall Study|Progressive Disease with Death|0|||
163356147|NCT02287233|590013635|FG002|Overall Study|Progressive Disease with Death|10|||
163356148|NCT02287233|590013633|FG000|Overall Study|Progressive Disease Without Death|2|||
163356149|NCT02287233|590013634|FG001|Overall Study|Progressive Disease Without Death|3|||
163356150|NCT02287233|590013635|FG002|Overall Study|Progressive Disease Without Death|20|||
163356151|NCT02287233|590013633|FG000|Overall Study|Withdrawal by Subject|1|||
163356152|NCT02287233|590013634|FG001|Overall Study|Withdrawal by Subject|1|||
163356153|NCT02287233|590013635|FG002|Overall Study|Withdrawal by Subject|7|||
163356154|NCT02287233|590013633|FG000|Overall Study|Other|3|||
163356155|NCT02287233|590013634|FG001|Overall Study|Other|0|||
163356156|NCT02287233|590013635|FG002|Overall Study|Other|15|||
163356157|NCT02287233|590013633|FG000|Overall Study|Did Not Receive Treatment|0|||
163356158|NCT02287233|590013634|FG001|Overall Study|Did Not Receive Treatment|0|||
163356159|NCT02287233|590013635|FG002|Overall Study|Did Not Receive Treatment|2|||
163356160|NCT02804399|590013638|FG000|Period 2|Adverse Event|0|||
163356161|NCT02804399|590013639|FG001|Period 2|Adverse Event|1|||
163356162|NCT02058836|590013640|FG000|Overall Study|Withdrawal by Subject|1|||
163356163|NCT02058836|590013641|FG001|Overall Study|Withdrawal by Subject|1|||
163356164|NCT00573651|590013643|FG000|Overall Study|Lost to Follow-up|3|||
163356165|NCT00573651|590013643|FG000|Overall Study|Withdrawal by Subject|1|||
163356166|NCT01225159|590013644|FG000|Overall Study|Change operation|1|||
163356167|NCT01225159|590013645|FG001|Overall Study|Change operation|0|||
163356168|NCT01220856|590013650|FG000|Overall Study|graft loss|3|||
163410440|NCT05103332|590211374|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163410441|NCT05103332|590211375|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163410442|NCT05103332|590211376|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163410443|NCT05103332|590211359|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163410444|NCT05103332|590211360|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163410445|NCT05103332|590211361|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163150668|NCT03486912|589265327|FG001|Treatment Period|Lost to Follow-up|0|||
163150669|NCT03486912|589265328|FG002|Treatment Period|Lost to Follow-up|0|||
163150670|NCT03486912|589265329|FG003|Treatment Period|Lost to Follow-up|2|||
163150671|NCT02491684|589265330|FG000|Treatment Phase|Adverse Event|2|||
163150672|NCT02491684|589265331|FG001|Treatment Phase|Adverse Event|2|||
163150673|NCT02491684|589265330|FG000|Treatment Phase|Incorrect randomisation|1|||
163150674|NCT02491684|589265331|FG001|Treatment Phase|Incorrect randomisation|0|||
163150675|NCT02491684|589265330|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
163150676|NCT02491684|589265331|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
163150677|NCT01149096|589265332|FG000|Overall Study|Lost to Follow-up|0|||
163150678|NCT01149096|589265333|FG001|Overall Study|Lost to Follow-up|1|||
163150679|NCT01263769|589265334|FG000|Overall Study|Non-Compliant with treatment|1|||
163150680|NCT03267277|589265335|FG000|Overall Study|Withdrawal by Subject|1|||
163150681|NCT00468169|589265336|FG000|Overall Study|Withdrawal by Subject|1|||
163150682|NCT00468169|589265337|FG001|Overall Study|Withdrawal by Subject|0|||
163150683|NCT01126749|589265342|FG000|Phase 1b|Other|0|||
163150684|NCT01126749|589265343|FG001|Phase 1b|Other|1|||
163150685|NCT01126749|589265344|FG002|Phase 1b|Other|0|||
163150686|NCT01126749|589265345|FG003|Phase 1b|Other|0|||
163150687|NCT01126749|589265342|FG000|Phase 1b|Withdrawal by Subject|0|||
163150688|NCT01126749|589265343|FG001|Phase 1b|Withdrawal by Subject|1|||
163150689|NCT01126749|589265344|FG002|Phase 1b|Withdrawal by Subject|0|||
163150690|NCT01126749|589265345|FG003|Phase 1b|Withdrawal by Subject|0|||
163150691|NCT01126749|589265342|FG000|Phase 1b|Death|3|||
163150692|NCT01126749|589265343|FG001|Phase 1b|Death|4|||
163150693|NCT01126749|589265344|FG002|Phase 1b|Death|0|||
163150694|NCT01126749|589265345|FG003|Phase 1b|Death|0|||
163150695|NCT01126749|589265342|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
163150696|NCT01126749|589265343|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
163150697|NCT01126749|589265344|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
163150698|NCT01126749|589265345|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
163150699|NCT01126749|589265342|FG000|Phase 2|Study Termination by Sponsor|0|||
163150700|NCT01126749|589265343|FG001|Phase 2|Study Termination by Sponsor|0|||
163150701|NCT01126749|589265344|FG002|Phase 2|Study Termination by Sponsor|12|||
163150702|NCT01126749|589265345|FG003|Phase 2|Study Termination by Sponsor|6|||
163150703|NCT01126749|589265342|FG000|Phase 2|Other|0|||
163150704|NCT01126749|589265343|FG001|Phase 2|Other|0|||
163150705|NCT01126749|589265344|FG002|Phase 2|Other|4|||
163150706|NCT01126749|589265345|FG003|Phase 2|Other|2|||
163150707|NCT01126749|589265342|FG000|Phase 2|Withdrawal by Subject|0|||
163150708|NCT01126749|589265343|FG001|Phase 2|Withdrawal by Subject|0|||
163150709|NCT01126749|589265344|FG002|Phase 2|Withdrawal by Subject|0|||
163150710|NCT01126749|589265345|FG003|Phase 2|Withdrawal by Subject|2|||
163150711|NCT01126749|589265342|FG000|Phase 2|Lost to Follow-up|0|||
163150712|NCT01126749|589265343|FG001|Phase 2|Lost to Follow-up|0|||
163150713|NCT01126749|589265344|FG002|Phase 2|Lost to Follow-up|0|||
163150714|NCT01126749|589265345|FG003|Phase 2|Lost to Follow-up|1|||
163150715|NCT01126749|589265342|FG000|Phase 2|Death|0|||
163150716|NCT01126749|589265343|FG001|Phase 2|Death|0|||
163150717|NCT01126749|589265344|FG002|Phase 2|Death|22|||
163150718|NCT01126749|589265345|FG003|Phase 2|Death|22|||
163150719|NCT01126749|589265342|FG000|Phase 2|Adverse Event|0|||
163150720|NCT01126749|589265343|FG001|Phase 2|Adverse Event|0|||
163150721|NCT01126749|589265344|FG002|Phase 2|Adverse Event|0|||
163150722|NCT01126749|589265345|FG003|Phase 2|Adverse Event|1|||
163150723|NCT03668873|589265346|FG000|Overall Study|Lost to Follow-up|6|||
163150724|NCT03668873|589265347|FG001|Overall Study|Lost to Follow-up|3|||
163150725|NCT02183675|589265348|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
163150726|NCT02183675|589265349|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
163150727|NCT02183675|589265350|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
163150728|NCT02183675|589265351|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
163150729|NCT02183675|589265352|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
163150730|NCT02183675|589265353|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
163150731|NCT01521117|589265354|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
163150732|NCT01521117|589265355|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
163150733|NCT01521117|589265354|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
163410446|NCT05103332|590211362|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163150734|NCT01521117|589265355|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
163150735|NCT01521117|589265354|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
163150736|NCT01521117|589265355|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
163150737|NCT00784563|589265358|FG000|Years 1 & 2|Withdrawal by Subject|3|||
163150738|NCT00784563|589265359|FG001|Years 1 & 2|Withdrawal by Subject|2|||
163150739|NCT00784563|589265360|FG002|Years 1 & 2|Withdrawal by Subject|0|||
163252422|NCT01830127|589632053|FG001|Overall Study|Other reason not defined above|2|||
163252423|NCT01302847|589632056|FG000|Overall Study|Death|0|||
163252424|NCT01302847|589632057|FG001|Overall Study|Death|1|||
163252425|NCT01302847|589632058|FG002|Overall Study|Death|0|||
163252426|NCT01302847|589632059|FG003|Overall Study|Death|0|||
163252427|NCT01302847|589632060|FG004|Overall Study|Death|0|||
163252428|NCT01302847|589632061|FG005|Overall Study|Death|1|||
163252429|NCT01302847|589632062|FG006|Overall Study|Death|1|||
163252430|NCT01302847|589632063|FG007|Overall Study|Death|0|||
163252431|NCT01302847|589632056|FG000|Overall Study|Pregnancy|2|||
163252432|NCT01302847|589632057|FG001|Overall Study|Pregnancy|0|||
163252433|NCT01302847|589632058|FG002|Overall Study|Pregnancy|0|||
163252434|NCT01302847|589632059|FG003|Overall Study|Pregnancy|0|||
163252435|NCT01302847|589632060|FG004|Overall Study|Pregnancy|0|||
163252436|NCT01302847|589632061|FG005|Overall Study|Pregnancy|0|||
163252437|NCT01302847|589632062|FG006|Overall Study|Pregnancy|0|||
163252438|NCT01302847|589632063|FG007|Overall Study|Pregnancy|0|||
163252439|NCT01302847|589632056|FG000|Overall Study|Virologic failure|0|||
163252440|NCT01302847|589632057|FG001|Overall Study|Virologic failure|2|||
163252441|NCT01302847|589632058|FG002|Overall Study|Virologic failure|0|||
163252442|NCT01302847|589632059|FG003|Overall Study|Virologic failure|2|||
163252443|NCT01302847|589632060|FG004|Overall Study|Virologic failure|1|||
163252444|NCT01302847|589632061|FG005|Overall Study|Virologic failure|3|||
163252445|NCT01302847|589632062|FG006|Overall Study|Virologic failure|1|||
163252446|NCT01302847|589632063|FG007|Overall Study|Virologic failure|2|||
163252447|NCT01302847|589632056|FG000|Overall Study|Severe debilitation, unable to continue|0|||
163252448|NCT01302847|589632057|FG001|Overall Study|Severe debilitation, unable to continue|0|||
163252449|NCT01302847|589632058|FG002|Overall Study|Severe debilitation, unable to continue|0|||
163252450|NCT01302847|589632059|FG003|Overall Study|Severe debilitation, unable to continue|0|||
163252451|NCT01302847|589632060|FG004|Overall Study|Severe debilitation, unable to continue|0|||
163252452|NCT01302847|589632061|FG005|Overall Study|Severe debilitation, unable to continue|1|||
163252453|NCT01302847|589632062|FG006|Overall Study|Severe debilitation, unable to continue|1|||
163252454|NCT01302847|589632063|FG007|Overall Study|Severe debilitation, unable to continue|0|||
163252455|NCT01302847|589632056|FG000|Overall Study|Not able to get to clinic|1|||
163252456|NCT01302847|589632057|FG001|Overall Study|Not able to get to clinic|1|||
163252457|NCT01302847|589632058|FG002|Overall Study|Not able to get to clinic|0|||
163252458|NCT01302847|589632059|FG003|Overall Study|Not able to get to clinic|0|||
163252459|NCT01302847|589632060|FG004|Overall Study|Not able to get to clinic|0|||
163252460|NCT01302847|589632061|FG005|Overall Study|Not able to get to clinic|0|||
163252461|NCT01302847|589632062|FG006|Overall Study|Not able to get to clinic|0|||
163252462|NCT01302847|589632063|FG007|Overall Study|Not able to get to clinic|0|||
163252463|NCT01302847|589632056|FG000|Overall Study|Site closing|2|||
163252464|NCT01302847|589632057|FG001|Overall Study|Site closing|2|||
163252465|NCT01302847|589632058|FG002|Overall Study|Site closing|0|||
163252466|NCT01302847|589632059|FG003|Overall Study|Site closing|0|||
163252467|NCT01302847|589632060|FG004|Overall Study|Site closing|0|||
163252468|NCT01302847|589632061|FG005|Overall Study|Site closing|0|||
163252469|NCT01302847|589632062|FG006|Overall Study|Site closing|0|||
163252470|NCT01302847|589632063|FG007|Overall Study|Site closing|0|||
163252471|NCT01302847|589632056|FG000|Overall Study|Withdrawal by Subject|1|||
163252472|NCT01302847|589632057|FG001|Overall Study|Withdrawal by Subject|0|||
163252473|NCT01302847|589632058|FG002|Overall Study|Withdrawal by Subject|0|||
163252474|NCT01302847|589632059|FG003|Overall Study|Withdrawal by Subject|0|||
163252475|NCT01302847|589632060|FG004|Overall Study|Withdrawal by Subject|1|||
163252476|NCT01302847|589632061|FG005|Overall Study|Withdrawal by Subject|0|||
163252477|NCT01302847|589632062|FG006|Overall Study|Withdrawal by Subject|0|||
163252478|NCT01302847|589632063|FG007|Overall Study|Withdrawal by Subject|1|||
163252479|NCT01302847|589632056|FG000|Overall Study|Not willing to adhere to requirements|5|||
163252480|NCT01302847|589632057|FG001|Overall Study|Not willing to adhere to requirements|0|||
163252481|NCT01302847|589632058|FG002|Overall Study|Not willing to adhere to requirements|1|||
163252482|NCT01302847|589632059|FG003|Overall Study|Not willing to adhere to requirements|0|||
163252483|NCT01302847|589632060|FG004|Overall Study|Not willing to adhere to requirements|0|||
163252484|NCT01302847|589632061|FG005|Overall Study|Not willing to adhere to requirements|0|||
163252485|NCT01302847|589632062|FG006|Overall Study|Not willing to adhere to requirements|0|||
163252486|NCT01302847|589632063|FG007|Overall Study|Not willing to adhere to requirements|2|||
163252487|NCT01302847|589632056|FG000|Overall Study|Site unable to contact participant|2|||
163252488|NCT01302847|589632057|FG001|Overall Study|Site unable to contact participant|1|||
163252489|NCT01302847|589632058|FG002|Overall Study|Site unable to contact participant|0|||
163252490|NCT01302847|589632059|FG003|Overall Study|Site unable to contact participant|0|||
163252491|NCT01302847|589632060|FG004|Overall Study|Site unable to contact participant|0|||
163252492|NCT01302847|589632061|FG005|Overall Study|Site unable to contact participant|0|||
163252493|NCT01302847|589632062|FG006|Overall Study|Site unable to contact participant|2|||
163252494|NCT01302847|589632063|FG007|Overall Study|Site unable to contact participant|0|||
163252495|NCT01565707|589632064|FG000|Overall Study|Adverse Event|1|||
163252496|NCT01565707|589632065|FG001|Overall Study|Adverse Event|6|||
163252497|NCT01565707|589632066|FG002|Overall Study|Adverse Event|2|||
163356169|NCT01220856|590013651|FG001|Overall Study|graft loss|3|||
163356170|NCT01220856|590013650|FG000|Overall Study|Lost to Follow-up|1|||
163356171|NCT01220856|590013651|FG001|Overall Study|Lost to Follow-up|0|||
163356172|NCT04814992|590013652|FG000|Overall Study|Withdrawal by Subject|6|||
163356173|NCT04814992|590013653|FG001|Overall Study|Withdrawal by Subject|3|||
163356174|NCT04814992|590013652|FG000|Overall Study|Lost to Follow-up|1|||
163356175|NCT04814992|590013653|FG001|Overall Study|Lost to Follow-up|4|||
163356176|NCT00691678|590013654|FG000|Overall Study|Adverse Event|5|||
163356177|NCT00691678|590013654|FG000|Overall Study|life events, pain|11|||
163356178|NCT02188784|590013656|FG000|Overall Study|Death|3|||
163356179|NCT02188784|590013657|FG001|Overall Study|Death|1|||
163356180|NCT02188784|590013656|FG000|Overall Study|Lost to Follow-up|1|||
163356181|NCT02188784|590013657|FG001|Overall Study|Lost to Follow-up|0|||
163252498|NCT01565707|589632067|FG003|Overall Study|Adverse Event|1|||
163252499|NCT01565707|589632064|FG000|Overall Study|Lost to Follow-up|1|||
163252500|NCT01565707|589632065|FG001|Overall Study|Lost to Follow-up|0|||
163252501|NCT01565707|589632066|FG002|Overall Study|Lost to Follow-up|0|||
163252502|NCT01565707|589632067|FG003|Overall Study|Lost to Follow-up|0|||
163252503|NCT01565707|589632064|FG000|Overall Study|Protocol Violation|1|||
163252504|NCT01565707|589632065|FG001|Overall Study|Protocol Violation|0|||
163252505|NCT01565707|589632066|FG002|Overall Study|Protocol Violation|0|||
163252506|NCT01565707|589632067|FG003|Overall Study|Protocol Violation|1|||
163252507|NCT01565707|589632064|FG000|Overall Study|Withdrawal by Subject|3|||
163252508|NCT01565707|589632065|FG001|Overall Study|Withdrawal by Subject|1|||
163252509|NCT01565707|589632066|FG002|Overall Study|Withdrawal by Subject|1|||
163252510|NCT01565707|589632067|FG003|Overall Study|Withdrawal by Subject|1|||
163252511|NCT01565707|589632064|FG000|Overall Study|Randomized but not evaluable|2|||
163252512|NCT01565707|589632065|FG001|Overall Study|Randomized but not evaluable|0|||
163252513|NCT01565707|589632066|FG002|Overall Study|Randomized but not evaluable|0|||
163252514|NCT01565707|589632067|FG003|Overall Study|Randomized but not evaluable|0|||
163252515|NCT01565707|589632064|FG000|Overall Study|Miscellaneous|1|||
163252516|NCT01565707|589632065|FG001|Overall Study|Miscellaneous|1|||
163252517|NCT01565707|589632066|FG002|Overall Study|Miscellaneous|0|||
163252518|NCT01565707|589632067|FG003|Overall Study|Miscellaneous|2|||
163252519|NCT01371851|589632068|FG000|Overall Study|Lost to Follow-up|5|||
163252520|NCT01371851|589632069|FG001|Overall Study|Lost to Follow-up|8|||
163252521|NCT01371851|589632068|FG000|Overall Study|was arrested and put in jail|0|||
163252522|NCT01371851|589632069|FG001|Overall Study|was arrested and put in jail|1|||
163252523|NCT01371851|589632068|FG000|Overall Study|non study related adverse event|1|||
163252524|NCT01371851|589632069|FG001|Overall Study|non study related adverse event|0|||
163252525|NCT01371851|589632068|FG000|Overall Study|Blood Pressure outside study parameters|2|||
163252526|NCT01371851|589632069|FG001|Overall Study|Blood Pressure outside study parameters|0|||
163252527|NCT03969719|589632080|FG000|Overall Study|Other reasons not specified|1|||
163252528|NCT03969719|589632081|FG001|Overall Study|Other reasons not specified|1|||
163252529|NCT03969719|589632082|FG002|Overall Study|Other reasons not specified|3|||
163252530|NCT03969719|589632080|FG000|Overall Study|Withdrawal by Subject|2|||
163252531|NCT03969719|589632081|FG001|Overall Study|Withdrawal by Subject|3|||
163252532|NCT03969719|589632082|FG002|Overall Study|Withdrawal by Subject|2|||
163252533|NCT03969719|589632080|FG000|Overall Study|Protocol Violation|1|||
163252534|NCT03969719|589632081|FG001|Overall Study|Protocol Violation|2|||
163252535|NCT03969719|589632082|FG002|Overall Study|Protocol Violation|0|||
163252536|NCT03969719|589632080|FG000|Overall Study|Adverse Event|0|||
163252537|NCT03969719|589632081|FG001|Overall Study|Adverse Event|2|||
163252538|NCT03969719|589632082|FG002|Overall Study|Adverse Event|0|||
163252539|NCT03969719|589632080|FG000|Overall Study|Lost to Follow-up|0|||
163252540|NCT03969719|589632081|FG001|Overall Study|Lost to Follow-up|1|||
163252541|NCT03969719|589632082|FG002|Overall Study|Lost to Follow-up|0|||
163252542|NCT05608629|589632083|FG000|Overall Study|Lost to Follow-up|2|||
163252543|NCT02130193|589632084|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
163252544|NCT02130193|589632085|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
163252545|NCT02130193|589632086|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
163252546|NCT02130193|589632084|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
163252547|NCT02130193|589632085|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
163252548|NCT02130193|589632086|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
163252549|NCT02130193|589632084|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
163252550|NCT02130193|589632085|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
163252551|NCT02130193|589632086|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
163252552|NCT02130193|589632084|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
163252553|NCT02130193|589632085|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
163252554|NCT02130193|589632086|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
163252555|NCT01212770|589632087|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
163252556|NCT01212770|589632088|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
163252557|NCT01212770|589632089|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
163252558|NCT01212770|589632090|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163356182|NCT02188784|590013656|FG000|Overall Study|Withdrawal by Subject|3|||
163356183|NCT02188784|590013657|FG001|Overall Study|Withdrawal by Subject|9|||
163356184|NCT02188784|590013656|FG000|Overall Study|Physician Decision|2|||
163356185|NCT02188784|590013657|FG001|Overall Study|Physician Decision|3|||
163356186|NCT01568112|590013660|FG000|Overall Study|Randomized But Not Treated|0|||
163356187|NCT01568112|590013661|FG001|Overall Study|Randomized But Not Treated|1|||
163356188|NCT01568112|590013662|FG002|Overall Study|Randomized But Not Treated|0|||
163356189|NCT01568112|590013663|FG003|Overall Study|Randomized But Not Treated|0|||
163356190|NCT01568112|590013660|FG000|Overall Study|Withdrew due to Adverse Event|2|||
163356191|NCT01568112|590013661|FG001|Overall Study|Withdrew due to Adverse Event|4|||
163356192|NCT01568112|590013662|FG002|Overall Study|Withdrew due to Adverse Event|6|||
163356193|NCT01568112|590013663|FG003|Overall Study|Withdrew due to Adverse Event|3|||
163356194|NCT01568112|590013660|FG000|Overall Study|Lost to Follow-up|0|||
163356195|NCT01568112|590013661|FG001|Overall Study|Lost to Follow-up|0|||
163356196|NCT01568112|590013662|FG002|Overall Study|Lost to Follow-up|0|||
163356197|NCT01568112|590013663|FG003|Overall Study|Lost to Follow-up|1|||
163356198|NCT01568112|590013660|FG000|Overall Study|Withdrawal by Subject|2|||
163356199|NCT01568112|590013661|FG001|Overall Study|Withdrawal by Subject|3|||
163356200|NCT01568112|590013662|FG002|Overall Study|Withdrawal by Subject|0|||
163356201|NCT01568112|590013663|FG003|Overall Study|Withdrawal by Subject|7|||
163356202|NCT01568112|590013660|FG000|Overall Study|Withdrawal by Physician|1|||
163356203|NCT01568112|590013661|FG001|Overall Study|Withdrawal by Physician|0|||
163356204|NCT01568112|590013662|FG002|Overall Study|Withdrawal by Physician|1|||
163356205|NCT01568112|590013663|FG003|Overall Study|Withdrawal by Physician|1|||
163356206|NCT00903760|590015753|FG000|Overall Study|Disease Progression/Death|8|||
163356207|NCT00903760|590015754|FG001|Overall Study|Disease Progression/Death|6|||
163356208|NCT00903760|590015753|FG000|Overall Study|Stem Cell Transplant|8|||
163356209|NCT00903760|590015754|FG001|Overall Study|Stem Cell Transplant|4|||
163356210|NCT00903760|590015753|FG000|Overall Study|Physician Decision|1|||
163356211|NCT00903760|590015754|FG001|Overall Study|Physician Decision|2|||
163356212|NCT00903760|590015753|FG000|Overall Study|Death|0|||
163356213|NCT00903760|590015754|FG001|Overall Study|Death|1|||
163356214|NCT00903760|590015753|FG000|Overall Study|Lost to Follow-up|1|||
163150740|NCT00784563|589265358|FG000|Years 1 & 2|Adverse Event|0|||
163150741|NCT00784563|589265359|FG001|Years 1 & 2|Adverse Event|3|||
163150742|NCT00784563|589265360|FG002|Years 1 & 2|Adverse Event|0|||
163150743|NCT00784563|589265358|FG000|Year 3|Withdrawal by Subject|0|||
163150744|NCT00784563|589265359|FG001|Year 3|Withdrawal by Subject|0|||
163150745|NCT00784563|589265360|FG002|Year 3|Withdrawal by Subject|2|||
163150746|NCT00784563|589265358|FG000|Year 3|Adverse Event|0|||
163150747|NCT00784563|589265359|FG001|Year 3|Adverse Event|0|||
163150748|NCT00784563|589265360|FG002|Year 3|Adverse Event|1|||
163150749|NCT00762164|589265361|FG000|Overall Study|Lost to Follow-up|1|||
163150750|NCT00762164|589265362|FG001|Overall Study|Lost to Follow-up|1|||
163150751|NCT00762164|589265361|FG000|Overall Study|Discontinued medication|2|||
163150752|NCT00762164|589265362|FG001|Overall Study|Discontinued medication|0|||
163150753|NCT00762164|589265361|FG000|Overall Study|Withdrawal by Subject|0|||
163150754|NCT00762164|589265362|FG001|Overall Study|Withdrawal by Subject|1|||
163150755|NCT02657889|589265369|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
163150756|NCT02657889|589265370|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
163150757|NCT02657889|589265371|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
163150758|NCT02657889|589265372|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
163150759|NCT02657889|589265369|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
163150760|NCT02657889|589265370|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
163150761|NCT02657889|589265371|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
163150762|NCT02657889|589265372|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
163356215|NCT00903760|590015754|FG001|Overall Study|Lost to Follow-up|0|||
163150763|NCT02657889|589265369|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
163150764|NCT02657889|589265370|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
163150765|NCT02657889|589265371|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
163150766|NCT02657889|589265372|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
163150767|NCT02657889|589265369|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
163150768|NCT02657889|589265370|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
163150769|NCT02657889|589265371|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
163150770|NCT02657889|589265372|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
163150771|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
163150772|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
163150773|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
163150774|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
163150775|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
163150776|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
163150777|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
163150778|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
163356216|NCT00903760|590015753|FG000|Overall Study|Withdrawal by Subject|1|||
163356217|NCT00903760|590015754|FG001|Overall Study|Withdrawal by Subject|2|||
163150779|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
163356218|NCT00903760|590015753|FG000|Overall Study|Off treatment for long period|0|||
163356219|NCT00903760|590015754|FG001|Overall Study|Off treatment for long period|1|||
163356220|NCT00487825|590015756|FG000|Overall Study|Adverse Event|2|||
163356221|NCT00487825|590015757|FG001|Overall Study|Adverse Event|2|||
163356222|NCT00487825|590015756|FG000|Overall Study|Lack of Efficacy|1|||
163356223|NCT00487825|590015757|FG001|Overall Study|Lack of Efficacy|1|||
163356224|NCT00487825|590015756|FG000|Overall Study|Other|3|||
163356225|NCT00487825|590015757|FG001|Overall Study|Other|2|||
163356226|NCT01639742|590015758|FG000|Overall Study|Study Ongoing|17|||
163356227|NCT01639742|590015758|FG000|Overall Study|Lost to Follow-up|1|||
163356228|NCT01256671|590015759|FG000|Overall Study|Adverse Event|29|||
163356229|NCT01256671|590015759|FG000|Overall Study|Lost to Follow-up|16|||
163356230|NCT01256671|590015759|FG000|Overall Study|Withdrawal by Subject|31|||
163356231|NCT01256671|590015759|FG000|Overall Study|Physician Decision|3|||
163356232|NCT01256671|590015759|FG000|Overall Study|Lack of Efficacy|4|||
163356233|NCT01256671|590015759|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
163356234|NCT01986114|590015760|FG000|Overall Study|Adverse Event|59|||
163356235|NCT01986114|590015760|FG000|Overall Study|Lack of Efficacy|23|||
163356236|NCT01986114|590015760|FG000|Overall Study|Withdrawal by Subject|58|||
163356237|NCT01986114|590015760|FG000|Overall Study|Noncompliance|3|||
163356238|NCT01986114|590015760|FG000|Overall Study|Protocol Violation|1|||
163356239|NCT01986114|590015760|FG000|Overall Study|Lost to Follow-up|5|||
163356240|NCT01986114|590015760|FG000|Overall Study|Other reason|7|||
163356241|NCT01190644|590015761|FG000|Overall Study|Death|2|||
163356242|NCT01190644|590015761|FG000|Overall Study|Disease progression|1|||
163356243|NCT02366143|590015762|FG000|Overall Study|Death|307|||
163356244|NCT02366143|590015763|FG001|Overall Study|Death|278|||
163356245|NCT02366143|590015764|FG002|Overall Study|Death|280|||
163356246|NCT02366143|590015762|FG000|Overall Study|Lost to Follow-up|2|||
163356247|NCT02366143|590015763|FG001|Overall Study|Lost to Follow-up|4|||
163356248|NCT02366143|590015764|FG002|Overall Study|Lost to Follow-up|2|||
163356249|NCT02366143|590015762|FG000|Overall Study|Physician Decision|1|||
163356250|NCT02366143|590015763|FG001|Overall Study|Physician Decision|2|||
163356251|NCT02366143|590015764|FG002|Overall Study|Physician Decision|1|||
163356252|NCT02366143|590015762|FG000|Overall Study|Protocol Violation|0|||
163356253|NCT02366143|590015763|FG001|Overall Study|Protocol Violation|0|||
163356254|NCT02366143|590015764|FG002|Overall Study|Protocol Violation|2|||
163356255|NCT02366143|590015762|FG000|Overall Study|Withdrawal by Subject|16|||
163356256|NCT02366143|590015763|FG001|Overall Study|Withdrawal by Subject|17|||
163356257|NCT02366143|590015764|FG002|Overall Study|Withdrawal by Subject|22|||
163356258|NCT02366143|590015762|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
163356259|NCT02366143|590015763|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
163356260|NCT02366143|590015764|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
163356261|NCT02366143|590015762|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
163356262|NCT02366143|590015763|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
163356263|NCT02366143|590015764|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
163356264|NCT02366143|590015762|FG000|Overall Study|Randomization Error|1|||
163356265|NCT02366143|590015763|FG001|Overall Study|Randomization Error|0|||
163356266|NCT02366143|590015764|FG002|Overall Study|Randomization Error|0|||
163356267|NCT02366143|590015762|FG000|Overall Study|PI Move and Site Closure|1|||
163356268|NCT02366143|590015763|FG001|Overall Study|PI Move and Site Closure|0|||
163356269|NCT02366143|590015764|FG002|Overall Study|PI Move and Site Closure|1|||
163356270|NCT02366143|590015762|FG000|Overall Study|Study Terminated By Sponsor|0|||
163356271|NCT02366143|590015763|FG001|Overall Study|Study Terminated By Sponsor|0|||
163356272|NCT02366143|590015764|FG002|Overall Study|Study Terminated By Sponsor|2|||
163356273|NCT02366143|590015762|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
163356274|NCT02366143|590015763|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
163356275|NCT02366143|590015764|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
163356276|NCT02366143|590015762|FG000|Overall Study|Patient moved to roll-over study|1|||
163356277|NCT02366143|590015763|FG001|Overall Study|Patient moved to roll-over study|19|||
163356278|NCT02366143|590015764|FG002|Overall Study|Patient moved to roll-over study|28|||
163356279|NCT02366143|590015762|FG000|Overall Study|Patient moved to commercial stock|0|||
163356280|NCT02366143|590015763|FG001|Overall Study|Patient moved to commercial stock|0|||
163356281|NCT02366143|590015764|FG002|Overall Study|Patient moved to commercial stock|1|||
163356282|NCT02366143|590015762|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
163356283|NCT02366143|590015763|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
163356284|NCT02366143|590015764|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
163356285|NCT02366143|590015762|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
163356286|NCT02366143|590015763|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
163356287|NCT02366143|590015764|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
163384899|NCT00427895|590119250|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
163356288|NCT02366143|590015762|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
163356289|NCT02366143|590015763|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
163356290|NCT02366143|590015764|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
163356291|NCT02366143|590015762|FG000|Overall Study|Requester's instructions|1|||
163356292|NCT02366143|590015763|FG001|Overall Study|Requester's instructions|1|||
163356293|NCT02366143|590015764|FG002|Overall Study|Requester's instructions|1|||
163356294|NCT02366143|590015762|FG000|Overall Study|Uneligible|0|||
163356295|NCT02366143|590015763|FG001|Overall Study|Uneligible|1|||
163356296|NCT02366143|590015764|FG002|Overall Study|Uneligible|0|||
163356297|NCT02366143|590015762|FG000|Overall Study|Post Trial Migration|0|||
163356298|NCT02366143|590015763|FG001|Overall Study|Post Trial Migration|1|||
163356299|NCT02366143|590015764|FG002|Overall Study|Post Trial Migration|0|||
163356300|NCT02366143|590015762|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
163356301|NCT02366143|590015763|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
163356302|NCT02366143|590015764|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
163356303|NCT02366143|590015762|FG000|Overall Study|Patient switched to PTAP|0|||
163356304|NCT02366143|590015763|FG001|Overall Study|Patient switched to PTAP|1|||
163356305|NCT02366143|590015764|FG002|Overall Study|Patient switched to PTAP|0|||
163356306|NCT02366143|590015762|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
163356307|NCT02366143|590015763|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
163356308|NCT02366143|590015764|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
163356309|NCT04411186|590015765|FG000|Overall Study|Withdrawn due to protocol violation|0|||
163356310|NCT04411186|590015766|FG001|Overall Study|Withdrawn due to protocol violation|1|||
163356311|NCT02172911|590015767|FG000|Overall Study|Serious Adverse Event|0|||
163356312|NCT02172911|590015768|FG001|Overall Study|Serious Adverse Event|1|||
163356313|NCT02172911|590015767|FG000|Overall Study|Progression of Disease|0|||
163356314|NCT02172911|590015768|FG001|Overall Study|Progression of Disease|1|||
163356315|NCT02172911|590015767|FG000|Overall Study|Loss of insurance coverage|1|||
163356316|NCT02172911|590015768|FG001|Overall Study|Loss of insurance coverage|0|||
163356317|NCT00575042|590015771|FG000|Overall Study|Adverse Event|2|||
163356318|NCT00575042|590015771|FG000|Overall Study|Lost to Follow-up|1|||
163356319|NCT04795336|590015774|FG000|Overall Study|Withdrawal by Subject|3|||
163356320|NCT04795336|590015775|FG001|Overall Study|Withdrawal by Subject|4|||
163356321|NCT04795336|590015776|FG002|Overall Study|Withdrawal by Subject|3|||
163356322|NCT04795336|590015777|FG003|Overall Study|Withdrawal by Subject|12|||
163356323|NCT04795336|590015774|FG000|Overall Study|Lost study logs|0|||
163356324|NCT04795336|590015775|FG001|Overall Study|Lost study logs|1|||
163356325|NCT04795336|590015776|FG002|Overall Study|Lost study logs|0|||
163356326|NCT04795336|590015777|FG003|Overall Study|Lost study logs|2|||
163356327|NCT04795336|590015774|FG000|Overall Study|Did not take study medication|2|||
163356328|NCT04795336|590015775|FG001|Overall Study|Did not take study medication|0|||
163356329|NCT04795336|590015776|FG002|Overall Study|Did not take study medication|0|||
163356330|NCT04795336|590015777|FG003|Overall Study|Did not take study medication|0|||
163356331|NCT01638390|590015778|FG000|Overall Study|screening failures|21|||
163356332|NCT01536587|590015781|FG000|Overall Study|Adverse Event|2|||
163356333|NCT02666664|590015782|FG000|Overall Study|Physician Decision|0|||
163356334|NCT02666664|590015783|FG001|Overall Study|Physician Decision|1|||
163356335|NCT02666664|590015782|FG000|Overall Study|Protocol Violation|0|||
163356336|NCT02666664|590015783|FG001|Overall Study|Protocol Violation|2|||
163356337|NCT02666664|590015782|FG000|Overall Study|Other|0|||
163356338|NCT02666664|590015783|FG001|Overall Study|Other|1|||
163356339|NCT02666664|590015782|FG000|Overall Study|Adverse Event|12|||
163356340|NCT02666664|590015783|FG001|Overall Study|Adverse Event|37|||
163356341|NCT02666664|590015782|FG000|Overall Study|Withdrawal by participant|23|||
163356342|NCT02666664|590015783|FG001|Overall Study|Withdrawal by participant|40|||
163356343|NCT02666664|590015782|FG000|Overall Study|Sponsor decision|0|||
163356344|NCT02666664|590015783|FG001|Overall Study|Sponsor decision|1|||
163356345|NCT02666664|590015782|FG000|Overall Study|Lost to Follow-up|1|||
163356346|NCT02666664|590015783|FG001|Overall Study|Lost to Follow-up|2|||
163356347|NCT03210519|590015784|FG000|Overall Study|Adverse Event|2|||
163356348|NCT03210519|590015785|FG001|Overall Study|Adverse Event|0|||
163356349|NCT03865953|590015790|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
163356350|NCT03865953|590015791|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
163356351|NCT03865953|590015790|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
163356352|NCT03865953|590015791|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
163356353|NCT03865953|590015790|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
163356354|NCT03865953|590015791|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
163356355|NCT03021551|590015802|FG000|Overall Study|Equipment Issues|2|||
163356356|NCT03021551|590015802|FG000|Overall Study|Protocol Violation|1|||
163356357|NCT00490945|590015805|FG000|Overall Study|Adverse Event|0|||
163356358|NCT00490945|590015806|FG001|Overall Study|Adverse Event|1|||
163356359|NCT00490945|590015807|FG002|Overall Study|Adverse Event|0|||
163356360|NCT00490945|590015808|FG003|Overall Study|Adverse Event|0|||
163356361|NCT00490945|590015809|FG004|Overall Study|Adverse Event|0|||
163356362|NCT02232399|590015810|FG000|Overall Study|Adverse Event|1|||
163252559|NCT01212770|589632091|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163252560|NCT01212770|589632092|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163252561|NCT01212770|589632093|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163252562|NCT01212770|589632094|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163252563|NCT01212770|589632095|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163252564|NCT01212770|589632087|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
163252565|NCT01212770|589632088|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
163252566|NCT01212770|589632089|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
163252567|NCT01212770|589632090|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163252568|NCT01212770|589632091|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163252569|NCT01212770|589632092|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163252570|NCT01212770|589632093|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163252571|NCT01212770|589632094|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163252572|NCT01212770|589632095|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163252573|NCT01212770|589632087|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
163252574|NCT01212770|589632088|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
163252575|NCT01212770|589632089|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
163252576|NCT01212770|589632090|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163252577|NCT01212770|589632091|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163252578|NCT01212770|589632092|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163252579|NCT01212770|589632093|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163252580|NCT01212770|589632094|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163252581|NCT01212770|589632095|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163252582|NCT01212770|589632087|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
163252583|NCT01212770|589632088|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163252584|NCT01212770|589632089|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
163252585|NCT01212770|589632090|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163252586|NCT01212770|589632091|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163252587|NCT01212770|589632092|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163252588|NCT01212770|589632093|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163252589|NCT01212770|589632094|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163252590|NCT01212770|589632095|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163252591|NCT01212770|589632087|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163252592|NCT01212770|589632088|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163252593|NCT01212770|589632089|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
163252594|NCT01212770|589632090|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163252595|NCT01212770|589632091|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163252596|NCT01212770|589632092|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163252597|NCT01212770|589632093|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163252598|NCT01212770|589632094|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163252599|NCT01212770|589632095|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163252600|NCT01212770|589632087|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
163252601|NCT01212770|589632088|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
163252602|NCT01212770|589632089|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
163252603|NCT01212770|589632090|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
163252604|NCT01212770|589632091|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
163252605|NCT01212770|589632092|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
163252606|NCT01212770|589632093|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
163252607|NCT01212770|589632094|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
163252608|NCT01212770|589632095|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
163252609|NCT01212770|589632087|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
163252610|NCT01212770|589632088|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
163252611|NCT01212770|589632089|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
163252612|NCT01212770|589632090|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
163252613|NCT01212770|589632091|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
163252614|NCT01212770|589632092|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
163252615|NCT01212770|589632093|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
163252616|NCT01212770|589632094|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
163252617|NCT01212770|589632095|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
163252618|NCT01212770|589632087|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
163252619|NCT01212770|589632088|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
163252620|NCT01212770|589632089|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
163252621|NCT01212770|589632090|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
163252622|NCT01212770|589632091|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
163252623|NCT01212770|589632092|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
163252624|NCT01212770|589632093|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
163252625|NCT01212770|589632094|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
163252626|NCT01212770|589632095|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
163252627|NCT01212770|589632087|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
163252628|NCT01212770|589632088|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
163252629|NCT01212770|589632089|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
163252630|NCT01212770|589632090|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
163252631|NCT01212770|589632091|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
163252632|NCT01212770|589632092|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
163252633|NCT01212770|589632093|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
163252634|NCT01212770|589632094|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
163252635|NCT01212770|589632095|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
163252636|NCT01212770|589632087|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163252637|NCT01212770|589632088|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163252638|NCT01212770|589632089|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
163252639|NCT01212770|589632090|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163252640|NCT01212770|589632091|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163252641|NCT01212770|589632092|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163252642|NCT01212770|589632093|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163252643|NCT01212770|589632094|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163252644|NCT01212770|589632095|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163252645|NCT01212770|589632087|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163252646|NCT01212770|589632088|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163252647|NCT01212770|589632089|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163252648|NCT01212770|589632090|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
163252649|NCT01212770|589632091|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163252650|NCT01212770|589632092|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163252651|NCT01212770|589632093|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163252652|NCT01212770|589632094|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163252653|NCT01212770|589632095|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163252654|NCT01212770|589632087|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
163252655|NCT01212770|589632088|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
163252656|NCT01212770|589632089|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
163252657|NCT01212770|589632090|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
163252658|NCT01212770|589632091|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
163252659|NCT01212770|589632092|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
163252660|NCT01212770|589632093|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
163252661|NCT01212770|589632094|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
163252662|NCT01212770|589632095|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
163252663|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163252664|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
163252665|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
163252666|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163252667|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163252668|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163252669|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163252670|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163252671|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
163252672|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163252673|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
163252674|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
163252675|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163252676|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163252677|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163252678|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163252679|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
163252680|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
163252681|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163252682|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
163252683|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163252684|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163252685|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163252686|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163252687|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163356363|NCT02232399|590015811|FG001|Overall Study|Adverse Event|0|||
163356364|NCT02232399|590015810|FG000|Overall Study|Withdrawal by Subject|0|||
163150780|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
163150781|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
163150782|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
163150783|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
163150784|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
163150785|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
163150786|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
163150787|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
163150788|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
163150789|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
163150790|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
163150791|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
163150792|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
163150793|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
163150794|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
163150795|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
163150796|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
163150797|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
163150798|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
163150799|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
163150800|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
163150801|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
163150802|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
163150803|NCT03050801|589265379|FG000|Experiment 1|Lost to Follow-up|0|||
163150804|NCT03050801|589265380|FG001|Experiment 1|Lost to Follow-up|1|||
163150805|NCT03050801|589265381|FG002|Experiment 1|Lost to Follow-up|0|||
163150806|NCT03050801|589265382|FG003|Experiment 1|Lost to Follow-up|0|||
163150807|NCT03050801|589265383|FG004|Experiment 1|Lost to Follow-up|0|||
163150808|NCT03050801|589265384|FG005|Experiment 1|Lost to Follow-up|0|||
163150809|NCT03050801|589265379|FG000|Experiment 1|Physician Decision|0|||
163150810|NCT03050801|589265380|FG001|Experiment 1|Physician Decision|3|||
163150811|NCT03050801|589265381|FG002|Experiment 1|Physician Decision|0|||
163150812|NCT03050801|589265382|FG003|Experiment 1|Physician Decision|0|||
163150813|NCT03050801|589265383|FG004|Experiment 1|Physician Decision|0|||
163150814|NCT03050801|589265384|FG005|Experiment 1|Physician Decision|0|||
163150815|NCT03050801|589265379|FG000|Experiment 1|Change of experimental design|0|||
163150816|NCT03050801|589265380|FG001|Experiment 1|Change of experimental design|3|||
163150817|NCT03050801|589265381|FG002|Experiment 1|Change of experimental design|0|||
163150818|NCT03050801|589265382|FG003|Experiment 1|Change of experimental design|0|||
163150819|NCT03050801|589265383|FG004|Experiment 1|Change of experimental design|0|||
163150820|NCT03050801|589265384|FG005|Experiment 1|Change of experimental design|0|||
163150821|NCT03050801|589265379|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
163150822|NCT03050801|589265380|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
163150823|NCT03050801|589265381|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
163150824|NCT03050801|589265382|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
163150825|NCT03050801|589265383|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
163150826|NCT03050801|589265384|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
163150827|NCT03050801|589265379|FG000|Experiment 2|Lost to Follow-up|0|||
163150828|NCT03050801|589265380|FG001|Experiment 2|Lost to Follow-up|0|||
163150829|NCT03050801|589265381|FG002|Experiment 2|Lost to Follow-up|0|||
163150830|NCT03050801|589265382|FG003|Experiment 2|Lost to Follow-up|1|||
163150831|NCT03050801|589265383|FG004|Experiment 2|Lost to Follow-up|1|||
163150832|NCT03050801|589265384|FG005|Experiment 2|Lost to Follow-up|0|||
163150833|NCT03050801|589265379|FG000|Experiment 2|Physician Decision|0|||
163150834|NCT03050801|589265380|FG001|Experiment 2|Physician Decision|0|||
163150835|NCT03050801|589265381|FG002|Experiment 2|Physician Decision|0|||
163150836|NCT03050801|589265382|FG003|Experiment 2|Physician Decision|0|||
163150837|NCT03050801|589265383|FG004|Experiment 2|Physician Decision|1|||
163150838|NCT03050801|589265384|FG005|Experiment 2|Physician Decision|0|||
163150839|NCT03050801|589265379|FG000|Experiment 2|Pregnancy|0|||
163150840|NCT03050801|589265380|FG001|Experiment 2|Pregnancy|0|||
163150841|NCT03050801|589265381|FG002|Experiment 2|Pregnancy|0|||
163150842|NCT03050801|589265382|FG003|Experiment 2|Pregnancy|0|||
163150843|NCT03050801|589265383|FG004|Experiment 2|Pregnancy|1|||
163252688|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163150844|NCT03050801|589265384|FG005|Experiment 2|Pregnancy|0|||
163150845|NCT03050801|589265379|FG000|Experiment 2|Withdrawal by Subject|0|||
163150846|NCT03050801|589265380|FG001|Experiment 2|Withdrawal by Subject|0|||
163150847|NCT03050801|589265381|FG002|Experiment 2|Withdrawal by Subject|0|||
163150848|NCT03050801|589265382|FG003|Experiment 2|Withdrawal by Subject|1|||
163150849|NCT03050801|589265383|FG004|Experiment 2|Withdrawal by Subject|0|||
163150850|NCT03050801|589265384|FG005|Experiment 2|Withdrawal by Subject|0|||
163150851|NCT03050801|589265379|FG000|Experiment 2|Poor data quality|0|||
163150852|NCT03050801|589265380|FG001|Experiment 2|Poor data quality|0|||
163150853|NCT03050801|589265381|FG002|Experiment 2|Poor data quality|0|||
163150854|NCT03050801|589265382|FG003|Experiment 2|Poor data quality|4|||
163150855|NCT03050801|589265383|FG004|Experiment 2|Poor data quality|1|||
163150856|NCT03050801|589265384|FG005|Experiment 2|Poor data quality|0|||
163150857|NCT03050801|589265379|FG000|Experiment 2|Discomfort during stimulation|0|||
163150858|NCT03050801|589265380|FG001|Experiment 2|Discomfort during stimulation|0|||
163150859|NCT03050801|589265381|FG002|Experiment 2|Discomfort during stimulation|0|||
163150860|NCT03050801|589265382|FG003|Experiment 2|Discomfort during stimulation|0|||
163150861|NCT03050801|589265383|FG004|Experiment 2|Discomfort during stimulation|0|||
163150862|NCT03050801|589265384|FG005|Experiment 2|Discomfort during stimulation|2|||
163150863|NCT01576341|589265385|FG000|Overall Study|Withdrawal by Subject|24|||
163150864|NCT01576341|589265385|FG000|Overall Study|Adverse Event|10|||
163150865|NCT01576341|589265385|FG000|Overall Study|Death|21|||
163150866|NCT01576341|589265385|FG000|Overall Study|Physician Decision|2|||
163150867|NCT01576341|589265385|FG000|Overall Study|Lost to Follow-up|2|||
163150868|NCT01576341|589265385|FG000|Overall Study|Kidney transplantation|10|||
163150869|NCT01576341|589265385|FG000|Overall Study|Protocol Violation|12|||
163150870|NCT01576341|589265385|FG000|Overall Study|Other|12|||
163150871|NCT03836625|589265386|FG000|Overall Study|Lost to Follow-up|9|||
163150872|NCT03836625|589265387|FG001|Overall Study|Lost to Follow-up|9|||
163150873|NCT03836625|589265386|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
163150874|NCT03836625|589265387|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
163150875|NCT03836625|589265386|FG000|Overall Study|Death|0|||
163150876|NCT03836625|589265387|FG001|Overall Study|Death|1|||
163150877|NCT03836625|589265386|FG000|Overall Study|Refused follow-up|0|||
163150878|NCT03836625|589265387|FG001|Overall Study|Refused follow-up|1|||
163150879|NCT00791934|589265390|FG000|Overall Study|Withdrawal by Subject|2|||
163150880|NCT00791934|589265390|FG000|Overall Study|Did not consent for extended follow-up|13|||
163150881|NCT03413891|589265392|FG000|Overall Study|Lost to Follow-up|2|||
163150882|NCT03413891|589265393|FG001|Overall Study|Lost to Follow-up|1|||
163150883|NCT03413891|589265392|FG000|Overall Study|Protocol Violation|0|||
163150884|NCT03413891|589265393|FG001|Overall Study|Protocol Violation|1|||
163150885|NCT03077542|589265398|FG000|Overall Study|Death|4|||
163150886|NCT03077542|589265399|FG001|Overall Study|Death|0|||
163150887|NCT03077542|589265398|FG000|Overall Study|Physician Decision|6|||
163150888|NCT03077542|589265399|FG001|Overall Study|Physician Decision|1|||
163150889|NCT03077542|589265398|FG000|Overall Study|Withdrawal by Subject|0|||
163150890|NCT03077542|589265399|FG001|Overall Study|Withdrawal by Subject|1|||
163150891|NCT00301808|589265400|FG000|Overall Study|Adverse Event|5|||
163150892|NCT00301808|589265400|FG000|Overall Study|Death|3|||
163150893|NCT00301808|589265400|FG000|Overall Study|Lack of Efficacy|4|||
163150894|NCT00844844|589265401|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
163150895|NCT00844844|589265401|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
163150896|NCT00844844|589265401|FG000|Extension Treatment Period|Adverse Event|2|||
163150897|NCT00844844|589265401|FG000|Post Treatment Period|Withdrawal by Subject|1|||
163150898|NCT04659044|589265414|FG000|Induction|Physician Decision|1|||
163150899|NCT04659044|589265414|FG000|Induction|Adverse Event|2|||
163150900|NCT04966013|589265416|FG000|Overall Study|Withdrawal by Subject|0|||
163150901|NCT04966013|589265417|FG001|Overall Study|Withdrawal by Subject|2|||
163150902|NCT04966013|589265418|FG002|Overall Study|Withdrawal by Subject|1|||
163150903|NCT04966013|589265416|FG000|Overall Study|Adverse Event|2|||
163150904|NCT04966013|589265417|FG001|Overall Study|Adverse Event|1|||
163150905|NCT04966013|589265418|FG002|Overall Study|Adverse Event|1|||
163150906|NCT04875975|589265422|FG000|Overall Study|Adverse Event|1|||
163150907|NCT04875975|589265423|FG001|Overall Study|Adverse Event|2|||
163150908|NCT04875975|589265422|FG000|Overall Study|Lack of Efficacy|2|||
163150909|NCT04875975|589265423|FG001|Overall Study|Lack of Efficacy|2|||
163150910|NCT04875975|589265422|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
163150911|NCT04875975|589265423|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
163150912|NCT04875975|589265422|FG000|Overall Study|Relapse With Insults|0|||
163150913|NCT04875975|589265423|FG001|Overall Study|Relapse With Insults|1|||
163150914|NCT04875975|589265422|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
163252689|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163150915|NCT04875975|589265423|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
163150916|NCT01910298|589265424|FG000|Overall Study|Adverse Event|1|||
163150917|NCT01910298|589265425|FG001|Overall Study|Adverse Event|0|||
163150918|NCT01910298|589265424|FG000|Overall Study|Withdrawal by Subject|2|||
163150919|NCT01910298|589265425|FG001|Overall Study|Withdrawal by Subject|7|||
163150920|NCT01910298|589265424|FG000|Overall Study|Protocol Deviation|0|||
163150921|NCT01910298|589265425|FG001|Overall Study|Protocol Deviation|5|||
163150922|NCT01910298|589265424|FG000|Overall Study|Lost to Follow-up|1|||
163150923|NCT01910298|589265425|FG001|Overall Study|Lost to Follow-up|1|||
163150924|NCT01910298|589265424|FG000|Overall Study|Study Terminated by Sponsor|1|||
163150925|NCT01910298|589265425|FG001|Overall Study|Study Terminated by Sponsor|17|||
163356365|NCT02232399|590015811|FG001|Overall Study|Withdrawal by Subject|1|||
163356366|NCT02706951|590015813|FG000|Period 1|Adverse Event|1|||
163356367|NCT02706951|590015814|FG001|Period 1|Adverse Event|5|||
163356368|NCT02706951|590015815|FG002|Period 1|Adverse Event|3|||
163356369|NCT02706951|590015816|FG003|Period 1|Adverse Event|0|||
163356370|NCT02706951|590015817|FG004|Period 1|Adverse Event|0|||
163356371|NCT02706951|590015813|FG000|Period 1|Withdrawal by Subject|10|||
163356372|NCT02706951|590015814|FG001|Period 1|Withdrawal by Subject|6|||
163356373|NCT02706951|590015815|FG002|Period 1|Withdrawal by Subject|6|||
163356374|NCT02706951|590015816|FG003|Period 1|Withdrawal by Subject|0|||
163356375|NCT02706951|590015817|FG004|Period 1|Withdrawal by Subject|0|||
163356376|NCT02706951|590015813|FG000|Period 1|Lost to Follow-up|0|||
163356377|NCT02706951|590015814|FG001|Period 1|Lost to Follow-up|4|||
163356378|NCT02706951|590015815|FG002|Period 1|Lost to Follow-up|1|||
163356379|NCT02706951|590015816|FG003|Period 1|Lost to Follow-up|0|||
163356380|NCT02706951|590015817|FG004|Period 1|Lost to Follow-up|0|||
163356381|NCT02706951|590015813|FG000|Period 1|Other|2|||
163356382|NCT02706951|590015814|FG001|Period 1|Other|1|||
163356383|NCT02706951|590015815|FG002|Period 1|Other|0|||
163356384|NCT02706951|590015816|FG003|Period 1|Other|0|||
163356385|NCT02706951|590015817|FG004|Period 1|Other|0|||
163356386|NCT02706951|590015813|FG000|Period 2|Adverse Event|0|||
163356387|NCT02706951|590015814|FG001|Period 2|Adverse Event|0|||
163356388|NCT02706951|590015815|FG002|Period 2|Adverse Event|0|||
163356389|NCT02706951|590015816|FG003|Period 2|Adverse Event|25|||
163356390|NCT02706951|590015817|FG004|Period 2|Adverse Event|34|||
163356391|NCT02706951|590015813|FG000|Period 2|Withdrawal by Subject|0|||
163356392|NCT02706951|590015814|FG001|Period 2|Withdrawal by Subject|0|||
163356393|NCT02706951|590015815|FG002|Period 2|Withdrawal by Subject|0|||
163356394|NCT02706951|590015816|FG003|Period 2|Withdrawal by Subject|38|||
163356395|NCT02706951|590015817|FG004|Period 2|Withdrawal by Subject|44|||
163356396|NCT02706951|590015813|FG000|Period 2|Lost to Follow-up|0|||
163356397|NCT02706951|590015814|FG001|Period 2|Lost to Follow-up|0|||
163356398|NCT02706951|590015815|FG002|Period 2|Lost to Follow-up|0|||
163356399|NCT02706951|590015816|FG003|Period 2|Lost to Follow-up|17|||
163356400|NCT02706951|590015817|FG004|Period 2|Lost to Follow-up|9|||
163356401|NCT02706951|590015813|FG000|Period 2|COVID-19 Related|0|||
163356402|NCT02706951|590015814|FG001|Period 2|COVID-19 Related|0|||
163356403|NCT02706951|590015815|FG002|Period 2|COVID-19 Related|0|||
163356404|NCT02706951|590015816|FG003|Period 2|COVID-19 Related|1|||
163356405|NCT02706951|590015817|FG004|Period 2|COVID-19 Related|2|||
163356406|NCT02706951|590015813|FG000|Period 2|Other|0|||
163356407|NCT02706951|590015814|FG001|Period 2|Other|0|||
163356408|NCT02706951|590015815|FG002|Period 2|Other|0|||
163356409|NCT02706951|590015816|FG003|Period 2|Other|37|||
163356410|NCT02706951|590015817|FG004|Period 2|Other|31|||
163356411|NCT03491215|590015818|FG000|Overall Study|Death|6|||
163356412|NCT03491215|590015819|FG001|Overall Study|Death|2|||
163356413|NCT03491215|590015820|FG002|Overall Study|Death|1|||
163356414|NCT03491215|590015821|FG003|Overall Study|Death|0|||
163356415|NCT03491215|590015818|FG000|Overall Study|Physician Decision|1|||
163356416|NCT03491215|590015819|FG001|Overall Study|Physician Decision|0|||
163356417|NCT03491215|590015820|FG002|Overall Study|Physician Decision|0|||
163356418|NCT03491215|590015821|FG003|Overall Study|Physician Decision|0|||
163356419|NCT04799418|590015836|FG000|Overall Study|Death|1|||
163356420|NCT04799418|590015837|FG001|Overall Study|Death|1|||
163356421|NCT04799418|590015836|FG000|Overall Study|Lack of Efficacy|14|||
163356422|NCT04799418|590015837|FG001|Overall Study|Lack of Efficacy|14|||
163356423|NCT04799418|590015836|FG000|Overall Study|Withdrawal by Subject|10|||
163356424|NCT04799418|590015837|FG001|Overall Study|Withdrawal by Subject|7|||
163356425|NCT04799418|590015836|FG000|Overall Study|Adverse Event|3|||
163356426|NCT04799418|590015837|FG001|Overall Study|Adverse Event|2|||
163356427|NCT03297398|590015838|FG000|Overall Study|Sponsor's decision|6|||
163356428|NCT03297398|590015839|FG001|Overall Study|Sponsor's decision|9|||
163356429|NCT03297398|590015840|FG002|Overall Study|Sponsor's decision|7|||
163356430|NCT03297398|590015838|FG000|Overall Study|Adverse Event|1|||
163356431|NCT03297398|590015839|FG001|Overall Study|Adverse Event|4|||
163356432|NCT03297398|590015840|FG002|Overall Study|Adverse Event|4|||
163356433|NCT03297398|590015838|FG000|Overall Study|Withdrawal by Subject|1|||
163356434|NCT03297398|590015839|FG001|Overall Study|Withdrawal by Subject|2|||
163356435|NCT03297398|590015840|FG002|Overall Study|Withdrawal by Subject|2|||
163356436|NCT03297398|590015838|FG000|Overall Study|Protocol Violation|0|||
163356437|NCT03297398|590015839|FG001|Overall Study|Protocol Violation|2|||
163356438|NCT03297398|590015840|FG002|Overall Study|Protocol Violation|0|||
163356439|NCT03297398|590015838|FG000|Overall Study|Physician Decision|0|||
163356440|NCT03297398|590015839|FG001|Overall Study|Physician Decision|0|||
163356441|NCT03297398|590015840|FG002|Overall Study|Physician Decision|1|||
163356442|NCT03297398|590015838|FG000|Overall Study|Lost to Follow-up|0|||
163356443|NCT03297398|590015839|FG001|Overall Study|Lost to Follow-up|0|||
163356444|NCT03297398|590015840|FG002|Overall Study|Lost to Follow-up|1|||
163356445|NCT00611715|590015845|FG000|Overall Study|Disease Progression|24|||
163356446|NCT00611715|590015846|FG001|Overall Study|Disease Progression|4|||
163356447|NCT00611715|590015845|FG000|Overall Study|Withdrawal by Subject|5|||
163356448|NCT00611715|590015846|FG001|Overall Study|Withdrawal by Subject|1|||
163356449|NCT00611715|590015845|FG000|Overall Study|Adverse Event|9|||
163356450|NCT00611715|590015846|FG001|Overall Study|Adverse Event|1|||
163356451|NCT00611715|590015845|FG000|Overall Study|Death|1|||
163356452|NCT00611715|590015846|FG001|Overall Study|Death|0|||
163356453|NCT00611715|590015845|FG000|Overall Study|two patients are still on treatment|2|||
163356454|NCT00611715|590015846|FG001|Overall Study|two patients are still on treatment|0|||
163356455|NCT00107978|590015847|FG000|Overall Study|Adverse Event|1|||
163356456|NCT00107978|590015848|FG001|Overall Study|Adverse Event|5|||
163356457|NCT00107978|590015847|FG000|Overall Study|Death|3|||
163356458|NCT00107978|590015848|FG001|Overall Study|Death|3|||
163356459|NCT00107978|590015847|FG000|Overall Study|Lost to Follow-up|20|||
163356460|NCT00107978|590015848|FG001|Overall Study|Lost to Follow-up|28|||
163356461|NCT00107978|590015847|FG000|Overall Study|Withdrawal by Subject|4|||
163356462|NCT00107978|590015848|FG001|Overall Study|Withdrawal by Subject|9|||
163356463|NCT00107978|590015847|FG000|Overall Study|Protocol Violation|0|||
163356464|NCT00107978|590015848|FG001|Overall Study|Protocol Violation|1|||
163356465|NCT00107978|590015847|FG000|Overall Study|Other|5|||
163356466|NCT00107978|590015848|FG001|Overall Study|Other|4|||
163356467|NCT02669407|590015849|FG000|Overall Study|Physician Decision|3|||
163356468|NCT00350298|590015852|FG000|Overall Study|Death|7|||
163356469|NCT00350298|590015853|FG001|Overall Study|Death|8|||
163356470|NCT00350298|590015852|FG000|Overall Study|Lost to Follow-up|1|||
163356471|NCT00350298|590015853|FG001|Overall Study|Lost to Follow-up|2|||
163356472|NCT00350298|590015852|FG000|Overall Study|Withdrawal by Subject|1|||
163356473|NCT00350298|590015853|FG001|Overall Study|Withdrawal by Subject|3|||
163356474|NCT00233389|590015854|FG000|Overall Study|Adverse Event|5|||
163356475|NCT00233389|590015855|FG001|Overall Study|Adverse Event|5|||
163356476|NCT00233389|590015854|FG000|Overall Study|Lack of Efficacy|11|||
163356477|NCT00233389|590015855|FG001|Overall Study|Lack of Efficacy|8|||
163356478|NCT00233389|590015854|FG000|Overall Study|Lost to Follow-up|1|||
163356479|NCT00233389|590015855|FG001|Overall Study|Lost to Follow-up|1|||
163356480|NCT00233389|590015854|FG000|Overall Study|Physician Decision|1|||
163356481|NCT00233389|590015855|FG001|Overall Study|Physician Decision|0|||
163356482|NCT00233389|590015854|FG000|Overall Study|Protocol Violation|0|||
163356483|NCT00233389|590015855|FG001|Overall Study|Protocol Violation|1|||
163356484|NCT00233389|590015854|FG000|Overall Study|Withdrawal by Subject|0|||
163356485|NCT00233389|590015855|FG001|Overall Study|Withdrawal by Subject|1|||
163356486|NCT00719043|590015861|FG000|Overall Study|Adverse Event|5|||
163356487|NCT00719043|590015862|FG001|Overall Study|Adverse Event|1|||
163356488|NCT00719043|590015863|FG002|Overall Study|Adverse Event|2|||
163356489|NCT00719043|590015864|FG003|Overall Study|Adverse Event|2|||
163356490|NCT00719043|590015865|FG004|Overall Study|Adverse Event|1|||
163356491|NCT00719043|590015866|FG005|Overall Study|Adverse Event|4|||
163356492|NCT00719043|590015867|FG006|Overall Study|Adverse Event|4|||
163356493|NCT00719043|590015861|FG000|Overall Study|Lost to Follow-up|14|||
163356494|NCT00719043|590015862|FG001|Overall Study|Lost to Follow-up|10|||
163356495|NCT00719043|590015863|FG002|Overall Study|Lost to Follow-up|8|||
163356496|NCT00719043|590015864|FG003|Overall Study|Lost to Follow-up|9|||
163356497|NCT00719043|590015865|FG004|Overall Study|Lost to Follow-up|10|||
163356498|NCT00719043|590015866|FG005|Overall Study|Lost to Follow-up|9|||
163356499|NCT00719043|590015867|FG006|Overall Study|Lost to Follow-up|9|||
163356500|NCT00719043|590015861|FG000|Overall Study|Protocol Violation|0|||
163356501|NCT00719043|590015862|FG001|Overall Study|Protocol Violation|0|||
163356502|NCT00719043|590015863|FG002|Overall Study|Protocol Violation|0|||
163356503|NCT00719043|590015864|FG003|Overall Study|Protocol Violation|0|||
163356504|NCT00719043|590015865|FG004|Overall Study|Protocol Violation|0|||
163356505|NCT00719043|590015866|FG005|Overall Study|Protocol Violation|1|||
163410447|NCT05103332|590211363|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163410448|NCT05103332|590211364|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163410449|NCT05103332|590211365|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
163410450|NCT05103332|590211366|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
163410451|NCT05103332|590211367|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163410452|NCT05103332|590211368|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
163150926|NCT01910298|589265424|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163356506|NCT00719043|590015867|FG006|Overall Study|Protocol Violation|0|||
163356507|NCT00719043|590015861|FG000|Overall Study|Other|1|||
163356508|NCT00719043|590015862|FG001|Overall Study|Other|0|||
163356509|NCT00719043|590015863|FG002|Overall Study|Other|1|||
163356510|NCT00719043|590015864|FG003|Overall Study|Other|2|||
163356511|NCT00719043|590015865|FG004|Overall Study|Other|0|||
163356512|NCT00719043|590015866|FG005|Overall Study|Other|2|||
163356513|NCT00719043|590015867|FG006|Overall Study|Other|1|||
163150927|NCT01910298|589265425|FG001|Overall Study|Other Miscellaneous Reasons|2|||
163356514|NCT00719043|590015861|FG000|Overall Study|Withdrawal by Subject|12|||
163356515|NCT00719043|590015862|FG001|Overall Study|Withdrawal by Subject|14|||
163356516|NCT00719043|590015863|FG002|Overall Study|Withdrawal by Subject|9|||
163356517|NCT00719043|590015864|FG003|Overall Study|Withdrawal by Subject|10|||
163356518|NCT00719043|590015865|FG004|Overall Study|Withdrawal by Subject|16|||
163356519|NCT00719043|590015866|FG005|Overall Study|Withdrawal by Subject|18|||
163356520|NCT00719043|590015867|FG006|Overall Study|Withdrawal by Subject|14|||
163356521|NCT00822770|590015868|FG000|Overall Study|Not treated|1|||
163356522|NCT00822770|590015869|FG001|Overall Study|Not treated|0|||
163356523|NCT00822770|590015868|FG000|Overall Study|Complication/Incomplete treatment|1|||
163356524|NCT00822770|590015869|FG001|Overall Study|Complication/Incomplete treatment|0|||
163356525|NCT00822770|590015868|FG000|Overall Study|Death|1|||
163356526|NCT00822770|590015869|FG001|Overall Study|Death|1|||
163356527|NCT04593823|590015870|FG000|Overall Study|Withdrawal by Subject|1|||
163356528|NCT04593823|590015871|FG001|Overall Study|Withdrawal by Subject|1|||
163356529|NCT04593823|590015870|FG000|Overall Study|Lost to Follow-up|0|||
163356530|NCT04593823|590015871|FG001|Overall Study|Lost to Follow-up|1|||
163356531|NCT00952848|590015878|FG000|Overall Study|Withdrawal by Subject|4|||
163356532|NCT00458393|590015879|FG000|Overall Study|Withdrawal by Subject|67|||
163356533|NCT00458393|590015880|FG001|Overall Study|Withdrawal by Subject|80|||
163356534|NCT00458393|590015879|FG000|Overall Study|Physician Decision|31|||
163356535|NCT00458393|590015880|FG001|Overall Study|Physician Decision|22|||
163356536|NCT00458393|590015879|FG000|Overall Study|Relocated|77|||
163356537|NCT00458393|590015880|FG001|Overall Study|Relocated|81|||
163356538|NCT00458393|590015879|FG000|Overall Study|Lost to Follow-up|115|||
163356539|NCT00458393|590015880|FG001|Overall Study|Lost to Follow-up|92|||
163356540|NCT00458393|590015879|FG000|Overall Study|Sites marked other on the form.|19|||
163356541|NCT00458393|590015880|FG001|Overall Study|Sites marked other on the form.|20|||
163356542|NCT02725567|590015881|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
163356543|NCT02725567|590015882|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
163356544|NCT02725567|590015881|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
163356545|NCT02725567|590015882|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
163356546|NCT02725567|590015881|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
163356547|NCT02725567|590015882|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
163356548|NCT02777242|590015884|FG000|Overall Study|Other|2|||
163356549|NCT02777242|590015884|FG000|Overall Study|Lost to Follow-up|1|||
163356550|NCT02777242|590015884|FG000|Overall Study|Multiple|1|||
163356551|NCT02777242|590015884|FG000|Overall Study|Sponsor's request|1|||
163356552|NCT02777242|590015884|FG000|Overall Study|Withdrawal by Subject|1|||
163356553|NCT05178979|590015885|FG000|Overall Study|Death|0|||
163356554|NCT05178979|590015886|FG001|Overall Study|Death|5|||
163356555|NCT05178979|590015887|FG002|Overall Study|Death|0|||
163356556|NCT05178979|590015888|FG003|Overall Study|Death|3|||
163356557|NCT05178979|590015885|FG000|Overall Study|Adverse Event|0|||
163356558|NCT05178979|590015886|FG001|Overall Study|Adverse Event|1|||
163356559|NCT05178979|590015887|FG002|Overall Study|Adverse Event|0|||
163356560|NCT05178979|590015888|FG003|Overall Study|Adverse Event|0|||
163356561|NCT05178979|590015885|FG000|Overall Study|Lost to Follow-up|1|||
163356562|NCT05178979|590015886|FG001|Overall Study|Lost to Follow-up|8|||
163356563|NCT05178979|590015887|FG002|Overall Study|Lost to Follow-up|3|||
163356564|NCT05178979|590015888|FG003|Overall Study|Lost to Follow-up|8|||
163356565|NCT00817336|590015889|FG000|Overall Study|Withdrawal by Subject|1|||
163356566|NCT00817336|590015890|FG001|Overall Study|Withdrawal by Subject|1|||
163356567|NCT02413593|590015898|FG000|Overall Study|Lost to Follow-up|3|||
163356568|NCT02413593|590015898|FG000|Overall Study|Adverse Event|1|||
163356569|NCT03845075|590015899|FG000|Part 1 - DB|Withdrawal by Subject|1|||
163356570|NCT03845075|590015900|FG001|Part 1 - DB|Withdrawal by Subject|1|||
163356571|NCT03845075|590015901|FG002|Part 1 - DB|Withdrawal by Subject|0|||
163356572|NCT03845075|590015902|FG003|Part 1 - DB|Withdrawal by Subject|0|||
163356573|NCT03845075|590015899|FG000|Part 1 - DB|Adverse Event|0|||
163356574|NCT03845075|590015900|FG001|Part 1 - DB|Adverse Event|1|||
163356575|NCT03845075|590015901|FG002|Part 1 - DB|Adverse Event|0|||
163252690|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163252691|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
163252692|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
163252693|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163252694|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163252695|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163252696|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163356576|NCT03845075|590015902|FG003|Part 1 - DB|Adverse Event|0|||
163356577|NCT03845075|590015899|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
163356578|NCT03845075|590015900|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
163356579|NCT03845075|590015901|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
163356580|NCT03845075|590015902|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
163356581|NCT00409409|590015903|FG000|Overall Study|Adverse Event|7|||
163356582|NCT00409409|590015904|FG001|Overall Study|Adverse Event|2|||
163356583|NCT00409409|590015903|FG000|Overall Study|Withdrawal by Subject|1|||
163356584|NCT00409409|590015904|FG001|Overall Study|Withdrawal by Subject|1|||
163356585|NCT00409409|590015903|FG000|Overall Study|Any other reason not above-mentioned|0|||
163356586|NCT00409409|590015904|FG001|Overall Study|Any other reason not above-mentioned|1|||
163356587|NCT01918371|590015908|FG000|Overall Study|Missing Data|1|||
163356588|NCT01918371|590015909|FG001|Overall Study|Missing Data|1|||
163356589|NCT03802617|590015910|FG000|Overall Study|Adverse Event|0|||
163356590|NCT03802617|590015911|FG001|Overall Study|Adverse Event|4|||
163356591|NCT03802617|590015912|FG002|Overall Study|Adverse Event|5|||
163356592|NCT03802617|590015913|FG003|Overall Study|Adverse Event|1|||
163356593|NCT03802617|590015910|FG000|Overall Study|Lack of Efficacy|0|||
163356594|NCT03802617|590015911|FG001|Overall Study|Lack of Efficacy|1|||
163356595|NCT03802617|590015912|FG002|Overall Study|Lack of Efficacy|0|||
163356596|NCT03802617|590015913|FG003|Overall Study|Lack of Efficacy|2|||
163356597|NCT03802617|590015910|FG000|Overall Study|Protocol Violation|1|||
163356598|NCT03802617|590015911|FG001|Overall Study|Protocol Violation|1|||
163356599|NCT03802617|590015912|FG002|Overall Study|Protocol Violation|1|||
163356600|NCT03802617|590015913|FG003|Overall Study|Protocol Violation|0|||
163356601|NCT03802617|590015910|FG000|Overall Study|Withdrawal by Subject|1|||
163356602|NCT03802617|590015911|FG001|Overall Study|Withdrawal by Subject|1|||
163356603|NCT03802617|590015912|FG002|Overall Study|Withdrawal by Subject|1|||
163356604|NCT03802617|590015913|FG003|Overall Study|Withdrawal by Subject|0|||
163356605|NCT03802617|590015910|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
163356606|NCT03802617|590015911|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
163356607|NCT03802617|590015912|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
163356608|NCT03802617|590015913|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
163252697|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
163252698|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
163252699|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
163252700|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
163252701|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
163252702|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
163252703|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
163252704|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
163252705|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
163252706|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
163252707|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
163252708|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163252709|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
163252710|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
163252711|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163252712|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163252713|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163252714|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163252715|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163252716|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
163252717|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163252718|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
163252719|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
163252720|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163252721|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163252722|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163252723|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163252724|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
163252725|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
163252726|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163252727|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
163252728|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
163252729|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163252730|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163252731|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163252732|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163252733|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
163252734|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
163252735|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163252736|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
163356609|NCT00621192|590015914|FG000|Overall Study|Withdrawal by Subject|0|||
163356610|NCT00621192|590015915|FG001|Overall Study|Withdrawal by Subject|0|||
163356611|NCT00621192|590015916|FG002|Overall Study|Withdrawal by Subject|2|||
163252737|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
163252738|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163252739|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163252740|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163252741|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163356612|NCT00621192|590015917|FG003|Overall Study|Withdrawal by Subject|0|||
163356613|NCT00621192|590015914|FG000|Overall Study|Physician Decision|1|||
163356614|NCT00621192|590015915|FG001|Overall Study|Physician Decision|3|||
163252742|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
163252743|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
163252744|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163252745|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
163252746|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163252747|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163252748|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163252749|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163252750|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163252751|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163252752|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163252753|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163252754|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163252755|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163252756|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163252757|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163252758|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163252759|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163252760|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
163252761|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163252762|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163252763|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
163252764|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
163252765|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163252766|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163252767|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163252768|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163252769|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
163252770|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
163252771|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163252772|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
163252773|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
163252774|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163252775|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163252776|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163252777|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163252778|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163252779|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
163252780|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163252781|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
163252782|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
163252783|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163252784|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163252785|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163252786|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163252787|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
163252788|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163252789|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
163252790|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
163252791|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
163252792|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
163252793|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
163252794|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
163252795|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
163252796|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
163252797|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
163252798|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163252799|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
163252800|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
163252801|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163252802|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163252803|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163252804|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163252805|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163252806|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163252807|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163252808|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163356615|NCT00621192|590015916|FG002|Overall Study|Physician Decision|0|||
163356616|NCT00621192|590015917|FG003|Overall Study|Physician Decision|0|||
163356617|NCT00621192|590015914|FG000|Overall Study|Protocol Violation|1|||
163356618|NCT00621192|590015915|FG001|Overall Study|Protocol Violation|0|||
163356619|NCT00621192|590015916|FG002|Overall Study|Protocol Violation|0|||
163356620|NCT00621192|590015917|FG003|Overall Study|Protocol Violation|1|||
163356621|NCT00621192|590015914|FG000|Overall Study|Adverse Event|0|||
163356622|NCT00621192|590015915|FG001|Overall Study|Adverse Event|1|||
163356623|NCT00621192|590015916|FG002|Overall Study|Adverse Event|0|||
163356624|NCT00621192|590015917|FG003|Overall Study|Adverse Event|1|||
163356625|NCT00621192|590015914|FG000|Overall Study|Death|2|||
163356626|NCT00621192|590015915|FG001|Overall Study|Death|5|||
163356627|NCT00621192|590015916|FG002|Overall Study|Death|0|||
163356628|NCT00621192|590015917|FG003|Overall Study|Death|0|||
163356629|NCT00621192|590015914|FG000|Overall Study|Final Assessments not Completed|0|||
163356630|NCT00621192|590015915|FG001|Overall Study|Final Assessments not Completed|0|||
163356631|NCT00621192|590015916|FG002|Overall Study|Final Assessments not Completed|3|||
163356632|NCT00621192|590015917|FG003|Overall Study|Final Assessments not Completed|1|||
163356633|NCT02635386|590015920|FG000|Overall Study|Pregnancy|2|||
163356634|NCT02635386|590015921|FG001|Overall Study|Pregnancy|0|||
163356635|NCT02635386|590015922|FG002|Overall Study|Pregnancy|0|||
163356636|NCT02635386|590015923|FG003|Overall Study|Pregnancy|0|||
163356637|NCT02635386|590015924|FG004|Overall Study|Pregnancy|2|||
163356638|NCT02635386|590015920|FG000|Overall Study|Withdrawal by Subject|1|||
163356639|NCT02635386|590015921|FG001|Overall Study|Withdrawal by Subject|1|||
163356640|NCT02635386|590015922|FG002|Overall Study|Withdrawal by Subject|0|||
163356641|NCT02635386|590015923|FG003|Overall Study|Withdrawal by Subject|1|||
163356642|NCT02635386|590015924|FG004|Overall Study|Withdrawal by Subject|0|||
163356643|NCT02635386|590015920|FG000|Overall Study|Physician Decision|0|||
163356644|NCT02635386|590015921|FG001|Overall Study|Physician Decision|1|||
163356645|NCT02635386|590015922|FG002|Overall Study|Physician Decision|0|||
163356646|NCT02635386|590015923|FG003|Overall Study|Physician Decision|0|||
163356647|NCT02635386|590015924|FG004|Overall Study|Physician Decision|0|||
163356648|NCT02635386|590015920|FG000|Overall Study|Moved Out of State|0|||
163356649|NCT02635386|590015921|FG001|Overall Study|Moved Out of State|1|||
163356650|NCT02635386|590015922|FG002|Overall Study|Moved Out of State|0|||
163252809|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
163252810|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163252811|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163252812|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163252813|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163252814|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163252815|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163252816|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163252817|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
163252818|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163252819|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163252820|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163252821|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163252822|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163252823|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163252824|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
163252825|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
163252826|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
163252827|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
163252828|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
163252829|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
163252830|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
163252831|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
163252832|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
163252833|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
163252834|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163252835|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163252836|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
163252837|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163252838|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163252839|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163252840|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163252841|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163356651|NCT02635386|590015923|FG003|Overall Study|Moved Out of State|0|||
163356652|NCT02635386|590015924|FG004|Overall Study|Moved Out of State|0|||
163356653|NCT02635386|590015920|FG000|Overall Study|Noncompliant|0|||
163356654|NCT02635386|590015921|FG001|Overall Study|Noncompliant|2|||
163356655|NCT02635386|590015922|FG002|Overall Study|Noncompliant|1|||
163356656|NCT02635386|590015923|FG003|Overall Study|Noncompliant|1|||
163356657|NCT02635386|590015924|FG004|Overall Study|Noncompliant|1|||
163252842|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163252843|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163252844|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163252845|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
163252846|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163252847|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163252848|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163252849|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163252850|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163252851|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
163252852|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163252853|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163252854|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
163252855|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163252856|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163252857|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163252858|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163252859|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163252860|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163252861|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163252862|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
163252863|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
163252864|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163252865|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163252866|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163252867|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163252868|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
163252869|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163252870|NCT01212770|589632087|FG000|Long-term Safety Phase (Year 5)|Death|0|||
163252871|NCT01212770|589632088|FG001|Long-term Safety Phase (Year 5)|Death|0|||
163252872|NCT01212770|589632089|FG002|Long-term Safety Phase (Year 5)|Death|0|||
163252873|NCT01212770|589632090|FG003|Long-term Safety Phase (Year 5)|Death|0|||
163252874|NCT01212770|589632091|FG004|Long-term Safety Phase (Year 5)|Death|0|||
163252875|NCT01212770|589632092|FG005|Long-term Safety Phase (Year 5)|Death|0|||
163252876|NCT01212770|589632093|FG006|Long-term Safety Phase (Year 5)|Death|0|||
163252877|NCT01212770|589632094|FG007|Long-term Safety Phase (Year 5)|Death|1|||
163252878|NCT01212770|589632095|FG008|Long-term Safety Phase (Year 5)|Death|0|||
163252879|NCT01297959|589632096|FG000|Overall Study|Adverse Event|0|||
163252880|NCT01297959|589632097|FG001|Overall Study|Adverse Event|1|||
163252881|NCT01297959|589632096|FG000|Overall Study|Protocol Violation|2|||
163252882|NCT01297959|589632097|FG001|Overall Study|Protocol Violation|1|||
163252883|NCT01297959|589632096|FG000|Overall Study|Withdrawal by Subject|5|||
163252884|NCT01297959|589632097|FG001|Overall Study|Withdrawal by Subject|4|||
163252885|NCT01297959|589632096|FG000|Overall Study|Physician Decision|0|||
163252886|NCT01297959|589632097|FG001|Overall Study|Physician Decision|1|||
163252887|NCT01297959|589632096|FG000|Overall Study|Unrelated medical illness / complication|0|||
163252888|NCT01297959|589632097|FG001|Overall Study|Unrelated medical illness / complication|2|||
163252889|NCT01297959|589632096|FG000|Overall Study|Other|13|||
163252890|NCT01297959|589632097|FG001|Overall Study|Other|7|||
163252891|NCT03519854|589632100|FG000|Overall Study|Technical Error|0|||
163252892|NCT03519854|589632101|FG001|Overall Study|Technical Error|0|||
163252893|NCT03519854|589632102|FG002|Overall Study|Technical Error|1|||
163252894|NCT03519854|589632103|FG003|Overall Study|Technical Error|0|||
163252895|NCT03519854|589632104|FG004|Overall Study|Technical Error|0|||
163252896|NCT03519854|589632105|FG005|Overall Study|Technical Error|0|||
163252897|NCT03519854|589632106|FG006|Overall Study|Technical Error|0|||
163252898|NCT03519854|589632107|FG007|Overall Study|Technical Error|0|||
163252899|NCT03519854|589632108|FG008|Overall Study|Technical Error|0|||
163252900|NCT03519854|589632109|FG009|Overall Study|Technical Error|0|||
163252901|NCT03519854|589632110|FG010|Overall Study|Technical Error|0|||
163252902|NCT03519854|589632111|FG011|Overall Study|Technical Error|0|||
163356658|NCT02635386|590015920|FG000|Overall Study|side effects|0|||
163356659|NCT02635386|590015921|FG001|Overall Study|side effects|0|||
163356660|NCT02635386|590015922|FG002|Overall Study|side effects|1|||
163356661|NCT02635386|590015923|FG003|Overall Study|side effects|4|||
163356662|NCT02635386|590015924|FG004|Overall Study|side effects|6|||
163252903|NCT03519854|589632112|FG012|Overall Study|Technical Error|0|||
163252904|NCT03519854|589632113|FG013|Overall Study|Technical Error|0|||
163252905|NCT03519854|589632114|FG014|Overall Study|Technical Error|0|||
163252906|NCT03519854|589632115|FG015|Overall Study|Technical Error|0|||
163252907|NCT03519854|589632116|FG016|Overall Study|Technical Error|0|||
163252908|NCT03519854|589632117|FG017|Overall Study|Technical Error|0|||
163252909|NCT00951275|589632118|FG000|Overall Study|Administrative Reason|1|||
163252910|NCT00951275|589632118|FG000|Overall Study|Adverse Event|7|||
163252911|NCT00951275|589632118|FG000|Overall Study|Withdrawal by Subject|4|||
163356663|NCT02635386|590015920|FG000|Overall Study|needed other major surgery|0|||
163356664|NCT02635386|590015921|FG001|Overall Study|needed other major surgery|1|||
163356665|NCT02635386|590015922|FG002|Overall Study|needed other major surgery|0|||
163356666|NCT02635386|590015923|FG003|Overall Study|needed other major surgery|0|||
163356667|NCT02635386|590015924|FG004|Overall Study|needed other major surgery|0|||
163356668|NCT02635386|590015920|FG000|Overall Study|Other medical problems not drug related|0|||
163356669|NCT02635386|590015921|FG001|Overall Study|Other medical problems not drug related|0|||
163356670|NCT02635386|590015922|FG002|Overall Study|Other medical problems not drug related|0|||
163356671|NCT02635386|590015923|FG003|Overall Study|Other medical problems not drug related|1|||
163356672|NCT02635386|590015924|FG004|Overall Study|Other medical problems not drug related|0|||
163356673|NCT00745498|590015925|FG000|Overall Study|Lost to Follow-up|1|||
163356674|NCT00745498|590015926|FG001|Overall Study|Lost to Follow-up|1|||
163356675|NCT00745498|590015927|FG002|Overall Study|Lost to Follow-up|3|||
163356676|NCT00745498|590015925|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
163356677|NCT00745498|590015926|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
163356678|NCT00745498|590015927|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
163356679|NCT00745498|590015925|FG000|Overall Study|Non-PDR related VH|0|||
163356680|NCT00745498|590015926|FG001|Overall Study|Non-PDR related VH|1|||
163356681|NCT00745498|590015927|FG002|Overall Study|Non-PDR related VH|1|||
163356682|NCT00745498|590015925|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
163356683|NCT00745498|590015926|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
163356684|NCT00745498|590015927|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
163356685|NCT00267098|590015929|FG000|Overall Study|Death|0|||
163356686|NCT00267098|590015930|FG001|Overall Study|Death|0|||
163356687|NCT00267098|590015931|FG002|Overall Study|Death|57|||
163356688|NCT00267098|590015932|FG003|Overall Study|Death|66|||
163356689|NCT00267098|590015933|FG004|Overall Study|Death|14|||
163356690|NCT00267098|590015934|FG005|Overall Study|Death|23|||
163356691|NCT00267098|590015935|FG006|Overall Study|Death|28|||
163356692|NCT00267098|590015936|FG007|Overall Study|Death|9|||
163356693|NCT00267098|590015929|FG000|Overall Study|Lost to Follow-up|0|||
163356694|NCT00267098|590015930|FG001|Overall Study|Lost to Follow-up|0|||
163356695|NCT00267098|590015931|FG002|Overall Study|Lost to Follow-up|6|||
163356696|NCT00267098|590015932|FG003|Overall Study|Lost to Follow-up|5|||
163356697|NCT00267098|590015933|FG004|Overall Study|Lost to Follow-up|2|||
163356698|NCT00267098|590015934|FG005|Overall Study|Lost to Follow-up|3|||
163356699|NCT00267098|590015935|FG006|Overall Study|Lost to Follow-up|1|||
163356700|NCT00267098|590015936|FG007|Overall Study|Lost to Follow-up|1|||
163356701|NCT00267098|590015929|FG000|Overall Study|Withdrawal by Subject|8|||
163356702|NCT00267098|590015930|FG001|Overall Study|Withdrawal by Subject|0|||
163356703|NCT00267098|590015931|FG002|Overall Study|Withdrawal by Subject|24|||
163356704|NCT00267098|590015932|FG003|Overall Study|Withdrawal by Subject|21|||
163356705|NCT00267098|590015933|FG004|Overall Study|Withdrawal by Subject|12|||
163356706|NCT00267098|590015934|FG005|Overall Study|Withdrawal by Subject|9|||
163356707|NCT00267098|590015935|FG006|Overall Study|Withdrawal by Subject|12|||
163356708|NCT00267098|590015936|FG007|Overall Study|Withdrawal by Subject|5|||
163356709|NCT00267098|590015929|FG000|Overall Study|Physician Decision|5|||
163356710|NCT00267098|590015930|FG001|Overall Study|Physician Decision|0|||
163356711|NCT00267098|590015931|FG002|Overall Study|Physician Decision|7|||
163356712|NCT00267098|590015932|FG003|Overall Study|Physician Decision|11|||
163356713|NCT00267098|590015933|FG004|Overall Study|Physician Decision|5|||
163356714|NCT00267098|590015934|FG005|Overall Study|Physician Decision|4|||
163356715|NCT00267098|590015935|FG006|Overall Study|Physician Decision|3|||
163356716|NCT00267098|590015936|FG007|Overall Study|Physician Decision|0|||
163356717|NCT00267098|590015929|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
163356718|NCT00267098|590015930|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163356719|NCT00267098|590015931|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163356720|NCT00267098|590015932|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163356721|NCT00267098|590015933|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
163356722|NCT00267098|590015934|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163356723|NCT00267098|590015935|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163356724|NCT00267098|590015936|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163356725|NCT00267098|590015929|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
163356726|NCT00267098|590015930|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
163356727|NCT00267098|590015931|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
163356728|NCT00267098|590015932|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
163356729|NCT00267098|590015933|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
163356730|NCT00267098|590015934|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
163356731|NCT00267098|590015935|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
163356732|NCT00267098|590015936|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
163356733|NCT00267098|590015929|FG000|Overall Study|Site closure|0|||
163356734|NCT00267098|590015930|FG001|Overall Study|Site closure|0|||
163356735|NCT00267098|590015931|FG002|Overall Study|Site closure|0|||
163356736|NCT00267098|590015932|FG003|Overall Study|Site closure|1|||
163252912|NCT00951275|589632118|FG000|Overall Study|Protocol Violation|1|||
163252913|NCT02925676|589632119|FG000|Overall Study|Withdrawal by Subject|1|||
163252914|NCT02048072|589632123|FG000|Overall Study|Adverse Event|3|||
163252915|NCT02048072|589632123|FG000|Overall Study|Lost to Follow-up|1|||
163252916|NCT04304833|589632124|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
163252917|NCT04304833|589632125|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
163252918|NCT03776136|589632126|FG000|Overall Study|Death|85|||
163252919|NCT03776136|589632126|FG000|Overall Study|Withdrawal by Subject|3|||
163252920|NCT03776136|589632126|FG000|Overall Study|Sponsor Decision|15|||
163252921|NCT02858895|589632127|FG000|Overall Study|Disease progression|31|||
163252922|NCT02858895|589632127|FG000|Overall Study|Death|2|||
163252923|NCT02858895|589632127|FG000|Overall Study|Adverse Event|1|||
163252924|NCT02858895|589632127|FG000|Overall Study|Withdrawal by Subject|3|||
163252925|NCT02858895|589632127|FG000|Overall Study|hospice,|1|||
163252926|NCT02858895|589632127|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
163252927|NCT00680407|589632135|FG000|Overall Study|Lost to Follow-up|3|||
163252928|NCT00680407|589632136|FG001|Overall Study|Lost to Follow-up|3|||
163252929|NCT00680407|589632137|FG002|Overall Study|Lost to Follow-up|1|||
163252930|NCT00680407|589632135|FG000|Overall Study|Withdrawal by Subject|5|||
163252931|NCT00680407|589632136|FG001|Overall Study|Withdrawal by Subject|2|||
163252932|NCT00680407|589632137|FG002|Overall Study|Withdrawal by Subject|2|||
163252933|NCT02543658|589633874|FG000|Overall Study|Lack of Efficacy|0|||
163252934|NCT02543658|589633875|FG001|Overall Study|Lack of Efficacy|4|||
163252935|NCT04539821|589633882|FG000|Overall Study|Withdrawal by Subject|2|||
163252936|NCT04539821|589633882|FG000|Overall Study|continued care with their physician|20|||
163252937|NCT04539821|589633882|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
163252938|NCT03813238|589633889|FG000|Overall Study|Adverse Event|0|||
163252939|NCT03813238|589633890|FG001|Overall Study|Adverse Event|6|||
163252940|NCT03813238|589633889|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163252941|NCT03813238|589633890|FG001|Overall Study|Withdrawal by parent/guardian|2|||
163252942|NCT03813238|589633889|FG000|Overall Study|Lost to Follow-up|0|||
163252943|NCT03813238|589633890|FG001|Overall Study|Lost to Follow-up|1|||
163252944|NCT03813238|589633889|FG000|Overall Study|Other than specified|1|||
163252945|NCT03813238|589633890|FG001|Overall Study|Other than specified|2|||
163252946|NCT02066402|589633891|FG000|Overall Study|Adverse Event|1|||
163252947|NCT02066402|589633892|FG001|Overall Study|Adverse Event|2|||
163252948|NCT02066402|589633891|FG000|Overall Study|Lost to Follow-up|11|||
163252949|NCT02066402|589633892|FG001|Overall Study|Lost to Follow-up|8|||
163252950|NCT02066402|589633891|FG000|Overall Study|Withdrawal by Subject|14|||
163252951|NCT02066402|589633892|FG001|Overall Study|Withdrawal by Subject|11|||
163252952|NCT02066402|589633891|FG000|Overall Study|Progressive disease-clinical progression|0|||
163252953|NCT02066402|589633892|FG001|Overall Study|Progressive disease-clinical progression|1|||
163252954|NCT02066402|589633891|FG000|Overall Study|Protocol driven decision point|0|||
163252955|NCT02066402|589633892|FG001|Overall Study|Protocol driven decision point|1|||
163252956|NCT00152464|589633893|FG000|Overall Study|Adverse Event|3|||
163252957|NCT00152464|589633894|FG001|Overall Study|Adverse Event|6|||
163252958|NCT00152464|589633893|FG000|Overall Study|Lost to Follow-up|8|||
163252959|NCT00152464|589633894|FG001|Overall Study|Lost to Follow-up|4|||
163252960|NCT00152464|589633893|FG000|Overall Study|Protocol Violation|3|||
163252961|NCT00152464|589633894|FG001|Overall Study|Protocol Violation|1|||
163252962|NCT00152464|589633893|FG000|Overall Study|Withdrawal by Subject|21|||
163252963|NCT00152464|589633894|FG001|Overall Study|Withdrawal by Subject|22|||
163252964|NCT00152464|589633893|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
163252965|NCT00152464|589633894|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
163252966|NCT00152464|589633893|FG000|Overall Study|Eczema deterioration|0|||
163252967|NCT00152464|589633894|FG001|Overall Study|Eczema deterioration|1|||
163252968|NCT00152464|589633893|FG000|Overall Study|Parent decision|1|||
163252969|NCT00152464|589633894|FG001|Overall Study|Parent decision|1|||
163252970|NCT00152464|589633893|FG000|Overall Study|Investigator decision|1|||
163252971|NCT00152464|589633894|FG001|Overall Study|Investigator decision|0|||
163252972|NCT00152464|589633893|FG000|Overall Study|Lack of Efficacy|1|||
163252973|NCT00152464|589633894|FG001|Overall Study|Lack of Efficacy|0|||
163252974|NCT00152464|589633893|FG000|Overall Study|Eczema poorly controlled|1|||
163252975|NCT00152464|589633894|FG001|Overall Study|Eczema poorly controlled|0|||
163252976|NCT00152464|589633893|FG000|Overall Study|Patient relocated|1|||
163252977|NCT00152464|589633894|FG001|Overall Study|Patient relocated|0|||
163252978|NCT02565914|589633895|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
163252979|NCT02565914|589633895|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
163252980|NCT02565914|589633895|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
163252981|NCT02565914|589633895|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
163252982|NCT02565914|589633895|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
163252983|NCT02565914|589633895|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
163252984|NCT02565914|589633895|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
163252985|NCT02565914|589633895|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
163252986|NCT02565914|589633895|FG000|Part A (Up to 96 Weeks)|Other|18|||
163356737|NCT00267098|590015933|FG004|Overall Study|Site closure|0|||
163356738|NCT00267098|590015934|FG005|Overall Study|Site closure|1|||
163356739|NCT00267098|590015935|FG006|Overall Study|Site closure|1|||
163356740|NCT00267098|590015936|FG007|Overall Study|Site closure|0|||
163356741|NCT00267098|590015929|FG000|Overall Study|Explanted Medtronic device|0|||
163356742|NCT00267098|590015930|FG001|Overall Study|Explanted Medtronic device|0|||
163356743|NCT00267098|590015931|FG002|Overall Study|Explanted Medtronic device|0|||
163356744|NCT00267098|590015932|FG003|Overall Study|Explanted Medtronic device|1|||
163356745|NCT00267098|590015933|FG004|Overall Study|Explanted Medtronic device|0|||
163356746|NCT00267098|590015934|FG005|Overall Study|Explanted Medtronic device|0|||
163356747|NCT00267098|590015935|FG006|Overall Study|Explanted Medtronic device|0|||
163356748|NCT00267098|590015936|FG007|Overall Study|Explanted Medtronic device|0|||
163356749|NCT00267098|590015929|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
163356750|NCT00267098|590015930|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
163356751|NCT00267098|590015931|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
163356752|NCT00267098|590015932|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
163356753|NCT00267098|590015933|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
163356754|NCT00267098|590015934|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
163356755|NCT00267098|590015935|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
163356756|NCT00267098|590015936|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
163356757|NCT00267098|590015929|FG000|Overall Study|Subject listed for heart transplant|0|||
163356758|NCT00267098|590015930|FG001|Overall Study|Subject listed for heart transplant|0|||
163356759|NCT00267098|590015931|FG002|Overall Study|Subject listed for heart transplant|0|||
163356760|NCT00267098|590015932|FG003|Overall Study|Subject listed for heart transplant|0|||
163356761|NCT00267098|590015933|FG004|Overall Study|Subject listed for heart transplant|0|||
163356762|NCT00267098|590015934|FG005|Overall Study|Subject listed for heart transplant|0|||
163356763|NCT00267098|590015935|FG006|Overall Study|Subject listed for heart transplant|1|||
163356764|NCT00267098|590015936|FG007|Overall Study|Subject listed for heart transplant|0|||
163356765|NCT00267098|590015929|FG000|Overall Study|Sponsor withdrew subject|0|||
163356766|NCT00267098|590015930|FG001|Overall Study|Sponsor withdrew subject|0|||
163356767|NCT00267098|590015931|FG002|Overall Study|Sponsor withdrew subject|0|||
163356768|NCT00267098|590015932|FG003|Overall Study|Sponsor withdrew subject|1|||
163356769|NCT00267098|590015933|FG004|Overall Study|Sponsor withdrew subject|0|||
163356770|NCT00267098|590015934|FG005|Overall Study|Sponsor withdrew subject|0|||
163356771|NCT00267098|590015935|FG006|Overall Study|Sponsor withdrew subject|0|||
163356772|NCT00267098|590015936|FG007|Overall Study|Sponsor withdrew subject|0|||
163356773|NCT00547534|590015937|FG000|Overall Study|Adverse Event|7|||
163356774|NCT00547534|590015937|FG000|Overall Study|Disease Progression|4|||
163356775|NCT01157377|590015938|FG000|Overall Study|Lost to Follow-up|0|||
163356776|NCT01157377|590015939|FG001|Overall Study|Lost to Follow-up|0|||
163356777|NCT01157377|590015940|FG002|Overall Study|Lost to Follow-up|1|||
163356778|NCT01157377|590015941|FG003|Overall Study|Lost to Follow-up|0|||
163150928|NCT00781768|589266966|FG000|Overall Study|Not transplanted.|0|||
163356779|NCT01157377|590015942|FG004|Overall Study|Lost to Follow-up|1|||
163356780|NCT01157377|590015943|FG005|Overall Study|Lost to Follow-up|1|||
163356781|NCT01157377|590015944|FG006|Overall Study|Lost to Follow-up|0|||
163356782|NCT01157377|590015938|FG000|Overall Study|Personal Reasons|2|||
163356783|NCT01157377|590015939|FG001|Overall Study|Personal Reasons|1|||
163356784|NCT01157377|590015940|FG002|Overall Study|Personal Reasons|0|||
163356785|NCT01157377|590015941|FG003|Overall Study|Personal Reasons|1|||
163356786|NCT01157377|590015942|FG004|Overall Study|Personal Reasons|0|||
163150929|NCT00781768|589266967|FG001|Overall Study|Not transplanted.|2|||
163150930|NCT00079417|589266974|FG000|Overall Study|Physician Decision|2|||
163150931|NCT00079417|589266974|FG000|Overall Study|Ineligible|7|||
163150932|NCT02458313|589266975|FG000|Overall Study|Withdrawal by Subject|6|||
163150933|NCT02458313|589266976|FG001|Overall Study|Withdrawal by Subject|8|||
163150934|NCT02458313|589266975|FG000|Overall Study|Excluded for motion during MRI|1|||
163150935|NCT02458313|589266976|FG001|Overall Study|Excluded for motion during MRI|2|||
163150936|NCT01615939|589266977|FG000|Overall Study|Lost to Follow-up|5|||
163150937|NCT01615939|589266978|FG001|Overall Study|Lost to Follow-up|0|||
163150938|NCT03453164|589266985|FG000|Overall Study|Lack of Efficacy|16|||
163150939|NCT03453164|589266985|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
163150940|NCT01428258|589266986|FG000|Intervention 1|Withdrawal by Subject|2|||
163150941|NCT01428258|589266987|FG001|Intervention 1|Withdrawal by Subject|0|||
163150942|NCT01074502|589266990|FG000|Overall Study|Withdrawal by Subject|1|||
163150943|NCT03459079|589266991|FG000|Overall Study|Adverse Event|4|||
163150944|NCT03459079|589266992|FG001|Overall Study|Adverse Event|2|||
163150945|NCT03459079|589266993|FG002|Overall Study|Adverse Event|0|||
163150946|NCT03459079|589266991|FG000|Overall Study|Withdrawal by Subject|2|||
163150947|NCT03459079|589266992|FG001|Overall Study|Withdrawal by Subject|2|||
163150948|NCT03459079|589266993|FG002|Overall Study|Withdrawal by Subject|0|||
163150949|NCT00674817|589267001|FG000|Period 1|Withdrawal by Subject|2|||
163150950|NCT00674817|589267001|FG000|Period 1|Protocol Violation|1|||
163150951|NCT00674817|589267001|FG000|Period 3|Adverse Event|1|||
163150952|NCT00674817|589267001|FG000|Period 3|Protocol Violation|1|||
163356787|NCT01157377|590015943|FG005|Overall Study|Personal Reasons|0|||
163356788|NCT01157377|590015944|FG006|Overall Study|Personal Reasons|0|||
163356789|NCT01157377|590015938|FG000|Overall Study|Protocol Violation|0|||
163356790|NCT01157377|590015939|FG001|Overall Study|Protocol Violation|0|||
163356791|NCT01157377|590015940|FG002|Overall Study|Protocol Violation|0|||
163356792|NCT01157377|590015941|FG003|Overall Study|Protocol Violation|0|||
163356793|NCT01157377|590015942|FG004|Overall Study|Protocol Violation|0|||
163356794|NCT01157377|590015943|FG005|Overall Study|Protocol Violation|1|||
163356795|NCT01157377|590015944|FG006|Overall Study|Protocol Violation|0|||
163356796|NCT01157377|590015938|FG000|Overall Study|Lack of Efficacy|0|||
163356797|NCT01157377|590015939|FG001|Overall Study|Lack of Efficacy|0|||
163356798|NCT01157377|590015940|FG002|Overall Study|Lack of Efficacy|0|||
163356799|NCT01157377|590015941|FG003|Overall Study|Lack of Efficacy|0|||
163356800|NCT01157377|590015942|FG004|Overall Study|Lack of Efficacy|0|||
163356801|NCT01157377|590015943|FG005|Overall Study|Lack of Efficacy|0|||
163356802|NCT01157377|590015944|FG006|Overall Study|Lack of Efficacy|1|||
163356803|NCT01157377|590015938|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163356804|NCT01157377|590015939|FG001|Overall Study|Other Miscellaneous Reasons|2|||
163356805|NCT01157377|590015940|FG002|Overall Study|Other Miscellaneous Reasons|0|||
163356806|NCT01157377|590015941|FG003|Overall Study|Other Miscellaneous Reasons|0|||
163356807|NCT01157377|590015942|FG004|Overall Study|Other Miscellaneous Reasons|1|||
163356808|NCT01157377|590015943|FG005|Overall Study|Other Miscellaneous Reasons|1|||
163356809|NCT01157377|590015944|FG006|Overall Study|Other Miscellaneous Reasons|1|||
163356810|NCT00904722|590015945|FG000|Overall Study|Physician Decision|1|||
163356811|NCT03561597|590015946|FG000|Overall Study|Lost to Follow-up|20|||
163356812|NCT05347485|590015949|FG000|Overall Study|Death|14|||
163356813|NCT05347485|590015949|FG000|Overall Study|Lost to Follow-up|2|||
163356814|NCT05347485|590015949|FG000|Overall Study|Withdrawal by Subject|13|||
163356815|NCT05347485|590015949|FG000|Overall Study|Progressive Disease|1|||
163356816|NCT05347485|590015949|FG000|Overall Study|Study Terminated by Sponsor|49|||
163356817|NCT05347485|590015949|FG000|Overall Study|Other|1|||
163356818|NCT05347485|590015949|FG000|Overall Study|Enrolled (consented) but not treated|4|||
163356819|NCT05347485|590015949|FG000|Overall Study|Disease Relapse|2|||
163356820|NCT05896696|590015950|FG000|Overall Study|Screening Failure|7|||
163356821|NCT05896696|590015950|FG000|Overall Study|Withdrawal by Subject|2|||
163384900|NCT00427895|590119251|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
163384901|NCT00427895|590119252|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
163384902|NCT00427895|590119253|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
163384903|NCT00427895|590119254|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
163384904|NCT00427895|590119255|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
163384905|NCT00427895|590119256|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
163384906|NCT00427895|590119257|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
163384907|NCT00427895|590119250|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
163384908|NCT00427895|590119251|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
163252987|NCT02565914|589633895|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
163252988|NCT02565914|589633895|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
163252989|NCT02565914|589633895|FG000|Part B (Up to 96 Weeks)|Other|1|||
163252990|NCT02565914|589633895|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
163252991|NCT02565914|589633895|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
163252992|NCT02565914|589633895|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
163252993|NCT02565914|589633895|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
163252994|NCT02565914|589633895|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
163252995|NCT02565914|589633895|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
163384909|NCT00427895|590119252|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
163384910|NCT00427895|590119253|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
163384911|NCT00427895|590119254|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
163384912|NCT00427895|590119255|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
163384913|NCT00427895|590119256|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
163384914|NCT00427895|590119257|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
163384915|NCT00427895|590119250|FG000|Vax 1/Year 1 Follow-up|Death|1|||
163252996|NCT02565914|589633895|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
163252997|NCT02565914|589633895|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
163384916|NCT00427895|590119251|FG001|Vax 1/Year 1 Follow-up|Death|0|||
163384917|NCT00427895|590119252|FG002|Vax 1/Year 1 Follow-up|Death|0|||
163384918|NCT00427895|590119253|FG003|Vax 1/Year 1 Follow-up|Death|0|||
163384919|NCT00427895|590119254|FG004|Vax 1/Year 1 Follow-up|Death|0|||
163384920|NCT00427895|590119255|FG005|Vax 1/Year 1 Follow-up|Death|0|||
163384921|NCT00427895|590119256|FG006|Vax 1/Year 1 Follow-up|Death|0|||
163384922|NCT00427895|590119257|FG007|Vax 1/Year 1 Follow-up|Death|0|||
163384923|NCT00427895|590119250|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
163384924|NCT00427895|590119251|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
163384925|NCT00427895|590119252|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
163384926|NCT00427895|590119253|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
163384927|NCT00427895|590119254|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
163384928|NCT00427895|590119255|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
163384929|NCT00427895|590119256|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
163252998|NCT02565914|589633895|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
163252999|NCT02565914|589633895|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
163253000|NCT02565914|589633895|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
163253001|NCT02565914|589633895|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
163253002|NCT00828984|589633896|FG000|Overall Study|Adverse Event|2|||
163253003|NCT00828984|589633897|FG001|Overall Study|Adverse Event|3|||
163253004|NCT00828984|589633898|FG002|Overall Study|Adverse Event|0|||
163253005|NCT00828984|589633896|FG000|Overall Study|Lost to Follow-up|5|||
163253006|NCT00828984|589633897|FG001|Overall Study|Lost to Follow-up|3|||
163253007|NCT00828984|589633898|FG002|Overall Study|Lost to Follow-up|1|||
163253008|NCT00828984|589633896|FG000|Overall Study|Withdrawal by Subject|4|||
163253009|NCT00828984|589633897|FG001|Overall Study|Withdrawal by Subject|4|||
163253010|NCT00828984|589633898|FG002|Overall Study|Withdrawal by Subject|4|||
163253011|NCT00828984|589633896|FG000|Overall Study|Ineligable|1|||
163253012|NCT00828984|589633897|FG001|Overall Study|Ineligable|2|||
163253013|NCT00828984|589633898|FG002|Overall Study|Ineligable|0|||
163253014|NCT00828984|589633896|FG000|Overall Study|Medical Contraindication|0|||
163253015|NCT00828984|589633897|FG001|Overall Study|Medical Contraindication|1|||
163253016|NCT00828984|589633898|FG002|Overall Study|Medical Contraindication|0|||
163253017|NCT00828984|589633896|FG000|Overall Study|Noncompliant|1|||
163253018|NCT00828984|589633897|FG001|Overall Study|Noncompliant|2|||
163253019|NCT00828984|589633898|FG002|Overall Study|Noncompliant|3|||
163253020|NCT00828984|589633896|FG000|Overall Study|ConMed|1|||
163253021|NCT00828984|589633897|FG001|Overall Study|ConMed|1|||
163253022|NCT00828984|589633898|FG002|Overall Study|ConMed|1|||
163253023|NCT00863655|589633899|FG000|Overall Study|Protocol Violation|4|||
163253024|NCT00863655|589633900|FG001|Overall Study|Protocol Violation|0|||
163253025|NCT00863655|589633899|FG000|Overall Study|Adverse Event|52|||
163253026|NCT00863655|589633900|FG001|Overall Study|Adverse Event|8|||
163253027|NCT00863655|589633899|FG000|Overall Study|Withdrawal by Subject|47|||
163253028|NCT00863655|589633900|FG001|Overall Study|Withdrawal by Subject|7|||
163253029|NCT00863655|589633899|FG000|Overall Study|Administrative problems|1|||
163253030|NCT00863655|589633900|FG001|Overall Study|Administrative problems|0|||
163253031|NCT00863655|589633899|FG000|Overall Study|Death|7|||
163253032|NCT00863655|589633900|FG001|Overall Study|Death|1|||
163253033|NCT00863655|589633899|FG000|Overall Study|New cancer therapy|5|||
163253034|NCT00863655|589633900|FG001|Overall Study|New cancer therapy|1|||
163253035|NCT00863655|589633899|FG000|Overall Study|Disease progression|364|||
163253036|NCT00863655|589633900|FG001|Overall Study|Disease progression|221|||
163253037|NCT00863655|589633899|FG000|Overall Study|Treatment completed as per protocol|5|||
163253038|NCT00863655|589633900|FG001|Overall Study|Treatment completed as per protocol|1|||
163253039|NCT00716092|589633911|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
163253040|NCT00716092|589633912|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
163253041|NCT00716092|589633913|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
163253042|NCT02436330|589633914|FG000|Cohort 1|Lost to Follow-up|5|||
163253043|NCT02436330|589633915|FG001|Cohort 1|Lost to Follow-up|2|||
163253044|NCT02436330|589633914|FG000|Cohort 1|Withdrawal by Subject|0|||
163253045|NCT02436330|589633915|FG001|Cohort 1|Withdrawal by Subject|1|||
163253046|NCT02436330|589633914|FG000|Cohort 2|Lost to Follow-up|2|||
163253047|NCT02436330|589633915|FG001|Cohort 2|Lost to Follow-up|0|||
163253048|NCT02436330|589633914|FG000|Cohort 2|Withdrawal by Subject|2|||
163253049|NCT02436330|589633915|FG001|Cohort 2|Withdrawal by Subject|3|||
163253050|NCT02436330|589633914|FG000|Cohort 3|Lost to Follow-up|1|||
163253051|NCT02436330|589633915|FG001|Cohort 3|Lost to Follow-up|0|||
163253052|NCT02436330|589633914|FG000|Cohort 3|Withdrawal by Subject|4|||
163253053|NCT02436330|589633915|FG001|Cohort 3|Withdrawal by Subject|0|||
163253054|NCT02436330|589633914|FG000|Cohort 4|Lost to Follow-up|1|||
163253055|NCT02436330|589633915|FG001|Cohort 4|Lost to Follow-up|0|||
163253056|NCT02436330|589633914|FG000|Cohort 4|Withdrawal by Subject|1|||
163253057|NCT02436330|589633915|FG001|Cohort 4|Withdrawal by Subject|0|||
163253058|NCT02436330|589633914|FG000|Cohort 5|Lost to Follow-up|3|||
163253059|NCT02436330|589633915|FG001|Cohort 5|Lost to Follow-up|2|||
163253060|NCT02436330|589633914|FG000|Cohort 5|Withdrawal by Subject|3|||
163253061|NCT02436330|589633915|FG001|Cohort 5|Withdrawal by Subject|2|||
163253062|NCT02436330|589633914|FG000|Cohort 6|Lost to Follow-up|2|||
163253063|NCT02436330|589633915|FG001|Cohort 6|Lost to Follow-up|0|||
163253064|NCT02436330|589633914|FG000|Cohort 6|Withdrawal by Subject|1|||
163253065|NCT02436330|589633915|FG001|Cohort 6|Withdrawal by Subject|1|||
163253066|NCT02054806|589633916|FG000|Overall Study|Sponsor Decision|31|||
163253067|NCT02054806|589633916|FG000|Overall Study|Withdrawal by Subject|43|||
163253068|NCT02054806|589633916|FG000|Overall Study|Protocol Violation|2|||
163253069|NCT02054806|589633916|FG000|Overall Study|Lost to Follow-up|10|||
163253070|NCT02054806|589633916|FG000|Overall Study|Death|391|||
163253071|NCT00677235|589633917|FG000|Overall Study|Withdrawal by Subject|1|||
163253072|NCT00677235|589633918|FG001|Overall Study|Withdrawal by Subject|1|||
163253073|NCT00677235|589633917|FG000|Overall Study|Lost to Follow-up|2|||
163253074|NCT00677235|589633918|FG001|Overall Study|Lost to Follow-up|1|||
163253075|NCT00677235|589633917|FG000|Overall Study|Death|37|||
163253076|NCT00677235|589633918|FG001|Overall Study|Death|36|||
163356822|NCT04978350|590017775|FG000|Overall Study|Lost to Follow-up|6|||
163356823|NCT05923112|590017776|FG000|Overall Study|Protocol Violation|4|||
163356824|NCT05923112|590017776|FG000|Overall Study|No informed consent on publication of study results|243|||
163356825|NCT04991766|590017777|FG000|Overall Study|Withdrawal by Subject|2|||
163356826|NCT04991766|590017778|FG001|Overall Study|Withdrawal by Subject|0|||
163356827|NCT00412880|590017784|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
163356828|NCT00412880|590017784|FG000|Overall Study|Consent withdrawn|1|||
163356829|NCT00412880|590017784|FG000|Overall Study|Adverse Event|1|||
163356830|NCT00412880|590017784|FG000|Overall Study|Progressive disease|20|||
163356831|NCT01162135|590017792|FG000|Overall Study|Withdrawal by Subject|1|||
163356832|NCT01162135|590017792|FG000|Overall Study|Severe back pain|1|||
163356833|NCT01162135|590017792|FG000|Overall Study|Ineligible|1|||
163356834|NCT01777334|590017793|FG000|Overall Study|Adverse Event|18|||
163356835|NCT01777334|590017794|FG001|Overall Study|Adverse Event|14|||
163356836|NCT01777334|590017793|FG000|Overall Study|Lack of Efficacy|15|||
163356837|NCT01777334|590017794|FG001|Overall Study|Lack of Efficacy|29|||
163356838|NCT01777334|590017793|FG000|Overall Study|Protocol Violation|3|||
163356839|NCT01777334|590017794|FG001|Overall Study|Protocol Violation|7|||
163356840|NCT01777334|590017793|FG000|Overall Study|Lost to Follow-up|3|||
163356841|NCT01777334|590017794|FG001|Overall Study|Lost to Follow-up|2|||
163356842|NCT01777334|590017793|FG000|Overall Study|Withdrawal by Subject|14|||
163356843|NCT01777334|590017794|FG001|Overall Study|Withdrawal by Subject|11|||
163356844|NCT01216072|590017795|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
163356845|NCT01216072|590017796|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
163356846|NCT01216072|590017795|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
163356847|NCT01216072|590017796|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
163356848|NCT01216072|590017795|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
163356849|NCT01216072|590017796|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
163356850|NCT01216072|590017795|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
163356851|NCT01216072|590017796|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
163356852|NCT01216072|590017795|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
163356853|NCT01216072|590017796|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
163356854|NCT01216072|590017795|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
163356855|NCT01216072|590017796|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
163356856|NCT01216072|590017795|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
163356857|NCT01216072|590017796|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
163356858|NCT01216072|590017795|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
163356859|NCT01216072|590017796|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
163356860|NCT01216072|590017795|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
163356861|NCT01216072|590017796|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
163356862|NCT01216072|590017795|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
163356863|NCT01216072|590017796|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
163356864|NCT06136897|590017797|FG000|Overall Study|Ineligible|3|||
163356865|NCT06136897|590017797|FG000|Overall Study|Mutation status not confirmed|7|||
163356866|NCT06136897|590017797|FG000|Overall Study|Adverse Event|2|||
163356867|NCT06136897|590017797|FG000|Overall Study|Death|1|||
163356868|NCT06136897|590017797|FG000|Overall Study|Disease progression|18|||
163356869|NCT06136897|590017797|FG000|Overall Study|Other complicating disease|1|||
163356870|NCT06136897|590017797|FG000|Overall Study|Withdrawal by Subject|1|||
163356871|NCT06136897|590017797|FG000|Overall Study|Still on treatment|1|||
163356872|NCT06136897|590017797|FG000|Overall Study|Lost to Follow-up|1|||
163356873|NCT01296555|590017798|FG000|Overall Study|Adverse Event|0|||
163356874|NCT01296555|590017799|FG001|Overall Study|Adverse Event|0|||
163356875|NCT01296555|590017800|FG002|Overall Study|Adverse Event|1|||
163356876|NCT01296555|590017801|FG003|Overall Study|Adverse Event|1|||
163356877|NCT01296555|590017802|FG004|Overall Study|Adverse Event|2|||
163356878|NCT01296555|590017803|FG005|Overall Study|Adverse Event|4|||
163356879|NCT01296555|590017804|FG006|Overall Study|Adverse Event|1|||
163356880|NCT01296555|590017805|FG007|Overall Study|Adverse Event|4|||
163356881|NCT01296555|590017806|FG008|Overall Study|Adverse Event|3|||
163356882|NCT01296555|590017807|FG009|Overall Study|Adverse Event|1|||
163356883|NCT01296555|590017808|FG010|Overall Study|Adverse Event|0|||
163356884|NCT01296555|590017809|FG011|Overall Study|Adverse Event|4|||
163356885|NCT01296555|590017810|FG012|Overall Study|Adverse Event|1|||
163356886|NCT01296555|590017811|FG013|Overall Study|Adverse Event|4|||
163356887|NCT01296555|590017812|FG014|Overall Study|Adverse Event|0|||
163356888|NCT01296555|590017813|FG015|Overall Study|Adverse Event|0|||
163356889|NCT01296555|590017814|FG016|Overall Study|Adverse Event|0|||
163356890|NCT01296555|590017815|FG017|Overall Study|Adverse Event|0|||
163356891|NCT01296555|590017816|FG018|Overall Study|Adverse Event|0|||
163356892|NCT01296555|590017817|FG019|Overall Study|Adverse Event|1|||
163410453|NCT05103332|590211369|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
163150953|NCT00674817|589267001|FG000|Period 4|Adverse Event|1|||
163356893|NCT01296555|590017818|FG020|Overall Study|Adverse Event|0|||
163356894|NCT01296555|590017819|FG021|Overall Study|Adverse Event|0|||
163356895|NCT01296555|590017820|FG022|Overall Study|Adverse Event|0|||
163356896|NCT01296555|590017821|FG023|Overall Study|Adverse Event|0|||
163356897|NCT01296555|590017822|FG024|Overall Study|Adverse Event|0|||
163356898|NCT01296555|590017823|FG025|Overall Study|Adverse Event|0|||
163356899|NCT01296555|590017824|FG026|Overall Study|Adverse Event|0|||
163356900|NCT01296555|590017825|FG027|Overall Study|Adverse Event|0|||
163356901|NCT01296555|590017826|FG028|Overall Study|Adverse Event|0|||
163356902|NCT01296555|590017798|FG000|Overall Study|Reason Not Specified|0|||
163356903|NCT01296555|590017799|FG001|Overall Study|Reason Not Specified|0|||
163356904|NCT01296555|590017800|FG002|Overall Study|Reason Not Specified|0|||
163356905|NCT01296555|590017801|FG003|Overall Study|Reason Not Specified|0|||
163356906|NCT01296555|590017802|FG004|Overall Study|Reason Not Specified|0|||
163356907|NCT01296555|590017803|FG005|Overall Study|Reason Not Specified|0|||
163356908|NCT01296555|590017804|FG006|Overall Study|Reason Not Specified|0|||
163356909|NCT01296555|590017805|FG007|Overall Study|Reason Not Specified|0|||
163356910|NCT01296555|590017806|FG008|Overall Study|Reason Not Specified|0|||
163356911|NCT01296555|590017807|FG009|Overall Study|Reason Not Specified|0|||
163356912|NCT01296555|590017808|FG010|Overall Study|Reason Not Specified|0|||
163356913|NCT01296555|590017809|FG011|Overall Study|Reason Not Specified|0|||
163356914|NCT01296555|590017810|FG012|Overall Study|Reason Not Specified|0|||
163356915|NCT01296555|590017811|FG013|Overall Study|Reason Not Specified|1|||
163356916|NCT01296555|590017812|FG014|Overall Study|Reason Not Specified|2|||
163356917|NCT01296555|590017813|FG015|Overall Study|Reason Not Specified|3|||
163356918|NCT01296555|590017814|FG016|Overall Study|Reason Not Specified|7|||
163356919|NCT01296555|590017815|FG017|Overall Study|Reason Not Specified|4|||
163356920|NCT01296555|590017816|FG018|Overall Study|Reason Not Specified|3|||
163356921|NCT01296555|590017817|FG019|Overall Study|Reason Not Specified|7|||
163356922|NCT01296555|590017818|FG020|Overall Study|Reason Not Specified|11|||
163356923|NCT01296555|590017819|FG021|Overall Study|Reason Not Specified|5|||
163356924|NCT01296555|590017820|FG022|Overall Study|Reason Not Specified|5|||
163356925|NCT01296555|590017821|FG023|Overall Study|Reason Not Specified|7|||
163356926|NCT01296555|590017822|FG024|Overall Study|Reason Not Specified|2|||
163356927|NCT01296555|590017823|FG025|Overall Study|Reason Not Specified|2|||
163356928|NCT01296555|590017824|FG026|Overall Study|Reason Not Specified|19|||
163356929|NCT01296555|590017825|FG027|Overall Study|Reason Not Specified|11|||
163356930|NCT01296555|590017826|FG028|Overall Study|Reason Not Specified|9|||
163356931|NCT01296555|590017798|FG000|Overall Study|Physician Decision|0|||
163356932|NCT01296555|590017799|FG001|Overall Study|Physician Decision|0|||
163356933|NCT01296555|590017800|FG002|Overall Study|Physician Decision|0|||
163356934|NCT01296555|590017801|FG003|Overall Study|Physician Decision|0|||
163356935|NCT01296555|590017802|FG004|Overall Study|Physician Decision|1|||
163356936|NCT01296555|590017803|FG005|Overall Study|Physician Decision|0|||
163356937|NCT01296555|590017804|FG006|Overall Study|Physician Decision|0|||
163356938|NCT01296555|590017805|FG007|Overall Study|Physician Decision|0|||
163356939|NCT01296555|590017806|FG008|Overall Study|Physician Decision|0|||
163356940|NCT01296555|590017807|FG009|Overall Study|Physician Decision|0|||
163356941|NCT01296555|590017808|FG010|Overall Study|Physician Decision|0|||
163356942|NCT01296555|590017809|FG011|Overall Study|Physician Decision|0|||
163356943|NCT01296555|590017810|FG012|Overall Study|Physician Decision|0|||
163356944|NCT01296555|590017811|FG013|Overall Study|Physician Decision|1|||
163356945|NCT01296555|590017812|FG014|Overall Study|Physician Decision|0|||
163356946|NCT01296555|590017813|FG015|Overall Study|Physician Decision|0|||
163356947|NCT01296555|590017814|FG016|Overall Study|Physician Decision|0|||
163356948|NCT01296555|590017815|FG017|Overall Study|Physician Decision|0|||
163356949|NCT01296555|590017816|FG018|Overall Study|Physician Decision|0|||
163356950|NCT01296555|590017817|FG019|Overall Study|Physician Decision|1|||
163356951|NCT01296555|590017818|FG020|Overall Study|Physician Decision|0|||
163356952|NCT01296555|590017819|FG021|Overall Study|Physician Decision|0|||
163356953|NCT01296555|590017820|FG022|Overall Study|Physician Decision|0|||
163356954|NCT01296555|590017821|FG023|Overall Study|Physician Decision|0|||
163356955|NCT01296555|590017822|FG024|Overall Study|Physician Decision|0|||
163356956|NCT01296555|590017823|FG025|Overall Study|Physician Decision|0|||
163356957|NCT01296555|590017824|FG026|Overall Study|Physician Decision|0|||
163356958|NCT01296555|590017825|FG027|Overall Study|Physician Decision|0|||
163356959|NCT01296555|590017826|FG028|Overall Study|Physician Decision|0|||
163356960|NCT01296555|590017798|FG000|Overall Study|Progressive Disease|6|||
163356961|NCT01296555|590017799|FG001|Overall Study|Progressive Disease|3|||
163356962|NCT01296555|590017800|FG002|Overall Study|Progressive Disease|3|||
163356963|NCT01296555|590017801|FG003|Overall Study|Progressive Disease|7|||
163356964|NCT01296555|590017802|FG004|Overall Study|Progressive Disease|6|||
163356965|NCT01296555|590017803|FG005|Overall Study|Progressive Disease|16|||
163356966|NCT01296555|590017804|FG006|Overall Study|Progressive Disease|16|||
163356967|NCT01296555|590017805|FG007|Overall Study|Progressive Disease|8|||
163356968|NCT01296555|590017806|FG008|Overall Study|Progressive Disease|7|||
163356969|NCT01296555|590017807|FG009|Overall Study|Progressive Disease|18|||
163356970|NCT01296555|590017808|FG010|Overall Study|Progressive Disease|7|||
163356971|NCT01296555|590017809|FG011|Overall Study|Progressive Disease|14|||
163356972|NCT01296555|590017810|FG012|Overall Study|Progressive Disease|5|||
163356973|NCT01296555|590017811|FG013|Overall Study|Progressive Disease|12|||
163356974|NCT01296555|590017812|FG014|Overall Study|Progressive Disease|1|||
163356975|NCT01296555|590017813|FG015|Overall Study|Progressive Disease|1|||
163356976|NCT01296555|590017814|FG016|Overall Study|Progressive Disease|0|||
163356977|NCT01296555|590017815|FG017|Overall Study|Progressive Disease|0|||
163356978|NCT01296555|590017816|FG018|Overall Study|Progressive Disease|0|||
163356979|NCT01296555|590017817|FG019|Overall Study|Progressive Disease|1|||
163150954|NCT04945733|589267005|FG000|Overall Study|Physician Decision|1|||
163150955|NCT04945733|589267006|FG001|Overall Study|Physician Decision|3|||
163150956|NCT04945733|589267007|FG002|Overall Study|Physician Decision|0|||
163150957|NCT04945733|589267005|FG000|Overall Study|Withdrawal by Subject|3|||
163150958|NCT04945733|589267006|FG001|Overall Study|Withdrawal by Subject|3|||
163150959|NCT04945733|589267007|FG002|Overall Study|Withdrawal by Subject|0|||
163150960|NCT05660577|589267008|FG000|Overall Study|Discontinued|9|||
163150961|NCT03363841|589267013|FG000|Overall Study|Adverse Event|1|||
163150962|NCT03363841|589267013|FG000|Overall Study|Withdrawal by Subject|1|||
163150963|NCT03363841|589267013|FG000|Overall Study|Death|7|||
163150964|NCT03363841|589267013|FG000|Overall Study|Physician Decision|1|||
163150965|NCT02156076|589267018|FG000|Treatment Period|no longer meets study criteria|0|||
163150966|NCT02156076|589267019|FG001|Treatment Period|no longer meets study criteria|0|||
163150967|NCT02156076|589267020|FG002|Treatment Period|no longer meets study criteria|1|||
163150968|NCT02156076|589267021|FG003|Treatment Period|no longer meets study criteria|0|||
163150969|NCT02156076|589267018|FG000|Treatment Period|Poor/non-compliance|0|||
163150970|NCT02156076|589267019|FG001|Treatment Period|Poor/non-compliance|1|||
163150971|NCT02156076|589267020|FG002|Treatment Period|Poor/non-compliance|0|||
163150972|NCT02156076|589267021|FG003|Treatment Period|Poor/non-compliance|0|||
163150973|NCT02156076|589267018|FG000|Treatment Period|Lost to Follow-up|0|||
163150974|NCT02156076|589267019|FG001|Treatment Period|Lost to Follow-up|0|||
163150975|NCT02156076|589267020|FG002|Treatment Period|Lost to Follow-up|0|||
163150976|NCT02156076|589267021|FG003|Treatment Period|Lost to Follow-up|1|||
163150977|NCT02156076|589267018|FG000|Treatment Period|Withdrawal by Subject|0|||
163150978|NCT02156076|589267019|FG001|Treatment Period|Withdrawal by Subject|0|||
163150979|NCT02156076|589267020|FG002|Treatment Period|Withdrawal by Subject|1|||
163150980|NCT02156076|589267021|FG003|Treatment Period|Withdrawal by Subject|0|||
163150981|NCT02156076|589267018|FG000|Treatment Period|Subject request to discontinue treatment|0|||
163150982|NCT02156076|589267019|FG001|Treatment Period|Subject request to discontinue treatment|1|||
163150983|NCT02156076|589267020|FG002|Treatment Period|Subject request to discontinue treatment|0|||
163150984|NCT02156076|589267021|FG003|Treatment Period|Subject request to discontinue treatment|0|||
163150985|NCT02156076|589267018|FG000|Treatment Period|Adverse Event|0|||
163150986|NCT02156076|589267019|FG001|Treatment Period|Adverse Event|0|||
163150987|NCT02156076|589267020|FG002|Treatment Period|Adverse Event|0|||
163150988|NCT02156076|589267021|FG003|Treatment Period|Adverse Event|1|||
163150989|NCT02156076|589267018|FG000|Follow-up Period|Withdrawal by Subject|1|||
163150990|NCT02156076|589267019|FG001|Follow-up Period|Withdrawal by Subject|0|||
163150991|NCT02156076|589267020|FG002|Follow-up Period|Withdrawal by Subject|0|||
163150992|NCT02156076|589267021|FG003|Follow-up Period|Withdrawal by Subject|0|||
163150993|NCT03566511|589267025|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
163150994|NCT03566511|589267026|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
163150995|NCT00981656|589267032|FG000|Overall Study|Protocol Violation|1|||
163150996|NCT00981656|589267032|FG000|Overall Study|Did not start protocol treatment|2|||
163150997|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
163150998|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
163150999|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
163151000|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
163151001|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
163151002|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
163151003|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
163151004|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
163151005|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
163151006|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163151007|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
163151008|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163151009|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
163151010|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
163151011|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
163151012|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
163151013|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
163151014|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
163151015|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
163356980|NCT01296555|590017818|FG020|Overall Study|Progressive Disease|0|||
163356981|NCT01296555|590017819|FG021|Overall Study|Progressive Disease|0|||
163356982|NCT01296555|590017820|FG022|Overall Study|Progressive Disease|0|||
163356983|NCT01296555|590017821|FG023|Overall Study|Progressive Disease|0|||
163356984|NCT01296555|590017822|FG024|Overall Study|Progressive Disease|1|||
163356985|NCT01296555|590017823|FG025|Overall Study|Progressive Disease|0|||
163356986|NCT01296555|590017824|FG026|Overall Study|Progressive Disease|5|||
163356987|NCT01296555|590017825|FG027|Overall Study|Progressive Disease|1|||
163356988|NCT01296555|590017826|FG028|Overall Study|Progressive Disease|0|||
163356989|NCT01296555|590017798|FG000|Overall Study|Protocol Violation|0|||
163356990|NCT01296555|590017799|FG001|Overall Study|Protocol Violation|0|||
163356991|NCT01296555|590017800|FG002|Overall Study|Protocol Violation|0|||
163356992|NCT01296555|590017801|FG003|Overall Study|Protocol Violation|0|||
163356993|NCT01296555|590017802|FG004|Overall Study|Protocol Violation|0|||
163356994|NCT01296555|590017803|FG005|Overall Study|Protocol Violation|0|||
163356995|NCT01296555|590017804|FG006|Overall Study|Protocol Violation|0|||
163356996|NCT01296555|590017805|FG007|Overall Study|Protocol Violation|0|||
163356997|NCT01296555|590017806|FG008|Overall Study|Protocol Violation|0|||
163356998|NCT01296555|590017807|FG009|Overall Study|Protocol Violation|0|||
163356999|NCT01296555|590017808|FG010|Overall Study|Protocol Violation|0|||
163357000|NCT01296555|590017809|FG011|Overall Study|Protocol Violation|0|||
163357001|NCT01296555|590017810|FG012|Overall Study|Protocol Violation|0|||
163357002|NCT01296555|590017811|FG013|Overall Study|Protocol Violation|1|||
163357003|NCT01296555|590017812|FG014|Overall Study|Protocol Violation|0|||
163357004|NCT01296555|590017813|FG015|Overall Study|Protocol Violation|0|||
163357005|NCT01296555|590017814|FG016|Overall Study|Protocol Violation|0|||
163357006|NCT01296555|590017815|FG017|Overall Study|Protocol Violation|0|||
163357007|NCT01296555|590017816|FG018|Overall Study|Protocol Violation|0|||
163357008|NCT01296555|590017817|FG019|Overall Study|Protocol Violation|0|||
163357009|NCT01296555|590017818|FG020|Overall Study|Protocol Violation|0|||
163357010|NCT01296555|590017819|FG021|Overall Study|Protocol Violation|0|||
163357011|NCT01296555|590017820|FG022|Overall Study|Protocol Violation|0|||
163357012|NCT01296555|590017821|FG023|Overall Study|Protocol Violation|0|||
163357013|NCT01296555|590017822|FG024|Overall Study|Protocol Violation|0|||
163357014|NCT01296555|590017823|FG025|Overall Study|Protocol Violation|0|||
163357015|NCT01296555|590017824|FG026|Overall Study|Protocol Violation|0|||
163357016|NCT01296555|590017825|FG027|Overall Study|Protocol Violation|0|||
163357017|NCT01296555|590017826|FG028|Overall Study|Protocol Violation|0|||
163357018|NCT01296555|590017798|FG000|Overall Study|Study Terminated By Sponsor|0|||
163357019|NCT01296555|590017799|FG001|Overall Study|Study Terminated By Sponsor|0|||
163357020|NCT01296555|590017800|FG002|Overall Study|Study Terminated By Sponsor|0|||
163357021|NCT01296555|590017801|FG003|Overall Study|Study Terminated By Sponsor|0|||
163357022|NCT01296555|590017802|FG004|Overall Study|Study Terminated By Sponsor|0|||
163357023|NCT01296555|590017803|FG005|Overall Study|Study Terminated By Sponsor|0|||
163357024|NCT01296555|590017804|FG006|Overall Study|Study Terminated By Sponsor|0|||
163357025|NCT01296555|590017805|FG007|Overall Study|Study Terminated By Sponsor|0|||
163357026|NCT01296555|590017806|FG008|Overall Study|Study Terminated By Sponsor|0|||
163357027|NCT01296555|590017807|FG009|Overall Study|Study Terminated By Sponsor|0|||
163357028|NCT01296555|590017808|FG010|Overall Study|Study Terminated By Sponsor|0|||
163357029|NCT01296555|590017809|FG011|Overall Study|Study Terminated By Sponsor|0|||
163357030|NCT01296555|590017810|FG012|Overall Study|Study Terminated By Sponsor|0|||
163357031|NCT01296555|590017811|FG013|Overall Study|Study Terminated By Sponsor|0|||
163357032|NCT01296555|590017812|FG014|Overall Study|Study Terminated By Sponsor|0|||
163357033|NCT01296555|590017813|FG015|Overall Study|Study Terminated By Sponsor|0|||
163357034|NCT01296555|590017814|FG016|Overall Study|Study Terminated By Sponsor|0|||
163357035|NCT01296555|590017815|FG017|Overall Study|Study Terminated By Sponsor|0|||
163357036|NCT01296555|590017816|FG018|Overall Study|Study Terminated By Sponsor|0|||
163357037|NCT01296555|590017817|FG019|Overall Study|Study Terminated By Sponsor|0|||
163357038|NCT01296555|590017818|FG020|Overall Study|Study Terminated By Sponsor|0|||
163357039|NCT01296555|590017819|FG021|Overall Study|Study Terminated By Sponsor|0|||
163357040|NCT01296555|590017820|FG022|Overall Study|Study Terminated By Sponsor|0|||
163357041|NCT01296555|590017821|FG023|Overall Study|Study Terminated By Sponsor|0|||
163357042|NCT01296555|590017822|FG024|Overall Study|Study Terminated By Sponsor|0|||
163357043|NCT01296555|590017823|FG025|Overall Study|Study Terminated By Sponsor|1|||
163357044|NCT01296555|590017824|FG026|Overall Study|Study Terminated By Sponsor|0|||
163357045|NCT01296555|590017825|FG027|Overall Study|Study Terminated By Sponsor|0|||
163357046|NCT01296555|590017826|FG028|Overall Study|Study Terminated By Sponsor|0|||
163357047|NCT01296555|590017798|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357048|NCT01296555|590017799|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357049|NCT01296555|590017800|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357050|NCT01296555|590017801|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357051|NCT01296555|590017802|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357052|NCT01296555|590017803|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357053|NCT01296555|590017804|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357054|NCT01296555|590017805|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357055|NCT01296555|590017806|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357056|NCT01296555|590017807|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163253077|NCT00677235|589633917|FG000|Overall Study|Adverse Experience|1|||
163253078|NCT00677235|589633918|FG001|Overall Study|Adverse Experience|0|||
163253079|NCT01040260|589633919|FG000|Overall Study|Withdrawal by Subject|12|||
163253080|NCT01040260|589633920|FG001|Overall Study|Withdrawal by Subject|6|||
163253081|NCT01040260|589633919|FG000|Overall Study|Lost to Follow-up|3|||
163253082|NCT01040260|589633920|FG001|Overall Study|Lost to Follow-up|5|||
163253083|NCT00708916|589633925|FG000|Overall Study|Subject Noncompliance|2|||
163253084|NCT00708916|589633925|FG000|Overall Study|Adverse Event|2|||
163253085|NCT03923959|589633928|FG000|Overall Study|Death|16|||
163253086|NCT03923959|589633929|FG001|Overall Study|Death|12|||
163253087|NCT03923959|589633928|FG000|Overall Study|Lost to Follow-up|56|||
163253088|NCT03923959|589633929|FG001|Overall Study|Lost to Follow-up|56|||
163253089|NCT03923959|589633928|FG000|Overall Study|Withdrawal by Subject|1|||
163253090|NCT03923959|589633929|FG001|Overall Study|Withdrawal by Subject|1|||
163253091|NCT03923959|589633928|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
163253092|NCT03923959|589633929|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
163253093|NCT04212091|589633930|FG000|Overall Study|Lost to Follow-up|0|||
163253094|NCT04212091|589633931|FG001|Overall Study|Lost to Follow-up|0|||
163253095|NCT04212091|589633932|FG002|Overall Study|Lost to Follow-up|0|||
163253096|NCT04212091|589633933|FG003|Overall Study|Lost to Follow-up|0|||
163253097|NCT04212091|589633934|FG004|Overall Study|Lost to Follow-up|1|||
163253098|NCT04212091|589633935|FG005|Overall Study|Lost to Follow-up|1|||
163253099|NCT04212091|589633930|FG000|Overall Study|Participant unable to adhere to visit|0|||
163253100|NCT04212091|589633931|FG001|Overall Study|Participant unable to adhere to visit|0|||
163253101|NCT04212091|589633932|FG002|Overall Study|Participant unable to adhere to visit|0|||
163253102|NCT04212091|589633933|FG003|Overall Study|Participant unable to adhere to visit|0|||
163253103|NCT04212091|589633934|FG004|Overall Study|Participant unable to adhere to visit|1|||
163253104|NCT04212091|589633935|FG005|Overall Study|Participant unable to adhere to visit|0|||
163253105|NCT04575051|589633936|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
163253106|NCT04575051|589633937|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
163253107|NCT04575051|589633938|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
163253108|NCT04575051|589633939|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
163253109|NCT04575051|589633940|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
163253110|NCT04575051|589633936|FG000|Time Period 1|Missing follow up|1|||
163253111|NCT04575051|589633937|FG001|Time Period 1|Missing follow up|3|||
163253112|NCT04575051|589633938|FG002|Time Period 1|Missing follow up|1|||
163253113|NCT04575051|589633939|FG003|Time Period 1|Missing follow up|3|||
163253114|NCT04575051|589633940|FG004|Time Period 1|Missing follow up|2|||
163253115|NCT04575051|589633936|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
163253116|NCT04575051|589633937|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
163253117|NCT04575051|589633938|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
163253118|NCT04575051|589633939|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
163253119|NCT04575051|589633940|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
163253120|NCT04575051|589633936|FG000|Time Period 2|Missing follow up|1|||
163253121|NCT04575051|589633937|FG001|Time Period 2|Missing follow up|8|||
163253122|NCT04575051|589633938|FG002|Time Period 2|Missing follow up|7|||
163253123|NCT04575051|589633939|FG003|Time Period 2|Missing follow up|0|||
163357057|NCT01296555|590017808|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357058|NCT01296555|590017809|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357059|NCT01296555|590017810|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357060|NCT01296555|590017811|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357061|NCT01296555|590017812|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357062|NCT01296555|590017813|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357063|NCT01296555|590017814|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357064|NCT01296555|590017815|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357065|NCT01296555|590017816|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357066|NCT01296555|590017817|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
163357067|NCT01296555|590017818|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357068|NCT01296555|590017819|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357069|NCT01296555|590017820|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357070|NCT01296555|590017821|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357071|NCT01296555|590017822|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357072|NCT01296555|590017823|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357073|NCT01296555|590017824|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357074|NCT01296555|590017825|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163357075|NCT01296555|590017826|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163253124|NCT04575051|589633940|FG004|Time Period 2|Missing follow up|1|||
163253125|NCT04575051|589633936|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
163357076|NCT01296555|590017798|FG000|Overall Study|Death|0|||
163357077|NCT01296555|590017799|FG001|Overall Study|Death|0|||
163357078|NCT01296555|590017800|FG002|Overall Study|Death|0|||
163253126|NCT04575051|589633937|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
163253127|NCT04575051|589633938|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
163253128|NCT04575051|589633939|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
163253129|NCT04575051|589633940|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
163253130|NCT04575051|589633936|FG000|Time Period 3|Missing follow up|8|||
163253131|NCT04575051|589633937|FG001|Time Period 3|Missing follow up|6|||
163253132|NCT04575051|589633938|FG002|Time Period 3|Missing follow up|4|||
163253133|NCT04575051|589633939|FG003|Time Period 3|Missing follow up|3|||
163253134|NCT04575051|589633940|FG004|Time Period 3|Missing follow up|0|||
163253135|NCT04575051|589633936|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
163253136|NCT04575051|589633937|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
163253137|NCT04575051|589633938|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
163253138|NCT04575051|589633939|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
163253139|NCT04575051|589633940|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
163253140|NCT04575051|589633936|FG000|Time Period 4|Missing follow up|17|||
163253141|NCT04575051|589633937|FG001|Time Period 4|Missing follow up|3|||
163253142|NCT04575051|589633938|FG002|Time Period 4|Missing follow up|4|||
163253143|NCT04575051|589633939|FG003|Time Period 4|Missing follow up|2|||
163253144|NCT04575051|589633940|FG004|Time Period 4|Missing follow up|1|||
163253145|NCT04575051|589633936|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
163253146|NCT04575051|589633937|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
163253147|NCT04575051|589633938|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
163253148|NCT04575051|589633939|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
163253149|NCT04575051|589633940|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
163253150|NCT04575051|589633936|FG000|Time Period 5|Missing follow up|11|||
163253151|NCT04575051|589633937|FG001|Time Period 5|Missing follow up|8|||
163253152|NCT04575051|589633938|FG002|Time Period 5|Missing follow up|12|||
163253153|NCT04575051|589633939|FG003|Time Period 5|Missing follow up|3|||
163253154|NCT04575051|589633940|FG004|Time Period 5|Missing follow up|11|||
163253155|NCT00951483|589633941|FG000|Overall Study|Physician Decision|4|||
163253156|NCT00951483|589633942|FG001|Overall Study|Physician Decision|0|||
163253157|NCT00951483|589633941|FG000|Overall Study|Withdrawal by Subject|15|||
163253158|NCT00951483|589633942|FG001|Overall Study|Withdrawal by Subject|0|||
163253159|NCT03565887|589633943|FG000|Overall Study|Adverse Event|1|||
163253160|NCT03565887|589633944|FG001|Overall Study|Adverse Event|0|||
163253161|NCT03565887|589633943|FG000|Overall Study|Withdrawal by Subject|0|||
163253162|NCT03565887|589633944|FG001|Overall Study|Withdrawal by Subject|2|||
163253163|NCT00689221|589633945|FG000|Overall Study|Ongoing at cut-off date|39|||
163253164|NCT00689221|589633946|FG001|Overall Study|Ongoing at cut-off date|36|||
163253165|NCT03182868|589633947|FG000|Overall Study|Protocol Violation|3|||
163253166|NCT03182868|589633948|FG001|Overall Study|Protocol Violation|0|||
163253167|NCT03182868|589633949|FG002|Overall Study|Protocol Violation|4|||
163253168|NCT03182868|589633950|FG003|Overall Study|Protocol Violation|1|||
163253169|NCT03182868|589633951|FG004|Overall Study|Protocol Violation|8|||
163253170|NCT01292239|589633952|FG000|Overall Study|Other|1|||
163253171|NCT01292239|589633953|FG001|Overall Study|Other|1|||
163253172|NCT01292239|589633952|FG000|Overall Study|Withdrawal by Subject|3|||
163253173|NCT01292239|589633953|FG001|Overall Study|Withdrawal by Subject|6|||
163253174|NCT00262821|589633954|FG000|Overall Study|Ineligible - wrong stage|0|||
163253175|NCT00262821|589633955|FG001|Overall Study|Ineligible - wrong stage|3|||
163253176|NCT00262821|589633954|FG000|Overall Study|Ineligible - wrong cell type|2|||
163253177|NCT00262821|589633955|FG001|Overall Study|Ineligible - wrong cell type|2|||
163253178|NCT00262821|589633954|FG000|Overall Study|Ineligible - wrong primary|0|||
163253179|NCT00262821|589633955|FG001|Overall Study|Ineligible - wrong primary|1|||
163253180|NCT00262821|589633954|FG000|Overall Study|Ineligible - inadequate pathology|1|||
163253181|NCT00262821|589633955|FG001|Overall Study|Ineligible - inadequate pathology|3|||
163253182|NCT00262821|589633954|FG000|Overall Study|Ineligible - elevated creatinine|0|||
163253183|NCT00262821|589633955|FG001|Overall Study|Ineligible - elevated creatinine|2|||
163253184|NCT00262821|589633954|FG000|Overall Study|Ineligible - required test not done|1|||
163253185|NCT00262821|589633955|FG001|Overall Study|Ineligible - required test not done|4|||
163253186|NCT00262821|589633954|FG000|Overall Study|Inevaluable - inadequate data|0|||
163253187|NCT00262821|589633955|FG001|Overall Study|Inevaluable - inadequate data|4|||
163253188|NCT00765388|589633956|FG000|Period 1|Lack of Efficacy|1|||
163253189|NCT00765388|589633957|FG001|Period 1|Lack of Efficacy|2|||
163253190|NCT00765388|589633956|FG000|Period 1|Lost to Follow-up|0|||
163253191|NCT00765388|589633957|FG001|Period 1|Lost to Follow-up|1|||
163253192|NCT00765388|589633956|FG000|Period 1|Herpes Zoster|0|||
163253193|NCT00765388|589633957|FG001|Period 1|Herpes Zoster|1|||
163253194|NCT00765388|589633956|FG000|Period 1|Hip operation|0|||
163253195|NCT00765388|589633957|FG001|Period 1|Hip operation|1|||
163253196|NCT03923933|589633958|FG000|Overall Study|Lost to Follow-up|1|||
163253197|NCT03923933|589633959|FG001|Overall Study|Lost to Follow-up|0|||
163253198|NCT03923933|589633958|FG000|Overall Study|Withdrawal by Subject|0|||
163253199|NCT03923933|589633959|FG001|Overall Study|Withdrawal by Subject|1|||
163253200|NCT01995461|589633960|FG000|Overall Study|Death|1|||
163253201|NCT01995461|589633960|FG000|Overall Study|Lost to Follow-up|2|||
163253202|NCT01995461|589633960|FG000|Overall Study|Withdrawal by Subject|2|||
163253203|NCT01777854|589633962|FG000|Overall Study|Physician Decision|3|||
163253204|NCT01777854|589633963|FG001|Overall Study|Physician Decision|3|||
163253205|NCT01939548|589633964|FG000|Overall Study|Non compliance|0|||
163253206|NCT01939548|589633965|FG001|Overall Study|Non compliance|2|||
163253207|NCT01939548|589633966|FG002|Overall Study|Non compliance|0|||
163253208|NCT01939548|589633964|FG000|Overall Study|Study Terminated by Sponsor|17|||
163253209|NCT01939548|589633965|FG001|Overall Study|Study Terminated by Sponsor|19|||
163253210|NCT01939548|589633966|FG002|Overall Study|Study Terminated by Sponsor|12|||
163253211|NCT01939548|589633964|FG000|Overall Study|Insufficient Clinical Response|1|||
163253212|NCT01939548|589633965|FG001|Overall Study|Insufficient Clinical Response|0|||
163253213|NCT01939548|589633966|FG002|Overall Study|Insufficient Clinical Response|0|||
163253214|NCT01939548|589633964|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
163253215|NCT01939548|589633965|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
163253216|NCT01939548|589633966|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
163253217|NCT01939548|589633964|FG000|Overall Study|Withdrawal by Subject|4|||
163253218|NCT01939548|589633965|FG001|Overall Study|Withdrawal by Subject|4|||
163253219|NCT01939548|589633966|FG002|Overall Study|Withdrawal by Subject|1|||
163253220|NCT01939548|589633964|FG000|Overall Study|Protocol Violation|7|||
163253221|NCT01939548|589633965|FG001|Overall Study|Protocol Violation|6|||
163253222|NCT01939548|589633966|FG002|Overall Study|Protocol Violation|5|||
163253223|NCT01939548|589633964|FG000|Overall Study|Lost to Follow-up|5|||
163253224|NCT01939548|589633965|FG001|Overall Study|Lost to Follow-up|5|||
163253225|NCT01939548|589633966|FG002|Overall Study|Lost to Follow-up|3|||
163253226|NCT01939548|589633964|FG000|Overall Study|Adverse Event|2|||
163253227|NCT01939548|589633965|FG001|Overall Study|Adverse Event|9|||
163253228|NCT01939548|589633966|FG002|Overall Study|Adverse Event|7|||
163151016|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
163151017|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
163151018|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
163151019|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
163151020|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
163151021|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
163151022|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
163151023|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
163151024|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
163151025|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
163151026|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
163151027|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
163151028|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
163151029|NCT04026113|589267033|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
163151030|NCT04026113|589267034|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
163151031|NCT04026113|589267035|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
163151032|NCT04026113|589267036|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
163151033|NCT00687596|589267037|FG000|Overall Study|Adverse Event (AE)|10|||
163151034|NCT00687596|589267038|FG001|Overall Study|Adverse Event (AE)|3|||
163151035|NCT00687596|589267037|FG000|Overall Study|Radiological Disease Progression|6|||
163151036|NCT00687596|589267038|FG001|Overall Study|Radiological Disease Progression|2|||
163151037|NCT00687596|589267037|FG000|Overall Study|Clinical Disease Progression|1|||
163151038|NCT00687596|589267038|FG001|Overall Study|Clinical Disease Progression|3|||
163151039|NCT00687596|589267037|FG000|Overall Study|Investigator Discretion|3|||
163151040|NCT00687596|589267038|FG001|Overall Study|Investigator Discretion|1|||
163151041|NCT00687596|589267037|FG000|Overall Study|Sponsor Terminated Study|6|||
163151042|NCT00687596|589267038|FG001|Overall Study|Sponsor Terminated Study|17|||
163151043|NCT01527149|589267039|FG000|Overall Study|Death|2|||
163151044|NCT01709721|589267040|FG000|Open Label Phase|Withdrawal by Subject|0|||
163151045|NCT01709721|589267041|FG001|Open Label Phase|Withdrawal by Subject|0|||
163151046|NCT01709721|589267042|FG002|Open Label Phase|Withdrawal by Subject|5|||
163151047|NCT01709721|589267040|FG000|Open Label Phase|Adverse Event|0|||
163151048|NCT01709721|589267041|FG001|Open Label Phase|Adverse Event|0|||
163151049|NCT01709721|589267042|FG002|Open Label Phase|Adverse Event|8|||
163151050|NCT01709721|589267040|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
163151051|NCT01709721|589267041|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
163253229|NCT01939548|589633964|FG000|Overall Study|Death|0|||
163253230|NCT01939548|589633965|FG001|Overall Study|Death|0|||
163253231|NCT01939548|589633966|FG002|Overall Study|Death|1|||
163253232|NCT01939548|589633964|FG000|Overall Study|Participant dropped|0|||
163253233|NCT01939548|589633965|FG001|Overall Study|Participant dropped|0|||
163253234|NCT01939548|589633966|FG002|Overall Study|Participant dropped|1|||
163253235|NCT01939548|589633964|FG000|Overall Study|Participant unwilling to continue|0|||
163253236|NCT01939548|589633965|FG001|Overall Study|Participant unwilling to continue|1|||
163357079|NCT01296555|590017801|FG003|Overall Study|Death|2|||
163357080|NCT01296555|590017802|FG004|Overall Study|Death|1|||
163357081|NCT01296555|590017803|FG005|Overall Study|Death|0|||
163357082|NCT01296555|590017804|FG006|Overall Study|Death|2|||
163357083|NCT01296555|590017805|FG007|Overall Study|Death|0|||
163357084|NCT01296555|590017806|FG008|Overall Study|Death|0|||
163357085|NCT01296555|590017807|FG009|Overall Study|Death|1|||
163357086|NCT01296555|590017808|FG010|Overall Study|Death|0|||
163357087|NCT01296555|590017809|FG011|Overall Study|Death|1|||
163357088|NCT01296555|590017810|FG012|Overall Study|Death|0|||
163357089|NCT01296555|590017811|FG013|Overall Study|Death|2|||
163357090|NCT01296555|590017812|FG014|Overall Study|Death|27|||
163357091|NCT01296555|590017813|FG015|Overall Study|Death|15|||
163357092|NCT01296555|590017814|FG016|Overall Study|Death|11|||
163357093|NCT01296555|590017815|FG017|Overall Study|Death|11|||
163357094|NCT01296555|590017816|FG018|Overall Study|Death|17|||
163357095|NCT01296555|590017817|FG019|Overall Study|Death|12|||
163357096|NCT01296555|590017818|FG020|Overall Study|Death|13|||
163357097|NCT01296555|590017819|FG021|Overall Study|Death|12|||
163357098|NCT01296555|590017820|FG022|Overall Study|Death|12|||
163357099|NCT01296555|590017821|FG023|Overall Study|Death|13|||
163357100|NCT01296555|590017822|FG024|Overall Study|Death|7|||
163357101|NCT01296555|590017823|FG025|Overall Study|Death|7|||
163357102|NCT01296555|590017824|FG026|Overall Study|Death|35|||
163357103|NCT01296555|590017825|FG027|Overall Study|Death|92|||
163357104|NCT01296555|590017826|FG028|Overall Study|Death|44|||
163357105|NCT01296555|590017798|FG000|Overall Study|Lost to Follow-up|0|||
163357106|NCT01296555|590017799|FG001|Overall Study|Lost to Follow-up|0|||
163357107|NCT01296555|590017800|FG002|Overall Study|Lost to Follow-up|0|||
163357108|NCT01296555|590017801|FG003|Overall Study|Lost to Follow-up|0|||
163357109|NCT01296555|590017802|FG004|Overall Study|Lost to Follow-up|0|||
163357110|NCT01296555|590017803|FG005|Overall Study|Lost to Follow-up|0|||
163357111|NCT01296555|590017804|FG006|Overall Study|Lost to Follow-up|0|||
163357112|NCT01296555|590017805|FG007|Overall Study|Lost to Follow-up|0|||
163357113|NCT01296555|590017806|FG008|Overall Study|Lost to Follow-up|0|||
163357114|NCT01296555|590017807|FG009|Overall Study|Lost to Follow-up|0|||
163357115|NCT01296555|590017808|FG010|Overall Study|Lost to Follow-up|0|||
163357116|NCT01296555|590017809|FG011|Overall Study|Lost to Follow-up|0|||
163357117|NCT01296555|590017810|FG012|Overall Study|Lost to Follow-up|0|||
163357118|NCT01296555|590017811|FG013|Overall Study|Lost to Follow-up|0|||
163357119|NCT01296555|590017812|FG014|Overall Study|Lost to Follow-up|2|||
163357120|NCT01296555|590017813|FG015|Overall Study|Lost to Follow-up|1|||
163357121|NCT01296555|590017814|FG016|Overall Study|Lost to Follow-up|0|||
163357122|NCT01296555|590017815|FG017|Overall Study|Lost to Follow-up|2|||
163357123|NCT01296555|590017816|FG018|Overall Study|Lost to Follow-up|0|||
163357124|NCT01296555|590017817|FG019|Overall Study|Lost to Follow-up|2|||
163357125|NCT01296555|590017818|FG020|Overall Study|Lost to Follow-up|3|||
163357126|NCT01296555|590017819|FG021|Overall Study|Lost to Follow-up|2|||
163357127|NCT01296555|590017820|FG022|Overall Study|Lost to Follow-up|0|||
163357128|NCT01296555|590017821|FG023|Overall Study|Lost to Follow-up|0|||
163357129|NCT01296555|590017822|FG024|Overall Study|Lost to Follow-up|0|||
163357130|NCT01296555|590017823|FG025|Overall Study|Lost to Follow-up|0|||
163357131|NCT01296555|590017824|FG026|Overall Study|Lost to Follow-up|3|||
163357132|NCT01296555|590017825|FG027|Overall Study|Lost to Follow-up|13|||
163357133|NCT01296555|590017826|FG028|Overall Study|Lost to Follow-up|5|||
163357134|NCT01296555|590017798|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163357135|NCT01296555|590017799|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163357136|NCT01296555|590017800|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163357137|NCT01296555|590017801|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163357138|NCT01296555|590017802|FG004|Overall Study|Non-Compliance With Study Drug|0|||
163357139|NCT01296555|590017803|FG005|Overall Study|Non-Compliance With Study Drug|0|||
163357140|NCT01296555|590017804|FG006|Overall Study|Non-Compliance With Study Drug|0|||
163357141|NCT01296555|590017805|FG007|Overall Study|Non-Compliance With Study Drug|1|||
163357142|NCT01296555|590017806|FG008|Overall Study|Non-Compliance With Study Drug|0|||
163357143|NCT01296555|590017807|FG009|Overall Study|Non-Compliance With Study Drug|0|||
163357144|NCT01296555|590017808|FG010|Overall Study|Non-Compliance With Study Drug|0|||
163357145|NCT01296555|590017809|FG011|Overall Study|Non-Compliance With Study Drug|0|||
163357146|NCT01296555|590017810|FG012|Overall Study|Non-Compliance With Study Drug|0|||
163357147|NCT01296555|590017811|FG013|Overall Study|Non-Compliance With Study Drug|0|||
163357148|NCT01296555|590017812|FG014|Overall Study|Non-Compliance With Study Drug|0|||
163357149|NCT01296555|590017813|FG015|Overall Study|Non-Compliance With Study Drug|0|||
163357150|NCT01296555|590017814|FG016|Overall Study|Non-Compliance With Study Drug|0|||
163357151|NCT01296555|590017815|FG017|Overall Study|Non-Compliance With Study Drug|0|||
163357152|NCT01296555|590017816|FG018|Overall Study|Non-Compliance With Study Drug|0|||
163357153|NCT01296555|590017817|FG019|Overall Study|Non-Compliance With Study Drug|0|||
163357154|NCT01296555|590017818|FG020|Overall Study|Non-Compliance With Study Drug|0|||
163357155|NCT01296555|590017819|FG021|Overall Study|Non-Compliance With Study Drug|0|||
163357156|NCT01296555|590017820|FG022|Overall Study|Non-Compliance With Study Drug|0|||
163357157|NCT01296555|590017821|FG023|Overall Study|Non-Compliance With Study Drug|0|||
163357158|NCT01296555|590017822|FG024|Overall Study|Non-Compliance With Study Drug|0|||
163357159|NCT01296555|590017823|FG025|Overall Study|Non-Compliance With Study Drug|0|||
163357160|NCT01296555|590017824|FG026|Overall Study|Non-Compliance With Study Drug|0|||
163357161|NCT01296555|590017825|FG027|Overall Study|Non-Compliance With Study Drug|0|||
163357162|NCT01296555|590017826|FG028|Overall Study|Non-Compliance With Study Drug|0|||
163357163|NCT01296555|590017798|FG000|Overall Study|Withdrawal by Subject|0|||
163357164|NCT01296555|590017799|FG001|Overall Study|Withdrawal by Subject|0|||
163357165|NCT01296555|590017800|FG002|Overall Study|Withdrawal by Subject|0|||
163357166|NCT01296555|590017801|FG003|Overall Study|Withdrawal by Subject|0|||
163357167|NCT01296555|590017802|FG004|Overall Study|Withdrawal by Subject|1|||
163357168|NCT01296555|590017803|FG005|Overall Study|Withdrawal by Subject|0|||
163357169|NCT01296555|590017804|FG006|Overall Study|Withdrawal by Subject|1|||
163357170|NCT01296555|590017805|FG007|Overall Study|Withdrawal by Subject|0|||
163357171|NCT01296555|590017806|FG008|Overall Study|Withdrawal by Subject|0|||
163357172|NCT01296555|590017807|FG009|Overall Study|Withdrawal by Subject|0|||
163357173|NCT01296555|590017808|FG010|Overall Study|Withdrawal by Subject|1|||
163357174|NCT01296555|590017809|FG011|Overall Study|Withdrawal by Subject|1|||
163357175|NCT01296555|590017810|FG012|Overall Study|Withdrawal by Subject|0|||
163357176|NCT01296555|590017811|FG013|Overall Study|Withdrawal by Subject|0|||
163357177|NCT01296555|590017812|FG014|Overall Study|Withdrawal by Subject|3|||
163357178|NCT01296555|590017813|FG015|Overall Study|Withdrawal by Subject|0|||
163357179|NCT01296555|590017814|FG016|Overall Study|Withdrawal by Subject|2|||
163357180|NCT01296555|590017815|FG017|Overall Study|Withdrawal by Subject|1|||
163357181|NCT01296555|590017816|FG018|Overall Study|Withdrawal by Subject|0|||
163357182|NCT01296555|590017817|FG019|Overall Study|Withdrawal by Subject|1|||
163357183|NCT01296555|590017818|FG020|Overall Study|Withdrawal by Subject|1|||
163357184|NCT01296555|590017819|FG021|Overall Study|Withdrawal by Subject|1|||
163357185|NCT01296555|590017820|FG022|Overall Study|Withdrawal by Subject|3|||
163357186|NCT01296555|590017821|FG023|Overall Study|Withdrawal by Subject|0|||
163357187|NCT01296555|590017822|FG024|Overall Study|Withdrawal by Subject|0|||
163357188|NCT01296555|590017823|FG025|Overall Study|Withdrawal by Subject|0|||
163357189|NCT01296555|590017824|FG026|Overall Study|Withdrawal by Subject|8|||
163357190|NCT01296555|590017825|FG027|Overall Study|Withdrawal by Subject|4|||
163357191|NCT01296555|590017826|FG028|Overall Study|Withdrawal by Subject|2|||
163357192|NCT00992992|590017827|FG000|Overall Study|Lost to Follow-up|3|||
163357193|NCT00992992|590017827|FG000|Overall Study|Death|16|||
163357194|NCT00992992|590017827|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
163357195|NCT00992992|590017827|FG000|Overall Study|Sponsor Closed the Study|4|||
163357196|NCT00217022|590017829|FG000|Overall Study|Withdrawal by Subject|1|||
163357197|NCT00217022|590017830|FG001|Overall Study|Withdrawal by Subject|1|||
163357198|NCT01253447|590017831|FG000|Overall Study|Adverse Event|2|||
163357199|NCT02299427|590017832|FG000|Overall Study|Withdrawal by Subject|1|||
163357200|NCT02299427|590017833|FG001|Overall Study|Withdrawal by Subject|0|||
163253237|NCT01939548|589633966|FG002|Overall Study|Participant unwilling to continue|0|||
163253238|NCT01939548|589633964|FG000|Overall Study|Participant withdrew consent|0|||
163253239|NCT01939548|589633965|FG001|Overall Study|Participant withdrew consent|2|||
163253240|NCT01939548|589633966|FG002|Overall Study|Participant withdrew consent|0|||
163253241|NCT01939548|589633964|FG000|Overall Study|Did not complete follow-up|0|||
163253242|NCT01939548|589633965|FG001|Overall Study|Did not complete follow-up|1|||
163253243|NCT01939548|589633966|FG002|Overall Study|Did not complete follow-up|0|||
163253244|NCT03311373|589633967|FG000|Overall Study|Adverse Event|1|||
163253245|NCT03311373|589633967|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
163253246|NCT03311373|589633967|FG000|Overall Study|Lost to Follow-up|1|||
163253247|NCT03311373|589633967|FG000|Overall Study|Physician Decision|1|||
163253248|NCT03311373|589633967|FG000|Overall Study|Withdrawal by Subject|3|||
163253249|NCT01022762|589633970|FG000|Overall Study|Adverse Event|3|||
163253250|NCT01022762|589633971|FG001|Overall Study|Adverse Event|1|||
163253251|NCT01022762|589633970|FG000|Overall Study|Lack of Efficacy|0|||
163253252|NCT01022762|589633971|FG001|Overall Study|Lack of Efficacy|1|||
163253253|NCT01022762|589633970|FG000|Overall Study|Protocol Violation|7|||
163253254|NCT01022762|589633971|FG001|Overall Study|Protocol Violation|6|||
163253255|NCT01022762|589633970|FG000|Overall Study|Unclassified|12|||
163253256|NCT01022762|589633971|FG001|Overall Study|Unclassified|20|||
163253257|NCT01302119|589633972|FG000|Overall Study|Withdrawal by Subject|30|||
163253258|NCT01302119|589633973|FG001|Overall Study|Withdrawal by Subject|20|||
163253259|NCT01302119|589633972|FG000|Overall Study|Lost to Follow-up|10|||
163253260|NCT01302119|589633973|FG001|Overall Study|Lost to Follow-up|4|||
163357201|NCT02299427|590017832|FG000|Overall Study|Lost to Follow-up|1|||
163357202|NCT02299427|590017833|FG001|Overall Study|Lost to Follow-up|3|||
163357203|NCT02299427|590017832|FG000|Overall Study|not adherent to dog website use|21|||
163357204|NCT02299427|590017833|FG001|Overall Study|not adherent to dog website use|0|||
163357205|NCT02108652|590017834|FG000|Overall Study|Death|253|||
163253261|NCT01302119|589633972|FG000|Overall Study|Adverse Event|2|||
163253262|NCT01302119|589633973|FG001|Overall Study|Adverse Event|1|||
163253263|NCT01302119|589633972|FG000|Overall Study|Non-compliance|4|||
163253264|NCT01302119|589633973|FG001|Overall Study|Non-compliance|2|||
163357206|NCT02108652|590017834|FG000|Overall Study|Lost to Follow-up|2|||
163357207|NCT02108652|590017834|FG000|Overall Study|Withdrawal by Subject|16|||
163357208|NCT02108652|590017834|FG000|Overall Study|Study Terminated By Sponsor|31|||
163357209|NCT02108652|590017834|FG000|Overall Study|Non-Compliance|1|||
163357210|NCT02108652|590017834|FG000|Overall Study|Physician Decision|6|||
163357211|NCT02108652|590017834|FG000|Overall Study|Progression Of Disease|1|||
163253265|NCT01302119|589633972|FG000|Overall Study|Non-specific|4|||
163253266|NCT01302119|589633973|FG001|Overall Study|Non-specific|1|||
163253267|NCT01775904|589633974|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
163253268|NCT01775904|589633974|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
163253269|NCT01662310|589633977|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
163253270|NCT01662310|589633978|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
163253271|NCT01662310|589633979|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
163253272|NCT01662310|589633980|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
163253273|NCT01662310|589633981|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
163253274|NCT01662310|589633977|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
163253275|NCT01662310|589633978|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
163253276|NCT01662310|589633979|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
163253277|NCT01662310|589633980|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
163253278|NCT01662310|589633981|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
163253279|NCT01662310|589633977|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
163253280|NCT01662310|589633978|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
163253281|NCT01662310|589633979|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
163253282|NCT01662310|589633980|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
163253283|NCT01662310|589633981|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
163253284|NCT01662310|589633977|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
163253285|NCT01662310|589633978|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
163253286|NCT01662310|589633979|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
163253287|NCT01662310|589633980|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
163253288|NCT01662310|589633981|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
163253289|NCT01662310|589633977|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
163253290|NCT01662310|589633978|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
163253291|NCT01662310|589633979|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
163253292|NCT01662310|589633980|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
163253293|NCT01662310|589633981|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
163253294|NCT01662310|589633977|FG000|Run-In or Stabilization Phase|Other|1|||
163253295|NCT01662310|589633978|FG001|Run-In or Stabilization Phase|Other|0|||
163253296|NCT01662310|589633979|FG002|Run-In or Stabilization Phase|Other|0|||
163253297|NCT01662310|589633980|FG003|Run-In or Stabilization Phase|Other|0|||
163253298|NCT01662310|589633981|FG004|Run-In or Stabilization Phase|Other|0|||
163253299|NCT01662310|589633977|FG000|Double-Blind Phase|Adverse Event|0|||
163253300|NCT01662310|589633978|FG001|Double-Blind Phase|Adverse Event|0|||
163253301|NCT01662310|589633979|FG002|Double-Blind Phase|Adverse Event|1|||
163253302|NCT01662310|589633980|FG003|Double-Blind Phase|Adverse Event|0|||
163253303|NCT01662310|589633981|FG004|Double-Blind Phase|Adverse Event|0|||
163253304|NCT01662310|589633977|FG000|Double-Blind Phase|Lost to Follow-up|0|||
163253305|NCT01662310|589633978|FG001|Double-Blind Phase|Lost to Follow-up|3|||
163253306|NCT01662310|589633979|FG002|Double-Blind Phase|Lost to Follow-up|0|||
163253307|NCT01662310|589633980|FG003|Double-Blind Phase|Lost to Follow-up|0|||
163253308|NCT01662310|589633981|FG004|Double-Blind Phase|Lost to Follow-up|0|||
163253309|NCT01662310|589633977|FG000|Double-Blind Phase|Pregnancy|0|||
163253310|NCT01662310|589633978|FG001|Double-Blind Phase|Pregnancy|2|||
163253311|NCT01662310|589633979|FG002|Double-Blind Phase|Pregnancy|0|||
163253312|NCT01662310|589633980|FG003|Double-Blind Phase|Pregnancy|0|||
163253313|NCT01662310|589633981|FG004|Double-Blind Phase|Pregnancy|0|||
163253314|NCT01662310|589633977|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
163253315|NCT01662310|589633978|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
163253316|NCT01662310|589633979|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
163253317|NCT01662310|589633980|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
163253318|NCT01662310|589633981|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
163253319|NCT01662310|589633977|FG000|Double-Blind Phase|Other|0|||
163253320|NCT01662310|589633978|FG001|Double-Blind Phase|Other|0|||
163253321|NCT01662310|589633979|FG002|Double-Blind Phase|Other|1|||
163253322|NCT01662310|589633980|FG003|Double-Blind Phase|Other|0|||
163253323|NCT01662310|589633981|FG004|Double-Blind Phase|Other|0|||
163253324|NCT01662310|589633977|FG000|Double-Blind Phase|Randomized but not treated|0|||
163357212|NCT01182181|590017835|FG000|First Intervention|Adverse Event|1|||
163253325|NCT01662310|589633978|FG001|Double-Blind Phase|Randomized but not treated|1|||
163253326|NCT01662310|589633979|FG002|Double-Blind Phase|Randomized but not treated|0|||
163253327|NCT01662310|589633980|FG003|Double-Blind Phase|Randomized but not treated|0|||
163253328|NCT01662310|589633981|FG004|Double-Blind Phase|Randomized but not treated|0|||
163253329|NCT01662310|589633977|FG000|Open-Label Extension Phase|Adverse Event|0|||
163253330|NCT01662310|589633978|FG001|Open-Label Extension Phase|Adverse Event|0|||
163357213|NCT01182181|590017836|FG001|First Intervention|Adverse Event|0|||
163357214|NCT01182181|590017835|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
163357215|NCT01182181|590017836|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
163357216|NCT00511797|590017837|FG000|Overall Study|Adverse Event|1|||
163357217|NCT00511797|590017838|FG001|Overall Study|Adverse Event|2|||
163357218|NCT00511797|590017839|FG002|Overall Study|Adverse Event|2|||
163357219|NCT00511797|590017840|FG003|Overall Study|Adverse Event|2|||
163357220|NCT00511797|590017837|FG000|Overall Study|Lost to Follow-up|1|||
163357221|NCT00511797|590017838|FG001|Overall Study|Lost to Follow-up|0|||
163357222|NCT00511797|590017839|FG002|Overall Study|Lost to Follow-up|0|||
163357223|NCT00511797|590017840|FG003|Overall Study|Lost to Follow-up|1|||
163357224|NCT00511797|590017837|FG000|Overall Study|Pregnancy|0|||
163357225|NCT00511797|590017838|FG001|Overall Study|Pregnancy|0|||
163357226|NCT00511797|590017839|FG002|Overall Study|Pregnancy|0|||
163357227|NCT00511797|590017840|FG003|Overall Study|Pregnancy|1|||
163357228|NCT00511797|590017837|FG000|Overall Study|Protocol Violation|0|||
163357229|NCT00511797|590017838|FG001|Overall Study|Protocol Violation|2|||
163357230|NCT00511797|590017839|FG002|Overall Study|Protocol Violation|2|||
163357231|NCT00511797|590017840|FG003|Overall Study|Protocol Violation|3|||
163357232|NCT00511797|590017837|FG000|Overall Study|Withdrawal by Subject|3|||
163357233|NCT00511797|590017838|FG001|Overall Study|Withdrawal by Subject|3|||
163357234|NCT00511797|590017839|FG002|Overall Study|Withdrawal by Subject|4|||
163357235|NCT00511797|590017840|FG003|Overall Study|Withdrawal by Subject|2|||
163357236|NCT00511797|590017837|FG000|Overall Study|Never dispensed|1|||
163357237|NCT00511797|590017838|FG001|Overall Study|Never dispensed|0|||
163357238|NCT00511797|590017839|FG002|Overall Study|Never dispensed|1|||
163357239|NCT00511797|590017840|FG003|Overall Study|Never dispensed|3|||
163357240|NCT00511797|590017837|FG000|Overall Study|Study drug not taken|0|||
163357241|NCT00511797|590017838|FG001|Overall Study|Study drug not taken|1|||
163357242|NCT00511797|590017839|FG002|Overall Study|Study drug not taken|0|||
163357243|NCT00511797|590017840|FG003|Overall Study|Study drug not taken|1|||
163357244|NCT00511797|590017837|FG000|Overall Study|Partially missing diary|0|||
163357245|NCT00511797|590017838|FG001|Overall Study|Partially missing diary|0|||
163357246|NCT00511797|590017839|FG002|Overall Study|Partially missing diary|1|||
163357247|NCT00511797|590017840|FG003|Overall Study|Partially missing diary|0|||
163357248|NCT00511797|590017837|FG000|Overall Study|Other (moving etc)|1|||
163357249|NCT00511797|590017838|FG001|Overall Study|Other (moving etc)|0|||
163357250|NCT00511797|590017839|FG002|Overall Study|Other (moving etc)|1|||
163357251|NCT00511797|590017840|FG003|Overall Study|Other (moving etc)|2|||
163357252|NCT01704547|590017841|FG000|Overall Study|Physician Decision|4|||
163357253|NCT01704547|590017841|FG000|Overall Study|Withdrawal by Subject|1|||
163357254|NCT02564718|590017842|FG000|Overall Study|Withdrew from treatment|0|||
163357255|NCT02564718|590017843|FG001|Overall Study|Withdrew from treatment|1|||
163357256|NCT00104637|590017844|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
163357257|NCT00104637|590017845|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
163357258|NCT01278615|590017846|FG000|Overall Study|Withdrawal by Subject|2|||
163357259|NCT02138253|590017847|FG000|Overall Study|Adverse Event|3|||
163357260|NCT02138253|590017848|FG001|Overall Study|Adverse Event|3|||
163357261|NCT02138253|590017847|FG000|Overall Study|Lost to Follow-up|2|||
163357262|NCT02138253|590017848|FG001|Overall Study|Lost to Follow-up|1|||
163357263|NCT02138253|590017847|FG000|Overall Study|Physician Decision|2|||
163357264|NCT02138253|590017848|FG001|Overall Study|Physician Decision|0|||
163357265|NCT02138253|590017847|FG000|Overall Study|Non compliance|1|||
163357266|NCT02138253|590017848|FG001|Overall Study|Non compliance|0|||
163357267|NCT02138253|590017847|FG000|Overall Study|Withdrawal by Subject|1|||
163357268|NCT02138253|590017848|FG001|Overall Study|Withdrawal by Subject|0|||
163357269|NCT01390441|590017853|FG000|Treatment Period|Protocol Violation|0|||
163357270|NCT01390441|590017854|FG001|Treatment Period|Protocol Violation|1|||
163357271|NCT01390441|590017855|FG002|Treatment Period|Protocol Violation|0|||
163357272|NCT01390441|590017856|FG003|Treatment Period|Protocol Violation|0|||
163357273|NCT01390441|590017857|FG004|Treatment Period|Protocol Violation|0|||
163357274|NCT01390441|590017853|FG000|Treatment Period|Physician Decision|0|||
163357275|NCT01390441|590017854|FG001|Treatment Period|Physician Decision|0|||
163357276|NCT01390441|590017855|FG002|Treatment Period|Physician Decision|0|||
163357277|NCT01390441|590017856|FG003|Treatment Period|Physician Decision|1|||
163410454|NCT05103332|590211370|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
163410455|NCT05103332|590211371|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163151052|NCT01709721|589267042|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
163151053|NCT01709721|589267040|FG000|Open Label Phase|Investigator Decision|0|||
163151054|NCT01709721|589267041|FG001|Open Label Phase|Investigator Decision|0|||
163151055|NCT01709721|589267042|FG002|Open Label Phase|Investigator Decision|1|||
163357278|NCT01390441|590017857|FG004|Treatment Period|Physician Decision|0|||
163357279|NCT01390441|590017853|FG000|Treatment Period|Lack of Efficacy|0|||
163357280|NCT01390441|590017854|FG001|Treatment Period|Lack of Efficacy|0|||
163357281|NCT01390441|590017855|FG002|Treatment Period|Lack of Efficacy|0|||
163357282|NCT01390441|590017856|FG003|Treatment Period|Lack of Efficacy|0|||
163357283|NCT01390441|590017857|FG004|Treatment Period|Lack of Efficacy|1|||
163357284|NCT01390441|590017853|FG000|Treatment Period|Unknown due to early stopping of study|0|||
163253331|NCT01662310|589633979|FG002|Open-Label Extension Phase|Adverse Event|0|||
163253332|NCT01662310|589633980|FG003|Open-Label Extension Phase|Adverse Event|3|||
163253333|NCT01662310|589633981|FG004|Open-Label Extension Phase|Adverse Event|0|||
163253334|NCT01662310|589633977|FG000|Open-Label Extension Phase|Death|0|||
163253335|NCT01662310|589633978|FG001|Open-Label Extension Phase|Death|0|||
163253336|NCT01662310|589633979|FG002|Open-Label Extension Phase|Death|0|||
163253337|NCT01662310|589633980|FG003|Open-Label Extension Phase|Death|1|||
163253338|NCT01662310|589633981|FG004|Open-Label Extension Phase|Death|0|||
163253339|NCT01662310|589633977|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
163253340|NCT01662310|589633978|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
163253341|NCT01662310|589633979|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
163253342|NCT01662310|589633980|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
163253343|NCT01662310|589633981|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
163253344|NCT01662310|589633977|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
163253345|NCT01662310|589633978|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
163253346|NCT01662310|589633979|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
163253347|NCT01662310|589633980|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
163253348|NCT01662310|589633981|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
163253349|NCT01662310|589633977|FG000|Open-Label Extension Phase|Pregnancy|0|||
163253350|NCT01662310|589633978|FG001|Open-Label Extension Phase|Pregnancy|0|||
163253351|NCT01662310|589633979|FG002|Open-Label Extension Phase|Pregnancy|0|||
163253352|NCT01662310|589633980|FG003|Open-Label Extension Phase|Pregnancy|1|||
163253353|NCT01662310|589633981|FG004|Open-Label Extension Phase|Pregnancy|0|||
163253354|NCT01662310|589633977|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
163253355|NCT01662310|589633978|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
163253356|NCT01662310|589633979|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
163253357|NCT01662310|589633980|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
163253358|NCT01662310|589633981|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
163253359|NCT02432105|589633985|FG000|Overall Study|Lost to Follow-up|1|||
163253360|NCT02432105|589633986|FG001|Overall Study|Lost to Follow-up|1|||
163253361|NCT02432105|589633987|FG002|Overall Study|Lost to Follow-up|0|||
163253362|NCT02432105|589633985|FG000|Overall Study|Withdrawal by Subject|1|||
163253363|NCT02432105|589633986|FG001|Overall Study|Withdrawal by Subject|0|||
163253364|NCT02432105|589633987|FG002|Overall Study|Withdrawal by Subject|1|||
163253365|NCT02432105|589633985|FG000|Overall Study|Culture positive for yeast|0|||
163253366|NCT02432105|589633986|FG001|Overall Study|Culture positive for yeast|1|||
163253367|NCT02432105|589633987|FG002|Overall Study|Culture positive for yeast|0|||
163253368|NCT02432105|589633985|FG000|Overall Study|Randomized in error|0|||
163253369|NCT02432105|589633986|FG001|Overall Study|Randomized in error|0|||
163253370|NCT02432105|589633987|FG002|Overall Study|Randomized in error|2|||
163253371|NCT00450411|589633989|FG000|Overall Study|Protocol Violation|6|||
163253372|NCT00450411|589633989|FG000|Overall Study|No protocol treatment|2|||
163253373|NCT00829387|589633992|FG000|Overall Study|Withdrawal by Subject|2|||
163253374|NCT00829387|589633993|FG001|Overall Study|Withdrawal by Subject|3|||
163253375|NCT00829387|589633992|FG000|Overall Study|Disqualified by PI|1|||
163253376|NCT00829387|589633993|FG001|Overall Study|Disqualified by PI|0|||
163253377|NCT00707031|589633994|FG000|Overall Study|Adverse Event|45|||
163253378|NCT00707031|589633995|FG001|Overall Study|Adverse Event|45|||
163253379|NCT00707031|589633994|FG000|Overall Study|Lack of Efficacy|19|||
163253380|NCT00707031|589633995|FG001|Overall Study|Lack of Efficacy|6|||
163253381|NCT00707031|589633994|FG000|Overall Study|Lost to Follow-up|2|||
163253382|NCT00707031|589633995|FG001|Overall Study|Lost to Follow-up|1|||
163253383|NCT00707031|589633994|FG000|Overall Study|Protocol Violation|1|||
163253384|NCT00707031|589633995|FG001|Overall Study|Protocol Violation|0|||
163253385|NCT00707031|589633994|FG000|Overall Study|Withdrawal by Subject|7|||
163253386|NCT00707031|589633995|FG001|Overall Study|Withdrawal by Subject|8|||
163253387|NCT00707031|589633994|FG000|Overall Study|Poor Compliance to Protocol|7|||
163253388|NCT00707031|589633995|FG001|Overall Study|Poor Compliance to Protocol|13|||
163253389|NCT00707031|589633994|FG000|Overall Study|Familial or Personal Reasons|12|||
163253390|NCT00707031|589633995|FG001|Overall Study|Familial or Personal Reasons|15|||
163253391|NCT00707031|589633994|FG000|Overall Study|Serious Noncompliance|2|||
163357285|NCT01390441|590017854|FG001|Treatment Period|Unknown due to early stopping of study|0|||
163253392|NCT00707031|589633995|FG001|Overall Study|Serious Noncompliance|3|||
163253393|NCT00707031|589633994|FG000|Overall Study|Sponsor Decision|9|||
163253394|NCT00707031|589633995|FG001|Overall Study|Sponsor Decision|8|||
163253395|NCT02085252|589633996|FG000|Overall Study|Withdrawal of Consent|1|||
163253396|NCT02085252|589633997|FG001|Overall Study|Withdrawal of Consent|0|||
163253397|NCT02085252|589633996|FG000|Overall Study|Adverse Event|0|||
163253398|NCT02085252|589633997|FG001|Overall Study|Adverse Event|1|||
163253399|NCT02085252|589633996|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
163253400|NCT02085252|589633997|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
163253401|NCT02085252|589633996|FG000|Overall Study|Reason Not Specified|0|||
163253402|NCT02085252|589633997|FG001|Overall Study|Reason Not Specified|1|||
163253403|NCT02085252|589633996|FG000|Overall Study|Reason Unknown|0|||
163253404|NCT02085252|589633997|FG001|Overall Study|Reason Unknown|1|||
163253405|NCT03260868|589633999|FG000|Overall Study|Poor Compliance to Protocol|0|||
163253406|NCT03260868|589634000|FG001|Overall Study|Poor Compliance to Protocol|2|||
163253407|NCT03260868|589633999|FG000|Overall Study|Study Terminated By Sponsor|2|||
163253408|NCT03260868|589634000|FG001|Overall Study|Study Terminated By Sponsor|1|||
163253409|NCT03260868|589633999|FG000|Overall Study|Other than specified above|1|||
163253410|NCT03260868|589634000|FG001|Overall Study|Other than specified above|0|||
163253411|NCT03645759|589634004|FG000|Overall Study|Lost to Follow-up|3|||
163253412|NCT03645759|589634005|FG001|Overall Study|Lost to Follow-up|2|||
163253413|NCT02693743|589634008|FG000|Overall Study|Physician Decision|1|||
163253414|NCT02693743|589634009|FG001|Overall Study|Physician Decision|0|||
163253415|NCT02626780|589634010|FG000|Overall Study|Withdrawal by Subject|3|||
163253416|NCT05540522|589634011|FG000|Overall Study|Adverse Event|1|||
163253417|NCT05540522|589634012|FG001|Overall Study|Adverse Event|0|||
163253418|NCT05540522|589634013|FG002|Overall Study|Adverse Event|2|||
163253419|NCT05540522|589634014|FG003|Overall Study|Adverse Event|5|||
163253420|NCT05540522|589634011|FG000|Overall Study|Lost to Follow-up|487|||
163253421|NCT05540522|589634012|FG001|Overall Study|Lost to Follow-up|427|||
163253422|NCT05540522|589634013|FG002|Overall Study|Lost to Follow-up|146|||
163253423|NCT05540522|589634014|FG003|Overall Study|Lost to Follow-up|166|||
163253424|NCT05540522|589634011|FG000|Overall Study|Physician Decision|11|||
163253425|NCT05540522|589634012|FG001|Overall Study|Physician Decision|19|||
163253426|NCT05540522|589634013|FG002|Overall Study|Physician Decision|8|||
163253427|NCT05540522|589634014|FG003|Overall Study|Physician Decision|13|||
163253428|NCT05540522|589634011|FG000|Overall Study|Pregnancy|1|||
163253429|NCT05540522|589634012|FG001|Overall Study|Pregnancy|0|||
163253430|NCT05540522|589634013|FG002|Overall Study|Pregnancy|0|||
163253431|NCT05540522|589634014|FG003|Overall Study|Pregnancy|0|||
163253432|NCT05540522|589634011|FG000|Overall Study|Protocol Violation|3|||
163253433|NCT05540522|589634012|FG001|Overall Study|Protocol Violation|1|||
163253434|NCT05540522|589634013|FG002|Overall Study|Protocol Violation|9|||
163253435|NCT05540522|589634014|FG003|Overall Study|Protocol Violation|7|||
163253436|NCT05540522|589634011|FG000|Overall Study|Withdrawal by Subject|168|||
163253437|NCT05540522|589634012|FG001|Overall Study|Withdrawal by Subject|134|||
163253438|NCT05540522|589634013|FG002|Overall Study|Withdrawal by Subject|331|||
163253439|NCT05540522|589634014|FG003|Overall Study|Withdrawal by Subject|322|||
163253440|NCT05540522|589634011|FG000|Overall Study|Death|7|||
163253441|NCT05540522|589634012|FG001|Overall Study|Death|9|||
163253442|NCT05540522|589634013|FG002|Overall Study|Death|49|||
163253443|NCT05540522|589634014|FG003|Overall Study|Death|46|||
163253444|NCT05540522|589634011|FG000|Overall Study|Not vaccinated|34|||
163253445|NCT05540522|589634012|FG001|Overall Study|Not vaccinated|53|||
163253446|NCT05540522|589634013|FG002|Overall Study|Not vaccinated|57|||
163253447|NCT05540522|589634014|FG003|Overall Study|Not vaccinated|50|||
163253448|NCT05540522|589634011|FG000|Overall Study|No longer meets eligibility criteria|0|||
163253449|NCT05540522|589634012|FG001|Overall Study|No longer meets eligibility criteria|0|||
163253450|NCT05540522|589634013|FG002|Overall Study|No longer meets eligibility criteria|3|||
163253451|NCT05540522|589634014|FG003|Overall Study|No longer meets eligibility criteria|2|||
163253452|NCT05540522|589634011|FG000|Overall Study|Other (Unspecified)|8|||
163253453|NCT05540522|589634012|FG001|Overall Study|Other (Unspecified)|10|||
163253454|NCT05540522|589634013|FG002|Overall Study|Other (Unspecified)|4|||
163253455|NCT05540522|589634014|FG003|Overall Study|Other (Unspecified)|2|||
163253456|NCT00251745|589634016|FG000|Overall Study|Adverse Event|7|||
163253457|NCT00251745|589634017|FG001|Overall Study|Adverse Event|9|||
163253458|NCT00251745|589634018|FG002|Overall Study|Adverse Event|11|||
163253459|NCT00251745|589634016|FG000|Overall Study|Lost to Follow-up|4|||
163253460|NCT00251745|589634017|FG001|Overall Study|Lost to Follow-up|2|||
163253461|NCT00251745|589634018|FG002|Overall Study|Lost to Follow-up|5|||
163253462|NCT00251745|589634016|FG000|Overall Study|Withdrawal by Subject|13|||
163253463|NCT00251745|589634017|FG001|Overall Study|Withdrawal by Subject|7|||
163253464|NCT00251745|589634018|FG002|Overall Study|Withdrawal by Subject|3|||
163253465|NCT00251745|589634016|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
163253466|NCT00251745|589634017|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
163253467|NCT00251745|589634018|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
163253468|NCT00251745|589634016|FG000|Overall Study|Lack of Efficacy|3|||
163253469|NCT00251745|589634017|FG001|Overall Study|Lack of Efficacy|0|||
163253470|NCT00251745|589634018|FG002|Overall Study|Lack of Efficacy|0|||
163253471|NCT00251745|589634016|FG000|Overall Study|Noncompliant|0|||
163253472|NCT00251745|589634017|FG001|Overall Study|Noncompliant|2|||
163253473|NCT00251745|589634018|FG002|Overall Study|Noncompliant|2|||
163253474|NCT00251745|589634016|FG000|Overall Study|Pregnancy|0|||
163253475|NCT00251745|589634017|FG001|Overall Study|Pregnancy|1|||
163253476|NCT00251745|589634018|FG002|Overall Study|Pregnancy|0|||
163253477|NCT00251745|589634016|FG000|Overall Study|Per Subject Request|0|||
163253478|NCT00251745|589634017|FG001|Overall Study|Per Subject Request|0|||
163253479|NCT00251745|589634018|FG002|Overall Study|Per Subject Request|1|||
163253480|NCT00251745|589634016|FG000|Overall Study|Per Investigator Request|1|||
163253481|NCT00251745|589634017|FG001|Overall Study|Per Investigator Request|0|||
163253482|NCT00251745|589634018|FG002|Overall Study|Per Investigator Request|0|||
163253483|NCT00789815|589635678|FG000|Overall Study|Protocol Violation|6|||
163357286|NCT01390441|590017855|FG002|Treatment Period|Unknown due to early stopping of study|8|||
163357287|NCT01390441|590017856|FG003|Treatment Period|Unknown due to early stopping of study|11|||
163357288|NCT01390441|590017857|FG004|Treatment Period|Unknown due to early stopping of study|7|||
163357289|NCT01390441|590017853|FG000|Treatment Period|Adverse Event|0|||
163357290|NCT01390441|590017854|FG001|Treatment Period|Adverse Event|0|||
163357291|NCT01390441|590017855|FG002|Treatment Period|Adverse Event|1|||
163357292|NCT01390441|590017856|FG003|Treatment Period|Adverse Event|1|||
163357293|NCT01390441|590017857|FG004|Treatment Period|Adverse Event|2|||
163357294|NCT01390441|590017853|FG000|Treatment Period|Withdrawal by Subject|0|||
163357295|NCT01390441|590017854|FG001|Treatment Period|Withdrawal by Subject|0|||
163357296|NCT01390441|590017855|FG002|Treatment Period|Withdrawal by Subject|1|||
163357297|NCT01390441|590017856|FG003|Treatment Period|Withdrawal by Subject|0|||
163357298|NCT01390441|590017857|FG004|Treatment Period|Withdrawal by Subject|1|||
163357299|NCT01390441|590017853|FG000|Treatment Period|Lost to Follow-up|1|||
163357300|NCT01390441|590017854|FG001|Treatment Period|Lost to Follow-up|0|||
163357301|NCT01390441|590017855|FG002|Treatment Period|Lost to Follow-up|0|||
163357302|NCT01390441|590017856|FG003|Treatment Period|Lost to Follow-up|0|||
163357303|NCT01390441|590017857|FG004|Treatment Period|Lost to Follow-up|0|||
163357304|NCT01390441|590017853|FG000|Extension Period|Protocol Violation|3|||
163357305|NCT01390441|590017854|FG001|Extension Period|Protocol Violation|1|||
163357306|NCT01390441|590017855|FG002|Extension Period|Protocol Violation|0|||
163357307|NCT01390441|590017856|FG003|Extension Period|Protocol Violation|1|||
163357308|NCT01390441|590017857|FG004|Extension Period|Protocol Violation|0|||
163357309|NCT04788511|590017860|FG000|Overall Study|Withdrawal by Subject|2|||
163357310|NCT04788511|590017861|FG001|Overall Study|Withdrawal by Subject|1|||
163357311|NCT04788511|590017860|FG000|Overall Study|Lost to Follow-up|2|||
163357312|NCT04788511|590017861|FG001|Overall Study|Lost to Follow-up|7|||
163357313|NCT04788511|590017860|FG000|Overall Study|Death|3|||
163357314|NCT04788511|590017861|FG001|Overall Study|Death|4|||
163357315|NCT03174782|590017862|FG000|Overall Study|Protocol Violation|1|||
163357316|NCT03174782|590017863|FG001|Overall Study|Protocol Violation|0|||
163357317|NCT03174782|590017862|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
163357318|NCT03174782|590017863|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
163357319|NCT00778921|590017864|FG000|Overall Study|Adverse Event|9|||
163357320|NCT00778921|590017865|FG001|Overall Study|Adverse Event|10|||
163357321|NCT00778921|590017866|FG002|Overall Study|Adverse Event|14|||
163357322|NCT00778921|590017864|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
163357323|NCT00778921|590017865|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
163357324|NCT00778921|590017866|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
163357325|NCT00778921|590017864|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
163357326|NCT00778921|590017865|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
163357327|NCT00778921|590017866|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
163357328|NCT00778921|590017864|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
163357329|NCT00778921|590017865|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
163357330|NCT00778921|590017866|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
163357331|NCT00778921|590017864|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
163357332|NCT00778921|590017865|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
163357333|NCT00778921|590017866|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
163357334|NCT00778921|590017864|FG000|Overall Study|Patient withdrew request|3|||
163357335|NCT00778921|590017865|FG001|Overall Study|Patient withdrew request|1|||
163357336|NCT00778921|590017866|FG002|Overall Study|Patient withdrew request|6|||
163357337|NCT00778921|590017864|FG000|Overall Study|Lost to Follow-up|0|||
163357338|NCT00778921|590017865|FG001|Overall Study|Lost to Follow-up|2|||
163357339|NCT00778921|590017866|FG002|Overall Study|Lost to Follow-up|1|||
163357340|NCT00778921|590017864|FG000|Overall Study|Administrative Problems|1|||
163357341|NCT00778921|590017865|FG001|Overall Study|Administrative Problems|2|||
163357342|NCT00778921|590017866|FG002|Overall Study|Administrative Problems|0|||
163357343|NCT00778921|590017864|FG000|Overall Study|Protocol Violation|3|||
163357344|NCT00778921|590017865|FG001|Overall Study|Protocol Violation|0|||
163357345|NCT00778921|590017866|FG002|Overall Study|Protocol Violation|2|||
163357346|NCT00778921|590017864|FG000|Overall Study|Not treated|0|||
163357347|NCT00778921|590017865|FG001|Overall Study|Not treated|2|||
163357348|NCT00778921|590017866|FG002|Overall Study|Not treated|2|||
163357349|NCT03178045|590017867|FG000|Overall Study|Withdrawal by Subject|5|||
163357350|NCT03178045|590017868|FG001|Overall Study|Withdrawal by Subject|7|||
163357351|NCT03178045|590017867|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
163357352|NCT03178045|590017868|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
163357353|NCT03178045|590017867|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
163357354|NCT03178045|590017868|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
163357355|NCT01078922|590017869|FG000|Overall Study|Adverse Event|1|||
163357356|NCT02353468|590017870|FG000|Overall Study|Study terminated|3|||
163357357|NCT00798304|590017872|FG000|Overall Study|Adverse Event|0|||
163357358|NCT00798304|590017873|FG001|Overall Study|Adverse Event|1|||
163357359|NCT00798304|590017874|FG002|Overall Study|Adverse Event|1|||
163357360|NCT00798304|590017872|FG000|Overall Study|Discontinuation by Sponsor|14|||
163410456|NCT05103332|590211372|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163410457|NCT05103332|590211373|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163410458|NCT05103332|590211374|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163253484|NCT00789815|589635679|FG001|Overall Study|Protocol Violation|1|||
163253485|NCT00789815|589635678|FG000|Overall Study|Intubation due to massive bleeding|1|||
163253486|NCT00789815|589635679|FG001|Overall Study|Intubation due to massive bleeding|0|||
163253487|NCT02586025|589635680|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
163253488|NCT02586025|589635681|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
163253489|NCT02586025|589635680|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
163253490|NCT02586025|589635681|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
163253491|NCT02586025|589635680|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
163253492|NCT02586025|589635681|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
163253493|NCT02586025|589635680|FG000|Neoadjuvant Treatment|Death|1|||
163253494|NCT02586025|589635681|FG001|Neoadjuvant Treatment|Death|0|||
163253495|NCT02586025|589635680|FG000|Neoadjuvant Treatment|Adverse Event|1|||
163253496|NCT02586025|589635681|FG001|Neoadjuvant Treatment|Adverse Event|0|||
163253497|NCT02586025|589635680|FG000|Neoadjuvant Treatment|Physician Decision|2|||
163253498|NCT02586025|589635681|FG001|Neoadjuvant Treatment|Physician Decision|1|||
163253499|NCT02586025|589635680|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
163253500|NCT02586025|589635681|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
163253501|NCT02586025|589635680|FG000|Adjuvant Treatment|Recurrent Disease|4|||
163253502|NCT02586025|589635681|FG001|Adjuvant Treatment|Recurrent Disease|5|||
163253503|NCT02586025|589635680|FG000|Adjuvant Treatment|Physician Decision|0|||
163253504|NCT02586025|589635681|FG001|Adjuvant Treatment|Physician Decision|1|||
163253505|NCT02586025|589635680|FG000|Adjuvant Treatment|Pregnancy|1|||
163253506|NCT02586025|589635681|FG001|Adjuvant Treatment|Pregnancy|0|||
163253507|NCT02586025|589635680|FG000|Treatment-Free Follow-Up|Death|11|||
163253508|NCT02586025|589635681|FG001|Treatment-Free Follow-Up|Death|11|||
163253509|NCT02586025|589635680|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
163253510|NCT02586025|589635681|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
163253511|NCT02586025|589635680|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
163253512|NCT02586025|589635681|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
163253513|NCT02586025|589635680|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
163253514|NCT02586025|589635681|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
163253515|NCT02586025|589635680|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
163253516|NCT02586025|589635681|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
163253517|NCT03822117|589635682|FG000|Overall Study|Death|18|||
163253518|NCT03822117|589635683|FG001|Overall Study|Death|17|||
163253519|NCT03822117|589635684|FG002|Overall Study|Death|12|||
163253520|NCT03822117|589635685|FG003|Overall Study|Death|4|||
163253521|NCT03822117|589635682|FG000|Overall Study|Lost to Follow-up|1|||
163253522|NCT03822117|589635683|FG001|Overall Study|Lost to Follow-up|2|||
163253523|NCT03822117|589635684|FG002|Overall Study|Lost to Follow-up|3|||
163253524|NCT03822117|589635685|FG003|Overall Study|Lost to Follow-up|0|||
163253525|NCT03822117|589635682|FG000|Overall Study|Study Terminated by Sponsor|25|||
163253526|NCT03822117|589635683|FG001|Overall Study|Study Terminated by Sponsor|11|||
163253527|NCT03822117|589635684|FG002|Overall Study|Study Terminated by Sponsor|6|||
163253528|NCT03822117|589635685|FG003|Overall Study|Study Terminated by Sponsor|0|||
163253529|NCT03822117|589635682|FG000|Overall Study|Withdrawal by Subject|4|||
163253530|NCT03822117|589635683|FG001|Overall Study|Withdrawal by Subject|0|||
163253531|NCT03822117|589635684|FG002|Overall Study|Withdrawal by Subject|3|||
163253532|NCT03822117|589635685|FG003|Overall Study|Withdrawal by Subject|0|||
163253533|NCT03822117|589635682|FG000|Overall Study|Disease Progression|1|||
163253534|NCT03822117|589635683|FG001|Overall Study|Disease Progression|2|||
163253535|NCT03822117|589635684|FG002|Overall Study|Disease Progression|1|||
163253536|NCT03822117|589635685|FG003|Overall Study|Disease Progression|0|||
163253537|NCT03822117|589635682|FG000|Overall Study|Never Returned to Hospital|0|||
163253538|NCT03822117|589635683|FG001|Overall Study|Never Returned to Hospital|0|||
163253539|NCT03822117|589635684|FG002|Overall Study|Never Returned to Hospital|1|||
163253540|NCT03822117|589635685|FG003|Overall Study|Never Returned to Hospital|0|||
163253541|NCT00415610|589635687|FG000|Overall Study|Death|3|||
163253542|NCT00415610|589635688|FG001|Overall Study|Death|2|||
163253543|NCT00415610|589635689|FG002|Overall Study|Death|5|||
163253544|NCT01357616|589635693|FG000|Overall Study|Adverse Event|1|||
163253545|NCT01357616|589635694|FG001|Overall Study|Adverse Event|1|||
163253546|NCT01357616|589635693|FG000|Overall Study|Lost to Follow-up|4|||
163253547|NCT01357616|589635694|FG001|Overall Study|Lost to Follow-up|3|||
163253548|NCT01357616|589635693|FG000|Overall Study|Protocol Violation|0|||
163253549|NCT01357616|589635694|FG001|Overall Study|Protocol Violation|2|||
163253550|NCT01357616|589635693|FG000|Overall Study|Inadequate Control of IOP|1|||
163253551|NCT01357616|589635694|FG001|Overall Study|Inadequate Control of IOP|2|||
163253552|NCT01357616|589635693|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
163253553|NCT01357616|589635694|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
163253554|NCT01357616|589635693|FG000|Overall Study|Withdrawal by Subject|1|||
163253555|NCT01357616|589635694|FG001|Overall Study|Withdrawal by Subject|0|||
163253556|NCT03255824|589635698|FG000|Overall Study|Under-sedation|2|||
163357361|NCT00798304|590017873|FG001|Overall Study|Discontinuation by Sponsor|21|||
163357362|NCT00798304|590017874|FG002|Overall Study|Discontinuation by Sponsor|9|||
163357363|NCT02031536|590017875|FG000|Overall Study|ineligible|1|||
163357364|NCT02031536|590017876|FG001|Overall Study|ineligible|0|||
163357365|NCT04211389|590017878|FG000|Overall Study|Adverse Event|1|||
163357366|NCT04211389|590017879|FG001|Overall Study|Adverse Event|2|||
163253557|NCT03255824|589635699|FG001|Overall Study|Under-sedation|1|||
163253558|NCT03432364|589635704|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
163253559|NCT00522301|589635705|FG000|Overall Study|Withdrawal by Subject|1|||
163253560|NCT00522301|589635705|FG000|Overall Study|Adverse Event|5|||
163253561|NCT03040713|589635706|FG000|Overall Study|Positive amyloid scan|3|||
163253562|NCT04465357|589635713|FG000|Overall Study|Adverse Event|2|||
163253563|NCT04465357|589635713|FG000|Overall Study|Lack of Efficacy|1|||
163253564|NCT04465357|589635713|FG000|Overall Study|Lost to Follow-up|2|||
163253565|NCT04465357|589635713|FG000|Overall Study|Withdrawal by Subject|6|||
163253566|NCT04465357|589635713|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
163253567|NCT00430248|589635724|FG000|Overall Study|Adverse Event|49|||
163253568|NCT00430248|589635725|FG001|Overall Study|Adverse Event|61|||
163253569|NCT00430248|589635726|FG002|Overall Study|Adverse Event|64|||
163253570|NCT00430248|589635724|FG000|Overall Study|Protocol Violation|10|||
163253571|NCT00430248|589635725|FG001|Overall Study|Protocol Violation|2|||
163253572|NCT00430248|589635726|FG002|Overall Study|Protocol Violation|4|||
163253573|NCT00430248|589635724|FG000|Overall Study|Personal Reasons|12|||
163253574|NCT00430248|589635725|FG001|Overall Study|Personal Reasons|24|||
163253575|NCT00430248|589635726|FG002|Overall Study|Personal Reasons|9|||
163253576|NCT00430248|589635724|FG000|Overall Study|Lost to Follow-up|28|||
163253577|NCT00430248|589635725|FG001|Overall Study|Lost to Follow-up|33|||
163253578|NCT00430248|589635726|FG002|Overall Study|Lost to Follow-up|28|||
163253579|NCT00430248|589635724|FG000|Overall Study|Therapeutic Failure|1|||
163253580|NCT00430248|589635725|FG001|Overall Study|Therapeutic Failure|1|||
163253581|NCT00430248|589635726|FG002|Overall Study|Therapeutic Failure|1|||
163253582|NCT00430248|589635724|FG000|Overall Study|Withdrawal by Subject|14|||
163253583|NCT00430248|589635725|FG001|Overall Study|Withdrawal by Subject|20|||
163253584|NCT00430248|589635726|FG002|Overall Study|Withdrawal by Subject|16|||
163253585|NCT00430248|589635724|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163253586|NCT00430248|589635725|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
163253587|NCT00430248|589635726|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163253588|NCT00430248|589635724|FG000|Overall Study|Gout Flare|3|||
163253589|NCT00430248|589635725|FG001|Overall Study|Gout Flare|7|||
163253590|NCT00430248|589635726|FG002|Overall Study|Gout Flare|2|||
163253591|NCT00430248|589635724|FG000|Overall Study|Reason Not Specified|8|||
163253592|NCT00430248|589635725|FG001|Overall Study|Reason Not Specified|8|||
163253593|NCT00430248|589635726|FG002|Overall Study|Reason Not Specified|11|||
163253594|NCT00002558|589635729|FG000|Overall Study|Withdrawal by Subject|0|||
163253595|NCT00002558|589635730|FG001|Overall Study|Withdrawal by Subject|1|||
163253596|NCT01260350|589635732|FG000|Overall Study|Lack of Efficacy|0|||
163253597|NCT01260350|589635733|FG001|Overall Study|Lack of Efficacy|0|||
163253598|NCT01260350|589635734|FG002|Overall Study|Lack of Efficacy|0|||
163253599|NCT01260350|589635735|FG003|Overall Study|Lack of Efficacy|0|||
163253600|NCT01260350|589635736|FG004|Overall Study|Lack of Efficacy|0|||
163253601|NCT01260350|589635737|FG005|Overall Study|Lack of Efficacy|0|||
163253602|NCT01260350|589635738|FG006|Overall Study|Lack of Efficacy|0|||
163253603|NCT01260350|589635739|FG007|Overall Study|Lack of Efficacy|0|||
163253604|NCT01260350|589635740|FG008|Overall Study|Lack of Efficacy|0|||
163253605|NCT01260350|589635741|FG009|Overall Study|Lack of Efficacy|0|||
163253606|NCT01260350|589635742|FG010|Overall Study|Lack of Efficacy|0|||
163253607|NCT01260350|589635743|FG011|Overall Study|Lack of Efficacy|0|||
163357367|NCT04211389|590017878|FG000|Overall Study|Lost to Follow-up|15|||
163357368|NCT04211389|590017879|FG001|Overall Study|Lost to Follow-up|7|||
163357369|NCT04211389|590017878|FG000|Overall Study|Protocol Violation|0|||
163357370|NCT04211389|590017879|FG001|Overall Study|Protocol Violation|1|||
163253608|NCT01260350|589635744|FG012|Overall Study|Lack of Efficacy|0|||
163253609|NCT01260350|589635745|FG013|Overall Study|Lack of Efficacy|0|||
163253610|NCT01260350|589635746|FG014|Overall Study|Lack of Efficacy|0|||
163357371|NCT04211389|590017878|FG000|Overall Study|Withdrawal by Subject|10|||
163357372|NCT04211389|590017879|FG001|Overall Study|Withdrawal by Subject|11|||
163357373|NCT01182207|590017888|FG000|First Intervention|Positive Hepatitis Results|0|||
163410459|NCT05103332|590211375|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163253611|NCT01260350|589635747|FG015|Overall Study|Lack of Efficacy|0|||
163253612|NCT01260350|589635748|FG016|Overall Study|Lack of Efficacy|0|||
163253613|NCT01260350|589635749|FG017|Overall Study|Lack of Efficacy|1|||
163253614|NCT01260350|589635750|FG018|Overall Study|Lack of Efficacy|0|||
163253615|NCT01260350|589635751|FG019|Overall Study|Lack of Efficacy|0|||
163253616|NCT01260350|589635752|FG020|Overall Study|Lack of Efficacy|3|||
163253617|NCT01260350|589635753|FG021|Overall Study|Lack of Efficacy|0|||
163253618|NCT01260350|589635732|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253619|NCT01260350|589635733|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253620|NCT01260350|589635734|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163357374|NCT01182207|590017889|FG001|First Intervention|Positive Hepatitis Results|1|||
163357375|NCT01182207|590017888|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
163357376|NCT01182207|590017889|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
163357377|NCT01427738|590017890|FG000|Overall Study|Death|12|||
163357378|NCT01427738|590017891|FG001|Overall Study|Death|9|||
163357379|NCT01427738|590017890|FG000|Overall Study|Severe debilitation, unable to continue|0|||
163357380|NCT01427738|590017891|FG001|Overall Study|Severe debilitation, unable to continue|1|||
163357381|NCT01427738|590017890|FG000|Overall Study|Subject unable to get to clinic|5|||
163357382|NCT01427738|590017891|FG001|Overall Study|Subject unable to get to clinic|2|||
163357383|NCT01427738|590017890|FG000|Overall Study|Withdrawal by Subject|0|||
163357384|NCT01427738|590017891|FG001|Overall Study|Withdrawal by Subject|2|||
163357385|NCT01427738|590017890|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
163357386|NCT01427738|590017891|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
163357387|NCT01427738|590017890|FG000|Overall Study|Lost to Follow-up|1|||
163357388|NCT01427738|590017891|FG001|Overall Study|Lost to Follow-up|5|||
163357389|NCT01801982|590017892|FG000|Overall Study|Lost to Follow-up|1|||
163357390|NCT00727506|590017895|FG000|Overall Study|Adverse Event|0|||
163357391|NCT00727506|590017896|FG001|Overall Study|Adverse Event|0|||
163357392|NCT00727506|590017897|FG002|Overall Study|Adverse Event|4|||
163357393|NCT00727506|590017898|FG003|Overall Study|Adverse Event|4|||
163410460|NCT05103332|590211376|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163253621|NCT01260350|589635735|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253622|NCT01260350|589635736|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253623|NCT01260350|589635737|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253624|NCT01260350|589635738|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253625|NCT01260350|589635739|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253626|NCT01260350|589635740|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
163253627|NCT01260350|589635741|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253628|NCT01260350|589635742|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253629|NCT01260350|589635743|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253630|NCT01260350|589635744|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253631|NCT01260350|589635745|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253632|NCT01260350|589635746|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253633|NCT01260350|589635747|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253634|NCT01260350|589635748|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253635|NCT01260350|589635749|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253636|NCT01260350|589635750|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253637|NCT01260350|589635751|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253638|NCT01260350|589635752|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253639|NCT01260350|589635753|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163253640|NCT04385368|589635756|FG000|Overall Study|Death|5|||
163253641|NCT04385368|589635757|FG001|Overall Study|Death|5|||
163253642|NCT04385368|589635756|FG000|Overall Study|Physician Decision|3|||
163253643|NCT04385368|589635757|FG001|Overall Study|Physician Decision|0|||
163253644|NCT04385368|589635756|FG000|Overall Study|Withdrawal by Subject|4|||
163253645|NCT04385368|589635757|FG001|Overall Study|Withdrawal by Subject|3|||
163253646|NCT02123108|589635758|FG000|Overall Study|Death|2|||
163253647|NCT02123108|589635759|FG001|Overall Study|Death|3|||
163253648|NCT02219048|589635763|FG000|Overall Study|Adverse Event|2|||
163253649|NCT02219048|589635764|FG001|Overall Study|Adverse Event|5|||
163253650|NCT02219048|589635763|FG000|Overall Study|No longer meets eligibility criteria|1|||
163253651|NCT02219048|589635764|FG001|Overall Study|No longer meets eligibility criteria|0|||
163253652|NCT02219048|589635763|FG000|Overall Study|Study terminated by sponsor|16|||
163253653|NCT02219048|589635764|FG001|Overall Study|Study terminated by sponsor|15|||
163253654|NCT02219048|589635763|FG000|Overall Study|Withdrawal by Subject|2|||
163253655|NCT02219048|589635764|FG001|Overall Study|Withdrawal by Subject|0|||
163253656|NCT02219048|589635763|FG000|Overall Study|Other|0|||
163253657|NCT02219048|589635764|FG001|Overall Study|Other|1|||
163253658|NCT04721925|589635765|FG000|2-Month Assessment|Lost to Follow-up|5|||
163253659|NCT04721925|589635766|FG001|2-Month Assessment|Lost to Follow-up|3|||
163253660|NCT04721925|589635765|FG000|4-Month Assessment|Lost to Follow-up|3|||
163253661|NCT04721925|589635766|FG001|4-Month Assessment|Lost to Follow-up|6|||
163253662|NCT01274182|589635775|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
163253663|NCT01274182|589635776|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
163253664|NCT01274182|589635777|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
163253665|NCT01274182|589635775|FG000|Overall Study|Adverse Event|4|||
163253666|NCT01274182|589635776|FG001|Overall Study|Adverse Event|5|||
163253667|NCT01274182|589635777|FG002|Overall Study|Adverse Event|3|||
163253668|NCT01274182|589635775|FG000|Overall Study|Withdrawal by Subject|5|||
163253669|NCT01274182|589635776|FG001|Overall Study|Withdrawal by Subject|5|||
163253670|NCT01274182|589635777|FG002|Overall Study|Withdrawal by Subject|3|||
163253671|NCT01274182|589635775|FG000|Overall Study|Lost to Follow-up|2|||
163253672|NCT01274182|589635776|FG001|Overall Study|Lost to Follow-up|3|||
163253673|NCT01274182|589635777|FG002|Overall Study|Lost to Follow-up|1|||
163253674|NCT01274182|589635775|FG000|Overall Study|Protocol Violation|3|||
163253675|NCT01274182|589635776|FG001|Overall Study|Protocol Violation|2|||
163253676|NCT01274182|589635777|FG002|Overall Study|Protocol Violation|0|||
163253677|NCT01274182|589635775|FG000|Overall Study|Death|1|||
163253678|NCT01274182|589635776|FG001|Overall Study|Death|0|||
163253679|NCT01274182|589635777|FG002|Overall Study|Death|1|||
163253680|NCT01970982|589635778|FG000|Overall Study|Withdrawal by Subject|0|||
163253681|NCT01970982|589635779|FG001|Overall Study|Withdrawal by Subject|0|||
163253682|NCT01970982|589635780|FG002|Overall Study|Withdrawal by Subject|2|||
163253683|NCT04040751|589635785|FG000|Overall Study|Withdrawal by Subject|2|||
163253684|NCT04040751|589635786|FG001|Overall Study|Withdrawal by Subject|0|||
163253685|NCT04040751|589635787|FG002|Overall Study|Withdrawal by Subject|2|||
163253686|NCT04040751|589635788|FG003|Overall Study|Withdrawal by Subject|0|||
163253687|NCT02862457|589635789|FG000|Overall Study|Death|1|||
163253688|NCT02862457|589635790|FG001|Overall Study|Death|3|||
163253689|NCT02862457|589635791|FG002|Overall Study|Death|2|||
163253690|NCT02862457|589635792|FG003|Overall Study|Death|3|||
163253691|NCT02862457|589635793|FG004|Overall Study|Death|0|||
163253692|NCT02862457|589635794|FG005|Overall Study|Death|2|||
163253693|NCT02862457|589635795|FG006|Overall Study|Death|1|||
163253694|NCT02862457|589635789|FG000|Overall Study|Lost to Follow-up|1|||
163253695|NCT02862457|589635790|FG001|Overall Study|Lost to Follow-up|0|||
163253696|NCT02862457|589635791|FG002|Overall Study|Lost to Follow-up|0|||
163253697|NCT02862457|589635792|FG003|Overall Study|Lost to Follow-up|1|||
163253698|NCT02862457|589635793|FG004|Overall Study|Lost to Follow-up|0|||
163253699|NCT02862457|589635794|FG005|Overall Study|Lost to Follow-up|0|||
163253700|NCT02862457|589635795|FG006|Overall Study|Lost to Follow-up|0|||
163253701|NCT02862457|589635789|FG000|Overall Study|Withdrawal by Subject|0|||
163253702|NCT02862457|589635790|FG001|Overall Study|Withdrawal by Subject|0|||
163253703|NCT02862457|589635791|FG002|Overall Study|Withdrawal by Subject|1|||
163253704|NCT02862457|589635792|FG003|Overall Study|Withdrawal by Subject|0|||
163253705|NCT02862457|589635793|FG004|Overall Study|Withdrawal by Subject|0|||
163253706|NCT02862457|589635794|FG005|Overall Study|Withdrawal by Subject|1|||
163253707|NCT02862457|589635795|FG006|Overall Study|Withdrawal by Subject|0|||
163253708|NCT03364751|589635796|FG000|Overall Study|Withdrawal by Subject|1|||
163253709|NCT03364751|589635797|FG001|Overall Study|Withdrawal by Subject|0|||
163253710|NCT03364751|589635798|FG002|Overall Study|Withdrawal by Subject|0|||
163253711|NCT03364751|589635799|FG003|Overall Study|Withdrawal by Subject|0|||
163253712|NCT03364751|589635796|FG000|Overall Study|Lost to Follow-up|0|||
163253713|NCT03364751|589635797|FG001|Overall Study|Lost to Follow-up|1|||
163253714|NCT03364751|589635798|FG002|Overall Study|Lost to Follow-up|0|||
163253715|NCT03364751|589635799|FG003|Overall Study|Lost to Follow-up|0|||
163253716|NCT02342886|589635801|FG000|Overall Study|Treatment non-compliance|1|||
163253717|NCT02342886|589635802|FG001|Overall Study|Treatment non-compliance|0|||
163253718|NCT02342886|589635803|FG002|Overall Study|Treatment non-compliance|0|||
163253719|NCT02342886|589635804|FG003|Overall Study|Treatment non-compliance|1|||
163253720|NCT02342886|589635805|FG004|Overall Study|Treatment non-compliance|0|||
163253721|NCT02342886|589635801|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
163253722|NCT02342886|589635802|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
163253723|NCT02342886|589635803|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
163253724|NCT02342886|589635804|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
163253725|NCT02342886|589635805|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
163253726|NCT02342886|589635801|FG000|Overall Study|Adverse event/specific toxicity|4|||
163253727|NCT02342886|589635802|FG001|Overall Study|Adverse event/specific toxicity|3|||
163253728|NCT02342886|589635803|FG002|Overall Study|Adverse event/specific toxicity|11|||
163253729|NCT02342886|589635804|FG003|Overall Study|Adverse event/specific toxicity|2|||
163253730|NCT02342886|589635805|FG004|Overall Study|Adverse event/specific toxicity|1|||
163253731|NCT02342886|589635801|FG000|Overall Study|Lost to Follow-up|1|||
163253732|NCT02342886|589635802|FG001|Overall Study|Lost to Follow-up|0|||
163253733|NCT02342886|589635803|FG002|Overall Study|Lost to Follow-up|0|||
163253734|NCT02342886|589635804|FG003|Overall Study|Lost to Follow-up|0|||
163253735|NCT02342886|589635805|FG004|Overall Study|Lost to Follow-up|0|||
163253736|NCT02342886|589635801|FG000|Overall Study|Death|1|||
163253737|NCT02342886|589635802|FG001|Overall Study|Death|2|||
163253738|NCT02342886|589635803|FG002|Overall Study|Death|1|||
163253739|NCT02342886|589635804|FG003|Overall Study|Death|0|||
163253740|NCT02342886|589635805|FG004|Overall Study|Death|1|||
163253741|NCT02342886|589635801|FG000|Overall Study|Withdrawal by Subject|0|||
163253742|NCT02342886|589635802|FG001|Overall Study|Withdrawal by Subject|1|||
163253743|NCT02342886|589635803|FG002|Overall Study|Withdrawal by Subject|0|||
163253744|NCT02342886|589635804|FG003|Overall Study|Withdrawal by Subject|1|||
163253745|NCT02342886|589635805|FG004|Overall Study|Withdrawal by Subject|0|||
163253746|NCT02342886|589635801|FG000|Overall Study|Investigator/sponsor decision|0|||
163253747|NCT02342886|589635802|FG001|Overall Study|Investigator/sponsor decision|2|||
163253748|NCT02342886|589635803|FG002|Overall Study|Investigator/sponsor decision|0|||
163253749|NCT02342886|589635804|FG003|Overall Study|Investigator/sponsor decision|3|||
163253750|NCT02342886|589635805|FG004|Overall Study|Investigator/sponsor decision|1|||
163151056|NCT01709721|589267040|FG000|Open Label Phase|Sponsor Decision|0|||
163151057|NCT01709721|589267041|FG001|Open Label Phase|Sponsor Decision|0|||
163151058|NCT01709721|589267042|FG002|Open Label Phase|Sponsor Decision|2|||
163151059|NCT01709721|589267040|FG000|Open Label Phase|Protocol Violation|0|||
163151060|NCT01709721|589267041|FG001|Open Label Phase|Protocol Violation|0|||
163151061|NCT01709721|589267042|FG002|Open Label Phase|Protocol Violation|1|||
163151062|NCT01709721|589267040|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
163151063|NCT01709721|589267041|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
163151064|NCT01709721|589267042|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
163151065|NCT01709721|589267040|FG000|Open Label Phase|Inadequate Pain Control|0|||
163151066|NCT01709721|589267041|FG001|Open Label Phase|Inadequate Pain Control|0|||
163151067|NCT01709721|589267042|FG002|Open Label Phase|Inadequate Pain Control|37|||
163151068|NCT01709721|589267040|FG000|Open Label Phase|Other, Specify in text field in database|0|||
163151069|NCT01709721|589267041|FG001|Open Label Phase|Other, Specify in text field in database|0|||
163151070|NCT01709721|589267042|FG002|Open Label Phase|Other, Specify in text field in database|14|||
163151071|NCT01709721|589267040|FG000|Randomized Phase|Adverse Event|0|||
163151072|NCT01709721|589267041|FG001|Randomized Phase|Adverse Event|1|||
163151073|NCT01709721|589267042|FG002|Randomized Phase|Adverse Event|0|||
163151074|NCT01709721|589267040|FG000|Randomized Phase|Lost to Follow-up|1|||
163151075|NCT01709721|589267041|FG001|Randomized Phase|Lost to Follow-up|0|||
163151076|NCT01709721|589267042|FG002|Randomized Phase|Lost to Follow-up|0|||
163151077|NCT01709721|589267040|FG000|Randomized Phase|Inadequate Pain Control|1|||
163151078|NCT01709721|589267041|FG001|Randomized Phase|Inadequate Pain Control|2|||
163151079|NCT01709721|589267042|FG002|Randomized Phase|Inadequate Pain Control|0|||
163151080|NCT01709721|589267040|FG000|Randomized Phase|Other, Specify text field in database|1|||
163151081|NCT01709721|589267041|FG001|Randomized Phase|Other, Specify text field in database|3|||
163151082|NCT01709721|589267042|FG002|Randomized Phase|Other, Specify text field in database|0|||
163151083|NCT02230410|589267045|FG000|Overall Study|Screen Failure|3|||
163151084|NCT02558894|589267051|FG000|Overall Study|Death; any cause, entire study duration|28|||
163151085|NCT02558894|589267052|FG001|Overall Study|Death; any cause, entire study duration|31|||
163151086|NCT02558894|589267051|FG000|Overall Study|Withdrawal by Subject|2|||
163151087|NCT02558894|589267052|FG001|Overall Study|Withdrawal by Subject|1|||
163151088|NCT02558894|589267051|FG000|Overall Study|Closure of Part A|2|||
163151089|NCT02558894|589267052|FG001|Overall Study|Closure of Part A|1|||
163151090|NCT02992288|589267053|FG000|Overall Study|Adverse Event|8|||
163151091|NCT02992288|589267054|FG001|Overall Study|Adverse Event|2|||
163151092|NCT02992288|589267055|FG002|Overall Study|Adverse Event|2|||
163151093|NCT02992288|589267056|FG003|Overall Study|Adverse Event|2|||
163151094|NCT02992288|589267057|FG004|Overall Study|Adverse Event|2|||
163151095|NCT02992288|589267058|FG005|Overall Study|Adverse Event|7|||
163151096|NCT02992288|589267053|FG000|Overall Study|Non-compliance with study drug|0|||
163151097|NCT02992288|589267054|FG001|Overall Study|Non-compliance with study drug|1|||
163151098|NCT02992288|589267055|FG002|Overall Study|Non-compliance with study drug|1|||
163151099|NCT02992288|589267056|FG003|Overall Study|Non-compliance with study drug|0|||
163151100|NCT02992288|589267057|FG004|Overall Study|Non-compliance with study drug|1|||
163151101|NCT02992288|589267058|FG005|Overall Study|Non-compliance with study drug|0|||
163151102|NCT02992288|589267053|FG000|Overall Study|Physician Decision|3|||
163151103|NCT02992288|589267054|FG001|Overall Study|Physician Decision|0|||
163151104|NCT02992288|589267055|FG002|Overall Study|Physician Decision|1|||
163151105|NCT02992288|589267056|FG003|Overall Study|Physician Decision|0|||
163151106|NCT02992288|589267057|FG004|Overall Study|Physician Decision|0|||
163151107|NCT02992288|589267058|FG005|Overall Study|Physician Decision|1|||
163151108|NCT02992288|589267053|FG000|Overall Study|Death|2|||
163151109|NCT02992288|589267054|FG001|Overall Study|Death|0|||
163151110|NCT02992288|589267055|FG002|Overall Study|Death|2|||
163151111|NCT02992288|589267056|FG003|Overall Study|Death|1|||
163151112|NCT02992288|589267057|FG004|Overall Study|Death|2|||
163151113|NCT02992288|589267058|FG005|Overall Study|Death|0|||
163151114|NCT02992288|589267053|FG000|Overall Study|Lost to Follow-up|0|||
163151115|NCT02992288|589267054|FG001|Overall Study|Lost to Follow-up|0|||
163151116|NCT02992288|589267055|FG002|Overall Study|Lost to Follow-up|0|||
163151117|NCT02992288|589267056|FG003|Overall Study|Lost to Follow-up|1|||
163151118|NCT02992288|589267057|FG004|Overall Study|Lost to Follow-up|0|||
163151119|NCT02992288|589267058|FG005|Overall Study|Lost to Follow-up|0|||
163151120|NCT02992288|589267053|FG000|Overall Study|Protocol Violation|0|||
163253751|NCT02342886|589635801|FG000|Overall Study|Pregnancy|0|||
163253752|NCT02342886|589635802|FG001|Overall Study|Pregnancy|0|||
163253753|NCT02342886|589635803|FG002|Overall Study|Pregnancy|2|||
163253754|NCT02342886|589635804|FG003|Overall Study|Pregnancy|0|||
163253755|NCT02342886|589635805|FG004|Overall Study|Pregnancy|0|||
163253756|NCT02342886|589635801|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
163253757|NCT02342886|589635802|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
163253758|NCT02342886|589635803|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
163253759|NCT02342886|589635804|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
163253760|NCT02342886|589635805|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
163253761|NCT02342886|589635801|FG000|Overall Study|Protocol Violation|0|||
163253762|NCT02342886|589635802|FG001|Overall Study|Protocol Violation|0|||
163253763|NCT02342886|589635803|FG002|Overall Study|Protocol Violation|0|||
163253764|NCT02342886|589635804|FG003|Overall Study|Protocol Violation|2|||
163253765|NCT02342886|589635805|FG004|Overall Study|Protocol Violation|0|||
163253766|NCT00862134|589635806|FG000|Overall Study|Death|1|||
163253767|NCT00862134|589635807|FG001|Overall Study|Death|0|||
163253768|NCT00862134|589635806|FG000|Overall Study|Physician Decision|0|||
163253769|NCT00862134|589635807|FG001|Overall Study|Physician Decision|1|||
163253770|NCT00862134|589635806|FG000|Overall Study|Withdrawal by Subject|1|||
163151121|NCT02992288|589267054|FG001|Overall Study|Protocol Violation|0|||
163151122|NCT02992288|589267055|FG002|Overall Study|Protocol Violation|0|||
163151123|NCT02992288|589267056|FG003|Overall Study|Protocol Violation|0|||
163151124|NCT02992288|589267057|FG004|Overall Study|Protocol Violation|0|||
163151125|NCT02992288|589267058|FG005|Overall Study|Protocol Violation|1|||
163151126|NCT02992288|589267053|FG000|Overall Study|Withdrawal by Subject|4|||
163151127|NCT02992288|589267054|FG001|Overall Study|Withdrawal by Subject|2|||
163151128|NCT02992288|589267055|FG002|Overall Study|Withdrawal by Subject|1|||
163151129|NCT02992288|589267056|FG003|Overall Study|Withdrawal by Subject|5|||
163151130|NCT02992288|589267057|FG004|Overall Study|Withdrawal by Subject|3|||
163151131|NCT02992288|589267058|FG005|Overall Study|Withdrawal by Subject|4|||
163151132|NCT00499486|589267059|FG000|Overall Study|Withdrawal by Subject|16|||
163151133|NCT00656513|589267060|FG000|Overall Study|Protocol Violation|1|||
163151134|NCT00656513|589267061|FG001|Overall Study|Protocol Violation|0|||
163151135|NCT00656513|589267062|FG002|Overall Study|Protocol Violation|2|||
163151136|NCT00656513|589267060|FG000|Overall Study|Withdrawal by Subject|0|||
163151137|NCT00656513|589267061|FG001|Overall Study|Withdrawal by Subject|11|||
163151138|NCT00656513|589267062|FG002|Overall Study|Withdrawal by Subject|4|||
163151139|NCT00656513|589267060|FG000|Overall Study|Death|0|||
163151140|NCT00656513|589267061|FG001|Overall Study|Death|0|||
163151141|NCT00656513|589267062|FG002|Overall Study|Death|1|||
163151142|NCT00656513|589267060|FG000|Overall Study|Missing data|0|||
163151143|NCT00656513|589267061|FG001|Overall Study|Missing data|11|||
163151144|NCT00656513|589267062|FG002|Overall Study|Missing data|9|||
163151145|NCT00656513|589267060|FG000|Overall Study|Incomplete treatment|3|||
163151146|NCT00656513|589267061|FG001|Overall Study|Incomplete treatment|0|||
163151147|NCT00656513|589267062|FG002|Overall Study|Incomplete treatment|0|||
163151148|NCT00656513|589267060|FG000|Overall Study|Treatment completed outside of timeframe|0|||
163151149|NCT00656513|589267061|FG001|Overall Study|Treatment completed outside of timeframe|3|||
163151150|NCT00656513|589267062|FG002|Overall Study|Treatment completed outside of timeframe|1|||
163151151|NCT00656513|589267060|FG000|Overall Study|Missing baseline form|0|||
163151152|NCT00656513|589267061|FG001|Overall Study|Missing baseline form|5|||
163151153|NCT00656513|589267062|FG002|Overall Study|Missing baseline form|5|||
163151154|NCT03796728|589267067|FG000|Overall Study|Lost to Follow-up|8|||
163151155|NCT03796728|589267067|FG000|Overall Study|Reason not Specified|16|||
163151156|NCT00333775|589267068|FG000|Overall Study|Death|144|||
163151157|NCT00333775|589267069|FG001|Overall Study|Death|149|||
163151158|NCT00333775|589267070|FG002|Overall Study|Death|143|||
163151159|NCT00333775|589267068|FG000|Overall Study|In Follow-up When Study Stopped|87|||
163151160|NCT00333775|589267069|FG001|Overall Study|In Follow-up When Study Stopped|92|||
163151161|NCT00333775|589267070|FG002|Overall Study|In Follow-up When Study Stopped|96|||
163151162|NCT00333775|589267068|FG000|Overall Study|Lost to Follow-up|10|||
163151163|NCT00333775|589267069|FG001|Overall Study|Lost to Follow-up|7|||
163151164|NCT00333775|589267070|FG002|Overall Study|Lost to Follow-up|8|||
163151165|NCT00412984|589267076|FG000|Overall Study|Death|331|||
163151166|NCT00412984|589267077|FG001|Overall Study|Death|349|||
163151167|NCT00412984|589267076|FG000|Overall Study|Adverse Event|679|||
163151168|NCT00412984|589267077|FG001|Overall Study|Adverse Event|738|||
163151169|NCT00412984|589267076|FG000|Overall Study|Withdrawal by Subject|921|||
163151170|NCT00412984|589267077|FG001|Overall Study|Withdrawal by Subject|989|||
163151171|NCT00412984|589267076|FG000|Overall Study|Lost to Follow-up|51|||
163151172|NCT00412984|589267077|FG001|Overall Study|Lost to Follow-up|39|||
163151173|NCT00412984|589267076|FG000|Overall Study|Poor/Noncompliance|57|||
163151174|NCT00412984|589267077|FG001|Overall Study|Poor/Noncompliance|77|||
163151175|NCT00412984|589267076|FG000|Overall Study|Pregnancy|1|||
163151176|NCT00412984|589267077|FG001|Overall Study|Pregnancy|0|||
163151177|NCT00412984|589267076|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
163151178|NCT00412984|589267077|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
163151179|NCT00412984|589267076|FG000|Overall Study|Administrative Reason by Sponsor|11|||
163151180|NCT00412984|589267077|FG001|Overall Study|Administrative Reason by Sponsor|8|||
163151181|NCT00412984|589267076|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
163151182|NCT00412984|589267077|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
163151183|NCT00412984|589267076|FG000|Overall Study|Other Reason|80|||
163151184|NCT00412984|589267077|FG001|Overall Study|Other Reason|92|||
163151185|NCT00412984|589267076|FG000|Overall Study|Not Reported|11|||
163151186|NCT00412984|589267077|FG001|Overall Study|Not Reported|12|||
163151187|NCT03651765|589267078|FG000|Overall Study|Adverse Event|6|||
163253771|NCT00862134|589635807|FG001|Overall Study|Withdrawal by Subject|2|||
163357394|NCT00727506|590017899|FG004|Overall Study|Adverse Event|1|||
163357395|NCT00727506|590017900|FG005|Overall Study|Adverse Event|8|||
163357396|NCT00727506|590017895|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
163357397|NCT00727506|590017896|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163357398|NCT00727506|590017897|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
163357399|NCT00727506|590017898|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163357400|NCT00727506|590017899|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163357401|NCT00727506|590017900|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163357402|NCT00727506|590017895|FG000|Overall Study|Progressive disease|4|||
163357403|NCT00727506|590017896|FG001|Overall Study|Progressive disease|7|||
163357404|NCT00727506|590017897|FG002|Overall Study|Progressive disease|9|||
163357405|NCT00727506|590017898|FG003|Overall Study|Progressive disease|28|||
163357406|NCT00727506|590017899|FG004|Overall Study|Progressive disease|38|||
163357407|NCT00727506|590017900|FG005|Overall Study|Progressive disease|28|||
163357408|NCT00727506|590017895|FG000|Overall Study|Refused to continue medication|0|||
163357409|NCT00727506|590017896|FG001|Overall Study|Refused to continue medication|1|||
163357410|NCT00727506|590017897|FG002|Overall Study|Refused to continue medication|2|||
163357411|NCT00727506|590017898|FG003|Overall Study|Refused to continue medication|3|||
163357412|NCT00727506|590017899|FG004|Overall Study|Refused to continue medication|1|||
163357413|NCT00727506|590017900|FG005|Overall Study|Refused to continue medication|2|||
163357414|NCT00727506|590017895|FG000|Overall Study|Other reason not described above|0|||
163357415|NCT00727506|590017896|FG001|Overall Study|Other reason not described above|0|||
163357416|NCT00727506|590017897|FG002|Overall Study|Other reason not described above|1|||
163357417|NCT00727506|590017898|FG003|Overall Study|Other reason not described above|4|||
163357418|NCT00727506|590017899|FG004|Overall Study|Other reason not described above|1|||
163357419|NCT00727506|590017900|FG005|Overall Study|Other reason not described above|1|||
163357420|NCT02650466|590017902|FG000|Overall Study|Physician Decision|1|||
163357421|NCT02650466|590017902|FG000|Overall Study|Withdrawal by Subject|5|||
163357422|NCT02650466|590017902|FG000|Overall Study|Lost to Follow-up|1|||
163357423|NCT01214421|590017906|FG000|Overall Study|Lost to Follow-up|7|||
163357424|NCT01214421|590017907|FG001|Overall Study|Lost to Follow-up|3|||
163357425|NCT01214421|590017908|FG002|Overall Study|Lost to Follow-up|7|||
163357426|NCT01214421|590017909|FG003|Overall Study|Lost to Follow-up|3|||
163357427|NCT01214421|590017906|FG000|Overall Study|Adverse Event|16|||
163357428|NCT01214421|590017907|FG001|Overall Study|Adverse Event|35|||
163357429|NCT01214421|590017908|FG002|Overall Study|Adverse Event|14|||
163357430|NCT01214421|590017909|FG003|Overall Study|Adverse Event|3|||
163357431|NCT01214421|590017906|FG000|Overall Study|Sponsor Discontinued Site|1|||
163357432|NCT01214421|590017907|FG001|Overall Study|Sponsor Discontinued Site|2|||
163357433|NCT01214421|590017908|FG002|Overall Study|Sponsor Discontinued Site|0|||
163357434|NCT01214421|590017909|FG003|Overall Study|Sponsor Discontinued Site|0|||
163357435|NCT01214421|590017906|FG000|Overall Study|Withdrawal Criteria Met|3|||
163357436|NCT01214421|590017907|FG001|Overall Study|Withdrawal Criteria Met|0|||
163357437|NCT01214421|590017908|FG002|Overall Study|Withdrawal Criteria Met|2|||
163357438|NCT01214421|590017909|FG003|Overall Study|Withdrawal Criteria Met|1|||
163357439|NCT01214421|590017906|FG000|Overall Study|Physician Decision|2|||
163357440|NCT01214421|590017907|FG001|Overall Study|Physician Decision|0|||
163357441|NCT01214421|590017908|FG002|Overall Study|Physician Decision|4|||
163357442|NCT01214421|590017909|FG003|Overall Study|Physician Decision|0|||
163357443|NCT01214421|590017906|FG000|Overall Study|Withdrawal by Subject|21|||
163357444|NCT01214421|590017907|FG001|Overall Study|Withdrawal by Subject|18|||
163357445|NCT01214421|590017908|FG002|Overall Study|Withdrawal by Subject|11|||
163253772|NCT00862134|589635806|FG000|Overall Study|Sponsor terminated study|5|||
163253773|NCT00862134|589635807|FG001|Overall Study|Sponsor terminated study|7|||
163253774|NCT00862134|589635806|FG000|Overall Study|Adverse Event|2|||
163253775|NCT00862134|589635807|FG001|Overall Study|Adverse Event|2|||
163253776|NCT00862134|589635806|FG000|Overall Study|Withdrew prior to dosing|2|||
163253777|NCT00862134|589635807|FG001|Overall Study|Withdrew prior to dosing|0|||
163253778|NCT00765674|589635808|FG000|Overall Study|Adverse Event|7|||
163253779|NCT00765674|589635809|FG001|Overall Study|Adverse Event|2|||
163253780|NCT00765674|589635810|FG002|Overall Study|Adverse Event|8|||
163253781|NCT00765674|589635811|FG003|Overall Study|Adverse Event|11|||
163253782|NCT00765674|589635808|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
163253783|NCT00765674|589635809|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
163357446|NCT01214421|590017909|FG003|Overall Study|Withdrawal by Subject|2|||
163357447|NCT02392104|590017911|FG000|Overall Study|discontinuation of warfarin|3|||
163357448|NCT02392104|590017911|FG000|Overall Study|bleeding event|1|||
163357449|NCT02392104|590017911|FG000|Overall Study|transferred care to another doctor|2|||
163357450|NCT02392104|590017911|FG000|Overall Study|INR goal range changed|1|||
163357451|NCT02392104|590017911|FG000|Overall Study|admitted to skilled nursing facility|3|||
163357452|NCT02392104|590017911|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
163357453|NCT04590404|590017912|FG000|Overall Study|Death|16|||
163357454|NCT04590404|590017913|FG001|Overall Study|Death|17|||
163357455|NCT04590404|590017912|FG000|Overall Study|Withdrawal by Subject|7|||
163357456|NCT04590404|590017913|FG001|Overall Study|Withdrawal by Subject|2|||
163357457|NCT03912532|590017914|FG000|Overall Study|Adverse Event|3|||
163357458|NCT03912532|590017915|FG001|Overall Study|Adverse Event|3|||
163357459|NCT03912532|590017916|FG002|Overall Study|Adverse Event|2|||
163357460|NCT03912532|590017917|FG003|Overall Study|Adverse Event|2|||
163357461|NCT03912532|590017914|FG000|Overall Study|Lost to Follow-up|3|||
163357462|NCT03912532|590017915|FG001|Overall Study|Lost to Follow-up|2|||
163357463|NCT03912532|590017916|FG002|Overall Study|Lost to Follow-up|1|||
163357464|NCT03912532|590017917|FG003|Overall Study|Lost to Follow-up|2|||
163357465|NCT03912532|590017914|FG000|Overall Study|Withdrawal by Subject|1|||
163357466|NCT03912532|590017915|FG001|Overall Study|Withdrawal by Subject|1|||
163357467|NCT03912532|590017916|FG002|Overall Study|Withdrawal by Subject|2|||
163357468|NCT03912532|590017917|FG003|Overall Study|Withdrawal by Subject|0|||
163357469|NCT03912532|590017914|FG000|Overall Study|Physician Decision|1|||
163357470|NCT03912532|590017915|FG001|Overall Study|Physician Decision|0|||
163357471|NCT03912532|590017916|FG002|Overall Study|Physician Decision|0|||
163357472|NCT03912532|590017917|FG003|Overall Study|Physician Decision|3|||
163357473|NCT03912532|590017914|FG000|Overall Study|Other|0|||
163357474|NCT03912532|590017915|FG001|Overall Study|Other|1|||
163357475|NCT03912532|590017916|FG002|Overall Study|Other|1|||
163357476|NCT03912532|590017917|FG003|Overall Study|Other|0|||
163357477|NCT03783871|590017920|FG000|Overall Study|Withdrawal by Subject|15|||
163357478|NCT03783871|590017920|FG000|Overall Study|Death|13|||
163357479|NCT03783871|590017920|FG000|Overall Study|Lost to Follow-up|2|||
163357480|NCT05990387|590017921|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
163357481|NCT05990387|590017922|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
163357482|NCT00815919|590017923|FG000|Overall Study|Unrelated Fungal Infection|1|||
163357483|NCT00815919|590017923|FG000|Overall Study|AML Relapse|1|||
163357484|NCT00815919|590017923|FG000|Overall Study|Lack of Efficacy|2|||
163357485|NCT03522389|590017924|FG000|Overall Study|Lost to Follow-up|1|||
163357486|NCT03522389|590017925|FG001|Overall Study|Lost to Follow-up|1|||
163357487|NCT03522389|590017926|FG002|Overall Study|Lost to Follow-up|2|||
163357488|NCT03522389|590017924|FG000|Overall Study|had herniated nucleus pulposus|0|||
163357489|NCT03522389|590017925|FG001|Overall Study|had herniated nucleus pulposus|1|||
163357490|NCT03522389|590017926|FG002|Overall Study|had herniated nucleus pulposus|0|||
163357491|NCT03522389|590017924|FG000|Overall Study|go to work in other province|1|||
163357492|NCT03522389|590017925|FG001|Overall Study|go to work in other province|0|||
163357493|NCT03522389|590017926|FG002|Overall Study|go to work in other province|0|||
163357494|NCT04750577|590017927|FG000|Overall Study|Adverse Event|2|||
163357495|NCT04750577|590017928|FG001|Overall Study|Adverse Event|10|||
163357496|NCT04750577|590017929|FG002|Overall Study|Adverse Event|8|||
163357497|NCT04750577|590017930|FG003|Overall Study|Adverse Event|1|||
163357498|NCT04750577|590017927|FG000|Overall Study|Change of residence|0|||
163357499|NCT04750577|590017928|FG001|Overall Study|Change of residence|0|||
163357500|NCT04750577|590017929|FG002|Overall Study|Change of residence|1|||
163357501|NCT04750577|590017930|FG003|Overall Study|Change of residence|0|||
163357502|NCT04750577|590017927|FG000|Overall Study|Burden of study procedures|0|||
163357503|NCT04750577|590017928|FG001|Overall Study|Burden of study procedures|2|||
163357504|NCT04750577|590017929|FG002|Overall Study|Burden of study procedures|2|||
163357505|NCT04750577|590017930|FG003|Overall Study|Burden of study procedures|0|||
163357506|NCT04750577|590017927|FG000|Overall Study|Prematurely discontinued|0|||
163357507|NCT04750577|590017928|FG001|Overall Study|Prematurely discontinued|0|||
163357508|NCT04750577|590017929|FG002|Overall Study|Prematurely discontinued|0|||
163357509|NCT04750577|590017930|FG003|Overall Study|Prematurely discontinued|2|||
163357510|NCT04750577|590017927|FG000|Overall Study|Protocol deviation|1|||
163357511|NCT04750577|590017928|FG001|Overall Study|Protocol deviation|1|||
163357512|NCT04750577|590017929|FG002|Overall Study|Protocol deviation|1|||
163357513|NCT04750577|590017930|FG003|Overall Study|Protocol deviation|1|||
163357514|NCT04750577|590017927|FG000|Overall Study|Other than listed|3|||
163357515|NCT04750577|590017928|FG001|Overall Study|Other than listed|2|||
163357516|NCT04750577|590017929|FG002|Overall Study|Other than listed|2|||
163357517|NCT04750577|590017930|FG003|Overall Study|Other than listed|1|||
163357518|NCT04750577|590017927|FG000|Overall Study|Not treated|0|||
163357519|NCT04750577|590017928|FG001|Overall Study|Not treated|0|||
163357520|NCT04750577|590017929|FG002|Overall Study|Not treated|0|||
163357521|NCT04750577|590017930|FG003|Overall Study|Not treated|2|||
163357522|NCT02473042|590017936|FG000|Overall Study|Withdrawal by Subject|1|||
163357523|NCT02473042|590017937|FG001|Overall Study|Withdrawal by Subject|0|||
163357524|NCT02473042|590017936|FG000|Overall Study|Patient became ineligible after enrollment|2|||
163357525|NCT02473042|590017937|FG001|Overall Study|Patient became ineligible after enrollment|5|||
163357526|NCT02473042|590017936|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
163357527|NCT02473042|590017937|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
163357528|NCT02473042|590017936|FG000|Overall Study|PACU data unable to be collected|3|||
163357529|NCT02473042|590017937|FG001|Overall Study|PACU data unable to be collected|0|||
163357530|NCT04680637|590017940|FG000|Overall Study|Lost to Follow-up|0|||
163357531|NCT04680637|590017941|FG001|Overall Study|Lost to Follow-up|1|||
163357532|NCT04680637|590017942|FG002|Overall Study|Lost to Follow-up|0|||
163357533|NCT04680637|590017943|FG003|Overall Study|Lost to Follow-up|1|||
163357534|NCT04680637|590017940|FG000|Overall Study|Death|1|||
163357535|NCT04680637|590017941|FG001|Overall Study|Death|0|||
163357536|NCT04680637|590017942|FG002|Overall Study|Death|0|||
163357537|NCT04680637|590017943|FG003|Overall Study|Death|0|||
163357538|NCT04680637|590017940|FG000|Overall Study|Withdrawal by Subject|7|||
163357539|NCT04680637|590017941|FG001|Overall Study|Withdrawal by Subject|10|||
163357540|NCT04680637|590017942|FG002|Overall Study|Withdrawal by Subject|17|||
163357541|NCT04680637|590017943|FG003|Overall Study|Withdrawal by Subject|15|||
163357542|NCT04680637|590017940|FG000|Overall Study|Decision by Sponsor|21|||
163357543|NCT04680637|590017941|FG001|Overall Study|Decision by Sponsor|15|||
163357544|NCT04680637|590017942|FG002|Overall Study|Decision by Sponsor|7|||
163357545|NCT04680637|590017943|FG003|Overall Study|Decision by Sponsor|32|||
163357546|NCT00604188|590017944|FG000|Overall Study|Adverse Event|1|||
163357547|NCT00604188|590017945|FG001|Overall Study|Adverse Event|4|||
163357548|NCT00604188|590017944|FG000|Overall Study|Lost to Follow-up|17|||
163357549|NCT00604188|590017945|FG001|Overall Study|Lost to Follow-up|15|||
163357550|NCT00604188|590017944|FG000|Overall Study|Withdrawal by Subject|5|||
163357551|NCT00604188|590017945|FG001|Overall Study|Withdrawal by Subject|1|||
163357552|NCT00604188|590017944|FG000|Overall Study|Non-compliance with protocol|4|||
163357553|NCT00604188|590017945|FG001|Overall Study|Non-compliance with protocol|4|||
163357554|NCT00604188|590017944|FG000|Overall Study|Did not receive study drug|0|||
163357555|NCT00604188|590017945|FG001|Overall Study|Did not receive study drug|1|||
163357556|NCT02242643|590017950|FG000|Overall Study|Protocol Violation|1|||
163357557|NCT02242643|590017951|FG001|Overall Study|Protocol Violation|2|||
163357558|NCT02242643|590017950|FG000|Overall Study|Withdrawal by Subject|15|||
163357559|NCT02242643|590017951|FG001|Overall Study|Withdrawal by Subject|10|||
163357560|NCT02242643|590017950|FG000|Overall Study|Migrated/moved from study area|1|||
163357561|NCT02242643|590017951|FG001|Overall Study|Migrated/moved from study area|3|||
163357562|NCT02242643|590017950|FG000|Overall Study|Lost to Follow-up|54|||
163357563|NCT02242643|590017951|FG001|Overall Study|Lost to Follow-up|61|||
163357564|NCT02242643|590017950|FG000|Overall Study|Child placed in foster care by family|0|||
163357565|NCT02242643|590017951|FG001|Overall Study|Child placed in foster care by family|1|||
163357566|NCT02242643|590017950|FG000|Overall Study|Non-compliance|1|||
163357567|NCT02242643|590017951|FG001|Overall Study|Non-compliance|0|||
163357568|NCT02242643|590017950|FG000|Overall Study|Consent withdrawal by parent|1|||
163357569|NCT02242643|590017951|FG001|Overall Study|Consent withdrawal by parent|0|||
163357570|NCT02242643|590017950|FG000|Overall Study|Protocol requirements not followed|1|||
163357571|NCT02242643|590017951|FG001|Overall Study|Protocol requirements not followed|0|||
163357572|NCT02242643|590017950|FG000|Overall Study|Language barrier|1|||
163357573|NCT02242643|590017951|FG001|Overall Study|Language barrier|0|||
163357574|NCT02242643|590017950|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
163357575|NCT02242643|590017951|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
163357576|NCT01103232|590017955|FG000|Overall Study|Withdrawal by Subject|1|||
163357577|NCT01103232|590017956|FG001|Overall Study|Withdrawal by Subject|1|||
163151188|NCT03651765|589267078|FG000|Overall Study|Lack of Efficacy|18|||
163151189|NCT03651765|589267078|FG000|Overall Study|Lost to Follow-up|5|||
163151190|NCT03651765|589267078|FG000|Overall Study|Non-Compliance with Study Drug|4|||
163151191|NCT03651765|589267078|FG000|Overall Study|Physician Decision|6|||
163151192|NCT03651765|589267078|FG000|Overall Study|Pregnancy|1|||
163151193|NCT03651765|589267078|FG000|Overall Study|Discontinued by Sponsor|40|||
163151194|NCT03651765|589267078|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
163151195|NCT03651765|589267078|FG000|Overall Study|Withdrawal by Subject|24|||
163151196|NCT03651765|589267078|FG000|Overall Study|Miscellaneous|6|||
163151197|NCT04097678|589267081|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
163151198|NCT04097678|589267082|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
163151199|NCT03694678|589267083|FG000|Overall Study|Withdrawal by Subject|2|||
163151200|NCT03694678|589267084|FG001|Overall Study|Withdrawal by Subject|0|||
163151201|NCT03694678|589267083|FG000|Overall Study|Lost to Follow-up|2|||
163151202|NCT03694678|589267084|FG001|Overall Study|Lost to Follow-up|3|||
163151203|NCT02435212|589267085|FG000|Core Phase|Adverse Event|8|||
163151204|NCT02435212|589267086|FG001|Core Phase|Adverse Event|5|||
163151205|NCT02435212|589267085|FG000|Core Phase|Withdrawal by Subject|3|||
163151206|NCT02435212|589267086|FG001|Core Phase|Withdrawal by Subject|0|||
163151207|NCT02435212|589267085|FG000|Core Phase|Withdrawal by parent/guardian|9|||
163151208|NCT02435212|589267086|FG001|Core Phase|Withdrawal by parent/guardian|4|||
163151209|NCT02435212|589267085|FG000|Core Phase|Protocol Violation|1|||
163151210|NCT02435212|589267086|FG001|Core Phase|Protocol Violation|2|||
163151211|NCT02435212|589267085|FG000|Core Phase|Physician Decision|3|||
163151212|NCT02435212|589267086|FG001|Core Phase|Physician Decision|0|||
163151213|NCT02435212|589267085|FG000|Core Phase|Lost to Follow-up|0|||
163151214|NCT02435212|589267086|FG001|Core Phase|Lost to Follow-up|1|||
163151215|NCT02435212|589267085|FG000|Core Phase|Lack of Efficacy|0|||
163151216|NCT02435212|589267086|FG001|Core Phase|Lack of Efficacy|1|||
163151217|NCT02435212|589267085|FG000|Core Phase|Recovery|1|||
163151218|NCT02435212|589267086|FG001|Core Phase|Recovery|0|||
163151219|NCT02435212|589267085|FG000|Optional Extension Phase|Adverse Event|3|||
163151220|NCT02435212|589267086|FG001|Optional Extension Phase|Adverse Event|9|||
163151221|NCT02435212|589267085|FG000|Optional Extension Phase|Physician Decision|6|||
163151222|NCT02435212|589267086|FG001|Optional Extension Phase|Physician Decision|8|||
163151223|NCT02435212|589267085|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
163151224|NCT02435212|589267086|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
163151225|NCT02435212|589267085|FG000|Optional Extension Phase|Lack of Efficacy|2|||
163151226|NCT02435212|589267086|FG001|Optional Extension Phase|Lack of Efficacy|3|||
163151227|NCT02435212|589267085|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
163151228|NCT02435212|589267086|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
163151229|NCT02435212|589267085|FG000|Optional Extension Phase|Protocol Violation|0|||
163151230|NCT02435212|589267086|FG001|Optional Extension Phase|Protocol Violation|1|||
163151231|NCT02435212|589267085|FG000|Optional Extension Phase|Recovery|1|||
163357578|NCT01103232|590017955|FG000|Overall Study|Protocol Violation|0|||
163357579|NCT01103232|590017956|FG001|Overall Study|Protocol Violation|1|||
163357580|NCT00443599|590017960|FG000|Overall Study|Physician Decision|2|||
163357581|NCT00443599|590017961|FG001|Overall Study|Physician Decision|1|||
163357582|NCT00443599|590017960|FG000|Overall Study|Death|1|||
163357583|NCT00443599|590017961|FG001|Overall Study|Death|1|||
163357584|NCT00443599|590017960|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
163357585|NCT00443599|590017961|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
163357586|NCT03049306|590017962|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
163357587|NCT03049306|590017963|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
163357588|NCT05093504|590017964|FG000|Overall Study|Death|0|||
163357589|NCT05093504|590017965|FG001|Overall Study|Death|1|||
163357590|NCT03151551|590017966|FG000|Open-Label Treatment Period|Adverse Event|0|||
163357591|NCT03151551|590017967|FG001|Open-Label Treatment Period|Adverse Event|2|||
163357592|NCT03151551|590017966|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
163357593|NCT03151551|590017967|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
163357594|NCT03151551|590017966|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
163357595|NCT03151551|590017967|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
163357596|NCT03151551|590017966|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
163357597|NCT03151551|590017967|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
163357598|NCT03151551|590017966|FG000|Open-Label Treatment Period|Physician Decision|3|||
163357599|NCT03151551|590017967|FG001|Open-Label Treatment Period|Physician Decision|0|||
163357600|NCT03151551|590017966|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
163357601|NCT03151551|590017967|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
163357602|NCT03151551|590017966|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
163357603|NCT03151551|590017967|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
163357604|NCT03151551|590017966|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
163357605|NCT03151551|590017967|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
163357606|NCT03151551|590017966|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
163357607|NCT03151551|590017967|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
163357608|NCT03151551|590017966|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
163357609|NCT03151551|590017967|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
163357610|NCT01190449|590017968|FG000|Overall Study|Ineligible|0|||
163357611|NCT01190449|590017969|FG001|Overall Study|Ineligible|4|||
163357612|NCT00129935|590019322|FG000|Overall Study|Adverse Event|18|||
163357613|NCT00129935|590019323|FG001|Overall Study|Adverse Event|56|||
163357614|NCT00129935|590019322|FG000|Overall Study|Death|1|||
163357615|NCT00129935|590019323|FG001|Overall Study|Death|1|||
163357616|NCT00129935|590019322|FG000|Overall Study|Withdrawal by Subject|7|||
163357617|NCT00129935|590019323|FG001|Overall Study|Withdrawal by Subject|20|||
163357618|NCT00129935|590019322|FG000|Overall Study|Protocol Violation|0|||
163357619|NCT00129935|590019323|FG001|Overall Study|Protocol Violation|4|||
163357620|NCT00129935|590019322|FG000|Overall Study|Physician Decision|3|||
163357621|NCT00129935|590019323|FG001|Overall Study|Physician Decision|4|||
163357622|NCT00129935|590019322|FG000|Overall Study|Recurrence|1|||
163357623|NCT00129935|590019323|FG001|Overall Study|Recurrence|3|||
163357624|NCT00129935|590019322|FG000|Overall Study|Second primary|0|||
163357625|NCT00129935|590019323|FG001|Overall Study|Second primary|1|||
163357626|NCT00129935|590019322|FG000|Overall Study|Other|3|||
163357627|NCT00129935|590019323|FG001|Overall Study|Other|2|||
163357628|NCT00129935|590019322|FG000|Overall Study|Crossed to the other arm|2|||
163357629|NCT00129935|590019323|FG001|Overall Study|Crossed to the other arm|1|||
163357630|NCT00129935|590019322|FG000|Overall Study|Incorrect study treatment|1|||
163357631|NCT00129935|590019323|FG001|Overall Study|Incorrect study treatment|0|||
163357632|NCT02783573|590019325|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
163357633|NCT02783573|590019326|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
163357634|NCT02783573|590019327|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
163357635|NCT02783573|590019325|FG000|Placebo-Controlled Treatment Period|Death|4|||
163357636|NCT02783573|590019326|FG001|Placebo-Controlled Treatment Period|Death|2|||
163357637|NCT02783573|590019327|FG002|Placebo-Controlled Treatment Period|Death|3|||
163357638|NCT02783573|590019325|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
163357639|NCT02783573|590019326|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
163357640|NCT02783573|590019327|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
163357641|NCT02783573|590019325|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
163357642|NCT02783573|590019326|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
163357643|NCT02783573|590019327|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
163357644|NCT02783573|590019325|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
163357645|NCT02783573|590019326|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
163357646|NCT02783573|590019327|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
163357647|NCT02783573|590019325|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
163357648|NCT02783573|590019326|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
163357649|NCT02783573|590019327|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
163357650|NCT02783573|590019325|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
163357651|NCT02783573|590019326|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
163357652|NCT02783573|590019327|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
163357653|NCT02783573|590019325|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
163357654|NCT02783573|590019326|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
163357655|NCT02783573|590019327|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
163357656|NCT02783573|590019325|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
163357657|NCT02783573|590019326|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
163357658|NCT02783573|590019327|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
163357659|NCT02783573|590019325|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
163357660|NCT02783573|590019326|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
163357661|NCT02783573|590019327|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
163357662|NCT02783573|590019325|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
163357663|NCT02783573|590019326|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
163357664|NCT02783573|590019327|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
163357665|NCT02783573|590019325|FG000|Delayed-Start Period|Sponsor Decision|0|||
163357666|NCT02783573|590019326|FG001|Delayed-Start Period|Sponsor Decision|17|||
163357667|NCT02783573|590019327|FG002|Delayed-Start Period|Sponsor Decision|12|||
163357668|NCT00590564|590019328|FG000|Overall Study|Withdrawal by Subject|4|||
163357669|NCT00590564|590019328|FG000|Overall Study|Lost to Follow-up|6|||
163357670|NCT00590564|590019328|FG000|Overall Study|Protocol Violation|1|||
163357671|NCT00590564|590019328|FG000|Overall Study|Patient Found to be Ineligible|1|||
163357672|NCT00590564|590019328|FG000|Overall Study|Patient Non-compliance|6|||
163357673|NCT01434680|590019331|FG000|Overall Study|Withdrawal by Subject|1|||
163357674|NCT01434680|590019332|FG001|Overall Study|Withdrawal by Subject|0|||
163357675|NCT01434680|590019333|FG002|Overall Study|Withdrawal by Subject|2|||
163357676|NCT01434680|590019334|FG003|Overall Study|Withdrawal by Subject|0|||
163357677|NCT01434680|590019331|FG000|Overall Study|Lost to Follow-up|1|||
163253784|NCT00765674|589635810|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
163253785|NCT00765674|589635811|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
163253786|NCT00765674|589635808|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
163253787|NCT00765674|589635809|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
163253788|NCT00765674|589635810|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
163253789|NCT00765674|589635811|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
163253790|NCT00765674|589635808|FG000|Overall Study|Lack of Efficacy|2|||
163253791|NCT00765674|589635809|FG001|Overall Study|Lack of Efficacy|3|||
163253792|NCT00765674|589635810|FG002|Overall Study|Lack of Efficacy|1|||
163253793|NCT00765674|589635811|FG003|Overall Study|Lack of Efficacy|2|||
163253794|NCT00765674|589635808|FG000|Overall Study|Protocol Violation|2|||
163253795|NCT00765674|589635809|FG001|Overall Study|Protocol Violation|0|||
163253796|NCT00765674|589635810|FG002|Overall Study|Protocol Violation|1|||
163253797|NCT00765674|589635811|FG003|Overall Study|Protocol Violation|0|||
163253798|NCT00765674|589635808|FG000|Overall Study|Withdrawal by Subject|5|||
163253799|NCT00765674|589635809|FG001|Overall Study|Withdrawal by Subject|7|||
163253800|NCT00765674|589635810|FG002|Overall Study|Withdrawal by Subject|3|||
163253801|NCT00765674|589635811|FG003|Overall Study|Withdrawal by Subject|8|||
163253802|NCT00765674|589635808|FG000|Overall Study|Lost to Follow-up|4|||
163253803|NCT00765674|589635809|FG001|Overall Study|Lost to Follow-up|6|||
163253804|NCT00765674|589635810|FG002|Overall Study|Lost to Follow-up|2|||
163253805|NCT00765674|589635811|FG003|Overall Study|Lost to Follow-up|1|||
163253806|NCT00765674|589635808|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
163253807|NCT00765674|589635809|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
163253808|NCT00765674|589635810|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
163253809|NCT00765674|589635811|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
163253810|NCT03015402|589635812|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
163253811|NCT03015402|589635813|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
163253812|NCT03015402|589635812|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
163357678|NCT01434680|590019332|FG001|Overall Study|Lost to Follow-up|1|||
163357679|NCT01434680|590019333|FG002|Overall Study|Lost to Follow-up|0|||
163253813|NCT03015402|589635813|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
163253814|NCT01813474|589635814|FG000|Overall Study|Withdrawal by Subject|0|||
163357680|NCT01434680|590019334|FG003|Overall Study|Lost to Follow-up|0|||
163357681|NCT01434680|590019331|FG000|Overall Study|Protocol Violation|1|||
163357682|NCT01434680|590019332|FG001|Overall Study|Protocol Violation|1|||
163357683|NCT01434680|590019333|FG002|Overall Study|Protocol Violation|0|||
163357684|NCT01434680|590019334|FG003|Overall Study|Protocol Violation|0|||
163357685|NCT01367847|590019336|FG000|Overall Study|Withdrawal by Subject|2|||
163357686|NCT01367847|590019337|FG001|Overall Study|Withdrawal by Subject|2|||
163357687|NCT02056626|590019340|FG000|Overall Study|patient did not follow directions|3|||
163357688|NCT02056626|590019341|FG001|Overall Study|patient did not follow directions|1|||
163357689|NCT02056626|590019342|FG002|Overall Study|patient did not follow directions|0|||
163357690|NCT02056626|590019343|FG003|Overall Study|patient did not follow directions|0|||
163357691|NCT04916002|590019345|FG000|Overall Study|Adverse Event|0|||
163357692|NCT04916002|590019346|FG001|Overall Study|Adverse Event|1|||
163357693|NCT04916002|590019347|FG002|Overall Study|Adverse Event|0|||
163357694|NCT04916002|590019348|FG003|Overall Study|Adverse Event|1|||
163357695|NCT04916002|590019349|FG004|Overall Study|Adverse Event|0|||
163357696|NCT04916002|590019345|FG000|Overall Study|Withdrawal by Subject|3|||
163357697|NCT04916002|590019346|FG001|Overall Study|Withdrawal by Subject|1|||
163357698|NCT04916002|590019347|FG002|Overall Study|Withdrawal by Subject|0|||
163357699|NCT04916002|590019348|FG003|Overall Study|Withdrawal by Subject|1|||
163357700|NCT04916002|590019349|FG004|Overall Study|Withdrawal by Subject|0|||
163357701|NCT04916002|590019345|FG000|Overall Study|Death|8|||
163357702|NCT04916002|590019346|FG001|Overall Study|Death|7|||
163357703|NCT04916002|590019347|FG002|Overall Study|Death|4|||
163357704|NCT04916002|590019348|FG003|Overall Study|Death|9|||
163357705|NCT04916002|590019349|FG004|Overall Study|Death|0|||
163357706|NCT04916002|590019345|FG000|Overall Study|Study Terminated by Sponsor|11|||
163357707|NCT04916002|590019346|FG001|Overall Study|Study Terminated by Sponsor|10|||
163357708|NCT04916002|590019347|FG002|Overall Study|Study Terminated by Sponsor|8|||
163357709|NCT04916002|590019348|FG003|Overall Study|Study Terminated by Sponsor|5|||
163357710|NCT04916002|590019349|FG004|Overall Study|Study Terminated by Sponsor|4|||
163357711|NCT04916002|590019345|FG000|Overall Study|End of trial|1|||
163357712|NCT04916002|590019346|FG001|Overall Study|End of trial|0|||
163357713|NCT04916002|590019347|FG002|Overall Study|End of trial|0|||
163357714|NCT04916002|590019348|FG003|Overall Study|End of trial|0|||
163357715|NCT04916002|590019349|FG004|Overall Study|End of trial|0|||
163357716|NCT04916002|590019345|FG000|Overall Study|Progressive disease|0|||
163357717|NCT04916002|590019346|FG001|Overall Study|Progressive disease|0|||
163357718|NCT04916002|590019347|FG002|Overall Study|Progressive disease|1|||
163357719|NCT04916002|590019348|FG003|Overall Study|Progressive disease|0|||
163357720|NCT04916002|590019349|FG004|Overall Study|Progressive disease|0|||
163357721|NCT04916002|590019345|FG000|Overall Study|Participant non-compliance|2|||
163357722|NCT04916002|590019346|FG001|Overall Study|Participant non-compliance|0|||
163357723|NCT04916002|590019347|FG002|Overall Study|Participant non-compliance|0|||
163357724|NCT04916002|590019348|FG003|Overall Study|Participant non-compliance|0|||
163357725|NCT04916002|590019349|FG004|Overall Study|Participant non-compliance|0|||
163357726|NCT04836559|590019350|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
163357727|NCT04836559|590019351|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
163357728|NCT04836559|590019352|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
163357729|NCT04836559|590019353|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
163357730|NCT04836559|590019354|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
163357731|NCT04836559|590019355|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
163357732|NCT04836559|590019356|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
163357733|NCT04836559|590019357|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
163357734|NCT04836559|590019350|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
163357735|NCT04836559|590019351|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
163357736|NCT04836559|590019352|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
163410461|NCT05103332|590211359|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410462|NCT05103332|590211360|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410463|NCT05103332|590211361|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410464|NCT05103332|590211362|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410465|NCT05103332|590211363|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163151232|NCT02435212|589267086|FG001|Optional Extension Phase|Recovery|1|||
163151233|NCT02435212|589267085|FG000|Optional Extension Phase|Death|1|||
163151234|NCT02435212|589267086|FG001|Optional Extension Phase|Death|0|||
163151235|NCT02435212|589267085|FG000|Optional Extension Phase|Technical problems|2|||
163151236|NCT02435212|589267086|FG001|Optional Extension Phase|Technical problems|0|||
163151237|NCT01346358|589267087|FG000|Overall Study|Withdrawal by Subject|1|||
163151238|NCT01346358|589267088|FG001|Overall Study|Withdrawal by Subject|0|||
163151239|NCT01346358|589267089|FG002|Overall Study|Withdrawal by Subject|1|||
163151240|NCT01346358|589267090|FG003|Overall Study|Withdrawal by Subject|1|||
163151241|NCT01346358|589267091|FG004|Overall Study|Withdrawal by Subject|0|||
163151242|NCT01346358|589267092|FG005|Overall Study|Withdrawal by Subject|2|||
163151243|NCT01346358|589267093|FG006|Overall Study|Withdrawal by Subject|1|||
163151244|NCT01346358|589267094|FG007|Overall Study|Withdrawal by Subject|1|||
163151245|NCT01346358|589267095|FG008|Overall Study|Withdrawal by Subject|1|||
163151246|NCT01346358|589267087|FG000|Overall Study|Adverse Event|1|||
163253815|NCT01813474|589635815|FG001|Overall Study|Withdrawal by Subject|0|||
163253816|NCT01813474|589635816|FG002|Overall Study|Withdrawal by Subject|1|||
163253817|NCT01813474|589635814|FG000|Overall Study|Adverse Event|1|||
163253818|NCT01813474|589635815|FG001|Overall Study|Adverse Event|1|||
163253819|NCT01813474|589635816|FG002|Overall Study|Adverse Event|0|||
163253820|NCT01813474|589635814|FG000|Overall Study|Lack of Efficacy|2|||
163253821|NCT01813474|589635815|FG001|Overall Study|Lack of Efficacy|6|||
163253822|NCT01813474|589635816|FG002|Overall Study|Lack of Efficacy|9|||
163253823|NCT01813474|589635814|FG000|Overall Study|Death|0|||
163253824|NCT01813474|589635815|FG001|Overall Study|Death|0|||
163253825|NCT01813474|589635816|FG002|Overall Study|Death|1|||
163253826|NCT00316082|589635822|FG000|Overall Study|Lack of Efficacy|2|||
163253827|NCT00316082|589635823|FG001|Overall Study|Lack of Efficacy|3|||
163253828|NCT00316082|589635824|FG002|Overall Study|Lack of Efficacy|3|||
163253829|NCT00316082|589635825|FG003|Overall Study|Lack of Efficacy|4|||
163253830|NCT00316082|589635826|FG004|Overall Study|Lack of Efficacy|6|||
163253831|NCT00316082|589635822|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
163253832|NCT00316082|589635823|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
163253833|NCT00316082|589635824|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
163253834|NCT00316082|589635825|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
163253835|NCT00316082|589635826|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
163253836|NCT00316082|589635822|FG000|Overall Study|Lost to Follow-up|7|||
163253837|NCT00316082|589635823|FG001|Overall Study|Lost to Follow-up|6|||
163253838|NCT00316082|589635824|FG002|Overall Study|Lost to Follow-up|7|||
163253839|NCT00316082|589635825|FG003|Overall Study|Lost to Follow-up|8|||
163253840|NCT00316082|589635826|FG004|Overall Study|Lost to Follow-up|6|||
163253841|NCT00316082|589635822|FG000|Overall Study|Poor/noncompliance|6|||
163253842|NCT00316082|589635823|FG001|Overall Study|Poor/noncompliance|1|||
163253843|NCT00316082|589635824|FG002|Overall Study|Poor/noncompliance|4|||
163253844|NCT00316082|589635825|FG003|Overall Study|Poor/noncompliance|1|||
163253845|NCT00316082|589635826|FG004|Overall Study|Poor/noncompliance|4|||
163253846|NCT00316082|589635822|FG000|Overall Study|Adverse Event|4|||
163253847|NCT00316082|589635823|FG001|Overall Study|Adverse Event|2|||
163253848|NCT00316082|589635824|FG002|Overall Study|Adverse Event|5|||
163253849|NCT00316082|589635825|FG003|Overall Study|Adverse Event|1|||
163253850|NCT00316082|589635826|FG004|Overall Study|Adverse Event|3|||
163253851|NCT00316082|589635822|FG000|Overall Study|Subject no longer meets study criteria|3|||
163253852|NCT00316082|589635823|FG001|Overall Study|Subject no longer meets study criteria|1|||
163253853|NCT00316082|589635824|FG002|Overall Study|Subject no longer meets study criteria|2|||
163253854|NCT00316082|589635825|FG003|Overall Study|Subject no longer meets study criteria|2|||
163253855|NCT00316082|589635826|FG004|Overall Study|Subject no longer meets study criteria|1|||
163253856|NCT00316082|589635822|FG000|Overall Study|Physician Decision|1|||
163253857|NCT00316082|589635823|FG001|Overall Study|Physician Decision|1|||
163253858|NCT00316082|589635824|FG002|Overall Study|Physician Decision|2|||
163253859|NCT00316082|589635825|FG003|Overall Study|Physician Decision|1|||
163253860|NCT00316082|589635826|FG004|Overall Study|Physician Decision|1|||
163253861|NCT00316082|589635822|FG000|Overall Study|Death|0|||
163253862|NCT00316082|589635823|FG001|Overall Study|Death|0|||
163253863|NCT00316082|589635824|FG002|Overall Study|Death|1|||
163253864|NCT00316082|589635825|FG003|Overall Study|Death|0|||
163253865|NCT00316082|589635826|FG004|Overall Study|Death|0|||
163253866|NCT00316082|589635822|FG000|Overall Study|Administrative reason by sponsor|0|||
163253867|NCT00316082|589635823|FG001|Overall Study|Administrative reason by sponsor|0|||
163253868|NCT00316082|589635824|FG002|Overall Study|Administrative reason by sponsor|1|||
163253869|NCT00316082|589635825|FG003|Overall Study|Administrative reason by sponsor|0|||
163253870|NCT00316082|589635826|FG004|Overall Study|Administrative reason by sponsor|0|||
163253871|NCT00528775|589635827|FG000|Overall Study|Other not specified|1|||
163253872|NCT02216773|589635828|FG000|Overall Study|Disease progression|4|||
163253873|NCT02216773|589635829|FG001|Overall Study|Disease progression|2|||
163253874|NCT02216773|589635828|FG000|Overall Study|Insufficient FLRV|4|||
163253875|NCT02216773|589635829|FG001|Overall Study|Insufficient FLRV|0|||
163253876|NCT02216773|589635828|FG000|Overall Study|Abandoned|4|||
163253877|NCT02216773|589635829|FG001|Overall Study|Abandoned|3|||
163253878|NCT00941330|589635845|FG000|Overall Study|Other|1|||
163253879|NCT00941330|589635846|FG001|Overall Study|Other|0|||
163253880|NCT00941330|589635845|FG000|Overall Study|Physician Decision|0|||
163253881|NCT00941330|589635846|FG001|Overall Study|Physician Decision|2|||
163253882|NCT00541450|589635847|FG000|Phase A|Adverse Event|3|||
163253883|NCT00541450|589635848|FG001|Phase A|Adverse Event|0|||
163253884|NCT00541450|589635847|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
163253885|NCT00541450|589635848|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
163253886|NCT00541450|589635847|FG000|Phase A|Hyperglycemia|0|||
163253887|NCT00541450|589635848|FG001|Phase A|Hyperglycemia|1|||
163253888|NCT00541450|589635847|FG000|Phase A|Lost to Follow-up|6|||
163253889|NCT00541450|589635848|FG001|Phase A|Lost to Follow-up|4|||
163253890|NCT00541450|589635847|FG000|Phase A|Physician Decision|2|||
163253891|NCT00541450|589635848|FG001|Phase A|Physician Decision|0|||
163253892|NCT00541450|589635847|FG000|Phase A|Protocol Violation|2|||
163253893|NCT00541450|589635848|FG001|Phase A|Protocol Violation|3|||
163357737|NCT04836559|590019353|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
163357738|NCT04836559|590019354|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
163357739|NCT04836559|590019355|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
163357740|NCT04836559|590019356|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
163357741|NCT04836559|590019357|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
163357742|NCT04836559|590019350|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
163357743|NCT04836559|590019351|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
163357744|NCT04836559|590019352|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
163357745|NCT04836559|590019353|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
163357746|NCT04836559|590019354|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
163357747|NCT04836559|590019355|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
163357748|NCT04836559|590019356|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
163357749|NCT04836559|590019357|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
163357750|NCT04836559|590019350|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
163357751|NCT04836559|590019351|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
163357752|NCT04836559|590019352|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
163357753|NCT04836559|590019353|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
163357754|NCT04836559|590019354|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
163357755|NCT04836559|590019355|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
163357756|NCT04836559|590019356|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
163357757|NCT04836559|590019357|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
163357758|NCT04836559|590019350|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
163357759|NCT04836559|590019351|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
163357760|NCT04836559|590019352|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
163357761|NCT04836559|590019353|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
163357762|NCT04836559|590019354|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
163357763|NCT04836559|590019355|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
163357764|NCT04836559|590019356|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
163357765|NCT04836559|590019357|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
163357766|NCT04836559|590019350|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
163357767|NCT04836559|590019351|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
163357768|NCT04836559|590019352|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
163357769|NCT04836559|590019353|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
163357770|NCT04836559|590019354|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
163357771|NCT04836559|590019355|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
163357772|NCT04836559|590019356|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
163357773|NCT04836559|590019357|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
163357774|NCT04836559|590019350|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
163357775|NCT04836559|590019351|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
163357776|NCT04836559|590019352|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
163357777|NCT04836559|590019353|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
163357778|NCT04836559|590019354|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
163357779|NCT04836559|590019355|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
163357780|NCT04836559|590019356|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
163357781|NCT04836559|590019357|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
163357782|NCT04836559|590019350|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
163357783|NCT04836559|590019351|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
163357784|NCT04836559|590019352|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
163357785|NCT04836559|590019353|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
163357786|NCT04836559|590019354|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
163357787|NCT04836559|590019355|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
163357788|NCT04836559|590019356|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
163357789|NCT04836559|590019357|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
163357790|NCT04836559|590019350|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
163357791|NCT04836559|590019351|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
163357792|NCT04836559|590019352|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
163357793|NCT04836559|590019353|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
163357794|NCT04836559|590019354|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
163384930|NCT00427895|590119257|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
163151247|NCT01346358|589267088|FG001|Overall Study|Adverse Event|0|||
163151248|NCT01346358|589267089|FG002|Overall Study|Adverse Event|0|||
163151249|NCT01346358|589267090|FG003|Overall Study|Adverse Event|0|||
163151250|NCT01346358|589267091|FG004|Overall Study|Adverse Event|1|||
163151251|NCT01346358|589267092|FG005|Overall Study|Adverse Event|0|||
163151252|NCT01346358|589267093|FG006|Overall Study|Adverse Event|0|||
163151253|NCT01346358|589267094|FG007|Overall Study|Adverse Event|0|||
163151254|NCT01346358|589267095|FG008|Overall Study|Adverse Event|1|||
163151255|NCT01346358|589267087|FG000|Overall Study|Non-Compliance|0|||
163151256|NCT01346358|589267088|FG001|Overall Study|Non-Compliance|0|||
163151257|NCT01346358|589267089|FG002|Overall Study|Non-Compliance|0|||
163151258|NCT01346358|589267090|FG003|Overall Study|Non-Compliance|0|||
163151259|NCT01346358|589267091|FG004|Overall Study|Non-Compliance|0|||
163151260|NCT01346358|589267092|FG005|Overall Study|Non-Compliance|0|||
163151261|NCT01346358|589267093|FG006|Overall Study|Non-Compliance|0|||
163151262|NCT01346358|589267094|FG007|Overall Study|Non-Compliance|2|||
163151263|NCT01346358|589267095|FG008|Overall Study|Non-Compliance|0|||
163151264|NCT01346358|589267087|FG000|Overall Study|Physician Decision|0|||
163151265|NCT01346358|589267088|FG001|Overall Study|Physician Decision|1|||
163151266|NCT01346358|589267089|FG002|Overall Study|Physician Decision|0|||
163151267|NCT01346358|589267090|FG003|Overall Study|Physician Decision|0|||
163151268|NCT01346358|589267091|FG004|Overall Study|Physician Decision|0|||
163151269|NCT01346358|589267092|FG005|Overall Study|Physician Decision|0|||
163151270|NCT01346358|589267093|FG006|Overall Study|Physician Decision|0|||
163151271|NCT01346358|589267094|FG007|Overall Study|Physician Decision|1|||
163151272|NCT01346358|589267095|FG008|Overall Study|Physician Decision|1|||
163151273|NCT05058365|589267098|FG000|Overall Study|Migration|1|||
163151274|NCT05058365|589267099|FG001|Overall Study|Migration|1|||
163151275|NCT00702702|589267100|FG000|Overall Study|Study prematurely terminated|56|||
163151276|NCT04819945|589267101|FG000|Overall Study|Lost to Follow-up|1|||
163151277|NCT04531176|589267108|FG000|Overall Study|Study was stopped early|24|||
163151278|NCT04531176|589267109|FG001|Overall Study|Study was stopped early|26|||
163151279|NCT04531176|589267110|FG002|Overall Study|Study was stopped early|24|||
163151280|NCT00561652|589267113|FG000|Overall Study|Withdrawal by Subject|0|||
163151281|NCT00561652|589267114|FG001|Overall Study|Withdrawal by Subject|1|||
163151282|NCT01451606|589267115|FG000|Overall Study|Withdrawal by Subject|4|||
163151283|NCT01451606|589267116|FG001|Overall Study|Withdrawal by Subject|3|||
163151284|NCT00685165|589267118|FG000|Washout Period of 14 Days|Adverse Event|1|||
163151285|NCT00685165|589267119|FG001|Washout Period of 14 Days|Adverse Event|0|||
163151286|NCT03155724|589267121|FG000|Overall Study|Death|3|||
163151287|NCT03155724|589267121|FG000|Overall Study|Physician Decision|1|||
163151288|NCT03155724|589267121|FG000|Overall Study|Study closure|7|||
163151289|NCT03361137|589267124|FG000|Overall Study|Reason not specified|1|||
163151290|NCT03361137|589267125|FG001|Overall Study|Reason not specified|0|||
163151291|NCT03361137|589267126|FG002|Overall Study|Reason not specified|0|||
163151292|NCT03361137|589267127|FG003|Overall Study|Reason not specified|0|||
163151293|NCT03361137|589267128|FG004|Overall Study|Reason not specified|0|||
163151294|NCT01586364|589269348|FG000|Overall Study|Withdrawal by Subject|40|||
163151295|NCT01586364|589269348|FG000|Overall Study|Adverse Event|37|||
163151296|NCT01586364|589269348|FG000|Overall Study|Lost to Follow-up|17|||
163151297|NCT01586364|589269348|FG000|Overall Study|Protocol Violation|16|||
163151298|NCT01586364|589269348|FG000|Overall Study|Lack of Efficacy|1|||
163151299|NCT01586364|589269348|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
163151300|NCT01586364|589269348|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
163151301|NCT01586364|589269348|FG000|Overall Study|Other-Site closure due to PI illness|1|||
163151302|NCT01586364|589269348|FG000|Overall Study|Other-PI discretion, site closing|2|||
163151303|NCT01586364|589269348|FG000|Overall Study|Other-Not specified|1|||
163151304|NCT02121535|589269349|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
163151305|NCT02121535|589269350|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
163151306|NCT02121535|589269349|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
163151307|NCT02121535|589269350|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
163151308|NCT04944992|589269351|FG000|Overall Study|Lost to Follow-up|1|||
163151309|NCT04944992|589269352|FG001|Overall Study|Lost to Follow-up|1|||
163151310|NCT04944992|589269351|FG000|Overall Study|Physician Decision|1|||
163151311|NCT04944992|589269352|FG001|Overall Study|Physician Decision|0|||
163151312|NCT04944992|589269351|FG000|Overall Study|Withdrawal by Subject|6|||
163151313|NCT04944992|589269352|FG001|Overall Study|Withdrawal by Subject|1|||
163151314|NCT05366738|589269353|FG000|Overall Study|Adverse Event|0|||
163151315|NCT05366738|589269354|FG001|Overall Study|Adverse Event|1|||
163151316|NCT05366738|589269355|FG002|Overall Study|Adverse Event|0|||
163151317|NCT05024032|589269362|FG000|Overall Study|Withdrawal by Subject|0|||
163151318|NCT05024032|589269363|FG001|Overall Study|Withdrawal by Subject|3|||
163151319|NCT05024032|589269364|FG002|Overall Study|Withdrawal by Subject|4|||
163151320|NCT05024032|589269362|FG000|Overall Study|Adverse Event|0|||
163151321|NCT05024032|589269363|FG001|Overall Study|Adverse Event|1|||
163151322|NCT05024032|589269364|FG002|Overall Study|Adverse Event|0|||
163151323|NCT05024032|589269362|FG000|Overall Study|Protocol Deviation|1|||
163151324|NCT05024032|589269363|FG001|Overall Study|Protocol Deviation|0|||
163151325|NCT05024032|589269364|FG002|Overall Study|Protocol Deviation|0|||
163151326|NCT00939393|589269365|FG000|Overall Study|Withdrawal by Subject|1|||
163151327|NCT00939393|589269366|FG001|Overall Study|Withdrawal by Subject|0|||
163151328|NCT00939393|589269365|FG000|Overall Study|Lost to Follow-up|3|||
163253894|NCT00541450|589635847|FG000|Phase A|Withdrawal by Subject|7|||
163253895|NCT00541450|589635848|FG001|Phase A|Withdrawal by Subject|7|||
163253896|NCT00541450|589635847|FG000|Phase B|Adverse Event|6|||
163253897|NCT00541450|589635848|FG001|Phase B|Adverse Event|6|||
163253898|NCT00541450|589635847|FG000|Phase B|Hyperglycemia|10|||
163253899|NCT00541450|589635848|FG001|Phase B|Hyperglycemia|9|||
163253900|NCT00541450|589635847|FG000|Phase B|Lost to Follow-up|6|||
163253901|NCT00541450|589635848|FG001|Phase B|Lost to Follow-up|4|||
163253902|NCT00541450|589635847|FG000|Phase B|Physician Decision|4|||
163253903|NCT00541450|589635848|FG001|Phase B|Physician Decision|2|||
163253904|NCT00541450|589635847|FG000|Phase B|Pregnancy|0|||
163253905|NCT00541450|589635848|FG001|Phase B|Pregnancy|1|||
163253906|NCT00541450|589635847|FG000|Phase B|Protocol Violation|3|||
163253907|NCT00541450|589635848|FG001|Phase B|Protocol Violation|3|||
163253908|NCT00541450|589635847|FG000|Phase B|Withdrawal by Subject|8|||
163253909|NCT00541450|589635848|FG001|Phase B|Withdrawal by Subject|6|||
163253910|NCT00981084|589635849|FG000|Post Intervention (Data Analysis)|poor effort|1|||
163253911|NCT00981084|589635850|FG001|Post Intervention (Data Analysis)|poor effort|1|||
163253912|NCT00981084|589635849|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
163253913|NCT00981084|589635850|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
163253914|NCT01112579|589635851|FG000|Overall Study|Missed Visit|1|||
163253915|NCT01112579|589635852|FG001|Overall Study|Missed Visit|1|||
163253916|NCT01112579|589635851|FG000|Overall Study|Death|0|||
163253917|NCT01112579|589635852|FG001|Overall Study|Death|2|||
163253918|NCT01648270|589635853|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
163253919|NCT04969263|589635854|FG000|Overall Study|Death|1|||
163253920|NCT04969263|589635854|FG000|Overall Study|Lost to Follow-up|2|||
163253921|NCT04969263|589635854|FG000|Overall Study|Withdrawal by Subject|5|||
163253922|NCT04969263|589635854|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
163253923|NCT01389973|589635855|FG000|Overall Study|Lost to Follow-up|1|||
163253924|NCT01389973|589635855|FG000|Overall Study|Trial Stopped by Sponsor|9|||
163253925|NCT01389973|589635855|FG000|Overall Study|Other|10|||
163253926|NCT00725296|589635856|FG000|Overall Study|Adverse Event|11|||
163253927|NCT00725296|589635856|FG000|Overall Study|Lack of Efficacy|7|||
163253928|NCT00725296|589635856|FG000|Overall Study|Withdrawal by Subject|3|||
163253929|NCT00725296|589635856|FG000|Overall Study|Non-Compliance|2|||
163253930|NCT00725296|589635856|FG000|Overall Study|Lost to Follow-up|1|||
163253931|NCT00725296|589635856|FG000|Overall Study|Other|38|||
163253932|NCT03360942|589635857|FG000|Overall Study|Device explanted|2|||
163253933|NCT03360942|589635857|FG000|Overall Study|Study closure|1|||
163253934|NCT03360942|589635857|FG000|Overall Study|Withdrawal by Subject|2|||
163253935|NCT03456700|589635858|FG000|Overall Study|Withdrawal by Subject|1|||
163253936|NCT00613951|589635859|FG000|Overall Study|Adverse Event|1|||
163253937|NCT00613951|589635860|FG001|Overall Study|Adverse Event|0|||
163253938|NCT00613951|589635861|FG002|Overall Study|Adverse Event|1|||
163253939|NCT00613951|589635859|FG000|Overall Study|Lack of Efficacy|0|||
163253940|NCT00613951|589635860|FG001|Overall Study|Lack of Efficacy|1|||
163253941|NCT00613951|589635861|FG002|Overall Study|Lack of Efficacy|1|||
163253942|NCT00613951|589635859|FG000|Overall Study|Protocol Violation|1|||
163253943|NCT00613951|589635860|FG001|Overall Study|Protocol Violation|1|||
163253944|NCT00613951|589635861|FG002|Overall Study|Protocol Violation|1|||
163253945|NCT00613951|589635859|FG000|Overall Study|Unclassified|5|||
163253946|NCT00613951|589635860|FG001|Overall Study|Unclassified|3|||
163253947|NCT00613951|589635861|FG002|Overall Study|Unclassified|2|||
163253948|NCT03053050|589635862|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
163410466|NCT05103332|590211364|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410467|NCT05103332|590211365|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163253949|NCT03053050|589635863|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
163253950|NCT03053050|589635864|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
163253951|NCT03053050|589635865|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
163253952|NCT03053050|589635862|FG000|Randomized Phase|Withdrew Consent|16|||
163253953|NCT03053050|589635863|FG001|Randomized Phase|Withdrew Consent|8|||
163253954|NCT03053050|589635864|FG002|Randomized Phase|Withdrew Consent|9|||
163253955|NCT03053050|589635865|FG003|Randomized Phase|Withdrew Consent|0|||
163253956|NCT03053050|589635862|FG000|Randomized Phase|Investigator's Discretion|6|||
163253957|NCT03053050|589635863|FG001|Randomized Phase|Investigator's Discretion|6|||
163253958|NCT03053050|589635864|FG002|Randomized Phase|Investigator's Discretion|3|||
163253959|NCT03053050|589635865|FG003|Randomized Phase|Investigator's Discretion|0|||
163253960|NCT03053050|589635862|FG000|Randomized Phase|Lost to Follow-up|5|||
163253961|NCT03053050|589635863|FG001|Randomized Phase|Lost to Follow-up|1|||
163253962|NCT03053050|589635864|FG002|Randomized Phase|Lost to Follow-up|1|||
163253963|NCT03053050|589635865|FG003|Randomized Phase|Lost to Follow-up|0|||
163253964|NCT03053050|589635862|FG000|Randomized Phase|Adverse Event|0|||
163253965|NCT03053050|589635863|FG001|Randomized Phase|Adverse Event|1|||
163253966|NCT03053050|589635864|FG002|Randomized Phase|Adverse Event|0|||
163253967|NCT03053050|589635865|FG003|Randomized Phase|Adverse Event|0|||
163253968|NCT03053050|589635862|FG000|Randomized Phase|Randomized but Never Treated|2|||
163253969|NCT03053050|589635863|FG001|Randomized Phase|Randomized but Never Treated|2|||
163357795|NCT04836559|590019355|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
163357796|NCT04836559|590019356|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
163357797|NCT04836559|590019357|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
163357798|NCT02786004|590019360|FG000|Overall Study|Withdrawal by Subject|0|||
163357799|NCT02786004|590019361|FG001|Overall Study|Withdrawal by Subject|1|||
163357800|NCT05147350|590019362|FG000|Overall Study|Death|2|||
163357801|NCT05147350|590019363|FG001|Overall Study|Death|3|||
163357802|NCT05147350|590019364|FG002|Overall Study|Death|3|||
163357803|NCT05147350|590019365|FG003|Overall Study|Death|2|||
163357804|NCT05147350|590019366|FG004|Overall Study|Death|2|||
163357805|NCT05147350|590019367|FG005|Overall Study|Death|1|||
163357806|NCT05147350|590019368|FG006|Overall Study|Death|1|||
163357807|NCT05147350|590019369|FG007|Overall Study|Death|3|||
163357808|NCT05147350|590019362|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
163357809|NCT05147350|590019363|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
163357810|NCT05147350|590019364|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
163357811|NCT05147350|590019365|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
163357812|NCT05147350|590019366|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
163357813|NCT05147350|590019367|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
163357814|NCT05147350|590019368|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
163357815|NCT05147350|590019369|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
163357816|NCT05147350|590019362|FG000|Overall Study|Withdrawal by Subject|0|||
163357817|NCT05147350|590019363|FG001|Overall Study|Withdrawal by Subject|0|||
163357818|NCT05147350|590019364|FG002|Overall Study|Withdrawal by Subject|3|||
163357819|NCT05147350|590019365|FG003|Overall Study|Withdrawal by Subject|1|||
163357820|NCT05147350|590019366|FG004|Overall Study|Withdrawal by Subject|1|||
163357821|NCT05147350|590019367|FG005|Overall Study|Withdrawal by Subject|0|||
163357822|NCT05147350|590019368|FG006|Overall Study|Withdrawal by Subject|1|||
163357823|NCT05147350|590019369|FG007|Overall Study|Withdrawal by Subject|0|||
163357824|NCT05147350|590019362|FG000|Overall Study|Other Reasons|0|||
163357825|NCT05147350|590019363|FG001|Overall Study|Other Reasons|0|||
163357826|NCT05147350|590019364|FG002|Overall Study|Other Reasons|2|||
163357827|NCT05147350|590019365|FG003|Overall Study|Other Reasons|0|||
163357828|NCT05147350|590019366|FG004|Overall Study|Other Reasons|0|||
163357829|NCT05147350|590019367|FG005|Overall Study|Other Reasons|2|||
163357830|NCT05147350|590019368|FG006|Overall Study|Other Reasons|1|||
163357831|NCT05147350|590019369|FG007|Overall Study|Other Reasons|1|||
163357832|NCT00756457|590019372|FG000|Overall Study|Lost to Follow-up|1|||
163357833|NCT00756457|590019373|FG001|Overall Study|Lost to Follow-up|2|||
163357834|NCT02472145|590019374|FG000|Overall Study|Death|10|||
163357835|NCT02472145|590019375|FG001|Overall Study|Death|101|||
163357836|NCT02472145|590019376|FG002|Overall Study|Death|99|||
163357837|NCT02472145|590019374|FG000|Overall Study|Lost to Follow-up|0|||
163357838|NCT02472145|590019375|FG001|Overall Study|Lost to Follow-up|1|||
163357839|NCT02472145|590019376|FG002|Overall Study|Lost to Follow-up|0|||
163357840|NCT02472145|590019374|FG000|Overall Study|Withdrawal by Subject|0|||
163357841|NCT02472145|590019375|FG001|Overall Study|Withdrawal by Subject|9|||
163357842|NCT02472145|590019376|FG002|Overall Study|Withdrawal by Subject|13|||
163357843|NCT02472145|590019374|FG000|Overall Study|Sponsor decision|0|||
163357844|NCT02472145|590019375|FG001|Overall Study|Sponsor decision|3|||
163357845|NCT02472145|590019376|FG002|Overall Study|Sponsor decision|2|||
163357846|NCT02472145|590019374|FG000|Overall Study|Other|0|||
163357847|NCT02472145|590019375|FG001|Overall Study|Other|45|||
163357848|NCT02472145|590019376|FG002|Overall Study|Other|43|||
163357849|NCT01080326|590019377|FG000|Overall Study|Patient deterioration prior to procedure|3|||
163357850|NCT01080326|590019377|FG000|Overall Study|Surgeon decision|1|||
163357851|NCT01560871|590019381|FG000|Overall Study|transportation issues|2|||
163357852|NCT01560871|590019382|FG001|Overall Study|transportation issues|1|||
163357853|NCT01560871|590019381|FG000|Overall Study|relocation|1|||
163357854|NCT01560871|590019382|FG001|Overall Study|relocation|0|||
163357855|NCT01560871|590019381|FG000|Overall Study|readmission to a hospital|2|||
163357856|NCT01560871|590019382|FG001|Overall Study|readmission to a hospital|1|||
163357857|NCT01560871|590019381|FG000|Overall Study|Lost to Follow-up|1|||
163357858|NCT01560871|590019382|FG001|Overall Study|Lost to Follow-up|0|||
163357859|NCT00857233|590019383|FG000|Overall Study|Adverse Event|24|||
163357860|NCT00857233|590019383|FG000|Overall Study|Lack of Efficacy|1|||
163357861|NCT00857233|590019383|FG000|Overall Study|Non-compliance|1|||
163357862|NCT00857233|590019383|FG000|Overall Study|Withdrawal of Consent|9|||
163357863|NCT00857233|590019383|FG000|Overall Study|Lost to Follow-up|4|||
163357864|NCT00857233|590019383|FG000|Overall Study|Nursing Home Placement|14|||
163357865|NCT00857233|590019383|FG000|Overall Study|Other Reasons|2|||
163410468|NCT05103332|590211366|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410469|NCT05103332|590211367|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163357866|NCT00572533|590019386|FG000|Overall Study|Death|4|||
163357867|NCT00572533|590019387|FG001|Overall Study|Death|1|||
163357868|NCT00572533|590019386|FG000|Overall Study|Received Kidney Transplant|2|||
163357869|NCT00572533|590019387|FG001|Overall Study|Received Kidney Transplant|1|||
163357870|NCT00572533|590019386|FG000|Overall Study|Social Issues|1|||
163410470|NCT05103332|590211368|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410471|NCT05103332|590211369|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410472|NCT05103332|590211370|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163410473|NCT05103332|590211371|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
163410474|NCT05103332|590211372|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
163410475|NCT05103332|590211373|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
163410476|NCT05103332|590211374|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
163410477|NCT05103332|590211375|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
163253970|NCT03053050|589635864|FG002|Randomized Phase|Randomized but Never Treated|2|||
163253971|NCT03053050|589635865|FG003|Randomized Phase|Randomized but Never Treated|0|||
163253972|NCT03053050|589635862|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
163253973|NCT03053050|589635863|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
163253974|NCT03053050|589635864|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
163253975|NCT03053050|589635865|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
163253976|NCT03053050|589635862|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
163253977|NCT03053050|589635863|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
163253978|NCT03053050|589635864|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
163253979|NCT03053050|589635865|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
163253980|NCT03053050|589635862|FG000|Open-label Phase|Withdrew Consent|0|||
163253981|NCT03053050|589635863|FG001|Open-label Phase|Withdrew Consent|0|||
163253982|NCT03053050|589635864|FG002|Open-label Phase|Withdrew Consent|0|||
163253983|NCT03053050|589635865|FG003|Open-label Phase|Withdrew Consent|6|||
163253984|NCT03053050|589635862|FG000|Open-label Phase|Investigator's Discretion|0|||
163253985|NCT03053050|589635863|FG001|Open-label Phase|Investigator's Discretion|0|||
163253986|NCT03053050|589635864|FG002|Open-label Phase|Investigator's Discretion|0|||
163253987|NCT03053050|589635865|FG003|Open-label Phase|Investigator's Discretion|4|||
163253988|NCT00655980|589635866|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
163253989|NCT00655980|589635867|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
163253990|NCT00655980|589635868|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
163253991|NCT02459574|589635873|FG000|Overall Study|Withdrawal by Subject|6|||
163253992|NCT02459574|589635874|FG001|Overall Study|Withdrawal by Subject|6|||
163253993|NCT02459574|589635875|FG002|Overall Study|Withdrawal by Subject|2|||
163253994|NCT02459574|589635873|FG000|Overall Study|Lost to Follow-up|1|||
163253995|NCT02459574|589635874|FG001|Overall Study|Lost to Follow-up|1|||
163253996|NCT02459574|589635875|FG002|Overall Study|Lost to Follow-up|0|||
163253997|NCT02459574|589635873|FG000|Overall Study|Death|0|||
163253998|NCT02459574|589635874|FG001|Overall Study|Death|1|||
163253999|NCT02459574|589635875|FG002|Overall Study|Death|0|||
163254000|NCT04508699|589635878|FG000|Overall Study|Lack of Efficacy|2|||
163254001|NCT04508699|589635879|FG001|Overall Study|Lack of Efficacy|15|||
163254002|NCT04508699|589635878|FG000|Overall Study|Withdrawal by Subject|0|||
163254003|NCT04508699|589635879|FG001|Overall Study|Withdrawal by Subject|2|||
163254004|NCT04866017|589635880|FG000|Overall Study|Study Terminated by Sponsor|13|||
163254005|NCT04866017|589635881|FG001|Overall Study|Study Terminated by Sponsor|14|||
163254006|NCT04866017|589635882|FG002|Overall Study|Study Terminated by Sponsor|13|||
163254007|NCT04866017|589635880|FG000|Overall Study|Death|8|||
163254008|NCT04866017|589635881|FG001|Overall Study|Death|4|||
163254009|NCT04866017|589635882|FG002|Overall Study|Death|8|||
163254010|NCT04866017|589635880|FG000|Overall Study|Withdrawal by Subject|1|||
163254011|NCT04866017|589635881|FG001|Overall Study|Withdrawal by Subject|0|||
163254012|NCT04866017|589635882|FG002|Overall Study|Withdrawal by Subject|1|||
163254013|NCT04866017|589635880|FG000|Overall Study|Physician Decision|0|||
163254014|NCT04866017|589635881|FG001|Overall Study|Physician Decision|1|||
163254015|NCT04866017|589635882|FG002|Overall Study|Physician Decision|0|||
163254016|NCT01266642|589635883|FG000|Overall Study|Protocol Violation|0|||
163254017|NCT01266642|589635884|FG001|Overall Study|Protocol Violation|1|||
163254018|NCT01553318|589637061|FG000|Overall Study|Protocol Violation|3|||
163254019|NCT01553318|589637062|FG001|Overall Study|Protocol Violation|2|||
163254020|NCT02293395|589637063|FG000|Overall Study|Lost to Follow-up|1|||
163254021|NCT02293395|589637064|FG001|Overall Study|Lost to Follow-up|0|||
163254022|NCT02293395|589637063|FG000|Overall Study|Withdrawal by Subject|8|||
163254023|NCT02293395|589637064|FG001|Overall Study|Withdrawal by Subject|7|||
163254024|NCT01464021|589637065|FG000|Overall Study|Withdrawal by Subject|13|||
163254025|NCT01464021|589637065|FG000|Overall Study|Lost to Follow-up|1|||
163254026|NCT01464021|589637065|FG000|Overall Study|Lack of Efficacy|1|||
163254027|NCT01464021|589637065|FG000|Overall Study|various|11|||
163254028|NCT01106430|589637071|FG000|Overall Study|Adverse Event|8|||
163254029|NCT01106430|589637072|FG001|Overall Study|Adverse Event|10|||
163254030|NCT01106430|589637071|FG000|Overall Study|Lack of Efficacy|2|||
163254031|NCT01106430|589637072|FG001|Overall Study|Lack of Efficacy|13|||
163254032|NCT01106430|589637071|FG000|Overall Study|Lost to Follow-up|5|||
163254033|NCT01106430|589637072|FG001|Overall Study|Lost to Follow-up|1|||
163254034|NCT01106430|589637071|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
163254035|NCT01106430|589637072|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
163254036|NCT01106430|589637071|FG000|Overall Study|Moved Out Of State|0|||
163357871|NCT00572533|590019387|FG001|Overall Study|Social Issues|0|||
163357872|NCT00572533|590019386|FG000|Overall Study|Transfer out of Facility|0|||
163357873|NCT00572533|590019387|FG001|Overall Study|Transfer out of Facility|1|||
163357874|NCT00003477|590019390|FG000|Overall Study|Not evalauable|4|||
163357875|NCT04206085|590019396|FG000|Overall Study|Lost to Follow-up|0|||
163357876|NCT04206085|590019397|FG001|Overall Study|Lost to Follow-up|1|||
163357877|NCT04206085|590019398|FG002|Overall Study|Lost to Follow-up|0|||
163357878|NCT04206085|590019396|FG000|Overall Study|Lost to Follow-up|0|||
163357879|NCT04206085|590019397|FG001|Overall Study|Lost to Follow-up|0|||
163357880|NCT04206085|590019398|FG002|Overall Study|Lost to Follow-up|1|||
163357881|NCT00725543|590019402|FG000|Overall Study|Adverse Event|10|||
163357882|NCT00725543|590019402|FG000|Overall Study|Lack of Efficacy|3|||
163357883|NCT00725543|590019402|FG000|Overall Study|Withdrawal by Subject|10|||
163357884|NCT00725543|590019402|FG000|Overall Study|Physician Decision|5|||
163357885|NCT00725543|590019402|FG000|Overall Study|Lost to Follow-up|4|||
163357886|NCT00725543|590019402|FG000|Overall Study|Non-compliance|2|||
163357887|NCT00725543|590019402|FG000|Overall Study|Other|119|||
163357888|NCT02168478|590019409|FG000|Overall Study|Withdrawal by Subject|1|||
163357889|NCT02168478|590019409|FG000|Overall Study|Did Not Consent to Participation|2|||
163357890|NCT02168478|590019409|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
163357891|NCT00087555|590019410|FG000|Overall Study|Adverse Event|3|||
163357892|NCT00087555|590019411|FG001|Overall Study|Adverse Event|6|||
163357893|NCT00087555|590019412|FG002|Overall Study|Adverse Event|14|||
163357894|NCT00087555|590019410|FG000|Overall Study|Lost to Follow-up|0|||
163357895|NCT00087555|590019411|FG001|Overall Study|Lost to Follow-up|1|||
163357896|NCT00087555|590019412|FG002|Overall Study|Lost to Follow-up|1|||
163357897|NCT00087555|590019410|FG000|Overall Study|Non - Compliance|1|||
163357898|NCT00087555|590019411|FG001|Overall Study|Non - Compliance|0|||
163357899|NCT00087555|590019412|FG002|Overall Study|Non - Compliance|0|||
163357900|NCT00087555|590019410|FG000|Overall Study|Protocol Violation|0|||
163357901|NCT00087555|590019411|FG001|Overall Study|Protocol Violation|0|||
163357902|NCT00087555|590019412|FG002|Overall Study|Protocol Violation|2|||
163357903|NCT00087555|590019410|FG000|Overall Study|Screen Failure|1|||
163357904|NCT00087555|590019411|FG001|Overall Study|Screen Failure|1|||
163357905|NCT00087555|590019412|FG002|Overall Study|Screen Failure|0|||
163357906|NCT00087555|590019410|FG000|Overall Study|Pregnancy|0|||
163357907|NCT00087555|590019411|FG001|Overall Study|Pregnancy|1|||
163357908|NCT00087555|590019412|FG002|Overall Study|Pregnancy|1|||
163357909|NCT00087555|590019410|FG000|Overall Study|Withdrawal by Subject|3|||
163357910|NCT00087555|590019411|FG001|Overall Study|Withdrawal by Subject|2|||
163357911|NCT00087555|590019412|FG002|Overall Study|Withdrawal by Subject|1|||
163357912|NCT00087555|590019410|FG000|Overall Study|Lack of Efficacy|2|||
163357913|NCT00087555|590019411|FG001|Overall Study|Lack of Efficacy|0|||
163357914|NCT00087555|590019412|FG002|Overall Study|Lack of Efficacy|1|||
163357915|NCT00087555|590019410|FG000|Overall Study|Non Compliance|0|||
163357916|NCT00087555|590019411|FG001|Overall Study|Non Compliance|0|||
163357917|NCT00087555|590019412|FG002|Overall Study|Non Compliance|1|||
163357918|NCT00087555|590019410|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
163357919|NCT00087555|590019411|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
163410478|NCT05103332|590211376|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
163410479|NCT05103332|590211359|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163357920|NCT00087555|590019412|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
163357921|NCT00087555|590019410|FG000|Overall Study|Patient wanted to go back on Med|1|||
163410480|NCT05103332|590211360|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163151329|NCT00939393|589269366|FG001|Overall Study|Lost to Follow-up|0|||
163151330|NCT01054885|589269367|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
163151331|NCT01054885|589269368|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163151332|NCT01054885|589269369|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163151333|NCT01054885|589269370|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163151334|NCT01054885|589269371|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163151335|NCT01054885|589269372|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163151336|NCT01054885|589269373|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163151337|NCT01054885|589269367|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
163151338|NCT01054885|589269368|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
163151339|NCT01054885|589269369|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
163151340|NCT01054885|589269370|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
163357922|NCT00087555|590019411|FG001|Overall Study|Patient wanted to go back on Med|0|||
163357923|NCT00087555|590019412|FG002|Overall Study|Patient wanted to go back on Med|0|||
163357924|NCT01062971|590019413|FG000|Overall Study|Protocol Violation|1|||
163357925|NCT01062971|590019414|FG001|Overall Study|Protocol Violation|3|||
163357926|NCT01062971|590019413|FG000|Overall Study|Lost to Follow-up|3|||
163357927|NCT01062971|590019414|FG001|Overall Study|Lost to Follow-up|4|||
163357928|NCT01530087|590019415|FG000|Overall Study|Physician Decision|2|||
163357929|NCT05523219|590019416|FG000|Overall Study|Wrong inclusion|1|||
163357930|NCT05523219|590019416|FG000|Overall Study|Lost to Follow-up|7|||
163254037|NCT01106430|589637072|FG001|Overall Study|Moved Out Of State|1|||
163254038|NCT01106430|589637071|FG000|Overall Study|Refused To Take Medication|0|||
163254039|NCT01106430|589637072|FG001|Overall Study|Refused To Take Medication|1|||
163357931|NCT02760485|590019417|FG000|Phase 1|Death|3|||
163357932|NCT02760485|590019418|FG001|Phase 1|Death|6|||
163357933|NCT02760485|590019419|FG002|Phase 1|Death|0|||
163357934|NCT02760485|590019417|FG000|Phase 1|Withdrawal by Subject|2|||
163357935|NCT02760485|590019418|FG001|Phase 1|Withdrawal by Subject|0|||
163357936|NCT02760485|590019419|FG002|Phase 1|Withdrawal by Subject|0|||
163357937|NCT02760485|590019417|FG000|Phase 1|Progressive Disease|1|||
163357938|NCT02760485|590019418|FG001|Phase 1|Progressive Disease|0|||
163357939|NCT02760485|590019419|FG002|Phase 1|Progressive Disease|0|||
163357940|NCT02760485|590019417|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
163357941|NCT02760485|590019418|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
163357942|NCT02760485|590019419|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
163357943|NCT02760485|590019417|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
163357944|NCT02760485|590019418|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
163357945|NCT02760485|590019419|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
163357946|NCT02760485|590019417|FG000|Phase 2|Death|0|||
163357947|NCT02760485|590019418|FG001|Phase 2|Death|0|||
163357948|NCT02760485|590019419|FG002|Phase 2|Death|12|||
163357949|NCT02760485|590019417|FG000|Phase 2|Withdrawal by Subject|0|||
163357950|NCT02760485|590019418|FG001|Phase 2|Withdrawal by Subject|0|||
163357951|NCT02760485|590019419|FG002|Phase 2|Withdrawal by Subject|3|||
163357952|NCT02760485|590019417|FG000|Phase 2|Progressive Disease|0|||
163357953|NCT02760485|590019418|FG001|Phase 2|Progressive Disease|0|||
163357954|NCT02760485|590019419|FG002|Phase 2|Progressive Disease|1|||
163357955|NCT02760485|590019417|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
163357956|NCT02760485|590019418|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
163357957|NCT02760485|590019419|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
163357958|NCT03845023|590019420|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
163357959|NCT03845023|590019421|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
163357960|NCT03845023|590019422|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
163357961|NCT03845023|590019423|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
163357962|NCT03845023|590019420|FG000|Follow-Up (14 Days)|Adverse Event|0|||
163357963|NCT03845023|590019421|FG001|Follow-Up (14 Days)|Adverse Event|0|||
163357964|NCT03845023|590019422|FG002|Follow-Up (14 Days)|Adverse Event|1|||
163357965|NCT03845023|590019423|FG003|Follow-Up (14 Days)|Adverse Event|1|||
163357966|NCT03738397|590019424|FG000|Overall Study|Adverse Event|3|||
163357967|NCT03738397|590019425|FG001|Overall Study|Adverse Event|7|||
163357968|NCT03738397|590019424|FG000|Overall Study|Withdrawal by Subject|8|||
163357969|NCT03738397|590019425|FG001|Overall Study|Withdrawal by Subject|11|||
163357970|NCT03738397|590019424|FG000|Overall Study|Lost to Follow-up|7|||
163357971|NCT03738397|590019425|FG001|Overall Study|Lost to Follow-up|5|||
163357972|NCT03738397|590019424|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
163357973|NCT03738397|590019425|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
163357974|NCT03738397|590019424|FG000|Overall Study|Other|4|||
163357975|NCT03738397|590019425|FG001|Overall Study|Other|6|||
163254040|NCT01106430|589637071|FG000|Overall Study|Noncompliance|0|||
163254041|NCT01106430|589637072|FG001|Overall Study|Noncompliance|1|||
163254042|NCT01106430|589637071|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
163254043|NCT01106430|589637072|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
163254044|NCT01106430|589637071|FG000|Overall Study|Previous Use Of Marijuana|1|||
163254045|NCT01106430|589637072|FG001|Overall Study|Previous Use Of Marijuana|0|||
163254046|NCT01106430|589637071|FG000|Overall Study|Protocol Violation|7|||
163254047|NCT01106430|589637072|FG001|Overall Study|Protocol Violation|2|||
163254048|NCT01106430|589637071|FG000|Overall Study|Withdrawal by Subject|8|||
163254049|NCT01106430|589637072|FG001|Overall Study|Withdrawal by Subject|4|||
163254050|NCT00175825|589637075|FG000|Overall Study|Adverse Event|3|||
163254051|NCT00175825|589637076|FG001|Overall Study|Adverse Event|2|||
163254052|NCT00175825|589637077|FG002|Overall Study|Adverse Event|1|||
163254053|NCT00175825|589637078|FG003|Overall Study|Adverse Event|1|||
163254054|NCT00175825|589637075|FG000|Overall Study|Lost to Follow-up|1|||
163254055|NCT00175825|589637076|FG001|Overall Study|Lost to Follow-up|2|||
163357976|NCT01087814|590019428|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
163357977|NCT01087814|590019429|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
163357978|NCT01087814|590019428|FG000|Second Intervention (5 Days)|Physician Decision|1|||
163357979|NCT01087814|590019429|FG001|Second Intervention (5 Days)|Physician Decision|0|||
163254056|NCT00175825|589637077|FG002|Overall Study|Lost to Follow-up|0|||
163254057|NCT00175825|589637078|FG003|Overall Study|Lost to Follow-up|0|||
163254058|NCT00175825|589637075|FG000|Overall Study|Withdrawal by Subject|1|||
163357980|NCT00661713|590019430|FG000|Overall Study|Death|1|||
163357981|NCT00661713|590019431|FG001|Overall Study|Death|0|||
163254059|NCT00175825|589637076|FG001|Overall Study|Withdrawal by Subject|0|||
163254060|NCT00175825|589637077|FG002|Overall Study|Withdrawal by Subject|0|||
163357982|NCT00661713|590019432|FG002|Overall Study|Death|0|||
163357983|NCT00661713|590019433|FG003|Overall Study|Death|0|||
163357984|NCT00661713|590019434|FG004|Overall Study|Death|1|||
163357985|NCT00661713|590019435|FG005|Overall Study|Death|0|||
163357986|NCT00661713|590019436|FG006|Overall Study|Death|0|||
163357987|NCT00661713|590019437|FG007|Overall Study|Death|0|||
163357988|NCT00661713|590019430|FG000|Overall Study|Unable to Classify|1|||
163357989|NCT00661713|590019431|FG001|Overall Study|Unable to Classify|0|||
163357990|NCT00661713|590019432|FG002|Overall Study|Unable to Classify|0|||
163357991|NCT00661713|590019433|FG003|Overall Study|Unable to Classify|0|||
163357992|NCT00661713|590019434|FG004|Overall Study|Unable to Classify|0|||
163357993|NCT00661713|590019435|FG005|Overall Study|Unable to Classify|0|||
163357994|NCT00661713|590019436|FG006|Overall Study|Unable to Classify|0|||
163357995|NCT00661713|590019437|FG007|Overall Study|Unable to Classify|0|||
163357996|NCT00661713|590019430|FG000|Overall Study|Protocol Violation|1|||
163357997|NCT00661713|590019431|FG001|Overall Study|Protocol Violation|6|||
163357998|NCT00661713|590019432|FG002|Overall Study|Protocol Violation|3|||
163357999|NCT00661713|590019433|FG003|Overall Study|Protocol Violation|3|||
163358000|NCT00661713|590019434|FG004|Overall Study|Protocol Violation|0|||
163358001|NCT00661713|590019435|FG005|Overall Study|Protocol Violation|2|||
163358002|NCT00661713|590019436|FG006|Overall Study|Protocol Violation|2|||
163254061|NCT00175825|589637078|FG003|Overall Study|Withdrawal by Subject|0|||
163254062|NCT03704584|589637079|FG000|Overall Study|Withdrawal by Subject|1|||
163254063|NCT03704584|589637080|FG001|Overall Study|Withdrawal by Subject|0|||
163254064|NCT03412812|589637081|FG000|Level 1|Death|3|||
163254065|NCT03412812|589637082|FG001|Level 1|Death|0|||
163254066|NCT03412812|589637081|FG000|Level 1|Adverse Event|0|||
163254067|NCT03412812|589637082|FG001|Level 1|Adverse Event|1|||
163254068|NCT02127372|589637083|FG000|Overall Study|Withdrawal by Subject|1|||
163254069|NCT02127372|589637084|FG001|Overall Study|Withdrawal by Subject|0|||
163254070|NCT03548207|589637087|FG000|Overall Study|Death|10|||
163254071|NCT03548207|589637088|FG001|Overall Study|Death|23|||
163254072|NCT03548207|589637089|FG002|Overall Study|Death|3|||
163254073|NCT03548207|589637087|FG000|Overall Study|Lost to Follow-up|0|||
163254074|NCT03548207|589637088|FG001|Overall Study|Lost to Follow-up|2|||
163254075|NCT03548207|589637089|FG002|Overall Study|Lost to Follow-up|0|||
163254076|NCT03548207|589637087|FG000|Overall Study|Withdrawal by Subject|0|||
163254077|NCT03548207|589637088|FG001|Overall Study|Withdrawal by Subject|3|||
163254078|NCT03548207|589637089|FG002|Overall Study|Withdrawal by Subject|0|||
163254079|NCT03548207|589637087|FG000|Overall Study|Sponsor decision|19|||
163254080|NCT03548207|589637088|FG001|Overall Study|Sponsor decision|40|||
163254081|NCT03548207|589637089|FG002|Overall Study|Sponsor decision|6|||
163254082|NCT03548207|589637087|FG000|Overall Study|Randomized but not treated|6|||
163254083|NCT03548207|589637088|FG001|Overall Study|Randomized but not treated|10|||
163254084|NCT03548207|589637089|FG002|Overall Study|Randomized but not treated|4|||
163254085|NCT01756352|589637090|FG000|Overall Study|moved away and lost to followup|1|||
163254086|NCT02641392|589637093|FG000|Overall Study|Lost to Follow-up|0|||
163254087|NCT02641392|589637094|FG001|Overall Study|Lost to Follow-up|0|||
163254088|NCT02641392|589637095|FG002|Overall Study|Lost to Follow-up|2|||
163358003|NCT00661713|590019437|FG007|Overall Study|Protocol Violation|1|||
163358004|NCT00661713|590019430|FG000|Overall Study|Withdrawal by Subject|11|||
163254089|NCT02641392|589637093|FG000|Overall Study|Withdrawal by Subject|0|||
163254090|NCT02641392|589637094|FG001|Overall Study|Withdrawal by Subject|0|||
163254091|NCT02641392|589637095|FG002|Overall Study|Withdrawal by Subject|17|||
163254092|NCT02641392|589637093|FG000|Overall Study|Adverse Event|0|||
163254093|NCT02641392|589637094|FG001|Overall Study|Adverse Event|1|||
163254094|NCT02641392|589637095|FG002|Overall Study|Adverse Event|25|||
163254095|NCT02641392|589637093|FG000|Overall Study|Study Terminated by Sponsor|4|||
163254096|NCT02641392|589637094|FG001|Overall Study|Study Terminated by Sponsor|12|||
163254097|NCT02641392|589637095|FG002|Overall Study|Study Terminated by Sponsor|144|||
163254098|NCT02641392|589637093|FG000|Overall Study|Lack of Efficacy|0|||
163254099|NCT02641392|589637094|FG001|Overall Study|Lack of Efficacy|0|||
163254100|NCT02641392|589637095|FG002|Overall Study|Lack of Efficacy|101|||
163254101|NCT02641392|589637093|FG000|Overall Study|Miscellaneous|0|||
163254102|NCT02641392|589637094|FG001|Overall Study|Miscellaneous|0|||
163254103|NCT02641392|589637095|FG002|Overall Study|Miscellaneous|3|||
163254104|NCT02641392|589637093|FG000|Overall Study|Death|0|||
163254105|NCT02641392|589637094|FG001|Overall Study|Death|0|||
163254106|NCT02641392|589637095|FG002|Overall Study|Death|1|||
163254107|NCT03466086|589637096|FG000|Period 1|Sponsor decision due to study timeline|1|||
163254108|NCT03466086|589637097|FG001|Period 1|Sponsor decision due to study timeline|0|||
163358005|NCT00661713|590019431|FG001|Overall Study|Withdrawal by Subject|25|||
163358006|NCT00661713|590019432|FG002|Overall Study|Withdrawal by Subject|12|||
163254109|NCT03466086|589637096|FG000|Period 1|Withdrawal by Subject|1|||
163254110|NCT03466086|589637097|FG001|Period 1|Withdrawal by Subject|0|||
163254111|NCT01113502|589637098|FG000|Overall Study|Withdrawal by Subject|1|||
163254112|NCT01113502|589637099|FG001|Overall Study|Withdrawal by Subject|0|||
163358007|NCT00661713|590019433|FG003|Overall Study|Withdrawal by Subject|21|||
163358008|NCT00661713|590019434|FG004|Overall Study|Withdrawal by Subject|12|||
163358009|NCT00661713|590019435|FG005|Overall Study|Withdrawal by Subject|26|||
163358010|NCT00661713|590019436|FG006|Overall Study|Withdrawal by Subject|45|||
163358011|NCT00661713|590019437|FG007|Overall Study|Withdrawal by Subject|9|||
163358012|NCT00661713|590019430|FG000|Overall Study|Lost to Follow-up|2|||
163254113|NCT01113502|589637100|FG002|Overall Study|Withdrawal by Subject|1|||
163254114|NCT01113502|589637101|FG003|Overall Study|Withdrawal by Subject|1|||
163254115|NCT01113502|589637102|FG004|Overall Study|Withdrawal by Subject|0|||
163254116|NCT01113502|589637098|FG000|Overall Study|Adverse Event|0|||
163254117|NCT01113502|589637099|FG001|Overall Study|Adverse Event|0|||
163254118|NCT01113502|589637100|FG002|Overall Study|Adverse Event|3|||
163254119|NCT01113502|589637101|FG003|Overall Study|Adverse Event|2|||
163254120|NCT01113502|589637102|FG004|Overall Study|Adverse Event|0|||
163254121|NCT03802123|589637105|FG000|Overall Study|Withdrawal by Subject|3|||
163254122|NCT03802123|589637105|FG000|Overall Study|Physician Decision|1|||
163254123|NCT03802123|589637105|FG000|Overall Study|Subject moved to hospice care|1|||
163254124|NCT03802123|589637105|FG000|Overall Study|technician error|1|||
163254125|NCT03802123|589637105|FG000|Overall Study|Death|3|||
163254126|NCT04555096|589637107|FG000|Overall Study|Death|4|||
163254127|NCT04555096|589637108|FG001|Overall Study|Death|4|||
163254128|NCT04555096|589637107|FG000|Overall Study|Withdrawal by Subject|1|||
163254129|NCT04555096|589637108|FG001|Overall Study|Withdrawal by Subject|0|||
163254130|NCT04555096|589637107|FG000|Overall Study|Other|0|||
163254131|NCT04555096|589637108|FG001|Overall Study|Other|1|||
163254132|NCT03575325|589637113|FG000|Overall Study|Death|1|||
163254133|NCT03440372|589637114|FG000|Treatment|Adverse Event|16|||
163254134|NCT03440372|589637115|FG001|Treatment|Adverse Event|8|||
163254135|NCT03440372|589637114|FG000|Treatment|Lack of Efficacy|4|||
163254136|NCT03440372|589637115|FG001|Treatment|Lack of Efficacy|2|||
163254137|NCT03440372|589637114|FG000|Treatment|Withdrawal by Subject|12|||
163254138|NCT03440372|589637115|FG001|Treatment|Withdrawal by Subject|8|||
163254139|NCT03440372|589637114|FG000|Treatment|Lost to Follow-up|1|||
163254140|NCT03440372|589637115|FG001|Treatment|Lost to Follow-up|0|||
163254141|NCT03440372|589637114|FG000|Treatment|Pregnancy|1|||
163254142|NCT03440372|589637115|FG001|Treatment|Pregnancy|0|||
163254143|NCT03440372|589637114|FG000|Treatment|Study Terminated by Sponsor|2|||
163254144|NCT03440372|589637115|FG001|Treatment|Study Terminated by Sponsor|1|||
163254145|NCT03440372|589637114|FG000|Treatment|Other Reason|2|||
163254146|NCT03440372|589637115|FG001|Treatment|Other Reason|3|||
163254147|NCT05711641|589637116|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
163254148|NCT05711641|589637117|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
163254149|NCT05711641|589637116|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
163254150|NCT05711641|589637117|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
163254151|NCT03574597|589637118|FG000|Overall Study|Withdrawal by Subject|67|||
163254152|NCT03574597|589637119|FG001|Overall Study|Withdrawal by Subject|96|||
163254153|NCT03574597|589637118|FG000|Overall Study|Lost to Follow-up|192|||
163254154|NCT03574597|589637119|FG001|Overall Study|Lost to Follow-up|188|||
163254155|NCT03804710|589637120|FG000|Overall Study|Adverse Event|0|||
163254156|NCT03804710|589637121|FG001|Overall Study|Adverse Event|3|||
163254157|NCT03804710|589637120|FG000|Overall Study|Withdrawal by Subject|2|||
163254158|NCT03804710|589637121|FG001|Overall Study|Withdrawal by Subject|1|||
163254159|NCT03804710|589637120|FG000|Overall Study|Other|0|||
163254160|NCT03804710|589637121|FG001|Overall Study|Other|1|||
163254161|NCT04542018|589637122|FG000|Overall Study|Withdrawal by Subject|0|||
163254162|NCT04542018|589637123|FG001|Overall Study|Withdrawal by Subject|0|||
163254163|NCT04542018|589637124|FG002|Overall Study|Withdrawal by Subject|4|||
163254164|NCT04542018|589637122|FG000|Overall Study|Protocol Violation|0|||
163254165|NCT04542018|589637123|FG001|Overall Study|Protocol Violation|0|||
163358013|NCT00661713|590019431|FG001|Overall Study|Lost to Follow-up|7|||
163358014|NCT00661713|590019432|FG002|Overall Study|Lost to Follow-up|2|||
163358015|NCT00661713|590019433|FG003|Overall Study|Lost to Follow-up|2|||
163358016|NCT00661713|590019434|FG004|Overall Study|Lost to Follow-up|5|||
163358017|NCT00661713|590019435|FG005|Overall Study|Lost to Follow-up|7|||
163358018|NCT00661713|590019436|FG006|Overall Study|Lost to Follow-up|14|||
163358019|NCT00661713|590019437|FG007|Overall Study|Lost to Follow-up|1|||
163358020|NCT00661713|590019430|FG000|Overall Study|Administrative Reason|0|||
163358021|NCT00661713|590019431|FG001|Overall Study|Administrative Reason|1|||
163358022|NCT00661713|590019432|FG002|Overall Study|Administrative Reason|0|||
163254166|NCT04542018|589637124|FG002|Overall Study|Protocol Violation|2|||
163254167|NCT03583554|589637125|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
163254168|NCT03583554|589637126|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
163254169|NCT03583554|589637127|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
163254170|NCT03178266|589637128|FG000|Overall Study|Death|0|||
163254171|NCT03178266|589637129|FG001|Overall Study|Death|1|||
163254172|NCT03178266|589637128|FG000|Overall Study|Disont. Early|0|||
163254173|NCT03178266|589637129|FG001|Overall Study|Disont. Early|1|||
163254174|NCT03178266|589637128|FG000|Overall Study|Withdrawal by Subject|0|||
163254175|NCT03178266|589637129|FG001|Overall Study|Withdrawal by Subject|2|||
163254176|NCT01596582|589637141|FG000|Overall Study|Deemed ineligible after study visit|3|||
163254177|NCT01596582|589637142|FG001|Overall Study|Deemed ineligible after study visit|6|||
163254178|NCT01596582|589637141|FG000|Overall Study|Missing all outcome data|1|||
163358023|NCT00661713|590019433|FG003|Overall Study|Administrative Reason|2|||
163254179|NCT01596582|589637142|FG001|Overall Study|Missing all outcome data|1|||
163254180|NCT02012491|589637147|FG000|Overall Study|Lost to Follow-up|1|||
163254181|NCT02012491|589637148|FG001|Overall Study|Lost to Follow-up|0|||
163254182|NCT02012491|589637147|FG000|Overall Study|Protocol Violation|0|||
163254183|NCT02012491|589637148|FG001|Overall Study|Protocol Violation|1|||
163254184|NCT02012491|589637147|FG000|Overall Study|Withdrawal by Subject|1|||
163254185|NCT02012491|589637148|FG001|Overall Study|Withdrawal by Subject|0|||
163254186|NCT01667432|589637149|FG000|Overall Study|Premature Study Termination|26|||
163254187|NCT01667432|589637149|FG000|Overall Study|Failure to Return|10|||
163254188|NCT01667432|589637149|FG000|Overall Study|Moved to Another Center|3|||
163254189|NCT01667432|589637149|FG000|Overall Study|Lost to Follow-up|3|||
163254190|NCT01667432|589637149|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
163254191|NCT01667432|589637149|FG000|Overall Study|Insufficient Therapeutic Response|4|||
163254192|NCT01667432|589637149|FG000|Overall Study|Adverse Event|1|||
163254193|NCT01667432|589637149|FG000|Overall Study|Protocol Deviation|2|||
163254194|NCT01667432|589637149|FG000|Overall Study|Principal Investigator Decision|1|||
163254195|NCT01667432|589637149|FG000|Overall Study|Reason Not Specified|2|||
163254196|NCT01667432|589637149|FG000|Overall Study|Missing Information|4|||
163254197|NCT00553696|589637158|FG000|Overall Study|Adverse Event|2|||
163254198|NCT00553696|589637159|FG001|Overall Study|Adverse Event|4|||
163254199|NCT00553696|589637160|FG002|Overall Study|Adverse Event|0|||
163254200|NCT00553696|589637161|FG003|Overall Study|Adverse Event|1|||
163254201|NCT00553696|589637158|FG000|Overall Study|Global deterioration of health status|0|||
163254202|NCT00553696|589637159|FG001|Overall Study|Global deterioration of health status|2|||
163254203|NCT00553696|589637160|FG002|Overall Study|Global deterioration of health status|0|||
163254204|NCT00553696|589637161|FG003|Overall Study|Global deterioration of health status|0|||
163254205|NCT00553696|589637158|FG000|Overall Study|Objective progression or relapse|2|||
163254206|NCT00553696|589637159|FG001|Overall Study|Objective progression or relapse|9|||
163254207|NCT00553696|589637160|FG002|Overall Study|Objective progression or relapse|6|||
163254208|NCT00553696|589637161|FG003|Overall Study|Objective progression or relapse|0|||
163254209|NCT00553696|589637158|FG000|Overall Study|Withdrawal by Subject|0|||
163254210|NCT00553696|589637159|FG001|Overall Study|Withdrawal by Subject|1|||
163254211|NCT00553696|589637160|FG002|Overall Study|Withdrawal by Subject|0|||
163254212|NCT00553696|589637161|FG003|Overall Study|Withdrawal by Subject|0|||
163254213|NCT00686881|589637164|FG000|Overall Study|Withdrawal by Subject|11|||
163254214|NCT00686881|589637165|FG001|Overall Study|Withdrawal by Subject|18|||
163254215|NCT00686881|589637164|FG000|Overall Study|Lost to Follow-up|0|||
163254216|NCT00686881|589637165|FG001|Overall Study|Lost to Follow-up|1|||
163254217|NCT00686881|589637164|FG000|Overall Study|Treatment-related adverse event|10|||
163254218|NCT00686881|589637165|FG001|Overall Study|Treatment-related adverse event|9|||
163254219|NCT00686881|589637164|FG000|Overall Study|Met discontinuation criteria|5|||
163254220|NCT00686881|589637165|FG001|Overall Study|Met discontinuation criteria|0|||
163254221|NCT00686881|589637164|FG000|Overall Study|Onset of malignant tumor|11|||
163254222|NCT00686881|589637165|FG001|Overall Study|Onset of malignant tumor|11|||
163254223|NCT00686881|589637164|FG000|Overall Study|Lack of Efficacy|4|||
163254224|NCT00686881|589637165|FG001|Overall Study|Lack of Efficacy|3|||
163254225|NCT00686881|589637164|FG000|Overall Study|Physician Decision|1|||
163254226|NCT00686881|589637165|FG001|Overall Study|Physician Decision|0|||
163254227|NCT00686881|589637164|FG000|Overall Study|Circumstances of site|1|||
163254228|NCT00686881|589637165|FG001|Overall Study|Circumstances of site|1|||
163254229|NCT00686881|589637164|FG000|Overall Study|Did not meet protocol eligibility|1|||
163254230|NCT00686881|589637165|FG001|Overall Study|Did not meet protocol eligibility|0|||
163254231|NCT00686881|589637164|FG000|Overall Study|Irregular visits|1|||
163254232|NCT00686881|589637165|FG001|Overall Study|Irregular visits|0|||
163254233|NCT00686881|589637164|FG000|Overall Study|Study discontinuation|35|||
163254234|NCT00686881|589637165|FG001|Overall Study|Study discontinuation|32|||
163254235|NCT00686881|589637164|FG000|Overall Study|Never received study drug|2|||
163254236|NCT00686881|589637165|FG001|Overall Study|Never received study drug|6|||
163254237|NCT00671931|589637166|FG000|Overall Study|Physician Decision|1|||
163254238|NCT00671931|589637167|FG001|Overall Study|Physician Decision|0|||
163254239|NCT00671931|589637168|FG002|Overall Study|Physician Decision|0|||
163254240|NCT00671931|589637169|FG003|Overall Study|Physician Decision|2|||
163254241|NCT00671931|589637170|FG004|Overall Study|Physician Decision|1|||
163254242|NCT01298999|589637171|FG000|Overall Study|Physician Decision|0|||
163254243|NCT01298999|589637172|FG001|Overall Study|Physician Decision|1|||
163254244|NCT01298999|589637171|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
163254245|NCT01298999|589637172|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
163254246|NCT02816138|589637173|FG000|Overall Study|Adverse Event|1|||
163254247|NCT00818753|589637174|FG000|Overall Study|Protocol Violation|1|||
163254248|NCT00818753|589637175|FG001|Overall Study|Protocol Violation|0|||
163254249|NCT00818753|589637176|FG002|Overall Study|Protocol Violation|0|||
163254250|NCT00818753|589637174|FG000|Overall Study|Other reason (not specified)|0|||
163254251|NCT00818753|589637175|FG001|Overall Study|Other reason (not specified)|0|||
163254252|NCT00818753|589637176|FG002|Overall Study|Other reason (not specified)|1|||
163254253|NCT00818753|589637174|FG000|Overall Study|Randomised and not treated|2|||
163254254|NCT00818753|589637175|FG001|Overall Study|Randomised and not treated|0|||
163254255|NCT00818753|589637176|FG002|Overall Study|Randomised and not treated|0|||
163410481|NCT05103332|590211361|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163254256|NCT00902694|589637177|FG000|Overall Study|Death|1|||
163254257|NCT00902694|589637178|FG001|Overall Study|Death|3|||
163254258|NCT00902694|589637177|FG000|Overall Study|Lost to Follow-up|1|||
163254259|NCT00902694|589637178|FG001|Overall Study|Lost to Follow-up|0|||
163254260|NCT00902694|589637177|FG000|Overall Study|Censored per protocol|3|||
163254261|NCT00902694|589637178|FG001|Overall Study|Censored per protocol|1|||
163254262|NCT00902694|589637177|FG000|Overall Study|Pregnancy|1|||
163254263|NCT00902694|589637178|FG001|Overall Study|Pregnancy|1|||
163254264|NCT00902694|589637177|FG000|Overall Study|Incarceration|1|||
163254265|NCT00902694|589637178|FG001|Overall Study|Incarceration|0|||
163254266|NCT04154787|589637179|FG000|Overall Study|Adverse Event|0|||
163254267|NCT04154787|589637180|FG001|Overall Study|Adverse Event|1|||
163254268|NCT04154787|589637181|FG002|Overall Study|Adverse Event|0|||
163254269|NCT04154787|589637179|FG000|Overall Study|Patient Requires Other Treatment|0|||
163254270|NCT04154787|589637180|FG001|Overall Study|Patient Requires Other Treatment|1|||
163254271|NCT04154787|589637181|FG002|Overall Study|Patient Requires Other Treatment|0|||
163254272|NCT04154787|589637179|FG000|Overall Study|Study Terminated By Sponsor|0|||
163254273|NCT04154787|589637180|FG001|Overall Study|Study Terminated By Sponsor|6|||
163254274|NCT04154787|589637181|FG002|Overall Study|Study Terminated By Sponsor|1|||
163254275|NCT04154787|589637179|FG000|Overall Study|Subject Decision|0|||
163254276|NCT04154787|589637180|FG001|Overall Study|Subject Decision|1|||
163254277|NCT04154787|589637181|FG002|Overall Study|Subject Decision|0|||
163254278|NCT04154787|589637179|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
163254279|NCT04154787|589637180|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
163254280|NCT04154787|589637181|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
163254281|NCT01337674|589638984|FG000|Treatment Period 1|Adverse Event|0|||
163254282|NCT01337674|589638985|FG001|Treatment Period 1|Adverse Event|1|||
163254283|NCT01337674|589638986|FG002|Treatment Period 1|Adverse Event|0|||
163254284|NCT01337674|589638987|FG003|Treatment Period 1|Adverse Event|0|||
163254285|NCT01337674|589638984|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
163254286|NCT01337674|589638985|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
163254287|NCT01337674|589638986|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
163254288|NCT01337674|589638987|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
163254289|NCT01337674|589638984|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163254290|NCT01337674|589638985|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163254291|NCT01337674|589638986|FG002|Treatment Period 2|Withdrawal by Subject|1|||
163254292|NCT01337674|589638987|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163254293|NCT00695786|589638988|FG000|Overall Study|Adverse Event|0|||
163254294|NCT00695786|589638989|FG001|Overall Study|Adverse Event|3|||
163254295|NCT00695786|589638990|FG002|Overall Study|Adverse Event|4|||
163254296|NCT00695786|589638991|FG003|Overall Study|Adverse Event|2|||
163254297|NCT00695786|589638988|FG000|Overall Study|Lost to Follow-up|0|||
163254298|NCT00695786|589638989|FG001|Overall Study|Lost to Follow-up|5|||
163254299|NCT00695786|589638990|FG002|Overall Study|Lost to Follow-up|1|||
163254300|NCT00695786|589638991|FG003|Overall Study|Lost to Follow-up|1|||
163254301|NCT00695786|589638988|FG000|Overall Study|Withdrawal by Subject|0|||
163254302|NCT00695786|589638989|FG001|Overall Study|Withdrawal by Subject|4|||
163254303|NCT00695786|589638990|FG002|Overall Study|Withdrawal by Subject|3|||
163254304|NCT00695786|589638991|FG003|Overall Study|Withdrawal by Subject|1|||
163254305|NCT00695786|589638988|FG000|Overall Study|Deemed Ineligible|1|||
163254306|NCT00695786|589638989|FG001|Overall Study|Deemed Ineligible|0|||
163254307|NCT00695786|589638990|FG002|Overall Study|Deemed Ineligible|0|||
163254308|NCT00695786|589638991|FG003|Overall Study|Deemed Ineligible|0|||
163254309|NCT00695786|589638988|FG000|Overall Study|Lack of Efficacy|0|||
163254310|NCT00695786|589638989|FG001|Overall Study|Lack of Efficacy|0|||
163254311|NCT00695786|589638990|FG002|Overall Study|Lack of Efficacy|0|||
163254312|NCT00695786|589638991|FG003|Overall Study|Lack of Efficacy|4|||
163254313|NCT04244396|589638995|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
163254314|NCT04244396|589638995|FG000|Overall Study|Withdrawal by Subject|2|||
163254315|NCT04244396|589638995|FG000|Overall Study|Study termination|37|||
163254316|NCT01787097|589638996|FG000|Overall Study|Withdrawal by Subject|1|||
163254317|NCT01787097|589638997|FG001|Overall Study|Withdrawal by Subject|0|||
163254318|NCT01787097|589638998|FG002|Overall Study|Withdrawal by Subject|0|||
163254319|NCT01787097|589638999|FG003|Overall Study|Withdrawal by Subject|0|||
163254320|NCT00245102|589639000|FG000|Overall Study|Not Treated|1|||
163254321|NCT00245102|589639001|FG001|Overall Study|Not Treated|0|||
163254322|NCT00245102|589639002|FG002|Overall Study|Not Treated|1|||
163254323|NCT00245102|589639003|FG003|Overall Study|Not Treated|0|||
163254324|NCT00245102|589639004|FG004|Overall Study|Not Treated|0|||
163254325|NCT00245102|589639005|FG005|Overall Study|Not Treated|0|||
163254326|NCT00245102|589639000|FG000|Overall Study|Protocol Violation|1|||
163254327|NCT00245102|589639001|FG001|Overall Study|Protocol Violation|0|||
163254328|NCT00245102|589639002|FG002|Overall Study|Protocol Violation|0|||
163254329|NCT00245102|589639003|FG003|Overall Study|Protocol Violation|0|||
163254330|NCT00245102|589639004|FG004|Overall Study|Protocol Violation|0|||
163254331|NCT00245102|589639005|FG005|Overall Study|Protocol Violation|0|||
163358024|NCT00661713|590019434|FG004|Overall Study|Administrative Reason|2|||
163358025|NCT00661713|590019435|FG005|Overall Study|Administrative Reason|2|||
163358026|NCT00661713|590019436|FG006|Overall Study|Administrative Reason|1|||
163358027|NCT00661713|590019437|FG007|Overall Study|Administrative Reason|0|||
163358028|NCT00661713|590019430|FG000|Overall Study|Adverse Event|0|||
163358029|NCT00661713|590019431|FG001|Overall Study|Adverse Event|0|||
163358030|NCT00661713|590019432|FG002|Overall Study|Adverse Event|0|||
163358031|NCT00661713|590019433|FG003|Overall Study|Adverse Event|0|||
163358032|NCT00661713|590019434|FG004|Overall Study|Adverse Event|0|||
163358033|NCT00661713|590019435|FG005|Overall Study|Adverse Event|0|||
163358034|NCT00661713|590019436|FG006|Overall Study|Adverse Event|1|||
163358035|NCT00661713|590019437|FG007|Overall Study|Adverse Event|0|||
163358036|NCT00661713|590019430|FG000|Overall Study|Inappropriate Enrollment|0|||
163358037|NCT00661713|590019431|FG001|Overall Study|Inappropriate Enrollment|0|||
163358038|NCT00661713|590019432|FG002|Overall Study|Inappropriate Enrollment|0|||
163358039|NCT00661713|590019433|FG003|Overall Study|Inappropriate Enrollment|0|||
163358040|NCT00661713|590019434|FG004|Overall Study|Inappropriate Enrollment|0|||
163358041|NCT00661713|590019435|FG005|Overall Study|Inappropriate Enrollment|0|||
163358042|NCT00661713|590019436|FG006|Overall Study|Inappropriate Enrollment|1|||
163358043|NCT00661713|590019437|FG007|Overall Study|Inappropriate Enrollment|0|||
163358044|NCT02353871|590019438|FG000|Overall Study|Protocol deviation|0|||
163358045|NCT02353871|590019439|FG001|Overall Study|Protocol deviation|1|||
163358046|NCT02353871|590019438|FG000|Overall Study|Consent withdrawn|1|||
163358047|NCT02353871|590019439|FG001|Overall Study|Consent withdrawn|8|||
163358048|NCT02353871|590019438|FG000|Overall Study|Lost to Follow-up|2|||
163358049|NCT02353871|590019439|FG001|Overall Study|Lost to Follow-up|0|||
163358050|NCT05314374|590019440|FG000|Overall Study|Adverse Event|2|||
163358051|NCT05314374|590019441|FG001|Overall Study|Adverse Event|2|||
163358052|NCT02658175|590019442|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
163358053|NCT02658175|590019443|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
163358054|NCT02658175|590019444|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
163358055|NCT02658175|590019442|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
163358056|NCT02658175|590019443|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
163358057|NCT02658175|590019444|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
163358058|NCT02658175|590019442|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
163358059|NCT02658175|590019443|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
163358060|NCT02658175|590019444|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
163358061|NCT02658175|590019442|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
163358062|NCT02658175|590019443|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
163358063|NCT02658175|590019444|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
163358064|NCT02658175|590019442|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
163358065|NCT02658175|590019443|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
163358066|NCT02658175|590019444|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
163358067|NCT02658175|590019442|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
163358068|NCT02658175|590019443|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
163358069|NCT02658175|590019444|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
163358070|NCT02658175|590019442|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
163358071|NCT02658175|590019443|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
163358072|NCT02658175|590019444|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
163358073|NCT02658175|590019442|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
163358074|NCT02658175|590019443|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
163358075|NCT02658175|590019444|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
163358076|NCT02658175|590019442|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
163358077|NCT02658175|590019443|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
163358078|NCT02658175|590019444|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
163358079|NCT02658175|590019442|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
163358080|NCT02658175|590019443|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
163358081|NCT02658175|590019444|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
163358082|NCT02554383|590019450|FG000|Overall Study|Ineligible|3|||
163358083|NCT02554383|590019451|FG001|Overall Study|Ineligible|2|||
163358084|NCT02554383|590019450|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
163358085|NCT02554383|590019451|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
163358086|NCT02554383|590019450|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
163358087|NCT02554383|590019451|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
163358088|NCT02554383|590019450|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
163358089|NCT02554383|590019451|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
163358090|NCT02918292|590019454|FG000|Study Enrollment Prior to Transplant|Death|1|||
163358091|NCT02918292|590019454|FG000|Study Follow up After Transplant|Death|6|||
163358092|NCT03783689|590019455|FG000|Overall Study|Adverse Event|2|||
163358093|NCT03783689|590019456|FG001|Overall Study|Adverse Event|0|||
163358094|NCT03783689|590019455|FG000|Overall Study|Lost to Follow-up|2|||
163358095|NCT03783689|590019456|FG001|Overall Study|Lost to Follow-up|1|||
163358096|NCT03783689|590019455|FG000|Overall Study|Physician Decision|2|||
163358097|NCT03783689|590019456|FG001|Overall Study|Physician Decision|1|||
163358098|NCT03783689|590019455|FG000|Overall Study|Withdrawal by Subject|3|||
163358099|NCT03783689|590019456|FG001|Overall Study|Withdrawal by Subject|3|||
163358100|NCT02165826|590019458|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
163358101|NCT02165826|590019459|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
163358102|NCT02165826|590019460|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
163358103|NCT02165826|590019458|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
163358104|NCT02165826|590019459|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
163358105|NCT02165826|590019460|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
163358106|NCT02165826|590019458|FG000|Main Treatment Period|Lost to Follow-up|4|||
163358107|NCT02165826|590019459|FG001|Main Treatment Period|Lost to Follow-up|2|||
163358108|NCT02165826|590019460|FG002|Main Treatment Period|Lost to Follow-up|1|||
163358109|NCT02165826|590019458|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
163358110|NCT02165826|590019459|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
163358111|NCT02165826|590019460|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
163358112|NCT02165826|590019458|FG000|Main Treatment Period|Lack of Efficacy|2|||
163358113|NCT02165826|590019459|FG001|Main Treatment Period|Lack of Efficacy|0|||
163358114|NCT02165826|590019460|FG002|Main Treatment Period|Lack of Efficacy|0|||
163358115|NCT02165826|590019458|FG000|Main Treatment Period|Reason Not Specified|8|||
163358116|NCT02165826|590019459|FG001|Main Treatment Period|Reason Not Specified|5|||
163358117|NCT02165826|590019460|FG002|Main Treatment Period|Reason Not Specified|16|||
163358118|NCT02165826|590019458|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
163358119|NCT02165826|590019459|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
163358120|NCT02165826|590019460|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
163358121|NCT02165826|590019458|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
163358122|NCT02165826|590019459|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
163358123|NCT02165826|590019460|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
163358124|NCT02165826|590019458|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
163358125|NCT02165826|590019459|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
163358126|NCT02165826|590019460|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
163358127|NCT02165826|590019458|FG000|Down-Titration Period|Reason Not Specified|1|||
163358128|NCT02165826|590019459|FG001|Down-Titration Period|Reason Not Specified|0|||
163358129|NCT02165826|590019460|FG002|Down-Titration Period|Reason Not Specified|2|||
163358130|NCT02581059|590019461|FG000|Study Treatment|Disease Progression|1|||
163358131|NCT02581059|590019462|FG001|Study Treatment|Disease Progression|1|||
163358132|NCT02581059|590019461|FG000|Study Treatment|Adverse Event|2|||
163358133|NCT02581059|590019462|FG001|Study Treatment|Adverse Event|1|||
163358134|NCT02581059|590019461|FG000|Study Treatment|Death|1|||
163358135|NCT02581059|590019462|FG001|Study Treatment|Death|1|||
163358136|NCT02581059|590019461|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
163358137|NCT02581059|590019462|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
163358138|NCT02581059|590019461|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
163358139|NCT02581059|590019462|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
163358140|NCT02581059|590019461|FG000|Follow up|Death|1|||
163358141|NCT02581059|590019462|FG001|Follow up|Death|3|||
163358142|NCT02581059|590019461|FG000|Follow up|study terminated|1|||
163410482|NCT05103332|590211362|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163151341|NCT01054885|589269371|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
163151342|NCT01054885|589269372|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
163151343|NCT01054885|589269373|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
163151344|NCT01054885|589269367|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
163151345|NCT01054885|589269368|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163151346|NCT01054885|589269369|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163151347|NCT01054885|589269370|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163151348|NCT01054885|589269371|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163151349|NCT01054885|589269372|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163151350|NCT01054885|589269373|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163151351|NCT01054885|589269367|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
163151352|NCT01054885|589269368|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163151353|NCT01054885|589269369|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163151354|NCT01054885|589269370|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163151355|NCT01054885|589269371|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163151356|NCT01054885|589269372|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163151357|NCT01054885|589269373|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163358143|NCT02581059|590019462|FG001|Follow up|study terminated|1|||
163254332|NCT00245102|589639000|FG000|Overall Study|Death|0|||
163254333|NCT00245102|589639001|FG001|Overall Study|Death|0|||
163254334|NCT00245102|589639002|FG002|Overall Study|Death|0|||
163254335|NCT00245102|589639003|FG003|Overall Study|Death|1|||
163254336|NCT00245102|589639004|FG004|Overall Study|Death|0|||
163254337|NCT00245102|589639005|FG005|Overall Study|Death|0|||
163254338|NCT00245102|589639000|FG000|Overall Study|Adverse Event|4|||
163254339|NCT00245102|589639001|FG001|Overall Study|Adverse Event|2|||
163254340|NCT00245102|589639002|FG002|Overall Study|Adverse Event|5|||
163254341|NCT00245102|589639003|FG003|Overall Study|Adverse Event|1|||
163254342|NCT00245102|589639004|FG004|Overall Study|Adverse Event|0|||
163254343|NCT00245102|589639005|FG005|Overall Study|Adverse Event|2|||
163254344|NCT00245102|589639000|FG000|Overall Study|Decline in performance|0|||
163254345|NCT00245102|589639001|FG001|Overall Study|Decline in performance|2|||
163254346|NCT00245102|589639002|FG002|Overall Study|Decline in performance|0|||
163254347|NCT00245102|589639003|FG003|Overall Study|Decline in performance|1|||
163254348|NCT00245102|589639004|FG004|Overall Study|Decline in performance|0|||
163254349|NCT00245102|589639005|FG005|Overall Study|Decline in performance|2|||
163254350|NCT00245102|589639000|FG000|Overall Study|Participant needed surgery|0|||
163254351|NCT00245102|589639001|FG001|Overall Study|Participant needed surgery|0|||
163254352|NCT00245102|589639002|FG002|Overall Study|Participant needed surgery|1|||
163254353|NCT00245102|589639003|FG003|Overall Study|Participant needed surgery|0|||
163254354|NCT00245102|589639004|FG004|Overall Study|Participant needed surgery|0|||
163254355|NCT00245102|589639005|FG005|Overall Study|Participant needed surgery|0|||
163254356|NCT00245102|589639000|FG000|Overall Study|Clinical progression|1|||
163254357|NCT00245102|589639001|FG001|Overall Study|Clinical progression|0|||
163254358|NCT00245102|589639002|FG002|Overall Study|Clinical progression|0|||
163254359|NCT00245102|589639003|FG003|Overall Study|Clinical progression|0|||
163254360|NCT00245102|589639004|FG004|Overall Study|Clinical progression|0|||
163254361|NCT00245102|589639005|FG005|Overall Study|Clinical progression|0|||
163254362|NCT00289887|589639006|FG000|Overall Study|Adverse Event|3|||
163254363|NCT00289887|589639007|FG001|Overall Study|Adverse Event|3|||
163254364|NCT00289887|589639006|FG000|Overall Study|Lack of Efficacy|3|||
163254365|NCT00289887|589639007|FG001|Overall Study|Lack of Efficacy|11|||
163254366|NCT00289887|589639006|FG000|Overall Study|Lost to Follow-up|3|||
163254367|NCT00289887|589639007|FG001|Overall Study|Lost to Follow-up|3|||
163254368|NCT00289887|589639006|FG000|Overall Study|Protocol Violation|3|||
163254369|NCT00289887|589639007|FG001|Overall Study|Protocol Violation|1|||
163254370|NCT00289887|589639006|FG000|Overall Study|Withdrawal by Subject|3|||
163254371|NCT00289887|589639007|FG001|Overall Study|Withdrawal by Subject|8|||
163254372|NCT00289887|589639006|FG000|Overall Study|Other|7|||
163254373|NCT00289887|589639007|FG001|Overall Study|Other|3|||
163254374|NCT00224770|589639010|FG000|Overall Study|Lost to Follow-up|4|||
163254375|NCT00224770|589639011|FG001|Overall Study|Lost to Follow-up|2|||
163254376|NCT00224770|589639012|FG002|Overall Study|Lost to Follow-up|0|||
163254377|NCT00437645|589639013|FG000|Overall Study|Adverse Event|15|||
163254378|NCT00437645|589639014|FG001|Overall Study|Adverse Event|84|||
163254379|NCT00437645|589639013|FG000|Overall Study|Withdrawal by Subject|10|||
163254380|NCT00437645|589639014|FG001|Overall Study|Withdrawal by Subject|22|||
163254381|NCT00437645|589639013|FG000|Overall Study|Protocol Violation|3|||
163254382|NCT00437645|589639014|FG001|Overall Study|Protocol Violation|3|||
163254383|NCT00437645|589639013|FG000|Overall Study|Lost to Follow-up|2|||
163254384|NCT00437645|589639014|FG001|Overall Study|Lost to Follow-up|3|||
163254385|NCT00437645|589639013|FG000|Overall Study|Administrative problems|2|||
163254386|NCT00437645|589639014|FG001|Overall Study|Administrative problems|1|||
163254387|NCT00437645|589639013|FG000|Overall Study|Lack of Efficacy|2|||
163254388|NCT00437645|589639014|FG001|Overall Study|Lack of Efficacy|1|||
163254389|NCT00437645|589639013|FG000|Overall Study|Condition no longer requires study drug|1|||
163254390|NCT00437645|589639014|FG001|Overall Study|Condition no longer requires study drug|1|||
163254391|NCT00989092|589639017|FG000|Overall Study|Physician Decision|9|||
163254392|NCT00989092|589639018|FG001|Overall Study|Physician Decision|6|||
163254393|NCT00989092|589639017|FG000|Overall Study|Adverse Event|20|||
163254394|NCT00989092|589639018|FG001|Overall Study|Adverse Event|1|||
163254395|NCT00989092|589639017|FG000|Overall Study|Chemotherapy initiated|12|||
163254396|NCT00989092|589639018|FG001|Overall Study|Chemotherapy initiated|4|||
163254397|NCT00989092|589639017|FG000|Overall Study|Withdrawal by Subject|17|||
163254398|NCT00989092|589639018|FG001|Overall Study|Withdrawal by Subject|9|||
163254399|NCT00989092|589639017|FG000|Overall Study|Death|14|||
163254400|NCT00989092|589639018|FG001|Overall Study|Death|2|||
163254401|NCT00989092|589639017|FG000|Overall Study|Ineligibility determined|3|||
163254402|NCT00989092|589639018|FG001|Overall Study|Ineligibility determined|3|||
163254403|NCT00989092|589639017|FG000|Overall Study|Lost to Follow-up|6|||
163254404|NCT00989092|589639018|FG001|Overall Study|Lost to Follow-up|2|||
163254405|NCT00989092|589639017|FG000|Overall Study|Other|3|||
163254406|NCT00989092|589639018|FG001|Overall Study|Other|1|||
163254407|NCT00989092|589639017|FG000|Overall Study|Protocol deviation|2|||
163254408|NCT00989092|589639018|FG001|Overall Study|Protocol deviation|0|||
163254409|NCT00989092|589639017|FG000|Overall Study|Erythropoietin therapy initiated|2|||
163254410|NCT00989092|589639018|FG001|Overall Study|Erythropoietin therapy initiated|0|||
163358144|NCT02581059|590019461|FG000|Follow up|screen failure|0|||
163358145|NCT02581059|590019462|FG001|Follow up|screen failure|1|||
163358146|NCT02581059|590019461|FG000|Follow up|Patient started new clinical trial|1|||
163358147|NCT02581059|590019462|FG001|Follow up|Patient started new clinical trial|0|||
163358148|NCT04887506|590019463|FG000|Overall Study|Death|1|||
163358149|NCT04887506|590019464|FG001|Overall Study|Death|1|||
163358150|NCT04887506|590019463|FG000|Overall Study|Withdrawal by Subject|0|||
163358151|NCT04887506|590019464|FG001|Overall Study|Withdrawal by Subject|3|||
163358152|NCT04887506|590019463|FG000|Overall Study|Adverse Event|4|||
163358153|NCT04887506|590019464|FG001|Overall Study|Adverse Event|3|||
163358154|NCT04887506|590019463|FG000|Overall Study|Other - Not Reported|1|||
163358155|NCT04887506|590019464|FG001|Overall Study|Other - Not Reported|1|||
163358156|NCT02636608|590019468|FG000|Overall Study|Failure to Return|4|||
163358157|NCT02636608|590019468|FG000|Overall Study|Insufficient Virological Response|1|||
163358158|NCT02636608|590019468|FG000|Overall Study|Death|3|||
163358159|NCT02636608|590019468|FG000|Overall Study|Other|2|||
163358160|NCT02636608|590019468|FG000|Overall Study|Did Not Receive Treatment|1|||
163358161|NCT04913948|590019470|FG000|Overall Study|Withdrawal by Subject|2|||
163358162|NCT04913948|590019470|FG000|Overall Study|Sample processing issues|1|||
163358163|NCT04913948|590019470|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
163358164|NCT05739994|590019474|FG000|Overall Study|Withdrawal by Subject|2|||
163358165|NCT05739994|590019475|FG001|Overall Study|Withdrawal by Subject|2|||
163358166|NCT05739994|590019476|FG002|Overall Study|Withdrawal by Subject|4|||
163358167|NCT03526679|590021327|FG000|Overall Study|still under treatment|2|||
163358168|NCT01246999|590021328|FG000|Overall Study|Lost to Follow-up|0|||
163358169|NCT01246999|590021329|FG001|Overall Study|Lost to Follow-up|1|||
163358170|NCT01246999|590021330|FG002|Overall Study|Lost to Follow-up|0|||
163358171|NCT01246999|590021331|FG003|Overall Study|Lost to Follow-up|0|||
163358172|NCT01246999|590021328|FG000|Overall Study|Withdrawal by Subject|0|||
163358173|NCT01246999|590021329|FG001|Overall Study|Withdrawal by Subject|0|||
163358174|NCT01246999|590021330|FG002|Overall Study|Withdrawal by Subject|0|||
163358175|NCT01246999|590021331|FG003|Overall Study|Withdrawal by Subject|2|||
163358176|NCT01867047|590021332|FG000|Overall Study|Lost to Follow-up|3|||
163358177|NCT01867047|590021333|FG001|Overall Study|Lost to Follow-up|3|||
163358178|NCT01867047|590021332|FG000|Overall Study|Withdrawal by Subject|2|||
163358179|NCT01867047|590021333|FG001|Overall Study|Withdrawal by Subject|0|||
163358180|NCT01867047|590021332|FG000|Overall Study|Physician Decision|2|||
163358181|NCT01867047|590021333|FG001|Overall Study|Physician Decision|0|||
163358182|NCT01867047|590021332|FG000|Overall Study|surgery not indicated in protocol|1|||
163358183|NCT01867047|590021333|FG001|Overall Study|surgery not indicated in protocol|2|||
163358184|NCT00307047|590021334|FG000|Overall Study|Lost to Follow-up|35|||
163358185|NCT00307047|590021335|FG001|Overall Study|Lost to Follow-up|24|||
163358186|NCT00307047|590021334|FG000|Overall Study|Withdrawal by Subject|6|||
163358187|NCT00307047|590021335|FG001|Overall Study|Withdrawal by Subject|6|||
163358188|NCT00307047|590021334|FG000|Overall Study|Physician Decision|1|||
163358189|NCT00307047|590021335|FG001|Overall Study|Physician Decision|2|||
163358190|NCT00307047|590021334|FG000|Overall Study|Lost to follow-up for other reasons|0|||
163358191|NCT00307047|590021335|FG001|Overall Study|Lost to follow-up for other reasons|1|||
163358192|NCT00307047|590021334|FG000|Overall Study|All death, all MI, all Revascularization|27|||
163358193|NCT00307047|590021335|FG001|Overall Study|All death, all MI, all Revascularization|16|||
163358194|NCT02825251|590021338|FG000|Overall Study|Adverse Event|0|||
163358195|NCT02825251|590021339|FG001|Overall Study|Adverse Event|1|||
163358196|NCT02825251|590021338|FG000|Overall Study|Lost to Follow-up|0|||
163358197|NCT02825251|590021339|FG001|Overall Study|Lost to Follow-up|1|||
163358198|NCT02825251|590021338|FG000|Overall Study|Withdrawal by Subject|1|||
163358199|NCT02825251|590021339|FG001|Overall Study|Withdrawal by Subject|4|||
163358200|NCT02825251|590021338|FG000|Overall Study|Unclassified|2|||
163358201|NCT02825251|590021339|FG001|Overall Study|Unclassified|0|||
163358202|NCT01689363|590021342|FG000|Overall Study|Protocol Violation|0|||
163358203|NCT01689363|590021343|FG001|Overall Study|Protocol Violation|1|||
163358204|NCT01689363|590021344|FG002|Overall Study|Protocol Violation|0|||
163358205|NCT01689363|590021345|FG003|Overall Study|Protocol Violation|0|||
163358206|NCT01689363|590021346|FG004|Overall Study|Protocol Violation|0|||
163358207|NCT01689363|590021347|FG005|Overall Study|Protocol Violation|0|||
163358208|NCT01689363|590021348|FG006|Overall Study|Protocol Violation|0|||
163358209|NCT01689363|590021349|FG007|Overall Study|Protocol Violation|0|||
163358210|NCT00321685|590021350|FG000|Overall Study|Adverse Event|18|||
163358211|NCT00321685|590021350|FG000|Overall Study|Death|2|||
163358212|NCT00321685|590021350|FG000|Overall Study|Withdrawal by Subject|8|||
163358213|NCT00321685|590021350|FG000|Overall Study|Alternative therapy|1|||
163358214|NCT00321685|590021350|FG000|Overall Study|Complicating disese|1|||
163358215|NCT00321685|590021350|FG000|Overall Study|Other|5|||
163358216|NCT00321685|590021350|FG000|Overall Study|Not start protocol therapy|2|||
163358217|NCT00321685|590021350|FG000|Overall Study|Ineligible|2|||
163358218|NCT05064488|590021354|FG000|Overall Study|Withdrawal by Subject|2|||
163358219|NCT05064488|590021355|FG001|Overall Study|Withdrawal by Subject|0|||
163358220|NCT03023722|590021356|FG000|Overall Study|No follow-up assessment|4|||
163410483|NCT05103332|590211363|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163410484|NCT05103332|590211364|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163410485|NCT05103332|590211365|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163410486|NCT05103332|590211366|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163254411|NCT00989092|589639017|FG000|Overall Study|Did not receive study drug|2|||
163254412|NCT00989092|589639018|FG001|Overall Study|Did not receive study drug|0|||
163254413|NCT03837509|589639023|FG000|Phase 1|Death|5|||
163254414|NCT03837509|589639024|FG001|Phase 1|Death|2|||
163254415|NCT03837509|589639025|FG002|Phase 1|Death|0|||
163254416|NCT03837509|589639026|FG003|Phase 1|Death|0|||
163254417|NCT03837509|589639027|FG004|Phase 1|Death|0|||
163254418|NCT03837509|589639023|FG000|Phase 2|Death|0|||
163254419|NCT03837509|589639024|FG001|Phase 2|Death|0|||
163254420|NCT03837509|589639025|FG002|Phase 2|Death|0|||
163254421|NCT03837509|589639026|FG003|Phase 2|Death|1|||
163254422|NCT03837509|589639027|FG004|Phase 2|Death|1|||
163254423|NCT03320018|589639034|FG000|Treatment Period|Withdrawal by Subject|1|||
163254424|NCT03320018|589639035|FG001|Treatment Period|Withdrawal by Subject|0|||
163254425|NCT03320018|589639034|FG000|Day 90 Follow up|Death|0|||
163254426|NCT03320018|589639035|FG001|Day 90 Follow up|Death|1|||
163254427|NCT00549757|589639036|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
163254428|NCT00549757|589639037|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
163254429|NCT00549757|589639036|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
163254430|NCT00549757|589639037|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
163254431|NCT00549757|589639036|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
163254432|NCT00549757|589639037|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
163254433|NCT00549757|589639036|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
163254434|NCT00549757|589639037|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
163254435|NCT00549757|589639036|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
163254436|NCT00549757|589639037|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
163254437|NCT00549757|589639036|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
163254438|NCT00549757|589639037|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
163254439|NCT00549757|589639036|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
163254440|NCT00549757|589639037|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
163254441|NCT00549757|589639036|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
163254442|NCT00549757|589639037|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
163254443|NCT00549757|589639036|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
163254444|NCT00549757|589639037|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
163254445|NCT00549757|589639036|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
163254446|NCT00549757|589639037|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
163254447|NCT00549757|589639036|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
163254448|NCT00549757|589639037|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
163254449|NCT00549757|589639036|FG000|Extension Period (in Average 9 Months)|Death|143|||
163254450|NCT00549757|589639037|FG001|Extension Period (in Average 9 Months)|Death|136|||
163254451|NCT00549757|589639036|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
163254452|NCT00549757|589639037|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
163254453|NCT00549757|589639036|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
163254454|NCT00549757|589639037|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
163254455|NCT00549757|589639036|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
163254456|NCT00549757|589639037|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
163254457|NCT01256411|589639042|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
163254458|NCT01256411|589639043|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
163254459|NCT01256411|589639044|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
163254460|NCT01256411|589639045|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
163254461|NCT01256411|589639046|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
163254462|NCT01256411|589639047|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
163254463|NCT01256411|589639042|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
163254464|NCT01256411|589639043|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
163254465|NCT01256411|589639044|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
163254466|NCT01256411|589639045|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
163254467|NCT01256411|589639046|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
163254468|NCT01256411|589639047|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
163254469|NCT01256411|589639042|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
163254470|NCT01256411|589639043|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
163254471|NCT01256411|589639044|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
163254472|NCT01256411|589639045|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
163254473|NCT01256411|589639046|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
163254474|NCT01256411|589639047|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
163254475|NCT01256411|589639042|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
163410487|NCT05103332|590211367|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163358221|NCT03616964|590021357|FG000|Overall Study|Adverse Event|15|||
163358222|NCT03616964|590021358|FG001|Overall Study|Adverse Event|10|||
163358223|NCT03616964|590021359|FG002|Overall Study|Adverse Event|16|||
163358224|NCT03616964|590021357|FG000|Overall Study|Death|3|||
163358225|NCT03616964|590021358|FG001|Overall Study|Death|0|||
163358226|NCT03616964|590021359|FG002|Overall Study|Death|4|||
163358227|NCT03616964|590021357|FG000|Overall Study|Lack of Efficacy|4|||
163358228|NCT03616964|590021358|FG001|Overall Study|Lack of Efficacy|8|||
163358229|NCT03616964|590021359|FG002|Overall Study|Lack of Efficacy|8|||
163358230|NCT03616964|590021357|FG000|Overall Study|Lost to Follow-up|2|||
163358231|NCT03616964|590021358|FG001|Overall Study|Lost to Follow-up|1|||
163358232|NCT03616964|590021359|FG002|Overall Study|Lost to Follow-up|3|||
163358233|NCT03616964|590021357|FG000|Overall Study|Withdrawal by Subject|18|||
163358234|NCT03616964|590021358|FG001|Overall Study|Withdrawal by Subject|14|||
163358235|NCT03616964|590021359|FG002|Overall Study|Withdrawal by Subject|21|||
163358236|NCT03616964|590021357|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
163358237|NCT03616964|590021358|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
163358238|NCT03616964|590021359|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
163358239|NCT03616964|590021357|FG000|Overall Study|Sponsor's Decision|1|||
163358240|NCT03616964|590021358|FG001|Overall Study|Sponsor's Decision|0|||
163358241|NCT03616964|590021359|FG002|Overall Study|Sponsor's Decision|0|||
163358242|NCT03616964|590021357|FG000|Overall Study|Physician Decision|0|||
163358243|NCT03616964|590021358|FG001|Overall Study|Physician Decision|2|||
163358244|NCT03616964|590021359|FG002|Overall Study|Physician Decision|0|||
163358245|NCT03616964|590021357|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
163358246|NCT03616964|590021358|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
163358247|NCT03616964|590021359|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
163358248|NCT03616964|590021357|FG000|Overall Study|Protocol Violation|0|||
163358249|NCT03616964|590021358|FG001|Overall Study|Protocol Violation|1|||
163254476|NCT01256411|589639043|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
163254477|NCT01256411|589639044|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
163254478|NCT01256411|589639045|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
163254479|NCT01256411|589639046|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
163254480|NCT01256411|589639047|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
163254481|NCT01256411|589639042|FG000|Extension by Maximum Treatment|Adverse Event|4|||
163254482|NCT01256411|589639043|FG001|Extension by Maximum Treatment|Adverse Event|2|||
163254483|NCT01256411|589639044|FG002|Extension by Maximum Treatment|Adverse Event|1|||
163254484|NCT01256411|589639045|FG003|Extension by Maximum Treatment|Adverse Event|0|||
163254485|NCT01256411|589639046|FG004|Extension by Maximum Treatment|Adverse Event|0|||
163254486|NCT01256411|589639047|FG005|Extension by Maximum Treatment|Adverse Event|0|||
163254487|NCT01256411|589639042|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
163254488|NCT01256411|589639043|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
163254489|NCT01256411|589639044|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
163254490|NCT01256411|589639045|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
163254491|NCT01256411|589639046|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
163254492|NCT01256411|589639047|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
163254493|NCT01256411|589639042|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
163254494|NCT01256411|589639043|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
163254495|NCT01256411|589639044|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
163254496|NCT01256411|589639045|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
163254497|NCT01256411|589639046|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
163254498|NCT01256411|589639047|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
163254499|NCT01256411|589639042|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
163254500|NCT01256411|589639043|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
163254501|NCT01256411|589639044|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
163254502|NCT01256411|589639045|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
163254503|NCT01256411|589639046|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
163254504|NCT01256411|589639047|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
163254505|NCT01256411|589639042|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
163254506|NCT01256411|589639043|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
163254507|NCT01256411|589639044|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
163254508|NCT01256411|589639045|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
163358250|NCT03616964|590021359|FG002|Overall Study|Protocol Violation|0|||
163358251|NCT03616964|590021357|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
163254509|NCT01256411|589639046|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
163358252|NCT03616964|590021358|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
163358253|NCT03616964|590021359|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
163358254|NCT03616964|590021357|FG000|Overall Study|Randomized but Never Treated|1|||
163358255|NCT03616964|590021358|FG001|Overall Study|Randomized but Never Treated|1|||
163358256|NCT03616964|590021359|FG002|Overall Study|Randomized but Never Treated|1|||
163254510|NCT01256411|589639047|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
163254511|NCT01256411|589639042|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
163254512|NCT01256411|589639043|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
163254513|NCT01256411|589639044|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
163254514|NCT01256411|589639045|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
163254515|NCT01256411|589639046|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
163254516|NCT01256411|589639047|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
163254517|NCT02274857|589639048|FG000|Overall Study|Adverse Event|1|||
163254518|NCT02274857|589639049|FG001|Overall Study|Adverse Event|0|||
163254519|NCT02274857|589639048|FG000|Overall Study|Death|1|||
163254520|NCT02274857|589639049|FG001|Overall Study|Death|2|||
163254521|NCT02274857|589639048|FG000|Overall Study|Lost to Follow-up|3|||
163254522|NCT02274857|589639049|FG001|Overall Study|Lost to Follow-up|0|||
163254523|NCT02274857|589639048|FG000|Overall Study|Physician Decision|2|||
163254524|NCT02274857|589639049|FG001|Overall Study|Physician Decision|0|||
163254525|NCT02274857|589639048|FG000|Overall Study|Trial screen failure|0|||
163254526|NCT02274857|589639049|FG001|Overall Study|Trial screen failure|2|||
163254527|NCT02274857|589639048|FG000|Overall Study|Withdrawal by Subject|11|||
163254528|NCT02274857|589639049|FG001|Overall Study|Withdrawal by Subject|2|||
163254529|NCT02274857|589639048|FG000|Overall Study|Other|2|||
163254530|NCT02274857|589639049|FG001|Overall Study|Other|0|||
163254531|NCT00117676|589639050|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
163254532|NCT00117676|589639051|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
163254533|NCT00117676|589639050|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
163254534|NCT00117676|589639051|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
163254535|NCT00117676|589639050|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
163254536|NCT00117676|589639051|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
163254537|NCT00117676|589639050|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
163254538|NCT00117676|589639051|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
163254539|NCT00117676|589639050|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
163254540|NCT00117676|589639051|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
163254541|NCT00117676|589639050|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
163254542|NCT00117676|589639051|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
163254543|NCT00117676|589639050|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
163254544|NCT00117676|589639051|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
163254545|NCT00117676|589639050|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
163254546|NCT00117676|589639051|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
163254547|NCT00117676|589639050|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
163254548|NCT00117676|589639051|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
163254549|NCT00117676|589639050|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
163254550|NCT00117676|589639051|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
163254551|NCT00117676|589639050|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
163254552|NCT00117676|589639051|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
163254553|NCT00117676|589639050|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
163254554|NCT00117676|589639051|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
163254555|NCT00117676|589639050|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
163254556|NCT00117676|589639051|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
163254557|NCT00117676|589639050|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
163254558|NCT00117676|589639051|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
163254559|NCT00117676|589639050|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
163254560|NCT00117676|589639051|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
163254561|NCT00117676|589639050|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
163254562|NCT00117676|589639051|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
163254563|NCT00117676|589639050|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
163254564|NCT00117676|589639051|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
163254565|NCT00117676|589639050|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
163254566|NCT00117676|589639051|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
163254567|NCT00117676|589639050|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
163254568|NCT00117676|589639051|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
163254569|NCT00117676|589639050|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
163254570|NCT00117676|589639051|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
163254571|NCT00117676|589639050|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
163254572|NCT00117676|589639051|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
163254573|NCT00117676|589639050|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
163254574|NCT00117676|589639051|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
163254575|NCT00117676|589639050|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
163254576|NCT00117676|589639051|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
163254577|NCT00117676|589639050|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
163254578|NCT00117676|589639051|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
163254579|NCT00117676|589639050|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
163254580|NCT00117676|589639051|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
163254581|NCT00117676|589639050|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
163254582|NCT00117676|589639051|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
163254583|NCT00117676|589639050|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
163254584|NCT00117676|589639051|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
163254585|NCT00117676|589639050|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
163254586|NCT00117676|589639051|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
163254587|NCT00117676|589639050|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
163254588|NCT00117676|589639051|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
163254589|NCT00117676|589639050|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
163254590|NCT00117676|589639051|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
163254591|NCT00117676|589639050|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
163254592|NCT00117676|589639051|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
163254593|NCT00117676|589639050|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
163151358|NCT01054885|589269367|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
163151359|NCT01054885|589269368|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
163151360|NCT01054885|589269369|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
163254594|NCT00117676|589639051|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
163254595|NCT00117676|589639050|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
163254596|NCT00117676|589639051|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
163254597|NCT00117676|589639050|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
163358257|NCT04596995|590021360|FG000|Overall Study|Lack of Efficacy|8|||
163358258|NCT04596995|590021360|FG000|Overall Study|Lost to Follow-up|3|||
163358259|NCT04596995|590021360|FG000|Overall Study|Withdrawal by Subject|12|||
163358260|NCT04596995|590021360|FG000|Overall Study|Sponsor decision|3|||
163358261|NCT04596995|590021360|FG000|Overall Study|Enrolled in managed access program|3|||
163151361|NCT01054885|589269370|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
163151362|NCT01054885|589269371|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
163151363|NCT01054885|589269372|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
163151364|NCT01054885|589269373|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
163151365|NCT01054885|589269367|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
163151366|NCT01054885|589269368|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163151367|NCT01054885|589269369|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163151368|NCT01054885|589269370|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163151369|NCT01054885|589269371|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163151370|NCT01054885|589269372|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163151371|NCT01054885|589269373|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163151372|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
163151373|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
163151374|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
163151375|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
163151376|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
163151377|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
163151378|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
163151379|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
163151380|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
163151381|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
163151382|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
163151383|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
163151384|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
163151385|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
163151386|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
163151387|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
163151388|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
163151389|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
163151390|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
163151391|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
163151392|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
163151393|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
163254598|NCT00117676|589639051|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
163254599|NCT00117676|589639050|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
163254600|NCT00117676|589639051|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
163254601|NCT00952822|589639052|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
163254602|NCT00952822|589639053|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
163254603|NCT00952822|589639054|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
163254604|NCT00952822|589639055|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
163254605|NCT00952822|589639052|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
163254606|NCT00952822|589639053|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
163254607|NCT00952822|589639054|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
163254608|NCT00952822|589639055|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
163254609|NCT00691938|589639056|FG000|Overall Study|QTc prolongation|1|||
163254610|NCT00691938|589639057|FG001|Overall Study|QTc prolongation|0|||
163254611|NCT00691938|589639058|FG002|Overall Study|QTc prolongation|0|||
163254612|NCT00691938|589639059|FG003|Overall Study|QTc prolongation|0|||
163254613|NCT00691938|589639060|FG004|Overall Study|QTc prolongation|0|||
163254614|NCT00691938|589639061|FG005|Overall Study|QTc prolongation|0|||
163254615|NCT00691938|589639062|FG006|Overall Study|QTc prolongation|0|||
163254616|NCT00594854|589639064|FG000|Overall Study|Study terminated|7|||
163254617|NCT00594854|589639065|FG001|Overall Study|Study terminated|10|||
163254618|NCT04918147|589639076|FG000|Overall Study|Disease flare as defined in protocol|0|||
163254619|NCT04918147|589639077|FG001|Overall Study|Disease flare as defined in protocol|2|||
163254620|NCT03292146|589639078|FG000|Baseline to 12 months|Relocation|1|||
163254621|NCT03292146|589639079|FG001|Baseline to 12 months|Relocation|0|||
163254622|NCT03292146|589639078|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
163254623|NCT03292146|589639079|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
163254624|NCT03292146|589639078|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
163254625|NCT03292146|589639079|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
163254626|NCT03292146|589639078|FG000|12 months to 24 months|Planning pregnancy|2|||
163254627|NCT03292146|589639079|FG001|12 months to 24 months|Planning pregnancy|2|||
163254628|NCT03292146|589639078|FG000|12 months to 24 months|Personal reasons|1|||
163254629|NCT03292146|589639079|FG001|12 months to 24 months|Personal reasons|0|||
163254630|NCT03292146|589639078|FG000|12 months to 24 months|Lost to Follow-up|0|||
163254631|NCT03292146|589639079|FG001|12 months to 24 months|Lost to Follow-up|1|||
163254632|NCT06134180|589639080|FG000|Overall Study|Lost to Follow-up|4|||
163254633|NCT01362439|589639081|FG000|Overall Study|Adverse Event|1|||
163254634|NCT01362439|589639081|FG000|Overall Study|Lack of Efficacy|3|||
163254635|NCT01362439|589639081|FG000|Overall Study|Lost to Follow-up|2|||
163254636|NCT01362439|589639081|FG000|Overall Study|Study medication non-compliant|1|||
163254637|NCT01362439|589639081|FG000|Overall Study|Participant who withdrew consent|8|||
163254638|NCT02712905|589639084|FG000|Monotherapy|Death|2|||
163254639|NCT02712905|589639085|FG001|Monotherapy|Death|5|||
163254640|NCT02712905|589639086|FG002|Monotherapy|Death|0|||
163254641|NCT02712905|589639087|FG003|Monotherapy|Death|3|||
163254642|NCT02712905|589639088|FG004|Monotherapy|Death|15|||
163254643|NCT02712905|589639089|FG005|Monotherapy|Death|1|||
163254644|NCT02712905|589639090|FG006|Monotherapy|Death|3|||
163254645|NCT02712905|589639091|FG007|Monotherapy|Death|3|||
163254646|NCT02712905|589639092|FG008|Monotherapy|Death|0|||
163254647|NCT02712905|589639093|FG009|Monotherapy|Death|27|||
163254648|NCT02712905|589639094|FG010|Monotherapy|Death|2|||
163254649|NCT02712905|589639095|FG011|Monotherapy|Death|5|||
163254650|NCT02712905|589639096|FG012|Monotherapy|Death|0|||
163254651|NCT02712905|589639097|FG013|Monotherapy|Death|0|||
163254652|NCT02712905|589639098|FG014|Monotherapy|Death|0|||
163254653|NCT02712905|589639099|FG015|Monotherapy|Death|0|||
163254654|NCT02712905|589639100|FG016|Monotherapy|Death|0|||
163254655|NCT02712905|589639101|FG017|Monotherapy|Death|0|||
163254656|NCT02712905|589639084|FG000|Monotherapy|Lost to Follow-up|0|||
163254657|NCT02712905|589639085|FG001|Monotherapy|Lost to Follow-up|1|||
163254658|NCT02712905|589639086|FG002|Monotherapy|Lost to Follow-up|0|||
163254659|NCT02712905|589639087|FG003|Monotherapy|Lost to Follow-up|1|||
163254660|NCT02712905|589639088|FG004|Monotherapy|Lost to Follow-up|0|||
163254661|NCT02712905|589639089|FG005|Monotherapy|Lost to Follow-up|0|||
163254662|NCT02712905|589639090|FG006|Monotherapy|Lost to Follow-up|0|||
163254663|NCT02712905|589639091|FG007|Monotherapy|Lost to Follow-up|0|||
163254664|NCT02712905|589639092|FG008|Monotherapy|Lost to Follow-up|0|||
163254665|NCT02712905|589639093|FG009|Monotherapy|Lost to Follow-up|2|||
163254666|NCT02712905|589639094|FG010|Monotherapy|Lost to Follow-up|0|||
163254667|NCT02712905|589639095|FG011|Monotherapy|Lost to Follow-up|0|||
163254668|NCT02712905|589639096|FG012|Monotherapy|Lost to Follow-up|0|||
163254669|NCT02712905|589639097|FG013|Monotherapy|Lost to Follow-up|0|||
163254670|NCT02712905|589639098|FG014|Monotherapy|Lost to Follow-up|0|||
163254671|NCT02712905|589639099|FG015|Monotherapy|Lost to Follow-up|0|||
163254672|NCT02712905|589639100|FG016|Monotherapy|Lost to Follow-up|0|||
163254673|NCT02712905|589639101|FG017|Monotherapy|Lost to Follow-up|0|||
163254674|NCT02712905|589639084|FG000|Monotherapy|Physician Decision|1|||
163254675|NCT02712905|589639085|FG001|Monotherapy|Physician Decision|0|||
163254676|NCT02712905|589639086|FG002|Monotherapy|Physician Decision|0|||
163358262|NCT01952847|590021361|FG000|Overall Study|Ineligible|1|||
163358263|NCT01952847|590021362|FG001|Overall Study|Ineligible|0|||
163358264|NCT01952847|590021363|FG002|Overall Study|Ineligible|0|||
163358265|NCT01952847|590021364|FG003|Overall Study|Ineligible|0|||
163358266|NCT01952847|590021361|FG000|Overall Study|Lack of Insurance Coverage|0|||
163358267|NCT01952847|590021362|FG001|Overall Study|Lack of Insurance Coverage|1|||
163358268|NCT01952847|590021363|FG002|Overall Study|Lack of Insurance Coverage|0|||
163358269|NCT01952847|590021364|FG003|Overall Study|Lack of Insurance Coverage|0|||
163358270|NCT01952847|590021361|FG000|Overall Study|Withdrawal by Subject|1|||
163358271|NCT01952847|590021362|FG001|Overall Study|Withdrawal by Subject|1|||
163358272|NCT01952847|590021363|FG002|Overall Study|Withdrawal by Subject|0|||
163358273|NCT01952847|590021364|FG003|Overall Study|Withdrawal by Subject|1|||
163358274|NCT05382039|590021365|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
163358275|NCT05382039|590021366|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
163358276|NCT05382039|590021367|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
163358277|NCT05382039|590021365|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
163358278|NCT05382039|590021366|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
163358279|NCT05382039|590021367|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
163358280|NCT05382039|590021365|FG000|Overall Study|waiting for confirmation|0|||
163358281|NCT05382039|590021366|FG001|Overall Study|waiting for confirmation|0|||
163358282|NCT05382039|590021367|FG002|Overall Study|waiting for confirmation|1|||
163358283|NCT04464421|590021368|FG000|Overall Study|Lost to Follow-up|2|||
163358284|NCT04464421|590021369|FG001|Overall Study|Lost to Follow-up|2|||
163358285|NCT02577003|590021370|FG000|Overall Study|Adverse Event|2|||
163358286|NCT02577003|590021371|FG001|Overall Study|Adverse Event|4|||
163358287|NCT02577003|590021370|FG000|Overall Study|Withdrawal by Subject|0|||
163358288|NCT02577003|590021371|FG001|Overall Study|Withdrawal by Subject|1|||
163358289|NCT01234883|590021372|FG000|Overall Study|Early treatment release|8|||
163358290|NCT01234883|590021373|FG001|Overall Study|Early treatment release|10|||
163358291|NCT01234883|590021372|FG000|Overall Study|Parent/guardian withdrew consent|1|||
163358292|NCT01234883|590021373|FG001|Overall Study|Parent/guardian withdrew consent|2|||
163358293|NCT01234883|590021372|FG000|Overall Study|Technical difficulties with IV infusion|0|||
163358294|NCT01234883|590021373|FG001|Overall Study|Technical difficulties with IV infusion|1|||
163358295|NCT01234883|590021372|FG000|Overall Study|Inclusion/exclusion failure|1|||
163358296|NCT01234883|590021373|FG001|Overall Study|Inclusion/exclusion failure|0|||
163358297|NCT01013961|590021374|FG000|Overall Study|Adverse Event|2|||
163358298|NCT01013961|590021375|FG001|Overall Study|Adverse Event|2|||
163358299|NCT01013961|590021374|FG000|Overall Study|Withdrawal by Subject|1|||
163358300|NCT01013961|590021375|FG001|Overall Study|Withdrawal by Subject|0|||
163358301|NCT01013961|590021374|FG000|Overall Study|Physician Decision|0|||
163358302|NCT01013961|590021375|FG001|Overall Study|Physician Decision|1|||
163358303|NCT01271504|590021376|FG000|Overall Study|Death|7|||
163358304|NCT01271504|590021377|FG001|Overall Study|Death|6|||
163358305|NCT01271504|590021378|FG002|Overall Study|Death|32|||
163358306|NCT01271504|590021379|FG003|Overall Study|Death|32|||
163358307|NCT01271504|590021376|FG000|Overall Study|Lost to Follow-up|0|||
163358308|NCT01271504|590021377|FG001|Overall Study|Lost to Follow-up|1|||
163358309|NCT01271504|590021378|FG002|Overall Study|Lost to Follow-up|3|||
163358310|NCT01271504|590021379|FG003|Overall Study|Lost to Follow-up|1|||
163358311|NCT01271504|590021376|FG000|Overall Study|Protocol Violation|0|||
163358312|NCT01271504|590021377|FG001|Overall Study|Protocol Violation|0|||
163358313|NCT01271504|590021378|FG002|Overall Study|Protocol Violation|0|||
163358314|NCT01271504|590021379|FG003|Overall Study|Protocol Violation|2|||
163358315|NCT01271504|590021376|FG000|Overall Study|Administrative Reasons|0|||
163358316|NCT01271504|590021377|FG001|Overall Study|Administrative Reasons|0|||
163358317|NCT01271504|590021378|FG002|Overall Study|Administrative Reasons|6|||
163358318|NCT01271504|590021379|FG003|Overall Study|Administrative Reasons|5|||
163358319|NCT01271504|590021376|FG000|Overall Study|Withdrawal by Subject|0|||
163358320|NCT01271504|590021377|FG001|Overall Study|Withdrawal by Subject|0|||
163358321|NCT01271504|590021378|FG002|Overall Study|Withdrawal by Subject|1|||
163358322|NCT01271504|590021379|FG003|Overall Study|Withdrawal by Subject|3|||
163358323|NCT01271504|590021376|FG000|Overall Study|Other|0|||
163358324|NCT01271504|590021377|FG001|Overall Study|Other|1|||
163358325|NCT01271504|590021378|FG002|Overall Study|Other|2|||
163358326|NCT01271504|590021379|FG003|Overall Study|Other|0|||
163358327|NCT01850589|590021386|FG000|Overall Study|Withdrawal by Subject|8|||
163358328|NCT01850589|590021387|FG001|Overall Study|Withdrawal by Subject|0|||
163358329|NCT03912662|590021388|FG000|Overall Study|Adverse Event|3|||
163358330|NCT03912662|590021388|FG000|Overall Study|Adverse Event and Death|1|||
163358331|NCT03912662|590021388|FG000|Overall Study|Death|1|||
163358332|NCT03912662|590021388|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
163358333|NCT03912662|590021388|FG000|Overall Study|Mesh Removal|1|||
163358334|NCT03912662|590021388|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
163254677|NCT02712905|589639087|FG003|Monotherapy|Physician Decision|1|||
163254678|NCT02712905|589639088|FG004|Monotherapy|Physician Decision|0|||
163254679|NCT02712905|589639089|FG005|Monotherapy|Physician Decision|0|||
163254680|NCT02712905|589639090|FG006|Monotherapy|Physician Decision|0|||
163254681|NCT02712905|589639091|FG007|Monotherapy|Physician Decision|0|||
163254682|NCT02712905|589639092|FG008|Monotherapy|Physician Decision|0|||
163254683|NCT02712905|589639093|FG009|Monotherapy|Physician Decision|1|||
163254684|NCT02712905|589639094|FG010|Monotherapy|Physician Decision|0|||
163254685|NCT02712905|589639095|FG011|Monotherapy|Physician Decision|0|||
163254686|NCT02712905|589639096|FG012|Monotherapy|Physician Decision|0|||
163254687|NCT02712905|589639097|FG013|Monotherapy|Physician Decision|0|||
163254688|NCT02712905|589639098|FG014|Monotherapy|Physician Decision|0|||
163254689|NCT02712905|589639099|FG015|Monotherapy|Physician Decision|0|||
163254690|NCT02712905|589639100|FG016|Monotherapy|Physician Decision|0|||
163254691|NCT02712905|589639101|FG017|Monotherapy|Physician Decision|0|||
163254692|NCT02712905|589639084|FG000|Monotherapy|Study Terminated by Sponsor|0|||
163254693|NCT02712905|589639085|FG001|Monotherapy|Study Terminated by Sponsor|0|||
163254694|NCT02712905|589639086|FG002|Monotherapy|Study Terminated by Sponsor|0|||
163254695|NCT02712905|589639087|FG003|Monotherapy|Study Terminated by Sponsor|0|||
163254696|NCT02712905|589639088|FG004|Monotherapy|Study Terminated by Sponsor|1|||
163254697|NCT02712905|589639089|FG005|Monotherapy|Study Terminated by Sponsor|0|||
163254698|NCT02712905|589639090|FG006|Monotherapy|Study Terminated by Sponsor|0|||
163254699|NCT02712905|589639091|FG007|Monotherapy|Study Terminated by Sponsor|0|||
163254700|NCT02712905|589639092|FG008|Monotherapy|Study Terminated by Sponsor|0|||
163254701|NCT02712905|589639093|FG009|Monotherapy|Study Terminated by Sponsor|2|||
163254702|NCT02712905|589639094|FG010|Monotherapy|Study Terminated by Sponsor|0|||
163254703|NCT02712905|589639095|FG011|Monotherapy|Study Terminated by Sponsor|0|||
163254704|NCT02712905|589639096|FG012|Monotherapy|Study Terminated by Sponsor|0|||
163254705|NCT02712905|589639097|FG013|Monotherapy|Study Terminated by Sponsor|0|||
163254706|NCT02712905|589639098|FG014|Monotherapy|Study Terminated by Sponsor|0|||
163254707|NCT02712905|589639099|FG015|Monotherapy|Study Terminated by Sponsor|0|||
163254708|NCT02712905|589639100|FG016|Monotherapy|Study Terminated by Sponsor|0|||
163254709|NCT02712905|589639101|FG017|Monotherapy|Study Terminated by Sponsor|0|||
163254710|NCT02712905|589639084|FG000|Monotherapy|Withdrawal by Subject|0|||
163254711|NCT02712905|589639085|FG001|Monotherapy|Withdrawal by Subject|0|||
163254712|NCT02712905|589639086|FG002|Monotherapy|Withdrawal by Subject|1|||
163254713|NCT02712905|589639087|FG003|Monotherapy|Withdrawal by Subject|0|||
163254714|NCT02712905|589639088|FG004|Monotherapy|Withdrawal by Subject|2|||
163254715|NCT02712905|589639089|FG005|Monotherapy|Withdrawal by Subject|0|||
163254716|NCT02712905|589639090|FG006|Monotherapy|Withdrawal by Subject|0|||
163254717|NCT02712905|589639091|FG007|Monotherapy|Withdrawal by Subject|0|||
163254718|NCT02712905|589639092|FG008|Monotherapy|Withdrawal by Subject|0|||
163254719|NCT02712905|589639093|FG009|Monotherapy|Withdrawal by Subject|4|||
163254720|NCT02712905|589639094|FG010|Monotherapy|Withdrawal by Subject|1|||
163254721|NCT02712905|589639095|FG011|Monotherapy|Withdrawal by Subject|2|||
163254722|NCT02712905|589639096|FG012|Monotherapy|Withdrawal by Subject|0|||
163254723|NCT02712905|589639097|FG013|Monotherapy|Withdrawal by Subject|0|||
163254724|NCT02712905|589639098|FG014|Monotherapy|Withdrawal by Subject|0|||
163254725|NCT02712905|589639099|FG015|Monotherapy|Withdrawal by Subject|0|||
163254726|NCT02712905|589639100|FG016|Monotherapy|Withdrawal by Subject|0|||
163254727|NCT02712905|589639101|FG017|Monotherapy|Withdrawal by Subject|0|||
163254728|NCT02712905|589639084|FG000|Monotherapy|Started New Cancer Drug|0|||
163254729|NCT02712905|589639085|FG001|Monotherapy|Started New Cancer Drug|0|||
163254730|NCT02712905|589639086|FG002|Monotherapy|Started New Cancer Drug|0|||
163254731|NCT02712905|589639087|FG003|Monotherapy|Started New Cancer Drug|0|||
163254732|NCT02712905|589639088|FG004|Monotherapy|Started New Cancer Drug|0|||
163254733|NCT02712905|589639089|FG005|Monotherapy|Started New Cancer Drug|1|||
163254734|NCT02712905|589639090|FG006|Monotherapy|Started New Cancer Drug|0|||
163254735|NCT02712905|589639091|FG007|Monotherapy|Started New Cancer Drug|0|||
163254736|NCT02712905|589639092|FG008|Monotherapy|Started New Cancer Drug|0|||
163254737|NCT02712905|589639093|FG009|Monotherapy|Started New Cancer Drug|0|||
163254738|NCT02712905|589639094|FG010|Monotherapy|Started New Cancer Drug|0|||
163254739|NCT02712905|589639095|FG011|Monotherapy|Started New Cancer Drug|0|||
163254740|NCT02712905|589639096|FG012|Monotherapy|Started New Cancer Drug|0|||
163254741|NCT02712905|589639097|FG013|Monotherapy|Started New Cancer Drug|0|||
163254742|NCT02712905|589639098|FG014|Monotherapy|Started New Cancer Drug|0|||
163254743|NCT02712905|589639099|FG015|Monotherapy|Started New Cancer Drug|0|||
163254744|NCT02712905|589639100|FG016|Monotherapy|Started New Cancer Drug|0|||
163254745|NCT02712905|589639101|FG017|Monotherapy|Started New Cancer Drug|0|||
163254746|NCT02712905|589639084|FG000|Monotherapy|Adverse Event|0|||
163254747|NCT02712905|589639085|FG001|Monotherapy|Adverse Event|0|||
163254748|NCT02712905|589639086|FG002|Monotherapy|Adverse Event|0|||
163254749|NCT02712905|589639087|FG003|Monotherapy|Adverse Event|0|||
163254750|NCT02712905|589639088|FG004|Monotherapy|Adverse Event|0|||
163254751|NCT02712905|589639089|FG005|Monotherapy|Adverse Event|0|||
163254752|NCT02712905|589639090|FG006|Monotherapy|Adverse Event|0|||
163254753|NCT02712905|589639091|FG007|Monotherapy|Adverse Event|0|||
163254754|NCT02712905|589639092|FG008|Monotherapy|Adverse Event|1|||
163254755|NCT02712905|589639093|FG009|Monotherapy|Adverse Event|0|||
163254756|NCT02712905|589639094|FG010|Monotherapy|Adverse Event|0|||
163254757|NCT02712905|589639095|FG011|Monotherapy|Adverse Event|0|||
163254758|NCT02712905|589639096|FG012|Monotherapy|Adverse Event|0|||
163254759|NCT02712905|589639097|FG013|Monotherapy|Adverse Event|0|||
163254760|NCT02712905|589639098|FG014|Monotherapy|Adverse Event|0|||
163254761|NCT02712905|589639099|FG015|Monotherapy|Adverse Event|0|||
163254762|NCT02712905|589639100|FG016|Monotherapy|Adverse Event|0|||
163254763|NCT02712905|589639101|FG017|Monotherapy|Adverse Event|0|||
163254764|NCT02712905|589639084|FG000|Combination Therapy|Death|0|||
163254765|NCT02712905|589639085|FG001|Combination Therapy|Death|0|||
163254766|NCT02712905|589639086|FG002|Combination Therapy|Death|0|||
163254767|NCT02712905|589639087|FG003|Combination Therapy|Death|0|||
163254768|NCT02712905|589639088|FG004|Combination Therapy|Death|0|||
163254769|NCT02712905|589639089|FG005|Combination Therapy|Death|0|||
163254770|NCT02712905|589639090|FG006|Combination Therapy|Death|0|||
163254771|NCT02712905|589639091|FG007|Combination Therapy|Death|0|||
163254772|NCT02712905|589639092|FG008|Combination Therapy|Death|0|||
163254773|NCT02712905|589639093|FG009|Combination Therapy|Death|0|||
163254774|NCT02712905|589639094|FG010|Combination Therapy|Death|0|||
163254775|NCT02712905|589639095|FG011|Combination Therapy|Death|0|||
163254776|NCT02712905|589639096|FG012|Combination Therapy|Death|5|||
163254777|NCT02712905|589639097|FG013|Combination Therapy|Death|6|||
163254778|NCT02712905|589639098|FG014|Combination Therapy|Death|1|||
163254779|NCT02712905|589639099|FG015|Combination Therapy|Death|3|||
163254780|NCT02712905|589639100|FG016|Combination Therapy|Death|1|||
163254781|NCT02712905|589639101|FG017|Combination Therapy|Death|3|||
163254782|NCT02712905|589639084|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
163254783|NCT02712905|589639085|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
163254784|NCT02712905|589639086|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
163254785|NCT02712905|589639087|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
163254786|NCT02712905|589639088|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
163254787|NCT02712905|589639089|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
163254788|NCT02712905|589639090|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
163254789|NCT02712905|589639091|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
163254790|NCT02712905|589639092|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
163254791|NCT02712905|589639093|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
163254792|NCT02712905|589639094|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
163254793|NCT02712905|589639095|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
163254794|NCT02712905|589639096|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
163254795|NCT02712905|589639097|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
163254796|NCT02712905|589639098|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
163254797|NCT02712905|589639099|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
163254798|NCT02712905|589639100|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
163254799|NCT02712905|589639101|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
163254800|NCT02712905|589639084|FG000|Combination Therapy|Withdrawal by Subject|0|||
163254801|NCT02712905|589639085|FG001|Combination Therapy|Withdrawal by Subject|0|||
163254802|NCT02712905|589639086|FG002|Combination Therapy|Withdrawal by Subject|0|||
163254803|NCT02712905|589639087|FG003|Combination Therapy|Withdrawal by Subject|0|||
163254804|NCT02712905|589639088|FG004|Combination Therapy|Withdrawal by Subject|0|||
163254805|NCT02712905|589639089|FG005|Combination Therapy|Withdrawal by Subject|0|||
163254806|NCT02712905|589639090|FG006|Combination Therapy|Withdrawal by Subject|0|||
163254807|NCT02712905|589639091|FG007|Combination Therapy|Withdrawal by Subject|0|||
163254808|NCT02712905|589639092|FG008|Combination Therapy|Withdrawal by Subject|0|||
163254809|NCT02712905|589639093|FG009|Combination Therapy|Withdrawal by Subject|0|||
163254810|NCT02712905|589639094|FG010|Combination Therapy|Withdrawal by Subject|0|||
163254811|NCT02712905|589639095|FG011|Combination Therapy|Withdrawal by Subject|0|||
163254812|NCT02712905|589639096|FG012|Combination Therapy|Withdrawal by Subject|0|||
163254813|NCT02712905|589639097|FG013|Combination Therapy|Withdrawal by Subject|0|||
163254814|NCT02712905|589639098|FG014|Combination Therapy|Withdrawal by Subject|0|||
163254815|NCT02712905|589639099|FG015|Combination Therapy|Withdrawal by Subject|1|||
163254816|NCT02712905|589639100|FG016|Combination Therapy|Withdrawal by Subject|0|||
163254817|NCT02712905|589639101|FG017|Combination Therapy|Withdrawal by Subject|2|||
163254818|NCT02712905|589639084|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163254819|NCT02712905|589639085|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163254820|NCT02712905|589639086|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163254821|NCT02712905|589639087|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163254822|NCT02712905|589639088|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163254823|NCT02712905|589639089|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163254824|NCT02712905|589639090|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163254825|NCT02712905|589639091|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163254826|NCT02712905|589639092|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163358335|NCT03912662|590021388|FG000|Overall Study|Early study termination|20|||
163358336|NCT03845140|590021389|FG000|Overall Study|Participant travelled outside study area|0|||
163358337|NCT03845140|590021390|FG001|Overall Study|Participant travelled outside study area|1|||
163358338|NCT03845140|590021391|FG002|Overall Study|Participant travelled outside study area|0|||
163358339|NCT03845140|590021392|FG003|Overall Study|Participant travelled outside study area|0|||
163358340|NCT03845140|590021393|FG004|Overall Study|Participant travelled outside study area|0|||
163358341|NCT03845140|590021394|FG005|Overall Study|Participant travelled outside study area|0|||
163358342|NCT01592045|590021395|FG000|Overall Study|Disease Progression|1|||
163358343|NCT01592045|590021396|FG001|Overall Study|Disease Progression|1|||
163358344|NCT01592045|590021395|FG000|Overall Study|Adverse Event|1|||
163358345|NCT01592045|590021396|FG001|Overall Study|Adverse Event|1|||
163358346|NCT01592045|590021395|FG000|Overall Study|Withdrawal by Subject|1|||
163358347|NCT01592045|590021396|FG001|Overall Study|Withdrawal by Subject|0|||
163358348|NCT01592045|590021395|FG000|Overall Study|Moved out of country|2|||
163358349|NCT01592045|590021396|FG001|Overall Study|Moved out of country|0|||
163358350|NCT01790295|590021399|FG000|Overall Study|Adverse Event|1|||
163358351|NCT01790295|590021399|FG000|Overall Study|Death|4|||
163358352|NCT01790295|590021399|FG000|Overall Study|Lack of Efficacy|2|||
163358353|NCT01790295|590021399|FG000|Overall Study|Study closure|4|||
163358354|NCT03721705|590021400|FG000|Overall Study|Adverse Event|2|||
163358355|NCT03721705|590021401|FG001|Overall Study|Adverse Event|0|||
163358356|NCT03721705|590021400|FG000|Overall Study|Withdrawal by Subject|4|||
163358357|NCT03721705|590021401|FG001|Overall Study|Withdrawal by Subject|10|||
163358358|NCT03721705|590021400|FG000|Overall Study|No Suitable Study Partner|1|||
163358359|NCT03721705|590021401|FG001|Overall Study|No Suitable Study Partner|0|||
163358360|NCT03721705|590021400|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
163358361|NCT03721705|590021401|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
163358362|NCT03721705|590021400|FG000|Overall Study|Death|0|||
163358363|NCT03721705|590021401|FG001|Overall Study|Death|1|||
163254827|NCT02712905|589639093|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163254828|NCT02712905|589639094|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163254829|NCT02712905|589639095|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163358364|NCT01843777|590021402|FG000|Overall Study|Withdrawal by Subject|1|||
163358365|NCT01843777|590021403|FG001|Overall Study|Withdrawal by Subject|0|||
163358366|NCT00420784|590021409|FG000|Overall Study|Adverse Event|11|||
163358367|NCT00420784|590021410|FG001|Overall Study|Adverse Event|29|||
163358368|NCT00420784|590021411|FG002|Overall Study|Adverse Event|10|||
163358369|NCT00420784|590021412|FG003|Overall Study|Adverse Event|5|||
163358370|NCT00420784|590021409|FG000|Overall Study|Withdrawal by Subject|0|||
163358371|NCT00420784|590021410|FG001|Overall Study|Withdrawal by Subject|1|||
163358372|NCT00420784|590021411|FG002|Overall Study|Withdrawal by Subject|0|||
163358373|NCT00420784|590021412|FG003|Overall Study|Withdrawal by Subject|0|||
163358374|NCT00420784|590021409|FG000|Overall Study|Lost to Follow-up|0|||
163358375|NCT00420784|590021410|FG001|Overall Study|Lost to Follow-up|0|||
163358376|NCT00420784|590021411|FG002|Overall Study|Lost to Follow-up|2|||
163358377|NCT00420784|590021412|FG003|Overall Study|Lost to Follow-up|1|||
163358378|NCT00420784|590021409|FG000|Overall Study|Virologic Stopping Rule|17|||
163358379|NCT00420784|590021410|FG001|Overall Study|Virologic Stopping Rule|26|||
163358380|NCT00420784|590021411|FG002|Overall Study|Virologic Stopping Rule|41|||
163358381|NCT00420784|590021412|FG003|Overall Study|Virologic Stopping Rule|67|||
163358382|NCT00420784|590021409|FG000|Overall Study|Other|1|||
163358383|NCT00420784|590021410|FG001|Overall Study|Other|2|||
163358384|NCT00420784|590021411|FG002|Overall Study|Other|0|||
163358385|NCT00420784|590021412|FG003|Overall Study|Other|5|||
163358386|NCT02599688|590021415|FG000|Overall Study|Lack of Efficacy|1|||
163358387|NCT02599688|590021415|FG000|Overall Study|Withdrawal by Subject|1|||
163358388|NCT02599688|590021415|FG000|Overall Study|Termination by Sponsor|2|||
163254830|NCT02712905|589639096|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163254831|NCT02712905|589639097|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163254832|NCT02712905|589639098|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163254833|NCT02712905|589639099|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
163254834|NCT02712905|589639100|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163254835|NCT02712905|589639101|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163254836|NCT03624504|589639102|FG000|Overall Study|Unsuccessful Implant|1|||
163358389|NCT02947100|590021421|FG000|Overall Study|study terminated early|3|||
163358390|NCT02947100|590021421|FG000|Overall Study|did not meet inclusion criteria|1|||
163358391|NCT02402322|590021422|FG000|Pretreatment|Withdrawal by Subject|3|||
163358392|NCT02402322|590021423|FG001|Pretreatment|Withdrawal by Subject|1|||
163358393|NCT02402322|590021424|FG002|Pretreatment|Withdrawal by Subject|1|||
163358394|NCT02402322|590021422|FG000|Follow-up|Withdrawal by Subject|6|||
163358395|NCT02402322|590021423|FG001|Follow-up|Withdrawal by Subject|3|||
163358396|NCT02402322|590021424|FG002|Follow-up|Withdrawal by Subject|24|||
163358397|NCT02818998|590021425|FG000|Overall Study|Adverse Event|3|||
163358398|NCT02818998|590021426|FG001|Overall Study|Adverse Event|2|||
163358399|NCT02818998|590021427|FG002|Overall Study|Adverse Event|1|||
163358400|NCT02818998|590021425|FG000|Overall Study|Lost to Follow-up|4|||
163358401|NCT02818998|590021426|FG001|Overall Study|Lost to Follow-up|1|||
163358402|NCT02818998|590021427|FG002|Overall Study|Lost to Follow-up|2|||
163358403|NCT02818998|590021425|FG000|Overall Study|Withdrawal by sponsor|0|||
163358404|NCT02818998|590021426|FG001|Overall Study|Withdrawal by sponsor|1|||
163358405|NCT02818998|590021427|FG002|Overall Study|Withdrawal by sponsor|1|||
163358406|NCT02818998|590021425|FG000|Overall Study|Death|3|||
163358407|NCT02818998|590021426|FG001|Overall Study|Death|6|||
163358408|NCT02818998|590021427|FG002|Overall Study|Death|8|||
163358409|NCT02818998|590021425|FG000|Overall Study|Withdrawal by Subject|7|||
163358410|NCT02818998|590021426|FG001|Overall Study|Withdrawal by Subject|6|||
163358411|NCT02818998|590021427|FG002|Overall Study|Withdrawal by Subject|6|||
163358412|NCT02818998|590021425|FG000|Overall Study|Physician Decision|1|||
163358413|NCT02818998|590021426|FG001|Overall Study|Physician Decision|0|||
163358414|NCT02818998|590021427|FG002|Overall Study|Physician Decision|0|||
163358415|NCT00632021|590021431|FG000|Overall Study|Withdrawal/death|4|||
163358416|NCT00632021|590021432|FG001|Overall Study|Withdrawal/death|7|||
163358417|NCT00443209|590021433|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
163358418|NCT00443209|590021434|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
163358419|NCT00443209|590021433|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
163358420|NCT00443209|590021434|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
163358421|NCT00443209|590021433|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
163358422|NCT00443209|590021434|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
163358423|NCT00443209|590021433|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
163358424|NCT00443209|590021434|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
163358425|NCT00443209|590021433|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
163358426|NCT00443209|590021434|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
163358427|NCT00443209|590021433|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
163358428|NCT00443209|590021434|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
163358429|NCT00443209|590021433|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
163358430|NCT00443209|590021434|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
163358431|NCT00443209|590021433|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
163358432|NCT00443209|590021434|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
163358433|NCT00443209|590021433|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
163358434|NCT00443209|590021434|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
163358435|NCT00443209|590021433|FG000|Months 1 to 12 Treatment Period|Missing|2|||
163358436|NCT00443209|590021434|FG001|Months 1 to 12 Treatment Period|Missing|1|||
163358437|NCT00443209|590021433|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
163358438|NCT00443209|590021434|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
163358439|NCT00443209|590021433|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
163358440|NCT00443209|590021434|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
163358441|NCT00443209|590021433|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
163358442|NCT00443209|590021434|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
163358443|NCT00443209|590021433|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
163358444|NCT00443209|590021434|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
163358445|NCT00443209|590021433|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
163358446|NCT00443209|590021434|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
163358447|NCT00443209|590021433|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
163358448|NCT00443209|590021434|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
163358449|NCT00443209|590021433|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
163358450|NCT00443209|590021434|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
163358451|NCT01318876|590021435|FG000|Day 8 Survey|email address invalid|96|||
163358452|NCT01318876|590021435|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
163358453|NCT01318876|590021435|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
163358454|NCT02250534|590021438|FG000|Overall Study|Lost to Follow-up|18|||
163358455|NCT02250534|590021439|FG001|Overall Study|Lost to Follow-up|28|||
163358456|NCT02250534|590021440|FG002|Overall Study|Lost to Follow-up|33|||
163358457|NCT02250534|590021438|FG000|Overall Study|Personal reasons|7|||
163358458|NCT02250534|590021439|FG001|Overall Study|Personal reasons|8|||
163358459|NCT02250534|590021440|FG002|Overall Study|Personal reasons|14|||
163358460|NCT02250534|590021438|FG000|Overall Study|Adverse Event|6|||
163358461|NCT02250534|590021439|FG001|Overall Study|Adverse Event|3|||
163358462|NCT02250534|590021440|FG002|Overall Study|Adverse Event|8|||
163358463|NCT02250534|590021438|FG000|Overall Study|incarcerated|2|||
163358464|NCT02250534|590021439|FG001|Overall Study|incarcerated|1|||
163358465|NCT02250534|590021440|FG002|Overall Study|incarcerated|2|||
163358466|NCT02250534|590021438|FG000|Overall Study|Withdrawal by Subject|0|||
163358467|NCT02250534|590021439|FG001|Overall Study|Withdrawal by Subject|1|||
163358468|NCT02250534|590021440|FG002|Overall Study|Withdrawal by Subject|2|||
163358469|NCT02250534|590021438|FG000|Overall Study|Death|0|||
163358470|NCT02250534|590021439|FG001|Overall Study|Death|1|||
163358471|NCT02250534|590021440|FG002|Overall Study|Death|1|||
163358472|NCT02250534|590021438|FG000|Overall Study|Physician Decision|1|||
163254837|NCT02975973|589639103|FG000|Overall Study|Adverse Event|1|||
163254838|NCT02975973|589639104|FG001|Overall Study|Adverse Event|1|||
163254839|NCT02975973|589639105|FG002|Overall Study|Adverse Event|1|||
163254840|NCT02975973|589639106|FG003|Overall Study|Adverse Event|0|||
163254841|NCT01812655|589639107|FG000|Overall Study|Protocol Violation|1|||
163254842|NCT01812655|589639108|FG001|Overall Study|Protocol Violation|1|||
163254843|NCT01812655|589639109|FG002|Overall Study|Protocol Violation|0|||
163254844|NCT01428076|589639110|FG000|Overall Study|Adverse Event|0|||
163254845|NCT01428076|589639111|FG001|Overall Study|Adverse Event|1|||
163254846|NCT04435665|589639112|FG000|Overall Study|Lost to Follow-up|0|||
163254847|NCT04435665|589639113|FG001|Overall Study|Lost to Follow-up|0|||
163254848|NCT04435665|589639114|FG002|Overall Study|Lost to Follow-up|0|||
163254849|NCT04435665|589639115|FG003|Overall Study|Lost to Follow-up|1|||
163254850|NCT02454101|589639116|FG000|Overall Study|Adverse Event|2|||
163254851|NCT02454101|589639117|FG001|Overall Study|Adverse Event|3|||
163254852|NCT02454101|589639116|FG000|Overall Study|Lost to Follow-up|3|||
163254853|NCT02454101|589639117|FG001|Overall Study|Lost to Follow-up|4|||
163254854|NCT00419263|589639118|FG000|Overall Study|Lost to Follow-up|2|||
163254855|NCT00419263|589639119|FG001|Overall Study|Lost to Follow-up|1|||
163358473|NCT02250534|590021439|FG001|Overall Study|Physician Decision|3|||
163254856|NCT00419263|589639120|FG002|Overall Study|Lost to Follow-up|1|||
163254857|NCT00419263|589639118|FG000|Overall Study|Randomized in Error, Not Treated|1|||
163358474|NCT02250534|590021440|FG002|Overall Study|Physician Decision|1|||
163358475|NCT02250534|590021438|FG000|Overall Study|Protocol Violation|1|||
163358476|NCT02250534|590021439|FG001|Overall Study|Protocol Violation|0|||
163358477|NCT02250534|590021440|FG002|Overall Study|Protocol Violation|1|||
163358478|NCT02250534|590021438|FG000|Overall Study|Reason unknown|1|||
163358479|NCT02250534|590021439|FG001|Overall Study|Reason unknown|0|||
163358480|NCT02250534|590021440|FG002|Overall Study|Reason unknown|0|||
163358481|NCT01628692|590021441|FG000|Overall Study|Lack of Efficacy|4|||
163151394|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
163151395|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
163151396|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
163151397|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
163151398|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
163151399|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
163151400|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
163151401|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
163151402|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
163151403|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
163151404|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
163151405|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
163151406|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
163151407|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
163151408|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
163151409|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
163254858|NCT00419263|589639119|FG001|Overall Study|Randomized in Error, Not Treated|1|||
163254859|NCT00419263|589639120|FG002|Overall Study|Randomized in Error, Not Treated|0|||
163254860|NCT00419263|589639118|FG000|Overall Study|Adverse Event|0|||
163254861|NCT00419263|589639119|FG001|Overall Study|Adverse Event|0|||
163254862|NCT00419263|589639120|FG002|Overall Study|Adverse Event|1|||
163254863|NCT00419263|589639118|FG000|Overall Study|Withdrawal by Subject|0|||
163254864|NCT00419263|589639119|FG001|Overall Study|Withdrawal by Subject|0|||
163254865|NCT00419263|589639120|FG002|Overall Study|Withdrawal by Subject|1|||
163151410|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
163254866|NCT00540124|589639124|FG000|Overall Study|Adverse Event|0|||
163254867|NCT00540124|589639125|FG001|Overall Study|Adverse Event|2|||
163254868|NCT00540124|589639126|FG002|Overall Study|Adverse Event|1|||
163254869|NCT00540124|589639124|FG000|Overall Study|Entry Criteria Not Met|2|||
163254870|NCT00540124|589639125|FG001|Overall Study|Entry Criteria Not Met|0|||
163254871|NCT00540124|589639126|FG002|Overall Study|Entry Criteria Not Met|0|||
163151411|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
163151412|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
163151413|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
163151414|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163151415|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
163151416|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
163358482|NCT01628692|590021442|FG001|Overall Study|Lack of Efficacy|4|||
163358483|NCT01628692|590021443|FG002|Overall Study|Lack of Efficacy|5|||
163254872|NCT00540124|589639124|FG000|Overall Study|Lack of Efficacy|1|||
163254873|NCT00540124|589639125|FG001|Overall Study|Lack of Efficacy|0|||
163254874|NCT00540124|589639126|FG002|Overall Study|Lack of Efficacy|0|||
163254875|NCT00540124|589639124|FG000|Overall Study|Withdrawal by Subject|1|||
163410488|NCT05103332|590211368|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163410489|NCT05103332|590211369|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163410490|NCT05103332|590211370|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163410491|NCT05103332|590211371|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163410492|NCT05103332|590211372|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163410493|NCT05103332|590211373|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163410494|NCT05103332|590211374|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163410495|NCT05103332|590211375|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163410496|NCT05103332|590211376|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
163410497|NCT05103332|590211359|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410498|NCT05103332|590211360|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410499|NCT05103332|590211361|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410500|NCT05103332|590211362|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410501|NCT05103332|590211363|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410502|NCT05103332|590211364|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410503|NCT05103332|590211365|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410504|NCT05103332|590211366|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410505|NCT05103332|590211367|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410506|NCT05103332|590211368|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410507|NCT05103332|590211369|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410508|NCT05103332|590211370|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163410509|NCT05103332|590211371|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
163410510|NCT05103332|590211372|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
163410511|NCT05103332|590211373|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
163410512|NCT05103332|590211374|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
163410513|NCT05103332|590211375|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
163410514|NCT05103332|590211376|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
163410515|NCT05103332|590211359|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163410516|NCT05103332|590211360|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163410517|NCT05103332|590211361|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163410518|NCT05103332|590211362|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163410519|NCT05103332|590211363|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163410520|NCT05103332|590211364|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163410521|NCT05103332|590211365|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163410522|NCT05103332|590211366|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163410523|NCT05103332|590211367|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163410524|NCT05103332|590211368|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163410525|NCT05103332|590211369|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163410526|NCT05103332|590211370|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163410527|NCT05103332|590211371|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163410528|NCT05103332|590211372|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163410529|NCT05103332|590211373|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
163410530|NCT05103332|590211374|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
163410531|NCT05103332|590211375|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163410532|NCT05103332|590211376|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
163410533|NCT05103332|590211359|FG000|SFU Period (6 Months=168 Days)|Death|0|||
163410534|NCT05103332|590211360|FG001|SFU Period (6 Months=168 Days)|Death|0|||
163410535|NCT05103332|590211361|FG002|SFU Period (6 Months=168 Days)|Death|0|||
163410536|NCT05103332|590211362|FG003|SFU Period (6 Months=168 Days)|Death|0|||
163410537|NCT05103332|590211363|FG004|SFU Period (6 Months=168 Days)|Death|0|||
163410538|NCT05103332|590211364|FG005|SFU Period (6 Months=168 Days)|Death|0|||
163410539|NCT05103332|590211365|FG006|SFU Period (6 Months=168 Days)|Death|0|||
163410540|NCT05103332|590211366|FG007|SFU Period (6 Months=168 Days)|Death|0|||
163410541|NCT05103332|590211367|FG008|SFU Period (6 Months=168 Days)|Death|0|||
163410542|NCT05103332|590211368|FG009|SFU Period (6 Months=168 Days)|Death|0|||
163358484|NCT01628692|590021444|FG003|Overall Study|Lack of Efficacy|1|||
163358485|NCT01628692|590021445|FG004|Overall Study|Lack of Efficacy|4|||
163358486|NCT01628692|590021446|FG005|Overall Study|Lack of Efficacy|7|||
163358487|NCT01628692|590021441|FG000|Overall Study|Adverse Event|2|||
163358488|NCT01628692|590021442|FG001|Overall Study|Adverse Event|0|||
163358489|NCT01628692|590021443|FG002|Overall Study|Adverse Event|2|||
163358490|NCT01628692|590021444|FG003|Overall Study|Adverse Event|0|||
163358491|NCT01628692|590021445|FG004|Overall Study|Adverse Event|0|||
163358492|NCT01628692|590021446|FG005|Overall Study|Adverse Event|0|||
163410543|NCT05103332|590211369|FG010|SFU Period (6 Months=168 Days)|Death|0|||
163410544|NCT05103332|590211370|FG011|SFU Period (6 Months=168 Days)|Death|0|||
163358493|NCT01628692|590021441|FG000|Overall Study|Withdrawal by Subject|0|||
163358494|NCT01628692|590021442|FG001|Overall Study|Withdrawal by Subject|1|||
163358495|NCT01628692|590021443|FG002|Overall Study|Withdrawal by Subject|1|||
163358496|NCT01628692|590021444|FG003|Overall Study|Withdrawal by Subject|0|||
163358497|NCT01628692|590021445|FG004|Overall Study|Withdrawal by Subject|0|||
163358498|NCT01628692|590021446|FG005|Overall Study|Withdrawal by Subject|0|||
163358499|NCT01628692|590021441|FG000|Overall Study|Death|0|||
163358500|NCT01628692|590021442|FG001|Overall Study|Death|1|||
163358501|NCT01628692|590021443|FG002|Overall Study|Death|0|||
163358502|NCT01628692|590021444|FG003|Overall Study|Death|0|||
163358503|NCT01628692|590021445|FG004|Overall Study|Death|0|||
163358504|NCT01628692|590021446|FG005|Overall Study|Death|0|||
163358505|NCT01628692|590021441|FG000|Overall Study|Poor compliance/noncompliance|1|||
163358506|NCT01628692|590021442|FG001|Overall Study|Poor compliance/noncompliance|0|||
163358507|NCT01628692|590021443|FG002|Overall Study|Poor compliance/noncompliance|0|||
163358508|NCT01628692|590021444|FG003|Overall Study|Poor compliance/noncompliance|0|||
163358509|NCT01628692|590021445|FG004|Overall Study|Poor compliance/noncompliance|0|||
163358510|NCT01628692|590021446|FG005|Overall Study|Poor compliance/noncompliance|0|||
163358511|NCT01628692|590021441|FG000|Overall Study|Administrative reason by sponsor|0|||
163358512|NCT01628692|590021442|FG001|Overall Study|Administrative reason by sponsor|0|||
163358513|NCT01628692|590021443|FG002|Overall Study|Administrative reason by sponsor|0|||
163358514|NCT01628692|590021444|FG003|Overall Study|Administrative reason by sponsor|0|||
163358515|NCT01628692|590021445|FG004|Overall Study|Administrative reason by sponsor|0|||
163358516|NCT01628692|590021446|FG005|Overall Study|Administrative reason by sponsor|1|||
163358517|NCT01628692|590021441|FG000|Overall Study|Completed 12 Week only|0|||
163358518|NCT01628692|590021442|FG001|Overall Study|Completed 12 Week only|0|||
163358519|NCT01628692|590021443|FG002|Overall Study|Completed 12 Week only|0|||
163358520|NCT01628692|590021444|FG003|Overall Study|Completed 12 Week only|0|||
163358521|NCT01628692|590021445|FG004|Overall Study|Completed 12 Week only|0|||
163358522|NCT01628692|590021446|FG005|Overall Study|Completed 12 Week only|1|||
163358523|NCT02437071|590021447|FG000|Overall Study|Withdrawal by Subject|1|||
163358524|NCT02437071|590021448|FG001|Overall Study|Withdrawal by Subject|0|||
163358525|NCT01587118|590021451|FG000|Overall Study|Adverse Event|3|||
163358526|NCT01587118|590021451|FG000|Overall Study|Lost to Follow-up|2|||
163358527|NCT01587118|590021451|FG000|Overall Study|Relocation|1|||
163358528|NCT01587118|590021451|FG000|Overall Study|nonresponse|1|||
163358529|NCT00537329|590021452|FG000|Overall Study|Death|10|||
163358530|NCT00537329|590021452|FG000|Overall Study|Adverse Event|3|||
163358531|NCT00537329|590021452|FG000|Overall Study|Lack of Efficacy|2|||
163358532|NCT00537329|590021452|FG000|Overall Study|Lost to Follow-up|6|||
163358533|NCT00537329|590021452|FG000|Overall Study|Withdrawal by Subject|4|||
163358534|NCT00537329|590021452|FG000|Overall Study|Other|1|||
163358535|NCT02049515|590021453|FG000|Overall Study|Adverse Event|46|||
163358536|NCT02049515|590021454|FG001|Overall Study|Adverse Event|2|||
163358537|NCT02049515|590021453|FG000|Overall Study|Protocol-specified Disease Progression|23|||
163358538|NCT02049515|590021454|FG001|Overall Study|Protocol-specified Disease Progression|2|||
163358539|NCT02049515|590021453|FG000|Overall Study|Death|6|||
163358540|NCT02049515|590021454|FG001|Overall Study|Death|0|||
163358541|NCT02049515|590021453|FG000|Overall Study|Physician Decision|5|||
163358542|NCT02049515|590021454|FG001|Overall Study|Physician Decision|1|||
163358543|NCT02049515|590021453|FG000|Overall Study|Withdrawal by Subject|3|||
163358544|NCT02049515|590021454|FG001|Overall Study|Withdrawal by Subject|0|||
163358545|NCT02049515|590021453|FG000|Overall Study|Termination of the Study by Sponsor|2|||
163358546|NCT02049515|590021454|FG001|Overall Study|Termination of the Study by Sponsor|0|||
163358547|NCT02049515|590021453|FG000|Overall Study|Protocol Violation|1|||
163358548|NCT02049515|590021454|FG001|Overall Study|Protocol Violation|1|||
163358549|NCT02049515|590021453|FG000|Overall Study|Clinical Deterioration|1|||
163358550|NCT02049515|590021454|FG001|Overall Study|Clinical Deterioration|0|||
163358551|NCT02049515|590021453|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
163358552|NCT02049515|590021454|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
163358553|NCT02049515|590021453|FG000|Overall Study|Treatment Interruption >42 Days|1|||
163358554|NCT02049515|590021454|FG001|Overall Study|Treatment Interruption >42 Days|0|||
163358555|NCT02049515|590021453|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
163358556|NCT02049515|590021454|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
163358557|NCT00224029|590021458|FG000|Overall Study|Lost to Follow-up|1|||
163358558|NCT00224029|590021458|FG000|Overall Study|Withdrawal by Subject|4|||
163358559|NCT00224029|590021458|FG000|Overall Study|Other|1|||
163358560|NCT00243022|590021459|FG000|Overall Study|Withdrawal by Subject|1|||
163358561|NCT00243022|590021460|FG001|Overall Study|Withdrawal by Subject|0|||
163358562|NCT00243022|590021459|FG000|Overall Study|Death|1|||
163358563|NCT00243022|590021460|FG001|Overall Study|Death|0|||
163358564|NCT00243022|590021459|FG000|Overall Study|Difficult Travel Distance|0|||
163358565|NCT00243022|590021460|FG001|Overall Study|Difficult Travel Distance|1|||
163151417|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163358566|NCT01099579|590021461|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
163358567|NCT01099579|590021462|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
163358568|NCT01099579|590021463|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
163358569|NCT01099579|590021461|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
163358570|NCT01099579|590021462|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
163358571|NCT01099579|590021463|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
163358572|NCT01099579|590021461|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
163358573|NCT01099579|590021462|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
163358574|NCT01099579|590021463|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
163358575|NCT01099579|590021461|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
163358576|NCT01099579|590021462|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
163358577|NCT01099579|590021463|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
163358578|NCT01099579|590021461|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
163358579|NCT01099579|590021462|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
163358580|NCT01099579|590021463|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
163358581|NCT01099579|590021461|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
163358582|NCT01099579|590021462|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
163358583|NCT01099579|590021463|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
163358584|NCT01099579|590021461|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
163358585|NCT01099579|590021462|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
163358586|NCT01099579|590021463|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
163358587|NCT01099579|590021461|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
163358588|NCT01099579|590021462|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
163254876|NCT00540124|589639125|FG001|Overall Study|Withdrawal by Subject|1|||
163254877|NCT00540124|589639126|FG002|Overall Study|Withdrawal by Subject|0|||
163254878|NCT02124265|589639127|FG000|Overall Study|Adverse Event|1|||
163254879|NCT00058123|589639128|FG000|Overall Study|Wrong histology|9|||
163254880|NCT00058123|589639128|FG000|Overall Study|Received >3 prior treatments|1|||
163254881|NCT00344461|589639131|FG000|Overall Study|Adverse Event|6|||
163254882|NCT00344461|589639131|FG000|Overall Study|Death|1|||
163254883|NCT00344461|589639131|FG000|Overall Study|Lack of Efficacy|2|||
163254884|NCT00344461|589639131|FG000|Overall Study|Lost to Follow-up|2|||
163254885|NCT00344461|589639131|FG000|Overall Study|Physician Decision|2|||
163254886|NCT00344461|589639131|FG000|Overall Study|Protocol Violation|6|||
163254887|NCT00344461|589639131|FG000|Overall Study|Withdrawal by Subject|2|||
163254888|NCT04839965|589639134|FG000|Overall Study|Death|6|||
163254889|NCT04839965|589639135|FG001|Overall Study|Death|6|||
163254890|NCT04839965|589639134|FG000|Overall Study|Lost to Follow-up|1|||
163254891|NCT04839965|589639135|FG001|Overall Study|Lost to Follow-up|0|||
163254892|NCT02291679|589639136|FG000|Overall Study|Adverse Event|2|||
163254893|NCT02291679|589639137|FG001|Overall Study|Adverse Event|12|||
163254894|NCT02291679|589639138|FG002|Overall Study|Adverse Event|19|||
163254895|NCT02291679|589639136|FG000|Overall Study|Protocol Violation|5|||
163254896|NCT02291679|589639137|FG001|Overall Study|Protocol Violation|1|||
163254897|NCT02291679|589639138|FG002|Overall Study|Protocol Violation|7|||
163254898|NCT02291679|589639136|FG000|Overall Study|Withdrew Consent|18|||
163254899|NCT02291679|589639137|FG001|Overall Study|Withdrew Consent|10|||
163254900|NCT02291679|589639138|FG002|Overall Study|Withdrew Consent|15|||
163254901|NCT02291679|589639136|FG000|Overall Study|Lost to Follow-up|12|||
163254902|NCT02291679|589639137|FG001|Overall Study|Lost to Follow-up|10|||
163254903|NCT02291679|589639138|FG002|Overall Study|Lost to Follow-up|9|||
163254904|NCT02291679|589639136|FG000|Overall Study|Insufficient Therapeutic Response|5|||
163254905|NCT02291679|589639137|FG001|Overall Study|Insufficient Therapeutic Response|5|||
163254906|NCT02291679|589639138|FG002|Overall Study|Insufficient Therapeutic Response|7|||
163254907|NCT02291679|589639136|FG000|Overall Study|Other|2|||
163254908|NCT02291679|589639137|FG001|Overall Study|Other|4|||
163254909|NCT02291679|589639138|FG002|Overall Study|Other|2|||
163254910|NCT02355028|589639139|FG000|Overall Study|Adverse Event|2|||
163254911|NCT02355028|589639140|FG001|Overall Study|Adverse Event|0|||
163254912|NCT02355028|589639139|FG000|Overall Study|Withdrawal by Subject|1|||
163254913|NCT02355028|589639140|FG001|Overall Study|Withdrawal by Subject|1|||
163254914|NCT02355028|589639139|FG000|Overall Study|Deemed ineligible after randomization|8|||
163254915|NCT02355028|589639140|FG001|Overall Study|Deemed ineligible after randomization|4|||
163254916|NCT02276222|589639141|FG000|Overall Study|Adverse Event|62|||
163254917|NCT02276222|589639142|FG001|Overall Study|Adverse Event|11|||
163254918|NCT02276222|589639141|FG000|Overall Study|Death|3|||
163254919|NCT02276222|589639142|FG001|Overall Study|Death|4|||
163254920|NCT02276222|589639141|FG000|Overall Study|Lack of Efficacy|13|||
163254921|NCT02276222|589639142|FG001|Overall Study|Lack of Efficacy|3|||
163254922|NCT02276222|589639141|FG000|Overall Study|Protocol Violation|3|||
163254923|NCT02276222|589639142|FG001|Overall Study|Protocol Violation|2|||
163254924|NCT02276222|589639141|FG000|Overall Study|Withdrawal by Subject|79|||
163254925|NCT02276222|589639142|FG001|Overall Study|Withdrawal by Subject|33|||
163254926|NCT02276222|589639141|FG000|Overall Study|non compliance with study medication|6|||
163254927|NCT02276222|589639142|FG001|Overall Study|non compliance with study medication|2|||
163254928|NCT02276222|589639141|FG000|Overall Study|sponsor decision|0|||
163254929|NCT02276222|589639142|FG001|Overall Study|sponsor decision|3|||
163254930|NCT02276222|589639141|FG000|Overall Study|Lost to Follow-up|15|||
163358589|NCT01099579|590021463|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
163358590|NCT01099579|590021461|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
163358591|NCT01099579|590021462|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
163358592|NCT01099579|590021463|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
163358593|NCT01099579|590021461|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
163358594|NCT01099579|590021462|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
163358595|NCT01099579|590021463|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
163358596|NCT02569957|590021464|FG000|Overall Study|Withdrawal by Subject|0|||
163358597|NCT02569957|590021465|FG001|Overall Study|Withdrawal by Subject|1|||
163358598|NCT03513068|590021466|FG000|Overall Study|Death|1|||
163358599|NCT03513068|590021467|FG001|Overall Study|Death|0|||
163358600|NCT03513068|590021466|FG000|Overall Study|Withdrawal by Subject|4|||
163358601|NCT03513068|590021467|FG001|Overall Study|Withdrawal by Subject|6|||
163358602|NCT03636373|590021469|FG000|Overall Study|Study closure due to Covid-19|1|||
163358603|NCT03636373|590021470|FG001|Overall Study|Study closure due to Covid-19|0|||
163358604|NCT01575873|590021471|FG000|Overall Study|Withdrawal by Subject|15|||
163358605|NCT01575873|590021472|FG001|Overall Study|Withdrawal by Subject|20|||
163358606|NCT01575873|590021473|FG002|Overall Study|Withdrawal by Subject|34|||
163358607|NCT01575873|590021474|FG003|Overall Study|Withdrawal by Subject|34|||
163358608|NCT01575873|590021471|FG000|Overall Study|Adverse Event|7|||
163358609|NCT01575873|590021472|FG001|Overall Study|Adverse Event|7|||
163358610|NCT01575873|590021473|FG002|Overall Study|Adverse Event|9|||
163358611|NCT01575873|590021474|FG003|Overall Study|Adverse Event|12|||
163358612|NCT01575873|590021471|FG000|Overall Study|Lost to Follow-up|1|||
163358613|NCT01575873|590021472|FG001|Overall Study|Lost to Follow-up|3|||
163358614|NCT01575873|590021473|FG002|Overall Study|Lost to Follow-up|13|||
163358615|NCT01575873|590021474|FG003|Overall Study|Lost to Follow-up|5|||
163358616|NCT01575873|590021471|FG000|Overall Study|Death|3|||
163358617|NCT01575873|590021472|FG001|Overall Study|Death|2|||
163358618|NCT01575873|590021473|FG002|Overall Study|Death|8|||
163358619|NCT01575873|590021474|FG003|Overall Study|Death|9|||
163358620|NCT01575873|590021471|FG000|Overall Study|Noncompliance|1|||
163358621|NCT01575873|590021472|FG001|Overall Study|Noncompliance|2|||
163358622|NCT01575873|590021473|FG002|Overall Study|Noncompliance|4|||
163358623|NCT01575873|590021474|FG003|Overall Study|Noncompliance|3|||
163358624|NCT01575873|590021471|FG000|Overall Study|Administrative decision|1|||
163358625|NCT01575873|590021472|FG001|Overall Study|Administrative decision|1|||
163358626|NCT01575873|590021473|FG002|Overall Study|Administrative decision|1|||
163358627|NCT01575873|590021474|FG003|Overall Study|Administrative decision|0|||
163358628|NCT01575873|590021471|FG000|Overall Study|Protocol deviation|0|||
163358629|NCT01575873|590021472|FG001|Overall Study|Protocol deviation|1|||
163358630|NCT01575873|590021473|FG002|Overall Study|Protocol deviation|0|||
163358631|NCT01575873|590021474|FG003|Overall Study|Protocol deviation|1|||
163358632|NCT01575873|590021471|FG000|Overall Study|Requirement for Alternative Therapy|0|||
163358633|NCT01575873|590021472|FG001|Overall Study|Requirement for Alternative Therapy|0|||
163358634|NCT01575873|590021473|FG002|Overall Study|Requirement for Alternative Therapy|1|||
163358635|NCT01575873|590021474|FG003|Overall Study|Requirement for Alternative Therapy|1|||
163358636|NCT01575873|590021471|FG000|Overall Study|Other|0|||
163358637|NCT01575873|590021472|FG001|Overall Study|Other|0|||
163358638|NCT01575873|590021473|FG002|Overall Study|Other|4|||
163358639|NCT01575873|590021474|FG003|Overall Study|Other|2|||
163358640|NCT01850030|590021475|FG000|Overall Study|Adverse Event|64|||
163358641|NCT01850030|590021476|FG001|Overall Study|Adverse Event|82|||
163358642|NCT01850030|590021475|FG000|Overall Study|Lack of Efficacy|3|||
163358643|NCT01850030|590021476|FG001|Overall Study|Lack of Efficacy|1|||
163358644|NCT01850030|590021475|FG000|Overall Study|Lost to Follow-up|5|||
163358645|NCT01850030|590021476|FG001|Overall Study|Lost to Follow-up|5|||
163358646|NCT01850030|590021475|FG000|Overall Study|Withdrawal by Subject|3|||
163358647|NCT01850030|590021476|FG001|Overall Study|Withdrawal by Subject|4|||
163358648|NCT01850030|590021475|FG000|Overall Study|Protocol Violation|24|||
163358649|NCT01850030|590021476|FG001|Overall Study|Protocol Violation|28|||
163358650|NCT01850030|590021475|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
163358651|NCT01850030|590021476|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
163358652|NCT02688530|590021480|FG000|Overall Study|Withdrawal by Subject|0|||
163358653|NCT02688530|590021481|FG001|Overall Study|Withdrawal by Subject|1|||
163358654|NCT02688530|590021482|FG002|Overall Study|Withdrawal by Subject|0|||
163358655|NCT02688530|590021483|FG003|Overall Study|Withdrawal by Subject|0|||
163358656|NCT02688530|590021480|FG000|Overall Study|Lost to Follow-up|0|||
163358657|NCT02688530|590021481|FG001|Overall Study|Lost to Follow-up|0|||
163358658|NCT02688530|590021482|FG002|Overall Study|Lost to Follow-up|2|||
163358659|NCT02688530|590021483|FG003|Overall Study|Lost to Follow-up|0|||
163358660|NCT01658020|590021484|FG000|Overall Study|Adverse Event|3|||
163358661|NCT01658020|590021485|FG001|Overall Study|Adverse Event|3|||
163358662|NCT01658020|590021484|FG000|Overall Study|Lost to Follow-up|1|||
163358663|NCT01658020|590021485|FG001|Overall Study|Lost to Follow-up|0|||
163358664|NCT01658020|590021484|FG000|Overall Study|Withdrawal by Subject|4|||
163358665|NCT01658020|590021485|FG001|Overall Study|Withdrawal by Subject|5|||
163410545|NCT05103332|590211371|FG012|SFU Period (6 Months=168 Days)|Death|0|||
163254931|NCT02276222|589639142|FG001|Overall Study|Lost to Follow-up|5|||
163254932|NCT02276222|589639141|FG000|Overall Study|Physician Decision|2|||
163254933|NCT02276222|589639142|FG001|Overall Study|Physician Decision|1|||
163254934|NCT02276222|589639141|FG000|Overall Study|sheduling conflict|1|||
163254935|NCT02276222|589639142|FG001|Overall Study|sheduling conflict|0|||
163254936|NCT02276222|589639141|FG000|Overall Study|subject withdrew after randomization|1|||
163254937|NCT02276222|589639142|FG001|Overall Study|subject withdrew after randomization|0|||
163254938|NCT02170025|589639143|FG000|Overall Study|Adverse Event|2|||
163254939|NCT02170025|589639144|FG001|Overall Study|Adverse Event|0|||
163254940|NCT01525602|589639145|FG000|Overall Study|Adverse Event|1|||
163254941|NCT01525602|589639146|FG001|Overall Study|Adverse Event|0|||
163254942|NCT01525602|589639147|FG002|Overall Study|Adverse Event|1|||
163254943|NCT01525602|589639148|FG003|Overall Study|Adverse Event|1|||
163254944|NCT01525602|589639149|FG004|Overall Study|Adverse Event|3|||
163254945|NCT01525602|589639150|FG005|Overall Study|Adverse Event|3|||
163254946|NCT01525602|589639151|FG006|Overall Study|Adverse Event|0|||
163254947|NCT01525602|589639152|FG007|Overall Study|Adverse Event|1|||
163254948|NCT01525602|589639145|FG000|Overall Study|Disease progression|6|||
163254949|NCT01525602|589639146|FG001|Overall Study|Disease progression|3|||
163254950|NCT01525602|589639147|FG002|Overall Study|Disease progression|2|||
163254951|NCT01525602|589639148|FG003|Overall Study|Disease progression|5|||
163254952|NCT01525602|589639149|FG004|Overall Study|Disease progression|22|||
163254953|NCT01525602|589639150|FG005|Overall Study|Disease progression|2|||
163254954|NCT01525602|589639151|FG006|Overall Study|Disease progression|3|||
163254955|NCT01525602|589639152|FG007|Overall Study|Disease progression|3|||
163254956|NCT01525602|589639145|FG000|Overall Study|Clinical progression|2|||
163254957|NCT01525602|589639146|FG001|Overall Study|Clinical progression|0|||
163254958|NCT01525602|589639147|FG002|Overall Study|Clinical progression|0|||
163254959|NCT01525602|589639148|FG003|Overall Study|Clinical progression|0|||
163254960|NCT01525602|589639149|FG004|Overall Study|Clinical progression|0|||
163254961|NCT01525602|589639150|FG005|Overall Study|Clinical progression|0|||
163254962|NCT01525602|589639151|FG006|Overall Study|Clinical progression|1|||
163254963|NCT01525602|589639152|FG007|Overall Study|Clinical progression|1|||
163254964|NCT01525602|589639145|FG000|Overall Study|Non-compliance|0|||
163254965|NCT01525602|589639146|FG001|Overall Study|Non-compliance|0|||
163254966|NCT01525602|589639147|FG002|Overall Study|Non-compliance|0|||
163254967|NCT01525602|589639148|FG003|Overall Study|Non-compliance|0|||
163254968|NCT01525602|589639149|FG004|Overall Study|Non-compliance|1|||
163254969|NCT01525602|589639150|FG005|Overall Study|Non-compliance|0|||
163254970|NCT01525602|589639151|FG006|Overall Study|Non-compliance|0|||
163254971|NCT01525602|589639152|FG007|Overall Study|Non-compliance|0|||
163254972|NCT01525602|589639145|FG000|Overall Study|Withdrawal by Subject|0|||
163254973|NCT01525602|589639146|FG001|Overall Study|Withdrawal by Subject|0|||
163254974|NCT01525602|589639147|FG002|Overall Study|Withdrawal by Subject|0|||
163254975|NCT01525602|589639148|FG003|Overall Study|Withdrawal by Subject|0|||
163254976|NCT01525602|589639149|FG004|Overall Study|Withdrawal by Subject|3|||
163254977|NCT01525602|589639150|FG005|Overall Study|Withdrawal by Subject|1|||
163254978|NCT01525602|589639151|FG006|Overall Study|Withdrawal by Subject|0|||
163254979|NCT01525602|589639152|FG007|Overall Study|Withdrawal by Subject|1|||
163254980|NCT01525602|589639145|FG000|Overall Study|Physician Decision|0|||
163254981|NCT01525602|589639146|FG001|Overall Study|Physician Decision|0|||
163254982|NCT01525602|589639147|FG002|Overall Study|Physician Decision|0|||
163254983|NCT01525602|589639148|FG003|Overall Study|Physician Decision|0|||
163254984|NCT01525602|589639149|FG004|Overall Study|Physician Decision|3|||
163254985|NCT01525602|589639150|FG005|Overall Study|Physician Decision|0|||
163254986|NCT01525602|589639151|FG006|Overall Study|Physician Decision|1|||
163254987|NCT01525602|589639152|FG007|Overall Study|Physician Decision|0|||
163254988|NCT01525602|589639145|FG000|Overall Study|Death|0|||
163254989|NCT01525602|589639146|FG001|Overall Study|Death|0|||
163254990|NCT01525602|589639147|FG002|Overall Study|Death|0|||
163254991|NCT01525602|589639148|FG003|Overall Study|Death|0|||
163254992|NCT01525602|589639149|FG004|Overall Study|Death|1|||
163254993|NCT01525602|589639150|FG005|Overall Study|Death|1|||
163254994|NCT01525602|589639151|FG006|Overall Study|Death|0|||
163254995|NCT01525602|589639152|FG007|Overall Study|Death|0|||
163410546|NCT05103332|590211372|FG013|SFU Period (6 Months=168 Days)|Death|0|||
163254996|NCT01525602|589639145|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
163254997|NCT01525602|589639146|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
163254998|NCT01525602|589639147|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
163254999|NCT01525602|589639148|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
163255000|NCT01525602|589639149|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
163255001|NCT01525602|589639150|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
163255002|NCT01525602|589639151|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
163255003|NCT01525602|589639152|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
163255004|NCT03703466|589639158|FG000|Overall Study|Death|2|||
163255005|NCT03703466|589639159|FG001|Overall Study|Death|1|||
163255006|NCT03703466|589639160|FG002|Overall Study|Death|0|||
163410547|NCT05103332|590211373|FG014|SFU Period (6 Months=168 Days)|Death|1|||
163255007|NCT03703466|589639158|FG000|Overall Study|Withdrawal by Subject|0|||
163255008|NCT03703466|589639159|FG001|Overall Study|Withdrawal by Subject|3|||
163255009|NCT03703466|589639160|FG002|Overall Study|Withdrawal by Subject|0|||
163255010|NCT03703466|589639158|FG000|Overall Study|Completed < 3 Cycles|2|||
163358666|NCT01658020|590021484|FG000|Overall Study|Protocol Violation|0|||
163358667|NCT01658020|590021485|FG001|Overall Study|Protocol Violation|1|||
163358668|NCT03698019|590021488|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
163358669|NCT03698019|590021489|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
163358670|NCT03698019|590021488|FG000|Step 1: Registration|Withdrawal by Subject|7|||
163358671|NCT03698019|590021489|FG001|Step 1: Registration|Withdrawal by Subject|2|||
163358672|NCT03698019|590021488|FG000|Step 1: Registration|Toxicity|0|||
163358673|NCT03698019|590021489|FG001|Step 1: Registration|Toxicity|1|||
163358674|NCT03698019|590021488|FG000|Step 1: Registration|Disease Progression|0|||
163358675|NCT03698019|590021489|FG001|Step 1: Registration|Disease Progression|12|||
163358676|NCT03698019|590021488|FG000|Step 1: Registration|Co-morbidities|0|||
163358677|NCT03698019|590021489|FG001|Step 1: Registration|Co-morbidities|1|||
163358678|NCT03698019|590021488|FG000|Step 1: Registration|Scheduling Issues|1|||
163358679|NCT03698019|590021489|FG001|Step 1: Registration|Scheduling Issues|0|||
163358680|NCT03698019|590021488|FG000|Step 1: Registration|Participant Refusal|0|||
163358681|NCT03698019|590021489|FG001|Step 1: Registration|Participant Refusal|1|||
163358682|NCT03698019|590021488|FG000|Step 2: Surgery|Participant Refusal|2|||
163358683|NCT03698019|590021489|FG001|Step 2: Surgery|Participant Refusal|1|||
163358684|NCT03698019|590021488|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
163358685|NCT03698019|590021489|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
163358686|NCT03698019|590021488|FG000|Step 2: Surgery|Metastatic Disease|16|||
163358687|NCT03698019|590021489|FG001|Step 2: Surgery|Metastatic Disease|9|||
163358688|NCT03698019|590021488|FG000|Step 2: Surgery|Residual Disease|2|||
163358689|NCT03698019|590021489|FG001|Step 2: Surgery|Residual Disease|1|||
163358690|NCT03698019|590021488|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
163358691|NCT03698019|590021489|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
163358692|NCT03698019|590021488|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
163358693|NCT03698019|590021489|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
163358694|NCT03698019|590021488|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
163358695|NCT03698019|590021489|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
163358696|NCT03698019|590021488|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
163358697|NCT03698019|590021489|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
163358698|NCT03698019|590021488|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
163358699|NCT03698019|590021489|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
163358700|NCT03698019|590021488|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
163358701|NCT03698019|590021489|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
163358702|NCT03698019|590021488|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
163358703|NCT03698019|590021489|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
163358704|NCT03698019|590021488|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
163358705|NCT03698019|590021489|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
163358706|NCT04021043|590023269|FG000|Overall Study|Adverse Event|3|||
163358707|NCT04021043|590023270|FG001|Overall Study|Adverse Event|1|||
163358708|NCT04021043|590023271|FG002|Overall Study|Adverse Event|1|||
163358709|NCT04021043|590023272|FG003|Overall Study|Adverse Event|0|||
163358710|NCT04021043|590023269|FG000|Overall Study|Death|2|||
163358711|NCT04021043|590023270|FG001|Overall Study|Death|3|||
163358712|NCT04021043|590023271|FG002|Overall Study|Death|1|||
163358713|NCT04021043|590023272|FG003|Overall Study|Death|3|||
163358714|NCT04021043|590023269|FG000|Overall Study|Withdrawal by Subject|1|||
163358715|NCT04021043|590023270|FG001|Overall Study|Withdrawal by Subject|1|||
163358716|NCT04021043|590023271|FG002|Overall Study|Withdrawal by Subject|1|||
163358717|NCT04021043|590023272|FG003|Overall Study|Withdrawal by Subject|6|||
163358718|NCT04021043|590023269|FG000|Overall Study|Discontinued due to disease progression|4|||
163358719|NCT04021043|590023270|FG001|Overall Study|Discontinued due to disease progression|5|||
163358720|NCT04021043|590023271|FG002|Overall Study|Discontinued due to disease progression|7|||
163255011|NCT03703466|589639159|FG001|Overall Study|Completed < 3 Cycles|2|||
163255012|NCT03703466|589639160|FG002|Overall Study|Completed < 3 Cycles|2|||
163358721|NCT04021043|590023272|FG003|Overall Study|Discontinued due to disease progression|10|||
163255013|NCT02412137|589639161|FG000|Overall Study|Withdrawal by Subject|2|||
163255014|NCT02412137|589639162|FG001|Overall Study|Withdrawal by Subject|0|||
163255015|NCT02412137|589639161|FG000|Overall Study|Lost to Follow-up|21|||
163255016|NCT02412137|589639162|FG001|Overall Study|Lost to Follow-up|14|||
163255017|NCT02412137|589639161|FG000|Overall Study|Physician Decision|28|||
163255018|NCT02412137|589639162|FG001|Overall Study|Physician Decision|9|||
163255019|NCT00506493|589639163|FG000|Overall Study|Death|6|||
163358722|NCT00826228|590023273|FG000|Overall Study|Withdrawal by Subject|1|||
163358723|NCT02035696|590023274|FG000|Overall Study|Lost to Follow-up|0|||
163358724|NCT02035696|590023275|FG001|Overall Study|Lost to Follow-up|3|||
163358725|NCT02035696|590023276|FG002|Overall Study|Lost to Follow-up|1|||
163358726|NCT02035696|590023277|FG003|Overall Study|Lost to Follow-up|2|||
163358727|NCT02035696|590023274|FG000|Overall Study|Withdrawal by Subject|3|||
163358728|NCT02035696|590023275|FG001|Overall Study|Withdrawal by Subject|0|||
163358729|NCT02035696|590023276|FG002|Overall Study|Withdrawal by Subject|2|||
163358730|NCT02035696|590023277|FG003|Overall Study|Withdrawal by Subject|1|||
163358731|NCT00379769|590023278|FG000|Main Study|Death|57|||
163358732|NCT00379769|590023279|FG001|Main Study|Death|67|||
163358733|NCT00379769|590023280|FG002|Main Study|Death|54|||
163358734|NCT00379769|590023281|FG003|Main Study|Death|72|||
163358735|NCT00379769|590023282|FG004|Main Study|Death|0|||
163358736|NCT00379769|590023283|FG005|Main Study|Death|0|||
163358737|NCT00379769|590023278|FG000|Main Study|Adverse Event|5|||
163358738|NCT00379769|590023279|FG001|Main Study|Adverse Event|8|||
163358739|NCT00379769|590023280|FG002|Main Study|Adverse Event|10|||
163358740|NCT00379769|590023281|FG003|Main Study|Adverse Event|11|||
163358741|NCT00379769|590023282|FG004|Main Study|Adverse Event|0|||
163358742|NCT00379769|590023283|FG005|Main Study|Adverse Event|0|||
163358743|NCT00379769|590023278|FG000|Main Study|Lost to Follow-up|29|||
163358744|NCT00379769|590023279|FG001|Main Study|Lost to Follow-up|29|||
163358745|NCT00379769|590023280|FG002|Main Study|Lost to Follow-up|25|||
163358746|NCT00379769|590023281|FG003|Main Study|Lost to Follow-up|26|||
163358747|NCT00379769|590023282|FG004|Main Study|Lost to Follow-up|0|||
163358748|NCT00379769|590023283|FG005|Main Study|Lost to Follow-up|0|||
163358749|NCT00379769|590023278|FG000|Main Study|Withdrawal by Subject|46|||
163358750|NCT00379769|590023279|FG001|Main Study|Withdrawal by Subject|56|||
163358751|NCT00379769|590023280|FG002|Main Study|Withdrawal by Subject|72|||
163358752|NCT00379769|590023281|FG003|Main Study|Withdrawal by Subject|70|||
163358753|NCT00379769|590023282|FG004|Main Study|Withdrawal by Subject|0|||
163358754|NCT00379769|590023283|FG005|Main Study|Withdrawal by Subject|0|||
163358755|NCT00379769|590023278|FG000|Main Study|Moved to survival status follow-up only|27|||
163358756|NCT00379769|590023279|FG001|Main Study|Moved to survival status follow-up only|25|||
163358757|NCT00379769|590023280|FG002|Main Study|Moved to survival status follow-up only|32|||
163358758|NCT00379769|590023281|FG003|Main Study|Moved to survival status follow-up only|36|||
163358759|NCT00379769|590023282|FG004|Main Study|Moved to survival status follow-up only|0|||
163358760|NCT00379769|590023283|FG005|Main Study|Moved to survival status follow-up only|0|||
163358761|NCT00379769|590023278|FG000|Main Study|Participant moved|3|||
163358762|NCT00379769|590023279|FG001|Main Study|Participant moved|2|||
163358763|NCT00379769|590023280|FG002|Main Study|Participant moved|3|||
163358764|NCT00379769|590023281|FG003|Main Study|Participant moved|3|||
163358765|NCT00379769|590023282|FG004|Main Study|Participant moved|0|||
163358766|NCT00379769|590023283|FG005|Main Study|Participant moved|0|||
163358767|NCT00379769|590023278|FG000|Main Study|Poor compliance|3|||
163358768|NCT00379769|590023279|FG001|Main Study|Poor compliance|2|||
163358769|NCT00379769|590023280|FG002|Main Study|Poor compliance|2|||
163358770|NCT00379769|590023281|FG003|Main Study|Poor compliance|1|||
163358771|NCT00379769|590023282|FG004|Main Study|Poor compliance|0|||
163358772|NCT00379769|590023283|FG005|Main Study|Poor compliance|0|||
163358773|NCT00379769|590023278|FG000|Main Study|Prohibited glucose lowering medication|0|||
163358774|NCT00379769|590023279|FG001|Main Study|Prohibited glucose lowering medication|3|||
163358775|NCT00379769|590023280|FG002|Main Study|Prohibited glucose lowering medication|0|||
163358776|NCT00379769|590023281|FG003|Main Study|Prohibited glucose lowering medication|1|||
163358777|NCT00379769|590023282|FG004|Main Study|Prohibited glucose lowering medication|0|||
163358778|NCT00379769|590023283|FG005|Main Study|Prohibited glucose lowering medication|0|||
163358779|NCT00379769|590023278|FG000|Main Study|Site closed|4|||
163358780|NCT00379769|590023279|FG001|Main Study|Site closed|4|||
163358781|NCT00379769|590023280|FG002|Main Study|Site closed|4|||
163358782|NCT00379769|590023281|FG003|Main Study|Site closed|8|||
163358783|NCT00379769|590023282|FG004|Main Study|Site closed|0|||
163358784|NCT00379769|590023283|FG005|Main Study|Site closed|0|||
163358785|NCT00379769|590023278|FG000|Main Study|Entry criteria violation|0|||
163358786|NCT00379769|590023279|FG001|Main Study|Entry criteria violation|0|||
163358787|NCT00379769|590023280|FG002|Main Study|Entry criteria violation|1|||
163358788|NCT00379769|590023281|FG003|Main Study|Entry criteria violation|1|||
163358789|NCT00379769|590023282|FG004|Main Study|Entry criteria violation|0|||
163358790|NCT00379769|590023283|FG005|Main Study|Entry criteria violation|0|||
163358791|NCT00379769|590023278|FG000|Main Study|Participant did not take study drug|0|||
163358792|NCT00379769|590023279|FG001|Main Study|Participant did not take study drug|0|||
163358793|NCT00379769|590023280|FG002|Main Study|Participant did not take study drug|1|||
163358794|NCT00379769|590023281|FG003|Main Study|Participant did not take study drug|0|||
163358795|NCT00379769|590023282|FG004|Main Study|Participant did not take study drug|0|||
163358796|NCT00379769|590023283|FG005|Main Study|Participant did not take study drug|0|||
163358797|NCT00379769|590023278|FG000|Main Study|Physician Decision|2|||
163358798|NCT00379769|590023279|FG001|Main Study|Physician Decision|2|||
163358799|NCT00379769|590023280|FG002|Main Study|Physician Decision|1|||
163358800|NCT00379769|590023281|FG003|Main Study|Physician Decision|1|||
163358801|NCT00379769|590023282|FG004|Main Study|Physician Decision|0|||
163358802|NCT00379769|590023283|FG005|Main Study|Physician Decision|0|||
163358803|NCT00379769|590023278|FG000|Main Study|Participant completed study at visit 27|1|||
163384931|NCT00427895|590119250|FG000|Vax 1/Year 1 Follow-up|Other|0|||
163384932|NCT00427895|590119251|FG001|Vax 1/Year 1 Follow-up|Other|0|||
163358804|NCT00379769|590023279|FG001|Main Study|Participant completed study at visit 27|0|||
163358805|NCT00379769|590023280|FG002|Main Study|Participant completed study at visit 27|0|||
163358806|NCT00379769|590023281|FG003|Main Study|Participant completed study at visit 27|0|||
163358807|NCT00379769|590023282|FG004|Main Study|Participant completed study at visit 27|0|||
163358808|NCT00379769|590023283|FG005|Main Study|Participant completed study at visit 27|0|||
163358809|NCT00379769|590023278|FG000|Main Study|Personal reasons|1|||
163358810|NCT00379769|590023279|FG001|Main Study|Personal reasons|0|||
163358811|NCT00379769|590023280|FG002|Main Study|Personal reasons|0|||
163358812|NCT00379769|590023281|FG003|Main Study|Personal reasons|0|||
163358813|NCT00379769|590023282|FG004|Main Study|Personal reasons|0|||
163358814|NCT00379769|590023283|FG005|Main Study|Personal reasons|0|||
163358815|NCT00379769|590023278|FG000|Main Study|Risk of heart failure|0|||
163358816|NCT00379769|590023279|FG001|Main Study|Risk of heart failure|1|||
163358817|NCT00379769|590023280|FG002|Main Study|Risk of heart failure|0|||
163358818|NCT00379769|590023281|FG003|Main Study|Risk of heart failure|0|||
163358819|NCT00379769|590023282|FG004|Main Study|Risk of heart failure|0|||
163358820|NCT00379769|590023283|FG005|Main Study|Risk of heart failure|0|||
163358821|NCT00379769|590023278|FG000|Main Study|Investigator refused to log temperature|0|||
163358822|NCT00379769|590023279|FG001|Main Study|Investigator refused to log temperature|0|||
163358823|NCT00379769|590023280|FG002|Main Study|Investigator refused to log temperature|1|||
163358824|NCT00379769|590023281|FG003|Main Study|Investigator refused to log temperature|0|||
163358825|NCT00379769|590023282|FG004|Main Study|Investigator refused to log temperature|0|||
163358826|NCT00379769|590023283|FG005|Main Study|Investigator refused to log temperature|0|||
163358827|NCT00379769|590023278|FG000|Main Study|Reason unspecified|0|||
163358828|NCT00379769|590023279|FG001|Main Study|Reason unspecified|0|||
163358829|NCT00379769|590023280|FG002|Main Study|Reason unspecified|1|||
163358830|NCT00379769|590023281|FG003|Main Study|Reason unspecified|0|||
163358831|NCT00379769|590023282|FG004|Main Study|Reason unspecified|0|||
163358832|NCT00379769|590023283|FG005|Main Study|Reason unspecified|0|||
163358833|NCT00379769|590023278|FG000|Observational Follow-up|Death|0|||
163358834|NCT00379769|590023279|FG001|Observational Follow-up|Death|0|||
163358835|NCT00379769|590023280|FG002|Observational Follow-up|Death|0|||
163358836|NCT00379769|590023281|FG003|Observational Follow-up|Death|0|||
163358837|NCT00379769|590023282|FG004|Observational Follow-up|Death|78|||
163358838|NCT00379769|590023283|FG005|Observational Follow-up|Death|70|||
163358839|NCT00379769|590023278|FG000|Observational Follow-up|Adverse Event|0|||
163358840|NCT00379769|590023279|FG001|Observational Follow-up|Adverse Event|0|||
163358841|NCT00379769|590023280|FG002|Observational Follow-up|Adverse Event|0|||
163358842|NCT00379769|590023281|FG003|Observational Follow-up|Adverse Event|0|||
163358843|NCT00379769|590023282|FG004|Observational Follow-up|Adverse Event|1|||
163358844|NCT00379769|590023283|FG005|Observational Follow-up|Adverse Event|0|||
163358845|NCT00379769|590023278|FG000|Observational Follow-up|Lost to Follow-up|0|||
163358846|NCT00379769|590023279|FG001|Observational Follow-up|Lost to Follow-up|0|||
163358847|NCT00379769|590023280|FG002|Observational Follow-up|Lost to Follow-up|0|||
163358848|NCT00379769|590023281|FG003|Observational Follow-up|Lost to Follow-up|0|||
163358849|NCT00379769|590023282|FG004|Observational Follow-up|Lost to Follow-up|25|||
163358850|NCT00379769|590023283|FG005|Observational Follow-up|Lost to Follow-up|27|||
163358851|NCT00379769|590023278|FG000|Observational Follow-up|Withdrawal by Subject|0|||
163358852|NCT00379769|590023279|FG001|Observational Follow-up|Withdrawal by Subject|0|||
163358853|NCT00379769|590023280|FG002|Observational Follow-up|Withdrawal by Subject|0|||
163358854|NCT00379769|590023281|FG003|Observational Follow-up|Withdrawal by Subject|0|||
163358855|NCT00379769|590023282|FG004|Observational Follow-up|Withdrawal by Subject|12|||
163358856|NCT00379769|590023283|FG005|Observational Follow-up|Withdrawal by Subject|12|||
163358857|NCT00379769|590023278|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
163358858|NCT00379769|590023279|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
163358859|NCT00379769|590023280|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
163358860|NCT00379769|590023281|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
163358861|NCT00379769|590023282|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
163358862|NCT00379769|590023283|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
163358863|NCT00379769|590023278|FG000|Observational Follow-up|Physician Decision|0|||
163358864|NCT00379769|590023279|FG001|Observational Follow-up|Physician Decision|0|||
163358865|NCT00379769|590023280|FG002|Observational Follow-up|Physician Decision|0|||
163358866|NCT00379769|590023281|FG003|Observational Follow-up|Physician Decision|0|||
163358867|NCT00379769|590023282|FG004|Observational Follow-up|Physician Decision|8|||
163358868|NCT00379769|590023283|FG005|Observational Follow-up|Physician Decision|8|||
163410548|NCT05103332|590211374|FG015|SFU Period (6 Months=168 Days)|Death|0|||
163358869|NCT00379769|590023278|FG000|Observational Follow-up|Site Closed Early|0|||
163358870|NCT00379769|590023279|FG001|Observational Follow-up|Site Closed Early|0|||
163358871|NCT00379769|590023280|FG002|Observational Follow-up|Site Closed Early|0|||
163358872|NCT00379769|590023281|FG003|Observational Follow-up|Site Closed Early|0|||
163358873|NCT00379769|590023282|FG004|Observational Follow-up|Site Closed Early|6|||
163358874|NCT00379769|590023283|FG005|Observational Follow-up|Site Closed Early|7|||
163358875|NCT00379769|590023278|FG000|Observational Follow-up|Participant Moved|0|||
163255020|NCT00506493|589639163|FG000|Overall Study|Withdrawal by Subject|5|||
163255021|NCT02532179|589640743|FG000|Overall Study|Lost to Follow-up|1|||
163255022|NCT02532179|589640743|FG000|Overall Study|Pregnancy|1|||
163255023|NCT02532179|589640743|FG000|Overall Study|Subject received depot steroid injection|1|||
163255024|NCT02240108|589640744|FG000|Overall Study|Other than specified|8|||
163255025|NCT02240108|589640745|FG001|Overall Study|Other than specified|6|||
163255026|NCT02240108|589640744|FG000|Overall Study|Adverse Event|1|||
163255027|NCT02240108|589640745|FG001|Overall Study|Adverse Event|9|||
163255028|NCT02240108|589640744|FG000|Overall Study|Pregnancy|1|||
163255029|NCT02240108|589640745|FG001|Overall Study|Pregnancy|0|||
163255030|NCT02240108|589640744|FG000|Overall Study|Withdrawal by Subject|4|||
163255031|NCT02240108|589640745|FG001|Overall Study|Withdrawal by Subject|9|||
163255032|NCT02240108|589640744|FG000|Overall Study|StudyTerminated by Sponsor|0|||
163255033|NCT02240108|589640745|FG001|Overall Study|StudyTerminated by Sponsor|1|||
163255034|NCT00119405|589640746|FG000|Overall Study|Withdrawal by Subject|1|||
163255035|NCT00939484|589640748|FG000|Overall Study|Progression/Relapse|8|||
163255036|NCT00939484|589640749|FG001|Overall Study|Progression/Relapse|20|||
163255037|NCT00939484|589640750|FG002|Overall Study|Progression/Relapse|3|||
163255038|NCT04233372|589640751|FG000|Overall Study|Lost to Follow-up|104|||
163255039|NCT04233372|589640751|FG000|Overall Study|Adverse Event|8|||
163255040|NCT04233372|589640751|FG000|Overall Study|Withdrawal by Subject|2|||
163255041|NCT04958785|589640752|FG000|Overall Study|Study Terminated by Sponsor|4|||
163255042|NCT04958785|589640753|FG001|Overall Study|Study Terminated by Sponsor|10|||
163255043|NCT04958785|589640754|FG002|Overall Study|Study Terminated by Sponsor|7|||
163255044|NCT04958785|589640755|FG003|Overall Study|Study Terminated by Sponsor|6|||
163255045|NCT04958785|589640756|FG004|Overall Study|Study Terminated by Sponsor|34|||
163255046|NCT04958785|589640752|FG000|Overall Study|Death|2|||
163255047|NCT04958785|589640753|FG001|Overall Study|Death|3|||
163255048|NCT04958785|589640754|FG002|Overall Study|Death|4|||
163255049|NCT04958785|589640755|FG003|Overall Study|Death|5|||
163255050|NCT04958785|589640756|FG004|Overall Study|Death|5|||
163255051|NCT04958785|589640752|FG000|Overall Study|Withdrew consent|2|||
163255052|NCT04958785|589640753|FG001|Overall Study|Withdrew consent|0|||
163255053|NCT04958785|589640754|FG002|Overall Study|Withdrew consent|3|||
163255054|NCT04958785|589640755|FG003|Overall Study|Withdrew consent|1|||
163255055|NCT04958785|589640756|FG004|Overall Study|Withdrew consent|0|||
163255056|NCT04958785|589640752|FG000|Overall Study|Investigator's discretion|0|||
163255057|NCT04958785|589640753|FG001|Overall Study|Investigator's discretion|1|||
163255058|NCT04958785|589640754|FG002|Overall Study|Investigator's discretion|0|||
163255059|NCT04958785|589640755|FG003|Overall Study|Investigator's discretion|1|||
163255060|NCT04958785|589640756|FG004|Overall Study|Investigator's discretion|2|||
163255061|NCT04958785|589640752|FG000|Overall Study|Adverse Event|0|||
163255062|NCT04958785|589640753|FG001|Overall Study|Adverse Event|0|||
163255063|NCT04958785|589640754|FG002|Overall Study|Adverse Event|0|||
163255064|NCT04958785|589640755|FG003|Overall Study|Adverse Event|0|||
163255065|NCT04958785|589640756|FG004|Overall Study|Adverse Event|1|||
163255066|NCT04958785|589640752|FG000|Overall Study|Lost to Follow-up|0|||
163255067|NCT04958785|589640753|FG001|Overall Study|Lost to Follow-up|0|||
163255068|NCT04958785|589640754|FG002|Overall Study|Lost to Follow-up|0|||
163255069|NCT04958785|589640755|FG003|Overall Study|Lost to Follow-up|0|||
163255070|NCT04958785|589640756|FG004|Overall Study|Lost to Follow-up|1|||
163255071|NCT01090310|589640757|FG000|Core Study|Adverse Event|2|||
163255072|NCT01090310|589640758|FG001|Core Study|Adverse Event|2|||
163255073|NCT01090310|589640759|FG002|Core Study|Adverse Event|1|||
163255074|NCT01090310|589640760|FG003|Core Study|Adverse Event|1|||
163255075|NCT01090310|589640757|FG000|Core Study|Subject withdrew consent|0|||
163255076|NCT01090310|589640758|FG001|Core Study|Subject withdrew consent|3|||
163255077|NCT01090310|589640759|FG002|Core Study|Subject withdrew consent|1|||
163255078|NCT01090310|589640760|FG003|Core Study|Subject withdrew consent|1|||
163255079|NCT01090310|589640757|FG000|Core Study|Abnormal test procedure result|0|||
163255080|NCT01090310|589640758|FG001|Core Study|Abnormal test procedure result|0|||
163358876|NCT00379769|590023279|FG001|Observational Follow-up|Participant Moved|0|||
163358877|NCT00379769|590023280|FG002|Observational Follow-up|Participant Moved|0|||
163255081|NCT01090310|589640759|FG002|Core Study|Abnormal test procedure result|1|||
163255082|NCT01090310|589640760|FG003|Core Study|Abnormal test procedure result|0|||
163255083|NCT01090310|589640757|FG000|Core Study|Administrative reasons|5|||
163255084|NCT01090310|589640758|FG001|Core Study|Administrative reasons|6|||
163255085|NCT01090310|589640759|FG002|Core Study|Administrative reasons|4|||
163255086|NCT01090310|589640760|FG003|Core Study|Administrative reasons|4|||
163255087|NCT01090310|589640757|FG000|Core Study|Protocol deviation|1|||
163255088|NCT01090310|589640758|FG001|Core Study|Protocol deviation|0|||
163255089|NCT01090310|589640759|FG002|Core Study|Protocol deviation|0|||
163255090|NCT01090310|589640760|FG003|Core Study|Protocol deviation|1|||
163255091|NCT01090310|589640757|FG000|Extension Study|Aministrative problems|13|||
163255092|NCT01090310|589640758|FG001|Extension Study|Aministrative problems|15|||
163255093|NCT01090310|589640759|FG002|Extension Study|Aministrative problems|14|||
163255094|NCT01090310|589640760|FG003|Extension Study|Aministrative problems|18|||
163358878|NCT00379769|590023281|FG003|Observational Follow-up|Participant Moved|0|||
163358879|NCT00379769|590023282|FG004|Observational Follow-up|Participant Moved|0|||
163410549|NCT05103332|590211375|FG016|SFU Period (6 Months=168 Days)|Death|0|||
163410550|NCT05103332|590211376|FG017|SFU Period (6 Months=168 Days)|Death|1|||
163410551|NCT04428476|590211377|FG000|Overall Study|Withdrawal by Subject|1|||
163410552|NCT04428476|590211377|FG000|Overall Study|Still on treatment|12|||
163255095|NCT01090310|589640757|FG000|Extension Study|Adverse Event|0|||
163255096|NCT01090310|589640758|FG001|Extension Study|Adverse Event|0|||
163255097|NCT01090310|589640759|FG002|Extension Study|Adverse Event|0|||
163255098|NCT01090310|589640760|FG003|Extension Study|Adverse Event|1|||
163255099|NCT01090310|589640757|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
163255100|NCT01090310|589640758|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
163255101|NCT01090310|589640759|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
163255102|NCT01090310|589640760|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
163255103|NCT01090310|589640757|FG000|Extension Study|Subject withdrew consent|0|||
163255104|NCT01090310|589640758|FG001|Extension Study|Subject withdrew consent|1|||
163255105|NCT01090310|589640759|FG002|Extension Study|Subject withdrew consent|0|||
163255106|NCT01090310|589640760|FG003|Extension Study|Subject withdrew consent|0|||
163255107|NCT01224925|589640761|FG000|Overall Study|Lost to Follow-up|3|||
163255108|NCT01224925|589640762|FG001|Overall Study|Lost to Follow-up|2|||
163255109|NCT02472652|589640767|FG000|Overall Study|Lost to Follow-up|1|||
163255110|NCT04586569|589640768|FG000|Overall Study|Withdrawal by Subject|0|||
163255111|NCT04586569|589640769|FG001|Overall Study|Withdrawal by Subject|2|||
163255112|NCT04586569|589640768|FG000|Overall Study|No longer eligible|2|||
163255113|NCT04586569|589640769|FG001|Overall Study|No longer eligible|3|||
163255114|NCT04586569|589640768|FG000|Overall Study|Physician Decision|1|||
163255115|NCT04586569|589640769|FG001|Overall Study|Physician Decision|0|||
163255116|NCT03185832|589640770|FG000|Overall Study|Death|9|||
163255117|NCT03185832|589640771|FG001|Overall Study|Death|14|||
163255118|NCT03185832|589640772|FG002|Overall Study|Death|9|||
163255119|NCT03185832|589640773|FG003|Overall Study|Death|7|||
163255120|NCT03185832|589640770|FG000|Overall Study|Withdrawn - vital status available|0|||
163255121|NCT03185832|589640771|FG001|Overall Study|Withdrawn - vital status available|1|||
163255122|NCT03185832|589640772|FG002|Overall Study|Withdrawn - vital status available|1|||
163255123|NCT03185832|589640773|FG003|Overall Study|Withdrawn - vital status available|4|||
163255124|NCT01083641|589640775|FG000|Overall Study|Withdrawal by Subject|2|||
163255125|NCT03439189|589640776|FG000|Overall Study|Protocol Violation|19|||
163255126|NCT03439189|589640776|FG000|Overall Study|Lack of Efficacy|63|||
163255127|NCT01777321|589640777|FG000|Overall Study|Withdrawal by Subject|0|||
163255128|NCT01777321|589640778|FG001|Overall Study|Withdrawal by Subject|1|||
163255129|NCT02173548|589640779|FG000|Overall Study|Lost to Follow-up|0|||
163255130|NCT02173548|589640780|FG001|Overall Study|Lost to Follow-up|2|||
163255131|NCT02173548|589640779|FG000|Overall Study|Withdrawal by Subject|1|||
163255132|NCT02173548|589640780|FG001|Overall Study|Withdrawal by Subject|0|||
163255133|NCT03597568|589640781|FG000|Overall Study|Withdrawal by Subject|1|||
163255134|NCT03597568|589640782|FG001|Overall Study|Withdrawal by Subject|1|||
163255135|NCT03597568|589640781|FG000|Overall Study|Unable to analyze vascular data|1|||
163255136|NCT03597568|589640782|FG001|Overall Study|Unable to analyze vascular data|1|||
163255137|NCT00999466|589640785|FG000|Main Part|Withdrawal by Subject|0|||
163255138|NCT00999466|589640786|FG001|Main Part|Withdrawal by Subject|0|||
163255139|NCT00999466|589640787|FG002|Main Part|Withdrawal by Subject|2|||
163255140|NCT00999466|589640785|FG000|Main Part|Adverse Event|0|||
163255141|NCT00999466|589640786|FG001|Main Part|Adverse Event|4|||
163255142|NCT00999466|589640787|FG002|Main Part|Adverse Event|2|||
163255143|NCT05131165|589640788|FG000|Overall Study|Death|1|||
163255144|NCT05131165|589640789|FG001|Overall Study|Death|1|||
163255145|NCT05131165|589640790|FG002|Overall Study|Death|0|||
163255146|NCT05131165|589640788|FG000|Overall Study|Lost to Follow-up|2|||
163255147|NCT05131165|589640789|FG001|Overall Study|Lost to Follow-up|2|||
163255148|NCT05131165|589640790|FG002|Overall Study|Lost to Follow-up|5|||
163255149|NCT05131165|589640788|FG000|Overall Study|Transferred out of clinic|1|||
163255150|NCT05131165|589640789|FG001|Overall Study|Transferred out of clinic|0|||
163255151|NCT05131165|589640790|FG002|Overall Study|Transferred out of clinic|3|||
163255152|NCT05131165|589640788|FG000|Overall Study|Dropped out|1|||
163255153|NCT05131165|589640789|FG001|Overall Study|Dropped out|2|||
163255154|NCT05131165|589640790|FG002|Overall Study|Dropped out|0|||
163255155|NCT00526630|589640791|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
163255156|NCT00526630|589640792|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
163255157|NCT00526630|589640791|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
163255158|NCT00526630|589640792|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
163255159|NCT00337272|589640795|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
163255160|NCT00337272|589640796|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
163255161|NCT00337272|589640795|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
163255162|NCT00337272|589640796|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
163255163|NCT00337272|589640795|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
163255164|NCT00337272|589640796|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
163255165|NCT00337272|589640795|FG000|Treatment Period|Non-compliance|1|||
163255166|NCT00337272|589640796|FG001|Treatment Period|Non-compliance|1|||
163255167|NCT00337272|589640795|FG000|Treatment Period|Withdrawal by Subject|0|||
163255168|NCT00337272|589640796|FG001|Treatment Period|Withdrawal by Subject|1|||
163255169|NCT00337272|589640795|FG000|Withdrawal Period|Non-compliance|0|||
163255170|NCT00337272|589640796|FG001|Withdrawal Period|Non-compliance|1|||
163255171|NCT05674890|589640802|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
163255172|NCT05674890|589640803|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
163255173|NCT05674890|589640802|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
163255174|NCT05674890|589640803|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
163255175|NCT05674890|589640802|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
163255176|NCT05674890|589640803|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
163255177|NCT05906368|589640816|FG000|Overall Study|Withdrawal by Subject|1|||
163255178|NCT05906368|589640817|FG001|Overall Study|Withdrawal by Subject|1|||
163255179|NCT05906368|589640816|FG000|Overall Study|Ineligibility criteria identified|2|||
163410553|NCT02043548|590211378|FG000|Overall Study|Lack of Efficacy|1|||
163410554|NCT02043548|590211379|FG001|Overall Study|Lack of Efficacy|0|||
163410555|NCT02043548|590211378|FG000|Overall Study|Adverse Event|0|||
163410556|NCT02043548|590211379|FG001|Overall Study|Adverse Event|1|||
163410557|NCT01425008|590211380|FG000|Dose Escalation Phase|Progressive Disease|2|||
163410558|NCT01425008|590211381|FG001|Dose Escalation Phase|Progressive Disease|3|||
163410559|NCT01425008|590211382|FG002|Dose Escalation Phase|Progressive Disease|2|||
163410560|NCT01425008|590211383|FG003|Dose Escalation Phase|Progressive Disease|3|||
163410561|NCT01425008|590211384|FG004|Dose Escalation Phase|Progressive Disease|5|||
163410562|NCT01425008|590211385|FG005|Dose Escalation Phase|Progressive Disease|4|||
163410563|NCT01425008|590211386|FG006|Dose Escalation Phase|Progressive Disease|0|||
163410564|NCT01425008|590211387|FG007|Dose Escalation Phase|Progressive Disease|2|||
163410565|NCT01425008|590211388|FG008|Dose Escalation Phase|Progressive Disease|6|||
163410566|NCT01425008|590211389|FG009|Dose Escalation Phase|Progressive Disease|2|||
163410567|NCT01425008|590211390|FG010|Dose Escalation Phase|Progressive Disease|0|||
163255180|NCT05906368|589640817|FG001|Overall Study|Ineligibility criteria identified|0|||
163255181|NCT01127646|589640818|FG000|Overall Study|Entry Criteria Not Met|1|||
163255182|NCT01127646|589640819|FG001|Overall Study|Entry Criteria Not Met|0|||
163358880|NCT00379769|590023283|FG005|Observational Follow-up|Participant Moved|1|||
163358881|NCT00379769|590023278|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
163358882|NCT00379769|590023279|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
163358883|NCT00379769|590023280|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
163358884|NCT00379769|590023281|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
163358885|NCT00379769|590023282|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
163358886|NCT00379769|590023283|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
163358887|NCT00667459|590023291|FG000|Overall Study|Death|0|||
163358888|NCT00667459|590023292|FG001|Overall Study|Death|2|||
163358889|NCT00667459|590023291|FG000|Overall Study|Lost to Follow-up|8|||
163358890|NCT00667459|590023292|FG001|Overall Study|Lost to Follow-up|43|||
163358891|NCT04546217|590023295|FG000|Overall Study|Withdrawal by Subject|2|||
163358892|NCT04546217|590023296|FG001|Overall Study|Withdrawal by Subject|0|||
163358893|NCT04546217|590023295|FG000|Overall Study|Uncontrolled hypertension|1|||
163358894|NCT04546217|590023296|FG001|Overall Study|Uncontrolled hypertension|0|||
163358895|NCT02550938|590023297|FG000|Overall Study|Lost to Follow-up|8|||
163358896|NCT02550938|590023298|FG001|Overall Study|Lost to Follow-up|7|||
163358897|NCT02550938|590023299|FG002|Overall Study|Lost to Follow-up|12|||
163358898|NCT02550938|590023300|FG003|Overall Study|Lost to Follow-up|11|||
163358899|NCT01245140|590023305|FG000|Overall Study|Adverse Event|1|||
163358900|NCT01245140|590023306|FG001|Overall Study|Adverse Event|3|||
163358901|NCT01245140|590023305|FG000|Overall Study|Lack of Efficacy|2|||
163358902|NCT01245140|590023306|FG001|Overall Study|Lack of Efficacy|4|||
163358903|NCT01245140|590023305|FG000|Overall Study|Protocol Violation|0|||
163358904|NCT01245140|590023306|FG001|Overall Study|Protocol Violation|1|||
163358905|NCT01245140|590023305|FG000|Overall Study|Withdrawal by Subject|0|||
163358906|NCT01245140|590023306|FG001|Overall Study|Withdrawal by Subject|1|||
163358907|NCT01245140|590023305|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
163358908|NCT01245140|590023306|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
163358909|NCT02037477|590023307|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
163358910|NCT02037477|590023308|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
163255183|NCT01127646|589640818|FG000|Overall Study|Protocol Violation|0|||
163255184|NCT01127646|589640819|FG001|Overall Study|Protocol Violation|1|||
163358911|NCT02037477|590023309|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
163358912|NCT02037477|590023310|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
163358913|NCT02635360|590023311|FG000|Overall Study|Adverse Event|0|||
163358914|NCT02635360|590023312|FG001|Overall Study|Adverse Event|3|||
163410568|NCT01425008|590211391|FG011|Dose Escalation Phase|Progressive Disease|0|||
163255185|NCT00595504|589640823|FG000|Overall Study|Withdrawal by Subject|1|||
163410569|NCT01425008|590211392|FG012|Dose Escalation Phase|Progressive Disease|0|||
163358915|NCT02635360|590023311|FG000|Overall Study|Withdrawal by Subject|2|||
163358916|NCT02635360|590023312|FG001|Overall Study|Withdrawal by Subject|0|||
163358917|NCT02635360|590023311|FG000|Overall Study|Non-Compliance|3|||
163358918|NCT02635360|590023312|FG001|Overall Study|Non-Compliance|1|||
163358919|NCT02635360|590023311|FG000|Overall Study|Disease Progression|0|||
163358920|NCT02635360|590023312|FG001|Overall Study|Disease Progression|2|||
163358921|NCT02635360|590023311|FG000|Overall Study|Lost to Follow-up|1|||
163358922|NCT02635360|590023312|FG001|Overall Study|Lost to Follow-up|1|||
163358923|NCT04082429|590023313|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
163358924|NCT04082429|590023314|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
163358925|NCT04082429|590023315|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
163358926|NCT04082429|590023316|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
163358927|NCT04082429|590023317|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
163358928|NCT04082429|590023318|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
163358929|NCT04082429|590023319|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
163358930|NCT04082429|590023320|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
163358931|NCT04082429|590023321|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
163358932|NCT04082429|590023313|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163358933|NCT04082429|590023314|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163358934|NCT04082429|590023315|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163358935|NCT04082429|590023316|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163358936|NCT04082429|590023317|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
163358937|NCT04082429|590023318|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163358938|NCT04082429|590023319|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163358939|NCT04082429|590023320|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163358940|NCT04082429|590023321|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163358941|NCT04082429|590023313|FG000|Main Part (After the Treatment Pause)|Death|0|||
163358942|NCT04082429|590023314|FG001|Main Part (After the Treatment Pause)|Death|0|||
163358943|NCT04082429|590023315|FG002|Main Part (After the Treatment Pause)|Death|0|||
163358944|NCT04082429|590023316|FG003|Main Part (After the Treatment Pause)|Death|0|||
163358945|NCT04082429|590023317|FG004|Main Part (After the Treatment Pause)|Death|1|||
163358946|NCT04082429|590023318|FG005|Main Part (After the Treatment Pause)|Death|0|||
163358947|NCT04082429|590023319|FG006|Main Part (After the Treatment Pause)|Death|0|||
163358948|NCT04082429|590023320|FG007|Main Part (After the Treatment Pause)|Death|0|||
163358949|NCT04082429|590023321|FG008|Main Part (After the Treatment Pause)|Death|0|||
163358950|NCT04082429|590023313|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
163358951|NCT04082429|590023314|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
163358952|NCT04082429|590023315|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
163358953|NCT04082429|590023316|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
163358954|NCT04082429|590023317|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
163358955|NCT04082429|590023318|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
163358956|NCT04082429|590023319|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
163358957|NCT04082429|590023320|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
163358958|NCT04082429|590023321|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
163358959|NCT04082429|590023313|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
163358960|NCT04082429|590023314|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
163358961|NCT04082429|590023315|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
163358962|NCT04082429|590023316|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
163358963|NCT04082429|590023317|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
163358964|NCT04082429|590023318|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
163358965|NCT04082429|590023319|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
163358966|NCT04082429|590023320|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
163358967|NCT04082429|590023321|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
163358968|NCT04082429|590023313|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
163358969|NCT04082429|590023314|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
163358970|NCT04082429|590023315|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
163358971|NCT04082429|590023316|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
163358972|NCT04082429|590023317|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
163358973|NCT04082429|590023318|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
163358974|NCT04082429|590023319|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
163358975|NCT04082429|590023320|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
163358976|NCT04082429|590023321|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
163358977|NCT04082429|590023313|FG000|Extension Part|Ongoing|0|||
163358978|NCT04082429|590023314|FG001|Extension Part|Ongoing|7|||
163358979|NCT04082429|590023315|FG002|Extension Part|Ongoing|17|||
163410570|NCT01425008|590211393|FG013|Dose Escalation Phase|Progressive Disease|0|||
163410571|NCT01425008|590211394|FG014|Dose Escalation Phase|Progressive Disease|0|||
163358980|NCT04082429|590023316|FG003|Extension Part|Ongoing|6|||
163358981|NCT04082429|590023317|FG004|Extension Part|Ongoing|45|||
163358982|NCT04082429|590023318|FG005|Extension Part|Ongoing|0|||
163358983|NCT04082429|590023319|FG006|Extension Part|Ongoing|10|||
163358984|NCT04082429|590023320|FG007|Extension Part|Ongoing|23|||
163358985|NCT04082429|590023321|FG008|Extension Part|Ongoing|25|||
163358986|NCT00334542|590023322|FG000|Overall Study|Adverse Event|3|||
163358987|NCT00334542|590023322|FG000|Overall Study|Withdrawal by Subject|1|||
163358988|NCT00334542|590023322|FG000|Overall Study|New cancer diagnosis|1|||
163358989|NCT03118050|590023323|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
163358990|NCT03118050|590023324|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
163358991|NCT03118050|590023325|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
163358992|NCT03118050|590023326|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
163358993|NCT03118050|590023327|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
163358994|NCT03118050|590023328|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
163358995|NCT03118050|590023329|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
163358996|NCT01454739|590023331|FG000|Overall Study|Protocol Violation|2|||
163358997|NCT01454739|590023332|FG001|Overall Study|Protocol Violation|3|||
163358998|NCT01454739|590023331|FG000|Overall Study|Withdrawal by Subject|2|||
163358999|NCT01454739|590023332|FG001|Overall Study|Withdrawal by Subject|6|||
163359000|NCT01454739|590023331|FG000|Overall Study|Other|3|||
163359001|NCT01454739|590023332|FG001|Overall Study|Other|5|||
163359002|NCT01454739|590023331|FG000|Overall Study|Physician Decision|0|||
163359003|NCT01454739|590023332|FG001|Overall Study|Physician Decision|5|||
163359004|NCT01454739|590023331|FG000|Overall Study|Lost to Follow-up|0|||
163359005|NCT01454739|590023332|FG001|Overall Study|Lost to Follow-up|1|||
163359006|NCT01454739|590023331|FG000|Overall Study|Adverse Event|0|||
163359007|NCT01454739|590023332|FG001|Overall Study|Adverse Event|1|||
163359008|NCT05765435|590023333|FG000|Overall Study|Lost to Follow-up|0|||
163359009|NCT05765435|590023334|FG001|Overall Study|Lost to Follow-up|1|||
163359010|NCT05765435|590023335|FG002|Overall Study|Lost to Follow-up|0|||
163359011|NCT05765435|590023333|FG000|Overall Study|Withdrawal by Subject|0|||
163359012|NCT05765435|590023334|FG001|Overall Study|Withdrawal by Subject|0|||
163359013|NCT05765435|590023335|FG002|Overall Study|Withdrawal by Subject|1|||
163359014|NCT04351269|590023336|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
163359015|NCT04351269|590023337|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
163359016|NCT04351269|590023338|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
163359017|NCT04351269|590023336|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
163359018|NCT04351269|590023337|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
163359019|NCT04351269|590023338|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
163359020|NCT04351269|590023336|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
163359021|NCT04351269|590023337|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
163359022|NCT04351269|590023338|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
163359023|NCT04351269|590023336|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
163359024|NCT04351269|590023337|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
163359025|NCT04351269|590023338|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
163359026|NCT04351269|590023336|FG000|Overall Study|Lost to Follow-up|1|||
163359027|NCT04351269|590023337|FG001|Overall Study|Lost to Follow-up|3|||
163359028|NCT04351269|590023338|FG002|Overall Study|Lost to Follow-up|0|||
163359029|NCT02980523|590023346|FG000|Overall Study|Lost to Follow-up|1|||
163359030|NCT02980523|590023347|FG001|Overall Study|Lost to Follow-up|4|||
163359031|NCT02980523|590023348|FG002|Overall Study|Lost to Follow-up|1|||
163359032|NCT02980523|590023349|FG003|Overall Study|Lost to Follow-up|2|||
163359033|NCT02980523|590023350|FG004|Overall Study|Lost to Follow-up|1|||
163359034|NCT02980523|590023346|FG000|Overall Study|Excluded from analysis|1|||
163359035|NCT02980523|590023347|FG001|Overall Study|Excluded from analysis|3|||
163359036|NCT02980523|590023348|FG002|Overall Study|Excluded from analysis|1|||
163359037|NCT02980523|590023349|FG003|Overall Study|Excluded from analysis|1|||
163359038|NCT02980523|590023350|FG004|Overall Study|Excluded from analysis|1|||
163359039|NCT02980523|590023346|FG000|Overall Study|Lack of Efficacy|1|||
163359040|NCT02980523|590023347|FG001|Overall Study|Lack of Efficacy|4|||
163359041|NCT02980523|590023348|FG002|Overall Study|Lack of Efficacy|4|||
163359042|NCT02980523|590023349|FG003|Overall Study|Lack of Efficacy|5|||
163359043|NCT02980523|590023350|FG004|Overall Study|Lack of Efficacy|8|||
163359044|NCT02980523|590023346|FG000|Overall Study|Did not receive intervention|0|||
163359045|NCT02980523|590023347|FG001|Overall Study|Did not receive intervention|0|||
163359046|NCT02980523|590023348|FG002|Overall Study|Did not receive intervention|0|||
163359047|NCT02980523|590023349|FG003|Overall Study|Did not receive intervention|1|||
163359048|NCT02980523|590023350|FG004|Overall Study|Did not receive intervention|0|||
163359049|NCT01236352|590023357|FG000|Overall Study|Death|0|||
163359050|NCT01236352|590023358|FG001|Overall Study|Death|0|||
163359051|NCT01236352|590023359|FG002|Overall Study|Death|0|||
163255186|NCT00595504|589640824|FG001|Overall Study|Withdrawal by Subject|3|||
163255187|NCT00595504|589640823|FG000|Overall Study|Physician Decision|1|||
163255188|NCT00595504|589640824|FG001|Overall Study|Physician Decision|0|||
163255189|NCT00293267|589640828|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
163255190|NCT00293267|589640829|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
163255191|NCT00293267|589640828|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
163255192|NCT00293267|589640829|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
163255193|NCT00293267|589640828|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
163255194|NCT00293267|589640829|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
163255195|NCT00293267|589640828|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
163255196|NCT00293267|589640829|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
163255197|NCT00293267|589640828|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
163255198|NCT00293267|589640829|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
163255199|NCT00293267|589640828|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
163255200|NCT00293267|589640829|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
163255201|NCT00293267|589640828|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
163255202|NCT00293267|589640829|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
163255203|NCT00293267|589640828|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
163255204|NCT00293267|589640829|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
163255205|NCT00293267|589640828|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
163255206|NCT00293267|589640829|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
163255207|NCT00293267|589640828|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
163255208|NCT00293267|589640829|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
163255209|NCT00293267|589640828|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
163255210|NCT00293267|589640829|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
163255211|NCT00293267|589640828|FG000|Extension - Double-Blind Week 49-156|Death|3|||
163255212|NCT00293267|589640829|FG001|Extension - Double-Blind Week 49-156|Death|0|||
163255213|NCT00293267|589640828|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
163255214|NCT00293267|589640829|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
163255215|NCT00293267|589640828|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
163255216|NCT00293267|589640829|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
163255217|NCT00293267|589640828|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
163255218|NCT00293267|589640829|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
163255219|NCT00293267|589640828|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
163255220|NCT00293267|589640829|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
163255221|NCT00293267|589640828|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
163255222|NCT00293267|589640829|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
163255223|NCT00293267|589640828|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
163255224|NCT00293267|589640829|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
163255225|NCT00293267|589640828|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
163255226|NCT00293267|589640829|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
163255227|NCT00293267|589640828|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
163255228|NCT00293267|589640829|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
163255229|NCT00293267|589640828|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
163255230|NCT00293267|589640829|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
163255231|NCT00293267|589640828|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
163255232|NCT00293267|589640829|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
163255233|NCT00293267|589640828|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
163255234|NCT00293267|589640829|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
163255235|NCT00293267|589640828|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
163255236|NCT00293267|589640829|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
163255237|NCT00293267|589640828|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
163255238|NCT00293267|589640829|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
163255239|NCT00293267|589640828|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
163255240|NCT00293267|589640829|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
163255241|NCT00293267|589640828|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
163255242|NCT00293267|589640829|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
163255243|NCT00293267|589640828|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
163255244|NCT00293267|589640829|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
163255245|NCT01804816|589640830|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
163255246|NCT01804816|589640830|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
163255247|NCT01754467|589640831|FG000|Overall Study|Lost to Follow-up|1|||
163359052|NCT01236352|590023360|FG003|Overall Study|Death|0|||
163359053|NCT01236352|590023361|FG004|Overall Study|Death|0|||
163359054|NCT01236352|590023362|FG005|Overall Study|Death|0|||
163359055|NCT01236352|590023363|FG006|Overall Study|Death|0|||
163255248|NCT01123382|589640834|FG000|Overall Study|Withdrawal by Subject|1|||
163255249|NCT01123382|589640835|FG001|Overall Study|Withdrawal by Subject|4|||
163255250|NCT01123382|589640834|FG000|Overall Study|Lost to Follow-up|1|||
163255251|NCT01123382|589640835|FG001|Overall Study|Lost to Follow-up|2|||
163255252|NCT02403180|589640836|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
163255253|NCT02403180|589640837|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
163255254|NCT02403180|589640836|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
163255255|NCT02403180|589640837|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
163255256|NCT02230956|589640840|FG000|Overall Study|Adverse Event|1|||
163255257|NCT02230956|589640841|FG001|Overall Study|Adverse Event|1|||
163255258|NCT02230956|589640842|FG002|Overall Study|Adverse Event|0|||
163255259|NCT02230956|589640840|FG000|Overall Study|Lack of Efficacy|1|||
163255260|NCT02230956|589640841|FG001|Overall Study|Lack of Efficacy|1|||
163255261|NCT02230956|589640842|FG002|Overall Study|Lack of Efficacy|1|||
163255262|NCT02230956|589640840|FG000|Overall Study|Lost to Follow-up|1|||
163255263|NCT02230956|589640841|FG001|Overall Study|Lost to Follow-up|1|||
163255264|NCT02230956|589640842|FG002|Overall Study|Lost to Follow-up|2|||
163255265|NCT02230956|589640840|FG000|Overall Study|Personal Reasons|2|||
163255266|NCT02230956|589640841|FG001|Overall Study|Personal Reasons|1|||
163255267|NCT02230956|589640842|FG002|Overall Study|Personal Reasons|1|||
163255268|NCT02230956|589640840|FG000|Overall Study|Protocol Violation|0|||
163255269|NCT02230956|589640841|FG001|Overall Study|Protocol Violation|1|||
163255270|NCT02230956|589640842|FG002|Overall Study|Protocol Violation|1|||
163255271|NCT02230956|589640840|FG000|Overall Study|Other Miscellaneous Reason|0|||
163255272|NCT02230956|589640841|FG001|Overall Study|Other Miscellaneous Reason|1|||
163255273|NCT02230956|589640842|FG002|Overall Study|Other Miscellaneous Reason|2|||
163255274|NCT01445652|589640843|FG000|Overall Study|Not comfortable in lenses|5|||
163255275|NCT01445652|589640844|FG001|Overall Study|Not comfortable in lenses|0|||
163255276|NCT01445652|589640843|FG000|Overall Study|Failed to attend scheduled visit|2|||
163255277|NCT01445652|589640844|FG001|Overall Study|Failed to attend scheduled visit|3|||
163255278|NCT01445652|589640843|FG000|Overall Study|Failed teach session|2|||
163255279|NCT01445652|589640844|FG001|Overall Study|Failed teach session|0|||
163255280|NCT01445652|589640843|FG000|Overall Study|Adverse Event|1|||
163255281|NCT01445652|589640844|FG001|Overall Study|Adverse Event|0|||
163255282|NCT03002610|589640845|FG000|Overall Study|Withdrawal by Subject|6|||
163255283|NCT03002610|589640846|FG001|Overall Study|Withdrawal by Subject|25|||
163255284|NCT03002610|589640847|FG002|Overall Study|Withdrawal by Subject|13|||
163255285|NCT00929162|589640848|FG000|Overall Study|Adverse Event|8|||
163255286|NCT00929162|589640849|FG001|Overall Study|Adverse Event|5|||
163255287|NCT00929162|589640848|FG000|Overall Study|Withdrawal by Subject|3|||
163255288|NCT00929162|589640849|FG001|Overall Study|Withdrawal by Subject|1|||
163255289|NCT00929162|589640848|FG000|Overall Study|Protocol Violation|32|||
163255290|NCT00929162|589640849|FG001|Overall Study|Protocol Violation|30|||
163255291|NCT00929162|589640848|FG000|Overall Study|Other termination reason|5|||
163255292|NCT00929162|589640849|FG001|Overall Study|Other termination reason|6|||
163255293|NCT01822587|589640850|FG000|Overall Study|Lost to Follow-up|7|||
163255294|NCT01822587|589640851|FG001|Overall Study|Lost to Follow-up|9|||
163255295|NCT01822587|589640852|FG002|Overall Study|Lost to Follow-up|12|||
163255296|NCT01822587|589640850|FG000|Overall Study|Physician Decision|9|||
163255297|NCT01822587|589640851|FG001|Overall Study|Physician Decision|6|||
163255298|NCT01822587|589640852|FG002|Overall Study|Physician Decision|6|||
163255299|NCT00658567|589640854|FG000|Overall Study|Adverse Event|5|||
163255300|NCT00658567|589640855|FG001|Overall Study|Adverse Event|2|||
163255301|NCT00658567|589640856|FG002|Overall Study|Adverse Event|3|||
163255302|NCT00658567|589640854|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
163255303|NCT00658567|589640855|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
163255304|NCT00658567|589640856|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
163255305|NCT00658567|589640854|FG000|Overall Study|Physician Decision|0|||
163359056|NCT01236352|590023364|FG007|Overall Study|Death|1|||
163359057|NCT01236352|590023365|FG008|Overall Study|Death|0|||
163359058|NCT01236352|590023366|FG009|Overall Study|Death|0|||
163359059|NCT01236352|590023367|FG010|Overall Study|Death|0|||
163359060|NCT01236352|590023357|FG000|Overall Study|Withdrawal by Subject|0|||
163359061|NCT01236352|590023358|FG001|Overall Study|Withdrawal by Subject|0|||
163255306|NCT00658567|589640855|FG001|Overall Study|Physician Decision|1|||
163255307|NCT00658567|589640856|FG002|Overall Study|Physician Decision|0|||
163255308|NCT00658567|589640854|FG000|Overall Study|At Discretion of Sponsor|1|||
163255309|NCT00658567|589640855|FG001|Overall Study|At Discretion of Sponsor|1|||
163255310|NCT00658567|589640856|FG002|Overall Study|At Discretion of Sponsor|1|||
163255311|NCT01755702|589640857|FG000|Wash Out Period I|Other Reason|3|||
163255312|NCT01755702|589640857|FG000|Washout Period II|Other Reason|5|||
163255313|NCT04860518|589640859|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
163255314|NCT04860518|589640860|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
163255315|NCT00636610|589640865|FG000|Overall Study|Adverse Event|4|||
163255316|NCT00636610|589640866|FG001|Overall Study|Adverse Event|4|||
163255317|NCT00636610|589640865|FG000|Overall Study|Death|6|||
163359062|NCT01236352|590023359|FG002|Overall Study|Withdrawal by Subject|0|||
163359063|NCT01236352|590023360|FG003|Overall Study|Withdrawal by Subject|0|||
163359064|NCT01236352|590023361|FG004|Overall Study|Withdrawal by Subject|0|||
163359065|NCT01236352|590023362|FG005|Overall Study|Withdrawal by Subject|0|||
163359066|NCT01236352|590023363|FG006|Overall Study|Withdrawal by Subject|0|||
163359067|NCT01236352|590023364|FG007|Overall Study|Withdrawal by Subject|0|||
163359068|NCT01236352|590023365|FG008|Overall Study|Withdrawal by Subject|0|||
163359069|NCT01236352|590023366|FG009|Overall Study|Withdrawal by Subject|2|||
163359070|NCT01236352|590023367|FG010|Overall Study|Withdrawal by Subject|1|||
163359071|NCT01236352|590023357|FG000|Overall Study|Adverse Event|0|||
163359072|NCT01236352|590023358|FG001|Overall Study|Adverse Event|0|||
163359073|NCT01236352|590023359|FG002|Overall Study|Adverse Event|0|||
163359074|NCT01236352|590023360|FG003|Overall Study|Adverse Event|0|||
163359075|NCT01236352|590023361|FG004|Overall Study|Adverse Event|0|||
163359076|NCT01236352|590023362|FG005|Overall Study|Adverse Event|0|||
163359077|NCT01236352|590023363|FG006|Overall Study|Adverse Event|2|||
163359078|NCT01236352|590023364|FG007|Overall Study|Adverse Event|0|||
163359079|NCT01236352|590023365|FG008|Overall Study|Adverse Event|0|||
163359080|NCT01236352|590023366|FG009|Overall Study|Adverse Event|4|||
163359081|NCT01236352|590023367|FG010|Overall Study|Adverse Event|1|||
163359082|NCT01236352|590023357|FG000|Overall Study|Study drug toxicity|0|||
163359083|NCT01236352|590023358|FG001|Overall Study|Study drug toxicity|0|||
163359084|NCT01236352|590023359|FG002|Overall Study|Study drug toxicity|0|||
163359085|NCT01236352|590023360|FG003|Overall Study|Study drug toxicity|0|||
163359086|NCT01236352|590023361|FG004|Overall Study|Study drug toxicity|0|||
163359087|NCT01236352|590023362|FG005|Overall Study|Study drug toxicity|1|||
163359088|NCT01236352|590023363|FG006|Overall Study|Study drug toxicity|1|||
163359089|NCT01236352|590023364|FG007|Overall Study|Study drug toxicity|0|||
163359090|NCT01236352|590023365|FG008|Overall Study|Study drug toxicity|0|||
163359091|NCT01236352|590023366|FG009|Overall Study|Study drug toxicity|2|||
163359092|NCT01236352|590023367|FG010|Overall Study|Study drug toxicity|2|||
163359093|NCT01236352|590023357|FG000|Overall Study|Disease progression|1|||
163359094|NCT01236352|590023358|FG001|Overall Study|Disease progression|2|||
163359095|NCT01236352|590023359|FG002|Overall Study|Disease progression|1|||
163359096|NCT01236352|590023360|FG003|Overall Study|Disease progression|2|||
163359097|NCT01236352|590023361|FG004|Overall Study|Disease progression|2|||
163359098|NCT01236352|590023362|FG005|Overall Study|Disease progression|2|||
163359099|NCT01236352|590023363|FG006|Overall Study|Disease progression|1|||
163359100|NCT01236352|590023364|FG007|Overall Study|Disease progression|3|||
163359101|NCT01236352|590023365|FG008|Overall Study|Disease progression|2|||
163359102|NCT01236352|590023366|FG009|Overall Study|Disease progression|2|||
163359103|NCT01236352|590023367|FG010|Overall Study|Disease progression|2|||
163359104|NCT01236352|590023357|FG000|Overall Study|Poor/Non-compliance|1|||
163359105|NCT01236352|590023358|FG001|Overall Study|Poor/Non-compliance|0|||
163359106|NCT01236352|590023359|FG002|Overall Study|Poor/Non-compliance|0|||
163359107|NCT01236352|590023360|FG003|Overall Study|Poor/Non-compliance|0|||
163359108|NCT01236352|590023361|FG004|Overall Study|Poor/Non-compliance|0|||
163359109|NCT01236352|590023362|FG005|Overall Study|Poor/Non-compliance|0|||
163359110|NCT01236352|590023363|FG006|Overall Study|Poor/Non-compliance|0|||
163359111|NCT01236352|590023364|FG007|Overall Study|Poor/Non-compliance|0|||
163359112|NCT01236352|590023365|FG008|Overall Study|Poor/Non-compliance|0|||
163359113|NCT01236352|590023366|FG009|Overall Study|Poor/Non-compliance|0|||
163359114|NCT01236352|590023367|FG010|Overall Study|Poor/Non-compliance|0|||
163359115|NCT01236352|590023357|FG000|Overall Study|Maximum clinical benefit|1|||
163359116|NCT01236352|590023358|FG001|Overall Study|Maximum clinical benefit|1|||
163359117|NCT01236352|590023359|FG002|Overall Study|Maximum clinical benefit|1|||
163359118|NCT01236352|590023360|FG003|Overall Study|Maximum clinical benefit|0|||
163359119|NCT01236352|590023361|FG004|Overall Study|Maximum clinical benefit|2|||
163359120|NCT01236352|590023362|FG005|Overall Study|Maximum clinical benefit|0|||
163359121|NCT01236352|590023363|FG006|Overall Study|Maximum clinical benefit|3|||
163359122|NCT01236352|590023364|FG007|Overall Study|Maximum clinical benefit|1|||
163359123|NCT01236352|590023365|FG008|Overall Study|Maximum clinical benefit|1|||
163359124|NCT01236352|590023366|FG009|Overall Study|Maximum clinical benefit|4|||
163359125|NCT01236352|590023367|FG010|Overall Study|Maximum clinical benefit|2|||
163359126|NCT01236352|590023357|FG000|Overall Study|Subject request to discontinue treatment|0|||
163359127|NCT01236352|590023358|FG001|Overall Study|Subject request to discontinue treatment|0|||
163359128|NCT01236352|590023359|FG002|Overall Study|Subject request to discontinue treatment|1|||
163359129|NCT01236352|590023360|FG003|Overall Study|Subject request to discontinue treatment|1|||
163359130|NCT01236352|590023361|FG004|Overall Study|Subject request to discontinue treatment|0|||
163359131|NCT01236352|590023362|FG005|Overall Study|Subject request to discontinue treatment|1|||
163359132|NCT01236352|590023363|FG006|Overall Study|Subject request to discontinue treatment|0|||
163359133|NCT01236352|590023364|FG007|Overall Study|Subject request to discontinue treatment|0|||
163359134|NCT01236352|590023365|FG008|Overall Study|Subject request to discontinue treatment|0|||
163359135|NCT01236352|590023366|FG009|Overall Study|Subject request to discontinue treatment|1|||
163359136|NCT01236352|590023367|FG010|Overall Study|Subject request to discontinue treatment|4|||
163359137|NCT01236352|590023357|FG000|Overall Study|Subject to receive drug via EAP|1|||
163359138|NCT01236352|590023358|FG001|Overall Study|Subject to receive drug via EAP|1|||
163359139|NCT01236352|590023359|FG002|Overall Study|Subject to receive drug via EAP|1|||
163384933|NCT00427895|590119252|FG002|Vax 1/Year 1 Follow-up|Other|0|||
163410572|NCT01425008|590211395|FG015|Dose Escalation Phase|Progressive Disease|0|||
163410573|NCT01425008|590211396|FG016|Dose Escalation Phase|Progressive Disease|0|||
163410574|NCT01425008|590211397|FG017|Dose Escalation Phase|Progressive Disease|0|||
163410575|NCT01425008|590211398|FG018|Dose Escalation Phase|Progressive Disease|0|||
163255318|NCT00636610|589640866|FG001|Overall Study|Death|3|||
163255319|NCT00636610|589640865|FG000|Overall Study|Physician decision to withdraw patient|15|||
163255320|NCT00636610|589640866|FG001|Overall Study|Physician decision to withdraw patient|9|||
163255321|NCT00636610|589640865|FG000|Overall Study|Subject decision to withdraw|15|||
163255322|NCT00636610|589640866|FG001|Overall Study|Subject decision to withdraw|11|||
163255323|NCT00636610|589640865|FG000|Overall Study|Disease progression - radiographic|41|||
163255324|NCT00636610|589640866|FG001|Overall Study|Disease progression - radiographic|51|||
163255325|NCT00636610|589640865|FG000|Overall Study|Disease progression - clinical|8|||
163255326|NCT00636610|589640866|FG001|Overall Study|Disease progression - clinical|3|||
163255327|NCT00636610|589640865|FG000|Overall Study|Reason for discontinuation not available|3|||
163255328|NCT00636610|589640866|FG001|Overall Study|Reason for discontinuation not available|2|||
163255329|NCT02151266|589640869|FG000|Overall Study|Lost to Follow-up|1|||
163255330|NCT02151266|589640870|FG001|Overall Study|Lost to Follow-up|4|||
163255331|NCT02151266|589640871|FG002|Overall Study|Lost to Follow-up|1|||
163255332|NCT02151266|589640869|FG000|Overall Study|Did NOT receive intervention|3|||
163255333|NCT02151266|589640870|FG001|Overall Study|Did NOT receive intervention|6|||
163255334|NCT02151266|589640871|FG002|Overall Study|Did NOT receive intervention|2|||
163255335|NCT02151266|589640869|FG000|Overall Study|Not able to exercise|4|||
163255336|NCT02151266|589640870|FG001|Overall Study|Not able to exercise|5|||
163255337|NCT02151266|589640871|FG002|Overall Study|Not able to exercise|4|||
163255338|NCT01169675|589640872|FG000|Overall Study|Progressive disease|13|||
163255339|NCT01169675|589640873|FG001|Overall Study|Progressive disease|2|||
163255340|NCT01169675|589640874|FG002|Overall Study|Progressive disease|5|||
163255341|NCT01169675|589640875|FG003|Overall Study|Progressive disease|15|||
163255342|NCT01169675|589640876|FG004|Overall Study|Progressive disease|1|||
163255343|NCT01169675|589640872|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
163255344|NCT01169675|589640873|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163255345|NCT01169675|589640874|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163255346|NCT01169675|589640875|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163255347|NCT01169675|589640876|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
163255348|NCT01169675|589640872|FG000|Overall Study|Adverse Event|5|||
163255349|NCT01169675|589640873|FG001|Overall Study|Adverse Event|1|||
163255350|NCT01169675|589640874|FG002|Overall Study|Adverse Event|2|||
163255351|NCT01169675|589640875|FG003|Overall Study|Adverse Event|0|||
163255352|NCT01169675|589640876|FG004|Overall Study|Adverse Event|0|||
163255353|NCT01169675|589640872|FG000|Overall Study|Withdrawal by Subject|1|||
163255354|NCT01169675|589640873|FG001|Overall Study|Withdrawal by Subject|0|||
163255355|NCT01169675|589640874|FG002|Overall Study|Withdrawal by Subject|0|||
163255356|NCT01169675|589640875|FG003|Overall Study|Withdrawal by Subject|1|||
163255357|NCT01169675|589640876|FG004|Overall Study|Withdrawal by Subject|2|||
163255358|NCT01169675|589640872|FG000|Overall Study|Other Reason Not Defined Above|0|||
163255359|NCT01169675|589640873|FG001|Overall Study|Other Reason Not Defined Above|0|||
163255360|NCT01169675|589640874|FG002|Overall Study|Other Reason Not Defined Above|0|||
163255361|NCT01169675|589640875|FG003|Overall Study|Other Reason Not Defined Above|1|||
163255362|NCT01169675|589640876|FG004|Overall Study|Other Reason Not Defined Above|1|||
163255363|NCT04102579|589640879|FG000|Overall Study|Withdrawal by Subject|3|||
163255364|NCT04102579|589640880|FG001|Overall Study|Withdrawal by Subject|4|||
163255365|NCT04102579|589640879|FG000|Overall Study|Lost to Follow-up|0|||
163255366|NCT04102579|589640880|FG001|Overall Study|Lost to Follow-up|1|||
163255367|NCT04102579|589640879|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
163255368|NCT04102579|589640880|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
163255369|NCT04102579|589640879|FG000|Overall Study|Other than Specified|1|||
163255370|NCT04102579|589640880|FG001|Overall Study|Other than Specified|0|||
163255371|NCT04102579|589640879|FG000|Overall Study|Not Dosed with Study Drug|0|||
163255372|NCT04102579|589640880|FG001|Overall Study|Not Dosed with Study Drug|1|||
163255373|NCT05899686|589640881|FG000|Overall Study|Protocol Violation|1|||
163255374|NCT00572195|589640882|FG000|Overall Study|Withdrawal by Subject|50|||
163255375|NCT00572195|589640882|FG000|Overall Study|Death|9|||
163255376|NCT00572195|589640882|FG000|Overall Study|Adverse Event|4|||
163255377|NCT00572195|589640882|FG000|Overall Study|Lost to Follow-up|5|||
163255378|NCT03076970|589642662|FG000|Washout Period 2|Adverse Event|0|||
163255379|NCT03076970|589642663|FG001|Washout Period 2|Adverse Event|0|||
163255380|NCT03076970|589642664|FG002|Washout Period 2|Adverse Event|0|||
163255381|NCT03076970|589642665|FG003|Washout Period 2|Adverse Event|0|||
163255382|NCT03076970|589642666|FG004|Washout Period 2|Adverse Event|1|||
163255383|NCT03076970|589642667|FG005|Washout Period 2|Adverse Event|0|||
163255384|NCT03076970|589642662|FG000|Period 3|Withdrawal by Subject|0|||
163255385|NCT03076970|589642663|FG001|Period 3|Withdrawal by Subject|0|||
163255386|NCT03076970|589642664|FG002|Period 3|Withdrawal by Subject|0|||
163255387|NCT03076970|589642665|FG003|Period 3|Withdrawal by Subject|0|||
163255388|NCT03076970|589642666|FG004|Period 3|Withdrawal by Subject|0|||
163255389|NCT03076970|589642667|FG005|Period 3|Withdrawal by Subject|1|||
163255390|NCT03076970|589642662|FG000|Period 3|Failure to meet I/E criteria|0|||
163255391|NCT03076970|589642663|FG001|Period 3|Failure to meet I/E criteria|0|||
163255392|NCT03076970|589642664|FG002|Period 3|Failure to meet I/E criteria|0|||
163255393|NCT03076970|589642665|FG003|Period 3|Failure to meet I/E criteria|0|||
163255394|NCT03076970|589642666|FG004|Period 3|Failure to meet I/E criteria|1|||
163255395|NCT03076970|589642667|FG005|Period 3|Failure to meet I/E criteria|0|||
163255396|NCT00949884|589642668|FG000|Overall Study|Adverse Event|14|||
163255397|NCT00949884|589642669|FG001|Overall Study|Adverse Event|3|||
163255398|NCT00949884|589642670|FG002|Overall Study|Adverse Event|12|||
163255399|NCT00949884|589642668|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
163255400|NCT00949884|589642669|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
163255401|NCT00949884|589642670|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
163255402|NCT00949884|589642668|FG000|Overall Study|Lost to Follow-up|7|||
163255403|NCT00949884|589642669|FG001|Overall Study|Lost to Follow-up|5|||
163255404|NCT00949884|589642670|FG002|Overall Study|Lost to Follow-up|5|||
163255405|NCT00949884|589642668|FG000|Overall Study|Physician Decision|5|||
163255406|NCT00949884|589642669|FG001|Overall Study|Physician Decision|0|||
163255407|NCT00949884|589642670|FG002|Overall Study|Physician Decision|6|||
163255408|NCT00949884|589642668|FG000|Overall Study|Treatment non-compliance|5|||
163255409|NCT00949884|589642669|FG001|Overall Study|Treatment non-compliance|0|||
163255410|NCT00949884|589642670|FG002|Overall Study|Treatment non-compliance|8|||
163255411|NCT00949884|589642668|FG000|Overall Study|Withdrawal by Subject|13|||
163255412|NCT00949884|589642669|FG001|Overall Study|Withdrawal by Subject|4|||
163255413|NCT00949884|589642670|FG002|Overall Study|Withdrawal by Subject|16|||
163255414|NCT00949884|589642668|FG000|Overall Study|Lack of Efficacy|4|||
163255415|NCT00949884|589642669|FG001|Overall Study|Lack of Efficacy|2|||
163255416|NCT00949884|589642670|FG002|Overall Study|Lack of Efficacy|7|||
163255417|NCT00949884|589642668|FG000|Overall Study|Study terminated by sponsor|0|||
163255418|NCT00949884|589642669|FG001|Overall Study|Study terminated by sponsor|0|||
163255419|NCT00949884|589642670|FG002|Overall Study|Study terminated by sponsor|1|||
163255420|NCT03391765|589642678|FG000|Overall Study|Adverse Event|2|||
163255421|NCT03391765|589642679|FG001|Overall Study|Adverse Event|0|||
163255422|NCT03391765|589642680|FG002|Overall Study|Adverse Event|0|||
163255423|NCT03391765|589642681|FG003|Overall Study|Adverse Event|2|||
163255424|NCT03391765|589642678|FG000|Overall Study|Withdrew consent|5|||
163255425|NCT03391765|589642679|FG001|Overall Study|Withdrew consent|7|||
163255426|NCT03391765|589642680|FG002|Overall Study|Withdrew consent|2|||
163255427|NCT03391765|589642681|FG003|Overall Study|Withdrew consent|5|||
163255428|NCT03391765|589642678|FG000|Overall Study|Other, not specified|44|||
163255429|NCT03391765|589642679|FG001|Overall Study|Other, not specified|38|||
163255430|NCT03391765|589642680|FG002|Overall Study|Other, not specified|21|||
163255431|NCT03391765|589642681|FG003|Overall Study|Other, not specified|16|||
163255432|NCT00662857|589642686|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
163255433|NCT00662857|589642687|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
163255434|NCT00662857|589642686|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
163255435|NCT00662857|589642687|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
163255436|NCT00662857|589642686|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
163255437|NCT00662857|589642687|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
163255438|NCT03966053|589642688|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
163255439|NCT02832622|589642690|FG000|Overall Study|MPP not programmed|1259|||
163255440|NCT02832622|589642690|FG000|Overall Study|Withdrawal by Subject|123|||
163255441|NCT02832622|589642690|FG000|Overall Study|Death|119|||
163255442|NCT02832622|589642690|FG000|Overall Study|Unsuccessful CRT implant|93|||
163359140|NCT01236352|590023360|FG003|Overall Study|Subject to receive drug via EAP|0|||
163359141|NCT01236352|590023361|FG004|Overall Study|Subject to receive drug via EAP|0|||
163359142|NCT01236352|590023362|FG005|Overall Study|Subject to receive drug via EAP|0|||
163359143|NCT01236352|590023363|FG006|Overall Study|Subject to receive drug via EAP|0|||
163359144|NCT01236352|590023364|FG007|Overall Study|Subject to receive drug via EAP|2|||
163359145|NCT01236352|590023365|FG008|Overall Study|Subject to receive drug via EAP|0|||
163255443|NCT02832622|589642690|FG000|Overall Study|Lost to Follow-up|45|||
163255444|NCT02832622|589642690|FG000|Overall Study|Patient non-compliance|42|||
163255445|NCT02832622|589642690|FG000|Overall Study|Withdrawal by other reasons|25|||
163255446|NCT02832622|589642690|FG000|Overall Study|System explant|24|||
163255447|NCT02832622|589642690|FG000|Overall Study|Physician Decision|6|||
163255448|NCT00998400|589642691|FG000|Overall Study|Lack of interest/motivation|1|||
163359146|NCT01236352|590023366|FG009|Overall Study|Subject to receive drug via EAP|4|||
163359147|NCT01236352|590023367|FG010|Overall Study|Subject to receive drug via EAP|0|||
163359148|NCT01236352|590023357|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
163359149|NCT01236352|590023358|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
163255449|NCT00998400|589642692|FG001|Overall Study|Lack of interest/motivation|2|||
163255450|NCT00998400|589642691|FG000|Overall Study|Logistical problems|1|||
163255451|NCT00998400|589642692|FG001|Overall Study|Logistical problems|0|||
163255452|NCT00800202|589642694|FG000|Overall Study|Adverse Event|7|||
163255453|NCT00800202|589642695|FG001|Overall Study|Adverse Event|6|||
163255454|NCT00800202|589642694|FG000|Overall Study|Death|1|||
163255455|NCT00800202|589642695|FG001|Overall Study|Death|0|||
163255456|NCT00800202|589642694|FG000|Overall Study|Other|5|||
163255457|NCT00800202|589642695|FG001|Overall Study|Other|0|||
163255458|NCT00800202|589642694|FG000|Overall Study|Disease Progression|54|||
163255459|NCT00800202|589642695|FG001|Overall Study|Disease Progression|18|||
163255460|NCT02691182|589642696|FG000|Overall Study|Withdrawal by Subject|4|||
163255461|NCT02691182|589642697|FG001|Overall Study|Withdrawal by Subject|7|||
163255462|NCT02691182|589642698|FG002|Overall Study|Withdrawal by Subject|6|||
163255463|NCT02691182|589642699|FG003|Overall Study|Withdrawal by Subject|8|||
163255464|NCT02691182|589642696|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
163255465|NCT02691182|589642697|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
163255466|NCT02691182|589642698|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
163255467|NCT02691182|589642699|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
163255468|NCT02691182|589642696|FG000|Overall Study|Lost to Follow-up|8|||
163255469|NCT02691182|589642697|FG001|Overall Study|Lost to Follow-up|33|||
163255470|NCT02691182|589642698|FG002|Overall Study|Lost to Follow-up|19|||
163255471|NCT02691182|589642699|FG003|Overall Study|Lost to Follow-up|22|||
163255472|NCT02691182|589642696|FG000|Overall Study|Adverse Event|3|||
163255473|NCT02691182|589642697|FG001|Overall Study|Adverse Event|10|||
163255474|NCT02691182|589642698|FG002|Overall Study|Adverse Event|10|||
163255475|NCT02691182|589642699|FG003|Overall Study|Adverse Event|11|||
163255476|NCT02691182|589642696|FG000|Overall Study|Physician Decision|3|||
163255477|NCT02691182|589642697|FG001|Overall Study|Physician Decision|7|||
163255478|NCT02691182|589642698|FG002|Overall Study|Physician Decision|14|||
163255479|NCT02691182|589642699|FG003|Overall Study|Physician Decision|8|||
163255480|NCT02691182|589642696|FG000|Overall Study|Lack of Efficacy|0|||
163255481|NCT02691182|589642697|FG001|Overall Study|Lack of Efficacy|0|||
163255482|NCT02691182|589642698|FG002|Overall Study|Lack of Efficacy|0|||
163255483|NCT02691182|589642699|FG003|Overall Study|Lack of Efficacy|4|||
163255484|NCT02691182|589642696|FG000|Overall Study|Protocol Violation|2|||
163255485|NCT02691182|589642697|FG001|Overall Study|Protocol Violation|6|||
163255486|NCT02691182|589642698|FG002|Overall Study|Protocol Violation|6|||
163255487|NCT02691182|589642699|FG003|Overall Study|Protocol Violation|8|||
163255488|NCT02691182|589642696|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
163255489|NCT02691182|589642697|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
163255490|NCT02691182|589642698|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
163255491|NCT02691182|589642699|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
163255492|NCT02691182|589642696|FG000|Overall Study|Missing|0|||
163255493|NCT02691182|589642697|FG001|Overall Study|Missing|5|||
163255494|NCT02691182|589642698|FG002|Overall Study|Missing|1|||
163255495|NCT02691182|589642699|FG003|Overall Study|Missing|5|||
163255496|NCT00105235|589642700|FG000|Overall Study|Death|4|||
163255497|NCT00105235|589642700|FG000|Overall Study|Physician Decision|1|||
163255498|NCT00105235|589642700|FG000|Overall Study|Withdrawal by Subject|2|||
163255499|NCT02052310|589642701|FG000|Overall Study|Death|64|||
163255500|NCT02052310|589642702|FG001|Overall Study|Death|54|||
163255501|NCT02052310|589642701|FG000|Overall Study|Withdrawal by Subject|37|||
163255502|NCT02052310|589642702|FG001|Overall Study|Withdrawal by Subject|49|||
163255503|NCT02052310|589642701|FG000|Overall Study|Other than specified|32|||
163255504|NCT02052310|589642702|FG001|Overall Study|Other than specified|29|||
163255505|NCT02052310|589642701|FG000|Overall Study|Adverse Event|29|||
163255506|NCT02052310|589642702|FG001|Overall Study|Adverse Event|22|||
163255507|NCT02052310|589642701|FG000|Overall Study|Kidney Transplant|23|||
163255508|NCT02052310|589642702|FG001|Overall Study|Kidney Transplant|29|||
163255509|NCT02052310|589642701|FG000|Overall Study|Physician Decision|14|||
163255510|NCT02052310|589642702|FG001|Overall Study|Physician Decision|7|||
163255511|NCT02052310|589642701|FG000|Overall Study|Lack of Efficacy|6|||
163255512|NCT02052310|589642702|FG001|Overall Study|Lack of Efficacy|1|||
163255513|NCT02052310|589642701|FG000|Overall Study|Site Terminated by Sponsor|5|||
163359150|NCT01236352|590023359|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
163359151|NCT01236352|590023360|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
163255514|NCT02052310|589642702|FG001|Overall Study|Site Terminated by Sponsor|13|||
163255515|NCT02052310|589642701|FG000|Overall Study|Lost to Follow-up|4|||
163255516|NCT02052310|589642702|FG001|Overall Study|Lost to Follow-up|2|||
163255517|NCT02052310|589642701|FG000|Overall Study|Protocol Violation|1|||
163255518|NCT02052310|589642702|FG001|Overall Study|Protocol Violation|6|||
163255519|NCT01964326|589642703|FG000|Overall Study|Adverse Event|48|||
163255520|NCT01964326|589642703|FG000|Overall Study|Death|2|||
163384934|NCT00427895|590119253|FG003|Vax 1/Year 1 Follow-up|Other|2|||
163255521|NCT01964326|589642703|FG000|Overall Study|Protocol Violation|4|||
163255522|NCT01964326|589642703|FG000|Overall Study|Lost to Follow-up|88|||
163255523|NCT01964326|589642703|FG000|Overall Study|Withdrawal by Subject|87|||
163255524|NCT01964326|589642703|FG000|Overall Study|Pregnancy|1|||
163255525|NCT01964326|589642703|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
163255526|NCT01964326|589642703|FG000|Overall Study|Physician Decision|55|||
163255527|NCT01964326|589642703|FG000|Overall Study|Investigator Discretion|1|||
163255528|NCT01964326|589642703|FG000|Overall Study|Other|9|||
163255529|NCT01964326|589642703|FG000|Overall Study|Did not meet eligibility criteria|1|||
163255530|NCT02563002|589642706|FG000|Overall Study|Death|72|||
163151418|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163151419|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
163151420|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
163151421|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
163151422|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
163151423|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
163151424|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
163151425|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
163151426|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
163151427|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
163151428|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
163151429|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
163151430|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
163151431|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
163151432|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
163151433|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
163151434|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
163151435|NCT00804908|589269374|FG000|Overall Study|Other|115|||
163151436|NCT00804908|589269375|FG001|Overall Study|Other|116|||
163151437|NCT00804908|589269376|FG002|Overall Study|Other|114|||
163151438|NCT01280903|589269377|FG000|Overall Study|Lost to Follow-up|23|||
163151439|NCT01280903|589269378|FG001|Overall Study|Lost to Follow-up|16|||
163151440|NCT03829228|589269379|FG000|Overall Study|Protocol Violation|1|||
163151441|NCT02177695|589269380|FG000|ITT Analysis|Ineligible|5|||
163151442|NCT02177695|589269381|FG001|ITT Analysis|Ineligible|5|||
163151443|NCT02177695|589269380|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
163151444|NCT02177695|589269381|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
163151445|NCT02177695|589269380|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
163151446|NCT02177695|589269381|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
163151447|NCT02177695|589269380|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
163151448|NCT02177695|589269381|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
163151449|NCT00744497|589269384|FG000|Overall Study|Withdrawal by Subject|21|||
163151450|NCT00744497|589269385|FG001|Overall Study|Withdrawal by Subject|18|||
163151451|NCT00744497|589269384|FG000|Overall Study|Death|11|||
163151452|NCT00744497|589269385|FG001|Overall Study|Death|9|||
163151453|NCT00744497|589269384|FG000|Overall Study|Lost to Follow-up|4|||
163151454|NCT00744497|589269385|FG001|Overall Study|Lost to Follow-up|2|||
163151455|NCT00744497|589269384|FG000|Overall Study|Poor compliance/noncompliance|9|||
163151456|NCT00744497|589269385|FG001|Overall Study|Poor compliance/noncompliance|5|||
163151457|NCT00744497|589269384|FG000|Overall Study|No longer meets study criteria|7|||
163151458|NCT00744497|589269385|FG001|Overall Study|No longer meets study criteria|3|||
163151459|NCT00744497|589269384|FG000|Overall Study|Administrative Reason By Sponsor|25|||
163151460|NCT00744497|589269385|FG001|Overall Study|Administrative Reason By Sponsor|8|||
163151461|NCT00744497|589269384|FG000|Overall Study|Disease progression|312|||
163151462|NCT00744497|589269385|FG001|Overall Study|Disease progression|219|||
163151463|NCT00744497|589269384|FG000|Overall Study|Study drug toxicity|68|||
163151464|NCT00744497|589269385|FG001|Overall Study|Study drug toxicity|141|||
163151465|NCT00744497|589269384|FG000|Overall Study|Adverse event unrelated to study drug|78|||
163151466|NCT00744497|589269385|FG001|Overall Study|Adverse event unrelated to study drug|122|||
163151467|NCT00744497|589269384|FG000|Overall Study|Patient requested to stop study drug|65|||
163151468|NCT00744497|589269385|FG001|Overall Study|Patient requested to stop study drug|80|||
163151469|NCT00744497|589269384|FG000|Overall Study|Maximum clinical benefit|141|||
163151470|NCT00744497|589269385|FG001|Overall Study|Maximum clinical benefit|142|||
163151471|NCT00744497|589269384|FG000|Overall Study|Not defined|19|||
163151472|NCT00744497|589269385|FG001|Overall Study|Not defined|13|||
163151473|NCT02443688|589269386|FG000|Overall Study|Adverse Event|2|||
163151474|NCT02443688|589269387|FG001|Overall Study|Adverse Event|3|||
163151475|NCT02443688|589269388|FG002|Overall Study|Adverse Event|2|||
163151476|NCT02443688|589269386|FG000|Overall Study|Lost to Follow-up|1|||
163151477|NCT02443688|589269387|FG001|Overall Study|Lost to Follow-up|0|||
163151478|NCT02443688|589269388|FG002|Overall Study|Lost to Follow-up|0|||
163151479|NCT02443688|589269386|FG000|Overall Study|Physician Decision|3|||
163151480|NCT02443688|589269387|FG001|Overall Study|Physician Decision|0|||
163151481|NCT02443688|589269388|FG002|Overall Study|Physician Decision|1|||
163151482|NCT02443688|589269386|FG000|Overall Study|Pregnancy|0|||
163151483|NCT02443688|589269387|FG001|Overall Study|Pregnancy|0|||
163151484|NCT02443688|589269388|FG002|Overall Study|Pregnancy|1|||
163151485|NCT02443688|589269386|FG000|Overall Study|Withdrawal by Subject|3|||
163151486|NCT02443688|589269387|FG001|Overall Study|Withdrawal by Subject|3|||
163151487|NCT02443688|589269388|FG002|Overall Study|Withdrawal by Subject|4|||
163151488|NCT02443688|589269386|FG000|Overall Study|Non-compliance with study drug|1|||
163151489|NCT02443688|589269387|FG001|Overall Study|Non-compliance with study drug|2|||
163151490|NCT02443688|589269388|FG002|Overall Study|Non-compliance with study drug|4|||
163151491|NCT02443688|589269386|FG000|Overall Study|Sponsor Request|2|||
163151492|NCT02443688|589269387|FG001|Overall Study|Sponsor Request|1|||
163151493|NCT02443688|589269388|FG002|Overall Study|Sponsor Request|0|||
163151494|NCT00726063|589269390|FG000|Overall Study|Adverse Event|9|||
163151495|NCT00726063|589269391|FG001|Overall Study|Adverse Event|7|||
163151496|NCT02007096|589269392|FG000|Overall Study|medication not available|2|||
163151497|NCT02007096|589269393|FG001|Overall Study|medication not available|0|||
163151498|NCT02007096|589269392|FG000|Overall Study|did not inject saline|0|||
163151499|NCT02007096|589269393|FG001|Overall Study|did not inject saline|3|||
163151500|NCT02007096|589269392|FG000|Overall Study|did not follow postoperative protocol|8|||
163151501|NCT02007096|589269393|FG001|Overall Study|did not follow postoperative protocol|11|||
163151502|NCT02007096|589269392|FG000|Overall Study|converted to open surgery|1|||
163151503|NCT02007096|589269393|FG001|Overall Study|converted to open surgery|1|||
163151504|NCT02007096|589269392|FG000|Overall Study|no mesh placed|0|||
163151505|NCT02007096|589269393|FG001|Overall Study|no mesh placed|1|||
163151506|NCT00837434|589269395|FG000|Overall Study|Physician Decision|3|||
163151507|NCT00837434|589269396|FG001|Overall Study|Physician Decision|0|||
163151508|NCT00837434|589269395|FG000|Overall Study|Lost to Follow-up|1|||
163151509|NCT00837434|589269396|FG001|Overall Study|Lost to Follow-up|1|||
163151510|NCT00837434|589269395|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
163151511|NCT00837434|589269396|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
163151512|NCT00837434|589269395|FG000|Overall Study|Noncompliant|2|||
163151513|NCT00837434|589269396|FG001|Overall Study|Noncompliant|0|||
163151514|NCT00837434|589269395|FG000|Overall Study|Baseline assessments not done in time|1|||
163151515|NCT00837434|589269396|FG001|Overall Study|Baseline assessments not done in time|0|||
163151516|NCT00837434|589269395|FG000|Overall Study|Unable to obtain study drug|1|||
163151517|NCT00837434|589269396|FG001|Overall Study|Unable to obtain study drug|0|||
163151518|NCT03044106|589269397|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
163151519|NCT03044106|589269398|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
163151520|NCT01207414|589269399|FG000|Overall Study|Adverse Event|25|||
163151521|NCT01207414|589269400|FG001|Overall Study|Adverse Event|39|||
163151522|NCT01207414|589269399|FG000|Overall Study|Abnormal test procedure results|0|||
163151523|NCT01207414|589269400|FG001|Overall Study|Abnormal test procedure results|1|||
163151524|NCT01207414|589269399|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
163151525|NCT01207414|589269400|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
163151526|NCT01207414|589269399|FG000|Overall Study|Patient withdrew consent|14|||
163255531|NCT02563002|589642707|FG001|Overall Study|Death|87|||
163255532|NCT02563002|589642706|FG000|Overall Study|Lost to Follow-up|5|||
163255533|NCT02563002|589642707|FG001|Overall Study|Lost to Follow-up|0|||
163255534|NCT02563002|589642706|FG000|Overall Study|Physician Decision|0|||
163255535|NCT02563002|589642707|FG001|Overall Study|Physician Decision|2|||
163255536|NCT02563002|589642706|FG000|Overall Study|Withdrawal by Subject|2|||
163255537|NCT02563002|589642707|FG001|Overall Study|Withdrawal by Subject|10|||
163255538|NCT02563002|589642706|FG000|Overall Study|Sponsor decision|74|||
163255539|NCT02563002|589642707|FG001|Overall Study|Sponsor decision|55|||
163255540|NCT03518125|589642708|FG000|Overall Study|Lost to Follow-up|0|||
163255541|NCT03518125|589642709|FG001|Overall Study|Lost to Follow-up|2|||
163255542|NCT03518125|589642710|FG002|Overall Study|Lost to Follow-up|0|||
163255543|NCT03518125|589642711|FG003|Overall Study|Lost to Follow-up|0|||
163255544|NCT03518125|589642712|FG004|Overall Study|Lost to Follow-up|3|||
163255545|NCT03518125|589642713|FG005|Overall Study|Lost to Follow-up|5|||
163255546|NCT03518125|589642708|FG000|Overall Study|Physician Decision|0|||
163255547|NCT03518125|589642709|FG001|Overall Study|Physician Decision|1|||
163255548|NCT03518125|589642710|FG002|Overall Study|Physician Decision|0|||
163255549|NCT03518125|589642711|FG003|Overall Study|Physician Decision|0|||
163255550|NCT03518125|589642712|FG004|Overall Study|Physician Decision|0|||
163255551|NCT03518125|589642713|FG005|Overall Study|Physician Decision|0|||
163255552|NCT03518125|589642708|FG000|Overall Study|Withdrawal by Subject|1|||
163255553|NCT03518125|589642709|FG001|Overall Study|Withdrawal by Subject|1|||
163255554|NCT03518125|589642710|FG002|Overall Study|Withdrawal by Subject|0|||
163255555|NCT03518125|589642711|FG003|Overall Study|Withdrawal by Subject|1|||
163255556|NCT03518125|589642712|FG004|Overall Study|Withdrawal by Subject|1|||
163255557|NCT03518125|589642713|FG005|Overall Study|Withdrawal by Subject|3|||
163255558|NCT03518125|589642708|FG000|Overall Study|Missed Day 394 Visit|1|||
163255559|NCT03518125|589642709|FG001|Overall Study|Missed Day 394 Visit|0|||
163255560|NCT03518125|589642710|FG002|Overall Study|Missed Day 394 Visit|0|||
163255561|NCT03518125|589642711|FG003|Overall Study|Missed Day 394 Visit|0|||
163255562|NCT03518125|589642712|FG004|Overall Study|Missed Day 394 Visit|0|||
163255563|NCT03518125|589642713|FG005|Overall Study|Missed Day 394 Visit|0|||
163255564|NCT02093663|589642718|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
163255565|NCT02093663|589642719|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
163255566|NCT02093663|589642720|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
163255567|NCT02093663|589642721|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
163255568|NCT02093663|589642722|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
163359152|NCT01236352|590023361|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
163359153|NCT01236352|590023362|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
163359154|NCT01236352|590023363|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
163359155|NCT01236352|590023364|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
163359156|NCT01236352|590023365|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
163359157|NCT01236352|590023366|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
163359158|NCT01236352|590023367|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
163359159|NCT01236352|590023357|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163359160|NCT01236352|590023358|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163359161|NCT01236352|590023359|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163359162|NCT01236352|590023360|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163359163|NCT01236352|590023361|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163359164|NCT01236352|590023362|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163359165|NCT01236352|590023363|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163359166|NCT01236352|590023364|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163359167|NCT01236352|590023365|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163359168|NCT01236352|590023366|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163359169|NCT01236352|590023367|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
163359170|NCT01236352|590023357|FG000|Overall Study|Lack of response to drug|0|||
163359171|NCT01236352|590023358|FG001|Overall Study|Lack of response to drug|0|||
163359172|NCT01236352|590023359|FG002|Overall Study|Lack of response to drug|0|||
163359173|NCT01236352|590023360|FG003|Overall Study|Lack of response to drug|0|||
163359174|NCT01236352|590023361|FG004|Overall Study|Lack of response to drug|0|||
163359175|NCT01236352|590023362|FG005|Overall Study|Lack of response to drug|0|||
163359176|NCT01236352|590023363|FG006|Overall Study|Lack of response to drug|0|||
163359177|NCT01236352|590023364|FG007|Overall Study|Lack of response to drug|0|||
163359178|NCT01236352|590023365|FG008|Overall Study|Lack of response to drug|0|||
163359179|NCT01236352|590023366|FG009|Overall Study|Lack of response to drug|1|||
163359180|NCT01236352|590023367|FG010|Overall Study|Lack of response to drug|1|||
163359181|NCT01236352|590023357|FG000|Overall Study|Patient transferred to IST|0|||
163359182|NCT01236352|590023358|FG001|Overall Study|Patient transferred to IST|0|||
163359183|NCT01236352|590023359|FG002|Overall Study|Patient transferred to IST|0|||
163359184|NCT01236352|590023360|FG003|Overall Study|Patient transferred to IST|0|||
163359185|NCT01236352|590023361|FG004|Overall Study|Patient transferred to IST|0|||
163359186|NCT01236352|590023362|FG005|Overall Study|Patient transferred to IST|0|||
163359187|NCT01236352|590023363|FG006|Overall Study|Patient transferred to IST|0|||
163359188|NCT01236352|590023364|FG007|Overall Study|Patient transferred to IST|0|||
163359189|NCT01236352|590023365|FG008|Overall Study|Patient transferred to IST|0|||
163359190|NCT01236352|590023366|FG009|Overall Study|Patient transferred to IST|2|||
163359191|NCT01236352|590023367|FG010|Overall Study|Patient transferred to IST|6|||
163359192|NCT05903183|590023372|FG000|Main Trial Part (365 Days)|Death|1|||
163359193|NCT05903183|590023373|FG001|Main Trial Part (365 Days)|Death|0|||
163359194|NCT05903183|590023374|FG002|Main Trial Part (365 Days)|Death|0|||
163359195|NCT05903183|590023375|FG003|Main Trial Part (365 Days)|Death|0|||
163359196|NCT05903183|590023376|FG004|Main Trial Part (365 Days)|Death|0|||
163359197|NCT05903183|590023372|FG000|Main Trial Part (365 Days)|Other|1|||
163359198|NCT05903183|590023373|FG001|Main Trial Part (365 Days)|Other|2|||
163255569|NCT02093663|589642718|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
163255570|NCT02093663|589642719|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163255571|NCT02093663|589642720|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163255572|NCT02093663|589642721|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163255573|NCT02093663|589642722|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163255574|NCT02093663|589642718|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
163255575|NCT02093663|589642719|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
163255576|NCT02093663|589642720|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
163255577|NCT02093663|589642721|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
163255578|NCT02093663|589642722|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
163255579|NCT02093663|589642718|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
163255580|NCT02093663|589642719|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
163255581|NCT02093663|589642720|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
163255582|NCT02093663|589642721|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
163255583|NCT02093663|589642722|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
163255584|NCT02093663|589642718|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163255585|NCT02093663|589642719|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163255586|NCT02093663|589642720|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
163255587|NCT02093663|589642721|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163255588|NCT02093663|589642722|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163255589|NCT02093663|589642718|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
163255590|NCT02093663|589642719|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
163359199|NCT05903183|590023374|FG002|Main Trial Part (365 Days)|Other|1|||
163359200|NCT05903183|590023375|FG003|Main Trial Part (365 Days)|Other|0|||
163359201|NCT05903183|590023376|FG004|Main Trial Part (365 Days)|Other|0|||
163359202|NCT05903183|590023372|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
163359203|NCT05903183|590023373|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
163359204|NCT05903183|590023374|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
163359205|NCT05903183|590023375|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
163359206|NCT05903183|590023376|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
163359207|NCT05903183|590023372|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
163359208|NCT05903183|590023373|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
163359209|NCT05903183|590023374|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
163359210|NCT05903183|590023375|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
163359211|NCT05903183|590023376|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
163359212|NCT05903183|590023372|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
163359213|NCT05903183|590023373|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
163359214|NCT05903183|590023374|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
163359215|NCT05903183|590023375|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
163359216|NCT05903183|590023376|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
163359217|NCT03149029|590023377|FG000|Overall Study|Adverse Event|2|||
163359218|NCT03149029|590023378|FG001|Overall Study|Adverse Event|0|||
163359219|NCT03735121|590023379|FG000|Overall Study|Death|3|||
163359220|NCT03735121|590023380|FG001|Overall Study|Death|6|||
163359221|NCT03735121|590023381|FG002|Overall Study|Death|19|||
163359222|NCT03735121|590023382|FG003|Overall Study|Death|97|||
163359223|NCT03735121|590023383|FG004|Overall Study|Death|205|||
163359224|NCT03735121|590023379|FG000|Overall Study|Lost to Follow-up|0|||
163359225|NCT03735121|590023380|FG001|Overall Study|Lost to Follow-up|0|||
163359226|NCT03735121|590023381|FG002|Overall Study|Lost to Follow-up|0|||
163359227|NCT03735121|590023382|FG003|Overall Study|Lost to Follow-up|2|||
163359228|NCT03735121|590023383|FG004|Overall Study|Lost to Follow-up|3|||
163359229|NCT03735121|590023379|FG000|Overall Study|New Therapy|0|||
163359230|NCT03735121|590023380|FG001|Overall Study|New Therapy|1|||
163359231|NCT03735121|590023381|FG002|Overall Study|New Therapy|0|||
163359232|NCT03735121|590023382|FG003|Overall Study|New Therapy|0|||
163359233|NCT03735121|590023383|FG004|Overall Study|New Therapy|0|||
163359234|NCT03735121|590023379|FG000|Overall Study|Study Ended by Sponsor|1|||
163359235|NCT03735121|590023380|FG001|Overall Study|Study Ended by Sponsor|0|||
163359236|NCT03735121|590023381|FG002|Overall Study|Study Ended by Sponsor|1|||
163359237|NCT03735121|590023382|FG003|Overall Study|Study Ended by Sponsor|17|||
163359238|NCT03735121|590023383|FG004|Overall Study|Study Ended by Sponsor|28|||
163359239|NCT03735121|590023379|FG000|Overall Study|Withdrawal by Subject|1|||
163359240|NCT03735121|590023380|FG001|Overall Study|Withdrawal by Subject|1|||
163359241|NCT03735121|590023381|FG002|Overall Study|Withdrawal by Subject|6|||
163359242|NCT03735121|590023382|FG003|Overall Study|Withdrawal by Subject|8|||
163359243|NCT03735121|590023383|FG004|Overall Study|Withdrawal by Subject|11|||
163359244|NCT02176863|590023384|FG000|Overall Study|Physician Decision|1|||
163359245|NCT02176863|590023385|FG001|Overall Study|Physician Decision|0|||
163359246|NCT02176863|590023386|FG002|Overall Study|Physician Decision|0|||
163359247|NCT02176863|590023387|FG003|Overall Study|Physician Decision|0|||
163359248|NCT02176863|590023388|FG004|Overall Study|Physician Decision|0|||
163359249|NCT02176863|590023384|FG000|Overall Study|Adverse Event|10|||
163359250|NCT02176863|590023385|FG001|Overall Study|Adverse Event|4|||
163359251|NCT02176863|590023386|FG002|Overall Study|Adverse Event|4|||
163359252|NCT02176863|590023387|FG003|Overall Study|Adverse Event|1|||
163359253|NCT02176863|590023388|FG004|Overall Study|Adverse Event|1|||
163359254|NCT02176863|590023384|FG000|Overall Study|Protocol Violation|2|||
163359255|NCT02176863|590023385|FG001|Overall Study|Protocol Violation|0|||
163359256|NCT02176863|590023386|FG002|Overall Study|Protocol Violation|1|||
163359257|NCT02176863|590023387|FG003|Overall Study|Protocol Violation|1|||
163359258|NCT02176863|590023388|FG004|Overall Study|Protocol Violation|0|||
163359259|NCT02176863|590023384|FG000|Overall Study|Withdrawal by Subject|4|||
163359260|NCT02176863|590023385|FG001|Overall Study|Withdrawal by Subject|2|||
163359261|NCT02176863|590023386|FG002|Overall Study|Withdrawal by Subject|2|||
163359262|NCT02176863|590023387|FG003|Overall Study|Withdrawal by Subject|3|||
163359263|NCT02176863|590023388|FG004|Overall Study|Withdrawal by Subject|4|||
163359264|NCT02176863|590023384|FG000|Overall Study|Reason not specified|0|||
163359265|NCT02176863|590023385|FG001|Overall Study|Reason not specified|1|||
163359266|NCT02176863|590023386|FG002|Overall Study|Reason not specified|1|||
163359267|NCT02176863|590023387|FG003|Overall Study|Reason not specified|2|||
163359268|NCT02176863|590023388|FG004|Overall Study|Reason not specified|1|||
163359269|NCT02176863|590023384|FG000|Overall Study|Lost to Follow-up|0|||
163359270|NCT02176863|590023385|FG001|Overall Study|Lost to Follow-up|1|||
163359271|NCT02176863|590023386|FG002|Overall Study|Lost to Follow-up|1|||
163359272|NCT02176863|590023387|FG003|Overall Study|Lost to Follow-up|0|||
163359273|NCT02176863|590023388|FG004|Overall Study|Lost to Follow-up|0|||
163359274|NCT02647645|590023389|FG000|Overall Study|Lost to Follow-up|2|||
163359275|NCT02647645|590023390|FG001|Overall Study|Lost to Follow-up|1|||
163359276|NCT02037256|590023391|FG000|Overall Study|Protocol Violation|0|||
163359277|NCT02037256|590023392|FG001|Overall Study|Protocol Violation|1|||
163359278|NCT02037256|590023391|FG000|Overall Study|Withdrawn prior to Velcade|0|||
163359279|NCT02037256|590023392|FG001|Overall Study|Withdrawn prior to Velcade|2|||
163359280|NCT04599907|590023397|FG000|Overall Study|Withdrawal by Subject|1|||
163359281|NCT04599907|590023398|FG001|Overall Study|Withdrawal by Subject|7|||
163359282|NCT04599907|590023399|FG002|Overall Study|Withdrawal by Subject|6|||
163359283|NCT04599907|590023397|FG000|Overall Study|Lost to Follow-up|0|||
163359284|NCT04599907|590023398|FG001|Overall Study|Lost to Follow-up|1|||
163359285|NCT04599907|590023399|FG002|Overall Study|Lost to Follow-up|0|||
163359286|NCT03007732|590023400|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
163359287|NCT03007732|590023401|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
163359288|NCT03007732|590023402|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
163359289|NCT03007732|590023403|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
163359290|NCT03371823|590023404|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
163359291|NCT03371823|590023405|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
163359292|NCT01466790|590023407|FG000|Overall Study|Adverse Event|1|||
163359293|NCT01466790|590023408|FG001|Overall Study|Adverse Event|0|||
163359294|NCT01466790|590023409|FG002|Overall Study|Adverse Event|0|||
163359295|NCT01466790|590023410|FG003|Overall Study|Adverse Event|0|||
163359296|NCT01466790|590023411|FG004|Overall Study|Adverse Event|2|||
163359297|NCT01466790|590023412|FG005|Overall Study|Adverse Event|0|||
163359298|NCT01466790|590023413|FG006|Overall Study|Adverse Event|0|||
163359299|NCT01466790|590023414|FG007|Overall Study|Adverse Event|0|||
163359300|NCT01466790|590023407|FG000|Overall Study|Lost to Follow-up|2|||
163359301|NCT01466790|590023408|FG001|Overall Study|Lost to Follow-up|0|||
163359302|NCT01466790|590023409|FG002|Overall Study|Lost to Follow-up|0|||
163359303|NCT01466790|590023410|FG003|Overall Study|Lost to Follow-up|0|||
163359304|NCT01466790|590023411|FG004|Overall Study|Lost to Follow-up|0|||
163359305|NCT01466790|590023412|FG005|Overall Study|Lost to Follow-up|0|||
163359306|NCT01466790|590023413|FG006|Overall Study|Lost to Follow-up|0|||
163359307|NCT01466790|590023414|FG007|Overall Study|Lost to Follow-up|0|||
163359308|NCT01466790|590023407|FG000|Overall Study|Withdrawal by Subject|1|||
163359309|NCT01466790|590023408|FG001|Overall Study|Withdrawal by Subject|1|||
163359310|NCT01466790|590023409|FG002|Overall Study|Withdrawal by Subject|0|||
163359311|NCT01466790|590023410|FG003|Overall Study|Withdrawal by Subject|0|||
163359312|NCT01466790|590023411|FG004|Overall Study|Withdrawal by Subject|1|||
163359313|NCT01466790|590023412|FG005|Overall Study|Withdrawal by Subject|0|||
163359314|NCT01466790|590023413|FG006|Overall Study|Withdrawal by Subject|1|||
163359315|NCT01466790|590023414|FG007|Overall Study|Withdrawal by Subject|1|||
163359316|NCT01310699|590023415|FG000|Overall Study|Patients did not complete tandem.|4|||
163359317|NCT01310699|590023416|FG001|Overall Study|Patients did not complete tandem.|6|||
163359318|NCT02386839|590023417|FG000|Overall Study|Death|1|||
163359319|NCT02386839|590023418|FG001|Overall Study|Death|0|||
163359320|NCT02386839|590023417|FG000|Overall Study|Withdrawal by Subject|9|||
163359321|NCT02386839|590023418|FG001|Overall Study|Withdrawal by Subject|10|||
163359322|NCT02386839|590023417|FG000|Overall Study|Lost to Follow-up|4|||
163359323|NCT02386839|590023418|FG001|Overall Study|Lost to Follow-up|4|||
163359324|NCT02386839|590023417|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
163359325|NCT02386839|590023418|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
163359326|NCT02386839|590023417|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
163359327|NCT02386839|590023418|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
163359328|NCT02386839|590023417|FG000|Overall Study|Other (unspecified)|1|||
163359329|NCT02386839|590023418|FG001|Overall Study|Other (unspecified)|0|||
163359330|NCT00926575|590023419|FG000|Overall Study|Adverse Event|1|||
163359331|NCT00926575|590023420|FG001|Overall Study|Adverse Event|1|||
163359332|NCT00926575|590023419|FG000|Overall Study|Death|4|||
163359333|NCT00926575|590023420|FG001|Overall Study|Death|4|||
163359334|NCT00926575|590023419|FG000|Overall Study|Lost to Follow-up|1|||
163359335|NCT00926575|590023420|FG001|Overall Study|Lost to Follow-up|1|||
163359336|NCT00926575|590023419|FG000|Overall Study|Physician Decision|1|||
163359337|NCT00926575|590023420|FG001|Overall Study|Physician Decision|2|||
163359338|NCT00926575|590023419|FG000|Overall Study|Protocol Violation|1|||
163359339|NCT00926575|590023420|FG001|Overall Study|Protocol Violation|0|||
163359340|NCT00926575|590023419|FG000|Overall Study|Withdrawal by Subject|8|||
163359341|NCT00926575|590023420|FG001|Overall Study|Withdrawal by Subject|9|||
163359342|NCT00490698|590023421|FG000|Overall Study|Withdrawal by Subject|1|||
163359343|NCT00490698|590023421|FG000|Overall Study|Disease Progression|7|||
163359344|NCT00490698|590023421|FG000|Overall Study|Physician Decision|2|||
163359345|NCT02101983|590023422|FG000|Overall Study|Physician Decision|1|||
163359346|NCT02101983|590023423|FG001|Overall Study|Physician Decision|0|||
163359347|NCT04124471|590023428|FG000|Overall Study|screen failure|1|||
163359348|NCT03668223|590023429|FG000|Overall Study|Death|10|||
163359349|NCT03668223|590023430|FG001|Overall Study|Death|5|||
163359350|NCT03668223|590023429|FG000|Overall Study|Lost to Follow-up|12|||
163359351|NCT03668223|590023430|FG001|Overall Study|Lost to Follow-up|12|||
163359352|NCT03668223|590023429|FG000|Overall Study|Withdrawal by Subject|8|||
163255591|NCT02093663|589642720|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
163255592|NCT02093663|589642721|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
163255593|NCT02093663|589642722|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
163255594|NCT02093663|589642718|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
163255595|NCT02093663|589642719|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
163255596|NCT02093663|589642720|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
163255597|NCT02093663|589642721|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
163255598|NCT02093663|589642722|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
163255599|NCT02093663|589642718|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
163255600|NCT02093663|589642719|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
163359353|NCT03668223|590023430|FG001|Overall Study|Withdrawal by Subject|3|||
163359354|NCT05502783|590023431|FG000|Overall Study|Lack of Efficacy|1|||
163359355|NCT04870957|590023432|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
163359356|NCT04870957|590023433|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
163255601|NCT02093663|589642720|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
163255602|NCT02093663|589642721|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
163255603|NCT02093663|589642722|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
163255604|NCT02093663|589642718|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
163255605|NCT02093663|589642719|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
163255606|NCT02093663|589642720|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
163255607|NCT02093663|589642721|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
163255608|NCT02093663|589642722|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
163255609|NCT00508404|589642723|FG000|Overall Study|Ongoing at Data Cut-off|12|||
163255610|NCT00508404|589642723|FG000|Overall Study|Adverse Event|2|||
163255611|NCT00508404|589642723|FG000|Overall Study|Death|16|||
163255612|NCT00508404|589642723|FG000|Overall Study|Physician Decision|2|||
163255613|NCT00508404|589642723|FG000|Overall Study|Withdrawal by Subject|3|||
163255614|NCT00508404|589642723|FG000|Overall Study|Protocol-specified Criteria|2|||
163255615|NCT00508404|589642723|FG000|Overall Study|Lost to Follow-up|2|||
163255616|NCT00508404|589642723|FG000|Overall Study|Other - Not Specified|3|||
163255617|NCT05453110|589642724|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
163255618|NCT05453110|589642725|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
163255619|NCT05453110|589642726|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
163255620|NCT01505387|589642727|FG000|Overall Study|Protocol Violation|1|||
163255621|NCT01505387|589642728|FG001|Overall Study|Protocol Violation|0|||
163255622|NCT01505387|589642727|FG000|Overall Study|Withdrawal by Subject|1|||
163255623|NCT01505387|589642728|FG001|Overall Study|Withdrawal by Subject|1|||
163255624|NCT01197508|589642729|FG000|Overall Study|Withdrawal by Subject|8|||
163255625|NCT01197508|589642730|FG001|Overall Study|Withdrawal by Subject|7|||
163255626|NCT01197508|589642731|FG002|Overall Study|Withdrawal by Subject|15|||
163255627|NCT01197508|589642732|FG003|Overall Study|Withdrawal by Subject|4|||
163255628|NCT01197508|589642729|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
163255629|NCT01197508|589642730|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
163255630|NCT01197508|589642731|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
163255631|NCT01197508|589642732|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
163255632|NCT01197508|589642729|FG000|Overall Study|Adverse Event|10|||
163255633|NCT01197508|589642730|FG001|Overall Study|Adverse Event|13|||
163255634|NCT01197508|589642731|FG002|Overall Study|Adverse Event|23|||
163255635|NCT01197508|589642732|FG003|Overall Study|Adverse Event|3|||
163255636|NCT01197508|589642729|FG000|Overall Study|Severe non-compliance to protocol|0|||
163255637|NCT01197508|589642730|FG001|Overall Study|Severe non-compliance to protocol|3|||
163255638|NCT01197508|589642731|FG002|Overall Study|Severe non-compliance to protocol|1|||
163255639|NCT01197508|589642732|FG003|Overall Study|Severe non-compliance to protocol|3|||
163255640|NCT01197508|589642729|FG000|Overall Study|Condition under investigation worsened|1|||
163255641|NCT01197508|589642730|FG001|Overall Study|Condition under investigation worsened|1|||
163255642|NCT01197508|589642731|FG002|Overall Study|Condition under investigation worsened|1|||
163255643|NCT01197508|589642732|FG003|Overall Study|Condition under investigation worsened|1|||
163255644|NCT01197508|589642729|FG000|Overall Study|Lack of Efficacy|1|||
163255645|NCT01197508|589642730|FG001|Overall Study|Lack of Efficacy|2|||
163255646|NCT01197508|589642731|FG002|Overall Study|Lack of Efficacy|2|||
163255647|NCT01197508|589642732|FG003|Overall Study|Lack of Efficacy|1|||
163255648|NCT01197508|589642729|FG000|Overall Study|Study-specific withdrawal criteria|0|||
163255649|NCT01197508|589642730|FG001|Overall Study|Study-specific withdrawal criteria|0|||
163255650|NCT01197508|589642731|FG002|Overall Study|Study-specific withdrawal criteria|1|||
163359357|NCT04870957|590023434|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
163255651|NCT01197508|589642732|FG003|Overall Study|Study-specific withdrawal criteria|2|||
163359358|NCT04870957|590023435|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
163255652|NCT01197508|589642729|FG000|Overall Study|Lost to Follow-up|1|||
163255653|NCT01197508|589642730|FG001|Overall Study|Lost to Follow-up|1|||
163255654|NCT01197508|589642731|FG002|Overall Study|Lost to Follow-up|2|||
163359359|NCT04870957|590023436|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
163359360|NCT04870957|590023437|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
163359361|NCT04870957|590023432|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
163359362|NCT04870957|590023433|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
163359363|NCT04870957|590023434|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
163359364|NCT04870957|590023435|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
163359365|NCT04870957|590023436|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
163359366|NCT04870957|590023437|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
163359367|NCT04870957|590023432|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
163359368|NCT04870957|590023433|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
163359369|NCT04870957|590023434|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
163359370|NCT04870957|590023435|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
163359371|NCT04870957|590023436|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
163359372|NCT04870957|590023437|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
163359373|NCT04870957|590023432|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
163359374|NCT04870957|590023433|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
163359375|NCT04870957|590023434|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
163359376|NCT04870957|590023435|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
163359377|NCT04870957|590023436|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
163359378|NCT04870957|590023437|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
163359379|NCT04870957|590023432|FG000|T2 (Randomization) - T3|Adverse Event|1|||
163359380|NCT04870957|590023433|FG001|T2 (Randomization) - T3|Adverse Event|1|||
163359381|NCT04870957|590023434|FG002|T2 (Randomization) - T3|Adverse Event|0|||
163359382|NCT04870957|590023435|FG003|T2 (Randomization) - T3|Adverse Event|0|||
163359383|NCT04870957|590023436|FG004|T2 (Randomization) - T3|Adverse Event|0|||
163359384|NCT04870957|590023437|FG005|T2 (Randomization) - T3|Adverse Event|0|||
163359385|NCT04870957|590023432|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
163359386|NCT04870957|590023433|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
163359387|NCT04870957|590023434|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
163359388|NCT04870957|590023435|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
163359389|NCT04870957|590023436|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
163359390|NCT04870957|590023437|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
163359391|NCT04870957|590023432|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
163359392|NCT04870957|590023433|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
163359393|NCT04870957|590023434|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
163359394|NCT04870957|590023435|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
163359395|NCT04870957|590023436|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
163359396|NCT04870957|590023437|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
163359397|NCT04870957|590023432|FG000|T2 (Randomization) - T3|Physician Decision|0|||
163359398|NCT04870957|590023433|FG001|T2 (Randomization) - T3|Physician Decision|0|||
163359399|NCT04870957|590023434|FG002|T2 (Randomization) - T3|Physician Decision|2|||
163359400|NCT04870957|590023435|FG003|T2 (Randomization) - T3|Physician Decision|1|||
163359401|NCT04870957|590023436|FG004|T2 (Randomization) - T3|Physician Decision|0|||
163359402|NCT04870957|590023437|FG005|T2 (Randomization) - T3|Physician Decision|0|||
163359403|NCT04870957|590023432|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
163359404|NCT04870957|590023433|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
163359405|NCT04870957|590023434|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
163359406|NCT04870957|590023435|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
163359407|NCT04870957|590023436|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
163359408|NCT04870957|590023437|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
163359409|NCT04870957|590023432|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
163359410|NCT04870957|590023433|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
163359411|NCT04870957|590023434|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
163359412|NCT04870957|590023435|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
163359413|NCT04870957|590023436|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
163359414|NCT04870957|590023437|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
163359415|NCT04870957|590023432|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
163359416|NCT04870957|590023433|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
163359417|NCT04870957|590023434|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
163359418|NCT04870957|590023435|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
163359419|NCT04870957|590023436|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
163359420|NCT04870957|590023437|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
163359421|NCT04870957|590023432|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
163359422|NCT04870957|590023433|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
163359423|NCT04870957|590023434|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
163359424|NCT04870957|590023435|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
163359425|NCT04870957|590023436|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
163359426|NCT04870957|590023437|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
163359427|NCT04870957|590023432|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
163359428|NCT04870957|590023433|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
163359429|NCT04870957|590023434|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
163359430|NCT04870957|590023435|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
163359431|NCT04870957|590023436|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
163359432|NCT04870957|590023437|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
163359433|NCT04870957|590023432|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
163359434|NCT04870957|590023433|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
163359435|NCT04870957|590023434|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
163359436|NCT04870957|590023435|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
163359437|NCT04870957|590023436|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
163359438|NCT04870957|590023437|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
163359439|NCT04870957|590023432|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
163359440|NCT04870957|590023433|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
163359441|NCT04870957|590023434|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
163359442|NCT04870957|590023435|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
163359443|NCT04870957|590023436|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
163359444|NCT04870957|590023437|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
163359445|NCT04870957|590023432|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
163359446|NCT04870957|590023433|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
163359447|NCT04870957|590023434|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
163359448|NCT04870957|590023435|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
163359449|NCT04870957|590023436|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
163359450|NCT04870957|590023437|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
163359451|NCT04870957|590023432|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
163359452|NCT04870957|590023433|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
163359453|NCT04870957|590023434|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
163359454|NCT04870957|590023435|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
163359455|NCT04870957|590023436|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
163359456|NCT04870957|590023437|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
163359457|NCT05970640|590023438|FG000|Overall Study|Adverse Event|1|||
163359458|NCT05970640|590023439|FG001|Overall Study|Adverse Event|3|||
163359459|NCT05970640|590023440|FG002|Overall Study|Adverse Event|1|||
163359460|NCT05970640|590023441|FG003|Overall Study|Adverse Event|0|||
163359461|NCT05970640|590023438|FG000|Overall Study|Withdrawal by Subject|0|||
163359462|NCT05970640|590023439|FG001|Overall Study|Withdrawal by Subject|0|||
163359463|NCT05970640|590023440|FG002|Overall Study|Withdrawal by Subject|1|||
163359464|NCT05970640|590023441|FG003|Overall Study|Withdrawal by Subject|1|||
163359465|NCT05970640|590023438|FG000|Overall Study|Sponsor decision|0|||
163359466|NCT05970640|590023439|FG001|Overall Study|Sponsor decision|0|||
163359467|NCT05970640|590023440|FG002|Overall Study|Sponsor decision|1|||
163359468|NCT05970640|590023441|FG003|Overall Study|Sponsor decision|1|||
163359469|NCT02394925|590023442|FG000|Overall Study|Adverse Event|1|||
163359470|NCT02394925|590023442|FG000|Overall Study|Lens Discomfort|3|||
163359471|NCT02394925|590023442|FG000|Overall Study|Lens handling difficulities|5|||
163359472|NCT02394925|590023442|FG000|Overall Study|Lost to Follow-up|9|||
163359473|NCT02394925|590023442|FG000|Overall Study|Protocol Violation|5|||
163359474|NCT02394925|590023442|FG000|Overall Study|No longer meet eligibility criteria|1|||
163359475|NCT02394925|590023442|FG000|Overall Study|Unsatisfactory Visual Response|5|||
163359476|NCT04340843|590023448|FG000|Overall Study|Adverse Event|0|||
163359477|NCT04340843|590023449|FG001|Overall Study|Adverse Event|2|||
163359478|NCT04340843|590023448|FG000|Overall Study|Withdrawal by Subject|0|||
163359479|NCT04340843|590023449|FG001|Overall Study|Withdrawal by Subject|2|||
163359480|NCT03733899|590023452|FG000|Period 1|Protocol Violation|0|||
163359481|NCT03733899|590023453|FG001|Period 1|Protocol Violation|0|||
163359482|NCT03733899|590023454|FG002|Period 1|Protocol Violation|0|||
163359483|NCT03733899|590023455|FG003|Period 1|Protocol Violation|0|||
163359484|NCT03733899|590023456|FG004|Period 1|Protocol Violation|0|||
163359485|NCT03733899|590023457|FG005|Period 1|Protocol Violation|1|||
163359486|NCT03733899|590023452|FG000|Period 2|Unscuccessful Treatment|0|||
163359487|NCT03733899|590023453|FG001|Period 2|Unscuccessful Treatment|1|||
163359488|NCT03733899|590023454|FG002|Period 2|Unscuccessful Treatment|0|||
163359489|NCT03733899|590023455|FG003|Period 2|Unscuccessful Treatment|0|||
163359490|NCT03733899|590023456|FG004|Period 2|Unscuccessful Treatment|0|||
163359491|NCT03733899|590023457|FG005|Period 2|Unscuccessful Treatment|0|||
163359492|NCT03733899|590023452|FG000|Period 3|Withdrawal by Subject|1|||
163359493|NCT03733899|590023453|FG001|Period 3|Withdrawal by Subject|0|||
163359494|NCT03733899|590023454|FG002|Period 3|Withdrawal by Subject|0|||
163359495|NCT03733899|590023455|FG003|Period 3|Withdrawal by Subject|0|||
163359496|NCT03733899|590023456|FG004|Period 3|Withdrawal by Subject|0|||
163359497|NCT03733899|590023457|FG005|Period 3|Withdrawal by Subject|0|||
163359498|NCT04650698|590025070|FG000|Overall Study|Protocol Violation|2|||
163359499|NCT04650698|590025071|FG001|Overall Study|Protocol Violation|1|||
163359500|NCT04650698|590025070|FG000|Overall Study|Withdrawal by Subject|0|||
163359501|NCT04650698|590025071|FG001|Overall Study|Withdrawal by Subject|1|||
163359502|NCT02358668|590025072|FG000|Overall Study|Adverse Event|2|||
163359503|NCT02358668|590025073|FG001|Overall Study|Adverse Event|0|||
163359504|NCT02358668|590025074|FG002|Overall Study|Adverse Event|0|||
163359505|NCT02358668|590025072|FG000|Overall Study|Withdrawal by Subject|0|||
163359506|NCT02358668|590025073|FG001|Overall Study|Withdrawal by Subject|1|||
163359507|NCT02358668|590025074|FG002|Overall Study|Withdrawal by Subject|0|||
163359508|NCT02104505|590025075|FG000|First Intervention (14 Days)|Adverse Event|2|||
163359509|NCT02104505|590025076|FG001|First Intervention (14 Days)|Adverse Event|0|||
163359510|NCT02104505|590025075|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
163359511|NCT02104505|590025076|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
163359512|NCT02104505|590025075|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
163359513|NCT02104505|590025076|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
163359514|NCT02104505|590025075|FG000|First Intervention (14 Days)|exclusionary condition|0|||
163359515|NCT02104505|590025076|FG001|First Intervention (14 Days)|exclusionary condition|1|||
163359516|NCT02104505|590025075|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
163359517|NCT02104505|590025076|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
163359518|NCT02104505|590025075|FG000|Second Intervention (14 Days)|Adverse Event|2|||
163359519|NCT02104505|590025076|FG001|Second Intervention (14 Days)|Adverse Event|0|||
163359520|NCT02859064|590025077|FG000|Overall Study|Progressive Disease|3|||
163359521|NCT02859064|590025077|FG000|Overall Study|Physician Decision|1|||
163359522|NCT02859064|590025077|FG000|Overall Study|Withdrawal by Subject|1|||
163359523|NCT02859064|590025077|FG000|Overall Study|Death|1|||
163359524|NCT01730950|590025080|FG000|Overall Study|Protocol Violation|6|||
163359525|NCT01730950|590025081|FG001|Overall Study|Protocol Violation|6|||
163359526|NCT02737826|590025082|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
163359527|NCT02737826|590025083|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
163359528|NCT02737826|590025084|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
163359529|NCT00078377|590025085|FG000|Overall Study|Adverse Event|2|||
163359530|NCT00078377|590025086|FG001|Overall Study|Adverse Event|5|||
163359531|NCT00078377|590025087|FG002|Overall Study|Adverse Event|1|||
163359532|NCT00078377|590025085|FG000|Overall Study|Lack of Efficacy|2|||
163359533|NCT00078377|590025086|FG001|Overall Study|Lack of Efficacy|0|||
163359534|NCT00078377|590025087|FG002|Overall Study|Lack of Efficacy|2|||
163359535|NCT00078377|590025085|FG000|Overall Study|Lost to Follow-up|0|||
163359536|NCT00078377|590025086|FG001|Overall Study|Lost to Follow-up|1|||
163359537|NCT00078377|590025087|FG002|Overall Study|Lost to Follow-up|1|||
163359538|NCT00078377|590025085|FG000|Overall Study|Physician Decision|2|||
163359539|NCT00078377|590025086|FG001|Overall Study|Physician Decision|0|||
163359540|NCT00078377|590025087|FG002|Overall Study|Physician Decision|0|||
163359541|NCT00078377|590025085|FG000|Overall Study|Withdrawal by Subject|3|||
163359542|NCT00078377|590025086|FG001|Overall Study|Withdrawal by Subject|4|||
163359543|NCT00078377|590025087|FG002|Overall Study|Withdrawal by Subject|4|||
163359544|NCT00078377|590025085|FG000|Overall Study|Miscellaneous|2|||
163359545|NCT00078377|590025086|FG001|Overall Study|Miscellaneous|6|||
163359546|NCT00078377|590025087|FG002|Overall Study|Miscellaneous|1|||
163359547|NCT02568397|590025088|FG000|Period 2|Withdrawal by Subject|0|||
163359548|NCT02568397|590025089|FG001|Period 2|Withdrawal by Subject|1|||
163359549|NCT02568397|590025088|FG000|Period 2|Physician Decision|0|||
163359550|NCT02568397|590025089|FG001|Period 2|Physician Decision|1|||
163359551|NCT02354651|590025090|FG000|Overall Study|Withdrawal by Subject|2|||
163359552|NCT02354651|590025090|FG000|Overall Study|Physician Decision|1|||
163359553|NCT01317875|590025091|FG000|Overall Study|Other|0|||
163359554|NCT01317875|590025092|FG001|Overall Study|Other|0|||
163359555|NCT01317875|590025093|FG002|Overall Study|Other|1|||
163359556|NCT01317875|590025094|FG003|Overall Study|Other|0|||
163359557|NCT01317875|590025095|FG004|Overall Study|Other|0|||
163359558|NCT01317875|590025096|FG005|Overall Study|Other|0|||
163359559|NCT01317875|590025097|FG006|Overall Study|Other|0|||
163359560|NCT01317875|590025098|FG007|Overall Study|Other|0|||
163359561|NCT01317875|590025099|FG008|Overall Study|Other|0|||
163359562|NCT01317875|590025100|FG009|Overall Study|Other|0|||
163359563|NCT01317875|590025091|FG000|Overall Study|Noncompliance with study drug|0|||
163359564|NCT01317875|590025092|FG001|Overall Study|Noncompliance with study drug|0|||
163359565|NCT01317875|590025093|FG002|Overall Study|Noncompliance with study drug|1|||
163359566|NCT01317875|590025094|FG003|Overall Study|Noncompliance with study drug|0|||
163359567|NCT01317875|590025095|FG004|Overall Study|Noncompliance with study drug|0|||
163359568|NCT01317875|590025096|FG005|Overall Study|Noncompliance with study drug|0|||
163359569|NCT01317875|590025097|FG006|Overall Study|Noncompliance with study drug|0|||
163359570|NCT01317875|590025098|FG007|Overall Study|Noncompliance with study drug|0|||
163359571|NCT01317875|590025099|FG008|Overall Study|Noncompliance with study drug|0|||
163359572|NCT01317875|590025100|FG009|Overall Study|Noncompliance with study drug|0|||
163359573|NCT01317875|590025091|FG000|Overall Study|Progressive Disease|1|||
163359574|NCT01317875|590025092|FG001|Overall Study|Progressive Disease|0|||
163410576|NCT01425008|590211380|FG000|Dose Escalation Phase|Adverse Event|2|||
163359575|NCT01317875|590025093|FG002|Overall Study|Progressive Disease|2|||
163359576|NCT01317875|590025094|FG003|Overall Study|Progressive Disease|0|||
163359577|NCT01317875|590025095|FG004|Overall Study|Progressive Disease|1|||
163410577|NCT01425008|590211381|FG001|Dose Escalation Phase|Adverse Event|0|||
163359578|NCT01317875|590025096|FG005|Overall Study|Progressive Disease|0|||
163359579|NCT01317875|590025097|FG006|Overall Study|Progressive Disease|0|||
163255655|NCT01197508|589642732|FG003|Overall Study|Lost to Follow-up|0|||
163255656|NCT01197508|589642729|FG000|Overall Study|Other|2|||
163255657|NCT01197508|589642730|FG001|Overall Study|Other|3|||
163255658|NCT01197508|589642731|FG002|Overall Study|Other|2|||
163255659|NCT01197508|589642732|FG003|Overall Study|Other|2|||
163255660|NCT00266825|589642733|FG000|Completed Follow-Up|Lost to Follow-up|14|||
163255661|NCT00266825|589642734|FG001|Completed Follow-Up|Lost to Follow-up|19|||
163255662|NCT00266825|589642733|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
163255663|NCT00266825|589642734|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
163255664|NCT02799784|589642737|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
163255665|NCT02799784|589642738|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
163255666|NCT02799784|589642737|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
163255667|NCT02799784|589642738|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
163255668|NCT02799784|589642737|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
163255669|NCT02799784|589642738|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
163255670|NCT02799784|589642737|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
163255671|NCT02799784|589642738|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
163255672|NCT02799784|589642737|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
163255673|NCT02799784|589642738|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
163255674|NCT02799784|589642737|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
163255675|NCT02799784|589642738|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
163255676|NCT01662063|589642739|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
163255677|NCT01662063|589642740|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
163255678|NCT01662063|589642741|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
163255679|NCT01662063|589642739|FG000|Overall Study|Lack of Efficacy|1|||
163255680|NCT01662063|589642740|FG001|Overall Study|Lack of Efficacy|6|||
163255681|NCT01662063|589642741|FG002|Overall Study|Lack of Efficacy|0|||
163255682|NCT01662063|589642739|FG000|Overall Study|Lost to Follow-up|0|||
163255683|NCT01662063|589642740|FG001|Overall Study|Lost to Follow-up|4|||
163255684|NCT01662063|589642741|FG002|Overall Study|Lost to Follow-up|0|||
163255685|NCT01662063|589642739|FG000|Overall Study|Protocol Violation|1|||
163255686|NCT01662063|589642740|FG001|Overall Study|Protocol Violation|0|||
163255687|NCT01662063|589642741|FG002|Overall Study|Protocol Violation|0|||
163255688|NCT01662063|589642739|FG000|Overall Study|Withdrawal by Subject|2|||
163255689|NCT01662063|589642740|FG001|Overall Study|Withdrawal by Subject|4|||
163255690|NCT01662063|589642741|FG002|Overall Study|Withdrawal by Subject|1|||
163255691|NCT01662063|589642739|FG000|Overall Study|Physician Decision|0|||
163255692|NCT01662063|589642740|FG001|Overall Study|Physician Decision|2|||
163255693|NCT01662063|589642741|FG002|Overall Study|Physician Decision|0|||
163255694|NCT01662063|589642739|FG000|Overall Study|Other|0|||
163255695|NCT01662063|589642740|FG001|Overall Study|Other|1|||
163255696|NCT01662063|589642741|FG002|Overall Study|Other|0|||
163255697|NCT01949870|589642742|FG000|Overall Study|Lack of Efficacy|2|||
163255698|NCT01949870|589642742|FG000|Overall Study|Adverse Event|1|||
163255699|NCT01949870|589642742|FG000|Overall Study|Study termination|1|||
163255700|NCT01949870|589642742|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
163255701|NCT01477853|589642743|FG000|Phase A|Adverse Event|1|||
163255702|NCT01477853|589642744|FG001|Phase A|Adverse Event|2|||
163255703|NCT01477853|589642745|FG002|Phase A|Adverse Event|2|||
163255704|NCT01477853|589642743|FG000|Phase A|Lost to Follow-up|4|||
163255705|NCT01477853|589642744|FG001|Phase A|Lost to Follow-up|3|||
163255706|NCT01477853|589642745|FG002|Phase A|Lost to Follow-up|2|||
163255707|NCT01477853|589642743|FG000|Phase A|Physician Decision|1|||
163255708|NCT01477853|589642744|FG001|Phase A|Physician Decision|0|||
163255709|NCT01477853|589642745|FG002|Phase A|Physician Decision|1|||
163255710|NCT01477853|589642743|FG000|Phase A|Study terminated by sponsor|37|||
163255711|NCT01477853|589642744|FG001|Phase A|Study terminated by sponsor|40|||
163255712|NCT01477853|589642745|FG002|Phase A|Study terminated by sponsor|39|||
163359580|NCT01317875|590025098|FG007|Overall Study|Progressive Disease|1|||
163359581|NCT01317875|590025099|FG008|Overall Study|Progressive Disease|0|||
163359582|NCT01317875|590025100|FG009|Overall Study|Progressive Disease|0|||
163359583|NCT01317875|590025091|FG000|Overall Study|Withdrawal by Subject|0|||
163359584|NCT01317875|590025092|FG001|Overall Study|Withdrawal by Subject|0|||
163255713|NCT01477853|589642743|FG000|Phase B|Lost to Follow-up|0|||
163255714|NCT01477853|589642744|FG001|Phase B|Lost to Follow-up|1|||
163255715|NCT01477853|589642745|FG002|Phase B|Lost to Follow-up|0|||
163255716|NCT01477853|589642743|FG000|Phase B|Study terminated by sponsor|12|||
163255717|NCT01477853|589642744|FG001|Phase B|Study terminated by sponsor|10|||
163359585|NCT01317875|590025093|FG002|Overall Study|Withdrawal by Subject|0|||
163255718|NCT01477853|589642745|FG002|Phase B|Study terminated by sponsor|11|||
163255719|NCT01050816|589642746|FG000|Overall Study|Lost to Follow-up|2|||
163255720|NCT01050816|589642746|FG000|Overall Study|patient's refusal|2|||
163255721|NCT03086330|589642747|FG000|Overall Study|Withdrawal by Subject|3|||
163255722|NCT03086330|589642748|FG001|Overall Study|Withdrawal by Subject|2|||
163359586|NCT01317875|590025094|FG003|Overall Study|Withdrawal by Subject|0|||
163359587|NCT01317875|590025095|FG004|Overall Study|Withdrawal by Subject|1|||
163255723|NCT03086330|589642747|FG000|Overall Study|Lost to Follow-up|1|||
163359588|NCT01317875|590025096|FG005|Overall Study|Withdrawal by Subject|0|||
163359589|NCT01317875|590025097|FG006|Overall Study|Withdrawal by Subject|0|||
163359590|NCT01317875|590025098|FG007|Overall Study|Withdrawal by Subject|3|||
163359591|NCT01317875|590025099|FG008|Overall Study|Withdrawal by Subject|0|||
163359592|NCT01317875|590025100|FG009|Overall Study|Withdrawal by Subject|0|||
163359593|NCT01317875|590025091|FG000|Overall Study|Physician Decision|0|||
163359594|NCT01317875|590025092|FG001|Overall Study|Physician Decision|1|||
163359595|NCT01317875|590025093|FG002|Overall Study|Physician Decision|1|||
163359596|NCT01317875|590025094|FG003|Overall Study|Physician Decision|0|||
163359597|NCT01317875|590025095|FG004|Overall Study|Physician Decision|2|||
163359598|NCT01317875|590025096|FG005|Overall Study|Physician Decision|0|||
163359599|NCT01317875|590025097|FG006|Overall Study|Physician Decision|0|||
163359600|NCT01317875|590025098|FG007|Overall Study|Physician Decision|2|||
163359601|NCT01317875|590025099|FG008|Overall Study|Physician Decision|0|||
163359602|NCT01317875|590025100|FG009|Overall Study|Physician Decision|0|||
163359603|NCT01317875|590025091|FG000|Overall Study|Death|0|||
163359604|NCT01317875|590025092|FG001|Overall Study|Death|0|||
163359605|NCT01317875|590025093|FG002|Overall Study|Death|2|||
163359606|NCT01317875|590025094|FG003|Overall Study|Death|1|||
163359607|NCT01317875|590025095|FG004|Overall Study|Death|0|||
163359608|NCT01317875|590025096|FG005|Overall Study|Death|1|||
163359609|NCT01317875|590025097|FG006|Overall Study|Death|0|||
163359610|NCT01317875|590025098|FG007|Overall Study|Death|4|||
163359611|NCT01317875|590025099|FG008|Overall Study|Death|0|||
163359612|NCT01317875|590025100|FG009|Overall Study|Death|0|||
163359613|NCT01317875|590025091|FG000|Overall Study|Adverse Event|2|||
163359614|NCT01317875|590025092|FG001|Overall Study|Adverse Event|1|||
163359615|NCT01317875|590025093|FG002|Overall Study|Adverse Event|2|||
163359616|NCT01317875|590025094|FG003|Overall Study|Adverse Event|1|||
163359617|NCT01317875|590025095|FG004|Overall Study|Adverse Event|5|||
163359618|NCT01317875|590025096|FG005|Overall Study|Adverse Event|1|||
163359619|NCT01317875|590025097|FG006|Overall Study|Adverse Event|2|||
163359620|NCT01317875|590025098|FG007|Overall Study|Adverse Event|5|||
163359621|NCT01317875|590025099|FG008|Overall Study|Adverse Event|0|||
163359622|NCT01317875|590025100|FG009|Overall Study|Adverse Event|0|||
163359623|NCT00581893|590025101|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
163359624|NCT00581893|590025102|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
163255724|NCT03086330|589642748|FG001|Overall Study|Lost to Follow-up|2|||
163255725|NCT01970462|589642749|FG000|Overall Study|Lost to Follow-up|0|||
163255726|NCT01970462|589642750|FG001|Overall Study|Lost to Follow-up|2|||
163255727|NCT01235546|589642751|FG000|Overall Study|Staff error, medication not administered|1|||
163255728|NCT01235546|589642752|FG001|Overall Study|Staff error, medication not administered|0|||
163255729|NCT01235546|589642751|FG000|Overall Study|Protocol Violation|1|||
163255730|NCT01235546|589642752|FG001|Overall Study|Protocol Violation|1|||
163359625|NCT01381575|590025103|FG000|Overall Study|Serious Adverse Event|1|||
163359626|NCT01381575|590025104|FG001|Overall Study|Serious Adverse Event|0|||
163359627|NCT01381575|590025105|FG002|Overall Study|Serious Adverse Event|0|||
163359628|NCT01381575|590025103|FG000|Overall Study|Non-Serious Adverse Event|0|||
163359629|NCT01381575|590025104|FG001|Overall Study|Non-Serious Adverse Event|0|||
163359630|NCT01381575|590025105|FG002|Overall Study|Non-Serious Adverse Event|1|||
163359631|NCT01381575|590025103|FG000|Overall Study|Protocol Violation|0|||
163359632|NCT01381575|590025104|FG001|Overall Study|Protocol Violation|1|||
163359633|NCT01381575|590025105|FG002|Overall Study|Protocol Violation|1|||
163359634|NCT01381575|590025103|FG000|Overall Study|Withdrawal by Subject|15|||
163359635|NCT01381575|590025104|FG001|Overall Study|Withdrawal by Subject|9|||
163359636|NCT01381575|590025105|FG002|Overall Study|Withdrawal by Subject|7|||
163359637|NCT01381575|590025103|FG000|Overall Study|Migrated/moved from study area|2|||
163359638|NCT01381575|590025104|FG001|Overall Study|Migrated/moved from study area|12|||
163359639|NCT01381575|590025105|FG002|Overall Study|Migrated/moved from study area|2|||
163359640|NCT01381575|590025103|FG000|Overall Study|Lost to Follow-up|8|||
163359641|NCT01381575|590025104|FG001|Overall Study|Lost to Follow-up|17|||
163359642|NCT01381575|590025105|FG002|Overall Study|Lost to Follow-up|9|||
163359643|NCT01377389|590025106|FG000|Overall Study|Withdrawal by Subject|1|||
163359644|NCT01377389|590025106|FG000|Overall Study|Screen failure|2|||
163359645|NCT04090528|590025107|FG000|Overall Study|participants still on study|9|||
163359646|NCT04090528|590025108|FG001|Overall Study|participants still on study|13|||
163359647|NCT03020069|590025109|FG000|Overall Study|Lost to Follow-up|0|||
163359648|NCT03020069|590025110|FG001|Overall Study|Lost to Follow-up|1|||
163359649|NCT02684123|590025111|FG000|Phase 1|Lack of Efficacy|5|||
163359650|NCT02684123|590025112|FG001|Phase 1|Lack of Efficacy|0|||
163359651|NCT02684123|590025111|FG000|Phase 1|Adverse Event|3|||
163359652|NCT02684123|590025112|FG001|Phase 1|Adverse Event|0|||
163359653|NCT02684123|590025111|FG000|Phase 1|Lost to Follow-up|0|||
163359654|NCT02684123|590025112|FG001|Phase 1|Lost to Follow-up|1|||
163359655|NCT02684123|590025111|FG000|Phase 2|Lack of Efficacy|1|||
163359656|NCT02684123|590025112|FG001|Phase 2|Lack of Efficacy|8|||
163359657|NCT01920932|590025114|FG000|Overall Study|Death|1|||
163359658|NCT01920932|590025114|FG000|Overall Study|Withdrawal of consent|1|||
163359659|NCT05274750|590025118|FG000|Overall Study|Adverse Event|0|||
163359660|NCT05274750|590025119|FG001|Overall Study|Adverse Event|1|||
163359661|NCT05274750|590025118|FG000|Overall Study|Lost to Follow-up|2|||
163359662|NCT05274750|590025119|FG001|Overall Study|Lost to Follow-up|3|||
163359663|NCT05274750|590025118|FG000|Overall Study|Physician Decision|3|||
163359664|NCT05274750|590025119|FG001|Overall Study|Physician Decision|0|||
163359665|NCT05274750|590025118|FG000|Overall Study|Withdrawal by Subject|10|||
163359666|NCT05274750|590025119|FG001|Overall Study|Withdrawal by Subject|9|||
163359667|NCT05274750|590025118|FG000|Overall Study|GCP Violation|0|||
163359668|NCT05274750|590025119|FG001|Overall Study|GCP Violation|4|||
163359669|NCT05274750|590025118|FG000|Overall Study|Randomized, not treated|0|||
163359670|NCT05274750|590025119|FG001|Overall Study|Randomized, not treated|1|||
163359671|NCT04328623|590025124|FG000|Overall Study|Protocol Violation|0|||
163359672|NCT04328623|590025125|FG001|Overall Study|Protocol Violation|1|||
163359673|NCT04340947|590025126|FG000|7-day Washout Period|Lost to Follow-up|5|||
163359674|NCT04340947|590025127|FG001|7-day Washout Period|Lost to Follow-up|4|||
163359675|NCT02312557|590025128|FG000|Overall Study|Survival follow-up|4|||
163359676|NCT04486313|590025134|FG000|Overall Study|Lost to Follow-up|7|||
163359677|NCT04486313|590025135|FG001|Overall Study|Lost to Follow-up|9|||
163359678|NCT04486313|590025134|FG000|Overall Study|Withdrawal by Subject|8|||
163359679|NCT04486313|590025135|FG001|Overall Study|Withdrawal by Subject|6|||
163359680|NCT04486313|590025134|FG000|Overall Study|Physician Decision|1|||
163359681|NCT04486313|590025135|FG001|Overall Study|Physician Decision|1|||
163359682|NCT04486313|590025134|FG000|Overall Study|Death|2|||
163359683|NCT04486313|590025135|FG001|Overall Study|Death|0|||
163359684|NCT04486313|590025134|FG000|Overall Study|Protocol Violation|1|||
163359685|NCT04486313|590025135|FG001|Overall Study|Protocol Violation|1|||
163359686|NCT01437423|590025138|FG000|Overall Study|Lost to Follow-up|12|||
163359687|NCT01437423|590025138|FG000|Overall Study|Off label usage|3|||
163359688|NCT01375751|590025139|FG000|Overall Study|Other|0|||
163359689|NCT01375751|590025140|FG001|Overall Study|Other|1|||
163359690|NCT01375751|590025141|FG002|Overall Study|Other|0|||
163359691|NCT00633945|590025142|FG000|Overall Study|Physician Decision|2|||
163359692|NCT00882115|590025143|FG000|Overall Study|Withdrawal by Subject|3|||
163359693|NCT00882115|590025143|FG000|Overall Study|did not respond to DEP challe|6|||
163359694|NCT02552147|590025144|FG000|First Intervention (7 Days)|Protocol Violation|1|||
163359695|NCT02552147|590025145|FG001|First Intervention (7 Days)|Protocol Violation|0|||
163359696|NCT02552147|590025144|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
163359697|NCT02552147|590025145|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
163359698|NCT00940875|590025146|FG000|Treatment Phase|Adverse Event|9|||
163359699|NCT00940875|590025147|FG001|Treatment Phase|Adverse Event|3|||
163359700|NCT00940875|590025146|FG000|Treatment Phase|Death|3|||
163359701|NCT00940875|590025147|FG001|Treatment Phase|Death|5|||
163359702|NCT00940875|590025146|FG000|Treatment Phase|Lack of Efficacy|1|||
163359703|NCT00940875|590025147|FG001|Treatment Phase|Lack of Efficacy|0|||
163359704|NCT00940875|590025146|FG000|Treatment Phase|Withdrawal by Subject|3|||
163359705|NCT00940875|590025147|FG001|Treatment Phase|Withdrawal by Subject|0|||
163359706|NCT00940875|590025146|FG000|Treatment Phase|Disease progression|9|||
163359707|NCT00940875|590025147|FG001|Treatment Phase|Disease progression|11|||
163359708|NCT00940875|590025146|FG000|Treatment Phase|Physician Decision|1|||
163359709|NCT00940875|590025147|FG001|Treatment Phase|Physician Decision|0|||
163359710|NCT00940875|590025146|FG000|Post-Study Treatment|Death|0|||
163359711|NCT00940875|590025147|FG001|Post-Study Treatment|Death|1|||
163359712|NCT00940875|590025146|FG000|Post-Study Treatment|Disease Progression|0|||
163359713|NCT00940875|590025147|FG001|Post-Study Treatment|Disease Progression|2|||
163359714|NCT00943787|590025148|FG000|Overall Study|Physician Decision|4|||
163359715|NCT00943787|590025148|FG000|Overall Study|Withdrawal by Subject|3|||
163359716|NCT01547598|590025149|FG000|Overall Study|Withdrew consent|1|||
163359717|NCT01547598|590025150|FG001|Overall Study|Withdrew consent|1|||
163359718|NCT01547598|590025149|FG000|Overall Study|Lost to Follow-up|1|||
163359719|NCT01547598|590025150|FG001|Overall Study|Lost to Follow-up|1|||
163359720|NCT01547598|590025149|FG000|Overall Study|Adverse Event|1|||
163359721|NCT01547598|590025150|FG001|Overall Study|Adverse Event|1|||
163359722|NCT01547598|590025149|FG000|Overall Study|Protocol Violation|1|||
163410578|NCT01425008|590211382|FG002|Dose Escalation Phase|Adverse Event|0|||
163359723|NCT01547598|590025150|FG001|Overall Study|Protocol Violation|1|||
163359724|NCT01547598|590025149|FG000|Overall Study|Other Miscellaneous Reasons|2|||
163359725|NCT01547598|590025150|FG001|Overall Study|Other Miscellaneous Reasons|1|||
163359726|NCT00872001|590025154|FG000|Overall Study|Adverse Event|34|||
163359727|NCT00872001|590025155|FG001|Overall Study|Adverse Event|23|||
163359728|NCT00872001|590025154|FG000|Overall Study|Protocol Defined Clinical Event|5|||
163359729|NCT00872001|590025155|FG001|Overall Study|Protocol Defined Clinical Event|7|||
163359730|NCT00872001|590025154|FG000|Overall Study|Lost to Follow-up|13|||
163359731|NCT00872001|590025155|FG001|Overall Study|Lost to Follow-up|12|||
163359732|NCT00872001|590025154|FG000|Overall Study|Withdrawal by Subject|18|||
163359733|NCT00872001|590025155|FG001|Overall Study|Withdrawal by Subject|30|||
163359734|NCT00872001|590025154|FG000|Overall Study|Protocol Violation|5|||
163359735|NCT00872001|590025155|FG001|Overall Study|Protocol Violation|8|||
163359736|NCT00872001|590025154|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
163359737|NCT00872001|590025155|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
163359738|NCT00872001|590025154|FG000|Overall Study|Administrative|23|||
163359739|NCT00872001|590025155|FG001|Overall Study|Administrative|15|||
163359740|NCT04071301|590025156|FG000|Overall Study|Withdrawal by Subject|6|||
163359741|NCT04071301|590025156|FG000|Overall Study|Death|1|||
163359742|NCT05186311|590025157|FG000|Part A: Serum|Withdrawal by Subject|1|||
163359743|NCT02879383|590025158|FG000|First 24 Weeks|Physician Decision|0|||
163359744|NCT02879383|590025159|FG001|First 24 Weeks|Physician Decision|1|||
163359745|NCT02879383|590025160|FG002|First 24 Weeks|Physician Decision|0|||
163359746|NCT02879383|590025161|FG003|First 24 Weeks|Physician Decision|0|||
163359747|NCT02125279|590025162|FG000|Overall Study|Lack of Efficacy|2|||
163359748|NCT02125279|590025162|FG000|Overall Study|Withdrawal by Subject|6|||
163359749|NCT02125279|590025162|FG000|Overall Study|Protocol Violation|1|||
163359750|NCT02125279|590025162|FG000|Overall Study|Lost to Follow-up|4|||
163359751|NCT01607879|590025167|FG000|Overall Study|Death|1|||
163359752|NCT01607879|590025168|FG001|Overall Study|Death|0|||
163359753|NCT03721172|590025178|FG000|Placebo-controlled Phase|Adverse Event|7|||
163359754|NCT03721172|590025179|FG001|Placebo-controlled Phase|Adverse Event|7|||
163359755|NCT03721172|590025180|FG002|Placebo-controlled Phase|Adverse Event|0|||
163359756|NCT03721172|590025178|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
163359757|NCT03721172|590025179|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
163359758|NCT03721172|590025180|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
163359759|NCT03721172|590025178|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
163359760|NCT03721172|590025179|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
163359761|NCT03721172|590025180|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
163359762|NCT03721172|590025178|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
163359763|NCT03721172|590025179|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
163359764|NCT03721172|590025180|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
163359765|NCT03721172|590025178|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
163359766|NCT03721172|590025179|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
163359767|NCT03721172|590025180|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
163359768|NCT03721172|590025178|FG000|Placebo-controlled Phase|Other|3|||
163359769|NCT03721172|590025179|FG001|Placebo-controlled Phase|Other|0|||
163359770|NCT03721172|590025180|FG002|Placebo-controlled Phase|Other|0|||
163359771|NCT03721172|590025178|FG000|Apremilast Extension Phase|Adverse Event|0|||
163359772|NCT03721172|590025179|FG001|Apremilast Extension Phase|Adverse Event|0|||
163359773|NCT03721172|590025180|FG002|Apremilast Extension Phase|Adverse Event|10|||
163359774|NCT03721172|590025178|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
163359775|NCT03721172|590025179|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
163359776|NCT03721172|590025180|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
163359777|NCT03721172|590025178|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
163359778|NCT03721172|590025179|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
163359779|NCT03721172|590025180|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
163359780|NCT03721172|590025178|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
163359781|NCT03721172|590025179|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
163359782|NCT03721172|590025180|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
163359783|NCT03721172|590025178|FG000|Apremilast Extension Phase|Protocol Violation|0|||
163359784|NCT03721172|590025179|FG001|Apremilast Extension Phase|Protocol Violation|0|||
163359785|NCT03721172|590025180|FG002|Apremilast Extension Phase|Protocol Violation|1|||
163359786|NCT03721172|590025178|FG000|Apremilast Extension Phase|Physician Decision|0|||
163359787|NCT03721172|590025179|FG001|Apremilast Extension Phase|Physician Decision|0|||
163359788|NCT03721172|590025180|FG002|Apremilast Extension Phase|Physician Decision|1|||
163359789|NCT03721172|590025178|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
163359790|NCT03721172|590025179|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
163359791|NCT03721172|590025180|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
163359792|NCT03721172|590025178|FG000|Apremilast Extension Phase|Other|0|||
163359793|NCT03721172|590025179|FG001|Apremilast Extension Phase|Other|0|||
163359794|NCT03721172|590025180|FG002|Apremilast Extension Phase|Other|3|||
163359795|NCT03721172|590025178|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
163359796|NCT03721172|590025179|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
163359797|NCT03721172|590025180|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
163359798|NCT02417441|590025181|FG000|Overall Study|Inconclusive due to missing data|52|||
163359799|NCT02417441|590025182|FG001|Overall Study|Inconclusive due to missing data|19|||
163359800|NCT05628285|590025185|FG000|Overall Study|Lost to Follow-up|1|||
163359801|NCT00983853|590025186|FG000|Overall Study|Lost to Follow-up|1|||
163359802|NCT00983853|590025187|FG001|Overall Study|Lost to Follow-up|1|||
163359803|NCT00983853|590025188|FG002|Overall Study|Lost to Follow-up|2|||
163359804|NCT00983853|590025189|FG003|Overall Study|Lost to Follow-up|2|||
163359805|NCT00983853|590025190|FG004|Overall Study|Lost to Follow-up|2|||
163359806|NCT00983853|590025191|FG005|Overall Study|Lost to Follow-up|1|||
163359807|NCT00983853|590025186|FG000|Overall Study|Withdrawal by Subject|0|||
163359808|NCT00983853|590025187|FG001|Overall Study|Withdrawal by Subject|0|||
163359809|NCT00983853|590025188|FG002|Overall Study|Withdrawal by Subject|1|||
163359810|NCT00983853|590025189|FG003|Overall Study|Withdrawal by Subject|0|||
163359811|NCT00983853|590025190|FG004|Overall Study|Withdrawal by Subject|1|||
163359812|NCT00983853|590025191|FG005|Overall Study|Withdrawal by Subject|0|||
163359813|NCT00983853|590025186|FG000|Overall Study|Unable to come to study follow-up visits|0|||
163359814|NCT00983853|590025187|FG001|Overall Study|Unable to come to study follow-up visits|1|||
163359815|NCT00983853|590025188|FG002|Overall Study|Unable to come to study follow-up visits|0|||
163359816|NCT00983853|590025189|FG003|Overall Study|Unable to come to study follow-up visits|0|||
163359817|NCT00983853|590025190|FG004|Overall Study|Unable to come to study follow-up visits|0|||
163359818|NCT00983853|590025191|FG005|Overall Study|Unable to come to study follow-up visits|0|||
163359819|NCT02339506|590025192|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
163359820|NCT02339506|590025193|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
163359821|NCT02339506|590025192|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
163359822|NCT02339506|590025193|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
163359823|NCT03016598|590025197|FG000|Overall Study|Lost to Follow-up|0|||
163359824|NCT03016598|590025198|FG001|Overall Study|Lost to Follow-up|2|||
163359825|NCT01101061|590025201|FG000|Overall Study|Adverse Event|0|||
163359826|NCT01101061|590025202|FG001|Overall Study|Adverse Event|0|||
163359827|NCT01101061|590025203|FG002|Overall Study|Adverse Event|1|||
163359828|NCT01101061|590025204|FG003|Overall Study|Adverse Event|0|||
163359829|NCT01101061|590025205|FG004|Overall Study|Adverse Event|0|||
163359830|NCT01101061|590025206|FG005|Overall Study|Adverse Event|0|||
163359831|NCT00478205|590025208|FG000|Overall Study|Adverse Event|182|||
163359832|NCT00478205|590025209|FG001|Overall Study|Adverse Event|39|||
163359833|NCT00478205|590025208|FG000|Overall Study|Medication Non-compliance|9|||
163359834|NCT00478205|590025209|FG001|Overall Study|Medication Non-compliance|4|||
163359835|NCT00478205|590025208|FG000|Overall Study|Protocol Violation|15|||
163359836|NCT00478205|590025209|FG001|Overall Study|Protocol Violation|5|||
163359837|NCT00478205|590025208|FG000|Overall Study|Request of Investigator or Sponsor|4|||
163359838|NCT00478205|590025209|FG001|Overall Study|Request of Investigator or Sponsor|5|||
163359839|NCT00478205|590025208|FG000|Overall Study|Withdrawal by Subject|61|||
163359840|NCT00478205|590025209|FG001|Overall Study|Withdrawal by Subject|22|||
163359841|NCT00478205|590025208|FG000|Overall Study|Lack of Efficacy|1|||
163359842|NCT00478205|590025209|FG001|Overall Study|Lack of Efficacy|0|||
163359843|NCT00478205|590025208|FG000|Overall Study|Other|24|||
163359844|NCT00478205|590025209|FG001|Overall Study|Other|12|||
163359845|NCT01791413|590025210|FG000|Overall Study|Lost to Follow-up|5|||
163359846|NCT01791413|590025211|FG001|Overall Study|Lost to Follow-up|1|||
163359847|NCT04016272|590025219|FG000|Overall Study|Withdrawal by Subject|1|||
163359848|NCT04016272|590025220|FG001|Overall Study|Withdrawal by Subject|2|||
163359849|NCT00825305|590025221|FG000|Overall Study|Adverse Event|1|||
163359850|NCT00825305|590025222|FG001|Overall Study|Adverse Event|1|||
163359851|NCT00825305|590025221|FG000|Overall Study|Withdrawal by Subject|6|||
163359852|NCT00825305|590025222|FG001|Overall Study|Withdrawal by Subject|12|||
163359853|NCT00825305|590025221|FG000|Overall Study|Inappropriate inclusion|1|||
163359854|NCT00825305|590025222|FG001|Overall Study|Inappropriate inclusion|0|||
163359855|NCT00825305|590025221|FG000|Overall Study|Protocol Violation|9|||
163359856|NCT00825305|590025222|FG001|Overall Study|Protocol Violation|9|||
163359857|NCT00825305|590025221|FG000|Overall Study|Can not be classified|0|||
163359858|NCT00825305|590025222|FG001|Overall Study|Can not be classified|1|||
163359859|NCT03725605|590025223|FG000|Overall Study|Unsuccessful TIL expansion|2|||
163359860|NCT01503086|590025224|FG000|Overall Study|Lost to Follow-up|0|||
163359861|NCT01503086|590025225|FG001|Overall Study|Lost to Follow-up|1|||
163359862|NCT01503086|590025226|FG002|Overall Study|Lost to Follow-up|0|||
163359863|NCT01503086|590025224|FG000|Overall Study|Did Not Start Treatment|4|||
163359864|NCT01503086|590025225|FG001|Overall Study|Did Not Start Treatment|3|||
163359865|NCT01503086|590025226|FG002|Overall Study|Did Not Start Treatment|3|||
163359866|NCT01503086|590025224|FG000|Overall Study|Progressive disease|3|||
163359867|NCT01503086|590025225|FG001|Overall Study|Progressive disease|1|||
163359868|NCT01503086|590025226|FG002|Overall Study|Progressive disease|0|||
163359869|NCT01503086|590025224|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
163359870|NCT01503086|590025225|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
163359871|NCT01503086|590025226|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
163359872|NCT01503086|590025224|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
163359873|NCT01503086|590025225|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
163410579|NCT01425008|590211383|FG003|Dose Escalation Phase|Adverse Event|0|||
163410580|NCT01425008|590211384|FG004|Dose Escalation Phase|Adverse Event|0|||
163359874|NCT01503086|590025226|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
163359875|NCT02419417|590027010|FG000|Overall Study|Disease progression|5|||
163359876|NCT02419417|590027011|FG001|Overall Study|Disease progression|4|||
163359877|NCT02419417|590027012|FG002|Overall Study|Disease progression|13|||
163359878|NCT02419417|590027013|FG003|Overall Study|Disease progression|10|||
163359879|NCT02419417|590027014|FG004|Overall Study|Disease progression|10|||
163359880|NCT02419417|590027015|FG005|Overall Study|Disease progression|3|||
163359881|NCT02419417|590027016|FG006|Overall Study|Disease progression|4|||
163359882|NCT02419417|590027017|FG007|Overall Study|Disease progression|5|||
163359883|NCT02419417|590027018|FG008|Overall Study|Disease progression|13|||
163410581|NCT01425008|590211385|FG005|Dose Escalation Phase|Adverse Event|2|||
163151527|NCT01207414|589269400|FG001|Overall Study|Patient withdrew consent|11|||
163151528|NCT01207414|589269399|FG000|Overall Study|Lost to Follow-up|15|||
163151529|NCT01207414|589269400|FG001|Overall Study|Lost to Follow-up|17|||
163151530|NCT01207414|589269399|FG000|Overall Study|Administrative problems|1|||
163151531|NCT01207414|589269400|FG001|Overall Study|Administrative problems|1|||
163151532|NCT01207414|589269399|FG000|Overall Study|Protocol deviation|12|||
163151533|NCT01207414|589269400|FG001|Overall Study|Protocol deviation|9|||
163151534|NCT01207414|589269399|FG000|Overall Study|Randomized in error|1|||
163151535|NCT01207414|589269400|FG001|Overall Study|Randomized in error|0|||
163151536|NCT01748292|589269401|FG000|Overall Study|Adverse Event|2|||
163151537|NCT01748292|589269402|FG001|Overall Study|Adverse Event|4|||
163151538|NCT01748292|589269401|FG000|Overall Study|Lost to Follow-up|0|||
163151539|NCT01748292|589269402|FG001|Overall Study|Lost to Follow-up|3|||
163151540|NCT01748292|589269401|FG000|Overall Study|Death|0|||
163151541|NCT01748292|589269402|FG001|Overall Study|Death|3|||
163151542|NCT01748292|589269401|FG000|Overall Study|Withdrawal by Subject|0|||
163151543|NCT01748292|589269402|FG001|Overall Study|Withdrawal by Subject|2|||
163151544|NCT02057250|589269403|FG000|AID Assessment Phase|Adverse Event|3|||
163151545|NCT02057250|589269404|FG001|AID Assessment Phase|Adverse Event|2|||
163151546|NCT02057250|589269405|FG002|AID Assessment Phase|Adverse Event|6|||
163151547|NCT02057250|589269406|FG003|AID Assessment Phase|Adverse Event|1|||
163151548|NCT02057250|589269407|FG004|AID Assessment Phase|Adverse Event|0|||
163151549|NCT02057250|589269403|FG000|AID Assessment Phase|Other than specified above|1|||
163151550|NCT02057250|589269404|FG001|AID Assessment Phase|Other than specified above|1|||
163151551|NCT02057250|589269405|FG002|AID Assessment Phase|Other than specified above|1|||
163151552|NCT02057250|589269406|FG003|AID Assessment Phase|Other than specified above|1|||
163151553|NCT02057250|589269407|FG004|AID Assessment Phase|Other than specified above|0|||
163151554|NCT02057250|589269403|FG000|Extension Phase|Adverse Event|0|||
163151555|NCT02057250|589269404|FG001|Extension Phase|Adverse Event|0|||
163151556|NCT02057250|589269405|FG002|Extension Phase|Adverse Event|0|||
163151557|NCT02057250|589269406|FG003|Extension Phase|Adverse Event|0|||
163151558|NCT02057250|589269407|FG004|Extension Phase|Adverse Event|15|||
163151559|NCT02057250|589269403|FG000|Extension Phase|Lack of Efficacy|0|||
163151560|NCT02057250|589269404|FG001|Extension Phase|Lack of Efficacy|0|||
163151561|NCT02057250|589269405|FG002|Extension Phase|Lack of Efficacy|0|||
163151562|NCT02057250|589269406|FG003|Extension Phase|Lack of Efficacy|0|||
163151563|NCT02057250|589269407|FG004|Extension Phase|Lack of Efficacy|10|||
163151564|NCT02057250|589269403|FG000|Extension Phase|Entered in this period but not treated|0|||
163151565|NCT02057250|589269404|FG001|Extension Phase|Entered in this period but not treated|0|||
163151566|NCT02057250|589269405|FG002|Extension Phase|Entered in this period but not treated|0|||
163151567|NCT02057250|589269406|FG003|Extension Phase|Entered in this period but not treated|0|||
163151568|NCT02057250|589269407|FG004|Extension Phase|Entered in this period but not treated|4|||
163151569|NCT02057250|589269403|FG000|Extension Phase|Other than specified above|0|||
163151570|NCT02057250|589269404|FG001|Extension Phase|Other than specified above|0|||
163151571|NCT02057250|589269405|FG002|Extension Phase|Other than specified above|0|||
163151572|NCT02057250|589269406|FG003|Extension Phase|Other than specified above|0|||
163151573|NCT02057250|589269407|FG004|Extension Phase|Other than specified above|7|||
163151574|NCT03199976|589269409|FG000|Overall Study|Lack of Efficacy|3|||
163151575|NCT03199976|589269410|FG001|Overall Study|Lack of Efficacy|6|||
163151576|NCT03199976|589269411|FG002|Overall Study|Lack of Efficacy|13|||
163151577|NCT03199976|589269409|FG000|Overall Study|Withdrawal by Subject|1|||
163151578|NCT03199976|589269410|FG001|Overall Study|Withdrawal by Subject|0|||
163151579|NCT03199976|589269411|FG002|Overall Study|Withdrawal by Subject|0|||
163151580|NCT03199976|589269409|FG000|Overall Study|Lost to Follow-up|0|||
163151581|NCT03199976|589269410|FG001|Overall Study|Lost to Follow-up|1|||
163151582|NCT03199976|589269411|FG002|Overall Study|Lost to Follow-up|1|||
163151583|NCT03367793|589269412|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
163151584|NCT03367793|589269413|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
163151585|NCT03367793|589269414|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
163151586|NCT03367793|589269415|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
163151587|NCT03367793|589269416|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
163151588|NCT03367793|589269417|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
163151589|NCT04218240|589269420|FG000|Overall Study|Withdrawal by Subject|6|||
163151590|NCT04218240|589269421|FG001|Overall Study|Withdrawal by Subject|0|||
163151591|NCT04218240|589269420|FG000|Overall Study|Lack of Efficacy|24|||
163151592|NCT04218240|589269421|FG001|Overall Study|Lack of Efficacy|19|||
163151593|NCT04218240|589269420|FG000|Overall Study|Physician Decision|0|||
163151594|NCT04218240|589269421|FG001|Overall Study|Physician Decision|1|||
163151595|NCT04218240|589269420|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
163151596|NCT04218240|589269421|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
163151597|NCT04711850|589269425|FG000|Overall Study|Graft loss|2|||
163151598|NCT04711850|589269426|FG001|Overall Study|Graft loss|1|||
163151599|NCT04711850|589269425|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
163151600|NCT04711850|589269426|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
163151601|NCT04711850|589269425|FG000|Overall Study|Study terminated by sponsor|5|||
163255731|NCT02740049|589642753|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
163255732|NCT00330174|589642756|FG000|Overall Study|Withdrawal by Subject|7|||
163255733|NCT00330174|589642757|FG001|Overall Study|Withdrawal by Subject|7|||
163255734|NCT00330174|589642756|FG000|Overall Study|Lost to Follow-up|4|||
163255735|NCT00330174|589642757|FG001|Overall Study|Lost to Follow-up|1|||
163255736|NCT00330174|589642756|FG000|Overall Study|Clinical deterioration|1|||
163255737|NCT00330174|589642757|FG001|Overall Study|Clinical deterioration|2|||
163255738|NCT00330174|589642756|FG000|Overall Study|Excessive missed visits|3|||
163255739|NCT00330174|589642757|FG001|Overall Study|Excessive missed visits|8|||
163255740|NCT00330174|589642756|FG000|Overall Study|Miscellaneous reasons|7|||
163255741|NCT00330174|589642757|FG001|Overall Study|Miscellaneous reasons|1|||
163255742|NCT04570436|589642761|FG000|Overall Study|Adverse Event|0|||
163255743|NCT04570436|589642762|FG001|Overall Study|Adverse Event|0|||
163255744|NCT04570436|589642763|FG002|Overall Study|Adverse Event|1|||
163255745|NCT04570436|589642764|FG003|Overall Study|Adverse Event|0|||
163255746|NCT04570436|589642765|FG004|Overall Study|Adverse Event|0|||
163255747|NCT04570436|589642766|FG005|Overall Study|Adverse Event|0|||
163255748|NCT04570436|589642767|FG006|Overall Study|Adverse Event|0|||
163255749|NCT04570436|589642768|FG007|Overall Study|Adverse Event|0|||
163255750|NCT04570436|589642769|FG008|Overall Study|Adverse Event|0|||
163255751|NCT04570436|589642770|FG009|Overall Study|Adverse Event|0|||
163255752|NCT04570436|589642761|FG000|Overall Study|Physician Decision|1|||
163255753|NCT04570436|589642762|FG001|Overall Study|Physician Decision|0|||
163255754|NCT04570436|589642763|FG002|Overall Study|Physician Decision|0|||
163255755|NCT04570436|589642764|FG003|Overall Study|Physician Decision|0|||
163255756|NCT04570436|589642765|FG004|Overall Study|Physician Decision|0|||
163255757|NCT04570436|589642766|FG005|Overall Study|Physician Decision|0|||
163255758|NCT04570436|589642767|FG006|Overall Study|Physician Decision|0|||
163255759|NCT04570436|589642768|FG007|Overall Study|Physician Decision|0|||
163255760|NCT04570436|589642769|FG008|Overall Study|Physician Decision|0|||
163255761|NCT04570436|589642770|FG009|Overall Study|Physician Decision|0|||
163255762|NCT00645164|589642771|FG000|Overall Study|Lost to Follow-up|2|||
163255763|NCT00645164|589642771|FG000|Overall Study|Withdrawal by Subject|4|||
163255764|NCT00645164|589642771|FG000|Overall Study|Protocol Violation|1|||
163255765|NCT03172702|589642772|FG000|Overall Study|Adverse Event|9|||
163255766|NCT03172702|589642772|FG000|Overall Study|Death|2|||
163255767|NCT03172702|589642772|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
163255768|NCT03172702|589642772|FG000|Overall Study|Withdrawal by Subject|5|||
163255769|NCT03172702|589642772|FG000|Overall Study|Other|2|||
163255770|NCT02355743|589642775|FG000|Overall Study|Withdrawal by Subject|1|||
163255771|NCT02355743|589642775|FG000|Overall Study|Lost to Follow-up|1|||
163255772|NCT02279043|589642781|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
163255773|NCT02279043|589642782|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
163255774|NCT02279043|589642783|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
163255775|NCT02279043|589642781|FG000|Overall Study|Lost to Follow-up|46|||
163255776|NCT02279043|589642782|FG001|Overall Study|Lost to Follow-up|88|||
163255777|NCT02279043|589642783|FG002|Overall Study|Lost to Follow-up|0|||
163255778|NCT00490282|589642784|FG000|Overall Study|Withdrawal by Subject|3|||
163255779|NCT01256567|589642790|FG000|Overall Study|Withdrawal by Subject|1|||
163255780|NCT00567190|589642791|FG000|Overall Study|Death|235|||
163255781|NCT00567190|589642792|FG001|Overall Study|Death|280|||
163255782|NCT00567190|589642791|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
163255783|NCT00567190|589642792|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
163255784|NCT03184792|589642800|FG000|Overall Study|Pandemic|2|||
163255785|NCT03184792|589642801|FG001|Overall Study|Pandemic|2|||
163255786|NCT00374322|589642802|FG000|Overall Study|Lost to Follow-up|92|||
163255787|NCT00374322|589642803|FG001|Overall Study|Lost to Follow-up|90|||
163255788|NCT00374322|589642802|FG000|Overall Study|Protocol Violation|8|||
163255789|NCT00374322|589642803|FG001|Overall Study|Protocol Violation|3|||
163255790|NCT00374322|589642802|FG000|Overall Study|Withdrawal by Subject|235|||
163255791|NCT00374322|589642803|FG001|Overall Study|Withdrawal by Subject|167|||
163255792|NCT00374322|589642802|FG000|Overall Study|Sponsor Terminated Study|866|||
163410582|NCT01425008|590211386|FG006|Dose Escalation Phase|Adverse Event|0|||
163410583|NCT01425008|590211387|FG007|Dose Escalation Phase|Adverse Event|0|||
163255793|NCT00374322|589642803|FG001|Overall Study|Sponsor Terminated Study|990|||
163255794|NCT00374322|589642802|FG000|Overall Study|Physician Decision|36|||
163255795|NCT00374322|589642803|FG001|Overall Study|Physician Decision|32|||
163255796|NCT00374322|589642802|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
163255797|NCT00374322|589642803|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
163255798|NCT00374322|589642802|FG000|Overall Study|Sponsor Decision|2|||
163255799|NCT00374322|589642803|FG001|Overall Study|Sponsor Decision|3|||
163255800|NCT00374322|589642802|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
163255801|NCT00374322|589642803|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
163255802|NCT00374322|589642802|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
163255803|NCT00374322|589642803|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
163255804|NCT00374322|589642802|FG000|Overall Study|Severe Toxicity|1|||
163255805|NCT00374322|589642803|FG001|Overall Study|Severe Toxicity|0|||
163359884|NCT02419417|590027019|FG009|Overall Study|Disease progression|9|||
163359885|NCT02419417|590027020|FG010|Overall Study|Disease progression|0|||
163359886|NCT02419417|590027010|FG000|Overall Study|Study drug toxicity|0|||
163359887|NCT02419417|590027011|FG001|Overall Study|Study drug toxicity|0|||
163359888|NCT02419417|590027012|FG002|Overall Study|Study drug toxicity|0|||
163359889|NCT02419417|590027013|FG003|Overall Study|Study drug toxicity|0|||
163359890|NCT02419417|590027014|FG004|Overall Study|Study drug toxicity|1|||
163359891|NCT02419417|590027015|FG005|Overall Study|Study drug toxicity|0|||
163359892|NCT02419417|590027016|FG006|Overall Study|Study drug toxicity|0|||
163359893|NCT02419417|590027017|FG007|Overall Study|Study drug toxicity|0|||
163359894|NCT02419417|590027018|FG008|Overall Study|Study drug toxicity|0|||
163359895|NCT02419417|590027019|FG009|Overall Study|Study drug toxicity|0|||
163359896|NCT02419417|590027020|FG010|Overall Study|Study drug toxicity|0|||
163359897|NCT02419417|590027010|FG000|Overall Study|Adverse event unrelated to study drug|0|||
163359898|NCT02419417|590027011|FG001|Overall Study|Adverse event unrelated to study drug|0|||
163359899|NCT02419417|590027012|FG002|Overall Study|Adverse event unrelated to study drug|0|||
163359900|NCT02419417|590027013|FG003|Overall Study|Adverse event unrelated to study drug|0|||
163359901|NCT02419417|590027014|FG004|Overall Study|Adverse event unrelated to study drug|2|||
163359902|NCT02419417|590027015|FG005|Overall Study|Adverse event unrelated to study drug|1|||
163359903|NCT02419417|590027016|FG006|Overall Study|Adverse event unrelated to study drug|0|||
163359904|NCT02419417|590027017|FG007|Overall Study|Adverse event unrelated to study drug|1|||
163359905|NCT02419417|590027018|FG008|Overall Study|Adverse event unrelated to study drug|0|||
163359906|NCT02419417|590027019|FG009|Overall Study|Adverse event unrelated to study drug|0|||
163359907|NCT02419417|590027020|FG010|Overall Study|Adverse event unrelated to study drug|0|||
163359908|NCT02419417|590027010|FG000|Overall Study|Participant request to discontinue|0|||
163359909|NCT02419417|590027011|FG001|Overall Study|Participant request to discontinue|0|||
163359910|NCT02419417|590027012|FG002|Overall Study|Participant request to discontinue|0|||
163359911|NCT02419417|590027013|FG003|Overall Study|Participant request to discontinue|0|||
163359912|NCT02419417|590027014|FG004|Overall Study|Participant request to discontinue|0|||
163359913|NCT02419417|590027015|FG005|Overall Study|Participant request to discontinue|0|||
163359914|NCT02419417|590027016|FG006|Overall Study|Participant request to discontinue|0|||
163359915|NCT02419417|590027017|FG007|Overall Study|Participant request to discontinue|0|||
163359916|NCT02419417|590027018|FG008|Overall Study|Participant request to discontinue|0|||
163359917|NCT02419417|590027019|FG009|Overall Study|Participant request to discontinue|1|||
163359918|NCT02419417|590027020|FG010|Overall Study|Participant request to discontinue|0|||
163359919|NCT02419417|590027010|FG000|Overall Study|Withdrawal by Subject|0|||
163359920|NCT02419417|590027011|FG001|Overall Study|Withdrawal by Subject|0|||
163359921|NCT02419417|590027012|FG002|Overall Study|Withdrawal by Subject|0|||
163359922|NCT02419417|590027013|FG003|Overall Study|Withdrawal by Subject|0|||
163359923|NCT02419417|590027014|FG004|Overall Study|Withdrawal by Subject|0|||
163359924|NCT02419417|590027015|FG005|Overall Study|Withdrawal by Subject|0|||
163359925|NCT02419417|590027016|FG006|Overall Study|Withdrawal by Subject|0|||
163359926|NCT02419417|590027017|FG007|Overall Study|Withdrawal by Subject|0|||
163359927|NCT02419417|590027018|FG008|Overall Study|Withdrawal by Subject|0|||
163359928|NCT02419417|590027019|FG009|Overall Study|Withdrawal by Subject|0|||
163359929|NCT02419417|590027020|FG010|Overall Study|Withdrawal by Subject|1|||
163359930|NCT01240551|590027021|FG000|Overall Study|Refused further treatment|3|||
163359931|NCT01240551|590027022|FG001|Overall Study|Refused further treatment|2|||
163359932|NCT01240551|590027021|FG000|Overall Study|Lost to Follow-up|1|||
163359933|NCT01240551|590027022|FG001|Overall Study|Lost to Follow-up|1|||
163359934|NCT01385748|590027023|FG000|Overall Study|Withdrawal by Subject|7|||
163359935|NCT01385748|590027024|FG001|Overall Study|Withdrawal by Subject|4|||
163359936|NCT01385748|590027025|FG002|Overall Study|Withdrawal by Subject|5|||
163359937|NCT01385748|590027023|FG000|Overall Study|Noncompliance|3|||
163359938|NCT01385748|590027024|FG001|Overall Study|Noncompliance|1|||
163359939|NCT01385748|590027025|FG002|Overall Study|Noncompliance|6|||
163359940|NCT01385748|590027023|FG000|Overall Study|Other|1|||
163359941|NCT01385748|590027024|FG001|Overall Study|Other|7|||
163359942|NCT01385748|590027025|FG002|Overall Study|Other|1|||
163359943|NCT01385748|590027023|FG000|Overall Study|Adverse Event|4|||
163359944|NCT01385748|590027024|FG001|Overall Study|Adverse Event|2|||
163359945|NCT01385748|590027025|FG002|Overall Study|Adverse Event|1|||
163151602|NCT04711850|589269426|FG001|Overall Study|Study terminated by sponsor|3|||
163359946|NCT01200342|590027032|FG000|Overall Study|Disease Progression|1|||
163359947|NCT00246090|590027041|FG000|Overall Study|Adverse Event|25|||
163359948|NCT00246090|590027041|FG000|Overall Study|Withdrawal by Subject|7|||
163359949|NCT00246090|590027041|FG000|Overall Study|Progressive Disease|212|||
163359950|NCT00246090|590027041|FG000|Overall Study|Clinical Progression|30|||
163359951|NCT00246090|590027041|FG000|Overall Study|Physician Decision|11|||
163359952|NCT00246090|590027041|FG000|Overall Study|Not Otherwise Specified|10|||
163359953|NCT03332784|590027044|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359954|NCT03332784|590027045|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
163359955|NCT03332784|590027046|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359956|NCT03332784|590027047|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163151603|NCT04711850|589269425|FG000|Overall Study|Sponsor decision|0|||
163255806|NCT00374322|589642802|FG000|Overall Study|Site Closed|2|||
163255807|NCT00374322|589642803|FG001|Overall Study|Site Closed|2|||
163255808|NCT00374322|589642802|FG000|Overall Study|Participant Changed Physician|1|||
163255809|NCT00374322|589642803|FG001|Overall Study|Participant Changed Physician|0|||
163255810|NCT00374322|589642802|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
163255811|NCT00374322|589642803|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
163359957|NCT03332784|590027048|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359958|NCT03332784|590027049|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359959|NCT03332784|590027050|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359960|NCT03332784|590027051|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359961|NCT03332784|590027052|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359962|NCT03332784|590027053|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359963|NCT03332784|590027054|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359964|NCT03332784|590027055|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359965|NCT03332784|590027056|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359966|NCT03332784|590027057|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359967|NCT03332784|590027058|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
163359968|NCT03332784|590027059|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359969|NCT03332784|590027060|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359970|NCT03332784|590027061|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359971|NCT03332784|590027062|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359972|NCT03332784|590027063|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163359973|NCT00763451|590027069|FG000|Overall Study|Adverse Event|4|||
163359974|NCT00763451|590027070|FG001|Overall Study|Adverse Event|6|||
163359975|NCT00763451|590027071|FG002|Overall Study|Adverse Event|19|||
163359976|NCT00763451|590027072|FG003|Overall Study|Adverse Event|14|||
163359977|NCT00763451|590027069|FG000|Overall Study|Lack of Efficacy|1|||
163359978|NCT00763451|590027070|FG001|Overall Study|Lack of Efficacy|4|||
163359979|NCT00763451|590027071|FG002|Overall Study|Lack of Efficacy|3|||
163359980|NCT00763451|590027072|FG003|Overall Study|Lack of Efficacy|2|||
163359981|NCT00763451|590027069|FG000|Overall Study|Withdrawal by Subject|1|||
163359982|NCT00763451|590027070|FG001|Overall Study|Withdrawal by Subject|6|||
163359983|NCT00763451|590027071|FG002|Overall Study|Withdrawal by Subject|9|||
163359984|NCT00763451|590027072|FG003|Overall Study|Withdrawal by Subject|7|||
163359985|NCT00763451|590027069|FG000|Overall Study|Protocol Violation|0|||
163359986|NCT00763451|590027070|FG001|Overall Study|Protocol Violation|0|||
163359987|NCT00763451|590027071|FG002|Overall Study|Protocol Violation|1|||
163359988|NCT00763451|590027072|FG003|Overall Study|Protocol Violation|0|||
163359989|NCT00763451|590027069|FG000|Overall Study|Poor Compliance to Protocol|1|||
163359990|NCT00763451|590027070|FG001|Overall Study|Poor Compliance to Protocol|1|||
163359991|NCT00763451|590027071|FG002|Overall Study|Poor Compliance to Protocol|2|||
163359992|NCT00763451|590027072|FG003|Overall Study|Poor Compliance to Protocol|2|||
163359993|NCT00763451|590027069|FG000|Overall Study|Familial and Personal Reasons|5|||
163359994|NCT00763451|590027070|FG001|Overall Study|Familial and Personal Reasons|3|||
163359995|NCT00763451|590027071|FG002|Overall Study|Familial and Personal Reasons|5|||
163359996|NCT00763451|590027072|FG003|Overall Study|Familial and Personal Reasons|4|||
163359997|NCT00763451|590027069|FG000|Overall Study|Randomized but not Treated|1|||
163359998|NCT00763451|590027070|FG001|Overall Study|Randomized but not Treated|1|||
163359999|NCT00763451|590027071|FG002|Overall Study|Randomized but not Treated|0|||
163360000|NCT00763451|590027072|FG003|Overall Study|Randomized but not Treated|0|||
163360001|NCT00763451|590027069|FG000|Overall Study|Study Site Reason|0|||
163360002|NCT00763451|590027070|FG001|Overall Study|Study Site Reason|1|||
163255812|NCT00374322|589642802|FG000|Overall Study|Noncompliance with Study Requirements|0|||
163255813|NCT00374322|589642803|FG001|Overall Study|Noncompliance with Study Requirements|1|||
163255814|NCT00374322|589642802|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
163255815|NCT00374322|589642803|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
163255816|NCT00374322|589642802|FG000|Overall Study|Did Not Receive Study Medication|8|||
163255817|NCT00374322|589642803|FG001|Overall Study|Did Not Receive Study Medication|6|||
163255818|NCT02495025|589642807|FG000|Overall Study|Lost to Follow-up|21|||
163255819|NCT02495025|589642808|FG001|Overall Study|Lost to Follow-up|14|||
163255820|NCT02495025|589642807|FG000|Overall Study|Withdrawal by Subject|5|||
163255821|NCT02495025|589642808|FG001|Overall Study|Withdrawal by Subject|0|||
163255822|NCT00313820|589642809|FG000|Assigned to Treatment|Other|1|||
163255823|NCT00313820|589642810|FG001|Assigned to Treatment|Other|0|||
163255824|NCT00313820|589642809|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
163255825|NCT00313820|589642810|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
163255826|NCT00313820|589642809|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
163255827|NCT00313820|589642810|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
163255828|NCT00313820|589642809|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
163360003|NCT00763451|590027071|FG002|Overall Study|Study Site Reason|1|||
163360004|NCT00763451|590027072|FG003|Overall Study|Study Site Reason|1|||
163360005|NCT01827046|590027073|FG000|Overall Study|Lost to Follow-up|1|||
163360006|NCT01827046|590027074|FG001|Overall Study|Lost to Follow-up|5|||
163360007|NCT01827046|590027073|FG000|Overall Study|Withdrawal by Subject|0|||
163255829|NCT00313820|589642810|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
163255830|NCT00313820|589642809|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
163255831|NCT00313820|589642810|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
163255832|NCT00313820|589642809|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
163255833|NCT00313820|589642810|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
163255834|NCT02453685|589642813|FG000|Overall Study|Adverse Event|0|||
163255835|NCT02453685|589642814|FG001|Overall Study|Adverse Event|1|||
163255836|NCT02453685|589642813|FG000|Overall Study|Protocol Violation|7|||
163255837|NCT02453685|589642814|FG001|Overall Study|Protocol Violation|4|||
163255838|NCT02453685|589642813|FG000|Overall Study|Lost to Follow-up|0|||
163255839|NCT02453685|589642814|FG001|Overall Study|Lost to Follow-up|1|||
163255840|NCT02453685|589642813|FG000|Overall Study|Withdrawal by Subject|8|||
163255841|NCT02453685|589642814|FG001|Overall Study|Withdrawal by Subject|4|||
163255842|NCT02453685|589642813|FG000|Overall Study|Unclassified|4|||
163255843|NCT02453685|589642814|FG001|Overall Study|Unclassified|2|||
163255844|NCT02778100|589642817|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
163255845|NCT02778100|589642818|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
163255846|NCT04120233|589642821|FG000|Overall Study|Adverse Event|0|||
163255847|NCT04120233|589642822|FG001|Overall Study|Adverse Event|0|||
163255848|NCT04120233|589642823|FG002|Overall Study|Adverse Event|0|||
163255849|NCT04120233|589642824|FG003|Overall Study|Adverse Event|0|||
163255850|NCT04120233|589642825|FG004|Overall Study|Adverse Event|1|||
163255851|NCT04120233|589642826|FG005|Overall Study|Adverse Event|0|||
163255852|NCT05809596|589642827|FG000|Overall Study|Death|16|||
163255853|NCT05809596|589642827|FG000|Overall Study|Withdrawal by Subject|4|||
163255854|NCT05809596|589642827|FG000|Overall Study|Physician Decision|1|||
163255855|NCT05809596|589642827|FG000|Overall Study|Missed Visit|2|||
163255856|NCT05809596|589642827|FG000|Overall Study|Other|3|||
163255857|NCT01984697|589644790|FG000|Overall Study|Adverse Event|0|||
163255858|NCT01984697|589644791|FG001|Overall Study|Adverse Event|0|||
163255859|NCT01984697|589644792|FG002|Overall Study|Adverse Event|2|||
163255860|NCT01984697|589644793|FG003|Overall Study|Adverse Event|0|||
163255861|NCT01984697|589644794|FG004|Overall Study|Adverse Event|0|||
163255862|NCT01984697|589644790|FG000|Overall Study|Lost to Follow-up|14|||
163255863|NCT01984697|589644791|FG001|Overall Study|Lost to Follow-up|5|||
163255864|NCT01984697|589644792|FG002|Overall Study|Lost to Follow-up|10|||
163255865|NCT01984697|589644793|FG003|Overall Study|Lost to Follow-up|6|||
163255866|NCT01984697|589644794|FG004|Overall Study|Lost to Follow-up|21|||
163255867|NCT01984697|589644790|FG000|Overall Study|Physician Decision|3|||
163255868|NCT01984697|589644791|FG001|Overall Study|Physician Decision|0|||
163255869|NCT01984697|589644792|FG002|Overall Study|Physician Decision|0|||
163255870|NCT01984697|589644793|FG003|Overall Study|Physician Decision|1|||
163255871|NCT01984697|589644794|FG004|Overall Study|Physician Decision|0|||
163255872|NCT01984697|589644790|FG000|Overall Study|Protocol Violation|8|||
163255873|NCT01984697|589644791|FG001|Overall Study|Protocol Violation|5|||
163255874|NCT01984697|589644792|FG002|Overall Study|Protocol Violation|3|||
163255875|NCT01984697|589644793|FG003|Overall Study|Protocol Violation|2|||
163255876|NCT01984697|589644794|FG004|Overall Study|Protocol Violation|0|||
163255877|NCT01984697|589644790|FG000|Overall Study|Withdrawal by Subject|15|||
163255878|NCT01984697|589644791|FG001|Overall Study|Withdrawal by Subject|21|||
163255879|NCT01984697|589644792|FG002|Overall Study|Withdrawal by Subject|13|||
163255880|NCT01984697|589644793|FG003|Overall Study|Withdrawal by Subject|11|||
163360008|NCT01827046|590027074|FG001|Overall Study|Withdrawal by Subject|4|||
163360009|NCT05594589|590027078|FG000|Overall Study|Other|0|||
163360010|NCT05594589|590027079|FG001|Overall Study|Other|1|||
163360011|NCT05594589|590027080|FG002|Overall Study|Other|0|||
163360012|NCT02282917|590027082|FG000|Overall Study|Withdrawal by Subject|1|||
163360013|NCT02282917|590027082|FG000|Overall Study|Screen Failure/Not Eligible|1|||
163360014|NCT00115336|590027083|FG000|Overall Study|Hospital discharge before study drug|0|||
163360015|NCT00115336|590027084|FG001|Overall Study|Hospital discharge before study drug|1|||
163360016|NCT00715117|590027093|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
163360017|NCT00715117|590027094|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
163360018|NCT01536171|590027098|FG000|Overall Study|Withdrawal by Subject|1|||
163360019|NCT01018732|590027099|FG000|Overall Study|Lost to Follow-up|0|||
163360020|NCT01018732|590027100|FG001|Overall Study|Lost to Follow-up|0|||
163410584|NCT01425008|590211388|FG008|Dose Escalation Phase|Adverse Event|2|||
163255881|NCT01984697|589644794|FG004|Overall Study|Withdrawal by Subject|13|||
163255882|NCT01984697|589644790|FG000|Overall Study|Missed last follow-up visit|1|||
163255883|NCT01984697|589644791|FG001|Overall Study|Missed last follow-up visit|0|||
163255884|NCT01984697|589644792|FG002|Overall Study|Missed last follow-up visit|0|||
163255885|NCT01984697|589644793|FG003|Overall Study|Missed last follow-up visit|0|||
163255886|NCT01984697|589644794|FG004|Overall Study|Missed last follow-up visit|0|||
163255887|NCT01984697|589644790|FG000|Overall Study|Death|0|||
163255888|NCT01984697|589644791|FG001|Overall Study|Death|0|||
163255889|NCT01984697|589644792|FG002|Overall Study|Death|0|||
163255890|NCT01984697|589644793|FG003|Overall Study|Death|1|||
163360021|NCT01018732|590027101|FG002|Overall Study|Lost to Follow-up|3|||
163360022|NCT01018732|590027099|FG000|Overall Study|Protocol Violation|1|||
163360023|NCT01018732|590027100|FG001|Overall Study|Protocol Violation|1|||
163360024|NCT01018732|590027101|FG002|Overall Study|Protocol Violation|0|||
163360025|NCT01018732|590027099|FG000|Overall Study|Inappropriate Enrollment|0|||
163360026|NCT01018732|590027100|FG001|Overall Study|Inappropriate Enrollment|1|||
163360027|NCT01018732|590027101|FG002|Overall Study|Inappropriate Enrollment|0|||
163360028|NCT01018732|590027099|FG000|Overall Study|Unable to Classify|0|||
163360029|NCT01018732|590027100|FG001|Overall Study|Unable to Classify|0|||
163360030|NCT01018732|590027101|FG002|Overall Study|Unable to Classify|1|||
163360031|NCT03566979|590027103|FG000|Overall Study|Withdrawal by Subject|2|||
163360032|NCT03566979|590027104|FG001|Overall Study|Withdrawal by Subject|0|||
163360033|NCT03566979|590027105|FG002|Overall Study|Withdrawal by Subject|1|||
163360034|NCT03566979|590027106|FG003|Overall Study|Withdrawal by Subject|1|||
163360035|NCT03566979|590027103|FG000|Overall Study|Lost to Follow-up|2|||
163360036|NCT03566979|590027104|FG001|Overall Study|Lost to Follow-up|7|||
163360037|NCT03566979|590027105|FG002|Overall Study|Lost to Follow-up|9|||
163360038|NCT03566979|590027106|FG003|Overall Study|Lost to Follow-up|5|||
163360039|NCT03566979|590027103|FG000|Overall Study|Adverse Event|1|||
163360040|NCT03566979|590027104|FG001|Overall Study|Adverse Event|0|||
163360041|NCT03566979|590027105|FG002|Overall Study|Adverse Event|0|||
163360042|NCT03566979|590027106|FG003|Overall Study|Adverse Event|0|||
163360043|NCT01262092|590027107|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
163360044|NCT01262092|590027108|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
163360045|NCT01262092|590027107|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
163360046|NCT01262092|590027108|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
163360047|NCT01262092|590027107|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
163360048|NCT01262092|590027108|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
163360049|NCT01262092|590027107|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
163360050|NCT01262092|590027108|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
163360051|NCT03784820|590027109|FG000|Overall Study|Lost to Follow-up|5|||
163360052|NCT03784820|590027110|FG001|Overall Study|Lost to Follow-up|5|||
163360053|NCT03784820|590027111|FG002|Overall Study|Lost to Follow-up|3|||
163360054|NCT03784820|590027112|FG003|Overall Study|Lost to Follow-up|3|||
163360055|NCT02336425|590027113|FG000|Overall Study|Study terminated.|2|||
163360056|NCT02336425|590027114|FG001|Overall Study|Study terminated.|2|||
163360057|NCT02336425|590027115|FG002|Overall Study|Study terminated.|3|||
163360058|NCT02336425|590027116|FG003|Overall Study|Study terminated.|3|||
163360059|NCT00978562|590027117|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
163360060|NCT02394665|590027120|FG000|Overall Study|Physician Decision|1|||
163360061|NCT02394665|590027121|FG001|Overall Study|Physician Decision|0|||
163360062|NCT02394665|590027122|FG002|Overall Study|Physician Decision|0|||
163360063|NCT00569127|590027123|FG000|Overall Study|Adverse Event|57|||
163360064|NCT00569127|590027124|FG001|Overall Study|Adverse Event|47|||
163360065|NCT00569127|590027123|FG000|Overall Study|Withdrawal by Subject|13|||
163360066|NCT00569127|590027124|FG001|Overall Study|Withdrawal by Subject|27|||
163360067|NCT00569127|590027123|FG000|Overall Study|Progression|99|||
163360068|NCT00569127|590027124|FG001|Overall Study|Progression|100|||
163360069|NCT00569127|590027123|FG000|Overall Study|Death|4|||
163360070|NCT00569127|590027124|FG001|Overall Study|Death|3|||
163360071|NCT00569127|590027123|FG000|Overall Study|Other|20|||
163360072|NCT00569127|590027124|FG001|Overall Study|Other|19|||
163360073|NCT00569127|590027123|FG000|Overall Study|Lost to Follow-up|0|||
163360074|NCT00569127|590027124|FG001|Overall Study|Lost to Follow-up|3|||
163360075|NCT00569127|590027123|FG000|Overall Study|Not Eligible|14|||
163360076|NCT00569127|590027124|FG001|Overall Study|Not Eligible|11|||
163360077|NCT00569127|590027123|FG000|Overall Study|Still on Treatment|7|||
163360078|NCT00569127|590027124|FG001|Overall Study|Still on Treatment|3|||
163360079|NCT03348631|590027139|FG000|Overall Study|Not Eligible, No treatment|0|||
163360080|NCT03348631|590027140|FG001|Overall Study|Not Eligible, No treatment|1|||
163360081|NCT03348631|590027139|FG000|Overall Study|Not Eligible, Treated|2|||
163360082|NCT03348631|590027140|FG001|Overall Study|Not Eligible, Treated|0|||
163360083|NCT03348631|590027139|FG000|Overall Study|Eligible, No Treatment|1|||
163360084|NCT03348631|590027140|FG001|Overall Study|Eligible, No Treatment|0|||
163360085|NCT01068210|590027141|FG000|Overall Study|Lost to Follow-up|1|||
163360086|NCT01068210|590027142|FG001|Overall Study|Lost to Follow-up|2|||
163360087|NCT01068210|590027143|FG002|Overall Study|Lost to Follow-up|2|||
163360088|NCT01068210|590027144|FG003|Overall Study|Lost to Follow-up|1|||
163360089|NCT01068210|590027141|FG000|Overall Study|Second cancer|0|||
163360090|NCT01068210|590027142|FG001|Overall Study|Second cancer|1|||
163360091|NCT01068210|590027143|FG002|Overall Study|Second cancer|0|||
163360092|NCT01068210|590027144|FG003|Overall Study|Second cancer|0|||
163360093|NCT01068210|590027141|FG000|Overall Study|Disease progression|0|||
163360094|NCT01068210|590027142|FG001|Overall Study|Disease progression|0|||
163360095|NCT01068210|590027143|FG002|Overall Study|Disease progression|0|||
163360096|NCT01068210|590027144|FG003|Overall Study|Disease progression|2|||
163360097|NCT03569891|590027145|FG000|Lead-in|Ineligible during lead-in|8|||
163360098|NCT03569891|590027145|FG000|Lead-in|Withdrawal by Subject|3|||
163360099|NCT03569891|590027145|FG000|Lead-in|Risks related to COVID-19|2|||
163360100|NCT03569891|590027145|FG000|AMT-061|Adverse Event|1|||
163410585|NCT01425008|590211389|FG009|Dose Escalation Phase|Adverse Event|0|||
163410586|NCT01425008|590211390|FG010|Dose Escalation Phase|Adverse Event|0|||
163410587|NCT01425008|590211391|FG011|Dose Escalation Phase|Adverse Event|0|||
163410588|NCT01425008|590211392|FG012|Dose Escalation Phase|Adverse Event|0|||
163410589|NCT01425008|590211393|FG013|Dose Escalation Phase|Adverse Event|0|||
163410590|NCT01425008|590211394|FG014|Dose Escalation Phase|Adverse Event|0|||
163410591|NCT01425008|590211395|FG015|Dose Escalation Phase|Adverse Event|0|||
163410592|NCT01425008|590211396|FG016|Dose Escalation Phase|Adverse Event|0|||
163410593|NCT01425008|590211397|FG017|Dose Escalation Phase|Adverse Event|0|||
163410594|NCT01425008|590211398|FG018|Dose Escalation Phase|Adverse Event|0|||
163410595|NCT01425008|590211380|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163410596|NCT01425008|590211381|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163410597|NCT01425008|590211382|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163410598|NCT01425008|590211383|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163410599|NCT01425008|590211384|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
163410600|NCT01425008|590211385|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163410601|NCT01425008|590211386|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
163255891|NCT01984697|589644794|FG004|Overall Study|Death|0|||
163255892|NCT01984697|589644790|FG000|Overall Study|Pregnancy|2|||
163255893|NCT01984697|589644791|FG001|Overall Study|Pregnancy|0|||
163255894|NCT01984697|589644792|FG002|Overall Study|Pregnancy|1|||
163255895|NCT01984697|589644793|FG003|Overall Study|Pregnancy|0|||
163255896|NCT01984697|589644794|FG004|Overall Study|Pregnancy|1|||
163255897|NCT01345630|589644795|FG000|Overall Study|Adverse Event|22|||
163255898|NCT01345630|589644796|FG001|Overall Study|Adverse Event|23|||
163255899|NCT01345630|589644795|FG000|Overall Study|Lost to Follow-up|17|||
163255900|NCT01345630|589644796|FG001|Overall Study|Lost to Follow-up|16|||
163255901|NCT01345630|589644795|FG000|Overall Study|Protocol Violation|4|||
163255902|NCT01345630|589644796|FG001|Overall Study|Protocol Violation|1|||
163255903|NCT01345630|589644795|FG000|Overall Study|Medication error without associated AE|0|||
163255904|NCT01345630|589644796|FG001|Overall Study|Medication error without associated AE|1|||
163255905|NCT01345630|589644795|FG000|Overall Study|Study terminated by sponsor|254|||
163255906|NCT01345630|589644796|FG001|Overall Study|Study terminated by sponsor|285|||
163255907|NCT01345630|589644795|FG000|Overall Study|Other reasons|6|||
163255908|NCT01345630|589644796|FG001|Overall Study|Other reasons|8|||
163255909|NCT01345630|589644795|FG000|Overall Study|Withdrawn due to pregnancy|1|||
163255910|NCT01345630|589644796|FG001|Overall Study|Withdrawn due to pregnancy|2|||
163255911|NCT01345630|589644795|FG000|Overall Study|No longer willing to participate|9|||
163255912|NCT01345630|589644796|FG001|Overall Study|No longer willing to participate|12|||
163255913|NCT01345630|589644795|FG000|Overall Study|Insufficient clinical response|48|||
163255914|NCT01345630|589644796|FG001|Overall Study|Insufficient clinical response|11|||
163255915|NCT01364922|589644804|FG000|Open-label (OL) Period|Adverse Event|7|||
163360101|NCT03299959|590027148|FG000|Overall Study|Lost to Follow-up|7|||
163360102|NCT03299959|590027149|FG001|Overall Study|Lost to Follow-up|9|||
163360103|NCT03299959|590027148|FG000|Overall Study|Death|1|||
163360104|NCT03299959|590027149|FG001|Overall Study|Death|0|||
163360105|NCT03299959|590027148|FG000|Overall Study|Withdrawal by Subject|13|||
163360106|NCT03299959|590027149|FG001|Overall Study|Withdrawal by Subject|9|||
163360107|NCT03299959|590027148|FG000|Overall Study|Changes in study team and government regulations|1|||
163360108|NCT03299959|590027149|FG001|Overall Study|Changes in study team and government regulations|1|||
163360109|NCT03299959|590027148|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
163360110|NCT03299959|590027149|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
163360111|NCT00356811|590027150|FG000|Overall Study|Death|35|||
163360112|NCT00356811|590027150|FG000|Overall Study|Lost to Follow-up|2|||
163360113|NCT00356811|590027150|FG000|Overall Study|Withdrawal by Subject|6|||
163360114|NCT00356811|590027150|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
163360115|NCT00356811|590027150|FG000|Overall Study|Study Is Terminating|3|||
163360116|NCT00356811|590027150|FG000|Overall Study|Site Closed during Follow-up|2|||
163360117|NCT02201901|590027152|FG000|Overall Study|Randomized but never treated|0|||
163360118|NCT02201901|590027153|FG001|Overall Study|Randomized but never treated|1|||
163360119|NCT02201901|590027154|FG002|Overall Study|Randomized but never treated|0|||
163360120|NCT02201901|590027152|FG000|Overall Study|Lack of Efficacy|7|||
163360121|NCT02201901|590027153|FG001|Overall Study|Lack of Efficacy|1|||
163360122|NCT02201901|590027154|FG002|Overall Study|Lack of Efficacy|6|||
163360123|NCT02201901|590027152|FG000|Overall Study|Death|3|||
163360124|NCT02201901|590027153|FG001|Overall Study|Death|3|||
163360125|NCT02201901|590027154|FG002|Overall Study|Death|3|||
163360126|NCT02201901|590027152|FG000|Overall Study|Lost to Follow-up|2|||
163410602|NCT01425008|590211387|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
163410603|NCT01425008|590211388|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
163255916|NCT01364922|589644805|FG001|Open-label (OL) Period|Adverse Event|0|||
163255917|NCT01364922|589644806|FG002|Open-label (OL) Period|Adverse Event|0|||
163360127|NCT02201901|590027153|FG001|Overall Study|Lost to Follow-up|3|||
163360128|NCT02201901|590027154|FG002|Overall Study|Lost to Follow-up|2|||
163360129|NCT02201901|590027152|FG000|Overall Study|Withdrew Consent|2|||
163360130|NCT02201901|590027153|FG001|Overall Study|Withdrew Consent|0|||
163360131|NCT02201901|590027154|FG002|Overall Study|Withdrew Consent|2|||
163360132|NCT02201901|590027152|FG000|Overall Study|Adverse Event|1|||
163360133|NCT02201901|590027153|FG001|Overall Study|Adverse Event|1|||
163360134|NCT02201901|590027154|FG002|Overall Study|Adverse Event|0|||
163360135|NCT00738283|590027157|FG000|Overall Study|Death|1|||
163360136|NCT00738283|590027157|FG000|Overall Study|Transfer to another facility|2|||
163360137|NCT00738283|590027157|FG000|Overall Study|Discharge home prior to end of study|1|||
163360138|NCT00469859|590027158|FG000|Overall Study|Inevaluable|0|||
163360139|NCT00469859|590027159|FG001|Overall Study|Inevaluable|2|||
163360140|NCT03494985|590027160|FG000|Overall Study|Adverse Event|3|||
163360141|NCT03494985|590027161|FG001|Overall Study|Adverse Event|2|||
163360142|NCT03494985|590027162|FG002|Overall Study|Adverse Event|3|||
163360143|NCT03494985|590027163|FG003|Overall Study|Adverse Event|0|||
163360144|NCT03494985|590027160|FG000|Overall Study|Other (Withdrawal of consent)|2|||
163360145|NCT03494985|590027161|FG001|Overall Study|Other (Withdrawal of consent)|3|||
163360146|NCT03494985|590027162|FG002|Overall Study|Other (Withdrawal of consent)|2|||
163360147|NCT03494985|590027163|FG003|Overall Study|Other (Withdrawal of consent)|5|||
163360148|NCT03494985|590027160|FG000|Overall Study|Other (Not specified)|0|||
163360149|NCT03494985|590027161|FG001|Overall Study|Other (Not specified)|1|||
163360150|NCT03494985|590027162|FG002|Overall Study|Other (Not specified)|1|||
163360151|NCT03494985|590027163|FG003|Overall Study|Other (Not specified)|0|||
163360152|NCT02282059|590027164|FG000|Overall Study|Other|15|||
163360153|NCT02282059|590027165|FG001|Overall Study|Other|3|||
163360154|NCT02282059|590027164|FG000|Overall Study|Participant refused further follow-up|8|||
163360155|NCT02282059|590027165|FG001|Overall Study|Participant refused further follow-up|4|||
163360156|NCT02282059|590027164|FG000|Overall Study|Lost to Follow-up|19|||
163360157|NCT02282059|590027165|FG001|Overall Study|Lost to Follow-up|3|||
163360158|NCT02282059|590027164|FG000|Overall Study|Death|40|||
163360159|NCT02282059|590027165|FG001|Overall Study|Death|8|||
163360160|NCT03459846|590027166|FG000|Overall Study|Death|52|||
163360161|NCT03459846|590027167|FG001|Overall Study|Death|46|||
163360162|NCT03459846|590027166|FG000|Overall Study|Study terminated by sponsor|24|||
163360163|NCT03459846|590027167|FG001|Overall Study|Study terminated by sponsor|28|||
163360164|NCT03459846|590027166|FG000|Overall Study|Withdrawal by Subject|2|||
163360165|NCT03459846|590027167|FG001|Overall Study|Withdrawal by Subject|2|||
163360166|NCT04886518|590027174|FG000|Overall Study|Noncompliance with study drug|1|||
163360167|NCT04886518|590027175|FG001|Overall Study|Noncompliance with study drug|0|||
163360168|NCT04886518|590027176|FG002|Overall Study|Noncompliance with study drug|0|||
163360169|NCT04886518|590027174|FG000|Overall Study|Adverse Event|0|||
163360170|NCT04886518|590027175|FG001|Overall Study|Adverse Event|1|||
163360171|NCT04886518|590027176|FG002|Overall Study|Adverse Event|0|||
163360172|NCT04886518|590027174|FG000|Overall Study|Withdrawal by Subject|1|||
163360173|NCT04886518|590027175|FG001|Overall Study|Withdrawal by Subject|0|||
163360174|NCT04886518|590027176|FG002|Overall Study|Withdrawal by Subject|0|||
163360175|NCT01443403|590029448|FG000|Overall Study|Adverse Event|1|||
163360176|NCT01443403|590029449|FG001|Overall Study|Adverse Event|1|||
163360177|NCT01443403|590029450|FG002|Overall Study|Adverse Event|4|||
163360178|NCT01443403|590029451|FG003|Overall Study|Adverse Event|5|||
163360179|NCT01443403|590029448|FG000|Overall Study|Withdrawal by Subject|0|||
163360180|NCT01443403|590029449|FG001|Overall Study|Withdrawal by Subject|1|||
163360181|NCT01443403|590029450|FG002|Overall Study|Withdrawal by Subject|2|||
163360182|NCT01443403|590029451|FG003|Overall Study|Withdrawal by Subject|1|||
163360183|NCT01443403|590029448|FG000|Overall Study|Lost to Follow-up|0|||
163360184|NCT01443403|590029449|FG001|Overall Study|Lost to Follow-up|0|||
163360185|NCT01443403|590029450|FG002|Overall Study|Lost to Follow-up|0|||
163360186|NCT01443403|590029451|FG003|Overall Study|Lost to Follow-up|1|||
163360187|NCT01443403|590029448|FG000|Overall Study|Protocol Violation|2|||
163360188|NCT01443403|590029449|FG001|Overall Study|Protocol Violation|1|||
163360189|NCT01443403|590029450|FG002|Overall Study|Protocol Violation|1|||
163360190|NCT01443403|590029451|FG003|Overall Study|Protocol Violation|1|||
163360191|NCT01443403|590029448|FG000|Overall Study|Use of Prohibited Treatment|2|||
163360192|NCT01443403|590029449|FG001|Overall Study|Use of Prohibited Treatment|3|||
163360193|NCT01443403|590029450|FG002|Overall Study|Use of Prohibited Treatment|0|||
163360194|NCT01443403|590029451|FG003|Overall Study|Use of Prohibited Treatment|0|||
163360195|NCT01443403|590029448|FG000|Overall Study|Other - Miscellaneous|1|||
163360196|NCT01443403|590029449|FG001|Overall Study|Other - Miscellaneous|0|||
163360197|NCT01443403|590029450|FG002|Overall Study|Other - Miscellaneous|0|||
163360198|NCT01443403|590029451|FG003|Overall Study|Other - Miscellaneous|1|||
163151604|NCT04711850|589269426|FG001|Overall Study|Sponsor decision|2|||
163410604|NCT01425008|590211389|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163410605|NCT01425008|590211390|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163410606|NCT01425008|590211391|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163410607|NCT01425008|590211392|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163410608|NCT01425008|590211393|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163410609|NCT01425008|590211394|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163410610|NCT01425008|590211395|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163410611|NCT01425008|590211396|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163410612|NCT01425008|590211397|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163410613|NCT01425008|590211398|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163410614|NCT01425008|590211380|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
163410615|NCT01425008|590211381|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
163410616|NCT01425008|590211382|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
163410617|NCT01425008|590211383|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
163410618|NCT01425008|590211384|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
163410619|NCT01425008|590211385|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
163410620|NCT01425008|590211386|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
163410621|NCT01425008|590211387|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
163410622|NCT01425008|590211388|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
163410623|NCT01425008|590211389|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
163410624|NCT01425008|590211390|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
163410625|NCT01425008|590211391|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
163410626|NCT01425008|590211392|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
163410627|NCT01425008|590211393|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
163410628|NCT01425008|590211394|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
163410629|NCT01425008|590211395|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
163410630|NCT01425008|590211396|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
163410631|NCT01425008|590211397|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
163410632|NCT01425008|590211398|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
163410633|NCT01425008|590211380|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
163410634|NCT01425008|590211381|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
163410635|NCT01425008|590211382|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
163410636|NCT01425008|590211383|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
163410637|NCT01425008|590211384|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
163410638|NCT01425008|590211385|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
163410639|NCT01425008|590211386|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
163410640|NCT01425008|590211387|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
163410641|NCT01425008|590211388|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
163255918|NCT01364922|589644804|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
163410642|NCT01425008|590211389|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
163410643|NCT01425008|590211390|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
163410644|NCT01425008|590211391|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
163255919|NCT01364922|589644805|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
163255920|NCT01364922|589644806|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
163255921|NCT01364922|589644804|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
163255922|NCT01364922|589644805|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
163255923|NCT01364922|589644806|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
163255924|NCT01364922|589644804|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
163255925|NCT01364922|589644805|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
163255926|NCT01364922|589644806|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
163255927|NCT01364922|589644804|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
163255928|NCT01364922|589644805|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
163255929|NCT01364922|589644806|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
163255930|NCT01364922|589644804|FG000|Open-label (OL) Period|Other, Unspecified|1|||
163255931|NCT01364922|589644805|FG001|Open-label (OL) Period|Other, Unspecified|0|||
163255932|NCT01364922|589644806|FG002|Open-label (OL) Period|Other, Unspecified|0|||
163255933|NCT01364922|589644804|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
163255934|NCT01364922|589644805|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
163255935|NCT01364922|589644806|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
163255936|NCT01364922|589644804|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
163255937|NCT01364922|589644805|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
163255938|NCT01364922|589644806|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
163255939|NCT01364922|589644804|FG000|Double-Blind (DB) Period|Adverse Event|0|||
163255940|NCT01364922|589644805|FG001|Double-Blind (DB) Period|Adverse Event|0|||
163255941|NCT01364922|589644806|FG002|Double-Blind (DB) Period|Adverse Event|1|||
163255942|NCT01364922|589644804|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
163255943|NCT01364922|589644805|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
163255944|NCT01364922|589644806|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
163255945|NCT05178121|589644807|FG000|Overall Study|Other|4|||
163255946|NCT05178121|589644807|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
163360211|NCT00725712|590029456|FG000|Overall Study|Withdrawal by Subject|2|||
163360212|NCT00725712|590029457|FG001|Overall Study|Withdrawal by Subject|1|||
163360213|NCT00725712|590029456|FG000|Overall Study|Protocol Violation|1|||
163360214|NCT00725712|590029457|FG001|Overall Study|Protocol Violation|0|||
163360215|NCT00725712|590029456|FG000|Overall Study|Progressive disease|37|||
163360216|NCT00725712|590029457|FG001|Overall Study|Progressive disease|16|||
163360217|NCT00725712|590029456|FG000|Overall Study|Clinical progression not based on RECIST|0|||
163360218|NCT00725712|590029457|FG001|Overall Study|Clinical progression not based on RECIST|3|||
163360219|NCT00725712|590029456|FG000|Overall Study|Adverse Event|5|||
163360220|NCT00725712|590029457|FG001|Overall Study|Adverse Event|5|||
163360221|NCT00725712|590029456|FG000|Overall Study|Death|2|||
163360222|NCT00725712|590029457|FG001|Overall Study|Death|0|||
163360223|NCT00725712|590029456|FG000|Overall Study|Other: Death|1|||
163360224|NCT00725712|590029457|FG001|Overall Study|Other: Death|0|||
163360225|NCT00725712|590029456|FG000|Overall Study|Hospitalized, unable to continue|0|||
163360226|NCT00725712|590029457|FG001|Overall Study|Hospitalized, unable to continue|1|||
163360227|NCT03607422|590029460|FG000|Overall Study|Adverse Event|7|||
163360228|NCT03607422|590029461|FG001|Overall Study|Adverse Event|3|||
163360229|NCT03607422|590029462|FG002|Overall Study|Adverse Event|2|||
163360230|NCT03607422|590029463|FG003|Overall Study|Adverse Event|0|||
163360231|NCT03607422|590029464|FG004|Overall Study|Adverse Event|2|||
163360232|NCT03607422|590029465|FG005|Overall Study|Adverse Event|0|||
163360233|NCT03607422|590029460|FG000|Overall Study|Withdrawal by Subject|11|||
163360234|NCT03607422|590029461|FG001|Overall Study|Withdrawal by Subject|3|||
163360235|NCT03607422|590029462|FG002|Overall Study|Withdrawal by Subject|6|||
163360236|NCT03607422|590029463|FG003|Overall Study|Withdrawal by Subject|2|||
163360237|NCT03607422|590029464|FG004|Overall Study|Withdrawal by Subject|0|||
163360238|NCT03607422|590029465|FG005|Overall Study|Withdrawal by Subject|0|||
163360239|NCT03607422|590029460|FG000|Overall Study|Lost to Follow-up|0|||
163360240|NCT03607422|590029461|FG001|Overall Study|Lost to Follow-up|0|||
163360241|NCT03607422|590029462|FG002|Overall Study|Lost to Follow-up|1|||
163360242|NCT03607422|590029463|FG003|Overall Study|Lost to Follow-up|0|||
163360243|NCT03607422|590029464|FG004|Overall Study|Lost to Follow-up|0|||
163360244|NCT03607422|590029465|FG005|Overall Study|Lost to Follow-up|0|||
163360245|NCT03607422|590029460|FG000|Overall Study|Other|12|||
163360246|NCT03607422|590029461|FG001|Overall Study|Other|4|||
163360247|NCT03607422|590029462|FG002|Overall Study|Other|1|||
163360248|NCT03607422|590029463|FG003|Overall Study|Other|2|||
163360249|NCT03607422|590029464|FG004|Overall Study|Other|0|||
163360250|NCT03607422|590029465|FG005|Overall Study|Other|2|||
163360251|NCT03607422|590029460|FG000|Overall Study|Ongoing at Time of Analysis|8|||
163360252|NCT03607422|590029461|FG001|Overall Study|Ongoing at Time of Analysis|0|||
163360253|NCT03607422|590029462|FG002|Overall Study|Ongoing at Time of Analysis|2|||
163360254|NCT03607422|590029463|FG003|Overall Study|Ongoing at Time of Analysis|1|||
163360255|NCT03607422|590029464|FG004|Overall Study|Ongoing at Time of Analysis|1|||
163360256|NCT03607422|590029465|FG005|Overall Study|Ongoing at Time of Analysis|1|||
163360257|NCT00863512|590029466|FG000|Overall Study|Adverse Event|2|||
163360258|NCT00863512|590029467|FG001|Overall Study|Adverse Event|0|||
163360259|NCT00863512|590029466|FG000|Overall Study|Withdrawal by Subject|11|||
163360260|NCT00863512|590029467|FG001|Overall Study|Withdrawal by Subject|0|||
163360261|NCT00863512|590029466|FG000|Overall Study|Physician Decision|1|||
163360262|NCT00863512|590029467|FG001|Overall Study|Physician Decision|0|||
163360263|NCT03258723|590029470|FG000|Overall Study|COVID Interruption of study|54|||
163360264|NCT03258723|590029470|FG000|Overall Study|Lost to Follow-up|8|||
163360265|NCT04832971|590029471|FG000|Double-Blind (DB) Treatment Period|Death|1|||
163360266|NCT04832971|590029472|FG001|Double-Blind (DB) Treatment Period|Death|0|||
163360267|NCT04832971|590029473|FG002|Double-Blind (DB) Treatment Period|Death|0|||
163360268|NCT04832971|590029474|FG003|Double-Blind (DB) Treatment Period|Death|0|||
163360269|NCT04832971|590029475|FG004|Double-Blind (DB) Treatment Period|Death|0|||
163360270|NCT04832971|590029476|FG005|Double-Blind (DB) Treatment Period|Death|0|||
163360271|NCT04832971|590029477|FG006|Double-Blind (DB) Treatment Period|Death|0|||
163410645|NCT01425008|590211392|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
163410646|NCT01425008|590211393|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
163360272|NCT04832971|590029478|FG007|Double-Blind (DB) Treatment Period|Death|0|||
163360273|NCT04832971|590029479|FG008|Double-Blind (DB) Treatment Period|Death|0|||
163360274|NCT04832971|590029480|FG009|Double-Blind (DB) Treatment Period|Death|0|||
163360275|NCT04832971|590029471|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
163360276|NCT04832971|590029472|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
163410647|NCT01425008|590211394|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
163360277|NCT04832971|590029473|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
163360278|NCT04832971|590029474|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163360279|NCT04832971|590029475|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163360280|NCT04832971|590029476|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163360281|NCT04832971|590029477|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163360282|NCT04832971|590029478|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163360283|NCT04832971|590029479|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163360284|NCT04832971|590029480|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163360285|NCT04832971|590029471|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
163360286|NCT04832971|590029472|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
163360287|NCT04832971|590029473|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
163360288|NCT04832971|590029474|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
163360289|NCT04832971|590029475|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
163360290|NCT04832971|590029476|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
163360291|NCT04832971|590029477|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
163360292|NCT04832971|590029478|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
163360293|NCT04832971|590029479|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
163360294|NCT04832971|590029480|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
163360295|NCT04832971|590029471|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163360296|NCT04832971|590029472|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
163360297|NCT04832971|590029473|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163360298|NCT04832971|590029474|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163360299|NCT04832971|590029475|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163360300|NCT04832971|590029476|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163360301|NCT04832971|590029477|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163360302|NCT04832971|590029478|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163360303|NCT04832971|590029479|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163360304|NCT04832971|590029480|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163360305|NCT04832971|590029471|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
163360306|NCT04832971|590029472|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
163360307|NCT04832971|590029473|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
163360308|NCT04832971|590029474|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
163360309|NCT04832971|590029475|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
163360310|NCT04832971|590029476|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
163360311|NCT04832971|590029477|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
163360312|NCT04832971|590029478|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
163360313|NCT04832971|590029479|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
163360314|NCT04832971|590029480|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
163360315|NCT04832971|590029471|FG000|Open-Label Extension (OLE) Period|Death|0|||
163360316|NCT04832971|590029472|FG001|Open-Label Extension (OLE) Period|Death|0|||
163360317|NCT04832971|590029473|FG002|Open-Label Extension (OLE) Period|Death|0|||
163360318|NCT04832971|590029474|FG003|Open-Label Extension (OLE) Period|Death|0|||
163360319|NCT04832971|590029475|FG004|Open-Label Extension (OLE) Period|Death|0|||
163360320|NCT04832971|590029476|FG005|Open-Label Extension (OLE) Period|Death|0|||
163360321|NCT04832971|590029477|FG006|Open-Label Extension (OLE) Period|Death|0|||
163360322|NCT04832971|590029478|FG007|Open-Label Extension (OLE) Period|Death|1|||
163360323|NCT04832971|590029479|FG008|Open-Label Extension (OLE) Period|Death|0|||
163360324|NCT04832971|590029480|FG009|Open-Label Extension (OLE) Period|Death|0|||
163360325|NCT04832971|590029471|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163360326|NCT04832971|590029472|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163360327|NCT04832971|590029473|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163360328|NCT04832971|590029474|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163360329|NCT04832971|590029475|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163360330|NCT04832971|590029476|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163360331|NCT04832971|590029477|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
163360332|NCT04832971|590029478|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
163360333|NCT04832971|590029479|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163360334|NCT04832971|590029480|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163360335|NCT04832971|590029471|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
163360336|NCT04832971|590029472|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
163360337|NCT04832971|590029473|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
163360338|NCT04832971|590029474|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
163360339|NCT04832971|590029475|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
163360340|NCT04832971|590029476|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
163360341|NCT04832971|590029477|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
163410648|NCT01425008|590211395|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
163410649|NCT01425008|590211396|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
163360342|NCT04832971|590029478|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
163410650|NCT01425008|590211397|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
163410651|NCT01425008|590211398|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
163255947|NCT01953003|589644808|FG000|Overall Study|Not treated|0|||
163255948|NCT01953003|589644809|FG001|Overall Study|Not treated|1|||
163255949|NCT01953003|589644808|FG000|Overall Study|Progressive disease|35|||
163255950|NCT01953003|589644809|FG001|Overall Study|Progressive disease|45|||
163255951|NCT01953003|589644808|FG000|Overall Study|Related Adverse events|7|||
163255952|NCT01953003|589644809|FG001|Overall Study|Related Adverse events|2|||
163255953|NCT01953003|589644808|FG000|Overall Study|Non-related adverse events|0|||
163255954|NCT01953003|589644809|FG001|Overall Study|Non-related adverse events|2|||
163255955|NCT01953003|589644808|FG000|Overall Study|Protocol Violation|0|||
163255956|NCT01953003|589644809|FG001|Overall Study|Protocol Violation|1|||
163255957|NCT01953003|589644808|FG000|Overall Study|Withdrawal by Subject|14|||
163255958|NCT01953003|589644809|FG001|Overall Study|Withdrawal by Subject|4|||
163255959|NCT00553501|589644811|FG000|Overall Study|Adverse Event|2|||
163255960|NCT00553501|589644811|FG000|Overall Study|Death|1|||
163255961|NCT00553501|589644811|FG000|Overall Study|Progression|1|||
163255962|NCT00949715|589644814|FG000|Overall Study|Physician Decision|1|||
163255963|NCT00949715|589644815|FG001|Overall Study|Physician Decision|0|||
163255964|NCT00949715|589644814|FG000|Overall Study|Lost to Follow-up|1|||
163255965|NCT00949715|589644815|FG001|Overall Study|Lost to Follow-up|0|||
163255966|NCT00949715|589644814|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
163255967|NCT00949715|589644815|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
163255968|NCT01582789|589644817|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
163255969|NCT01582789|589644818|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
163255970|NCT04044456|589644827|FG000|Overall Study|Lost to Follow-up|4|||
163255971|NCT04044456|589644828|FG001|Overall Study|Lost to Follow-up|1|||
163255972|NCT04044456|589644827|FG000|Overall Study|Withdrawal by Subject|1|||
163255973|NCT04044456|589644828|FG001|Overall Study|Withdrawal by Subject|0|||
163255974|NCT02316769|589644830|FG000|Overall Study|Physician Decision|1|||
163255975|NCT02316769|589644831|FG001|Overall Study|Physician Decision|0|||
163255976|NCT02316769|589644830|FG000|Overall Study|Withdrawal by Subject|1|||
163255977|NCT02316769|589644831|FG001|Overall Study|Withdrawal by Subject|0|||
163255978|NCT04209725|589644838|FG000|Overall Study|Adverse Event|1|||
163255979|NCT01281644|589644841|FG000|Overall Study|Lost to Follow-up|3|||
163255980|NCT01281644|589644841|FG000|Overall Study|Withdrawal by Subject|2|||
163255981|NCT02954354|589644842|FG000|Overall Study|Adverse Event|2|||
163255982|NCT02954354|589644843|FG001|Overall Study|Adverse Event|2|||
163255983|NCT02954354|589644844|FG002|Overall Study|Adverse Event|4|||
163255984|NCT02954354|589644842|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
163255985|NCT02954354|589644843|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
163255986|NCT02954354|589644844|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
163255987|NCT02954354|589644842|FG000|Overall Study|Lack of Efficacy|0|||
163255988|NCT02954354|589644843|FG001|Overall Study|Lack of Efficacy|2|||
163255989|NCT02954354|589644844|FG002|Overall Study|Lack of Efficacy|0|||
163255990|NCT02954354|589644842|FG000|Overall Study|Withdrawal by Subject|17|||
163255991|NCT02954354|589644843|FG001|Overall Study|Withdrawal by Subject|9|||
163255992|NCT02954354|589644844|FG002|Overall Study|Withdrawal by Subject|11|||
163255993|NCT02954354|589644842|FG000|Overall Study|Lost to Follow-up|12|||
163255994|NCT02954354|589644843|FG001|Overall Study|Lost to Follow-up|5|||
163255995|NCT02954354|589644844|FG002|Overall Study|Lost to Follow-up|0|||
163255996|NCT02954354|589644842|FG000|Overall Study|Miscellaneous|2|||
163255997|NCT02954354|589644843|FG001|Overall Study|Miscellaneous|2|||
163255998|NCT02954354|589644844|FG002|Overall Study|Miscellaneous|1|||
163255999|NCT03039023|589644847|FG000|Overall Study|Withdrawal by Subject|1|||
163256000|NCT03039023|589644848|FG001|Overall Study|Withdrawal by Subject|0|||
163360343|NCT04832971|590029479|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
163360344|NCT04832971|590029480|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
163360345|NCT04832971|590029471|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163360346|NCT04832971|590029472|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163256001|NCT03039023|589644849|FG002|Overall Study|Withdrawal by Subject|1|||
163256002|NCT03039023|589644850|FG003|Overall Study|Withdrawal by Subject|1|||
163256003|NCT03039023|589644851|FG004|Overall Study|Withdrawal by Subject|0|||
163256004|NCT03039023|589644847|FG000|Overall Study|Physician Decision|0|||
163256005|NCT03039023|589644848|FG001|Overall Study|Physician Decision|0|||
163256006|NCT03039023|589644849|FG002|Overall Study|Physician Decision|0|||
163256007|NCT03039023|589644850|FG003|Overall Study|Physician Decision|1|||
163256008|NCT03039023|589644851|FG004|Overall Study|Physician Decision|0|||
163256009|NCT03338829|589644853|FG000|Overall Study|Lost to Follow-up|4|||
163256010|NCT03338829|589644854|FG001|Overall Study|Lost to Follow-up|2|||
163256011|NCT03338829|589644855|FG002|Overall Study|Lost to Follow-up|4|||
163256012|NCT03338829|589644853|FG000|Overall Study|Pregnancy loss|1|||
163256013|NCT03338829|589644854|FG001|Overall Study|Pregnancy loss|1|||
163256014|NCT03338829|589644855|FG002|Overall Study|Pregnancy loss|0|||
163256015|NCT03338829|589644853|FG000|Overall Study|Protocol Violation|0|||
163256016|NCT03338829|589644854|FG001|Overall Study|Protocol Violation|1|||
163256017|NCT03338829|589644855|FG002|Overall Study|Protocol Violation|0|||
163256018|NCT00448448|589644859|FG000|Overall Study|Withdrawal by Subject|13|||
163256019|NCT00448448|589644860|FG001|Overall Study|Withdrawal by Subject|2|||
163360347|NCT04832971|590029473|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163360348|NCT04832971|590029474|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163360349|NCT04832971|590029475|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
163360350|NCT04832971|590029476|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
163360351|NCT04832971|590029477|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163360352|NCT04832971|590029478|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
163360353|NCT04832971|590029479|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
163360354|NCT04832971|590029480|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
163360355|NCT04832971|590029471|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
163360356|NCT04832971|590029472|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
163360357|NCT04832971|590029473|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
163360358|NCT04832971|590029474|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
163360359|NCT04832971|590029475|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
163360360|NCT04832971|590029476|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
163360361|NCT04832971|590029477|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
163360362|NCT04832971|590029478|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
163360363|NCT04832971|590029479|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
163360364|NCT04832971|590029480|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
163360365|NCT01107899|590029481|FG000|Overall Study|Physician Decision|5|||
163360366|NCT01107899|590029482|FG001|Overall Study|Physician Decision|0|||
163360367|NCT01107899|590029483|FG002|Overall Study|Physician Decision|3|||
163360368|NCT01107899|590029481|FG000|Overall Study|Withdrawal by Subject|0|||
163360369|NCT01107899|590029482|FG001|Overall Study|Withdrawal by Subject|0|||
163360370|NCT01107899|590029483|FG002|Overall Study|Withdrawal by Subject|1|||
163360371|NCT03584152|590029484|FG000|Overall Study|Discontinued intervention|7|||
163360372|NCT03584152|590029485|FG001|Overall Study|Discontinued intervention|4|||
163360373|NCT04024462|590029486|FG000|Overall Study|Withdrawal by Subject|6|||
163360374|NCT04024462|590029487|FG001|Overall Study|Withdrawal by Subject|7|||
163360375|NCT04024462|590029486|FG000|Overall Study|Progressive Disease|0|||
163360376|NCT04024462|590029487|FG001|Overall Study|Progressive Disease|1|||
163360377|NCT04024462|590029486|FG000|Overall Study|Adverse Event|0|||
163360378|NCT04024462|590029487|FG001|Overall Study|Adverse Event|1|||
163360379|NCT04024462|590029486|FG000|Overall Study|Death|0|||
163360380|NCT04024462|590029487|FG001|Overall Study|Death|1|||
163360381|NCT04024462|590029486|FG000|Overall Study|Lost to Follow-up|1|||
163360382|NCT04024462|590029487|FG001|Overall Study|Lost to Follow-up|0|||
163360383|NCT04024462|590029486|FG000|Overall Study|Ongoing in the Study|94|||
163360384|NCT04024462|590029487|FG001|Overall Study|Ongoing in the Study|89|||
163360385|NCT00983749|590029492|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
163360386|NCT00983749|590029493|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
163360387|NCT04292470|590029494|FG000|Overall Study|Withdrawal by Subject|0|||
163360388|NCT04292470|590029495|FG001|Overall Study|Withdrawal by Subject|1|||
163360389|NCT02906020|590029509|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
163360390|NCT02906020|590029510|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
163360391|NCT02906020|590029511|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
163360392|NCT02906020|590029512|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
163360393|NCT02906020|590029513|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
163360394|NCT02906020|590029514|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
163360395|NCT02906020|590029515|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
163360396|NCT02906020|590029516|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
163360397|NCT02906020|590029517|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
163360398|NCT02906020|590029518|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
163360399|NCT02906020|590029519|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
163360400|NCT02906020|590029520|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
163360401|NCT02906020|590029521|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
163360402|NCT02906020|590029522|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
163360403|NCT02906020|590029523|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
163360404|NCT02906020|590029524|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
163360405|NCT02906020|590029509|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163360406|NCT02906020|590029510|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163360407|NCT02906020|590029511|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163360408|NCT02906020|590029512|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163360409|NCT02906020|590029513|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163360410|NCT02906020|590029514|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163360411|NCT02906020|590029515|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163360412|NCT02906020|590029516|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163360413|NCT02906020|590029517|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
163360414|NCT02906020|590029518|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
163360415|NCT02906020|590029519|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163360416|NCT02906020|590029520|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163410652|NCT01425008|590211380|FG000|Dose Escalation Phase|Other|0|||
163410653|NCT01425008|590211381|FG001|Dose Escalation Phase|Other|0|||
163410654|NCT01425008|590211382|FG002|Dose Escalation Phase|Other|0|||
163410655|NCT01425008|590211383|FG003|Dose Escalation Phase|Other|0|||
163410656|NCT01425008|590211384|FG004|Dose Escalation Phase|Other|0|||
163410657|NCT01425008|590211385|FG005|Dose Escalation Phase|Other|0|||
163410658|NCT01425008|590211386|FG006|Dose Escalation Phase|Other|0|||
163410659|NCT01425008|590211387|FG007|Dose Escalation Phase|Other|0|||
163410660|NCT01425008|590211388|FG008|Dose Escalation Phase|Other|1|||
163410661|NCT01425008|590211389|FG009|Dose Escalation Phase|Other|0|||
163410662|NCT01425008|590211390|FG010|Dose Escalation Phase|Other|0|||
163410663|NCT01425008|590211391|FG011|Dose Escalation Phase|Other|0|||
163410664|NCT01425008|590211392|FG012|Dose Escalation Phase|Other|0|||
163410665|NCT01425008|590211393|FG013|Dose Escalation Phase|Other|0|||
163410666|NCT01425008|590211394|FG014|Dose Escalation Phase|Other|0|||
163410667|NCT01425008|590211395|FG015|Dose Escalation Phase|Other|0|||
163410668|NCT01425008|590211396|FG016|Dose Escalation Phase|Other|0|||
163410669|NCT01425008|590211397|FG017|Dose Escalation Phase|Other|0|||
163410670|NCT01425008|590211398|FG018|Dose Escalation Phase|Other|0|||
163410671|NCT01425008|590211380|FG000|Dose Expansion Phase|Progressive Disease|0|||
163410672|NCT01425008|590211381|FG001|Dose Expansion Phase|Progressive Disease|0|||
163410673|NCT01425008|590211382|FG002|Dose Expansion Phase|Progressive Disease|0|||
163410674|NCT01425008|590211383|FG003|Dose Expansion Phase|Progressive Disease|0|||
163410675|NCT01425008|590211384|FG004|Dose Expansion Phase|Progressive Disease|0|||
163410676|NCT01425008|590211385|FG005|Dose Expansion Phase|Progressive Disease|0|||
163410677|NCT01425008|590211386|FG006|Dose Expansion Phase|Progressive Disease|0|||
163410678|NCT01425008|590211387|FG007|Dose Expansion Phase|Progressive Disease|0|||
163410679|NCT01425008|590211388|FG008|Dose Expansion Phase|Progressive Disease|0|||
163410680|NCT01425008|590211389|FG009|Dose Expansion Phase|Progressive Disease|0|||
163410681|NCT01425008|590211390|FG010|Dose Expansion Phase|Progressive Disease|10|||
163410682|NCT01425008|590211391|FG011|Dose Expansion Phase|Progressive Disease|4|||
163410683|NCT01425008|590211392|FG012|Dose Expansion Phase|Progressive Disease|12|||
163410684|NCT01425008|590211393|FG013|Dose Expansion Phase|Progressive Disease|1|||
163410685|NCT01425008|590211394|FG014|Dose Expansion Phase|Progressive Disease|5|||
163410686|NCT01425008|590211395|FG015|Dose Expansion Phase|Progressive Disease|8|||
163410687|NCT01425008|590211396|FG016|Dose Expansion Phase|Progressive Disease|9|||
163410688|NCT01425008|590211397|FG017|Dose Expansion Phase|Progressive Disease|2|||
163410689|NCT01425008|590211398|FG018|Dose Expansion Phase|Progressive Disease|10|||
163410690|NCT01425008|590211380|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
163410691|NCT01425008|590211381|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
163410692|NCT01425008|590211382|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
163410693|NCT01425008|590211383|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
163410694|NCT01425008|590211384|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
163410695|NCT01425008|590211385|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
163410696|NCT01425008|590211386|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
163410697|NCT01425008|590211387|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
163410698|NCT01425008|590211388|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
163410699|NCT01425008|590211389|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
163410700|NCT01425008|590211390|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
163410701|NCT01425008|590211391|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
163410702|NCT01425008|590211392|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
163410703|NCT01425008|590211393|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
163410704|NCT01425008|590211394|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
163410705|NCT01425008|590211395|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
163410706|NCT01425008|590211396|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
163410707|NCT01425008|590211397|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
163410708|NCT01425008|590211398|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
163410709|NCT01425008|590211380|FG000|Dose Expansion Phase|Other|0|||
163151605|NCT02738801|589269449|FG000|Overall Study|Adverse Event|1|||
163151606|NCT02738801|589269450|FG001|Overall Study|Adverse Event|1|||
163151607|NCT02738801|589269449|FG000|Overall Study|Withdrawal by Subject|0|||
163151608|NCT02738801|589269450|FG001|Overall Study|Withdrawal by Subject|1|||
163151609|NCT03279081|589269451|FG000|Overall Study|Withdrawal by Subject|12|||
163151610|NCT03279081|589269452|FG001|Overall Study|Withdrawal by Subject|20|||
163151611|NCT03279081|589269451|FG000|Overall Study|Physician Decision|4|||
163151612|NCT03279081|589269452|FG001|Overall Study|Physician Decision|1|||
163410710|NCT01425008|590211381|FG001|Dose Expansion Phase|Other|0|||
163410711|NCT01425008|590211382|FG002|Dose Expansion Phase|Other|0|||
163410712|NCT01425008|590211383|FG003|Dose Expansion Phase|Other|0|||
163410713|NCT01425008|590211384|FG004|Dose Expansion Phase|Other|0|||
163410714|NCT01425008|590211385|FG005|Dose Expansion Phase|Other|0|||
163410715|NCT01425008|590211386|FG006|Dose Expansion Phase|Other|0|||
163410716|NCT01425008|590211387|FG007|Dose Expansion Phase|Other|0|||
163410717|NCT01425008|590211388|FG008|Dose Expansion Phase|Other|0|||
163410718|NCT01425008|590211389|FG009|Dose Expansion Phase|Other|0|||
163151613|NCT03279081|589269451|FG000|Overall Study|Lost to Follow-up|8|||
163360417|NCT02906020|590029521|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163360418|NCT02906020|590029522|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163360419|NCT02906020|590029523|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163360420|NCT02906020|590029524|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163360421|NCT02906020|590029509|FG000|Part 2: Double-blind Treatment Period|Other|0|||
163360422|NCT02906020|590029510|FG001|Part 2: Double-blind Treatment Period|Other|0|||
163360423|NCT02906020|590029511|FG002|Part 2: Double-blind Treatment Period|Other|0|||
163360424|NCT02906020|590029512|FG003|Part 2: Double-blind Treatment Period|Other|0|||
163360425|NCT02906020|590029513|FG004|Part 2: Double-blind Treatment Period|Other|0|||
163360426|NCT02906020|590029514|FG005|Part 2: Double-blind Treatment Period|Other|0|||
163360427|NCT02906020|590029515|FG006|Part 2: Double-blind Treatment Period|Other|0|||
163360428|NCT02906020|590029516|FG007|Part 2: Double-blind Treatment Period|Other|0|||
163360429|NCT02906020|590029517|FG008|Part 2: Double-blind Treatment Period|Other|6|||
163360430|NCT02906020|590029518|FG009|Part 2: Double-blind Treatment Period|Other|10|||
163360431|NCT02906020|590029519|FG010|Part 2: Double-blind Treatment Period|Other|0|||
163360432|NCT02906020|590029520|FG011|Part 2: Double-blind Treatment Period|Other|0|||
163360433|NCT02906020|590029521|FG012|Part 2: Double-blind Treatment Period|Other|0|||
163360434|NCT02906020|590029522|FG013|Part 2: Double-blind Treatment Period|Other|0|||
163360435|NCT02906020|590029523|FG014|Part 2: Double-blind Treatment Period|Other|0|||
163360436|NCT02906020|590029524|FG015|Part 2: Double-blind Treatment Period|Other|0|||
163360437|NCT02906020|590029509|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163360438|NCT02906020|590029510|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163360439|NCT02906020|590029511|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163360440|NCT02906020|590029512|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163360441|NCT02906020|590029513|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163360442|NCT02906020|590029514|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163360443|NCT02906020|590029515|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163360444|NCT02906020|590029516|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163360445|NCT02906020|590029517|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163360446|NCT02906020|590029518|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163360447|NCT02906020|590029519|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163360448|NCT02906020|590029520|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163360449|NCT02906020|590029521|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
163360450|NCT02906020|590029522|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
163360451|NCT02906020|590029523|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163360452|NCT02906020|590029524|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163360453|NCT02906020|590029509|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163360454|NCT02906020|590029510|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163360455|NCT02906020|590029511|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163360456|NCT02906020|590029512|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163360457|NCT02906020|590029513|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163360458|NCT02906020|590029514|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163360459|NCT02906020|590029515|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163360460|NCT02906020|590029516|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163360461|NCT02906020|590029517|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163360462|NCT02906020|590029518|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163360463|NCT02906020|590029519|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163360464|NCT02906020|590029520|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163360465|NCT02906020|590029521|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
163360466|NCT02906020|590029522|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
163360467|NCT02906020|590029523|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163360468|NCT02906020|590029524|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
163360469|NCT02906020|590029509|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163360470|NCT02906020|590029510|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163360471|NCT02906020|590029511|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163360472|NCT02906020|590029512|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163360473|NCT02906020|590029513|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163360474|NCT02906020|590029514|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163360475|NCT02906020|590029515|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163360476|NCT02906020|590029516|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163360477|NCT02906020|590029517|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163360478|NCT02906020|590029518|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163360479|NCT02906020|590029519|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163360480|NCT02906020|590029520|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163360481|NCT02906020|590029521|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
163360482|NCT02906020|590029522|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
163360483|NCT02906020|590029523|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163384935|NCT00427895|590119254|FG004|Vax 1/Year 1 Follow-up|Other|0|||
163360484|NCT02906020|590029524|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163360485|NCT02906020|590029509|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163360486|NCT02906020|590029510|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163360487|NCT02906020|590029511|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163360488|NCT02906020|590029512|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163360489|NCT02906020|590029513|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163360490|NCT02906020|590029514|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163360491|NCT02906020|590029515|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163360492|NCT02906020|590029516|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163360493|NCT02906020|590029517|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163360494|NCT02906020|590029518|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163360495|NCT02906020|590029519|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163360496|NCT02906020|590029520|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163360497|NCT02906020|590029521|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
163360498|NCT02906020|590029522|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
163360499|NCT02906020|590029523|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163360500|NCT02906020|590029524|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163360501|NCT02906020|590029509|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163360502|NCT02906020|590029510|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163360503|NCT02906020|590029511|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163360504|NCT02906020|590029512|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163360505|NCT02906020|590029513|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163360506|NCT02906020|590029514|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163360507|NCT02906020|590029515|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163360508|NCT02906020|590029516|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163360509|NCT02906020|590029517|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163360510|NCT02906020|590029518|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163360511|NCT02906020|590029519|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163360512|NCT02906020|590029520|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163360513|NCT02906020|590029521|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
163360514|NCT02906020|590029522|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
163360515|NCT02906020|590029523|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
163360516|NCT02906020|590029524|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
163360517|NCT02906020|590029509|FG000|Part 2: Long-term Follow-up Period|Other|0|||
163360518|NCT02906020|590029510|FG001|Part 2: Long-term Follow-up Period|Other|0|||
163360519|NCT02906020|590029511|FG002|Part 2: Long-term Follow-up Period|Other|0|||
163360520|NCT02906020|590029512|FG003|Part 2: Long-term Follow-up Period|Other|0|||
163360521|NCT02906020|590029513|FG004|Part 2: Long-term Follow-up Period|Other|0|||
163360522|NCT02906020|590029514|FG005|Part 2: Long-term Follow-up Period|Other|0|||
163360523|NCT02906020|590029515|FG006|Part 2: Long-term Follow-up Period|Other|0|||
163360524|NCT02906020|590029516|FG007|Part 2: Long-term Follow-up Period|Other|0|||
163360525|NCT02906020|590029517|FG008|Part 2: Long-term Follow-up Period|Other|0|||
163360526|NCT02906020|590029518|FG009|Part 2: Long-term Follow-up Period|Other|0|||
163360527|NCT02906020|590029519|FG010|Part 2: Long-term Follow-up Period|Other|0|||
163360528|NCT02906020|590029520|FG011|Part 2: Long-term Follow-up Period|Other|0|||
163360529|NCT02906020|590029521|FG012|Part 2: Long-term Follow-up Period|Other|13|||
163360530|NCT02906020|590029522|FG013|Part 2: Long-term Follow-up Period|Other|8|||
163360531|NCT02906020|590029523|FG014|Part 2: Long-term Follow-up Period|Other|3|||
163360532|NCT02906020|590029524|FG015|Part 2: Long-term Follow-up Period|Other|2|||
163360533|NCT01907906|590029530|FG000|Overall Study|Withdrawal by Subject|1|||
163360534|NCT01907906|590029531|FG001|Overall Study|Withdrawal by Subject|0|||
163360535|NCT01907906|590029530|FG000|Overall Study|Physician Decision|3|||
163360536|NCT01907906|590029531|FG001|Overall Study|Physician Decision|1|||
163360537|NCT00559377|590029541|FG000|Overall Study|Withdrawal by Subject|9|||
163360538|NCT00203047|590029546|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
163360539|NCT00203047|590029547|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
163360540|NCT00203047|590029546|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
163360541|NCT00203047|590029547|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
163360542|NCT00203047|590029546|FG000|Overall Study|Withdrawal by Subject|13|||
163360543|NCT00203047|590029547|FG001|Overall Study|Withdrawal by Subject|47|||
163360544|NCT00203047|590029546|FG000|Overall Study|Teva requested participant withdrawal|1|||
163360545|NCT00203047|590029547|FG001|Overall Study|Teva requested participant withdrawal|1|||
163360546|NCT00203047|590029546|FG000|Overall Study|Physician Decision|8|||
163410719|NCT01425008|590211390|FG010|Dose Expansion Phase|Other|0|||
163410720|NCT01425008|590211391|FG011|Dose Expansion Phase|Other|0|||
163151614|NCT03279081|589269452|FG001|Overall Study|Lost to Follow-up|8|||
163151615|NCT03279081|589269451|FG000|Overall Study|Death|0|||
163151616|NCT03279081|589269452|FG001|Overall Study|Death|1|||
163360547|NCT00203047|590029547|FG001|Overall Study|Physician Decision|7|||
163360548|NCT00203047|590029546|FG000|Overall Study|Non-compliance|4|||
163360549|NCT00203047|590029547|FG001|Overall Study|Non-compliance|8|||
163360550|NCT00203047|590029546|FG000|Overall Study|Protocol Violation|1|||
163360551|NCT00203047|590029547|FG001|Overall Study|Protocol Violation|0|||
163360552|NCT00203047|590029546|FG000|Overall Study|Lost to Follow-up|11|||
163360553|NCT00203047|590029547|FG001|Overall Study|Lost to Follow-up|5|||
163360554|NCT00203047|590029546|FG000|Overall Study|Adverse Event|8|||
163360555|NCT00203047|590029547|FG001|Overall Study|Adverse Event|18|||
163360556|NCT00203047|590029546|FG000|Overall Study|Death|1|||
163360557|NCT00203047|590029547|FG001|Overall Study|Death|2|||
163360558|NCT00203047|590029546|FG000|Overall Study|Pregnancy|3|||
163360559|NCT00203047|590029547|FG001|Overall Study|Pregnancy|0|||
163360560|NCT00203047|590029546|FG000|Overall Study|Other|5|||
163360561|NCT00203047|590029547|FG001|Overall Study|Other|5|||
163360562|NCT02229227|590029548|FG000|Overall Study|Adverse Event|14|||
163360563|NCT02229227|590029549|FG001|Overall Study|Adverse Event|9|||
163360564|NCT02229227|590029548|FG000|Overall Study|Lack of Efficacy|3|||
163360565|NCT02229227|590029549|FG001|Overall Study|Lack of Efficacy|3|||
163360566|NCT02229227|590029548|FG000|Overall Study|Protocol Violation|6|||
163360567|NCT02229227|590029549|FG001|Overall Study|Protocol Violation|8|||
163360568|NCT02229227|590029548|FG000|Overall Study|Protocol defined stopping criteria|1|||
163360569|NCT02229227|590029549|FG001|Overall Study|Protocol defined stopping criteria|3|||
163360570|NCT02229227|590029548|FG000|Overall Study|Lost to Follow-up|3|||
163360571|NCT02229227|590029549|FG001|Overall Study|Lost to Follow-up|3|||
163360572|NCT02229227|590029548|FG000|Overall Study|Study terminated by sponsor|11|||
163360573|NCT02229227|590029549|FG001|Overall Study|Study terminated by sponsor|11|||
163360574|NCT02229227|590029548|FG000|Overall Study|Withdrawal by Subject|8|||
163360575|NCT02229227|590029549|FG001|Overall Study|Withdrawal by Subject|12|||
163360576|NCT02229227|590029548|FG000|Overall Study|Other|0|||
163360577|NCT02229227|590029549|FG001|Overall Study|Other|1|||
163360578|NCT02229227|590029548|FG000|Overall Study|Physician Decision|5|||
163360579|NCT02229227|590029549|FG001|Overall Study|Physician Decision|12|||
163360580|NCT01453023|590029550|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
163360581|NCT01453023|590029551|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
163360582|NCT01453023|590029550|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
163360583|NCT01453023|590029551|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
163360584|NCT01453023|590029550|FG000|Treatment Period 2|Protocol Violation|0|||
163360585|NCT01453023|590029551|FG001|Treatment Period 2|Protocol Violation|1|||
163360586|NCT03934099|590029554|FG000|Overall Study|Adverse Event|0|||
163360587|NCT03934099|590029555|FG001|Overall Study|Adverse Event|3|||
163360588|NCT03934099|590029556|FG002|Overall Study|Adverse Event|1|||
163360589|NCT03934099|590029557|FG003|Overall Study|Adverse Event|0|||
163360590|NCT03934099|590029554|FG000|Overall Study|Lost to Follow-up|1|||
163360591|NCT03934099|590029555|FG001|Overall Study|Lost to Follow-up|2|||
163360592|NCT03934099|590029556|FG002|Overall Study|Lost to Follow-up|1|||
163360593|NCT03934099|590029557|FG003|Overall Study|Lost to Follow-up|1|||
163360594|NCT03934099|590029554|FG000|Overall Study|Protocol Violation|1|||
163360595|NCT03934099|590029555|FG001|Overall Study|Protocol Violation|0|||
163360596|NCT03934099|590029556|FG002|Overall Study|Protocol Violation|0|||
163360597|NCT03934099|590029557|FG003|Overall Study|Protocol Violation|0|||
163360598|NCT03934099|590029554|FG000|Overall Study|Withdrawal by Subject|2|||
163360599|NCT03934099|590029555|FG001|Overall Study|Withdrawal by Subject|0|||
163360600|NCT03934099|590029556|FG002|Overall Study|Withdrawal by Subject|1|||
163360601|NCT03934099|590029557|FG003|Overall Study|Withdrawal by Subject|1|||
163360602|NCT03934099|590029554|FG000|Overall Study|Other reasons|0|||
163360603|NCT03934099|590029555|FG001|Overall Study|Other reasons|1|||
163360604|NCT03934099|590029556|FG002|Overall Study|Other reasons|0|||
163360605|NCT03934099|590029557|FG003|Overall Study|Other reasons|0|||
163360606|NCT02869867|590029558|FG000|Overall Study|Protocol Violation|1|||
163360607|NCT02869867|590029559|FG001|Overall Study|Protocol Violation|0|||
163360608|NCT02869867|590029558|FG000|Overall Study|Lost to Follow-up|5|||
163151617|NCT03279081|589269451|FG000|Overall Study|Adverse Event|1|||
163151618|NCT03279081|589269452|FG001|Overall Study|Adverse Event|0|||
163151619|NCT03279081|589269451|FG000|Overall Study|Reason not Specified|14|||
163360609|NCT02869867|590029559|FG001|Overall Study|Lost to Follow-up|5|||
163360610|NCT05555615|590029560|FG000|Overall Study|Adverse Event|7|||
163360611|NCT05555615|590029560|FG000|Overall Study|Lack of Efficacy|12|||
163360612|NCT05555615|590029560|FG000|Overall Study|Lost to Follow-up|10|||
163360613|NCT05555615|590029560|FG000|Overall Study|Noncompliance with study drug|5|||
163360614|NCT05555615|590029560|FG000|Overall Study|Physician Decision|2|||
163360615|NCT05555615|590029560|FG000|Overall Study|Study terminated by sponsor|80|||
163360616|NCT05555615|590029560|FG000|Overall Study|Prohibited medication use|2|||
163360617|NCT05555615|590029560|FG000|Overall Study|Withdrawal by Subject|20|||
163360618|NCT05555615|590029560|FG000|Overall Study|Not further specified|4|||
163360619|NCT02872012|590029564|FG000|Overall Study|Withdrawal by Subject|1|||
163360620|NCT02872012|590029565|FG001|Overall Study|Withdrawal by Subject|0|||
163360621|NCT02872012|590029566|FG002|Overall Study|Withdrawal by Subject|0|||
163360622|NCT02872012|590029567|FG003|Overall Study|Withdrawal by Subject|0|||
163256020|NCT00448448|589644859|FG000|Overall Study|On protocol when study ended|83|||
163256021|NCT00448448|589644860|FG001|Overall Study|On protocol when study ended|36|||
163256022|NCT00448448|589644859|FG000|Overall Study|Lost to Follow-up|2|||
163256023|NCT00448448|589644860|FG001|Overall Study|Lost to Follow-up|1|||
163256024|NCT00448448|589644859|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
163256025|NCT00448448|589644860|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
163256026|NCT00448448|589644859|FG000|Overall Study|Signed consent lost|0|||
163256027|NCT00448448|589644860|FG001|Overall Study|Signed consent lost|1|||
163256028|NCT02340026|589644861|FG000|Treatment Phase|Withdrawal by Subject|2|||
163256029|NCT02340026|589644862|FG001|Treatment Phase|Withdrawal by Subject|2|||
163256030|NCT02340026|589644861|FG000|Follow-up Phase|Lost to Follow-up|1|||
163256031|NCT02340026|589644862|FG001|Follow-up Phase|Lost to Follow-up|0|||
163256032|NCT02684006|589644863|FG000|Overall Study|Other|18|||
163256033|NCT02684006|589644864|FG001|Overall Study|Other|6|||
163256034|NCT02684006|589644863|FG000|Overall Study|Protocol Violation|2|||
163256035|NCT02684006|589644864|FG001|Overall Study|Protocol Violation|1|||
163256036|NCT02684006|589644863|FG000|Overall Study|Non-compliance with study drug|1|||
163256037|NCT02684006|589644864|FG001|Overall Study|Non-compliance with study drug|1|||
163256038|NCT02684006|589644863|FG000|Overall Study|No longer met eligibility criteria|6|||
163256039|NCT02684006|589644864|FG001|Overall Study|No longer met eligibility criteria|2|||
163256040|NCT02684006|589644863|FG000|Overall Study|Lost to Follow-up|0|||
163256041|NCT02684006|589644864|FG001|Overall Study|Lost to Follow-up|1|||
163256042|NCT02684006|589644863|FG000|Overall Study|Death|25|||
163256043|NCT02684006|589644864|FG001|Overall Study|Death|22|||
163256044|NCT02684006|589644863|FG000|Overall Study|Global deterioration of health status|18|||
163256045|NCT02684006|589644864|FG001|Overall Study|Global deterioration of health status|20|||
163256046|NCT02684006|589644863|FG000|Overall Study|Physician Decision|15|||
163256047|NCT02684006|589644864|FG001|Overall Study|Physician Decision|8|||
163256048|NCT02684006|589644863|FG000|Overall Study|Adverse Event|86|||
163256049|NCT02684006|589644864|FG001|Overall Study|Adverse Event|65|||
163256050|NCT02684006|589644863|FG000|Overall Study|Withdrawal by Subject|29|||
163256051|NCT02684006|589644864|FG001|Overall Study|Withdrawal by Subject|43|||
163256052|NCT02684006|589644863|FG000|Overall Study|Progressive disease|236|||
163256053|NCT02684006|589644864|FG001|Overall Study|Progressive disease|266|||
163256054|NCT02684006|589644863|FG000|Overall Study|Participation terminated by sponsor|6|||
163256055|NCT02684006|589644864|FG001|Overall Study|Participation terminated by sponsor|9|||
163256056|NCT04642898|589644865|FG000|Overall Study|Withdrawal by Subject|2|||
163256057|NCT04642898|589644866|FG001|Overall Study|Withdrawal by Subject|4|||
163256058|NCT04642898|589644867|FG002|Overall Study|Withdrawal by Subject|4|||
163256059|NCT04642898|589644868|FG003|Overall Study|Withdrawal by Subject|6|||
163256060|NCT04642898|589644869|FG004|Overall Study|Withdrawal by Subject|2|||
163256061|NCT04642898|589644870|FG005|Overall Study|Withdrawal by Subject|6|||
163256062|NCT04642898|589644865|FG000|Overall Study|Lost to Follow-up|0|||
163256063|NCT04642898|589644866|FG001|Overall Study|Lost to Follow-up|0|||
163256064|NCT04642898|589644867|FG002|Overall Study|Lost to Follow-up|0|||
163256065|NCT04642898|589644868|FG003|Overall Study|Lost to Follow-up|2|||
163256066|NCT04642898|589644869|FG004|Overall Study|Lost to Follow-up|0|||
163256067|NCT04642898|589644870|FG005|Overall Study|Lost to Follow-up|1|||
163256068|NCT04642898|589644865|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
163256069|NCT04642898|589644866|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
163256070|NCT04642898|589644867|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
163256071|NCT04642898|589644868|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
163256072|NCT04642898|589644869|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
163256073|NCT04642898|589644870|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
163256074|NCT04642898|589644865|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
163256075|NCT04642898|589644866|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
163256076|NCT04642898|589644867|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
163256077|NCT04642898|589644868|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
163256078|NCT04642898|589644869|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
163256079|NCT04642898|589644870|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
163256080|NCT04495179|589644871|FG000|Overall Study|Lost to Follow-up|0|||
163256081|NCT04495179|589644872|FG001|Overall Study|Lost to Follow-up|1|||
163256082|NCT04495179|589644871|FG000|Overall Study|Withdrawal by Subject|2|||
163256083|NCT04495179|589644872|FG001|Overall Study|Withdrawal by Subject|4|||
163256084|NCT04495179|589644871|FG000|Overall Study|Study terminated by sponsor|0|||
163256085|NCT04495179|589644872|FG001|Overall Study|Study terminated by sponsor|18|||
163256086|NCT04495179|589644871|FG000|Overall Study|Death|0|||
163256087|NCT04495179|589644872|FG001|Overall Study|Death|4|||
163256088|NCT04495179|589644871|FG000|Overall Study|Adverse Event|0|||
163256089|NCT04495179|589644872|FG001|Overall Study|Adverse Event|1|||
163256090|NCT04280562|589644873|FG000|Study|Adverse Event|2|||
163256091|NCT04280562|589644874|FG001|Study|Adverse Event|0|||
163256092|NCT04280562|589644873|FG000|Study|Lost to Follow-up|3|||
163256093|NCT04280562|589644874|FG001|Study|Lost to Follow-up|3|||
163360623|NCT02872012|590029568|FG004|Overall Study|Withdrawal by Subject|0|||
163360624|NCT01728623|590029569|FG000|Overall Study|Disease progression|26|||
163360625|NCT01728623|590029569|FG000|Overall Study|Adverse Event|1|||
163360626|NCT01728623|590029569|FG000|Overall Study|Withdrawal by Subject|1|||
163360627|NCT03000348|590029570|FG000|Overall Study|Adverse Event|1|||
163360628|NCT03000348|590029571|FG001|Overall Study|Adverse Event|1|||
163360629|NCT03000348|590029572|FG002|Overall Study|Adverse Event|1|||
163360630|NCT03000348|590029573|FG003|Overall Study|Adverse Event|1|||
163360631|NCT03000348|590029574|FG004|Overall Study|Adverse Event|1|||
163360632|NCT03000348|590029575|FG005|Overall Study|Adverse Event|1|||
163360633|NCT03000348|590029570|FG000|Overall Study|Lost to Follow-up|0|||
163360634|NCT03000348|590029571|FG001|Overall Study|Lost to Follow-up|0|||
163360635|NCT03000348|590029572|FG002|Overall Study|Lost to Follow-up|1|||
163360636|NCT03000348|590029573|FG003|Overall Study|Lost to Follow-up|0|||
163360637|NCT03000348|590029574|FG004|Overall Study|Lost to Follow-up|0|||
163360638|NCT03000348|590029575|FG005|Overall Study|Lost to Follow-up|0|||
163360639|NCT03000348|590029570|FG000|Overall Study|Withdrawal by Subject|0|||
163360640|NCT03000348|590029571|FG001|Overall Study|Withdrawal by Subject|1|||
163360641|NCT03000348|590029572|FG002|Overall Study|Withdrawal by Subject|0|||
163360642|NCT03000348|590029573|FG003|Overall Study|Withdrawal by Subject|0|||
163360643|NCT03000348|590029574|FG004|Overall Study|Withdrawal by Subject|0|||
163360644|NCT03000348|590029575|FG005|Overall Study|Withdrawal by Subject|0|||
163360645|NCT03000348|590029570|FG000|Overall Study|Consent|0|||
163360646|NCT03000348|590029571|FG001|Overall Study|Consent|0|||
163360647|NCT03000348|590029572|FG002|Overall Study|Consent|0|||
163360648|NCT03000348|590029573|FG003|Overall Study|Consent|0|||
163360649|NCT03000348|590029574|FG004|Overall Study|Consent|1|||
163360650|NCT03000348|590029575|FG005|Overall Study|Consent|0|||
163360651|NCT03000348|590029570|FG000|Overall Study|Failure to expectorate sputum|1|||
163360652|NCT03000348|590029571|FG001|Overall Study|Failure to expectorate sputum|0|||
163360653|NCT03000348|590029572|FG002|Overall Study|Failure to expectorate sputum|1|||
163360654|NCT03000348|590029573|FG003|Overall Study|Failure to expectorate sputum|0|||
163360655|NCT03000348|590029574|FG004|Overall Study|Failure to expectorate sputum|1|||
163360656|NCT03000348|590029575|FG005|Overall Study|Failure to expectorate sputum|0|||
163360657|NCT03000348|590029570|FG000|Overall Study|No gram negative|1|||
163360658|NCT03000348|590029571|FG001|Overall Study|No gram negative|2|||
163360659|NCT03000348|590029572|FG002|Overall Study|No gram negative|1|||
163360660|NCT03000348|590029573|FG003|Overall Study|No gram negative|1|||
163360661|NCT03000348|590029574|FG004|Overall Study|No gram negative|1|||
163360662|NCT03000348|590029575|FG005|Overall Study|No gram negative|1|||
163360663|NCT03000348|590029570|FG000|Overall Study|Patient had no transport|0|||
163360664|NCT03000348|590029571|FG001|Overall Study|Patient had no transport|0|||
163360665|NCT03000348|590029572|FG002|Overall Study|Patient had no transport|0|||
163360666|NCT03000348|590029573|FG003|Overall Study|Patient had no transport|1|||
163360667|NCT03000348|590029574|FG004|Overall Study|Patient had no transport|0|||
163360668|NCT03000348|590029575|FG005|Overall Study|Patient had no transport|0|||
163360669|NCT03000348|590029570|FG000|Overall Study|Dosing|0|||
163360670|NCT03000348|590029571|FG001|Overall Study|Dosing|0|||
163360671|NCT03000348|590029572|FG002|Overall Study|Dosing|0|||
163360672|NCT03000348|590029573|FG003|Overall Study|Dosing|0|||
163360673|NCT03000348|590029574|FG004|Overall Study|Dosing|1|||
163360674|NCT03000348|590029575|FG005|Overall Study|Dosing|0|||
163360675|NCT00723125|590029576|FG000|Overall Study|Met Dx|1|||
163360676|NCT00723125|590029577|FG001|Overall Study|Met Dx|0|||
163360677|NCT00723125|590029576|FG000|Overall Study|Withdrawal by Subject|15|||
163360678|NCT00723125|590029577|FG001|Overall Study|Withdrawal by Subject|6|||
163360679|NCT00723125|590029576|FG000|Overall Study|Adverse Event|2|||
163360680|NCT00723125|590029577|FG001|Overall Study|Adverse Event|0|||
163360681|NCT01667549|590029578|FG000|Overall Study|Withdrawal by Subject|3|||
163360682|NCT01667549|590029579|FG001|Overall Study|Withdrawal by Subject|5|||
163360683|NCT01667549|590029580|FG002|Overall Study|Withdrawal by Subject|7|||
163360684|NCT01667549|590029581|FG003|Overall Study|Withdrawal by Subject|6|||
163360685|NCT01667549|590029582|FG004|Overall Study|Withdrawal by Subject|1|||
163360686|NCT01407276|590029583|FG000|Overall Study|Withdrawal by Subject|0|||
163360687|NCT01407276|590029584|FG001|Overall Study|Withdrawal by Subject|0|||
163360688|NCT01407276|590029585|FG002|Overall Study|Withdrawal by Subject|0|||
163360689|NCT01407276|590029586|FG003|Overall Study|Withdrawal by Subject|0|||
163360690|NCT01407276|590029587|FG004|Overall Study|Withdrawal by Subject|0|||
163360691|NCT01407276|590029588|FG005|Overall Study|Withdrawal by Subject|0|||
163360692|NCT01407276|590029589|FG006|Overall Study|Withdrawal by Subject|0|||
163360693|NCT01407276|590029590|FG007|Overall Study|Withdrawal by Subject|1|||
163360694|NCT01807182|590029593|FG000|Overall Study|Death|1|||
163360695|NCT01807182|590029593|FG000|Overall Study|New therapy|1|||
163360696|NCT01807182|590029593|FG000|Overall Study|Moved to hospice care|1|||
163360697|NCT04092452|590029594|FG000|Overall Study|Adverse Event|1|||
163360698|NCT04092452|590029595|FG001|Overall Study|Adverse Event|3|||
163360699|NCT04092452|590029596|FG002|Overall Study|Adverse Event|3|||
163360700|NCT04092452|590029597|FG003|Overall Study|Adverse Event|7|||
163360701|NCT04092452|590029594|FG000|Overall Study|Lack of Efficacy|1|||
163410721|NCT01425008|590211392|FG012|Dose Expansion Phase|Other|1|||
163410722|NCT01425008|590211393|FG013|Dose Expansion Phase|Other|0|||
163410723|NCT01425008|590211394|FG014|Dose Expansion Phase|Other|0|||
163410724|NCT01425008|590211395|FG015|Dose Expansion Phase|Other|0|||
163410725|NCT01425008|590211396|FG016|Dose Expansion Phase|Other|2|||
163410726|NCT01425008|590211397|FG017|Dose Expansion Phase|Other|0|||
163410727|NCT01425008|590211398|FG018|Dose Expansion Phase|Other|4|||
163410728|NCT01425008|590211380|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
163410729|NCT01425008|590211381|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
163410730|NCT01425008|590211382|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
163410731|NCT01425008|590211383|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
163410732|NCT01425008|590211384|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
163410733|NCT01425008|590211385|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
163410734|NCT01425008|590211386|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
163410735|NCT01425008|590211387|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
163410736|NCT01425008|590211388|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
163410737|NCT01425008|590211389|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
163410738|NCT01425008|590211390|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
163410739|NCT01425008|590211391|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
163410740|NCT01425008|590211392|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
163410741|NCT01425008|590211393|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
163410742|NCT01425008|590211394|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
163410743|NCT01425008|590211395|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
163410744|NCT01425008|590211396|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
163410745|NCT01425008|590211397|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
163410746|NCT01425008|590211398|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
163410747|NCT01425008|590211380|FG000|Dose Expansion Phase|Adverse Event|0|||
163410748|NCT01425008|590211381|FG001|Dose Expansion Phase|Adverse Event|0|||
163410749|NCT01425008|590211382|FG002|Dose Expansion Phase|Adverse Event|0|||
163410750|NCT01425008|590211383|FG003|Dose Expansion Phase|Adverse Event|0|||
163410751|NCT01425008|590211384|FG004|Dose Expansion Phase|Adverse Event|0|||
163410752|NCT01425008|590211385|FG005|Dose Expansion Phase|Adverse Event|0|||
163410753|NCT01425008|590211386|FG006|Dose Expansion Phase|Adverse Event|0|||
163410754|NCT01425008|590211387|FG007|Dose Expansion Phase|Adverse Event|0|||
163256094|NCT03434678|589644875|FG000|Overall Study|Withdrawal by Subject|13|||
163256095|NCT03434678|589644876|FG001|Overall Study|Withdrawal by Subject|13|||
163256096|NCT03434678|589644875|FG000|Overall Study|Found to be ineligible post randomization|2|||
163256097|NCT03434678|589644876|FG001|Overall Study|Found to be ineligible post randomization|1|||
163256098|NCT00162370|589644880|FG000|Efficacy Population|Lost to Follow-up|51|||
163256099|NCT02061202|589644881|FG000|Overall Study|Lost to Follow-up|1|||
163256100|NCT02061202|589644882|FG001|Overall Study|Lost to Follow-up|1|||
163256101|NCT04559568|589644883|FG000|Overall Study|Physician Decision|0|||
163256102|NCT04559568|589644884|FG001|Overall Study|Physician Decision|0|||
163256103|NCT04559568|589644885|FG002|Overall Study|Physician Decision|0|||
163256104|NCT04559568|589644886|FG003|Overall Study|Physician Decision|0|||
163256105|NCT04559568|589644887|FG004|Overall Study|Physician Decision|0|||
163256106|NCT04559568|589644888|FG005|Overall Study|Physician Decision|0|||
163256107|NCT04559568|589644889|FG006|Overall Study|Physician Decision|0|||
163256108|NCT04559568|589644890|FG007|Overall Study|Physician Decision|0|||
163256109|NCT04559568|589644891|FG008|Overall Study|Physician Decision|0|||
163256110|NCT04559568|589644892|FG009|Overall Study|Physician Decision|1|||
163256111|NCT04559568|589644893|FG010|Overall Study|Physician Decision|0|||
163256112|NCT04559568|589644883|FG000|Overall Study|Withdrawal by Subject|0|||
163256113|NCT04559568|589644884|FG001|Overall Study|Withdrawal by Subject|0|||
163256114|NCT04559568|589644885|FG002|Overall Study|Withdrawal by Subject|0|||
163256115|NCT04559568|589644886|FG003|Overall Study|Withdrawal by Subject|0|||
163256116|NCT04559568|589644887|FG004|Overall Study|Withdrawal by Subject|0|||
163256117|NCT04559568|589644888|FG005|Overall Study|Withdrawal by Subject|0|||
163256118|NCT04559568|589644889|FG006|Overall Study|Withdrawal by Subject|0|||
163256119|NCT04559568|589644890|FG007|Overall Study|Withdrawal by Subject|0|||
163256120|NCT04559568|589644891|FG008|Overall Study|Withdrawal by Subject|0|||
163256121|NCT04559568|589644892|FG009|Overall Study|Withdrawal by Subject|0|||
163256122|NCT04559568|589644893|FG010|Overall Study|Withdrawal by Subject|1|||
163256123|NCT03721965|589644896|FG000|Overall Study|Death|1|||
163256124|NCT03721965|589644896|FG000|Overall Study|Study Terminated by Sponsor|1|||
163256125|NCT04085328|589644898|FG000|Overall Study|Witihdrew Consent|16|||
163256126|NCT04085328|589644899|FG001|Overall Study|Witihdrew Consent|16|||
163256127|NCT04085328|589644898|FG000|Overall Study|Adverse Event|8|||
163256128|NCT04085328|589644899|FG001|Overall Study|Adverse Event|7|||
163256129|NCT04085328|589644898|FG000|Overall Study|Lost to Follow-up|7|||
163256130|NCT04085328|589644899|FG001|Overall Study|Lost to Follow-up|2|||
163256131|NCT04085328|589644898|FG000|Overall Study|Physician Decision|0|||
163256132|NCT04085328|589644899|FG001|Overall Study|Physician Decision|1|||
163256133|NCT04085328|589644898|FG000|Overall Study|Pregnancy|0|||
163256134|NCT04085328|589644899|FG001|Overall Study|Pregnancy|1|||
163256135|NCT04085328|589644898|FG000|Overall Study|Reasons Related to COVID-19|5|||
163410755|NCT01425008|590211388|FG008|Dose Expansion Phase|Adverse Event|0|||
163410756|NCT01425008|590211389|FG009|Dose Expansion Phase|Adverse Event|0|||
163410757|NCT01425008|590211390|FG010|Dose Expansion Phase|Adverse Event|2|||
163410758|NCT01425008|590211391|FG011|Dose Expansion Phase|Adverse Event|3|||
163256136|NCT04085328|589644899|FG001|Overall Study|Reasons Related to COVID-19|8|||
163256137|NCT04085328|589644898|FG000|Overall Study|Did not meet inclusion criteria|1|||
163256138|NCT04085328|589644899|FG001|Overall Study|Did not meet inclusion criteria|1|||
163256139|NCT04085328|589644898|FG000|Overall Study|Early termination|1|||
163256140|NCT04085328|589644899|FG001|Overall Study|Early termination|0|||
163256141|NCT05608499|589644900|FG000|Overall Study|Lack of Efficacy|1|||
163256142|NCT05608499|589644901|FG001|Overall Study|Lack of Efficacy|0|||
163256143|NCT05608499|589644900|FG000|Overall Study|Lost to Follow-up|0|||
163256144|NCT05608499|589644901|FG001|Overall Study|Lost to Follow-up|1|||
163256145|NCT01422408|589644904|FG000|Overall Study|Adverse Event|1|||
163256146|NCT01422408|589644904|FG000|Overall Study|Withdrawal by Subject|3|||
163256147|NCT00724152|589644911|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
163256148|NCT00724152|589644912|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
163256149|NCT00724152|589644913|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
163256150|NCT00724152|589644911|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
163256151|NCT00724152|589644912|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
163256152|NCT00724152|589644913|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
163256153|NCT01328080|589644915|FG000|Overall Study|Lost to Follow-up|5|||
163256154|NCT00045305|589644916|FG000|Overall Study|Lack of Efficacy|6|||
163256155|NCT00045305|589644916|FG000|Overall Study|Adverse Event|3|||
163256156|NCT00045305|589644916|FG000|Overall Study|Death|3|||
163256157|NCT00045305|589644916|FG000|Overall Study|site error|2|||
163256158|NCT03266770|589644917|FG000|Overall Study|Physician Decision|3|||
163256159|NCT03266770|589644917|FG000|Overall Study|Insufficient study supplies|1|||
163256160|NCT03266770|589644917|FG000|Overall Study|Adverse Event|1|||
163256161|NCT04274894|589644918|FG000|Overall Study|Adverse Event|7|||
163256162|NCT04274894|589644918|FG000|Overall Study|Withdrew consent|5|||
163256163|NCT04274894|589644918|FG000|Overall Study|Lost to Follow-up|9|||
163256164|NCT04274894|589644918|FG000|Overall Study|COVID-19 infection|1|||
163256165|NCT04274894|589644918|FG000|Overall Study|Other, not specified|20|||
163256166|NCT01936857|589644919|FG000|Overall Study|Sent to prison or 06 center|11|||
163256167|NCT01936857|589644920|FG001|Overall Study|Sent to prison or 06 center|12|||
163256168|NCT01936857|589644919|FG000|Overall Study|Lost to Follow-up|10|||
163256169|NCT01936857|589644920|FG001|Overall Study|Lost to Follow-up|7|||
163256170|NCT01936857|589644919|FG000|Overall Study|Death|7|||
163256171|NCT01936857|589644920|FG001|Overall Study|Death|3|||
163256172|NCT01936857|589644919|FG000|Overall Study|Moved|2|||
163256173|NCT01936857|589644920|FG001|Overall Study|Moved|1|||
163256174|NCT01936857|589644919|FG000|Overall Study|Withdrawal by Subject|1|||
163256175|NCT01936857|589644920|FG001|Overall Study|Withdrawal by Subject|0|||
163256176|NCT01936857|589644919|FG000|Overall Study|Side effect of medication|1|||
163256177|NCT01936857|589644920|FG001|Overall Study|Side effect of medication|0|||
163256178|NCT01936857|589644919|FG000|Overall Study|Other|2|||
163256179|NCT01936857|589644920|FG001|Overall Study|Other|2|||
163256180|NCT03848403|589644921|FG000|Period 2 (Day 8)|Adverse Event|1|||
163256181|NCT03848403|589644922|FG001|Period 2 (Day 8)|Adverse Event|2|||
163256182|NCT03848403|589644923|FG002|Period 2 (Day 8)|Adverse Event|2|||
163256183|NCT03848403|589644921|FG000|Period 2 (Day 8)|Physician Decision|0|||
163256184|NCT03848403|589644922|FG001|Period 2 (Day 8)|Physician Decision|1|||
163256185|NCT03848403|589644923|FG002|Period 2 (Day 8)|Physician Decision|0|||
163256186|NCT03848403|589644921|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
163256187|NCT03848403|589644922|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
163256188|NCT03848403|589644923|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
163256189|NCT00168038|589644924|FG000|Overall Study|Adverse Event|1|||
163256190|NCT00168038|589644924|FG000|Overall Study|Therapy failure|1|||
163256191|NCT01494584|589644932|FG000|Overall Study|Study Closed/Terminated|1|||
163256192|NCT01218126|589644937|FG000|Overall Study|Adverse Event|8|||
163256193|NCT01218126|589644938|FG001|Overall Study|Adverse Event|10|||
163256194|NCT01218126|589644939|FG002|Overall Study|Adverse Event|12|||
163256195|NCT01218126|589644940|FG003|Overall Study|Adverse Event|16|||
163256196|NCT01218126|589644937|FG000|Overall Study|Lack of Efficacy|7|||
163256197|NCT01218126|589644938|FG001|Overall Study|Lack of Efficacy|2|||
163256198|NCT01218126|589644939|FG002|Overall Study|Lack of Efficacy|2|||
163256199|NCT01218126|589644940|FG003|Overall Study|Lack of Efficacy|6|||
163256200|NCT01218126|589644937|FG000|Overall Study|Protocol Violation|5|||
163256201|NCT01218126|589644938|FG001|Overall Study|Protocol Violation|2|||
163256202|NCT01218126|589644939|FG002|Overall Study|Protocol Violation|2|||
163256203|NCT01218126|589644940|FG003|Overall Study|Protocol Violation|3|||
163256204|NCT01218126|589644937|FG000|Overall Study|Protocol-defined stopping criteria|1|||
163256205|NCT01218126|589644938|FG001|Overall Study|Protocol-defined stopping criteria|1|||
163256206|NCT01218126|589644939|FG002|Overall Study|Protocol-defined stopping criteria|0|||
163256207|NCT01218126|589644940|FG003|Overall Study|Protocol-defined stopping criteria|0|||
163256208|NCT01218126|589644937|FG000|Overall Study|Lost to Follow-up|0|||
163256209|NCT01218126|589644938|FG001|Overall Study|Lost to Follow-up|0|||
163360702|NCT04092452|590029595|FG001|Overall Study|Lack of Efficacy|1|||
163360703|NCT04092452|590029596|FG002|Overall Study|Lack of Efficacy|1|||
163360704|NCT04092452|590029597|FG003|Overall Study|Lack of Efficacy|0|||
163360705|NCT04092452|590029594|FG000|Overall Study|Lost to Follow-up|4|||
163360706|NCT04092452|590029595|FG001|Overall Study|Lost to Follow-up|3|||
163360707|NCT04092452|590029596|FG002|Overall Study|Lost to Follow-up|5|||
163360708|NCT04092452|590029597|FG003|Overall Study|Lost to Follow-up|1|||
163360709|NCT04092452|590029594|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163360710|NCT04092452|590029595|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163360711|NCT04092452|590029596|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163360712|NCT04092452|590029597|FG003|Overall Study|Non-Compliance With Study Drug|1|||
163360713|NCT04092452|590029594|FG000|Overall Study|Physician Decision|1|||
163360714|NCT04092452|590029595|FG001|Overall Study|Physician Decision|0|||
163360715|NCT04092452|590029596|FG002|Overall Study|Physician Decision|1|||
163360716|NCT04092452|590029597|FG003|Overall Study|Physician Decision|0|||
163360717|NCT04092452|590029594|FG000|Overall Study|Pregnancy|2|||
163360718|NCT04092452|590029595|FG001|Overall Study|Pregnancy|0|||
163360719|NCT04092452|590029596|FG002|Overall Study|Pregnancy|0|||
163360720|NCT04092452|590029597|FG003|Overall Study|Pregnancy|0|||
163360721|NCT04092452|590029594|FG000|Overall Study|Protocol Deviation|1|||
163360722|NCT04092452|590029595|FG001|Overall Study|Protocol Deviation|0|||
163360723|NCT04092452|590029596|FG002|Overall Study|Protocol Deviation|0|||
163360724|NCT04092452|590029597|FG003|Overall Study|Protocol Deviation|0|||
163360725|NCT04092452|590029594|FG000|Overall Study|Withdrawal by Subject|3|||
163360726|NCT04092452|590029595|FG001|Overall Study|Withdrawal by Subject|10|||
163360727|NCT04092452|590029596|FG002|Overall Study|Withdrawal by Subject|3|||
163360728|NCT04092452|590029597|FG003|Overall Study|Withdrawal by Subject|5|||
163360729|NCT04092452|590029594|FG000|Overall Study|Other|0|||
163360730|NCT04092452|590029595|FG001|Overall Study|Other|0|||
163360731|NCT04092452|590029596|FG002|Overall Study|Other|1|||
163360732|NCT04092452|590029597|FG003|Overall Study|Other|2|||
163360733|NCT01012947|590029606|FG000|Overall Study|Lost to Follow-up|131|||
163360734|NCT01012947|590029607|FG001|Overall Study|Lost to Follow-up|135|||
163360735|NCT01012947|590029608|FG002|Overall Study|Lost to Follow-up|130|||
163360736|NCT01012947|590029609|FG003|Overall Study|Lost to Follow-up|118|||
163360737|NCT01012947|590029610|FG004|Overall Study|Lost to Follow-up|142|||
163360738|NCT02127125|590029611|FG000|Overall Study|Lost to Follow-up|0|||
163360739|NCT02127125|590029612|FG001|Overall Study|Lost to Follow-up|0|||
163360740|NCT02127125|590029613|FG002|Overall Study|Lost to Follow-up|0|||
163360741|NCT02127125|590029614|FG003|Overall Study|Lost to Follow-up|0|||
163360742|NCT02127125|590029615|FG004|Overall Study|Lost to Follow-up|2|||
163360743|NCT02127125|590029616|FG005|Overall Study|Lost to Follow-up|1|||
163360744|NCT02127125|590029617|FG006|Overall Study|Lost to Follow-up|0|||
163360745|NCT02127125|590029618|FG007|Overall Study|Lost to Follow-up|0|||
163360746|NCT02127125|590029619|FG008|Overall Study|Lost to Follow-up|0|||
163360747|NCT02127125|590029611|FG000|Overall Study|Withdrawal by Subject|0|||
163360748|NCT02127125|590029612|FG001|Overall Study|Withdrawal by Subject|0|||
163360749|NCT02127125|590029613|FG002|Overall Study|Withdrawal by Subject|0|||
163360750|NCT02127125|590029614|FG003|Overall Study|Withdrawal by Subject|1|||
163360751|NCT02127125|590029615|FG004|Overall Study|Withdrawal by Subject|0|||
163360752|NCT02127125|590029616|FG005|Overall Study|Withdrawal by Subject|0|||
163360753|NCT02127125|590029617|FG006|Overall Study|Withdrawal by Subject|0|||
163360754|NCT02127125|590029618|FG007|Overall Study|Withdrawal by Subject|0|||
163360755|NCT02127125|590029619|FG008|Overall Study|Withdrawal by Subject|0|||
163360756|NCT02127125|590029611|FG000|Overall Study|Physician Decision|0|||
163360757|NCT02127125|590029612|FG001|Overall Study|Physician Decision|0|||
163360758|NCT02127125|590029613|FG002|Overall Study|Physician Decision|1|||
163360759|NCT02127125|590029614|FG003|Overall Study|Physician Decision|0|||
163360760|NCT02127125|590029615|FG004|Overall Study|Physician Decision|1|||
163360761|NCT02127125|590029616|FG005|Overall Study|Physician Decision|2|||
163360762|NCT02127125|590029617|FG006|Overall Study|Physician Decision|0|||
163360763|NCT02127125|590029618|FG007|Overall Study|Physician Decision|0|||
163360764|NCT02127125|590029619|FG008|Overall Study|Physician Decision|0|||
163151620|NCT03279081|589269452|FG001|Overall Study|Reason not Specified|4|||
163151621|NCT00771914|589269453|FG000|Overall Study|Physician Decision|0|||
163151622|NCT00771914|589269454|FG001|Overall Study|Physician Decision|0|||
163151623|NCT00771914|589269455|FG002|Overall Study|Physician Decision|0|||
163151624|NCT00771914|589269456|FG003|Overall Study|Physician Decision|1|||
163151625|NCT00771914|589269453|FG000|Overall Study|Lost to Follow-up|0|||
163151626|NCT00771914|589269454|FG001|Overall Study|Lost to Follow-up|0|||
163151627|NCT00771914|589269455|FG002|Overall Study|Lost to Follow-up|0|||
163151628|NCT00771914|589269456|FG003|Overall Study|Lost to Follow-up|1|||
163151629|NCT04484961|589269465|FG000|Overall Study|Lost to Follow-up|9|||
163151630|NCT04484961|589269466|FG001|Overall Study|Lost to Follow-up|9|||
163360765|NCT02498236|590029623|FG000|Overall Study|Did not show for testing|1|||
163360766|NCT02498236|590029624|FG001|Overall Study|Did not show for testing|0|||
163360767|NCT02498236|590029625|FG002|Overall Study|Did not show for testing|0|||
163360768|NCT02498236|590029626|FG003|Overall Study|Did not show for testing|0|||
163151631|NCT00388349|589269467|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
163360769|NCT02498236|590029627|FG004|Overall Study|Did not show for testing|0|||
163360770|NCT02498236|590029628|FG005|Overall Study|Did not show for testing|0|||
163360771|NCT02498236|590029629|FG006|Overall Study|Did not show for testing|0|||
163360772|NCT02498236|590029630|FG007|Overall Study|Did not show for testing|1|||
163360773|NCT02498236|590029623|FG000|Overall Study|Equipment failure|0|||
163360774|NCT02498236|590029624|FG001|Overall Study|Equipment failure|0|||
163360775|NCT02498236|590029625|FG002|Overall Study|Equipment failure|0|||
163360776|NCT02498236|590029626|FG003|Overall Study|Equipment failure|0|||
163360777|NCT02498236|590029627|FG004|Overall Study|Equipment failure|0|||
163360778|NCT02498236|590029628|FG005|Overall Study|Equipment failure|0|||
163360779|NCT02498236|590029629|FG006|Overall Study|Equipment failure|1|||
163360780|NCT02498236|590029630|FG007|Overall Study|Equipment failure|0|||
163360781|NCT02498236|590029623|FG000|Overall Study|Withdrawal by Subject|0|||
163360782|NCT02498236|590029624|FG001|Overall Study|Withdrawal by Subject|0|||
163360783|NCT02498236|590029625|FG002|Overall Study|Withdrawal by Subject|0|||
163360784|NCT02498236|590029626|FG003|Overall Study|Withdrawal by Subject|0|||
163360785|NCT02498236|590029627|FG004|Overall Study|Withdrawal by Subject|1|||
163360786|NCT02498236|590029628|FG005|Overall Study|Withdrawal by Subject|0|||
163360787|NCT02498236|590029629|FG006|Overall Study|Withdrawal by Subject|0|||
163360788|NCT02498236|590029630|FG007|Overall Study|Withdrawal by Subject|0|||
163360789|NCT01255761|590029631|FG000|Overall Study|Adverse Event|29|||
163360790|NCT01255761|590029632|FG001|Overall Study|Adverse Event|43|||
163360791|NCT01255761|590029631|FG000|Overall Study|Lack of Efficacy|86|||
163360792|NCT01255761|590029632|FG001|Overall Study|Lack of Efficacy|74|||
163360793|NCT01255761|590029631|FG000|Overall Study|Protocol Violation|9|||
163360794|NCT01255761|590029632|FG001|Overall Study|Protocol Violation|5|||
163360795|NCT01255761|590029631|FG000|Overall Study|Lost to Follow-up|10|||
163360796|NCT01255761|590029632|FG001|Overall Study|Lost to Follow-up|8|||
163360797|NCT01255761|590029631|FG000|Overall Study|Withdrawal by Subject|11|||
163360798|NCT01255761|590029632|FG001|Overall Study|Withdrawal by Subject|27|||
163360799|NCT01255761|590029631|FG000|Overall Study|Other Reasons|37|||
163360800|NCT01255761|590029632|FG001|Overall Study|Other Reasons|18|||
163360801|NCT00658606|590029633|FG000|Overall Study|Adverse Event|2|||
163360802|NCT00658606|590029634|FG001|Overall Study|Adverse Event|1|||
163360803|NCT00658606|590029633|FG000|Overall Study|Lack of Efficacy|6|||
163360804|NCT00658606|590029634|FG001|Overall Study|Lack of Efficacy|3|||
163360805|NCT00658606|590029633|FG000|Overall Study|Lost to Follow-up|1|||
163360806|NCT00658606|590029634|FG001|Overall Study|Lost to Follow-up|0|||
163360807|NCT00658606|590029633|FG000|Overall Study|Withdrawal by Subject|7|||
163360808|NCT00658606|590029634|FG001|Overall Study|Withdrawal by Subject|16|||
163360809|NCT00658606|590029633|FG000|Overall Study|Lack of Compliance|0|||
163360810|NCT00658606|590029634|FG001|Overall Study|Lack of Compliance|3|||
163360811|NCT01191008|590029635|FG000|Overall Study|Protocol Violation|7|||
163360812|NCT01191008|590029635|FG000|Overall Study|Lost to Follow-up|8|||
163360813|NCT03170518|590029636|FG000|Overall Study|Lost to Follow-up|4|||
163360814|NCT03170518|590029637|FG001|Overall Study|Lost to Follow-up|1|||
163360815|NCT03170518|590029638|FG002|Overall Study|Lost to Follow-up|0|||
163360816|NCT03170518|590029636|FG000|Overall Study|Physician Decision|1|||
163360817|NCT03170518|590029637|FG001|Overall Study|Physician Decision|0|||
163360818|NCT03170518|590029638|FG002|Overall Study|Physician Decision|0|||
163360819|NCT03170518|590029636|FG000|Overall Study|Withdrawal by Subject|4|||
163360820|NCT03170518|590029637|FG001|Overall Study|Withdrawal by Subject|5|||
163360821|NCT03170518|590029638|FG002|Overall Study|Withdrawal by Subject|2|||
163360822|NCT03170518|590029636|FG000|Overall Study|Site terminated by sponsor|0|||
163360823|NCT03170518|590029637|FG001|Overall Study|Site terminated by sponsor|1|||
163360824|NCT03170518|590029638|FG002|Overall Study|Site terminated by sponsor|0|||
163360825|NCT03170518|590029636|FG000|Overall Study|Non-compliance with study drug|1|||
163360826|NCT03170518|590029637|FG001|Overall Study|Non-compliance with study drug|0|||
163360827|NCT03170518|590029638|FG002|Overall Study|Non-compliance with study drug|1|||
163360828|NCT03170518|590029636|FG000|Overall Study|Withdrawal by parent/guardian|2|||
163360829|NCT03170518|590029637|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163360830|NCT03170518|590029638|FG002|Overall Study|Withdrawal by parent/guardian|0|||
163360831|NCT03842436|590029639|FG000|Overall Study|Lost to Follow-up|1|||
163360832|NCT01948076|590029640|FG000|Overall Study|Withdrawal by Subject|0|||
163360833|NCT01948076|590029641|FG001|Overall Study|Withdrawal by Subject|1|||
163360834|NCT00936598|590029643|FG000|Overall Study|Withdrawal by Subject|1|||
163360835|NCT00936598|590029644|FG001|Overall Study|Withdrawal by Subject|0|||
163360836|NCT00936598|590029643|FG000|Overall Study|Ineligible after consent|1|||
163360837|NCT00936598|590029644|FG001|Overall Study|Ineligible after consent|0|||
163360838|NCT01431950|590029645|FG000|Overall Study|Study Site Closed/Terminated|7|||
163360839|NCT01431950|590029646|FG001|Overall Study|Study Site Closed/Terminated|3|||
163360840|NCT01431950|590029645|FG000|Overall Study|Withdrawal by Subject|4|||
163360841|NCT01431950|590029646|FG001|Overall Study|Withdrawal by Subject|3|||
163360842|NCT01431950|590029645|FG000|Overall Study|Protocol Violation|2|||
163360843|NCT01431950|590029646|FG001|Overall Study|Protocol Violation|3|||
163360844|NCT01431950|590029645|FG000|Overall Study|Adverse Event|2|||
163360845|NCT01431950|590029646|FG001|Overall Study|Adverse Event|2|||
163360846|NCT01431950|590029645|FG000|Overall Study|Physician Decision|2|||
163360847|NCT01431950|590029646|FG001|Overall Study|Physician Decision|1|||
163360848|NCT01431950|590029645|FG000|Overall Study|Lack of Efficacy|2|||
163360849|NCT01431950|590029646|FG001|Overall Study|Lack of Efficacy|1|||
163360850|NCT01431950|590029645|FG000|Overall Study|Lost to Follow-up|0|||
163360851|NCT01431950|590029646|FG001|Overall Study|Lost to Follow-up|1|||
163360852|NCT01431950|590029645|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
163360853|NCT01431950|590029646|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
163360854|NCT00486252|590029649|FG000|Overall Study|Adverse Event|7|||
163360855|NCT00486252|590029649|FG000|Overall Study|Lack of Efficacy|9|||
163360856|NCT00486252|590029649|FG000|Overall Study|Lost to Follow-up|24|||
163360857|NCT00486252|590029649|FG000|Overall Study|Other|18|||
163360858|NCT01210651|590029650|FG000|Overall Study|Lost to Follow-up|1|||
163360859|NCT01210651|590029651|FG001|Overall Study|Lost to Follow-up|1|||
163360860|NCT01210651|590029650|FG000|Overall Study|schedule conflicts|1|||
163360861|NCT01210651|590029651|FG001|Overall Study|schedule conflicts|5|||
163360862|NCT01210651|590029650|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
163360863|NCT01210651|590029651|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
163360864|NCT01210651|590029650|FG000|Overall Study|Withdrawal by Subject|1|||
163360865|NCT01210651|590029651|FG001|Overall Study|Withdrawal by Subject|1|||
163360866|NCT01210651|590029650|FG000|Overall Study|Injury outside study|2|||
163360867|NCT01210651|590029651|FG001|Overall Study|Injury outside study|0|||
163360868|NCT02559310|590029652|FG000|Overall Study|Death|4|||
163360869|NCT02559310|590029653|FG001|Overall Study|Death|3|||
163360870|NCT02559310|590029652|FG000|Overall Study|Lost to Follow-up|5|||
163360871|NCT02559310|590029653|FG001|Overall Study|Lost to Follow-up|3|||
163360872|NCT02559310|590029652|FG000|Overall Study|Physician Decision|2|||
163360873|NCT02559310|590029653|FG001|Overall Study|Physician Decision|1|||
163360874|NCT02559310|590029652|FG000|Overall Study|Withdrawal by Subject|13|||
163360875|NCT02559310|590029653|FG001|Overall Study|Withdrawal by Subject|9|||
163360876|NCT02559310|590029652|FG000|Overall Study|Sponsor Decision|0|||
163360877|NCT02559310|590029653|FG001|Overall Study|Sponsor Decision|1|||
163360878|NCT02559310|590029652|FG000|Overall Study|Randomized but not treated|3|||
163360879|NCT02559310|590029653|FG001|Overall Study|Randomized but not treated|2|||
163360880|NCT04596540|590029654|FG000|Overall Study|Withdrawal by Subject|9|||
163360881|NCT04596540|590029655|FG001|Overall Study|Withdrawal by Subject|8|||
163360882|NCT04596540|590029656|FG002|Overall Study|Withdrawal by Subject|5|||
163360883|NCT04596540|590029654|FG000|Overall Study|Lost to Follow-up|1|||
163360884|NCT04596540|590029655|FG001|Overall Study|Lost to Follow-up|2|||
163360885|NCT04596540|590029656|FG002|Overall Study|Lost to Follow-up|1|||
163360886|NCT04596540|590029654|FG000|Overall Study|Sponsor Decision|2|||
163360887|NCT04596540|590029655|FG001|Overall Study|Sponsor Decision|0|||
163360888|NCT04596540|590029656|FG002|Overall Study|Sponsor Decision|0|||
163360889|NCT04596540|590029654|FG000|Overall Study|Physician Decision|0|||
163360890|NCT04596540|590029655|FG001|Overall Study|Physician Decision|1|||
163360891|NCT04596540|590029656|FG002|Overall Study|Physician Decision|1|||
163360892|NCT04596540|590029654|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
163360893|NCT04596540|590029655|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
163360894|NCT04596540|590029656|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
163360895|NCT04596540|590029654|FG000|Overall Study|Other Than Specified|5|||
163360896|NCT04596540|590029655|FG001|Overall Study|Other Than Specified|5|||
163360897|NCT04596540|590029656|FG002|Overall Study|Other Than Specified|2|||
163360898|NCT01090011|590031590|FG000|Overall Study|Progressive disease|128|||
163360899|NCT01090011|590031590|FG000|Overall Study|Adverse Event|32|||
163360900|NCT01090011|590031590|FG000|Overall Study|Protocol Violation|1|||
163360901|NCT01090011|590031590|FG000|Overall Study|Refusal to start/continue medication|5|||
163360902|NCT01090011|590031590|FG000|Overall Study|Other reason not defined above|5|||
163360903|NCT00433511|590031591|FG000|Step 1|Adverse Event|50|||
163360904|NCT00433511|590031592|FG001|Step 1|Adverse Event|157|||
163360905|NCT00433511|590031593|FG002|Step 1|Adverse Event|153|||
163360906|NCT00433511|590031591|FG000|Step 1|Withdrawal by Subject|45|||
163360907|NCT00433511|590031592|FG001|Step 1|Withdrawal by Subject|143|||
163360908|NCT00433511|590031593|FG002|Step 1|Withdrawal by Subject|154|||
163360909|NCT00433511|590031591|FG000|Step 1|Death|3|||
163360910|NCT00433511|590031592|FG001|Step 1|Death|1|||
163360911|NCT00433511|590031593|FG002|Step 1|Death|1|||
163360912|NCT00433511|590031591|FG000|Step 1|Physician Decision|1|||
163360913|NCT00433511|590031592|FG001|Step 1|Physician Decision|4|||
163360914|NCT00433511|590031593|FG002|Step 1|Physician Decision|3|||
163360915|NCT00433511|590031591|FG000|Step 1|Never started protocol therapy|28|||
163360916|NCT00433511|590031592|FG001|Step 1|Never started protocol therapy|64|||
163410759|NCT01425008|590211392|FG012|Dose Expansion Phase|Adverse Event|3|||
163360917|NCT00433511|590031593|FG002|Step 1|Never started protocol therapy|66|||
163360918|NCT00433511|590031591|FG000|Step 1|Alternative therapy|2|||
163360919|NCT00433511|590031592|FG001|Step 1|Alternative therapy|1|||
163360920|NCT00433511|590031593|FG002|Step 1|Alternative therapy|3|||
163360921|NCT00433511|590031591|FG000|Step 1|Disease progression, relapse|5|||
163360922|NCT00433511|590031592|FG001|Step 1|Disease progression, relapse|3|||
163360923|NCT00433511|590031593|FG002|Step 1|Disease progression, relapse|3|||
163360924|NCT00433511|590031591|FG000|Step 1|Other complicating disease|2|||
163360925|NCT00433511|590031592|FG001|Step 1|Other complicating disease|6|||
163256210|NCT01218126|589644939|FG002|Overall Study|Lost to Follow-up|0|||
163256211|NCT01218126|589644940|FG003|Overall Study|Lost to Follow-up|2|||
163256212|NCT01218126|589644937|FG000|Overall Study|Physician Decision|1|||
163256213|NCT01218126|589644938|FG001|Overall Study|Physician Decision|2|||
163256214|NCT01218126|589644939|FG002|Overall Study|Physician Decision|4|||
163256215|NCT01218126|589644940|FG003|Overall Study|Physician Decision|2|||
163256216|NCT01218126|589644937|FG000|Overall Study|Withdrawal by Subject|2|||
163256217|NCT01218126|589644938|FG001|Overall Study|Withdrawal by Subject|5|||
163256218|NCT01218126|589644939|FG002|Overall Study|Withdrawal by Subject|4|||
163256219|NCT01218126|589644940|FG003|Overall Study|Withdrawal by Subject|6|||
163256220|NCT05380947|589644944|FG000|Washout Period 1|Not attend visit|1|||
163256221|NCT05380947|589644945|FG001|Washout Period 1|Not attend visit|0|||
163256222|NCT05380947|589644946|FG002|Washout Period 1|Not attend visit|0|||
163256223|NCT05380947|589644947|FG003|Washout Period 1|Not attend visit|0|||
163256224|NCT05380947|589644944|FG000|Washout Period 2|Adverse Event|1|||
163256225|NCT05380947|589644945|FG001|Washout Period 2|Adverse Event|0|||
163256226|NCT05380947|589644946|FG002|Washout Period 2|Adverse Event|0|||
163256227|NCT05380947|589644947|FG003|Washout Period 2|Adverse Event|0|||
163256228|NCT05380947|589644944|FG000|Washout Period 3|Adverse Event|0|||
163256229|NCT05380947|589644945|FG001|Washout Period 3|Adverse Event|1|||
163256230|NCT05380947|589644946|FG002|Washout Period 3|Adverse Event|0|||
163256231|NCT05380947|589644947|FG003|Washout Period 3|Adverse Event|0|||
163256232|NCT05380947|589644944|FG000|Washout Period 3|Not attend visit|0|||
163256233|NCT05380947|589644945|FG001|Washout Period 3|Not attend visit|1|||
163256234|NCT05380947|589644946|FG002|Washout Period 3|Not attend visit|0|||
163256235|NCT05380947|589644947|FG003|Washout Period 3|Not attend visit|1|||
163256236|NCT01563536|589644948|FG000|Overall Study|Withdrawal by Subject|0|||
163256237|NCT01563536|589644949|FG001|Overall Study|Withdrawal by Subject|2|||
163256238|NCT01563536|589644948|FG000|Overall Study|Lost to Follow-up|1|||
163256239|NCT01563536|589644949|FG001|Overall Study|Lost to Follow-up|0|||
163256240|NCT01860703|589644950|FG000|Overall Study|Adverse Event|1|||
163256241|NCT01860703|589644951|FG001|Overall Study|Adverse Event|4|||
163256242|NCT01860703|589644952|FG002|Overall Study|Adverse Event|0|||
163256243|NCT01860703|589644953|FG003|Overall Study|Adverse Event|2|||
163256244|NCT01860703|589644950|FG000|Overall Study|Withdrawal by Subject|0|||
163256245|NCT01860703|589644951|FG001|Overall Study|Withdrawal by Subject|1|||
163256246|NCT01860703|589644952|FG002|Overall Study|Withdrawal by Subject|0|||
163256247|NCT01860703|589644953|FG003|Overall Study|Withdrawal by Subject|0|||
163256248|NCT01860703|589644950|FG000|Overall Study|Personal reason|1|||
163256249|NCT01860703|589644951|FG001|Overall Study|Personal reason|0|||
163256250|NCT01860703|589644952|FG002|Overall Study|Personal reason|1|||
163256251|NCT01860703|589644953|FG003|Overall Study|Personal reason|0|||
163256252|NCT06213701|589644957|FG000|Overall Study|Withdrawal by Subject|2|||
163256253|NCT06213701|589644958|FG001|Overall Study|Withdrawal by Subject|1|||
163256254|NCT06213701|589644959|FG002|Overall Study|Withdrawal by Subject|0|||
163256255|NCT00538590|589644960|FG000|Overall Study|Death|1|||
163256256|NCT00538590|589644961|FG001|Overall Study|Death|0|||
163256257|NCT01515748|589644973|FG000|Overall Study|Withdrawal by Subject|32|||
163256258|NCT01515748|589644974|FG001|Overall Study|Withdrawal by Subject|41|||
163256259|NCT01515748|589644973|FG000|Overall Study|Lost to Follow-up|2|||
163256260|NCT01515748|589644974|FG001|Overall Study|Lost to Follow-up|4|||
163256261|NCT01515748|589644973|FG000|Overall Study|Other than specified above|5|||
163256262|NCT01515748|589644974|FG001|Overall Study|Other than specified above|10|||
163256263|NCT03221387|589644975|FG000|Overall Study|Lost to Follow-up|1|||
163256264|NCT03221387|589644975|FG000|Overall Study|Lung transplant|1|||
163256265|NCT06223373|589644981|FG000|Overall Study|Lost to Follow-up|1|||
163256266|NCT06223373|589644982|FG001|Overall Study|Lost to Follow-up|2|||
163256267|NCT03770494|589644983|FG000|Overall Study|Lost to Follow-up|0|||
163256268|NCT03770494|589644984|FG001|Overall Study|Lost to Follow-up|0|||
163256269|NCT03770494|589644985|FG002|Overall Study|Lost to Follow-up|1|||
163256270|NCT03770494|589644986|FG003|Overall Study|Lost to Follow-up|1|||
163256271|NCT03770494|589644987|FG004|Overall Study|Lost to Follow-up|1|||
163256272|NCT03770494|589644988|FG005|Overall Study|Lost to Follow-up|0|||
163256273|NCT03770494|589644989|FG006|Overall Study|Lost to Follow-up|0|||
163256274|NCT03770494|589644990|FG007|Overall Study|Lost to Follow-up|0|||
163256275|NCT03770494|589644991|FG008|Overall Study|Lost to Follow-up|0|||
163256276|NCT03770494|589644992|FG009|Overall Study|Lost to Follow-up|0|||
163410760|NCT01425008|590211393|FG013|Dose Expansion Phase|Adverse Event|0|||
163410761|NCT01425008|590211394|FG014|Dose Expansion Phase|Adverse Event|1|||
163410762|NCT01425008|590211395|FG015|Dose Expansion Phase|Adverse Event|1|||
163256277|NCT03770494|589644993|FG010|Overall Study|Lost to Follow-up|0|||
163256278|NCT03770494|589644994|FG011|Overall Study|Lost to Follow-up|0|||
163256279|NCT03770494|589644995|FG012|Overall Study|Lost to Follow-up|0|||
163256280|NCT03770494|589644996|FG013|Overall Study|Lost to Follow-up|0|||
163256281|NCT03770494|589644983|FG000|Overall Study|Study terminated by sponsor|1|||
163256282|NCT03770494|589644984|FG001|Overall Study|Study terminated by sponsor|2|||
163256283|NCT03770494|589644985|FG002|Overall Study|Study terminated by sponsor|1|||
163256284|NCT03770494|589644986|FG003|Overall Study|Study terminated by sponsor|1|||
163256285|NCT03770494|589644987|FG004|Overall Study|Study terminated by sponsor|1|||
163360926|NCT00433511|590031593|FG002|Step 1|Other complicating disease|3|||
163360927|NCT00433511|590031591|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
163360928|NCT00433511|590031592|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
163360929|NCT00433511|590031593|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
163360930|NCT00433511|590031591|FG000|Step 1|Suspected recurrence|0|||
163360931|NCT00433511|590031592|FG001|Step 1|Suspected recurrence|1|||
163360932|NCT00433511|590031593|FG002|Step 1|Suspected recurrence|0|||
163360933|NCT00433511|590031591|FG000|Step 1|Insurance/drug distribution issues|0|||
163360934|NCT00433511|590031592|FG001|Step 1|Insurance/drug distribution issues|1|||
163360935|NCT00433511|590031593|FG002|Step 1|Insurance/drug distribution issues|2|||
163360936|NCT00433511|590031591|FG000|Step 1|Patient moved|0|||
163360937|NCT00433511|590031592|FG001|Step 1|Patient moved|0|||
163360938|NCT00433511|590031593|FG002|Step 1|Patient moved|1|||
163360939|NCT00433511|590031591|FG000|Step 2 (Arm D)|Adverse Event|0|||
163360940|NCT00433511|590031592|FG001|Step 2 (Arm D)|Adverse Event|0|||
163360941|NCT00433511|590031593|FG002|Step 2 (Arm D)|Adverse Event|135|||
163360942|NCT00433511|590031591|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
163360943|NCT00433511|590031592|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
163360944|NCT00433511|590031593|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
163360945|NCT00433511|590031591|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
163360946|NCT00433511|590031592|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
163360947|NCT00433511|590031593|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
163360948|NCT00433511|590031591|FG000|Step 2 (Arm D)|Physician Decision|0|||
163360949|NCT00433511|590031592|FG001|Step 2 (Arm D)|Physician Decision|0|||
163360950|NCT00433511|590031593|FG002|Step 2 (Arm D)|Physician Decision|9|||
163360951|NCT00433511|590031591|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
163360952|NCT00433511|590031592|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
163360953|NCT00433511|590031593|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
163360954|NCT00433511|590031591|FG000|Step 2 (Arm D)|Other complicating disease|0|||
163360955|NCT00433511|590031592|FG001|Step 2 (Arm D)|Other complicating disease|0|||
163360956|NCT00433511|590031593|FG002|Step 2 (Arm D)|Other complicating disease|3|||
163360957|NCT00433511|590031591|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
163360958|NCT00433511|590031592|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
163360959|NCT00433511|590031593|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
163360960|NCT00433511|590031591|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
163360961|NCT00433511|590031592|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
163360962|NCT00433511|590031593|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
163360963|NCT00433511|590031591|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
163360964|NCT00433511|590031592|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
163360965|NCT00433511|590031593|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
163360966|NCT00433511|590031591|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
163360967|NCT00433511|590031592|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
163360968|NCT00433511|590031593|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
163360969|NCT01375673|590031594|FG000|Overall Study|Withdrawal by Subject|0|||
163360970|NCT01375673|590031595|FG001|Overall Study|Withdrawal by Subject|1|||
163360971|NCT04698915|590031600|FG000|Overall Study|Adverse Event|2|||
163360972|NCT04698915|590031601|FG001|Overall Study|Adverse Event|0|||
163360973|NCT04698915|590031600|FG000|Overall Study|Death|23|||
163360974|NCT04698915|590031601|FG001|Overall Study|Death|20|||
163360975|NCT04698915|590031600|FG000|Overall Study|Physician Decision|1|||
163360976|NCT04698915|590031601|FG001|Overall Study|Physician Decision|1|||
163360977|NCT04698915|590031600|FG000|Overall Study|Lost to Follow-up|1|||
163360978|NCT04698915|590031601|FG001|Overall Study|Lost to Follow-up|0|||
163360979|NCT04698915|590031600|FG000|Overall Study|Study Terminated by Sponsor|55|||
163360980|NCT04698915|590031601|FG001|Overall Study|Study Terminated by Sponsor|60|||
163360981|NCT04698915|590031600|FG000|Overall Study|Withdrawal by Subject|2|||
163360982|NCT04698915|590031601|FG001|Overall Study|Withdrawal by Subject|3|||
163360983|NCT00979953|590031606|FG000|Overall Study|Adverse Event|5|||
163360984|NCT00979953|590031607|FG001|Overall Study|Adverse Event|2|||
163151632|NCT00388349|589269468|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
163151633|NCT01667900|589269473|FG000|Part B|Death|0|||
163151634|NCT01667900|589269474|FG001|Part B|Death|0|||
163151635|NCT01667900|589269475|FG002|Part B|Death|0|||
163151636|NCT01667900|589269476|FG003|Part B|Death|0|||
163151637|NCT01667900|589269477|FG004|Part B|Death|0|||
163151638|NCT01667900|589269478|FG005|Part B|Death|0|||
163151639|NCT01667900|589269479|FG006|Part B|Death|0|||
163151640|NCT01667900|589269480|FG007|Part B|Death|0|||
163151641|NCT01667900|589269481|FG008|Part B|Death|0|||
163151642|NCT01667900|589269482|FG009|Part B|Death|0|||
163151643|NCT01667900|589269483|FG010|Part B|Death|0|||
163360985|NCT00979953|590031608|FG002|Overall Study|Adverse Event|17|||
163360986|NCT00979953|590031609|FG003|Overall Study|Adverse Event|4|||
163360987|NCT00979953|590031606|FG000|Overall Study|Lack of Efficacy|1|||
163151644|NCT01667900|589269484|FG011|Part B|Death|0|||
163151645|NCT01667900|589269485|FG012|Part B|Death|0|||
163151646|NCT01667900|589269486|FG013|Part B|Death|0|||
163151647|NCT01667900|589269487|FG014|Part B|Death|0|||
163360988|NCT00979953|590031607|FG001|Overall Study|Lack of Efficacy|2|||
163410763|NCT01425008|590211396|FG016|Dose Expansion Phase|Adverse Event|5|||
163410764|NCT01425008|590211397|FG017|Dose Expansion Phase|Adverse Event|0|||
163410765|NCT01425008|590211398|FG018|Dose Expansion Phase|Adverse Event|3|||
163410766|NCT01425008|590211380|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
163410767|NCT01425008|590211381|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
163410768|NCT01425008|590211382|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
163410769|NCT01425008|590211383|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
163410770|NCT01425008|590211384|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
163410771|NCT01425008|590211385|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
163410772|NCT01425008|590211386|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
163410773|NCT01425008|590211387|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
163410774|NCT01425008|590211388|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
163256286|NCT03770494|589644988|FG005|Overall Study|Study terminated by sponsor|2|||
163410775|NCT01425008|590211389|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
163410776|NCT01425008|590211390|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
163256287|NCT03770494|589644989|FG006|Overall Study|Study terminated by sponsor|1|||
163256288|NCT03770494|589644990|FG007|Overall Study|Study terminated by sponsor|2|||
163256289|NCT03770494|589644991|FG008|Overall Study|Study terminated by sponsor|1|||
163256290|NCT03770494|589644992|FG009|Overall Study|Study terminated by sponsor|2|||
163256291|NCT03770494|589644993|FG010|Overall Study|Study terminated by sponsor|1|||
163256292|NCT03770494|589644994|FG011|Overall Study|Study terminated by sponsor|2|||
163256293|NCT03770494|589644995|FG012|Overall Study|Study terminated by sponsor|0|||
163256294|NCT03770494|589644996|FG013|Overall Study|Study terminated by sponsor|0|||
163256295|NCT03770494|589644983|FG000|Overall Study|Withdrawal by Subject|1|||
163256296|NCT03770494|589644984|FG001|Overall Study|Withdrawal by Subject|1|||
163256297|NCT03770494|589644985|FG002|Overall Study|Withdrawal by Subject|0|||
163256298|NCT03770494|589644986|FG003|Overall Study|Withdrawal by Subject|0|||
163256299|NCT03770494|589644987|FG004|Overall Study|Withdrawal by Subject|2|||
163256300|NCT03770494|589644988|FG005|Overall Study|Withdrawal by Subject|2|||
163256301|NCT03770494|589644989|FG006|Overall Study|Withdrawal by Subject|2|||
163256302|NCT03770494|589644990|FG007|Overall Study|Withdrawal by Subject|0|||
163256303|NCT03770494|589644991|FG008|Overall Study|Withdrawal by Subject|2|||
163256304|NCT03770494|589644992|FG009|Overall Study|Withdrawal by Subject|3|||
163256305|NCT03770494|589644993|FG010|Overall Study|Withdrawal by Subject|1|||
163256306|NCT03770494|589644994|FG011|Overall Study|Withdrawal by Subject|0|||
163256307|NCT03770494|589644995|FG012|Overall Study|Withdrawal by Subject|0|||
163256308|NCT03770494|589644996|FG013|Overall Study|Withdrawal by Subject|0|||
163256309|NCT05050578|589647008|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
163256310|NCT05050578|589647009|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
163256311|NCT05050578|589647008|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
163256312|NCT05050578|589647009|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
163256313|NCT05050578|589647008|FG000|Period 2, 30 Days|Protocol Violation|0|||
163256314|NCT05050578|589647009|FG001|Period 2, 30 Days|Protocol Violation|1|||
163256315|NCT02243280|589647010|FG000|Treated|Adverse Event|1|||
163256316|NCT02243280|589647011|FG001|Treated|Adverse Event|0|||
163256317|NCT02243280|589647012|FG002|Treated|Adverse Event|0|||
163256318|NCT02243280|589647013|FG003|Treated|Adverse Event|0|||
163256319|NCT02243280|589647014|FG004|Treated|Adverse Event|0|||
163256320|NCT02243280|589647015|FG005|Treated|Adverse Event|0|||
163256321|NCT02243280|589647016|FG006|Treated|Adverse Event|0|||
163256322|NCT02243280|589647017|FG007|Treated|Adverse Event|0|||
163256323|NCT02243280|589647018|FG008|Treated|Adverse Event|0|||
163256324|NCT02243280|589647019|FG009|Treated|Adverse Event|0|||
163256325|NCT02243280|589647020|FG010|Treated|Adverse Event|1|||
163256326|NCT02243280|589647010|FG000|Treated|Lost to Follow-up|0|||
163256327|NCT02243280|589647011|FG001|Treated|Lost to Follow-up|0|||
163256328|NCT02243280|589647012|FG002|Treated|Lost to Follow-up|0|||
163256329|NCT02243280|589647013|FG003|Treated|Lost to Follow-up|0|||
163256330|NCT02243280|589647014|FG004|Treated|Lost to Follow-up|0|||
163256331|NCT02243280|589647015|FG005|Treated|Lost to Follow-up|0|||
163256332|NCT02243280|589647016|FG006|Treated|Lost to Follow-up|0|||
163256333|NCT02243280|589647017|FG007|Treated|Lost to Follow-up|0|||
163256334|NCT02243280|589647018|FG008|Treated|Lost to Follow-up|1|||
163256335|NCT02243280|589647019|FG009|Treated|Lost to Follow-up|0|||
163256336|NCT02243280|589647020|FG010|Treated|Lost to Follow-up|2|||
163256337|NCT03386032|589647029|FG000|Overall Study|Lack of Efficacy|6|||
163256338|NCT03386032|589647030|FG001|Overall Study|Lack of Efficacy|2|||
163256339|NCT03386032|589647031|FG002|Overall Study|Lack of Efficacy|0|||
163256340|NCT03386032|589647029|FG000|Overall Study|Adverse Event|2|||
163256341|NCT03386032|589647030|FG001|Overall Study|Adverse Event|2|||
163256342|NCT03386032|589647031|FG002|Overall Study|Adverse Event|0|||
163256343|NCT03386032|589647029|FG000|Overall Study|Withdrawal by Subject|1|||
163256344|NCT03386032|589647030|FG001|Overall Study|Withdrawal by Subject|0|||
163256345|NCT03386032|589647031|FG002|Overall Study|Withdrawal by Subject|0|||
163256346|NCT03386032|589647029|FG000|Overall Study|Lost to Follow-up|9|||
163256347|NCT03386032|589647030|FG001|Overall Study|Lost to Follow-up|3|||
163256348|NCT03386032|589647031|FG002|Overall Study|Lost to Follow-up|0|||
163256349|NCT04525547|589647040|FG000|Overall Study|Not treated with Ofev|2|||
163256350|NCT04525547|589647040|FG000|Overall Study|Off-label use|2|||
163410777|NCT01425008|590211391|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
163410778|NCT01425008|590211392|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
163410779|NCT01425008|590211393|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
163410780|NCT01425008|590211394|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
163410781|NCT01425008|590211395|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
163410782|NCT01425008|590211396|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
163410783|NCT01425008|590211397|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
163410784|NCT01425008|590211398|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
163410785|NCT01425008|590211380|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410786|NCT01425008|590211381|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410787|NCT01425008|590211382|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410788|NCT01425008|590211383|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410789|NCT01425008|590211384|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410790|NCT01425008|590211385|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410791|NCT01425008|590211386|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410792|NCT01425008|590211387|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410793|NCT01425008|590211388|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410794|NCT01425008|590211389|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410795|NCT01425008|590211390|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410796|NCT01425008|590211391|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410797|NCT01425008|590211392|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410798|NCT01425008|590211393|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410799|NCT01425008|590211394|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410800|NCT01425008|590211395|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410801|NCT01425008|590211396|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410802|NCT01425008|590211397|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163410803|NCT01425008|590211398|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
163410804|NCT03359759|590211399|FG000|Overall Study|Death|3|||
163410805|NCT03359759|590211399|FG000|Overall Study|Lost to Follow-up|2|||
163410806|NCT04818593|590211400|FG000|Overall Study|Low Oocyte Yield|8|||
163410807|NCT04818593|590211401|FG001|Overall Study|Low Oocyte Yield|8|||
163410808|NCT04818593|590211400|FG000|Overall Study|Not ICSI Insemination|7|||
163410809|NCT04818593|590211401|FG001|Overall Study|Not ICSI Insemination|7|||
163410810|NCT04818593|590211400|FG000|Overall Study|Poor Sperm Quality|2|||
163410811|NCT04818593|590211401|FG001|Overall Study|Poor Sperm Quality|2|||
163410812|NCT04818593|590211400|FG000|Overall Study|Withdrawal by Subject|2|||
163410813|NCT04818593|590211401|FG001|Overall Study|Withdrawal by Subject|2|||
163410814|NCT04818593|590211400|FG000|Overall Study|Conversion to IUI due to low response|1|||
163410815|NCT04818593|590211401|FG001|Overall Study|Conversion to IUI due to low response|1|||
163410816|NCT02600494|590211402|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
163410817|NCT02600494|590211403|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
163410818|NCT02600494|590211404|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
163410819|NCT02600494|590211402|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
163410820|NCT02600494|590211403|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
163410821|NCT02600494|590211404|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
163410822|NCT02600494|590211402|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
163410823|NCT02600494|590211403|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
163410824|NCT02600494|590211404|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
163410825|NCT02600494|590211402|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
163410826|NCT02600494|590211403|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
163410827|NCT02600494|590211404|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
163410828|NCT02600494|590211402|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
163410829|NCT02600494|590211403|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
163410830|NCT02600494|590211404|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
163410831|NCT02600494|590211402|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
163410832|NCT02600494|590211403|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
163410833|NCT02600494|590211404|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
163410834|NCT02600494|590211402|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
163410835|NCT02600494|590211403|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
163410836|NCT02600494|590211404|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
163410837|NCT02600494|590211402|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
163410838|NCT02600494|590211403|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
163410839|NCT02600494|590211404|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
163151648|NCT01667900|589269488|FG015|Part B|Death|0|||
163151649|NCT01667900|589269489|FG016|Part B|Death|1|||
163410840|NCT02600494|590211402|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
163151650|NCT01667900|589269490|FG017|Part B|Death|0|||
163151651|NCT01667900|589269491|FG018|Part B|Death|0|||
163360989|NCT00979953|590031608|FG002|Overall Study|Lack of Efficacy|0|||
163360990|NCT00979953|590031609|FG003|Overall Study|Lack of Efficacy|0|||
163360991|NCT00979953|590031606|FG000|Overall Study|Lost to Follow-up|1|||
163360992|NCT00979953|590031607|FG001|Overall Study|Lost to Follow-up|1|||
163360993|NCT00979953|590031608|FG002|Overall Study|Lost to Follow-up|1|||
163360994|NCT00979953|590031609|FG003|Overall Study|Lost to Follow-up|0|||
163360995|NCT00979953|590031606|FG000|Overall Study|Withdrawal by Subject|0|||
163360996|NCT00979953|590031607|FG001|Overall Study|Withdrawal by Subject|0|||
163360997|NCT00979953|590031608|FG002|Overall Study|Withdrawal by Subject|2|||
163360998|NCT00979953|590031609|FG003|Overall Study|Withdrawal by Subject|1|||
163360999|NCT00979953|590031606|FG000|Overall Study|Protocol Violation|1|||
163361000|NCT00979953|590031607|FG001|Overall Study|Protocol Violation|0|||
163361001|NCT00979953|590031608|FG002|Overall Study|Protocol Violation|2|||
163361002|NCT00979953|590031609|FG003|Overall Study|Protocol Violation|2|||
163361003|NCT01124097|590031610|FG000|Overall Study|Withdrawal by Subject|4|||
163361004|NCT01124097|590031611|FG001|Overall Study|Withdrawal by Subject|3|||
163361005|NCT01124097|590031612|FG002|Overall Study|Withdrawal by Subject|2|||
163361006|NCT01124097|590031613|FG003|Overall Study|Withdrawal by Subject|3|||
163361007|NCT01124097|590031610|FG000|Overall Study|Lack of Efficacy|2|||
163361008|NCT01124097|590031611|FG001|Overall Study|Lack of Efficacy|3|||
163361009|NCT01124097|590031612|FG002|Overall Study|Lack of Efficacy|1|||
163361010|NCT01124097|590031613|FG003|Overall Study|Lack of Efficacy|3|||
163361011|NCT01124097|590031610|FG000|Overall Study|Adverse Event|24|||
163361012|NCT01124097|590031611|FG001|Overall Study|Adverse Event|15|||
163361013|NCT01124097|590031612|FG002|Overall Study|Adverse Event|15|||
163361014|NCT01124097|590031613|FG003|Overall Study|Adverse Event|7|||
163361015|NCT01124097|590031610|FG000|Overall Study|Protocol Violation|2|||
163361016|NCT01124097|590031611|FG001|Overall Study|Protocol Violation|0|||
163361017|NCT01124097|590031612|FG002|Overall Study|Protocol Violation|2|||
163361018|NCT01124097|590031613|FG003|Overall Study|Protocol Violation|1|||
163361019|NCT01124097|590031610|FG000|Overall Study|Physician Decision|2|||
163361020|NCT01124097|590031611|FG001|Overall Study|Physician Decision|1|||
163361021|NCT01124097|590031612|FG002|Overall Study|Physician Decision|0|||
163361022|NCT01124097|590031613|FG003|Overall Study|Physician Decision|0|||
163361023|NCT05687032|590031614|FG000|Treatment Phase|Adverse Event|13|||
163361024|NCT05687032|590031614|FG000|Treatment Phase|Death|1|||
163361025|NCT05687032|590031614|FG000|Treatment Phase|Physician Decision|3|||
163361026|NCT05687032|590031614|FG000|Treatment Phase|Progressive disease|9|||
163361027|NCT05687032|590031614|FG000|Treatment Phase|Withdrawal by Subject|5|||
163361028|NCT05687032|590031614|FG000|Follow-Up Phase|Death|16|||
163361029|NCT05687032|590031614|FG000|Follow-Up Phase|Ongoing|26|||
163361030|NCT04829747|590031615|FG000|Overall Study|Protocol Violation|1|||
163361031|NCT02367352|590031618|FG000|Overall Study|Progressive disease|7|||
163361032|NCT02367352|590031619|FG001|Overall Study|Progressive disease|0|||
163361033|NCT02367352|590031620|FG002|Overall Study|Progressive disease|0|||
163361034|NCT02367352|590031618|FG000|Overall Study|Participant Received Alternative Therapy|1|||
163361035|NCT02367352|590031619|FG001|Overall Study|Participant Received Alternative Therapy|0|||
163361036|NCT02367352|590031620|FG002|Overall Study|Participant Received Alternative Therapy|0|||
163361037|NCT02367352|590031618|FG000|Overall Study|Adverse Event|1|||
163361038|NCT02367352|590031619|FG001|Overall Study|Adverse Event|0|||
163361039|NCT02367352|590031620|FG002|Overall Study|Adverse Event|0|||
163361040|NCT05878873|590031625|FG000|Overall Study|Lost to Follow-up|2|||
163361041|NCT05878873|590031626|FG001|Overall Study|Lost to Follow-up|0|||
163361042|NCT02375347|590031628|FG000|Overall Study|Protocol Violation|1|||
163361043|NCT00193479|590031629|FG000|Induction Chemotherapy|Adverse Event|2|||
163361044|NCT00193479|590031629|FG000|Induction Chemotherapy|Disease Progression|1|||
163361045|NCT00193479|590031629|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
163361046|NCT00193479|590031629|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
163361047|NCT00425607|590031630|FG000|Overall Study|Death|1|||
163361048|NCT00425607|590031630|FG000|Overall Study|Withdrawal by Subject|1|||
163361049|NCT00079339|590031631|FG000|Overall Study|Adverse Event|1|||
163361050|NCT00079339|590031632|FG001|Overall Study|Adverse Event|7|||
163361051|NCT00079339|590031633|FG002|Overall Study|Adverse Event|2|||
163361052|NCT00079339|590031631|FG000|Overall Study|Death|1|||
163361053|NCT00079339|590031632|FG001|Overall Study|Death|0|||
163361054|NCT00079339|590031633|FG002|Overall Study|Death|0|||
163361055|NCT00079339|590031631|FG000|Overall Study|Non-compliance|0|||
163361056|NCT00079339|590031632|FG001|Overall Study|Non-compliance|0|||
163361057|NCT00079339|590031633|FG002|Overall Study|Non-compliance|1|||
163361058|NCT00079339|590031631|FG000|Overall Study|Withdrawal by Subject|0|||
163361059|NCT00079339|590031632|FG001|Overall Study|Withdrawal by Subject|4|||
163361060|NCT00079339|590031633|FG002|Overall Study|Withdrawal by Subject|1|||
163361061|NCT00079339|590031631|FG000|Overall Study|Disease progression|3|||
163361062|NCT00079339|590031632|FG001|Overall Study|Disease progression|28|||
163361063|NCT00079339|590031633|FG002|Overall Study|Disease progression|2|||
163361064|NCT02563548|590031634|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
163384936|NCT00427895|590119255|FG005|Vax 1/Year 1 Follow-up|Other|0|||
163384937|NCT00427895|590119256|FG006|Vax 1/Year 1 Follow-up|Other|0|||
163384938|NCT00427895|590119257|FG007|Vax 1/Year 1 Follow-up|Other|0|||
163256351|NCT04525547|589647040|FG000|Overall Study|Lost to Follow-up|1|||
163256352|NCT03122119|589647041|FG000|Overall Study|Did not meet eligibility critria|1|||
163256353|NCT01493687|589647048|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
163256354|NCT01493687|589647049|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
163256355|NCT01493687|589647048|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
163256356|NCT01493687|589647049|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
163256357|NCT01493687|589647048|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
163256358|NCT01493687|589647049|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
163256359|NCT01493687|589647048|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
163256360|NCT01493687|589647049|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
163256361|NCT01493687|589647048|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
163256362|NCT01493687|589647049|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
163256363|NCT01493687|589647048|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
163256364|NCT01493687|589647049|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
163256365|NCT01493687|589647048|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
163256366|NCT01493687|589647049|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
163256367|NCT01493687|589647048|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
163256368|NCT01493687|589647049|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
163256369|NCT01493687|589647048|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
163256370|NCT01493687|589647049|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
163256371|NCT01493687|589647048|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
163256372|NCT01493687|589647049|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
163256373|NCT01493687|589647048|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
163256374|NCT01493687|589647049|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
163256375|NCT01493687|589647048|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
163256376|NCT01493687|589647049|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
163256377|NCT01493687|589647048|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
163256378|NCT01493687|589647049|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
163256379|NCT01493687|589647048|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
163256380|NCT01493687|589647049|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
163256381|NCT01493687|589647048|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
163256382|NCT01493687|589647049|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
163256383|NCT02364180|589647050|FG000|Overall Study|Screen Fail|1|||
163256384|NCT01783418|589647051|FG000|Overall Study|Withdrawal by Subject|1|||
163256385|NCT01783418|589647052|FG001|Overall Study|Withdrawal by Subject|0|||
163256386|NCT00521144|589647053|FG000|Overall Study|Not Treated|0|||
163256387|NCT00521144|589647054|FG001|Overall Study|Not Treated|0|||
163256388|NCT00521144|589647055|FG002|Overall Study|Not Treated|0|||
163256389|NCT00521144|589647056|FG003|Overall Study|Not Treated|1|||
163256390|NCT00521144|589647057|FG004|Overall Study|Not Treated|0|||
163256391|NCT00521144|589647053|FG000|Overall Study|Adverse Event|0|||
163256392|NCT00521144|589647054|FG001|Overall Study|Adverse Event|1|||
163256393|NCT00521144|589647055|FG002|Overall Study|Adverse Event|0|||
163256394|NCT00521144|589647056|FG003|Overall Study|Adverse Event|0|||
163256395|NCT00521144|589647057|FG004|Overall Study|Adverse Event|1|||
163256396|NCT00521144|589647053|FG000|Overall Study|Progressive Disease|4|||
163256397|NCT00521144|589647054|FG001|Overall Study|Progressive Disease|2|||
163256398|NCT00521144|589647055|FG002|Overall Study|Progressive Disease|2|||
163256399|NCT00521144|589647056|FG003|Overall Study|Progressive Disease|0|||
163256400|NCT00521144|589647057|FG004|Overall Study|Progressive Disease|6|||
163256401|NCT00508261|589647059|FG000|Overall Study|Other|0|||
163256402|NCT00508261|589647060|FG001|Overall Study|Other|1|||
163256403|NCT00508261|589647061|FG002|Overall Study|Other|1|||
163256404|NCT00508261|589647062|FG003|Overall Study|Other|0|||
163256405|NCT00508261|589647059|FG000|Overall Study|Serious Adverse Event|0|||
163256406|NCT00508261|589647060|FG001|Overall Study|Serious Adverse Event|1|||
163256407|NCT00508261|589647061|FG002|Overall Study|Serious Adverse Event|0|||
163256408|NCT00508261|589647062|FG003|Overall Study|Serious Adverse Event|0|||
163256409|NCT00508261|589647059|FG000|Overall Study|Withdrawal by Subject|3|||
163256410|NCT00508261|589647060|FG001|Overall Study|Withdrawal by Subject|4|||
163256411|NCT00508261|589647061|FG002|Overall Study|Withdrawal by Subject|4|||
163256412|NCT00508261|589647062|FG003|Overall Study|Withdrawal by Subject|0|||
163256413|NCT00508261|589647059|FG000|Overall Study|Migrated/ moved from study area|0|||
163256414|NCT00508261|589647060|FG001|Overall Study|Migrated/ moved from study area|1|||
163256415|NCT00508261|589647061|FG002|Overall Study|Migrated/ moved from study area|0|||
163256416|NCT00508261|589647062|FG003|Overall Study|Migrated/ moved from study area|0|||
163256417|NCT00508261|589647059|FG000|Overall Study|Lost to Follow-up|0|||
163256418|NCT00508261|589647060|FG001|Overall Study|Lost to Follow-up|1|||
163256419|NCT00508261|589647061|FG002|Overall Study|Lost to Follow-up|1|||
163256420|NCT00508261|589647062|FG003|Overall Study|Lost to Follow-up|1|||
163256421|NCT00180479|589647063|FG000|Overall Study|Death|4|||
163256422|NCT00180479|589647064|FG001|Overall Study|Death|2|||
163361065|NCT02563548|590031635|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
163410841|NCT02600494|590211403|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
163410842|NCT02600494|590211404|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
163410843|NCT02600494|590211402|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
163410844|NCT02600494|590211403|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
163410845|NCT02600494|590211404|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
163410846|NCT02600494|590211402|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
163410847|NCT02600494|590211403|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
163410848|NCT02600494|590211404|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
163410849|NCT02600494|590211402|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
163410850|NCT02600494|590211403|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
163410851|NCT02600494|590211404|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
163410852|NCT02600494|590211402|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
163410853|NCT02600494|590211403|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
163410854|NCT02600494|590211404|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
163410855|NCT04179175|590212936|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
163410856|NCT04179175|590212937|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
163410857|NCT04179175|590212938|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
163410858|NCT04179175|590212939|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
163410859|NCT04179175|590212940|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
163410860|NCT04179175|590212941|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
163410861|NCT04179175|590212936|FG000|Overall Study|Adverse Event|5|||
163410862|NCT04179175|590212937|FG001|Overall Study|Adverse Event|3|||
163410863|NCT04179175|590212938|FG002|Overall Study|Adverse Event|3|||
163410864|NCT04179175|590212939|FG003|Overall Study|Adverse Event|4|||
163410865|NCT04179175|590212940|FG004|Overall Study|Adverse Event|6|||
163410866|NCT04179175|590212941|FG005|Overall Study|Adverse Event|6|||
163410867|NCT04179175|590212936|FG000|Overall Study|Lack of Efficacy|5|||
163410868|NCT04179175|590212937|FG001|Overall Study|Lack of Efficacy|1|||
163410869|NCT04179175|590212938|FG002|Overall Study|Lack of Efficacy|3|||
163410870|NCT04179175|590212939|FG003|Overall Study|Lack of Efficacy|2|||
163410871|NCT04179175|590212940|FG004|Overall Study|Lack of Efficacy|18|||
163410872|NCT04179175|590212941|FG005|Overall Study|Lack of Efficacy|7|||
163151652|NCT01667900|589269492|FG019|Part B|Death|0|||
163151653|NCT00774046|589269495|FG000|Screening|Not eligible|56|||
163151654|NCT00774046|589269495|FG000|Enrollment|Desired other therapy/refused|28|||
163151655|NCT00774046|589269495|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
163151656|NCT00976274|589269496|FG000|Overall Study|Lost to Follow-up|5|||
163151657|NCT00976274|589269497|FG001|Overall Study|Lost to Follow-up|5|||
163410873|NCT04179175|590212936|FG000|Overall Study|Lost to Follow-up|5|||
163410874|NCT04179175|590212937|FG001|Overall Study|Lost to Follow-up|3|||
163410875|NCT04179175|590212938|FG002|Overall Study|Lost to Follow-up|2|||
163410876|NCT04179175|590212939|FG003|Overall Study|Lost to Follow-up|2|||
163410877|NCT04179175|590212940|FG004|Overall Study|Lost to Follow-up|4|||
163410878|NCT04179175|590212941|FG005|Overall Study|Lost to Follow-up|5|||
163410879|NCT04179175|590212936|FG000|Overall Study|Physician Decision|2|||
163410880|NCT04179175|590212937|FG001|Overall Study|Physician Decision|0|||
163410881|NCT04179175|590212938|FG002|Overall Study|Physician Decision|2|||
163410882|NCT04179175|590212939|FG003|Overall Study|Physician Decision|3|||
163410883|NCT04179175|590212940|FG004|Overall Study|Physician Decision|1|||
163410884|NCT04179175|590212941|FG005|Overall Study|Physician Decision|1|||
163410885|NCT04179175|590212936|FG000|Overall Study|Pregnancy|3|||
163410886|NCT04179175|590212937|FG001|Overall Study|Pregnancy|0|||
163410887|NCT04179175|590212938|FG002|Overall Study|Pregnancy|3|||
163410888|NCT04179175|590212939|FG003|Overall Study|Pregnancy|0|||
163410889|NCT04179175|590212940|FG004|Overall Study|Pregnancy|1|||
163410890|NCT04179175|590212941|FG005|Overall Study|Pregnancy|2|||
163410891|NCT04179175|590212936|FG000|Overall Study|Withdrawal by Subject|22|||
163410892|NCT04179175|590212937|FG001|Overall Study|Withdrawal by Subject|10|||
163410893|NCT04179175|590212938|FG002|Overall Study|Withdrawal by Subject|12|||
163410894|NCT04179175|590212939|FG003|Overall Study|Withdrawal by Subject|8|||
163410895|NCT04179175|590212940|FG004|Overall Study|Withdrawal by Subject|23|||
163410896|NCT04179175|590212941|FG005|Overall Study|Withdrawal by Subject|31|||
163410897|NCT04179175|590212936|FG000|Overall Study|Technical problems|0|||
163410898|NCT04179175|590212937|FG001|Overall Study|Technical problems|0|||
163410899|NCT04179175|590212938|FG002|Overall Study|Technical problems|1|||
163410900|NCT04179175|590212939|FG003|Overall Study|Technical problems|1|||
163410901|NCT04179175|590212940|FG004|Overall Study|Technical problems|0|||
163410902|NCT04179175|590212941|FG005|Overall Study|Technical problems|0|||
163410903|NCT03215030|590212946|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
163410904|NCT03215030|590212947|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
163410905|NCT03215030|590212948|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
163410906|NCT03215030|590212949|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
163410907|NCT03215030|590212950|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
163410908|NCT03215030|590212951|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
163151658|NCT00976274|589269496|FG000|Overall Study|Withdrawal by Subject|1|||
163256423|NCT00180479|589647063|FG000|Overall Study|Lost to Follow-up|9|||
163256424|NCT00180479|589647064|FG001|Overall Study|Lost to Follow-up|7|||
163256425|NCT00180479|589647063|FG000|Overall Study|Withdrawal by Subject|3|||
163256426|NCT00180479|589647064|FG001|Overall Study|Withdrawal by Subject|3|||
163256427|NCT00180479|589647063|FG000|Overall Study|Informed consent not signed|0|||
163256428|NCT00180479|589647064|FG001|Overall Study|Informed consent not signed|1|||
163256429|NCT03315143|589647069|FG000|Overall Study|Death|240|||
163256430|NCT03315143|589647070|FG001|Overall Study|Death|246|||
163256431|NCT03315143|589647069|FG000|Overall Study|Withdrawal by Subject|57|||
163256432|NCT03315143|589647070|FG001|Overall Study|Withdrawal by Subject|68|||
163256433|NCT03315143|589647069|FG000|Overall Study|Site Terminated by Sponsor|256|||
163256434|NCT03315143|589647070|FG001|Overall Study|Site Terminated by Sponsor|282|||
163256435|NCT03315143|589647069|FG000|Overall Study|Study Terminated by Sponsor|4723|||
163256436|NCT03315143|589647070|FG001|Overall Study|Study Terminated by Sponsor|4664|||
163256437|NCT03315143|589647069|FG000|Overall Study|Reason not Specified|16|||
163256438|NCT03315143|589647070|FG001|Overall Study|Reason not Specified|32|||
163256439|NCT00840801|589647071|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
163256440|NCT00840801|589647072|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
163256441|NCT00840801|589647073|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
163256442|NCT00840801|589647071|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
163256443|NCT00840801|589647072|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
163256444|NCT00840801|589647073|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
163256445|NCT00840801|589647071|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
163256446|NCT00840801|589647072|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
163256447|NCT00840801|589647073|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
163256448|NCT00840801|589647071|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
163256449|NCT00840801|589647072|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
163256450|NCT00840801|589647073|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
163256451|NCT00335452|589647074|FG000|Overall Study|Death|156|||
163256452|NCT00335452|589647075|FG001|Overall Study|Death|144|||
163256453|NCT00335452|589647076|FG002|Overall Study|Death|158|||
163256454|NCT00335452|589647077|FG003|Overall Study|Death|129|||
163256455|NCT00335452|589647074|FG000|Overall Study|Lost to Follow-up|2|||
163256456|NCT00335452|589647075|FG001|Overall Study|Lost to Follow-up|3|||
163256457|NCT00335452|589647076|FG002|Overall Study|Lost to Follow-up|1|||
163256458|NCT00335452|589647077|FG003|Overall Study|Lost to Follow-up|2|||
163256459|NCT02736825|589647078|FG000|Overall Study|Lost to Follow-up|10|||
163256460|NCT02736825|589647079|FG001|Overall Study|Lost to Follow-up|11|||
163256461|NCT02736825|589647078|FG000|Overall Study|Early Termination|0|||
163256462|NCT02736825|589647079|FG001|Overall Study|Early Termination|1|||
163256463|NCT00790452|589647080|FG000|Overall Study|Drug supply issue|1|||
163256464|NCT00790452|589647081|FG001|Overall Study|Drug supply issue|0|||
163256465|NCT02901626|589647082|FG000|Overall Study|Lost to Follow-up|1|||
163256466|NCT02901626|589647083|FG001|Overall Study|Lost to Follow-up|1|||
163256467|NCT04082884|589647084|FG000|Overall Study|Withdrawal by Subject|1|||
163256468|NCT02421666|589647087|FG000|6-month Follow-up|Lost to Follow-up|8|||
163256469|NCT02421666|589647088|FG001|6-month Follow-up|Lost to Follow-up|7|||
163256470|NCT02421666|589647087|FG000|6-month Follow-up|Withdrawal by Subject|5|||
163256471|NCT02421666|589647088|FG001|6-month Follow-up|Withdrawal by Subject|6|||
163256472|NCT02421666|589647087|FG000|12-month Follow-up|Lost to Follow-up|5|||
163256473|NCT02421666|589647088|FG001|12-month Follow-up|Lost to Follow-up|5|||
163256474|NCT02421666|589647087|FG000|12-month Follow-up|Withdrawal by Subject|6|||
163256475|NCT02421666|589647088|FG001|12-month Follow-up|Withdrawal by Subject|11|||
163256476|NCT01078155|589647090|FG000|Overall Study|Adverse Event|7|||
163256477|NCT01078155|589647090|FG000|Overall Study|Lack of Efficacy|16|||
163256478|NCT01078155|589647090|FG000|Overall Study|Participant's Decision|6|||
163410909|NCT03215030|590212952|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
163410910|NCT03215030|590212953|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
163410911|NCT03215030|590212954|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
163410912|NCT03215030|590212955|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
163256479|NCT01078155|589647090|FG000|Overall Study|Lost to Follow-up|15|||
163256480|NCT01621880|589647091|FG000|Overall Study|Adverse Event|5|||
163256481|NCT01621880|589647092|FG001|Overall Study|Adverse Event|1|||
163256482|NCT01621880|589647091|FG000|Overall Study|Withdrawal by Subject|5|||
163256483|NCT01621880|589647092|FG001|Overall Study|Withdrawal by Subject|4|||
163256484|NCT03701399|589647103|FG000|Overall Study|Adverse Event|3|||
163256485|NCT03701399|589647104|FG001|Overall Study|Adverse Event|5|||
163256486|NCT03701399|589647103|FG000|Overall Study|Withdrawal by Subject|6|||
163256487|NCT03701399|589647104|FG001|Overall Study|Withdrawal by Subject|3|||
163256488|NCT03701399|589647103|FG000|Overall Study|Investigators decision|1|||
163256489|NCT03701399|589647104|FG001|Overall Study|Investigators decision|2|||
163256490|NCT03701399|589647103|FG000|Overall Study|Lost to Follow-up|1|||
163256491|NCT03701399|589647104|FG001|Overall Study|Lost to Follow-up|2|||
163256492|NCT03701399|589647103|FG000|Overall Study|Death|1|||
163256493|NCT03701399|589647104|FG001|Overall Study|Death|1|||
163256494|NCT03701399|589647103|FG000|Overall Study|Randomized but not treated|1|||
163256495|NCT03701399|589647104|FG001|Overall Study|Randomized but not treated|0|||
163256496|NCT04179032|589647105|FG000|Part B (Up to Week 52)|Adverse Event|1|||
163256497|NCT04179032|589647105|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
163256498|NCT04179032|589647105|FG000|Access Extension Phase|Ongoing|11|||
163256499|NCT03945292|589647106|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
163256500|NCT03945292|589647107|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
163256501|NCT03945292|589647108|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
163256502|NCT03945292|589647109|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
163256503|NCT03945292|589647110|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
163256504|NCT03945292|589647111|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
163256505|NCT03945292|589647112|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
163256506|NCT03945292|589647113|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
163256507|NCT03945292|589647106|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
163256508|NCT03945292|589647107|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
163256509|NCT03945292|589647108|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
163256510|NCT03945292|589647109|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
163256511|NCT03945292|589647110|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
163256512|NCT03945292|589647111|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
163256513|NCT03945292|589647112|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
163256514|NCT03945292|589647113|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
163256515|NCT03945292|589647106|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
163256516|NCT03945292|589647107|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
163256517|NCT03945292|589647108|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
163256518|NCT03945292|589647109|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
163256519|NCT03945292|589647110|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
163256520|NCT03945292|589647111|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
163256521|NCT03945292|589647112|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
163256522|NCT03945292|589647113|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
163256523|NCT03033225|589647114|FG000|Overall Study|Withdrawal by Subject|5|||
163256524|NCT00946296|589647115|FG000|Overall Study|Physician Decision|3|||
163256525|NCT00946296|589647116|FG001|Overall Study|Physician Decision|0|||
163256526|NCT01368965|589647119|FG000|Overall Study|Lost to Follow-up|12|||
163256527|NCT02618967|589647120|FG000|Overall Study|Lost to Follow-up|0|||
163256528|NCT02618967|589647121|FG001|Overall Study|Lost to Follow-up|0|||
163256529|NCT02618967|589647122|FG002|Overall Study|Lost to Follow-up|1|||
163256530|NCT02618967|589647123|FG003|Overall Study|Lost to Follow-up|0|||
163256531|NCT02618967|589647124|FG004|Overall Study|Lost to Follow-up|2|||
163256532|NCT02618967|589647125|FG005|Overall Study|Lost to Follow-up|0|||
163256533|NCT02618967|589647126|FG006|Overall Study|Lost to Follow-up|0|||
163256534|NCT02618967|589647127|FG007|Overall Study|Lost to Follow-up|0|||
163256535|NCT02618967|589647120|FG000|Overall Study|Withdrawal by Subject|1|||
163256536|NCT02618967|589647121|FG001|Overall Study|Withdrawal by Subject|0|||
163256537|NCT02618967|589647122|FG002|Overall Study|Withdrawal by Subject|0|||
163256538|NCT02618967|589647123|FG003|Overall Study|Withdrawal by Subject|0|||
163256539|NCT02618967|589647124|FG004|Overall Study|Withdrawal by Subject|0|||
163256540|NCT02618967|589647125|FG005|Overall Study|Withdrawal by Subject|0|||
163256541|NCT02618967|589647126|FG006|Overall Study|Withdrawal by Subject|0|||
163256542|NCT02618967|589647127|FG007|Overall Study|Withdrawal by Subject|0|||
163256543|NCT06060457|589647128|FG000|Overall Study|Adverse Event|1|||
163256544|NCT06060457|589647129|FG001|Overall Study|Adverse Event|1|||
163256545|NCT06060457|589647128|FG000|Overall Study|Death|2|||
163256546|NCT06060457|589647129|FG001|Overall Study|Death|2|||
163256547|NCT06060457|589647128|FG000|Overall Study|Lost to Follow-up|17|||
163256548|NCT06060457|589647129|FG001|Overall Study|Lost to Follow-up|19|||
163256549|NCT06060457|589647128|FG000|Overall Study|Physician Decision|0|||
163256550|NCT06060457|589647129|FG001|Overall Study|Physician Decision|1|||
163256551|NCT06060457|589647128|FG000|Overall Study|Protocol Violation|1|||
163256552|NCT06060457|589647129|FG001|Overall Study|Protocol Violation|1|||
163256553|NCT06060457|589647128|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
163256554|NCT06060457|589647129|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
163256555|NCT06060457|589647128|FG000|Overall Study|Withdrawal by Subject|12|||
163256556|NCT06060457|589647129|FG001|Overall Study|Withdrawal by Subject|15|||
163361066|NCT02563548|590031636|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
163256557|NCT06060457|589647128|FG000|Overall Study|Other Than Specified|2|||
163256558|NCT06060457|589647129|FG001|Overall Study|Other Than Specified|1|||
163256559|NCT00569582|589647143|FG000|Overall Study|Withdrawal by Subject|5|||
163256560|NCT00569582|589647143|FG000|Overall Study|Death|2|||
163256561|NCT00569582|589647143|FG000|Overall Study|Adverse Event|7|||
163256562|NCT00569582|589647143|FG000|Overall Study|Subject was too ill to travel.|1|||
163256563|NCT00569582|589647143|FG000|Overall Study|Subject was non-compliant.|1|||
163256564|NCT05103384|589647146|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
163361067|NCT02563548|590031637|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
163256565|NCT02612311|589647147|FG000|Overall Study|Adverse Event|16|||
163256566|NCT02612311|589647148|FG001|Overall Study|Adverse Event|12|||
163256567|NCT02612311|589647149|FG002|Overall Study|Adverse Event|7|||
163256568|NCT02612311|589647150|FG003|Overall Study|Adverse Event|13|||
163256569|NCT02612311|589647147|FG000|Overall Study|Death|29|||
163256570|NCT02612311|589647148|FG001|Overall Study|Death|10|||
163256571|NCT02612311|589647149|FG002|Overall Study|Death|11|||
163256572|NCT02612311|589647150|FG003|Overall Study|Death|11|||
163256573|NCT02612311|589647147|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
163256574|NCT02612311|589647148|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
163256575|NCT02612311|589647149|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
163256576|NCT02612311|589647150|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
163256577|NCT02612311|589647147|FG000|Overall Study|Investigator's Decision|11|||
163256578|NCT02612311|589647148|FG001|Overall Study|Investigator's Decision|15|||
163256579|NCT02612311|589647149|FG002|Overall Study|Investigator's Decision|6|||
163256580|NCT02612311|589647150|FG003|Overall Study|Investigator's Decision|6|||
163256581|NCT02612311|589647147|FG000|Overall Study|Lack of Efficacy|0|||
163256582|NCT02612311|589647148|FG001|Overall Study|Lack of Efficacy|0|||
163256583|NCT02612311|589647149|FG002|Overall Study|Lack of Efficacy|1|||
163256584|NCT02612311|589647150|FG003|Overall Study|Lack of Efficacy|1|||
163256585|NCT02612311|589647147|FG000|Overall Study|Lost to Follow-up|2|||
163256586|NCT02612311|589647148|FG001|Overall Study|Lost to Follow-up|2|||
163256587|NCT02612311|589647149|FG002|Overall Study|Lost to Follow-up|1|||
163256588|NCT02612311|589647150|FG003|Overall Study|Lost to Follow-up|2|||
163256589|NCT02612311|589647147|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
163256590|NCT02612311|589647148|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
163256591|NCT02612311|589647149|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
163256592|NCT02612311|589647150|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
163256593|NCT02612311|589647147|FG000|Overall Study|Site Terminated by Sponsor|29|||
163361068|NCT02563548|590031638|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
163361069|NCT02563548|590031639|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
163361070|NCT02563548|590031634|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
163361071|NCT02563548|590031635|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
163361072|NCT02563548|590031636|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
163361073|NCT02563548|590031637|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
163361074|NCT02563548|590031638|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
163361075|NCT02563548|590031639|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
163361076|NCT02563548|590031634|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
163361077|NCT02563548|590031635|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
163361078|NCT02563548|590031636|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
163361079|NCT02563548|590031637|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
163361080|NCT02563548|590031638|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
163361081|NCT02563548|590031639|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
163361082|NCT02563548|590031634|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
163361083|NCT02563548|590031635|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
163361084|NCT02563548|590031636|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
163361085|NCT02563548|590031637|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
163361086|NCT02563548|590031638|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
163361087|NCT02563548|590031639|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
163361088|NCT02563548|590031634|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
163361089|NCT02563548|590031635|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
163361090|NCT02563548|590031636|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
163361091|NCT02563548|590031637|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
163361092|NCT02563548|590031638|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
163361093|NCT02563548|590031639|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
163361094|NCT02563548|590031634|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
163361095|NCT02563548|590031635|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
163361096|NCT02563548|590031636|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
163361097|NCT02563548|590031637|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
163361098|NCT02563548|590031638|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
163361099|NCT02563548|590031639|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
163361100|NCT02563548|590031634|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
163410913|NCT03215030|590212956|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
163410914|NCT03215030|590212957|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
163410915|NCT03215030|590212946|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
163410916|NCT03215030|590212947|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163410917|NCT03215030|590212948|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163256594|NCT02612311|589647148|FG001|Overall Study|Site Terminated by Sponsor|12|||
163256595|NCT02612311|589647149|FG002|Overall Study|Site Terminated by Sponsor|13|||
163256596|NCT02612311|589647150|FG003|Overall Study|Site Terminated by Sponsor|5|||
163256597|NCT02612311|589647147|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
163256598|NCT02612311|589647148|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
163256599|NCT02612311|589647149|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
163256600|NCT02612311|589647150|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
163256601|NCT02612311|589647147|FG000|Overall Study|Reason Not Specified|3|||
163256602|NCT02612311|589647148|FG001|Overall Study|Reason Not Specified|7|||
163256603|NCT02612311|589647149|FG002|Overall Study|Reason Not Specified|4|||
163256604|NCT02612311|589647150|FG003|Overall Study|Reason Not Specified|5|||
163256605|NCT02612311|589647147|FG000|Overall Study|Unknown/Missing|10|||
163256606|NCT02612311|589647148|FG001|Overall Study|Unknown/Missing|13|||
163256607|NCT02612311|589647149|FG002|Overall Study|Unknown/Missing|4|||
163256608|NCT02612311|589647150|FG003|Overall Study|Unknown/Missing|0|||
163256609|NCT02612311|589647147|FG000|Overall Study|Non-Compliance with Study|1|||
163256610|NCT02612311|589647148|FG001|Overall Study|Non-Compliance with Study|0|||
163256611|NCT02612311|589647149|FG002|Overall Study|Non-Compliance with Study|0|||
163256612|NCT02612311|589647150|FG003|Overall Study|Non-Compliance with Study|0|||
163256613|NCT00514735|589647154|FG000|Overall Study|Withdrawal by Subject|13|||
163256614|NCT00514735|589647155|FG001|Overall Study|Withdrawal by Subject|5|||
163256615|NCT00514735|589647154|FG000|Overall Study|Death|1|||
163256616|NCT00514735|589647155|FG001|Overall Study|Death|0|||
163256617|NCT00514735|589647154|FG000|Overall Study|Lost to Follow-up|0|||
163256618|NCT00514735|589647155|FG001|Overall Study|Lost to Follow-up|1|||
163256619|NCT04751942|589647157|FG000|Overall Study|Lost to Follow-up|9|||
163256620|NCT04751942|589647158|FG001|Overall Study|Lost to Follow-up|6|||
163256621|NCT04510675|589647159|FG000|Overall Study|Withdrawal by Subject|5|||
163256622|NCT01499082|589647160|FG000|Overall Study|Randomized but not Treated|0|||
163256623|NCT01499082|589647161|FG001|Overall Study|Randomized but not Treated|1|||
163256624|NCT01499082|589647160|FG000|Overall Study|Adverse Event|12|||
163256625|NCT01499082|589647161|FG001|Overall Study|Adverse Event|16|||
163256626|NCT01499082|589647160|FG000|Overall Study|Lack of Efficacy|1|||
163256627|NCT01499082|589647161|FG001|Overall Study|Lack of Efficacy|1|||
163256628|NCT01499082|589647160|FG000|Overall Study|Protocol Violation|6|||
163256629|NCT01499082|589647161|FG001|Overall Study|Protocol Violation|8|||
163256630|NCT01499082|589647160|FG000|Overall Study|Diverse Reasons|18|||
163256631|NCT01499082|589647161|FG001|Overall Study|Diverse Reasons|14|||
163256632|NCT01499082|589647160|FG000|Overall Study|Site Closure for Noncompliance|5|||
163256633|NCT01499082|589647161|FG001|Overall Study|Site Closure for Noncompliance|2|||
163256634|NCT01499082|589647160|FG000|Overall Study|Hypoglycemia|2|||
163256635|NCT01499082|589647161|FG001|Overall Study|Hypoglycemia|3|||
163256636|NCT01499082|589647160|FG000|Overall Study|Lost to Follow-up|1|||
163256637|NCT01499082|589647161|FG001|Overall Study|Lost to Follow-up|3|||
163256638|NCT00500903|589647172|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
163256639|NCT00500903|589647173|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
163256640|NCT00500903|589647174|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
163256641|NCT00500903|589647172|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
163256642|NCT00500903|589647173|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
163256643|NCT00500903|589647174|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
163256644|NCT00500903|589647172|FG000|Overall Study|Progressive Disease|41|||
163256645|NCT00500903|589647173|FG001|Overall Study|Progressive Disease|2|||
163256646|NCT00500903|589647174|FG002|Overall Study|Progressive Disease|15|||
163256647|NCT00500903|589647172|FG000|Overall Study|Patient Declined Further Treatment|0|||
163256648|NCT00500903|589647173|FG001|Overall Study|Patient Declined Further Treatment|0|||
163256649|NCT00500903|589647174|FG002|Overall Study|Patient Declined Further Treatment|3|||
163256650|NCT00500903|589647172|FG000|Overall Study|Symptomatic Deterioration|2|||
163256651|NCT00500903|589647173|FG001|Overall Study|Symptomatic Deterioration|0|||
163256652|NCT00500903|589647174|FG002|Overall Study|Symptomatic Deterioration|0|||
163256653|NCT00500903|589647172|FG000|Overall Study|Reason Not Specified|10|||
163256654|NCT00500903|589647173|FG001|Overall Study|Reason Not Specified|0|||
163256655|NCT00500903|589647174|FG002|Overall Study|Reason Not Specified|2|||
163256656|NCT00522626|589647178|FG000|Overall Study|Lost to Follow-up|7|||
163256657|NCT00803452|589647179|FG000|Overall Study|Adverse Event|0|||
163256658|NCT00803452|589647180|FG001|Overall Study|Adverse Event|2|||
163256659|NCT00803452|589647179|FG000|Overall Study|Lost to Follow-up|0|||
163256660|NCT00803452|589647180|FG001|Overall Study|Lost to Follow-up|3|||
163256661|NCT02365519|589647182|FG000|Randomized and Treated|Adverse Event|0|||
163256662|NCT02365519|589647183|FG001|Randomized and Treated|Adverse Event|1|||
163256663|NCT02365519|589647184|FG002|Randomized and Treated|Adverse Event|0|||
163256664|NCT02365519|589647182|FG000|Randomized and Treated|Withdrawal by Subject|0|||
163256665|NCT02365519|589647183|FG001|Randomized and Treated|Withdrawal by Subject|1|||
163256666|NCT02365519|589647184|FG002|Randomized and Treated|Withdrawal by Subject|1|||
163256667|NCT01971723|589647185|FG000|Overall Study|Withdrawal by Subject|1|||
163256668|NCT01971723|589647186|FG001|Overall Study|Withdrawal by Subject|1|||
163256669|NCT01971723|589647185|FG000|Overall Study|Protocol Violation|1|||
163256670|NCT01971723|589647186|FG001|Overall Study|Protocol Violation|2|||
163256671|NCT03017079|589647187|FG000|Overall Study|Physician Decision|1|||
163256672|NCT03017079|589647188|FG001|Overall Study|Physician Decision|1|||
163256673|NCT03017079|589647187|FG000|Overall Study|Death|3|||
163410918|NCT03215030|590212949|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
163410919|NCT03215030|590212950|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163410920|NCT03215030|590212951|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163410921|NCT03215030|590212952|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163410922|NCT03215030|590212953|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163410923|NCT03215030|590212954|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163410924|NCT03215030|590212955|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163410925|NCT03215030|590212956|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163410926|NCT03215030|590212957|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163410927|NCT03215030|590212946|FG000|Part 1: Dose Escalation|Death|15|||
163410928|NCT03215030|590212947|FG001|Part 1: Dose Escalation|Death|6|||
163410929|NCT03215030|590212948|FG002|Part 1: Dose Escalation|Death|6|||
163410930|NCT03215030|590212949|FG003|Part 1: Dose Escalation|Death|8|||
163410931|NCT03215030|590212950|FG004|Part 1: Dose Escalation|Death|0|||
163410932|NCT03215030|590212951|FG005|Part 1: Dose Escalation|Death|0|||
163410933|NCT03215030|590212952|FG006|Part 1: Dose Escalation|Death|0|||
163410934|NCT03215030|590212953|FG007|Part 1: Dose Escalation|Death|0|||
163410935|NCT03215030|590212954|FG008|Part 1: Dose Escalation|Death|0|||
163410936|NCT03215030|590212955|FG009|Part 1: Dose Escalation|Death|0|||
163256674|NCT03017079|589647188|FG001|Overall Study|Death|2|||
163256675|NCT03017079|589647187|FG000|Overall Study|Lack of Efficacy|2|||
163256676|NCT03017079|589647188|FG001|Overall Study|Lack of Efficacy|2|||
163256677|NCT03017079|589647187|FG000|Overall Study|Protocol Violation|0|||
163256678|NCT03017079|589647188|FG001|Overall Study|Protocol Violation|1|||
163256679|NCT01255592|589648789|FG000|Overall Study|Adverse Event|5|||
163256680|NCT01255592|589648790|FG001|Overall Study|Adverse Event|0|||
163256681|NCT01255592|589648789|FG000|Overall Study|Withdrawal by Subject|1|||
163256682|NCT01255592|589648790|FG001|Overall Study|Withdrawal by Subject|0|||
163256683|NCT01255592|589648789|FG000|Overall Study|Other|0|||
163256684|NCT01255592|589648790|FG001|Overall Study|Other|1|||
163256685|NCT02882282|589648791|FG000|Overall Study|Adverse Event|1|||
163256686|NCT02882282|589648792|FG001|Overall Study|Adverse Event|0|||
163256687|NCT03928028|589648793|FG000|Overall Study|Physician Decision|9|||
163410937|NCT03215030|590212956|FG010|Part 1: Dose Escalation|Death|0|||
163410938|NCT03215030|590212957|FG011|Part 1: Dose Escalation|Death|0|||
163410939|NCT03215030|590212946|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
163410940|NCT03215030|590212947|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
163410941|NCT03215030|590212948|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
163410942|NCT03215030|590212949|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
163410943|NCT03215030|590212950|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
163410944|NCT03215030|590212951|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
163410945|NCT03215030|590212952|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
163410946|NCT03215030|590212953|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
163410947|NCT03215030|590212954|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
163410948|NCT03215030|590212955|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
163410949|NCT03215030|590212956|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
163410950|NCT03215030|590212957|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
163410951|NCT03215030|590212946|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163151659|NCT00976274|589269497|FG001|Overall Study|Withdrawal by Subject|1|||
163151660|NCT00976274|589269496|FG000|Overall Study|Physician Decision|1|||
163151661|NCT00976274|589269497|FG001|Overall Study|Physician Decision|2|||
163151662|NCT01614249|589269499|FG000|Overall Study|Lost to Follow-up|11|||
163151663|NCT01614249|589269500|FG001|Overall Study|Lost to Follow-up|23|||
163151664|NCT02954536|589269501|FG000|Overall Study|Adverse Event|2|||
163151665|NCT02954536|589269501|FG000|Overall Study|Death|12|||
163151666|NCT05498649|589269502|FG000|Overall Study|Lost to Follow-up|1|||
163151667|NCT02946580|589269503|FG000|Overall Study|Withdrawal by Subject|1|||
163151668|NCT02946580|589269504|FG001|Overall Study|Withdrawal by Subject|2|||
163151669|NCT02946580|589269503|FG000|Overall Study|Adverse Event|0|||
163151670|NCT02946580|589269504|FG001|Overall Study|Adverse Event|2|||
163151671|NCT02946580|589269503|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
163151672|NCT02946580|589269504|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
163151673|NCT03094416|589269505|FG000|Run-in|Screening failure|8|||
163151674|NCT03094416|589269505|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
163151675|NCT03094416|589269505|FG000|Run-in|Withdrawal by Subject|3|||
163151676|NCT03094416|589269505|FG000|Treatment Period|Withdrawal by Subject|2|||
163151677|NCT00321789|589269508|FG000|Overall Study|Lost to Follow-up|4|||
163151678|NCT00321789|589269509|FG001|Overall Study|Lost to Follow-up|7|||
163151679|NCT00321789|589269508|FG000|Overall Study|Withdrawal by Subject|6|||
163151680|NCT00321789|589269509|FG001|Overall Study|Withdrawal by Subject|6|||
163151681|NCT00321789|589269508|FG000|Overall Study|Protocol Violation|5|||
163151682|NCT00321789|589269509|FG001|Overall Study|Protocol Violation|3|||
163256688|NCT03928028|589648794|FG001|Overall Study|Physician Decision|6|||
163256689|NCT03928028|589648795|FG002|Overall Study|Physician Decision|3|||
163361101|NCT02563548|590031635|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
163361102|NCT02563548|590031636|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
163151683|NCT00005780|589269510|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
163151684|NCT00374140|589269511|FG000|Overall Study|Lost to Follow-up|1|||
163151685|NCT00374140|589269511|FG000|Overall Study|Protocol Violation|1|||
163151686|NCT02485691|589269512|FG000|Overall Study|Adverse Event|25|||
163151687|NCT02485691|589269513|FG001|Overall Study|Adverse Event|11|||
163151688|NCT02485691|589269512|FG000|Overall Study|Poor compliance to protocol|0|||
163151689|NCT02485691|589269513|FG001|Overall Study|Poor compliance to protocol|1|||
163151690|NCT02485691|589269512|FG000|Overall Study|Disease progression|57|||
163151691|NCT02485691|589269513|FG001|Overall Study|Disease progression|92|||
163151692|NCT02485691|589269512|FG000|Overall Study|Investigator's decision|23|||
163151693|NCT02485691|589269513|FG001|Overall Study|Investigator's decision|5|||
163151694|NCT02485691|589269512|FG000|Overall Study|Participant's request|13|||
163151695|NCT02485691|589269513|FG001|Overall Study|Participant's request|6|||
163151696|NCT02485691|589269512|FG000|Overall Study|Other reason|8|||
163151697|NCT02485691|589269513|FG001|Overall Study|Other reason|9|||
163151698|NCT02485691|589269512|FG000|Overall Study|Randomized and not treated|3|||
163151699|NCT02485691|589269513|FG001|Overall Study|Randomized and not treated|2|||
163151700|NCT04292535|589269514|FG000|Overall Study|Withdrawal by Subject|0|||
163151701|NCT04292535|589269515|FG001|Overall Study|Withdrawal by Subject|0|||
163151702|NCT04292535|589269516|FG002|Overall Study|Withdrawal by Subject|0|||
163151703|NCT04292535|589269517|FG003|Overall Study|Withdrawal by Subject|0|||
163151704|NCT04292535|589269518|FG004|Overall Study|Withdrawal by Subject|0|||
163151705|NCT04292535|589269519|FG005|Overall Study|Withdrawal by Subject|0|||
163151706|NCT04292535|589269520|FG006|Overall Study|Withdrawal by Subject|0|||
163151707|NCT04292535|589269521|FG007|Overall Study|Withdrawal by Subject|1|||
163151708|NCT04292535|589269522|FG008|Overall Study|Withdrawal by Subject|0|||
163151709|NCT04292535|589269523|FG009|Overall Study|Withdrawal by Subject|0|||
163151710|NCT04292535|589269524|FG010|Overall Study|Withdrawal by Subject|0|||
163151711|NCT04292535|589269525|FG011|Overall Study|Withdrawal by Subject|0|||
163151712|NCT04292535|589269526|FG012|Overall Study|Withdrawal by Subject|0|||
163151713|NCT04292535|589269527|FG013|Overall Study|Withdrawal by Subject|0|||
163151714|NCT04292535|589269514|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151715|NCT04292535|589269515|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151716|NCT04292535|589269516|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151717|NCT04292535|589269517|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151718|NCT04292535|589269518|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151719|NCT04292535|589269519|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151720|NCT04292535|589269520|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151721|NCT04292535|589269521|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
163151722|NCT04292535|589269522|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151723|NCT04292535|589269523|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151724|NCT04292535|589269524|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151725|NCT04292535|589269525|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151726|NCT04292535|589269526|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
163151727|NCT04292535|589269527|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
163151728|NCT04292535|589269514|FG000|Overall Study|Report of Dizziness|0|||
163151729|NCT04292535|589269515|FG001|Overall Study|Report of Dizziness|0|||
163151730|NCT04292535|589269516|FG002|Overall Study|Report of Dizziness|0|||
163151731|NCT04292535|589269517|FG003|Overall Study|Report of Dizziness|0|||
163151732|NCT04292535|589269518|FG004|Overall Study|Report of Dizziness|0|||
163151733|NCT04292535|589269519|FG005|Overall Study|Report of Dizziness|0|||
163151734|NCT04292535|589269520|FG006|Overall Study|Report of Dizziness|0|||
163151735|NCT04292535|589269521|FG007|Overall Study|Report of Dizziness|0|||
163151736|NCT04292535|589269522|FG008|Overall Study|Report of Dizziness|0|||
163151737|NCT04292535|589269523|FG009|Overall Study|Report of Dizziness|0|||
163151738|NCT04292535|589269524|FG010|Overall Study|Report of Dizziness|0|||
163151739|NCT04292535|589269525|FG011|Overall Study|Report of Dizziness|0|||
163151740|NCT04292535|589269526|FG012|Overall Study|Report of Dizziness|0|||
163151741|NCT04292535|589269527|FG013|Overall Study|Report of Dizziness|1|||
163151742|NCT04292535|589269514|FG000|Overall Study|Equipment Failure|0|||
163151743|NCT04292535|589269515|FG001|Overall Study|Equipment Failure|0|||
163151744|NCT04292535|589269516|FG002|Overall Study|Equipment Failure|0|||
163151745|NCT04292535|589269517|FG003|Overall Study|Equipment Failure|0|||
163151746|NCT04292535|589269518|FG004|Overall Study|Equipment Failure|0|||
163151747|NCT04292535|589269519|FG005|Overall Study|Equipment Failure|0|||
163151748|NCT04292535|589269520|FG006|Overall Study|Equipment Failure|0|||
163151749|NCT04292535|589269521|FG007|Overall Study|Equipment Failure|0|||
163151750|NCT04292535|589269522|FG008|Overall Study|Equipment Failure|0|||
163151751|NCT04292535|589269523|FG009|Overall Study|Equipment Failure|0|||
163151752|NCT04292535|589269524|FG010|Overall Study|Equipment Failure|0|||
163151753|NCT04292535|589269525|FG011|Overall Study|Equipment Failure|1|||
163151754|NCT04292535|589269526|FG012|Overall Study|Equipment Failure|0|||
163410952|NCT03215030|590212947|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163410953|NCT03215030|590212948|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163410954|NCT03215030|590212949|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163410955|NCT03215030|590212950|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163256690|NCT03928028|589648793|FG000|Overall Study|Withdrawal by Subject|12|||
163256691|NCT03928028|589648794|FG001|Overall Study|Withdrawal by Subject|3|||
163256692|NCT03928028|589648795|FG002|Overall Study|Withdrawal by Subject|3|||
163256693|NCT02710292|589648802|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
163256694|NCT02710292|589648803|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
163256695|NCT02710292|589648802|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
163256696|NCT02710292|589648803|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
163256697|NCT02323646|589648814|FG000|Treatment Course 1|Adverse Event|1|||
163256698|NCT02323646|589648815|FG001|Treatment Course 1|Adverse Event|0|||
163256699|NCT02323646|589648816|FG002|Treatment Course 1|Adverse Event|1|||
163256700|NCT02323646|589648814|FG000|Treatment Course 1|Heavy Bleeding|1|||
163256701|NCT02323646|589648815|FG001|Treatment Course 1|Heavy Bleeding|1|||
163256702|NCT02323646|589648816|FG002|Treatment Course 1|Heavy Bleeding|0|||
163256703|NCT02323646|589648814|FG000|Treatment Course 1|Lost to Follow-up|1|||
163256704|NCT02323646|589648815|FG001|Treatment Course 1|Lost to Follow-up|0|||
163256705|NCT02323646|589648816|FG002|Treatment Course 1|Lost to Follow-up|2|||
163256706|NCT02323646|589648814|FG000|Treatment Course 1|Withdrawal by Subject|0|||
163256707|NCT02323646|589648815|FG001|Treatment Course 1|Withdrawal by Subject|2|||
163256708|NCT02323646|589648816|FG002|Treatment Course 1|Withdrawal by Subject|0|||
163256709|NCT02323646|589648814|FG000|Treatment Course 2|Adverse Event|1|||
163256710|NCT02323646|589648815|FG001|Treatment Course 2|Adverse Event|0|||
163256711|NCT02323646|589648816|FG002|Treatment Course 2|Adverse Event|1|||
163256712|NCT02323646|589648814|FG000|Treatment Course 2|Lost to Follow-up|0|||
163256713|NCT02323646|589648815|FG001|Treatment Course 2|Lost to Follow-up|0|||
163256714|NCT02323646|589648816|FG002|Treatment Course 2|Lost to Follow-up|1|||
163256715|NCT02323646|589648814|FG000|Treatment Course 2|Non-compliance|0|||
163256716|NCT02323646|589648815|FG001|Treatment Course 2|Non-compliance|1|||
163256717|NCT02323646|589648816|FG002|Treatment Course 2|Non-compliance|1|||
163256718|NCT00089141|589648817|FG000|Overall Study|Termination of trial|18|||
163256719|NCT00089141|589648818|FG001|Overall Study|Termination of trial|24|||
163256720|NCT02459262|589648821|FG000|Overall Study|Withdrawal by Subject|0|||
163256721|NCT02459262|589648822|FG001|Overall Study|Withdrawal by Subject|0|||
163256722|NCT02459262|589648823|FG002|Overall Study|Withdrawal by Subject|0|||
163256723|NCT02459262|589648824|FG003|Overall Study|Withdrawal by Subject|0|||
163256724|NCT02459262|589648825|FG004|Overall Study|Withdrawal by Subject|0|||
163256725|NCT02459262|589648826|FG005|Overall Study|Withdrawal by Subject|0|||
163256726|NCT02459262|589648827|FG006|Overall Study|Withdrawal by Subject|0|||
163256727|NCT02459262|589648828|FG007|Overall Study|Withdrawal by Subject|0|||
163256728|NCT02459262|589648829|FG008|Overall Study|Withdrawal by Subject|0|||
163256729|NCT02459262|589648830|FG009|Overall Study|Withdrawal by Subject|1|||
163256730|NCT02459262|589648831|FG010|Overall Study|Withdrawal by Subject|0|||
163256731|NCT05168579|589648832|FG000|Overall Study|Lack of Consent|1|||
163256732|NCT05168579|589648833|FG001|Overall Study|Lack of Consent|0|||
163256733|NCT05168579|589648832|FG000|Overall Study|Conflicts with time|2|||
163256734|NCT05168579|589648833|FG001|Overall Study|Conflicts with time|0|||
163256735|NCT05168579|589648832|FG000|Overall Study|Time slots were full|3|||
163256736|NCT05168579|589648833|FG001|Overall Study|Time slots were full|0|||
163256737|NCT05168579|589648832|FG000|Overall Study|Lost to Follow-up|0|||
163256738|NCT05168579|589648833|FG001|Overall Study|Lost to Follow-up|15|||
163256739|NCT01242748|589648834|FG000|Overall Study|Adverse Event|10|||
163256740|NCT01242748|589648835|FG001|Overall Study|Adverse Event|5|||
163256741|NCT01242748|589648834|FG000|Overall Study|Lost to Follow-up|6|||
163256742|NCT01242748|589648835|FG001|Overall Study|Lost to Follow-up|2|||
163256743|NCT01242748|589648834|FG000|Overall Study|Physician Decision|3|||
163256744|NCT01242748|589648835|FG001|Overall Study|Physician Decision|2|||
163256745|NCT01242748|589648834|FG000|Overall Study|Protocol Violation|1|||
163256746|NCT01242748|589648835|FG001|Overall Study|Protocol Violation|0|||
163256747|NCT01242748|589648834|FG000|Overall Study|Withdrawal by Subject|10|||
163256748|NCT01242748|589648835|FG001|Overall Study|Withdrawal by Subject|2|||
163410956|NCT03215030|590212951|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163256749|NCT01242748|589648834|FG000|Overall Study|Miscellaneous reasons|8|||
163256750|NCT01242748|589648835|FG001|Overall Study|Miscellaneous reasons|3|||
163256751|NCT00387894|589648836|FG000|Overall Study|Withdrawal by Subject|1|||
163256752|NCT00659490|589648839|FG000|Overall Study|Lost to Follow-up|2|||
163256753|NCT00659490|589648840|FG001|Overall Study|Lost to Follow-up|0|||
163256754|NCT00659490|589648841|FG002|Overall Study|Lost to Follow-up|1|||
163256755|NCT00827541|589648842|FG000|Overall Study|Exitus|1|||
163256756|NCT00827541|589648843|FG001|Overall Study|Exitus|8|||
163256757|NCT00827541|589648842|FG000|Overall Study|Other|1|||
163256758|NCT00827541|589648843|FG001|Overall Study|Other|3|||
163256759|NCT00827541|589648842|FG000|Overall Study|Pathogen not susceptible|1|||
163256760|NCT00827541|589648843|FG001|Overall Study|Pathogen not susceptible|0|||
163256761|NCT00827541|589648842|FG000|Overall Study|Lack of effectiveness|1|||
163256762|NCT00827541|589648843|FG001|Overall Study|Lack of effectiveness|0|||
163256763|NCT01649232|589648844|FG000|Overall Study|Physician Decision|2|||
163256764|NCT01649232|589648845|FG001|Overall Study|Physician Decision|0|||
163256765|NCT01750879|589648846|FG000|Overall Study|Adverse Event|8|||
163256766|NCT01750879|589648847|FG001|Overall Study|Adverse Event|0|||
163256767|NCT01750879|589648846|FG000|Overall Study|Lack of Efficacy|1|||
163256768|NCT01750879|589648847|FG001|Overall Study|Lack of Efficacy|0|||
163256769|NCT01750879|589648846|FG000|Overall Study|Withdrawal by Subject|1|||
163256770|NCT01750879|589648847|FG001|Overall Study|Withdrawal by Subject|0|||
163256771|NCT01750879|589648846|FG000|Overall Study|Did not complete per protocol|0|||
163256772|NCT01750879|589648847|FG001|Overall Study|Did not complete per protocol|3|||
163256773|NCT02347657|589648848|FG000|Overall Study|Physician Decision|0|||
163256774|NCT02347657|589648849|FG001|Overall Study|Physician Decision|1|||
163256775|NCT02347657|589648848|FG000|Overall Study|Adverse Event|8|||
163256776|NCT02347657|589648849|FG001|Overall Study|Adverse Event|4|||
163256777|NCT02347657|589648848|FG000|Overall Study|Withdrawal by Subject|6|||
163256778|NCT02347657|589648849|FG001|Overall Study|Withdrawal by Subject|7|||
163256779|NCT02347657|589648848|FG000|Overall Study|Randomized but not treated|1|||
163256780|NCT02347657|589648849|FG001|Overall Study|Randomized but not treated|0|||
163256781|NCT02347657|589648848|FG000|Overall Study|Other|3|||
163256782|NCT02347657|589648849|FG001|Overall Study|Other|3|||
163256783|NCT00677352|589648852|FG000|Treatment Phase|Adverse Event|14|||
163256784|NCT00677352|589648853|FG001|Treatment Phase|Adverse Event|22|||
163256785|NCT00677352|589648852|FG000|Treatment Phase|Lack of Efficacy|2|||
163256786|NCT00677352|589648853|FG001|Treatment Phase|Lack of Efficacy|3|||
163256787|NCT00677352|589648852|FG000|Treatment Phase|Lost to Follow-up|0|||
163256788|NCT00677352|589648853|FG001|Treatment Phase|Lost to Follow-up|1|||
163256789|NCT00677352|589648852|FG000|Treatment Phase|Withdrawal by Subject|7|||
163256790|NCT00677352|589648853|FG001|Treatment Phase|Withdrawal by Subject|7|||
163256791|NCT00677352|589648852|FG000|Treatment Phase|Physician Decision|1|||
163256792|NCT00677352|589648853|FG001|Treatment Phase|Physician Decision|0|||
163256793|NCT00677352|589648852|FG000|Treatment Phase|Pregnancy|0|||
163256794|NCT00677352|589648853|FG001|Treatment Phase|Pregnancy|1|||
163256795|NCT00677352|589648852|FG000|Treatment Phase|Protocol Violation|1|||
163256796|NCT00677352|589648853|FG001|Treatment Phase|Protocol Violation|1|||
163256797|NCT00677352|589648852|FG000|Treatment Phase|Transference or work related matter|0|||
163256798|NCT00677352|589648853|FG001|Treatment Phase|Transference or work related matter|5|||
163256799|NCT00677352|589648852|FG000|Treatment Phase|Not treated|0|||
163256800|NCT00677352|589648853|FG001|Treatment Phase|Not treated|2|||
163256801|NCT00677352|589648852|FG000|Tapering Phase|Adverse Event|1|||
163256802|NCT00677352|589648853|FG001|Tapering Phase|Adverse Event|5|||
163256803|NCT00677352|589648852|FG000|Tapering Phase|Withdrawal by Subject|5|||
163256804|NCT00677352|589648853|FG001|Tapering Phase|Withdrawal by Subject|3|||
163256805|NCT00677352|589648852|FG000|Tapering Phase|Pregnancy|0|||
163256806|NCT00677352|589648853|FG001|Tapering Phase|Pregnancy|1|||
163256807|NCT00677352|589648852|FG000|Tapering Phase|Job transfer|0|||
163256808|NCT00677352|589648853|FG001|Tapering Phase|Job transfer|1|||
163256809|NCT02182973|589648854|FG000|Overall Study|Withdrawal by Subject|3|||
163256810|NCT02182973|589648855|FG001|Overall Study|Withdrawal by Subject|0|||
163256811|NCT05614089|589648859|FG000|Overall Study|Pregnancy|5|||
163256812|NCT05614089|589648860|FG001|Overall Study|Pregnancy|2|||
163256813|NCT05614089|589648859|FG000|Overall Study|Lost to Follow-up|5|||
163256814|NCT05614089|589648860|FG001|Overall Study|Lost to Follow-up|1|||
163256815|NCT05614089|589648859|FG000|Overall Study|Death|0|||
163256816|NCT05614089|589648860|FG001|Overall Study|Death|1|||
163256817|NCT05614089|589648859|FG000|Overall Study|Adverse Event|1|||
163256818|NCT05614089|589648860|FG001|Overall Study|Adverse Event|0|||
163256819|NCT03937219|589648866|FG000|Overall Study|Death|223|||
163256820|NCT03937219|589648867|FG001|Overall Study|Death|211|||
163361103|NCT02563548|590031637|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
163361104|NCT02563548|590031638|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
163361105|NCT02563548|590031639|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
163256821|NCT03937219|589648866|FG000|Overall Study|Withdrawal by Subject|17|||
163361106|NCT02563548|590031634|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
163361107|NCT02563548|590031635|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
163361108|NCT02563548|590031636|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
163361109|NCT02563548|590031637|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
163256822|NCT03937219|589648867|FG001|Overall Study|Withdrawal by Subject|25|||
163361110|NCT02563548|590031638|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
163256823|NCT03937219|589648866|FG000|Overall Study|Lost to Follow-up|3|||
163256824|NCT03937219|589648867|FG001|Overall Study|Lost to Follow-up|4|||
163256825|NCT04393441|589648868|FG000|Overall Study|Adverse Event|0|||
163256826|NCT04393441|589648869|FG001|Overall Study|Adverse Event|3|||
163256827|NCT04393441|589648868|FG000|Overall Study|Withdrawal by Subject|5|||
163256828|NCT04393441|589648869|FG001|Overall Study|Withdrawal by Subject|7|||
163256829|NCT04393441|589648868|FG000|Overall Study|Lost to Follow-up|0|||
163256830|NCT04393441|589648869|FG001|Overall Study|Lost to Follow-up|2|||
163256831|NCT04393441|589648868|FG000|Overall Study|Protocol Deviation|2|||
163256832|NCT04393441|589648869|FG001|Overall Study|Protocol Deviation|1|||
163256833|NCT04393441|589648868|FG000|Overall Study|Reason not Specified|1|||
163256834|NCT04393441|589648869|FG001|Overall Study|Reason not Specified|1|||
163256835|NCT02782169|589648870|FG000|Overall Study|Lost to Follow-up|1|||
163256836|NCT02782169|589648871|FG001|Overall Study|Lost to Follow-up|2|||
163256837|NCT04003610|589648872|FG000|Overall Study|Lost to Follow-up|0|||
163256838|NCT04003610|589648873|FG001|Overall Study|Lost to Follow-up|1|||
163256839|NCT04003610|589648874|FG002|Overall Study|Lost to Follow-up|0|||
163256840|NCT04003610|589648872|FG000|Overall Study|Death|0|||
163256841|NCT04003610|589648873|FG001|Overall Study|Death|0|||
163256842|NCT04003610|589648874|FG002|Overall Study|Death|3|||
163256843|NCT04003610|589648872|FG000|Overall Study|Study Terminated by Sponsor|0|||
163256844|NCT04003610|589648873|FG001|Overall Study|Study Terminated by Sponsor|0|||
163256845|NCT04003610|589648874|FG002|Overall Study|Study Terminated by Sponsor|3|||
163256846|NCT00771810|589648875|FG000|Overall Study|Adverse Event|3|||
163256847|NCT00771810|589648876|FG001|Overall Study|Adverse Event|0|||
163256848|NCT00771810|589648877|FG002|Overall Study|Adverse Event|2|||
163256849|NCT00771810|589648875|FG000|Overall Study|Lost to Follow-up|0|||
163256850|NCT00771810|589648876|FG001|Overall Study|Lost to Follow-up|0|||
163256851|NCT00771810|589648877|FG002|Overall Study|Lost to Follow-up|1|||
163256852|NCT00771810|589648875|FG000|Overall Study|Physician Decision|1|||
163256853|NCT00771810|589648876|FG001|Overall Study|Physician Decision|2|||
163256854|NCT00771810|589648877|FG002|Overall Study|Physician Decision|2|||
163256855|NCT00771810|589648875|FG000|Overall Study|Protocol Violation|0|||
163256856|NCT00771810|589648876|FG001|Overall Study|Protocol Violation|1|||
163256857|NCT00771810|589648877|FG002|Overall Study|Protocol Violation|1|||
163256858|NCT00771810|589648875|FG000|Overall Study|Withdrawal by Subject|1|||
163256859|NCT00771810|589648876|FG001|Overall Study|Withdrawal by Subject|2|||
163256860|NCT00771810|589648877|FG002|Overall Study|Withdrawal by Subject|0|||
163256861|NCT00771810|589648875|FG000|Overall Study|Other|0|||
163256862|NCT00771810|589648876|FG001|Overall Study|Other|0|||
163256863|NCT00771810|589648877|FG002|Overall Study|Other|1|||
163256864|NCT02660827|589648882|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
163256865|NCT02660827|589648882|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
163256866|NCT02660827|589648882|FG000|From Study to End of Continued Access|Adverse Event|3|||
163256867|NCT02660827|589648882|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
163256868|NCT02660827|589648882|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
163256869|NCT02660827|589648882|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
163256870|NCT02660827|589648882|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
163256871|NCT02660827|589648882|FG000|Period 2: Continued Access Period|Adverse Event|3|||
163256872|NCT02953938|589648883|FG000|Overall Study|Adverse Event|0|||
163256873|NCT02953938|589648884|FG001|Overall Study|Adverse Event|1|||
163256874|NCT02953938|589648883|FG000|Overall Study|Withdrawal by Subject|1|||
163256875|NCT02953938|589648884|FG001|Overall Study|Withdrawal by Subject|1|||
163256876|NCT02657031|589648891|FG000|Overall Study|Adverse Event|1|||
163256877|NCT02657031|589648892|FG001|Overall Study|Adverse Event|2|||
163256878|NCT04198805|589648893|FG000|Overall Study|Death|0|||
163256879|NCT04198805|589648894|FG001|Overall Study|Death|0|||
163256880|NCT04198805|589648895|FG002|Overall Study|Death|0|||
163256881|NCT04198805|589648896|FG003|Overall Study|Death|1|||
163256882|NCT04198805|589648893|FG000|Overall Study|Early Termination|8|||
163256883|NCT04198805|589648894|FG001|Overall Study|Early Termination|4|||
163256884|NCT04198805|589648895|FG002|Overall Study|Early Termination|6|||
163256885|NCT04198805|589648896|FG003|Overall Study|Early Termination|9|||
163256886|NCT03078816|589648897|FG000|Overall Study|Withdrawal by Subject|1|||
163256887|NCT02114151|589648898|FG000|Overall Study|Death|1|||
163256888|NCT02114151|589648898|FG000|Overall Study|Lost to Follow-up|1|||
163361111|NCT02563548|590031639|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
163361112|NCT02563548|590031634|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
163361113|NCT02563548|590031635|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
163361114|NCT02563548|590031636|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
163256889|NCT02114151|589648898|FG000|Overall Study|Withdrawal by Subject|5|||
163256890|NCT03599349|589648899|FG000|Overall Study|Lost to Follow-up|1|||
163256891|NCT00810264|589648902|FG000|Overall Study|Lost to Follow-up|191|||
163256892|NCT00810264|589648902|FG000|Overall Study|Withdrawal by subject or physician|721|||
163256893|NCT00810264|589648902|FG000|Overall Study|Death|641|||
163256894|NCT01648348|589648905|FG000|Overall Study|Cancel|1|||
163256895|NCT01648348|589648906|FG001|Overall Study|Cancel|0|||
163256896|NCT01648348|589648907|FG002|Overall Study|Cancel|0|||
163256897|NCT01648348|589648908|FG003|Overall Study|Cancel|0|||
163256898|NCT01648348|589648909|FG004|Overall Study|Cancel|3|||
163256899|NCT01648348|589648910|FG005|Overall Study|Cancel|6|||
163256900|NCT01648348|589648905|FG000|Overall Study|Replaced for MTD analysis|1|||
163256901|NCT01648348|589648906|FG001|Overall Study|Replaced for MTD analysis|0|||
163256902|NCT01648348|589648907|FG002|Overall Study|Replaced for MTD analysis|1|||
163256903|NCT01648348|589648908|FG003|Overall Study|Replaced for MTD analysis|0|||
163410957|NCT03215030|590212952|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163410958|NCT03215030|590212953|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
163410959|NCT03215030|590212954|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163410960|NCT03215030|590212955|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163410961|NCT03215030|590212956|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163410962|NCT03215030|590212957|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163410963|NCT03215030|590212946|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163410964|NCT03215030|590212947|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163410965|NCT03215030|590212948|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163410966|NCT03215030|590212949|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163410967|NCT03215030|590212950|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
163410968|NCT03215030|590212951|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
163410969|NCT03215030|590212952|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
163410970|NCT03215030|590212953|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
163410971|NCT03215030|590212954|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163410972|NCT03215030|590212955|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163410973|NCT03215030|590212956|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163410974|NCT03215030|590212957|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163410975|NCT03215030|590212946|FG000|Part 2: Dose Expansion|Death|0|||
163410976|NCT03215030|590212947|FG001|Part 2: Dose Expansion|Death|0|||
163410977|NCT03215030|590212948|FG002|Part 2: Dose Expansion|Death|0|||
163410978|NCT03215030|590212949|FG003|Part 2: Dose Expansion|Death|0|||
163410979|NCT03215030|590212950|FG004|Part 2: Dose Expansion|Death|3|||
163410980|NCT03215030|590212951|FG005|Part 2: Dose Expansion|Death|1|||
163410981|NCT03215030|590212952|FG006|Part 2: Dose Expansion|Death|5|||
163410982|NCT03215030|590212953|FG007|Part 2: Dose Expansion|Death|4|||
163410983|NCT03215030|590212954|FG008|Part 2: Dose Expansion|Death|0|||
163410984|NCT03215030|590212955|FG009|Part 2: Dose Expansion|Death|0|||
163410985|NCT03215030|590212956|FG010|Part 2: Dose Expansion|Death|0|||
163410986|NCT03215030|590212957|FG011|Part 2: Dose Expansion|Death|0|||
163410987|NCT03215030|590212946|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
163410988|NCT03215030|590212947|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
163410989|NCT03215030|590212948|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
163410990|NCT03215030|590212949|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
163410991|NCT03215030|590212950|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
163410992|NCT03215030|590212951|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
163410993|NCT03215030|590212952|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
163410994|NCT03215030|590212953|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
163410995|NCT03215030|590212954|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
163410996|NCT03215030|590212955|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
163410997|NCT03215030|590212956|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
163410998|NCT03215030|590212957|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
163410999|NCT03215030|590212946|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
163411000|NCT03215030|590212947|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
163411001|NCT03215030|590212948|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
163411002|NCT03215030|590212949|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
163151755|NCT04292535|589269527|FG013|Overall Study|Equipment Failure|0|||
163151756|NCT01420861|589269528|FG000|Overall Study|Adverse Event|2|||
163151757|NCT01420861|589269528|FG000|Overall Study|Study terminated by Sponsor|7|||
163151758|NCT01420861|589269528|FG000|Overall Study|Screen failure|7|||
163151759|NCT01420861|589269528|FG000|Overall Study|Randomized not Treated|2|||
163151760|NCT03341299|589269529|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
163151761|NCT03341299|589269530|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
163151762|NCT03341299|589269531|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
163151763|NCT03341299|589269532|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
163151764|NCT04905134|589269535|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
163151765|NCT04905134|589269535|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
163151766|NCT03009058|589269536|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
163151767|NCT05556265|589269537|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
163151768|NCT05556265|589269538|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
163151769|NCT05556265|589269539|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
163151770|NCT05556265|589269540|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
163151771|NCT05556265|589269541|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
163151772|NCT05556265|589269537|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
163151773|NCT05556265|589269538|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
163151774|NCT05556265|589269539|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
163411003|NCT03215030|590212950|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
163411004|NCT03215030|590212951|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
163411005|NCT03215030|590212952|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
163411006|NCT03215030|590212953|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
163256904|NCT01648348|589648909|FG004|Overall Study|Replaced for MTD analysis|0|||
163256905|NCT01648348|589648910|FG005|Overall Study|Replaced for MTD analysis|0|||
163256906|NCT00696410|589648911|FG000|Overall Study|Lost to Follow-up|2|||
163256907|NCT00696410|589648912|FG001|Overall Study|Lost to Follow-up|0|||
163256908|NCT00696410|589648911|FG000|Overall Study|Withdrawal by Subject|8|||
163256909|NCT00696410|589648912|FG001|Overall Study|Withdrawal by Subject|0|||
163256910|NCT00696410|589648911|FG000|Overall Study|Physician Decision|3|||
163256911|NCT00696410|589648912|FG001|Overall Study|Physician Decision|0|||
163256912|NCT00265889|589648913|FG000|Overall Study|Physician Decision|1|||
163256913|NCT00265889|589648913|FG000|Overall Study|Protocol Violation|1|||
163256914|NCT00265889|589648913|FG000|Overall Study|Insurance denied the request|3|||
163256915|NCT02134587|589648914|FG000|Overall Study|Did not completed all meetings|30|||
163256916|NCT00453986|589648915|FG000|Overall Study|Lost to Follow-up|6|||
163256917|NCT00453986|589648916|FG001|Overall Study|Lost to Follow-up|5|||
163256918|NCT00453986|589648917|FG002|Overall Study|Lost to Follow-up|6|||
163256919|NCT00453986|589648918|FG003|Overall Study|Lost to Follow-up|2|||
163256920|NCT00453986|589648919|FG004|Overall Study|Lost to Follow-up|0|||
163256921|NCT03419364|589648926|FG000|Overall Study|Delivery due to maternal condition|2|||
163256922|NCT03419364|589648927|FG001|Overall Study|Delivery due to maternal condition|0|||
163256923|NCT03419364|589648928|FG002|Overall Study|Delivery due to maternal condition|0|||
163256924|NCT03355326|589648936|FG000|Overall Study|Protocol Violation|3|||
163256925|NCT03355326|589648937|FG001|Overall Study|Protocol Violation|3|||
163256926|NCT00608582|589648946|FG000|Overall Study|Lost to Follow-up|2|||
163256927|NCT00608582|589648947|FG001|Overall Study|Lost to Follow-up|0|||
163256928|NCT00608582|589648946|FG000|Overall Study|No Best Response in Phase 1 located|1|||
163256929|NCT00608582|589648947|FG001|Overall Study|No Best Response in Phase 1 located|1|||
163256930|NCT00608582|589648946|FG000|Overall Study|Illicit Drug Use|1|||
163256931|NCT00608582|589648947|FG001|Overall Study|Illicit Drug Use|0|||
163256932|NCT00608582|589648946|FG000|Overall Study|Early stage Design Change|0|||
163256933|NCT00608582|589648947|FG001|Overall Study|Early stage Design Change|3|||
163256934|NCT04922554|589648948|FG000|Overall Study|Adverse Event|4|||
163256935|NCT04922554|589648949|FG001|Overall Study|Adverse Event|0|||
163256936|NCT04922554|589648948|FG000|Overall Study|Withdrawal by Subject|1|||
163256937|NCT04922554|589648949|FG001|Overall Study|Withdrawal by Subject|0|||
163256938|NCT03308825|589650496|FG000|Overall Study|Lost to Follow-up|2|||
163256939|NCT03308825|589650497|FG001|Overall Study|Lost to Follow-up|2|||
163256940|NCT03308825|589650498|FG002|Overall Study|Lost to Follow-up|1|||
163256941|NCT03308825|589650499|FG003|Overall Study|Lost to Follow-up|0|||
163256942|NCT03308825|589650496|FG000|Overall Study|Protocol Violation|0|||
163256943|NCT03308825|589650497|FG001|Overall Study|Protocol Violation|2|||
163256944|NCT03308825|589650498|FG002|Overall Study|Protocol Violation|0|||
163256945|NCT03308825|589650499|FG003|Overall Study|Protocol Violation|0|||
163256946|NCT03559218|589650500|FG000|Overall Study|Withdrawal by Subject|1|||
163256947|NCT03559218|589650501|FG001|Overall Study|Withdrawal by Subject|0|||
163256948|NCT04737109|589650511|FG000|Study Treatment|Disease Progression|5|||
163256949|NCT04737109|589650512|FG001|Study Treatment|Disease Progression|0|||
163256950|NCT04737109|589650513|FG002|Study Treatment|Disease Progression|0|||
163256951|NCT04737109|589650514|FG003|Study Treatment|Disease Progression|0|||
163256952|NCT04737109|589650511|FG000|Study Treatment|Death on study|1|||
163256953|NCT04737109|589650512|FG001|Study Treatment|Death on study|0|||
163256954|NCT04737109|589650513|FG002|Study Treatment|Death on study|0|||
163256955|NCT04737109|589650514|FG003|Study Treatment|Death on study|0|||
163256956|NCT03092375|589650515|FG000|Overall Study|Lack of Efficacy|0|||
163256957|NCT03092375|589650516|FG001|Overall Study|Lack of Efficacy|1|||
163256958|NCT03092375|589650517|FG002|Overall Study|Lack of Efficacy|1|||
163256959|NCT03092375|589650518|FG003|Overall Study|Lack of Efficacy|0|||
163256960|NCT01679301|589650519|FG000|Screening Period|screen failure|3|||
163256961|NCT01679301|589650520|FG001|Screening Period|screen failure|0|||
163256962|NCT01679301|589650521|FG002|Screening Period|screen failure|0|||
163256963|NCT03328143|589650524|FG000|Overall Study|Declined|3|||
163361115|NCT02563548|590031637|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
163361116|NCT02563548|590031638|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
163361117|NCT02563548|590031639|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
163256964|NCT03328143|589650524|FG000|Overall Study|Required increased sedation|4|||
163361118|NCT02563548|590031634|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
163256965|NCT03328143|589650524|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
163256966|NCT03328143|589650524|FG000|Overall Study|Surgery cancelled|1|||
163256967|NCT00861614|589650525|FG000|Overall Study|Disease Progression|182|||
163256968|NCT00861614|589650526|FG001|Overall Study|Disease Progression|263|||
163256969|NCT00861614|589650525|FG000|Overall Study|Study Drug Toxicity|79|||
163256970|NCT00861614|589650526|FG001|Overall Study|Study Drug Toxicity|6|||
163256971|NCT00861614|589650525|FG000|Overall Study|Death|32|||
163256972|NCT00861614|589650526|FG001|Overall Study|Death|19|||
163256973|NCT00861614|589650525|FG000|Overall Study|Adverse Event|27|||
163256974|NCT00861614|589650526|FG001|Overall Study|Adverse Event|23|||
163256975|NCT00861614|589650525|FG000|Overall Study|Withdrawal by Subject|34|||
163256976|NCT00861614|589650526|FG001|Overall Study|Withdrawal by Subject|35|||
163256977|NCT00861614|589650525|FG000|Overall Study|Other|17|||
163256978|NCT00861614|589650526|FG001|Overall Study|Other|22|||
163256979|NCT00944658|589650527|FG000|Treatment 12 Weeks|Adverse Event|0|||
163256980|NCT00944658|589650528|FG001|Treatment 12 Weeks|Adverse Event|2|||
163256981|NCT02259517|589650529|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
163256982|NCT02259517|589650530|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
163256983|NCT02259517|589650531|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
163256984|NCT02259517|589650529|FG000|Overall Study|Withdrawal by Subject|0|||
163256985|NCT02259517|589650530|FG001|Overall Study|Withdrawal by Subject|0|||
163256986|NCT02259517|589650531|FG002|Overall Study|Withdrawal by Subject|3|||
163256987|NCT01289418|589650535|FG000|Day 8 Survey|email address invalid|283|||
163256988|NCT01289418|589650535|FG000|Day 8 Survey|participants did not complete the survey|1935|||
163256989|NCT01289418|589650535|FG000|Day 29 Survey|email address invalid|283|||
163256990|NCT01289418|589650535|FG000|Day 29 Survey|participants did not complete the survey|2185|||
163256991|NCT01352585|589650537|FG000|Overall Study|Adverse Event|2|||
163256992|NCT01352585|589650538|FG001|Overall Study|Adverse Event|1|||
163256993|NCT01352585|589650537|FG000|Overall Study|Lost to Follow-up|1|||
163256994|NCT01352585|589650538|FG001|Overall Study|Lost to Follow-up|0|||
163256995|NCT01352585|589650537|FG000|Overall Study|Other|5|||
163256996|NCT01352585|589650538|FG001|Overall Study|Other|2|||
163256997|NCT00838682|589650541|FG000|Overall Study|Lost to Follow-up|21|||
163256998|NCT00838682|589650542|FG001|Overall Study|Lost to Follow-up|14|||
163256999|NCT00838682|589650541|FG000|Overall Study|detection of exclusion criteria|4|||
163257000|NCT00838682|589650542|FG001|Overall Study|detection of exclusion criteria|3|||
163257001|NCT00838682|589650541|FG000|Overall Study|Protocol Violation|0|||
163257002|NCT00838682|589650542|FG001|Overall Study|Protocol Violation|1|||
163257003|NCT00838682|589650541|FG000|Overall Study|Withdrawal by Subject|0|||
163361119|NCT02563548|590031635|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
163361120|NCT02563548|590031636|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
163361121|NCT02563548|590031637|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
163361122|NCT02563548|590031638|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
163361123|NCT02563548|590031639|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
163361124|NCT02563548|590031634|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
163361125|NCT02563548|590031635|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
163361126|NCT02563548|590031636|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
163361127|NCT02563548|590031637|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
163361128|NCT02563548|590031638|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
163361129|NCT02563548|590031639|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
163361130|NCT02563548|590031634|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
163361131|NCT02563548|590031635|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
163361132|NCT02563548|590031636|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
163361133|NCT02563548|590031637|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
163361134|NCT02563548|590031638|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
163361135|NCT02563548|590031639|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
163361136|NCT00340704|590031645|FG000|PK Study|Adverse Event|0|||
163361137|NCT00340704|590031646|FG001|PK Study|Adverse Event|1|||
163361138|NCT00340704|590031647|FG002|PK Study|Adverse Event|0|||
163361139|NCT00340704|590031648|FG003|PK Study|Adverse Event|0|||
163361140|NCT00340704|590031649|FG004|PK Study|Adverse Event|0|||
163361141|NCT00340704|590031650|FG005|PK Study|Adverse Event|0|||
163361142|NCT00340704|590031651|FG006|PK Study|Adverse Event|0|||
163361143|NCT00340704|590031652|FG007|PK Study|Adverse Event|0|||
163361144|NCT00340704|590031653|FG008|PK Study|Adverse Event|0|||
163361145|NCT00340704|590031645|FG000|PK Study|Not treated|0|||
163361146|NCT00340704|590031646|FG001|PK Study|Not treated|0|||
163361147|NCT00340704|590031647|FG002|PK Study|Not treated|1|||
163361148|NCT00340704|590031648|FG003|PK Study|Not treated|0|||
163361149|NCT00340704|590031649|FG004|PK Study|Not treated|0|||
163361150|NCT00340704|590031650|FG005|PK Study|Not treated|0|||
163361151|NCT00340704|590031651|FG006|PK Study|Not treated|0|||
163361152|NCT00340704|590031652|FG007|PK Study|Not treated|0|||
163361153|NCT00340704|590031653|FG008|PK Study|Not treated|0|||
163361154|NCT00340704|590031645|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
163257004|NCT00838682|589650542|FG001|Overall Study|Withdrawal by Subject|1|||
163257005|NCT02305381|589650543|FG000|Overall Study|Unclassified|5|||
163257006|NCT02305381|589650544|FG001|Overall Study|Unclassified|5|||
163257007|NCT02305381|589650545|FG002|Overall Study|Unclassified|7|||
163257008|NCT02276066|589650546|FG000|Overall Study|Lost to Follow-up|21|||
163257009|NCT02276066|589650547|FG001|Overall Study|Lost to Follow-up|11|||
163361155|NCT00340704|590031646|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
163361156|NCT00340704|590031647|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
163361157|NCT00340704|590031648|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
163361158|NCT00340704|590031649|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
163361159|NCT00340704|590031650|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
163411007|NCT03215030|590212954|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
163257010|NCT01807156|589650548|FG000|Overall Study|Physician Decision|1|||
163257011|NCT01370525|589650549|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
163257012|NCT01370525|589650550|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
163257013|NCT01370525|589650549|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
163257014|NCT01370525|589650550|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
163257015|NCT01370525|589650549|FG000|Overall Study|Adverse Event|0|||
163257016|NCT01370525|589650550|FG001|Overall Study|Adverse Event|1|||
163257017|NCT01370525|589650549|FG000|Overall Study|Protocol Violation|2|||
163257018|NCT01370525|589650550|FG001|Overall Study|Protocol Violation|1|||
163257019|NCT01370525|589650549|FG000|Overall Study|Lost to follow up|2|||
163257020|NCT01370525|589650550|FG001|Overall Study|Lost to follow up|6|||
163257021|NCT03642938|589650552|FG000|Overall Study|Withdrawal by Subject|0|||
163257022|NCT03642938|589650553|FG001|Overall Study|Withdrawal by Subject|0|||
163257023|NCT03642938|589650554|FG002|Overall Study|Withdrawal by Subject|0|||
163257024|NCT03642938|589650555|FG003|Overall Study|Withdrawal by Subject|1|||
163257025|NCT01424930|589650556|FG000|Overall Study|Adverse Event|0|||
163257026|NCT01424930|589650557|FG001|Overall Study|Adverse Event|1|||
163257027|NCT01424930|589650556|FG000|Overall Study|Death|1|||
163257028|NCT01424930|589650557|FG001|Overall Study|Death|0|||
163257029|NCT01424930|589650556|FG000|Overall Study|Progressive Disease|3|||
163257030|NCT01424930|589650557|FG001|Overall Study|Progressive Disease|6|||
163257031|NCT01424930|589650556|FG000|Overall Study|Screen Failure|0|||
163257032|NCT01424930|589650557|FG001|Overall Study|Screen Failure|1|||
163257033|NCT01424930|589650556|FG000|Overall Study|Reason not specified|0|||
163257034|NCT01424930|589650557|FG001|Overall Study|Reason not specified|6|||
163257035|NCT03286751|589650562|FG000|Washout Period 1|Withdrawal by Subject|0|||
163257036|NCT03286751|589650563|FG001|Washout Period 1|Withdrawal by Subject|0|||
163257037|NCT03286751|589650564|FG002|Washout Period 1|Withdrawal by Subject|0|||
163257038|NCT03286751|589650565|FG003|Washout Period 1|Withdrawal by Subject|0|||
163257039|NCT03286751|589650566|FG004|Washout Period 1|Withdrawal by Subject|1|||
163257040|NCT03286751|589650567|FG005|Washout Period 1|Withdrawal by Subject|0|||
163257041|NCT03286751|589650562|FG000|Washout Period 2|Personal Reasons|0|||
163257042|NCT03286751|589650563|FG001|Washout Period 2|Personal Reasons|1|||
163257043|NCT03286751|589650564|FG002|Washout Period 2|Personal Reasons|0|||
163257044|NCT03286751|589650565|FG003|Washout Period 2|Personal Reasons|0|||
163257045|NCT03286751|589650566|FG004|Washout Period 2|Personal Reasons|0|||
163257046|NCT03286751|589650567|FG005|Washout Period 2|Personal Reasons|0|||
163257047|NCT03286751|589650562|FG000|Washout Period 5|Adverse Event|0|||
163257048|NCT03286751|589650563|FG001|Washout Period 5|Adverse Event|0|||
163257049|NCT03286751|589650564|FG002|Washout Period 5|Adverse Event|0|||
163257050|NCT03286751|589650565|FG003|Washout Period 5|Adverse Event|0|||
163257051|NCT03286751|589650566|FG004|Washout Period 5|Adverse Event|1|||
163257052|NCT03286751|589650567|FG005|Washout Period 5|Adverse Event|0|||
163257053|NCT01119768|589650568|FG000|Treatment Period|Lack of Efficacy|18|||
163257054|NCT01119768|589650569|FG001|Treatment Period|Lack of Efficacy|25|||
163257055|NCT01301391|589650570|FG000|Overall Study|Death|13|||
163257056|NCT01301391|589650570|FG000|Overall Study|Lost to Follow-up|3|||
163257057|NCT01301391|589650570|FG000|Overall Study|Physician Decision|2|||
163257058|NCT01301391|589650570|FG000|Overall Study|Sponsor's decision|8|||
163257059|NCT01059643|589650571|FG000|Overall Study|Adverse Event|3|||
163257060|NCT01059643|589650571|FG000|Overall Study|Withdrawal by Subject|2|||
163257061|NCT01059643|589650571|FG000|Overall Study|Physician Decision|1|||
163257062|NCT00106184|589650572|FG000|Overall Study|Withdrawal by Subject|3|||
163257063|NCT00106184|589650573|FG001|Overall Study|Withdrawal by Subject|2|||
163257064|NCT05292534|589650579|FG000|Overall Study|Protocol Violation|3|||
163257065|NCT05292534|589650580|FG001|Overall Study|Protocol Violation|4|||
163257066|NCT05292534|589650579|FG000|Overall Study|Withdrawal by Subject|0|||
163257067|NCT05292534|589650580|FG001|Overall Study|Withdrawal by Subject|1|||
163257068|NCT00238433|589650586|FG000|Overall Study|Screen failure|1|||
163257069|NCT00238433|589650586|FG000|Overall Study|Lost to Follow-up|1|||
163257070|NCT00238433|589650586|FG000|Overall Study|Death|1|||
163257071|NCT01814748|589650587|FG000|Overall Study|Lost to Follow-up|1|||
163257072|NCT01814748|589650588|FG001|Overall Study|Lost to Follow-up|2|||
163257073|NCT01814748|589650587|FG000|Overall Study|Study site terminated by sponsor|1|||
163257074|NCT01814748|589650588|FG001|Overall Study|Study site terminated by sponsor|1|||
163257075|NCT01814748|589650587|FG000|Overall Study|Withdrawal by Subject|6|||
163257076|NCT01814748|589650588|FG001|Overall Study|Withdrawal by Subject|4|||
163257077|NCT00409682|589650595|FG000|Open-label Induction Period|Adverse Event|1|||
163257078|NCT00409682|589650596|FG001|Open-label Induction Period|Adverse Event|0|||
163257079|NCT00409682|589650597|FG002|Open-label Induction Period|Adverse Event|0|||
163257080|NCT00409682|589650595|FG000|Open-label Induction Period|Lack of Efficacy|1|||
163257081|NCT00409682|589650596|FG001|Open-label Induction Period|Lack of Efficacy|0|||
163257082|NCT00409682|589650597|FG002|Open-label Induction Period|Lack of Efficacy|0|||
163257083|NCT00409682|589650595|FG000|Open-label Induction Period|Protocol Violation|1|||
163257084|NCT00409682|589650596|FG001|Open-label Induction Period|Protocol Violation|0|||
163257085|NCT00409682|589650597|FG002|Open-label Induction Period|Protocol Violation|0|||
163257086|NCT00409682|589650595|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
163257087|NCT00409682|589650596|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
163361160|NCT00340704|590031651|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
163361161|NCT00340704|590031652|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
163361162|NCT00340704|590031653|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
163361163|NCT00340704|590031645|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163361164|NCT00340704|590031646|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163361165|NCT00340704|590031647|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163361166|NCT00340704|590031648|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163361167|NCT00340704|590031649|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163361168|NCT00340704|590031650|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
163361169|NCT00340704|590031651|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163361170|NCT00340704|590031652|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163361171|NCT00340704|590031653|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163361172|NCT00340704|590031645|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
163361173|NCT00340704|590031646|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
163361174|NCT00340704|590031647|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
163361175|NCT00340704|590031648|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
163361176|NCT00340704|590031649|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
163361177|NCT00340704|590031650|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
163361178|NCT00340704|590031651|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
163361179|NCT00340704|590031652|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
163361180|NCT00340704|590031653|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
163361181|NCT00340704|590031645|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
163361182|NCT00340704|590031646|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
163361183|NCT00340704|590031647|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
163361184|NCT00340704|590031648|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
163361185|NCT00340704|590031649|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
163361186|NCT00340704|590031650|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
163361187|NCT00340704|590031651|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
163361188|NCT00340704|590031652|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
163361189|NCT00340704|590031653|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
163361190|NCT01732549|590031654|FG000|Overall Study|Adverse Event|13|||
163361191|NCT01732549|590031655|FG001|Overall Study|Adverse Event|3|||
163361192|NCT01732549|590031654|FG000|Overall Study|Consent withdrawn|13|||
163361193|NCT01732549|590031655|FG001|Overall Study|Consent withdrawn|6|||
163361194|NCT01732549|590031654|FG000|Overall Study|Disease progression|37|||
163361195|NCT01732549|590031655|FG001|Overall Study|Disease progression|50|||
163361196|NCT01732549|590031654|FG000|Overall Study|Other|8|||
163361197|NCT01732549|590031655|FG001|Overall Study|Other|14|||
163361198|NCT00121667|590031656|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
163361199|NCT00121667|590031657|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
163361200|NCT00121667|590031658|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
163361201|NCT00121667|590031659|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
163361202|NCT00121667|590031656|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
163361203|NCT00121667|590031657|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
163361204|NCT00121667|590031658|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
163361205|NCT00121667|590031659|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
163361206|NCT00121667|590031656|FG000|Short Term (ST) Period|Adverse Event|5|||
163361207|NCT00121667|590031657|FG001|Short Term (ST) Period|Adverse Event|6|||
163411008|NCT03215030|590212955|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
163151775|NCT05556265|589269540|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
163151776|NCT05556265|589269541|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
163151777|NCT05556265|589269537|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
163151778|NCT05556265|589269538|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
163151779|NCT05556265|589269539|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
163151780|NCT05556265|589269540|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
163151781|NCT05556265|589269541|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
163151782|NCT05556265|589269537|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
163151783|NCT05556265|589269538|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
163151784|NCT05556265|589269539|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
163151785|NCT05556265|589269540|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
163151786|NCT05556265|589269541|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
163151787|NCT05556265|589269537|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
163151788|NCT05556265|589269538|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
163151789|NCT05556265|589269539|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
163257088|NCT00409682|589650597|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
163411009|NCT03215030|590212956|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
163411010|NCT03215030|590212957|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
163257089|NCT00409682|589650595|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
163257090|NCT00409682|589650596|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
163257091|NCT00409682|589650597|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
163257092|NCT00409682|589650595|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
163257093|NCT00409682|589650596|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
163257094|NCT00409682|589650597|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
163257095|NCT00409682|589650595|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
163257096|NCT00409682|589650596|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
163257097|NCT00409682|589650597|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
163257098|NCT00409682|589650595|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
163257099|NCT00409682|589650596|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
163257100|NCT00409682|589650597|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
163257101|NCT00409682|589650595|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
163257102|NCT00409682|589650596|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
163257103|NCT00409682|589650597|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
163257104|NCT00409682|589650595|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
163257105|NCT00409682|589650596|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
163257106|NCT00409682|589650597|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
163257107|NCT04710927|589650600|FG000|Overall Study|Lost to Follow-up|7|||
163257108|NCT04710927|589650601|FG001|Overall Study|Lost to Follow-up|6|||
163257109|NCT04710927|589650602|FG002|Overall Study|Lost to Follow-up|5|||
163257110|NCT03595332|589650603|FG000|Overall Study|Lost to Follow-up|16|||
163257111|NCT03595332|589650604|FG001|Overall Study|Lost to Follow-up|22|||
163257112|NCT03595332|589650603|FG000|Overall Study|Unable to retrieve ID from school|0|||
163257113|NCT03595332|589650604|FG001|Overall Study|Unable to retrieve ID from school|2|||
163257114|NCT02227875|589650605|FG000|Overall Study|Protocol Violation|10|||
163257115|NCT02227875|589650606|FG001|Overall Study|Protocol Violation|7|||
163257116|NCT02227875|589650605|FG000|Overall Study|Other|1|||
163257117|NCT02227875|589650606|FG001|Overall Study|Other|3|||
163257118|NCT02227875|589650605|FG000|Overall Study|Physician Decision|1|||
163257119|NCT02227875|589650606|FG001|Overall Study|Physician Decision|0|||
163257120|NCT02227875|589650605|FG000|Overall Study|Adverse Event|3|||
163257121|NCT02227875|589650606|FG001|Overall Study|Adverse Event|0|||
163257122|NCT02227875|589650605|FG000|Overall Study|Withdrawal by Subject|12|||
163257123|NCT02227875|589650606|FG001|Overall Study|Withdrawal by Subject|13|||
163257124|NCT02227875|589650605|FG000|Overall Study|Lost to Follow-up|10|||
163257125|NCT02227875|589650606|FG001|Overall Study|Lost to Follow-up|10|||
163257126|NCT01201811|589650607|FG000|Overall Study|Adverse Event|6|||
163257127|NCT01201811|589650607|FG000|Overall Study|Disease progression|3|||
163257128|NCT01201811|589650607|FG000|Overall Study|Withdrawal by Subject|3|||
163257129|NCT01201811|589650607|FG000|Overall Study|Death|4|||
163257130|NCT01201811|589650607|FG000|Overall Study|Treatment Failure|2|||
163411011|NCT03215030|590212946|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163411012|NCT03215030|590212947|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163411013|NCT03215030|590212948|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163411014|NCT03215030|590212949|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163411015|NCT03215030|590212950|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163411016|NCT03215030|590212951|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163411017|NCT03215030|590212952|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163411018|NCT03215030|590212953|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163411019|NCT03215030|590212954|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
163411020|NCT03215030|590212955|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
163411021|NCT03215030|590212956|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163257131|NCT01201811|589650607|FG000|Overall Study|Physician Decision|1|||
163257132|NCT02857426|589650608|FG000|Overall Study|Disease progression|34|||
163257133|NCT02857426|589650609|FG001|Overall Study|Disease progression|13|||
163257134|NCT02857426|589650608|FG000|Overall Study|Study drug toxicity|4|||
163411022|NCT03215030|590212957|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163411023|NCT03215030|590212946|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
163411024|NCT03215030|590212947|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
163411025|NCT03215030|590212948|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
163411026|NCT03215030|590212949|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
163411027|NCT03215030|590212950|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
163257135|NCT02857426|589650609|FG001|Overall Study|Study drug toxicity|1|||
163257136|NCT02857426|589650608|FG000|Overall Study|Death|1|||
163411028|NCT03215030|590212951|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
163257137|NCT02857426|589650609|FG001|Overall Study|Death|0|||
163257138|NCT02857426|589650608|FG000|Overall Study|Adverse event unrelated to study drug|6|||
163257139|NCT02857426|589650609|FG001|Overall Study|Adverse event unrelated to study drug|2|||
163257140|NCT02857426|589650608|FG000|Overall Study|Participant withdrew consent|1|||
163257141|NCT02857426|589650609|FG001|Overall Study|Participant withdrew consent|1|||
163257142|NCT02857426|589650608|FG000|Overall Study|Maximum clinical benefit|1|||
163257143|NCT02857426|589650609|FG001|Overall Study|Maximum clinical benefit|0|||
163257144|NCT02857426|589650608|FG000|Overall Study|Completed treatment|0|||
163257145|NCT02857426|589650609|FG001|Overall Study|Completed treatment|2|||
163257146|NCT01960725|589650610|FG000|Overall Study|Lost to Follow-up|4|||
163257147|NCT01960725|589650611|FG001|Overall Study|Lost to Follow-up|3|||
163257148|NCT01960725|589650610|FG000|Overall Study|Withdrawal by Subject|1|||
163257149|NCT01960725|589650611|FG001|Overall Study|Withdrawal by Subject|0|||
163257150|NCT01960725|589650610|FG000|Overall Study|unable to obtain blood sample|1|||
163257151|NCT01960725|589650611|FG001|Overall Study|unable to obtain blood sample|2|||
163257152|NCT02831257|589650612|FG000|Overall Study|Lack of Efficacy|3|||
163257153|NCT02831257|589650612|FG000|Overall Study|Adverse Event|2|||
163257154|NCT02831257|589650612|FG000|Overall Study|Physician Decision|1|||
163257155|NCT02831257|589650612|FG000|Overall Study|Withdrawal by Subject|6|||
163257156|NCT00611858|589650613|FG000|Overall Study|Adverse Event|2|||
163257157|NCT00611858|589650613|FG000|Overall Study|Withdrawal by Subject|2|||
163257158|NCT01844284|589650614|FG000|Overall Study|Lost to Follow-up|12|||
163257159|NCT01844284|589650615|FG001|Overall Study|Lost to Follow-up|7|||
163257160|NCT03138733|589650617|FG000|Overall Study|Death|17|||
163257161|NCT03138733|589650618|FG001|Overall Study|Death|18|||
163257162|NCT03138733|589650617|FG000|Overall Study|Withdrawal by Subject|11|||
163257163|NCT03138733|589650618|FG001|Overall Study|Withdrawal by Subject|6|||
163257164|NCT03138733|589650617|FG000|Overall Study|Lost to Follow-up|3|||
163257165|NCT03138733|589650618|FG001|Overall Study|Lost to Follow-up|2|||
163257166|NCT03138733|589650617|FG000|Overall Study|Adverse Event|1|||
163257167|NCT03138733|589650618|FG001|Overall Study|Adverse Event|0|||
163257168|NCT03138733|589650617|FG000|Overall Study|Protocol Violation|1|||
163257169|NCT03138733|589650618|FG001|Overall Study|Protocol Violation|3|||
163257170|NCT03138733|589650617|FG000|Overall Study|Administrative or logistical reason|1|||
163257171|NCT03138733|589650618|FG001|Overall Study|Administrative or logistical reason|0|||
163257172|NCT03138733|589650617|FG000|Overall Study|The patient was transferred to another hospital|1|||
163257173|NCT03138733|589650618|FG001|Overall Study|The patient was transferred to another hospital|0|||
163257174|NCT03641313|589650619|FG000|Overall Study|Death|1|||
163257175|NCT03641313|589650619|FG000|Overall Study|Withdrawal by Subject|2|||
163257176|NCT03641313|589650619|FG000|Overall Study|Declining health|1|||
163257177|NCT03641313|589650619|FG000|Overall Study|Adverse Event|1|||
163257178|NCT05163522|589650622|FG000|Overall Study|Withdrawal by Subject|0|||
163257179|NCT05163522|589650623|FG001|Overall Study|Withdrawal by Subject|0|||
163257180|NCT05163522|589650624|FG002|Overall Study|Withdrawal by Subject|1|||
163257181|NCT05163522|589650625|FG003|Overall Study|Withdrawal by Subject|0|||
163257182|NCT05163522|589650626|FG004|Overall Study|Withdrawal by Subject|0|||
163257183|NCT05163522|589650627|FG005|Overall Study|Withdrawal by Subject|0|||
163257184|NCT05163522|589650628|FG006|Overall Study|Withdrawal by Subject|0|||
163257185|NCT05163522|589650629|FG007|Overall Study|Withdrawal by Subject|0|||
163257186|NCT05163522|589650630|FG008|Overall Study|Withdrawal by Subject|0|||
163257187|NCT05163522|589650631|FG009|Overall Study|Withdrawal by Subject|0|||
163257188|NCT05163522|589650632|FG010|Overall Study|Withdrawal by Subject|0|||
163257189|NCT02521285|589650634|FG000|Overall Study|Lost to Follow-up|1|||
163257190|NCT02521285|589650635|FG001|Overall Study|Lost to Follow-up|1|||
163257191|NCT02521285|589650634|FG000|Overall Study|Withdrawal by Subject|1|||
163257192|NCT02521285|589650635|FG001|Overall Study|Withdrawal by Subject|1|||
163257193|NCT02521285|589650634|FG000|Overall Study|Adverse Event|0|||
163257194|NCT02521285|589650635|FG001|Overall Study|Adverse Event|1|||
163257195|NCT05701995|589650637|FG000|Pre-Treatment|Randomization Error|1|||
163257196|NCT05701995|589650638|FG001|Pre-Treatment|Randomization Error|1|||
163257197|NCT05701995|589650637|FG000|Treatment|Withdrawal by Subject|8|||
163361208|NCT00121667|590031658|FG002|Short Term (ST) Period|Adverse Event|5|||
163361209|NCT00121667|590031659|FG003|Short Term (ST) Period|Adverse Event|3|||
163361210|NCT00121667|590031656|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
163361211|NCT00121667|590031657|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
163361212|NCT00121667|590031658|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
163361213|NCT00121667|590031659|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
163257198|NCT05701995|589650638|FG001|Treatment|Withdrawal by Subject|4|||
163257199|NCT05701995|589650637|FG000|Treatment|Lost to Follow-up|2|||
163257200|NCT05701995|589650638|FG001|Treatment|Lost to Follow-up|3|||
163257201|NCT05701995|589650637|FG000|Treatment|Adverse Event|3|||
163257202|NCT05701995|589650638|FG001|Treatment|Adverse Event|1|||
163257203|NCT05701995|589650637|FG000|Treatment|Other Reason|1|||
163257204|NCT05701995|589650638|FG001|Treatment|Other Reason|1|||
163257205|NCT05701995|589650637|FG000|Treatment|Death|1|||
163257206|NCT05701995|589650638|FG001|Treatment|Death|0|||
163257207|NCT05701995|589650637|FG000|Treatment|Physician Decision|0|||
163257208|NCT05701995|589650638|FG001|Treatment|Physician Decision|1|||
163257209|NCT00715429|589650639|FG000|Overall Study|Did not complete the study diary|0|||
163257210|NCT00715429|589650640|FG001|Overall Study|Did not complete the study diary|1|||
163361214|NCT00121667|590031656|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
163257211|NCT04899245|589650645|FG000|Overall Study|Withdrawal by Subject|3|||
163257212|NCT04899245|589650646|FG001|Overall Study|Withdrawal by Subject|5|||
163257213|NCT04899245|589650647|FG002|Overall Study|Withdrawal by Subject|2|||
163257214|NCT04899245|589650645|FG000|Overall Study|No longer eligible - Left staff position|0|||
163257215|NCT04899245|589650646|FG001|Overall Study|No longer eligible - Left staff position|0|||
163257216|NCT04899245|589650647|FG002|Overall Study|No longer eligible - Left staff position|1|||
163257217|NCT04899245|589650645|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
163257218|NCT04899245|589650646|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
163257219|NCT04899245|589650647|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
163257220|NCT04899245|589650645|FG000|Overall Study|No longer eligible - Moved away from area|2|||
163257221|NCT04899245|589650646|FG001|Overall Study|No longer eligible - Moved away from area|2|||
163257222|NCT04899245|589650647|FG002|Overall Study|No longer eligible - Moved away from area|0|||
163257223|NCT00045708|589652623|FG000|Phase 1|early progressive disease|0|||
163257224|NCT00045708|589652624|FG001|Phase 1|early progressive disease|1|||
163257225|NCT00045708|589652625|FG002|Phase 1|early progressive disease|0|||
163257226|NCT00685945|589652627|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
163257227|NCT00847405|589652629|FG000|First Intervention|Adverse Event|0|||
163257228|NCT00847405|589652630|FG001|First Intervention|Adverse Event|1|||
163257229|NCT00847405|589652629|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
163257230|NCT00847405|589652630|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
163257231|NCT01728792|589652631|FG000|Overall Study|Withdrawal of Consent|1|||
163257232|NCT01728792|589652632|FG001|Overall Study|Withdrawal of Consent|1|||
163257233|NCT01728792|589652633|FG002|Overall Study|Withdrawal of Consent|0|||
163257234|NCT01728792|589652634|FG003|Overall Study|Withdrawal of Consent|1|||
163257235|NCT01728792|589652635|FG004|Overall Study|Withdrawal of Consent|0|||
163257236|NCT01728792|589652631|FG000|Overall Study|Lost to Follow-up|2|||
163257237|NCT01728792|589652632|FG001|Overall Study|Lost to Follow-up|1|||
163257238|NCT01728792|589652633|FG002|Overall Study|Lost to Follow-up|4|||
163257239|NCT01728792|589652634|FG003|Overall Study|Lost to Follow-up|2|||
163257240|NCT01728792|589652635|FG004|Overall Study|Lost to Follow-up|0|||
163257241|NCT04277455|589652636|FG000|Overall Study|Lost to Follow-up|1|||
163257242|NCT02790073|589652637|FG000|Overall Study|Death|1|||
163257243|NCT02790073|589652637|FG000|Overall Study|Withdrawal from HD|1|||
163257244|NCT02790073|589652637|FG000|Overall Study|Withdrawal by Subject|1|||
163257245|NCT00514683|589652639|FG000|Overall Study|Not treated|2|||
163257246|NCT00514683|589652640|FG001|Overall Study|Not treated|1|||
163257247|NCT00514683|589652641|FG002|Overall Study|Not treated|0|||
163257248|NCT00514683|589652642|FG003|Overall Study|Not treated|0|||
163257249|NCT00514683|589652643|FG004|Overall Study|Not treated|1|||
163257250|NCT00514683|589652639|FG000|Overall Study|Adverse Event|21|||
163257251|NCT00514683|589652640|FG001|Overall Study|Adverse Event|20|||
163257252|NCT00514683|589652641|FG002|Overall Study|Adverse Event|15|||
163257253|NCT00514683|589652642|FG003|Overall Study|Adverse Event|13|||
163257254|NCT00514683|589652643|FG004|Overall Study|Adverse Event|27|||
163257255|NCT00514683|589652639|FG000|Overall Study|Protocol Violation|1|||
163257256|NCT00514683|589652640|FG001|Overall Study|Protocol Violation|1|||
163257257|NCT00514683|589652641|FG002|Overall Study|Protocol Violation|0|||
163257258|NCT00514683|589652642|FG003|Overall Study|Protocol Violation|1|||
163257259|NCT00514683|589652643|FG004|Overall Study|Protocol Violation|0|||
163257260|NCT00514683|589652639|FG000|Overall Study|Withdrawal by Subject|2|||
163257261|NCT00514683|589652640|FG001|Overall Study|Withdrawal by Subject|2|||
163257262|NCT00514683|589652641|FG002|Overall Study|Withdrawal by Subject|1|||
163257263|NCT00514683|589652642|FG003|Overall Study|Withdrawal by Subject|0|||
163257264|NCT00514683|589652643|FG004|Overall Study|Withdrawal by Subject|4|||
163257265|NCT00514683|589652639|FG000|Overall Study|Reason other than listed above|0|||
163257266|NCT00514683|589652640|FG001|Overall Study|Reason other than listed above|1|||
163257267|NCT00514683|589652641|FG002|Overall Study|Reason other than listed above|2|||
163257268|NCT00514683|589652642|FG003|Overall Study|Reason other than listed above|0|||
163257269|NCT00514683|589652643|FG004|Overall Study|Reason other than listed above|1|||
163257270|NCT00643123|589652646|FG000|Overall Study|Lost to Follow-up|4|||
163257271|NCT00643123|589652647|FG001|Overall Study|Lost to Follow-up|0|||
163257272|NCT00643123|589652646|FG000|Overall Study|Withdrawal by Subject|1|||
163257273|NCT00643123|589652647|FG001|Overall Study|Withdrawal by Subject|1|||
163257274|NCT01896869|589652649|FG000|Overall Study|Withdrawal by Subject|0|||
163257275|NCT01896869|589652650|FG001|Overall Study|Withdrawal by Subject|6|||
163257276|NCT01896869|589652649|FG000|Overall Study|Lost to Follow-up|1|||
163257277|NCT01896869|589652650|FG001|Overall Study|Lost to Follow-up|0|||
163257278|NCT00454571|589652657|FG000|Overall Study|Adverse Event|2|||
163257279|NCT00454571|589652658|FG001|Overall Study|Adverse Event|0|||
163257280|NCT00454571|589652657|FG000|Overall Study|Physician Decision|0|||
163257281|NCT00454571|589652658|FG001|Overall Study|Physician Decision|1|||
163257282|NCT00454571|589652657|FG000|Overall Study|Protocol Violation|1|||
163257283|NCT00454571|589652658|FG001|Overall Study|Protocol Violation|0|||
163257284|NCT00454571|589652657|FG000|Overall Study|Withdrawal by Subject|10|||
163257285|NCT00454571|589652658|FG001|Overall Study|Withdrawal by Subject|5|||
163257286|NCT01376323|589652659|FG000|Overall Study|Adverse Event|1|||
163257287|NCT01376323|589652660|FG001|Overall Study|Adverse Event|0|||
163257288|NCT01376323|589652661|FG002|Overall Study|Adverse Event|0|||
163257289|NCT01376323|589652662|FG003|Overall Study|Adverse Event|2|||
163257290|NCT01376323|589652663|FG004|Overall Study|Adverse Event|0|||
163257291|NCT01376323|589652659|FG000|Overall Study|Lost to Follow-up|0|||
163257292|NCT01376323|589652660|FG001|Overall Study|Lost to Follow-up|0|||
163257293|NCT01376323|589652661|FG002|Overall Study|Lost to Follow-up|0|||
163257294|NCT01376323|589652662|FG003|Overall Study|Lost to Follow-up|2|||
163257295|NCT01376323|589652663|FG004|Overall Study|Lost to Follow-up|0|||
163257296|NCT01376323|589652659|FG000|Overall Study|Physician Decision|1|||
163257297|NCT01376323|589652660|FG001|Overall Study|Physician Decision|0|||
163257298|NCT01376323|589652661|FG002|Overall Study|Physician Decision|2|||
163257299|NCT01376323|589652662|FG003|Overall Study|Physician Decision|1|||
163257300|NCT01376323|589652663|FG004|Overall Study|Physician Decision|1|||
163257301|NCT01376323|589652659|FG000|Overall Study|Withdrawal by Subject|0|||
163257302|NCT01376323|589652660|FG001|Overall Study|Withdrawal by Subject|1|||
163257303|NCT01376323|589652661|FG002|Overall Study|Withdrawal by Subject|1|||
163257304|NCT01376323|589652662|FG003|Overall Study|Withdrawal by Subject|0|||
163257305|NCT01376323|589652663|FG004|Overall Study|Withdrawal by Subject|0|||
163257306|NCT04681729|589652664|FG000|Overall Study|Lack of Efficacy|2|||
163257307|NCT04681729|589652665|FG001|Overall Study|Lack of Efficacy|2|||
163257308|NCT04681729|589652664|FG000|Overall Study|Withdrawal by Subject|8|||
163257309|NCT04681729|589652665|FG001|Overall Study|Withdrawal by Subject|9|||
163257310|NCT02436811|589652666|FG000|Overall Study|Lost to Follow-up|2|||
163257311|NCT02436811|589652667|FG001|Overall Study|Lost to Follow-up|9|||
163257312|NCT02436811|589652668|FG002|Overall Study|Lost to Follow-up|7|||
163257313|NCT00792103|589652669|FG000|Overall Study|Enrolled, not treated|15|||
163257314|NCT00792103|589652669|FG000|Overall Study|Lost to Follow-up|17|||
163257315|NCT00792103|589652669|FG000|Overall Study|Adverse Event|25|||
163257316|NCT00792103|589652669|FG000|Overall Study|Withdrawal by Subject|52|||
163257317|NCT00792103|589652669|FG000|Overall Study|Protocol Violation|10|||
163257318|NCT00792103|589652669|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
163257319|NCT02856113|589652670|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
163257320|NCT02856113|589652671|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
163257321|NCT02856113|589652670|FG000|Overall Study|Significant Protocol Deviation|1|||
163257322|NCT02856113|589652671|FG001|Overall Study|Significant Protocol Deviation|0|||
163257323|NCT02856113|589652670|FG000|Overall Study|Lost to Follow-up|3|||
163257324|NCT02856113|589652671|FG001|Overall Study|Lost to Follow-up|5|||
163257325|NCT02856113|589652670|FG000|Overall Study|Voluntary Withdrawal|3|||
163257326|NCT02856113|589652671|FG001|Overall Study|Voluntary Withdrawal|5|||
163257327|NCT02856113|589652670|FG000|Overall Study|Pregnancy|0|||
163257328|NCT02856113|589652671|FG001|Overall Study|Pregnancy|1|||
163361215|NCT00121667|590031657|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
163361216|NCT00121667|590031658|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
163361217|NCT00121667|590031659|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
163361218|NCT00121667|590031656|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
163361219|NCT00121667|590031657|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
163361220|NCT00121667|590031658|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
163361221|NCT00121667|590031659|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
163361222|NCT00121667|590031656|FG000|Short Term (ST) Period|Other Reason|3|||
163361223|NCT00121667|590031657|FG001|Short Term (ST) Period|Other Reason|0|||
163361224|NCT00121667|590031658|FG002|Short Term (ST) Period|Other Reason|0|||
163361225|NCT00121667|590031659|FG003|Short Term (ST) Period|Other Reason|0|||
163361226|NCT00121667|590031656|FG000|Short Term (ST) Period|Death|0|||
163361227|NCT00121667|590031657|FG001|Short Term (ST) Period|Death|0|||
163361228|NCT00121667|590031658|FG002|Short Term (ST) Period|Death|0|||
163361229|NCT00121667|590031659|FG003|Short Term (ST) Period|Death|1|||
163361230|NCT00121667|590031656|FG000|Short Term (ST) Period|Pregnancy|0|||
163361231|NCT00121667|590031657|FG001|Short Term (ST) Period|Pregnancy|0|||
163361232|NCT00121667|590031658|FG002|Short Term (ST) Period|Pregnancy|0|||
163361233|NCT00121667|590031659|FG003|Short Term (ST) Period|Pregnancy|1|||
163361234|NCT00121667|590031656|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
163361235|NCT00121667|590031657|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
163361236|NCT00121667|590031658|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
163361237|NCT00121667|590031659|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
163361238|NCT00121667|590031656|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
163361239|NCT00121667|590031657|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
163257329|NCT02856113|589652670|FG000|Overall Study|Principal Investigator Discretion|2|||
163257330|NCT02856113|589652671|FG001|Overall Study|Principal Investigator Discretion|1|||
163257331|NCT02856113|589652670|FG000|Overall Study|Randomized but not Treated|1|||
163257332|NCT02856113|589652671|FG001|Overall Study|Randomized but not Treated|0|||
163257333|NCT02856113|589652670|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
163257334|NCT02856113|589652671|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
163257335|NCT03494166|589652672|FG000|Overall Study|Death|0|||
163361240|NCT00121667|590031658|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
163257336|NCT03494166|589652673|FG001|Overall Study|Death|0|||
163257337|NCT03494166|589652674|FG002|Overall Study|Death|0|||
163257338|NCT03494166|589652675|FG003|Overall Study|Death|1|||
163257339|NCT03494166|589652676|FG004|Overall Study|Death|3|||
163257340|NCT03494166|589652677|FG005|Overall Study|Death|0|||
163257341|NCT03494166|589652672|FG000|Overall Study|Lost to Follow-up|2|||
163257342|NCT03494166|589652673|FG001|Overall Study|Lost to Follow-up|2|||
163257343|NCT03494166|589652674|FG002|Overall Study|Lost to Follow-up|2|||
163257344|NCT03494166|589652675|FG003|Overall Study|Lost to Follow-up|2|||
163257345|NCT03494166|589652676|FG004|Overall Study|Lost to Follow-up|14|||
163257346|NCT03494166|589652677|FG005|Overall Study|Lost to Follow-up|0|||
163257347|NCT03494166|589652672|FG000|Overall Study|Withdrawal by Subject|10|||
163257348|NCT03494166|589652673|FG001|Overall Study|Withdrawal by Subject|7|||
163257349|NCT03494166|589652674|FG002|Overall Study|Withdrawal by Subject|0|||
163257350|NCT03494166|589652675|FG003|Overall Study|Withdrawal by Subject|5|||
163257351|NCT03494166|589652676|FG004|Overall Study|Withdrawal by Subject|3|||
163257352|NCT03494166|589652677|FG005|Overall Study|Withdrawal by Subject|17|||
163257353|NCT03494166|589652672|FG000|Overall Study|Screen failure|1|||
163257354|NCT03494166|589652673|FG001|Overall Study|Screen failure|0|||
163257355|NCT03494166|589652674|FG002|Overall Study|Screen failure|0|||
163257356|NCT03494166|589652675|FG003|Overall Study|Screen failure|0|||
163257357|NCT03494166|589652676|FG004|Overall Study|Screen failure|1|||
163257358|NCT03494166|589652677|FG005|Overall Study|Screen failure|0|||
163257359|NCT02110901|589652682|FG000|Overall Study|Death|6|||
163257360|NCT02110901|589652683|FG001|Overall Study|Death|3|||
163257361|NCT02110901|589652682|FG000|Overall Study|Lost to Follow-up|12|||
163257362|NCT02110901|589652683|FG001|Overall Study|Lost to Follow-up|8|||
163257363|NCT02110901|589652682|FG000|Overall Study|Withdrawal by Subject|7|||
163257364|NCT02110901|589652683|FG001|Overall Study|Withdrawal by Subject|3|||
163257365|NCT02110901|589652682|FG000|Overall Study|received a kidney transplant|5|||
163257366|NCT02110901|589652683|FG001|Overall Study|received a kidney transplant|0|||
163257367|NCT00855595|589652685|FG000|Overall Study|Withdrawal by Subject|1|||
163257368|NCT00855595|589652686|FG001|Overall Study|Withdrawal by Subject|2|||
163257369|NCT00855595|589652685|FG000|Overall Study|Lost to Follow-up|3|||
163257370|NCT00855595|589652686|FG001|Overall Study|Lost to Follow-up|3|||
163257371|NCT00855595|589652685|FG000|Overall Study|Adverse Event|1|||
163257372|NCT00855595|589652686|FG001|Overall Study|Adverse Event|1|||
163257373|NCT00855595|589652685|FG000|Overall Study|patient moved out of state|1|||
163257374|NCT00855595|589652686|FG001|Overall Study|patient moved out of state|0|||
163257375|NCT00855595|589652685|FG000|Overall Study|patient left country|0|||
163257376|NCT00855595|589652686|FG001|Overall Study|patient left country|1|||
163257377|NCT01058304|589652688|FG000|Overall Study|Withdrawal by Subject|8|||
163257378|NCT01058304|589652689|FG001|Overall Study|Withdrawal by Subject|5|||
163257379|NCT01058304|589652688|FG000|Overall Study|Lost to Follow-up|13|||
163257380|NCT01058304|589652689|FG001|Overall Study|Lost to Follow-up|16|||
163257381|NCT01058304|589652688|FG000|Overall Study|Developed exclusion criterion|6|||
163257382|NCT01058304|589652689|FG001|Overall Study|Developed exclusion criterion|12|||
163257383|NCT01820559|589652690|FG000|Overall Study|Adverse Event|4|||
163257384|NCT01820559|589652691|FG001|Overall Study|Adverse Event|6|||
163257385|NCT01820559|589652692|FG002|Overall Study|Adverse Event|13|||
163257386|NCT01820559|589652690|FG000|Overall Study|Withdrawal by Subject|1|||
163257387|NCT01820559|589652691|FG001|Overall Study|Withdrawal by Subject|2|||
163257388|NCT01820559|589652692|FG002|Overall Study|Withdrawal by Subject|5|||
163257389|NCT01820559|589652690|FG000|Overall Study|Protocol Violation|2|||
163257390|NCT01820559|589652691|FG001|Overall Study|Protocol Violation|1|||
163257391|NCT01820559|589652692|FG002|Overall Study|Protocol Violation|3|||
163257392|NCT01820559|589652690|FG000|Overall Study|Subject's non-compliance|1|||
163257393|NCT01820559|589652691|FG001|Overall Study|Subject's non-compliance|0|||
163257394|NCT01820559|589652692|FG002|Overall Study|Subject's non-compliance|2|||
163257395|NCT01820559|589652690|FG000|Overall Study|Lost to Follow-up|3|||
163257396|NCT01820559|589652691|FG001|Overall Study|Lost to Follow-up|2|||
163257397|NCT01820559|589652692|FG002|Overall Study|Lost to Follow-up|2|||
163257398|NCT01820559|589652690|FG000|Overall Study|At sponsor request|0|||
163257399|NCT01820559|589652691|FG001|Overall Study|At sponsor request|0|||
163257400|NCT01820559|589652692|FG002|Overall Study|At sponsor request|1|||
163257401|NCT01820559|589652690|FG000|Overall Study|Lack of Efficacy|3|||
163257402|NCT01820559|589652691|FG001|Overall Study|Lack of Efficacy|2|||
163257403|NCT01820559|589652692|FG002|Overall Study|Lack of Efficacy|3|||
163257404|NCT02496767|589652693|FG000|Open-label Lead-in Phase|Adverse Event|176|||
163257405|NCT02496767|589652694|FG001|Open-label Lead-in Phase|Adverse Event|0|||
163257406|NCT02496767|589652695|FG002|Open-label Lead-in Phase|Adverse Event|0|||
163257407|NCT02496767|589652696|FG003|Open-label Lead-in Phase|Adverse Event|0|||
163257408|NCT02496767|589652697|FG004|Open-label Lead-in Phase|Adverse Event|0|||
163257409|NCT02496767|589652698|FG005|Open-label Lead-in Phase|Adverse Event|0|||
163257410|NCT02496767|589652699|FG006|Open-label Lead-in Phase|Adverse Event|0|||
163257411|NCT02496767|589652700|FG007|Open-label Lead-in Phase|Adverse Event|0|||
163257412|NCT02496767|589652693|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
163257413|NCT02496767|589652694|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
163257414|NCT02496767|589652695|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
163411029|NCT03215030|590212952|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
163151790|NCT05556265|589269540|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
163151791|NCT05556265|589269541|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
163151792|NCT05556265|589269537|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
163151793|NCT05556265|589269538|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
163151794|NCT05556265|589269539|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
163151795|NCT05556265|589269540|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
163151796|NCT05556265|589269541|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
163151797|NCT05556265|589269537|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
163151798|NCT05556265|589269538|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
163151799|NCT05556265|589269539|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
163151800|NCT05556265|589269540|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
163151801|NCT05556265|589269541|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
163151802|NCT05556265|589269537|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
163151803|NCT05556265|589269538|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
163151804|NCT05556265|589269539|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
163151805|NCT05556265|589269540|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
163151806|NCT05556265|589269541|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
163151807|NCT05556265|589269537|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
163151808|NCT05556265|589269538|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
163151809|NCT05556265|589269539|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
163151810|NCT05556265|589269540|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
163151811|NCT05556265|589269541|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
163151812|NCT01486966|589269546|FG000|Overall Study|Adverse Event|0|||
163151813|NCT01486966|589269547|FG001|Overall Study|Adverse Event|1|||
163151814|NCT01486966|589269546|FG000|Overall Study|Withdrawal by Subject|0|||
163151815|NCT01486966|589269547|FG001|Overall Study|Withdrawal by Subject|1|||
163151816|NCT03518086|589269550|FG000|Overall Study|Adverse Event|23|||
163151817|NCT03518086|589269551|FG001|Overall Study|Adverse Event|15|||
163151818|NCT03518086|589269552|FG002|Overall Study|Adverse Event|3|||
163151819|NCT03518086|589269553|FG003|Overall Study|Adverse Event|2|||
163151820|NCT03518086|589269550|FG000|Overall Study|Withdrawal by Subject|8|||
163151821|NCT03518086|589269551|FG001|Overall Study|Withdrawal by Subject|5|||
163151822|NCT03518086|589269552|FG002|Overall Study|Withdrawal by Subject|1|||
163151823|NCT03518086|589269553|FG003|Overall Study|Withdrawal by Subject|0|||
163151824|NCT03518086|589269550|FG000|Overall Study|Lack of Efficacy|5|||
163151825|NCT03518086|589269551|FG001|Overall Study|Lack of Efficacy|5|||
163151826|NCT03518086|589269552|FG002|Overall Study|Lack of Efficacy|0|||
163151827|NCT03518086|589269553|FG003|Overall Study|Lack of Efficacy|2|||
163151828|NCT03518086|589269550|FG000|Overall Study|Protocol Violation|1|||
163151829|NCT03518086|589269551|FG001|Overall Study|Protocol Violation|5|||
163151830|NCT03518086|589269552|FG002|Overall Study|Protocol Violation|1|||
163151831|NCT03518086|589269553|FG003|Overall Study|Protocol Violation|3|||
163151832|NCT03518086|589269550|FG000|Overall Study|Lost to Follow-up|0|||
163151833|NCT03518086|589269551|FG001|Overall Study|Lost to Follow-up|3|||
163151834|NCT03518086|589269552|FG002|Overall Study|Lost to Follow-up|0|||
163151835|NCT03518086|589269553|FG003|Overall Study|Lost to Follow-up|0|||
163151836|NCT03518086|589269550|FG000|Overall Study|Insufficient Diary Data|0|||
163151837|NCT03518086|589269551|FG001|Overall Study|Insufficient Diary Data|2|||
163151838|NCT03518086|589269552|FG002|Overall Study|Insufficient Diary Data|0|||
163151839|NCT03518086|589269553|FG003|Overall Study|Insufficient Diary Data|0|||
163151840|NCT03518086|589269550|FG000|Overall Study|Non- compliance to Protocol|0|||
163151841|NCT03518086|589269551|FG001|Overall Study|Non- compliance to Protocol|1|||
163151842|NCT03518086|589269552|FG002|Overall Study|Non- compliance to Protocol|0|||
163151843|NCT03518086|589269553|FG003|Overall Study|Non- compliance to Protocol|0|||
163151844|NCT03518086|589269550|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
163151845|NCT03518086|589269551|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
163151846|NCT03518086|589269552|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
163151847|NCT03518086|589269553|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
163151848|NCT03518086|589269550|FG000|Overall Study|Site Terminated by Sponsor|0|||
163151849|NCT03518086|589269551|FG001|Overall Study|Site Terminated by Sponsor|1|||
163151850|NCT03518086|589269552|FG002|Overall Study|Site Terminated by Sponsor|0|||
163151851|NCT03518086|589269553|FG003|Overall Study|Site Terminated by Sponsor|0|||
163151852|NCT03518086|589269550|FG000|Overall Study|Pregnancy|0|||
163151853|NCT03518086|589269551|FG001|Overall Study|Pregnancy|0|||
163151854|NCT03518086|589269552|FG002|Overall Study|Pregnancy|0|||
163151855|NCT03518086|589269553|FG003|Overall Study|Pregnancy|2|||
163151856|NCT02336282|589269554|FG000|Overall Study|Unrelated illness|1|||
163151857|NCT02336282|589269554|FG000|Overall Study|Uncomfortable with technology|1|||
163151858|NCT02336282|589269554|FG000|Overall Study|Lost to Follow-up|1|||
163151859|NCT02336282|589269554|FG000|Overall Study|Not enough time to complete sessions|2|||
163257415|NCT02496767|589652696|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
163257416|NCT02496767|589652697|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
163257417|NCT02496767|589652698|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
163257418|NCT02496767|589652699|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
163257419|NCT02496767|589652700|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
163257420|NCT02496767|589652693|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
163257421|NCT02496767|589652694|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
163257422|NCT02496767|589652695|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
163257423|NCT02496767|589652696|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
163257424|NCT02496767|589652697|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
163257425|NCT02496767|589652698|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
163257426|NCT02496767|589652699|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
163257427|NCT02496767|589652700|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
163257428|NCT02496767|589652693|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
163257429|NCT02496767|589652694|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
163257430|NCT02496767|589652695|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
163257431|NCT02496767|589652696|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
163257432|NCT02496767|589652697|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
163257433|NCT02496767|589652698|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
163257434|NCT02496767|589652699|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
163257435|NCT02496767|589652700|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
163257436|NCT02496767|589652693|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
163257437|NCT02496767|589652694|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
163257438|NCT02496767|589652695|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
163257439|NCT02496767|589652696|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
163257440|NCT02496767|589652697|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
163257441|NCT02496767|589652698|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
163257442|NCT02496767|589652699|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
163257443|NCT02496767|589652700|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
163257444|NCT02496767|589652693|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
163257445|NCT02496767|589652694|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
163257446|NCT02496767|589652695|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
163257447|NCT02496767|589652696|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
163257448|NCT02496767|589652697|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
163257449|NCT02496767|589652698|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
163257450|NCT02496767|589652699|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
163257451|NCT02496767|589652700|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
163257452|NCT02496767|589652693|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
163257453|NCT02496767|589652694|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
163257454|NCT02496767|589652695|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
163257455|NCT02496767|589652696|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
163257456|NCT02496767|589652697|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
163257457|NCT02496767|589652698|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
163257458|NCT02496767|589652699|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
163257459|NCT02496767|589652700|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
163257460|NCT02496767|589652693|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
163257461|NCT02496767|589652694|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
163257462|NCT02496767|589652695|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
163257463|NCT02496767|589652696|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
163257464|NCT02496767|589652697|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
163257465|NCT02496767|589652698|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
163257466|NCT02496767|589652699|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
163257467|NCT02496767|589652700|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
163257468|NCT02496767|589652693|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
163257469|NCT02496767|589652694|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
163257470|NCT02496767|589652695|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
163257471|NCT02496767|589652696|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
163257472|NCT02496767|589652697|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
163257473|NCT02496767|589652698|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
163257474|NCT02496767|589652699|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
163257475|NCT02496767|589652700|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
163257476|NCT02496767|589652693|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
163411030|NCT03215030|590212953|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
163411031|NCT03215030|590212954|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
163257477|NCT02496767|589652694|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
163257478|NCT02496767|589652695|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
163257479|NCT02496767|589652696|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
163257480|NCT02496767|589652697|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
163257481|NCT02496767|589652698|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
163257482|NCT02496767|589652699|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
163257483|NCT02496767|589652700|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
163257484|NCT02496767|589652693|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
163257485|NCT02496767|589652694|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
163257486|NCT02496767|589652695|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
163257487|NCT02496767|589652696|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
163257488|NCT02496767|589652697|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
163257489|NCT02496767|589652698|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
163257490|NCT02496767|589652699|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
163257491|NCT02496767|589652700|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
163257492|NCT02496767|589652693|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
163257493|NCT02496767|589652694|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
163257494|NCT02496767|589652695|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
163257495|NCT02496767|589652696|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
163257496|NCT02496767|589652697|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
163257497|NCT02496767|589652698|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
163257498|NCT02496767|589652699|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
163257499|NCT02496767|589652700|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
163257500|NCT02496767|589652693|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
163257501|NCT02496767|589652694|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
163257502|NCT02496767|589652695|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
163257503|NCT02496767|589652696|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
163257504|NCT02496767|589652697|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
163257505|NCT02496767|589652698|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
163257506|NCT02496767|589652699|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
163257507|NCT02496767|589652700|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
163257508|NCT02496767|589652693|FG000|Double-blind, Withdrawal Phase|Death|0|||
163257509|NCT02496767|589652694|FG001|Double-blind, Withdrawal Phase|Death|0|||
163257510|NCT02496767|589652695|FG002|Double-blind, Withdrawal Phase|Death|0|||
163257511|NCT02496767|589652696|FG003|Double-blind, Withdrawal Phase|Death|0|||
163257512|NCT02496767|589652697|FG004|Double-blind, Withdrawal Phase|Death|0|||
163257513|NCT02496767|589652698|FG005|Double-blind, Withdrawal Phase|Death|0|||
163257514|NCT02496767|589652699|FG006|Double-blind, Withdrawal Phase|Death|1|||
163257515|NCT02496767|589652700|FG007|Double-blind, Withdrawal Phase|Death|2|||
163257516|NCT02496767|589652693|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
163257517|NCT02496767|589652694|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
163257518|NCT02496767|589652695|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
163257519|NCT02496767|589652696|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
163257520|NCT02496767|589652697|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
163257521|NCT02496767|589652698|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
163257522|NCT02496767|589652699|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
163257523|NCT02496767|589652700|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
163257524|NCT00166296|589652701|FG000|Overall Study|Withdrawal by Subject|1|||
163257525|NCT00166296|589652702|FG001|Overall Study|Withdrawal by Subject|3|||
163257526|NCT00166296|589652701|FG000|Overall Study|Adverse Event|2|||
163257527|NCT00166296|589652702|FG001|Overall Study|Adverse Event|4|||
163257528|NCT00166296|589652701|FG000|Overall Study|Lost to Follow-up|4|||
163257529|NCT00166296|589652702|FG001|Overall Study|Lost to Follow-up|2|||
163257530|NCT04035200|589652708|FG000|Overall Study|Lost to Follow-up|0|||
163257531|NCT04035200|589652709|FG001|Overall Study|Lost to Follow-up|1|||
163257532|NCT04035200|589652710|FG002|Overall Study|Lost to Follow-up|0|||
163361241|NCT00121667|590031659|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
163361242|NCT00121667|590031656|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
163361243|NCT00121667|590031657|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
163361244|NCT00121667|590031658|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
163361245|NCT00121667|590031659|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
163361246|NCT00121667|590031656|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
163361247|NCT00121667|590031657|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
163361248|NCT00121667|590031658|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
163361249|NCT00121667|590031659|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
163411032|NCT03215030|590212955|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
163257533|NCT04035200|589652708|FG000|Overall Study|Withdrawal by Subject|1|||
163257534|NCT04035200|589652709|FG001|Overall Study|Withdrawal by Subject|4|||
163257535|NCT04035200|589652710|FG002|Overall Study|Withdrawal by Subject|4|||
163257536|NCT04035200|589652708|FG000|Overall Study|COVID-19|1|||
163257537|NCT04035200|589652709|FG001|Overall Study|COVID-19|0|||
163257538|NCT04035200|589652710|FG002|Overall Study|COVID-19|0|||
163257539|NCT04035200|589652708|FG000|Overall Study|Early Termination|0|||
163257540|NCT04035200|589652709|FG001|Overall Study|Early Termination|1|||
163257541|NCT04035200|589652710|FG002|Overall Study|Early Termination|0|||
163257542|NCT04035200|589652708|FG000|Overall Study|Non-compliance|0|||
163257543|NCT04035200|589652709|FG001|Overall Study|Non-compliance|1|||
163257544|NCT04035200|589652710|FG002|Overall Study|Non-compliance|0|||
163257545|NCT02277990|589652711|FG000|Overall Study|Death|170|||
163257546|NCT02277990|589652712|FG001|Overall Study|Death|188|||
163257547|NCT02277990|589652711|FG000|Overall Study|Withdrawal by Subject|64|||
163257548|NCT02277990|589652712|FG001|Overall Study|Withdrawal by Subject|53|||
163257549|NCT02277990|589652711|FG000|Overall Study|Physician Decision|40|||
163257550|NCT02277990|589652712|FG001|Overall Study|Physician Decision|34|||
163257551|NCT02277990|589652711|FG000|Overall Study|Lost to Follow-up|66|||
163257552|NCT02277990|589652712|FG001|Overall Study|Lost to Follow-up|69|||
163257553|NCT02277990|589652711|FG000|Overall Study|Had other reason|26|||
163257554|NCT02277990|589652712|FG001|Overall Study|Had other reason|32|||
163257555|NCT04581200|589652713|FG000|Overall Study|Lost to Follow-up|6|||
163257556|NCT04581200|589652714|FG001|Overall Study|Lost to Follow-up|5|||
163257557|NCT04711603|589652715|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
163257558|NCT04711603|589652716|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
163257559|NCT04711603|589652717|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
163257560|NCT04711603|589652718|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
163257561|NCT04711603|589652715|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
163257562|NCT04711603|589652716|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
163257563|NCT04711603|589652717|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
163257564|NCT04711603|589652718|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
163257565|NCT04711603|589652715|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
163257566|NCT04711603|589652716|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
163257567|NCT04711603|589652717|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
163257568|NCT04711603|589652718|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
163257569|NCT04711603|589652715|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
163257570|NCT04711603|589652716|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
163257571|NCT04711603|589652717|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
163257572|NCT04711603|589652718|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
163257573|NCT04711603|589652715|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
163257574|NCT04711603|589652716|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
163257575|NCT04711603|589652717|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
163257576|NCT04711603|589652718|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
163257577|NCT04711603|589652715|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
163257578|NCT04711603|589652716|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
163257579|NCT04711603|589652717|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
163257580|NCT04711603|589652718|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
163257581|NCT04711603|589652715|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
163257582|NCT04711603|589652716|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
163257583|NCT04711603|589652717|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
163257584|NCT04711603|589652718|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
163257585|NCT04711603|589652715|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
163257586|NCT04711603|589652716|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
163257587|NCT04711603|589652717|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
163257588|NCT04711603|589652718|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
163257589|NCT04711603|589652715|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
163257590|NCT04711603|589652716|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
163257591|NCT04711603|589652717|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
163257592|NCT04711603|589652718|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
163257593|NCT04711603|589652715|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
163257594|NCT04711603|589652716|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
163257595|NCT04711603|589652717|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
163257596|NCT04711603|589652718|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
163257597|NCT04711603|589652715|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
163257598|NCT04711603|589652716|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
163257599|NCT04711603|589652717|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
163257600|NCT04711603|589652718|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
163257601|NCT04711603|589652715|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
163257602|NCT04711603|589652716|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
163257603|NCT04711603|589652717|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
163257604|NCT04711603|589652718|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
163257605|NCT03351738|589652719|FG000|Overall Study|Withdrawal by Subject|0|||
163257606|NCT03351738|589652720|FG001|Overall Study|Withdrawal by Subject|1|||
163257607|NCT03351738|589652721|FG002|Overall Study|Withdrawal by Subject|0|||
163257608|NCT03351738|589652722|FG003|Overall Study|Withdrawal by Subject|1|||
163257609|NCT03351738|589652723|FG004|Overall Study|Withdrawal by Subject|0|||
163257610|NCT03351738|589652724|FG005|Overall Study|Withdrawal by Subject|0|||
163257611|NCT01089374|589652729|FG000|Overall Study|Lost to Follow-up|3|||
163257612|NCT01089374|589652730|FG001|Overall Study|Lost to Follow-up|0|||
163257613|NCT01089374|589652729|FG000|Overall Study|Withdrawal by Subject|1|||
163257614|NCT01089374|589652730|FG001|Overall Study|Withdrawal by Subject|0|||
163257615|NCT01089374|589652729|FG000|Overall Study|Study closed early - low accrual|6|||
163257616|NCT01089374|589652730|FG001|Overall Study|Study closed early - low accrual|0|||
163257617|NCT02597036|589652743|FG000|Overall Study|Progressive Disease|0|||
163257618|NCT02597036|589652744|FG001|Overall Study|Progressive Disease|0|||
163257619|NCT02597036|589652745|FG002|Overall Study|Progressive Disease|0|||
163257620|NCT02597036|589652746|FG003|Overall Study|Progressive Disease|0|||
163257621|NCT02597036|589652747|FG004|Overall Study|Progressive Disease|1|||
163257622|NCT02597036|589652748|FG005|Overall Study|Progressive Disease|1|||
163257623|NCT02597036|589652749|FG006|Overall Study|Progressive Disease|1|||
163257624|NCT02597036|589652750|FG007|Overall Study|Progressive Disease|0|||
163257625|NCT02597036|589652751|FG008|Overall Study|Progressive Disease|0|||
163257626|NCT02597036|589652752|FG009|Overall Study|Progressive Disease|0|||
163257627|NCT02597036|589652753|FG010|Overall Study|Progressive Disease|0|||
163257628|NCT02597036|589652754|FG011|Overall Study|Progressive Disease|0|||
163257629|NCT02597036|589652743|FG000|Overall Study|Adverse Event|0|||
163257630|NCT02597036|589652744|FG001|Overall Study|Adverse Event|0|||
163257631|NCT02597036|589652745|FG002|Overall Study|Adverse Event|0|||
163257632|NCT02597036|589652746|FG003|Overall Study|Adverse Event|0|||
163257633|NCT02597036|589652747|FG004|Overall Study|Adverse Event|0|||
163257634|NCT02597036|589652748|FG005|Overall Study|Adverse Event|0|||
163257635|NCT02597036|589652749|FG006|Overall Study|Adverse Event|0|||
163257636|NCT02597036|589652750|FG007|Overall Study|Adverse Event|1|||
163257637|NCT02597036|589652751|FG008|Overall Study|Adverse Event|0|||
163257638|NCT02597036|589652752|FG009|Overall Study|Adverse Event|0|||
163257639|NCT02597036|589652753|FG010|Overall Study|Adverse Event|0|||
163257640|NCT02597036|589652754|FG011|Overall Study|Adverse Event|1|||
163257641|NCT02597036|589652743|FG000|Overall Study|Death|0|||
163257642|NCT02597036|589652744|FG001|Overall Study|Death|0|||
163257643|NCT02597036|589652745|FG002|Overall Study|Death|0|||
163361250|NCT00121667|590031656|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
163361251|NCT00121667|590031657|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
163361252|NCT00121667|590031658|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
163361253|NCT00121667|590031659|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
163361254|NCT00121667|590031656|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
163361255|NCT00121667|590031657|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
163361256|NCT00121667|590031658|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
163361257|NCT00121667|590031659|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
163361258|NCT00121667|590031656|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
163361259|NCT00121667|590031657|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
163361260|NCT00121667|590031658|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
163361261|NCT00121667|590031659|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
163361262|NCT00121667|590031656|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
163361263|NCT00121667|590031657|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
163361264|NCT00121667|590031658|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
163361265|NCT00121667|590031659|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
163361266|NCT00121667|590031656|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
163361267|NCT00121667|590031657|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
163361268|NCT00121667|590031658|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
163361269|NCT00121667|590031659|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
163361270|NCT04468230|590031665|FG000|Overall Study|Adverse Event|2|||
163361271|NCT03994731|590031670|FG000|Pegloticase + IMM Period|Death|2|||
163361272|NCT03994731|590031671|FG001|Pegloticase + IMM Period|Death|0|||
163257644|NCT02597036|589652746|FG003|Overall Study|Death|0|||
163257645|NCT02597036|589652747|FG004|Overall Study|Death|0|||
163257646|NCT02597036|589652748|FG005|Overall Study|Death|0|||
163257647|NCT02597036|589652749|FG006|Overall Study|Death|0|||
163257648|NCT02597036|589652750|FG007|Overall Study|Death|0|||
163257649|NCT02597036|589652751|FG008|Overall Study|Death|0|||
163257650|NCT02597036|589652752|FG009|Overall Study|Death|1|||
163257651|NCT02597036|589652753|FG010|Overall Study|Death|1|||
163257652|NCT02597036|589652754|FG011|Overall Study|Death|0|||
163257653|NCT02597036|589652743|FG000|Overall Study|Lost to Follow-up|0|||
163257654|NCT02597036|589652744|FG001|Overall Study|Lost to Follow-up|0|||
163257655|NCT02597036|589652745|FG002|Overall Study|Lost to Follow-up|0|||
163257656|NCT02597036|589652746|FG003|Overall Study|Lost to Follow-up|0|||
163257657|NCT02597036|589652747|FG004|Overall Study|Lost to Follow-up|0|||
163257658|NCT02597036|589652748|FG005|Overall Study|Lost to Follow-up|0|||
163257659|NCT02597036|589652749|FG006|Overall Study|Lost to Follow-up|0|||
163257660|NCT02597036|589652750|FG007|Overall Study|Lost to Follow-up|0|||
163257661|NCT02597036|589652751|FG008|Overall Study|Lost to Follow-up|0|||
163257662|NCT02597036|589652752|FG009|Overall Study|Lost to Follow-up|0|||
163257663|NCT02597036|589652753|FG010|Overall Study|Lost to Follow-up|1|||
163257664|NCT02597036|589652754|FG011|Overall Study|Lost to Follow-up|0|||
163257665|NCT02597036|589652743|FG000|Overall Study|Withdrawal by Subject|0|||
163257666|NCT02597036|589652744|FG001|Overall Study|Withdrawal by Subject|0|||
163257667|NCT02597036|589652745|FG002|Overall Study|Withdrawal by Subject|0|||
163257668|NCT02597036|589652746|FG003|Overall Study|Withdrawal by Subject|0|||
163257669|NCT02597036|589652747|FG004|Overall Study|Withdrawal by Subject|0|||
163257670|NCT02597036|589652748|FG005|Overall Study|Withdrawal by Subject|0|||
163257671|NCT02597036|589652749|FG006|Overall Study|Withdrawal by Subject|0|||
163257672|NCT02597036|589652750|FG007|Overall Study|Withdrawal by Subject|0|||
163257673|NCT02597036|589652751|FG008|Overall Study|Withdrawal by Subject|0|||
163257674|NCT02597036|589652752|FG009|Overall Study|Withdrawal by Subject|0|||
163257675|NCT02597036|589652753|FG010|Overall Study|Withdrawal by Subject|0|||
163257676|NCT02597036|589652754|FG011|Overall Study|Withdrawal by Subject|1|||
163257677|NCT01533493|589652755|FG000|Overall Study|Adverse Event|2|||
163257678|NCT01533493|589652756|FG001|Overall Study|Adverse Event|1|||
163257679|NCT01533493|589652755|FG000|Overall Study|Withdrawal by Subject|1|||
163257680|NCT01533493|589652756|FG001|Overall Study|Withdrawal by Subject|2|||
163257681|NCT01533493|589652755|FG000|Overall Study|Lost to Follow-up|2|||
163257682|NCT01533493|589652756|FG001|Overall Study|Lost to Follow-up|0|||
163257683|NCT04672941|589652765|FG000|Overall Study|Investigator decision|1|||
163257684|NCT04672941|589652765|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
163257685|NCT04672941|589652765|FG000|Overall Study|COVID-19 related but no adverse event|1|||
163257686|NCT04672941|589652765|FG000|Overall Study|Adverse Event|2|||
163257687|NCT04672941|589652765|FG000|Overall Study|Lost to Follow-up|2|||
163257688|NCT00386022|589652771|FG000|Plus Estrogen|Lost to Follow-up|2|||
163257689|NCT00386022|589652772|FG001|Plus Estrogen|Lost to Follow-up|0|||
163257690|NCT00386022|589652771|FG000|Plus Estrogen|Adverse Event|0|||
163257691|NCT00386022|589652772|FG001|Plus Estrogen|Adverse Event|1|||
163257692|NCT00504426|589652773|FG000|Overall Study|Adverse Event|0|||
163257693|NCT00504426|589652774|FG001|Overall Study|Adverse Event|0|||
163257694|NCT00504426|589652775|FG002|Overall Study|Adverse Event|2|||
163257695|NCT00504426|589652776|FG003|Overall Study|Adverse Event|0|||
163257696|NCT00504426|589652773|FG000|Overall Study|Protocol Violation|1|||
163257697|NCT00504426|589652774|FG001|Overall Study|Protocol Violation|1|||
163257698|NCT00504426|589652775|FG002|Overall Study|Protocol Violation|2|||
163257699|NCT00504426|589652776|FG003|Overall Study|Protocol Violation|0|||
163257700|NCT00504426|589652773|FG000|Overall Study|Withdrawal by Subject|2|||
163257701|NCT00504426|589652774|FG001|Overall Study|Withdrawal by Subject|0|||
163257702|NCT00504426|589652775|FG002|Overall Study|Withdrawal by Subject|0|||
163257703|NCT00504426|589652776|FG003|Overall Study|Withdrawal by Subject|0|||
163257704|NCT03685591|589652777|FG000|Overall Study|Global Deterioration of Health Status|0|||
163257705|NCT03685591|589652778|FG001|Overall Study|Global Deterioration of Health Status|0|||
163257706|NCT03685591|589652779|FG002|Overall Study|Global Deterioration of Health Status|0|||
163257707|NCT03685591|589652780|FG003|Overall Study|Global Deterioration of Health Status|1|||
163257708|NCT03685591|589652781|FG004|Overall Study|Global Deterioration of Health Status|2|||
163257709|NCT03685591|589652782|FG005|Overall Study|Global Deterioration of Health Status|4|||
163257710|NCT03685591|589652783|FG006|Overall Study|Global Deterioration of Health Status|1|||
163257711|NCT03685591|589652784|FG007|Overall Study|Global Deterioration of Health Status|1|||
163257712|NCT03685591|589652785|FG008|Overall Study|Global Deterioration of Health Status|0|||
163257713|NCT03685591|589652777|FG000|Overall Study|Progressive Disease|1|||
163257714|NCT03685591|589652778|FG001|Overall Study|Progressive Disease|1|||
163257715|NCT03685591|589652779|FG002|Overall Study|Progressive Disease|0|||
163257716|NCT03685591|589652780|FG003|Overall Study|Progressive Disease|3|||
163257717|NCT03685591|589652781|FG004|Overall Study|Progressive Disease|5|||
163257718|NCT03685591|589652782|FG005|Overall Study|Progressive Disease|4|||
163257719|NCT03685591|589652783|FG006|Overall Study|Progressive Disease|3|||
163257720|NCT03685591|589652784|FG007|Overall Study|Progressive Disease|2|||
163257721|NCT03685591|589652785|FG008|Overall Study|Progressive Disease|1|||
163257722|NCT03685591|589652777|FG000|Overall Study|Other|0|||
163257723|NCT03685591|589652778|FG001|Overall Study|Other|0|||
163257724|NCT03685591|589652779|FG002|Overall Study|Other|1|||
163257725|NCT03685591|589652780|FG003|Overall Study|Other|0|||
163257726|NCT03685591|589652781|FG004|Overall Study|Other|2|||
163257727|NCT03685591|589652782|FG005|Overall Study|Other|3|||
163257728|NCT03685591|589652783|FG006|Overall Study|Other|0|||
163257729|NCT03685591|589652784|FG007|Overall Study|Other|0|||
163257730|NCT03685591|589652785|FG008|Overall Study|Other|0|||
163257731|NCT03685591|589652777|FG000|Overall Study|Withdrawal by Subject|0|||
163257732|NCT03685591|589652778|FG001|Overall Study|Withdrawal by Subject|0|||
163257733|NCT03685591|589652779|FG002|Overall Study|Withdrawal by Subject|0|||
163257734|NCT03685591|589652780|FG003|Overall Study|Withdrawal by Subject|0|||
163257735|NCT03685591|589652781|FG004|Overall Study|Withdrawal by Subject|3|||
163257736|NCT03685591|589652782|FG005|Overall Study|Withdrawal by Subject|2|||
163257737|NCT03685591|589652783|FG006|Overall Study|Withdrawal by Subject|0|||
163257738|NCT03685591|589652784|FG007|Overall Study|Withdrawal by Subject|0|||
163257739|NCT03685591|589652785|FG008|Overall Study|Withdrawal by Subject|1|||
163257740|NCT03685591|589652777|FG000|Overall Study|Adverse Event|0|||
163257741|NCT03685591|589652778|FG001|Overall Study|Adverse Event|0|||
163257742|NCT03685591|589652779|FG002|Overall Study|Adverse Event|0|||
163257743|NCT03685591|589652780|FG003|Overall Study|Adverse Event|1|||
163257744|NCT03685591|589652781|FG004|Overall Study|Adverse Event|1|||
163257745|NCT03685591|589652782|FG005|Overall Study|Adverse Event|4|||
163257746|NCT03685591|589652783|FG006|Overall Study|Adverse Event|0|||
163257747|NCT03685591|589652784|FG007|Overall Study|Adverse Event|1|||
163257748|NCT03685591|589652785|FG008|Overall Study|Adverse Event|1|||
163257749|NCT03988166|589652790|FG000|Overall Study|Lost to Follow-up|2|||
163257750|NCT03988166|589652790|FG000|Overall Study|Death|1|||
163257751|NCT03933826|589652792|FG000|Overall Study|Withdrawal by Subject|8|||
163257752|NCT03933826|589652793|FG001|Overall Study|Withdrawal by Subject|1|||
163257753|NCT03933826|589652792|FG000|Overall Study|Death|19|||
163257754|NCT03933826|589652793|FG001|Overall Study|Death|11|||
163257755|NCT03933826|589652792|FG000|Overall Study|Lost to Follow-up|41|||
163257756|NCT03933826|589652793|FG001|Overall Study|Lost to Follow-up|13|||
163257757|NCT02638948|589652794|FG000|Overall Study|Withdrawal by Subject|4|||
163257758|NCT02638948|589652795|FG001|Overall Study|Withdrawal by Subject|5|||
163257759|NCT02638948|589652796|FG002|Overall Study|Withdrawal by Subject|3|||
163257760|NCT02638948|589652797|FG003|Overall Study|Withdrawal by Subject|1|||
163257761|NCT02638948|589652794|FG000|Overall Study|Administrative Reason by Sponsor|0|||
163257762|NCT02638948|589652795|FG001|Overall Study|Administrative Reason by Sponsor|1|||
163257763|NCT02638948|589652796|FG002|Overall Study|Administrative Reason by Sponsor|0|||
163257764|NCT02638948|589652797|FG003|Overall Study|Administrative Reason by Sponsor|4|||
163257765|NCT02638948|589652794|FG000|Overall Study|Adverse Event|0|||
163257766|NCT02638948|589652795|FG001|Overall Study|Adverse Event|0|||
163257767|NCT02638948|589652796|FG002|Overall Study|Adverse Event|1|||
163257768|NCT02638948|589652797|FG003|Overall Study|Adverse Event|1|||
163257769|NCT02638948|589652794|FG000|Overall Study|Lack of Efficacy|1|||
163257770|NCT02638948|589652795|FG001|Overall Study|Lack of Efficacy|1|||
163257771|NCT02638948|589652796|FG002|Overall Study|Lack of Efficacy|0|||
163257772|NCT02638948|589652797|FG003|Overall Study|Lack of Efficacy|0|||
163257773|NCT02638948|589652794|FG000|Overall Study|Lost to Follow-up|0|||
163257774|NCT02638948|589652795|FG001|Overall Study|Lost to Follow-up|0|||
163257775|NCT02638948|589652796|FG002|Overall Study|Lost to Follow-up|1|||
163257776|NCT02638948|589652797|FG003|Overall Study|Lost to Follow-up|1|||
163257777|NCT02638948|589652794|FG000|Overall Study|Poor/Non-Compliance|0|||
163257778|NCT02638948|589652795|FG001|Overall Study|Poor/Non-Compliance|2|||
163257779|NCT02638948|589652796|FG002|Overall Study|Poor/Non-Compliance|1|||
163257780|NCT02638948|589652797|FG003|Overall Study|Poor/Non-Compliance|0|||
163257781|NCT02638948|589652794|FG000|Overall Study|Participant no longer met study criteria|0|||
163257782|NCT02638948|589652795|FG001|Overall Study|Participant no longer met study criteria|1|||
163257783|NCT02638948|589652796|FG002|Overall Study|Participant no longer met study criteria|0|||
163257784|NCT02638948|589652797|FG003|Overall Study|Participant no longer met study criteria|0|||
163257785|NCT02638948|589652794|FG000|Overall Study|Other than specified above|4|||
163257786|NCT02638948|589652795|FG001|Overall Study|Other than specified above|1|||
163257787|NCT02638948|589652796|FG002|Overall Study|Other than specified above|1|||
163257788|NCT02638948|589652797|FG003|Overall Study|Other than specified above|1|||
163257789|NCT04992546|589652798|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
163257790|NCT04992546|589652798|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
163361273|NCT03994731|590031670|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
163361274|NCT03994731|590031671|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
163361275|NCT03994731|590031670|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
163361276|NCT03994731|590031671|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
163361277|NCT03377361|590031676|FG000|Pre-Treatment|Subject withdrew consent|0|||
163361278|NCT03377361|590031677|FG001|Pre-Treatment|Subject withdrew consent|0|||
163361279|NCT03377361|590031678|FG002|Pre-Treatment|Subject withdrew consent|0|||
163361280|NCT03377361|590031679|FG003|Pre-Treatment|Subject withdrew consent|0|||
163361281|NCT03377361|590031680|FG004|Pre-Treatment|Subject withdrew consent|0|||
163361282|NCT03377361|590031681|FG005|Pre-Treatment|Subject withdrew consent|0|||
163257791|NCT04992546|589652798|FG000|Open-Label Treatment Period|Adverse Event|3|||
163257792|NCT04992546|589652798|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
163257793|NCT05007392|589652800|FG000|Overall Study|Randomized but not treated|1|||
163257794|NCT05007392|589652801|FG001|Overall Study|Randomized but not treated|2|||
163257795|NCT05007392|589652800|FG000|Overall Study|Other|5|||
163257796|NCT05007392|589652801|FG001|Overall Study|Other|4|||
163257797|NCT05007392|589652800|FG000|Overall Study|Lost to Follow-up|1|||
163257798|NCT05007392|589652801|FG001|Overall Study|Lost to Follow-up|2|||
163257799|NCT05007392|589652800|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
163361283|NCT03377361|590031682|FG006|Pre-Treatment|Subject withdrew consent|0|||
163361284|NCT03377361|590031683|FG007|Pre-Treatment|Subject withdrew consent|3|||
163361285|NCT03377361|590031684|FG008|Pre-Treatment|Subject withdrew consent|1|||
163361286|NCT03377361|590031685|FG009|Pre-Treatment|Subject withdrew consent|0|||
163361287|NCT03377361|590031676|FG000|Pre-Treatment|Not Reported|0|||
163361288|NCT03377361|590031677|FG001|Pre-Treatment|Not Reported|0|||
163361289|NCT03377361|590031678|FG002|Pre-Treatment|Not Reported|0|||
163361290|NCT03377361|590031679|FG003|Pre-Treatment|Not Reported|0|||
163361291|NCT03377361|590031680|FG004|Pre-Treatment|Not Reported|0|||
163361292|NCT03377361|590031681|FG005|Pre-Treatment|Not Reported|0|||
163361293|NCT03377361|590031682|FG006|Pre-Treatment|Not Reported|0|||
163361294|NCT03377361|590031683|FG007|Pre-Treatment|Not Reported|0|||
163361295|NCT03377361|590031684|FG008|Pre-Treatment|Not Reported|3|||
163361296|NCT03377361|590031685|FG009|Pre-Treatment|Not Reported|0|||
163361297|NCT03377361|590031676|FG000|Treatment Period|Disease Progression|3|||
163361298|NCT03377361|590031677|FG001|Treatment Period|Disease Progression|2|||
163361299|NCT03377361|590031678|FG002|Treatment Period|Disease Progression|5|||
163361300|NCT03377361|590031679|FG003|Treatment Period|Disease Progression|3|||
163361301|NCT03377361|590031680|FG004|Treatment Period|Disease Progression|3|||
163361302|NCT03377361|590031681|FG005|Treatment Period|Disease Progression|3|||
163361303|NCT03377361|590031682|FG006|Treatment Period|Disease Progression|6|||
163361304|NCT03377361|590031683|FG007|Treatment Period|Disease Progression|106|||
163151860|NCT04163341|589269556|FG000|Overall Study|Withdrawal by Subject|2|||
163151861|NCT04163341|589269557|FG001|Overall Study|Withdrawal by Subject|0|||
163151862|NCT04163341|589269556|FG000|Overall Study|Lost to Follow-up|3|||
163151863|NCT04163341|589269557|FG001|Overall Study|Lost to Follow-up|4|||
163151864|NCT00303069|589271325|FG000|Overall Study|Lost to Follow-up|1|||
163151865|NCT00303069|589271326|FG001|Overall Study|Lost to Follow-up|0|||
163151866|NCT00303069|589271327|FG002|Overall Study|Lost to Follow-up|0|||
163151867|NCT00303069|589271328|FG003|Overall Study|Lost to Follow-up|2|||
163151868|NCT00303069|589271325|FG000|Overall Study|subject moved|1|||
163151869|NCT00303069|589271326|FG001|Overall Study|subject moved|0|||
163151870|NCT00303069|589271327|FG002|Overall Study|subject moved|0|||
163151871|NCT00303069|589271328|FG003|Overall Study|subject moved|0|||
163151872|NCT00303069|589271325|FG000|Overall Study|Recruitment into Army Reserves|0|||
163151873|NCT00303069|589271326|FG001|Overall Study|Recruitment into Army Reserves|0|||
163151874|NCT00303069|589271327|FG002|Overall Study|Recruitment into Army Reserves|1|||
163151875|NCT00303069|589271328|FG003|Overall Study|Recruitment into Army Reserves|0|||
163151876|NCT00092417|589271329|FG000|Overall Study|Lost to Follow-up|2|||
163151877|NCT00092417|589271330|FG001|Overall Study|Lost to Follow-up|0|||
163151878|NCT00092417|589271329|FG000|Overall Study|Withdrawal by Subject|2|||
163151879|NCT00092417|589271330|FG001|Overall Study|Withdrawal by Subject|1|||
163151880|NCT00092417|589271329|FG000|Overall Study|Other|1|||
163151881|NCT00092417|589271330|FG001|Overall Study|Other|0|||
163151882|NCT01084655|589271333|FG000|Overall Study|Radiographic disease progression|3|||
163151883|NCT01084655|589271334|FG001|Overall Study|Radiographic disease progression|2|||
163151884|NCT01084655|589271335|FG002|Overall Study|Radiographic disease progression|8|||
163151885|NCT01084655|589271333|FG000|Overall Study|Withdrawal by Subject|1|||
163151886|NCT01084655|589271334|FG001|Overall Study|Withdrawal by Subject|0|||
163151887|NCT01084655|589271335|FG002|Overall Study|Withdrawal by Subject|4|||
163151888|NCT01084655|589271333|FG000|Overall Study|Adverse Event|2|||
163151889|NCT01084655|589271334|FG001|Overall Study|Adverse Event|1|||
163151890|NCT01084655|589271335|FG002|Overall Study|Adverse Event|2|||
163151891|NCT01084655|589271333|FG000|Overall Study|Other|0|||
163151892|NCT01084655|589271334|FG001|Overall Study|Other|3|||
163151893|NCT01084655|589271335|FG002|Overall Study|Other|2|||
163151894|NCT01084655|589271333|FG000|Overall Study|Symptomatic deterioration|0|||
163151895|NCT01084655|589271334|FG001|Overall Study|Symptomatic deterioration|0|||
163151896|NCT01084655|589271335|FG002|Overall Study|Symptomatic deterioration|2|||
163151897|NCT01084655|589271333|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
163151898|NCT01084655|589271334|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
163151899|NCT01084655|589271335|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
163151900|NCT03182374|589271342|FG000|Overall Study|Lost to Follow-up|3|||
163151901|NCT03182374|589271343|FG001|Overall Study|Lost to Follow-up|2|||
163151902|NCT03182374|589271342|FG000|Overall Study|Lack of Efficacy|8|||
163151903|NCT03182374|589271343|FG001|Overall Study|Lack of Efficacy|14|||
163151904|NCT03182374|589271342|FG000|Overall Study|Withdrawal by Subject|1|||
163151905|NCT03182374|589271343|FG001|Overall Study|Withdrawal by Subject|1|||
163151906|NCT03182374|589271342|FG000|Overall Study|exit for non-compliance|1|||
163151907|NCT03182374|589271343|FG001|Overall Study|exit for non-compliance|1|||
163151908|NCT03182374|589271342|FG000|Overall Study|one subject was randomized but not treated|1|||
163151909|NCT03182374|589271343|FG001|Overall Study|one subject was randomized but not treated|0|||
163151910|NCT03182374|589271342|FG000|Overall Study|Other reasons|0|||
163151911|NCT03182374|589271343|FG001|Overall Study|Other reasons|3|||
163151912|NCT01462370|589271344|FG000|Overall Study|Lack of Qualifying Event|1|||
163151913|NCT01462370|589271345|FG001|Overall Study|Lack of Qualifying Event|1|||
163151914|NCT01462370|589271344|FG000|Overall Study|Physician Decision|0|||
163361305|NCT03377361|590031684|FG008|Treatment Period|Disease Progression|48|||
163257800|NCT05007392|589652801|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
163257801|NCT05007392|589652800|FG000|Overall Study|Use of prohibited concomitant drug|1|||
163257802|NCT05007392|589652801|FG001|Overall Study|Use of prohibited concomitant drug|1|||
163257803|NCT05007392|589652800|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
163257804|NCT05007392|589652801|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
163257805|NCT05007392|589652800|FG000|Overall Study|Adverse Event|10|||
163257806|NCT05007392|589652801|FG001|Overall Study|Adverse Event|6|||
163257807|NCT05007392|589652800|FG000|Overall Study|Participant choice|5|||
163257808|NCT05007392|589652801|FG001|Overall Study|Participant choice|10|||
163257809|NCT05007392|589652800|FG000|Overall Study|Withdrawal of consent|5|||
163257810|NCT05007392|589652801|FG001|Overall Study|Withdrawal of consent|4|||
163257811|NCT04058353|589652805|FG000|Overall Study|Adverse Event|2|||
163257812|NCT04058353|589652806|FG001|Overall Study|Adverse Event|1|||
163257813|NCT04058353|589652805|FG000|Overall Study|Physician Decision|1|||
163257814|NCT04058353|589652806|FG001|Overall Study|Physician Decision|0|||
163257815|NCT04058353|589652805|FG000|Overall Study|Other|1|||
163257816|NCT04058353|589652806|FG001|Overall Study|Other|0|||
163257817|NCT00316173|589652810|FG000|Run-in Phase|Adverse Event|1|||
163257818|NCT00316173|589652811|FG001|Run-in Phase|Adverse Event|0|||
163257819|NCT00316173|589652810|FG000|Run-in Phase|Protocol Violation|1|||
163257820|NCT00316173|589652811|FG001|Run-in Phase|Protocol Violation|0|||
163257821|NCT00316173|589652810|FG000|Run-in Phase|Study Follow-up Stopped|5|||
163257822|NCT00316173|589652811|FG001|Run-in Phase|Study Follow-up Stopped|0|||
163257823|NCT00316173|589652810|FG000|Treatment Phase|Adverse Event|0|||
163257824|NCT00316173|589652811|FG001|Treatment Phase|Adverse Event|1|||
163257825|NCT00316173|589652810|FG000|Treatment Phase|Lack of Efficacy|0|||
163257826|NCT00316173|589652811|FG001|Treatment Phase|Lack of Efficacy|3|||
163257827|NCT00316173|589652810|FG000|Treatment Phase|Lost to Follow-up|0|||
163257828|NCT00316173|589652811|FG001|Treatment Phase|Lost to Follow-up|3|||
163257829|NCT00316173|589652810|FG000|Treatment Phase|Withdrawal by Subject|0|||
163257830|NCT00316173|589652811|FG001|Treatment Phase|Withdrawal by Subject|1|||
163257831|NCT00316173|589652810|FG000|Treatment Phase|Study Follow-up Stopped|0|||
163257832|NCT00316173|589652811|FG001|Treatment Phase|Study Follow-up Stopped|34|||
163257833|NCT02390531|589652812|FG000|Overall Study|Death|0|||
163257834|NCT02390531|589652813|FG001|Overall Study|Death|2|||
163257835|NCT02390531|589652814|FG002|Overall Study|Death|0|||
163257836|NCT02390531|589652815|FG003|Overall Study|Death|1|||
163257837|NCT02390531|589652816|FG004|Overall Study|Death|0|||
163257838|NCT02390531|589652817|FG005|Overall Study|Death|0|||
163257839|NCT02390531|589652818|FG006|Overall Study|Death|0|||
163257840|NCT02390531|589652819|FG007|Overall Study|Death|1|||
163257841|NCT02390531|589652812|FG000|Overall Study|Protocol Violation|0|||
163257842|NCT02390531|589652813|FG001|Overall Study|Protocol Violation|0|||
163257843|NCT02390531|589652814|FG002|Overall Study|Protocol Violation|0|||
163257844|NCT02390531|589652815|FG003|Overall Study|Protocol Violation|0|||
163257845|NCT02390531|589652816|FG004|Overall Study|Protocol Violation|1|||
163257846|NCT02390531|589652817|FG005|Overall Study|Protocol Violation|0|||
163257847|NCT02390531|589652818|FG006|Overall Study|Protocol Violation|2|||
163257848|NCT02390531|589652819|FG007|Overall Study|Protocol Violation|0|||
163257849|NCT03764072|589652823|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
163257850|NCT03764072|589652824|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
163257851|NCT03764072|589652825|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
163257852|NCT03764072|589652826|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
163257853|NCT03764072|589652827|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
163257854|NCT03764072|589652828|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
163257855|NCT03764072|589652823|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
163257856|NCT03764072|589652824|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
163257857|NCT03764072|589652825|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
163257858|NCT03764072|589652826|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
163257859|NCT03764072|589652827|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
163257860|NCT03764072|589652828|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
163257861|NCT03764072|589652823|FG000|Overall Study|Lost to Follow-up|0|||
163257862|NCT03764072|589652824|FG001|Overall Study|Lost to Follow-up|0|||
163257863|NCT03764072|589652825|FG002|Overall Study|Lost to Follow-up|0|||
163257864|NCT03764072|589652826|FG003|Overall Study|Lost to Follow-up|0|||
163257865|NCT03764072|589652827|FG004|Overall Study|Lost to Follow-up|1|||
163257866|NCT03764072|589652828|FG005|Overall Study|Lost to Follow-up|0|||
163257867|NCT03657277|589652829|FG000|Overall Study|Physician Decision|2|||
163257868|NCT03657277|589652829|FG000|Overall Study|Lost to Follow-up|1|||
163361306|NCT03377361|590031685|FG009|Treatment Period|Disease Progression|59|||
163361307|NCT03377361|590031676|FG000|Treatment Period|Study Drug Toxicity|0|||
163257869|NCT03657277|589652829|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
163257870|NCT01024608|589652832|FG000|Overall Study|Adverse Event|1|||
163257871|NCT01024608|589652833|FG001|Overall Study|Adverse Event|0|||
163257872|NCT01024608|589652832|FG000|Overall Study|Withdrawal by Subject|1|||
163257873|NCT01024608|589652833|FG001|Overall Study|Withdrawal by Subject|0|||
163257874|NCT01024608|589652832|FG000|Overall Study|Lost to Follow-up|0|||
163257875|NCT01024608|589652833|FG001|Overall Study|Lost to Follow-up|1|||
163257876|NCT01024608|589652832|FG000|Overall Study|Protocol Violation|0|||
163257877|NCT01024608|589652833|FG001|Overall Study|Protocol Violation|3|||
163257878|NCT01024608|589652832|FG000|Overall Study|Never received study treatment|2|||
163257879|NCT01024608|589652833|FG001|Overall Study|Never received study treatment|0|||
163257880|NCT02286089|589652834|FG000|Overall Study|Ongoing in Study|1|||
163257881|NCT02286089|589652835|FG001|Overall Study|Ongoing in Study|1|||
163257882|NCT02286089|589652836|FG002|Overall Study|Ongoing in Study|4|||
163257883|NCT02286089|589652837|FG003|Overall Study|Ongoing in Study|10|||
163257884|NCT02286089|589652834|FG000|Overall Study|Withdrawal by Subject|0|||
163257885|NCT02286089|589652835|FG001|Overall Study|Withdrawal by Subject|0|||
163257886|NCT02286089|589652836|FG002|Overall Study|Withdrawal by Subject|2|||
163257887|NCT02286089|589652837|FG003|Overall Study|Withdrawal by Subject|2|||
163257888|NCT04791761|589654025|FG000|Overall Study|Lost to Follow-up|8|||
163257889|NCT04791761|589654026|FG001|Overall Study|Lost to Follow-up|6|||
163257890|NCT04791761|589654027|FG002|Overall Study|Lost to Follow-up|10|||
163257891|NCT04791761|589654025|FG000|Overall Study|Withdrawal by Subject|0|||
163257892|NCT04791761|589654026|FG001|Overall Study|Withdrawal by Subject|1|||
163257893|NCT04791761|589654027|FG002|Overall Study|Withdrawal by Subject|1|||
163257894|NCT04791761|589654025|FG000|Overall Study|Protocol Violation|0|||
163257895|NCT04791761|589654026|FG001|Overall Study|Protocol Violation|1|||
163257896|NCT04791761|589654027|FG002|Overall Study|Protocol Violation|1|||
163257897|NCT04669600|589654028|FG000|Overall Study|Withdrawal by Subject|1|||
163257898|NCT04669600|589654028|FG000|Overall Study|Other|6|||
163257899|NCT00676130|589654035|FG000|Overall Study|Lost to Follow-up|0|||
163257900|NCT00676130|589654036|FG001|Overall Study|Lost to Follow-up|1|||
163257901|NCT00676130|589654035|FG000|Overall Study|Found ineligible|3|||
163257902|NCT00676130|589654036|FG001|Overall Study|Found ineligible|2|||
163257903|NCT00676130|589654035|FG000|Overall Study|Withdrawal by Subject|0|||
163257904|NCT00676130|589654036|FG001|Overall Study|Withdrawal by Subject|1|||
163257905|NCT01564368|589654037|FG000|Overall Study|Ineligible|18|||
163257906|NCT01564368|589654037|FG000|Overall Study|Not Randomized in Parent study|116|||
163257907|NCT01564368|589654037|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
163257908|NCT01564368|589654037|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
163257909|NCT01802437|589654038|FG000|Overall Study|Lost to Follow-up|1|||
163257910|NCT01802437|589654039|FG001|Overall Study|Lost to Follow-up|0|||
163257911|NCT01802437|589654038|FG000|Overall Study|Withdrawal by Subject|3|||
163257912|NCT01802437|589654039|FG001|Overall Study|Withdrawal by Subject|4|||
163257913|NCT04857034|589654044|FG000|Placebo-Controlled Period|Request to discontinue|2|||
163257914|NCT04857034|589654045|FG001|Placebo-Controlled Period|Request to discontinue|2|||
163257915|NCT04857034|589654046|FG002|Placebo-Controlled Period|Request to discontinue|0|||
163257916|NCT04857034|589654047|FG003|Placebo-Controlled Period|Request to discontinue|0|||
163257917|NCT04857034|589654048|FG004|Placebo-Controlled Period|Request to discontinue|0|||
163257918|NCT04857034|589654044|FG000|Placebo-Controlled Period|withdrew consent|1|||
163257919|NCT04857034|589654045|FG001|Placebo-Controlled Period|withdrew consent|1|||
163257920|NCT04857034|589654046|FG002|Placebo-Controlled Period|withdrew consent|2|||
163257921|NCT04857034|589654047|FG003|Placebo-Controlled Period|withdrew consent|0|||
163257922|NCT04857034|589654048|FG004|Placebo-Controlled Period|withdrew consent|0|||
163257923|NCT04857034|589654044|FG000|Placebo-Controlled Period|Pregnancy|1|||
163257924|NCT04857034|589654045|FG001|Placebo-Controlled Period|Pregnancy|1|||
163257925|NCT04857034|589654046|FG002|Placebo-Controlled Period|Pregnancy|0|||
163257926|NCT04857034|589654047|FG003|Placebo-Controlled Period|Pregnancy|0|||
163257927|NCT04857034|589654048|FG004|Placebo-Controlled Period|Pregnancy|0|||
163257928|NCT04857034|589654044|FG000|Placebo-Controlled Period|Ongoing study period|0|||
163257929|NCT04857034|589654045|FG001|Placebo-Controlled Period|Ongoing study period|1|||
163257930|NCT04857034|589654046|FG002|Placebo-Controlled Period|Ongoing study period|0|||
163257931|NCT04857034|589654047|FG003|Placebo-Controlled Period|Ongoing study period|0|||
163257932|NCT04857034|589654048|FG004|Placebo-Controlled Period|Ongoing study period|0|||
163257933|NCT04857034|589654044|FG000|Active Treatment Period|Lack of Efficacy|1|||
163257934|NCT04857034|589654045|FG001|Active Treatment Period|Lack of Efficacy|0|||
163257935|NCT04857034|589654046|FG002|Active Treatment Period|Lack of Efficacy|0|||
163257936|NCT04857034|589654047|FG003|Active Treatment Period|Lack of Efficacy|0|||
163257937|NCT04857034|589654048|FG004|Active Treatment Period|Lack of Efficacy|0|||
163257938|NCT04857034|589654044|FG000|Active Treatment Period|request to discontinue|0|||
163257939|NCT04857034|589654045|FG001|Active Treatment Period|request to discontinue|1|||
163257940|NCT04857034|589654046|FG002|Active Treatment Period|request to discontinue|0|||
163257941|NCT04857034|589654047|FG003|Active Treatment Period|request to discontinue|1|||
163257942|NCT04857034|589654048|FG004|Active Treatment Period|request to discontinue|0|||
163257943|NCT04857034|589654044|FG000|Active Treatment Period|administrative reason by sponsor|1|||
163257944|NCT04857034|589654045|FG001|Active Treatment Period|administrative reason by sponsor|5|||
163257945|NCT04857034|589654046|FG002|Active Treatment Period|administrative reason by sponsor|0|||
163257946|NCT04857034|589654047|FG003|Active Treatment Period|administrative reason by sponsor|2|||
163361308|NCT03377361|590031677|FG001|Treatment Period|Study Drug Toxicity|0|||
163361309|NCT03377361|590031678|FG002|Treatment Period|Study Drug Toxicity|0|||
163361310|NCT03377361|590031679|FG003|Treatment Period|Study Drug Toxicity|1|||
163361311|NCT03377361|590031680|FG004|Treatment Period|Study Drug Toxicity|0|||
163361312|NCT03377361|590031681|FG005|Treatment Period|Study Drug Toxicity|0|||
163361313|NCT03377361|590031682|FG006|Treatment Period|Study Drug Toxicity|0|||
163257947|NCT04857034|589654048|FG004|Active Treatment Period|administrative reason by sponsor|2|||
163257948|NCT04857034|589654044|FG000|Active Treatment Period|other reasons|1|||
163257949|NCT04857034|589654045|FG001|Active Treatment Period|other reasons|1|||
163257950|NCT04857034|589654046|FG002|Active Treatment Period|other reasons|0|||
163257951|NCT04857034|589654047|FG003|Active Treatment Period|other reasons|0|||
163257952|NCT04857034|589654048|FG004|Active Treatment Period|other reasons|1|||
163257953|NCT04857034|589654044|FG000|Active Treatment Period|Ongoing Study Period|2|||
163257954|NCT04857034|589654045|FG001|Active Treatment Period|Ongoing Study Period|4|||
163257955|NCT04857034|589654046|FG002|Active Treatment Period|Ongoing Study Period|0|||
163257956|NCT04857034|589654047|FG003|Active Treatment Period|Ongoing Study Period|1|||
163257957|NCT04857034|589654048|FG004|Active Treatment Period|Ongoing Study Period|0|||
163257958|NCT04810221|589654049|FG000|Overall Study|Physician Decision|3|||
163257959|NCT01181726|589654052|FG000|First Intervention|Adverse Event|1|||
163257960|NCT01181726|589654053|FG001|First Intervention|Adverse Event|0|||
163257961|NCT01264380|589654054|FG000|Period C|Disease Progression|0|||
163257962|NCT01264380|589654055|FG001|Period C|Disease Progression|0|||
163257963|NCT01264380|589654056|FG002|Period C|Disease Progression|4|||
163257964|NCT01264380|589654054|FG000|Period C|Death|0|||
163257965|NCT01264380|589654055|FG001|Period C|Death|0|||
163257966|NCT01264380|589654056|FG002|Period C|Death|2|||
163257967|NCT01264380|589654054|FG000|Period C|Follow-up for survival status|0|||
163257968|NCT01264380|589654055|FG001|Period C|Follow-up for survival status|0|||
163257969|NCT01264380|589654056|FG002|Period C|Follow-up for survival status|6|||
163257970|NCT01264380|589654054|FG000|Period C|Withdrawal by Subject|0|||
163257971|NCT01264380|589654055|FG001|Period C|Withdrawal by Subject|0|||
163257972|NCT01264380|589654056|FG002|Period C|Withdrawal by Subject|1|||
163257973|NCT01264380|589654054|FG000|Period C|Adverse Event|0|||
163257974|NCT01264380|589654055|FG001|Period C|Adverse Event|0|||
163257975|NCT01264380|589654056|FG002|Period C|Adverse Event|1|||
163257976|NCT04998604|589654058|FG000|Overall Study|Adverse Event|3|||
163257977|NCT04998604|589654059|FG001|Overall Study|Adverse Event|2|||
163257978|NCT04998604|589654058|FG000|Overall Study|Withdrawal by Subject|2|||
163257979|NCT04998604|589654059|FG001|Overall Study|Withdrawal by Subject|4|||
163257980|NCT04998604|589654058|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
163257981|NCT04998604|589654059|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
163257982|NCT03953898|589654062|FG000|Overall Study|Lack of Efficacy|8|||
163257983|NCT03953898|589654062|FG000|Overall Study|Death|3|||
163257984|NCT03953898|589654062|FG000|Overall Study|Withdrawal by Subject|2|||
163257985|NCT03953898|589654062|FG000|Overall Study|Adverse Event|1|||
163257986|NCT01520402|589654067|FG000|Overall Study|Withdrawal by Subject|2|||
163257987|NCT01520402|589654067|FG000|Overall Study|Physician Decision|3|||
163257988|NCT01722162|589654073|FG000|Overall Study|Withdrawal by Subject|1|||
163257989|NCT01722162|589654074|FG001|Overall Study|Withdrawal by Subject|1|||
163257990|NCT01722162|589654073|FG000|Overall Study|Found ineligible|1|||
163257991|NCT01722162|589654074|FG001|Overall Study|Found ineligible|0|||
163257992|NCT01722162|589654073|FG000|Overall Study|Unrelated to study adverse event|2|||
163257993|NCT01722162|589654074|FG001|Overall Study|Unrelated to study adverse event|2|||
163257994|NCT01722162|589654073|FG000|Overall Study|Adverse Event|1|||
163257995|NCT01722162|589654074|FG001|Overall Study|Adverse Event|1|||
163257996|NCT01722162|589654073|FG000|Overall Study|Insurance denial post enrollment|0|||
163257997|NCT01722162|589654074|FG001|Overall Study|Insurance denial post enrollment|1|||
163257998|NCT01722162|589654073|FG000|Overall Study|Noncompliance|0|||
163151915|NCT01462370|589271345|FG001|Overall Study|Physician Decision|1|||
163151916|NCT01462370|589271344|FG000|Overall Study|Withdrawal by Subject|0|||
163151917|NCT01462370|589271345|FG001|Overall Study|Withdrawal by Subject|3|||
163151918|NCT00473564|589271348|FG000|Overall Study|robot surgery aborted in OR|23|||
163151919|NCT00914316|589271351|FG000|Phase 1|Physician Decision|4|||
163151920|NCT00914316|589271352|FG001|Phase 1|Physician Decision|0|||
163151921|NCT00914316|589271353|FG002|Phase 1|Physician Decision|1|||
163151922|NCT00914316|589271354|FG003|Phase 1|Physician Decision|2|||
163151923|NCT00914316|589271351|FG000|Phase 1|Withdrawal by Subject|0|||
163151924|NCT00914316|589271352|FG001|Phase 1|Withdrawal by Subject|2|||
163151925|NCT00914316|589271353|FG002|Phase 1|Withdrawal by Subject|4|||
163151926|NCT00914316|589271354|FG003|Phase 1|Withdrawal by Subject|0|||
163151927|NCT00914316|589271351|FG000|Phase 1|Adverse Event|1|||
163151928|NCT00914316|589271352|FG001|Phase 1|Adverse Event|0|||
163151929|NCT00914316|589271353|FG002|Phase 1|Adverse Event|0|||
163151930|NCT00914316|589271354|FG003|Phase 1|Adverse Event|0|||
163151931|NCT00914316|589271351|FG000|Phase 2|Withdrawal by Subject|1|||
163151932|NCT00914316|589271352|FG001|Phase 2|Withdrawal by Subject|0|||
163257999|NCT01722162|589654074|FG001|Overall Study|Noncompliance|1|||
163258000|NCT03086018|589654075|FG000|Final Testing for End of Trial|Adverse Event|1|||
163258001|NCT03086018|589654075|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
163258002|NCT01538472|589654076|FG000|Overall Study|Disease Progression|3|||
163258003|NCT01538472|589654076|FG000|Overall Study|Death|1|||
163258004|NCT00659984|589654079|FG000|Overall Study|Adverse Event|1|||
163258005|NCT02133872|589654080|FG000|Overall Study|Withdrawal by Subject|5|||
163258006|NCT02133872|589654081|FG001|Overall Study|Withdrawal by Subject|3|||
163258007|NCT02133872|589654082|FG002|Overall Study|Withdrawal by Subject|0|||
163258008|NCT02923739|589654083|FG000|Overall Study|Withdrawal by Subject|2|||
163258009|NCT02923739|589654084|FG001|Overall Study|Withdrawal by Subject|0|||
163258010|NCT02923739|589654085|FG002|Overall Study|Withdrawal by Subject|0|||
163258011|NCT02923739|589654086|FG003|Overall Study|Withdrawal by Subject|0|||
163258012|NCT02923739|589654083|FG000|Overall Study|Failed Screening|3|||
163258013|NCT02923739|589654084|FG001|Overall Study|Failed Screening|0|||
163258014|NCT02923739|589654085|FG002|Overall Study|Failed Screening|0|||
163258015|NCT02923739|589654086|FG003|Overall Study|Failed Screening|0|||
163258016|NCT00948974|589654091|FG000|Overall Study|Lost to Follow-up|23|||
163258017|NCT00948974|589654092|FG001|Overall Study|Lost to Follow-up|20|||
163258018|NCT02487810|589654093|FG000|Overall Study|Withdrawal by Subject|1|||
163258019|NCT02487810|589654094|FG001|Overall Study|Withdrawal by Subject|0|||
163258020|NCT01972529|589654095|FG000|Overall Study|Adverse Event|0|||
163258021|NCT01972529|589654096|FG001|Overall Study|Adverse Event|1|||
163258022|NCT01972529|589654097|FG002|Overall Study|Adverse Event|0|||
163258023|NCT01972529|589654098|FG003|Overall Study|Adverse Event|0|||
163258024|NCT01972529|589654095|FG000|Overall Study|Lost to Follow-up|1|||
163258025|NCT01972529|589654096|FG001|Overall Study|Lost to Follow-up|0|||
163258026|NCT01972529|589654097|FG002|Overall Study|Lost to Follow-up|0|||
163258027|NCT01972529|589654098|FG003|Overall Study|Lost to Follow-up|0|||
163258028|NCT01972529|589654095|FG000|Overall Study|Participant Choice|0|||
163258029|NCT01972529|589654096|FG001|Overall Study|Participant Choice|1|||
163258030|NCT01972529|589654097|FG002|Overall Study|Participant Choice|0|||
163258031|NCT01972529|589654098|FG003|Overall Study|Participant Choice|0|||
163258032|NCT01972529|589654095|FG000|Overall Study|Withdrawl of Consent|1|||
163258033|NCT01972529|589654096|FG001|Overall Study|Withdrawl of Consent|2|||
163258034|NCT01972529|589654097|FG002|Overall Study|Withdrawl of Consent|0|||
163258035|NCT01972529|589654098|FG003|Overall Study|Withdrawl of Consent|1|||
163258036|NCT01972529|589654095|FG000|Overall Study|Other|0|||
163258037|NCT01972529|589654096|FG001|Overall Study|Other|0|||
163258038|NCT01972529|589654097|FG002|Overall Study|Other|0|||
163258039|NCT01972529|589654098|FG003|Overall Study|Other|2|||
163258040|NCT01972529|589654095|FG000|Overall Study|Not treated|0|||
163258041|NCT01972529|589654096|FG001|Overall Study|Not treated|1|||
163258042|NCT01972529|589654097|FG002|Overall Study|Not treated|2|||
163258043|NCT01972529|589654098|FG003|Overall Study|Not treated|1|||
163258044|NCT01889186|589654099|FG000|Overall Study|Adverse event- not related to progression|18|||
163258045|NCT01889186|589654100|FG001|Overall Study|Adverse event- not related to progression|5|||
163258046|NCT01889186|589654099|FG000|Overall Study|Adverse event- related to progression|7|||
163258047|NCT01889186|589654100|FG001|Overall Study|Adverse event- related to progression|2|||
163258048|NCT01889186|589654099|FG000|Overall Study|COVID-19 logistical restrictions|1|||
163258049|NCT01889186|589654100|FG001|Overall Study|COVID-19 logistical restrictions|0|||
163258050|NCT01889186|589654099|FG000|Overall Study|Investigator request|1|||
163258051|NCT01889186|589654100|FG001|Overall Study|Investigator request|1|||
163258052|NCT01889186|589654099|FG000|Overall Study|Progressive disease- Richter's|12|||
163258053|NCT01889186|589654100|FG001|Overall Study|Progressive disease- Richter's|7|||
163258054|NCT01889186|589654099|FG000|Overall Study|Progressive disease per protocol|46|||
163258055|NCT01889186|589654100|FG001|Overall Study|Progressive disease per protocol|17|||
163258056|NCT01889186|589654099|FG000|Overall Study|Stem cell transplant|2|||
163258057|NCT01889186|589654100|FG001|Overall Study|Stem cell transplant|1|||
163258058|NCT01889186|589654099|FG000|Overall Study|Withdrew consent|2|||
163258059|NCT01889186|589654100|FG001|Overall Study|Withdrew consent|3|||
163258060|NCT01889186|589654099|FG000|Overall Study|Other, not specified|18|||
163258061|NCT01889186|589654100|FG001|Overall Study|Other, not specified|15|||
163258062|NCT00118716|589654104|FG000|Overall Study|Adverse Event|2|||
163258063|NCT00118716|589654105|FG001|Overall Study|Adverse Event|7|||
163258064|NCT00118716|589654104|FG000|Overall Study|Protocol Violation|5|||
163258065|NCT00118716|589654105|FG001|Overall Study|Protocol Violation|4|||
163258066|NCT00118716|589654104|FG000|Overall Study|Withdrawal by Subject|0|||
163258067|NCT00118716|589654105|FG001|Overall Study|Withdrawal by Subject|1|||
163258068|NCT00118716|589654104|FG000|Overall Study|Exacerbation|2|||
163258069|NCT00118716|589654105|FG001|Overall Study|Exacerbation|2|||
163258070|NCT00118716|589654104|FG000|Overall Study|Discontinued by sponsor|1|||
163258071|NCT00118716|589654105|FG001|Overall Study|Discontinued by sponsor|1|||
163411033|NCT03215030|590212956|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
163258072|NCT00118716|589654104|FG000|Overall Study|Non-compliance|1|||
163258073|NCT00118716|589654105|FG001|Overall Study|Non-compliance|3|||
163258074|NCT00118716|589654104|FG000|Overall Study|misrandomized|1|||
163258075|NCT00118716|589654105|FG001|Overall Study|misrandomized|1|||
163258076|NCT00118716|589654104|FG000|Overall Study|Expired drug use|1|||
163258077|NCT00118716|589654105|FG001|Overall Study|Expired drug use|2|||
163258078|NCT00118716|589654104|FG000|Overall Study|Investigator discretion|0|||
163258079|NCT00118716|589654105|FG001|Overall Study|Investigator discretion|1|||
163258080|NCT00621543|589654106|FG000|Overall Study|Lost to Follow-up|23|||
163258081|NCT00855062|589654107|FG000|Step1|Early Study Closure|5|||
163258082|NCT00855062|589654108|FG001|Step1|Early Study Closure|7|||
163258083|NCT00855062|589654107|FG000|Step1|Adverse Event|1|||
163258084|NCT00855062|589654108|FG001|Step1|Adverse Event|1|||
163258085|NCT00855062|589654107|FG000|Step1|Protocol Violation|1|||
163258086|NCT00855062|589654108|FG001|Step1|Protocol Violation|0|||
163258087|NCT00855062|589654107|FG000|Step1|Pregnancy|1|||
163258088|NCT00855062|589654108|FG001|Step1|Pregnancy|0|||
163258089|NCT00855062|589654107|FG000|Step1|Withdrawal by Subject|2|||
163258090|NCT00855062|589654108|FG001|Step1|Withdrawal by Subject|3|||
163258091|NCT00855062|589654107|FG000|Step2|Early Study Closure|6|||
163258092|NCT00855062|589654108|FG001|Step2|Early Study Closure|2|||
163258093|NCT00855062|589654107|FG000|Step2|Adverse Event|0|||
163258094|NCT00855062|589654108|FG001|Step2|Adverse Event|3|||
163258095|NCT00855062|589654107|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
163258096|NCT00855062|589654108|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
163258097|NCT02755597|589654109|FG000|Overall Study|Withdrew consent|27|||
163258098|NCT02755597|589654110|FG001|Overall Study|Withdrew consent|11|||
163258099|NCT02755597|589654109|FG000|Overall Study|Lost to Follow-up|1|||
163258100|NCT02755597|589654110|FG001|Overall Study|Lost to Follow-up|0|||
163258101|NCT02755597|589654109|FG000|Overall Study|Death|78|||
163258102|NCT02755597|589654110|FG001|Overall Study|Death|36|||
163258103|NCT02755597|589654109|FG000|Overall Study|Study terminated by Sponsor|67|||
163258104|NCT02755597|589654110|FG001|Overall Study|Study terminated by Sponsor|47|||
163258105|NCT02755597|589654109|FG000|Overall Study|Other, not specified|20|||
163258106|NCT02755597|589654110|FG001|Overall Study|Other, not specified|3|||
163258107|NCT02755597|589654109|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
163258108|NCT02755597|589654110|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
163258109|NCT04252742|589654111|FG000|Overall Study|Decision by sponsor|0|||
163258110|NCT04252742|589654112|FG001|Overall Study|Decision by sponsor|2|||
163258111|NCT04252742|589654111|FG000|Overall Study|Withdrawal by Subject|15|||
163258112|NCT04252742|589654112|FG001|Overall Study|Withdrawal by Subject|9|||
163258113|NCT04252742|589654111|FG000|Overall Study|Lost to Follow-up|0|||
163258114|NCT04252742|589654112|FG001|Overall Study|Lost to Follow-up|1|||
163258115|NCT03759834|589654113|FG000|Overall Study|Withdrawal by Subject|1|||
163258116|NCT00031486|589654116|FG000|Overall Study|Adverse Event|1|||
163258117|NCT00031486|589654117|FG001|Overall Study|Adverse Event|0|||
163258118|NCT00031486|589654116|FG000|Overall Study|Lost to Follow-up|0|||
163258119|NCT00031486|589654117|FG001|Overall Study|Lost to Follow-up|1|||
163258120|NCT00031486|589654116|FG000|Overall Study|Withdrawal by Subject|3|||
163258121|NCT00031486|589654117|FG001|Overall Study|Withdrawal by Subject|2|||
163258122|NCT00031486|589654116|FG000|Overall Study|Death|0|||
163258123|NCT00031486|589654117|FG001|Overall Study|Death|3|||
163258124|NCT00031486|589654116|FG000|Overall Study|Non-compliant|0|||
163258125|NCT00031486|589654117|FG001|Overall Study|Non-compliant|4|||
163258126|NCT00031486|589654116|FG000|Overall Study|Did not meet eligibility requirement|2|||
163258127|NCT00031486|589654117|FG001|Overall Study|Did not meet eligibility requirement|1|||
163258128|NCT00031486|589654116|FG000|Overall Study|Other|1|||
163258129|NCT00031486|589654117|FG001|Overall Study|Other|1|||
163258130|NCT01685138|589654118|FG000|Overall Study|Lost to Follow-up|1|||
163258131|NCT01685138|589654118|FG000|Overall Study|Protocol Violation|1|||
163258132|NCT01685138|589654118|FG000|Overall Study|No longer requires treatment|1|||
163258133|NCT01685138|589654118|FG000|Overall Study|Subject/guardian decision|2|||
163258134|NCT01685138|589654118|FG000|Overall Study|Physician Decision|6|||
163258135|NCT01685138|589654118|FG000|Overall Study|Death|10|||
163258136|NCT01685138|589654118|FG000|Overall Study|Adverse Event|18|||
163258137|NCT01685138|589654118|FG000|Overall Study|Progressive disease|53|||
163258138|NCT00689026|589654121|FG000|Overall Study|Withdrawal by Subject|13|||
163258139|NCT00689026|589654122|FG001|Overall Study|Withdrawal by Subject|6|||
163258140|NCT03996291|589654127|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
163258141|NCT03996291|589654128|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
163258142|NCT03996291|589654129|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
163258143|NCT03996291|589654130|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
163258144|NCT03996291|589654131|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
163258145|NCT03996291|589654132|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
163258146|NCT03996291|589654133|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
163258147|NCT03996291|589654134|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
163258148|NCT03996291|589654127|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
163258149|NCT03996291|589654128|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
163258150|NCT03996291|589654129|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
163258151|NCT03996291|589654130|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
163258152|NCT03996291|589654131|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
163258153|NCT03996291|589654132|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
163258154|NCT03996291|589654133|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
163258155|NCT03996291|589654134|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
163258156|NCT03996291|589654127|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
163258157|NCT03996291|589654128|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
163258158|NCT03996291|589654129|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
163258159|NCT03996291|589654130|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
163258160|NCT03996291|589654131|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
163258161|NCT03996291|589654132|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
163258162|NCT03996291|589654133|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
163258163|NCT03996291|589654134|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
163258164|NCT03996291|589654127|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
163258165|NCT03996291|589654128|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
163258166|NCT03996291|589654129|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
163258167|NCT03996291|589654130|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
163258168|NCT03996291|589654131|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
163258169|NCT03996291|589654132|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
163258170|NCT03996291|589654133|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
163258171|NCT03996291|589654134|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
163258172|NCT03996291|589654127|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
163258173|NCT03996291|589654128|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
163258174|NCT03996291|589654129|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
163258175|NCT03996291|589654130|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
163258176|NCT03996291|589654131|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
163258177|NCT03996291|589654132|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
163258178|NCT03996291|589654133|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
163258179|NCT03996291|589654134|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
163258180|NCT02703922|589654135|FG000|Overall Study|Death|5|||
163258181|NCT02703922|589654136|FG001|Overall Study|Death|8|||
163258182|NCT02703922|589654135|FG000|Overall Study|Lost to Follow-up|10|||
163258183|NCT02703922|589654136|FG001|Overall Study|Lost to Follow-up|10|||
163258184|NCT05805657|589654138|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
163258185|NCT05805657|589654139|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
163258186|NCT01951638|589654140|FG000|Treatment Period|Protocol Violation|0|||
163258187|NCT01951638|589654141|FG001|Treatment Period|Protocol Violation|0|||
163258188|NCT01951638|589654142|FG002|Treatment Period|Protocol Violation|0|||
163258189|NCT01951638|589654143|FG003|Treatment Period|Protocol Violation|2|||
163258190|NCT01951638|589654144|FG004|Treatment Period|Protocol Violation|0|||
163258191|NCT01951638|589654140|FG000|Treatment Period|Protocol-driven decision point|1|||
163258192|NCT01951638|589654141|FG001|Treatment Period|Protocol-driven decision point|3|||
163258193|NCT01951638|589654142|FG002|Treatment Period|Protocol-driven decision point|0|||
163258194|NCT01951638|589654143|FG003|Treatment Period|Protocol-driven decision point|0|||
163258195|NCT01951638|589654144|FG004|Treatment Period|Protocol-driven decision point|0|||
163258196|NCT01951638|589654140|FG000|Treatment Period|Logistical difficulties|0|||
163258197|NCT01951638|589654141|FG001|Treatment Period|Logistical difficulties|1|||
163258198|NCT01951638|589654142|FG002|Treatment Period|Logistical difficulties|1|||
163258199|NCT01951638|589654143|FG003|Treatment Period|Logistical difficulties|0|||
163258200|NCT01951638|589654144|FG004|Treatment Period|Logistical difficulties|0|||
163258201|NCT01951638|589654140|FG000|Treatment Period|Withdrawal by Subject|9|||
163258202|NCT01951638|589654141|FG001|Treatment Period|Withdrawal by Subject|6|||
163258203|NCT01951638|589654142|FG002|Treatment Period|Withdrawal by Subject|4|||
163258204|NCT01951638|589654143|FG003|Treatment Period|Withdrawal by Subject|5|||
163258205|NCT01951638|589654144|FG004|Treatment Period|Withdrawal by Subject|4|||
163258206|NCT01951638|589654140|FG000|Treatment Period|Death|0|||
163258207|NCT01951638|589654141|FG001|Treatment Period|Death|0|||
163258208|NCT01951638|589654142|FG002|Treatment Period|Death|0|||
163258209|NCT01951638|589654143|FG003|Treatment Period|Death|3|||
163258210|NCT01951638|589654144|FG004|Treatment Period|Death|1|||
163258211|NCT01951638|589654140|FG000|Treatment Period|Adverse Event|3|||
163258212|NCT01951638|589654141|FG001|Treatment Period|Adverse Event|4|||
163258213|NCT01951638|589654142|FG002|Treatment Period|Adverse Event|8|||
163258214|NCT01951638|589654143|FG003|Treatment Period|Adverse Event|6|||
163361314|NCT03377361|590031683|FG007|Treatment Period|Study Drug Toxicity|7|||
163361315|NCT03377361|590031684|FG008|Treatment Period|Study Drug Toxicity|2|||
163361316|NCT03377361|590031685|FG009|Treatment Period|Study Drug Toxicity|16|||
163258215|NCT01951638|589654144|FG004|Treatment Period|Adverse Event|5|||
163258216|NCT01951638|589654140|FG000|Follow-up Period|Protocol Violation|0|||
163258217|NCT01951638|589654141|FG001|Follow-up Period|Protocol Violation|0|||
163258218|NCT01951638|589654142|FG002|Follow-up Period|Protocol Violation|0|||
163258219|NCT01951638|589654143|FG003|Follow-up Period|Protocol Violation|1|||
163258220|NCT01951638|589654144|FG004|Follow-up Period|Protocol Violation|0|||
163258221|NCT01951638|589654140|FG000|Follow-up Period|Logistical difficulties|0|||
163258222|NCT01951638|589654141|FG001|Follow-up Period|Logistical difficulties|2|||
163411034|NCT03215030|590212957|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
163411035|NCT03215030|590212946|FG000|Part 3: Dose Extension|Death|0|||
163411036|NCT03215030|590212947|FG001|Part 3: Dose Extension|Death|0|||
163411037|NCT03215030|590212948|FG002|Part 3: Dose Extension|Death|0|||
163411038|NCT03215030|590212949|FG003|Part 3: Dose Extension|Death|0|||
163411039|NCT03215030|590212950|FG004|Part 3: Dose Extension|Death|0|||
163411040|NCT03215030|590212951|FG005|Part 3: Dose Extension|Death|0|||
163411041|NCT03215030|590212952|FG006|Part 3: Dose Extension|Death|0|||
163411042|NCT03215030|590212953|FG007|Part 3: Dose Extension|Death|0|||
163411043|NCT03215030|590212954|FG008|Part 3: Dose Extension|Death|19|||
163411044|NCT03215030|590212955|FG009|Part 3: Dose Extension|Death|20|||
163411045|NCT03215030|590212956|FG010|Part 3: Dose Extension|Death|0|||
163411046|NCT03215030|590212957|FG011|Part 3: Dose Extension|Death|0|||
163411047|NCT03215030|590212946|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
163411048|NCT03215030|590212947|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
163411049|NCT03215030|590212948|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
163411050|NCT03215030|590212949|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
163411051|NCT03215030|590212950|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
163411052|NCT03215030|590212951|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
163411053|NCT03215030|590212952|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
163411054|NCT03215030|590212953|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
163411055|NCT03215030|590212954|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
163411056|NCT03215030|590212955|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
163411057|NCT03215030|590212956|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
163151933|NCT00914316|589271353|FG002|Phase 2|Withdrawal by Subject|1|||
163151934|NCT00914316|589271354|FG003|Phase 2|Withdrawal by Subject|0|||
163151935|NCT02177123|589271355|FG000|Overall Study|Lost to Follow-up|6|||
163151936|NCT02177123|589271355|FG000|Overall Study|Withdrawal by Subject|4|||
163151937|NCT02177123|589271355|FG000|Overall Study|Adverse Event|4|||
163151938|NCT02177123|589271355|FG000|Overall Study|Physician Decision|3|||
163151939|NCT02177123|589271355|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
163411058|NCT03215030|590212957|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
163411059|NCT03215030|590212946|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163411060|NCT03215030|590212947|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163411061|NCT03215030|590212948|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163411062|NCT03215030|590212949|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163411063|NCT03215030|590212950|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163411064|NCT03215030|590212951|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163411065|NCT03215030|590212952|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163411066|NCT03215030|590212953|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163411067|NCT03215030|590212954|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163411068|NCT03215030|590212955|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163411069|NCT03215030|590212956|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
163411070|NCT03215030|590212957|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
163411071|NCT01745146|590212960|FG000|Overall Study|Withdrawal by Subject|1|||
163411072|NCT01745146|590212961|FG001|Overall Study|Withdrawal by Subject|3|||
163411073|NCT01745146|590212960|FG000|Overall Study|Lost to Follow-up|2|||
163411074|NCT01745146|590212961|FG001|Overall Study|Lost to Follow-up|0|||
163411075|NCT04316585|590212962|FG000|Overall Study|Adverse Event|2|||
163411076|NCT04316585|590212963|FG001|Overall Study|Adverse Event|1|||
163411077|NCT04316585|590212962|FG000|Overall Study|Lost to Follow-up|1|||
163411078|NCT04316585|590212963|FG001|Overall Study|Lost to Follow-up|0|||
163411079|NCT04316585|590212962|FG000|Overall Study|Withdrawal by Subject|2|||
163411080|NCT04316585|590212963|FG001|Overall Study|Withdrawal by Subject|3|||
163411081|NCT04316585|590212962|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
163411082|NCT04316585|590212963|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
163411083|NCT04316585|590212962|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
163411084|NCT04316585|590212963|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
163411085|NCT00130832|590212964|FG000|Overall Study|Adverse Event|1|||
163411086|NCT00130832|590212965|FG001|Overall Study|Adverse Event|1|||
163411087|NCT00130832|590212964|FG000|Overall Study|Lost to Follow-up|1|||
163411088|NCT00130832|590212965|FG001|Overall Study|Lost to Follow-up|2|||
163411089|NCT00130832|590212964|FG000|Overall Study|Protocol Violation|6|||
163411090|NCT00130832|590212965|FG001|Overall Study|Protocol Violation|8|||
163411091|NCT00130832|590212964|FG000|Overall Study|Withdrawal by Subject|6|||
163411092|NCT00130832|590212965|FG001|Overall Study|Withdrawal by Subject|1|||
163411093|NCT00130832|590212964|FG000|Overall Study|Moved|2|||
163411094|NCT00130832|590212965|FG001|Overall Study|Moved|2|||
163411095|NCT00130832|590212964|FG000|Overall Study|Other|0|||
163151940|NCT02177123|589271355|FG000|Overall Study|Excluded for medical reasons|2|||
163151941|NCT02177123|589271355|FG000|Overall Study|Death|1|||
163151942|NCT02177123|589271355|FG000|Overall Study|Other|1|||
163411096|NCT00130832|590212965|FG001|Overall Study|Other|3|||
163411097|NCT02770326|590212967|FG000|Overall Study|Death|3|||
163411098|NCT02770326|590212967|FG000|Overall Study|Lost to Follow-up|1|||
163411099|NCT03118297|590212968|FG000|Overall Study|Lost to Follow-up|0|||
163258223|NCT01951638|589654142|FG002|Follow-up Period|Logistical difficulties|0|||
163258224|NCT01951638|589654143|FG003|Follow-up Period|Logistical difficulties|0|||
163258225|NCT01951638|589654144|FG004|Follow-up Period|Logistical difficulties|1|||
163258226|NCT01951638|589654140|FG000|Follow-up Period|Withdrawal by Subject|1|||
163258227|NCT01951638|589654141|FG001|Follow-up Period|Withdrawal by Subject|5|||
163258228|NCT01951638|589654142|FG002|Follow-up Period|Withdrawal by Subject|2|||
163258229|NCT01951638|589654143|FG003|Follow-up Period|Withdrawal by Subject|1|||
163258230|NCT01951638|589654144|FG004|Follow-up Period|Withdrawal by Subject|2|||
163258231|NCT01951638|589654140|FG000|Follow-up Period|Lost to Follow-up|0|||
163258232|NCT01951638|589654141|FG001|Follow-up Period|Lost to Follow-up|1|||
163258233|NCT01951638|589654142|FG002|Follow-up Period|Lost to Follow-up|0|||
163258234|NCT01951638|589654143|FG003|Follow-up Period|Lost to Follow-up|1|||
163258235|NCT01951638|589654144|FG004|Follow-up Period|Lost to Follow-up|0|||
163258236|NCT01951638|589654140|FG000|Follow-up Period|Death|1|||
163258237|NCT01951638|589654141|FG001|Follow-up Period|Death|0|||
163258238|NCT01951638|589654142|FG002|Follow-up Period|Death|1|||
163258239|NCT01951638|589654143|FG003|Follow-up Period|Death|4|||
163258240|NCT01951638|589654144|FG004|Follow-up Period|Death|1|||
163258241|NCT01951638|589654140|FG000|Follow-up Period|Adverse Event|0|||
163258242|NCT01951638|589654141|FG001|Follow-up Period|Adverse Event|1|||
163258243|NCT01951638|589654142|FG002|Follow-up Period|Adverse Event|2|||
163258244|NCT01951638|589654143|FG003|Follow-up Period|Adverse Event|1|||
163258245|NCT01951638|589654144|FG004|Follow-up Period|Adverse Event|1|||
163258246|NCT00552084|589654145|FG000|Overall Study|Adverse Event|2|||
163258247|NCT00552084|589654146|FG001|Overall Study|Adverse Event|3|||
163258248|NCT00552084|589654145|FG000|Overall Study|Withdrawal by Subject|4|||
163258249|NCT00552084|589654146|FG001|Overall Study|Withdrawal by Subject|5|||
163258250|NCT00552084|589654145|FG000|Overall Study|Protocol Violation|1|||
163258251|NCT00552084|589654146|FG001|Overall Study|Protocol Violation|0|||
163258252|NCT00552084|589654145|FG000|Overall Study|change in anti-arrythmic drug|1|||
163258253|NCT00552084|589654146|FG001|Overall Study|change in anti-arrythmic drug|1|||
163258254|NCT01338025|589654147|FG000|Overall Study|Unexpected closure of study|10|||
163258255|NCT01338025|589654148|FG001|Overall Study|Unexpected closure of study|9|||
163258256|NCT01338025|589654147|FG000|Overall Study|Withdrawal by Subject|0|||
163258257|NCT01338025|589654148|FG001|Overall Study|Withdrawal by Subject|2|||
163258258|NCT01338025|589654147|FG000|Overall Study|Found ineligible after starting|1|||
163258259|NCT01338025|589654148|FG001|Overall Study|Found ineligible after starting|0|||
163258260|NCT03188055|589654149|FG000|Overall Study|Unavailable for training|0|||
163258261|NCT03188055|589654150|FG001|Overall Study|Unavailable for training|0|||
163258262|NCT03188055|589654151|FG002|Overall Study|Unavailable for training|19|||
163258263|NCT03188055|589654152|FG003|Overall Study|Unavailable for training|0|||
163258264|NCT03188055|589654153|FG004|Overall Study|Unavailable for training|0|||
163258265|NCT03188055|589654154|FG005|Overall Study|Unavailable for training|0|||
163258266|NCT03188055|589654149|FG000|Overall Study|Lost to Follow-up|0|||
163258267|NCT03188055|589654150|FG001|Overall Study|Lost to Follow-up|18|||
163258268|NCT03188055|589654151|FG002|Overall Study|Lost to Follow-up|0|||
163258269|NCT03188055|589654152|FG003|Overall Study|Lost to Follow-up|11|||
163258270|NCT03188055|589654153|FG004|Overall Study|Lost to Follow-up|0|||
163258271|NCT03188055|589654154|FG005|Overall Study|Lost to Follow-up|0|||
163258272|NCT03188055|589654149|FG000|Overall Study|Withdrawal by Subject|0|||
163258273|NCT03188055|589654150|FG001|Overall Study|Withdrawal by Subject|1|||
163258274|NCT03188055|589654151|FG002|Overall Study|Withdrawal by Subject|0|||
163258275|NCT03188055|589654152|FG003|Overall Study|Withdrawal by Subject|1|||
163258276|NCT03188055|589654153|FG004|Overall Study|Withdrawal by Subject|0|||
163258277|NCT03188055|589654154|FG005|Overall Study|Withdrawal by Subject|0|||
163258278|NCT04349280|589654155|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
163258279|NCT04349280|589654156|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
163258280|NCT04349280|589654155|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
163258281|NCT04349280|589654156|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
163258282|NCT04349280|589654155|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
163258283|NCT04349280|589654156|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
163258284|NCT00657618|589654161|FG000|Overall Study|Adverse Event|32|||
163258285|NCT00657618|589654161|FG000|Overall Study|Withdrawal by Subject|8|||
163258286|NCT00657618|589654161|FG000|Overall Study|negative for leishmaniasis|2|||
163258287|NCT00657618|589654161|FG000|Overall Study|didn't start due to schedule conflicts|1|||
163258288|NCT01659151|589654162|FG000|Overall Study|Inadequate TIL growth|1|||
163258289|NCT05774197|589654163|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
163258290|NCT05073133|589654164|FG000|Overall Study|Death|2|||
163258291|NCT04981678|589654165|FG000|Overall Study|Lost to Follow-up|0|||
163258292|NCT04981678|589654166|FG001|Overall Study|Lost to Follow-up|1|||
163258293|NCT02044848|589656091|FG000|Overall Study|Administrative Problems|2|||
163258294|NCT02044848|589656092|FG001|Overall Study|Administrative Problems|3|||
163258295|NCT00284141|589656097|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
163258296|NCT00284141|589656097|FG000|Overall Study|Adverse Event|19|||
163258297|NCT00284141|589656097|FG000|Overall Study|Participant's request|9|||
163258298|NCT00284141|589656097|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
163411100|NCT03118297|590212969|FG001|Overall Study|Lost to Follow-up|2|||
163411101|NCT02363686|590212970|FG000|Overall Study|Withdrawal by Subject|22|||
163411102|NCT02363686|590212970|FG000|Overall Study|incomplete FEES examinations|13|||
163411103|NCT01121393|590212973|FG000|Overall Study|Progressive disease|201|||
163411104|NCT01121393|590212974|FG001|Overall Study|Progressive disease|20|||
163411105|NCT01121393|590212973|FG000|Overall Study|Other Adverse events|24|||
163411106|NCT01121393|590212974|FG001|Overall Study|Other Adverse events|45|||
163411107|NCT01121393|590212973|FG000|Overall Study|Non-compliant with protocol|0|||
163411108|NCT01121393|590212974|FG001|Overall Study|Non-compliant with protocol|3|||
163411109|NCT01121393|590212973|FG000|Overall Study|Lost to Follow-up|1|||
163411110|NCT01121393|590212974|FG001|Overall Study|Lost to Follow-up|0|||
163411111|NCT01121393|590212973|FG000|Overall Study|Refused cont. medication|7|||
163411112|NCT01121393|590212974|FG001|Overall Study|Refused cont. medication|7|||
163411113|NCT01121393|590212973|FG000|Overall Study|Not treated|3|||
163411114|NCT01121393|590212974|FG001|Overall Study|Not treated|9|||
163411115|NCT01121393|590212973|FG000|Overall Study|Other than listed|6|||
163411116|NCT01121393|590212974|FG001|Overall Study|Other than listed|0|||
163411117|NCT03215771|590212979|FG000|Overall Study|Withdrawal by Subject|2|||
163411118|NCT03215771|590212979|FG000|Overall Study|Physician Decision|1|||
163411119|NCT02703311|590212986|FG000|Overall Study|Death|5|||
163411120|NCT02703311|590212986|FG000|Overall Study|Withdrawal by Subject|3|||
163411121|NCT00343889|590212989|FG000|Overall Study|Lost to Follow-up|2|||
163411122|NCT00343889|590212990|FG001|Overall Study|Lost to Follow-up|0|||
163411123|NCT00343889|590212989|FG000|Overall Study|Withdrawal by Subject|0|||
163411124|NCT00343889|590212990|FG001|Overall Study|Withdrawal by Subject|1|||
163411125|NCT00343889|590212989|FG000|Overall Study|Protocol Violation|1|||
163411126|NCT00343889|590212990|FG001|Overall Study|Protocol Violation|0|||
163411127|NCT00137111|590212991|FG000|Total Therapy|Death|35|||
163411128|NCT00137111|590212992|FG001|Total Therapy|Death|0|||
163411129|NCT00137111|590212993|FG002|Total Therapy|Death|0|||
163411130|NCT00137111|590212994|FG003|Total Therapy|Death|0|||
163411131|NCT00137111|590212991|FG000|Total Therapy|Non Compliance|5|||
163411132|NCT00137111|590212992|FG001|Total Therapy|Non Compliance|0|||
163411133|NCT00137111|590212993|FG002|Total Therapy|Non Compliance|0|||
163411134|NCT00137111|590212994|FG003|Total Therapy|Non Compliance|0|||
163411135|NCT00088374|590212995|FG000|Overall Study|patient did not receive any 17AAG|1|||
163411136|NCT00088374|590212995|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
163258299|NCT00284141|589656097|FG000|Overall Study|Clinical deterioration / death|2|||
163258300|NCT00284141|589656097|FG000|Overall Study|General decline|1|||
163258301|NCT00284141|589656097|FG000|Overall Study|Pneumonia|1|||
163258302|NCT00284141|589656097|FG000|Overall Study|Did not take study medication|2|||
163258303|NCT00284141|589656097|FG000|Overall Study|Ongoing treatment|2|||
163258304|NCT01782742|589656106|FG000|Double-blind Treatment Phase|Adverse Event|1|||
163258305|NCT01782742|589656107|FG001|Double-blind Treatment Phase|Adverse Event|0|||
163258306|NCT04170686|589656108|FG000|Screening|Physician Decision|12|||
163258307|NCT04170686|589656109|FG001|Screening|Physician Decision|13|||
163258308|NCT04170686|589656108|FG000|Randomization and Treatment|Lost to Follow-up|26|||
163258309|NCT04170686|589656109|FG001|Randomization and Treatment|Lost to Follow-up|15|||
163258310|NCT04425902|589656112|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
163258311|NCT01191840|589656113|FG000|Overall Study|withdrew consent|2|||
163258312|NCT01191840|589656114|FG001|Overall Study|withdrew consent|1|||
163258313|NCT01191840|589656113|FG000|Overall Study|Subject discontinued treatment|1|||
163258314|NCT01191840|589656114|FG001|Overall Study|Subject discontinued treatment|2|||
163258315|NCT01191840|589656113|FG000|Overall Study|Lost to Follow-up|4|||
163258316|NCT01191840|589656114|FG001|Overall Study|Lost to Follow-up|6|||
163258317|NCT01191840|589656113|FG000|Overall Study|Non Staph Infection|4|||
163258318|NCT01191840|589656114|FG001|Overall Study|Non Staph Infection|3|||
163258319|NCT01191840|589656113|FG000|Overall Study|ineligible at enrollment|1|||
163258320|NCT01191840|589656114|FG001|Overall Study|ineligible at enrollment|0|||
163258321|NCT01191840|589656113|FG000|Overall Study|IRB approval lapse|0|||
163258322|NCT01191840|589656114|FG001|Overall Study|IRB approval lapse|2|||
163258323|NCT01191840|589656113|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
163411137|NCT00852995|590212996|FG000|Overall Study|Adverse Event|1|||
163411138|NCT00852995|590212997|FG001|Overall Study|Adverse Event|0|||
163411139|NCT00852995|590212998|FG002|Overall Study|Adverse Event|4|||
163411140|NCT00852995|590212999|FG003|Overall Study|Adverse Event|0|||
163258324|NCT01191840|589656114|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
163258325|NCT01191840|589656113|FG000|Overall Study|Withdrawal by Subject|2|||
163258326|NCT01191840|589656114|FG001|Overall Study|Withdrawal by Subject|0|||
163258327|NCT00331344|589656120|FG000|Phase I|Adverse Event|0|||
163258328|NCT00331344|589656121|FG001|Phase I|Adverse Event|0|||
163258329|NCT00331344|589656122|FG002|Phase I|Adverse Event|0|||
163258330|NCT00331344|589656123|FG003|Phase I|Adverse Event|1|||
163258331|NCT00331344|589656124|FG004|Phase I|Adverse Event|2|||
163411141|NCT00852995|590213000|FG004|Overall Study|Adverse Event|0|||
163411142|NCT00852995|590212996|FG000|Overall Study|Lost to Follow-up|0|||
163411143|NCT00852995|590212997|FG001|Overall Study|Lost to Follow-up|1|||
163411144|NCT00852995|590212998|FG002|Overall Study|Lost to Follow-up|1|||
163411145|NCT00852995|590212999|FG003|Overall Study|Lost to Follow-up|0|||
163258332|NCT00331344|589656125|FG005|Phase I|Adverse Event|2|||
163258333|NCT00331344|589656126|FG006|Phase I|Adverse Event|0|||
163258334|NCT00331344|589656127|FG007|Phase I|Adverse Event|1|||
163258335|NCT00331344|589656128|FG008|Phase I|Adverse Event|0|||
163258336|NCT00331344|589656120|FG000|Phase II|Death|0|||
163258337|NCT00331344|589656121|FG001|Phase II|Death|0|||
163258338|NCT00331344|589656122|FG002|Phase II|Death|0|||
163258339|NCT00331344|589656123|FG003|Phase II|Death|0|||
163258340|NCT00331344|589656124|FG004|Phase II|Death|0|||
163258341|NCT00331344|589656125|FG005|Phase II|Death|0|||
163258342|NCT00331344|589656126|FG006|Phase II|Death|0|||
163258343|NCT00331344|589656127|FG007|Phase II|Death|0|||
163258344|NCT00331344|589656128|FG008|Phase II|Death|4|||
163258345|NCT02940574|589656130|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
163258346|NCT02940574|589656131|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
163258347|NCT02940574|589656130|FG000|1-year Follow-up|Lost to Follow-up|3|||
163258348|NCT02940574|589656131|FG001|1-year Follow-up|Lost to Follow-up|4|||
163258349|NCT04538144|589656132|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
163258350|NCT04538144|589656133|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
163258351|NCT04538144|589656134|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
163258352|NCT04538144|589656135|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
163258353|NCT00520975|589656136|FG000|Overall Study|Disease progression|31|||
163258354|NCT00520975|589656137|FG001|Overall Study|Disease progression|23|||
163258355|NCT00520975|589656136|FG000|Overall Study|Adverse Event|7|||
163258356|NCT00520975|589656137|FG001|Overall Study|Adverse Event|10|||
163258357|NCT00520975|589656136|FG000|Overall Study|Death|0|||
163258358|NCT00520975|589656137|FG001|Overall Study|Death|2|||
163258359|NCT00520975|589656136|FG000|Overall Study|Withdrawal by Subject|3|||
163258360|NCT00520975|589656137|FG001|Overall Study|Withdrawal by Subject|5|||
163258361|NCT00520975|589656136|FG000|Overall Study|Other therapy|2|||
163258362|NCT00520975|589656137|FG001|Overall Study|Other therapy|4|||
163258363|NCT00520975|589656136|FG000|Overall Study|Other reasons|4|||
163258364|NCT00520975|589656137|FG001|Overall Study|Other reasons|2|||
163258365|NCT00520975|589656136|FG000|Overall Study|Not start protocol therapy|1|||
163258366|NCT00520975|589656137|FG001|Overall Study|Not start protocol therapy|2|||
163258367|NCT01682213|589656138|FG000|Overall Study|Withdrawal by Subject|2|||
163258368|NCT04382924|589656139|FG000|Overall Study|Death|2|||
163258369|NCT04382924|589656140|FG001|Overall Study|Death|5|||
163258370|NCT04382924|589656141|FG002|Overall Study|Death|4|||
163258371|NCT04382924|589656139|FG000|Overall Study|Protocol Violation|0|||
163258372|NCT04382924|589656140|FG001|Overall Study|Protocol Violation|1|||
163258373|NCT04382924|589656141|FG002|Overall Study|Protocol Violation|1|||
163258374|NCT04382924|589656139|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
163258375|NCT04382924|589656140|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
163258376|NCT04382924|589656141|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
163258377|NCT04382924|589656139|FG000|Overall Study|Withdrawal by Subject|6|||
163258378|NCT04382924|589656140|FG001|Overall Study|Withdrawal by Subject|3|||
163258379|NCT04382924|589656141|FG002|Overall Study|Withdrawal by Subject|6|||
163258380|NCT00261495|589656144|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
163258381|NCT00261495|589656145|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
163258382|NCT00261495|589656144|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
163361317|NCT03377361|590031676|FG000|Treatment Period|Death|0|||
163361318|NCT03377361|590031677|FG001|Treatment Period|Death|0|||
163361319|NCT03377361|590031678|FG002|Treatment Period|Death|1|||
163258383|NCT00261495|589656145|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
163258384|NCT00261495|589656144|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
163258385|NCT00261495|589656145|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
163258386|NCT00261495|589656144|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
163258387|NCT00261495|589656145|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
163258388|NCT00261495|589656144|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
163258389|NCT00261495|589656145|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
163258390|NCT00261495|589656144|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
163258391|NCT00261495|589656145|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
163258392|NCT00261495|589656144|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
163258393|NCT00261495|589656145|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
163258394|NCT00261495|589656144|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
163258395|NCT00261495|589656145|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
163258396|NCT00261495|589656144|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
163258397|NCT00261495|589656145|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
163361320|NCT03377361|590031679|FG003|Treatment Period|Death|0|||
163258398|NCT00261495|589656144|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
163361321|NCT03377361|590031680|FG004|Treatment Period|Death|0|||
163361322|NCT03377361|590031681|FG005|Treatment Period|Death|0|||
163258399|NCT00261495|589656145|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
163258400|NCT00261495|589656144|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
163258401|NCT00261495|589656145|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
163361323|NCT03377361|590031682|FG006|Treatment Period|Death|0|||
163258402|NCT00261495|589656144|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
163258403|NCT00261495|589656145|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
163258404|NCT00261495|589656144|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
163258405|NCT00261495|589656145|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
163258406|NCT00261495|589656144|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
163258407|NCT00261495|589656145|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
163258408|NCT00261495|589656144|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
163258409|NCT00261495|589656145|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
163258410|NCT00261495|589656144|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
163258411|NCT00261495|589656145|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
163258412|NCT00261495|589656144|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
163258413|NCT00261495|589656145|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
163258414|NCT00261495|589656144|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
163258415|NCT00261495|589656145|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
163258416|NCT00261495|589656144|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
163258417|NCT00261495|589656145|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
163258418|NCT00261495|589656144|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
163258419|NCT00261495|589656145|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
163258420|NCT00261495|589656144|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
163258421|NCT00261495|589656145|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163258422|NCT00642902|589656146|FG000|Overall Study|Adverse Event|0|||
163258423|NCT00642902|589656147|FG001|Overall Study|Adverse Event|1|||
163258424|NCT00642902|589656148|FG002|Overall Study|Adverse Event|3|||
163258425|NCT00642902|589656149|FG003|Overall Study|Adverse Event|1|||
163258426|NCT00642902|589656146|FG000|Overall Study|Lost to Follow-up|1|||
163258427|NCT00642902|589656147|FG001|Overall Study|Lost to Follow-up|1|||
163258428|NCT00642902|589656148|FG002|Overall Study|Lost to Follow-up|0|||
163258429|NCT00642902|589656149|FG003|Overall Study|Lost to Follow-up|0|||
163258430|NCT00642902|589656146|FG000|Overall Study|Lack of Efficacy|0|||
163258431|NCT00642902|589656147|FG001|Overall Study|Lack of Efficacy|3|||
163258432|NCT00642902|589656148|FG002|Overall Study|Lack of Efficacy|3|||
163258433|NCT00642902|589656149|FG003|Overall Study|Lack of Efficacy|0|||
163258434|NCT00642902|589656146|FG000|Overall Study|Death|1|||
163258435|NCT00642902|589656147|FG001|Overall Study|Death|0|||
163258436|NCT00642902|589656148|FG002|Overall Study|Death|0|||
163258437|NCT00642902|589656149|FG003|Overall Study|Death|0|||
163258438|NCT00642902|589656146|FG000|Overall Study|Premature termination of clinical trial|37|||
163258439|NCT00642902|589656147|FG001|Overall Study|Premature termination of clinical trial|32|||
163258440|NCT00642902|589656148|FG002|Overall Study|Premature termination of clinical trial|35|||
163258441|NCT00642902|589656149|FG003|Overall Study|Premature termination of clinical trial|35|||
163258442|NCT00642902|589656146|FG000|Overall Study|Randomized, but not treated|0|||
163258443|NCT00642902|589656147|FG001|Overall Study|Randomized, but not treated|0|||
163258444|NCT00642902|589656148|FG002|Overall Study|Randomized, but not treated|1|||
163258445|NCT00642902|589656149|FG003|Overall Study|Randomized, but not treated|0|||
163258446|NCT00642902|589656146|FG000|Overall Study|Other|1|||
163258447|NCT00642902|589656147|FG001|Overall Study|Other|5|||
163258448|NCT00642902|589656148|FG002|Overall Study|Other|1|||
163258449|NCT00642902|589656149|FG003|Overall Study|Other|4|||
163258450|NCT00429663|589656150|FG000|Overall Study|Lost to Follow-up|24|||
163258451|NCT00429663|589656151|FG001|Overall Study|Lost to Follow-up|31|||
163258452|NCT00429663|589656150|FG000|Overall Study|Physician Decision|6|||
163258453|NCT00429663|589656151|FG001|Overall Study|Physician Decision|3|||
163258454|NCT00429663|589656150|FG000|Overall Study|Withdrawal by Subject|2|||
163258455|NCT00429663|589656151|FG001|Overall Study|Withdrawal by Subject|5|||
163258456|NCT00429663|589656150|FG000|Overall Study|Death|4|||
163258457|NCT00429663|589656151|FG001|Overall Study|Death|0|||
163258458|NCT04207840|589656152|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
163258459|NCT04207840|589656153|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
163258460|NCT04207840|589656154|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
163258461|NCT04207840|589656152|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
163258462|NCT04207840|589656153|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
163258463|NCT04207840|589656154|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
163258464|NCT03243422|589656157|FG000|Overall Study|Death|20|||
163258465|NCT03243422|589656158|FG001|Overall Study|Death|21|||
163258466|NCT03243422|589656157|FG000|Overall Study|Lost to Follow-up|9|||
163258467|NCT03243422|589656158|FG001|Overall Study|Lost to Follow-up|21|||
163258468|NCT03243422|589656157|FG000|Overall Study|Withdrawal by Subject|22|||
163258469|NCT03243422|589656158|FG001|Overall Study|Withdrawal by Subject|8|||
163258470|NCT03420781|589656161|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
163258471|NCT03420781|589656162|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
163258472|NCT03420781|589656163|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
163258473|NCT03420781|589656164|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
163258474|NCT03420781|589656165|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
163258475|NCT03420781|589656161|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
163258476|NCT03420781|589656162|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
163258477|NCT03420781|589656163|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
163258478|NCT03420781|589656164|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
163258479|NCT03420781|589656165|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
163258480|NCT03420781|589656161|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
163258481|NCT03420781|589656162|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
163258482|NCT03420781|589656163|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
163258483|NCT03420781|589656164|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
163258484|NCT03420781|589656165|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
163258485|NCT03420781|589656161|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
163258486|NCT03420781|589656162|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
163258487|NCT03420781|589656163|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
163258488|NCT03420781|589656164|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
163258489|NCT03420781|589656165|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
163258490|NCT03420781|589656161|FG000|Treatment Period (40 Weeks)|Death|2|||
163258491|NCT03420781|589656162|FG001|Treatment Period (40 Weeks)|Death|2|||
163258492|NCT03420781|589656163|FG002|Treatment Period (40 Weeks)|Death|0|||
163258493|NCT03420781|589656164|FG003|Treatment Period (40 Weeks)|Death|0|||
163258494|NCT03420781|589656165|FG004|Treatment Period (40 Weeks)|Death|0|||
163258495|NCT03420781|589656161|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
163258496|NCT03420781|589656162|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
163258497|NCT03420781|589656163|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
163258498|NCT03420781|589656164|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
163258499|NCT03420781|589656165|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
163258500|NCT03420781|589656161|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
163258501|NCT03420781|589656162|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
163258502|NCT03420781|589656163|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
163258503|NCT03420781|589656164|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
163258504|NCT03420781|589656165|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
163258505|NCT03420781|589656161|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
163258506|NCT03420781|589656162|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
163258507|NCT03420781|589656163|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
163258508|NCT03420781|589656164|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
163258509|NCT03420781|589656165|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
163258510|NCT03420781|589656161|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
163258511|NCT03420781|589656162|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
163258512|NCT03420781|589656163|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
163258513|NCT03420781|589656164|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
163258514|NCT03420781|589656165|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
163258515|NCT03420781|589656161|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
163258516|NCT03420781|589656162|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
163258517|NCT03420781|589656163|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
163258518|NCT03420781|589656164|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
163258519|NCT03420781|589656165|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
163258520|NCT03420781|589656161|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
163258521|NCT03420781|589656162|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
163258522|NCT03420781|589656163|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
163258523|NCT03420781|589656164|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
163258524|NCT03420781|589656165|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
163258525|NCT03420781|589656161|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
163258526|NCT03420781|589656162|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
163258527|NCT03420781|589656163|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
163258528|NCT03420781|589656164|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
163258529|NCT03420781|589656165|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
163258530|NCT03420781|589656161|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
163258531|NCT03420781|589656162|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
163258532|NCT03420781|589656163|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
163258533|NCT03420781|589656164|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
163258534|NCT03420781|589656165|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
163258535|NCT01226511|589656170|FG000|Acute Treatment Period|Adverse Event|7|||
163258536|NCT01226511|589656171|FG001|Acute Treatment Period|Adverse Event|6|||
163258537|NCT01226511|589656170|FG000|Acute Treatment Period|Lack of Efficacy|2|||
163258538|NCT01226511|589656171|FG001|Acute Treatment Period|Lack of Efficacy|1|||
163258539|NCT01226511|589656170|FG000|Acute Treatment Period|Lost to Follow-up|3|||
163258540|NCT01226511|589656171|FG001|Acute Treatment Period|Lost to Follow-up|6|||
163258541|NCT01226511|589656170|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
163258542|NCT01226511|589656171|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
163258543|NCT01226511|589656170|FG000|Acute Treatment Period|Protocol Violation|5|||
163258544|NCT01226511|589656171|FG001|Acute Treatment Period|Protocol Violation|5|||
163258545|NCT01226511|589656170|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
163258546|NCT01226511|589656171|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
163258547|NCT01226511|589656170|FG000|Extension Treatment Period|Adverse Event|8|||
163258548|NCT01226511|589656171|FG001|Extension Treatment Period|Adverse Event|8|||
163258549|NCT01226511|589656170|FG000|Extension Treatment Period|Lack of Efficacy|3|||
163258550|NCT01226511|589656171|FG001|Extension Treatment Period|Lack of Efficacy|2|||
163258551|NCT01226511|589656170|FG000|Extension Treatment Period|Lost to Follow-up|4|||
163258552|NCT01226511|589656171|FG001|Extension Treatment Period|Lost to Follow-up|3|||
163258553|NCT01226511|589656170|FG000|Extension Treatment Period|Protocol Violation|2|||
163258554|NCT01226511|589656171|FG001|Extension Treatment Period|Protocol Violation|2|||
163258555|NCT01226511|589656170|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
163258556|NCT01226511|589656171|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
163258557|NCT01226511|589656170|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
163258558|NCT01226511|589656171|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
163258559|NCT01226511|589656170|FG000|Extension Treatment Period|Sponsor Decision|1|||
163258560|NCT01226511|589656171|FG001|Extension Treatment Period|Sponsor Decision|1|||
163258561|NCT01226511|589656170|FG000|Taper Period|Adverse Event|1|||
163258562|NCT01226511|589656171|FG001|Taper Period|Adverse Event|0|||
163258563|NCT01226511|589656170|FG000|Taper Period|Lost to Follow-up|2|||
163258564|NCT01226511|589656171|FG001|Taper Period|Lost to Follow-up|2|||
163258565|NCT01226511|589656170|FG000|Taper Period|Protocol Violation|1|||
163258566|NCT01226511|589656171|FG001|Taper Period|Protocol Violation|0|||
163258567|NCT01226511|589656170|FG000|Taper Period|Parent/Caregiver Decision|1|||
163258568|NCT01226511|589656171|FG001|Taper Period|Parent/Caregiver Decision|1|||
163258569|NCT02696564|589656172|FG000|Overall Study|Death|1|||
163258570|NCT02696564|589656173|FG001|Overall Study|Death|2|||
163258571|NCT02696564|589656172|FG000|Overall Study|Withdrawal by Subject|3|||
163258572|NCT02696564|589656173|FG001|Overall Study|Withdrawal by Subject|2|||
163258573|NCT02696564|589656172|FG000|Overall Study|Lost to Follow-up|3|||
163258574|NCT02696564|589656173|FG001|Overall Study|Lost to Follow-up|3|||
163258575|NCT02696564|589656172|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
163258576|NCT02696564|589656173|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
163258577|NCT02696564|589656172|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
163258578|NCT02696564|589656173|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
163258579|NCT02696564|589656172|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
163258580|NCT02696564|589656173|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
163258581|NCT02696564|589656172|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
163258582|NCT02696564|589656173|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
163258583|NCT02696564|589656172|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
163258584|NCT02696564|589656173|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
163258585|NCT05267600|589656174|FG000|Overall Study|Adverse Event|1|||
163258586|NCT05267600|589656175|FG001|Overall Study|Adverse Event|4|||
163258587|NCT05267600|589656174|FG000|Overall Study|Death|1|||
163258588|NCT05267600|589656175|FG001|Overall Study|Death|2|||
163258589|NCT05267600|589656174|FG000|Overall Study|Lack of Efficacy|1|||
163258590|NCT05267600|589656175|FG001|Overall Study|Lack of Efficacy|2|||
163258591|NCT05267600|589656174|FG000|Overall Study|Lost to Follow-up|3|||
163258592|NCT05267600|589656175|FG001|Overall Study|Lost to Follow-up|0|||
163258593|NCT05267600|589656174|FG000|Overall Study|Physician Decision|4|||
163258594|NCT05267600|589656175|FG001|Overall Study|Physician Decision|0|||
163258595|NCT05267600|589656174|FG000|Overall Study|Treatment Unblinded|0|||
163258596|NCT05267600|589656175|FG001|Overall Study|Treatment Unblinded|1|||
163258597|NCT05267600|589656174|FG000|Overall Study|Withdrawal by Subject|5|||
163258598|NCT05267600|589656175|FG001|Overall Study|Withdrawal by Subject|4|||
163258599|NCT04067401|589656176|FG000|Overall Study|Withdrawal by Subject|7|||
163258600|NCT04067401|589656177|FG001|Overall Study|Withdrawal by Subject|0|||
163258601|NCT04067401|589656176|FG000|Overall Study|no data provided|1|||
163258602|NCT04067401|589656177|FG001|Overall Study|no data provided|0|||
163258603|NCT03633929|589656180|FG000|Overall Study|Lost to Follow-up|1|||
163258604|NCT03633929|589656180|FG000|Overall Study|Did not login to software. Did not participate|3|||
163258605|NCT02287584|589656182|FG000|the Double-blind Phase|Adverse Event|17|||
163258606|NCT02287584|589656183|FG001|the Double-blind Phase|Adverse Event|17|||
163258607|NCT02287584|589656184|FG002|the Double-blind Phase|Adverse Event|12|||
163361324|NCT03377361|590031683|FG007|Treatment Period|Death|2|||
163361325|NCT03377361|590031684|FG008|Treatment Period|Death|1|||
163258608|NCT02287584|589656185|FG003|the Double-blind Phase|Adverse Event|0|||
163258609|NCT02287584|589656186|FG004|the Double-blind Phase|Adverse Event|0|||
163258610|NCT02287584|589656187|FG005|the Double-blind Phase|Adverse Event|0|||
163258611|NCT02287584|589656182|FG000|the Double-blind Phase|Lack of Efficacy|18|||
163258612|NCT02287584|589656183|FG001|the Double-blind Phase|Lack of Efficacy|8|||
163258613|NCT02287584|589656184|FG002|the Double-blind Phase|Lack of Efficacy|8|||
163361326|NCT03377361|590031685|FG009|Treatment Period|Death|3|||
163258614|NCT02287584|589656185|FG003|the Double-blind Phase|Lack of Efficacy|0|||
163258615|NCT02287584|589656186|FG004|the Double-blind Phase|Lack of Efficacy|0|||
163258616|NCT02287584|589656187|FG005|the Double-blind Phase|Lack of Efficacy|0|||
163258617|NCT02287584|589656182|FG000|the Double-blind Phase|Lost to Follow-up|0|||
163258618|NCT02287584|589656183|FG001|the Double-blind Phase|Lost to Follow-up|1|||
163258619|NCT02287584|589656184|FG002|the Double-blind Phase|Lost to Follow-up|1|||
163258620|NCT02287584|589656185|FG003|the Double-blind Phase|Lost to Follow-up|0|||
163258621|NCT02287584|589656186|FG004|the Double-blind Phase|Lost to Follow-up|0|||
163258622|NCT02287584|589656187|FG005|the Double-blind Phase|Lost to Follow-up|0|||
163258623|NCT02287584|589656182|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
163258624|NCT02287584|589656183|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
163258625|NCT02287584|589656184|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
163258626|NCT02287584|589656185|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
163258627|NCT02287584|589656186|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
163258628|NCT02287584|589656187|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
163258629|NCT02287584|589656182|FG000|the Double-blind Phase|Pregnancy|0|||
163258630|NCT02287584|589656183|FG001|the Double-blind Phase|Pregnancy|1|||
163258631|NCT02287584|589656184|FG002|the Double-blind Phase|Pregnancy|0|||
163258632|NCT02287584|589656185|FG003|the Double-blind Phase|Pregnancy|0|||
163258633|NCT02287584|589656186|FG004|the Double-blind Phase|Pregnancy|0|||
163258634|NCT02287584|589656187|FG005|the Double-blind Phase|Pregnancy|0|||
163258635|NCT02287584|589656182|FG000|the Double-blind Phase|Protocol Violation|0|||
163258636|NCT02287584|589656183|FG001|the Double-blind Phase|Protocol Violation|3|||
163258637|NCT02287584|589656184|FG002|the Double-blind Phase|Protocol Violation|0|||
163258638|NCT02287584|589656185|FG003|the Double-blind Phase|Protocol Violation|0|||
163258639|NCT02287584|589656186|FG004|the Double-blind Phase|Protocol Violation|0|||
163258640|NCT02287584|589656187|FG005|the Double-blind Phase|Protocol Violation|0|||
163258641|NCT02287584|589656182|FG000|the Double-blind Phase|other reasons|0|||
163258642|NCT02287584|589656183|FG001|the Double-blind Phase|other reasons|0|||
163258643|NCT02287584|589656184|FG002|the Double-blind Phase|other reasons|1|||
163258644|NCT02287584|589656185|FG003|the Double-blind Phase|other reasons|0|||
163258645|NCT02287584|589656186|FG004|the Double-blind Phase|other reasons|0|||
163258646|NCT02287584|589656187|FG005|the Double-blind Phase|other reasons|0|||
163258647|NCT02287584|589656182|FG000|the Open-label Phase|Did not receive drug|0|||
163258648|NCT02287584|589656183|FG001|the Open-label Phase|Did not receive drug|0|||
163258649|NCT02287584|589656184|FG002|the Open-label Phase|Did not receive drug|0|||
163258650|NCT02287584|589656185|FG003|the Open-label Phase|Did not receive drug|7|||
163258651|NCT02287584|589656186|FG004|the Open-label Phase|Did not receive drug|6|||
163258652|NCT02287584|589656187|FG005|the Open-label Phase|Did not receive drug|4|||
163258653|NCT02287584|589656182|FG000|the Open-label Phase|Adverse Event|0|||
163258654|NCT02287584|589656183|FG001|the Open-label Phase|Adverse Event|0|||
163258655|NCT02287584|589656184|FG002|the Open-label Phase|Adverse Event|0|||
163258656|NCT02287584|589656185|FG003|the Open-label Phase|Adverse Event|15|||
163258657|NCT02287584|589656186|FG004|the Open-label Phase|Adverse Event|12|||
163258658|NCT02287584|589656187|FG005|the Open-label Phase|Adverse Event|16|||
163258659|NCT02287584|589656182|FG000|the Open-label Phase|Lack of Efficacy|0|||
163258660|NCT02287584|589656183|FG001|the Open-label Phase|Lack of Efficacy|0|||
163258661|NCT02287584|589656184|FG002|the Open-label Phase|Lack of Efficacy|0|||
163258662|NCT02287584|589656185|FG003|the Open-label Phase|Lack of Efficacy|8|||
163258663|NCT02287584|589656186|FG004|the Open-label Phase|Lack of Efficacy|3|||
163258664|NCT02287584|589656187|FG005|the Open-label Phase|Lack of Efficacy|7|||
163258665|NCT02287584|589656182|FG000|the Open-label Phase|Lost to Follow-up|0|||
163258666|NCT02287584|589656183|FG001|the Open-label Phase|Lost to Follow-up|0|||
163258667|NCT02287584|589656184|FG002|the Open-label Phase|Lost to Follow-up|0|||
163258668|NCT02287584|589656185|FG003|the Open-label Phase|Lost to Follow-up|4|||
163258669|NCT02287584|589656186|FG004|the Open-label Phase|Lost to Follow-up|1|||
163258670|NCT02287584|589656187|FG005|the Open-label Phase|Lost to Follow-up|2|||
163411146|NCT00852995|590213000|FG004|Overall Study|Lost to Follow-up|0|||
163411147|NCT00852995|590212996|FG000|Overall Study|Withdrawal by Subject|4|||
163411148|NCT00852995|590212997|FG001|Overall Study|Withdrawal by Subject|0|||
163411149|NCT00852995|590212998|FG002|Overall Study|Withdrawal by Subject|0|||
163411150|NCT00852995|590212999|FG003|Overall Study|Withdrawal by Subject|1|||
163411151|NCT00852995|590213000|FG004|Overall Study|Withdrawal by Subject|2|||
163258671|NCT02287584|589656182|FG000|the Open-label Phase|Withdrawal by Subject|0|||
163258672|NCT02287584|589656183|FG001|the Open-label Phase|Withdrawal by Subject|0|||
163258673|NCT02287584|589656184|FG002|the Open-label Phase|Withdrawal by Subject|0|||
163258674|NCT02287584|589656185|FG003|the Open-label Phase|Withdrawal by Subject|18|||
163258675|NCT02287584|589656186|FG004|the Open-label Phase|Withdrawal by Subject|29|||
163258676|NCT02287584|589656187|FG005|the Open-label Phase|Withdrawal by Subject|21|||
163258677|NCT02287584|589656182|FG000|the Open-label Phase|non-compliance|0|||
163258678|NCT02287584|589656183|FG001|the Open-label Phase|non-compliance|0|||
163258679|NCT02287584|589656184|FG002|the Open-label Phase|non-compliance|0|||
163258680|NCT02287584|589656185|FG003|the Open-label Phase|non-compliance|2|||
163258681|NCT02287584|589656186|FG004|the Open-label Phase|non-compliance|5|||
163411152|NCT00852995|590212996|FG000|Overall Study|Non-Compliance|0|||
163258682|NCT02287584|589656187|FG005|the Open-label Phase|non-compliance|1|||
163258683|NCT02287584|589656182|FG000|the Open-label Phase|other reasons|0|||
163258684|NCT02287584|589656183|FG001|the Open-label Phase|other reasons|0|||
163258685|NCT02287584|589656184|FG002|the Open-label Phase|other reasons|0|||
163258686|NCT02287584|589656185|FG003|the Open-label Phase|other reasons|3|||
163258687|NCT02287584|589656186|FG004|the Open-label Phase|other reasons|6|||
163258688|NCT02287584|589656187|FG005|the Open-label Phase|other reasons|6|||
163258689|NCT01892345|589656188|FG000|Overall Study|Adverse Event|0|||
163258690|NCT01892345|589656189|FG001|Overall Study|Adverse Event|2|||
163258691|NCT01892345|589656188|FG000|Overall Study|Death|1|||
163258692|NCT01892345|589656189|FG001|Overall Study|Death|0|||
163258693|NCT01892345|589656188|FG000|Overall Study|Lost to Follow-up|3|||
163258694|NCT01892345|589656189|FG001|Overall Study|Lost to Follow-up|0|||
163258695|NCT01892345|589656188|FG000|Overall Study|Withdrawal by Subject|12|||
163258696|NCT01892345|589656189|FG001|Overall Study|Withdrawal by Subject|1|||
163258697|NCT03745222|589656190|FG000|Overall Study|Withdrawal by Subject|0|||
163258698|NCT03745222|589656191|FG001|Overall Study|Withdrawal by Subject|1|||
163258699|NCT03745222|589656192|FG002|Overall Study|Withdrawal by Subject|0|||
163258700|NCT02657317|589656193|FG000|Overall Study|Withdrawal by Subject|2|||
163258701|NCT02657317|589656194|FG001|Overall Study|Withdrawal by Subject|0|||
163258702|NCT02657317|589656193|FG000|Overall Study|Lost to Follow-up|3|||
163258703|NCT02657317|589656194|FG001|Overall Study|Lost to Follow-up|3|||
163258704|NCT01784068|589656198|FG000|NTCS Phase|Adverse Event|5|||
163258705|NCT01784068|589656199|FG001|NTCS Phase|Adverse Event|0|||
163258706|NCT01784068|589656198|FG000|NTCS Phase|Physician Decision|2|||
163258707|NCT01784068|589656199|FG001|NTCS Phase|Physician Decision|0|||
163258708|NCT01784068|589656198|FG000|NTCS Phase|Patient/guardian decision|3|||
163258709|NCT01784068|589656199|FG001|NTCS Phase|Patient/guardian decision|0|||
163258710|NCT01784068|589656198|FG000|NTCS Phase|Death|2|||
163258711|NCT01784068|589656199|FG001|NTCS Phase|Death|0|||
163258712|NCT01784068|589656198|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
163258713|NCT01784068|589656199|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
163258714|NCT01784068|589656198|FG000|TFR Phase|Physician Decision|0|||
163258715|NCT01784068|589656199|FG001|TFR Phase|Physician Decision|1|||
163258716|NCT01784068|589656198|FG000|TFR Phase|Patient/guardian decision|0|||
163258717|NCT01784068|589656199|FG001|TFR Phase|Patient/guardian decision|3|||
163258718|NCT01784068|589656198|FG000|TFR Phase|Death|0|||
163258719|NCT01784068|589656199|FG001|TFR Phase|Death|1|||
163258720|NCT01784068|589656198|FG000|TFR Phase|Lack of Efficacy|0|||
163258721|NCT01784068|589656199|FG001|TFR Phase|Lack of Efficacy|88|||
163258722|NCT06351371|589656200|FG000|Overall Study|Mutation Status Not Confirmed|9|||
163258723|NCT06351371|589656200|FG000|Overall Study|Ineligible|1|||
163258724|NCT06351371|589656200|FG000|Overall Study|Adverse Event|4|||
163258725|NCT06351371|589656200|FG000|Overall Study|Death|1|||
163258726|NCT06351371|589656200|FG000|Overall Study|Disease progression|14|||
163258727|NCT06351371|589656200|FG000|Overall Study|Withdrawal by Subject|3|||
163258728|NCT06351371|589656200|FG000|Overall Study|Physician Decision|3|||
163258729|NCT04359784|589656201|FG000|Overall Study|Death|2|||
163258730|NCT02063828|589656202|FG000|Overall Study|Withdrawal by Subject|4|||
163258731|NCT02063828|589656203|FG001|Overall Study|Withdrawal by Subject|6|||
163258732|NCT02063828|589656204|FG002|Overall Study|Withdrawal by Subject|3|||
163258733|NCT02063828|589656202|FG000|Overall Study|Death|0|||
163361327|NCT03377361|590031676|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
163361328|NCT03377361|590031677|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
163361329|NCT03377361|590031678|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
163361330|NCT03377361|590031679|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
163361331|NCT03377361|590031680|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
163361332|NCT03377361|590031681|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
163361333|NCT03377361|590031682|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
163361334|NCT03377361|590031683|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
163361335|NCT03377361|590031684|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
163361336|NCT03377361|590031685|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
163361337|NCT03377361|590031676|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
163411153|NCT00852995|590212997|FG001|Overall Study|Non-Compliance|0|||
163258734|NCT02063828|589656203|FG001|Overall Study|Death|0|||
163258735|NCT02063828|589656204|FG002|Overall Study|Death|1|||
163258736|NCT02753595|589656205|FG000|Overall Study|Sponsor termination|2|||
163258737|NCT02753595|589656206|FG001|Overall Study|Sponsor termination|2|||
163258738|NCT02515279|589656210|FG000|Overall Study|Adverse Event|7|||
163258739|NCT02515279|589656210|FG000|Overall Study|Lack of Efficacy|31|||
163258740|NCT02515279|589656210|FG000|Overall Study|Lost to Follow-up|9|||
163258741|NCT02515279|589656210|FG000|Overall Study|Withdrawal by Subject|18|||
163258742|NCT02515279|589656210|FG000|Overall Study|End-of-treatment visit not attended|17|||
163258743|NCT02515279|589656210|FG000|Overall Study|Other|22|||
163258744|NCT01800968|589656211|FG000|Overall Study|Death|23|||
163258745|NCT01800968|589656212|FG001|Overall Study|Death|16|||
163258746|NCT01800968|589656211|FG000|Overall Study|Lost to Follow-up|5|||
163258747|NCT01800968|589656212|FG001|Overall Study|Lost to Follow-up|7|||
163258748|NCT01800968|589656211|FG000|Overall Study|Withdrawal by Subject|7|||
163258749|NCT01800968|589656212|FG001|Overall Study|Withdrawal by Subject|9|||
163258750|NCT01800968|589656211|FG000|Overall Study|Physician Decision|1|||
163258751|NCT01800968|589656212|FG001|Overall Study|Physician Decision|0|||
163258752|NCT04987762|589656214|FG000|Overall Study|Study was Terminated by Sponsor|103|||
163258753|NCT02068495|589656215|FG000|Overall Study|Case Report Forms Uncollected|60|||
163258754|NCT02068495|589656215|FG000|Overall Study|Protocol Deviation|49|||
163258755|NCT01666808|589656218|FG000|Overall Study|Lost to Follow-up|9|||
163258756|NCT01666808|589656219|FG001|Overall Study|Lost to Follow-up|15|||
163258757|NCT01666808|589656218|FG000|Overall Study|Withdrawal by Subject|3|||
163258758|NCT01666808|589656219|FG001|Overall Study|Withdrawal by Subject|1|||
163258759|NCT01666808|589656218|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
163258760|NCT01666808|589656219|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
163258761|NCT02220894|589656220|FG000|Overall Study|Adverse Event|127|||
163258762|NCT02220894|589656221|FG001|Overall Study|Adverse Event|74|||
163258763|NCT02220894|589656220|FG000|Overall Study|Death|418|||
163258764|NCT02220894|589656221|FG001|Overall Study|Death|508|||
163258765|NCT02220894|589656220|FG000|Overall Study|Lost to Follow-up|0|||
163258766|NCT02220894|589656221|FG001|Overall Study|Lost to Follow-up|4|||
163258767|NCT02220894|589656220|FG000|Overall Study|Site Terminated by Sponsor|2|||
163258768|NCT02220894|589656221|FG001|Overall Study|Site Terminated by Sponsor|0|||
163258769|NCT02220894|589656220|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
163258770|NCT02220894|589656221|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
163258771|NCT02220894|589656220|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163258772|NCT02220894|589656221|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163258773|NCT02220894|589656220|FG000|Overall Study|Withdrawal by Subject|10|||
163258774|NCT02220894|589656221|FG001|Overall Study|Withdrawal by Subject|9|||
163258775|NCT03217747|589656222|FG000|Overall Study|Adverse Event|0|||
163258776|NCT03217747|589656223|FG001|Overall Study|Adverse Event|1|||
163258777|NCT03217747|589656224|FG002|Overall Study|Adverse Event|0|||
163258778|NCT03217747|589656225|FG003|Overall Study|Adverse Event|0|||
163258779|NCT03217747|589656226|FG004|Overall Study|Adverse Event|0|||
163258780|NCT03217747|589656227|FG005|Overall Study|Adverse Event|0|||
163258781|NCT03217747|589656228|FG006|Overall Study|Adverse Event|0|||
163258782|NCT03217747|589656229|FG007|Overall Study|Adverse Event|0|||
163258783|NCT03217747|589656230|FG008|Overall Study|Adverse Event|0|||
163258784|NCT03217747|589656231|FG009|Overall Study|Adverse Event|0|||
163258785|NCT03217747|589656232|FG010|Overall Study|Adverse Event|0|||
163258786|NCT03217747|589656233|FG011|Overall Study|Adverse Event|0|||
163258787|NCT03217747|589656234|FG012|Overall Study|Adverse Event|1|||
163258788|NCT03217747|589656235|FG013|Overall Study|Adverse Event|1|||
163258789|NCT03217747|589656222|FG000|Overall Study|Death|0|||
163258790|NCT03217747|589656223|FG001|Overall Study|Death|0|||
163258791|NCT03217747|589656224|FG002|Overall Study|Death|0|||
163258792|NCT03217747|589656225|FG003|Overall Study|Death|0|||
163258793|NCT03217747|589656226|FG004|Overall Study|Death|0|||
163258794|NCT03217747|589656227|FG005|Overall Study|Death|0|||
163258795|NCT03217747|589656228|FG006|Overall Study|Death|0|||
163258796|NCT03217747|589656229|FG007|Overall Study|Death|0|||
163258797|NCT03217747|589656230|FG008|Overall Study|Death|1|||
163258798|NCT03217747|589656231|FG009|Overall Study|Death|0|||
163258799|NCT03217747|589656232|FG010|Overall Study|Death|0|||
163258800|NCT03217747|589656233|FG011|Overall Study|Death|0|||
163258801|NCT03217747|589656234|FG012|Overall Study|Death|0|||
163258802|NCT03217747|589656235|FG013|Overall Study|Death|0|||
163258803|NCT03217747|589656222|FG000|Overall Study|Lack of Efficacy|12|||
163258804|NCT03217747|589656223|FG001|Overall Study|Lack of Efficacy|6|||
163258805|NCT03217747|589656224|FG002|Overall Study|Lack of Efficacy|15|||
163258806|NCT03217747|589656225|FG003|Overall Study|Lack of Efficacy|11|||
163258807|NCT03217747|589656226|FG004|Overall Study|Lack of Efficacy|3|||
163361338|NCT03377361|590031677|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
163361339|NCT03377361|590031678|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
163361340|NCT03377361|590031679|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
163361341|NCT03377361|590031680|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
163258808|NCT03217747|589656227|FG005|Overall Study|Lack of Efficacy|14|||
163258809|NCT03217747|589656228|FG006|Overall Study|Lack of Efficacy|10|||
163258810|NCT03217747|589656229|FG007|Overall Study|Lack of Efficacy|4|||
163258811|NCT03217747|589656230|FG008|Overall Study|Lack of Efficacy|2|||
163258812|NCT03217747|589656231|FG009|Overall Study|Lack of Efficacy|7|||
163258813|NCT03217747|589656232|FG010|Overall Study|Lack of Efficacy|3|||
163258814|NCT03217747|589656233|FG011|Overall Study|Lack of Efficacy|1|||
163258815|NCT03217747|589656234|FG012|Overall Study|Lack of Efficacy|3|||
163258816|NCT03217747|589656235|FG013|Overall Study|Lack of Efficacy|1|||
163258817|NCT03217747|589656222|FG000|Overall Study|Withdrawal by Subject|2|||
163258818|NCT03217747|589656223|FG001|Overall Study|Withdrawal by Subject|1|||
163258819|NCT03217747|589656224|FG002|Overall Study|Withdrawal by Subject|1|||
163258820|NCT03217747|589656225|FG003|Overall Study|Withdrawal by Subject|1|||
163258821|NCT03217747|589656226|FG004|Overall Study|Withdrawal by Subject|1|||
163258822|NCT03217747|589656227|FG005|Overall Study|Withdrawal by Subject|2|||
163258823|NCT03217747|589656228|FG006|Overall Study|Withdrawal by Subject|1|||
163258824|NCT03217747|589656229|FG007|Overall Study|Withdrawal by Subject|0|||
163258825|NCT03217747|589656230|FG008|Overall Study|Withdrawal by Subject|0|||
163258826|NCT03217747|589656231|FG009|Overall Study|Withdrawal by Subject|0|||
163258827|NCT03217747|589656232|FG010|Overall Study|Withdrawal by Subject|0|||
163258828|NCT03217747|589656233|FG011|Overall Study|Withdrawal by Subject|1|||
163258829|NCT03217747|589656234|FG012|Overall Study|Withdrawal by Subject|0|||
163258830|NCT03217747|589656235|FG013|Overall Study|Withdrawal by Subject|1|||
163258831|NCT03217747|589656222|FG000|Overall Study|Toxicity and progression|1|||
163258832|NCT03217747|589656223|FG001|Overall Study|Toxicity and progression|0|||
163258833|NCT03217747|589656224|FG002|Overall Study|Toxicity and progression|0|||
163258834|NCT03217747|589656225|FG003|Overall Study|Toxicity and progression|0|||
163258835|NCT03217747|589656226|FG004|Overall Study|Toxicity and progression|0|||
163258836|NCT03217747|589656227|FG005|Overall Study|Toxicity and progression|0|||
163258837|NCT03217747|589656228|FG006|Overall Study|Toxicity and progression|0|||
163258838|NCT03217747|589656229|FG007|Overall Study|Toxicity and progression|0|||
163258839|NCT03217747|589656230|FG008|Overall Study|Toxicity and progression|0|||
163258840|NCT03217747|589656231|FG009|Overall Study|Toxicity and progression|0|||
163258841|NCT03217747|589656232|FG010|Overall Study|Toxicity and progression|0|||
163258842|NCT03217747|589656233|FG011|Overall Study|Toxicity and progression|0|||
163258843|NCT03217747|589656234|FG012|Overall Study|Toxicity and progression|0|||
163258844|NCT03217747|589656235|FG013|Overall Study|Toxicity and progression|0|||
163258845|NCT03217747|589656222|FG000|Overall Study|Removal of sole target lesion|1|||
163258846|NCT03217747|589656223|FG001|Overall Study|Removal of sole target lesion|0|||
163258847|NCT03217747|589656224|FG002|Overall Study|Removal of sole target lesion|0|||
163258848|NCT03217747|589656225|FG003|Overall Study|Removal of sole target lesion|0|||
163258849|NCT03217747|589656226|FG004|Overall Study|Removal of sole target lesion|0|||
163258850|NCT03217747|589656227|FG005|Overall Study|Removal of sole target lesion|0|||
163258851|NCT03217747|589656228|FG006|Overall Study|Removal of sole target lesion|0|||
163258852|NCT03217747|589656229|FG007|Overall Study|Removal of sole target lesion|0|||
163258853|NCT03217747|589656230|FG008|Overall Study|Removal of sole target lesion|0|||
163258854|NCT03217747|589656231|FG009|Overall Study|Removal of sole target lesion|0|||
163258855|NCT03217747|589656232|FG010|Overall Study|Removal of sole target lesion|0|||
163258856|NCT03217747|589656233|FG011|Overall Study|Removal of sole target lesion|0|||
163258857|NCT03217747|589656234|FG012|Overall Study|Removal of sole target lesion|0|||
163258858|NCT03217747|589656235|FG013|Overall Study|Removal of sole target lesion|0|||
163258859|NCT03217747|589656222|FG000|Overall Study|Stroke|0|||
163258860|NCT03217747|589656223|FG001|Overall Study|Stroke|0|||
163258861|NCT03217747|589656224|FG002|Overall Study|Stroke|0|||
163258862|NCT03217747|589656225|FG003|Overall Study|Stroke|0|||
163258863|NCT03217747|589656226|FG004|Overall Study|Stroke|0|||
163258864|NCT03217747|589656227|FG005|Overall Study|Stroke|1|||
163258865|NCT03217747|589656228|FG006|Overall Study|Stroke|0|||
163258866|NCT03217747|589656229|FG007|Overall Study|Stroke|0|||
163258867|NCT03217747|589656230|FG008|Overall Study|Stroke|0|||
163258868|NCT03217747|589656231|FG009|Overall Study|Stroke|0|||
163258869|NCT03217747|589656232|FG010|Overall Study|Stroke|0|||
163258870|NCT03217747|589656233|FG011|Overall Study|Stroke|1|||
163258871|NCT03217747|589656234|FG012|Overall Study|Stroke|0|||
163258872|NCT03217747|589656235|FG013|Overall Study|Stroke|0|||
163258873|NCT03248375|589656236|FG000|Overall Study|Lost to Follow-up|5|||
163361342|NCT03377361|590031681|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
163361343|NCT03377361|590031682|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
163361344|NCT03377361|590031683|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
163361345|NCT03377361|590031684|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
163361346|NCT03377361|590031685|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
163361347|NCT03377361|590031676|FG000|Treatment Period|Subject Withdrew Consent|0|||
163258874|NCT00394355|589656237|FG000|Overall Study|Adverse Event|10|||
163258875|NCT00394355|589656238|FG001|Overall Study|Adverse Event|6|||
163258876|NCT00394355|589656239|FG002|Overall Study|Adverse Event|7|||
163258877|NCT00394355|589656240|FG003|Overall Study|Adverse Event|8|||
163361348|NCT03377361|590031677|FG001|Treatment Period|Subject Withdrew Consent|0|||
163361349|NCT03377361|590031678|FG002|Treatment Period|Subject Withdrew Consent|0|||
163258878|NCT00394355|589656237|FG000|Overall Study|Did not meet protocol eligibility|1|||
163258879|NCT00394355|589656238|FG001|Overall Study|Did not meet protocol eligibility|5|||
163258880|NCT00394355|589656239|FG002|Overall Study|Did not meet protocol eligibility|4|||
163258881|NCT00394355|589656240|FG003|Overall Study|Did not meet protocol eligibility|2|||
163258882|NCT00394355|589656237|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
163258883|NCT00394355|589656238|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
163258884|NCT00394355|589656239|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
163258885|NCT00394355|589656240|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
163258886|NCT00394355|589656237|FG000|Overall Study|Subject withdrawal - related to drug|1|||
163258887|NCT00394355|589656238|FG001|Overall Study|Subject withdrawal - related to drug|0|||
163258888|NCT00394355|589656239|FG002|Overall Study|Subject withdrawal - related to drug|0|||
163258889|NCT00394355|589656240|FG003|Overall Study|Subject withdrawal - related to drug|0|||
163258890|NCT00394355|589656237|FG000|Overall Study|Lost to Follow-up|7|||
163258891|NCT00394355|589656238|FG001|Overall Study|Lost to Follow-up|5|||
163258892|NCT00394355|589656239|FG002|Overall Study|Lost to Follow-up|4|||
163258893|NCT00394355|589656240|FG003|Overall Study|Lost to Follow-up|3|||
163258894|NCT00394355|589656237|FG000|Overall Study|Noncompliance with protocol|4|||
163258895|NCT00394355|589656238|FG001|Overall Study|Noncompliance with protocol|3|||
163258896|NCT00394355|589656239|FG002|Overall Study|Noncompliance with protocol|10|||
163258897|NCT00394355|589656240|FG003|Overall Study|Noncompliance with protocol|8|||
163258898|NCT00394355|589656237|FG000|Overall Study|Administrative|0|||
163258899|NCT00394355|589656238|FG001|Overall Study|Administrative|1|||
163258900|NCT00394355|589656239|FG002|Overall Study|Administrative|1|||
163258901|NCT00394355|589656240|FG003|Overall Study|Administrative|1|||
163258902|NCT00394355|589656237|FG000|Overall Study|Lack of Efficacy|0|||
163258903|NCT00394355|589656238|FG001|Overall Study|Lack of Efficacy|0|||
163258904|NCT00394355|589656239|FG002|Overall Study|Lack of Efficacy|2|||
163258905|NCT00394355|589656240|FG003|Overall Study|Lack of Efficacy|3|||
163258906|NCT02618616|589656243|FG000|Overall Study|Lack of Efficacy|4|||
163258907|NCT02618616|589656244|FG001|Overall Study|Lack of Efficacy|0|||
163258908|NCT02618616|589656243|FG000|Overall Study|Pregnancy|0|||
163258909|NCT02618616|589656244|FG001|Overall Study|Pregnancy|1|||
163258910|NCT02618616|589656243|FG000|Overall Study|Adverse Event|8|||
163258911|NCT02618616|589656244|FG001|Overall Study|Adverse Event|0|||
163258912|NCT02618616|589656243|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
163258913|NCT02618616|589656244|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
163258914|NCT02618616|589656243|FG000|Overall Study|Consent withdrawn by subject|8|||
163258915|NCT02618616|589656244|FG001|Overall Study|Consent withdrawn by subject|5|||
163258916|NCT02618616|589656243|FG000|Overall Study|Lost to Follow-up|0|||
163258917|NCT02618616|589656244|FG001|Overall Study|Lost to Follow-up|1|||
163258918|NCT03904043|589656245|FG000|Overall Study|Adverse Event|1|||
163258919|NCT03904043|589656246|FG001|Overall Study|Adverse Event|1|||
163258920|NCT03904043|589656245|FG000|Overall Study|Withdrawal by Subject|1|||
163258921|NCT03904043|589656246|FG001|Overall Study|Withdrawal by Subject|0|||
163258922|NCT03904043|589656245|FG000|Overall Study|Non-compliance|1|||
163258923|NCT03904043|589656246|FG001|Overall Study|Non-compliance|0|||
163258924|NCT03904043|589656245|FG000|Overall Study|Did not start treatment|1|||
163258925|NCT03904043|589656246|FG001|Overall Study|Did not start treatment|0|||
163258926|NCT05002218|589656254|FG000|Overall Study|Lost to Follow-up|5|||
163258927|NCT05002218|589656255|FG001|Overall Study|Lost to Follow-up|6|||
163258928|NCT03779906|589656256|FG000|Overall Study|Lost to Follow-up|7|||
163258929|NCT03779906|589656256|FG000|Overall Study|COVID pandemic|1|||
163258930|NCT03421808|589656257|FG000|Overall Study|COVID related problems|2|||
163258931|NCT03421808|589656258|FG001|Overall Study|COVID related problems|0|||
163258932|NCT03421808|589656257|FG000|Overall Study|Withdrawal by Subject|1|||
163258933|NCT03421808|589656258|FG001|Overall Study|Withdrawal by Subject|0|||
163258934|NCT03421808|589656257|FG000|Overall Study|Protocol Violation|0|||
163258935|NCT03421808|589656258|FG001|Overall Study|Protocol Violation|1|||
163258936|NCT00766675|589657526|FG000|Overall Study|Adverse Event|16|||
163258937|NCT00766675|589657526|FG000|Overall Study|Lost to Follow-up|2|||
163258938|NCT00766675|589657526|FG000|Overall Study|Withdrawal by Subject|11|||
163258939|NCT00766675|589657526|FG000|Overall Study|Protocol Violation|8|||
163258940|NCT00766675|589657526|FG000|Overall Study|Participant took prohibited medication|1|||
163258941|NCT00766675|589657526|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
163258942|NCT00766675|589657526|FG000|Overall Study|Insufficient therapy|1|||
163258943|NCT03183388|589657527|FG000|Overall Study|Lost to Follow-up|3|||
163258944|NCT03183388|589657528|FG001|Overall Study|Lost to Follow-up|5|||
163258945|NCT03183388|589657527|FG000|Overall Study|Physician Decision|1|||
163258946|NCT03183388|589657528|FG001|Overall Study|Physician Decision|4|||
163258947|NCT03183388|589657527|FG000|Overall Study|Withdrawal by Subject|4|||
163258948|NCT03183388|589657528|FG001|Overall Study|Withdrawal by Subject|1|||
163258949|NCT03183388|589657527|FG000|Overall Study|Moved|1|||
163258950|NCT03183388|589657528|FG001|Overall Study|Moved|0|||
163258951|NCT03183388|589657527|FG000|Overall Study|Met Exclusion Criteria|2|||
163258952|NCT03183388|589657528|FG001|Overall Study|Met Exclusion Criteria|2|||
163258953|NCT03183388|589657527|FG000|Overall Study|COVID Pandemic Related|2|||
163258954|NCT03183388|589657528|FG001|Overall Study|COVID Pandemic Related|4|||
163258955|NCT01679236|589657529|FG000|Overall Study|Lost to Follow-up|15|||
163258956|NCT01679236|589657530|FG001|Overall Study|Lost to Follow-up|15|||
163258957|NCT03935217|589657531|FG000|Overall Study|Adverse Event|1|||
163258958|NCT03935217|589657532|FG001|Overall Study|Adverse Event|0|||
163361350|NCT03377361|590031679|FG003|Treatment Period|Subject Withdrew Consent|0|||
163361351|NCT03377361|590031680|FG004|Treatment Period|Subject Withdrew Consent|0|||
163258959|NCT03935217|589657531|FG000|Overall Study|Lost to Follow-up|0|||
163258960|NCT03935217|589657532|FG001|Overall Study|Lost to Follow-up|1|||
163258961|NCT03935217|589657531|FG000|Overall Study|Withdrawal by Subject|0|||
163258962|NCT03935217|589657532|FG001|Overall Study|Withdrawal by Subject|2|||
163258963|NCT00803101|589657536|FG000|Overall Study|Death / Serious Adverse Event|4|||
163258964|NCT00803101|589657537|FG001|Overall Study|Death / Serious Adverse Event|6|||
163258965|NCT00803101|589657536|FG000|Overall Study|Withdrawal by Subject|6|||
163258966|NCT00803101|589657537|FG001|Overall Study|Withdrawal by Subject|4|||
163258967|NCT00803101|589657536|FG000|Overall Study|Lost to Follow-up|2|||
163258968|NCT00803101|589657537|FG001|Overall Study|Lost to Follow-up|2|||
163258969|NCT00803101|589657536|FG000|Overall Study|Protocol Violation|1|||
163258970|NCT00803101|589657537|FG001|Overall Study|Protocol Violation|7|||
163258971|NCT00803101|589657536|FG000|Overall Study|Surgery finished outside protocol window|1|||
163258972|NCT00803101|589657537|FG001|Overall Study|Surgery finished outside protocol window|1|||
163258973|NCT00803101|589657536|FG000|Overall Study|Patient died outside SAE report period|1|||
163258974|NCT00803101|589657537|FG001|Overall Study|Patient died outside SAE report period|0|||
163258975|NCT00803101|589657536|FG000|Overall Study|Patient did not attend scheduled visit|2|||
163258976|NCT00803101|589657537|FG001|Overall Study|Patient did not attend scheduled visit|1|||
163258977|NCT00803101|589657536|FG000|Overall Study|Patient did not have surgery|1|||
163258978|NCT00803101|589657537|FG001|Overall Study|Patient did not have surgery|1|||
163258979|NCT02026232|589657540|FG000|Overall Study|incomplete visit/missing data|3|||
163258980|NCT02026232|589657541|FG001|Overall Study|incomplete visit/missing data|2|||
163258981|NCT01529008|589657542|FG000|Bone Marrow Harvesting|Physician Decision|1|||
163258982|NCT01529008|589657543|FG001|Bone Marrow Harvesting|Physician Decision|1|||
163258983|NCT01529008|589657542|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
163258984|NCT01529008|589657543|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
163258985|NCT01529008|589657542|FG000|Treatment|Adverse Event|6|||
163258986|NCT01529008|589657543|FG001|Treatment|Adverse Event|0|||
163258987|NCT01529008|589657542|FG000|Treatment|Other|3|||
163258988|NCT01529008|589657543|FG001|Treatment|Other|1|||
163258989|NCT01529008|589657542|FG000|Efficacy Analysis|Protocol Violation|2|||
163258990|NCT01529008|589657543|FG001|Efficacy Analysis|Protocol Violation|0|||
163258991|NCT01529008|589657542|FG000|Efficacy Analysis|Physician Decision|0|||
163258992|NCT01529008|589657543|FG001|Efficacy Analysis|Physician Decision|1|||
163258993|NCT01529008|589657542|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
163258994|NCT01529008|589657543|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
163258995|NCT02487498|589657544|FG000|Period: Period 1|Adverse Event|2|||
163258996|NCT02487498|589657545|FG001|Period: Period 1|Adverse Event|4|||
163258997|NCT02487498|589657544|FG000|Period: Period 1|Subject/guardian decision|2|||
163258998|NCT02487498|589657545|FG001|Period: Period 1|Subject/guardian decision|4|||
163258999|NCT02487498|589657544|FG000|Period: Period 1|Lost to Follow-up|0|||
163259000|NCT02487498|589657545|FG001|Period: Period 1|Lost to Follow-up|2|||
163259001|NCT02487498|589657544|FG000|Period: Period 1|Lack of Efficacy|1|||
163259002|NCT02487498|589657545|FG001|Period: Period 1|Lack of Efficacy|0|||
163259003|NCT02487498|589657544|FG000|Period: Period 1|Physician Decision|0|||
163259004|NCT02487498|589657545|FG001|Period: Period 1|Physician Decision|1|||
163259005|NCT02487498|589657544|FG000|Period: Period 1|Protocol deviation|1|||
163259006|NCT02487498|589657545|FG001|Period: Period 1|Protocol deviation|0|||
163259007|NCT02487498|589657544|FG000|Period: Washout|Subject/guardian decision|0|||
163259008|NCT02487498|589657545|FG001|Period: Washout|Subject/guardian decision|5|||
163259009|NCT02487498|589657544|FG000|Period: Washout|Lack of Efficacy|1|||
163259010|NCT02487498|589657545|FG001|Period: Washout|Lack of Efficacy|1|||
163259011|NCT02487498|589657544|FG000|Period: Washout|Physician Decision|1|||
163259012|NCT02487498|589657545|FG001|Period: Washout|Physician Decision|0|||
163259013|NCT02487498|589657544|FG000|Period: Washout|Non-compliance with study treatment|0|||
163259014|NCT02487498|589657545|FG001|Period: Washout|Non-compliance with study treatment|1|||
163259015|NCT02487498|589657544|FG000|Period: Period 2|Adverse Event|2|||
163259016|NCT02487498|589657545|FG001|Period: Period 2|Adverse Event|2|||
163259017|NCT02487498|589657544|FG000|Period: Period 2|Subject/guardian decision|2|||
163259018|NCT02487498|589657545|FG001|Period: Period 2|Subject/guardian decision|1|||
163259019|NCT02487498|589657544|FG000|Period: Period 2|Lost to Follow-up|1|||
163259020|NCT02487498|589657545|FG001|Period: Period 2|Lost to Follow-up|1|||
163259021|NCT02487498|589657544|FG000|Period: Period 2|Death|0|||
163259022|NCT02487498|589657545|FG001|Period: Period 2|Death|1|||
163259023|NCT02487498|589657544|FG000|Period: Period 2|Physician Decision|1|||
163259024|NCT02487498|589657545|FG001|Period: Period 2|Physician Decision|0|||
163259025|NCT00755222|589657546|FG000|Overall Study|Withdrawal by Subject|4|||
163259026|NCT00755222|589657547|FG001|Overall Study|Withdrawal by Subject|2|||
163259027|NCT00755222|589657546|FG000|Overall Study|Adverse Event|2|||
163361352|NCT03377361|590031681|FG005|Treatment Period|Subject Withdrew Consent|0|||
163361353|NCT03377361|590031682|FG006|Treatment Period|Subject Withdrew Consent|0|||
163361354|NCT03377361|590031683|FG007|Treatment Period|Subject Withdrew Consent|0|||
163361355|NCT03377361|590031684|FG008|Treatment Period|Subject Withdrew Consent|2|||
163361356|NCT03377361|590031685|FG009|Treatment Period|Subject Withdrew Consent|1|||
163361357|NCT03377361|590031676|FG000|Treatment Period|No longer meets study criteria|0|||
163259028|NCT00755222|589657547|FG001|Overall Study|Adverse Event|0|||
163259029|NCT00755222|589657546|FG000|Overall Study|Protocol Violation|2|||
163259030|NCT00755222|589657547|FG001|Overall Study|Protocol Violation|0|||
163361358|NCT03377361|590031677|FG001|Treatment Period|No longer meets study criteria|1|||
163259031|NCT02228967|589657553|FG000|Overall Study|Lost to Follow-up|146|||
163259032|NCT02228967|589657554|FG001|Overall Study|Lost to Follow-up|142|||
163259033|NCT02228967|589657553|FG000|Overall Study|Withdrawal by Subject|13|||
163259034|NCT02228967|589657554|FG001|Overall Study|Withdrawal by Subject|18|||
163259035|NCT01995539|589657556|FG000|Overall Study|Screening Failure|1|||
163259036|NCT01995539|589657556|FG000|Overall Study|Withdrawal by Investigator|15|||
163259037|NCT01995539|589657556|FG000|Overall Study|Withdrawal by Subject|11|||
163259038|NCT01995539|589657556|FG000|Overall Study|Lost to Follow-up|5|||
163259039|NCT01995539|589657556|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
163259040|NCT03261271|589657560|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
163259041|NCT03261271|589657561|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
163259042|NCT02173054|589657562|FG000|Overall Study|lack of compliance|1|||
163259043|NCT02173054|589657563|FG001|Overall Study|lack of compliance|0|||
163259044|NCT02173054|589657564|FG002|Overall Study|lack of compliance|0|||
163259045|NCT02173054|589657562|FG000|Overall Study|Withdrawal by Subject|0|||
163259046|NCT02173054|589657563|FG001|Overall Study|Withdrawal by Subject|0|||
163259047|NCT02173054|589657564|FG002|Overall Study|Withdrawal by Subject|1|||
163259048|NCT01932697|589657565|FG000|Overall Study|Received a different amount of tx|1|||
163259049|NCT01932697|589657566|FG001|Overall Study|Received a different amount of tx|0|||
163259050|NCT01932697|589657565|FG000|Overall Study|Ineligible|1|||
163259051|NCT01932697|589657566|FG001|Overall Study|Ineligible|0|||
163259052|NCT01330316|589657567|FG000|Overall Study|Adverse Event|2|||
163259053|NCT01330316|589657568|FG001|Overall Study|Adverse Event|2|||
163259054|NCT01330316|589657567|FG000|Overall Study|Lack of Efficacy|0|||
163259055|NCT01330316|589657568|FG001|Overall Study|Lack of Efficacy|10|||
163259056|NCT01330316|589657567|FG000|Overall Study|Lost to Follow-up|0|||
163259057|NCT01330316|589657568|FG001|Overall Study|Lost to Follow-up|1|||
163259058|NCT01330316|589657567|FG000|Overall Study|Withdrawal by Subject|0|||
163259059|NCT01330316|589657568|FG001|Overall Study|Withdrawal by Subject|1|||
163259060|NCT01330316|589657567|FG000|Overall Study|other than above|0|||
163259061|NCT01330316|589657568|FG001|Overall Study|other than above|1|||
163259062|NCT00215540|589657569|FG000|Overall Study|Withdrew from study medication|1|||
163259063|NCT00215540|589657570|FG001|Overall Study|Withdrew from study medication|0|||
163259064|NCT00215540|589657571|FG002|Overall Study|Withdrew from study medication|0|||
163259065|NCT00246337|589657574|FG000|Overall Study|Lost to Follow-up|3|||
163259066|NCT00246337|589657575|FG001|Overall Study|Lost to Follow-up|0|||
163259067|NCT00246337|589657576|FG002|Overall Study|Lost to Follow-up|0|||
163259068|NCT00246337|589657577|FG003|Overall Study|Lost to Follow-up|0|||
163259069|NCT00246337|589657578|FG004|Overall Study|Lost to Follow-up|2|||
163259070|NCT00246337|589657579|FG005|Overall Study|Lost to Follow-up|2|||
163259071|NCT00246337|589657580|FG006|Overall Study|Lost to Follow-up|1|||
163259072|NCT00246337|589657581|FG007|Overall Study|Lost to Follow-up|2|||
163259073|NCT00246337|589657582|FG008|Overall Study|Lost to Follow-up|0|||
163259074|NCT00246337|589657574|FG000|Overall Study|Protocol Violation|1|||
163259075|NCT00246337|589657575|FG001|Overall Study|Protocol Violation|0|||
163259076|NCT00246337|589657576|FG002|Overall Study|Protocol Violation|0|||
163259077|NCT00246337|589657577|FG003|Overall Study|Protocol Violation|0|||
163259078|NCT00246337|589657578|FG004|Overall Study|Protocol Violation|1|||
163259079|NCT00246337|589657579|FG005|Overall Study|Protocol Violation|0|||
163259080|NCT00246337|589657580|FG006|Overall Study|Protocol Violation|1|||
163259081|NCT00246337|589657581|FG007|Overall Study|Protocol Violation|1|||
163259082|NCT00246337|589657582|FG008|Overall Study|Protocol Violation|0|||
163259083|NCT00246337|589657574|FG000|Overall Study|Withdrawal by Subject|2|||
163259084|NCT00246337|589657575|FG001|Overall Study|Withdrawal by Subject|0|||
163259085|NCT00246337|589657576|FG002|Overall Study|Withdrawal by Subject|0|||
163259086|NCT00246337|589657577|FG003|Overall Study|Withdrawal by Subject|0|||
163259087|NCT00246337|589657578|FG004|Overall Study|Withdrawal by Subject|0|||
163259088|NCT00246337|589657579|FG005|Overall Study|Withdrawal by Subject|0|||
163259089|NCT00246337|589657580|FG006|Overall Study|Withdrawal by Subject|1|||
163259090|NCT00246337|589657581|FG007|Overall Study|Withdrawal by Subject|1|||
163259091|NCT00246337|589657582|FG008|Overall Study|Withdrawal by Subject|0|||
163259092|NCT00246337|589657574|FG000|Overall Study|Lack of Qualifying Event|8|||
163259093|NCT00246337|589657575|FG001|Overall Study|Lack of Qualifying Event|2|||
163259094|NCT00246337|589657576|FG002|Overall Study|Lack of Qualifying Event|1|||
163259095|NCT00246337|589657577|FG003|Overall Study|Lack of Qualifying Event|1|||
163259096|NCT00246337|589657578|FG004|Overall Study|Lack of Qualifying Event|1|||
163259097|NCT00246337|589657579|FG005|Overall Study|Lack of Qualifying Event|3|||
163259098|NCT00246337|589657580|FG006|Overall Study|Lack of Qualifying Event|3|||
163259099|NCT00246337|589657581|FG007|Overall Study|Lack of Qualifying Event|2|||
163259100|NCT00246337|589657582|FG008|Overall Study|Lack of Qualifying Event|5|||
163259101|NCT00246337|589657574|FG000|Overall Study|Site Terminated|10|||
163259102|NCT00246337|589657575|FG001|Overall Study|Site Terminated|0|||
163259103|NCT00246337|589657576|FG002|Overall Study|Site Terminated|0|||
163259104|NCT00246337|589657577|FG003|Overall Study|Site Terminated|0|||
163259105|NCT00246337|589657578|FG004|Overall Study|Site Terminated|0|||
163259106|NCT00246337|589657579|FG005|Overall Study|Site Terminated|7|||
163259107|NCT00246337|589657580|FG006|Overall Study|Site Terminated|1|||
163259108|NCT00246337|589657581|FG007|Overall Study|Site Terminated|6|||
163259109|NCT00246337|589657582|FG008|Overall Study|Site Terminated|2|||
163259110|NCT00246337|589657574|FG000|Overall Study|Abnormal baseline lab values|7|||
163259111|NCT00246337|589657575|FG001|Overall Study|Abnormal baseline lab values|0|||
163259112|NCT00246337|589657576|FG002|Overall Study|Abnormal baseline lab values|2|||
163259113|NCT00246337|589657577|FG003|Overall Study|Abnormal baseline lab values|0|||
163259114|NCT00246337|589657578|FG004|Overall Study|Abnormal baseline lab values|0|||
163259115|NCT00246337|589657579|FG005|Overall Study|Abnormal baseline lab values|2|||
163259116|NCT00246337|589657580|FG006|Overall Study|Abnormal baseline lab values|2|||
163259117|NCT00246337|589657581|FG007|Overall Study|Abnormal baseline lab values|0|||
163259118|NCT00246337|589657582|FG008|Overall Study|Abnormal baseline lab values|4|||
163259119|NCT00246337|589657574|FG000|Overall Study|Overwhelmed|0|||
163259120|NCT00246337|589657575|FG001|Overall Study|Overwhelmed|0|||
163259121|NCT00246337|589657576|FG002|Overall Study|Overwhelmed|0|||
163259122|NCT00246337|589657577|FG003|Overall Study|Overwhelmed|0|||
163259123|NCT00246337|589657578|FG004|Overall Study|Overwhelmed|0|||
163259124|NCT00246337|589657579|FG005|Overall Study|Overwhelmed|1|||
163259125|NCT00246337|589657580|FG006|Overall Study|Overwhelmed|0|||
163259126|NCT00246337|589657581|FG007|Overall Study|Overwhelmed|0|||
163259127|NCT00246337|589657582|FG008|Overall Study|Overwhelmed|0|||
163259128|NCT00246337|589657574|FG000|Overall Study|Protocol Violator|1|||
163259129|NCT00246337|589657575|FG001|Overall Study|Protocol Violator|0|||
163259130|NCT00246337|589657576|FG002|Overall Study|Protocol Violator|0|||
163259131|NCT00246337|589657577|FG003|Overall Study|Protocol Violator|0|||
163259132|NCT00246337|589657578|FG004|Overall Study|Protocol Violator|0|||
163259133|NCT00246337|589657579|FG005|Overall Study|Protocol Violator|0|||
163259134|NCT00246337|589657580|FG006|Overall Study|Protocol Violator|0|||
163259135|NCT00246337|589657581|FG007|Overall Study|Protocol Violator|0|||
163259136|NCT00246337|589657582|FG008|Overall Study|Protocol Violator|0|||
163259137|NCT00246337|589657574|FG000|Overall Study|Reported as completing trial in error|0|||
163259138|NCT00246337|589657575|FG001|Overall Study|Reported as completing trial in error|0|||
163259139|NCT00246337|589657576|FG002|Overall Study|Reported as completing trial in error|0|||
163259140|NCT00246337|589657577|FG003|Overall Study|Reported as completing trial in error|0|||
163259141|NCT00246337|589657578|FG004|Overall Study|Reported as completing trial in error|0|||
163259142|NCT00246337|589657579|FG005|Overall Study|Reported as completing trial in error|0|||
163259143|NCT00246337|589657580|FG006|Overall Study|Reported as completing trial in error|0|||
163259144|NCT00246337|589657581|FG007|Overall Study|Reported as completing trial in error|1|||
163259145|NCT00246337|589657582|FG008|Overall Study|Reported as completing trial in error|0|||
163259146|NCT00674570|589657584|FG000|Overall Study|Withdrawal by Subject|0|||
163259147|NCT00674570|589657585|FG001|Overall Study|Withdrawal by Subject|2|||
163259148|NCT00674570|589657586|FG002|Overall Study|Withdrawal by Subject|0|||
163259149|NCT03430063|589657587|FG000|Overall Study|Adverse Event|0|||
163259150|NCT03430063|589657588|FG001|Overall Study|Adverse Event|1|||
163259151|NCT03430063|589657589|FG002|Overall Study|Adverse Event|0|||
163411154|NCT00852995|590212998|FG002|Overall Study|Non-Compliance|0|||
163411155|NCT00852995|590212999|FG003|Overall Study|Non-Compliance|2|||
163411156|NCT00852995|590213000|FG004|Overall Study|Non-Compliance|0|||
163411157|NCT00852995|590212996|FG000|Overall Study|Progressive Disease|1|||
163151943|NCT02177123|589271355|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
163151944|NCT01391546|589271356|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
163151945|NCT01391546|589271357|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
163151946|NCT06271993|589271358|FG000|Overall Study|Not reactive to histamine|5|||
163151947|NCT06271993|589271359|FG001|Overall Study|Not reactive to histamine|5|||
163151948|NCT06271993|589271360|FG002|Overall Study|Not reactive to histamine|5|||
163151949|NCT01980017|589271365|FG000|Overall Study|Lost to Follow-up|30|||
163151950|NCT01980017|589271366|FG001|Overall Study|Lost to Follow-up|21|||
163151951|NCT01980017|589271365|FG000|Overall Study|Death|0|||
163151952|NCT01980017|589271366|FG001|Overall Study|Death|1|||
163151953|NCT01435382|589271369|FG000|Overall Study|Lost to Follow-up|1|||
163151954|NCT01435382|589271370|FG001|Overall Study|Lost to Follow-up|0|||
163151955|NCT01435382|589271371|FG002|Overall Study|Lost to Follow-up|1|||
163151956|NCT01435382|589271372|FG003|Overall Study|Lost to Follow-up|0|||
163259152|NCT03430063|589657587|FG000|Overall Study|Death|3|||
163259153|NCT03430063|589657588|FG001|Overall Study|Death|2|||
163259154|NCT03430063|589657589|FG002|Overall Study|Death|3|||
163259155|NCT03430063|589657587|FG000|Overall Study|Lost to Follow-up|0|||
163259156|NCT03430063|589657588|FG001|Overall Study|Lost to Follow-up|1|||
163259157|NCT03430063|589657589|FG002|Overall Study|Lost to Follow-up|0|||
163259158|NCT03430063|589657587|FG000|Overall Study|Withdrawal by Subject|0|||
163259159|NCT03430063|589657588|FG001|Overall Study|Withdrawal by Subject|0|||
163259160|NCT03430063|589657589|FG002|Overall Study|Withdrawal by Subject|1|||
163259161|NCT03430063|589657587|FG000|Overall Study|Withdrawal of consent|3|||
163259162|NCT03430063|589657588|FG001|Overall Study|Withdrawal of consent|1|||
163151957|NCT01435382|589271369|FG000|Overall Study|Withdrawal by Subject|0|||
163151958|NCT01435382|589271370|FG001|Overall Study|Withdrawal by Subject|2|||
163259163|NCT03430063|589657589|FG002|Overall Study|Withdrawal of consent|2|||
163411158|NCT00852995|590212997|FG001|Overall Study|Progressive Disease|0|||
163259164|NCT03430063|589657587|FG000|Overall Study|Progressive disease|1|||
163259165|NCT03430063|589657588|FG001|Overall Study|Progressive disease|2|||
163259166|NCT03430063|589657589|FG002|Overall Study|Progressive disease|1|||
163259167|NCT03430063|589657587|FG000|Overall Study|Other un-specified|1|||
163259168|NCT03430063|589657588|FG001|Overall Study|Other un-specified|1|||
163151959|NCT01435382|589271371|FG002|Overall Study|Withdrawal by Subject|0|||
163151960|NCT01435382|589271372|FG003|Overall Study|Withdrawal by Subject|1|||
163151961|NCT00910650|589271373|FG000|Overall Study|Death|2|||
163151962|NCT00260533|589271374|FG000|Overall Study|Other|3|||
163151963|NCT00260533|589271375|FG001|Overall Study|Other|3|||
163151964|NCT01761877|589271378|FG000|Overall Study|Adverse Event|7|||
163151965|NCT01761877|589271379|FG001|Overall Study|Adverse Event|0|||
163151966|NCT01761877|589271378|FG000|Overall Study|Withdrawal by Subject|6|||
163151967|NCT01761877|589271379|FG001|Overall Study|Withdrawal by Subject|4|||
163151968|NCT01761877|589271378|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
163151969|NCT01761877|589271379|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
163151970|NCT01761877|589271378|FG000|Overall Study|Death|0|||
163151971|NCT01761877|589271379|FG001|Overall Study|Death|1|||
163151972|NCT01761877|589271378|FG000|Overall Study|MRI intolerant|1|||
163151973|NCT01761877|589271379|FG001|Overall Study|MRI intolerant|6|||
163151974|NCT01310777|589271381|FG000|Overall Study|Adverse Event|23|||
163151975|NCT01310777|589271382|FG001|Overall Study|Adverse Event|1|||
163151976|NCT01310777|589271383|FG002|Overall Study|Adverse Event|15|||
163151977|NCT01310777|589271381|FG000|Overall Study|Lost to Follow-up|0|||
163151978|NCT01310777|589271382|FG001|Overall Study|Lost to Follow-up|4|||
163151979|NCT01310777|589271383|FG002|Overall Study|Lost to Follow-up|1|||
163151980|NCT01310777|589271381|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
163151981|NCT01310777|589271382|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
163151982|NCT01310777|589271383|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
163151983|NCT01310777|589271381|FG000|Overall Study|Inadequate Control of IOP|5|||
163151984|NCT01310777|589271382|FG001|Overall Study|Inadequate Control of IOP|7|||
163151985|NCT01310777|589271383|FG002|Overall Study|Inadequate Control of IOP|10|||
163151986|NCT01310777|589271381|FG000|Overall Study|Other|4|||
163151987|NCT01310777|589271382|FG001|Overall Study|Other|1|||
163151988|NCT01310777|589271383|FG002|Overall Study|Other|2|||
163151989|NCT03962491|589271384|FG000|Overall Study|Lost to Follow-up|4|||
163151990|NCT03962491|589271385|FG001|Overall Study|Lost to Follow-up|5|||
163151991|NCT03697252|589271392|FG000|Overall Study|Adverse Event|3|||
163151992|NCT03697252|589271393|FG001|Overall Study|Adverse Event|2|||
163151993|NCT03697252|589271392|FG000|Overall Study|Withdrawal by Subject|14|||
163151994|NCT03697252|589271393|FG001|Overall Study|Withdrawal by Subject|14|||
163151995|NCT03697252|589271392|FG000|Overall Study|Lost to Follow-up|0|||
163151996|NCT03697252|589271393|FG001|Overall Study|Lost to Follow-up|1|||
163151997|NCT03697252|589271392|FG000|Overall Study|Physician Decision|1|||
163151998|NCT03697252|589271393|FG001|Overall Study|Physician Decision|1|||
163151999|NCT03697252|589271392|FG000|Overall Study|Other|0|||
163152000|NCT03697252|589271393|FG001|Overall Study|Other|1|||
163152001|NCT00106704|589271394|FG000|Overall Study|Adverse Event|10|||
163152002|NCT00106704|589271395|FG001|Overall Study|Adverse Event|7|||
163152003|NCT00106704|589271394|FG000|Overall Study|Death|2|||
163152004|NCT00106704|589271395|FG001|Overall Study|Death|1|||
163152005|NCT00106704|589271394|FG000|Overall Study|Lack of Efficacy|67|||
163152006|NCT00106704|589271395|FG001|Overall Study|Lack of Efficacy|69|||
163152007|NCT00106704|589271394|FG000|Overall Study|Lost to Follow-up|7|||
163152008|NCT00106704|589271395|FG001|Overall Study|Lost to Follow-up|3|||
163152009|NCT00106704|589271394|FG000|Overall Study|Pregnancy|1|||
163152010|NCT00106704|589271395|FG001|Overall Study|Pregnancy|0|||
163152011|NCT00106704|589271394|FG000|Overall Study|Protocol Violation|4|||
163152012|NCT00106704|589271395|FG001|Overall Study|Protocol Violation|7|||
163152013|NCT00106704|589271394|FG000|Overall Study|Withdrawal by Subject|14|||
163152014|NCT00106704|589271395|FG001|Overall Study|Withdrawal by Subject|21|||
163152015|NCT00106704|589271394|FG000|Overall Study|Patient moved|1|||
163152016|NCT00106704|589271395|FG001|Overall Study|Patient moved|0|||
163152017|NCT00106704|589271394|FG000|Overall Study|Site terminated|0|||
163152018|NCT00106704|589271395|FG001|Overall Study|Site terminated|1|||
163152019|NCT00106704|589271394|FG000|Overall Study|Planned major surgery|1|||
163152020|NCT00106704|589271395|FG001|Overall Study|Planned major surgery|0|||
163152021|NCT00106704|589271394|FG000|Overall Study|Patient Received Glycemic Medication|22|||
163152022|NCT00106704|589271395|FG001|Overall Study|Patient Received Glycemic Medication|41|||
163152023|NCT00106704|589271394|FG000|Overall Study|Unable to re-enter US|1|||
163152024|NCT00106704|589271395|FG001|Overall Study|Unable to re-enter US|0|||
163152025|NCT00106704|589271394|FG000|Overall Study|Laboratory test|1|||
163152026|NCT00106704|589271395|FG001|Overall Study|Laboratory test|1|||
163152027|NCT01780506|589271396|FG000|Double-Blind Phase|Randomized but not Treated|3|||
163152028|NCT01780506|589271397|FG001|Double-Blind Phase|Randomized but not Treated|2|||
163152029|NCT01780506|589271396|FG000|Double-Blind Phase|Adverse Event|4|||
163152030|NCT01780506|589271397|FG001|Double-Blind Phase|Adverse Event|14|||
163152031|NCT01780506|589271396|FG000|Double-Blind Phase|Death|1|||
163259169|NCT03430063|589657589|FG002|Overall Study|Other un-specified|0|||
163259170|NCT03430063|589657587|FG000|Overall Study|Randomized, but never treated|0|||
163259171|NCT03430063|589657588|FG001|Overall Study|Randomized, but never treated|0|||
163259172|NCT03430063|589657589|FG002|Overall Study|Randomized, but never treated|1|||
163259173|NCT03124199|589657590|FG000|Overall Study|Lost to Follow-up|4|||
163259174|NCT02798211|589657591|FG000|Period 1|Adverse Event|1|||
163259175|NCT02798211|589657592|FG001|Period 1|Adverse Event|1|||
163259176|NCT02798211|589657593|FG002|Period 1|Adverse Event|0|||
163259177|NCT02798211|589657594|FG003|Period 1|Adverse Event|0|||
163259178|NCT02798211|589657595|FG004|Period 1|Adverse Event|0|||
163259179|NCT02798211|589657596|FG005|Period 1|Adverse Event|0|||
163259180|NCT02798211|589657591|FG000|Period 1|Lost to Follow-up|2|||
163259181|NCT02798211|589657592|FG001|Period 1|Lost to Follow-up|1|||
163259182|NCT02798211|589657593|FG002|Period 1|Lost to Follow-up|0|||
163259183|NCT02798211|589657594|FG003|Period 1|Lost to Follow-up|0|||
163259184|NCT02798211|589657595|FG004|Period 1|Lost to Follow-up|0|||
163259185|NCT02798211|589657596|FG005|Period 1|Lost to Follow-up|0|||
163259186|NCT02798211|589657591|FG000|Period 1|Protocol Violation|0|||
163259187|NCT02798211|589657592|FG001|Period 1|Protocol Violation|0|||
163259188|NCT02798211|589657593|FG002|Period 1|Protocol Violation|2|||
163259189|NCT02798211|589657594|FG003|Period 1|Protocol Violation|0|||
163259190|NCT02798211|589657595|FG004|Period 1|Protocol Violation|0|||
163259191|NCT02798211|589657596|FG005|Period 1|Protocol Violation|0|||
163259192|NCT02798211|589657591|FG000|Period 1|Withdrawal by Subject|1|||
163259193|NCT02798211|589657592|FG001|Period 1|Withdrawal by Subject|1|||
163259194|NCT02798211|589657593|FG002|Period 1|Withdrawal by Subject|0|||
163259195|NCT02798211|589657594|FG003|Period 1|Withdrawal by Subject|0|||
163259196|NCT02798211|589657595|FG004|Period 1|Withdrawal by Subject|0|||
163259197|NCT02798211|589657596|FG005|Period 1|Withdrawal by Subject|0|||
163259198|NCT02798211|589657591|FG000|Period 1|Death|0|||
163259199|NCT02798211|589657592|FG001|Period 1|Death|0|||
163259200|NCT02798211|589657593|FG002|Period 1|Death|1|||
163259201|NCT02798211|589657594|FG003|Period 1|Death|0|||
163259202|NCT02798211|589657595|FG004|Period 1|Death|0|||
163259203|NCT02798211|589657596|FG005|Period 1|Death|0|||
163259204|NCT02798211|589657591|FG000|Period 1|Withdrawal of Informed Consent|2|||
163259205|NCT02798211|589657592|FG001|Period 1|Withdrawal of Informed Consent|7|||
163259206|NCT02798211|589657593|FG002|Period 1|Withdrawal of Informed Consent|3|||
163259207|NCT02798211|589657594|FG003|Period 1|Withdrawal of Informed Consent|0|||
163259208|NCT02798211|589657595|FG004|Period 1|Withdrawal of Informed Consent|0|||
163259209|NCT02798211|589657596|FG005|Period 1|Withdrawal of Informed Consent|0|||
163259210|NCT02798211|589657591|FG000|Period 2|Withdrawal by Subject|2|||
163259211|NCT02798211|589657592|FG001|Period 2|Withdrawal by Subject|0|||
163259212|NCT02798211|589657593|FG002|Period 2|Withdrawal by Subject|0|||
163259213|NCT02798211|589657594|FG003|Period 2|Withdrawal by Subject|0|||
163259214|NCT02798211|589657595|FG004|Period 2|Withdrawal by Subject|2|||
163259215|NCT02798211|589657596|FG005|Period 2|Withdrawal by Subject|2|||
163259216|NCT02798211|589657591|FG000|Period 2|Adverse Event|5|||
163259217|NCT02798211|589657592|FG001|Period 2|Adverse Event|0|||
163259218|NCT02798211|589657593|FG002|Period 2|Adverse Event|0|||
163259219|NCT02798211|589657594|FG003|Period 2|Adverse Event|0|||
163259220|NCT02798211|589657595|FG004|Period 2|Adverse Event|1|||
163259221|NCT02798211|589657596|FG005|Period 2|Adverse Event|0|||
163259222|NCT02798211|589657591|FG000|Period 2|Lack of Efficacy|1|||
163259223|NCT02798211|589657592|FG001|Period 2|Lack of Efficacy|0|||
163259224|NCT02798211|589657593|FG002|Period 2|Lack of Efficacy|0|||
163259225|NCT02798211|589657594|FG003|Period 2|Lack of Efficacy|1|||
163259226|NCT02798211|589657595|FG004|Period 2|Lack of Efficacy|0|||
163259227|NCT02798211|589657596|FG005|Period 2|Lack of Efficacy|1|||
163259228|NCT02798211|589657591|FG000|Period 2|Lost to Follow-up|3|||
163259229|NCT02798211|589657592|FG001|Period 2|Lost to Follow-up|0|||
163259230|NCT02798211|589657593|FG002|Period 2|Lost to Follow-up|0|||
163259231|NCT02798211|589657594|FG003|Period 2|Lost to Follow-up|0|||
163361359|NCT03377361|590031678|FG002|Treatment Period|No longer meets study criteria|0|||
163361360|NCT03377361|590031679|FG003|Treatment Period|No longer meets study criteria|0|||
163259232|NCT02798211|589657595|FG004|Period 2|Lost to Follow-up|2|||
163259233|NCT02798211|589657596|FG005|Period 2|Lost to Follow-up|0|||
163259234|NCT02798211|589657591|FG000|Period 2|Physician Decision|1|||
163259235|NCT02798211|589657592|FG001|Period 2|Physician Decision|0|||
163259236|NCT02798211|589657593|FG002|Period 2|Physician Decision|0|||
163259237|NCT02798211|589657594|FG003|Period 2|Physician Decision|1|||
163259238|NCT02798211|589657595|FG004|Period 2|Physician Decision|1|||
163361361|NCT03377361|590031680|FG004|Treatment Period|No longer meets study criteria|0|||
163259239|NCT02798211|589657596|FG005|Period 2|Physician Decision|0|||
163259240|NCT02798211|589657591|FG000|Period 2|Pregnancy|0|||
163259241|NCT02798211|589657592|FG001|Period 2|Pregnancy|0|||
163259242|NCT02798211|589657593|FG002|Period 2|Pregnancy|0|||
163361362|NCT03377361|590031681|FG005|Treatment Period|No longer meets study criteria|0|||
163259243|NCT02798211|589657594|FG003|Period 2|Pregnancy|2|||
163259244|NCT02798211|589657595|FG004|Period 2|Pregnancy|0|||
163259245|NCT02798211|589657596|FG005|Period 2|Pregnancy|0|||
163259246|NCT02798211|589657591|FG000|Period 2|Technical problems|1|||
163259247|NCT02798211|589657592|FG001|Period 2|Technical problems|0|||
163259248|NCT02798211|589657593|FG002|Period 2|Technical problems|0|||
163259249|NCT02798211|589657594|FG003|Period 2|Technical problems|1|||
163259250|NCT02798211|589657595|FG004|Period 2|Technical problems|0|||
163259251|NCT02798211|589657596|FG005|Period 2|Technical problems|0|||
163259252|NCT02798211|589657591|FG000|Period 2|Withdrawal of Informed Consent|1|||
163259253|NCT02798211|589657592|FG001|Period 2|Withdrawal of Informed Consent|0|||
163259254|NCT02798211|589657593|FG002|Period 2|Withdrawal of Informed Consent|0|||
163259255|NCT02798211|589657594|FG003|Period 2|Withdrawal of Informed Consent|2|||
163259256|NCT02798211|589657595|FG004|Period 2|Withdrawal of Informed Consent|2|||
163259257|NCT02798211|589657596|FG005|Period 2|Withdrawal of Informed Consent|3|||
163259258|NCT02309112|589657598|FG000|Overall Study|Withdrawal by Subject|1|||
163259259|NCT02309112|589657599|FG001|Overall Study|Withdrawal by Subject|0|||
163259260|NCT02309112|589657600|FG002|Overall Study|Withdrawal by Subject|1|||
163259261|NCT02309112|589657598|FG000|Overall Study|Lost to Follow-up|0|||
163259262|NCT02309112|589657599|FG001|Overall Study|Lost to Follow-up|1|||
163259263|NCT02309112|589657600|FG002|Overall Study|Lost to Follow-up|0|||
163259264|NCT03505476|589657602|FG000|Overall Study|Physician Decision|18|||
163259265|NCT03505476|589657602|FG000|Overall Study|Device Malfunctioned|101|||
163259266|NCT03505476|589657602|FG000|Overall Study|Data Corrupt|6|||
163259267|NCT03505476|589657602|FG000|Overall Study|Device application insufficiant|3|||
163259268|NCT01287611|589657604|FG000|Overall Study|Lost to Follow-up|29|||
163259269|NCT01287611|589657605|FG001|Overall Study|Lost to Follow-up|16|||
163259270|NCT01287611|589657604|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
163259271|NCT01287611|589657605|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
163259272|NCT02255357|589657606|FG000|Overall Study|Physician Decision|10|||
163259273|NCT02255357|589657607|FG001|Overall Study|Physician Decision|24|||
163259274|NCT02192970|589657614|FG000|Overall Study|Lost to Follow-up|6|||
163259275|NCT02192970|589657615|FG001|Overall Study|Lost to Follow-up|0|||
163259276|NCT04074590|589657616|FG000|Overall Study|Adverse Event|1|||
163259277|NCT04074590|589657617|FG001|Overall Study|Adverse Event|0|||
163259278|NCT04074590|589657616|FG000|Overall Study|Physician Decision|1|||
163259279|NCT04074590|589657617|FG001|Overall Study|Physician Decision|0|||
163259280|NCT04074590|589657616|FG000|Overall Study|Withdrawal by Subject|2|||
163259281|NCT04074590|589657617|FG001|Overall Study|Withdrawal by Subject|0|||
163259282|NCT00509236|589657620|FG000|Overall Study|Adverse Event|7|||
163259283|NCT00509236|589657621|FG001|Overall Study|Adverse Event|9|||
163259284|NCT00509236|589657620|FG000|Overall Study|Withdrawal by Subject|5|||
163259285|NCT00509236|589657621|FG001|Overall Study|Withdrawal by Subject|10|||
163259286|NCT00509236|589657620|FG000|Overall Study|Protocol Violation|3|||
163259287|NCT00509236|589657621|FG001|Overall Study|Protocol Violation|0|||
163259288|NCT00509236|589657620|FG000|Overall Study|Excluded Medication|1|||
163259289|NCT00509236|589657621|FG001|Overall Study|Excluded Medication|1|||
163259290|NCT00509236|589657620|FG000|Overall Study|Scheduled Kidney Transplant|1|||
163259291|NCT00509236|589657621|FG001|Overall Study|Scheduled Kidney Transplant|0|||
163259292|NCT02709005|589657633|FG000|Overall Study|Lost to Follow-up|1|||
163259293|NCT02709005|589657634|FG001|Overall Study|Lost to Follow-up|1|||
163259294|NCT02709005|589657633|FG000|Overall Study|Withdrawal by Subject|3|||
163259295|NCT02709005|589657634|FG001|Overall Study|Withdrawal by Subject|0|||
163259296|NCT01572389|589657635|FG000|Overall Study|Death|1|||
163259297|NCT01572389|589657636|FG001|Overall Study|Death|3|||
163259298|NCT01572389|589657635|FG000|Overall Study|Withdrawal by Subject|14|||
163259299|NCT01572389|589657636|FG001|Overall Study|Withdrawal by Subject|2|||
163259300|NCT01572389|589657635|FG000|Overall Study|Lost to Follow-up|25|||
163259301|NCT01572389|589657636|FG001|Overall Study|Lost to Follow-up|14|||
163259302|NCT01572389|589657635|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
163259303|NCT01572389|589657636|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
163259304|NCT02634788|589657637|FG000|Overall Study|Adverse Event|0|||
163259305|NCT02634788|589657638|FG001|Overall Study|Adverse Event|8|||
163259306|NCT02634788|589657639|FG002|Overall Study|Adverse Event|3|||
163259307|NCT02634788|589657640|FG003|Overall Study|Adverse Event|1|||
163259308|NCT02634788|589657637|FG000|Overall Study|Lack of Efficacy|4|||
163259309|NCT02634788|589657638|FG001|Overall Study|Lack of Efficacy|0|||
163259310|NCT02634788|589657639|FG002|Overall Study|Lack of Efficacy|1|||
163259311|NCT02634788|589657640|FG003|Overall Study|Lack of Efficacy|4|||
163259312|NCT02634788|589657637|FG000|Overall Study|Lost to Follow-up|0|||
163259313|NCT02634788|589657638|FG001|Overall Study|Lost to Follow-up|1|||
163259314|NCT02634788|589657639|FG002|Overall Study|Lost to Follow-up|0|||
163259315|NCT02634788|589657640|FG003|Overall Study|Lost to Follow-up|0|||
163259316|NCT02634788|589657637|FG000|Overall Study|Withdrawal by Subject|0|||
163259317|NCT02634788|589657638|FG001|Overall Study|Withdrawal by Subject|1|||
163259318|NCT02634788|589657639|FG002|Overall Study|Withdrawal by Subject|1|||
163259319|NCT02634788|589657640|FG003|Overall Study|Withdrawal by Subject|0|||
163259320|NCT00758459|589657641|FG000|Overall Study|Adverse Event|3|||
163259321|NCT00758459|589657642|FG001|Overall Study|Adverse Event|2|||
163259322|NCT00758459|589657641|FG000|Overall Study|Protocol Violation|0|||
163259323|NCT00758459|589657642|FG001|Overall Study|Protocol Violation|1|||
163259324|NCT00758459|589657641|FG000|Overall Study|Withdrawal by Subject|0|||
163259325|NCT00758459|589657642|FG001|Overall Study|Withdrawal by Subject|1|||
163259326|NCT01780935|589657646|FG000|Overall Study|Admin problems due to early termination|321|||
163259327|NCT01780935|589657647|FG001|Overall Study|Admin problems due to early termination|309|||
163259328|NCT01780935|589657646|FG000|Overall Study|Adverse Event|2|||
163259329|NCT01780935|589657647|FG001|Overall Study|Adverse Event|4|||
163259330|NCT01780935|589657646|FG000|Overall Study|Death|1|||
163259331|NCT01780935|589657647|FG001|Overall Study|Death|6|||
163259332|NCT01780935|589657646|FG000|Overall Study|Lost to Follow-up|2|||
163259333|NCT01780935|589657647|FG001|Overall Study|Lost to Follow-up|6|||
163259334|NCT01780935|589657646|FG000|Overall Study|Physician Decision|1|||
163259335|NCT01780935|589657647|FG001|Overall Study|Physician Decision|1|||
163259336|NCT01780935|589657646|FG000|Overall Study|Protocol deviation|0|||
163259337|NCT01780935|589657647|FG001|Overall Study|Protocol deviation|1|||
163259338|NCT01780935|589657646|FG000|Overall Study|Patient withdrew consent|8|||
163259339|NCT01780935|589657647|FG001|Overall Study|Patient withdrew consent|9|||
163259340|NCT01281202|589657648|FG000|Overall Study|Adverse Event|2|||
163259341|NCT01281202|589657649|FG001|Overall Study|Adverse Event|0|||
163259342|NCT01281202|589657648|FG000|Overall Study|Withdrawal by Subject|2|||
163259343|NCT01281202|589657649|FG001|Overall Study|Withdrawal by Subject|2|||
163259344|NCT01281202|589657648|FG000|Overall Study|Protocol Violation|11|||
163259345|NCT01281202|589657649|FG001|Overall Study|Protocol Violation|10|||
163259346|NCT01281202|589657648|FG000|Overall Study|Administrative|2|||
163259347|NCT01281202|589657649|FG001|Overall Study|Administrative|8|||
163259348|NCT01281202|589657648|FG000|Overall Study|Lost to Follow-up|11|||
163259349|NCT01281202|589657649|FG001|Overall Study|Lost to Follow-up|13|||
163259350|NCT01281202|589657648|FG000|Overall Study|Incarceration|0|||
163259351|NCT01281202|589657649|FG001|Overall Study|Incarceration|3|||
163259352|NCT01215357|589657650|FG000|Overall Study|Withdrawal by Subject|3|||
163259353|NCT01215357|589657650|FG000|Overall Study|Protocol Violation|9|||
163152032|NCT01780506|589271397|FG001|Double-Blind Phase|Death|2|||
163152033|NCT01780506|589271396|FG000|Double-Blind Phase|Pregnancy|2|||
163152034|NCT01780506|589271397|FG001|Double-Blind Phase|Pregnancy|1|||
163152035|NCT01780506|589271396|FG000|Double-Blind Phase|Lack of Efficacy|1|||
163152036|NCT01780506|589271397|FG001|Double-Blind Phase|Lack of Efficacy|1|||
163152037|NCT01780506|589271396|FG000|Double-Blind Phase|Investigator's Discretion|5|||
163152038|NCT01780506|589271397|FG001|Double-Blind Phase|Investigator's Discretion|2|||
163152039|NCT01780506|589271396|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
163152040|NCT01780506|589271397|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
163152041|NCT01780506|589271396|FG000|Double-Blind Phase|Protocol Violation|4|||
163152042|NCT01780506|589271397|FG001|Double-Blind Phase|Protocol Violation|3|||
163152043|NCT01780506|589271396|FG000|Double-Blind Phase|Withdrew Consent|23|||
163152044|NCT01780506|589271397|FG001|Double-Blind Phase|Withdrew Consent|24|||
163152045|NCT01780506|589271396|FG000|Double-Blind Phase|Lost to Follow-up|23|||
163152046|NCT01780506|589271397|FG001|Double-Blind Phase|Lost to Follow-up|26|||
163152047|NCT01780506|589271396|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
163152048|NCT01780506|589271397|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
163152049|NCT01867671|589271401|FG000|Overall Study|Adverse Event|5|||
163152050|NCT01867671|589271402|FG001|Overall Study|Adverse Event|3|||
163152051|NCT01867671|589271401|FG000|Overall Study|Anaphylaxis|0|||
163152052|NCT01867671|589271402|FG001|Overall Study|Anaphylaxis|1|||
163152053|NCT01867671|589271401|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
163152054|NCT01867671|589271402|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
163152055|NCT01867671|589271401|FG000|Overall Study|Lost to Follow-up|0|||
163152056|NCT01867671|589271402|FG001|Overall Study|Lost to Follow-up|1|||
163152057|NCT01867671|589271401|FG000|Overall Study|Non-compliance with Study Drug|1|||
163152058|NCT01867671|589271402|FG001|Overall Study|Non-compliance with Study Drug|2|||
163152059|NCT01867671|589271401|FG000|Overall Study|Withdrawal by Subject|21|||
163152060|NCT01867671|589271402|FG001|Overall Study|Withdrawal by Subject|21|||
163152061|NCT04852302|589271403|FG000|Overall Study|Withdrawal by Subject|2|||
163152062|NCT04852302|589271403|FG000|Overall Study|Did not complete CALM therapy.|2|||
163152063|NCT05249582|589271404|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
163152064|NCT05249582|589271405|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
163152065|NCT05249582|589271404|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
163152066|NCT05249582|589271405|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
163152067|NCT05249582|589271404|FG000|Overall Study|Declined to use virtual reality headset|1|||
163152068|NCT05249582|589271405|FG001|Overall Study|Declined to use virtual reality headset|0|||
163259354|NCT05479604|589657651|FG000|Overall Study|Lost to Follow-up|1|||
163259355|NCT05479604|589657652|FG001|Overall Study|Lost to Follow-up|5|||
163259356|NCT01591382|589657653|FG000|Overall Study|Discharged Prior to Study Completion|2|||
163259357|NCT01591382|589657654|FG001|Overall Study|Discharged Prior to Study Completion|1|||
163259358|NCT01591382|589657653|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
163259359|NCT01591382|589657654|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
163259360|NCT00701038|589657658|FG000|Overall Study|study amended pilot group of patients|4|||
163259361|NCT00701038|589657659|FG001|Overall Study|study amended pilot group of patients|4|||
163259362|NCT05099926|589657662|FG000|Overall Study|Lost to Follow-up|1|||
163361363|NCT03377361|590031682|FG006|Treatment Period|No longer meets study criteria|0|||
163361364|NCT03377361|590031683|FG007|Treatment Period|No longer meets study criteria|1|||
163361365|NCT03377361|590031684|FG008|Treatment Period|No longer meets study criteria|0|||
163259363|NCT00459342|589657670|FG000|Overall Study|Not eligible|1|||
163259364|NCT00558064|589657671|FG000|Overall Study|Adverse Event|3|||
163259365|NCT00558064|589657672|FG001|Overall Study|Adverse Event|2|||
163259366|NCT00558064|589657671|FG000|Overall Study|Lack of Efficacy|0|||
163259367|NCT00558064|589657672|FG001|Overall Study|Lack of Efficacy|1|||
163259368|NCT00558064|589657671|FG000|Overall Study|Protocol Violation|1|||
163259369|NCT00558064|589657672|FG001|Overall Study|Protocol Violation|0|||
163259370|NCT00558064|589657671|FG000|Overall Study|Lost to Follow-up|0|||
163259371|NCT00558064|589657672|FG001|Overall Study|Lost to Follow-up|1|||
163259372|NCT00558064|589657671|FG000|Overall Study|Withdrawal by Subject|0|||
163259373|NCT00558064|589657672|FG001|Overall Study|Withdrawal by Subject|1|||
163259374|NCT00558064|589657671|FG000|Overall Study|No visit within allowance period|1|||
163259375|NCT00558064|589657672|FG001|Overall Study|No visit within allowance period|0|||
163259376|NCT02027402|589657673|FG000|Overall Study|Withdrawal by Subject|4|||
163259377|NCT02027402|589657674|FG001|Overall Study|Withdrawal by Subject|1|||
163259378|NCT04108000|589657677|FG000|Overall Study|Death of patient|1|||
163259379|NCT04108000|589657678|FG001|Overall Study|Death of patient|0|||
163259380|NCT04108000|589657679|FG002|Overall Study|Death of patient|1|||
163259381|NCT04108000|589657680|FG003|Overall Study|Death of patient|0|||
163259382|NCT04108000|589657677|FG000|Overall Study|Withdrawal by Subject|2|||
163259383|NCT04108000|589657678|FG001|Overall Study|Withdrawal by Subject|2|||
163259384|NCT04108000|589657679|FG002|Overall Study|Withdrawal by Subject|0|||
163259385|NCT04108000|589657680|FG003|Overall Study|Withdrawal by Subject|0|||
163259386|NCT04108000|589657677|FG000|Overall Study|Death of surrogate partner|0|||
163259387|NCT04108000|589657678|FG001|Overall Study|Death of surrogate partner|1|||
163259388|NCT04108000|589657679|FG002|Overall Study|Death of surrogate partner|0|||
163259389|NCT04108000|589657680|FG003|Overall Study|Death of surrogate partner|1|||
163259390|NCT03764774|589657683|FG000|Overall Study|Withdrawal by Subject|0|||
163259391|NCT03764774|589657684|FG001|Overall Study|Withdrawal by Subject|0|||
163259392|NCT03764774|589657685|FG002|Overall Study|Withdrawal by Subject|0|||
163259393|NCT03764774|589657686|FG003|Overall Study|Withdrawal by Subject|0|||
163259394|NCT03764774|589657687|FG004|Overall Study|Withdrawal by Subject|0|||
163259395|NCT03764774|589657688|FG005|Overall Study|Withdrawal by Subject|0|||
163259396|NCT03764774|589657689|FG006|Overall Study|Withdrawal by Subject|0|||
163259397|NCT03764774|589657690|FG007|Overall Study|Withdrawal by Subject|0|||
163259398|NCT03764774|589657691|FG008|Overall Study|Withdrawal by Subject|0|||
163259399|NCT03764774|589657692|FG009|Overall Study|Withdrawal by Subject|0|||
163259400|NCT03764774|589657693|FG010|Overall Study|Withdrawal by Subject|1|||
163259401|NCT03764774|589657694|FG011|Overall Study|Withdrawal by Subject|0|||
163259402|NCT03764774|589657695|FG012|Overall Study|Withdrawal by Subject|0|||
163259403|NCT03764774|589657696|FG013|Overall Study|Withdrawal by Subject|0|||
163259404|NCT03764774|589657683|FG000|Overall Study|Adverse Event|0|||
163259405|NCT03764774|589657684|FG001|Overall Study|Adverse Event|0|||
163259406|NCT03764774|589657685|FG002|Overall Study|Adverse Event|0|||
163259407|NCT03764774|589657686|FG003|Overall Study|Adverse Event|0|||
163259408|NCT03764774|589657687|FG004|Overall Study|Adverse Event|0|||
163259409|NCT03764774|589657688|FG005|Overall Study|Adverse Event|0|||
163259410|NCT03764774|589657689|FG006|Overall Study|Adverse Event|0|||
163259411|NCT03764774|589657690|FG007|Overall Study|Adverse Event|0|||
163259412|NCT03764774|589657691|FG008|Overall Study|Adverse Event|0|||
163259413|NCT03764774|589657692|FG009|Overall Study|Adverse Event|0|||
163259414|NCT03764774|589657693|FG010|Overall Study|Adverse Event|0|||
163259415|NCT03764774|589657694|FG011|Overall Study|Adverse Event|0|||
163259416|NCT03764774|589657695|FG012|Overall Study|Adverse Event|2|||
163259417|NCT03764774|589657696|FG013|Overall Study|Adverse Event|0|||
163259418|NCT03764774|589657683|FG000|Overall Study|Lost to Follow-up|0|||
163259419|NCT03764774|589657684|FG001|Overall Study|Lost to Follow-up|0|||
163259420|NCT03764774|589657685|FG002|Overall Study|Lost to Follow-up|0|||
163259421|NCT03764774|589657686|FG003|Overall Study|Lost to Follow-up|0|||
163259422|NCT03764774|589657687|FG004|Overall Study|Lost to Follow-up|0|||
163259423|NCT03764774|589657688|FG005|Overall Study|Lost to Follow-up|0|||
163259424|NCT03764774|589657689|FG006|Overall Study|Lost to Follow-up|0|||
163259425|NCT03764774|589657690|FG007|Overall Study|Lost to Follow-up|0|||
163259426|NCT03764774|589657691|FG008|Overall Study|Lost to Follow-up|0|||
163259427|NCT03764774|589657692|FG009|Overall Study|Lost to Follow-up|0|||
163259428|NCT03764774|589657693|FG010|Overall Study|Lost to Follow-up|0|||
163259429|NCT03764774|589657694|FG011|Overall Study|Lost to Follow-up|0|||
163259430|NCT03764774|589657695|FG012|Overall Study|Lost to Follow-up|0|||
163259431|NCT03764774|589657696|FG013|Overall Study|Lost to Follow-up|1|||
163259432|NCT03764774|589657683|FG000|Overall Study|Physician Decision|0|||
163259433|NCT03764774|589657684|FG001|Overall Study|Physician Decision|0|||
163259434|NCT03764774|589657685|FG002|Overall Study|Physician Decision|0|||
163259435|NCT03764774|589657686|FG003|Overall Study|Physician Decision|0|||
163361366|NCT03377361|590031685|FG009|Treatment Period|No longer meets study criteria|0|||
163259436|NCT03764774|589657687|FG004|Overall Study|Physician Decision|0|||
163259437|NCT03764774|589657688|FG005|Overall Study|Physician Decision|0|||
163259438|NCT03764774|589657689|FG006|Overall Study|Physician Decision|0|||
163259439|NCT03764774|589657690|FG007|Overall Study|Physician Decision|0|||
163259440|NCT03764774|589657691|FG008|Overall Study|Physician Decision|0|||
163259441|NCT03764774|589657692|FG009|Overall Study|Physician Decision|4|||
163259442|NCT03764774|589657693|FG010|Overall Study|Physician Decision|1|||
163259443|NCT03764774|589657694|FG011|Overall Study|Physician Decision|4|||
163259444|NCT03764774|589657695|FG012|Overall Study|Physician Decision|9|||
163259445|NCT03764774|589657696|FG013|Overall Study|Physician Decision|0|||
163259446|NCT03764774|589657683|FG000|Overall Study|Study Termination|0|||
163259447|NCT03764774|589657684|FG001|Overall Study|Study Termination|0|||
163259448|NCT03764774|589657685|FG002|Overall Study|Study Termination|0|||
163259449|NCT03764774|589657686|FG003|Overall Study|Study Termination|0|||
163259450|NCT03764774|589657687|FG004|Overall Study|Study Termination|0|||
163259451|NCT03764774|589657688|FG005|Overall Study|Study Termination|0|||
163259452|NCT03764774|589657689|FG006|Overall Study|Study Termination|0|||
163259453|NCT03764774|589657690|FG007|Overall Study|Study Termination|0|||
163259454|NCT03764774|589657691|FG008|Overall Study|Study Termination|0|||
163259455|NCT03764774|589657692|FG009|Overall Study|Study Termination|1|||
163259456|NCT03764774|589657693|FG010|Overall Study|Study Termination|0|||
163259457|NCT03764774|589657694|FG011|Overall Study|Study Termination|0|||
163259458|NCT03764774|589657695|FG012|Overall Study|Study Termination|0|||
163259459|NCT03764774|589657696|FG013|Overall Study|Study Termination|2|||
163259460|NCT06027619|589657697|FG000|Overall Study|Adverse Event|0|||
163259461|NCT06027619|589657698|FG001|Overall Study|Adverse Event|0|||
163259462|NCT06027619|589657699|FG002|Overall Study|Adverse Event|1|||
163259463|NCT01493960|589659389|FG000|Overall Study|Adverse Event|0|||
163259464|NCT01493960|589659390|FG001|Overall Study|Adverse Event|1|||
163259465|NCT01493960|589659389|FG000|Overall Study|Lack of Efficacy|15|||
163259466|NCT01493960|589659390|FG001|Overall Study|Lack of Efficacy|9|||
163259467|NCT01493960|589659389|FG000|Overall Study|Protocol Violation|3|||
163259468|NCT01493960|589659390|FG001|Overall Study|Protocol Violation|0|||
163259469|NCT01493960|589659389|FG000|Overall Study|Withdrawal by Subject|10|||
163259470|NCT01493960|589659390|FG001|Overall Study|Withdrawal by Subject|4|||
163259471|NCT01493960|589659389|FG000|Overall Study|Non-specified|4|||
163259472|NCT01493960|589659390|FG001|Overall Study|Non-specified|4|||
163259473|NCT01160484|589659391|FG000|Overall Study|Lack of Efficacy|9|||
163259474|NCT01160484|589659391|FG000|Overall Study|Adverse Event|6|||
163259475|NCT01160484|589659391|FG000|Overall Study|Withdrawal by Subject|2|||
163259476|NCT01160484|589659391|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
163259477|NCT01382602|589659392|FG000|Overall Study|Protocol Violation|0|||
163259478|NCT01382602|589659393|FG001|Overall Study|Protocol Violation|3|||
163259479|NCT01382602|589659392|FG000|Overall Study|Withdrawal by Subject|0|||
163259480|NCT01382602|589659393|FG001|Overall Study|Withdrawal by Subject|1|||
163259481|NCT01392300|589659401|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
163259482|NCT01392300|589659402|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
163259483|NCT01392300|589659403|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
163259484|NCT01392300|589659401|FG000|Main Period (MP)|Withdrawal by Subject|5|||
163259485|NCT01392300|589659402|FG001|Main Period (MP)|Withdrawal by Subject|1|||
163259486|NCT01392300|589659403|FG002|Main Period (MP)|Withdrawal by Subject|0|||
163259487|NCT01392300|589659401|FG000|Main Period (MP)|Lost to Follow-up|3|||
163259488|NCT01392300|589659402|FG001|Main Period (MP)|Lost to Follow-up|3|||
163259489|NCT01392300|589659403|FG002|Main Period (MP)|Lost to Follow-up|0|||
163259490|NCT01392300|589659401|FG000|Main Period (MP)|Non-compliance|1|||
163259491|NCT01392300|589659402|FG001|Main Period (MP)|Non-compliance|0|||
163259492|NCT01392300|589659403|FG002|Main Period (MP)|Non-compliance|0|||
163259493|NCT01392300|589659401|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
163259494|NCT01392300|589659402|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
163259495|NCT01392300|589659403|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
163259496|NCT01392300|589659401|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
163259497|NCT01392300|589659402|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
163259498|NCT01392300|589659403|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
163259499|NCT01392300|589659401|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
163259500|NCT01392300|589659402|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
163259501|NCT01392300|589659403|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
163259502|NCT01392300|589659401|FG000|Open Label Extension (OLEX) Period|Death|0|||
163259503|NCT01392300|589659402|FG001|Open Label Extension (OLEX) Period|Death|0|||
163259504|NCT01392300|589659403|FG002|Open Label Extension (OLEX) Period|Death|4|||
163259505|NCT01392300|589659401|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
163259506|NCT01392300|589659402|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
163259507|NCT01392300|589659403|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
163259508|NCT01392300|589659401|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
163259509|NCT01392300|589659402|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
163259510|NCT01392300|589659403|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
163259511|NCT01392300|589659401|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
163259512|NCT01392300|589659402|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
163152069|NCT01743469|589271406|FG000|Active Treatment Phase|Adverse Event|10|||
163152070|NCT01743469|589271407|FG001|Active Treatment Phase|Adverse Event|5|||
163152071|NCT01743469|589271408|FG002|Active Treatment Phase|Adverse Event|8|||
163152072|NCT01743469|589271409|FG003|Active Treatment Phase|Adverse Event|1|||
163152073|NCT01743469|589271406|FG000|Active Treatment Phase|Disease Progression|40|||
163152074|NCT01743469|589271407|FG001|Active Treatment Phase|Disease Progression|47|||
163152075|NCT01743469|589271408|FG002|Active Treatment Phase|Disease Progression|30|||
163152076|NCT01743469|589271409|FG003|Active Treatment Phase|Disease Progression|20|||
163152077|NCT01743469|589271406|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
163152078|NCT01743469|589271407|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
163152079|NCT01743469|589271408|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
163152080|NCT01743469|589271409|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
163152081|NCT01743469|589271406|FG000|Active Treatment Phase|Missing|1|||
163152082|NCT01743469|589271407|FG001|Active Treatment Phase|Missing|0|||
163152083|NCT01743469|589271408|FG002|Active Treatment Phase|Missing|0|||
163152084|NCT01743469|589271409|FG003|Active Treatment Phase|Missing|0|||
163152085|NCT01743469|589271406|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
163152086|NCT01743469|589271407|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
163152087|NCT01743469|589271408|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
163152088|NCT01743469|589271409|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
163152089|NCT01743469|589271406|FG000|Follow-up Period - Post-Treatment|Death|43|||
163152090|NCT01743469|589271407|FG001|Follow-up Period - Post-Treatment|Death|47|||
163152091|NCT01743469|589271408|FG002|Follow-up Period - Post-Treatment|Death|22|||
163152092|NCT01743469|589271409|FG003|Follow-up Period - Post-Treatment|Death|16|||
163152093|NCT01743469|589271406|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
163152094|NCT01743469|589271407|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
163152095|NCT01743469|589271408|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
163152096|NCT01743469|589271409|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
163152097|NCT00317473|589271410|FG000|Overall Study|Withdrawal by Subject|2|||
163152098|NCT00317473|589271411|FG001|Overall Study|Withdrawal by Subject|1|||
163152099|NCT00317473|589271412|FG002|Overall Study|Withdrawal by Subject|2|||
163152100|NCT00317473|589271413|FG003|Overall Study|Withdrawal by Subject|1|||
163152101|NCT00317473|589271414|FG004|Overall Study|Withdrawal by Subject|3|||
163152102|NCT00317473|589271415|FG005|Overall Study|Withdrawal by Subject|1|||
163152103|NCT00317473|589271410|FG000|Overall Study|Relocation|1|||
163152104|NCT00317473|589271411|FG001|Overall Study|Relocation|0|||
163152105|NCT00317473|589271412|FG002|Overall Study|Relocation|1|||
163152106|NCT00317473|589271413|FG003|Overall Study|Relocation|1|||
163152107|NCT00317473|589271414|FG004|Overall Study|Relocation|5|||
163152108|NCT00317473|589271415|FG005|Overall Study|Relocation|2|||
163152109|NCT00317473|589271410|FG000|Overall Study|Death|1|||
163152110|NCT00317473|589271411|FG001|Overall Study|Death|0|||
163152111|NCT00317473|589271412|FG002|Overall Study|Death|0|||
163152112|NCT00317473|589271413|FG003|Overall Study|Death|0|||
163152113|NCT00317473|589271414|FG004|Overall Study|Death|0|||
163152114|NCT00317473|589271415|FG005|Overall Study|Death|0|||
163152115|NCT00317473|589271410|FG000|Overall Study|Other|0|||
163152116|NCT00317473|589271411|FG001|Overall Study|Other|2|||
163152117|NCT00317473|589271412|FG002|Overall Study|Other|0|||
163152118|NCT00317473|589271413|FG003|Overall Study|Other|0|||
163152119|NCT00317473|589271414|FG004|Overall Study|Other|0|||
163152120|NCT00317473|589271415|FG005|Overall Study|Other|0|||
163152121|NCT03253796|589271416|FG000|Period 1: Run-In|Adverse Event|4|||
163152122|NCT03253796|589271417|FG001|Period 1: Run-In|Adverse Event|0|||
163152123|NCT03253796|589271418|FG002|Period 1: Run-In|Adverse Event|0|||
163152124|NCT03253796|589271419|FG003|Period 1: Run-In|Adverse Event|0|||
163152125|NCT03253796|589271420|FG004|Period 1: Run-In|Adverse Event|0|||
163259513|NCT01392300|589659403|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
163259514|NCT01337986|589659413|FG000|Overall Study|Adverse Event|2|||
163259515|NCT01337986|589659414|FG001|Overall Study|Adverse Event|2|||
163259516|NCT01337986|589659413|FG000|Overall Study|Lost to Follow-up|1|||
163259517|NCT01337986|589659414|FG001|Overall Study|Lost to Follow-up|0|||
163259518|NCT01337986|589659413|FG000|Overall Study|Protocol Violation|0|||
163259519|NCT01337986|589659414|FG001|Overall Study|Protocol Violation|3|||
163259520|NCT02313909|589659415|FG000|Overall Study|Consent withdrawn by participant|33|||
163259521|NCT02313909|589659416|FG001|Overall Study|Consent withdrawn by participant|33|||
163259522|NCT02313909|589659415|FG000|Overall Study|Lost to Follow-up|24|||
163259523|NCT02313909|589659416|FG001|Overall Study|Lost to Follow-up|17|||
163259524|NCT01782872|589659417|FG000|Overall Study|Protocol Violation|0|||
163259525|NCT01782872|589659418|FG001|Overall Study|Protocol Violation|0|||
163259526|NCT01782872|589659419|FG002|Overall Study|Protocol Violation|0|||
163259527|NCT01782872|589659420|FG003|Overall Study|Protocol Violation|1|||
163259528|NCT01782872|589659417|FG000|Overall Study|Withdrawal by Subject|0|||
163259529|NCT01782872|589659418|FG001|Overall Study|Withdrawal by Subject|1|||
163259530|NCT01782872|589659419|FG002|Overall Study|Withdrawal by Subject|0|||
163259531|NCT01782872|589659420|FG003|Overall Study|Withdrawal by Subject|0|||
163259532|NCT04026165|589659421|FG000|Run-in Placebo Period|Enrollment Error|13|||
163259533|NCT04026165|589659422|FG001|Run-in Placebo Period|Enrollment Error|0|||
163152126|NCT03253796|589271416|FG000|Period 1: Run-In|Lack of Efficacy|1|||
163152127|NCT03253796|589271417|FG001|Period 1: Run-In|Lack of Efficacy|0|||
163152128|NCT03253796|589271418|FG002|Period 1: Run-In|Lack of Efficacy|0|||
163152129|NCT03253796|589271419|FG003|Period 1: Run-In|Lack of Efficacy|0|||
163152130|NCT03253796|589271420|FG004|Period 1: Run-In|Lack of Efficacy|0|||
163152131|NCT03253796|589271416|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
163152132|NCT03253796|589271417|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
163152133|NCT03253796|589271418|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
163152134|NCT03253796|589271419|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
163152135|NCT03253796|589271420|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
163152136|NCT03253796|589271416|FG000|Period 1: Run-In|Protocol Violation|5|||
163152137|NCT03253796|589271417|FG001|Period 1: Run-In|Protocol Violation|0|||
163152138|NCT03253796|589271418|FG002|Period 1: Run-In|Protocol Violation|0|||
163152139|NCT03253796|589271419|FG003|Period 1: Run-In|Protocol Violation|0|||
163152140|NCT03253796|589271420|FG004|Period 1: Run-In|Protocol Violation|0|||
163152141|NCT03253796|589271416|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
163152142|NCT03253796|589271417|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
163152143|NCT03253796|589271418|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
163152144|NCT03253796|589271419|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
163152145|NCT03253796|589271420|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
163152146|NCT03253796|589271416|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
163152147|NCT03253796|589271417|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
163152148|NCT03253796|589271418|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
163152149|NCT03253796|589271419|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
163152150|NCT03253796|589271420|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
163152151|NCT03253796|589271416|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
163152152|NCT03253796|589271417|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
163152153|NCT03253796|589271418|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
163152154|NCT03253796|589271419|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
163152155|NCT03253796|589271420|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
163152156|NCT03253796|589271416|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
163152157|NCT03253796|589271417|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
163152158|NCT03253796|589271418|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
163152159|NCT03253796|589271419|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
163152160|NCT03253796|589271420|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
163152161|NCT03253796|589271416|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
163152162|NCT03253796|589271417|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
163152163|NCT03253796|589271418|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
163152164|NCT03253796|589271419|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
163152165|NCT03253796|589271420|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
163152166|NCT03253796|589271416|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
163152167|NCT03253796|589271417|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
163259534|NCT04026165|589659423|FG002|Run-in Placebo Period|Enrollment Error|0|||
163259535|NCT04026165|589659424|FG003|Run-in Placebo Period|Enrollment Error|0|||
163259536|NCT04026165|589659421|FG000|Run-in Placebo Period|Run-in Failure|4|||
163259537|NCT04026165|589659422|FG001|Run-in Placebo Period|Run-in Failure|0|||
163259538|NCT04026165|589659423|FG002|Run-in Placebo Period|Run-in Failure|0|||
163259539|NCT04026165|589659424|FG003|Run-in Placebo Period|Run-in Failure|0|||
163259540|NCT04026165|589659421|FG000|Run-in Placebo Period|Protocol Violation|2|||
163259541|NCT04026165|589659422|FG001|Run-in Placebo Period|Protocol Violation|0|||
163259542|NCT04026165|589659423|FG002|Run-in Placebo Period|Protocol Violation|0|||
163259543|NCT04026165|589659424|FG003|Run-in Placebo Period|Protocol Violation|0|||
163259544|NCT04026165|589659421|FG000|Run-in Placebo Period|Withdrew Consent|2|||
163259545|NCT04026165|589659422|FG001|Run-in Placebo Period|Withdrew Consent|0|||
163259546|NCT04026165|589659423|FG002|Run-in Placebo Period|Withdrew Consent|0|||
163259547|NCT04026165|589659424|FG003|Run-in Placebo Period|Withdrew Consent|0|||
163259548|NCT04026165|589659421|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
163259549|NCT04026165|589659422|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
163259550|NCT04026165|589659423|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
163259551|NCT04026165|589659424|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
163259552|NCT04026165|589659421|FG000|Run-in SEL Period|Run-in Failure|0|||
163259553|NCT04026165|589659422|FG001|Run-in SEL Period|Run-in Failure|26|||
163259554|NCT04026165|589659423|FG002|Run-in SEL Period|Run-in Failure|0|||
163259555|NCT04026165|589659424|FG003|Run-in SEL Period|Run-in Failure|0|||
163259556|NCT04026165|589659421|FG000|Run-in SEL Period|Withdrew Consent|0|||
163259557|NCT04026165|589659422|FG001|Run-in SEL Period|Withdrew Consent|10|||
163259558|NCT04026165|589659423|FG002|Run-in SEL Period|Withdrew Consent|0|||
163259559|NCT04026165|589659424|FG003|Run-in SEL Period|Withdrew Consent|0|||
163361367|NCT03377361|590031676|FG000|Treatment Period|Other Reasons|0|||
163259560|NCT04026165|589659421|FG000|Run-in SEL Period|Enrollment Error|0|||
163259561|NCT04026165|589659422|FG001|Run-in SEL Period|Enrollment Error|4|||
163259562|NCT04026165|589659423|FG002|Run-in SEL Period|Enrollment Error|0|||
163259563|NCT04026165|589659424|FG003|Run-in SEL Period|Enrollment Error|0|||
163259564|NCT04026165|589659421|FG000|Run-in SEL Period|Protocol Violation|0|||
163259565|NCT04026165|589659422|FG001|Run-in SEL Period|Protocol Violation|3|||
163259566|NCT04026165|589659423|FG002|Run-in SEL Period|Protocol Violation|0|||
163259567|NCT04026165|589659424|FG003|Run-in SEL Period|Protocol Violation|0|||
163259568|NCT04026165|589659421|FG000|Run-in SEL Period|Investigator's Discretion|0|||
163259569|NCT04026165|589659422|FG001|Run-in SEL Period|Investigator's Discretion|2|||
163259570|NCT04026165|589659423|FG002|Run-in SEL Period|Investigator's Discretion|0|||
163259571|NCT04026165|589659424|FG003|Run-in SEL Period|Investigator's Discretion|0|||
163259572|NCT04026165|589659421|FG000|Run-in SEL Period|Death|0|||
163259573|NCT04026165|589659422|FG001|Run-in SEL Period|Death|1|||
163259574|NCT04026165|589659423|FG002|Run-in SEL Period|Death|0|||
163259575|NCT04026165|589659424|FG003|Run-in SEL Period|Death|0|||
163259576|NCT04026165|589659421|FG000|Randomized Period|Withdrew Consent|0|||
163259577|NCT04026165|589659422|FG001|Randomized Period|Withdrew Consent|0|||
163259578|NCT04026165|589659423|FG002|Randomized Period|Withdrew Consent|5|||
163259579|NCT04026165|589659424|FG003|Randomized Period|Withdrew Consent|8|||
163259580|NCT04026165|589659421|FG000|Randomized Period|Death|0|||
163259581|NCT04026165|589659422|FG001|Randomized Period|Death|0|||
163259582|NCT04026165|589659423|FG002|Randomized Period|Death|5|||
163259583|NCT04026165|589659424|FG003|Randomized Period|Death|7|||
163259584|NCT04026165|589659421|FG000|Randomized Period|Investigator's Discretion|0|||
163259585|NCT04026165|589659422|FG001|Randomized Period|Investigator's Discretion|0|||
163259586|NCT04026165|589659423|FG002|Randomized Period|Investigator's Discretion|2|||
163259587|NCT04026165|589659424|FG003|Randomized Period|Investigator's Discretion|2|||
163259588|NCT04026165|589659421|FG000|Randomized Period|Lost to Follow-up|0|||
163259589|NCT04026165|589659422|FG001|Randomized Period|Lost to Follow-up|0|||
163259590|NCT04026165|589659423|FG002|Randomized Period|Lost to Follow-up|2|||
163259591|NCT04026165|589659424|FG003|Randomized Period|Lost to Follow-up|2|||
163259592|NCT01059630|589659427|FG000|Overall Study|Death|100|||
163259593|NCT01059630|589659428|FG001|Overall Study|Death|84|||
163259594|NCT01059630|589659427|FG000|Overall Study|Lost to Follow-up|4|||
163259595|NCT01059630|589659428|FG001|Overall Study|Lost to Follow-up|1|||
163259596|NCT01059630|589659427|FG000|Overall Study|Physician Decision|2|||
163259597|NCT01059630|589659428|FG001|Overall Study|Physician Decision|4|||
163259598|NCT01059630|589659427|FG000|Overall Study|Withdrawal by Subject|21|||
163259599|NCT01059630|589659428|FG001|Overall Study|Withdrawal by Subject|14|||
163259600|NCT02569437|589659429|FG000|Overall Study|Lost to Follow-up|12|||
163259601|NCT02569437|589659430|FG001|Overall Study|Lost to Follow-up|14|||
163259602|NCT00441701|589659431|FG000|Overall Study|Adverse Event|3|||
163259603|NCT00441701|589659432|FG001|Overall Study|Adverse Event|2|||
163259604|NCT00441701|589659433|FG002|Overall Study|Adverse Event|1|||
163259605|NCT00441701|589659434|FG003|Overall Study|Adverse Event|0|||
163259606|NCT00441701|589659435|FG004|Overall Study|Adverse Event|2|||
163259607|NCT00441701|589659436|FG005|Overall Study|Adverse Event|2|||
163259608|NCT00441701|589659437|FG006|Overall Study|Adverse Event|0|||
163259609|NCT00441701|589659438|FG007|Overall Study|Adverse Event|0|||
163259610|NCT00441701|589659439|FG008|Overall Study|Adverse Event|0|||
163259611|NCT00441701|589659440|FG009|Overall Study|Adverse Event|0|||
163259612|NCT00441701|589659431|FG000|Overall Study|Lack of Efficacy|2|||
163259613|NCT00441701|589659432|FG001|Overall Study|Lack of Efficacy|0|||
163259614|NCT00441701|589659433|FG002|Overall Study|Lack of Efficacy|2|||
163259615|NCT00441701|589659434|FG003|Overall Study|Lack of Efficacy|2|||
163259616|NCT00441701|589659435|FG004|Overall Study|Lack of Efficacy|0|||
163259617|NCT00441701|589659436|FG005|Overall Study|Lack of Efficacy|1|||
163259618|NCT00441701|589659437|FG006|Overall Study|Lack of Efficacy|0|||
163259619|NCT00441701|589659438|FG007|Overall Study|Lack of Efficacy|0|||
163259620|NCT00441701|589659439|FG008|Overall Study|Lack of Efficacy|0|||
163259621|NCT00441701|589659440|FG009|Overall Study|Lack of Efficacy|0|||
163259622|NCT00441701|589659431|FG000|Overall Study|Withdrawal by Subject|0|||
163259623|NCT00441701|589659432|FG001|Overall Study|Withdrawal by Subject|2|||
163259624|NCT00441701|589659433|FG002|Overall Study|Withdrawal by Subject|1|||
163259625|NCT00441701|589659434|FG003|Overall Study|Withdrawal by Subject|1|||
163259626|NCT00441701|589659435|FG004|Overall Study|Withdrawal by Subject|0|||
163259627|NCT00441701|589659436|FG005|Overall Study|Withdrawal by Subject|0|||
163259628|NCT00441701|589659437|FG006|Overall Study|Withdrawal by Subject|0|||
163259629|NCT00441701|589659438|FG007|Overall Study|Withdrawal by Subject|0|||
163259630|NCT00441701|589659439|FG008|Overall Study|Withdrawal by Subject|0|||
163259631|NCT00441701|589659440|FG009|Overall Study|Withdrawal by Subject|0|||
163361368|NCT03377361|590031677|FG001|Treatment Period|Other Reasons|0|||
163259632|NCT00985985|589659444|FG000|Overall Study|Adverse Event|4|||
163259633|NCT00985985|589659445|FG001|Overall Study|Adverse Event|2|||
163259634|NCT00985985|589659446|FG002|Overall Study|Adverse Event|2|||
163259635|NCT00985985|589659447|FG003|Overall Study|Adverse Event|2|||
163259636|NCT00985985|589659444|FG000|Overall Study|Lost to Follow-up|4|||
163152168|NCT03253796|589271418|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
163152169|NCT03253796|589271419|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
163152170|NCT03253796|589271420|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
163152171|NCT03253796|589271416|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
163152172|NCT03253796|589271417|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
163152173|NCT03253796|589271418|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
163152174|NCT03253796|589271419|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
163152175|NCT03253796|589271420|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
163259637|NCT00985985|589659445|FG001|Overall Study|Lost to Follow-up|11|||
163259638|NCT00985985|589659446|FG002|Overall Study|Lost to Follow-up|2|||
163259639|NCT00985985|589659447|FG003|Overall Study|Lost to Follow-up|3|||
163259640|NCT00985985|589659444|FG000|Overall Study|Protocol Violation|1|||
163259641|NCT00985985|589659445|FG001|Overall Study|Protocol Violation|2|||
163259642|NCT00985985|589659446|FG002|Overall Study|Protocol Violation|0|||
163259643|NCT00985985|589659447|FG003|Overall Study|Protocol Violation|1|||
163259644|NCT00985985|589659444|FG000|Overall Study|Lack of Efficacy|5|||
163259645|NCT00985985|589659445|FG001|Overall Study|Lack of Efficacy|6|||
163259646|NCT00985985|589659446|FG002|Overall Study|Lack of Efficacy|1|||
163259647|NCT00985985|589659447|FG003|Overall Study|Lack of Efficacy|3|||
163259648|NCT00985985|589659444|FG000|Overall Study|Withdrawal by Subject|4|||
163259649|NCT00985985|589659445|FG001|Overall Study|Withdrawal by Subject|2|||
163259650|NCT00985985|589659446|FG002|Overall Study|Withdrawal by Subject|2|||
163259651|NCT00985985|589659447|FG003|Overall Study|Withdrawal by Subject|2|||
163259652|NCT00985985|589659444|FG000|Overall Study|Other Reason|6|||
163259653|NCT00985985|589659445|FG001|Overall Study|Other Reason|1|||
163259654|NCT00985985|589659446|FG002|Overall Study|Other Reason|4|||
163259655|NCT00985985|589659447|FG003|Overall Study|Other Reason|2|||
163259656|NCT02535364|589659455|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
163259657|NCT02535364|589659455|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
163259658|NCT02535364|589659455|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
163259659|NCT02535364|589659455|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
163259660|NCT02535364|589659455|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
163259661|NCT02535364|589659455|FG000|Part B Screening|Death|2|||
163259662|NCT02535364|589659455|FG000|Part B Screening|Physician Decision|1|||
163259663|NCT02535364|589659455|FG000|Part B Screening|Withdrawal by Subject|1|||
163259664|NCT02535364|589659455|FG000|Part B Screening|Adverse Event|1|||
163259665|NCT02535364|589659455|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
163259666|NCT02535364|589659455|FG000|Study Treatment|Death|1|||
163259667|NCT02535364|589659455|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
163259668|NCT02535364|589659455|FG000|12-Month Follow-up Period|Disease progression|22|||
163259669|NCT02535364|589659455|FG000|12-Month Follow-up Period|Death|5|||
163259670|NCT02535364|589659455|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
163259671|NCT02535364|589659455|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
163259672|NCT02535364|589659455|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
163259673|NCT00499863|589659456|FG000|Overall Study|Lack of Efficacy|21|||
163259674|NCT00499863|589659457|FG001|Overall Study|Lack of Efficacy|27|||
163259675|NCT00499863|589659456|FG000|Overall Study|Protocol Violation|12|||
163259676|NCT00499863|589659457|FG001|Overall Study|Protocol Violation|7|||
163259677|NCT00499863|589659456|FG000|Overall Study|Withdrawal by Subject|6|||
163259678|NCT00499863|589659457|FG001|Overall Study|Withdrawal by Subject|4|||
163259679|NCT00499863|589659456|FG000|Overall Study|Adverse Event|8|||
163259680|NCT00499863|589659457|FG001|Overall Study|Adverse Event|2|||
163259681|NCT00499863|589659456|FG000|Overall Study|Sponsor decision|2|||
163259682|NCT00499863|589659457|FG001|Overall Study|Sponsor decision|2|||
163259683|NCT00499863|589659456|FG000|Overall Study|Lost to Follow-up|1|||
163259684|NCT00499863|589659457|FG001|Overall Study|Lost to Follow-up|1|||
163259685|NCT00571701|589659458|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
163259686|NCT00571701|589659459|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
163259687|NCT00571701|589659458|FG000|First Intervention 12 Months|Death|1|||
163259688|NCT00571701|589659459|FG001|First Intervention 12 Months|Death|0|||
163259689|NCT00571701|589659458|FG000|Second Intervention 12 Months|Adverse Event|0|||
163259690|NCT00571701|589659459|FG001|Second Intervention 12 Months|Adverse Event|1|||
163259691|NCT00571701|589659458|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
163259692|NCT00571701|589659459|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
163259693|NCT00691132|589659460|FG000|Overall Study|Adverse Event|2|||
163259694|NCT00691132|589659461|FG001|Overall Study|Adverse Event|3|||
163152176|NCT02285855|589271421|FG000|Overall Study|Withdrawal by Subject|2|||
163259695|NCT00691132|589659460|FG000|Overall Study|Withdrawal by Subject|10|||
163259696|NCT00691132|589659461|FG001|Overall Study|Withdrawal by Subject|10|||
163259697|NCT01959347|589659472|FG000|Overall Study|Protocol Violation|9|||
163259698|NCT01959347|589659473|FG001|Overall Study|Protocol Violation|7|||
163259699|NCT01282801|589659474|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
163361369|NCT03377361|590031678|FG002|Treatment Period|Other Reasons|0|||
163259700|NCT01282801|589659475|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
163259701|NCT02889133|589659479|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
163259702|NCT02889133|589659480|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
163259703|NCT02889133|589659479|FG000|Completed Primary Outcome|Manufacturing error|3|||
163259704|NCT02889133|589659480|FG001|Completed Primary Outcome|Manufacturing error|8|||
163259705|NCT02889133|589659479|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
163259706|NCT02889133|589659480|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
163259707|NCT02889133|589659479|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
163259708|NCT02889133|589659480|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
163259709|NCT02889133|589659479|FG000|Completed Primary Outcome|Protocol Violation|1|||
163259710|NCT02889133|589659480|FG001|Completed Primary Outcome|Protocol Violation|0|||
163259711|NCT02889133|589659479|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
163259712|NCT02889133|589659480|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
163152177|NCT02285855|589271422|FG001|Overall Study|Withdrawal by Subject|1|||
163152178|NCT00528112|589271423|FG000|Treatment up to 3 Years|Adverse Event|313|||
163152179|NCT00528112|589271424|FG001|Treatment up to 3 Years|Adverse Event|278|||
163152180|NCT00528112|589271423|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
163152181|NCT00528112|589271424|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
163152182|NCT00528112|589271423|FG000|Treatment up to 3 Years|Protocol Violation|16|||
163152183|NCT00528112|589271424|FG001|Treatment up to 3 Years|Protocol Violation|16|||
163152184|NCT00528112|589271423|FG000|Treatment up to 3 Years|Death|0|||
163152185|NCT00528112|589271424|FG001|Treatment up to 3 Years|Death|1|||
163152186|NCT00528112|589271423|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
163259713|NCT02889133|589659479|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
163259714|NCT02889133|589659480|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
163259715|NCT02889133|589659479|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
163259716|NCT02889133|589659480|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
163259717|NCT02889133|589659479|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
163259718|NCT02889133|589659480|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
163259719|NCT02889133|589659479|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
163259720|NCT02889133|589659480|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
163259721|NCT01781390|589659482|FG000|Overall Study|Withdrawal of Consent|0|||
163259722|NCT01781390|589659483|FG001|Overall Study|Withdrawal of Consent|3|||
163259723|NCT01781390|589659484|FG002|Overall Study|Withdrawal of Consent|1|||
163259724|NCT01781390|589659482|FG000|Overall Study|Lost to Follow-up|1|||
163259725|NCT01781390|589659483|FG001|Overall Study|Lost to Follow-up|1|||
163259726|NCT01781390|589659484|FG002|Overall Study|Lost to Follow-up|1|||
163259727|NCT01781390|589659482|FG000|Overall Study|Adverse Event|1|||
163259728|NCT01781390|589659483|FG001|Overall Study|Adverse Event|2|||
163259729|NCT01781390|589659484|FG002|Overall Study|Adverse Event|1|||
163259730|NCT01781390|589659482|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
163259731|NCT01781390|589659483|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
163259732|NCT01781390|589659484|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
163259733|NCT01862796|589659485|FG000|Overall Study|Prohibited medications|0|||
163259734|NCT01862796|589659486|FG001|Overall Study|Prohibited medications|0|||
163259735|NCT01862796|589659487|FG002|Overall Study|Prohibited medications|1|||
163259736|NCT01375205|589659492|FG000|Overall Study|Lost to Follow-up|15|||
163259737|NCT01375205|589659493|FG001|Overall Study|Lost to Follow-up|12|||
163259738|NCT01375205|589659492|FG000|Overall Study|Withdrawal by Subject|6|||
163259739|NCT01375205|589659493|FG001|Overall Study|Withdrawal by Subject|1|||
163259740|NCT01859793|589659494|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
163259741|NCT01859793|589659495|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
163259742|NCT01859793|589659494|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
163259743|NCT01859793|589659495|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
163259744|NCT01859793|589659494|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
163259745|NCT01859793|589659495|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
163259746|NCT01859793|589659494|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
163259747|NCT01859793|589659495|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
163259748|NCT03185481|589659504|FG000|Overall Study|Adverse Event|1|||
163259749|NCT03185481|589659504|FG000|Overall Study|Study Terminated by Sponsor|4|||
163259750|NCT03371940|589659507|FG000|Overall Study|Withdrawal by Subject|8|||
163259751|NCT03371940|589659508|FG001|Overall Study|Withdrawal by Subject|1|||
163259752|NCT03371940|589659509|FG002|Overall Study|Withdrawal by Subject|3|||
163259753|NCT03371940|589659510|FG003|Overall Study|Withdrawal by Subject|4|||
163259754|NCT01064297|589659511|FG000|Overall Study|Lost to Follow-up|791|||
163259755|NCT01064297|589659512|FG001|Overall Study|Lost to Follow-up|48|||
163259756|NCT01064297|589659513|FG002|Overall Study|Lost to Follow-up|133|||
163259757|NCT00511875|589659525|FG000|Overall Study|Lost to Follow-up|4|||
163259758|NCT00511875|589659526|FG001|Overall Study|Lost to Follow-up|0|||
163259759|NCT00511875|589659525|FG000|Overall Study|Missing variables|1|||
163259760|NCT00511875|589659526|FG001|Overall Study|Missing variables|0|||
163259761|NCT02686034|589659528|FG000|Run-In Period 1|Eligibility|12|||
163259762|NCT02686034|589659529|FG001|Run-In Period 1|Eligibility|10|||
163259763|NCT02686034|589659528|FG000|Run-In Period 1|Withdrawal by Subject|4|||
163259764|NCT02686034|589659529|FG001|Run-In Period 1|Withdrawal by Subject|3|||
163259765|NCT02686034|589659528|FG000|Run-In Period 1|Lost to Follow-up|4|||
163259766|NCT02686034|589659529|FG001|Run-In Period 1|Lost to Follow-up|4|||
163259767|NCT02686034|589659528|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
163259768|NCT02686034|589659529|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
163259769|NCT02686034|589659528|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
163259770|NCT02686034|589659529|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
163259771|NCT02686034|589659528|FG000|Randomized Controlled Period 2|Adverse Event|0|||
163259772|NCT02686034|589659529|FG001|Randomized Controlled Period 2|Adverse Event|2|||
163259773|NCT02686034|589659528|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
163259774|NCT02686034|589659529|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
163259775|NCT02686034|589659528|FG000|Open Label Period 3|Lost to Follow-up|0|||
163259776|NCT02686034|589659529|FG001|Open Label Period 3|Lost to Follow-up|1|||
163259777|NCT00542880|589659530|FG000|Period 1|Eligibility criteria not fulfilled|2|||
163259778|NCT00542880|589659531|FG001|Period 1|Eligibility criteria not fulfilled|6|||
163259779|NCT00542880|589659530|FG000|Period 1|Adverse Event|2|||
163259780|NCT00542880|589659531|FG001|Period 1|Adverse Event|2|||
163259781|NCT00542880|589659530|FG000|Period 1|Development of study-specific criteria|1|||
163259782|NCT00542880|589659531|FG001|Period 1|Development of study-specific criteria|2|||
163259783|NCT00542880|589659530|FG000|Period 1|Withdrawal by Subject|1|||
163259784|NCT00542880|589659531|FG001|Period 1|Withdrawal by Subject|1|||
163259785|NCT00542880|589659530|FG000|Period 1|Protocol Violation|0|||
163259786|NCT00542880|589659531|FG001|Period 1|Protocol Violation|1|||
163259787|NCT00542880|589659530|FG000|Period 2|Adverse Event|5|||
163259788|NCT00542880|589659531|FG001|Period 2|Adverse Event|7|||
163259789|NCT00542880|589659530|FG000|Period 2|Eligibility not fulfilled|0|||
163259790|NCT00542880|589659531|FG001|Period 2|Eligibility not fulfilled|1|||
163259791|NCT00542880|589659530|FG000|Period 2|Discontinuation criteria|2|||
163259792|NCT00542880|589659531|FG001|Period 2|Discontinuation criteria|0|||
163259793|NCT00542880|589659530|FG000|Period 2|Severe non-compliance|0|||
163259794|NCT00542880|589659531|FG001|Period 2|Severe non-compliance|1|||
163259795|NCT00542880|589659530|FG000|Period 2|Other|0|||
163259796|NCT00542880|589659531|FG001|Period 2|Other|1|||
163259797|NCT00542880|589659530|FG000|Period 3|Adverse Event|0|||
163259798|NCT00542880|589659531|FG001|Period 3|Adverse Event|2|||
163259799|NCT01678131|589659532|FG000|Overall Study|Adverse Event|0|||
163259800|NCT01678131|589659533|FG001|Overall Study|Adverse Event|1|||
163259801|NCT01678131|589659534|FG002|Overall Study|Adverse Event|0|||
163259802|NCT01678131|589659532|FG000|Overall Study|Withdrawal by Subject|0|||
163259803|NCT01678131|589659533|FG001|Overall Study|Withdrawal by Subject|0|||
163259804|NCT01678131|589659534|FG002|Overall Study|Withdrawal by Subject|2|||
163259805|NCT00982930|589659538|FG000|Overall Study|Adverse Event|1|||
163259806|NCT00982930|589659538|FG000|Overall Study|Withdrawal by Subject|1|||
163259807|NCT00982930|589659538|FG000|Overall Study|Administrative Problems|2|||
163259808|NCT00941798|589659539|FG000|Overall Study|Withdrawal by Subject|72|||
163259809|NCT00941798|589659540|FG001|Overall Study|Withdrawal by Subject|74|||
163259810|NCT00941798|589659539|FG000|Overall Study|Adverse Event|43|||
163259811|NCT00941798|589659540|FG001|Overall Study|Adverse Event|23|||
163259812|NCT00941798|589659539|FG000|Overall Study|Lost to Follow-up|29|||
163259813|NCT00941798|589659540|FG001|Overall Study|Lost to Follow-up|23|||
163259814|NCT00941798|589659539|FG000|Overall Study|Protocol Violation|17|||
163259815|NCT00941798|589659540|FG001|Overall Study|Protocol Violation|20|||
163259816|NCT00941798|589659539|FG000|Overall Study|Administrative problems|13|||
163259817|NCT00941798|589659540|FG001|Overall Study|Administrative problems|23|||
163259818|NCT00941798|589659539|FG000|Overall Study|Lack of Efficacy|10|||
163259819|NCT00941798|589659540|FG001|Overall Study|Lack of Efficacy|17|||
163259820|NCT00941798|589659539|FG000|Overall Study|Patient's inability to use device|6|||
163259821|NCT00941798|589659540|FG001|Overall Study|Patient's inability to use device|1|||
163259822|NCT00941798|589659539|FG000|Overall Study|Abnormal test procedure results|3|||
163259823|NCT00941798|589659540|FG001|Overall Study|Abnormal test procedure results|1|||
163259824|NCT00941798|589659539|FG000|Overall Study|Abnormal laboratory values|1|||
163259825|NCT00941798|589659540|FG001|Overall Study|Abnormal laboratory values|2|||
163259826|NCT00941798|589659539|FG000|Overall Study|Death|0|||
163259827|NCT00941798|589659540|FG001|Overall Study|Death|1|||
163259828|NCT05597722|589659541|FG000|Overall Study|Study was terminated|6|||
163259829|NCT05597722|589659542|FG001|Overall Study|Study was terminated|1|||
163259830|NCT00404495|589659543|FG000|Overall Study|Death|37|||
163259831|NCT00404495|589659544|FG001|Overall Study|Death|11|||
163259832|NCT00404495|589659543|FG000|Overall Study|Lost to Follow-up|5|||
163259833|NCT00404495|589659544|FG001|Overall Study|Lost to Follow-up|0|||
163259834|NCT00404495|589659543|FG000|Overall Study|Other|1|||
163259835|NCT00404495|589659544|FG001|Overall Study|Other|0|||
163259836|NCT00404495|589659543|FG000|Overall Study|Withdrawal by Subject|1|||
163259837|NCT00404495|589659544|FG001|Overall Study|Withdrawal by Subject|0|||
163259838|NCT03750006|589659549|FG000|Overall Study|Withdrawal by Subject|8|||
163259839|NCT03750006|589659549|FG000|Overall Study|COVID PANDEMIC|11|||
163259840|NCT03538951|589659550|FG000|Overall Study|Withdrawal by Subject|1|||
163259841|NCT03538951|589659551|FG001|Overall Study|Withdrawal by Subject|2|||
163259842|NCT01816763|589660882|FG000|Overall Study|The main reason for an incomplete survey|4|||
163259843|NCT01816763|589660883|FG001|Overall Study|The main reason for an incomplete survey|15|||
163259844|NCT01816763|589660884|FG002|Overall Study|The main reason for an incomplete survey|11|||
163259845|NCT01147822|589660885|FG000|Overall Study|Lost to Follow-up|14|||
163259846|NCT01147822|589660886|FG001|Overall Study|Lost to Follow-up|6|||
163259847|NCT01147822|589660885|FG000|Overall Study|Withdrawal by Subject|10|||
163259848|NCT01147822|589660886|FG001|Overall Study|Withdrawal by Subject|16|||
163259849|NCT01147822|589660885|FG000|Overall Study|Physician Decision|9|||
163259850|NCT01147822|589660886|FG001|Overall Study|Physician Decision|8|||
163259851|NCT01147822|589660885|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
163259852|NCT01147822|589660886|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
163259853|NCT01147822|589660885|FG000|Overall Study|Protocol Violation|1|||
163259854|NCT01147822|589660886|FG001|Overall Study|Protocol Violation|1|||
163259855|NCT03010462|589660890|FG000|Overall Study|Withdrawal by Subject|3|||
163259856|NCT03010462|589660891|FG001|Overall Study|Withdrawal by Subject|1|||
163259857|NCT01966003|589660892|FG000|Overall Study|Death|43|||
163259858|NCT01966003|589660893|FG001|Overall Study|Death|36|||
163259859|NCT01966003|589660892|FG000|Overall Study|Protocol Violation|6|||
163259860|NCT01966003|589660893|FG001|Overall Study|Protocol Violation|4|||
163259861|NCT01966003|589660892|FG000|Overall Study|Lost to Follow-up|4|||
163259862|NCT01966003|589660893|FG001|Overall Study|Lost to Follow-up|3|||
163259863|NCT01966003|589660892|FG000|Overall Study|Physician Decision|12|||
163259864|NCT01966003|589660893|FG001|Overall Study|Physician Decision|13|||
163259865|NCT01966003|589660892|FG000|Overall Study|Withdrawal by Subject|29|||
163259866|NCT01966003|589660893|FG001|Overall Study|Withdrawal by Subject|19|||
163259867|NCT01966003|589660892|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
163259868|NCT01966003|589660893|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
163259869|NCT01966003|589660892|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
163259870|NCT01966003|589660893|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
163259871|NCT01966003|589660892|FG000|Overall Study|Other|1|||
163259872|NCT01966003|589660893|FG001|Overall Study|Other|1|||
163259873|NCT02748694|589660900|FG000|Overall Study|Voluntary Withdrawal|0|||
163259874|NCT02748694|589660901|FG001|Overall Study|Voluntary Withdrawal|0|||
163259875|NCT02748694|589660902|FG002|Overall Study|Voluntary Withdrawal|0|||
163361370|NCT03377361|590031679|FG003|Treatment Period|Other Reasons|3|||
163361371|NCT03377361|590031680|FG004|Treatment Period|Other Reasons|0|||
163361372|NCT03377361|590031681|FG005|Treatment Period|Other Reasons|0|||
163361373|NCT03377361|590031682|FG006|Treatment Period|Other Reasons|0|||
163361374|NCT03377361|590031683|FG007|Treatment Period|Other Reasons|2|||
163361375|NCT03377361|590031684|FG008|Treatment Period|Other Reasons|0|||
163361376|NCT03377361|590031685|FG009|Treatment Period|Other Reasons|1|||
163361377|NCT03698994|590031697|FG000|Overall Study|Adverse Event|2|||
163361378|NCT03698994|590031697|FG000|Overall Study|Death|1|||
163361379|NCT03698994|590031697|FG000|Overall Study|Physician Decision|1|||
163361380|NCT03698994|590031697|FG000|Overall Study|Withdrawal by Subject|3|||
163361381|NCT03698994|590031697|FG000|Overall Study|Progressive Disease|12|||
163361382|NCT03482752|590031704|FG000|Overall Study|Withdrawal by Subject|2|||
163361383|NCT03482752|590031704|FG000|Overall Study|Lost to Follow-up|1|||
163361384|NCT03482752|590031704|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
163361385|NCT02844777|590031705|FG000|Overall Study|Withdrawal by Subject|2|||
163361386|NCT02844777|590031706|FG001|Overall Study|Withdrawal by Subject|0|||
163361387|NCT02844777|590031707|FG002|Overall Study|Withdrawal by Subject|0|||
163361388|NCT01776008|590031708|FG000|Overall Study|ineligible|2|||
163361389|NCT00150618|590031709|FG000|Overall Study|Adverse Event|2|||
163361390|NCT00150618|590031710|FG001|Overall Study|Adverse Event|2|||
163361391|NCT00150618|590031711|FG002|Overall Study|Adverse Event|6|||
163361392|NCT00150618|590031712|FG003|Overall Study|Adverse Event|9|||
163361393|NCT00150618|590031713|FG004|Overall Study|Adverse Event|5|||
163361394|NCT00150618|590031709|FG000|Overall Study|Withdrawal by Subject|6|||
163361395|NCT00150618|590031710|FG001|Overall Study|Withdrawal by Subject|8|||
163361396|NCT00150618|590031711|FG002|Overall Study|Withdrawal by Subject|8|||
163259876|NCT02748694|589660903|FG003|Overall Study|Voluntary Withdrawal|0|||
163259877|NCT02748694|589660904|FG004|Overall Study|Voluntary Withdrawal|0|||
163259878|NCT02748694|589660905|FG005|Overall Study|Voluntary Withdrawal|0|||
163259879|NCT02748694|589660906|FG006|Overall Study|Voluntary Withdrawal|0|||
163259880|NCT02748694|589660907|FG007|Overall Study|Voluntary Withdrawal|0|||
163259881|NCT02748694|589660908|FG008|Overall Study|Voluntary Withdrawal|0|||
163259882|NCT02748694|589660909|FG009|Overall Study|Voluntary Withdrawal|0|||
163259883|NCT02748694|589660910|FG010|Overall Study|Voluntary Withdrawal|0|||
163259884|NCT02748694|589660911|FG011|Overall Study|Voluntary Withdrawal|0|||
163259885|NCT02748694|589660912|FG012|Overall Study|Voluntary Withdrawal|0|||
163361397|NCT00150618|590031712|FG003|Overall Study|Withdrawal by Subject|4|||
163361398|NCT00150618|590031713|FG004|Overall Study|Withdrawal by Subject|5|||
163259886|NCT02748694|589660913|FG013|Overall Study|Voluntary Withdrawal|0|||
163259887|NCT02748694|589660914|FG014|Overall Study|Voluntary Withdrawal|2|||
163259888|NCT00077064|589660915|FG000|Overall Study|Adverse Event|0|||
163259889|NCT00077064|589660916|FG001|Overall Study|Adverse Event|4|||
163259890|NCT00077064|589660915|FG000|Overall Study|Patient refusal|0|||
163259891|NCT00077064|589660916|FG001|Overall Study|Patient refusal|2|||
163259892|NCT00927355|589660917|FG000|Overall Study|Adverse Event|1|||
163259893|NCT00927355|589660918|FG001|Overall Study|Adverse Event|1|||
163259894|NCT03299686|589660919|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
163259895|NCT03299686|589660920|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
163259896|NCT03299686|589660919|FG000|Treatment Epoch|Physician Decision|1|||
163259897|NCT03299686|589660920|FG001|Treatment Epoch|Physician Decision|0|||
163259898|NCT03299686|589660919|FG000|Treatment Epoch|Adverse Event|8|||
163259899|NCT03299686|589660920|FG001|Treatment Epoch|Adverse Event|4|||
163259900|NCT03299686|589660919|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
163259901|NCT03299686|589660920|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
163259902|NCT01060553|589660922|FG000|Overall Study|Lost to Follow-up|3|||
163259903|NCT01060553|589660923|FG001|Overall Study|Lost to Follow-up|5|||
163259904|NCT01060553|589660922|FG000|Overall Study|Withdrawal by Subject|5|||
163259905|NCT01060553|589660923|FG001|Overall Study|Withdrawal by Subject|5|||
163259906|NCT01060553|589660922|FG000|Overall Study|Lack of Efficacy|1|||
163259907|NCT01060553|589660923|FG001|Overall Study|Lack of Efficacy|0|||
163259908|NCT01446796|589660924|FG000|Overall Study|Withdrawal by Subject|1|||
163259909|NCT01446796|589660925|FG001|Overall Study|Withdrawal by Subject|0|||
163259910|NCT03131960|589660929|FG000|Overall Study|Adverse Event|0|||
163259911|NCT03131960|589660930|FG001|Overall Study|Adverse Event|1|||
163259912|NCT04707196|589660931|FG000|Overall Study|Withdrawal by Subject|9|||
163259913|NCT04707196|589660932|FG001|Overall Study|Withdrawal by Subject|6|||
163259914|NCT04707196|589660931|FG000|Overall Study|Lost to Follow-up|1|||
163259915|NCT04707196|589660932|FG001|Overall Study|Lost to Follow-up|0|||
163259916|NCT04707196|589660931|FG000|Overall Study|Protocol Violation|4|||
163259917|NCT04707196|589660932|FG001|Overall Study|Protocol Violation|1|||
163259918|NCT04707196|589660931|FG000|Overall Study|Adverse Event|2|||
163259919|NCT04707196|589660932|FG001|Overall Study|Adverse Event|2|||
163259920|NCT04707196|589660931|FG000|Overall Study|Death|3|||
163259921|NCT04707196|589660932|FG001|Overall Study|Death|1|||
163259922|NCT04707196|589660931|FG000|Overall Study|Non-compliance with study drug|1|||
163259923|NCT04707196|589660932|FG001|Overall Study|Non-compliance with study drug|0|||
163259924|NCT04707196|589660931|FG000|Overall Study|Progressive disease|9|||
163259925|NCT04707196|589660932|FG001|Overall Study|Progressive disease|10|||
163259926|NCT01462162|589660936|FG000|Overall Study|Adverse Event|5|||
163259927|NCT01462162|589660936|FG000|Overall Study|Lack of Efficacy|4|||
163259928|NCT01462162|589660936|FG000|Overall Study|Abnormal laboratory parameters|1|||
163259929|NCT01462162|589660936|FG000|Overall Study|Other|2|||
163259930|NCT03485911|589660937|FG000|Part 1|Perceived lack of efficacy|1|||
163259931|NCT03485911|589660938|FG001|Part 1|Perceived lack of efficacy|1|||
163259932|NCT03485911|589660939|FG002|Part 1|Perceived lack of efficacy|2|||
163259933|NCT03485911|589660940|FG003|Part 1|Perceived lack of efficacy|0|||
163259934|NCT03485911|589660937|FG000|Part 1|Subject withdrew consent|0|||
163259935|NCT03485911|589660938|FG001|Part 1|Subject withdrew consent|1|||
163259936|NCT03485911|589660939|FG002|Part 1|Subject withdrew consent|0|||
163259937|NCT03485911|589660940|FG003|Part 1|Subject withdrew consent|1|||
163259938|NCT03485911|589660937|FG000|Part 1|Lab abnormalities/AEs|3|||
163259939|NCT03485911|589660938|FG001|Part 1|Lab abnormalities/AEs|1|||
163259940|NCT03485911|589660939|FG002|Part 1|Lab abnormalities/AEs|1|||
163259941|NCT03485911|589660940|FG003|Part 1|Lab abnormalities/AEs|0|||
163259942|NCT03485911|589660937|FG000|Part 1|Withdrew Consent prior to dosing|0|||
163259943|NCT03485911|589660938|FG001|Part 1|Withdrew Consent prior to dosing|0|||
163259944|NCT03485911|589660939|FG002|Part 1|Withdrew Consent prior to dosing|0|||
163259945|NCT03485911|589660940|FG003|Part 1|Withdrew Consent prior to dosing|1|||
163259946|NCT03485911|589660937|FG000|Part 1|Other NOS|0|||
163259947|NCT03485911|589660938|FG001|Part 1|Other NOS|0|||
163259948|NCT03485911|589660939|FG002|Part 1|Other NOS|0|||
163259949|NCT03485911|589660940|FG003|Part 1|Other NOS|1|||
163259950|NCT03485911|589660937|FG000|Part 2|Perceived lack of efficacy|5|||
163259951|NCT03485911|589660938|FG001|Part 2|Perceived lack of efficacy|3|||
163259952|NCT03485911|589660939|FG002|Part 2|Perceived lack of efficacy|0|||
163259953|NCT03485911|589660940|FG003|Part 2|Perceived lack of efficacy|2|||
163259954|NCT03485911|589660937|FG000|Part 2|Subject withdrew consent|1|||
163259955|NCT03485911|589660938|FG001|Part 2|Subject withdrew consent|0|||
163259956|NCT03485911|589660939|FG002|Part 2|Subject withdrew consent|2|||
163259957|NCT03485911|589660940|FG003|Part 2|Subject withdrew consent|1|||
163259958|NCT03485911|589660937|FG000|Part 2|Lab abnormalities/AEs|1|||
163259959|NCT03485911|589660938|FG001|Part 2|Lab abnormalities/AEs|2|||
163259960|NCT03485911|589660939|FG002|Part 2|Lab abnormalities/AEs|0|||
163259961|NCT03485911|589660940|FG003|Part 2|Lab abnormalities/AEs|0|||
163259962|NCT03485911|589660937|FG000|Part 2|Other NOS|0|||
163259963|NCT03485911|589660938|FG001|Part 2|Other NOS|1|||
163259964|NCT03485911|589660939|FG002|Part 2|Other NOS|0|||
163259965|NCT03485911|589660940|FG003|Part 2|Other NOS|0|||
163259966|NCT03485911|589660937|FG000|Part 2|Intercurrent illness/new medical condition|1|||
163259967|NCT03485911|589660938|FG001|Part 2|Intercurrent illness/new medical condition|0|||
163259968|NCT03485911|589660939|FG002|Part 2|Intercurrent illness/new medical condition|0|||
163259969|NCT03485911|589660940|FG003|Part 2|Intercurrent illness/new medical condition|0|||
163259970|NCT03485911|589660937|FG000|Part 2|Investigator judgement|1|||
163259971|NCT03485911|589660938|FG001|Part 2|Investigator judgement|0|||
163259972|NCT03485911|589660939|FG002|Part 2|Investigator judgement|0|||
163259973|NCT03485911|589660940|FG003|Part 2|Investigator judgement|0|||
163259974|NCT03485911|589660937|FG000|Part 3|Perceived lack of efficacy|2|||
163259975|NCT03485911|589660938|FG001|Part 3|Perceived lack of efficacy|2|||
163259976|NCT03485911|589660939|FG002|Part 3|Perceived lack of efficacy|2|||
163259977|NCT03485911|589660940|FG003|Part 3|Perceived lack of efficacy|0|||
163259978|NCT03485911|589660937|FG000|Part 3|Subject withdrew consent|1|||
163259979|NCT03485911|589660938|FG001|Part 3|Subject withdrew consent|4|||
163259980|NCT03485911|589660939|FG002|Part 3|Subject withdrew consent|0|||
163259981|NCT03485911|589660940|FG003|Part 3|Subject withdrew consent|1|||
163259982|NCT03485911|589660937|FG000|Part 3|Lab abnormalities/AEs|1|||
163259983|NCT03485911|589660938|FG001|Part 3|Lab abnormalities/AEs|1|||
163259984|NCT03485911|589660939|FG002|Part 3|Lab abnormalities/AEs|0|||
163259985|NCT03485911|589660940|FG003|Part 3|Lab abnormalities/AEs|2|||
163259986|NCT03485911|589660937|FG000|Part 3|Other NOS|1|||
163259987|NCT03485911|589660938|FG001|Part 3|Other NOS|1|||
163259988|NCT03485911|589660939|FG002|Part 3|Other NOS|0|||
163259989|NCT03485911|589660940|FG003|Part 3|Other NOS|0|||
163259990|NCT03485911|589660937|FG000|Part 3|Intercurrent illness/new medical condition|0|||
163259991|NCT03485911|589660938|FG001|Part 3|Intercurrent illness/new medical condition|1|||
163259992|NCT03485911|589660939|FG002|Part 3|Intercurrent illness/new medical condition|1|||
163259993|NCT03485911|589660940|FG003|Part 3|Intercurrent illness/new medical condition|0|||
163259994|NCT03485911|589660937|FG000|Part 3|Sponsor discontinuation|1|||
163259995|NCT03485911|589660938|FG001|Part 3|Sponsor discontinuation|0|||
163259996|NCT03485911|589660939|FG002|Part 3|Sponsor discontinuation|0|||
163259997|NCT03485911|589660940|FG003|Part 3|Sponsor discontinuation|0|||
163259998|NCT03485911|589660937|FG000|Part 3|Berotralstat provided by alternative means|13|||
163259999|NCT03485911|589660938|FG001|Part 3|Berotralstat provided by alternative means|13|||
163260000|NCT03485911|589660939|FG002|Part 3|Berotralstat provided by alternative means|7|||
163260001|NCT03485911|589660940|FG003|Part 3|Berotralstat provided by alternative means|7|||
163260002|NCT03333928|589660941|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
163260003|NCT03333928|589660942|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
163260004|NCT03333928|589660943|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
163260005|NCT03333928|589660941|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
163152187|NCT00528112|589271424|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
163152188|NCT00528112|589271423|FG000|Treatment up to 3 Years|Pregnancy|9|||
163152189|NCT00528112|589271424|FG001|Treatment up to 3 Years|Pregnancy|10|||
163152190|NCT00528112|589271423|FG000|Treatment up to 3 Years|Other reasons|186|||
163152191|NCT00528112|589271424|FG001|Treatment up to 3 Years|Other reasons|186|||
163152192|NCT00528112|589271423|FG000|Extension Phase|Withdrawal by Subject|0|||
163152193|NCT00528112|589271424|FG001|Extension Phase|Withdrawal by Subject|3|||
163152194|NCT00528112|589271423|FG000|Extension Phase|Other reasons|0|||
163152195|NCT00528112|589271424|FG001|Extension Phase|Other reasons|100|||
163152196|NCT00528112|589271423|FG000|Extension Phase|Pregnancy|0|||
163152197|NCT00528112|589271424|FG001|Extension Phase|Pregnancy|3|||
163152198|NCT00528112|589271423|FG000|Extension Phase|Lost to Follow-up|0|||
163152199|NCT00528112|589271424|FG001|Extension Phase|Lost to Follow-up|12|||
163152200|NCT00528112|589271423|FG000|Extension Phase|Death|0|||
163152201|NCT00528112|589271424|FG001|Extension Phase|Death|1|||
163152202|NCT00528112|589271423|FG000|Extension Phase|Adverse Event|0|||
163152203|NCT00528112|589271424|FG001|Extension Phase|Adverse Event|36|||
163152204|NCT00528112|589271423|FG000|Extension Phase|Protocol Violation|0|||
163152205|NCT00528112|589271424|FG001|Extension Phase|Protocol Violation|2|||
163152206|NCT02718898|589271427|FG000|Blinded Treatment Period|Adverse Event|5|||
163152207|NCT02718898|589271428|FG001|Blinded Treatment Period|Adverse Event|1|||
163152208|NCT02718898|589271429|FG002|Blinded Treatment Period|Adverse Event|0|||
163152209|NCT02718898|589271430|FG003|Blinded Treatment Period|Adverse Event|0|||
163152210|NCT02718898|589271431|FG004|Blinded Treatment Period|Adverse Event|0|||
163152211|NCT02718898|589271432|FG005|Blinded Treatment Period|Adverse Event|0|||
163152212|NCT02718898|589271433|FG006|Blinded Treatment Period|Adverse Event|0|||
163152213|NCT02718898|589271427|FG000|Blinded Treatment Period|Physician Decision|1|||
163152214|NCT02718898|589271428|FG001|Blinded Treatment Period|Physician Decision|0|||
163152215|NCT02718898|589271429|FG002|Blinded Treatment Period|Physician Decision|0|||
163152216|NCT02718898|589271430|FG003|Blinded Treatment Period|Physician Decision|0|||
163152217|NCT02718898|589271431|FG004|Blinded Treatment Period|Physician Decision|0|||
163152218|NCT02718898|589271432|FG005|Blinded Treatment Period|Physician Decision|0|||
163152219|NCT02718898|589271433|FG006|Blinded Treatment Period|Physician Decision|0|||
163152220|NCT02718898|589271427|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
163260006|NCT03333928|589660942|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
163260007|NCT03333928|589660943|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
163260008|NCT03333928|589660941|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
163260009|NCT03333928|589660942|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
163260010|NCT03333928|589660943|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
163260011|NCT03333928|589660941|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
163260012|NCT03333928|589660942|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
163260013|NCT03333928|589660943|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
163260014|NCT03333928|589660941|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
163260015|NCT03333928|589660942|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
163260016|NCT03333928|589660943|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
163260017|NCT03333928|589660941|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
163260018|NCT03333928|589660942|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
163260019|NCT03333928|589660943|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
163260020|NCT03333928|589660941|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
163260021|NCT03333928|589660942|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
163260022|NCT03333928|589660943|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
163260023|NCT03333928|589660941|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
163260024|NCT03333928|589660942|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
163260025|NCT03333928|589660943|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
163260026|NCT00728962|589660944|FG000|Implant Placement Surgery|Adverse Event|8|||
163260027|NCT00728962|589660944|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
163260028|NCT00728962|589660944|FG000|Implant Placement Surgery|Protocol Violation|1|||
163260029|NCT00728962|589660944|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
163260030|NCT00728962|589660944|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
163260031|NCT04954586|589660945|FG000|Overall Study|Withdrawal by Subject|5|||
163260032|NCT01987817|589660957|FG000|Overall Study|Adverse Event|4|||
163260033|NCT01987817|589660958|FG001|Overall Study|Adverse Event|0|||
163260034|NCT01987817|589660957|FG000|Overall Study|Withdrawal by Subject|1|||
163260035|NCT01987817|589660958|FG001|Overall Study|Withdrawal by Subject|1|||
163260036|NCT01987817|589660957|FG000|Overall Study|Physician Decision|1|||
163260037|NCT01987817|589660958|FG001|Overall Study|Physician Decision|0|||
163260038|NCT05918978|589660963|FG000|Overall Study|Study Terminated by Sponsor|17|||
163260039|NCT05918978|589660964|FG001|Overall Study|Study Terminated by Sponsor|11|||
163260040|NCT05918978|589660963|FG000|Overall Study|Withdrawal by Subject|1|||
163260041|NCT05918978|589660964|FG001|Overall Study|Withdrawal by Subject|1|||
163260042|NCT05918978|589660963|FG000|Overall Study|Adverse Event|1|||
163260043|NCT05918978|589660964|FG001|Overall Study|Adverse Event|0|||
163260044|NCT05918978|589660963|FG000|Overall Study|Other|0|||
163260045|NCT05918978|589660964|FG001|Overall Study|Other|1|||
163260046|NCT00622180|589660965|FG000|Overall Study|Lost to Follow-up|1|||
163260047|NCT00622180|589660966|FG001|Overall Study|Lost to Follow-up|2|||
163260048|NCT00698646|589660969|FG000|Overall Study|Adverse Event|8|||
163260049|NCT00698646|589660970|FG001|Overall Study|Adverse Event|7|||
163260050|NCT00698646|589660971|FG002|Overall Study|Adverse Event|8|||
163260051|NCT00698646|589660969|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
163260052|NCT00698646|589660970|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
163260053|NCT00698646|589660971|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
163260054|NCT00698646|589660969|FG000|Overall Study|Protocol Deviation|6|||
163260055|NCT00698646|589660970|FG001|Overall Study|Protocol Deviation|2|||
163260056|NCT00698646|589660971|FG002|Overall Study|Protocol Deviation|3|||
163260057|NCT00698646|589660969|FG000|Overall Study|Withdrawal by Subject|10|||
163260058|NCT00698646|589660970|FG001|Overall Study|Withdrawal by Subject|11|||
163260059|NCT00698646|589660971|FG002|Overall Study|Withdrawal by Subject|8|||
163260060|NCT00698646|589660969|FG000|Overall Study|Lost to Follow-up|0|||
163260061|NCT00698646|589660970|FG001|Overall Study|Lost to Follow-up|0|||
163260062|NCT00698646|589660971|FG002|Overall Study|Lost to Follow-up|2|||
163260063|NCT00698646|589660969|FG000|Overall Study|Administrative problems|1|||
163260064|NCT00698646|589660970|FG001|Overall Study|Administrative problems|0|||
163260065|NCT00698646|589660971|FG002|Overall Study|Administrative problems|1|||
163260066|NCT00279201|589660974|FG000|Initiation|Death|1|||
163260067|NCT00279201|589660975|FG001|Initiation|Death|5|||
163260068|NCT00279201|589660976|FG002|Initiation|Death|0|||
163260069|NCT00279201|589660977|FG003|Initiation|Death|0|||
163260070|NCT00279201|589660978|FG004|Initiation|Death|0|||
163260071|NCT00279201|589660979|FG005|Initiation|Death|0|||
163260072|NCT00279201|589660974|FG000|Initiation|Adverse Event|6|||
163260073|NCT00279201|589660975|FG001|Initiation|Adverse Event|15|||
163260074|NCT00279201|589660976|FG002|Initiation|Adverse Event|0|||
163260075|NCT00279201|589660977|FG003|Initiation|Adverse Event|0|||
163260076|NCT00279201|589660978|FG004|Initiation|Adverse Event|0|||
163260077|NCT00279201|589660979|FG005|Initiation|Adverse Event|0|||
163260078|NCT00279201|589660974|FG000|Initiation|Lost to Follow-up|42|||
163260079|NCT00279201|589660975|FG001|Initiation|Lost to Follow-up|41|||
163260080|NCT00279201|589660976|FG002|Initiation|Lost to Follow-up|0|||
163260081|NCT00279201|589660977|FG003|Initiation|Lost to Follow-up|0|||
163260082|NCT00279201|589660978|FG004|Initiation|Lost to Follow-up|0|||
163260083|NCT00279201|589660979|FG005|Initiation|Lost to Follow-up|0|||
163260084|NCT00279201|589660974|FG000|Initiation|Entry Criteria Exclusion|7|||
163260085|NCT00279201|589660975|FG001|Initiation|Entry Criteria Exclusion|9|||
163260086|NCT00279201|589660976|FG002|Initiation|Entry Criteria Exclusion|0|||
163260087|NCT00279201|589660977|FG003|Initiation|Entry Criteria Exclusion|0|||
163260088|NCT00279201|589660978|FG004|Initiation|Entry Criteria Exclusion|0|||
163260089|NCT00279201|589660979|FG005|Initiation|Entry Criteria Exclusion|0|||
163260090|NCT00279201|589660974|FG000|Initiation|Protocol Violation|9|||
163260091|NCT00279201|589660975|FG001|Initiation|Protocol Violation|10|||
163260092|NCT00279201|589660976|FG002|Initiation|Protocol Violation|0|||
163260093|NCT00279201|589660977|FG003|Initiation|Protocol Violation|0|||
163260094|NCT00279201|589660978|FG004|Initiation|Protocol Violation|0|||
163260095|NCT00279201|589660979|FG005|Initiation|Protocol Violation|0|||
163260096|NCT00279201|589660974|FG000|Initiation|Withdrawal by Subject|35|||
163260097|NCT00279201|589660975|FG001|Initiation|Withdrawal by Subject|41|||
163260098|NCT00279201|589660976|FG002|Initiation|Withdrawal by Subject|0|||
163260099|NCT00279201|589660977|FG003|Initiation|Withdrawal by Subject|0|||
163260100|NCT00279201|589660978|FG004|Initiation|Withdrawal by Subject|0|||
163260101|NCT00279201|589660979|FG005|Initiation|Withdrawal by Subject|0|||
163260102|NCT00279201|589660974|FG000|Initiation|Physician Decision|15|||
163260103|NCT00279201|589660975|FG001|Initiation|Physician Decision|18|||
163260104|NCT00279201|589660976|FG002|Initiation|Physician Decision|0|||
163260105|NCT00279201|589660977|FG003|Initiation|Physician Decision|0|||
163260106|NCT00279201|589660978|FG004|Initiation|Physician Decision|0|||
163260107|NCT00279201|589660979|FG005|Initiation|Physician Decision|0|||
163260108|NCT00279201|589660974|FG000|Initiation|Sponsor Decision|13|||
163260109|NCT00279201|589660975|FG001|Initiation|Sponsor Decision|5|||
163260110|NCT00279201|589660976|FG002|Initiation|Sponsor Decision|0|||
163260111|NCT00279201|589660977|FG003|Initiation|Sponsor Decision|0|||
163260112|NCT00279201|589660978|FG004|Initiation|Sponsor Decision|0|||
163260113|NCT00279201|589660979|FG005|Initiation|Sponsor Decision|0|||
163260114|NCT00279201|589660974|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
163260115|NCT00279201|589660975|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
163260116|NCT00279201|589660976|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
163260117|NCT00279201|589660977|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
163260118|NCT00279201|589660978|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
163260119|NCT00279201|589660979|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
163260120|NCT00279201|589660974|FG000|Maintenance|Lack of Efficacy|32|||
163260121|NCT00279201|589660975|FG001|Maintenance|Lack of Efficacy|30|||
163260122|NCT00279201|589660976|FG002|Maintenance|Lack of Efficacy|0|||
163260123|NCT00279201|589660977|FG003|Maintenance|Lack of Efficacy|0|||
163260124|NCT00279201|589660978|FG004|Maintenance|Lack of Efficacy|0|||
163260125|NCT00279201|589660979|FG005|Maintenance|Lack of Efficacy|0|||
163260126|NCT00279201|589660974|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
163260127|NCT00279201|589660975|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
163260128|NCT00279201|589660976|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
163260129|NCT00279201|589660977|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
163260130|NCT00279201|589660978|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
163260131|NCT00279201|589660979|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
163260132|NCT00279201|589660974|FG000|Maintenance|Adverse Event|4|||
163260133|NCT00279201|589660975|FG001|Maintenance|Adverse Event|4|||
163260134|NCT00279201|589660976|FG002|Maintenance|Adverse Event|0|||
163260135|NCT00279201|589660977|FG003|Maintenance|Adverse Event|0|||
163260136|NCT00279201|589660978|FG004|Maintenance|Adverse Event|0|||
163260137|NCT00279201|589660979|FG005|Maintenance|Adverse Event|0|||
163260138|NCT00279201|589660974|FG000|Maintenance|Death|4|||
163260139|NCT00279201|589660975|FG001|Maintenance|Death|4|||
163260140|NCT00279201|589660976|FG002|Maintenance|Death|0|||
163260141|NCT00279201|589660977|FG003|Maintenance|Death|0|||
163260142|NCT00279201|589660978|FG004|Maintenance|Death|0|||
163260143|NCT00279201|589660979|FG005|Maintenance|Death|0|||
163361399|NCT00150618|590031709|FG000|Overall Study|Lost to Follow-up|4|||
163361400|NCT00150618|590031710|FG001|Overall Study|Lost to Follow-up|1|||
163361401|NCT00150618|590031711|FG002|Overall Study|Lost to Follow-up|5|||
163361402|NCT00150618|590031712|FG003|Overall Study|Lost to Follow-up|8|||
163260144|NCT00279201|589660974|FG000|Maintenance|Lost to Follow-up|17|||
163260145|NCT00279201|589660975|FG001|Maintenance|Lost to Follow-up|13|||
163260146|NCT00279201|589660976|FG002|Maintenance|Lost to Follow-up|0|||
163260147|NCT00279201|589660977|FG003|Maintenance|Lost to Follow-up|0|||
163260148|NCT00279201|589660978|FG004|Maintenance|Lost to Follow-up|0|||
163260149|NCT00279201|589660979|FG005|Maintenance|Lost to Follow-up|0|||
163260150|NCT00279201|589660974|FG000|Maintenance|Entry Criteria Exclusion|1|||
163260151|NCT00279201|589660975|FG001|Maintenance|Entry Criteria Exclusion|4|||
163260152|NCT00279201|589660976|FG002|Maintenance|Entry Criteria Exclusion|0|||
163361403|NCT00150618|590031713|FG004|Overall Study|Lost to Follow-up|4|||
163260153|NCT00279201|589660977|FG003|Maintenance|Entry Criteria Exclusion|0|||
163260154|NCT00279201|589660978|FG004|Maintenance|Entry Criteria Exclusion|0|||
163260155|NCT00279201|589660979|FG005|Maintenance|Entry Criteria Exclusion|0|||
163260156|NCT00279201|589660974|FG000|Maintenance|Protocol Violation|16|||
163260157|NCT00279201|589660975|FG001|Maintenance|Protocol Violation|24|||
163260158|NCT00279201|589660976|FG002|Maintenance|Protocol Violation|0|||
163260159|NCT00279201|589660977|FG003|Maintenance|Protocol Violation|0|||
163260160|NCT00279201|589660978|FG004|Maintenance|Protocol Violation|0|||
163260161|NCT00279201|589660979|FG005|Maintenance|Protocol Violation|0|||
163260162|NCT00279201|589660974|FG000|Maintenance|Withdrawal by Subject|18|||
163260163|NCT00279201|589660975|FG001|Maintenance|Withdrawal by Subject|18|||
163260164|NCT00279201|589660976|FG002|Maintenance|Withdrawal by Subject|0|||
163260165|NCT00279201|589660977|FG003|Maintenance|Withdrawal by Subject|0|||
163260166|NCT00279201|589660978|FG004|Maintenance|Withdrawal by Subject|0|||
163260167|NCT00279201|589660979|FG005|Maintenance|Withdrawal by Subject|0|||
163260168|NCT00279201|589660974|FG000|Maintenance|Physician Decision|9|||
163260169|NCT00279201|589660975|FG001|Maintenance|Physician Decision|9|||
163260170|NCT00279201|589660976|FG002|Maintenance|Physician Decision|0|||
163260171|NCT00279201|589660977|FG003|Maintenance|Physician Decision|0|||
163260172|NCT00279201|589660978|FG004|Maintenance|Physician Decision|0|||
163260173|NCT00279201|589660979|FG005|Maintenance|Physician Decision|0|||
163260174|NCT00279201|589660974|FG000|Maintenance|Sponsor Decision|4|||
163260175|NCT00279201|589660975|FG001|Maintenance|Sponsor Decision|0|||
163260176|NCT00279201|589660976|FG002|Maintenance|Sponsor Decision|0|||
163260177|NCT00279201|589660977|FG003|Maintenance|Sponsor Decision|0|||
163260178|NCT00279201|589660978|FG004|Maintenance|Sponsor Decision|0|||
163260179|NCT00279201|589660979|FG005|Maintenance|Sponsor Decision|0|||
163260180|NCT00279201|589660974|FG000|Maintenance|HbA1c>7.5%|123|||
163260181|NCT00279201|589660975|FG001|Maintenance|HbA1c>7.5%|126|||
163260182|NCT00279201|589660976|FG002|Maintenance|HbA1c>7.5%|0|||
163260183|NCT00279201|589660977|FG003|Maintenance|HbA1c>7.5%|0|||
163260184|NCT00279201|589660978|FG004|Maintenance|HbA1c>7.5%|0|||
163260185|NCT00279201|589660979|FG005|Maintenance|HbA1c>7.5%|0|||
163260186|NCT00279201|589660974|FG000|Intensification Addendum|Withdrawal by Subject|0|||
163260187|NCT00279201|589660975|FG001|Intensification Addendum|Withdrawal by Subject|0|||
163260188|NCT00279201|589660976|FG002|Intensification Addendum|Withdrawal by Subject|12|||
163260189|NCT00279201|589660977|FG003|Intensification Addendum|Withdrawal by Subject|14|||
163260190|NCT00279201|589660978|FG004|Intensification Addendum|Withdrawal by Subject|9|||
163260191|NCT00279201|589660979|FG005|Intensification Addendum|Withdrawal by Subject|18|||
163260192|NCT00279201|589660974|FG000|Intensification Addendum|Lost to Follow-up|0|||
163260193|NCT00279201|589660975|FG001|Intensification Addendum|Lost to Follow-up|0|||
163260194|NCT00279201|589660976|FG002|Intensification Addendum|Lost to Follow-up|4|||
163260195|NCT00279201|589660977|FG003|Intensification Addendum|Lost to Follow-up|6|||
163260196|NCT00279201|589660978|FG004|Intensification Addendum|Lost to Follow-up|7|||
163260197|NCT00279201|589660979|FG005|Intensification Addendum|Lost to Follow-up|7|||
163260198|NCT00279201|589660974|FG000|Intensification Addendum|Protocol Violation|0|||
163260199|NCT00279201|589660975|FG001|Intensification Addendum|Protocol Violation|0|||
163260200|NCT00279201|589660976|FG002|Intensification Addendum|Protocol Violation|2|||
163260201|NCT00279201|589660977|FG003|Intensification Addendum|Protocol Violation|2|||
163260202|NCT00279201|589660978|FG004|Intensification Addendum|Protocol Violation|6|||
163260203|NCT00279201|589660979|FG005|Intensification Addendum|Protocol Violation|6|||
163260204|NCT00279201|589660974|FG000|Intensification Addendum|Adverse Event|0|||
163260205|NCT00279201|589660975|FG001|Intensification Addendum|Adverse Event|0|||
163260206|NCT00279201|589660976|FG002|Intensification Addendum|Adverse Event|0|||
163260207|NCT00279201|589660977|FG003|Intensification Addendum|Adverse Event|4|||
163260208|NCT00279201|589660978|FG004|Intensification Addendum|Adverse Event|1|||
163260209|NCT00279201|589660979|FG005|Intensification Addendum|Adverse Event|3|||
163260210|NCT00279201|589660974|FG000|Intensification Addendum|Physician Decision|0|||
163260211|NCT00279201|589660975|FG001|Intensification Addendum|Physician Decision|0|||
163260212|NCT00279201|589660976|FG002|Intensification Addendum|Physician Decision|4|||
163260213|NCT00279201|589660977|FG003|Intensification Addendum|Physician Decision|1|||
163260214|NCT00279201|589660978|FG004|Intensification Addendum|Physician Decision|3|||
163260215|NCT00279201|589660979|FG005|Intensification Addendum|Physician Decision|2|||
163260216|NCT00279201|589660974|FG000|Intensification Addendum|Sponsor Decision|0|||
163260217|NCT00279201|589660975|FG001|Intensification Addendum|Sponsor Decision|0|||
163260218|NCT00279201|589660976|FG002|Intensification Addendum|Sponsor Decision|0|||
163260219|NCT00279201|589660977|FG003|Intensification Addendum|Sponsor Decision|0|||
163361404|NCT00150618|590031709|FG000|Overall Study|Protocol Violation|1|||
163260220|NCT00279201|589660978|FG004|Intensification Addendum|Sponsor Decision|1|||
163260221|NCT00279201|589660979|FG005|Intensification Addendum|Sponsor Decision|1|||
163260222|NCT00279201|589660974|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
163361405|NCT00150618|590031710|FG001|Overall Study|Protocol Violation|0|||
163361406|NCT00150618|590031711|FG002|Overall Study|Protocol Violation|0|||
163260223|NCT00279201|589660975|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
163260224|NCT00279201|589660976|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
163260225|NCT00279201|589660977|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
163260226|NCT00279201|589660978|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
163260227|NCT00279201|589660979|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
163260228|NCT00279201|589660974|FG000|Intensification Addendum|Lack of Efficacy|0|||
163260229|NCT00279201|589660975|FG001|Intensification Addendum|Lack of Efficacy|0|||
163260230|NCT00279201|589660976|FG002|Intensification Addendum|Lack of Efficacy|0|||
163260231|NCT00279201|589660977|FG003|Intensification Addendum|Lack of Efficacy|1|||
163260232|NCT00279201|589660978|FG004|Intensification Addendum|Lack of Efficacy|1|||
163260233|NCT00279201|589660979|FG005|Intensification Addendum|Lack of Efficacy|0|||
163260234|NCT00279201|589660974|FG000|Intensification Addendum|Death|0|||
163260235|NCT00279201|589660975|FG001|Intensification Addendum|Death|0|||
163260236|NCT00279201|589660976|FG002|Intensification Addendum|Death|0|||
163260237|NCT00279201|589660977|FG003|Intensification Addendum|Death|0|||
163260238|NCT00279201|589660978|FG004|Intensification Addendum|Death|1|||
163260239|NCT00279201|589660979|FG005|Intensification Addendum|Death|0|||
163260240|NCT04179721|589660995|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
163260241|NCT04179721|589660996|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
163260242|NCT04179721|589660995|FG000|Overall Study|Lost to Follow-up|0|||
163260243|NCT04179721|589660996|FG001|Overall Study|Lost to Follow-up|1|||
163260244|NCT05559866|589660997|FG000|Overall Study|Withdrawal by Subject|1|||
163260245|NCT05559866|589660998|FG001|Overall Study|Withdrawal by Subject|0|||
163260246|NCT03444376|589661000|FG000|Part A|Disease relapse or Progression|1|||
163260247|NCT03444376|589661000|FG000|Part A|Withdrawal by Subject|2|||
163260248|NCT03444376|589661000|FG000|Part A|Adverse Event|1|||
163260249|NCT03444376|589661000|FG000|Part B|Disease relapse or Progression|18|||
163260250|NCT03444376|589661000|FG000|Part B|Withdrawal by Subject|2|||
163260251|NCT03444376|589661000|FG000|Part B|Adverse Event|2|||
163260252|NCT03444376|589661000|FG000|Part B|Physician Decision|1|||
163260253|NCT03444376|589661000|FG000|Part C|Disease relapse or Progression|43|||
163260254|NCT03444376|589661000|FG000|Part C|Withdrawal by Subject|5|||
163260255|NCT03444376|589661000|FG000|Part C|Adverse Event|2|||
163260256|NCT03444376|589661000|FG000|Part C|Physician Decision|2|||
163260257|NCT03444376|589661000|FG000|Part C|Death|1|||
163260258|NCT00856167|589661002|FG000|Period 1|Withdrawal by Subject|1|||
163260259|NCT00856167|589661003|FG001|Period 1|Withdrawal by Subject|4|||
163260260|NCT00856167|589661004|FG002|Period 1|Withdrawal by Subject|0|||
163260261|NCT00856167|589661005|FG003|Period 1|Withdrawal by Subject|0|||
163260262|NCT00856167|589661002|FG000|Period 1|Lost to Follow-up|2|||
163260263|NCT00856167|589661003|FG001|Period 1|Lost to Follow-up|1|||
163260264|NCT00856167|589661004|FG002|Period 1|Lost to Follow-up|0|||
163260265|NCT00856167|589661005|FG003|Period 1|Lost to Follow-up|0|||
163260266|NCT00856167|589661002|FG000|Period 2|Lost to Follow-up|0|||
163260267|NCT00856167|589661003|FG001|Period 2|Lost to Follow-up|0|||
163260268|NCT00856167|589661004|FG002|Period 2|Lost to Follow-up|3|||
163260269|NCT00856167|589661005|FG003|Period 2|Lost to Follow-up|1|||
163260270|NCT00856167|589661002|FG000|Period 2|Withdrawal by Subject|0|||
163260271|NCT00856167|589661003|FG001|Period 2|Withdrawal by Subject|0|||
163260272|NCT00856167|589661004|FG002|Period 2|Withdrawal by Subject|2|||
163260273|NCT00856167|589661005|FG003|Period 2|Withdrawal by Subject|4|||
163260274|NCT01061333|589661008|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
163260275|NCT01061333|589661009|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
163260276|NCT01186328|589662691|FG000|Overall Study|Death|1|||
163260277|NCT01186328|589662692|FG001|Overall Study|Death|0|||
163260278|NCT01186328|589662693|FG002|Overall Study|Death|0|||
163260279|NCT02243202|589662698|FG000|Overall Study|Adverse Event|5|||
163260280|NCT02243202|589662699|FG001|Overall Study|Adverse Event|6|||
163260281|NCT02243202|589662700|FG002|Overall Study|Adverse Event|10|||
163260282|NCT02243202|589662701|FG003|Overall Study|Adverse Event|4|||
163260283|NCT02243202|589662698|FG000|Overall Study|Lost to Follow-up|9|||
163260284|NCT02243202|589662699|FG001|Overall Study|Lost to Follow-up|9|||
163260285|NCT02243202|589662700|FG002|Overall Study|Lost to Follow-up|14|||
163260286|NCT02243202|589662701|FG003|Overall Study|Lost to Follow-up|11|||
163260287|NCT02243202|589662698|FG000|Overall Study|Protocol Violation|3|||
163260288|NCT02243202|589662699|FG001|Overall Study|Protocol Violation|1|||
163260289|NCT02243202|589662700|FG002|Overall Study|Protocol Violation|2|||
163260290|NCT02243202|589662701|FG003|Overall Study|Protocol Violation|1|||
163260291|NCT02243202|589662698|FG000|Overall Study|Withdrawal by Subject|7|||
163260292|NCT02243202|589662699|FG001|Overall Study|Withdrawal by Subject|6|||
163260293|NCT02243202|589662700|FG002|Overall Study|Withdrawal by Subject|4|||
163260294|NCT02243202|589662701|FG003|Overall Study|Withdrawal by Subject|4|||
163260295|NCT02243202|589662698|FG000|Overall Study|Other|1|||
163260296|NCT02243202|589662699|FG001|Overall Study|Other|3|||
163361407|NCT00150618|590031712|FG003|Overall Study|Protocol Violation|0|||
163361408|NCT00150618|590031713|FG004|Overall Study|Protocol Violation|1|||
163260297|NCT02243202|589662700|FG002|Overall Study|Other|1|||
163361409|NCT00150618|590031709|FG000|Overall Study|Lack of Efficacy|1|||
163361410|NCT00150618|590031710|FG001|Overall Study|Lack of Efficacy|4|||
163260298|NCT02243202|589662701|FG003|Overall Study|Other|2|||
163260299|NCT02243202|589662698|FG000|Overall Study|Randomized but not received treatment|0|||
163260300|NCT02243202|589662699|FG001|Overall Study|Randomized but not received treatment|0|||
163260301|NCT02243202|589662700|FG002|Overall Study|Randomized but not received treatment|0|||
163361411|NCT00150618|590031711|FG002|Overall Study|Lack of Efficacy|7|||
163361412|NCT00150618|590031712|FG003|Overall Study|Lack of Efficacy|4|||
163260302|NCT02243202|589662701|FG003|Overall Study|Randomized but not received treatment|1|||
163361413|NCT00150618|590031713|FG004|Overall Study|Lack of Efficacy|6|||
163260303|NCT00871403|589662702|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
163260304|NCT00871403|589662703|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
163260305|NCT00871403|589662704|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
163260306|NCT00871403|589662702|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
163260307|NCT00871403|589662703|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
163260308|NCT00871403|589662704|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
163260309|NCT00871403|589662702|FG000|Combination Treatment Phase|Adverse Event|0|||
163260310|NCT00871403|589662703|FG001|Combination Treatment Phase|Adverse Event|17|||
163260311|NCT00871403|589662704|FG002|Combination Treatment Phase|Adverse Event|2|||
163260312|NCT00871403|589662702|FG000|Combination Treatment Phase|Disease Progression|0|||
163260313|NCT00871403|589662703|FG001|Combination Treatment Phase|Disease Progression|8|||
163260314|NCT00871403|589662704|FG002|Combination Treatment Phase|Disease Progression|5|||
163260315|NCT00871403|589662702|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
163260316|NCT00871403|589662703|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
163260317|NCT00871403|589662704|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
163260318|NCT00871403|589662702|FG000|Combination Treatment Phase|Physician Decision|0|||
163260319|NCT00871403|589662703|FG001|Combination Treatment Phase|Physician Decision|1|||
163260320|NCT00871403|589662704|FG002|Combination Treatment Phase|Physician Decision|3|||
163260321|NCT00871403|589662702|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
163260322|NCT00871403|589662703|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
163260323|NCT00871403|589662704|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
163260324|NCT00871403|589662702|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
163260325|NCT00871403|589662703|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
163260326|NCT00871403|589662704|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
163260327|NCT03170375|589662707|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
163260328|NCT03170375|589662708|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
163260329|NCT03170375|589662709|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
163260330|NCT03170375|589662707|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
163260331|NCT03170375|589662708|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
163260332|NCT03170375|589662709|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
163260333|NCT02007434|589662710|FG000|Overall Study|Lost to Follow-up|0|||
163260334|NCT02007434|589662711|FG001|Overall Study|Lost to Follow-up|1|||
163260335|NCT02007434|589662712|FG002|Overall Study|Lost to Follow-up|0|||
163260336|NCT02007434|589662713|FG003|Overall Study|Lost to Follow-up|0|||
163260337|NCT02007434|589662714|FG004|Overall Study|Lost to Follow-up|0|||
163260338|NCT02007434|589662715|FG005|Overall Study|Lost to Follow-up|0|||
163260339|NCT02007434|589662716|FG006|Overall Study|Lost to Follow-up|0|||
163260340|NCT02007434|589662717|FG007|Overall Study|Lost to Follow-up|0|||
163260341|NCT02007434|589662710|FG000|Overall Study|Non-compliance|1|||
163260342|NCT02007434|589662711|FG001|Overall Study|Non-compliance|0|||
163260343|NCT02007434|589662712|FG002|Overall Study|Non-compliance|1|||
163260344|NCT02007434|589662713|FG003|Overall Study|Non-compliance|0|||
163260345|NCT02007434|589662714|FG004|Overall Study|Non-compliance|0|||
163260346|NCT02007434|589662715|FG005|Overall Study|Non-compliance|0|||
163260347|NCT02007434|589662716|FG006|Overall Study|Non-compliance|0|||
163260348|NCT02007434|589662717|FG007|Overall Study|Non-compliance|0|||
163260349|NCT00763958|589662718|FG000|Overall Study|did not meet final criteria|4|||
163260350|NCT00763958|589662719|FG001|Overall Study|did not meet final criteria|4|||
163260351|NCT00763958|589662718|FG000|Overall Study|Lost to Follow-up|10|||
163260352|NCT00763958|589662719|FG001|Overall Study|Lost to Follow-up|2|||
163260353|NCT00763958|589662718|FG000|Overall Study|Believed they were receiving placebo|0|||
163260354|NCT00763958|589662719|FG001|Overall Study|Believed they were receiving placebo|5|||
163260355|NCT01691521|589662720|FG000|Overall Study|Adverse Event|4|||
163260356|NCT01691521|589662721|FG001|Overall Study|Adverse Event|0|||
163260357|NCT01691521|589662722|FG002|Overall Study|Adverse Event|1|||
163260358|NCT01691521|589662720|FG000|Overall Study|Lack of Efficacy|1|||
163260359|NCT01691521|589662721|FG001|Overall Study|Lack of Efficacy|1|||
163260360|NCT01691521|589662722|FG002|Overall Study|Lack of Efficacy|2|||
163260361|NCT01691521|589662720|FG000|Overall Study|Protocol Violation|0|||
163260362|NCT01691521|589662721|FG001|Overall Study|Protocol Violation|3|||
163260363|NCT01691521|589662722|FG002|Overall Study|Protocol Violation|0|||
163260364|NCT01691521|589662720|FG000|Overall Study|Lost to Follow-up|0|||
163260365|NCT01691521|589662721|FG001|Overall Study|Lost to Follow-up|2|||
163260366|NCT01691521|589662722|FG002|Overall Study|Lost to Follow-up|2|||
163260367|NCT01691521|589662720|FG000|Overall Study|Physician Decision|2|||
163260368|NCT01691521|589662721|FG001|Overall Study|Physician Decision|1|||
163260369|NCT01691521|589662722|FG002|Overall Study|Physician Decision|0|||
163260370|NCT01691521|589662720|FG000|Overall Study|Withdrawal by Subject|5|||
163260371|NCT01691521|589662721|FG001|Overall Study|Withdrawal by Subject|9|||
163260372|NCT01691521|589662722|FG002|Overall Study|Withdrawal by Subject|4|||
163260373|NCT02343003|589662723|FG000|Overall Study|Withdrawal by Subject|9|||
163260374|NCT02343003|589662724|FG001|Overall Study|Withdrawal by Subject|4|||
163260375|NCT02343003|589662723|FG000|Overall Study|Lost to Follow-up|5|||
163260376|NCT02343003|589662724|FG001|Overall Study|Lost to Follow-up|1|||
163260377|NCT02343003|589662723|FG000|Overall Study|Protocol Violation|1|||
163260378|NCT02343003|589662724|FG001|Overall Study|Protocol Violation|0|||
163260379|NCT02343003|589662723|FG000|Overall Study|Death|0|||
163260380|NCT02343003|589662724|FG001|Overall Study|Death|1|||
163260381|NCT02343003|589662723|FG000|Overall Study|exclusion criteria met|1|||
163260382|NCT02343003|589662724|FG001|Overall Study|exclusion criteria met|1|||
163260383|NCT02343003|589662723|FG000|Overall Study|terminated by sponsor|2|||
163260384|NCT02343003|589662724|FG001|Overall Study|terminated by sponsor|0|||
163260385|NCT00954733|589662729|FG000|Overall Study|blood gas machine did not work|1|||
163260386|NCT00622713|589662730|FG000|Overall Study|Adverse Event|35|||
163260387|NCT00622713|589662730|FG000|Overall Study|Administrative problems|4|||
163260388|NCT00622713|589662730|FG000|Overall Study|Withdrawal by Subject|11|||
163260389|NCT00622713|589662730|FG000|Overall Study|Lost to Follow-up|5|||
163260390|NCT00622713|589662730|FG000|Overall Study|Death|2|||
163260391|NCT00622713|589662730|FG000|Overall Study|Subject no longer required study drug|1|||
163260392|NCT00622713|589662730|FG000|Overall Study|Did not meet eligibility criteria|1|||
163260393|NCT04404478|589662731|FG000|Overall Study|Withdrawal by Subject|1|||
163260394|NCT04404478|589662732|FG001|Overall Study|Withdrawal by Subject|3|||
163260395|NCT00879996|589662742|FG000|Overall Study|Lost to Follow-up|7|||
163260396|NCT00879996|589662743|FG001|Overall Study|Lost to Follow-up|6|||
163260397|NCT00879996|589662742|FG000|Overall Study|non-compliance|6|||
163260398|NCT00879996|589662743|FG001|Overall Study|non-compliance|4|||
163260399|NCT00879996|589662742|FG000|Overall Study|Physician Decision|1|||
163260400|NCT00879996|589662743|FG001|Overall Study|Physician Decision|2|||
163260401|NCT00879996|589662742|FG000|Overall Study|psychiatric problem|0|||
163260402|NCT00879996|589662743|FG001|Overall Study|psychiatric problem|1|||
163260403|NCT00879996|589662742|FG000|Overall Study|put on parole|1|||
163260404|NCT00879996|589662743|FG001|Overall Study|put on parole|0|||
163260405|NCT01148862|589662748|FG000|Second Intervention|Withdrawal by Subject|0|||
163260406|NCT01148862|589662749|FG001|Second Intervention|Withdrawal by Subject|2|||
163260407|NCT03056534|589662750|FG000|Overall Study|Participant withdrew consent|8|||
163260408|NCT03056534|589662750|FG000|Overall Study|Participant not able to return|6|||
163260409|NCT03056534|589662750|FG000|Overall Study|Lost to Follow-up|37|||
163260410|NCT03056534|589662750|FG000|Overall Study|Investigator judgment|1|||
163260411|NCT03056534|589662750|FG000|Overall Study|Death|4|||
163260412|NCT03056534|589662750|FG000|Overall Study|Adverse Event|1|||
163260413|NCT03056534|589662750|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
163260414|NCT04543188|589662751|FG000|Phase 1a|Adverse Event|0|||
163260415|NCT04543188|589662752|FG001|Phase 1a|Adverse Event|0|||
163260416|NCT04543188|589662753|FG002|Phase 1a|Adverse Event|0|||
163260417|NCT04543188|589662754|FG003|Phase 1a|Adverse Event|1|||
163260418|NCT04543188|589662755|FG004|Phase 1a|Adverse Event|0|||
163260419|NCT04543188|589662756|FG005|Phase 1a|Adverse Event|0|||
163260420|NCT04543188|589662757|FG006|Phase 1a|Adverse Event|1|||
163260421|NCT04543188|589662758|FG007|Phase 1a|Adverse Event|0|||
163260422|NCT04543188|589662759|FG008|Phase 1a|Adverse Event|0|||
163260423|NCT04543188|589662760|FG009|Phase 1a|Adverse Event|0|||
163260424|NCT04543188|589662761|FG010|Phase 1a|Adverse Event|0|||
163260425|NCT04543188|589662762|FG011|Phase 1a|Adverse Event|0|||
163260426|NCT04543188|589662763|FG012|Phase 1a|Adverse Event|0|||
163260427|NCT04543188|589662764|FG013|Phase 1a|Adverse Event|0|||
163260428|NCT04543188|589662765|FG014|Phase 1a|Adverse Event|0|||
163260429|NCT04543188|589662751|FG000|Phase 1a|Other (Death)|0|||
163260430|NCT04543188|589662752|FG001|Phase 1a|Other (Death)|1|||
163260431|NCT04543188|589662753|FG002|Phase 1a|Other (Death)|0|||
163260432|NCT04543188|589662754|FG003|Phase 1a|Other (Death)|0|||
163260433|NCT04543188|589662755|FG004|Phase 1a|Other (Death)|1|||
163260434|NCT04543188|589662756|FG005|Phase 1a|Other (Death)|0|||
163260435|NCT04543188|589662757|FG006|Phase 1a|Other (Death)|0|||
163260436|NCT04543188|589662758|FG007|Phase 1a|Other (Death)|0|||
163260437|NCT04543188|589662759|FG008|Phase 1a|Other (Death)|0|||
163260438|NCT04543188|589662760|FG009|Phase 1a|Other (Death)|1|||
163260439|NCT04543188|589662761|FG010|Phase 1a|Other (Death)|0|||
163260440|NCT04543188|589662762|FG011|Phase 1a|Other (Death)|0|||
163361414|NCT00150618|590031709|FG000|Overall Study|No study meds|0|||
163361415|NCT00150618|590031710|FG001|Overall Study|No study meds|0|||
163361416|NCT00150618|590031711|FG002|Overall Study|No study meds|0|||
163361417|NCT00150618|590031712|FG003|Overall Study|No study meds|0|||
163260441|NCT04543188|589662763|FG012|Phase 1a|Other (Death)|0|||
163260442|NCT04543188|589662764|FG013|Phase 1a|Other (Death)|0|||
163260443|NCT04543188|589662765|FG014|Phase 1a|Other (Death)|0|||
163260444|NCT04543188|589662751|FG000|Phase 1a|Lost to Follow-up|0|||
163260445|NCT04543188|589662752|FG001|Phase 1a|Lost to Follow-up|0|||
163260446|NCT04543188|589662753|FG002|Phase 1a|Lost to Follow-up|0|||
163260447|NCT04543188|589662754|FG003|Phase 1a|Lost to Follow-up|0|||
163260448|NCT04543188|589662755|FG004|Phase 1a|Lost to Follow-up|0|||
163361418|NCT00150618|590031713|FG004|Overall Study|No study meds|2|||
163260449|NCT04543188|589662756|FG005|Phase 1a|Lost to Follow-up|0|||
163361419|NCT00150618|590031709|FG000|Overall Study|Physician Decision|0|||
163260450|NCT04543188|589662757|FG006|Phase 1a|Lost to Follow-up|0|||
163260451|NCT04543188|589662758|FG007|Phase 1a|Lost to Follow-up|0|||
163260452|NCT04543188|589662759|FG008|Phase 1a|Lost to Follow-up|0|||
163260453|NCT04543188|589662760|FG009|Phase 1a|Lost to Follow-up|0|||
163260454|NCT04543188|589662761|FG010|Phase 1a|Lost to Follow-up|1|||
163361420|NCT00150618|590031710|FG001|Overall Study|Physician Decision|2|||
163260455|NCT04543188|589662762|FG011|Phase 1a|Lost to Follow-up|0|||
163260456|NCT04543188|589662763|FG012|Phase 1a|Lost to Follow-up|0|||
163260457|NCT04543188|589662764|FG013|Phase 1a|Lost to Follow-up|0|||
163260458|NCT04543188|589662765|FG014|Phase 1a|Lost to Follow-up|0|||
163260459|NCT04543188|589662751|FG000|Phase 1a|Progressive Disease|2|||
163260460|NCT04543188|589662752|FG001|Phase 1a|Progressive Disease|2|||
163260461|NCT04543188|589662753|FG002|Phase 1a|Progressive Disease|3|||
163260462|NCT04543188|589662754|FG003|Phase 1a|Progressive Disease|1|||
163260463|NCT04543188|589662755|FG004|Phase 1a|Progressive Disease|4|||
163260464|NCT04543188|589662756|FG005|Phase 1a|Progressive Disease|2|||
163260465|NCT04543188|589662757|FG006|Phase 1a|Progressive Disease|3|||
163260466|NCT04543188|589662758|FG007|Phase 1a|Progressive Disease|4|||
163260467|NCT04543188|589662759|FG008|Phase 1a|Progressive Disease|1|||
163260468|NCT04543188|589662760|FG009|Phase 1a|Progressive Disease|0|||
163260469|NCT04543188|589662761|FG010|Phase 1a|Progressive Disease|4|||
163260470|NCT04543188|589662762|FG011|Phase 1a|Progressive Disease|0|||
163260471|NCT04543188|589662763|FG012|Phase 1a|Progressive Disease|0|||
163260472|NCT04543188|589662764|FG013|Phase 1a|Progressive Disease|0|||
163260473|NCT04543188|589662765|FG014|Phase 1a|Progressive Disease|0|||
163260474|NCT04543188|589662751|FG000|Phase 1a|Study terminated by sponsor|0|||
163260475|NCT04543188|589662752|FG001|Phase 1a|Study terminated by sponsor|0|||
163260476|NCT04543188|589662753|FG002|Phase 1a|Study terminated by sponsor|0|||
163260477|NCT04543188|589662754|FG003|Phase 1a|Study terminated by sponsor|0|||
163260478|NCT04543188|589662755|FG004|Phase 1a|Study terminated by sponsor|1|||
163260479|NCT04543188|589662756|FG005|Phase 1a|Study terminated by sponsor|0|||
163260480|NCT04543188|589662757|FG006|Phase 1a|Study terminated by sponsor|0|||
163260481|NCT04543188|589662758|FG007|Phase 1a|Study terminated by sponsor|0|||
163260482|NCT04543188|589662759|FG008|Phase 1a|Study terminated by sponsor|0|||
163260483|NCT04543188|589662760|FG009|Phase 1a|Study terminated by sponsor|0|||
163260484|NCT04543188|589662761|FG010|Phase 1a|Study terminated by sponsor|1|||
163260485|NCT04543188|589662762|FG011|Phase 1a|Study terminated by sponsor|0|||
163361421|NCT00150618|590031711|FG002|Overall Study|Physician Decision|0|||
163361422|NCT00150618|590031712|FG003|Overall Study|Physician Decision|0|||
163361423|NCT00150618|590031713|FG004|Overall Study|Physician Decision|1|||
163361424|NCT00150618|590031709|FG000|Overall Study|Lack of compliance|2|||
163361425|NCT00150618|590031710|FG001|Overall Study|Lack of compliance|1|||
163361426|NCT00150618|590031711|FG002|Overall Study|Lack of compliance|1|||
163361427|NCT00150618|590031712|FG003|Overall Study|Lack of compliance|0|||
163361428|NCT00150618|590031713|FG004|Overall Study|Lack of compliance|1|||
163361429|NCT00150618|590031709|FG000|Overall Study|Abnormal ECG|1|||
163361430|NCT00150618|590031710|FG001|Overall Study|Abnormal ECG|0|||
163361431|NCT00150618|590031711|FG002|Overall Study|Abnormal ECG|0|||
163361432|NCT00150618|590031712|FG003|Overall Study|Abnormal ECG|0|||
163361433|NCT00150618|590031713|FG004|Overall Study|Abnormal ECG|0|||
163361434|NCT00150618|590031709|FG000|Overall Study|Sponsor's decision|0|||
163361435|NCT00150618|590031710|FG001|Overall Study|Sponsor's decision|0|||
163361436|NCT00150618|590031711|FG002|Overall Study|Sponsor's decision|0|||
163361437|NCT00150618|590031712|FG003|Overall Study|Sponsor's decision|1|||
163361438|NCT00150618|590031713|FG004|Overall Study|Sponsor's decision|0|||
163361439|NCT01162486|590031714|FG000|Overall Study|low ANC|1|||
163361440|NCT01162486|590031715|FG001|Overall Study|low ANC|0|||
163361441|NCT01162486|590031716|FG002|Overall Study|low ANC|0|||
163361442|NCT01162486|590031717|FG003|Overall Study|low ANC|0|||
163361443|NCT01162486|590031718|FG004|Overall Study|low ANC|0|||
163361444|NCT01162486|590031714|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
163361445|NCT01162486|590031715|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
163361446|NCT01162486|590031716|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
163361447|NCT01162486|590031717|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
163361448|NCT01162486|590031718|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
163361449|NCT01162486|590031714|FG000|Overall Study|elevated LFTs|0|||
163361450|NCT01162486|590031715|FG001|Overall Study|elevated LFTs|0|||
163361451|NCT01162486|590031716|FG002|Overall Study|elevated LFTs|1|||
163361452|NCT01162486|590031717|FG003|Overall Study|elevated LFTs|0|||
163361453|NCT01162486|590031718|FG004|Overall Study|elevated LFTs|0|||
163361454|NCT01162486|590031714|FG000|Overall Study|Pregnancy|0|||
163260486|NCT04543188|589662763|FG012|Phase 1a|Study terminated by sponsor|0|||
163260487|NCT04543188|589662764|FG013|Phase 1a|Study terminated by sponsor|0|||
163260488|NCT04543188|589662765|FG014|Phase 1a|Study terminated by sponsor|0|||
163260489|NCT04543188|589662751|FG000|Phase 1a|Withdrawal by Subject|0|||
163260490|NCT04543188|589662752|FG001|Phase 1a|Withdrawal by Subject|0|||
163260491|NCT04543188|589662753|FG002|Phase 1a|Withdrawal by Subject|0|||
163260492|NCT04543188|589662754|FG003|Phase 1a|Withdrawal by Subject|0|||
163361455|NCT01162486|590031715|FG001|Overall Study|Pregnancy|0|||
163361456|NCT01162486|590031716|FG002|Overall Study|Pregnancy|0|||
163361457|NCT01162486|590031717|FG003|Overall Study|Pregnancy|1|||
163361458|NCT01162486|590031718|FG004|Overall Study|Pregnancy|0|||
163260493|NCT04543188|589662755|FG004|Phase 1a|Withdrawal by Subject|3|||
163260494|NCT04543188|589662756|FG005|Phase 1a|Withdrawal by Subject|0|||
163260495|NCT04543188|589662757|FG006|Phase 1a|Withdrawal by Subject|0|||
163411159|NCT00852995|590212998|FG002|Overall Study|Progressive Disease|0|||
163260496|NCT04543188|589662758|FG007|Phase 1a|Withdrawal by Subject|0|||
163260497|NCT04543188|589662759|FG008|Phase 1a|Withdrawal by Subject|1|||
163260498|NCT04543188|589662760|FG009|Phase 1a|Withdrawal by Subject|1|||
163260499|NCT04543188|589662761|FG010|Phase 1a|Withdrawal by Subject|2|||
163260500|NCT04543188|589662762|FG011|Phase 1a|Withdrawal by Subject|0|||
163260501|NCT04543188|589662763|FG012|Phase 1a|Withdrawal by Subject|0|||
163260502|NCT04543188|589662764|FG013|Phase 1a|Withdrawal by Subject|0|||
163260503|NCT04543188|589662765|FG014|Phase 1a|Withdrawal by Subject|0|||
163260504|NCT04543188|589662751|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
163260505|NCT04543188|589662752|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
163260506|NCT04543188|589662753|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
163260507|NCT04543188|589662754|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
163260508|NCT04543188|589662755|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
163260509|NCT04543188|589662756|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
163260510|NCT04543188|589662757|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
163260511|NCT04543188|589662758|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
163260512|NCT04543188|589662759|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
163260513|NCT04543188|589662760|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
163260514|NCT04543188|589662761|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
163260515|NCT04543188|589662762|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
163260516|NCT04543188|589662763|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
163260517|NCT04543188|589662764|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
163260518|NCT04543188|589662765|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
163260519|NCT04543188|589662751|FG000|Phase 1a|Other|0|||
163260520|NCT04543188|589662752|FG001|Phase 1a|Other|0|||
163260521|NCT04543188|589662753|FG002|Phase 1a|Other|0|||
163260522|NCT04543188|589662754|FG003|Phase 1a|Other|0|||
163260523|NCT04543188|589662755|FG004|Phase 1a|Other|0|||
163260524|NCT04543188|589662756|FG005|Phase 1a|Other|0|||
163260525|NCT04543188|589662757|FG006|Phase 1a|Other|0|||
163260526|NCT04543188|589662758|FG007|Phase 1a|Other|0|||
163260527|NCT04543188|589662759|FG008|Phase 1a|Other|0|||
163260528|NCT04543188|589662760|FG009|Phase 1a|Other|1|||
163260529|NCT04543188|589662761|FG010|Phase 1a|Other|0|||
163260530|NCT04543188|589662762|FG011|Phase 1a|Other|0|||
163260531|NCT04543188|589662763|FG012|Phase 1a|Other|0|||
163260532|NCT04543188|589662764|FG013|Phase 1a|Other|0|||
163260533|NCT04543188|589662765|FG014|Phase 1a|Other|0|||
163260534|NCT04543188|589662751|FG000|Phase 1b|Adverse Event|0|||
163260535|NCT04543188|589662752|FG001|Phase 1b|Adverse Event|0|||
163260536|NCT04543188|589662753|FG002|Phase 1b|Adverse Event|0|||
163260537|NCT04543188|589662754|FG003|Phase 1b|Adverse Event|0|||
163260538|NCT04543188|589662755|FG004|Phase 1b|Adverse Event|0|||
163260539|NCT04543188|589662756|FG005|Phase 1b|Adverse Event|0|||
163260540|NCT04543188|589662757|FG006|Phase 1b|Adverse Event|0|||
163260541|NCT04543188|589662758|FG007|Phase 1b|Adverse Event|0|||
163260542|NCT04543188|589662759|FG008|Phase 1b|Adverse Event|0|||
163260543|NCT04543188|589662760|FG009|Phase 1b|Adverse Event|0|||
163260544|NCT04543188|589662761|FG010|Phase 1b|Adverse Event|0|||
163260545|NCT04543188|589662762|FG011|Phase 1b|Adverse Event|0|||
163260546|NCT04543188|589662763|FG012|Phase 1b|Adverse Event|0|||
163260547|NCT04543188|589662764|FG013|Phase 1b|Adverse Event|0|||
163260548|NCT04543188|589662765|FG014|Phase 1b|Adverse Event|2|||
163260549|NCT04543188|589662751|FG000|Phase 1b|Other (Death)|0|||
163260550|NCT04543188|589662752|FG001|Phase 1b|Other (Death)|0|||
163260551|NCT04543188|589662753|FG002|Phase 1b|Other (Death)|0|||
163260552|NCT04543188|589662754|FG003|Phase 1b|Other (Death)|0|||
163260553|NCT04543188|589662755|FG004|Phase 1b|Other (Death)|0|||
163260554|NCT04543188|589662756|FG005|Phase 1b|Other (Death)|0|||
163260555|NCT04543188|589662757|FG006|Phase 1b|Other (Death)|0|||
163260556|NCT04543188|589662758|FG007|Phase 1b|Other (Death)|0|||
163260557|NCT04543188|589662759|FG008|Phase 1b|Other (Death)|0|||
163260558|NCT04543188|589662760|FG009|Phase 1b|Other (Death)|0|||
163260559|NCT04543188|589662761|FG010|Phase 1b|Other (Death)|0|||
163260560|NCT04543188|589662762|FG011|Phase 1b|Other (Death)|0|||
163260561|NCT04543188|589662763|FG012|Phase 1b|Other (Death)|1|||
163260562|NCT04543188|589662764|FG013|Phase 1b|Other (Death)|0|||
163361459|NCT02296892|590031723|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
163260563|NCT04543188|589662765|FG014|Phase 1b|Other (Death)|1|||
163260564|NCT04543188|589662751|FG000|Phase 1b|Progressive Disease|0|||
163361460|NCT02296892|590031724|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
163361461|NCT02296892|590031725|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
163361462|NCT02296892|590031723|FG000|Overall Study|Lost to Follow-up|5|||
163260565|NCT04543188|589662752|FG001|Phase 1b|Progressive Disease|0|||
163260566|NCT04543188|589662753|FG002|Phase 1b|Progressive Disease|0|||
163260567|NCT04543188|589662754|FG003|Phase 1b|Progressive Disease|0|||
163260568|NCT04543188|589662755|FG004|Phase 1b|Progressive Disease|0|||
163260569|NCT04543188|589662756|FG005|Phase 1b|Progressive Disease|0|||
163260570|NCT04543188|589662757|FG006|Phase 1b|Progressive Disease|0|||
163260571|NCT04543188|589662758|FG007|Phase 1b|Progressive Disease|0|||
163260572|NCT04543188|589662759|FG008|Phase 1b|Progressive Disease|0|||
163260573|NCT04543188|589662760|FG009|Phase 1b|Progressive Disease|0|||
163260574|NCT04543188|589662761|FG010|Phase 1b|Progressive Disease|0|||
163260575|NCT04543188|589662762|FG011|Phase 1b|Progressive Disease|0|||
163260576|NCT04543188|589662763|FG012|Phase 1b|Progressive Disease|2|||
163260577|NCT04543188|589662764|FG013|Phase 1b|Progressive Disease|1|||
163260578|NCT04543188|589662765|FG014|Phase 1b|Progressive Disease|5|||
163260579|NCT04543188|589662751|FG000|Phase 1b|Study Terminated By Sponsor|0|||
163260580|NCT04543188|589662752|FG001|Phase 1b|Study Terminated By Sponsor|0|||
163260581|NCT04543188|589662753|FG002|Phase 1b|Study Terminated By Sponsor|0|||
163260582|NCT04543188|589662754|FG003|Phase 1b|Study Terminated By Sponsor|0|||
163260583|NCT04543188|589662755|FG004|Phase 1b|Study Terminated By Sponsor|0|||
163260584|NCT04543188|589662756|FG005|Phase 1b|Study Terminated By Sponsor|0|||
163260585|NCT04543188|589662757|FG006|Phase 1b|Study Terminated By Sponsor|0|||
163260586|NCT04543188|589662758|FG007|Phase 1b|Study Terminated By Sponsor|0|||
163260587|NCT04543188|589662759|FG008|Phase 1b|Study Terminated By Sponsor|0|||
163260588|NCT04543188|589662760|FG009|Phase 1b|Study Terminated By Sponsor|0|||
163260589|NCT04543188|589662761|FG010|Phase 1b|Study Terminated By Sponsor|0|||
163260590|NCT04543188|589662762|FG011|Phase 1b|Study Terminated By Sponsor|1|||
163260591|NCT04543188|589662763|FG012|Phase 1b|Study Terminated By Sponsor|1|||
163260592|NCT04543188|589662764|FG013|Phase 1b|Study Terminated By Sponsor|0|||
163260593|NCT04543188|589662765|FG014|Phase 1b|Study Terminated By Sponsor|1|||
163260594|NCT04543188|589662751|FG000|Phase 1b|Withdrawal by Subject|0|||
163260595|NCT04543188|589662752|FG001|Phase 1b|Withdrawal by Subject|0|||
163260596|NCT04543188|589662753|FG002|Phase 1b|Withdrawal by Subject|0|||
163260597|NCT04543188|589662754|FG003|Phase 1b|Withdrawal by Subject|0|||
163260598|NCT04543188|589662755|FG004|Phase 1b|Withdrawal by Subject|0|||
163260599|NCT04543188|589662756|FG005|Phase 1b|Withdrawal by Subject|0|||
163260600|NCT04543188|589662757|FG006|Phase 1b|Withdrawal by Subject|0|||
163260601|NCT04543188|589662758|FG007|Phase 1b|Withdrawal by Subject|0|||
163260602|NCT04543188|589662759|FG008|Phase 1b|Withdrawal by Subject|0|||
163260603|NCT04543188|589662760|FG009|Phase 1b|Withdrawal by Subject|0|||
163260604|NCT04543188|589662761|FG010|Phase 1b|Withdrawal by Subject|0|||
163260605|NCT04543188|589662762|FG011|Phase 1b|Withdrawal by Subject|0|||
163260606|NCT04543188|589662763|FG012|Phase 1b|Withdrawal by Subject|0|||
163260607|NCT04543188|589662764|FG013|Phase 1b|Withdrawal by Subject|0|||
163260608|NCT04543188|589662765|FG014|Phase 1b|Withdrawal by Subject|2|||
163260609|NCT03815019|589662768|FG000|Overall Study|Withdrawal by Subject|6|||
163260610|NCT03815019|589662769|FG001|Overall Study|Withdrawal by Subject|8|||
163260611|NCT05398796|589662770|FG000|Overall Study|Participant moved from the area|0|||
163260612|NCT05398796|589662771|FG001|Overall Study|Participant moved from the area|1|||
163260613|NCT05398796|589662772|FG002|Overall Study|Participant moved from the area|0|||
163260614|NCT05398796|589662773|FG003|Overall Study|Participant moved from the area|0|||
163260615|NCT04270747|589662775|FG000|Through Week 16|Adverse Event|1|||
163260616|NCT04270747|589662776|FG001|Through Week 16|Adverse Event|2|||
163260617|NCT04270747|589662777|FG002|Through Week 16|Adverse Event|0|||
163260618|NCT04270747|589662775|FG000|Through Week 16|Death|0|||
163260619|NCT04270747|589662776|FG001|Through Week 16|Death|2|||
163260620|NCT04270747|589662777|FG002|Through Week 16|Death|0|||
163260621|NCT04270747|589662775|FG000|Through Week 16|Consent Withdrawn|3|||
163260622|NCT04270747|589662776|FG001|Through Week 16|Consent Withdrawn|3|||
163260623|NCT04270747|589662777|FG002|Through Week 16|Consent Withdrawn|0|||
163260624|NCT04270747|589662775|FG000|Through Week 16|Physician Decision|1|||
163260625|NCT04270747|589662776|FG001|Through Week 16|Physician Decision|1|||
163260626|NCT04270747|589662777|FG002|Through Week 16|Physician Decision|0|||
163260627|NCT04270747|589662775|FG000|Through Week 16|Lost to Follow-up|2|||
163260628|NCT04270747|589662776|FG001|Through Week 16|Lost to Follow-up|0|||
163260629|NCT04270747|589662777|FG002|Through Week 16|Lost to Follow-up|0|||
163260630|NCT04270747|589662775|FG000|Through Week 16|Protocol Violation|1|||
163260631|NCT04270747|589662776|FG001|Through Week 16|Protocol Violation|2|||
163260632|NCT04270747|589662777|FG002|Through Week 16|Protocol Violation|0|||
163260633|NCT04270747|589662775|FG000|Through Week 16|Protocol Specified Criteria|6|||
163260634|NCT04270747|589662776|FG001|Through Week 16|Protocol Specified Criteria|7|||
163260635|NCT04270747|589662777|FG002|Through Week 16|Protocol Specified Criteria|0|||
163260636|NCT04270747|589662775|FG000|Through Week 16|Miscellaneous|1|||
163260637|NCT04270747|589662776|FG001|Through Week 16|Miscellaneous|1|||
163260638|NCT04270747|589662777|FG002|Through Week 16|Miscellaneous|0|||
163260639|NCT04270747|589662775|FG000|Post Week 16|Adverse Event|7|||
163260640|NCT04270747|589662776|FG001|Post Week 16|Adverse Event|5|||
163260641|NCT04270747|589662777|FG002|Post Week 16|Adverse Event|1|||
163260642|NCT04270747|589662775|FG000|Post Week 16|Death|2|||
163260643|NCT04270747|589662776|FG001|Post Week 16|Death|0|||
163260644|NCT04270747|589662777|FG002|Post Week 16|Death|2|||
163260645|NCT04270747|589662775|FG000|Post Week 16|Consent Withdrawn|4|||
163260646|NCT04270747|589662776|FG001|Post Week 16|Consent Withdrawn|3|||
163260647|NCT04270747|589662777|FG002|Post Week 16|Consent Withdrawn|6|||
163260648|NCT04270747|589662775|FG000|Post Week 16|Physician Decision|3|||
163260649|NCT04270747|589662776|FG001|Post Week 16|Physician Decision|1|||
163260650|NCT04270747|589662777|FG002|Post Week 16|Physician Decision|1|||
163260651|NCT04270747|589662775|FG000|Post Week 16|Lost to Follow-up|2|||
163260652|NCT04270747|589662776|FG001|Post Week 16|Lost to Follow-up|1|||
163260653|NCT04270747|589662777|FG002|Post Week 16|Lost to Follow-up|0|||
163260654|NCT04270747|589662775|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
163260655|NCT04270747|589662776|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
163260656|NCT04270747|589662777|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
163260657|NCT04270747|589662775|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
163260658|NCT04270747|589662776|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
163260659|NCT04270747|589662777|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
163260660|NCT04270747|589662775|FG000|Post Week 16|Miscellaneous|1|||
163260661|NCT04270747|589662776|FG001|Post Week 16|Miscellaneous|0|||
163260662|NCT04270747|589662777|FG002|Post Week 16|Miscellaneous|1|||
163260663|NCT05004688|589662778|FG000|Overall Study|Protocol Violation|7|||
163260664|NCT05004688|589662778|FG000|Overall Study|Physician Decision|2|||
163260665|NCT05004688|589662778|FG000|Overall Study|Withdrawal by Subject|2|||
163260666|NCT05960097|589662779|FG000|Overall Study|Lost to Follow-up|3|||
163260667|NCT05960097|589662780|FG001|Overall Study|Lost to Follow-up|1|||
163260668|NCT05960097|589662781|FG002|Overall Study|Lost to Follow-up|1|||
163260669|NCT05960097|589662782|FG003|Overall Study|Lost to Follow-up|2|||
163260670|NCT05960097|589662783|FG004|Overall Study|Lost to Follow-up|1|||
163260671|NCT05960097|589662784|FG005|Overall Study|Lost to Follow-up|1|||
163260672|NCT05960097|589662785|FG006|Overall Study|Lost to Follow-up|2|||
163260673|NCT05960097|589662786|FG007|Overall Study|Lost to Follow-up|3|||
163260674|NCT05960097|589662779|FG000|Overall Study|Physician Decision|0|||
163260675|NCT05960097|589662780|FG001|Overall Study|Physician Decision|0|||
163260676|NCT05960097|589662781|FG002|Overall Study|Physician Decision|0|||
163260677|NCT05960097|589662782|FG003|Overall Study|Physician Decision|0|||
163260678|NCT05960097|589662783|FG004|Overall Study|Physician Decision|0|||
163260679|NCT05960097|589662784|FG005|Overall Study|Physician Decision|0|||
163260680|NCT05960097|589662785|FG006|Overall Study|Physician Decision|1|||
163260681|NCT05960097|589662786|FG007|Overall Study|Physician Decision|0|||
163260682|NCT05960097|589662779|FG000|Overall Study|Withdrawal by Subject|1|||
163260683|NCT05960097|589662780|FG001|Overall Study|Withdrawal by Subject|0|||
163260684|NCT05960097|589662781|FG002|Overall Study|Withdrawal by Subject|0|||
163260685|NCT05960097|589662782|FG003|Overall Study|Withdrawal by Subject|1|||
163260686|NCT05960097|589662783|FG004|Overall Study|Withdrawal by Subject|1|||
163260687|NCT05960097|589662784|FG005|Overall Study|Withdrawal by Subject|0|||
163260688|NCT05960097|589662785|FG006|Overall Study|Withdrawal by Subject|0|||
163260689|NCT05960097|589662786|FG007|Overall Study|Withdrawal by Subject|0|||
163260690|NCT05960097|589662779|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
163260691|NCT05960097|589662780|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
163260692|NCT05960097|589662781|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
163260693|NCT05960097|589662782|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
163260694|NCT05960097|589662783|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
163260695|NCT05960097|589662784|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
163260696|NCT05960097|589662785|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
163260697|NCT05960097|589662786|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
163260698|NCT02134925|589662787|FG000|Overall Study|Withdrawal by Subject|1|||
163260699|NCT02134925|589662788|FG001|Overall Study|Withdrawal by Subject|0|||
163260700|NCT02134925|589662787|FG000|Overall Study|Cancel|1|||
163260701|NCT02134925|589662788|FG001|Overall Study|Cancel|6|||
163260702|NCT02158884|589662789|FG000|Baseline Assessment|Missed performance assessment|3|||
163260703|NCT02158884|589662789|FG000|Baseline Assessment|Missed SMFA|1|||
163260704|NCT02158884|589662789|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
163361463|NCT02296892|590031724|FG001|Overall Study|Lost to Follow-up|0|||
163361464|NCT02296892|590031725|FG002|Overall Study|Lost to Follow-up|1|||
163260705|NCT02158884|589662789|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
163260706|NCT02158884|589662789|FG000|6 Month Assessment|Missed SMFA|20|||
163260707|NCT02158884|589662789|FG000|12 Month Assessment|Missed SMFA|17|||
163260708|NCT05158296|589662790|FG000|Overall Study|Sponsor Decision|2|||
163260709|NCT05158296|589662791|FG001|Overall Study|Sponsor Decision|3|||
163260710|NCT05158296|589662792|FG002|Overall Study|Sponsor Decision|2|||
163260711|NCT01521884|589662795|FG000|Overall Study|Non Responders|10|||
163260712|NCT01521884|589662795|FG000|Overall Study|Adverse Event|5|||
163260713|NCT01521884|589662795|FG000|Overall Study|Pregnancy|1|||
163260714|NCT01521884|589662795|FG000|Overall Study|Withdrawal by Subject|1|||
163260715|NCT01521884|589662795|FG000|Overall Study|Physician Decision|2|||
163260716|NCT01521884|589662795|FG000|Overall Study|Protocol Violation|3|||
163260717|NCT01521884|589662795|FG000|Overall Study|Participant non-eligible|1|||
163260718|NCT01521884|589662795|FG000|Overall Study|Lost to Follow-up|4|||
163260719|NCT04098250|589662796|FG000|Overall Study|Withdrawal by Subject|1|||
163260720|NCT04098250|589662797|FG001|Overall Study|Withdrawal by Subject|0|||
163260721|NCT04098250|589662796|FG000|Overall Study|Lost to Follow-up|0|||
163260722|NCT04098250|589662797|FG001|Overall Study|Lost to Follow-up|1|||
163260723|NCT00633464|589662802|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
163361465|NCT01056263|590031730|FG000|Overall Study|Adverse Event|12|||
163361466|NCT01056263|590031730|FG000|Overall Study|Death|1|||
163152221|NCT02718898|589271428|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
163152222|NCT02718898|589271429|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
163152223|NCT02718898|589271430|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
163152224|NCT02718898|589271431|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
163152225|NCT02718898|589271432|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
163152226|NCT02718898|589271433|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
163152227|NCT02718898|589271427|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
163152228|NCT02718898|589271428|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
163152229|NCT02718898|589271429|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
163152230|NCT02718898|589271430|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
163152231|NCT02718898|589271431|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
163152232|NCT02718898|589271432|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
163152233|NCT02718898|589271433|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
163152234|NCT02718898|589271427|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
163152235|NCT02718898|589271428|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
163152236|NCT02718898|589271429|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
163152237|NCT02718898|589271430|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
163152238|NCT02718898|589271431|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
163152239|NCT02718898|589271432|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
163152240|NCT02718898|589271433|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
163152241|NCT02718898|589271427|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
163152242|NCT02718898|589271428|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
163152243|NCT02718898|589271429|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
163152244|NCT02718898|589271430|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
163152245|NCT02718898|589271431|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
163152246|NCT02718898|589271432|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
163152247|NCT02718898|589271433|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
163152248|NCT02718898|589271427|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152249|NCT02718898|589271428|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152250|NCT02718898|589271429|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
163152251|NCT02718898|589271430|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
163152252|NCT02718898|589271431|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152253|NCT02718898|589271432|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152254|NCT02718898|589271433|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152255|NCT02718898|589271427|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
163152256|NCT02718898|589271428|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
163152257|NCT02718898|589271429|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
163152258|NCT02718898|589271430|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
163152259|NCT02718898|589271431|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
163152260|NCT02718898|589271432|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
163152261|NCT02718898|589271433|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
163152262|NCT02718898|589271427|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
163152263|NCT02718898|589271428|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
163152264|NCT02718898|589271429|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
163152265|NCT02718898|589271430|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
163152266|NCT02718898|589271431|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
163152267|NCT02718898|589271432|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
163152268|NCT02718898|589271433|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
163152269|NCT02718898|589271427|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
163152270|NCT02718898|589271428|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
163152271|NCT02718898|589271429|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
163152272|NCT02718898|589271430|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
163152273|NCT02718898|589271431|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
163152274|NCT02718898|589271432|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
163152275|NCT02718898|589271433|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
163152276|NCT02718898|589271427|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
163152277|NCT02718898|589271428|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
163152278|NCT02718898|589271429|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
163152279|NCT02718898|589271430|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
163152280|NCT02718898|589271431|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
163152281|NCT02718898|589271432|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
163152282|NCT02718898|589271433|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
163152283|NCT02718898|589271427|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
163152284|NCT02718898|589271428|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
163152285|NCT02718898|589271429|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
163152286|NCT02718898|589271430|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
163260724|NCT00633464|589662803|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
163260725|NCT00633464|589662802|FG000|Overall Study|Never Treated (Randomized in error)|0|||
163260726|NCT00633464|589662803|FG001|Overall Study|Never Treated (Randomized in error)|1|||
163260727|NCT04241094|589662805|FG000|Overall Study|Dropped out of treatment|4|||
163260728|NCT04241094|589662805|FG000|Overall Study|Ineligible after clinical assessment|2|||
163260729|NCT04241094|589662805|FG000|Overall Study|Lost to Follow-up|2|||
163260730|NCT02612064|589662806|FG000|Overall Study|Withdrawal by Subject|1|||
163260731|NCT02612064|589662807|FG001|Overall Study|Withdrawal by Subject|1|||
163260732|NCT02612064|589662806|FG000|Overall Study|Other|0|||
163260733|NCT02612064|589662807|FG001|Overall Study|Other|2|||
163260734|NCT06387472|589662808|FG000|Overall Study|Withdrawal by Subject|1|||
163260735|NCT06387472|589662808|FG000|Overall Study|Lost to Follow-up|2|||
163260736|NCT06387472|589662808|FG000|Overall Study|Physician Decision|1|||
163260737|NCT04182880|589662809|FG000|Overall Study|Pregnancy|1|||
163260738|NCT04182880|589662810|FG001|Overall Study|Pregnancy|0|||
163260739|NCT02036645|589662811|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163260740|NCT02036645|589662812|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163361467|NCT01056263|590031730|FG000|Overall Study|Withdrawal by Subject|1|||
163361468|NCT01056263|590031730|FG000|Overall Study|Lack of Efficacy|29|||
163361469|NCT01056263|590031730|FG000|Overall Study|Progressive disease|2|||
163361470|NCT01056263|590031730|FG000|Overall Study|Neoplasm progression|1|||
163361471|NCT01056263|590031730|FG000|Overall Study|Objective progression or relapse|1|||
163361472|NCT01056263|590031730|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
163361473|NCT03375320|590031735|FG000|Overall Study|Adverse Event|34|||
163361474|NCT03375320|590031736|FG001|Overall Study|Adverse Event|9|||
163361475|NCT03375320|590031737|FG002|Overall Study|Adverse Event|10|||
163361476|NCT03375320|590031738|FG003|Overall Study|Adverse Event|0|||
163361477|NCT03375320|590031735|FG000|Overall Study|Death|6|||
163361478|NCT03375320|590031736|FG001|Overall Study|Death|3|||
163361479|NCT03375320|590031737|FG002|Overall Study|Death|0|||
163361480|NCT03375320|590031738|FG003|Overall Study|Death|0|||
163361481|NCT03375320|590031735|FG000|Overall Study|Withdrawal by Subject|7|||
163361482|NCT03375320|590031736|FG001|Overall Study|Withdrawal by Subject|4|||
163361483|NCT03375320|590031737|FG002|Overall Study|Withdrawal by Subject|5|||
163361484|NCT03375320|590031738|FG003|Overall Study|Withdrawal by Subject|4|||
163361485|NCT03375320|590031735|FG000|Overall Study|Progressive disease|55|||
163361486|NCT03375320|590031736|FG001|Overall Study|Progressive disease|41|||
163361487|NCT03375320|590031737|FG002|Overall Study|Progressive disease|29|||
163361488|NCT03375320|590031738|FG003|Overall Study|Progressive disease|24|||
163361489|NCT03375320|590031735|FG000|Overall Study|Alternative treatment|6|||
163361490|NCT03375320|590031736|FG001|Overall Study|Alternative treatment|1|||
163361491|NCT03375320|590031737|FG002|Overall Study|Alternative treatment|1|||
163361492|NCT03375320|590031738|FG003|Overall Study|Alternative treatment|0|||
163361493|NCT03375320|590031735|FG000|Overall Study|Other disease|1|||
163361494|NCT03375320|590031736|FG001|Overall Study|Other disease|1|||
163361495|NCT03375320|590031737|FG002|Overall Study|Other disease|3|||
163361496|NCT03375320|590031738|FG003|Overall Study|Other disease|0|||
163361497|NCT03375320|590031735|FG000|Overall Study|Withdrawal prior to initiation|2|||
163361498|NCT03375320|590031736|FG001|Overall Study|Withdrawal prior to initiation|2|||
163361499|NCT03375320|590031737|FG002|Overall Study|Withdrawal prior to initiation|1|||
163361500|NCT03375320|590031738|FG003|Overall Study|Withdrawal prior to initiation|0|||
163361501|NCT03375320|590031735|FG000|Overall Study|Physician Decision|1|||
163361502|NCT03375320|590031736|FG001|Overall Study|Physician Decision|1|||
163361503|NCT03375320|590031737|FG002|Overall Study|Physician Decision|1|||
163361504|NCT03375320|590031738|FG003|Overall Study|Physician Decision|1|||
163361505|NCT03375320|590031735|FG000|Overall Study|Non-compliance|1|||
163361506|NCT03375320|590031736|FG001|Overall Study|Non-compliance|0|||
163361507|NCT03375320|590031737|FG002|Overall Study|Non-compliance|0|||
163361508|NCT03375320|590031738|FG003|Overall Study|Non-compliance|0|||
163361509|NCT04907357|590031747|FG000|Overall Study|Death|0|||
163361510|NCT04907357|590031748|FG001|Overall Study|Death|1|||
163361511|NCT04907357|590031747|FG000|Overall Study|Lost to Follow-up|9|||
163361512|NCT04907357|590031748|FG001|Overall Study|Lost to Follow-up|18|||
163361513|NCT04907357|590031747|FG000|Overall Study|Physician Decision|1|||
163260741|NCT02036645|589662813|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163260742|NCT02036645|589662814|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163361514|NCT04907357|590031748|FG001|Overall Study|Physician Decision|0|||
163361515|NCT04907357|590031747|FG000|Overall Study|Withdrawal by Subject|0|||
163260743|NCT02036645|589662815|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163361516|NCT04907357|590031748|FG001|Overall Study|Withdrawal by Subject|1|||
163361517|NCT04907357|590031747|FG000|Overall Study|Unable to attend visits|1|||
163361518|NCT04907357|590031748|FG001|Overall Study|Unable to attend visits|0|||
163361519|NCT04907357|590031747|FG000|Overall Study|Incarcerated|1|||
163361520|NCT04907357|590031748|FG001|Overall Study|Incarcerated|1|||
163361521|NCT00365547|590031749|FG000|Overall Study|Insurance did not cover Avastin|1|||
163361522|NCT00365547|590031749|FG000|Overall Study|Screen failure|1|||
163361523|NCT00365547|590031749|FG000|Overall Study|Withdrawal by Subject|1|||
163361524|NCT00546078|590031750|FG000|Overall Study|Lost to Follow-up|1|||
163260744|NCT02036645|589662816|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163260745|NCT02036645|589662817|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
163260746|NCT02036645|589662818|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163260747|NCT02036645|589662819|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163260748|NCT02036645|589662820|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163260749|NCT02036645|589662821|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163260750|NCT02036645|589662822|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163260751|NCT02036645|589662811|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163260752|NCT02036645|589662812|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163260753|NCT02036645|589662813|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163260754|NCT02036645|589662814|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
163260755|NCT02036645|589662815|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163260756|NCT02036645|589662816|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163260757|NCT02036645|589662817|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163260758|NCT02036645|589662818|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163260759|NCT02036645|589662819|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163260760|NCT02036645|589662820|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163260761|NCT02036645|589662821|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163260762|NCT02036645|589662822|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163260763|NCT00717860|589662827|FG000|Overall Study|Clinical adverse experience|5|||
163260764|NCT00717860|589662828|FG001|Overall Study|Clinical adverse experience|9|||
163260765|NCT00717860|589662827|FG000|Overall Study|Laboratory adverse experience|2|||
163260766|NCT00717860|589662828|FG001|Overall Study|Laboratory adverse experience|2|||
163260767|NCT00717860|589662827|FG000|Overall Study|Lack of Efficacy|7|||
163260768|NCT00717860|589662828|FG001|Overall Study|Lack of Efficacy|13|||
163260769|NCT00717860|589662827|FG000|Overall Study|Discontinued for other reason|6|||
163260770|NCT00717860|589662828|FG001|Overall Study|Discontinued for other reason|1|||
163260771|NCT00717860|589662827|FG000|Overall Study|Withdrew consent|7|||
163260772|NCT00717860|589662828|FG001|Overall Study|Withdrew consent|3|||
163260773|NCT00696384|589662829|FG000|Open Label Phase|Adverse Event|27|||
163260774|NCT00696384|589662830|FG001|Open Label Phase|Adverse Event|0|||
163260775|NCT00696384|589662831|FG002|Open Label Phase|Adverse Event|0|||
163260776|NCT00696384|589662829|FG000|Open Label Phase|Protocol Violation|18|||
163260777|NCT00696384|589662830|FG001|Open Label Phase|Protocol Violation|0|||
163260778|NCT00696384|589662831|FG002|Open Label Phase|Protocol Violation|0|||
163260779|NCT00696384|589662829|FG000|Open Label Phase|Lost to Follow-up|24|||
163260780|NCT00696384|589662830|FG001|Open Label Phase|Lost to Follow-up|0|||
163260781|NCT00696384|589662831|FG002|Open Label Phase|Lost to Follow-up|0|||
163260782|NCT00696384|589662829|FG000|Open Label Phase|Withdrawal by Subject|37|||
163260783|NCT00696384|589662830|FG001|Open Label Phase|Withdrawal by Subject|0|||
163260784|NCT00696384|589662831|FG002|Open Label Phase|Withdrawal by Subject|0|||
163260785|NCT00696384|589662829|FG000|Open Label Phase|Other|6|||
163260786|NCT00696384|589662830|FG001|Open Label Phase|Other|0|||
163260787|NCT00696384|589662831|FG002|Open Label Phase|Other|0|||
163260788|NCT00696384|589662829|FG000|Open Label Phase|Lack of Efficacy|3|||
163260789|NCT00696384|589662830|FG001|Open Label Phase|Lack of Efficacy|0|||
163260790|NCT00696384|589662831|FG002|Open Label Phase|Lack of Efficacy|0|||
163260791|NCT00696384|589662829|FG000|Open Label Phase|Physician Decision|4|||
163260792|NCT00696384|589662830|FG001|Open Label Phase|Physician Decision|0|||
163260793|NCT00696384|589662831|FG002|Open Label Phase|Physician Decision|0|||
163260794|NCT00696384|589662829|FG000|Double Blind Phase|Adverse Event|0|||
163260795|NCT00696384|589662830|FG001|Double Blind Phase|Adverse Event|2|||
163260796|NCT00696384|589662831|FG002|Double Blind Phase|Adverse Event|2|||
163260797|NCT00696384|589662829|FG000|Double Blind Phase|Lost to Follow-up|0|||
163260798|NCT00696384|589662830|FG001|Double Blind Phase|Lost to Follow-up|2|||
163260799|NCT00696384|589662831|FG002|Double Blind Phase|Lost to Follow-up|1|||
163260800|NCT00696384|589662829|FG000|Double Blind Phase|Withdrawal by Subject|0|||
163260801|NCT00696384|589662830|FG001|Double Blind Phase|Withdrawal by Subject|4|||
163260802|NCT00696384|589662831|FG002|Double Blind Phase|Withdrawal by Subject|3|||
163361525|NCT00546078|590031751|FG001|Overall Study|Lost to Follow-up|3|||
163361526|NCT00546078|590031750|FG000|Overall Study|Withdrawal by Subject|2|||
163361527|NCT00546078|590031751|FG001|Overall Study|Withdrawal by Subject|3|||
163260803|NCT00696384|589662829|FG000|Double Blind Phase|Lack of Efficacy|0|||
163260804|NCT00696384|589662830|FG001|Double Blind Phase|Lack of Efficacy|1|||
163361528|NCT00546078|590031750|FG000|Overall Study|Other reason|1|||
163260805|NCT00696384|589662831|FG002|Double Blind Phase|Lack of Efficacy|0|||
163260806|NCT00696384|589662829|FG000|Double Blind Phase|Physician Decision|0|||
163260807|NCT00696384|589662830|FG001|Double Blind Phase|Physician Decision|2|||
163260808|NCT00696384|589662831|FG002|Double Blind Phase|Physician Decision|0|||
163260809|NCT03995784|589662832|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
163260810|NCT01489189|589662833|FG000|Overall Study|Withdrawal by Subject|20|||
163260811|NCT01489189|589662834|FG001|Overall Study|Withdrawal by Subject|23|||
163260812|NCT01489189|589662833|FG000|Overall Study|Death|10|||
163260813|NCT01489189|589662834|FG001|Overall Study|Death|8|||
163361529|NCT00546078|590031751|FG001|Overall Study|Other reason|1|||
163260814|NCT01489189|589662833|FG000|Overall Study|Missed Visit|1|||
163260815|NCT01489189|589662834|FG001|Overall Study|Missed Visit|4|||
163260816|NCT00112580|589662835|FG000|Overall Study|Adverse Event|1|||
163260817|NCT00112580|589662836|FG001|Overall Study|Adverse Event|2|||
163260818|NCT00112580|589662835|FG000|Overall Study|Disease progression|5|||
163260819|NCT00112580|589662836|FG001|Overall Study|Disease progression|16|||
163260820|NCT00112580|589662835|FG000|Overall Study|Participant withdrew consent|2|||
163260821|NCT00112580|589662836|FG001|Overall Study|Participant withdrew consent|1|||
163260822|NCT03881696|589662843|FG000|Overall Study|Adverse Event|2|||
163260823|NCT03881696|589662844|FG001|Overall Study|Adverse Event|0|||
163260824|NCT03881696|589662843|FG000|Overall Study|Withdrawal by Subject|2|||
163260825|NCT03881696|589662844|FG001|Overall Study|Withdrawal by Subject|0|||
163260826|NCT03881696|589662843|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
163260827|NCT03881696|589662844|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
163260828|NCT03881696|589662843|FG000|Overall Study|Failure to meet continuation criteria|1|||
163260829|NCT03881696|589662844|FG001|Overall Study|Failure to meet continuation criteria|0|||
163260830|NCT02764775|589664479|FG000|Overall Study|Death|1|||
163260831|NCT02764775|589664479|FG000|Overall Study|Lost to Follow-up|2|||
163260832|NCT02764775|589664479|FG000|Overall Study|Withdrawal by Subject|3|||
163260833|NCT00975221|589664480|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
163260834|NCT00975221|589664481|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
163260835|NCT00975221|589664480|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
163260836|NCT00975221|589664481|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
163260837|NCT00975221|589664480|FG000|Titration Phase (Weeks 1-12)|Other|0|||
163260838|NCT00975221|589664481|FG001|Titration Phase (Weeks 1-12)|Other|1|||
163260839|NCT00975221|589664480|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
163260840|NCT00975221|589664481|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
163260841|NCT00975221|589664480|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
163260842|NCT00975221|589664481|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
163260843|NCT00975221|589664480|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
163260844|NCT00975221|589664481|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
163260845|NCT04022889|589664482|FG000|Stage 1: Period 1|Adverse Event|1|||
163260846|NCT04022889|589664483|FG001|Stage 1: Period 1|Adverse Event|0|||
163260847|NCT04022889|589664484|FG002|Stage 1: Period 1|Adverse Event|0|||
163260848|NCT04022889|589664482|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
163260849|NCT04022889|589664483|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
163260850|NCT04022889|589664484|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
163260851|NCT04022889|589664482|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
163260852|NCT04022889|589664483|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
163260853|NCT04022889|589664484|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
163260854|NCT04022889|589664482|FG000|Stage 2|Screen Failure|0|||
163260855|NCT04022889|589664483|FG001|Stage 2|Screen Failure|0|||
163260856|NCT04022889|589664484|FG002|Stage 2|Screen Failure|3|||
163260857|NCT04022889|589664482|FG000|Stage 2|Ineligible for apheresis donation|0|||
163260858|NCT04022889|589664483|FG001|Stage 2|Ineligible for apheresis donation|0|||
163260859|NCT04022889|589664484|FG002|Stage 2|Ineligible for apheresis donation|2|||
163260860|NCT04022889|589664482|FG000|Stage 2|Adverse Event|0|||
163260861|NCT04022889|589664483|FG001|Stage 2|Adverse Event|0|||
163260862|NCT04022889|589664484|FG002|Stage 2|Adverse Event|2|||
163260863|NCT04022889|589664482|FG000|Stage 2|Protocol Violation|0|||
163260864|NCT04022889|589664483|FG001|Stage 2|Protocol Violation|0|||
163260865|NCT04022889|589664484|FG002|Stage 2|Protocol Violation|1|||
163260866|NCT04022889|589664482|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
163260867|NCT04022889|589664483|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
163260868|NCT04022889|589664484|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
163260869|NCT02202434|589664485|FG000|Overall Study|Death|70|||
163260870|NCT02202434|589664486|FG001|Overall Study|Death|39|||
163260871|NCT02202434|589664487|FG002|Overall Study|Death|13|||
163260872|NCT02202434|589664488|FG003|Overall Study|Death|27|||
163260873|NCT02202434|589664485|FG000|Overall Study|Lost to Follow-up|1|||
163260874|NCT02202434|589664486|FG001|Overall Study|Lost to Follow-up|1|||
163260875|NCT02202434|589664487|FG002|Overall Study|Lost to Follow-up|1|||
163361530|NCT03512197|590031752|FG000|Overall Study|Guardian decision|1|||
163361531|NCT03512197|590031753|FG001|Overall Study|Guardian decision|1|||
163260876|NCT02202434|589664488|FG003|Overall Study|Lost to Follow-up|0|||
163260877|NCT02202434|589664485|FG000|Overall Study|Physician Decision|2|||
163260878|NCT02202434|589664486|FG001|Overall Study|Physician Decision|3|||
163260879|NCT02202434|589664487|FG002|Overall Study|Physician Decision|0|||
163260880|NCT02202434|589664488|FG003|Overall Study|Physician Decision|0|||
163260881|NCT02202434|589664485|FG000|Overall Study|Withdrawal by Subject|13|||
163260882|NCT02202434|589664486|FG001|Overall Study|Withdrawal by Subject|14|||
163260883|NCT02202434|589664487|FG002|Overall Study|Withdrawal by Subject|1|||
163260884|NCT02202434|589664488|FG003|Overall Study|Withdrawal by Subject|4|||
163260885|NCT02202434|589664485|FG000|Overall Study|Completed Study|1|||
163361532|NCT03512197|590031752|FG000|Overall Study|Lack of Efficacy|19|||
163361533|NCT03512197|590031753|FG001|Overall Study|Lack of Efficacy|11|||
163361534|NCT03512197|590031752|FG000|Overall Study|New Therapy for Study Indication|16|||
163361535|NCT03512197|590031753|FG001|Overall Study|New Therapy for Study Indication|16|||
163361536|NCT03512197|590031752|FG000|Overall Study|Physician Decision|60|||
163361537|NCT03512197|590031753|FG001|Overall Study|Physician Decision|60|||
163361538|NCT03512197|590031752|FG000|Overall Study|Protocol Violation|0|||
163361539|NCT03512197|590031753|FG001|Overall Study|Protocol Violation|2|||
163361540|NCT03512197|590031752|FG000|Overall Study|Terminated by Sponsored|46|||
163361541|NCT03512197|590031753|FG001|Overall Study|Terminated by Sponsored|50|||
163361542|NCT03512197|590031752|FG000|Overall Study|Subject Decision|15|||
163361543|NCT03512197|590031753|FG001|Overall Study|Subject Decision|12|||
163361544|NCT03512197|590031752|FG000|Overall Study|Withdrawal of informed consent|20|||
163361545|NCT03512197|590031753|FG001|Overall Study|Withdrawal of informed consent|14|||
163361546|NCT03512197|590031752|FG000|Overall Study|Adverse Event|30|||
163361547|NCT03512197|590031753|FG001|Overall Study|Adverse Event|34|||
163361548|NCT03512197|590031752|FG000|Overall Study|Death|14|||
163361549|NCT03512197|590031753|FG001|Overall Study|Death|9|||
163361550|NCT03512197|590031752|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
163361551|NCT03512197|590031753|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
163361552|NCT03512197|590031752|FG000|Overall Study|Missing|3|||
163361553|NCT03512197|590031753|FG001|Overall Study|Missing|13|||
163361554|NCT01806389|590031754|FG000|Overall Study|Withdrawal by Subject|4|||
163361555|NCT03358238|590031759|FG000|Overall Study|Withdrawal by Subject|0|||
163361556|NCT03358238|590031760|FG001|Overall Study|Withdrawal by Subject|1|||
163361557|NCT02633397|590031761|FG000|Overall Study|Adverse Event|8|||
163361558|NCT02633397|590031762|FG001|Overall Study|Adverse Event|8|||
163361559|NCT02633397|590031761|FG000|Overall Study|Study Burden|4|||
163361560|NCT02633397|590031762|FG001|Overall Study|Study Burden|1|||
163361561|NCT02633397|590031761|FG000|Overall Study|Treatment interruption|2|||
163361562|NCT02633397|590031762|FG001|Overall Study|Treatment interruption|5|||
163361563|NCT02633397|590031761|FG000|Overall Study|Death|2|||
163361564|NCT02633397|590031762|FG001|Overall Study|Death|2|||
163361565|NCT02633397|590031761|FG000|Overall Study|Physician Decision|0|||
163361566|NCT02633397|590031762|FG001|Overall Study|Physician Decision|1|||
163361567|NCT03595878|590031763|FG000|Overall Study|Death|2|||
163361568|NCT03595878|590031764|FG001|Overall Study|Death|1|||
163361569|NCT03595878|590031765|FG002|Overall Study|Death|0|||
163361570|NCT03595878|590031763|FG000|Overall Study|Disease progression|2|||
163361571|NCT03595878|590031764|FG001|Overall Study|Disease progression|1|||
163361572|NCT03595878|590031765|FG002|Overall Study|Disease progression|2|||
163361573|NCT03036124|590031766|FG000|Overall Study|Lost to Follow-up|0|||
163361574|NCT03036124|590031767|FG001|Overall Study|Lost to Follow-up|2|||
163361575|NCT03036124|590031766|FG000|Overall Study|Withdrawal by Subject|5|||
163361576|NCT03036124|590031767|FG001|Overall Study|Withdrawal by Subject|4|||
163361587|NCT04949802|590033233|FG000|Overall Study|Lost to Follow-up|3|||
163361588|NCT03778294|590033234|FG000|Overall Study|Death|1|||
163361589|NCT03778294|590033234|FG000|Overall Study|Issues with insurance|1|||
163361590|NCT03778294|590033234|FG000|Overall Study|disease progression before treatment|2|||
163361591|NCT01845805|590033235|FG000|Overall Study|Withdrawal by Subject|1|||
163361592|NCT01845805|590033236|FG001|Overall Study|Withdrawal by Subject|2|||
163361593|NCT01845805|590033235|FG000|Overall Study|Disease Progression|13|||
163361594|NCT01845805|590033236|FG001|Overall Study|Disease Progression|14|||
163361595|NCT01845805|590033235|FG000|Overall Study|Drug-related Toxicity|4|||
163361596|NCT01845805|590033236|FG001|Overall Study|Drug-related Toxicity|0|||
163361597|NCT00127842|590033237|FG000|Overall Study|Adverse Event|15|||
163361598|NCT00127842|590033237|FG000|Overall Study|Withdrawal by Subject|3|||
163361599|NCT00127842|590033237|FG000|Overall Study|Lost to Follow-up|1|||
163361600|NCT00127842|590033237|FG000|Overall Study|Lack of Efficacy|12|||
163361601|NCT00127842|590033237|FG000|Overall Study|Noncompliance|2|||
163361602|NCT00127842|590033237|FG000|Overall Study|Protocol Violation|1|||
163361603|NCT00127842|590033237|FG000|Overall Study|Other|5|||
163361604|NCT03595124|590033241|FG000|Overall Study|Physician Decision|1|||
163361605|NCT03595124|590033242|FG001|Overall Study|Physician Decision|1|||
163361606|NCT03595124|590033243|FG002|Overall Study|Physician Decision|1|||
163361607|NCT03595124|590033241|FG000|Overall Study|Ineligible|1|||
163361608|NCT03595124|590033242|FG001|Overall Study|Ineligible|1|||
163361609|NCT03595124|590033243|FG002|Overall Study|Ineligible|0|||
163361610|NCT03595124|590033241|FG000|Overall Study|Disease Progression|4|||
163361611|NCT03595124|590033242|FG001|Overall Study|Disease Progression|1|||
163361612|NCT03595124|590033243|FG002|Overall Study|Disease Progression|4|||
163260886|NCT02202434|589664486|FG001|Overall Study|Completed Study|0|||
163260887|NCT02202434|589664487|FG002|Overall Study|Completed Study|0|||
163260888|NCT02202434|589664488|FG003|Overall Study|Completed Study|0|||
163260889|NCT02202434|589664485|FG000|Overall Study|Visit Missed|21|||
163260890|NCT02202434|589664486|FG001|Overall Study|Visit Missed|12|||
163260891|NCT02202434|589664487|FG002|Overall Study|Visit Missed|0|||
163260892|NCT02202434|589664488|FG003|Overall Study|Visit Missed|5|||
163260893|NCT02202434|589664485|FG000|Overall Study|Other|1|||
163260894|NCT02202434|589664486|FG001|Overall Study|Other|0|||
163260895|NCT02202434|589664487|FG002|Overall Study|Other|0|||
163260896|NCT02202434|589664488|FG003|Overall Study|Other|1|||
163260897|NCT03237858|589664489|FG000|Overall Study|Death|19|||
163260898|NCT03237858|589664489|FG000|Overall Study|Withdrawal by Subject|37|||
163260899|NCT03015116|589664490|FG000|Overall Study|Lost to Follow-up|3|||
163260900|NCT03015116|589664491|FG001|Overall Study|Lost to Follow-up|0|||
163260901|NCT03015116|589664492|FG002|Overall Study|Lost to Follow-up|2|||
163260902|NCT03015116|589664490|FG000|Overall Study|Withdrawal by Subject|3|||
163260903|NCT03015116|589664491|FG001|Overall Study|Withdrawal by Subject|1|||
163260904|NCT03015116|589664492|FG002|Overall Study|Withdrawal by Subject|0|||
163260905|NCT03015116|589664490|FG000|Overall Study|Subject has New Medical Status|1|||
163260906|NCT03015116|589664491|FG001|Overall Study|Subject has New Medical Status|0|||
163260907|NCT03015116|589664492|FG002|Overall Study|Subject has New Medical Status|0|||
163260908|NCT03015116|589664490|FG000|Overall Study|Physician Decision|0|||
163260909|NCT03015116|589664491|FG001|Overall Study|Physician Decision|1|||
163260910|NCT03015116|589664492|FG002|Overall Study|Physician Decision|0|||
163260911|NCT01862991|589664493|FG000|Overall Study|Lost to Follow-up|2|||
163260912|NCT01862991|589664494|FG001|Overall Study|Lost to Follow-up|1|||
163260913|NCT01862991|589664495|FG002|Overall Study|Lost to Follow-up|1|||
163260914|NCT01862991|589664493|FG000|Overall Study|Protocol Violation|1|||
163260915|NCT01862991|589664494|FG001|Overall Study|Protocol Violation|0|||
163260916|NCT01862991|589664495|FG002|Overall Study|Protocol Violation|0|||
163260917|NCT04858802|589664496|FG000|Overall Study|Lost to Follow-up|1|||
163260918|NCT04858802|589664497|FG001|Overall Study|Lost to Follow-up|1|||
163260919|NCT04858802|589664496|FG000|Overall Study|Withdrawal by Subject|1|||
163260920|NCT04858802|589664497|FG001|Overall Study|Withdrawal by Subject|1|||
163260921|NCT00332332|589664498|FG000|Overall Study|Adverse Event|13|||
163260922|NCT00332332|589664498|FG000|Overall Study|Death|1|||
163260923|NCT00332332|589664498|FG000|Overall Study|Withdrawal by Subject|8|||
163260924|NCT00332332|589664498|FG000|Overall Study|Physician Decision|1|||
163260925|NCT00332332|589664498|FG000|Overall Study|Lost to Follow-up|3|||
163260926|NCT00332332|589664498|FG000|Overall Study|Protocol deviation|4|||
163260927|NCT00332332|589664498|FG000|Overall Study|Noncompliance|2|||
163260928|NCT00332332|589664498|FG000|Overall Study|Disease progression|2|||
163260929|NCT00332332|589664498|FG000|Overall Study|Other|18|||
163260930|NCT00332332|589664498|FG000|Overall Study|Did not receive study treatment|16|||
163260931|NCT01108458|589664499|FG000|Overall Study|Withdrawal by Subject|1|||
163260932|NCT00710606|589664506|FG000|Overall Study|Adverse Event|0|||
163260933|NCT00710606|589664507|FG001|Overall Study|Adverse Event|2|||
163260934|NCT02670538|589664508|FG000|Overall Study|Withdrawal of Consent|8|||
163260935|NCT02670538|589664509|FG001|Overall Study|Withdrawal of Consent|6|||
163260936|NCT02670538|589664510|FG002|Overall Study|Withdrawal of Consent|5|||
163260937|NCT02670538|589664508|FG000|Overall Study|Lost to Follow-up|8|||
163260938|NCT02670538|589664509|FG001|Overall Study|Lost to Follow-up|12|||
163260939|NCT02670538|589664510|FG002|Overall Study|Lost to Follow-up|7|||
163260940|NCT02670538|589664508|FG000|Overall Study|Adverse Event|5|||
163260941|NCT02670538|589664509|FG001|Overall Study|Adverse Event|5|||
163260942|NCT02670538|589664510|FG002|Overall Study|Adverse Event|11|||
163260943|NCT02670538|589664508|FG000|Overall Study|Lack of Efficacy|7|||
163260944|NCT02670538|589664509|FG001|Overall Study|Lack of Efficacy|1|||
163361613|NCT01888874|590033244|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
163361614|NCT01888874|590033245|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
163361615|NCT01888874|590033246|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
163260945|NCT02670538|589664510|FG002|Overall Study|Lack of Efficacy|2|||
163361616|NCT01888874|590033247|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
163361617|NCT01888874|590033248|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
163361618|NCT01888874|590033249|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
163260946|NCT02670538|589664508|FG000|Overall Study|Protocol Violation|3|||
163260947|NCT02670538|589664509|FG001|Overall Study|Protocol Violation|4|||
163260948|NCT02670538|589664510|FG002|Overall Study|Protocol Violation|1|||
163361619|NCT01888874|590033250|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
163260949|NCT02670538|589664508|FG000|Overall Study|Noncompliance with Study Drug|1|||
163260950|NCT02670538|589664509|FG001|Overall Study|Noncompliance with Study Drug|3|||
163260951|NCT02670538|589664510|FG002|Overall Study|Noncompliance with Study Drug|2|||
163260952|NCT02670538|589664508|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163260953|NCT02670538|589664509|FG001|Overall Study|Other Miscellaneous Reasons|1|||
163260954|NCT02670538|589664510|FG002|Overall Study|Other Miscellaneous Reasons|2|||
163260955|NCT02207725|589664514|FG000|Overall Study|Did Not Receive Treatment|0|||
163260956|NCT02207725|589664515|FG001|Overall Study|Did Not Receive Treatment|1|||
163260957|NCT02207725|589664516|FG002|Overall Study|Did Not Receive Treatment|1|||
163260958|NCT02207725|589664517|FG003|Overall Study|Did Not Receive Treatment|1|||
163260959|NCT00185640|589664521|FG000|Overall Study|Not Eligible|4|||
163260960|NCT00185640|589664521|FG000|Overall Study|Withdrawal by Subject|3|||
163260961|NCT00185640|589664521|FG000|Overall Study|Death|138|||
163260962|NCT00058422|589664522|FG000|Overall Study|Not treated|2|||
163260963|NCT00708435|589664525|FG000|Overall Study|Death / Serious Adverse Event|10|||
163260964|NCT00708435|589664526|FG001|Overall Study|Death / Serious Adverse Event|5|||
163152287|NCT02718898|589271431|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
163152288|NCT02718898|589271432|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
163152289|NCT02718898|589271433|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
163152290|NCT02718898|589271427|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163152291|NCT02718898|589271428|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163152292|NCT02718898|589271429|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163152293|NCT02718898|589271430|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163152294|NCT02718898|589271431|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163152295|NCT02718898|589271432|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
163152296|NCT02718898|589271433|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
163152297|NCT02163538|589271434|FG000|Overall Study|Protocol Violation|1|||
163152298|NCT02163538|589271435|FG001|Overall Study|Protocol Violation|0|||
163152299|NCT02163538|589271434|FG000|Overall Study|Physician Decision|0|||
163152300|NCT02163538|589271435|FG001|Overall Study|Physician Decision|1|||
163152301|NCT01345240|589271436|FG000|Overall Study|Adverse Event|3|||
163152302|NCT01345240|589271437|FG001|Overall Study|Adverse Event|5|||
163152303|NCT01345240|589271438|FG002|Overall Study|Adverse Event|4|||
163152304|NCT01345240|589271439|FG003|Overall Study|Adverse Event|2|||
163152305|NCT01345240|589271440|FG004|Overall Study|Adverse Event|1|||
163152306|NCT01345240|589271436|FG000|Overall Study|Lost to Follow-up|8|||
163152307|NCT01345240|589271437|FG001|Overall Study|Lost to Follow-up|9|||
163152308|NCT01345240|589271438|FG002|Overall Study|Lost to Follow-up|14|||
163152309|NCT01345240|589271439|FG003|Overall Study|Lost to Follow-up|7|||
163152310|NCT01345240|589271440|FG004|Overall Study|Lost to Follow-up|9|||
163152311|NCT00231816|589271443|FG000|Overall Study|Adverse Event|1|||
163152312|NCT00231816|589271444|FG001|Overall Study|Adverse Event|0|||
163152313|NCT00231816|589271443|FG000|Overall Study|Lost to Follow-up|8|||
163152314|NCT00231816|589271444|FG001|Overall Study|Lost to Follow-up|5|||
163152315|NCT00231816|589271443|FG000|Overall Study|Protocol Violation|2|||
163152316|NCT00231816|589271444|FG001|Overall Study|Protocol Violation|3|||
163152317|NCT00231816|589271443|FG000|Overall Study|Withdrawal by Subject|3|||
163152318|NCT00231816|589271444|FG001|Overall Study|Withdrawal by Subject|3|||
163152319|NCT00231816|589271443|FG000|Overall Study|Other|2|||
163152320|NCT00231816|589271444|FG001|Overall Study|Other|1|||
163152321|NCT02158442|589271446|FG000|Overall Study|Withdrawal by Subject|1|||
163152322|NCT02158442|589271447|FG001|Overall Study|Withdrawal by Subject|0|||
163152323|NCT02158442|589271446|FG000|Overall Study|Perfusion staff not available|1|||
163152324|NCT02158442|589271447|FG001|Overall Study|Perfusion staff not available|0|||
163152325|NCT02651675|589271449|FG000|Overall Study|Death|0|||
163152326|NCT02651675|589271450|FG001|Overall Study|Death|0|||
163152327|NCT02651675|589271451|FG002|Overall Study|Death|1|||
163152328|NCT02246530|589271452|FG000|Overall Study|Lost to Follow-up|4|||
163152329|NCT02246530|589271453|FG001|Overall Study|Lost to Follow-up|0|||
163152330|NCT00617734|589271454|FG000|Overall Study|Withdrew Consent|2|||
163152331|NCT00617734|589271455|FG001|Overall Study|Withdrew Consent|0|||
163152332|NCT00617734|589271454|FG000|Overall Study|Adverse Event|4|||
163152333|NCT00617734|589271455|FG001|Overall Study|Adverse Event|1|||
163152334|NCT00617734|589271454|FG000|Overall Study|Protocol Violation|1|||
163152335|NCT00617734|589271455|FG001|Overall Study|Protocol Violation|0|||
163152336|NCT00617734|589271454|FG000|Overall Study|Found Ineligible After Randomization|1|||
163152337|NCT00617734|589271455|FG001|Overall Study|Found Ineligible After Randomization|4|||
163152338|NCT00617734|589271454|FG000|Overall Study|Lost to Follow-up|0|||
163152339|NCT00617734|589271455|FG001|Overall Study|Lost to Follow-up|1|||
163152340|NCT05712460|589271456|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152341|NCT05712460|589271457|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152342|NCT05712460|589271458|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152343|NCT05712460|589271459|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152344|NCT05712460|589271460|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163260965|NCT00708435|589664525|FG000|Overall Study|Lost to Follow-up|9|||
163152345|NCT05712460|589271461|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152346|NCT05712460|589271462|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152347|NCT05712460|589271463|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
163152348|NCT05712460|589271464|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152349|NCT05712460|589271465|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152350|NCT05712460|589271466|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163260966|NCT00708435|589664526|FG001|Overall Study|Lost to Follow-up|4|||
163260967|NCT00708435|589664525|FG000|Overall Study|Withdrawal by Subject|3|||
163361620|NCT01888874|590033244|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
163361621|NCT01888874|590033245|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
163361622|NCT01888874|590033246|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
163361623|NCT01888874|590033247|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
163361624|NCT01888874|590033248|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
163361625|NCT01888874|590033249|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
163361626|NCT01888874|590033250|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
163361627|NCT01888874|590033244|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
163411160|NCT00852995|590212999|FG003|Overall Study|Progressive Disease|2|||
163152351|NCT05712460|589271467|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152352|NCT05135767|589271471|FG000|Baseline|Lost to Follow-up|1|||
163152353|NCT05135767|589271472|FG001|Baseline|Lost to Follow-up|1|||
163152354|NCT05135767|589271471|FG000|Baseline|Withdrawal by Subject|0|||
163152355|NCT05135767|589271472|FG001|Baseline|Withdrawal by Subject|2|||
163152356|NCT05135767|589271471|FG000|Active Study Phase|Lost to Follow-up|2|||
163152357|NCT05135767|589271472|FG001|Active Study Phase|Lost to Follow-up|0|||
163152358|NCT02694185|589271473|FG000|Overall Study|Withdrawal by Subject|45|||
163152359|NCT02694185|589271474|FG001|Overall Study|Withdrawal by Subject|0|||
163152360|NCT05082857|589271475|FG000|Overall Study|participants relocated and could not continue|2|||
163152361|NCT05082857|589271476|FG001|Overall Study|participants relocated and could not continue|1|||
163152362|NCT05082857|589271475|FG000|Overall Study|Lost to Follow-up|1|||
163152363|NCT05082857|589271476|FG001|Overall Study|Lost to Follow-up|3|||
163152364|NCT04366349|589271477|FG000|Overall Study|Withdrawal by Subject|1|||
163152365|NCT04366349|589271478|FG001|Overall Study|Withdrawal by Subject|0|||
163152366|NCT04366349|589271479|FG002|Overall Study|Withdrawal by Subject|0|||
163152367|NCT04366349|589271480|FG003|Overall Study|Withdrawal by Subject|0|||
163152368|NCT04366349|589271481|FG004|Overall Study|Withdrawal by Subject|0|||
163152369|NCT04366349|589271482|FG005|Overall Study|Withdrawal by Subject|0|||
163152370|NCT02331134|589271489|FG000|Overall Study|Withdrawal by Subject|1|||
163152371|NCT05967260|589271490|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
163152372|NCT05967260|589271491|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
163152373|NCT05565742|589271492|FG000|Overall Study|Withdrawal by Subject|0|||
163152374|NCT05565742|589271493|FG001|Overall Study|Withdrawal by Subject|0|||
163152375|NCT05565742|589271494|FG002|Overall Study|Withdrawal by Subject|2|||
163152376|NCT05565742|589271495|FG003|Overall Study|Withdrawal by Subject|2|||
163152377|NCT05565742|589271496|FG004|Overall Study|Withdrawal by Subject|2|||
163152378|NCT05565742|589271492|FG000|Overall Study|Death|1|||
163152379|NCT05565742|589271493|FG001|Overall Study|Death|0|||
163152380|NCT05565742|589271494|FG002|Overall Study|Death|0|||
163152381|NCT05565742|589271495|FG003|Overall Study|Death|0|||
163152382|NCT05565742|589271496|FG004|Overall Study|Death|0|||
163152383|NCT05565742|589271492|FG000|Overall Study|Participant Travelled Abroad|0|||
163152384|NCT05565742|589271493|FG001|Overall Study|Participant Travelled Abroad|0|||
163152385|NCT05565742|589271494|FG002|Overall Study|Participant Travelled Abroad|0|||
163152386|NCT05565742|589271495|FG003|Overall Study|Participant Travelled Abroad|0|||
163152387|NCT05565742|589271496|FG004|Overall Study|Participant Travelled Abroad|1|||
163152388|NCT00668148|589271497|FG000|Overall Study|Adverse Event|5|||
163152389|NCT00668148|589271497|FG000|Overall Study|Subject Non-compliance|1|||
163152390|NCT00668148|589271497|FG000|Overall Study|Progressive Disease Before Treatment|2|||
163152391|NCT00668148|589271497|FG000|Overall Study|Withdrawal of Consent|2|||
163152392|NCT05472090|589271499|FG000|Overall Study|Adverse Event|2|||
163152393|NCT05472090|589271500|FG001|Overall Study|Adverse Event|3|||
163152394|NCT05472090|589271499|FG000|Overall Study|Lack of Efficacy|1|||
163152395|NCT05472090|589271500|FG001|Overall Study|Lack of Efficacy|0|||
163152396|NCT05472090|589271499|FG000|Overall Study|Physician Decision|1|||
163152397|NCT05472090|589271500|FG001|Overall Study|Physician Decision|0|||
163152398|NCT05472090|589271499|FG000|Overall Study|Withdrawal by Subject|2|||
163152399|NCT05472090|589271500|FG001|Overall Study|Withdrawal by Subject|0|||
163152400|NCT05472090|589271499|FG000|Overall Study|Lost to Follow-up|0|||
163152401|NCT05472090|589271500|FG001|Overall Study|Lost to Follow-up|3|||
163152402|NCT00425269|589274526|FG000|Overall Study|Pregnancy|5|||
163152403|NCT00425269|589274527|FG001|Overall Study|Pregnancy|7|||
163152404|NCT00425269|589274526|FG000|Overall Study|Lost to Follow-up|9|||
163152405|NCT00425269|589274527|FG001|Overall Study|Lost to Follow-up|9|||
163152406|NCT00425269|589274526|FG000|Overall Study|moved or medical reason|5|||
163152407|NCT00425269|589274527|FG001|Overall Study|moved or medical reason|4|||
163152408|NCT00335777|589274534|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
163152409|NCT00335777|589274534|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
163152410|NCT00335777|589274534|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
163152411|NCT00335777|589274534|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
163152412|NCT00335777|589274534|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
163152413|NCT00992108|589274535|FG000|Overall Study|Lost to Follow-up|0|||
163152414|NCT00992108|589274536|FG001|Overall Study|Lost to Follow-up|1|||
163152415|NCT04639245|589274537|FG000|Overall Study|Death|1|||
163260968|NCT00708435|589664526|FG001|Overall Study|Withdrawal by Subject|7|||
163260969|NCT00708435|589664525|FG000|Overall Study|Adverse Event|1|||
163260970|NCT00708435|589664526|FG001|Overall Study|Adverse Event|0|||
163260971|NCT00708435|589664525|FG000|Overall Study|Protocol Violation|0|||
163260972|NCT00708435|589664526|FG001|Overall Study|Protocol Violation|1|||
163260973|NCT00708435|589664525|FG000|Overall Study|Intervention by primary care physician|1|||
163260974|NCT00708435|589664526|FG001|Overall Study|Intervention by primary care physician|0|||
163260975|NCT00708435|589664525|FG000|Overall Study|Refused hospitalization|1|||
163260976|NCT00708435|589664526|FG001|Overall Study|Refused hospitalization|0|||
163260977|NCT04766086|589664527|FG000|Overall Study|Lost to Follow-up|3|||
163260978|NCT04766086|589664528|FG001|Overall Study|Lost to Follow-up|5|||
163260979|NCT04766086|589664529|FG002|Overall Study|Lost to Follow-up|3|||
163260980|NCT04766086|589664527|FG000|Overall Study|Withdrawal by Subject|1|||
163260981|NCT04766086|589664528|FG001|Overall Study|Withdrawal by Subject|1|||
163260982|NCT04766086|589664529|FG002|Overall Study|Withdrawal by Subject|2|||
163260983|NCT04766086|589664527|FG000|Overall Study|Other|0|||
163260984|NCT04766086|589664528|FG001|Overall Study|Other|0|||
163260985|NCT04766086|589664529|FG002|Overall Study|Other|1|||
163260986|NCT02635724|589664532|FG000|Overall Study|Withdrawal by Subject|0|||
163260987|NCT02635724|589664533|FG001|Overall Study|Withdrawal by Subject|1|||
163260988|NCT02635724|589664534|FG002|Overall Study|Withdrawal by Subject|0|||
163260989|NCT03579290|589664535|FG000|Overall Study|Lost to Follow-up|9|||
163260990|NCT01674621|589664542|FG000|Overall Study|Adverse Event|3|||
163260991|NCT01674621|589664543|FG001|Overall Study|Adverse Event|2|||
163260992|NCT01674621|589664544|FG002|Overall Study|Adverse Event|5|||
163260993|NCT01674621|589664545|FG003|Overall Study|Adverse Event|5|||
163260994|NCT01674621|589664546|FG004|Overall Study|Adverse Event|1|||
163260995|NCT01674621|589664542|FG000|Overall Study|Inability to Complete Study Procedures|0|||
163260996|NCT01674621|589664543|FG001|Overall Study|Inability to Complete Study Procedures|0|||
163260997|NCT01674621|589664544|FG002|Overall Study|Inability to Complete Study Procedures|0|||
163260998|NCT01674621|589664545|FG003|Overall Study|Inability to Complete Study Procedures|0|||
163260999|NCT01674621|589664546|FG004|Overall Study|Inability to Complete Study Procedures|2|||
163261000|NCT01674621|589664542|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
163261001|NCT01674621|589664543|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
163261002|NCT01674621|589664544|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
163261003|NCT01674621|589664545|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
163261004|NCT01674621|589664546|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
163261005|NCT01674621|589664542|FG000|Overall Study|Withdrawal by Subject|2|||
163361628|NCT01888874|590033245|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
163361629|NCT01888874|590033246|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
163361630|NCT01888874|590033247|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
163361631|NCT01888874|590033248|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
163361632|NCT01888874|590033249|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
163361633|NCT01888874|590033250|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
163361634|NCT01888874|590033244|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
163361635|NCT01888874|590033245|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
163361636|NCT01888874|590033246|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
163361637|NCT01888874|590033247|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
163361638|NCT01888874|590033248|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
163361639|NCT01888874|590033249|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
163361640|NCT01888874|590033250|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
163361641|NCT01888874|590033244|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
163361642|NCT01888874|590033245|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
163361643|NCT01888874|590033246|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
163361644|NCT01888874|590033247|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
163361645|NCT01888874|590033248|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
163361646|NCT01888874|590033249|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
163361647|NCT01888874|590033250|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
163361648|NCT01888874|590033244|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
163361649|NCT01888874|590033245|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
163361650|NCT01888874|590033246|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
163361651|NCT01888874|590033247|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
163361652|NCT01888874|590033248|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
163261006|NCT01674621|589664543|FG001|Overall Study|Withdrawal by Subject|5|||
163261007|NCT01674621|589664544|FG002|Overall Study|Withdrawal by Subject|2|||
163261008|NCT01674621|589664545|FG003|Overall Study|Withdrawal by Subject|0|||
163261009|NCT01674621|589664546|FG004|Overall Study|Withdrawal by Subject|1|||
163261010|NCT01674621|589664542|FG000|Overall Study|Other than specified|0|||
163261011|NCT01674621|589664543|FG001|Overall Study|Other than specified|1|||
163261012|NCT01674621|589664544|FG002|Overall Study|Other than specified|0|||
163261013|NCT01674621|589664545|FG003|Overall Study|Other than specified|0|||
163261014|NCT01674621|589664546|FG004|Overall Study|Other than specified|2|||
163261015|NCT01725386|589664547|FG000|Overall Study|Death|84|||
163261016|NCT01725386|589664548|FG001|Overall Study|Death|40|||
163261017|NCT01725386|589664547|FG000|Overall Study|Lost to Follow-up|81|||
163261018|NCT01725386|589664548|FG001|Overall Study|Lost to Follow-up|6|||
163261019|NCT01725386|589664547|FG000|Overall Study|Withdrawal by Subject|10|||
163261020|NCT01725386|589664548|FG001|Overall Study|Withdrawal by Subject|0|||
163261021|NCT01216163|589664553|FG000|Overall Study|Withdrawal by Subject|1|||
163261022|NCT01216163|589664554|FG001|Overall Study|Withdrawal by Subject|1|||
163261023|NCT01216163|589664555|FG002|Overall Study|Withdrawal by Subject|0|||
163261024|NCT02914314|589664556|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
163261025|NCT02914314|589664557|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
163261026|NCT02914314|589664558|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
163261027|NCT02914314|589664559|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
163261028|NCT02914314|589664556|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
163261029|NCT02914314|589664557|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
163261030|NCT02914314|589664558|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
163261031|NCT02914314|589664559|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
163261032|NCT02914314|589664556|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
163261033|NCT02914314|589664557|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
163261034|NCT02914314|589664558|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
163261035|NCT02914314|589664559|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
163261036|NCT02914314|589664556|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
163261037|NCT02914314|589664557|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
163261038|NCT02914314|589664558|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
163261039|NCT02914314|589664559|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
163261040|NCT02914314|589664556|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
163261041|NCT02914314|589664557|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
163261042|NCT02914314|589664558|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
163261043|NCT02914314|589664559|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
163261044|NCT00532155|589664560|FG000|Overall Study|Adverse Event|66|||
163261045|NCT00532155|589664561|FG001|Overall Study|Adverse Event|123|||
163261046|NCT00532155|589664560|FG000|Overall Study|Lack of Efficacy|332|||
163261047|NCT00532155|589664561|FG001|Overall Study|Lack of Efficacy|255|||
163261048|NCT00532155|589664560|FG000|Overall Study|Protocol Violation|1|||
163261049|NCT00532155|589664561|FG001|Overall Study|Protocol Violation|3|||
163261050|NCT00532155|589664560|FG000|Overall Study|Lost to Follow-up|2|||
163261051|NCT00532155|589664561|FG001|Overall Study|Lost to Follow-up|0|||
163261052|NCT00532155|589664560|FG000|Overall Study|Physician Decision|16|||
163261053|NCT00532155|589664561|FG001|Overall Study|Physician Decision|15|||
163261054|NCT00532155|589664560|FG000|Overall Study|Withdrawal by Subject|23|||
163261055|NCT00532155|589664561|FG001|Overall Study|Withdrawal by Subject|44|||
163261056|NCT00532155|589664560|FG000|Overall Study|Consent withdrawn|5|||
163261057|NCT00532155|589664561|FG001|Overall Study|Consent withdrawn|7|||
163261058|NCT00532155|589664560|FG000|Overall Study|Moved|1|||
163261059|NCT00532155|589664561|FG001|Overall Study|Moved|0|||
163261060|NCT00532155|589664560|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
163261061|NCT00532155|589664561|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
163261062|NCT00532155|589664560|FG000|Overall Study|Occurence of a second cancer|0|||
163261063|NCT00532155|589664561|FG001|Overall Study|Occurence of a second cancer|1|||
163261064|NCT00532155|589664560|FG000|Overall Study|Occurence of a secondary cancer|0|||
163261065|NCT00532155|589664561|FG001|Overall Study|Occurence of a secondary cancer|1|||
163261066|NCT00532155|589664560|FG000|Overall Study|Promotor ended study|1|||
163261067|NCT00532155|589664561|FG001|Overall Study|Promotor ended study|0|||
163261068|NCT00532155|589664560|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
163261069|NCT00532155|589664561|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
163261070|NCT00532155|589664560|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
163261071|NCT00532155|589664561|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
163361653|NCT01888874|590033249|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
163261072|NCT00532155|589664560|FG000|Overall Study|Study stopped|1|||
163261073|NCT00532155|589664561|FG001|Overall Study|Study stopped|0|||
163261074|NCT00532155|589664560|FG000|Overall Study|Study terminated by sponsor|1|||
163261075|NCT00532155|589664561|FG001|Overall Study|Study terminated by sponsor|0|||
163411161|NCT00852995|590213000|FG004|Overall Study|Progressive Disease|1|||
163261076|NCT00532155|589664560|FG000|Overall Study|Study termination stop further treatment|4|||
163261077|NCT00532155|589664561|FG001|Overall Study|Study termination stop further treatment|0|||
163261078|NCT00532155|589664560|FG000|Overall Study|Did not receive study medication|2|||
163261079|NCT00532155|589664561|FG001|Overall Study|Did not receive study medication|6|||
163261080|NCT03483038|589664562|FG000|Overall Study|Subjects still in follow-up|18|||
163261081|NCT00654901|589664563|FG000|Overall Study|Lost to Follow-up|1|||
163261082|NCT00654901|589664564|FG001|Overall Study|Lost to Follow-up|0|||
163261083|NCT00654901|589664565|FG002|Overall Study|Lost to Follow-up|1|||
163261084|NCT00654901|589664566|FG003|Overall Study|Lost to Follow-up|0|||
163261085|NCT00654901|589664563|FG000|Overall Study|Withdrawal by Subject|3|||
163261086|NCT00654901|589664564|FG001|Overall Study|Withdrawal by Subject|0|||
163261087|NCT00654901|589664565|FG002|Overall Study|Withdrawal by Subject|1|||
163261088|NCT00654901|589664566|FG003|Overall Study|Withdrawal by Subject|0|||
163261089|NCT04843930|589664568|FG000|Randomization|Withdrawal by Subject|6|||
163261090|NCT04843930|589664569|FG001|Randomization|Withdrawal by Subject|6|||
163261091|NCT04843930|589664570|FG002|Randomization|Withdrawal by Subject|0|||
163261092|NCT04843930|589664571|FG003|Randomization|Withdrawal by Subject|0|||
163261093|NCT04843930|589664568|FG000|Week 6 Assessment|Adverse Event|3|||
163261094|NCT04843930|589664569|FG001|Week 6 Assessment|Adverse Event|0|||
163261095|NCT04843930|589664570|FG002|Week 6 Assessment|Adverse Event|0|||
163261096|NCT04843930|589664571|FG003|Week 6 Assessment|Adverse Event|0|||
163261097|NCT04843930|589664568|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
163261098|NCT04843930|589664569|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
163261099|NCT04843930|589664570|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
163261100|NCT04843930|589664571|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
163261101|NCT04843930|589664568|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
163261102|NCT04843930|589664569|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
163261103|NCT04843930|589664570|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
163261104|NCT04843930|589664571|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
163261105|NCT02552238|589664572|FG000|Overall Study|Withdrawal by Subject|2|||
163261106|NCT02552238|589664572|FG000|Overall Study|Adverse Event|2|||
163261107|NCT01576718|589664573|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
163261108|NCT01576718|589664574|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163261109|NCT01576718|589664575|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163261110|NCT01576718|589664576|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163261111|NCT01576718|589664577|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163261112|NCT01576718|589664578|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163261113|NCT01576718|589664579|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163261114|NCT01576718|589664573|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
163261115|NCT01576718|589664574|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163261116|NCT01576718|589664575|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163261117|NCT01576718|589664576|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163261118|NCT01576718|589664577|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163261119|NCT01576718|589664578|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163261120|NCT01576718|589664579|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163261121|NCT01576718|589664573|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
163261122|NCT01576718|589664574|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163261123|NCT01576718|589664575|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163261124|NCT01576718|589664576|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163261125|NCT01576718|589664577|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163261126|NCT01576718|589664578|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163261127|NCT01576718|589664579|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163261128|NCT01576718|589664573|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
163261129|NCT01576718|589664574|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163261130|NCT01576718|589664575|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163261131|NCT01576718|589664576|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163261132|NCT01576718|589664577|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163261133|NCT01576718|589664578|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163261134|NCT01576718|589664579|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163261135|NCT01576718|589664573|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
163261136|NCT01576718|589664574|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163261137|NCT01576718|589664575|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163261138|NCT01576718|589664576|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163261139|NCT01576718|589664577|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163261140|NCT01576718|589664578|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163261141|NCT01576718|589664579|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163261142|NCT01576718|589664573|FG000|Treatment Period|Adverse Event|0|||
163261143|NCT01576718|589664574|FG001|Treatment Period|Adverse Event|1|||
163261144|NCT01576718|589664575|FG002|Treatment Period|Adverse Event|1|||
163261145|NCT01576718|589664576|FG003|Treatment Period|Adverse Event|1|||
163261146|NCT01576718|589664577|FG004|Treatment Period|Adverse Event|1|||
163261147|NCT01576718|589664578|FG005|Treatment Period|Adverse Event|1|||
163261148|NCT01576718|589664579|FG006|Treatment Period|Adverse Event|0|||
163261149|NCT01576718|589664573|FG000|Treatment Period|Withdrawal by Subject|0|||
163261150|NCT01576718|589664574|FG001|Treatment Period|Withdrawal by Subject|1|||
163411162|NCT00852995|590212996|FG000|Overall Study|Physician Decision|1|||
163261151|NCT01576718|589664575|FG002|Treatment Period|Withdrawal by Subject|1|||
163261152|NCT01576718|589664576|FG003|Treatment Period|Withdrawal by Subject|0|||
163261153|NCT01576718|589664577|FG004|Treatment Period|Withdrawal by Subject|2|||
163261154|NCT01576718|589664578|FG005|Treatment Period|Withdrawal by Subject|4|||
163261155|NCT01576718|589664579|FG006|Treatment Period|Withdrawal by Subject|2|||
163261156|NCT01576718|589664573|FG000|Treatment Period|Physician Decision|0|||
163261157|NCT01576718|589664574|FG001|Treatment Period|Physician Decision|1|||
163261158|NCT01576718|589664575|FG002|Treatment Period|Physician Decision|1|||
163261159|NCT01576718|589664576|FG003|Treatment Period|Physician Decision|1|||
163261160|NCT01576718|589664577|FG004|Treatment Period|Physician Decision|1|||
163261161|NCT01576718|589664578|FG005|Treatment Period|Physician Decision|0|||
163261162|NCT01576718|589664579|FG006|Treatment Period|Physician Decision|0|||
163261163|NCT01576718|589664573|FG000|Treatment Period|Protocol Violation|0|||
163261164|NCT01576718|589664574|FG001|Treatment Period|Protocol Violation|5|||
163261165|NCT01576718|589664575|FG002|Treatment Period|Protocol Violation|4|||
163261166|NCT01576718|589664576|FG003|Treatment Period|Protocol Violation|10|||
163261167|NCT01576718|589664577|FG004|Treatment Period|Protocol Violation|6|||
163261168|NCT01576718|589664578|FG005|Treatment Period|Protocol Violation|8|||
163261169|NCT01576718|589664579|FG006|Treatment Period|Protocol Violation|12|||
163261170|NCT01576718|589664573|FG000|Treatment Period|Sponsor request|0|||
163261171|NCT01576718|589664574|FG001|Treatment Period|Sponsor request|1|||
163261172|NCT01576718|589664575|FG002|Treatment Period|Sponsor request|0|||
163261173|NCT01576718|589664576|FG003|Treatment Period|Sponsor request|0|||
163261174|NCT01576718|589664577|FG004|Treatment Period|Sponsor request|0|||
163261175|NCT01576718|589664578|FG005|Treatment Period|Sponsor request|1|||
163261176|NCT01576718|589664579|FG006|Treatment Period|Sponsor request|0|||
163261177|NCT01576718|589664573|FG000|Treatment Period|Met stopping criteria|0|||
163261178|NCT01576718|589664574|FG001|Treatment Period|Met stopping criteria|16|||
163261179|NCT01576718|589664575|FG002|Treatment Period|Met stopping criteria|13|||
163261180|NCT01576718|589664576|FG003|Treatment Period|Met stopping criteria|19|||
163261181|NCT01576718|589664577|FG004|Treatment Period|Met stopping criteria|16|||
163261182|NCT01576718|589664578|FG005|Treatment Period|Met stopping criteria|33|||
163261183|NCT01576718|589664579|FG006|Treatment Period|Met stopping criteria|15|||
163261184|NCT01576718|589664573|FG000|Treatment Period|Lost to Follow-up|0|||
163261185|NCT01576718|589664574|FG001|Treatment Period|Lost to Follow-up|0|||
163261186|NCT01576718|589664575|FG002|Treatment Period|Lost to Follow-up|0|||
163261187|NCT01576718|589664576|FG003|Treatment Period|Lost to Follow-up|0|||
163261188|NCT01576718|589664577|FG004|Treatment Period|Lost to Follow-up|1|||
163261189|NCT01576718|589664578|FG005|Treatment Period|Lost to Follow-up|0|||
163261190|NCT01576718|589664579|FG006|Treatment Period|Lost to Follow-up|0|||
163261191|NCT01576718|589664573|FG000|Treatment Period|Noncompliance to study medication|0|||
163261192|NCT01576718|589664574|FG001|Treatment Period|Noncompliance to study medication|0|||
163261193|NCT01576718|589664575|FG002|Treatment Period|Noncompliance to study medication|0|||
163261194|NCT01576718|589664576|FG003|Treatment Period|Noncompliance to study medication|0|||
163261195|NCT01576718|589664577|FG004|Treatment Period|Noncompliance to study medication|0|||
163261196|NCT01576718|589664578|FG005|Treatment Period|Noncompliance to study medication|1|||
163261197|NCT01576718|589664579|FG006|Treatment Period|Noncompliance to study medication|1|||
163261198|NCT04631705|589664580|FG000|Overall Study|Withdrawal by Subject|0|||
163261199|NCT04631705|589664581|FG001|Overall Study|Withdrawal by Subject|0|||
163261200|NCT04631705|589664582|FG002|Overall Study|Withdrawal by Subject|0|||
163261201|NCT04631705|589664583|FG003|Overall Study|Withdrawal by Subject|0|||
163261202|NCT04631705|589664584|FG004|Overall Study|Withdrawal by Subject|0|||
163261203|NCT04631705|589664585|FG005|Overall Study|Withdrawal by Subject|0|||
163261204|NCT04631705|589664586|FG006|Overall Study|Withdrawal by Subject|1|||
163261205|NCT04631705|589664587|FG007|Overall Study|Withdrawal by Subject|0|||
163261206|NCT04631705|589664588|FG008|Overall Study|Withdrawal by Subject|0|||
163261207|NCT02070484|589664594|FG000|Overall Study|Withdrawal by Subject|1|||
163361654|NCT01888874|590033250|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
163361655|NCT01888874|590033244|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
163361656|NCT01888874|590033245|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
163361657|NCT01888874|590033246|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
163361658|NCT01888874|590033247|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
163361659|NCT01888874|590033248|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
163261208|NCT02070484|589664595|FG001|Overall Study|Withdrawal by Subject|0|||
163261209|NCT02821819|589664596|FG000|Overall Study|Protocol Violation|1|||
163261210|NCT02332590|589664597|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
163261211|NCT02332590|589664598|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
163261212|NCT02332590|589664597|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
163361660|NCT01888874|590033249|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
163361661|NCT01888874|590033250|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
163261213|NCT02332590|589664598|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
163261214|NCT02332590|589664597|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
163261215|NCT02332590|589664598|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
163261216|NCT02332590|589664597|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
163261217|NCT02332590|589664598|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
163261218|NCT02332590|589664597|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
163261219|NCT02332590|589664598|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
163261220|NCT02332590|589664597|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
163261221|NCT02332590|589664598|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
163261222|NCT02332590|589664597|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
163261223|NCT02332590|589664598|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
163261224|NCT02332590|589664597|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
163261225|NCT02332590|589664598|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
163261226|NCT02332590|589664597|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
163261227|NCT02332590|589664598|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
163261228|NCT04225988|589664600|FG000|Overall Study|Withdrawal by Subject|2|||
163261229|NCT04225988|589664601|FG001|Overall Study|Withdrawal by Subject|0|||
163261230|NCT05619003|589664603|FG000|Overall Study|Adverse Event|1|||
163261231|NCT02272725|589664608|FG000|Overall Study|equipment malfunction|2|||
163261232|NCT02272725|589664609|FG001|Overall Study|equipment malfunction|0|||
163361662|NCT01888874|590033244|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
163361663|NCT01888874|590033245|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
163361664|NCT01888874|590033246|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
163361665|NCT01888874|590033247|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
163361666|NCT01888874|590033248|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
163361667|NCT01888874|590033249|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
163361668|NCT01888874|590033250|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
163152416|NCT02419001|589274540|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
163152417|NCT02419001|589274541|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
163152418|NCT00535496|589274542|FG000|Overall Study|Lost to Follow-up|0|||
163152419|NCT00535496|589274543|FG001|Overall Study|Lost to Follow-up|1|||
163152420|NCT00535496|589274544|FG002|Overall Study|Lost to Follow-up|0|||
163152421|NCT00535496|589274545|FG003|Overall Study|Lost to Follow-up|0|||
163152422|NCT00535496|589274542|FG000|Overall Study|Not treated with sugammadex|0|||
163152423|NCT00535496|589274543|FG001|Overall Study|Not treated with sugammadex|1|||
163152424|NCT00535496|589274544|FG002|Overall Study|Not treated with sugammadex|0|||
163152425|NCT00535496|589274545|FG003|Overall Study|Not treated with sugammadex|0|||
163152426|NCT01209689|589274549|FG000|Overall Study|Insufficient Therapeutic Response|7|||
163152427|NCT01209689|589274550|FG001|Overall Study|Insufficient Therapeutic Response|2|||
163152428|NCT01209689|589274549|FG000|Overall Study|Refused Treatment|8|||
163152429|NCT01209689|589274550|FG001|Overall Study|Refused Treatment|3|||
163152430|NCT01209689|589274549|FG000|Overall Study|Adverse Event|4|||
163152431|NCT01209689|589274550|FG001|Overall Study|Adverse Event|0|||
163152432|NCT01209689|589274549|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
163152433|NCT01209689|589274550|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
163152434|NCT01209689|589274549|FG000|Overall Study|Failure to Return|3|||
163152435|NCT01209689|589274550|FG001|Overall Study|Failure to Return|0|||
163152436|NCT01209689|589274549|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
163152437|NCT01209689|589274550|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
163152438|NCT03780244|589274553|FG000|Overall Study|Lost to Follow-up|1|||
163152439|NCT03780244|589274554|FG001|Overall Study|Lost to Follow-up|0|||
163152440|NCT01083771|589274555|FG000|Overall Study|non-compliant|2|||
163152441|NCT01083771|589274555|FG000|Overall Study|Withdrawal by Subject|3|||
163152442|NCT03175367|589274556|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
163152443|NCT03175367|589274557|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
163152444|NCT03175367|589274558|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
163152445|NCT03175367|589274559|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
163152446|NCT03175367|589274560|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
163152447|NCT03175367|589274561|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
163152448|NCT03175367|589274562|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
163152449|NCT03175367|589274556|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
163152450|NCT03175367|589274557|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
163152451|NCT03175367|589274558|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
163152452|NCT03175367|589274559|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
163152453|NCT03175367|589274560|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
163152454|NCT03175367|589274561|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
163152455|NCT03175367|589274562|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
163152456|NCT03175367|589274556|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
163152457|NCT03175367|589274557|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
163152458|NCT03175367|589274558|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
163261233|NCT07018999|589664610|FG000|Overall Study|Protocol Violation|0|||
163261234|NCT07018999|589664611|FG001|Overall Study|Protocol Violation|1|||
163261235|NCT07018999|589664610|FG000|Overall Study|Incomplete data entry|4|||
163261236|NCT07018999|589664611|FG001|Overall Study|Incomplete data entry|7|||
163261237|NCT04739761|589664614|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
163261238|NCT04739761|589664615|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
163261239|NCT04739761|589664614|FG000|Overall Study|By complete response from the participant|1|||
163261240|NCT04739761|589664615|FG001|Overall Study|By complete response from the participant|0|||
163261241|NCT04739761|589664614|FG000|Overall Study|Lost to Follow-up|3|||
163261242|NCT04739761|589664615|FG001|Overall Study|Lost to Follow-up|3|||
163261243|NCT04739761|589664614|FG000|Overall Study|Death|13|||
163261244|NCT04739761|589664615|FG001|Overall Study|Death|13|||
163261245|NCT04739761|589664614|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
163261246|NCT04739761|589664615|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
163261247|NCT04739761|589664614|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
163261248|NCT04739761|589664615|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
163261249|NCT04739761|589664614|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
163261250|NCT04739761|589664615|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
163261251|NCT04739761|589664614|FG000|Overall Study|Adverse Event|0|||
163261252|NCT04739761|589664615|FG001|Overall Study|Adverse Event|3|||
163261253|NCT04739761|589664614|FG000|Overall Study|Participant decision|1|||
163261254|NCT04739761|589664615|FG001|Overall Study|Participant decision|0|||
163261255|NCT04739761|589664614|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
163261256|NCT04739761|589664615|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
163261257|NCT04739761|589664614|FG000|Overall Study|Participant immediately started next line of treatment|1|||
163261258|NCT04739761|589664615|FG001|Overall Study|Participant immediately started next line of treatment|0|||
163261259|NCT04739761|589664614|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
163261260|NCT04739761|589664615|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
163261261|NCT04739761|589664614|FG000|Overall Study|Lack of clinical benefit|1|||
163261262|NCT04739761|589664615|FG001|Overall Study|Lack of clinical benefit|0|||
163261263|NCT04739761|589664614|FG000|Overall Study|Disease progression|5|||
163152459|NCT03175367|589274559|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
163152460|NCT03175367|589274560|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
163152461|NCT03175367|589274561|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
163152462|NCT03175367|589274562|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
163152463|NCT03175367|589274556|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
163152464|NCT03175367|589274557|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
163152465|NCT03175367|589274558|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
163152466|NCT03175367|589274559|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
163152467|NCT03175367|589274560|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
163152468|NCT03175367|589274561|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
163152469|NCT03175367|589274562|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
163152470|NCT03175367|589274556|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163152471|NCT03175367|589274557|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163152472|NCT03175367|589274558|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
163152473|NCT03175367|589274559|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163152474|NCT03175367|589274560|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
163152475|NCT03175367|589274561|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163152476|NCT03175367|589274562|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163152477|NCT03175367|589274556|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
163152478|NCT03175367|589274557|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
163152479|NCT03175367|589274558|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
163152480|NCT03175367|589274559|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
163152481|NCT03175367|589274560|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
163152482|NCT03175367|589274561|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
163152483|NCT03175367|589274562|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
163152484|NCT03175367|589274556|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152485|NCT03175367|589274557|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163261264|NCT04739761|589664615|FG001|Overall Study|Disease progression|5|||
163261265|NCT04739761|589664614|FG000|Overall Study|Withdrawal by Subject|14|||
163261266|NCT04739761|589664615|FG001|Overall Study|Withdrawal by Subject|13|||
163411163|NCT00852995|590212997|FG001|Overall Study|Physician Decision|0|||
163152486|NCT03175367|589274558|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152487|NCT03175367|589274559|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152488|NCT03175367|589274560|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163261267|NCT04739761|589664614|FG000|Overall Study|Protocol Violation|1|||
163261268|NCT04739761|589664615|FG001|Overall Study|Protocol Violation|0|||
163261269|NCT04739761|589664614|FG000|Overall Study|Physician Decision|2|||
163261270|NCT04739761|589664615|FG001|Overall Study|Physician Decision|0|||
163261271|NCT03075501|589666564|FG000|Overall Study|Scheduling difficulties|15|||
163261272|NCT03075501|589666565|FG001|Overall Study|Scheduling difficulties|9|||
163261273|NCT00857805|589666568|FG000|Overall Study|Withdrawal by Subject|1|||
163261274|NCT00857805|589666569|FG001|Overall Study|Withdrawal by Subject|1|||
163261275|NCT01289041|589666570|FG000|Overall Study|Adverse Event|24|||
163261276|NCT01289041|589666570|FG000|Overall Study|Physician Decision|1|||
163261277|NCT01289041|589666570|FG000|Overall Study|Progressive Disease|41|||
163261278|NCT01289041|589666570|FG000|Overall Study|Withdrawal by Subject|3|||
163261279|NCT01289041|589666570|FG000|Overall Study|Death|1|||
163261280|NCT03610737|589666573|FG000|Overall Study|Withdrawal by Subject|1|||
163261281|NCT03610737|589666574|FG001|Overall Study|Withdrawal by Subject|5|||
163261282|NCT03610737|589666573|FG000|Overall Study|Death|1|||
163261283|NCT03610737|589666574|FG001|Overall Study|Death|0|||
163261284|NCT03610737|589666573|FG000|Overall Study|Not treated|5|||
163261285|NCT03610737|589666574|FG001|Overall Study|Not treated|2|||
163261286|NCT03610737|589666573|FG000|Overall Study|Missed Visit|1|||
163261287|NCT03610737|589666574|FG001|Overall Study|Missed Visit|2|||
163261288|NCT02714868|589666579|FG000|Overall Study|Withdrawal by Subject|3|||
163261289|NCT02714868|589666580|FG001|Overall Study|Withdrawal by Subject|0|||
163261290|NCT02714868|589666579|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
163261291|NCT02714868|589666580|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
163152489|NCT03175367|589274561|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
163152490|NCT03175367|589274562|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
163152491|NCT02851615|589274563|FG000|Overall Study|Cognitive Issue|1|||
163152492|NCT02851615|589274564|FG001|Overall Study|Cognitive Issue|0|||
163152493|NCT02851615|589274563|FG000|Overall Study|Lost to Follow-up|0|||
163152494|NCT02851615|589274564|FG001|Overall Study|Lost to Follow-up|4|||
163152495|NCT02345070|589274566|FG000|Overall Study|Adverse Event|12|||
163152496|NCT02345070|589274567|FG001|Overall Study|Adverse Event|8|||
163152497|NCT02345070|589274568|FG002|Overall Study|Adverse Event|16|||
163152498|NCT02345070|589274566|FG000|Overall Study|Poor compliance to protocol|2|||
163152499|NCT02345070|589274567|FG001|Overall Study|Poor compliance to protocol|0|||
163152500|NCT02345070|589274568|FG002|Overall Study|Poor compliance to protocol|0|||
163152501|NCT02345070|589274566|FG000|Overall Study|Other than specified above|6|||
163152502|NCT02345070|589274567|FG001|Overall Study|Other than specified above|3|||
163152503|NCT02345070|589274568|FG002|Overall Study|Other than specified above|7|||
163152504|NCT02151058|589274569|FG000|Overall Study|Withdrawal by Subject|1|||
163152505|NCT02151058|589274570|FG001|Overall Study|Withdrawal by Subject|1|||
163152506|NCT02151058|589274571|FG002|Overall Study|Withdrawal by Subject|3|||
163152507|NCT02151058|589274569|FG000|Overall Study|Lost to Follow-up|1|||
163152508|NCT02151058|589274570|FG001|Overall Study|Lost to Follow-up|0|||
163152509|NCT02151058|589274571|FG002|Overall Study|Lost to Follow-up|2|||
163152510|NCT00321620|589274573|FG000|Overall Study|Death|269|||
163152511|NCT00321620|589274574|FG001|Overall Study|Death|294|||
163152512|NCT00321620|589274573|FG000|Overall Study|Withdrawal by Subject|164|||
163152513|NCT00321620|589274574|FG001|Overall Study|Withdrawal by Subject|147|||
163152514|NCT00321620|589274573|FG000|Overall Study|Disease progression|113|||
163152515|NCT00321620|589274574|FG001|Overall Study|Disease progression|117|||
163152516|NCT00321620|589274573|FG000|Overall Study|Adverse Event|43|||
163152517|NCT00321620|589274574|FG001|Overall Study|Adverse Event|56|||
163152518|NCT00321620|589274573|FG000|Overall Study|Lost to Follow-up|13|||
163152519|NCT00321620|589274574|FG001|Overall Study|Lost to Follow-up|9|||
163152520|NCT00321620|589274573|FG000|Overall Study|Physician Decision|4|||
163152521|NCT00321620|589274574|FG001|Overall Study|Physician Decision|1|||
163152522|NCT00321620|589274573|FG000|Overall Study|Noncompliance|14|||
163152523|NCT00321620|589274574|FG001|Overall Study|Noncompliance|7|||
163152524|NCT00321620|589274573|FG000|Overall Study|Protocol deviation|4|||
163152525|NCT00321620|589274574|FG001|Overall Study|Protocol deviation|3|||
163152526|NCT00321620|589274573|FG000|Overall Study|Ineligibility determined|2|||
163152527|NCT00321620|589274574|FG001|Overall Study|Ineligibility determined|3|||
163152528|NCT00321620|589274573|FG000|Overall Study|Participant request|75|||
163152529|NCT00321620|589274574|FG001|Overall Study|Participant request|52|||
163152530|NCT00321620|589274573|FG000|Overall Study|Other|42|||
163152531|NCT00321620|589274574|FG001|Overall Study|Other|33|||
163152532|NCT03337477|589274575|FG000|Overall Study|not categorized into the listed ones|11|||
163152533|NCT03337477|589274576|FG001|Overall Study|not categorized into the listed ones|9|||
163152534|NCT03337477|589274575|FG000|Overall Study|Withdrawal by Subject|0|||
163152535|NCT03337477|589274576|FG001|Overall Study|Withdrawal by Subject|1|||
163152536|NCT03337477|589274575|FG000|Overall Study|Death|0|||
163152537|NCT03337477|589274576|FG001|Overall Study|Death|1|||
163152538|NCT03337477|589274575|FG000|Overall Study|Lost to Follow-up|0|||
163152539|NCT03337477|589274576|FG001|Overall Study|Lost to Follow-up|2|||
163152540|NCT03198715|589274578|FG000|Overall Study|Death|0|||
163152541|NCT03198715|589274579|FG001|Overall Study|Death|0|||
163152542|NCT03198715|589274580|FG002|Overall Study|Death|1|||
163152543|NCT03198715|589274581|FG003|Overall Study|Death|0|||
163152544|NCT03198715|589274582|FG004|Overall Study|Death|2|||
163152545|NCT03198715|589274578|FG000|Overall Study|Other|0|||
163152546|NCT03198715|589274579|FG001|Overall Study|Other|1|||
163152547|NCT03198715|589274580|FG002|Overall Study|Other|1|||
163152548|NCT03198715|589274581|FG003|Overall Study|Other|0|||
163152549|NCT03198715|589274582|FG004|Overall Study|Other|0|||
163152550|NCT02379728|589274583|FG000|Overall Study|Lost to Follow-up|1|||
163152551|NCT02379728|589274584|FG001|Overall Study|Lost to Follow-up|0|||
163152552|NCT02379728|589274585|FG002|Overall Study|Lost to Follow-up|3|||
163152553|NCT02379728|589274586|FG003|Overall Study|Lost to Follow-up|0|||
163152554|NCT02379728|589274583|FG000|Overall Study|Withdrawal by Subject|5|||
163152555|NCT02379728|589274584|FG001|Overall Study|Withdrawal by Subject|0|||
163152556|NCT02379728|589274585|FG002|Overall Study|Withdrawal by Subject|5|||
163152557|NCT02379728|589274586|FG003|Overall Study|Withdrawal by Subject|3|||
163152558|NCT02379728|589274583|FG000|Overall Study|Protocol Violation|0|||
163152559|NCT02379728|589274584|FG001|Overall Study|Protocol Violation|0|||
163152560|NCT02379728|589274585|FG002|Overall Study|Protocol Violation|2|||
163152561|NCT02379728|589274586|FG003|Overall Study|Protocol Violation|0|||
163152562|NCT01112917|589274588|FG000|Overall Study|Death|2|||
163152563|NCT01112917|589274589|FG001|Overall Study|Death|11|||
163152564|NCT01112917|589274588|FG000|Overall Study|Lost to Follow-up|1|||
163152565|NCT01112917|589274589|FG001|Overall Study|Lost to Follow-up|1|||
163152566|NCT01112917|589274588|FG000|Overall Study|Withdrawal by Subject|1|||
163152567|NCT01112917|589274589|FG001|Overall Study|Withdrawal by Subject|3|||
163152568|NCT01112917|589274588|FG000|Overall Study|Unable to Convert Filter|3|||
163152569|NCT01112917|589274589|FG001|Overall Study|Unable to Convert Filter|0|||
163152570|NCT05101122|589274590|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
163152571|NCT05101122|589274590|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
163152572|NCT05101122|589274590|FG000|AD313 80/5|Withdrawal by Subject|1|||
163152573|NCT05101122|589274590|FG000|AD313 80/10|Physician Decision|1|||
163152574|NCT03131219|589274591|FG000|Initial Evaluation Period|Adverse Event|2|||
163152575|NCT03131219|589274592|FG001|Initial Evaluation Period|Adverse Event|0|||
163152576|NCT03131219|589274591|FG000|Initial Evaluation Period|Protocol Violation|1|||
163152577|NCT03131219|589274592|FG001|Initial Evaluation Period|Protocol Violation|0|||
163152578|NCT03131219|589274591|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
163152579|NCT03131219|589274592|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
163152580|NCT03131219|589274591|FG000|Initial Evaluation Period|Physician Decision|1|||
163152581|NCT03131219|589274592|FG001|Initial Evaluation Period|Physician Decision|0|||
163152582|NCT03131219|589274591|FG000|Extension Period|Physician Decision|1|||
163152583|NCT03131219|589274592|FG001|Extension Period|Physician Decision|0|||
163152584|NCT00616759|589274594|FG000|Overall Study|Physician Decision|2|||
163152585|NCT00616759|589274595|FG001|Overall Study|Physician Decision|0|||
163152586|NCT00616759|589274594|FG000|Overall Study|Withdrawal by Subject|1|||
163152587|NCT00616759|589274595|FG001|Overall Study|Withdrawal by Subject|2|||
163152588|NCT02399163|589274598|FG000|Overall Study|Adverse Event|2|||
163152589|NCT02399163|589274598|FG000|Overall Study|Protocol Deviation|2|||
163152590|NCT02399163|589274598|FG000|Overall Study|Withdrawal by Participant|5|||
163152591|NCT04613362|589274609|FG000|3 Month Follow-up|Lost to Follow-up|1|||
163152592|NCT04613362|589274610|FG001|3 Month Follow-up|Lost to Follow-up|2|||
163152593|NCT04613362|589274609|FG000|6 Month Follow-up|Lost to Follow-up|0|||
163152594|NCT04613362|589274610|FG001|6 Month Follow-up|Lost to Follow-up|1|||
163152595|NCT04225897|589274611|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152596|NCT04225897|589274612|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
163152597|NCT04225897|589274613|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152598|NCT04225897|589274614|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152599|NCT04225897|589274615|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152600|NCT04225897|589274616|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152601|NCT04225897|589274617|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152602|NCT04225897|589274618|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152603|NCT04225897|589274619|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152604|NCT04225897|589274620|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152605|NCT04225897|589274621|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152606|NCT04225897|589274622|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152607|NCT04225897|589274611|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152608|NCT04225897|589274612|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152609|NCT04225897|589274613|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
163261292|NCT02714868|589666579|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
163152610|NCT04225897|589274614|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152611|NCT04225897|589274615|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152612|NCT04225897|589274616|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152613|NCT04225897|589274617|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152614|NCT04225897|589274618|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152615|NCT04225897|589274619|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152616|NCT04225897|589274620|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163261293|NCT02714868|589666580|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
163261294|NCT05056870|589666585|FG000|Period 1|Site COVID-19 Related|3|||
163261295|NCT05056870|589666586|FG001|Period 1|Site COVID-19 Related|3|||
163261296|NCT05056870|589666585|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
163261297|NCT05056870|589666586|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
163261298|NCT05056870|589666585|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
163261299|NCT05056870|589666586|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
163261300|NCT05056870|589666585|FG000|Period 2|COVID-19 Related|1|||
163261301|NCT05056870|589666586|FG001|Period 2|COVID-19 Related|0|||
163261302|NCT05056870|589666585|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
163261303|NCT05056870|589666586|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
163261304|NCT05044325|589666589|FG000|Part A:Treatment Period 1|Adverse Event|0|||
163261305|NCT05044325|589666590|FG001|Part A:Treatment Period 1|Adverse Event|0|||
163261306|NCT05044325|589666591|FG002|Part A:Treatment Period 1|Adverse Event|0|||
163261307|NCT05044325|589666592|FG003|Part A:Treatment Period 1|Adverse Event|0|||
163261308|NCT05044325|589666593|FG004|Part A:Treatment Period 1|Adverse Event|0|||
163261309|NCT05044325|589666594|FG005|Part A:Treatment Period 1|Adverse Event|1|||
163261310|NCT05044325|589666595|FG006|Part A:Treatment Period 1|Adverse Event|0|||
163261311|NCT05044325|589666596|FG007|Part A:Treatment Period 1|Adverse Event|1|||
163261312|NCT05044325|589666597|FG008|Part A:Treatment Period 1|Adverse Event|0|||
163261313|NCT05044325|589666598|FG009|Part A:Treatment Period 1|Adverse Event|0|||
163261314|NCT05044325|589666589|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
163261315|NCT05044325|589666590|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
163152617|NCT04225897|589274621|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152618|NCT04225897|589274622|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152619|NCT04225897|589274611|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152620|NCT04225897|589274612|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152621|NCT04225897|589274613|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
163152622|NCT04225897|589274614|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152623|NCT04225897|589274615|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152624|NCT04225897|589274616|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152625|NCT04225897|589274617|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152626|NCT04225897|589274618|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152627|NCT04225897|589274619|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152628|NCT04225897|589274620|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152629|NCT04225897|589274621|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152630|NCT04225897|589274622|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152631|NCT04225897|589274611|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152632|NCT04225897|589274612|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152633|NCT04225897|589274613|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152634|NCT04225897|589274614|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152635|NCT04225897|589274615|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152636|NCT04225897|589274616|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152637|NCT04225897|589274617|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152638|NCT04225897|589274618|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
163152639|NCT04225897|589274619|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152640|NCT04225897|589274620|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152641|NCT04225897|589274621|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152642|NCT04225897|589274622|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152643|NCT00074711|589274624|FG000|Overall Study|Withdrawal by Subject|1|||
163152644|NCT00074711|589274625|FG001|Overall Study|Withdrawal by Subject|1|||
163152645|NCT00074711|589274624|FG000|Overall Study|Lost to Follow-up|10|||
163152646|NCT00074711|589274625|FG001|Overall Study|Lost to Follow-up|8|||
163152647|NCT00074711|589274624|FG000|Overall Study|Participant stopped study drug|4|||
163152648|NCT00074711|589274625|FG001|Overall Study|Participant stopped study drug|6|||
163152649|NCT03466658|589274626|FG000|Overall Study|Withdrawal by Subject|3|||
163152650|NCT01921205|589274627|FG000|Overall Study|Adverse Event|12|||
163152651|NCT01921205|589274628|FG001|Overall Study|Adverse Event|7|||
163152652|NCT01921205|589274627|FG000|Overall Study|Lack of Efficacy|1|||
163261316|NCT05044325|589666591|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
163261317|NCT05044325|589666592|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
163261318|NCT05044325|589666593|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
163261319|NCT05044325|589666594|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
163261320|NCT05044325|589666595|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
163261321|NCT05044325|589666596|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
163261322|NCT05044325|589666597|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
163261323|NCT05044325|589666598|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
163152653|NCT01921205|589274628|FG001|Overall Study|Lack of Efficacy|0|||
163152654|NCT01921205|589274627|FG000|Overall Study|Protocol Violation|1|||
163152655|NCT01921205|589274628|FG001|Overall Study|Protocol Violation|3|||
163152656|NCT01921205|589274627|FG000|Overall Study|Lost to Follow-up|1|||
163152657|NCT01921205|589274628|FG001|Overall Study|Lost to Follow-up|1|||
163152658|NCT01921205|589274627|FG000|Overall Study|Withdrawal by Subject|6|||
163152659|NCT01921205|589274628|FG001|Overall Study|Withdrawal by Subject|5|||
163152660|NCT01921205|589274627|FG000|Overall Study|Use Of Prohibited Medication|0|||
163152661|NCT01921205|589274628|FG001|Overall Study|Use Of Prohibited Medication|1|||
163152662|NCT01921205|589274627|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
163152663|NCT01921205|589274628|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
163152664|NCT01921205|589274627|FG000|Overall Study|Non Compliance Of The Parent|0|||
163152665|NCT01921205|589274628|FG001|Overall Study|Non Compliance Of The Parent|1|||
163152666|NCT01921205|589274627|FG000|Overall Study|Non Compliance Of Child|0|||
163152667|NCT01921205|589274628|FG001|Overall Study|Non Compliance Of Child|1|||
163152668|NCT00456846|589274629|FG000|Overall Study|Adverse Event|2|||
163152669|NCT00456846|589274630|FG001|Overall Study|Adverse Event|15|||
163152670|NCT00456846|589274629|FG000|Overall Study|Physician Decision|11|||
163152671|NCT00456846|589274630|FG001|Overall Study|Physician Decision|6|||
163152672|NCT00456846|589274629|FG000|Overall Study|Protocol Deviation|2|||
163152673|NCT00456846|589274630|FG001|Overall Study|Protocol Deviation|0|||
163152674|NCT00456846|589274629|FG000|Overall Study|Participant Discretion|1|||
163152675|NCT00456846|589274630|FG001|Overall Study|Participant Discretion|5|||
163152676|NCT00456846|589274629|FG000|Overall Study|Other|0|||
163152677|NCT00456846|589274630|FG001|Overall Study|Other|2|||
163152678|NCT00886379|589274631|FG000|Overall Study|Transferred Schools|0|||
163152679|NCT00886379|589274632|FG001|Overall Study|Transferred Schools|0|||
163152680|NCT00886379|589274633|FG002|Overall Study|Transferred Schools|2|||
163152681|NCT00886379|589274634|FG003|Overall Study|Transferred Schools|1|||
163152682|NCT00886379|589274635|FG004|Overall Study|Transferred Schools|1|||
163152683|NCT00886379|589274631|FG000|Overall Study|Final blood draw not obtained|3|||
163152684|NCT00886379|589274632|FG001|Overall Study|Final blood draw not obtained|3|||
163152685|NCT00886379|589274633|FG002|Overall Study|Final blood draw not obtained|4|||
163152686|NCT00886379|589274634|FG003|Overall Study|Final blood draw not obtained|2|||
163152687|NCT00886379|589274635|FG004|Overall Study|Final blood draw not obtained|2|||
163152688|NCT03137381|589274636|FG000|Overall Study|Adverse Event|3|||
163152689|NCT03137381|589274637|FG001|Overall Study|Adverse Event|0|||
163152690|NCT03137381|589274638|FG002|Overall Study|Adverse Event|2|||
163152691|NCT03137381|589274639|FG003|Overall Study|Adverse Event|0|||
163152692|NCT03137381|589274636|FG000|Overall Study|Lost to Follow-up|2|||
163152693|NCT03137381|589274637|FG001|Overall Study|Lost to Follow-up|1|||
163152694|NCT03137381|589274638|FG002|Overall Study|Lost to Follow-up|1|||
163152695|NCT03137381|589274639|FG003|Overall Study|Lost to Follow-up|0|||
163152696|NCT03137381|589274636|FG000|Overall Study|Protocol deviation|1|||
163152697|NCT03137381|589274637|FG001|Overall Study|Protocol deviation|1|||
163152698|NCT03137381|589274638|FG002|Overall Study|Protocol deviation|0|||
163152699|NCT03137381|589274639|FG003|Overall Study|Protocol deviation|1|||
163152700|NCT03137381|589274636|FG000|Overall Study|Withdrawal by Investigator|0|||
163152701|NCT03137381|589274637|FG001|Overall Study|Withdrawal by Investigator|1|||
163152702|NCT03137381|589274638|FG002|Overall Study|Withdrawal by Investigator|1|||
163152703|NCT03137381|589274639|FG003|Overall Study|Withdrawal by Investigator|0|||
163152704|NCT03137381|589274636|FG000|Overall Study|Withdrawal by Subject|3|||
163152705|NCT03137381|589274637|FG001|Overall Study|Withdrawal by Subject|4|||
163152706|NCT03137381|589274638|FG002|Overall Study|Withdrawal by Subject|3|||
163152707|NCT03137381|589274639|FG003|Overall Study|Withdrawal by Subject|0|||
163152708|NCT03137381|589274636|FG000|Overall Study|Pregnancy|0|||
163152709|NCT03137381|589274637|FG001|Overall Study|Pregnancy|0|||
163152710|NCT03137381|589274638|FG002|Overall Study|Pregnancy|1|||
163152711|NCT03137381|589274639|FG003|Overall Study|Pregnancy|0|||
163152712|NCT00459316|589274644|FG000|Steps 1 & 2|Other eligibility failure|1|||
163152713|NCT00459316|589274645|FG001|Steps 1 & 2|Other eligibility failure|1|||
163152714|NCT00459316|589274646|FG002|Steps 1 & 2|Other eligibility failure|0|||
163152715|NCT00459316|589274644|FG000|Steps 1 & 2|Death|1|||
163152716|NCT00459316|589274645|FG001|Steps 1 & 2|Death|1|||
163152717|NCT00459316|589274646|FG002|Steps 1 & 2|Death|0|||
163152718|NCT00459316|589274644|FG000|Steps 1 & 2|Not able to get to clinic|7|||
163152719|NCT00459316|589274645|FG001|Steps 1 & 2|Not able to get to clinic|4|||
163152720|NCT00459316|589274646|FG002|Steps 1 & 2|Not able to get to clinic|0|||
163152721|NCT00459316|589274644|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
163152722|NCT00459316|589274645|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
163152723|NCT00459316|589274646|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
163152724|NCT00459316|589274644|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
163152725|NCT00459316|589274645|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
163152726|NCT00459316|589274646|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
163152727|NCT00459316|589274644|FG000|Steps 1 & 2|Lost to Follow-up|5|||
163152728|NCT00459316|589274645|FG001|Steps 1 & 2|Lost to Follow-up|0|||
163152729|NCT00459316|589274646|FG002|Steps 1 & 2|Lost to Follow-up|2|||
163152730|NCT00459316|589274644|FG000|Step 3|Withdrawal by Subject|3|||
163361669|NCT01888874|590033244|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
163361670|NCT01888874|590033245|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
163361671|NCT01888874|590033246|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
163361672|NCT01888874|590033247|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
163361673|NCT01888874|590033248|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
163361674|NCT01888874|590033249|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
163361675|NCT01888874|590033250|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
163361676|NCT01888874|590033244|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
163361677|NCT01888874|590033245|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
163361678|NCT01888874|590033246|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
163361679|NCT01888874|590033247|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
163361680|NCT01888874|590033248|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
163361681|NCT01888874|590033249|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
163361682|NCT01888874|590033250|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
163361683|NCT01888874|590033244|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
163361684|NCT01888874|590033245|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
163361685|NCT01888874|590033246|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
163361686|NCT01888874|590033247|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
163361687|NCT01888874|590033248|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
163361688|NCT01888874|590033249|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
163361689|NCT01888874|590033250|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
163361690|NCT01888874|590033244|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
163361691|NCT01888874|590033245|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
163361692|NCT01888874|590033246|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
163361693|NCT01888874|590033247|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
163361694|NCT01888874|590033248|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
163361695|NCT01888874|590033249|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
163361696|NCT01888874|590033250|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
163361697|NCT01888874|590033244|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
163361698|NCT01888874|590033245|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
163361699|NCT01888874|590033246|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
163361700|NCT01888874|590033247|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
163361701|NCT01888874|590033248|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
163361702|NCT01888874|590033249|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
163361703|NCT01888874|590033250|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
163361704|NCT02763215|590033251|FG000|Overall Study|Participants withdrew from study|3|||
163361705|NCT02763215|590033251|FG000|Overall Study|Missed visit|1|||
163361706|NCT02763215|590033251|FG000|Overall Study|Visit outside visit-window|1|||
163361707|NCT02763215|590033251|FG000|Overall Study|Death|1|||
163361708|NCT02763215|590033251|FG000|Overall Study|Lost to Follow-up|1|||
163361709|NCT01020877|590033254|FG000|Second Intervention|Withdrawal by Subject|1|||
163361710|NCT01020877|590033255|FG001|Second Intervention|Withdrawal by Subject|0|||
163361711|NCT02963090|590033257|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
163361712|NCT02963090|590033258|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
163361713|NCT01784523|590033259|FG000|Overall Study|Study closed early|7|||
163361714|NCT01784523|590033260|FG001|Overall Study|Study closed early|4|||
163361715|NCT00709228|590033261|FG000|Overall Study|Not treated|14|||
163361716|NCT00709228|590033261|FG000|Overall Study|Eligibility criteria not met|281|||
163361717|NCT00709228|590033261|FG000|Overall Study|Adverse events|2|||
163361718|NCT00709228|590033261|FG000|Overall Study|Discontinued treatment|14|||
163361719|NCT00709228|590033261|FG000|Overall Study|Did not enter follow-up|4|||
163361720|NCT00709228|590033261|FG000|Overall Study|Discontinued follow-up|5|||
163361721|NCT00709228|590033261|FG000|Overall Study|Disease progression|1|||
163361722|NCT00709228|590033261|FG000|Overall Study|Lost to Follow-up|6|||
163361723|NCT00709228|590033261|FG000|Overall Study|Non-compliance|5|||
163361724|NCT02179177|590033262|FG000|Overall Study|Lost to Follow-up|1|||
163361725|NCT02179177|590033263|FG001|Overall Study|Lost to Follow-up|1|||
163361726|NCT02179177|590033262|FG000|Overall Study|Withdrawal by Subject|1|||
163361727|NCT02179177|590033263|FG001|Overall Study|Withdrawal by Subject|1|||
163361728|NCT00022659|590033264|FG000|Overall Study|Ineligible: wrong primary|1|||
163361729|NCT00022659|590033264|FG000|Overall Study|Never treated|1|||
163361730|NCT00884650|590033265|FG000|Overall Study|Did not return complete pain diaries|7|||
163361731|NCT00884650|590033266|FG001|Overall Study|Did not return complete pain diaries|7|||
163361732|NCT00884650|590033265|FG000|Overall Study|Admitted Post-Op|1|||
163361733|NCT00884650|590033266|FG001|Overall Study|Admitted Post-Op|0|||
163361734|NCT00884650|590033265|FG000|Overall Study|Femoral Stress Fracture|1|||
163361735|NCT00884650|590033266|FG001|Overall Study|Femoral Stress Fracture|0|||
163361736|NCT00884650|590033265|FG000|Overall Study|Pain Pump Complication|0|||
163361737|NCT00884650|590033266|FG001|Overall Study|Pain Pump Complication|1|||
163361738|NCT04334278|590033267|FG000|Overall Study|Lost to Follow-up|0|||
163261324|NCT05044325|589666589|FG000|Part A:Treatment Period 1|Physician Decision|0|||
163261325|NCT05044325|589666590|FG001|Part A:Treatment Period 1|Physician Decision|0|||
163261326|NCT05044325|589666591|FG002|Part A:Treatment Period 1|Physician Decision|0|||
163261327|NCT05044325|589666592|FG003|Part A:Treatment Period 1|Physician Decision|0|||
163261328|NCT05044325|589666593|FG004|Part A:Treatment Period 1|Physician Decision|0|||
163261329|NCT05044325|589666594|FG005|Part A:Treatment Period 1|Physician Decision|0|||
163261330|NCT05044325|589666595|FG006|Part A:Treatment Period 1|Physician Decision|1|||
163261331|NCT05044325|589666596|FG007|Part A:Treatment Period 1|Physician Decision|0|||
163261332|NCT05044325|589666597|FG008|Part A:Treatment Period 1|Physician Decision|0|||
163261333|NCT05044325|589666598|FG009|Part A:Treatment Period 1|Physician Decision|0|||
163261334|NCT05044325|589666589|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163261335|NCT05044325|589666590|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163261336|NCT05044325|589666591|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
163261337|NCT05044325|589666592|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163261338|NCT05044325|589666593|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163261339|NCT05044325|589666594|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163261340|NCT05044325|589666595|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163261341|NCT05044325|589666596|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163261342|NCT05044325|589666597|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163261343|NCT05044325|589666598|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163261344|NCT05044325|589666589|FG000|Part A:Treatment Period 2|Adverse Event|0|||
163261345|NCT05044325|589666590|FG001|Part A:Treatment Period 2|Adverse Event|1|||
163261346|NCT05044325|589666591|FG002|Part A:Treatment Period 2|Adverse Event|0|||
163261347|NCT05044325|589666592|FG003|Part A:Treatment Period 2|Adverse Event|0|||
163261348|NCT05044325|589666593|FG004|Part A:Treatment Period 2|Adverse Event|1|||
163261349|NCT05044325|589666594|FG005|Part A:Treatment Period 2|Adverse Event|1|||
163261350|NCT05044325|589666595|FG006|Part A:Treatment Period 2|Adverse Event|0|||
163361739|NCT04334278|590033268|FG001|Overall Study|Lost to Follow-up|3|||
163361740|NCT04334278|590033267|FG000|Overall Study|Withdrawal by Subject|4|||
163361741|NCT04334278|590033268|FG001|Overall Study|Withdrawal by Subject|2|||
163361742|NCT01516749|590033269|FG000|Active Therapy|Lost to Follow-up|1|||
163361743|NCT01516749|590033269|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
163361744|NCT00742326|590033277|FG000|Overall Study|Physician Decision|0|||
163361745|NCT00742326|590033278|FG001|Overall Study|Physician Decision|1|||
163361746|NCT03635086|590033281|FG000|Overall Study|Withdrawal of consent|0|||
163361747|NCT03635086|590033282|FG001|Overall Study|Withdrawal of consent|0|||
163361748|NCT03635086|590033283|FG002|Overall Study|Withdrawal of consent|1|||
163361749|NCT03635086|590033284|FG003|Overall Study|Withdrawal of consent|0|||
163361750|NCT03635086|590033285|FG004|Overall Study|Withdrawal of consent|0|||
163361751|NCT03635086|590033281|FG000|Overall Study|Adverse Event|0|||
163361752|NCT03635086|590033282|FG001|Overall Study|Adverse Event|1|||
163361753|NCT03635086|590033283|FG002|Overall Study|Adverse Event|0|||
163361754|NCT03635086|590033284|FG003|Overall Study|Adverse Event|0|||
163361755|NCT03635086|590033285|FG004|Overall Study|Adverse Event|0|||
163361756|NCT03635086|590033281|FG000|Overall Study|Lost to Follow-up|1|||
163361757|NCT03635086|590033282|FG001|Overall Study|Lost to Follow-up|0|||
163361758|NCT03635086|590033283|FG002|Overall Study|Lost to Follow-up|0|||
163361759|NCT03635086|590033284|FG003|Overall Study|Lost to Follow-up|0|||
163361760|NCT03635086|590033285|FG004|Overall Study|Lost to Follow-up|0|||
163361761|NCT02196077|590033286|FG000|Overall Study|Adverse Event|4|||
163361762|NCT02196077|590033286|FG000|Overall Study|Lack of Efficacy|1|||
163361763|NCT02196077|590033286|FG000|Overall Study|Withdrawal by Subject|14|||
163361764|NCT02196077|590033286|FG000|Overall Study|Physician Decision|1|||
163361765|NCT02196077|590033286|FG000|Overall Study|Lost to Follow-up|3|||
163361766|NCT02196077|590033286|FG000|Overall Study|Protocol Violation|24|||
163361767|NCT00732992|590033287|FG000|Overall Study|Adverse Event|1|||
163361768|NCT00732992|590033288|FG001|Overall Study|Adverse Event|1|||
163361769|NCT00732992|590033287|FG000|Overall Study|Objective Progression or Relapse|3|||
163361770|NCT00732992|590033288|FG001|Overall Study|Objective Progression or Relapse|5|||
163361771|NCT00732992|590033287|FG000|Overall Study|Global Deterioration of Health Status|1|||
163361772|NCT00732992|590033288|FG001|Overall Study|Global Deterioration of Health Status|0|||
163361773|NCT00732992|590033287|FG000|Overall Study|Withdrawal by Subject|1|||
163361774|NCT00732992|590033288|FG001|Overall Study|Withdrawal by Subject|0|||
163361775|NCT01163474|590033294|FG000|Overall Study|Withdrawal by Subject|1|||
163361776|NCT01163474|590033294|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
163261351|NCT05044325|589666596|FG007|Part A:Treatment Period 2|Adverse Event|0|||
163261352|NCT05044325|589666597|FG008|Part A:Treatment Period 2|Adverse Event|0|||
163361777|NCT01163474|590033294|FG000|Overall Study|Lost to Follow-up|3|||
163261353|NCT05044325|589666598|FG009|Part A:Treatment Period 2|Adverse Event|0|||
163361778|NCT02493946|590033295|FG000|DB Period|Withdrawal by Subject|8|||
163361779|NCT02493946|590033296|FG001|DB Period|Withdrawal by Subject|5|||
163361780|NCT02493946|590033297|FG002|DB Period|Withdrawal by Subject|0|||
163361781|NCT02493946|590033295|FG000|Open Label Period|Withdrawal by Subject|0|||
163361782|NCT02493946|590033296|FG001|Open Label Period|Withdrawal by Subject|0|||
163361783|NCT02493946|590033297|FG002|Open Label Period|Withdrawal by Subject|74|||
163152731|NCT00459316|589274645|FG001|Step 3|Withdrawal by Subject|0|||
163152732|NCT00459316|589274646|FG002|Step 3|Withdrawal by Subject|1|||
163152733|NCT01614886|589274647|FG000|Overall Study|Adverse Event|15|||
163152734|NCT01614886|589274648|FG001|Overall Study|Adverse Event|20|||
163152735|NCT01614886|589274647|FG000|Overall Study|Withdrawal by Subject|4|||
163152736|NCT01614886|589274648|FG001|Overall Study|Withdrawal by Subject|4|||
163152737|NCT01614886|589274647|FG000|Overall Study|Death|1|||
163152738|NCT01614886|589274648|FG001|Overall Study|Death|0|||
163152739|NCT01614886|589274647|FG000|Overall Study|Protocol deviation|0|||
163152740|NCT01614886|589274648|FG001|Overall Study|Protocol deviation|2|||
163152741|NCT03379818|589274650|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
163152742|NCT03379818|589274651|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
163152743|NCT03379818|589274650|FG000|Overall Study|Withdrawal by Subject|2|||
163152744|NCT03379818|589274651|FG001|Overall Study|Withdrawal by Subject|3|||
163152745|NCT03379818|589274650|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
163152746|NCT03379818|589274651|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
163152747|NCT00423579|589274652|FG000|Overall Study|Lost to Follow-up|3|||
163152748|NCT00423579|589274653|FG001|Overall Study|Lost to Follow-up|0|||
163152749|NCT00423579|589274652|FG000|Overall Study|Protocol Violation|1|||
163261354|NCT05044325|589666589|FG000|Part A:Treatment Period 2|Physician Decision|0|||
163261355|NCT05044325|589666590|FG001|Part A:Treatment Period 2|Physician Decision|0|||
163261356|NCT05044325|589666591|FG002|Part A:Treatment Period 2|Physician Decision|0|||
163261357|NCT05044325|589666592|FG003|Part A:Treatment Period 2|Physician Decision|0|||
163261358|NCT05044325|589666593|FG004|Part A:Treatment Period 2|Physician Decision|0|||
163261359|NCT05044325|589666594|FG005|Part A:Treatment Period 2|Physician Decision|1|||
163261360|NCT05044325|589666595|FG006|Part A:Treatment Period 2|Physician Decision|0|||
163261361|NCT05044325|589666596|FG007|Part A:Treatment Period 2|Physician Decision|0|||
163261362|NCT05044325|589666597|FG008|Part A:Treatment Period 2|Physician Decision|0|||
163261363|NCT05044325|589666598|FG009|Part A:Treatment Period 2|Physician Decision|0|||
163261364|NCT05044325|589666589|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163261365|NCT05044325|589666590|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163261366|NCT05044325|589666591|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163261367|NCT05044325|589666592|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
163261368|NCT05044325|589666593|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
163261369|NCT05044325|589666594|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163152750|NCT00423579|589274653|FG001|Overall Study|Protocol Violation|3|||
163152751|NCT00423579|589274652|FG000|Overall Study|Diagnosis of diabetes|0|||
163152752|NCT00423579|589274653|FG001|Overall Study|Diagnosis of diabetes|1|||
163152753|NCT04004988|589274655|FG000|Period 1|Physician Decision|2|||
163152754|NCT04004988|589274656|FG001|Period 1|Physician Decision|0|||
163152755|NCT04004988|589274655|FG000|Period 1|Withdrawal by Subject|0|||
163261370|NCT05044325|589666595|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163261371|NCT05044325|589666596|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163261372|NCT05044325|589666597|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163261373|NCT05044325|589666598|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163261374|NCT01373931|589666601|FG000|Lead-in Period|Adverse Event|2|||
163261375|NCT01373931|589666602|FG001|Lead-in Period|Adverse Event|0|||
163261376|NCT01373931|589666601|FG000|Period 1|Adverse Event|2|||
163261377|NCT01373931|589666602|FG001|Period 1|Adverse Event|0|||
163261378|NCT01373931|589666601|FG000|Period 1|Withdrawal by Subject|0|||
163261379|NCT01373931|589666602|FG001|Period 1|Withdrawal by Subject|2|||
163261380|NCT00674323|589666603|FG000|Overall Study|Adverse Event|0|||
163261381|NCT00674323|589666604|FG001|Overall Study|Adverse Event|1|||
163261382|NCT00674323|589666605|FG002|Overall Study|Adverse Event|0|||
163152756|NCT04004988|589274656|FG001|Period 1|Withdrawal by Subject|1|||
163152757|NCT04004988|589274655|FG000|Period 1|Adverse Event|1|||
163152758|NCT04004988|589274656|FG001|Period 1|Adverse Event|2|||
163152759|NCT03873116|589274657|FG000|Part 1|Study drug discontinuation due to rash|0|||
163152760|NCT03873116|589274658|FG001|Part 1|Study drug discontinuation due to rash|0|||
163152761|NCT03873116|589274659|FG002|Part 1|Study drug discontinuation due to rash|0|||
163152762|NCT03873116|589274660|FG003|Part 1|Study drug discontinuation due to rash|0|||
163261383|NCT00674323|589666603|FG000|Overall Study|Protocol Violation|1|||
163261384|NCT00674323|589666604|FG001|Overall Study|Protocol Violation|0|||
163261385|NCT00674323|589666605|FG002|Overall Study|Protocol Violation|0|||
163261386|NCT00742079|589666606|FG000|Overall Study|Lost to Follow-up|0|||
163152763|NCT03873116|589274661|FG004|Part 1|Study drug discontinuation due to rash|0|||
163152764|NCT03873116|589274662|FG005|Part 1|Study drug discontinuation due to rash|1|||
163152765|NCT03873116|589274657|FG000|Part 2|Withdrawal by Subject|0|||
163152766|NCT03873116|589274658|FG001|Part 2|Withdrawal by Subject|0|||
163152767|NCT03873116|589274659|FG002|Part 2|Withdrawal by Subject|1|||
163261387|NCT00742079|589666607|FG001|Overall Study|Lost to Follow-up|1|||
163261388|NCT02013388|589666613|FG000|Overall Study|work emergency|1|||
163152768|NCT03873116|589274660|FG003|Part 2|Withdrawal by Subject|0|||
163152769|NCT03873116|589274661|FG004|Part 2|Withdrawal by Subject|0|||
163152770|NCT03873116|589274662|FG005|Part 2|Withdrawal by Subject|0|||
163152771|NCT03873116|589274657|FG000|Part 2|Lab abnormality or AE|0|||
163152772|NCT03873116|589274658|FG001|Part 2|Lab abnormality or AE|0|||
163152773|NCT03873116|589274659|FG002|Part 2|Lab abnormality or AE|0|||
163152774|NCT03873116|589274660|FG003|Part 2|Lab abnormality or AE|0|||
163152775|NCT03873116|589274661|FG004|Part 2|Lab abnormality or AE|1|||
163152776|NCT03873116|589274662|FG005|Part 2|Lab abnormality or AE|0|||
163152777|NCT03873116|589274657|FG000|Part 3|Withdrawal by Subject|0|||
163152778|NCT03873116|589274658|FG001|Part 3|Withdrawal by Subject|0|||
163152779|NCT03873116|589274659|FG002|Part 3|Withdrawal by Subject|0|||
163152780|NCT03873116|589274660|FG003|Part 3|Withdrawal by Subject|0|||
163152781|NCT03873116|589274661|FG004|Part 3|Withdrawal by Subject|1|||
163152782|NCT03873116|589274662|FG005|Part 3|Withdrawal by Subject|0|||
163152783|NCT00003475|589274663|FG000|Overall Study|Not evaluable|13|||
163261389|NCT02013388|589666614|FG001|Overall Study|work emergency|0|||
163261390|NCT02013388|589666615|FG002|Overall Study|work emergency|0|||
163261391|NCT02013388|589666616|FG003|Overall Study|work emergency|0|||
163261392|NCT02013388|589666617|FG004|Overall Study|work emergency|1|||
163261393|NCT02013388|589666618|FG005|Overall Study|work emergency|0|||
163261394|NCT02013388|589666619|FG006|Overall Study|work emergency|0|||
163261395|NCT02013388|589666620|FG007|Overall Study|work emergency|0|||
163261396|NCT01114204|589666624|FG000|Overall Study|Adverse Event|3|||
163261397|NCT01114204|589666625|FG001|Overall Study|Adverse Event|2|||
163261398|NCT01114204|589666624|FG000|Overall Study|Lost to Follow-up|1|||
163261399|NCT01114204|589666625|FG001|Overall Study|Lost to Follow-up|0|||
163152784|NCT04682366|589274664|FG000|Overall Study|Lost to Follow-up|1|||
163152785|NCT04682366|589274665|FG001|Overall Study|Lost to Follow-up|1|||
163152786|NCT03125395|589274666|FG000|Overall Study|Adverse Event|2|||
163152787|NCT03125395|589274666|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
163152788|NCT03125395|589274666|FG000|Overall Study|Physician Decision|2|||
163152789|NCT03125395|589274666|FG000|Overall Study|Commercial drug is available|5|||
163152790|NCT02531802|589274667|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
163152791|NCT02531802|589274668|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
163152792|NCT02531802|589274669|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
163152793|NCT02531802|589274670|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
163261400|NCT01114204|589666624|FG000|Overall Study|Withdrawal by Subject|10|||
163261401|NCT01114204|589666625|FG001|Overall Study|Withdrawal by Subject|6|||
163261402|NCT01114204|589666624|FG000|Overall Study|Death|1|||
163261403|NCT01114204|589666625|FG001|Overall Study|Death|0|||
163261404|NCT01114204|589666624|FG000|Overall Study|Other-Personal reasons|2|||
163261405|NCT01114204|589666625|FG001|Overall Study|Other-Personal reasons|0|||
163261406|NCT01114204|589666624|FG000|Overall Study|Other-Medical monitor request|1|||
163261407|NCT01114204|589666625|FG001|Overall Study|Other-Medical monitor request|0|||
163261408|NCT01114204|589666624|FG000|Overall Study|Other-Participant request|2|||
163261409|NCT01114204|589666625|FG001|Overall Study|Other-Participant request|0|||
163261410|NCT01114204|589666624|FG000|Overall Study|Other-Protocol Violation|1|||
163261411|NCT01114204|589666625|FG001|Overall Study|Other-Protocol Violation|0|||
163261412|NCT00991341|589666630|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
163261413|NCT00991341|589666631|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
163261414|NCT00991341|589666630|FG000|Overall Study|Death|3|||
163261415|NCT00991341|589666631|FG001|Overall Study|Death|0|||
163261416|NCT00991341|589666630|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
163261417|NCT00991341|589666631|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
163261418|NCT00991341|589666630|FG000|Overall Study|Physician Decision|1|||
163261419|NCT00991341|589666631|FG001|Overall Study|Physician Decision|2|||
163261420|NCT00991341|589666630|FG000|Overall Study|Withdrawal by Subject|3|||
163261421|NCT00991341|589666631|FG001|Overall Study|Withdrawal by Subject|4|||
163261422|NCT03145766|589666642|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
163261423|NCT03145766|589666643|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
163261424|NCT03145766|589666644|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
163261425|NCT03145766|589666645|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
163261426|NCT03145766|589666646|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
163261427|NCT03145766|589666642|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
163261428|NCT03145766|589666643|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
163261429|NCT03145766|589666644|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
163152794|NCT02531802|589274671|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
163152795|NCT02531802|589274672|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
163261430|NCT03145766|589666645|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
163261431|NCT03145766|589666646|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
163152796|NCT02531802|589274673|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
163152797|NCT02531802|589274674|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
163152798|NCT02531802|589274675|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
163261432|NCT03145766|589666642|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
163261433|NCT03145766|589666643|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
163261434|NCT03145766|589666644|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
163261435|NCT03145766|589666645|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
163261436|NCT03145766|589666646|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
163261437|NCT03145766|589666642|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
163261438|NCT03145766|589666643|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
163261439|NCT03145766|589666644|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
163261440|NCT03145766|589666645|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
163261441|NCT03145766|589666646|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
163261442|NCT03145766|589666642|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
163261443|NCT03145766|589666643|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
163261444|NCT03145766|589666644|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
163261445|NCT03145766|589666645|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
163261446|NCT03145766|589666646|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
163261447|NCT03145766|589666642|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
163261448|NCT03145766|589666643|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
163261449|NCT03145766|589666644|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
163261450|NCT03145766|589666645|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
163261451|NCT03145766|589666646|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
163152799|NCT02531802|589274676|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
163152800|NCT02531802|589274677|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
163152801|NCT02531802|589274678|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
163152802|NCT02531802|589274679|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
163152803|NCT02531802|589274680|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
163152804|NCT02531802|589274681|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
163152805|NCT02531802|589274682|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
163152806|NCT02531802|589274683|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
163152807|NCT02531802|589274684|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
163152808|NCT02531802|589274685|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
163152809|NCT02531802|589274686|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
163152810|NCT02531802|589274687|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
163152811|NCT02531802|589274667|FG000|Received Vaccination 2|Physician Decision|0|||
163152812|NCT02531802|589274668|FG001|Received Vaccination 2|Physician Decision|0|||
163152813|NCT02531802|589274669|FG002|Received Vaccination 2|Physician Decision|0|||
163152814|NCT02531802|589274670|FG003|Received Vaccination 2|Physician Decision|0|||
163152815|NCT02531802|589274671|FG004|Received Vaccination 2|Physician Decision|0|||
163152816|NCT02531802|589274672|FG005|Received Vaccination 2|Physician Decision|1|||
163152817|NCT02531802|589274673|FG006|Received Vaccination 2|Physician Decision|0|||
163152818|NCT02531802|589274674|FG007|Received Vaccination 2|Physician Decision|0|||
163152819|NCT02531802|589274675|FG008|Received Vaccination 2|Physician Decision|0|||
163152820|NCT02531802|589274676|FG009|Received Vaccination 2|Physician Decision|2|||
163152821|NCT02531802|589274677|FG010|Received Vaccination 2|Physician Decision|0|||
163152822|NCT02531802|589274678|FG011|Received Vaccination 2|Physician Decision|0|||
163152823|NCT02531802|589274679|FG012|Received Vaccination 2|Physician Decision|0|||
163152824|NCT02531802|589274680|FG013|Received Vaccination 2|Physician Decision|1|||
163152825|NCT02531802|589274681|FG014|Received Vaccination 2|Physician Decision|0|||
163152826|NCT02531802|589274682|FG015|Received Vaccination 2|Physician Decision|0|||
163152827|NCT02531802|589274683|FG016|Received Vaccination 2|Physician Decision|0|||
163152828|NCT02531802|589274684|FG017|Received Vaccination 2|Physician Decision|1|||
163152829|NCT02531802|589274685|FG018|Received Vaccination 2|Physician Decision|0|||
163152830|NCT02531802|589274686|FG019|Received Vaccination 2|Physician Decision|0|||
163152831|NCT02531802|589274687|FG020|Received Vaccination 2|Physician Decision|0|||
163152832|NCT02531802|589274667|FG000|Received Vaccination 2|Adverse Event|0|||
163152833|NCT02531802|589274668|FG001|Received Vaccination 2|Adverse Event|0|||
163152834|NCT02531802|589274669|FG002|Received Vaccination 2|Adverse Event|0|||
163152835|NCT02531802|589274670|FG003|Received Vaccination 2|Adverse Event|0|||
163152836|NCT02531802|589274671|FG004|Received Vaccination 2|Adverse Event|0|||
163152837|NCT02531802|589274672|FG005|Received Vaccination 2|Adverse Event|2|||
163152838|NCT02531802|589274673|FG006|Received Vaccination 2|Adverse Event|0|||
163152839|NCT02531802|589274674|FG007|Received Vaccination 2|Adverse Event|0|||
163152840|NCT02531802|589274675|FG008|Received Vaccination 2|Adverse Event|0|||
163152841|NCT02531802|589274676|FG009|Received Vaccination 2|Adverse Event|0|||
163152842|NCT02531802|589274677|FG010|Received Vaccination 2|Adverse Event|0|||
163152843|NCT02531802|589274678|FG011|Received Vaccination 2|Adverse Event|0|||
163152844|NCT02531802|589274679|FG012|Received Vaccination 2|Adverse Event|0|||
163261452|NCT03145766|589666642|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
163361784|NCT02493946|590033295|FG000|Open Label Period|Adverse Event|0|||
163361785|NCT02493946|590033296|FG001|Open Label Period|Adverse Event|0|||
163361786|NCT02493946|590033297|FG002|Open Label Period|Adverse Event|4|||
163361787|NCT02493946|590033295|FG000|Open Label Period|Lost to Follow-up|0|||
163361788|NCT02493946|590033296|FG001|Open Label Period|Lost to Follow-up|0|||
163361789|NCT02493946|590033297|FG002|Open Label Period|Lost to Follow-up|1|||
163361790|NCT02493946|590033295|FG000|Open Label Period|Investigator decision, non-compliance|0|||
163361791|NCT02493946|590033296|FG001|Open Label Period|Investigator decision, non-compliance|0|||
163361792|NCT02493946|590033297|FG002|Open Label Period|Investigator decision, non-compliance|2|||
163361793|NCT02493946|590033295|FG000|Open Label Period|Investigator decision, non-availability|0|||
163361794|NCT02493946|590033296|FG001|Open Label Period|Investigator decision, non-availability|0|||
163361795|NCT02493946|590033297|FG002|Open Label Period|Investigator decision, non-availability|1|||
163361796|NCT02493946|590033295|FG000|Open Label Period|Pregnancy|0|||
163361797|NCT02493946|590033296|FG001|Open Label Period|Pregnancy|0|||
163361798|NCT02493946|590033297|FG002|Open Label Period|Pregnancy|3|||
163361799|NCT02493946|590033295|FG000|Open Label Period|Site error|0|||
163361800|NCT02493946|590033296|FG001|Open Label Period|Site error|0|||
163361801|NCT02493946|590033297|FG002|Open Label Period|Site error|1|||
163361802|NCT01294436|590033302|FG000|Overall Study|Adverse Event|10|||
163361803|NCT01294436|590033303|FG001|Overall Study|Adverse Event|17|||
163361804|NCT01294436|590033302|FG000|Overall Study|Withdrawal by Subject|11|||
163361805|NCT01294436|590033303|FG001|Overall Study|Withdrawal by Subject|28|||
163361806|NCT01294436|590033302|FG000|Overall Study|subject no longer meets study criteria|5|||
163361807|NCT01294436|590033303|FG001|Overall Study|subject no longer meets study criteria|20|||
163361808|NCT01294436|590033302|FG000|Overall Study|poor/non-compliance|2|||
163361809|NCT01294436|590033303|FG001|Overall Study|poor/non-compliance|5|||
163361810|NCT02389764|590033304|FG000|Overall Study|Lack of Efficacy|9|||
163361811|NCT00585078|590033307|FG000|Overall Study|Withdrawal by Subject|4|||
163361812|NCT00585078|590033307|FG000|Overall Study|Poor performance status|1|||
163361813|NCT00585078|590033307|FG000|Overall Study|Disease Progression|24|||
163361814|NCT00585078|590033307|FG000|Overall Study|Adverse Event|10|||
163361815|NCT00585078|590033307|FG000|Overall Study|Death|1|||
163361816|NCT00383123|590033310|FG000|Overall Study|Adverse Event|1|||
163361817|NCT00383123|590033311|FG001|Overall Study|Adverse Event|0|||
163361818|NCT00383123|590033310|FG000|Overall Study|Lost to Follow-up|68|||
163361819|NCT00383123|590033311|FG001|Overall Study|Lost to Follow-up|61|||
163361820|NCT00383123|590033310|FG000|Overall Study|Protocol Violation|5|||
163361821|NCT00383123|590033311|FG001|Overall Study|Protocol Violation|1|||
163361822|NCT00383123|590033310|FG000|Overall Study|Withdrawal by Subject|27|||
163361823|NCT00383123|590033311|FG001|Overall Study|Withdrawal by Subject|18|||
163361824|NCT00383123|590033310|FG000|Overall Study|Other reason|10|||
163361825|NCT00383123|590033311|FG001|Overall Study|Other reason|6|||
163361826|NCT01814072|590033312|FG000|Overall Study|Lost to Follow-up|2|||
163361827|NCT01814072|590033313|FG001|Overall Study|Lost to Follow-up|2|||
163361828|NCT01814072|590033314|FG002|Overall Study|Lost to Follow-up|2|||
163361829|NCT01814072|590033315|FG003|Overall Study|Lost to Follow-up|0|||
163361830|NCT01814072|590033316|FG004|Overall Study|Lost to Follow-up|2|||
163361831|NCT01814072|590033317|FG005|Overall Study|Lost to Follow-up|3|||
163361832|NCT01814072|590033318|FG006|Overall Study|Lost to Follow-up|3|||
163361833|NCT01814072|590033319|FG007|Overall Study|Lost to Follow-up|1|||
163361834|NCT01814072|590033320|FG008|Overall Study|Lost to Follow-up|2|||
163361835|NCT01814072|590033321|FG009|Overall Study|Lost to Follow-up|3|||
163361836|NCT01814072|590033322|FG010|Overall Study|Lost to Follow-up|1|||
163361837|NCT01814072|590033323|FG011|Overall Study|Lost to Follow-up|2|||
163361838|NCT01814072|590033324|FG012|Overall Study|Lost to Follow-up|2|||
163361839|NCT01814072|590033325|FG013|Overall Study|Lost to Follow-up|1|||
163361840|NCT01814072|590033326|FG014|Overall Study|Lost to Follow-up|2|||
163361841|NCT01814072|590033327|FG015|Overall Study|Lost to Follow-up|1|||
163361842|NCT01814072|590033328|FG016|Overall Study|Lost to Follow-up|3|||
163361843|NCT01814072|590033329|FG017|Overall Study|Lost to Follow-up|1|||
163361844|NCT01814072|590033330|FG018|Overall Study|Lost to Follow-up|3|||
163361845|NCT01814072|590033331|FG019|Overall Study|Lost to Follow-up|3|||
163361846|NCT01814072|590033332|FG020|Overall Study|Lost to Follow-up|2|||
163361847|NCT01814072|590033333|FG021|Overall Study|Lost to Follow-up|1|||
163361848|NCT01814072|590033334|FG022|Overall Study|Lost to Follow-up|3|||
163361849|NCT01814072|590033335|FG023|Overall Study|Lost to Follow-up|1|||
163361850|NCT01814072|590033336|FG024|Overall Study|Lost to Follow-up|4|||
163361851|NCT01814072|590033337|FG025|Overall Study|Lost to Follow-up|1|||
163361852|NCT01814072|590033338|FG026|Overall Study|Lost to Follow-up|1|||
163361853|NCT01814072|590033339|FG027|Overall Study|Lost to Follow-up|2|||
163361854|NCT01814072|590033340|FG028|Overall Study|Lost to Follow-up|3|||
163361855|NCT01814072|590033341|FG029|Overall Study|Lost to Follow-up|3|||
163361856|NCT01814072|590033342|FG030|Overall Study|Lost to Follow-up|2|||
163361857|NCT01814072|590033343|FG031|Overall Study|Lost to Follow-up|0|||
163361858|NCT01814072|590033312|FG000|Overall Study|Withdrawal by Subject|2|||
163361859|NCT01814072|590033313|FG001|Overall Study|Withdrawal by Subject|0|||
163361860|NCT01814072|590033314|FG002|Overall Study|Withdrawal by Subject|1|||
163361861|NCT01814072|590033315|FG003|Overall Study|Withdrawal by Subject|0|||
163361862|NCT01814072|590033316|FG004|Overall Study|Withdrawal by Subject|2|||
163261453|NCT03145766|589666643|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
163261454|NCT03145766|589666644|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
163261455|NCT03145766|589666645|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
163261456|NCT03145766|589666646|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
163261457|NCT02799472|589666647|FG000|Overall Study|Withdrawal by Subject|2|||
163152845|NCT02531802|589274680|FG013|Received Vaccination 2|Adverse Event|0|||
163152846|NCT02531802|589274681|FG014|Received Vaccination 2|Adverse Event|0|||
163152847|NCT02531802|589274682|FG015|Received Vaccination 2|Adverse Event|0|||
163152848|NCT02531802|589274683|FG016|Received Vaccination 2|Adverse Event|0|||
163152849|NCT02531802|589274684|FG017|Received Vaccination 2|Adverse Event|2|||
163152850|NCT02531802|589274685|FG018|Received Vaccination 2|Adverse Event|1|||
163152851|NCT02531802|589274686|FG019|Received Vaccination 2|Adverse Event|0|||
163152852|NCT02531802|589274687|FG020|Received Vaccination 2|Adverse Event|1|||
163152853|NCT02531802|589274667|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
163152854|NCT02531802|589274668|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
163152855|NCT02531802|589274669|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
163152856|NCT02531802|589274670|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
163152857|NCT02531802|589274671|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
163152858|NCT02531802|589274672|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
163152859|NCT02531802|589274673|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
163152860|NCT02531802|589274674|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
163152861|NCT02531802|589274675|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
163152862|NCT02531802|589274676|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
163152863|NCT02531802|589274677|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
163152864|NCT02531802|589274678|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
163152865|NCT02531802|589274679|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
163152866|NCT02531802|589274680|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
163152867|NCT02531802|589274681|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
163152868|NCT02531802|589274682|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
163152869|NCT02531802|589274683|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
163152870|NCT02531802|589274684|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
163152871|NCT02531802|589274685|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
163152872|NCT02531802|589274686|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
163152873|NCT02531802|589274687|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
163152874|NCT00482053|589274688|FG000|Inter-treatment Period|Disease progression|1|||
163152875|NCT04842747|589274692|FG000|Overall Study|Withdrawal by Subject|6|||
163152876|NCT04842747|589274693|FG001|Overall Study|Withdrawal by Subject|2|||
163152877|NCT04842747|589274692|FG000|Overall Study|Lost to Follow-up|1|||
163152878|NCT04842747|589274693|FG001|Overall Study|Lost to Follow-up|2|||
163152879|NCT04842747|589274692|FG000|Overall Study|Physician Decision|1|||
163152880|NCT04842747|589274693|FG001|Overall Study|Physician Decision|0|||
163152881|NCT04842747|589274692|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
163152882|NCT04842747|589274693|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
163152883|NCT02559622|589274695|FG000|Overall Study|Progressive disease|0|||
163152884|NCT02559622|589274696|FG001|Overall Study|Progressive disease|1|||
163152885|NCT02559622|589274697|FG002|Overall Study|Progressive disease|0|||
163152886|NCT02559622|589274698|FG003|Overall Study|Progressive disease|0|||
163152887|NCT02559622|589274695|FG000|Overall Study|Adverse Event|0|||
163152888|NCT02559622|589274696|FG001|Overall Study|Adverse Event|2|||
163152889|NCT02559622|589274697|FG002|Overall Study|Adverse Event|2|||
163152890|NCT02559622|589274698|FG003|Overall Study|Adverse Event|2|||
163152891|NCT02559622|589274695|FG000|Overall Study|Patient/guardian decision|1|||
163152892|NCT02559622|589274696|FG001|Overall Study|Patient/guardian decision|2|||
163261458|NCT02799472|589666648|FG001|Overall Study|Withdrawal by Subject|4|||
163261459|NCT02799472|589666647|FG000|Overall Study|Lack of Efficacy|2|||
163261460|NCT02799472|589666648|FG001|Overall Study|Lack of Efficacy|0|||
163261461|NCT02799472|589666647|FG000|Overall Study|Lost to Follow-up|0|||
163261462|NCT02799472|589666648|FG001|Overall Study|Lost to Follow-up|1|||
163261463|NCT02801669|589666649|FG000|Overall Study|Death|66|||
163261464|NCT02801669|589666650|FG001|Overall Study|Death|69|||
163261465|NCT02801669|589666649|FG000|Overall Study|Withdrawal by Subject|81|||
163261466|NCT02801669|589666650|FG001|Overall Study|Withdrawal by Subject|77|||
163261467|NCT02801669|589666649|FG000|Overall Study|Other|4|||
163261468|NCT02801669|589666650|FG001|Overall Study|Other|6|||
163261469|NCT04461795|589666651|FG000|Overall Study|Lost to Follow-up|2|||
163261470|NCT04461795|589666651|FG000|Overall Study|Withdrawal by Subject|2|||
163261471|NCT04461795|589666651|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
163261472|NCT00615264|589666652|FG000|Overall Study|Withdrawal by Subject|17|||
163261473|NCT00615264|589666653|FG001|Overall Study|Withdrawal by Subject|19|||
163261474|NCT00615264|589666652|FG000|Overall Study|Lost to Follow-up|6|||
163261475|NCT00615264|589666653|FG001|Overall Study|Lost to Follow-up|13|||
163261476|NCT00615264|589666652|FG000|Overall Study|Adverse Event|8|||
163261477|NCT00615264|589666653|FG001|Overall Study|Adverse Event|5|||
163261478|NCT00615264|589666652|FG000|Overall Study|Death|1|||
163261479|NCT00615264|589666653|FG001|Overall Study|Death|1|||
163261480|NCT00615264|589666652|FG000|Overall Study|Protocol Violation|11|||
163261481|NCT00615264|589666653|FG001|Overall Study|Protocol Violation|7|||
163261482|NCT00615264|589666652|FG000|Overall Study|Not defined|7|||
163261483|NCT00615264|589666653|FG001|Overall Study|Not defined|4|||
163261484|NCT00615264|589666652|FG000|Overall Study|Dermal Hypersensitivity|0|||
163261485|NCT00615264|589666653|FG001|Overall Study|Dermal Hypersensitivity|3|||
163261486|NCT00633932|589666654|FG000|Overall Study|Adverse Event|1|||
163261487|NCT00633932|589666655|FG001|Overall Study|Adverse Event|3|||
163261488|NCT00633932|589666656|FG002|Overall Study|Adverse Event|4|||
163261489|NCT00633932|589666654|FG000|Overall Study|Withdrawal by Subject|3|||
163261490|NCT00633932|589666655|FG001|Overall Study|Withdrawal by Subject|9|||
163261491|NCT00633932|589666656|FG002|Overall Study|Withdrawal by Subject|1|||
163261492|NCT00633932|589666654|FG000|Overall Study|Lost to Follow-up|1|||
163261493|NCT00633932|589666655|FG001|Overall Study|Lost to Follow-up|0|||
163261494|NCT00633932|589666656|FG002|Overall Study|Lost to Follow-up|2|||
163261495|NCT00633932|589666654|FG000|Overall Study|Protocol Violation|5|||
163261496|NCT00633932|589666655|FG001|Overall Study|Protocol Violation|2|||
163261497|NCT00633932|589666656|FG002|Overall Study|Protocol Violation|3|||
163261498|NCT00633932|589666654|FG000|Overall Study|Physician Decision|0|||
163261499|NCT00633932|589666655|FG001|Overall Study|Physician Decision|0|||
163261500|NCT00633932|589666656|FG002|Overall Study|Physician Decision|1|||
163261501|NCT00633932|589666654|FG000|Overall Study|Doctor's judgement|1|||
163261502|NCT00633932|589666655|FG001|Overall Study|Doctor's judgement|0|||
163261503|NCT00633932|589666656|FG002|Overall Study|Doctor's judgement|0|||
163261504|NCT00633932|589666654|FG000|Overall Study|Moved Away|1|||
163261505|NCT00633932|589666655|FG001|Overall Study|Moved Away|0|||
163261506|NCT00633932|589666656|FG002|Overall Study|Moved Away|0|||
163261507|NCT04836858|589666657|FG000|Overall Study|Adverse Event|0|||
163261508|NCT04836858|589666658|FG001|Overall Study|Adverse Event|0|||
163261509|NCT04836858|589666659|FG002|Overall Study|Adverse Event|0|||
163261510|NCT04836858|589666660|FG003|Overall Study|Adverse Event|1|||
163261511|NCT04836858|589666657|FG000|Overall Study|Lost to Follow-up|1|||
163261512|NCT04836858|589666658|FG001|Overall Study|Lost to Follow-up|0|||
163261513|NCT04836858|589666659|FG002|Overall Study|Lost to Follow-up|0|||
163261514|NCT04836858|589666660|FG003|Overall Study|Lost to Follow-up|0|||
163261515|NCT04836858|589666657|FG000|Overall Study|Subject/Guardian decision|3|||
163261516|NCT04836858|589666658|FG001|Overall Study|Subject/Guardian decision|0|||
163261517|NCT04836858|589666659|FG002|Overall Study|Subject/Guardian decision|0|||
163261518|NCT04836858|589666660|FG003|Overall Study|Subject/Guardian decision|1|||
163261519|NCT04836858|589666657|FG000|Overall Study|Randomized but not treated|4|||
163261520|NCT04836858|589666658|FG001|Overall Study|Randomized but not treated|0|||
163261521|NCT04836858|589666659|FG002|Overall Study|Randomized but not treated|0|||
163261522|NCT04836858|589666660|FG003|Overall Study|Randomized but not treated|0|||
163261523|NCT01982435|589666662|FG000|Overall Study|Adverse Event|1|||
163261524|NCT01982435|589666663|FG001|Overall Study|Adverse Event|0|||
163261525|NCT03954743|589666664|FG000|Overall Study|Adverse Event|1|||
163261526|NCT03954743|589666665|FG001|Overall Study|Adverse Event|0|||
163261527|NCT03954743|589666664|FG000|Overall Study|Lost to Follow-up|6|||
163261528|NCT03954743|589666665|FG001|Overall Study|Lost to Follow-up|4|||
163261529|NCT03954743|589666664|FG000|Overall Study|Protocol Violation|1|||
163261530|NCT03954743|589666665|FG001|Overall Study|Protocol Violation|0|||
163261531|NCT03954743|589666664|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
163261532|NCT03954743|589666665|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
163261533|NCT03954743|589666664|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
163261534|NCT03954743|589666665|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163261535|NCT03541044|589666666|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
163261536|NCT03541044|589666667|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
163261537|NCT03541044|589666666|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
163261538|NCT03541044|589666667|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
163261539|NCT01153269|589666668|FG000|Overall Study|Withdrawal by Subject|1|||
163261540|NCT01153269|589666668|FG000|Overall Study|Antiretroviral therapy break|1|||
163261541|NCT02281760|589666679|FG000|Overall Study|Withdrawal by Subject|1|||
163261542|NCT00860067|589666680|FG000|Overall Study|Lost to Follow-up|46|||
163261543|NCT00860067|589666681|FG001|Overall Study|Lost to Follow-up|9|||
163261544|NCT00860067|589666682|FG002|Overall Study|Lost to Follow-up|9|||
163261545|NCT00860067|589666680|FG000|Overall Study|Withdrawal by Subject|4|||
163261546|NCT00860067|589666681|FG001|Overall Study|Withdrawal by Subject|0|||
163261547|NCT00860067|589666682|FG002|Overall Study|Withdrawal by Subject|0|||
163261548|NCT00860067|589666680|FG000|Overall Study|Pregnancy|1|||
163261549|NCT00860067|589666681|FG001|Overall Study|Pregnancy|0|||
163261550|NCT00860067|589666682|FG002|Overall Study|Pregnancy|0|||
163261551|NCT00100932|589666689|FG000|Overall Study|Adverse Event|11|||
163261552|NCT00100932|589666690|FG001|Overall Study|Adverse Event|2|||
163261553|NCT00100932|589666689|FG000|Overall Study|Withdrawal by Subject|6|||
163261554|NCT00100932|589666690|FG001|Overall Study|Withdrawal by Subject|0|||
163261555|NCT00100932|589666689|FG000|Overall Study|Progressive Disease|44|||
163261556|NCT00100932|589666690|FG001|Overall Study|Progressive Disease|18|||
163152893|NCT02559622|589274697|FG002|Overall Study|Patient/guardian decision|0|||
163152894|NCT02559622|589274698|FG003|Overall Study|Patient/guardian decision|1|||
163152895|NCT04011540|589274699|FG000|Overall Study|Lost to Follow-up|9|||
163152896|NCT04011540|589274700|FG001|Overall Study|Lost to Follow-up|6|||
163152897|NCT01668784|589274714|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
163152898|NCT01668784|589274715|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
163152899|NCT01668784|589274714|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
163152900|NCT01668784|589274715|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
163152901|NCT01668784|589274714|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
163152902|NCT01668784|589274715|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
163152903|NCT01668784|589274714|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
163152904|NCT01668784|589274715|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
163152905|NCT01668784|589274714|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
163152906|NCT01668784|589274715|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
163152907|NCT01668784|589274714|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
163152908|NCT01668784|589274715|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
163152909|NCT01668784|589274714|FG000|Treatment Period|Disease Progression|316|||
163152910|NCT01668784|589274715|FG001|Treatment Period|Disease Progression|293|||
163152911|NCT01668784|589274714|FG000|Treatment Period|Study Drug Toxicity|46|||
163152912|NCT01668784|589274715|FG001|Treatment Period|Study Drug Toxicity|53|||
163152913|NCT01668784|589274714|FG000|Treatment Period|Death|1|||
163152914|NCT01668784|589274715|FG001|Treatment Period|Death|1|||
163152915|NCT01668784|589274714|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
163152916|NCT01668784|589274715|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
163152917|NCT01668784|589274714|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
163152918|NCT01668784|589274715|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
163152919|NCT01668784|589274714|FG000|Treatment Period|Withdrawal by Subject|5|||
163152920|NCT01668784|589274715|FG001|Treatment Period|Withdrawal by Subject|3|||
163152921|NCT01668784|589274714|FG000|Treatment Period|Maximal Clinical Benefit|3|||
163152922|NCT01668784|589274715|FG001|Treatment Period|Maximal Clinical Benefit|3|||
163152923|NCT01668784|589274714|FG000|Treatment Period|Other|2|||
163152924|NCT01668784|589274715|FG001|Treatment Period|Other|8|||
163152925|NCT01668784|589274714|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
163152926|NCT01668784|589274715|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
163152927|NCT02761330|589274716|FG000|Treatment Week 1|Withdrawal by Subject|0|||
163152928|NCT02761330|589274717|FG001|Treatment Week 1|Withdrawal by Subject|0|||
163152929|NCT02761330|589274718|FG002|Treatment Week 1|Withdrawal by Subject|0|||
163152930|NCT02761330|589274719|FG003|Treatment Week 1|Withdrawal by Subject|1|||
163152931|NCT02761330|589274720|FG004|Treatment Week 1|Withdrawal by Subject|0|||
163152932|NCT02761330|589274721|FG005|Treatment Week 1|Withdrawal by Subject|1|||
163152933|NCT05386329|589274722|FG000|Overall Study|Lost to Follow-up|3|||
163152934|NCT03043313|589274725|FG000|Overall Study|Withdrawal by Subject|5|||
163152935|NCT03043313|589274726|FG001|Overall Study|Withdrawal by Subject|1|||
163152936|NCT03043313|589274727|FG002|Overall Study|Withdrawal by Subject|1|||
163152937|NCT03043313|589274725|FG000|Overall Study|Lost to Follow-up|1|||
163152938|NCT03043313|589274726|FG001|Overall Study|Lost to Follow-up|1|||
163152939|NCT03043313|589274727|FG002|Overall Study|Lost to Follow-up|0|||
163152940|NCT03043313|589274725|FG000|Overall Study|Death|28|||
163152941|NCT03043313|589274726|FG001|Overall Study|Death|26|||
163152942|NCT03043313|589274727|FG002|Overall Study|Death|17|||
163152943|NCT03043313|589274725|FG000|Overall Study|Participation terminated by sponsor|11|||
163152944|NCT03043313|589274726|FG001|Overall Study|Participation terminated by sponsor|13|||
163152945|NCT03043313|589274727|FG002|Overall Study|Participation terminated by sponsor|13|||
163152946|NCT04973449|589274730|FG000|Overall Study|Withdrawal by Subject|3|||
163152947|NCT04973449|589274731|FG001|Overall Study|Withdrawal by Subject|3|||
163152948|NCT04973449|589274732|FG002|Overall Study|Withdrawal by Subject|2|||
163152949|NCT04973449|589274733|FG003|Overall Study|Withdrawal by Subject|5|||
163152950|NCT04973449|589274734|FG004|Overall Study|Withdrawal by Subject|5|||
163152951|NCT04973449|589274735|FG005|Overall Study|Withdrawal by Subject|4|||
163152952|NCT04973449|589274736|FG006|Overall Study|Withdrawal by Subject|7|||
163152953|NCT04973449|589274737|FG007|Overall Study|Withdrawal by Subject|5|||
163261557|NCT00100932|589666689|FG000|Overall Study|Physician Decision|7|||
163261558|NCT00100932|589666690|FG001|Overall Study|Physician Decision|5|||
163152954|NCT04973449|589274730|FG000|Overall Study|Lost to Follow-up|15|||
163152955|NCT04973449|589274731|FG001|Overall Study|Lost to Follow-up|16|||
163152956|NCT04973449|589274732|FG002|Overall Study|Lost to Follow-up|16|||
163152957|NCT04973449|589274733|FG003|Overall Study|Lost to Follow-up|13|||
163152958|NCT04973449|589274734|FG004|Overall Study|Lost to Follow-up|5|||
163152959|NCT04973449|589274735|FG005|Overall Study|Lost to Follow-up|6|||
163152960|NCT04973449|589274736|FG006|Overall Study|Lost to Follow-up|10|||
163152961|NCT04973449|589274737|FG007|Overall Study|Lost to Follow-up|6|||
163152962|NCT04973449|589274730|FG000|Overall Study|Death|1|||
163152963|NCT04973449|589274731|FG001|Overall Study|Death|0|||
163152964|NCT04973449|589274732|FG002|Overall Study|Death|0|||
163152965|NCT04973449|589274733|FG003|Overall Study|Death|0|||
163361863|NCT01814072|590033317|FG005|Overall Study|Withdrawal by Subject|3|||
163361864|NCT01814072|590033318|FG006|Overall Study|Withdrawal by Subject|1|||
163361865|NCT01814072|590033319|FG007|Overall Study|Withdrawal by Subject|0|||
163361866|NCT01814072|590033320|FG008|Overall Study|Withdrawal by Subject|1|||
163361867|NCT01814072|590033321|FG009|Overall Study|Withdrawal by Subject|2|||
163361868|NCT01814072|590033322|FG010|Overall Study|Withdrawal by Subject|0|||
163361869|NCT01814072|590033323|FG011|Overall Study|Withdrawal by Subject|0|||
163361870|NCT01814072|590033324|FG012|Overall Study|Withdrawal by Subject|1|||
163361871|NCT01814072|590033325|FG013|Overall Study|Withdrawal by Subject|1|||
163361872|NCT01814072|590033326|FG014|Overall Study|Withdrawal by Subject|1|||
163361873|NCT01814072|590033327|FG015|Overall Study|Withdrawal by Subject|1|||
163361874|NCT01814072|590033328|FG016|Overall Study|Withdrawal by Subject|0|||
163361875|NCT01814072|590033329|FG017|Overall Study|Withdrawal by Subject|0|||
163361876|NCT01814072|590033330|FG018|Overall Study|Withdrawal by Subject|0|||
163361877|NCT01814072|590033331|FG019|Overall Study|Withdrawal by Subject|2|||
163361878|NCT01814072|590033332|FG020|Overall Study|Withdrawal by Subject|0|||
163361879|NCT01814072|590033333|FG021|Overall Study|Withdrawal by Subject|0|||
163361880|NCT01814072|590033334|FG022|Overall Study|Withdrawal by Subject|1|||
163361881|NCT01814072|590033335|FG023|Overall Study|Withdrawal by Subject|0|||
163361882|NCT01814072|590033336|FG024|Overall Study|Withdrawal by Subject|2|||
163361883|NCT01814072|590033337|FG025|Overall Study|Withdrawal by Subject|1|||
163361884|NCT01814072|590033338|FG026|Overall Study|Withdrawal by Subject|1|||
163361885|NCT01814072|590033339|FG027|Overall Study|Withdrawal by Subject|2|||
163361886|NCT01814072|590033340|FG028|Overall Study|Withdrawal by Subject|1|||
163361887|NCT01814072|590033341|FG029|Overall Study|Withdrawal by Subject|0|||
163361888|NCT01814072|590033342|FG030|Overall Study|Withdrawal by Subject|0|||
163361889|NCT01814072|590033343|FG031|Overall Study|Withdrawal by Subject|0|||
163361890|NCT02781311|590033344|FG000|Overall Study|Adverse Event|2|||
163361891|NCT02781311|590033345|FG001|Overall Study|Adverse Event|6|||
163361892|NCT02781311|590033346|FG002|Overall Study|Adverse Event|1|||
163361893|NCT02781311|590033344|FG000|Overall Study|Withdrawal of Consent|11|||
163361894|NCT02781311|590033345|FG001|Overall Study|Withdrawal of Consent|12|||
163361895|NCT02781311|590033346|FG002|Overall Study|Withdrawal of Consent|2|||
163361896|NCT02781311|590033344|FG000|Overall Study|Lost to Follow-up|11|||
163361897|NCT02781311|590033345|FG001|Overall Study|Lost to Follow-up|8|||
163361898|NCT02781311|590033346|FG002|Overall Study|Lost to Follow-up|1|||
163361899|NCT02781311|590033344|FG000|Overall Study|Non-Compliance with Study Drug|2|||
163361900|NCT02781311|590033345|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163361901|NCT02781311|590033346|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163361902|NCT00250432|590033353|FG000|Overall Study|Adverse Event|25|||
163361903|NCT00250432|590033354|FG001|Overall Study|Adverse Event|29|||
163361904|NCT00250432|590033353|FG000|Overall Study|Lack of Efficacy|2|||
163361905|NCT00250432|590033354|FG001|Overall Study|Lack of Efficacy|1|||
163361906|NCT00250432|590033353|FG000|Overall Study|Lost to Follow-up|6|||
163361907|NCT00250432|590033354|FG001|Overall Study|Lost to Follow-up|5|||
163361908|NCT00250432|590033353|FG000|Overall Study|Patient Moved|0|||
163361909|NCT00250432|590033354|FG001|Overall Study|Patient Moved|1|||
163361910|NCT00250432|590033353|FG000|Overall Study|Protocol Violation|0|||
163361911|NCT00250432|590033354|FG001|Overall Study|Protocol Violation|3|||
163361912|NCT00250432|590033353|FG000|Overall Study|Withdrawal by Subject|6|||
163361913|NCT00250432|590033354|FG001|Overall Study|Withdrawal by Subject|2|||
163361914|NCT00250432|590033353|FG000|Overall Study|Pt died out of posttherapy report period|6|||
163361915|NCT00250432|590033354|FG001|Overall Study|Pt died out of posttherapy report period|5|||
163361916|NCT00250432|590033353|FG000|Overall Study|Pt was considered untreatable|0|||
163361917|NCT00250432|590033354|FG001|Overall Study|Pt was considered untreatable|1|||
163361918|NCT01011868|590033355|FG000|After Week 18 Follow-up|Adverse Event|8|||
163361919|NCT01011868|590033356|FG001|After Week 18 Follow-up|Adverse Event|6|||
163361920|NCT01011868|590033357|FG002|After Week 18 Follow-up|Adverse Event|13|||
163361921|NCT01011868|590033355|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
163361922|NCT01011868|590033356|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
163361923|NCT01011868|590033357|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
163361924|NCT01011868|590033355|FG000|After Week 18 Follow-up|Protocol Violation|1|||
163361925|NCT01011868|590033356|FG001|After Week 18 Follow-up|Protocol Violation|1|||
163361926|NCT01011868|590033357|FG002|After Week 18 Follow-up|Protocol Violation|1|||
163361927|NCT01011868|590033355|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
163361928|NCT01011868|590033356|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
163361929|NCT01011868|590033357|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
163361930|NCT01011868|590033355|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
163361931|NCT01011868|590033356|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
163361932|NCT01011868|590033357|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
163361933|NCT01011868|590033355|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
163361934|NCT01011868|590033356|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
163361935|NCT01011868|590033357|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
163361936|NCT01011868|590033355|FG000|After Week 78 Follow-up|Adverse Event|14|||
163361937|NCT01011868|590033356|FG001|After Week 78 Follow-up|Adverse Event|18|||
163152966|NCT04973449|589274734|FG004|Overall Study|Death|0|||
163152967|NCT04973449|589274735|FG005|Overall Study|Death|1|||
163152968|NCT04973449|589274736|FG006|Overall Study|Death|0|||
163152969|NCT04973449|589274737|FG007|Overall Study|Death|0|||
163152970|NCT04973449|589274730|FG000|Overall Study|Other|1|||
163152971|NCT04973449|589274731|FG001|Overall Study|Other|1|||
163152972|NCT04973449|589274732|FG002|Overall Study|Other|2|||
163152973|NCT04973449|589274733|FG003|Overall Study|Other|1|||
163152974|NCT04973449|589274734|FG004|Overall Study|Other|4|||
163152975|NCT04973449|589274735|FG005|Overall Study|Other|0|||
163152976|NCT04973449|589274736|FG006|Overall Study|Other|2|||
163152977|NCT04973449|589274737|FG007|Overall Study|Other|2|||
163152978|NCT01506596|589274738|FG000|Overall Study|ineligible pathology|1|||
163152979|NCT03137992|589274740|FG000|Washout Period 1|Adverse Event|1|||
163152980|NCT03137992|589274741|FG001|Washout Period 1|Adverse Event|1|||
163152981|NCT03137992|589274742|FG002|Washout Period 1|Adverse Event|0|||
163152982|NCT03137992|589274743|FG003|Washout Period 1|Adverse Event|0|||
163152983|NCT03137992|589274744|FG004|Washout Period 1|Adverse Event|0|||
163152984|NCT03137992|589274745|FG005|Washout Period 1|Adverse Event|1|||
163152985|NCT03137992|589274740|FG000|Washout Period 1|Withdrawal by Subject|0|||
163152986|NCT03137992|589274741|FG001|Washout Period 1|Withdrawal by Subject|1|||
163152987|NCT03137992|589274742|FG002|Washout Period 1|Withdrawal by Subject|1|||
163152988|NCT03137992|589274743|FG003|Washout Period 1|Withdrawal by Subject|0|||
163152989|NCT03137992|589274744|FG004|Washout Period 1|Withdrawal by Subject|0|||
163152990|NCT03137992|589274745|FG005|Washout Period 1|Withdrawal by Subject|0|||
163152991|NCT03137992|589274740|FG000|Washout Period 1|Principal Investigator Discretion|0|||
163152992|NCT03137992|589274741|FG001|Washout Period 1|Principal Investigator Discretion|1|||
163152993|NCT03137992|589274742|FG002|Washout Period 1|Principal Investigator Discretion|0|||
163152994|NCT03137992|589274743|FG003|Washout Period 1|Principal Investigator Discretion|0|||
163152995|NCT03137992|589274744|FG004|Washout Period 1|Principal Investigator Discretion|0|||
163152996|NCT03137992|589274745|FG005|Washout Period 1|Principal Investigator Discretion|0|||
163152997|NCT03137992|589274740|FG000|Washout Period 1|COPD Exacerbation|1|||
163152998|NCT03137992|589274741|FG001|Washout Period 1|COPD Exacerbation|1|||
163152999|NCT03137992|589274742|FG002|Washout Period 1|COPD Exacerbation|1|||
163153000|NCT03137992|589274743|FG003|Washout Period 1|COPD Exacerbation|0|||
163153001|NCT03137992|589274744|FG004|Washout Period 1|COPD Exacerbation|1|||
163153002|NCT03137992|589274745|FG005|Washout Period 1|COPD Exacerbation|1|||
163153003|NCT03137992|589274740|FG000|Washout Period 1|Subject Noncompliance|1|||
163153004|NCT03137992|589274741|FG001|Washout Period 1|Subject Noncompliance|0|||
163153005|NCT03137992|589274742|FG002|Washout Period 1|Subject Noncompliance|0|||
163153006|NCT03137992|589274743|FG003|Washout Period 1|Subject Noncompliance|0|||
163153007|NCT03137992|589274744|FG004|Washout Period 1|Subject Noncompliance|1|||
163153008|NCT03137992|589274745|FG005|Washout Period 1|Subject Noncompliance|0|||
163153009|NCT03137992|589274740|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
163153010|NCT03137992|589274741|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
163153011|NCT03137992|589274742|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
163153012|NCT03137992|589274743|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
163153013|NCT03137992|589274744|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
163153014|NCT03137992|589274745|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
163261559|NCT00100932|589666689|FG000|Overall Study|Other|5|||
163261560|NCT00100932|589666690|FG001|Overall Study|Other|2|||
163261561|NCT02387996|589666691|FG000|Overall Study|Disease Progression|167|||
163261562|NCT02387996|589666691|FG000|Overall Study|Study Drug Toxicity|31|||
163261563|NCT02387996|589666691|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
163261564|NCT02387996|589666691|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
163261565|NCT02387996|589666691|FG000|Overall Study|Subject Withdrew Consent|5|||
163153015|NCT03137992|589274740|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
163153016|NCT03137992|589274741|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
163153017|NCT03137992|589274742|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
163153018|NCT03137992|589274743|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
163153019|NCT03137992|589274744|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
163261566|NCT02387996|589666691|FG000|Overall Study|Lost to Follow-up|1|||
163261567|NCT02387996|589666691|FG000|Overall Study|Poor/Non-Compliance|1|||
163261568|NCT02387996|589666691|FG000|Overall Study|Other Reasons|5|||
163261569|NCT02387996|589666691|FG000|Overall Study|Death|1|||
163261570|NCT00312702|589666692|FG000|Immunization Phase|Lost to Follow-up|0|||
163261571|NCT00312702|589666693|FG001|Immunization Phase|Lost to Follow-up|1|||
163261572|NCT00312702|589666694|FG002|Immunization Phase|Lost to Follow-up|0|||
163261573|NCT00770432|589666695|FG000|Overall Study|Other|4|||
163261574|NCT00770432|589666696|FG001|Overall Study|Other|6|||
163261575|NCT00770432|589666695|FG000|Overall Study|Non-compliance|0|||
163261576|NCT00770432|589666696|FG001|Overall Study|Non-compliance|1|||
163261577|NCT01453348|589666697|FG000|Overall Study|Death|0|||
163261578|NCT01453348|589666698|FG001|Overall Study|Death|0|||
163261579|NCT01453348|589666699|FG002|Overall Study|Death|1|||
163261580|NCT01453348|589666697|FG000|Overall Study|Withdrawal by Subject|0|||
163261581|NCT01453348|589666698|FG001|Overall Study|Withdrawal by Subject|1|||
163153020|NCT03137992|589274745|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
163153021|NCT03137992|589274740|FG000|Period 2 (Visit 3)|Adverse Event|0|||
163153022|NCT03137992|589274741|FG001|Period 2 (Visit 3)|Adverse Event|1|||
163153023|NCT03137992|589274742|FG002|Period 2 (Visit 3)|Adverse Event|0|||
163153024|NCT03137992|589274743|FG003|Period 2 (Visit 3)|Adverse Event|0|||
163153025|NCT03137992|589274744|FG004|Period 2 (Visit 3)|Adverse Event|0|||
163153026|NCT03137992|589274745|FG005|Period 2 (Visit 3)|Adverse Event|0|||
163153027|NCT03137992|589274740|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
163153028|NCT03137992|589274741|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
163153029|NCT03137992|589274742|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
163153030|NCT03137992|589274743|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
163153031|NCT03137992|589274744|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
163153032|NCT03137992|589274745|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
163153033|NCT03137992|589274740|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
163153034|NCT03137992|589274741|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
163153035|NCT03137992|589274742|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
163153036|NCT03137992|589274743|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
163153037|NCT03137992|589274744|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
163153038|NCT03137992|589274745|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
163153039|NCT03137992|589274740|FG000|Washout Period 2|COPD Exacerbation|1|||
163153040|NCT03137992|589274741|FG001|Washout Period 2|COPD Exacerbation|1|||
163153041|NCT03137992|589274742|FG002|Washout Period 2|COPD Exacerbation|0|||
163153042|NCT03137992|589274743|FG003|Washout Period 2|COPD Exacerbation|0|||
163153043|NCT03137992|589274744|FG004|Washout Period 2|COPD Exacerbation|1|||
163153044|NCT03137992|589274745|FG005|Washout Period 2|COPD Exacerbation|0|||
163153045|NCT03137992|589274740|FG000|Washout Period 2|Subject Non-compliance|0|||
163153046|NCT03137992|589274741|FG001|Washout Period 2|Subject Non-compliance|1|||
163153047|NCT03137992|589274742|FG002|Washout Period 2|Subject Non-compliance|0|||
163153048|NCT03137992|589274743|FG003|Washout Period 2|Subject Non-compliance|0|||
163153049|NCT03137992|589274744|FG004|Washout Period 2|Subject Non-compliance|0|||
163153050|NCT03137992|589274745|FG005|Washout Period 2|Subject Non-compliance|0|||
163153051|NCT03137992|589274740|FG000|Washout Period 2|Adverse Event|0|||
163153052|NCT03137992|589274741|FG001|Washout Period 2|Adverse Event|0|||
163153053|NCT03137992|589274742|FG002|Washout Period 2|Adverse Event|0|||
163153054|NCT03137992|589274743|FG003|Washout Period 2|Adverse Event|1|||
163153055|NCT03137992|589274744|FG004|Washout Period 2|Adverse Event|1|||
163153056|NCT03137992|589274745|FG005|Washout Period 2|Adverse Event|0|||
163153057|NCT03137992|589274740|FG000|Washout Period 2|Withdrawal by Subject|1|||
163261582|NCT01453348|589666699|FG002|Overall Study|Withdrawal by Subject|0|||
163261583|NCT01453348|589666697|FG000|Overall Study|Protocol Violation|1|||
163261584|NCT01453348|589666698|FG001|Overall Study|Protocol Violation|0|||
163261585|NCT01453348|589666699|FG002|Overall Study|Protocol Violation|0|||
163261586|NCT02756832|589666700|FG000|Overall Study|Lost for Observation after Baseline|6|||
163261587|NCT02756832|589666700|FG000|Overall Study|Lost for Observation|13|||
163261588|NCT02756832|589666700|FG000|Overall Study|Patient's Unwillingness|12|||
163261589|NCT02756832|589666700|FG000|Overall Study|Insufficient Efficacy|2|||
163261590|NCT02756832|589666700|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
163261591|NCT02756832|589666700|FG000|Overall Study|Reason not Specified|9|||
163261592|NCT02756832|589666700|FG000|Overall Study|Protocol Deviation|10|||
163261593|NCT01498822|589666702|FG000|Overall Study|Protocol Violation|8|||
163261594|NCT01498822|589666703|FG001|Overall Study|Protocol Violation|4|||
163261595|NCT01498822|589666702|FG000|Overall Study|Other Reason|5|||
163261596|NCT01498822|589666703|FG001|Overall Study|Other Reason|2|||
163261597|NCT01498822|589666702|FG000|Overall Study|Lack of Efficacy|7|||
163261598|NCT01498822|589666703|FG001|Overall Study|Lack of Efficacy|2|||
163261599|NCT01498822|589666702|FG000|Overall Study|AE, non-serious non-fatal|8|||
163261600|NCT01498822|589666703|FG001|Overall Study|AE, non-serious non-fatal|17|||
163261601|NCT01498822|589666702|FG000|Overall Study|SAE, non-fatal|2|||
163261602|NCT01498822|589666703|FG001|Overall Study|SAE, non-fatal|2|||
163261603|NCT01498822|589666702|FG000|Overall Study|Adverse Event, serious fatal|1|||
163261604|NCT01498822|589666703|FG001|Overall Study|Adverse Event, serious fatal|1|||
163261605|NCT01498822|589666702|FG000|Overall Study|Withdrawal by Subject|15|||
163261606|NCT01498822|589666703|FG001|Overall Study|Withdrawal by Subject|25|||
163261607|NCT01498822|589666702|FG000|Overall Study|Lost to Follow-up|8|||
163261608|NCT01498822|589666703|FG001|Overall Study|Lost to Follow-up|3|||
163261609|NCT03592277|589666704|FG000|Overall Study|Withdrawal by Subject|6|||
163261610|NCT03592277|589666705|FG001|Overall Study|Withdrawal by Subject|8|||
163261611|NCT02917265|589666708|FG000|Overall Study|Physician Decision|1|||
163153058|NCT03137992|589274741|FG001|Washout Period 2|Withdrawal by Subject|0|||
163153059|NCT03137992|589274742|FG002|Washout Period 2|Withdrawal by Subject|0|||
163153060|NCT03137992|589274743|FG003|Washout Period 2|Withdrawal by Subject|0|||
163153061|NCT03137992|589274744|FG004|Washout Period 2|Withdrawal by Subject|1|||
163153062|NCT03137992|589274745|FG005|Washout Period 2|Withdrawal by Subject|0|||
163153063|NCT03137992|589274740|FG000|Washout Period 2|Sponsor Decision|0|||
163153064|NCT03137992|589274741|FG001|Washout Period 2|Sponsor Decision|0|||
163153065|NCT03137992|589274742|FG002|Washout Period 2|Sponsor Decision|0|||
163153066|NCT03137992|589274743|FG003|Washout Period 2|Sponsor Decision|0|||
163361938|NCT01011868|590033357|FG002|After Week 78 Follow-up|Adverse Event|21|||
163361939|NCT01011868|590033355|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
163361940|NCT01011868|590033356|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
163361941|NCT01011868|590033357|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
163361942|NCT01011868|590033355|FG000|After Week 78 Follow-up|Protocol Violation|9|||
163361943|NCT01011868|590033356|FG001|After Week 78 Follow-up|Protocol Violation|1|||
163361944|NCT01011868|590033357|FG002|After Week 78 Follow-up|Protocol Violation|2|||
163361945|NCT01011868|590033355|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
163361946|NCT01011868|590033356|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
163361947|NCT01011868|590033357|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
163361948|NCT01011868|590033355|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
163361949|NCT01011868|590033356|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
163361950|NCT01011868|590033357|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
163361951|NCT01011868|590033355|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
163361952|NCT01011868|590033356|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
163361953|NCT01011868|590033357|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
163361954|NCT04147858|590033358|FG000|Overall Study|Adverse Event|6|||
163361955|NCT04147858|590033359|FG001|Overall Study|Adverse Event|6|||
163361956|NCT04147858|590033360|FG002|Overall Study|Adverse Event|6|||
163361957|NCT04147858|590033358|FG000|Overall Study|Lack of Efficacy|3|||
163361958|NCT04147858|590033359|FG001|Overall Study|Lack of Efficacy|3|||
163361959|NCT04147858|590033360|FG002|Overall Study|Lack of Efficacy|1|||
163361960|NCT04147858|590033358|FG000|Overall Study|Lost to Follow-up|1|||
163361961|NCT04147858|590033359|FG001|Overall Study|Lost to Follow-up|6|||
163361962|NCT04147858|590033360|FG002|Overall Study|Lost to Follow-up|2|||
163361963|NCT04147858|590033358|FG000|Overall Study|Withdrawal by Subject|3|||
163361964|NCT04147858|590033359|FG001|Overall Study|Withdrawal by Subject|4|||
163361965|NCT04147858|590033360|FG002|Overall Study|Withdrawal by Subject|10|||
163361966|NCT04147858|590033358|FG000|Overall Study|Subject Noncompliance, Other|4|||
163361967|NCT04147858|590033359|FG001|Overall Study|Subject Noncompliance, Other|3|||
163361968|NCT04147858|590033360|FG002|Overall Study|Subject Noncompliance, Other|1|||
163361969|NCT02615938|590033361|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
163361970|NCT02615938|590033362|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
163361971|NCT02615938|590033363|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
163361972|NCT02615938|590033364|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
163361973|NCT02615938|590033361|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
163361974|NCT02615938|590033362|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
163361975|NCT02615938|590033363|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
163361976|NCT02615938|590033364|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
163361977|NCT02615938|590033361|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
163361978|NCT02615938|590033362|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
163361979|NCT02615938|590033363|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
163361980|NCT02615938|590033364|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
163361981|NCT04905849|590033366|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
163361982|NCT04905849|590033367|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
163361983|NCT00838929|590033373|FG000|Overall Study|Protocol Violation|0|||
163361984|NCT00838929|590033374|FG001|Overall Study|Protocol Violation|1|||
163361985|NCT00838929|590033375|FG002|Overall Study|Protocol Violation|0|||
163361986|NCT00838929|590033373|FG000|Overall Study|Disease progression|0|||
163361987|NCT00838929|590033374|FG001|Overall Study|Disease progression|2|||
163361988|NCT00838929|590033375|FG002|Overall Study|Disease progression|1|||
163361989|NCT01340014|590033383|FG000|Period 1, First 7 Days|Adverse Event|1|||
163361990|NCT01340014|590033384|FG001|Period 1, First 7 Days|Adverse Event|0|||
163361991|NCT01340014|590033383|FG000|Period 1, First 7 Days|Personal Reasons|1|||
163361992|NCT01340014|590033384|FG001|Period 1, First 7 Days|Personal Reasons|0|||
163361993|NCT01340014|590033383|FG000|Period 2, Second 7 Days|Adverse Event|0|||
163361994|NCT01340014|590033384|FG001|Period 2, Second 7 Days|Adverse Event|1|||
163361995|NCT05101993|590033389|FG000|Overall Study|Withdrawal by Subject|1|||
163361996|NCT04577573|590033390|FG000|Overall Study|Technical - invalid protocol|0|||
163361997|NCT04577573|590033391|FG001|Overall Study|Technical - invalid protocol|2|||
163361998|NCT04577573|590033392|FG002|Overall Study|Technical - invalid protocol|0|||
163361999|NCT02113124|590034654|FG000|Overall Study|Unable to retrieve blood sample|1|||
163362000|NCT02113124|590034655|FG001|Overall Study|Unable to retrieve blood sample|1|||
163362001|NCT01439867|590034656|FG000|Overall Study|Non-compliance|0|||
163362002|NCT01439867|590034657|FG001|Overall Study|Non-compliance|1|||
163362003|NCT01439867|590034656|FG000|Overall Study|Withdrawal by Subject|1|||
163362004|NCT01439867|590034657|FG001|Overall Study|Withdrawal by Subject|2|||
163362005|NCT01439867|590034656|FG000|Overall Study|Administrative Decision|4|||
163362006|NCT01439867|590034657|FG001|Overall Study|Administrative Decision|5|||
163362007|NCT01439867|590034656|FG000|Overall Study|Protocol-specified Criteria|1|||
163362008|NCT01439867|590034657|FG001|Overall Study|Protocol-specified Criteria|0|||
163362009|NCT04042077|590034662|FG000|Overall Study|Adverse Event|0|||
163261612|NCT02917265|589666709|FG001|Overall Study|Physician Decision|0|||
163261613|NCT02917265|589666708|FG000|Overall Study|Withdrawal by Subject|1|||
163261614|NCT02917265|589666709|FG001|Overall Study|Withdrawal by Subject|0|||
163261615|NCT00979602|589666722|FG000|Overall Study|Serious Adverse Event|5|||
163261616|NCT00979602|589666723|FG001|Overall Study|Serious Adverse Event|3|||
163261617|NCT00979602|589666722|FG000|Overall Study|Protocol Violation|3|||
163261618|NCT00979602|589666723|FG001|Overall Study|Protocol Violation|0|||
163261619|NCT00979602|589666722|FG000|Overall Study|Withdrawal by Subject|31|||
163261620|NCT00979602|589666723|FG001|Overall Study|Withdrawal by Subject|25|||
163261621|NCT00979602|589666722|FG000|Overall Study|Lost to Follow-up|100|||
163261622|NCT00979602|589666723|FG001|Overall Study|Lost to Follow-up|96|||
163261623|NCT00979602|589666722|FG000|Overall Study|Migrated/moved from study area|3|||
163261624|NCT00979602|589666723|FG001|Overall Study|Migrated/moved from study area|6|||
163261625|NCT00979602|589666722|FG000|Overall Study|Others|3|||
163261626|NCT00979602|589666723|FG001|Overall Study|Others|3|||
163261627|NCT02002182|589666726|FG000|Overall Study|Withdraw from study|3|||
163261628|NCT02002182|589666727|FG001|Overall Study|Withdraw from study|1|||
163261629|NCT02002182|589666726|FG000|Overall Study|Health Reasons|1|||
163261630|NCT02002182|589666727|FG001|Overall Study|Health Reasons|0|||
163261631|NCT02002182|589666726|FG000|Overall Study|Death|1|||
163261632|NCT02002182|589666727|FG001|Overall Study|Death|0|||
163261633|NCT01320943|589666735|FG000|Overall Study|Lost to Follow-up|1|||
163261634|NCT01320943|589666736|FG001|Overall Study|Lost to Follow-up|0|||
163261635|NCT01320943|589666735|FG000|Overall Study|Physician Decision|0|||
163261636|NCT01320943|589666736|FG001|Overall Study|Physician Decision|1|||
163261637|NCT01320943|589666735|FG000|Overall Study|Randomized but not Treated|0|||
163261638|NCT01320943|589666736|FG001|Overall Study|Randomized but not Treated|1|||
163261639|NCT03635489|589666744|FG000|Overall Study|Death|19|||
163261640|NCT03635489|589666745|FG001|Overall Study|Death|13|||
163261641|NCT03635489|589666744|FG000|Overall Study|Lost to Follow-up|1|||
163261642|NCT03635489|589666745|FG001|Overall Study|Lost to Follow-up|2|||
163261643|NCT03635489|589666744|FG000|Overall Study|Withdrawal by Subject|1|||
163261644|NCT03635489|589666745|FG001|Overall Study|Withdrawal by Subject|2|||
163261645|NCT03635489|589666744|FG000|Overall Study|Study Ended by Sponsor|28|||
163261646|NCT03635489|589666745|FG001|Overall Study|Study Ended by Sponsor|34|||
163261647|NCT01368900|589666746|FG000|Overall Study|Lost to Follow-up|7|||
163261648|NCT04027348|589666751|FG000|Overall Study|Adverse Event|2|||
163261649|NCT02487472|589666752|FG000|Overall Study|Did not complete telephonic interviews|9|||
163261650|NCT02487472|589666752|FG000|Overall Study|Other|2|||
163261651|NCT01313286|589666753|FG000|Period 1|Withdrawal by Subject|2|||
163261652|NCT01313286|589666754|FG001|Period 1|Withdrawal by Subject|0|||
163261653|NCT02010632|589666755|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
163261654|NCT02010632|589666756|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
163261655|NCT02404389|589666757|FG000|Overall Study|Adverse Event|1|||
163261656|NCT02404389|589666758|FG001|Overall Study|Adverse Event|0|||
163261657|NCT02404389|589666759|FG002|Overall Study|Adverse Event|1|||
163261658|NCT02404389|589666760|FG003|Overall Study|Adverse Event|0|||
163261659|NCT02404389|589666761|FG004|Overall Study|Adverse Event|2|||
163261660|NCT02404389|589666757|FG000|Overall Study|Subject/guardian decision|1|||
163261661|NCT02404389|589666758|FG001|Overall Study|Subject/guardian decision|0|||
163261662|NCT02404389|589666759|FG002|Overall Study|Subject/guardian decision|0|||
163261663|NCT02404389|589666760|FG003|Overall Study|Subject/guardian decision|1|||
163261664|NCT02404389|589666761|FG004|Overall Study|Subject/guardian decision|1|||
163261665|NCT01669798|589666762|FG000|Overall Study|Physician Decision|5|||
163261666|NCT01806584|589666766|FG000|Overall Study|Adverse Event|2|||
163261667|NCT01806584|589666767|FG001|Overall Study|Adverse Event|1|||
163261668|NCT01806584|589666766|FG000|Overall Study|Death|1|||
163261669|NCT01806584|589666767|FG001|Overall Study|Death|0|||
163261670|NCT01806584|589666766|FG000|Overall Study|Lost to Follow-up|0|||
163261671|NCT01806584|589666767|FG001|Overall Study|Lost to Follow-up|2|||
163261672|NCT01806584|589666766|FG000|Overall Study|Study terminated by sponsor|9|||
163362010|NCT04042077|590034663|FG001|Overall Study|Adverse Event|1|||
163362011|NCT04042077|590034662|FG000|Overall Study|Death|2|||
163362012|NCT04042077|590034663|FG001|Overall Study|Death|1|||
163261673|NCT01806584|589666767|FG001|Overall Study|Study terminated by sponsor|14|||
163261674|NCT01806584|589666766|FG000|Overall Study|Withdrawal by Subject|1|||
163261675|NCT01806584|589666767|FG001|Overall Study|Withdrawal by Subject|1|||
163261676|NCT01806584|589666766|FG000|Overall Study|Other unspecified|1|||
163261677|NCT01806584|589666767|FG001|Overall Study|Other unspecified|0|||
163261678|NCT00311155|589668646|FG000|Overall Study|Adverse Event|21|||
163261679|NCT00311155|589668646|FG000|Overall Study|Withdrawal by Subject|17|||
163261680|NCT00311155|589668646|FG000|Overall Study|Did not meet entry criteria|55|||
163261681|NCT00429494|589668650|FG000|Overall Study|Withdrawal by Subject|9|||
163261682|NCT00429494|589668650|FG000|Overall Study|Death|6|||
163261683|NCT00976703|589668653|FG000|Overall Study|Physician Decision|1|||
163261684|NCT00976703|589668654|FG001|Overall Study|Physician Decision|1|||
163261685|NCT00976703|589668653|FG000|Overall Study|ineligible for study|2|||
163261686|NCT00976703|589668654|FG001|Overall Study|ineligible for study|2|||
163261687|NCT02243631|589668660|FG000|Overall Study|no synovial fluid on second aspirate|0|||
163261688|NCT02243631|589668661|FG001|Overall Study|no synovial fluid on second aspirate|1|||
163261689|NCT01992549|589668668|FG000|Overall Study|Lost to Follow-up|2|||
163261690|NCT01992549|589668668|FG000|Overall Study|Serious Adverse Event|1|||
163261691|NCT01992549|589668668|FG000|Overall Study|Product Switch to Extend Half Life|1|||
163261692|NCT01590771|589668669|FG000|Overall Study|Other Protocol Specified Criteria|5|||
163261693|NCT01590771|589668670|FG001|Overall Study|Other Protocol Specified Criteria|14|||
163261694|NCT01590771|589668669|FG000|Overall Study|Withdrawal by Subject|8|||
163261695|NCT01590771|589668670|FG001|Overall Study|Withdrawal by Subject|15|||
163261696|NCT01590771|589668669|FG000|Overall Study|Protocol Violation|1|||
163261697|NCT01590771|589668670|FG001|Overall Study|Protocol Violation|2|||
163261698|NCT01590771|589668669|FG000|Overall Study|Lost to Follow-up|1|||
163261699|NCT01590771|589668670|FG001|Overall Study|Lost to Follow-up|1|||
163261700|NCT01590771|589668669|FG000|Overall Study|Lack of Efficacy|1|||
163261701|NCT01590771|589668670|FG001|Overall Study|Lack of Efficacy|0|||
163261702|NCT01590771|589668669|FG000|Overall Study|Adverse Event|3|||
163261703|NCT01590771|589668670|FG001|Overall Study|Adverse Event|7|||
163261704|NCT01785628|589668671|FG000|Overall Study|Lost to Follow-up|2|||
163261705|NCT01785628|589668672|FG001|Overall Study|Lost to Follow-up|3|||
163261706|NCT01250119|589668680|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
163261707|NCT01250119|589668681|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
163261708|NCT01250119|589668680|FG000|Diagnostic Phase|Participants Not Tested|44|||
163261709|NCT01250119|589668681|FG001|Diagnostic Phase|Participants Not Tested|0|||
163261710|NCT01250119|589668680|FG000|Treatment Phase|Progressive Disease|0|||
163261711|NCT01250119|589668681|FG001|Treatment Phase|Progressive Disease|32|||
163261712|NCT01250119|589668680|FG000|Treatment Phase|Death|0|||
163261713|NCT01250119|589668681|FG001|Treatment Phase|Death|2|||
163261714|NCT01250119|589668680|FG000|Treatment Phase|Withdrawal by Subject|0|||
163261715|NCT01250119|589668681|FG001|Treatment Phase|Withdrawal by Subject|1|||
163261716|NCT01250119|589668680|FG000|Treatment Phase|Adverse Event|0|||
163261717|NCT01250119|589668681|FG001|Treatment Phase|Adverse Event|2|||
163261718|NCT01250119|589668680|FG000|Treatment Phase|Unknown reason|0|||
163261719|NCT01250119|589668681|FG001|Treatment Phase|Unknown reason|4|||
163261720|NCT01559454|589668682|FG000|Overall Study|Lost to Follow-up|3|||
163261721|NCT01559454|589668683|FG001|Overall Study|Lost to Follow-up|2|||
163261722|NCT01559454|589668682|FG000|Overall Study|Withdrawal by Subject|0|||
163261723|NCT01559454|589668683|FG001|Overall Study|Withdrawal by Subject|1|||
163261724|NCT01559454|589668682|FG000|Overall Study|Physician Decision|0|||
163261725|NCT01559454|589668683|FG001|Overall Study|Physician Decision|1|||
163261726|NCT01559454|589668682|FG000|Overall Study|Protocol Violation|0|||
163261727|NCT01559454|589668683|FG001|Overall Study|Protocol Violation|1|||
163261728|NCT01559454|589668682|FG000|Overall Study|Lack of Efficacy|0|||
163261729|NCT01559454|589668683|FG001|Overall Study|Lack of Efficacy|1|||
163261730|NCT00462670|589668687|FG000|Overall Study|Adverse Event|3|||
163261731|NCT00462670|589668688|FG001|Overall Study|Adverse Event|5|||
163261732|NCT00462670|589668687|FG000|Overall Study|Lack of Efficacy|1|||
163261733|NCT00462670|589668688|FG001|Overall Study|Lack of Efficacy|0|||
163261734|NCT00462670|589668687|FG000|Overall Study|Protocol Violation|1|||
163261735|NCT00462670|589668688|FG001|Overall Study|Protocol Violation|0|||
163261736|NCT00462670|589668687|FG000|Overall Study|Resolution of signs and symptoms|0|||
163261737|NCT00462670|589668688|FG001|Overall Study|Resolution of signs and symptoms|2|||
163261738|NCT00482274|589668693|FG000|Overall Study|Adverse Event|1|||
163261739|NCT02396537|589668694|FG000|Overall Study|Protocol Violation|0|||
163261740|NCT02396537|589668695|FG001|Overall Study|Protocol Violation|1|||
163261741|NCT00787319|589668699|FG000|Overall Study|Lost to Follow-up|2|||
163261742|NCT00787319|589668699|FG000|Overall Study|Withdrawal by Subject|15|||
163261743|NCT00787319|589668699|FG000|Overall Study|Adverse Event|3|||
163261744|NCT00787319|589668699|FG000|Overall Study|Objective progression or relapse|30|||
163261745|NCT00787319|589668699|FG000|Overall Study|Lack of Efficacy|1|||
163261746|NCT00787319|589668699|FG000|Overall Study|Budget exhausted/exceeded|1|||
163261747|NCT00787319|589668699|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
163261748|NCT00787319|589668699|FG000|Overall Study|No health insurance reimbursement|2|||
163261749|NCT00787319|589668699|FG000|Overall Study|Stabilized disease findings|3|||
163261750|NCT00787319|589668699|FG000|Overall Study|Inactive disease|5|||
163261751|NCT01932294|589668700|FG000|Overall Study|Death|43|||
163261752|NCT01932294|589668700|FG000|Overall Study|Lost to Follow-up|8|||
163261753|NCT01932294|589668700|FG000|Overall Study|VAD Implantation|20|||
163261754|NCT01932294|589668700|FG000|Overall Study|Heart Transplantation|16|||
163261755|NCT01932294|589668700|FG000|Overall Study|Transferred to other hospitals|12|||
163261756|NCT00409786|589668703|FG000|Overall Study|Withdrawal by Subject|3|||
163261757|NCT03075904|589668710|FG000|Overall Study|Physician Decision|3|||
163261758|NCT03075904|589668710|FG000|Overall Study|Need for Medication not Permitted|1|||
163362013|NCT04042077|590034662|FG000|Overall Study|Physician Decision|2|||
163261759|NCT00597714|589668711|FG000|Overall Study|Death|56|||
163261760|NCT00597714|589668712|FG001|Overall Study|Death|46|||
163261761|NCT00597714|589668713|FG002|Overall Study|Death|0|||
163261762|NCT00597714|589668711|FG000|Overall Study|Recipient death|0|||
163261763|NCT00597714|589668712|FG001|Overall Study|Recipient death|0|||
163261764|NCT00597714|589668713|FG002|Overall Study|Recipient death|10|||
163261765|NCT02228395|589668714|FG000|First Intervention Period|No longer willing to participate|1|||
163261766|NCT02228395|589668715|FG001|First Intervention Period|No longer willing to participate|0|||
163261767|NCT02228395|589668716|FG002|First Intervention Period|No longer willing to participate|0|||
163261768|NCT02228395|589668714|FG000|First Intervention Period|Unable to comply with study dates|0|||
163261769|NCT02228395|589668715|FG001|First Intervention Period|Unable to comply with study dates|1|||
163261770|NCT02228395|589668716|FG002|First Intervention Period|Unable to comply with study dates|1|||
163261771|NCT02424591|589668721|FG000|Overall Study|Protocol Violation|2|||
163261772|NCT02424591|589668722|FG001|Overall Study|Protocol Violation|3|||
163261773|NCT00988221|589668723|FG000|Part I|Adverse Event|0|||
163261774|NCT00988221|589668724|FG001|Part I|Adverse Event|1|||
163261775|NCT00988221|589668725|FG002|Part I|Adverse Event|2|||
163261776|NCT00988221|589668726|FG003|Part I|Adverse Event|0|||
163261777|NCT00988221|589668723|FG000|Part I|Insufficient Therapeutic Response|4|||
163261778|NCT00988221|589668724|FG001|Part I|Insufficient Therapeutic Response|6|||
163261779|NCT00988221|589668725|FG002|Part I|Insufficient Therapeutic Response|5|||
163261780|NCT00988221|589668726|FG003|Part I|Insufficient Therapeutic Response|0|||
163261781|NCT00988221|589668723|FG000|Part I|Refused Treatment|0|||
163261782|NCT00988221|589668724|FG001|Part I|Refused Treatment|2|||
163261783|NCT00988221|589668725|FG002|Part I|Refused Treatment|1|||
163261784|NCT00988221|589668726|FG003|Part I|Refused Treatment|0|||
163261785|NCT00988221|589668723|FG000|Part I|Lost to Follow-up|0|||
163261786|NCT00988221|589668724|FG001|Part I|Lost to Follow-up|1|||
163261787|NCT00988221|589668725|FG002|Part I|Lost to Follow-up|0|||
163261788|NCT00988221|589668726|FG003|Part I|Lost to Follow-up|0|||
163261789|NCT00988221|589668723|FG000|Part II|Adverse Event|1|||
163261790|NCT00988221|589668724|FG001|Part II|Adverse Event|0|||
163261791|NCT00988221|589668725|FG002|Part II|Adverse Event|0|||
163261792|NCT00988221|589668726|FG003|Part II|Adverse Event|1|||
163261793|NCT00988221|589668723|FG000|Part II|Withdrawal by Subject|0|||
163261794|NCT00988221|589668724|FG001|Part II|Withdrawal by Subject|0|||
163261795|NCT00988221|589668725|FG002|Part II|Withdrawal by Subject|2|||
163261796|NCT00988221|589668726|FG003|Part II|Withdrawal by Subject|2|||
163261797|NCT00988221|589668723|FG000|Part II|Reason not Specified|0|||
163261798|NCT00988221|589668724|FG001|Part II|Reason not Specified|0|||
163261799|NCT00988221|589668725|FG002|Part II|Reason not Specified|1|||
163261800|NCT00988221|589668726|FG003|Part II|Reason not Specified|0|||
163261801|NCT00988221|589668723|FG000|Part III|Adverse Event|1|||
163261802|NCT00988221|589668724|FG001|Part III|Adverse Event|0|||
163261803|NCT00988221|589668725|FG002|Part III|Adverse Event|1|||
163261804|NCT00988221|589668726|FG003|Part III|Adverse Event|0|||
163261805|NCT00988221|589668723|FG000|Part III|Insufficient Therapeutic Response|0|||
163261806|NCT00988221|589668724|FG001|Part III|Insufficient Therapeutic Response|1|||
163261807|NCT00988221|589668725|FG002|Part III|Insufficient Therapeutic Response|1|||
163261808|NCT00988221|589668726|FG003|Part III|Insufficient Therapeutic Response|0|||
163261809|NCT00988221|589668723|FG000|Part III|Refused Treatment|0|||
163261810|NCT00988221|589668724|FG001|Part III|Refused Treatment|0|||
163261811|NCT00988221|589668725|FG002|Part III|Refused Treatment|1|||
163261812|NCT00988221|589668726|FG003|Part III|Refused Treatment|0|||
163261813|NCT02712398|589668734|FG000|Overall Study|Withdrawal by Subject|6|||
163261814|NCT02712398|589668734|FG000|Overall Study|Lost to Follow-up|6|||
163261815|NCT02712398|589668734|FG000|Overall Study|Sponsor Decision|1|||
163261816|NCT02712398|589668734|FG000|Overall Study|Physician Decision|1|||
163261817|NCT02712398|589668734|FG000|Overall Study|Death|2|||
163261818|NCT02712398|589668734|FG000|Overall Study|Re-operation|21|||
163261819|NCT01719237|589668735|FG000|Overall Study|Physician Decision|0|||
163261820|NCT01719237|589668736|FG001|Overall Study|Physician Decision|1|||
163261821|NCT04772053|589668746|FG000|Overall Study|Physician Decision|2|||
163261822|NCT04772053|589668746|FG000|Overall Study|Withdrawal by Subject|3|||
163261823|NCT04772053|589668746|FG000|Overall Study|Study Terminated by Sponsor|1|||
163261824|NCT04146896|589668751|FG000|Overall Study|Adverse Event|5|||
163261825|NCT04146896|589668752|FG001|Overall Study|Adverse Event|8|||
163261826|NCT04146896|589668751|FG000|Overall Study|Lack of Efficacy|3|||
163261827|NCT04146896|589668752|FG001|Overall Study|Lack of Efficacy|2|||
163261828|NCT04146896|589668751|FG000|Overall Study|Lost to Follow-up|0|||
163261829|NCT04146896|589668752|FG001|Overall Study|Lost to Follow-up|1|||
163261830|NCT04146896|589668751|FG000|Overall Study|Non-compliance|5|||
163261831|NCT04146896|589668752|FG001|Overall Study|Non-compliance|4|||
163261832|NCT04146896|589668751|FG000|Overall Study|Withdrawal by Subject|3|||
163261833|NCT04146896|589668752|FG001|Overall Study|Withdrawal by Subject|5|||
163261834|NCT04146896|589668751|FG000|Overall Study|Randomized in error|1|||
163261835|NCT04146896|589668752|FG001|Overall Study|Randomized in error|2|||
163261836|NCT03107377|589668753|FG000|Overall Study|Adverse Event|3|||
163261837|NCT03107377|589668754|FG001|Overall Study|Adverse Event|3|||
163261838|NCT03107377|589668753|FG000|Overall Study|Protocol Violation|9|||
163261839|NCT03107377|589668754|FG001|Overall Study|Protocol Violation|12|||
163261840|NCT03107377|589668753|FG000|Overall Study|Physician Decision|3|||
163261841|NCT03107377|589668754|FG001|Overall Study|Physician Decision|6|||
163261842|NCT03107377|589668753|FG000|Overall Study|Pregnancy|7|||
163261843|NCT03107377|589668754|FG001|Overall Study|Pregnancy|7|||
163261844|NCT03107377|589668753|FG000|Overall Study|Withdrawal by Subject|16|||
163261845|NCT03107377|589668754|FG001|Overall Study|Withdrawal by Subject|22|||
163261846|NCT03107377|589668753|FG000|Overall Study|Lost to Follow-up|37|||
163261847|NCT03107377|589668754|FG001|Overall Study|Lost to Follow-up|34|||
163261848|NCT03107377|589668753|FG000|Overall Study|Other reason not specified|16|||
163261849|NCT03107377|589668754|FG001|Overall Study|Other reason not specified|15|||
163261850|NCT01597505|589668755|FG000|Overall Study|Physician Decision|5|||
163261851|NCT01597505|589668756|FG001|Overall Study|Physician Decision|0|||
163261852|NCT01597505|589668755|FG000|Overall Study|Adverse Event|19|||
163261853|NCT01597505|589668756|FG001|Overall Study|Adverse Event|7|||
163261854|NCT01597505|589668755|FG000|Overall Study|Lost to Follow-up|4|||
163261855|NCT01597505|589668756|FG001|Overall Study|Lost to Follow-up|2|||
163261856|NCT01597505|589668755|FG000|Overall Study|Withdrawal by Subject|10|||
163261857|NCT01597505|589668756|FG001|Overall Study|Withdrawal by Subject|18|||
163261858|NCT01597505|589668755|FG000|Overall Study|Other|5|||
163261859|NCT01597505|589668756|FG001|Overall Study|Other|6|||
163261860|NCT01597505|589668755|FG000|Overall Study|Missing|1|||
163261861|NCT01597505|589668756|FG001|Overall Study|Missing|0|||
163261862|NCT02675465|589668758|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
163261863|NCT02675465|589668759|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
163261864|NCT02675465|589668760|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
163261865|NCT02675465|589668761|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
163261866|NCT02675465|589668762|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
163261867|NCT02675465|589668763|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
163261868|NCT02675465|589668758|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
163261869|NCT02675465|589668759|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
163261870|NCT02675465|589668760|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
163261871|NCT02675465|589668761|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
163261872|NCT02675465|589668762|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
163261873|NCT02675465|589668763|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
163261874|NCT02675465|589668758|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
163261875|NCT02675465|589668759|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
163261876|NCT02675465|589668760|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
163261877|NCT02675465|589668761|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
163261878|NCT02675465|589668762|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
163261879|NCT02675465|589668763|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
163261880|NCT02675465|589668758|FG000|Stage 4: Long Term Extension|Death|0|||
163261881|NCT02675465|589668759|FG001|Stage 4: Long Term Extension|Death|0|||
163261882|NCT02675465|589668760|FG002|Stage 4: Long Term Extension|Death|0|||
163261883|NCT02675465|589668761|FG003|Stage 4: Long Term Extension|Death|1|||
163261884|NCT02675465|589668762|FG004|Stage 4: Long Term Extension|Death|0|||
163261885|NCT02675465|589668763|FG005|Stage 4: Long Term Extension|Death|0|||
163261886|NCT00453102|589668764|FG000|Overall Study|Withdrawal by Subject|2|||
163261887|NCT05031078|589668765|FG000|Overall Study|Withdrawal by Subject|0|||
163261888|NCT05031078|589668766|FG001|Overall Study|Withdrawal by Subject|1|||
163261889|NCT05031078|589668767|FG002|Overall Study|Withdrawal by Subject|0|||
163261890|NCT03728972|589668768|FG000|Overall Study|Death|1|||
163261891|NCT03728972|589668769|FG001|Overall Study|Death|0|||
163261892|NCT03728972|589668768|FG000|Overall Study|Lack of Efficacy|1|||
163261893|NCT03728972|589668769|FG001|Overall Study|Lack of Efficacy|0|||
163261894|NCT03728972|589668768|FG000|Overall Study|Physician Decision|3|||
163261895|NCT03728972|589668769|FG001|Overall Study|Physician Decision|0|||
163261896|NCT03728972|589668768|FG000|Overall Study|Disease progression|4|||
163261897|NCT03728972|589668769|FG001|Overall Study|Disease progression|3|||
163261898|NCT03787680|589668774|FG000|Overall Study|Physician Decision|2|||
163261899|NCT03787680|589668775|FG001|Overall Study|Physician Decision|3|||
163261900|NCT03787680|589668774|FG000|Overall Study|Adverse Event|7|||
163261901|NCT03787680|589668775|FG001|Overall Study|Adverse Event|3|||
163261902|NCT03787680|589668774|FG000|Overall Study|Withdrawal by Subject|2|||
163261903|NCT03787680|589668775|FG001|Overall Study|Withdrawal by Subject|1|||
163261904|NCT05454410|589668778|FG000|Overall Study|Withdrawal by Subject|0|||
163261905|NCT05454410|589668779|FG001|Overall Study|Withdrawal by Subject|0|||
163261906|NCT05454410|589668780|FG002|Overall Study|Withdrawal by Subject|1|||
163261907|NCT05454410|589668781|FG003|Overall Study|Withdrawal by Subject|1|||
163261908|NCT00895622|589668782|FG000|Overall Study|Protocol Violation|5|||
163261909|NCT00895622|589668783|FG001|Overall Study|Protocol Violation|4|||
163261910|NCT00895622|589668784|FG002|Overall Study|Protocol Violation|4|||
163261911|NCT01490125|589668785|FG000|Period I|Adverse Event|4|||
163261912|NCT01490125|589668786|FG001|Period I|Adverse Event|1|||
163261913|NCT01490125|589668787|FG002|Period I|Adverse Event|1|||
163261914|NCT01490125|589668788|FG003|Period I|Adverse Event|3|||
163261915|NCT01490125|589668789|FG004|Period I|Adverse Event|2|||
163261916|NCT01490125|589668790|FG005|Period I|Adverse Event|4|||
163261917|NCT01490125|589668785|FG000|Period I|Protocol Violation|1|||
163261918|NCT01490125|589668786|FG001|Period I|Protocol Violation|1|||
163261919|NCT01490125|589668787|FG002|Period I|Protocol Violation|1|||
163261920|NCT01490125|589668788|FG003|Period I|Protocol Violation|1|||
163261921|NCT01490125|589668789|FG004|Period I|Protocol Violation|0|||
163261922|NCT01490125|589668790|FG005|Period I|Protocol Violation|0|||
163261923|NCT01490125|589668785|FG000|Period I|Withdrawal by Subject|1|||
163261924|NCT01490125|589668786|FG001|Period I|Withdrawal by Subject|3|||
163261925|NCT01490125|589668787|FG002|Period I|Withdrawal by Subject|2|||
163261926|NCT01490125|589668788|FG003|Period I|Withdrawal by Subject|1|||
163261927|NCT01490125|589668789|FG004|Period I|Withdrawal by Subject|2|||
163261928|NCT01490125|589668790|FG005|Period I|Withdrawal by Subject|1|||
163261929|NCT01490125|589668785|FG000|Period II|Adverse Event|2|||
163261930|NCT01490125|589668786|FG001|Period II|Adverse Event|3|||
163261931|NCT01490125|589668787|FG002|Period II|Adverse Event|2|||
163261932|NCT01490125|589668788|FG003|Period II|Adverse Event|2|||
163261933|NCT01490125|589668789|FG004|Period II|Adverse Event|4|||
163261934|NCT01490125|589668790|FG005|Period II|Adverse Event|2|||
163261935|NCT01490125|589668785|FG000|Period II|Protocol Violation|0|||
163261936|NCT01490125|589668786|FG001|Period II|Protocol Violation|0|||
163261937|NCT01490125|589668787|FG002|Period II|Protocol Violation|1|||
163261938|NCT01490125|589668788|FG003|Period II|Protocol Violation|1|||
163261939|NCT01490125|589668789|FG004|Period II|Protocol Violation|0|||
163261940|NCT01490125|589668790|FG005|Period II|Protocol Violation|0|||
163261941|NCT01490125|589668785|FG000|Period II|Lost to Follow-up|0|||
163261942|NCT01490125|589668786|FG001|Period II|Lost to Follow-up|1|||
163261943|NCT01490125|589668787|FG002|Period II|Lost to Follow-up|0|||
163261944|NCT01490125|589668788|FG003|Period II|Lost to Follow-up|0|||
163261945|NCT01490125|589668789|FG004|Period II|Lost to Follow-up|0|||
163261946|NCT01490125|589668790|FG005|Period II|Lost to Follow-up|0|||
163261947|NCT01490125|589668785|FG000|Period II|Withdrawal by Subject|1|||
163261948|NCT01490125|589668786|FG001|Period II|Withdrawal by Subject|0|||
163261949|NCT01490125|589668787|FG002|Period II|Withdrawal by Subject|0|||
163261950|NCT01490125|589668788|FG003|Period II|Withdrawal by Subject|0|||
163261951|NCT01490125|589668789|FG004|Period II|Withdrawal by Subject|0|||
163261952|NCT01490125|589668790|FG005|Period II|Withdrawal by Subject|0|||
163261953|NCT01490125|589668785|FG000|Period III|Adverse Event|3|||
163261954|NCT01490125|589668786|FG001|Period III|Adverse Event|1|||
163261955|NCT01490125|589668787|FG002|Period III|Adverse Event|0|||
163261956|NCT01490125|589668788|FG003|Period III|Adverse Event|1|||
163261957|NCT01490125|589668789|FG004|Period III|Adverse Event|0|||
163261958|NCT01490125|589668790|FG005|Period III|Adverse Event|0|||
163261959|NCT01490125|589668785|FG000|Period III|Death|0|||
163261960|NCT01490125|589668786|FG001|Period III|Death|0|||
163261961|NCT01490125|589668787|FG002|Period III|Death|0|||
163261962|NCT01490125|589668788|FG003|Period III|Death|1|||
163261963|NCT01490125|589668789|FG004|Period III|Death|0|||
163261964|NCT01490125|589668790|FG005|Period III|Death|0|||
163261965|NCT01490125|589668785|FG000|Period III|Lack of Efficacy|0|||
163261966|NCT01490125|589668786|FG001|Period III|Lack of Efficacy|0|||
163261967|NCT01490125|589668787|FG002|Period III|Lack of Efficacy|0|||
163261968|NCT01490125|589668788|FG003|Period III|Lack of Efficacy|0|||
163261969|NCT01490125|589668789|FG004|Period III|Lack of Efficacy|1|||
163261970|NCT01490125|589668790|FG005|Period III|Lack of Efficacy|0|||
163261971|NCT01412801|589668791|FG000|Overall Study|Death|0|||
163261972|NCT01412801|589668792|FG001|Overall Study|Death|1|||
163261973|NCT01412801|589668793|FG002|Overall Study|Death|0|||
163261974|NCT01412801|589668794|FG003|Overall Study|Death|4|||
163261975|NCT01412801|589668795|FG004|Overall Study|Death|2|||
163261976|NCT01412801|589668796|FG005|Overall Study|Death|2|||
163261977|NCT01412801|589668791|FG000|Overall Study|Lost to Follow-up|1|||
163261978|NCT01412801|589668792|FG001|Overall Study|Lost to Follow-up|2|||
163261979|NCT01412801|589668793|FG002|Overall Study|Lost to Follow-up|4|||
163261980|NCT01412801|589668794|FG003|Overall Study|Lost to Follow-up|0|||
163261981|NCT01412801|589668795|FG004|Overall Study|Lost to Follow-up|1|||
163261982|NCT01412801|589668796|FG005|Overall Study|Lost to Follow-up|1|||
163261983|NCT01412801|589668791|FG000|Overall Study|Withdrawal by Subject|3|||
163261984|NCT01412801|589668792|FG001|Overall Study|Withdrawal by Subject|2|||
163261985|NCT01412801|589668793|FG002|Overall Study|Withdrawal by Subject|1|||
163261986|NCT01412801|589668794|FG003|Overall Study|Withdrawal by Subject|0|||
163261987|NCT01412801|589668795|FG004|Overall Study|Withdrawal by Subject|0|||
163261988|NCT01412801|589668796|FG005|Overall Study|Withdrawal by Subject|0|||
163261989|NCT01412801|589668791|FG000|Overall Study|Relocated to another area|0|||
163261990|NCT01412801|589668792|FG001|Overall Study|Relocated to another area|0|||
163261991|NCT01412801|589668793|FG002|Overall Study|Relocated to another area|2|||
163261992|NCT01412801|589668794|FG003|Overall Study|Relocated to another area|0|||
163261993|NCT01412801|589668795|FG004|Overall Study|Relocated to another area|0|||
163261994|NCT01412801|589668796|FG005|Overall Study|Relocated to another area|0|||
163261995|NCT01919970|589668797|FG000|Overall Study|Withdrawal by Subject|3|||
163261996|NCT01919970|589668798|FG001|Overall Study|Withdrawal by Subject|0|||
163261997|NCT00990340|589668799|FG000|First 14-day Treatment|Not Compliant|2|||
163261998|NCT00990340|589668800|FG001|First 14-day Treatment|Not Compliant|1|||
163261999|NCT00990340|589668799|FG000|First 14-day Treatment|Lost to Follow-up|2|||
163262000|NCT00990340|589668800|FG001|First 14-day Treatment|Lost to Follow-up|1|||
163262001|NCT00990340|589668799|FG000|First 14-day Treatment|Protocol Violation|2|||
163262002|NCT00990340|589668800|FG001|First 14-day Treatment|Protocol Violation|2|||
163262003|NCT04615182|589668801|FG000|Overall Study|Re-transplanted|2|||
163262004|NCT04615182|589668801|FG000|Overall Study|Protocol Violation|6|||
163262005|NCT04615182|589668801|FG000|Overall Study|Death|6|||
163262006|NCT04615182|589668801|FG000|Overall Study|Death and protocol violation|1|||
163262007|NCT01126060|589668802|FG000|Overall Study|Protocol Violation|0|||
163262008|NCT01126060|589668803|FG001|Overall Study|Protocol Violation|2|||
163262009|NCT03565068|589668804|FG000|Overall Study|Protocol Violation|0|||
163262010|NCT03565068|589668805|FG001|Overall Study|Protocol Violation|0|||
163262011|NCT03565068|589668806|FG002|Overall Study|Protocol Violation|0|||
163262012|NCT03565068|589668807|FG003|Overall Study|Protocol Violation|0|||
163262013|NCT03565068|589668808|FG004|Overall Study|Protocol Violation|1|||
163262014|NCT03565068|589668809|FG005|Overall Study|Protocol Violation|0|||
163262015|NCT03565068|589668810|FG006|Overall Study|Protocol Violation|0|||
163262016|NCT03565068|589668811|FG007|Overall Study|Protocol Violation|1|||
163262017|NCT03565068|589668812|FG008|Overall Study|Protocol Violation|0|||
163262018|NCT03565068|589668804|FG000|Overall Study|Sponsor decision|0|||
163262019|NCT03565068|589668805|FG001|Overall Study|Sponsor decision|0|||
163262020|NCT03565068|589668806|FG002|Overall Study|Sponsor decision|0|||
163262021|NCT03565068|589668807|FG003|Overall Study|Sponsor decision|0|||
163262022|NCT03565068|589668808|FG004|Overall Study|Sponsor decision|1|||
163262023|NCT03565068|589668809|FG005|Overall Study|Sponsor decision|1|||
163262024|NCT03565068|589668810|FG006|Overall Study|Sponsor decision|0|||
163262025|NCT03565068|589668811|FG007|Overall Study|Sponsor decision|0|||
163262026|NCT03565068|589668812|FG008|Overall Study|Sponsor decision|0|||
163262027|NCT03565068|589668804|FG000|Overall Study|Withdrawal by Subject|0|||
163262028|NCT03565068|589668805|FG001|Overall Study|Withdrawal by Subject|0|||
163262029|NCT03565068|589668806|FG002|Overall Study|Withdrawal by Subject|1|||
163262030|NCT03565068|589668807|FG003|Overall Study|Withdrawal by Subject|0|||
163262031|NCT03565068|589668808|FG004|Overall Study|Withdrawal by Subject|2|||
163262032|NCT03565068|589668809|FG005|Overall Study|Withdrawal by Subject|0|||
163262033|NCT03565068|589668810|FG006|Overall Study|Withdrawal by Subject|1|||
163262034|NCT03565068|589668811|FG007|Overall Study|Withdrawal by Subject|5|||
163262035|NCT03565068|589668812|FG008|Overall Study|Withdrawal by Subject|1|||
163262036|NCT03565068|589668804|FG000|Overall Study|Physician Decision|0|||
163262037|NCT03565068|589668805|FG001|Overall Study|Physician Decision|0|||
163262038|NCT03565068|589668806|FG002|Overall Study|Physician Decision|0|||
163262039|NCT03565068|589668807|FG003|Overall Study|Physician Decision|0|||
163262040|NCT03565068|589668808|FG004|Overall Study|Physician Decision|0|||
163262041|NCT03565068|589668809|FG005|Overall Study|Physician Decision|0|||
163262042|NCT03565068|589668810|FG006|Overall Study|Physician Decision|0|||
163262043|NCT03565068|589668811|FG007|Overall Study|Physician Decision|1|||
163262044|NCT03565068|589668812|FG008|Overall Study|Physician Decision|0|||
163262045|NCT03565068|589668804|FG000|Overall Study|Lost to Follow-up|0|||
163262046|NCT03565068|589668805|FG001|Overall Study|Lost to Follow-up|0|||
163262047|NCT03565068|589668806|FG002|Overall Study|Lost to Follow-up|0|||
163262048|NCT03565068|589668807|FG003|Overall Study|Lost to Follow-up|0|||
163262049|NCT03565068|589668808|FG004|Overall Study|Lost to Follow-up|0|||
163262050|NCT03565068|589668809|FG005|Overall Study|Lost to Follow-up|0|||
163262051|NCT03565068|589668810|FG006|Overall Study|Lost to Follow-up|0|||
163262052|NCT03565068|589668811|FG007|Overall Study|Lost to Follow-up|1|||
163262053|NCT03565068|589668812|FG008|Overall Study|Lost to Follow-up|0|||
163262054|NCT02200939|589671051|FG000|Overall Study|Participant withdrew consent|0|||
163262055|NCT02200939|589671052|FG001|Overall Study|Participant withdrew consent|1|||
163262056|NCT02200939|589671051|FG000|Overall Study|Lost to Follow-up|2|||
163262057|NCT02200939|589671052|FG001|Overall Study|Lost to Follow-up|9|||
163262058|NCT02200939|589671051|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
163262059|NCT02200939|589671052|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
163262060|NCT04567693|589671053|FG000|Overall Study|Death|0|||
163262061|NCT04567693|589671054|FG001|Overall Study|Death|0|||
163262062|NCT04567693|589671055|FG002|Overall Study|Death|2|||
163262063|NCT04567693|589671053|FG000|Overall Study|Lost to Follow-up|1|||
163262064|NCT04567693|589671054|FG001|Overall Study|Lost to Follow-up|0|||
163262065|NCT04567693|589671055|FG002|Overall Study|Lost to Follow-up|2|||
163262066|NCT04567693|589671053|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
163262067|NCT04567693|589671054|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
163262068|NCT04567693|589671055|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
163262069|NCT03722264|589671061|FG000|Overall Study|Physician Decision|3|||
163262070|NCT00957931|589671062|FG000|Overall Study|Death|4|||
163262071|NCT01486758|589671063|FG000|Overall Study|Lost to Follow-up|0|||
163262072|NCT01486758|589671064|FG001|Overall Study|Lost to Follow-up|1|||
163262073|NCT02392611|589671070|FG000|Overall Study|Adverse Event|0|||
163262074|NCT02392611|589671071|FG001|Overall Study|Adverse Event|0|||
163262075|NCT02392611|589671072|FG002|Overall Study|Adverse Event|0|||
163262076|NCT02392611|589671073|FG003|Overall Study|Adverse Event|1|||
163262077|NCT02392611|589671074|FG004|Overall Study|Adverse Event|0|||
163262078|NCT02392611|589671075|FG005|Overall Study|Adverse Event|0|||
163262079|NCT02392611|589671076|FG006|Overall Study|Adverse Event|0|||
163262080|NCT02392611|589671077|FG007|Overall Study|Adverse Event|0|||
163262081|NCT02392611|589671078|FG008|Overall Study|Adverse Event|0|||
163262082|NCT02392611|589671070|FG000|Overall Study|Progressive disease|0|||
163262083|NCT02392611|589671071|FG001|Overall Study|Progressive disease|0|||
163262084|NCT02392611|589671072|FG002|Overall Study|Progressive disease|0|||
163262085|NCT02392611|589671073|FG003|Overall Study|Progressive disease|2|||
163262086|NCT02392611|589671074|FG004|Overall Study|Progressive disease|1|||
163262087|NCT02392611|589671075|FG005|Overall Study|Progressive disease|0|||
163262088|NCT02392611|589671076|FG006|Overall Study|Progressive disease|0|||
163262089|NCT02392611|589671077|FG007|Overall Study|Progressive disease|0|||
163262090|NCT02392611|589671078|FG008|Overall Study|Progressive disease|0|||
163262091|NCT02392611|589671070|FG000|Overall Study|Death|1|||
163262092|NCT02392611|589671071|FG001|Overall Study|Death|0|||
163262093|NCT02392611|589671072|FG002|Overall Study|Death|0|||
163262094|NCT02392611|589671073|FG003|Overall Study|Death|0|||
163262095|NCT02392611|589671074|FG004|Overall Study|Death|0|||
163262096|NCT02392611|589671075|FG005|Overall Study|Death|1|||
163262097|NCT02392611|589671076|FG006|Overall Study|Death|0|||
163262098|NCT02392611|589671077|FG007|Overall Study|Death|0|||
163262099|NCT02392611|589671078|FG008|Overall Study|Death|0|||
163262100|NCT02392611|589671070|FG000|Overall Study|Withdrawal by Subject|0|||
163262101|NCT02392611|589671071|FG001|Overall Study|Withdrawal by Subject|0|||
163262102|NCT02392611|589671072|FG002|Overall Study|Withdrawal by Subject|0|||
163262103|NCT02392611|589671073|FG003|Overall Study|Withdrawal by Subject|1|||
163262104|NCT02392611|589671074|FG004|Overall Study|Withdrawal by Subject|0|||
163262105|NCT02392611|589671075|FG005|Overall Study|Withdrawal by Subject|0|||
163262106|NCT02392611|589671076|FG006|Overall Study|Withdrawal by Subject|0|||
163262107|NCT02392611|589671077|FG007|Overall Study|Withdrawal by Subject|0|||
163262108|NCT02392611|589671078|FG008|Overall Study|Withdrawal by Subject|0|||
163262109|NCT02392611|589671070|FG000|Overall Study|Lost to Follow-up|0|||
163262110|NCT02392611|589671071|FG001|Overall Study|Lost to Follow-up|0|||
163262111|NCT02392611|589671072|FG002|Overall Study|Lost to Follow-up|0|||
163262112|NCT02392611|589671073|FG003|Overall Study|Lost to Follow-up|0|||
163262113|NCT02392611|589671074|FG004|Overall Study|Lost to Follow-up|0|||
163262114|NCT02392611|589671075|FG005|Overall Study|Lost to Follow-up|0|||
163262115|NCT02392611|589671076|FG006|Overall Study|Lost to Follow-up|1|||
163262116|NCT02392611|589671077|FG007|Overall Study|Lost to Follow-up|0|||
163262117|NCT02392611|589671078|FG008|Overall Study|Lost to Follow-up|0|||
163262118|NCT02392611|589671070|FG000|Overall Study|Enrolled, not treated|0|||
163262119|NCT02392611|589671071|FG001|Overall Study|Enrolled, not treated|0|||
163262120|NCT02392611|589671072|FG002|Overall Study|Enrolled, not treated|0|||
163262121|NCT02392611|589671073|FG003|Overall Study|Enrolled, not treated|2|||
163262122|NCT02392611|589671074|FG004|Overall Study|Enrolled, not treated|0|||
163262123|NCT02392611|589671075|FG005|Overall Study|Enrolled, not treated|0|||
163262124|NCT02392611|589671076|FG006|Overall Study|Enrolled, not treated|0|||
163262125|NCT02392611|589671077|FG007|Overall Study|Enrolled, not treated|0|||
163262126|NCT02392611|589671078|FG008|Overall Study|Enrolled, not treated|0|||
163262127|NCT00553202|589671085|FG000|Overall Study|Death|16|||
163262128|NCT00553202|589671085|FG000|Overall Study|Lost to Follow-up|1|||
163262129|NCT00553202|589671085|FG000|Overall Study|Physician Decision|28|||
163262130|NCT00553202|589671085|FG000|Overall Study|Withdrawal by Subject|1|||
163262131|NCT00553202|589671085|FG000|Overall Study|No donor identified|16|||
163262132|NCT00553202|589671085|FG000|Overall Study|Fails to meet organ function|6|||
163262133|NCT00369681|589671086|FG000|Overall Study|Death|1|||
163262134|NCT03239873|589671087|FG000|Overall Study|Lost to Follow-up|15|||
163262135|NCT03239873|589671088|FG001|Overall Study|Lost to Follow-up|16|||
163262136|NCT03239873|589671087|FG000|Overall Study|Physician Decision|1|||
163262137|NCT03239873|589671088|FG001|Overall Study|Physician Decision|0|||
163262138|NCT03239873|589671087|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
163262139|NCT03239873|589671088|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
163262140|NCT03239873|589671087|FG000|Overall Study|Withdrawal by Subject|2|||
163262141|NCT03239873|589671088|FG001|Overall Study|Withdrawal by Subject|0|||
163262142|NCT03239873|589671087|FG000|Overall Study|Contraindication to study medication|1|||
163262143|NCT03239873|589671088|FG001|Overall Study|Contraindication to study medication|0|||
163262144|NCT03239873|589671087|FG000|Overall Study|Protocol Violation|1|||
163262145|NCT03239873|589671088|FG001|Overall Study|Protocol Violation|0|||
163262146|NCT02045433|589671095|FG000|Overall Study|Withdrawal by Subject|1|||
163262147|NCT02948959|589671098|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
163362014|NCT04042077|590034663|FG001|Overall Study|Physician Decision|0|||
163362015|NCT04042077|590034662|FG000|Overall Study|Withdrawal by Subject|3|||
163362016|NCT04042077|590034663|FG001|Overall Study|Withdrawal by Subject|2|||
163362017|NCT04042077|590034662|FG000|Overall Study|Lack of Efficacy|0|||
163262148|NCT02948959|589671099|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
163262149|NCT02948959|589671098|FG000|52 Weeks Treatment Period|Adverse Event|2|||
163262150|NCT02948959|589671099|FG001|52 Weeks Treatment Period|Adverse Event|5|||
163262151|NCT02948959|589671098|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
163262152|NCT02948959|589671099|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
163262153|NCT02948959|589671098|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
163262154|NCT02948959|589671099|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
163362018|NCT04042077|590034663|FG001|Overall Study|Lack of Efficacy|1|||
163262155|NCT02948959|589671098|FG000|52 Weeks Treatment Period|Randomized by error|0|||
163262156|NCT02948959|589671099|FG001|52 Weeks Treatment Period|Randomized by error|5|||
163262157|NCT02948959|589671098|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
163262158|NCT02948959|589671099|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
163262159|NCT02948959|589671098|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
163262160|NCT02948959|589671099|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
163262161|NCT02948959|589671098|FG000|52 Weeks Treatment Period|Change of residence location|0|||
163262162|NCT02948959|589671099|FG001|52 Weeks Treatment Period|Change of residence location|1|||
163262163|NCT02948959|589671098|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
163262164|NCT02948959|589671099|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
163262165|NCT02948959|589671098|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
163262166|NCT02948959|589671099|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
163262167|NCT02948959|589671098|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
163262168|NCT02948959|589671099|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
163262169|NCT02948959|589671098|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
163262170|NCT02948959|589671099|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
163262171|NCT02948959|589671098|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
163262172|NCT02948959|589671099|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
163262173|NCT02948959|589671098|FG000|12 Weeks Follow-up Period|Study site closure|1|||
163262174|NCT02948959|589671099|FG001|12 Weeks Follow-up Period|Study site closure|0|||
163262175|NCT01800201|589671101|FG000|Overall Study|Withdrawal by Subject|2|||
163262176|NCT01800201|589671102|FG001|Overall Study|Withdrawal by Subject|0|||
163262177|NCT01800201|589671101|FG000|Overall Study|patient privacy concerns|1|||
163262178|NCT01800201|589671102|FG001|Overall Study|patient privacy concerns|1|||
163262179|NCT01800201|589671101|FG000|Overall Study|did not want to use device|0|||
163262180|NCT01800201|589671102|FG001|Overall Study|did not want to use device|1|||
163262181|NCT01800201|589671101|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
163262182|NCT01800201|589671102|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
163262183|NCT01480596|589671103|FG000|Overall Study|Adverse Event|3|||
163262184|NCT01480596|589671104|FG001|Overall Study|Adverse Event|0|||
163262185|NCT01480596|589671103|FG000|Overall Study|MG exacerbation or change in medication|2|||
163262186|NCT01480596|589671104|FG001|Overall Study|MG exacerbation or change in medication|2|||
163262187|NCT02904902|589671109|FG000|Overall Study|Withdrawal by Subject|1|||
163262188|NCT00980005|589671116|FG000|Overall Study|Withdrawal by Subject|6|||
163262189|NCT00980005|589671117|FG001|Overall Study|Withdrawal by Subject|17|||
163262190|NCT00980005|589671116|FG000|Overall Study|Lost to Follow-up|37|||
163262191|NCT00980005|589671117|FG001|Overall Study|Lost to Follow-up|43|||
163262192|NCT00980005|589671116|FG000|Overall Study|Other|4|||
163262193|NCT00980005|589671117|FG001|Overall Study|Other|3|||
163262194|NCT00572624|589671118|FG000|Overall Study|Lost to Follow-up|10|||
163262195|NCT00572624|589671119|FG001|Overall Study|Lost to Follow-up|4|||
163262196|NCT00572624|589671118|FG000|Overall Study|Wanted to do a different diet program|1|||
163262197|NCT00572624|589671119|FG001|Overall Study|Wanted to do a different diet program|0|||
163262198|NCT00572624|589671118|FG000|Overall Study|Medication change|1|||
163262199|NCT00572624|589671119|FG001|Overall Study|Medication change|0|||
163262200|NCT00572624|589671118|FG000|Overall Study|Started a new job-- no time for study|1|||
163262201|NCT00572624|589671119|FG001|Overall Study|Started a new job-- no time for study|0|||
163262202|NCT00572624|589671118|FG000|Overall Study|Admitted to being a smoker|1|||
163262203|NCT00572624|589671119|FG001|Overall Study|Admitted to being a smoker|0|||
163262204|NCT00572624|589671118|FG000|Overall Study|Refused to do the stress test|1|||
163262205|NCT00572624|589671119|FG001|Overall Study|Refused to do the stress test|0|||
163262206|NCT00572624|589671118|FG000|Overall Study|Problem with vascular access|1|||
163262207|NCT00572624|589671119|FG001|Overall Study|Problem with vascular access|0|||
163262208|NCT00572624|589671118|FG000|Overall Study|Health issues unrelated to the study|1|||
163262209|NCT00572624|589671119|FG001|Overall Study|Health issues unrelated to the study|0|||
163262210|NCT05400746|589671124|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
163262211|NCT05400746|589671125|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
163262212|NCT05400746|589671126|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
163262213|NCT05375955|589671127|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
163262214|NCT05375955|589671128|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
163262215|NCT05375955|589671129|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
163262216|NCT05375955|589671130|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
163362019|NCT00965497|590034665|FG000|Overall Study|Physician Decision|1|||
163362020|NCT02878603|590034666|FG000|Overall Study|Lost to Follow-up|4|||
163362021|NCT02878603|590034667|FG001|Overall Study|Lost to Follow-up|1|||
163262217|NCT05375955|589671131|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
163262218|NCT05375955|589671132|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
163262219|NCT05375955|589671133|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
163262220|NCT05375955|589671127|FG000|Treatment (12 Weeks)|Physician Decision|4|||
163262221|NCT05375955|589671128|FG001|Treatment (12 Weeks)|Physician Decision|1|||
163262222|NCT05375955|589671129|FG002|Treatment (12 Weeks)|Physician Decision|3|||
163262223|NCT05375955|589671130|FG003|Treatment (12 Weeks)|Physician Decision|0|||
163153067|NCT03137992|589274744|FG004|Washout Period 2|Sponsor Decision|0|||
163153068|NCT03137992|589274745|FG005|Washout Period 2|Sponsor Decision|1|||
163153069|NCT03137992|589274740|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
163153070|NCT03137992|589274741|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
163153071|NCT03137992|589274742|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
163153072|NCT03137992|589274743|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
163153073|NCT03137992|589274744|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
163153074|NCT03137992|589274745|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
163153075|NCT03137992|589274740|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
163153076|NCT03137992|589274741|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
163153077|NCT03137992|589274742|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
163153078|NCT03137992|589274743|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
163153079|NCT03137992|589274744|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
163153080|NCT03137992|589274745|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
163153081|NCT03137992|589274740|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
163153082|NCT03137992|589274741|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
163153083|NCT03137992|589274742|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
163153084|NCT03137992|589274743|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
163153085|NCT03137992|589274744|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
163153086|NCT03137992|589274745|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
163153087|NCT03137992|589274740|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
163153088|NCT03137992|589274741|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
163153089|NCT03137992|589274742|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
163153090|NCT03137992|589274743|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
163153091|NCT03137992|589274744|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
163153092|NCT03137992|589274745|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
163153093|NCT03137992|589274740|FG000|Part 2 (Open-label Extension)|Per study team|1|||
163153094|NCT03137992|589274741|FG001|Part 2 (Open-label Extension)|Per study team|0|||
163153095|NCT03137992|589274742|FG002|Part 2 (Open-label Extension)|Per study team|0|||
163153096|NCT03137992|589274743|FG003|Part 2 (Open-label Extension)|Per study team|0|||
163153097|NCT03137992|589274744|FG004|Part 2 (Open-label Extension)|Per study team|0|||
163153098|NCT03137992|589274745|FG005|Part 2 (Open-label Extension)|Per study team|0|||
163153099|NCT03137992|589274740|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
163153100|NCT03137992|589274741|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
163153101|NCT03137992|589274742|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
163153102|NCT03137992|589274743|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
163153103|NCT03137992|589274744|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
163153104|NCT03137992|589274745|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
163153105|NCT04609319|589274746|FG000|Overall Study|Death|64|||
163153106|NCT04609319|589274747|FG001|Overall Study|Death|49|||
163262224|NCT05375955|589671131|FG004|Treatment (12 Weeks)|Physician Decision|0|||
163262225|NCT05375955|589671132|FG005|Treatment (12 Weeks)|Physician Decision|1|||
163262226|NCT05375955|589671133|FG006|Treatment (12 Weeks)|Physician Decision|0|||
163262227|NCT05375955|589671127|FG000|Treatment (12 Weeks)|Other|0|||
163262228|NCT05375955|589671128|FG001|Treatment (12 Weeks)|Other|1|||
163262229|NCT05375955|589671129|FG002|Treatment (12 Weeks)|Other|0|||
163262230|NCT05375955|589671130|FG003|Treatment (12 Weeks)|Other|0|||
163262231|NCT05375955|589671131|FG004|Treatment (12 Weeks)|Other|0|||
163262232|NCT05375955|589671132|FG005|Treatment (12 Weeks)|Other|0|||
163262233|NCT05375955|589671133|FG006|Treatment (12 Weeks)|Other|0|||
163262234|NCT05375955|589671127|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
163262235|NCT05375955|589671128|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
163262236|NCT05375955|589671129|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
163262237|NCT05375955|589671130|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
163262238|NCT05375955|589671131|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
163262239|NCT05375955|589671132|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
163262240|NCT05375955|589671133|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
163262241|NCT05375955|589671127|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
163262242|NCT05375955|589671128|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
163262243|NCT05375955|589671129|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
163262244|NCT05375955|589671130|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
163262245|NCT05375955|589671131|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
163262246|NCT05375955|589671132|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
163262247|NCT05375955|589671133|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
163262248|NCT05375955|589671127|FG000|Treatment (12 Weeks)|Pregnancy|0|||
163262249|NCT05375955|589671128|FG001|Treatment (12 Weeks)|Pregnancy|0|||
163262250|NCT05375955|589671129|FG002|Treatment (12 Weeks)|Pregnancy|1|||
163262251|NCT05375955|589671130|FG003|Treatment (12 Weeks)|Pregnancy|0|||
163262252|NCT05375955|589671131|FG004|Treatment (12 Weeks)|Pregnancy|0|||
163262253|NCT05375955|589671132|FG005|Treatment (12 Weeks)|Pregnancy|0|||
163262254|NCT05375955|589671133|FG006|Treatment (12 Weeks)|Pregnancy|0|||
163411164|NCT00852995|590212998|FG002|Overall Study|Physician Decision|0|||
163262255|NCT05375955|589671127|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
163262256|NCT05375955|589671128|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
163262257|NCT05375955|589671129|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
163262258|NCT05375955|589671130|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
163262259|NCT05375955|589671131|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
163262260|NCT05375955|589671132|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
163262261|NCT05375955|589671133|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
163262262|NCT05375955|589671127|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
163262263|NCT05375955|589671128|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
163262264|NCT05375955|589671129|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
163262265|NCT05375955|589671130|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
163262266|NCT05375955|589671131|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
163262267|NCT05375955|589671132|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
163262268|NCT05375955|589671133|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
163262269|NCT05375955|589671127|FG000|Follow-up (up to 5 Weeks)|Other|0|||
163262270|NCT05375955|589671128|FG001|Follow-up (up to 5 Weeks)|Other|1|||
163262271|NCT05375955|589671129|FG002|Follow-up (up to 5 Weeks)|Other|0|||
163262272|NCT05375955|589671130|FG003|Follow-up (up to 5 Weeks)|Other|0|||
163262273|NCT05375955|589671131|FG004|Follow-up (up to 5 Weeks)|Other|0|||
163262274|NCT05375955|589671132|FG005|Follow-up (up to 5 Weeks)|Other|0|||
163262275|NCT05375955|589671133|FG006|Follow-up (up to 5 Weeks)|Other|0|||
163262276|NCT05375955|589671127|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
163262277|NCT05375955|589671128|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
163262278|NCT05375955|589671129|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
163262279|NCT05375955|589671130|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
163262280|NCT05375955|589671131|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
163262281|NCT05375955|589671132|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
163262282|NCT05375955|589671133|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
163262283|NCT05375955|589671127|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
163262284|NCT05375955|589671128|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
163262285|NCT05375955|589671129|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
163262286|NCT05375955|589671130|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
163262287|NCT05375955|589671131|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
163262288|NCT05375955|589671132|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
163262289|NCT05375955|589671133|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
163262290|NCT03879408|589671143|FG000|Overall Study|Lost to Follow-up|0|||
163262291|NCT03879408|589671144|FG001|Overall Study|Lost to Follow-up|3|||
163262292|NCT03879408|589671145|FG002|Overall Study|Lost to Follow-up|2|||
163262293|NCT03879408|589671146|FG003|Overall Study|Lost to Follow-up|1|||
163262294|NCT03879408|589671147|FG004|Overall Study|Lost to Follow-up|0|||
163262295|NCT03879408|589671143|FG000|Overall Study|Withdrawal by Subject|2|||
163262296|NCT03879408|589671144|FG001|Overall Study|Withdrawal by Subject|1|||
163262297|NCT03879408|589671145|FG002|Overall Study|Withdrawal by Subject|1|||
163262298|NCT03879408|589671146|FG003|Overall Study|Withdrawal by Subject|0|||
163262299|NCT03879408|589671147|FG004|Overall Study|Withdrawal by Subject|1|||
163262300|NCT04522180|589671148|FG000|Overall Study|Investigator judgement|3|||
163262301|NCT04522180|589671149|FG001|Overall Study|Investigator judgement|4|||
163262302|NCT04522180|589671148|FG000|Overall Study|Voluntary withdrawal|1|||
163262303|NCT04522180|589671149|FG001|Overall Study|Voluntary withdrawal|0|||
163262304|NCT04522180|589671148|FG000|Overall Study|Pregnancy|0|||
163262305|NCT04522180|589671149|FG001|Overall Study|Pregnancy|1|||
163262306|NCT04522180|589671148|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
163262307|NCT04522180|589671149|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
163262308|NCT04522180|589671148|FG000|Overall Study|Reason not specified|8|||
163262309|NCT04522180|589671149|FG001|Overall Study|Reason not specified|5|||
163262310|NCT01224158|589671156|FG000|Overall Study|Withdrawal by Subject|1|||
163362022|NCT02878603|590034666|FG000|Overall Study|Withdrawal by Subject|1|||
163362023|NCT02878603|590034667|FG001|Overall Study|Withdrawal by Subject|1|||
163362024|NCT02878603|590034666|FG000|Overall Study|Death|1|||
163362025|NCT02878603|590034667|FG001|Overall Study|Death|0|||
163362026|NCT02878603|590034666|FG000|Overall Study|Physician Decision|0|||
163362027|NCT02878603|590034667|FG001|Overall Study|Physician Decision|3|||
163362028|NCT02689453|590034668|FG000|Overall Study|Progressive disease|0|||
163362029|NCT02689453|590034669|FG001|Overall Study|Progressive disease|1|||
163362030|NCT02689453|590034670|FG002|Overall Study|Progressive disease|1|||
163262311|NCT01224158|589671157|FG001|Overall Study|Withdrawal by Subject|0|||
163262312|NCT03976466|589671160|FG000|Overall Study|Lost to Follow-up|1|||
163362031|NCT00794924|590034671|FG000|Overall Study|Lost to Follow-up|6|||
163262313|NCT03976466|589671161|FG001|Overall Study|Lost to Follow-up|3|||
163262314|NCT02055157|589671162|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
163262315|NCT02055157|589671163|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
163262316|NCT02055157|589671164|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
163262317|NCT02055157|589671165|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
163262318|NCT02055157|589671162|FG000|Initial 6 Months|Adverse Event|0|||
163262319|NCT02055157|589671163|FG001|Initial 6 Months|Adverse Event|0|||
163262320|NCT02055157|589671164|FG002|Initial 6 Months|Adverse Event|0|||
163262321|NCT02055157|589671165|FG003|Initial 6 Months|Adverse Event|1|||
163262322|NCT02055157|589671162|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
163262323|NCT02055157|589671163|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
163262324|NCT02055157|589671164|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
163262325|NCT02055157|589671165|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
163262326|NCT02055157|589671162|FG000|18-month Extension|Investigator decision|0|||
163262327|NCT02055157|589671163|FG001|18-month Extension|Investigator decision|1|||
163262328|NCT02055157|589671164|FG002|18-month Extension|Investigator decision|0|||
163262329|NCT02055157|589671165|FG003|18-month Extension|Investigator decision|0|||
163262330|NCT02055157|589671162|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
163262331|NCT02055157|589671163|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
163262332|NCT02055157|589671164|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
163262333|NCT02055157|589671165|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
163262334|NCT02034708|589671166|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
163262335|NCT02034708|589671167|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
163262336|NCT02034708|589671166|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
163262337|NCT02034708|589671167|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
163262338|NCT02034708|589671166|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
163262339|NCT02034708|589671167|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
163262340|NCT02034708|589671166|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
163262341|NCT02034708|589671167|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
163262342|NCT00733499|589671170|FG000|Pre-operative|Protocol Violation|0|||
163262343|NCT00733499|589671171|FG001|Pre-operative|Protocol Violation|1|||
163262344|NCT00733499|589671170|FG000|3 Months Follow-up|Death|1|||
163262345|NCT00733499|589671171|FG001|3 Months Follow-up|Death|2|||
163262346|NCT00733499|589671170|FG000|6 Months Follow-up|Death|0|||
163262347|NCT00733499|589671171|FG001|6 Months Follow-up|Death|2|||
163262348|NCT00733499|589671170|FG000|6 Months Follow-up|Adverse Event|0|||
163262349|NCT00733499|589671171|FG001|6 Months Follow-up|Adverse Event|1|||
163262350|NCT00733499|589671170|FG000|12 Months Follow-up|Death|2|||
163262351|NCT00733499|589671171|FG001|12 Months Follow-up|Death|1|||
163262352|NCT00733499|589671170|FG000|24 Months Follow-up|Death|0|||
163262353|NCT00733499|589671171|FG001|24 Months Follow-up|Death|1|||
163262354|NCT00733499|589671170|FG000|5 Year Followup|Adverse Event|2|||
163262355|NCT00733499|589671171|FG001|5 Year Followup|Adverse Event|2|||
163262356|NCT00733499|589671170|FG000|5 Year Followup|Non device related AE|0|||
163262357|NCT00733499|589671171|FG001|5 Year Followup|Non device related AE|1|||
163262358|NCT00733499|589671170|FG000|5 Year Followup|Revision of Study Implant|0|||
163262359|NCT00733499|589671171|FG001|5 Year Followup|Revision of Study Implant|1|||
163262360|NCT00733499|589671170|FG000|5 Year Followup|Lost to Follow-up|2|||
163262361|NCT00733499|589671171|FG001|5 Year Followup|Lost to Follow-up|0|||
163262362|NCT00733499|589671170|FG000|5 Year Followup|Death|13|||
163262363|NCT00733499|589671171|FG001|5 Year Followup|Death|19|||
163262364|NCT00733499|589671170|FG000|5 Year Followup|missing, unable to locate|0|||
163262365|NCT00733499|589671171|FG001|5 Year Followup|missing, unable to locate|1|||
163262366|NCT00733499|589671170|FG000|5 Year Followup|Withdrawal by Subject|4|||
163262367|NCT00733499|589671171|FG001|5 Year Followup|Withdrawal by Subject|1|||
163262368|NCT00733499|589671170|FG000|10 Year Followup|Death|9|||
163262369|NCT00733499|589671171|FG001|10 Year Followup|Death|7|||
163262370|NCT00733499|589671170|FG000|10 Year Followup|Adverse Event|3|||
163262371|NCT00733499|589671171|FG001|10 Year Followup|Adverse Event|3|||
163362032|NCT00794924|590034672|FG001|Overall Study|Lost to Follow-up|8|||
163362033|NCT00794924|590034671|FG000|Overall Study|Withdrawal by Subject|48|||
163362034|NCT00794924|590034672|FG001|Overall Study|Withdrawal by Subject|60|||
163362035|NCT00794924|590034671|FG000|Overall Study|Adverse Event|6|||
163362036|NCT00794924|590034672|FG001|Overall Study|Adverse Event|2|||
163362037|NCT00953615|590034673|FG000|Overall Study|Adverse Event|1|||
163362038|NCT03274895|590034674|FG000|Overall Study|Lack of Efficacy|1|||
163362039|NCT03274895|590034675|FG001|Overall Study|Lack of Efficacy|0|||
163362040|NCT03274895|590034674|FG000|Overall Study|Adverse Event|8|||
163362041|NCT03274895|590034675|FG001|Overall Study|Adverse Event|7|||
163362042|NCT03274895|590034674|FG000|Overall Study|Lost to Follow-up|1|||
163362043|NCT03274895|590034675|FG001|Overall Study|Lost to Follow-up|0|||
163362044|NCT03274895|590034674|FG000|Overall Study|Diagnosis not confirmed|3|||
163362045|NCT03274895|590034675|FG001|Overall Study|Diagnosis not confirmed|4|||
163362046|NCT01969851|590034676|FG000|Overall Study|Adverse Event|0|||
163362047|NCT01969851|590034677|FG001|Overall Study|Adverse Event|0|||
163362048|NCT01969851|590034678|FG002|Overall Study|Adverse Event|3|||
163262372|NCT00733499|589671170|FG000|10 Year Followup|Lost to Follow-up|3|||
163262373|NCT00733499|589671171|FG001|10 Year Followup|Lost to Follow-up|2|||
163262374|NCT00733499|589671170|FG000|10 Year Followup|Withdrawal by Subject|5|||
163262375|NCT00733499|589671171|FG001|10 Year Followup|Withdrawal by Subject|5|||
163262376|NCT00733499|589671170|FG000|10 Year Followup|missing, unable to locate|0|||
163362049|NCT01969851|590034676|FG000|Overall Study|Lack of Efficacy|0|||
163362050|NCT01969851|590034677|FG001|Overall Study|Lack of Efficacy|3|||
163262377|NCT00733499|589671171|FG001|10 Year Followup|missing, unable to locate|2|||
163262378|NCT00733980|589671172|FG000|Overall Study|Adverse Event|5|||
163262379|NCT00733980|589671173|FG001|Overall Study|Adverse Event|2|||
163262380|NCT00733980|589671172|FG000|Overall Study|Lack of Efficacy|0|||
163262381|NCT00733980|589671173|FG001|Overall Study|Lack of Efficacy|1|||
163262382|NCT00733980|589671172|FG000|Overall Study|Protocol Violation|2|||
163262383|NCT00733980|589671173|FG001|Overall Study|Protocol Violation|1|||
163262384|NCT00733980|589671172|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
163262385|NCT00733980|589671173|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
163262386|NCT00733980|589671172|FG000|Overall Study|Lost to Follow-up|6|||
163262387|NCT00733980|589671173|FG001|Overall Study|Lost to Follow-up|11|||
163262388|NCT00733980|589671172|FG000|Overall Study|Physician Decision|2|||
163262389|NCT00733980|589671173|FG001|Overall Study|Physician Decision|3|||
163262390|NCT00733980|589671172|FG000|Overall Study|Withdrawal by Subject|6|||
163262391|NCT00733980|589671173|FG001|Overall Study|Withdrawal by Subject|2|||
163262392|NCT01931735|589671174|FG000|Randomized Phase|Lost to Follow-up|2|||
163262393|NCT01931735|589671175|FG001|Randomized Phase|Lost to Follow-up|2|||
163262394|NCT01931735|589671176|FG002|Randomized Phase|Lost to Follow-up|5|||
163262395|NCT01931735|589671177|FG003|Randomized Phase|Lost to Follow-up|0|||
163262396|NCT01931735|589671174|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
163262397|NCT01931735|589671175|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
163262398|NCT01931735|589671176|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
163262399|NCT01931735|589671177|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
163262400|NCT01931735|589671174|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
163262401|NCT01931735|589671175|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
163262402|NCT01931735|589671176|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
163262403|NCT01931735|589671177|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
163262404|NCT02719990|589671181|FG000|Overall Study|Physician Decision|2|||
163262405|NCT02719990|589671181|FG000|Overall Study|Withdrawal by Subject|2|||
163262406|NCT02719990|589671181|FG000|Overall Study|Study Terminated By Sponsor|32|||
163262407|NCT03324880|589671185|FG000|Overall Study|Adverse Event|0|||
163262408|NCT03324880|589671186|FG001|Overall Study|Adverse Event|2|||
163262409|NCT03324880|589671185|FG000|Overall Study|Withdrawal by Subject|2|||
163262410|NCT03324880|589671186|FG001|Overall Study|Withdrawal by Subject|2|||
163262411|NCT03324880|589671185|FG000|Overall Study|Lost to Follow-up|0|||
163262412|NCT03324880|589671186|FG001|Overall Study|Lost to Follow-up|1|||
163262413|NCT03324880|589671185|FG000|Overall Study|Product Recall|0|||
163262414|NCT03324880|589671186|FG001|Overall Study|Product Recall|1|||
163262415|NCT00652938|589671190|FG000|Overall Study|Adverse Event|1|||
163262416|NCT00652938|589671191|FG001|Overall Study|Adverse Event|0|||
163262417|NCT00652938|589671192|FG002|Overall Study|Adverse Event|2|||
163262418|NCT00652938|589671190|FG000|Overall Study|Withdrawal by Subject|0|||
163262419|NCT00652938|589671191|FG001|Overall Study|Withdrawal by Subject|6|||
163262420|NCT00652938|589671192|FG002|Overall Study|Withdrawal by Subject|1|||
163262421|NCT00652938|589671190|FG000|Overall Study|Lost to Follow-up|0|||
163262422|NCT00652938|589671191|FG001|Overall Study|Lost to Follow-up|0|||
163262423|NCT00652938|589671192|FG002|Overall Study|Lost to Follow-up|2|||
163262424|NCT00652938|589671190|FG000|Overall Study|fear of blood sampling|0|||
163262425|NCT00652938|589671191|FG001|Overall Study|fear of blood sampling|1|||
163262426|NCT00652938|589671192|FG002|Overall Study|fear of blood sampling|0|||
163262427|NCT01547299|589671195|FG000|Overall Study|Withdrawal by Subject|2|||
163262428|NCT01547299|589671196|FG001|Overall Study|Withdrawal by Subject|2|||
163262429|NCT05076149|589671197|FG000|Overall Study|Adverse Event|3|||
163262430|NCT05076149|589671198|FG001|Overall Study|Adverse Event|9|||
163262431|NCT05076149|589671197|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
163262432|NCT05076149|589671198|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
163262433|NCT05076149|589671197|FG000|Overall Study|Lost to Follow-up|0|||
163262434|NCT05076149|589671198|FG001|Overall Study|Lost to Follow-up|1|||
163262435|NCT05076149|589671197|FG000|Overall Study|Commercial drug is available for participant|0|||
163262436|NCT05076149|589671198|FG001|Overall Study|Commercial drug is available for participant|1|||
163262437|NCT05076149|589671197|FG000|Overall Study|Other non compliance|1|||
163262438|NCT05076149|589671198|FG001|Overall Study|Other non compliance|1|||
163262439|NCT05076149|589671197|FG000|Overall Study|Physician Decision|0|||
163262440|NCT05076149|589671198|FG001|Overall Study|Physician Decision|1|||
163262441|NCT05076149|589671197|FG000|Overall Study|Other|5|||
163262442|NCT05076149|589671198|FG001|Overall Study|Other|4|||
163362051|NCT01969851|590034678|FG002|Overall Study|Lack of Efficacy|1|||
163362052|NCT01969851|590034676|FG000|Overall Study|Withdrawal by Subject|1|||
163362053|NCT01969851|590034677|FG001|Overall Study|Withdrawal by Subject|0|||
163262443|NCT02087501|589671199|FG000|Overall Study|Death|7|||
163262444|NCT02087501|589671199|FG000|Overall Study|Open repair of aneurysm|1|||
163262445|NCT02087501|589671199|FG000|Overall Study|Lost to Follow-up|2|||
163362054|NCT01969851|590034678|FG002|Overall Study|Withdrawal by Subject|1|||
163262446|NCT03682705|589671202|FG000|Overall Study|Adverse Event|1|||
163262447|NCT03682705|589671203|FG001|Overall Study|Adverse Event|1|||
163262448|NCT03682705|589671204|FG002|Overall Study|Adverse Event|1|||
163262449|NCT03682705|589671205|FG003|Overall Study|Adverse Event|0|||
163262450|NCT03682705|589671206|FG004|Overall Study|Adverse Event|1|||
163262451|NCT03682705|589671207|FG005|Overall Study|Adverse Event|1|||
163262452|NCT03682705|589671202|FG000|Overall Study|Withdrawal by Subject|1|||
163262453|NCT03682705|589671203|FG001|Overall Study|Withdrawal by Subject|3|||
163262454|NCT03682705|589671204|FG002|Overall Study|Withdrawal by Subject|2|||
163262455|NCT03682705|589671205|FG003|Overall Study|Withdrawal by Subject|4|||
163262456|NCT03682705|589671206|FG004|Overall Study|Withdrawal by Subject|0|||
163262457|NCT03682705|589671207|FG005|Overall Study|Withdrawal by Subject|1|||
163262458|NCT03682705|589671202|FG000|Overall Study|Other, not specified|0|||
163262459|NCT03682705|589671203|FG001|Overall Study|Other, not specified|0|||
163262460|NCT03682705|589671204|FG002|Overall Study|Other, not specified|0|||
163262461|NCT03682705|589671205|FG003|Overall Study|Other, not specified|1|||
163262462|NCT03682705|589671206|FG004|Overall Study|Other, not specified|2|||
163262463|NCT03682705|589671207|FG005|Overall Study|Other, not specified|0|||
163262464|NCT03682705|589671202|FG000|Overall Study|Lost to Follow-up|0|||
163262465|NCT03682705|589671203|FG001|Overall Study|Lost to Follow-up|0|||
163262466|NCT03682705|589671204|FG002|Overall Study|Lost to Follow-up|0|||
163262467|NCT03682705|589671205|FG003|Overall Study|Lost to Follow-up|0|||
163262468|NCT03682705|589671206|FG004|Overall Study|Lost to Follow-up|3|||
163262469|NCT03682705|589671207|FG005|Overall Study|Lost to Follow-up|0|||
163262470|NCT00094328|589671208|FG000|Overall Study|Lost to Follow-up|1|||
163262471|NCT00117156|589671209|FG000|Overall Study|Adverse Event|9|||
163262472|NCT00117156|589671209|FG000|Overall Study|Physician Decision|1|||
163262473|NCT00117156|589671209|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
163262474|NCT02213328|589671210|FG000|Overall Study|Withdrawal by Subject|10|||
163262475|NCT02213328|589671210|FG000|Overall Study|Physician Decision|2|||
163262476|NCT02213328|589671210|FG000|Overall Study|Lost to Follow-up|16|||
163153107|NCT04609319|589274748|FG002|Overall Study|Death|1|||
163153108|NCT04609319|589274746|FG000|Overall Study|Withdrawal of consent|15|||
163153109|NCT04609319|589274747|FG001|Overall Study|Withdrawal of consent|3|||
163153110|NCT04609319|589274748|FG002|Overall Study|Withdrawal of consent|0|||
163153111|NCT04609319|589274746|FG000|Overall Study|Lost to Follow-up|20|||
163153112|NCT04609319|589274747|FG001|Overall Study|Lost to Follow-up|33|||
163153113|NCT04609319|589274748|FG002|Overall Study|Lost to Follow-up|0|||
163153114|NCT04609319|589274746|FG000|Overall Study|Alive until end of follow-up|60|||
163153115|NCT04609319|589274747|FG001|Overall Study|Alive until end of follow-up|53|||
163153116|NCT04609319|589274748|FG002|Overall Study|Alive until end of follow-up|1|||
163153117|NCT03221556|589274749|FG000|Allocation|post-randomization exclusion|0|||
163153118|NCT03221556|589274750|FG001|Allocation|post-randomization exclusion|1|||
163153119|NCT03221556|589274749|FG000|Follow-Up|Withdrawal by Subject|0|||
163153120|NCT03221556|589274750|FG001|Follow-Up|Withdrawal by Subject|1|||
163153121|NCT04825574|589274754|FG000|Overall Study|Commercial treatment became available|1|||
163153122|NCT04825574|589274754|FG000|Overall Study|Disease progression|1|||
163153123|NCT01520506|589276196|FG000|Overall Study|Missed Visit|4|||
163153124|NCT01520506|589276196|FG000|Overall Study|Lost to Follow-up|1|||
163153125|NCT01520506|589276196|FG000|Overall Study|Withdrawal by Subject|1|||
163153126|NCT00906204|589276197|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
163153127|NCT00906204|589276198|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
163153128|NCT00906204|589276197|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
163153129|NCT00906204|589276198|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
163153130|NCT00906204|589276197|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
163153131|NCT00906204|589276198|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
163153132|NCT00906204|589276197|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
163153133|NCT00906204|589276198|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
163153134|NCT00906204|589276197|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
163153135|NCT00906204|589276198|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
163153136|NCT00696072|589276199|FG000|Overall Study|continuing active treatment|10|||
163153137|NCT00696072|589276200|FG001|Overall Study|continuing active treatment|13|||
163153138|NCT00696072|589276199|FG000|Overall Study|Adverse Event|10|||
163153139|NCT00696072|589276200|FG001|Overall Study|Adverse Event|6|||
163153140|NCT00696072|589276199|FG000|Overall Study|Patient Request|3|||
163153141|NCT00696072|589276200|FG001|Overall Study|Patient Request|7|||
163153142|NCT00696072|589276199|FG000|Overall Study|Investigator Request|1|||
163153143|NCT00696072|589276200|FG001|Overall Study|Investigator Request|4|||
163153144|NCT00696072|589276199|FG000|Overall Study|Sponsor Request|0|||
163153145|NCT00696072|589276200|FG001|Overall Study|Sponsor Request|1|||
163153146|NCT00696072|589276199|FG000|Overall Study|Disease Progression|32|||
163153147|NCT00696072|589276200|FG001|Overall Study|Disease Progression|30|||
163153148|NCT00696072|589276199|FG000|Overall Study|Non-specified|1|||
163262477|NCT04043962|589671211|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
163262478|NCT04043962|589671211|FG000|Post-Treatment|Withdrawal by Subject|5|||
163262479|NCT04043962|589671211|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
163262480|NCT01874145|589671212|FG000|Core Period|Non-compliance|1|||
163262481|NCT01874145|589671213|FG001|Core Period|Non-compliance|0|||
163262482|NCT01874145|589671212|FG000|Core Period|Protocol Violation|1|||
163262483|NCT01874145|589671213|FG001|Core Period|Protocol Violation|1|||
163262484|NCT01874145|589671212|FG000|Core Period|Physician Decision|1|||
163262485|NCT01874145|589671213|FG001|Core Period|Physician Decision|1|||
163262486|NCT01874145|589671212|FG000|Core Period|Adverse Event|0|||
163262487|NCT01874145|589671213|FG001|Core Period|Adverse Event|1|||
163262488|NCT01874145|589671212|FG000|Core Period|Withdrawal by Subject|0|||
163262489|NCT01874145|589671213|FG001|Core Period|Withdrawal by Subject|4|||
163262490|NCT01874145|589671212|FG000|Extension Period|Adverse Event|3|||
163262491|NCT01874145|589671213|FG001|Extension Period|Adverse Event|2|||
163262492|NCT01874145|589671212|FG000|Extension Period|Withdrawal by Subject|2|||
163262493|NCT01874145|589671213|FG001|Extension Period|Withdrawal by Subject|1|||
163262494|NCT01874145|589671212|FG000|Extension Period|Lost to Follow-up|1|||
163262495|NCT01874145|589671213|FG001|Extension Period|Lost to Follow-up|1|||
163262496|NCT00402337|589671214|FG000|Overall Study|Adverse Event|0|||
163262497|NCT00402337|589671215|FG001|Overall Study|Adverse Event|2|||
163262498|NCT00402337|589671216|FG002|Overall Study|Adverse Event|2|||
163262499|NCT00402337|589671217|FG003|Overall Study|Adverse Event|3|||
163262500|NCT00402337|589671218|FG004|Overall Study|Adverse Event|2|||
163262501|NCT00402337|589671214|FG000|Overall Study|Noncompliance|0|||
163262502|NCT00402337|589671215|FG001|Overall Study|Noncompliance|0|||
163262503|NCT00402337|589671216|FG002|Overall Study|Noncompliance|0|||
163262504|NCT00402337|589671217|FG003|Overall Study|Noncompliance|0|||
163262505|NCT00402337|589671218|FG004|Overall Study|Noncompliance|2|||
163262506|NCT00402337|589671214|FG000|Overall Study|Withdrawal by Subject|5|||
163262507|NCT00402337|589671215|FG001|Overall Study|Withdrawal by Subject|3|||
163262508|NCT00402337|589671216|FG002|Overall Study|Withdrawal by Subject|1|||
163262509|NCT00402337|589671217|FG003|Overall Study|Withdrawal by Subject|6|||
163262510|NCT00402337|589671218|FG004|Overall Study|Withdrawal by Subject|4|||
163262511|NCT00402337|589671214|FG000|Overall Study|Lost to Follow-up|0|||
163262512|NCT00402337|589671215|FG001|Overall Study|Lost to Follow-up|0|||
163262513|NCT00402337|589671216|FG002|Overall Study|Lost to Follow-up|1|||
163262514|NCT00402337|589671217|FG003|Overall Study|Lost to Follow-up|2|||
163262515|NCT00402337|589671218|FG004|Overall Study|Lost to Follow-up|0|||
163262516|NCT00402337|589671214|FG000|Overall Study|Physician Decision|0|||
163262517|NCT00402337|589671215|FG001|Overall Study|Physician Decision|0|||
163262518|NCT00402337|589671216|FG002|Overall Study|Physician Decision|0|||
163262519|NCT00402337|589671217|FG003|Overall Study|Physician Decision|1|||
163262520|NCT00402337|589671218|FG004|Overall Study|Physician Decision|0|||
163262521|NCT00402337|589671214|FG000|Overall Study|Other Reason|0|||
163262522|NCT00402337|589671215|FG001|Overall Study|Other Reason|1|||
163262523|NCT00402337|589671216|FG002|Overall Study|Other Reason|0|||
163262524|NCT00402337|589671217|FG003|Overall Study|Other Reason|0|||
163262525|NCT00402337|589671218|FG004|Overall Study|Other Reason|0|||
163262526|NCT01654601|589671219|FG000|1st Administration|Withdrawal by Subject|2|||
163262527|NCT01654601|589671220|FG001|1st Administration|Withdrawal by Subject|0|||
163262528|NCT01654601|589671219|FG000|1st Administration|Protocol Violation|0|||
163262529|NCT01654601|589671220|FG001|1st Administration|Protocol Violation|2|||
163262530|NCT01654601|589671219|FG000|2nd Administration|Adverse Event|1|||
163262531|NCT01654601|589671220|FG001|2nd Administration|Adverse Event|0|||
163262532|NCT01654601|589671219|FG000|2nd Administration|Protocol Violation|0|||
163262533|NCT01654601|589671220|FG001|2nd Administration|Protocol Violation|1|||
163262534|NCT02636270|589671221|FG000|Overall Study|Adverse Event|1|||
163262535|NCT02636270|589671222|FG001|Overall Study|Adverse Event|0|||
163262536|NCT02636270|589671223|FG002|Overall Study|Adverse Event|0|||
163262537|NCT02636270|589671221|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
163262538|NCT02636270|589671222|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
163262539|NCT02636270|589671223|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
163262540|NCT00767104|589673518|FG000|Overall Study|Lost to Follow-up|1|||
163262541|NCT00767104|589673519|FG001|Overall Study|Lost to Follow-up|2|||
163262542|NCT00840996|589673520|FG000|Overall Study|Withdrawal by Subject|1|||
163262543|NCT00840996|589673521|FG001|Overall Study|Withdrawal by Subject|0|||
163262544|NCT03285295|589673525|FG000|Alinity s HBsAg|Protocol Violation|11|||
163262545|NCT03285295|589673526|FG001|Alinity s HBsAg|Protocol Violation|0|||
163262546|NCT03285295|589673527|FG002|Alinity s HBsAg|Protocol Violation|0|||
163262547|NCT03285295|589673528|FG003|Alinity s HBsAg|Protocol Violation|0|||
163262548|NCT03285295|589673529|FG004|Alinity s HBsAg|Protocol Violation|0|||
163262549|NCT03285295|589673525|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
163262550|NCT03285295|589673526|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
163262551|NCT03285295|589673527|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
163262552|NCT03285295|589673528|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
163262553|NCT03285295|589673529|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
163262554|NCT03285295|589673525|FG000|Alinity s HBsAg|No Results Generated|74|||
163262555|NCT03285295|589673526|FG001|Alinity s HBsAg|No Results Generated|6|||
163262556|NCT03285295|589673527|FG002|Alinity s HBsAg|No Results Generated|0|||
163262557|NCT03285295|589673528|FG003|Alinity s HBsAg|No Results Generated|0|||
163262558|NCT03285295|589673529|FG004|Alinity s HBsAg|No Results Generated|0|||
163262559|NCT03285295|589673525|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
163262560|NCT03285295|589673526|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
163262561|NCT03285295|589673527|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
163262562|NCT03285295|589673528|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
163262563|NCT03285295|589673529|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
163262564|NCT03285295|589673525|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
163262565|NCT03285295|589673526|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
163262566|NCT03285295|589673527|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
163262567|NCT03285295|589673528|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
163262568|NCT03285295|589673529|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
163262569|NCT03285295|589673525|FG000|Alinity s HTLV I/II|No Results Generated|70|||
163262570|NCT03285295|589673526|FG001|Alinity s HTLV I/II|No Results Generated|0|||
163262571|NCT03285295|589673527|FG002|Alinity s HTLV I/II|No Results Generated|0|||
163262572|NCT03285295|589673528|FG003|Alinity s HTLV I/II|No Results Generated|0|||
163262573|NCT03285295|589673529|FG004|Alinity s HTLV I/II|No Results Generated|0|||
163262574|NCT03285295|589673525|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
163262575|NCT03285295|589673526|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
163262576|NCT03285295|589673527|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
163262577|NCT03285295|589673528|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
163262578|NCT03285295|589673529|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
163262579|NCT03285295|589673525|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
163262580|NCT03285295|589673526|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
163262581|NCT03285295|589673527|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
163262582|NCT03285295|589673528|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
163262583|NCT03285295|589673529|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
163262584|NCT03285295|589673525|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
163262585|NCT03285295|589673526|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
163262586|NCT03285295|589673527|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
163262587|NCT03285295|589673528|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
163262588|NCT03285295|589673529|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
163262589|NCT03285295|589673525|FG000|Alinity s Anti-HCV|No Results Generated|71|||
163262590|NCT03285295|589673526|FG001|Alinity s Anti-HCV|No Results Generated|0|||
163262591|NCT03285295|589673527|FG002|Alinity s Anti-HCV|No Results Generated|0|||
163262592|NCT03285295|589673528|FG003|Alinity s Anti-HCV|No Results Generated|0|||
163262593|NCT03285295|589673529|FG004|Alinity s Anti-HCV|No Results Generated|0|||
163262594|NCT03285295|589673525|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
163262595|NCT03285295|589673526|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
163262596|NCT03285295|589673527|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
163262597|NCT03285295|589673528|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
163262598|NCT03285295|589673529|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
163262599|NCT03285295|589673525|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
163262600|NCT03285295|589673526|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
163262601|NCT03285295|589673527|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
163262602|NCT03285295|589673528|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
163262603|NCT03285295|589673529|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
163262604|NCT03285295|589673525|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
163262605|NCT03285295|589673526|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
163262606|NCT03285295|589673527|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
163262607|NCT03285295|589673528|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
163262608|NCT03285295|589673529|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
163262609|NCT03285295|589673525|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
163262610|NCT03285295|589673526|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
163262611|NCT03285295|589673527|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
163262612|NCT03285295|589673528|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
163262613|NCT03285295|589673529|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
163262614|NCT03285295|589673525|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
163262615|NCT03285295|589673526|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
163262616|NCT03285295|589673527|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
163262617|NCT03285295|589673528|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
163262618|NCT03285295|589673529|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
163262619|NCT03285295|589673525|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
163362055|NCT01969851|590034676|FG000|Overall Study|No effective dose in Titration period|0|||
163362056|NCT01969851|590034677|FG001|Overall Study|No effective dose in Titration period|0|||
163362057|NCT01969851|590034678|FG002|Overall Study|No effective dose in Titration period|1|||
163262620|NCT03285295|589673526|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
163262621|NCT03285295|589673527|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
163262622|NCT03285295|589673528|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
163262623|NCT03285295|589673529|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
163362058|NCT01969851|590034676|FG000|Overall Study|Sponsor decision|0|||
163262624|NCT03285295|589673525|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
163262625|NCT03285295|589673526|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
163262626|NCT03285295|589673527|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
163262627|NCT03285295|589673528|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
163262628|NCT03285295|589673529|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
163262629|NCT03285295|589673525|FG000|Alinity s Anti-HBc|No Results Generated|70|||
163262630|NCT03285295|589673526|FG001|Alinity s Anti-HBc|No Results Generated|0|||
163262631|NCT03285295|589673527|FG002|Alinity s Anti-HBc|No Results Generated|0|||
163262632|NCT03285295|589673528|FG003|Alinity s Anti-HBc|No Results Generated|0|||
163262633|NCT03285295|589673529|FG004|Alinity s Anti-HBc|No Results Generated|0|||
163262634|NCT03285295|589673525|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
163262635|NCT03285295|589673526|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
163262636|NCT03285295|589673527|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
163262637|NCT03285295|589673528|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
163262638|NCT03285295|589673529|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
163262639|NCT03285295|589673525|FG000|Alinity s Chagas|Protocol Violation|76|||
163262640|NCT03285295|589673526|FG001|Alinity s Chagas|Protocol Violation|0|||
163262641|NCT03285295|589673527|FG002|Alinity s Chagas|Protocol Violation|0|||
163262642|NCT03285295|589673528|FG003|Alinity s Chagas|Protocol Violation|0|||
163262643|NCT03285295|589673529|FG004|Alinity s Chagas|Protocol Violation|0|||
163262644|NCT03285295|589673525|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
163262645|NCT03285295|589673526|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
163262646|NCT03285295|589673527|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
163262647|NCT03285295|589673528|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
163262648|NCT03285295|589673529|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
163262649|NCT03285295|589673525|FG000|Alinity s Chagas|No Results Generated|105|||
163262650|NCT03285295|589673526|FG001|Alinity s Chagas|No Results Generated|0|||
163262651|NCT03285295|589673527|FG002|Alinity s Chagas|No Results Generated|0|||
163262652|NCT03285295|589673528|FG003|Alinity s Chagas|No Results Generated|0|||
163262653|NCT03285295|589673529|FG004|Alinity s Chagas|No Results Generated|0|||
163262654|NCT03285295|589673525|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
163262655|NCT03285295|589673526|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
163262656|NCT03285295|589673527|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
163262657|NCT03285295|589673528|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
163262658|NCT03285295|589673529|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
163262659|NCT02762981|589673530|FG000|Overall Study|Adverse Event|2|||
163262660|NCT02762981|589673531|FG001|Overall Study|Adverse Event|3|||
163262661|NCT02762981|589673532|FG002|Overall Study|Adverse Event|1|||
163262662|NCT02762981|589673533|FG003|Overall Study|Adverse Event|1|||
163262663|NCT02762981|589673534|FG004|Overall Study|Adverse Event|3|||
163262664|NCT02762981|589673530|FG000|Overall Study|Physician Decision|0|||
163262665|NCT02762981|589673531|FG001|Overall Study|Physician Decision|1|||
163262666|NCT02762981|589673532|FG002|Overall Study|Physician Decision|0|||
163262667|NCT02762981|589673533|FG003|Overall Study|Physician Decision|0|||
163262668|NCT02762981|589673534|FG004|Overall Study|Physician Decision|1|||
163262669|NCT02762981|589673530|FG000|Overall Study|Disease progression|11|||
163262670|NCT02762981|589673531|FG001|Overall Study|Disease progression|23|||
163262671|NCT02762981|589673532|FG002|Overall Study|Disease progression|4|||
163262672|NCT02762981|589673533|FG003|Overall Study|Disease progression|10|||
163262673|NCT02762981|589673534|FG004|Overall Study|Disease progression|1|||
163262674|NCT02762981|589673530|FG000|Overall Study|Enrolled not treated|1|||
163262675|NCT02762981|589673531|FG001|Overall Study|Enrolled not treated|5|||
163262676|NCT02762981|589673532|FG002|Overall Study|Enrolled not treated|0|||
163262677|NCT02762981|589673533|FG003|Overall Study|Enrolled not treated|2|||
163262678|NCT02762981|589673534|FG004|Overall Study|Enrolled not treated|0|||
163262679|NCT02762981|589673530|FG000|Overall Study|Other|2|||
163262680|NCT02762981|589673531|FG001|Overall Study|Other|3|||
163262681|NCT02762981|589673532|FG002|Overall Study|Other|1|||
163262682|NCT02762981|589673533|FG003|Overall Study|Other|0|||
163262683|NCT02762981|589673534|FG004|Overall Study|Other|0|||
163262684|NCT02762981|589673530|FG000|Overall Study|Missing|1|||
163262685|NCT02762981|589673531|FG001|Overall Study|Missing|0|||
163262686|NCT02762981|589673532|FG002|Overall Study|Missing|0|||
163362059|NCT01969851|590034677|FG001|Overall Study|Sponsor decision|0|||
163262687|NCT02762981|589673533|FG003|Overall Study|Missing|0|||
163262688|NCT02762981|589673534|FG004|Overall Study|Missing|0|||
163262689|NCT02762981|589673530|FG000|Overall Study|Withdrawal by Subject|0|||
163262690|NCT02762981|589673531|FG001|Overall Study|Withdrawal by Subject|5|||
163262691|NCT02762981|589673532|FG002|Overall Study|Withdrawal by Subject|1|||
163262692|NCT02762981|589673533|FG003|Overall Study|Withdrawal by Subject|3|||
163262693|NCT02762981|589673534|FG004|Overall Study|Withdrawal by Subject|0|||
163262694|NCT04867785|589673536|FG000|Overall Study|Adverse Event|1|||
163262695|NCT04867785|589673537|FG001|Overall Study|Adverse Event|0|||
163262696|NCT04867785|589673538|FG002|Overall Study|Adverse Event|1|||
163262697|NCT04867785|589673539|FG003|Overall Study|Adverse Event|0|||
163262698|NCT04867785|589673540|FG004|Overall Study|Adverse Event|0|||
163262699|NCT04867785|589673541|FG005|Overall Study|Adverse Event|0|||
163262700|NCT04867785|589673542|FG006|Overall Study|Adverse Event|0|||
163153149|NCT00696072|589276200|FG001|Overall Study|Non-specified|2|||
163153150|NCT01597596|589276201|FG000|Overall Study|Study terminated by sponsor|1|||
163153151|NCT01597596|589276202|FG001|Overall Study|Study terminated by sponsor|0|||
163153152|NCT01597596|589276201|FG000|Overall Study|Physician Decision|0|||
163153153|NCT01597596|589276202|FG001|Overall Study|Physician Decision|1|||
163262701|NCT04867785|589673543|FG007|Overall Study|Adverse Event|2|||
163262702|NCT04867785|589673536|FG000|Overall Study|Lost to Follow-up|4|||
163262703|NCT04867785|589673537|FG001|Overall Study|Lost to Follow-up|4|||
163262704|NCT04867785|589673538|FG002|Overall Study|Lost to Follow-up|3|||
163262705|NCT04867785|589673539|FG003|Overall Study|Lost to Follow-up|2|||
163262706|NCT04867785|589673540|FG004|Overall Study|Lost to Follow-up|0|||
163153154|NCT00371150|589276203|FG000|Overall Study|Lost to Follow-up|3|||
163153155|NCT00371150|589276204|FG001|Overall Study|Lost to Follow-up|2|||
163153156|NCT00124943|589276206|FG000|Phase II|Adverse Event|0|||
163153157|NCT00124943|589276207|FG001|Phase II|Adverse Event|2|||
163153158|NCT00124943|589276208|FG002|Phase II|Adverse Event|0|||
163153159|NCT00124943|589276209|FG003|Phase II|Adverse Event|1|||
163262707|NCT04867785|589673541|FG005|Overall Study|Lost to Follow-up|1|||
163262708|NCT04867785|589673542|FG006|Overall Study|Lost to Follow-up|0|||
163262709|NCT04867785|589673543|FG007|Overall Study|Lost to Follow-up|1|||
163262710|NCT04867785|589673536|FG000|Overall Study|Withdrawal by Subject|6|||
163262711|NCT04867785|589673537|FG001|Overall Study|Withdrawal by Subject|2|||
163262712|NCT04867785|589673538|FG002|Overall Study|Withdrawal by Subject|2|||
163262713|NCT04867785|589673539|FG003|Overall Study|Withdrawal by Subject|1|||
163262714|NCT04867785|589673540|FG004|Overall Study|Withdrawal by Subject|2|||
163262715|NCT04867785|589673541|FG005|Overall Study|Withdrawal by Subject|0|||
163262716|NCT04867785|589673542|FG006|Overall Study|Withdrawal by Subject|2|||
163262717|NCT04867785|589673543|FG007|Overall Study|Withdrawal by Subject|5|||
163262718|NCT04867785|589673536|FG000|Overall Study|Physician Decision|0|||
163262719|NCT04867785|589673537|FG001|Overall Study|Physician Decision|0|||
163262720|NCT04867785|589673538|FG002|Overall Study|Physician Decision|0|||
163262721|NCT04867785|589673539|FG003|Overall Study|Physician Decision|0|||
163262722|NCT04867785|589673540|FG004|Overall Study|Physician Decision|0|||
163262723|NCT04867785|589673541|FG005|Overall Study|Physician Decision|0|||
163262724|NCT04867785|589673542|FG006|Overall Study|Physician Decision|0|||
163262725|NCT04867785|589673543|FG007|Overall Study|Physician Decision|1|||
163262726|NCT04867785|589673536|FG000|Overall Study|Inadvertent Enrollment|0|||
163262727|NCT04867785|589673537|FG001|Overall Study|Inadvertent Enrollment|0|||
163262728|NCT04867785|589673538|FG002|Overall Study|Inadvertent Enrollment|0|||
163262729|NCT04867785|589673539|FG003|Overall Study|Inadvertent Enrollment|1|||
163262730|NCT04867785|589673540|FG004|Overall Study|Inadvertent Enrollment|1|||
163262731|NCT04867785|589673541|FG005|Overall Study|Inadvertent Enrollment|0|||
163262732|NCT04867785|589673542|FG006|Overall Study|Inadvertent Enrollment|0|||
163262733|NCT04867785|589673543|FG007|Overall Study|Inadvertent Enrollment|1|||
163262734|NCT04867785|589673536|FG000|Overall Study|Eligibility Criteria Not Met|0|||
163262735|NCT04867785|589673537|FG001|Overall Study|Eligibility Criteria Not Met|0|||
163262736|NCT04867785|589673538|FG002|Overall Study|Eligibility Criteria Not Met|0|||
163262737|NCT04867785|589673539|FG003|Overall Study|Eligibility Criteria Not Met|0|||
163262738|NCT04867785|589673540|FG004|Overall Study|Eligibility Criteria Not Met|0|||
163262739|NCT04867785|589673541|FG005|Overall Study|Eligibility Criteria Not Met|0|||
163262740|NCT04867785|589673542|FG006|Overall Study|Eligibility Criteria Not Met|0|||
163262741|NCT04867785|589673543|FG007|Overall Study|Eligibility Criteria Not Met|1|||
163262742|NCT01062763|589673544|FG000|Overall Study|Adverse Event|3|||
163262743|NCT01062763|589673545|FG001|Overall Study|Adverse Event|4|||
163262744|NCT02494921|589673547|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
163262745|NCT02494921|589673548|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
163262746|NCT02494921|589673549|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
163262747|NCT02494921|589673550|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
163262748|NCT02494921|589673551|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
163262749|NCT02494921|589673547|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
163262750|NCT02494921|589673548|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
163262751|NCT02494921|589673549|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
163262752|NCT02494921|589673550|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
163262753|NCT02494921|589673551|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
163262754|NCT02494921|589673547|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
163153160|NCT00124943|589276206|FG000|Phase II|Protocol Violation|0|||
163262755|NCT02494921|589673548|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
163262756|NCT02494921|589673549|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
163262757|NCT02494921|589673550|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
163262758|NCT02494921|589673551|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
163262759|NCT00605319|589673554|FG000|Overall Study|Adverse Event|6|||
163262760|NCT02991482|589673555|FG000|Overall Study|Disease progression|56|||
163262761|NCT02991482|589673556|FG001|Overall Study|Disease progression|47|||
163262762|NCT02991482|589673555|FG000|Overall Study|Death|4|||
163153161|NCT00124943|589276207|FG001|Phase II|Protocol Violation|0|||
163262763|NCT02991482|589673556|FG001|Overall Study|Death|4|||
163262764|NCT02991482|589673555|FG000|Overall Study|Adverse Event|1|||
163262765|NCT02991482|589673556|FG001|Overall Study|Adverse Event|6|||
163262766|NCT02991482|589673555|FG000|Overall Study|Patient decision|1|||
163262767|NCT02991482|589673556|FG001|Overall Study|Patient decision|1|||
163262768|NCT02991482|589673555|FG000|Overall Study|Physician Decision|0|||
163262769|NCT02991482|589673556|FG001|Overall Study|Physician Decision|6|||
163262770|NCT02991482|589673555|FG000|Overall Study|Clinical deterioration|1|||
163262771|NCT02991482|589673556|FG001|Overall Study|Clinical deterioration|0|||
163262772|NCT02991482|589673555|FG000|Overall Study|Patient feeling too unwell|1|||
163262773|NCT02991482|589673556|FG001|Overall Study|Patient feeling too unwell|0|||
163262774|NCT02991482|589673555|FG000|Overall Study|Worsening of performance status|0|||
163262775|NCT02991482|589673556|FG001|Overall Study|Worsening of performance status|1|||
163262776|NCT02991482|589673555|FG000|Overall Study|Death prior to study drug initiation|1|||
163262777|NCT02991482|589673556|FG001|Overall Study|Death prior to study drug initiation|0|||
163262778|NCT02991482|589673555|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
163262779|NCT02991482|589673556|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
163262780|NCT02887989|589673562|FG000|Overall Study|Withdrawal by Subject|8|||
163262781|NCT02887989|589673563|FG001|Overall Study|Withdrawal by Subject|11|||
163262782|NCT02887989|589673562|FG000|Overall Study|Death|1|||
163262783|NCT02887989|589673563|FG001|Overall Study|Death|0|||
163262784|NCT05648357|589673567|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
163262785|NCT00768430|589673568|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
163262786|NCT00768430|589673569|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
163262787|NCT03585296|589673572|FG000|Overall Study|Adverse Event|1|||
163262788|NCT03585296|589673572|FG000|Overall Study|Lost to Follow-up|2|||
163262789|NCT03585296|589673572|FG000|Overall Study|Withdrawal by Subject|2|||
163262790|NCT00041756|589673573|FG000|Overall Study|Adverse Event|4|||
163262791|NCT00041756|589673574|FG001|Overall Study|Adverse Event|10|||
163262792|NCT00041756|589673575|FG002|Overall Study|Adverse Event|6|||
163262793|NCT00041756|589673576|FG003|Overall Study|Adverse Event|11|||
163262794|NCT00041756|589673577|FG004|Overall Study|Adverse Event|34|||
163262795|NCT00041756|589673573|FG000|Overall Study|Protocol Violation|1|||
163262796|NCT00041756|589673574|FG001|Overall Study|Protocol Violation|1|||
163262797|NCT00041756|589673575|FG002|Overall Study|Protocol Violation|2|||
163362060|NCT01969851|590034678|FG002|Overall Study|Sponsor decision|1|||
163362061|NCT01754753|590034679|FG000|Overall Study|Study close|43|||
163362062|NCT01754753|590034680|FG001|Overall Study|Study close|44|||
163362063|NCT01754753|590034679|FG000|Overall Study|Lost to Follow-up|9|||
163362064|NCT01754753|590034680|FG001|Overall Study|Lost to Follow-up|5|||
163362065|NCT03229486|590034681|FG000|Overall Study|Protocol Violation|0|||
163362066|NCT03229486|590034682|FG001|Overall Study|Protocol Violation|1|||
163362067|NCT00856245|590034683|FG000|Overall Study|Was not transplanted|5|||
163362068|NCT01782690|590034687|FG000|Overall Study|Not reported|7|||
163153162|NCT00124943|589276208|FG002|Phase II|Protocol Violation|0|||
163153163|NCT00124943|589276209|FG003|Phase II|Protocol Violation|1|||
163153164|NCT00124943|589276206|FG000|Phase II|Lost to Follow-up|0|||
163153165|NCT00124943|589276207|FG001|Phase II|Lost to Follow-up|0|||
163153166|NCT00124943|589276208|FG002|Phase II|Lost to Follow-up|0|||
163153167|NCT00124943|589276209|FG003|Phase II|Lost to Follow-up|1|||
163153168|NCT00124943|589276206|FG000|Phase II|Withdrawal by Subject|0|||
163153169|NCT00124943|589276207|FG001|Phase II|Withdrawal by Subject|0|||
163153170|NCT00124943|589276208|FG002|Phase II|Withdrawal by Subject|0|||
163153171|NCT00124943|589276209|FG003|Phase II|Withdrawal by Subject|2|||
163153172|NCT03181932|589276210|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
163153173|NCT03181932|589276211|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
163153174|NCT03181932|589276210|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
163153175|NCT03181932|589276211|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
163153176|NCT03181932|589276210|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
163153177|NCT03181932|589276211|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
163153178|NCT03181932|589276210|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
163153179|NCT03181932|589276211|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
163153180|NCT03181932|589276210|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
163153181|NCT03181932|589276211|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
163153182|NCT03181932|589276210|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
163153183|NCT03181932|589276211|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
163153184|NCT03181932|589276210|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
163153185|NCT03181932|589276211|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
163262798|NCT00041756|589673576|FG003|Overall Study|Protocol Violation|2|||
163262799|NCT00041756|589673577|FG004|Overall Study|Protocol Violation|1|||
163262800|NCT00041756|589673573|FG000|Overall Study|Withdrawal by Subject|3|||
163262801|NCT00041756|589673574|FG001|Overall Study|Withdrawal by Subject|3|||
163262802|NCT00041756|589673575|FG002|Overall Study|Withdrawal by Subject|4|||
163362069|NCT01782690|590034687|FG000|Overall Study|Toxicity of gemcitabine|1|||
163262803|NCT00041756|589673576|FG003|Overall Study|Withdrawal by Subject|2|||
163262804|NCT00041756|589673577|FG004|Overall Study|Withdrawal by Subject|3|||
163262805|NCT00041756|589673573|FG000|Overall Study|Lost to Follow-up|0|||
163362070|NCT01782690|590034687|FG000|Overall Study|Toxicity of erlotinib|1|||
163262806|NCT00041756|589673574|FG001|Overall Study|Lost to Follow-up|1|||
163262807|NCT00041756|589673575|FG002|Overall Study|Lost to Follow-up|0|||
163262808|NCT00041756|589673576|FG003|Overall Study|Lost to Follow-up|1|||
163262809|NCT00041756|589673577|FG004|Overall Study|Lost to Follow-up|0|||
163262810|NCT00041756|589673573|FG000|Overall Study|Unable to meet protocol criteria|0|||
163262811|NCT00041756|589673574|FG001|Overall Study|Unable to meet protocol criteria|0|||
163262812|NCT00041756|589673575|FG002|Overall Study|Unable to meet protocol criteria|1|||
163262813|NCT00041756|589673576|FG003|Overall Study|Unable to meet protocol criteria|0|||
163262814|NCT00041756|589673577|FG004|Overall Study|Unable to meet protocol criteria|1|||
163262815|NCT00041756|589673573|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
163262816|NCT00041756|589673574|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
163262817|NCT00041756|589673575|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
163262818|NCT00041756|589673576|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
163262819|NCT00041756|589673577|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
163262820|NCT02002884|589673578|FG000|Main Period (MP)|Other|0|||
163262821|NCT02002884|589673579|FG001|Main Period (MP)|Other|3|||
163262822|NCT02002884|589673580|FG002|Main Period (MP)|Other|3|||
163262823|NCT02002884|589673581|FG003|Main Period (MP)|Other|0|||
163262824|NCT02002884|589673578|FG000|Main Period (MP)|Adverse Event|0|||
163262825|NCT02002884|589673579|FG001|Main Period (MP)|Adverse Event|1|||
163262826|NCT02002884|589673580|FG002|Main Period (MP)|Adverse Event|1|||
163262827|NCT02002884|589673581|FG003|Main Period (MP)|Adverse Event|0|||
163262828|NCT02002884|589673578|FG000|Main Period (MP)|Withdrawal by Subject|6|||
163262829|NCT02002884|589673579|FG001|Main Period (MP)|Withdrawal by Subject|2|||
163262830|NCT02002884|589673580|FG002|Main Period (MP)|Withdrawal by Subject|2|||
163262831|NCT02002884|589673581|FG003|Main Period (MP)|Withdrawal by Subject|0|||
163262832|NCT02002884|589673578|FG000|Main Period (MP)|Lost to Follow-up|0|||
163262833|NCT02002884|589673579|FG001|Main Period (MP)|Lost to Follow-up|0|||
163262834|NCT02002884|589673580|FG002|Main Period (MP)|Lost to Follow-up|2|||
163262835|NCT02002884|589673581|FG003|Main Period (MP)|Lost to Follow-up|0|||
163262836|NCT02002884|589673578|FG000|Open-Label Extension Period (OLEX)|Other|0|||
163262837|NCT02002884|589673579|FG001|Open-Label Extension Period (OLEX)|Other|0|||
163262838|NCT02002884|589673580|FG002|Open-Label Extension Period (OLEX)|Other|0|||
163262839|NCT02002884|589673581|FG003|Open-Label Extension Period (OLEX)|Other|24|||
163262840|NCT02002884|589673578|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
163262841|NCT02002884|589673579|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
163262842|NCT02002884|589673580|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
163262843|NCT02002884|589673581|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
163262844|NCT02002884|589673578|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
163262845|NCT02002884|589673579|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
163262846|NCT02002884|589673580|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
163262847|NCT02002884|589673581|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
163262848|NCT02002884|589673578|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
163262849|NCT02002884|589673579|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
163262850|NCT02002884|589673580|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
163262851|NCT02002884|589673581|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
163262852|NCT02002884|589673578|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
163262853|NCT02002884|589673579|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
163262854|NCT02002884|589673580|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
163262855|NCT02002884|589673581|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
163262856|NCT02110732|589673582|FG000|Overall Study|Physician Decision|5|||
163262857|NCT02110732|589673583|FG001|Overall Study|Physician Decision|2|||
163262858|NCT02110732|589673582|FG000|Overall Study|Lost to Follow-up|1|||
163262859|NCT02110732|589673583|FG001|Overall Study|Lost to Follow-up|1|||
163262860|NCT04887948|589673587|FG000|Overall Study|Death|1|||
163262861|NCT04887948|589673588|FG001|Overall Study|Death|0|||
163262862|NCT04887948|589673589|FG002|Overall Study|Death|0|||
163262863|NCT04887948|589673587|FG000|Overall Study|Lost to Follow-up|1|||
163262864|NCT04887948|589673588|FG001|Overall Study|Lost to Follow-up|0|||
163262865|NCT04887948|589673589|FG002|Overall Study|Lost to Follow-up|3|||
163262866|NCT04887948|589673587|FG000|Overall Study|Physician Decision|0|||
163262867|NCT04887948|589673588|FG001|Overall Study|Physician Decision|4|||
163262868|NCT04887948|589673589|FG002|Overall Study|Physician Decision|1|||
163262869|NCT04887948|589673587|FG000|Overall Study|Protocol Violation|1|||
163362071|NCT01782690|590034687|FG000|Overall Study|Lost to Follow-up|31|||
163411165|NCT00852995|590212999|FG003|Overall Study|Physician Decision|0|||
163262870|NCT04887948|589673588|FG001|Overall Study|Protocol Violation|1|||
163262871|NCT04887948|589673589|FG002|Overall Study|Protocol Violation|0|||
163262872|NCT04887948|589673587|FG000|Overall Study|Withdrawal by Subject|0|||
163262873|NCT04887948|589673588|FG001|Overall Study|Withdrawal by Subject|6|||
163262874|NCT04887948|589673589|FG002|Overall Study|Withdrawal by Subject|1|||
163262875|NCT04887948|589673587|FG000|Overall Study|No longer met eligibility criteria|1|||
163262876|NCT04887948|589673588|FG001|Overall Study|No longer met eligibility criteria|2|||
163262877|NCT04887948|589673589|FG002|Overall Study|No longer met eligibility criteria|1|||
163262878|NCT04887948|589673587|FG000|Overall Study|Other|2|||
163153186|NCT03181932|589276210|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
163153187|NCT03181932|589276211|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
163153188|NCT03181932|589276210|FG000|Period 2 (Open-label Period)|Reason missing|2|||
163262879|NCT04887948|589673588|FG001|Overall Study|Other|1|||
163262880|NCT04887948|589673589|FG002|Overall Study|Other|1|||
163262881|NCT02312856|589673590|FG000|Overall Study|Death|1|||
163262882|NCT02312856|589673590|FG000|Overall Study|Lost to Follow-up|3|||
163262883|NCT04415151|589673591|FG000|Overall Study|Death|1|||
163153189|NCT03181932|589276211|FG001|Period 2 (Open-label Period)|Reason missing|0|||
163153190|NCT03304626|589276212|FG000|Overall Study|Adverse Event|1|||
163153191|NCT03304626|589276213|FG001|Overall Study|Adverse Event|0|||
163153192|NCT03304626|589276212|FG000|Overall Study|Lack of Efficacy|1|||
163153193|NCT03304626|589276213|FG001|Overall Study|Lack of Efficacy|1|||
163153194|NCT00408317|589276220|FG000|First Intervention Period|Adverse Event|0|||
163153195|NCT00408317|589276221|FG001|First Intervention Period|Adverse Event|1|||
163153196|NCT00408317|589276220|FG000|Second Intervention Period|Adverse Event|2|||
163153197|NCT00408317|589276221|FG001|Second Intervention Period|Adverse Event|0|||
163153198|NCT00408317|589276220|FG000|Second Intervention Period|Protocol Violation|0|||
163153199|NCT00408317|589276221|FG001|Second Intervention Period|Protocol Violation|1|||
163153200|NCT00408317|589276220|FG000|Second Intervention Period|Withdrawal of consent|0|||
163153201|NCT00408317|589276221|FG001|Second Intervention Period|Withdrawal of consent|1|||
163153202|NCT01747876|589276222|FG000|Overall Study|Adverse Event|1|||
163262884|NCT04415151|589673592|FG001|Overall Study|Death|1|||
163262885|NCT04415151|589673591|FG000|Overall Study|Withdrawal by Subject|1|||
163262886|NCT04415151|589673592|FG001|Overall Study|Withdrawal by Subject|0|||
163262887|NCT00638235|589673593|FG000|Overall Study|Lost to Follow-up|31|||
163262888|NCT00638235|589673594|FG001|Overall Study|Lost to Follow-up|3|||
163262889|NCT00638235|589673595|FG002|Overall Study|Lost to Follow-up|18|||
163262890|NCT00638235|589673596|FG003|Overall Study|Lost to Follow-up|10|||
163262891|NCT00638235|589673597|FG004|Overall Study|Lost to Follow-up|13|||
163262892|NCT00638235|589673598|FG005|Overall Study|Lost to Follow-up|26|||
163262893|NCT00638235|589673599|FG006|Overall Study|Lost to Follow-up|0|||
163262894|NCT00638235|589673600|FG007|Overall Study|Lost to Follow-up|1|||
163262895|NCT00638235|589673601|FG008|Overall Study|Lost to Follow-up|18|||
163262896|NCT01588990|589673604|FG000|Phase A|Withdrawal by Subject|5|||
163262897|NCT01588990|589673604|FG000|Phase A|Physician Decision|11|||
163262898|NCT01588990|589673604|FG000|Phase A|Other|14|||
163262899|NCT01588990|589673604|FG000|Phase A|Lost to Follow-up|1|||
163262900|NCT01588990|589673604|FG000|Phase A|Death|5|||
163262901|NCT01588990|589673604|FG000|Phase A|Adverse Event|28|||
163262902|NCT01588990|589673604|FG000|Phase A|Still on therapy at end of study|6|||
163262903|NCT01588990|589673604|FG000|Phase B|Adverse Event|2|||
163262904|NCT01588990|589673604|FG000|Phase B|Still on therapy at end of study|5|||
163262905|NCT01588990|589673604|FG000|Phase B|Withdrawal by Subject|3|||
163262906|NCT01588990|589673604|FG000|Phase B|Physician Decision|4|||
163262907|NCT01588990|589673604|FG000|Phase B|Other|2|||
163262908|NCT02367716|589673605|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
163262909|NCT01473381|589673606|FG000|Overall Study|Adverse Event|8|||
163262910|NCT01473381|589673607|FG001|Overall Study|Adverse Event|20|||
163262911|NCT01473381|589673608|FG002|Overall Study|Adverse Event|25|||
163262912|NCT01473381|589673609|FG003|Overall Study|Adverse Event|17|||
163262913|NCT01473381|589673606|FG000|Overall Study|Insufficient Therapeutic Response|10|||
163262914|NCT01473381|589673607|FG001|Overall Study|Insufficient Therapeutic Response|1|||
163262915|NCT01473381|589673608|FG002|Overall Study|Insufficient Therapeutic Response|2|||
163262916|NCT01473381|589673609|FG003|Overall Study|Insufficient Therapeutic Response|3|||
163262917|NCT01473381|589673606|FG000|Overall Study|Protocol Violation|17|||
163262918|NCT01473381|589673607|FG001|Overall Study|Protocol Violation|23|||
163262919|NCT01473381|589673608|FG002|Overall Study|Protocol Violation|19|||
163262920|NCT01473381|589673609|FG003|Overall Study|Protocol Violation|17|||
163262921|NCT01473381|589673606|FG000|Overall Study|Withdrawal of Consent|20|||
163262922|NCT01473381|589673607|FG001|Overall Study|Withdrawal of Consent|21|||
163262923|NCT01473381|589673608|FG002|Overall Study|Withdrawal of Consent|20|||
163262924|NCT01473381|589673609|FG003|Overall Study|Withdrawal of Consent|26|||
163262925|NCT01473381|589673606|FG000|Overall Study|Lost to Follow-up|25|||
163262926|NCT01473381|589673607|FG001|Overall Study|Lost to Follow-up|28|||
163153203|NCT01747876|589276223|FG001|Overall Study|Adverse Event|0|||
163153204|NCT01747876|589276224|FG002|Overall Study|Adverse Event|2|||
163153205|NCT01747876|589276222|FG000|Overall Study|Withdrawal by Subject|0|||
163153206|NCT01747876|589276223|FG001|Overall Study|Withdrawal by Subject|1|||
163262927|NCT01473381|589673608|FG002|Overall Study|Lost to Follow-up|35|||
163262928|NCT01473381|589673609|FG003|Overall Study|Lost to Follow-up|23|||
163262929|NCT01473381|589673606|FG000|Overall Study|Other Reasons|0|||
163262930|NCT01473381|589673607|FG001|Overall Study|Other Reasons|0|||
163262931|NCT01473381|589673608|FG002|Overall Study|Other Reasons|1|||
163262932|NCT01473381|589673609|FG003|Overall Study|Other Reasons|3|||
163262933|NCT00539643|589673610|FG000|Overall Study|Adverse Event|1|||
163262934|NCT00539643|589673611|FG001|Overall Study|Adverse Event|0|||
163262935|NCT00539643|589673610|FG000|Overall Study|Death|2|||
163262936|NCT00539643|589673611|FG001|Overall Study|Death|1|||
163153207|NCT01747876|589276224|FG002|Overall Study|Withdrawal by Subject|1|||
163153208|NCT01747876|589276222|FG000|Overall Study|Disease progression|4|||
163153209|NCT01747876|589276223|FG001|Overall Study|Disease progression|13|||
163153210|NCT01747876|589276224|FG002|Overall Study|Disease progression|8|||
163153211|NCT01747876|589276222|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
163153212|NCT01747876|589276223|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
163153213|NCT01747876|589276224|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
163153214|NCT00853307|589276227|FG000|Overall Study|Adverse Event|1|||
163153215|NCT00853307|589276228|FG001|Overall Study|Adverse Event|2|||
163153216|NCT00853307|589276227|FG000|Overall Study|Withdrawal by Subject|1|||
163153217|NCT00853307|589276228|FG001|Overall Study|Withdrawal by Subject|2|||
163153218|NCT00853307|589276227|FG000|Overall Study|Reason Not Specified|0|||
163153219|NCT00853307|589276228|FG001|Overall Study|Reason Not Specified|1|||
163153220|NCT03331315|589276235|FG000|Overall Study|Physician Decision|18|||
163153221|NCT03331315|589276236|FG001|Overall Study|Physician Decision|14|||
163262937|NCT00539643|589673610|FG000|Overall Study|Physician Decision|3|||
163262938|NCT00539643|589673611|FG001|Overall Study|Physician Decision|1|||
163153222|NCT00360230|589276237|FG000|Overall Study|Withdrawal by Subject|1|||
163153223|NCT00360230|589276238|FG001|Overall Study|Withdrawal by Subject|1|||
163153224|NCT00360230|589276239|FG002|Overall Study|Withdrawal by Subject|0|||
163262939|NCT00539643|589673610|FG000|Overall Study|Withdrawal by Subject|0|||
163262940|NCT00539643|589673611|FG001|Overall Study|Withdrawal by Subject|1|||
163262941|NCT02508532|589673612|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163262942|NCT02508532|589673613|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163153225|NCT00360230|589276240|FG003|Overall Study|Withdrawal by Subject|1|||
163153226|NCT00360230|589276241|FG004|Overall Study|Withdrawal by Subject|1|||
163153227|NCT00360230|589276242|FG005|Overall Study|Withdrawal by Subject|1|||
163153228|NCT00360230|589276243|FG006|Overall Study|Withdrawal by Subject|0|||
163153229|NCT00360230|589276237|FG000|Overall Study|Migrated|4|||
163153230|NCT00360230|589276238|FG001|Overall Study|Migrated|1|||
163153231|NCT00360230|589276239|FG002|Overall Study|Migrated|3|||
163153232|NCT00360230|589276240|FG003|Overall Study|Migrated|1|||
163262943|NCT02508532|589673614|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163262944|NCT02508532|589673615|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163262945|NCT02508532|589673616|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163262946|NCT02508532|589673617|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163262947|NCT02508532|589673618|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
163262948|NCT02508532|589673619|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163262949|NCT02508532|589673620|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163262950|NCT02508532|589673612|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
163262951|NCT02508532|589673613|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
163262952|NCT02508532|589673614|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
163262953|NCT02508532|589673615|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
163262954|NCT02508532|589673616|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
163262955|NCT02508532|589673617|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
163262956|NCT02508532|589673618|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
163262957|NCT02508532|589673619|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
163262958|NCT02508532|589673620|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
163262959|NCT02508532|589673612|FG000|Part 2 - Treatment|Disease Progression|0|||
163262960|NCT02508532|589673613|FG001|Part 2 - Treatment|Disease Progression|0|||
163262961|NCT02508532|589673614|FG002|Part 2 - Treatment|Disease Progression|0|||
163262962|NCT02508532|589673615|FG003|Part 2 - Treatment|Disease Progression|0|||
163262963|NCT02508532|589673616|FG004|Part 2 - Treatment|Disease Progression|0|||
163262964|NCT02508532|589673617|FG005|Part 2 - Treatment|Disease Progression|0|||
163262965|NCT02508532|589673618|FG006|Part 2 - Treatment|Disease Progression|0|||
163262966|NCT02508532|589673619|FG007|Part 2 - Treatment|Disease Progression|0|||
163262967|NCT02508532|589673620|FG008|Part 2 - Treatment|Disease Progression|118|||
163262968|NCT02508532|589673612|FG000|Part 2 - Treatment|Adverse Event|0|||
163262969|NCT02508532|589673613|FG001|Part 2 - Treatment|Adverse Event|0|||
163262970|NCT02508532|589673614|FG002|Part 2 - Treatment|Adverse Event|0|||
163262971|NCT02508532|589673615|FG003|Part 2 - Treatment|Adverse Event|0|||
163262972|NCT02508532|589673616|FG004|Part 2 - Treatment|Adverse Event|0|||
163262973|NCT02508532|589673617|FG005|Part 2 - Treatment|Adverse Event|0|||
163262974|NCT02508532|589673618|FG006|Part 2 - Treatment|Adverse Event|0|||
163362072|NCT01782690|590034687|FG000|Overall Study|Withdrawal of informed consent|2|||
163153233|NCT00360230|589276241|FG004|Overall Study|Migrated|4|||
163153234|NCT00360230|589276242|FG005|Overall Study|Migrated|1|||
163153235|NCT00360230|589276243|FG006|Overall Study|Migrated|1|||
163153236|NCT00360230|589276237|FG000|Overall Study|Other|1|||
163153237|NCT00360230|589276238|FG001|Overall Study|Other|0|||
163153238|NCT00360230|589276239|FG002|Overall Study|Other|0|||
163153239|NCT00360230|589276240|FG003|Overall Study|Other|0|||
163262975|NCT02508532|589673619|FG007|Part 2 - Treatment|Adverse Event|0|||
163262976|NCT02508532|589673620|FG008|Part 2 - Treatment|Adverse Event|49|||
163262977|NCT02508532|589673612|FG000|Part 2 - Treatment|Physician Decision|0|||
163262978|NCT02508532|589673613|FG001|Part 2 - Treatment|Physician Decision|0|||
163262979|NCT02508532|589673614|FG002|Part 2 - Treatment|Physician Decision|0|||
163262980|NCT02508532|589673615|FG003|Part 2 - Treatment|Physician Decision|0|||
163262981|NCT02508532|589673616|FG004|Part 2 - Treatment|Physician Decision|0|||
163262982|NCT02508532|589673617|FG005|Part 2 - Treatment|Physician Decision|0|||
163262983|NCT02508532|589673618|FG006|Part 2 - Treatment|Physician Decision|0|||
163262984|NCT02508532|589673619|FG007|Part 2 - Treatment|Physician Decision|0|||
163262985|NCT02508532|589673620|FG008|Part 2 - Treatment|Physician Decision|12|||
163262986|NCT02508532|589673612|FG000|Part 2 - Treatment|Administrative|0|||
163262987|NCT02508532|589673613|FG001|Part 2 - Treatment|Administrative|0|||
163262988|NCT02508532|589673614|FG002|Part 2 - Treatment|Administrative|0|||
163262989|NCT02508532|589673615|FG003|Part 2 - Treatment|Administrative|0|||
163262990|NCT02508532|589673616|FG004|Part 2 - Treatment|Administrative|0|||
163262991|NCT02508532|589673617|FG005|Part 2 - Treatment|Administrative|0|||
163262992|NCT02508532|589673618|FG006|Part 2 - Treatment|Administrative|0|||
163262993|NCT02508532|589673619|FG007|Part 2 - Treatment|Administrative|0|||
163262994|NCT02508532|589673620|FG008|Part 2 - Treatment|Administrative|3|||
163262995|NCT02508532|589673612|FG000|Part 2 - Treatment|Sponsor Decision|0|||
163262996|NCT02508532|589673613|FG001|Part 2 - Treatment|Sponsor Decision|0|||
163262997|NCT02508532|589673614|FG002|Part 2 - Treatment|Sponsor Decision|0|||
163262998|NCT02508532|589673615|FG003|Part 2 - Treatment|Sponsor Decision|0|||
163262999|NCT02508532|589673616|FG004|Part 2 - Treatment|Sponsor Decision|0|||
163263000|NCT02508532|589673617|FG005|Part 2 - Treatment|Sponsor Decision|0|||
163263001|NCT02508532|589673618|FG006|Part 2 - Treatment|Sponsor Decision|0|||
163263002|NCT02508532|589673619|FG007|Part 2 - Treatment|Sponsor Decision|0|||
163263003|NCT02508532|589673620|FG008|Part 2 - Treatment|Sponsor Decision|28|||
163263004|NCT02508532|589673612|FG000|Part 2 - Treatment|Death|0|||
163263005|NCT02508532|589673613|FG001|Part 2 - Treatment|Death|0|||
163263006|NCT02508532|589673614|FG002|Part 2 - Treatment|Death|0|||
163263007|NCT02508532|589673615|FG003|Part 2 - Treatment|Death|0|||
163263008|NCT02508532|589673616|FG004|Part 2 - Treatment|Death|0|||
163263009|NCT02508532|589673617|FG005|Part 2 - Treatment|Death|0|||
163263010|NCT02508532|589673618|FG006|Part 2 - Treatment|Death|0|||
163263011|NCT02508532|589673619|FG007|Part 2 - Treatment|Death|0|||
163263012|NCT02508532|589673620|FG008|Part 2 - Treatment|Death|1|||
163263013|NCT02508532|589673612|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
163263014|NCT02508532|589673613|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
163263015|NCT02508532|589673614|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
163263016|NCT02508532|589673615|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
163263017|NCT02508532|589673616|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
163263018|NCT02508532|589673617|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
163263019|NCT02508532|589673618|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
163263020|NCT02508532|589673619|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
163263021|NCT02508532|589673620|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
163263022|NCT02508532|589673612|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
163263023|NCT02508532|589673613|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
163263024|NCT02508532|589673614|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
163263025|NCT02508532|589673615|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
163263026|NCT02508532|589673616|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
163263027|NCT02508532|589673617|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
163263028|NCT02508532|589673618|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
163263029|NCT02508532|589673619|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
163263030|NCT02508532|589673620|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
163263031|NCT02508532|589673612|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
163263032|NCT02508532|589673613|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
163263033|NCT02508532|589673614|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
163263034|NCT02508532|589673615|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
163263035|NCT02508532|589673616|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
163263036|NCT02508532|589673617|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
163263037|NCT02508532|589673618|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
163263038|NCT02508532|589673619|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
163263039|NCT02508532|589673620|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
163263040|NCT02508532|589673612|FG000|Part 1 and Part 2 End of Study|Death|0|||
163263041|NCT02508532|589673613|FG001|Part 1 and Part 2 End of Study|Death|4|||
163263042|NCT02508532|589673614|FG002|Part 1 and Part 2 End of Study|Death|2|||
163263043|NCT02508532|589673615|FG003|Part 1 and Part 2 End of Study|Death|4|||
163263044|NCT02508532|589673616|FG004|Part 1 and Part 2 End of Study|Death|3|||
163263045|NCT02508532|589673617|FG005|Part 1 and Part 2 End of Study|Death|0|||
163263046|NCT02508532|589673618|FG006|Part 1 and Part 2 End of Study|Death|0|||
163263047|NCT02508532|589673619|FG007|Part 1 and Part 2 End of Study|Death|1|||
163263048|NCT02508532|589673620|FG008|Part 1 and Part 2 End of Study|Death|111|||
163263049|NCT02508532|589673612|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
163263050|NCT02508532|589673613|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
163263051|NCT02508532|589673614|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
163263052|NCT02508532|589673615|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
163263053|NCT02508532|589673616|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
163263054|NCT02508532|589673617|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
163263055|NCT02508532|589673618|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
163263056|NCT02508532|589673619|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
163263057|NCT02508532|589673620|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
163263058|NCT02508532|589673612|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
163263059|NCT02508532|589673613|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
163263060|NCT02508532|589673614|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
163263061|NCT02508532|589673615|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
163263062|NCT02508532|589673616|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
163263063|NCT02508532|589673617|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
163263064|NCT02508532|589673618|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
163263065|NCT02508532|589673619|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
163263066|NCT02508532|589673620|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
163263067|NCT02508532|589673612|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
163263068|NCT02508532|589673613|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
163263069|NCT02508532|589673614|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
163263070|NCT02508532|589673615|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
163263071|NCT02508532|589673616|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
163263072|NCT02508532|589673617|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
163263073|NCT02508532|589673618|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
163263074|NCT02508532|589673619|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
163263075|NCT02508532|589673620|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
163263076|NCT02508532|589673612|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163263077|NCT02508532|589673613|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163263078|NCT02508532|589673614|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163263079|NCT02508532|589673615|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163263080|NCT02508532|589673616|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163263081|NCT02508532|589673617|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163263082|NCT02508532|589673618|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163263083|NCT02508532|589673619|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163263084|NCT02508532|589673620|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
163263085|NCT02508532|589673612|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
163263086|NCT02508532|589673613|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
163263087|NCT02508532|589673614|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
163263088|NCT02508532|589673615|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
163263089|NCT02508532|589673616|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
163263090|NCT02508532|589673617|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
163263091|NCT02508532|589673618|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
163263092|NCT02508532|589673619|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
163263093|NCT02508532|589673620|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
163263094|NCT01641926|589673623|FG000|Overall Study|Adverse Event|5|||
163263095|NCT01641926|589673624|FG001|Overall Study|Adverse Event|2|||
163263096|NCT01641926|589673625|FG002|Overall Study|Adverse Event|3|||
163263097|NCT01641926|589673626|FG003|Overall Study|Adverse Event|1|||
163263098|NCT01641926|589673623|FG000|Overall Study|Lost to Follow-up|2|||
163263099|NCT01641926|589673624|FG001|Overall Study|Lost to Follow-up|2|||
163263100|NCT01641926|589673625|FG002|Overall Study|Lost to Follow-up|1|||
163263101|NCT01641926|589673626|FG003|Overall Study|Lost to Follow-up|0|||
163263102|NCT01641926|589673623|FG000|Overall Study|Physician Decision|6|||
163263103|NCT01641926|589673624|FG001|Overall Study|Physician Decision|5|||
163263104|NCT01641926|589673625|FG002|Overall Study|Physician Decision|0|||
163263105|NCT01641926|589673626|FG003|Overall Study|Physician Decision|1|||
163263106|NCT01641926|589673623|FG000|Overall Study|Protocol Violation|1|||
163263107|NCT01641926|589673624|FG001|Overall Study|Protocol Violation|0|||
163263108|NCT01641926|589673625|FG002|Overall Study|Protocol Violation|0|||
163263109|NCT01641926|589673626|FG003|Overall Study|Protocol Violation|1|||
163263110|NCT01641926|589673623|FG000|Overall Study|Withdrawal by Subject|13|||
163263111|NCT01641926|589673624|FG001|Overall Study|Withdrawal by Subject|5|||
163263112|NCT01641926|589673625|FG002|Overall Study|Withdrawal by Subject|6|||
163263113|NCT01641926|589673626|FG003|Overall Study|Withdrawal by Subject|1|||
163263114|NCT01641926|589673623|FG000|Overall Study|Not Treated|1|||
163263115|NCT01641926|589673624|FG001|Overall Study|Not Treated|1|||
163263116|NCT01641926|589673625|FG002|Overall Study|Not Treated|1|||
163263117|NCT01641926|589673626|FG003|Overall Study|Not Treated|0|||
163263118|NCT01111838|589673627|FG000|Overall Study|Patient Ineligible|2|||
163263119|NCT01111838|589673627|FG000|Overall Study|Not Treated|3|||
163263120|NCT01111838|589673627|FG000|Overall Study|Clinical deterioration|1|||
163263121|NCT01111838|589673627|FG000|Overall Study|Other Complicating Disease|1|||
163263122|NCT04399356|589673628|FG000|Overall Study|Lost to Follow-up|1|||
163263123|NCT04399356|589673629|FG001|Overall Study|Lost to Follow-up|1|||
163263124|NCT04399356|589673628|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
163263125|NCT04399356|589673629|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
163263126|NCT04399356|589673628|FG000|Overall Study|Withdrawal by Subject|1|||
163263127|NCT04399356|589673629|FG001|Overall Study|Withdrawal by Subject|0|||
163263128|NCT03812536|589673630|FG000|Overall Study|Protocol Violation|2|||
163263129|NCT03812536|589673631|FG001|Overall Study|Protocol Violation|0|||
163263130|NCT03812536|589673630|FG000|Overall Study|Withdrawal by Subject|1|||
163263131|NCT03812536|589673631|FG001|Overall Study|Withdrawal by Subject|1|||
163263132|NCT00152009|589673632|FG000|Overall Study|Adverse Event|9|||
163263133|NCT00152009|589673633|FG001|Overall Study|Adverse Event|13|||
163263134|NCT00152009|589673634|FG002|Overall Study|Adverse Event|20|||
163263135|NCT00152009|589673635|FG003|Overall Study|Adverse Event|1|||
163263136|NCT00152009|589673632|FG000|Overall Study|Protocol Violation|3|||
163263137|NCT00152009|589673633|FG001|Overall Study|Protocol Violation|0|||
163263138|NCT00152009|589673634|FG002|Overall Study|Protocol Violation|0|||
163263139|NCT00152009|589673635|FG003|Overall Study|Protocol Violation|1|||
163263140|NCT00152009|589673632|FG000|Overall Study|Withdrawal by Subject|2|||
163263141|NCT00152009|589673633|FG001|Overall Study|Withdrawal by Subject|3|||
163263142|NCT00152009|589673634|FG002|Overall Study|Withdrawal by Subject|4|||
163263143|NCT00152009|589673635|FG003|Overall Study|Withdrawal by Subject|9|||
163263144|NCT00152009|589673632|FG000|Overall Study|Lost to Follow-up|2|||
163263145|NCT00152009|589673633|FG001|Overall Study|Lost to Follow-up|4|||
163263146|NCT00152009|589673634|FG002|Overall Study|Lost to Follow-up|3|||
163263147|NCT00152009|589673635|FG003|Overall Study|Lost to Follow-up|3|||
163263148|NCT00152009|589673632|FG000|Overall Study|Lack of Efficacy|8|||
163263149|NCT00152009|589673633|FG001|Overall Study|Lack of Efficacy|6|||
163263150|NCT00152009|589673634|FG002|Overall Study|Lack of Efficacy|7|||
163263151|NCT00152009|589673635|FG003|Overall Study|Lack of Efficacy|15|||
163263152|NCT00152009|589673632|FG000|Overall Study|ECG abnormalities|2|||
163263153|NCT00152009|589673633|FG001|Overall Study|ECG abnormalities|2|||
163263154|NCT00152009|589673634|FG002|Overall Study|ECG abnormalities|2|||
163263155|NCT00152009|589673635|FG003|Overall Study|ECG abnormalities|1|||
163263156|NCT00152009|589673632|FG000|Overall Study|Sponsor's decision|3|||
163263157|NCT00152009|589673633|FG001|Overall Study|Sponsor's decision|3|||
163263158|NCT00152009|589673634|FG002|Overall Study|Sponsor's decision|1|||
163263159|NCT00152009|589673635|FG003|Overall Study|Sponsor's decision|3|||
163263160|NCT01306201|589673636|FG000|Overall Study|Arrhythmia|4|||
163263161|NCT01306201|589673636|FG000|Overall Study|Files could not be processed|3|||
163263162|NCT01306201|589673636|FG000|Overall Study|Files unreadable|3|||
163263163|NCT00098254|589673639|FG000|Overall Study|Adverse Event|2|||
163263164|NCT00098254|589673639|FG000|Overall Study|Death|1|||
163263165|NCT02118337|589673640|FG000|Overall Study|Other|1|||
163263166|NCT02118337|589673641|FG001|Overall Study|Other|0|||
163263167|NCT02118337|589673642|FG002|Overall Study|Other|0|||
163263168|NCT02118337|589673643|FG003|Overall Study|Other|0|||
163263169|NCT02118337|589673644|FG004|Overall Study|Other|2|||
163263170|NCT02118337|589673645|FG005|Overall Study|Other|3|||
163263171|NCT02118337|589673646|FG006|Overall Study|Other|1|||
163263172|NCT02118337|589673647|FG007|Overall Study|Other|28|||
163263173|NCT02118337|589673648|FG008|Overall Study|Other|15|||
163263174|NCT02118337|589673640|FG000|Overall Study|Lost to Follow-up|0|||
163263175|NCT02118337|589673641|FG001|Overall Study|Lost to Follow-up|0|||
163263176|NCT02118337|589673642|FG002|Overall Study|Lost to Follow-up|0|||
163263177|NCT02118337|589673643|FG003|Overall Study|Lost to Follow-up|0|||
163263178|NCT02118337|589673644|FG004|Overall Study|Lost to Follow-up|0|||
163263179|NCT02118337|589673645|FG005|Overall Study|Lost to Follow-up|0|||
163263180|NCT02118337|589673646|FG006|Overall Study|Lost to Follow-up|0|||
163263181|NCT02118337|589673647|FG007|Overall Study|Lost to Follow-up|1|||
163263182|NCT02118337|589673648|FG008|Overall Study|Lost to Follow-up|0|||
163263183|NCT02118337|589673640|FG000|Overall Study|Withdrawal by Subject|1|||
163263184|NCT02118337|589673641|FG001|Overall Study|Withdrawal by Subject|3|||
163263185|NCT02118337|589673642|FG002|Overall Study|Withdrawal by Subject|2|||
163263186|NCT02118337|589673643|FG003|Overall Study|Withdrawal by Subject|1|||
163263187|NCT02118337|589673644|FG004|Overall Study|Withdrawal by Subject|2|||
163263188|NCT02118337|589673645|FG005|Overall Study|Withdrawal by Subject|2|||
163263189|NCT02118337|589673646|FG006|Overall Study|Withdrawal by Subject|1|||
163263190|NCT02118337|589673647|FG007|Overall Study|Withdrawal by Subject|4|||
163263191|NCT02118337|589673648|FG008|Overall Study|Withdrawal by Subject|2|||
163263192|NCT02118337|589673640|FG000|Overall Study|Death|2|||
163263193|NCT02118337|589673641|FG001|Overall Study|Death|2|||
163263194|NCT02118337|589673642|FG002|Overall Study|Death|1|||
163263195|NCT02118337|589673643|FG003|Overall Study|Death|2|||
163263196|NCT02118337|589673644|FG004|Overall Study|Death|5|||
163263197|NCT02118337|589673645|FG005|Overall Study|Death|1|||
163263198|NCT02118337|589673646|FG006|Overall Study|Death|2|||
163263199|NCT02118337|589673647|FG007|Overall Study|Death|9|||
163263200|NCT02118337|589673648|FG008|Overall Study|Death|4|||
163263201|NCT00130793|589673650|FG000|Overall Study|Lost to Follow-up|1|||
163263202|NCT00130793|589673651|FG001|Overall Study|Lost to Follow-up|4|||
163263203|NCT00130793|589673650|FG000|Overall Study|Withdrew consent|2|||
163263204|NCT00130793|589673651|FG001|Overall Study|Withdrew consent|0|||
163263205|NCT00211237|589673652|FG000|Baseline|Withdrew|1|||
163263206|NCT00211237|589673653|FG001|Baseline|Withdrew|3|||
163263207|NCT00211237|589673654|FG002|Baseline|Withdrew|0|||
163263208|NCT00211237|589673652|FG000|Baseline|Refused random assignment|1|||
163263209|NCT00211237|589673653|FG001|Baseline|Refused random assignment|0|||
163263210|NCT00211237|589673654|FG002|Baseline|Refused random assignment|0|||
163153240|NCT00360230|589276241|FG004|Overall Study|Other|0|||
163153241|NCT00360230|589276242|FG005|Overall Study|Other|0|||
163153242|NCT00360230|589276243|FG006|Overall Study|Other|0|||
163153243|NCT00360230|589276237|FG000|Overall Study|Protocol Violation|0|||
163153244|NCT00360230|589276238|FG001|Overall Study|Protocol Violation|0|||
163153245|NCT00360230|589276239|FG002|Overall Study|Protocol Violation|0|||
163153246|NCT00360230|589276240|FG003|Overall Study|Protocol Violation|0|||
163153247|NCT00360230|589276241|FG004|Overall Study|Protocol Violation|0|||
163153248|NCT00360230|589276242|FG005|Overall Study|Protocol Violation|1|||
163153249|NCT00360230|589276243|FG006|Overall Study|Protocol Violation|0|||
163153250|NCT00360230|589276237|FG000|Overall Study|Death|0|||
163263211|NCT00211237|589673652|FG000|1 Month|Death|2|||
163263212|NCT00211237|589673653|FG001|1 Month|Death|1|||
163263213|NCT00211237|589673654|FG002|1 Month|Death|0|||
163263214|NCT00211237|589673652|FG000|1 Month|Lost to Follow-up|0|||
163263215|NCT00211237|589673653|FG001|1 Month|Lost to Follow-up|2|||
163263216|NCT00211237|589673654|FG002|1 Month|Lost to Follow-up|0|||
163263217|NCT00211237|589673652|FG000|1 Month|Withdrew|0|||
163263218|NCT00211237|589673653|FG001|1 Month|Withdrew|4|||
163263219|NCT00211237|589673654|FG002|1 Month|Withdrew|0|||
163263220|NCT00211237|589673652|FG000|1 Month|Additional surgery needed|1|||
163263221|NCT00211237|589673653|FG001|1 Month|Additional surgery needed|0|||
163263222|NCT00211237|589673654|FG002|1 Month|Additional surgery needed|0|||
163263223|NCT00211237|589673652|FG000|1 Month|Non-medical problem|0|||
163153251|NCT00360230|589276238|FG001|Overall Study|Death|1|||
163153252|NCT00360230|589276239|FG002|Overall Study|Death|0|||
163153253|NCT00360230|589276240|FG003|Overall Study|Death|0|||
163153254|NCT00360230|589276241|FG004|Overall Study|Death|0|||
163153255|NCT00360230|589276242|FG005|Overall Study|Death|1|||
163153256|NCT00360230|589276243|FG006|Overall Study|Death|1|||
163153257|NCT02703597|589276244|FG000|Assignment to Baseline|Lost to Follow-up|17|||
163153258|NCT02703597|589276245|FG001|Assignment to Baseline|Lost to Follow-up|16|||
163153259|NCT02703597|589276244|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
163153260|NCT02703597|589276245|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
163153261|NCT02703597|589276244|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
163153262|NCT02703597|589276245|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
163153263|NCT02703597|589276244|FG000|First Post-test to First Follow-up|Site drop out|0|||
163153264|NCT02703597|589276245|FG001|First Post-test to First Follow-up|Site drop out|58|||
163153265|NCT02703597|589276244|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
163153266|NCT02703597|589276245|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
163153267|NCT02703597|589276244|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
163153268|NCT02703597|589276245|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
163153269|NCT02703597|589276244|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
163153270|NCT02703597|589276245|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
163153271|NCT00481832|589276246|FG000|Enrollment|Physician Decision|8|||
163153272|NCT00481832|589276246|FG000|Enrollment|Unable to collect enough stem cells|2|||
163153273|NCT00481832|589276246|FG000|Inter-transplant Period|Adverse Event|4|||
163153274|NCT00481832|589276246|FG000|Inter-transplant Period|Death|3|||
163153275|NCT00481832|589276246|FG000|Inter-transplant Period|Physician Decision|4|||
163153276|NCT00481832|589276246|FG000|Inter-transplant Period|Disease relapse|11|||
163153277|NCT00481832|589276246|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
163153278|NCT00581308|589276247|FG000|Pre Discharge|Lost to Follow-up|1|||
163153279|NCT00581308|589276247|FG000|Pre Discharge|Device Removed|1|||
163153280|NCT00581308|589276247|FG000|Month 1|Lost to Follow-up|3|||
163153281|NCT00581308|589276247|FG000|Month 1|Withdrawal by Subject|2|||
163153282|NCT00581308|589276247|FG000|Month 1|Device Removed|2|||
163153283|NCT00581308|589276247|FG000|Month 1|Uknown|1|||
163153284|NCT00581308|589276247|FG000|Month 6|Lost to Follow-up|1|||
163153285|NCT00581308|589276247|FG000|Month 6|Withdrawal by Subject|2|||
163153286|NCT00581308|589276247|FG000|Month 12|Death|1|||
163153287|NCT00581308|589276247|FG000|Month 12|Lost to Follow-up|14|||
163153288|NCT00581308|589276247|FG000|Month 12|Withdrawal by Subject|3|||
163153289|NCT00581308|589276247|FG000|Month 12|Device Removed|1|||
163153290|NCT00581308|589276247|FG000|Month 12|Other|1|||
163153291|NCT02006472|589276251|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
163153292|NCT02006472|589276252|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
163153293|NCT02006472|589276253|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
163153294|NCT02006472|589276254|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
163263224|NCT00211237|589673653|FG001|1 Month|Non-medical problem|2|||
163263225|NCT00211237|589673654|FG002|1 Month|Non-medical problem|0|||
163263226|NCT00211237|589673652|FG000|3 Months|Death|7|||
163263227|NCT00211237|589673653|FG001|3 Months|Death|3|||
163263228|NCT00211237|589673654|FG002|3 Months|Death|0|||
163263229|NCT00211237|589673652|FG000|3 Months|Could not comply with protocol|1|||
163263230|NCT00211237|589673653|FG001|3 Months|Could not comply with protocol|0|||
163153295|NCT02006472|589276255|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
163153296|NCT02006472|589276251|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
163263231|NCT00211237|589673654|FG002|3 Months|Could not comply with protocol|0|||
163263232|NCT00211237|589673652|FG000|3 Months|Withdrew|0|||
163263233|NCT00211237|589673653|FG001|3 Months|Withdrew|1|||
163263234|NCT00211237|589673654|FG002|3 Months|Withdrew|0|||
163263235|NCT00211237|589673652|FG000|3 Months|Non-medical problem|0|||
163263236|NCT00211237|589673653|FG001|3 Months|Non-medical problem|0|||
163263237|NCT00211237|589673654|FG002|3 Months|Non-medical problem|1|||
163263238|NCT00211237|589673652|FG000|6 Months|Death|6|||
163263239|NCT00211237|589673653|FG001|6 Months|Death|0|||
163263240|NCT00211237|589673654|FG002|6 Months|Death|3|||
163263241|NCT00211237|589673652|FG000|6 Months|Lost to Follow-up|2|||
163263242|NCT00211237|589673653|FG001|6 Months|Lost to Follow-up|0|||
163263243|NCT00211237|589673654|FG002|6 Months|Lost to Follow-up|0|||
163263244|NCT00211237|589673652|FG000|6 Months|Could not comply with protocol|0|||
163263245|NCT00211237|589673653|FG001|6 Months|Could not comply with protocol|2|||
163263246|NCT00211237|589673654|FG002|6 Months|Could not comply with protocol|0|||
163263247|NCT00211237|589673652|FG000|12 Months|Death|8|||
163263248|NCT00211237|589673653|FG001|12 Months|Death|2|||
163263249|NCT00211237|589673654|FG002|12 Months|Death|3|||
163263250|NCT00211237|589673652|FG000|12 Months|Lost to Follow-up|1|||
163263251|NCT00211237|589673653|FG001|12 Months|Lost to Follow-up|0|||
163263252|NCT00211237|589673654|FG002|12 Months|Lost to Follow-up|1|||
163263253|NCT00211237|589673652|FG000|12 Months|Withdrew|0|||
163263254|NCT00211237|589673653|FG001|12 Months|Withdrew|0|||
163263255|NCT00211237|589673654|FG002|12 Months|Withdrew|1|||
163153297|NCT02006472|589276252|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
163153298|NCT02006472|589276253|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
163153299|NCT02006472|589276254|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
163153300|NCT02006472|589276255|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
163153301|NCT02006472|589276251|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
163153302|NCT02006472|589276252|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
163153303|NCT02006472|589276253|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
163263256|NCT00211237|589673652|FG000|12 Months|unrelated medical problem|0|||
163263257|NCT00211237|589673653|FG001|12 Months|unrelated medical problem|0|||
163263258|NCT00211237|589673654|FG002|12 Months|unrelated medical problem|1|||
163263259|NCT01003639|589673657|FG000|Overall Study|Lost to Follow-up|6|||
163263260|NCT01003639|589673658|FG001|Overall Study|Lost to Follow-up|9|||
163263261|NCT01003639|589673657|FG000|Overall Study|Withdrawal by Subject|9|||
163263262|NCT01003639|589673658|FG001|Overall Study|Withdrawal by Subject|5|||
163153304|NCT02006472|589276254|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
163153305|NCT02006472|589276255|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
163263263|NCT01003639|589673657|FG000|Overall Study|Lack of Efficacy|1|||
163263264|NCT01003639|589673658|FG001|Overall Study|Lack of Efficacy|6|||
163153306|NCT02006472|589276251|FG000|Period 1 (Through Week 26)|Other|1|||
163153307|NCT02006472|589276252|FG001|Period 1 (Through Week 26)|Other|5|||
163153308|NCT02006472|589276253|FG002|Period 1 (Through Week 26)|Other|0|||
163153309|NCT02006472|589276254|FG003|Period 1 (Through Week 26)|Other|2|||
163153310|NCT02006472|589276255|FG004|Period 1 (Through Week 26)|Other|3|||
163153311|NCT02006472|589276251|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
163263265|NCT01003639|589673657|FG000|Overall Study|Adverse Event|0|||
163263266|NCT01003639|589673658|FG001|Overall Study|Adverse Event|1|||
163263267|NCT01003639|589673657|FG000|Overall Study|Protocol Violation|0|||
163263268|NCT01003639|589673658|FG001|Overall Study|Protocol Violation|1|||
163263269|NCT01003639|589673657|FG000|Overall Study|Physician Decision|1|||
163153312|NCT02006472|589276252|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
163153313|NCT02006472|589276253|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
163153314|NCT02006472|589276254|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
163153315|NCT02006472|589276255|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
163153316|NCT02006472|589276251|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
163153317|NCT02006472|589276252|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
163153318|NCT02006472|589276253|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
163153319|NCT02006472|589276254|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
163153320|NCT02006472|589276255|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
163153321|NCT02006472|589276251|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
163153322|NCT02006472|589276252|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
163153323|NCT02006472|589276253|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
163153324|NCT02006472|589276254|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
163263270|NCT01003639|589673658|FG001|Overall Study|Physician Decision|0|||
163263271|NCT05458024|589673659|FG000|Overall Study|Withdrawal by Subject|1|||
163263272|NCT05458024|589673660|FG001|Overall Study|Withdrawal by Subject|1|||
163263273|NCT04000594|589673661|FG000|Overall Study|Withdrawal by Subject|1|||
163263274|NCT04000594|589673662|FG001|Overall Study|Withdrawal by Subject|0|||
163263275|NCT04000594|589673663|FG002|Overall Study|Withdrawal by Subject|0|||
163263276|NCT05807919|589673664|FG000|Overall Study|Received antibiotics - excluded|0|||
163263277|NCT05807919|589673665|FG001|Overall Study|Received antibiotics - excluded|1|||
163153325|NCT02006472|589276255|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
163153326|NCT02006472|589276251|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
163153327|NCT02006472|589276252|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
163153328|NCT02006472|589276253|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
163153329|NCT02006472|589276254|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
163153330|NCT02006472|589276255|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
163153331|NCT02006472|589276251|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
163153332|NCT02006472|589276252|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
163153333|NCT02006472|589276253|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
163153334|NCT02006472|589276254|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
163153335|NCT02006472|589276255|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
163153336|NCT02006472|589276251|FG000|Period 2 (Through Week 52)|Other|0|||
163153337|NCT02006472|589276252|FG001|Period 2 (Through Week 52)|Other|1|||
163153338|NCT02006472|589276253|FG002|Period 2 (Through Week 52)|Other|0|||
163153339|NCT02006472|589276254|FG003|Period 2 (Through Week 52)|Other|1|||
163153340|NCT02006472|589276255|FG004|Period 2 (Through Week 52)|Other|0|||
163153341|NCT02006472|589276251|FG000|Period 2 (Through Week 52)|Not treated|0|||
163153342|NCT02006472|589276252|FG001|Period 2 (Through Week 52)|Not treated|0|||
163153343|NCT02006472|589276253|FG002|Period 2 (Through Week 52)|Not treated|2|||
163153344|NCT02006472|589276254|FG003|Period 2 (Through Week 52)|Not treated|0|||
163153345|NCT02006472|589276255|FG004|Period 2 (Through Week 52)|Not treated|0|||
163153346|NCT02006472|589276251|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
163153347|NCT02006472|589276252|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
163153348|NCT02006472|589276253|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
163153349|NCT02006472|589276254|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
163153350|NCT02006472|589276255|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
163153351|NCT02006472|589276251|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
163153352|NCT02006472|589276252|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
163153353|NCT02006472|589276253|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
163153354|NCT02006472|589276254|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
163153355|NCT02006472|589276255|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
163153356|NCT03219723|589276256|FG000|Overall Study|Case Report Forms Uncollected|6|||
163153357|NCT03219723|589276256|FG000|Overall Study|Protocol Deviation|4|||
163153358|NCT04558125|589276257|FG000|Overall Study|Death|1|||
163153359|NCT01710345|589276265|FG000|Overall Study|Adverse Event|0|||
163153360|NCT01710345|589276266|FG001|Overall Study|Adverse Event|2|||
163153361|NCT01710345|589276267|FG002|Overall Study|Adverse Event|0|||
163153362|NCT01710345|589276265|FG000|Overall Study|Lack of Efficacy|2|||
163153363|NCT01710345|589276266|FG001|Overall Study|Lack of Efficacy|3|||
163153364|NCT01710345|589276267|FG002|Overall Study|Lack of Efficacy|1|||
163153365|NCT01710345|589276265|FG000|Overall Study|Drug Dosing Error|1|||
163153366|NCT01710345|589276266|FG001|Overall Study|Drug Dosing Error|0|||
163153367|NCT01710345|589276267|FG002|Overall Study|Drug Dosing Error|0|||
163153368|NCT01033019|589276269|FG000|Overall Study|Withdrawal by Subject|1|||
163153369|NCT01033019|589276270|FG001|Overall Study|Withdrawal by Subject|0|||
163153370|NCT01339832|589276271|FG000|Overall Study|Lost to Follow-up|3|||
163153371|NCT01339832|589276271|FG000|Overall Study|Death|11|||
163153372|NCT01052493|589276272|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
163153373|NCT01052493|589276273|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
163153374|NCT01052493|589276274|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
163153375|NCT01075243|589276280|FG000|Overall Study|Lost to Follow-up|5|||
163153376|NCT01075243|589276281|FG001|Overall Study|Lost to Follow-up|2|||
163153377|NCT01075243|589276282|FG002|Overall Study|Lost to Follow-up|0|||
163153378|NCT01075243|589276280|FG000|Overall Study|Withdrawal by Subject|1|||
163263278|NCT05807919|589673664|FG000|Overall Study|Withdrawal by Subject|0|||
163263279|NCT05807919|589673665|FG001|Overall Study|Withdrawal by Subject|3|||
163263280|NCT05807919|589673664|FG000|Overall Study|Adverse Event|1|||
163153379|NCT01075243|589276281|FG001|Overall Study|Withdrawal by Subject|1|||
163153380|NCT01075243|589276282|FG002|Overall Study|Withdrawal by Subject|0|||
163153381|NCT00627393|589276283|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
163153382|NCT00627393|589276284|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
163153383|NCT00627393|589276283|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
163153384|NCT00627393|589276284|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
163153385|NCT00627393|589276283|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
163153386|NCT00627393|589276284|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
163153387|NCT00627393|589276283|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
163153388|NCT00627393|589276284|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
163153389|NCT00551642|589276285|FG000|Treatment Period|Protocol Deviation|6|||
163153390|NCT00551642|589276286|FG001|Treatment Period|Protocol Deviation|11|||
163153391|NCT00551642|589276285|FG000|Treatment Period|Delivery device failure|1|||
163153392|NCT00551642|589276286|FG001|Treatment Period|Delivery device failure|3|||
163263281|NCT05807919|589673665|FG001|Overall Study|Adverse Event|1|||
163263282|NCT00747123|589673666|FG000|Overall Study|Investigator's request|0|||
163263283|NCT00747123|589673667|FG001|Overall Study|Investigator's request|0|||
163153393|NCT00551642|589276285|FG000|Treatment Period|Physician Decision|0|||
163153394|NCT00551642|589276286|FG001|Treatment Period|Physician Decision|1|||
163153395|NCT00551642|589276285|FG000|Treatment Period|Death|33|||
163153396|NCT00551642|589276286|FG001|Treatment Period|Death|31|||
163153397|NCT00551642|589276285|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
163153398|NCT00551642|589276286|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
163153399|NCT00551642|589276285|FG000|Treatment Period|Adverse Event|15|||
163153400|NCT00551642|589276286|FG001|Treatment Period|Adverse Event|12|||
163153401|NCT00551642|589276285|FG000|Treatment Period|Withdrawal by Subject|2|||
163153402|NCT00551642|589276286|FG001|Treatment Period|Withdrawal by Subject|1|||
163153403|NCT03337308|589276287|FG000|Overall Study|Adverse Event|2|||
163153404|NCT03337308|589276288|FG001|Overall Study|Adverse Event|3|||
163153405|NCT03337308|589276289|FG002|Overall Study|Adverse Event|3|||
163153406|NCT03337308|589276290|FG003|Overall Study|Adverse Event|1|||
163153407|NCT03337308|589276287|FG000|Overall Study|Lost to Follow-up|1|||
163153408|NCT03337308|589276288|FG001|Overall Study|Lost to Follow-up|2|||
163153409|NCT03337308|589276289|FG002|Overall Study|Lost to Follow-up|0|||
163153410|NCT03337308|589276290|FG003|Overall Study|Lost to Follow-up|0|||
163153411|NCT03337308|589276287|FG000|Overall Study|Withdrawal by Subject|2|||
163153412|NCT03337308|589276288|FG001|Overall Study|Withdrawal by Subject|1|||
163153413|NCT03337308|589276289|FG002|Overall Study|Withdrawal by Subject|2|||
163153414|NCT03337308|589276290|FG003|Overall Study|Withdrawal by Subject|1|||
163153415|NCT03337308|589276287|FG000|Overall Study|Protocol Violation|0|||
163153416|NCT03337308|589276288|FG001|Overall Study|Protocol Violation|1|||
163153417|NCT03337308|589276289|FG002|Overall Study|Protocol Violation|0|||
163153418|NCT03337308|589276290|FG003|Overall Study|Protocol Violation|0|||
163153419|NCT00283296|589276292|FG000|Overall Study|in-home trial not completed|5|||
163153420|NCT03558737|589276293|FG000|Overall Study|Death|1|||
163153421|NCT03558737|589276294|FG001|Overall Study|Death|1|||
163153422|NCT01294553|589276295|FG000|Overall Study|Duplicated Participants|1|||
163153423|NCT01294553|589276295|FG000|Overall Study|Protocol Violation|268|||
163153424|NCT00888134|589276296|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
163153425|NCT00888134|589276296|FG000|Follow-up|being followed for long-term survival|1|||
163153426|NCT00795535|589276297|FG000|Overall Study|incomplete data and technical problems|20|||
163153427|NCT01903460|589276300|FG000|Overall Study|Adverse Event|0|||
163153428|NCT01903460|589276301|FG001|Overall Study|Adverse Event|0|||
163153429|NCT01903460|589276302|FG002|Overall Study|Adverse Event|0|||
163153430|NCT01903460|589276303|FG003|Overall Study|Adverse Event|1|||
163153431|NCT03104868|589276304|FG000|6 Week Follow up|Lost to Follow-up|5|||
163153432|NCT03104868|589276305|FG001|6 Week Follow up|Lost to Follow-up|8|||
163153433|NCT03104868|589276304|FG000|6 Week Follow up|Death|1|||
163153434|NCT03104868|589276305|FG001|6 Week Follow up|Death|1|||
163153435|NCT03104868|589276304|FG000|6 Week Follow up|Withdrawal by Subject|7|||
163153436|NCT03104868|589276305|FG001|6 Week Follow up|Withdrawal by Subject|6|||
163153437|NCT03104868|589276304|FG000|6 Week Follow up|Completed Later Timepoint|24|||
163153438|NCT03104868|589276305|FG001|6 Week Follow up|Completed Later Timepoint|22|||
163153439|NCT03104868|589276304|FG000|6 Month Follow up|Lost to Follow-up|2|||
163153440|NCT03104868|589276305|FG001|6 Month Follow up|Lost to Follow-up|2|||
163153441|NCT03104868|589276304|FG000|6 Month Follow up|Death|0|||
163153442|NCT03104868|589276305|FG001|6 Month Follow up|Death|1|||
163153443|NCT03104868|589276304|FG000|6 Month Follow up|Completed Later Timepoint|22|||
163153444|NCT03104868|589276305|FG001|6 Month Follow up|Completed Later Timepoint|32|||
163153445|NCT03104868|589276304|FG000|12 Month Follow up|Lost to Follow-up|1|||
163153446|NCT03104868|589276305|FG001|12 Month Follow up|Lost to Follow-up|2|||
163153447|NCT03104868|589276304|FG000|12 Month Follow up|Death|0|||
163153448|NCT03104868|589276305|FG001|12 Month Follow up|Death|1|||
163153449|NCT03104868|589276304|FG000|12 Month Follow up|Withdrawal by Subject|0|||
163153450|NCT03104868|589276305|FG001|12 Month Follow up|Withdrawal by Subject|3|||
163153451|NCT03104868|589276304|FG000|12 Month Follow up|Completed Later Timepoint|32|||
163153452|NCT03104868|589276305|FG001|12 Month Follow up|Completed Later Timepoint|29|||
163153453|NCT03104868|589276304|FG000|18 Month Follow up|Lost to Follow-up|7|||
163153454|NCT03104868|589276305|FG001|18 Month Follow up|Lost to Follow-up|11|||
163153455|NCT03104868|589276304|FG000|18 Month Follow up|Death|2|||
163153456|NCT03104868|589276305|FG001|18 Month Follow up|Death|1|||
163153457|NCT03104868|589276304|FG000|18 Month Follow up|Withdrawal by Subject|1|||
163153458|NCT03104868|589276305|FG001|18 Month Follow up|Withdrawal by Subject|2|||
163153459|NCT03104868|589276304|FG000|18 Month Follow up|Graft Loss|1|||
163153460|NCT03104868|589276305|FG001|18 Month Follow up|Graft Loss|1|||
163153461|NCT03104868|589276304|FG000|18 Month Follow up|Completed Later Timepoint|19|||
163153462|NCT03104868|589276305|FG001|18 Month Follow up|Completed Later Timepoint|20|||
163153463|NCT03104868|589276304|FG000|24 Month Follow up|Lost to Follow-up|15|||
163153464|NCT03104868|589276305|FG001|24 Month Follow up|Lost to Follow-up|16|||
163153465|NCT03104868|589276304|FG000|24 Month Follow up|Death|3|||
163153466|NCT03104868|589276305|FG001|24 Month Follow up|Death|2|||
163153467|NCT03104868|589276304|FG000|24 Month Follow up|Withdrawal by Subject|1|||
163153468|NCT03104868|589276305|FG001|24 Month Follow up|Withdrawal by Subject|0|||
163153469|NCT03104868|589276304|FG000|24 Month Follow up|Graft Loss|2|||
163153470|NCT03104868|589276305|FG001|24 Month Follow up|Graft Loss|0|||
163263284|NCT00747123|589673668|FG002|Overall Study|Investigator's request|1|||
163263285|NCT00747123|589673669|FG003|Overall Study|Investigator's request|0|||
163263286|NCT00747123|589673666|FG000|Overall Study|Withdrew consent|0|||
163263287|NCT00747123|589673667|FG001|Overall Study|Withdrew consent|1|||
163263288|NCT00747123|589673668|FG002|Overall Study|Withdrew consent|0|||
163263289|NCT00747123|589673669|FG003|Overall Study|Withdrew consent|0|||
163263290|NCT00747123|589673666|FG000|Overall Study|Adverse Event|0|||
163263291|NCT00747123|589673667|FG001|Overall Study|Adverse Event|1|||
163263292|NCT00747123|589673668|FG002|Overall Study|Adverse Event|0|||
163263293|NCT00747123|589673669|FG003|Overall Study|Adverse Event|1|||
163263294|NCT03489057|589673670|FG000|Overall Study|Lost to Follow-up|16|||
163263295|NCT03489057|589673671|FG001|Overall Study|Lost to Follow-up|16|||
163263296|NCT03489057|589673672|FG002|Overall Study|Lost to Follow-up|14|||
163263297|NCT03489057|589673673|FG003|Overall Study|Lost to Follow-up|14|||
163263298|NCT03489057|589673670|FG000|Overall Study|Withdrawal by Subject|12|||
163263299|NCT03489057|589673671|FG001|Overall Study|Withdrawal by Subject|12|||
163263300|NCT03489057|589673672|FG002|Overall Study|Withdrawal by Subject|8|||
163263301|NCT03489057|589673673|FG003|Overall Study|Withdrawal by Subject|8|||
163263302|NCT03489057|589673670|FG000|Overall Study|Protocol Violation|7|||
163263303|NCT03489057|589673671|FG001|Overall Study|Protocol Violation|7|||
163263304|NCT03489057|589673672|FG002|Overall Study|Protocol Violation|2|||
163263305|NCT03489057|589673673|FG003|Overall Study|Protocol Violation|2|||
163263306|NCT02277743|589673676|FG000|Overall Study|Protocol Violation|1|||
163263307|NCT02277743|589673677|FG001|Overall Study|Protocol Violation|1|||
163263308|NCT02277743|589673678|FG002|Overall Study|Protocol Violation|1|||
163263309|NCT02277743|589673676|FG000|Overall Study|Adverse Event|10|||
163263310|NCT02277743|589673677|FG001|Overall Study|Adverse Event|6|||
163153471|NCT00888173|589276307|FG000|Overall Study|Wrong Primary|1|||
163153472|NCT00888173|589276307|FG000|Overall Study|Ineligible: required test not done|1|||
163153473|NCT01488890|589276308|FG000|Overall Study|Serious adverse event|2|||
163153474|NCT01488890|589276309|FG001|Overall Study|Serious adverse event|0|||
163153475|NCT01488890|589276310|FG002|Overall Study|Serious adverse event|0|||
163153476|NCT01488890|589276311|FG003|Overall Study|Serious adverse event|0|||
163153477|NCT01488890|589276308|FG000|Overall Study|Protocol Violation|3|||
163153478|NCT01488890|589276309|FG001|Overall Study|Protocol Violation|0|||
163153479|NCT01488890|589276310|FG002|Overall Study|Protocol Violation|4|||
163263311|NCT02277743|589673678|FG002|Overall Study|Adverse Event|6|||
163263312|NCT02277743|589673676|FG000|Overall Study|Lack of Efficacy|11|||
163263313|NCT02277743|589673677|FG001|Overall Study|Lack of Efficacy|4|||
163263314|NCT02277743|589673678|FG002|Overall Study|Lack of Efficacy|3|||
163263315|NCT02277743|589673676|FG000|Overall Study|Other than specified above|18|||
163263316|NCT02277743|589673677|FG001|Overall Study|Other than specified above|5|||
163263317|NCT02277743|589673678|FG002|Overall Study|Other than specified above|16|||
163263318|NCT00943306|589673684|FG000|Overall Study|Physician Decision|1|||
163263319|NCT00943306|589673684|FG000|Overall Study|Death|1|||
163263320|NCT00943306|589673684|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
163263321|NCT02739347|589673685|FG000|Overall Study|Adverse Event|3|||
163263322|NCT02739347|589673686|FG001|Overall Study|Adverse Event|0|||
163263323|NCT02739347|589673685|FG000|Overall Study|Protocol Violation|0|||
163263324|NCT02739347|589673686|FG001|Overall Study|Protocol Violation|1|||
163263325|NCT02739347|589673685|FG000|Overall Study|Lost to Follow-up|0|||
163263326|NCT02739347|589673686|FG001|Overall Study|Lost to Follow-up|2|||
163263327|NCT01552954|589673687|FG000|Overall Study|Adverse Event|1|||
163263328|NCT01552954|589673688|FG001|Overall Study|Adverse Event|2|||
163263329|NCT01552954|589673687|FG000|Overall Study|Lost to Follow-up|1|||
163263330|NCT01552954|589673688|FG001|Overall Study|Lost to Follow-up|1|||
163263331|NCT01552954|589673687|FG000|Overall Study|Withdrawal by Subject|1|||
163263332|NCT01552954|589673688|FG001|Overall Study|Withdrawal by Subject|1|||
163263333|NCT01552954|589673687|FG000|Overall Study|Protocol Violation|1|||
163263334|NCT01552954|589673688|FG001|Overall Study|Protocol Violation|2|||
163263335|NCT01552954|589673687|FG000|Overall Study|diagnosed DM|1|||
163263336|NCT01552954|589673688|FG001|Overall Study|diagnosed DM|0|||
163263337|NCT00779779|589673689|FG000|Overall Study|Adverse Event|1|||
163263338|NCT00779779|589673689|FG000|Overall Study|Protocol Violation|14|||
163263339|NCT00779779|589673689|FG000|Overall Study|Withdrawal by Subject|4|||
163263340|NCT00779779|589673689|FG000|Overall Study|Lost to Follow-up|5|||
163263341|NCT01395823|589673690|FG000|Overall Study|Death|4|||
163263342|NCT01395823|589673691|FG001|Overall Study|Death|4|||
163263343|NCT01395823|589673690|FG000|Overall Study|Physician Decision|3|||
163263344|NCT01395823|589673691|FG001|Overall Study|Physician Decision|1|||
163263345|NCT01395823|589673690|FG000|Overall Study|Lost to Follow-up|1|||
163263346|NCT01395823|589673691|FG001|Overall Study|Lost to Follow-up|0|||
163263347|NCT01395823|589673690|FG000|Overall Study|Transplant|1|||
163263348|NCT01395823|589673691|FG001|Overall Study|Transplant|0|||
163263349|NCT01395823|589673690|FG000|Overall Study|GI symptoms|1|||
163263350|NCT01395823|589673691|FG001|Overall Study|GI symptoms|0|||
163263351|NCT01395823|589673690|FG000|Overall Study|Withdrawal by Subject|5|||
163263352|NCT01395823|589673691|FG001|Overall Study|Withdrawal by Subject|4|||
163263353|NCT00116272|589673692|FG000|Overall Study|Lost to Follow-up|11|||
163263354|NCT00116272|589673693|FG001|Overall Study|Lost to Follow-up|6|||
163263355|NCT01235403|589673694|FG000|Overall Study|Adverse Event|14|||
163263356|NCT01235403|589673694|FG000|Overall Study|Lost to Follow-up|2|||
163263357|NCT01235403|589673694|FG000|Overall Study|Withdrawal by Subject|4|||
163263358|NCT01235403|589673694|FG000|Overall Study|Lack of Efficacy|2|||
163263359|NCT01235403|589673694|FG000|Overall Study|Other reasons for premature termination|4|||
163263360|NCT05096208|589673695|FG000|Overall Study|Lost to Follow-up|3|||
163263361|NCT05096208|589673696|FG001|Overall Study|Lost to Follow-up|5|||
163263362|NCT05096208|589673697|FG002|Overall Study|Lost to Follow-up|5|||
163263363|NCT05096208|589673698|FG003|Overall Study|Lost to Follow-up|2|||
163263364|NCT05096208|589673695|FG000|Overall Study|Withdrawal by Subject|0|||
163263365|NCT05096208|589673696|FG001|Overall Study|Withdrawal by Subject|1|||
163263366|NCT05096208|589673697|FG002|Overall Study|Withdrawal by Subject|2|||
163263367|NCT05096208|589673698|FG003|Overall Study|Withdrawal by Subject|3|||
163263368|NCT05096208|589673695|FG000|Overall Study|No longer met eligibility criteria|1|||
163263369|NCT05096208|589673696|FG001|Overall Study|No longer met eligibility criteria|0|||
163263370|NCT05096208|589673697|FG002|Overall Study|No longer met eligibility criteria|0|||
163263371|NCT05096208|589673698|FG003|Overall Study|No longer met eligibility criteria|0|||
163263372|NCT05096208|589673695|FG000|Overall Study|Other|0|||
163263373|NCT05096208|589673696|FG001|Overall Study|Other|0|||
163263374|NCT05096208|589673697|FG002|Overall Study|Other|1|||
163263375|NCT05096208|589673698|FG003|Overall Study|Other|0|||
163263376|NCT00782496|589673699|FG000|Overall Study|Lost to Follow-up|14|||
163263377|NCT00782496|589673700|FG001|Overall Study|Lost to Follow-up|15|||
163263378|NCT01833143|589673702|FG000|Overall Study|Not Treated|1|||
163263379|NCT00386308|589675237|FG000|Overall Study|Adverse Event|3|||
163263380|NCT00386308|589675238|FG001|Overall Study|Adverse Event|3|||
163263381|NCT00386308|589675237|FG000|Overall Study|Protocol Violation|2|||
163263382|NCT00386308|589675238|FG001|Overall Study|Protocol Violation|5|||
163263383|NCT00386308|589675237|FG000|Overall Study|Lack of Efficacy|0|||
163263384|NCT00386308|589675238|FG001|Overall Study|Lack of Efficacy|2|||
163263385|NCT00386308|589675237|FG000|Overall Study|Lost to Follow-up|10|||
163263386|NCT00386308|589675238|FG001|Overall Study|Lost to Follow-up|6|||
163263387|NCT00386308|589675237|FG000|Overall Study|Withdrawal by Subject|6|||
163263388|NCT00386308|589675238|FG001|Overall Study|Withdrawal by Subject|2|||
163263389|NCT00386308|589675237|FG000|Overall Study|Other Event|8|||
163263390|NCT00386308|589675238|FG001|Overall Study|Other Event|1|||
163263391|NCT03518658|589675239|FG000|Overall Study|Other|51|||
163263392|NCT03518658|589675240|FG001|Overall Study|Other|0|||
163263393|NCT00649389|589675241|FG000|Overall Study|Adverse Event|22|||
163263394|NCT00649389|589675242|FG001|Overall Study|Adverse Event|46|||
163263395|NCT00649389|589675243|FG002|Overall Study|Adverse Event|38|||
163263396|NCT00649389|589675244|FG003|Overall Study|Adverse Event|48|||
163263397|NCT00649389|589675241|FG000|Overall Study|Lost to Follow-up|15|||
163263398|NCT00649389|589675242|FG001|Overall Study|Lost to Follow-up|17|||
163263399|NCT00649389|589675243|FG002|Overall Study|Lost to Follow-up|21|||
163263400|NCT00649389|589675244|FG003|Overall Study|Lost to Follow-up|26|||
163263401|NCT00649389|589675241|FG000|Overall Study|Protocol Violation|11|||
163263402|NCT00649389|589675242|FG001|Overall Study|Protocol Violation|13|||
163263403|NCT00649389|589675243|FG002|Overall Study|Protocol Violation|9|||
163263404|NCT00649389|589675244|FG003|Overall Study|Protocol Violation|8|||
163263405|NCT00649389|589675241|FG000|Overall Study|Withdrawal by Subject|20|||
163263406|NCT00649389|589675242|FG001|Overall Study|Withdrawal by Subject|21|||
163263407|NCT00649389|589675243|FG002|Overall Study|Withdrawal by Subject|19|||
163263408|NCT00649389|589675244|FG003|Overall Study|Withdrawal by Subject|23|||
163263409|NCT00649389|589675241|FG000|Overall Study|Other|3|||
163263410|NCT00649389|589675242|FG001|Overall Study|Other|9|||
163263411|NCT00649389|589675243|FG002|Overall Study|Other|1|||
163263412|NCT00649389|589675244|FG003|Overall Study|Other|6|||
163153480|NCT01488890|589276311|FG003|Overall Study|Protocol Violation|0|||
163153481|NCT01488890|589276308|FG000|Overall Study|Lost to Follow-up|13|||
163153482|NCT01488890|589276309|FG001|Overall Study|Lost to Follow-up|10|||
163153483|NCT01488890|589276310|FG002|Overall Study|Lost to Follow-up|20|||
163153484|NCT01488890|589276311|FG003|Overall Study|Lost to Follow-up|3|||
163153485|NCT01488890|589276308|FG000|Overall Study|Withdrawal by Subject|14|||
163153486|NCT01488890|589276309|FG001|Overall Study|Withdrawal by Subject|10|||
163153487|NCT01488890|589276310|FG002|Overall Study|Withdrawal by Subject|11|||
163153488|NCT01488890|589276311|FG003|Overall Study|Withdrawal by Subject|2|||
163153489|NCT00829426|589276312|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
163153490|NCT00829426|589276313|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
163153491|NCT04408989|589276314|FG000|Overall Study|Lost to Follow-up|0|||
163153492|NCT04408989|589276315|FG001|Overall Study|Lost to Follow-up|0|||
163153493|NCT04408989|589276316|FG002|Overall Study|Lost to Follow-up|1|||
163263413|NCT02746575|589675247|FG000|Overall Study|Surgery cancelled or time chaned|13|||
163263414|NCT02746575|589675247|FG000|Overall Study|Received epidural|10|||
163263415|NCT02746575|589675247|FG000|Overall Study|Withdrawal by Subject|3|||
163263416|NCT02746575|589675247|FG000|Overall Study|Bradycardia/hypotension|9|||
163263417|NCT02746575|589675247|FG000|Overall Study|Study paused|8|||
163263418|NCT02746575|589675247|FG000|Overall Study|put on beta-blocker|3|||
163263419|NCT02746575|589675247|FG000|Overall Study|type of surgery|1|||
163263420|NCT02746575|589675247|FG000|Overall Study|typ of surgery|1|||
163263421|NCT02746575|589675247|FG000|Overall Study|PI unavailable|1|||
163263422|NCT02746575|589675247|FG000|Overall Study|Unknown history of CVA|1|||
163263423|NCT00976482|589675248|FG000|Overall Study|Death|208|||
163263424|NCT00976482|589675248|FG000|Overall Study|Withdrawal by Subject|45|||
163263425|NCT00976482|589675248|FG000|Overall Study|Center terminated|1|||
163263426|NCT00976482|589675248|FG000|Overall Study|Protocol Violation|5|||
163263427|NCT02959671|589675249|FG000|Overall Study|Adverse Event|2|||
163263428|NCT02959671|589675249|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
163263429|NCT00432835|589675257|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
163263430|NCT00432835|589675258|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
163263431|NCT01287520|589675268|FG000|Overall Study|Adverse Event|2|||
163263432|NCT01287520|589675269|FG001|Overall Study|Adverse Event|2|||
163263433|NCT01287520|589675270|FG002|Overall Study|Adverse Event|2|||
163263434|NCT01287520|589675271|FG003|Overall Study|Adverse Event|1|||
163263435|NCT01287520|589675272|FG004|Overall Study|Adverse Event|1|||
163263436|NCT01287520|589675273|FG005|Overall Study|Adverse Event|2|||
163263437|NCT01287520|589675274|FG006|Overall Study|Adverse Event|0|||
163263438|NCT01287520|589675275|FG007|Overall Study|Adverse Event|2|||
163263439|NCT01287520|589675276|FG008|Overall Study|Adverse Event|0|||
163263440|NCT01287520|589675268|FG000|Overall Study|Physician Decision|1|||
163263441|NCT01287520|589675269|FG001|Overall Study|Physician Decision|1|||
163263442|NCT01287520|589675270|FG002|Overall Study|Physician Decision|2|||
163263443|NCT01287520|589675271|FG003|Overall Study|Physician Decision|0|||
163263444|NCT01287520|589675272|FG004|Overall Study|Physician Decision|1|||
163263445|NCT01287520|589675273|FG005|Overall Study|Physician Decision|1|||
163263446|NCT01287520|589675274|FG006|Overall Study|Physician Decision|0|||
163263447|NCT01287520|589675275|FG007|Overall Study|Physician Decision|1|||
163263448|NCT01287520|589675276|FG008|Overall Study|Physician Decision|0|||
163263449|NCT01287520|589675268|FG000|Overall Study|Progressive disease|0|||
163263450|NCT01287520|589675269|FG001|Overall Study|Progressive disease|4|||
163263451|NCT01287520|589675270|FG002|Overall Study|Progressive disease|1|||
163263452|NCT01287520|589675271|FG003|Overall Study|Progressive disease|6|||
163263453|NCT01287520|589675272|FG004|Overall Study|Progressive disease|1|||
163263454|NCT01287520|589675273|FG005|Overall Study|Progressive disease|0|||
163263455|NCT01287520|589675274|FG006|Overall Study|Progressive disease|2|||
163263456|NCT01287520|589675275|FG007|Overall Study|Progressive disease|2|||
163263457|NCT01287520|589675276|FG008|Overall Study|Progressive disease|4|||
163263458|NCT01287520|589675268|FG000|Overall Study|Withdrawal by Subject|0|||
163263459|NCT01287520|589675269|FG001|Overall Study|Withdrawal by Subject|0|||
163263460|NCT01287520|589675270|FG002|Overall Study|Withdrawal by Subject|0|||
163263461|NCT01287520|589675271|FG003|Overall Study|Withdrawal by Subject|0|||
163263462|NCT01287520|589675272|FG004|Overall Study|Withdrawal by Subject|0|||
163263463|NCT01287520|589675273|FG005|Overall Study|Withdrawal by Subject|1|||
163263464|NCT01287520|589675274|FG006|Overall Study|Withdrawal by Subject|0|||
163263465|NCT01287520|589675275|FG007|Overall Study|Withdrawal by Subject|0|||
163263466|NCT01287520|589675276|FG008|Overall Study|Withdrawal by Subject|1|||
163263467|NCT03587142|589675277|FG000|Overall Study|Lost to Follow-up|5|||
163263468|NCT03587142|589675278|FG001|Overall Study|Lost to Follow-up|3|||
163263469|NCT03587142|589675277|FG000|Overall Study|Did not complete the f4 visit|3|||
163263470|NCT03587142|589675278|FG001|Overall Study|Did not complete the f4 visit|7|||
163263471|NCT03673462|589675279|FG000|Overall Study|Adverse Event|11|||
163263472|NCT03673462|589675280|FG001|Overall Study|Adverse Event|1|||
163263473|NCT03673462|589675279|FG000|Overall Study|Protocol Violation|25|||
163263474|NCT03673462|589675280|FG001|Overall Study|Protocol Violation|11|||
163263475|NCT03673462|589675279|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
163263476|NCT03673462|589675280|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
163263477|NCT03673462|589675279|FG000|Overall Study|Lost to Follow-up|102|||
163263478|NCT03673462|589675280|FG001|Overall Study|Lost to Follow-up|19|||
163263479|NCT01616771|589675283|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
163263480|NCT04359771|589675288|FG000|Overall Study|Lack of Efficacy|2|||
163263481|NCT04359771|589675289|FG001|Overall Study|Lack of Efficacy|2|||
163263482|NCT04041440|589675291|FG000|Overall Study|Withdrawal by Subject|0|||
163263483|NCT04041440|589675292|FG001|Overall Study|Withdrawal by Subject|1|||
163263484|NCT04041440|589675291|FG000|Overall Study|Lost to Follow-up|0|||
163263485|NCT04041440|589675292|FG001|Overall Study|Lost to Follow-up|1|||
163263486|NCT02306265|589675293|FG000|Overall Study|Withdrawal by Subject|1|||
163263487|NCT02247804|589675294|FG000|Treatment Period 1|Adverse Event|9|||
163263488|NCT02247804|589675295|FG001|Treatment Period 1|Adverse Event|2|||
163263489|NCT02247804|589675296|FG002|Treatment Period 1|Adverse Event|0|||
163263490|NCT02247804|589675294|FG000|Treatment Period 1|Lack of Efficacy|0|||
163263491|NCT02247804|589675295|FG001|Treatment Period 1|Lack of Efficacy|0|||
163263492|NCT02247804|589675296|FG002|Treatment Period 1|Lack of Efficacy|2|||
163263493|NCT02247804|589675294|FG000|Treatment Period 1|Lost to Follow-up|1|||
163263494|NCT02247804|589675295|FG001|Treatment Period 1|Lost to Follow-up|0|||
163263495|NCT02247804|589675296|FG002|Treatment Period 1|Lost to Follow-up|2|||
163263496|NCT02247804|589675294|FG000|Treatment Period 1|Personal Reasons|7|||
163362073|NCT01782690|590034687|FG000|Overall Study|Absent rash|9|||
163362074|NCT01782690|590034687|FG000|Overall Study|Physician Decision|13|||
163263497|NCT02247804|589675295|FG001|Treatment Period 1|Personal Reasons|1|||
163263498|NCT02247804|589675296|FG002|Treatment Period 1|Personal Reasons|2|||
163263499|NCT02247804|589675294|FG000|Treatment Period 1|Protocol Deviation|0|||
163263500|NCT02247804|589675295|FG001|Treatment Period 1|Protocol Deviation|0|||
163263501|NCT02247804|589675296|FG002|Treatment Period 1|Protocol Deviation|1|||
163263502|NCT02247804|589675294|FG000|Treatment Period 1|Randomized but not Treated|5|||
163263503|NCT02247804|589675295|FG001|Treatment Period 1|Randomized but not Treated|1|||
163263504|NCT02247804|589675296|FG002|Treatment Period 1|Randomized but not Treated|1|||
163263505|NCT02247804|589675294|FG000|Treatment Period 2|Adverse Event|6|||
163263506|NCT02247804|589675295|FG001|Treatment Period 2|Adverse Event|3|||
163263507|NCT02247804|589675296|FG002|Treatment Period 2|Adverse Event|3|||
163263508|NCT02247804|589675294|FG000|Treatment Period 2|Lack of Efficacy|0|||
163263509|NCT02247804|589675295|FG001|Treatment Period 2|Lack of Efficacy|0|||
163263510|NCT02247804|589675296|FG002|Treatment Period 2|Lack of Efficacy|1|||
163263511|NCT02247804|589675294|FG000|Treatment Period 2|Lost to Follow-up|0|||
163263512|NCT02247804|589675295|FG001|Treatment Period 2|Lost to Follow-up|1|||
163263513|NCT02247804|589675296|FG002|Treatment Period 2|Lost to Follow-up|1|||
163263514|NCT02247804|589675294|FG000|Treatment Period 2|Personal Reasons|2|||
163263515|NCT02247804|589675295|FG001|Treatment Period 2|Personal Reasons|1|||
163263516|NCT02247804|589675296|FG002|Treatment Period 2|Personal Reasons|1|||
163263517|NCT02247804|589675294|FG000|Treatment Period 2|Reason not Specified|0|||
163263518|NCT02247804|589675295|FG001|Treatment Period 2|Reason not Specified|0|||
163263519|NCT02247804|589675296|FG002|Treatment Period 2|Reason not Specified|2|||
163263520|NCT02247804|589675294|FG000|Treatment Period 3|Adverse Event|4|||
163263521|NCT02247804|589675295|FG001|Treatment Period 3|Adverse Event|3|||
163263522|NCT02247804|589675296|FG002|Treatment Period 3|Adverse Event|3|||
163263523|NCT02247804|589675294|FG000|Treatment Period 3|Lack of Efficacy|0|||
163263524|NCT02247804|589675295|FG001|Treatment Period 3|Lack of Efficacy|1|||
163263525|NCT02247804|589675296|FG002|Treatment Period 3|Lack of Efficacy|0|||
163263526|NCT02247804|589675294|FG000|Treatment Period 3|Lost to Follow-up|1|||
163263527|NCT02247804|589675295|FG001|Treatment Period 3|Lost to Follow-up|2|||
163263528|NCT02247804|589675296|FG002|Treatment Period 3|Lost to Follow-up|2|||
163263529|NCT02247804|589675294|FG000|Treatment Period 3|Personal Reasons|4|||
163263530|NCT02247804|589675295|FG001|Treatment Period 3|Personal Reasons|3|||
163263531|NCT02247804|589675296|FG002|Treatment Period 3|Personal Reasons|2|||
163263532|NCT02247804|589675294|FG000|Treatment Period 3|Reason not Specified|2|||
163263533|NCT02247804|589675295|FG001|Treatment Period 3|Reason not Specified|1|||
163263534|NCT02247804|589675296|FG002|Treatment Period 3|Reason not Specified|3|||
163263535|NCT01346514|589675303|FG000|Overall Study|Lost to Follow-up|19|||
163263536|NCT01346514|589675304|FG001|Overall Study|Lost to Follow-up|30|||
163263537|NCT01346514|589675303|FG000|Overall Study|Withdrawal by Subject|7|||
163263538|NCT01346514|589675304|FG001|Overall Study|Withdrawal by Subject|3|||
163263539|NCT01346514|589675303|FG000|Overall Study|Death|3|||
163263540|NCT01346514|589675304|FG001|Overall Study|Death|4|||
163263541|NCT00909480|589675305|FG000|Overall Study|Adverse Event|5|||
163263542|NCT00909480|589675306|FG001|Overall Study|Adverse Event|3|||
163263543|NCT00909480|589675305|FG000|Overall Study|Protocol Violation|6|||
163263544|NCT00909480|589675306|FG001|Overall Study|Protocol Violation|8|||
163263545|NCT00909480|589675305|FG000|Overall Study|Withdrawal criteria|9|||
163263546|NCT00909480|589675306|FG001|Overall Study|Withdrawal criteria|11|||
163263547|NCT00909480|589675305|FG000|Overall Study|Unclassified|18|||
163263548|NCT00909480|589675306|FG001|Overall Study|Unclassified|19|||
163263549|NCT03002038|589675310|FG000|Overall Study|Adverse Event|3|||
163263550|NCT03002038|589675311|FG001|Overall Study|Adverse Event|1|||
163263551|NCT03002038|589675310|FG000|Overall Study|Withdrawal by Subject|8|||
163263552|NCT03002038|589675311|FG001|Overall Study|Withdrawal by Subject|4|||
163263553|NCT03002038|589675310|FG000|Overall Study|Immigration to another region|0|||
163263554|NCT03002038|589675311|FG001|Overall Study|Immigration to another region|2|||
163263555|NCT01054573|589675312|FG000|Overall Study|Adverse Event|1|||
163263556|NCT01054573|589675313|FG001|Overall Study|Adverse Event|0|||
163263557|NCT01054573|589675314|FG002|Overall Study|Adverse Event|1|||
163263558|NCT01054573|589675315|FG003|Overall Study|Adverse Event|1|||
163263559|NCT01054573|589675312|FG000|Overall Study|Lost to Follow-up|0|||
163263560|NCT01054573|589675313|FG001|Overall Study|Lost to Follow-up|2|||
163263561|NCT01054573|589675314|FG002|Overall Study|Lost to Follow-up|0|||
163263562|NCT01054573|589675315|FG003|Overall Study|Lost to Follow-up|0|||
163263563|NCT01054573|589675312|FG000|Overall Study|Withdrawal by Subject|0|||
163263564|NCT01054573|589675313|FG001|Overall Study|Withdrawal by Subject|2|||
163263565|NCT01054573|589675314|FG002|Overall Study|Withdrawal by Subject|2|||
163263566|NCT01054573|589675315|FG003|Overall Study|Withdrawal by Subject|1|||
163263567|NCT00393523|589675316|FG000|Overall Study|Lost to Follow-up|0|||
163263568|NCT00393523|589675317|FG001|Overall Study|Lost to Follow-up|0|||
163263569|NCT00393523|589675318|FG002|Overall Study|Lost to Follow-up|0|||
163263570|NCT00393523|589675319|FG003|Overall Study|Lost to Follow-up|2|||
163263571|NCT00393523|589675320|FG004|Overall Study|Lost to Follow-up|1|||
163263572|NCT00393523|589675316|FG000|Overall Study|Protocol Violation|6|||
163263573|NCT00393523|589675317|FG001|Overall Study|Protocol Violation|2|||
163263574|NCT00393523|589675318|FG002|Overall Study|Protocol Violation|0|||
163263575|NCT00393523|589675319|FG003|Overall Study|Protocol Violation|1|||
163263576|NCT00393523|589675320|FG004|Overall Study|Protocol Violation|0|||
163263577|NCT00393523|589675316|FG000|Overall Study|Withdrawal by Subject|6|||
163263578|NCT00393523|589675317|FG001|Overall Study|Withdrawal by Subject|7|||
163263579|NCT00393523|589675318|FG002|Overall Study|Withdrawal by Subject|2|||
163263580|NCT00393523|589675319|FG003|Overall Study|Withdrawal by Subject|3|||
163263581|NCT00393523|589675320|FG004|Overall Study|Withdrawal by Subject|0|||
163263582|NCT00393523|589675316|FG000|Overall Study|Difficulties in specimen collection|0|||
163263583|NCT00393523|589675317|FG001|Overall Study|Difficulties in specimen collection|0|||
163263584|NCT00393523|589675318|FG002|Overall Study|Difficulties in specimen collection|1|||
163263585|NCT00393523|589675319|FG003|Overall Study|Difficulties in specimen collection|0|||
163263586|NCT00393523|589675320|FG004|Overall Study|Difficulties in specimen collection|0|||
163263587|NCT00393523|589675316|FG000|Overall Study|Vaccine supply issue|0|||
163263588|NCT00393523|589675317|FG001|Overall Study|Vaccine supply issue|0|||
163263589|NCT00393523|589675318|FG002|Overall Study|Vaccine supply issue|1|||
163263590|NCT00393523|589675319|FG003|Overall Study|Vaccine supply issue|0|||
163263591|NCT00393523|589675320|FG004|Overall Study|Vaccine supply issue|0|||
163263592|NCT01735396|589675324|FG000|Overall Study|not evaluable|1|||
163263593|NCT03724396|589675327|FG000|Overall Study|Lost to Follow-up|1|||
163263594|NCT03724396|589675328|FG001|Overall Study|Lost to Follow-up|1|||
163263595|NCT03724396|589675327|FG000|Overall Study|Withdrawal by Subject|1|||
163263596|NCT03724396|589675328|FG001|Overall Study|Withdrawal by Subject|0|||
163263597|NCT02237508|589675330|FG000|Overall Study|Withdrawal by Subject|0|||
163263598|NCT02237508|589675331|FG001|Overall Study|Withdrawal by Subject|2|||
163263599|NCT02237508|589675332|FG002|Overall Study|Withdrawal by Subject|0|||
163263600|NCT02237508|589675333|FG003|Overall Study|Withdrawal by Subject|1|||
163263601|NCT02237508|589675334|FG004|Overall Study|Withdrawal by Subject|0|||
163263602|NCT02237508|589675335|FG005|Overall Study|Withdrawal by Subject|1|||
163263603|NCT02237508|589675336|FG006|Overall Study|Withdrawal by Subject|1|||
163263604|NCT02237508|589675337|FG007|Overall Study|Withdrawal by Subject|0|||
163263605|NCT02237508|589675338|FG008|Overall Study|Withdrawal by Subject|1|||
163263606|NCT02237508|589675339|FG009|Overall Study|Withdrawal by Subject|0|||
163263607|NCT02237508|589675330|FG000|Overall Study|Physician Decision|0|||
163263608|NCT02237508|589675331|FG001|Overall Study|Physician Decision|1|||
163263609|NCT02237508|589675332|FG002|Overall Study|Physician Decision|0|||
163263610|NCT02237508|589675333|FG003|Overall Study|Physician Decision|0|||
163263611|NCT02237508|589675334|FG004|Overall Study|Physician Decision|0|||
163263612|NCT02237508|589675335|FG005|Overall Study|Physician Decision|0|||
163263613|NCT02237508|589675336|FG006|Overall Study|Physician Decision|0|||
163263614|NCT02237508|589675337|FG007|Overall Study|Physician Decision|0|||
163263615|NCT02237508|589675338|FG008|Overall Study|Physician Decision|0|||
163263616|NCT02237508|589675339|FG009|Overall Study|Physician Decision|0|||
163263617|NCT02237508|589675330|FG000|Overall Study|Protocol Violation|0|||
163263618|NCT02237508|589675331|FG001|Overall Study|Protocol Violation|0|||
163263619|NCT02237508|589675332|FG002|Overall Study|Protocol Violation|1|||
163263620|NCT02237508|589675333|FG003|Overall Study|Protocol Violation|0|||
163263621|NCT02237508|589675334|FG004|Overall Study|Protocol Violation|0|||
163263622|NCT02237508|589675335|FG005|Overall Study|Protocol Violation|0|||
163263623|NCT02237508|589675336|FG006|Overall Study|Protocol Violation|0|||
163263624|NCT02237508|589675337|FG007|Overall Study|Protocol Violation|0|||
163263625|NCT02237508|589675338|FG008|Overall Study|Protocol Violation|0|||
163263626|NCT02237508|589675339|FG009|Overall Study|Protocol Violation|0|||
163263627|NCT01650519|589675340|FG000|Overall Study|Withdrawal by Subject|1|||
163263628|NCT01650519|589675341|FG001|Overall Study|Withdrawal by Subject|0|||
163263629|NCT03300570|589675344|FG000|Overall Study|Adverse Event|0|||
163263630|NCT03300570|589675345|FG001|Overall Study|Adverse Event|1|||
163263631|NCT03300570|589675344|FG000|Overall Study|Withdrawal by Subject|1|||
163263632|NCT03300570|589675345|FG001|Overall Study|Withdrawal by Subject|0|||
163263633|NCT03300570|589675344|FG000|Overall Study|Inadequate bowel prep|1|||
163263634|NCT03300570|589675345|FG001|Overall Study|Inadequate bowel prep|0|||
163263635|NCT03188120|589675346|FG000|Overall Study|Adverse Event|4|||
163263636|NCT03188120|589675346|FG000|Overall Study|Insufficient Effectiveness|8|||
163263637|NCT03188120|589675346|FG000|Overall Study|Improved|12|||
163263638|NCT03188120|589675346|FG000|Overall Study|Lost to Follow-up|7|||
163263639|NCT03188120|589675346|FG000|Overall Study|Other than specified|3|||
163263640|NCT03188120|589675346|FG000|Overall Study|No visit after the first visit|13|||
163263641|NCT02296190|589675348|FG000|Overall Study|Lost to Follow-up|0|||
163362075|NCT01782690|590034687|FG000|Overall Study|Patient's wish|21|||
163362076|NCT01782690|590034687|FG000|Overall Study|Tumor progression|74|||
163362077|NCT01782690|590034687|FG000|Overall Study|Death|133|||
163362078|NCT01782690|590034687|FG000|Overall Study|Study completion unknown|7|||
163362079|NCT01637077|590034693|FG000|Overall Study|Cancel|1|||
163263642|NCT02296190|589675349|FG001|Overall Study|Lost to Follow-up|0|||
163263643|NCT02296190|589675350|FG002|Overall Study|Lost to Follow-up|0|||
163263644|NCT02296190|589675351|FG003|Overall Study|Lost to Follow-up|0|||
163263645|NCT02296190|589675352|FG004|Overall Study|Lost to Follow-up|1|||
163362080|NCT01637077|590034694|FG001|Overall Study|Cancel|1|||
163263646|NCT02296190|589675353|FG005|Overall Study|Lost to Follow-up|0|||
163263647|NCT02296190|589675348|FG000|Overall Study|Failure to induce PSVT|6|||
163263648|NCT02296190|589675349|FG001|Overall Study|Failure to induce PSVT|10|||
163263649|NCT02296190|589675350|FG002|Overall Study|Failure to induce PSVT|5|||
163263650|NCT02296190|589675351|FG003|Overall Study|Failure to induce PSVT|13|||
163263651|NCT02296190|589675352|FG004|Overall Study|Failure to induce PSVT|8|||
163263652|NCT02296190|589675353|FG005|Overall Study|Failure to induce PSVT|0|||
163263653|NCT02296190|589675348|FG000|Overall Study|Physician Decision|1|||
163263654|NCT02296190|589675349|FG001|Overall Study|Physician Decision|1|||
163263655|NCT02296190|589675350|FG002|Overall Study|Physician Decision|0|||
163263656|NCT02296190|589675351|FG003|Overall Study|Physician Decision|1|||
163263657|NCT02296190|589675352|FG004|Overall Study|Physician Decision|2|||
163263658|NCT02296190|589675353|FG005|Overall Study|Physician Decision|0|||
163263659|NCT02296190|589675348|FG000|Overall Study|Withdrawal by Subject|0|||
163263660|NCT02296190|589675349|FG001|Overall Study|Withdrawal by Subject|1|||
163263661|NCT02296190|589675350|FG002|Overall Study|Withdrawal by Subject|0|||
163263662|NCT02296190|589675351|FG003|Overall Study|Withdrawal by Subject|0|||
163263663|NCT02296190|589675352|FG004|Overall Study|Withdrawal by Subject|0|||
163263664|NCT02296190|589675353|FG005|Overall Study|Withdrawal by Subject|0|||
163263665|NCT02296190|589675348|FG000|Overall Study|PSVT < 5 minutes|5|||
163263666|NCT02296190|589675349|FG001|Overall Study|PSVT < 5 minutes|6|||
163263667|NCT02296190|589675350|FG002|Overall Study|PSVT < 5 minutes|6|||
163263668|NCT02296190|589675351|FG003|Overall Study|PSVT < 5 minutes|6|||
163263669|NCT02296190|589675352|FG004|Overall Study|PSVT < 5 minutes|5|||
163263670|NCT02296190|589675353|FG005|Overall Study|PSVT < 5 minutes|0|||
163263671|NCT02296190|589675348|FG000|Overall Study|Patient was given Propofol|0|||
163263672|NCT02296190|589675349|FG001|Overall Study|Patient was given Propofol|1|||
163263673|NCT02296190|589675350|FG002|Overall Study|Patient was given Propofol|0|||
163263674|NCT02296190|589675351|FG003|Overall Study|Patient was given Propofol|1|||
163263675|NCT02296190|589675352|FG004|Overall Study|Patient was given Propofol|0|||
163263676|NCT02296190|589675353|FG005|Overall Study|Patient was given Propofol|0|||
163263677|NCT02296190|589675348|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
163263678|NCT02296190|589675349|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
163263679|NCT02296190|589675350|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
163263680|NCT02296190|589675351|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
163263681|NCT02296190|589675352|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
163263682|NCT02296190|589675353|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
163263683|NCT02296190|589675348|FG000|Overall Study|Blood pressure <100 after sedation|0|||
163263684|NCT02296190|589675349|FG001|Overall Study|Blood pressure <100 after sedation|0|||
163263685|NCT02296190|589675350|FG002|Overall Study|Blood pressure <100 after sedation|0|||
163263686|NCT02296190|589675351|FG003|Overall Study|Blood pressure <100 after sedation|1|||
163263687|NCT02296190|589675352|FG004|Overall Study|Blood pressure <100 after sedation|0|||
163263688|NCT02296190|589675353|FG005|Overall Study|Blood pressure <100 after sedation|0|||
163263689|NCT02296190|589675348|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
163263690|NCT02296190|589675349|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
163263691|NCT02296190|589675350|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
163263692|NCT02296190|589675351|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
163263693|NCT02296190|589675352|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
163263694|NCT02296190|589675353|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
163263695|NCT02296190|589675348|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
163263696|NCT02296190|589675349|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
163263697|NCT02296190|589675350|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
163263698|NCT02296190|589675351|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
163263699|NCT02296190|589675352|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
163263700|NCT02296190|589675353|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
163263701|NCT02296190|589675348|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
163263702|NCT02296190|589675349|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
163263703|NCT02296190|589675350|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
163263704|NCT02296190|589675351|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
163263705|NCT02296190|589675352|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
163263706|NCT02296190|589675353|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
163263707|NCT02296190|589675348|FG000|Overall Study|Lab result not available in time|1|||
163263708|NCT02296190|589675349|FG001|Overall Study|Lab result not available in time|0|||
163263709|NCT02296190|589675350|FG002|Overall Study|Lab result not available in time|0|||
163263710|NCT02296190|589675351|FG003|Overall Study|Lab result not available in time|0|||
163263711|NCT02296190|589675352|FG004|Overall Study|Lab result not available in time|0|||
163263712|NCT02296190|589675353|FG005|Overall Study|Lab result not available in time|0|||
163263713|NCT00717314|589675355|FG000|Overall Study|Adverse Event|3|||
163263714|NCT00717314|589675356|FG001|Overall Study|Adverse Event|2|||
163263715|NCT00717314|589675355|FG000|Overall Study|Protocol Violation|1|||
163263716|NCT00717314|589675356|FG001|Overall Study|Protocol Violation|0|||
163263717|NCT00717314|589675355|FG000|Overall Study|Lost to Follow-up|1|||
163263718|NCT00717314|589675356|FG001|Overall Study|Lost to Follow-up|5|||
163263719|NCT00717314|589675355|FG000|Overall Study|Withdrawal by Subject|1|||
163153494|NCT04408989|589276314|FG000|Overall Study|Withdrawal by Subject|0|||
163153495|NCT04408989|589276315|FG001|Overall Study|Withdrawal by Subject|0|||
163153496|NCT04408989|589276316|FG002|Overall Study|Withdrawal by Subject|2|||
163153497|NCT02260934|589276331|FG000|Overall Study|Lost to Follow-up|2|||
163153498|NCT02260934|589276332|FG001|Overall Study|Lost to Follow-up|1|||
163153499|NCT02260934|589276331|FG000|Overall Study|Withdrawal by Subject|0|||
163153500|NCT02260934|589276332|FG001|Overall Study|Withdrawal by Subject|2|||
163153501|NCT02260934|589276331|FG000|Overall Study|Participant Relocated|1|||
163153502|NCT02260934|589276332|FG001|Overall Study|Participant Relocated|0|||
163153503|NCT02260934|589276331|FG000|Overall Study|Site error|0|||
163153504|NCT02260934|589276332|FG001|Overall Study|Site error|1|||
163153505|NCT02628873|589276335|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
163153506|NCT02628873|589276336|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
163153507|NCT02628873|589276335|FG000|Second Test (1 Hour)|Physician Decision|1|||
163153508|NCT02628873|589276336|FG001|Second Test (1 Hour)|Physician Decision|0|||
163153509|NCT03597347|589276339|FG000|Overall Study|Withdrawal by Subject|1|||
163153510|NCT03597347|589276340|FG001|Overall Study|Withdrawal by Subject|1|||
163153511|NCT03597347|589276341|FG002|Overall Study|Withdrawal by Subject|0|||
163153512|NCT03597347|589276339|FG000|Overall Study|Withdrawal due to Covid-19|3|||
163153513|NCT03597347|589276340|FG001|Overall Study|Withdrawal due to Covid-19|0|||
163153514|NCT03597347|589276341|FG002|Overall Study|Withdrawal due to Covid-19|0|||
163153515|NCT03597347|589276339|FG000|Overall Study|Sponsor decision to terminate study|3|||
163153516|NCT03597347|589276340|FG001|Overall Study|Sponsor decision to terminate study|2|||
163153517|NCT03597347|589276341|FG002|Overall Study|Sponsor decision to terminate study|4|||
163153518|NCT04606134|589276342|FG000|Overall Study|Adverse Event|0|||
163153519|NCT04606134|589276343|FG001|Overall Study|Adverse Event|1|||
163153520|NCT00107653|589276344|FG000|Overall Study|Adverse Event|24|||
163153521|NCT00107653|589276345|FG001|Overall Study|Adverse Event|43|||
163153522|NCT00107653|589276344|FG000|Overall Study|Insufficient Therapeutic Response|25|||
163153523|NCT00107653|589276345|FG001|Overall Study|Insufficient Therapeutic Response|11|||
163153524|NCT00107653|589276344|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
163153525|NCT00107653|589276345|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
163153526|NCT00107653|589276344|FG000|Overall Study|Protocol Violation|1|||
163153527|NCT00107653|589276345|FG001|Overall Study|Protocol Violation|0|||
163153528|NCT00107653|589276344|FG000|Overall Study|Withdrawal by Subject|12|||
163153529|NCT00107653|589276345|FG001|Overall Study|Withdrawal by Subject|13|||
163153530|NCT00107653|589276344|FG000|Overall Study|Lost to Follow-up|13|||
163153531|NCT00107653|589276345|FG001|Overall Study|Lost to Follow-up|5|||
163153532|NCT00107653|589276344|FG000|Overall Study|Administrative Reasons|3|||
163153533|NCT00107653|589276345|FG001|Overall Study|Administrative Reasons|3|||
163153534|NCT01099267|589276347|FG000|MDS-003 Study|Adverse Event|37|||
163153535|NCT01099267|589276347|FG000|MDS-003 Study|Lack of Efficacy|52|||
163153536|NCT01099267|589276347|FG000|MDS-003 Study|Withdrawal by Subject|8|||
163153537|NCT01099267|589276347|FG000|MDS-003 Study|Lost to Follow-up|1|||
163153538|NCT01099267|589276347|FG000|MDS-003 Study|Death|11|||
163153539|NCT01099267|589276347|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
163153540|NCT01099267|589276347|FG000|MDS-003 Study|Disease Progression|7|||
163153541|NCT01099267|589276347|FG000|MDS-003 Study|Investigator Decision|2|||
163153542|NCT01099267|589276347|FG000|MDS-003 Study|Non-Compliance|2|||
163153543|NCT01099267|589276347|FG000|MDS-003 Study|Loss of Response|1|||
163153544|NCT01099267|589276347|FG000|MDS-003 Study|Secondary Malign Disease|1|||
163153545|NCT04986904|589276348|FG000|Overall Study|Lost to Follow-up|11|||
163153546|NCT04986904|589276348|FG000|Overall Study|Withdrawal by Subject|1|||
163153547|NCT02532517|589276349|FG000|Overall Study|Did not complete 24-Month visit|4|||
163153548|NCT02532517|589276349|FG000|Overall Study|Failed Angiographic eligibility|1|||
163153549|NCT02532517|589276349|FG000|Overall Study|Lost to Follow-up|4|||
163153550|NCT02532517|589276349|FG000|Overall Study|Withdrawal by Subject|4|||
163153551|NCT02532517|589276349|FG000|Overall Study|Death|4|||
163153552|NCT02234843|589276350|FG000|Overall Study|Death|1|||
163153553|NCT02234843|589276351|FG001|Overall Study|Death|0|||
163153554|NCT02234843|589276352|FG002|Overall Study|Death|0|||
163153555|NCT02234843|589276353|FG003|Overall Study|Death|0|||
163153556|NCT02234843|589276354|FG004|Overall Study|Death|0|||
163153557|NCT02234843|589276355|FG005|Overall Study|Death|0|||
163153558|NCT02234843|589276356|FG006|Overall Study|Death|0|||
163153559|NCT02234843|589276357|FG007|Overall Study|Death|0|||
163153560|NCT02234843|589276358|FG008|Overall Study|Death|0|||
163153561|NCT02234843|589276359|FG009|Overall Study|Death|0|||
163153562|NCT02234843|589276350|FG000|Overall Study|Protocol Violation|1|||
163153563|NCT02234843|589276351|FG001|Overall Study|Protocol Violation|0|||
163153564|NCT02234843|589276352|FG002|Overall Study|Protocol Violation|1|||
163153565|NCT02234843|589276353|FG003|Overall Study|Protocol Violation|0|||
163153566|NCT02234843|589276354|FG004|Overall Study|Protocol Violation|0|||
163153567|NCT02234843|589276355|FG005|Overall Study|Protocol Violation|0|||
163153568|NCT02234843|589276356|FG006|Overall Study|Protocol Violation|0|||
163153569|NCT02234843|589276357|FG007|Overall Study|Protocol Violation|0|||
163153570|NCT02234843|589276358|FG008|Overall Study|Protocol Violation|0|||
163153571|NCT02234843|589276359|FG009|Overall Study|Protocol Violation|0|||
163411166|NCT00852995|590213000|FG004|Overall Study|Physician Decision|0|||
163263720|NCT00717314|589675356|FG001|Overall Study|Withdrawal by Subject|3|||
163263721|NCT01483937|589675357|FG000|Overall Study|Withdrawal by Subject|4|||
163263722|NCT01483937|589675358|FG001|Overall Study|Withdrawal by Subject|3|||
163263723|NCT00682643|589675360|FG000|Overall Study|Adverse Event|12|||
163263724|NCT00682643|589675361|FG001|Overall Study|Adverse Event|23|||
163263725|NCT00682643|589675360|FG000|Overall Study|Lack of Efficacy|2|||
163263726|NCT00682643|589675361|FG001|Overall Study|Lack of Efficacy|0|||
163263727|NCT00682643|589675360|FG000|Overall Study|Protocol Violation|38|||
163263728|NCT00682643|589675361|FG001|Overall Study|Protocol Violation|76|||
163153572|NCT02234843|589276350|FG000|Overall Study|Efficacy outcome reached|2|||
163153573|NCT02234843|589276351|FG001|Overall Study|Efficacy outcome reached|0|||
163153574|NCT02234843|589276352|FG002|Overall Study|Efficacy outcome reached|0|||
163153575|NCT02234843|589276353|FG003|Overall Study|Efficacy outcome reached|0|||
163153576|NCT02234843|589276354|FG004|Overall Study|Efficacy outcome reached|0|||
163153577|NCT02234843|589276355|FG005|Overall Study|Efficacy outcome reached|2|||
163153578|NCT02234843|589276356|FG006|Overall Study|Efficacy outcome reached|0|||
163153579|NCT02234843|589276357|FG007|Overall Study|Efficacy outcome reached|0|||
163153580|NCT02234843|589276358|FG008|Overall Study|Efficacy outcome reached|0|||
163153581|NCT02234843|589276359|FG009|Overall Study|Efficacy outcome reached|0|||
163263729|NCT00682643|589675360|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
163263730|NCT00682643|589675361|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
163263731|NCT00682643|589675360|FG000|Overall Study|Lost to Follow-up|1|||
163263732|NCT00682643|589675361|FG001|Overall Study|Lost to Follow-up|6|||
163263733|NCT00682643|589675360|FG000|Overall Study|Physician Decision|2|||
163263734|NCT00682643|589675361|FG001|Overall Study|Physician Decision|6|||
163153582|NCT02234843|589276350|FG000|Overall Study|Patient convenience|2|||
163153583|NCT02234843|589276351|FG001|Overall Study|Patient convenience|0|||
163153584|NCT02234843|589276352|FG002|Overall Study|Patient convenience|0|||
163153585|NCT02234843|589276353|FG003|Overall Study|Patient convenience|0|||
163153586|NCT02234843|589276354|FG004|Overall Study|Patient convenience|0|||
163153587|NCT02234843|589276355|FG005|Overall Study|Patient convenience|1|||
163153588|NCT02234843|589276356|FG006|Overall Study|Patient convenience|0|||
163153589|NCT02234843|589276357|FG007|Overall Study|Patient convenience|0|||
163153590|NCT02234843|589276358|FG008|Overall Study|Patient convenience|0|||
163153591|NCT02234843|589276359|FG009|Overall Study|Patient convenience|0|||
163153592|NCT02234843|589276350|FG000|Overall Study|Withdrawal by Subject|5|||
163153593|NCT02234843|589276351|FG001|Overall Study|Withdrawal by Subject|1|||
163153594|NCT02234843|589276352|FG002|Overall Study|Withdrawal by Subject|1|||
163153595|NCT02234843|589276353|FG003|Overall Study|Withdrawal by Subject|0|||
163153596|NCT02234843|589276354|FG004|Overall Study|Withdrawal by Subject|0|||
163263735|NCT00682643|589675360|FG000|Overall Study|Withdrawal by Subject|19|||
163263736|NCT00682643|589675361|FG001|Overall Study|Withdrawal by Subject|53|||
163263737|NCT00682643|589675360|FG000|Overall Study|Did Not Receive Study Drug|1|||
163263738|NCT00682643|589675361|FG001|Overall Study|Did Not Receive Study Drug|1|||
163263739|NCT01875185|589675362|FG000|Overall Study|study was terminated|52|||
163263740|NCT01875185|589675363|FG001|Overall Study|study was terminated|48|||
163153597|NCT02234843|589276355|FG005|Overall Study|Withdrawal by Subject|7|||
163153598|NCT02234843|589276356|FG006|Overall Study|Withdrawal by Subject|0|||
163153599|NCT02234843|589276357|FG007|Overall Study|Withdrawal by Subject|0|||
163153600|NCT02234843|589276358|FG008|Overall Study|Withdrawal by Subject|0|||
163153601|NCT02234843|589276359|FG009|Overall Study|Withdrawal by Subject|0|||
163153602|NCT02234843|589276350|FG000|Overall Study|Recovery|1|||
163153603|NCT02234843|589276351|FG001|Overall Study|Recovery|0|||
163153604|NCT02234843|589276352|FG002|Overall Study|Recovery|0|||
163153605|NCT02234843|589276353|FG003|Overall Study|Recovery|0|||
163153606|NCT02234843|589276354|FG004|Overall Study|Recovery|0|||
163263741|NCT03238300|589675364|FG000|Baseline (Before Intervention)|Physician Decision|0|||
163263742|NCT03238300|589675365|FG001|Baseline (Before Intervention)|Physician Decision|1|||
163263743|NCT03238300|589675364|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
163263744|NCT03238300|589675365|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
163263745|NCT03238300|589675364|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
163263746|NCT03238300|589675365|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
163263747|NCT03238300|589675364|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
163263748|NCT03238300|589675365|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
163263749|NCT00399763|589675372|FG000|Overall Study|Lost to Follow-up|2|||
163263750|NCT00399763|589675373|FG001|Overall Study|Lost to Follow-up|3|||
163153607|NCT02234843|589276355|FG005|Overall Study|Recovery|0|||
163153608|NCT02234843|589276356|FG006|Overall Study|Recovery|0|||
163153609|NCT02234843|589276357|FG007|Overall Study|Recovery|0|||
163153610|NCT02234843|589276358|FG008|Overall Study|Recovery|0|||
163153611|NCT02234843|589276359|FG009|Overall Study|Recovery|0|||
163153612|NCT02234843|589276350|FG000|Overall Study|Other|0|||
163153613|NCT02234843|589276351|FG001|Overall Study|Other|2|||
163153614|NCT02234843|589276352|FG002|Overall Study|Other|0|||
163153615|NCT02234843|589276353|FG003|Overall Study|Other|1|||
163153616|NCT02234843|589276354|FG004|Overall Study|Other|0|||
163263751|NCT03389477|589675376|FG000|Step 1|Withdrawal by Subject|1|||
163153617|NCT02234843|589276355|FG005|Overall Study|Other|1|||
163263752|NCT03389477|589675377|FG001|Step 1|Withdrawal by Subject|0|||
163263753|NCT03389477|589675376|FG000|Step 2|Withdrawal by Subject|1|||
163263754|NCT03389477|589675377|FG001|Step 2|Withdrawal by Subject|2|||
163263755|NCT03389477|589675376|FG000|Step 2|Disease progression|1|||
163263756|NCT03389477|589675377|FG001|Step 2|Disease progression|0|||
163263757|NCT03389477|589675376|FG000|Step 2|Death|0|||
163263758|NCT03389477|589675377|FG001|Step 2|Death|1|||
163263759|NCT03389477|589675376|FG000|Step 2|Poor performance status and nutrition|0|||
163263760|NCT03389477|589675377|FG001|Step 2|Poor performance status and nutrition|1|||
163263761|NCT03389477|589675376|FG000|Step 3|Withdrawal after 3 cycles|0|||
163263762|NCT03389477|589675377|FG001|Step 3|Withdrawal after 3 cycles|1|||
163263763|NCT03389477|589675376|FG000|Step 3|Still receiving active treatment|4|||
163263764|NCT03389477|589675377|FG001|Step 3|Still receiving active treatment|0|||
163263765|NCT03389477|589675376|FG000|Step 3|Progressive disease after 2 cycles|1|||
163263766|NCT03389477|589675377|FG001|Step 3|Progressive disease after 2 cycles|0|||
163263767|NCT04512066|589675380|FG000|Double-blind Treatment Period|Adverse Event|6|||
163263768|NCT04512066|589675381|FG001|Double-blind Treatment Period|Adverse Event|4|||
163263769|NCT04512066|589675382|FG002|Double-blind Treatment Period|Adverse Event|5|||
163263770|NCT04512066|589675383|FG003|Double-blind Treatment Period|Adverse Event|1|||
163263771|NCT04512066|589675384|FG004|Double-blind Treatment Period|Adverse Event|0|||
163263772|NCT04512066|589675385|FG005|Double-blind Treatment Period|Adverse Event|0|||
163263773|NCT04512066|589675380|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
163263774|NCT04512066|589675381|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
163263775|NCT04512066|589675382|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
163263776|NCT04512066|589675383|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
163263777|NCT04512066|589675384|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
163263778|NCT04512066|589675385|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
163263779|NCT04512066|589675380|FG000|Double-blind Treatment Period|Physician Decision|1|||
163263780|NCT04512066|589675381|FG001|Double-blind Treatment Period|Physician Decision|0|||
163263781|NCT04512066|589675382|FG002|Double-blind Treatment Period|Physician Decision|1|||
163263782|NCT04512066|589675383|FG003|Double-blind Treatment Period|Physician Decision|0|||
163263783|NCT04512066|589675384|FG004|Double-blind Treatment Period|Physician Decision|0|||
163263784|NCT04512066|589675385|FG005|Double-blind Treatment Period|Physician Decision|0|||
163263785|NCT04512066|589675380|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
163263786|NCT04512066|589675381|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
163263787|NCT04512066|589675382|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
163263788|NCT04512066|589675383|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
163263789|NCT04512066|589675384|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
163263790|NCT04512066|589675385|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
163263791|NCT04512066|589675380|FG000|Extension Period|Adverse Event|0|||
163263792|NCT04512066|589675381|FG001|Extension Period|Adverse Event|1|||
163263793|NCT04512066|589675382|FG002|Extension Period|Adverse Event|4|||
163263794|NCT04512066|589675383|FG003|Extension Period|Adverse Event|3|||
163263795|NCT04512066|589675384|FG004|Extension Period|Adverse Event|1|||
163263796|NCT04512066|589675385|FG005|Extension Period|Adverse Event|3|||
163263797|NCT04512066|589675380|FG000|Extension Period|Death|0|||
163263798|NCT04512066|589675381|FG001|Extension Period|Death|0|||
163263799|NCT04512066|589675382|FG002|Extension Period|Death|0|||
163263800|NCT04512066|589675383|FG003|Extension Period|Death|0|||
163263801|NCT04512066|589675384|FG004|Extension Period|Death|0|||
163263802|NCT04512066|589675385|FG005|Extension Period|Death|1|||
163263803|NCT04512066|589675380|FG000|Extension Period|Lack of Efficacy|0|||
163263804|NCT04512066|589675381|FG001|Extension Period|Lack of Efficacy|4|||
163263805|NCT04512066|589675382|FG002|Extension Period|Lack of Efficacy|4|||
163263806|NCT04512066|589675383|FG003|Extension Period|Lack of Efficacy|1|||
163263807|NCT04512066|589675384|FG004|Extension Period|Lack of Efficacy|3|||
163263808|NCT04512066|589675385|FG005|Extension Period|Lack of Efficacy|3|||
163263809|NCT04512066|589675380|FG000|Extension Period|Lost to Follow-up|0|||
163263810|NCT04512066|589675381|FG001|Extension Period|Lost to Follow-up|1|||
163263811|NCT04512066|589675382|FG002|Extension Period|Lost to Follow-up|5|||
163263812|NCT04512066|589675383|FG003|Extension Period|Lost to Follow-up|2|||
163263813|NCT04512066|589675384|FG004|Extension Period|Lost to Follow-up|3|||
163263814|NCT04512066|589675385|FG005|Extension Period|Lost to Follow-up|2|||
163263815|NCT04512066|589675380|FG000|Extension Period|Non-compliance with study drug|0|||
163263816|NCT04512066|589675381|FG001|Extension Period|Non-compliance with study drug|1|||
163263817|NCT04512066|589675382|FG002|Extension Period|Non-compliance with study drug|0|||
163263818|NCT04512066|589675383|FG003|Extension Period|Non-compliance with study drug|0|||
163263819|NCT04512066|589675384|FG004|Extension Period|Non-compliance with study drug|0|||
163263820|NCT04512066|589675385|FG005|Extension Period|Non-compliance with study drug|1|||
163263821|NCT04512066|589675380|FG000|Extension Period|Other|0|||
163362081|NCT01637077|590034693|FG000|Overall Study|Withdrawal by Subject|1|||
163362082|NCT01637077|590034694|FG001|Overall Study|Withdrawal by Subject|0|||
163362083|NCT01637077|590034693|FG000|Overall Study|No cycle 1 questionnaire data|2|||
163362084|NCT01637077|590034694|FG001|Overall Study|No cycle 1 questionnaire data|0|||
163362085|NCT02638103|590034695|FG000|Overall Study|Adverse Event|13|||
163153618|NCT02234843|589276356|FG006|Overall Study|Other|0|||
163153619|NCT02234843|589276357|FG007|Overall Study|Other|1|||
163153620|NCT02234843|589276358|FG008|Overall Study|Other|0|||
163153621|NCT02234843|589276359|FG009|Overall Study|Other|0|||
163153622|NCT02234843|589276350|FG000|Overall Study|Physician Decision|4|||
163153623|NCT02234843|589276351|FG001|Overall Study|Physician Decision|1|||
163263822|NCT04512066|589675381|FG001|Extension Period|Other|2|||
163263823|NCT04512066|589675382|FG002|Extension Period|Other|0|||
163153624|NCT02234843|589276352|FG002|Overall Study|Physician Decision|0|||
163153625|NCT02234843|589276353|FG003|Overall Study|Physician Decision|1|||
163153626|NCT02234843|589276354|FG004|Overall Study|Physician Decision|0|||
163153627|NCT02234843|589276355|FG005|Overall Study|Physician Decision|0|||
163263824|NCT04512066|589675383|FG003|Extension Period|Other|0|||
163263825|NCT04512066|589675384|FG004|Extension Period|Other|0|||
163263826|NCT04512066|589675385|FG005|Extension Period|Other|0|||
163263827|NCT04512066|589675380|FG000|Extension Period|Physician Decision|0|||
163263828|NCT04512066|589675381|FG001|Extension Period|Physician Decision|2|||
163263829|NCT04512066|589675382|FG002|Extension Period|Physician Decision|0|||
163263830|NCT04512066|589675383|FG003|Extension Period|Physician Decision|1|||
163263831|NCT04512066|589675384|FG004|Extension Period|Physician Decision|1|||
163263832|NCT04512066|589675385|FG005|Extension Period|Physician Decision|0|||
163263833|NCT04512066|589675380|FG000|Extension Period|Withdrawal by Subject|0|||
163263834|NCT04512066|589675381|FG001|Extension Period|Withdrawal by Subject|3|||
163263835|NCT04512066|589675382|FG002|Extension Period|Withdrawal by Subject|7|||
163263836|NCT04512066|589675383|FG003|Extension Period|Withdrawal by Subject|11|||
163263837|NCT04512066|589675384|FG004|Extension Period|Withdrawal by Subject|8|||
163263838|NCT04512066|589675385|FG005|Extension Period|Withdrawal by Subject|4|||
163263839|NCT03403426|589675387|FG000|Overall Study|Death|1|||
163263840|NCT03403426|589675387|FG000|Overall Study|Lost to Follow-up|2|||
163263841|NCT01657266|589675391|FG000|Overall Study|Lost to Follow-up|2|||
163263842|NCT01657266|589675392|FG001|Overall Study|Lost to Follow-up|2|||
163263843|NCT01657266|589675391|FG000|Overall Study|Adverse Event|2|||
163263844|NCT01657266|589675392|FG001|Overall Study|Adverse Event|3|||
163263845|NCT03520400|589675393|FG000|Overall Study|Physician Decision|15|||
163263846|NCT03520400|589675394|FG001|Overall Study|Physician Decision|7|||
163263847|NCT00445679|589675395|FG000|Overall Study|Adverse Event|22|||
163263848|NCT00445679|589675396|FG001|Overall Study|Adverse Event|12|||
163263849|NCT00445679|589675397|FG002|Overall Study|Adverse Event|30|||
163263850|NCT00445679|589675398|FG003|Overall Study|Adverse Event|19|||
163263851|NCT00445679|589675395|FG000|Overall Study|Failed to return|1|||
163263852|NCT00445679|589675396|FG001|Overall Study|Failed to return|3|||
163263853|NCT00445679|589675397|FG002|Overall Study|Failed to return|2|||
163263854|NCT00445679|589675398|FG003|Overall Study|Failed to return|2|||
163153628|NCT02234843|589276356|FG006|Overall Study|Physician Decision|0|||
163153629|NCT02234843|589276357|FG007|Overall Study|Physician Decision|1|||
163153630|NCT02234843|589276358|FG008|Overall Study|Physician Decision|0|||
163153631|NCT02234843|589276359|FG009|Overall Study|Physician Decision|0|||
163263855|NCT00445679|589675395|FG000|Overall Study|Physician Decision|0|||
163263856|NCT00445679|589675396|FG001|Overall Study|Physician Decision|0|||
163263857|NCT00445679|589675397|FG002|Overall Study|Physician Decision|1|||
163263858|NCT00445679|589675398|FG003|Overall Study|Physician Decision|0|||
163263859|NCT00445679|589675395|FG000|Overall Study|Lost to Follow-up|10|||
163263860|NCT00445679|589675396|FG001|Overall Study|Lost to Follow-up|6|||
163263861|NCT00445679|589675397|FG002|Overall Study|Lost to Follow-up|6|||
163263862|NCT00445679|589675398|FG003|Overall Study|Lost to Follow-up|5|||
163263863|NCT00445679|589675395|FG000|Overall Study|Compliance|3|||
163263864|NCT00445679|589675396|FG001|Overall Study|Compliance|2|||
163153632|NCT02234843|589276350|FG000|Overall Study|Adverse Event|5|||
163153633|NCT02234843|589276351|FG001|Overall Study|Adverse Event|1|||
163263865|NCT00445679|589675397|FG002|Overall Study|Compliance|1|||
163263866|NCT00445679|589675398|FG003|Overall Study|Compliance|2|||
163263867|NCT00445679|589675395|FG000|Overall Study|Withdrawal of Informed Consent|0|||
163263868|NCT00445679|589675396|FG001|Overall Study|Withdrawal of Informed Consent|0|||
163263869|NCT00445679|589675397|FG002|Overall Study|Withdrawal of Informed Consent|1|||
163263870|NCT00445679|589675398|FG003|Overall Study|Withdrawal of Informed Consent|0|||
163263871|NCT00445679|589675395|FG000|Overall Study|Protocol Violation|2|||
163263872|NCT00445679|589675396|FG001|Overall Study|Protocol Violation|3|||
163153634|NCT02234843|589276352|FG002|Overall Study|Adverse Event|1|||
163263873|NCT00445679|589675397|FG002|Overall Study|Protocol Violation|3|||
163153635|NCT02234843|589276353|FG003|Overall Study|Adverse Event|3|||
163153636|NCT02234843|589276354|FG004|Overall Study|Adverse Event|2|||
163263874|NCT00445679|589675398|FG003|Overall Study|Protocol Violation|1|||
163263875|NCT00445679|589675395|FG000|Overall Study|Withdrawal by Subject|8|||
163263876|NCT00445679|589675396|FG001|Overall Study|Withdrawal by Subject|14|||
163263877|NCT00445679|589675397|FG002|Overall Study|Withdrawal by Subject|20|||
163263878|NCT00445679|589675398|FG003|Overall Study|Withdrawal by Subject|18|||
163263879|NCT00445679|589675395|FG000|Overall Study|Lack of Efficacy|2|||
163263880|NCT00445679|589675396|FG001|Overall Study|Lack of Efficacy|6|||
163263881|NCT00445679|589675397|FG002|Overall Study|Lack of Efficacy|2|||
163263882|NCT00445679|589675398|FG003|Overall Study|Lack of Efficacy|0|||
163263883|NCT00909428|589675402|FG000|Overall Study|Lost to Follow-up|13|||
163263884|NCT00909428|589675403|FG001|Overall Study|Lost to Follow-up|10|||
163263885|NCT00909428|589675404|FG002|Overall Study|Lost to Follow-up|9|||
163263886|NCT00116844|589675407|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
163263887|NCT00116844|589675408|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
163263888|NCT00116844|589675407|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
163263889|NCT00116844|589675408|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
163263890|NCT00116844|589675407|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
163263891|NCT00116844|589675408|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
163263892|NCT00116844|589675407|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
163263893|NCT00116844|589675408|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
163263894|NCT00116844|589675407|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
163263895|NCT00116844|589675408|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
163263896|NCT00116844|589675407|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
163263897|NCT00116844|589675408|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
163263898|NCT00116844|589675407|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
163263899|NCT00116844|589675408|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
163263900|NCT00116844|589675407|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
163263901|NCT00116844|589675408|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
163263902|NCT00116844|589675407|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
163263903|NCT00116844|589675408|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
163263904|NCT01933880|589675409|FG000|Overall Study|Withdrawal by Subject|5|||
163263905|NCT01933880|589675410|FG001|Overall Study|Withdrawal by Subject|0|||
163263906|NCT01933880|589675409|FG000|Overall Study|Lack of Efficacy|1|||
163263907|NCT01933880|589675410|FG001|Overall Study|Lack of Efficacy|0|||
163263908|NCT01933880|589675409|FG000|Overall Study|Concomitant medication Interference|0|||
163263909|NCT01933880|589675410|FG001|Overall Study|Concomitant medication Interference|1|||
163263910|NCT01933880|589675409|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
163263911|NCT01933880|589675410|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
163263912|NCT01933880|589675409|FG000|Overall Study|Other|4|||
163263913|NCT01933880|589675410|FG001|Overall Study|Other|0|||
163263914|NCT01933880|589675409|FG000|Overall Study|Protocol Violation|1|||
163263915|NCT01933880|589675410|FG001|Overall Study|Protocol Violation|0|||
163263916|NCT01125722|589675411|FG000|Overall Study|Withdrawal by Subject|2|||
163263917|NCT01125722|589675412|FG001|Overall Study|Withdrawal by Subject|1|||
163263918|NCT01125722|589675411|FG000|Overall Study|Lost to Follow-up|1|||
163263919|NCT01125722|589675412|FG001|Overall Study|Lost to Follow-up|0|||
163263920|NCT03474549|589675413|FG000|Overall Study|Death|31|||
163263921|NCT03474549|589675413|FG000|Overall Study|Lost to Follow-up|4|||
163263922|NCT03474549|589675413|FG000|Overall Study|Withdrawal by Subject|2|||
163263923|NCT00069784|589675414|FG000|Overall Study|Adverse Event|105|||
163263924|NCT00069784|589675415|FG001|Overall Study|Adverse Event|0|||
163263925|NCT00069784|589675414|FG000|Overall Study|Withdrawal by Subject|1090|||
163263926|NCT00069784|589675415|FG001|Overall Study|Withdrawal by Subject|0|||
163263927|NCT00069784|589675414|FG000|Overall Study|Other|17|||
163263928|NCT00069784|589675415|FG001|Overall Study|Other|0|||
163263929|NCT00926003|589675418|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
163263930|NCT00926003|589675419|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
163263931|NCT00926003|589675420|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
163263932|NCT00926003|589675418|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
163263933|NCT00926003|589675419|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
163263934|NCT00926003|589675420|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
163263935|NCT00709059|589675422|FG000|Overall Study|Lost to Follow-up|34|||
163263936|NCT00709059|589675422|FG000|Overall Study|Withdrawal by Subject|19|||
163263937|NCT00709059|589675422|FG000|Overall Study|Physician Decision|7|||
163263938|NCT00709059|589675422|FG000|Overall Study|Disease complication|3|||
163263939|NCT00709059|589675422|FG000|Overall Study|Side effects|20|||
163263940|NCT00709059|589675422|FG000|Overall Study|Serious side effects|11|||
163263941|NCT01786330|589675423|FG000|Overall Study|Withdrawal by Subject|0|||
163263942|NCT01786330|589675424|FG001|Overall Study|Withdrawal by Subject|1|||
163263943|NCT01786330|589675423|FG000|Overall Study|Lost to Follow-up|0|||
163362086|NCT02638103|590034696|FG001|Overall Study|Adverse Event|12|||
163362087|NCT02638103|590034697|FG002|Overall Study|Adverse Event|19|||
163362088|NCT02638103|590034698|FG003|Overall Study|Adverse Event|12|||
163362089|NCT02638103|590034695|FG000|Overall Study|Withdrawal by Subject|43|||
163362090|NCT02638103|590034696|FG001|Overall Study|Withdrawal by Subject|53|||
163362091|NCT02638103|590034697|FG002|Overall Study|Withdrawal by Subject|30|||
163362092|NCT02638103|590034698|FG003|Overall Study|Withdrawal by Subject|61|||
163263944|NCT01786330|589675424|FG001|Overall Study|Lost to Follow-up|1|||
163263945|NCT01786330|589675423|FG000|Overall Study|Excluded intraoperatively|0|||
163263946|NCT01786330|589675424|FG001|Overall Study|Excluded intraoperatively|1|||
163263947|NCT01786330|589675423|FG000|Overall Study|Protocol Violation|1|||
163362093|NCT02638103|590034695|FG000|Overall Study|Protocol Violation|1|||
163362094|NCT02638103|590034696|FG001|Overall Study|Protocol Violation|2|||
163263948|NCT01786330|589675424|FG001|Overall Study|Protocol Violation|0|||
163263949|NCT01167179|589677671|FG000|Overall Study|disease recurrence|4|||
163263950|NCT01167179|589677672|FG001|Overall Study|disease recurrence|4|||
163263951|NCT01167179|589677671|FG000|Overall Study|Death|4|||
163263952|NCT01167179|589677672|FG001|Overall Study|Death|10|||
163263953|NCT01167179|589677671|FG000|Overall Study|Withdrawal by Subject|1|||
163263954|NCT01167179|589677672|FG001|Overall Study|Withdrawal by Subject|2|||
163263955|NCT01167179|589677671|FG000|Overall Study|diverse|6|||
163263956|NCT01167179|589677672|FG001|Overall Study|diverse|5|||
163263957|NCT02769065|589677673|FG000|Overall Study|Voluntary Withdrawal|1|||
163263958|NCT02769065|589677674|FG001|Overall Study|Voluntary Withdrawal|0|||
163263959|NCT02769065|589677675|FG002|Overall Study|Voluntary Withdrawal|0|||
163263960|NCT02769065|589677676|FG003|Overall Study|Voluntary Withdrawal|0|||
163263961|NCT02769065|589677677|FG004|Overall Study|Voluntary Withdrawal|0|||
163263962|NCT02769065|589677678|FG005|Overall Study|Voluntary Withdrawal|0|||
163263963|NCT02769065|589677679|FG006|Overall Study|Voluntary Withdrawal|0|||
163263964|NCT02769065|589677680|FG007|Overall Study|Voluntary Withdrawal|0|||
163263965|NCT02769065|589677681|FG008|Overall Study|Voluntary Withdrawal|0|||
163263966|NCT02769065|589677682|FG009|Overall Study|Voluntary Withdrawal|0|||
163263967|NCT02769065|589677683|FG010|Overall Study|Voluntary Withdrawal|0|||
163263968|NCT02769065|589677684|FG011|Overall Study|Voluntary Withdrawal|0|||
163263969|NCT02769065|589677685|FG012|Overall Study|Voluntary Withdrawal|0|||
163263970|NCT02769065|589677686|FG013|Overall Study|Voluntary Withdrawal|0|||
163263971|NCT02769065|589677687|FG014|Overall Study|Voluntary Withdrawal|0|||
163263972|NCT02769065|589677688|FG015|Overall Study|Voluntary Withdrawal|0|||
163263973|NCT02769065|589677689|FG016|Overall Study|Voluntary Withdrawal|0|||
163263974|NCT02769065|589677690|FG017|Overall Study|Voluntary Withdrawal|0|||
163263975|NCT02769065|589677691|FG018|Overall Study|Voluntary Withdrawal|0|||
163263976|NCT02769065|589677692|FG019|Overall Study|Voluntary Withdrawal|0|||
163263977|NCT02769065|589677693|FG020|Overall Study|Voluntary Withdrawal|0|||
163263978|NCT02769065|589677694|FG021|Overall Study|Voluntary Withdrawal|0|||
163263979|NCT02769065|589677695|FG022|Overall Study|Voluntary Withdrawal|0|||
163263980|NCT02769065|589677696|FG023|Overall Study|Voluntary Withdrawal|0|||
163263981|NCT02769065|589677697|FG024|Overall Study|Voluntary Withdrawal|0|||
163263982|NCT02769065|589677698|FG025|Overall Study|Voluntary Withdrawal|0|||
163263983|NCT02769065|589677699|FG026|Overall Study|Voluntary Withdrawal|0|||
163263984|NCT02769065|589677700|FG027|Overall Study|Voluntary Withdrawal|0|||
163263985|NCT02769065|589677701|FG028|Overall Study|Voluntary Withdrawal|0|||
163263986|NCT02769065|589677702|FG029|Overall Study|Voluntary Withdrawal|0|||
163263987|NCT02769065|589677673|FG000|Overall Study|Reason Not Specified|0|||
163263988|NCT02769065|589677674|FG001|Overall Study|Reason Not Specified|0|||
163263989|NCT02769065|589677675|FG002|Overall Study|Reason Not Specified|0|||
163263990|NCT02769065|589677676|FG003|Overall Study|Reason Not Specified|0|||
163263991|NCT02769065|589677677|FG004|Overall Study|Reason Not Specified|0|||
163263992|NCT02769065|589677678|FG005|Overall Study|Reason Not Specified|0|||
163263993|NCT02769065|589677679|FG006|Overall Study|Reason Not Specified|1|||
163263994|NCT02769065|589677680|FG007|Overall Study|Reason Not Specified|0|||
163263995|NCT02769065|589677681|FG008|Overall Study|Reason Not Specified|0|||
163263996|NCT02769065|589677682|FG009|Overall Study|Reason Not Specified|0|||
163263997|NCT02769065|589677683|FG010|Overall Study|Reason Not Specified|0|||
163263998|NCT02769065|589677684|FG011|Overall Study|Reason Not Specified|0|||
163263999|NCT02769065|589677685|FG012|Overall Study|Reason Not Specified|0|||
163264000|NCT02769065|589677686|FG013|Overall Study|Reason Not Specified|0|||
163264001|NCT02769065|589677687|FG014|Overall Study|Reason Not Specified|0|||
163264002|NCT02769065|589677688|FG015|Overall Study|Reason Not Specified|0|||
163264003|NCT02769065|589677689|FG016|Overall Study|Reason Not Specified|0|||
163264004|NCT02769065|589677690|FG017|Overall Study|Reason Not Specified|0|||
163264005|NCT02769065|589677691|FG018|Overall Study|Reason Not Specified|0|||
163264006|NCT02769065|589677692|FG019|Overall Study|Reason Not Specified|0|||
163264007|NCT02769065|589677693|FG020|Overall Study|Reason Not Specified|0|||
163264008|NCT02769065|589677694|FG021|Overall Study|Reason Not Specified|0|||
163264009|NCT02769065|589677695|FG022|Overall Study|Reason Not Specified|0|||
163264010|NCT02769065|589677696|FG023|Overall Study|Reason Not Specified|0|||
163264011|NCT02769065|589677697|FG024|Overall Study|Reason Not Specified|0|||
163264012|NCT02769065|589677698|FG025|Overall Study|Reason Not Specified|0|||
163264013|NCT02769065|589677699|FG026|Overall Study|Reason Not Specified|0|||
163264014|NCT02769065|589677700|FG027|Overall Study|Reason Not Specified|0|||
163264015|NCT02769065|589677701|FG028|Overall Study|Reason Not Specified|0|||
163264016|NCT02769065|589677702|FG029|Overall Study|Reason Not Specified|0|||
163264017|NCT02769065|589677673|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264018|NCT02769065|589677674|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264019|NCT02769065|589677675|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264020|NCT02769065|589677676|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264021|NCT02769065|589677677|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
163362095|NCT02638103|590034697|FG002|Overall Study|Protocol Violation|1|||
163362096|NCT02638103|590034698|FG003|Overall Study|Protocol Violation|4|||
163264022|NCT02769065|589677678|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264023|NCT02769065|589677679|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264024|NCT02769065|589677680|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264025|NCT02769065|589677681|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264026|NCT02769065|589677682|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
163153637|NCT02234843|589276355|FG005|Overall Study|Adverse Event|1|||
163153638|NCT02234843|589276356|FG006|Overall Study|Adverse Event|0|||
163153639|NCT02234843|589276357|FG007|Overall Study|Adverse Event|0|||
163153640|NCT02234843|589276358|FG008|Overall Study|Adverse Event|1|||
163153641|NCT02234843|589276359|FG009|Overall Study|Adverse Event|0|||
163153642|NCT02234843|589276350|FG000|Overall Study|Non-compliance with study drug|1|||
163153643|NCT02234843|589276351|FG001|Overall Study|Non-compliance with study drug|0|||
163153644|NCT02234843|589276352|FG002|Overall Study|Non-compliance with study drug|0|||
163153645|NCT02234843|589276353|FG003|Overall Study|Non-compliance with study drug|0|||
163153646|NCT02234843|589276354|FG004|Overall Study|Non-compliance with study drug|0|||
163153647|NCT02234843|589276355|FG005|Overall Study|Non-compliance with study drug|1|||
163153648|NCT02234843|589276356|FG006|Overall Study|Non-compliance with study drug|1|||
163153649|NCT02234843|589276357|FG007|Overall Study|Non-compliance with study drug|0|||
163153650|NCT02234843|589276358|FG008|Overall Study|Non-compliance with study drug|0|||
163153651|NCT02234843|589276359|FG009|Overall Study|Non-compliance with study drug|0|||
163153652|NCT02234843|589276350|FG000|Overall Study|Lost to Follow-up|0|||
163153653|NCT02234843|589276351|FG001|Overall Study|Lost to Follow-up|1|||
163153654|NCT02234843|589276352|FG002|Overall Study|Lost to Follow-up|0|||
163153655|NCT02234843|589276353|FG003|Overall Study|Lost to Follow-up|0|||
163153656|NCT02234843|589276354|FG004|Overall Study|Lost to Follow-up|0|||
163153657|NCT02234843|589276355|FG005|Overall Study|Lost to Follow-up|0|||
163153658|NCT02234843|589276356|FG006|Overall Study|Lost to Follow-up|1|||
163153659|NCT02234843|589276357|FG007|Overall Study|Lost to Follow-up|0|||
163153660|NCT02234843|589276358|FG008|Overall Study|Lost to Follow-up|0|||
163153661|NCT02234843|589276359|FG009|Overall Study|Lost to Follow-up|0|||
163153662|NCT04272242|589276366|FG000|Overall Study|Withdrawal by Subject|3|||
163153663|NCT04272242|589276366|FG000|Overall Study|Lost to Follow-up|1|||
163153664|NCT04272242|589276366|FG000|Overall Study|Adverse Event|1|||
163153665|NCT03204188|589276370|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
163153666|NCT03204188|589276370|FG000|Immunotherapy Phase (1 Year)|Death|1|||
163153667|NCT03204188|589276370|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
163153668|NCT03204188|589276370|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
163153669|NCT00091949|589278236|FG000|Overall Study|Withdrawal by Subject|117|||
163153670|NCT00091949|589278237|FG001|Overall Study|Withdrawal by Subject|110|||
163153671|NCT00091949|589278236|FG000|Overall Study|Lost to Follow-up|58|||
163153672|NCT00091949|589278237|FG001|Overall Study|Lost to Follow-up|41|||
163153673|NCT01256788|589278240|FG000|Overall Study|Lost to Follow-up|5|||
163153674|NCT01256788|589278241|FG001|Overall Study|Lost to Follow-up|8|||
163153675|NCT01256788|589278242|FG002|Overall Study|Lost to Follow-up|3|||
163153676|NCT05966142|589278243|FG000|Overall Study|Death|3|||
163153677|NCT05966142|589278244|FG001|Overall Study|Death|3|||
163153678|NCT05966142|589278243|FG000|Overall Study|Lost to Follow-up|55|||
163153679|NCT05966142|589278244|FG001|Overall Study|Lost to Follow-up|52|||
163153680|NCT05966142|589278243|FG000|Overall Study|Physician Decision|1|||
163153681|NCT05966142|589278244|FG001|Overall Study|Physician Decision|0|||
163153682|NCT05966142|589278243|FG000|Overall Study|Withdrawal by Subject|9|||
163153683|NCT05966142|589278244|FG001|Overall Study|Withdrawal by Subject|8|||
163153684|NCT05966142|589278243|FG000|Overall Study|Duplicate Enrollment|1|||
163153685|NCT05966142|589278244|FG001|Overall Study|Duplicate Enrollment|0|||
163153686|NCT05966142|589278243|FG000|Overall Study|Study Logistical Reason|1|||
163153687|NCT05966142|589278244|FG001|Overall Study|Study Logistical Reason|0|||
163153688|NCT05966142|589278243|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
163153689|NCT05966142|589278244|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
163153690|NCT04849364|589278245|FG000|Overall Study|Eligibility criteria not meet|0|||
163153691|NCT04849364|589278246|FG001|Overall Study|Eligibility criteria not meet|1|||
163153692|NCT04849364|589278247|FG002|Overall Study|Eligibility criteria not meet|0|||
163153693|NCT00894803|589278248|FG000|Overall Study|Death|20|||
163153694|NCT00894803|589278249|FG001|Overall Study|Death|4|||
163264027|NCT02769065|589677683|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
163264028|NCT02769065|589677684|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264029|NCT02769065|589677685|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264030|NCT02769065|589677686|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
163153695|NCT00894803|589278248|FG000|Overall Study|Lost to Follow-up|0|||
163153696|NCT00894803|589278249|FG001|Overall Study|Lost to Follow-up|1|||
163153697|NCT00449696|589278256|FG000|Overall Study|Other Treatment Required|6|||
163153698|NCT00449696|589278257|FG001|Overall Study|Other Treatment Required|1|||
163153699|NCT00449696|589278256|FG000|Overall Study|Withdrawal by Subject|5|||
163153700|NCT00449696|589278257|FG001|Overall Study|Withdrawal by Subject|5|||
163153701|NCT00449696|589278256|FG000|Overall Study|Lost to Follow-up|2|||
163153702|NCT00449696|589278257|FG001|Overall Study|Lost to Follow-up|3|||
163153703|NCT00449696|589278256|FG000|Overall Study|Others|7|||
163153704|NCT00449696|589278257|FG001|Overall Study|Others|0|||
163153705|NCT00307801|589278262|FG000|Overall Study|Adverse Event|12|||
163362097|NCT02638103|590034695|FG000|Overall Study|Pregnancy|2|||
163362098|NCT02638103|590034696|FG001|Overall Study|Pregnancy|3|||
163362099|NCT02638103|590034697|FG002|Overall Study|Pregnancy|0|||
163362100|NCT02638103|590034698|FG003|Overall Study|Pregnancy|1|||
163362101|NCT02638103|590034695|FG000|Overall Study|Non-compliance to Study Procedures|2|||
163362102|NCT02638103|590034696|FG001|Overall Study|Non-compliance to Study Procedures|1|||
163362103|NCT02638103|590034697|FG002|Overall Study|Non-compliance to Study Procedures|1|||
163362104|NCT02638103|590034698|FG003|Overall Study|Non-compliance to Study Procedures|1|||
163362105|NCT02638103|590034695|FG000|Overall Study|Lost to Follow-up|26|||
163362106|NCT02638103|590034696|FG001|Overall Study|Lost to Follow-up|33|||
163362107|NCT02638103|590034697|FG002|Overall Study|Lost to Follow-up|20|||
163362108|NCT02638103|590034698|FG003|Overall Study|Lost to Follow-up|37|||
163362109|NCT02638103|590034695|FG000|Overall Study|Lack of Efficacy|14|||
163362110|NCT02638103|590034696|FG001|Overall Study|Lack of Efficacy|10|||
163362111|NCT02638103|590034697|FG002|Overall Study|Lack of Efficacy|12|||
163362112|NCT02638103|590034698|FG003|Overall Study|Lack of Efficacy|22|||
163362113|NCT02638103|590034695|FG000|Overall Study|Other than specified|5|||
163362114|NCT02638103|590034696|FG001|Overall Study|Other than specified|4|||
163362115|NCT02638103|590034697|FG002|Overall Study|Other than specified|2|||
163362116|NCT02638103|590034698|FG003|Overall Study|Other than specified|4|||
163362117|NCT04199052|590034701|FG000|Overall Study|Lost to Follow-up|11|||
163362118|NCT04199052|590034702|FG001|Overall Study|Lost to Follow-up|18|||
163362119|NCT00699842|590034703|FG000|Overall Study|Death|0|||
163362120|NCT00699842|590034704|FG001|Overall Study|Death|1|||
163362121|NCT00699842|590034705|FG002|Overall Study|Death|0|||
163362122|NCT01358331|590034706|FG000|Overall Study|Lost to Follow-up|0|||
163362123|NCT01358331|590034707|FG001|Overall Study|Lost to Follow-up|0|||
163362124|NCT01358331|590034708|FG002|Overall Study|Lost to Follow-up|0|||
163362125|NCT01358331|590034709|FG003|Overall Study|Lost to Follow-up|1|||
163362126|NCT01358331|590034710|FG004|Overall Study|Lost to Follow-up|0|||
163362127|NCT01358331|590034711|FG005|Overall Study|Lost to Follow-up|0|||
163362128|NCT01358331|590034706|FG000|Overall Study|Withdrawal by Subject|0|||
163362129|NCT01358331|590034707|FG001|Overall Study|Withdrawal by Subject|0|||
163362130|NCT01358331|590034708|FG002|Overall Study|Withdrawal by Subject|0|||
163362131|NCT01358331|590034709|FG003|Overall Study|Withdrawal by Subject|1|||
163362132|NCT01358331|590034710|FG004|Overall Study|Withdrawal by Subject|1|||
163362133|NCT01358331|590034711|FG005|Overall Study|Withdrawal by Subject|1|||
163362134|NCT01358331|590034706|FG000|Overall Study|Adverse Events|1|||
163362135|NCT01358331|590034707|FG001|Overall Study|Adverse Events|1|||
163362136|NCT01358331|590034708|FG002|Overall Study|Adverse Events|1|||
163362137|NCT01358331|590034709|FG003|Overall Study|Adverse Events|0|||
163362138|NCT01358331|590034710|FG004|Overall Study|Adverse Events|1|||
163362139|NCT01358331|590034711|FG005|Overall Study|Adverse Events|5|||
163362140|NCT01358331|590034706|FG000|Overall Study|Symptomatic Deterioration|0|||
163362141|NCT01358331|590034707|FG001|Overall Study|Symptomatic Deterioration|0|||
163362142|NCT01358331|590034708|FG002|Overall Study|Symptomatic Deterioration|0|||
163362143|NCT01358331|590034709|FG003|Overall Study|Symptomatic Deterioration|0|||
163362144|NCT01358331|590034710|FG004|Overall Study|Symptomatic Deterioration|1|||
163362145|NCT01358331|590034711|FG005|Overall Study|Symptomatic Deterioration|0|||
163362146|NCT01358331|590034706|FG000|Overall Study|Participants did not wish to continue|0|||
163153706|NCT00307801|589278263|FG001|Overall Study|Adverse Event|4|||
163153707|NCT00307801|589278262|FG000|Overall Study|Withdrawal by Subject|9|||
163153708|NCT00307801|589278263|FG001|Overall Study|Withdrawal by Subject|4|||
163153709|NCT00307801|589278262|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
163153710|NCT00307801|589278263|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
163153711|NCT00307801|589278262|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
163153712|NCT00307801|589278263|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
163153713|NCT00307801|589278262|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
163153714|NCT00307801|589278263|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
163153715|NCT00307801|589278262|FG000|Overall Study|Wrong Randomization|1|||
163153716|NCT00307801|589278263|FG001|Overall Study|Wrong Randomization|0|||
163153717|NCT00307801|589278262|FG000|Overall Study|Lack of Efficacy|0|||
163153718|NCT00307801|589278263|FG001|Overall Study|Lack of Efficacy|2|||
163153719|NCT00307801|589278262|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
163153720|NCT00307801|589278263|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
163153721|NCT00307801|589278262|FG000|Overall Study|Frustration with e-diary|1|||
163153722|NCT00307801|589278263|FG001|Overall Study|Frustration with e-diary|0|||
163153723|NCT00307801|589278262|FG000|Overall Study|Protocol Violation|3|||
163153724|NCT00307801|589278263|FG001|Overall Study|Protocol Violation|2|||
163153725|NCT00307801|589278262|FG000|Overall Study|No reason specified|2|||
163153726|NCT00307801|589278263|FG001|Overall Study|No reason specified|0|||
163153727|NCT00307801|589278262|FG000|Overall Study|Pregnancy|0|||
163153728|NCT00307801|589278263|FG001|Overall Study|Pregnancy|1|||
163153729|NCT01217229|589278271|FG000|Overall Study|Adverse Event|1|||
163362147|NCT01358331|590034707|FG001|Overall Study|Participants did not wish to continue|0|||
163264031|NCT02769065|589677687|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264032|NCT02769065|589677688|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264033|NCT02769065|589677689|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264034|NCT02769065|589677690|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264035|NCT02769065|589677691|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264036|NCT02769065|589677692|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264037|NCT02769065|589677693|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264038|NCT02769065|589677694|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264039|NCT02769065|589677695|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264040|NCT02769065|589677696|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264041|NCT02769065|589677697|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264042|NCT02769065|589677698|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264043|NCT02769065|589677699|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264044|NCT02769065|589677700|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264045|NCT02769065|589677701|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264046|NCT02769065|589677702|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
163264047|NCT03017235|589677703|FG000|Overall Study|Withdrawal by Subject|4|||
163264048|NCT03017235|589677704|FG001|Overall Study|Withdrawal by Subject|3|||
163264049|NCT03017235|589677703|FG000|Overall Study|Lost to Follow-up|2|||
163264050|NCT03017235|589677704|FG001|Overall Study|Lost to Follow-up|7|||
163264051|NCT03017235|589677703|FG000|Overall Study|Adverse Event|0|||
163264052|NCT03017235|589677704|FG001|Overall Study|Adverse Event|1|||
163264053|NCT03017235|589677703|FG000|Overall Study|Protocol Violation|2|||
163264054|NCT03017235|589677704|FG001|Overall Study|Protocol Violation|1|||
163264055|NCT03017235|589677703|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
163264056|NCT03017235|589677704|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
163264057|NCT01478113|589677707|FG000|Overall Study|Withdrawal by Subject|0|||
163264058|NCT01478113|589677708|FG001|Overall Study|Withdrawal by Subject|1|||
163264059|NCT01478113|589677707|FG000|Overall Study|Physician Decision|1|||
163264060|NCT01478113|589677708|FG001|Overall Study|Physician Decision|0|||
163264061|NCT00289770|589677709|FG000|Year 15|Withdrawal by Subject|1|||
163264062|NCT02966002|589677716|FG000|Overall Study|Withdrawal by Subject|2|||
163264063|NCT02966002|589677716|FG000|Overall Study|Adverse Event|1|||
163264064|NCT02966002|589677716|FG000|Overall Study|Lost to Follow-up|1|||
163264065|NCT00067990|589677717|FG000|Overall Study|Death|5|||
163264066|NCT00067990|589677718|FG001|Overall Study|Death|7|||
163264067|NCT00067990|589677717|FG000|Overall Study|ESRD, Non IF/TA|1|||
163264068|NCT00067990|589677718|FG001|Overall Study|ESRD, Non IF/TA|3|||
163264069|NCT00067990|589677717|FG000|Overall Study|Withdrawal by Subject|4|||
163264070|NCT00067990|589677718|FG001|Overall Study|Withdrawal by Subject|12|||
163264071|NCT02291432|589677719|FG000|Overall Study|Withdrawal by Subject|2|||
163264072|NCT02145078|589677720|FG000|Overall Study|Death|1|||
163264073|NCT02145078|589677720|FG000|Overall Study|Reason not given|3|||
163264074|NCT01350141|589677721|FG000|Overall Study|Lost to Follow-up|1|||
163264075|NCT01350141|589677722|FG001|Overall Study|Lost to Follow-up|0|||
163264076|NCT01350141|589677723|FG002|Overall Study|Lost to Follow-up|1|||
163264077|NCT01350141|589677721|FG000|Overall Study|Withdrawal by Subject|1|||
163264078|NCT01350141|589677722|FG001|Overall Study|Withdrawal by Subject|0|||
163264079|NCT01350141|589677723|FG002|Overall Study|Withdrawal by Subject|0|||
163264080|NCT01350141|589677721|FG000|Overall Study|Randomized but not treated|1|||
163264081|NCT01350141|589677722|FG001|Overall Study|Randomized but not treated|0|||
163264082|NCT01350141|589677723|FG002|Overall Study|Randomized but not treated|0|||
163264083|NCT00810082|589677724|FG000|Overall Study|Lost to Follow-up|0|||
163264084|NCT00810082|589677725|FG001|Overall Study|Lost to Follow-up|4|||
163264085|NCT01454830|589677728|FG000|Overall Study|Withdrawal by Subject|4|||
163264086|NCT01454830|589677729|FG001|Overall Study|Withdrawal by Subject|4|||
163264087|NCT01454830|589677728|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
163264088|NCT01454830|589677729|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
163264089|NCT01454830|589677728|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
163264090|NCT01454830|589677729|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
163264091|NCT01454830|589677728|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
163264092|NCT01454830|589677729|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
163264093|NCT01454830|589677728|FG000|Overall Study|Withdrawal - no polysomnography|3|||
163264094|NCT01454830|589677729|FG001|Overall Study|Withdrawal - no polysomnography|2|||
163264095|NCT03810313|589677730|FG000|Overall Study|Study terminated by sponsor|164|||
163264096|NCT03810313|589677731|FG001|Overall Study|Study terminated by sponsor|159|||
163264097|NCT03810313|589677730|FG000|Overall Study|Subject decision|10|||
163264098|NCT03810313|589677731|FG001|Overall Study|Subject decision|11|||
163264099|NCT03810313|589677730|FG000|Overall Study|Lost to Follow-up|3|||
163264100|NCT03810313|589677731|FG001|Overall Study|Lost to Follow-up|3|||
163264101|NCT03810313|589677730|FG000|Overall Study|Adverse Event|2|||
163264102|NCT03810313|589677731|FG001|Overall Study|Adverse Event|1|||
163264103|NCT03810313|589677730|FG000|Overall Study|Death|2|||
163264104|NCT03810313|589677731|FG001|Overall Study|Death|1|||
163264105|NCT03810313|589677730|FG000|Overall Study|Physician Decision|0|||
163264106|NCT03810313|589677731|FG001|Overall Study|Physician Decision|1|||
163264107|NCT00584805|589677732|FG000|Overall Study|No longer at risk of exposure|39|||
163264108|NCT00584805|589677732|FG000|Overall Study|Relocation|36|||
163264109|NCT00584805|589677732|FG000|Overall Study|Withdrawal by Subject|18|||
163264110|NCT00584805|589677732|FG000|Overall Study|Non-compliance|1|||
163264111|NCT00584805|589677732|FG000|Overall Study|Lost to follow up|3|||
163264112|NCT00584805|589677732|FG000|Overall Study|Screen failures|2|||
163264113|NCT02341456|589677736|FG000|Overall Study|Disease progression|2|||
163264114|NCT02341456|589677737|FG001|Overall Study|Disease progression|3|||
163264115|NCT02341456|589677738|FG002|Overall Study|Disease progression|1|||
163264116|NCT02341456|589677736|FG000|Overall Study|Death|1|||
163264117|NCT02341456|589677737|FG001|Overall Study|Death|1|||
163264118|NCT02341456|589677738|FG002|Overall Study|Death|1|||
163264119|NCT02341456|589677736|FG000|Overall Study|Withdrawal by Subject|0|||
163264120|NCT02341456|589677737|FG001|Overall Study|Withdrawal by Subject|1|||
163264121|NCT02341456|589677738|FG002|Overall Study|Withdrawal by Subject|1|||
163264122|NCT02341456|589677736|FG000|Overall Study|Moved to local access programme.|0|||
163264123|NCT02341456|589677737|FG001|Overall Study|Moved to local access programme.|1|||
163264124|NCT02341456|589677738|FG002|Overall Study|Moved to local access programme.|1|||
163264125|NCT02341456|589677736|FG000|Overall Study|Physician Decision|1|||
163264126|NCT02341456|589677737|FG001|Overall Study|Physician Decision|0|||
163264127|NCT02341456|589677738|FG002|Overall Study|Physician Decision|0|||
163264128|NCT01077362|589677739|FG000|Overall Study|Lack of Efficacy|13|||
163264129|NCT01077362|589677740|FG001|Overall Study|Lack of Efficacy|8|||
163264130|NCT01077362|589677741|FG002|Overall Study|Lack of Efficacy|10|||
163264131|NCT01077362|589677739|FG000|Overall Study|Lost to Follow-up|1|||
163264132|NCT01077362|589677740|FG001|Overall Study|Lost to Follow-up|0|||
163264133|NCT01077362|589677741|FG002|Overall Study|Lost to Follow-up|3|||
163264134|NCT01077362|589677739|FG000|Overall Study|Adverse Event|12|||
163264135|NCT01077362|589677740|FG001|Overall Study|Adverse Event|7|||
163264136|NCT01077362|589677741|FG002|Overall Study|Adverse Event|4|||
163264137|NCT01077362|589677739|FG000|Overall Study|Withdrawal by Subject|5|||
163264138|NCT01077362|589677740|FG001|Overall Study|Withdrawal by Subject|3|||
163264139|NCT01077362|589677741|FG002|Overall Study|Withdrawal by Subject|5|||
163264140|NCT01077362|589677739|FG000|Overall Study|Other|0|||
163264141|NCT01077362|589677740|FG001|Overall Study|Other|1|||
163264142|NCT01077362|589677741|FG002|Overall Study|Other|2|||
163264143|NCT00301080|589677745|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
163264144|NCT00301080|589677746|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
163264145|NCT00301080|589677747|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
163264146|NCT00301080|589677748|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
163264147|NCT00301080|589677749|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
163264148|NCT02768662|589677752|FG000|Overall Study|Adverse Event|1|||
163264149|NCT02768662|589677752|FG000|Overall Study|Lost to Follow-up|4|||
163264150|NCT02768662|589677752|FG000|Overall Study|Withdrawal by Subject|3|||
163264151|NCT02768662|589677752|FG000|Overall Study|Study terminated by Sponsor|78|||
163264152|NCT02567825|589677757|FG000|Overall Study|No follow-up post-randomization|5|||
163264153|NCT02567825|589677758|FG001|Overall Study|No follow-up post-randomization|1|||
163264154|NCT02567825|589677757|FG000|Overall Study|Follow-up less than 23 months|16|||
163264155|NCT02567825|589677758|FG001|Overall Study|Follow-up less than 23 months|20|||
163264156|NCT03097861|589677765|FG000|Overall Study|Adverse Event|3|||
163264157|NCT03097861|589677766|FG001|Overall Study|Adverse Event|8|||
163264158|NCT03097861|589677767|FG002|Overall Study|Adverse Event|4|||
163264159|NCT03097861|589677765|FG000|Overall Study|Investigator Decision|0|||
163264160|NCT03097861|589677766|FG001|Overall Study|Investigator Decision|1|||
163264161|NCT03097861|589677767|FG002|Overall Study|Investigator Decision|0|||
163264162|NCT03097861|589677765|FG000|Overall Study|Lost to Follow-up|0|||
163264163|NCT03097861|589677766|FG001|Overall Study|Lost to Follow-up|7|||
163264164|NCT03097861|589677767|FG002|Overall Study|Lost to Follow-up|1|||
163264165|NCT03097861|589677765|FG000|Overall Study|Withdrawal by Subject|1|||
163264166|NCT03097861|589677766|FG001|Overall Study|Withdrawal by Subject|5|||
163264167|NCT03097861|589677767|FG002|Overall Study|Withdrawal by Subject|3|||
163264168|NCT03097861|589677765|FG000|Overall Study|Reason not provided|3|||
163264169|NCT03097861|589677766|FG001|Overall Study|Reason not provided|1|||
163264170|NCT03097861|589677767|FG002|Overall Study|Reason not provided|1|||
163264171|NCT05061537|589677769|FG000|Treatment Phase|Progressive disease|0|||
163264172|NCT05061537|589677770|FG001|Treatment Phase|Progressive disease|1|||
163264173|NCT05061537|589677771|FG002|Treatment Phase|Progressive disease|2|||
163264174|NCT05061537|589677772|FG003|Treatment Phase|Progressive disease|0|||
163264175|NCT05061537|589677773|FG004|Treatment Phase|Progressive disease|0|||
163264176|NCT05061537|589677769|FG000|Treatment Phase|Adverse Event|0|||
163264177|NCT05061537|589677770|FG001|Treatment Phase|Adverse Event|0|||
163264178|NCT05061537|589677771|FG002|Treatment Phase|Adverse Event|2|||
163264179|NCT05061537|589677772|FG003|Treatment Phase|Adverse Event|0|||
163264180|NCT05061537|589677773|FG004|Treatment Phase|Adverse Event|0|||
163264181|NCT05061537|589677769|FG000|Treatment Phase|Global deterioration of health status|0|||
163264182|NCT05061537|589677770|FG001|Treatment Phase|Global deterioration of health status|1|||
163264183|NCT05061537|589677771|FG002|Treatment Phase|Global deterioration of health status|0|||
163264184|NCT05061537|589677772|FG003|Treatment Phase|Global deterioration of health status|0|||
163264185|NCT05061537|589677773|FG004|Treatment Phase|Global deterioration of health status|0|||
163264186|NCT05061537|589677769|FG000|Follow up|Other|2|||
163264187|NCT05061537|589677770|FG001|Follow up|Other|0|||
163264188|NCT05061537|589677771|FG002|Follow up|Other|2|||
163264189|NCT05061537|589677772|FG003|Follow up|Other|0|||
163264190|NCT05061537|589677773|FG004|Follow up|Other|0|||
163264191|NCT05061537|589677769|FG000|Follow up|Study terminated by sponsor|0|||
163264192|NCT05061537|589677770|FG001|Follow up|Study terminated by sponsor|0|||
163264193|NCT05061537|589677771|FG002|Follow up|Study terminated by sponsor|2|||
163153730|NCT01217229|589278271|FG000|Overall Study|Disease progression, deterioration|2|||
163153731|NCT01217229|589278271|FG000|Overall Study|Disease progression, Cheson criteria|14|||
163264194|NCT05061537|589677772|FG003|Follow up|Study terminated by sponsor|0|||
163153732|NCT01217229|589278271|FG000|Overall Study|Protocol Violation|1|||
163153733|NCT01217229|589278271|FG000|Overall Study|Disease progression not confirmed|2|||
163153734|NCT00577889|589278274|FG000|Overall Study|Withdrawal by Subject|1|||
163153735|NCT00577889|589278275|FG001|Overall Study|Withdrawal by Subject|0|||
163153736|NCT00577889|589278276|FG002|Overall Study|Withdrawal by Subject|0|||
163153737|NCT01523756|589278278|FG000|Baseline Period|Adverse Event|0|||
163153738|NCT01523756|589278279|FG001|Baseline Period|Adverse Event|1|||
163153739|NCT01523756|589278278|FG000|Test Period 1|Adverse Event|1|||
163153740|NCT01523756|589278279|FG001|Test Period 1|Adverse Event|0|||
163153741|NCT01523756|589278278|FG000|Test Period 2|Withdrawal by Subject|0|||
163153742|NCT01523756|589278279|FG001|Test Period 2|Withdrawal by Subject|1|||
163153743|NCT03224819|589278282|FG000|Overall Study|Withdrawal by Subject|0|||
163153744|NCT03224819|589278283|FG001|Overall Study|Withdrawal by Subject|0|||
163153745|NCT03224819|589278284|FG002|Overall Study|Withdrawal by Subject|0|||
163153746|NCT03224819|589278285|FG003|Overall Study|Withdrawal by Subject|0|||
163153747|NCT03224819|589278286|FG004|Overall Study|Withdrawal by Subject|0|||
163153748|NCT03224819|589278287|FG005|Overall Study|Withdrawal by Subject|0|||
163153749|NCT03224819|589278288|FG006|Overall Study|Withdrawal by Subject|0|||
163153750|NCT03224819|589278289|FG007|Overall Study|Withdrawal by Subject|0|||
163153751|NCT03224819|589278290|FG008|Overall Study|Withdrawal by Subject|0|||
163153752|NCT03224819|589278291|FG009|Overall Study|Withdrawal by Subject|0|||
163153753|NCT03224819|589278292|FG010|Overall Study|Withdrawal by Subject|0|||
163153754|NCT03224819|589278293|FG011|Overall Study|Withdrawal by Subject|0|||
163153755|NCT03224819|589278294|FG012|Overall Study|Withdrawal by Subject|1|||
163153756|NCT03224819|589278295|FG013|Overall Study|Withdrawal by Subject|0|||
163153757|NCT03224819|589278282|FG000|Overall Study|Sponsor Decision|0|||
163153758|NCT03224819|589278283|FG001|Overall Study|Sponsor Decision|0|||
163153759|NCT03224819|589278284|FG002|Overall Study|Sponsor Decision|0|||
163153760|NCT03224819|589278285|FG003|Overall Study|Sponsor Decision|1|||
163264195|NCT05061537|589677773|FG004|Follow up|Study terminated by sponsor|0|||
163264196|NCT05061537|589677769|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
163264197|NCT05061537|589677770|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
163264198|NCT05061537|589677771|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
163264199|NCT05061537|589677772|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
163264200|NCT05061537|589677773|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
163264201|NCT05061537|589677769|FG000|Long-term Follow-up|Death|0|||
163264202|NCT05061537|589677770|FG001|Long-term Follow-up|Death|1|||
163264203|NCT05061537|589677771|FG002|Long-term Follow-up|Death|0|||
163264204|NCT05061537|589677772|FG003|Long-term Follow-up|Death|0|||
163264205|NCT05061537|589677773|FG004|Long-term Follow-up|Death|0|||
163264206|NCT03502616|589677774|FG000|Up to Week 16|Withdrawal by Subject|1|||
163264207|NCT03502616|589677775|FG001|Up to Week 16|Withdrawal by Subject|2|||
163264208|NCT03502616|589677774|FG000|Up to Week 16|Lost to Follow-up|0|||
163264209|NCT03502616|589677775|FG001|Up to Week 16|Lost to Follow-up|1|||
163264210|NCT03502616|589677774|FG000|Up to Week 16|Randomized, but not treated|1|||
163264211|NCT03502616|589677775|FG001|Up to Week 16|Randomized, but not treated|0|||
163264212|NCT03502616|589677774|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
163264213|NCT03502616|589677775|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
163264214|NCT03502616|589677774|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
163264215|NCT03502616|589677775|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
163264216|NCT04503096|589677776|FG000|Overall Study|Withdrawal by Subject|3|||
163264217|NCT01785563|589677777|FG000|Overall Study|Physician Decision|10|||
163153761|NCT03224819|589278286|FG004|Overall Study|Sponsor Decision|1|||
163153762|NCT03224819|589278287|FG005|Overall Study|Sponsor Decision|2|||
163264218|NCT01785563|589677777|FG000|Overall Study|Withdrawal by Subject|1|||
163153763|NCT03224819|589278288|FG006|Overall Study|Sponsor Decision|1|||
163264219|NCT01785563|589677777|FG000|Overall Study|Protocol Violation|2|||
163264220|NCT01872910|589677778|FG000|Overall Study|Lost to Follow-up|2|||
163264221|NCT01872910|589677779|FG001|Overall Study|Lost to Follow-up|0|||
163264222|NCT01872910|589677780|FG002|Overall Study|Lost to Follow-up|2|||
163264223|NCT01872910|589677781|FG003|Overall Study|Lost to Follow-up|0|||
163264224|NCT01872910|589677782|FG004|Overall Study|Lost to Follow-up|0|||
163264225|NCT01872910|589677783|FG005|Overall Study|Lost to Follow-up|0|||
163264226|NCT00744328|589677786|FG000|Overall Study|Lost to Follow-up|2|||
163264227|NCT00744328|589677787|FG001|Overall Study|Lost to Follow-up|5|||
163264228|NCT00744328|589677788|FG002|Overall Study|Lost to Follow-up|3|||
163264229|NCT00744328|589677786|FG000|Overall Study|Withdrawal by Subject|5|||
163264230|NCT00744328|589677787|FG001|Overall Study|Withdrawal by Subject|3|||
163264231|NCT00744328|589677788|FG002|Overall Study|Withdrawal by Subject|4|||
163264232|NCT00744328|589677786|FG000|Overall Study|Found ineligible after randomization|0|||
163264233|NCT00744328|589677787|FG001|Overall Study|Found ineligible after randomization|0|||
163264234|NCT00744328|589677788|FG002|Overall Study|Found ineligible after randomization|1|||
163264235|NCT01576367|589677789|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163264236|NCT01576367|589677789|FG000|Overall Study|Moved to commercial use after 6 months|1|||
163264237|NCT02387216|589677793|FG000|Overall Study|Progressive disease|2|||
163264238|NCT02387216|589677794|FG001|Overall Study|Progressive disease|0|||
163264239|NCT02387216|589677793|FG000|Overall Study|Withdrawal by Subject|3|||
163264240|NCT02387216|589677794|FG001|Overall Study|Withdrawal by Subject|5|||
163264241|NCT02387216|589677793|FG000|Overall Study|Physician Decision|2|||
163264242|NCT02387216|589677794|FG001|Overall Study|Physician Decision|0|||
163264243|NCT02387216|589677793|FG000|Overall Study|Sponsor Decision|28|||
163264244|NCT02387216|589677794|FG001|Overall Study|Sponsor Decision|12|||
163264245|NCT02387216|589677793|FG000|Overall Study|Death|60|||
163264246|NCT02387216|589677794|FG001|Overall Study|Death|23|||
163264247|NCT02387216|589677793|FG000|Overall Study|Other|5|||
163264248|NCT02387216|589677794|FG001|Overall Study|Other|4|||
163264249|NCT02387216|589677793|FG000|Overall Study|Lost to Follow-up|0|||
163264250|NCT02387216|589677794|FG001|Overall Study|Lost to Follow-up|3|||
163264251|NCT02091739|589677795|FG000|MP: 16 Weeks|Adverse Event|1|||
163264252|NCT02091739|589677796|FG001|MP: 16 Weeks|Adverse Event|1|||
163264253|NCT02091739|589677797|FG002|MP: 16 Weeks|Adverse Event|1|||
163264254|NCT02091739|589677798|FG003|MP: 16 Weeks|Adverse Event|0|||
163264255|NCT02091739|589677799|FG004|MP: 16 Weeks|Adverse Event|0|||
163264256|NCT02091739|589677795|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
163264257|NCT02091739|589677796|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
163264258|NCT02091739|589677797|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
163264259|NCT02091739|589677798|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
163264260|NCT02091739|589677799|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
163264261|NCT02091739|589677795|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
163264262|NCT02091739|589677796|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
163264263|NCT02091739|589677797|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
163264264|NCT02091739|589677798|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
163264265|NCT02091739|589677799|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
163264266|NCT02091739|589677795|FG000|EP: 48 Weeks|Other|0|||
163264267|NCT02091739|589677796|FG001|EP: 48 Weeks|Other|0|||
163264268|NCT02091739|589677797|FG002|EP: 48 Weeks|Other|0|||
163264269|NCT02091739|589677798|FG003|EP: 48 Weeks|Other|1|||
163264270|NCT02091739|589677799|FG004|EP: 48 Weeks|Other|0|||
163264271|NCT02091739|589677795|FG000|EP: 48 Weeks|Death|0|||
163264272|NCT02091739|589677796|FG001|EP: 48 Weeks|Death|0|||
163264273|NCT02091739|589677797|FG002|EP: 48 Weeks|Death|0|||
163264274|NCT02091739|589677798|FG003|EP: 48 Weeks|Death|3|||
163264275|NCT02091739|589677799|FG004|EP: 48 Weeks|Death|2|||
163264276|NCT02091739|589677795|FG000|EP: 48 Weeks|Adverse Event|0|||
163264277|NCT02091739|589677796|FG001|EP: 48 Weeks|Adverse Event|0|||
163264278|NCT02091739|589677797|FG002|EP: 48 Weeks|Adverse Event|0|||
163264279|NCT02091739|589677798|FG003|EP: 48 Weeks|Adverse Event|2|||
163264280|NCT02091739|589677799|FG004|EP: 48 Weeks|Adverse Event|6|||
163264281|NCT02091739|589677795|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
163264282|NCT02091739|589677796|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
163264283|NCT02091739|589677797|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
163264284|NCT02091739|589677798|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
163264285|NCT02091739|589677799|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
163264286|NCT03528174|589677800|FG000|Overall Study|Adverse Event|1|||
163264287|NCT03528174|589677800|FG000|Overall Study|sensors dislodged|1|||
163264288|NCT04251065|589677801|FG000|Overall Study|Death|2|||
163362148|NCT01358331|590034708|FG002|Overall Study|Participants did not wish to continue|0|||
163264289|NCT04251065|589677801|FG000|Overall Study|Lack of Efficacy|3|||
163264290|NCT04251065|589677801|FG000|Overall Study|Death|1|||
163264291|NCT01778556|589677802|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
163264292|NCT01778556|589677803|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
163264293|NCT01778556|589677802|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
163264294|NCT01778556|589677803|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
163264295|NCT01778556|589677802|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
163264296|NCT01778556|589677803|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
163264297|NCT01778556|589677802|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
163264298|NCT01778556|589677803|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
163264299|NCT00576732|589677804|FG000|DOUBLE BLIND|Adverse Event|0|||
163264300|NCT00576732|589677805|FG001|DOUBLE BLIND|Adverse Event|0|||
163264301|NCT00576732|589677806|FG002|DOUBLE BLIND|Adverse Event|1|||
163264302|NCT00576732|589677807|FG003|DOUBLE BLIND|Adverse Event|0|||
163264303|NCT00576732|589677808|FG004|DOUBLE BLIND|Adverse Event|0|||
163264304|NCT00576732|589677809|FG005|DOUBLE BLIND|Adverse Event|0|||
163264305|NCT00576732|589677804|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
163264306|NCT00576732|589677805|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
163264307|NCT00576732|589677806|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
163264308|NCT00576732|589677807|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
163264309|NCT00576732|589677808|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
163264310|NCT00576732|589677809|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
163264311|NCT00576732|589677804|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
163264312|NCT00576732|589677805|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
163264313|NCT00576732|589677806|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
163264314|NCT00576732|589677807|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
163264315|NCT00576732|589677808|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
163264316|NCT00576732|589677809|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
163264317|NCT00576732|589677804|FG000|DOUBLE BLIND|OTHER|0|||
163264318|NCT00576732|589677805|FG001|DOUBLE BLIND|OTHER|2|||
163264319|NCT00576732|589677806|FG002|DOUBLE BLIND|OTHER|1|||
163264320|NCT00576732|589677807|FG003|DOUBLE BLIND|OTHER|0|||
163264321|NCT00576732|589677808|FG004|DOUBLE BLIND|OTHER|0|||
163264322|NCT00576732|589677809|FG005|DOUBLE BLIND|OTHER|0|||
163264323|NCT00576732|589677804|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
163264324|NCT00576732|589677805|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
163264325|NCT00576732|589677806|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
163264326|NCT00576732|589677807|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
163264327|NCT00576732|589677808|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
163264328|NCT00576732|589677809|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
163264329|NCT00576732|589677804|FG000|DOUBLE BLIND|Protocol Violation|1|||
163264330|NCT00576732|589677805|FG001|DOUBLE BLIND|Protocol Violation|0|||
163264331|NCT00576732|589677806|FG002|DOUBLE BLIND|Protocol Violation|0|||
163264332|NCT00576732|589677807|FG003|DOUBLE BLIND|Protocol Violation|0|||
163264333|NCT00576732|589677808|FG004|DOUBLE BLIND|Protocol Violation|0|||
163264334|NCT00576732|589677809|FG005|DOUBLE BLIND|Protocol Violation|0|||
163264335|NCT00576732|589677804|FG000|OPEN LABEL|Adverse Event|0|||
163264336|NCT00576732|589677805|FG001|OPEN LABEL|Adverse Event|0|||
163264337|NCT00576732|589677806|FG002|OPEN LABEL|Adverse Event|0|||
163264338|NCT00576732|589677807|FG003|OPEN LABEL|Adverse Event|4|||
163264339|NCT00576732|589677808|FG004|OPEN LABEL|Adverse Event|0|||
163264340|NCT00576732|589677809|FG005|OPEN LABEL|Adverse Event|1|||
163264341|NCT00576732|589677804|FG000|OPEN LABEL|Lost to Follow-up|0|||
163264342|NCT00576732|589677805|FG001|OPEN LABEL|Lost to Follow-up|0|||
163264343|NCT00576732|589677806|FG002|OPEN LABEL|Lost to Follow-up|0|||
163264344|NCT00576732|589677807|FG003|OPEN LABEL|Lost to Follow-up|2|||
163264345|NCT00576732|589677808|FG004|OPEN LABEL|Lost to Follow-up|1|||
163264346|NCT00576732|589677809|FG005|OPEN LABEL|Lost to Follow-up|1|||
163264347|NCT00576732|589677804|FG000|OPEN LABEL|Withdrawal by Subject|0|||
163264348|NCT00576732|589677805|FG001|OPEN LABEL|Withdrawal by Subject|0|||
163264349|NCT00576732|589677806|FG002|OPEN LABEL|Withdrawal by Subject|0|||
163264350|NCT00576732|589677807|FG003|OPEN LABEL|Withdrawal by Subject|1|||
163264351|NCT00576732|589677808|FG004|OPEN LABEL|Withdrawal by Subject|0|||
163264352|NCT00576732|589677809|FG005|OPEN LABEL|Withdrawal by Subject|1|||
163264353|NCT00576732|589677804|FG000|OPEN LABEL|OTHER|0|||
163264354|NCT00576732|589677805|FG001|OPEN LABEL|OTHER|0|||
163264355|NCT00576732|589677806|FG002|OPEN LABEL|OTHER|0|||
163264356|NCT00576732|589677807|FG003|OPEN LABEL|OTHER|0|||
163264357|NCT00576732|589677808|FG004|OPEN LABEL|OTHER|0|||
163264358|NCT00576732|589677809|FG005|OPEN LABEL|OTHER|2|||
163264359|NCT00576732|589677804|FG000|OPEN LABEL|Lack of Efficacy|0|||
163264360|NCT00576732|589677805|FG001|OPEN LABEL|Lack of Efficacy|0|||
163264361|NCT00576732|589677806|FG002|OPEN LABEL|Lack of Efficacy|0|||
163362149|NCT01358331|590034709|FG003|Overall Study|Participants did not wish to continue|0|||
163362150|NCT01358331|590034710|FG004|Overall Study|Participants did not wish to continue|1|||
163362151|NCT01358331|590034711|FG005|Overall Study|Participants did not wish to continue|0|||
163362152|NCT01358331|590034706|FG000|Overall Study|Progress of disease under investigation|1|||
163362153|NCT01358331|590034707|FG001|Overall Study|Progress of disease under investigation|2|||
163362154|NCT01358331|590034708|FG002|Overall Study|Progress of disease under investigation|3|||
163362155|NCT01358331|590034709|FG003|Overall Study|Progress of disease under investigation|1|||
163264362|NCT00576732|589677807|FG003|OPEN LABEL|Lack of Efficacy|2|||
163264363|NCT00576732|589677808|FG004|OPEN LABEL|Lack of Efficacy|2|||
163362156|NCT01358331|590034710|FG004|Overall Study|Progress of disease under investigation|3|||
163362157|NCT01358331|590034711|FG005|Overall Study|Progress of disease under investigation|0|||
163362158|NCT04946942|590034712|FG000|Overall Study|Lost to Follow-up|6|||
163264364|NCT00576732|589677809|FG005|OPEN LABEL|Lack of Efficacy|3|||
163264365|NCT00576732|589677804|FG000|OPEN LABEL|Protocol Violation|0|||
163264366|NCT00576732|589677805|FG001|OPEN LABEL|Protocol Violation|0|||
163264367|NCT00576732|589677806|FG002|OPEN LABEL|Protocol Violation|0|||
163264368|NCT00576732|589677807|FG003|OPEN LABEL|Protocol Violation|2|||
163264369|NCT00576732|589677808|FG004|OPEN LABEL|Protocol Violation|1|||
163264370|NCT00576732|589677809|FG005|OPEN LABEL|Protocol Violation|0|||
163264371|NCT00265330|589677810|FG000|Overall Study|Adverse Event|41|||
163264372|NCT00265330|589677810|FG000|Overall Study|Lost to Follow-up|8|||
163264373|NCT00265330|589677810|FG000|Overall Study|Withdrawal by Subject|34|||
163264374|NCT00265330|589677810|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
163264375|NCT00265330|589677810|FG000|Overall Study|Lack of Efficacy|4|||
163264376|NCT00265330|589677810|FG000|Overall Study|Family Scheduling Conflicts|1|||
163264377|NCT00265330|589677810|FG000|Overall Study|Began Taking Formulary Geodon|1|||
163264378|NCT00265330|589677810|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
163264379|NCT00265330|589677810|FG000|Overall Study|Site Closed by Sponsor|1|||
163264380|NCT00265330|589677810|FG000|Overall Study|Principal Investigators Request|1|||
163264381|NCT00265330|589677810|FG000|Overall Study|Withdrew Consent|1|||
163264382|NCT00265330|589677810|FG000|Overall Study|Protocol Violation|1|||
163264383|NCT02178566|589677818|FG000|Overall Study|patient did not complete due to noncompliance|0|||
163264384|NCT02178566|589677819|FG001|Overall Study|patient did not complete due to noncompliance|1|||
163264385|NCT02658630|589677820|FG000|Overall Study|Withdrawal by Subject|4|||
163264386|NCT00085202|589677821|FG000|Overall Study|Still on therapy|2|||
163264387|NCT00085202|589677822|FG001|Overall Study|Still on therapy|0|||
163264388|NCT00085202|589677821|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
163264389|NCT00085202|589677822|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
163264390|NCT00085202|589677821|FG000|Overall Study|Excessive toxicity|6|||
163264391|NCT00085202|589677822|FG001|Overall Study|Excessive toxicity|5|||
163264392|NCT00085202|589677821|FG000|Overall Study|Non-specified|3|||
163264393|NCT00085202|589677822|FG001|Overall Study|Non-specified|5|||
163264394|NCT00085202|589677821|FG000|Overall Study|Withdrawal by Subject|2|||
163264395|NCT00085202|589677822|FG001|Overall Study|Withdrawal by Subject|1|||
163264396|NCT00085202|589677821|FG000|Overall Study|Physician Decision|4|||
163264397|NCT00085202|589677822|FG001|Overall Study|Physician Decision|1|||
163264398|NCT00085202|589677821|FG000|Overall Study|Progressive disease|1|||
163264399|NCT00085202|589677822|FG001|Overall Study|Progressive disease|11|||
163264400|NCT01436201|589677824|FG000|Overall Study|Adverse Event|2|||
163264401|NCT01436201|589677824|FG000|Overall Study|Withdrawal by Subject|1|||
163264402|NCT01436201|589677824|FG000|Overall Study|Protocol Violation|1|||
163264403|NCT00110890|589677825|FG000|Overall Study|Adverse Event|30|||
163264404|NCT00110890|589677826|FG001|Overall Study|Adverse Event|7|||
163264405|NCT00110890|589677825|FG000|Overall Study|Death|16|||
163264406|NCT00110890|589677826|FG001|Overall Study|Death|9|||
163264407|NCT00110890|589677825|FG000|Overall Study|Lost to Follow-up|3|||
163264408|NCT00110890|589677826|FG001|Overall Study|Lost to Follow-up|1|||
163264409|NCT00110890|589677825|FG000|Overall Study|Physician Decision|4|||
163264410|NCT00110890|589677826|FG001|Overall Study|Physician Decision|5|||
163264411|NCT00110890|589677825|FG000|Overall Study|Withdrawal by Subject|17|||
163264412|NCT00110890|589677826|FG001|Overall Study|Withdrawal by Subject|5|||
163264413|NCT00110890|589677825|FG000|Overall Study|Protocol Deviation|1|||
163264414|NCT00110890|589677826|FG001|Overall Study|Protocol Deviation|0|||
163264415|NCT00110890|589677825|FG000|Overall Study|Noncompliance|10|||
163264416|NCT00110890|589677826|FG001|Overall Study|Noncompliance|0|||
163264417|NCT00110890|589677825|FG000|Overall Study|Kidney Transplant|16|||
163264418|NCT00110890|589677826|FG001|Overall Study|Kidney Transplant|12|||
163264419|NCT00110890|589677825|FG000|Overall Study|Invest. Product Commercially Available|217|||
163264420|NCT00110890|589677826|FG001|Overall Study|Invest. Product Commercially Available|110|||
163264421|NCT00110890|589677825|FG000|Overall Study|Other|34|||
163264422|NCT00110890|589677826|FG001|Overall Study|Other|23|||
163264423|NCT00110890|589677825|FG000|Overall Study|Ineligibility determined|3|||
163264424|NCT00110890|589677826|FG001|Overall Study|Ineligibility determined|0|||
163264425|NCT00110890|589677825|FG000|Overall Study|Requirement for alternative therapy|0|||
163264426|NCT00110890|589677826|FG001|Overall Study|Requirement for alternative therapy|1|||
163264427|NCT00110890|589677825|FG000|Overall Study|Disease progression|0|||
163264428|NCT00110890|589677826|FG001|Overall Study|Disease progression|1|||
163264429|NCT00110890|589677825|FG000|Overall Study|Parathyroidectomy|0|||
163264430|NCT00110890|589677826|FG001|Overall Study|Parathyroidectomy|1|||
163264431|NCT00110890|589677825|FG000|Overall Study|Did not enter follow-up phase|10|||
163264432|NCT00110890|589677826|FG001|Overall Study|Did not enter follow-up phase|4|||
163264433|NCT01686581|589677827|FG000|Overall Study|Side-effects or Health Problems|15|||
163264434|NCT01686581|589677827|FG000|Overall Study|Lack of Efficacy|90|||
163264435|NCT01686581|589677827|FG000|Overall Study|Participant Concerned about Risks|6|||
163264436|NCT01686581|589677827|FG000|Overall Study|Thinks Injections Too Painful|8|||
163264437|NCT01686581|589677827|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
163264438|NCT01686581|589677827|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
163264439|NCT01686581|589677827|FG000|Overall Study|Thinks it is Inconvenient|17|||
163264440|NCT01686581|589677827|FG000|Overall Study|Other Miscellaneous Reasons|36|||
163264441|NCT01686581|589677827|FG000|Overall Study|Reason Missing|1|||
163264442|NCT01975220|589677828|FG000|Test Period 1|Not treated|0|||
163264443|NCT01975220|589677829|FG001|Test Period 1|Not treated|1|||
163264444|NCT01975220|589677830|FG002|Test Period 1|Not treated|0|||
163264445|NCT01975220|589677831|FG003|Test Period 1|Not treated|0|||
163264446|NCT01975220|589677832|FG004|Test Period 1|Not treated|0|||
163264447|NCT01975220|589677833|FG005|Test Period 1|Not treated|0|||
163264448|NCT00263328|589677837|FG000|Overall Study|Death|0|||
163264449|NCT00263328|589677838|FG001|Overall Study|Death|0|||
163264450|NCT00263328|589677839|FG002|Overall Study|Death|1|||
163264451|NCT00263328|589677837|FG000|Overall Study|Lost to Follow-up|1|||
163264452|NCT00263328|589677838|FG001|Overall Study|Lost to Follow-up|1|||
163264453|NCT00263328|589677839|FG002|Overall Study|Lost to Follow-up|0|||
163264454|NCT00263328|589677837|FG000|Overall Study|Withdrawal by Subject|3|||
163264455|NCT00263328|589677838|FG001|Overall Study|Withdrawal by Subject|0|||
163264456|NCT00263328|589677839|FG002|Overall Study|Withdrawal by Subject|1|||
163264457|NCT00263328|589677837|FG000|Overall Study|Other|3|||
163264458|NCT00263328|589677838|FG001|Overall Study|Other|0|||
163264459|NCT00263328|589677839|FG002|Overall Study|Other|1|||
163264460|NCT00263328|589677837|FG000|Overall Study|Adverse Event|1|||
163264461|NCT00263328|589677838|FG001|Overall Study|Adverse Event|1|||
163264462|NCT00263328|589677839|FG002|Overall Study|Adverse Event|4|||
163264463|NCT01008475|589677843|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
163264464|NCT01008475|589677844|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
163264465|NCT01008475|589677845|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
163264466|NCT01008475|589677846|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
163264467|NCT01008475|589677847|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
163264468|NCT01008475|589677848|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
163264469|NCT01008475|589677849|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
163264470|NCT01301274|589677850|FG000|Overall Study|Physician Decision|2|||
163264471|NCT01301274|589677851|FG001|Overall Study|Physician Decision|1|||
163264472|NCT00661661|589677852|FG000|Overall Study|Adverse Event|99|||
163264473|NCT00661661|589677853|FG001|Overall Study|Adverse Event|24|||
163264474|NCT00661661|589677852|FG000|Overall Study|Lack of Efficacy|3|||
163264475|NCT00661661|589677853|FG001|Overall Study|Lack of Efficacy|2|||
163264476|NCT00661661|589677852|FG000|Overall Study|Lost to Follow-up|0|||
163264477|NCT00661661|589677853|FG001|Overall Study|Lost to Follow-up|1|||
163264478|NCT00661661|589677852|FG000|Overall Study|Withdrawal by Subject|15|||
163264479|NCT00661661|589677853|FG001|Overall Study|Withdrawal by Subject|5|||
163264480|NCT00661661|589677852|FG000|Overall Study|Other|22|||
163264481|NCT00661661|589677853|FG001|Overall Study|Other|7|||
163264482|NCT00661661|589677852|FG000|Overall Study|Not assigned treatment|1|||
163264483|NCT00661661|589677853|FG001|Overall Study|Not assigned treatment|0|||
163264484|NCT02917941|589677854|FG000|Treatment Period|Adverse Event|11|||
163264485|NCT02917941|589677854|FG000|Treatment Period|Progressive Disease|11|||
163264486|NCT02917941|589677854|FG000|Treatment Period|Reason not Specified|2|||
163264487|NCT02917941|589677854|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
163264488|NCT02917941|589677854|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
163264489|NCT01893827|589677855|FG000|Overall Study|Lost to Follow-up|19|||
163264490|NCT01893827|589677856|FG001|Overall Study|Lost to Follow-up|26|||
163264491|NCT03021668|589677859|FG000|Overall Study|Physician Decision|0|||
163264492|NCT03021668|589677860|FG001|Overall Study|Physician Decision|1|||
163264493|NCT01382940|589679011|FG000|Overall Study|Adverse Event|19|||
163264494|NCT01382940|589679011|FG000|Overall Study|Lost to Follow-up|4|||
163264495|NCT01382940|589679011|FG000|Overall Study|Physician Decision|7|||
163264496|NCT01382940|589679011|FG000|Overall Study|Withdrawal by Subject|23|||
163264497|NCT01382940|589679011|FG000|Overall Study|Protocol Violation|20|||
163264498|NCT02105636|589679012|FG000|Pre-Treatment|Disease Progression|1|||
163264499|NCT02105636|589679013|FG001|Pre-Treatment|Disease Progression|0|||
163264500|NCT02105636|589679012|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
163264501|NCT02105636|589679013|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
163264502|NCT02105636|589679012|FG000|Pre-Treatment|Participant withdrew consent|0|||
163264503|NCT02105636|589679013|FG001|Pre-Treatment|Participant withdrew consent|6|||
163264504|NCT02105636|589679012|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
163264505|NCT02105636|589679013|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
163264506|NCT02105636|589679012|FG000|Treatment|Study Drug Toxicity|14|||
163264507|NCT02105636|589679013|FG001|Treatment|Study Drug Toxicity|10|||
163264508|NCT02105636|589679012|FG000|Treatment|Adverse event unrelated to study drug|19|||
163264509|NCT02105636|589679013|FG001|Treatment|Adverse event unrelated to study drug|3|||
163264510|NCT02105636|589679012|FG000|Treatment|Participant request to discontinue study treatment|8|||
163264511|NCT02105636|589679013|FG001|Treatment|Participant request to discontinue study treatment|6|||
163264512|NCT02105636|589679012|FG000|Treatment|Participant withdrew consent|5|||
163264513|NCT02105636|589679013|FG001|Treatment|Participant withdrew consent|1|||
163264514|NCT02105636|589679012|FG000|Treatment|Lost to Follow-up|1|||
163264515|NCT02105636|589679013|FG001|Treatment|Lost to Follow-up|0|||
163264516|NCT02105636|589679012|FG000|Treatment|Maximum Clinical Benefit|1|||
163264517|NCT02105636|589679013|FG001|Treatment|Maximum Clinical Benefit|3|||
163264518|NCT02105636|589679012|FG000|Treatment|Poor/Non-compliance|0|||
163264519|NCT02105636|589679013|FG001|Treatment|Poor/Non-compliance|1|||
163264520|NCT02105636|589679012|FG000|Treatment|Participant no longer meets study criteria|1|||
163264521|NCT02105636|589679013|FG001|Treatment|Participant no longer meets study criteria|0|||
163264522|NCT02105636|589679012|FG000|Treatment|Other reasons|1|||
163264523|NCT02105636|589679013|FG001|Treatment|Other reasons|0|||
163264524|NCT02105636|589679012|FG000|Treatment|Disease Progression|185|||
163264525|NCT02105636|589679013|FG001|Treatment|Disease Progression|87|||
163264526|NCT00720902|589679014|FG000|Overall Study|Withdrawal by Subject|1|||
163264527|NCT00720902|589679015|FG001|Overall Study|Withdrawal by Subject|0|||
163362159|NCT04946942|590034713|FG001|Overall Study|Lost to Follow-up|2|||
163264528|NCT00720902|589679014|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
163264529|NCT00720902|589679015|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
163264530|NCT02254408|589679021|FG000|Overall Study|Randomized But Not Treated|1|||
163264531|NCT02254408|589679022|FG001|Overall Study|Randomized But Not Treated|3|||
163264532|NCT02254408|589679021|FG000|Overall Study|Adverse Event|1|||
163264533|NCT02254408|589679022|FG001|Overall Study|Adverse Event|0|||
163264534|NCT02254408|589679021|FG000|Overall Study|Death|2|||
163264535|NCT02254408|589679022|FG001|Overall Study|Death|3|||
163264536|NCT02254408|589679021|FG000|Overall Study|Investigator's Discretion|0|||
163264537|NCT02254408|589679022|FG001|Overall Study|Investigator's Discretion|1|||
163264538|NCT02254408|589679021|FG000|Overall Study|Withdrawal by Subject|3|||
163264539|NCT02254408|589679022|FG001|Overall Study|Withdrawal by Subject|3|||
163264540|NCT02254408|589679021|FG000|Overall Study|Lost to Follow-up|1|||
163264541|NCT02254408|589679022|FG001|Overall Study|Lost to Follow-up|0|||
163264542|NCT01993017|589679023|FG000|Overall Study|Death|23|||
163264543|NCT01993017|589679024|FG001|Overall Study|Death|26|||
163264544|NCT01993017|589679025|FG002|Overall Study|Death|18|||
163264545|NCT01993017|589679023|FG000|Overall Study|Could not be contacted|43|||
163264546|NCT01993017|589679024|FG001|Overall Study|Could not be contacted|42|||
163264547|NCT01993017|589679025|FG002|Overall Study|Could not be contacted|38|||
163264548|NCT01993017|589679023|FG000|Overall Study|Dropped out|19|||
163264549|NCT01993017|589679024|FG001|Overall Study|Dropped out|6|||
163264550|NCT01993017|589679025|FG002|Overall Study|Dropped out|11|||
163264551|NCT01993017|589679023|FG000|Overall Study|Other reasons|17|||
163264552|NCT01993017|589679024|FG001|Overall Study|Other reasons|11|||
163264553|NCT01993017|589679025|FG002|Overall Study|Other reasons|7|||
163264554|NCT01993017|589679023|FG000|Overall Study|Ineligible after randomization|4|||
163264555|NCT01993017|589679024|FG001|Overall Study|Ineligible after randomization|5|||
163264556|NCT01993017|589679025|FG002|Overall Study|Ineligible after randomization|5|||
163264557|NCT00003511|589679026|FG000|Overall Study|Not evaluable|4|||
163264558|NCT00917267|589679027|FG000|Overall Study|Adverse Event|15|||
163264559|NCT00917267|589679028|FG001|Overall Study|Adverse Event|36|||
163264560|NCT00917267|589679027|FG000|Overall Study|Physician Decision|2|||
163264561|NCT00917267|589679028|FG001|Overall Study|Physician Decision|4|||
163264562|NCT00917267|589679027|FG000|Overall Study|Protocol Violation|9|||
163264563|NCT00917267|589679028|FG001|Overall Study|Protocol Violation|18|||
163264564|NCT00917267|589679027|FG000|Overall Study|Withdrawal by Subject|5|||
163264565|NCT00917267|589679028|FG001|Overall Study|Withdrawal by Subject|12|||
163264566|NCT00917267|589679027|FG000|Overall Study|Lost to follow up|0|||
163264567|NCT00917267|589679028|FG001|Overall Study|Lost to follow up|2|||
163264568|NCT00917267|589679027|FG000|Overall Study|Entry Criteria Not Met|1|||
163264569|NCT00917267|589679028|FG001|Overall Study|Entry Criteria Not Met|0|||
163264570|NCT00917267|589679027|FG000|Overall Study|Sponsor Decision|5|||
163264571|NCT00917267|589679028|FG001|Overall Study|Sponsor Decision|5|||
163264572|NCT00917267|589679027|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
163264573|NCT00917267|589679028|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
163264574|NCT03638635|589679029|FG000|Initial Hospitalization|Study terminated prematurely|0|||
163264575|NCT03638635|589679030|FG001|Initial Hospitalization|Study terminated prematurely|1|||
163264576|NCT03638635|589679029|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
163264577|NCT03638635|589679030|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
163264578|NCT03638635|589679029|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
163264579|NCT03638635|589679030|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
163264580|NCT00423293|589679031|FG000|Overall Study|Ineligible / No protocol treatment|11|||
163264581|NCT00519896|589679038|FG000|Overall Study|Protocol Violation|1|||
163264582|NCT00519896|589679038|FG000|Overall Study|Adverse Event|1|||
163264583|NCT03327402|589679039|FG000|Overall Study|Withdrawal by Subject|1|||
163264584|NCT03327402|589679039|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
163264585|NCT01540565|589679045|FG000|Overall Study|Ineligible|2|||
163264586|NCT03469349|589679046|FG000|Overall Study|Withdrawal by Subject|1|||
163264587|NCT03469349|589679047|FG001|Overall Study|Withdrawal by Subject|3|||
163362160|NCT04946942|590034714|FG002|Overall Study|Lost to Follow-up|0|||
163362161|NCT03342196|590034715|FG000|Overall Study|Physician Decision|1|||
163362162|NCT02257918|590034716|FG000|Overall Study|Lost to Follow-up|4|||
163362163|NCT02257918|590034717|FG001|Overall Study|Lost to Follow-up|1|||
163362164|NCT02257918|590034718|FG002|Overall Study|Lost to Follow-up|0|||
163362165|NCT02257918|590034716|FG000|Overall Study|Withdrawal by Subject|0|||
163362166|NCT02257918|590034717|FG001|Overall Study|Withdrawal by Subject|0|||
163264588|NCT03469349|589679046|FG000|Overall Study|Progressive Disease|0|||
163264589|NCT03469349|589679047|FG001|Overall Study|Progressive Disease|1|||
163264590|NCT03469349|589679046|FG000|Overall Study|Lost to Follow-up|2|||
163264591|NCT03469349|589679047|FG001|Overall Study|Lost to Follow-up|2|||
163264592|NCT03469349|589679046|FG000|Overall Study|Adverse Event|2|||
163264593|NCT03469349|589679047|FG001|Overall Study|Adverse Event|4|||
163264594|NCT01827254|589679048|FG000|Overall Study|Death|10|||
163264595|NCT01827254|589679048|FG000|Overall Study|Case report form not completed|4|||
163264596|NCT01827254|589679048|FG000|Overall Study|Invalidated centre|3|||
163264597|NCT01827254|589679048|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
163264598|NCT01827254|589679048|FG000|Overall Study|Did not complete re-challenge|1|||
163264599|NCT01827254|589679048|FG000|Overall Study|Disease progression|36|||
163264600|NCT01827254|589679048|FG000|Overall Study|Intolerance to treatment|4|||
163264601|NCT04145037|589679054|FG000|Overall Study|Study terminated|2|||
163264602|NCT04145037|589679055|FG001|Overall Study|Study terminated|0|||
163264603|NCT04145037|589679054|FG000|Overall Study|Withdrawal by Subject|1|||
163264604|NCT04145037|589679055|FG001|Overall Study|Withdrawal by Subject|0|||
163264605|NCT04145037|589679054|FG000|Overall Study|Lost to Follow-up|1|||
163264606|NCT04145037|589679055|FG001|Overall Study|Lost to Follow-up|0|||
163264607|NCT02307513|589679058|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
163264608|NCT02307513|589679059|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
163264609|NCT02307513|589679058|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
163264610|NCT02307513|589679059|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
163264611|NCT02307513|589679058|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
163264612|NCT02307513|589679059|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
163264613|NCT02307513|589679058|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
163264614|NCT02307513|589679059|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
163264615|NCT02307513|589679058|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
163264616|NCT02307513|589679059|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
163264617|NCT02307513|589679058|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
163264618|NCT02307513|589679059|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
163264619|NCT02307513|589679058|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
163264620|NCT02307513|589679059|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
163264621|NCT02307513|589679058|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
163264622|NCT02307513|589679059|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
163264623|NCT02307513|589679058|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
163264624|NCT02307513|589679059|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
163153764|NCT03224819|589278289|FG007|Overall Study|Sponsor Decision|1|||
163153765|NCT03224819|589278290|FG008|Overall Study|Sponsor Decision|1|||
163153766|NCT03224819|589278291|FG009|Overall Study|Sponsor Decision|2|||
163153767|NCT03224819|589278292|FG010|Overall Study|Sponsor Decision|1|||
163153768|NCT03224819|589278293|FG011|Overall Study|Sponsor Decision|1|||
163153769|NCT03224819|589278294|FG012|Overall Study|Sponsor Decision|1|||
163153770|NCT03224819|589278295|FG013|Overall Study|Sponsor Decision|0|||
163153771|NCT03224819|589278282|FG000|Overall Study|Lost to Follow-up|0|||
163153772|NCT03224819|589278283|FG001|Overall Study|Lost to Follow-up|0|||
163153773|NCT03224819|589278284|FG002|Overall Study|Lost to Follow-up|0|||
163153774|NCT03224819|589278285|FG003|Overall Study|Lost to Follow-up|0|||
163153775|NCT03224819|589278286|FG004|Overall Study|Lost to Follow-up|0|||
163153776|NCT03224819|589278287|FG005|Overall Study|Lost to Follow-up|0|||
163153777|NCT03224819|589278288|FG006|Overall Study|Lost to Follow-up|0|||
163153778|NCT03224819|589278289|FG007|Overall Study|Lost to Follow-up|0|||
163153779|NCT03224819|589278290|FG008|Overall Study|Lost to Follow-up|1|||
163153780|NCT03224819|589278291|FG009|Overall Study|Lost to Follow-up|0|||
163153781|NCT03224819|589278292|FG010|Overall Study|Lost to Follow-up|0|||
163153782|NCT03224819|589278293|FG011|Overall Study|Lost to Follow-up|0|||
163153783|NCT03224819|589278294|FG012|Overall Study|Lost to Follow-up|0|||
163153784|NCT03224819|589278295|FG013|Overall Study|Lost to Follow-up|0|||
163153785|NCT03224819|589278282|FG000|Overall Study|Death|0|||
163153786|NCT03224819|589278283|FG001|Overall Study|Death|1|||
163153787|NCT03224819|589278284|FG002|Overall Study|Death|0|||
163153788|NCT03224819|589278285|FG003|Overall Study|Death|0|||
163153789|NCT03224819|589278286|FG004|Overall Study|Death|0|||
163153790|NCT03224819|589278287|FG005|Overall Study|Death|0|||
163153791|NCT03224819|589278288|FG006|Overall Study|Death|0|||
163153792|NCT03224819|589278289|FG007|Overall Study|Death|1|||
163153793|NCT03224819|589278290|FG008|Overall Study|Death|0|||
163153794|NCT03224819|589278291|FG009|Overall Study|Death|0|||
163153795|NCT03224819|589278292|FG010|Overall Study|Death|0|||
163153796|NCT03224819|589278293|FG011|Overall Study|Death|1|||
163153797|NCT03224819|589278294|FG012|Overall Study|Death|0|||
163153798|NCT03224819|589278295|FG013|Overall Study|Death|0|||
163153799|NCT03783078|589278296|FG000|Overall Study|Death|31|||
163153800|NCT03783078|589278296|FG000|Overall Study|Sponsor Decision|23|||
163153801|NCT03783078|589278296|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163153802|NCT02059278|589278299|FG000|Overall Study|Adverse Event|1|||
163153803|NCT02059278|589278300|FG001|Overall Study|Adverse Event|1|||
163153804|NCT02059278|589278299|FG000|Overall Study|Lost to Follow-up|1|||
163153805|NCT02059278|589278300|FG001|Overall Study|Lost to Follow-up|0|||
163153806|NCT02059278|589278299|FG000|Overall Study|Withdrawal by Subject|0|||
163153807|NCT02059278|589278300|FG001|Overall Study|Withdrawal by Subject|3|||
163153808|NCT02059278|589278299|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
163153809|NCT02059278|589278300|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
163153810|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
163153811|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
163264625|NCT02307513|589679058|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
163264626|NCT02307513|589679059|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
163264627|NCT02307513|589679058|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
163264628|NCT02307513|589679059|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
163264629|NCT02307513|589679058|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
163264630|NCT02307513|589679059|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
163264631|NCT02307513|589679058|FG000|Long-term Extension|Physician Decision|1|||
163264632|NCT02307513|589679059|FG001|Long-term Extension|Physician Decision|0|||
163264633|NCT00525265|589679067|FG000|Overall Study|Protocol Violation|1|||
163264634|NCT00525265|589679068|FG001|Overall Study|Protocol Violation|0|||
163264635|NCT01107743|589679069|FG000|Overall Study|Protocol Violation|46|||
163264636|NCT00744263|589679072|FG000|Overall Study|Death|3006|||
163264637|NCT00744263|589679073|FG001|Overall Study|Death|3005|||
163264638|NCT00744263|589679072|FG000|Overall Study|Lost to Follow-up|2038|||
163264639|NCT00744263|589679073|FG001|Overall Study|Lost to Follow-up|2135|||
163264640|NCT00744263|589679072|FG000|Overall Study|Withdrawal by Subject|166|||
163264641|NCT00744263|589679073|FG001|Overall Study|Withdrawal by Subject|150|||
163264642|NCT00744263|589679072|FG000|Overall Study|Physician Decision|20|||
163264643|NCT00744263|589679073|FG001|Overall Study|Physician Decision|23|||
163264644|NCT00744263|589679072|FG000|Overall Study|Protocol Violation|3|||
163264645|NCT00744263|589679073|FG001|Overall Study|Protocol Violation|5|||
163264646|NCT00744263|589679072|FG000|Overall Study|Adverse Event|1|||
163264647|NCT00744263|589679073|FG001|Overall Study|Adverse Event|0|||
163264648|NCT00744263|589679072|FG000|Overall Study|Other|2|||
163264649|NCT00744263|589679073|FG001|Overall Study|Other|2|||
163264650|NCT01913639|589679074|FG000|Overall Study|Not Eligible|3|||
163264651|NCT01290822|589679077|FG000|Overall Study|Withdrawal by Subject|1|||
163264652|NCT01290822|589679077|FG000|Overall Study|Physician Decision|10|||
163264653|NCT04078035|589679078|FG000|Session 2|Lost to Follow-up|3|||
163264654|NCT04078035|589679079|FG001|Session 2|Lost to Follow-up|1|||
163264655|NCT04078035|589679078|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
163264656|NCT04078035|589679079|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
163264657|NCT04296890|589679082|FG000|Overall Study|Withdrawal by Subject|1|||
163264658|NCT04296890|589679082|FG000|Overall Study|Death|62|||
163264659|NCT04296890|589679082|FG000|Overall Study|Lost to Follow-up|3|||
163264660|NCT04296890|589679082|FG000|Overall Study|Other than specified|2|||
163264661|NCT02100722|589679083|FG000|Overall Study|Withdrawal pre-procedure|4|||
163264662|NCT02100722|589679084|FG001|Overall Study|Withdrawal pre-procedure|9|||
163264663|NCT02100722|589679083|FG000|Overall Study|Withdrawal post-procedure|0|||
163264664|NCT02100722|589679084|FG001|Overall Study|Withdrawal post-procedure|3|||
163264665|NCT02100722|589679083|FG000|Overall Study|Lost to Follow-up|2|||
163264666|NCT02100722|589679084|FG001|Overall Study|Lost to Follow-up|2|||
163264667|NCT02100722|589679083|FG000|Overall Study|Continuing on study|751|||
163264668|NCT02100722|589679084|FG001|Overall Study|Continuing on study|729|||
163264669|NCT04986982|589679086|FG000|Overall Study|Withdrawal by Subject|3|||
163264670|NCT04986982|589679087|FG001|Overall Study|Withdrawal by Subject|1|||
163264671|NCT04986982|589679086|FG000|Overall Study|Lack of Efficacy|0|||
163264672|NCT04986982|589679087|FG001|Overall Study|Lack of Efficacy|2|||
163264673|NCT04986982|589679086|FG000|Overall Study|Ineligibility|3|||
163264674|NCT04986982|589679087|FG001|Overall Study|Ineligibility|0|||
163264675|NCT04986982|589679086|FG000|Overall Study|Adverse Event|4|||
163264676|NCT04986982|589679087|FG001|Overall Study|Adverse Event|4|||
163264677|NCT04986982|589679086|FG000|Overall Study|Lost to Follow-up|0|||
163264678|NCT04986982|589679087|FG001|Overall Study|Lost to Follow-up|1|||
163264679|NCT04986982|589679086|FG000|Overall Study|Sponsor's discretion|1|||
163264680|NCT04986982|589679087|FG001|Overall Study|Sponsor's discretion|0|||
163264681|NCT03500640|589679088|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
163264682|NCT03500640|589679089|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
163264683|NCT03500640|589679090|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
163264684|NCT03500640|589679088|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
163264685|NCT03500640|589679089|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
163264686|NCT03500640|589679090|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
163264687|NCT03500640|589679088|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
163264688|NCT03500640|589679089|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
163362167|NCT02257918|590034718|FG002|Overall Study|Withdrawal by Subject|1|||
163264689|NCT03500640|589679090|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
163264690|NCT03500640|589679088|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
163264691|NCT03500640|589679089|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
163264692|NCT03500640|589679090|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
163264693|NCT03500640|589679088|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
163264694|NCT03500640|589679089|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
163264695|NCT03500640|589679090|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
163264696|NCT03500640|589679088|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
163362168|NCT02257918|590034716|FG000|Overall Study|Pregnancy|0|||
163362169|NCT02257918|590034717|FG001|Overall Study|Pregnancy|0|||
163264697|NCT03500640|589679089|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
163264698|NCT03500640|589679090|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
163264699|NCT03500640|589679088|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
163264700|NCT03500640|589679089|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
163264701|NCT03500640|589679090|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
163264702|NCT03500640|589679088|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
163264703|NCT03500640|589679089|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
163264704|NCT03500640|589679090|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
163264705|NCT03500640|589679088|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
163264706|NCT03500640|589679089|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
163264707|NCT03500640|589679090|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
163264708|NCT03500640|589679088|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
163264709|NCT03500640|589679089|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
163264710|NCT03500640|589679090|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
163264711|NCT02613221|589679091|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
163264712|NCT02613221|589679091|FG000|Overall Study|Adverse Event|2|||
163264713|NCT02613221|589679091|FG000|Overall Study|Voluntary Discontinuation|1|||
163264714|NCT02613221|589679091|FG000|Overall Study|Delayed Treatment|1|||
163264715|NCT02613221|589679091|FG000|Overall Study|Enrolled but Not Treated|1|||
163264716|NCT01119898|589679094|FG000|Overall Study|Adverse Event|4|||
163264717|NCT01119898|589679095|FG001|Overall Study|Adverse Event|5|||
163264718|NCT01119898|589679094|FG000|Overall Study|Withdrawal by Subject|1|||
163264719|NCT01119898|589679095|FG001|Overall Study|Withdrawal by Subject|4|||
163264720|NCT01119898|589679094|FG000|Overall Study|Lack of Efficacy|0|||
163264721|NCT01119898|589679095|FG001|Overall Study|Lack of Efficacy|2|||
163264722|NCT01119898|589679094|FG000|Overall Study|Protocol Violation|1|||
163264723|NCT01119898|589679095|FG001|Overall Study|Protocol Violation|1|||
163264724|NCT01119898|589679094|FG000|Overall Study|Medical procedure|1|||
163264725|NCT01119898|589679095|FG001|Overall Study|Medical procedure|0|||
163264726|NCT01119898|589679094|FG000|Overall Study|Randomized in error did not participate|1|||
163264727|NCT01119898|589679095|FG001|Overall Study|Randomized in error did not participate|0|||
163264728|NCT01807650|589679096|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
163264729|NCT01807650|589679096|FG000|Overall Study|Adverse Event|5|||
163264730|NCT01807650|589679096|FG000|Overall Study|Other|2|||
163264731|NCT02217280|589679099|FG000|Overall Study|Withdrawal by Subject|2|||
163264732|NCT02217280|589679099|FG000|Overall Study|Post-consent sceen fail|2|||
163264733|NCT03573908|589679105|FG000|Treatment Period|Adverse Event|4|||
163264734|NCT03573908|589679106|FG001|Treatment Period|Adverse Event|9|||
163264735|NCT03573908|589679107|FG002|Treatment Period|Adverse Event|0|||
163264736|NCT03573908|589679108|FG003|Treatment Period|Adverse Event|0|||
163264737|NCT03573908|589679109|FG004|Treatment Period|Adverse Event|0|||
163264738|NCT03573908|589679105|FG000|Treatment Period|Protocol Violation|1|||
163264739|NCT03573908|589679106|FG001|Treatment Period|Protocol Violation|0|||
163264740|NCT03573908|589679107|FG002|Treatment Period|Protocol Violation|0|||
163264741|NCT03573908|589679108|FG003|Treatment Period|Protocol Violation|0|||
163264742|NCT03573908|589679109|FG004|Treatment Period|Protocol Violation|0|||
163264743|NCT03573908|589679105|FG000|Treatment Period|Withdrawal by Subject|7|||
163264744|NCT03573908|589679106|FG001|Treatment Period|Withdrawal by Subject|5|||
163264745|NCT03573908|589679107|FG002|Treatment Period|Withdrawal by Subject|0|||
163264746|NCT03573908|589679108|FG003|Treatment Period|Withdrawal by Subject|0|||
163264747|NCT03573908|589679109|FG004|Treatment Period|Withdrawal by Subject|0|||
163264748|NCT03573908|589679105|FG000|Treatment Period|Lost to Follow-up|7|||
163264749|NCT03573908|589679106|FG001|Treatment Period|Lost to Follow-up|6|||
163264750|NCT03573908|589679107|FG002|Treatment Period|Lost to Follow-up|0|||
163264751|NCT03573908|589679108|FG003|Treatment Period|Lost to Follow-up|0|||
163264752|NCT03573908|589679109|FG004|Treatment Period|Lost to Follow-up|0|||
163264753|NCT03573908|589679105|FG000|Treatment Period|Pregnancy|1|||
163264754|NCT03573908|589679106|FG001|Treatment Period|Pregnancy|0|||
163264755|NCT03573908|589679107|FG002|Treatment Period|Pregnancy|0|||
163264756|NCT03573908|589679108|FG003|Treatment Period|Pregnancy|0|||
163264757|NCT03573908|589679109|FG004|Treatment Period|Pregnancy|0|||
163264758|NCT03573908|589679105|FG000|Treatment Period|Other, Not Specified|4|||
163264759|NCT03573908|589679106|FG001|Treatment Period|Other, Not Specified|6|||
163264760|NCT03573908|589679107|FG002|Treatment Period|Other, Not Specified|0|||
163264761|NCT03573908|589679108|FG003|Treatment Period|Other, Not Specified|0|||
163264762|NCT03573908|589679109|FG004|Treatment Period|Other, Not Specified|0|||
163264763|NCT03573908|589679105|FG000|Randomized Withdrawal Period|Adverse Event|0|||
163264764|NCT03573908|589679106|FG001|Randomized Withdrawal Period|Adverse Event|0|||
163264765|NCT03573908|589679107|FG002|Randomized Withdrawal Period|Adverse Event|3|||
163264766|NCT03573908|589679108|FG003|Randomized Withdrawal Period|Adverse Event|0|||
163264767|NCT03573908|589679109|FG004|Randomized Withdrawal Period|Adverse Event|0|||
163264768|NCT03573908|589679105|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163264769|NCT03573908|589679106|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163264770|NCT03573908|589679107|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163264771|NCT03573908|589679108|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163264772|NCT03573908|589679109|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
163264773|NCT03573908|589679105|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
163264774|NCT03573908|589679106|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
163264775|NCT03573908|589679107|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
163264776|NCT03573908|589679108|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
163264777|NCT03573908|589679109|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
163264778|NCT03573908|589679105|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
163264779|NCT03573908|589679106|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
163264780|NCT03573908|589679107|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
163264781|NCT03573908|589679108|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
163264782|NCT03573908|589679109|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
163264783|NCT04006925|589679110|FG000|Overall Study|Side effects|2|||
163264784|NCT04006925|589679111|FG001|Overall Study|Side effects|0|||
163264785|NCT01396317|589679112|FG000|Overall Study|Adverse Event|1|||
163264786|NCT01396317|589679113|FG001|Overall Study|Adverse Event|0|||
163264787|NCT02906683|589680790|FG000|Overall Study|Adverse Event|0|||
163264788|NCT02906683|589680791|FG001|Overall Study|Adverse Event|1|||
163264789|NCT02906683|589680792|FG002|Overall Study|Adverse Event|0|||
163264790|NCT02906683|589680790|FG000|Overall Study|Physician Decision|0|||
163264791|NCT02906683|589680791|FG001|Overall Study|Physician Decision|1|||
163264792|NCT02906683|589680792|FG002|Overall Study|Physician Decision|1|||
163264793|NCT02906683|589680790|FG000|Overall Study|Withdrawal by Subject|0|||
163264794|NCT02906683|589680791|FG001|Overall Study|Withdrawal by Subject|2|||
163264795|NCT02906683|589680792|FG002|Overall Study|Withdrawal by Subject|1|||
163264796|NCT02906683|589680790|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
163264797|NCT02906683|589680791|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
163264798|NCT02906683|589680792|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
163264799|NCT02906683|589680790|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
163264800|NCT02906683|589680791|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
163264801|NCT02906683|589680792|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
163264802|NCT01158378|589680793|FG000|Overall Study|Death|4|||
163264803|NCT01158378|589680794|FG001|Overall Study|Death|5|||
163264804|NCT01158378|589680793|FG000|Overall Study|Lost to Follow-up|2|||
163264805|NCT01158378|589680794|FG001|Overall Study|Lost to Follow-up|4|||
163264806|NCT01158378|589680793|FG000|Overall Study|Withdrawal by Subject|4|||
163264807|NCT01158378|589680794|FG001|Overall Study|Withdrawal by Subject|0|||
163264808|NCT02531295|589680799|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
163264809|NCT02531295|589680800|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
163264810|NCT02531295|589680801|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
163264811|NCT02531295|589680802|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
163264812|NCT02531295|589680803|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
163264813|NCT02531295|589680804|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
163264814|NCT00453310|589680805|FG000|Overall Study|Progression of Disease|10|||
163264815|NCT01806740|589680806|FG000|Overall Study|Withdrawal by Subject|4|||
163264816|NCT01806740|589680806|FG000|Overall Study|Physician Decision|1|||
163264817|NCT01806740|589680806|FG000|Overall Study|Patient's refusal of treatment|1|||
163264818|NCT04666922|589680807|FG000|Overall Study|Withdrawal by Subject|1|||
163264819|NCT04666922|589680808|FG001|Overall Study|Withdrawal by Subject|0|||
163264820|NCT04666922|589680809|FG002|Overall Study|Withdrawal by Subject|0|||
163264821|NCT04666922|589680810|FG003|Overall Study|Withdrawal by Subject|0|||
163264822|NCT04666922|589680811|FG004|Overall Study|Withdrawal by Subject|0|||
163264823|NCT04666922|589680812|FG005|Overall Study|Withdrawal by Subject|0|||
163264824|NCT04666922|589680813|FG006|Overall Study|Withdrawal by Subject|0|||
163264825|NCT04651114|589680814|FG000|Overall Study|Withdrawal by Subject|8|||
163264826|NCT03661996|589680815|FG000|Overall Study|Adverse Event|0|||
163264827|NCT03661996|589680816|FG001|Overall Study|Adverse Event|0|||
163264828|NCT03661996|589680817|FG002|Overall Study|Adverse Event|1|||
163264829|NCT03661996|589680818|FG003|Overall Study|Adverse Event|1|||
163264830|NCT03661996|589680819|FG004|Overall Study|Adverse Event|0|||
163264831|NCT03661996|589680815|FG000|Overall Study|Lost to Follow-up|5|||
163264832|NCT03661996|589680816|FG001|Overall Study|Lost to Follow-up|1|||
163264833|NCT03661996|589680817|FG002|Overall Study|Lost to Follow-up|2|||
163264834|NCT03661996|589680818|FG003|Overall Study|Lost to Follow-up|2|||
163264835|NCT03661996|589680819|FG004|Overall Study|Lost to Follow-up|6|||
163264836|NCT03661996|589680815|FG000|Overall Study|Physician Decision|1|||
163264837|NCT03661996|589680816|FG001|Overall Study|Physician Decision|1|||
163264838|NCT03661996|589680817|FG002|Overall Study|Physician Decision|1|||
163264839|NCT03661996|589680818|FG003|Overall Study|Physician Decision|2|||
163264840|NCT03661996|589680819|FG004|Overall Study|Physician Decision|0|||
163264841|NCT03661996|589680815|FG000|Overall Study|Protocol Violation|0|||
163264842|NCT03661996|589680816|FG001|Overall Study|Protocol Violation|0|||
163264843|NCT03661996|589680817|FG002|Overall Study|Protocol Violation|0|||
163264844|NCT03661996|589680818|FG003|Overall Study|Protocol Violation|0|||
163264845|NCT03661996|589680819|FG004|Overall Study|Protocol Violation|1|||
163264846|NCT03661996|589680815|FG000|Overall Study|Withdrawal by Subject|3|||
163264847|NCT03661996|589680816|FG001|Overall Study|Withdrawal by Subject|5|||
163264848|NCT03661996|589680817|FG002|Overall Study|Withdrawal by Subject|1|||
163264849|NCT03661996|589680818|FG003|Overall Study|Withdrawal by Subject|7|||
163264850|NCT03661996|589680819|FG004|Overall Study|Withdrawal by Subject|7|||
163264851|NCT03661996|589680815|FG000|Overall Study|Sponsors Decision|2|||
163264852|NCT03661996|589680816|FG001|Overall Study|Sponsors Decision|0|||
163264853|NCT03661996|589680817|FG002|Overall Study|Sponsors Decision|0|||
163264854|NCT03661996|589680818|FG003|Overall Study|Sponsors Decision|0|||
163264855|NCT03661996|589680819|FG004|Overall Study|Sponsors Decision|0|||
163264856|NCT03661996|589680815|FG000|Overall Study|Other|1|||
163153812|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
163153813|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
163153814|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Adverse Event|2|||
163153815|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Adverse Event|5|||
163153816|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Adverse Event|1|||
163153817|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Adverse Event|2|||
163153818|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Death|13|||
163153819|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Death|17|||
163153820|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Death|1|||
163153821|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Death|0|||
163153822|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
163153823|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
163153824|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
163153825|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
163153826|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Disease Progression|2|||
163153827|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Disease Progression|0|||
163153828|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Disease Progression|0|||
163153829|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Disease Progression|0|||
163153830|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
163153831|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
163153832|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
163153833|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
163153834|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
163153835|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
163153836|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
163153837|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
163153838|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
163153839|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
163153840|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
163153841|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
163153842|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Participant Decision|9|||
163153843|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Participant Decision|12|||
163153844|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Participant Decision|1|||
163153845|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Participant Decision|1|||
163153846|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
163153847|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
163153848|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
163153849|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
163153850|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
163153851|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
163153852|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
163153853|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
163153854|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
163153855|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
163153856|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
163153857|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
163153858|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
163153859|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
163153860|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
163153861|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
163153862|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
163153863|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
163153864|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
163153865|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
163153866|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
163153867|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
163153868|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
163153869|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
163264857|NCT03661996|589680816|FG001|Overall Study|Other|1|||
163264858|NCT03661996|589680817|FG002|Overall Study|Other|1|||
163264859|NCT03661996|589680818|FG003|Overall Study|Other|1|||
163264860|NCT03661996|589680819|FG004|Overall Study|Other|0|||
163264861|NCT01161472|589680820|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
163264862|NCT01161472|589680821|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
163264863|NCT01161472|589680822|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
163264864|NCT01161472|589680823|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
163264865|NCT03980184|589680826|FG000|Overall Study|Dropped out before treatment|2|||
163264866|NCT03980184|589680827|FG001|Overall Study|Dropped out before treatment|2|||
163264867|NCT03980184|589680826|FG000|Overall Study|Lost to Follow-up|11|||
163264868|NCT03980184|589680827|FG001|Overall Study|Lost to Follow-up|13|||
163264869|NCT02176421|589680828|FG000|Overall Study|Lost to Follow-up|4|||
163264870|NCT02176421|589680828|FG000|Overall Study|Adverse Event|1|||
163264871|NCT01129336|589680832|FG000|Overall Study|Protocol Violation|1|||
163264872|NCT01129336|589680833|FG001|Overall Study|Protocol Violation|0|||
163264873|NCT01129336|589680832|FG000|Overall Study|Disease Progression|1|||
163264874|NCT01129336|589680833|FG001|Overall Study|Disease Progression|4|||
163264875|NCT01129336|589680832|FG000|Overall Study|Lost to Follow-up|1|||
163264876|NCT01129336|589680833|FG001|Overall Study|Lost to Follow-up|0|||
163264877|NCT01129336|589680832|FG000|Overall Study|Withdrawal by Subject|7|||
163264878|NCT01129336|589680833|FG001|Overall Study|Withdrawal by Subject|4|||
163264879|NCT01129336|589680832|FG000|Overall Study|Adverse Event|0|||
163264880|NCT01129336|589680833|FG001|Overall Study|Adverse Event|1|||
163264881|NCT01129336|589680832|FG000|Overall Study|Missing Study Completion Status|2|||
163264882|NCT01129336|589680833|FG001|Overall Study|Missing Study Completion Status|3|||
163264883|NCT01129336|589680832|FG000|Overall Study|Death|0|||
163264884|NCT01129336|589680833|FG001|Overall Study|Death|4|||
163264885|NCT00791921|589680836|FG000|Overall Study|Protocol planed|24|||
163264886|NCT00791921|589680837|FG001|Overall Study|Protocol planed|88|||
163264887|NCT00791921|589680836|FG000|Overall Study|Withdrawal by Subject|1|||
163264888|NCT00791921|589680837|FG001|Overall Study|Withdrawal by Subject|2|||
163264889|NCT00791921|589680836|FG000|Overall Study|Adverse Event|8|||
163264890|NCT00791921|589680837|FG001|Overall Study|Adverse Event|2|||
163264891|NCT00791921|589680836|FG000|Overall Study|Lack of Efficacy|0|||
163264892|NCT00791921|589680837|FG001|Overall Study|Lack of Efficacy|2|||
163264893|NCT00791921|589680836|FG000|Overall Study|Lack of study drug administration|1|||
163264894|NCT00791921|589680837|FG001|Overall Study|Lack of study drug administration|1|||
163264895|NCT00791921|589680836|FG000|Overall Study|Reason other than those above|0|||
163264896|NCT00791921|589680837|FG001|Overall Study|Reason other than those above|1|||
163264897|NCT01965158|589680838|FG000|Overall Study|Adverse Event|14|||
163264898|NCT01965158|589680839|FG001|Overall Study|Adverse Event|5|||
163264899|NCT01965158|589680838|FG000|Overall Study|Withdrawal by Subject|16|||
163264900|NCT01965158|589680839|FG001|Overall Study|Withdrawal by Subject|24|||
163264901|NCT01965158|589680838|FG000|Overall Study|Lost to Follow-up|7|||
163264902|NCT01965158|589680839|FG001|Overall Study|Lost to Follow-up|5|||
163264903|NCT01965158|589680838|FG000|Overall Study|Protocol Violation|1|||
163264904|NCT01965158|589680839|FG001|Overall Study|Protocol Violation|1|||
163264905|NCT01965158|589680838|FG000|Overall Study|Other - Miscellaneous|3|||
163264906|NCT01965158|589680839|FG001|Overall Study|Other - Miscellaneous|0|||
163264907|NCT00467142|589680840|FG000|Overall Study|Withdrawal by Subject|1|||
163264908|NCT00467142|589680840|FG000|Overall Study|Adverse Event|1|||
163264909|NCT00467142|589680840|FG000|Overall Study|Protocol Violation|1|||
163264910|NCT00154310|589680841|FG000|Overall Study|Adverse Event|19|||
163264911|NCT00154310|589680842|FG001|Overall Study|Adverse Event|9|||
163264912|NCT00154310|589680841|FG000|Overall Study|Lack of Efficacy|5|||
163264913|NCT00154310|589680842|FG001|Overall Study|Lack of Efficacy|4|||
163264914|NCT00154310|589680841|FG000|Overall Study|Protocol Violation|4|||
163264915|NCT00154310|589680842|FG001|Overall Study|Protocol Violation|2|||
163264916|NCT00154310|589680841|FG000|Overall Study|Withdrawal by Subject|9|||
163264917|NCT00154310|589680842|FG001|Overall Study|Withdrawal by Subject|3|||
163264918|NCT00154310|589680841|FG000|Overall Study|Lost to Follow-up|0|||
163264919|NCT00154310|589680842|FG001|Overall Study|Lost to Follow-up|8|||
163264920|NCT00154310|589680841|FG000|Overall Study|Administrative problems|0|||
163264921|NCT00154310|589680842|FG001|Overall Study|Administrative problems|1|||
163362170|NCT02257918|590034718|FG002|Overall Study|Pregnancy|1|||
163264922|NCT00154310|589680841|FG000|Overall Study|Death|0|||
163264923|NCT00154310|589680842|FG001|Overall Study|Death|1|||
163264924|NCT02086162|589680844|FG000|Overall Study|Withdrawal by Subject|4|||
163264925|NCT02086162|589680845|FG001|Overall Study|Withdrawal by Subject|4|||
163264926|NCT02086162|589680844|FG000|Overall Study|moved|1|||
163264927|NCT02086162|589680845|FG001|Overall Study|moved|1|||
163264928|NCT02086162|589680844|FG000|Overall Study|Lost to Follow-up|4|||
163264929|NCT02086162|589680845|FG001|Overall Study|Lost to Follow-up|2|||
163264930|NCT02086162|589680844|FG000|Overall Study|Death|1|||
163264931|NCT02086162|589680845|FG001|Overall Study|Death|0|||
163362171|NCT03023423|590034721|FG000|Overall Study|Death|5|||
163264932|NCT03447730|589680846|FG000|Overall Study|Adverse Event|0|||
163264933|NCT03447730|589680847|FG001|Overall Study|Adverse Event|2|||
163362172|NCT03023423|590034722|FG001|Overall Study|Death|12|||
163264934|NCT03447730|589680848|FG002|Overall Study|Adverse Event|0|||
163264935|NCT01248962|589680852|FG000|Overall Study|Withdrawal by Subject|1|||
163264936|NCT01248962|589680853|FG001|Overall Study|Withdrawal by Subject|1|||
163264937|NCT01248962|589680852|FG000|Overall Study|Adverse Event|2|||
163264938|NCT01248962|589680853|FG001|Overall Study|Adverse Event|1|||
163264939|NCT01248962|589680852|FG000|Overall Study|Complete Response after 4 Cycles|1|||
163264940|NCT01248962|589680853|FG001|Overall Study|Complete Response after 4 Cycles|0|||
163264941|NCT01248962|589680852|FG000|Overall Study|Complete Response after 3 Cycles|0|||
163264942|NCT01248962|589680853|FG001|Overall Study|Complete Response after 3 Cycles|1|||
163264943|NCT01248962|589680852|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
163264944|NCT01248962|589680853|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
163264945|NCT04848662|589680855|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
163264946|NCT04848662|589680856|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
163264947|NCT01350505|589680857|FG000|Overall Study|Lost to Follow-up|4|||
163264948|NCT01834222|589680858|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
163264949|NCT04702568|589680859|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
163264950|NCT04702568|589680860|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
163264951|NCT04702568|589680859|FG000|Overall Study|Pregnancy|1|||
163264952|NCT04702568|589680860|FG001|Overall Study|Pregnancy|0|||
163264953|NCT04702568|589680859|FG000|Overall Study|Bone marrow transplant|1|||
163264954|NCT04702568|589680860|FG001|Overall Study|Bone marrow transplant|0|||
163264955|NCT04702568|589680859|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
163264956|NCT04702568|589680860|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
163264957|NCT04702568|589680859|FG000|Overall Study|Withdrawal by Subject|0|||
163264958|NCT04702568|589680860|FG001|Overall Study|Withdrawal by Subject|2|||
163264959|NCT00423852|589680863|FG000|Overall Study|Removed pior to the high-dose portion|3|||
163264960|NCT00308737|589680866|FG000|Overall Study|Adverse Event|104|||
163264961|NCT00308737|589680867|FG001|Overall Study|Adverse Event|9|||
163264962|NCT00308737|589680868|FG002|Overall Study|Adverse Event|0|||
163264963|NCT00308737|589680866|FG000|Overall Study|Death|4|||
163264964|NCT00308737|589680867|FG001|Overall Study|Death|3|||
163264965|NCT00308737|589680868|FG002|Overall Study|Death|0|||
163264966|NCT00308737|589680866|FG000|Overall Study|Lost to Follow-up|56|||
163264967|NCT00308737|589680867|FG001|Overall Study|Lost to Follow-up|80|||
163264968|NCT00308737|589680868|FG002|Overall Study|Lost to Follow-up|5|||
163264969|NCT00308737|589680866|FG000|Overall Study|Physician Decision|15|||
163264970|NCT00308737|589680867|FG001|Overall Study|Physician Decision|2|||
163264971|NCT00308737|589680868|FG002|Overall Study|Physician Decision|1|||
163264972|NCT00308737|589680866|FG000|Overall Study|Protocol Violation|34|||
163264973|NCT00308737|589680867|FG001|Overall Study|Protocol Violation|9|||
163264974|NCT00308737|589680868|FG002|Overall Study|Protocol Violation|5|||
163264975|NCT00308737|589680866|FG000|Overall Study|Withdrawal by Subject|218|||
163264976|NCT00308737|589680867|FG001|Overall Study|Withdrawal by Subject|166|||
163264977|NCT00308737|589680868|FG002|Overall Study|Withdrawal by Subject|18|||
163264978|NCT00308737|589680866|FG000|Overall Study|Various|32|||
163264979|NCT00308737|589680867|FG001|Overall Study|Various|20|||
163264980|NCT00308737|589680868|FG002|Overall Study|Various|8|||
163264981|NCT01225822|589680878|FG000|Overall Study|Adverse Event|13|||
163264982|NCT01225822|589680879|FG001|Overall Study|Adverse Event|31|||
163264983|NCT01225822|589680880|FG002|Overall Study|Adverse Event|18|||
163264984|NCT01225822|589680881|FG003|Overall Study|Adverse Event|23|||
163264985|NCT01225822|589680882|FG004|Overall Study|Adverse Event|14|||
163264986|NCT01225822|589680878|FG000|Overall Study|Protocol Violation|6|||
163264987|NCT01225822|589680879|FG001|Overall Study|Protocol Violation|8|||
163264988|NCT01225822|589680880|FG002|Overall Study|Protocol Violation|6|||
163264989|NCT01225822|589680881|FG003|Overall Study|Protocol Violation|7|||
163264990|NCT01225822|589680882|FG004|Overall Study|Protocol Violation|4|||
163264991|NCT01225822|589680878|FG000|Overall Study|Lost to Follow-up|0|||
163264992|NCT01225822|589680879|FG001|Overall Study|Lost to Follow-up|0|||
163264993|NCT01225822|589680880|FG002|Overall Study|Lost to Follow-up|0|||
163264994|NCT01225822|589680881|FG003|Overall Study|Lost to Follow-up|1|||
163264995|NCT01225822|589680882|FG004|Overall Study|Lost to Follow-up|0|||
163264996|NCT01225822|589680878|FG000|Overall Study|Withdrawal by Subject|6|||
163264997|NCT01225822|589680879|FG001|Overall Study|Withdrawal by Subject|7|||
163264998|NCT01225822|589680880|FG002|Overall Study|Withdrawal by Subject|7|||
163264999|NCT01225822|589680881|FG003|Overall Study|Withdrawal by Subject|11|||
163265000|NCT01225822|589680882|FG004|Overall Study|Withdrawal by Subject|6|||
163265001|NCT01225822|589680878|FG000|Overall Study|Other|13|||
163265002|NCT01225822|589680879|FG001|Overall Study|Other|10|||
163265003|NCT01225822|589680880|FG002|Overall Study|Other|7|||
163265004|NCT01225822|589680881|FG003|Overall Study|Other|10|||
163265005|NCT01225822|589680882|FG004|Overall Study|Other|7|||
163265006|NCT00089895|589680883|FG000|Overall Study|Consent Withdrawn|11|||
163265007|NCT00089895|589680884|FG001|Overall Study|Consent Withdrawn|14|||
163265008|NCT00089895|589680883|FG000|Overall Study|Technical reason|7|||
163265009|NCT00089895|589680884|FG001|Overall Study|Technical reason|2|||
163265010|NCT00089895|589680883|FG000|Overall Study|Surgery|0|||
163265011|NCT00089895|589680884|FG001|Overall Study|Surgery|1|||
163265012|NCT00089895|589680883|FG000|Overall Study|Bleeding|0|||
163265013|NCT00089895|589680884|FG001|Overall Study|Bleeding|2|||
163265014|NCT00089895|589680883|FG000|Overall Study|Physician Decision|3|||
163265015|NCT00089895|589680884|FG001|Overall Study|Physician Decision|7|||
163265016|NCT00089895|589680883|FG000|Overall Study|Exclusion criteria met|6|||
163265017|NCT00089895|589680884|FG001|Overall Study|Exclusion criteria met|6|||
163265018|NCT00089895|589680883|FG000|Overall Study|Not otherwise specified|4|||
163265019|NCT00089895|589680884|FG001|Overall Study|Not otherwise specified|8|||
163265020|NCT00089895|589680883|FG000|Overall Study|Missing|4|||
163265021|NCT00089895|589680884|FG001|Overall Study|Missing|2|||
163265022|NCT05644353|589680885|FG000|Overall Study|Physician Decision|1|||
163265023|NCT05644353|589680886|FG001|Overall Study|Physician Decision|0|||
163265024|NCT05644353|589680887|FG002|Overall Study|Physician Decision|0|||
163265025|NCT05644353|589680888|FG003|Overall Study|Physician Decision|0|||
163265026|NCT05644353|589680889|FG004|Overall Study|Physician Decision|0|||
163265027|NCT05644353|589680890|FG005|Overall Study|Physician Decision|0|||
163265028|NCT05644353|589680885|FG000|Overall Study|Protocol Violation|1|||
163265029|NCT05644353|589680886|FG001|Overall Study|Protocol Violation|0|||
163265030|NCT05644353|589680887|FG002|Overall Study|Protocol Violation|0|||
163265031|NCT05644353|589680888|FG003|Overall Study|Protocol Violation|0|||
163265032|NCT05644353|589680889|FG004|Overall Study|Protocol Violation|0|||
163265033|NCT05644353|589680890|FG005|Overall Study|Protocol Violation|0|||
163265034|NCT05644353|589680885|FG000|Overall Study|Withdrawal by Subject|0|||
163265035|NCT05644353|589680886|FG001|Overall Study|Withdrawal by Subject|2|||
163265036|NCT05644353|589680887|FG002|Overall Study|Withdrawal by Subject|0|||
163265037|NCT05644353|589680888|FG003|Overall Study|Withdrawal by Subject|0|||
163265038|NCT05644353|589680889|FG004|Overall Study|Withdrawal by Subject|1|||
163265039|NCT05644353|589680890|FG005|Overall Study|Withdrawal by Subject|0|||
163265040|NCT05644353|589680885|FG000|Overall Study|Lost to Follow-up|0|||
163265041|NCT05644353|589680886|FG001|Overall Study|Lost to Follow-up|0|||
163265042|NCT05644353|589680887|FG002|Overall Study|Lost to Follow-up|1|||
163265043|NCT05644353|589680888|FG003|Overall Study|Lost to Follow-up|0|||
163265044|NCT05644353|589680889|FG004|Overall Study|Lost to Follow-up|0|||
163265045|NCT05644353|589680890|FG005|Overall Study|Lost to Follow-up|0|||
163265046|NCT01535274|589680891|FG000|Overall Study|Determined to be ineligible|0|||
163265047|NCT01535274|589680892|FG001|Overall Study|Determined to be ineligible|1|||
163265048|NCT01535274|589680891|FG000|Overall Study|Misallocated to propofol intervention|0|||
163265049|NCT01535274|589680892|FG001|Overall Study|Misallocated to propofol intervention|1|||
163265050|NCT02954458|589680895|FG000|Overall Study|Adverse Event|0|||
163265051|NCT02954458|589680896|FG001|Overall Study|Adverse Event|0|||
163265052|NCT02954458|589680897|FG002|Overall Study|Adverse Event|0|||
163265053|NCT02954458|589680898|FG003|Overall Study|Adverse Event|1|||
163265054|NCT02954458|589680895|FG000|Overall Study|Withdrawal by Subject|0|||
163265055|NCT02954458|589680896|FG001|Overall Study|Withdrawal by Subject|0|||
163265056|NCT02954458|589680897|FG002|Overall Study|Withdrawal by Subject|0|||
163265057|NCT02954458|589680898|FG003|Overall Study|Withdrawal by Subject|1|||
163265058|NCT02954458|589680895|FG000|Overall Study|Physician Decision|0|||
163265059|NCT02954458|589680896|FG001|Overall Study|Physician Decision|0|||
163265060|NCT02954458|589680897|FG002|Overall Study|Physician Decision|1|||
163265061|NCT02954458|589680898|FG003|Overall Study|Physician Decision|1|||
163265062|NCT02954458|589680895|FG000|Overall Study|Lost to Follow-up|1|||
163265063|NCT02954458|589680896|FG001|Overall Study|Lost to Follow-up|0|||
163265064|NCT02954458|589680897|FG002|Overall Study|Lost to Follow-up|0|||
163265065|NCT02954458|589680898|FG003|Overall Study|Lost to Follow-up|1|||
163265066|NCT02954458|589680895|FG000|Overall Study|Death|0|||
163265067|NCT02954458|589680896|FG001|Overall Study|Death|0|||
163265068|NCT02954458|589680897|FG002|Overall Study|Death|0|||
163265069|NCT02954458|589680898|FG003|Overall Study|Death|1|||
163265070|NCT02954458|589680895|FG000|Overall Study|Other|0|||
163265071|NCT02954458|589680896|FG001|Overall Study|Other|0|||
163265072|NCT02954458|589680897|FG002|Overall Study|Other|0|||
163265073|NCT02954458|589680898|FG003|Overall Study|Other|7|||
163265074|NCT02690077|589680901|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
163265075|NCT02690077|589680902|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
163265076|NCT02690077|589680901|FG000|Overall Study|Withdrawal by Subject|0|||
163265077|NCT02690077|589680902|FG001|Overall Study|Withdrawal by Subject|5|||
163265078|NCT02690077|589680901|FG000|Overall Study|Excluded by IRB|0|||
163265079|NCT02690077|589680902|FG001|Overall Study|Excluded by IRB|2|||
163265080|NCT01845974|589680903|FG000|Overall Study|screen failure|1|||
163265081|NCT01845974|589680904|FG001|Overall Study|screen failure|0|||
163265082|NCT02667886|589680905|FG000|Dose Escalation (Part A)|Adverse Event|1|||
163265083|NCT02667886|589680906|FG001|Dose Escalation (Part A)|Adverse Event|3|||
163265084|NCT02667886|589680907|FG002|Dose Escalation (Part A)|Adverse Event|1|||
163265085|NCT02667886|589680908|FG003|Dose Escalation (Part A)|Adverse Event|0|||
163265086|NCT02667886|589680909|FG004|Dose Escalation (Part A)|Adverse Event|0|||
163265087|NCT02667886|589680905|FG000|Dose Escalation (Part A)|Disease Progression|1|||
163265088|NCT02667886|589680906|FG001|Dose Escalation (Part A)|Disease Progression|4|||
163265089|NCT02667886|589680907|FG002|Dose Escalation (Part A)|Disease Progression|3|||
163265090|NCT02667886|589680908|FG003|Dose Escalation (Part A)|Disease Progression|0|||
163265091|NCT02667886|589680909|FG004|Dose Escalation (Part A)|Disease Progression|0|||
163265092|NCT02667886|589680905|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
163265093|NCT02667886|589680906|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
163265094|NCT02667886|589680907|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
163265095|NCT02667886|589680908|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
163265096|NCT02667886|589680909|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
163265097|NCT02667886|589680905|FG000|Dose Expansion (Part B)|Adverse Event|0|||
163265098|NCT02667886|589680906|FG001|Dose Expansion (Part B)|Adverse Event|0|||
163265099|NCT02667886|589680907|FG002|Dose Expansion (Part B)|Adverse Event|0|||
163265100|NCT02667886|589680908|FG003|Dose Expansion (Part B)|Adverse Event|9|||
163265101|NCT02667886|589680909|FG004|Dose Expansion (Part B)|Adverse Event|0|||
163265102|NCT02667886|589680905|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
163265103|NCT02667886|589680906|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
163265104|NCT02667886|589680907|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
163265105|NCT02667886|589680908|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
163265106|NCT02667886|589680909|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
163265107|NCT02667886|589680905|FG000|Dose Expansion (Part B)|Disease Progression|0|||
163265108|NCT02667886|589680906|FG001|Dose Expansion (Part B)|Disease Progression|0|||
163265109|NCT02667886|589680907|FG002|Dose Expansion (Part B)|Disease Progression|0|||
163265110|NCT02667886|589680908|FG003|Dose Expansion (Part B)|Disease Progression|38|||
163265111|NCT02667886|589680909|FG004|Dose Expansion (Part B)|Disease Progression|0|||
163265112|NCT02667886|589680905|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
163265113|NCT02667886|589680906|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
163265114|NCT02667886|589680907|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
163265115|NCT02667886|589680908|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
163265116|NCT02667886|589680909|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
163265117|NCT02667886|589680905|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
163265118|NCT02667886|589680906|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
163265119|NCT02667886|589680907|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
163265120|NCT02667886|589680908|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
163265121|NCT02667886|589680909|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
163265122|NCT02667886|589680905|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
163265123|NCT02667886|589680906|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
163265124|NCT02667886|589680907|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
163265125|NCT02667886|589680908|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
163265126|NCT02667886|589680909|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
163265127|NCT01905046|589680910|FG000|Months 13-24|Withdrawal by Subject|10|||
163265128|NCT01905046|589680911|FG001|Months 13-24|Withdrawal by Subject|10|||
163265129|NCT01905046|589680910|FG000|Months 13-24|Adverse Event|3|||
163265130|NCT01905046|589680911|FG001|Months 13-24|Adverse Event|2|||
163265131|NCT01905046|589680910|FG000|Months 13-24|Protocol Violation|3|||
163265132|NCT01905046|589680911|FG001|Months 13-24|Protocol Violation|3|||
163265133|NCT01905046|589680910|FG000|Months 13-24|Physician Decision|1|||
163265134|NCT01905046|589680911|FG001|Months 13-24|Physician Decision|0|||
163265135|NCT05672680|589680912|FG000|Overall Study|Patient Did Not Complete the Form|5|||
163265136|NCT05672680|589680913|FG001|Overall Study|Patient Did Not Complete the Form|4|||
163265137|NCT05672680|589680912|FG000|Overall Study|Procedure Aborted|1|||
163265138|NCT05672680|589680913|FG001|Overall Study|Procedure Aborted|0|||
163265139|NCT03929562|589680914|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
163265140|NCT03929562|589680915|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
163265141|NCT03929562|589680914|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
163265142|NCT03929562|589680915|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
163265143|NCT03929562|589680914|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
163265144|NCT03929562|589680915|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
163265145|NCT02778399|589680924|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
163265146|NCT02778399|589680925|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
163362173|NCT03023423|590034723|FG002|Overall Study|Death|20|||
163362174|NCT03023423|590034721|FG000|Overall Study|Other|0|||
163362175|NCT03023423|590034722|FG001|Overall Study|Other|2|||
163362176|NCT03023423|590034723|FG002|Overall Study|Other|2|||
163362177|NCT03023423|590034721|FG000|Overall Study|Ongoing|2|||
163362178|NCT03023423|590034722|FG001|Overall Study|Ongoing|32|||
163362179|NCT03023423|590034723|FG002|Overall Study|Ongoing|24|||
163265147|NCT02778399|589680926|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
163265148|NCT02778399|589680927|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
163265149|NCT02778399|589680928|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
163265150|NCT02778399|589680929|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
163265151|NCT02778399|589680924|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
163265152|NCT02778399|589680925|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
163265153|NCT02778399|589680926|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
163362180|NCT01151423|590034724|FG000|Overall Study|Study terminated by Sponsor|9|||
163265154|NCT02778399|589680927|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
163265155|NCT02778399|589680928|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
163153870|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
163153871|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
163153872|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
163153873|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
163153874|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
163153875|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
163153876|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
163153877|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
163153878|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
163153879|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
163153880|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
163153881|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
163153882|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
163153883|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
163153884|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
163153885|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
163153886|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
163153887|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
163153888|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
163153889|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
163153890|NCT04363320|589278305|FG000|Overall Study|Lost to Follow-up|43|||
163153891|NCT04363320|589278306|FG001|Overall Study|Lost to Follow-up|42|||
163153892|NCT04363320|589278307|FG002|Overall Study|Lost to Follow-up|24|||
163265156|NCT02778399|589680929|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
163265157|NCT02778399|589680924|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
163265158|NCT02778399|589680925|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
163265159|NCT02778399|589680926|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
163265160|NCT02778399|589680927|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
163265161|NCT02778399|589680928|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
163265162|NCT02778399|589680929|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
163265163|NCT02778399|589680924|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
163265164|NCT02778399|589680925|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
163265165|NCT02778399|589680926|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
163265166|NCT02778399|589680927|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
163265167|NCT02778399|589680928|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
163265168|NCT02778399|589680929|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
163153893|NCT04363320|589278308|FG003|Overall Study|Lost to Follow-up|29|||
163153894|NCT04363320|589278305|FG000|Overall Study|Death|0|||
163153895|NCT04363320|589278306|FG001|Overall Study|Death|0|||
163153896|NCT04363320|589278307|FG002|Overall Study|Death|1|||
163153897|NCT04363320|589278308|FG003|Overall Study|Death|0|||
163153898|NCT00604565|589278309|FG000|Overall Study|Study terminated|0|||
163153899|NCT00604565|589278310|FG001|Overall Study|Study terminated|3|||
163153900|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
163153901|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
163153902|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
163265169|NCT02778399|589680924|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
163265170|NCT02778399|589680925|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
163265171|NCT02778399|589680926|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
163265172|NCT02778399|589680927|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
163265173|NCT02778399|589680928|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
163265174|NCT02778399|589680929|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
163265175|NCT02778399|589680924|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
163265176|NCT02778399|589680925|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
163265177|NCT02778399|589680926|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
163265178|NCT02778399|589680927|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
163265179|NCT02778399|589680928|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
163265180|NCT02778399|589680929|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
163265181|NCT02778399|589680924|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
163265182|NCT02778399|589680925|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
163265183|NCT02778399|589680926|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
163265184|NCT02778399|589680927|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
163265185|NCT02778399|589680928|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
163153903|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
163153904|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
163153905|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
163153906|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
163265186|NCT02778399|589680929|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
163265187|NCT02778399|589680924|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
163265188|NCT02778399|589680925|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
163265189|NCT02778399|589680926|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
163265190|NCT02778399|589680927|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
163265191|NCT02778399|589680928|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
163265192|NCT02778399|589680929|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
163265193|NCT02778399|589680924|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
163265194|NCT02778399|589680925|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
163265195|NCT02778399|589680926|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
163265196|NCT02778399|589680927|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
163265197|NCT02778399|589680928|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
163265198|NCT02778399|589680929|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
163265199|NCT02778399|589680924|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
163265200|NCT02778399|589680925|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
163265201|NCT02778399|589680926|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
163265202|NCT02778399|589680927|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
163265203|NCT02778399|589680928|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
163265204|NCT02778399|589680929|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
163265205|NCT02778399|589680924|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
163265206|NCT02778399|589680925|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
163265207|NCT02778399|589680926|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
163265208|NCT02778399|589680927|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
163265209|NCT02778399|589680928|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
163265210|NCT02778399|589680929|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
163265211|NCT02978443|589680931|FG000|Overall Study|Withdrawal by Subject|1|||
163265212|NCT02978443|589680931|FG000|Overall Study|Adverse Event|3|||
163265213|NCT02978443|589680931|FG000|Overall Study|Disease Progression on study|6|||
163265214|NCT02978443|589680931|FG000|Overall Study|Death|1|||
163265215|NCT02978443|589680931|FG000|Overall Study|Physician Decision|1|||
163265216|NCT02978443|589680931|FG000|Overall Study|Switch to alternative therapy|1|||
163265217|NCT02978443|589680931|FG000|Overall Study|Refused further treatment|1|||
163265218|NCT00405639|589680932|FG000|Overall Study|Withdrawal by Subject|1|||
163265219|NCT00405639|589680933|FG001|Overall Study|Withdrawal by Subject|0|||
163265220|NCT00405639|589680932|FG000|Overall Study|Adverse Event|1|||
163265221|NCT00405639|589680933|FG001|Overall Study|Adverse Event|0|||
163265222|NCT00405639|589680932|FG000|Overall Study|Seizure prior to receiving BNP|1|||
163265223|NCT00405639|589680933|FG001|Overall Study|Seizure prior to receiving BNP|0|||
163265224|NCT00612534|589680937|FG000|Overall Study|Adverse Event|0|||
163265225|NCT00612534|589680938|FG001|Overall Study|Adverse Event|4|||
163265226|NCT00612534|589680939|FG002|Overall Study|Adverse Event|2|||
163265227|NCT00612534|589680940|FG003|Overall Study|Adverse Event|1|||
163265228|NCT00612534|589680937|FG000|Overall Study|Lack of Efficacy|13|||
163265229|NCT00612534|589680938|FG001|Overall Study|Lack of Efficacy|12|||
163265230|NCT00612534|589680939|FG002|Overall Study|Lack of Efficacy|5|||
163265231|NCT00612534|589680940|FG003|Overall Study|Lack of Efficacy|16|||
163265232|NCT00612534|589680937|FG000|Overall Study|Other Reason|0|||
163265233|NCT00612534|589680938|FG001|Overall Study|Other Reason|1|||
163265234|NCT00612534|589680939|FG002|Overall Study|Other Reason|0|||
163265235|NCT00612534|589680940|FG003|Overall Study|Other Reason|0|||
163265236|NCT02130284|589680947|FG000|Overall Study|Withdrawal by Subject|3|||
163265237|NCT02130284|589680947|FG000|Overall Study|Subject Withdrew Consent|1|||
163265238|NCT02130284|589680947|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
163265239|NCT02130284|589680947|FG000|Overall Study|Subject was screened as backup for study|3|||
163265240|NCT02130284|589680947|FG000|Overall Study|Screen Failure|1|||
163265241|NCT01852058|589680949|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
163265242|NCT01852058|589680950|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163265243|NCT01852058|589680951|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163265244|NCT01852058|589680952|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163265245|NCT01852058|589680953|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163265246|NCT01852058|589680954|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163265247|NCT01852058|589680955|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163265248|NCT01852058|589680956|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163265249|NCT01852058|589680957|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163265250|NCT01852058|589680958|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163362181|NCT01151423|590034725|FG001|Overall Study|Study terminated by Sponsor|10|||
163362182|NCT01151423|590034724|FG000|Overall Study|Protocol Violation|0|||
163362183|NCT01151423|590034725|FG001|Overall Study|Protocol Violation|1|||
163362184|NCT01151423|590034724|FG000|Overall Study|Physician Decision|1|||
163362185|NCT01151423|590034725|FG001|Overall Study|Physician Decision|1|||
163362186|NCT01151423|590034724|FG000|Overall Study|Pregnancy|0|||
163153907|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
163153908|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
163153909|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
163153910|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
163153911|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
163153912|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
163153913|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
163153914|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
163153915|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
163153916|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
163153917|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
163153918|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
163153919|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
163153920|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
163153921|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
163153922|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Other|6|||
163153923|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Other|8|||
163153924|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
163153925|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
163153926|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
163153927|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
163153928|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
163153929|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
163153930|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
163153931|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
163153932|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
163153933|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
163153934|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
163153935|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
163153936|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Death|0|||
163153937|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Death|2|||
163153938|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
163153939|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
163153940|NCT05632211|589278313|FG000|Overall Study|Withdrawal by Subject|2|||
163153941|NCT05632211|589278314|FG001|Overall Study|Withdrawal by Subject|0|||
163153942|NCT05632211|589278315|FG002|Overall Study|Withdrawal by Subject|2|||
163153943|NCT05632211|589278313|FG000|Overall Study|Other reasons|1|||
163153944|NCT05632211|589278314|FG001|Overall Study|Other reasons|1|||
163153945|NCT05632211|589278315|FG002|Overall Study|Other reasons|1|||
163153946|NCT00541658|589278316|FG000|Overall Study|Adverse Event|28|||
163153947|NCT00541658|589278317|FG001|Overall Study|Adverse Event|37|||
163153948|NCT00541658|589278318|FG002|Overall Study|Adverse Event|25|||
163153949|NCT00541658|589278316|FG000|Overall Study|Physician Decision|0|||
163153950|NCT00541658|589278317|FG001|Overall Study|Physician Decision|0|||
163153951|NCT00541658|589278318|FG002|Overall Study|Physician Decision|4|||
163153952|NCT00541658|589278316|FG000|Overall Study|Lost to Follow-up|3|||
163153953|NCT00541658|589278317|FG001|Overall Study|Lost to Follow-up|3|||
163153954|NCT00541658|589278318|FG002|Overall Study|Lost to Follow-up|6|||
163153955|NCT00541658|589278316|FG000|Overall Study|Protocol Violation|0|||
163153956|NCT00541658|589278317|FG001|Overall Study|Protocol Violation|1|||
163153957|NCT00541658|589278318|FG002|Overall Study|Protocol Violation|1|||
163153958|NCT00541658|589278316|FG000|Overall Study|Withdrawal by Subject|28|||
163153959|NCT00541658|589278317|FG001|Overall Study|Withdrawal by Subject|32|||
163153960|NCT00541658|589278318|FG002|Overall Study|Withdrawal by Subject|32|||
163153961|NCT00541658|589278316|FG000|Overall Study|Took No Study Drug|1|||
163153962|NCT00541658|589278317|FG001|Overall Study|Took No Study Drug|0|||
163153963|NCT00541658|589278318|FG002|Overall Study|Took No Study Drug|0|||
163153964|NCT05194124|589278332|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153965|NCT05194124|589278333|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153966|NCT05194124|589278334|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153967|NCT05194124|589278335|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
163153968|NCT05194124|589278336|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153969|NCT05194124|589278337|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
163153970|NCT05194124|589278338|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153971|NCT05194124|589278339|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153972|NCT05194124|589278340|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153973|NCT05194124|589278341|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153974|NCT05194124|589278332|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153975|NCT05194124|589278333|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153976|NCT05194124|589278334|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163362187|NCT01151423|590034725|FG001|Overall Study|Pregnancy|1|||
163265251|NCT01852058|589680959|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163265252|NCT01852058|589680960|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163265253|NCT01852058|589680949|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163265254|NCT01852058|589680950|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163265255|NCT01852058|589680951|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163265256|NCT01852058|589680952|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163265257|NCT01852058|589680953|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
163265258|NCT01852058|589680954|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163265259|NCT01852058|589680955|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163265260|NCT01852058|589680956|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163265261|NCT01852058|589680957|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163265262|NCT01852058|589680958|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163265263|NCT01852058|589680959|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163265264|NCT01852058|589680960|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163265265|NCT01852058|589680949|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163265266|NCT01852058|589680950|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163265267|NCT01852058|589680951|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163265268|NCT01852058|589680952|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163265269|NCT01852058|589680953|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
163265270|NCT01852058|589680954|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
163265271|NCT01852058|589680955|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163265272|NCT01852058|589680956|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163265273|NCT01852058|589680957|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163265274|NCT01852058|589680958|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163265275|NCT01852058|589680959|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163265276|NCT01852058|589680960|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163265277|NCT01852058|589680949|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163265278|NCT01852058|589680950|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163265279|NCT01852058|589680951|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163265280|NCT01852058|589680952|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163265281|NCT01852058|589680953|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
163265282|NCT01852058|589680954|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163265283|NCT01852058|589680955|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163265284|NCT01852058|589680956|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163265285|NCT01852058|589680957|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163265286|NCT01852058|589680958|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163265287|NCT01852058|589680959|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163265288|NCT01852058|589680960|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163265289|NCT01852058|589680949|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163265290|NCT01852058|589680950|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163265291|NCT01852058|589680951|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163265292|NCT01852058|589680952|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163265293|NCT01852058|589680953|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
163265294|NCT01852058|589680954|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
163265295|NCT01852058|589680955|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163265296|NCT01852058|589680956|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163265297|NCT01852058|589680957|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163265298|NCT01852058|589680958|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163265299|NCT01852058|589680959|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163265300|NCT01852058|589680960|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163265301|NCT01852058|589680949|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163265302|NCT01852058|589680950|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163265303|NCT01852058|589680951|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163265304|NCT01852058|589680952|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
163265305|NCT01852058|589680953|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163265306|NCT01852058|589680954|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163265307|NCT01852058|589680955|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163265308|NCT01852058|589680956|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163265309|NCT01852058|589680957|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163265310|NCT01852058|589680958|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163265311|NCT01852058|589680959|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163265312|NCT01852058|589680960|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163265313|NCT01852058|589680949|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163265314|NCT01852058|589680950|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163265315|NCT01852058|589680951|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163265316|NCT01852058|589680952|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163265317|NCT01852058|589680953|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
163265318|NCT01852058|589680954|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
163265319|NCT01852058|589680955|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163265320|NCT01852058|589680956|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163265321|NCT01852058|589680957|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163265322|NCT01852058|589680958|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163265323|NCT01852058|589680959|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163265324|NCT01852058|589680960|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163265325|NCT01852058|589680949|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163265326|NCT01852058|589680950|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163265327|NCT01852058|589680951|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163265328|NCT01852058|589680952|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163265329|NCT01852058|589680953|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163265330|NCT01852058|589680954|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163265331|NCT01852058|589680955|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163265332|NCT01852058|589680956|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
163265333|NCT01852058|589680957|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163265334|NCT01852058|589680958|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163265335|NCT01852058|589680959|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163265336|NCT01852058|589680960|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163265337|NCT01852058|589680949|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163265338|NCT01852058|589680950|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163265339|NCT01852058|589680951|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163265340|NCT01852058|589680952|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163265341|NCT01852058|589680953|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163265342|NCT01852058|589680954|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163265343|NCT01852058|589680955|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163265344|NCT01852058|589680956|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163265345|NCT01852058|589680957|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
163265346|NCT01852058|589680958|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163265347|NCT01852058|589680959|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163265348|NCT01852058|589680960|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163265349|NCT01279343|589680961|FG000|Overall Study|Did not receive treatment|2|||
163265350|NCT01279343|589680962|FG001|Overall Study|Did not receive treatment|6|||
163265351|NCT03287414|589680963|FG000|Treatment Epoch|Adverse Event|0|||
163265352|NCT03287414|589680964|FG001|Treatment Epoch|Adverse Event|1|||
163265353|NCT03287414|589680963|FG000|Treatment Epoch|Study terminated by sponsor|2|||
163265354|NCT03287414|589680964|FG001|Treatment Epoch|Study terminated by sponsor|2|||
163265355|NCT03287414|589680963|FG000|Treatment Epoch|Subject/Guardian decision|4|||
163265356|NCT03287414|589680964|FG001|Treatment Epoch|Subject/Guardian decision|0|||
163265357|NCT03287414|589680963|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
163265358|NCT03287414|589680964|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
163265359|NCT03287414|589680963|FG000|Treatment Epoch|Withdrawal by Subject|1|||
163265360|NCT03287414|589680964|FG001|Treatment Epoch|Withdrawal by Subject|0|||
163265361|NCT03287414|589680963|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
163265362|NCT03287414|589680964|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
163265363|NCT03287414|589680963|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
163265364|NCT03287414|589680964|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
163265365|NCT01353222|589680969|FG000|Overall Study|Death|30|||
163265366|NCT01353222|589680970|FG001|Overall Study|Death|30|||
163265367|NCT01353222|589680969|FG000|Overall Study|Withdrawal by Subject|8|||
163265368|NCT01353222|589680970|FG001|Overall Study|Withdrawal by Subject|5|||
163265369|NCT01353222|589680969|FG000|Overall Study|Study Terminated|31|||
163265370|NCT01353222|589680970|FG001|Overall Study|Study Terminated|37|||
163265371|NCT01353222|589680969|FG000|Overall Study|Site closed research department|1|||
163362188|NCT01151423|590034724|FG000|Overall Study|Death|0|||
163362189|NCT01151423|590034725|FG001|Overall Study|Death|1|||
163362190|NCT01151423|590034724|FG000|Overall Study|Adverse Event|3|||
163362191|NCT01151423|590034725|FG001|Overall Study|Adverse Event|0|||
163362192|NCT01151423|590034724|FG000|Overall Study|Withdrawal by Subject|1|||
163265372|NCT01353222|589680970|FG001|Overall Study|Site closed research department|0|||
163265373|NCT01122381|589680971|FG000|Overall Study|study terminated early|0|||
163362193|NCT01151423|590034725|FG001|Overall Study|Withdrawal by Subject|3|||
163362194|NCT01151423|590034724|FG000|Overall Study|Lost to Follow-up|1|||
163265374|NCT01122381|589680972|FG001|Overall Study|study terminated early|1|||
163265375|NCT00736489|589680973|FG000|Period 1|Lost to Follow-up|1|||
163265376|NCT00736489|589680974|FG001|Period 1|Lost to Follow-up|0|||
163265377|NCT00736489|589680975|FG002|Period 1|Lost to Follow-up|0|||
163265378|NCT00736489|589680976|FG003|Period 1|Lost to Follow-up|0|||
163265379|NCT00736489|589680977|FG004|Period 1|Lost to Follow-up|0|||
163265380|NCT00736489|589680978|FG005|Period 1|Lost to Follow-up|0|||
163265381|NCT00736489|589680973|FG000|Period 1|Withdrawal by Subject|0|||
163265382|NCT00736489|589680974|FG001|Period 1|Withdrawal by Subject|0|||
163265383|NCT00736489|589680975|FG002|Period 1|Withdrawal by Subject|0|||
163265384|NCT00736489|589680976|FG003|Period 1|Withdrawal by Subject|0|||
163265385|NCT00736489|589680977|FG004|Period 1|Withdrawal by Subject|0|||
163265386|NCT00736489|589680978|FG005|Period 1|Withdrawal by Subject|1|||
163265387|NCT02395133|589680979|FG000|Overall Study|Adverse Event|4|||
163265388|NCT02395133|589680980|FG001|Overall Study|Adverse Event|1|||
163265389|NCT02395133|589680981|FG002|Overall Study|Adverse Event|3|||
163265390|NCT02395133|589680982|FG003|Overall Study|Adverse Event|0|||
163265391|NCT02395133|589680979|FG000|Overall Study|Lack of Efficacy|1|||
163265392|NCT02395133|589680980|FG001|Overall Study|Lack of Efficacy|0|||
163265393|NCT02395133|589680981|FG002|Overall Study|Lack of Efficacy|1|||
163265394|NCT02395133|589680982|FG003|Overall Study|Lack of Efficacy|1|||
163265395|NCT02395133|589680979|FG000|Overall Study|Protocol Violation|1|||
163265396|NCT02395133|589680980|FG001|Overall Study|Protocol Violation|1|||
163265397|NCT02395133|589680981|FG002|Overall Study|Protocol Violation|0|||
163265398|NCT02395133|589680982|FG003|Overall Study|Protocol Violation|3|||
163265399|NCT02395133|589680979|FG000|Overall Study|Lost to Follow-up|0|||
163265400|NCT02395133|589680980|FG001|Overall Study|Lost to Follow-up|1|||
163265401|NCT02395133|589680981|FG002|Overall Study|Lost to Follow-up|1|||
163265402|NCT02395133|589680982|FG003|Overall Study|Lost to Follow-up|0|||
163265403|NCT02395133|589680979|FG000|Overall Study|Pregnancy|0|||
163265404|NCT02395133|589680980|FG001|Overall Study|Pregnancy|0|||
163265405|NCT02395133|589680981|FG002|Overall Study|Pregnancy|3|||
163265406|NCT02395133|589680982|FG003|Overall Study|Pregnancy|0|||
163265407|NCT02395133|589680979|FG000|Overall Study|Consent withdrawn with no reason given|1|||
163265408|NCT02395133|589680980|FG001|Overall Study|Consent withdrawn with no reason given|3|||
163265409|NCT02395133|589680981|FG002|Overall Study|Consent withdrawn with no reason given|0|||
163265410|NCT02395133|589680982|FG003|Overall Study|Consent withdrawn with no reason given|2|||
163265411|NCT02395133|589680979|FG000|Overall Study|Consent withdrawn with personal reason|0|||
163265412|NCT02395133|589680980|FG001|Overall Study|Consent withdrawn with personal reason|1|||
163265413|NCT02395133|589680981|FG002|Overall Study|Consent withdrawn with personal reason|0|||
163265414|NCT02395133|589680982|FG003|Overall Study|Consent withdrawn with personal reason|3|||
163265415|NCT02395133|589680979|FG000|Overall Study|Sponsor decision|2|||
163265416|NCT02395133|589680980|FG001|Overall Study|Sponsor decision|0|||
163265417|NCT02395133|589680981|FG002|Overall Study|Sponsor decision|0|||
163265418|NCT02395133|589680982|FG003|Overall Study|Sponsor decision|1|||
163265419|NCT02395133|589680979|FG000|Overall Study|Other than specified above|5|||
163265420|NCT02395133|589680980|FG001|Overall Study|Other than specified above|2|||
163265421|NCT02395133|589680981|FG002|Overall Study|Other than specified above|2|||
163265422|NCT02395133|589680982|FG003|Overall Study|Other than specified above|4|||
163265423|NCT02669095|589680986|FG000|Overall Study|Adverse Event|1|||
163265424|NCT02669095|589680987|FG001|Overall Study|Adverse Event|0|||
163265425|NCT02669095|589680986|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
163265426|NCT02669095|589680987|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
163265427|NCT02669095|589680986|FG000|Overall Study|Torn Lens|0|||
163265428|NCT02669095|589680987|FG001|Overall Study|Torn Lens|1|||
163265429|NCT02669095|589680986|FG000|Overall Study|Visit 5 assessments not completed|0|||
163265430|NCT02669095|589680987|FG001|Overall Study|Visit 5 assessments not completed|1|||
163265431|NCT00738101|589680989|FG000|Overall Study|Physician Decision|5|||
163265432|NCT00738101|589680989|FG000|Overall Study|Death|1|||
163265433|NCT00738101|589680989|FG000|Overall Study|Repeat enrollment|1|||
163265434|NCT00663117|589682822|FG000|Overall Study|Lack of Efficacy|1|||
163265435|NCT00663117|589682823|FG001|Overall Study|Lack of Efficacy|0|||
163265436|NCT02781506|589682824|FG000|Overall Study|Adverse Event|5|||
163265437|NCT02593539|589682825|FG000|Overall Study|Adverse Event|1|||
163362195|NCT01151423|590034725|FG001|Overall Study|Lost to Follow-up|0|||
163265438|NCT00437125|589682826|FG000|Overall Study|Adverse Event|12|||
163265439|NCT00437125|589682826|FG000|Overall Study|Death|1|||
163265440|NCT00437125|589682826|FG000|Overall Study|Clinical Relapse|1|||
163265441|NCT00437125|589682826|FG000|Overall Study|Lack of Efficacy|1|||
163265442|NCT00437125|589682826|FG000|Overall Study|Lost to Follow-up|1|||
163265443|NCT00437125|589682826|FG000|Overall Study|Withdrawal by Subject|13|||
163265444|NCT00437125|589682826|FG000|Overall Study|Withdrawal by Caregiver|2|||
163265445|NCT00437125|589682826|FG000|Overall Study|Physician Decision|1|||
163265446|NCT02248961|589682829|FG000|Overall Study|Adverse Event|1|||
163265447|NCT02248961|589682830|FG001|Overall Study|Adverse Event|0|||
163265448|NCT02248961|589682829|FG000|Overall Study|Withdrawal by Subject|1|||
163265449|NCT02248961|589682830|FG001|Overall Study|Withdrawal by Subject|2|||
163265450|NCT02248961|589682829|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
163411167|NCT00852995|590212996|FG000|Overall Study|Protocol Violation|0|||
163265451|NCT02248961|589682830|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
163265452|NCT00244374|589682837|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
163265453|NCT00244374|589682838|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
163265454|NCT00244374|589682839|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
163265455|NCT00244374|589682840|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
163265456|NCT00244374|589682841|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
163265457|NCT00244374|589682837|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
163265458|NCT00244374|589682838|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
163265459|NCT00244374|589682839|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
163265460|NCT00244374|589682840|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
163265461|NCT00244374|589682841|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
163265462|NCT00244374|589682837|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
163265463|NCT00244374|589682838|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
163265464|NCT00244374|589682839|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
163265465|NCT00244374|589682840|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
163265466|NCT00244374|589682841|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
163265467|NCT00244374|589682837|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
163265468|NCT00244374|589682838|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
163265469|NCT00244374|589682839|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
163265470|NCT00244374|589682840|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
163265471|NCT00244374|589682841|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
163265472|NCT00244374|589682837|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
163265473|NCT00244374|589682838|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
163265474|NCT00244374|589682839|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
163265475|NCT00244374|589682840|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
163265476|NCT00244374|589682841|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
163265477|NCT00244374|589682837|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
163265478|NCT00244374|589682838|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
163265479|NCT00244374|589682839|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
163265480|NCT00244374|589682840|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
163265481|NCT00244374|589682841|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
163265482|NCT00244374|589682837|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
163265483|NCT00244374|589682838|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
163265484|NCT00244374|589682839|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
163265485|NCT00244374|589682840|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
163265486|NCT00244374|589682841|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
163265487|NCT00244374|589682837|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
163265488|NCT00244374|589682838|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
163265489|NCT00244374|589682839|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
163265490|NCT00244374|589682840|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
163265491|NCT00244374|589682841|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
163265492|NCT00244374|589682837|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
163265493|NCT00244374|589682838|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
163265494|NCT00244374|589682839|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
163265495|NCT00244374|589682840|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
163265496|NCT00244374|589682841|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
163265497|NCT03462706|589682843|FG000|Overall Study|Polyp was pedunculated|1|||
163265498|NCT03462706|589682844|FG001|Overall Study|Polyp was pedunculated|0|||
163265499|NCT03462706|589682845|FG002|Overall Study|Polyp was pedunculated|1|||
163265500|NCT03462706|589682846|FG003|Overall Study|Polyp was pedunculated|0|||
163265501|NCT03462706|589682843|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
163265502|NCT03462706|589682844|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
163265503|NCT03462706|589682845|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
163265504|NCT03462706|589682846|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
163265505|NCT04105972|589682855|FG000|Overall Study|Adverse Event|2|||
163265506|NCT04105972|589682856|FG001|Overall Study|Adverse Event|1|||
163265507|NCT03545113|589682861|FG000|Overall Study|Surgery Cancelled|1|||
163265508|NCT03545113|589682862|FG001|Overall Study|Surgery Cancelled|0|||
163265509|NCT03545113|589682861|FG000|Overall Study|Death|1|||
163265510|NCT03545113|589682862|FG001|Overall Study|Death|0|||
163265511|NCT03545113|589682861|FG000|Overall Study|Adverse Event|2|||
163265512|NCT03545113|589682862|FG001|Overall Study|Adverse Event|0|||
163265513|NCT03545113|589682861|FG000|Overall Study|Received different surgery|1|||
163265514|NCT03545113|589682862|FG001|Overall Study|Received different surgery|0|||
163265515|NCT00235443|589682863|FG000|Overall Study|Adverse Event|4|||
163265516|NCT00235443|589682864|FG001|Overall Study|Adverse Event|12|||
163265517|NCT00235443|589682865|FG002|Overall Study|Adverse Event|17|||
163265518|NCT00235443|589682866|FG003|Overall Study|Adverse Event|44|||
163265519|NCT00235443|589682867|FG004|Overall Study|Adverse Event|10|||
163265520|NCT00235443|589682868|FG005|Overall Study|Adverse Event|15|||
163265521|NCT00235443|589682863|FG000|Overall Study|Lack of Efficacy|0|||
163265522|NCT00235443|589682864|FG001|Overall Study|Lack of Efficacy|1|||
163265523|NCT00235443|589682865|FG002|Overall Study|Lack of Efficacy|5|||
163265524|NCT00235443|589682866|FG003|Overall Study|Lack of Efficacy|12|||
163265525|NCT00235443|589682867|FG004|Overall Study|Lack of Efficacy|2|||
163265526|NCT00235443|589682868|FG005|Overall Study|Lack of Efficacy|9|||
163265527|NCT00235443|589682863|FG000|Overall Study|Withdrawal by Subject|3|||
163265528|NCT00235443|589682864|FG001|Overall Study|Withdrawal by Subject|9|||
163265529|NCT00235443|589682865|FG002|Overall Study|Withdrawal by Subject|25|||
163265530|NCT00235443|589682866|FG003|Overall Study|Withdrawal by Subject|24|||
163265531|NCT00235443|589682867|FG004|Overall Study|Withdrawal by Subject|10|||
163265532|NCT00235443|589682868|FG005|Overall Study|Withdrawal by Subject|12|||
163265533|NCT00235443|589682863|FG000|Overall Study|Lost to Follow-up|0|||
163265534|NCT00235443|589682864|FG001|Overall Study|Lost to Follow-up|8|||
163265535|NCT00235443|589682865|FG002|Overall Study|Lost to Follow-up|6|||
163265536|NCT00235443|589682866|FG003|Overall Study|Lost to Follow-up|6|||
163265537|NCT00235443|589682867|FG004|Overall Study|Lost to Follow-up|4|||
163265538|NCT00235443|589682868|FG005|Overall Study|Lost to Follow-up|3|||
163265539|NCT00235443|589682863|FG000|Overall Study|Unsatisfactory compliance|0|||
163265540|NCT00235443|589682864|FG001|Overall Study|Unsatisfactory compliance|2|||
163265541|NCT00235443|589682865|FG002|Overall Study|Unsatisfactory compliance|3|||
163265542|NCT00235443|589682866|FG003|Overall Study|Unsatisfactory compliance|4|||
163265543|NCT00235443|589682867|FG004|Overall Study|Unsatisfactory compliance|1|||
163265544|NCT00235443|589682868|FG005|Overall Study|Unsatisfactory compliance|0|||
163265545|NCT00235443|589682863|FG000|Overall Study|Other reasons for premature termination|1|||
163265546|NCT00235443|589682864|FG001|Overall Study|Other reasons for premature termination|6|||
163265547|NCT00235443|589682865|FG002|Overall Study|Other reasons for premature termination|6|||
163265548|NCT00235443|589682866|FG003|Overall Study|Other reasons for premature termination|7|||
163265549|NCT00235443|589682867|FG004|Overall Study|Other reasons for premature termination|3|||
163265550|NCT00235443|589682868|FG005|Overall Study|Other reasons for premature termination|6|||
163265551|NCT03321513|589682872|FG000|Overall Study|Death|11|||
163265552|NCT03321513|589682873|FG001|Overall Study|Death|5|||
163265553|NCT03321513|589682872|FG000|Overall Study|Withdrawal by Subject|5|||
163265554|NCT03321513|589682873|FG001|Overall Study|Withdrawal by Subject|10|||
163265555|NCT03321513|589682872|FG000|Overall Study|Lost to Follow-up|10|||
163265556|NCT03321513|589682873|FG001|Overall Study|Lost to Follow-up|11|||
163265557|NCT03029247|589682874|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
163265558|NCT03029247|589682875|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
163265559|NCT03029247|589682874|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
163265560|NCT03029247|589682875|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
163265561|NCT03029247|589682874|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
163265562|NCT03029247|589682875|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
163265563|NCT03029247|589682874|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
163265564|NCT03029247|589682875|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
163265565|NCT02757521|589682876|FG000|Overall Study|Adverse Event|1|||
163265566|NCT02757521|589682877|FG001|Overall Study|Adverse Event|0|||
163265567|NCT02912468|589682901|FG000|Overall Study|Adverse Event|3|||
163265568|NCT02912468|589682902|FG001|Overall Study|Adverse Event|2|||
163265569|NCT02912468|589682901|FG000|Overall Study|Withdrawal by Subject|6|||
163265570|NCT02912468|589682902|FG001|Overall Study|Withdrawal by Subject|2|||
163265571|NCT02912468|589682901|FG000|Overall Study|Randomized and not treated|0|||
163265572|NCT02912468|589682902|FG001|Overall Study|Randomized and not treated|1|||
163265573|NCT01515189|589682903|FG000|Induction|Disease Progression|109|||
163265574|NCT01515189|589682904|FG001|Induction|Disease Progression|155|||
163265575|NCT01515189|589682903|FG000|Induction|Study drug toxicity|86|||
163265576|NCT01515189|589682904|FG001|Induction|Study drug toxicity|36|||
163265577|NCT01515189|589682903|FG000|Induction|Death|24|||
163265578|NCT01515189|589682904|FG001|Induction|Death|17|||
163265579|NCT01515189|589682903|FG000|Induction|Adverse Event|14|||
163265580|NCT01515189|589682904|FG001|Induction|Adverse Event|9|||
163265581|NCT01515189|589682903|FG000|Induction|Withdrawal by Subject|3|||
163265582|NCT01515189|589682904|FG001|Induction|Withdrawal by Subject|9|||
163265583|NCT01515189|589682903|FG000|Induction|No longer meets study criteria|0|||
163265584|NCT01515189|589682904|FG001|Induction|No longer meets study criteria|2|||
163265585|NCT01515189|589682903|FG000|Induction|Lost to Follow-up|1|||
163265586|NCT01515189|589682904|FG001|Induction|Lost to Follow-up|0|||
163265587|NCT01515189|589682903|FG000|Induction|Other|0|||
163265588|NCT01515189|589682904|FG001|Induction|Other|4|||
163265589|NCT01515189|589682903|FG000|First Re-Induction Phase|Disease progression|6|||
163265590|NCT01515189|589682904|FG001|First Re-Induction Phase|Disease progression|14|||
163265591|NCT01515189|589682903|FG000|First Re-Induction Phase|Study drug toxicity|5|||
163265592|NCT01515189|589682904|FG001|First Re-Induction Phase|Study drug toxicity|0|||
163265593|NCT01515189|589682903|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
163265594|NCT01515189|589682904|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
163265595|NCT01515189|589682903|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
163265596|NCT01515189|589682904|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
163265597|NCT01515189|589682903|FG000|First Re-Induction Phase|Other|1|||
163265598|NCT01515189|589682904|FG001|First Re-Induction Phase|Other|0|||
163265599|NCT00284089|589682905|FG000|Multiple Dose Phase|Adverse Event|1|||
163265600|NCT00284089|589682906|FG001|Multiple Dose Phase|Adverse Event|0|||
163265601|NCT00284089|589682907|FG002|Multiple Dose Phase|Adverse Event|1|||
163265602|NCT00284089|589682908|FG003|Multiple Dose Phase|Adverse Event|1|||
163265603|NCT00284089|589682905|FG000|Multiple Dose Phase|Protocol Violation|0|||
163265604|NCT00284089|589682906|FG001|Multiple Dose Phase|Protocol Violation|0|||
163265605|NCT00284089|589682907|FG002|Multiple Dose Phase|Protocol Violation|1|||
163265606|NCT00284089|589682908|FG003|Multiple Dose Phase|Protocol Violation|0|||
163265607|NCT00284089|589682905|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
163265608|NCT00284089|589682906|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
163265609|NCT00284089|589682907|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
163153977|NCT05194124|589278335|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153978|NCT05194124|589278336|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153979|NCT05194124|589278337|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153980|NCT05194124|589278338|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153981|NCT05194124|589278339|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153982|NCT05194124|589278340|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153983|NCT05194124|589278341|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
163153984|NCT05408429|589278346|FG000|Overall Study|Lost to Follow-up|1|||
163153985|NCT05408429|589278347|FG001|Overall Study|Lost to Follow-up|1|||
163153986|NCT05408429|589278348|FG002|Overall Study|Lost to Follow-up|0|||
163153987|NCT05408429|589278346|FG000|Overall Study|Withdrawal by Subject|5|||
163153988|NCT05408429|589278347|FG001|Overall Study|Withdrawal by Subject|0|||
163153989|NCT05408429|589278348|FG002|Overall Study|Withdrawal by Subject|1|||
163153990|NCT03642873|589278349|FG000|Third Intervention (1 Day)|Screen failure|0|||
163153991|NCT03642873|589278350|FG001|Third Intervention (1 Day)|Screen failure|0|||
163153992|NCT03642873|589278351|FG002|Third Intervention (1 Day)|Screen failure|0|||
163153993|NCT03642873|589278352|FG003|Third Intervention (1 Day)|Screen failure|0|||
163153994|NCT03642873|589278353|FG004|Third Intervention (1 Day)|Screen failure|1|||
163153995|NCT03642873|589278354|FG005|Third Intervention (1 Day)|Screen failure|0|||
163153996|NCT01253291|589278356|FG000|Overall Study|Withdrawal by Subject|1|||
163153997|NCT01253291|589278357|FG001|Overall Study|Withdrawal by Subject|1|||
163153998|NCT01253291|589278358|FG002|Overall Study|Withdrawal by Subject|0|||
163153999|NCT01253291|589278359|FG003|Overall Study|Withdrawal by Subject|0|||
163154000|NCT01253291|589278360|FG004|Overall Study|Withdrawal by Subject|0|||
163154001|NCT01253291|589278356|FG000|Overall Study|Adverse Event|0|||
163154002|NCT01253291|589278357|FG001|Overall Study|Adverse Event|1|||
163154003|NCT01253291|589278358|FG002|Overall Study|Adverse Event|0|||
163154004|NCT01253291|589278359|FG003|Overall Study|Adverse Event|0|||
163154005|NCT01253291|589278360|FG004|Overall Study|Adverse Event|0|||
163154006|NCT01253291|589278356|FG000|Overall Study|Lack of Efficacy|1|||
163154007|NCT01253291|589278357|FG001|Overall Study|Lack of Efficacy|0|||
163154008|NCT01253291|589278358|FG002|Overall Study|Lack of Efficacy|0|||
163154009|NCT01253291|589278359|FG003|Overall Study|Lack of Efficacy|0|||
163154010|NCT01253291|589278360|FG004|Overall Study|Lack of Efficacy|0|||
163154011|NCT01253291|589278356|FG000|Overall Study|Physician Decision|2|||
163154012|NCT01253291|589278357|FG001|Overall Study|Physician Decision|0|||
163154013|NCT01253291|589278358|FG002|Overall Study|Physician Decision|0|||
163154014|NCT01253291|589278359|FG003|Overall Study|Physician Decision|0|||
163154015|NCT01253291|589278360|FG004|Overall Study|Physician Decision|2|||
163154016|NCT03312231|589278364|FG000|Overall Study|Lost to Follow-up|2|||
163154017|NCT03312231|589278365|FG001|Overall Study|Lost to Follow-up|6|||
163154018|NCT03312231|589278366|FG002|Overall Study|Lost to Follow-up|1|||
163154019|NCT03312231|589278367|FG003|Overall Study|Lost to Follow-up|3|||
163154020|NCT03312231|589278368|FG004|Overall Study|Lost to Follow-up|1|||
163154021|NCT03312231|589278364|FG000|Overall Study|Withdrawal by Subject|0|||
163154022|NCT03312231|589278365|FG001|Overall Study|Withdrawal by Subject|3|||
163154023|NCT03312231|589278366|FG002|Overall Study|Withdrawal by Subject|1|||
163265610|NCT00284089|589682908|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
163265611|NCT00284089|589682905|FG000|Multiple Dose Phase|Death|0|||
163265612|NCT00284089|589682906|FG001|Multiple Dose Phase|Death|0|||
163265613|NCT00284089|589682907|FG002|Multiple Dose Phase|Death|1|||
163154024|NCT03312231|589278367|FG003|Overall Study|Withdrawal by Subject|0|||
163154025|NCT03312231|589278368|FG004|Overall Study|Withdrawal by Subject|0|||
163154026|NCT03312231|589278364|FG000|Overall Study|Death|0|||
163265614|NCT00284089|589682908|FG003|Multiple Dose Phase|Death|1|||
163265615|NCT00284089|589682905|FG000|Extension Phase|Adverse Event|0|||
163265616|NCT00284089|589682906|FG001|Extension Phase|Adverse Event|0|||
163265617|NCT00284089|589682907|FG002|Extension Phase|Adverse Event|2|||
163265618|NCT00284089|589682908|FG003|Extension Phase|Adverse Event|2|||
163265619|NCT00284089|589682905|FG000|Extension Phase|condition no longer requires study drug|2|||
163265620|NCT00284089|589682906|FG001|Extension Phase|condition no longer requires study drug|0|||
163265621|NCT00284089|589682907|FG002|Extension Phase|condition no longer requires study drug|2|||
163265622|NCT00284089|589682908|FG003|Extension Phase|condition no longer requires study drug|7|||
163265623|NCT00284089|589682905|FG000|Extension Phase|Protocol Violation|0|||
163265624|NCT00284089|589682906|FG001|Extension Phase|Protocol Violation|0|||
163265625|NCT00284089|589682907|FG002|Extension Phase|Protocol Violation|1|||
163265626|NCT00284089|589682908|FG003|Extension Phase|Protocol Violation|0|||
163265627|NCT00284089|589682905|FG000|Extension Phase|Withdrawal by Subject|0|||
163265628|NCT00284089|589682906|FG001|Extension Phase|Withdrawal by Subject|0|||
163265629|NCT00284089|589682907|FG002|Extension Phase|Withdrawal by Subject|1|||
163265630|NCT00284089|589682908|FG003|Extension Phase|Withdrawal by Subject|3|||
163265631|NCT02541383|589682909|FG000|Overall Study|Death|50|||
163265632|NCT02541383|589682910|FG001|Overall Study|Death|37|||
163265633|NCT02541383|589682911|FG002|Overall Study|Death|48|||
163265634|NCT02541383|589682912|FG003|Overall Study|Death|41|||
163265635|NCT02541383|589682913|FG004|Overall Study|Death|21|||
163265636|NCT02541383|589682914|FG005|Overall Study|Death|25|||
163265637|NCT02541383|589682909|FG000|Overall Study|Lost to Follow-up|5|||
163265638|NCT02541383|589682910|FG001|Overall Study|Lost to Follow-up|3|||
163265639|NCT02541383|589682911|FG002|Overall Study|Lost to Follow-up|1|||
163265640|NCT02541383|589682912|FG003|Overall Study|Lost to Follow-up|1|||
163265641|NCT02541383|589682913|FG004|Overall Study|Lost to Follow-up|3|||
163265642|NCT02541383|589682914|FG005|Overall Study|Lost to Follow-up|0|||
163265643|NCT02541383|589682909|FG000|Overall Study|Consent withdrawn|5|||
163265644|NCT02541383|589682910|FG001|Overall Study|Consent withdrawn|6|||
163265645|NCT02541383|589682911|FG002|Overall Study|Consent withdrawn|1|||
163265646|NCT02541383|589682912|FG003|Overall Study|Consent withdrawn|1|||
163265647|NCT02541383|589682913|FG004|Overall Study|Consent withdrawn|0|||
163265648|NCT02541383|589682914|FG005|Overall Study|Consent withdrawn|0|||
163265649|NCT02541383|589682909|FG000|Overall Study|Sponsor's decision|1|||
163265650|NCT02541383|589682910|FG001|Overall Study|Sponsor's decision|1|||
163265651|NCT02541383|589682911|FG002|Overall Study|Sponsor's decision|0|||
163265652|NCT02541383|589682912|FG003|Overall Study|Sponsor's decision|0|||
163265653|NCT02541383|589682913|FG004|Overall Study|Sponsor's decision|0|||
163265654|NCT02541383|589682914|FG005|Overall Study|Sponsor's decision|0|||
163265655|NCT05796518|589682915|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
163265656|NCT00594217|589682916|FG000|Overall Study|Withdrawal by Subject|1|||
163265657|NCT00594217|589682917|FG001|Overall Study|Withdrawal by Subject|3|||
163265658|NCT05778526|589682920|FG000|Overall Study|Lost to Follow-up|0|||
163265659|NCT05778526|589682921|FG001|Overall Study|Lost to Follow-up|1|||
163265660|NCT05778526|589682922|FG002|Overall Study|Lost to Follow-up|3|||
163265661|NCT05778526|589682920|FG000|Overall Study|Protocol Violation|0|||
163265662|NCT05778526|589682921|FG001|Overall Study|Protocol Violation|0|||
163265663|NCT05778526|589682922|FG002|Overall Study|Protocol Violation|8|||
163265664|NCT03108157|589682925|FG000|Overall Study|Protocol Violation|15|||
163265665|NCT03108157|589682926|FG001|Overall Study|Protocol Violation|4|||
163265666|NCT01435655|589682927|FG000|Overall Study|Death|2|||
163265667|NCT01435655|589682927|FG000|Overall Study|Other|1|||
163265668|NCT02839343|589682930|FG000|Overall Study|Withdrawal by Subject|3|||
163265669|NCT02839343|589682931|FG001|Overall Study|Withdrawal by Subject|1|||
163265670|NCT02839343|589682930|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
163265671|NCT02839343|589682931|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
163265672|NCT02839343|589682930|FG000|Overall Study|Adverse Event|1|||
163265673|NCT02839343|589682931|FG001|Overall Study|Adverse Event|0|||
163265674|NCT02223754|589682932|FG000|Period 1|Adverse Event|1|||
163265675|NCT02223754|589682933|FG001|Period 1|Adverse Event|0|||
163265676|NCT02223754|589682932|FG000|Period 1|Lost to Follow-up|0|||
163265677|NCT02223754|589682933|FG001|Period 1|Lost to Follow-up|1|||
163265678|NCT02223754|589682932|FG000|Period 1|Protocol Violation|2|||
163265679|NCT02223754|589682933|FG001|Period 1|Protocol Violation|4|||
163265680|NCT02223754|589682932|FG000|Period 1|Withdrawal by Subject|0|||
163265681|NCT02223754|589682933|FG001|Period 1|Withdrawal by Subject|4|||
163265682|NCT02223754|589682932|FG000|Period 1|Test Article No Longer Available|1|||
163265683|NCT02223754|589682933|FG001|Period 1|Test Article No Longer Available|5|||
163265684|NCT02223754|589682932|FG000|Period 1|Unsatisfactory Visual Response|0|||
163362196|NCT01151423|590034724|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
163265685|NCT02223754|589682933|FG001|Period 1|Unsatisfactory Visual Response|1|||
163265686|NCT02223754|589682932|FG000|Period 2|Adverse Event|0|||
163265687|NCT02223754|589682933|FG001|Period 2|Adverse Event|1|||
163265688|NCT02223754|589682932|FG000|Period 2|Protocol Violation|1|||
163265689|NCT02223754|589682933|FG001|Period 2|Protocol Violation|0|||
163265690|NCT02223754|589682932|FG000|Period 2|Lens Discomfort|1|||
163265691|NCT02223754|589682933|FG001|Period 2|Lens Discomfort|1|||
163265692|NCT02223754|589682932|FG000|Period 2|Lost to Follow-up|1|||
163265693|NCT02223754|589682933|FG001|Period 2|Lost to Follow-up|0|||
163265694|NCT02223754|589682932|FG000|Period 2|Test Article No Longer Available|0|||
163265695|NCT02223754|589682933|FG001|Period 2|Test Article No Longer Available|1|||
163265696|NCT04395183|589682935|FG000|Overall Study|Withdrawal by Subject|1|||
163265697|NCT04395183|589682936|FG001|Overall Study|Withdrawal by Subject|0|||
163265698|NCT04395183|589682937|FG002|Overall Study|Withdrawal by Subject|2|||
163265699|NCT04395183|589682938|FG003|Overall Study|Withdrawal by Subject|2|||
163265700|NCT02668016|589682939|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
163265701|NCT02668016|589682939|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
163265702|NCT02668016|589682939|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
163265703|NCT02668016|589682939|FG000|Month 4|Withdrawal due to severe symptoms|1|||
163265704|NCT02668016|589682939|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
163265705|NCT02668016|589682939|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
163265706|NCT02668016|589682939|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
163265707|NCT02668016|589682939|FG000|Month 6|Withdrawal due to severe symptoms|2|||
163265708|NCT02668016|589682939|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
163265709|NCT02668016|589682939|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
163265710|NCT02668016|589682939|FG000|Month 8|Withdrawal due to severe symptoms|1|||
163265711|NCT02668016|589682939|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
163265712|NCT02668016|589682939|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
163265713|NCT02668016|589682939|FG000|Month 10|Withdrawal due to severe symptoms|1|||
163265714|NCT02668016|589682939|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
163265715|NCT02234063|589682946|FG000|Overall Study|Lost to Follow-up|235|||
163265716|NCT02234063|589682947|FG001|Overall Study|Lost to Follow-up|42|||
163265717|NCT02234063|589682946|FG000|Overall Study|Withdrawal by Subject|20|||
163265718|NCT02234063|589682947|FG001|Overall Study|Withdrawal by Subject|1|||
163265719|NCT00510458|589682950|FG000|Overall Study|5 year not evaluable/missed|21|||
163265720|NCT00510458|589682950|FG000|Overall Study|Death|1|||
163265721|NCT00510458|589682950|FG000|Overall Study|Terminated|14|||
163265722|NCT00510458|589682950|FG000|Overall Study|Lost to Follow-up|6|||
163362197|NCT01151423|590034725|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
163362198|NCT01151423|590034724|FG000|Overall Study|Participated in other clinical trial|1|||
163362199|NCT01151423|590034725|FG001|Overall Study|Participated in other clinical trial|0|||
163362200|NCT01263054|590034726|FG000|Overall Study|Death|1|||
163362201|NCT01263054|590034727|FG001|Overall Study|Death|0|||
163362202|NCT01263054|590034726|FG000|Overall Study|Lost to Follow-up|2|||
163362203|NCT01263054|590034727|FG001|Overall Study|Lost to Follow-up|2|||
163362204|NCT01263054|590034726|FG000|Overall Study|Withdrawal by Subject|1|||
163362205|NCT01263054|590034727|FG001|Overall Study|Withdrawal by Subject|3|||
163362206|NCT01263054|590034726|FG000|Overall Study|Qualification Violation|1|||
163362207|NCT01263054|590034727|FG001|Overall Study|Qualification Violation|0|||
163362208|NCT01263054|590034726|FG000|Overall Study|Other|0|||
163362209|NCT01263054|590034727|FG001|Overall Study|Other|1|||
163362210|NCT00681668|590034728|FG000|Overall Study|Protocol Violation|1|||
163362211|NCT00681668|590034728|FG000|Overall Study|Withdrawal by Subject|1|||
163362212|NCT04277507|590034730|FG000|Overall Study|Lost to Follow-up|17|||
163362213|NCT04277507|590034730|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
163362214|NCT04277507|590034730|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
163362215|NCT04277507|590034730|FG000|Overall Study|Withdrawal by Subject|3|||
163362216|NCT04277507|590034730|FG000|Overall Study|Death due to COVID-19|1|||
163362217|NCT04277507|590034730|FG000|Overall Study|Data missing for full evaluation|5|||
163362218|NCT01740154|590034734|FG000|Overall Study|Adverse Event|1|||
163362219|NCT02520310|590034738|FG000|At 6 Months Clinical Follow-up|Death|1|||
163362220|NCT02520310|590034738|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
163362221|NCT02520310|590034738|FG000|AT 3 Year Clinical Follow-up|Death|2|||
163362222|NCT02520310|590034738|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
163362223|NCT02520310|590034738|FG000|AT 4 Year Clinical Follow-up|Death|1|||
163362224|NCT02520310|590034738|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
163362225|NCT05032066|590034739|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
163362226|NCT05032066|590034740|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
163362227|NCT05032066|590034741|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
163362228|NCT05032066|590034739|FG000|Part 1: Core Phase|Physician Decision|0|||
163362229|NCT05032066|590034740|FG001|Part 1: Core Phase|Physician Decision|1|||
163362230|NCT05032066|590034741|FG002|Part 1: Core Phase|Physician Decision|1|||
163362231|NCT05032066|590034739|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
163362232|NCT05032066|590034740|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
163362233|NCT05032066|590034741|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
163362234|NCT05032066|590034739|FG000|Part 1: Core Phase|Death|3|||
163362235|NCT05032066|590034740|FG001|Part 1: Core Phase|Death|4|||
163362236|NCT05032066|590034741|FG002|Part 1: Core Phase|Death|2|||
163362237|NCT05032066|590034739|FG000|Part 1: Core Phase|Adverse Event|2|||
163362238|NCT05032066|590034740|FG001|Part 1: Core Phase|Adverse Event|3|||
163362239|NCT05032066|590034741|FG002|Part 1: Core Phase|Adverse Event|0|||
163362240|NCT05032066|590034739|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
163362241|NCT05032066|590034740|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
163362242|NCT05032066|590034741|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
163362243|NCT05032066|590034739|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
163362244|NCT05032066|590034740|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
163362245|NCT05032066|590034741|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
163362246|NCT05032066|590034739|FG000|Part 2: Extension Phase|Physician Decision|1|||
163362247|NCT05032066|590034740|FG001|Part 2: Extension Phase|Physician Decision|2|||
163362248|NCT05032066|590034741|FG002|Part 2: Extension Phase|Physician Decision|0|||
163154027|NCT03312231|589278365|FG001|Overall Study|Death|1|||
163154028|NCT03312231|589278366|FG002|Overall Study|Death|1|||
163154029|NCT03312231|589278367|FG003|Overall Study|Death|0|||
163154030|NCT03312231|589278368|FG004|Overall Study|Death|0|||
163154031|NCT03312231|589278364|FG000|Overall Study|Study Vaccination not Received|1|||
163154032|NCT03312231|589278365|FG001|Overall Study|Study Vaccination not Received|1|||
163154033|NCT03312231|589278366|FG002|Overall Study|Study Vaccination not Received|1|||
163154034|NCT03312231|589278367|FG003|Overall Study|Study Vaccination not Received|0|||
163154035|NCT03312231|589278368|FG004|Overall Study|Study Vaccination not Received|0|||
163154036|NCT03157830|589278372|FG000|Overall Study|Lost to Follow-up|1|||
163154037|NCT03157830|589278372|FG000|Overall Study|Withdrawal by Subject|1|||
163154038|NCT02195518|589278373|FG000|Overall Study|Adverse Event|1|||
163154039|NCT02195518|589278373|FG000|Overall Study|Protocol Violation|4|||
163154040|NCT02195518|589278373|FG000|Overall Study|Pregnancy|2|||
163154041|NCT02195518|589278373|FG000|Overall Study|Withdrawal by Subject|1|||
163154042|NCT02195518|589278373|FG000|Overall Study|Lost to Follow-up|1|||
163154043|NCT03694353|589278374|FG000|Overall Study|Withdrawal by Subject|1|||
163154044|NCT03694353|589278374|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
163154045|NCT03804528|589278379|FG000|Overall Study|Time Commitment|18|||
163154046|NCT03804528|589278379|FG000|Overall Study|Health Reasons|5|||
163154047|NCT00651742|589278381|FG000|Overall Study|Objective Disease Progression|22|||
163154048|NCT00651742|589278381|FG000|Overall Study|Toxicity|3|||
163154049|NCT00651742|589278381|FG000|Overall Study|Investigator Judgment|1|||
163154050|NCT00651742|589278381|FG000|Overall Study|Withdrawal of Consent|1|||
163154051|NCT00651742|589278381|FG000|Overall Study|Enrolled but not treated|1|||
163154052|NCT01074970|589278382|FG000|Overall Study|Never Treated|0|||
163154053|NCT01074970|589278383|FG001|Overall Study|Never Treated|0|||
163154054|NCT01074970|589278384|FG002|Overall Study|Never Treated|8|||
163154055|NCT01074970|589278385|FG003|Overall Study|Never Treated|1|||
163154056|NCT01074970|589278382|FG000|Overall Study|Adverse Event|1|||
163154057|NCT01074970|589278383|FG001|Overall Study|Adverse Event|0|||
163154058|NCT01074970|589278384|FG002|Overall Study|Adverse Event|4|||
163154059|NCT01074970|589278385|FG003|Overall Study|Adverse Event|3|||
163154060|NCT01074970|589278382|FG000|Overall Study|Disease progression during treatment|3|||
163154061|NCT01074970|589278383|FG001|Overall Study|Disease progression during treatment|1|||
163154062|NCT01074970|589278384|FG002|Overall Study|Disease progression during treatment|2|||
163154063|NCT01074970|589278385|FG003|Overall Study|Disease progression during treatment|9|||
163154064|NCT01074970|589278382|FG000|Overall Study|Lost to Follow-up|0|||
163154065|NCT01074970|589278383|FG001|Overall Study|Lost to Follow-up|0|||
163154066|NCT01074970|589278384|FG002|Overall Study|Lost to Follow-up|1|||
163154067|NCT01074970|589278385|FG003|Overall Study|Lost to Follow-up|0|||
163154068|NCT01074970|589278382|FG000|Overall Study|Withdrawal by Subject|0|||
163154069|NCT01074970|589278383|FG001|Overall Study|Withdrawal by Subject|0|||
163154070|NCT01074970|589278384|FG002|Overall Study|Withdrawal by Subject|6|||
163154071|NCT01074970|589278385|FG003|Overall Study|Withdrawal by Subject|4|||
163154072|NCT00734149|589278387|FG000|Overall Study|Withdrawal by Subject|1|||
163154073|NCT04314284|589278388|FG000|Overall Study|Withdrawal by Subject|4|||
163154074|NCT04314284|589278389|FG001|Overall Study|Withdrawal by Subject|7|||
163154075|NCT04314284|589278388|FG000|Overall Study|Consented but did not complete survey|0|||
163154076|NCT04314284|589278389|FG001|Overall Study|Consented but did not complete survey|6|||
163154077|NCT01652235|589278392|FG000|Overall Study|Death|9|||
163154078|NCT01652235|589278392|FG000|Overall Study|Lost to Follow-up|5|||
163154079|NCT01652235|589278392|FG000|Overall Study|Withdrawal by Subject|2|||
163154080|NCT05138653|589278393|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
163154081|NCT05138653|589278394|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154082|NCT05138653|589278395|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154083|NCT05138653|589278396|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154084|NCT05138653|589278397|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154085|NCT05138653|589278398|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154086|NCT05138653|589278399|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154087|NCT05138653|589278400|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154088|NCT05138653|589278401|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163265723|NCT00510458|589682950|FG000|Overall Study|Withdrawal by Subject|3|||
163265724|NCT00510458|589682950|FG000|Overall Study|Revision|2|||
163265725|NCT02569710|589682951|FG000|Overall Study|Adverse Event|1|||
163265726|NCT02569710|589682952|FG001|Overall Study|Adverse Event|0|||
163265727|NCT02569710|589682953|FG002|Overall Study|Adverse Event|0|||
163265728|NCT02569710|589682954|FG003|Overall Study|Adverse Event|0|||
163265729|NCT02569710|589682955|FG004|Overall Study|Adverse Event|0|||
163265730|NCT02569710|589682956|FG005|Overall Study|Adverse Event|0|||
163265731|NCT02569710|589682957|FG006|Overall Study|Adverse Event|0|||
163265732|NCT02569710|589682958|FG007|Overall Study|Adverse Event|0|||
163265733|NCT02569710|589682959|FG008|Overall Study|Adverse Event|0|||
163265734|NCT02569710|589682960|FG009|Overall Study|Adverse Event|0|||
163265735|NCT02569710|589682951|FG000|Overall Study|Lost to Follow-up|0|||
163265736|NCT02569710|589682952|FG001|Overall Study|Lost to Follow-up|0|||
163265737|NCT02569710|589682953|FG002|Overall Study|Lost to Follow-up|0|||
163265738|NCT02569710|589682954|FG003|Overall Study|Lost to Follow-up|0|||
163265739|NCT02569710|589682955|FG004|Overall Study|Lost to Follow-up|0|||
163265740|NCT02569710|589682956|FG005|Overall Study|Lost to Follow-up|0|||
163265741|NCT02569710|589682957|FG006|Overall Study|Lost to Follow-up|1|||
163265742|NCT02569710|589682958|FG007|Overall Study|Lost to Follow-up|0|||
163265743|NCT02569710|589682959|FG008|Overall Study|Lost to Follow-up|1|||
163265744|NCT02569710|589682960|FG009|Overall Study|Lost to Follow-up|0|||
163265745|NCT02569710|589682951|FG000|Overall Study|Virologic failure|0|||
163265746|NCT02569710|589682952|FG001|Overall Study|Virologic failure|0|||
163265747|NCT02569710|589682953|FG002|Overall Study|Virologic failure|0|||
163265748|NCT02569710|589682954|FG003|Overall Study|Virologic failure|0|||
163265749|NCT02569710|589682955|FG004|Overall Study|Virologic failure|1|||
163265750|NCT02569710|589682956|FG005|Overall Study|Virologic failure|0|||
163265751|NCT02569710|589682957|FG006|Overall Study|Virologic failure|1|||
163265752|NCT02569710|589682958|FG007|Overall Study|Virologic failure|0|||
163265753|NCT02569710|589682959|FG008|Overall Study|Virologic failure|0|||
163265754|NCT02569710|589682960|FG009|Overall Study|Virologic failure|0|||
163265755|NCT02569710|589682951|FG000|Overall Study|Withdrawal by Subject|0|||
163265756|NCT02569710|589682952|FG001|Overall Study|Withdrawal by Subject|0|||
163265757|NCT02569710|589682953|FG002|Overall Study|Withdrawal by Subject|0|||
163265758|NCT02569710|589682954|FG003|Overall Study|Withdrawal by Subject|0|||
163265759|NCT02569710|589682955|FG004|Overall Study|Withdrawal by Subject|0|||
163265760|NCT02569710|589682956|FG005|Overall Study|Withdrawal by Subject|1|||
163265761|NCT02569710|589682957|FG006|Overall Study|Withdrawal by Subject|0|||
163265762|NCT02569710|589682958|FG007|Overall Study|Withdrawal by Subject|0|||
163265763|NCT02569710|589682959|FG008|Overall Study|Withdrawal by Subject|0|||
163265764|NCT02569710|589682960|FG009|Overall Study|Withdrawal by Subject|0|||
163265765|NCT02946918|589682961|FG000|Overall Study|Patient unblinded himself|1|||
163265766|NCT02946918|589682962|FG001|Overall Study|Patient unblinded himself|0|||
163265767|NCT02946918|589682961|FG000|Overall Study|Physician Decision|0|||
163265768|NCT02946918|589682962|FG001|Overall Study|Physician Decision|2|||
163265769|NCT02946918|589682961|FG000|Overall Study|Ran out of study medication|0|||
163265770|NCT02946918|589682962|FG001|Overall Study|Ran out of study medication|1|||
163154089|NCT05138653|589278402|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154090|NCT05138653|589278403|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154091|NCT05138653|589278404|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154092|NCT05138653|589278405|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154093|NCT05138653|589278406|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154094|NCT05138653|589278407|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154095|NCT05138653|589278408|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154096|NCT05138653|589278393|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154097|NCT05138653|589278394|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
163154098|NCT05138653|589278395|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154099|NCT05138653|589278396|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154100|NCT05138653|589278397|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154101|NCT05138653|589278398|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154102|NCT05138653|589278399|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154103|NCT05138653|589278400|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154104|NCT05138653|589278401|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
163154105|NCT05138653|589278402|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154106|NCT05138653|589278403|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154107|NCT05138653|589278404|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154108|NCT05138653|589278405|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154109|NCT05138653|589278406|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163265771|NCT03203694|589682969|FG000|Overall Study|Withdrawal by Subject|2|||
163265772|NCT03203694|589682970|FG001|Overall Study|Withdrawal by Subject|0|||
163265773|NCT03203694|589682971|FG002|Overall Study|Withdrawal by Subject|0|||
163265774|NCT03203694|589682972|FG003|Overall Study|Withdrawal by Subject|0|||
163265775|NCT03203694|589682973|FG004|Overall Study|Withdrawal by Subject|0|||
163265776|NCT03203694|589682974|FG005|Overall Study|Withdrawal by Subject|0|||
163265777|NCT03535337|589682981|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
163265778|NCT03535337|589682982|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
163265779|NCT03535337|589682983|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
163265780|NCT03535337|589682984|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
163265781|NCT03535337|589682985|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
163265782|NCT03535337|589682986|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
163265783|NCT03535337|589682987|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
163265784|NCT03535337|589682988|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
163265785|NCT03535337|589682989|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
163154110|NCT05138653|589278407|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154111|NCT05138653|589278408|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154112|NCT05138653|589278393|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154113|NCT05138653|589278394|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
163154114|NCT05138653|589278395|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154115|NCT05138653|589278396|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154116|NCT05138653|589278397|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
163154117|NCT05138653|589278398|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154118|NCT05138653|589278399|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154119|NCT05138653|589278400|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154120|NCT05138653|589278401|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154121|NCT05138653|589278402|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154122|NCT05138653|589278403|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154123|NCT05138653|589278404|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154124|NCT05138653|589278405|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154125|NCT05138653|589278406|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154126|NCT05138653|589278407|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154127|NCT05138653|589278408|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154128|NCT05138653|589278393|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154129|NCT05138653|589278394|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154130|NCT05138653|589278395|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154131|NCT05138653|589278396|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154132|NCT05138653|589278397|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154133|NCT05138653|589278398|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154134|NCT05138653|589278399|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
163154135|NCT05138653|589278400|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154136|NCT05138653|589278401|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154137|NCT05138653|589278402|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154138|NCT05138653|589278403|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154139|NCT05138653|589278404|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154140|NCT05138653|589278405|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154141|NCT05138653|589278406|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154142|NCT05138653|589278407|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154143|NCT05138653|589278408|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154144|NCT05138653|589278393|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154145|NCT05138653|589278394|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154146|NCT05138653|589278395|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154147|NCT05138653|589278396|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154148|NCT05138653|589278397|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154149|NCT05138653|589278398|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154150|NCT05138653|589278399|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154151|NCT05138653|589278400|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154152|NCT05138653|589278401|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154153|NCT05138653|589278402|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154154|NCT05138653|589278403|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
163154155|NCT05138653|589278404|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154156|NCT05138653|589278405|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
163154157|NCT05138653|589278406|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154158|NCT05138653|589278407|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
163154159|NCT05138653|589278408|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154160|NCT05138653|589278393|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154161|NCT05138653|589278394|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154162|NCT05138653|589278395|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154163|NCT05138653|589278396|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154164|NCT05138653|589278397|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163265786|NCT03535337|589682990|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
163265787|NCT05879198|589682991|FG000|Overall Study|Lost to Follow-up|1|||
163265788|NCT01598298|589682992|FG000|Overall Study|Not eligible|5|||
163265789|NCT01598298|589682993|FG001|Overall Study|Not eligible|5|||
163265790|NCT01598298|589682992|FG000|Overall Study|Adverse Event|21|||
163265791|NCT01598298|589682993|FG001|Overall Study|Adverse Event|19|||
163265792|NCT01598298|589682992|FG000|Overall Study|Progression/relapse|0|||
163265793|NCT01598298|589682993|FG001|Overall Study|Progression/relapse|2|||
163265794|NCT01598298|589682992|FG000|Overall Study|Withdrawal by Subject|10|||
163265795|NCT01598298|589682993|FG001|Overall Study|Withdrawal by Subject|15|||
163265796|NCT01598298|589682992|FG000|Overall Study|Other reason (not protocol specified)|4|||
163265797|NCT01598298|589682993|FG001|Overall Study|Other reason (not protocol specified)|0|||
163265798|NCT02802319|589684897|FG000|Overall Study|Physician Decision|2|||
163265799|NCT02802319|589684898|FG001|Overall Study|Physician Decision|1|||
163265800|NCT02802319|589684897|FG000|Overall Study|Lost to Follow-up|0|||
163265801|NCT02802319|589684898|FG001|Overall Study|Lost to Follow-up|4|||
163265802|NCT01923896|589684899|FG000|Overall Study|Adverse Event|1|||
163265803|NCT01923896|589684900|FG001|Overall Study|Adverse Event|0|||
163265804|NCT00474929|589684903|FG000|Overall Study|Withdrawal by Subject|0|||
163265805|NCT00474929|589684904|FG001|Overall Study|Withdrawal by Subject|1|||
163265806|NCT00474929|589684905|FG002|Overall Study|Withdrawal by Subject|0|||
163265807|NCT00474929|589684906|FG003|Overall Study|Withdrawal by Subject|0|||
163265808|NCT00474929|589684907|FG004|Overall Study|Withdrawal by Subject|0|||
163265809|NCT00474929|589684903|FG000|Overall Study|Unrelated medical condition|0|||
163265810|NCT00474929|589684904|FG001|Overall Study|Unrelated medical condition|0|||
163265811|NCT00474929|589684905|FG002|Overall Study|Unrelated medical condition|1|||
163265812|NCT00474929|589684906|FG003|Overall Study|Unrelated medical condition|0|||
163265813|NCT00474929|589684907|FG004|Overall Study|Unrelated medical condition|0|||
163265814|NCT00474929|589684903|FG000|Overall Study|Physician Decision|0|||
163265815|NCT00474929|589684904|FG001|Overall Study|Physician Decision|0|||
163265816|NCT00474929|589684905|FG002|Overall Study|Physician Decision|1|||
163265817|NCT00474929|589684906|FG003|Overall Study|Physician Decision|2|||
163265818|NCT00474929|589684907|FG004|Overall Study|Physician Decision|0|||
163265819|NCT02593305|589684910|FG000|Post 1|Comparison only group. No intervention.|0|||
163265820|NCT02593305|589684911|FG001|Post 1|Comparison only group. No intervention.|0|||
163265821|NCT02593305|589684912|FG002|Post 1|Comparison only group. No intervention.|10|||
163265822|NCT00798174|589684913|FG000|Overall Study|inability to implant azygos coil|3|||
163265823|NCT00798174|589684914|FG001|Overall Study|inability to implant azygos coil|3|||
163265824|NCT00798174|589684913|FG000|Overall Study|Inability to sedate for DFT testing|1|||
163265825|NCT00798174|589684914|FG001|Overall Study|Inability to sedate for DFT testing|0|||
163265826|NCT01683994|589684916|FG000|Overall Study|Withdrawal by Subject|1|||
163265827|NCT01683994|589684917|FG001|Overall Study|Withdrawal by Subject|0|||
163265828|NCT01683994|589684918|FG002|Overall Study|Withdrawal by Subject|0|||
163265829|NCT01683994|589684919|FG003|Overall Study|Withdrawal by Subject|1|||
163265830|NCT01683994|589684920|FG004|Overall Study|Withdrawal by Subject|0|||
163265831|NCT01683994|589684916|FG000|Overall Study|Intercurrent illness|0|||
163265832|NCT01683994|589684917|FG001|Overall Study|Intercurrent illness|0|||
163265833|NCT01683994|589684918|FG002|Overall Study|Intercurrent illness|0|||
163265834|NCT01683994|589684919|FG003|Overall Study|Intercurrent illness|2|||
163265835|NCT01683994|589684920|FG004|Overall Study|Intercurrent illness|1|||
163265836|NCT00999661|589684921|FG000|Overall Study|Lost to Follow-up|59|||
163265837|NCT00999661|589684921|FG000|Overall Study|Adverse Event|1|||
163265838|NCT00999661|589684921|FG000|Overall Study|Withdrawal by Subject|1|||
163265839|NCT00999661|589684921|FG000|Overall Study|Not meeting eligibility criteria|9|||
163265840|NCT00312858|589684925|FG000|Overall Study|Adverse Event|0|||
163265841|NCT00312858|589684926|FG001|Overall Study|Adverse Event|1|||
163265842|NCT00312858|589684925|FG000|Overall Study|Lost to Follow-up|25|||
163265843|NCT00312858|589684926|FG001|Overall Study|Lost to Follow-up|42|||
163265844|NCT00312858|589684925|FG000|Overall Study|Protocol Violation|3|||
163265845|NCT00312858|589684926|FG001|Overall Study|Protocol Violation|8|||
163265846|NCT00312858|589684925|FG000|Overall Study|Withdraw by Participant|20|||
163265847|NCT00312858|589684926|FG001|Overall Study|Withdraw by Participant|20|||
163265848|NCT00312858|589684925|FG000|Overall Study|Participant Moved|11|||
163265849|NCT00312858|589684926|FG001|Overall Study|Participant Moved|10|||
163265850|NCT00312858|589684925|FG000|Overall Study|Other|9|||
163265851|NCT00312858|589684926|FG001|Overall Study|Other|12|||
163265852|NCT02318719|589684929|FG000|Double-blind Phase|Adverse Event|7|||
163265853|NCT02318719|589684930|FG001|Double-blind Phase|Adverse Event|6|||
163265854|NCT02318719|589684931|FG002|Double-blind Phase|Adverse Event|12|||
163265855|NCT02318719|589684932|FG003|Double-blind Phase|Adverse Event|4|||
163265856|NCT02318719|589684933|FG004|Double-blind Phase|Adverse Event|0|||
163265857|NCT02318719|589684929|FG000|Double-blind Phase|Lack of Efficacy|5|||
163265858|NCT02318719|589684930|FG001|Double-blind Phase|Lack of Efficacy|0|||
163265859|NCT02318719|589684931|FG002|Double-blind Phase|Lack of Efficacy|1|||
163265860|NCT02318719|589684932|FG003|Double-blind Phase|Lack of Efficacy|1|||
163265861|NCT02318719|589684933|FG004|Double-blind Phase|Lack of Efficacy|0|||
163265862|NCT02318719|589684929|FG000|Double-blind Phase|Protocol Violation|0|||
163265863|NCT02318719|589684930|FG001|Double-blind Phase|Protocol Violation|1|||
163265864|NCT02318719|589684931|FG002|Double-blind Phase|Protocol Violation|3|||
163265865|NCT02318719|589684932|FG003|Double-blind Phase|Protocol Violation|0|||
163265866|NCT02318719|589684933|FG004|Double-blind Phase|Protocol Violation|0|||
163265867|NCT02318719|589684929|FG000|Double-blind Phase|Withdrawal by Subject|25|||
163265868|NCT02318719|589684930|FG001|Double-blind Phase|Withdrawal by Subject|7|||
163265869|NCT02318719|589684931|FG002|Double-blind Phase|Withdrawal by Subject|9|||
163265870|NCT02318719|589684932|FG003|Double-blind Phase|Withdrawal by Subject|10|||
163265871|NCT02318719|589684933|FG004|Double-blind Phase|Withdrawal by Subject|0|||
163154165|NCT05138653|589278398|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154166|NCT05138653|589278399|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154167|NCT05138653|589278400|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154168|NCT05138653|589278401|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154169|NCT05138653|589278402|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154170|NCT05138653|589278403|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154171|NCT05138653|589278404|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163265872|NCT02318719|589684929|FG000|Double-blind Phase|Other|1|||
163265873|NCT02318719|589684930|FG001|Double-blind Phase|Other|2|||
163265874|NCT02318719|589684931|FG002|Double-blind Phase|Other|0|||
163265875|NCT02318719|589684932|FG003|Double-blind Phase|Other|0|||
163265876|NCT02318719|589684933|FG004|Double-blind Phase|Other|0|||
163265877|NCT02318719|589684929|FG000|Open-label Extension Phase|Adverse Event|0|||
163265878|NCT02318719|589684930|FG001|Open-label Extension Phase|Adverse Event|0|||
163265879|NCT02318719|589684931|FG002|Open-label Extension Phase|Adverse Event|0|||
163265880|NCT02318719|589684932|FG003|Open-label Extension Phase|Adverse Event|0|||
163265881|NCT02318719|589684933|FG004|Open-label Extension Phase|Adverse Event|15|||
163265882|NCT02318719|589684929|FG000|Open-label Extension Phase|Death|0|||
163265883|NCT02318719|589684930|FG001|Open-label Extension Phase|Death|0|||
163265884|NCT02318719|589684931|FG002|Open-label Extension Phase|Death|0|||
163265885|NCT02318719|589684932|FG003|Open-label Extension Phase|Death|0|||
163265886|NCT02318719|589684933|FG004|Open-label Extension Phase|Death|1|||
163265887|NCT02318719|589684929|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
163265888|NCT02318719|589684930|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
163265889|NCT02318719|589684931|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
163265890|NCT02318719|589684932|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
163265891|NCT02318719|589684933|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
163265892|NCT02318719|589684929|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
163265893|NCT02318719|589684930|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
163265894|NCT02318719|589684931|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
163265895|NCT02318719|589684932|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
163265896|NCT02318719|589684933|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
163265897|NCT02318719|589684929|FG000|Open-label Extension Phase|Other|0|||
163265898|NCT02318719|589684930|FG001|Open-label Extension Phase|Other|0|||
163265899|NCT02318719|589684931|FG002|Open-label Extension Phase|Other|0|||
163265900|NCT02318719|589684932|FG003|Open-label Extension Phase|Other|0|||
163265901|NCT02318719|589684933|FG004|Open-label Extension Phase|Other|7|||
163265902|NCT00854295|589684934|FG000|Overall Study|Death|7|||
163265903|NCT00854295|589684935|FG001|Overall Study|Death|0|||
163265904|NCT00854295|589684936|FG002|Overall Study|Death|1|||
163265905|NCT00854295|589684937|FG003|Overall Study|Death|1|||
163265906|NCT00854295|589684934|FG000|Overall Study|Adverse Event|6|||
163265907|NCT00854295|589684935|FG001|Overall Study|Adverse Event|1|||
163265908|NCT00854295|589684936|FG002|Overall Study|Adverse Event|1|||
163265909|NCT00854295|589684937|FG003|Overall Study|Adverse Event|3|||
163265910|NCT00854295|589684934|FG000|Overall Study|Lost to Follow-up|18|||
163265911|NCT00854295|589684935|FG001|Overall Study|Lost to Follow-up|5|||
163265912|NCT00854295|589684936|FG002|Overall Study|Lost to Follow-up|21|||
163265913|NCT00854295|589684937|FG003|Overall Study|Lost to Follow-up|21|||
163265914|NCT00854295|589684934|FG000|Overall Study|Physician Decision|10|||
163265915|NCT00854295|589684935|FG001|Overall Study|Physician Decision|0|||
163265916|NCT00854295|589684936|FG002|Overall Study|Physician Decision|0|||
163265917|NCT00854295|589684937|FG003|Overall Study|Physician Decision|0|||
163265918|NCT02440594|589684938|FG000|Overall Study|Lost to Follow-up|34|||
163265919|NCT02440594|589684939|FG001|Overall Study|Lost to Follow-up|33|||
163265920|NCT02440594|589684940|FG002|Overall Study|Lost to Follow-up|54|||
163265921|NCT02440594|589684941|FG003|Overall Study|Lost to Follow-up|47|||
163265922|NCT02440594|589684942|FG004|Overall Study|Lost to Follow-up|5|||
163265923|NCT02440594|589684943|FG005|Overall Study|Lost to Follow-up|4|||
163265924|NCT02440594|589684944|FG006|Overall Study|Lost to Follow-up|28|||
163265925|NCT02440594|589684945|FG007|Overall Study|Lost to Follow-up|48|||
163265926|NCT02440594|589684938|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
163265927|NCT02440594|589684939|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
163265928|NCT02440594|589684940|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
163265929|NCT02440594|589684941|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
163265930|NCT02440594|589684942|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
163265931|NCT02440594|589684943|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
163265932|NCT02440594|589684944|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
163154172|NCT05138653|589278405|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154173|NCT05138653|589278406|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154174|NCT05138653|589278407|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154175|NCT05138653|589278408|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
163154176|NCT05138653|589278393|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154177|NCT05138653|589278394|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154178|NCT05138653|589278395|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154179|NCT05138653|589278396|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154180|NCT05138653|589278397|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154181|NCT05138653|589278398|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154182|NCT05138653|589278399|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154183|NCT05138653|589278400|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154184|NCT05138653|589278401|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154185|NCT05138653|589278402|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154186|NCT05138653|589278403|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154187|NCT05138653|589278404|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154188|NCT05138653|589278405|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154189|NCT05138653|589278406|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
163154190|NCT05138653|589278407|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154191|NCT05138653|589278408|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154192|NCT02023086|589278411|FG000|Overall Study|Withdrawal by Subject|2|||
163154193|NCT02023086|589278412|FG001|Overall Study|Withdrawal by Subject|0|||
163154194|NCT04607005|589278413|FG000|Overall Study|Adverse Event|0|||
163154195|NCT04607005|589278414|FG001|Overall Study|Adverse Event|1|||
163154196|NCT04607005|589278413|FG000|Overall Study|Lack of Efficacy|1|||
163154197|NCT04607005|589278414|FG001|Overall Study|Lack of Efficacy|6|||
163154198|NCT04607005|589278413|FG000|Overall Study|Withdrawal by Subject|4|||
163154199|NCT04607005|589278414|FG001|Overall Study|Withdrawal by Subject|9|||
163154200|NCT04607005|589278413|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
163154201|NCT04607005|589278414|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
163154202|NCT01148979|589280029|FG000|Overall Study|Lost to Follow-up|0|||
163154203|NCT01148979|589280030|FG001|Overall Study|Lost to Follow-up|1|||
163154204|NCT00777153|589280031|FG000|Overall Study|Lost to Follow-up|1|||
163154205|NCT00777153|589280032|FG001|Overall Study|Lost to Follow-up|1|||
163154206|NCT00777153|589280033|FG002|Overall Study|Lost to Follow-up|0|||
163154207|NCT00777153|589280031|FG000|Overall Study|Death|85|||
163154208|NCT00777153|589280032|FG001|Overall Study|Death|73|||
163154209|NCT00777153|589280033|FG002|Overall Study|Death|33|||
163154210|NCT00777153|589280031|FG000|Overall Study|Withdrawal by Subject|3|||
163154211|NCT00777153|589280032|FG001|Overall Study|Withdrawal by Subject|4|||
163154212|NCT00777153|589280033|FG002|Overall Study|Withdrawal by Subject|3|||
163154213|NCT00777153|589280031|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
163154214|NCT00777153|589280032|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
163154215|NCT00777153|589280033|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
163154216|NCT02266888|589280044|FG000|Overall Study|Death|2|||
163154217|NCT02266888|589280045|FG001|Overall Study|Death|2|||
163154218|NCT02266888|589280046|FG002|Overall Study|Death|4|||
163154219|NCT02266888|589280047|FG003|Overall Study|Death|2|||
163154220|NCT02266888|589280044|FG000|Overall Study|Physician Decision|0|||
163154221|NCT02266888|589280045|FG001|Overall Study|Physician Decision|1|||
163154222|NCT02266888|589280046|FG002|Overall Study|Physician Decision|2|||
163154223|NCT02266888|589280047|FG003|Overall Study|Physician Decision|2|||
163154224|NCT02266888|589280044|FG000|Overall Study|Study Terminated|5|||
163154225|NCT02266888|589280045|FG001|Overall Study|Study Terminated|1|||
163154226|NCT02266888|589280046|FG002|Overall Study|Study Terminated|0|||
163154227|NCT02266888|589280047|FG003|Overall Study|Study Terminated|0|||
163154228|NCT02266888|589280044|FG000|Overall Study|No Longer Eligible|0|||
163154229|NCT02266888|589280045|FG001|Overall Study|No Longer Eligible|0|||
163154230|NCT02266888|589280046|FG002|Overall Study|No Longer Eligible|0|||
163154231|NCT02266888|589280047|FG003|Overall Study|No Longer Eligible|2|||
163154232|NCT02266888|589280044|FG000|Overall Study|Randomization Closed|0|||
163154233|NCT02266888|589280045|FG001|Overall Study|Randomization Closed|0|||
163154234|NCT02266888|589280046|FG002|Overall Study|Randomization Closed|4|||
163154235|NCT02266888|589280047|FG003|Overall Study|Randomization Closed|0|||
163154236|NCT02266888|589280044|FG000|Overall Study|Personnel unavailable at transplant|0|||
163154237|NCT02266888|589280045|FG001|Overall Study|Personnel unavailable at transplant|0|||
163154238|NCT02266888|589280046|FG002|Overall Study|Personnel unavailable at transplant|0|||
163154239|NCT02266888|589280047|FG003|Overall Study|Personnel unavailable at transplant|1|||
163154240|NCT02266888|589280044|FG000|Overall Study|Transfer of care|0|||
163154241|NCT02266888|589280045|FG001|Overall Study|Transfer of care|0|||
163154242|NCT02266888|589280046|FG002|Overall Study|Transfer of care|1|||
163154243|NCT02266888|589280047|FG003|Overall Study|Transfer of care|0|||
163265933|NCT02440594|589684945|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
163265934|NCT02440594|589684938|FG000|Overall Study|Withdrawal by Subject|81|||
163265935|NCT02440594|589684939|FG001|Overall Study|Withdrawal by Subject|67|||
163265936|NCT02440594|589684940|FG002|Overall Study|Withdrawal by Subject|59|||
163265937|NCT02440594|589684941|FG003|Overall Study|Withdrawal by Subject|38|||
163265938|NCT02440594|589684942|FG004|Overall Study|Withdrawal by Subject|2|||
163265939|NCT02440594|589684943|FG005|Overall Study|Withdrawal by Subject|2|||
163265940|NCT02440594|589684944|FG006|Overall Study|Withdrawal by Subject|7|||
163265941|NCT02440594|589684945|FG007|Overall Study|Withdrawal by Subject|7|||
163154244|NCT02224560|589280052|FG000|Overall Study|Protocol Deviation|1|||
163154245|NCT02224560|589280053|FG001|Overall Study|Protocol Deviation|0|||
163154246|NCT02224560|589280054|FG002|Overall Study|Protocol Deviation|0|||
163154247|NCT02224560|589280052|FG000|Overall Study|Withdrawal by Subject|2|||
163154248|NCT02224560|589280053|FG001|Overall Study|Withdrawal by Subject|0|||
163154249|NCT02224560|589280054|FG002|Overall Study|Withdrawal by Subject|1|||
163154250|NCT02224560|589280052|FG000|Overall Study|Met Withdrawal Criteria|1|||
163154251|NCT02224560|589280053|FG001|Overall Study|Met Withdrawal Criteria|0|||
163154252|NCT02224560|589280054|FG002|Overall Study|Met Withdrawal Criteria|0|||
163154253|NCT02224560|589280052|FG000|Overall Study|Adverse Event|4|||
163154254|NCT02224560|589280053|FG001|Overall Study|Adverse Event|1|||
163154255|NCT02224560|589280054|FG002|Overall Study|Adverse Event|1|||
163154256|NCT02224560|589280052|FG000|Overall Study|Withdrawn by Investigator|1|||
163154257|NCT02224560|589280053|FG001|Overall Study|Withdrawn by Investigator|1|||
163154258|NCT02224560|589280054|FG002|Overall Study|Withdrawn by Investigator|0|||
163154259|NCT00728689|589280055|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
163154260|NCT00728689|589280056|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
163154261|NCT01523366|589280057|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163154262|NCT01523366|589280058|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163154263|NCT01523366|589280057|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
163154264|NCT01523366|589280058|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
163154265|NCT02461758|589280059|FG000|Overall Study|Lost to Follow-up|0|||
163154266|NCT02461758|589280060|FG001|Overall Study|Lost to Follow-up|1|||
163154267|NCT02461758|589280061|FG002|Overall Study|Lost to Follow-up|1|||
163154268|NCT02461758|589280062|FG003|Overall Study|Lost to Follow-up|0|||
163154269|NCT04543279|589280064|FG000|Overall Study|Withdrawal by Subject|1|||
163154270|NCT04543279|589280065|FG001|Overall Study|Withdrawal by Subject|0|||
163154271|NCT04543279|589280064|FG000|Overall Study|Adverse Event|1|||
163154272|NCT04543279|589280065|FG001|Overall Study|Adverse Event|0|||
163154273|NCT04543279|589280064|FG000|Overall Study|Physician Decision|1|||
163154274|NCT04543279|589280065|FG001|Overall Study|Physician Decision|0|||
163362249|NCT05032066|590034739|FG000|Part 2: Extension Phase|Death|2|||
163362250|NCT05032066|590034740|FG001|Part 2: Extension Phase|Death|4|||
163362251|NCT05032066|590034741|FG002|Part 2: Extension Phase|Death|5|||
163362252|NCT02065882|590034744|FG000|Part I: PK/PD|Screening failure|5|||
163362253|NCT02065882|590034744|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
163362254|NCT02065882|590034744|FG000|Part I: PK/PD|Adverse Event|1|||
163362255|NCT02065882|590034744|FG000|Part II: Clinical Efficacy|Screening failure|7|||
163362256|NCT02065882|590034744|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
163362257|NCT02065882|590034744|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
163362258|NCT02065882|590034744|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
163362259|NCT02065882|590034744|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
163362260|NCT02065882|590034744|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
163362261|NCT06719986|590034745|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
163362262|NCT06719986|590034746|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
163362263|NCT06719986|590034747|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
163362264|NCT06719986|590034745|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
163362265|NCT06719986|590034746|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
163362266|NCT06719986|590034747|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
163362267|NCT03213704|590034749|FG000|Overall Study|Physician Decision|3|||
163362268|NCT03213704|590034749|FG000|Overall Study|Protocol Violation|1|||
163362269|NCT03213704|590034749|FG000|Overall Study|Progressive disease|4|||
163362270|NCT00233480|590036433|FG000|Overall Study|Underwent status II heart transplant|0|||
163362271|NCT00233480|590036434|FG001|Overall Study|Underwent status II heart transplant|1|||
163362272|NCT01667926|590036440|FG000|Overall Study|Withdrawal by Subject|1|||
163154275|NCT00929695|589280068|FG000|Overall Study|Death|2|||
163154276|NCT00929695|589280069|FG001|Overall Study|Death|1|||
163154277|NCT00929695|589280068|FG000|Overall Study|Withdrawal by Subject|0|||
163154278|NCT00929695|589280069|FG001|Overall Study|Withdrawal by Subject|2|||
163154279|NCT00929695|589280068|FG000|Overall Study|discharge home|4|||
163154280|NCT00929695|589280069|FG001|Overall Study|discharge home|3|||
163154281|NCT00929695|589280068|FG000|Overall Study|incorrect stratification|2|||
163265942|NCT02440594|589684938|FG000|Overall Study|Administratively w/drawn|3|||
163362273|NCT01667926|590036441|FG001|Overall Study|Withdrawal by Subject|2|||
163362274|NCT01667926|590036442|FG002|Overall Study|Withdrawal by Subject|2|||
163362275|NCT01667926|590036440|FG000|Overall Study|Physician Decision|0|||
163265943|NCT02440594|589684939|FG001|Overall Study|Administratively w/drawn|2|||
163154282|NCT00929695|589280069|FG001|Overall Study|incorrect stratification|0|||
163154283|NCT04030143|589280070|FG000|Overall Study|Adverse Event|5|||
163154284|NCT04030143|589280071|FG001|Overall Study|Adverse Event|10|||
163154285|NCT04030143|589280070|FG000|Overall Study|Lost to Follow-up|3|||
163154286|NCT04030143|589280071|FG001|Overall Study|Lost to Follow-up|7|||
163154287|NCT04030143|589280070|FG000|Overall Study|Protocol Deviation|2|||
163154288|NCT04030143|589280071|FG001|Overall Study|Protocol Deviation|2|||
163154289|NCT04030143|589280070|FG000|Overall Study|Withdrawal by Subject|16|||
163154290|NCT04030143|589280071|FG001|Overall Study|Withdrawal by Subject|18|||
163154291|NCT04030143|589280070|FG000|Overall Study|Physician Decision|1|||
163154292|NCT04030143|589280071|FG001|Overall Study|Physician Decision|1|||
163154293|NCT04030143|589280070|FG000|Overall Study|Due to Covid-19|2|||
163154294|NCT04030143|589280071|FG001|Overall Study|Due to Covid-19|3|||
163154295|NCT04030143|589280070|FG000|Overall Study|Not Due to Covid-19|1|||
163154296|NCT04030143|589280071|FG001|Overall Study|Not Due to Covid-19|1|||
163154297|NCT03216226|589280072|FG000|Overall Study|Adverse Event|3|||
163154298|NCT03216226|589280073|FG001|Overall Study|Adverse Event|0|||
163154299|NCT03216226|589280072|FG000|Overall Study|Protocol Violation|1|||
163154300|NCT03216226|589280073|FG001|Overall Study|Protocol Violation|3|||
163154301|NCT03216226|589280072|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
163154302|NCT03216226|589280073|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
163154303|NCT03216226|589280072|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
163154304|NCT03216226|589280073|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
163154305|NCT03216226|589280072|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
163154306|NCT03216226|589280073|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
163154307|NCT01352715|589280075|FG000|Overall Study|Death|3|||
163154308|NCT01352715|589280076|FG001|Overall Study|Death|3|||
163154309|NCT01352715|589280075|FG000|Overall Study|Lost to Follow-up|5|||
163154310|NCT01352715|589280076|FG001|Overall Study|Lost to Follow-up|7|||
163154311|NCT01352715|589280075|FG000|Overall Study|Withdrawal by Subject|4|||
163154312|NCT01352715|589280076|FG001|Overall Study|Withdrawal by Subject|8|||
163154313|NCT01352715|589280075|FG000|Overall Study|site closure|16|||
163154314|NCT01352715|589280076|FG001|Overall Study|site closure|15|||
163154315|NCT01352715|589280075|FG000|Overall Study|no final visit in closeout period|15|||
163154316|NCT01352715|589280076|FG001|Overall Study|no final visit in closeout period|12|||
163154317|NCT01352715|589280075|FG000|Overall Study|major ineligibility|2|||
163154318|NCT01352715|589280076|FG001|Overall Study|major ineligibility|1|||
163154319|NCT02000440|589280078|FG000|Overall Study|Adverse Event|3|||
163154320|NCT02000440|589280078|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
163154321|NCT02383576|589280079|FG000|Overall Study|Death|53|||
163154322|NCT02383576|589280080|FG001|Overall Study|Death|33|||
163154323|NCT02383576|589280079|FG000|Overall Study|Lost to Follow-up|7|||
163154324|NCT02383576|589280080|FG001|Overall Study|Lost to Follow-up|1|||
163154325|NCT02383576|589280079|FG000|Overall Study|Withdrew Consent|1|||
163154326|NCT02383576|589280080|FG001|Overall Study|Withdrew Consent|6|||
163154327|NCT02383576|589280079|FG000|Overall Study|Investigator's Decision|0|||
163154328|NCT02383576|589280080|FG001|Overall Study|Investigator's Decision|1|||
163154329|NCT02383576|589280079|FG000|Overall Study|Administrative/Other|2|||
163154330|NCT02383576|589280080|FG001|Overall Study|Administrative/Other|4|||
163154331|NCT00871975|589280081|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
163154332|NCT00871975|589280081|FG000|Overall Study|Catheters could not be inserted|1|||
163154333|NCT00871975|589280081|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
163154334|NCT00871975|589280081|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
163154335|NCT01436149|589280082|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
163154336|NCT01436149|589280083|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
163154337|NCT01436149|589280084|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
163154338|NCT01436149|589280082|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
163154339|NCT01436149|589280083|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
163154340|NCT01436149|589280084|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
163154341|NCT01436149|589280082|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
163154342|NCT01436149|589280083|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
163154343|NCT01436149|589280084|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
163154344|NCT01436149|589280082|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
163154345|NCT01436149|589280083|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
163154346|NCT01436149|589280084|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
163154347|NCT01436149|589280082|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
163154348|NCT01436149|589280083|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
163154349|NCT01436149|589280084|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
163154350|NCT01436149|589280082|FG000|Antidepressant Lead-in Phase|Other|119|||
163154351|NCT01436149|589280083|FG001|Antidepressant Lead-in Phase|Other|0|||
163154352|NCT01436149|589280084|FG002|Antidepressant Lead-in Phase|Other|0|||
163154353|NCT01436149|589280082|FG000|Randomized Phase|Adverse Event|9|||
163362276|NCT01667926|590036441|FG001|Overall Study|Physician Decision|0|||
163362277|NCT01667926|590036442|FG002|Overall Study|Physician Decision|1|||
163362278|NCT01667926|590036440|FG000|Overall Study|Time committment|0|||
163362279|NCT01667926|590036441|FG001|Overall Study|Time committment|0|||
163362280|NCT01667926|590036442|FG002|Overall Study|Time committment|2|||
163362281|NCT01667926|590036440|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
163362282|NCT01667926|590036441|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
163362283|NCT01667926|590036442|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
163362284|NCT01667926|590036440|FG000|Overall Study|Lost to Follow-up|1|||
163362285|NCT01667926|590036441|FG001|Overall Study|Lost to Follow-up|2|||
163362286|NCT01667926|590036442|FG002|Overall Study|Lost to Follow-up|1|||
163362287|NCT01667926|590036440|FG000|Overall Study|Side effects|3|||
163362288|NCT01667926|590036441|FG001|Overall Study|Side effects|0|||
163362289|NCT01667926|590036442|FG002|Overall Study|Side effects|0|||
163362290|NCT01411241|590036446|FG000|Overall Study|Protocol Violation|0|||
163362291|NCT01411241|590036447|FG001|Overall Study|Protocol Violation|5|||
163362292|NCT01411241|590036446|FG000|Overall Study|Withdrawal by Subject|9|||
163362293|NCT01411241|590036447|FG001|Overall Study|Withdrawal by Subject|10|||
163362294|NCT01411241|590036446|FG000|Overall Study|Serious Adverse Event|0|||
163362295|NCT01411241|590036447|FG001|Overall Study|Serious Adverse Event|3|||
163362296|NCT01411241|590036446|FG000|Overall Study|Lost to Follow-up|2|||
163362297|NCT01411241|590036447|FG001|Overall Study|Lost to Follow-up|4|||
163362298|NCT02980042|590036450|FG000|Overall Study|Lost to Follow-up|5|||
163362299|NCT02980042|590036451|FG001|Overall Study|Lost to Follow-up|0|||
163362300|NCT02980042|590036450|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
163362301|NCT02980042|590036451|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
163362302|NCT02521363|590036452|FG000|Overall Study|Withdrawal by Subject|1|||
163362303|NCT02521363|590036453|FG001|Overall Study|Withdrawal by Subject|2|||
163362304|NCT00953771|590036454|FG000|Overall Study|Death|1|||
163362305|NCT00953771|590036455|FG001|Overall Study|Death|0|||
163362306|NCT00974259|590036456|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
163362307|NCT00974259|590036457|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
163362308|NCT00592293|590036461|FG000|Overall Study|Withdrawal by Subject|1|||
163362309|NCT01270828|590036464|FG000|Pregabalin CR SB|Reason Unspecified|0|||
163362310|NCT01270828|590036465|FG001|Pregabalin CR SB|Reason Unspecified|0|||
163362311|NCT01270828|590036466|FG002|Pregabalin CR SB|Reason Unspecified|8|||
163362312|NCT01270828|590036464|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
163362313|NCT01270828|590036465|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
163362314|NCT01270828|590036466|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
163362315|NCT01270828|590036464|FG000|Pregabalin CR SB|Related adverse event|0|||
163362316|NCT01270828|590036465|FG001|Pregabalin CR SB|Related adverse event|0|||
163362317|NCT01270828|590036466|FG002|Pregabalin CR SB|Related adverse event|46|||
163362318|NCT01270828|590036464|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
163362319|NCT01270828|590036465|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
163362320|NCT01270828|590036466|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
163362321|NCT01270828|590036464|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
163362322|NCT01270828|590036465|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
163362323|NCT01270828|590036466|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
163362324|NCT01270828|590036464|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
163362325|NCT01270828|590036465|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
163362326|NCT01270828|590036466|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
163362327|NCT01270828|590036464|FG000|Pregabalin CR SB|Unrelated AE|0|||
163362328|NCT01270828|590036465|FG001|Pregabalin CR SB|Unrelated AE|0|||
163362329|NCT01270828|590036466|FG002|Pregabalin CR SB|Unrelated AE|8|||
163362330|NCT01270828|590036464|FG000|Pregabalin CR SB|Protocol Violation|0|||
163362331|NCT01270828|590036465|FG001|Pregabalin CR SB|Protocol Violation|0|||
163362332|NCT01270828|590036466|FG002|Pregabalin CR SB|Protocol Violation|8|||
163362333|NCT01270828|590036464|FG000|Double Blind Phase|Death|0|||
163362334|NCT01270828|590036465|FG001|Double Blind Phase|Death|1|||
163362335|NCT01270828|590036466|FG002|Double Blind Phase|Death|0|||
163362336|NCT01270828|590036464|FG000|Double Blind Phase|Protocol Violation|0|||
163362337|NCT01270828|590036465|FG001|Double Blind Phase|Protocol Violation|1|||
163362338|NCT01270828|590036466|FG002|Double Blind Phase|Protocol Violation|0|||
163362339|NCT01270828|590036464|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
163362340|NCT01270828|590036465|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
163362341|NCT01270828|590036466|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
163362342|NCT01270828|590036464|FG000|Double Blind Phase|Reason Unspecified|7|||
163362343|NCT01270828|590036465|FG001|Double Blind Phase|Reason Unspecified|4|||
163362344|NCT01270828|590036466|FG002|Double Blind Phase|Reason Unspecified|0|||
163362345|NCT01270828|590036464|FG000|Double Blind Phase|Withdrawal by Subject|6|||
163362346|NCT01270828|590036465|FG001|Double Blind Phase|Withdrawal by Subject|15|||
163411168|NCT00852995|590212997|FG001|Overall Study|Protocol Violation|0|||
163362347|NCT01270828|590036466|FG002|Double Blind Phase|Withdrawal by Subject|0|||
163362348|NCT01270828|590036464|FG000|Double Blind Phase|Lost to Follow-up|1|||
163362349|NCT01270828|590036465|FG001|Double Blind Phase|Lost to Follow-up|2|||
163362350|NCT01270828|590036466|FG002|Double Blind Phase|Lost to Follow-up|0|||
163154354|NCT01436149|589280083|FG001|Randomized Phase|Adverse Event|10|||
163154355|NCT01436149|589280084|FG002|Randomized Phase|Adverse Event|11|||
163154356|NCT01436149|589280082|FG000|Randomized Phase|Protocol Violation|4|||
163154357|NCT01436149|589280083|FG001|Randomized Phase|Protocol Violation|5|||
163154358|NCT01436149|589280084|FG002|Randomized Phase|Protocol Violation|0|||
163154359|NCT01436149|589280082|FG000|Randomized Phase|Withdrawal by Subject|16|||
163154360|NCT01436149|589280083|FG001|Randomized Phase|Withdrawal by Subject|10|||
163154361|NCT01436149|589280084|FG002|Randomized Phase|Withdrawal by Subject|10|||
163154362|NCT01436149|589280082|FG000|Randomized Phase|Lost to Follow-up|34|||
163154363|NCT01436149|589280083|FG001|Randomized Phase|Lost to Follow-up|5|||
163154364|NCT01436149|589280084|FG002|Randomized Phase|Lost to Follow-up|6|||
163154365|NCT01436149|589280082|FG000|Randomized Phase|Lack of Efficacy|0|||
163154366|NCT01436149|589280083|FG001|Randomized Phase|Lack of Efficacy|0|||
163154367|NCT01436149|589280084|FG002|Randomized Phase|Lack of Efficacy|1|||
163154368|NCT01436149|589280082|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
163154369|NCT01436149|589280083|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
163154370|NCT01436149|589280084|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
163154371|NCT01436149|589280082|FG000|Randomized Phase|Other|12|||
163154372|NCT01436149|589280083|FG001|Randomized Phase|Other|5|||
163154373|NCT01436149|589280084|FG002|Randomized Phase|Other|11|||
163154374|NCT01690143|589280085|FG000|Overall Study|Withdrawal by Subject|1|||
163154375|NCT01643668|589280086|FG000|Overall Study|Death|1|||
163154376|NCT01409707|589280087|FG000|Overall Study|Withdrawal by Subject|5|||
163154377|NCT01409707|589280088|FG001|Overall Study|Withdrawal by Subject|17|||
163154378|NCT01409707|589280089|FG002|Overall Study|Withdrawal by Subject|16|||
163154379|NCT00632229|589280090|FG000|Overall Study|Adverse Event|6|||
163154380|NCT00632229|589280091|FG001|Overall Study|Adverse Event|0|||
163154381|NCT00632229|589280090|FG000|Overall Study|Lost to Follow-up|0|||
163154382|NCT00632229|589280091|FG001|Overall Study|Lost to Follow-up|3|||
163154383|NCT00632229|589280090|FG000|Overall Study|Lack of Efficacy|0|||
163154384|NCT00632229|589280091|FG001|Overall Study|Lack of Efficacy|2|||
163154385|NCT00632229|589280090|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
163154386|NCT00632229|589280091|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
163154387|NCT01716234|589280092|FG000|Overall Study|Protocol Violation|0|||
163154388|NCT01716234|589280093|FG001|Overall Study|Protocol Violation|0|||
163154389|NCT01716234|589280094|FG002|Overall Study|Protocol Violation|0|||
163154390|NCT01716234|589280095|FG003|Overall Study|Protocol Violation|1|||
163154391|NCT01716234|589280096|FG004|Overall Study|Protocol Violation|1|||
163154392|NCT01716234|589280097|FG005|Overall Study|Protocol Violation|1|||
163154393|NCT01716234|589280098|FG006|Overall Study|Protocol Violation|0|||
163154394|NCT01716234|589280092|FG000|Overall Study|Lack of Efficacy|0|||
163154395|NCT01716234|589280093|FG001|Overall Study|Lack of Efficacy|0|||
163154396|NCT01716234|589280094|FG002|Overall Study|Lack of Efficacy|0|||
163154397|NCT01716234|589280095|FG003|Overall Study|Lack of Efficacy|1|||
163154398|NCT01716234|589280096|FG004|Overall Study|Lack of Efficacy|0|||
163154399|NCT01716234|589280097|FG005|Overall Study|Lack of Efficacy|0|||
163154400|NCT01716234|589280098|FG006|Overall Study|Lack of Efficacy|0|||
163154401|NCT01716234|589280092|FG000|Overall Study|Did not meet protocol eligibility|0|||
163154402|NCT01716234|589280093|FG001|Overall Study|Did not meet protocol eligibility|0|||
163154403|NCT01716234|589280094|FG002|Overall Study|Did not meet protocol eligibility|1|||
163154404|NCT01716234|589280095|FG003|Overall Study|Did not meet protocol eligibility|0|||
163154405|NCT01716234|589280096|FG004|Overall Study|Did not meet protocol eligibility|0|||
163154406|NCT01716234|589280097|FG005|Overall Study|Did not meet protocol eligibility|4|||
163154407|NCT01716234|589280098|FG006|Overall Study|Did not meet protocol eligibility|0|||
163154408|NCT01716234|589280092|FG000|Overall Study|Adverse Event|7|||
163154409|NCT01716234|589280093|FG001|Overall Study|Adverse Event|10|||
163154410|NCT01716234|589280094|FG002|Overall Study|Adverse Event|2|||
163154411|NCT01716234|589280095|FG003|Overall Study|Adverse Event|8|||
163154412|NCT01716234|589280096|FG004|Overall Study|Adverse Event|3|||
163154413|NCT01716234|589280097|FG005|Overall Study|Adverse Event|6|||
163154414|NCT01716234|589280098|FG006|Overall Study|Adverse Event|0|||
163154415|NCT01716234|589280092|FG000|Overall Study|Withdrawal by Subject|3|||
163154416|NCT01716234|589280093|FG001|Overall Study|Withdrawal by Subject|0|||
163154417|NCT01716234|589280094|FG002|Overall Study|Withdrawal by Subject|2|||
163154418|NCT01716234|589280095|FG003|Overall Study|Withdrawal by Subject|2|||
163154419|NCT01716234|589280096|FG004|Overall Study|Withdrawal by Subject|1|||
163154420|NCT01716234|589280097|FG005|Overall Study|Withdrawal by Subject|3|||
163154421|NCT01716234|589280098|FG006|Overall Study|Withdrawal by Subject|0|||
163154422|NCT01467960|589280099|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
163154423|NCT01467960|589280100|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
163154424|NCT01467960|589280101|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
163154425|NCT01467960|589280102|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
163154426|NCT01467960|589280103|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
163154427|NCT01467960|589280104|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
163154428|NCT00474812|589280105|FG000|Overall Study|Withdrawal by Subject|5|||
163154429|NCT00474812|589280105|FG000|Overall Study|No Initiation of treatment|2|||
163154430|NCT00737672|589280114|FG000|Overall Study|Graft Abandonment|48|||
163154431|NCT00737672|589280115|FG001|Overall Study|Graft Abandonment|56|||
163154432|NCT00737672|589280114|FG000|Overall Study|Death|23|||
163154433|NCT00737672|589280115|FG001|Overall Study|Death|22|||
163154434|NCT00737672|589280114|FG000|Overall Study|Withdrawal by Subject|1|||
163154435|NCT00737672|589280115|FG001|Overall Study|Withdrawal by Subject|2|||
163154436|NCT00737672|589280114|FG000|Overall Study|Lost to Follow-up|1|||
163154437|NCT00737672|589280115|FG001|Overall Study|Lost to Follow-up|0|||
163154438|NCT00737672|589280114|FG000|Overall Study|Miscellaneous|7|||
163154439|NCT00737672|589280115|FG001|Overall Study|Miscellaneous|1|||
163154440|NCT00737672|589280114|FG000|Overall Study|Physician Decision|0|||
163154441|NCT00737672|589280115|FG001|Overall Study|Physician Decision|2|||
163154442|NCT02002598|589280122|FG000|Dose Level 1|Withdrawal by Subject|1|||
163154443|NCT02002598|589280123|FG001|Dose Level 1|Withdrawal by Subject|0|||
163154444|NCT02002598|589280124|FG002|Dose Level 1|Withdrawal by Subject|0|||
163154445|NCT02002598|589280125|FG003|Dose Level 1|Withdrawal by Subject|0|||
163154446|NCT02002598|589280126|FG004|Dose Level 1|Withdrawal by Subject|0|||
163154447|NCT02018562|589280128|FG000|Overall Study|Withdrawal by Subject|2|||
163154448|NCT02018562|589280129|FG001|Overall Study|Withdrawal by Subject|0|||
163154449|NCT02018562|589280128|FG000|Overall Study|Discharged prior to study completion|1|||
163154450|NCT02018562|589280129|FG001|Overall Study|Discharged prior to study completion|0|||
163154451|NCT03435211|589280130|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
163154452|NCT01838395|589280131|FG000|Overall Study|Withdrawal by Subject|0|||
163154453|NCT01838395|589280132|FG001|Overall Study|Withdrawal by Subject|0|||
163154454|NCT01838395|589280133|FG002|Overall Study|Withdrawal by Subject|0|||
163154455|NCT01838395|589280134|FG003|Overall Study|Withdrawal by Subject|0|||
163154456|NCT01838395|589280135|FG004|Overall Study|Withdrawal by Subject|1|||
163154457|NCT01838395|589280136|FG005|Overall Study|Withdrawal by Subject|0|||
163154458|NCT01838395|589280131|FG000|Overall Study|Death|0|||
163154459|NCT01838395|589280132|FG001|Overall Study|Death|0|||
163154460|NCT01838395|589280133|FG002|Overall Study|Death|1|||
163154461|NCT01838395|589280134|FG003|Overall Study|Death|0|||
163362351|NCT01270828|590036464|FG000|Double Blind Phase|Lack of Efficacy|2|||
163362352|NCT01270828|590036465|FG001|Double Blind Phase|Lack of Efficacy|11|||
163362353|NCT01270828|590036466|FG002|Double Blind Phase|Lack of Efficacy|0|||
163362354|NCT01270828|590036464|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
163362355|NCT01270828|590036465|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
163362356|NCT01270828|590036466|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
163362357|NCT01270828|590036464|FG000|Double Blind Phase|Adverse event related to study drug|5|||
163362358|NCT01270828|590036465|FG001|Double Blind Phase|Adverse event related to study drug|7|||
163362359|NCT01270828|590036466|FG002|Double Blind Phase|Adverse event related to study drug|0|||
163362360|NCT02870972|590036472|FG000|Overall Study|Adverse Event|1|||
163362361|NCT02870972|590036473|FG001|Overall Study|Adverse Event|0|||
163362362|NCT02870972|590036474|FG002|Overall Study|Adverse Event|0|||
163362363|NCT02870972|590036475|FG003|Overall Study|Adverse Event|0|||
163362364|NCT02870972|590036476|FG004|Overall Study|Adverse Event|0|||
163362365|NCT04052425|590036480|FG000|24-Week Double-blind Period|Adverse Event|0|||
163362366|NCT04052425|590036481|FG001|24-Week Double-blind Period|Adverse Event|1|||
163362367|NCT04052425|590036482|FG002|24-Week Double-blind Period|Adverse Event|0|||
163362368|NCT04052425|590036483|FG003|24-Week Double-blind Period|Adverse Event|0|||
163362369|NCT04052425|590036480|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
163362370|NCT04052425|590036481|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
163362371|NCT04052425|590036482|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
163362372|NCT04052425|590036483|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
163362373|NCT04052425|590036480|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
163362374|NCT04052425|590036481|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
163362375|NCT04052425|590036482|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
163362376|NCT04052425|590036483|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
163362377|NCT04052425|590036480|FG000|24-Week Double-blind Period|Physician Decision|1|||
163362378|NCT04052425|590036481|FG001|24-Week Double-blind Period|Physician Decision|0|||
163362379|NCT04052425|590036482|FG002|24-Week Double-blind Period|Physician Decision|0|||
163362380|NCT04052425|590036483|FG003|24-Week Double-blind Period|Physician Decision|0|||
163154462|NCT01838395|589280135|FG004|Overall Study|Death|0|||
163154463|NCT01838395|589280136|FG005|Overall Study|Death|0|||
163154464|NCT01838395|589280131|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
163154465|NCT01838395|589280132|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
163154466|NCT01838395|589280133|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
163154467|NCT01838395|589280134|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
163362381|NCT04052425|590036480|FG000|24-Week Double-blind Period|Protocol Violation|1|||
163362382|NCT04052425|590036481|FG001|24-Week Double-blind Period|Protocol Violation|0|||
163362383|NCT04052425|590036482|FG002|24-Week Double-blind Period|Protocol Violation|0|||
163362384|NCT04052425|590036483|FG003|24-Week Double-blind Period|Protocol Violation|0|||
163362385|NCT04052425|590036480|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
163154468|NCT01838395|589280135|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
163154469|NCT01838395|589280136|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
163154470|NCT05972993|589280137|FG000|Overall Study|Lost to Follow-up|2|||
163154471|NCT05972993|589280138|FG001|Overall Study|Lost to Follow-up|0|||
163154472|NCT05972993|589280139|FG002|Overall Study|Lost to Follow-up|1|||
163265944|NCT02440594|589684940|FG002|Overall Study|Administratively w/drawn|0|||
163154473|NCT05972993|589280140|FG003|Overall Study|Lost to Follow-up|0|||
163154474|NCT05972993|589280141|FG004|Overall Study|Lost to Follow-up|0|||
163154475|NCT05972993|589280142|FG005|Overall Study|Lost to Follow-up|0|||
163154476|NCT05972993|589280143|FG006|Overall Study|Lost to Follow-up|0|||
163154477|NCT05972993|589280144|FG007|Overall Study|Lost to Follow-up|2|||
163154478|NCT05972993|589280145|FG008|Overall Study|Lost to Follow-up|0|||
163154479|NCT05720897|589280152|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
163154480|NCT05720897|589280153|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
163154481|NCT00400179|589280154|FG000|Overall Study|Adverse Event|2|||
163154482|NCT00400179|589280155|FG001|Overall Study|Adverse Event|2|||
163154483|NCT00400179|589280154|FG000|Overall Study|Death|1|||
163154484|NCT00400179|589280155|FG001|Overall Study|Death|2|||
163154485|NCT00400179|589280154|FG000|Overall Study|Withdrew Consent|1|||
163154486|NCT00400179|589280155|FG001|Overall Study|Withdrew Consent|5|||
163154487|NCT00400179|589280154|FG000|Overall Study|Disease progression|1|||
163154488|NCT00400179|589280155|FG001|Overall Study|Disease progression|1|||
163154489|NCT00400179|589280154|FG000|Overall Study|Intercurrent illness|0|||
163154490|NCT00400179|589280155|FG001|Overall Study|Intercurrent illness|1|||
163154491|NCT00400179|589280154|FG000|Overall Study|Investigator judgment|0|||
163154492|NCT00400179|589280155|FG001|Overall Study|Investigator judgment|1|||
163154493|NCT00400179|589280154|FG000|Overall Study|Randomization error/patient ineligible|1|||
163154494|NCT00400179|589280155|FG001|Overall Study|Randomization error/patient ineligible|6|||
163154495|NCT04780061|589280156|FG000|Overall Study|Withdrawal by Subject|5|||
163154496|NCT04780061|589280157|FG001|Overall Study|Withdrawal by Subject|8|||
163154497|NCT04780061|589280156|FG000|Overall Study|Adverse Event|2|||
163154498|NCT04780061|589280157|FG001|Overall Study|Adverse Event|2|||
163154499|NCT04780061|589280156|FG000|Overall Study|Lost to Follow-up|1|||
163154500|NCT04780061|589280157|FG001|Overall Study|Lost to Follow-up|5|||
163154501|NCT04050553|589280159|FG000|Period 1|Physician Decision|2|||
163154502|NCT04050553|589280160|FG001|Period 1|Physician Decision|2|||
163154503|NCT04050553|589280159|FG000|Period 1|Adverse Event|1|||
163154504|NCT04050553|589280160|FG001|Period 1|Adverse Event|1|||
163154505|NCT04050553|589280159|FG000|Period 1|Withdrawal by Subject|0|||
163154506|NCT04050553|589280160|FG001|Period 1|Withdrawal by Subject|1|||
163154507|NCT04050553|589280159|FG000|Wash-out|Adverse Event|0|||
163154508|NCT04050553|589280160|FG001|Wash-out|Adverse Event|1|||
163154509|NCT04050553|589280159|FG000|Wash-out|Withdrawal by Subject|0|||
163154510|NCT04050553|589280160|FG001|Wash-out|Withdrawal by Subject|1|||
163154511|NCT01535040|589280161|FG000|Overall Study|Physician Decision|0|||
163154512|NCT01535040|589280162|FG001|Overall Study|Physician Decision|1|||
163154513|NCT01535040|589280161|FG000|Overall Study|Withdrawal by Subject|13|||
163154514|NCT01535040|589280162|FG001|Overall Study|Withdrawal by Subject|10|||
163154515|NCT01535040|589280161|FG000|Overall Study|Never Started|9|||
163154516|NCT01535040|589280162|FG001|Overall Study|Never Started|4|||
163154517|NCT01535040|589280161|FG000|Overall Study|Toxicity|7|||
163154518|NCT01535040|589280162|FG001|Overall Study|Toxicity|5|||
163154519|NCT01535040|589280161|FG000|Overall Study|Multiple Reasons|1|||
163154520|NCT01535040|589280162|FG001|Overall Study|Multiple Reasons|1|||
163154521|NCT03589859|589280170|FG000|Overall Study|Withdrawal by Subject|0|||
163154522|NCT03589859|589280171|FG001|Overall Study|Withdrawal by Subject|6|||
163154523|NCT03043794|589280174|FG000|Overall Study|Lost to Follow-up|1|||
163154524|NCT00626106|589280176|FG000|Overall Study|Withdrawal by Subject|2|||
163265945|NCT02440594|589684941|FG003|Overall Study|Administratively w/drawn|0|||
163265946|NCT02440594|589684942|FG004|Overall Study|Administratively w/drawn|0|||
163265947|NCT02440594|589684943|FG005|Overall Study|Administratively w/drawn|0|||
163265948|NCT02440594|589684944|FG006|Overall Study|Administratively w/drawn|2|||
163265949|NCT02440594|589684945|FG007|Overall Study|Administratively w/drawn|1|||
163265950|NCT00152763|589684946|FG000|Overall Study|Death|4|||
163154525|NCT00626106|589280177|FG001|Overall Study|Withdrawal by Subject|1|||
163154526|NCT00626106|589280176|FG000|Overall Study|Lost to Follow-up|1|||
163154527|NCT00626106|589280177|FG001|Overall Study|Lost to Follow-up|4|||
163154528|NCT00626106|589280176|FG000|Overall Study|Death|64|||
163154529|NCT00626106|589280177|FG001|Overall Study|Death|19|||
163154530|NCT03472885|589280178|FG000|24-Week Treatment Period|Adverse Event|1|||
163154531|NCT05417438|589280179|FG000|Overall Study|Withdrawal by Subject|3|||
163154532|NCT02201953|589280184|FG000|Overall Study|Randomized but Never Treated|1|||
163154533|NCT02201953|589280185|FG001|Overall Study|Randomized but Never Treated|5|||
163154534|NCT02201953|589280184|FG000|Overall Study|Lack of Efficacy|9|||
163154535|NCT02201953|589280185|FG001|Overall Study|Lack of Efficacy|30|||
163154536|NCT02201953|589280184|FG000|Overall Study|Lost to Follow-up|8|||
163265951|NCT00152763|589684947|FG001|Overall Study|Death|1|||
163265952|NCT00152763|589684948|FG002|Overall Study|Death|2|||
163265953|NCT00152763|589684949|FG003|Overall Study|Death|1|||
163265954|NCT00152763|589684946|FG000|Overall Study|Lost to Follow-up|6|||
163265955|NCT00152763|589684947|FG001|Overall Study|Lost to Follow-up|4|||
163265956|NCT00152763|589684948|FG002|Overall Study|Lost to Follow-up|2|||
163265957|NCT00152763|589684949|FG003|Overall Study|Lost to Follow-up|13|||
163265958|NCT04668989|589684950|FG000|First Intervention|Covid-19 related self-isolation|0|||
163265959|NCT04668989|589684951|FG001|First Intervention|Covid-19 related self-isolation|1|||
163265960|NCT04668989|589684950|FG000|Second Intervention|Adverse Event|0|||
163265961|NCT04668989|589684951|FG001|Second Intervention|Adverse Event|1|||
163265962|NCT01622348|589684955|FG000|Overall Study|Withdrawal by Subject|1|||
163265963|NCT01622348|589684956|FG001|Overall Study|Withdrawal by Subject|0|||
163265964|NCT01622348|589684957|FG002|Overall Study|Withdrawal by Subject|1|||
163265965|NCT00474175|589684960|FG000|Overall Study|Lack of Efficacy|0|||
163265966|NCT00474175|589684961|FG001|Overall Study|Lack of Efficacy|0|||
163265967|NCT00474175|589684962|FG002|Overall Study|Lack of Efficacy|1|||
163265968|NCT00474175|589684960|FG000|Overall Study|Withdrawal by Subject|0|||
163265969|NCT00474175|589684961|FG001|Overall Study|Withdrawal by Subject|1|||
163265970|NCT00474175|589684962|FG002|Overall Study|Withdrawal by Subject|1|||
163265971|NCT00474175|589684960|FG000|Overall Study|Ineligible|1|||
163265972|NCT00474175|589684961|FG001|Overall Study|Ineligible|3|||
163265973|NCT00474175|589684962|FG002|Overall Study|Ineligible|1|||
163265974|NCT00474175|589684960|FG000|Overall Study|Protocol Violation|0|||
163265975|NCT00474175|589684961|FG001|Overall Study|Protocol Violation|2|||
163265976|NCT00474175|589684962|FG002|Overall Study|Protocol Violation|1|||
163265977|NCT00474175|589684960|FG000|Overall Study|Administrative|0|||
163265978|NCT00474175|589684961|FG001|Overall Study|Administrative|1|||
163265979|NCT00474175|589684962|FG002|Overall Study|Administrative|0|||
163265980|NCT01619787|589684963|FG000|Overall Study|Lost to Follow-up|5|||
163265981|NCT04537897|589684964|FG000|Overall Study|Other than listed|0|||
163265982|NCT04537897|589684965|FG001|Overall Study|Other than listed|0|||
163265983|NCT04537897|589684966|FG002|Overall Study|Other than listed|0|||
163265984|NCT04537897|589684967|FG003|Overall Study|Other than listed|0|||
163265985|NCT04537897|589684968|FG004|Overall Study|Other than listed|0|||
163265986|NCT04537897|589684969|FG005|Overall Study|Other than listed|0|||
163265987|NCT04537897|589684970|FG006|Overall Study|Other than listed|1|||
163265988|NCT04537897|589684971|FG007|Overall Study|Other than listed|0|||
163265989|NCT04537897|589684972|FG008|Overall Study|Other than listed|0|||
163265990|NCT04537897|589684964|FG000|Overall Study|Adverse Event|0|||
163265991|NCT04537897|589684965|FG001|Overall Study|Adverse Event|0|||
163265992|NCT04537897|589684966|FG002|Overall Study|Adverse Event|0|||
163265993|NCT04537897|589684967|FG003|Overall Study|Adverse Event|1|||
163265994|NCT04537897|589684968|FG004|Overall Study|Adverse Event|0|||
163265995|NCT04537897|589684969|FG005|Overall Study|Adverse Event|0|||
163265996|NCT04537897|589684970|FG006|Overall Study|Adverse Event|0|||
163265997|NCT04537897|589684971|FG007|Overall Study|Adverse Event|0|||
163265998|NCT04537897|589684972|FG008|Overall Study|Adverse Event|0|||
163265999|NCT04537897|589684964|FG000|Overall Study|Withdrawal by Subject|0|||
163266000|NCT04537897|589684965|FG001|Overall Study|Withdrawal by Subject|1|||
163266001|NCT04537897|589684966|FG002|Overall Study|Withdrawal by Subject|0|||
163266002|NCT04537897|589684967|FG003|Overall Study|Withdrawal by Subject|0|||
163266003|NCT04537897|589684968|FG004|Overall Study|Withdrawal by Subject|0|||
163266004|NCT04537897|589684969|FG005|Overall Study|Withdrawal by Subject|0|||
163266005|NCT04537897|589684970|FG006|Overall Study|Withdrawal by Subject|0|||
163266006|NCT04537897|589684971|FG007|Overall Study|Withdrawal by Subject|0|||
163266007|NCT04537897|589684972|FG008|Overall Study|Withdrawal by Subject|0|||
163266008|NCT00197028|589684976|FG000|Overall Study|Adverse Event|2|||
163266009|NCT00197028|589684977|FG001|Overall Study|Adverse Event|2|||
163266010|NCT00197028|589684976|FG000|Overall Study|Protocol Violation|2|||
163266011|NCT00197028|589684977|FG001|Overall Study|Protocol Violation|1|||
163266012|NCT00197028|589684976|FG000|Overall Study|Withdrawal by Subject|8|||
163266013|NCT00197028|589684977|FG001|Overall Study|Withdrawal by Subject|12|||
163266014|NCT00197028|589684976|FG000|Overall Study|Lost to Follow-up|1|||
163266015|NCT00197028|589684977|FG001|Overall Study|Lost to Follow-up|0|||
163266016|NCT00197028|589684976|FG000|Overall Study|Other|3|||
163266017|NCT00197028|589684977|FG001|Overall Study|Other|6|||
163266018|NCT03893825|589684978|FG000|Overall Study|Death|2|||
163266019|NCT03893825|589684979|FG001|Overall Study|Death|1|||
163266020|NCT03893825|589684978|FG000|Overall Study|Adverse Event|0|||
163266021|NCT03893825|589684979|FG001|Overall Study|Adverse Event|2|||
163266022|NCT03893825|589684978|FG000|Overall Study|Withdrawal by Subject|19|||
163266023|NCT03893825|589684979|FG001|Overall Study|Withdrawal by Subject|21|||
163266024|NCT03893825|589684978|FG000|Overall Study|Protocol deviation|1|||
163266025|NCT03893825|589684979|FG001|Overall Study|Protocol deviation|0|||
163266026|NCT03893825|589684978|FG000|Overall Study|Lost to Follow-up|10|||
163266027|NCT03893825|589684979|FG001|Overall Study|Lost to Follow-up|10|||
163266028|NCT03893825|589684978|FG000|Overall Study|Other than specified|7|||
163266029|NCT03893825|589684979|FG001|Overall Study|Other than specified|6|||
163266030|NCT04488003|589684985|FG000|Assessed for Eligibility|Screen Failure|24|||
163266031|NCT04488003|589684986|FG001|Assessed for Eligibility|Screen Failure|0|||
163266032|NCT04488003|589684987|FG002|Assessed for Eligibility|Screen Failure|0|||
163266033|NCT04488003|589684985|FG000|Assessed for Eligibility|Adverse Event|1|||
163266034|NCT04488003|589684986|FG001|Assessed for Eligibility|Adverse Event|0|||
163266035|NCT04488003|589684987|FG002|Assessed for Eligibility|Adverse Event|0|||
163266036|NCT04488003|589684985|FG000|Assessed for Eligibility|Death|1|||
163266037|NCT04488003|589684986|FG001|Assessed for Eligibility|Death|0|||
163266038|NCT04488003|589684987|FG002|Assessed for Eligibility|Death|0|||
163266039|NCT04488003|589684985|FG000|Assessed for Eligibility|Physician Decision|1|||
163266040|NCT04488003|589684986|FG001|Assessed for Eligibility|Physician Decision|0|||
163266041|NCT04488003|589684987|FG002|Assessed for Eligibility|Physician Decision|0|||
163266042|NCT04488003|589684985|FG000|Allocated to Treatment|Progressive Disease|51|||
163266043|NCT04488003|589684986|FG001|Allocated to Treatment|Progressive Disease|0|||
163266044|NCT04488003|589684987|FG002|Allocated to Treatment|Progressive Disease|0|||
163266045|NCT04488003|589684985|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
163266046|NCT04488003|589684986|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
163266047|NCT04488003|589684987|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
163266048|NCT04488003|589684985|FG000|Allocated to Treatment|Adverse Event|6|||
163266049|NCT04488003|589684986|FG001|Allocated to Treatment|Adverse Event|0|||
163266050|NCT04488003|589684987|FG002|Allocated to Treatment|Adverse Event|0|||
163266051|NCT04488003|589684985|FG000|Allocated to Treatment|Other|5|||
163266052|NCT04488003|589684986|FG001|Allocated to Treatment|Other|0|||
163266053|NCT04488003|589684987|FG002|Allocated to Treatment|Other|0|||
163266054|NCT04488003|589684985|FG000|Allocated to Treatment|Physician Decision|4|||
163266055|NCT04488003|589684986|FG001|Allocated to Treatment|Physician Decision|0|||
163266056|NCT04488003|589684987|FG002|Allocated to Treatment|Physician Decision|0|||
163266057|NCT04488003|589684985|FG000|Allocated to Treatment|Death|4|||
163266058|NCT04488003|589684986|FG001|Allocated to Treatment|Death|0|||
163266059|NCT04488003|589684987|FG002|Allocated to Treatment|Death|0|||
163266060|NCT01468922|589684990|FG000|Overall Study|Screening failure|0|||
163266061|NCT01468922|589684991|FG001|Overall Study|Screening failure|0|||
163266062|NCT01468922|589684992|FG002|Overall Study|Screening failure|0|||
163266063|NCT01468922|589684993|FG003|Overall Study|Screening failure|0|||
163266064|NCT01468922|589684994|FG004|Overall Study|Screening failure|0|||
163266065|NCT01468922|589684995|FG005|Overall Study|Screening failure|0|||
163266066|NCT01468922|589684996|FG006|Overall Study|Screening failure|0|||
163266067|NCT01468922|589684997|FG007|Overall Study|Screening failure|0|||
163266068|NCT01468922|589684998|FG008|Overall Study|Screening failure|1|||
163266069|NCT01468922|589684990|FG000|Overall Study|Per patient choice|1|||
163266070|NCT01468922|589684991|FG001|Overall Study|Per patient choice|0|||
163266071|NCT01468922|589684992|FG002|Overall Study|Per patient choice|0|||
163266072|NCT01468922|589684993|FG003|Overall Study|Per patient choice|0|||
163266073|NCT01468922|589684994|FG004|Overall Study|Per patient choice|0|||
163266074|NCT01468922|589684995|FG005|Overall Study|Per patient choice|0|||
163266075|NCT01468922|589684996|FG006|Overall Study|Per patient choice|0|||
163266076|NCT01468922|589684997|FG007|Overall Study|Per patient choice|0|||
163266077|NCT01468922|589684998|FG008|Overall Study|Per patient choice|0|||
163266078|NCT01468922|589684990|FG000|Overall Study|Switched to alternative treatment|1|||
163266079|NCT01468922|589684991|FG001|Overall Study|Switched to alternative treatment|0|||
163266080|NCT01468922|589684992|FG002|Overall Study|Switched to alternative treatment|0|||
163266081|NCT01468922|589684993|FG003|Overall Study|Switched to alternative treatment|0|||
163266082|NCT01468922|589684994|FG004|Overall Study|Switched to alternative treatment|1|||
163266083|NCT01468922|589684995|FG005|Overall Study|Switched to alternative treatment|0|||
163266084|NCT01468922|589684996|FG006|Overall Study|Switched to alternative treatment|0|||
163266085|NCT01468922|589684997|FG007|Overall Study|Switched to alternative treatment|0|||
163266086|NCT01468922|589684998|FG008|Overall Study|Switched to alternative treatment|0|||
163266087|NCT01468922|589684990|FG000|Overall Study|Enrolled on new protocol|0|||
163266088|NCT01468922|589684991|FG001|Overall Study|Enrolled on new protocol|0|||
163266089|NCT01468922|589684992|FG002|Overall Study|Enrolled on new protocol|0|||
163266090|NCT01468922|589684993|FG003|Overall Study|Enrolled on new protocol|0|||
163266091|NCT01468922|589684994|FG004|Overall Study|Enrolled on new protocol|1|||
163266092|NCT01468922|589684995|FG005|Overall Study|Enrolled on new protocol|0|||
163266093|NCT01468922|589684996|FG006|Overall Study|Enrolled on new protocol|0|||
163266094|NCT01468922|589684997|FG007|Overall Study|Enrolled on new protocol|0|||
163266095|NCT01468922|589684998|FG008|Overall Study|Enrolled on new protocol|0|||
163266096|NCT01468922|589684990|FG000|Overall Study|Adverse Event|0|||
163266097|NCT01468922|589684991|FG001|Overall Study|Adverse Event|0|||
163266098|NCT01468922|589684992|FG002|Overall Study|Adverse Event|0|||
163266099|NCT01468922|589684993|FG003|Overall Study|Adverse Event|0|||
163266100|NCT01468922|589684994|FG004|Overall Study|Adverse Event|0|||
163266101|NCT01468922|589684995|FG005|Overall Study|Adverse Event|0|||
163266102|NCT01468922|589684996|FG006|Overall Study|Adverse Event|0|||
163266103|NCT01468922|589684997|FG007|Overall Study|Adverse Event|1|||
163266104|NCT01468922|589684998|FG008|Overall Study|Adverse Event|0|||
163266105|NCT01468922|589684990|FG000|Overall Study|Infection of blood|0|||
163266106|NCT01468922|589684991|FG001|Overall Study|Infection of blood|0|||
163266107|NCT01468922|589684992|FG002|Overall Study|Infection of blood|0|||
163266108|NCT01468922|589684993|FG003|Overall Study|Infection of blood|0|||
163266109|NCT01468922|589684994|FG004|Overall Study|Infection of blood|0|||
163266110|NCT01468922|589684995|FG005|Overall Study|Infection of blood|0|||
163266111|NCT01468922|589684996|FG006|Overall Study|Infection of blood|0|||
163266112|NCT01468922|589684997|FG007|Overall Study|Infection of blood|1|||
163266113|NCT01468922|589684998|FG008|Overall Study|Infection of blood|0|||
163266114|NCT01468922|589684990|FG000|Overall Study|Patient choice - surgery|0|||
163266115|NCT01468922|589684991|FG001|Overall Study|Patient choice - surgery|0|||
163266116|NCT01468922|589684992|FG002|Overall Study|Patient choice - surgery|0|||
163266117|NCT01468922|589684993|FG003|Overall Study|Patient choice - surgery|0|||
163266118|NCT01468922|589684994|FG004|Overall Study|Patient choice - surgery|0|||
163266119|NCT01468922|589684995|FG005|Overall Study|Patient choice - surgery|0|||
163266120|NCT01468922|589684996|FG006|Overall Study|Patient choice - surgery|0|||
163266121|NCT01468922|589684997|FG007|Overall Study|Patient choice - surgery|1|||
163266122|NCT01468922|589684998|FG008|Overall Study|Patient choice - surgery|0|||
163266123|NCT01468922|589684990|FG000|Overall Study|Refused further treatment|0|||
163266124|NCT01468922|589684991|FG001|Overall Study|Refused further treatment|0|||
163266125|NCT01468922|589684992|FG002|Overall Study|Refused further treatment|0|||
163266126|NCT01468922|589684993|FG003|Overall Study|Refused further treatment|0|||
163266127|NCT01468922|589684994|FG004|Overall Study|Refused further treatment|0|||
163266128|NCT01468922|589684995|FG005|Overall Study|Refused further treatment|0|||
163266129|NCT01468922|589684996|FG006|Overall Study|Refused further treatment|0|||
163266130|NCT01468922|589684997|FG007|Overall Study|Refused further treatment|1|||
163266131|NCT01468922|589684998|FG008|Overall Study|Refused further treatment|0|||
163266132|NCT00007475|589685001|FG000|Overall Study|Withdrawal by Subject|1|||
163266133|NCT00007475|589685002|FG001|Overall Study|Withdrawal by Subject|0|||
163266134|NCT00007475|589685003|FG002|Overall Study|Withdrawal by Subject|0|||
163266135|NCT00007475|589685004|FG003|Overall Study|Withdrawal by Subject|0|||
163266136|NCT00007475|589685001|FG000|Overall Study|Adverse Event|3|||
163266137|NCT00007475|589685002|FG001|Overall Study|Adverse Event|0|||
163266138|NCT00007475|589685003|FG002|Overall Study|Adverse Event|0|||
163266139|NCT00007475|589685004|FG003|Overall Study|Adverse Event|0|||
163266140|NCT01719224|589685005|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
163266141|NCT01719224|589685006|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
163266142|NCT00258440|589685007|FG000|Overall Study|Withdrawal by Subject|0|||
163266143|NCT00258440|589685008|FG001|Overall Study|Withdrawal by Subject|0|||
163266144|NCT00258440|589685009|FG002|Overall Study|Withdrawal by Subject|1|||
163266145|NCT00737061|589685010|FG000|Waiting Period|Lost to Follow-up|6|||
163266146|NCT00737061|589685010|FG000|Waiting Period|Withdrawal by Subject|1|||
163266147|NCT00737061|589685010|FG000|Waiting Period|Bilateral placement failure|34|||
163266148|NCT00737061|589685010|FG000|Waiting Period|Deemed patent following HSG|26|||
163266149|NCT00737061|589685010|FG000|Waiting Period|Alternative contraception failure|3|||
163266150|NCT00737061|589685010|FG000|Waiting Period|Elected surgical tubal ligation|5|||
163266151|NCT00737061|589685010|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
163266152|NCT00737061|589685010|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
163266153|NCT00737061|589685010|FG000|1 Year Wearing Period|Discontinued reilance|3|||
163266154|NCT00737061|589685010|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
163266155|NCT03000673|589685011|FG000|Overall Study|Withdrawal by Subject|1|||
163266156|NCT03000673|589685012|FG001|Overall Study|Withdrawal by Subject|0|||
163266157|NCT03000673|589685013|FG002|Overall Study|Withdrawal by Subject|0|||
163266158|NCT03000673|589685014|FG003|Overall Study|Withdrawal by Subject|0|||
163266159|NCT00692406|589685015|FG000|Overall Study|PI dropped, bad data|57|||
163266160|NCT04186403|589685018|FG000|Overall Study|Adverse Event|1|||
163266161|NCT04186403|589685019|FG001|Overall Study|Adverse Event|8|||
163266162|NCT04186403|589685018|FG000|Overall Study|Lost to Follow-up|7|||
163266163|NCT04186403|589685019|FG001|Overall Study|Lost to Follow-up|3|||
163266164|NCT04186403|589685018|FG000|Overall Study|Physician Decision|1|||
163266165|NCT04186403|589685019|FG001|Overall Study|Physician Decision|0|||
163362386|NCT04052425|590036481|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
163362387|NCT04052425|590036482|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
163266166|NCT04186403|589685018|FG000|Overall Study|Withdrawal by Subject|7|||
163266167|NCT04186403|589685019|FG001|Overall Study|Withdrawal by Subject|8|||
163266168|NCT04186403|589685018|FG000|Overall Study|Other: Not Related to Covid-19|3|||
163266169|NCT04186403|589685019|FG001|Overall Study|Other: Not Related to Covid-19|0|||
163266170|NCT01407354|589685024|FG000|First Intervention|Withdrawal by Subject|0|||
163266171|NCT01407354|589685025|FG001|First Intervention|Withdrawal by Subject|2|||
163266172|NCT01407354|589685024|FG000|First Intervention|Adverse Event|1|||
163266173|NCT01407354|589685025|FG001|First Intervention|Adverse Event|0|||
163266174|NCT01407354|589685024|FG000|First Intervention|Physician Decision|1|||
163266175|NCT01407354|589685025|FG001|First Intervention|Physician Decision|0|||
163266176|NCT01036022|589685026|FG000|Overall Study|Adverse Event|1|||
163266177|NCT01036022|589685027|FG001|Overall Study|Adverse Event|3|||
163266178|NCT01036022|589685028|FG002|Overall Study|Adverse Event|2|||
163266179|NCT01036022|589685029|FG003|Overall Study|Adverse Event|1|||
163266180|NCT01036022|589685030|FG004|Overall Study|Adverse Event|0|||
163266181|NCT01036022|589685031|FG005|Overall Study|Adverse Event|2|||
163266182|NCT01036022|589685026|FG000|Overall Study|Lack of Efficacy|1|||
163154537|NCT02201953|589280185|FG001|Overall Study|Lost to Follow-up|8|||
163154538|NCT02201953|589280184|FG000|Overall Study|Withdrew Consent|2|||
163154539|NCT02201953|589280185|FG001|Overall Study|Withdrew Consent|5|||
163154540|NCT02201953|589280184|FG000|Overall Study|Adverse Event|0|||
163154541|NCT02201953|589280185|FG001|Overall Study|Adverse Event|5|||
163154542|NCT02201953|589280184|FG000|Overall Study|Death|0|||
163154543|NCT02201953|589280185|FG001|Overall Study|Death|3|||
163154544|NCT03312634|589281298|FG000|Overall Study|Adverse Event|11|||
163154545|NCT03312634|589281299|FG001|Overall Study|Adverse Event|0|||
163154546|NCT03312634|589281298|FG000|Overall Study|Sponsor request|2|||
163154547|NCT03312634|589281299|FG001|Overall Study|Sponsor request|0|||
163154548|NCT03312634|589281298|FG000|Overall Study|Withdrawal by Subject|31|||
163154549|NCT03312634|589281299|FG001|Overall Study|Withdrawal by Subject|9|||
163154550|NCT03312634|589281298|FG000|Overall Study|Enrolled in an interventional study|0|||
163154551|NCT03312634|589281299|FG001|Overall Study|Enrolled in an interventional study|52|||
163154552|NCT03312634|589281298|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
163154553|NCT03312634|589281299|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
163154554|NCT03312634|589281298|FG000|Overall Study|Death|0|||
163154555|NCT03312634|589281299|FG001|Overall Study|Death|1|||
163154556|NCT03312634|589281298|FG000|Overall Study|Non-compliance|0|||
163154557|NCT03312634|589281299|FG001|Overall Study|Non-compliance|2|||
163154558|NCT03312634|589281298|FG000|Overall Study|Lost to Follow-up|0|||
163154559|NCT03312634|589281299|FG001|Overall Study|Lost to Follow-up|1|||
163154560|NCT03312634|589281298|FG000|Overall Study|Enrolled into non-interventional study|0|||
163154561|NCT03312634|589281299|FG001|Overall Study|Enrolled into non-interventional study|5|||
163154562|NCT03312634|589281298|FG000|Overall Study|Worsening clinical condition|0|||
163154563|NCT03312634|589281299|FG001|Overall Study|Worsening clinical condition|1|||
163154564|NCT03312634|589281298|FG000|Overall Study|Participant did not want to travel|0|||
163154565|NCT03312634|589281299|FG001|Overall Study|Participant did not want to travel|1|||
163154566|NCT03312634|589281298|FG000|Overall Study|Physician Decision|1|||
163154567|NCT03312634|589281299|FG001|Overall Study|Physician Decision|0|||
163154568|NCT03312634|589281298|FG000|Overall Study|Other|13|||
163154569|NCT03312634|589281299|FG001|Overall Study|Other|0|||
163154570|NCT04610281|589281300|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
163154571|NCT04610281|589281301|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
163154572|NCT01942837|589281302|FG000|Overall Study|Death|1|||
163154573|NCT01942837|589281302|FG000|Overall Study|Symptomatic or radiographic progression|49|||
163154574|NCT01942837|589281302|FG000|Overall Study|Adverse Event|6|||
163154575|NCT01942837|589281302|FG000|Overall Study|Physician Decision|3|||
163154576|NCT01942837|589281302|FG000|Overall Study|Withdrawal by Subject|2|||
163154577|NCT01942837|589281302|FG000|Overall Study|Intercurrent Illness|1|||
163154578|NCT01942837|589281302|FG000|Overall Study|On treatment|3|||
163154579|NCT01942837|589281302|FG000|Overall Study|Never initiate the treatment|2|||
163154580|NCT01298648|589281303|FG000|Overall Study|Withdrawal by Subject|2|||
163154581|NCT01298648|589281303|FG000|Overall Study|Lost to Follow-up|21|||
163154582|NCT01458392|589281308|FG000|Overall Study|Death|2|||
163154583|NCT01458392|589281309|FG001|Overall Study|Death|11|||
163154584|NCT01458392|589281310|FG002|Overall Study|Death|22|||
163154585|NCT01458392|589281308|FG000|Overall Study|At the discretion of the sponsor|0|||
163154586|NCT01458392|589281309|FG001|Overall Study|At the discretion of the sponsor|2|||
163154587|NCT01458392|589281310|FG002|Overall Study|At the discretion of the sponsor|7|||
163154588|NCT01458392|589281308|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
163154589|NCT01458392|589281309|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
163154590|NCT01458392|589281310|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
163154591|NCT00918255|589281311|FG000|Overall Study|Adverse Event|1|||
163154592|NCT00918255|589281312|FG001|Overall Study|Adverse Event|0|||
163154593|NCT00918255|589281313|FG002|Overall Study|Adverse Event|0|||
163154594|NCT00918255|589281311|FG000|Overall Study|Withdrawal by Subject|1|||
163154595|NCT00918255|589281312|FG001|Overall Study|Withdrawal by Subject|0|||
163154596|NCT00918255|589281313|FG002|Overall Study|Withdrawal by Subject|2|||
163154597|NCT00918255|589281311|FG000|Overall Study|Lack of Efficacy|1|||
163154598|NCT00918255|589281312|FG001|Overall Study|Lack of Efficacy|0|||
163154599|NCT00918255|589281313|FG002|Overall Study|Lack of Efficacy|0|||
163154600|NCT00918255|589281311|FG000|Overall Study|Lost to Follow-up|1|||
163154601|NCT00918255|589281312|FG001|Overall Study|Lost to Follow-up|0|||
163154602|NCT00918255|589281313|FG002|Overall Study|Lost to Follow-up|2|||
163154603|NCT00918255|589281311|FG000|Overall Study|Exceeded allowed number of interventions|0|||
163154604|NCT00918255|589281312|FG001|Overall Study|Exceeded allowed number of interventions|0|||
163154605|NCT00918255|589281313|FG002|Overall Study|Exceeded allowed number of interventions|1|||
163154606|NCT00918255|589281311|FG000|Overall Study|Non-compliance|1|||
163154607|NCT00918255|589281312|FG001|Overall Study|Non-compliance|0|||
163154608|NCT00918255|589281313|FG002|Overall Study|Non-compliance|0|||
163154609|NCT00918255|589281311|FG000|Overall Study|Investigator discretion|1|||
163154610|NCT00918255|589281312|FG001|Overall Study|Investigator discretion|0|||
163154611|NCT00918255|589281313|FG002|Overall Study|Investigator discretion|0|||
163362388|NCT04052425|590036483|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
163362389|NCT04052425|590036480|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
163362390|NCT04052425|590036481|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
163362391|NCT04052425|590036482|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
163362392|NCT04052425|590036483|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
163362393|NCT04052425|590036480|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
163362394|NCT04052425|590036481|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
163362395|NCT04052425|590036482|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
163362396|NCT04052425|590036483|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
163362397|NCT04052425|590036480|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
163362398|NCT04052425|590036481|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
163362399|NCT04052425|590036482|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
163362400|NCT04052425|590036483|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
163362401|NCT04052425|590036480|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
163362402|NCT04052425|590036481|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
163362403|NCT04052425|590036482|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
163362404|NCT04052425|590036483|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
163362405|NCT04052425|590036480|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
163362406|NCT04052425|590036481|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
163362407|NCT04052425|590036482|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
163362408|NCT04052425|590036483|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
163362409|NCT04052425|590036480|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
163362410|NCT04052425|590036481|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
163362411|NCT04052425|590036482|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
163362412|NCT04052425|590036483|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
163362413|NCT04052425|590036480|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
163362414|NCT04052425|590036481|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
163362415|NCT04052425|590036482|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
163362416|NCT04052425|590036483|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
163362417|NCT04052425|590036480|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
163362418|NCT04052425|590036481|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
163362419|NCT04052425|590036482|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
163362420|NCT04052425|590036483|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
163362421|NCT00945672|590036486|FG000|Overall Study|Withdrawal by Subject|0|||
163362422|NCT00945672|590036487|FG001|Overall Study|Withdrawal by Subject|0|||
163362423|NCT00945672|590036488|FG002|Overall Study|Withdrawal by Subject|0|||
163362424|NCT00945672|590036489|FG003|Overall Study|Withdrawal by Subject|1|||
163362425|NCT01681992|590036492|FG000|Overall Study|Adverse Event|3|||
163362426|NCT01681992|590036493|FG001|Overall Study|Adverse Event|2|||
163362427|NCT01681992|590036494|FG002|Overall Study|Adverse Event|3|||
163362428|NCT01681992|590036492|FG000|Overall Study|Lost to Follow-up|36|||
163362429|NCT01681992|590036493|FG001|Overall Study|Lost to Follow-up|38|||
163362430|NCT01681992|590036494|FG002|Overall Study|Lost to Follow-up|53|||
163362431|NCT01681992|590036492|FG000|Overall Study|As Per Sponsor Decision|0|||
163362432|NCT01681992|590036493|FG001|Overall Study|As Per Sponsor Decision|0|||
163362433|NCT01681992|590036494|FG002|Overall Study|As Per Sponsor Decision|1|||
163362434|NCT01681992|590036492|FG000|Overall Study|Protocol Violation|0|||
163362435|NCT01681992|590036493|FG001|Overall Study|Protocol Violation|0|||
163362436|NCT01681992|590036494|FG002|Overall Study|Protocol Violation|1|||
163362437|NCT01681992|590036492|FG000|Overall Study|Withdrawal by Subject|27|||
163362438|NCT01681992|590036493|FG001|Overall Study|Withdrawal by Subject|30|||
163362439|NCT01681992|590036494|FG002|Overall Study|Withdrawal by Subject|25|||
163362440|NCT00447590|590036495|FG000|Overall Study|Withdrawal by Subject|26|||
163362441|NCT00447590|590036495|FG000|Overall Study|Lost to Follow-up|24|||
163362442|NCT00447590|590036495|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
163362443|NCT03880019|590036496|FG000|Overall Study|Competing disease|1|||
163362444|NCT03812029|590036501|FG000|Overall Study|Protocol Violation|1|||
163362445|NCT03812029|590036502|FG001|Overall Study|Protocol Violation|0|||
163362446|NCT03812029|590036503|FG002|Overall Study|Protocol Violation|0|||
163362447|NCT03812029|590036504|FG003|Overall Study|Protocol Violation|1|||
163362448|NCT03812029|590036505|FG004|Overall Study|Protocol Violation|0|||
163362449|NCT03812029|590036501|FG000|Overall Study|Withdrawal by Subject|1|||
163362450|NCT03812029|590036502|FG001|Overall Study|Withdrawal by Subject|0|||
163362451|NCT03812029|590036503|FG002|Overall Study|Withdrawal by Subject|0|||
163362452|NCT03812029|590036504|FG003|Overall Study|Withdrawal by Subject|2|||
163362453|NCT03812029|590036505|FG004|Overall Study|Withdrawal by Subject|2|||
163362454|NCT03812029|590036501|FG000|Overall Study|Stopping rules|0|||
163362455|NCT03812029|590036502|FG001|Overall Study|Stopping rules|1|||
163362456|NCT03812029|590036503|FG002|Overall Study|Stopping rules|0|||
163362457|NCT03812029|590036504|FG003|Overall Study|Stopping rules|0|||
163362458|NCT03812029|590036505|FG004|Overall Study|Stopping rules|0|||
163154612|NCT02038933|589281314|FG000|Overall Study|Disease progression|104|||
163154613|NCT02038933|589281314|FG000|Overall Study|Study drug toxicity|6|||
163154614|NCT02038933|589281314|FG000|Overall Study|Adverse event unrelated to study drug|6|||
163154615|NCT02038933|589281314|FG000|Overall Study|Participant request to discontinue treatment|2|||
163154616|NCT02038933|589281314|FG000|Overall Study|Lost to Follow-up|1|||
163154617|NCT02038933|589281314|FG000|Overall Study|Other reasons|2|||
163266183|NCT01036022|589685027|FG001|Overall Study|Lack of Efficacy|1|||
163266184|NCT01036022|589685028|FG002|Overall Study|Lack of Efficacy|1|||
163266185|NCT01036022|589685029|FG003|Overall Study|Lack of Efficacy|0|||
163266186|NCT01036022|589685030|FG004|Overall Study|Lack of Efficacy|1|||
163266187|NCT01036022|589685031|FG005|Overall Study|Lack of Efficacy|1|||
163266188|NCT01036022|589685026|FG000|Overall Study|Physician Decision|0|||
163266189|NCT01036022|589685027|FG001|Overall Study|Physician Decision|0|||
163266190|NCT01036022|589685028|FG002|Overall Study|Physician Decision|1|||
163266191|NCT01036022|589685029|FG003|Overall Study|Physician Decision|0|||
163266192|NCT01036022|589685030|FG004|Overall Study|Physician Decision|0|||
163266193|NCT01036022|589685031|FG005|Overall Study|Physician Decision|0|||
163266194|NCT01036022|589685026|FG000|Overall Study|Withdrawal by Subject|0|||
163266195|NCT01036022|589685027|FG001|Overall Study|Withdrawal by Subject|0|||
163266196|NCT01036022|589685028|FG002|Overall Study|Withdrawal by Subject|0|||
163266197|NCT01036022|589685029|FG003|Overall Study|Withdrawal by Subject|1|||
163266198|NCT01036022|589685030|FG004|Overall Study|Withdrawal by Subject|2|||
163266199|NCT01036022|589685031|FG005|Overall Study|Withdrawal by Subject|0|||
163266200|NCT00962247|589685037|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
163266201|NCT00962247|589685037|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
163266202|NCT01555164|589685041|FG000|Overall Study|Adverse Event|5|||
163266203|NCT01555164|589685042|FG001|Overall Study|Adverse Event|7|||
163266204|NCT01555164|589685041|FG000|Overall Study|Hyperglycemia|0|||
163266205|NCT01555164|589685042|FG001|Overall Study|Hyperglycemia|1|||
163266206|NCT01555164|589685041|FG000|Overall Study|Investigator's Discretion|2|||
163266207|NCT01555164|589685042|FG001|Overall Study|Investigator's Discretion|2|||
163266208|NCT01555164|589685041|FG000|Overall Study|Lost to Follow-up|4|||
163266209|NCT01555164|589685042|FG001|Overall Study|Lost to Follow-up|3|||
163266210|NCT01555164|589685041|FG000|Overall Study|Protocol Violation|9|||
163266211|NCT01555164|589685042|FG001|Overall Study|Protocol Violation|5|||
163266212|NCT01555164|589685041|FG000|Overall Study|Subject Non-compliance|14|||
163266213|NCT01555164|589685042|FG001|Overall Study|Subject Non-compliance|6|||
163266214|NCT01555164|589685041|FG000|Overall Study|Subject Withdrew Consent|6|||
163266215|NCT01555164|589685042|FG001|Overall Study|Subject Withdrew Consent|11|||
163266216|NCT00886639|589685045|FG000|Overall Study|acute exacerbation|14|||
163266217|NCT00886639|589685045|FG000|Overall Study|non-compliance|2|||
163266218|NCT01871558|589685046|FG000|Overall Study|Other reason|0|||
163266219|NCT01871558|589685047|FG001|Overall Study|Other reason|1|||
163266220|NCT01871558|589685046|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
163266221|NCT01871558|589685047|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
163266222|NCT01871558|589685046|FG000|Overall Study|Withdrawal by Subject|2|||
163266223|NCT01871558|589685047|FG001|Overall Study|Withdrawal by Subject|0|||
163266224|NCT01709305|589685048|FG000|Phase 1|Clinical Adverse Event|80|||
163266225|NCT01709305|589685049|FG001|Phase 1|Clinical Adverse Event|0|||
163266226|NCT01709305|589685050|FG002|Phase 1|Clinical Adverse Event|0|||
163266227|NCT01709305|589685051|FG003|Phase 1|Clinical Adverse Event|0|||
163266228|NCT01709305|589685052|FG004|Phase 1|Clinical Adverse Event|0|||
163266229|NCT01709305|589685048|FG000|Phase 1|Death|2|||
163266230|NCT01709305|589685049|FG001|Phase 1|Death|0|||
163266231|NCT01709305|589685050|FG002|Phase 1|Death|0|||
163266232|NCT01709305|589685051|FG003|Phase 1|Death|0|||
163266233|NCT01709305|589685052|FG004|Phase 1|Death|0|||
163266234|NCT01709305|589685048|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
163266235|NCT01709305|589685049|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
163266236|NCT01709305|589685050|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
163266237|NCT01709305|589685051|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
163266238|NCT01709305|589685052|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
163266239|NCT01709305|589685048|FG000|Phase 1|Laboratory Adverse Event|16|||
163266240|NCT01709305|589685049|FG001|Phase 1|Laboratory Adverse Event|0|||
163266241|NCT01709305|589685050|FG002|Phase 1|Laboratory Adverse Event|0|||
163266242|NCT01709305|589685051|FG003|Phase 1|Laboratory Adverse Event|0|||
163266243|NCT01709305|589685052|FG004|Phase 1|Laboratory Adverse Event|0|||
163266244|NCT01709305|589685048|FG000|Phase 1|Lost to Follow-up|147|||
163266245|NCT01709305|589685049|FG001|Phase 1|Lost to Follow-up|0|||
163266246|NCT01709305|589685050|FG002|Phase 1|Lost to Follow-up|0|||
163154618|NCT03250273|589281347|FG000|Overall Study|Disease Progression|2|||
163266247|NCT01709305|589685051|FG003|Phase 1|Lost to Follow-up|0|||
163266248|NCT01709305|589685052|FG004|Phase 1|Lost to Follow-up|0|||
163154619|NCT03250273|589281348|FG001|Overall Study|Disease Progression|11|||
163154620|NCT03250273|589281347|FG000|Overall Study|Death|0|||
163266249|NCT01709305|589685048|FG000|Phase 1|Travel, moving, etc.|30|||
163266250|NCT01709305|589685049|FG001|Phase 1|Travel, moving, etc.|0|||
163266251|NCT01709305|589685050|FG002|Phase 1|Travel, moving, etc.|0|||
163266252|NCT01709305|589685051|FG003|Phase 1|Travel, moving, etc.|0|||
163266253|NCT01709305|589685052|FG004|Phase 1|Travel, moving, etc.|0|||
163266254|NCT01709305|589685048|FG000|Phase 1|Physician Decision|13|||
163266255|NCT01709305|589685049|FG001|Phase 1|Physician Decision|0|||
163266256|NCT01709305|589685050|FG002|Phase 1|Physician Decision|0|||
163266257|NCT01709305|589685051|FG003|Phase 1|Physician Decision|0|||
163266258|NCT01709305|589685052|FG004|Phase 1|Physician Decision|0|||
163266259|NCT01709305|589685048|FG000|Phase 1|Protocol Violation|118|||
163266260|NCT01709305|589685049|FG001|Phase 1|Protocol Violation|0|||
163266261|NCT01709305|589685050|FG002|Phase 1|Protocol Violation|0|||
163266262|NCT01709305|589685051|FG003|Phase 1|Protocol Violation|0|||
163266263|NCT01709305|589685052|FG004|Phase 1|Protocol Violation|0|||
163266264|NCT01709305|589685048|FG000|Phase 1|Withdrawal by Subject|218|||
163266265|NCT01709305|589685049|FG001|Phase 1|Withdrawal by Subject|0|||
163266266|NCT01709305|589685050|FG002|Phase 1|Withdrawal by Subject|0|||
163266267|NCT01709305|589685051|FG003|Phase 1|Withdrawal by Subject|0|||
163266268|NCT01709305|589685052|FG004|Phase 1|Withdrawal by Subject|0|||
163266269|NCT01709305|589685048|FG000|Phase 2|Clinical Adverse Event|0|||
163266270|NCT01709305|589685049|FG001|Phase 2|Clinical Adverse Event|10|||
163266271|NCT01709305|589685050|FG002|Phase 2|Clinical Adverse Event|10|||
163266272|NCT01709305|589685051|FG003|Phase 2|Clinical Adverse Event|6|||
163266273|NCT01709305|589685052|FG004|Phase 2|Clinical Adverse Event|11|||
163266274|NCT01709305|589685048|FG000|Phase 2|Death|0|||
163266275|NCT01709305|589685049|FG001|Phase 2|Death|0|||
163266276|NCT01709305|589685050|FG002|Phase 2|Death|1|||
163266277|NCT01709305|589685051|FG003|Phase 2|Death|0|||
163266278|NCT01709305|589685052|FG004|Phase 2|Death|0|||
163266279|NCT01709305|589685048|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
163266280|NCT01709305|589685049|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
163266281|NCT01709305|589685050|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
163266282|NCT01709305|589685051|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
163266283|NCT01709305|589685052|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
163266284|NCT01709305|589685048|FG000|Phase 2|Laboratory Adverse Event|0|||
163266285|NCT01709305|589685049|FG001|Phase 2|Laboratory Adverse Event|1|||
163266286|NCT01709305|589685050|FG002|Phase 2|Laboratory Adverse Event|0|||
163266287|NCT01709305|589685051|FG003|Phase 2|Laboratory Adverse Event|1|||
163266288|NCT01709305|589685052|FG004|Phase 2|Laboratory Adverse Event|1|||
163266289|NCT01709305|589685048|FG000|Phase 2|Lost to Follow-up|0|||
163266290|NCT01709305|589685049|FG001|Phase 2|Lost to Follow-up|10|||
163266291|NCT01709305|589685050|FG002|Phase 2|Lost to Follow-up|6|||
163266292|NCT01709305|589685051|FG003|Phase 2|Lost to Follow-up|9|||
163266293|NCT01709305|589685052|FG004|Phase 2|Lost to Follow-up|5|||
163266294|NCT01709305|589685048|FG000|Phase 2|Travel, moving, etc.|0|||
163266295|NCT01709305|589685049|FG001|Phase 2|Travel, moving, etc.|2|||
163266296|NCT01709305|589685050|FG002|Phase 2|Travel, moving, etc.|3|||
163266297|NCT01709305|589685051|FG003|Phase 2|Travel, moving, etc.|3|||
163266298|NCT01709305|589685052|FG004|Phase 2|Travel, moving, etc.|5|||
163266299|NCT01709305|589685048|FG000|Phase 2|Physician Decision|0|||
163266300|NCT01709305|589685049|FG001|Phase 2|Physician Decision|2|||
163266301|NCT01709305|589685050|FG002|Phase 2|Physician Decision|0|||
163266302|NCT01709305|589685051|FG003|Phase 2|Physician Decision|1|||
163266303|NCT01709305|589685052|FG004|Phase 2|Physician Decision|2|||
163266304|NCT01709305|589685048|FG000|Phase 2|Protocol Violation|0|||
163266305|NCT01709305|589685049|FG001|Phase 2|Protocol Violation|19|||
163266306|NCT01709305|589685050|FG002|Phase 2|Protocol Violation|19|||
163266307|NCT01709305|589685051|FG003|Phase 2|Protocol Violation|13|||
163266308|NCT01709305|589685052|FG004|Phase 2|Protocol Violation|9|||
163266309|NCT01709305|589685048|FG000|Phase 2|Withdrawal by Subject|0|||
163266310|NCT01709305|589685049|FG001|Phase 2|Withdrawal by Subject|8|||
163266311|NCT01709305|589685050|FG002|Phase 2|Withdrawal by Subject|6|||
163266312|NCT01709305|589685051|FG003|Phase 2|Withdrawal by Subject|15|||
163266313|NCT01709305|589685052|FG004|Phase 2|Withdrawal by Subject|12|||
163266314|NCT03443713|589685055|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
163266315|NCT03443713|589685056|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
163266316|NCT03443713|589685057|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
163266317|NCT01672853|589685058|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
163266318|NCT01672853|589685059|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
163266319|NCT01672853|589685060|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
163266320|NCT01672853|589685058|FG000|Overall Study|Pregnancy|0|||
163266321|NCT01672853|589685059|FG001|Overall Study|Pregnancy|1|||
163266322|NCT01672853|589685060|FG002|Overall Study|Pregnancy|0|||
163266323|NCT01672853|589685058|FG000|Overall Study|Investigator's Discretion|1|||
163266324|NCT01672853|589685059|FG001|Overall Study|Investigator's Discretion|0|||
163266325|NCT01672853|589685060|FG002|Overall Study|Investigator's Discretion|0|||
163266326|NCT01672853|589685058|FG000|Overall Study|Withdrew Consent|5|||
163266327|NCT01672853|589685059|FG001|Overall Study|Withdrew Consent|5|||
163266328|NCT01672853|589685060|FG002|Overall Study|Withdrew Consent|5|||
163266329|NCT01672853|589685058|FG000|Overall Study|Adverse Event|4|||
163266330|NCT01672853|589685059|FG001|Overall Study|Adverse Event|6|||
163266331|NCT01672853|589685060|FG002|Overall Study|Adverse Event|8|||
163266332|NCT01672853|589685058|FG000|Overall Study|Lost to Follow-up|0|||
163266333|NCT01672853|589685059|FG001|Overall Study|Lost to Follow-up|1|||
163266334|NCT01672853|589685060|FG002|Overall Study|Lost to Follow-up|0|||
163266335|NCT01672853|589685058|FG000|Overall Study|Randomized but Never Treated|0|||
163266336|NCT01672853|589685059|FG001|Overall Study|Randomized but Never Treated|0|||
163266337|NCT01672853|589685060|FG002|Overall Study|Randomized but Never Treated|1|||
163266338|NCT02969525|589685061|FG000|Double-Blind Period|Adverse Event|0|||
163266339|NCT02969525|589685062|FG001|Double-Blind Period|Adverse Event|0|||
163266340|NCT02969525|589685063|FG002|Double-Blind Period|Adverse Event|1|||
163266341|NCT02969525|589685064|FG003|Double-Blind Period|Adverse Event|1|||
163266342|NCT02969525|589685065|FG004|Double-Blind Period|Adverse Event|0|||
163266343|NCT02969525|589685066|FG005|Double-Blind Period|Adverse Event|0|||
163266344|NCT02969525|589685067|FG006|Double-Blind Period|Adverse Event|0|||
163266345|NCT02969525|589685068|FG007|Double-Blind Period|Adverse Event|0|||
163266346|NCT02969525|589685069|FG008|Double-Blind Period|Adverse Event|0|||
163266347|NCT02969525|589685070|FG009|Double-Blind Period|Adverse Event|0|||
163266348|NCT02969525|589685071|FG010|Double-Blind Period|Adverse Event|0|||
163266349|NCT02969525|589685072|FG011|Double-Blind Period|Adverse Event|0|||
163266350|NCT02969525|589685061|FG000|Double-Blind Period|LOW EGFR|0|||
163266351|NCT02969525|589685062|FG001|Double-Blind Period|LOW EGFR|0|||
163266352|NCT02969525|589685063|FG002|Double-Blind Period|LOW EGFR|0|||
163266353|NCT02969525|589685064|FG003|Double-Blind Period|LOW EGFR|1|||
163266354|NCT02969525|589685065|FG004|Double-Blind Period|LOW EGFR|0|||
163266355|NCT02969525|589685066|FG005|Double-Blind Period|LOW EGFR|0|||
163266356|NCT02969525|589685067|FG006|Double-Blind Period|LOW EGFR|0|||
163266357|NCT02969525|589685068|FG007|Double-Blind Period|LOW EGFR|0|||
163266358|NCT02969525|589685069|FG008|Double-Blind Period|LOW EGFR|0|||
163266359|NCT02969525|589685070|FG009|Double-Blind Period|LOW EGFR|0|||
163266360|NCT02969525|589685071|FG010|Double-Blind Period|LOW EGFR|0|||
163266361|NCT02969525|589685072|FG011|Double-Blind Period|LOW EGFR|0|||
163266362|NCT02969525|589685061|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
163266363|NCT02969525|589685062|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163266364|NCT02969525|589685063|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163266365|NCT02969525|589685064|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
163266366|NCT02969525|589685065|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163266367|NCT02969525|589685066|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163266368|NCT02969525|589685067|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163266369|NCT02969525|589685068|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163266370|NCT02969525|589685069|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163266371|NCT02969525|589685070|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163266372|NCT02969525|589685071|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163266373|NCT02969525|589685072|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163266374|NCT02969525|589685061|FG000|Dose-Blind Period|Adverse Event|0|||
163266375|NCT02969525|589685062|FG001|Dose-Blind Period|Adverse Event|0|||
163266376|NCT02969525|589685063|FG002|Dose-Blind Period|Adverse Event|0|||
163266377|NCT02969525|589685064|FG003|Dose-Blind Period|Adverse Event|0|||
163266378|NCT02969525|589685065|FG004|Dose-Blind Period|Adverse Event|0|||
163266379|NCT02969525|589685066|FG005|Dose-Blind Period|Adverse Event|0|||
163266380|NCT02969525|589685067|FG006|Dose-Blind Period|Adverse Event|0|||
163266381|NCT02969525|589685068|FG007|Dose-Blind Period|Adverse Event|0|||
163266382|NCT02969525|589685069|FG008|Dose-Blind Period|Adverse Event|0|||
163266383|NCT02969525|589685070|FG009|Dose-Blind Period|Adverse Event|1|||
163266384|NCT02969525|589685071|FG010|Dose-Blind Period|Adverse Event|1|||
163266385|NCT02969525|589685072|FG011|Dose-Blind Period|Adverse Event|1|||
163266386|NCT02969525|589685061|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
163266387|NCT02969525|589685062|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
163266388|NCT02969525|589685063|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
163266389|NCT02969525|589685064|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
163266390|NCT02969525|589685065|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
163266391|NCT02969525|589685066|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
163266392|NCT02969525|589685067|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
163266393|NCT02969525|589685068|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
163266394|NCT02969525|589685069|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
163266395|NCT02969525|589685070|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
163266396|NCT02969525|589685071|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
163266397|NCT02969525|589685072|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
163266398|NCT02969525|589685061|FG000|Dose-Blind Period|Non-cooperating patient|0|||
163266399|NCT02969525|589685062|FG001|Dose-Blind Period|Non-cooperating patient|0|||
163266400|NCT02969525|589685063|FG002|Dose-Blind Period|Non-cooperating patient|0|||
163266401|NCT02969525|589685064|FG003|Dose-Blind Period|Non-cooperating patient|0|||
163266402|NCT02969525|589685065|FG004|Dose-Blind Period|Non-cooperating patient|0|||
163266403|NCT02969525|589685066|FG005|Dose-Blind Period|Non-cooperating patient|0|||
163266404|NCT02969525|589685067|FG006|Dose-Blind Period|Non-cooperating patient|0|||
163266405|NCT02969525|589685068|FG007|Dose-Blind Period|Non-cooperating patient|0|||
163266406|NCT02969525|589685069|FG008|Dose-Blind Period|Non-cooperating patient|0|||
163266407|NCT02969525|589685070|FG009|Dose-Blind Period|Non-cooperating patient|0|||
163362459|NCT03812029|590036501|FG000|Overall Study|Adverse Event|0|||
163266408|NCT02969525|589685071|FG010|Dose-Blind Period|Non-cooperating patient|0|||
163266409|NCT02969525|589685072|FG011|Dose-Blind Period|Non-cooperating patient|1|||
163266410|NCT02969525|589685061|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163266411|NCT02969525|589685062|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163266412|NCT02969525|589685063|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163266413|NCT02969525|589685064|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163266414|NCT02969525|589685065|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163266415|NCT02969525|589685066|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163266416|NCT02969525|589685067|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163266417|NCT02969525|589685068|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163266418|NCT02969525|589685069|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163266419|NCT02969525|589685070|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163266420|NCT02969525|589685071|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
163266421|NCT02969525|589685072|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163266422|NCT03445065|589685073|FG000|Overall Study|Withdrawal by Subject|3|||
163266423|NCT03445065|589685074|FG001|Overall Study|Withdrawal by Subject|6|||
163266424|NCT03445065|589685075|FG002|Overall Study|Withdrawal by Subject|2|||
163266425|NCT03445065|589685076|FG003|Overall Study|Withdrawal by Subject|2|||
163266426|NCT03445065|589685073|FG000|Overall Study|Other|4|||
163266427|NCT03445065|589685074|FG001|Overall Study|Other|3|||
163266428|NCT03445065|589685075|FG002|Overall Study|Other|3|||
163266429|NCT03445065|589685076|FG003|Overall Study|Other|1|||
163266430|NCT02172625|589685077|FG000|Overall Study|Adverse Event|0|||
163266431|NCT02172625|589685078|FG001|Overall Study|Adverse Event|1|||
163266432|NCT02172625|589685077|FG000|Overall Study|Pregnancy|0|||
163266433|NCT02172625|589685078|FG001|Overall Study|Pregnancy|1|||
163266434|NCT02172625|589685077|FG000|Overall Study|car accident|0|||
163266435|NCT02172625|589685078|FG001|Overall Study|car accident|1|||
163266436|NCT03315130|589685079|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
163266437|NCT03315130|589685080|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
163266438|NCT03315130|589685081|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
163266439|NCT03315130|589685082|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
163266440|NCT03315130|589685079|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
163266441|NCT03315130|589685080|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
163266442|NCT03315130|589685081|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
163266443|NCT03315130|589685082|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
163266444|NCT03315130|589685079|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
163266445|NCT03315130|589685080|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
163266446|NCT03315130|589685081|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
163266447|NCT03315130|589685082|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
163266448|NCT03315130|589685079|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
163266449|NCT03315130|589685080|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
163266450|NCT03315130|589685081|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
163266451|NCT03315130|589685082|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
163266452|NCT03315130|589685079|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
163266453|NCT03315130|589685080|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
163266454|NCT03315130|589685081|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
163266455|NCT03315130|589685082|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
163266456|NCT03315130|589685079|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
163266457|NCT03315130|589685080|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
163266458|NCT03315130|589685081|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
163266459|NCT03315130|589685082|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
163266460|NCT00524030|589685083|FG000|Overall Study|Lack of Efficacy|10|||
163266461|NCT00524030|589685084|FG001|Overall Study|Lack of Efficacy|24|||
163266462|NCT00524030|589685083|FG000|Overall Study|Lost to Follow-up|0|||
163266463|NCT00524030|589685084|FG001|Overall Study|Lost to Follow-up|2|||
163266464|NCT00524030|589685083|FG000|Overall Study|Withdrawal by Subject|3|||
163266465|NCT00524030|589685084|FG001|Overall Study|Withdrawal by Subject|8|||
163266466|NCT00524030|589685083|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
163266467|NCT00524030|589685084|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
163266468|NCT00524030|589685083|FG000|Overall Study|Protocol Violation|0|||
163266469|NCT00524030|589685084|FG001|Overall Study|Protocol Violation|1|||
163266470|NCT00524030|589685083|FG000|Overall Study|Pregnancy|1|||
163266471|NCT00524030|589685084|FG001|Overall Study|Pregnancy|0|||
163266472|NCT00524030|589685083|FG000|Overall Study|Adverse Event|3|||
163266473|NCT00524030|589685084|FG001|Overall Study|Adverse Event|21|||
163266474|NCT00524030|589685083|FG000|Overall Study|Death|0|||
163266475|NCT00524030|589685084|FG001|Overall Study|Death|1|||
163266476|NCT02944656|589685085|FG000|Overall Study|No longer eligible|3|||
163266477|NCT02944656|589685086|FG001|Overall Study|No longer eligible|0|||
163266478|NCT02944656|589685085|FG000|Overall Study|Lost to Follow-up|7|||
163266479|NCT02944656|589685086|FG001|Overall Study|Lost to Follow-up|10|||
163266480|NCT04398537|589685087|FG000|Overall Study|Physician Decision|10|||
163266481|NCT04398537|589685088|FG001|Overall Study|Physician Decision|15|||
163266482|NCT00118898|589685089|FG000|Overall Study|Death|6|||
163266483|NCT00118898|589685090|FG001|Overall Study|Death|11|||
163266484|NCT00118898|589685091|FG002|Overall Study|Death|6|||
163266485|NCT00118898|589685092|FG003|Overall Study|Death|8|||
163266486|NCT00118898|589685089|FG000|Overall Study|Lost to Follow-up|26|||
163266487|NCT00118898|589685090|FG001|Overall Study|Lost to Follow-up|34|||
163266488|NCT00118898|589685091|FG002|Overall Study|Lost to Follow-up|33|||
163266489|NCT00118898|589685092|FG003|Overall Study|Lost to Follow-up|33|||
163266490|NCT00118898|589685089|FG000|Overall Study|Withdrawal by Subject|10|||
163266491|NCT00118898|589685090|FG001|Overall Study|Withdrawal by Subject|5|||
163266492|NCT00118898|589685091|FG002|Overall Study|Withdrawal by Subject|8|||
163266493|NCT00118898|589685092|FG003|Overall Study|Withdrawal by Subject|8|||
163266494|NCT00118898|589685089|FG000|Overall Study|Site Closure|33|||
163266495|NCT00118898|589685090|FG001|Overall Study|Site Closure|31|||
163266496|NCT00118898|589685091|FG002|Overall Study|Site Closure|28|||
163266497|NCT00118898|589685092|FG003|Overall Study|Site Closure|37|||
163266498|NCT00118898|589685089|FG000|Overall Study|Severe debilitation|1|||
163266499|NCT00118898|589685090|FG001|Overall Study|Severe debilitation|4|||
163266500|NCT00118898|589685091|FG002|Overall Study|Severe debilitation|6|||
163266501|NCT00118898|589685092|FG003|Overall Study|Severe debilitation|4|||
163266502|NCT00118898|589685089|FG000|Overall Study|Not compliant with requirements|11|||
163266503|NCT00118898|589685090|FG001|Overall Study|Not compliant with requirements|13|||
163266504|NCT00118898|589685091|FG002|Overall Study|Not compliant with requirements|11|||
163266505|NCT00118898|589685092|FG003|Overall Study|Not compliant with requirements|11|||
163266506|NCT00118898|589685089|FG000|Overall Study|Not able to get to clinic|34|||
163266507|NCT00118898|589685090|FG001|Overall Study|Not able to get to clinic|43|||
163266508|NCT00118898|589685091|FG002|Overall Study|Not able to get to clinic|31|||
163266509|NCT00118898|589685092|FG003|Overall Study|Not able to get to clinic|40|||
163266510|NCT02714205|589685095|FG000|Overall Study|Cannot tolerate medication|1|||
163266511|NCT02714205|589685096|FG001|Overall Study|Cannot tolerate medication|0|||
163266512|NCT02714205|589685095|FG000|Overall Study|Adverse Event|2|||
163266513|NCT02714205|589685096|FG001|Overall Study|Adverse Event|0|||
163266514|NCT02714205|589685095|FG000|Overall Study|Too busy|1|||
163266515|NCT02714205|589685096|FG001|Overall Study|Too busy|0|||
163266516|NCT02714205|589685095|FG000|Overall Study|Incomplete outcome data|0|||
163266517|NCT02714205|589685096|FG001|Overall Study|Incomplete outcome data|1|||
163266518|NCT02073097|589685097|FG000|Overall Study|Adverse Event|0|||
163266519|NCT02073097|589685098|FG001|Overall Study|Adverse Event|0|||
163266520|NCT02073097|589685099|FG002|Overall Study|Adverse Event|0|||
163266521|NCT02073097|589685100|FG003|Overall Study|Adverse Event|0|||
163266522|NCT02073097|589685101|FG004|Overall Study|Adverse Event|0|||
163266523|NCT02073097|589685102|FG005|Overall Study|Adverse Event|0|||
163266524|NCT02073097|589685103|FG006|Overall Study|Adverse Event|0|||
163266525|NCT02073097|589685104|FG007|Overall Study|Adverse Event|2|||
163266526|NCT02073097|589685097|FG000|Overall Study|Withdrawal by Subject|0|||
163266527|NCT02073097|589685098|FG001|Overall Study|Withdrawal by Subject|0|||
163266528|NCT02073097|589685099|FG002|Overall Study|Withdrawal by Subject|0|||
163266529|NCT02073097|589685100|FG003|Overall Study|Withdrawal by Subject|0|||
163266530|NCT02073097|589685101|FG004|Overall Study|Withdrawal by Subject|0|||
163266531|NCT02073097|589685102|FG005|Overall Study|Withdrawal by Subject|0|||
163266532|NCT02073097|589685103|FG006|Overall Study|Withdrawal by Subject|0|||
163266533|NCT02073097|589685104|FG007|Overall Study|Withdrawal by Subject|2|||
163266534|NCT02073097|589685097|FG000|Overall Study|Death|0|||
163266535|NCT02073097|589685098|FG001|Overall Study|Death|0|||
163266536|NCT02073097|589685099|FG002|Overall Study|Death|0|||
163266537|NCT02073097|589685100|FG003|Overall Study|Death|0|||
163266538|NCT02073097|589685101|FG004|Overall Study|Death|0|||
163266539|NCT02073097|589685102|FG005|Overall Study|Death|0|||
163266540|NCT02073097|589685103|FG006|Overall Study|Death|0|||
163266541|NCT02073097|589685104|FG007|Overall Study|Death|1|||
163266542|NCT02073097|589685097|FG000|Overall Study|Physician Decision|0|||
163266543|NCT02073097|589685098|FG001|Overall Study|Physician Decision|0|||
163266544|NCT02073097|589685099|FG002|Overall Study|Physician Decision|0|||
163266545|NCT02073097|589685100|FG003|Overall Study|Physician Decision|0|||
163266546|NCT02073097|589685101|FG004|Overall Study|Physician Decision|0|||
163266547|NCT02073097|589685102|FG005|Overall Study|Physician Decision|0|||
163266548|NCT02073097|589685103|FG006|Overall Study|Physician Decision|0|||
163266549|NCT02073097|589685104|FG007|Overall Study|Physician Decision|1|||
163266550|NCT03813147|589685107|FG000|Overall Study|Lack of Efficacy|4|||
163266551|NCT03813147|589685108|FG001|Overall Study|Lack of Efficacy|4|||
163266552|NCT03813147|589685107|FG000|Overall Study|Physician Decision|2|||
163266553|NCT03813147|589685108|FG001|Overall Study|Physician Decision|1|||
163266554|NCT01693692|589685109|FG000|Overall Study|Withdrawal by Subject|12|||
163266555|NCT01693692|589685110|FG001|Overall Study|Withdrawal by Subject|10|||
163266556|NCT01693692|589685111|FG002|Overall Study|Withdrawal by Subject|11|||
163266557|NCT01693692|589685109|FG000|Overall Study|Adverse Event|7|||
163266558|NCT01693692|589685110|FG001|Overall Study|Adverse Event|14|||
163266559|NCT01693692|589685111|FG002|Overall Study|Adverse Event|9|||
163266560|NCT01693692|589685109|FG000|Overall Study|Physician Decision|0|||
163266561|NCT01693692|589685110|FG001|Overall Study|Physician Decision|0|||
163266562|NCT01693692|589685111|FG002|Overall Study|Physician Decision|1|||
163266563|NCT01693692|589685109|FG000|Overall Study|Protocol Violation|5|||
163266564|NCT01693692|589685110|FG001|Overall Study|Protocol Violation|4|||
163266565|NCT01693692|589685111|FG002|Overall Study|Protocol Violation|6|||
163266566|NCT01693692|589685109|FG000|Overall Study|Lost to Follow-up|2|||
163266567|NCT01693692|589685110|FG001|Overall Study|Lost to Follow-up|2|||
163266568|NCT01693692|589685111|FG002|Overall Study|Lost to Follow-up|3|||
163266569|NCT01693692|589685109|FG000|Overall Study|Other|4|||
163266570|NCT01693692|589685110|FG001|Overall Study|Other|4|||
163266571|NCT01693692|589685111|FG002|Overall Study|Other|6|||
163266572|NCT04424290|589686969|FG000|Overall Study|Not treated|0|||
163266573|NCT04424290|589686970|FG001|Overall Study|Not treated|0|||
163266574|NCT04424290|589686971|FG002|Overall Study|Not treated|1|||
163266575|NCT04424290|589686972|FG003|Overall Study|Not treated|0|||
163266576|NCT04424290|589686973|FG004|Overall Study|Not treated|1|||
163266577|NCT04424290|589686969|FG000|Overall Study|Adverse Event|0|||
163266578|NCT04424290|589686970|FG001|Overall Study|Adverse Event|0|||
163266579|NCT04424290|589686971|FG002|Overall Study|Adverse Event|0|||
163266580|NCT04424290|589686972|FG003|Overall Study|Adverse Event|2|||
163266581|NCT04424290|589686973|FG004|Overall Study|Adverse Event|0|||
163266582|NCT04424290|589686969|FG000|Overall Study|Withdrawal by Subject|0|||
163266583|NCT04424290|589686970|FG001|Overall Study|Withdrawal by Subject|0|||
163266584|NCT04424290|589686971|FG002|Overall Study|Withdrawal by Subject|0|||
163266585|NCT04424290|589686972|FG003|Overall Study|Withdrawal by Subject|0|||
163266586|NCT04424290|589686973|FG004|Overall Study|Withdrawal by Subject|1|||
163266587|NCT04424290|589686969|FG000|Overall Study|Other than listed|0|||
163266588|NCT04424290|589686970|FG001|Overall Study|Other than listed|0|||
163266589|NCT04424290|589686971|FG002|Overall Study|Other than listed|0|||
163266590|NCT04424290|589686972|FG003|Overall Study|Other than listed|1|||
163266591|NCT04424290|589686973|FG004|Overall Study|Other than listed|0|||
163266592|NCT02914184|589686977|FG000|Overall Study|Lost to Follow-up|7|||
163266593|NCT02914184|589686978|FG001|Overall Study|Lost to Follow-up|10|||
163266594|NCT02914184|589686979|FG002|Overall Study|Lost to Follow-up|8|||
163266595|NCT02914184|589686980|FG003|Overall Study|Lost to Follow-up|7|||
163266596|NCT02914184|589686977|FG000|Overall Study|Withdrawal by Subject|4|||
163266597|NCT02914184|589686978|FG001|Overall Study|Withdrawal by Subject|2|||
163266598|NCT02914184|589686979|FG002|Overall Study|Withdrawal by Subject|7|||
163266599|NCT02914184|589686980|FG003|Overall Study|Withdrawal by Subject|3|||
163266600|NCT02914184|589686977|FG000|Overall Study|Other|1|||
163266601|NCT02914184|589686978|FG001|Overall Study|Other|0|||
163266602|NCT02914184|589686979|FG002|Overall Study|Other|0|||
163266603|NCT02914184|589686980|FG003|Overall Study|Other|0|||
163266604|NCT02914184|589686977|FG000|Overall Study|Migrated/moved from the study area|2|||
163266605|NCT02914184|589686978|FG001|Overall Study|Migrated/moved from the study area|1|||
163266606|NCT02914184|589686979|FG002|Overall Study|Migrated/moved from the study area|2|||
163266607|NCT02914184|589686980|FG003|Overall Study|Migrated/moved from the study area|1|||
163266608|NCT00802659|589686981|FG000|Overall Study|Physician Decision|0|||
163266609|NCT00802659|589686982|FG001|Overall Study|Physician Decision|1|||
163266610|NCT00802659|589686983|FG002|Overall Study|Physician Decision|0|||
163266611|NCT00802659|589686984|FG003|Overall Study|Physician Decision|0|||
163266612|NCT00806624|589686985|FG000|Overall Study|Adverse Event|2|||
163266613|NCT00806624|589686986|FG001|Overall Study|Adverse Event|8|||
163266614|NCT00806624|589686987|FG002|Overall Study|Adverse Event|0|||
163266615|NCT00806624|589686985|FG000|Overall Study|Death|0|||
163266616|NCT00806624|589686986|FG001|Overall Study|Death|1|||
163266617|NCT00806624|589686987|FG002|Overall Study|Death|1|||
163266618|NCT00806624|589686985|FG000|Overall Study|Lost to Follow-up|1|||
163266619|NCT00806624|589686986|FG001|Overall Study|Lost to Follow-up|0|||
163266620|NCT00806624|589686987|FG002|Overall Study|Lost to Follow-up|1|||
163266621|NCT00806624|589686985|FG000|Overall Study|Withdrawal by Subject|6|||
163266622|NCT00806624|589686986|FG001|Overall Study|Withdrawal by Subject|3|||
163266623|NCT00806624|589686987|FG002|Overall Study|Withdrawal by Subject|3|||
163266624|NCT00806624|589686985|FG000|Overall Study|discontinued before start of treatment|0|||
163266625|NCT00806624|589686986|FG001|Overall Study|discontinued before start of treatment|0|||
163266626|NCT00806624|589686987|FG002|Overall Study|discontinued before start of treatment|1|||
163266627|NCT03093428|589686988|FG000|Overall Study|Not eligible for treatment|2|||
163266628|NCT03093428|589686989|FG001|Overall Study|Not eligible for treatment|1|||
163266629|NCT03093428|589686988|FG000|Overall Study|Progression|14|||
163266630|NCT03093428|589686989|FG001|Overall Study|Progression|4|||
163266631|NCT03093428|589686988|FG000|Overall Study|Death|1|||
163266632|NCT03093428|589686989|FG001|Overall Study|Death|0|||
163266633|NCT03093428|589686988|FG000|Overall Study|Adverse Event|1|||
163266634|NCT03093428|589686989|FG001|Overall Study|Adverse Event|0|||
163266635|NCT03093428|589686988|FG000|Overall Study|Withdrawal by Subject|1|||
163266636|NCT03093428|589686989|FG001|Overall Study|Withdrawal by Subject|1|||
163266637|NCT01336634|589686993|FG000|Overall Study|Study closed/terminated|5|||
163266638|NCT01336634|589686994|FG001|Overall Study|Study closed/terminated|6|||
163266639|NCT01336634|589686995|FG002|Overall Study|Study closed/terminated|6|||
163266640|NCT01336634|589686993|FG000|Overall Study|Lost to Follow-up|2|||
163266641|NCT01336634|589686994|FG001|Overall Study|Lost to Follow-up|1|||
163266642|NCT01336634|589686995|FG002|Overall Study|Lost to Follow-up|1|||
163266643|NCT01336634|589686993|FG000|Overall Study|Physician Decision|1|||
163266644|NCT01336634|589686994|FG001|Overall Study|Physician Decision|1|||
163266645|NCT01336634|589686995|FG002|Overall Study|Physician Decision|0|||
163266646|NCT01336634|589686993|FG000|Overall Study|Withdrawal by Subject|6|||
163266647|NCT01336634|589686994|FG001|Overall Study|Withdrawal by Subject|0|||
163266648|NCT01336634|589686995|FG002|Overall Study|Withdrawal by Subject|2|||
163266649|NCT01973491|589686996|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
163266650|NCT01973491|589686996|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
163266651|NCT01973491|589686996|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
163266652|NCT01863043|589687000|FG000|Overall Study|Death|6|||
163266653|NCT01863043|589687001|FG001|Overall Study|Death|1|||
163266654|NCT01863043|589687000|FG000|Overall Study|Withdrawal by Subject|0|||
163266655|NCT01863043|589687001|FG001|Overall Study|Withdrawal by Subject|2|||
163266656|NCT01863043|589687000|FG000|Overall Study|Adverse Event|7|||
163266657|NCT01863043|589687001|FG001|Overall Study|Adverse Event|8|||
163266658|NCT01863043|589687000|FG000|Overall Study|exclusion criteria found after enrollment|0|||
163266659|NCT01863043|589687001|FG001|Overall Study|exclusion criteria found after enrollment|1|||
163266660|NCT00313911|589687002|FG000|Overall Study|Serious adverse event|6|||
163266661|NCT00313911|589687003|FG001|Overall Study|Serious adverse event|1|||
163266662|NCT00313911|589687002|FG000|Overall Study|Adverse Event|2|||
163266663|NCT00313911|589687003|FG001|Overall Study|Adverse Event|3|||
163266664|NCT00313911|589687002|FG000|Overall Study|Protocol Violation|19|||
163266665|NCT00313911|589687003|FG001|Overall Study|Protocol Violation|10|||
163266666|NCT00313911|589687002|FG000|Overall Study|Lost to Follow-up|27|||
163266667|NCT00313911|589687003|FG001|Overall Study|Lost to Follow-up|14|||
163266668|NCT00313911|589687002|FG000|Overall Study|Withdrawal by Subject|39|||
163266669|NCT00313911|589687003|FG001|Overall Study|Withdrawal by Subject|12|||
163266670|NCT00313911|589687002|FG000|Overall Study|Did not meet age criteria|1|||
163266671|NCT00313911|589687003|FG001|Overall Study|Did not meet age criteria|1|||
163266672|NCT01987596|589687004|FG000|Overall Study|Physician Decision|1|||
163266673|NCT01987596|589687005|FG001|Overall Study|Physician Decision|0|||
163266674|NCT01987596|589687004|FG000|Overall Study|Progressive Disease; missing all period|0|||
163266675|NCT01987596|589687005|FG001|Overall Study|Progressive Disease; missing all period|1|||
163266676|NCT02632786|589687008|FG000|Overall Study|Adverse Event|2|||
163266677|NCT02632786|589687009|FG001|Overall Study|Adverse Event|1|||
163266678|NCT02632786|589687008|FG000|Overall Study|Death|3|||
163266679|NCT02632786|589687009|FG001|Overall Study|Death|2|||
163266680|NCT02632786|589687008|FG000|Overall Study|Physician Decision|5|||
163266681|NCT02632786|589687009|FG001|Overall Study|Physician Decision|4|||
163266682|NCT02632786|589687008|FG000|Overall Study|Withdrawal by Subject|1|||
163266683|NCT02632786|589687009|FG001|Overall Study|Withdrawal by Subject|0|||
163266684|NCT00709592|589687010|FG000|Overall Study|Unable to proceed to transplant|0|||
163266685|NCT00709592|589687011|FG001|Overall Study|Unable to proceed to transplant|1|||
163266686|NCT00451217|589687013|FG000|Overall Study|Lost to Follow-up|0|||
163266687|NCT00451217|589687014|FG001|Overall Study|Lost to Follow-up|1|||
163266688|NCT00451217|589687015|FG002|Overall Study|Lost to Follow-up|1|||
163266689|NCT00451217|589687016|FG003|Overall Study|Lost to Follow-up|1|||
163266690|NCT00451217|589687013|FG000|Overall Study|Withdrawal by Subject|1|||
163266691|NCT00451217|589687014|FG001|Overall Study|Withdrawal by Subject|0|||
163266692|NCT00451217|589687015|FG002|Overall Study|Withdrawal by Subject|0|||
163266693|NCT00451217|589687016|FG003|Overall Study|Withdrawal by Subject|0|||
163266694|NCT00451217|589687013|FG000|Overall Study|Not Treated|1|||
163266695|NCT00451217|589687014|FG001|Overall Study|Not Treated|1|||
163266696|NCT00451217|589687015|FG002|Overall Study|Not Treated|3|||
163266697|NCT00451217|589687016|FG003|Overall Study|Not Treated|4|||
163266698|NCT03154359|589687019|FG000|Overall Study|Adverse Event|1|||
163266699|NCT03154359|589687019|FG000|Overall Study|Lack of Efficacy|2|||
163266700|NCT03154359|589687019|FG000|Overall Study|Lost to Follow-up|3|||
163266701|NCT03154359|589687019|FG000|Overall Study|Physician Decision|3|||
163266702|NCT03154359|589687019|FG000|Overall Study|Protocol Violation|4|||
163266703|NCT03154359|589687019|FG000|Overall Study|Withdrawal by Subject|5|||
163266704|NCT03154359|589687019|FG000|Overall Study|Disruption of study due to COVID-19|4|||
163266705|NCT00569803|589687022|FG000|Overall Study|Lost to Follow-up|1|||
163266706|NCT00569803|589687023|FG001|Overall Study|Lost to Follow-up|0|||
163266707|NCT00569803|589687024|FG002|Overall Study|Lost to Follow-up|0|||
163266708|NCT00569803|589687025|FG003|Overall Study|Lost to Follow-up|0|||
163266709|NCT00569803|589687026|FG004|Overall Study|Lost to Follow-up|0|||
163266710|NCT00569803|589687027|FG005|Overall Study|Lost to Follow-up|0|||
163266711|NCT00569803|589687028|FG006|Overall Study|Lost to Follow-up|0|||
163266712|NCT00569803|589687029|FG007|Overall Study|Lost to Follow-up|0|||
163266713|NCT00569803|589687022|FG000|Overall Study|injection syringe leaked during dosing|0|||
163266714|NCT00569803|589687023|FG001|Overall Study|injection syringe leaked during dosing|0|||
163266715|NCT00569803|589687024|FG002|Overall Study|injection syringe leaked during dosing|0|||
163266716|NCT00569803|589687025|FG003|Overall Study|injection syringe leaked during dosing|1|||
163266717|NCT00569803|589687026|FG004|Overall Study|injection syringe leaked during dosing|0|||
163266718|NCT00569803|589687027|FG005|Overall Study|injection syringe leaked during dosing|0|||
163266719|NCT00569803|589687028|FG006|Overall Study|injection syringe leaked during dosing|0|||
163266720|NCT00569803|589687029|FG007|Overall Study|injection syringe leaked during dosing|0|||
163266721|NCT00569803|589687022|FG000|Overall Study|Withdrawal by Subject|0|||
163266722|NCT00569803|589687023|FG001|Overall Study|Withdrawal by Subject|0|||
163266723|NCT00569803|589687024|FG002|Overall Study|Withdrawal by Subject|0|||
163266724|NCT00569803|589687025|FG003|Overall Study|Withdrawal by Subject|0|||
163266725|NCT00569803|589687026|FG004|Overall Study|Withdrawal by Subject|0|||
163266726|NCT00569803|589687027|FG005|Overall Study|Withdrawal by Subject|0|||
163266727|NCT00569803|589687028|FG006|Overall Study|Withdrawal by Subject|0|||
163266728|NCT00569803|589687029|FG007|Overall Study|Withdrawal by Subject|1|||
163266729|NCT01993823|589687030|FG000|Overall Study|Requested by the patient|6|||
163266730|NCT01993823|589687031|FG001|Overall Study|Requested by the patient|11|||
163266731|NCT01993823|589687030|FG000|Overall Study|Protocol Violation|0|||
163266732|NCT01993823|589687031|FG001|Overall Study|Protocol Violation|1|||
163266733|NCT01993823|589687030|FG000|Overall Study|Lost to Follow-up|1|||
163266734|NCT01993823|589687031|FG001|Overall Study|Lost to Follow-up|4|||
163266735|NCT01592695|589687035|FG000|Overall Study|Lost to Follow-up|8|||
163266736|NCT01592695|589687036|FG001|Overall Study|Lost to Follow-up|4|||
163266737|NCT00422799|589687037|FG000|Overall Study|Withdrawal by Subject|6|||
163266738|NCT00422799|589687037|FG000|Overall Study|Adverse Event|7|||
163266739|NCT03029780|589687041|FG000|Overall Study|Disease Progression|20|||
163266740|NCT03029780|589687042|FG001|Overall Study|Disease Progression|22|||
163266741|NCT03029780|589687041|FG000|Overall Study|Study Drug Toxicity|15|||
163266742|NCT03029780|589687042|FG001|Overall Study|Study Drug Toxicity|11|||
163266743|NCT03029780|589687041|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
163266744|NCT03029780|589687042|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
163266745|NCT03029780|589687041|FG000|Overall Study|Participant request to discontinue study treatment|4|||
163266746|NCT03029780|589687042|FG001|Overall Study|Participant request to discontinue study treatment|1|||
163266747|NCT03029780|589687041|FG000|Overall Study|Maximum clinical benefit|1|||
163266748|NCT03029780|589687042|FG001|Overall Study|Maximum clinical benefit|0|||
163266749|NCT03029780|589687041|FG000|Overall Study|Participant no longer meets study criteria|0|||
163266750|NCT03029780|589687042|FG001|Overall Study|Participant no longer meets study criteria|1|||
163266751|NCT03029780|589687041|FG000|Overall Study|Other reasons|6|||
163266752|NCT03029780|589687042|FG001|Overall Study|Other reasons|6|||
163266753|NCT03029780|589687041|FG000|Overall Study|Not reported|1|||
163266754|NCT03029780|589687042|FG001|Overall Study|Not reported|1|||
163266755|NCT03029780|589687041|FG000|Overall Study|Death|2|||
163266756|NCT03029780|589687042|FG001|Overall Study|Death|6|||
163266757|NCT00178256|589687043|FG000|Overall Study|Adverse Event|2|||
163266758|NCT00178256|589687044|FG001|Overall Study|Adverse Event|0|||
163266759|NCT00178256|589687045|FG002|Overall Study|Adverse Event|0|||
163266760|NCT00178256|589687046|FG003|Overall Study|Adverse Event|0|||
163266761|NCT00178256|589687043|FG000|Overall Study|Death|0|||
163266762|NCT00178256|589687044|FG001|Overall Study|Death|1|||
163266763|NCT00178256|589687045|FG002|Overall Study|Death|0|||
163266764|NCT00178256|589687046|FG003|Overall Study|Death|1|||
163266765|NCT00178256|589687043|FG000|Overall Study|Cancer progression|2|||
163266766|NCT00178256|589687044|FG001|Overall Study|Cancer progression|0|||
163266767|NCT00178256|589687045|FG002|Overall Study|Cancer progression|0|||
163266768|NCT00178256|589687046|FG003|Overall Study|Cancer progression|1|||
163266769|NCT03066622|589687047|FG000|Overall Study|Lost to Follow-up|24|||
163266770|NCT03066622|589687048|FG001|Overall Study|Lost to Follow-up|25|||
163266771|NCT03066622|589687047|FG000|Overall Study|Withdrawal by Subject|2|||
163266772|NCT03066622|589687048|FG001|Overall Study|Withdrawal by Subject|1|||
163266773|NCT01763788|589687049|FG000|Overall Study|Lost to Follow-up|0|||
163266774|NCT01763788|589687050|FG001|Overall Study|Lost to Follow-up|0|||
163266775|NCT01763788|589687051|FG002|Overall Study|Lost to Follow-up|1|||
163266776|NCT01763788|589687052|FG003|Overall Study|Lost to Follow-up|0|||
163266777|NCT03321006|589687053|FG000|Overall Study|Death|1|||
163266778|NCT03321006|589687054|FG001|Overall Study|Death|0|||
163362460|NCT03812029|590036502|FG001|Overall Study|Adverse Event|9|||
163362461|NCT03812029|590036503|FG002|Overall Study|Adverse Event|0|||
163362462|NCT03812029|590036504|FG003|Overall Study|Adverse Event|3|||
163266779|NCT03321006|589687053|FG000|Overall Study|Lack of Efficacy|1|||
163266780|NCT03321006|589687054|FG001|Overall Study|Lack of Efficacy|0|||
163266781|NCT02006121|589687057|FG000|Double Blind Phase|Adverse Event|6|||
163266782|NCT02006121|589687058|FG001|Double Blind Phase|Adverse Event|0|||
163266783|NCT02006121|589687057|FG000|Double Blind Phase|Lack of Efficacy|1|||
163266784|NCT02006121|589687058|FG001|Double Blind Phase|Lack of Efficacy|16|||
163266785|NCT02006121|589687057|FG000|Double Blind Phase|Withdrawal by Subject|3|||
163362463|NCT03812029|590036505|FG004|Overall Study|Adverse Event|5|||
163362464|NCT03812029|590036501|FG000|Overall Study|Lost to Follow-up|0|||
163266786|NCT02006121|589687058|FG001|Double Blind Phase|Withdrawal by Subject|4|||
163266787|NCT02006121|589687057|FG000|Double Blind Phase|Non-compliance with study drug|1|||
163266788|NCT02006121|589687058|FG001|Double Blind Phase|Non-compliance with study drug|3|||
163362465|NCT03812029|590036502|FG001|Overall Study|Lost to Follow-up|0|||
163362466|NCT03812029|590036503|FG002|Overall Study|Lost to Follow-up|0|||
163266789|NCT02006121|589687057|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
163266790|NCT02006121|589687058|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
163266791|NCT02006121|589687057|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
163266792|NCT02006121|589687058|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
163266793|NCT02006121|589687057|FG000|Open Label Phase|Adverse Event|15|||
163266794|NCT02006121|589687058|FG001|Open Label Phase|Adverse Event|0|||
163266795|NCT02006121|589687057|FG000|Open Label Phase|Lack of Efficacy|2|||
163266796|NCT02006121|589687058|FG001|Open Label Phase|Lack of Efficacy|0|||
163266797|NCT02006121|589687057|FG000|Open Label Phase|Protocol Violation|2|||
163266798|NCT02006121|589687058|FG001|Open Label Phase|Protocol Violation|0|||
163266799|NCT02006121|589687057|FG000|Open Label Phase|Withdrawal by Subject|3|||
163266800|NCT02006121|589687058|FG001|Open Label Phase|Withdrawal by Subject|0|||
163266801|NCT02006121|589687057|FG000|Open Label Phase|Non-compliance with study drug|3|||
163266802|NCT02006121|589687058|FG001|Open Label Phase|Non-compliance with study drug|0|||
163266803|NCT04498247|589687062|FG000|Overall Study|Lost to Follow-up|0|||
163266804|NCT04498247|589687063|FG001|Overall Study|Lost to Follow-up|0|||
163266805|NCT04498247|589687064|FG002|Overall Study|Lost to Follow-up|0|||
163266806|NCT04498247|589687065|FG003|Overall Study|Lost to Follow-up|1|||
163266807|NCT04498247|589687066|FG004|Overall Study|Lost to Follow-up|0|||
163266808|NCT04498247|589687067|FG005|Overall Study|Lost to Follow-up|0|||
163266809|NCT04498247|589687068|FG006|Overall Study|Lost to Follow-up|0|||
163266810|NCT04498247|589687069|FG007|Overall Study|Lost to Follow-up|0|||
163266811|NCT04498247|589687062|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
163266812|NCT04498247|589687063|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
163266813|NCT04498247|589687064|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
163266814|NCT04498247|589687065|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
163266815|NCT04498247|589687066|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
163266816|NCT04498247|589687067|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
163266817|NCT04498247|589687068|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
163266818|NCT04498247|589687069|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
163266819|NCT04498247|589687062|FG000|Overall Study|Withdrawal by Subject|0|||
163266820|NCT04498247|589687063|FG001|Overall Study|Withdrawal by Subject|8|||
163266821|NCT04498247|589687064|FG002|Overall Study|Withdrawal by Subject|0|||
163266822|NCT04498247|589687065|FG003|Overall Study|Withdrawal by Subject|7|||
163266823|NCT04498247|589687066|FG004|Overall Study|Withdrawal by Subject|0|||
163266824|NCT04498247|589687067|FG005|Overall Study|Withdrawal by Subject|0|||
163266825|NCT04498247|589687068|FG006|Overall Study|Withdrawal by Subject|1|||
163266826|NCT04498247|589687069|FG007|Overall Study|Withdrawal by Subject|0|||
163266827|NCT04498247|589687062|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
163266828|NCT04498247|589687063|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
163266829|NCT04498247|589687064|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
163266830|NCT04498247|589687065|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
163266831|NCT04498247|589687066|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
163266832|NCT04498247|589687067|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
163266833|NCT04498247|589687068|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
163266834|NCT04498247|589687069|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
163266835|NCT01737996|589687070|FG000|Overall Study|Adverse Event|0|||
163266836|NCT01737996|589687071|FG001|Overall Study|Adverse Event|1|||
163362467|NCT03812029|590036504|FG003|Overall Study|Lost to Follow-up|0|||
163362468|NCT03812029|590036505|FG004|Overall Study|Lost to Follow-up|3|||
163362469|NCT01080300|590036506|FG000|Overall Study|Adverse Event|49|||
163266837|NCT01737996|589687072|FG002|Overall Study|Adverse Event|1|||
163266838|NCT01737996|589687070|FG000|Overall Study|Withdrawal by Subject|0|||
163266839|NCT01737996|589687071|FG001|Overall Study|Withdrawal by Subject|0|||
163266840|NCT01737996|589687072|FG002|Overall Study|Withdrawal by Subject|1|||
163266841|NCT01003184|589687073|FG000|Overall Study|Adverse Event|12|||
163266842|NCT01003184|589687074|FG001|Overall Study|Adverse Event|5|||
163266843|NCT01003184|589687073|FG000|Overall Study|Lost to Follow-up|1|||
163266844|NCT01003184|589687074|FG001|Overall Study|Lost to Follow-up|0|||
163266845|NCT01003184|589687073|FG000|Overall Study|Loss of glucose control|1|||
163266846|NCT01003184|589687074|FG001|Overall Study|Loss of glucose control|1|||
163266847|NCT01003184|589687073|FG000|Overall Study|Protocol Violation|3|||
163266848|NCT01003184|589687074|FG001|Overall Study|Protocol Violation|0|||
163266849|NCT01003184|589687073|FG000|Overall Study|Withdrawal by Subject|1|||
163266850|NCT01003184|589687074|FG001|Overall Study|Withdrawal by Subject|6|||
163266851|NCT01003184|589687073|FG000|Overall Study|Physician Decision|1|||
163266852|NCT01003184|589687074|FG001|Overall Study|Physician Decision|0|||
163266853|NCT00557622|589687075|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
163266854|NCT00557622|589687076|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
163266855|NCT00557622|589687075|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
163266856|NCT00557622|589687076|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
163266857|NCT00557622|589687075|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
163266858|NCT00557622|589687076|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
163266859|NCT02765490|589687077|FG000|Overall Study|Lost to Follow-up|1|||
163266860|NCT02765490|589687078|FG001|Overall Study|Lost to Follow-up|1|||
163266861|NCT02765490|589687077|FG000|Overall Study|Other|0|||
163266862|NCT02765490|589687078|FG001|Overall Study|Other|1|||
163266863|NCT02765490|589687077|FG000|Overall Study|Death|0|||
163266864|NCT02765490|589687078|FG001|Overall Study|Death|1|||
163266865|NCT01923389|589687079|FG000|Overall Study|Protocol Violation|1|||
163266866|NCT01923389|589687080|FG001|Overall Study|Protocol Violation|0|||
163266867|NCT03237013|589687081|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
163266868|NCT03237013|589687082|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
163266869|NCT03237013|589687083|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
163266870|NCT05266963|589687084|FG000|Drug Period A|Withdrawal by Subject|0|||
163266871|NCT05266963|589687085|FG001|Drug Period A|Withdrawal by Subject|1|||
163266872|NCT00152971|589687086|FG000|Overall Study|Adverse Event|12|||
163266873|NCT00152971|589687087|FG001|Overall Study|Adverse Event|10|||
163266874|NCT00152971|589687088|FG002|Overall Study|Adverse Event|9|||
163266875|NCT00152971|589687086|FG000|Overall Study|Protocol Violation|10|||
163266876|NCT00152971|589687087|FG001|Overall Study|Protocol Violation|11|||
163266877|NCT00152971|589687088|FG002|Overall Study|Protocol Violation|8|||
163266878|NCT00152971|589687086|FG000|Overall Study|Lost to Follow-up|17|||
163266879|NCT00152971|589687087|FG001|Overall Study|Lost to Follow-up|14|||
163266880|NCT00152971|589687088|FG002|Overall Study|Lost to Follow-up|13|||
163266881|NCT00152971|589687086|FG000|Overall Study|Withdrawal by Subject|9|||
163266882|NCT00152971|589687087|FG001|Overall Study|Withdrawal by Subject|8|||
163266883|NCT00152971|589687088|FG002|Overall Study|Withdrawal by Subject|14|||
163266884|NCT00152971|589687086|FG000|Overall Study|Other|3|||
163266885|NCT00152971|589687087|FG001|Overall Study|Other|5|||
163266886|NCT00152971|589687088|FG002|Overall Study|Other|5|||
163266887|NCT00152971|589687086|FG000|Treatment|Adverse Event|49|||
163266888|NCT00152971|589687087|FG001|Treatment|Adverse Event|40|||
163266889|NCT00152971|589687088|FG002|Treatment|Adverse Event|54|||
163266890|NCT00152971|589687086|FG000|Treatment|Protocol Violation|8|||
163266891|NCT00152971|589687087|FG001|Treatment|Protocol Violation|6|||
163266892|NCT00152971|589687088|FG002|Treatment|Protocol Violation|10|||
163266893|NCT00152971|589687086|FG000|Treatment|Lost to Follow-up|1|||
163266894|NCT00152971|589687087|FG001|Treatment|Lost to Follow-up|2|||
163266895|NCT00152971|589687088|FG002|Treatment|Lost to Follow-up|1|||
163266896|NCT00152971|589687086|FG000|Treatment|Withdrawal by Subject|4|||
163266897|NCT00152971|589687087|FG001|Treatment|Withdrawal by Subject|4|||
163266898|NCT00152971|589687088|FG002|Treatment|Withdrawal by Subject|5|||
163266899|NCT00152971|589687086|FG000|Treatment|Other|9|||
163266900|NCT00152971|589687087|FG001|Treatment|Other|11|||
163266901|NCT00152971|589687088|FG002|Treatment|Other|10|||
163266902|NCT04091360|589687089|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163266903|NCT04091360|589687090|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163266904|NCT04091360|589687091|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163266905|NCT04091360|589687092|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163266906|NCT04091360|589687093|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163266907|NCT04091360|589687094|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163266908|NCT04091360|589687095|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163266909|NCT04091360|589687096|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163266910|NCT04091360|589687097|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
163266911|NCT04091360|589687098|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
163266912|NCT04091360|589687089|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163266913|NCT04091360|589687090|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163266914|NCT04091360|589687091|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163266915|NCT04091360|589687092|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163266916|NCT04091360|589687093|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163266917|NCT04091360|589687094|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163266918|NCT04091360|589687095|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
163266919|NCT04091360|589687096|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
163266920|NCT04091360|589687097|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163266921|NCT04091360|589687098|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163266922|NCT04091360|589687089|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163266923|NCT04091360|589687090|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163266924|NCT04091360|589687091|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163266925|NCT04091360|589687092|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163266926|NCT04091360|589687093|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163266927|NCT04091360|589687094|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163266928|NCT04091360|589687095|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
163266929|NCT04091360|589687096|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163266930|NCT04091360|589687097|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163266931|NCT04091360|589687098|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
163362470|NCT01080300|590036507|FG001|Overall Study|Adverse Event|35|||
163266932|NCT02597933|589687099|FG000|Overall Study|Withdrawal by Subject|7|||
163266933|NCT02597933|589687100|FG001|Overall Study|Withdrawal by Subject|5|||
163266934|NCT02597933|589687099|FG000|Overall Study|Protocol Violation|2|||
163266935|NCT02597933|589687100|FG001|Overall Study|Protocol Violation|2|||
163266936|NCT02597933|589687099|FG000|Overall Study|Adverse Event|20|||
163266937|NCT02597933|589687100|FG001|Overall Study|Adverse Event|28|||
163266938|NCT02597933|589687099|FG000|Overall Study|Not treated|2|||
163266939|NCT02597933|589687100|FG001|Overall Study|Not treated|2|||
163266940|NCT02597933|589687099|FG000|Overall Study|Other than stated above|7|||
163266941|NCT02597933|589687100|FG001|Overall Study|Other than stated above|14|||
163266942|NCT01617005|589687101|FG000|Overall Study|Pregnancy|1|||
163266943|NCT01617005|589687101|FG000|Overall Study|Lack of motivation for treatment|1|||
163266944|NCT01336621|589687108|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
163266945|NCT01336621|589687108|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
163266946|NCT01336621|589687108|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
163266947|NCT01336621|589687108|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
163266948|NCT01336621|589687108|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
163266949|NCT01336621|589687108|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
163266950|NCT01336621|589687108|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
163266951|NCT01336621|589687108|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
163266952|NCT01336621|589687108|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
163266953|NCT01336621|589687108|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
163266954|NCT01336621|589687108|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
163266955|NCT01336621|589687108|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
163266956|NCT01336621|589687108|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
163266957|NCT01336621|589687108|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
163266958|NCT02487095|589687109|FG000|Dose Expansion|Unable to scan/restage participant|0|||
163266959|NCT02487095|589687110|FG001|Dose Expansion|Unable to scan/restage participant|0|||
163266960|NCT02487095|589687111|FG002|Dose Expansion|Unable to scan/restage participant|0|||
163266961|NCT02487095|589687112|FG003|Dose Expansion|Unable to scan/restage participant|0|||
163266962|NCT02487095|589687113|FG004|Dose Expansion|Unable to scan/restage participant|1|||
163266963|NCT04534114|589687114|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
163266964|NCT04534114|589687115|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
163266965|NCT04534114|589687116|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
163266966|NCT04534114|589687117|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
163266967|NCT04534114|589687114|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
163266968|NCT04534114|589687115|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
163266969|NCT04534114|589687116|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
163266970|NCT04534114|589687117|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
163266971|NCT04534114|589687114|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
163266972|NCT04534114|589687115|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
163266973|NCT04534114|589687116|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
163266974|NCT04534114|589687117|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
163266975|NCT04534114|589687114|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
163266976|NCT04534114|589687115|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
163266977|NCT04534114|589687116|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
163266978|NCT04534114|589687117|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
163266979|NCT04534114|589687114|FG000|Main Treatment Period|Physician Decision|0|||
163266980|NCT04534114|589687115|FG001|Main Treatment Period|Physician Decision|0|||
163266981|NCT04534114|589687116|FG002|Main Treatment Period|Physician Decision|0|||
163266982|NCT04534114|589687117|FG003|Main Treatment Period|Physician Decision|1|||
163266983|NCT04534114|589687114|FG000|Main Treatment Period|Death|1|||
163266984|NCT04534114|589687115|FG001|Main Treatment Period|Death|0|||
163266985|NCT04534114|589687116|FG002|Main Treatment Period|Death|0|||
163266986|NCT04534114|589687117|FG003|Main Treatment Period|Death|1|||
163266987|NCT04534114|589687114|FG000|Main Treatment Period|Other reason|1|||
163266988|NCT04534114|589687115|FG001|Main Treatment Period|Other reason|1|||
163266989|NCT04534114|589687116|FG002|Main Treatment Period|Other reason|0|||
163266990|NCT04534114|589687117|FG003|Main Treatment Period|Other reason|0|||
163266991|NCT04534114|589687114|FG000|Main Treatment Period|Participant decision|1|||
163266992|NCT04534114|589687115|FG001|Main Treatment Period|Participant decision|3|||
163266993|NCT04534114|589687116|FG002|Main Treatment Period|Participant decision|3|||
163266994|NCT04534114|589687117|FG003|Main Treatment Period|Participant decision|1|||
163266995|NCT04534114|589687114|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
163266996|NCT04534114|589687115|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
163266997|NCT04534114|589687116|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
163266998|NCT04534114|589687117|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
163266999|NCT04534114|589687114|FG000|Main Treatment Period|Adverse Event|4|||
163267000|NCT04534114|589687115|FG001|Main Treatment Period|Adverse Event|2|||
163267001|NCT04534114|589687116|FG002|Main Treatment Period|Adverse Event|1|||
163267002|NCT04534114|589687117|FG003|Main Treatment Period|Adverse Event|2|||
163267003|NCT04534114|589687114|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
163267004|NCT04534114|589687115|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
163267005|NCT04534114|589687116|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
163267006|NCT04534114|589687117|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
163267007|NCT04534114|589687114|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
163267008|NCT04534114|589687115|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
163267009|NCT04534114|589687116|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
163267010|NCT04534114|589687117|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
163267011|NCT04534114|589687114|FG000|Extension Treatment Period|Other reason|0|||
163267012|NCT04534114|589687115|FG001|Extension Treatment Period|Other reason|1|||
163267013|NCT04534114|589687116|FG002|Extension Treatment Period|Other reason|0|||
163267014|NCT04534114|589687117|FG003|Extension Treatment Period|Other reason|0|||
163267015|NCT04534114|589687114|FG000|Extension Treatment Period|Death|0|||
163267016|NCT04534114|589687115|FG001|Extension Treatment Period|Death|0|||
163267017|NCT04534114|589687116|FG002|Extension Treatment Period|Death|1|||
163267018|NCT04534114|589687117|FG003|Extension Treatment Period|Death|2|||
163267019|NCT04534114|589687114|FG000|Extension Treatment Period|Adverse Event|0|||
163267020|NCT04534114|589687115|FG001|Extension Treatment Period|Adverse Event|1|||
163267021|NCT04534114|589687116|FG002|Extension Treatment Period|Adverse Event|0|||
163267022|NCT04534114|589687117|FG003|Extension Treatment Period|Adverse Event|1|||
163267023|NCT04534114|589687114|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
163267024|NCT04534114|589687115|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
163267025|NCT04534114|589687116|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
163267026|NCT04534114|589687117|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
163267027|NCT02759185|589687118|FG000|Stage 1|Adverse Event|0|||
163267028|NCT02759185|589687119|FG001|Stage 1|Adverse Event|1|||
163267029|NCT02759185|589687120|FG002|Stage 1|Adverse Event|3|||
163267030|NCT02759185|589687121|FG003|Stage 1|Adverse Event|0|||
163267031|NCT02759185|589687122|FG004|Stage 1|Adverse Event|0|||
163267032|NCT02759185|589687123|FG005|Stage 1|Adverse Event|0|||
163267033|NCT02759185|589687124|FG006|Stage 1|Adverse Event|0|||
163267034|NCT02759185|589687118|FG000|Stage 1|Withdrawal by Subject|1|||
163267035|NCT02759185|589687119|FG001|Stage 1|Withdrawal by Subject|0|||
163267036|NCT02759185|589687120|FG002|Stage 1|Withdrawal by Subject|0|||
163267037|NCT02759185|589687121|FG003|Stage 1|Withdrawal by Subject|0|||
163267038|NCT02759185|589687122|FG004|Stage 1|Withdrawal by Subject|0|||
163267039|NCT02759185|589687123|FG005|Stage 1|Withdrawal by Subject|0|||
163267040|NCT02759185|589687124|FG006|Stage 1|Withdrawal by Subject|0|||
163267041|NCT02759185|589687118|FG000|Stage 2|Adverse Event|0|||
163267042|NCT02759185|589687119|FG001|Stage 2|Adverse Event|0|||
163267043|NCT02759185|589687120|FG002|Stage 2|Adverse Event|0|||
163267044|NCT02759185|589687121|FG003|Stage 2|Adverse Event|0|||
163267045|NCT02759185|589687122|FG004|Stage 2|Adverse Event|1|||
163267046|NCT02759185|589687123|FG005|Stage 2|Adverse Event|2|||
163267047|NCT02759185|589687124|FG006|Stage 2|Adverse Event|0|||
163267048|NCT02759185|589687118|FG000|Stage 2|Withdrawal by Subject|0|||
163267049|NCT02759185|589687119|FG001|Stage 2|Withdrawal by Subject|0|||
163267050|NCT02759185|589687120|FG002|Stage 2|Withdrawal by Subject|0|||
163267051|NCT02759185|589687121|FG003|Stage 2|Withdrawal by Subject|0|||
163267052|NCT02759185|589687122|FG004|Stage 2|Withdrawal by Subject|1|||
163267053|NCT02759185|589687123|FG005|Stage 2|Withdrawal by Subject|1|||
163267054|NCT02759185|589687124|FG006|Stage 2|Withdrawal by Subject|1|||
163267055|NCT01065350|589687129|FG000|Overall Study|Received incorrect drug allocation|0|||
163267056|NCT01065350|589687130|FG001|Overall Study|Received incorrect drug allocation|1|||
163267057|NCT02875834|589687131|FG000|Open-label Phase|Withdrawal by Subject|3|||
163267058|NCT02875834|589687132|FG001|Open-label Phase|Withdrawal by Subject|0|||
163267059|NCT02875834|589687133|FG002|Open-label Phase|Withdrawal by Subject|0|||
163267060|NCT02875834|589687134|FG003|Open-label Phase|Withdrawal by Subject|0|||
163267061|NCT02875834|589687131|FG000|Open-label Phase|(Not collected)|4|||
163267062|NCT02875834|589687132|FG001|Open-label Phase|(Not collected)|0|||
163267063|NCT02875834|589687133|FG002|Open-label Phase|(Not collected)|0|||
163267064|NCT02875834|589687134|FG003|Open-label Phase|(Not collected)|0|||
163267065|NCT02875834|589687131|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
163267066|NCT02875834|589687132|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
163267067|NCT02875834|589687133|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
163267068|NCT02875834|589687134|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
163267069|NCT02875834|589687131|FG000|Randomized Treatment Phase|Protocol Violation|0|||
163267070|NCT02875834|589687132|FG001|Randomized Treatment Phase|Protocol Violation|2|||
163267071|NCT02875834|589687133|FG002|Randomized Treatment Phase|Protocol Violation|0|||
163267072|NCT02875834|589687134|FG003|Randomized Treatment Phase|Protocol Violation|0|||
163267073|NCT02875834|589687131|FG000|Randomized Treatment Phase|(Not collected)|0|||
163267074|NCT02875834|589687132|FG001|Randomized Treatment Phase|(Not collected)|9|||
163267075|NCT02875834|589687133|FG002|Randomized Treatment Phase|(Not collected)|10|||
163267076|NCT02875834|589687134|FG003|Randomized Treatment Phase|(Not collected)|9|||
163267077|NCT01302938|589687135|FG000|Overall Study|Withdrawal by Subject|1|||
163267078|NCT01302938|589687136|FG001|Overall Study|Withdrawal by Subject|0|||
163267079|NCT01302938|589687135|FG000|Overall Study|Adverse Event|1|||
163267080|NCT01302938|589687136|FG001|Overall Study|Adverse Event|0|||
163267081|NCT00539279|589687138|FG000|Treatment|Withdrawal by Subject|10|||
163267082|NCT00539279|589687139|FG001|Treatment|Withdrawal by Subject|8|||
163267083|NCT00539279|589687138|FG000|Treatment|Death|1|||
163267084|NCT00539279|589687139|FG001|Treatment|Death|0|||
163267085|NCT00539279|589687138|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
163267086|NCT00539279|589687139|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
163267087|NCT00539279|589687138|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
163267088|NCT00539279|589687139|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
163267089|NCT01811563|589688657|FG000|Overall Study|Lost to Follow-up|5|||
163267090|NCT01811563|589688658|FG001|Overall Study|Lost to Follow-up|2|||
163267091|NCT01811563|589688657|FG000|Overall Study|Incorrect Randomization procedure|0|||
163267092|NCT01811563|589688658|FG001|Overall Study|Incorrect Randomization procedure|1|||
163267093|NCT02936037|589688659|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
163267094|NCT02936037|589688660|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
163267095|NCT02936037|589688659|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
163267096|NCT02936037|589688660|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
163267097|NCT02936037|589688659|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
163267098|NCT02936037|589688660|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
163267099|NCT02936037|589688659|FG000|Double-Blind Treatment Period|Death|0|||
163267100|NCT02936037|589688660|FG001|Double-Blind Treatment Period|Death|1|||
163267101|NCT02936037|589688659|FG000|Double-Blind Treatment Period|Adverse Event|11|||
163267102|NCT02936037|589688660|FG001|Double-Blind Treatment Period|Adverse Event|11|||
163267103|NCT02936037|589688659|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
163267104|NCT02936037|589688660|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
163267105|NCT02936037|589688659|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163267106|NCT02936037|589688660|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
163267107|NCT02936037|589688659|FG000|Open Label Extension|Adverse Event|0|||
163267108|NCT02936037|589688660|FG001|Open Label Extension|Adverse Event|3|||
163267109|NCT02936037|589688659|FG000|Open Label Extension|Other|0|||
163267110|NCT02936037|589688660|FG001|Open Label Extension|Other|3|||
163267111|NCT02936037|589688659|FG000|Open Label Extension|Withdrawal by Subject|0|||
163267112|NCT02936037|589688660|FG001|Open Label Extension|Withdrawal by Subject|4|||
163267113|NCT01267825|589688661|FG000|Overall Study|study terminated. no data collected.|1|||
163267114|NCT01267825|589688662|FG001|Overall Study|study terminated. no data collected.|0|||
163267115|NCT04249336|589688663|FG000|Overall Study|Lost to Follow-up|3|||
163267116|NCT04249336|589688664|FG001|Overall Study|Lost to Follow-up|3|||
163267117|NCT04249336|589688665|FG002|Overall Study|Lost to Follow-up|3|||
163267118|NCT04249336|589688666|FG003|Overall Study|Lost to Follow-up|3|||
163267119|NCT01189890|589688670|FG000|Overall Study|Adverse Event|3|||
163267120|NCT01189890|589688671|FG001|Overall Study|Adverse Event|4|||
163267121|NCT01189890|589688670|FG000|Overall Study|Lack of Efficacy|7|||
163267122|NCT01189890|589688671|FG001|Overall Study|Lack of Efficacy|2|||
163267123|NCT01189890|589688670|FG000|Overall Study|Lost to Follow-up|1|||
163267124|NCT01189890|589688671|FG001|Overall Study|Lost to Follow-up|7|||
163267125|NCT01189890|589688670|FG000|Overall Study|Protocol Violation|1|||
163267126|NCT01189890|589688671|FG001|Overall Study|Protocol Violation|5|||
163267127|NCT01189890|589688670|FG000|Overall Study|Withdrawal by Subject|15|||
163267128|NCT01189890|589688671|FG001|Overall Study|Withdrawal by Subject|11|||
163267129|NCT01189890|589688670|FG000|Overall Study|Non Compliance|0|||
163267130|NCT01189890|589688671|FG001|Overall Study|Non Compliance|1|||
163267131|NCT01189890|589688670|FG000|Overall Study|Physician Decision|5|||
163267132|NCT01189890|589688671|FG001|Overall Study|Physician Decision|4|||
163267133|NCT01189890|589688670|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
163267134|NCT01189890|589688671|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
163267135|NCT00077636|589688672|FG000|Overall Study|Refused Treatment|9|||
163267136|NCT00077636|589688673|FG001|Overall Study|Refused Treatment|31|||
163267137|NCT00077636|589688672|FG000|Overall Study|Admin|3|||
163267138|NCT00077636|589688673|FG001|Overall Study|Admin|3|||
163267139|NCT00077636|589688672|FG000|Overall Study|Withdrawal by Subject|2|||
163267140|NCT00077636|589688673|FG001|Overall Study|Withdrawal by Subject|2|||
163267141|NCT00077636|589688672|FG000|Overall Study|Adverse Event|17|||
163267142|NCT00077636|589688673|FG001|Overall Study|Adverse Event|34|||
163267143|NCT00077636|589688672|FG000|Overall Study|Protocol Violation|0|||
163267144|NCT00077636|589688673|FG001|Overall Study|Protocol Violation|2|||
163267145|NCT00077636|589688672|FG000|Overall Study|Lost to Follow-up|10|||
163267146|NCT00077636|589688673|FG001|Overall Study|Lost to Follow-up|18|||
163267147|NCT00077636|589688672|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
163267148|NCT00077636|589688673|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
163267149|NCT00068380|589688674|FG000|Overall Study|Withdrawal by Subject|3|||
163267150|NCT00068380|589688674|FG000|Overall Study|Adverse Event|2|||
163362471|NCT01080300|590036506|FG000|Overall Study|Lack of Efficacy|12|||
163267151|NCT01976364|589688675|FG000|Main Study (36 Months)|Adverse Event|63|||
163267152|NCT01976364|589688676|FG001|Main Study (36 Months)|Adverse Event|0|||
163267153|NCT01976364|589688677|FG002|Main Study (36 Months)|Adverse Event|0|||
163267154|NCT01976364|589688675|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
163267155|NCT01976364|589688676|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
163267156|NCT01976364|589688677|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
163267157|NCT01976364|589688675|FG000|Main Study (36 Months)|Other|13|||
163267158|NCT01976364|589688676|FG001|Main Study (36 Months)|Other|0|||
163267159|NCT01976364|589688677|FG002|Main Study (36 Months)|Other|0|||
163267160|NCT01976364|589688675|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
163267161|NCT01976364|589688676|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
163267162|NCT01976364|589688677|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
163267163|NCT01976364|589688675|FG000|Main Study (36 Months)|Medication error|1|||
163267164|NCT01976364|589688676|FG001|Main Study (36 Months)|Medication error|0|||
163267165|NCT01976364|589688677|FG002|Main Study (36 Months)|Medication error|0|||
163267166|NCT01976364|589688675|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
163267167|NCT01976364|589688676|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
163267168|NCT01976364|589688677|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
163267169|NCT01976364|589688675|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
163267170|NCT01976364|589688676|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
163267171|NCT01976364|589688677|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
163267172|NCT01976364|589688675|FG000|Main Study (36 Months)|Protocol Violation|13|||
163267173|NCT01976364|589688676|FG001|Main Study (36 Months)|Protocol Violation|0|||
163267174|NCT01976364|589688677|FG002|Main Study (36 Months)|Protocol Violation|0|||
163267175|NCT01976364|589688675|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
163267176|NCT01976364|589688676|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
163267177|NCT01976364|589688677|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
163267178|NCT01976364|589688675|FG000|Main Study (36 Months)|Death|5|||
163267179|NCT01976364|589688676|FG001|Main Study (36 Months)|Death|0|||
163267180|NCT01976364|589688677|FG002|Main Study (36 Months)|Death|0|||
163267181|NCT01976364|589688675|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
163267182|NCT01976364|589688676|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
163267183|NCT01976364|589688677|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
163267184|NCT01976364|589688675|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
163267185|NCT01976364|589688676|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
163267186|NCT01976364|589688677|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
163267187|NCT01976364|589688675|FG000|Sub-study (12 Months)|Protocol Violation|0|||
163267188|NCT01976364|589688676|FG001|Sub-study (12 Months)|Protocol Violation|1|||
163267189|NCT01976364|589688677|FG002|Sub-study (12 Months)|Protocol Violation|1|||
163267190|NCT01976364|589688675|FG000|Sub-study (12 Months)|Adverse Event|0|||
163267191|NCT01976364|589688676|FG001|Sub-study (12 Months)|Adverse Event|4|||
163267192|NCT01976364|589688677|FG002|Sub-study (12 Months)|Adverse Event|3|||
163267193|NCT01190215|589688678|FG000|Up to Month 6|Lost to Follow-up|2|||
163267194|NCT01190215|589688679|FG001|Up to Month 6|Lost to Follow-up|0|||
163267195|NCT04250337|589688681|FG000|Overall Study|Adverse Event|0|||
163267196|NCT04250337|589688682|FG001|Overall Study|Adverse Event|3|||
163267197|NCT04250337|589688681|FG000|Overall Study|Lack of Efficacy|1|||
163267198|NCT04250337|589688682|FG001|Overall Study|Lack of Efficacy|3|||
163267199|NCT04250337|589688681|FG000|Overall Study|Physician Decision|1|||
163267200|NCT04250337|589688682|FG001|Overall Study|Physician Decision|0|||
163267201|NCT04250337|589688681|FG000|Overall Study|Protocol Deviation|2|||
163267202|NCT04250337|589688682|FG001|Overall Study|Protocol Deviation|2|||
163267203|NCT04250337|589688681|FG000|Overall Study|Withdrawal by Subject|4|||
163267204|NCT04250337|589688682|FG001|Overall Study|Withdrawal by Subject|3|||
163267205|NCT00641719|589688685|FG000|Overall Study|Lack of Efficacy|1|||
163267206|NCT00641719|589688686|FG001|Overall Study|Lack of Efficacy|2|||
163267207|NCT00641719|589688685|FG000|Overall Study|Adverse Event|24|||
163267208|NCT00641719|589688686|FG001|Overall Study|Adverse Event|29|||
163267209|NCT00641719|589688685|FG000|Overall Study|Withdrawal by Subject|4|||
163267210|NCT00641719|589688686|FG001|Overall Study|Withdrawal by Subject|4|||
163267211|NCT00641719|589688685|FG000|Overall Study|Reason Not Specified|1|||
163267212|NCT00641719|589688686|FG001|Overall Study|Reason Not Specified|2|||
163267213|NCT03303469|589688687|FG000|Overall Study|Lost to Follow-up|2|||
163267214|NCT00885352|589688688|FG000|Overall Study|Adverse Event|2|||
163267215|NCT00885352|589688689|FG001|Overall Study|Adverse Event|3|||
163267216|NCT00885352|589688688|FG000|Overall Study|Lost to Follow-up|2|||
163267217|NCT00885352|589688689|FG001|Overall Study|Lost to Follow-up|2|||
163267218|NCT00885352|589688688|FG000|Overall Study|Physician Decision|0|||
163267219|NCT00885352|589688689|FG001|Overall Study|Physician Decision|3|||
163267220|NCT00885352|589688688|FG000|Overall Study|Protocol Violation|0|||
163267221|NCT00885352|589688689|FG001|Overall Study|Protocol Violation|2|||
163267222|NCT00885352|589688688|FG000|Overall Study|Withdrawal by Subject|1|||
163267223|NCT00885352|589688689|FG001|Overall Study|Withdrawal by Subject|5|||
163267224|NCT00885352|589688688|FG000|Overall Study|Contradiction to study medication|0|||
163267225|NCT00885352|589688689|FG001|Overall Study|Contradiction to study medication|2|||
163267226|NCT00885352|589688688|FG000|Overall Study|Excluded medication|2|||
163267227|NCT00885352|589688689|FG001|Overall Study|Excluded medication|2|||
163267228|NCT00885352|589688688|FG000|Overall Study|Lab abnormalities|1|||
163267229|NCT00885352|589688689|FG001|Overall Study|Lab abnormalities|1|||
163267230|NCT03560258|589688690|FG000|Overall Study|Lost to Follow-up|3|||
163267231|NCT03560258|589688691|FG001|Overall Study|Lost to Follow-up|0|||
163267232|NCT03560258|589688692|FG002|Overall Study|Lost to Follow-up|0|||
163267233|NCT03560258|589688690|FG000|Overall Study|Protocol Violation|0|||
163267234|NCT03560258|589688691|FG001|Overall Study|Protocol Violation|1|||
163267235|NCT03560258|589688692|FG002|Overall Study|Protocol Violation|0|||
163267236|NCT03560258|589688690|FG000|Overall Study|Withdrawal by Subject|0|||
163267237|NCT03560258|589688691|FG001|Overall Study|Withdrawal by Subject|0|||
163267238|NCT03560258|589688692|FG002|Overall Study|Withdrawal by Subject|1|||
163267239|NCT01460160|589688693|FG000|Treatment Phase|Lack of Efficacy|3|||
163267240|NCT01460160|589688693|FG000|Treatment Phase|Study Drug Toxicity|2|||
163267241|NCT01460160|589688693|FG000|Treatment Phase|Adverse Event|8|||
163267242|NCT01460160|589688693|FG000|Treatment Phase|Withdrawal by Subject|4|||
163267243|NCT01460160|589688693|FG000|Treatment Phase|Death|2|||
163267244|NCT01460160|589688693|FG000|Treatment Phase|Other reasons|9|||
163267245|NCT01460160|589688693|FG000|Follow-up Phase|Withdrawal by Subject|4|||
163267246|NCT01460160|589688693|FG000|Follow-up Phase|Death|14|||
163267247|NCT01460160|589688693|FG000|Follow-up Phase|Lost to Follow-up|7|||
163267248|NCT01460160|589688693|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
163267249|NCT01460160|589688693|FG000|Follow-up Phase|Other and not reported reasons|5|||
163267250|NCT03101241|589688694|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
163267251|NCT03101241|589688695|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
163267252|NCT03101241|589688694|FG000|Overall Study|Participant withdrew consent|3|||
163267253|NCT03101241|589688695|FG001|Overall Study|Participant withdrew consent|1|||
163267254|NCT03101241|589688694|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
163267255|NCT03101241|589688695|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
163267256|NCT03101241|589688694|FG000|Overall Study|Lost to Follow-up|2|||
163267257|NCT03101241|589688695|FG001|Overall Study|Lost to Follow-up|0|||
163267258|NCT03101241|589688694|FG000|Overall Study|Lack of Efficacy|0|||
163267259|NCT03101241|589688695|FG001|Overall Study|Lack of Efficacy|1|||
163267260|NCT03101241|589688694|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
163267261|NCT03101241|589688695|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
163267262|NCT00669903|589688696|FG000|Overall Study|Adverse Event|0|||
163267263|NCT00669903|589688697|FG001|Overall Study|Adverse Event|1|||
163267264|NCT00669903|589688698|FG002|Overall Study|Adverse Event|3|||
163267265|NCT00669903|589688699|FG003|Overall Study|Adverse Event|1|||
163267266|NCT00669903|589688696|FG000|Overall Study|Withdrawal by Subject|0|||
163267267|NCT00669903|589688697|FG001|Overall Study|Withdrawal by Subject|2|||
163267268|NCT00669903|589688698|FG002|Overall Study|Withdrawal by Subject|2|||
163267269|NCT00669903|589688699|FG003|Overall Study|Withdrawal by Subject|2|||
163267270|NCT00669903|589688696|FG000|Overall Study|Lost to Follow-up|1|||
163267271|NCT00669903|589688697|FG001|Overall Study|Lost to Follow-up|1|||
163267272|NCT00669903|589688698|FG002|Overall Study|Lost to Follow-up|0|||
163267273|NCT00669903|589688699|FG003|Overall Study|Lost to Follow-up|1|||
163267274|NCT00669903|589688696|FG000|Overall Study|Protocol Violation|0|||
163267275|NCT00669903|589688697|FG001|Overall Study|Protocol Violation|1|||
163267276|NCT00669903|589688698|FG002|Overall Study|Protocol Violation|0|||
163267277|NCT00669903|589688699|FG003|Overall Study|Protocol Violation|0|||
163267278|NCT00251927|589688700|FG000|Overall Study|Adverse Event|3|||
163267279|NCT00251927|589688701|FG001|Overall Study|Adverse Event|15|||
163267280|NCT00251927|589688700|FG000|Overall Study|Lack of Efficacy|22|||
163267281|NCT00251927|589688701|FG001|Overall Study|Lack of Efficacy|16|||
163267282|NCT00251927|589688700|FG000|Overall Study|Lost to Follow-up|22|||
163267283|NCT00251927|589688701|FG001|Overall Study|Lost to Follow-up|8|||
163267284|NCT00251927|589688700|FG000|Overall Study|Protocol Violation|1|||
163267285|NCT00251927|589688701|FG001|Overall Study|Protocol Violation|2|||
163267286|NCT00251927|589688700|FG000|Overall Study|Pregnancy|2|||
163267287|NCT00251927|589688701|FG001|Overall Study|Pregnancy|0|||
163267288|NCT00251927|589688700|FG000|Overall Study|Withdrawal by Subject|40|||
163267289|NCT00251927|589688701|FG001|Overall Study|Withdrawal by Subject|25|||
163267290|NCT00251927|589688700|FG000|Overall Study|Study-specific discont. achieved|13|||
163267291|NCT00251927|589688701|FG001|Overall Study|Study-specific discont. achieved|2|||
163267292|NCT00251927|589688700|FG000|Overall Study|Study procedure non-compliance|5|||
163267293|NCT00251927|589688701|FG001|Overall Study|Study procedure non-compliance|6|||
163267294|NCT01678820|589688702|FG000|Overall Study|Study Terminated by Sponsor|45|||
163267295|NCT01678820|589688703|FG001|Overall Study|Study Terminated by Sponsor|43|||
163267296|NCT01678820|589688704|FG002|Overall Study|Study Terminated by Sponsor|43|||
163267297|NCT01678820|589688702|FG000|Overall Study|Withdrawal by Subject|2|||
163267298|NCT01678820|589688703|FG001|Overall Study|Withdrawal by Subject|5|||
163267299|NCT01678820|589688704|FG002|Overall Study|Withdrawal by Subject|2|||
163267300|NCT01678820|589688702|FG000|Overall Study|Protocol Specified Criteria|2|||
163267301|NCT01678820|589688703|FG001|Overall Study|Protocol Specified Criteria|3|||
163267302|NCT01678820|589688704|FG002|Overall Study|Protocol Specified Criteria|1|||
163154621|NCT03250273|589281348|FG001|Overall Study|Death|1|||
163154622|NCT04154904|589281349|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
163154623|NCT04154904|589281350|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
163154624|NCT04154904|589281351|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
163154625|NCT02392624|589281352|FG000|Overall Study|Withdrawal by Subject|15|||
163154626|NCT02392624|589281353|FG001|Overall Study|Withdrawal by Subject|12|||
163154627|NCT02392624|589281354|FG002|Overall Study|Withdrawal by Subject|9|||
163154628|NCT02392624|589281352|FG000|Overall Study|Adverse Event|4|||
163154629|NCT02392624|589281353|FG001|Overall Study|Adverse Event|1|||
163154630|NCT02392624|589281354|FG002|Overall Study|Adverse Event|2|||
163154631|NCT02392624|589281352|FG000|Overall Study|Pregnancy|1|||
163154632|NCT02392624|589281353|FG001|Overall Study|Pregnancy|0|||
163154633|NCT02392624|589281354|FG002|Overall Study|Pregnancy|0|||
163154634|NCT02392624|589281352|FG000|Overall Study|Protocol Violation|0|||
163154635|NCT02392624|589281353|FG001|Overall Study|Protocol Violation|0|||
163154636|NCT02392624|589281354|FG002|Overall Study|Protocol Violation|1|||
163154637|NCT02392624|589281352|FG000|Overall Study|Sponsor/Investigator Decision|2|||
163154638|NCT02392624|589281353|FG001|Overall Study|Sponsor/Investigator Decision|1|||
163154639|NCT02392624|589281354|FG002|Overall Study|Sponsor/Investigator Decision|0|||
163154640|NCT02392624|589281352|FG000|Overall Study|Other|49|||
163154641|NCT02392624|589281353|FG001|Overall Study|Other|1|||
163154642|NCT02392624|589281354|FG002|Overall Study|Other|1|||
163154643|NCT00936715|589281355|FG000|Overall Study|Investigators Discretion|1|||
163154644|NCT00936715|589281355|FG000|Overall Study|Protocol Violation|1|||
163154645|NCT00936715|589281355|FG000|Overall Study|Safety or Tolerability Reasons|4|||
163154646|NCT03841604|589281358|FG000|Overall Study|Withdrawal by Subject|3|||
163154647|NCT03841604|589281359|FG001|Overall Study|Withdrawal by Subject|1|||
163154648|NCT03841604|589281358|FG000|Overall Study|Adverse Event|4|||
163154649|NCT03841604|589281359|FG001|Overall Study|Adverse Event|2|||
163154650|NCT03841604|589281358|FG000|Overall Study|Physician Decision|1|||
163154651|NCT03841604|589281359|FG001|Overall Study|Physician Decision|0|||
163154652|NCT01337960|589281360|FG000|Overall Study|Lost to Follow-up|1|||
163154653|NCT01337960|589281361|FG001|Overall Study|Lost to Follow-up|0|||
163154654|NCT01337960|589281362|FG002|Overall Study|Lost to Follow-up|0|||
163154655|NCT01337960|589281360|FG000|Overall Study|Withdrawal by Subject|1|||
163154656|NCT01337960|589281361|FG001|Overall Study|Withdrawal by Subject|0|||
163154657|NCT01337960|589281362|FG002|Overall Study|Withdrawal by Subject|0|||
163154658|NCT03877510|589281363|FG000|Overall Study|Death|6|||
163154659|NCT03877510|589281363|FG000|Overall Study|Lost to Follow-up|2|||
163154660|NCT03877510|589281363|FG000|Overall Study|Non-compliance with study drug|2|||
163154661|NCT03877510|589281363|FG000|Overall Study|Lack of Efficacy|14|||
163154662|NCT03877510|589281363|FG000|Overall Study|Adverse Event|20|||
163154663|NCT03877510|589281363|FG000|Overall Study|Withdrawal by Subject|22|||
163154664|NCT03877510|589281363|FG000|Overall Study|Miscellaneous|1|||
163154665|NCT03763877|589281365|FG000|Overall Study|Withdrawal by Subject|3|||
163154666|NCT03763877|589281366|FG001|Overall Study|Withdrawal by Subject|1|||
163154667|NCT03763877|589281367|FG002|Overall Study|Withdrawal by Subject|3|||
163154668|NCT03763877|589281368|FG003|Overall Study|Withdrawal by Subject|4|||
163154669|NCT03763877|589281365|FG000|Overall Study|Adverse Event|1|||
163154670|NCT03763877|589281366|FG001|Overall Study|Adverse Event|1|||
163154671|NCT03763877|589281367|FG002|Overall Study|Adverse Event|3|||
163154672|NCT03763877|589281368|FG003|Overall Study|Adverse Event|1|||
163154673|NCT03763877|589281365|FG000|Overall Study|Protocol Violation|1|||
163154674|NCT03763877|589281366|FG001|Overall Study|Protocol Violation|1|||
163154675|NCT03763877|589281367|FG002|Overall Study|Protocol Violation|0|||
163154676|NCT03763877|589281368|FG003|Overall Study|Protocol Violation|0|||
163154677|NCT03763877|589281365|FG000|Overall Study|Lost to Follow-up|0|||
163154678|NCT03763877|589281366|FG001|Overall Study|Lost to Follow-up|1|||
163154679|NCT03763877|589281367|FG002|Overall Study|Lost to Follow-up|1|||
163154680|NCT03763877|589281368|FG003|Overall Study|Lost to Follow-up|0|||
163154681|NCT03040336|589281369|FG000|Overall Study|Death|1|||
163154682|NCT03040336|589281370|FG001|Overall Study|Death|0|||
163154683|NCT03040336|589281369|FG000|Overall Study|Withdrawal by Subject|2|||
163154684|NCT03040336|589281370|FG001|Overall Study|Withdrawal by Subject|3|||
163154685|NCT01524796|589281379|FG000|Overall Study|Adverse Event|13|||
163154686|NCT01524796|589281379|FG000|Overall Study|Lack of Efficacy|3|||
163154687|NCT01524796|589281379|FG000|Overall Study|Lost to Follow-up|1|||
163154688|NCT01524796|589281379|FG000|Overall Study|The price|1|||
163154689|NCT01524796|589281379|FG000|Overall Study|Withdrawal by Subject|4|||
163154690|NCT01524796|589281379|FG000|Overall Study|Move|1|||
163154691|NCT01524796|589281379|FG000|Overall Study|Deterioration of pains|1|||
163154692|NCT01524796|589281379|FG000|Overall Study|Gall stone surgery|1|||
163154693|NCT01524796|589281379|FG000|Overall Study|Nervous about confidentiality|1|||
163154694|NCT01524796|589281379|FG000|Overall Study|Switch to carbamazapine|1|||
163154695|NCT01524796|589281379|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
163154696|NCT03938259|589281380|FG000|Overall Study|unable to establish baseline for ventilation|1|||
163267303|NCT01678820|589688702|FG000|Overall Study|Adverse Event|2|||
163267304|NCT01678820|589688703|FG001|Overall Study|Adverse Event|2|||
163267305|NCT01678820|589688704|FG002|Overall Study|Adverse Event|2|||
163267306|NCT01678820|589688702|FG000|Overall Study|Lost to Follow-up|7|||
163267307|NCT01678820|589688703|FG001|Overall Study|Lost to Follow-up|2|||
163267308|NCT01678820|589688704|FG002|Overall Study|Lost to Follow-up|2|||
163267309|NCT01678820|589688702|FG000|Overall Study|Non-compliance with study drug|0|||
163267310|NCT01678820|589688703|FG001|Overall Study|Non-compliance with study drug|1|||
163267311|NCT01678820|589688704|FG002|Overall Study|Non-compliance with study drug|0|||
163267312|NCT01678820|589688702|FG000|Overall Study|Physician Decision|0|||
163267313|NCT01678820|589688703|FG001|Overall Study|Physician Decision|0|||
163267314|NCT01678820|589688704|FG002|Overall Study|Physician Decision|1|||
163267315|NCT01678820|589688702|FG000|Overall Study|Protocol Violation|4|||
163267316|NCT01678820|589688703|FG001|Overall Study|Protocol Violation|5|||
163267317|NCT01678820|589688704|FG002|Overall Study|Protocol Violation|4|||
163267318|NCT01678820|589688702|FG000|Overall Study|Not treated with double-blind study drug|0|||
163267319|NCT01678820|589688703|FG001|Overall Study|Not treated with double-blind study drug|2|||
163267320|NCT01678820|589688704|FG002|Overall Study|Not treated with double-blind study drug|2|||
163267321|NCT03283696|589688705|FG000|Overall Study|Physician Decision|5|||
163267322|NCT03283696|589688706|FG001|Overall Study|Physician Decision|6|||
163267323|NCT03283696|589688705|FG000|Overall Study|Withdrawal by Subject|2|||
163267324|NCT03283696|589688706|FG001|Overall Study|Withdrawal by Subject|0|||
163267325|NCT00245856|589688707|FG000|Period Two|Withdrawal by Subject|0|||
163267326|NCT00245856|589688708|FG001|Period Two|Withdrawal by Subject|1|||
163267327|NCT01512745|589688710|FG000|Overall Study|Adverse Event|22|||
163267328|NCT01512745|589688711|FG001|Overall Study|Adverse Event|3|||
163267329|NCT01512745|589688710|FG000|Overall Study|Death|9|||
163267330|NCT01512745|589688711|FG001|Overall Study|Death|13|||
163267331|NCT01512745|589688710|FG000|Overall Study|Withdrawal by Subject|2|||
163267332|NCT01512745|589688711|FG001|Overall Study|Withdrawal by Subject|2|||
163267333|NCT01512745|589688710|FG000|Overall Study|Lost to Follow-up|4|||
163267334|NCT01512745|589688711|FG001|Overall Study|Lost to Follow-up|0|||
163267335|NCT01512745|589688710|FG000|Overall Study|Lack of Efficacy|2|||
163267336|NCT01512745|589688711|FG001|Overall Study|Lack of Efficacy|2|||
163267337|NCT01512745|589688710|FG000|Overall Study|Protocol Violation|1|||
163267338|NCT01512745|589688711|FG001|Overall Study|Protocol Violation|0|||
163267339|NCT00439179|589688712|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
163267340|NCT00439179|589688713|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
163267341|NCT00439179|589688714|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
163267342|NCT00439179|589688715|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
163267343|NCT02761629|589688716|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
163267344|NCT02761629|589688717|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
163267345|NCT02761629|589688716|FG000|Overall Study|Insufficient Therapeutic Response|2|||
163267346|NCT02761629|589688717|FG001|Overall Study|Insufficient Therapeutic Response|7|||
163267347|NCT02761629|589688716|FG000|Overall Study|Failure to Return|2|||
163267348|NCT02761629|589688717|FG001|Overall Study|Failure to Return|4|||
163267349|NCT02761629|589688716|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
163267350|NCT02761629|589688717|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
163267351|NCT02761629|589688716|FG000|Overall Study|Protocol Violation|2|||
163267352|NCT02761629|589688717|FG001|Overall Study|Protocol Violation|2|||
163267353|NCT02761629|589688716|FG000|Overall Study|Withdrawal by Subject|0|||
163267354|NCT02761629|589688717|FG001|Overall Study|Withdrawal by Subject|3|||
163267355|NCT02761629|589688716|FG000|Overall Study|Other|0|||
163267356|NCT02761629|589688717|FG001|Overall Study|Other|2|||
163267357|NCT02761629|589688716|FG000|Overall Study|Lost to Follow-up|4|||
163267358|NCT02761629|589688717|FG001|Overall Study|Lost to Follow-up|1|||
163267359|NCT02761629|589688716|FG000|Overall Study|Randomized But Not Treated|8|||
163267360|NCT02761629|589688717|FG001|Overall Study|Randomized But Not Treated|4|||
163267361|NCT02357810|589688718|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
163267362|NCT02357810|589688718|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
163267363|NCT02357810|589688718|FG000|Reached 12 Weeks Response|Adverse Event|5|||
163267364|NCT02357810|589688718|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
163267365|NCT02357810|589688718|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
163267366|NCT02357810|589688718|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
163267367|NCT02357810|589688718|FG000|Reached 12 Weeks Response|Death|1|||
163267368|NCT02357810|589688718|FG000|Reached 12 Weeks Response|Physician Decision|1|||
163267369|NCT02357810|589688718|FG000|Reached 12 Weeks Response|Other|1|||
163267370|NCT02357810|589688718|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
163267371|NCT02357810|589688718|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
163267372|NCT02357810|589688718|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
163267373|NCT02357810|589688718|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
163267374|NCT02357810|589688718|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
163267375|NCT02357810|589688718|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
163267376|NCT00562978|589688719|FG000|Overall Study|Patient had imaging dose only|1|||
163267377|NCT00562978|589688720|FG001|Overall Study|Patient had imaging dose only|11|||
163267378|NCT00675506|589688722|FG000|Overall Study|Lost to Follow-up|1|||
163267379|NCT00675506|589688723|FG001|Overall Study|Lost to Follow-up|5|||
163267380|NCT00675506|589688722|FG000|Overall Study|Lost interest|3|||
163267381|NCT00675506|589688723|FG001|Overall Study|Lost interest|5|||
163267382|NCT00675506|589688722|FG000|Overall Study|Elevated fasting glucose|2|||
163267383|NCT00675506|589688723|FG001|Overall Study|Elevated fasting glucose|1|||
163267384|NCT00675506|589688722|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
163267385|NCT00675506|589688723|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
163267386|NCT00675506|589688722|FG000|Overall Study|Elevated IGF-1|2|||
163267387|NCT00675506|589688723|FG001|Overall Study|Elevated IGF-1|0|||
163267388|NCT00675506|589688722|FG000|Overall Study|Hypersensitivity Reaction|1|||
163267389|NCT00675506|589688723|FG001|Overall Study|Hypersensitivity Reaction|0|||
163267390|NCT00675506|589688722|FG000|Overall Study|Disclosed history of cancer|1|||
163267391|NCT00675506|589688723|FG001|Overall Study|Disclosed history of cancer|0|||
163267392|NCT00675506|589688722|FG000|Overall Study|Declined participation|1|||
163267393|NCT00675506|589688723|FG001|Overall Study|Declined participation|0|||
163267394|NCT00675506|589688722|FG000|Overall Study|Schedule conflict|0|||
163267395|NCT00675506|589688723|FG001|Overall Study|Schedule conflict|1|||
163267396|NCT06173570|589688724|FG000|Overall Study|Adverse Event|1|||
163267397|NCT06173570|589688725|FG001|Overall Study|Adverse Event|0|||
163267398|NCT06173570|589688726|FG002|Overall Study|Adverse Event|0|||
163267399|NCT06173570|589688727|FG003|Overall Study|Adverse Event|2|||
163267400|NCT06173570|589688728|FG004|Overall Study|Adverse Event|0|||
163267401|NCT06173570|589688724|FG000|Overall Study|Lost to Follow-up|1|||
163267402|NCT06173570|589688725|FG001|Overall Study|Lost to Follow-up|0|||
163267403|NCT06173570|589688726|FG002|Overall Study|Lost to Follow-up|0|||
163267404|NCT06173570|589688727|FG003|Overall Study|Lost to Follow-up|0|||
163267405|NCT06173570|589688728|FG004|Overall Study|Lost to Follow-up|2|||
163267406|NCT06173570|589688724|FG000|Overall Study|Protocol Violation|0|||
163267407|NCT06173570|589688725|FG001|Overall Study|Protocol Violation|2|||
163267408|NCT06173570|589688726|FG002|Overall Study|Protocol Violation|0|||
163267409|NCT06173570|589688727|FG003|Overall Study|Protocol Violation|0|||
163267410|NCT06173570|589688728|FG004|Overall Study|Protocol Violation|1|||
163267411|NCT06173570|589688724|FG000|Overall Study|Withdrawal by Subject|0|||
163267412|NCT06173570|589688725|FG001|Overall Study|Withdrawal by Subject|1|||
163267413|NCT06173570|589688726|FG002|Overall Study|Withdrawal by Subject|1|||
163267414|NCT06173570|589688727|FG003|Overall Study|Withdrawal by Subject|1|||
163267415|NCT06173570|589688728|FG004|Overall Study|Withdrawal by Subject|1|||
163267416|NCT06173570|589688724|FG000|Overall Study|Non-compliance with Study Drug|1|||
163267417|NCT06173570|589688725|FG001|Overall Study|Non-compliance with Study Drug|0|||
163267418|NCT06173570|589688726|FG002|Overall Study|Non-compliance with Study Drug|0|||
163267419|NCT06173570|589688727|FG003|Overall Study|Non-compliance with Study Drug|0|||
163267420|NCT06173570|589688728|FG004|Overall Study|Non-compliance with Study Drug|0|||
163267421|NCT06173570|589688724|FG000|Overall Study|Screen Failure|0|||
163267422|NCT06173570|589688725|FG001|Overall Study|Screen Failure|0|||
163267423|NCT06173570|589688726|FG002|Overall Study|Screen Failure|0|||
163267424|NCT06173570|589688727|FG003|Overall Study|Screen Failure|0|||
163267425|NCT06173570|589688728|FG004|Overall Study|Screen Failure|1|||
163267426|NCT06173570|589688724|FG000|Overall Study|Other|2|||
163267427|NCT06173570|589688725|FG001|Overall Study|Other|1|||
163267428|NCT06173570|589688726|FG002|Overall Study|Other|0|||
163267429|NCT06173570|589688727|FG003|Overall Study|Other|2|||
163267430|NCT06173570|589688728|FG004|Overall Study|Other|0|||
163267431|NCT03820323|589688729|FG000|Overall Study|Lost to Follow-up|2|||
163267432|NCT03820323|589688730|FG001|Overall Study|Lost to Follow-up|1|||
163267433|NCT03820323|589688729|FG000|Overall Study|Missed 12-month visit|22|||
163267434|NCT03820323|589688730|FG001|Overall Study|Missed 12-month visit|14|||
163267435|NCT03820323|589688729|FG000|Overall Study|Death|2|||
163267436|NCT03820323|589688730|FG001|Overall Study|Death|1|||
163267437|NCT03820323|589688729|FG000|Overall Study|Transferred out|13|||
163267438|NCT03820323|589688730|FG001|Overall Study|Transferred out|11|||
163267439|NCT03820323|589688729|FG000|Overall Study|Terminated|0|||
163267440|NCT03820323|589688730|FG001|Overall Study|Terminated|3|||
163267441|NCT03820323|589688729|FG000|Overall Study|Withdrawal by Subject|1|||
163267442|NCT03820323|589688730|FG001|Overall Study|Withdrawal by Subject|6|||
163267443|NCT03151395|589688731|FG000|Overall Study|Adverse Event|2|||
163267444|NCT03151395|589688731|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
163267445|NCT03151395|589688731|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
163267446|NCT03151395|589688731|FG000|Overall Study|Unspecified reason|4|||
163267447|NCT00366301|589688732|FG000|Overall Study|Lost to Follow-up|4|||
163267448|NCT00366301|589688733|FG001|Overall Study|Lost to Follow-up|4|||
163267449|NCT00366301|589688734|FG002|Overall Study|Lost to Follow-up|3|||
163267450|NCT00366301|589688735|FG003|Overall Study|Lost to Follow-up|7|||
163267451|NCT00366301|589688732|FG000|Overall Study|Withdrawal by Subject|4|||
163267452|NCT00366301|589688733|FG001|Overall Study|Withdrawal by Subject|2|||
163267453|NCT00366301|589688734|FG002|Overall Study|Withdrawal by Subject|1|||
163267454|NCT00366301|589688735|FG003|Overall Study|Withdrawal by Subject|1|||
163267455|NCT02153359|589688736|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
163267456|NCT02153359|589688737|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
163267457|NCT01348776|589688738|FG000|Overall Study|Lost to Follow-up|3|||
163267458|NCT01372605|589688739|FG000|Overall Study|Death|1|||
163267459|NCT01372605|589688740|FG001|Overall Study|Death|2|||
163267460|NCT01372605|589688739|FG000|Overall Study|Lost to Follow-up|2|||
163267461|NCT01372605|589688740|FG001|Overall Study|Lost to Follow-up|1|||
163267462|NCT01372605|589688739|FG000|Overall Study|Withdrawal by Subject|4|||
163267463|NCT01372605|589688740|FG001|Overall Study|Withdrawal by Subject|7|||
163267464|NCT01372605|589688739|FG000|Overall Study|Moved|3|||
163267465|NCT01372605|589688740|FG001|Overall Study|Moved|0|||
163267466|NCT01372605|589688739|FG000|Overall Study|Changed medical home|2|||
163267467|NCT01372605|589688740|FG001|Overall Study|Changed medical home|0|||
163267468|NCT01830881|589688744|FG000|Overall Study|Changed decision to have an abortion|0|||
163267469|NCT01830881|589688745|FG001|Overall Study|Changed decision to have an abortion|1|||
163267470|NCT00734214|589688746|FG000|Overall Study|Withdrawal by Subject|3|||
163267471|NCT00734214|589688747|FG001|Overall Study|Withdrawal by Subject|4|||
163267472|NCT00734214|589688746|FG000|Overall Study|MD withdrawal|1|||
163267473|NCT00734214|589688747|FG001|Overall Study|MD withdrawal|0|||
163267474|NCT01320735|589688748|FG000|Overall Study|Adverse Event|3|||
163267475|NCT01320735|589688748|FG000|Overall Study|Withdrawal by Subject|3|||
163267476|NCT01320735|589688748|FG000|Overall Study|Lost to Follow-up|13|||
163267477|NCT01320735|589688748|FG000|Overall Study|Administrative Reason|6|||
163267478|NCT01320735|589688748|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
163267479|NCT01320735|589688748|FG000|Overall Study|Protocol Violation|1|||
163267480|NCT01320735|589688748|FG000|Overall Study|Other|1|||
163267481|NCT01320735|589688748|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
163267482|NCT01320735|589688748|FG000|Overall Study|Investigator Unable to be Contacted|17|||
163267483|NCT04599101|589688749|FG000|Overall Study|Lost to Follow-up|5|||
163267484|NCT04599101|589688750|FG001|Overall Study|Lost to Follow-up|5|||
163267485|NCT05952297|589688751|FG000|Overall Study|Withdrawal by Subject|1|||
163267486|NCT05952297|589688752|FG001|Overall Study|Withdrawal by Subject|0|||
163267487|NCT03856996|589688753|FG000|Overall Study|Withdrawal by Subject|1|||
163267488|NCT03856996|589688754|FG001|Overall Study|Withdrawal by Subject|0|||
163267489|NCT03856996|589688753|FG000|Overall Study|Lost to Follow-up|0|||
163267490|NCT03856996|589688754|FG001|Overall Study|Lost to Follow-up|1|||
163267491|NCT03856996|589688753|FG000|Overall Study|Adverse Event|1|||
163267492|NCT03856996|589688754|FG001|Overall Study|Adverse Event|1|||
163267493|NCT03856996|589688753|FG000|Overall Study|Other|1|||
163267494|NCT03856996|589688754|FG001|Overall Study|Other|0|||
163267495|NCT04362137|589688757|FG000|Overall Study|Death|9|||
163267496|NCT04362137|589688758|FG001|Overall Study|Death|3|||
163267497|NCT04362137|589688757|FG000|Overall Study|Patient decision|6|||
163267498|NCT04362137|589688758|FG001|Overall Study|Patient decision|3|||
163267499|NCT04362137|589688757|FG000|Overall Study|Adverse Event|1|||
163267500|NCT04362137|589688758|FG001|Overall Study|Adverse Event|0|||
163267501|NCT04362137|589688757|FG000|Overall Study|Lost to Follow-up|1|||
163267502|NCT04362137|589688758|FG001|Overall Study|Lost to Follow-up|0|||
163267503|NCT04362137|589688757|FG000|Overall Study|Protocol deviation|1|||
163267504|NCT04362137|589688758|FG001|Overall Study|Protocol deviation|0|||
163267505|NCT03556358|589688766|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
163267506|NCT03556358|589688767|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
163267507|NCT03556358|589688766|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
163267508|NCT03556358|589688767|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
163267509|NCT03556358|589688766|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
163267510|NCT03556358|589688767|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
163267511|NCT03556358|589688766|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
163267512|NCT03556358|589688767|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
163267513|NCT03556358|589688766|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
163267514|NCT03556358|589688767|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
163267515|NCT03556358|589688766|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
163267516|NCT03556358|589688767|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
163267517|NCT03556358|589688766|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
163267518|NCT03556358|589688767|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
163267519|NCT05067933|589688770|FG000|Overall Study|Withdrawal by Subject|2|||
163267520|NCT05067933|589688771|FG001|Overall Study|Withdrawal by Subject|0|||
163267521|NCT05067933|589688772|FG002|Overall Study|Withdrawal by Subject|0|||
163267522|NCT05067933|589688773|FG003|Overall Study|Withdrawal by Subject|0|||
163267523|NCT05067933|589688774|FG004|Overall Study|Withdrawal by Subject|0|||
163267524|NCT05067933|589688775|FG005|Overall Study|Withdrawal by Subject|0|||
163267525|NCT05067933|589688770|FG000|Overall Study|Lost to Follow-up|1|||
163267526|NCT05067933|589688771|FG001|Overall Study|Lost to Follow-up|1|||
163267527|NCT05067933|589688772|FG002|Overall Study|Lost to Follow-up|1|||
163267528|NCT05067933|589688773|FG003|Overall Study|Lost to Follow-up|2|||
163267529|NCT05067933|589688774|FG004|Overall Study|Lost to Follow-up|1|||
163267530|NCT05067933|589688775|FG005|Overall Study|Lost to Follow-up|0|||
163267531|NCT05067933|589688770|FG000|Overall Study|Miscellaneous|1|||
163267532|NCT05067933|589688771|FG001|Overall Study|Miscellaneous|0|||
163267533|NCT05067933|589688772|FG002|Overall Study|Miscellaneous|0|||
163267534|NCT05067933|589688773|FG003|Overall Study|Miscellaneous|0|||
163267535|NCT05067933|589688774|FG004|Overall Study|Miscellaneous|0|||
163267536|NCT05067933|589688775|FG005|Overall Study|Miscellaneous|0|||
163267537|NCT05067933|589688770|FG000|Overall Study|Death|0|||
163267538|NCT05067933|589688771|FG001|Overall Study|Death|0|||
163267539|NCT05067933|589688772|FG002|Overall Study|Death|0|||
163267540|NCT05067933|589688773|FG003|Overall Study|Death|1|||
163267541|NCT05067933|589688774|FG004|Overall Study|Death|0|||
163267542|NCT05067933|589688775|FG005|Overall Study|Death|0|||
163267543|NCT02716038|589688782|FG000|Overall Study|Not evaluable|1|||
163267544|NCT02716038|589688782|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
163267545|NCT02716038|589688782|FG000|Overall Study|Unresectable|3|||
163267546|NCT00550550|589688783|FG000|Overall Study|Adverse Event|13|||
163267547|NCT00550550|589688784|FG001|Overall Study|Adverse Event|5|||
163267548|NCT00550550|589688783|FG000|Overall Study|Treatment Failure|0|||
163267549|NCT00550550|589688784|FG001|Overall Study|Treatment Failure|1|||
163267550|NCT00550550|589688783|FG000|Overall Study|Lost to Follow-up|4|||
163267551|NCT00550550|589688784|FG001|Overall Study|Lost to Follow-up|0|||
163267552|NCT00550550|589688783|FG000|Overall Study|Withdrawal by Subject|10|||
163267553|NCT00550550|589688784|FG001|Overall Study|Withdrawal by Subject|8|||
163267554|NCT00550550|589688783|FG000|Overall Study|Protocol Violation|5|||
163267555|NCT00550550|589688784|FG001|Overall Study|Protocol Violation|14|||
163267556|NCT00550550|589688783|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
163267557|NCT00550550|589688784|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
163267558|NCT00550550|589688783|FG000|Overall Study|Randomized But Not Treated|1|||
163267559|NCT00550550|589688784|FG001|Overall Study|Randomized But Not Treated|0|||
163267560|NCT00591864|589688785|FG000|Overall Study|Incomplete Imaging|5|||
163267561|NCT02459093|589688786|FG000|Overall Study|Protocol Violation|6|||
163267562|NCT02459093|589688787|FG001|Overall Study|Protocol Violation|11|||
163267563|NCT02459093|589688786|FG000|Overall Study|Lost to Follow-up|6|||
163267564|NCT02459093|589688787|FG001|Overall Study|Lost to Follow-up|7|||
163267565|NCT00118092|589688788|FG000|Overall Study|Withdrawal by Subject|1|||
163267566|NCT00118092|589688788|FG000|Overall Study|Protocol Violation|1|||
163267567|NCT01103960|589688795|FG000|Overall Study|Adverse Event|2|||
163267568|NCT01103960|589688796|FG001|Overall Study|Adverse Event|1|||
163267569|NCT01103960|589688795|FG000|Overall Study|Withdrawal by Subject|2|||
163267570|NCT01103960|589688796|FG001|Overall Study|Withdrawal by Subject|1|||
163267571|NCT01103960|589688795|FG000|Overall Study|Other|1|||
163267572|NCT01103960|589688796|FG001|Overall Study|Other|0|||
163267573|NCT04921969|589688797|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
163267574|NCT04921969|589688798|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
163267575|NCT04921969|589688799|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
163267576|NCT04921969|589688800|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
163267577|NCT04921969|589688801|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
163267578|NCT04921969|589688802|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
163267579|NCT04921969|589688803|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
163267580|NCT04921969|589688797|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
163267581|NCT04921969|589688798|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163267582|NCT04921969|589688799|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163267583|NCT04921969|589688800|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163267584|NCT04921969|589688801|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163267585|NCT04921969|589688802|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163267586|NCT04921969|589688803|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163267587|NCT04921969|589688797|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
163267588|NCT04921969|589688798|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
163267589|NCT04921969|589688799|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
163267590|NCT04921969|589688800|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163267591|NCT04921969|589688801|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163267592|NCT04921969|589688802|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163267593|NCT04921969|589688803|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163267594|NCT04921969|589688797|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
163267595|NCT04921969|589688798|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
163267596|NCT04921969|589688799|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
163267597|NCT04921969|589688800|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
163267598|NCT04921969|589688801|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
163267599|NCT04921969|589688802|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
163267600|NCT04921969|589688803|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
163267601|NCT04921969|589688797|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
163267602|NCT04921969|589688798|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
163267603|NCT04921969|589688799|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
163267604|NCT04921969|589688800|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
163267605|NCT04921969|589688801|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
163267606|NCT04921969|589688802|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
163267607|NCT04921969|589688803|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
163267608|NCT04921969|589688797|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
163267609|NCT04921969|589688798|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
163267610|NCT04921969|589688799|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
163267611|NCT04921969|589688800|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163267612|NCT04921969|589688801|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163267613|NCT04921969|589688802|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163267614|NCT04921969|589688803|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163267615|NCT04921969|589688797|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
163267616|NCT04921969|589688798|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
163267617|NCT04921969|589688799|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
163267618|NCT04921969|589688800|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
163267619|NCT04921969|589688801|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
163267620|NCT04921969|589688802|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
163267621|NCT04921969|589688803|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
163267622|NCT04921969|589688797|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
163267623|NCT04921969|589688798|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
163267624|NCT04921969|589688799|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
163267625|NCT04921969|589688800|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
163267626|NCT04921969|589688801|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
163267627|NCT04921969|589688802|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
163267628|NCT04921969|589688803|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
163267629|NCT04921969|589688797|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163267630|NCT04921969|589688798|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163267631|NCT04921969|589688799|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163267632|NCT04921969|589688800|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
163267633|NCT04921969|589688801|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163267634|NCT04921969|589688802|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
163267635|NCT04921969|589688803|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
163267636|NCT04921969|589688797|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163267637|NCT04921969|589688798|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163267638|NCT04921969|589688799|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163267639|NCT04921969|589688800|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
163267640|NCT04921969|589688801|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
163267641|NCT04921969|589688802|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
163267642|NCT04921969|589688803|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
163267643|NCT04921969|589688797|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
163267644|NCT04921969|589688798|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
163267645|NCT04921969|589688799|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
163267646|NCT04921969|589688800|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
163267647|NCT04921969|589688801|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
163267648|NCT04921969|589688802|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
163267649|NCT04921969|589688803|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
163267650|NCT04921969|589688797|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163267651|NCT04921969|589688798|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163267652|NCT04921969|589688799|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163267653|NCT04921969|589688800|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
163267654|NCT04921969|589688801|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
163267655|NCT04921969|589688802|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
163267656|NCT04921969|589688803|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
163267657|NCT04921969|589688797|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
163267658|NCT04921969|589688798|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
163267659|NCT04921969|589688799|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
163267660|NCT04921969|589688800|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
163267661|NCT04921969|589688801|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
163267662|NCT04921969|589688802|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
163267663|NCT04921969|589688803|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
163267664|NCT04921969|589688797|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
163267665|NCT04921969|589688798|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
163267666|NCT04921969|589688799|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
163267667|NCT04921969|589688800|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
163267668|NCT04921969|589688801|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
163267669|NCT04921969|589688802|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
163362472|NCT01080300|590036507|FG001|Overall Study|Lack of Efficacy|15|||
163362473|NCT01080300|590036506|FG000|Overall Study|Protocol Violation|7|||
163362474|NCT01080300|590036507|FG001|Overall Study|Protocol Violation|13|||
163362475|NCT01080300|590036506|FG000|Overall Study|Lost to Follow-up|10|||
163267670|NCT04921969|589688803|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
163267671|NCT04921969|589688797|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
163267672|NCT04921969|589688798|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
163267673|NCT04921969|589688799|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
163267674|NCT04921969|589688800|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
163267675|NCT04921969|589688801|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
163267676|NCT04921969|589688802|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
163267677|NCT04921969|589688803|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
163267678|NCT04287868|589688804|FG000|Overall Study|Screening fail|1|||
163267679|NCT04287868|589688805|FG001|Overall Study|Screening fail|0|||
163267680|NCT02791490|589690196|FG000|Overall Study|Lost to Follow-up|1|||
163267681|NCT02791490|589690197|FG001|Overall Study|Lost to Follow-up|2|||
163267682|NCT02791490|589690196|FG000|Overall Study|Withdrawal by Subject|2|||
163267683|NCT02791490|589690197|FG001|Overall Study|Withdrawal by Subject|6|||
163267684|NCT02960763|589690198|FG000|Step 1|Withdrawal by Subject|10|||
163267685|NCT02960763|589690199|FG001|Step 1|Withdrawal by Subject|8|||
163267686|NCT02960763|589690200|FG002|Step 1|Withdrawal by Subject|13|||
163267687|NCT02960763|589690201|FG003|Step 1|Withdrawal by Subject|0|||
163267688|NCT02960763|589690202|FG004|Step 1|Withdrawal by Subject|0|||
163267689|NCT02960763|589690198|FG000|Step 1|Lost to Follow-up|7|||
163267690|NCT02960763|589690199|FG001|Step 1|Lost to Follow-up|9|||
163267691|NCT02960763|589690200|FG002|Step 1|Lost to Follow-up|12|||
163267692|NCT02960763|589690201|FG003|Step 1|Lost to Follow-up|0|||
163267693|NCT02960763|589690202|FG004|Step 1|Lost to Follow-up|0|||
163267694|NCT02960763|589690198|FG000|Step 1|Death|1|||
163267695|NCT02960763|589690199|FG001|Step 1|Death|1|||
163267696|NCT02960763|589690200|FG002|Step 1|Death|1|||
163267697|NCT02960763|589690201|FG003|Step 1|Death|0|||
163267698|NCT02960763|589690202|FG004|Step 1|Death|0|||
163267699|NCT02960763|589690198|FG000|Step 1|Investigator discretion|1|||
163267700|NCT02960763|589690199|FG001|Step 1|Investigator discretion|0|||
163267701|NCT02960763|589690200|FG002|Step 1|Investigator discretion|1|||
163267702|NCT02960763|589690201|FG003|Step 1|Investigator discretion|0|||
163267703|NCT02960763|589690202|FG004|Step 1|Investigator discretion|0|||
163267704|NCT02960763|589690198|FG000|Step 1|Other|0|||
163267705|NCT02960763|589690199|FG001|Step 1|Other|0|||
163267706|NCT02960763|589690200|FG002|Step 1|Other|1|||
163267707|NCT02960763|589690201|FG003|Step 1|Other|0|||
163267708|NCT02960763|589690202|FG004|Step 1|Other|0|||
163267709|NCT02960763|589690198|FG000|Step 2|Withdrawal by Subject|0|||
163267710|NCT02960763|589690199|FG001|Step 2|Withdrawal by Subject|0|||
163267711|NCT02960763|589690200|FG002|Step 2|Withdrawal by Subject|0|||
163267712|NCT02960763|589690201|FG003|Step 2|Withdrawal by Subject|7|||
163267713|NCT02960763|589690202|FG004|Step 2|Withdrawal by Subject|3|||
163267714|NCT02960763|589690198|FG000|Step 2|Lost to Follow-up|0|||
163267715|NCT02960763|589690199|FG001|Step 2|Lost to Follow-up|0|||
163267716|NCT02960763|589690200|FG002|Step 2|Lost to Follow-up|0|||
163267717|NCT02960763|589690201|FG003|Step 2|Lost to Follow-up|4|||
163267718|NCT02960763|589690202|FG004|Step 2|Lost to Follow-up|1|||
163267719|NCT02960763|589690198|FG000|Step 2|Investigator discretion|0|||
163267720|NCT02960763|589690199|FG001|Step 2|Investigator discretion|0|||
163267721|NCT02960763|589690200|FG002|Step 2|Investigator discretion|0|||
163267722|NCT02960763|589690201|FG003|Step 2|Investigator discretion|0|||
163267723|NCT02960763|589690202|FG004|Step 2|Investigator discretion|1|||
163267724|NCT01017120|589690203|FG000|Overall Study|Adverse Event|9|||
163267725|NCT01017120|589690204|FG001|Overall Study|Adverse Event|0|||
163267726|NCT01017120|589690203|FG000|Overall Study|Lost to Follow-up|13|||
163267727|NCT01017120|589690204|FG001|Overall Study|Lost to Follow-up|11|||
163267728|NCT01017120|589690203|FG000|Overall Study|Lack of Efficacy|1|||
163267729|NCT01017120|589690204|FG001|Overall Study|Lack of Efficacy|0|||
163267730|NCT01017120|589690203|FG000|Overall Study|Withdrawal by Subject|39|||
163267731|NCT01017120|589690204|FG001|Overall Study|Withdrawal by Subject|21|||
163267732|NCT01017120|589690203|FG000|Overall Study|Pregnancy|1|||
163267733|NCT01017120|589690204|FG001|Overall Study|Pregnancy|1|||
163267734|NCT01017120|589690203|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
163267735|NCT01017120|589690204|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
163267736|NCT01017120|589690203|FG000|Overall Study|Relocated Out of Town|0|||
163267737|NCT01017120|589690204|FG001|Overall Study|Relocated Out of Town|2|||
163267738|NCT01017120|589690203|FG000|Overall Study|Protocol Violation|1|||
163267739|NCT01017120|589690204|FG001|Overall Study|Protocol Violation|0|||
163267740|NCT01017120|589690203|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
163267741|NCT01017120|589690204|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
163267742|NCT05340751|589690205|FG000|Overall Study|Physician Decision|3|||
163267743|NCT01014975|589690218|FG000|Overall Study|Withdrawal by Subject|1|||
163267744|NCT01014975|589690219|FG001|Overall Study|Withdrawal by Subject|0|||
163267745|NCT01014975|589690220|FG002|Overall Study|Withdrawal by Subject|1|||
163267746|NCT01014975|589690218|FG000|Overall Study|Death|3|||
163267747|NCT01014975|589690219|FG001|Overall Study|Death|3|||
163267748|NCT01014975|589690220|FG002|Overall Study|Death|4|||
163267749|NCT01014975|589690218|FG000|Overall Study|Lost to Follow-up|0|||
163267750|NCT01014975|589690219|FG001|Overall Study|Lost to Follow-up|0|||
163267751|NCT01014975|589690220|FG002|Overall Study|Lost to Follow-up|1|||
163267752|NCT01642602|589690221|FG000|Overall Study|Adverse Event|2|||
163267753|NCT01112514|589690222|FG000|Overall Study|Lost to Follow-up|1|||
163267754|NCT01024959|589690223|FG000|Overall Study|ineligible|12|||
163267755|NCT01024959|589690223|FG000|Overall Study|results not evaluable|12|||
163267756|NCT01024959|589690223|FG000|Overall Study|missing results required for analysis|17|||
163267757|NCT02961881|589690224|FG000|Overall Study|Adverse Event|1|||
163267758|NCT02961881|589690225|FG001|Overall Study|Adverse Event|2|||
163267759|NCT02961881|589690226|FG002|Overall Study|Adverse Event|2|||
163267760|NCT02961881|589690227|FG003|Overall Study|Adverse Event|0|||
163267761|NCT02961881|589690228|FG004|Overall Study|Adverse Event|1|||
163267762|NCT02961881|589690224|FG000|Overall Study|Participant request|0|||
163267763|NCT02961881|589690225|FG001|Overall Study|Participant request|2|||
163267764|NCT02961881|589690226|FG002|Overall Study|Participant request|0|||
163267765|NCT02961881|589690227|FG003|Overall Study|Participant request|0|||
163267766|NCT02961881|589690228|FG004|Overall Study|Participant request|0|||
163267767|NCT02961881|589690224|FG000|Overall Study|Disease progression|1|||
163267768|NCT02961881|589690225|FG001|Overall Study|Disease progression|0|||
163267769|NCT02961881|589690226|FG002|Overall Study|Disease progression|1|||
163267770|NCT02961881|589690227|FG003|Overall Study|Disease progression|0|||
163267771|NCT02961881|589690228|FG004|Overall Study|Disease progression|0|||
163267772|NCT00636792|589690233|FG000|Overall Study|Adverse Event|16|||
163267773|NCT00636792|589690233|FG000|Overall Study|Physician Decision|7|||
163267774|NCT00636792|589690233|FG000|Overall Study|Progressive Disease|4|||
163267775|NCT00636792|589690233|FG000|Overall Study|Withdrawal by Subject|3|||
163267776|NCT00636792|589690233|FG000|Overall Study|Other|3|||
163267777|NCT01928225|589690234|FG000|Overall Study|Pregnancy|1|||
163267778|NCT01928225|589690235|FG001|Overall Study|Pregnancy|0|||
163267779|NCT01928225|589690234|FG000|Overall Study|basaloid cervical cancer|1|||
163267780|NCT01928225|589690235|FG001|Overall Study|basaloid cervical cancer|0|||
163267781|NCT01928225|589690234|FG000|Overall Study|Lost to Follow-up|1|||
163267782|NCT01928225|589690235|FG001|Overall Study|Lost to Follow-up|3|||
163267783|NCT01235975|589690240|FG000|Overall Study|Serious Adverse Event|0|||
163267784|NCT01235975|589690241|FG001|Overall Study|Serious Adverse Event|1|||
163267785|NCT01235975|589690240|FG000|Overall Study|Withdrawal by Subject|8|||
163267786|NCT01235975|589690241|FG001|Overall Study|Withdrawal by Subject|2|||
163267787|NCT01235975|589690240|FG000|Overall Study|Migrated/moved from study area|2|||
163267788|NCT01235975|589690241|FG001|Overall Study|Migrated/moved from study area|1|||
163267789|NCT01235975|589690240|FG000|Overall Study|Lost to Follow-up|7|||
163267790|NCT01235975|589690241|FG001|Overall Study|Lost to Follow-up|3|||
163267791|NCT01381874|589690242|FG000|Overall Study|Lost to Follow-up|1|||
163267792|NCT01381874|589690243|FG001|Overall Study|Lost to Follow-up|1|||
163267793|NCT01381874|589690244|FG002|Overall Study|Lost to Follow-up|0|||
163267794|NCT01381874|589690242|FG000|Overall Study|Withdrawal by Subject|9|||
163267795|NCT01381874|589690243|FG001|Overall Study|Withdrawal by Subject|10|||
163267796|NCT01381874|589690244|FG002|Overall Study|Withdrawal by Subject|9|||
163267797|NCT01381874|589690242|FG000|Overall Study|Other|67|||
163267798|NCT01381874|589690243|FG001|Overall Study|Other|52|||
163267799|NCT01381874|589690244|FG002|Overall Study|Other|67|||
163267800|NCT03119610|589690248|FG000|Overall Study|Adverse Event|1|||
163267801|NCT03119610|589690249|FG001|Overall Study|Adverse Event|0|||
163267802|NCT03119610|589690248|FG000|Overall Study|Lost to Follow-up|0|||
163267803|NCT03119610|589690249|FG001|Overall Study|Lost to Follow-up|1|||
163267804|NCT00114634|589690250|FG000|Overall Study|failure to return forms|3|||
163267805|NCT00684762|589690253|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
163267806|NCT00684762|589690254|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
163267807|NCT03662997|589690262|FG000|Overall Study|Adverse Event|0|||
163267808|NCT03662997|589690263|FG001|Overall Study|Adverse Event|2|||
163267809|NCT03662997|589690264|FG002|Overall Study|Adverse Event|0|||
163267810|NCT03662997|589690265|FG003|Overall Study|Adverse Event|0|||
163267811|NCT00936221|589690272|FG000|Overall Study|Withdrawal by Subject|1|||
163267812|NCT00936221|589690273|FG001|Overall Study|Withdrawal by Subject|1|||
163267813|NCT01844115|589690276|FG000|Overall Study|Adverse Event|4|||
163267814|NCT01844115|589690277|FG001|Overall Study|Adverse Event|22|||
163267815|NCT01844115|589690276|FG000|Overall Study|Lack of Efficacy|1|||
163267816|NCT01844115|589690277|FG001|Overall Study|Lack of Efficacy|4|||
163267817|NCT01844115|589690276|FG000|Overall Study|Protocol Violation|12|||
163267818|NCT01844115|589690277|FG001|Overall Study|Protocol Violation|10|||
163267819|NCT01844115|589690276|FG000|Overall Study|Withdrawal by Subject|11|||
163267820|NCT01844115|589690277|FG001|Overall Study|Withdrawal by Subject|11|||
163267821|NCT01844115|589690276|FG000|Overall Study|Lost to Follow-up|11|||
163267822|NCT01844115|589690277|FG001|Overall Study|Lost to Follow-up|10|||
163267823|NCT01844115|589690276|FG000|Overall Study|Pregnancy|0|||
163267824|NCT01844115|589690277|FG001|Overall Study|Pregnancy|1|||
163267825|NCT00545363|589690278|FG000|Overall Study|Adverse Event|6|||
163267826|NCT00545363|589690279|FG001|Overall Study|Adverse Event|7|||
163267827|NCT00545363|589690278|FG000|Overall Study|Withdrawal by Subject|6|||
163267828|NCT00545363|589690279|FG001|Overall Study|Withdrawal by Subject|5|||
163267829|NCT00545363|589690278|FG000|Overall Study|Non-compliance|3|||
163267830|NCT00545363|589690279|FG001|Overall Study|Non-compliance|1|||
163267831|NCT00545363|589690278|FG000|Overall Study|Did not meet entry criteria|1|||
163267832|NCT00545363|589690279|FG001|Overall Study|Did not meet entry criteria|1|||
163267833|NCT00545363|589690278|FG000|Overall Study|Lost to Follow-up|2|||
163267834|NCT00545363|589690279|FG001|Overall Study|Lost to Follow-up|0|||
163267835|NCT00545363|589690278|FG000|Overall Study|Other|1|||
163267836|NCT00545363|589690279|FG001|Overall Study|Other|1|||
163267837|NCT00210119|589690280|FG000|Overall Study|Protocol Violation|1|||
163267838|NCT00210119|589690280|FG000|Overall Study|Withdrawal by Subject|1|||
163267839|NCT00951509|589690281|FG000|Overall Study|Withdrawal by Subject|2|||
163267840|NCT03125941|589690283|FG000|Overall Study|did not receive intervention|1|||
163267841|NCT03125941|589690284|FG001|Overall Study|did not receive intervention|2|||
163267842|NCT00406419|589690291|FG000|Overall Study|Death|3|||
163267843|NCT00406419|589690292|FG001|Overall Study|Death|1|||
163267844|NCT00406419|589690293|FG002|Overall Study|Death|4|||
163267845|NCT00406419|589690291|FG000|Overall Study|Protocol Violation|6|||
163267846|NCT00406419|589690292|FG001|Overall Study|Protocol Violation|2|||
163267847|NCT00406419|589690293|FG002|Overall Study|Protocol Violation|5|||
163267848|NCT00406419|589690291|FG000|Overall Study|Study Terminated by Sponsor|260|||
163267849|NCT00406419|589690292|FG001|Overall Study|Study Terminated by Sponsor|288|||
163267850|NCT00406419|589690293|FG002|Overall Study|Study Terminated by Sponsor|282|||
163267851|NCT00406419|589690291|FG000|Overall Study|Withdrawal by Subject|17|||
163267852|NCT00406419|589690292|FG001|Overall Study|Withdrawal by Subject|24|||
163267853|NCT00406419|589690293|FG002|Overall Study|Withdrawal by Subject|26|||
163267854|NCT00406419|589690291|FG000|Overall Study|Lack of Efficacy|12|||
163267855|NCT00406419|589690292|FG001|Overall Study|Lack of Efficacy|1|||
163267856|NCT00406419|589690293|FG002|Overall Study|Lack of Efficacy|6|||
163267857|NCT00406419|589690291|FG000|Overall Study|Non-Compliance with Study Drug|5|||
163267858|NCT00406419|589690292|FG001|Overall Study|Non-Compliance with Study Drug|6|||
163267859|NCT00406419|589690293|FG002|Overall Study|Non-Compliance with Study Drug|3|||
163267860|NCT00406419|589690291|FG000|Overall Study|Adverse Event|10|||
163267861|NCT00406419|589690292|FG001|Overall Study|Adverse Event|12|||
163267862|NCT00406419|589690293|FG002|Overall Study|Adverse Event|16|||
163267863|NCT00406419|589690291|FG000|Overall Study|Lost to Follow-up|11|||
163267864|NCT00406419|589690292|FG001|Overall Study|Lost to Follow-up|10|||
163267865|NCT00406419|589690293|FG002|Overall Study|Lost to Follow-up|5|||
163267866|NCT01461993|589690294|FG000|Overall Study|Withdrawal by Subject|60|||
163267867|NCT01461993|589690295|FG001|Overall Study|Withdrawal by Subject|53|||
163267868|NCT01461993|589690296|FG002|Overall Study|Withdrawal by Subject|16|||
163267869|NCT01461993|589690294|FG000|Overall Study|Lost to Follow-up|44|||
163267870|NCT01461993|589690295|FG001|Overall Study|Lost to Follow-up|48|||
163267871|NCT01461993|589690296|FG002|Overall Study|Lost to Follow-up|22|||
163267872|NCT01461993|589690294|FG000|Overall Study|Protocol Violation|10|||
163267873|NCT01461993|589690295|FG001|Overall Study|Protocol Violation|9|||
163267874|NCT01461993|589690296|FG002|Overall Study|Protocol Violation|7|||
163267875|NCT01461993|589690294|FG000|Overall Study|Adverse Event|9|||
163267876|NCT01461993|589690295|FG001|Overall Study|Adverse Event|11|||
163267877|NCT01461993|589690296|FG002|Overall Study|Adverse Event|3|||
163267878|NCT01461993|589690294|FG000|Overall Study|No longer met eligibility criteria|13|||
163267879|NCT01461993|589690295|FG001|Overall Study|No longer met eligibility criteria|18|||
163267880|NCT01461993|589690296|FG002|Overall Study|No longer met eligibility criteria|10|||
163267881|NCT01461993|589690294|FG000|Overall Study|Did not meet entrance criteria|2|||
163267882|NCT01461993|589690295|FG001|Overall Study|Did not meet entrance criteria|3|||
163267883|NCT01461993|589690296|FG002|Overall Study|Did not meet entrance criteria|0|||
163267884|NCT01461993|589690294|FG000|Overall Study|Other|13|||
163267885|NCT01461993|589690295|FG001|Overall Study|Other|15|||
163267886|NCT01461993|589690296|FG002|Overall Study|Other|6|||
163267887|NCT01821898|589690298|FG000|Overall Study|Withdrawal by Subject|2|||
163267888|NCT01821898|589690299|FG001|Overall Study|Withdrawal by Subject|1|||
163267889|NCT01121484|589690301|FG000|Overall Study|Adverse Event|12|||
163267890|NCT01121484|589690302|FG001|Overall Study|Adverse Event|5|||
163267891|NCT01121484|589690301|FG000|Overall Study|Lack of Efficacy|3|||
163267892|NCT01121484|589690302|FG001|Overall Study|Lack of Efficacy|11|||
163267893|NCT01121484|589690301|FG000|Overall Study|Lost to Follow-up|5|||
163267894|NCT01121484|589690302|FG001|Overall Study|Lost to Follow-up|9|||
163267895|NCT01121484|589690301|FG000|Overall Study|Physician Decision|0|||
163267896|NCT01121484|589690302|FG001|Overall Study|Physician Decision|3|||
163267897|NCT01121484|589690301|FG000|Overall Study|Protocol Violation|1|||
163267898|NCT01121484|589690302|FG001|Overall Study|Protocol Violation|0|||
163267899|NCT01121484|589690301|FG000|Overall Study|Withdrawal by Subject|8|||
163267900|NCT01121484|589690302|FG001|Overall Study|Withdrawal by Subject|7|||
163267901|NCT01121484|589690301|FG000|Overall Study|Discontinuation of study by sponsor|0|||
163267902|NCT01121484|589690302|FG001|Overall Study|Discontinuation of study by sponsor|1|||
163267903|NCT01121484|589690301|FG000|Overall Study|Other|3|||
163362476|NCT01080300|590036507|FG001|Overall Study|Lost to Follow-up|6|||
163267904|NCT01121484|589690302|FG001|Overall Study|Other|3|||
163267905|NCT01121484|589690301|FG000|Overall Study|Randomized, not treated|1|||
163267906|NCT01121484|589690302|FG001|Overall Study|Randomized, not treated|4|||
163267907|NCT06390826|589690304|FG000|Overall Study|Never Start Protocol Therapy|1|||
163267908|NCT06390826|589690304|FG000|Overall Study|Adverse Event|1|||
163267909|NCT06390826|589690304|FG000|Overall Study|Disease Progression|8|||
163267910|NCT03679767|589690305|FG000|Overall Study|Death|16|||
163267911|NCT03679767|589690306|FG001|Overall Study|Death|11|||
163267912|NCT03679767|589690307|FG002|Overall Study|Death|17|||
163267913|NCT03679767|589690308|FG003|Overall Study|Death|10|||
163267914|NCT03679767|589690305|FG000|Overall Study|Lost to Follow-up|1|||
163267915|NCT03679767|589690306|FG001|Overall Study|Lost to Follow-up|1|||
163267916|NCT03679767|589690307|FG002|Overall Study|Lost to Follow-up|1|||
163267917|NCT03679767|589690308|FG003|Overall Study|Lost to Follow-up|1|||
163267918|NCT03679767|589690305|FG000|Overall Study|Withdrawal by Subject|0|||
163267919|NCT03679767|589690306|FG001|Overall Study|Withdrawal by Subject|0|||
163267920|NCT03679767|589690307|FG002|Overall Study|Withdrawal by Subject|0|||
163267921|NCT03679767|589690308|FG003|Overall Study|Withdrawal by Subject|1|||
163267922|NCT03679767|589690305|FG000|Overall Study|Follow-up Completed|18|||
163267923|NCT03679767|589690306|FG001|Overall Study|Follow-up Completed|11|||
163267924|NCT03679767|589690307|FG002|Overall Study|Follow-up Completed|11|||
163267925|NCT03679767|589690308|FG003|Overall Study|Follow-up Completed|20|||
163267926|NCT03679767|589690305|FG000|Overall Study|Entered Hospice Care|0|||
163267927|NCT03679767|589690306|FG001|Overall Study|Entered Hospice Care|0|||
163267928|NCT03679767|589690307|FG002|Overall Study|Entered Hospice Care|0|||
163267929|NCT03679767|589690308|FG003|Overall Study|Entered Hospice Care|1|||
163267930|NCT03679767|589690305|FG000|Overall Study|Progressive Disease|0|||
163267931|NCT03679767|589690306|FG001|Overall Study|Progressive Disease|0|||
163267932|NCT03679767|589690307|FG002|Overall Study|Progressive Disease|0|||
163267933|NCT03679767|589690308|FG003|Overall Study|Progressive Disease|1|||
163267934|NCT03915951|589690309|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
163267935|NCT03915951|589690310|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
163267936|NCT03915951|589690309|FG000|Overall Study|Adverse Event|12|||
163267937|NCT03915951|589690310|FG001|Overall Study|Adverse Event|6|||
163267938|NCT03915951|589690309|FG000|Overall Study|Disease progression (radiological)|17|||
163267939|NCT03915951|589690310|FG001|Overall Study|Disease progression (radiological)|15|||
163267940|NCT03915951|589690309|FG000|Overall Study|Disease progression (clinical)|4|||
163267941|NCT03915951|589690310|FG001|Overall Study|Disease progression (clinical)|1|||
163267942|NCT03915951|589690309|FG000|Overall Study|Patient decision|0|||
163267943|NCT03915951|589690310|FG001|Overall Study|Patient decision|4|||
163267944|NCT03915951|589690309|FG000|Overall Study|Investigator decision|0|||
163267945|NCT03915951|589690310|FG001|Overall Study|Investigator decision|1|||
163267946|NCT03915951|589690309|FG000|Overall Study|Consent withdrawn|1|||
163267947|NCT03915951|589690310|FG001|Overall Study|Consent withdrawn|1|||
163267948|NCT03915951|589690309|FG000|Overall Study|Death|0|||
163267949|NCT03915951|589690310|FG001|Overall Study|Death|3|||
163267950|NCT05408468|589690311|FG000|Overall Study|Lost to Follow-up|3|||
163267951|NCT05408468|589690312|FG001|Overall Study|Lost to Follow-up|1|||
163267952|NCT05408468|589690311|FG000|Overall Study|Physician Decision|1|||
163267953|NCT05408468|589690312|FG001|Overall Study|Physician Decision|0|||
163267954|NCT05408468|589690311|FG000|Overall Study|Overwhelmed by clinical situation|3|||
163267955|NCT05408468|589690312|FG001|Overall Study|Overwhelmed by clinical situation|0|||
163267956|NCT05408468|589690311|FG000|Overall Study|Personal illness precluding participation|1|||
163267957|NCT05408468|589690312|FG001|Overall Study|Personal illness precluding participation|0|||
163267958|NCT05408468|589690311|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
163267959|NCT05408468|589690312|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
163267960|NCT02204579|589690317|FG000|Overall Study|Screen failures|2|||
163267961|NCT01396395|589690318|FG000|Overall Study|Withdrawal by Subject|10|||
163267962|NCT01396395|589690319|FG001|Overall Study|Withdrawal by Subject|12|||
163267963|NCT01396395|589690318|FG000|Overall Study|Protocol Violation|3|||
163267964|NCT01396395|589690319|FG001|Overall Study|Protocol Violation|1|||
163267965|NCT01396395|589690318|FG000|Overall Study|Adverse Event|10|||
163267966|NCT01396395|589690319|FG001|Overall Study|Adverse Event|2|||
163267967|NCT01396395|589690318|FG000|Overall Study|Lost to Follow-up|17|||
163267968|NCT01396395|589690319|FG001|Overall Study|Lost to Follow-up|11|||
163267969|NCT01396395|589690318|FG000|Overall Study|Other|0|||
163267970|NCT01396395|589690319|FG001|Overall Study|Other|1|||
163267971|NCT02120664|589690320|FG000|Overall Study|Withdrawal by Subject|0|||
163267972|NCT02120664|589690321|FG001|Overall Study|Withdrawal by Subject|0|||
163267973|NCT02120664|589690322|FG002|Overall Study|Withdrawal by Subject|0|||
163362477|NCT01080300|590036506|FG000|Overall Study|Death|0|||
163267974|NCT02120664|589690323|FG003|Overall Study|Withdrawal by Subject|1|||
163267975|NCT02120664|589690324|FG004|Overall Study|Withdrawal by Subject|0|||
163267976|NCT02460263|589690325|FG000|Transition Period|Withdrawal by Subject|1|||
163267977|NCT02460263|589690325|FG000|Transition Period|Death|1|||
163267978|NCT03916744|589690326|FG000|Overall Study|Withdrawal by Subject|0|||
163267979|NCT03916744|589690327|FG001|Overall Study|Withdrawal by Subject|1|||
163267980|NCT03916744|589690328|FG002|Overall Study|Withdrawal by Subject|2|||
163267981|NCT03176238|589690331|FG000|Overall Study|Unacceptable AEs|15|||
163362478|NCT01080300|590036507|FG001|Overall Study|Death|1|||
163267982|NCT03176238|589690332|FG001|Overall Study|Unacceptable AEs|8|||
163267983|NCT03176238|589690331|FG000|Overall Study|Abnormal lab value(s)|2|||
163267984|NCT03176238|589690332|FG001|Overall Study|Abnormal lab value(s)|0|||
163267985|NCT03176238|589690331|FG000|Overall Study|Inter-current illness|0|||
163267986|NCT03176238|589690332|FG001|Overall Study|Inter-current illness|1|||
163267987|NCT03176238|589690331|FG000|Overall Study|Consent withdrawal|14|||
163267988|NCT03176238|589690332|FG001|Overall Study|Consent withdrawal|2|||
163267989|NCT03176238|589690331|FG000|Overall Study|Lost to Follow-up|3|||
163267990|NCT03176238|589690332|FG001|Overall Study|Lost to Follow-up|0|||
163267991|NCT03176238|589690331|FG000|Overall Study|Administrative problems|1|||
163267992|NCT03176238|589690332|FG001|Overall Study|Administrative problems|0|||
163267993|NCT03176238|589690331|FG000|Overall Study|Death|3|||
163267994|NCT03176238|589690332|FG001|Overall Study|Death|0|||
163267995|NCT03176238|589690331|FG000|Overall Study|Disease Progression|133|||
163267996|NCT03176238|589690332|FG001|Overall Study|Disease Progression|22|||
163267997|NCT03176238|589690331|FG000|Overall Study|Tx duration completed per EAP|0|||
163267998|NCT03176238|589690332|FG001|Overall Study|Tx duration completed per EAP|1|||
163267999|NCT03176238|589690331|FG000|Overall Study|Patient is switched to commercial drug|16|||
163268000|NCT03176238|589690332|FG001|Overall Study|Patient is switched to commercial drug|1|||
163268001|NCT03176238|589690331|FG000|Overall Study|Protocol Violation|1|||
163268002|NCT03176238|589690332|FG001|Overall Study|Protocol Violation|0|||
163268003|NCT03176238|589690331|FG000|Overall Study|Changes in the patient's condition|2|||
163268004|NCT03176238|589690332|FG001|Overall Study|Changes in the patient's condition|1|||
163268005|NCT03176238|589690331|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
163268006|NCT03176238|589690332|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
163268007|NCT01351025|589690335|FG000|Week 0 - 20|Lost to Follow-up|2|||
163268008|NCT01351025|589690336|FG001|Week 0 - 20|Lost to Follow-up|1|||
163268009|NCT01351025|589690335|FG000|Week 0 - 20|Withdrawal by Subject|1|||
163268010|NCT01351025|589690336|FG001|Week 0 - 20|Withdrawal by Subject|0|||
163268011|NCT01351025|589690335|FG000|Week 24 - 44|Lost to Follow-up|0|||
163268012|NCT01351025|589690336|FG001|Week 24 - 44|Lost to Follow-up|2|||
163268013|NCT01351025|589690335|FG000|Week 24 - 44|Site closed|0|||
163268014|NCT01351025|589690336|FG001|Week 24 - 44|Site closed|1|||
163268015|NCT01351025|589690335|FG000|Week 24 - 44|unable to get to clinic|1|||
163268016|NCT01351025|589690336|FG001|Week 24 - 44|unable to get to clinic|1|||
163268017|NCT02089230|589690348|FG000|Overall Study|Death|0|||
163268018|NCT02089230|589690349|FG001|Overall Study|Death|0|||
163268019|NCT02089230|589690350|FG002|Overall Study|Death|2|||
163268020|NCT02089230|589690348|FG000|Overall Study|Seeking Alternative Therapy|0|||
163268021|NCT02089230|589690349|FG001|Overall Study|Seeking Alternative Therapy|0|||
163268022|NCT02089230|589690350|FG002|Overall Study|Seeking Alternative Therapy|4|||
163268023|NCT01242176|589691848|FG000|Washout Period of 7 Days|Adverse Event|0|||
163268024|NCT01242176|589691849|FG001|Washout Period of 7 Days|Adverse Event|2|||
163268025|NCT01242176|589691848|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
163268026|NCT01242176|589691849|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
163268027|NCT00358215|589691850|FG000|Overall Study|Ineligibility determined|4|||
163268028|NCT00358215|589691851|FG001|Overall Study|Ineligibility determined|3|||
163268029|NCT00358215|589691850|FG000|Overall Study|Adverse Event|83|||
163268030|NCT00358215|589691851|FG001|Overall Study|Adverse Event|65|||
163268031|NCT00358215|589691850|FG000|Overall Study|Withdrawal by Subject|111|||
163268032|NCT00358215|589691851|FG001|Overall Study|Withdrawal by Subject|102|||
163268033|NCT00358215|589691850|FG000|Overall Study|Participant request|65|||
163268034|NCT00358215|589691851|FG001|Overall Study|Participant request|64|||
163268035|NCT00358215|589691850|FG000|Overall Study|Physician Decision|47|||
163268036|NCT00358215|589691851|FG001|Overall Study|Physician Decision|39|||
163268037|NCT00358215|589691850|FG000|Overall Study|Lost to Follow-up|16|||
163268038|NCT00358215|589691851|FG001|Overall Study|Lost to Follow-up|22|||
163268039|NCT00358215|589691850|FG000|Overall Study|Death|265|||
163268040|NCT00358215|589691851|FG001|Overall Study|Death|281|||
163268041|NCT00358215|589691850|FG000|Overall Study|Protocol Violation|64|||
163268042|NCT00358215|589691851|FG001|Overall Study|Protocol Violation|59|||
163268043|NCT00358215|589691850|FG000|Overall Study|Pregnancy|1|||
163268044|NCT00358215|589691851|FG001|Overall Study|Pregnancy|0|||
163268045|NCT00358215|589691850|FG000|Overall Study|Other|21|||
163268046|NCT00358215|589691851|FG001|Overall Study|Other|14|||
163268047|NCT00358215|589691850|FG000|Overall Study|Did not receive investigational product|2|||
163268048|NCT00358215|589691851|FG001|Overall Study|Did not receive investigational product|3|||
163268049|NCT00871351|589691852|FG000|Overall Study|Withdrawal by Subject|1|||
163268050|NCT00871351|589691853|FG001|Overall Study|Withdrawal by Subject|0|||
163268051|NCT00871351|589691854|FG002|Overall Study|Withdrawal by Subject|0|||
163268052|NCT00871351|589691852|FG000|Overall Study|Adverse Event|3|||
163268053|NCT00871351|589691853|FG001|Overall Study|Adverse Event|1|||
163268054|NCT00871351|589691854|FG002|Overall Study|Adverse Event|0|||
163268055|NCT00744237|589691855|FG000|Overall Study|Lack of Efficacy|1|||
163268056|NCT00744237|589691856|FG001|Overall Study|Lack of Efficacy|1|||
163268057|NCT00744237|589691857|FG002|Overall Study|Lack of Efficacy|0|||
163268058|NCT00744237|589691855|FG000|Overall Study|Withdrawal by Subject|9|||
163268059|NCT00744237|589691856|FG001|Overall Study|Withdrawal by Subject|5|||
163268060|NCT00744237|589691857|FG002|Overall Study|Withdrawal by Subject|3|||
163268061|NCT00744237|589691855|FG000|Overall Study|Lost to Follow-up|1|||
163268062|NCT00744237|589691856|FG001|Overall Study|Lost to Follow-up|1|||
163268063|NCT00744237|589691857|FG002|Overall Study|Lost to Follow-up|1|||
163268064|NCT00744237|589691855|FG000|Overall Study|Protocol Violation|3|||
163268065|NCT00744237|589691856|FG001|Overall Study|Protocol Violation|4|||
163268066|NCT00744237|589691857|FG002|Overall Study|Protocol Violation|3|||
163268067|NCT00744237|589691855|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
163268068|NCT00744237|589691856|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
163268069|NCT00744237|589691857|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
163268070|NCT00744237|589691855|FG000|Overall Study|Dosing Error|1|||
163268071|NCT00744237|589691856|FG001|Overall Study|Dosing Error|0|||
163268072|NCT00744237|589691857|FG002|Overall Study|Dosing Error|1|||
163268073|NCT00744237|589691855|FG000|Overall Study|Study Drug Error|1|||
163268074|NCT00744237|589691856|FG001|Overall Study|Study Drug Error|0|||
163268075|NCT00744237|589691857|FG002|Overall Study|Study Drug Error|0|||
163268076|NCT00744237|589691855|FG000|Overall Study|Prohibited Concomitant Medication|0|||
163268077|NCT00744237|589691856|FG001|Overall Study|Prohibited Concomitant Medication|0|||
163268078|NCT00744237|589691857|FG002|Overall Study|Prohibited Concomitant Medication|1|||
163268079|NCT00744237|589691855|FG000|Overall Study|Poor Compliance|0|||
163268080|NCT00744237|589691856|FG001|Overall Study|Poor Compliance|2|||
163268081|NCT00744237|589691857|FG002|Overall Study|Poor Compliance|0|||
163268082|NCT00744237|589691855|FG000|Overall Study|Administrative. Site Closed|1|||
163268083|NCT00744237|589691856|FG001|Overall Study|Administrative. Site Closed|1|||
163268084|NCT00744237|589691857|FG002|Overall Study|Administrative. Site Closed|1|||
163268085|NCT00744237|589691855|FG000|Overall Study|Adverse Event|9|||
163268086|NCT00744237|589691856|FG001|Overall Study|Adverse Event|13|||
163268087|NCT00744237|589691857|FG002|Overall Study|Adverse Event|5|||
163268088|NCT02032173|589691860|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
163268089|NCT02291289|589691864|FG000|Induction Treatment|Withdrawal by Subject|0|||
163268090|NCT02291289|589691865|FG001|Induction Treatment|Withdrawal by Subject|0|||
163268091|NCT02291289|589691866|FG002|Induction Treatment|Withdrawal by Subject|0|||
163268092|NCT02291289|589691867|FG003|Induction Treatment|Withdrawal by Subject|24|||
163268093|NCT02291289|589691868|FG004|Induction Treatment|Withdrawal by Subject|0|||
163268094|NCT02291289|589691869|FG005|Induction Treatment|Withdrawal by Subject|0|||
163268095|NCT02291289|589691870|FG006|Induction Treatment|Withdrawal by Subject|0|||
163268096|NCT02291289|589691871|FG007|Induction Treatment|Withdrawal by Subject|0|||
163268097|NCT02291289|589691872|FG008|Induction Treatment|Withdrawal by Subject|0|||
163268098|NCT02291289|589691873|FG009|Induction Treatment|Withdrawal by Subject|18|||
163268099|NCT02291289|589691874|FG010|Induction Treatment|Withdrawal by Subject|0|||
163268100|NCT02291289|589691875|FG011|Induction Treatment|Withdrawal by Subject|0|||
163268101|NCT02291289|589691876|FG012|Induction Treatment|Withdrawal by Subject|0|||
163268102|NCT02291289|589691864|FG000|Induction Treatment|Adverse Event|0|||
163268103|NCT02291289|589691865|FG001|Induction Treatment|Adverse Event|0|||
163268104|NCT02291289|589691866|FG002|Induction Treatment|Adverse Event|0|||
163268105|NCT02291289|589691867|FG003|Induction Treatment|Adverse Event|3|||
163268106|NCT02291289|589691868|FG004|Induction Treatment|Adverse Event|0|||
163268107|NCT02291289|589691869|FG005|Induction Treatment|Adverse Event|0|||
163268108|NCT02291289|589691870|FG006|Induction Treatment|Adverse Event|0|||
163268109|NCT02291289|589691871|FG007|Induction Treatment|Adverse Event|0|||
163268110|NCT02291289|589691872|FG008|Induction Treatment|Adverse Event|0|||
163268111|NCT02291289|589691873|FG009|Induction Treatment|Adverse Event|1|||
163268112|NCT02291289|589691874|FG010|Induction Treatment|Adverse Event|0|||
163268113|NCT02291289|589691875|FG011|Induction Treatment|Adverse Event|0|||
163268114|NCT02291289|589691876|FG012|Induction Treatment|Adverse Event|0|||
163268115|NCT02291289|589691864|FG000|Induction Treatment|Death|25|||
163268116|NCT02291289|589691865|FG001|Induction Treatment|Death|0|||
163268117|NCT02291289|589691866|FG002|Induction Treatment|Death|0|||
163268118|NCT02291289|589691867|FG003|Induction Treatment|Death|111|||
163268119|NCT02291289|589691868|FG004|Induction Treatment|Death|0|||
163268120|NCT02291289|589691869|FG005|Induction Treatment|Death|0|||
163268121|NCT02291289|589691870|FG006|Induction Treatment|Death|1|||
163268122|NCT02291289|589691871|FG007|Induction Treatment|Death|0|||
163268123|NCT02291289|589691872|FG008|Induction Treatment|Death|0|||
163268124|NCT02291289|589691873|FG009|Induction Treatment|Death|82|||
163268125|NCT02291289|589691874|FG010|Induction Treatment|Death|0|||
163268126|NCT02291289|589691875|FG011|Induction Treatment|Death|0|||
163268127|NCT02291289|589691876|FG012|Induction Treatment|Death|0|||
163268128|NCT02291289|589691864|FG000|Induction Treatment|Lost to Follow-up|1|||
163268129|NCT02291289|589691865|FG001|Induction Treatment|Lost to Follow-up|0|||
163268130|NCT02291289|589691866|FG002|Induction Treatment|Lost to Follow-up|0|||
163268131|NCT02291289|589691867|FG003|Induction Treatment|Lost to Follow-up|12|||
163268132|NCT02291289|589691868|FG004|Induction Treatment|Lost to Follow-up|0|||
163268133|NCT02291289|589691869|FG005|Induction Treatment|Lost to Follow-up|0|||
163268134|NCT02291289|589691870|FG006|Induction Treatment|Lost to Follow-up|0|||
163268135|NCT02291289|589691871|FG007|Induction Treatment|Lost to Follow-up|0|||
163268136|NCT02291289|589691872|FG008|Induction Treatment|Lost to Follow-up|0|||
163268137|NCT02291289|589691873|FG009|Induction Treatment|Lost to Follow-up|9|||
163268138|NCT02291289|589691874|FG010|Induction Treatment|Lost to Follow-up|0|||
163268139|NCT02291289|589691875|FG011|Induction Treatment|Lost to Follow-up|0|||
163268140|NCT02291289|589691876|FG012|Induction Treatment|Lost to Follow-up|0|||
163268141|NCT02291289|589691864|FG000|Induction Treatment|Non-Compliance|0|||
163268142|NCT02291289|589691865|FG001|Induction Treatment|Non-Compliance|0|||
163268143|NCT02291289|589691866|FG002|Induction Treatment|Non-Compliance|0|||
163268144|NCT02291289|589691867|FG003|Induction Treatment|Non-Compliance|1|||
163268145|NCT02291289|589691868|FG004|Induction Treatment|Non-Compliance|0|||
163268146|NCT02291289|589691869|FG005|Induction Treatment|Non-Compliance|0|||
163268147|NCT02291289|589691870|FG006|Induction Treatment|Non-Compliance|0|||
163268148|NCT02291289|589691871|FG007|Induction Treatment|Non-Compliance|0|||
163268149|NCT02291289|589691872|FG008|Induction Treatment|Non-Compliance|0|||
163268150|NCT02291289|589691873|FG009|Induction Treatment|Non-Compliance|1|||
163268151|NCT02291289|589691874|FG010|Induction Treatment|Non-Compliance|0|||
163268152|NCT02291289|589691875|FG011|Induction Treatment|Non-Compliance|0|||
163268153|NCT02291289|589691876|FG012|Induction Treatment|Non-Compliance|0|||
163268154|NCT02291289|589691864|FG000|Induction Treatment|Reason Not Specified|0|||
163268155|NCT02291289|589691865|FG001|Induction Treatment|Reason Not Specified|0|||
163268156|NCT02291289|589691866|FG002|Induction Treatment|Reason Not Specified|0|||
163268157|NCT02291289|589691867|FG003|Induction Treatment|Reason Not Specified|4|||
163268158|NCT02291289|589691868|FG004|Induction Treatment|Reason Not Specified|0|||
163268159|NCT02291289|589691869|FG005|Induction Treatment|Reason Not Specified|0|||
163268160|NCT02291289|589691870|FG006|Induction Treatment|Reason Not Specified|0|||
163268161|NCT02291289|589691871|FG007|Induction Treatment|Reason Not Specified|0|||
163268162|NCT02291289|589691872|FG008|Induction Treatment|Reason Not Specified|0|||
163268163|NCT02291289|589691873|FG009|Induction Treatment|Reason Not Specified|7|||
163268164|NCT02291289|589691874|FG010|Induction Treatment|Reason Not Specified|0|||
163268165|NCT02291289|589691875|FG011|Induction Treatment|Reason Not Specified|0|||
163268166|NCT02291289|589691876|FG012|Induction Treatment|Reason Not Specified|0|||
163268167|NCT02291289|589691864|FG000|Induction Treatment|Physician Decision|0|||
163268168|NCT02291289|589691865|FG001|Induction Treatment|Physician Decision|0|||
163268169|NCT02291289|589691866|FG002|Induction Treatment|Physician Decision|0|||
163268170|NCT02291289|589691867|FG003|Induction Treatment|Physician Decision|3|||
163268171|NCT02291289|589691868|FG004|Induction Treatment|Physician Decision|0|||
163268172|NCT02291289|589691869|FG005|Induction Treatment|Physician Decision|0|||
163268173|NCT02291289|589691870|FG006|Induction Treatment|Physician Decision|0|||
163268174|NCT02291289|589691871|FG007|Induction Treatment|Physician Decision|0|||
163268175|NCT02291289|589691872|FG008|Induction Treatment|Physician Decision|0|||
163268176|NCT02291289|589691873|FG009|Induction Treatment|Physician Decision|1|||
163268177|NCT02291289|589691874|FG010|Induction Treatment|Physician Decision|0|||
163268178|NCT02291289|589691875|FG011|Induction Treatment|Physician Decision|0|||
163268179|NCT02291289|589691876|FG012|Induction Treatment|Physician Decision|0|||
163268180|NCT02291289|589691864|FG000|Induction Treatment|Protocol Violation|0|||
163268181|NCT02291289|589691865|FG001|Induction Treatment|Protocol Violation|0|||
163268182|NCT02291289|589691866|FG002|Induction Treatment|Protocol Violation|0|||
163268183|NCT02291289|589691867|FG003|Induction Treatment|Protocol Violation|3|||
163268184|NCT02291289|589691868|FG004|Induction Treatment|Protocol Violation|0|||
163268185|NCT02291289|589691869|FG005|Induction Treatment|Protocol Violation|0|||
163268186|NCT02291289|589691870|FG006|Induction Treatment|Protocol Violation|0|||
163268187|NCT02291289|589691871|FG007|Induction Treatment|Protocol Violation|0|||
163268188|NCT02291289|589691872|FG008|Induction Treatment|Protocol Violation|0|||
163268189|NCT02291289|589691873|FG009|Induction Treatment|Protocol Violation|2|||
163268190|NCT02291289|589691874|FG010|Induction Treatment|Protocol Violation|0|||
163268191|NCT02291289|589691875|FG011|Induction Treatment|Protocol Violation|0|||
163268192|NCT02291289|589691876|FG012|Induction Treatment|Protocol Violation|0|||
163268193|NCT02291289|589691864|FG000|Induction Treatment|Missing|4|||
163268194|NCT02291289|589691865|FG001|Induction Treatment|Missing|0|||
163268195|NCT02291289|589691866|FG002|Induction Treatment|Missing|0|||
163268196|NCT02291289|589691867|FG003|Induction Treatment|Missing|14|||
163268197|NCT02291289|589691868|FG004|Induction Treatment|Missing|0|||
163268198|NCT02291289|589691869|FG005|Induction Treatment|Missing|0|||
163268199|NCT02291289|589691870|FG006|Induction Treatment|Missing|0|||
163268200|NCT02291289|589691871|FG007|Induction Treatment|Missing|0|||
163268201|NCT02291289|589691872|FG008|Induction Treatment|Missing|0|||
163268202|NCT02291289|589691873|FG009|Induction Treatment|Missing|54|||
163268203|NCT02291289|589691874|FG010|Induction Treatment|Missing|0|||
163268204|NCT02291289|589691875|FG011|Induction Treatment|Missing|0|||
163411169|NCT00852995|590212998|FG002|Overall Study|Protocol Violation|0|||
163268205|NCT02291289|589691876|FG012|Induction Treatment|Missing|0|||
163268206|NCT02291289|589691864|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163268207|NCT02291289|589691865|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163268208|NCT02291289|589691866|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163268209|NCT02291289|589691867|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163268210|NCT02291289|589691868|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
163268211|NCT02291289|589691869|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
163268212|NCT02291289|589691870|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163268213|NCT02291289|589691871|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163268214|NCT02291289|589691872|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163268215|NCT02291289|589691873|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163268216|NCT02291289|589691874|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
163268217|NCT02291289|589691875|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
163268218|NCT02291289|589691876|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163268219|NCT02291289|589691864|FG000|Maintenance Treatment Phase|Death|0|||
163268220|NCT02291289|589691865|FG001|Maintenance Treatment Phase|Death|29|||
163268221|NCT02291289|589691866|FG002|Maintenance Treatment Phase|Death|16|||
163268222|NCT02291289|589691867|FG003|Maintenance Treatment Phase|Death|0|||
163268223|NCT02291289|589691868|FG004|Maintenance Treatment Phase|Death|188|||
163268224|NCT02291289|589691869|FG005|Maintenance Treatment Phase|Death|107|||
163268225|NCT02291289|589691870|FG006|Maintenance Treatment Phase|Death|0|||
163268226|NCT02291289|589691871|FG007|Maintenance Treatment Phase|Death|1|||
163268227|NCT02291289|589691872|FG008|Maintenance Treatment Phase|Death|1|||
163268228|NCT02291289|589691873|FG009|Maintenance Treatment Phase|Death|0|||
163268229|NCT02291289|589691874|FG010|Maintenance Treatment Phase|Death|46|||
163268230|NCT02291289|589691875|FG011|Maintenance Treatment Phase|Death|19|||
163268231|NCT02291289|589691876|FG012|Maintenance Treatment Phase|Death|0|||
163268232|NCT02291289|589691864|FG000|Maintenance Treatment Phase|Adverse Event|0|||
163268233|NCT02291289|589691865|FG001|Maintenance Treatment Phase|Adverse Event|0|||
163268234|NCT02291289|589691866|FG002|Maintenance Treatment Phase|Adverse Event|0|||
163268235|NCT02291289|589691867|FG003|Maintenance Treatment Phase|Adverse Event|0|||
163268236|NCT02291289|589691868|FG004|Maintenance Treatment Phase|Adverse Event|1|||
163268237|NCT02291289|589691869|FG005|Maintenance Treatment Phase|Adverse Event|1|||
163268238|NCT02291289|589691870|FG006|Maintenance Treatment Phase|Adverse Event|0|||
163268239|NCT02291289|589691871|FG007|Maintenance Treatment Phase|Adverse Event|0|||
163268240|NCT02291289|589691872|FG008|Maintenance Treatment Phase|Adverse Event|0|||
163268241|NCT02291289|589691873|FG009|Maintenance Treatment Phase|Adverse Event|0|||
163268242|NCT02291289|589691874|FG010|Maintenance Treatment Phase|Adverse Event|0|||
163268243|NCT02291289|589691875|FG011|Maintenance Treatment Phase|Adverse Event|0|||
163268244|NCT02291289|589691876|FG012|Maintenance Treatment Phase|Adverse Event|0|||
163268245|NCT02291289|589691864|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
163268246|NCT02291289|589691865|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
163268247|NCT02291289|589691866|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
163268248|NCT02291289|589691867|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
163268249|NCT02291289|589691868|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
163268250|NCT02291289|589691869|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
163268251|NCT02291289|589691870|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
163268252|NCT02291289|589691871|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
163268253|NCT02291289|589691872|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
163268254|NCT02291289|589691873|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
163268255|NCT02291289|589691874|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
163268256|NCT02291289|589691875|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
163268257|NCT02291289|589691876|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
163268258|NCT02291289|589691864|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
163268259|NCT02291289|589691865|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
163268260|NCT02291289|589691866|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
163268261|NCT02291289|589691867|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
163268262|NCT02291289|589691868|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
163268263|NCT02291289|589691869|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
163268264|NCT02291289|589691870|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
163268265|NCT02291289|589691871|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
163268266|NCT02291289|589691872|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
163268267|NCT02291289|589691873|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
163268268|NCT02291289|589691874|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
163268269|NCT02291289|589691875|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
163268270|NCT02291289|589691876|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
163268271|NCT02291289|589691864|FG000|Maintenance Treatment Phase|Physician Decision|0|||
163268272|NCT02291289|589691865|FG001|Maintenance Treatment Phase|Physician Decision|2|||
163268273|NCT02291289|589691866|FG002|Maintenance Treatment Phase|Physician Decision|0|||
163268274|NCT02291289|589691867|FG003|Maintenance Treatment Phase|Physician Decision|0|||
163268275|NCT02291289|589691868|FG004|Maintenance Treatment Phase|Physician Decision|3|||
163268276|NCT02291289|589691869|FG005|Maintenance Treatment Phase|Physician Decision|0|||
163268277|NCT02291289|589691870|FG006|Maintenance Treatment Phase|Physician Decision|0|||
163268278|NCT02291289|589691871|FG007|Maintenance Treatment Phase|Physician Decision|0|||
163268279|NCT02291289|589691872|FG008|Maintenance Treatment Phase|Physician Decision|0|||
163268280|NCT02291289|589691873|FG009|Maintenance Treatment Phase|Physician Decision|0|||
163268281|NCT02291289|589691874|FG010|Maintenance Treatment Phase|Physician Decision|1|||
163268282|NCT02291289|589691875|FG011|Maintenance Treatment Phase|Physician Decision|3|||
163268283|NCT02291289|589691876|FG012|Maintenance Treatment Phase|Physician Decision|0|||
163268284|NCT02291289|589691864|FG000|Maintenance Treatment Phase|Not Treated|0|||
163268285|NCT02291289|589691865|FG001|Maintenance Treatment Phase|Not Treated|0|||
163268286|NCT02291289|589691866|FG002|Maintenance Treatment Phase|Not Treated|2|||
163268287|NCT02291289|589691867|FG003|Maintenance Treatment Phase|Not Treated|0|||
163268288|NCT02291289|589691868|FG004|Maintenance Treatment Phase|Not Treated|0|||
163268289|NCT02291289|589691869|FG005|Maintenance Treatment Phase|Not Treated|0|||
163268290|NCT02291289|589691870|FG006|Maintenance Treatment Phase|Not Treated|0|||
163268291|NCT02291289|589691871|FG007|Maintenance Treatment Phase|Not Treated|0|||
163268292|NCT02291289|589691872|FG008|Maintenance Treatment Phase|Not Treated|0|||
163268293|NCT02291289|589691873|FG009|Maintenance Treatment Phase|Not Treated|0|||
163268294|NCT02291289|589691874|FG010|Maintenance Treatment Phase|Not Treated|0|||
163268295|NCT02291289|589691875|FG011|Maintenance Treatment Phase|Not Treated|0|||
163268296|NCT02291289|589691876|FG012|Maintenance Treatment Phase|Not Treated|0|||
163268297|NCT02291289|589691864|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163268298|NCT02291289|589691865|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
163268299|NCT02291289|589691866|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163268300|NCT02291289|589691867|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163268301|NCT02291289|589691868|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163268302|NCT02291289|589691869|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163268303|NCT02291289|589691870|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163268304|NCT02291289|589691871|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163268305|NCT02291289|589691872|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163268306|NCT02291289|589691873|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163268307|NCT02291289|589691874|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163268308|NCT02291289|589691875|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163268309|NCT02291289|589691876|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163268310|NCT02291289|589691864|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
163268311|NCT02291289|589691865|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
163268312|NCT02291289|589691866|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
163268313|NCT02291289|589691867|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
163268314|NCT02291289|589691868|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
163268315|NCT02291289|589691869|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
163268316|NCT02291289|589691870|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
163268317|NCT02291289|589691871|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
163268318|NCT02291289|589691872|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
163268319|NCT02291289|589691873|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
163268320|NCT02291289|589691874|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
163268321|NCT02291289|589691875|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
163268322|NCT02291289|589691876|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
163268323|NCT02291289|589691864|FG000|Early Disease Progression|Death|0|||
163268324|NCT02291289|589691865|FG001|Early Disease Progression|Death|0|||
163268325|NCT02291289|589691866|FG002|Early Disease Progression|Death|0|||
163268326|NCT02291289|589691867|FG003|Early Disease Progression|Death|0|||
163268327|NCT02291289|589691868|FG004|Early Disease Progression|Death|0|||
163268328|NCT02291289|589691869|FG005|Early Disease Progression|Death|0|||
163268329|NCT02291289|589691870|FG006|Early Disease Progression|Death|0|||
163268330|NCT02291289|589691871|FG007|Early Disease Progression|Death|0|||
163268331|NCT02291289|589691872|FG008|Early Disease Progression|Death|0|||
163268332|NCT02291289|589691873|FG009|Early Disease Progression|Death|0|||
163268333|NCT02291289|589691874|FG010|Early Disease Progression|Death|0|||
163268334|NCT02291289|589691875|FG011|Early Disease Progression|Death|0|||
163268335|NCT02291289|589691876|FG012|Early Disease Progression|Death|10|||
163268336|NCT02291289|589691864|FG000|Early Disease Progression|Lost to Follow-up|0|||
163268337|NCT02291289|589691865|FG001|Early Disease Progression|Lost to Follow-up|0|||
163268338|NCT02291289|589691866|FG002|Early Disease Progression|Lost to Follow-up|0|||
163268339|NCT02291289|589691867|FG003|Early Disease Progression|Lost to Follow-up|0|||
163268340|NCT02291289|589691868|FG004|Early Disease Progression|Lost to Follow-up|0|||
163268341|NCT02291289|589691869|FG005|Early Disease Progression|Lost to Follow-up|0|||
163268342|NCT02291289|589691870|FG006|Early Disease Progression|Lost to Follow-up|0|||
163268343|NCT02291289|589691871|FG007|Early Disease Progression|Lost to Follow-up|0|||
163268344|NCT02291289|589691872|FG008|Early Disease Progression|Lost to Follow-up|0|||
163268345|NCT02291289|589691873|FG009|Early Disease Progression|Lost to Follow-up|0|||
163268346|NCT02291289|589691874|FG010|Early Disease Progression|Lost to Follow-up|0|||
163268347|NCT02291289|589691875|FG011|Early Disease Progression|Lost to Follow-up|0|||
163268348|NCT02291289|589691876|FG012|Early Disease Progression|Lost to Follow-up|1|||
163268349|NCT01118455|589691877|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
163268350|NCT01118455|589691878|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
163268351|NCT05033743|589691879|FG000|Overall Study|Lost to Follow-up|1|||
163268352|NCT05033743|589691879|FG000|Overall Study|Protocol Violation|2|||
163268353|NCT05033743|589691879|FG000|Overall Study|Withdrawal by Subject|1|||
163268354|NCT00452413|589691892|FG000|Overall Study|Progressive Disease|4|||
163268355|NCT00452413|589691893|FG001|Overall Study|Progressive Disease|11|||
163268356|NCT00452413|589691894|FG002|Overall Study|Progressive Disease|30|||
163268357|NCT00452413|589691892|FG000|Overall Study|Withdrawal by Subject|0|||
163268358|NCT00452413|589691893|FG001|Overall Study|Withdrawal by Subject|1|||
163411170|NCT00852995|590212999|FG003|Overall Study|Protocol Violation|0|||
163268359|NCT00452413|589691894|FG002|Overall Study|Withdrawal by Subject|4|||
163268360|NCT00452413|589691892|FG000|Overall Study|Adverse Event|0|||
163268361|NCT00452413|589691893|FG001|Overall Study|Adverse Event|0|||
163268362|NCT00452413|589691894|FG002|Overall Study|Adverse Event|5|||
163268363|NCT00452413|589691892|FG000|Overall Study|Physician Decision|0|||
163268364|NCT00452413|589691893|FG001|Overall Study|Physician Decision|0|||
163268365|NCT00452413|589691894|FG002|Overall Study|Physician Decision|4|||
163268366|NCT00452413|589691892|FG000|Overall Study|Death due to study disease|0|||
163268367|NCT00452413|589691893|FG001|Overall Study|Death due to study disease|0|||
163268368|NCT00452413|589691894|FG002|Overall Study|Death due to study disease|2|||
163268369|NCT00452413|589691892|FG000|Overall Study|Death due to adverse event (AE)|0|||
163268370|NCT00452413|589691893|FG001|Overall Study|Death due to adverse event (AE)|0|||
163268371|NCT00452413|589691894|FG002|Overall Study|Death due to adverse event (AE)|1|||
163268372|NCT00452413|589691892|FG000|Overall Study|On treatment|0|||
163268373|NCT00452413|589691893|FG001|Overall Study|On treatment|0|||
163268374|NCT00452413|589691894|FG002|Overall Study|On treatment|3|||
163268375|NCT02310126|589691903|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
163268376|NCT02310126|589691904|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
163268377|NCT02310126|589691903|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
163268378|NCT02310126|589691904|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
163268379|NCT01539863|589691907|FG000|Overall Study|Lost to Follow-up|5|||
163268380|NCT01539863|589691908|FG001|Overall Study|Lost to Follow-up|4|||
163268381|NCT02693834|589691912|FG000|Baseline Measurement|Withdrawal by Subject|1|||
163268382|NCT02693834|589691913|FG001|Baseline Measurement|Withdrawal by Subject|0|||
163268383|NCT02693834|589691912|FG000|Baseline Measurement|Adverse Event|1|||
163268384|NCT02693834|589691913|FG001|Baseline Measurement|Adverse Event|0|||
163268385|NCT02693834|589691912|FG000|Week 2 Practice|Adverse Event|0|||
163268386|NCT02693834|589691913|FG001|Week 2 Practice|Adverse Event|1|||
163268387|NCT02111213|589691916|FG000|Overall Study|Withdrawal by Subject|3|||
163362479|NCT01080300|590036506|FG000|Overall Study|Withdrawal by Subject|12|||
163268388|NCT02111213|589691917|FG001|Overall Study|Withdrawal by Subject|2|||
163268389|NCT02111213|589691916|FG000|Overall Study|Lost to Follow-up|3|||
163268390|NCT02111213|589691917|FG001|Overall Study|Lost to Follow-up|4|||
163268391|NCT02226172|589691922|FG000|Overall Study|Participant refused further follow-up|4|||
163268392|NCT02226172|589691922|FG000|Overall Study|Other|5|||
163268393|NCT02226172|589691922|FG000|Overall Study|Death|1|||
163268394|NCT02226172|589691922|FG000|Overall Study|Study terminated by sponsor|1|||
163268395|NCT02226172|589691922|FG000|Overall Study|Adverse Event|6|||
163268396|NCT00758160|589691931|FG000|Overall Study|No Longer Requires Study Medication|4|||
163268397|NCT00758160|589691931|FG000|Overall Study|Administration Problems|3|||
163268398|NCT00758160|589691931|FG000|Overall Study|Adverse Event|15|||
163268399|NCT00758160|589691931|FG000|Overall Study|Lack of Efficacy|10|||
163268400|NCT00758160|589691931|FG000|Overall Study|Lost to Follow-up|14|||
163268401|NCT00758160|589691931|FG000|Overall Study|Protocol Violation|12|||
163268402|NCT00758160|589691931|FG000|Overall Study|Withdrawal by Subject|8|||
163268403|NCT01108510|589691935|FG000|Overall Study|Randomized but Not Treated|5|||
163268404|NCT01108510|589691936|FG001|Overall Study|Randomized but Not Treated|1|||
163268405|NCT01108510|589691935|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
163268406|NCT01108510|589691936|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
163268407|NCT01108510|589691935|FG000|Overall Study|Adverse Event|26|||
163268408|NCT01108510|589691936|FG001|Overall Study|Adverse Event|19|||
163268409|NCT01108510|589691935|FG000|Overall Study|Lost to Follow-up|20|||
163268410|NCT01108510|589691936|FG001|Overall Study|Lost to Follow-up|17|||
163268411|NCT01108510|589691935|FG000|Overall Study|Withdrew Consent|21|||
163268412|NCT01108510|589691936|FG001|Overall Study|Withdrew Consent|15|||
163268413|NCT01108510|589691935|FG000|Overall Study|Investigator's Discretion|12|||
163268414|NCT01108510|589691936|FG001|Overall Study|Investigator's Discretion|10|||
163268415|NCT01108510|589691935|FG000|Overall Study|Participant Noncompliance|5|||
163268416|NCT01108510|589691936|FG001|Overall Study|Participant Noncompliance|7|||
163268417|NCT01108510|589691935|FG000|Overall Study|Lack of Efficacy|3|||
163268418|NCT01108510|589691936|FG001|Overall Study|Lack of Efficacy|0|||
163268419|NCT01108510|589691935|FG000|Overall Study|Pregnancy|0|||
163268420|NCT01108510|589691936|FG001|Overall Study|Pregnancy|3|||
163268421|NCT01108510|589691935|FG000|Overall Study|Death|1|||
163268422|NCT01108510|589691936|FG001|Overall Study|Death|1|||
163268423|NCT00582491|589691937|FG000|Overall Study|Withdrawal by Subject|1|||
163268424|NCT00582491|589691938|FG001|Overall Study|Withdrawal by Subject|0|||
163268425|NCT00779584|589691941|FG000|Overall Study|Protocol Violation|0|||
163268426|NCT00779584|589691942|FG001|Overall Study|Protocol Violation|0|||
163268427|NCT00779584|589691943|FG002|Overall Study|Protocol Violation|0|||
163268428|NCT00779584|589691944|FG003|Overall Study|Protocol Violation|0|||
163268429|NCT00779584|589691945|FG004|Overall Study|Protocol Violation|0|||
163268430|NCT00779584|589691946|FG005|Overall Study|Protocol Violation|1|||
163268431|NCT00779584|589691947|FG006|Overall Study|Protocol Violation|0|||
163268432|NCT00779584|589691948|FG007|Overall Study|Protocol Violation|0|||
163268433|NCT00779584|589691949|FG008|Overall Study|Protocol Violation|0|||
163268434|NCT00779584|589691941|FG000|Overall Study|Withdrawal by Subject|1|||
163268435|NCT00779584|589691942|FG001|Overall Study|Withdrawal by Subject|1|||
163268436|NCT00779584|589691943|FG002|Overall Study|Withdrawal by Subject|2|||
163268437|NCT00779584|589691944|FG003|Overall Study|Withdrawal by Subject|0|||
163268438|NCT00779584|589691945|FG004|Overall Study|Withdrawal by Subject|0|||
163268439|NCT00779584|589691946|FG005|Overall Study|Withdrawal by Subject|2|||
163268440|NCT00779584|589691947|FG006|Overall Study|Withdrawal by Subject|1|||
163268441|NCT00779584|589691948|FG007|Overall Study|Withdrawal by Subject|0|||
163268442|NCT00779584|589691949|FG008|Overall Study|Withdrawal by Subject|0|||
163268443|NCT00779584|589691941|FG000|Overall Study|Lost to Follow-up|0|||
163268444|NCT00779584|589691942|FG001|Overall Study|Lost to Follow-up|0|||
163268445|NCT00779584|589691943|FG002|Overall Study|Lost to Follow-up|0|||
163268446|NCT00779584|589691944|FG003|Overall Study|Lost to Follow-up|0|||
163268447|NCT00779584|589691945|FG004|Overall Study|Lost to Follow-up|1|||
163268448|NCT00779584|589691946|FG005|Overall Study|Lost to Follow-up|0|||
163268449|NCT00779584|589691947|FG006|Overall Study|Lost to Follow-up|0|||
163268450|NCT00779584|589691948|FG007|Overall Study|Lost to Follow-up|0|||
163268451|NCT00779584|589691949|FG008|Overall Study|Lost to Follow-up|0|||
163268452|NCT00779584|589691941|FG000|Overall Study|Progression of Disease|0|||
163268453|NCT00779584|589691942|FG001|Overall Study|Progression of Disease|1|||
163268454|NCT00779584|589691943|FG002|Overall Study|Progression of Disease|2|||
163268455|NCT00779584|589691944|FG003|Overall Study|Progression of Disease|6|||
163268456|NCT00779584|589691945|FG004|Overall Study|Progression of Disease|5|||
163268457|NCT00779584|589691946|FG005|Overall Study|Progression of Disease|1|||
163268458|NCT00779584|589691947|FG006|Overall Study|Progression of Disease|4|||
163268459|NCT00779584|589691948|FG007|Overall Study|Progression of Disease|2|||
163268460|NCT00779584|589691949|FG008|Overall Study|Progression of Disease|1|||
163268461|NCT00779584|589691941|FG000|Overall Study|Adverse Event|1|||
163268462|NCT00779584|589691942|FG001|Overall Study|Adverse Event|0|||
163268463|NCT00779584|589691943|FG002|Overall Study|Adverse Event|2|||
163268464|NCT00779584|589691944|FG003|Overall Study|Adverse Event|0|||
163268465|NCT00779584|589691945|FG004|Overall Study|Adverse Event|0|||
163268466|NCT00779584|589691946|FG005|Overall Study|Adverse Event|0|||
163268467|NCT00779584|589691947|FG006|Overall Study|Adverse Event|2|||
163268468|NCT00779584|589691948|FG007|Overall Study|Adverse Event|1|||
163268469|NCT00779584|589691949|FG008|Overall Study|Adverse Event|1|||
163268470|NCT00779584|589691941|FG000|Overall Study|Symptomatic Deterioration|1|||
163268471|NCT00779584|589691942|FG001|Overall Study|Symptomatic Deterioration|1|||
163268472|NCT00779584|589691943|FG002|Overall Study|Symptomatic Deterioration|1|||
163268473|NCT00779584|589691944|FG003|Overall Study|Symptomatic Deterioration|0|||
163268474|NCT00779584|589691945|FG004|Overall Study|Symptomatic Deterioration|0|||
163268475|NCT00779584|589691946|FG005|Overall Study|Symptomatic Deterioration|1|||
163268476|NCT00779584|589691947|FG006|Overall Study|Symptomatic Deterioration|1|||
163268477|NCT00779584|589691948|FG007|Overall Study|Symptomatic Deterioration|0|||
163268478|NCT00779584|589691949|FG008|Overall Study|Symptomatic Deterioration|0|||
163268479|NCT00779584|589691941|FG000|Overall Study|Ongoing in Study|0|||
163268480|NCT00779584|589691942|FG001|Overall Study|Ongoing in Study|0|||
163268481|NCT00779584|589691943|FG002|Overall Study|Ongoing in Study|0|||
163268482|NCT00779584|589691944|FG003|Overall Study|Ongoing in Study|0|||
163268483|NCT00779584|589691945|FG004|Overall Study|Ongoing in Study|1|||
163268484|NCT00779584|589691946|FG005|Overall Study|Ongoing in Study|1|||
163268485|NCT00779584|589691947|FG006|Overall Study|Ongoing in Study|0|||
163268486|NCT00779584|589691948|FG007|Overall Study|Ongoing in Study|0|||
163268487|NCT00779584|589691949|FG008|Overall Study|Ongoing in Study|0|||
163268488|NCT01115491|589691952|FG000|Overall Study|Death|22|||
163268489|NCT01115491|589691952|FG000|Overall Study|Adverse Event|3|||
163268490|NCT01115491|589691952|FG000|Overall Study|Lost to Follow-up|3|||
163268491|NCT01115491|589691952|FG000|Overall Study|Withdrawal by Subject|1|||
163268492|NCT01115491|589691952|FG000|Overall Study|Physician Decision|1|||
163268493|NCT01868074|589691955|FG000|Overall Study|Lost to Follow-up|3|||
163268494|NCT01868074|589691956|FG001|Overall Study|Lost to Follow-up|2|||
163268495|NCT01868074|589691955|FG000|Overall Study|Withdrawal by Subject|4|||
163268496|NCT01868074|589691956|FG001|Overall Study|Withdrawal by Subject|2|||
163268497|NCT03306043|589691957|FG000|Overall Study|Adverse Event|1|||
163268498|NCT03306043|589691957|FG000|Overall Study|Lost to Follow-up|1|||
163268499|NCT03306043|589691957|FG000|Overall Study|Withdrawal by Subject|2|||
163268500|NCT01544491|589691958|FG000|Overall Study|Withdrawal by Subject|3|||
163268501|NCT01544491|589691959|FG001|Overall Study|Withdrawal by Subject|2|||
163268502|NCT01544491|589691958|FG000|Overall Study|Lost to Follow-up|0|||
163268503|NCT01544491|589691959|FG001|Overall Study|Lost to Follow-up|1|||
163268504|NCT01544491|589691958|FG000|Overall Study|administrative problems|2|||
163268505|NCT01544491|589691959|FG001|Overall Study|administrative problems|0|||
163268506|NCT02494206|589691960|FG000|Overall Study|Adverse Event|1|||
163268507|NCT02494206|589691960|FG000|Overall Study|Disease Progression|1|||
163268508|NCT01013792|589691961|FG000|Overall Study|Study suspended|2|||
163268509|NCT01013792|589691962|FG001|Overall Study|Study suspended|1|||
163268510|NCT01013792|589691961|FG000|Overall Study|Adverse Event|0|||
163268511|NCT01013792|589691962|FG001|Overall Study|Adverse Event|3|||
163268512|NCT01013792|589691961|FG000|Overall Study|Lost to Follow-up|0|||
163268513|NCT01013792|589691962|FG001|Overall Study|Lost to Follow-up|1|||
163268514|NCT01234649|589691963|FG000|Overall Study|Withdrawal by Subject|32|||
163268515|NCT01234649|589691964|FG001|Overall Study|Withdrawal by Subject|26|||
163268516|NCT01234649|589691963|FG000|Overall Study|Pregnancy|6|||
163268517|NCT01234649|589691964|FG001|Overall Study|Pregnancy|6|||
163268518|NCT01234649|589691963|FG000|Overall Study|intolerant to side effects|4|||
163268519|NCT01234649|589691964|FG001|Overall Study|intolerant to side effects|3|||
163268520|NCT01234649|589691963|FG000|Overall Study|Allergic reaction|1|||
163268521|NCT01234649|589691964|FG001|Overall Study|Allergic reaction|0|||
163268522|NCT01234649|589691963|FG000|Overall Study|Lack of Efficacy|0|||
163268523|NCT01234649|589691964|FG001|Overall Study|Lack of Efficacy|3|||
163268524|NCT00680056|589691968|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
163268525|NCT00680056|589691969|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
163268526|NCT00680056|589691968|FG000|Second Intervention|Protocol Violation|3|||
163268527|NCT00680056|589691969|FG001|Second Intervention|Protocol Violation|1|||
163268528|NCT03688711|589691970|FG000|Overall Study|Withdrawal by Subject|0|||
163268529|NCT03688711|589691971|FG001|Overall Study|Withdrawal by Subject|1|||
163268530|NCT05229653|589691972|FG000|Overall Study|Lost to Follow-up|1|||
163268531|NCT05229653|589691973|FG001|Overall Study|Lost to Follow-up|0|||
163268532|NCT01370005|589691974|FG000|Overall Study|Not treated|1|||
163268533|NCT01370005|589691975|FG001|Overall Study|Not treated|0|||
163268534|NCT01370005|589691976|FG002|Overall Study|Not treated|0|||
163268535|NCT01370005|589691974|FG000|Overall Study|Adverse Event|5|||
163268536|NCT01370005|589691975|FG001|Overall Study|Adverse Event|5|||
163268537|NCT01370005|589691976|FG002|Overall Study|Adverse Event|6|||
163268538|NCT01370005|589691974|FG000|Overall Study|Lack of Efficacy|1|||
163268539|NCT01370005|589691975|FG001|Overall Study|Lack of Efficacy|0|||
163268540|NCT01370005|589691976|FG002|Overall Study|Lack of Efficacy|0|||
163268541|NCT01370005|589691974|FG000|Overall Study|Non compliant with protocol|0|||
163268542|NCT01370005|589691975|FG001|Overall Study|Non compliant with protocol|1|||
163268543|NCT01370005|589691976|FG002|Overall Study|Non compliant with protocol|2|||
163268544|NCT01370005|589691974|FG000|Overall Study|Lost to Follow-up|1|||
163268545|NCT01370005|589691975|FG001|Overall Study|Lost to Follow-up|1|||
163268546|NCT01370005|589691976|FG002|Overall Study|Lost to Follow-up|1|||
163268547|NCT01370005|589691974|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
163268548|NCT01370005|589691975|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
163268549|NCT01370005|589691976|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
163268550|NCT01370005|589691974|FG000|Overall Study|Other reason not defined above|3|||
163268551|NCT01370005|589691975|FG001|Overall Study|Other reason not defined above|0|||
163268552|NCT01370005|589691976|FG002|Overall Study|Other reason not defined above|2|||
163268553|NCT03691948|589691977|FG000|Overall Study|Lost to Follow-up|1|||
163268554|NCT03691948|589691978|FG001|Overall Study|Lost to Follow-up|3|||
163268555|NCT02009696|589691979|FG000|Overall Study|Withdrawal by Subject|2|||
163268556|NCT01018563|589691981|FG000|Overall Study|Termination of the study by Sponsor|2|||
163268557|NCT01018563|589691982|FG001|Overall Study|Termination of the study by Sponsor|1|||
163268558|NCT02344537|589691983|FG000|Overall Study|Protocol Violation|1|||
163268559|NCT02344537|589691984|FG001|Overall Study|Protocol Violation|1|||
163268560|NCT02344537|589691983|FG000|Overall Study|Subject started another treatment after wk 6|1|||
163268561|NCT02344537|589691984|FG001|Overall Study|Subject started another treatment after wk 6|0|||
163268562|NCT02344537|589691983|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
163268563|NCT02344537|589691984|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
163268564|NCT05490329|589691987|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
163268565|NCT05490329|589691988|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
163268566|NCT05490329|589691987|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
163268567|NCT05490329|589691988|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
163268568|NCT05490329|589691987|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
163268569|NCT05490329|589691988|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
163268570|NCT04524598|589691989|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
163268571|NCT04524598|589691990|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
163268572|NCT04524598|589691991|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
163268573|NCT04524598|589691992|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
163268574|NCT04524598|589691993|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
163268575|NCT04524598|589691989|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
163268576|NCT04524598|589691990|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
163268577|NCT04524598|589691991|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
163268578|NCT04524598|589691992|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
163268579|NCT04524598|589691993|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
163268580|NCT04524598|589691989|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
163268581|NCT04524598|589691990|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
163268582|NCT04524598|589691991|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
163268583|NCT04524598|589691992|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
163268584|NCT04524598|589691993|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
163268585|NCT04524598|589691989|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
163268586|NCT04524598|589691990|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
163268587|NCT04524598|589691991|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
163268588|NCT04524598|589691992|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
163268589|NCT04524598|589691993|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
163268590|NCT04524598|589691989|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
163268591|NCT04524598|589691990|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
163268592|NCT04524598|589691991|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
163268593|NCT04524598|589691992|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
163268594|NCT04524598|589691993|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
163268595|NCT04524598|589691989|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
163268596|NCT04524598|589691990|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
163268597|NCT04524598|589691991|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
163268598|NCT04524598|589691992|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
163268599|NCT04524598|589691993|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
163268600|NCT04524598|589691989|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
163268601|NCT04524598|589691990|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
163268602|NCT04524598|589691991|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
163268603|NCT04524598|589691992|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
163268604|NCT04524598|589691993|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
163268605|NCT02306122|589691994|FG000|Initial Physician Randomization|Physician Decision|0|||
163268606|NCT02306122|589691995|FG001|Initial Physician Randomization|Physician Decision|0|||
163268607|NCT02306122|589691996|FG002|Initial Physician Randomization|Physician Decision|0|||
163268608|NCT02306122|589691997|FG003|Initial Physician Randomization|Physician Decision|0|||
163268609|NCT02306122|589691998|FG004|Initial Physician Randomization|Physician Decision|0|||
163268610|NCT02306122|589691999|FG005|Initial Physician Randomization|Physician Decision|0|||
163268611|NCT02306122|589692000|FG006|Initial Physician Randomization|Physician Decision|0|||
163268612|NCT02306122|589692001|FG007|Initial Physician Randomization|Physician Decision|0|||
163268613|NCT02306122|589692002|FG008|Initial Physician Randomization|Physician Decision|1|||
163268614|NCT02306122|589692003|FG009|Initial Physician Randomization|Physician Decision|0|||
163268615|NCT02306122|589692004|FG010|Initial Physician Randomization|Physician Decision|0|||
163268616|NCT00180713|589692005|FG000|Overall Study|Withdrawal by Subject|2|||
163268617|NCT00180713|589692006|FG001|Overall Study|Withdrawal by Subject|0|||
163268618|NCT00180713|589692005|FG000|Overall Study|Adverse Event|3|||
163268619|NCT00180713|589692006|FG001|Overall Study|Adverse Event|3|||
163268620|NCT05295732|589692007|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
163268621|NCT05295732|589692008|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
163268622|NCT05295732|589692009|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
163268623|NCT05295732|589692010|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
163268624|NCT05295732|589692011|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
163268625|NCT05295732|589692007|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
163268626|NCT05295732|589692008|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
163268627|NCT05295732|589692009|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
163268628|NCT05295732|589692010|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
163268629|NCT05295732|589692011|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
163268630|NCT02322814|589692012|FG000|Overall Study|Death|7|||
163268631|NCT02322814|589692013|FG001|Overall Study|Death|29|||
163268632|NCT02322814|589692014|FG002|Overall Study|Death|32|||
163268633|NCT02322814|589692015|FG003|Overall Study|Death|23|||
163268634|NCT02322814|589692016|FG004|Overall Study|Death|14|||
163268635|NCT02322814|589692012|FG000|Overall Study|Lost to Follow-up|1|||
163268636|NCT02322814|589692013|FG001|Overall Study|Lost to Follow-up|3|||
163268637|NCT02322814|589692014|FG002|Overall Study|Lost to Follow-up|3|||
163268638|NCT02322814|589692015|FG003|Overall Study|Lost to Follow-up|1|||
163268639|NCT02322814|589692016|FG004|Overall Study|Lost to Follow-up|0|||
163268640|NCT02322814|589692012|FG000|Overall Study|Various Reasons|2|||
163268641|NCT02322814|589692013|FG001|Overall Study|Various Reasons|0|||
163268642|NCT02322814|589692014|FG002|Overall Study|Various Reasons|1|||
163268643|NCT02322814|589692015|FG003|Overall Study|Various Reasons|1|||
163268644|NCT02322814|589692016|FG004|Overall Study|Various Reasons|0|||
163268645|NCT02322814|589692012|FG000|Overall Study|Progressive Disease|0|||
163268646|NCT02322814|589692013|FG001|Overall Study|Progressive Disease|0|||
163268647|NCT02322814|589692014|FG002|Overall Study|Progressive Disease|0|||
163268648|NCT02322814|589692015|FG003|Overall Study|Progressive Disease|1|||
163268649|NCT02322814|589692016|FG004|Overall Study|Progressive Disease|1|||
163268650|NCT02322814|589692012|FG000|Overall Study|Protocol Violation|1|||
163268651|NCT02322814|589692013|FG001|Overall Study|Protocol Violation|0|||
163268652|NCT02322814|589692014|FG002|Overall Study|Protocol Violation|0|||
163268653|NCT02322814|589692015|FG003|Overall Study|Protocol Violation|0|||
163268654|NCT02322814|589692016|FG004|Overall Study|Protocol Violation|0|||
163362480|NCT01080300|590036507|FG001|Overall Study|Withdrawal by Subject|28|||
163362481|NCT01080300|590036506|FG000|Overall Study|Reasons not specified|4|||
163268655|NCT02322814|589692012|FG000|Overall Study|Study Terminated by Sponsor|0|||
163268656|NCT02322814|589692013|FG001|Overall Study|Study Terminated by Sponsor|7|||
163268657|NCT02322814|589692014|FG002|Overall Study|Study Terminated by Sponsor|9|||
163268658|NCT02322814|589692015|FG003|Overall Study|Study Terminated by Sponsor|5|||
163268659|NCT02322814|589692016|FG004|Overall Study|Study Terminated by Sponsor|13|||
163268660|NCT02322814|589692012|FG000|Overall Study|Withdrawal by Subject|5|||
163268661|NCT02322814|589692013|FG001|Overall Study|Withdrawal by Subject|4|||
163268662|NCT02322814|589692014|FG002|Overall Study|Withdrawal by Subject|2|||
163268663|NCT02322814|589692015|FG003|Overall Study|Withdrawal by Subject|1|||
163268664|NCT02322814|589692016|FG004|Overall Study|Withdrawal by Subject|3|||
163268665|NCT01965938|589692017|FG000|Overall Study|Withdrawal by Subject|1|||
163268666|NCT01965938|589692018|FG001|Overall Study|Withdrawal by Subject|0|||
163268667|NCT01164228|589692019|FG000|Overall Study|Progression|24|||
163268668|NCT01164228|589692020|FG001|Overall Study|Progression|25|||
163268669|NCT01164228|589692019|FG000|Overall Study|Adverse Event|13|||
163268670|NCT01164228|589692020|FG001|Overall Study|Adverse Event|7|||
163268671|NCT01164228|589692019|FG000|Overall Study|Death|1|||
163268672|NCT01164228|589692020|FG001|Overall Study|Death|1|||
163268673|NCT01164228|589692019|FG000|Overall Study|Withdrawal by Subject|2|||
163268674|NCT01164228|589692020|FG001|Overall Study|Withdrawal by Subject|0|||
163268675|NCT01164228|589692019|FG000|Overall Study|Physician Decision|1|||
163268676|NCT01164228|589692020|FG001|Overall Study|Physician Decision|2|||
163268677|NCT01164228|589692019|FG000|Overall Study|Symptomatic deterioration|1|||
163268678|NCT01164228|589692020|FG001|Overall Study|Symptomatic deterioration|0|||
163268679|NCT01164228|589692019|FG000|Overall Study|Never started treatment|1|||
163268680|NCT01164228|589692020|FG001|Overall Study|Never started treatment|3|||
163268681|NCT01164228|589692019|FG000|Overall Study|Ineligible|1|||
163268682|NCT01164228|589692020|FG001|Overall Study|Ineligible|0|||
163268683|NCT03311230|589692026|FG000|Overall Study|Withdrawal by Subject|1|||
163268684|NCT03311230|589692027|FG001|Overall Study|Withdrawal by Subject|4|||
163268685|NCT03311230|589692028|FG002|Overall Study|Withdrawal by Subject|2|||
163268686|NCT03311230|589692029|FG003|Overall Study|Withdrawal by Subject|7|||
163268687|NCT03311230|589692026|FG000|Overall Study|Unrelated injury|0|||
163268688|NCT03311230|589692027|FG001|Overall Study|Unrelated injury|1|||
163268689|NCT03311230|589692028|FG002|Overall Study|Unrelated injury|0|||
163268690|NCT03311230|589692029|FG003|Overall Study|Unrelated injury|0|||
163268691|NCT02998021|589692030|FG000|Overall Study|Withdrawal by Subject|3|||
163268692|NCT02998021|589692031|FG001|Overall Study|Withdrawal by Subject|1|||
163268693|NCT02998021|589692030|FG000|Overall Study|unsafe home|0|||
163268694|NCT02998021|589692031|FG001|Overall Study|unsafe home|1|||
163268695|NCT05200936|589692032|FG000|Overall Study|Withdrawal by Subject|2|||
163268696|NCT05200936|589692033|FG001|Overall Study|Withdrawal by Subject|2|||
163268697|NCT05200936|589692032|FG000|Overall Study|Lost to Follow-up|2|||
163268698|NCT05200936|589692033|FG001|Overall Study|Lost to Follow-up|0|||
163268699|NCT05200936|589692032|FG000|Overall Study|Pregnancy|0|||
163268700|NCT05200936|589692033|FG001|Overall Study|Pregnancy|1|||
163268701|NCT00127413|589692034|FG000|Overall Study|Lost to Follow-up|6|||
163268702|NCT00127413|589692035|FG001|Overall Study|Lost to Follow-up|4|||
163268703|NCT00127413|589692036|FG002|Overall Study|Lost to Follow-up|8|||
163268704|NCT00127413|589692037|FG003|Overall Study|Lost to Follow-up|2|||
163268705|NCT03713021|589692038|FG000|Overall Study|Did not have CT sim scan available|6|||
163268706|NCT03713021|589692038|FG000|Overall Study|Not eligible|4|||
163268707|NCT03713021|589692038|FG000|Overall Study|Issues with TraceIT markers|5|||
163268708|NCT01338012|589692039|FG000|Overall Study|Death|4|||
163268709|NCT01338012|589692039|FG000|Overall Study|Study terminated|4|||
163268710|NCT00603265|589693940|FG000|Overall Study|Adverse Event|2|||
163268711|NCT00603265|589693941|FG001|Overall Study|Adverse Event|11|||
163268712|NCT00603265|589693942|FG002|Overall Study|Adverse Event|1|||
163268713|NCT00603265|589693940|FG000|Overall Study|Withdrawal by Subject|1|||
163268714|NCT00603265|589693941|FG001|Overall Study|Withdrawal by Subject|2|||
163268715|NCT00603265|589693942|FG002|Overall Study|Withdrawal by Subject|1|||
163268716|NCT00603265|589693940|FG000|Overall Study|Lack of Efficacy|3|||
163268717|NCT00603265|589693941|FG001|Overall Study|Lack of Efficacy|0|||
163268718|NCT00603265|589693942|FG002|Overall Study|Lack of Efficacy|3|||
163268719|NCT00603265|589693940|FG000|Overall Study|Lost to Follow-up|0|||
163268720|NCT00603265|589693941|FG001|Overall Study|Lost to Follow-up|1|||
163268721|NCT00603265|589693942|FG002|Overall Study|Lost to Follow-up|0|||
163268722|NCT00603265|589693940|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
163268723|NCT00603265|589693941|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
163268724|NCT00603265|589693942|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
163268725|NCT00603265|589693940|FG000|Overall Study|Participant Left Country, No Responses|0|||
163268726|NCT00603265|589693941|FG001|Overall Study|Participant Left Country, No Responses|1|||
163268727|NCT00603265|589693942|FG002|Overall Study|Participant Left Country, No Responses|0|||
163268728|NCT00603265|589693940|FG000|Overall Study|Protocol Violation|1|||
163268729|NCT00603265|589693941|FG001|Overall Study|Protocol Violation|0|||
163268730|NCT00603265|589693942|FG002|Overall Study|Protocol Violation|0|||
163268731|NCT04399551|589693943|FG000|Overall Study|Adverse Event|15|||
163268732|NCT04399551|589693943|FG000|Overall Study|Withdrawal by Subject|6|||
163268733|NCT04399551|589693943|FG000|Overall Study|Physician Decision|3|||
163268734|NCT04399551|589693943|FG000|Overall Study|Lost to Follow-up|2|||
163268735|NCT04399551|589693943|FG000|Overall Study|Protocol Deviation|2|||
163268736|NCT01912781|589693950|FG000|Overall Study|Withdrawal by Subject|2|||
163268737|NCT01912781|589693951|FG001|Overall Study|Withdrawal by Subject|0|||
163268738|NCT03377790|589693954|FG000|Overall Study|Withdrawal by Subject|1|||
163268739|NCT03377790|589693955|FG001|Overall Study|Withdrawal by Subject|0|||
163268740|NCT03377790|589693954|FG000|Overall Study|Adverse Event|1|||
163268741|NCT03377790|589693955|FG001|Overall Study|Adverse Event|0|||
163268742|NCT03377790|589693954|FG000|Overall Study|Lost to Follow-up|0|||
163268743|NCT03377790|589693955|FG001|Overall Study|Lost to Follow-up|2|||
163268744|NCT03377790|589693954|FG000|Overall Study|Randomized but not treated|1|||
163268745|NCT03377790|589693955|FG001|Overall Study|Randomized but not treated|0|||
163268746|NCT03377790|589693954|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
163268747|NCT03377790|589693955|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
163268748|NCT01533714|589693956|FG000|Overall Study|Adverse Event|0|||
163268749|NCT01533714|589693957|FG001|Overall Study|Adverse Event|1|||
163268750|NCT01533714|589693958|FG002|Overall Study|Adverse Event|2|||
163268751|NCT01533714|589693959|FG003|Overall Study|Adverse Event|2|||
163268752|NCT01533714|589693960|FG004|Overall Study|Adverse Event|2|||
163268753|NCT01533714|589693961|FG005|Overall Study|Adverse Event|1|||
163268754|NCT01533714|589693956|FG000|Overall Study|Lack of Efficacy|0|||
163268755|NCT01533714|589693957|FG001|Overall Study|Lack of Efficacy|0|||
163268756|NCT01533714|589693958|FG002|Overall Study|Lack of Efficacy|0|||
163268757|NCT01533714|589693959|FG003|Overall Study|Lack of Efficacy|0|||
163268758|NCT01533714|589693960|FG004|Overall Study|Lack of Efficacy|0|||
163268759|NCT01533714|589693961|FG005|Overall Study|Lack of Efficacy|1|||
163268760|NCT01533714|589693956|FG000|Overall Study|Withdrawal by Subject|0|||
163268761|NCT01533714|589693957|FG001|Overall Study|Withdrawal by Subject|1|||
163268762|NCT01533714|589693958|FG002|Overall Study|Withdrawal by Subject|0|||
163268763|NCT01533714|589693959|FG003|Overall Study|Withdrawal by Subject|1|||
163268764|NCT01533714|589693960|FG004|Overall Study|Withdrawal by Subject|1|||
163268765|NCT01533714|589693961|FG005|Overall Study|Withdrawal by Subject|0|||
163268766|NCT01533714|589693956|FG000|Overall Study|Exclusion criteria|0|||
163268767|NCT01533714|589693957|FG001|Overall Study|Exclusion criteria|1|||
163268768|NCT01533714|589693958|FG002|Overall Study|Exclusion criteria|0|||
163268769|NCT01533714|589693959|FG003|Overall Study|Exclusion criteria|0|||
163268770|NCT01533714|589693960|FG004|Overall Study|Exclusion criteria|0|||
163268771|NCT01533714|589693961|FG005|Overall Study|Exclusion criteria|0|||
163268772|NCT01533714|589693956|FG000|Overall Study|Positive for purified protein derivative|0|||
163268773|NCT01533714|589693957|FG001|Overall Study|Positive for purified protein derivative|0|||
163268774|NCT01533714|589693958|FG002|Overall Study|Positive for purified protein derivative|1|||
163268775|NCT01533714|589693959|FG003|Overall Study|Positive for purified protein derivative|0|||
163268776|NCT01533714|589693960|FG004|Overall Study|Positive for purified protein derivative|1|||
163268777|NCT01533714|589693961|FG005|Overall Study|Positive for purified protein derivative|0|||
163268778|NCT01533714|589693956|FG000|Overall Study|Withdrawal criteria|0|||
163268779|NCT01533714|589693957|FG001|Overall Study|Withdrawal criteria|0|||
163268780|NCT01533714|589693958|FG002|Overall Study|Withdrawal criteria|1|||
163268781|NCT01533714|589693959|FG003|Overall Study|Withdrawal criteria|0|||
163268782|NCT01533714|589693960|FG004|Overall Study|Withdrawal criteria|3|||
163268783|NCT01533714|589693961|FG005|Overall Study|Withdrawal criteria|1|||
163268784|NCT01533714|589693956|FG000|Overall Study|Ineligibility reason|0|||
163268785|NCT01533714|589693957|FG001|Overall Study|Ineligibility reason|0|||
163268786|NCT01533714|589693958|FG002|Overall Study|Ineligibility reason|0|||
163268787|NCT01533714|589693959|FG003|Overall Study|Ineligibility reason|1|||
163268788|NCT01533714|589693960|FG004|Overall Study|Ineligibility reason|0|||
163268789|NCT01533714|589693961|FG005|Overall Study|Ineligibility reason|0|||
163268790|NCT02564055|589693962|FG000|Overall Study|Adverse Event|1|||
163268791|NCT02564055|589693963|FG001|Overall Study|Adverse Event|0|||
163268792|NCT02564055|589693964|FG002|Overall Study|Adverse Event|4|||
163268793|NCT02564055|589693965|FG003|Overall Study|Adverse Event|1|||
163268794|NCT02564055|589693966|FG004|Overall Study|Adverse Event|4|||
163268795|NCT02564055|589693967|FG005|Overall Study|Adverse Event|1|||
163268796|NCT02564055|589693962|FG000|Overall Study|Protocol Violation|1|||
163362482|NCT01080300|590036507|FG001|Overall Study|Reasons not specified|6|||
163268797|NCT02564055|589693963|FG001|Overall Study|Protocol Violation|0|||
163268798|NCT02564055|589693964|FG002|Overall Study|Protocol Violation|0|||
163268799|NCT02564055|589693965|FG003|Overall Study|Protocol Violation|0|||
163268800|NCT02564055|589693966|FG004|Overall Study|Protocol Violation|0|||
163362483|NCT02269423|590036515|FG000|Overall Study|Discontinued due to change in residence|0|||
163362484|NCT02269423|590036516|FG001|Overall Study|Discontinued due to change in residence|1|||
163362485|NCT02269423|590036517|FG002|Overall Study|Discontinued due to change in residence|0|||
163268801|NCT02564055|589693967|FG005|Overall Study|Protocol Violation|0|||
163268802|NCT02564055|589693962|FG000|Overall Study|Reached stopping criteria|0|||
163268803|NCT02564055|589693963|FG001|Overall Study|Reached stopping criteria|0|||
163268804|NCT02564055|589693964|FG002|Overall Study|Reached stopping criteria|0|||
163268805|NCT02564055|589693965|FG003|Overall Study|Reached stopping criteria|0|||
163268806|NCT02564055|589693966|FG004|Overall Study|Reached stopping criteria|0|||
163268807|NCT02564055|589693967|FG005|Overall Study|Reached stopping criteria|1|||
163268808|NCT02564055|589693962|FG000|Overall Study|Lost to Follow-up|0|||
163268809|NCT02564055|589693963|FG001|Overall Study|Lost to Follow-up|1|||
163268810|NCT02564055|589693964|FG002|Overall Study|Lost to Follow-up|4|||
163268811|NCT02564055|589693965|FG003|Overall Study|Lost to Follow-up|2|||
163268812|NCT02564055|589693966|FG004|Overall Study|Lost to Follow-up|1|||
163268813|NCT02564055|589693967|FG005|Overall Study|Lost to Follow-up|0|||
163268814|NCT02564055|589693962|FG000|Overall Study|Physician Decision|0|||
163268815|NCT02564055|589693963|FG001|Overall Study|Physician Decision|0|||
163268816|NCT02564055|589693964|FG002|Overall Study|Physician Decision|1|||
163268817|NCT02564055|589693965|FG003|Overall Study|Physician Decision|0|||
163268818|NCT02564055|589693966|FG004|Overall Study|Physician Decision|0|||
163268819|NCT02564055|589693967|FG005|Overall Study|Physician Decision|0|||
163268820|NCT02564055|589693962|FG000|Overall Study|Withdrawal by Subject|4|||
163268821|NCT02564055|589693963|FG001|Overall Study|Withdrawal by Subject|4|||
163268822|NCT02564055|589693964|FG002|Overall Study|Withdrawal by Subject|3|||
163268823|NCT02564055|589693965|FG003|Overall Study|Withdrawal by Subject|3|||
163268824|NCT02564055|589693966|FG004|Overall Study|Withdrawal by Subject|10|||
163268825|NCT02564055|589693967|FG005|Overall Study|Withdrawal by Subject|10|||
163268826|NCT00919893|589693971|FG000|Overall Study|Protocol Violation|19|||
163268827|NCT00919893|589693972|FG001|Overall Study|Protocol Violation|9|||
163268828|NCT01375959|589693973|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
163268829|NCT01375959|589693974|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
163268830|NCT01375959|589693973|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
163268831|NCT01375959|589693974|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
163268832|NCT01375959|589693973|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
163268833|NCT01375959|589693974|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
163268834|NCT00365378|589693982|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
163268835|NCT00365378|589693983|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
163268836|NCT00365378|589693984|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
163268837|NCT00365378|589693982|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
163268838|NCT00365378|589693983|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
163268839|NCT00365378|589693984|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
163268840|NCT00365378|589693982|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
163268841|NCT00365378|589693983|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
163268842|NCT00365378|589693984|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
163268843|NCT00365378|589693982|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
163268844|NCT00365378|589693983|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
163268845|NCT00365378|589693984|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
163268846|NCT00365378|589693982|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
163268847|NCT00365378|589693983|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
163268848|NCT00365378|589693984|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
163268849|NCT00365378|589693982|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
163268850|NCT00365378|589693983|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
163268851|NCT00365378|589693984|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
163268852|NCT00365378|589693982|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
163268853|NCT00365378|589693983|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
163268854|NCT00365378|589693984|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
163268855|NCT00365378|589693982|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
163268856|NCT00365378|589693983|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
163268857|NCT00365378|589693984|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
163268858|NCT00365378|589693982|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
163268859|NCT00365378|589693983|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
163268860|NCT00365378|589693984|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
163268861|NCT00365378|589693982|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
163268862|NCT00365378|589693983|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
163268863|NCT00365378|589693984|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
163268864|NCT00365378|589693982|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
163268865|NCT00365378|589693983|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
163268866|NCT00365378|589693984|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
163268867|NCT00365378|589693982|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
163268868|NCT00365378|589693983|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
163411171|NCT00852995|590213000|FG004|Overall Study|Protocol Violation|1|||
163268869|NCT00365378|589693984|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
163268870|NCT00365378|589693982|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
163268871|NCT00365378|589693983|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
163268872|NCT00365378|589693984|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
163268873|NCT00365378|589693982|FG000|Extension|Adverse Event|0|||
163268874|NCT00365378|589693983|FG001|Extension|Adverse Event|0|||
163268875|NCT00365378|589693984|FG002|Extension|Adverse Event|1|||
163268876|NCT00365378|589693982|FG000|Extension|Moved|0|||
163268877|NCT00365378|589693983|FG001|Extension|Moved|0|||
163268878|NCT00365378|589693984|FG002|Extension|Moved|8|||
163268879|NCT00365378|589693982|FG000|Extension|Lost to Follow-up|0|||
163268880|NCT00365378|589693983|FG001|Extension|Lost to Follow-up|0|||
163268881|NCT00365378|589693984|FG002|Extension|Lost to Follow-up|57|||
163268882|NCT00365378|589693982|FG000|Extension|Protocol Violation|0|||
163268883|NCT00365378|589693983|FG001|Extension|Protocol Violation|0|||
163268884|NCT00365378|589693984|FG002|Extension|Protocol Violation|2|||
163268885|NCT00365378|589693982|FG000|Extension|Withdrawal by Subject|0|||
163268886|NCT00365378|589693983|FG001|Extension|Withdrawal by Subject|0|||
163268887|NCT00365378|589693984|FG002|Extension|Withdrawal by Subject|98|||
163268888|NCT00365378|589693982|FG000|Extension|Other|0|||
163268889|NCT00365378|589693983|FG001|Extension|Other|0|||
163268890|NCT00365378|589693984|FG002|Extension|Other|31|||
163268891|NCT04741802|589693985|FG000|Overall Study|Death|1|||
163268892|NCT04741802|589693985|FG000|Overall Study|Lost to Follow-up|11|||
163268893|NCT04161807|589693991|FG000|Overall Study|Withdrawal by Subject|2|||
163268894|NCT04161807|589693991|FG000|Overall Study|Performed only 1 treatment|2|||
163268895|NCT00708305|589693994|FG000|Period 1|Protocol Violation|1|||
163268896|NCT00708305|589693995|FG001|Period 1|Protocol Violation|0|||
163268897|NCT00708305|589693996|FG002|Period 1|Protocol Violation|1|||
163268898|NCT00708305|589693997|FG003|Period 1|Protocol Violation|0|||
163268899|NCT00708305|589693994|FG000|Period 1|Other Reason|0|||
163268900|NCT00708305|589693995|FG001|Period 1|Other Reason|0|||
163268901|NCT00708305|589693996|FG002|Period 1|Other Reason|0|||
163268902|NCT00708305|589693997|FG003|Period 1|Other Reason|2|||
163268903|NCT00708305|589693994|FG000|Period 2|Lost to Follow-up|0|||
163268904|NCT00708305|589693995|FG001|Period 2|Lost to Follow-up|1|||
163268905|NCT00708305|589693996|FG002|Period 2|Lost to Follow-up|0|||
163268906|NCT00708305|589693997|FG003|Period 2|Lost to Follow-up|0|||
163268907|NCT00708305|589693994|FG000|Period 2|Protocol Violation|0|||
163268908|NCT00708305|589693995|FG001|Period 2|Protocol Violation|1|||
163268909|NCT00708305|589693996|FG002|Period 2|Protocol Violation|0|||
163268910|NCT00708305|589693997|FG003|Period 2|Protocol Violation|0|||
163268911|NCT00708305|589693994|FG000|Period 2|Other Reason|1|||
163268912|NCT00708305|589693995|FG001|Period 2|Other Reason|0|||
163268913|NCT00708305|589693996|FG002|Period 2|Other Reason|0|||
163268914|NCT00708305|589693997|FG003|Period 2|Other Reason|1|||
163268915|NCT00708305|589693994|FG000|Period 3|Protocol Violation|0|||
163268916|NCT00708305|589693995|FG001|Period 3|Protocol Violation|2|||
163268917|NCT00708305|589693996|FG002|Period 3|Protocol Violation|0|||
163268918|NCT00708305|589693997|FG003|Period 3|Protocol Violation|0|||
163268919|NCT00708305|589693994|FG000|Period 3|Other Reason|1|||
163268920|NCT00708305|589693995|FG001|Period 3|Other Reason|0|||
163268921|NCT00708305|589693996|FG002|Period 3|Other Reason|0|||
163268922|NCT00708305|589693997|FG003|Period 3|Other Reason|0|||
163268923|NCT00192023|589694002|FG000|Period III - Double-Blind|Adverse Event|3|||
163268924|NCT00192023|589694003|FG001|Period III - Double-Blind|Adverse Event|0|||
163268925|NCT00192023|589694002|FG000|Period III - Double-Blind|Physician Decision|2|||
163268926|NCT00192023|589694003|FG001|Period III - Double-Blind|Physician Decision|0|||
163268927|NCT00192023|589694002|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
163268928|NCT00192023|589694003|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
163268929|NCT00192023|589694002|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
163268930|NCT00192023|589694003|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
163268931|NCT00192023|589694002|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
163268932|NCT00192023|589694003|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
163268933|NCT00192023|589694002|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
163268934|NCT00192023|589694003|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
163268935|NCT00192023|589694002|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
163268936|NCT00192023|589694003|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
163268937|NCT00192023|589694002|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
163268938|NCT00192023|589694003|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
163268939|NCT00192023|589694002|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
163268940|NCT00192023|589694003|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
163268941|NCT00192023|589694002|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
163268942|NCT00192023|589694003|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
163268943|NCT02572817|589694028|FG000|Overall Study|Death|6|||
163268944|NCT02572817|589694029|FG001|Overall Study|Death|3|||
163268945|NCT02572817|589694028|FG000|Overall Study|Lost to Follow-up|3|||
163268946|NCT02572817|589694029|FG001|Overall Study|Lost to Follow-up|3|||
163362486|NCT02269423|590036518|FG003|Overall Study|Discontinued due to change in residence|1|||
163268947|NCT01258660|589694033|FG000|Overall Study|Adverse Event|2|||
163362487|NCT01281839|590036519|FG000|Overall Study|Lost to Follow-up|6|||
163268948|NCT01258660|589694034|FG001|Overall Study|Adverse Event|4|||
163268949|NCT01258660|589694033|FG000|Overall Study|Withdrawal by Subject|3|||
163268950|NCT01258660|589694034|FG001|Overall Study|Withdrawal by Subject|0|||
163268951|NCT01258660|589694033|FG000|Overall Study|due to relocation|2|||
163268952|NCT01258660|589694034|FG001|Overall Study|due to relocation|0|||
163268953|NCT01258660|589694033|FG000|Overall Study|Protocol Violation|0|||
163268954|NCT01258660|589694034|FG001|Overall Study|Protocol Violation|1|||
163268955|NCT01258660|589694033|FG000|Overall Study|Invalid for primary analysis data set|4|||
163268956|NCT01258660|589694034|FG001|Overall Study|Invalid for primary analysis data set|6|||
163268957|NCT04192630|589694035|FG000|Overall Study|Discontinued before surgery|2|||
163268958|NCT04192630|589694036|FG001|Overall Study|Discontinued before surgery|0|||
163268959|NCT04192630|589694035|FG000|Overall Study|Discontinued after surgery|5|||
163268960|NCT04192630|589694036|FG001|Overall Study|Discontinued after surgery|3|||
163268961|NCT01193582|589694037|FG000|Vaccination Series|Withdrawal by Subject|11|||
163268962|NCT01193582|589694038|FG001|Vaccination Series|Withdrawal by Subject|13|||
163268963|NCT01193582|589694039|FG002|Vaccination Series|Withdrawal by Subject|8|||
163268964|NCT01193582|589694040|FG003|Vaccination Series|Withdrawal by Subject|3|||
163268965|NCT01193582|589694037|FG000|12 Month Follow-up|Death|0|||
163268966|NCT01193582|589694038|FG001|12 Month Follow-up|Death|0|||
163268967|NCT01193582|589694039|FG002|12 Month Follow-up|Death|1|||
163268968|NCT01193582|589694040|FG003|12 Month Follow-up|Death|0|||
163268969|NCT01193582|589694037|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
163268970|NCT01193582|589694038|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
163268971|NCT01193582|589694039|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
163268972|NCT01193582|589694040|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
163268973|NCT01775930|589694046|FG000|Overall Study|Futility stopping boundary met|1|||
163268974|NCT01208415|589694047|FG000|Overall Study|Death|1|||
163268975|NCT01208415|589694047|FG000|Overall Study|Lost to Follow-up|2|||
163268976|NCT01208415|589694047|FG000|Overall Study|Withdrawal by Subject|3|||
163268977|NCT01208415|589694047|FG000|Overall Study|Device not placed|1|||
163268978|NCT01208415|589694047|FG000|Overall Study|Still be eligible for follow-up|33|||
163268979|NCT02340520|589694048|FG000|Overall Study|Lost to Follow-up|1|||
163268980|NCT02340520|589694048|FG000|Overall Study|Patient did not take drug as specified|1|||
163268981|NCT02340520|589694048|FG000|Overall Study|Withdrawal by Subject|1|||
163268982|NCT01586338|589694050|FG000|Overall Study|Adverse Event|3|||
163268983|NCT01586338|589694050|FG000|Overall Study|Lost to Follow-up|1|||
163268984|NCT01586338|589694050|FG000|Overall Study|Withdrawal by participant|3|||
163268985|NCT01586338|589694050|FG000|Overall Study|Other|1|||
163268986|NCT00896454|589694066|FG000|Overall Study|Death|10|||
163268987|NCT00896454|589694066|FG000|Overall Study|Adverse Event|8|||
163268988|NCT00896454|589694066|FG000|Overall Study|Disease Progression|5|||
163268989|NCT00896454|589694066|FG000|Overall Study|Other|4|||
163268990|NCT00896454|589694066|FG000|Overall Study|Requirement for alternative therapy|3|||
163268991|NCT00896454|589694066|FG000|Overall Study|Ongoing in study|2|||
163268992|NCT00896454|589694066|FG000|Overall Study|Withdrawal by Subject|1|||
163268993|NCT00856661|589694069|FG000|Overall Study|Death|15|||
163268994|NCT00856661|589694070|FG001|Overall Study|Death|18|||
163268995|NCT00856661|589694069|FG000|Overall Study|Protocol Violation|2|||
163268996|NCT00856661|589694070|FG001|Overall Study|Protocol Violation|1|||
163268997|NCT00856661|589694069|FG000|Overall Study|Withdrawal by Subject|1|||
163268998|NCT00856661|589694070|FG001|Overall Study|Withdrawal by Subject|2|||
163268999|NCT00856661|589694069|FG000|Overall Study|Lost to Follow-up|1|||
163269000|NCT00856661|589694070|FG001|Overall Study|Lost to Follow-up|3|||
163269001|NCT00856661|589694069|FG000|Overall Study|Physician Judgement|8|||
163269002|NCT00856661|589694070|FG001|Overall Study|Physician Judgement|5|||
163269003|NCT03936777|589694071|FG000|Overall Study|Adverse Event|3|||
163269004|NCT03936777|589694071|FG000|Overall Study|Death|3|||
163269005|NCT03936777|589694071|FG000|Overall Study|Lack of Efficacy|24|||
163269006|NCT03936777|589694071|FG000|Overall Study|Lost to Follow-up|3|||
163269007|NCT03936777|589694071|FG000|Overall Study|Physician Decision|1|||
163269008|NCT03936777|589694071|FG000|Overall Study|Withdrawal by Subject|11|||
163269009|NCT03936777|589694071|FG000|Overall Study|Subjected Weaned of ZX008|1|||
163269010|NCT03936777|589694071|FG000|Overall Study|Missing|6|||
163269011|NCT02301156|589694072|FG000|Overall Study|Adverse Event|13|||
163269012|NCT02301156|589694073|FG001|Overall Study|Adverse Event|14|||
163269013|NCT02301156|589694072|FG000|Overall Study|Death|1|||
163269014|NCT02301156|589694073|FG001|Overall Study|Death|5|||
163269015|NCT02301156|589694072|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
163269016|NCT02301156|589694073|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
163269017|NCT02301156|589694072|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
163269018|NCT02301156|589694073|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
163269019|NCT02301156|589694072|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
163269020|NCT02301156|589694073|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
163269021|NCT02301156|589694072|FG000|Overall Study|Reason not Specified|6|||
163269022|NCT02301156|589694073|FG001|Overall Study|Reason not Specified|3|||
163269023|NCT03734991|589694078|FG000|Overall Study|Adverse Event|4|||
163269024|NCT03734991|589694079|FG001|Overall Study|Adverse Event|0|||
163362488|NCT01281839|590036520|FG001|Overall Study|Lost to Follow-up|3|||
163362489|NCT01281839|590036519|FG000|Overall Study|Withdrawal by Subject|4|||
163269025|NCT03734991|589694078|FG000|Overall Study|Lost to Follow-up|4|||
163362490|NCT01281839|590036520|FG001|Overall Study|Withdrawal by Subject|10|||
163269026|NCT03734991|589694079|FG001|Overall Study|Lost to Follow-up|0|||
163269027|NCT03734991|589694078|FG000|Overall Study|Physician Decision|0|||
163269028|NCT03734991|589694079|FG001|Overall Study|Physician Decision|1|||
163269029|NCT03734991|589694078|FG000|Overall Study|Pregnancy|1|||
163269030|NCT03734991|589694079|FG001|Overall Study|Pregnancy|0|||
163269031|NCT03734991|589694078|FG000|Overall Study|Withdrawal by Subject|6|||
163269032|NCT03734991|589694079|FG001|Overall Study|Withdrawal by Subject|3|||
163269033|NCT03734991|589694078|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
163269034|NCT03734991|589694079|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
163269035|NCT03734991|589694078|FG000|Overall Study|Other|2|||
163269036|NCT03734991|589694079|FG001|Overall Study|Other|2|||
163269037|NCT02638623|589694080|FG000|Overall Study|Surgery timing|5|||
163269038|NCT02638623|589694081|FG001|Overall Study|Surgery timing|6|||
163269039|NCT02638623|589694080|FG000|Overall Study|Not given intervention|2|||
163269040|NCT02638623|589694081|FG001|Overall Study|Not given intervention|0|||
163269041|NCT03797326|589694087|FG000|Overall Study|Lost to Follow-up|1|||
163269042|NCT03797326|589694088|FG001|Overall Study|Lost to Follow-up|0|||
163269043|NCT03797326|589694089|FG002|Overall Study|Lost to Follow-up|0|||
163269044|NCT03797326|589694090|FG003|Overall Study|Lost to Follow-up|1|||
163269045|NCT03797326|589694091|FG004|Overall Study|Lost to Follow-up|0|||
163269046|NCT03797326|589694092|FG005|Overall Study|Lost to Follow-up|0|||
163269047|NCT03797326|589694093|FG006|Overall Study|Lost to Follow-up|0|||
163269048|NCT03797326|589694094|FG007|Overall Study|Lost to Follow-up|0|||
163269049|NCT03797326|589694087|FG000|Overall Study|Withdrawal by Subject|0|||
163269050|NCT03797326|589694088|FG001|Overall Study|Withdrawal by Subject|0|||
163269051|NCT03797326|589694089|FG002|Overall Study|Withdrawal by Subject|1|||
163269052|NCT03797326|589694090|FG003|Overall Study|Withdrawal by Subject|3|||
163269053|NCT03797326|589694091|FG004|Overall Study|Withdrawal by Subject|0|||
163269054|NCT03797326|589694092|FG005|Overall Study|Withdrawal by Subject|2|||
163269055|NCT03797326|589694093|FG006|Overall Study|Withdrawal by Subject|2|||
163269056|NCT03797326|589694094|FG007|Overall Study|Withdrawal by Subject|3|||
163269057|NCT03797326|589694087|FG000|Overall Study|Sponsor Decision|3|||
163269058|NCT03797326|589694088|FG001|Overall Study|Sponsor Decision|3|||
163269059|NCT03797326|589694089|FG002|Overall Study|Sponsor Decision|3|||
163269060|NCT03797326|589694090|FG003|Overall Study|Sponsor Decision|6|||
163269061|NCT03797326|589694091|FG004|Overall Study|Sponsor Decision|0|||
163269062|NCT03797326|589694092|FG005|Overall Study|Sponsor Decision|3|||
163269063|NCT03797326|589694093|FG006|Overall Study|Sponsor Decision|3|||
163269064|NCT03797326|589694094|FG007|Overall Study|Sponsor Decision|2|||
163269065|NCT03797326|589694087|FG000|Overall Study|Death|27|||
163269066|NCT03797326|589694088|FG001|Overall Study|Death|28|||
163269067|NCT03797326|589694089|FG002|Overall Study|Death|95|||
163269068|NCT03797326|589694090|FG003|Overall Study|Death|95|||
163269069|NCT03797326|589694091|FG004|Overall Study|Death|30|||
163269070|NCT03797326|589694092|FG005|Overall Study|Death|96|||
163269071|NCT03797326|589694093|FG006|Overall Study|Death|97|||
163269072|NCT03797326|589694094|FG007|Overall Study|Death|98|||
163269073|NCT03797326|589694087|FG000|Overall Study|Enrolled in error|0|||
163269074|NCT03797326|589694088|FG001|Overall Study|Enrolled in error|0|||
163269075|NCT03797326|589694089|FG002|Overall Study|Enrolled in error|3|||
163269076|NCT03797326|589694090|FG003|Overall Study|Enrolled in error|2|||
163269077|NCT03797326|589694091|FG004|Overall Study|Enrolled in error|2|||
163269078|NCT03797326|589694092|FG005|Overall Study|Enrolled in error|1|||
163269079|NCT03797326|589694093|FG006|Overall Study|Enrolled in error|1|||
163269080|NCT03797326|589694094|FG007|Overall Study|Enrolled in error|0|||
163269081|NCT03012061|589694095|FG000|Overall Study|Withdrawal by Subject|1|||
163269082|NCT03012061|589694096|FG001|Overall Study|Withdrawal by Subject|5|||
163269083|NCT03012061|589694097|FG002|Overall Study|Withdrawal by Subject|4|||
163269084|NCT03012061|589694095|FG000|Overall Study|Investigator Site Closed|1|||
163269085|NCT03012061|589694096|FG001|Overall Study|Investigator Site Closed|2|||
163269086|NCT03012061|589694097|FG002|Overall Study|Investigator Site Closed|0|||
163269087|NCT03012061|589694095|FG000|Overall Study|Lost to Follow-up|2|||
163269088|NCT03012061|589694096|FG001|Overall Study|Lost to Follow-up|1|||
163269089|NCT03012061|589694097|FG002|Overall Study|Lost to Follow-up|0|||
163269090|NCT03012061|589694095|FG000|Overall Study|Study closed/ Terminated|0|||
163269091|NCT03012061|589694096|FG001|Overall Study|Study closed/ Terminated|0|||
163269092|NCT03012061|589694097|FG002|Overall Study|Study closed/ Terminated|1|||
163269093|NCT03012061|589694095|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
163269094|NCT03012061|589694096|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
163269095|NCT03012061|589694097|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
163269096|NCT03012061|589694095|FG000|Overall Study|Protocol Violation|0|||
163269097|NCT03012061|589694096|FG001|Overall Study|Protocol Violation|0|||
163269098|NCT03012061|589694097|FG002|Overall Study|Protocol Violation|2|||
163269099|NCT03012061|589694095|FG000|Overall Study|Lack of Efficacy|0|||
163269100|NCT03012061|589694096|FG001|Overall Study|Lack of Efficacy|1|||
163269101|NCT03012061|589694097|FG002|Overall Study|Lack of Efficacy|0|||
163269102|NCT03012061|589694095|FG000|Overall Study|Adverse Event|2|||
163269103|NCT03012061|589694096|FG001|Overall Study|Adverse Event|0|||
163269104|NCT03012061|589694097|FG002|Overall Study|Adverse Event|0|||
163269105|NCT04152343|589694098|FG000|Overall Study|Transplanted|5|||
163269106|NCT04152343|589694098|FG000|Overall Study|Death|20|||
163269107|NCT04152343|589694098|FG000|Overall Study|Lost to Follow-up|3|||
163269108|NCT03342053|589694099|FG000|Overall Study|Adverse Event|2|||
163269109|NCT03342053|589694100|FG001|Overall Study|Adverse Event|0|||
163269110|NCT03342053|589694099|FG000|Overall Study|Withdrawal by Subject|0|||
163269111|NCT03342053|589694100|FG001|Overall Study|Withdrawal by Subject|1|||
163269112|NCT00309608|589694103|FG000|Overall Study|Adverse Event|1|||
163269113|NCT00309608|589694104|FG001|Overall Study|Adverse Event|5|||
163269114|NCT00309608|589694105|FG002|Overall Study|Adverse Event|3|||
163269115|NCT00309608|589694106|FG003|Overall Study|Adverse Event|2|||
163269116|NCT00309608|589694107|FG004|Overall Study|Adverse Event|3|||
163269117|NCT00309608|589694103|FG000|Overall Study|Protocol Violation|2|||
163269118|NCT00309608|589694104|FG001|Overall Study|Protocol Violation|0|||
163269119|NCT00309608|589694105|FG002|Overall Study|Protocol Violation|0|||
163269120|NCT00309608|589694106|FG003|Overall Study|Protocol Violation|0|||
163269121|NCT00309608|589694107|FG004|Overall Study|Protocol Violation|0|||
163269122|NCT00309608|589694103|FG000|Overall Study|Lost to Follow-up|0|||
163269123|NCT00309608|589694104|FG001|Overall Study|Lost to Follow-up|0|||
163269124|NCT00309608|589694105|FG002|Overall Study|Lost to Follow-up|2|||
163269125|NCT00309608|589694106|FG003|Overall Study|Lost to Follow-up|0|||
163269126|NCT00309608|589694107|FG004|Overall Study|Lost to Follow-up|1|||
163269127|NCT00309608|589694103|FG000|Overall Study|Withdrawal by Subject|1|||
163269128|NCT00309608|589694104|FG001|Overall Study|Withdrawal by Subject|4|||
163269129|NCT00309608|589694105|FG002|Overall Study|Withdrawal by Subject|2|||
163269130|NCT00309608|589694106|FG003|Overall Study|Withdrawal by Subject|0|||
163269131|NCT00309608|589694107|FG004|Overall Study|Withdrawal by Subject|0|||
163269132|NCT00309608|589694103|FG000|Overall Study|Other incl. Lack of efficacy|10|||
163269133|NCT00309608|589694104|FG001|Overall Study|Other incl. Lack of efficacy|4|||
163269134|NCT00309608|589694105|FG002|Overall Study|Other incl. Lack of efficacy|3|||
163269135|NCT00309608|589694106|FG003|Overall Study|Other incl. Lack of efficacy|4|||
163269136|NCT00309608|589694107|FG004|Overall Study|Other incl. Lack of efficacy|0|||
163269137|NCT01340482|589695673|FG000|Overall Study|Adverse Event|2|||
163269138|NCT01340482|589695674|FG001|Overall Study|Adverse Event|0|||
163269139|NCT01340482|589695675|FG002|Overall Study|Adverse Event|0|||
163269140|NCT01282476|589695676|FG000|Overall Study|Death|11|||
163269141|NCT00592319|589695682|FG000|Overall Study|Lost to Follow-up|0|||
163269142|NCT00592319|589695683|FG001|Overall Study|Lost to Follow-up|3|||
163269143|NCT01912222|589695690|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
163269144|NCT01912222|589695691|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
163269145|NCT01912222|589695692|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
163269146|NCT01912222|589695690|FG000|Part B: Treatment Period|Progressive disease|10|||
163269147|NCT01912222|589695691|FG001|Part B: Treatment Period|Progressive disease|12|||
163269148|NCT01912222|589695692|FG002|Part B: Treatment Period|Progressive disease|15|||
163269149|NCT01912222|589695690|FG000|Part B: Treatment Period|Adverse Event|1|||
163269150|NCT01912222|589695691|FG001|Part B: Treatment Period|Adverse Event|2|||
163269151|NCT01912222|589695692|FG002|Part B: Treatment Period|Adverse Event|3|||
163269152|NCT01912222|589695690|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
163269153|NCT01912222|589695691|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
163269154|NCT01912222|589695692|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
163269155|NCT00154063|589695693|FG000|Overall Study|Adverse Event|4|||
163269156|NCT00154063|589695694|FG001|Overall Study|Adverse Event|8|||
163269157|NCT00154063|589695693|FG000|Overall Study|Protocol Violation|1|||
163269158|NCT00154063|589695694|FG001|Overall Study|Protocol Violation|1|||
163269159|NCT00154063|589695693|FG000|Overall Study|Investigator or Sponsor Request|0|||
163269160|NCT00154063|589695694|FG001|Overall Study|Investigator or Sponsor Request|1|||
163269161|NCT00154063|589695693|FG000|Overall Study|Withdrawal by Subject|4|||
163269162|NCT00154063|589695694|FG001|Overall Study|Withdrawal by Subject|9|||
163269163|NCT00154063|589695693|FG000|Overall Study|Other|3|||
163269164|NCT00154063|589695694|FG001|Overall Study|Other|3|||
163269165|NCT01804673|589695695|FG000|Overall Study|Adverse Event|4|||
163269166|NCT01804673|589695695|FG000|Overall Study|Withdrawal by Subject|1|||
163269167|NCT01804673|589695695|FG000|Overall Study|Lack of Efficacy|9|||
163269168|NCT01804673|589695695|FG000|Overall Study|Change to Oral Therapy|37|||
163269169|NCT01804673|589695695|FG000|Overall Study|No Further Therapy Required|84|||
163269170|NCT01804673|589695695|FG000|Overall Study|Use of Prohibited Medication|1|||
163269171|NCT01804673|589695695|FG000|Overall Study|Other|4|||
163269172|NCT01857934|589695703|FG000|Overall Study|Relapse or progression|2|||
163269173|NCT01857934|589695703|FG000|Overall Study|Unacceptable toxicity|3|||
163269174|NCT01857934|589695703|FG000|Overall Study|Unwillingness or inability to comply|2|||
163269175|NCT01857934|589695703|FG000|Overall Study|Physician Decision|3|||
163269176|NCT04012814|589695710|FG000|Overall Study|Lost to Follow-up|4|||
163269177|NCT04012814|589695710|FG000|Overall Study|Withdrawal by Subject|2|||
163269178|NCT04012814|589695710|FG000|Overall Study|Protocol Violation|1|||
163269179|NCT04012814|589695710|FG000|Overall Study|Adverse Event|1|||
163269180|NCT04789577|589695711|FG000|Overall Study|Withdrawal by Subject|1|||
163269181|NCT04789577|589695712|FG001|Overall Study|Withdrawal by Subject|1|||
163269182|NCT04789577|589695713|FG002|Overall Study|Withdrawal by Subject|1|||
163362491|NCT01281839|590036519|FG000|Overall Study|Reason not specified|0|||
163362492|NCT01281839|590036520|FG001|Overall Study|Reason not specified|1|||
163362493|NCT01305239|590036521|FG000|Overall Study|Adverse Event|22|||
163362494|NCT01305239|590036521|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
163362495|NCT04674189|590036523|FG000|Overall Study|Adverse Event|0|||
163362496|NCT04674189|590036524|FG001|Overall Study|Adverse Event|0|||
163362497|NCT04674189|590036525|FG002|Overall Study|Adverse Event|1|||
163362498|NCT04674189|590036523|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
163269183|NCT04789577|589695714|FG003|Overall Study|Withdrawal by Subject|3|||
163269184|NCT04789577|589695715|FG004|Overall Study|Withdrawal by Subject|1|||
163269185|NCT04789577|589695716|FG005|Overall Study|Withdrawal by Subject|7|||
163269186|NCT04789577|589695717|FG006|Overall Study|Withdrawal by Subject|1|||
163269187|NCT04789577|589695711|FG000|Overall Study|Lost to Follow-up|7|||
163269188|NCT04789577|589695712|FG001|Overall Study|Lost to Follow-up|12|||
163269189|NCT04789577|589695713|FG002|Overall Study|Lost to Follow-up|7|||
163269190|NCT04789577|589695714|FG003|Overall Study|Lost to Follow-up|10|||
163269191|NCT04789577|589695715|FG004|Overall Study|Lost to Follow-up|8|||
163269192|NCT04789577|589695716|FG005|Overall Study|Lost to Follow-up|6|||
163269193|NCT04789577|589695717|FG006|Overall Study|Lost to Follow-up|10|||
163269194|NCT04789577|589695711|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
163269195|NCT04789577|589695712|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
163269196|NCT04789577|589695713|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
163269197|NCT04789577|589695714|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
163269198|NCT04789577|589695715|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
163269199|NCT04789577|589695716|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
163269200|NCT04789577|589695717|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
163269201|NCT04789577|589695711|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
163269202|NCT04789577|589695712|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
163269203|NCT04789577|589695713|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
163269204|NCT04789577|589695714|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
163269205|NCT04789577|589695715|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
163269206|NCT04789577|589695716|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
163269207|NCT04789577|589695717|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
163269208|NCT02441946|589695718|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
163269209|NCT02441946|589695719|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
163269210|NCT02441946|589695720|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
163269211|NCT02441946|589695718|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
163269212|NCT02441946|589695719|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
163269213|NCT02441946|589695720|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
163269214|NCT02441946|589695718|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
163269215|NCT02441946|589695719|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
163269216|NCT02441946|589695720|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
163269217|NCT02441946|589695718|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
163269218|NCT02441946|589695719|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
163269219|NCT02441946|589695720|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
163269220|NCT02441946|589695718|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
163269221|NCT02441946|589695719|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
163269222|NCT02441946|589695720|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
163269223|NCT02441946|589695718|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
163269224|NCT02441946|589695719|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
163269225|NCT02441946|589695720|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
163269226|NCT02441946|589695718|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
163269227|NCT02441946|589695719|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
163269228|NCT02441946|589695720|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
163269229|NCT02441946|589695718|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
163269230|NCT02441946|589695719|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
163269231|NCT02441946|589695720|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
163269232|NCT02441946|589695718|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
163269233|NCT02441946|589695719|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
163269234|NCT02441946|589695720|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
163269235|NCT02441946|589695718|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
163269236|NCT02441946|589695719|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
163269237|NCT02441946|589695720|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
163269238|NCT02441946|589695718|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
163269239|NCT02441946|589695719|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
163269240|NCT02441946|589695720|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
163269241|NCT00579982|589695725|FG000|Overall Study|Adverse Event|4|||
163269242|NCT00579982|589695725|FG000|Overall Study|Protocol Violation|4|||
163269243|NCT00988351|589695727|FG000|Overall Study|Withdrawal by Subject|8|||
163269244|NCT00988351|589695728|FG001|Overall Study|Withdrawal by Subject|0|||
163269245|NCT00988351|589695727|FG000|Overall Study|Lost to Follow-up|6|||
163269246|NCT00988351|589695728|FG001|Overall Study|Lost to Follow-up|9|||
163269247|NCT00988351|589695727|FG000|Overall Study|not using CPAP|5|||
163269248|NCT00988351|589695728|FG001|Overall Study|not using CPAP|3|||
163269249|NCT02038764|589695729|FG000|Overall Study|Adverse Event|0|||
163269250|NCT02038764|589695730|FG001|Overall Study|Adverse Event|0|||
163269251|NCT02038764|589695731|FG002|Overall Study|Adverse Event|1|||
163269252|NCT02038764|589695732|FG003|Overall Study|Adverse Event|0|||
163269253|NCT02038764|589695733|FG004|Overall Study|Adverse Event|0|||
163269254|NCT02038764|589695729|FG000|Overall Study|Lost to Follow-up|0|||
163269255|NCT02038764|589695730|FG001|Overall Study|Lost to Follow-up|1|||
163269256|NCT02038764|589695731|FG002|Overall Study|Lost to Follow-up|0|||
163269257|NCT02038764|589695732|FG003|Overall Study|Lost to Follow-up|0|||
163269258|NCT02038764|589695733|FG004|Overall Study|Lost to Follow-up|0|||
163269259|NCT02038764|589695729|FG000|Overall Study|Withdrawal by Subject|0|||
163269260|NCT02038764|589695730|FG001|Overall Study|Withdrawal by Subject|0|||
163269261|NCT02038764|589695731|FG002|Overall Study|Withdrawal by Subject|0|||
163269262|NCT02038764|589695732|FG003|Overall Study|Withdrawal by Subject|0|||
163269263|NCT02038764|589695733|FG004|Overall Study|Withdrawal by Subject|1|||
163269264|NCT02038764|589695729|FG000|Overall Study|Other|1|||
163269265|NCT02038764|589695730|FG001|Overall Study|Other|0|||
163269266|NCT02038764|589695731|FG002|Overall Study|Other|1|||
163269267|NCT02038764|589695732|FG003|Overall Study|Other|0|||
163269268|NCT02038764|589695733|FG004|Overall Study|Other|0|||
163269269|NCT01464255|589695742|FG000|Overall Study|unresolve corneal staining|0|||
163269270|NCT01464255|589695743|FG001|Overall Study|unresolve corneal staining|1|||
163269271|NCT04175912|589695753|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
163269272|NCT04175912|589695754|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
163269273|NCT04175912|589695753|FG000|Overall Study|Adverse Event|0|||
163269274|NCT04175912|589695754|FG001|Overall Study|Adverse Event|3|||
163269275|NCT04175912|589695753|FG000|Overall Study|Never started treatment|3|||
163269276|NCT04175912|589695754|FG001|Overall Study|Never started treatment|3|||
163269277|NCT04175912|589695753|FG000|Overall Study|Death|0|||
163269278|NCT04175912|589695754|FG001|Overall Study|Death|1|||
163269279|NCT04654468|589695755|FG000|Overall Study|Death|1|||
163269280|NCT04654468|589695755|FG000|Overall Study|Ongoing in the Study|50|||
163269281|NCT01155661|589695756|FG000|Overall Study|Adverse Event|101|||
163269282|NCT01155661|589695756|FG000|Overall Study|Death|1|||
163269283|NCT01155661|589695756|FG000|Overall Study|Lack of Efficacy|32|||
163269284|NCT01155661|589695756|FG000|Overall Study|Lost to Follow-up|22|||
163269285|NCT01155661|589695756|FG000|Overall Study|Physician Decision|3|||
163269286|NCT01155661|589695756|FG000|Overall Study|Protocol Violation|35|||
163269287|NCT01155661|589695756|FG000|Overall Study|Withdrawal by Subject|73|||
163269288|NCT01155661|589695756|FG000|Overall Study|Sponsor Decision|13|||
163269289|NCT05064735|589695757|FG000|Overall Study|Withdrawal by Subject|7|||
163269290|NCT05064735|589695758|FG001|Overall Study|Withdrawal by Subject|8|||
163269291|NCT05064735|589695757|FG000|Overall Study|Lost to Follow-up|7|||
163269292|NCT05064735|589695758|FG001|Overall Study|Lost to Follow-up|2|||
163269293|NCT05064735|589695757|FG000|Overall Study|Physician Decision|2|||
163269294|NCT05064735|589695758|FG001|Overall Study|Physician Decision|1|||
163269295|NCT05064735|589695757|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
163269296|NCT05064735|589695758|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
163269297|NCT05064735|589695757|FG000|Overall Study|Site Closure|7|||
163269298|NCT05064735|589695758|FG001|Overall Study|Site Closure|2|||
163269299|NCT04844970|589695763|FG000|Overall Study|Adverse Event|0|||
163269300|NCT04844970|589695764|FG001|Overall Study|Adverse Event|1|||
163269301|NCT04844970|589695763|FG000|Overall Study|Withdrawal by Subject|2|||
163269302|NCT04844970|589695764|FG001|Overall Study|Withdrawal by Subject|0|||
163269303|NCT00447954|589695765|FG000|Overall Study|Adverse Event|0|||
163269304|NCT00447954|589695766|FG001|Overall Study|Adverse Event|2|||
163269305|NCT00447954|589695767|FG002|Overall Study|Adverse Event|0|||
163269306|NCT00447954|589695765|FG000|Overall Study|Withdrawal by Subject|0|||
163269307|NCT00447954|589695766|FG001|Overall Study|Withdrawal by Subject|1|||
163269308|NCT00447954|589695767|FG002|Overall Study|Withdrawal by Subject|1|||
163269309|NCT00447954|589695765|FG000|Overall Study|Lost to Follow-up|0|||
163362499|NCT04674189|590036524|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
163269310|NCT00447954|589695766|FG001|Overall Study|Lost to Follow-up|1|||
163269311|NCT00447954|589695767|FG002|Overall Study|Lost to Follow-up|0|||
163269312|NCT00447954|589695765|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
163269313|NCT00447954|589695766|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
163269314|NCT00447954|589695767|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
163269315|NCT03757234|589695768|FG000|Overall Study|Adverse Event|0|||
163269316|NCT03757234|589695769|FG001|Overall Study|Adverse Event|0|||
163269317|NCT03757234|589695770|FG002|Overall Study|Adverse Event|0|||
163269318|NCT03757234|589695771|FG003|Overall Study|Adverse Event|0|||
163269319|NCT03757234|589695772|FG004|Overall Study|Adverse Event|1|||
163269320|NCT03757234|589695768|FG000|Overall Study|Lost to Follow-up|1|||
163269321|NCT03757234|589695769|FG001|Overall Study|Lost to Follow-up|0|||
163269322|NCT03757234|589695770|FG002|Overall Study|Lost to Follow-up|0|||
163269323|NCT03757234|589695771|FG003|Overall Study|Lost to Follow-up|0|||
163269324|NCT03757234|589695772|FG004|Overall Study|Lost to Follow-up|1|||
163269325|NCT03757234|589695768|FG000|Overall Study|Withdrawal by Subject|1|||
163269326|NCT03757234|589695769|FG001|Overall Study|Withdrawal by Subject|1|||
163269327|NCT03757234|589695770|FG002|Overall Study|Withdrawal by Subject|0|||
163269328|NCT03757234|589695771|FG003|Overall Study|Withdrawal by Subject|1|||
163269329|NCT03757234|589695772|FG004|Overall Study|Withdrawal by Subject|2|||
163269330|NCT03757234|589695768|FG000|Overall Study|Other|1|||
163269331|NCT03757234|589695769|FG001|Overall Study|Other|1|||
163269332|NCT03757234|589695770|FG002|Overall Study|Other|0|||
163269333|NCT03757234|589695771|FG003|Overall Study|Other|0|||
163269334|NCT03757234|589695772|FG004|Overall Study|Other|0|||
163269335|NCT04908449|589695776|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
163269336|NCT04908449|589695777|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
163269337|NCT04908449|589695776|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
163269338|NCT04908449|589695777|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
163269339|NCT02401308|589695780|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
163269340|NCT02401308|589695781|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
163269341|NCT02736968|589695782|FG000|Overall Study|Lost to Follow-up|0|||
163269342|NCT02736968|589695783|FG001|Overall Study|Lost to Follow-up|0|||
163269343|NCT02736968|589695784|FG002|Overall Study|Lost to Follow-up|0|||
163269344|NCT02736968|589695785|FG003|Overall Study|Lost to Follow-up|0|||
163269345|NCT02736968|589695786|FG004|Overall Study|Lost to Follow-up|0|||
163269346|NCT02736968|589695787|FG005|Overall Study|Lost to Follow-up|0|||
163269347|NCT02736968|589695788|FG006|Overall Study|Lost to Follow-up|5|||
163269348|NCT02736968|589695789|FG007|Overall Study|Lost to Follow-up|2|||
163269349|NCT02736968|589695782|FG000|Overall Study|COVID-19 Pandemic|0|||
163269350|NCT02736968|589695783|FG001|Overall Study|COVID-19 Pandemic|0|||
163269351|NCT02736968|589695784|FG002|Overall Study|COVID-19 Pandemic|0|||
163269352|NCT02736968|589695785|FG003|Overall Study|COVID-19 Pandemic|0|||
163269353|NCT02736968|589695786|FG004|Overall Study|COVID-19 Pandemic|0|||
163269354|NCT02736968|589695787|FG005|Overall Study|COVID-19 Pandemic|0|||
163269355|NCT02736968|589695788|FG006|Overall Study|COVID-19 Pandemic|2|||
163269356|NCT02736968|589695789|FG007|Overall Study|COVID-19 Pandemic|0|||
163269357|NCT02736968|589695782|FG000|Overall Study|Withdrawal by Subject|0|||
163269358|NCT02736968|589695783|FG001|Overall Study|Withdrawal by Subject|0|||
163269359|NCT02736968|589695784|FG002|Overall Study|Withdrawal by Subject|0|||
163269360|NCT02736968|589695785|FG003|Overall Study|Withdrawal by Subject|0|||
163269361|NCT02736968|589695786|FG004|Overall Study|Withdrawal by Subject|0|||
163269362|NCT02736968|589695787|FG005|Overall Study|Withdrawal by Subject|0|||
163269363|NCT02736968|589695788|FG006|Overall Study|Withdrawal by Subject|1|||
163269364|NCT02736968|589695789|FG007|Overall Study|Withdrawal by Subject|0|||
163269365|NCT02294474|589695790|FG000|Overall Study|Adverse Event|7|||
163269366|NCT02294474|589695791|FG001|Overall Study|Adverse Event|7|||
163269367|NCT02294474|589695790|FG000|Overall Study|Lack of Efficacy|2|||
163269368|NCT02294474|589695791|FG001|Overall Study|Lack of Efficacy|1|||
163269369|NCT02294474|589695790|FG000|Overall Study|Protocol Violation|4|||
163269370|NCT02294474|589695791|FG001|Overall Study|Protocol Violation|2|||
163269371|NCT02294474|589695790|FG000|Overall Study|Other than specified above|12|||
163269372|NCT02294474|589695791|FG001|Overall Study|Other than specified above|12|||
163269373|NCT02961374|589695792|FG000|Overall Study|Adverse Event|4|||
163269374|NCT00171873|589695793|FG000|Overall Study|Withdrawal by Subject|4|||
163269375|NCT00171873|589695794|FG001|Overall Study|Withdrawal by Subject|2|||
163269376|NCT00171873|589695793|FG000|Overall Study|Adverse Event|5|||
163269377|NCT00171873|589695794|FG001|Overall Study|Adverse Event|0|||
163269378|NCT00171873|589695793|FG000|Overall Study|Switched to Octreotide|0|||
163269379|NCT00171873|589695794|FG001|Overall Study|Switched to Octreotide|1|||
163269380|NCT02041923|589695795|FG000|Overall Study|Lost to Follow-up|26|||
163269381|NCT02041923|589695796|FG001|Overall Study|Lost to Follow-up|30|||
163269382|NCT02023879|589695799|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
163269383|NCT02023879|589695800|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
163269384|NCT02023879|589695801|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
163269385|NCT02023879|589695799|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
163269386|NCT02023879|589695800|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
163269387|NCT02023879|589695801|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
163269388|NCT02023879|589695799|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
163269389|NCT02023879|589695800|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
163269390|NCT02023879|589695801|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
163269391|NCT02023879|589695799|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
163269392|NCT02023879|589695800|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
163269393|NCT02023879|589695801|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
163269394|NCT02023879|589695799|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
163269395|NCT02023879|589695800|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
163269396|NCT02023879|589695801|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
163269397|NCT02023879|589695799|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
163269398|NCT02023879|589695800|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
163269399|NCT02023879|589695801|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
163269400|NCT02023879|589695799|FG000|Extension Open Label Treatment|Adverse Event|1|||
163269401|NCT02023879|589695800|FG001|Extension Open Label Treatment|Adverse Event|7|||
163269402|NCT02023879|589695801|FG002|Extension Open Label Treatment|Adverse Event|3|||
163269403|NCT02023879|589695799|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
163269404|NCT02023879|589695800|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
163269405|NCT02023879|589695801|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
163269406|NCT02023879|589695799|FG000|Extension Open Label Treatment|Participant moved|1|||
163269407|NCT02023879|589695800|FG001|Extension Open Label Treatment|Participant moved|2|||
163269408|NCT02023879|589695801|FG002|Extension Open Label Treatment|Participant moved|0|||
163269409|NCT02023879|589695799|FG000|Extension Open Label Treatment|Other than specified above|2|||
163269410|NCT02023879|589695800|FG001|Extension Open Label Treatment|Other than specified above|7|||
163269411|NCT02023879|589695801|FG002|Extension Open Label Treatment|Other than specified above|2|||
163269412|NCT00874432|589695802|FG000|Overall Study|Withdrawal by Subject|1|||
163269413|NCT00874432|589695803|FG001|Overall Study|Withdrawal by Subject|0|||
163269414|NCT00874432|589695804|FG002|Overall Study|Withdrawal by Subject|0|||
163269415|NCT00874432|589695805|FG003|Overall Study|Withdrawal by Subject|0|||
163269416|NCT00874432|589695802|FG000|Overall Study|Physician Decision|1|||
163269417|NCT00874432|589695803|FG001|Overall Study|Physician Decision|0|||
163269418|NCT00874432|589695804|FG002|Overall Study|Physician Decision|0|||
163269419|NCT00874432|589695805|FG003|Overall Study|Physician Decision|0|||
163269420|NCT00874432|589695802|FG000|Overall Study|Other|1|||
163269421|NCT00874432|589695803|FG001|Overall Study|Other|2|||
163269422|NCT00874432|589695804|FG002|Overall Study|Other|8|||
163269423|NCT00874432|589695805|FG003|Overall Study|Other|3|||
163269424|NCT05256381|589695806|FG000|Overall Study|Withdrawal by Subject|4|||
163269425|NCT05256381|589695807|FG001|Overall Study|Withdrawal by Subject|0|||
163269426|NCT05256381|589695808|FG002|Overall Study|Withdrawal by Subject|2|||
163269427|NCT05256381|589695809|FG003|Overall Study|Withdrawal by Subject|2|||
163269428|NCT05256381|589695810|FG004|Overall Study|Withdrawal by Subject|8|||
163269429|NCT05256381|589695811|FG005|Overall Study|Withdrawal by Subject|6|||
163269430|NCT05256381|589695806|FG000|Overall Study|Physician Decision|0|||
163269431|NCT05256381|589695807|FG001|Overall Study|Physician Decision|0|||
163269432|NCT05256381|589695808|FG002|Overall Study|Physician Decision|1|||
163269433|NCT05256381|589695809|FG003|Overall Study|Physician Decision|0|||
163269434|NCT05256381|589695810|FG004|Overall Study|Physician Decision|2|||
163269435|NCT05256381|589695811|FG005|Overall Study|Physician Decision|0|||
163269436|NCT05256381|589695806|FG000|Overall Study|Death|17|||
163269437|NCT05256381|589695807|FG001|Overall Study|Death|3|||
163269438|NCT05256381|589695808|FG002|Overall Study|Death|4|||
163269439|NCT05256381|589695809|FG003|Overall Study|Death|5|||
163269440|NCT05256381|589695810|FG004|Overall Study|Death|24|||
163269441|NCT05256381|589695811|FG005|Overall Study|Death|21|||
163269442|NCT05256381|589695806|FG000|Overall Study|Other, not specified|0|||
163269443|NCT05256381|589695807|FG001|Overall Study|Other, not specified|0|||
163269444|NCT05256381|589695808|FG002|Overall Study|Other, not specified|0|||
163269445|NCT05256381|589695809|FG003|Overall Study|Other, not specified|0|||
163269446|NCT05256381|589695810|FG004|Overall Study|Other, not specified|2|||
163269447|NCT05256381|589695811|FG005|Overall Study|Other, not specified|1|||
163269448|NCT05256381|589695806|FG000|Overall Study|Study terminated by sponsor|18|||
163269449|NCT05256381|589695807|FG001|Overall Study|Study terminated by sponsor|5|||
163269450|NCT05256381|589695808|FG002|Overall Study|Study terminated by sponsor|5|||
163269451|NCT05256381|589695809|FG003|Overall Study|Study terminated by sponsor|5|||
163269452|NCT05256381|589695810|FG004|Overall Study|Study terminated by sponsor|18|||
163269453|NCT05256381|589695811|FG005|Overall Study|Study terminated by sponsor|11|||
163269454|NCT05256381|589695806|FG000|Overall Study|Lost to Follow-up|1|||
163269455|NCT05256381|589695807|FG001|Overall Study|Lost to Follow-up|0|||
163269456|NCT05256381|589695808|FG002|Overall Study|Lost to Follow-up|0|||
163269457|NCT05256381|589695809|FG003|Overall Study|Lost to Follow-up|0|||
163269458|NCT05256381|589695810|FG004|Overall Study|Lost to Follow-up|1|||
163269459|NCT05256381|589695811|FG005|Overall Study|Lost to Follow-up|0|||
163269460|NCT01518946|589695812|FG000|Open-label Phase|Other|4|||
163269461|NCT01518946|589695813|FG001|Open-label Phase|Other|0|||
163269462|NCT01518946|589695814|FG002|Open-label Phase|Other|0|||
163269463|NCT01518946|589695812|FG000|Randomized Phase (First Intervention)|Other|0|||
163269464|NCT01518946|589695813|FG001|Randomized Phase (First Intervention)|Other|1|||
163269465|NCT01518946|589695814|FG002|Randomized Phase (First Intervention)|Other|0|||
163269466|NCT00381641|589695815|FG000|Overall Study|Withdrawal by Subject|0|||
163269467|NCT00381641|589695816|FG001|Overall Study|Withdrawal by Subject|2|||
163269468|NCT00802737|589697887|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
163269469|NCT00802737|589697888|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
163269470|NCT00802737|589697889|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
163269471|NCT00802737|589697887|FG000|Overall Study|Death|6|||
163269472|NCT00802737|589697888|FG001|Overall Study|Death|5|||
163269473|NCT00802737|589697889|FG002|Overall Study|Death|1|||
163269474|NCT00802737|589697887|FG000|Overall Study|Adverse Event|1|||
163269475|NCT00802737|589697888|FG001|Overall Study|Adverse Event|0|||
163269476|NCT00802737|589697889|FG002|Overall Study|Adverse Event|0|||
163269477|NCT00802737|589697887|FG000|Overall Study|Received Prohibited Therapy|1|||
163269478|NCT00802737|589697888|FG001|Overall Study|Received Prohibited Therapy|0|||
163269479|NCT00802737|589697889|FG002|Overall Study|Received Prohibited Therapy|0|||
163269480|NCT00802737|589697887|FG000|Overall Study|Ongoing CLL-Treatment|0|||
163269481|NCT00802737|589697888|FG001|Overall Study|Ongoing CLL-Treatment|1|||
163269482|NCT00802737|589697889|FG002|Overall Study|Ongoing CLL-Treatment|0|||
163269483|NCT00802737|589697887|FG000|Overall Study|Participant too Unwell|0|||
163269484|NCT00802737|589697888|FG001|Overall Study|Participant too Unwell|2|||
163269485|NCT00802737|589697889|FG002|Overall Study|Participant too Unwell|0|||
163269486|NCT03864926|589697890|FG000|Overall Study|Death|0|||
163269487|NCT03864926|589697891|FG001|Overall Study|Death|2|||
163269488|NCT00445601|589697892|FG000|Overall Study|Withdrawal by Subject|11|||
163269489|NCT00445601|589697893|FG001|Overall Study|Withdrawal by Subject|11|||
163269490|NCT00445601|589697892|FG000|Overall Study|TURBT Complication|12|||
163269491|NCT00445601|589697893|FG001|Overall Study|TURBT Complication|8|||
163269492|NCT00445601|589697892|FG000|Overall Study|Incorrect Disease Status|6|||
163269493|NCT00445601|589697893|FG001|Overall Study|Incorrect Disease Status|6|||
163269494|NCT00445601|589697892|FG000|Overall Study|Drug Delivery Issue|2|||
163269495|NCT00445601|589697893|FG001|Overall Study|Drug Delivery Issue|2|||
163269496|NCT00445601|589697892|FG000|Overall Study|Adverse Event|2|||
163269497|NCT00445601|589697893|FG001|Overall Study|Adverse Event|0|||
163269498|NCT00445601|589697892|FG000|Overall Study|Death prior to TURBT|0|||
163269499|NCT00445601|589697893|FG001|Overall Study|Death prior to TURBT|1|||
163269500|NCT00619476|589697894|FG000|Overall Study|Adverse Event|12|||
163269501|NCT00619476|589697895|FG001|Overall Study|Adverse Event|6|||
163269502|NCT00619476|589697896|FG002|Overall Study|Adverse Event|12|||
163269503|NCT00619476|589697897|FG003|Overall Study|Adverse Event|16|||
163269504|NCT00619476|589697894|FG000|Overall Study|Lack of Efficacy|6|||
163269505|NCT00619476|589697895|FG001|Overall Study|Lack of Efficacy|1|||
163269506|NCT00619476|589697896|FG002|Overall Study|Lack of Efficacy|1|||
163269507|NCT00619476|589697897|FG003|Overall Study|Lack of Efficacy|4|||
163269508|NCT00619476|589697894|FG000|Overall Study|Protocol Violation|5|||
163269509|NCT00619476|589697895|FG001|Overall Study|Protocol Violation|4|||
163269510|NCT00619476|589697896|FG002|Overall Study|Protocol Violation|4|||
163269511|NCT00619476|589697897|FG003|Overall Study|Protocol Violation|9|||
163269512|NCT00619476|589697894|FG000|Overall Study|Lost to Follow-up|1|||
163269513|NCT00619476|589697895|FG001|Overall Study|Lost to Follow-up|2|||
163269514|NCT00619476|589697896|FG002|Overall Study|Lost to Follow-up|0|||
163269515|NCT00619476|589697897|FG003|Overall Study|Lost to Follow-up|1|||
163269516|NCT00619476|589697894|FG000|Overall Study|Investigator Discretion|2|||
163269517|NCT00619476|589697895|FG001|Overall Study|Investigator Discretion|2|||
163269518|NCT00619476|589697896|FG002|Overall Study|Investigator Discretion|2|||
163269519|NCT00619476|589697897|FG003|Overall Study|Investigator Discretion|0|||
163269520|NCT00619476|589697894|FG000|Overall Study|Withdrawal by Subject|5|||
163269521|NCT00619476|589697895|FG001|Overall Study|Withdrawal by Subject|7|||
163269522|NCT00619476|589697896|FG002|Overall Study|Withdrawal by Subject|5|||
163269523|NCT00619476|589697897|FG003|Overall Study|Withdrawal by Subject|4|||
163269524|NCT01091428|589697898|FG000|Phase 1|Progressive Disease|24|||
163269525|NCT01091428|589697899|FG001|Phase 1|Progressive Disease|8|||
163269526|NCT01091428|589697900|FG002|Phase 1|Progressive Disease|0|||
163269527|NCT01091428|589697901|FG003|Phase 1|Progressive Disease|0|||
163269528|NCT01091428|589697898|FG000|Phase 1|Symptomatic Deterioration|3|||
163269529|NCT01091428|589697899|FG001|Phase 1|Symptomatic Deterioration|2|||
163269530|NCT01091428|589697900|FG002|Phase 1|Symptomatic Deterioration|0|||
163269531|NCT01091428|589697901|FG003|Phase 1|Symptomatic Deterioration|0|||
163269532|NCT01091428|589697898|FG000|Phase 1|Adverse Event|2|||
163269533|NCT01091428|589697899|FG001|Phase 1|Adverse Event|0|||
163269534|NCT01091428|589697900|FG002|Phase 1|Adverse Event|0|||
163269535|NCT01091428|589697901|FG003|Phase 1|Adverse Event|0|||
163269536|NCT01091428|589697898|FG000|Phase 1|Withdrawal by Subject|7|||
163269537|NCT01091428|589697899|FG001|Phase 1|Withdrawal by Subject|0|||
163269538|NCT01091428|589697900|FG002|Phase 1|Withdrawal by Subject|0|||
163269539|NCT01091428|589697901|FG003|Phase 1|Withdrawal by Subject|0|||
163269540|NCT01091428|589697898|FG000|Phase 1|Reason not specified|0|||
163269541|NCT01091428|589697899|FG001|Phase 1|Reason not specified|1|||
163269542|NCT01091428|589697900|FG002|Phase 1|Reason not specified|0|||
163269543|NCT01091428|589697901|FG003|Phase 1|Reason not specified|0|||
163269544|NCT01091428|589697898|FG000|Phase 1|Single-Patient IND|2|||
163269545|NCT01091428|589697899|FG001|Phase 1|Single-Patient IND|0|||
163269546|NCT01091428|589697900|FG002|Phase 1|Single-Patient IND|0|||
163269547|NCT01091428|589697901|FG003|Phase 1|Single-Patient IND|0|||
163269548|NCT01091428|589697898|FG000|Phase 2|Progressive Disease|0|||
163269549|NCT01091428|589697899|FG001|Phase 2|Progressive Disease|0|||
163269550|NCT01091428|589697900|FG002|Phase 2|Progressive Disease|44|||
163269551|NCT01091428|589697901|FG003|Phase 2|Progressive Disease|46|||
163269552|NCT01091428|589697898|FG000|Phase 2|Symptomatic Deterioration|0|||
163269553|NCT01091428|589697899|FG001|Phase 2|Symptomatic Deterioration|0|||
163269554|NCT01091428|589697900|FG002|Phase 2|Symptomatic Deterioration|1|||
163269555|NCT01091428|589697901|FG003|Phase 2|Symptomatic Deterioration|6|||
163269556|NCT01091428|589697898|FG000|Phase 2|Adverse Event|0|||
163269557|NCT01091428|589697899|FG001|Phase 2|Adverse Event|0|||
163269558|NCT01091428|589697900|FG002|Phase 2|Adverse Event|12|||
163269559|NCT01091428|589697901|FG003|Phase 2|Adverse Event|5|||
163269560|NCT01091428|589697898|FG000|Phase 2|Withdrawal by Subject|0|||
163269561|NCT01091428|589697899|FG001|Phase 2|Withdrawal by Subject|0|||
163269562|NCT01091428|589697900|FG002|Phase 2|Withdrawal by Subject|9|||
163269563|NCT01091428|589697901|FG003|Phase 2|Withdrawal by Subject|8|||
163269564|NCT01091428|589697898|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
163269565|NCT01091428|589697899|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
163269566|NCT01091428|589697900|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
163269567|NCT01091428|589697901|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
163269568|NCT01091428|589697898|FG000|Phase 2|Reason not specified|0|||
163269569|NCT01091428|589697899|FG001|Phase 2|Reason not specified|0|||
163269570|NCT01091428|589697900|FG002|Phase 2|Reason not specified|4|||
163269571|NCT01091428|589697901|FG003|Phase 2|Reason not specified|3|||
163269572|NCT01091428|589697898|FG000|Phase 2|Physician Decision|0|||
163269573|NCT01091428|589697899|FG001|Phase 2|Physician Decision|0|||
163269574|NCT01091428|589697900|FG002|Phase 2|Physician Decision|2|||
163269575|NCT01091428|589697901|FG003|Phase 2|Physician Decision|0|||
163269576|NCT01625910|589697906|FG000|Overall Study|Lost to Follow-up|3|||
163269577|NCT01625910|589697907|FG001|Overall Study|Lost to Follow-up|4|||
163269578|NCT03918239|589697913|FG000|Overall Study|Lost to Follow-up|3|||
163269579|NCT03918239|589697914|FG001|Overall Study|Lost to Follow-up|1|||
163269580|NCT03918239|589697913|FG000|Overall Study|Pregnancy|0|||
163269581|NCT03918239|589697914|FG001|Overall Study|Pregnancy|2|||
163269582|NCT03918239|589697913|FG000|Overall Study|Withdrawal by Subject|3|||
163269583|NCT03918239|589697914|FG001|Overall Study|Withdrawal by Subject|3|||
163269584|NCT03918239|589697913|FG000|Overall Study|positive urine drug screening results|4|||
163269585|NCT03918239|589697914|FG001|Overall Study|positive urine drug screening results|1|||
163269586|NCT01984424|589697916|FG000|Overall Study|Withdrawal by Subject|3|||
163269587|NCT01984424|589697917|FG001|Overall Study|Withdrawal by Subject|5|||
163269588|NCT01984424|589697916|FG000|Overall Study|Sponsor Decision|0|||
163269589|NCT01984424|589697917|FG001|Overall Study|Sponsor Decision|1|||
163269590|NCT01984424|589697916|FG000|Overall Study|Lost to Follow-up|0|||
163269591|NCT01984424|589697917|FG001|Overall Study|Lost to Follow-up|1|||
163269592|NCT01807221|589697920|FG000|Overall Study|Progressive disease|1|||
163269593|NCT01807221|589697921|FG001|Overall Study|Progressive disease|0|||
163269594|NCT01807221|589697922|FG002|Overall Study|Progressive disease|1|||
163269595|NCT01807221|589697923|FG003|Overall Study|Progressive disease|0|||
163269596|NCT01807221|589697924|FG004|Overall Study|Progressive disease|0|||
163269597|NCT01807221|589697925|FG005|Overall Study|Progressive disease|0|||
163269598|NCT01807221|589697920|FG000|Overall Study|Death|7|||
163269599|NCT01807221|589697921|FG001|Overall Study|Death|9|||
163269600|NCT01807221|589697922|FG002|Overall Study|Death|4|||
163269601|NCT01807221|589697923|FG003|Overall Study|Death|2|||
163269602|NCT01807221|589697924|FG004|Overall Study|Death|1|||
163269603|NCT01807221|589697925|FG005|Overall Study|Death|6|||
163269604|NCT01807221|589697920|FG000|Overall Study|Physician Decision|2|||
163269605|NCT01807221|589697921|FG001|Overall Study|Physician Decision|1|||
163269606|NCT01807221|589697922|FG002|Overall Study|Physician Decision|0|||
163269607|NCT01807221|589697923|FG003|Overall Study|Physician Decision|0|||
163269608|NCT01807221|589697924|FG004|Overall Study|Physician Decision|0|||
163269609|NCT01807221|589697925|FG005|Overall Study|Physician Decision|0|||
163269610|NCT01807221|589697920|FG000|Overall Study|Adverse Event|33|||
163269611|NCT01807221|589697921|FG001|Overall Study|Adverse Event|22|||
163269612|NCT01807221|589697922|FG002|Overall Study|Adverse Event|26|||
163269613|NCT01807221|589697923|FG003|Overall Study|Adverse Event|25|||
163269614|NCT01807221|589697924|FG004|Overall Study|Adverse Event|18|||
163269615|NCT01807221|589697925|FG005|Overall Study|Adverse Event|21|||
163269616|NCT01807221|589697920|FG000|Overall Study|Protocol Violation|0|||
163269617|NCT01807221|589697921|FG001|Overall Study|Protocol Violation|2|||
163269618|NCT01807221|589697922|FG002|Overall Study|Protocol Violation|1|||
163269619|NCT01807221|589697923|FG003|Overall Study|Protocol Violation|2|||
163269620|NCT01807221|589697924|FG004|Overall Study|Protocol Violation|0|||
163269621|NCT01807221|589697925|FG005|Overall Study|Protocol Violation|1|||
163269622|NCT01807221|589697920|FG000|Overall Study|Non-compliance|1|||
163269623|NCT01807221|589697921|FG001|Overall Study|Non-compliance|2|||
163269624|NCT01807221|589697922|FG002|Overall Study|Non-compliance|0|||
163269625|NCT01807221|589697923|FG003|Overall Study|Non-compliance|1|||
163269626|NCT01807221|589697924|FG004|Overall Study|Non-compliance|0|||
163269627|NCT01807221|589697925|FG005|Overall Study|Non-compliance|0|||
163269628|NCT01807221|589697920|FG000|Overall Study|Logistical difficulties|0|||
163269629|NCT01807221|589697921|FG001|Overall Study|Logistical difficulties|1|||
163269630|NCT01807221|589697922|FG002|Overall Study|Logistical difficulties|0|||
163269631|NCT01807221|589697923|FG003|Overall Study|Logistical difficulties|0|||
163269632|NCT01807221|589697924|FG004|Overall Study|Logistical difficulties|1|||
163269633|NCT01807221|589697925|FG005|Overall Study|Logistical difficulties|0|||
163269634|NCT01807221|589697920|FG000|Overall Study|Withdrawal by Subject|33|||
163269635|NCT01807221|589697921|FG001|Overall Study|Withdrawal by Subject|15|||
163269636|NCT01807221|589697922|FG002|Overall Study|Withdrawal by Subject|8|||
163269637|NCT01807221|589697923|FG003|Overall Study|Withdrawal by Subject|14|||
163269638|NCT01807221|589697924|FG004|Overall Study|Withdrawal by Subject|16|||
163269639|NCT01807221|589697925|FG005|Overall Study|Withdrawal by Subject|13|||
163269640|NCT01807221|589697920|FG000|Overall Study|Sponsor decision|2|||
163269641|NCT01807221|589697921|FG001|Overall Study|Sponsor decision|0|||
163269642|NCT01807221|589697922|FG002|Overall Study|Sponsor decision|1|||
163269643|NCT01807221|589697923|FG003|Overall Study|Sponsor decision|1|||
163269644|NCT01807221|589697924|FG004|Overall Study|Sponsor decision|0|||
163269645|NCT01807221|589697925|FG005|Overall Study|Sponsor decision|0|||
163269646|NCT01807221|589697920|FG000|Overall Study|Lost to Follow-up|1|||
163269647|NCT01807221|589697921|FG001|Overall Study|Lost to Follow-up|0|||
163269648|NCT01807221|589697922|FG002|Overall Study|Lost to Follow-up|2|||
163269649|NCT01807221|589697923|FG003|Overall Study|Lost to Follow-up|1|||
163269650|NCT01807221|589697924|FG004|Overall Study|Lost to Follow-up|0|||
163269651|NCT01807221|589697925|FG005|Overall Study|Lost to Follow-up|0|||
163269652|NCT01087723|589697927|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
163269653|NCT01087723|589697928|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
163269654|NCT01087723|589697927|FG000|Overall Study|Withdrawal by Subject|10|||
163269655|NCT01087723|589697928|FG001|Overall Study|Withdrawal by Subject|13|||
163269656|NCT01087723|589697927|FG000|Overall Study|Physician Decision|2|||
163269657|NCT01087723|589697928|FG001|Overall Study|Physician Decision|0|||
163269658|NCT01087723|589697927|FG000|Overall Study|Lost to Follow-up|1|||
163269659|NCT01087723|589697928|FG001|Overall Study|Lost to Follow-up|4|||
163269660|NCT01087723|589697927|FG000|Overall Study|Reason Not Specified|1|||
163269661|NCT01087723|589697928|FG001|Overall Study|Reason Not Specified|2|||
163269662|NCT01868035|589697929|FG000|Overall Study|Lost to Follow-up|3|||
163269663|NCT01868035|589697929|FG000|Overall Study|Withdrawal by Subject|1|||
163269664|NCT01868035|589697929|FG000|Overall Study|Progressive Disease|2|||
163269665|NCT01868035|589697929|FG000|Overall Study|Non-compliance|1|||
163269666|NCT01757665|589697935|FG000|Overall Study|Still on Study - Visit Completed|240|||
163269667|NCT01757665|589697936|FG001|Overall Study|Still on Study - Visit Completed|30|||
163269668|NCT01757665|589697935|FG000|Overall Study|Still on Study - Visit Pending|398|||
163269669|NCT01757665|589697936|FG001|Overall Study|Still on Study - Visit Pending|40|||
163269670|NCT01757665|589697935|FG000|Overall Study|Still on Study - Missed Visit|14|||
163269671|NCT01757665|589697936|FG001|Overall Study|Still on Study - Missed Visit|1|||
163269672|NCT01757665|589697935|FG000|Overall Study|Death|25|||
163269673|NCT01757665|589697936|FG001|Overall Study|Death|8|||
163269674|NCT01757665|589697935|FG000|Overall Study|Explant|1|||
163269675|NCT01757665|589697936|FG001|Overall Study|Explant|2|||
163269676|NCT01757665|589697935|FG000|Overall Study|Withdrawal by Subject|10|||
163269677|NCT01757665|589697936|FG001|Overall Study|Withdrawal by Subject|0|||
163269678|NCT01757665|589697935|FG000|Overall Study|Lost to Follow-up|1|||
163269679|NCT01757665|589697936|FG001|Overall Study|Lost to Follow-up|1|||
163269680|NCT01757665|589697935|FG000|Overall Study|Not Implanted with Device|5|||
163269681|NCT01757665|589697936|FG001|Overall Study|Not Implanted with Device|1|||
163269682|NCT03632434|589697941|FG000|Overall Study|Withdrawal by Subject|2|||
163269683|NCT04297241|589697942|FG000|Overall Study|Withdrawal by Subject|1|||
163269684|NCT04297241|589697942|FG000|Overall Study|Adverse Event|1|||
163269685|NCT04297241|589697942|FG000|Overall Study|Physician Decision|3|||
163269686|NCT02836613|589697949|FG000|Overall Study|Accidental drowning|1|||
163269687|NCT02836613|589697950|FG001|Overall Study|Accidental drowning|0|||
163269688|NCT02836613|589697949|FG000|Overall Study|Lost to Follow-up|0|||
163269689|NCT02836613|589697950|FG001|Overall Study|Lost to Follow-up|1|||
163269690|NCT02836613|589697949|FG000|Overall Study|Withdrawal by Subject|0|||
163269691|NCT02836613|589697950|FG001|Overall Study|Withdrawal by Subject|2|||
163269692|NCT01799720|589697951|FG000|Overall Study|Withdrawal by Subject|3|||
163269693|NCT01799720|589697952|FG001|Overall Study|Withdrawal by Subject|0|||
163269694|NCT01799720|589697953|FG002|Overall Study|Withdrawal by Subject|0|||
163269695|NCT01799720|589697951|FG000|Overall Study|Protocol Violation|0|||
163269696|NCT01799720|589697952|FG001|Overall Study|Protocol Violation|1|||
163269697|NCT01799720|589697953|FG002|Overall Study|Protocol Violation|0|||
163269698|NCT01799720|589697951|FG000|Overall Study|Pregnancy|0|||
163269699|NCT01799720|589697952|FG001|Overall Study|Pregnancy|0|||
163269700|NCT01799720|589697953|FG002|Overall Study|Pregnancy|1|||
163269701|NCT04276090|589697954|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
163269702|NCT04276090|589697955|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
163269703|NCT05407311|589697971|FG000|Overall Study|Withdrawal by Subject|5|||
163269704|NCT05407311|589697971|FG000|Overall Study|Protocol Violation|3|||
163269705|NCT05407311|589697971|FG000|Overall Study|Physician Decision|1|||
163269706|NCT05407311|589697971|FG000|Overall Study|Non-compliance|1|||
163269707|NCT01265823|589697972|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
163269708|NCT01265823|589697972|FG000|Overall Study|Failure to Return|4|||
163269709|NCT01265823|589697972|FG000|Overall Study|Protocol Violation|1|||
163269710|NCT01265823|589697972|FG000|Overall Study|Participant Request|1|||
163269711|NCT01263106|589697973|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
163269712|NCT01263106|589697974|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
163269713|NCT05027074|589697980|FG000|Overall Study|Death|47|||
163269714|NCT05027074|589697981|FG001|Overall Study|Death|42|||
163269715|NCT05027074|589697982|FG002|Overall Study|Death|39|||
163269716|NCT05027074|589697980|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163269717|NCT05027074|589697981|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163269718|NCT05027074|589697982|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163269719|NCT05027074|589697980|FG000|Overall Study|Site Terminated By Sponsor|3|||
163269720|NCT05027074|589697981|FG001|Overall Study|Site Terminated By Sponsor|0|||
163269721|NCT05027074|589697982|FG002|Overall Study|Site Terminated By Sponsor|2|||
163269722|NCT05027074|589697980|FG000|Overall Study|Withdrawal by Subject|13|||
163269723|NCT05027074|589697981|FG001|Overall Study|Withdrawal by Subject|8|||
163269724|NCT05027074|589697982|FG002|Overall Study|Withdrawal by Subject|10|||
163269725|NCT05027074|589697980|FG000|Overall Study|Lost to Follow-up|2|||
163269726|NCT05027074|589697981|FG001|Overall Study|Lost to Follow-up|4|||
163269727|NCT05027074|589697982|FG002|Overall Study|Lost to Follow-up|3|||
163269728|NCT05027074|589697980|FG000|Overall Study|Status Not Recorded|0|||
163269729|NCT05027074|589697981|FG001|Overall Study|Status Not Recorded|0|||
163269730|NCT05027074|589697982|FG002|Overall Study|Status Not Recorded|1|||
163269731|NCT03169881|589697983|FG000|Overall Study|Incomplete Follow-up|10|||
163269732|NCT03169881|589697984|FG001|Overall Study|Incomplete Follow-up|15|||
163269733|NCT03169881|589697983|FG000|Overall Study|Lost to Follow-up|18|||
163269734|NCT03169881|589697984|FG001|Overall Study|Lost to Follow-up|20|||
163269735|NCT03169881|589697983|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
163269736|NCT03169881|589697984|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
163269737|NCT02180438|589697990|FG000|Overall Study|Lost to Follow-up|1|||
163269738|NCT00785707|589697991|FG000|Overall Study|Lost to Follow-up|7|||
163269739|NCT02090634|589697992|FG000|Overall Study|Lost to Follow-up|0|||
163269740|NCT02090634|589697993|FG001|Overall Study|Lost to Follow-up|1|||
163269741|NCT02090634|589697992|FG000|Overall Study|Death|0|||
163269742|NCT02090634|589697993|FG001|Overall Study|Death|1|||
163269743|NCT02090634|589697992|FG000|Overall Study|Protocol Violation|3|||
163269744|NCT02090634|589697993|FG001|Overall Study|Protocol Violation|1|||
163269745|NCT02090634|589697992|FG000|Overall Study|Adverse Event|2|||
163269746|NCT02090634|589697993|FG001|Overall Study|Adverse Event|0|||
163269747|NCT00147225|589697999|FG000|Overall Study|Withdrawal by Subject|1|||
163269748|NCT00147225|589698000|FG001|Overall Study|Withdrawal by Subject|0|||
163269749|NCT00147225|589698001|FG002|Overall Study|Withdrawal by Subject|1|||
163269750|NCT00147225|589698002|FG003|Overall Study|Withdrawal by Subject|0|||
163269751|NCT00147225|589698003|FG004|Overall Study|Withdrawal by Subject|0|||
163269752|NCT00147225|589698004|FG005|Overall Study|Withdrawal by Subject|1|||
163269753|NCT00147225|589697999|FG000|Overall Study|Adverse Event|0|||
163269754|NCT00147225|589698000|FG001|Overall Study|Adverse Event|0|||
163269755|NCT00147225|589698001|FG002|Overall Study|Adverse Event|1|||
163269756|NCT00147225|589698002|FG003|Overall Study|Adverse Event|1|||
163269757|NCT00147225|589698003|FG004|Overall Study|Adverse Event|0|||
163269758|NCT00147225|589698004|FG005|Overall Study|Adverse Event|0|||
163269759|NCT00147225|589697999|FG000|Overall Study|Screen Failure|0|||
163269760|NCT00147225|589698000|FG001|Overall Study|Screen Failure|0|||
163269761|NCT00147225|589698001|FG002|Overall Study|Screen Failure|0|||
163269762|NCT00147225|589698002|FG003|Overall Study|Screen Failure|0|||
163269763|NCT00147225|589698003|FG004|Overall Study|Screen Failure|1|||
163269764|NCT00147225|589698004|FG005|Overall Study|Screen Failure|0|||
163269765|NCT00147225|589697999|FG000|Overall Study|Chemotherapy Changed|0|||
163269766|NCT00147225|589698000|FG001|Overall Study|Chemotherapy Changed|0|||
163269767|NCT00147225|589698001|FG002|Overall Study|Chemotherapy Changed|0|||
163269768|NCT00147225|589698002|FG003|Overall Study|Chemotherapy Changed|0|||
163269769|NCT00147225|589698003|FG004|Overall Study|Chemotherapy Changed|0|||
163269770|NCT00147225|589698004|FG005|Overall Study|Chemotherapy Changed|1|||
163269771|NCT01032044|589698007|FG000|Overall Study|Protocol Violation|14|||
163269772|NCT01032044|589698008|FG001|Overall Study|Protocol Violation|8|||
163269773|NCT01032044|589698007|FG000|Overall Study|Adverse Event|0|||
163269774|NCT01032044|589698008|FG001|Overall Study|Adverse Event|1|||
163269775|NCT01032044|589698007|FG000|Overall Study|Lost to Follow-up|11|||
163269776|NCT01032044|589698008|FG001|Overall Study|Lost to Follow-up|11|||
163269777|NCT01567865|589698015|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
163269778|NCT01567865|589698016|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
163269779|NCT01567865|589698017|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
163411172|NCT00852995|590212996|FG000|Overall Study|Moved Out of Area|1|||
163269780|NCT01567865|589698018|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
163269781|NCT01567865|589698015|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
163269782|NCT01567865|589698016|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
163269783|NCT01567865|589698017|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
163269784|NCT01567865|589698018|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
163269785|NCT01051063|589698031|FG000|Overall Study|Death|2|||
163269786|NCT01051063|589698032|FG001|Overall Study|Death|2|||
163269787|NCT01051063|589698031|FG000|Overall Study|Withdrawal by Subject|1|||
163269788|NCT01051063|589698032|FG001|Overall Study|Withdrawal by Subject|1|||
163269789|NCT01051063|589698031|FG000|Overall Study|Termination of the study|5|||
163269790|NCT01051063|589698032|FG001|Overall Study|Termination of the study|0|||
163269791|NCT01051063|589698031|FG000|Overall Study|Moved from the study site area|1|||
163269792|NCT01051063|589698032|FG001|Overall Study|Moved from the study site area|0|||
163269793|NCT01051063|589698031|FG000|Overall Study|Other|1|||
163269794|NCT01051063|589698032|FG001|Overall Study|Other|0|||
163269795|NCT01051063|589698031|FG000|Overall Study|Lost to Follow-up|0|||
163269796|NCT01051063|589698032|FG001|Overall Study|Lost to Follow-up|1|||
163269797|NCT05569954|589698033|FG000|Overall Study|Lost to Follow-up|3|||
163269798|NCT05569954|589698034|FG001|Overall Study|Lost to Follow-up|4|||
163269799|NCT05569954|589698033|FG000|Overall Study|Protocol Violation|1|||
163269800|NCT05569954|589698034|FG001|Overall Study|Protocol Violation|2|||
163269801|NCT05569954|589698033|FG000|Overall Study|Withdrawal by Subject|4|||
163269802|NCT05569954|589698034|FG001|Overall Study|Withdrawal by Subject|2|||
163269803|NCT03857841|589698044|FG000|Overall Study|Death|1|||
163269804|NCT03857841|589698045|FG001|Overall Study|Death|0|||
163269805|NCT03857841|589698046|FG002|Overall Study|Death|0|||
163269806|NCT03857841|589698047|FG003|Overall Study|Death|0|||
163269807|NCT03857841|589698044|FG000|Overall Study|Study Terminated by Sponsor|1|||
163269808|NCT03857841|589698045|FG001|Overall Study|Study Terminated by Sponsor|0|||
163269809|NCT03857841|589698046|FG002|Overall Study|Study Terminated by Sponsor|0|||
163269810|NCT03857841|589698047|FG003|Overall Study|Study Terminated by Sponsor|0|||
163269811|NCT00384059|589698048|FG000|Infant Series|Not consented|2|||
163269812|NCT00384059|589698049|FG001|Infant Series|Not consented|6|||
163269813|NCT00384059|589698048|FG000|Infant Series|Withdrawal by Subject|2|||
163269814|NCT00384059|589698049|FG001|Infant Series|Withdrawal by Subject|2|||
163269815|NCT00384059|589698048|FG000|Infant Series|Adverse Event|1|||
163269816|NCT00384059|589698049|FG001|Infant Series|Adverse Event|2|||
163269817|NCT00384059|589698048|FG000|Infant Series|Protocol Violation|1|||
163269818|NCT00384059|589698049|FG001|Infant Series|Protocol Violation|2|||
163269819|NCT00384059|589698048|FG000|Infant Series|Lost to Follow-up|0|||
163269820|NCT00384059|589698049|FG001|Infant Series|Lost to Follow-up|1|||
163269821|NCT00384059|589698048|FG000|After Infant Series|Protocol Violation|2|||
163269822|NCT00384059|589698049|FG001|After Infant Series|Protocol Violation|3|||
163269823|NCT00384059|589698048|FG000|After Infant Series|Withdrawal by Subject|2|||
163269824|NCT00384059|589698049|FG001|After Infant Series|Withdrawal by Subject|2|||
163269825|NCT00384059|589698048|FG000|After Infant Series|Failed to Return|0|||
163269826|NCT00384059|589698049|FG001|After Infant Series|Failed to Return|2|||
163269827|NCT00384059|589698048|FG000|After Infant Series|Adverse Event|0|||
163269828|NCT00384059|589698049|FG001|After Infant Series|Adverse Event|1|||
163269829|NCT00384059|589698048|FG000|After Infant Series|Physician Decision|0|||
163269830|NCT00384059|589698049|FG001|After Infant Series|Physician Decision|1|||
163269831|NCT00384059|589698048|FG000|After Infant Series|Lost to Follow-up|0|||
163269832|NCT00384059|589698049|FG001|After Infant Series|Lost to Follow-up|1|||
163269833|NCT00384059|589698048|FG000|Toddler Dose|Lost to Follow-up|1|||
163269834|NCT00384059|589698049|FG001|Toddler Dose|Lost to Follow-up|1|||
163269835|NCT00384059|589698048|FG000|Toddler Dose|Failed to return|0|||
163269836|NCT00384059|589698049|FG001|Toddler Dose|Failed to return|1|||
163362500|NCT04674189|590036525|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
163362501|NCT04674189|590036523|FG000|Overall Study|Physician Decision|1|||
163362502|NCT04674189|590036524|FG001|Overall Study|Physician Decision|0|||
163362503|NCT04674189|590036525|FG002|Overall Study|Physician Decision|0|||
163362504|NCT04674189|590036523|FG000|Overall Study|Withdrawal by Participant|83|||
163362505|NCT04674189|590036524|FG001|Overall Study|Withdrawal by Participant|71|||
163362506|NCT04674189|590036525|FG002|Overall Study|Withdrawal by Participant|142|||
163362507|NCT04674189|590036523|FG000|Overall Study|Lost to Follow-up|55|||
163362508|NCT04674189|590036524|FG001|Overall Study|Lost to Follow-up|53|||
163362509|NCT04674189|590036525|FG002|Overall Study|Lost to Follow-up|44|||
163362510|NCT04674189|590036523|FG000|Overall Study|Miscellaneous|27|||
163362511|NCT04674189|590036524|FG001|Overall Study|Miscellaneous|23|||
163362512|NCT04674189|590036525|FG002|Overall Study|Miscellaneous|207|||
163362513|NCT04674189|590036523|FG000|Overall Study|Did Not Receive Treatment|3|||
163362514|NCT04674189|590036524|FG001|Overall Study|Did Not Receive Treatment|1|||
163362515|NCT04674189|590036525|FG002|Overall Study|Did Not Receive Treatment|2|||
163362516|NCT00583947|590036535|FG000|Cross-over Period|Adverse Event|2|||
163362517|NCT00583947|590036536|FG001|Cross-over Period|Adverse Event|0|||
163362518|NCT00583947|590036535|FG000|Cross-over Period|Withdrawal by Subject|2|||
163362519|NCT00583947|590036536|FG001|Cross-over Period|Withdrawal by Subject|0|||
163362520|NCT00583947|590036535|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
163362521|NCT00583947|590036536|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
163362522|NCT00583947|590036535|FG000|Cross-over Period|Other|1|||
163362523|NCT00583947|590036536|FG001|Cross-over Period|Other|1|||
163362524|NCT01261247|590036537|FG000|Overall Study|Ineligible|2|||
163362525|NCT05226130|590036538|FG000|Overall Study|Lost to Follow-up|0|||
163362526|NCT05226130|590036539|FG001|Overall Study|Lost to Follow-up|1|||
163362527|NCT05226130|590036538|FG000|Overall Study|Not treatment adherent|0|||
163362528|NCT05226130|590036539|FG001|Overall Study|Not treatment adherent|2|||
163362529|NCT03358472|590036540|FG000|Overall Study|Death|6|||
163362530|NCT03358472|590036541|FG001|Overall Study|Death|3|||
163362531|NCT03358472|590036542|FG002|Overall Study|Death|10|||
163362532|NCT03358472|590036540|FG000|Overall Study|Physician Decision|0|||
163362533|NCT03358472|590036541|FG001|Overall Study|Physician Decision|1|||
163362534|NCT03358472|590036542|FG002|Overall Study|Physician Decision|0|||
163362535|NCT03358472|590036540|FG000|Overall Study|Withdrawal by Subject|0|||
163362536|NCT03358472|590036541|FG001|Overall Study|Withdrawal by Subject|0|||
163362537|NCT03358472|590036542|FG002|Overall Study|Withdrawal by Subject|1|||
163362538|NCT03358472|590036540|FG000|Overall Study|On-going at clinical cut off date|9|||
163362539|NCT03358472|590036541|FG001|Overall Study|On-going at clinical cut off date|6|||
163362540|NCT03358472|590036542|FG002|Overall Study|On-going at clinical cut off date|5|||
163362541|NCT03974022|590036543|FG000|Overall Study|Death|0|||
163362542|NCT03974022|590036544|FG001|Overall Study|Death|1|||
163362543|NCT03974022|590036545|FG002|Overall Study|Death|0|||
163362544|NCT03974022|590036546|FG003|Overall Study|Death|2|||
163362545|NCT03974022|590036547|FG004|Overall Study|Death|0|||
163362546|NCT03974022|590036548|FG005|Overall Study|Death|1|||
163362547|NCT03974022|590036549|FG006|Overall Study|Death|0|||
163362548|NCT03974022|590036550|FG007|Overall Study|Death|2|||
163362549|NCT03974022|590036551|FG008|Overall Study|Death|1|||
163362550|NCT03974022|590036552|FG009|Overall Study|Death|4|||
163362551|NCT03974022|590036553|FG010|Overall Study|Death|0|||
163362552|NCT03974022|590036554|FG011|Overall Study|Death|0|||
163362553|NCT03974022|590036555|FG012|Overall Study|Death|0|||
163362554|NCT03974022|590036556|FG013|Overall Study|Death|33|||
163362555|NCT03974022|590036557|FG014|Overall Study|Death|40|||
163362556|NCT03974022|590036543|FG000|Overall Study|Withdrawal by Subject|0|||
163362557|NCT03974022|590036544|FG001|Overall Study|Withdrawal by Subject|0|||
163362558|NCT03974022|590036545|FG002|Overall Study|Withdrawal by Subject|0|||
163362559|NCT03974022|590036546|FG003|Overall Study|Withdrawal by Subject|0|||
163362560|NCT03974022|590036547|FG004|Overall Study|Withdrawal by Subject|0|||
163362561|NCT03974022|590036548|FG005|Overall Study|Withdrawal by Subject|4|||
163362562|NCT03974022|590036549|FG006|Overall Study|Withdrawal by Subject|4|||
163362563|NCT03974022|590036550|FG007|Overall Study|Withdrawal by Subject|2|||
163362564|NCT03974022|590036551|FG008|Overall Study|Withdrawal by Subject|2|||
163362565|NCT03974022|590036552|FG009|Overall Study|Withdrawal by Subject|3|||
163362566|NCT03974022|590036553|FG010|Overall Study|Withdrawal by Subject|0|||
163362567|NCT03974022|590036554|FG011|Overall Study|Withdrawal by Subject|1|||
163362568|NCT03974022|590036555|FG012|Overall Study|Withdrawal by Subject|0|||
163362569|NCT03974022|590036556|FG013|Overall Study|Withdrawal by Subject|3|||
163362570|NCT03974022|590036557|FG014|Overall Study|Withdrawal by Subject|9|||
163362571|NCT03974022|590036543|FG000|Overall Study|Lost to Follow-up|0|||
163362572|NCT03974022|590036544|FG001|Overall Study|Lost to Follow-up|0|||
163362573|NCT03974022|590036545|FG002|Overall Study|Lost to Follow-up|0|||
163362574|NCT03974022|590036546|FG003|Overall Study|Lost to Follow-up|0|||
163362575|NCT03974022|590036547|FG004|Overall Study|Lost to Follow-up|0|||
163362576|NCT03974022|590036548|FG005|Overall Study|Lost to Follow-up|0|||
163362577|NCT03974022|590036549|FG006|Overall Study|Lost to Follow-up|1|||
163362578|NCT03974022|590036550|FG007|Overall Study|Lost to Follow-up|0|||
163362579|NCT03974022|590036551|FG008|Overall Study|Lost to Follow-up|0|||
163362580|NCT03974022|590036552|FG009|Overall Study|Lost to Follow-up|0|||
163362581|NCT03974022|590036553|FG010|Overall Study|Lost to Follow-up|0|||
163362582|NCT03974022|590036554|FG011|Overall Study|Lost to Follow-up|0|||
163362583|NCT03974022|590036555|FG012|Overall Study|Lost to Follow-up|0|||
163362584|NCT03974022|590036556|FG013|Overall Study|Lost to Follow-up|1|||
163362585|NCT03974022|590036557|FG014|Overall Study|Lost to Follow-up|1|||
163362586|NCT03974022|590036543|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
163362587|NCT03974022|590036544|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
163362588|NCT03974022|590036545|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
163362589|NCT03974022|590036546|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
163362590|NCT03974022|590036547|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
163362591|NCT03974022|590036548|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
163362592|NCT03974022|590036549|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
163362593|NCT03974022|590036550|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
163362594|NCT03974022|590036551|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
163362595|NCT03974022|590036552|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
163362596|NCT03974022|590036553|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
163362597|NCT03974022|590036554|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
163362598|NCT03974022|590036555|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
163362599|NCT03974022|590036556|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
163362600|NCT03974022|590036557|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
163362601|NCT01124838|590036562|FG000|Overall Study|Miscellaneous|4|||
163362602|NCT01124838|590036563|FG001|Overall Study|Miscellaneous|2|||
163362603|NCT01124838|590036562|FG000|Overall Study|Adverse Event|7|||
163362604|NCT01124838|590036563|FG001|Overall Study|Adverse Event|11|||
163362605|NCT01124838|590036562|FG000|Overall Study|Lack of Efficacy|2|||
163362606|NCT01124838|590036563|FG001|Overall Study|Lack of Efficacy|0|||
163362607|NCT01124838|590036562|FG000|Overall Study|Withdrawal by Subject|3|||
163362608|NCT01124838|590036563|FG001|Overall Study|Withdrawal by Subject|2|||
163362609|NCT01124838|590036562|FG000|Overall Study|Lost to Follow-up|2|||
163362610|NCT01124838|590036563|FG001|Overall Study|Lost to Follow-up|0|||
163362611|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
163362612|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
163362613|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
163362614|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
163362615|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
163362616|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
163362617|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
163362618|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
163362619|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
163362620|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
163362621|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
163362622|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
163362623|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
163362624|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
163362625|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
163362626|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
163362627|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
163362628|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
163362629|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
163362630|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
163362631|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
163362632|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
163362633|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
163362634|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
163362635|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
163362636|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
163362637|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
163362638|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
163362639|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
163362640|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
163362641|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
163362642|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
163362643|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
163362644|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
163362645|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
163362646|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
163362647|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
163362648|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
163362649|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
163362650|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
163362651|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
163362652|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
163362653|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
163362654|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
163362655|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
163362656|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
163362657|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
163362658|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
163362659|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
163362660|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
163362661|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
163362662|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
163362663|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
163362664|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
163362665|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
163362666|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
163362667|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
163362668|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
163362669|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
163362670|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
163362671|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
163362672|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
163362673|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
163362674|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
163362675|NCT00217737|590036566|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
163362676|NCT00217737|590036567|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
163362677|NCT00217737|590036568|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
163362678|NCT00217737|590036569|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
163362679|NCT00217737|590036566|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
163362680|NCT00217737|590036567|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
163362681|NCT00217737|590036568|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
163362682|NCT00217737|590036569|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
163362683|NCT00217737|590036566|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
163362684|NCT00217737|590036567|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
163362685|NCT00217737|590036568|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
163362686|NCT00217737|590036569|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
163362687|NCT00217737|590036566|FG000|Step 2 Randomization/Registration|Study suspension|0|||
163362688|NCT00217737|590036567|FG001|Step 2 Randomization/Registration|Study suspension|45|||
163362689|NCT00217737|590036568|FG002|Step 2 Randomization/Registration|Study suspension|0|||
163362690|NCT00217737|590036569|FG003|Step 2 Randomization/Registration|Study suspension|0|||
163362691|NCT00217737|590036566|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
163362692|NCT00217737|590036567|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
163362693|NCT00217737|590036568|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
163362694|NCT00217737|590036569|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
163362695|NCT00217737|590036566|FG000|Step 2 Randomization/Registration|Death|2|||
163362696|NCT00217737|590036567|FG001|Step 2 Randomization/Registration|Death|3|||
163362697|NCT00217737|590036568|FG002|Step 2 Randomization/Registration|Death|0|||
163362698|NCT00217737|590036569|FG003|Step 2 Randomization/Registration|Death|0|||
163362699|NCT00217737|590036566|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
163362700|NCT00217737|590036567|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
163362701|NCT00217737|590036568|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
163362702|NCT00217737|590036569|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
163362703|NCT00217737|590036566|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
163362704|NCT00217737|590036567|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
163362705|NCT00217737|590036568|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
163362706|NCT00217737|590036569|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
163362707|NCT00217737|590036566|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
163362708|NCT00217737|590036567|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
163362709|NCT00217737|590036568|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
163362710|NCT00217737|590036569|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
163362711|NCT00217737|590036566|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
163362712|NCT00217737|590036567|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
163362713|NCT00217737|590036568|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
163362714|NCT00217737|590036569|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
163362715|NCT00217737|590036566|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
163362716|NCT00217737|590036567|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
163362717|NCT00217737|590036568|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
163362718|NCT00217737|590036569|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
163362719|NCT00217737|590036566|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
163362720|NCT00217737|590036567|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
163362721|NCT00217737|590036568|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
163362722|NCT00217737|590036569|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
163362723|NCT00217737|590036566|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
163362724|NCT00217737|590036567|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
163362725|NCT00217737|590036568|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
163362726|NCT00217737|590036569|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
163362727|NCT00217737|590036566|FG000|Step 2 Randomization/Registration|Other|1|||
163362728|NCT00217737|590036567|FG001|Step 2 Randomization/Registration|Other|2|||
163362729|NCT00217737|590036568|FG002|Step 2 Randomization/Registration|Other|0|||
163362730|NCT00217737|590036569|FG003|Step 2 Randomization/Registration|Other|0|||
163362731|NCT04680533|590036573|FG000|Overall Study|Screen failure|1|||
163362732|NCT01183390|590038388|FG000|First Intervention|Adverse Event|0|||
163362733|NCT01183390|590038389|FG001|First Intervention|Adverse Event|1|||
163362734|NCT04057573|590038392|FG000|24-Week Double-Blind Period|Adverse Event|2|||
163362735|NCT04057573|590038393|FG001|24-Week Double-Blind Period|Adverse Event|0|||
163362736|NCT04057573|590038394|FG002|24-Week Double-Blind Period|Adverse Event|0|||
163362737|NCT04057573|590038395|FG003|24-Week Double-Blind Period|Adverse Event|0|||
163362738|NCT04057573|590038392|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
163362739|NCT04057573|590038393|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
163362740|NCT04057573|590038394|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
163362741|NCT04057573|590038395|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
163362742|NCT04057573|590038392|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
163362743|NCT04057573|590038393|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
163362744|NCT04057573|590038394|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
163362745|NCT04057573|590038395|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
163362746|NCT04057573|590038392|FG000|24-Week Double-Blind Period|Physician Decision|1|||
163362747|NCT04057573|590038393|FG001|24-Week Double-Blind Period|Physician Decision|0|||
163362748|NCT04057573|590038394|FG002|24-Week Double-Blind Period|Physician Decision|0|||
163362749|NCT04057573|590038395|FG003|24-Week Double-Blind Period|Physician Decision|0|||
163362750|NCT04057573|590038392|FG000|24-Week Double-Blind Period|Pregnancy|1|||
163362751|NCT04057573|590038393|FG001|24-Week Double-Blind Period|Pregnancy|0|||
163362752|NCT04057573|590038394|FG002|24-Week Double-Blind Period|Pregnancy|0|||
163362753|NCT04057573|590038395|FG003|24-Week Double-Blind Period|Pregnancy|0|||
163362754|NCT04057573|590038392|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
163362755|NCT04057573|590038393|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
163362756|NCT04057573|590038394|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
163362757|NCT04057573|590038395|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
163362758|NCT04057573|590038392|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
163362759|NCT04057573|590038393|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
163362760|NCT04057573|590038394|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
163362761|NCT04057573|590038395|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
163362762|NCT04057573|590038392|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
163362763|NCT04057573|590038393|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
163362764|NCT04057573|590038394|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
163362765|NCT04057573|590038395|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
163362766|NCT04057573|590038392|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
163362767|NCT04057573|590038393|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
163362768|NCT04057573|590038394|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
163362769|NCT04057573|590038395|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
163362770|NCT04057573|590038392|FG000|24-Week Double-Blind Period|Not Treated|1|||
163362771|NCT04057573|590038393|FG001|24-Week Double-Blind Period|Not Treated|0|||
163362772|NCT04057573|590038394|FG002|24-Week Double-Blind Period|Not Treated|0|||
163362773|NCT04057573|590038395|FG003|24-Week Double-Blind Period|Not Treated|0|||
163362774|NCT04057573|590038392|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
163362775|NCT04057573|590038393|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
163362776|NCT04057573|590038394|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
163362777|NCT04057573|590038395|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
163362778|NCT04057573|590038392|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
163362779|NCT04057573|590038393|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
163362780|NCT04057573|590038394|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
163362781|NCT04057573|590038395|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
163362782|NCT04057573|590038392|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
163362783|NCT04057573|590038393|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
163362784|NCT04057573|590038394|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
163362785|NCT04057573|590038395|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
163362786|NCT04057573|590038392|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
163362787|NCT04057573|590038393|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
163362788|NCT04057573|590038394|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
163362789|NCT04057573|590038395|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
163362790|NCT04057573|590038392|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
163362791|NCT04057573|590038393|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
163362792|NCT04057573|590038394|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
163362793|NCT04057573|590038395|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
163362794|NCT04991753|590038396|FG000|Overall Study|Withdrawal by Subject|0|||
163411173|NCT00852995|590212997|FG001|Overall Study|Moved Out of Area|0|||
163362795|NCT04991753|590038397|FG001|Overall Study|Withdrawal by Subject|1|||
163362796|NCT01484431|590038398|FG000|Period 1: High Dose|Physician Decision|0|||
163362797|NCT01484431|590038399|FG001|Period 1: High Dose|Physician Decision|1|||
163362798|NCT01484431|590038400|FG002|Period 1: High Dose|Physician Decision|0|||
163362799|NCT01484431|590038398|FG000|Period 2|Death|0|||
163362800|NCT01484431|590038399|FG001|Period 2|Death|1|||
163362801|NCT01484431|590038400|FG002|Period 2|Death|1|||
163362802|NCT01484431|590038398|FG000|Period 2|Physician Decision|0|||
163362803|NCT01484431|590038399|FG001|Period 2|Physician Decision|0|||
163362804|NCT01484431|590038400|FG002|Period 2|Physician Decision|1|||
163362805|NCT01484431|590038398|FG000|Period 2|Non-Compliance with Study Drug|1|||
163362806|NCT01484431|590038399|FG001|Period 2|Non-Compliance with Study Drug|0|||
163362807|NCT01484431|590038400|FG002|Period 2|Non-Compliance with Study Drug|0|||
163362808|NCT01251770|590038401|FG000|Overall Study|Protocol Violation|13|||
163362809|NCT01251770|590038402|FG001|Overall Study|Protocol Violation|7|||
163362810|NCT02514239|590038403|FG000|Overall Study|Refused to continue trial medication|0|||
163362811|NCT02514239|590038404|FG001|Overall Study|Refused to continue trial medication|0|||
163362812|NCT02514239|590038405|FG002|Overall Study|Refused to continue trial medication|0|||
163362813|NCT02514239|590038406|FG003|Overall Study|Refused to continue trial medication|0|||
163411174|NCT00852995|590212998|FG002|Overall Study|Moved Out of Area|0|||
163411175|NCT00852995|590212999|FG003|Overall Study|Moved Out of Area|0|||
163411176|NCT00852995|590213000|FG004|Overall Study|Moved Out of Area|0|||
163411177|NCT02508194|590213003|FG000|Overall Study|Death|5|||
163411178|NCT02508194|590213004|FG001|Overall Study|Death|3|||
163411179|NCT02508194|590213003|FG000|Overall Study|Lost to Follow-up|25|||
163411180|NCT02508194|590213004|FG001|Overall Study|Lost to Follow-up|18|||
163411181|NCT02508194|590213003|FG000|Overall Study|Withdrawal by Subject|20|||
163411182|NCT02508194|590213004|FG001|Overall Study|Withdrawal by Subject|18|||
163411183|NCT02508194|590213003|FG000|Overall Study|Error in Randomization|1|||
163411184|NCT02508194|590213004|FG001|Overall Study|Error in Randomization|3|||
163411185|NCT02508194|590213003|FG000|Overall Study|Principal Investigator Decision|1|||
163411186|NCT02508194|590213004|FG001|Overall Study|Principal Investigator Decision|2|||
163411187|NCT00626093|590213005|FG000|Overall Study|Lost to Follow-up|5|||
163411188|NCT00626093|590213005|FG000|Overall Study|Death|1|||
163411189|NCT00626093|590213005|FG000|Overall Study|Physician Decision|4|||
163411190|NCT00626093|590213005|FG000|Overall Study|Withdrawal by Subject|6|||
163411191|NCT00626093|590213005|FG000|Overall Study|Protocol Violation|1|||
163411192|NCT00626093|590213005|FG000|Overall Study|One of the required devices not implante|6|||
163411193|NCT00511355|590213006|FG000|Overall Study|Adverse Event|4|||
163411194|NCT00511355|590213007|FG001|Overall Study|Adverse Event|4|||
163411195|NCT00511355|590213006|FG000|Overall Study|Pregnancy Wish|1|||
163411196|NCT00511355|590213007|FG001|Overall Study|Pregnancy Wish|0|||
163411197|NCT00511355|590213006|FG000|Overall Study|Lost to Follow-up|2|||
163411198|NCT00511355|590213007|FG001|Overall Study|Lost to Follow-up|1|||
163411199|NCT00511355|590213006|FG000|Overall Study|Other Reason|0|||
163411200|NCT00511355|590213007|FG001|Overall Study|Other Reason|1|||
163411201|NCT00511355|590213006|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
163411202|NCT00511355|590213007|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
163411203|NCT00511355|590213006|FG000|Overall Study|Withdrawal of informed consent|0|||
163411204|NCT00511355|590213007|FG001|Overall Study|Withdrawal of informed consent|1|||
163411205|NCT00511355|590213006|FG000|Overall Study|Other reason pre-treatment|0|||
163411206|NCT00511355|590213007|FG001|Overall Study|Other reason pre-treatment|1|||
163411207|NCT01632566|590213009|FG000|Overall Study|Withdrawal by Subject|0|||
163411208|NCT01632566|590213010|FG001|Overall Study|Withdrawal by Subject|1|||
163411209|NCT01632566|590213011|FG002|Overall Study|Withdrawal by Subject|0|||
163411210|NCT01632566|590213012|FG003|Overall Study|Withdrawal by Subject|0|||
163411211|NCT01632566|590213013|FG004|Overall Study|Withdrawal by Subject|0|||
163411212|NCT01632566|590213009|FG000|Overall Study|Sponsor Decision|0|||
163411213|NCT01632566|590213010|FG001|Overall Study|Sponsor Decision|2|||
163411214|NCT01632566|590213011|FG002|Overall Study|Sponsor Decision|9|||
163362814|NCT02514239|590038407|FG004|Overall Study|Refused to continue trial medication|0|||
163362815|NCT02514239|590038408|FG005|Overall Study|Refused to continue trial medication|0|||
163411215|NCT01632566|590213012|FG003|Overall Study|Sponsor Decision|2|||
163411216|NCT01632566|590213013|FG004|Overall Study|Sponsor Decision|2|||
163411217|NCT00454805|590213014|FG000|Overall Study|Withdrawal by Subject|9|||
163411218|NCT00454805|590213015|FG001|Overall Study|Withdrawal by Subject|2|||
163411219|NCT00454805|590213014|FG000|Overall Study|Death|0|||
163411220|NCT00454805|590213015|FG001|Overall Study|Death|2|||
163411221|NCT00454805|590213014|FG000|Overall Study|Disease progression|16|||
163411222|NCT00454805|590213015|FG001|Overall Study|Disease progression|19|||
163411223|NCT00454805|590213014|FG000|Overall Study|In order to begin radiotherapy|1|||
163362816|NCT02514239|590038409|FG006|Overall Study|Refused to continue trial medication|0|||
163362817|NCT02514239|590038410|FG007|Overall Study|Refused to continue trial medication|0|||
163362818|NCT02514239|590038411|FG008|Overall Study|Refused to continue trial medication|0|||
163411224|NCT00454805|590213015|FG001|Overall Study|In order to begin radiotherapy|0|||
163411225|NCT00217087|590213016|FG000|Overall Study|decided to have esophagectomy|1|||
163411226|NCT00217087|590213017|FG001|Overall Study|decided to have esophagectomy|2|||
163411227|NCT00217087|590213016|FG000|Overall Study|completed less than 12 months return|10|||
163411228|NCT00217087|590213017|FG001|Overall Study|completed less than 12 months return|18|||
163411229|NCT03208231|590213022|FG000|Overall Study|Death|1|||
163362819|NCT02514239|590038412|FG009|Overall Study|Refused to continue trial medication|1|||
163362820|NCT02514239|590038403|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
163362821|NCT02514239|590038404|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
163362822|NCT02514239|590038405|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
163362823|NCT02514239|590038406|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
163362824|NCT02514239|590038407|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
163362825|NCT02514239|590038408|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
163362826|NCT02514239|590038409|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
163362827|NCT02514239|590038410|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
163362828|NCT02514239|590038411|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
163362829|NCT02514239|590038412|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
163362830|NCT02514239|590038403|FG000|Overall Study|Not treated|0|||
163362831|NCT02514239|590038404|FG001|Overall Study|Not treated|1|||
163362832|NCT02514239|590038405|FG002|Overall Study|Not treated|0|||
163362833|NCT02514239|590038406|FG003|Overall Study|Not treated|0|||
163362834|NCT02514239|590038407|FG004|Overall Study|Not treated|0|||
163362835|NCT02514239|590038408|FG005|Overall Study|Not treated|0|||
163362836|NCT02514239|590038409|FG006|Overall Study|Not treated|0|||
163362837|NCT02514239|590038410|FG007|Overall Study|Not treated|0|||
163362838|NCT02514239|590038411|FG008|Overall Study|Not treated|0|||
163362839|NCT02514239|590038412|FG009|Overall Study|Not treated|0|||
163362840|NCT02514239|590038403|FG000|Overall Study|Other Adverse Events|2|||
163362841|NCT02514239|590038404|FG001|Overall Study|Other Adverse Events|0|||
163362842|NCT02514239|590038405|FG002|Overall Study|Other Adverse Events|0|||
163362843|NCT02514239|590038406|FG003|Overall Study|Other Adverse Events|1|||
163362844|NCT02514239|590038407|FG004|Overall Study|Other Adverse Events|0|||
163362845|NCT02514239|590038408|FG005|Overall Study|Other Adverse Events|1|||
163362846|NCT02514239|590038409|FG006|Overall Study|Other Adverse Events|0|||
163362847|NCT02514239|590038410|FG007|Overall Study|Other Adverse Events|1|||
163362848|NCT02514239|590038411|FG008|Overall Study|Other Adverse Events|2|||
163362849|NCT02514239|590038412|FG009|Overall Study|Other Adverse Events|0|||
163362850|NCT02514239|590038403|FG000|Overall Study|Progressive disease|3|||
163362851|NCT02514239|590038404|FG001|Overall Study|Progressive disease|3|||
163362852|NCT02514239|590038405|FG002|Overall Study|Progressive disease|2|||
163362853|NCT02514239|590038406|FG003|Overall Study|Progressive disease|2|||
163362854|NCT02514239|590038407|FG004|Overall Study|Progressive disease|3|||
163362855|NCT02514239|590038408|FG005|Overall Study|Progressive disease|3|||
163362856|NCT02514239|590038409|FG006|Overall Study|Progressive disease|4|||
163362857|NCT02514239|590038410|FG007|Overall Study|Progressive disease|2|||
163362858|NCT02514239|590038411|FG008|Overall Study|Progressive disease|5|||
163362859|NCT02514239|590038412|FG009|Overall Study|Progressive disease|0|||
163362860|NCT03299049|590038413|FG000|Overall Study|On-going|486|||
163362861|NCT03299049|590038414|FG001|Overall Study|On-going|481|||
163362862|NCT03299049|590038413|FG000|Overall Study|Withdrawal by Subject|6|||
163362863|NCT03299049|590038414|FG001|Overall Study|Withdrawal by Subject|21|||
163362864|NCT03299049|590038413|FG000|Overall Study|Physician Decision|5|||
163362865|NCT03299049|590038414|FG001|Overall Study|Physician Decision|1|||
163362866|NCT03299049|590038413|FG000|Overall Study|Lost to Follow-up|2|||
163362867|NCT03299049|590038414|FG001|Overall Study|Lost to Follow-up|0|||
163362868|NCT03299049|590038413|FG000|Overall Study|Pregnancy|1|||
163362869|NCT03299049|590038414|FG001|Overall Study|Pregnancy|3|||
163362870|NCT03299049|590038413|FG000|Overall Study|Protocol Violation|1|||
163362871|NCT03299049|590038414|FG001|Overall Study|Protocol Violation|1|||
163362872|NCT03299049|590038413|FG000|Overall Study|Lack of Efficacy|9|||
163362873|NCT03299049|590038414|FG001|Overall Study|Lack of Efficacy|3|||
163362874|NCT03299049|590038413|FG000|Overall Study|Adverse Event|12|||
163362875|NCT03299049|590038414|FG001|Overall Study|Adverse Event|13|||
163362876|NCT01901419|590038415|FG000|Overall Study|Protocol Violation|2|||
163362877|NCT01901419|590038416|FG001|Overall Study|Protocol Violation|6|||
163362878|NCT01901419|590038415|FG000|Overall Study|unavailable researchers|6|||
163362879|NCT01901419|590038416|FG001|Overall Study|unavailable researchers|3|||
163362880|NCT00475644|590038417|FG000|Overall Study|Protocol Violation|13|||
163362881|NCT00699153|590038421|FG000|Overall Study|Lost to Follow-up|1|||
163362882|NCT00699153|590038422|FG001|Overall Study|Lost to Follow-up|0|||
163362883|NCT00699153|590038421|FG000|Overall Study|Adverse Event|0|||
163362884|NCT00699153|590038422|FG001|Overall Study|Adverse Event|2|||
163362885|NCT00699153|590038421|FG000|Overall Study|Protocol Violation|1|||
163362886|NCT00699153|590038422|FG001|Overall Study|Protocol Violation|0|||
163362887|NCT00699153|590038421|FG000|Overall Study|Travel Problem|1|||
163362888|NCT00699153|590038422|FG001|Overall Study|Travel Problem|0|||
163362889|NCT00078338|590038424|FG000|Overall Study|Adverse Event|31|||
163362890|NCT00078338|590038425|FG001|Overall Study|Adverse Event|24|||
163362891|NCT00078338|590038424|FG000|Overall Study|Lost to Follow-up|17|||
163362892|NCT00078338|590038425|FG001|Overall Study|Lost to Follow-up|2|||
163362893|NCT00078338|590038424|FG000|Overall Study|Protocol Violation|2|||
163362894|NCT00078338|590038425|FG001|Overall Study|Protocol Violation|2|||
163362895|NCT00078338|590038424|FG000|Overall Study|Disease Progression|4|||
163362896|NCT00078338|590038425|FG001|Overall Study|Disease Progression|7|||
163362897|NCT00078338|590038424|FG000|Overall Study|Other|28|||
163362898|NCT00078338|590038425|FG001|Overall Study|Other|16|||
163362899|NCT00078338|590038424|FG000|Overall Study|Subjects randomized, but not treated|3|||
163362900|NCT00078338|590038425|FG001|Overall Study|Subjects randomized, but not treated|3|||
163362901|NCT02124811|590038426|FG000|Overall Study|Early termination|2|||
163362902|NCT02124811|590038427|FG001|Overall Study|Early termination|2|||
163362903|NCT02124811|590038426|FG000|Overall Study|Withdrawal by Subject|1|||
163362904|NCT02124811|590038427|FG001|Overall Study|Withdrawal by Subject|0|||
163362905|NCT04201288|590038435|FG000|Overall Study|Death|1|||
163362906|NCT04201288|590038436|FG001|Overall Study|Death|1|||
163362907|NCT04201288|590038435|FG000|Overall Study|Lost to Follow-up|5|||
163362908|NCT04201288|590038436|FG001|Overall Study|Lost to Follow-up|3|||
163362909|NCT04201288|590038435|FG000|Overall Study|Withdrawal by Subject|1|||
163362910|NCT04201288|590038436|FG001|Overall Study|Withdrawal by Subject|0|||
163362911|NCT01606319|590038437|FG000|Overall Study|Lost to Follow-up|17|||
163362912|NCT01606319|590038438|FG001|Overall Study|Lost to Follow-up|14|||
163362913|NCT01606319|590038437|FG000|Overall Study|Withdrawal by Subject|9|||
163362914|NCT01606319|590038438|FG001|Overall Study|Withdrawal by Subject|12|||
163362915|NCT01606319|590038437|FG000|Overall Study|Physician Decision|1|||
163362916|NCT01606319|590038438|FG001|Overall Study|Physician Decision|2|||
163362917|NCT01606319|590038437|FG000|Overall Study|Lack of Efficacy|6|||
163362918|NCT01606319|590038438|FG001|Overall Study|Lack of Efficacy|8|||
163362919|NCT01606319|590038437|FG000|Overall Study|Adverse Event|1|||
163362920|NCT01606319|590038438|FG001|Overall Study|Adverse Event|4|||
163362921|NCT01821937|590038440|FG000|Overall Study|Adverse Event|0|||
163362922|NCT01821937|590038441|FG001|Overall Study|Adverse Event|3|||
163362923|NCT02615509|590038442|FG000|Overall Study|Lost to Follow-up|134|||
163362924|NCT02615509|590038442|FG000|Overall Study|Death|4|||
163362925|NCT02615509|590038442|FG000|Overall Study|Withdrawal by Subject|8|||
163362926|NCT02030002|590038446|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
163362927|NCT02030002|590038446|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
163362928|NCT02030002|590038446|FG000|Follow-up|Lost to Follow-up|2|||
163362929|NCT01294397|590038447|FG000|Overall Study|Withdrawal by Subject|1|||
163362930|NCT01294397|590038447|FG000|Overall Study|Administrative Decision|1|||
163362931|NCT00504075|590038448|FG000|Overall Study|Adverse Event|1|||
163362932|NCT00504075|590038448|FG000|Overall Study|Lost to Follow-up|5|||
163362933|NCT00504075|590038448|FG000|Overall Study|Withdrawal by Subject|1|||
163362934|NCT00504075|590038448|FG000|Overall Study|Required other therapeutic intervention|1|||
163362935|NCT02406248|590038449|FG000|Overall Study|Death|7|||
163362936|NCT02406248|590038449|FG000|Overall Study|Withdrawal by Subject|2|||
163362937|NCT01689857|590038451|FG000|Overall Study|Lost to Follow-up|5|||
163362938|NCT01689857|590038452|FG001|Overall Study|Lost to Follow-up|2|||
163362939|NCT00479882|590038455|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
163362940|NCT00479882|590038456|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
163362941|NCT00479882|590038457|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
163362942|NCT00479882|590038458|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
163362943|NCT00479882|590038455|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
163362944|NCT00479882|590038456|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
163362945|NCT00479882|590038457|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
163362946|NCT00479882|590038458|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
163362947|NCT00479882|590038455|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
163362948|NCT00479882|590038456|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
163362949|NCT00479882|590038457|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
163362950|NCT00479882|590038458|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
163362951|NCT00479882|590038455|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
163362952|NCT00479882|590038456|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
163362953|NCT00479882|590038457|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
163362954|NCT00479882|590038458|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
163362955|NCT00479882|590038455|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
163362956|NCT00479882|590038456|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
163362957|NCT00479882|590038457|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
163362958|NCT00479882|590038458|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
163362959|NCT00479882|590038455|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
163362960|NCT00479882|590038456|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
163362961|NCT00479882|590038457|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
163362962|NCT00479882|590038458|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
163362963|NCT00479882|590038455|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
163362964|NCT00479882|590038456|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
163362965|NCT00479882|590038457|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
163362966|NCT00479882|590038458|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
163411230|NCT03208231|590213023|FG001|Overall Study|Death|2|||
163411231|NCT03208231|590213022|FG000|Overall Study|Moved and unable to get to clinic|1|||
163411232|NCT03208231|590213023|FG001|Overall Study|Moved and unable to get to clinic|0|||
163411233|NCT03208231|590213022|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
163411234|NCT03208231|590213023|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
163411235|NCT03205995|590213024|FG000|Overall Study|Adverse Event|1|||
163411236|NCT03205995|590213024|FG000|Overall Study|Death|1|||
163411237|NCT03205995|590213024|FG000|Overall Study|Physician Decision|2|||
163411238|NCT03205995|590213024|FG000|Overall Study|Protocol Violation|2|||
163411239|NCT03892746|590213027|FG000|Overall Study|Withdrawal by Subject|2|||
163411240|NCT03892746|590213028|FG001|Overall Study|Withdrawal by Subject|1|||
163411241|NCT03892746|590213027|FG000|Overall Study|Lost to Follow-up|2|||
163411242|NCT03892746|590213028|FG001|Overall Study|Lost to Follow-up|0|||
163411243|NCT03977467|590213029|FG000|Overall Study|Disease Progression|1|||
163411244|NCT03977467|590213030|FG001|Overall Study|Disease Progression|1|||
163411245|NCT03977467|590213031|FG002|Overall Study|Disease Progression|30|||
163411246|NCT03977467|590213032|FG003|Overall Study|Disease Progression|0|||
163411247|NCT03977467|590213029|FG000|Overall Study|Adverse Event|0|||
163411248|NCT03977467|590213030|FG001|Overall Study|Adverse Event|1|||
163411249|NCT03977467|590213031|FG002|Overall Study|Adverse Event|0|||
163411250|NCT03977467|590213032|FG003|Overall Study|Adverse Event|0|||
163411251|NCT03977467|590213029|FG000|Overall Study|Death|0|||
163411252|NCT03977467|590213030|FG001|Overall Study|Death|0|||
163411253|NCT03977467|590213031|FG002|Overall Study|Death|3|||
163411254|NCT03977467|590213032|FG003|Overall Study|Death|0|||
163411255|NCT03977467|590213029|FG000|Overall Study|Lack of Efficacy|0|||
163411256|NCT03977467|590213030|FG001|Overall Study|Lack of Efficacy|0|||
163411257|NCT03977467|590213031|FG002|Overall Study|Lack of Efficacy|1|||
163411258|NCT03977467|590213032|FG003|Overall Study|Lack of Efficacy|0|||
163411259|NCT03977467|590213029|FG000|Overall Study|Withdrawal by Subject|2|||
163411260|NCT03977467|590213030|FG001|Overall Study|Withdrawal by Subject|1|||
163411261|NCT03977467|590213031|FG002|Overall Study|Withdrawal by Subject|4|||
163411262|NCT03977467|590213032|FG003|Overall Study|Withdrawal by Subject|0|||
163411263|NCT03977467|590213029|FG000|Overall Study|Study Terminated|1|||
163411264|NCT03977467|590213030|FG001|Overall Study|Study Terminated|0|||
163411265|NCT03977467|590213031|FG002|Overall Study|Study Terminated|0|||
163411266|NCT03977467|590213032|FG003|Overall Study|Study Terminated|1|||
163411267|NCT01328951|590213033|FG000|Overall Study|Disease Progression|17|||
163411268|NCT01328951|590213034|FG001|Overall Study|Disease Progression|14|||
163411269|NCT01328951|590213033|FG000|Overall Study|Adverse Event|2|||
163411270|NCT01328951|590213034|FG001|Overall Study|Adverse Event|0|||
163411271|NCT01328951|590213033|FG000|Overall Study|Death|243|||
163411272|NCT01328951|590213034|FG001|Overall Study|Death|258|||
163411273|NCT01328951|590213033|FG000|Overall Study|Lost to Follow-up|6|||
163411274|NCT01328951|590213034|FG001|Overall Study|Lost to Follow-up|7|||
163411275|NCT01328951|590213033|FG000|Overall Study|Withdrawal by Subject|6|||
163411276|NCT01328951|590213034|FG001|Overall Study|Withdrawal by Subject|6|||
163411277|NCT01328951|590213033|FG000|Overall Study|Study Closed by the Sponsor|36|||
163411278|NCT01328951|590213034|FG001|Overall Study|Study Closed by the Sponsor|31|||
163411279|NCT01328951|590213033|FG000|Overall Study|Other|11|||
163411280|NCT01328951|590213034|FG001|Overall Study|Other|6|||
163411281|NCT01627899|590213037|FG000|Overall Study|Study terminated early by sponsor.|5|||
163362967|NCT00479882|590038455|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
163362968|NCT00479882|590038456|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
163362969|NCT00479882|590038457|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
163411282|NCT04042103|590213044|FG000|Overall Study|Lost to Follow-up|1|||
163411283|NCT04042103|590213044|FG000|Overall Study|Withdrawal by Subject|1|||
163411284|NCT04209855|590213045|FG000|Overall Study|Death|161|||
163411285|NCT04209855|590213046|FG001|Overall Study|Death|177|||
163411286|NCT04209855|590213045|FG000|Overall Study|PI Discretion|1|||
163411287|NCT04209855|590213046|FG001|Overall Study|PI Discretion|1|||
163411288|NCT04209855|590213045|FG000|Overall Study|Lost to Follow-up|5|||
163362970|NCT00479882|590038458|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
163362971|NCT00479882|590038455|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
163362972|NCT00479882|590038456|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
163411289|NCT04209855|590213046|FG001|Overall Study|Lost to Follow-up|2|||
163411290|NCT04209855|590213045|FG000|Overall Study|Withdrew consent|10|||
163362973|NCT00479882|590038457|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
163362974|NCT00479882|590038458|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
163362975|NCT00479882|590038455|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
163362976|NCT00479882|590038456|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
163362977|NCT00479882|590038457|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
163362978|NCT00479882|590038458|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
163362979|NCT00479882|590038455|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
163362980|NCT00479882|590038456|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
163362981|NCT00479882|590038457|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
163362982|NCT00479882|590038458|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
163362983|NCT00479882|590038455|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
163362984|NCT00479882|590038456|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
163362985|NCT00479882|590038457|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
163362986|NCT00479882|590038458|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
163362987|NCT00479882|590038455|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
163362988|NCT00479882|590038456|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
163362989|NCT00479882|590038457|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
163362990|NCT00479882|590038458|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
163362991|NCT00479882|590038455|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
163362992|NCT00479882|590038456|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
163362993|NCT00479882|590038457|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
163362994|NCT00479882|590038458|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
163362995|NCT03106753|590038459|FG000|Overall Study|Withdrawal by Subject|0|||
163362996|NCT03106753|590038460|FG001|Overall Study|Withdrawal by Subject|1|||
163362997|NCT03149042|590038464|FG000|Overall Study|Invasive FFR not performed|21|||
163362998|NCT03149042|590038464|FG000|Overall Study|Poor CT Image Quality|1|||
163362999|NCT03149042|590038464|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
163363000|NCT01643044|590038465|FG000|Overall Study|Lost to Follow-up|1|||
163363001|NCT01643044|590038466|FG001|Overall Study|Lost to Follow-up|1|||
163363002|NCT01643044|590038465|FG000|Overall Study|Miscarried baby|2|||
163363003|NCT01643044|590038466|FG001|Overall Study|Miscarried baby|2|||
163363004|NCT01643044|590038465|FG000|Overall Study|Delivered outside of hospital|1|||
163363005|NCT01643044|590038466|FG001|Overall Study|Delivered outside of hospital|2|||
163363006|NCT01023958|590038471|FG000|Overall Study|Progressive disease|48|||
163363007|NCT01023958|590038471|FG000|Overall Study|Other adverse event|1|||
163363008|NCT01023958|590038471|FG000|Overall Study|Refused to continue medication|1|||
163363009|NCT01031628|590038472|FG000|Overall Study|Study terminated early|0|||
163363010|NCT01031628|590038473|FG001|Overall Study|Study terminated early|1|||
163363011|NCT01031628|590038474|FG002|Overall Study|Study terminated early|3|||
163363012|NCT01031628|590038475|FG003|Overall Study|Study terminated early|0|||
163363013|NCT02362503|590038476|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
163363014|NCT02362503|590038477|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
163363015|NCT02362503|590038478|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
163363016|NCT02362503|590038476|FG000|Double-blind Period-Up to 8 Days|Death|1|||
163363017|NCT02362503|590038477|FG001|Double-blind Period-Up to 8 Days|Death|0|||
163363018|NCT02362503|590038478|FG002|Double-blind Period-Up to 8 Days|Death|0|||
163363019|NCT02362503|590038476|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
163363020|NCT02362503|590038477|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
163363021|NCT02362503|590038478|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
163363022|NCT02362503|590038476|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
163363023|NCT02362503|590038477|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
163363024|NCT02362503|590038478|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
163363025|NCT02362503|590038476|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
163363026|NCT02362503|590038477|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
163363027|NCT02362503|590038478|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
163363028|NCT02362503|590038476|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
163363029|NCT02362503|590038477|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
163363030|NCT02362503|590038478|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
163363031|NCT02362503|590038476|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
163363032|NCT02362503|590038477|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
163363033|NCT02362503|590038478|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
163363034|NCT02362503|590038476|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
163363035|NCT02362503|590038477|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
163363036|NCT02362503|590038478|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
163363037|NCT02362503|590038476|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
163363038|NCT02362503|590038477|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
163363039|NCT02362503|590038478|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
163363040|NCT02362503|590038476|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
163363041|NCT02362503|590038477|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
163363042|NCT02362503|590038478|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
163363043|NCT02362503|590038476|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
163363044|NCT02362503|590038477|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
163363045|NCT02362503|590038478|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
163363046|NCT02362503|590038476|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
163363047|NCT02362503|590038477|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
163363048|NCT02362503|590038478|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
163363049|NCT02362503|590038476|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
163363050|NCT02362503|590038477|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
163363051|NCT02362503|590038478|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
163411291|NCT04209855|590213046|FG001|Overall Study|Withdrew consent|24|||
163411292|NCT04209855|590213045|FG000|Overall Study|Sponsor decision|44|||
163411293|NCT04209855|590213046|FG001|Overall Study|Sponsor decision|18|||
163411294|NCT04209855|590213045|FG000|Overall Study|Other than specified|6|||
163411295|NCT04209855|590213046|FG001|Overall Study|Other than specified|4|||
163411296|NCT02289950|590213048|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
163411297|NCT02289950|590213049|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
163411298|NCT02289950|590213048|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
163411299|NCT02289950|590213049|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
163411300|NCT02289950|590213048|FG000|Overall Study|Lost to Follow-up|1|||
163411301|NCT02289950|590213049|FG001|Overall Study|Lost to Follow-up|0|||
163411302|NCT02289950|590213048|FG000|Overall Study|Physician Decision|9|||
163411303|NCT02289950|590213049|FG001|Overall Study|Physician Decision|3|||
163411304|NCT02289950|590213048|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
163411305|NCT02289950|590213049|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
163411306|NCT02289950|590213048|FG000|Overall Study|Withdrawal by Subject|1|||
163411307|NCT02289950|590213049|FG001|Overall Study|Withdrawal by Subject|3|||
163411308|NCT02289950|590213048|FG000|Overall Study|Test article held for greater than 28 days|0|||
163411309|NCT02289950|590213049|FG001|Overall Study|Test article held for greater than 28 days|1|||
163411310|NCT02289950|590213048|FG000|Overall Study|Adverse Event|11|||
163411311|NCT02289950|590213049|FG001|Overall Study|Adverse Event|3|||
163411312|NCT02289950|590213048|FG000|Overall Study|Death|1|||
163411313|NCT02289950|590213049|FG001|Overall Study|Death|1|||
163411314|NCT02289950|590213048|FG000|Overall Study|Other|5|||
163411315|NCT02289950|590213049|FG001|Overall Study|Other|2|||
163411316|NCT02289950|590213048|FG000|Overall Study|Not Treated|2|||
163411317|NCT02289950|590213049|FG001|Overall Study|Not Treated|1|||
163411318|NCT00271817|590213050|FG000|Part 1|Adverse Event|68|||
163411319|NCT00271817|590213051|FG001|Part 1|Adverse Event|25|||
163411320|NCT00271817|590213052|FG002|Part 1|Adverse Event|156|||
163411321|NCT00271817|590213050|FG000|Part 1|Lost to Follow-up|6|||
163411322|NCT00271817|590213051|FG001|Part 1|Lost to Follow-up|8|||
163411323|NCT00271817|590213052|FG002|Part 1|Lost to Follow-up|24|||
163411324|NCT00271817|590213050|FG000|Part 1|Protocol Violation|5|||
163411325|NCT00271817|590213051|FG001|Part 1|Protocol Violation|4|||
163411326|NCT00271817|590213052|FG002|Part 1|Protocol Violation|7|||
163411327|NCT00271817|590213050|FG000|Part 1|Patient Moved|3|||
163411328|NCT00271817|590213051|FG001|Part 1|Patient Moved|1|||
163411329|NCT00271817|590213052|FG002|Part 1|Patient Moved|5|||
163411330|NCT00271817|590213050|FG000|Part 1|Withdrawal by Subject|23|||
163411331|NCT00271817|590213051|FG001|Part 1|Withdrawal by Subject|17|||
163411332|NCT00271817|590213052|FG002|Part 1|Withdrawal by Subject|45|||
163411333|NCT00271817|590213050|FG000|Part 1|LDL < 50 mg/dL|1|||
163411334|NCT00271817|590213051|FG001|Part 1|LDL < 50 mg/dL|4|||
163411335|NCT00271817|590213052|FG002|Part 1|LDL < 50 mg/dL|48|||
163411336|NCT00271817|590213050|FG000|Part 2|Adverse Event|0|||
163411337|NCT00271817|590213051|FG001|Part 2|Adverse Event|17|||
163411338|NCT00271817|590213052|FG002|Part 2|Adverse Event|33|||
163411339|NCT00271817|590213050|FG000|Part 2|Lack of Efficacy|0|||
163411340|NCT00271817|590213051|FG001|Part 2|Lack of Efficacy|1|||
163411341|NCT00271817|590213052|FG002|Part 2|Lack of Efficacy|6|||
163411342|NCT00271817|590213050|FG000|Part 2|Lost to Follow-up|0|||
163411343|NCT00271817|590213051|FG001|Part 2|Lost to Follow-up|6|||
163411344|NCT00271817|590213052|FG002|Part 2|Lost to Follow-up|18|||
163411345|NCT00271817|590213050|FG000|Part 2|Protocol Violation|0|||
163411346|NCT00271817|590213051|FG001|Part 2|Protocol Violation|3|||
163363052|NCT02362503|590038476|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
163363053|NCT02362503|590038477|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
163411347|NCT00271817|590213052|FG002|Part 2|Protocol Violation|5|||
163411348|NCT00271817|590213050|FG000|Part 2|Patient Moved|0|||
163363054|NCT02362503|590038478|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
163363055|NCT03017742|590038481|FG000|Overall Study|Protocol Violation|36|||
163363056|NCT03017742|590038481|FG000|Overall Study|Withdrawal by Subject|37|||
163363057|NCT04148651|590038482|FG000|Overall Study|Lost to Follow-up|2|||
163411349|NCT00271817|590213051|FG001|Part 2|Patient Moved|0|||
163411350|NCT00271817|590213052|FG002|Part 2|Patient Moved|5|||
163411351|NCT00271817|590213050|FG000|Part 2|Withdrawal by Subject|0|||
163411352|NCT00271817|590213051|FG001|Part 2|Withdrawal by Subject|2|||
163411353|NCT00271817|590213052|FG002|Part 2|Withdrawal by Subject|13|||
163411354|NCT00271817|590213050|FG000|Part 2|LDL < 50 mg/dL|0|||
163411355|NCT00271817|590213051|FG001|Part 2|LDL < 50 mg/dL|3|||
163363058|NCT03690427|590038483|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
163363059|NCT03690427|590038484|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
163363060|NCT03519204|590038485|FG000|Overall Study|Lost to Follow-up|3|||
163363061|NCT03519204|590038486|FG001|Overall Study|Lost to Follow-up|8|||
163363062|NCT03519204|590038485|FG000|Overall Study|Withdrawal by Subject|9|||
163363063|NCT03519204|590038486|FG001|Overall Study|Withdrawal by Subject|7|||
163363064|NCT03519204|590038485|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163363065|NCT03519204|590038486|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163363066|NCT02609672|590038487|FG000|Overall Study|Lost to Follow-up|3|||
163363067|NCT02609672|590038488|FG001|Overall Study|Lost to Follow-up|1|||
163363068|NCT03392168|590038492|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
163363069|NCT03392168|590038493|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
163363070|NCT03392168|590038494|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
163363071|NCT03392168|590038495|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
163363072|NCT03392168|590038492|FG000|Period 2: Cohort 2|Other|0|||
163363073|NCT03392168|590038493|FG001|Period 2: Cohort 2|Other|1|||
163363074|NCT03392168|590038494|FG002|Period 2: Cohort 2|Other|0|||
163363075|NCT03392168|590038495|FG003|Period 2: Cohort 2|Other|0|||
163363076|NCT00762476|590038496|FG000|Overall Study|Adverse Event|7|||
163363077|NCT00762476|590038497|FG001|Overall Study|Adverse Event|1|||
163363078|NCT00762476|590038496|FG000|Overall Study|Lost to Follow-up|2|||
163363079|NCT00762476|590038497|FG001|Overall Study|Lost to Follow-up|0|||
163363080|NCT00762476|590038496|FG000|Overall Study|Protocol Violation|5|||
163363081|NCT00762476|590038497|FG001|Overall Study|Protocol Violation|6|||
163363082|NCT00762476|590038496|FG000|Overall Study|Physician Decision|2|||
163363083|NCT00762476|590038497|FG001|Overall Study|Physician Decision|14|||
163363084|NCT00762476|590038496|FG000|Overall Study|Withdrawal by Subject|6|||
163363085|NCT00762476|590038497|FG001|Overall Study|Withdrawal by Subject|12|||
163363086|NCT00762476|590038496|FG000|Overall Study|antibiotic use|0|||
163363087|NCT00762476|590038497|FG001|Overall Study|antibiotic use|1|||
163363088|NCT00762476|590038496|FG000|Overall Study|non-compliance with study visits|0|||
163363089|NCT00762476|590038497|FG001|Overall Study|non-compliance with study visits|2|||
163363090|NCT00762476|590038496|FG000|Overall Study|Seasonal allergies|1|||
163363091|NCT00762476|590038497|FG001|Overall Study|Seasonal allergies|0|||
163363092|NCT01441635|590038498|FG000|Overall Study|Adverse Event|4|||
163363093|NCT01441635|590038499|FG001|Overall Study|Adverse Event|3|||
163363094|NCT01441635|590038500|FG002|Overall Study|Adverse Event|1|||
163363095|NCT01441635|590038501|FG003|Overall Study|Adverse Event|5|||
163363096|NCT01441635|590038502|FG004|Overall Study|Adverse Event|1|||
163363097|NCT01441635|590038503|FG005|Overall Study|Adverse Event|2|||
163363098|NCT01441635|590038504|FG006|Overall Study|Adverse Event|2|||
163363099|NCT01441635|590038505|FG007|Overall Study|Adverse Event|2|||
163363100|NCT01441635|590038506|FG008|Overall Study|Adverse Event|1|||
163363101|NCT01441635|590038507|FG009|Overall Study|Adverse Event|0|||
163363102|NCT01441635|590038498|FG000|Overall Study|Withdrawal by Subject|1|||
163363103|NCT01441635|590038499|FG001|Overall Study|Withdrawal by Subject|1|||
163363104|NCT01441635|590038500|FG002|Overall Study|Withdrawal by Subject|0|||
163363105|NCT01441635|590038501|FG003|Overall Study|Withdrawal by Subject|1|||
163363106|NCT01441635|590038502|FG004|Overall Study|Withdrawal by Subject|0|||
163363107|NCT01441635|590038503|FG005|Overall Study|Withdrawal by Subject|0|||
163363108|NCT01441635|590038504|FG006|Overall Study|Withdrawal by Subject|2|||
163363109|NCT01441635|590038505|FG007|Overall Study|Withdrawal by Subject|0|||
163363110|NCT01441635|590038506|FG008|Overall Study|Withdrawal by Subject|1|||
163363111|NCT01441635|590038507|FG009|Overall Study|Withdrawal by Subject|1|||
163363112|NCT01441635|590038498|FG000|Overall Study|Lost to Follow-up|0|||
163363113|NCT01441635|590038499|FG001|Overall Study|Lost to Follow-up|1|||
163363114|NCT01441635|590038500|FG002|Overall Study|Lost to Follow-up|1|||
163363115|NCT01441635|590038501|FG003|Overall Study|Lost to Follow-up|1|||
163363116|NCT01441635|590038502|FG004|Overall Study|Lost to Follow-up|1|||
163363117|NCT01441635|590038503|FG005|Overall Study|Lost to Follow-up|3|||
163363118|NCT01441635|590038504|FG006|Overall Study|Lost to Follow-up|1|||
163363119|NCT01441635|590038505|FG007|Overall Study|Lost to Follow-up|1|||
163363120|NCT01441635|590038506|FG008|Overall Study|Lost to Follow-up|0|||
163411356|NCT00271817|590213052|FG002|Part 2|LDL < 50 mg/dL|4|||
163363121|NCT01441635|590038507|FG009|Overall Study|Lost to Follow-up|1|||
163363122|NCT01441635|590038498|FG000|Overall Study|Noncompliance|0|||
163363123|NCT01441635|590038499|FG001|Overall Study|Noncompliance|1|||
163363124|NCT01441635|590038500|FG002|Overall Study|Noncompliance|0|||
163363125|NCT01441635|590038501|FG003|Overall Study|Noncompliance|0|||
163363126|NCT01441635|590038502|FG004|Overall Study|Noncompliance|0|||
163363127|NCT01441635|590038503|FG005|Overall Study|Noncompliance|0|||
163363128|NCT01441635|590038504|FG006|Overall Study|Noncompliance|1|||
163363129|NCT01441635|590038505|FG007|Overall Study|Noncompliance|0|||
163363130|NCT01441635|590038506|FG008|Overall Study|Noncompliance|0|||
163363131|NCT01441635|590038507|FG009|Overall Study|Noncompliance|0|||
163363132|NCT01441635|590038498|FG000|Overall Study|Surgery or Invasive Intervention|0|||
163363133|NCT01441635|590038499|FG001|Overall Study|Surgery or Invasive Intervention|0|||
163363134|NCT01441635|590038500|FG002|Overall Study|Surgery or Invasive Intervention|1|||
163363135|NCT01441635|590038501|FG003|Overall Study|Surgery or Invasive Intervention|0|||
163363136|NCT01441635|590038502|FG004|Overall Study|Surgery or Invasive Intervention|0|||
163363137|NCT01441635|590038503|FG005|Overall Study|Surgery or Invasive Intervention|0|||
163363138|NCT01441635|590038504|FG006|Overall Study|Surgery or Invasive Intervention|0|||
163363139|NCT01441635|590038505|FG007|Overall Study|Surgery or Invasive Intervention|0|||
163363140|NCT01441635|590038506|FG008|Overall Study|Surgery or Invasive Intervention|0|||
163363141|NCT01441635|590038507|FG009|Overall Study|Surgery or Invasive Intervention|0|||
163363142|NCT01441635|590038498|FG000|Overall Study|Received Exclusionary Medication|1|||
163411357|NCT01471782|590213056|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
163411358|NCT01471782|590213057|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
163411359|NCT01471782|590213058|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
163411360|NCT01471782|590213059|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
163411361|NCT01471782|590213060|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
163411362|NCT01471782|590213061|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
163411363|NCT01471782|590213056|FG000|Overall Study|Lack of Efficacy|1|||
163411364|NCT01471782|590213057|FG001|Overall Study|Lack of Efficacy|2|||
163411365|NCT01471782|590213058|FG002|Overall Study|Lack of Efficacy|1|||
163411366|NCT01471782|590213059|FG003|Overall Study|Lack of Efficacy|1|||
163411367|NCT01471782|590213060|FG004|Overall Study|Lack of Efficacy|5|||
163411368|NCT01471782|590213061|FG005|Overall Study|Lack of Efficacy|18|||
163411369|NCT01471782|590213056|FG000|Overall Study|Adverse Event|1|||
163411370|NCT01471782|590213057|FG001|Overall Study|Adverse Event|1|||
163411371|NCT01471782|590213058|FG002|Overall Study|Adverse Event|2|||
163411372|NCT01471782|590213059|FG003|Overall Study|Adverse Event|2|||
163411373|NCT01471782|590213060|FG004|Overall Study|Adverse Event|3|||
163411374|NCT01471782|590213061|FG005|Overall Study|Adverse Event|1|||
163411375|NCT01471782|590213056|FG000|Overall Study|Other|0|||
163411376|NCT01471782|590213057|FG001|Overall Study|Other|0|||
163411377|NCT01471782|590213058|FG002|Overall Study|Other|1|||
163411378|NCT01471782|590213059|FG003|Overall Study|Other|1|||
163411379|NCT01471782|590213060|FG004|Overall Study|Other|6|||
163411380|NCT01471782|590213061|FG005|Overall Study|Other|5|||
163411381|NCT01471782|590213056|FG000|Overall Study|Change of Chemotherapy|1|||
163411382|NCT01471782|590213057|FG001|Overall Study|Change of Chemotherapy|1|||
163411383|NCT01471782|590213058|FG002|Overall Study|Change of Chemotherapy|0|||
163411384|NCT01471782|590213059|FG003|Overall Study|Change of Chemotherapy|0|||
163411385|NCT01471782|590213060|FG004|Overall Study|Change of Chemotherapy|1|||
163411386|NCT01471782|590213061|FG005|Overall Study|Change of Chemotherapy|4|||
163411387|NCT01471782|590213056|FG000|Overall Study|Disease Relapse|0|||
163411388|NCT01471782|590213057|FG001|Overall Study|Disease Relapse|0|||
163411389|NCT01471782|590213058|FG002|Overall Study|Disease Relapse|0|||
163411390|NCT01471782|590213059|FG003|Overall Study|Disease Relapse|1|||
163411391|NCT01471782|590213060|FG004|Overall Study|Disease Relapse|2|||
163411392|NCT01471782|590213061|FG005|Overall Study|Disease Relapse|1|||
163411393|NCT01471782|590213056|FG000|Overall Study|Physician Decision|0|||
163411394|NCT01471782|590213057|FG001|Overall Study|Physician Decision|0|||
163411395|NCT01471782|590213058|FG002|Overall Study|Physician Decision|0|||
163411396|NCT01471782|590213059|FG003|Overall Study|Physician Decision|0|||
163411397|NCT01471782|590213060|FG004|Overall Study|Physician Decision|3|||
163411398|NCT01471782|590213061|FG005|Overall Study|Physician Decision|8|||
163411399|NCT01471782|590213056|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163411400|NCT01471782|590213057|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163411401|NCT01471782|590213058|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163411402|NCT01471782|590213059|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163411403|NCT01471782|590213060|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
163411404|NCT01471782|590213061|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
163411405|NCT01471782|590213056|FG000|Overall Study|Death|0|||
163411406|NCT01471782|590213057|FG001|Overall Study|Death|0|||
163411407|NCT01471782|590213058|FG002|Overall Study|Death|0|||
163411408|NCT01471782|590213059|FG003|Overall Study|Death|0|||
163411409|NCT01471782|590213060|FG004|Overall Study|Death|0|||
163411410|NCT01471782|590213061|FG005|Overall Study|Death|1|||
163411411|NCT00264238|590213062|FG000|Overall Study|Protocol Violation|1|||
163411412|NCT00936208|590213063|FG000|Overall Study|Protocol Violation|37|||
163411413|NCT00936208|590213064|FG001|Overall Study|Protocol Violation|22|||
163411414|NCT04428424|590213065|FG000|Overall Study|Does not meet entrance criteria|132|||
163411415|NCT04428424|590213065|FG000|Overall Study|Lost to Follow-up|115|||
163411416|NCT01411085|590213066|FG000|Overall Study|Physician Decision|1|||
163411417|NCT01411085|590213066|FG000|Overall Study|Protocol Violation|1|||
163411418|NCT01411085|590213066|FG000|Overall Study|Adverse Event|1|||
163411419|NCT01564862|590213067|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
163411420|NCT01564862|590213068|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
163411421|NCT01564862|590213069|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
163411422|NCT01564862|590213067|FG000|Overall Study|Major Protocol Deviation|3|||
163411423|NCT01564862|590213068|FG001|Overall Study|Major Protocol Deviation|3|||
163411424|NCT01564862|590213069|FG002|Overall Study|Major Protocol Deviation|4|||
163411425|NCT01564862|590213067|FG000|Overall Study|Lost to Follow-up|10|||
163411426|NCT01564862|590213068|FG001|Overall Study|Lost to Follow-up|8|||
163411427|NCT01564862|590213069|FG002|Overall Study|Lost to Follow-up|6|||
163411428|NCT01564862|590213067|FG000|Overall Study|Voluntary Withdrawal|9|||
163411429|NCT01564862|590213068|FG001|Overall Study|Voluntary Withdrawal|6|||
163411430|NCT01564862|590213069|FG002|Overall Study|Voluntary Withdrawal|8|||
163411431|NCT01564862|590213067|FG000|Overall Study|Lack of Efficacy|1|||
163411432|NCT01564862|590213068|FG001|Overall Study|Lack of Efficacy|5|||
163411433|NCT01564862|590213069|FG002|Overall Study|Lack of Efficacy|6|||
163411434|NCT01564862|590213067|FG000|Overall Study|Other reason(s)|1|||
163363143|NCT01441635|590038499|FG001|Overall Study|Received Exclusionary Medication|0|||
163363144|NCT01441635|590038500|FG002|Overall Study|Received Exclusionary Medication|0|||
163363145|NCT01441635|590038501|FG003|Overall Study|Received Exclusionary Medication|0|||
163363146|NCT01441635|590038502|FG004|Overall Study|Received Exclusionary Medication|0|||
163363147|NCT01441635|590038503|FG005|Overall Study|Received Exclusionary Medication|0|||
163363148|NCT01441635|590038504|FG006|Overall Study|Received Exclusionary Medication|0|||
163363149|NCT01441635|590038505|FG007|Overall Study|Received Exclusionary Medication|0|||
163363150|NCT01441635|590038506|FG008|Overall Study|Received Exclusionary Medication|0|||
163363151|NCT01441635|590038507|FG009|Overall Study|Received Exclusionary Medication|0|||
163363152|NCT01441635|590038498|FG000|Overall Study|Other|0|||
163363153|NCT01441635|590038499|FG001|Overall Study|Other|0|||
163363154|NCT01441635|590038500|FG002|Overall Study|Other|0|||
163363155|NCT01441635|590038501|FG003|Overall Study|Other|0|||
163363156|NCT01441635|590038502|FG004|Overall Study|Other|0|||
163363157|NCT01441635|590038503|FG005|Overall Study|Other|0|||
163363158|NCT01441635|590038504|FG006|Overall Study|Other|0|||
163363159|NCT01441635|590038505|FG007|Overall Study|Other|1|||
163363160|NCT01441635|590038506|FG008|Overall Study|Other|0|||
163363161|NCT01441635|590038507|FG009|Overall Study|Other|0|||
163363162|NCT02637323|590038509|FG000|Overall Study|Lost to Follow-up|2|||
163363163|NCT02637323|590038510|FG001|Overall Study|Lost to Follow-up|0|||
163363164|NCT02637323|590038509|FG000|Overall Study|Protocol Violation|0|||
163363165|NCT02637323|590038510|FG001|Overall Study|Protocol Violation|1|||
163363166|NCT02838134|590038511|FG000|Overall Study|Lost to Follow-up|1|||
163363167|NCT02838134|590038512|FG001|Overall Study|Lost to Follow-up|2|||
163363168|NCT02838134|590038511|FG000|Overall Study|logistic problems|1|||
163363169|NCT02838134|590038512|FG001|Overall Study|logistic problems|1|||
163363170|NCT01912404|590038513|FG000|Overall Study|Due to personal reasons|1|||
163363171|NCT01912404|590038514|FG001|Overall Study|Due to personal reasons|0|||
163363172|NCT01430468|590038515|FG000|Overall Study|Physician Decision|2|||
163363173|NCT01430468|590038516|FG001|Overall Study|Physician Decision|1|||
163363174|NCT01430468|590038515|FG000|Overall Study|Withdrawal by Subject|5|||
163363175|NCT01430468|590038516|FG001|Overall Study|Withdrawal by Subject|5|||
163363176|NCT01443923|590038517|FG000|Overall Study|Adverse Event|1|||
163363177|NCT01443923|590038518|FG001|Overall Study|Adverse Event|0|||
163363178|NCT04547023|590038521|FG000|Overall Study|Did Not Receive Intervention|3|||
163363179|NCT04547023|590038522|FG001|Overall Study|Did Not Receive Intervention|2|||
163363180|NCT04547023|590038521|FG000|Overall Study|Lost to Follow-up|1|||
163363181|NCT04547023|590038522|FG001|Overall Study|Lost to Follow-up|1|||
163363182|NCT01245374|590038523|FG000|Overall Study|Protocol Violation|1|||
163363183|NCT01245374|590038523|FG000|Overall Study|Withdrawal by Subject|3|||
163363184|NCT04013971|590038525|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
163363185|NCT04013971|590038526|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
163363186|NCT04013971|590038525|FG000|Overall Study|Missing biomechanical data|0|||
163363187|NCT04013971|590038526|FG001|Overall Study|Missing biomechanical data|1|||
163363188|NCT04704219|590038527|FG000|Overall Study|Screen Failure|1|||
163363189|NCT04704219|590038527|FG000|Overall Study|Withdrawal by Subject|1|||
163363190|NCT04704219|590038527|FG000|Overall Study|Death|78|||
163363191|NCT04704219|590038527|FG000|Overall Study|Participants Ongoing|80|||
163363192|NCT02600897|590038528|FG000|Overall Study|Death|1|||
163363193|NCT02600897|590038529|FG001|Overall Study|Death|2|||
163363194|NCT02600897|590038530|FG002|Overall Study|Death|1|||
163363195|NCT02600897|590038531|FG003|Overall Study|Death|2|||
163363196|NCT02600897|590038532|FG004|Overall Study|Death|3|||
163363197|NCT02600897|590038533|FG005|Overall Study|Death|2|||
163363198|NCT02600897|590038534|FG006|Overall Study|Death|10|||
163363199|NCT02600897|590038535|FG007|Overall Study|Death|7|||
163363200|NCT02600897|590038536|FG008|Overall Study|Death|20|||
163363201|NCT02600897|590038528|FG000|Overall Study|Lost to Follow-up|1|||
163363202|NCT02600897|590038529|FG001|Overall Study|Lost to Follow-up|0|||
163363203|NCT02600897|590038530|FG002|Overall Study|Lost to Follow-up|0|||
163363204|NCT02600897|590038531|FG003|Overall Study|Lost to Follow-up|0|||
163363205|NCT02600897|590038532|FG004|Overall Study|Lost to Follow-up|0|||
163363206|NCT02600897|590038533|FG005|Overall Study|Lost to Follow-up|0|||
163363207|NCT02600897|590038534|FG006|Overall Study|Lost to Follow-up|0|||
163363208|NCT02600897|590038535|FG007|Overall Study|Lost to Follow-up|1|||
163363209|NCT02600897|590038536|FG008|Overall Study|Lost to Follow-up|0|||
163363210|NCT02600897|590038528|FG000|Overall Study|Withdrawal by Subject|0|||
163363211|NCT02600897|590038529|FG001|Overall Study|Withdrawal by Subject|0|||
163363212|NCT02600897|590038530|FG002|Overall Study|Withdrawal by Subject|0|||
163363213|NCT02600897|590038531|FG003|Overall Study|Withdrawal by Subject|0|||
163363214|NCT02600897|590038532|FG004|Overall Study|Withdrawal by Subject|0|||
163363215|NCT02600897|590038533|FG005|Overall Study|Withdrawal by Subject|0|||
163363216|NCT02600897|590038534|FG006|Overall Study|Withdrawal by Subject|0|||
163363217|NCT02600897|590038535|FG007|Overall Study|Withdrawal by Subject|4|||
163363218|NCT02600897|590038536|FG008|Overall Study|Withdrawal by Subject|2|||
163363219|NCT02600897|590038528|FG000|Overall Study|Reason Not Specified|0|||
163363220|NCT02600897|590038529|FG001|Overall Study|Reason Not Specified|0|||
163363221|NCT02600897|590038530|FG002|Overall Study|Reason Not Specified|0|||
163411435|NCT01564862|590213068|FG001|Overall Study|Other reason(s)|0|||
163411436|NCT01564862|590213069|FG002|Overall Study|Other reason(s)|0|||
163411437|NCT03809611|590213070|FG000|Overall Study|Withdrawal by Subject|1|||
163411438|NCT03809611|590213071|FG001|Overall Study|Withdrawal by Subject|1|||
163411439|NCT03124563|590213075|FG000|Overall Study|Lost to Follow-up|1|||
163411440|NCT03124563|590213076|FG001|Overall Study|Lost to Follow-up|1|||
163411441|NCT03124563|590213075|FG000|Overall Study|Withdrawal by Subject|1|||
163411442|NCT03124563|590213076|FG001|Overall Study|Withdrawal by Subject|1|||
163411443|NCT04745689|590213077|FG000|Overall Study|Death|9|||
163411444|NCT04745689|590213078|FG001|Overall Study|Death|6|||
163411445|NCT04745689|590213077|FG000|Overall Study|Lost to Follow-up|1|||
163411446|NCT04745689|590213078|FG001|Overall Study|Lost to Follow-up|0|||
163411447|NCT04745689|590213077|FG000|Overall Study|Withdrawal by Subject|2|||
163411448|NCT04745689|590213078|FG001|Overall Study|Withdrawal by Subject|0|||
163411449|NCT04745689|590213077|FG000|Overall Study|Study terminated by sponsor|10|||
163411450|NCT04745689|590213078|FG001|Overall Study|Study terminated by sponsor|3|||
163411451|NCT00608985|590215195|FG000|Overall Study|Adverse Event|2|||
163411452|NCT00608985|590215196|FG001|Overall Study|Adverse Event|7|||
163411453|NCT00608985|590215197|FG002|Overall Study|Adverse Event|4|||
163411454|NCT00608985|590215198|FG003|Overall Study|Adverse Event|6|||
163411455|NCT00608985|590215195|FG000|Overall Study|Administrative/Other|7|||
163411456|NCT00608985|590215196|FG001|Overall Study|Administrative/Other|4|||
163411457|NCT00608985|590215197|FG002|Overall Study|Administrative/Other|1|||
163411458|NCT00608985|590215198|FG003|Overall Study|Administrative/Other|2|||
163411459|NCT00608985|590215195|FG000|Overall Study|Withdrawal of Consent|5|||
163411460|NCT00608985|590215196|FG001|Overall Study|Withdrawal of Consent|1|||
163411461|NCT00608985|590215197|FG002|Overall Study|Withdrawal of Consent|1|||
163411462|NCT00608985|590215198|FG003|Overall Study|Withdrawal of Consent|1|||
163411463|NCT00608985|590215195|FG000|Overall Study|Lost to Follow-up|2|||
163411464|NCT00608985|590215196|FG001|Overall Study|Lost to Follow-up|1|||
163411465|NCT00608985|590215197|FG002|Overall Study|Lost to Follow-up|0|||
163411466|NCT00608985|590215198|FG003|Overall Study|Lost to Follow-up|0|||
163411467|NCT00661271|590215199|FG000|Overall Study|Lost to Follow-up|28|||
163411468|NCT00661271|590215200|FG001|Overall Study|Lost to Follow-up|25|||
163411469|NCT00953758|590215201|FG000|Overall Study|Death|2|||
163411470|NCT00953758|590215202|FG001|Overall Study|Death|0|||
163411471|NCT00953758|590215203|FG002|Overall Study|Death|1|||
163411472|NCT00953758|590215204|FG003|Overall Study|Death|1|||
163411473|NCT00953758|590215205|FG004|Overall Study|Death|1|||
163411474|NCT00953758|590215206|FG005|Overall Study|Death|1|||
163411475|NCT00953758|590215207|FG006|Overall Study|Death|1|||
163411476|NCT00953758|590215208|FG007|Overall Study|Death|3|||
163411477|NCT00953758|590215209|FG008|Overall Study|Death|1|||
163411478|NCT00953758|590215210|FG009|Overall Study|Death|0|||
163411479|NCT00953758|590215201|FG000|Overall Study|Participant refused further follow-up|0|||
163411480|NCT00953758|590215202|FG001|Overall Study|Participant refused further follow-up|0|||
163411481|NCT00953758|590215203|FG002|Overall Study|Participant refused further follow-up|1|||
163411482|NCT00953758|590215204|FG003|Overall Study|Participant refused further follow-up|0|||
163411483|NCT00953758|590215205|FG004|Overall Study|Participant refused further follow-up|3|||
163411484|NCT00953758|590215206|FG005|Overall Study|Participant refused further follow-up|0|||
163411485|NCT00953758|590215207|FG006|Overall Study|Participant refused further follow-up|0|||
163411486|NCT00953758|590215208|FG007|Overall Study|Participant refused further follow-up|0|||
163411487|NCT00953758|590215209|FG008|Overall Study|Participant refused further follow-up|1|||
163411488|NCT00953758|590215210|FG009|Overall Study|Participant refused further follow-up|0|||
163411489|NCT00953758|590215201|FG000|Overall Study|Lost to Follow-up|0|||
163411490|NCT00953758|590215202|FG001|Overall Study|Lost to Follow-up|0|||
163411491|NCT00953758|590215203|FG002|Overall Study|Lost to Follow-up|0|||
163411492|NCT00953758|590215204|FG003|Overall Study|Lost to Follow-up|1|||
163411493|NCT00953758|590215205|FG004|Overall Study|Lost to Follow-up|0|||
163411494|NCT00953758|590215206|FG005|Overall Study|Lost to Follow-up|0|||
163411495|NCT00953758|590215207|FG006|Overall Study|Lost to Follow-up|0|||
163411496|NCT00953758|590215208|FG007|Overall Study|Lost to Follow-up|1|||
163411497|NCT00953758|590215209|FG008|Overall Study|Lost to Follow-up|0|||
163411498|NCT00953758|590215210|FG009|Overall Study|Lost to Follow-up|1|||
163411499|NCT00953758|590215201|FG000|Overall Study|Physician Decision|0|||
163411500|NCT00953758|590215202|FG001|Overall Study|Physician Decision|0|||
163411501|NCT00953758|590215203|FG002|Overall Study|Physician Decision|0|||
163411502|NCT00953758|590215204|FG003|Overall Study|Physician Decision|0|||
163411503|NCT00953758|590215205|FG004|Overall Study|Physician Decision|1|||
163411504|NCT00953758|590215206|FG005|Overall Study|Physician Decision|0|||
163411505|NCT00953758|590215207|FG006|Overall Study|Physician Decision|0|||
163411506|NCT00953758|590215208|FG007|Overall Study|Physician Decision|0|||
163411507|NCT00953758|590215209|FG008|Overall Study|Physician Decision|0|||
163411508|NCT00953758|590215210|FG009|Overall Study|Physician Decision|0|||
163411509|NCT00953758|590215201|FG000|Overall Study|Disease progression|0|||
163411510|NCT00953758|590215202|FG001|Overall Study|Disease progression|0|||
163411511|NCT00953758|590215203|FG002|Overall Study|Disease progression|0|||
163411512|NCT00953758|590215204|FG003|Overall Study|Disease progression|0|||
163363222|NCT02600897|590038531|FG003|Overall Study|Reason Not Specified|0|||
163363223|NCT02600897|590038532|FG004|Overall Study|Reason Not Specified|0|||
163363224|NCT02600897|590038533|FG005|Overall Study|Reason Not Specified|0|||
163363225|NCT02600897|590038534|FG006|Overall Study|Reason Not Specified|0|||
163363226|NCT02600897|590038535|FG007|Overall Study|Reason Not Specified|0|||
163363227|NCT02600897|590038536|FG008|Overall Study|Reason Not Specified|1|||
163363228|NCT02614183|590038537|FG000|Double Blind Treatment Phase|Adverse Event|10|||
163363229|NCT02614183|590038538|FG001|Double Blind Treatment Phase|Adverse Event|9|||
163363230|NCT02614183|590038539|FG002|Double Blind Treatment Phase|Adverse Event|7|||
163363231|NCT02614183|590038537|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
163363232|NCT02614183|590038538|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
163363233|NCT02614183|590038539|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
163363234|NCT02614183|590038537|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
163363235|NCT02614183|590038538|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
163363236|NCT02614183|590038539|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
163363237|NCT02614183|590038537|FG000|Double Blind Treatment Phase|Physician Decision|7|||
163363238|NCT02614183|590038538|FG001|Double Blind Treatment Phase|Physician Decision|3|||
163363239|NCT02614183|590038539|FG002|Double Blind Treatment Phase|Physician Decision|2|||
163363240|NCT02614183|590038537|FG000|Double Blind Treatment Phase|Pregnancy|2|||
163363241|NCT02614183|590038538|FG001|Double Blind Treatment Phase|Pregnancy|1|||
163363242|NCT02614183|590038539|FG002|Double Blind Treatment Phase|Pregnancy|3|||
163363243|NCT02614183|590038537|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
163363244|NCT02614183|590038538|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
163363245|NCT02614183|590038539|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
163363246|NCT02614183|590038537|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
163363247|NCT02614183|590038538|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
163363248|NCT02614183|590038539|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
163363249|NCT02614183|590038537|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
163363250|NCT02614183|590038538|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
163363251|NCT02614183|590038539|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
163363252|NCT02614183|590038537|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
163363253|NCT02614183|590038538|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
163363254|NCT02614183|590038539|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
163363255|NCT02614183|590038537|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
163363256|NCT02614183|590038538|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
163363257|NCT02614183|590038539|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
163363258|NCT02614183|590038537|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
163363259|NCT02614183|590038538|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
163363260|NCT02614183|590038539|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
163363261|NCT02614183|590038537|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
163363262|NCT02614183|590038538|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
163363263|NCT02614183|590038539|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
163363264|NCT03816761|590040576|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
163363265|NCT03816761|590040577|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
163363266|NCT03816761|590040578|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
163363267|NCT03816761|590040579|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
163363268|NCT03816761|590040580|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
163363269|NCT03816761|590040581|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
163363270|NCT03816761|590040576|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
163363271|NCT03816761|590040577|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
163363272|NCT03816761|590040578|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
163363273|NCT03816761|590040579|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
163363274|NCT03816761|590040580|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
163363275|NCT03816761|590040581|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
163363276|NCT00474526|590040590|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
163363277|NCT00474526|590040591|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
163363278|NCT00474526|590040592|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
163363279|NCT00474526|590040593|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
163363280|NCT00474526|590040594|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
163363281|NCT00474526|590040595|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
163363282|NCT00474526|590040596|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
163363283|NCT00474526|590040597|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
163363284|NCT00474526|590040598|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
163363285|NCT00474526|590040599|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
163363286|NCT00474526|590040600|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
163363287|NCT00474526|590040601|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
163363288|NCT00474526|590040602|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
163363289|NCT00474526|590040603|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
163363290|NCT00474526|590040604|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
163363291|NCT00474526|590040605|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
163363292|NCT00474526|590040606|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
163363293|NCT00474526|590040590|FG000|Overall Study|Adverse Event|2|||
163363294|NCT00474526|590040591|FG001|Overall Study|Adverse Event|0|||
163363295|NCT00474526|590040592|FG002|Overall Study|Adverse Event|2|||
163363296|NCT00474526|590040593|FG003|Overall Study|Adverse Event|4|||
163363297|NCT00474526|590040594|FG004|Overall Study|Adverse Event|2|||
163363298|NCT00474526|590040595|FG005|Overall Study|Adverse Event|1|||
163363299|NCT00474526|590040596|FG006|Overall Study|Adverse Event|1|||
163363300|NCT00474526|590040597|FG007|Overall Study|Adverse Event|0|||
163363301|NCT00474526|590040598|FG008|Overall Study|Adverse Event|0|||
163363302|NCT00474526|590040599|FG009|Overall Study|Adverse Event|0|||
163363303|NCT00474526|590040600|FG010|Overall Study|Adverse Event|0|||
163363304|NCT00474526|590040601|FG011|Overall Study|Adverse Event|0|||
163363305|NCT00474526|590040602|FG012|Overall Study|Adverse Event|0|||
163363306|NCT00474526|590040603|FG013|Overall Study|Adverse Event|0|||
163363307|NCT00474526|590040604|FG014|Overall Study|Adverse Event|1|||
163363308|NCT00474526|590040605|FG015|Overall Study|Adverse Event|1|||
163363309|NCT00474526|590040606|FG016|Overall Study|Adverse Event|0|||
163363310|NCT00474526|590040590|FG000|Overall Study|Death|0|||
163363311|NCT00474526|590040591|FG001|Overall Study|Death|0|||
163363312|NCT00474526|590040592|FG002|Overall Study|Death|0|||
163363313|NCT00474526|590040593|FG003|Overall Study|Death|0|||
163363314|NCT00474526|590040594|FG004|Overall Study|Death|0|||
163363315|NCT00474526|590040595|FG005|Overall Study|Death|0|||
163363316|NCT00474526|590040596|FG006|Overall Study|Death|0|||
163363317|NCT00474526|590040597|FG007|Overall Study|Death|0|||
163363318|NCT00474526|590040598|FG008|Overall Study|Death|0|||
163363319|NCT00474526|590040599|FG009|Overall Study|Death|0|||
163363320|NCT00474526|590040600|FG010|Overall Study|Death|0|||
163363321|NCT00474526|590040601|FG011|Overall Study|Death|0|||
163363322|NCT00474526|590040602|FG012|Overall Study|Death|0|||
163363323|NCT00474526|590040603|FG013|Overall Study|Death|3|||
163363324|NCT00474526|590040604|FG014|Overall Study|Death|0|||
163363325|NCT00474526|590040605|FG015|Overall Study|Death|0|||
163363326|NCT00474526|590040606|FG016|Overall Study|Death|0|||
163363327|NCT00474526|590040590|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163363328|NCT00474526|590040591|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
163363329|NCT00474526|590040592|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163363330|NCT00474526|590040593|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
163363331|NCT00474526|590040594|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
163363332|NCT00474526|590040595|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163363333|NCT00474526|590040596|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163363334|NCT00474526|590040597|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163363335|NCT00474526|590040598|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163363336|NCT00474526|590040599|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163363337|NCT00474526|590040600|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163363338|NCT00474526|590040601|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163363339|NCT00474526|590040602|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163363340|NCT00474526|590040603|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
163363341|NCT00474526|590040604|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
163363342|NCT00474526|590040605|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163363343|NCT00474526|590040606|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163363344|NCT00474526|590040590|FG000|Overall Study|Lost to Follow-up|8|||
163363345|NCT00474526|590040591|FG001|Overall Study|Lost to Follow-up|6|||
163363346|NCT00474526|590040592|FG002|Overall Study|Lost to Follow-up|13|||
163363347|NCT00474526|590040593|FG003|Overall Study|Lost to Follow-up|29|||
163363348|NCT00474526|590040594|FG004|Overall Study|Lost to Follow-up|11|||
163363349|NCT00474526|590040595|FG005|Overall Study|Lost to Follow-up|5|||
163363350|NCT00474526|590040596|FG006|Overall Study|Lost to Follow-up|8|||
163363351|NCT00474526|590040597|FG007|Overall Study|Lost to Follow-up|1|||
163363352|NCT00474526|590040598|FG008|Overall Study|Lost to Follow-up|0|||
163363353|NCT00474526|590040599|FG009|Overall Study|Lost to Follow-up|6|||
163363354|NCT00474526|590040600|FG010|Overall Study|Lost to Follow-up|2|||
163363355|NCT00474526|590040601|FG011|Overall Study|Lost to Follow-up|4|||
163363356|NCT00474526|590040602|FG012|Overall Study|Lost to Follow-up|6|||
163363357|NCT00474526|590040603|FG013|Overall Study|Lost to Follow-up|74|||
163363358|NCT00474526|590040604|FG014|Overall Study|Lost to Follow-up|29|||
163363359|NCT00474526|590040605|FG015|Overall Study|Lost to Follow-up|4|||
163363360|NCT00474526|590040606|FG016|Overall Study|Lost to Follow-up|5|||
163363361|NCT00474526|590040590|FG000|Overall Study|Protocol Violation|2|||
163363362|NCT00474526|590040591|FG001|Overall Study|Protocol Violation|6|||
163363363|NCT00474526|590040592|FG002|Overall Study|Protocol Violation|4|||
163363364|NCT00474526|590040593|FG003|Overall Study|Protocol Violation|12|||
163363365|NCT00474526|590040594|FG004|Overall Study|Protocol Violation|3|||
163363366|NCT00474526|590040595|FG005|Overall Study|Protocol Violation|1|||
163363367|NCT00474526|590040596|FG006|Overall Study|Protocol Violation|3|||
163363368|NCT00474526|590040597|FG007|Overall Study|Protocol Violation|0|||
163363369|NCT00474526|590040598|FG008|Overall Study|Protocol Violation|0|||
163363370|NCT00474526|590040599|FG009|Overall Study|Protocol Violation|4|||
163363371|NCT00474526|590040600|FG010|Overall Study|Protocol Violation|2|||
163363372|NCT00474526|590040601|FG011|Overall Study|Protocol Violation|2|||
163363373|NCT00474526|590040602|FG012|Overall Study|Protocol Violation|4|||
163411513|NCT00953758|590215205|FG004|Overall Study|Disease progression|1|||
163411514|NCT00953758|590215206|FG005|Overall Study|Disease progression|0|||
163411515|NCT00953758|590215207|FG006|Overall Study|Disease progression|0|||
163411516|NCT00953758|590215208|FG007|Overall Study|Disease progression|0|||
163411517|NCT00953758|590215209|FG008|Overall Study|Disease progression|0|||
163411518|NCT00953758|590215210|FG009|Overall Study|Disease progression|0|||
163411519|NCT00953758|590215201|FG000|Overall Study|Participant went for transplant|0|||
163411520|NCT00953758|590215202|FG001|Overall Study|Participant went for transplant|0|||
163411521|NCT00953758|590215203|FG002|Overall Study|Participant went for transplant|0|||
163411522|NCT00953758|590215204|FG003|Overall Study|Participant went for transplant|0|||
163411523|NCT00953758|590215205|FG004|Overall Study|Participant went for transplant|0|||
163411524|NCT00953758|590215206|FG005|Overall Study|Participant went for transplant|0|||
163411525|NCT00953758|590215207|FG006|Overall Study|Participant went for transplant|0|||
163411526|NCT00953758|590215208|FG007|Overall Study|Participant went for transplant|0|||
163411527|NCT00953758|590215209|FG008|Overall Study|Participant went for transplant|1|||
163411528|NCT00953758|590215210|FG009|Overall Study|Participant went for transplant|0|||
163411529|NCT00706030|590215212|FG000|Overall Study|Disease Progression|4|||
163411530|NCT00706030|590215213|FG001|Overall Study|Disease Progression|6|||
163411531|NCT00706030|590215214|FG002|Overall Study|Disease Progression|46|||
163411532|NCT00706030|590215215|FG003|Overall Study|Disease Progression|12|||
163411533|NCT00706030|590215212|FG000|Overall Study|Adverse Event|1|||
163411534|NCT00706030|590215213|FG001|Overall Study|Adverse Event|0|||
163411535|NCT00706030|590215214|FG002|Overall Study|Adverse Event|4|||
163411536|NCT00706030|590215215|FG003|Overall Study|Adverse Event|2|||
163411537|NCT00706030|590215212|FG000|Overall Study|Withdrawal by Subject|1|||
163411538|NCT00706030|590215213|FG001|Overall Study|Withdrawal by Subject|0|||
163411539|NCT00706030|590215214|FG002|Overall Study|Withdrawal by Subject|2|||
163411540|NCT00706030|590215215|FG003|Overall Study|Withdrawal by Subject|0|||
163411541|NCT00706030|590215212|FG000|Overall Study|Physician Decision|0|||
163411542|NCT00706030|590215213|FG001|Overall Study|Physician Decision|0|||
163411543|NCT00706030|590215214|FG002|Overall Study|Physician Decision|2|||
163363374|NCT00474526|590040603|FG013|Overall Study|Protocol Violation|19|||
163363375|NCT00474526|590040604|FG014|Overall Study|Protocol Violation|9|||
163363376|NCT00474526|590040605|FG015|Overall Study|Protocol Violation|6|||
163363377|NCT00474526|590040606|FG016|Overall Study|Protocol Violation|2|||
163363378|NCT00474526|590040590|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
163363379|NCT00474526|590040591|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
163363380|NCT00474526|590040592|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
163363381|NCT00474526|590040593|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
163363382|NCT00474526|590040594|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
163363383|NCT00474526|590040595|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
163363384|NCT00474526|590040596|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
163363385|NCT00474526|590040597|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
163363386|NCT00474526|590040598|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
163363387|NCT00474526|590040599|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
163363388|NCT00474526|590040600|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
163363389|NCT00474526|590040601|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
163363390|NCT00474526|590040602|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
163363391|NCT00474526|590040603|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
163363392|NCT00474526|590040604|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
163363393|NCT00474526|590040605|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
163363394|NCT00474526|590040606|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
163363395|NCT00474526|590040590|FG000|Overall Study|Withdrawal by Subject|9|||
163363396|NCT00474526|590040591|FG001|Overall Study|Withdrawal by Subject|24|||
163363397|NCT00474526|590040592|FG002|Overall Study|Withdrawal by Subject|21|||
163363398|NCT00474526|590040593|FG003|Overall Study|Withdrawal by Subject|52|||
163363399|NCT00474526|590040594|FG004|Overall Study|Withdrawal by Subject|38|||
163363400|NCT00474526|590040595|FG005|Overall Study|Withdrawal by Subject|6|||
163411544|NCT00706030|590215215|FG003|Overall Study|Physician Decision|0|||
163411545|NCT00706030|590215212|FG000|Overall Study|Not recorded|0|||
163411546|NCT00706030|590215213|FG001|Overall Study|Not recorded|0|||
163411547|NCT00706030|590215214|FG002|Overall Study|Not recorded|2|||
163411548|NCT00706030|590215215|FG003|Overall Study|Not recorded|0|||
163411549|NCT00706030|590215212|FG000|Overall Study|Protocol Violation|0|||
163363401|NCT00474526|590040596|FG006|Overall Study|Withdrawal by Subject|12|||
163363402|NCT00474526|590040597|FG007|Overall Study|Withdrawal by Subject|4|||
163363403|NCT00474526|590040598|FG008|Overall Study|Withdrawal by Subject|4|||
163363404|NCT00474526|590040599|FG009|Overall Study|Withdrawal by Subject|13|||
163363405|NCT00474526|590040600|FG010|Overall Study|Withdrawal by Subject|5|||
163363406|NCT00474526|590040601|FG011|Overall Study|Withdrawal by Subject|4|||
163411550|NCT00706030|590215213|FG001|Overall Study|Protocol Violation|0|||
163411551|NCT00706030|590215214|FG002|Overall Study|Protocol Violation|1|||
163411552|NCT00706030|590215215|FG003|Overall Study|Protocol Violation|1|||
163411553|NCT00706030|590215212|FG000|Overall Study|Failed to return|0|||
163411554|NCT00706030|590215213|FG001|Overall Study|Failed to return|0|||
163411555|NCT00706030|590215214|FG002|Overall Study|Failed to return|1|||
163411556|NCT00706030|590215215|FG003|Overall Study|Failed to return|0|||
163363407|NCT00474526|590040602|FG012|Overall Study|Withdrawal by Subject|4|||
163363408|NCT00474526|590040603|FG013|Overall Study|Withdrawal by Subject|37|||
163363409|NCT00474526|590040604|FG014|Overall Study|Withdrawal by Subject|22|||
163363410|NCT00474526|590040605|FG015|Overall Study|Withdrawal by Subject|1|||
163363411|NCT00474526|590040606|FG016|Overall Study|Withdrawal by Subject|1|||
163363412|NCT00132678|590040607|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
163363413|NCT00132678|590040608|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
163363414|NCT00132678|590040609|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
163363415|NCT00132678|590040607|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
163363416|NCT00132678|590040608|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
163363417|NCT00132678|590040609|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
163363418|NCT00132678|590040607|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
163363419|NCT00132678|590040608|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
163363420|NCT00132678|590040609|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
163363421|NCT00132678|590040607|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
163363422|NCT00132678|590040608|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
163363423|NCT00132678|590040609|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
163363424|NCT00132678|590040607|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
163363425|NCT00132678|590040608|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
163363426|NCT00132678|590040609|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
163363427|NCT00132678|590040607|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
163363428|NCT00132678|590040608|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
163363429|NCT00132678|590040609|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
163363430|NCT00132678|590040607|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
163363431|NCT00132678|590040608|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
163363432|NCT00132678|590040609|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
163363433|NCT00132678|590040607|FG000|Period III (Open-Label Stabilization)|Death|2|||
163363434|NCT00132678|590040608|FG001|Period III (Open-Label Stabilization)|Death|0|||
163363435|NCT00132678|590040609|FG002|Period III (Open-Label Stabilization)|Death|0|||
163363436|NCT00132678|590040607|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
163363437|NCT00132678|590040608|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
163363438|NCT00132678|590040609|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
163363439|NCT00132678|590040607|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
163363440|NCT00132678|590040608|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
163363441|NCT00132678|590040609|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
163363442|NCT00132678|590040607|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
163363443|NCT00132678|590040608|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
163363444|NCT00132678|590040609|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
163363445|NCT00132678|590040607|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
163363446|NCT00132678|590040608|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
163363447|NCT00132678|590040609|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
163363448|NCT00132678|590040607|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
163363449|NCT00132678|590040608|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
163363450|NCT00132678|590040609|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
163363451|NCT00132678|590040607|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
163363452|NCT00132678|590040608|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
163363453|NCT00132678|590040609|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
163363454|NCT00132678|590040607|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
163363455|NCT00132678|590040608|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
163363456|NCT00132678|590040609|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
163363457|NCT00132678|590040607|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
163363458|NCT00132678|590040608|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
163363459|NCT00132678|590040609|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
163363460|NCT00132678|590040607|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
163363461|NCT00132678|590040608|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
163363462|NCT00132678|590040609|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
163363463|NCT00132678|590040607|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
163363464|NCT00132678|590040608|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
163363465|NCT00132678|590040609|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
163363466|NCT00132678|590040607|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
163363467|NCT00132678|590040608|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
163363468|NCT00132678|590040609|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
163363469|NCT00132678|590040607|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
163363470|NCT00132678|590040608|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
163363471|NCT00132678|590040609|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
163363472|NCT00132678|590040607|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
163363473|NCT00132678|590040608|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
163363474|NCT00132678|590040609|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
163363475|NCT00132678|590040607|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
163363476|NCT00132678|590040608|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
163363477|NCT00132678|590040609|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
163363478|NCT00132678|590040607|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
163363479|NCT00132678|590040608|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
163363480|NCT00132678|590040609|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
163363481|NCT00953147|590040610|FG000|Overall Study|Adverse Event|8|||
163363482|NCT00953147|590040611|FG001|Overall Study|Adverse Event|16|||
163363483|NCT00953147|590040612|FG002|Overall Study|Adverse Event|6|||
163363484|NCT00953147|590040610|FG000|Overall Study|Protocol Violation|2|||
163363485|NCT00953147|590040611|FG001|Overall Study|Protocol Violation|8|||
163363486|NCT00953147|590040612|FG002|Overall Study|Protocol Violation|4|||
163363487|NCT00953147|590040610|FG000|Overall Study|Withdrawal by Subject|13|||
163363488|NCT00953147|590040611|FG001|Overall Study|Withdrawal by Subject|15|||
163363489|NCT00953147|590040612|FG002|Overall Study|Withdrawal by Subject|12|||
163363490|NCT00953147|590040610|FG000|Overall Study|Lost to Follow-up|8|||
163363491|NCT00953147|590040611|FG001|Overall Study|Lost to Follow-up|9|||
163363492|NCT00953147|590040612|FG002|Overall Study|Lost to Follow-up|4|||
163363493|NCT00953147|590040610|FG000|Overall Study|Physician Decision|2|||
163363494|NCT00953147|590040611|FG001|Overall Study|Physician Decision|7|||
163363495|NCT00953147|590040612|FG002|Overall Study|Physician Decision|3|||
163363496|NCT00953147|590040610|FG000|Overall Study|Other|4|||
163363497|NCT00953147|590040611|FG001|Overall Study|Other|11|||
163363498|NCT00953147|590040612|FG002|Overall Study|Other|13|||
163363499|NCT00790400|590040619|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
163363500|NCT00790400|590040620|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
163363501|NCT00790400|590040619|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
163363502|NCT00790400|590040620|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
163363503|NCT00790400|590040619|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
163363504|NCT00790400|590040620|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
163363505|NCT00790400|590040619|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
163363506|NCT00790400|590040620|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
163363507|NCT00790400|590040619|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
163363508|NCT00790400|590040620|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
163363509|NCT00790400|590040619|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
163363510|NCT00790400|590040620|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
163363511|NCT00790400|590040619|FG000|Double-blind Period (Core Phase)|Death|1|||
163363512|NCT00790400|590040620|FG001|Double-blind Period (Core Phase)|Death|0|||
163363513|NCT00790400|590040619|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
163363514|NCT00790400|590040620|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
163363515|NCT00790400|590040619|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
163363516|NCT00790400|590040620|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
163363517|NCT00790400|590040619|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
163363518|NCT00790400|590040620|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
163363519|NCT00790400|590040619|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
163363520|NCT00790400|590040620|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
163363521|NCT00790400|590040619|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
163363522|NCT00790400|590040620|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
163363523|NCT00790400|590040619|FG000|Everolimus Period (Core or Extension)|Death|1|||
163363524|NCT00790400|590040620|FG001|Everolimus Period (Core or Extension)|Death|0|||
163363525|NCT00790400|590040619|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
163363526|NCT00790400|590040620|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
163363527|NCT00790400|590040619|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
163363528|NCT00790400|590040620|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
163363529|NCT00790400|590040619|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
163363530|NCT00790400|590040620|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
163363531|NCT02412735|590040623|FG000|Overall Study|Adverse Event|0|||
163363532|NCT02412735|590040624|FG001|Overall Study|Adverse Event|1|||
163363533|NCT02412735|590040625|FG002|Overall Study|Adverse Event|2|||
163363534|NCT02412735|590040623|FG000|Overall Study|Withdrawal by Subject|23|||
163363535|NCT02412735|590040624|FG001|Overall Study|Withdrawal by Subject|27|||
163363536|NCT02412735|590040625|FG002|Overall Study|Withdrawal by Subject|22|||
163363537|NCT02412735|590040623|FG000|Overall Study|Investigator Decision|3|||
163363538|NCT02412735|590040624|FG001|Overall Study|Investigator Decision|3|||
163363539|NCT02412735|590040625|FG002|Overall Study|Investigator Decision|2|||
163363540|NCT02412735|590040623|FG000|Overall Study|Lost to Follow-up|17|||
163363541|NCT02412735|590040624|FG001|Overall Study|Lost to Follow-up|11|||
163363542|NCT02412735|590040625|FG002|Overall Study|Lost to Follow-up|18|||
163363543|NCT02412735|590040623|FG000|Overall Study|Reason not Specified|3|||
163363544|NCT02412735|590040624|FG001|Overall Study|Reason not Specified|2|||
163363545|NCT02412735|590040625|FG002|Overall Study|Reason not Specified|2|||
163363546|NCT01006980|590040626|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
163363547|NCT01006980|590040627|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
163363548|NCT01006980|590040626|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
163363549|NCT01006980|590040627|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
163363550|NCT01006980|590040626|FG000|Vemurafenib and Dacarbazine|Death|13|||
163363551|NCT01006980|590040627|FG001|Vemurafenib and Dacarbazine|Death|12|||
163363552|NCT01006980|590040626|FG000|Vemurafenib and Dacarbazine|Progression|257|||
163363553|NCT01006980|590040627|FG001|Vemurafenib and Dacarbazine|Progression|218|||
163363554|NCT01006980|590040626|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
163363555|NCT01006980|590040627|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
163363556|NCT01006980|590040626|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
163363557|NCT01006980|590040627|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
163363558|NCT01006980|590040626|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
163363559|NCT01006980|590040627|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
163363560|NCT01006980|590040626|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
163363561|NCT01006980|590040627|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
163363562|NCT01006980|590040626|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
163363563|NCT01006980|590040627|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
163363564|NCT01006980|590040626|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
163363565|NCT01006980|590040627|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
163363566|NCT01006980|590040626|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
163363567|NCT01006980|590040627|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
163363568|NCT01006980|590040626|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
163363569|NCT01006980|590040627|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
163363570|NCT01006980|590040626|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
163363571|NCT01006980|590040627|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
163363572|NCT04043143|590040628|FG000|Overall Study|Lost to Follow-up|5|||
163363573|NCT04043143|590040629|FG001|Overall Study|Lost to Follow-up|5|||
163363574|NCT04043143|590040628|FG000|Overall Study|screen failure|1|||
163363575|NCT04043143|590040629|FG001|Overall Study|screen failure|0|||
163363576|NCT04307940|590040630|FG000|Overall Study|Adverse Event|1|||
163363577|NCT04307940|590040631|FG001|Overall Study|Adverse Event|0|||
163363578|NCT04307940|590040632|FG002|Overall Study|Adverse Event|0|||
163363579|NCT04307940|590040630|FG000|Overall Study|Withdrawal by Subject|2|||
163363580|NCT04307940|590040631|FG001|Overall Study|Withdrawal by Subject|3|||
163363581|NCT04307940|590040632|FG002|Overall Study|Withdrawal by Subject|1|||
163363582|NCT04307940|590040630|FG000|Overall Study|Lost to Follow-up|2|||
163363583|NCT04307940|590040631|FG001|Overall Study|Lost to Follow-up|0|||
163363584|NCT04307940|590040632|FG002|Overall Study|Lost to Follow-up|1|||
163363585|NCT03445533|590040633|FG000|Overall Study|Progressive Disease|48|||
163363586|NCT03445533|590040634|FG001|Overall Study|Progressive Disease|81|||
163363587|NCT03445533|590040633|FG000|Overall Study|Adverse Event|60|||
163363588|NCT03445533|590040634|FG001|Overall Study|Adverse Event|64|||
163363589|NCT03445533|590040633|FG000|Overall Study|Death|9|||
163363590|NCT03445533|590040634|FG001|Overall Study|Death|19|||
163363591|NCT03445533|590040633|FG000|Overall Study|Miscellaneous|0|||
163363592|NCT03445533|590040634|FG001|Overall Study|Miscellaneous|16|||
163363593|NCT03445533|590040633|FG000|Overall Study|Withdrawal by Subject|3|||
163363594|NCT03445533|590040634|FG001|Overall Study|Withdrawal by Subject|4|||
163363595|NCT03445533|590040633|FG000|Overall Study|Physician Decision|1|||
163363596|NCT03445533|590040634|FG001|Overall Study|Physician Decision|3|||
163363597|NCT03445533|590040633|FG000|Overall Study|Sponsor Decision|0|||
163363598|NCT03445533|590040634|FG001|Overall Study|Sponsor Decision|1|||
163363599|NCT03445533|590040633|FG000|Overall Study|Lost to Follow-up|0|||
163363600|NCT03445533|590040634|FG001|Overall Study|Lost to Follow-up|1|||
163363601|NCT03445533|590040633|FG000|Overall Study|Never Received any Study Treatment|7|||
163363602|NCT03445533|590040634|FG001|Overall Study|Never Received any Study Treatment|4|||
163363603|NCT02153905|590040635|FG000|Overall Study|Death|1|||
163363604|NCT02153905|590040636|FG001|Overall Study|Death|0|||
163363605|NCT03334253|590040637|FG000|Overall Study|Withdrawal by Subject|1|||
163363606|NCT03334253|590040638|FG001|Overall Study|Withdrawal by Subject|0|||
163363607|NCT03334253|590040637|FG000|Overall Study|Lost to Follow-up|4|||
163363608|NCT03334253|590040638|FG001|Overall Study|Lost to Follow-up|3|||
163363609|NCT03334253|590040637|FG000|Overall Study|Moved residence|2|||
163363610|NCT03334253|590040638|FG001|Overall Study|Moved residence|2|||
163363611|NCT03274453|590040639|FG000|Overall Study|Lost to Follow-up|2|||
163363612|NCT03274453|590040640|FG001|Overall Study|Lost to Follow-up|5|||
163363613|NCT03274453|590040641|FG002|Overall Study|Lost to Follow-up|4|||
163363614|NCT03274453|590040642|FG003|Overall Study|Lost to Follow-up|1|||
163363615|NCT03274453|590040639|FG000|Overall Study|Physician Decision|2|||
163363616|NCT03274453|590040640|FG001|Overall Study|Physician Decision|0|||
163363617|NCT03274453|590040641|FG002|Overall Study|Physician Decision|0|||
163363618|NCT03274453|590040642|FG003|Overall Study|Physician Decision|3|||
163363619|NCT03274453|590040639|FG000|Overall Study|Surgery Cancelled|0|||
163411557|NCT00706030|590215212|FG000|Overall Study|Symptomatic Deterioration|0|||
163411558|NCT00706030|590215213|FG001|Overall Study|Symptomatic Deterioration|0|||
163411559|NCT00706030|590215214|FG002|Overall Study|Symptomatic Deterioration|1|||
163411560|NCT00706030|590215215|FG003|Overall Study|Symptomatic Deterioration|0|||
163411561|NCT00706030|590215212|FG000|Overall Study|No treatment received|0|||
163411562|NCT00706030|590215213|FG001|Overall Study|No treatment received|0|||
163411563|NCT00706030|590215214|FG002|Overall Study|No treatment received|0|||
163411564|NCT00706030|590215215|FG003|Overall Study|No treatment received|1|||
163411565|NCT00706030|590215212|FG000|Overall Study|Death|0|||
163411566|NCT00706030|590215213|FG001|Overall Study|Death|0|||
163411567|NCT00706030|590215214|FG002|Overall Study|Death|1|||
163411568|NCT00706030|590215215|FG003|Overall Study|Death|0|||
163411569|NCT05779072|590215216|FG000|Overall Study|Lost to Follow-up|0|||
163411570|NCT05779072|590215217|FG001|Overall Study|Lost to Follow-up|1|||
163411571|NCT05779072|590215216|FG000|Overall Study|Withdrawal by Subject|1|||
163411572|NCT05779072|590215217|FG001|Overall Study|Withdrawal by Subject|5|||
163411573|NCT03870555|590215218|FG000|Period 3 (2 Days)|Adverse Event|1|||
163411574|NCT03870555|590215219|FG001|Period 3 (2 Days)|Adverse Event|0|||
163411575|NCT03870555|590215220|FG002|Period 3 (2 Days)|Adverse Event|0|||
163411576|NCT00293579|590215221|FG000|Overall Study|Withdrawal by Subject|1|||
163411577|NCT03847610|590215222|FG000|Overall Study|Withdrawal by Subject|1|||
163411578|NCT02004873|590215223|FG000|Overall Study|Implant unsuccessful|6|||
163411579|NCT02004873|590215223|FG000|Overall Study|Awaiting 6-month visit|390|||
163411580|NCT02004873|590215223|FG000|Overall Study|Missed 6-month visit|4|||
163411581|NCT02004873|590215223|FG000|Overall Study|Death|23|||
163411582|NCT02004873|590215223|FG000|Overall Study|Withdrawal by Subject|1|||
163411583|NCT01445769|590215225|FG000|Overall Study|Consent Withdrawn|2|||
163411584|NCT01445769|590215225|FG000|Overall Study|Disease Progression|1|||
163411585|NCT01445769|590215225|FG000|Overall Study|Lost to Follow-up|5|||
163411586|NCT01276236|590215226|FG000|Overall Study|Lack of Efficacy|2|||
163411587|NCT01276236|590215226|FG000|Overall Study|Withdrawal by Subject|4|||
163411588|NCT00044512|590215227|FG000|Follow Up|Lost to Follow-up|2|||
163411589|NCT02799069|590215228|FG000|Overall Study|Adverse Event|0|||
163411590|NCT02799069|590215229|FG001|Overall Study|Adverse Event|2|||
163411591|NCT02799069|590215230|FG002|Overall Study|Adverse Event|2|||
163411592|NCT02799069|590215228|FG000|Overall Study|Lack of Efficacy|2|||
163411593|NCT02799069|590215229|FG001|Overall Study|Lack of Efficacy|0|||
163411594|NCT02799069|590215230|FG002|Overall Study|Lack of Efficacy|0|||
163411595|NCT02799069|590215228|FG000|Overall Study|Lost to Follow-up|1|||
163411596|NCT02799069|590215229|FG001|Overall Study|Lost to Follow-up|1|||
163411597|NCT02799069|590215230|FG002|Overall Study|Lost to Follow-up|0|||
163411598|NCT02799069|590215228|FG000|Overall Study|Withdrawal by Subject|4|||
163411599|NCT02799069|590215229|FG001|Overall Study|Withdrawal by Subject|4|||
163411600|NCT02799069|590215230|FG002|Overall Study|Withdrawal by Subject|3|||
163411601|NCT02799069|590215228|FG000|Overall Study|Protocol Violation|1|||
163411602|NCT02799069|590215229|FG001|Overall Study|Protocol Violation|0|||
163411603|NCT02799069|590215230|FG002|Overall Study|Protocol Violation|2|||
163411604|NCT03440814|590215235|FG000|Overall Study|Adverse Event|2|||
163411605|NCT03440814|590215236|FG001|Overall Study|Adverse Event|1|||
163411606|NCT03440814|590215235|FG000|Overall Study|Lost to Follow-up|2|||
163411607|NCT03440814|590215236|FG001|Overall Study|Lost to Follow-up|0|||
163411608|NCT03440814|590215235|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
163411609|NCT03440814|590215236|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
163411610|NCT01437397|590215237|FG000|Overall Study|Lost to Follow-up|9|||
163411611|NCT01437397|590215238|FG001|Overall Study|Lost to Follow-up|4|||
163411612|NCT01437397|590215239|FG002|Overall Study|Lost to Follow-up|2|||
163411613|NCT01437397|590215240|FG003|Overall Study|Lost to Follow-up|4|||
163411614|NCT01437397|590215241|FG004|Overall Study|Lost to Follow-up|5|||
163411615|NCT01437397|590215237|FG000|Overall Study|Withdrawal by Subject|11|||
163411616|NCT01437397|590215238|FG001|Overall Study|Withdrawal by Subject|12|||
163411617|NCT01437397|590215239|FG002|Overall Study|Withdrawal by Subject|24|||
163411618|NCT01437397|590215240|FG003|Overall Study|Withdrawal by Subject|11|||
163411619|NCT01437397|590215241|FG004|Overall Study|Withdrawal by Subject|22|||
163411620|NCT01437397|590215237|FG000|Overall Study|Protocol Violation|10|||
163411621|NCT01437397|590215238|FG001|Overall Study|Protocol Violation|12|||
163411622|NCT01437397|590215239|FG002|Overall Study|Protocol Violation|13|||
163411623|NCT01437397|590215240|FG003|Overall Study|Protocol Violation|21|||
163411624|NCT01437397|590215241|FG004|Overall Study|Protocol Violation|19|||
163411625|NCT01437397|590215237|FG000|Overall Study|Lack of Efficacy|5|||
163411626|NCT01437397|590215238|FG001|Overall Study|Lack of Efficacy|4|||
163411627|NCT01437397|590215239|FG002|Overall Study|Lack of Efficacy|8|||
163411628|NCT01437397|590215240|FG003|Overall Study|Lack of Efficacy|10|||
163411629|NCT01437397|590215241|FG004|Overall Study|Lack of Efficacy|20|||
163411630|NCT01437397|590215237|FG000|Overall Study|Adverse Event|21|||
163411631|NCT01437397|590215238|FG001|Overall Study|Adverse Event|22|||
163411632|NCT01437397|590215239|FG002|Overall Study|Adverse Event|16|||
163411633|NCT01437397|590215240|FG003|Overall Study|Adverse Event|14|||
163411634|NCT01437397|590215241|FG004|Overall Study|Adverse Event|21|||
163411635|NCT01437397|590215237|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
163411636|NCT01437397|590215238|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
163411637|NCT01437397|590215239|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
163411638|NCT01437397|590215240|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
163411639|NCT01437397|590215241|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
163411640|NCT00866307|590215243|FG000|Induction|Adverse Event|5|||
163411641|NCT00866307|590215244|FG001|Induction|Adverse Event|0|||
163411642|NCT00866307|590215245|FG002|Induction|Adverse Event|0|||
163411643|NCT00866307|590215243|FG000|Induction|Death|2|||
163411644|NCT00866307|590215244|FG001|Induction|Death|0|||
163411645|NCT00866307|590215245|FG002|Induction|Death|0|||
163411646|NCT00866307|590215243|FG000|Induction|Physician Decision|5|||
163411647|NCT00866307|590215244|FG001|Induction|Physician Decision|0|||
163411648|NCT00866307|590215245|FG002|Induction|Physician Decision|0|||
163411649|NCT00866307|590215243|FG000|Induction|Progressive Disease|1|||
163411650|NCT00866307|590215244|FG001|Induction|Progressive Disease|0|||
163411651|NCT00866307|590215245|FG002|Induction|Progressive Disease|0|||
163411652|NCT00866307|590215243|FG000|Induction|Identification of Patients with Day 29 M|3|||
163411653|NCT00866307|590215244|FG001|Induction|Identification of Patients with Day 29 M|0|||
163411654|NCT00866307|590215245|FG002|Induction|Identification of Patients with Day 29 M|0|||
163411655|NCT00866307|590215243|FG000|Induction|Inadequate cytognetic samples th|1|||
163411656|NCT00866307|590215244|FG001|Induction|Inadequate cytognetic samples th|0|||
163411657|NCT00866307|590215245|FG002|Induction|Inadequate cytognetic samples th|0|||
163411658|NCT00866307|590215243|FG000|Induction|Improper post-induction consent|2|||
163411659|NCT00866307|590215244|FG001|Induction|Improper post-induction consent|0|||
163363620|NCT03274453|590040640|FG001|Overall Study|Surgery Cancelled|1|||
163363621|NCT03274453|590040641|FG002|Overall Study|Surgery Cancelled|0|||
163363622|NCT03274453|590040642|FG003|Overall Study|Surgery Cancelled|0|||
163411660|NCT00866307|590215245|FG002|Induction|Improper post-induction consent|0|||
163411661|NCT00866307|590215243|FG000|Induction|Study was closed at the time|1|||
163411662|NCT00866307|590215244|FG001|Induction|Study was closed at the time|0|||
163411663|NCT00866307|590215245|FG002|Induction|Study was closed at the time|0|||
163411664|NCT00866307|590215243|FG000|Consolidation/Maintenance|Adverse Event|0|||
163411665|NCT00866307|590215244|FG001|Consolidation/Maintenance|Adverse Event|0|||
163411666|NCT00866307|590215245|FG002|Consolidation/Maintenance|Adverse Event|8|||
163411667|NCT00866307|590215243|FG000|Consolidation/Maintenance|Death|0|||
163411668|NCT00866307|590215244|FG001|Consolidation/Maintenance|Death|0|||
163411669|NCT00866307|590215245|FG002|Consolidation/Maintenance|Death|1|||
163411670|NCT00866307|590215243|FG000|Consolidation/Maintenance|Physician Decision|0|||
163411671|NCT00866307|590215244|FG001|Consolidation/Maintenance|Physician Decision|3|||
163411672|NCT00866307|590215245|FG002|Consolidation/Maintenance|Physician Decision|2|||
163411673|NCT00866307|590215243|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
163411674|NCT00866307|590215244|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
163411675|NCT00866307|590215245|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
163411676|NCT00866307|590215243|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
163411677|NCT00866307|590215244|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
163411678|NCT00866307|590215245|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
163411679|NCT00866307|590215243|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
163411680|NCT00866307|590215244|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
163411681|NCT00866307|590215245|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
163411682|NCT00866307|590215243|FG000|Consolidation/Maintenance|Therapy error|0|||
163411683|NCT00866307|590215244|FG001|Consolidation/Maintenance|Therapy error|1|||
163411684|NCT00866307|590215245|FG002|Consolidation/Maintenance|Therapy error|0|||
163411685|NCT00866307|590215243|FG000|Consolidation/Maintenance|Non-compliance|0|||
163411686|NCT00866307|590215244|FG001|Consolidation/Maintenance|Non-compliance|0|||
163411687|NCT00866307|590215245|FG002|Consolidation/Maintenance|Non-compliance|1|||
163411688|NCT00866307|590215243|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
163363623|NCT00968526|590040643|FG000|Overall Study|Adverse Event|2|||
163411689|NCT00866307|590215244|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
163411690|NCT00866307|590215245|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
163411691|NCT02573155|590215248|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
163363624|NCT00968526|590040644|FG001|Overall Study|Adverse Event|0|||
163363625|NCT00968526|590040643|FG000|Overall Study|Migrated/moved from study area|1|||
163363626|NCT00968526|590040644|FG001|Overall Study|Migrated/moved from study area|0|||
163411692|NCT02573155|590215249|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
163411693|NCT02573155|590215248|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
163411694|NCT02573155|590215249|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
163411695|NCT02573155|590215248|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
163411696|NCT02573155|590215249|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
163411697|NCT02573155|590215248|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
163411698|NCT02573155|590215249|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
163411699|NCT02573155|590215248|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
163363627|NCT02493062|590040645|FG000|Overall Study|Physician Decision|12|||
163363628|NCT03926195|590040646|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
163363629|NCT03926195|590040647|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
163363630|NCT03926195|590040646|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
163363631|NCT03926195|590040647|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
163363632|NCT03926195|590040646|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
163363633|NCT03926195|590040647|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
163363634|NCT03926195|590040646|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
163363635|NCT03926195|590040647|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
163363636|NCT03926195|590040646|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
163363637|NCT03926195|590040647|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
163363638|NCT03926195|590040646|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
163363639|NCT03926195|590040647|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
163363640|NCT03054337|590040648|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
163363641|NCT03054337|590040649|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
163363642|NCT03054337|590040650|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
163363643|NCT03054337|590040651|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
163363644|NCT03054337|590040652|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
163363645|NCT03054337|590040653|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
163363646|NCT01327612|590040654|FG000|Overall Study|Withdrawal by Subject|0|||
163363647|NCT01327612|590040655|FG001|Overall Study|Withdrawal by Subject|0|||
163363648|NCT01327612|590040656|FG002|Overall Study|Withdrawal by Subject|0|||
163363649|NCT01327612|590040657|FG003|Overall Study|Withdrawal by Subject|0|||
163363650|NCT01327612|590040658|FG004|Overall Study|Withdrawal by Subject|0|||
163363651|NCT01327612|590040659|FG005|Overall Study|Withdrawal by Subject|1|||
163363652|NCT01327612|590040660|FG006|Overall Study|Withdrawal by Subject|0|||
163363653|NCT01327612|590040654|FG000|Overall Study|Disease Progression|1|||
163363654|NCT01327612|590040655|FG001|Overall Study|Disease Progression|1|||
163363655|NCT01327612|590040656|FG002|Overall Study|Disease Progression|1|||
163363656|NCT01327612|590040657|FG003|Overall Study|Disease Progression|0|||
163363657|NCT01327612|590040658|FG004|Overall Study|Disease Progression|1|||
163363658|NCT01327612|590040659|FG005|Overall Study|Disease Progression|2|||
163363659|NCT01327612|590040660|FG006|Overall Study|Disease Progression|2|||
163363660|NCT01327612|590040654|FG000|Overall Study|Administrative Decision|0|||
163363661|NCT01327612|590040655|FG001|Overall Study|Administrative Decision|0|||
163363662|NCT01327612|590040656|FG002|Overall Study|Administrative Decision|0|||
163363663|NCT01327612|590040657|FG003|Overall Study|Administrative Decision|1|||
163363664|NCT01327612|590040658|FG004|Overall Study|Administrative Decision|0|||
163363665|NCT01327612|590040659|FG005|Overall Study|Administrative Decision|0|||
163363666|NCT01327612|590040660|FG006|Overall Study|Administrative Decision|0|||
163363667|NCT01327612|590040654|FG000|Overall Study|Death|0|||
163363668|NCT01327612|590040655|FG001|Overall Study|Death|0|||
163363669|NCT01327612|590040656|FG002|Overall Study|Death|0|||
163363670|NCT01327612|590040657|FG003|Overall Study|Death|0|||
163363671|NCT01327612|590040658|FG004|Overall Study|Death|1|||
163363672|NCT01327612|590040659|FG005|Overall Study|Death|0|||
163363673|NCT01327612|590040660|FG006|Overall Study|Death|0|||
163363674|NCT01967069|590040664|FG000|Overall Study|Adverse Event|2|||
163363675|NCT01967069|590040665|FG001|Overall Study|Adverse Event|2|||
163363676|NCT01967069|590040664|FG000|Overall Study|Lost to Follow-up|5|||
163363677|NCT01967069|590040665|FG001|Overall Study|Lost to Follow-up|2|||
163363678|NCT01967069|590040664|FG000|Overall Study|Withdrawal by Subject|1|||
163363679|NCT01967069|590040665|FG001|Overall Study|Withdrawal by Subject|3|||
163363680|NCT01967069|590040664|FG000|Overall Study|Lack of Efficacy|0|||
163363681|NCT01967069|590040665|FG001|Overall Study|Lack of Efficacy|1|||
163363682|NCT00609947|590040666|FG000|Overall Study|Death|1|||
163363683|NCT05569421|590040668|FG000|Overall Study|Withdrawal by Subject|1|||
163363684|NCT05569421|590040669|FG001|Overall Study|Withdrawal by Subject|0|||
163363685|NCT05569421|590040670|FG002|Overall Study|Withdrawal by Subject|0|||
163363686|NCT00874731|590040672|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
163363687|NCT00874731|590040673|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
163363688|NCT00874731|590040674|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
163363689|NCT00874731|590040672|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
163363690|NCT00874731|590040673|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
163363691|NCT00874731|590040674|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
163363692|NCT00874731|590040672|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
163363693|NCT00874731|590040673|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
163363694|NCT00874731|590040674|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
163363695|NCT01736540|590040675|FG000|Overall Study|Did not complete scan within 45 days|2|||
163363696|NCT01736540|590040675|FG000|Overall Study|Death|1|||
163363697|NCT01736540|590040675|FG000|Overall Study|Abnormal test procedure|1|||
163363698|NCT01736540|590040675|FG000|Overall Study|Withdrawal by Subject|5|||
163363699|NCT01736540|590040675|FG000|Overall Study|Protocol Violation|1|||
163363700|NCT01736540|590040675|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
163363701|NCT01736540|590040675|FG000|Overall Study|No show for MRI appointment|1|||
163363702|NCT01736540|590040675|FG000|Overall Study|Unable to make MRI appointment|3|||
163363703|NCT00581477|590040676|FG000|Overall Study|Physician Decision|2|||
163363704|NCT00790205|590040682|FG000|Overall Study|Lost to Follow-up|61|||
163363705|NCT00790205|590040683|FG001|Overall Study|Lost to Follow-up|71|||
163363706|NCT00790205|590040682|FG000|Overall Study|Withdrawal by Subject|299|||
163363707|NCT00790205|590040683|FG001|Overall Study|Withdrawal by Subject|363|||
163363708|NCT02643628|590040686|FG000|Overall Study|Lost to Follow-up|1|||
163363709|NCT02643628|590040687|FG001|Overall Study|Lost to Follow-up|4|||
163363710|NCT02643628|590040686|FG000|Overall Study|Withdrawal by Subject|0|||
163363711|NCT02643628|590040687|FG001|Overall Study|Withdrawal by Subject|1|||
163363712|NCT02643628|590040686|FG000|Overall Study|Relocated out of state|0|||
163363713|NCT02643628|590040687|FG001|Overall Study|Relocated out of state|1|||
163363714|NCT05143138|590040688|FG000|Overall Study|Death|5|||
163363715|NCT05143138|590040689|FG001|Overall Study|Death|35|||
163363716|NCT05143138|590040690|FG002|Overall Study|Death|1|||
163363717|NCT05143138|590040688|FG000|Overall Study|Lost to Follow-up|2|||
163363718|NCT05143138|590040689|FG001|Overall Study|Lost to Follow-up|4|||
163363719|NCT05143138|590040690|FG002|Overall Study|Lost to Follow-up|0|||
163363720|NCT05143138|590040688|FG000|Overall Study|withdrawal|1|||
163363721|NCT05143138|590040689|FG001|Overall Study|withdrawal|1|||
163363722|NCT05143138|590040690|FG002|Overall Study|withdrawal|0|||
163363723|NCT04245345|590040693|FG000|Overall Study|Death|1|||
163363724|NCT04245345|590040693|FG000|Overall Study|Exited prior to implant|5|||
163363725|NCT04245345|590040693|FG000|Overall Study|Exited prior to 1-month|9|||
163363726|NCT04245345|590040693|FG000|Overall Study|Missed 1-month visit|3|||
163363727|NCT04245345|590040693|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
163363728|NCT04245345|590040693|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
163363729|NCT04805073|590040701|FG000|Overall Study|study personnel not available|2|||
163363730|NCT04805073|590040702|FG001|Overall Study|study personnel not available|0|||
163363731|NCT04805073|590040701|FG000|Overall Study|spinal anesthesia failure|0|||
163363732|NCT04805073|590040702|FG001|Overall Study|spinal anesthesia failure|1|||
163363733|NCT04805073|590040701|FG000|Overall Study|Lost to Follow-up|0|||
163363734|NCT04805073|590040702|FG001|Overall Study|Lost to Follow-up|2|||
163363735|NCT00422734|590040706|FG000|Overall Study|Physician Decision|1|||
163363736|NCT00422734|590040707|FG001|Overall Study|Physician Decision|1|||
163363737|NCT00422734|590040706|FG000|Overall Study|Protocol Violation|1|||
163363738|NCT00422734|590040707|FG001|Overall Study|Protocol Violation|6|||
163363739|NCT00422734|590040706|FG000|Overall Study|Withdrawal by Subject|12|||
163363740|NCT00422734|590040707|FG001|Overall Study|Withdrawal by Subject|8|||
163363741|NCT00422734|590040706|FG000|Overall Study|Adverse Event|0|||
163363742|NCT00422734|590040707|FG001|Overall Study|Adverse Event|3|||
163363743|NCT00422734|590040706|FG000|Overall Study|Partner Decision|0|||
163363744|NCT00422734|590040707|FG001|Overall Study|Partner Decision|3|||
163363745|NCT00848484|590040708|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
163363746|NCT00848484|590040709|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
163363747|NCT00848484|590040708|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
163363748|NCT00848484|590040709|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
163363749|NCT00848484|590040708|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
163363750|NCT00848484|590040709|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
163363751|NCT00848484|590040708|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
163363752|NCT00848484|590040709|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
163363753|NCT00848484|590040708|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
163363754|NCT00848484|590040709|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
163363755|NCT01081886|590040711|FG000|Overall Study|Study termination|11|||
163363756|NCT01081886|590040712|FG001|Overall Study|Study termination|13|||
163363757|NCT02567708|590040713|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
163363758|NCT02567708|590040714|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
163363759|NCT02567708|590040713|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
163363760|NCT02567708|590040714|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
163363761|NCT02567708|590040713|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
163363762|NCT02567708|590040714|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
163363763|NCT02567708|590040713|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
163363764|NCT02567708|590040714|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
163363765|NCT00706654|590040715|FG000|Conversion Phase|Lost to Follow-up|4|||
163363766|NCT00706654|590040716|FG001|Conversion Phase|Lost to Follow-up|0|||
163363767|NCT00706654|590040717|FG002|Conversion Phase|Lost to Follow-up|0|||
163363768|NCT00706654|590040718|FG003|Conversion Phase|Lost to Follow-up|0|||
163363769|NCT00706654|590040715|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
163363770|NCT00706654|590040716|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
163363771|NCT00706654|590040717|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
163363772|NCT00706654|590040718|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
163363773|NCT00706654|590040715|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
163363774|NCT00706654|590040716|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
163363775|NCT00706654|590040717|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
163411700|NCT02573155|590215249|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
163411701|NCT02573155|590215248|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
163411702|NCT02573155|590215249|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
163411703|NCT02573155|590215248|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
163411704|NCT02573155|590215249|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
163411705|NCT02573155|590215248|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
163411706|NCT02573155|590215249|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
163411707|NCT01681433|590215250|FG000|Overall Study|Lack of Efficacy|23|||
163411708|NCT01681433|590215251|FG001|Overall Study|Lack of Efficacy|23|||
163411709|NCT01681433|590215250|FG000|Overall Study|Withdrawal by Subject|5|||
163411710|NCT01681433|590215251|FG001|Overall Study|Withdrawal by Subject|5|||
163411711|NCT01681433|590215250|FG000|Overall Study|Protocol Violation|2|||
163411712|NCT01681433|590215251|FG001|Overall Study|Protocol Violation|0|||
163411713|NCT01681433|590215250|FG000|Overall Study|Adverse Event|2|||
163411714|NCT01681433|590215251|FG001|Overall Study|Adverse Event|4|||
163411715|NCT01681433|590215250|FG000|Overall Study|Lost to Follow-up|0|||
163411716|NCT01681433|590215251|FG001|Overall Study|Lost to Follow-up|1|||
163411717|NCT00903929|590215252|FG000|Overall Study|Withdrawal by Subject|0|||
163411718|NCT00903929|590215253|FG001|Overall Study|Withdrawal by Subject|0|||
163411719|NCT00903929|590215254|FG002|Overall Study|Withdrawal by Subject|1|||
163411720|NCT00903929|590215255|FG003|Overall Study|Withdrawal by Subject|2|||
163411721|NCT00903929|590215252|FG000|Overall Study|Adverse Event|0|||
163411722|NCT00903929|590215253|FG001|Overall Study|Adverse Event|0|||
163411723|NCT00903929|590215254|FG002|Overall Study|Adverse Event|0|||
163411724|NCT00903929|590215255|FG003|Overall Study|Adverse Event|1|||
163411725|NCT04947800|590215259|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
163363776|NCT00706654|590040718|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
163363777|NCT00706654|590040715|FG000|Conversion Phase|Withdrawn by Investigator|14|||
163363778|NCT00706654|590040716|FG001|Conversion Phase|Withdrawn by Investigator|0|||
163363779|NCT00706654|590040717|FG002|Conversion Phase|Withdrawn by Investigator|0|||
163363780|NCT00706654|590040718|FG003|Conversion Phase|Withdrawn by Investigator|0|||
163363781|NCT00706654|590040715|FG000|Conversion Phase|Withdrew Consent|38|||
163363782|NCT00706654|590040716|FG001|Conversion Phase|Withdrew Consent|0|||
163363783|NCT00706654|590040717|FG002|Conversion Phase|Withdrew Consent|0|||
163363784|NCT00706654|590040718|FG003|Conversion Phase|Withdrew Consent|0|||
163363785|NCT00706654|590040715|FG000|Conversion Phase|Adverse Event|18|||
163363786|NCT00706654|590040716|FG001|Conversion Phase|Adverse Event|0|||
163363787|NCT00706654|590040717|FG002|Conversion Phase|Adverse Event|0|||
163363788|NCT00706654|590040718|FG003|Conversion Phase|Adverse Event|0|||
163363789|NCT00706654|590040715|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
163363790|NCT00706654|590040716|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
163363791|NCT00706654|590040717|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
163363792|NCT00706654|590040718|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
163363793|NCT00706654|590040715|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
163363794|NCT00706654|590040716|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
163363795|NCT00706654|590040717|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
163363796|NCT00706654|590040718|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
163363797|NCT00706654|590040715|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
163363798|NCT00706654|590040716|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
163363799|NCT00706654|590040717|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
163363800|NCT00706654|590040718|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
163363801|NCT00706654|590040715|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
163363802|NCT00706654|590040716|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
163363803|NCT00706654|590040717|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
163363804|NCT00706654|590040718|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
163363805|NCT00706654|590040715|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
163363806|NCT00706654|590040716|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
163363807|NCT00706654|590040717|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
163363808|NCT00706654|590040718|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
163363809|NCT00706654|590040715|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
163363810|NCT00706654|590040716|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
163411726|NCT04947800|590215260|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
163411727|NCT04947800|590215261|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
163411728|NCT02158091|590215262|FG000|Overall Study|DLT|2|||
163363811|NCT00706654|590040717|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
163363812|NCT00706654|590040718|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
163363813|NCT00706654|590040715|FG000|Oral Stabilization Phase|Withdrew consent|55|||
163363814|NCT00706654|590040716|FG001|Oral Stabilization Phase|Withdrew consent|0|||
163363815|NCT00706654|590040717|FG002|Oral Stabilization Phase|Withdrew consent|0|||
163363816|NCT00706654|590040718|FG003|Oral Stabilization Phase|Withdrew consent|0|||
163363817|NCT00706654|590040715|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
163363818|NCT00706654|590040716|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
163363819|NCT00706654|590040717|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
163363820|NCT00706654|590040718|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
163363821|NCT00706654|590040715|FG000|Oral Stabilization Phase|Adverse Event|21|||
163363822|NCT00706654|590040716|FG001|Oral Stabilization Phase|Adverse Event|0|||
163363823|NCT00706654|590040717|FG002|Oral Stabilization Phase|Adverse Event|0|||
163363824|NCT00706654|590040718|FG003|Oral Stabilization Phase|Adverse Event|0|||
163363825|NCT00706654|590040715|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
163363826|NCT00706654|590040716|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
163363827|NCT00706654|590040717|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
163363828|NCT00706654|590040718|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
163363829|NCT00706654|590040715|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
163363830|NCT00706654|590040716|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
163363831|NCT00706654|590040717|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
163363832|NCT00706654|590040718|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
163363833|NCT00706654|590040715|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
163363834|NCT00706654|590040716|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
163363835|NCT00706654|590040717|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
163363836|NCT00706654|590040718|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
163363837|NCT00706654|590040715|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
163363838|NCT00706654|590040716|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
163363839|NCT00706654|590040717|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
163363840|NCT00706654|590040718|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
163363841|NCT00706654|590040715|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
163363842|NCT00706654|590040716|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
163363843|NCT00706654|590040717|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
163363844|NCT00706654|590040718|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
163363845|NCT00706654|590040715|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
163363846|NCT00706654|590040716|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
163363847|NCT00706654|590040717|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
163363848|NCT00706654|590040718|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
163363849|NCT00706654|590040715|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
163363850|NCT00706654|590040716|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
163363851|NCT00706654|590040717|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
163363852|NCT00706654|590040718|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
163363853|NCT00706654|590040715|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
163363854|NCT00706654|590040716|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
163363855|NCT00706654|590040717|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
163363856|NCT00706654|590040718|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
163363857|NCT00706654|590040715|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
163363858|NCT00706654|590040716|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
163363859|NCT00706654|590040717|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
163363860|NCT00706654|590040718|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
163363861|NCT00706654|590040715|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
163363862|NCT00706654|590040716|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
163363863|NCT00706654|590040717|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
163363864|NCT00706654|590040718|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
163363865|NCT02975102|590040722|FG000|Overall Study|Adverse Event|2|||
163363866|NCT02975102|590040723|FG001|Overall Study|Adverse Event|1|||
163363867|NCT05262751|590040728|FG000|Washout Period 2|Adverse Event|1|||
163363868|NCT05262751|590040729|FG001|Washout Period 2|Adverse Event|0|||
163363869|NCT05262751|590040730|FG002|Washout Period 2|Adverse Event|0|||
163363870|NCT05262751|590040731|FG003|Washout Period 2|Adverse Event|0|||
163363871|NCT05262751|590040732|FG004|Washout Period 2|Adverse Event|0|||
163363872|NCT05262751|590040733|FG005|Washout Period 2|Adverse Event|0|||
163363873|NCT05262751|590040728|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
163363874|NCT05262751|590040729|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
163363875|NCT05262751|590040730|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
163363876|NCT05262751|590040731|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
163363877|NCT05262751|590040732|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
163363878|NCT05262751|590040733|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
163363879|NCT01001390|590040734|FG000|Overall Study|Failure to wear AFO device|2|||
163363880|NCT01001390|590040735|FG001|Overall Study|Failure to wear AFO device|0|||
163363881|NCT02956837|590040736|FG000|Overall Study|Serious Adverse Events|0|||
163363882|NCT02956837|590040737|FG001|Overall Study|Serious Adverse Events|1|||
163363883|NCT02956837|590040738|FG002|Overall Study|Serious Adverse Events|0|||
163363884|NCT02956837|590040739|FG003|Overall Study|Serious Adverse Events|0|||
163363885|NCT02956837|590040736|FG000|Overall Study|Withdrawal by Subject|0|||
163411729|NCT02158091|590215263|FG001|Overall Study|DLT|1|||
163411730|NCT02158091|590215264|FG002|Overall Study|DLT|0|||
163411731|NCT01358864|590215269|FG000|Overall Study|Adverse Event|0|||
163411732|NCT01358864|590215270|FG001|Overall Study|Adverse Event|6|||
163411733|NCT01358864|590215271|FG002|Overall Study|Adverse Event|9|||
163411734|NCT01358864|590215272|FG003|Overall Study|Adverse Event|0|||
163411735|NCT01358864|590215273|FG004|Overall Study|Adverse Event|4|||
163411736|NCT01358864|590215274|FG005|Overall Study|Adverse Event|8|||
163411737|NCT01358864|590215275|FG006|Overall Study|Adverse Event|12|||
163411738|NCT01358864|590215276|FG007|Overall Study|Adverse Event|7|||
163411739|NCT01358864|590215269|FG000|Overall Study|Lack of Efficacy|26|||
163411740|NCT01358864|590215270|FG001|Overall Study|Lack of Efficacy|3|||
163411741|NCT01358864|590215271|FG002|Overall Study|Lack of Efficacy|4|||
163411742|NCT01358864|590215272|FG003|Overall Study|Lack of Efficacy|19|||
163411743|NCT01358864|590215273|FG004|Overall Study|Lack of Efficacy|7|||
163411744|NCT01358864|590215274|FG005|Overall Study|Lack of Efficacy|4|||
163411745|NCT01358864|590215275|FG006|Overall Study|Lack of Efficacy|49|||
163411746|NCT01358864|590215276|FG007|Overall Study|Lack of Efficacy|44|||
163411747|NCT01358864|590215269|FG000|Overall Study|Lost to Follow-up|0|||
163411748|NCT01358864|590215270|FG001|Overall Study|Lost to Follow-up|0|||
163411749|NCT01358864|590215271|FG002|Overall Study|Lost to Follow-up|1|||
163411750|NCT01358864|590215272|FG003|Overall Study|Lost to Follow-up|0|||
163411751|NCT01358864|590215273|FG004|Overall Study|Lost to Follow-up|0|||
163411752|NCT01358864|590215274|FG005|Overall Study|Lost to Follow-up|0|||
163411753|NCT01358864|590215275|FG006|Overall Study|Lost to Follow-up|0|||
163411754|NCT01358864|590215276|FG007|Overall Study|Lost to Follow-up|1|||
163411755|NCT01358864|590215269|FG000|Overall Study|Withdrawal by Subject|3|||
163411756|NCT01358864|590215270|FG001|Overall Study|Withdrawal by Subject|4|||
163411757|NCT01358864|590215271|FG002|Overall Study|Withdrawal by Subject|2|||
163411758|NCT01358864|590215272|FG003|Overall Study|Withdrawal by Subject|0|||
163411759|NCT01358864|590215273|FG004|Overall Study|Withdrawal by Subject|0|||
163411760|NCT01358864|590215274|FG005|Overall Study|Withdrawal by Subject|1|||
163411761|NCT01358864|590215275|FG006|Overall Study|Withdrawal by Subject|1|||
163411762|NCT01358864|590215276|FG007|Overall Study|Withdrawal by Subject|3|||
163411763|NCT01358864|590215269|FG000|Overall Study|Other reason not defined above|2|||
163411764|NCT01358864|590215270|FG001|Overall Study|Other reason not defined above|0|||
163411765|NCT01358864|590215271|FG002|Overall Study|Other reason not defined above|0|||
163411766|NCT01358864|590215272|FG003|Overall Study|Other reason not defined above|0|||
163411767|NCT01358864|590215273|FG004|Overall Study|Other reason not defined above|0|||
163411768|NCT01358864|590215274|FG005|Overall Study|Other reason not defined above|0|||
163411769|NCT01358864|590215275|FG006|Overall Study|Other reason not defined above|2|||
163411770|NCT01358864|590215276|FG007|Overall Study|Other reason not defined above|0|||
163411771|NCT01358864|590215269|FG000|Overall Study|Not treated|0|||
163411772|NCT01358864|590215270|FG001|Overall Study|Not treated|0|||
163411773|NCT01358864|590215271|FG002|Overall Study|Not treated|0|||
163411774|NCT01358864|590215272|FG003|Overall Study|Not treated|0|||
163411775|NCT01358864|590215273|FG004|Overall Study|Not treated|0|||
163411776|NCT01358864|590215274|FG005|Overall Study|Not treated|0|||
163411777|NCT01358864|590215275|FG006|Overall Study|Not treated|1|||
163411778|NCT01358864|590215276|FG007|Overall Study|Not treated|0|||
163411779|NCT04518462|590215282|FG000|Overall Study|Withdrawal by Subject|0|||
163411780|NCT04518462|590215283|FG001|Overall Study|Withdrawal by Subject|0|||
163411781|NCT04518462|590215284|FG002|Overall Study|Withdrawal by Subject|1|||
163411782|NCT04518462|590215282|FG000|Overall Study|Physician Decision|1|||
163411783|NCT04518462|590215283|FG001|Overall Study|Physician Decision|1|||
163411784|NCT04518462|590215284|FG002|Overall Study|Physician Decision|0|||
163411785|NCT01003210|590215285|FG000|Overall Study|Lost to Follow-up|1|||
163411786|NCT01003210|590215286|FG001|Overall Study|Lost to Follow-up|3|||
163411787|NCT00861744|590215289|FG000|Overall Study|Adverse Event|0|||
163411788|NCT00861744|590215290|FG001|Overall Study|Adverse Event|0|||
163363886|NCT02956837|590040737|FG001|Overall Study|Withdrawal by Subject|1|||
163363887|NCT02956837|590040738|FG002|Overall Study|Withdrawal by Subject|0|||
163363888|NCT02956837|590040739|FG003|Overall Study|Withdrawal by Subject|3|||
163363889|NCT02956837|590040736|FG000|Overall Study|Lost to Follow-up|0|||
163363890|NCT02956837|590040737|FG001|Overall Study|Lost to Follow-up|1|||
163363891|NCT02956837|590040738|FG002|Overall Study|Lost to Follow-up|2|||
163363892|NCT02956837|590040739|FG003|Overall Study|Lost to Follow-up|0|||
163363893|NCT01727505|590040747|FG000|First 24 Hours|Adverse Event|0|||
163363894|NCT01727505|590040748|FG001|First 24 Hours|Adverse Event|1|||
163363895|NCT01727505|590040747|FG000|Second 24 Hours|Missing data|0|||
163363896|NCT01727505|590040748|FG001|Second 24 Hours|Missing data|1|||
163363897|NCT01154140|590040749|FG000|Overall Study|Death|71|||
163363898|NCT01154140|590040750|FG001|Overall Study|Death|81|||
163363899|NCT01154140|590040749|FG000|Overall Study|Lost to Follow-up|4|||
163363900|NCT01154140|590040750|FG001|Overall Study|Lost to Follow-up|5|||
163363901|NCT01154140|590040749|FG000|Overall Study|Withdrawal by Subject|12|||
163363902|NCT01154140|590040750|FG001|Overall Study|Withdrawal by Subject|13|||
163363903|NCT01154140|590040749|FG000|Overall Study|Other|3|||
163363904|NCT01154140|590040750|FG001|Overall Study|Other|1|||
163363905|NCT01154140|590040749|FG000|Overall Study|Randomized but not treated|1|||
163363906|NCT01154140|590040750|FG001|Overall Study|Randomized but not treated|2|||
163363907|NCT00358644|590040751|FG000|Overall Study|Progressive Disease|21|||
163363908|NCT00358644|590040751|FG000|Overall Study|Adverse Event|7|||
163363909|NCT00358644|590040751|FG000|Overall Study|Death|11|||
163363910|NCT00358644|590040751|FG000|Overall Study|Withdrawal by Subject|4|||
163363911|NCT00358644|590040751|FG000|Overall Study|Physician Decision|6|||
163363912|NCT00358644|590040751|FG000|Overall Study|Patient not eligible for study|1|||
163363913|NCT00368875|590040752|FG000|Overall Study|Adverse Event|0|||
163363914|NCT00368875|590040753|FG001|Overall Study|Adverse Event|12|||
163363915|NCT00368875|590040752|FG000|Overall Study|Progressive disease|3|||
163363916|NCT00368875|590040753|FG001|Overall Study|Progressive disease|27|||
163363917|NCT00368875|590040752|FG000|Overall Study|Withdrawal by Subject|2|||
163363918|NCT00368875|590040753|FG001|Overall Study|Withdrawal by Subject|6|||
163363919|NCT00368875|590040752|FG000|Overall Study|Other Reason|0|||
163363920|NCT00368875|590040753|FG001|Overall Study|Other Reason|2|||
163363921|NCT00368875|590040752|FG000|Overall Study|Alternative Therapy|1|||
163363922|NCT00368875|590040753|FG001|Overall Study|Alternative Therapy|1|||
163363923|NCT03327831|590040754|FG000|Overall Study|Lost to Follow-up|2|||
163363924|NCT02595372|590040755|FG000|Overall Study|Adverse Event|6|||
163363925|NCT02595372|590040755|FG000|Overall Study|Physician Decision|2|||
163363926|NCT02595372|590040755|FG000|Overall Study|Disease Progression|1|||
163363927|NCT00401258|590040758|FG000|Overall Study|Adverse Event|7|||
163363928|NCT04297618|590040768|FG000|Overall Study|Adverse Event|1|||
163363929|NCT04297618|590040768|FG000|Overall Study|Withdrawal by Subject|1|||
163363930|NCT03838731|590042460|FG000|Overall Study|Pregnancy|0|||
163363931|NCT03838731|590042461|FG001|Overall Study|Pregnancy|1|||
163363932|NCT03838731|590042460|FG000|Overall Study|Withdrawal of consent|1|||
163363933|NCT03838731|590042461|FG001|Overall Study|Withdrawal of consent|0|||
163363934|NCT00603525|590042468|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
163363935|NCT00603525|590042469|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
163363936|NCT00603525|590042470|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
163363937|NCT00603525|590042468|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
163363938|NCT00603525|590042469|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
163363939|NCT00603525|590042470|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
163363940|NCT00603525|590042468|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
163363941|NCT00603525|590042469|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
163363942|NCT00603525|590042470|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
163363943|NCT00603525|590042468|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
163363944|NCT00603525|590042469|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
163363945|NCT00603525|590042470|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163363946|NCT00603525|590042468|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
163363947|NCT00603525|590042469|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
163363948|NCT00603525|590042470|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163363949|NCT00603525|590042468|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
163363950|NCT00603525|590042469|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
163363951|NCT00603525|590042470|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
163363952|NCT00603525|590042468|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
163363953|NCT00603525|590042469|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
163363954|NCT00603525|590042470|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
163363955|NCT00603525|590042468|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
163363956|NCT00603525|590042469|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
163363957|NCT00603525|590042470|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
163363958|NCT00603525|590042468|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
163363959|NCT00603525|590042469|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
163363960|NCT00603525|590042470|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
163363961|NCT00603525|590042468|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
163363962|NCT00603525|590042469|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
163363963|NCT00603525|590042470|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
163363964|NCT00603525|590042468|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
163363965|NCT00603525|590042469|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
163363966|NCT00603525|590042470|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
163363967|NCT00603525|590042468|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
163363968|NCT00603525|590042469|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
163363969|NCT00603525|590042470|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
163363970|NCT00603525|590042468|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
163363971|NCT00603525|590042469|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
163363972|NCT00603525|590042470|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
163363973|NCT00603525|590042468|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
163363974|NCT00603525|590042469|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
163363975|NCT00603525|590042470|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
163411789|NCT00861744|590215291|FG002|Overall Study|Adverse Event|0|||
163363976|NCT00603525|590042468|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
163363977|NCT00603525|590042469|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
163363978|NCT00603525|590042470|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
163363979|NCT01483144|590042471|FG000|Overall Study|Adverse Event|9|||
163363980|NCT01483144|590042472|FG001|Overall Study|Adverse Event|4|||
163363981|NCT01483144|590042473|FG002|Overall Study|Adverse Event|6|||
163363982|NCT01483144|590042471|FG000|Overall Study|Withdrawal by Subject|0|||
163363983|NCT01483144|590042472|FG001|Overall Study|Withdrawal by Subject|2|||
163363984|NCT01483144|590042473|FG002|Overall Study|Withdrawal by Subject|5|||
163363985|NCT01483144|590042471|FG000|Overall Study|Physician Decision|1|||
163363986|NCT01483144|590042472|FG001|Overall Study|Physician Decision|0|||
163363987|NCT01483144|590042473|FG002|Overall Study|Physician Decision|0|||
163363988|NCT01483144|590042471|FG000|Overall Study|Lost to Follow-up|2|||
163363989|NCT01483144|590042472|FG001|Overall Study|Lost to Follow-up|4|||
163363990|NCT01483144|590042473|FG002|Overall Study|Lost to Follow-up|1|||
163363991|NCT01483144|590042471|FG000|Overall Study|Protocol Violation|3|||
163363992|NCT01483144|590042472|FG001|Overall Study|Protocol Violation|3|||
163363993|NCT01483144|590042473|FG002|Overall Study|Protocol Violation|3|||
163363994|NCT02460575|590042474|FG000|Overall Study|Lost to Follow-up|1|||
163363995|NCT02460575|590042475|FG001|Overall Study|Lost to Follow-up|0|||
163363996|NCT04624243|590042479|FG000|Overall Study|Death|0|||
163363997|NCT04624243|590042480|FG001|Overall Study|Death|1|||
163363998|NCT04624243|590042481|FG002|Overall Study|Death|0|||
163363999|NCT04624243|590042482|FG003|Overall Study|Death|0|||
163364000|NCT04624243|590042483|FG004|Overall Study|Death|0|||
163364001|NCT04624243|590042479|FG000|Overall Study|Lost to Follow-up|2|||
163364002|NCT04624243|590042480|FG001|Overall Study|Lost to Follow-up|3|||
163364003|NCT04624243|590042481|FG002|Overall Study|Lost to Follow-up|7|||
163364004|NCT04624243|590042482|FG003|Overall Study|Lost to Follow-up|1|||
163364005|NCT04624243|590042483|FG004|Overall Study|Lost to Follow-up|3|||
163364006|NCT04624243|590042479|FG000|Overall Study|Physician Decision|3|||
163364007|NCT04624243|590042480|FG001|Overall Study|Physician Decision|8|||
163364008|NCT04624243|590042481|FG002|Overall Study|Physician Decision|15|||
163364009|NCT04624243|590042482|FG003|Overall Study|Physician Decision|2|||
163364010|NCT04624243|590042483|FG004|Overall Study|Physician Decision|11|||
163364011|NCT04624243|590042479|FG000|Overall Study|Withdrawal by Subject|19|||
163364012|NCT04624243|590042480|FG001|Overall Study|Withdrawal by Subject|44|||
163364013|NCT04624243|590042481|FG002|Overall Study|Withdrawal by Subject|40|||
163364014|NCT04624243|590042482|FG003|Overall Study|Withdrawal by Subject|21|||
163364015|NCT04624243|590042483|FG004|Overall Study|Withdrawal by Subject|39|||
163364016|NCT04624243|590042479|FG000|Overall Study|Miscellaneous|3|||
163364017|NCT04624243|590042480|FG001|Overall Study|Miscellaneous|12|||
163364018|NCT04624243|590042481|FG002|Overall Study|Miscellaneous|9|||
163364019|NCT04624243|590042482|FG003|Overall Study|Miscellaneous|4|||
163364020|NCT04624243|590042483|FG004|Overall Study|Miscellaneous|6|||
163364021|NCT04996004|590042484|FG000|Phase I|Death|1|||
163364022|NCT04996004|590042485|FG001|Phase I|Death|2|||
163364023|NCT04996004|590042486|FG002|Phase I|Death|1|||
163364024|NCT04996004|590042487|FG003|Phase I|Death|0|||
163364025|NCT04996004|590042488|FG004|Phase I|Death|0|||
163364026|NCT04996004|590042489|FG005|Phase I|Death|0|||
163364027|NCT04996004|590042484|FG000|Phase I|Study terminated by sponsor|2|||
163364028|NCT04996004|590042485|FG001|Phase I|Study terminated by sponsor|1|||
163364029|NCT04996004|590042486|FG002|Phase I|Study terminated by sponsor|2|||
163364030|NCT04996004|590042487|FG003|Phase I|Study terminated by sponsor|0|||
163364031|NCT04996004|590042488|FG004|Phase I|Study terminated by sponsor|0|||
163364032|NCT04996004|590042489|FG005|Phase I|Study terminated by sponsor|0|||
163364033|NCT04996004|590042484|FG000|Phase II|Study terminated by sponsor|0|||
163364034|NCT04996004|590042485|FG001|Phase II|Study terminated by sponsor|0|||
163364035|NCT04996004|590042486|FG002|Phase II|Study terminated by sponsor|0|||
163364036|NCT04996004|590042487|FG003|Phase II|Study terminated by sponsor|20|||
163364037|NCT04996004|590042488|FG004|Phase II|Study terminated by sponsor|10|||
163364038|NCT04996004|590042489|FG005|Phase II|Study terminated by sponsor|10|||
163364039|NCT04996004|590042484|FG000|Phase II|Withdrawal by Subject|0|||
163364040|NCT04996004|590042485|FG001|Phase II|Withdrawal by Subject|0|||
163364041|NCT04996004|590042486|FG002|Phase II|Withdrawal by Subject|0|||
163364042|NCT04996004|590042487|FG003|Phase II|Withdrawal by Subject|0|||
163364043|NCT04996004|590042488|FG004|Phase II|Withdrawal by Subject|1|||
163411790|NCT00861744|590215292|FG003|Overall Study|Adverse Event|1|||
163364044|NCT04996004|590042489|FG005|Phase II|Withdrawal by Subject|2|||
163364045|NCT04996004|590042484|FG000|Phase II|Death|0|||
163364046|NCT04996004|590042485|FG001|Phase II|Death|0|||
163364047|NCT04996004|590042486|FG002|Phase II|Death|0|||
163364048|NCT04996004|590042487|FG003|Phase II|Death|12|||
163364049|NCT04996004|590042488|FG004|Phase II|Death|2|||
163364050|NCT04996004|590042489|FG005|Phase II|Death|9|||
163364051|NCT04996004|590042484|FG000|Phase II|Other|0|||
163364052|NCT04996004|590042485|FG001|Phase II|Other|0|||
163364053|NCT04996004|590042486|FG002|Phase II|Other|0|||
163364054|NCT04996004|590042487|FG003|Phase II|Other|0|||
163364055|NCT04996004|590042488|FG004|Phase II|Other|0|||
163411791|NCT00861744|590215289|FG000|Overall Study|Lost to Follow-up|7|||
163411792|NCT00861744|590215290|FG001|Overall Study|Lost to Follow-up|19|||
163411793|NCT00861744|590215291|FG002|Overall Study|Lost to Follow-up|17|||
163411794|NCT00861744|590215292|FG003|Overall Study|Lost to Follow-up|12|||
163411795|NCT00861744|590215289|FG000|Overall Study|Withdrawal by Subject|10|||
163411796|NCT00861744|590215290|FG001|Overall Study|Withdrawal by Subject|6|||
163411797|NCT00861744|590215291|FG002|Overall Study|Withdrawal by Subject|6|||
163411798|NCT00861744|590215292|FG003|Overall Study|Withdrawal by Subject|19|||
163411799|NCT00861744|590215289|FG000|Overall Study|Protocol Violation|0|||
163411800|NCT00861744|590215290|FG001|Overall Study|Protocol Violation|1|||
163411801|NCT00861744|590215291|FG002|Overall Study|Protocol Violation|0|||
163411802|NCT00861744|590215292|FG003|Overall Study|Protocol Violation|0|||
163411803|NCT00861744|590215289|FG000|Overall Study|Migration from study area|0|||
163411804|NCT00861744|590215290|FG001|Overall Study|Migration from study area|3|||
163411805|NCT00861744|590215291|FG002|Overall Study|Migration from study area|1|||
163411806|NCT00861744|590215292|FG003|Overall Study|Migration from study area|0|||
163411807|NCT00861744|590215289|FG000|Overall Study|Blood draws|0|||
163411808|NCT00861744|590215290|FG001|Overall Study|Blood draws|0|||
163411809|NCT00861744|590215291|FG002|Overall Study|Blood draws|0|||
163411810|NCT00861744|590215292|FG003|Overall Study|Blood draws|1|||
163411811|NCT05568888|590215293|FG000|Overall Study|Physician Decision|1|||
163411812|NCT05568888|590215294|FG001|Overall Study|Physician Decision|0|||
163411813|NCT05568888|590215293|FG000|Overall Study|Protocol Deviation|2|||
163411814|NCT05568888|590215294|FG001|Overall Study|Protocol Deviation|1|||
163411815|NCT05568888|590215293|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
163411816|NCT05568888|590215294|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
163411817|NCT05568888|590215293|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
163411818|NCT05568888|590215294|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
163411819|NCT05568888|590215293|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
163411820|NCT05568888|590215294|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
163411821|NCT02193074|590215295|FG000|Overall Study|Withdrawal by Subject|1|||
163411822|NCT02193074|590215296|FG001|Overall Study|Withdrawal by Subject|2|||
163411823|NCT02193074|590215295|FG000|Overall Study|Adverse Event|16|||
163411824|NCT02193074|590215296|FG001|Overall Study|Adverse Event|13|||
163411825|NCT05036083|590215304|FG000|Overall Study|Physician Decision|1|||
163411826|NCT05036083|590215304|FG000|Overall Study|Withdrawal by Subject|1|||
163411827|NCT05036083|590215304|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
163411828|NCT05036083|590215304|FG000|Overall Study|IV not sustainable|1|||
163411829|NCT01844986|590215305|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
163411830|NCT01844986|590215306|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
163411831|NCT01844986|590215305|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
163411832|NCT01844986|590215306|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
163411833|NCT01844986|590215305|FG000|Overall Study (Global Cohort)|Death|55|||
163411834|NCT01844986|590215306|FG001|Overall Study (Global Cohort)|Death|26|||
163411835|NCT01844986|590215305|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
163411836|NCT01844986|590215306|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
163411837|NCT01844986|590215305|FG000|Overall Study (China Cohort)|Death|10|||
163411838|NCT01844986|590215306|FG001|Overall Study (China Cohort)|Death|6|||
163411839|NCT02396589|590215309|FG000|Intervention|Lost to Follow-up|1|||
163411840|NCT02396589|590215310|FG001|Intervention|Lost to Follow-up|0|||
163411841|NCT02396589|590215309|FG000|6 Month Follow-up|change in health status|0|||
163411842|NCT02396589|590215310|FG001|6 Month Follow-up|change in health status|1|||
163411843|NCT02396589|590215309|FG000|9 Month Follow-up|Death|0|||
163411844|NCT02396589|590215310|FG001|9 Month Follow-up|Death|1|||
163411845|NCT02396589|590215309|FG000|12 Month Follow up|Lost to Follow-up|0|||
163411846|NCT02396589|590215310|FG001|12 Month Follow up|Lost to Follow-up|2|||
163411847|NCT04381650|590215311|FG000|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163411848|NCT04381650|590215312|FG001|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163411849|NCT04381650|590215313|FG002|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163411850|NCT04381650|590215314|FG003|Phase 1b (Dose Escalation)|New anti-cancer therapy|1|||
163411851|NCT04381650|590215315|FG004|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163411852|NCT04381650|590215316|FG005|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163411853|NCT04381650|590215317|FG006|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163411854|NCT04381650|590215318|FG007|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163411855|NCT04381650|590215319|FG008|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163411856|NCT04381650|590215320|FG009|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163411857|NCT04381650|590215321|FG010|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163411858|NCT04381650|590215311|FG000|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163411859|NCT04381650|590215312|FG001|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163411860|NCT04381650|590215313|FG002|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163411861|NCT04381650|590215314|FG003|Phase 1b (Dose Escalation)|Lost to Follow-up|1|||
163411862|NCT04381650|590215315|FG004|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163411863|NCT04381650|590215316|FG005|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163364056|NCT04996004|590042489|FG005|Phase II|Other|1|||
163364057|NCT05543174|590042490|FG000|Overall Study|Ongoing|7|||
163364058|NCT03374488|590042491|FG000|Overall Study|Death|13|||
163364059|NCT03374488|590042492|FG001|Overall Study|Death|13|||
163364060|NCT03374488|590042491|FG000|Overall Study|Withdrawal by Subject|3|||
163364061|NCT03374488|590042492|FG001|Overall Study|Withdrawal by Subject|1|||
163364062|NCT03374488|590042491|FG000|Overall Study|Physician Decision|3|||
163364063|NCT03374488|590042492|FG001|Overall Study|Physician Decision|0|||
163364064|NCT03104075|590042493|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
163364065|NCT03104075|590042494|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
163364066|NCT04896008|590042495|FG000|Overall Study|Ongoing|70|||
163364067|NCT04896008|590042496|FG001|Overall Study|Ongoing|38|||
163364068|NCT04896008|590042495|FG000|Overall Study|Adverse Event|0|||
163364069|NCT04896008|590042496|FG001|Overall Study|Adverse Event|2|||
163364070|NCT04896008|590042495|FG000|Overall Study|Death|5|||
163364071|NCT04896008|590042496|FG001|Overall Study|Death|10|||
163364072|NCT04896008|590042495|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
163364073|NCT04896008|590042496|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
163364074|NCT04896008|590042495|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
163364075|NCT04896008|590042496|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
163364076|NCT04896008|590042495|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
163364077|NCT04896008|590042496|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
163364078|NCT04896008|590042495|FG000|Overall Study|Withdrawal by Subject|1|||
163364079|NCT04896008|590042496|FG001|Overall Study|Withdrawal by Subject|4|||
163364080|NCT04896008|590042495|FG000|Overall Study|Investigator Decision|2|||
163364081|NCT04896008|590042496|FG001|Overall Study|Investigator Decision|0|||
163364082|NCT04896008|590042495|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
163364083|NCT04896008|590042496|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
163364084|NCT00944229|590042499|FG000|Overall Study|Withdrawal by Subject|11|||
163364085|NCT00944229|590042499|FG000|Overall Study|Physician Decision|14|||
163364086|NCT01810939|590042502|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
163364087|NCT01810939|590042503|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
163364088|NCT01810939|590042504|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
163364089|NCT01810939|590042502|FG000|Part A Treatment Period|Protocol Violation|2|||
163364090|NCT01810939|590042503|FG001|Part A Treatment Period|Protocol Violation|0|||
163364091|NCT01810939|590042504|FG002|Part A Treatment Period|Protocol Violation|0|||
163364092|NCT01810939|590042502|FG000|Part A Treatment Period|Adverse Event|10|||
163364093|NCT01810939|590042503|FG001|Part A Treatment Period|Adverse Event|0|||
163364094|NCT01810939|590042504|FG002|Part A Treatment Period|Adverse Event|0|||
163364095|NCT01810939|590042502|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
163364096|NCT01810939|590042503|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
163364097|NCT01810939|590042504|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
163364098|NCT01810939|590042502|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
163364099|NCT01810939|590042503|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
163364100|NCT01810939|590042504|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
163364101|NCT01810939|590042502|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
163364102|NCT01810939|590042503|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
163364103|NCT01810939|590042504|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
163364104|NCT01810939|590042502|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
163364105|NCT01810939|590042503|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
163364106|NCT01810939|590042504|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
163364107|NCT01810939|590042502|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
163364108|NCT01810939|590042503|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
163364109|NCT01810939|590042504|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
163364110|NCT01810939|590042502|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
163364111|NCT01810939|590042503|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
163364112|NCT01810939|590042504|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
163364113|NCT01810939|590042502|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
163364114|NCT01810939|590042503|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
163364115|NCT01810939|590042504|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
163364116|NCT01810939|590042502|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
163364117|NCT01810939|590042503|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
163364118|NCT01810939|590042504|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
163364119|NCT01810939|590042502|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
163364120|NCT01810939|590042503|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
163364121|NCT01810939|590042504|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
163364122|NCT01810939|590042502|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
163364123|NCT01810939|590042503|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
163364124|NCT01810939|590042504|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
163364125|NCT01810939|590042502|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
163364126|NCT01810939|590042503|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
163364127|NCT01810939|590042504|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
163364128|NCT01810939|590042502|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
163364129|NCT01810939|590042503|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
163364130|NCT01810939|590042504|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
163364131|NCT01810939|590042502|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
163364132|NCT01810939|590042503|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
163364133|NCT01810939|590042504|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
163364134|NCT01810939|590042502|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
163364135|NCT01810939|590042503|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
163364136|NCT01810939|590042504|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
163364137|NCT04497389|590042507|FG000|Overall Study|Withdrawal by Subject|1|||
163364138|NCT04497389|590042508|FG001|Overall Study|Withdrawal by Subject|0|||
163364139|NCT04400487|590042509|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
163364140|NCT04400487|590042509|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
163364141|NCT04400487|590042509|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
163364142|NCT03559062|590042510|FG000|Overall Study|Other|0|||
163364143|NCT03559062|590042511|FG001|Overall Study|Other|1|||
163364144|NCT03559062|590042512|FG002|Overall Study|Other|0|||
163364145|NCT01757197|590042513|FG000|Overall Study|Death|2|||
163364146|NCT03322540|590042519|FG000|Overall Study|Death|21|||
163364147|NCT03322540|590042520|FG001|Overall Study|Death|28|||
163364148|NCT03322540|590042519|FG000|Overall Study|Lost to Follow-up|0|||
163364149|NCT03322540|590042520|FG001|Overall Study|Lost to Follow-up|1|||
163364150|NCT03322540|590042519|FG000|Overall Study|Physician Decision|7|||
163364151|NCT03322540|590042520|FG001|Overall Study|Physician Decision|6|||
163364152|NCT03322540|590042519|FG000|Overall Study|Withdrawal by Subject|3|||
163364153|NCT03322540|590042520|FG001|Overall Study|Withdrawal by Subject|1|||
163364154|NCT03322540|590042519|FG000|Overall Study|Study terminated by sponsor|0|||
163364155|NCT03322540|590042520|FG001|Overall Study|Study terminated by sponsor|1|||
163364156|NCT01594827|590042523|FG000|Overall Study|Adverse Event|1|||
163364157|NCT01594827|590042524|FG001|Overall Study|Adverse Event|0|||
163364158|NCT01594827|590042523|FG000|Overall Study|Physician Decision|3|||
163364159|NCT01594827|590042524|FG001|Overall Study|Physician Decision|0|||
163364160|NCT01677299|590042525|FG000|Overall Study|Adverse Event|0|||
163364161|NCT01677299|590042526|FG001|Overall Study|Adverse Event|2|||
163364162|NCT01677299|590042527|FG002|Overall Study|Adverse Event|1|||
163364163|NCT01677299|590042528|FG003|Overall Study|Adverse Event|0|||
163364164|NCT01677299|590042525|FG000|Overall Study|Withdrawal by Subject|0|||
163364165|NCT01677299|590042526|FG001|Overall Study|Withdrawal by Subject|1|||
163364166|NCT01677299|590042527|FG002|Overall Study|Withdrawal by Subject|0|||
163364167|NCT01677299|590042528|FG003|Overall Study|Withdrawal by Subject|1|||
163364168|NCT00520845|590042529|FG000|Overall Study|Death|3|||
163364169|NCT00520845|590042529|FG000|Overall Study|Adverse Event|4|||
163364170|NCT00520845|590042529|FG000|Overall Study|Disease Progression, relapse|13|||
163364171|NCT00520845|590042529|FG000|Overall Study|Withdrawal by Subject|1|||
163364172|NCT00520845|590042529|FG000|Overall Study|Alternative Therapy|1|||
163364173|NCT05105087|590042532|FG000|Overall Study|Withdrawal by Subject|2|||
163364174|NCT05105087|590042532|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
163364175|NCT00755417|590042535|FG000|Overall Study|Adverse Event|28|||
163364176|NCT00755417|590042536|FG001|Overall Study|Adverse Event|20|||
163364177|NCT00755417|590042537|FG002|Overall Study|Adverse Event|7|||
163364178|NCT00755417|590042535|FG000|Overall Study|Lack of Efficacy|8|||
163364179|NCT00755417|590042536|FG001|Overall Study|Lack of Efficacy|4|||
163364180|NCT00755417|590042537|FG002|Overall Study|Lack of Efficacy|9|||
163364181|NCT00755417|590042535|FG000|Overall Study|Protocol Violation|2|||
163364182|NCT00755417|590042536|FG001|Overall Study|Protocol Violation|1|||
163364183|NCT00755417|590042537|FG002|Overall Study|Protocol Violation|1|||
163364184|NCT00755417|590042535|FG000|Overall Study|Lost to Follow-up|3|||
163364185|NCT00755417|590042536|FG001|Overall Study|Lost to Follow-up|0|||
163364186|NCT00755417|590042537|FG002|Overall Study|Lost to Follow-up|1|||
163364187|NCT00755417|590042535|FG000|Overall Study|Withdrawal by Subject|12|||
163364188|NCT00755417|590042536|FG001|Overall Study|Withdrawal by Subject|12|||
163364189|NCT00755417|590042537|FG002|Overall Study|Withdrawal by Subject|12|||
163364190|NCT00755417|590042535|FG000|Overall Study|Not specified or missing data|9|||
163364191|NCT00755417|590042536|FG001|Overall Study|Not specified or missing data|18|||
163364192|NCT00755417|590042537|FG002|Overall Study|Not specified or missing data|12|||
163364193|NCT02803593|590042538|FG000|Overall Study|Lost to Follow-up|17|||
163364194|NCT02803593|590042539|FG001|Overall Study|Lost to Follow-up|35|||
163364195|NCT03443414|590042540|FG000|Overall Study|Adverse Event|6|||
163364196|NCT03443414|590042541|FG001|Overall Study|Adverse Event|0|||
163364197|NCT03443414|590042542|FG002|Overall Study|Adverse Event|4|||
163364198|NCT03443414|590042543|FG003|Overall Study|Adverse Event|2|||
163364199|NCT03443414|590042544|FG004|Overall Study|Adverse Event|3|||
163364200|NCT03443414|590042540|FG000|Overall Study|Withdrawal by Subject|3|||
163364201|NCT03443414|590042541|FG001|Overall Study|Withdrawal by Subject|2|||
163364202|NCT03443414|590042542|FG002|Overall Study|Withdrawal by Subject|2|||
163364203|NCT03443414|590042543|FG003|Overall Study|Withdrawal by Subject|2|||
163364204|NCT03443414|590042544|FG004|Overall Study|Withdrawal by Subject|1|||
163364205|NCT03443414|590042540|FG000|Overall Study|Death|0|||
163364206|NCT03443414|590042541|FG001|Overall Study|Death|1|||
163364207|NCT03443414|590042542|FG002|Overall Study|Death|0|||
163364208|NCT03443414|590042543|FG003|Overall Study|Death|1|||
163364209|NCT03443414|590042544|FG004|Overall Study|Death|0|||
163364210|NCT03443414|590042540|FG000|Overall Study|Reason not specified|2|||
163364211|NCT03443414|590042541|FG001|Overall Study|Reason not specified|0|||
163364212|NCT03443414|590042542|FG002|Overall Study|Reason not specified|0|||
163364213|NCT03443414|590042543|FG003|Overall Study|Reason not specified|0|||
163364214|NCT03443414|590042544|FG004|Overall Study|Reason not specified|1|||
163364215|NCT03933462|590042545|FG000|Overall Study|Adverse Event|2|||
163364216|NCT03933462|590042546|FG001|Overall Study|Adverse Event|0|||
163364217|NCT02522728|590042547|FG000|Overall Study|Withdrawal by Subject|6|||
163364218|NCT02522728|590042548|FG001|Overall Study|Withdrawal by Subject|6|||
163364219|NCT02522728|590042547|FG000|Overall Study|Death|4|||
163364220|NCT02522728|590042548|FG001|Overall Study|Death|3|||
163364221|NCT02522728|590042547|FG000|Overall Study|Adverse Event|2|||
163364222|NCT02522728|590042548|FG001|Overall Study|Adverse Event|1|||
163364223|NCT02522728|590042547|FG000|Overall Study|Did not receive randomized study device|0|||
163364224|NCT02522728|590042548|FG001|Overall Study|Did not receive randomized study device|1|||
163364225|NCT01436305|590042549|FG000|Overall Study|Death|1|||
163364226|NCT01436305|590042550|FG001|Overall Study|Death|0|||
163364227|NCT01436305|590042551|FG002|Overall Study|Death|0|||
163364228|NCT01436305|590042549|FG000|Overall Study|Lost to Follow-up|0|||
163364229|NCT01436305|590042550|FG001|Overall Study|Lost to Follow-up|1|||
163364230|NCT01436305|590042551|FG002|Overall Study|Lost to Follow-up|0|||
163364231|NCT01436305|590042549|FG000|Overall Study|Withdrawal by Subject|1|||
163364232|NCT01436305|590042550|FG001|Overall Study|Withdrawal by Subject|3|||
163364233|NCT01436305|590042551|FG002|Overall Study|Withdrawal by Subject|0|||
163364234|NCT01485120|590042552|FG000|Overall Study|Withdrawal by Subject|2|||
163364235|NCT02344342|590042553|FG000|Overall Study|Industry partner dropped out|11|||
163364236|NCT02344342|590042554|FG001|Overall Study|Industry partner dropped out|9|||
163364237|NCT02344342|590042555|FG002|Overall Study|Industry partner dropped out|14|||
163364238|NCT02344342|590042556|FG003|Overall Study|Industry partner dropped out|10|||
163364239|NCT03355209|590042557|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
163364240|NCT03355209|590042558|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
163364241|NCT03355209|590042559|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
163364242|NCT03355209|590042560|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
163364243|NCT03355209|590042561|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
163364244|NCT03355209|590042562|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
163364245|NCT03355209|590042557|FG000|Part 1: Double-Blind Period|Death|0|||
163364246|NCT03355209|590042558|FG001|Part 1: Double-Blind Period|Death|0|||
163364247|NCT03355209|590042559|FG002|Part 1: Double-Blind Period|Death|1|||
163364248|NCT03355209|590042560|FG003|Part 1: Double-Blind Period|Death|0|||
163364249|NCT03355209|590042561|FG004|Part 1: Double-Blind Period|Death|0|||
163364250|NCT03355209|590042562|FG005|Part 1: Double-Blind Period|Death|0|||
163364251|NCT03355209|590042557|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
163364252|NCT03355209|590042558|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
163364253|NCT03355209|590042559|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
163364254|NCT03355209|590042560|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
163364255|NCT03355209|590042561|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
163364256|NCT03355209|590042562|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
163364257|NCT03355209|590042557|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
163364258|NCT03355209|590042558|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
163364259|NCT03355209|590042559|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
163364260|NCT03355209|590042560|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
163364261|NCT03355209|590042561|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
163364262|NCT03355209|590042562|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
163364263|NCT03355209|590042557|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
163364264|NCT03355209|590042558|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
163364265|NCT03355209|590042559|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
163364266|NCT03355209|590042560|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
163364267|NCT03355209|590042561|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
163364268|NCT03355209|590042562|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
163364269|NCT03355209|590042557|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
163364270|NCT03355209|590042558|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
163364271|NCT03355209|590042559|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
163364272|NCT03355209|590042560|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
163364273|NCT03355209|590042561|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
163364274|NCT03355209|590042562|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
163364275|NCT03355209|590042557|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
163364276|NCT03355209|590042558|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
163364277|NCT03355209|590042559|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
163364278|NCT03355209|590042560|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
163364279|NCT03355209|590042561|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
163364280|NCT03355209|590042562|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
163364281|NCT03355209|590042557|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
163364282|NCT03355209|590042558|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
163364283|NCT03355209|590042559|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
163364284|NCT03355209|590042560|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
163364285|NCT03355209|590042561|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
163364286|NCT03355209|590042562|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
163364287|NCT03355209|590042557|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
163364288|NCT03355209|590042558|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
163364289|NCT03355209|590042559|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
163364290|NCT03355209|590042560|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163364291|NCT03355209|590042561|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
163364292|NCT03355209|590042562|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163364293|NCT03355209|590042557|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
163364294|NCT03355209|590042558|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
163364295|NCT03355209|590042559|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
163364296|NCT03355209|590042560|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
163364297|NCT03355209|590042561|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
163364298|NCT03355209|590042562|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
163364299|NCT03355209|590042557|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
163364300|NCT03355209|590042558|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
163364301|NCT03355209|590042559|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
163364302|NCT03355209|590042560|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
163364303|NCT03355209|590042561|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
163364304|NCT03355209|590042562|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
163364305|NCT01151215|590042566|FG000|Overall Study|Worsening of condition under study|1|||
163364306|NCT01151215|590042567|FG001|Overall Study|Worsening of condition under study|1|||
163364307|NCT01151215|590042568|FG002|Overall Study|Worsening of condition under study|1|||
163364308|NCT01151215|590042566|FG000|Overall Study|Death|16|||
163364309|NCT01151215|590042567|FG001|Overall Study|Death|20|||
163364310|NCT01151215|590042568|FG002|Overall Study|Death|11|||
163364311|NCT01151215|590042566|FG000|Overall Study|Lost to Follow-up|0|||
163364312|NCT01151215|590042567|FG001|Overall Study|Lost to Follow-up|0|||
163364313|NCT01151215|590042568|FG002|Overall Study|Lost to Follow-up|3|||
163364314|NCT01151215|590042566|FG000|Overall Study|Withdrawal by Subject|3|||
163364315|NCT01151215|590042567|FG001|Overall Study|Withdrawal by Subject|1|||
163364316|NCT01151215|590042568|FG002|Overall Study|Withdrawal by Subject|2|||
163364317|NCT01151215|590042566|FG000|Overall Study|Disease progression|0|||
163364318|NCT01151215|590042567|FG001|Overall Study|Disease progression|1|||
163364319|NCT01151215|590042568|FG002|Overall Study|Disease progression|1|||
163364320|NCT01151215|590042566|FG000|Overall Study|Safety as judged by the investigator|0|||
163364321|NCT01151215|590042567|FG001|Overall Study|Safety as judged by the investigator|0|||
163364322|NCT01151215|590042568|FG002|Overall Study|Safety as judged by the investigator|1|||
163364323|NCT02597712|590042569|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
163364324|NCT02597712|590042570|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
163364325|NCT02597712|590042569|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
163364326|NCT02597712|590042570|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
163364327|NCT02597712|590042569|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
163364328|NCT02597712|590042570|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
163364329|NCT00513708|590042571|FG000|Overall Study|Lost to Follow-up|4|||
163364330|NCT00513708|590042572|FG001|Overall Study|Lost to Follow-up|4|||
163364331|NCT00513708|590042573|FG002|Overall Study|Lost to Follow-up|4|||
163364332|NCT01564277|590042574|FG000|Overall Study|Protocol Violation|0|||
163364333|NCT01564277|590042575|FG001|Overall Study|Protocol Violation|1|||
163364334|NCT01564277|590042574|FG000|Overall Study|Physician Decision|1|||
163364335|NCT01564277|590042575|FG001|Overall Study|Physician Decision|0|||
163364336|NCT01594970|590042576|FG000|Overall Study|Non-Adverse Event Related|4|||
163364337|NCT01594970|590042577|FG001|Overall Study|Non-Adverse Event Related|5|||
163364338|NCT01594970|590042578|FG002|Overall Study|Non-Adverse Event Related|6|||
163364339|NCT01594970|590042576|FG000|Overall Study|Adverse Event|17|||
163364340|NCT01594970|590042577|FG001|Overall Study|Adverse Event|23|||
163364341|NCT01594970|590042578|FG002|Overall Study|Adverse Event|23|||
163411864|NCT04381650|590215317|FG006|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163411865|NCT04381650|590215318|FG007|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163411866|NCT04381650|590215319|FG008|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163411867|NCT04381650|590215320|FG009|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163411868|NCT04381650|590215321|FG010|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163411869|NCT04381650|590215311|FG000|Phase 1b (Dose Escalation)|Progressive Disease|1|||
163411870|NCT04381650|590215312|FG001|Phase 1b (Dose Escalation)|Progressive Disease|3|||
163411871|NCT04381650|590215313|FG002|Phase 1b (Dose Escalation)|Progressive Disease|12|||
163411872|NCT04381650|590215314|FG003|Phase 1b (Dose Escalation)|Progressive Disease|8|||
163411873|NCT04381650|590215315|FG004|Phase 1b (Dose Escalation)|Progressive Disease|0|||
163411874|NCT04381650|590215316|FG005|Phase 1b (Dose Escalation)|Progressive Disease|0|||
163411875|NCT04381650|590215317|FG006|Phase 1b (Dose Escalation)|Progressive Disease|0|||
163411876|NCT04381650|590215318|FG007|Phase 1b (Dose Escalation)|Progressive Disease|0|||
163411877|NCT04381650|590215319|FG008|Phase 1b (Dose Escalation)|Progressive Disease|0|||
163411878|NCT04381650|590215320|FG009|Phase 1b (Dose Escalation)|Progressive Disease|0|||
163364342|NCT01594970|590042576|FG000|Overall Study|Lost to Follow-up|54|||
163364343|NCT01594970|590042577|FG001|Overall Study|Lost to Follow-up|54|||
163364344|NCT01594970|590042578|FG002|Overall Study|Lost to Follow-up|37|||
163364345|NCT04276051|590042581|FG000|Overall Study|Lost to Follow-up|0|||
163364346|NCT04276051|590042582|FG001|Overall Study|Lost to Follow-up|1|||
163364347|NCT04276051|590042581|FG000|Overall Study|Physician Decision|0|||
163364348|NCT04276051|590042582|FG001|Overall Study|Physician Decision|1|||
163364349|NCT04276051|590042581|FG000|Overall Study|Withdrawal by Subject|1|||
163364350|NCT04276051|590042582|FG001|Overall Study|Withdrawal by Subject|1|||
163364351|NCT01299480|590042583|FG000|Overall Study|No longer willing to participate|19|||
163364352|NCT01299480|590042584|FG001|Overall Study|No longer willing to participate|17|||
163364353|NCT01299480|590042585|FG002|Overall Study|No longer willing to participate|14|||
163364354|NCT01299480|590042586|FG003|Overall Study|No longer willing to participate|13|||
163364355|NCT01299480|590042587|FG004|Overall Study|No longer willing to participate|10|||
163364356|NCT01299480|590042583|FG000|Overall Study|Protocol Violation|7|||
163364357|NCT01299480|590042584|FG001|Overall Study|Protocol Violation|5|||
163364358|NCT01299480|590042585|FG002|Overall Study|Protocol Violation|8|||
163364359|NCT01299480|590042586|FG003|Overall Study|Protocol Violation|1|||
163364360|NCT01299480|590042587|FG004|Overall Study|Protocol Violation|1|||
163364361|NCT01299480|590042583|FG000|Overall Study|Withdrawal by Subject|3|||
163364362|NCT01299480|590042584|FG001|Overall Study|Withdrawal by Subject|4|||
163364363|NCT01299480|590042585|FG002|Overall Study|Withdrawal by Subject|7|||
163364364|NCT01299480|590042586|FG003|Overall Study|Withdrawal by Subject|3|||
163364365|NCT01299480|590042587|FG004|Overall Study|Withdrawal by Subject|4|||
163364366|NCT01299480|590042583|FG000|Overall Study|Adverse Event|6|||
163364367|NCT01299480|590042584|FG001|Overall Study|Adverse Event|4|||
163364368|NCT01299480|590042585|FG002|Overall Study|Adverse Event|5|||
163364369|NCT01299480|590042586|FG003|Overall Study|Adverse Event|4|||
163364370|NCT01299480|590042587|FG004|Overall Study|Adverse Event|0|||
163364371|NCT01299480|590042583|FG000|Overall Study|Withdrawal due to pregnancy|0|||
163364372|NCT01299480|590042584|FG001|Overall Study|Withdrawal due to pregnancy|1|||
163364373|NCT01299480|590042585|FG002|Overall Study|Withdrawal due to pregnancy|1|||
163364374|NCT01299480|590042586|FG003|Overall Study|Withdrawal due to pregnancy|0|||
163364375|NCT01299480|590042587|FG004|Overall Study|Withdrawal due to pregnancy|0|||
163364376|NCT01299480|590042583|FG000|Overall Study|Physician Decision|1|||
163364377|NCT01299480|590042584|FG001|Overall Study|Physician Decision|1|||
163364378|NCT01299480|590042585|FG002|Overall Study|Physician Decision|0|||
163364379|NCT01299480|590042586|FG003|Overall Study|Physician Decision|2|||
163364380|NCT01299480|590042587|FG004|Overall Study|Physician Decision|0|||
163364381|NCT01299480|590042583|FG000|Overall Study|Lost to Follow-up|3|||
163364382|NCT01299480|590042584|FG001|Overall Study|Lost to Follow-up|1|||
163364383|NCT01299480|590042585|FG002|Overall Study|Lost to Follow-up|2|||
163364384|NCT01299480|590042586|FG003|Overall Study|Lost to Follow-up|1|||
163364385|NCT01299480|590042587|FG004|Overall Study|Lost to Follow-up|2|||
163364386|NCT01299480|590042583|FG000|Overall Study|Other|3|||
163364387|NCT01299480|590042584|FG001|Overall Study|Other|2|||
163364388|NCT01299480|590042585|FG002|Overall Study|Other|3|||
163364389|NCT01299480|590042586|FG003|Overall Study|Other|0|||
163364390|NCT01299480|590042587|FG004|Overall Study|Other|3|||
163364391|NCT01299480|590042583|FG000|Overall Study|Started, but not vaccinated|0|||
163364392|NCT01299480|590042584|FG001|Overall Study|Started, but not vaccinated|0|||
163364393|NCT01299480|590042585|FG002|Overall Study|Started, but not vaccinated|1|||
163364394|NCT01299480|590042586|FG003|Overall Study|Started, but not vaccinated|1|||
163364395|NCT01299480|590042587|FG004|Overall Study|Started, but not vaccinated|0|||
163364396|NCT00604708|590042593|FG000|Overall Study|Withdrawal by Subject|9|||
163364397|NCT00604708|590042594|FG001|Overall Study|Withdrawal by Subject|10|||
163364398|NCT00604708|590042593|FG000|Overall Study|Protocol Violation|2|||
163364399|NCT00604708|590042594|FG001|Overall Study|Protocol Violation|8|||
163364400|NCT00604708|590042593|FG000|Overall Study|Lost to Follow-up|5|||
163411879|NCT04381650|590215321|FG010|Phase 1b (Dose Escalation)|Progressive Disease|0|||
163411880|NCT04381650|590215311|FG000|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163411881|NCT04381650|590215312|FG001|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163411882|NCT04381650|590215313|FG002|Phase 1b (Dose Escalation)|Withdrawal by Subject|11|||
163411883|NCT04381650|590215314|FG003|Phase 1b (Dose Escalation)|Withdrawal by Subject|4|||
163411884|NCT04381650|590215315|FG004|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163411885|NCT04381650|590215316|FG005|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163411886|NCT04381650|590215317|FG006|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163411887|NCT04381650|590215318|FG007|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163411888|NCT04381650|590215319|FG008|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163411889|NCT04381650|590215320|FG009|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163411890|NCT04381650|590215321|FG010|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163411891|NCT04381650|590215311|FG000|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163411892|NCT04381650|590215312|FG001|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
163411893|NCT04381650|590215313|FG002|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
163411894|NCT04381650|590215314|FG003|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
163411895|NCT04381650|590215315|FG004|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163411896|NCT04381650|590215316|FG005|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163411897|NCT04381650|590215317|FG006|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163411898|NCT04381650|590215318|FG007|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163411899|NCT04381650|590215319|FG008|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163411900|NCT04381650|590215320|FG009|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163411901|NCT04381650|590215321|FG010|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163411902|NCT04381650|590215311|FG000|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
163411903|NCT04381650|590215312|FG001|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
163411904|NCT04381650|590215313|FG002|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
163411905|NCT04381650|590215314|FG003|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
163411906|NCT04381650|590215315|FG004|Phase 2 (Dose Expansion)|New anti-cancer therapy|3|||
163411907|NCT04381650|590215316|FG005|Phase 2 (Dose Expansion)|New anti-cancer therapy|1|||
163411908|NCT04381650|590215317|FG006|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
163411909|NCT04381650|590215318|FG007|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
163411910|NCT04381650|590215319|FG008|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
163411911|NCT04381650|590215320|FG009|Phase 2 (Dose Expansion)|New anti-cancer therapy|2|||
163411912|NCT04381650|590215321|FG010|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
163411913|NCT04381650|590215311|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163411914|NCT04381650|590215312|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163411915|NCT04381650|590215313|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163411916|NCT04381650|590215314|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163411917|NCT04381650|590215315|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163411918|NCT04381650|590215316|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163411919|NCT04381650|590215317|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163411920|NCT04381650|590215318|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
163411921|NCT04381650|590215319|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
163411922|NCT04381650|590215320|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
163411923|NCT04381650|590215321|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163411924|NCT04381650|590215311|FG000|Phase 2 (Dose Expansion)|Progressive Disease|0|||
163411925|NCT04381650|590215312|FG001|Phase 2 (Dose Expansion)|Progressive Disease|0|||
163411926|NCT04381650|590215313|FG002|Phase 2 (Dose Expansion)|Progressive Disease|0|||
163411927|NCT04381650|590215314|FG003|Phase 2 (Dose Expansion)|Progressive Disease|0|||
163411928|NCT04381650|590215315|FG004|Phase 2 (Dose Expansion)|Progressive Disease|2|||
163411929|NCT04381650|590215316|FG005|Phase 2 (Dose Expansion)|Progressive Disease|1|||
163411930|NCT04381650|590215317|FG006|Phase 2 (Dose Expansion)|Progressive Disease|0|||
163411931|NCT04381650|590215318|FG007|Phase 2 (Dose Expansion)|Progressive Disease|3|||
163411932|NCT04381650|590215319|FG008|Phase 2 (Dose Expansion)|Progressive Disease|3|||
163411933|NCT04381650|590215320|FG009|Phase 2 (Dose Expansion)|Progressive Disease|4|||
163411934|NCT04381650|590215321|FG010|Phase 2 (Dose Expansion)|Progressive Disease|2|||
163411935|NCT04381650|590215311|FG000|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
163411936|NCT04381650|590215312|FG001|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
163411937|NCT04381650|590215313|FG002|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
163411938|NCT04381650|590215314|FG003|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
163411939|NCT04381650|590215315|FG004|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
163411940|NCT04381650|590215316|FG005|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
163411941|NCT04381650|590215317|FG006|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
163411942|NCT04381650|590215318|FG007|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
163411943|NCT04381650|590215319|FG008|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
163411944|NCT04381650|590215320|FG009|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
163411945|NCT04381650|590215321|FG010|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
163411946|NCT04381650|590215311|FG000|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163411947|NCT04381650|590215312|FG001|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163411948|NCT04381650|590215313|FG002|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163411949|NCT04381650|590215314|FG003|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163411950|NCT04381650|590215315|FG004|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163411951|NCT04381650|590215316|FG005|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163411952|NCT04381650|590215317|FG006|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163411953|NCT04381650|590215318|FG007|Phase 2 (Dose Expansion)|Reason Not Specified|1|||
163411954|NCT04381650|590215319|FG008|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163411955|NCT04381650|590215320|FG009|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163411956|NCT04381650|590215321|FG010|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163411957|NCT05593016|590216744|FG000|Overall Study|Death|1|||
163411958|NCT05593016|590216745|FG001|Overall Study|Death|1|||
163411959|NCT05593016|590216746|FG002|Overall Study|Death|1|||
163411960|NCT05593016|590216747|FG003|Overall Study|Death|0|||
163411961|NCT05593016|590216748|FG004|Overall Study|Death|0|||
163411962|NCT05593016|590216744|FG000|Overall Study|Lost to Follow-up|1|||
163411963|NCT05593016|590216745|FG001|Overall Study|Lost to Follow-up|1|||
163411964|NCT05593016|590216746|FG002|Overall Study|Lost to Follow-up|1|||
163411965|NCT05593016|590216747|FG003|Overall Study|Lost to Follow-up|2|||
163411966|NCT05593016|590216748|FG004|Overall Study|Lost to Follow-up|0|||
163411967|NCT05416138|590216749|FG000|Overall Study|Withdrawal by Subject|2|||
163411968|NCT05416138|590216750|FG001|Overall Study|Withdrawal by Subject|1|||
163411969|NCT04705051|590216751|FG000|Overall Study|Enrolled but not treated|1|||
163411970|NCT04705051|590216751|FG000|Overall Study|Study terminated by sponsor|23|||
163411971|NCT03686397|590216752|FG000|Overall Study|Lack of Efficacy|3|||
163411972|NCT03686397|590216753|FG001|Overall Study|Lack of Efficacy|5|||
163411973|NCT03686397|590216752|FG000|Overall Study|Adverse Event|0|||
163411974|NCT03686397|590216753|FG001|Overall Study|Adverse Event|1|||
163411975|NCT03686397|590216752|FG000|Overall Study|Protocol Violation|0|||
163411976|NCT03686397|590216753|FG001|Overall Study|Protocol Violation|1|||
163411977|NCT03686397|590216752|FG000|Overall Study|Withdrawal by Subject|0|||
163411978|NCT03686397|590216753|FG001|Overall Study|Withdrawal by Subject|1|||
163411979|NCT03686397|590216752|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
163411980|NCT03686397|590216753|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
163411981|NCT00542997|590216756|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
163411982|NCT00542997|590216756|FG000|Wash in / Wash Out Period|Adverse Event|3|||
163411983|NCT00542997|590216756|FG000|Efficacy Period|Adverse Event|3|||
163411984|NCT00598975|590216757|FG000|Overall Study|Adverse Event|1|||
163411985|NCT00598975|590216758|FG001|Overall Study|Adverse Event|1|||
163411986|NCT00598975|590216757|FG000|Overall Study|Brain metastases|1|||
163411987|NCT00598975|590216758|FG001|Overall Study|Brain metastases|0|||
163411988|NCT00598975|590216757|FG000|Overall Study|Withdrawal by Subject|1|||
163411989|NCT00598975|590216758|FG001|Overall Study|Withdrawal by Subject|1|||
163411990|NCT00598975|590216757|FG000|Overall Study|Withdrawal of consent|0|||
163411991|NCT00598975|590216758|FG001|Overall Study|Withdrawal of consent|1|||
163411992|NCT00598975|590216757|FG000|Overall Study|Disease progression|8|||
163411993|NCT00598975|590216758|FG001|Overall Study|Disease progression|3|||
163411994|NCT00598975|590216757|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
163411995|NCT00598975|590216758|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
163411996|NCT01178138|590216761|FG000|Overall Study|Lost to Follow-up|8|||
163411997|NCT01178138|590216761|FG000|Overall Study|Withdrawal by Subject|7|||
163411998|NCT01178138|590216761|FG000|Overall Study|Physician Decision|8|||
163411999|NCT03160560|590216762|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
163412000|NCT03160560|590216763|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
163412001|NCT03160560|590216764|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
163412002|NCT03160560|590216765|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
163412003|NCT03160560|590216762|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
163412004|NCT03160560|590216763|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
163412005|NCT03160560|590216764|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
163412006|NCT03160560|590216765|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
163412007|NCT00403260|590216766|FG000|Overall Study|Adverse Event|5|||
163412008|NCT00403260|590216767|FG001|Overall Study|Adverse Event|4|||
163412009|NCT00403260|590216766|FG000|Overall Study|Withdrawal by Subject|5|||
163412010|NCT00403260|590216767|FG001|Overall Study|Withdrawal by Subject|6|||
163412011|NCT00403260|590216766|FG000|Overall Study|Lost to Follow-up|49|||
163412012|NCT00403260|590216767|FG001|Overall Study|Lost to Follow-up|25|||
163412013|NCT00403260|590216766|FG000|Overall Study|Re-appearance of P. falciparum|34|||
163412014|NCT00403260|590216767|FG001|Overall Study|Re-appearance of P. falciparum|25|||
163412015|NCT00403260|590216766|FG000|Overall Study|P. vivax infection|26|||
163412016|NCT00403260|590216767|FG001|Overall Study|P. vivax infection|4|||
163412017|NCT00403260|590216766|FG000|Overall Study|Mixed infection with P. vivax|2|||
163412018|NCT00403260|590216767|FG001|Overall Study|Mixed infection with P. vivax|0|||
163412019|NCT00403260|590216766|FG000|Overall Study|Mixed infection with P. falciparum|1|||
163412020|NCT00403260|590216767|FG001|Overall Study|Mixed infection with P. falciparum|0|||
163412021|NCT00403260|590216766|FG000|Overall Study|P. vivax infection at screening|1|||
163412022|NCT00403260|590216767|FG001|Overall Study|P. vivax infection at screening|0|||
163412023|NCT00403260|590216766|FG000|Overall Study|P. ovale infection|1|||
163364401|NCT00604708|590042594|FG001|Overall Study|Lost to Follow-up|5|||
163364402|NCT00604708|590042593|FG000|Overall Study|administrative reasons|9|||
163364403|NCT00604708|590042594|FG001|Overall Study|administrative reasons|11|||
163364404|NCT00604708|590042593|FG000|Overall Study|Adverse Event|6|||
163364405|NCT00604708|590042594|FG001|Overall Study|Adverse Event|6|||
163364406|NCT04916730|590042595|FG000|Overall Study|Withdrawal by Subject|4|||
163364407|NCT04916730|590042596|FG001|Overall Study|Withdrawal by Subject|2|||
163364408|NCT04916730|590042595|FG000|Overall Study|Lost to Follow-up|0|||
163364409|NCT04916730|590042596|FG001|Overall Study|Lost to Follow-up|2|||
163364410|NCT04916730|590042595|FG000|Overall Study|Physician Decision|1|||
163364411|NCT04916730|590042596|FG001|Overall Study|Physician Decision|0|||
163364412|NCT00617929|590042597|FG000|Overall Study|Physician Decision|1|||
163364413|NCT00760747|590042601|FG000|Study Period II|Adverse Event|3|||
163364414|NCT00760747|590042602|FG001|Study Period II|Adverse Event|4|||
163364415|NCT00760747|590042601|FG000|Study Period II|Lack of Efficacy|0|||
163364416|NCT00760747|590042602|FG001|Study Period II|Lack of Efficacy|6|||
163364417|NCT00760747|590042601|FG000|Study Period II|Parent/Caregiver Decision|3|||
163364418|NCT00760747|590042602|FG001|Study Period II|Parent/Caregiver Decision|0|||
163364419|NCT00760747|590042601|FG000|Study Period II|Protocol Violation|6|||
163364420|NCT00760747|590042602|FG001|Study Period II|Protocol Violation|3|||
163364421|NCT00760747|590042601|FG000|Study Period II|Withdrawal by Subject|1|||
163364422|NCT00760747|590042602|FG001|Study Period II|Withdrawal by Subject|0|||
163364423|NCT00760747|590042601|FG000|Study Period II|No drug administered|0|||
163364424|NCT00760747|590042602|FG001|Study Period II|No drug administered|1|||
163364425|NCT00760747|590042601|FG000|Study Period III|Adverse Event|1|||
163364426|NCT00760747|590042602|FG001|Study Period III|Adverse Event|0|||
163364427|NCT00760747|590042601|FG000|Study Period III|Lack of Efficacy|1|||
163364428|NCT00760747|590042602|FG001|Study Period III|Lack of Efficacy|0|||
163364429|NCT00760747|590042601|FG000|Study Period III|Parent/Caregiver Decision|0|||
163364430|NCT00760747|590042602|FG001|Study Period III|Parent/Caregiver Decision|1|||
163364431|NCT00760747|590042601|FG000|Study Period III|Protocol Violation|1|||
163364432|NCT00760747|590042602|FG001|Study Period III|Protocol Violation|1|||
163364433|NCT00760747|590042601|FG000|Study Period III|Physician Decision|0|||
163364434|NCT00760747|590042602|FG001|Study Period III|Physician Decision|1|||
163364435|NCT01228175|590042603|FG000|Overall Study|Lost to Follow-up|64|||
163364436|NCT01228175|590042604|FG001|Overall Study|Lost to Follow-up|50|||
163364437|NCT01228175|590042603|FG000|Overall Study|Withdrawal by Subject|1|||
163364438|NCT01228175|590042604|FG001|Overall Study|Withdrawal by Subject|2|||
163364439|NCT01228175|590042603|FG000|Overall Study|Physician Decision|1|||
163364440|NCT01228175|590042604|FG001|Overall Study|Physician Decision|1|||
163364441|NCT00402051|590042607|FG000|Overall Study|Progressive Disease|13|||
163364442|NCT00402051|590042608|FG001|Overall Study|Progressive Disease|20|||
163364443|NCT00402051|590042607|FG000|Overall Study|Adverse Event|11|||
163364444|NCT00402051|590042608|FG001|Overall Study|Adverse Event|4|||
163364445|NCT00402051|590042607|FG000|Overall Study|Physician Decision|7|||
163364446|NCT00402051|590042608|FG001|Overall Study|Physician Decision|3|||
163364447|NCT00402051|590042607|FG000|Overall Study|Withdrawal by Subject|3|||
163364448|NCT00402051|590042608|FG001|Overall Study|Withdrawal by Subject|3|||
163364449|NCT00402051|590042607|FG000|Overall Study|Death - Related to Study Drug|1|||
163364450|NCT00402051|590042608|FG001|Overall Study|Death - Related to Study Drug|2|||
163364451|NCT00402051|590042607|FG000|Overall Study|Death Due to Study Disease|2|||
163364452|NCT00402051|590042608|FG001|Overall Study|Death Due to Study Disease|1|||
163364453|NCT00402051|590042607|FG000|Overall Study|Death Due to Adverse Event|0|||
163364454|NCT00402051|590042608|FG001|Overall Study|Death Due to Adverse Event|2|||
163364455|NCT00402051|590042607|FG000|Overall Study|Lost to Follow-up|1|||
163364456|NCT00402051|590042608|FG001|Overall Study|Lost to Follow-up|0|||
163364457|NCT02194829|590042614|FG000|Overall Study|Adverse Event|2|||
163364458|NCT02194829|590042615|FG001|Overall Study|Adverse Event|2|||
163364459|NCT02194829|590042614|FG000|Overall Study|Death|0|||
163364460|NCT02194829|590042615|FG001|Overall Study|Death|1|||
163364461|NCT02194829|590042614|FG000|Overall Study|Disease progression|0|||
163364462|NCT02194829|590042615|FG001|Overall Study|Disease progression|1|||
163364463|NCT02194829|590042614|FG000|Overall Study|Withdrawal by Subject|0|||
163364464|NCT02194829|590042615|FG001|Overall Study|Withdrawal by Subject|1|||
163364465|NCT02194829|590042614|FG000|Overall Study|Never started protocol therapy|0|||
163364466|NCT02194829|590042615|FG001|Overall Study|Never started protocol therapy|1|||
163364467|NCT02706405|590044376|FG000|Overall Study|Death|3|||
163364468|NCT02706405|590044377|FG001|Overall Study|Death|2|||
163364469|NCT02706405|590044378|FG002|Overall Study|Death|0|||
163364470|NCT02706405|590044379|FG003|Overall Study|Death|1|||
163364471|NCT02706405|590044380|FG004|Overall Study|Death|0|||
163364472|NCT02706405|590044381|FG005|Overall Study|Death|0|||
163364473|NCT02706405|590044382|FG006|Overall Study|Death|3|||
163364474|NCT02706405|590044383|FG007|Overall Study|Death|4|||
163364475|NCT02706405|590044376|FG000|Overall Study|Disease progression|0|||
163364476|NCT02706405|590044377|FG001|Overall Study|Disease progression|0|||
163364477|NCT02706405|590044378|FG002|Overall Study|Disease progression|0|||
163364478|NCT02706405|590044379|FG003|Overall Study|Disease progression|0|||
163364479|NCT02706405|590044380|FG004|Overall Study|Disease progression|0|||
163364480|NCT02706405|590044381|FG005|Overall Study|Disease progression|0|||
163364481|NCT02706405|590044382|FG006|Overall Study|Disease progression|0|||
163364482|NCT02706405|590044383|FG007|Overall Study|Disease progression|1|||
163364483|NCT02706405|590044376|FG000|Overall Study|Pt moved to new therapy|0|||
163364484|NCT02706405|590044377|FG001|Overall Study|Pt moved to new therapy|0|||
163364485|NCT02706405|590044378|FG002|Overall Study|Pt moved to new therapy|0|||
163364486|NCT02706405|590044379|FG003|Overall Study|Pt moved to new therapy|0|||
163364487|NCT02706405|590044380|FG004|Overall Study|Pt moved to new therapy|0|||
163364488|NCT02706405|590044381|FG005|Overall Study|Pt moved to new therapy|1|||
163364489|NCT02706405|590044382|FG006|Overall Study|Pt moved to new therapy|0|||
163364490|NCT02706405|590044383|FG007|Overall Study|Pt moved to new therapy|1|||
163364491|NCT02706405|590044376|FG000|Overall Study|Physician Decision|1|||
163364492|NCT02706405|590044377|FG001|Overall Study|Physician Decision|0|||
163364493|NCT02706405|590044378|FG002|Overall Study|Physician Decision|0|||
163364494|NCT02706405|590044379|FG003|Overall Study|Physician Decision|0|||
163364495|NCT02706405|590044380|FG004|Overall Study|Physician Decision|0|||
163364496|NCT02706405|590044381|FG005|Overall Study|Physician Decision|0|||
163364497|NCT02706405|590044382|FG006|Overall Study|Physician Decision|0|||
163364498|NCT02706405|590044383|FG007|Overall Study|Physician Decision|0|||
163364499|NCT00789360|590044390|FG000|Overall Study|Protocol Violation|3|||
163364500|NCT00789360|590044391|FG001|Overall Study|Protocol Violation|1|||
163364501|NCT03057847|590044392|FG000|Overall Study|Lost to Follow-up|16|||
163364502|NCT00351377|590044393|FG000|Overall Study|Adverse Event|5|||
163364503|NCT00351377|590044393|FG000|Overall Study|Death|1|||
163364504|NCT00351377|590044393|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163364505|NCT02088957|590044394|FG000|Overall Study|Lack of Efficacy|1|||
163364506|NCT02088957|590044395|FG001|Overall Study|Lack of Efficacy|0|||
163364507|NCT01661205|590044396|FG000|Overall Study|Physician Decision|2|||
163364508|NCT00426127|590044397|FG000|Overall Study|Adverse Event|1|||
163364509|NCT00426127|590044397|FG000|Overall Study|Removed due to disease progression|1|||
163364510|NCT03111095|590044398|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
163364511|NCT03111095|590044399|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
163364512|NCT03111095|590044398|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
163364513|NCT03111095|590044399|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
163364514|NCT00955708|590044400|FG000|Overall Study|Death|269|||
163364515|NCT00955708|590044400|FG000|Overall Study|Lost to Follow-up|72|||
163364516|NCT00955708|590044400|FG000|Overall Study|Physician Decision|36|||
163364517|NCT00955708|590044400|FG000|Overall Study|Protocol Violation|134|||
163364518|NCT00955708|590044400|FG000|Overall Study|Registry Conclusion|186|||
163364519|NCT00955708|590044400|FG000|Overall Study|Product removed from service|94|||
163364520|NCT00955708|590044400|FG000|Overall Study|Patient Refused to participate further|116|||
163364521|NCT00955708|590044400|FG000|Overall Study|Closure of study location|60|||
163364522|NCT00955708|590044400|FG000|Overall Study|Patient changed care provider/moved|91|||
163364523|NCT01735175|590044410|FG000|Overall Study|Withdrawal by Subject|9|||
163364524|NCT01735175|590044411|FG001|Overall Study|Withdrawal by Subject|2|||
163364525|NCT01735175|590044410|FG000|Overall Study|Lost to Follow-up|4|||
163364526|NCT01735175|590044411|FG001|Overall Study|Lost to Follow-up|2|||
163364527|NCT01735175|590044410|FG000|Overall Study|Death|3|||
163364528|NCT01735175|590044411|FG001|Overall Study|Death|2|||
163364529|NCT01735175|590044410|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
163364530|NCT01735175|590044411|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
163364531|NCT04210843|590044414|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
163364532|NCT04210843|590044415|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
163364533|NCT04210843|590044414|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
163364534|NCT04210843|590044415|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
163364535|NCT04210843|590044414|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
163364536|NCT04210843|590044415|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
163364537|NCT04210843|590044414|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
163364538|NCT04210843|590044415|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
163364539|NCT04210843|590044414|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
163364540|NCT04210843|590044415|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
163364541|NCT04210843|590044414|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
163364542|NCT04210843|590044415|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
163364543|NCT04210843|590044414|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
163364544|NCT04210843|590044415|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
163364545|NCT04210843|590044414|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
163364546|NCT04210843|590044415|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
163364547|NCT04210843|590044414|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
163364548|NCT04210843|590044415|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
163364549|NCT04210843|590044414|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
163364550|NCT04210843|590044415|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
163364551|NCT04210843|590044414|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
163364552|NCT04210843|590044415|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
163364553|NCT04210843|590044414|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
163364554|NCT04210843|590044415|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
163364555|NCT04210843|590044414|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
163364556|NCT04210843|590044415|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
163364557|NCT04210843|590044414|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
163364558|NCT04210843|590044415|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
163364559|NCT04210843|590044414|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
163364560|NCT04210843|590044415|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
163364561|NCT04210843|590044414|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
163364562|NCT04210843|590044415|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
163364563|NCT04210843|590044414|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
163364564|NCT04210843|590044415|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
163364565|NCT04210843|590044414|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
163364566|NCT04210843|590044415|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
163364567|NCT04210843|590044414|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
163364568|NCT04210843|590044415|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
163364569|NCT04210843|590044414|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
163364570|NCT04210843|590044415|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
163364571|NCT04210843|590044414|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
163364572|NCT04210843|590044415|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
163364573|NCT04210843|590044414|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
163364574|NCT04210843|590044415|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
163364575|NCT04210843|590044414|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
163364576|NCT04210843|590044415|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
163364577|NCT04210843|590044414|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
163364578|NCT04210843|590044415|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
163364579|NCT01266161|590044416|FG000|Overall Study|Ineligible|1|||
163364580|NCT01266161|590044417|FG001|Overall Study|Ineligible|0|||
163364581|NCT01266161|590044416|FG000|Overall Study|Lack of Efficacy|0|||
163364582|NCT01266161|590044417|FG001|Overall Study|Lack of Efficacy|1|||
163364583|NCT01266161|590044416|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
163364584|NCT01266161|590044417|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
163364585|NCT01427725|590044422|FG000|Overall Study|Lost to Follow-up|17|||
163364586|NCT01427725|590044422|FG000|Overall Study|Protocol Violation|1|||
163364587|NCT01427725|590044422|FG000|Overall Study|Drug not administered|1|||
163364588|NCT01427725|590044422|FG000|Overall Study|Failure to visit|7|||
163364589|NCT01427725|590044422|FG000|Overall Study|Adverse Event|46|||
163364590|NCT01427725|590044422|FG000|Overall Study|Failure to visit after administration|40|||
163364591|NCT01427725|590044422|FG000|Overall Study|Patient's rejection|27|||
163364592|NCT01427725|590044422|FG000|Overall Study|Transfer to a different hospital|17|||
163364593|NCT01427725|590044422|FG000|Overall Study|Lack of Efficacy|8|||
163364594|NCT01427725|590044422|FG000|Overall Study|Death|7|||
163364595|NCT01427725|590044422|FG000|Overall Study|Symptom improvement|6|||
163364596|NCT01427725|590044422|FG000|Overall Study|AE and Patient's rejection|5|||
163364597|NCT01427725|590044422|FG000|Overall Study|Physician Decision|5|||
163364598|NCT01427725|590044422|FG000|Overall Study|Exacerbation of underlying disease|5|||
163364599|NCT01427725|590044422|FG000|Overall Study|Oral feeding difficulty|5|||
163364600|NCT01427725|590044422|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
163364601|NCT01427725|590044422|FG000|Overall Study|Forgetting prescription|1|||
163364602|NCT01427725|590044422|FG000|Overall Study|Other|2|||
163364603|NCT01374568|590044423|FG000|Overall Study|Lab unable to analyze BTM|0|||
163364604|NCT01374568|590044424|FG001|Overall Study|Lab unable to analyze BTM|2|||
163364605|NCT01277887|590044426|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
163364606|NCT01277887|590044427|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
163364607|NCT01277887|590044426|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
163364608|NCT01277887|590044427|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
163364609|NCT01277887|590044426|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
163364610|NCT01277887|590044427|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
163364611|NCT00415051|590044428|FG000|Overall Study|Protocol Violation|1|||
163364612|NCT04160988|590044437|FG000|Overall Study|poor image quality|28|||
163364613|NCT00844597|590044438|FG000|Overall Study|Adverse Event|0|||
163364614|NCT00844597|590044439|FG001|Overall Study|Adverse Event|0|||
163364615|NCT00844597|590044440|FG002|Overall Study|Adverse Event|0|||
163364616|NCT00844597|590044441|FG003|Overall Study|Adverse Event|1|||
163364617|NCT00844597|590044442|FG004|Overall Study|Adverse Event|0|||
163364618|NCT00844597|590044443|FG005|Overall Study|Adverse Event|0|||
163364619|NCT01250509|590044444|FG000|Overall Study|Lost to Follow-up|5|||
163364620|NCT01250509|590044445|FG001|Overall Study|Lost to Follow-up|2|||
163364621|NCT00243074|590044452|FG000|Overall Study|Ineligible|6|||
163364622|NCT00243074|590044452|FG000|Overall Study|Adverse Event|6|||
163412024|NCT00403260|590216767|FG001|Overall Study|P. ovale infection|0|||
163412025|NCT00403260|590216766|FG000|Overall Study|Gametocyte re-appearance|1|||
163412026|NCT00403260|590216767|FG001|Overall Study|Gametocyte re-appearance|1|||
163412027|NCT00403260|590216766|FG000|Overall Study|Withdrawn from study accidentally|0|||
163412028|NCT00403260|590216767|FG001|Overall Study|Withdrawn from study accidentally|1|||
163412029|NCT01241708|590216774|FG000|Overall Study|Withdrawal by Subject|6|||
163412030|NCT01241708|590216774|FG000|Overall Study|Screen Failure|6|||
163412031|NCT01241708|590216774|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
163412032|NCT01241708|590216774|FG000|Overall Study|Lost to Follow-up|5|||
163412033|NCT04137887|590216777|FG000|Overall Study|Death|102|||
163412034|NCT04137887|590216778|FG001|Overall Study|Death|92|||
163412035|NCT04137887|590216777|FG000|Overall Study|Withdrawal by Subject|2|||
163412036|NCT04137887|590216778|FG001|Overall Study|Withdrawal by Subject|3|||
163412037|NCT04137887|590216777|FG000|Overall Study|Randomized but not treated|0|||
163412038|NCT04137887|590216778|FG001|Overall Study|Randomized but not treated|1|||
163412039|NCT01790503|590216781|FG000|Overall Study|Adverse Event|1|||
163412040|NCT01790503|590216782|FG001|Overall Study|Adverse Event|0|||
163412041|NCT01790503|590216783|FG002|Overall Study|Adverse Event|0|||
163412042|NCT01790503|590216784|FG003|Overall Study|Adverse Event|0|||
163412043|NCT01790503|590216785|FG004|Overall Study|Adverse Event|0|||
163412044|NCT01790503|590216786|FG005|Overall Study|Adverse Event|2|||
163412045|NCT01790503|590216787|FG006|Overall Study|Adverse Event|0|||
163412046|NCT01790503|590216788|FG007|Overall Study|Adverse Event|0|||
163412047|NCT01790503|590216789|FG008|Overall Study|Adverse Event|2|||
163412048|NCT01790503|590216790|FG009|Overall Study|Adverse Event|4|||
163412049|NCT01790503|590216791|FG010|Overall Study|Adverse Event|7|||
163412050|NCT01790503|590216781|FG000|Overall Study|Withdrawal by Subject|0|||
163412051|NCT01790503|590216782|FG001|Overall Study|Withdrawal by Subject|0|||
163412052|NCT01790503|590216783|FG002|Overall Study|Withdrawal by Subject|1|||
163412053|NCT01790503|590216784|FG003|Overall Study|Withdrawal by Subject|1|||
163412054|NCT01790503|590216785|FG004|Overall Study|Withdrawal by Subject|1|||
163412055|NCT01790503|590216786|FG005|Overall Study|Withdrawal by Subject|2|||
163412056|NCT01790503|590216787|FG006|Overall Study|Withdrawal by Subject|1|||
163412057|NCT01790503|590216788|FG007|Overall Study|Withdrawal by Subject|0|||
163412058|NCT01790503|590216789|FG008|Overall Study|Withdrawal by Subject|0|||
163412059|NCT01790503|590216790|FG009|Overall Study|Withdrawal by Subject|0|||
163412060|NCT01790503|590216791|FG010|Overall Study|Withdrawal by Subject|1|||
163412061|NCT01790503|590216781|FG000|Overall Study|Disease progression|2|||
163412062|NCT01790503|590216782|FG001|Overall Study|Disease progression|1|||
163412063|NCT01790503|590216783|FG002|Overall Study|Disease progression|0|||
163412064|NCT01790503|590216784|FG003|Overall Study|Disease progression|1|||
163412065|NCT01790503|590216785|FG004|Overall Study|Disease progression|2|||
163412066|NCT01790503|590216786|FG005|Overall Study|Disease progression|1|||
163412067|NCT01790503|590216787|FG006|Overall Study|Disease progression|0|||
163412068|NCT01790503|590216788|FG007|Overall Study|Disease progression|1|||
163412069|NCT01790503|590216789|FG008|Overall Study|Disease progression|0|||
163412070|NCT01790503|590216790|FG009|Overall Study|Disease progression|17|||
163412071|NCT01790503|590216791|FG010|Overall Study|Disease progression|7|||
163412072|NCT01790503|590216781|FG000|Overall Study|Protocol Violation|0|||
163412073|NCT01790503|590216782|FG001|Overall Study|Protocol Violation|0|||
163412074|NCT01790503|590216783|FG002|Overall Study|Protocol Violation|0|||
163412075|NCT01790503|590216784|FG003|Overall Study|Protocol Violation|0|||
163412076|NCT01790503|590216785|FG004|Overall Study|Protocol Violation|0|||
163412077|NCT01790503|590216786|FG005|Overall Study|Protocol Violation|0|||
163412078|NCT01790503|590216787|FG006|Overall Study|Protocol Violation|0|||
163412079|NCT01790503|590216788|FG007|Overall Study|Protocol Violation|0|||
163412080|NCT01790503|590216789|FG008|Overall Study|Protocol Violation|0|||
163412081|NCT01790503|590216790|FG009|Overall Study|Protocol Violation|1|||
163412082|NCT01790503|590216791|FG010|Overall Study|Protocol Violation|0|||
163412083|NCT01790503|590216781|FG000|Overall Study|Physician Decision|0|||
163412084|NCT01790503|590216782|FG001|Overall Study|Physician Decision|0|||
163412085|NCT01790503|590216783|FG002|Overall Study|Physician Decision|0|||
163412086|NCT01790503|590216784|FG003|Overall Study|Physician Decision|0|||
163412087|NCT01790503|590216785|FG004|Overall Study|Physician Decision|0|||
163412088|NCT01790503|590216786|FG005|Overall Study|Physician Decision|0|||
163412089|NCT01790503|590216787|FG006|Overall Study|Physician Decision|0|||
163412090|NCT01790503|590216788|FG007|Overall Study|Physician Decision|0|||
163412091|NCT01790503|590216789|FG008|Overall Study|Physician Decision|0|||
163412092|NCT01790503|590216790|FG009|Overall Study|Physician Decision|1|||
163412093|NCT01790503|590216791|FG010|Overall Study|Physician Decision|1|||
163412094|NCT01790503|590216781|FG000|Overall Study|Death|0|||
163412095|NCT01790503|590216782|FG001|Overall Study|Death|0|||
163412096|NCT01790503|590216783|FG002|Overall Study|Death|0|||
163412097|NCT01790503|590216784|FG003|Overall Study|Death|0|||
163412098|NCT01790503|590216785|FG004|Overall Study|Death|0|||
163412099|NCT01790503|590216786|FG005|Overall Study|Death|0|||
163412100|NCT01790503|590216787|FG006|Overall Study|Death|0|||
163412101|NCT01790503|590216788|FG007|Overall Study|Death|0|||
163412102|NCT01790503|590216789|FG008|Overall Study|Death|0|||
163412103|NCT01790503|590216790|FG009|Overall Study|Death|1|||
163412104|NCT01790503|590216791|FG010|Overall Study|Death|0|||
163364623|NCT00243074|590044452|FG000|Overall Study|Withdrawal by Subject|2|||
163364624|NCT00243074|590044452|FG000|Overall Study|Lack of Efficacy|36|||
163364625|NCT00243074|590044452|FG000|Overall Study|Death|2|||
163364626|NCT00243074|590044452|FG000|Overall Study|not protocol specified|1|||
163364627|NCT00243074|590044452|FG000|Overall Study|Did not receive any treatment|1|||
163364628|NCT00570908|590044455|FG000|Overall Study|Adverse Event|5|||
163364629|NCT00570908|590044455|FG000|Overall Study|Withdrawal by Subject|2|||
163364630|NCT01213524|590044456|FG000|Baseline|Withdrawal by Subject|5|||
163364631|NCT01213524|590044456|FG000|Baseline|high breath alcohol levels|1|||
163364632|NCT01213524|590044456|FG000|Baseline|Physician Decision|1|||
163364633|NCT01213524|590044456|FG000|Session 2|Withdrawal by Subject|5|||
163364634|NCT01213524|590044456|FG000|Session 3|Withdrawal by Subject|4|||
163364635|NCT01213524|590044456|FG000|Session 4|Physician Decision|1|||
163364636|NCT01213524|590044456|FG000|Session 4|Withdrawal by Subject|2|||
163364637|NCT05415748|590044457|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
163364638|NCT05415748|590044458|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
163364639|NCT05415748|590044459|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
163364640|NCT05415748|590044460|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
163364641|NCT05415748|590044457|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
163364642|NCT05415748|590044458|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
163364643|NCT05415748|590044459|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
163364644|NCT05415748|590044460|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
163364645|NCT01447576|590044461|FG000|Overall Study|Lost to Follow-up|52|||
163364646|NCT01447576|590044461|FG000|Overall Study|Adverse Event|127|||
163364647|NCT01447576|590044461|FG000|Overall Study|Participant met withdrawal criteria|40|||
163364648|NCT01447576|590044461|FG000|Overall Study|Withdrawal by Subject|100|||
163364649|NCT01447576|590044461|FG000|Overall Study|Protocol deviation|83|||
163364650|NCT01447576|590044461|FG000|Overall Study|Lack of Efficacy|68|||
163364651|NCT01447576|590044461|FG000|Overall Study|Physician Decision|6|||
163364652|NCT00975676|590044462|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
163364653|NCT00975676|590044463|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
163364654|NCT02209181|590044464|FG000|Overall Study|Adverse Event|1|||
163364655|NCT02209181|590044465|FG001|Overall Study|Adverse Event|0|||
163364656|NCT02209181|590044466|FG002|Overall Study|Adverse Event|1|||
163364657|NCT02209181|590044467|FG003|Overall Study|Adverse Event|0|||
163364658|NCT02209181|590044464|FG000|Overall Study|Withdrawal by Subject|0|||
163364659|NCT02209181|590044465|FG001|Overall Study|Withdrawal by Subject|1|||
163364660|NCT02209181|590044466|FG002|Overall Study|Withdrawal by Subject|0|||
163364661|NCT02209181|590044467|FG003|Overall Study|Withdrawal by Subject|0|||
163364662|NCT02579772|590044468|FG000|Overall Study|Withdrawal by Subject|0|||
163364663|NCT02579772|590044469|FG001|Overall Study|Withdrawal by Subject|1|||
163364664|NCT02579772|590044468|FG000|Overall Study|Usage of additional antioxidants|1|||
163364665|NCT02579772|590044469|FG001|Overall Study|Usage of additional antioxidants|0|||
163364666|NCT02579772|590044468|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
163364667|NCT02579772|590044469|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
163364668|NCT03128671|590044470|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
163364669|NCT03128671|590044471|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
163364670|NCT03128671|590044470|FG000|Allocation|Death|1|||
163364671|NCT03128671|590044471|FG001|Allocation|Death|0|||
163364672|NCT03128671|590044470|FG000|Allocation|Withdrawal by Subject|4|||
163364673|NCT03128671|590044471|FG001|Allocation|Withdrawal by Subject|0|||
163364674|NCT03128671|590044470|FG000|Intervention|Withdrawal by Subject|11|||
163364675|NCT03128671|590044471|FG001|Intervention|Withdrawal by Subject|10|||
163364676|NCT03128671|590044470|FG000|Intervention|Palliative/hospice care initiated|9|||
163364677|NCT03128671|590044471|FG001|Intervention|Palliative/hospice care initiated|10|||
163364678|NCT03128671|590044470|FG000|Intervention|Death|13|||
163364679|NCT03128671|590044471|FG001|Intervention|Death|11|||
163364680|NCT03128671|590044470|FG000|Intervention|Interrupted by hurricane|1|||
163364681|NCT03128671|590044471|FG001|Intervention|Interrupted by hurricane|0|||
163364682|NCT03128671|590044470|FG000|Intervention|Physician Decision|2|||
163364683|NCT03128671|590044471|FG001|Intervention|Physician Decision|3|||
163364684|NCT04641962|590044473|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
163364685|NCT04641962|590044474|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
163364686|NCT04641962|590044475|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
163364687|NCT04641962|590044476|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
163364688|NCT04641962|590044477|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
163364689|NCT04641962|590044473|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
163364690|NCT04641962|590044474|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
163364691|NCT04641962|590044475|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
163364692|NCT04641962|590044476|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
163364693|NCT04641962|590044477|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
163364694|NCT04641962|590044473|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
163364695|NCT04641962|590044474|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
163364696|NCT04641962|590044475|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
163364697|NCT04641962|590044476|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
163364698|NCT04641962|590044477|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
163364699|NCT04641962|590044473|FG000|DBT Period: Up to 52 Weeks|Death|1|||
163364700|NCT04641962|590044474|FG001|DBT Period: Up to 52 Weeks|Death|0|||
163364701|NCT04641962|590044475|FG002|DBT Period: Up to 52 Weeks|Death|0|||
163364702|NCT04641962|590044476|FG003|DBT Period: Up to 52 Weeks|Death|0|||
163364703|NCT04641962|590044477|FG004|DBT Period: Up to 52 Weeks|Death|0|||
163364704|NCT04641962|590044473|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
163364705|NCT04641962|590044474|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
163364706|NCT04641962|590044475|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
163364707|NCT04641962|590044476|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
163364708|NCT04641962|590044477|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
163364709|NCT04641962|590044473|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
163364710|NCT04641962|590044474|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
163364711|NCT04641962|590044475|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
163364712|NCT04641962|590044476|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
163364713|NCT04641962|590044477|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
163364714|NCT04641962|590044473|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
163364715|NCT04641962|590044474|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
163364716|NCT04641962|590044475|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
163364717|NCT04641962|590044476|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
163364718|NCT04641962|590044477|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
163364719|NCT00862836|590044478|FG000|Overall Study|Withdrawal by Subject|1|||
163364720|NCT04463680|590044481|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
163364721|NCT04463680|590044481|FG000|Overall Study|Not eligible due to implant duration of use|1|||
163364722|NCT04463680|590044481|FG000|Overall Study|Withdrawal by Subject|3|||
163364723|NCT02998476|590044484|FG000|Overall Study|Lost to Follow-up|1|||
163364724|NCT02998476|590044485|FG001|Overall Study|Lost to Follow-up|0|||
163364725|NCT02998476|590044484|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
163364726|NCT02998476|590044485|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
163364727|NCT02998476|590044484|FG000|Overall Study|Withdrawal by Subject|1|||
163364728|NCT02998476|590044485|FG001|Overall Study|Withdrawal by Subject|2|||
163364729|NCT02998476|590044484|FG000|Overall Study|Death|45|||
163364730|NCT02998476|590044485|FG001|Overall Study|Death|2|||
163364731|NCT02998476|590044484|FG000|Overall Study|Other|6|||
163364732|NCT02998476|590044485|FG001|Overall Study|Other|1|||
163364733|NCT00344032|590044487|FG000|Overall Study|Adverse Event|0|||
163364734|NCT00344032|590044488|FG001|Overall Study|Adverse Event|1|||
163364735|NCT00344032|590044487|FG000|Overall Study|Withdrawal by Subject|6|||
163364736|NCT00344032|590044488|FG001|Overall Study|Withdrawal by Subject|2|||
163364737|NCT00344032|590044487|FG000|Overall Study|Lost to Follow-up|4|||
163364738|NCT00344032|590044488|FG001|Overall Study|Lost to Follow-up|6|||
163364739|NCT00344032|590044487|FG000|Overall Study|Physician Decision|4|||
163364740|NCT00344032|590044488|FG001|Overall Study|Physician Decision|1|||
163364741|NCT05131477|590044489|FG000|PART 1|Withdrawal by Subject|2|||
163364742|NCT05131477|590044490|FG001|PART 1|Withdrawal by Subject|9|||
163364743|NCT05131477|590044491|FG002|PART 1|Withdrawal by Subject|6|||
163364744|NCT05131477|590044492|FG003|PART 1|Withdrawal by Subject|2|||
163364745|NCT05131477|590044493|FG004|PART 1|Withdrawal by Subject|8|||
163364746|NCT05131477|590044494|FG005|PART 1|Withdrawal by Subject|0|||
163364747|NCT05131477|590044495|FG006|PART 1|Withdrawal by Subject|0|||
163364748|NCT05131477|590044496|FG007|PART 1|Withdrawal by Subject|0|||
163364749|NCT05131477|590044497|FG008|PART 1|Withdrawal by Subject|0|||
163364750|NCT05131477|590044498|FG009|PART 1|Withdrawal by Subject|0|||
163364751|NCT05131477|590044499|FG010|PART 1|Withdrawal by Subject|0|||
163364752|NCT05131477|590044500|FG011|PART 1|Withdrawal by Subject|0|||
163364753|NCT05131477|590044501|FG012|PART 1|Withdrawal by Subject|0|||
163364754|NCT05131477|590044502|FG013|PART 1|Withdrawal by Subject|0|||
163364755|NCT05131477|590044489|FG000|PART 1|Physician Decision|1|||
163364756|NCT05131477|590044490|FG001|PART 1|Physician Decision|0|||
163364757|NCT05131477|590044491|FG002|PART 1|Physician Decision|0|||
163364758|NCT05131477|590044492|FG003|PART 1|Physician Decision|0|||
163364759|NCT05131477|590044493|FG004|PART 1|Physician Decision|0|||
163364760|NCT05131477|590044494|FG005|PART 1|Physician Decision|0|||
163364761|NCT05131477|590044495|FG006|PART 1|Physician Decision|0|||
163364762|NCT05131477|590044496|FG007|PART 1|Physician Decision|0|||
163364763|NCT05131477|590044497|FG008|PART 1|Physician Decision|0|||
163364764|NCT05131477|590044498|FG009|PART 1|Physician Decision|0|||
163364765|NCT05131477|590044499|FG010|PART 1|Physician Decision|0|||
163364766|NCT05131477|590044500|FG011|PART 1|Physician Decision|0|||
163364767|NCT05131477|590044501|FG012|PART 1|Physician Decision|0|||
163364768|NCT05131477|590044502|FG013|PART 1|Physician Decision|0|||
163364769|NCT05131477|590044489|FG000|PART 1|Adverse Event|3|||
163364770|NCT05131477|590044490|FG001|PART 1|Adverse Event|5|||
163364771|NCT05131477|590044491|FG002|PART 1|Adverse Event|1|||
163364772|NCT05131477|590044492|FG003|PART 1|Adverse Event|6|||
163364773|NCT05131477|590044493|FG004|PART 1|Adverse Event|4|||
163364774|NCT05131477|590044494|FG005|PART 1|Adverse Event|0|||
163364775|NCT05131477|590044495|FG006|PART 1|Adverse Event|0|||
163364776|NCT05131477|590044496|FG007|PART 1|Adverse Event|0|||
163364777|NCT05131477|590044497|FG008|PART 1|Adverse Event|0|||
163364778|NCT05131477|590044498|FG009|PART 1|Adverse Event|0|||
163364779|NCT05131477|590044499|FG010|PART 1|Adverse Event|0|||
163364780|NCT05131477|590044500|FG011|PART 1|Adverse Event|0|||
163364781|NCT05131477|590044501|FG012|PART 1|Adverse Event|0|||
163364782|NCT05131477|590044502|FG013|PART 1|Adverse Event|0|||
163364783|NCT05131477|590044489|FG000|PART 1|unclassified|1|||
163364784|NCT05131477|590044490|FG001|PART 1|unclassified|1|||
163364785|NCT05131477|590044491|FG002|PART 1|unclassified|0|||
163364786|NCT05131477|590044492|FG003|PART 1|unclassified|0|||
163364787|NCT05131477|590044493|FG004|PART 1|unclassified|4|||
163364788|NCT05131477|590044494|FG005|PART 1|unclassified|0|||
163364789|NCT05131477|590044495|FG006|PART 1|unclassified|0|||
163364790|NCT05131477|590044496|FG007|PART 1|unclassified|0|||
163364791|NCT05131477|590044497|FG008|PART 1|unclassified|0|||
163364792|NCT05131477|590044498|FG009|PART 1|unclassified|0|||
163364793|NCT05131477|590044499|FG010|PART 1|unclassified|0|||
163364794|NCT05131477|590044500|FG011|PART 1|unclassified|0|||
163364795|NCT05131477|590044501|FG012|PART 1|unclassified|0|||
163364796|NCT05131477|590044502|FG013|PART 1|unclassified|0|||
163364797|NCT05131477|590044489|FG000|PART 1|Randomized and not treated|0|||
163364798|NCT05131477|590044490|FG001|PART 1|Randomized and not treated|0|||
163364799|NCT05131477|590044491|FG002|PART 1|Randomized and not treated|0|||
163364800|NCT05131477|590044492|FG003|PART 1|Randomized and not treated|1|||
163364801|NCT05131477|590044493|FG004|PART 1|Randomized and not treated|1|||
163364802|NCT05131477|590044494|FG005|PART 1|Randomized and not treated|0|||
163364803|NCT05131477|590044495|FG006|PART 1|Randomized and not treated|0|||
163364804|NCT05131477|590044496|FG007|PART 1|Randomized and not treated|0|||
163364805|NCT05131477|590044497|FG008|PART 1|Randomized and not treated|0|||
163364806|NCT05131477|590044498|FG009|PART 1|Randomized and not treated|0|||
163364807|NCT05131477|590044499|FG010|PART 1|Randomized and not treated|0|||
163364808|NCT05131477|590044500|FG011|PART 1|Randomized and not treated|0|||
163364809|NCT05131477|590044501|FG012|PART 1|Randomized and not treated|0|||
163364810|NCT05131477|590044502|FG013|PART 1|Randomized and not treated|0|||
163364811|NCT05131477|590044489|FG000|PART 1|Protocol Violation|2|||
163364812|NCT05131477|590044490|FG001|PART 1|Protocol Violation|0|||
163364813|NCT05131477|590044491|FG002|PART 1|Protocol Violation|0|||
163364814|NCT05131477|590044492|FG003|PART 1|Protocol Violation|1|||
163364815|NCT05131477|590044493|FG004|PART 1|Protocol Violation|0|||
163364816|NCT05131477|590044494|FG005|PART 1|Protocol Violation|0|||
163364817|NCT05131477|590044495|FG006|PART 1|Protocol Violation|0|||
163364818|NCT05131477|590044496|FG007|PART 1|Protocol Violation|0|||
163364819|NCT05131477|590044497|FG008|PART 1|Protocol Violation|0|||
163364820|NCT05131477|590044498|FG009|PART 1|Protocol Violation|0|||
163364821|NCT05131477|590044499|FG010|PART 1|Protocol Violation|0|||
163364822|NCT05131477|590044500|FG011|PART 1|Protocol Violation|0|||
163364823|NCT05131477|590044501|FG012|PART 1|Protocol Violation|0|||
163364824|NCT05131477|590044502|FG013|PART 1|Protocol Violation|0|||
163364825|NCT05131477|590044489|FG000|PART 1|Lack of Efficacy|0|||
163364826|NCT05131477|590044490|FG001|PART 1|Lack of Efficacy|1|||
163364827|NCT05131477|590044491|FG002|PART 1|Lack of Efficacy|1|||
163364828|NCT05131477|590044492|FG003|PART 1|Lack of Efficacy|2|||
163364829|NCT05131477|590044493|FG004|PART 1|Lack of Efficacy|5|||
163364830|NCT05131477|590044494|FG005|PART 1|Lack of Efficacy|0|||
163364831|NCT05131477|590044495|FG006|PART 1|Lack of Efficacy|0|||
163364832|NCT05131477|590044496|FG007|PART 1|Lack of Efficacy|0|||
163364833|NCT05131477|590044497|FG008|PART 1|Lack of Efficacy|0|||
163364834|NCT05131477|590044498|FG009|PART 1|Lack of Efficacy|0|||
163364835|NCT05131477|590044499|FG010|PART 1|Lack of Efficacy|0|||
163364836|NCT05131477|590044500|FG011|PART 1|Lack of Efficacy|0|||
163364837|NCT05131477|590044501|FG012|PART 1|Lack of Efficacy|0|||
163364838|NCT05131477|590044502|FG013|PART 1|Lack of Efficacy|0|||
163364839|NCT05131477|590044489|FG000|PART 2|Withdrawal by Subject|0|||
163364840|NCT05131477|590044490|FG001|PART 2|Withdrawal by Subject|0|||
163364841|NCT05131477|590044491|FG002|PART 2|Withdrawal by Subject|0|||
163364842|NCT05131477|590044492|FG003|PART 2|Withdrawal by Subject|0|||
163364843|NCT05131477|590044493|FG004|PART 2|Withdrawal by Subject|0|||
163364844|NCT05131477|590044494|FG005|PART 2|Withdrawal by Subject|0|||
163364845|NCT05131477|590044495|FG006|PART 2|Withdrawal by Subject|2|||
163364846|NCT05131477|590044496|FG007|PART 2|Withdrawal by Subject|0|||
163364847|NCT05131477|590044497|FG008|PART 2|Withdrawal by Subject|0|||
163364848|NCT05131477|590044498|FG009|PART 2|Withdrawal by Subject|0|||
163364849|NCT05131477|590044499|FG010|PART 2|Withdrawal by Subject|2|||
163364850|NCT05131477|590044500|FG011|PART 2|Withdrawal by Subject|0|||
163364851|NCT05131477|590044501|FG012|PART 2|Withdrawal by Subject|2|||
163364852|NCT05131477|590044502|FG013|PART 2|Withdrawal by Subject|2|||
163364853|NCT05131477|590044489|FG000|PART 2|Other|0|||
163364854|NCT05131477|590044490|FG001|PART 2|Other|0|||
163364855|NCT05131477|590044491|FG002|PART 2|Other|0|||
163364856|NCT05131477|590044492|FG003|PART 2|Other|0|||
163364857|NCT05131477|590044493|FG004|PART 2|Other|0|||
163364858|NCT05131477|590044494|FG005|PART 2|Other|0|||
163364859|NCT05131477|590044495|FG006|PART 2|Other|0|||
163364860|NCT05131477|590044496|FG007|PART 2|Other|0|||
163364861|NCT05131477|590044497|FG008|PART 2|Other|1|||
163364862|NCT05131477|590044498|FG009|PART 2|Other|1|||
163364863|NCT05131477|590044499|FG010|PART 2|Other|0|||
163412105|NCT01790503|590216781|FG000|Overall Study|Non Compliance|0|||
163412106|NCT01790503|590216782|FG001|Overall Study|Non Compliance|0|||
163412107|NCT01790503|590216783|FG002|Overall Study|Non Compliance|0|||
163412108|NCT01790503|590216784|FG003|Overall Study|Non Compliance|0|||
163412109|NCT01790503|590216785|FG004|Overall Study|Non Compliance|1|||
163412110|NCT01790503|590216786|FG005|Overall Study|Non Compliance|0|||
163412111|NCT01790503|590216787|FG006|Overall Study|Non Compliance|0|||
163412112|NCT01790503|590216788|FG007|Overall Study|Non Compliance|0|||
163412113|NCT01790503|590216789|FG008|Overall Study|Non Compliance|0|||
163412114|NCT01790503|590216790|FG009|Overall Study|Non Compliance|0|||
163412115|NCT01790503|590216791|FG010|Overall Study|Non Compliance|0|||
163412116|NCT01790503|590216781|FG000|Overall Study|Other|0|||
163412117|NCT01790503|590216782|FG001|Overall Study|Other|0|||
163412118|NCT01790503|590216783|FG002|Overall Study|Other|0|||
163412119|NCT01790503|590216784|FG003|Overall Study|Other|0|||
163412120|NCT01790503|590216785|FG004|Overall Study|Other|1|||
163412121|NCT01790503|590216786|FG005|Overall Study|Other|0|||
163412122|NCT01790503|590216787|FG006|Overall Study|Other|0|||
163412123|NCT01790503|590216788|FG007|Overall Study|Other|0|||
163412124|NCT01790503|590216789|FG008|Overall Study|Other|1|||
163364864|NCT05131477|590044500|FG011|PART 2|Other|0|||
163364865|NCT05131477|590044501|FG012|PART 2|Other|1|||
163364866|NCT05131477|590044502|FG013|PART 2|Other|0|||
163364867|NCT05131477|590044489|FG000|PART 2|Lack of Efficacy|0|||
163364868|NCT05131477|590044490|FG001|PART 2|Lack of Efficacy|0|||
163364869|NCT05131477|590044491|FG002|PART 2|Lack of Efficacy|0|||
163364870|NCT05131477|590044492|FG003|PART 2|Lack of Efficacy|0|||
163364871|NCT05131477|590044493|FG004|PART 2|Lack of Efficacy|0|||
163364872|NCT05131477|590044494|FG005|PART 2|Lack of Efficacy|1|||
163364873|NCT05131477|590044495|FG006|PART 2|Lack of Efficacy|1|||
163364874|NCT05131477|590044496|FG007|PART 2|Lack of Efficacy|0|||
163364875|NCT05131477|590044497|FG008|PART 2|Lack of Efficacy|3|||
163364876|NCT05131477|590044498|FG009|PART 2|Lack of Efficacy|0|||
163364877|NCT05131477|590044499|FG010|PART 2|Lack of Efficacy|1|||
163364878|NCT05131477|590044500|FG011|PART 2|Lack of Efficacy|0|||
163364879|NCT05131477|590044501|FG012|PART 2|Lack of Efficacy|2|||
163364880|NCT05131477|590044502|FG013|PART 2|Lack of Efficacy|0|||
163364881|NCT05131477|590044489|FG000|PART 2|Unclassified|0|||
163364882|NCT05131477|590044490|FG001|PART 2|Unclassified|0|||
163364883|NCT05131477|590044491|FG002|PART 2|Unclassified|0|||
163364884|NCT05131477|590044492|FG003|PART 2|Unclassified|0|||
163364885|NCT05131477|590044493|FG004|PART 2|Unclassified|0|||
163364886|NCT05131477|590044494|FG005|PART 2|Unclassified|0|||
163364887|NCT05131477|590044495|FG006|PART 2|Unclassified|0|||
163364888|NCT05131477|590044496|FG007|PART 2|Unclassified|0|||
163364889|NCT05131477|590044497|FG008|PART 2|Unclassified|0|||
163364890|NCT05131477|590044498|FG009|PART 2|Unclassified|0|||
163364891|NCT05131477|590044499|FG010|PART 2|Unclassified|1|||
163364892|NCT05131477|590044500|FG011|PART 2|Unclassified|0|||
163364893|NCT05131477|590044501|FG012|PART 2|Unclassified|0|||
163364894|NCT05131477|590044502|FG013|PART 2|Unclassified|0|||
163364895|NCT05131477|590044489|FG000|PART 2|Re-randomized and not treated|0|||
163364896|NCT05131477|590044490|FG001|PART 2|Re-randomized and not treated|0|||
163364897|NCT05131477|590044491|FG002|PART 2|Re-randomized and not treated|0|||
163364898|NCT05131477|590044492|FG003|PART 2|Re-randomized and not treated|0|||
163364899|NCT05131477|590044493|FG004|PART 2|Re-randomized and not treated|0|||
163364900|NCT05131477|590044494|FG005|PART 2|Re-randomized and not treated|0|||
163364901|NCT05131477|590044495|FG006|PART 2|Re-randomized and not treated|0|||
163364902|NCT05131477|590044496|FG007|PART 2|Re-randomized and not treated|1|||
163364903|NCT05131477|590044497|FG008|PART 2|Re-randomized and not treated|0|||
163364904|NCT05131477|590044498|FG009|PART 2|Re-randomized and not treated|0|||
163364905|NCT05131477|590044499|FG010|PART 2|Re-randomized and not treated|1|||
163364906|NCT05131477|590044500|FG011|PART 2|Re-randomized and not treated|0|||
163364907|NCT05131477|590044501|FG012|PART 2|Re-randomized and not treated|1|||
163364908|NCT05131477|590044502|FG013|PART 2|Re-randomized and not treated|1|||
163364909|NCT06840769|590044504|FG000|Overall Study|Withdrawal by Subject|1|||
163364910|NCT06840769|590044505|FG001|Overall Study|Withdrawal by Subject|0|||
163364911|NCT06840769|590044506|FG002|Overall Study|Withdrawal by Subject|0|||
163364912|NCT06840769|590044507|FG003|Overall Study|Withdrawal by Subject|0|||
163412125|NCT01790503|590216790|FG009|Overall Study|Other|2|||
163364913|NCT06840769|590044508|FG004|Overall Study|Withdrawal by Subject|0|||
163364914|NCT02726945|590044509|FG000|Overall Study|Withdrawal by Subject|0|||
163364915|NCT02726945|590044510|FG001|Overall Study|Withdrawal by Subject|0|||
163364916|NCT02726945|590044511|FG002|Overall Study|Withdrawal by Subject|1|||
163364917|NCT02726945|590044509|FG000|Overall Study|Elected to have total knee replacement|0|||
163364918|NCT02726945|590044510|FG001|Overall Study|Elected to have total knee replacement|1|||
163412126|NCT01790503|590216791|FG010|Overall Study|Other|0|||
163412127|NCT04183335|590216792|FG000|Overall Study|Adverse Event|1|||
163412128|NCT04183335|590216793|FG001|Overall Study|Adverse Event|0|||
163412129|NCT04183335|590216792|FG000|Overall Study|Withdrawal by Subject|12|||
163412130|NCT04183335|590216793|FG001|Overall Study|Withdrawal by Subject|3|||
163412131|NCT00049673|590216794|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
163364919|NCT02726945|590044511|FG002|Overall Study|Elected to have total knee replacement|0|||
163364920|NCT05992922|590044512|FG000|Overall Study|Adverse Event|6|||
163364921|NCT05992922|590044513|FG001|Overall Study|Adverse Event|0|||
163364922|NCT05992922|590044512|FG000|Overall Study|Sponsor Termination of Study|14|||
163364923|NCT05992922|590044513|FG001|Overall Study|Sponsor Termination of Study|20|||
163364924|NCT04427280|590046108|FG000|Overall Study|Withdrawal by Subject|0|||
163364925|NCT04427280|590046109|FG001|Overall Study|Withdrawal by Subject|2|||
163364926|NCT02473965|590046111|FG000|Overall Study|Adverse Event|6|||
163364927|NCT02473965|590046112|FG001|Overall Study|Adverse Event|4|||
163364928|NCT02473965|590046111|FG000|Overall Study|MG worsening|4|||
163364929|NCT02473965|590046112|FG001|Overall Study|MG worsening|1|||
163364930|NCT02473965|590046111|FG000|Overall Study|Withdrawal by Subject|2|||
163364931|NCT02473965|590046112|FG001|Overall Study|Withdrawal by Subject|3|||
163364932|NCT02473965|590046111|FG000|Overall Study|Physician Decision|0|||
163364933|NCT02473965|590046112|FG001|Overall Study|Physician Decision|2|||
163364934|NCT01920477|590046115|FG000|Overall Study|Adverse Event|0|||
163364935|NCT01920477|590046116|FG001|Overall Study|Adverse Event|1|||
163364936|NCT01920477|590046115|FG000|Overall Study|Lack of Efficacy|1|||
163364937|NCT01920477|590046116|FG001|Overall Study|Lack of Efficacy|0|||
163364938|NCT01920477|590046115|FG000|Overall Study|Study closed/terminated|14|||
163364939|NCT01920477|590046116|FG001|Overall Study|Study closed/terminated|15|||
163364940|NCT01920477|590046115|FG000|Overall Study|Withdrawal by Subject|0|||
163364941|NCT01920477|590046116|FG001|Overall Study|Withdrawal by Subject|1|||
163364942|NCT01681277|590046117|FG000|Overall Study|Adverse Event|1|||
163364943|NCT01681277|590046118|FG001|Overall Study|Adverse Event|0|||
163364944|NCT01681277|590046119|FG002|Overall Study|Adverse Event|0|||
163364945|NCT01681277|590046120|FG003|Overall Study|Adverse Event|0|||
163364946|NCT01681277|590046121|FG004|Overall Study|Adverse Event|0|||
163364947|NCT02271984|590046124|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163364948|NCT02271984|590046125|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163364949|NCT02271984|590046126|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163364950|NCT02271984|590046127|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163364951|NCT02271984|590046128|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163364952|NCT02271984|590046129|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
163364953|NCT02271984|590046130|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163364954|NCT02271984|590046131|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
163364955|NCT02271984|590046132|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163364956|NCT02271984|590046133|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163364957|NCT02271984|590046134|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163364958|NCT02271984|590046135|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163364959|NCT01088984|590046136|FG000|Phase 1|Death|2|||
163364960|NCT01088984|590046137|FG001|Phase 1|Death|1|||
163364961|NCT01088984|590046136|FG000|Phase 1|Disease Progression|2|||
163364962|NCT01088984|590046137|FG001|Phase 1|Disease Progression|4|||
163364963|NCT01088984|590046136|FG000|Phase 1|Other|1|||
163364964|NCT01088984|590046137|FG001|Phase 1|Other|1|||
163364965|NCT01088984|590046136|FG000|Phase 2|Death|0|||
163364966|NCT01088984|590046137|FG001|Phase 2|Death|5|||
163364967|NCT01088984|590046136|FG000|Phase 2|Withdrawal by Subject|0|||
163364968|NCT01088984|590046137|FG001|Phase 2|Withdrawal by Subject|1|||
163364969|NCT01088984|590046136|FG000|Phase 2|DIsease Progression|0|||
163364970|NCT01088984|590046137|FG001|Phase 2|DIsease Progression|25|||
163364971|NCT01088984|590046136|FG000|Phase 2|Other|0|||
163364972|NCT01088984|590046137|FG001|Phase 2|Other|1|||
163364973|NCT02304705|590046138|FG000|Overall Study|Withdrawal by Subject|2|||
163364974|NCT02304705|590046139|FG001|Overall Study|Withdrawal by Subject|0|||
163364975|NCT02304705|590046138|FG000|Overall Study|Physician Decision|2|||
163364976|NCT02304705|590046139|FG001|Overall Study|Physician Decision|4|||
163364977|NCT02304705|590046138|FG000|Overall Study|Death|0|||
163364978|NCT02304705|590046139|FG001|Overall Study|Death|1|||
163364979|NCT02304705|590046138|FG000|Overall Study|Lost to Follow-up|0|||
163364980|NCT02304705|590046139|FG001|Overall Study|Lost to Follow-up|2|||
163364981|NCT00770029|590046140|FG000|Overall Study|Lost to Follow-up|2|||
163364982|NCT00770029|590046141|FG001|Overall Study|Lost to Follow-up|0|||
163364983|NCT00770029|590046140|FG000|Overall Study|Withdrawal by Subject|3|||
163364984|NCT00770029|590046141|FG001|Overall Study|Withdrawal by Subject|3|||
163364985|NCT00770029|590046140|FG000|Overall Study|Adverse Event|1|||
163364986|NCT00770029|590046141|FG001|Overall Study|Adverse Event|0|||
163364987|NCT05620108|590046144|FG000|Overall Study|Physician Decision|1|||
163364988|NCT05620108|590046145|FG001|Overall Study|Physician Decision|2|||
163364989|NCT05602727|590046146|FG000|Overall Study|Physician Decision|0|||
163364990|NCT05602727|590046147|FG001|Overall Study|Physician Decision|1|||
163364991|NCT05602727|590046148|FG002|Overall Study|Physician Decision|0|||
163364992|NCT05602727|590046146|FG000|Overall Study|Randomized by mistake without study medication|1|||
163364993|NCT05602727|590046147|FG001|Overall Study|Randomized by mistake without study medication|0|||
163364994|NCT05602727|590046148|FG002|Overall Study|Randomized by mistake without study medication|0|||
163364995|NCT05602727|590046146|FG000|Overall Study|Study termination by Sponsor|18|||
163364996|NCT05602727|590046147|FG001|Overall Study|Study termination by Sponsor|15|||
163364997|NCT05602727|590046148|FG002|Overall Study|Study termination by Sponsor|19|||
163364998|NCT05602727|590046146|FG000|Overall Study|Withdrawal by Subject|2|||
163364999|NCT05602727|590046147|FG001|Overall Study|Withdrawal by Subject|1|||
163365000|NCT05602727|590046148|FG002|Overall Study|Withdrawal by Subject|1|||
163365001|NCT05602727|590046146|FG000|Overall Study|Various reasons|1|||
163365002|NCT05602727|590046147|FG001|Overall Study|Various reasons|6|||
163365003|NCT05602727|590046148|FG002|Overall Study|Various reasons|1|||
163365004|NCT02038842|590046150|FG000|Overall Study|Withdrawal by Subject|2|||
163365005|NCT02038842|590046151|FG001|Overall Study|Withdrawal by Subject|2|||
163365006|NCT02038842|590046152|FG002|Overall Study|Withdrawal by Subject|0|||
163365007|NCT02038842|590046153|FG003|Overall Study|Withdrawal by Subject|0|||
163365008|NCT02038842|590046150|FG000|Overall Study|Participant decision|0|||
163365009|NCT02038842|590046151|FG001|Overall Study|Participant decision|0|||
163365010|NCT02038842|590046152|FG002|Overall Study|Participant decision|2|||
163365011|NCT02038842|590046153|FG003|Overall Study|Participant decision|1|||
163365012|NCT02038842|590046150|FG000|Overall Study|Adverse Event|0|||
163365013|NCT02038842|590046151|FG001|Overall Study|Adverse Event|0|||
163365014|NCT02038842|590046152|FG002|Overall Study|Adverse Event|3|||
163365015|NCT02038842|590046153|FG003|Overall Study|Adverse Event|1|||
163365016|NCT02038842|590046150|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
163365017|NCT02038842|590046151|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
163365018|NCT02038842|590046152|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
163365019|NCT02038842|590046153|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
163365020|NCT03412773|590046156|FG000|Overall Study|Lost to Follow-up|0|||
163365021|NCT03412773|590046157|FG001|Overall Study|Lost to Follow-up|7|||
163365022|NCT03412773|590046158|FG002|Overall Study|Lost to Follow-up|6|||
163365023|NCT03412773|590046156|FG000|Overall Study|Withdrawal by Subject|0|||
163365024|NCT03412773|590046157|FG001|Overall Study|Withdrawal by Subject|15|||
163365025|NCT03412773|590046158|FG002|Overall Study|Withdrawal by Subject|19|||
163365026|NCT03412773|590046156|FG000|Overall Study|Study Closed By Sponsor|3|||
163365027|NCT03412773|590046157|FG001|Overall Study|Study Closed By Sponsor|46|||
163365028|NCT03412773|590046158|FG002|Overall Study|Study Closed By Sponsor|33|||
163365029|NCT03412773|590046156|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
163365030|NCT03412773|590046157|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
163365031|NCT03412773|590046158|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
163365032|NCT03412773|590046156|FG000|Overall Study|Death|7|||
163365033|NCT03412773|590046157|FG001|Overall Study|Death|259|||
163365034|NCT03412773|590046158|FG002|Overall Study|Death|273|||
163365035|NCT03412773|590046156|FG000|Overall Study|Physician Decision|0|||
163365036|NCT03412773|590046157|FG001|Overall Study|Physician Decision|0|||
163365037|NCT03412773|590046158|FG002|Overall Study|Physician Decision|1|||
163365038|NCT01250925|590046162|FG000|Overall Study|Lost to Follow-up|1|||
163365039|NCT01250925|590046163|FG001|Overall Study|Lost to Follow-up|1|||
163365040|NCT01250925|590046164|FG002|Overall Study|Lost to Follow-up|0|||
163365041|NCT01250925|590046162|FG000|Overall Study|Withdrawal by Subject|2|||
163365042|NCT01250925|590046163|FG001|Overall Study|Withdrawal by Subject|0|||
163365043|NCT01250925|590046164|FG002|Overall Study|Withdrawal by Subject|0|||
163365044|NCT01250925|590046162|FG000|Overall Study|Protocol Violation|2|||
163365045|NCT01250925|590046163|FG001|Overall Study|Protocol Violation|0|||
163365046|NCT01250925|590046164|FG002|Overall Study|Protocol Violation|0|||
163365047|NCT01250925|590046162|FG000|Overall Study|Physician Decision|0|||
163365048|NCT01250925|590046163|FG001|Overall Study|Physician Decision|2|||
163365049|NCT01250925|590046164|FG002|Overall Study|Physician Decision|1|||
163365050|NCT01250925|590046162|FG000|Overall Study|Adverse Event|0|||
163365051|NCT01250925|590046163|FG001|Overall Study|Adverse Event|0|||
163365052|NCT01250925|590046164|FG002|Overall Study|Adverse Event|1|||
163365053|NCT00678301|590046168|FG000|Overall Study|Non-compliance with study procedures|0|||
163365054|NCT00678301|590046169|FG001|Overall Study|Non-compliance with study procedures|1|||
163365055|NCT00678301|590046168|FG000|Overall Study|Adverse Event|1|||
163365056|NCT00678301|590046169|FG001|Overall Study|Adverse Event|0|||
163365057|NCT00678301|590046168|FG000|Overall Study|Withdrawal by Subject|4|||
163365058|NCT00678301|590046169|FG001|Overall Study|Withdrawal by Subject|0|||
163412132|NCT00049673|590216795|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
163365059|NCT00678301|590046168|FG000|Overall Study|Lost to Follow-up|3|||
163365060|NCT00678301|590046169|FG001|Overall Study|Lost to Follow-up|1|||
163365061|NCT02476175|590046172|FG000|Overall Study|Adverse Event|2|||
163365062|NCT01016262|590046178|FG000|Double-blind Phase|Adverse Event|0|||
163365063|NCT01016262|590046179|FG001|Double-blind Phase|Adverse Event|0|||
163365064|NCT01016262|590046180|FG002|Double-blind Phase|Adverse Event|1|||
163412133|NCT01535729|590216796|FG000|Overall Study|Withdrawal by Subject|2|||
163365065|NCT01016262|590046181|FG003|Double-blind Phase|Adverse Event|0|||
163365066|NCT01016262|590046182|FG004|Double-blind Phase|Adverse Event|0|||
163365067|NCT01016262|590046183|FG005|Double-blind Phase|Adverse Event|0|||
163365068|NCT01016262|590046178|FG000|Double-blind Phase|Lack of Efficacy|1|||
163365069|NCT01016262|590046179|FG001|Double-blind Phase|Lack of Efficacy|0|||
163412134|NCT01535729|590216796|FG000|Overall Study|Disease progression|230|||
163412135|NCT01535729|590216796|FG000|Overall Study|Discontinued treatment|25|||
163412136|NCT01535729|590216796|FG000|Overall Study|Lost to Follow-up|8|||
163412137|NCT01535729|590216796|FG000|Overall Study|Death|52|||
163412138|NCT01535729|590216796|FG000|Overall Study|Other|19|||
163412139|NCT01535729|590216796|FG000|Overall Study|Did not sign informed consent|1|||
163412140|NCT01535729|590216796|FG000|Overall Study|No previous chemotherapy|33|||
163412141|NCT01535729|590216796|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
163412142|NCT01535729|590216796|FG000|Overall Study|Protocol Violation|11|||
163412143|NCT01535729|590216796|FG000|Overall Study|Screening failure|1|||
163412144|NCT01535729|590216796|FG000|Overall Study|Not treated|9|||
163412145|NCT01535729|590216796|FG000|Overall Study|No participant record available|5|||
163412146|NCT03733392|590216799|FG000|Overall Study|Withdrawal by Subject|11|||
163412147|NCT03733392|590216800|FG001|Overall Study|Withdrawal by Subject|1|||
163365070|NCT01016262|590046180|FG002|Double-blind Phase|Lack of Efficacy|5|||
163365071|NCT01016262|590046181|FG003|Double-blind Phase|Lack of Efficacy|0|||
163365072|NCT01016262|590046182|FG004|Double-blind Phase|Lack of Efficacy|0|||
163365073|NCT01016262|590046183|FG005|Double-blind Phase|Lack of Efficacy|0|||
163365074|NCT01016262|590046178|FG000|Double-blind Phase|Disease Progression|0|||
163365075|NCT01016262|590046179|FG001|Double-blind Phase|Disease Progression|1|||
163365076|NCT01016262|590046180|FG002|Double-blind Phase|Disease Progression|2|||
163365077|NCT01016262|590046181|FG003|Double-blind Phase|Disease Progression|0|||
163365078|NCT01016262|590046182|FG004|Double-blind Phase|Disease Progression|0|||
163365079|NCT01016262|590046183|FG005|Double-blind Phase|Disease Progression|0|||
163365080|NCT01016262|590046178|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
163365081|NCT01016262|590046179|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
163365082|NCT01016262|590046180|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
163365083|NCT01016262|590046181|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
163365084|NCT01016262|590046182|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
163365085|NCT01016262|590046183|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
163365086|NCT01016262|590046178|FG000|Open-Label Phase|Adverse Event|0|||
163365087|NCT01016262|590046179|FG001|Open-Label Phase|Adverse Event|0|||
163365088|NCT01016262|590046180|FG002|Open-Label Phase|Adverse Event|0|||
163365089|NCT01016262|590046181|FG003|Open-Label Phase|Adverse Event|1|||
163365090|NCT01016262|590046182|FG004|Open-Label Phase|Adverse Event|0|||
163365091|NCT01016262|590046183|FG005|Open-Label Phase|Adverse Event|0|||
163365092|NCT01016262|590046178|FG000|Open-Label Phase|Lost to Follow-up|0|||
163365093|NCT01016262|590046179|FG001|Open-Label Phase|Lost to Follow-up|0|||
163365094|NCT01016262|590046180|FG002|Open-Label Phase|Lost to Follow-up|0|||
163365095|NCT01016262|590046181|FG003|Open-Label Phase|Lost to Follow-up|0|||
163365096|NCT01016262|590046182|FG004|Open-Label Phase|Lost to Follow-up|1|||
163365097|NCT01016262|590046183|FG005|Open-Label Phase|Lost to Follow-up|0|||
163365098|NCT01016262|590046178|FG000|Open-Label Phase|Lack of Efficacy|0|||
163365099|NCT01016262|590046179|FG001|Open-Label Phase|Lack of Efficacy|0|||
163365100|NCT01016262|590046180|FG002|Open-Label Phase|Lack of Efficacy|0|||
163365101|NCT01016262|590046181|FG003|Open-Label Phase|Lack of Efficacy|1|||
163365102|NCT01016262|590046182|FG004|Open-Label Phase|Lack of Efficacy|0|||
163365103|NCT01016262|590046183|FG005|Open-Label Phase|Lack of Efficacy|0|||
163365104|NCT01016262|590046178|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
163365105|NCT01016262|590046179|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
163365106|NCT01016262|590046180|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
163365107|NCT01016262|590046181|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
163365108|NCT01016262|590046182|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
163365109|NCT01016262|590046183|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
163365110|NCT03738475|590046185|FG000|Overall Study|Participant Non-Compliance|1|||
163365111|NCT03738475|590046186|FG001|Overall Study|Participant Non-Compliance|0|||
163365112|NCT00677534|590046187|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
163365113|NCT00677534|590046187|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
163365114|NCT00677534|590046187|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
163365115|NCT00667394|590046188|FG000|Overall Study|Adverse Event|3|||
163365116|NCT00667394|590046189|FG001|Overall Study|Adverse Event|0|||
163365117|NCT00667394|590046188|FG000|Overall Study|Progressive disease|1|||
163365118|NCT00667394|590046189|FG001|Overall Study|Progressive disease|0|||
163365119|NCT04638660|590046190|FG000|Overall Study|Withdrawal by Subject|2|||
163365120|NCT04638660|590046191|FG001|Overall Study|Withdrawal by Subject|0|||
163365121|NCT04638660|590046190|FG000|Overall Study|Lost to Follow-up|1|||
163365122|NCT04638660|590046191|FG001|Overall Study|Lost to Follow-up|0|||
163412148|NCT03733392|590216799|FG000|Overall Study|Death|1|||
163412149|NCT03733392|590216800|FG001|Overall Study|Death|0|||
163365123|NCT04076943|590046192|FG000|Overall Study|Withdrawal by Subject|12|||
163365124|NCT04076943|590046192|FG000|Overall Study|Adverse Event|1|||
163365125|NCT04076943|590046192|FG000|Overall Study|Progressive Disease|2|||
163365126|NCT04076943|590046192|FG000|Overall Study|Death|13|||
163365127|NCT04076943|590046192|FG000|Overall Study|Other than specified|6|||
163365128|NCT01304498|590046194|FG000|Overall Study|Adverse Event|1|||
163365129|NCT01304498|590046195|FG001|Overall Study|Adverse Event|1|||
163365130|NCT01304498|590046194|FG000|Overall Study|Withdrawal by Subject|2|||
163412150|NCT03733392|590216799|FG000|Overall Study|Lost to Follow-up|5|||
163412151|NCT03733392|590216800|FG001|Overall Study|Lost to Follow-up|0|||
163412152|NCT03733392|590216799|FG000|Overall Study|Protocol Violation|0|||
163412153|NCT03733392|590216800|FG001|Overall Study|Protocol Violation|1|||
163412154|NCT03733392|590216799|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
163412155|NCT03733392|590216800|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
163412156|NCT03733392|590216799|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
163412157|NCT03733392|590216800|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
163412158|NCT03733392|590216799|FG000|Overall Study|Patient Non-Compliance|2|||
163412159|NCT03733392|590216800|FG001|Overall Study|Patient Non-Compliance|1|||
163412160|NCT03733392|590216799|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
163412161|NCT03733392|590216800|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
163412162|NCT03733392|590216799|FG000|Overall Study|Withdrawal prior to procedure|5|||
163412163|NCT03733392|590216800|FG001|Overall Study|Withdrawal prior to procedure|2|||
163412164|NCT02740478|590216801|FG000|Overall Study|Withdrawal by Subject|1|||
163412165|NCT01934140|590216808|FG000|Persistence Phase (Year 6-10)|Other|24|||
163412166|NCT01934140|590216809|FG001|Persistence Phase (Year 6-10)|Other|6|||
163412167|NCT01934140|590216808|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
163412168|NCT01934140|590216809|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
163412169|NCT01934140|590216808|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
163412170|NCT01934140|590216809|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
163412171|NCT01934140|590216808|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
163412172|NCT01934140|590216809|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
163412173|NCT01934140|590216808|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
163412174|NCT01934140|590216809|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
163412175|NCT01934140|590216808|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
163412176|NCT01934140|590216809|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
163412177|NCT01934140|590216808|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
163412178|NCT01934140|590216809|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
163365131|NCT01304498|590046195|FG001|Overall Study|Withdrawal by Subject|3|||
163365132|NCT01304498|590046194|FG000|Overall Study|Protocol Violation|1|||
163365133|NCT01304498|590046195|FG001|Overall Study|Protocol Violation|0|||
163365134|NCT01304498|590046194|FG000|Overall Study|Lost to Follow-up|2|||
163365135|NCT01304498|590046195|FG001|Overall Study|Lost to Follow-up|1|||
163365136|NCT03080493|590046196|FG000|Overall Study|Did not provide NRS pain results|1|||
163365137|NCT03080493|590046197|FG001|Overall Study|Did not provide NRS pain results|0|||
163365138|NCT03080493|590046196|FG000|Overall Study|Adverse Event|0|||
163365139|NCT03080493|590046197|FG001|Overall Study|Adverse Event|1|||
163365140|NCT03080493|590046196|FG000|Overall Study|Randomization error (parity group)|0|||
163365141|NCT03080493|590046197|FG001|Overall Study|Randomization error (parity group)|1|||
163365142|NCT03325777|590046198|FG000|Overall Study|Lost to Follow-up|9|||
163365143|NCT03325777|590046199|FG001|Overall Study|Lost to Follow-up|12|||
163365144|NCT03004404|590046201|FG000|Period 2|Adverse Event|0|||
163365145|NCT03004404|590046202|FG001|Period 2|Adverse Event|0|||
163365146|NCT03004404|590046203|FG002|Period 2|Adverse Event|0|||
163365147|NCT03004404|590046204|FG003|Period 2|Adverse Event|0|||
163365148|NCT03004404|590046205|FG004|Period 2|Adverse Event|0|||
163365149|NCT03004404|590046206|FG005|Period 2|Adverse Event|0|||
163365150|NCT03004404|590046207|FG006|Period 2|Adverse Event|0|||
163365151|NCT03004404|590046208|FG007|Period 2|Adverse Event|0|||
163365152|NCT03004404|590046209|FG008|Period 2|Adverse Event|1|||
163365153|NCT03004404|590046210|FG009|Period 2|Adverse Event|0|||
163365154|NCT03004404|590046211|FG010|Period 2|Adverse Event|0|||
163365155|NCT03004404|590046212|FG011|Period 2|Adverse Event|0|||
163365156|NCT03004404|590046213|FG012|Period 2|Adverse Event|0|||
163365157|NCT03004404|590046214|FG013|Period 2|Adverse Event|0|||
163365158|NCT03004404|590046215|FG014|Period 2|Adverse Event|0|||
163365159|NCT03004404|590046216|FG015|Period 2|Adverse Event|1|||
163365160|NCT01099917|590046221|FG000|Overall Study|Adverse Event|3|||
163365161|NCT01099917|590046221|FG000|Overall Study|Not Treated|24|||
163365162|NCT02990468|590046222|FG000|Phase 2: MTD|Change in treatment|0|||
163365163|NCT02990468|590046223|FG001|Phase 2: MTD|Change in treatment|0|||
163365164|NCT02990468|590046224|FG002|Phase 2: MTD|Change in treatment|1|||
163365165|NCT01602510|590046229|FG000|Open Label Phase|Adverse Event|46|||
163365166|NCT01602510|590046230|FG001|Open Label Phase|Adverse Event|0|||
163365167|NCT01602510|590046231|FG002|Open Label Phase|Adverse Event|0|||
163365168|NCT01602510|590046229|FG000|Open Label Phase|Lack of Efficacy|22|||
163365169|NCT01602510|590046230|FG001|Open Label Phase|Lack of Efficacy|0|||
163365170|NCT01602510|590046231|FG002|Open Label Phase|Lack of Efficacy|0|||
163365171|NCT01602510|590046229|FG000|Open Label Phase|Protocol Violation|15|||
163365172|NCT01602510|590046230|FG001|Open Label Phase|Protocol Violation|0|||
163365173|NCT01602510|590046231|FG002|Open Label Phase|Protocol Violation|0|||
163365174|NCT01602510|590046229|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
163365175|NCT01602510|590046230|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
163365176|NCT01602510|590046231|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
163365177|NCT01602510|590046229|FG000|Open Label Phase|Lost to Follow-up|22|||
163365178|NCT01602510|590046230|FG001|Open Label Phase|Lost to Follow-up|0|||
163365179|NCT01602510|590046231|FG002|Open Label Phase|Lost to Follow-up|0|||
163365180|NCT01602510|590046229|FG000|Open Label Phase|Physician Decision|19|||
163365181|NCT01602510|590046230|FG001|Open Label Phase|Physician Decision|0|||
163365182|NCT01602510|590046231|FG002|Open Label Phase|Physician Decision|0|||
163365183|NCT01602510|590046229|FG000|Open Label Phase|Withdrawal by Subject|57|||
163365184|NCT01602510|590046230|FG001|Open Label Phase|Withdrawal by Subject|0|||
163365185|NCT01602510|590046231|FG002|Open Label Phase|Withdrawal by Subject|0|||
163365186|NCT01602510|590046229|FG000|Randomized Phase|Adverse Event|0|||
163365187|NCT01602510|590046230|FG001|Randomized Phase|Adverse Event|2|||
163365188|NCT01602510|590046231|FG002|Randomized Phase|Adverse Event|6|||
163365189|NCT01602510|590046229|FG000|Randomized Phase|Lack of Efficacy|0|||
163365190|NCT01602510|590046230|FG001|Randomized Phase|Lack of Efficacy|4|||
163365191|NCT01602510|590046231|FG002|Randomized Phase|Lack of Efficacy|4|||
163365192|NCT01602510|590046229|FG000|Randomized Phase|Protocol Violation|0|||
163365193|NCT01602510|590046230|FG001|Randomized Phase|Protocol Violation|3|||
163365194|NCT01602510|590046231|FG002|Randomized Phase|Protocol Violation|3|||
163365195|NCT01602510|590046229|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
163365196|NCT01602510|590046230|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
163365197|NCT01602510|590046231|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
163365198|NCT01602510|590046229|FG000|Randomized Phase|Lost to Follow-up|0|||
163365199|NCT01602510|590046230|FG001|Randomized Phase|Lost to Follow-up|1|||
163365200|NCT01602510|590046231|FG002|Randomized Phase|Lost to Follow-up|3|||
163365201|NCT01602510|590046229|FG000|Randomized Phase|Physician Decision|0|||
163365202|NCT01602510|590046230|FG001|Randomized Phase|Physician Decision|0|||
163365203|NCT01602510|590046231|FG002|Randomized Phase|Physician Decision|2|||
163365204|NCT01602510|590046229|FG000|Randomized Phase|Withdrawal by Subject|0|||
163365205|NCT01602510|590046230|FG001|Randomized Phase|Withdrawal by Subject|6|||
163365206|NCT01602510|590046231|FG002|Randomized Phase|Withdrawal by Subject|7|||
163365207|NCT01825577|590046232|FG000|Overall Study|Physician Decision|2|||
163365208|NCT01825577|590046232|FG000|Overall Study|Withdrawal by Subject|1|||
163365209|NCT01825577|590046232|FG000|Overall Study|Withdrawn by family members|2|||
163365210|NCT01825577|590046232|FG000|Overall Study|Lack of Efficacy|3|||
163365211|NCT04191616|590046235|FG000|Pre-assignment Period|Did not receive study treatment|2|||
163365212|NCT04191616|590046235|FG000|Treatment Period|Death|37|||
163365213|NCT04191616|590046235|FG000|Treatment Period|Sponsor decision|11|||
163365214|NCT04191616|590046235|FG000|Treatment Period|Withdrawal by Subject|4|||
163365215|NCT04230122|590046236|FG000|Overall Study|Lost to Follow-up|1|||
163365216|NCT04230122|590046237|FG001|Overall Study|Lost to Follow-up|0|||
163365217|NCT01361594|590046239|FG000|Overall Study|Withdrawal by Subject|1|||
163365218|NCT01361594|590046240|FG001|Overall Study|Withdrawal by Subject|2|||
163365219|NCT02670122|590046243|FG000|Overall Study|Lost to Follow-up|4|||
163365220|NCT02762903|590046244|FG000|Overall Study|Lost to Follow-up|0|||
163365221|NCT02762903|590046245|FG001|Overall Study|Lost to Follow-up|1|||
163365222|NCT00108745|590046246|FG000|Overall Study|Withdrawal by Subject|19|||
163365223|NCT00108745|590046247|FG001|Overall Study|Withdrawal by Subject|12|||
163365224|NCT00108745|590046248|FG002|Overall Study|Withdrawal by Subject|12|||
163365225|NCT00108745|590046246|FG000|Overall Study|Never Treated|8|||
163365226|NCT00108745|590046247|FG001|Overall Study|Never Treated|10|||
163365227|NCT00108745|590046248|FG002|Overall Study|Never Treated|12|||
163365228|NCT00108745|590046246|FG000|Overall Study|Ineligible|7|||
163365229|NCT00108745|590046247|FG001|Overall Study|Ineligible|13|||
163365230|NCT00108745|590046248|FG002|Overall Study|Ineligible|13|||
163365231|NCT00632502|590046252|FG000|Overall Study|Adverse Event|0|||
163365232|NCT00632502|590046253|FG001|Overall Study|Adverse Event|1|||
163365233|NCT00632502|590046252|FG000|Overall Study|Randomized not treated|3|||
163365234|NCT00632502|590046253|FG001|Overall Study|Randomized not treated|0|||
163365235|NCT00277095|590046254|FG000|Overall Study|Death|2|||
163365236|NCT00277095|590046254|FG000|Overall Study|Explanted|7|||
163365237|NCT00277095|590046254|FG000|Overall Study|Lost to Follow-up|2|||
163412179|NCT01934140|590216808|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
163412180|NCT01934140|590216809|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
163365238|NCT00277095|590046254|FG000|Overall Study|Missed Follow-up|9|||
163365239|NCT00277095|590046254|FG000|Overall Study|Physician Decision|1|||
163365240|NCT02548078|590046261|FG000|Overall Study|Serious adverse event/Adverse event|1|||
163365241|NCT02548078|590046262|FG001|Overall Study|Serious adverse event/Adverse event|0|||
163365242|NCT02548078|590046261|FG000|Overall Study|Moved from study area|3|||
163365243|NCT02548078|590046262|FG001|Overall Study|Moved from study area|3|||
163365244|NCT02548078|590046261|FG000|Overall Study|Lost to Follow-up|1|||
163365245|NCT02548078|590046262|FG001|Overall Study|Lost to Follow-up|3|||
163365246|NCT01040169|590046263|FG000|Overall Study|Lost to Follow-up|3|||
163365247|NCT01040169|590046264|FG001|Overall Study|Lost to Follow-up|8|||
163365248|NCT05239598|590046267|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
163365249|NCT05239598|590046268|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
163365250|NCT05239598|590046267|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
163365251|NCT05239598|590046268|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
163412181|NCT01461044|590216813|FG000|Overall Study|Death|58|||
163412182|NCT01461044|590216814|FG001|Overall Study|Death|35|||
163412183|NCT01461044|590216813|FG000|Overall Study|Lost to Follow-up|12|||
163412184|NCT01461044|590216814|FG001|Overall Study|Lost to Follow-up|5|||
163412185|NCT00618748|590216815|FG000|Overall Study|Adverse Event|4|||
163412186|NCT00618748|590216816|FG001|Overall Study|Adverse Event|3|||
163412187|NCT00618748|590216817|FG002|Overall Study|Adverse Event|8|||
163412188|NCT00618748|590216815|FG000|Overall Study|Physician Decision|3|||
163412189|NCT00618748|590216816|FG001|Overall Study|Physician Decision|1|||
163365252|NCT02592707|590046269|FG000|Overall Study|Consent Withdrawn|0|||
163365253|NCT02592707|590046270|FG001|Overall Study|Consent Withdrawn|1|||
163365254|NCT02592707|590046271|FG002|Overall Study|Consent Withdrawn|2|||
163365255|NCT02592707|590046272|FG003|Overall Study|Consent Withdrawn|0|||
163365256|NCT02592707|590046269|FG000|Overall Study|Death|1|||
163365257|NCT02592707|590046270|FG001|Overall Study|Death|0|||
163365258|NCT02592707|590046271|FG002|Overall Study|Death|0|||
163365259|NCT02592707|590046272|FG003|Overall Study|Death|0|||
163365260|NCT02592707|590046269|FG000|Overall Study|Progressive Disease|4|||
163365261|NCT02592707|590046270|FG001|Overall Study|Progressive Disease|4|||
163365262|NCT02592707|590046271|FG002|Overall Study|Progressive Disease|3|||
163365263|NCT02592707|590046272|FG003|Overall Study|Progressive Disease|3|||
163365264|NCT02592707|590046269|FG000|Overall Study|Other|0|||
163365265|NCT02592707|590046270|FG001|Overall Study|Other|0|||
163365266|NCT02592707|590046271|FG002|Overall Study|Other|1|||
163365267|NCT02592707|590046272|FG003|Overall Study|Other|2|||
163365268|NCT02592707|590046269|FG000|Overall Study|Never entered LTFU period|1|||
163365269|NCT02592707|590046270|FG001|Overall Study|Never entered LTFU period|0|||
163365270|NCT02592707|590046271|FG002|Overall Study|Never entered LTFU period|0|||
163365271|NCT02592707|590046272|FG003|Overall Study|Never entered LTFU period|2|||
163365272|NCT04855734|590046275|FG000|Overall Study|Lost to Follow-up|2|||
163365273|NCT04855734|590046276|FG001|Overall Study|Lost to Follow-up|2|||
163365274|NCT03832595|590046277|FG000|Overall Study|Death|142|||
163365275|NCT03832595|590046278|FG001|Overall Study|Death|130|||
163365276|NCT03832595|590046277|FG000|Overall Study|Medical management without dialysis|37|||
163365277|NCT03832595|590046278|FG001|Overall Study|Medical management without dialysis|1|||
163365278|NCT03277352|590046279|FG000|Overall Study|Study Terminated By Sponsor|2|||
163365279|NCT03277352|590046279|FG000|Overall Study|Withdrawal by Subject|4|||
163365280|NCT03277352|590046279|FG000|Overall Study|Death|4|||
163365281|NCT03939689|590048337|FG000|Overall Study|Radiographic progression|14|||
163365282|NCT03939689|590048338|FG001|Overall Study|Radiographic progression|17|||
163365283|NCT03939689|590048337|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
163365284|NCT03939689|590048338|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
163365285|NCT03939689|590048337|FG000|Overall Study|Adverse Event|1|||
163365286|NCT03939689|590048338|FG001|Overall Study|Adverse Event|8|||
163365287|NCT03939689|590048337|FG000|Overall Study|Unequivocal clinical progression|2|||
163365288|NCT03939689|590048338|FG001|Overall Study|Unequivocal clinical progression|5|||
163365289|NCT03939689|590048337|FG000|Overall Study|Other|1|||
163365290|NCT03939689|590048338|FG001|Overall Study|Other|4|||
163365291|NCT03939689|590048337|FG000|Overall Study|Death|0|||
163365292|NCT03939689|590048338|FG001|Overall Study|Death|3|||
163365293|NCT03939689|590048337|FG000|Overall Study|Participant decision|0|||
163365294|NCT03939689|590048338|FG001|Overall Study|Participant decision|3|||
163365295|NCT03939689|590048337|FG000|Overall Study|Withdrawal of consent|2|||
163365296|NCT03939689|590048338|FG001|Overall Study|Withdrawal of consent|1|||
163365297|NCT03939689|590048337|FG000|Overall Study|Investigator decision|1|||
163365298|NCT03939689|590048338|FG001|Overall Study|Investigator decision|0|||
163365299|NCT03554629|590048339|FG000|Overall Study|Inadequate data|6|||
163365300|NCT01228318|590048340|FG000|Overall Study|Clinic no show to receive intervention|1|||
163365301|NCT01228318|590048341|FG001|Overall Study|Clinic no show to receive intervention|0|||
163365302|NCT01228318|590048340|FG000|Overall Study|Unable to contact|2|||
163365303|NCT01228318|590048341|FG001|Overall Study|Unable to contact|5|||
163365304|NCT01228318|590048340|FG000|Overall Study|Moved|0|||
163365305|NCT01228318|590048341|FG001|Overall Study|Moved|2|||
163365306|NCT01228318|590048340|FG000|Overall Study|Incarcerated|1|||
163365307|NCT01228318|590048341|FG001|Overall Study|Incarcerated|0|||
163365308|NCT03140280|590048342|FG000|Overall Study|Physician Decision|5|||
163365309|NCT05577715|590048349|FG000|Overall Study|Withdrawal by Subject|1|||
163365310|NCT05577715|590048349|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
163365311|NCT05577715|590048349|FG000|Overall Study|Lost to Follow-up|1|||
163365312|NCT05577715|590048349|FG000|Overall Study|Death|6|||
163365313|NCT02643303|590048354|FG000|Overall Study|Progressive Disease|4|||
163412190|NCT00618748|590216817|FG002|Overall Study|Physician Decision|1|||
163412191|NCT00618748|590216815|FG000|Overall Study|Withdrawal by Subject|4|||
163412192|NCT00618748|590216816|FG001|Overall Study|Withdrawal by Subject|1|||
163365314|NCT02643303|590048355|FG001|Overall Study|Progressive Disease|4|||
163365315|NCT02643303|590048356|FG002|Overall Study|Progressive Disease|1|||
163365316|NCT02643303|590048357|FG003|Overall Study|Progressive Disease|12|||
163365317|NCT02643303|590048358|FG004|Overall Study|Progressive Disease|6|||
163365318|NCT02643303|590048359|FG005|Overall Study|Progressive Disease|4|||
163412193|NCT00618748|590216817|FG002|Overall Study|Withdrawal by Subject|5|||
163365319|NCT02643303|590048360|FG006|Overall Study|Progressive Disease|8|||
163365320|NCT02643303|590048361|FG007|Overall Study|Progressive Disease|2|||
163365321|NCT02643303|590048362|FG008|Overall Study|Progressive Disease|6|||
163365322|NCT02643303|590048354|FG000|Overall Study|Adverse Event|0|||
163365323|NCT02643303|590048355|FG001|Overall Study|Adverse Event|1|||
163365324|NCT02643303|590048356|FG002|Overall Study|Adverse Event|0|||
163365325|NCT02643303|590048357|FG003|Overall Study|Adverse Event|0|||
163365326|NCT02643303|590048358|FG004|Overall Study|Adverse Event|1|||
163365327|NCT02643303|590048359|FG005|Overall Study|Adverse Event|0|||
163365328|NCT02643303|590048360|FG006|Overall Study|Adverse Event|0|||
163365329|NCT02643303|590048361|FG007|Overall Study|Adverse Event|0|||
163365330|NCT02643303|590048362|FG008|Overall Study|Adverse Event|0|||
163365331|NCT02643303|590048354|FG000|Overall Study|Withdrawal by Subject|0|||
163365332|NCT02643303|590048355|FG001|Overall Study|Withdrawal by Subject|0|||
163365333|NCT02643303|590048356|FG002|Overall Study|Withdrawal by Subject|0|||
163365334|NCT02643303|590048357|FG003|Overall Study|Withdrawal by Subject|1|||
163365335|NCT02643303|590048358|FG004|Overall Study|Withdrawal by Subject|0|||
163365336|NCT02643303|590048359|FG005|Overall Study|Withdrawal by Subject|0|||
163365337|NCT02643303|590048360|FG006|Overall Study|Withdrawal by Subject|1|||
163365338|NCT02643303|590048361|FG007|Overall Study|Withdrawal by Subject|1|||
163365339|NCT02643303|590048362|FG008|Overall Study|Withdrawal by Subject|1|||
163365340|NCT00626197|590048365|FG000|Overall Study|Did not cooperate|2|||
163365341|NCT00626197|590048366|FG001|Overall Study|Did not cooperate|6|||
163365342|NCT00626197|590048367|FG002|Overall Study|Did not cooperate|1|||
163365343|NCT00626197|590048365|FG000|Overall Study|Failure to return|6|||
163365344|NCT00626197|590048366|FG001|Overall Study|Failure to return|5|||
163365345|NCT00626197|590048367|FG002|Overall Study|Failure to return|6|||
163365346|NCT00626197|590048365|FG000|Overall Study|Adverse event, serious fatal|3|||
163365347|NCT00626197|590048366|FG001|Overall Study|Adverse event, serious fatal|6|||
163365348|NCT00626197|590048367|FG002|Overall Study|Adverse event, serious fatal|6|||
163365349|NCT00626197|590048365|FG000|Overall Study|Adverse Event|1|||
163365350|NCT00626197|590048366|FG001|Overall Study|Adverse Event|1|||
163365351|NCT00626197|590048367|FG002|Overall Study|Adverse Event|2|||
163365352|NCT00626197|590048365|FG000|Overall Study|Withdrawal by Subject|17|||
163365353|NCT00626197|590048366|FG001|Overall Study|Withdrawal by Subject|17|||
163365354|NCT00626197|590048367|FG002|Overall Study|Withdrawal by Subject|7|||
163365355|NCT00626197|590048365|FG000|Overall Study|Administrative reasons|15|||
163365356|NCT00626197|590048366|FG001|Overall Study|Administrative reasons|19|||
163365357|NCT00626197|590048367|FG002|Overall Study|Administrative reasons|55|||
163365358|NCT05332912|590048372|FG000|Overall Study|Withdrawal by Subject|0|||
163365359|NCT05332912|590048373|FG001|Overall Study|Withdrawal by Subject|1|||
163365360|NCT05332912|590048374|FG002|Overall Study|Withdrawal by Subject|2|||
163365361|NCT05332912|590048375|FG003|Overall Study|Withdrawal by Subject|0|||
163365362|NCT05332912|590048372|FG000|Overall Study|Lost to Follow-up|0|||
163365363|NCT05332912|590048373|FG001|Overall Study|Lost to Follow-up|0|||
163365364|NCT05332912|590048374|FG002|Overall Study|Lost to Follow-up|1|||
163365365|NCT05332912|590048375|FG003|Overall Study|Lost to Follow-up|0|||
163365366|NCT05282121|590048376|FG000|Overall Study|Adverse Event|1|||
163365367|NCT05282121|590048377|FG001|Overall Study|Adverse Event|1|||
163365368|NCT05282121|590048378|FG002|Overall Study|Adverse Event|4|||
163365369|NCT05282121|590048379|FG003|Overall Study|Adverse Event|1|||
163365370|NCT05282121|590048376|FG000|Overall Study|Study Terminated by Sponsor|1|||
163365371|NCT05282121|590048377|FG001|Overall Study|Study Terminated by Sponsor|2|||
163365372|NCT05282121|590048378|FG002|Overall Study|Study Terminated by Sponsor|2|||
163365373|NCT05282121|590048379|FG003|Overall Study|Study Terminated by Sponsor|2|||
163365374|NCT05282121|590048376|FG000|Overall Study|Other than listed|0|||
163365375|NCT05282121|590048377|FG001|Overall Study|Other than listed|0|||
163365376|NCT05282121|590048378|FG002|Overall Study|Other than listed|1|||
163365377|NCT05282121|590048379|FG003|Overall Study|Other than listed|0|||
163365378|NCT05282121|590048376|FG000|Overall Study|No reason available|0|||
163365379|NCT05282121|590048377|FG001|Overall Study|No reason available|0|||
163365380|NCT05282121|590048378|FG002|Overall Study|No reason available|1|||
163365381|NCT05282121|590048379|FG003|Overall Study|No reason available|0|||
163365382|NCT01174446|590048382|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
163365383|NCT01174446|590048383|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
163365384|NCT01174446|590048384|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
163365385|NCT01174446|590048385|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
163365386|NCT01174446|590048382|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
163365387|NCT01174446|590048383|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
163365388|NCT01174446|590048384|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
163365389|NCT01174446|590048385|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
163365390|NCT01174446|590048382|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
163365391|NCT01174446|590048383|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
163412194|NCT00200850|590216818|FG000|Overall Study|relocation|1|||
163412195|NCT00200850|590216819|FG001|Overall Study|relocation|0|||
163412196|NCT00200850|590216820|FG002|Overall Study|relocation|1|||
163412197|NCT00200850|590216818|FG000|Overall Study|too busy|1|||
163412198|NCT00200850|590216819|FG001|Overall Study|too busy|0|||
163412199|NCT00200850|590216820|FG002|Overall Study|too busy|0|||
163412200|NCT00200850|590216818|FG000|Overall Study|Pregnancy|0|||
163412201|NCT00200850|590216819|FG001|Overall Study|Pregnancy|0|||
163412202|NCT00200850|590216820|FG002|Overall Study|Pregnancy|1|||
163412203|NCT00200850|590216818|FG000|Overall Study|Poor adherence|0|||
163412204|NCT00200850|590216819|FG001|Overall Study|Poor adherence|0|||
163412205|NCT00200850|590216820|FG002|Overall Study|Poor adherence|1|||
163412206|NCT00200850|590216818|FG000|Overall Study|optic neuritis|0|||
163412207|NCT00200850|590216819|FG001|Overall Study|optic neuritis|0|||
163412208|NCT00200850|590216820|FG002|Overall Study|optic neuritis|1|||
163412209|NCT00200850|590216818|FG000|Overall Study|Adverse Event|1|||
163412210|NCT00200850|590216819|FG001|Overall Study|Adverse Event|1|||
163412211|NCT00200850|590216820|FG002|Overall Study|Adverse Event|2|||
163412212|NCT02814565|590216824|FG000|Overall Study|Lack of Efficacy|0|||
163412213|NCT02814565|590216825|FG001|Overall Study|Lack of Efficacy|1|||
163412214|NCT02814565|590216824|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
163412215|NCT02814565|590216825|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
163412216|NCT01414257|590216826|FG000|Overall Study|No Visit After First Day of Treatment|12|||
163412217|NCT01414257|590216826|FG000|Overall Study|Protocol Violation|10|||
163412218|NCT01978093|590216827|FG000|Overall Study|Death|1|||
163412219|NCT01978093|590216828|FG001|Overall Study|Death|0|||
163412220|NCT01978093|590216827|FG000|Overall Study|Adverse Event|0|||
163412221|NCT01978093|590216828|FG001|Overall Study|Adverse Event|5|||
163412222|NCT01978093|590216827|FG000|Overall Study|Protocol Violation|8|||
163365392|NCT01174446|590048384|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
163365393|NCT01174446|590048385|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
163365394|NCT01174446|590048382|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
163365395|NCT01174446|590048383|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
163365396|NCT01174446|590048384|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
163365397|NCT01174446|590048385|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
163365398|NCT00847626|590048388|FG000|Overall Study|Adverse Event|10|||
163365399|NCT00847626|590048389|FG001|Overall Study|Adverse Event|10|||
163365400|NCT00847626|590048390|FG002|Overall Study|Adverse Event|6|||
163365401|NCT00847626|590048391|FG003|Overall Study|Adverse Event|19|||
163365402|NCT00847626|590048392|FG004|Overall Study|Adverse Event|11|||
163365403|NCT00847626|590048393|FG005|Overall Study|Adverse Event|22|||
163365404|NCT00847626|590048394|FG006|Overall Study|Adverse Event|4|||
163365405|NCT00847626|590048395|FG007|Overall Study|Adverse Event|6|||
163365406|NCT00847626|590048396|FG008|Overall Study|Adverse Event|3|||
163365407|NCT00847626|590048397|FG009|Overall Study|Adverse Event|6|||
163365408|NCT00847626|590048398|FG010|Overall Study|Adverse Event|6|||
163365409|NCT00847626|590048388|FG000|Overall Study|Protocol Violation|2|||
163365410|NCT00847626|590048389|FG001|Overall Study|Protocol Violation|1|||
163365411|NCT00847626|590048390|FG002|Overall Study|Protocol Violation|2|||
163365412|NCT00847626|590048391|FG003|Overall Study|Protocol Violation|1|||
163365413|NCT00847626|590048392|FG004|Overall Study|Protocol Violation|1|||
163365414|NCT00847626|590048393|FG005|Overall Study|Protocol Violation|1|||
163365415|NCT00847626|590048394|FG006|Overall Study|Protocol Violation|1|||
163365416|NCT00847626|590048395|FG007|Overall Study|Protocol Violation|1|||
163365417|NCT00847626|590048396|FG008|Overall Study|Protocol Violation|0|||
163365418|NCT00847626|590048397|FG009|Overall Study|Protocol Violation|1|||
163365419|NCT00847626|590048398|FG010|Overall Study|Protocol Violation|1|||
163365420|NCT00847626|590048388|FG000|Overall Study|Lost to Follow-up|0|||
163365421|NCT00847626|590048389|FG001|Overall Study|Lost to Follow-up|1|||
163365422|NCT00847626|590048390|FG002|Overall Study|Lost to Follow-up|1|||
163365423|NCT00847626|590048391|FG003|Overall Study|Lost to Follow-up|1|||
163412223|NCT01978093|590216828|FG001|Overall Study|Protocol Violation|2|||
163412224|NCT01978093|590216827|FG000|Overall Study|Withdrawal by Subject|29|||
163412225|NCT01978093|590216828|FG001|Overall Study|Withdrawal by Subject|25|||
163412226|NCT01978093|590216827|FG000|Overall Study|Lost to Follow-up|11|||
163412227|NCT01978093|590216828|FG001|Overall Study|Lost to Follow-up|15|||
163412228|NCT01978093|590216827|FG000|Overall Study|Migrated/moved from study area|11|||
163365424|NCT00847626|590048392|FG004|Overall Study|Lost to Follow-up|0|||
163365425|NCT00847626|590048393|FG005|Overall Study|Lost to Follow-up|3|||
163365426|NCT00847626|590048394|FG006|Overall Study|Lost to Follow-up|1|||
163365427|NCT00847626|590048395|FG007|Overall Study|Lost to Follow-up|3|||
163365428|NCT00847626|590048396|FG008|Overall Study|Lost to Follow-up|1|||
163365429|NCT00847626|590048397|FG009|Overall Study|Lost to Follow-up|0|||
163365430|NCT00847626|590048398|FG010|Overall Study|Lost to Follow-up|1|||
163365431|NCT00847626|590048388|FG000|Overall Study|Withdrawal by Subject|5|||
163365432|NCT00847626|590048389|FG001|Overall Study|Withdrawal by Subject|5|||
163412229|NCT01978093|590216828|FG001|Overall Study|Migrated/moved from study area|13|||
163412230|NCT01978093|590216827|FG000|Overall Study|Loss of kaiser coverage|4|||
163412231|NCT01978093|590216828|FG001|Overall Study|Loss of kaiser coverage|10|||
163365433|NCT00847626|590048390|FG002|Overall Study|Withdrawal by Subject|3|||
163365434|NCT00847626|590048391|FG003|Overall Study|Withdrawal by Subject|8|||
163365435|NCT00847626|590048392|FG004|Overall Study|Withdrawal by Subject|12|||
163365436|NCT00847626|590048393|FG005|Overall Study|Withdrawal by Subject|9|||
163365437|NCT00847626|590048394|FG006|Overall Study|Withdrawal by Subject|8|||
163365438|NCT00847626|590048395|FG007|Overall Study|Withdrawal by Subject|4|||
163365439|NCT00847626|590048396|FG008|Overall Study|Withdrawal by Subject|4|||
163365440|NCT00847626|590048397|FG009|Overall Study|Withdrawal by Subject|5|||
163365441|NCT00847626|590048398|FG010|Overall Study|Withdrawal by Subject|2|||
163365442|NCT00847626|590048388|FG000|Overall Study|Lack of Efficacy|3|||
163365443|NCT00847626|590048389|FG001|Overall Study|Lack of Efficacy|1|||
163365444|NCT00847626|590048390|FG002|Overall Study|Lack of Efficacy|0|||
163365445|NCT00847626|590048391|FG003|Overall Study|Lack of Efficacy|1|||
163365446|NCT00847626|590048392|FG004|Overall Study|Lack of Efficacy|2|||
163365447|NCT00847626|590048393|FG005|Overall Study|Lack of Efficacy|0|||
163365448|NCT00847626|590048394|FG006|Overall Study|Lack of Efficacy|6|||
163365449|NCT00847626|590048395|FG007|Overall Study|Lack of Efficacy|2|||
163365450|NCT00847626|590048396|FG008|Overall Study|Lack of Efficacy|5|||
163365451|NCT00847626|590048397|FG009|Overall Study|Lack of Efficacy|1|||
163365452|NCT00847626|590048398|FG010|Overall Study|Lack of Efficacy|7|||
163365453|NCT00847626|590048388|FG000|Overall Study|Other|1|||
163365454|NCT00847626|590048389|FG001|Overall Study|Other|5|||
163365455|NCT00847626|590048390|FG002|Overall Study|Other|4|||
163365456|NCT00847626|590048391|FG003|Overall Study|Other|1|||
163365457|NCT00847626|590048392|FG004|Overall Study|Other|2|||
163365458|NCT00847626|590048393|FG005|Overall Study|Other|2|||
163365459|NCT00847626|590048394|FG006|Overall Study|Other|2|||
163365460|NCT00847626|590048395|FG007|Overall Study|Other|3|||
163365461|NCT00847626|590048396|FG008|Overall Study|Other|1|||
163365462|NCT00847626|590048397|FG009|Overall Study|Other|1|||
163365463|NCT00847626|590048398|FG010|Overall Study|Other|3|||
163365464|NCT03301155|590048399|FG000|Overall Study|Сompliance with exclusion criteria|8|||
163365465|NCT03301155|590048400|FG001|Overall Study|Сompliance with exclusion criteria|7|||
163365466|NCT03510455|590048403|FG000|Overall Study|Physician Decision|1|||
163365467|NCT00384189|590048407|FG000|Overall Study|Reason Not Specified|50|||
163365468|NCT00384189|590048408|FG001|Overall Study|Reason Not Specified|57|||
163365469|NCT00384189|590048409|FG002|Overall Study|Reason Not Specified|58|||
163365470|NCT00384189|590048410|FG003|Overall Study|Reason Not Specified|40|||
163365471|NCT04958642|590048411|FG000|Overall Study|Transferred to OLEX program|3|||
163365472|NCT04958642|590048412|FG001|Overall Study|Transferred to OLEX program|0|||
163365473|NCT04958642|590048413|FG002|Overall Study|Transferred to OLEX program|5|||
163365474|NCT04958642|590048411|FG000|Overall Study|Death|0|||
163365475|NCT04958642|590048412|FG001|Overall Study|Death|0|||
163365476|NCT04958642|590048413|FG002|Overall Study|Death|1|||
163365477|NCT04958642|590048411|FG000|Overall Study|Withdrawal by Subject|4|||
163365478|NCT04958642|590048412|FG001|Overall Study|Withdrawal by Subject|9|||
163365479|NCT04958642|590048413|FG002|Overall Study|Withdrawal by Subject|13|||
163365480|NCT04958642|590048411|FG000|Overall Study|Investigator's Decision|0|||
163365481|NCT04958642|590048412|FG001|Overall Study|Investigator's Decision|0|||
163365482|NCT04958642|590048413|FG002|Overall Study|Investigator's Decision|1|||
163365483|NCT04958642|590048411|FG000|Overall Study|Adverse Event|1|||
163365484|NCT04958642|590048412|FG001|Overall Study|Adverse Event|0|||
163365485|NCT04958642|590048413|FG002|Overall Study|Adverse Event|1|||
163365486|NCT04958642|590048411|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
163365487|NCT04958642|590048412|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
163365488|NCT04958642|590048413|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
163365489|NCT04958642|590048411|FG000|Overall Study|Lost to Follow-up|1|||
163365490|NCT04958642|590048412|FG001|Overall Study|Lost to Follow-up|0|||
163365491|NCT04958642|590048413|FG002|Overall Study|Lost to Follow-up|0|||
163365492|NCT04958642|590048411|FG000|Overall Study|Transferred to EAP following study termination|0|||
163365493|NCT04958642|590048412|FG001|Overall Study|Transferred to EAP following study termination|0|||
163365494|NCT04958642|590048413|FG002|Overall Study|Transferred to EAP following study termination|1|||
163365495|NCT04958642|590048411|FG000|Overall Study|Transferred to Expanded Access Program|1|||
163365496|NCT04958642|590048412|FG001|Overall Study|Transferred to Expanded Access Program|0|||
163365497|NCT04958642|590048413|FG002|Overall Study|Transferred to Expanded Access Program|0|||
163365498|NCT02942004|590048414|FG000|Overall Study|Withdrawal by Subject|0|||
163412232|NCT01978093|590216827|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
163365499|NCT02942004|590048415|FG001|Overall Study|Withdrawal by Subject|2|||
163412233|NCT01978093|590216828|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
163412234|NCT01978093|590216827|FG000|Overall Study|Mother lost custody of child|0|||
163365500|NCT02942004|590048416|FG002|Overall Study|Withdrawal by Subject|3|||
163365501|NCT02942004|590048414|FG000|Overall Study|Lost to Follow-up|1|||
163365502|NCT02942004|590048415|FG001|Overall Study|Lost to Follow-up|1|||
163365503|NCT02942004|590048416|FG002|Overall Study|Lost to Follow-up|2|||
163365504|NCT02942004|590048414|FG000|Overall Study|Randomized but not dosed|3|||
163365505|NCT02942004|590048415|FG001|Overall Study|Randomized but not dosed|9|||
163365506|NCT02942004|590048416|FG002|Overall Study|Randomized but not dosed|4|||
163365507|NCT05627258|590048417|FG000|Overall Study|Lost to Follow-up|1|||
163365508|NCT05627258|590048418|FG001|Overall Study|Lost to Follow-up|0|||
163365509|NCT05627258|590048419|FG002|Overall Study|Lost to Follow-up|0|||
163365510|NCT05627258|590048420|FG003|Overall Study|Lost to Follow-up|0|||
163365511|NCT05627258|590048421|FG004|Overall Study|Lost to Follow-up|0|||
163365512|NCT05627258|590048422|FG005|Overall Study|Lost to Follow-up|0|||
163365513|NCT05627258|590048417|FG000|Overall Study|Withdrawal by Subject|0|||
163365514|NCT05627258|590048418|FG001|Overall Study|Withdrawal by Subject|0|||
163365515|NCT05627258|590048419|FG002|Overall Study|Withdrawal by Subject|0|||
163365516|NCT05627258|590048420|FG003|Overall Study|Withdrawal by Subject|0|||
163365517|NCT05627258|590048421|FG004|Overall Study|Withdrawal by Subject|2|||
163365518|NCT05627258|590048422|FG005|Overall Study|Withdrawal by Subject|0|||
163365519|NCT05627258|590048417|FG000|Overall Study|Enrolled, but product not administered|1|||
163365520|NCT05627258|590048418|FG001|Overall Study|Enrolled, but product not administered|0|||
163365521|NCT05627258|590048419|FG002|Overall Study|Enrolled, but product not administered|0|||
163365522|NCT05627258|590048420|FG003|Overall Study|Enrolled, but product not administered|0|||
163365523|NCT05627258|590048421|FG004|Overall Study|Enrolled, but product not administered|0|||
163365524|NCT05627258|590048422|FG005|Overall Study|Enrolled, but product not administered|0|||
163365525|NCT05627258|590048417|FG000|Overall Study|Other subject illness/injury|1|||
163365526|NCT05627258|590048418|FG001|Overall Study|Other subject illness/injury|0|||
163365527|NCT05627258|590048419|FG002|Overall Study|Other subject illness/injury|0|||
163365528|NCT05627258|590048420|FG003|Overall Study|Other subject illness/injury|0|||
163365529|NCT05627258|590048421|FG004|Overall Study|Other subject illness/injury|0|||
163365530|NCT05627258|590048422|FG005|Overall Study|Other subject illness/injury|0|||
163365531|NCT05627258|590048417|FG000|Overall Study|Subject moved from area|0|||
163365532|NCT05627258|590048418|FG001|Overall Study|Subject moved from area|0|||
163365533|NCT05627258|590048419|FG002|Overall Study|Subject moved from area|1|||
163365534|NCT05627258|590048420|FG003|Overall Study|Subject moved from area|0|||
163365535|NCT05627258|590048421|FG004|Overall Study|Subject moved from area|0|||
163365536|NCT05627258|590048422|FG005|Overall Study|Subject moved from area|0|||
163365537|NCT04517669|590048423|FG000|Overall Study|Lost to Follow-up|2|||
163365538|NCT04517669|590048423|FG000|Overall Study|Withdrawal by Subject|3|||
163365539|NCT04517669|590048423|FG000|Overall Study|Drug withdrawn|44|||
163365540|NCT04517669|590048423|FG000|Overall Study|Other|1|||
163365541|NCT04517669|590048423|FG000|Overall Study|Eligibility criteria not met|4|||
163365542|NCT04517669|590048423|FG000|Overall Study|Did not receive treatment|3|||
163365543|NCT02138786|590048424|FG000|Overall Study|Adverse Event|0|||
163365544|NCT02138786|590048425|FG001|Overall Study|Adverse Event|2|||
163365545|NCT02138786|590048426|FG002|Overall Study|Adverse Event|1|||
163365546|NCT02138786|590048424|FG000|Overall Study|Death|1|||
163365547|NCT02138786|590048425|FG001|Overall Study|Death|7|||
163365548|NCT02138786|590048426|FG002|Overall Study|Death|2|||
163365549|NCT02138786|590048424|FG000|Overall Study|Disease Progression|1|||
163365550|NCT02138786|590048425|FG001|Overall Study|Disease Progression|1|||
163365551|NCT02138786|590048426|FG002|Overall Study|Disease Progression|3|||
163365552|NCT02138786|590048424|FG000|Overall Study|Withdrawal by Subject|1|||
163365553|NCT02138786|590048425|FG001|Overall Study|Withdrawal by Subject|2|||
163365554|NCT02138786|590048426|FG002|Overall Study|Withdrawal by Subject|0|||
163365555|NCT02138786|590048424|FG000|Overall Study|Patient's Wish|0|||
163365556|NCT02138786|590048425|FG001|Overall Study|Patient's Wish|2|||
163365557|NCT02138786|590048426|FG002|Overall Study|Patient's Wish|0|||
163365558|NCT02138786|590048424|FG000|Overall Study|Sponsor Terminated Study|0|||
163365559|NCT02138786|590048425|FG001|Overall Study|Sponsor Terminated Study|1|||
163365560|NCT02138786|590048426|FG002|Overall Study|Sponsor Terminated Study|1|||
163365561|NCT02138786|590048424|FG000|Overall Study|Non-Compliance|0|||
163365562|NCT02138786|590048425|FG001|Overall Study|Non-Compliance|0|||
163365563|NCT02138786|590048426|FG002|Overall Study|Non-Compliance|1|||
163365564|NCT01923662|590048427|FG000|Overall Study|Withdrawal by Subject|1|||
163365565|NCT01199068|590048428|FG000|Overall Study|Unacceptable toxicity|0|||
163365566|NCT01199068|590048429|FG001|Overall Study|Unacceptable toxicity|0|||
163365567|NCT01199068|590048430|FG002|Overall Study|Unacceptable toxicity|2|||
163365568|NCT01199068|590048428|FG000|Overall Study|Progressive disease|3|||
163365569|NCT01199068|590048429|FG001|Overall Study|Progressive disease|3|||
163365570|NCT01199068|590048430|FG002|Overall Study|Progressive disease|6|||
163365571|NCT01199068|590048428|FG000|Overall Study|Withdrawal by Subject|0|||
163365572|NCT01199068|590048429|FG001|Overall Study|Withdrawal by Subject|0|||
163365573|NCT01199068|590048430|FG002|Overall Study|Withdrawal by Subject|1|||
163365574|NCT05048238|590048431|FG000|Overall Study|Withdrawal by Subject|1|||
163365575|NCT02224703|590048440|FG000|Overall Study|Adverse Event|0|||
163365576|NCT02224703|590048441|FG001|Overall Study|Adverse Event|5|||
163365577|NCT02224703|590048442|FG002|Overall Study|Adverse Event|0|||
163365578|NCT02224703|590048440|FG000|Overall Study|Withdrawn by investigator|1|||
163365579|NCT02224703|590048441|FG001|Overall Study|Withdrawn by investigator|0|||
163365580|NCT02224703|590048442|FG002|Overall Study|Withdrawn by investigator|0|||
163365581|NCT02224703|590048440|FG000|Overall Study|Advised by medical monitor|1|||
163365582|NCT02224703|590048441|FG001|Overall Study|Advised by medical monitor|0|||
163365583|NCT02224703|590048442|FG002|Overall Study|Advised by medical monitor|0|||
163365584|NCT02224703|590048440|FG000|Overall Study|Withdrawn by parent/guardian|0|||
163365585|NCT02224703|590048441|FG001|Overall Study|Withdrawn by parent/guardian|1|||
163365586|NCT02224703|590048442|FG002|Overall Study|Withdrawn by parent/guardian|0|||
163365587|NCT02224703|590048440|FG000|Overall Study|Lack of Efficacy|1|||
163365588|NCT02224703|590048441|FG001|Overall Study|Lack of Efficacy|0|||
163365589|NCT02224703|590048442|FG002|Overall Study|Lack of Efficacy|0|||
163365590|NCT02057575|590048443|FG000|Overall Study|Adverse Event|0|||
163365591|NCT02057575|590048444|FG001|Overall Study|Adverse Event|2|||
163365592|NCT02057575|590048445|FG002|Overall Study|Adverse Event|0|||
163365593|NCT02057575|590048446|FG003|Overall Study|Adverse Event|1|||
163365594|NCT02057575|590048443|FG000|Overall Study|Withdrawal by Subject|1|||
163365595|NCT02057575|590048444|FG001|Overall Study|Withdrawal by Subject|0|||
163365596|NCT02057575|590048445|FG002|Overall Study|Withdrawal by Subject|0|||
163365597|NCT02057575|590048446|FG003|Overall Study|Withdrawal by Subject|0|||
163365598|NCT02057575|590048443|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
163365599|NCT02057575|590048444|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
163365600|NCT02057575|590048445|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
163365601|NCT02057575|590048446|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
163365602|NCT02057575|590048443|FG000|Overall Study|Protocol Violation|0|||
163365603|NCT02057575|590048444|FG001|Overall Study|Protocol Violation|1|||
163365604|NCT02057575|590048445|FG002|Overall Study|Protocol Violation|0|||
163365605|NCT02057575|590048446|FG003|Overall Study|Protocol Violation|0|||
163365606|NCT00332462|590048447|FG000|Overall Study|Adverse Event|5|||
163365607|NCT00332462|590048447|FG000|Overall Study|Abnormal Lab Value|1|||
163365608|NCT00332462|590048447|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
163365609|NCT00332462|590048447|FG000|Overall Study|no longer requires study drug|1|||
163365610|NCT00332462|590048447|FG000|Overall Study|Death|3|||
163365611|NCT00332462|590048447|FG000|Overall Study|Graft Loss|2|||
163365612|NCT02922023|590048452|FG000|Overall Study|Lost to Follow-up|2|||
163365613|NCT02922023|590048453|FG001|Overall Study|Lost to Follow-up|0|||
163365614|NCT00863681|590048454|FG000|Overall Study|Other|2|||
163365615|NCT00863681|590048455|FG001|Overall Study|Other|0|||
163365616|NCT00863681|590048456|FG002|Overall Study|Other|0|||
163365617|NCT00863681|590048454|FG000|Overall Study|Missing|1|||
163365618|NCT00863681|590048455|FG001|Overall Study|Missing|0|||
163365619|NCT00863681|590048456|FG002|Overall Study|Missing|0|||
163365620|NCT00863681|590048454|FG000|Overall Study|Death|40|||
163365621|NCT00863681|590048455|FG001|Overall Study|Death|23|||
163365622|NCT00863681|590048456|FG002|Overall Study|Death|6|||
163365623|NCT00863681|590048454|FG000|Overall Study|Withdrawal by Subject|12|||
163365624|NCT00863681|590048455|FG001|Overall Study|Withdrawal by Subject|5|||
163365625|NCT00863681|590048456|FG002|Overall Study|Withdrawal by Subject|2|||
163365626|NCT00863681|590048454|FG000|Overall Study|Protocol Violation|2|||
163365627|NCT00863681|590048455|FG001|Overall Study|Protocol Violation|0|||
163365628|NCT00863681|590048456|FG002|Overall Study|Protocol Violation|0|||
163365629|NCT00863681|590048454|FG000|Overall Study|Lost to Follow-up|3|||
163365630|NCT00863681|590048455|FG001|Overall Study|Lost to Follow-up|0|||
163365631|NCT00863681|590048456|FG002|Overall Study|Lost to Follow-up|3|||
163365632|NCT00863681|590048454|FG000|Overall Study|Adverse Event|28|||
163365633|NCT00863681|590048455|FG001|Overall Study|Adverse Event|10|||
163365634|NCT00863681|590048456|FG002|Overall Study|Adverse Event|6|||
163365635|NCT00863681|590048454|FG000|Overall Study|Lack of Efficacy|2|||
163365636|NCT00863681|590048455|FG001|Overall Study|Lack of Efficacy|2|||
163365637|NCT00863681|590048456|FG002|Overall Study|Lack of Efficacy|1|||
163365638|NCT00863681|590048454|FG000|Overall Study|Non-compliance with study drug|1|||
163365639|NCT00863681|590048455|FG001|Overall Study|Non-compliance with study drug|3|||
163365640|NCT00863681|590048456|FG002|Overall Study|Non-compliance with study drug|0|||
163365641|NCT02159040|590048457|FG000|Overall Study|Death|1|||
163365642|NCT02766777|590048461|FG000|Overall Study|Adverse Event|12|||
163365643|NCT02766777|590048461|FG000|Overall Study|Lost to Follow-up|16|||
163365644|NCT02766777|590048461|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163365645|NCT02766777|590048461|FG000|Overall Study|Protocol Violation|1|||
163365646|NCT02766777|590048461|FG000|Overall Study|Withdrawal by Subject|4|||
163365647|NCT01886287|590048462|FG000|Overall Study|Radiographic disease progression|1|||
163365648|NCT01886287|590048462|FG000|Overall Study|Clinical progression due to disease|1|||
163365649|NCT01371825|590048466|FG000|Overall Study|Death|4|||
163365650|NCT00895895|590048467|FG000|Period 1|Adverse Event|7|||
163365651|NCT00895895|590048468|FG001|Period 1|Adverse Event|6|||
163365652|NCT00895895|590048469|FG002|Period 1|Adverse Event|4|||
163365653|NCT00895895|590048470|FG003|Period 1|Adverse Event|6|||
163365654|NCT00895895|590048471|FG004|Period 1|Adverse Event|7|||
163365655|NCT00895895|590048467|FG000|Period 1|Death|0|||
163365656|NCT00895895|590048468|FG001|Period 1|Death|0|||
163365657|NCT00895895|590048469|FG002|Period 1|Death|0|||
163365658|NCT00895895|590048470|FG003|Period 1|Death|0|||
163365659|NCT00895895|590048471|FG004|Period 1|Death|1|||
163365660|NCT00895895|590048467|FG000|Period 1|discontinued by sponsor|2|||
163365661|NCT00895895|590048468|FG001|Period 1|discontinued by sponsor|1|||
163365662|NCT00895895|590048469|FG002|Period 1|discontinued by sponsor|2|||
163365663|NCT00895895|590048470|FG003|Period 1|discontinued by sponsor|1|||
163365664|NCT00895895|590048471|FG004|Period 1|discontinued by sponsor|1|||
163365665|NCT00895895|590048467|FG000|Period 1|failed to return|0|||
163365666|NCT00895895|590048468|FG001|Period 1|failed to return|0|||
163365667|NCT00895895|590048469|FG002|Period 1|failed to return|1|||
163365668|NCT00895895|590048470|FG003|Period 1|failed to return|0|||
163365669|NCT00895895|590048471|FG004|Period 1|failed to return|1|||
163365670|NCT00895895|590048467|FG000|Period 1|investigator request|0|||
163365671|NCT00895895|590048468|FG001|Period 1|investigator request|1|||
163365672|NCT00895895|590048469|FG002|Period 1|investigator request|0|||
163365673|NCT00895895|590048470|FG003|Period 1|investigator request|0|||
163365674|NCT00895895|590048471|FG004|Period 1|investigator request|0|||
163365675|NCT00895895|590048467|FG000|Period 1|Lost to Follow-up|2|||
163365676|NCT00895895|590048468|FG001|Period 1|Lost to Follow-up|1|||
163365677|NCT00895895|590048469|FG002|Period 1|Lost to Follow-up|3|||
163365678|NCT00895895|590048470|FG003|Period 1|Lost to Follow-up|2|||
163365679|NCT00895895|590048471|FG004|Period 1|Lost to Follow-up|3|||
163365680|NCT00895895|590048467|FG000|Period 1|Other|1|||
163365681|NCT00895895|590048468|FG001|Period 1|Other|2|||
163365682|NCT00895895|590048469|FG002|Period 1|Other|1|||
163365683|NCT00895895|590048470|FG003|Period 1|Other|1|||
163365684|NCT00895895|590048471|FG004|Period 1|Other|1|||
163365685|NCT00895895|590048467|FG000|Period 1|Protocol Violation|0|||
163365686|NCT00895895|590048468|FG001|Period 1|Protocol Violation|1|||
163365687|NCT00895895|590048469|FG002|Period 1|Protocol Violation|0|||
163365688|NCT00895895|590048470|FG003|Period 1|Protocol Violation|0|||
163365689|NCT00895895|590048471|FG004|Period 1|Protocol Violation|0|||
163365690|NCT00895895|590048467|FG000|Period 1|Withdrawal by Subject|6|||
163365691|NCT00895895|590048468|FG001|Period 1|Withdrawal by Subject|6|||
163365692|NCT00895895|590048469|FG002|Period 1|Withdrawal by Subject|8|||
163365693|NCT00895895|590048470|FG003|Period 1|Withdrawal by Subject|2|||
163365694|NCT00895895|590048471|FG004|Period 1|Withdrawal by Subject|4|||
163365695|NCT00895895|590048467|FG000|Period 1|unsatisfactory response-efficacy|2|||
163365696|NCT00895895|590048468|FG001|Period 1|unsatisfactory response-efficacy|0|||
163365697|NCT00895895|590048469|FG002|Period 1|unsatisfactory response-efficacy|0|||
163365698|NCT00895895|590048470|FG003|Period 1|unsatisfactory response-efficacy|0|||
163365699|NCT00895895|590048471|FG004|Period 1|unsatisfactory response-efficacy|0|||
163365700|NCT00895895|590048467|FG000|Period 1|randomized and not treated|1|||
163365701|NCT00895895|590048468|FG001|Period 1|randomized and not treated|3|||
163365702|NCT00895895|590048469|FG002|Period 1|randomized and not treated|1|||
163365703|NCT00895895|590048470|FG003|Period 1|randomized and not treated|1|||
163365704|NCT00895895|590048471|FG004|Period 1|randomized and not treated|2|||
163365705|NCT00895895|590048467|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
163365706|NCT00895895|590048468|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
163365707|NCT00895895|590048469|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
163365708|NCT00895895|590048470|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
163365709|NCT00895895|590048471|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
163365710|NCT00895895|590048467|FG000|After Period 1, Prior to Period 2|Other|0|||
163365711|NCT00895895|590048468|FG001|After Period 1, Prior to Period 2|Other|0|||
163365712|NCT00895895|590048469|FG002|After Period 1, Prior to Period 2|Other|1|||
163365713|NCT00895895|590048470|FG003|After Period 1, Prior to Period 2|Other|0|||
163365714|NCT00895895|590048471|FG004|After Period 1, Prior to Period 2|Other|0|||
163365715|NCT00895895|590048467|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
163365716|NCT00895895|590048468|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
163365717|NCT00895895|590048469|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
163365718|NCT00895895|590048470|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
163365719|NCT00895895|590048471|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
163365720|NCT00895895|590048467|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
163365721|NCT00895895|590048468|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
163365722|NCT00895895|590048469|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
163365723|NCT00895895|590048470|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
163365724|NCT00895895|590048471|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
163365725|NCT00895895|590048467|FG000|Period 2|Adverse Event|3|||
163365726|NCT00895895|590048468|FG001|Period 2|Adverse Event|3|||
163365727|NCT00895895|590048469|FG002|Period 2|Adverse Event|5|||
163365728|NCT00895895|590048470|FG003|Period 2|Adverse Event|2|||
163365729|NCT00895895|590048471|FG004|Period 2|Adverse Event|5|||
163365730|NCT00895895|590048467|FG000|Period 2|Death|0|||
163365731|NCT00895895|590048468|FG001|Period 2|Death|0|||
163365732|NCT00895895|590048469|FG002|Period 2|Death|1|||
163365733|NCT00895895|590048470|FG003|Period 2|Death|0|||
163365734|NCT00895895|590048471|FG004|Period 2|Death|0|||
163365735|NCT00895895|590048467|FG000|Period 2|discontinued by sponsor|44|||
163365736|NCT00895895|590048468|FG001|Period 2|discontinued by sponsor|44|||
163365737|NCT00895895|590048469|FG002|Period 2|discontinued by sponsor|38|||
163365738|NCT00895895|590048470|FG003|Period 2|discontinued by sponsor|46|||
163365739|NCT00895895|590048471|FG004|Period 2|discontinued by sponsor|37|||
163365740|NCT00895895|590048467|FG000|Period 2|failed to return|2|||
163412235|NCT01978093|590216828|FG001|Overall Study|Mother lost custody of child|1|||
163412236|NCT01978093|590216827|FG000|Overall Study|Child was in care of grandmother|0|||
163412237|NCT01978093|590216828|FG001|Overall Study|Child was in care of grandmother|1|||
163412238|NCT01978093|590216827|FG000|Overall Study|N/A for vaccine administration|0|||
163412239|NCT01978093|590216828|FG001|Overall Study|N/A for vaccine administration|1|||
163412240|NCT03124784|590216833|FG000|Overall Study|Adverse Event|1|||
163412241|NCT03124784|590216833|FG000|Overall Study|Computer/Equip Malfunction|1|||
163412242|NCT02450487|590216836|FG000|Overall Study|Lost to Follow-up|3|||
163412243|NCT05587296|590216837|FG000|Overall Study|Adverse Event|15|||
163412244|NCT05587296|590216838|FG001|Overall Study|Adverse Event|7|||
163412245|NCT05587296|590216837|FG000|Overall Study|Lack of Efficacy|2|||
163412246|NCT05587296|590216838|FG001|Overall Study|Lack of Efficacy|0|||
163412247|NCT05587296|590216837|FG000|Overall Study|Lost to Follow-up|1|||
163412248|NCT05587296|590216838|FG001|Overall Study|Lost to Follow-up|0|||
163412249|NCT05587296|590216837|FG000|Overall Study|Withdrawal by Subject|14|||
163412250|NCT05587296|590216838|FG001|Overall Study|Withdrawal by Subject|4|||
163412251|NCT05587296|590216837|FG000|Overall Study|miscellaneous|3|||
163412252|NCT05587296|590216838|FG001|Overall Study|miscellaneous|6|||
163412253|NCT05587296|590216837|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
163412254|NCT05587296|590216838|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
163412255|NCT02847624|590216841|FG000|Overall Study|Lost to Follow-up|28|||
163412256|NCT02847624|590216841|FG000|Overall Study|Protocol Violation|98|||
163412257|NCT02847624|590216841|FG000|Overall Study|Case report failures|4|||
163412258|NCT04735653|590216842|FG000|Overall Study|Lost to Follow-up|17|||
163412259|NCT04735653|590216843|FG001|Overall Study|Lost to Follow-up|7|||
163412260|NCT04735653|590216842|FG000|Overall Study|Withdrawal by Subject|8|||
163412261|NCT04735653|590216843|FG001|Overall Study|Withdrawal by Subject|2|||
163412262|NCT04735653|590216842|FG000|Overall Study|Death|0|||
163412263|NCT04735653|590216843|FG001|Overall Study|Death|2|||
163412264|NCT04735653|590216842|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
163412265|NCT04735653|590216843|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
163412266|NCT03033745|590216849|FG000|Overall Study|Protocol Violation|0|||
163412267|NCT03033745|590216850|FG001|Overall Study|Protocol Violation|0|||
163412268|NCT03033745|590216851|FG002|Overall Study|Protocol Violation|1|||
163412269|NCT03033745|590216849|FG000|Overall Study|Adverse Event|1|||
163412270|NCT03033745|590216850|FG001|Overall Study|Adverse Event|0|||
163412271|NCT03033745|590216851|FG002|Overall Study|Adverse Event|1|||
163412272|NCT03033745|590216849|FG000|Overall Study|Withdrawal by Subject|0|||
163412273|NCT03033745|590216850|FG001|Overall Study|Withdrawal by Subject|1|||
163412274|NCT03033745|590216851|FG002|Overall Study|Withdrawal by Subject|0|||
163412275|NCT03728309|590216855|FG000|Overall Study|Randomized but not Treated|0|||
163412276|NCT03728309|590216856|FG001|Overall Study|Randomized but not Treated|1|||
163412277|NCT03728309|590216855|FG000|Overall Study|Adverse Event|0|||
163412278|NCT03728309|590216856|FG001|Overall Study|Adverse Event|1|||
163412279|NCT03728309|590216855|FG000|Overall Study|Withdrawal by Subject|2|||
163412280|NCT03728309|590216856|FG001|Overall Study|Withdrawal by Subject|8|||
163412281|NCT03728309|590216855|FG000|Overall Study|Lost to Follow-up|9|||
163412282|NCT03728309|590216856|FG001|Overall Study|Lost to Follow-up|10|||
163412283|NCT03728309|590216855|FG000|Overall Study|Protocol Deviation|0|||
163412284|NCT03728309|590216856|FG001|Overall Study|Protocol Deviation|1|||
163412285|NCT03728309|590216855|FG000|Overall Study|Due to COVID|1|||
163412286|NCT03728309|590216856|FG001|Overall Study|Due to COVID|3|||
163412287|NCT03403205|590216857|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
163412288|NCT03403205|590216858|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
163412289|NCT03403205|590216859|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
163412290|NCT03403205|590216860|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
163412291|NCT03403205|590216861|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
163412292|NCT03403205|590216862|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
163412293|NCT03403205|590216857|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
163412294|NCT03403205|590216858|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163412295|NCT03403205|590216859|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
163412296|NCT03403205|590216860|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163412297|NCT03403205|590216861|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163412298|NCT03403205|590216862|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163412299|NCT03403205|590216857|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
163412300|NCT03403205|590216858|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
163412301|NCT03403205|590216859|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
163412302|NCT03403205|590216860|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
163412303|NCT03403205|590216861|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
163412304|NCT03403205|590216862|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
163412305|NCT03403205|590216857|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
163412306|NCT03403205|590216858|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
163365741|NCT00895895|590048468|FG001|Period 2|failed to return|0|||
163365742|NCT00895895|590048469|FG002|Period 2|failed to return|0|||
163365743|NCT00895895|590048470|FG003|Period 2|failed to return|0|||
163365744|NCT00895895|590048471|FG004|Period 2|failed to return|0|||
163365745|NCT00895895|590048467|FG000|Period 2|investigator request|2|||
163365746|NCT00895895|590048468|FG001|Period 2|investigator request|0|||
163365747|NCT00895895|590048469|FG002|Period 2|investigator request|0|||
163365748|NCT00895895|590048470|FG003|Period 2|investigator request|0|||
163365749|NCT00895895|590048471|FG004|Period 2|investigator request|0|||
163365750|NCT00895895|590048467|FG000|Period 2|Lost to Follow-up|1|||
163365751|NCT00895895|590048468|FG001|Period 2|Lost to Follow-up|2|||
163365752|NCT00895895|590048469|FG002|Period 2|Lost to Follow-up|1|||
163365753|NCT00895895|590048470|FG003|Period 2|Lost to Follow-up|1|||
163365754|NCT00895895|590048471|FG004|Period 2|Lost to Follow-up|0|||
163365755|NCT00895895|590048467|FG000|Period 2|Other|1|||
163365756|NCT00895895|590048468|FG001|Period 2|Other|1|||
163365757|NCT00895895|590048469|FG002|Period 2|Other|3|||
163365758|NCT00895895|590048470|FG003|Period 2|Other|1|||
163365759|NCT00895895|590048471|FG004|Period 2|Other|1|||
163365760|NCT00895895|590048467|FG000|Period 2|Protocol Violation|1|||
163365761|NCT00895895|590048468|FG001|Period 2|Protocol Violation|0|||
163365762|NCT00895895|590048469|FG002|Period 2|Protocol Violation|1|||
163365763|NCT00895895|590048470|FG003|Period 2|Protocol Violation|1|||
163365764|NCT00895895|590048471|FG004|Period 2|Protocol Violation|1|||
163365765|NCT00895895|590048467|FG000|Period 2|Withdrawal by Subject|0|||
163365766|NCT00895895|590048468|FG001|Period 2|Withdrawal by Subject|2|||
163365767|NCT00895895|590048469|FG002|Period 2|Withdrawal by Subject|0|||
163365768|NCT00895895|590048470|FG003|Period 2|Withdrawal by Subject|3|||
163365769|NCT00895895|590048471|FG004|Period 2|Withdrawal by Subject|5|||
163365770|NCT00895895|590048467|FG000|Period 2|unsatisfactory response-efficacy|2|||
163365771|NCT00895895|590048468|FG001|Period 2|unsatisfactory response-efficacy|1|||
163365772|NCT00895895|590048469|FG002|Period 2|unsatisfactory response-efficacy|0|||
163365773|NCT00895895|590048470|FG003|Period 2|unsatisfactory response-efficacy|0|||
163365774|NCT00895895|590048471|FG004|Period 2|unsatisfactory response-efficacy|0|||
163365775|NCT01261000|590048472|FG000|Overall Study|Screen failure|1|||
163365776|NCT03019640|590048473|FG000|Overall Study|Screen Failures|4|||
163365777|NCT03019640|590048473|FG000|Overall Study|Adverse Event|3|||
163365778|NCT03019640|590048473|FG000|Overall Study|Participant Relapsed|1|||
163365779|NCT01721954|590048474|FG000|Overall Study|Death|58|||
163365780|NCT01721954|590048475|FG001|Overall Study|Death|64|||
163365781|NCT01721954|590048474|FG000|Overall Study|Withdrawal by Subject|8|||
163365782|NCT01721954|590048475|FG001|Overall Study|Withdrawal by Subject|4|||
163365783|NCT01721954|590048474|FG000|Overall Study|Adverse Event|2|||
163365784|NCT01721954|590048475|FG001|Overall Study|Adverse Event|0|||
163365785|NCT01721954|590048474|FG000|Overall Study|Lost to Follow-up|2|||
163365786|NCT01721954|590048475|FG001|Overall Study|Lost to Follow-up|1|||
163365787|NCT01195623|590048476|FG000|Overall Study|Lost to Follow-up|35|||
163365788|NCT01195623|590048477|FG001|Overall Study|Lost to Follow-up|37|||
163365789|NCT00534495|590048478|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
163365790|NCT00534495|590048479|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
163365791|NCT00534495|590048480|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
163365792|NCT00534495|590048478|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
163365793|NCT00534495|590048479|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
163365794|NCT00534495|590048480|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
163365795|NCT00534495|590048478|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
163365796|NCT00534495|590048479|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
163365797|NCT00534495|590048480|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
163365798|NCT00534495|590048478|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
163365799|NCT00534495|590048479|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
163365800|NCT00534495|590048480|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
163365801|NCT00534495|590048478|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
163365802|NCT00534495|590048479|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
163365803|NCT00534495|590048480|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
163365804|NCT00534495|590048478|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
163365805|NCT00534495|590048479|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
163365806|NCT00534495|590048480|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
163365807|NCT00534495|590048478|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
163365808|NCT00534495|590048479|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
163365809|NCT00534495|590048480|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
163365810|NCT00534495|590048478|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
163365811|NCT00534495|590048479|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
163365812|NCT00534495|590048480|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
163365813|NCT00534495|590048478|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
163365814|NCT00534495|590048479|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
163365815|NCT00534495|590048480|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
163412307|NCT03403205|590216859|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
163412308|NCT03403205|590216860|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
163412309|NCT03403205|590216861|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
163412310|NCT03403205|590216862|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
163412311|NCT03403205|590216857|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
163412312|NCT03403205|590216858|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
163412313|NCT03403205|590216859|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
163412314|NCT03403205|590216860|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
163412315|NCT03403205|590216861|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
163412316|NCT03403205|590216862|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
163412317|NCT03403205|590216857|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
163412318|NCT03403205|590216858|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
163412319|NCT03403205|590216859|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
163412320|NCT03403205|590216860|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
163412321|NCT03403205|590216861|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
163412322|NCT03403205|590216862|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
163412323|NCT03403205|590216857|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
163412324|NCT03403205|590216858|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
163412325|NCT03403205|590216859|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
163412326|NCT03403205|590216860|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
163412327|NCT03403205|590216861|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
163412328|NCT03403205|590216862|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
163412329|NCT03403205|590216857|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
163412330|NCT03403205|590216858|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
163412331|NCT03403205|590216859|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
163412332|NCT03403205|590216860|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
163412333|NCT03403205|590216861|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
163412334|NCT03403205|590216862|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
163412335|NCT03403205|590216857|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
163412336|NCT03403205|590216858|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
163412337|NCT03403205|590216859|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
163412338|NCT03403205|590216860|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
163412339|NCT03403205|590216861|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
163412340|NCT03403205|590216862|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
163412341|NCT03403205|590216857|FG000|Extension Period (Up to 60 Months)|Death|1|||
163412342|NCT03403205|590216858|FG001|Extension Period (Up to 60 Months)|Death|0|||
163412343|NCT03403205|590216859|FG002|Extension Period (Up to 60 Months)|Death|0|||
163412344|NCT03403205|590216860|FG003|Extension Period (Up to 60 Months)|Death|0|||
163412345|NCT03403205|590216861|FG004|Extension Period (Up to 60 Months)|Death|0|||
163412346|NCT03403205|590216862|FG005|Extension Period (Up to 60 Months)|Death|0|||
163412347|NCT03403205|590216857|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
163412348|NCT03403205|590216858|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
163412349|NCT03403205|590216859|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
163412350|NCT03403205|590216860|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
163412351|NCT03403205|590216861|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
163412352|NCT03403205|590216862|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
163412353|NCT03403205|590216857|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
163412354|NCT03403205|590216858|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
163412355|NCT03403205|590216859|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
163412356|NCT03403205|590216860|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
163412357|NCT03403205|590216861|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
163412358|NCT03403205|590216862|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
163412359|NCT03403205|590216857|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
163412360|NCT03403205|590216858|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
163412361|NCT03403205|590216859|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
163412362|NCT03403205|590216860|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
163412363|NCT03403205|590216861|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
163412364|NCT03403205|590216862|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
163412365|NCT03403205|590216857|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
163412366|NCT03403205|590216858|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
163412367|NCT03403205|590216859|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
163412368|NCT03403205|590216860|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
163412369|NCT03403205|590216861|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
163412370|NCT03403205|590216862|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
163412371|NCT03403205|590216857|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
163412372|NCT03403205|590216858|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
163412373|NCT03403205|590216859|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
163412374|NCT03403205|590216860|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
163412375|NCT03403205|590216861|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
163412376|NCT03403205|590216862|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
163412377|NCT03403205|590216857|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
163412378|NCT03403205|590216858|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
163412379|NCT03403205|590216859|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
163412380|NCT03403205|590216860|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
163412381|NCT03403205|590216861|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
163412382|NCT03403205|590216862|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
163412383|NCT05130463|590216865|FG000|Overall Study|Unspecified reasons|2|||
163412384|NCT05130463|590216865|FG000|Overall Study|off-label indication dose|435|||
163412385|NCT03652662|590216869|FG000|Overall Study|Withdrawal by Subject|2|||
163412386|NCT03652662|590216870|FG001|Overall Study|Withdrawal by Subject|1|||
163412387|NCT03652662|590216869|FG000|Overall Study|Lost to Follow-up|1|||
163412388|NCT03652662|590216870|FG001|Overall Study|Lost to Follow-up|0|||
163412389|NCT00487539|590216871|FG000|Overall Study|Adverse Event|3|||
163412390|NCT00487539|590216872|FG001|Overall Study|Adverse Event|2|||
163412391|NCT00487539|590216873|FG002|Overall Study|Adverse Event|1|||
163412392|NCT00487539|590216874|FG003|Overall Study|Adverse Event|1|||
163412393|NCT00487539|590216871|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163412394|NCT00487539|590216872|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163412395|NCT00487539|590216873|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
163412396|NCT00487539|590216874|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
163412397|NCT00487539|590216871|FG000|Overall Study|Other|3|||
163412398|NCT00487539|590216872|FG001|Overall Study|Other|1|||
163412399|NCT00487539|590216873|FG002|Overall Study|Other|2|||
163412400|NCT00487539|590216874|FG003|Overall Study|Other|2|||
163412401|NCT02751502|590216875|FG000|Overall Study|Lack of funding|4|||
163412402|NCT02695628|590216876|FG000|Overall Study|Withdrawal by Subject|1|||
163365816|NCT02920970|590048484|FG000|First Intervention|Protocol Violation|0|||
163412403|NCT02678390|590216877|FG000|AE (1 Day)|Withdrawal by Subject|0|||
163412404|NCT02678390|590216878|FG001|AE (1 Day)|Withdrawal by Subject|1|||
163365817|NCT02920970|590048485|FG001|First Intervention|Protocol Violation|1|||
163365818|NCT02920970|590048484|FG000|First Intervention|Adverse Event|0|||
163365819|NCT02920970|590048485|FG001|First Intervention|Adverse Event|1|||
163365820|NCT02920970|590048484|FG000|Second Intervention|Poor Lens Fit|1|||
163365821|NCT02920970|590048485|FG001|Second Intervention|Poor Lens Fit|0|||
163365822|NCT01711853|590048486|FG000|Overall Study|Not treated|3|||
163365823|NCT01889069|590048489|FG000|Overall Study|Death|18|||
163365824|NCT01889069|590048489|FG000|Overall Study|Progression of Disease|14|||
163365825|NCT01889069|590048489|FG000|Overall Study|Lost to Follow-up|6|||
163365826|NCT01889069|590048489|FG000|Overall Study|Other|4|||
163365827|NCT01889069|590048489|FG000|Overall Study|Consent Withdrawal|3|||
163365828|NCT04978090|590048490|FG000|Overall Study|unable to adequately fit device|2|||
163365829|NCT01509547|590048495|FG000|Overall Study|Lost to Follow-up|24|||
163365830|NCT01509547|590048496|FG001|Overall Study|Lost to Follow-up|14|||
163365831|NCT01509547|590048495|FG000|Overall Study|Withdrawal by Subject|11|||
163365832|NCT01509547|590048496|FG001|Overall Study|Withdrawal by Subject|24|||
163365833|NCT01509547|590048495|FG000|Overall Study|Physician Decision|0|||
163365834|NCT01509547|590048496|FG001|Overall Study|Physician Decision|1|||
163365835|NCT02227992|590048497|FG000|Overall Study|Lost to Follow-up|1|||
163365836|NCT02227992|590048498|FG001|Overall Study|Lost to Follow-up|1|||
163365837|NCT01371708|590048501|FG000|Overall Study|Insufficient clinical response|3|||
163365838|NCT01371708|590048502|FG001|Overall Study|Insufficient clinical response|2|||
163365839|NCT01371708|590048503|FG002|Overall Study|Insufficient clinical response|0|||
163365840|NCT01371708|590048501|FG000|Overall Study|Lost to Follow-up|5|||
163365841|NCT01371708|590048502|FG001|Overall Study|Lost to Follow-up|9|||
163365842|NCT01371708|590048503|FG002|Overall Study|Lost to Follow-up|7|||
163365843|NCT01371708|590048501|FG000|Overall Study|Protocol Violation|2|||
163365844|NCT01371708|590048502|FG001|Overall Study|Protocol Violation|1|||
163365845|NCT01371708|590048503|FG002|Overall Study|Protocol Violation|2|||
163365846|NCT01371708|590048501|FG000|Overall Study|No longer willing to participate|7|||
163365847|NCT01371708|590048502|FG001|Overall Study|No longer willing to participate|7|||
163365848|NCT01371708|590048503|FG002|Overall Study|No longer willing to participate|13|||
163365849|NCT01371708|590048501|FG000|Overall Study|Medication error/not related to AE|0|||
163365850|NCT01371708|590048502|FG001|Overall Study|Medication error/not related to AE|1|||
163365851|NCT01371708|590048503|FG002|Overall Study|Medication error/not related to AE|0|||
163365852|NCT01371708|590048501|FG000|Overall Study|Other|3|||
163365853|NCT01371708|590048502|FG001|Overall Study|Other|2|||
163412405|NCT03499028|590216879|FG000|Overall Study|Lost to Follow-up|12|||
163412406|NCT03499028|590216880|FG001|Overall Study|Lost to Follow-up|9|||
163365854|NCT01371708|590048503|FG002|Overall Study|Other|4|||
163365855|NCT01371708|590048501|FG000|Overall Study|Adverse Event|5|||
163365856|NCT01371708|590048502|FG001|Overall Study|Adverse Event|8|||
163365857|NCT01371708|590048503|FG002|Overall Study|Adverse Event|12|||
163365858|NCT01371708|590048501|FG000|Overall Study|Started but did not receive treatment|1|||
163412407|NCT03499028|590216879|FG000|Overall Study|Withdrawal by Subject|5|||
163365859|NCT01371708|590048502|FG001|Overall Study|Started but did not receive treatment|0|||
163365860|NCT01371708|590048503|FG002|Overall Study|Started but did not receive treatment|1|||
163365861|NCT02514551|590048504|FG000|Overall Study|Lost to Follow-up|0|||
163365862|NCT02514551|590048505|FG001|Overall Study|Lost to Follow-up|1|||
163365863|NCT02514551|590048504|FG000|Overall Study|Participant Never Treated|0|||
163365864|NCT02514551|590048505|FG001|Overall Study|Participant Never Treated|2|||
163365865|NCT00350727|590048516|FG000|Phase I: Dose Escalation|Adverse Event|4|||
163365866|NCT00350727|590048517|FG001|Phase I: Dose Escalation|Adverse Event|0|||
163365867|NCT00350727|590048518|FG002|Phase I: Dose Escalation|Adverse Event|0|||
163365868|NCT00350727|590048516|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
163365869|NCT00350727|590048517|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
163365870|NCT00350727|590048518|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
163365871|NCT00350727|590048516|FG000|Phase I: Dose Escalation|Death|1|||
163365872|NCT00350727|590048517|FG001|Phase I: Dose Escalation|Death|0|||
163365873|NCT00350727|590048518|FG002|Phase I: Dose Escalation|Death|0|||
163365874|NCT00350727|590048516|FG000|Phase I: Dose Escalation|Physician Decision|1|||
163365875|NCT00350727|590048517|FG001|Phase I: Dose Escalation|Physician Decision|0|||
163365876|NCT00350727|590048518|FG002|Phase I: Dose Escalation|Physician Decision|0|||
163365877|NCT00350727|590048516|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
163365878|NCT00350727|590048517|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
163365879|NCT00350727|590048518|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
163365880|NCT00350727|590048516|FG000|Phase II|Disease Progression|0|||
163365881|NCT00350727|590048517|FG001|Phase II|Disease Progression|15|||
163365882|NCT00350727|590048518|FG002|Phase II|Disease Progression|16|||
163365883|NCT00350727|590048516|FG000|Phase II|Clinical Deterioration|0|||
163365884|NCT00350727|590048517|FG001|Phase II|Clinical Deterioration|1|||
163365885|NCT00350727|590048518|FG002|Phase II|Clinical Deterioration|0|||
163365886|NCT00350727|590048516|FG000|Phase II|Withdrawal by Subject|0|||
163365887|NCT00350727|590048517|FG001|Phase II|Withdrawal by Subject|2|||
163365888|NCT00350727|590048518|FG002|Phase II|Withdrawal by Subject|1|||
163365889|NCT00350727|590048516|FG000|Phase II|Adverse Event|0|||
163365890|NCT00350727|590048517|FG001|Phase II|Adverse Event|1|||
163365891|NCT00350727|590048518|FG002|Phase II|Adverse Event|1|||
163365892|NCT00350727|590048516|FG000|Phase II|Death|0|||
163365893|NCT00350727|590048517|FG001|Phase II|Death|0|||
163365894|NCT00350727|590048518|FG002|Phase II|Death|2|||
163365895|NCT00350727|590048516|FG000|Phase II|Sponsor Terminated Study|0|||
163365896|NCT00350727|590048517|FG001|Phase II|Sponsor Terminated Study|0|||
163365897|NCT00350727|590048518|FG002|Phase II|Sponsor Terminated Study|1|||
163365898|NCT00350727|590048516|FG000|Phase II|Enrolled in Rollover Study|0|||
163365899|NCT00350727|590048517|FG001|Phase II|Enrolled in Rollover Study|0|||
163365900|NCT00350727|590048518|FG002|Phase II|Enrolled in Rollover Study|1|||
163365901|NCT04535544|590048519|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
163365902|NCT04535544|590048520|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
163365903|NCT04535544|590048521|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
163365904|NCT04535544|590048522|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
163365905|NCT04535544|590048519|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
163365906|NCT04535544|590048520|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
163365907|NCT04535544|590048521|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
163365908|NCT04535544|590048522|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
163365909|NCT04535544|590048519|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
163365910|NCT04535544|590048520|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
163365911|NCT04535544|590048521|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
163365912|NCT04535544|590048522|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
163365913|NCT04535544|590048519|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
163365914|NCT04535544|590048520|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
163365915|NCT04535544|590048521|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
163365916|NCT04535544|590048522|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
163365917|NCT04535544|590048519|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
163365918|NCT04535544|590048520|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
163365919|NCT04535544|590048521|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
163365920|NCT04535544|590048522|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
163365921|NCT04535544|590048519|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
163365922|NCT04535544|590048520|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
163365923|NCT04535544|590048521|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
163365924|NCT04535544|590048522|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
163365925|NCT04535544|590048519|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
163365926|NCT04535544|590048520|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
163365927|NCT04535544|590048521|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
163365928|NCT04535544|590048522|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
163365929|NCT04535544|590048519|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
163365930|NCT04535544|590048520|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
163365931|NCT04535544|590048521|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
163365932|NCT04535544|590048522|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
163365933|NCT01123070|590050564|FG000|Part B Double Blind Period|Protocol Violation|0|||
163365934|NCT01123070|590050565|FG001|Part B Double Blind Period|Protocol Violation|0|||
163365935|NCT01123070|590050566|FG002|Part B Double Blind Period|Protocol Violation|0|||
163365936|NCT01123070|590050567|FG003|Part B Double Blind Period|Protocol Violation|1|||
163365937|NCT01123070|590050564|FG000|Part B Double Blind Period|Adverse Event|0|||
163365938|NCT01123070|590050565|FG001|Part B Double Blind Period|Adverse Event|0|||
163365939|NCT01123070|590050566|FG002|Part B Double Blind Period|Adverse Event|2|||
163365940|NCT01123070|590050567|FG003|Part B Double Blind Period|Adverse Event|0|||
163365941|NCT01123070|590050564|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
163365942|NCT01123070|590050565|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
163365943|NCT01123070|590050566|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
163365944|NCT01123070|590050567|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
163365945|NCT04942366|590050568|FG000|Overall Study|Withdrawal by Subject|5|||
163365946|NCT04942366|590050569|FG001|Overall Study|Withdrawal by Subject|5|||
163365947|NCT00747227|590050572|FG000|Overall Study|Death|3|||
163365948|NCT00747227|590050573|FG001|Overall Study|Death|1|||
163365949|NCT00747227|590050572|FG000|Overall Study|Withdrawal by Subject|1|||
163365950|NCT00747227|590050573|FG001|Overall Study|Withdrawal by Subject|0|||
163365951|NCT00747227|590050572|FG000|Overall Study|Lost to Follow-up|1|||
163365952|NCT00747227|590050573|FG001|Overall Study|Lost to Follow-up|2|||
163365953|NCT00747227|590050572|FG000|Overall Study|Illness|1|||
163365954|NCT00747227|590050573|FG001|Overall Study|Illness|1|||
163365955|NCT03284229|590050574|FG000|Overall Study|Lost to Follow-up|3|||
163365956|NCT00918879|590050575|FG000|Overall Study|Withdrawal by Subject|4|||
163365957|NCT00918879|590050576|FG001|Overall Study|Withdrawal by Subject|4|||
163365958|NCT00918879|590050575|FG000|Overall Study|Lost to Follow-up|1|||
163365959|NCT00918879|590050576|FG001|Overall Study|Lost to Follow-up|1|||
163365960|NCT00918879|590050575|FG000|Overall Study|Severe non-compliance to protocol|1|||
163365961|NCT00918879|590050576|FG001|Overall Study|Severe non-compliance to protocol|1|||
163365962|NCT01182441|590050579|FG000|Overall Study|Patient Still in Follow-up|152|||
163365963|NCT01182441|590050580|FG001|Overall Study|Patient Still in Follow-up|72|||
163365964|NCT01182441|590050579|FG000|Overall Study|Death|37|||
163365965|NCT01182441|590050580|FG001|Overall Study|Death|25|||
163365966|NCT01182441|590050579|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
163365967|NCT01182441|590050580|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
163365968|NCT01182441|590050579|FG000|Overall Study|Lost to Follow-up|5|||
163365969|NCT01182441|590050580|FG001|Overall Study|Lost to Follow-up|8|||
163365970|NCT01182441|590050579|FG000|Overall Study|Withdrawal by Subject|6|||
163365971|NCT01182441|590050580|FG001|Overall Study|Withdrawal by Subject|13|||
163365972|NCT01182441|590050579|FG000|Overall Study|Implant Not Attempted|4|||
163365973|NCT01182441|590050580|FG001|Overall Study|Implant Not Attempted|0|||
163365974|NCT01182441|590050579|FG000|Overall Study|Adverse Event|2|||
163365975|NCT01182441|590050580|FG001|Overall Study|Adverse Event|0|||
163365976|NCT01182441|590050579|FG000|Overall Study|Physician Decision|1|||
163365977|NCT01182441|590050580|FG001|Overall Study|Physician Decision|1|||
163365978|NCT00663702|590050589|FG000|Overall Study|Adverse Event|8|||
163365979|NCT00663702|590050590|FG001|Overall Study|Adverse Event|4|||
163365980|NCT00663702|590050589|FG000|Overall Study|Withdrawal by Subject|3|||
163365981|NCT00663702|590050590|FG001|Overall Study|Withdrawal by Subject|1|||
163365982|NCT00663702|590050589|FG000|Overall Study|Pregnancy|0|||
163365983|NCT00663702|590050590|FG001|Overall Study|Pregnancy|1|||
163365984|NCT00663702|590050589|FG000|Overall Study|Lost to Follow-up|3|||
163365985|NCT00663702|590050590|FG001|Overall Study|Lost to Follow-up|0|||
163365986|NCT00663702|590050589|FG000|Overall Study|Death|1|||
163365987|NCT00663702|590050590|FG001|Overall Study|Death|1|||
163365988|NCT00663702|590050589|FG000|Overall Study|Lack of Efficacy|3|||
163365989|NCT00663702|590050590|FG001|Overall Study|Lack of Efficacy|3|||
163365990|NCT01370655|590050594|FG000|Period 1|Adverse Event|2|||
163365991|NCT01370655|590050595|FG001|Period 1|Adverse Event|0|||
163365992|NCT01370655|590050596|FG002|Period 1|Adverse Event|0|||
163365993|NCT01370655|590050597|FG003|Period 1|Adverse Event|0|||
163365994|NCT01370655|590050598|FG004|Period 1|Adverse Event|0|||
163365995|NCT01370655|590050599|FG005|Period 1|Adverse Event|0|||
163365996|NCT01370655|590050600|FG006|Period 1|Adverse Event|1|||
163365997|NCT01370655|590050601|FG007|Period 1|Adverse Event|0|||
163365998|NCT01370655|590050602|FG008|Period 1|Adverse Event|0|||
163365999|NCT01370655|590050603|FG009|Period 1|Adverse Event|0|||
163366000|NCT01370655|590050604|FG010|Period 1|Adverse Event|0|||
163366001|NCT01370655|590050605|FG011|Period 1|Adverse Event|0|||
163366002|NCT01370655|590050594|FG000|Period 2|Adverse Event|0|||
163366003|NCT01370655|590050595|FG001|Period 2|Adverse Event|0|||
163366004|NCT01370655|590050596|FG002|Period 2|Adverse Event|1|||
163366005|NCT01370655|590050597|FG003|Period 2|Adverse Event|0|||
163366006|NCT01370655|590050598|FG004|Period 2|Adverse Event|1|||
163366007|NCT01370655|590050599|FG005|Period 2|Adverse Event|0|||
163366008|NCT01370655|590050600|FG006|Period 2|Adverse Event|0|||
163366009|NCT01370655|590050601|FG007|Period 2|Adverse Event|1|||
163366010|NCT01370655|590050602|FG008|Period 2|Adverse Event|0|||
163366011|NCT01370655|590050603|FG009|Period 2|Adverse Event|0|||
163412408|NCT03499028|590216880|FG001|Overall Study|Withdrawal by Subject|8|||
163412409|NCT03499028|590216879|FG000|Overall Study|Unplanned SNF discharge|5|||
163412410|NCT03499028|590216880|FG001|Overall Study|Unplanned SNF discharge|8|||
163412411|NCT02925156|590216881|FG000|Overall Study|Lost to Follow-up|27|||
163412412|NCT02925156|590216882|FG001|Overall Study|Lost to Follow-up|53|||
163412413|NCT02925156|590216883|FG002|Overall Study|Lost to Follow-up|51|||
163412414|NCT02925156|590216884|FG003|Overall Study|Lost to Follow-up|59|||
163412415|NCT02925156|590216885|FG004|Overall Study|Lost to Follow-up|89|||
163412416|NCT02925156|590216886|FG005|Overall Study|Lost to Follow-up|107|||
163412417|NCT02925156|590216887|FG006|Overall Study|Lost to Follow-up|34|||
163412418|NCT02925156|590216888|FG007|Overall Study|Lost to Follow-up|36|||
163412419|NCT02925156|590216889|FG008|Overall Study|Lost to Follow-up|73|||
163412420|NCT02925156|590216890|FG009|Overall Study|Lost to Follow-up|34|||
163412421|NCT01844895|590216891|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
163412422|NCT01844895|590216891|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
163412423|NCT01844895|590216891|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
163412424|NCT01844895|590216891|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
163412425|NCT01844895|590216891|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
163412426|NCT01844895|590216891|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
163412427|NCT01844895|590216891|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
163412428|NCT01318109|590216892|FG000|Overall Study|Adverse Event|0|||
163412429|NCT01318109|590216893|FG001|Overall Study|Adverse Event|2|||
163412430|NCT01318109|590216894|FG002|Overall Study|Adverse Event|0|||
163412431|NCT01318109|590216892|FG000|Overall Study|Withdrawal by Subject|1|||
163412432|NCT01318109|590216893|FG001|Overall Study|Withdrawal by Subject|0|||
163412433|NCT01318109|590216894|FG002|Overall Study|Withdrawal by Subject|0|||
163412434|NCT01318109|590216892|FG000|Overall Study|Schedule Conflict|0|||
163412435|NCT01318109|590216893|FG001|Overall Study|Schedule Conflict|1|||
163412436|NCT01318109|590216894|FG002|Overall Study|Schedule Conflict|0|||
163412437|NCT04982250|590216902|FG000|Overall Study|Lost to Follow-up|0|||
163412438|NCT04982250|590216903|FG001|Overall Study|Lost to Follow-up|26|||
163412439|NCT04982250|590216904|FG002|Overall Study|Lost to Follow-up|0|||
163412440|NCT04982250|590216905|FG003|Overall Study|Lost to Follow-up|0|||
163412441|NCT04982250|590216906|FG004|Overall Study|Lost to Follow-up|72|||
163412442|NCT04982250|590216907|FG005|Overall Study|Lost to Follow-up|69|||
163412443|NCT04982250|590216902|FG000|Overall Study|Not Eligible to Enroll|0|||
163412444|NCT04982250|590216903|FG001|Overall Study|Not Eligible to Enroll|0|||
163412445|NCT04982250|590216904|FG002|Overall Study|Not Eligible to Enroll|0|||
163412446|NCT04982250|590216905|FG003|Overall Study|Not Eligible to Enroll|0|||
163412447|NCT04982250|590216906|FG004|Overall Study|Not Eligible to Enroll|10|||
163412448|NCT04982250|590216907|FG005|Overall Study|Not Eligible to Enroll|7|||
163412449|NCT02028455|590216913|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
163412450|NCT02028455|590216914|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
163412451|NCT02028455|590216915|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
163412452|NCT02028455|590216916|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
163412453|NCT02028455|590216917|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
163412454|NCT02028455|590216918|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
163412455|NCT02028455|590216919|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
163412456|NCT02028455|590216920|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
163412457|NCT02028455|590216913|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
163412458|NCT02028455|590216914|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
163412459|NCT02028455|590216915|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
163412460|NCT02028455|590216916|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
163412461|NCT02028455|590216917|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
163412462|NCT02028455|590216918|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
163412463|NCT02028455|590216919|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
163412464|NCT02028455|590216920|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
163412465|NCT02028455|590216913|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
163412466|NCT02028455|590216914|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
163412467|NCT02028455|590216915|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
163412468|NCT02028455|590216916|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
163412469|NCT02028455|590216917|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
163412470|NCT02028455|590216918|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
163412471|NCT02028455|590216919|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
163412472|NCT02028455|590216920|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
163412473|NCT02028455|590216913|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
163412474|NCT02028455|590216914|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
163412475|NCT02028455|590216915|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
163412476|NCT02028455|590216916|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
163412477|NCT02028455|590216917|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
163412478|NCT02028455|590216918|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
163412479|NCT02028455|590216919|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
163412480|NCT02028455|590216920|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
163412481|NCT07099521|590216921|FG000|Overall Study|Incompeleted stimulus program|1|||
163412482|NCT07099521|590216922|FG001|Overall Study|Incompeleted stimulus program|0|||
163412483|NCT07099521|590216921|FG000|Overall Study|Non-social anxiety symtpoms|0|||
163366012|NCT01370655|590050604|FG010|Period 2|Adverse Event|0|||
163366013|NCT01370655|590050605|FG011|Period 2|Adverse Event|0|||
163366014|NCT01370655|590050594|FG000|Period 2|met protocol specified stopping criteria|0|||
163366015|NCT01370655|590050595|FG001|Period 2|met protocol specified stopping criteria|0|||
163366016|NCT01370655|590050596|FG002|Period 2|met protocol specified stopping criteria|1|||
163366017|NCT01370655|590050597|FG003|Period 2|met protocol specified stopping criteria|0|||
163366018|NCT01370655|590050598|FG004|Period 2|met protocol specified stopping criteria|0|||
163366019|NCT01370655|590050599|FG005|Period 2|met protocol specified stopping criteria|0|||
163366020|NCT01370655|590050600|FG006|Period 2|met protocol specified stopping criteria|1|||
163366021|NCT01370655|590050601|FG007|Period 2|met protocol specified stopping criteria|0|||
163366022|NCT01370655|590050602|FG008|Period 2|met protocol specified stopping criteria|1|||
163366023|NCT01370655|590050603|FG009|Period 2|met protocol specified stopping criteria|0|||
163366024|NCT01370655|590050604|FG010|Period 2|met protocol specified stopping criteria|1|||
163366025|NCT01370655|590050605|FG011|Period 2|met protocol specified stopping criteria|0|||
163366026|NCT01370655|590050594|FG000|Period 2|Withdrawal by Subject|0|||
163366027|NCT01370655|590050595|FG001|Period 2|Withdrawal by Subject|0|||
163366028|NCT01370655|590050596|FG002|Period 2|Withdrawal by Subject|0|||
163366029|NCT01370655|590050597|FG003|Period 2|Withdrawal by Subject|0|||
163366030|NCT01370655|590050598|FG004|Period 2|Withdrawal by Subject|0|||
163366031|NCT01370655|590050599|FG005|Period 2|Withdrawal by Subject|0|||
163366032|NCT01370655|590050600|FG006|Period 2|Withdrawal by Subject|0|||
163366033|NCT01370655|590050601|FG007|Period 2|Withdrawal by Subject|0|||
163366034|NCT01370655|590050602|FG008|Period 2|Withdrawal by Subject|1|||
163366035|NCT01370655|590050603|FG009|Period 2|Withdrawal by Subject|0|||
163366036|NCT01370655|590050604|FG010|Period 2|Withdrawal by Subject|0|||
163366037|NCT01370655|590050605|FG011|Period 2|Withdrawal by Subject|0|||
163366038|NCT01730378|590050606|FG000|Overall Study|Lost to Follow-up|1|||
163366039|NCT01730378|590050607|FG001|Overall Study|Lost to Follow-up|0|||
163412484|NCT07099521|590216922|FG001|Overall Study|Non-social anxiety symtpoms|1|||
163412485|NCT07099521|590216921|FG000|Overall Study|Extreme values|2|||
163412486|NCT07099521|590216922|FG001|Overall Study|Extreme values|4|||
163412487|NCT02615990|590218882|FG000|Overall Study|study terminated|1|||
163412488|NCT02615990|590218883|FG001|Overall Study|study terminated|1|||
163412489|NCT00808444|590218884|FG000|Overall Study|Withdrawal by Subject|1|||
163412490|NCT00808444|590218885|FG001|Overall Study|Withdrawal by Subject|0|||
163412491|NCT00808444|590218884|FG000|Overall Study|Lost to Follow-up|0|||
163412492|NCT00808444|590218885|FG001|Overall Study|Lost to Follow-up|1|||
163412493|NCT04401267|590218886|FG000|Overall Study|Death|0|||
163412494|NCT04401267|590218887|FG001|Overall Study|Death|1|||
163412495|NCT04401267|590218886|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
163412496|NCT04401267|590218887|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
163412497|NCT04401267|590218886|FG000|Overall Study|Found to be Ineligible|1|||
163412498|NCT04401267|590218887|FG001|Overall Study|Found to be Ineligible|0|||
163412499|NCT01449708|590218897|FG000|Overall Study|Protocol Violation|0|||
163412500|NCT01449708|590218898|FG001|Overall Study|Protocol Violation|1|||
163412501|NCT01449708|590218897|FG000|Overall Study|surgical complication|1|||
163412502|NCT01449708|590218898|FG001|Overall Study|surgical complication|2|||
163366040|NCT04481373|590050611|FG000|Overall Study|Protocol Violation|1|||
163366041|NCT04481373|590050612|FG001|Overall Study|Protocol Violation|0|||
163366042|NCT04481373|590050611|FG000|Overall Study|Viral load in hospital not over 1000|2|||
163412503|NCT01449708|590218897|FG000|Overall Study|respiratory failure|1|||
163412504|NCT01449708|590218898|FG001|Overall Study|respiratory failure|0|||
163412505|NCT02889796|590218899|FG000|Overall Study|Withdrew Consent|18|||
163412506|NCT02889796|590218900|FG001|Overall Study|Withdrew Consent|29|||
163412507|NCT02889796|590218901|FG002|Overall Study|Withdrew Consent|20|||
163412508|NCT02889796|590218902|FG003|Overall Study|Withdrew Consent|1|||
163412509|NCT02889796|590218903|FG004|Overall Study|Withdrew Consent|2|||
163412510|NCT02889796|590218904|FG005|Overall Study|Withdrew Consent|35|||
163412511|NCT02889796|590218899|FG000|Overall Study|Investigator's Discretion|10|||
163412512|NCT02889796|590218900|FG001|Overall Study|Investigator's Discretion|9|||
163412513|NCT02889796|590218901|FG002|Overall Study|Investigator's Discretion|10|||
163412514|NCT02889796|590218902|FG003|Overall Study|Investigator's Discretion|3|||
163412515|NCT02889796|590218903|FG004|Overall Study|Investigator's Discretion|0|||
163412516|NCT02889796|590218904|FG005|Overall Study|Investigator's Discretion|15|||
163412517|NCT02889796|590218899|FG000|Overall Study|Adverse Event|17|||
163412518|NCT02889796|590218900|FG001|Overall Study|Adverse Event|8|||
163412519|NCT02889796|590218901|FG002|Overall Study|Adverse Event|8|||
163412520|NCT02889796|590218902|FG003|Overall Study|Adverse Event|4|||
163366043|NCT04481373|590050612|FG001|Overall Study|Viral load in hospital not over 1000|1|||
163366044|NCT04481373|590050611|FG000|Overall Study|Death before hospital discharge|1|||
163366045|NCT04481373|590050612|FG001|Overall Study|Death before hospital discharge|0|||
163366046|NCT02979249|590050615|FG000|Overall Study|Lost to Follow-up|2|||
163366047|NCT02979249|590050615|FG000|Overall Study|Withdrawal by Subject|4|||
163366048|NCT01125046|590050616|FG000|First 6 Months of Treatment|Death|1|||
163366049|NCT01125046|590050616|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
163366050|NCT01125046|590050616|FG000|First 6 Months of Treatment|Non-compliance|1|||
163366051|NCT01125046|590050616|FG000|First 6 Months of Treatment|Surgery|1|||
163366052|NCT01125046|590050616|FG000|First 6 Months of Treatment|Progressive Disease|7|||
163366053|NCT01125046|590050616|FG000|First 6 Months of Treatment|Adverse Event|2|||
163366054|NCT01125046|590050616|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
163366055|NCT01125046|590050616|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
163366056|NCT01125046|590050616|FG000|Follow-up/Data Cut Off Point|Death|29|||
163366057|NCT01125046|590050616|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
163366058|NCT01685229|590050617|FG000|Overall Study|Subjects missing Study Exit form|3|||
163366059|NCT01685229|590050618|FG001|Overall Study|Subjects missing Study Exit form|1|||
163366060|NCT01685229|590050617|FG000|Overall Study|Lost to Follow-up|16|||
163366061|NCT01685229|590050618|FG001|Overall Study|Lost to Follow-up|10|||
163366062|NCT01685229|590050617|FG000|Overall Study|Withdrawal by Subject|6|||
163366063|NCT01685229|590050618|FG001|Overall Study|Withdrawal by Subject|5|||
163366064|NCT01685229|590050617|FG000|Overall Study|Death|1|||
163366065|NCT01685229|590050618|FG001|Overall Study|Death|0|||
163366066|NCT00659880|590050633|FG000|Overall Study|Lost to Follow-up|5|||
163366067|NCT01853475|590050634|FG000|Overall Study|Withdrawal by Subject|0|||
163366068|NCT01853475|590050635|FG001|Overall Study|Withdrawal by Subject|1|||
163366069|NCT01853475|590050636|FG002|Overall Study|Withdrawal by Subject|0|||
163366070|NCT02964325|590050637|FG000|Overall Study|Lost to Follow-up|3|||
163366071|NCT02964325|590050638|FG001|Overall Study|Lost to Follow-up|3|||
163366072|NCT02964325|590050637|FG000|Overall Study|Physician Decision|5|||
163366073|NCT02964325|590050638|FG001|Overall Study|Physician Decision|4|||
163366074|NCT02964325|590050637|FG000|Overall Study|Death|1|||
163366075|NCT02964325|590050638|FG001|Overall Study|Death|3|||
163366076|NCT02964325|590050637|FG000|Overall Study|Withdrawal by Subject|2|||
163366077|NCT02964325|590050638|FG001|Overall Study|Withdrawal by Subject|1|||
163366078|NCT02964325|590050637|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
163366079|NCT02964325|590050638|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
163366080|NCT03596762|590050639|FG000|Overall Study|Protocol Violation|0|||
163366081|NCT03596762|590050640|FG001|Overall Study|Protocol Violation|0|||
163366082|NCT03596762|590050641|FG002|Overall Study|Protocol Violation|0|||
163366083|NCT03596762|590050642|FG003|Overall Study|Protocol Violation|0|||
163366084|NCT03596762|590050643|FG004|Overall Study|Protocol Violation|1|||
163366085|NCT03596762|590050639|FG000|Overall Study|Adverse Event|2|||
163366086|NCT03596762|590050640|FG001|Overall Study|Adverse Event|0|||
163366087|NCT03596762|590050641|FG002|Overall Study|Adverse Event|1|||
163366088|NCT03596762|590050642|FG003|Overall Study|Adverse Event|0|||
163366089|NCT03596762|590050643|FG004|Overall Study|Adverse Event|5|||
163366090|NCT03596762|590050639|FG000|Overall Study|Withdrawal by Subject|2|||
163366091|NCT03596762|590050640|FG001|Overall Study|Withdrawal by Subject|1|||
163366092|NCT03596762|590050641|FG002|Overall Study|Withdrawal by Subject|0|||
163366093|NCT03596762|590050642|FG003|Overall Study|Withdrawal by Subject|1|||
163366094|NCT03596762|590050643|FG004|Overall Study|Withdrawal by Subject|1|||
163366095|NCT02510040|590050644|FG000|Overall Study|Deemed no longer eligible|18|||
163366096|NCT02510040|590050645|FG001|Overall Study|Deemed no longer eligible|3|||
163366097|NCT02510040|590050646|FG002|Overall Study|Deemed no longer eligible|1|||
163366098|NCT03842228|590050647|FG000|Overall Study|Adverse Event|1|||
163366099|NCT03842228|590050648|FG001|Overall Study|Adverse Event|1|||
163366100|NCT03842228|590050649|FG002|Overall Study|Adverse Event|1|||
163366101|NCT03842228|590050650|FG003|Overall Study|Adverse Event|0|||
163366102|NCT03842228|590050651|FG004|Overall Study|Adverse Event|0|||
163366103|NCT03842228|590050652|FG005|Overall Study|Adverse Event|0|||
163366104|NCT03842228|590050653|FG006|Overall Study|Adverse Event|0|||
163366105|NCT03842228|590050647|FG000|Overall Study|Death|0|||
163366106|NCT03842228|590050648|FG001|Overall Study|Death|1|||
163366107|NCT03842228|590050649|FG002|Overall Study|Death|0|||
163366108|NCT03842228|590050650|FG003|Overall Study|Death|0|||
163366109|NCT03842228|590050651|FG004|Overall Study|Death|0|||
163366110|NCT03842228|590050652|FG005|Overall Study|Death|0|||
163366111|NCT03842228|590050653|FG006|Overall Study|Death|0|||
163366112|NCT03842228|590050647|FG000|Overall Study|Withdrawal by Subject|0|||
163366113|NCT03842228|590050648|FG001|Overall Study|Withdrawal by Subject|0|||
163366114|NCT03842228|590050649|FG002|Overall Study|Withdrawal by Subject|2|||
163366115|NCT03842228|590050650|FG003|Overall Study|Withdrawal by Subject|1|||
163366116|NCT03842228|590050651|FG004|Overall Study|Withdrawal by Subject|0|||
163366117|NCT03842228|590050652|FG005|Overall Study|Withdrawal by Subject|0|||
163366118|NCT03842228|590050653|FG006|Overall Study|Withdrawal by Subject|2|||
163366119|NCT03842228|590050647|FG000|Overall Study|Progression|8|||
163366120|NCT03842228|590050648|FG001|Overall Study|Progression|1|||
163412521|NCT02889796|590218903|FG004|Overall Study|Adverse Event|1|||
163412522|NCT02889796|590218904|FG005|Overall Study|Adverse Event|7|||
163412523|NCT02889796|590218899|FG000|Overall Study|Lost to Follow-up|5|||
163412524|NCT02889796|590218900|FG001|Overall Study|Lost to Follow-up|7|||
163412525|NCT02889796|590218901|FG002|Overall Study|Lost to Follow-up|2|||
163412526|NCT02889796|590218902|FG003|Overall Study|Lost to Follow-up|0|||
163412527|NCT02889796|590218903|FG004|Overall Study|Lost to Follow-up|2|||
163412528|NCT02889796|590218904|FG005|Overall Study|Lost to Follow-up|6|||
163412529|NCT02889796|590218899|FG000|Overall Study|Protocol Violation|0|||
163412530|NCT02889796|590218900|FG001|Overall Study|Protocol Violation|1|||
163412531|NCT02889796|590218901|FG002|Overall Study|Protocol Violation|3|||
163412532|NCT02889796|590218902|FG003|Overall Study|Protocol Violation|0|||
163412533|NCT02889796|590218903|FG004|Overall Study|Protocol Violation|0|||
163412534|NCT02889796|590218904|FG005|Overall Study|Protocol Violation|4|||
163412535|NCT02889796|590218899|FG000|Overall Study|Non-compliance With Study Drug|0|||
163412536|NCT02889796|590218900|FG001|Overall Study|Non-compliance With Study Drug|2|||
163412537|NCT02889796|590218901|FG002|Overall Study|Non-compliance With Study Drug|0|||
163412538|NCT02889796|590218902|FG003|Overall Study|Non-compliance With Study Drug|0|||
163412539|NCT02889796|590218903|FG004|Overall Study|Non-compliance With Study Drug|1|||
163412540|NCT02889796|590218904|FG005|Overall Study|Non-compliance With Study Drug|2|||
163412541|NCT02889796|590218899|FG000|Overall Study|Death|1|||
163412542|NCT02889796|590218900|FG001|Overall Study|Death|1|||
163412543|NCT02889796|590218901|FG002|Overall Study|Death|0|||
163412544|NCT02889796|590218902|FG003|Overall Study|Death|1|||
163412545|NCT02889796|590218903|FG004|Overall Study|Death|0|||
163412546|NCT02889796|590218904|FG005|Overall Study|Death|1|||
163412547|NCT02889796|590218899|FG000|Overall Study|Pregnancy|0|||
163412548|NCT02889796|590218900|FG001|Overall Study|Pregnancy|1|||
163412549|NCT02889796|590218901|FG002|Overall Study|Pregnancy|1|||
163412550|NCT02889796|590218902|FG003|Overall Study|Pregnancy|0|||
163412551|NCT02889796|590218903|FG004|Overall Study|Pregnancy|0|||
163412552|NCT02889796|590218904|FG005|Overall Study|Pregnancy|0|||
163412553|NCT02889796|590218899|FG000|Overall Study|Randomized but not Dosed|2|||
163412554|NCT02889796|590218900|FG001|Overall Study|Randomized but not Dosed|0|||
163412555|NCT02889796|590218901|FG002|Overall Study|Randomized but not Dosed|0|||
163412556|NCT02889796|590218902|FG003|Overall Study|Randomized but not Dosed|0|||
163412557|NCT02889796|590218903|FG004|Overall Study|Randomized but not Dosed|0|||
163412558|NCT02889796|590218904|FG005|Overall Study|Randomized but not Dosed|2|||
163412559|NCT04294459|590218905|FG000|Overall Study|Adverse Event|0|||
163412560|NCT04294459|590218906|FG001|Overall Study|Adverse Event|1|||
163412561|NCT02787863|590218907|FG000|Overall Study|Death|1|||
163412562|NCT02787863|590218908|FG001|Overall Study|Death|0|||
163412563|NCT02787863|590218909|FG002|Overall Study|Death|1|||
163412564|NCT02787863|590218910|FG003|Overall Study|Death|0|||
163412565|NCT02787863|590218911|FG004|Overall Study|Death|0|||
163412566|NCT02787863|590218912|FG005|Overall Study|Death|0|||
163412567|NCT02787863|590218913|FG006|Overall Study|Death|0|||
163412568|NCT02787863|590218914|FG007|Overall Study|Death|0|||
163412569|NCT02787863|590218907|FG000|Overall Study|Withdrawal by Subject|0|||
163412570|NCT02787863|590218908|FG001|Overall Study|Withdrawal by Subject|1|||
163412571|NCT02787863|590218909|FG002|Overall Study|Withdrawal by Subject|1|||
163412572|NCT02787863|590218910|FG003|Overall Study|Withdrawal by Subject|0|||
163412573|NCT02787863|590218911|FG004|Overall Study|Withdrawal by Subject|0|||
163412574|NCT02787863|590218912|FG005|Overall Study|Withdrawal by Subject|0|||
163412575|NCT02787863|590218913|FG006|Overall Study|Withdrawal by Subject|0|||
163412576|NCT02787863|590218914|FG007|Overall Study|Withdrawal by Subject|0|||
163412577|NCT02479802|590218915|FG000|Overall Study|Lost to Follow-up|1|||
163412578|NCT02479802|590218915|FG000|Overall Study|Adverse Event|1|||
163412579|NCT02421887|590218916|FG000|Overall Study|Lost to Follow-up|5|||
163412580|NCT02421887|590218917|FG001|Overall Study|Lost to Follow-up|0|||
163412581|NCT02421887|590218916|FG000|Overall Study|Withdrawal by Subject|8|||
163412582|NCT02421887|590218917|FG001|Overall Study|Withdrawal by Subject|5|||
163412583|NCT02421887|590218916|FG000|Overall Study|Physician Decision|2|||
163412584|NCT02421887|590218917|FG001|Overall Study|Physician Decision|4|||
163412585|NCT02421887|590218916|FG000|Overall Study|Adverse Event|2|||
163412586|NCT02421887|590218917|FG001|Overall Study|Adverse Event|0|||
163412587|NCT01882907|590218918|FG000|Overall Study|Adverse Event|3|||
163412588|NCT01882907|590218919|FG001|Overall Study|Adverse Event|1|||
163412589|NCT01882907|590218918|FG000|Overall Study|Lack of Efficacy|0|||
163412590|NCT01882907|590218919|FG001|Overall Study|Lack of Efficacy|3|||
163412591|NCT01882907|590218918|FG000|Overall Study|Lost to Follow-up|1|||
163412592|NCT01882907|590218919|FG001|Overall Study|Lost to Follow-up|4|||
163412593|NCT01882907|590218918|FG000|Overall Study|Protocol Violation|10|||
163412594|NCT01882907|590218919|FG001|Overall Study|Protocol Violation|14|||
163412595|NCT01882907|590218918|FG000|Overall Study|Withdrawal by Subject|0|||
163412596|NCT01882907|590218919|FG001|Overall Study|Withdrawal by Subject|6|||
163412597|NCT02162732|590218920|FG000|Overall Study|Biopsy not performed.|18|||
163412598|NCT01784965|590218921|FG000|Overall Study|Withdrawal by Subject|6|||
163412599|NCT01784965|590218922|FG001|Overall Study|Withdrawal by Subject|3|||
163412600|NCT01784965|590218921|FG000|Overall Study|Adverse Event|0|||
163366121|NCT03842228|590050649|FG002|Overall Study|Progression|7|||
163366122|NCT03842228|590050650|FG003|Overall Study|Progression|5|||
163366123|NCT03842228|590050651|FG004|Overall Study|Progression|4|||
163366124|NCT03842228|590050652|FG005|Overall Study|Progression|2|||
163366125|NCT03842228|590050653|FG006|Overall Study|Progression|3|||
163366126|NCT02195479|590050666|FG000|Overall Study|Lost to Follow-up|18|||
163366127|NCT02195479|590050667|FG001|Overall Study|Lost to Follow-up|15|||
163366128|NCT02195479|590050666|FG000|Overall Study|Death|217|||
163366129|NCT02195479|590050667|FG001|Overall Study|Death|171|||
163366130|NCT02195479|590050666|FG000|Overall Study|Physician Decision|1|||
163366131|NCT02195479|590050667|FG001|Overall Study|Physician Decision|0|||
163366132|NCT02195479|590050666|FG000|Overall Study|Withdrawal by Subject|30|||
163366133|NCT02195479|590050667|FG001|Overall Study|Withdrawal by Subject|30|||
163366134|NCT02195479|590050666|FG000|Overall Study|Other|3|||
163366135|NCT02195479|590050667|FG001|Overall Study|Other|4|||
163366136|NCT02195479|590050666|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
163366137|NCT02195479|590050667|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
163366138|NCT01834586|590050668|FG000|Overall Study|Adverse Event|1|||
163366139|NCT01263509|590050671|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
163366140|NCT01263509|590050672|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
163366141|NCT01263509|590050673|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
163366142|NCT01263509|590050674|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
163366143|NCT01263509|590050671|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
163366144|NCT01263509|590050672|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
163366145|NCT01263509|590050673|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
163366146|NCT01263509|590050674|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
163366147|NCT01263509|590050671|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163366148|NCT01263509|590050672|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
163366149|NCT01263509|590050673|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
163366150|NCT01263509|590050674|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
163366151|NCT01263509|590050671|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
163366152|NCT01263509|590050672|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
163366153|NCT01263509|590050673|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163366154|NCT01263509|590050674|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163366155|NCT01263509|590050671|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
163366156|NCT01263509|590050672|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
163366157|NCT01263509|590050673|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
163366158|NCT01263509|590050674|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
163366159|NCT01818531|590050684|FG000|Overall Study|Withdrawn for case delay after block|1|||
163366160|NCT01818531|590050685|FG001|Overall Study|Withdrawn for case delay after block|0|||
163366161|NCT01818531|590050684|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
163366162|NCT01818531|590050685|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
163366163|NCT01818531|590050684|FG000|Overall Study|Withdrawn for failure to place block|0|||
163366164|NCT01818531|590050685|FG001|Overall Study|Withdrawn for failure to place block|1|||
163366165|NCT00214019|590050686|FG000|Overall Study|Lost to Follow-up|11|||
163366166|NCT00214019|590050686|FG000|Overall Study|Withdrawal by Subject|2|||
163366167|NCT00214019|590050686|FG000|Overall Study|Screen Failed prior to randomization|17|||
163366168|NCT00477490|590050687|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
163366169|NCT00477490|590050688|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
163366170|NCT00477490|590050689|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
163366171|NCT00477490|590050690|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
163366172|NCT00477490|590050691|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
163366173|NCT00477490|590050692|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
163366174|NCT00477490|590050693|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
163366175|NCT00477490|590050694|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
163366176|NCT00477490|590050695|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
163366177|NCT00477490|590050687|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
163366178|NCT00477490|590050688|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
163366179|NCT00477490|590050689|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
163366180|NCT00477490|590050690|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
163366181|NCT00477490|590050691|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
163366182|NCT00477490|590050692|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
163366183|NCT00477490|590050693|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
163366184|NCT00477490|590050694|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
163366185|NCT00477490|590050695|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
163366186|NCT00477490|590050687|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
163366187|NCT00477490|590050688|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
163366188|NCT00477490|590050689|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
163366189|NCT00477490|590050690|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
163366190|NCT00477490|590050691|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
163366191|NCT00477490|590050692|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
163366192|NCT00477490|590050693|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
163366193|NCT00477490|590050694|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
163366194|NCT00477490|590050695|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
163366195|NCT00477490|590050687|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
163366196|NCT00477490|590050688|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
163366197|NCT00477490|590050689|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
163366198|NCT00477490|590050690|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
163366199|NCT00477490|590050691|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
163366200|NCT00477490|590050692|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
163366201|NCT00477490|590050693|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
163366202|NCT00477490|590050694|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
163366203|NCT00477490|590050695|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
163366204|NCT00477490|590050687|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
163366205|NCT00477490|590050688|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
163366206|NCT00477490|590050689|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
163366207|NCT00477490|590050690|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
163366208|NCT00477490|590050691|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
163366209|NCT00477490|590050692|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
163366210|NCT00477490|590050693|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
163366211|NCT00477490|590050694|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
163366212|NCT00477490|590050695|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
163366213|NCT00477490|590050687|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
163366214|NCT00477490|590050688|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
163366215|NCT00477490|590050689|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
163366216|NCT00477490|590050690|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
163366217|NCT00477490|590050691|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
163366218|NCT00477490|590050692|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
163366219|NCT00477490|590050693|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
163366220|NCT00477490|590050694|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
163366221|NCT00477490|590050695|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
163366222|NCT00477490|590050687|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
163366223|NCT00477490|590050688|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
163366224|NCT00477490|590050689|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
163366225|NCT00477490|590050690|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
163366226|NCT00477490|590050691|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
163366227|NCT00477490|590050692|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
163366228|NCT00477490|590050693|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
163366229|NCT00477490|590050694|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
163366230|NCT00477490|590050695|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
163366231|NCT00477490|590050687|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
163366232|NCT00477490|590050688|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
163366233|NCT00477490|590050689|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
163366234|NCT00477490|590050690|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
163366235|NCT00477490|590050691|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
163366236|NCT00477490|590050692|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
163366237|NCT00477490|590050693|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
163366238|NCT00477490|590050694|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
163366239|NCT00477490|590050695|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
163366240|NCT00477490|590050687|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
163366241|NCT00477490|590050688|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
163366242|NCT00477490|590050689|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
163366243|NCT00477490|590050690|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
163366244|NCT00477490|590050691|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
163366245|NCT00477490|590050692|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
163366246|NCT00477490|590050693|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
163366247|NCT00477490|590050694|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
163366248|NCT00477490|590050695|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
163366249|NCT00477490|590050687|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
163366250|NCT00477490|590050688|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
163366251|NCT00477490|590050689|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
163366252|NCT00477490|590050690|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
163366253|NCT00477490|590050691|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
163366254|NCT00477490|590050692|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
163366255|NCT00477490|590050693|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
163366256|NCT00477490|590050694|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
163366257|NCT00477490|590050695|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
163366258|NCT00477490|590050687|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
163366259|NCT00477490|590050688|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
163366260|NCT00477490|590050689|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
163366261|NCT00477490|590050690|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
163366262|NCT00477490|590050691|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
163366263|NCT00477490|590050692|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
163366264|NCT00477490|590050693|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
163366265|NCT00477490|590050694|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
163366266|NCT00477490|590050695|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
163366267|NCT00477490|590050687|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163366268|NCT00477490|590050688|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
163366269|NCT00477490|590050689|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163366270|NCT00477490|590050690|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163366271|NCT00477490|590050691|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163366272|NCT00477490|590050692|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163366273|NCT00477490|590050693|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163366274|NCT00477490|590050694|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163366275|NCT00477490|590050695|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163366276|NCT00477490|590050687|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
163366277|NCT00477490|590050688|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
163366278|NCT00477490|590050689|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
163366279|NCT00477490|590050690|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
163366280|NCT00477490|590050691|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
163366281|NCT00477490|590050692|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
163366282|NCT00477490|590050693|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
163366283|NCT00477490|590050694|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
163366284|NCT00477490|590050695|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
163366285|NCT00477490|590050687|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
163366286|NCT00477490|590050688|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
163366287|NCT00477490|590050689|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
163366288|NCT00477490|590050690|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
163366289|NCT00477490|590050691|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
163366290|NCT00477490|590050692|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
163366291|NCT00477490|590050693|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
163366292|NCT00477490|590050694|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
163366293|NCT00477490|590050695|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
163366294|NCT01465763|590050698|FG000|Overall Study|Withdrawal by Subject|4|||
163366295|NCT01465763|590050699|FG001|Overall Study|Withdrawal by Subject|0|||
163366296|NCT01465763|590050700|FG002|Overall Study|Withdrawal by Subject|1|||
163366297|NCT01465763|590050698|FG000|Overall Study|Insufficient Clinical Response|11|||
163366298|NCT01465763|590050699|FG001|Overall Study|Insufficient Clinical Response|0|||
163366299|NCT01465763|590050700|FG002|Overall Study|Insufficient Clinical Response|1|||
163366300|NCT01465763|590050698|FG000|Overall Study|Adverse Event|9|||
163366301|NCT01465763|590050699|FG001|Overall Study|Adverse Event|0|||
163366302|NCT01465763|590050700|FG002|Overall Study|Adverse Event|1|||
163366303|NCT01465763|590050698|FG000|Overall Study|Other|2|||
163366304|NCT01465763|590050699|FG001|Overall Study|Other|0|||
163366305|NCT01465763|590050700|FG002|Overall Study|Other|0|||
163366306|NCT01465763|590050698|FG000|Overall Study|Protocol Violation|4|||
163366307|NCT01465763|590050699|FG001|Overall Study|Protocol Violation|1|||
163366308|NCT01465763|590050700|FG002|Overall Study|Protocol Violation|1|||
163366309|NCT01465763|590050698|FG000|Overall Study|Death|1|||
163366310|NCT01465763|590050699|FG001|Overall Study|Death|0|||
163366311|NCT01465763|590050700|FG002|Overall Study|Death|0|||
163366312|NCT01646177|590050701|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
163366313|NCT01646177|590050702|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
163366314|NCT01646177|590050703|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
163366315|NCT01646177|590050704|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
163366316|NCT01646177|590050705|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163366317|NCT01646177|590050706|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163366318|NCT01646177|590050707|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163366319|NCT01646177|590050708|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163366320|NCT01646177|590050709|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163366321|NCT01646177|590050710|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163366322|NCT01646177|590050711|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163412601|NCT01784965|590218922|FG001|Overall Study|Adverse Event|8|||
163366323|NCT01646177|590050712|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163366324|NCT01646177|590050701|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
163366325|NCT01646177|590050702|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
163366326|NCT01646177|590050703|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
163412602|NCT03757988|590218923|FG000|Overall Study|Withdrawal by Subject|1|||
163412603|NCT04269395|590218926|FG000|Overall Study|Lost to Follow-up|1|||
163412604|NCT04269395|590218927|FG001|Overall Study|Lost to Follow-up|0|||
163412605|NCT04269395|590218926|FG000|Overall Study|Study terminated by Sponsor|13|||
163412606|NCT04269395|590218927|FG001|Overall Study|Study terminated by Sponsor|10|||
163412607|NCT04161495|590218928|FG000|Overall Study|Withdrawal by Subject|3|||
163412608|NCT04161495|590218929|FG001|Overall Study|Withdrawal by Subject|0|||
163412609|NCT04161495|590218928|FG000|Overall Study|Protocol Violation|1|||
163412610|NCT04161495|590218929|FG001|Overall Study|Protocol Violation|0|||
163412611|NCT04161495|590218928|FG000|Overall Study|Prohibited concomitant medication|3|||
163412612|NCT04161495|590218929|FG001|Overall Study|Prohibited concomitant medication|0|||
163412613|NCT04161495|590218928|FG000|Overall Study|Adverse Event|1|||
163412614|NCT04161495|590218929|FG001|Overall Study|Adverse Event|0|||
163412615|NCT04161495|590218928|FG000|Overall Study|Other - Unspecified|1|||
163412616|NCT04161495|590218929|FG001|Overall Study|Other - Unspecified|0|||
163412617|NCT04161495|590218928|FG000|Overall Study|Death|0|||
163412618|NCT04161495|590218929|FG001|Overall Study|Death|1|||
163412619|NCT00252057|590218932|FG000|Overall Study|Withdrawal by Subject|2|||
163412620|NCT00252057|590218933|FG001|Overall Study|Withdrawal by Subject|5|||
163412621|NCT00252057|590218932|FG000|Overall Study|Death|1|||
163412622|NCT00252057|590218933|FG001|Overall Study|Death|2|||
163412623|NCT00252057|590218932|FG000|Overall Study|Participant previously enrolled|0|||
163412624|NCT00252057|590218933|FG001|Overall Study|Participant previously enrolled|1|||
163412625|NCT02926209|590218934|FG000|Study Cohort|Poor Bowel Preparation|1|||
163412626|NCT02926209|590218935|FG001|Study Cohort|Poor Bowel Preparation|0|||
163412627|NCT00429858|590218936|FG000|Overall Study|Withdrawal by Subject|1|||
163412628|NCT00429858|590218936|FG000|Overall Study|Study Termination|1|||
163412629|NCT01587079|590218937|FG000|Overall Study|Protocol-specified criteria|9|||
163412630|NCT01587079|590218937|FG000|Overall Study|Protocol Violation|5|||
163412631|NCT01587079|590218937|FG000|Overall Study|Lost to Follow-up|2|||
163412632|NCT01587079|590218937|FG000|Overall Study|Physician Decision|2|||
163412633|NCT01587079|590218937|FG000|Overall Study|Withdrawal by Subject|7|||
163412634|NCT01587079|590218937|FG000|Overall Study|Adverse Event|14|||
163412635|NCT01764633|590218938|FG000|Overall Study|Withdrawal by Subject|105|||
163412636|NCT01764633|590218939|FG001|Overall Study|Withdrawal by Subject|88|||
163412637|NCT01764633|590218938|FG000|Overall Study|Lost to Follow-up|13|||
163412638|NCT01764633|590218939|FG001|Overall Study|Lost to Follow-up|5|||
163412639|NCT02268058|590218940|FG000|Overall Study|Protocol Violation|1|||
163412640|NCT02268058|590218941|FG001|Overall Study|Protocol Violation|0|||
163412641|NCT02268058|590218942|FG002|Overall Study|Protocol Violation|0|||
163412642|NCT02268058|590218943|FG003|Overall Study|Protocol Violation|0|||
163412643|NCT04142983|590218944|FG000|Overall Study|Lost to Follow-up|73|||
163412644|NCT04142983|590218944|FG000|Overall Study|Withdrawal by Subject|10|||
163412645|NCT04142983|590218944|FG000|Overall Study|Physician Decision|1|||
163412646|NCT04142983|590218944|FG000|Overall Study|Adverse Event|1|||
163412647|NCT04142983|590218944|FG000|Overall Study|No longer eligible|4|||
163412648|NCT04142983|590218944|FG000|Overall Study|Screen Failure|10|||
163412649|NCT04781816|590218945|FG000|Overall Study|Adverse Event|0|||
163412650|NCT04781816|590218946|FG001|Overall Study|Adverse Event|1|||
163412651|NCT04781816|590218945|FG000|Overall Study|Withdrawal by Subject|1|||
163412652|NCT04781816|590218946|FG001|Overall Study|Withdrawal by Subject|1|||
163412653|NCT04781816|590218945|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
163412654|NCT04781816|590218946|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
163412655|NCT04372927|590218951|FG000|Overall Study|Death|1|||
163412656|NCT01847885|590218955|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
163412657|NCT01847885|590218956|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
163412658|NCT01847885|590218957|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
163412659|NCT01847885|590218955|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
163412660|NCT01847885|590218956|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
163412661|NCT01847885|590218957|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
163412662|NCT01847885|590218955|FG000|Initial Enrollment (Consented)|Screen failure|39|||
163412663|NCT01847885|590218956|FG001|Initial Enrollment (Consented)|Screen failure|0|||
163412664|NCT01847885|590218957|FG002|Initial Enrollment (Consented)|Screen failure|0|||
163412665|NCT01847885|590218955|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
163412666|NCT01847885|590218956|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
163412667|NCT01847885|590218957|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
163412668|NCT01847885|590218955|FG000|Randomization|Protocol Violation|0|||
163412669|NCT01847885|590218956|FG001|Randomization|Protocol Violation|1|||
163412670|NCT01847885|590218957|FG002|Randomization|Protocol Violation|0|||
163412671|NCT01847885|590218955|FG000|Randomization|Withdrawal by Subject|0|||
163412672|NCT01847885|590218956|FG001|Randomization|Withdrawal by Subject|0|||
163412673|NCT01847885|590218957|FG002|Randomization|Withdrawal by Subject|2|||
163412674|NCT01847885|590218955|FG000|Randomization|Screen Failure|0|||
163412675|NCT01847885|590218956|FG001|Randomization|Screen Failure|3|||
163412676|NCT01847885|590218957|FG002|Randomization|Screen Failure|0|||
163412677|NCT00662792|590218961|FG000|Period 1|Personal Reasons|0|||
163412678|NCT00662792|590218962|FG001|Period 1|Personal Reasons|0|||
163412679|NCT00662792|590218963|FG002|Period 1|Personal Reasons|1|||
163412680|NCT00662792|590218964|FG003|Period 1|Personal Reasons|0|||
163412681|NCT00662792|590218961|FG000|Period 1|Refused continuing medication|0|||
163412682|NCT00662792|590218962|FG001|Period 1|Refused continuing medication|1|||
163412683|NCT00662792|590218963|FG002|Period 1|Refused continuing medication|1|||
163412684|NCT00662792|590218964|FG003|Period 1|Refused continuing medication|0|||
163412685|NCT00662792|590218961|FG000|Period 1|Lost to Follow-up|1|||
163412686|NCT00662792|590218962|FG001|Period 1|Lost to Follow-up|0|||
163412687|NCT00662792|590218963|FG002|Period 1|Lost to Follow-up|0|||
163412688|NCT00662792|590218964|FG003|Period 1|Lost to Follow-up|0|||
163412689|NCT00662792|590218961|FG000|Period 1|Other adverse event (AE)|0|||
163412690|NCT00662792|590218962|FG001|Period 1|Other adverse event (AE)|2|||
163412691|NCT00662792|590218963|FG002|Period 1|Other adverse event (AE)|0|||
163412692|NCT00662792|590218964|FG003|Period 1|Other adverse event (AE)|0|||
163366327|NCT01646177|590050704|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
163366328|NCT01646177|590050705|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163366329|NCT01646177|590050706|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163366330|NCT01646177|590050707|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163366331|NCT01646177|590050708|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163366332|NCT01646177|590050709|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163366333|NCT01646177|590050710|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163366334|NCT01646177|590050711|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163366335|NCT01646177|590050712|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163366336|NCT01646177|590050701|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
163366337|NCT01646177|590050702|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
163366338|NCT01646177|590050703|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
163366339|NCT01646177|590050704|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
163366340|NCT01646177|590050705|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163366341|NCT01646177|590050706|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163366342|NCT01646177|590050707|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163366343|NCT01646177|590050708|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163366344|NCT01646177|590050709|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163366345|NCT01646177|590050710|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163366346|NCT01646177|590050711|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163366347|NCT01646177|590050712|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163366348|NCT01646177|590050701|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
163366349|NCT01646177|590050702|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
163366350|NCT01646177|590050703|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
163366351|NCT01646177|590050704|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
163366352|NCT01646177|590050705|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
163366353|NCT01646177|590050706|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
163366354|NCT01646177|590050707|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
163366355|NCT01646177|590050708|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
163366356|NCT01646177|590050709|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
163366357|NCT01646177|590050710|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
163366358|NCT01646177|590050711|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
163366359|NCT01646177|590050712|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
163366360|NCT01646177|590050701|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163366361|NCT01646177|590050702|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163366362|NCT01646177|590050703|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
163366363|NCT01646177|590050704|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
163366364|NCT01646177|590050705|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163366365|NCT01646177|590050706|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163366366|NCT01646177|590050707|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163366367|NCT01646177|590050708|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163366368|NCT01646177|590050709|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163366369|NCT01646177|590050710|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163366370|NCT01646177|590050711|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163366371|NCT01646177|590050712|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163366372|NCT01646177|590050701|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
163366373|NCT01646177|590050702|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
163366374|NCT01646177|590050703|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
163366375|NCT01646177|590050704|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163412693|NCT00662792|590218961|FG000|Period 1|Worsening of disease under study (AE)|1|||
163412694|NCT00662792|590218962|FG001|Period 1|Worsening of disease under study (AE)|3|||
163412695|NCT00662792|590218963|FG002|Period 1|Worsening of disease under study (AE)|2|||
163412696|NCT00662792|590218964|FG003|Period 1|Worsening of disease under study (AE)|0|||
163366376|NCT01646177|590050705|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163366377|NCT01646177|590050706|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163366378|NCT01646177|590050707|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163366379|NCT01646177|590050708|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163366380|NCT01646177|590050709|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163366381|NCT01646177|590050710|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163366382|NCT01646177|590050711|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163366383|NCT01646177|590050712|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163366384|NCT01646177|590050701|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163366385|NCT01646177|590050702|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163366386|NCT01646177|590050703|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163366387|NCT01646177|590050704|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163366388|NCT01646177|590050705|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
163366389|NCT01646177|590050706|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
163366390|NCT01646177|590050707|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
163366391|NCT01646177|590050708|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
163366392|NCT01646177|590050709|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163366393|NCT01646177|590050710|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163366394|NCT01646177|590050711|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163366395|NCT01646177|590050712|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163366396|NCT01646177|590050701|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163366397|NCT01646177|590050702|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163366398|NCT01646177|590050703|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163366399|NCT01646177|590050704|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163366400|NCT01646177|590050705|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
163366401|NCT01646177|590050706|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
163366402|NCT01646177|590050707|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
163366403|NCT01646177|590050708|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
163366404|NCT01646177|590050709|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163366405|NCT01646177|590050710|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163366406|NCT01646177|590050711|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163366407|NCT01646177|590050712|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163366408|NCT01646177|590050701|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
163366409|NCT01646177|590050702|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
163366410|NCT01646177|590050703|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
163366411|NCT01646177|590050704|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
163366412|NCT01646177|590050705|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
163366413|NCT01646177|590050706|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
163366414|NCT01646177|590050707|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
163366415|NCT01646177|590050708|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
163366416|NCT01646177|590050709|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
163366417|NCT01646177|590050710|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
163366418|NCT01646177|590050711|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
163366419|NCT01646177|590050712|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
163366420|NCT01646177|590050701|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163366421|NCT01646177|590050702|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163366422|NCT01646177|590050703|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163366423|NCT01646177|590050704|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163366424|NCT01646177|590050705|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
163366425|NCT01646177|590050706|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
163366426|NCT01646177|590050707|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
163366427|NCT01646177|590050708|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
163366428|NCT01646177|590050709|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163366429|NCT01646177|590050710|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163366430|NCT01646177|590050711|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163366431|NCT01646177|590050712|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163366432|NCT01646177|590050701|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163366433|NCT01646177|590050702|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163366434|NCT01646177|590050703|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163366435|NCT01646177|590050704|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163366436|NCT01646177|590050705|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
163366437|NCT01646177|590050706|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
163366438|NCT01646177|590050707|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
163412697|NCT00662792|590218961|FG000|Period 1|Not treated|0|||
163366439|NCT01646177|590050708|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
163366440|NCT01646177|590050709|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163366441|NCT01646177|590050710|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163366442|NCT01646177|590050711|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163366443|NCT01646177|590050712|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163366444|NCT01646177|590050701|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163366445|NCT01646177|590050702|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163366446|NCT01646177|590050703|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163366447|NCT01646177|590050704|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163366448|NCT01646177|590050705|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
163366449|NCT01646177|590050706|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
163366450|NCT01646177|590050707|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163366451|NCT01646177|590050708|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
163366452|NCT01646177|590050709|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163366453|NCT01646177|590050710|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163366454|NCT01646177|590050711|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163366455|NCT01646177|590050712|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163366456|NCT01646177|590050701|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163366457|NCT01646177|590050702|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163366458|NCT01646177|590050703|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163366459|NCT01646177|590050704|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163366460|NCT01646177|590050705|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
163366461|NCT01646177|590050706|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
163366462|NCT01646177|590050707|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
163366463|NCT01646177|590050708|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
163366464|NCT01646177|590050709|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163366465|NCT01646177|590050710|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163366466|NCT01646177|590050711|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163366467|NCT01646177|590050712|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163366468|NCT01646177|590050701|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
163366469|NCT01646177|590050702|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
163366470|NCT01646177|590050703|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
163366471|NCT01646177|590050704|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
163366472|NCT01646177|590050705|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
163366473|NCT01646177|590050706|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
163366474|NCT01646177|590050707|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
163366475|NCT01646177|590050708|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
163366476|NCT01646177|590050709|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
163366477|NCT01646177|590050710|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
163366478|NCT01646177|590050711|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
163366479|NCT01646177|590050712|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
163366480|NCT01646177|590050701|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
163366481|NCT01646177|590050702|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
163366482|NCT01646177|590050703|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
163366483|NCT01646177|590050704|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
163366484|NCT01646177|590050705|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
163366485|NCT01646177|590050706|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
163366486|NCT01646177|590050707|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
163366487|NCT01646177|590050708|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
163366488|NCT01646177|590050709|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
163366489|NCT01646177|590050710|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
163366490|NCT01646177|590050711|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
163366491|NCT01646177|590050712|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
163366492|NCT01646177|590050701|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163366493|NCT01646177|590050702|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163366494|NCT01646177|590050703|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163366495|NCT01646177|590050704|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163366496|NCT01646177|590050705|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163366497|NCT01646177|590050706|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163366498|NCT01646177|590050707|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163366499|NCT01646177|590050708|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
163366500|NCT01646177|590050709|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163366501|NCT01646177|590050710|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163366502|NCT01646177|590050711|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163366503|NCT01646177|590050712|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163366504|NCT01646177|590050701|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163366505|NCT01646177|590050702|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163366506|NCT01646177|590050703|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163366507|NCT01646177|590050704|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163366508|NCT01646177|590050705|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163366509|NCT01646177|590050706|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
163366510|NCT01646177|590050707|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
163366511|NCT01646177|590050708|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
163366512|NCT01646177|590050709|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163366513|NCT01646177|590050710|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163366514|NCT01646177|590050711|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163366515|NCT01646177|590050712|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163366516|NCT01646177|590050701|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
163366517|NCT01646177|590050702|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
163366518|NCT01646177|590050703|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
163366519|NCT01646177|590050704|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
163366520|NCT01646177|590050705|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
163366521|NCT01646177|590050706|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
163366522|NCT01646177|590050707|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
163366523|NCT01646177|590050708|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
163366524|NCT01646177|590050709|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
163366525|NCT01646177|590050710|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
163366526|NCT01646177|590050711|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
163366527|NCT01646177|590050712|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
163366528|NCT01646177|590050701|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163366529|NCT01646177|590050702|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163366530|NCT01646177|590050703|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163366531|NCT01646177|590050704|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163366532|NCT01646177|590050705|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163366533|NCT01646177|590050706|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163366534|NCT01646177|590050707|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163366535|NCT01646177|590050708|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163366536|NCT01646177|590050709|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
163366537|NCT01646177|590050710|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
163366538|NCT01646177|590050711|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
163366539|NCT01646177|590050712|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
163366540|NCT01646177|590050701|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163366541|NCT01646177|590050702|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163366542|NCT01646177|590050703|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163366543|NCT01646177|590050704|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163366544|NCT01646177|590050705|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163366545|NCT01646177|590050706|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163366546|NCT01646177|590050707|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163366547|NCT01646177|590050708|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163366548|NCT01646177|590050709|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
163366549|NCT01646177|590050710|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
163366550|NCT01646177|590050711|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
163366551|NCT01646177|590050712|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
163366552|NCT01646177|590050701|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163366553|NCT01646177|590050702|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163366554|NCT01646177|590050703|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163366555|NCT01646177|590050704|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163366556|NCT01646177|590050705|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163366557|NCT01646177|590050706|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163366558|NCT01646177|590050707|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163366559|NCT01646177|590050708|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163366560|NCT01646177|590050709|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
163366561|NCT01646177|590050710|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
163366562|NCT01646177|590050711|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
163366563|NCT01646177|590050712|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
163366564|NCT01646177|590050701|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163366565|NCT01646177|590050702|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163366566|NCT01646177|590050703|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163412698|NCT00662792|590218962|FG001|Period 1|Not treated|1|||
163412699|NCT00662792|590218963|FG002|Period 1|Not treated|0|||
163412700|NCT00662792|590218964|FG003|Period 1|Not treated|0|||
163412701|NCT00662792|590218961|FG000|Period 2|Worsening of disease under study|1|||
163412702|NCT00662792|590218962|FG001|Period 2|Worsening of disease under study|0|||
163412703|NCT00662792|590218963|FG002|Period 2|Worsening of disease under study|0|||
163412704|NCT00662792|590218964|FG003|Period 2|Worsening of disease under study|3|||
163412705|NCT00662792|590218961|FG000|Period 3|Refused continuing medication|1|||
163412706|NCT00662792|590218962|FG001|Period 3|Refused continuing medication|0|||
163412707|NCT00662792|590218963|FG002|Period 3|Refused continuing medication|1|||
163366567|NCT01646177|590050704|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163366568|NCT01646177|590050705|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163366569|NCT01646177|590050706|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163366570|NCT01646177|590050707|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163366571|NCT01646177|590050708|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163366572|NCT01646177|590050709|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
163366573|NCT01646177|590050710|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
163366574|NCT01646177|590050711|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
163366575|NCT01646177|590050712|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
163366576|NCT01646177|590050701|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
163366577|NCT01646177|590050702|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
163366578|NCT01646177|590050703|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
163366579|NCT01646177|590050704|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
163366580|NCT01646177|590050705|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
163366581|NCT01646177|590050706|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
163366582|NCT01646177|590050707|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
163366583|NCT01646177|590050708|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
163366584|NCT01646177|590050709|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
163366585|NCT01646177|590050710|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
163366586|NCT01646177|590050711|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
163366587|NCT01646177|590050712|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
163366588|NCT01646177|590050701|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163366589|NCT01646177|590050702|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163366590|NCT01646177|590050703|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163366591|NCT01646177|590050704|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163366592|NCT01646177|590050705|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163366593|NCT01646177|590050706|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163366594|NCT01646177|590050707|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163366595|NCT01646177|590050708|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163366596|NCT01646177|590050709|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163366597|NCT01646177|590050710|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
163366598|NCT01646177|590050711|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
163366599|NCT01646177|590050712|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
163366600|NCT01646177|590050701|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163366601|NCT01646177|590050702|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163366602|NCT01646177|590050703|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163366603|NCT01646177|590050704|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163366604|NCT01646177|590050705|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163366605|NCT01646177|590050706|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163366606|NCT01646177|590050707|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163366607|NCT01646177|590050708|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163366608|NCT01646177|590050709|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163366609|NCT01646177|590050710|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
163366610|NCT01646177|590050711|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
163366611|NCT01646177|590050712|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
163366612|NCT01646177|590050701|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163366613|NCT01646177|590050702|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163412708|NCT00662792|590218964|FG003|Period 3|Refused continuing medication|0|||
163412709|NCT00662792|590218961|FG000|Period 3|Other adverse event (AE)|0|||
163412710|NCT00662792|590218962|FG001|Period 3|Other adverse event (AE)|0|||
163412711|NCT00662792|590218963|FG002|Period 3|Other adverse event (AE)|1|||
163412712|NCT00662792|590218964|FG003|Period 3|Other adverse event (AE)|1|||
163412713|NCT00662792|590218961|FG000|Period 4|Refused continuing medication|0|||
163412714|NCT00662792|590218962|FG001|Period 4|Refused continuing medication|1|||
163412715|NCT00662792|590218963|FG002|Period 4|Refused continuing medication|0|||
163412716|NCT00662792|590218964|FG003|Period 4|Refused continuing medication|0|||
163412717|NCT00662792|590218961|FG000|Period 4|Other adverse event (AE)|1|||
163412718|NCT00662792|590218962|FG001|Period 4|Other adverse event (AE)|0|||
163412719|NCT00662792|590218963|FG002|Period 4|Other adverse event (AE)|0|||
163412720|NCT00662792|590218964|FG003|Period 4|Other adverse event (AE)|0|||
163412721|NCT00662792|590218961|FG000|Period 4|Worsening of disease under study (AE)|0|||
163412722|NCT00662792|590218962|FG001|Period 4|Worsening of disease under study (AE)|0|||
163412723|NCT00662792|590218963|FG002|Period 4|Worsening of disease under study (AE)|0|||
163412724|NCT00662792|590218964|FG003|Period 4|Worsening of disease under study (AE)|1|||
163412725|NCT01999582|590218965|FG000|Overall Study|Withdrawal by Subject|0|||
163412726|NCT01999582|590218966|FG001|Overall Study|Withdrawal by Subject|0|||
163412727|NCT01999582|590218967|FG002|Overall Study|Withdrawal by Subject|0|||
163412728|NCT01999582|590218968|FG003|Overall Study|Withdrawal by Subject|1|||
163412729|NCT01999582|590218969|FG004|Overall Study|Withdrawal by Subject|0|||
163412730|NCT01999582|590218970|FG005|Overall Study|Withdrawal by Subject|0|||
163412731|NCT01999582|590218965|FG000|Overall Study|Adverse Event|0|||
163412732|NCT01999582|590218966|FG001|Overall Study|Adverse Event|0|||
163412733|NCT01999582|590218967|FG002|Overall Study|Adverse Event|3|||
163412734|NCT01999582|590218968|FG003|Overall Study|Adverse Event|0|||
163412735|NCT01999582|590218969|FG004|Overall Study|Adverse Event|1|||
163412736|NCT01999582|590218970|FG005|Overall Study|Adverse Event|0|||
163412737|NCT01999582|590218965|FG000|Overall Study|Other Reasons|1|||
163412738|NCT01999582|590218966|FG001|Overall Study|Other Reasons|0|||
163412739|NCT01999582|590218967|FG002|Overall Study|Other Reasons|3|||
163412740|NCT01999582|590218968|FG003|Overall Study|Other Reasons|1|||
163412741|NCT01999582|590218969|FG004|Overall Study|Other Reasons|1|||
163412742|NCT01999582|590218970|FG005|Overall Study|Other Reasons|2|||
163412743|NCT01999582|590218965|FG000|Overall Study|Protocol Violation|1|||
163412744|NCT01999582|590218966|FG001|Overall Study|Protocol Violation|0|||
163412745|NCT01999582|590218967|FG002|Overall Study|Protocol Violation|0|||
163412746|NCT01999582|590218968|FG003|Overall Study|Protocol Violation|0|||
163412747|NCT01999582|590218969|FG004|Overall Study|Protocol Violation|0|||
163412748|NCT01999582|590218970|FG005|Overall Study|Protocol Violation|1|||
163412749|NCT01999582|590218965|FG000|Overall Study|Lack of Efficacy|1|||
163412750|NCT01999582|590218966|FG001|Overall Study|Lack of Efficacy|3|||
163412751|NCT01999582|590218967|FG002|Overall Study|Lack of Efficacy|0|||
163412752|NCT01999582|590218968|FG003|Overall Study|Lack of Efficacy|1|||
163412753|NCT01999582|590218969|FG004|Overall Study|Lack of Efficacy|0|||
163412754|NCT01999582|590218970|FG005|Overall Study|Lack of Efficacy|0|||
163412755|NCT00411554|590218971|FG000|Overall Study|Adverse Event|2|||
163412756|NCT00411554|590218972|FG001|Overall Study|Adverse Event|4|||
163412757|NCT00411554|590218971|FG000|Overall Study|Lack of Efficacy|2|||
163412758|NCT00411554|590218972|FG001|Overall Study|Lack of Efficacy|5|||
163412759|NCT00411554|590218971|FG000|Overall Study|Withdrawal by Subject|3|||
163412760|NCT00411554|590218972|FG001|Overall Study|Withdrawal by Subject|0|||
163412761|NCT00411554|590218971|FG000|Overall Study|Patient Moved|1|||
163412762|NCT00411554|590218972|FG001|Overall Study|Patient Moved|0|||
163412763|NCT00927095|590218978|FG000|Overall Study|Adverse Event|3|||
163412764|NCT00927095|590218979|FG001|Overall Study|Adverse Event|1|||
163412765|NCT00927095|590218980|FG002|Overall Study|Adverse Event|0|||
163412766|NCT00927095|590218978|FG000|Overall Study|Withdrawal by Subject|2|||
163412767|NCT00927095|590218979|FG001|Overall Study|Withdrawal by Subject|1|||
163412768|NCT00927095|590218980|FG002|Overall Study|Withdrawal by Subject|1|||
163412769|NCT00927095|590218978|FG000|Overall Study|Physician Decision|1|||
163412770|NCT00927095|590218979|FG001|Overall Study|Physician Decision|2|||
163366614|NCT01646177|590050703|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163366615|NCT01646177|590050704|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163366616|NCT01646177|590050705|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163366617|NCT01646177|590050706|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163366618|NCT01646177|590050707|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163366619|NCT01646177|590050708|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163366620|NCT01646177|590050709|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
163366621|NCT01646177|590050710|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163366622|NCT01646177|590050711|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
163366623|NCT01646177|590050712|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
163412771|NCT00927095|590218980|FG002|Overall Study|Physician Decision|1|||
163412772|NCT00720109|590218989|FG000|Induction Period|Did not meet eligibility criteria|3|||
163366624|NCT01646177|590050701|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163366625|NCT01646177|590050702|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163412773|NCT00720109|590218990|FG001|Induction Period|Did not meet eligibility criteria|0|||
163412774|NCT00720109|590218991|FG002|Induction Period|Did not meet eligibility criteria|0|||
163412775|NCT00720109|590218989|FG000|Induction Period|Bone Marrow Transplant|2|||
163412776|NCT00720109|590218990|FG001|Induction Period|Bone Marrow Transplant|0|||
163412777|NCT00720109|590218991|FG002|Induction Period|Bone Marrow Transplant|0|||
163412778|NCT00720109|590218989|FG000|Induction Period|Physician Decision|1|||
163412779|NCT00720109|590218990|FG001|Induction Period|Physician Decision|0|||
163412780|NCT00720109|590218991|FG002|Induction Period|Physician Decision|0|||
163366626|NCT01646177|590050703|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163412781|NCT00720109|590218989|FG000|Risk Stratification Period|Adverse Event|0|||
163412782|NCT00720109|590218990|FG001|Risk Stratification Period|Adverse Event|1|||
163366627|NCT01646177|590050704|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163366628|NCT01646177|590050705|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163366629|NCT01646177|590050706|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163412783|NCT00720109|590218991|FG002|Risk Stratification Period|Adverse Event|0|||
163412784|NCT00720109|590218989|FG000|Risk Stratification Period|Physician Decision|0|||
163412785|NCT00720109|590218990|FG001|Risk Stratification Period|Physician Decision|2|||
163366630|NCT01646177|590050707|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163366631|NCT01646177|590050708|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163366632|NCT01646177|590050709|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163366633|NCT01646177|590050710|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163366634|NCT01646177|590050711|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
163366635|NCT01646177|590050712|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
163366636|NCT02992691|590050715|FG000|Overall Study|Adverse Event|2|||
163366637|NCT02992691|590050715|FG000|Overall Study|Withdrawal by Subject|1|||
163366638|NCT00588692|590050716|FG000|Overall Study|Withdrawal by Subject|4|||
163366639|NCT00588692|590050717|FG001|Overall Study|Withdrawal by Subject|2|||
163366640|NCT00588692|590050716|FG000|Overall Study|Hip Surgery|0|||
163366641|NCT00588692|590050717|FG001|Overall Study|Hip Surgery|1|||
163366642|NCT00588692|590050716|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
163366643|NCT00588692|590050717|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
163366644|NCT00588692|590050716|FG000|Overall Study|Cancer|1|||
163366645|NCT00588692|590050717|FG001|Overall Study|Cancer|0|||
163366646|NCT00588692|590050716|FG000|Overall Study|Death|1|||
163366647|NCT00588692|590050717|FG001|Overall Study|Death|0|||
163366648|NCT00820170|590050719|FG000|Overall Study|Adverse Event|0|||
163366649|NCT00820170|590050720|FG001|Overall Study|Adverse Event|0|||
163366650|NCT00820170|590050721|FG002|Overall Study|Adverse Event|0|||
163366651|NCT00820170|590050722|FG003|Overall Study|Adverse Event|0|||
163366652|NCT00820170|590050723|FG004|Overall Study|Adverse Event|2|||
163366653|NCT00820170|590050719|FG000|Overall Study|Progressive Disease|0|||
163366654|NCT00820170|590050720|FG001|Overall Study|Progressive Disease|0|||
163366655|NCT00820170|590050721|FG002|Overall Study|Progressive Disease|0|||
163366656|NCT00820170|590050722|FG003|Overall Study|Progressive Disease|0|||
163366657|NCT00820170|590050723|FG004|Overall Study|Progressive Disease|2|||
163366658|NCT02180243|590050724|FG000|Overall Study|Withdrawal by Subject|12|||
163366659|NCT02180243|590050725|FG001|Overall Study|Withdrawal by Subject|12|||
163366660|NCT02180243|590050724|FG000|Overall Study|Lost to Follow-up|12|||
163366661|NCT02180243|590050725|FG001|Overall Study|Lost to Follow-up|2|||
163366662|NCT01137578|590050726|FG000|Overall Study|Participant requested to Discontinue|3|||
163366663|NCT01137578|590050727|FG001|Overall Study|Participant requested to Discontinue|0|||
163366664|NCT01137578|590050728|FG002|Overall Study|Participant requested to Discontinue|0|||
163366665|NCT01137578|590050726|FG000|Overall Study|Withdrawal by Subject|1|||
163366666|NCT01137578|590050727|FG001|Overall Study|Withdrawal by Subject|0|||
163366667|NCT01137578|590050728|FG002|Overall Study|Withdrawal by Subject|0|||
163366668|NCT01137578|590050726|FG000|Overall Study|Other|12|||
163366669|NCT01137578|590050727|FG001|Overall Study|Other|2|||
163366670|NCT01137578|590050728|FG002|Overall Study|Other|6|||
163366671|NCT03651700|590050731|FG000|Overall Study|Withdrawal by Subject|1|||
163366672|NCT03651700|590050732|FG001|Overall Study|Withdrawal by Subject|0|||
163366673|NCT05479734|590050734|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
163366674|NCT05479734|590050735|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
163366675|NCT05479734|590050734|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
163366676|NCT05479734|590050735|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
163366677|NCT05479734|590050734|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
163366678|NCT05479734|590050735|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
163366679|NCT05479734|590050734|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
163366680|NCT05479734|590050735|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
163366681|NCT01461005|590050736|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
163366682|NCT01426347|590050740|FG000|Overall Study|Lost to Follow-up|0|||
163366683|NCT01426347|590050741|FG001|Overall Study|Lost to Follow-up|3|||
163366684|NCT01426347|590050740|FG000|Overall Study|Protocol Violation|2|||
163366685|NCT01426347|590050741|FG001|Overall Study|Protocol Violation|0|||
163366686|NCT01426347|590050740|FG000|Overall Study|Withdrawal by Subject|5|||
163366687|NCT01426347|590050741|FG001|Overall Study|Withdrawal by Subject|0|||
163366688|NCT00455741|590050742|FG000|Overall Study|Physician Decision|0|||
163366689|NCT00455741|590050743|FG001|Overall Study|Physician Decision|1|||
163366690|NCT00203268|590050744|FG000|Early Treatment|only treated one headache|2|||
163366691|NCT00203268|590050744|FG000|Early Treatment|Lost to Follow-up|1|||
163366692|NCT00203268|590050744|FG000|Early Treatment|Withdrawal by Subject|1|||
163366693|NCT00996606|590050745|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
163366694|NCT00996606|590050745|FG000|Overall Study|Insufficient Therapeutic Response|2|||
163366695|NCT00996606|590050745|FG000|Overall Study|Protocol Violation|1|||
163366696|NCT00996606|590050745|FG000|Overall Study|Withdrawal by Subject|3|||
163366697|NCT03197766|590050746|FG000|Overall Study|Withdrawal by Subject|2|||
163366698|NCT03197766|590050747|FG001|Overall Study|Withdrawal by Subject|0|||
163366699|NCT03633799|590050760|FG000|Overall Study|Adverse Event|349|||
163366700|NCT03633799|590050760|FG000|Overall Study|Withdrawal by Subject|288|||
163366701|NCT03633799|590050760|FG000|Overall Study|Lost to Follow-up|97|||
163366702|NCT03633799|590050760|FG000|Overall Study|Physician Decision|9|||
163366703|NCT03633799|590050760|FG000|Overall Study|Protocol Violation|4|||
163412786|NCT00720109|590218991|FG002|Risk Stratification Period|Physician Decision|1|||
163412787|NCT00720109|590218989|FG000|Risk Stratification Period|Bone marrow transplant|0|||
163412788|NCT00720109|590218990|FG001|Risk Stratification Period|Bone marrow transplant|9|||
163412789|NCT00720109|590218991|FG002|Risk Stratification Period|Bone marrow transplant|7|||
163412790|NCT00720109|590218989|FG000|Risk Stratification Period|Disease progression or relapse|0|||
163412791|NCT00720109|590218990|FG001|Risk Stratification Period|Disease progression or relapse|2|||
163366704|NCT03633799|590050760|FG000|Overall Study|Pregnancy|20|||
163366705|NCT03633799|590050760|FG000|Overall Study|other|39|||
163366706|NCT03633799|590050760|FG000|Overall Study|ongoing within third year of study|106|||
163366707|NCT03633799|590050760|FG000|Overall Study|unsuccessful study drug placement|19|||
163366708|NCT03551691|590050763|FG000|Overall Study|Withdrawal by Subject|3|||
163366709|NCT03551691|590050764|FG001|Overall Study|Withdrawal by Subject|3|||
163366710|NCT03829501|590053858|FG000|Overall Study|Withdrawal of Consent|2|||
163366711|NCT03829501|590053859|FG001|Overall Study|Withdrawal of Consent|0|||
163366712|NCT03829501|590053860|FG002|Overall Study|Withdrawal of Consent|3|||
163366713|NCT03829501|590053861|FG003|Overall Study|Withdrawal of Consent|0|||
163366714|NCT03829501|590053862|FG004|Overall Study|Withdrawal of Consent|1|||
163366715|NCT03829501|590053863|FG005|Overall Study|Withdrawal of Consent|1|||
163366716|NCT03829501|590053864|FG006|Overall Study|Withdrawal of Consent|0|||
163366717|NCT03829501|590053865|FG007|Overall Study|Withdrawal of Consent|10|||
163366718|NCT03829501|590053866|FG008|Overall Study|Withdrawal of Consent|10|||
163366719|NCT03829501|590053867|FG009|Overall Study|Withdrawal of Consent|3|||
163366720|NCT03829501|590053868|FG010|Overall Study|Withdrawal of Consent|4|||
163366721|NCT03829501|590053869|FG011|Overall Study|Withdrawal of Consent|4|||
163366722|NCT03829501|590053870|FG012|Overall Study|Withdrawal of Consent|4|||
163366723|NCT03829501|590053871|FG013|Overall Study|Withdrawal of Consent|0|||
163366724|NCT03829501|590053872|FG014|Overall Study|Withdrawal of Consent|3|||
163366725|NCT03829501|590053873|FG015|Overall Study|Withdrawal of Consent|0|||
163366726|NCT03829501|590053874|FG016|Overall Study|Withdrawal of Consent|1|||
163366727|NCT03829501|590053875|FG017|Overall Study|Withdrawal of Consent|1|||
163366728|NCT03829501|590053876|FG018|Overall Study|Withdrawal of Consent|0|||
163366729|NCT03829501|590053877|FG019|Overall Study|Withdrawal of Consent|0|||
163366730|NCT03829501|590053878|FG020|Overall Study|Withdrawal of Consent|3|||
163366731|NCT03829501|590053879|FG021|Overall Study|Withdrawal of Consent|0|||
163366732|NCT03829501|590053880|FG022|Overall Study|Withdrawal of Consent|1|||
163366733|NCT03829501|590053858|FG000|Overall Study|PD|0|||
163366734|NCT03829501|590053859|FG001|Overall Study|PD|0|||
163366735|NCT03829501|590053860|FG002|Overall Study|PD|0|||
163366736|NCT03829501|590053861|FG003|Overall Study|PD|2|||
163366737|NCT03829501|590053862|FG004|Overall Study|PD|0|||
163366738|NCT03829501|590053863|FG005|Overall Study|PD|0|||
163366739|NCT03829501|590053864|FG006|Overall Study|PD|0|||
163366740|NCT03829501|590053865|FG007|Overall Study|PD|0|||
163366741|NCT03829501|590053866|FG008|Overall Study|PD|0|||
163366742|NCT03829501|590053867|FG009|Overall Study|PD|0|||
163366743|NCT03829501|590053868|FG010|Overall Study|PD|0|||
163366744|NCT03829501|590053869|FG011|Overall Study|PD|0|||
163366745|NCT03829501|590053870|FG012|Overall Study|PD|0|||
163366746|NCT03829501|590053871|FG013|Overall Study|PD|0|||
163366747|NCT03829501|590053872|FG014|Overall Study|PD|0|||
163366748|NCT03829501|590053873|FG015|Overall Study|PD|1|||
163366749|NCT03829501|590053874|FG016|Overall Study|PD|0|||
163366750|NCT03829501|590053875|FG017|Overall Study|PD|0|||
163366751|NCT03829501|590053876|FG018|Overall Study|PD|0|||
163366752|NCT03829501|590053877|FG019|Overall Study|PD|0|||
163366753|NCT03829501|590053878|FG020|Overall Study|PD|1|||
163366754|NCT03829501|590053879|FG021|Overall Study|PD|0|||
163366755|NCT03829501|590053880|FG022|Overall Study|PD|0|||
163366756|NCT03829501|590053858|FG000|Overall Study|Study Terminated by Sponsor|0|||
163366757|NCT03829501|590053859|FG001|Overall Study|Study Terminated by Sponsor|0|||
163366758|NCT03829501|590053860|FG002|Overall Study|Study Terminated by Sponsor|0|||
163366759|NCT03829501|590053861|FG003|Overall Study|Study Terminated by Sponsor|0|||
163366760|NCT03829501|590053862|FG004|Overall Study|Study Terminated by Sponsor|0|||
163366761|NCT03829501|590053863|FG005|Overall Study|Study Terminated by Sponsor|0|||
163366762|NCT03829501|590053864|FG006|Overall Study|Study Terminated by Sponsor|0|||
163366763|NCT03829501|590053865|FG007|Overall Study|Study Terminated by Sponsor|3|||
163366764|NCT03829501|590053866|FG008|Overall Study|Study Terminated by Sponsor|1|||
163366765|NCT03829501|590053867|FG009|Overall Study|Study Terminated by Sponsor|0|||
163366766|NCT03829501|590053868|FG010|Overall Study|Study Terminated by Sponsor|0|||
163366767|NCT03829501|590053869|FG011|Overall Study|Study Terminated by Sponsor|0|||
163366768|NCT03829501|590053870|FG012|Overall Study|Study Terminated by Sponsor|0|||
163366769|NCT03829501|590053871|FG013|Overall Study|Study Terminated by Sponsor|0|||
163366770|NCT03829501|590053872|FG014|Overall Study|Study Terminated by Sponsor|3|||
163412792|NCT00720109|590218991|FG002|Risk Stratification Period|Disease progression or relapse|0|||
163412793|NCT00720109|590218989|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
163412794|NCT00720109|590218990|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
163412795|NCT00720109|590218991|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
163412796|NCT04153188|590219005|FG000|Overall Study|Lost to Follow-up|1|||
163412797|NCT04153188|590219006|FG001|Overall Study|Lost to Follow-up|1|||
163412798|NCT04153188|590219005|FG000|Overall Study|Withdrawal by Subject|2|||
163412799|NCT04153188|590219006|FG001|Overall Study|Withdrawal by Subject|0|||
163412800|NCT04153188|590219005|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
163412801|NCT04153188|590219006|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
163412802|NCT01489527|590219007|FG000|Overall Study|Pregnancy|9|||
163412803|NCT01489527|590219008|FG001|Overall Study|Pregnancy|14|||
163412804|NCT01489527|590219007|FG000|Overall Study|Participant moved|6|||
163412805|NCT01489527|590219008|FG001|Overall Study|Participant moved|7|||
163412806|NCT01489527|590219007|FG000|Overall Study|Withdrawal by Subject|0|||
163412807|NCT01489527|590219008|FG001|Overall Study|Withdrawal by Subject|4|||
163412808|NCT01489527|590219007|FG000|Overall Study|Lost to Follow-up|5|||
163412809|NCT01489527|590219008|FG001|Overall Study|Lost to Follow-up|1|||
163412810|NCT01489527|590219007|FG000|Overall Study|Procedures|1|||
163412811|NCT01489527|590219008|FG001|Overall Study|Procedures|0|||
163412812|NCT01489527|590219007|FG000|Overall Study|Not compliant|1|||
163412813|NCT01489527|590219008|FG001|Overall Study|Not compliant|0|||
163412814|NCT04899232|590219009|FG000|Screening Period|Physician Decision|1|||
163412815|NCT04899232|590219010|FG001|Screening Period|Physician Decision|0|||
163412816|NCT04899232|590219011|FG002|Screening Period|Physician Decision|0|||
163412817|NCT04899232|590219009|FG000|Screening Period|Withdrawal by Subject|1|||
163412818|NCT04899232|590219010|FG001|Screening Period|Withdrawal by Subject|0|||
163412819|NCT04899232|590219011|FG002|Screening Period|Withdrawal by Subject|0|||
163412820|NCT04899232|590219009|FG000|Screening Period|Participant discharged before receiving intervention|3|||
163412821|NCT04899232|590219010|FG001|Screening Period|Participant discharged before receiving intervention|0|||
163412822|NCT04899232|590219011|FG002|Screening Period|Participant discharged before receiving intervention|0|||
163366771|NCT03829501|590053873|FG015|Overall Study|Study Terminated by Sponsor|2|||
163366772|NCT03829501|590053874|FG016|Overall Study|Study Terminated by Sponsor|2|||
163366773|NCT03829501|590053875|FG017|Overall Study|Study Terminated by Sponsor|0|||
163366774|NCT03829501|590053876|FG018|Overall Study|Study Terminated by Sponsor|0|||
163366775|NCT03829501|590053877|FG019|Overall Study|Study Terminated by Sponsor|0|||
163366776|NCT03829501|590053878|FG020|Overall Study|Study Terminated by Sponsor|1|||
163366777|NCT03829501|590053879|FG021|Overall Study|Study Terminated by Sponsor|0|||
163366778|NCT03829501|590053880|FG022|Overall Study|Study Terminated by Sponsor|3|||
163366779|NCT03829501|590053858|FG000|Overall Study|Lost to Follow Up|0|||
163366780|NCT03829501|590053859|FG001|Overall Study|Lost to Follow Up|0|||
163366781|NCT03829501|590053860|FG002|Overall Study|Lost to Follow Up|0|||
163366782|NCT03829501|590053861|FG003|Overall Study|Lost to Follow Up|0|||
163366783|NCT03829501|590053862|FG004|Overall Study|Lost to Follow Up|1|||
163366784|NCT03829501|590053863|FG005|Overall Study|Lost to Follow Up|0|||
163366785|NCT03829501|590053864|FG006|Overall Study|Lost to Follow Up|0|||
163366786|NCT03829501|590053865|FG007|Overall Study|Lost to Follow Up|2|||
163366787|NCT03829501|590053866|FG008|Overall Study|Lost to Follow Up|2|||
163366788|NCT03829501|590053867|FG009|Overall Study|Lost to Follow Up|0|||
163366789|NCT03829501|590053868|FG010|Overall Study|Lost to Follow Up|2|||
163366790|NCT03829501|590053869|FG011|Overall Study|Lost to Follow Up|1|||
163366791|NCT03829501|590053870|FG012|Overall Study|Lost to Follow Up|0|||
163366792|NCT03829501|590053871|FG013|Overall Study|Lost to Follow Up|1|||
163366793|NCT03829501|590053872|FG014|Overall Study|Lost to Follow Up|1|||
163366794|NCT03829501|590053873|FG015|Overall Study|Lost to Follow Up|0|||
163366795|NCT03829501|590053874|FG016|Overall Study|Lost to Follow Up|0|||
163366796|NCT03829501|590053875|FG017|Overall Study|Lost to Follow Up|0|||
163366797|NCT03829501|590053876|FG018|Overall Study|Lost to Follow Up|0|||
163366798|NCT03829501|590053877|FG019|Overall Study|Lost to Follow Up|0|||
163366799|NCT03829501|590053878|FG020|Overall Study|Lost to Follow Up|0|||
163366800|NCT03829501|590053879|FG021|Overall Study|Lost to Follow Up|0|||
163366801|NCT03829501|590053880|FG022|Overall Study|Lost to Follow Up|1|||
163366802|NCT03829501|590053858|FG000|Overall Study|Death|2|||
163366803|NCT03829501|590053859|FG001|Overall Study|Death|4|||
163366804|NCT03829501|590053860|FG002|Overall Study|Death|5|||
163366805|NCT03829501|590053861|FG003|Overall Study|Death|6|||
163366806|NCT03829501|590053862|FG004|Overall Study|Death|5|||
163366807|NCT03829501|590053863|FG005|Overall Study|Death|4|||
163366808|NCT03829501|590053864|FG006|Overall Study|Death|5|||
163366809|NCT03829501|590053865|FG007|Overall Study|Death|24|||
163366810|NCT03829501|590053866|FG008|Overall Study|Death|22|||
163366811|NCT03829501|590053867|FG009|Overall Study|Death|6|||
163366812|NCT03829501|590053868|FG010|Overall Study|Death|3|||
163366813|NCT03829501|590053869|FG011|Overall Study|Death|10|||
163366814|NCT03829501|590053870|FG012|Overall Study|Death|10|||
163366815|NCT03829501|590053871|FG013|Overall Study|Death|5|||
163366816|NCT03829501|590053872|FG014|Overall Study|Death|7|||
163366817|NCT03829501|590053873|FG015|Overall Study|Death|2|||
163366818|NCT03829501|590053874|FG016|Overall Study|Death|2|||
163366819|NCT03829501|590053875|FG017|Overall Study|Death|1|||
163366820|NCT03829501|590053876|FG018|Overall Study|Death|1|||
163366821|NCT03829501|590053877|FG019|Overall Study|Death|1|||
163366822|NCT03829501|590053878|FG020|Overall Study|Death|1|||
163366823|NCT03829501|590053879|FG021|Overall Study|Death|2|||
163366824|NCT03829501|590053880|FG022|Overall Study|Death|3|||
163366825|NCT03829501|590053858|FG000|Overall Study|Miscellaneous|0|||
163366826|NCT03829501|590053859|FG001|Overall Study|Miscellaneous|0|||
163366827|NCT03829501|590053860|FG002|Overall Study|Miscellaneous|1|||
163366828|NCT03829501|590053861|FG003|Overall Study|Miscellaneous|0|||
163366829|NCT03829501|590053862|FG004|Overall Study|Miscellaneous|0|||
163366830|NCT03829501|590053863|FG005|Overall Study|Miscellaneous|0|||
163366831|NCT03829501|590053864|FG006|Overall Study|Miscellaneous|0|||
163366832|NCT03829501|590053865|FG007|Overall Study|Miscellaneous|1|||
163366833|NCT03829501|590053866|FG008|Overall Study|Miscellaneous|0|||
163366834|NCT03829501|590053867|FG009|Overall Study|Miscellaneous|0|||
163366835|NCT03829501|590053868|FG010|Overall Study|Miscellaneous|0|||
163366836|NCT03829501|590053869|FG011|Overall Study|Miscellaneous|0|||
163366837|NCT03829501|590053870|FG012|Overall Study|Miscellaneous|0|||
163366838|NCT03829501|590053871|FG013|Overall Study|Miscellaneous|0|||
163366839|NCT03829501|590053872|FG014|Overall Study|Miscellaneous|0|||
163366840|NCT03829501|590053873|FG015|Overall Study|Miscellaneous|0|||
163366841|NCT03829501|590053874|FG016|Overall Study|Miscellaneous|0|||
163366842|NCT03829501|590053875|FG017|Overall Study|Miscellaneous|0|||
163366843|NCT03829501|590053876|FG018|Overall Study|Miscellaneous|0|||
163366844|NCT03829501|590053877|FG019|Overall Study|Miscellaneous|0|||
163366845|NCT03829501|590053878|FG020|Overall Study|Miscellaneous|0|||
163366846|NCT03829501|590053879|FG021|Overall Study|Miscellaneous|0|||
163366847|NCT03829501|590053880|FG022|Overall Study|Miscellaneous|1|||
163366848|NCT02964013|590053881|FG000|Overall Study|Death|58|||
163366849|NCT02964013|590053882|FG001|Overall Study|Death|239|||
163366850|NCT02964013|590053883|FG002|Overall Study|Death|38|||
163366851|NCT02964013|590053884|FG003|Overall Study|Death|10|||
163366852|NCT02964013|590053885|FG004|Overall Study|Death|33|||
163366853|NCT02964013|590053881|FG000|Overall Study|Lost to Follow-up|1|||
163366854|NCT02964013|590053882|FG001|Overall Study|Lost to Follow-up|4|||
163366855|NCT02964013|590053883|FG002|Overall Study|Lost to Follow-up|2|||
163366856|NCT02964013|590053884|FG003|Overall Study|Lost to Follow-up|0|||
163366857|NCT02964013|590053885|FG004|Overall Study|Lost to Follow-up|0|||
163366858|NCT02964013|590053881|FG000|Overall Study|Physician Decision|0|||
163366859|NCT02964013|590053882|FG001|Overall Study|Physician Decision|1|||
163366860|NCT02964013|590053883|FG002|Overall Study|Physician Decision|0|||
163366861|NCT02964013|590053884|FG003|Overall Study|Physician Decision|0|||
163366862|NCT02964013|590053885|FG004|Overall Study|Physician Decision|0|||
163366863|NCT02964013|590053881|FG000|Overall Study|Sponsor Decision|3|||
163366864|NCT02964013|590053882|FG001|Overall Study|Sponsor Decision|22|||
163366865|NCT02964013|590053883|FG002|Overall Study|Sponsor Decision|11|||
163366866|NCT02964013|590053884|FG003|Overall Study|Sponsor Decision|0|||
163366867|NCT02964013|590053885|FG004|Overall Study|Sponsor Decision|7|||
163366868|NCT02964013|590053881|FG000|Overall Study|Withdrawal by Subject|6|||
163366869|NCT02964013|590053882|FG001|Overall Study|Withdrawal by Subject|27|||
163366870|NCT02964013|590053883|FG002|Overall Study|Withdrawal by Subject|9|||
163366871|NCT02964013|590053884|FG003|Overall Study|Withdrawal by Subject|0|||
163366872|NCT02964013|590053885|FG004|Overall Study|Withdrawal by Subject|0|||
163366873|NCT02964013|590053881|FG000|Overall Study|Not Treated|0|||
163366874|NCT02964013|590053882|FG001|Overall Study|Not Treated|2|||
163366875|NCT02964013|590053883|FG002|Overall Study|Not Treated|0|||
163366876|NCT02964013|590053884|FG003|Overall Study|Not Treated|1|||
163366877|NCT02964013|590053885|FG004|Overall Study|Not Treated|0|||
163366878|NCT04707664|590053891|FG000|Overall Study|Adverse Event|2|||
163366879|NCT04707664|590053892|FG001|Overall Study|Adverse Event|0|||
163366880|NCT04707664|590053891|FG000|Overall Study|Death|1|||
163366881|NCT04707664|590053892|FG001|Overall Study|Death|2|||
163412823|NCT00700271|590219012|FG000|Overall Study|Adverse Event|4|||
163366882|NCT04707664|590053891|FG000|Overall Study|Withdrawal by Subject|13|||
163366883|NCT04707664|590053892|FG001|Overall Study|Withdrawal by Subject|21|||
163366884|NCT04707664|590053891|FG000|Overall Study|Lost to Follow-up|11|||
163366885|NCT04707664|590053892|FG001|Overall Study|Lost to Follow-up|13|||
163366886|NCT04707664|590053891|FG000|Overall Study|Not treated|2|||
163366887|NCT04707664|590053892|FG001|Overall Study|Not treated|0|||
163366888|NCT00357110|590053893|FG000|Overall Study|Early study termination|5|||
163366889|NCT00357110|590053894|FG001|Overall Study|Early study termination|5|||
163366890|NCT03339245|590053902|FG000|Overall Study|Adverse Event|1|||
163366891|NCT03339245|590053903|FG001|Overall Study|Adverse Event|1|||
163366892|NCT03339245|590053902|FG000|Overall Study|Withdrawal by Subject|1|||
163366893|NCT03339245|590053903|FG001|Overall Study|Withdrawal by Subject|0|||
163366894|NCT00288639|590053911|FG000|Overall Study|Adverse Event|5|||
163366895|NCT00288639|590053911|FG000|Overall Study|Lack of Efficacy|4|||
163366896|NCT00288639|590053911|FG000|Overall Study|Withdrawal by Subject|2|||
163366897|NCT00288639|590053911|FG000|Overall Study|Other|1|||
163366898|NCT03480932|590053912|FG000|Overall Study|Death|1|||
163366899|NCT03480932|590053913|FG001|Overall Study|Death|1|||
163366900|NCT03480932|590053914|FG002|Overall Study|Death|0|||
163366901|NCT03480932|590053912|FG000|Overall Study|Lost to Follow-up|0|||
163366902|NCT03480932|590053913|FG001|Overall Study|Lost to Follow-up|2|||
163366903|NCT03480932|590053914|FG002|Overall Study|Lost to Follow-up|3|||
163366904|NCT03480932|590053912|FG000|Overall Study|Incarcerated|2|||
163366905|NCT03480932|590053913|FG001|Overall Study|Incarcerated|2|||
163366906|NCT03480932|590053914|FG002|Overall Study|Incarcerated|2|||
163366907|NCT03056300|590053915|FG000|Overall Study|Surgical reason per study protocol|3|||
163366908|NCT05262517|590053916|FG000|Overall Study|Randomized but not treated|5|||
163366909|NCT05262517|590053917|FG001|Overall Study|Randomized but not treated|11|||
163366910|NCT01939353|590053924|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
163366911|NCT01939353|590053924|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
163366912|NCT01939353|590053924|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
163366913|NCT01939353|590053924|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
163366914|NCT01939353|590053924|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
163366915|NCT04421950|590053928|FG000|Overall Study|Dropped or lost to follow up|4|||
163366916|NCT04421950|590053929|FG001|Overall Study|Dropped or lost to follow up|2|||
163366917|NCT00335140|590053932|FG000|Overall Study|Ineligible|1|||
163366918|NCT04546425|590053933|FG000|Overall Study|Protocol Violation|1|||
163366919|NCT04546425|590053934|FG001|Overall Study|Protocol Violation|1|||
163366920|NCT04546425|590053935|FG002|Overall Study|Protocol Violation|0|||
163366921|NCT04546425|590053936|FG003|Overall Study|Protocol Violation|0|||
163366922|NCT04546425|590053933|FG000|Overall Study|Adverse Event|3|||
163366923|NCT04546425|590053934|FG001|Overall Study|Adverse Event|0|||
163366924|NCT04546425|590053935|FG002|Overall Study|Adverse Event|0|||
163366925|NCT04546425|590053936|FG003|Overall Study|Adverse Event|0|||
163366926|NCT04546425|590053933|FG000|Overall Study|Lost to Follow-up|5|||
163366927|NCT04546425|590053934|FG001|Overall Study|Lost to Follow-up|4|||
163366928|NCT04546425|590053935|FG002|Overall Study|Lost to Follow-up|0|||
163366929|NCT04546425|590053936|FG003|Overall Study|Lost to Follow-up|0|||
163366930|NCT04546425|590053933|FG000|Overall Study|No Longer met eligibility criteria|3|||
163366931|NCT04546425|590053934|FG001|Overall Study|No Longer met eligibility criteria|3|||
163366932|NCT04546425|590053935|FG002|Overall Study|No Longer met eligibility criteria|1|||
163366933|NCT04546425|590053936|FG003|Overall Study|No Longer met eligibility criteria|1|||
163366934|NCT04546425|590053933|FG000|Overall Study|Withdrawal by parent/guardian|6|||
163366935|NCT04546425|590053934|FG001|Overall Study|Withdrawal by parent/guardian|5|||
163366936|NCT04546425|590053935|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163366937|NCT04546425|590053936|FG003|Overall Study|Withdrawal by parent/guardian|1|||
163366938|NCT00737477|590053940|FG000|Overall Study|Adverse Event|9|||
163366939|NCT00737477|590053940|FG000|Overall Study|Death|9|||
163366940|NCT00737477|590053940|FG000|Overall Study|Treatment Refusal|1|||
163366941|NCT00737477|590053940|FG000|Overall Study|Withdrawal by Subject|1|||
163366942|NCT00737477|590053940|FG000|Overall Study|Renal Transplantation|10|||
163366943|NCT00737477|590053940|FG000|Overall Study|Other|4|||
163366944|NCT01132820|590053941|FG000|Overall Study|Ineligible: wrong cell type|1|||
163366945|NCT01132820|590053941|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
163366946|NCT01132820|590053941|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
163366947|NCT01132820|590053941|FG000|Overall Study|Never treated|1|||
163366948|NCT01132820|590053941|FG000|Overall Study|Inadequate data|1|||
163366949|NCT02687035|590053942|FG000|Overall Study|Withdrawal by Subject|1|||
163366950|NCT02687035|590053942|FG000|Overall Study|Death|87|||
163366951|NCT02687035|590053942|FG000|Overall Study|Lost to Follow-up|1|||
163366952|NCT02687035|590053942|FG000|Overall Study|Missed Visit|87|||
163366953|NCT02687035|590053942|FG000|Overall Study|Did not receive Study Device|8|||
163366954|NCT05000216|590053943|FG000|Stage 1|Lost to Follow-up|0|||
163366955|NCT05000216|590053944|FG001|Stage 1|Lost to Follow-up|0|||
163366956|NCT05000216|590053945|FG002|Stage 1|Lost to Follow-up|0|||
163366957|NCT05000216|590053946|FG003|Stage 1|Lost to Follow-up|0|||
163366958|NCT05000216|590053947|FG004|Stage 1|Lost to Follow-up|0|||
163366959|NCT05000216|590053948|FG005|Stage 1|Lost to Follow-up|0|||
163366960|NCT05000216|590053949|FG006|Stage 1|Lost to Follow-up|1|||
163366961|NCT05000216|590053950|FG007|Stage 1|Lost to Follow-up|1|||
163366962|NCT05000216|590053951|FG008|Stage 1|Lost to Follow-up|0|||
163366963|NCT05000216|590053952|FG009|Stage 1|Lost to Follow-up|2|||
163366964|NCT05000216|590053953|FG010|Stage 1|Lost to Follow-up|3|||
163366965|NCT05000216|590053954|FG011|Stage 1|Lost to Follow-up|0|||
163366966|NCT05000216|590053955|FG012|Stage 1|Lost to Follow-up|0|||
163366967|NCT05000216|590053956|FG013|Stage 1|Lost to Follow-up|0|||
163366968|NCT05000216|590053957|FG014|Stage 1|Lost to Follow-up|0|||
163366969|NCT05000216|590053958|FG015|Stage 1|Lost to Follow-up|0|||
163366970|NCT05000216|590053959|FG016|Stage 1|Lost to Follow-up|0|||
163366971|NCT05000216|590053960|FG017|Stage 1|Lost to Follow-up|0|||
163366972|NCT05000216|590053961|FG018|Stage 1|Lost to Follow-up|0|||
163366973|NCT05000216|590053962|FG019|Stage 1|Lost to Follow-up|0|||
163366974|NCT05000216|590053963|FG020|Stage 1|Lost to Follow-up|0|||
163366975|NCT05000216|590053964|FG021|Stage 1|Lost to Follow-up|0|||
163366976|NCT05000216|590053943|FG000|Stage 1|Physician Decision|0|||
163366977|NCT05000216|590053944|FG001|Stage 1|Physician Decision|0|||
163366978|NCT05000216|590053945|FG002|Stage 1|Physician Decision|0|||
163366979|NCT05000216|590053946|FG003|Stage 1|Physician Decision|0|||
163366980|NCT05000216|590053947|FG004|Stage 1|Physician Decision|0|||
163366981|NCT05000216|590053948|FG005|Stage 1|Physician Decision|0|||
163366982|NCT05000216|590053949|FG006|Stage 1|Physician Decision|0|||
163366983|NCT05000216|590053950|FG007|Stage 1|Physician Decision|1|||
163366984|NCT05000216|590053951|FG008|Stage 1|Physician Decision|1|||
163366985|NCT05000216|590053952|FG009|Stage 1|Physician Decision|0|||
163366986|NCT05000216|590053953|FG010|Stage 1|Physician Decision|0|||
163366987|NCT05000216|590053954|FG011|Stage 1|Physician Decision|0|||
163366988|NCT05000216|590053955|FG012|Stage 1|Physician Decision|0|||
163366989|NCT05000216|590053956|FG013|Stage 1|Physician Decision|0|||
163366990|NCT05000216|590053957|FG014|Stage 1|Physician Decision|0|||
163366991|NCT05000216|590053958|FG015|Stage 1|Physician Decision|0|||
163366992|NCT05000216|590053959|FG016|Stage 1|Physician Decision|0|||
163366993|NCT05000216|590053960|FG017|Stage 1|Physician Decision|0|||
163366994|NCT05000216|590053961|FG018|Stage 1|Physician Decision|0|||
163366995|NCT05000216|590053962|FG019|Stage 1|Physician Decision|0|||
163366996|NCT05000216|590053963|FG020|Stage 1|Physician Decision|0|||
163366997|NCT05000216|590053964|FG021|Stage 1|Physician Decision|0|||
163366998|NCT05000216|590053943|FG000|Stage 1|Withdrawal by Subject|0|||
163366999|NCT05000216|590053944|FG001|Stage 1|Withdrawal by Subject|1|||
163367000|NCT05000216|590053945|FG002|Stage 1|Withdrawal by Subject|0|||
163367001|NCT05000216|590053946|FG003|Stage 1|Withdrawal by Subject|0|||
163367002|NCT05000216|590053947|FG004|Stage 1|Withdrawal by Subject|0|||
163367003|NCT05000216|590053948|FG005|Stage 1|Withdrawal by Subject|0|||
163367004|NCT05000216|590053949|FG006|Stage 1|Withdrawal by Subject|0|||
163367005|NCT05000216|590053950|FG007|Stage 1|Withdrawal by Subject|0|||
163367006|NCT05000216|590053951|FG008|Stage 1|Withdrawal by Subject|0|||
163367007|NCT05000216|590053952|FG009|Stage 1|Withdrawal by Subject|3|||
163367008|NCT05000216|590053953|FG010|Stage 1|Withdrawal by Subject|10|||
163367009|NCT05000216|590053954|FG011|Stage 1|Withdrawal by Subject|0|||
163367010|NCT05000216|590053955|FG012|Stage 1|Withdrawal by Subject|0|||
163367011|NCT05000216|590053956|FG013|Stage 1|Withdrawal by Subject|0|||
163367012|NCT05000216|590053957|FG014|Stage 1|Withdrawal by Subject|0|||
163367013|NCT05000216|590053958|FG015|Stage 1|Withdrawal by Subject|0|||
163367014|NCT05000216|590053959|FG016|Stage 1|Withdrawal by Subject|0|||
163367015|NCT05000216|590053960|FG017|Stage 1|Withdrawal by Subject|0|||
163367016|NCT05000216|590053961|FG018|Stage 1|Withdrawal by Subject|0|||
163367017|NCT05000216|590053962|FG019|Stage 1|Withdrawal by Subject|0|||
163367018|NCT05000216|590053963|FG020|Stage 1|Withdrawal by Subject|0|||
163367019|NCT05000216|590053964|FG021|Stage 1|Withdrawal by Subject|0|||
163367020|NCT05000216|590053943|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
163367021|NCT05000216|590053944|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
163367022|NCT05000216|590053945|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
163367023|NCT05000216|590053946|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
163367024|NCT05000216|590053947|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
163367025|NCT05000216|590053948|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
163367026|NCT05000216|590053949|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
163367027|NCT05000216|590053950|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
163367028|NCT05000216|590053951|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
163367029|NCT05000216|590053952|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
163367030|NCT05000216|590053953|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
163367031|NCT05000216|590053954|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
163367032|NCT05000216|590053955|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
163367033|NCT05000216|590053956|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
163367034|NCT05000216|590053957|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
163367035|NCT05000216|590053958|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
163367036|NCT05000216|590053959|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
163367037|NCT05000216|590053960|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
163412824|NCT00700271|590219013|FG001|Overall Study|Adverse Event|6|||
163367038|NCT05000216|590053961|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
163367039|NCT05000216|590053962|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
163367040|NCT05000216|590053963|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
163367041|NCT05000216|590053964|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
163367042|NCT05000216|590053943|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367043|NCT05000216|590053944|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367044|NCT05000216|590053945|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367045|NCT05000216|590053946|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367046|NCT05000216|590053947|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367047|NCT05000216|590053948|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367048|NCT05000216|590053949|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367049|NCT05000216|590053950|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367050|NCT05000216|590053951|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
163367051|NCT05000216|590053952|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367052|NCT05000216|590053953|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367053|NCT05000216|590053954|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163412825|NCT00700271|590219012|FG000|Overall Study|Protocol Violation|1|||
163367054|NCT05000216|590053955|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367055|NCT05000216|590053956|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367056|NCT05000216|590053957|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367057|NCT05000216|590053958|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367058|NCT05000216|590053959|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367059|NCT05000216|590053960|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367060|NCT05000216|590053961|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367061|NCT05000216|590053962|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367062|NCT05000216|590053963|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367063|NCT05000216|590053964|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163367064|NCT05000216|590053943|FG000|Stage 1|Other|0|||
163367065|NCT05000216|590053944|FG001|Stage 1|Other|0|||
163367066|NCT05000216|590053945|FG002|Stage 1|Other|0|||
163367067|NCT05000216|590053946|FG003|Stage 1|Other|0|||
163367068|NCT05000216|590053947|FG004|Stage 1|Other|1|||
163367069|NCT05000216|590053948|FG005|Stage 1|Other|0|||
163367070|NCT05000216|590053949|FG006|Stage 1|Other|0|||
163367071|NCT05000216|590053950|FG007|Stage 1|Other|2|||
163367072|NCT05000216|590053951|FG008|Stage 1|Other|0|||
163367073|NCT05000216|590053952|FG009|Stage 1|Other|0|||
163367074|NCT05000216|590053953|FG010|Stage 1|Other|1|||
163367075|NCT05000216|590053954|FG011|Stage 1|Other|1|||
163367076|NCT05000216|590053955|FG012|Stage 1|Other|0|||
163367077|NCT05000216|590053956|FG013|Stage 1|Other|0|||
163367078|NCT05000216|590053957|FG014|Stage 1|Other|0|||
163367079|NCT05000216|590053958|FG015|Stage 1|Other|0|||
163367080|NCT05000216|590053959|FG016|Stage 1|Other|0|||
163367081|NCT05000216|590053960|FG017|Stage 1|Other|0|||
163367082|NCT05000216|590053961|FG018|Stage 1|Other|0|||
163367083|NCT05000216|590053962|FG019|Stage 1|Other|0|||
163367084|NCT05000216|590053963|FG020|Stage 1|Other|0|||
163367085|NCT05000216|590053964|FG021|Stage 1|Other|0|||
163367086|NCT05000216|590053943|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
163367087|NCT05000216|590053944|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
163367088|NCT05000216|590053945|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
163367089|NCT05000216|590053946|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
163367090|NCT05000216|590053947|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
163367091|NCT05000216|590053948|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
163367092|NCT05000216|590053949|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
163367093|NCT05000216|590053950|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
163367094|NCT05000216|590053951|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
163367095|NCT05000216|590053952|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
163367096|NCT05000216|590053953|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
163367097|NCT05000216|590053954|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
163367098|NCT05000216|590053955|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
163367099|NCT05000216|590053956|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
163367100|NCT05000216|590053957|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
163367101|NCT05000216|590053958|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
163367102|NCT05000216|590053959|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
163367103|NCT05000216|590053960|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
163367104|NCT05000216|590053961|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
163367105|NCT05000216|590053962|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
163367106|NCT05000216|590053963|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
163367107|NCT05000216|590053964|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
163367108|NCT05000216|590053943|FG000|Stage 2|Lost to Follow-up|0|||
163367109|NCT05000216|590053944|FG001|Stage 2|Lost to Follow-up|0|||
163412826|NCT00700271|590219013|FG001|Overall Study|Protocol Violation|0|||
163412827|NCT00700271|590219012|FG000|Overall Study|Administrative Reasons|1|||
163412828|NCT00700271|590219013|FG001|Overall Study|Administrative Reasons|0|||
163367110|NCT05000216|590053945|FG002|Stage 2|Lost to Follow-up|0|||
163367111|NCT05000216|590053946|FG003|Stage 2|Lost to Follow-up|0|||
163367112|NCT05000216|590053947|FG004|Stage 2|Lost to Follow-up|0|||
163367113|NCT05000216|590053948|FG005|Stage 2|Lost to Follow-up|0|||
163412829|NCT00700271|590219012|FG000|Overall Study|Withdrawal by Subject|6|||
163367114|NCT05000216|590053949|FG006|Stage 2|Lost to Follow-up|0|||
163367115|NCT05000216|590053950|FG007|Stage 2|Lost to Follow-up|0|||
163367116|NCT05000216|590053951|FG008|Stage 2|Lost to Follow-up|0|||
163367117|NCT05000216|590053952|FG009|Stage 2|Lost to Follow-up|0|||
163367118|NCT05000216|590053953|FG010|Stage 2|Lost to Follow-up|0|||
163367119|NCT05000216|590053954|FG011|Stage 2|Lost to Follow-up|0|||
163367120|NCT05000216|590053955|FG012|Stage 2|Lost to Follow-up|0|||
163367121|NCT05000216|590053956|FG013|Stage 2|Lost to Follow-up|0|||
163367122|NCT05000216|590053957|FG014|Stage 2|Lost to Follow-up|0|||
163367123|NCT05000216|590053958|FG015|Stage 2|Lost to Follow-up|0|||
163367124|NCT05000216|590053959|FG016|Stage 2|Lost to Follow-up|4|||
163367125|NCT05000216|590053960|FG017|Stage 2|Lost to Follow-up|0|||
163367126|NCT05000216|590053961|FG018|Stage 2|Lost to Follow-up|0|||
163367127|NCT05000216|590053962|FG019|Stage 2|Lost to Follow-up|0|||
163367128|NCT05000216|590053963|FG020|Stage 2|Lost to Follow-up|0|||
163367129|NCT05000216|590053964|FG021|Stage 2|Lost to Follow-up|0|||
163367130|NCT05000216|590053943|FG000|Stage 2|Physician Decision|0|||
163412830|NCT00700271|590219013|FG001|Overall Study|Withdrawal by Subject|4|||
163412831|NCT00700271|590219012|FG000|Overall Study|Lost to Follow-up|2|||
163412832|NCT00700271|590219013|FG001|Overall Study|Lost to Follow-up|2|||
163412833|NCT02926950|590219014|FG000|Overall Study|Adverse Event|4|||
163412834|NCT02926950|590219015|FG001|Overall Study|Adverse Event|6|||
163412835|NCT02926950|590219014|FG000|Overall Study|At the participant's own request|21|||
163412836|NCT02926950|590219015|FG001|Overall Study|At the participant's own request|25|||
163412837|NCT02926950|590219014|FG000|Overall Study|Reason not Specified|17|||
163412838|NCT02926950|590219015|FG001|Overall Study|Reason not Specified|9|||
163412839|NCT02926950|590219014|FG000|Overall Study|Lost to Follow-up|7|||
163412840|NCT02926950|590219015|FG001|Overall Study|Lost to Follow-up|8|||
163412841|NCT02553460|590219016|FG000|Overall Study|Death|3|||
163412842|NCT02553460|590219016|FG000|Overall Study|Withdrawal by Subject|1|||
163412843|NCT02553460|590219016|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
163412844|NCT02553460|590219016|FG000|Overall Study|Relapse or Transplant|14|||
163412845|NCT02553460|590219016|FG000|Overall Study|No response to treatment|2|||
163412846|NCT02553460|590219016|FG000|Overall Study|CAR T cells|2|||
163412847|NCT02392429|590220785|FG000|Screening|Screen failure|15|||
163412848|NCT02392429|590220785|FG000|Enrolled Participants|Ineligible due to disease|3|||
163412849|NCT02392429|590220785|FG000|Enrolled Participants|Withdrawal by Subject|4|||
163412850|NCT02392429|590220785|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
163412851|NCT02392429|590220785|FG000|Evaluable|Death|5|||
163412852|NCT02392429|590220785|FG000|Evaluable|Withdrawal by Subject|1|||
163412853|NCT02392429|590220785|FG000|Evaluable|Adverse Event|1|||
163412854|NCT02392429|590220785|FG000|Evaluable|remission bone marrow biopsy|3|||
163412855|NCT03266016|590220786|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
163412856|NCT03266016|590220787|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
163412857|NCT03266016|590220788|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
163412858|NCT03266016|590220789|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
163412859|NCT03266016|590220786|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
163412860|NCT03266016|590220787|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
163412861|NCT03266016|590220788|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
163412862|NCT03266016|590220789|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
163412863|NCT00482014|590220790|FG000|Overall Study|Withdrawal by Subject|1|||
163412864|NCT00482014|590220791|FG001|Overall Study|Withdrawal by Subject|2|||
163412865|NCT00482014|590220792|FG002|Overall Study|Withdrawal by Subject|3|||
163412866|NCT00482014|590220793|FG003|Overall Study|Withdrawal by Subject|4|||
163412867|NCT00482014|590220790|FG000|Overall Study|Adverse Event|3|||
163412868|NCT00482014|590220791|FG001|Overall Study|Adverse Event|0|||
163412869|NCT00482014|590220792|FG002|Overall Study|Adverse Event|2|||
163412870|NCT00482014|590220793|FG003|Overall Study|Adverse Event|8|||
163412871|NCT00482014|590220790|FG000|Overall Study|Death|1|||
163412872|NCT00482014|590220791|FG001|Overall Study|Death|2|||
163412873|NCT00482014|590220792|FG002|Overall Study|Death|1|||
163412874|NCT00482014|590220793|FG003|Overall Study|Death|4|||
163412875|NCT00482014|590220790|FG000|Overall Study|Lack of Efficacy|1|||
163412876|NCT00482014|590220791|FG001|Overall Study|Lack of Efficacy|0|||
163412877|NCT00482014|590220792|FG002|Overall Study|Lack of Efficacy|4|||
163412878|NCT00482014|590220793|FG003|Overall Study|Lack of Efficacy|6|||
163412879|NCT00482014|590220790|FG000|Overall Study|Sponsor Decision|1|||
163412880|NCT00482014|590220791|FG001|Overall Study|Sponsor Decision|2|||
163412881|NCT00482014|590220792|FG002|Overall Study|Sponsor Decision|1|||
163412882|NCT00482014|590220793|FG003|Overall Study|Sponsor Decision|1|||
163412883|NCT00768898|590220794|FG000|Overall Study|Unrelated injury|1|||
163412884|NCT00768898|590220794|FG000|Overall Study|Headache|1|||
163412885|NCT01284114|590220799|FG000|Overall Study|viral infection|1|||
163412886|NCT01284114|590220799|FG000|Overall Study|From the results of ALLTITUDE study|1|||
163412887|NCT01284114|590220799|FG000|Overall Study|Symptomatic hypotension|1|||
163412888|NCT01284114|590220799|FG000|Overall Study|dizziness|1|||
163412889|NCT01777763|590220800|FG000|Overall Study|Adverse Event|2|||
163412890|NCT01777763|590220801|FG001|Overall Study|Adverse Event|32|||
163412891|NCT01777763|590220800|FG000|Overall Study|Protocol Violation|1|||
163412892|NCT01777763|590220801|FG001|Overall Study|Protocol Violation|7|||
163412893|NCT01777763|590220800|FG000|Overall Study|Withdrawal by Subject|0|||
163412894|NCT01777763|590220801|FG001|Overall Study|Withdrawal by Subject|2|||
163412895|NCT01777763|590220800|FG000|Overall Study|Treatment Failure|1|||
163412896|NCT01777763|590220801|FG001|Overall Study|Treatment Failure|6|||
163412897|NCT02787850|590220806|FG000|Overall Study|Withdrawal by Subject|0|||
163412898|NCT02787850|590220807|FG001|Overall Study|Withdrawal by Subject|1|||
163412899|NCT03718143|590220808|FG000|Overall Study|Death|1|||
163412900|NCT03718143|590220809|FG001|Overall Study|Death|0|||
163412901|NCT03718143|590220810|FG002|Overall Study|Death|0|||
163412902|NCT03718143|590220808|FG000|Overall Study|Progression of Disease|1|||
163412903|NCT03718143|590220809|FG001|Overall Study|Progression of Disease|0|||
163412904|NCT03718143|590220810|FG002|Overall Study|Progression of Disease|0|||
163412905|NCT03718143|590220808|FG000|Overall Study|Withdrawal of Informed Consent|1|||
163412906|NCT03718143|590220809|FG001|Overall Study|Withdrawal of Informed Consent|2|||
163367131|NCT05000216|590053944|FG001|Stage 2|Physician Decision|0|||
163367132|NCT05000216|590053945|FG002|Stage 2|Physician Decision|0|||
163367133|NCT05000216|590053946|FG003|Stage 2|Physician Decision|0|||
163367134|NCT05000216|590053947|FG004|Stage 2|Physician Decision|0|||
163367135|NCT05000216|590053948|FG005|Stage 2|Physician Decision|0|||
163367136|NCT05000216|590053949|FG006|Stage 2|Physician Decision|0|||
163367137|NCT05000216|590053950|FG007|Stage 2|Physician Decision|0|||
163367138|NCT05000216|590053951|FG008|Stage 2|Physician Decision|0|||
163367139|NCT05000216|590053952|FG009|Stage 2|Physician Decision|0|||
163367140|NCT05000216|590053953|FG010|Stage 2|Physician Decision|0|||
163367141|NCT05000216|590053954|FG011|Stage 2|Physician Decision|0|||
163367142|NCT05000216|590053955|FG012|Stage 2|Physician Decision|1|||
163367143|NCT05000216|590053956|FG013|Stage 2|Physician Decision|0|||
163367144|NCT05000216|590053957|FG014|Stage 2|Physician Decision|0|||
163367145|NCT05000216|590053958|FG015|Stage 2|Physician Decision|0|||
163367146|NCT05000216|590053959|FG016|Stage 2|Physician Decision|0|||
163367147|NCT05000216|590053960|FG017|Stage 2|Physician Decision|0|||
163367148|NCT05000216|590053961|FG018|Stage 2|Physician Decision|0|||
163367149|NCT05000216|590053962|FG019|Stage 2|Physician Decision|0|||
163367150|NCT05000216|590053963|FG020|Stage 2|Physician Decision|0|||
163367151|NCT05000216|590053964|FG021|Stage 2|Physician Decision|0|||
163367152|NCT05000216|590053943|FG000|Stage 2|Withdrawal by Subject|0|||
163367153|NCT05000216|590053944|FG001|Stage 2|Withdrawal by Subject|0|||
163367154|NCT05000216|590053945|FG002|Stage 2|Withdrawal by Subject|0|||
163367155|NCT05000216|590053946|FG003|Stage 2|Withdrawal by Subject|0|||
163367156|NCT05000216|590053947|FG004|Stage 2|Withdrawal by Subject|0|||
163367157|NCT05000216|590053948|FG005|Stage 2|Withdrawal by Subject|0|||
163367158|NCT05000216|590053949|FG006|Stage 2|Withdrawal by Subject|0|||
163367159|NCT05000216|590053950|FG007|Stage 2|Withdrawal by Subject|0|||
163367160|NCT05000216|590053951|FG008|Stage 2|Withdrawal by Subject|0|||
163367161|NCT05000216|590053952|FG009|Stage 2|Withdrawal by Subject|0|||
163367162|NCT05000216|590053953|FG010|Stage 2|Withdrawal by Subject|0|||
163367163|NCT05000216|590053954|FG011|Stage 2|Withdrawal by Subject|0|||
163367164|NCT05000216|590053955|FG012|Stage 2|Withdrawal by Subject|0|||
163367165|NCT05000216|590053956|FG013|Stage 2|Withdrawal by Subject|0|||
163367166|NCT05000216|590053957|FG014|Stage 2|Withdrawal by Subject|2|||
163367167|NCT05000216|590053958|FG015|Stage 2|Withdrawal by Subject|0|||
163367168|NCT05000216|590053959|FG016|Stage 2|Withdrawal by Subject|9|||
163367169|NCT05000216|590053960|FG017|Stage 2|Withdrawal by Subject|0|||
163367170|NCT05000216|590053961|FG018|Stage 2|Withdrawal by Subject|0|||
163367171|NCT05000216|590053962|FG019|Stage 2|Withdrawal by Subject|0|||
163367172|NCT05000216|590053963|FG020|Stage 2|Withdrawal by Subject|0|||
163367173|NCT05000216|590053964|FG021|Stage 2|Withdrawal by Subject|0|||
163367174|NCT05000216|590053943|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
163367175|NCT05000216|590053944|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
163367176|NCT05000216|590053945|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
163367177|NCT05000216|590053946|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
163367178|NCT05000216|590053947|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
163367179|NCT05000216|590053948|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
163367180|NCT05000216|590053949|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
163367181|NCT05000216|590053950|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
163367182|NCT05000216|590053951|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
163367183|NCT05000216|590053952|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
163367184|NCT05000216|590053953|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
163367185|NCT05000216|590053954|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
163367186|NCT05000216|590053955|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
163367187|NCT05000216|590053956|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
163367188|NCT05000216|590053957|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
163367189|NCT05000216|590053958|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
163367190|NCT05000216|590053959|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
163367191|NCT05000216|590053960|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
163367192|NCT05000216|590053961|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
163367193|NCT05000216|590053962|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
163367194|NCT05000216|590053963|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
163367195|NCT05000216|590053964|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
163367196|NCT05000216|590053943|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367197|NCT05000216|590053944|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367198|NCT05000216|590053945|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367199|NCT05000216|590053946|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367200|NCT05000216|590053947|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367201|NCT05000216|590053948|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367202|NCT05000216|590053949|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367203|NCT05000216|590053950|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367204|NCT05000216|590053951|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367205|NCT05000216|590053952|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367206|NCT05000216|590053953|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367207|NCT05000216|590053954|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367208|NCT05000216|590053955|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367209|NCT05000216|590053956|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367210|NCT05000216|590053957|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
163367211|NCT05000216|590053958|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367212|NCT05000216|590053959|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
163367213|NCT05000216|590053960|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367214|NCT05000216|590053961|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367215|NCT05000216|590053962|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367216|NCT05000216|590053963|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367217|NCT05000216|590053964|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163367218|NCT05000216|590053943|FG000|Stage 2|Other reason|0|||
163367219|NCT05000216|590053944|FG001|Stage 2|Other reason|0|||
163367220|NCT05000216|590053945|FG002|Stage 2|Other reason|0|||
163367221|NCT05000216|590053946|FG003|Stage 2|Other reason|0|||
163367222|NCT05000216|590053947|FG004|Stage 2|Other reason|0|||
163367223|NCT05000216|590053948|FG005|Stage 2|Other reason|0|||
163367224|NCT05000216|590053949|FG006|Stage 2|Other reason|0|||
163367225|NCT05000216|590053950|FG007|Stage 2|Other reason|0|||
163367226|NCT05000216|590053951|FG008|Stage 2|Other reason|0|||
163367227|NCT05000216|590053952|FG009|Stage 2|Other reason|0|||
163367228|NCT05000216|590053953|FG010|Stage 2|Other reason|0|||
163367229|NCT05000216|590053954|FG011|Stage 2|Other reason|0|||
163367230|NCT05000216|590053955|FG012|Stage 2|Other reason|0|||
163367231|NCT05000216|590053956|FG013|Stage 2|Other reason|0|||
163367232|NCT05000216|590053957|FG014|Stage 2|Other reason|0|||
163367233|NCT05000216|590053958|FG015|Stage 2|Other reason|0|||
163367234|NCT05000216|590053959|FG016|Stage 2|Other reason|1|||
163367235|NCT05000216|590053960|FG017|Stage 2|Other reason|0|||
163367236|NCT05000216|590053961|FG018|Stage 2|Other reason|0|||
163367237|NCT05000216|590053962|FG019|Stage 2|Other reason|0|||
163367238|NCT05000216|590053963|FG020|Stage 2|Other reason|0|||
163367239|NCT05000216|590053964|FG021|Stage 2|Other reason|0|||
163367240|NCT05000216|590053943|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
163367241|NCT05000216|590053944|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
163367242|NCT05000216|590053945|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
163367243|NCT05000216|590053946|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
163367244|NCT05000216|590053947|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
163367245|NCT05000216|590053948|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
163367246|NCT05000216|590053949|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
163367247|NCT05000216|590053950|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
163367248|NCT05000216|590053951|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
163367249|NCT05000216|590053952|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
163367250|NCT05000216|590053953|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
163367251|NCT05000216|590053954|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
163367252|NCT05000216|590053955|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
163367253|NCT05000216|590053956|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
163367254|NCT05000216|590053957|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
163367255|NCT05000216|590053958|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
163367256|NCT05000216|590053959|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
163367257|NCT05000216|590053960|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
163367258|NCT05000216|590053961|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
163367259|NCT05000216|590053962|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
163367260|NCT05000216|590053963|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
163367261|NCT05000216|590053964|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
163367262|NCT05000216|590053943|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367263|NCT05000216|590053944|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367264|NCT05000216|590053945|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367265|NCT05000216|590053946|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367266|NCT05000216|590053947|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367267|NCT05000216|590053948|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367268|NCT05000216|590053949|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367269|NCT05000216|590053950|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367270|NCT05000216|590053951|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367271|NCT05000216|590053952|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367272|NCT05000216|590053953|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367273|NCT05000216|590053954|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367274|NCT05000216|590053955|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367275|NCT05000216|590053956|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367276|NCT05000216|590053957|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367277|NCT05000216|590053958|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
163367278|NCT05000216|590053959|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367279|NCT05000216|590053960|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367280|NCT05000216|590053961|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367281|NCT05000216|590053962|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367282|NCT05000216|590053963|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367283|NCT05000216|590053964|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
163367284|NCT05000216|590053943|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367285|NCT05000216|590053944|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367286|NCT05000216|590053945|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367287|NCT05000216|590053946|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367288|NCT05000216|590053947|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367289|NCT05000216|590053948|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367290|NCT05000216|590053949|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367291|NCT05000216|590053950|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367292|NCT05000216|590053951|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367293|NCT05000216|590053952|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367294|NCT05000216|590053953|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367295|NCT05000216|590053954|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367296|NCT05000216|590053955|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367297|NCT05000216|590053956|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
163367298|NCT05000216|590053957|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367299|NCT05000216|590053958|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
163367300|NCT05000216|590053959|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367301|NCT05000216|590053960|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367302|NCT05000216|590053961|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
163367303|NCT05000216|590053962|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367304|NCT05000216|590053963|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367305|NCT05000216|590053964|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163367306|NCT03435692|590053965|FG000|Overall Study|Lack of Efficacy|2|||
163367307|NCT03435692|590053966|FG001|Overall Study|Lack of Efficacy|2|||
163367308|NCT03435692|590053967|FG002|Overall Study|Lack of Efficacy|0|||
163367309|NCT00967005|590053968|FG000|Overall Study|Lost to Follow-up|7|||
163367310|NCT00967005|590053969|FG001|Overall Study|Lost to Follow-up|10|||
163367311|NCT05071053|590053970|FG000|Overall Study|Progressive disease|30|||
163367312|NCT05071053|590053970|FG000|Overall Study|Adverse Event|5|||
163367313|NCT02593123|590053971|FG000|Overall Study|Physician Decision|2|||
163367314|NCT02593123|590053972|FG001|Overall Study|Physician Decision|1|||
163367315|NCT02593123|590053971|FG000|Overall Study|Relapse|1|||
163367316|NCT02593123|590053972|FG001|Overall Study|Relapse|1|||
163412907|NCT03718143|590220810|FG002|Overall Study|Withdrawal of Informed Consent|1|||
163412908|NCT02322710|590220811|FG000|Overall Study|No efficacy assessment post-baseline|0|||
163412909|NCT02322710|590220812|FG001|Overall Study|No efficacy assessment post-baseline|1|||
163412910|NCT02322710|590220811|FG000|Overall Study|Protocol Violation|20|||
163412911|NCT02322710|590220812|FG001|Overall Study|Protocol Violation|25|||
163412912|NCT04161131|590220813|FG000|Overall Study|Ineligible|2|||
163412913|NCT04161131|590220813|FG000|Overall Study|Lost to Follow-up|4|||
163412914|NCT05064059|590220814|FG000|Overall Study|Death|199|||
163412915|NCT05064059|590220815|FG001|Overall Study|Death|196|||
163367317|NCT01038427|590053973|FG000|Overall Study|Lost to follow up|1|||
163367318|NCT01038427|590053974|FG001|Overall Study|Lost to follow up|1|||
163367319|NCT01038427|590053975|FG002|Overall Study|Lost to follow up|0|||
163367320|NCT01038427|590053973|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
163367321|NCT01038427|590053974|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
163367322|NCT01038427|590053975|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
163367323|NCT01038427|590053973|FG000|Overall Study|Withdrew consent|0|||
163367324|NCT01038427|590053974|FG001|Overall Study|Withdrew consent|0|||
163367325|NCT01038427|590053975|FG002|Overall Study|Withdrew consent|1|||
163367326|NCT01038427|590053973|FG000|Overall Study|Adverse Event|2|||
163367327|NCT01038427|590053974|FG001|Overall Study|Adverse Event|2|||
163367328|NCT01038427|590053975|FG002|Overall Study|Adverse Event|1|||
163367329|NCT01038427|590053973|FG000|Overall Study|Enrolled in error|0|||
163367330|NCT01038427|590053974|FG001|Overall Study|Enrolled in error|1|||
163367331|NCT01038427|590053975|FG002|Overall Study|Enrolled in error|1|||
163367332|NCT01038427|590053973|FG000|Overall Study|Other|0|||
163367333|NCT01038427|590053974|FG001|Overall Study|Other|2|||
163367334|NCT01038427|590053975|FG002|Overall Study|Other|0|||
163412916|NCT05064059|590220814|FG000|Overall Study|Physician Decision|4|||
163412917|NCT05064059|590220815|FG001|Overall Study|Physician Decision|2|||
163367335|NCT03538938|590053976|FG000|Overall Study|Death|0|||
163367336|NCT03538938|590053977|FG001|Overall Study|Death|0|||
163367337|NCT03538938|590053978|FG002|Overall Study|Death|2|||
163367338|NCT03538938|590053979|FG003|Overall Study|Death|0|||
163367339|NCT03538938|590053980|FG004|Overall Study|Death|0|||
163367340|NCT03538938|590053981|FG005|Overall Study|Death|1|||
163367341|NCT03538938|590053982|FG006|Overall Study|Death|0|||
163367342|NCT03538938|590053983|FG007|Overall Study|Death|1|||
163367343|NCT03538938|590053984|FG008|Overall Study|Death|1|||
163367344|NCT03538938|590053985|FG009|Overall Study|Death|1|||
163367345|NCT03538938|590053986|FG010|Overall Study|Death|0|||
163367346|NCT03538938|590053987|FG011|Overall Study|Death|0|||
163367347|NCT03538938|590053988|FG012|Overall Study|Death|1|||
163367348|NCT03538938|590053989|FG013|Overall Study|Death|1|||
163367349|NCT03538938|590053990|FG014|Overall Study|Death|0|||
163367350|NCT03538938|590053991|FG015|Overall Study|Death|1|||
163367351|NCT03538938|590053976|FG000|Overall Study|Withdrawal by Subject|4|||
163412918|NCT05064059|590220814|FG000|Overall Study|Sponsor Decision|14|||
163367352|NCT03538938|590053977|FG001|Overall Study|Withdrawal by Subject|6|||
163367353|NCT03538938|590053978|FG002|Overall Study|Withdrawal by Subject|5|||
163367354|NCT03538938|590053979|FG003|Overall Study|Withdrawal by Subject|3|||
163367355|NCT03538938|590053980|FG004|Overall Study|Withdrawal by Subject|0|||
163367356|NCT03538938|590053981|FG005|Overall Study|Withdrawal by Subject|0|||
163367357|NCT03538938|590053982|FG006|Overall Study|Withdrawal by Subject|3|||
163367358|NCT03538938|590053983|FG007|Overall Study|Withdrawal by Subject|1|||
163367359|NCT03538938|590053984|FG008|Overall Study|Withdrawal by Subject|5|||
163367360|NCT03538938|590053985|FG009|Overall Study|Withdrawal by Subject|1|||
163367361|NCT03538938|590053986|FG010|Overall Study|Withdrawal by Subject|2|||
163367362|NCT03538938|590053987|FG011|Overall Study|Withdrawal by Subject|1|||
163367363|NCT03538938|590053988|FG012|Overall Study|Withdrawal by Subject|3|||
163367364|NCT03538938|590053989|FG013|Overall Study|Withdrawal by Subject|0|||
163367365|NCT03538938|590053990|FG014|Overall Study|Withdrawal by Subject|2|||
163367366|NCT03538938|590053991|FG015|Overall Study|Withdrawal by Subject|4|||
163367367|NCT03538938|590053976|FG000|Overall Study|Incarcerated|0|||
163367368|NCT03538938|590053977|FG001|Overall Study|Incarcerated|0|||
163367369|NCT03538938|590053978|FG002|Overall Study|Incarcerated|0|||
163367370|NCT03538938|590053979|FG003|Overall Study|Incarcerated|0|||
163367371|NCT03538938|590053980|FG004|Overall Study|Incarcerated|0|||
163367372|NCT03538938|590053981|FG005|Overall Study|Incarcerated|0|||
163367373|NCT03538938|590053982|FG006|Overall Study|Incarcerated|0|||
163367374|NCT03538938|590053983|FG007|Overall Study|Incarcerated|0|||
163367375|NCT03538938|590053984|FG008|Overall Study|Incarcerated|0|||
163367376|NCT03538938|590053985|FG009|Overall Study|Incarcerated|0|||
163367377|NCT03538938|590053986|FG010|Overall Study|Incarcerated|0|||
163367378|NCT03538938|590053987|FG011|Overall Study|Incarcerated|1|||
163367379|NCT03538938|590053988|FG012|Overall Study|Incarcerated|0|||
163367380|NCT03538938|590053989|FG013|Overall Study|Incarcerated|0|||
163367381|NCT03538938|590053990|FG014|Overall Study|Incarcerated|0|||
163367382|NCT03538938|590053991|FG015|Overall Study|Incarcerated|0|||
163367383|NCT00755105|590053992|FG000|Overall Study|Withdrawal by Subject|9|||
163367384|NCT00755105|590053993|FG001|Overall Study|Withdrawal by Subject|11|||
163367385|NCT00755105|590053994|FG002|Overall Study|Withdrawal by Subject|4|||
163367386|NCT03995316|590053995|FG000|Overall Study|Lost to Follow-up|10|||
163367387|NCT03995316|590053996|FG001|Overall Study|Lost to Follow-up|3|||
163367388|NCT02202785|590053997|FG000|Overall Study|Study Terminated by Sponsor|1|||
163367389|NCT02202785|590053998|FG001|Overall Study|Study Terminated by Sponsor|6|||
163367390|NCT02202785|590053999|FG002|Overall Study|Study Terminated by Sponsor|4|||
163367391|NCT02202785|590053997|FG000|Overall Study|Withdrawal by Subject|0|||
163367392|NCT02202785|590053998|FG001|Overall Study|Withdrawal by Subject|1|||
163367393|NCT02202785|590053999|FG002|Overall Study|Withdrawal by Subject|0|||
163367394|NCT02202785|590053997|FG000|Overall Study|Lost to Follow-up|0|||
163367395|NCT02202785|590053998|FG001|Overall Study|Lost to Follow-up|1|||
163367396|NCT02202785|590053999|FG002|Overall Study|Lost to Follow-up|0|||
163367397|NCT02202785|590053997|FG000|Overall Study|Reason not Specified|10|||
163367398|NCT02202785|590053998|FG001|Overall Study|Reason not Specified|7|||
163367399|NCT02202785|590053999|FG002|Overall Study|Reason not Specified|13|||
163367400|NCT03945825|590054006|FG000|Overall Study|Enrolled but treatment not administered|0|||
163367401|NCT03945825|590054007|FG001|Overall Study|Enrolled but treatment not administered|0|||
163367402|NCT03945825|590054008|FG002|Overall Study|Enrolled but treatment not administered|0|||
163367403|NCT03945825|590054009|FG003|Overall Study|Enrolled but treatment not administered|0|||
163367404|NCT03945825|590054010|FG004|Overall Study|Enrolled but treatment not administered|1|||
163367405|NCT03945825|590054011|FG005|Overall Study|Enrolled but treatment not administered|0|||
163367406|NCT03945825|590054006|FG000|Overall Study|Lost to Follow-up|1|||
163367407|NCT03945825|590054007|FG001|Overall Study|Lost to Follow-up|5|||
163367408|NCT03945825|590054008|FG002|Overall Study|Lost to Follow-up|0|||
163367409|NCT03945825|590054009|FG003|Overall Study|Lost to Follow-up|1|||
163367410|NCT03945825|590054010|FG004|Overall Study|Lost to Follow-up|2|||
163367411|NCT03945825|590054011|FG005|Overall Study|Lost to Follow-up|2|||
163367412|NCT03945825|590054006|FG000|Overall Study|Withdrawal by Subject|1|||
163367413|NCT03945825|590054007|FG001|Overall Study|Withdrawal by Subject|0|||
163367414|NCT03945825|590054008|FG002|Overall Study|Withdrawal by Subject|1|||
163367415|NCT03945825|590054009|FG003|Overall Study|Withdrawal by Subject|1|||
163367416|NCT03945825|590054010|FG004|Overall Study|Withdrawal by Subject|0|||
163367417|NCT03945825|590054011|FG005|Overall Study|Withdrawal by Subject|1|||
163367418|NCT00600613|590054012|FG000|Overall Study|Protocol Deviation|1|||
163367419|NCT00664534|590054013|FG000|Overall Study|Adverse Event|2|||
163367420|NCT00664534|590054014|FG001|Overall Study|Adverse Event|3|||
163367421|NCT00664534|590054013|FG000|Overall Study|Lost to Follow-up|6|||
163367422|NCT00664534|590054014|FG001|Overall Study|Lost to Follow-up|10|||
163367423|NCT00664534|590054013|FG000|Overall Study|Protocol Violation|10|||
163367424|NCT00664534|590054014|FG001|Overall Study|Protocol Violation|8|||
163367425|NCT00664534|590054013|FG000|Overall Study|Withdrawal by Subject|7|||
163412919|NCT05064059|590220815|FG001|Overall Study|Sponsor Decision|11|||
163412920|NCT05064059|590220814|FG000|Overall Study|Withdrawal by Subject|4|||
163412921|NCT05064059|590220815|FG001|Overall Study|Withdrawal by Subject|11|||
163412922|NCT03905863|590220816|FG000|Overall Study|Adverse Event|2|||
163412923|NCT03905863|590220817|FG001|Overall Study|Adverse Event|4|||
163367426|NCT00664534|590054014|FG001|Overall Study|Withdrawal by Subject|6|||
163367427|NCT00664534|590054013|FG000|Overall Study|Physician Decision|8|||
163367428|NCT00664534|590054014|FG001|Overall Study|Physician Decision|0|||
163367429|NCT00664534|590054013|FG000|Overall Study|Sponsor decision|8|||
163367430|NCT00664534|590054014|FG001|Overall Study|Sponsor decision|6|||
163367431|NCT03041792|590054017|FG000|Overall Study|Adverse Event|4|||
163367432|NCT03041792|590054018|FG001|Overall Study|Adverse Event|0|||
163367433|NCT03041792|590054017|FG000|Overall Study|Death in the family|0|||
163367434|NCT03041792|590054018|FG001|Overall Study|Death in the family|2|||
163367435|NCT03041792|590054017|FG000|Overall Study|Randomized but not treated|0|||
163367436|NCT03041792|590054018|FG001|Overall Study|Randomized but not treated|1|||
163367437|NCT00935532|590054021|FG000|Overall Study|Adverse Event|11|||
163367438|NCT00935532|590054022|FG001|Overall Study|Adverse Event|6|||
163367439|NCT00935532|590054021|FG000|Overall Study|Death|1|||
163367440|NCT00935532|590054022|FG001|Overall Study|Death|0|||
163367441|NCT00935532|590054021|FG000|Overall Study|Lost to Follow-up|1|||
163367442|NCT00935532|590054022|FG001|Overall Study|Lost to Follow-up|0|||
163367443|NCT00935532|590054021|FG000|Overall Study|Physician Decision|1|||
163367444|NCT00935532|590054022|FG001|Overall Study|Physician Decision|2|||
163367445|NCT00935532|590054021|FG000|Overall Study|Protocol Violation|2|||
163367446|NCT00935532|590054022|FG001|Overall Study|Protocol Violation|1|||
163367447|NCT00935532|590054021|FG000|Overall Study|Subject Decision|2|||
163367448|NCT00935532|590054022|FG001|Overall Study|Subject Decision|1|||
163367449|NCT00935532|590054021|FG000|Overall Study|Sponsor Decision|0|||
163367450|NCT00935532|590054022|FG001|Overall Study|Sponsor Decision|1|||
163367451|NCT00935532|590054021|FG000|Overall Study|Loss Glucose Control|4|||
163367452|NCT00935532|590054022|FG001|Overall Study|Loss Glucose Control|0|||
163367453|NCT01399918|590054024|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
163367454|NCT00245960|590054025|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
163367455|NCT00245960|590054026|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
163367456|NCT00245960|590054025|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
163367457|NCT00245960|590054026|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
163367458|NCT00245960|590054025|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
163367459|NCT00245960|590054026|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
163367460|NCT00245960|590054025|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
163367461|NCT00245960|590054026|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
163367462|NCT00245960|590054025|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
163367463|NCT00245960|590054026|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
163367464|NCT00245960|590054025|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
163367465|NCT00245960|590054026|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
163367466|NCT00245960|590054025|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
163367467|NCT00245960|590054026|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
163367468|NCT00245960|590054025|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
163367469|NCT00245960|590054026|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
163367470|NCT00245960|590054025|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
163367471|NCT00245960|590054026|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
163367472|NCT00245960|590054025|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
163367473|NCT00245960|590054026|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
163367474|NCT00245960|590054025|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
163367475|NCT00245960|590054026|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
163367476|NCT00245960|590054025|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
163367477|NCT00245960|590054026|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
163367478|NCT01436253|590054027|FG000|Overall Study|Lost to Follow-up|182|||
163367479|NCT01436253|590054027|FG000|Overall Study|Not meeting all eligibility criteria|117|||
163367480|NCT03083665|590054028|FG000|Double-Blind Period|Adverse Event|5|||
163367481|NCT03083665|590054029|FG001|Double-Blind Period|Adverse Event|4|||
163367482|NCT03083665|590054030|FG002|Double-Blind Period|Adverse Event|5|||
163367483|NCT03083665|590054031|FG003|Double-Blind Period|Adverse Event|0|||
163412924|NCT03905863|590220816|FG000|Overall Study|Withdrawal by Subject|2|||
163367484|NCT03083665|590054032|FG004|Double-Blind Period|Adverse Event|0|||
163367485|NCT03083665|590054033|FG005|Double-Blind Period|Adverse Event|0|||
163367486|NCT03083665|590054028|FG000|Double-Blind Period|Lack of Efficacy|0|||
163367487|NCT03083665|590054029|FG001|Double-Blind Period|Lack of Efficacy|0|||
163412925|NCT03905863|590220817|FG001|Overall Study|Withdrawal by Subject|2|||
163412926|NCT03905863|590220816|FG000|Overall Study|Physician Decision|0|||
163412927|NCT03905863|590220817|FG001|Overall Study|Physician Decision|3|||
163367488|NCT03083665|590054030|FG002|Double-Blind Period|Lack of Efficacy|1|||
163367489|NCT03083665|590054031|FG003|Double-Blind Period|Lack of Efficacy|0|||
163367490|NCT03083665|590054032|FG004|Double-Blind Period|Lack of Efficacy|0|||
163367491|NCT03083665|590054033|FG005|Double-Blind Period|Lack of Efficacy|0|||
163367492|NCT03083665|590054028|FG000|Double-Blind Period|Protocol Violation|1|||
163367493|NCT03083665|590054029|FG001|Double-Blind Period|Protocol Violation|0|||
163367494|NCT03083665|590054030|FG002|Double-Blind Period|Protocol Violation|1|||
163367495|NCT03083665|590054031|FG003|Double-Blind Period|Protocol Violation|0|||
163367496|NCT03083665|590054032|FG004|Double-Blind Period|Protocol Violation|0|||
163367497|NCT03083665|590054033|FG005|Double-Blind Period|Protocol Violation|0|||
163367498|NCT03083665|590054028|FG000|Double-Blind Period|Lost to Follow-up|1|||
163367499|NCT03083665|590054029|FG001|Double-Blind Period|Lost to Follow-up|0|||
163367500|NCT03083665|590054030|FG002|Double-Blind Period|Lost to Follow-up|1|||
163367501|NCT03083665|590054031|FG003|Double-Blind Period|Lost to Follow-up|0|||
163367502|NCT03083665|590054032|FG004|Double-Blind Period|Lost to Follow-up|0|||
163367503|NCT03083665|590054033|FG005|Double-Blind Period|Lost to Follow-up|0|||
163367504|NCT03083665|590054028|FG000|Double-Blind Period|Withdrawal by Subject|3|||
163367505|NCT03083665|590054029|FG001|Double-Blind Period|Withdrawal by Subject|0|||
163367506|NCT03083665|590054030|FG002|Double-Blind Period|Withdrawal by Subject|0|||
163367507|NCT03083665|590054031|FG003|Double-Blind Period|Withdrawal by Subject|0|||
163367508|NCT03083665|590054032|FG004|Double-Blind Period|Withdrawal by Subject|0|||
163367509|NCT03083665|590054033|FG005|Double-Blind Period|Withdrawal by Subject|0|||
163367510|NCT03083665|590054028|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
163367511|NCT03083665|590054029|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
163367512|NCT03083665|590054030|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
163367513|NCT03083665|590054031|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
163367514|NCT03083665|590054032|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
163367515|NCT03083665|590054033|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
163367516|NCT03083665|590054028|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
163367517|NCT03083665|590054029|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
163367518|NCT03083665|590054030|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
163367519|NCT03083665|590054031|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
163367520|NCT03083665|590054032|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
163367521|NCT03083665|590054033|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
163367522|NCT03083665|590054028|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
163367523|NCT03083665|590054029|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
163367524|NCT03083665|590054030|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
163367525|NCT03083665|590054031|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
163367526|NCT03083665|590054032|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
163367527|NCT03083665|590054033|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
163367528|NCT03083665|590054028|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
163367529|NCT03083665|590054029|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
163367530|NCT03083665|590054030|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
163367531|NCT03083665|590054031|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
163367532|NCT03083665|590054032|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
163367533|NCT03083665|590054033|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
163367534|NCT03083665|590054028|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
163367535|NCT03083665|590054029|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
163367536|NCT03083665|590054030|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
163367537|NCT03083665|590054031|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
163367538|NCT03083665|590054032|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
163367539|NCT03083665|590054033|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
163367540|NCT03083665|590054028|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
163367541|NCT03083665|590054029|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
163367542|NCT03083665|590054030|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
163367543|NCT03083665|590054031|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
163367544|NCT03083665|590054032|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
163367545|NCT03083665|590054033|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
163367546|NCT03083665|590054028|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
163367547|NCT03083665|590054029|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
163367548|NCT03083665|590054030|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
163367549|NCT03083665|590054031|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
163367550|NCT03083665|590054032|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
163367551|NCT03083665|590054033|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
163367552|NCT03083665|590054028|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
163367553|NCT03083665|590054029|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
163367554|NCT03083665|590054030|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
163367555|NCT03083665|590054031|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
163412928|NCT03905863|590220816|FG000|Overall Study|Lost to Follow-up|1|||
163412929|NCT03905863|590220817|FG001|Overall Study|Lost to Follow-up|0|||
163412930|NCT03905863|590220816|FG000|Overall Study|Protocol Violation|0|||
163412931|NCT03905863|590220817|FG001|Overall Study|Protocol Violation|2|||
163412932|NCT03905863|590220816|FG000|Overall Study|Death|0|||
163412933|NCT03905863|590220817|FG001|Overall Study|Death|1|||
163412934|NCT01191697|590220822|FG000|Overall Study|Death|1|||
163412935|NCT01191697|590220822|FG000|Overall Study|Physician Decision|2|||
163412936|NCT01191697|590220822|FG000|Overall Study|Pursue chemoradiation|2|||
163412937|NCT01191697|590220822|FG000|Overall Study|Break from chemotherapy|2|||
163412938|NCT01191697|590220822|FG000|Overall Study|Withdrawal by Subject|1|||
163412939|NCT01191697|590220822|FG000|Overall Study|Surveillance|1|||
163412940|NCT01191697|590220822|FG000|Overall Study|Adverse Event|2|||
163412941|NCT01191697|590220822|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
163412942|NCT01191697|590220822|FG000|Overall Study|Not completed but analyzed|25|||
163412943|NCT05702515|590220825|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
163412944|NCT01396005|590220826|FG000|Overall Study|Withdrawal by Subject|0|||
163412945|NCT01396005|590220827|FG001|Overall Study|Withdrawal by Subject|1|||
163412946|NCT01396005|590220826|FG000|Overall Study|Non-compliance with protocol|0|||
163412947|NCT01396005|590220827|FG001|Overall Study|Non-compliance with protocol|1|||
163412948|NCT02397473|590220830|FG000|Treatment Phase|Adverse Event|1|||
163412949|NCT02397473|590220831|FG001|Treatment Phase|Adverse Event|2|||
163412950|NCT02397473|590220830|FG000|Treatment Phase|Lack of Efficacy|8|||
163412951|NCT02397473|590220831|FG001|Treatment Phase|Lack of Efficacy|1|||
163412952|NCT02397473|590220830|FG000|Treatment Phase|Lost to Follow-up|1|||
163412953|NCT02397473|590220831|FG001|Treatment Phase|Lost to Follow-up|0|||
163412954|NCT02397473|590220830|FG000|Treatment Phase|Withdrawal by Subject|2|||
163412955|NCT02397473|590220831|FG001|Treatment Phase|Withdrawal by Subject|1|||
163412956|NCT02397473|590220830|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
163412957|NCT02397473|590220831|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
163367556|NCT03083665|590054032|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
163367557|NCT03083665|590054033|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
163367558|NCT03083665|590054028|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
163367559|NCT03083665|590054029|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
163367560|NCT03083665|590054030|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
163367561|NCT03083665|590054031|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
163367562|NCT03083665|590054032|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
163367563|NCT03083665|590054033|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
163367564|NCT02519348|590054034|FG000|Overall Study|Death|31|||
163367565|NCT02519348|590054035|FG001|Overall Study|Death|74|||
163367566|NCT02519348|590054036|FG002|Overall Study|Death|47|||
163367567|NCT02519348|590054037|FG003|Overall Study|Death|54|||
163367568|NCT02519348|590054038|FG004|Overall Study|Death|63|||
163367569|NCT02519348|590054039|FG005|Overall Study|Death|18|||
163367570|NCT02519348|590054040|FG006|Overall Study|Death|2|||
163367571|NCT02519348|590054041|FG007|Overall Study|Death|5|||
163367572|NCT02519348|590054042|FG008|Overall Study|Death|5|||
163367573|NCT02519348|590054034|FG000|Overall Study|Withdrawal by Subject|4|||
163367574|NCT02519348|590054035|FG001|Overall Study|Withdrawal by Subject|7|||
163367575|NCT02519348|590054036|FG002|Overall Study|Withdrawal by Subject|4|||
163367576|NCT02519348|590054037|FG003|Overall Study|Withdrawal by Subject|3|||
163367577|NCT02519348|590054038|FG004|Overall Study|Withdrawal by Subject|3|||
163367578|NCT02519348|590054039|FG005|Overall Study|Withdrawal by Subject|2|||
163367579|NCT02519348|590054040|FG006|Overall Study|Withdrawal by Subject|0|||
163367580|NCT02519348|590054041|FG007|Overall Study|Withdrawal by Subject|0|||
163367581|NCT02519348|590054042|FG008|Overall Study|Withdrawal by Subject|1|||
163367582|NCT02519348|590054034|FG000|Overall Study|Lost to Follow-up|0|||
163367583|NCT02519348|590054035|FG001|Overall Study|Lost to Follow-up|0|||
163367584|NCT02519348|590054036|FG002|Overall Study|Lost to Follow-up|1|||
163367585|NCT02519348|590054037|FG003|Overall Study|Lost to Follow-up|0|||
163367586|NCT02519348|590054038|FG004|Overall Study|Lost to Follow-up|2|||
163367587|NCT02519348|590054039|FG005|Overall Study|Lost to Follow-up|1|||
163367588|NCT02519348|590054040|FG006|Overall Study|Lost to Follow-up|1|||
163367589|NCT02519348|590054041|FG007|Overall Study|Lost to Follow-up|0|||
163367590|NCT02519348|590054042|FG008|Overall Study|Lost to Follow-up|0|||
163367591|NCT02519348|590054034|FG000|Overall Study|Other|0|||
163367592|NCT02519348|590054035|FG001|Overall Study|Other|3|||
163367593|NCT02519348|590054036|FG002|Overall Study|Other|0|||
163367594|NCT02519348|590054037|FG003|Overall Study|Other|0|||
163367595|NCT02519348|590054038|FG004|Overall Study|Other|1|||
163367596|NCT02519348|590054039|FG005|Overall Study|Other|0|||
163367597|NCT02519348|590054040|FG006|Overall Study|Other|0|||
163367598|NCT02519348|590054041|FG007|Overall Study|Other|0|||
163367599|NCT02519348|590054042|FG008|Overall Study|Other|0|||
163412958|NCT02397473|590220830|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
163412959|NCT02397473|590220831|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
163412960|NCT02397473|590220830|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
163412961|NCT02397473|590220831|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
163412962|NCT02397473|590220830|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
163412963|NCT02397473|590220831|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
163412964|NCT02397473|590220830|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
163412965|NCT02397473|590220831|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
163412966|NCT01467492|590220832|FG000|Overall Study|Withdrawal by Subject|6|||
163412967|NCT01467492|590220833|FG001|Overall Study|Withdrawal by Subject|4|||
163412968|NCT01467492|590220832|FG000|Overall Study|Study Terminated by Sponsor|6|||
163412969|NCT01467492|590220833|FG001|Overall Study|Study Terminated by Sponsor|4|||
163412970|NCT01467492|590220832|FG000|Overall Study|Adverse Event|4|||
163412971|NCT01467492|590220833|FG001|Overall Study|Adverse Event|3|||
163412972|NCT01467492|590220832|FG000|Overall Study|Lost to Follow-up|3|||
163412973|NCT01467492|590220833|FG001|Overall Study|Lost to Follow-up|2|||
163412974|NCT01467492|590220832|FG000|Overall Study|Undefined|2|||
163412975|NCT01467492|590220833|FG001|Overall Study|Undefined|0|||
163412976|NCT01467492|590220832|FG000|Overall Study|Enrolled But Not Treated|1|||
163412977|NCT01467492|590220833|FG001|Overall Study|Enrolled But Not Treated|0|||
163412978|NCT01790048|590220836|FG000|Overall Study|Incorrect Age|9|||
163412979|NCT01790048|590220837|FG001|Overall Study|Incorrect Age|14|||
163412980|NCT01790048|590220836|FG000|Overall Study|data entry error|0|||
163412981|NCT01790048|590220837|FG001|Overall Study|data entry error|1|||
163412982|NCT01790048|590220836|FG000|Overall Study|Other|0|||
163412983|NCT01790048|590220837|FG001|Overall Study|Other|2|||
163412984|NCT01790048|590220836|FG000|Overall Study|SAM at Enrollment|2|||
163412985|NCT01790048|590220837|FG001|Overall Study|SAM at Enrollment|0|||
163412986|NCT01790048|590220836|FG000|Overall Study|Measurement error|1|||
163412987|NCT01790048|590220837|FG001|Overall Study|Measurement error|0|||
163412988|NCT01415752|590220840|FG000|Induction (Step 1)|Ineligible|4|||
163412989|NCT01415752|590220841|FG001|Induction (Step 1)|Ineligible|3|||
163412990|NCT01415752|590220842|FG002|Induction (Step 1)|Ineligible|4|||
163412991|NCT01415752|590220843|FG003|Induction (Step 1)|Ineligible|4|||
163412992|NCT01415752|590220840|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
163412993|NCT01415752|590220841|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
163412994|NCT01415752|590220842|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
163412995|NCT01415752|590220843|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
163412996|NCT01415752|590220840|FG000|Maintenance (Step 2)|Adverse Event|3|||
163412997|NCT01415752|590220841|FG001|Maintenance (Step 2)|Adverse Event|4|||
163412998|NCT01415752|590220842|FG002|Maintenance (Step 2)|Adverse Event|9|||
163412999|NCT01415752|590220843|FG003|Maintenance (Step 2)|Adverse Event|6|||
163413000|NCT01415752|590220840|FG000|Maintenance (Step 2)|Death|1|||
163413001|NCT01415752|590220841|FG001|Maintenance (Step 2)|Death|1|||
163413002|NCT01415752|590220842|FG002|Maintenance (Step 2)|Death|2|||
163413003|NCT01415752|590220843|FG003|Maintenance (Step 2)|Death|0|||
163413004|NCT01415752|590220840|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
163413005|NCT01415752|590220841|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
163413006|NCT01415752|590220842|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
163413007|NCT01415752|590220843|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
163413008|NCT01415752|590220840|FG000|Maintenance (Step 2)|Alternative therapy|0|||
163413009|NCT01415752|590220841|FG001|Maintenance (Step 2)|Alternative therapy|1|||
163413010|NCT01415752|590220842|FG002|Maintenance (Step 2)|Alternative therapy|0|||
163413011|NCT01415752|590220843|FG003|Maintenance (Step 2)|Alternative therapy|0|||
163367600|NCT02519348|590054034|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
163367601|NCT02519348|590054035|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
163413012|NCT01415752|590220840|FG000|Maintenance (Step 2)|Other reasons|3|||
163413013|NCT01415752|590220841|FG001|Maintenance (Step 2)|Other reasons|6|||
163413014|NCT01415752|590220842|FG002|Maintenance (Step 2)|Other reasons|4|||
163413015|NCT01415752|590220843|FG003|Maintenance (Step 2)|Other reasons|6|||
163413016|NCT01415752|590220840|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
163367602|NCT02519348|590054036|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
163367603|NCT02519348|590054037|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
163367604|NCT02519348|590054038|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
163367605|NCT02519348|590054039|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
163367606|NCT02519348|590054040|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
163367607|NCT02519348|590054041|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
163367608|NCT02519348|590054042|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
163367609|NCT03635099|590054043|FG000|Period 1|Adverse Event|1|||
163367610|NCT03635099|590054044|FG001|Period 1|Adverse Event|0|||
163367611|NCT03635099|590054045|FG002|Period 1|Adverse Event|0|||
163367612|NCT03635099|590054046|FG003|Period 1|Adverse Event|1|||
163367613|NCT03635099|590054047|FG004|Period 1|Adverse Event|0|||
163367614|NCT03635099|590054048|FG005|Period 1|Adverse Event|0|||
163367615|NCT03635099|590054049|FG006|Period 1|Adverse Event|0|||
163367616|NCT03635099|590054050|FG007|Period 1|Adverse Event|0|||
163367617|NCT03635099|590054043|FG000|Period 1|Protocol Violation|0|||
163367618|NCT03635099|590054044|FG001|Period 1|Protocol Violation|0|||
163367619|NCT03635099|590054045|FG002|Period 1|Protocol Violation|1|||
163367620|NCT03635099|590054046|FG003|Period 1|Protocol Violation|0|||
163367621|NCT03635099|590054047|FG004|Period 1|Protocol Violation|0|||
163367622|NCT03635099|590054048|FG005|Period 1|Protocol Violation|0|||
163367623|NCT03635099|590054049|FG006|Period 1|Protocol Violation|0|||
163367624|NCT03635099|590054050|FG007|Period 1|Protocol Violation|0|||
163367625|NCT03635099|590054043|FG000|Period 1|Lost to Follow-up|0|||
163367626|NCT03635099|590054044|FG001|Period 1|Lost to Follow-up|0|||
163367627|NCT03635099|590054045|FG002|Period 1|Lost to Follow-up|1|||
163367628|NCT03635099|590054046|FG003|Period 1|Lost to Follow-up|2|||
163367629|NCT03635099|590054047|FG004|Period 1|Lost to Follow-up|1|||
163367630|NCT03635099|590054048|FG005|Period 1|Lost to Follow-up|0|||
163367631|NCT03635099|590054049|FG006|Period 1|Lost to Follow-up|1|||
163367632|NCT03635099|590054050|FG007|Period 1|Lost to Follow-up|2|||
163367633|NCT03635099|590054043|FG000|Period 1|Withdrawal by Subject|3|||
163367634|NCT03635099|590054044|FG001|Period 1|Withdrawal by Subject|3|||
163367635|NCT03635099|590054045|FG002|Period 1|Withdrawal by Subject|5|||
163367636|NCT03635099|590054046|FG003|Period 1|Withdrawal by Subject|2|||
163367637|NCT03635099|590054047|FG004|Period 1|Withdrawal by Subject|2|||
163367638|NCT03635099|590054048|FG005|Period 1|Withdrawal by Subject|0|||
163367639|NCT03635099|590054049|FG006|Period 1|Withdrawal by Subject|3|||
163367640|NCT03635099|590054050|FG007|Period 1|Withdrawal by Subject|0|||
163367641|NCT03635099|590054043|FG000|Period 1|History of suicidal ideation|0|||
163367642|NCT03635099|590054044|FG001|Period 1|History of suicidal ideation|0|||
163367643|NCT03635099|590054045|FG002|Period 1|History of suicidal ideation|1|||
163367644|NCT03635099|590054046|FG003|Period 1|History of suicidal ideation|0|||
163367645|NCT03635099|590054047|FG004|Period 1|History of suicidal ideation|0|||
163367646|NCT03635099|590054048|FG005|Period 1|History of suicidal ideation|0|||
163367647|NCT03635099|590054049|FG006|Period 1|History of suicidal ideation|0|||
163367648|NCT03635099|590054050|FG007|Period 1|History of suicidal ideation|0|||
163367649|NCT03635099|590054043|FG000|Period 1|pursue other treatment options|0|||
163367650|NCT03635099|590054044|FG001|Period 1|pursue other treatment options|0|||
163367651|NCT03635099|590054045|FG002|Period 1|pursue other treatment options|0|||
163367652|NCT03635099|590054046|FG003|Period 1|pursue other treatment options|0|||
163367653|NCT03635099|590054047|FG004|Period 1|pursue other treatment options|0|||
163367654|NCT03635099|590054048|FG005|Period 1|pursue other treatment options|1|||
163367655|NCT03635099|590054049|FG006|Period 1|pursue other treatment options|0|||
163367656|NCT03635099|590054050|FG007|Period 1|pursue other treatment options|0|||
163367657|NCT03635099|590054043|FG000|Not Eligible for Period 2|Pregnancy|0|||
163367658|NCT03635099|590054044|FG001|Not Eligible for Period 2|Pregnancy|0|||
163367659|NCT03635099|590054045|FG002|Not Eligible for Period 2|Pregnancy|0|||
163367660|NCT03635099|590054046|FG003|Not Eligible for Period 2|Pregnancy|1|||
163367661|NCT03635099|590054047|FG004|Not Eligible for Period 2|Pregnancy|0|||
163367662|NCT03635099|590054048|FG005|Not Eligible for Period 2|Pregnancy|0|||
163367663|NCT03635099|590054049|FG006|Not Eligible for Period 2|Pregnancy|0|||
163367664|NCT03635099|590054050|FG007|Not Eligible for Period 2|Pregnancy|0|||
163367665|NCT03635099|590054043|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
163367666|NCT03635099|590054044|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
163367667|NCT03635099|590054045|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
163367668|NCT03635099|590054046|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
163367669|NCT03635099|590054047|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
163367670|NCT03635099|590054048|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
163367671|NCT03635099|590054049|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
163367672|NCT03635099|590054050|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
163367673|NCT03635099|590054043|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
163367674|NCT03635099|590054044|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
163367675|NCT03635099|590054045|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
163367676|NCT03635099|590054046|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
163367677|NCT03635099|590054047|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
163367678|NCT03635099|590054048|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
163367679|NCT03635099|590054049|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
163367680|NCT03635099|590054050|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
163367681|NCT03635099|590054043|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
163367682|NCT03635099|590054044|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
163367683|NCT03635099|590054045|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
163367684|NCT03635099|590054046|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
163367685|NCT03635099|590054047|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
163413017|NCT01415752|590220841|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
163413018|NCT01415752|590220842|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
163413019|NCT01415752|590220843|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
163413020|NCT01415752|590220840|FG000|Maintenance (Step 2)|ineligible|1|||
163413021|NCT01415752|590220841|FG001|Maintenance (Step 2)|ineligible|1|||
163413022|NCT01415752|590220842|FG002|Maintenance (Step 2)|ineligible|1|||
163413023|NCT01415752|590220843|FG003|Maintenance (Step 2)|ineligible|0|||
163413024|NCT01415752|590220840|FG000|Maintenance (Step 2)|Missing|4|||
163367686|NCT03635099|590054048|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
163367687|NCT03635099|590054049|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
163367688|NCT03635099|590054050|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
163367689|NCT03635099|590054043|FG000|Period 2|Adverse Event|0|||
163413025|NCT01415752|590220841|FG001|Maintenance (Step 2)|Missing|1|||
163367690|NCT03635099|590054044|FG001|Period 2|Adverse Event|0|||
163367691|NCT03635099|590054045|FG002|Period 2|Adverse Event|1|||
163367692|NCT03635099|590054046|FG003|Period 2|Adverse Event|0|||
163367693|NCT03635099|590054047|FG004|Period 2|Adverse Event|1|||
163367694|NCT03635099|590054048|FG005|Period 2|Adverse Event|0|||
163367695|NCT03635099|590054049|FG006|Period 2|Adverse Event|0|||
163367696|NCT03635099|590054050|FG007|Period 2|Adverse Event|0|||
163367697|NCT03635099|590054043|FG000|Period 2|Lost to Follow-up|0|||
163367698|NCT03635099|590054044|FG001|Period 2|Lost to Follow-up|0|||
163367699|NCT03635099|590054045|FG002|Period 2|Lost to Follow-up|1|||
163367700|NCT03635099|590054046|FG003|Period 2|Lost to Follow-up|0|||
163367701|NCT03635099|590054047|FG004|Period 2|Lost to Follow-up|4|||
163367702|NCT03635099|590054048|FG005|Period 2|Lost to Follow-up|0|||
163367703|NCT03635099|590054049|FG006|Period 2|Lost to Follow-up|0|||
163367704|NCT03635099|590054050|FG007|Period 2|Lost to Follow-up|0|||
163367705|NCT03635099|590054043|FG000|Period 2|Withdrawal by Subject|0|||
163367706|NCT03635099|590054044|FG001|Period 2|Withdrawal by Subject|0|||
163367707|NCT03635099|590054045|FG002|Period 2|Withdrawal by Subject|7|||
163367708|NCT03635099|590054046|FG003|Period 2|Withdrawal by Subject|4|||
163367709|NCT03635099|590054047|FG004|Period 2|Withdrawal by Subject|7|||
163367710|NCT03635099|590054048|FG005|Period 2|Withdrawal by Subject|0|||
163367711|NCT03635099|590054049|FG006|Period 2|Withdrawal by Subject|0|||
163367712|NCT03635099|590054050|FG007|Period 2|Withdrawal by Subject|0|||
163367713|NCT01289210|590054051|FG000|Overall Study|Adverse Event|1|||
163367714|NCT06285240|590054052|FG000|Overall Study|Withdrawal by Subject|2|||
163367715|NCT06285240|590054053|FG001|Overall Study|Withdrawal by Subject|0|||
163367716|NCT06285240|590054054|FG002|Overall Study|Withdrawal by Subject|0|||
163367717|NCT06285240|590054055|FG003|Overall Study|Withdrawal by Subject|0|||
163367718|NCT06285240|590054052|FG000|Overall Study|Serious Adverse Event|0|||
163367719|NCT06285240|590054053|FG001|Overall Study|Serious Adverse Event|0|||
163367720|NCT06285240|590054054|FG002|Overall Study|Serious Adverse Event|1|||
163367721|NCT06285240|590054055|FG003|Overall Study|Serious Adverse Event|0|||
163367722|NCT04844879|590054058|FG000|Overall Study|Death|1|||
163367723|NCT04844879|590054058|FG000|Overall Study|Withdrawal by Subject|1|||
163367724|NCT04844879|590054058|FG000|Overall Study|Adverse Event|1|||
163367725|NCT04103892|590054064|FG000|Overall Study|Adverse Event|0|||
163367726|NCT04103892|590054065|FG001|Overall Study|Adverse Event|0|||
163367727|NCT04103892|590054066|FG002|Overall Study|Adverse Event|0|||
163367728|NCT04103892|590054067|FG003|Overall Study|Adverse Event|3|||
163367729|NCT04103892|590054064|FG000|Overall Study|Lost to Follow-up|0|||
163367730|NCT04103892|590054065|FG001|Overall Study|Lost to Follow-up|0|||
163367731|NCT04103892|590054066|FG002|Overall Study|Lost to Follow-up|2|||
163367732|NCT04103892|590054067|FG003|Overall Study|Lost to Follow-up|0|||
163367733|NCT04103892|590054064|FG000|Overall Study|Protocol Violation|0|||
163367734|NCT04103892|590054065|FG001|Overall Study|Protocol Violation|0|||
163367735|NCT04103892|590054066|FG002|Overall Study|Protocol Violation|1|||
163367736|NCT04103892|590054067|FG003|Overall Study|Protocol Violation|1|||
163367737|NCT04103892|590054064|FG000|Overall Study|Withdrawal by Subject|1|||
163367738|NCT04103892|590054065|FG001|Overall Study|Withdrawal by Subject|0|||
163367739|NCT04103892|590054066|FG002|Overall Study|Withdrawal by Subject|2|||
163367740|NCT04103892|590054067|FG003|Overall Study|Withdrawal by Subject|5|||
163367741|NCT04103892|590054064|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
163367742|NCT04103892|590054065|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
163367743|NCT04103892|590054066|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
163367744|NCT04103892|590054067|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
163367745|NCT05576662|590054068|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
163413026|NCT01415752|590220842|FG002|Maintenance (Step 2)|Missing|4|||
163413027|NCT01415752|590220843|FG003|Maintenance (Step 2)|Missing|3|||
163367746|NCT05576662|590054069|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
163367747|NCT05576662|590054068|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
163367748|NCT05576662|590054069|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
163413028|NCT01391507|590220844|FG000|Overall Study|Death|0|||
163413029|NCT01391507|590220845|FG001|Overall Study|Death|0|||
163413030|NCT01391507|590220846|FG002|Overall Study|Death|0|||
163413031|NCT01391507|590220847|FG003|Overall Study|Death|1|||
163413032|NCT01391507|590220844|FG000|Overall Study|Adverse Event|1|||
163413033|NCT01391507|590220845|FG001|Overall Study|Adverse Event|1|||
163413034|NCT01391507|590220846|FG002|Overall Study|Adverse Event|2|||
163413035|NCT01391507|590220847|FG003|Overall Study|Adverse Event|2|||
163413036|NCT01391507|590220844|FG000|Overall Study|Withdrawal by Subject|1|||
163413037|NCT01391507|590220845|FG001|Overall Study|Withdrawal by Subject|2|||
163413038|NCT01391507|590220846|FG002|Overall Study|Withdrawal by Subject|1|||
163413039|NCT01391507|590220847|FG003|Overall Study|Withdrawal by Subject|1|||
163413040|NCT01391507|590220844|FG000|Overall Study|Lack of Efficacy|0|||
163413041|NCT01391507|590220845|FG001|Overall Study|Lack of Efficacy|0|||
163413042|NCT01391507|590220846|FG002|Overall Study|Lack of Efficacy|0|||
163413043|NCT01391507|590220847|FG003|Overall Study|Lack of Efficacy|1|||
163413044|NCT01391507|590220844|FG000|Overall Study|Protocol Violation|2|||
163413045|NCT01391507|590220845|FG001|Overall Study|Protocol Violation|1|||
163413046|NCT01391507|590220846|FG002|Overall Study|Protocol Violation|1|||
163413047|NCT01391507|590220847|FG003|Overall Study|Protocol Violation|2|||
163413048|NCT01453855|590220848|FG000|Overall Study|Adverse Event|3|||
163413049|NCT01453855|590220849|FG001|Overall Study|Adverse Event|4|||
163413050|NCT01453855|590220848|FG000|Overall Study|Lost to Follow-up|2|||
163413051|NCT01453855|590220849|FG001|Overall Study|Lost to Follow-up|1|||
163413052|NCT01453855|590220848|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
163413053|NCT01453855|590220849|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
163413054|NCT01453855|590220848|FG000|Overall Study|Noncompliance|1|||
163413055|NCT01453855|590220849|FG001|Overall Study|Noncompliance|0|||
163413056|NCT01453855|590220848|FG000|Overall Study|Inadequate Control of IOP|1|||
163413057|NCT01453855|590220849|FG001|Overall Study|Inadequate Control of IOP|5|||
163413058|NCT01453855|590220848|FG000|Overall Study|Other|0|||
163413059|NCT01453855|590220849|FG001|Overall Study|Other|1|||
163413060|NCT01496066|590220850|FG000|Overall Study|Lost to Follow-up|8|||
163413061|NCT01496066|590220851|FG001|Overall Study|Lost to Follow-up|5|||
163413062|NCT01496066|590220850|FG000|Overall Study|Explant|3|||
163413063|NCT01496066|590220851|FG001|Overall Study|Explant|0|||
163413064|NCT01496066|590220850|FG000|Overall Study|Death|1|||
163413065|NCT01496066|590220851|FG001|Overall Study|Death|4|||
163413066|NCT01340209|590220852|FG000|Overall Study|Adverse Event|1|||
163413067|NCT01340209|590220853|FG001|Overall Study|Adverse Event|1|||
163413068|NCT01340209|590220854|FG002|Overall Study|Adverse Event|2|||
163413069|NCT01340209|590220852|FG000|Overall Study|Protocol Violation|1|||
163413070|NCT01340209|590220853|FG001|Overall Study|Protocol Violation|2|||
163413071|NCT01340209|590220854|FG002|Overall Study|Protocol Violation|1|||
163413072|NCT01340209|590220852|FG000|Overall Study|Withdrawal by Subject|0|||
163413073|NCT01340209|590220853|FG001|Overall Study|Withdrawal by Subject|0|||
163413074|NCT01340209|590220854|FG002|Overall Study|Withdrawal by Subject|1|||
163413075|NCT01340209|590220852|FG000|Overall Study|Other reason not defined above|3|||
163413076|NCT01340209|590220853|FG001|Overall Study|Other reason not defined above|5|||
163413077|NCT01340209|590220854|FG002|Overall Study|Other reason not defined above|4|||
163413078|NCT00253630|590220855|FG000|Overall Study|ineligible|2|||
163413079|NCT01239160|590220856|FG000|Overall Study|Lost to Follow-up|3|||
163413080|NCT01239160|590220857|FG001|Overall Study|Lost to Follow-up|5|||
163413081|NCT01239160|590220858|FG002|Overall Study|Lost to Follow-up|0|||
163413082|NCT01239160|590220856|FG000|Overall Study|Withdrawal by Subject|17|||
163413083|NCT01239160|590220857|FG001|Overall Study|Withdrawal by Subject|6|||
163413084|NCT01239160|590220858|FG002|Overall Study|Withdrawal by Subject|2|||
163413085|NCT01239160|590220856|FG000|Overall Study|Physician Decision|5|||
163413086|NCT01239160|590220857|FG001|Overall Study|Physician Decision|7|||
163413087|NCT01239160|590220858|FG002|Overall Study|Physician Decision|2|||
163413088|NCT01239160|590220856|FG000|Overall Study|Early Termination Due to Study Closure|0|||
163413089|NCT01239160|590220857|FG001|Overall Study|Early Termination Due to Study Closure|1|||
163413090|NCT01239160|590220858|FG002|Overall Study|Early Termination Due to Study Closure|6|||
163367749|NCT05576662|590054068|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
163367750|NCT05576662|590054069|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
163367751|NCT05576662|590054068|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
163367752|NCT05576662|590054069|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
163367753|NCT00281320|590054070|FG000|Overall Study|Adverse Event|12|||
163367754|NCT00281320|590054071|FG001|Overall Study|Adverse Event|9|||
163367755|NCT00281320|590054070|FG000|Overall Study|Lack of Efficacy|4|||
163367756|NCT00281320|590054071|FG001|Overall Study|Lack of Efficacy|3|||
163367757|NCT00281320|590054070|FG000|Overall Study|Withdrawal by Subject|5|||
163413091|NCT01789970|590220863|FG000|Open-label Titration Period|Adverse Event|68|||
163413092|NCT01789970|590220864|FG001|Open-label Titration Period|Adverse Event|0|||
163413093|NCT01789970|590220865|FG002|Open-label Titration Period|Adverse Event|0|||
163413094|NCT01789970|590220863|FG000|Open-label Titration Period|Lack of Efficacy|31|||
163413095|NCT01789970|590220864|FG001|Open-label Titration Period|Lack of Efficacy|0|||
163413096|NCT01789970|590220865|FG002|Open-label Titration Period|Lack of Efficacy|0|||
163413097|NCT01789970|590220863|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
163413098|NCT01789970|590220864|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
163413099|NCT01789970|590220865|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
163413100|NCT01789970|590220863|FG000|Open-label Titration Period|Protocol Violation|18|||
163413101|NCT01789970|590220864|FG001|Open-label Titration Period|Protocol Violation|0|||
163413102|NCT01789970|590220865|FG002|Open-label Titration Period|Protocol Violation|0|||
163413103|NCT01789970|590220863|FG000|Open-label Titration Period|Lost to Follow-up|5|||
163413104|NCT01789970|590220864|FG001|Open-label Titration Period|Lost to Follow-up|0|||
163413105|NCT01789970|590220865|FG002|Open-label Titration Period|Lost to Follow-up|0|||
163413106|NCT01789970|590220863|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
163413107|NCT01789970|590220864|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
163413108|NCT01789970|590220865|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
163413109|NCT01789970|590220863|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
163413110|NCT01789970|590220864|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
163413111|NCT01789970|590220865|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
163413112|NCT01789970|590220863|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
163413113|NCT01789970|590220864|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
163413114|NCT01789970|590220865|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
163413115|NCT01789970|590220863|FG000|Open-label Titration Period|Pregnancy|2|||
163413116|NCT01789970|590220864|FG001|Open-label Titration Period|Pregnancy|0|||
163413117|NCT01789970|590220865|FG002|Open-label Titration Period|Pregnancy|0|||
163413118|NCT01789970|590220863|FG000|Open-label Titration Period|Other|76|||
163413119|NCT01789970|590220864|FG001|Open-label Titration Period|Other|0|||
163413120|NCT01789970|590220865|FG002|Open-label Titration Period|Other|0|||
163367758|NCT00281320|590054071|FG001|Overall Study|Withdrawal by Subject|6|||
163367759|NCT00281320|590054070|FG000|Overall Study|Lost to Follow-up|1|||
163367760|NCT00281320|590054071|FG001|Overall Study|Lost to Follow-up|2|||
163367761|NCT00281320|590054070|FG000|Overall Study|Other|3|||
163367762|NCT00281320|590054071|FG001|Overall Study|Other|1|||
163367763|NCT03008005|590054078|FG000|Overall Study|Physician Decision|1|||
163367764|NCT03008005|590054079|FG001|Overall Study|Physician Decision|0|||
163367765|NCT03008005|590054080|FG002|Overall Study|Physician Decision|0|||
163367766|NCT03008005|590054078|FG000|Overall Study|Withdrawal by Subject|1|||
163367767|NCT03008005|590054079|FG001|Overall Study|Withdrawal by Subject|0|||
163367768|NCT03008005|590054080|FG002|Overall Study|Withdrawal by Subject|0|||
163367769|NCT03008005|590054078|FG000|Overall Study|Ineligible|0|||
163367770|NCT03008005|590054079|FG001|Overall Study|Ineligible|1|||
163367771|NCT03008005|590054080|FG002|Overall Study|Ineligible|0|||
163367772|NCT05292586|590054081|FG000|Overall Study|Withdrawal by Subject|3|||
163367773|NCT05292586|590054082|FG001|Overall Study|Withdrawal by Subject|10|||
163367774|NCT05292586|590054081|FG000|Overall Study|Randomization error|3|||
163367775|NCT05292586|590054082|FG001|Overall Study|Randomization error|7|||
163367776|NCT05292586|590054081|FG000|Overall Study|Adverse Event|3|||
163367777|NCT05292586|590054082|FG001|Overall Study|Adverse Event|0|||
163367778|NCT05292586|590054081|FG000|Overall Study|Lost to Follow-up|0|||
163367779|NCT05292586|590054082|FG001|Overall Study|Lost to Follow-up|1|||
163367780|NCT05292586|590054081|FG000|Overall Study|Patient refused treatment|1|||
163367781|NCT05292586|590054082|FG001|Overall Study|Patient refused treatment|0|||
163367782|NCT05292586|590054081|FG000|Overall Study|Patient could not travel to the study site|1|||
163367783|NCT05292586|590054082|FG001|Overall Study|Patient could not travel to the study site|0|||
163367784|NCT05292586|590054081|FG000|Overall Study|Technical issues with the masterscope|0|||
163367785|NCT05292586|590054082|FG001|Overall Study|Technical issues with the masterscope|3|||
163367786|NCT05292586|590054081|FG000|Overall Study|Patient moved to a different state|0|||
163367787|NCT05292586|590054082|FG001|Overall Study|Patient moved to a different state|1|||
163367788|NCT00475228|590054083|FG000|Overall Study|Lost to Follow-up|17|||
163367789|NCT00475228|590054084|FG001|Overall Study|Lost to Follow-up|17|||
163367790|NCT02367040|590054097|FG000|Overall Study|Lost to Follow-up|1|||
163367791|NCT02367040|590054098|FG001|Overall Study|Lost to Follow-up|1|||
163367792|NCT02367040|590054097|FG000|Overall Study|Lack of Efficacy|1|||
163367793|NCT02367040|590054098|FG001|Overall Study|Lack of Efficacy|0|||
163367794|NCT02367040|590054097|FG000|Overall Study|Additional primary malignancy|1|||
163367795|NCT02367040|590054098|FG001|Overall Study|Additional primary malignancy|1|||
163367796|NCT02367040|590054097|FG000|Overall Study|AE not associated with clinical disease progression|117|||
163367797|NCT02367040|590054098|FG001|Overall Study|AE not associated with clinical disease progression|12|||
163367798|NCT02367040|590054097|FG000|Overall Study|AE associated with clinical disease progression|1|||
163367799|NCT02367040|590054098|FG001|Overall Study|AE associated with clinical disease progression|4|||
163367800|NCT02367040|590054097|FG000|Overall Study|Physician Decision|2|||
163367801|NCT02367040|590054098|FG001|Overall Study|Physician Decision|8|||
163367802|NCT02367040|590054097|FG000|Overall Study|Non-compliance to study drug|1|||
163413121|NCT01789970|590220863|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
163413122|NCT01789970|590220864|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
163413123|NCT01789970|590220865|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
163367803|NCT02367040|590054098|FG001|Overall Study|Non-compliance to study drug|0|||
163367804|NCT02367040|590054097|FG000|Overall Study|Failure to meet continuation criteria|1|||
163367805|NCT02367040|590054098|FG001|Overall Study|Failure to meet continuation criteria|0|||
163367806|NCT02367040|590054097|FG000|Overall Study|Switching to other therapy|2|||
163367807|NCT02367040|590054098|FG001|Overall Study|Switching to other therapy|0|||
163367808|NCT02367040|590054097|FG000|Overall Study|Withdrawal by Subject|51|||
163367809|NCT02367040|590054098|FG001|Overall Study|Withdrawal by Subject|16|||
163367810|NCT02367040|590054097|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
163367811|NCT02367040|590054098|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
163367812|NCT02367040|590054097|FG000|Overall Study|Patient decision|40|||
163367813|NCT02367040|590054098|FG001|Overall Study|Patient decision|14|||
163367814|NCT02367040|590054097|FG000|Overall Study|Required procedure failed|1|||
163367815|NCT02367040|590054098|FG001|Overall Study|Required procedure failed|0|||
163367816|NCT02367040|590054097|FG000|Overall Study|Randomized by mistake with study treatment|1|||
163367817|NCT02367040|590054098|FG001|Overall Study|Randomized by mistake with study treatment|0|||
163367818|NCT02367040|590054097|FG000|Overall Study|Protocol Violation|1|||
163367819|NCT02367040|590054098|FG001|Overall Study|Protocol Violation|0|||
163367820|NCT02367040|590054097|FG000|Overall Study|Progressive disease - radiological progression|54|||
163367821|NCT02367040|590054098|FG001|Overall Study|Progressive disease - radiological progression|80|||
163367822|NCT02367040|590054097|FG000|Overall Study|Progressive disease - clinical progression|6|||
163367823|NCT02367040|590054098|FG001|Overall Study|Progressive disease - clinical progression|6|||
163367824|NCT02367040|590054097|FG000|Overall Study|Drug not administered|3|||
163367825|NCT02367040|590054098|FG001|Overall Study|Drug not administered|2|||
163367826|NCT02367040|590054097|FG000|Overall Study|Progressive disease|0|||
163367827|NCT02367040|590054098|FG001|Overall Study|Progressive disease|1|||
163367828|NCT02367040|590054097|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
163367829|NCT02367040|590054098|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
163367830|NCT02367040|590054097|FG000|Overall Study|Death|2|||
163367831|NCT02367040|590054098|FG001|Overall Study|Death|0|||
163367832|NCT02367040|590054097|FG000|Overall Study|Study terminated by sponsor|19|||
163367833|NCT02367040|590054098|FG001|Overall Study|Study terminated by sponsor|2|||
163367834|NCT02477618|590054099|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
163367835|NCT02477618|590054100|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
163367836|NCT02477618|590054099|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
163367837|NCT02477618|590054100|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
163367838|NCT02477618|590054099|FG000|Overall Study|Adverse Event|1|||
163367839|NCT02477618|590054100|FG001|Overall Study|Adverse Event|1|||
163367840|NCT02477618|590054099|FG000|Overall Study|Transferred Away from Study Site|1|||
163367841|NCT02477618|590054100|FG001|Overall Study|Transferred Away from Study Site|0|||
163367842|NCT02477618|590054099|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
163367843|NCT02477618|590054100|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
163367844|NCT05855967|590054101|FG000|Overall Study|Withdrawal by Subject|7|||
163367845|NCT05855967|590054102|FG001|Overall Study|Withdrawal by Subject|5|||
163367846|NCT05855967|590054101|FG000|Overall Study|Lost to Follow-up|2|||
163367847|NCT05855967|590054102|FG001|Overall Study|Lost to Follow-up|1|||
163367848|NCT02446821|590054103|FG000|Overall Study|Adverse Event|28|||
163367849|NCT02446821|590054103|FG000|Overall Study|Withdrawal by Subject|6|||
163367850|NCT02446821|590054103|FG000|Overall Study|Lost to Follow-up|22|||
163367851|NCT02446821|590054103|FG000|Overall Study|other|9|||
163367852|NCT02446821|590054103|FG000|Overall Study|insertion failure|3|||
163367853|NCT07149155|590054110|FG000|Overall Study|Lost to Follow-up|10|||
163367854|NCT01876082|590055727|FG000|Overall Study|Withdrawal by Subject|0|||
163367855|NCT01876082|590055728|FG001|Overall Study|Withdrawal by Subject|2|||
163367856|NCT01876082|590055727|FG000|Overall Study|Protocol Violation|1|||
163367857|NCT01876082|590055728|FG001|Overall Study|Protocol Violation|0|||
163367858|NCT01876082|590055727|FG000|Overall Study|Adverse Event|1|||
163367859|NCT01876082|590055728|FG001|Overall Study|Adverse Event|1|||
163367860|NCT01876082|590055727|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
163367861|NCT01876082|590055728|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
163367862|NCT04020185|590055739|FG000|Overall Study|Death|0|||
163367863|NCT04020185|590055740|FG001|Overall Study|Death|0|||
163367864|NCT04020185|590055741|FG002|Overall Study|Death|1|||
163367865|NCT04020185|590055742|FG003|Overall Study|Death|2|||
163367866|NCT04020185|590055743|FG004|Overall Study|Death|1|||
163367867|NCT04020185|590055744|FG005|Overall Study|Death|0|||
163367868|NCT04020185|590055745|FG006|Overall Study|Death|1|||
163367869|NCT04020185|590055746|FG007|Overall Study|Death|0|||
163367870|NCT04020185|590055739|FG000|Overall Study|Consent withdrawn|1|||
163367871|NCT04020185|590055740|FG001|Overall Study|Consent withdrawn|0|||
163367872|NCT04020185|590055741|FG002|Overall Study|Consent withdrawn|0|||
163367873|NCT04020185|590055742|FG003|Overall Study|Consent withdrawn|0|||
163367874|NCT04020185|590055743|FG004|Overall Study|Consent withdrawn|2|||
163367875|NCT04020185|590055744|FG005|Overall Study|Consent withdrawn|0|||
163367876|NCT04020185|590055745|FG006|Overall Study|Consent withdrawn|1|||
163367877|NCT04020185|590055746|FG007|Overall Study|Consent withdrawn|1|||
163367878|NCT04020185|590055739|FG000|Overall Study|Patient in hospice|0|||
163367879|NCT04020185|590055740|FG001|Overall Study|Patient in hospice|1|||
163367880|NCT04020185|590055741|FG002|Overall Study|Patient in hospice|0|||
163367881|NCT04020185|590055742|FG003|Overall Study|Patient in hospice|0|||
163367882|NCT04020185|590055743|FG004|Overall Study|Patient in hospice|0|||
163367883|NCT04020185|590055744|FG005|Overall Study|Patient in hospice|0|||
163367884|NCT04020185|590055745|FG006|Overall Study|Patient in hospice|0|||
163367885|NCT04020185|590055746|FG007|Overall Study|Patient in hospice|0|||
163367886|NCT04020185|590055739|FG000|Overall Study|Continuing on expanded access|0|||
163367887|NCT04020185|590055740|FG001|Overall Study|Continuing on expanded access|0|||
163367888|NCT04020185|590055741|FG002|Overall Study|Continuing on expanded access|0|||
163367889|NCT04020185|590055742|FG003|Overall Study|Continuing on expanded access|0|||
163367890|NCT04020185|590055743|FG004|Overall Study|Continuing on expanded access|0|||
163367891|NCT04020185|590055744|FG005|Overall Study|Continuing on expanded access|0|||
163367892|NCT04020185|590055745|FG006|Overall Study|Continuing on expanded access|1|||
163367893|NCT04020185|590055746|FG007|Overall Study|Continuing on expanded access|1|||
163367894|NCT00527787|590055748|FG000|Overall Study|Adverse Event|14|||
163367895|NCT00527787|590055749|FG001|Overall Study|Adverse Event|24|||
163413124|NCT01789970|590220863|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
163413125|NCT01789970|590220864|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
163413126|NCT01789970|590220865|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
163413127|NCT01789970|590220863|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
163413128|NCT01789970|590220864|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
163413129|NCT01789970|590220865|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
163413130|NCT01789970|590220863|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163413131|NCT01789970|590220864|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
163367896|NCT00527787|590055748|FG000|Overall Study|Withdrawal by Subject|13|||
163367897|NCT00527787|590055749|FG001|Overall Study|Withdrawal by Subject|25|||
163367898|NCT00527787|590055748|FG000|Overall Study|Lost to Follow-up|5|||
163367899|NCT00527787|590055749|FG001|Overall Study|Lost to Follow-up|2|||
163367900|NCT00527787|590055748|FG000|Overall Study|Duodenal Ulcer|1|||
163367901|NCT00527787|590055749|FG001|Overall Study|Duodenal Ulcer|10|||
163367902|NCT00527787|590055748|FG000|Overall Study|misc|5|||
163367903|NCT00527787|590055749|FG001|Overall Study|misc|2|||
163367904|NCT04335591|590055752|FG000|Overall Study|Adverse Event|5|||
163367905|NCT04335591|590055753|FG001|Overall Study|Adverse Event|2|||
163367906|NCT04335591|590055754|FG002|Overall Study|Adverse Event|3|||
163367907|NCT04335591|590055755|FG003|Overall Study|Adverse Event|2|||
163367908|NCT04335591|590055752|FG000|Overall Study|Protocol Violation|1|||
163367909|NCT04335591|590055753|FG001|Overall Study|Protocol Violation|0|||
163367910|NCT04335591|590055754|FG002|Overall Study|Protocol Violation|0|||
163367911|NCT04335591|590055755|FG003|Overall Study|Protocol Violation|0|||
163367912|NCT04335591|590055752|FG000|Overall Study|Withdrawal by Subject|8|||
163367913|NCT04335591|590055753|FG001|Overall Study|Withdrawal by Subject|4|||
163367914|NCT04335591|590055754|FG002|Overall Study|Withdrawal by Subject|4|||
163367915|NCT04335591|590055755|FG003|Overall Study|Withdrawal by Subject|5|||
163367916|NCT04335591|590055752|FG000|Overall Study|Subject planning pregnancy|0|||
163367917|NCT04335591|590055753|FG001|Overall Study|Subject planning pregnancy|1|||
163367918|NCT04335591|590055754|FG002|Overall Study|Subject planning pregnancy|0|||
163367919|NCT04335591|590055755|FG003|Overall Study|Subject planning pregnancy|0|||
163367920|NCT04335591|590055752|FG000|Overall Study|Ukrainian Russian war conflict|4|||
163367921|NCT04335591|590055753|FG001|Overall Study|Ukrainian Russian war conflict|5|||
163367922|NCT04335591|590055754|FG002|Overall Study|Ukrainian Russian war conflict|2|||
163367923|NCT04335591|590055755|FG003|Overall Study|Ukrainian Russian war conflict|0|||
163367924|NCT01077128|590055765|FG000|Overall Study|Adverse Event|8|||
163367925|NCT01077128|590055765|FG000|Overall Study|Lack of Efficacy|1|||
163367926|NCT01077128|590055765|FG000|Overall Study|Disease exacerbation|1|||
163367927|NCT01077128|590055765|FG000|Overall Study|Adverse event and consent withdrawal|1|||
163367928|NCT01077128|590055765|FG000|Overall Study|Adverse event and disease exacerbation|1|||
163367929|NCT01077128|590055765|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
163367930|NCT01077128|590055765|FG000|Overall Study|Other|54|||
163367931|NCT01706705|590055767|FG000|Overall Study|Death|1|||
163367932|NCT01706705|590055767|FG000|Overall Study|Lack of Efficacy|13|||
163367933|NCT01706705|590055767|FG000|Overall Study|Non-clinical|6|||
163367934|NCT02242097|590055769|FG000|Ibrutinib Treatment|Adverse Event|16|||
163367935|NCT02242097|590055769|FG000|Ibrutinib Treatment|Physician Decision|1|||
163367936|NCT02242097|590055769|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
163413132|NCT01789970|590220865|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
163367937|NCT02242097|590055769|FG000|Ibrutinib Treatment|Death|1|||
163367938|NCT02242097|590055769|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
163367939|NCT02242097|590055769|FG000|Post Therapy Follow Up|Death|3|||
163367940|NCT02242097|590055769|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
163367941|NCT01712061|590055772|FG000|Overall Study|Adverse Event|4|||
163367942|NCT01712061|590055773|FG001|Overall Study|Adverse Event|9|||
163367943|NCT01712061|590055774|FG002|Overall Study|Adverse Event|5|||
163367944|NCT01712061|590055772|FG000|Overall Study|Death|0|||
163367945|NCT01712061|590055773|FG001|Overall Study|Death|0|||
163367946|NCT01712061|590055774|FG002|Overall Study|Death|1|||
163367947|NCT01712061|590055772|FG000|Overall Study|Lost to Follow-up|1|||
163367948|NCT01712061|590055773|FG001|Overall Study|Lost to Follow-up|0|||
163367949|NCT01712061|590055774|FG002|Overall Study|Lost to Follow-up|1|||
163367950|NCT01712061|590055772|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
163367951|NCT01712061|590055773|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
163367952|NCT01712061|590055774|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
163367953|NCT01712061|590055772|FG000|Overall Study|Medication Error Without Associated AE|0|||
163367954|NCT01712061|590055773|FG001|Overall Study|Medication Error Without Associated AE|1|||
163367955|NCT01712061|590055774|FG002|Overall Study|Medication Error Without Associated AE|0|||
163367956|NCT01712061|590055772|FG000|Overall Study|Withdrawal by Subject|1|||
163367957|NCT01712061|590055773|FG001|Overall Study|Withdrawal by Subject|7|||
163367958|NCT01712061|590055774|FG002|Overall Study|Withdrawal by Subject|1|||
163367959|NCT01712061|590055772|FG000|Overall Study|Other|0|||
163367960|NCT01712061|590055773|FG001|Overall Study|Other|3|||
163367961|NCT01712061|590055774|FG002|Overall Study|Other|0|||
163367962|NCT00504777|590055779|FG000|Overall Study|Adverse Event|1|||
163367963|NCT04868539|590055783|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
163367964|NCT04868539|590055784|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
163367965|NCT01572740|590055785|FG000|Overall Study|Adverse Event|1|||
163367966|NCT01572740|590055786|FG001|Overall Study|Adverse Event|1|||
163367967|NCT01572740|590055785|FG000|Overall Study|Withdrawal by Subject|1|||
163367968|NCT01572740|590055786|FG001|Overall Study|Withdrawal by Subject|1|||
163367969|NCT01572740|590055785|FG000|Overall Study|unclassified|4|||
163367970|NCT01572740|590055786|FG001|Overall Study|unclassified|3|||
163367971|NCT01401153|590055787|FG000|First Test Day|Learning disabilities; illness|1|||
163367972|NCT01401153|590055788|FG001|First Test Day|Learning disabilities; illness|10|||
163367973|NCT01401153|590055787|FG000|Second Test Day|illness|0|||
163367974|NCT01401153|590055788|FG001|Second Test Day|illness|5|||
163367975|NCT01677767|590055789|FG000|Overall Study|Adverse Event|1|||
163367976|NCT01677767|590055789|FG000|Overall Study|Death|4|||
163367977|NCT01677767|590055789|FG000|Overall Study|Protocol Violation|4|||
163367978|NCT01677767|590055789|FG000|Overall Study|Withdrawal by Subject|10|||
163367979|NCT01677767|590055789|FG000|Overall Study|Non-compliance by the participants|3|||
163367980|NCT00842244|590055790|FG000|Overall Study|Death|3|||
163367981|NCT00842244|590055790|FG000|Overall Study|Withdrawal by Subject|1|||
163367982|NCT00842244|590055790|FG000|Overall Study|Other|17|||
163367983|NCT01068665|590055791|FG000|Overall Study|Adverse Event|5|||
163367984|NCT01068665|590055792|FG001|Overall Study|Adverse Event|4|||
163367985|NCT01068665|590055791|FG000|Overall Study|Lack of Efficacy|0|||
163367986|NCT01068665|590055792|FG001|Overall Study|Lack of Efficacy|2|||
163367987|NCT01068665|590055791|FG000|Overall Study|Protocol Violation|5|||
163367988|NCT01068665|590055792|FG001|Overall Study|Protocol Violation|2|||
163367989|NCT01068665|590055791|FG000|Overall Study|Withdrawal Criteria|3|||
163367990|NCT01068665|590055792|FG001|Overall Study|Withdrawal Criteria|9|||
163367991|NCT01068665|590055791|FG000|Overall Study|Other|17|||
163367992|NCT01068665|590055792|FG001|Overall Study|Other|12|||
163367993|NCT00839956|590055794|FG000|Overall Study|Adverse Event|2|||
163367994|NCT00839956|590055794|FG000|Overall Study|Lack of Efficacy|6|||
163367995|NCT00839956|590055794|FG000|Overall Study|Physician Decision|1|||
163367996|NCT00839956|590055794|FG000|Overall Study|Withdrawal by Subject|3|||
163413133|NCT01789970|590220863|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
163413134|NCT01789970|590220864|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
163413135|NCT01789970|590220865|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
163413136|NCT01789970|590220863|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
163413137|NCT01789970|590220864|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
163413138|NCT01789970|590220865|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
163413139|NCT01789970|590220863|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
163413140|NCT01789970|590220864|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
163413141|NCT01789970|590220865|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
163413142|NCT01789970|590220863|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163413143|NCT01789970|590220864|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
163367997|NCT00846807|590055797|FG000|Overall Study|Adverse Event|270|||
163367998|NCT00846807|590055797|FG000|Overall Study|Lost to Follow-up|94|||
163367999|NCT00846807|590055797|FG000|Overall Study|Withdrawal by Subject|56|||
163368000|NCT00846807|590055797|FG000|Overall Study|Non compliant with European label|7|||
163368001|NCT00846807|590055797|FG000|Overall Study|Switch to other anticoagulants|89|||
163368002|NCT00846807|590055797|FG000|Overall Study|No prescription after hospital discharge|56|||
163368003|NCT00846807|590055797|FG000|Overall Study|Other|60|||
163368004|NCT00737698|590055798|FG000|Overall Study|Withdrawal by Subject|6|||
163368005|NCT00737698|590055799|FG001|Overall Study|Withdrawal by Subject|5|||
163368006|NCT00737698|590055800|FG002|Overall Study|Withdrawal by Subject|3|||
163368007|NCT00737698|590055798|FG000|Overall Study|Death|0|||
163368008|NCT00737698|590055799|FG001|Overall Study|Death|0|||
163368009|NCT00737698|590055800|FG002|Overall Study|Death|1|||
163368010|NCT01067846|590055801|FG000|Overall Study|Lost to Follow-up|17|||
163368011|NCT01067846|590055802|FG001|Overall Study|Lost to Follow-up|19|||
163368012|NCT01067846|590055801|FG000|Overall Study|Withdrawal by Subject|1|||
163368013|NCT01067846|590055802|FG001|Overall Study|Withdrawal by Subject|0|||
163368014|NCT01067846|590055801|FG000|Overall Study|participation in other tx study|1|||
163368015|NCT01067846|590055802|FG001|Overall Study|participation in other tx study|0|||
163368016|NCT02817906|590055803|FG000|Overall Study|Adverse Event|3|||
163368017|NCT02817906|590055804|FG001|Overall Study|Adverse Event|0|||
163368018|NCT02817906|590055803|FG000|Overall Study|Lack of Efficacy|1|||
163368019|NCT02817906|590055804|FG001|Overall Study|Lack of Efficacy|0|||
163368020|NCT02817906|590055803|FG000|Overall Study|Protocol Violation|1|||
163368021|NCT02817906|590055804|FG001|Overall Study|Protocol Violation|1|||
163368022|NCT02817906|590055803|FG000|Overall Study|Study Terminated by Sponsor|2|||
163368023|NCT02817906|590055804|FG001|Overall Study|Study Terminated by Sponsor|2|||
163368024|NCT02817906|590055803|FG000|Overall Study|Withdrawal by Subject|7|||
163368025|NCT02817906|590055804|FG001|Overall Study|Withdrawal by Subject|0|||
163368026|NCT02817906|590055803|FG000|Overall Study|Other|2|||
163368027|NCT02817906|590055804|FG001|Overall Study|Other|2|||
163368028|NCT03686423|590055813|FG000|Overall Study|Withdrawal by Subject|9|||
163368029|NCT03686423|590055813|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
163368030|NCT04954326|590055814|FG000|Overall Study|Protocol Violation|0|||
163368031|NCT04954326|590055815|FG001|Overall Study|Protocol Violation|1|||
163368032|NCT04954326|590055814|FG000|Overall Study|Death|0|||
163368033|NCT04954326|590055815|FG001|Overall Study|Death|2|||
163368034|NCT04954326|590055814|FG000|Overall Study|Physician Decision|0|||
163368035|NCT04954326|590055815|FG001|Overall Study|Physician Decision|1|||
163368036|NCT01495598|590055818|FG000|Overall Study|Death during follow up period|2|||
163368037|NCT01495598|590055818|FG000|Overall Study|Death on study|1|||
163368038|NCT01495598|590055818|FG000|Overall Study|Lost to Follow-up|3|||
163368039|NCT01495598|590055818|FG000|Overall Study|Physician Decision|8|||
163368040|NCT01110408|590055821|FG000|Overall Study|Protocol Violation|1|||
163368041|NCT01110408|590055822|FG001|Overall Study|Protocol Violation|0|||
163368042|NCT00669877|590055823|FG000|Overall Study|Disease Progression/Death|4|||
163368043|NCT05140915|590055824|FG000|Overall Study|Lost to Follow-up|2|||
163368044|NCT05140915|590055825|FG001|Overall Study|Lost to Follow-up|1|||
163368045|NCT04520659|590055826|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
163368046|NCT04520659|590055827|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
163368047|NCT04520659|590055828|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
163368048|NCT04520659|590055829|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
163368049|NCT04485611|590055834|FG000|Prehabilitation|Physician Decision|1|||
163368050|NCT04879849|590055835|FG000|Overall Study|Lost to Follow-up|0|||
163368051|NCT04879849|590055836|FG001|Overall Study|Lost to Follow-up|0|||
163368052|NCT04879849|590055837|FG002|Overall Study|Lost to Follow-up|0|||
163368053|NCT04879849|590055838|FG003|Overall Study|Lost to Follow-up|1|||
163368054|NCT04879849|590055839|FG004|Overall Study|Lost to Follow-up|0|||
163368055|NCT04879849|590055840|FG005|Overall Study|Lost to Follow-up|0|||
163368056|NCT04879849|590055841|FG006|Overall Study|Lost to Follow-up|0|||
163368057|NCT04879849|590055842|FG007|Overall Study|Lost to Follow-up|0|||
163368058|NCT04879849|590055835|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
163368059|NCT04879849|590055836|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
163368060|NCT04879849|590055837|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
163368061|NCT04879849|590055838|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
163368062|NCT04879849|590055839|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
163368063|NCT04879849|590055840|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
163368064|NCT04879849|590055841|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
163368065|NCT04879849|590055842|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
163368066|NCT04879849|590055835|FG000|Overall Study|Withdrawal by Subject|0|||
163368067|NCT04879849|590055836|FG001|Overall Study|Withdrawal by Subject|0|||
163368068|NCT04879849|590055837|FG002|Overall Study|Withdrawal by Subject|0|||
163368069|NCT04879849|590055838|FG003|Overall Study|Withdrawal by Subject|0|||
163368070|NCT04879849|590055839|FG004|Overall Study|Withdrawal by Subject|2|||
163368071|NCT04879849|590055840|FG005|Overall Study|Withdrawal by Subject|0|||
163368072|NCT04879849|590055841|FG006|Overall Study|Withdrawal by Subject|1|||
163413144|NCT01789970|590220865|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
163368073|NCT04879849|590055842|FG007|Overall Study|Withdrawal by Subject|0|||
163368074|NCT04879849|590055835|FG000|Overall Study|Progressive Disease|0|||
163368075|NCT04879849|590055836|FG001|Overall Study|Progressive Disease|0|||
163368076|NCT04879849|590055837|FG002|Overall Study|Progressive Disease|1|||
163368077|NCT04879849|590055838|FG003|Overall Study|Progressive Disease|0|||
163368078|NCT04879849|590055839|FG004|Overall Study|Progressive Disease|0|||
163368079|NCT04879849|590055840|FG005|Overall Study|Progressive Disease|0|||
163368080|NCT04879849|590055841|FG006|Overall Study|Progressive Disease|0|||
163368081|NCT04879849|590055842|FG007|Overall Study|Progressive Disease|0|||
163368082|NCT04879849|590055835|FG000|Overall Study|Death|0|||
163368083|NCT04879849|590055836|FG001|Overall Study|Death|0|||
163368084|NCT04879849|590055837|FG002|Overall Study|Death|1|||
163368085|NCT04879849|590055838|FG003|Overall Study|Death|1|||
163368086|NCT04879849|590055839|FG004|Overall Study|Death|1|||
163368087|NCT04879849|590055840|FG005|Overall Study|Death|2|||
163368088|NCT04879849|590055841|FG006|Overall Study|Death|1|||
163368089|NCT04879849|590055842|FG007|Overall Study|Death|2|||
163368090|NCT04879849|590055835|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
163368091|NCT04879849|590055836|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
163368092|NCT04879849|590055837|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
163368093|NCT04879849|590055838|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
163368094|NCT04879849|590055839|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
163368095|NCT04879849|590055840|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
163368096|NCT04879849|590055841|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
163368097|NCT04879849|590055842|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
163368098|NCT04879849|590055835|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
163368099|NCT04879849|590055836|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
163368100|NCT04879849|590055837|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
163368101|NCT04879849|590055838|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
163368102|NCT04879849|590055839|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
163368103|NCT04879849|590055840|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
163368104|NCT04879849|590055841|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
163368105|NCT04879849|590055842|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
163368106|NCT04879849|590055835|FG000|Overall Study|Reason Not Specified|1|||
163368107|NCT04879849|590055836|FG001|Overall Study|Reason Not Specified|0|||
163368108|NCT04879849|590055837|FG002|Overall Study|Reason Not Specified|0|||
163368109|NCT04879849|590055838|FG003|Overall Study|Reason Not Specified|0|||
163368110|NCT04879849|590055839|FG004|Overall Study|Reason Not Specified|0|||
163368111|NCT04879849|590055840|FG005|Overall Study|Reason Not Specified|0|||
163368112|NCT04879849|590055841|FG006|Overall Study|Reason Not Specified|0|||
163368113|NCT04879849|590055842|FG007|Overall Study|Reason Not Specified|0|||
163368114|NCT03007420|590055844|FG000|Overall Study|Withdrawal by Subject|0|||
163368115|NCT03007420|590055845|FG001|Overall Study|Withdrawal by Subject|2|||
163368116|NCT03007420|590055844|FG000|Overall Study|Physician Decision|0|||
163368117|NCT03007420|590055845|FG001|Overall Study|Physician Decision|1|||
163368118|NCT02284009|590055849|FG000|Overall Study|Adverse Event|3|||
163368119|NCT02284009|590055850|FG001|Overall Study|Adverse Event|0|||
163368120|NCT02284009|590055849|FG000|Overall Study|Lost to Follow-up|1|||
163368121|NCT02284009|590055850|FG001|Overall Study|Lost to Follow-up|3|||
163368122|NCT02284009|590055849|FG000|Overall Study|Physician Decision|0|||
163368123|NCT02284009|590055850|FG001|Overall Study|Physician Decision|2|||
163368124|NCT02284009|590055849|FG000|Overall Study|Withdrawal by Subject|2|||
163368125|NCT02284009|590055850|FG001|Overall Study|Withdrawal by Subject|5|||
163368126|NCT04147195|590055851|FG000|Overall Study|Adverse Event|0|||
163368127|NCT04147195|590055852|FG001|Overall Study|Adverse Event|3|||
163368128|NCT04147195|590055851|FG000|Overall Study|Study Terminated by Sponsor|4|||
163368129|NCT04147195|590055852|FG001|Overall Study|Study Terminated by Sponsor|2|||
163368130|NCT04147195|590055851|FG000|Overall Study|Withdrawal by Subject|0|||
163368131|NCT04147195|590055852|FG001|Overall Study|Withdrawal by Subject|1|||
163368132|NCT03841526|590055853|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
163368133|NCT03841526|590055854|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
163368134|NCT03841526|590055855|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
163368135|NCT03841526|590055856|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
163368136|NCT03841526|590055857|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
163368137|NCT03841526|590055858|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
163368138|NCT03841526|590055853|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
163368139|NCT03841526|590055854|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
163368140|NCT03841526|590055855|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
163368141|NCT03841526|590055856|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
163368142|NCT03841526|590055857|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
163368143|NCT03841526|590055858|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
163368144|NCT03841526|590055853|FG000|Outpatient Phase Treatment|Physician Decision|0|||
163368145|NCT03841526|590055854|FG001|Outpatient Phase Treatment|Physician Decision|1|||
163368146|NCT03841526|590055855|FG002|Outpatient Phase Treatment|Physician Decision|0|||
163368147|NCT03841526|590055856|FG003|Outpatient Phase Treatment|Physician Decision|0|||
163368148|NCT03841526|590055857|FG004|Outpatient Phase Treatment|Physician Decision|0|||
163368149|NCT03841526|590055858|FG005|Outpatient Phase Treatment|Physician Decision|0|||
163368150|NCT03841526|590055853|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
163368151|NCT03841526|590055854|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
163413145|NCT01789970|590220863|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
163413146|NCT01789970|590220864|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
163413147|NCT01789970|590220865|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
163413148|NCT01789970|590220863|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
163413149|NCT01789970|590220864|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
163413150|NCT01789970|590220865|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
163413151|NCT01789970|590220863|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
163413152|NCT01789970|590220864|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
163413153|NCT01789970|590220865|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
163413154|NCT02475655|590220866|FG000|Overall Study|Lost to Follow-up|0|||
163413155|NCT02475655|590220867|FG001|Overall Study|Lost to Follow-up|1|||
163413156|NCT00643994|590220868|FG000|Overall Study|Death|24|||
163413157|NCT00643994|590220868|FG000|Overall Study|Lost to Follow-up|72|||
163413158|NCT04016311|590220872|FG000|Overall Study|Withdrawal by Subject|1|||
163413159|NCT04016311|590220873|FG001|Overall Study|Withdrawal by Subject|0|||
163413160|NCT04029519|590220875|FG000|Overall Study|Protocol Violation|1|||
163413161|NCT04029519|590220875|FG000|Overall Study|Withdrawal by Subject|3|||
163413162|NCT04029519|590220875|FG000|Overall Study|Lost to Follow-up|1|||
163413163|NCT02706730|590220876|FG000|Overall Study|Adverse Event|3|||
163413164|NCT02706730|590220876|FG000|Overall Study|Lack of Efficacy|5|||
163413165|NCT02706730|590220876|FG000|Overall Study|Withdrawal by Subject|11|||
163413166|NCT02706730|590220876|FG000|Overall Study|Study Terminated by Sponsor|11|||
163413167|NCT02706730|590220876|FG000|Overall Study|Subject chose not to receive injection|3|||
163413168|NCT02499029|590220881|FG000|Overall Study|Lost to Follow-up|2|||
163413169|NCT02499029|590220882|FG001|Overall Study|Lost to Follow-up|2|||
163413170|NCT02499029|590220881|FG000|Overall Study|Physician Decision|2|||
163413171|NCT02499029|590220882|FG001|Overall Study|Physician Decision|1|||
163413172|NCT02499029|590220881|FG000|Overall Study|Death|1|||
163413173|NCT02499029|590220882|FG001|Overall Study|Death|0|||
163413174|NCT04823949|590220883|FG000|Overall Study|Withdrawal by Subject|0|||
163413175|NCT04823949|590220884|FG001|Overall Study|Withdrawal by Subject|4|||
163413176|NCT04823949|590220883|FG000|Overall Study|Physician Decision|0|||
163413177|NCT04823949|590220884|FG001|Overall Study|Physician Decision|1|||
163413178|NCT00756938|590220885|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
163413179|NCT00756938|590220886|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
163413180|NCT00756938|590220887|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
163413181|NCT00756938|590220888|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
163413182|NCT00756938|590220885|FG000|12-week Base Study|Protocol Violation|0|||
163413183|NCT00756938|590220886|FG001|12-week Base Study|Protocol Violation|0|||
163413184|NCT00756938|590220887|FG002|12-week Base Study|Protocol Violation|1|||
163413185|NCT00756938|590220888|FG003|12-week Base Study|Protocol Violation|0|||
163413186|NCT00756938|590220885|FG000|12-week Base Study|Lost to Follow-up|1|||
163413187|NCT00756938|590220886|FG001|12-week Base Study|Lost to Follow-up|0|||
163413188|NCT00756938|590220887|FG002|12-week Base Study|Lost to Follow-up|0|||
163413189|NCT00756938|590220888|FG003|12-week Base Study|Lost to Follow-up|0|||
163413190|NCT00756938|590220885|FG000|Optional Extension|Lack of Efficacy|0|||
163413191|NCT00756938|590220886|FG001|Optional Extension|Lack of Efficacy|0|||
163413192|NCT00756938|590220887|FG002|Optional Extension|Lack of Efficacy|0|||
163413193|NCT00756938|590220888|FG003|Optional Extension|Lack of Efficacy|1|||
163413194|NCT00756938|590220885|FG000|Optional Extension|End of Study|0|||
163413195|NCT00756938|590220886|FG001|Optional Extension|End of Study|0|||
163413196|NCT00756938|590220887|FG002|Optional Extension|End of Study|0|||
163413197|NCT00756938|590220888|FG003|Optional Extension|End of Study|11|||
163413198|NCT00756938|590220885|FG000|Optional Extension|Protocol-specific criteria met|0|||
163413199|NCT00756938|590220886|FG001|Optional Extension|Protocol-specific criteria met|0|||
163413200|NCT00756938|590220887|FG002|Optional Extension|Protocol-specific criteria met|0|||
163413201|NCT00756938|590220888|FG003|Optional Extension|Protocol-specific criteria met|9|||
163413202|NCT00756938|590220885|FG000|Optional Extension|Physician Decision|0|||
163413203|NCT00756938|590220886|FG001|Optional Extension|Physician Decision|0|||
163413204|NCT00756938|590220887|FG002|Optional Extension|Physician Decision|0|||
163413205|NCT00756938|590220888|FG003|Optional Extension|Physician Decision|3|||
163413206|NCT00756938|590220885|FG000|Optional Extension|Lost to Follow-up|0|||
163413207|NCT00756938|590220886|FG001|Optional Extension|Lost to Follow-up|0|||
163413208|NCT00756938|590220887|FG002|Optional Extension|Lost to Follow-up|0|||
163413209|NCT00756938|590220888|FG003|Optional Extension|Lost to Follow-up|1|||
163413210|NCT00756938|590220885|FG000|Optional Extension|Protocol Violation|0|||
163413211|NCT00756938|590220886|FG001|Optional Extension|Protocol Violation|0|||
163413212|NCT00756938|590220887|FG002|Optional Extension|Protocol Violation|0|||
163413213|NCT00756938|590220888|FG003|Optional Extension|Protocol Violation|1|||
163413214|NCT00756938|590220885|FG000|Optional Extension|Withdrawal by Subject|0|||
163413215|NCT00756938|590220886|FG001|Optional Extension|Withdrawal by Subject|0|||
163413216|NCT00756938|590220887|FG002|Optional Extension|Withdrawal by Subject|0|||
163413217|NCT00756938|590220888|FG003|Optional Extension|Withdrawal by Subject|10|||
163413218|NCT00756938|590220885|FG000|Optional Extension|Adverse Event|0|||
163413219|NCT00756938|590220886|FG001|Optional Extension|Adverse Event|0|||
163368152|NCT03841526|590055855|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
163368153|NCT03841526|590055856|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
163368154|NCT03841526|590055857|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
163368155|NCT03841526|590055858|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
163368156|NCT01435772|590055859|FG000|Overall Study|Adverse Event|1|||
163368157|NCT01435772|590055860|FG001|Overall Study|Adverse Event|0|||
163368158|NCT01435772|590055861|FG002|Overall Study|Adverse Event|2|||
163368159|NCT01435772|590055859|FG000|Overall Study|Withdrawal by Subject|0|||
163368160|NCT01435772|590055860|FG001|Overall Study|Withdrawal by Subject|1|||
163368161|NCT01435772|590055861|FG002|Overall Study|Withdrawal by Subject|3|||
163368162|NCT01435772|590055859|FG000|Overall Study|Other - study termination|2|||
163368163|NCT01435772|590055860|FG001|Overall Study|Other - study termination|2|||
163368164|NCT01435772|590055861|FG002|Overall Study|Other - study termination|10|||
163368165|NCT03238963|590055862|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
163368166|NCT03238963|590055863|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
163368167|NCT03238963|590055862|FG000|Overall Study|Withdrawal by Subject|1|||
163368168|NCT03238963|590055863|FG001|Overall Study|Withdrawal by Subject|1|||
163368169|NCT03238963|590055862|FG000|Overall Study|Lost to Follow-up|1|||
163368170|NCT03238963|590055863|FG001|Overall Study|Lost to Follow-up|0|||
163368171|NCT03238963|590055862|FG000|Overall Study|Protocol Violation|1|||
163368172|NCT03238963|590055863|FG001|Overall Study|Protocol Violation|1|||
163368173|NCT03238963|590055862|FG000|Overall Study|Adverse Event|1|||
163368174|NCT03238963|590055863|FG001|Overall Study|Adverse Event|0|||
163368175|NCT05823012|590055864|FG000|Titration Period|Adverse Event|1|||
163368176|NCT05823012|590055864|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
163368177|NCT05823012|590055864|FG000|Maintenance Period|Adverse Event|1|||
163368178|NCT05823012|590055864|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
163368179|NCT05823012|590055864|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
163368180|NCT01424813|590055865|FG000|Overall Study|Withdrawal by Subject|3|||
163368181|NCT01424813|590055866|FG001|Overall Study|Withdrawal by Subject|0|||
163368182|NCT01424813|590055865|FG000|Overall Study|Protocol Violation|1|||
163368183|NCT01424813|590055866|FG001|Overall Study|Protocol Violation|0|||
163368184|NCT01424813|590055865|FG000|Overall Study|Other|1|||
163368185|NCT01424813|590055866|FG001|Overall Study|Other|2|||
163368186|NCT01255631|590057543|FG000|Overall Study|poor enrollment, no data analyzed|9|||
163368187|NCT01255631|590057544|FG001|Overall Study|poor enrollment, no data analyzed|6|||
163368188|NCT00515671|590057545|FG000|Overall Study|Lost to Follow-up|13|||
163368189|NCT00515671|590057546|FG001|Overall Study|Lost to Follow-up|10|||
163368190|NCT00515671|590057545|FG000|Overall Study|Withdrawal by Subject|3|||
163368191|NCT00515671|590057546|FG001|Overall Study|Withdrawal by Subject|5|||
163368192|NCT00515671|590057545|FG000|Overall Study|incarcerated|1|||
163368193|NCT00515671|590057546|FG001|Overall Study|incarcerated|2|||
163368194|NCT01195948|590057549|FG000|Overall Study|Lost to Follow-up|0|||
163368195|NCT01195948|590057550|FG001|Overall Study|Lost to Follow-up|1|||
163368196|NCT01195948|590057551|FG002|Overall Study|Lost to Follow-up|2|||
163368197|NCT00818168|590057561|FG000|Overall Study|Lack of Efficacy|18|||
163368198|NCT00818168|590057561|FG000|Overall Study|Pregnancy|2|||
163368199|NCT00818168|590057561|FG000|Overall Study|Withdrawal by Subject|16|||
163368200|NCT00818168|590057561|FG000|Overall Study|Lost to Follow-up|7|||
163368201|NCT00818168|590057561|FG000|Overall Study|Adverse Event|19|||
163368202|NCT00818168|590057561|FG000|Overall Study|Reason for Non-completion Not reported|6|||
163368203|NCT00818168|590057561|FG000|Overall Study|Participant Moved|2|||
163368204|NCT01977677|590057562|FG000|Overall Study|Unrelated Adverse Event|0|||
163368205|NCT01977677|590057563|FG001|Overall Study|Unrelated Adverse Event|0|||
163368206|NCT01977677|590057564|FG002|Overall Study|Unrelated Adverse Event|1|||
163368207|NCT01498887|590057565|FG000|Overall Study|Administrative problems|1|||
163368208|NCT01498887|590057566|FG001|Overall Study|Administrative problems|0|||
163368209|NCT01498887|590057565|FG000|Overall Study|Lost to Follow-up|1|||
163368210|NCT01498887|590057566|FG001|Overall Study|Lost to Follow-up|1|||
163368211|NCT01498887|590057565|FG000|Overall Study|Withdrawal by Subject|1|||
163368212|NCT01498887|590057566|FG001|Overall Study|Withdrawal by Subject|0|||
163368213|NCT01498887|590057565|FG000|Overall Study|Protocol Violation|1|||
163368214|NCT01498887|590057566|FG001|Overall Study|Protocol Violation|3|||
163368215|NCT01498887|590057565|FG000|Overall Study|Lack of Efficacy|5|||
163368216|NCT01498887|590057566|FG001|Overall Study|Lack of Efficacy|3|||
163368217|NCT01498887|590057565|FG000|Overall Study|Abnormal result from test procedure|1|||
163368218|NCT01498887|590057566|FG001|Overall Study|Abnormal result from test procedure|1|||
163368219|NCT01498887|590057565|FG000|Overall Study|Abnormal laboratory value|2|||
163368220|NCT01498887|590057566|FG001|Overall Study|Abnormal laboratory value|2|||
163368221|NCT01498887|590057565|FG000|Overall Study|Adverse Event|4|||
163368222|NCT01498887|590057566|FG001|Overall Study|Adverse Event|1|||
163368223|NCT00667225|590057571|FG000|Overall Study|Subject had no more lesions to treat.|1|||
163368224|NCT00667225|590057572|FG001|Overall Study|Subject had no more lesions to treat.|0|||
163413220|NCT00756938|590220887|FG002|Optional Extension|Adverse Event|0|||
163368225|NCT00667225|590057571|FG000|Overall Study|Lost to Follow-up|0|||
163368226|NCT00667225|590057572|FG001|Overall Study|Lost to Follow-up|1|||
163368227|NCT02993406|590057573|FG000|Overall Study|Withdrawal by Subject|170|||
163368228|NCT02993406|590057574|FG001|Overall Study|Withdrawal by Subject|196|||
163368229|NCT02993406|590057573|FG000|Overall Study|Physician Decision|3|||
163368230|NCT02993406|590057574|FG001|Overall Study|Physician Decision|5|||
163368231|NCT02993406|590057573|FG000|Overall Study|Lost to Follow-up|12|||
163368232|NCT02993406|590057574|FG001|Overall Study|Lost to Follow-up|13|||
163368233|NCT02993406|590057573|FG000|Overall Study|Unclassifiable Response|105|||
163368234|NCT02993406|590057574|FG001|Overall Study|Unclassifiable Response|139|||
163368235|NCT02993406|590057573|FG000|Overall Study|Administrative decision|1|||
163368236|NCT02993406|590057574|FG001|Overall Study|Administrative decision|0|||
163368237|NCT02993406|590057573|FG000|Overall Study|Sponsor decision|4|||
163368238|NCT02993406|590057574|FG001|Overall Study|Sponsor decision|5|||
163368239|NCT02248818|590057575|FG000|Screening|Protocol Violation|0|||
163368240|NCT02248818|590057576|FG001|Screening|Protocol Violation|0|||
163368241|NCT02248818|590057577|FG002|Screening|Protocol Violation|0|||
163368242|NCT02248818|590057578|FG003|Screening|Protocol Violation|0|||
163368243|NCT02248818|590057579|FG004|Screening|Protocol Violation|0|||
163368244|NCT02248818|590057580|FG005|Screening|Protocol Violation|0|||
163368245|NCT02248818|590057581|FG006|Screening|Protocol Violation|0|||
163368246|NCT02248818|590057582|FG007|Screening|Protocol Violation|0|||
163368247|NCT02248818|590057583|FG008|Screening|Protocol Violation|7|||
163368248|NCT02248818|590057575|FG000|Screening|Study fully enrolled|0|||
163368249|NCT02248818|590057576|FG001|Screening|Study fully enrolled|0|||
163368250|NCT02248818|590057577|FG002|Screening|Study fully enrolled|0|||
163368251|NCT02248818|590057578|FG003|Screening|Study fully enrolled|0|||
163368252|NCT02248818|590057579|FG004|Screening|Study fully enrolled|0|||
163368253|NCT02248818|590057580|FG005|Screening|Study fully enrolled|0|||
163368254|NCT02248818|590057581|FG006|Screening|Study fully enrolled|0|||
163368255|NCT02248818|590057582|FG007|Screening|Study fully enrolled|0|||
163368256|NCT02248818|590057583|FG008|Screening|Study fully enrolled|14|||
163368257|NCT02248818|590057575|FG000|Screening|Physician Decision|0|||
163368258|NCT02248818|590057576|FG001|Screening|Physician Decision|0|||
163368259|NCT02248818|590057577|FG002|Screening|Physician Decision|0|||
163368260|NCT02248818|590057578|FG003|Screening|Physician Decision|0|||
163368261|NCT02248818|590057579|FG004|Screening|Physician Decision|0|||
163368262|NCT02248818|590057580|FG005|Screening|Physician Decision|0|||
163368263|NCT02248818|590057581|FG006|Screening|Physician Decision|0|||
163368264|NCT02248818|590057582|FG007|Screening|Physician Decision|0|||
163368265|NCT02248818|590057583|FG008|Screening|Physician Decision|73|||
163368266|NCT02248818|590057575|FG000|Screening|Withdrawal by Subject|0|||
163368267|NCT02248818|590057576|FG001|Screening|Withdrawal by Subject|0|||
163368268|NCT02248818|590057577|FG002|Screening|Withdrawal by Subject|0|||
163368269|NCT02248818|590057578|FG003|Screening|Withdrawal by Subject|0|||
163368270|NCT02248818|590057579|FG004|Screening|Withdrawal by Subject|0|||
163368271|NCT02248818|590057580|FG005|Screening|Withdrawal by Subject|0|||
163368272|NCT02248818|590057581|FG006|Screening|Withdrawal by Subject|0|||
163368273|NCT02248818|590057582|FG007|Screening|Withdrawal by Subject|0|||
163368274|NCT02248818|590057583|FG008|Screening|Withdrawal by Subject|6|||
163368275|NCT02248818|590057575|FG000|Screening|Lost to Follow-up|0|||
163368276|NCT02248818|590057576|FG001|Screening|Lost to Follow-up|0|||
163368277|NCT02248818|590057577|FG002|Screening|Lost to Follow-up|0|||
163368278|NCT02248818|590057578|FG003|Screening|Lost to Follow-up|0|||
163368279|NCT02248818|590057579|FG004|Screening|Lost to Follow-up|0|||
163368280|NCT02248818|590057580|FG005|Screening|Lost to Follow-up|0|||
163368281|NCT02248818|590057581|FG006|Screening|Lost to Follow-up|0|||
163368282|NCT02248818|590057582|FG007|Screening|Lost to Follow-up|0|||
163368283|NCT02248818|590057583|FG008|Screening|Lost to Follow-up|7|||
163368284|NCT02248818|590057575|FG000|Randomised Study|Administrative - randomization error|0|||
163368285|NCT02248818|590057576|FG001|Randomised Study|Administrative - randomization error|0|||
163368286|NCT02248818|590057577|FG002|Randomised Study|Administrative - randomization error|0|||
163368287|NCT02248818|590057578|FG003|Randomised Study|Administrative - randomization error|0|||
163368288|NCT02248818|590057579|FG004|Randomised Study|Administrative - randomization error|0|||
163368289|NCT02248818|590057580|FG005|Randomised Study|Administrative - randomization error|8|||
163368290|NCT02248818|590057581|FG006|Randomised Study|Administrative - randomization error|0|||
163368291|NCT02248818|590057582|FG007|Randomised Study|Administrative - randomization error|0|||
163368292|NCT02248818|590057583|FG008|Randomised Study|Administrative - randomization error|0|||
163368293|NCT04079868|590057584|FG000|Overall Study|Lost to Follow-up|100|||
163368294|NCT04079868|590057585|FG001|Overall Study|Lost to Follow-up|200|||
163368295|NCT04079868|590057584|FG000|Overall Study|Physician Decision|100|||
163368296|NCT04079868|590057585|FG001|Overall Study|Physician Decision|0|||
163368297|NCT04325282|590057588|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
163368298|NCT04325282|590057589|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
163368299|NCT04325282|590057588|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
163368300|NCT04325282|590057589|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
163368301|NCT00608868|590057594|FG000|Overall Study|Withdrawal by Subject|7|||
163368302|NCT00608868|590057594|FG000|Overall Study|Protocol Violation|3|||
163368303|NCT00608868|590057594|FG000|Overall Study|Lost to Follow-up|2|||
163368304|NCT00608868|590057594|FG000|Overall Study|Adverse Event|1|||
163368305|NCT00608868|590057594|FG000|Overall Study|Physician Decision|2|||
163368306|NCT03338296|590057595|FG000|Overall Study|Adverse Event|0|||
163368307|NCT03338296|590057596|FG001|Overall Study|Adverse Event|1|||
163368308|NCT03338296|590057595|FG000|Overall Study|Withdrawal by Subject|14|||
163368309|NCT03338296|590057596|FG001|Overall Study|Withdrawal by Subject|13|||
163368310|NCT03338296|590057595|FG000|Overall Study|Lost to Follow-up|10|||
163368311|NCT03338296|590057596|FG001|Overall Study|Lost to Follow-up|10|||
163368312|NCT03338296|590057595|FG000|Overall Study|Study Terminated by Sponsor|77|||
163368313|NCT03338296|590057596|FG001|Overall Study|Study Terminated by Sponsor|76|||
163368314|NCT03338296|590057595|FG000|Overall Study|Other|2|||
163368315|NCT03338296|590057596|FG001|Overall Study|Other|7|||
163368316|NCT03338296|590057595|FG000|Overall Study|Missing|0|||
163368317|NCT03338296|590057596|FG001|Overall Study|Missing|1|||
163368318|NCT00702962|590057599|FG000|Overall Study|Progressive disease|0|||
163368319|NCT00702962|590057600|FG001|Overall Study|Progressive disease|1|||
163368320|NCT00702962|590057599|FG000|Overall Study|Hospitalized for other health disorder|1|||
163368321|NCT00702962|590057600|FG001|Overall Study|Hospitalized for other health disorder|0|||
163368322|NCT01252355|590057601|FG000|Overall Study|Adverse Event|9|||
163368323|NCT01252355|590057602|FG001|Overall Study|Adverse Event|17|||
163368324|NCT01252355|590057603|FG002|Overall Study|Adverse Event|22|||
163368325|NCT01252355|590057601|FG000|Overall Study|Lack of Efficacy|6|||
163368326|NCT01252355|590057602|FG001|Overall Study|Lack of Efficacy|4|||
163368327|NCT01252355|590057603|FG002|Overall Study|Lack of Efficacy|2|||
163368328|NCT01252355|590057601|FG000|Overall Study|Lost to Follow-up|0|||
163368329|NCT01252355|590057602|FG001|Overall Study|Lost to Follow-up|0|||
163368330|NCT01252355|590057603|FG002|Overall Study|Lost to Follow-up|1|||
163368331|NCT01252355|590057601|FG000|Overall Study|Poor Compliance to Protocol|1|||
163368332|NCT01252355|590057602|FG001|Overall Study|Poor Compliance to Protocol|1|||
163368333|NCT01252355|590057603|FG002|Overall Study|Poor Compliance to Protocol|1|||
163368334|NCT01252355|590057601|FG000|Overall Study|Progressive Disease|2|||
163368335|NCT01252355|590057602|FG001|Overall Study|Progressive Disease|0|||
163368336|NCT01252355|590057603|FG002|Overall Study|Progressive Disease|0|||
163368337|NCT01252355|590057601|FG000|Overall Study|Sponsor Early Termination of Study|149|||
163368338|NCT01252355|590057602|FG001|Overall Study|Sponsor Early Termination of Study|149|||
163368339|NCT01252355|590057603|FG002|Overall Study|Sponsor Early Termination of Study|146|||
163368340|NCT01252355|590057601|FG000|Overall Study|Randomized but not Treated|2|||
163368341|NCT01252355|590057602|FG001|Overall Study|Randomized but not Treated|0|||
163368342|NCT01252355|590057603|FG002|Overall Study|Randomized but not Treated|0|||
163368343|NCT01252355|590057601|FG000|Overall Study|Other Than Above|8|||
163368344|NCT01252355|590057602|FG001|Overall Study|Other Than Above|7|||
163368345|NCT01252355|590057603|FG002|Overall Study|Other Than Above|7|||
163368346|NCT02175641|590057604|FG000|Overall Study|Death|3|||
163368347|NCT02175641|590057605|FG001|Overall Study|Death|4|||
163368348|NCT02175641|590057604|FG000|Overall Study|Lost to Follow-up|4|||
163368349|NCT02175641|590057605|FG001|Overall Study|Lost to Follow-up|4|||
163368350|NCT02175641|590057604|FG000|Overall Study|Withdrawal by Subject|7|||
163368351|NCT02175641|590057605|FG001|Overall Study|Withdrawal by Subject|4|||
163368352|NCT02175641|590057604|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
163368353|NCT02175641|590057605|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
163368354|NCT02175641|590057604|FG000|Overall Study|Developed Contraindicated Condition|8|||
163368355|NCT02175641|590057605|FG001|Overall Study|Developed Contraindicated Condition|0|||
163368356|NCT01876901|590057608|FG000|Overall Study|Protocol Violation|10|||
163368357|NCT01876901|590057609|FG001|Overall Study|Protocol Violation|2|||
163368358|NCT01876901|590057608|FG000|Overall Study|No or other surgical intervention|7|||
163368359|NCT01876901|590057609|FG001|Overall Study|No or other surgical intervention|5|||
163368360|NCT03031496|590057612|FG000|Period 1|Adverse Event|2|||
163368361|NCT03031496|590057613|FG001|Period 1|Adverse Event|0|||
163368362|NCT03031496|590057612|FG000|Period 1|Withdrawal by Subject|0|||
163368363|NCT03031496|590057613|FG001|Period 1|Withdrawal by Subject|2|||
163368364|NCT03868787|590057615|FG000|Overall Study|Withdrawal by Subject|2|||
163368365|NCT03868787|590057616|FG001|Overall Study|Withdrawal by Subject|1|||
163368366|NCT01399697|590057617|FG000|Overall Study|Adverse Event|13|||
163368367|NCT01399697|590057618|FG001|Overall Study|Adverse Event|3|||
163368368|NCT01399697|590057619|FG002|Overall Study|Adverse Event|1|||
163368369|NCT01399697|590057617|FG000|Overall Study|Lost to Follow-up|2|||
163368370|NCT01399697|590057618|FG001|Overall Study|Lost to Follow-up|0|||
163368371|NCT01399697|590057619|FG002|Overall Study|Lost to Follow-up|0|||
163368372|NCT01399697|590057617|FG000|Overall Study|Withdrawal by Subject|8|||
163368373|NCT01399697|590057618|FG001|Overall Study|Withdrawal by Subject|0|||
163368374|NCT01399697|590057619|FG002|Overall Study|Withdrawal by Subject|0|||
163368375|NCT01399697|590057617|FG000|Overall Study|Investigator Decisión|1|||
163368376|NCT01399697|590057618|FG001|Overall Study|Investigator Decisión|0|||
163368377|NCT01399697|590057619|FG002|Overall Study|Investigator Decisión|2|||
163368378|NCT01399697|590057617|FG000|Overall Study|Lack of Efficacy|9|||
163368379|NCT01399697|590057618|FG001|Overall Study|Lack of Efficacy|0|||
163368380|NCT01399697|590057619|FG002|Overall Study|Lack of Efficacy|1|||
163368381|NCT01399697|590057617|FG000|Overall Study|Protocol Violation|2|||
163368382|NCT01399697|590057618|FG001|Overall Study|Protocol Violation|0|||
163368383|NCT01399697|590057619|FG002|Overall Study|Protocol Violation|0|||
163368384|NCT01399697|590057617|FG000|Overall Study|Non-Compliant|1|||
163368385|NCT01399697|590057618|FG001|Overall Study|Non-Compliant|0|||
163368386|NCT01399697|590057619|FG002|Overall Study|Non-Compliant|0|||
163368387|NCT01399697|590057617|FG000|Overall Study|Inclusion Error|2|||
163368388|NCT01399697|590057618|FG001|Overall Study|Inclusion Error|0|||
163368389|NCT01399697|590057619|FG002|Overall Study|Inclusion Error|0|||
163368390|NCT01399697|590057617|FG000|Overall Study|Positive result for hepatitis B|1|||
163368391|NCT01399697|590057618|FG001|Overall Study|Positive result for hepatitis B|0|||
163368392|NCT01399697|590057619|FG002|Overall Study|Positive result for hepatitis B|0|||
163368393|NCT01399697|590057617|FG000|Overall Study|Clinical RA remission|1|||
163368394|NCT01399697|590057618|FG001|Overall Study|Clinical RA remission|0|||
163368395|NCT01399697|590057619|FG002|Overall Study|Clinical RA remission|0|||
163368396|NCT01399697|590057617|FG000|Overall Study|Sponsor Decision|1|||
163368397|NCT01399697|590057618|FG001|Overall Study|Sponsor Decision|0|||
163368398|NCT01399697|590057619|FG002|Overall Study|Sponsor Decision|0|||
163368399|NCT02807272|590057627|FG000|Overall Study|Death|9|||
163368400|NCT02807272|590057628|FG001|Overall Study|Death|5|||
163368401|NCT02807272|590057629|FG002|Overall Study|Death|2|||
163368402|NCT02807272|590057630|FG003|Overall Study|Death|0|||
163368403|NCT02807272|590057631|FG004|Overall Study|Death|1|||
163368404|NCT02807272|590057627|FG000|Overall Study|Lost to Follow-up|1|||
163368405|NCT02807272|590057628|FG001|Overall Study|Lost to Follow-up|0|||
163368406|NCT02807272|590057629|FG002|Overall Study|Lost to Follow-up|0|||
163368407|NCT02807272|590057630|FG003|Overall Study|Lost to Follow-up|0|||
163368408|NCT02807272|590057631|FG004|Overall Study|Lost to Follow-up|0|||
163368409|NCT02807272|590057627|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
163368410|NCT02807272|590057628|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
163368411|NCT02807272|590057629|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
163368412|NCT02807272|590057630|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
163368413|NCT02807272|590057631|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
163368414|NCT02807272|590057627|FG000|Overall Study|Protocol-defined Disease Progression|0|||
163368415|NCT02807272|590057628|FG001|Overall Study|Protocol-defined Disease Progression|1|||
163368416|NCT02807272|590057629|FG002|Overall Study|Protocol-defined Disease Progression|0|||
163368417|NCT02807272|590057630|FG003|Overall Study|Protocol-defined Disease Progression|0|||
163368418|NCT02807272|590057631|FG004|Overall Study|Protocol-defined Disease Progression|1|||
163368419|NCT02807272|590057627|FG000|Overall Study|Study Terminated by Sponsor|1|||
163368420|NCT02807272|590057628|FG001|Overall Study|Study Terminated by Sponsor|0|||
163368421|NCT02807272|590057629|FG002|Overall Study|Study Terminated by Sponsor|0|||
163368422|NCT02807272|590057630|FG003|Overall Study|Study Terminated by Sponsor|1|||
163368423|NCT02807272|590057631|FG004|Overall Study|Study Terminated by Sponsor|0|||
163368424|NCT02807272|590057627|FG000|Overall Study|Other|1|||
163368425|NCT02807272|590057628|FG001|Overall Study|Other|0|||
163368426|NCT02807272|590057629|FG002|Overall Study|Other|0|||
163368427|NCT02807272|590057630|FG003|Overall Study|Other|0|||
163368428|NCT02807272|590057631|FG004|Overall Study|Other|1|||
163368429|NCT01162863|590057634|FG000|Overall Study|Lack of Efficacy|1|||
163368430|NCT01162863|590057635|FG001|Overall Study|Lack of Efficacy|0|||
163368431|NCT01162863|590057636|FG002|Overall Study|Lack of Efficacy|0|||
163368432|NCT01162863|590057634|FG000|Overall Study|Adverse Event|0|||
163368433|NCT01162863|590057635|FG001|Overall Study|Adverse Event|1|||
163368434|NCT01162863|590057636|FG002|Overall Study|Adverse Event|0|||
163368435|NCT00392925|590057637|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
163368436|NCT00392925|590057638|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
163368437|NCT00392925|590057639|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
163368438|NCT00392925|590057640|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
163368439|NCT00392925|590057637|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
163368440|NCT00392925|590057638|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
163368441|NCT00392925|590057639|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
163368442|NCT00392925|590057640|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
163368443|NCT00392925|590057637|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
163368444|NCT00392925|590057638|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
163368445|NCT00392925|590057639|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
163368446|NCT00392925|590057640|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
163368447|NCT00392925|590057637|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
163368448|NCT00392925|590057638|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
163368449|NCT00392925|590057639|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
163368450|NCT00392925|590057640|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
163368451|NCT00392925|590057637|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
163368452|NCT00392925|590057638|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
163368453|NCT00392925|590057639|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
163368454|NCT00392925|590057640|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
163368455|NCT00392925|590057637|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
163368456|NCT00392925|590057638|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
163368457|NCT00392925|590057639|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
163368458|NCT00392925|590057640|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
163368459|NCT00392925|590057637|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
163368460|NCT00392925|590057638|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
163368461|NCT00392925|590057639|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
163368462|NCT00392925|590057640|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
163368463|NCT00392925|590057637|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
163368464|NCT00392925|590057638|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
163368465|NCT00392925|590057639|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
163368466|NCT00392925|590057640|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
163368467|NCT00392925|590057637|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
163368468|NCT00392925|590057638|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
163368469|NCT00392925|590057639|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
163368470|NCT00392925|590057640|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
163368471|NCT03552523|590057641|FG000|Overall Study|Withdrawal by Subject|1|||
163368472|NCT03552523|590057642|FG001|Overall Study|Withdrawal by Subject|1|||
163368473|NCT04145700|590057643|FG000|Overall Study|Withdrawal by Subject|8|||
163368474|NCT04145700|590057644|FG001|Overall Study|Withdrawal by Subject|3|||
163368475|NCT00780559|590057645|FG000|Overall Study|Lost to Follow-up|2|||
163368476|NCT00780559|590057646|FG001|Overall Study|Lost to Follow-up|7|||
163368477|NCT00780559|590057645|FG000|Overall Study|Death|1|||
163368478|NCT00780559|590057646|FG001|Overall Study|Death|0|||
163368479|NCT01840410|590057650|FG000|Overall Study|Physician Decision|1|||
163368480|NCT01840410|590057651|FG001|Overall Study|Physician Decision|2|||
163368481|NCT01840410|590057650|FG000|Overall Study|Pregnancy|1|||
163368482|NCT01840410|590057651|FG001|Overall Study|Pregnancy|0|||
163368483|NCT01840410|590057650|FG000|Overall Study|Protocol deviation|1|||
163368484|NCT01840410|590057651|FG001|Overall Study|Protocol deviation|0|||
163368485|NCT01840410|590057650|FG000|Overall Study|Lost to Follow-up|1|||
163368486|NCT01840410|590057651|FG001|Overall Study|Lost to Follow-up|0|||
163368487|NCT01840410|590057650|FG000|Overall Study|Withdrawal by Subject|2|||
163368488|NCT01840410|590057651|FG001|Overall Study|Withdrawal by Subject|1|||
163368489|NCT01840410|590057650|FG000|Overall Study|Adverse Event|1|||
163368490|NCT01840410|590057651|FG001|Overall Study|Adverse Event|1|||
163368491|NCT00594880|590057652|FG000|Overall Study|Withdrawal by Subject|1|||
163368492|NCT00594880|590057653|FG001|Overall Study|Withdrawal by Subject|1|||
163368493|NCT00594880|590057652|FG000|Overall Study|Lost to Follow-up|1|||
163368494|NCT00594880|590057653|FG001|Overall Study|Lost to Follow-up|0|||
163368495|NCT02206061|590057654|FG000|Overall Study|Withdrawal by Subject|4|||
163368496|NCT02206061|590057655|FG001|Overall Study|Withdrawal by Subject|7|||
163368497|NCT02206061|590057656|FG002|Overall Study|Withdrawal by Subject|1|||
163368498|NCT02206061|590057654|FG000|Overall Study|Lost to Follow-up|14|||
163368499|NCT02206061|590057655|FG001|Overall Study|Lost to Follow-up|7|||
163368500|NCT02206061|590057656|FG002|Overall Study|Lost to Follow-up|20|||
163368501|NCT00694109|590057657|FG000|Overall Study|Physician Decision|3|||
163368502|NCT00694109|590057657|FG000|Overall Study|Adverse Event|74|||
163368503|NCT00694109|590057657|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
163368504|NCT00694109|590057657|FG000|Overall Study|Lack of Efficacy|2|||
163368505|NCT00694109|590057657|FG000|Overall Study|Withdrawal by Subject|13|||
163368506|NCT00694109|590057657|FG000|Overall Study|Pregnancy|1|||
163368507|NCT00694109|590057657|FG000|Overall Study|Enrolled but not treated|1|||
163368508|NCT00694109|590057657|FG000|Overall Study|Other|2|||
163368509|NCT00694109|590057657|FG000|Overall Study|Consented but no additional treatment|3|||
163368510|NCT01077518|590057660|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
163368511|NCT01077518|590057661|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
163368512|NCT01077518|590057662|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
163368513|NCT01077518|590057660|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
163368514|NCT01077518|590057661|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
163368515|NCT01077518|590057662|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
163368516|NCT01077518|590057660|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
163368517|NCT01077518|590057661|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
163368518|NCT01077518|590057662|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
163368519|NCT01077518|590057660|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
163368520|NCT01077518|590057661|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
163368521|NCT01077518|590057662|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
163368522|NCT01077518|590057660|FG000|Optional Ofa Phase|Physician Decision|0|||
163368523|NCT01077518|590057661|FG001|Optional Ofa Phase|Physician Decision|0|||
163368524|NCT01077518|590057662|FG002|Optional Ofa Phase|Physician Decision|1|||
163368525|NCT01077518|590057660|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
163368526|NCT01077518|590057661|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
163368527|NCT01077518|590057662|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
163368528|NCT01077518|590057660|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
163368529|NCT01077518|590057661|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
163368530|NCT01077518|590057662|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
163368531|NCT04958200|590057663|FG000|Overall Study|Withdrawal by Subject|0|||
163368532|NCT04958200|590057664|FG001|Overall Study|Withdrawal by Subject|2|||
163368533|NCT04958200|590057663|FG000|Overall Study|Lost to Follow-up|3|||
163368534|NCT04958200|590057664|FG001|Overall Study|Lost to Follow-up|2|||
163368535|NCT04157400|590057669|FG000|Overall Study|Withdrawal by Subject|1|||
163368536|NCT04157400|590057669|FG000|Overall Study|Lost to Follow-up|3|||
163368537|NCT02819024|590057672|FG000|Overall Study|Withdrawal by Subject|1|||
163368538|NCT05217641|590057676|FG000|Overall Study|Lost to Follow-up|1|||
163368539|NCT05217641|590057677|FG001|Overall Study|Lost to Follow-up|1|||
163368540|NCT05217641|590057678|FG002|Overall Study|Lost to Follow-up|0|||
163368541|NCT05217641|590057679|FG003|Overall Study|Lost to Follow-up|1|||
163368542|NCT05217641|590057680|FG004|Overall Study|Lost to Follow-up|1|||
163368543|NCT05217641|590057681|FG005|Overall Study|Lost to Follow-up|0|||
163368544|NCT05217641|590057676|FG000|Overall Study|Withdrawal by Subject|0|||
163368545|NCT05217641|590057677|FG001|Overall Study|Withdrawal by Subject|0|||
163368546|NCT05217641|590057678|FG002|Overall Study|Withdrawal by Subject|0|||
163368547|NCT05217641|590057679|FG003|Overall Study|Withdrawal by Subject|3|||
163368548|NCT05217641|590057680|FG004|Overall Study|Withdrawal by Subject|1|||
163368549|NCT05217641|590057681|FG005|Overall Study|Withdrawal by Subject|0|||
163368550|NCT05217641|590057676|FG000|Overall Study|Other: participant did not specify reason|0|||
163368551|NCT05217641|590057677|FG001|Overall Study|Other: participant did not specify reason|0|||
163368552|NCT05217641|590057678|FG002|Overall Study|Other: participant did not specify reason|0|||
163368553|NCT05217641|590057679|FG003|Overall Study|Other: participant did not specify reason|0|||
163368554|NCT05217641|590057680|FG004|Overall Study|Other: participant did not specify reason|1|||
163368555|NCT05217641|590057681|FG005|Overall Study|Other: participant did not specify reason|0|||
163368556|NCT05217641|590057676|FG000|Overall Study|Extended Follow up|1|||
163368557|NCT05217641|590057677|FG001|Overall Study|Extended Follow up|1|||
163368558|NCT05217641|590057678|FG002|Overall Study|Extended Follow up|0|||
163368559|NCT05217641|590057679|FG003|Overall Study|Extended Follow up|0|||
163368560|NCT05217641|590057680|FG004|Overall Study|Extended Follow up|1|||
163368561|NCT05217641|590057681|FG005|Overall Study|Extended Follow up|0|||
163368562|NCT03548220|590057683|FG000|Overall Study|Lost to Follow-up|1|||
163368563|NCT03548220|590057684|FG001|Overall Study|Lost to Follow-up|0|||
163368564|NCT03548220|590057685|FG002|Overall Study|Lost to Follow-up|0|||
163368565|NCT03548220|590057686|FG003|Overall Study|Lost to Follow-up|0|||
163368566|NCT02397447|590057687|FG000|Overall Study|Lost to Follow-up|2|||
163368567|NCT02397447|590057688|FG001|Overall Study|Lost to Follow-up|2|||
163368568|NCT02994069|590057691|FG000|Overall Study|Death|7|||
163368569|NCT02994069|590057692|FG001|Overall Study|Death|13|||
163368570|NCT02994069|590057691|FG000|Overall Study|Adverse Event|1|||
163368571|NCT02994069|590057692|FG001|Overall Study|Adverse Event|0|||
163368572|NCT02994069|590057691|FG000|Overall Study|Other|2|||
163368573|NCT02994069|590057692|FG001|Overall Study|Other|0|||
163368574|NCT02994069|590057691|FG000|Overall Study|still on follow up/treatment|5|||
163368575|NCT02994069|590057692|FG001|Overall Study|still on follow up/treatment|6|||
163368576|NCT03345576|590057695|FG000|Overall Study|Withdrawal by Subject|2|||
163368577|NCT03345576|590057696|FG001|Overall Study|Withdrawal by Subject|2|||
163368578|NCT03345576|590057695|FG000|Overall Study|Adverse Event|1|||
163368579|NCT03345576|590057696|FG001|Overall Study|Adverse Event|0|||
163368580|NCT05718466|590059265|FG000|Overall Study|Withdrawal by Subject|1|||
163368581|NCT05718466|590059266|FG001|Overall Study|Withdrawal by Subject|2|||
163368582|NCT05718466|590059265|FG000|Overall Study|Death|0|||
163368583|NCT05718466|590059266|FG001|Overall Study|Death|1|||
163368584|NCT01253135|590059269|FG000|Original Protocol|Protocol Amendment|15|||
163368585|NCT01253135|590059269|FG000|Amended Protocol|Non-compliance|1|||
163368586|NCT00833261|590059270|FG000|Overall Study|Withdrawal by Subject|4|||
163368587|NCT00264303|590059280|FG000|Overall Study|Adverse Event|4|||
163368588|NCT00264303|590059281|FG001|Overall Study|Adverse Event|3|||
163368589|NCT00264303|590059280|FG000|Overall Study|Lack of Efficacy|10|||
163368590|NCT00264303|590059281|FG001|Overall Study|Lack of Efficacy|13|||
163368591|NCT00264303|590059280|FG000|Overall Study|Lost to Follow-up|3|||
163368592|NCT00264303|590059281|FG001|Overall Study|Lost to Follow-up|3|||
163368593|NCT00264303|590059280|FG000|Overall Study|Withdrawal by Subject|2|||
163368594|NCT00264303|590059281|FG001|Overall Study|Withdrawal by Subject|3|||
163368595|NCT00264303|590059280|FG000|Overall Study|Various reasons listed in study report|6|||
163368596|NCT00264303|590059281|FG001|Overall Study|Various reasons listed in study report|7|||
163368597|NCT02815579|590059282|FG000|Overall Study|Non-payment of loan down-payment|16|||
163368598|NCT02815579|590059283|FG001|Overall Study|Non-payment of loan down-payment|0|||
163368599|NCT02815579|590059282|FG000|Overall Study|Withdrawal by Subject|7|||
163368600|NCT02815579|590059283|FG001|Overall Study|Withdrawal by Subject|1|||
163368601|NCT02815579|590059282|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
163368602|NCT02815579|590059283|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
163368603|NCT02815579|590059282|FG000|Overall Study|Lost to Follow-up|7|||
163368604|NCT02815579|590059283|FG001|Overall Study|Lost to Follow-up|4|||
163368605|NCT02815579|590059282|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
163368606|NCT02815579|590059283|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
163368607|NCT02815579|590059282|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
163368608|NCT02815579|590059283|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
163368609|NCT02815579|590059282|FG000|Overall Study|Death|5|||
163368610|NCT02815579|590059283|FG001|Overall Study|Death|4|||
163368611|NCT02815579|590059282|FG000|Overall Study|Imprisoned|0|||
163368612|NCT02815579|590059283|FG001|Overall Study|Imprisoned|2|||
163368613|NCT02815579|590059282|FG000|Overall Study|Did not meet enrollment criteria|0|||
163368614|NCT02815579|590059283|FG001|Overall Study|Did not meet enrollment criteria|1|||
163368615|NCT02389452|590059284|FG000|Overall Study|Lost to Follow-up|13|||
163368616|NCT02389452|590059284|FG000|Overall Study|Adverse Event|1|||
163368617|NCT02389452|590059284|FG000|Overall Study|Withdrawal by Subject|5|||
163368618|NCT02389452|590059284|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
163368619|NCT02311673|590059285|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
163368620|NCT02311673|590059286|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
163368621|NCT02311673|590059287|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
163368622|NCT02311673|590059288|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
163368623|NCT00414908|590059291|FG000|Overall Study|Protocol Violation|1|||
163368624|NCT00414908|590059292|FG001|Overall Study|Protocol Violation|1|||
163368625|NCT01076153|590059293|FG000|Overall Study|Symptoms improved/resolved|10|||
163368626|NCT01076153|590059293|FG000|Overall Study|Adverse Event|1|||
163368627|NCT04165031|590059294|FG000|Overall Study|Adverse Event|1|||
163368628|NCT04165031|590059295|FG001|Overall Study|Adverse Event|1|||
163368629|NCT04165031|590059296|FG002|Overall Study|Adverse Event|0|||
163368630|NCT04165031|590059297|FG003|Overall Study|Adverse Event|0|||
163368631|NCT04165031|590059298|FG004|Overall Study|Adverse Event|0|||
163368632|NCT04165031|590059299|FG005|Overall Study|Adverse Event|0|||
163368633|NCT04165031|590059294|FG000|Overall Study|Withdrawal by Subject|0|||
163368634|NCT04165031|590059295|FG001|Overall Study|Withdrawal by Subject|0|||
163368635|NCT04165031|590059296|FG002|Overall Study|Withdrawal by Subject|1|||
163368636|NCT04165031|590059297|FG003|Overall Study|Withdrawal by Subject|0|||
163368637|NCT04165031|590059298|FG004|Overall Study|Withdrawal by Subject|0|||
163368638|NCT04165031|590059299|FG005|Overall Study|Withdrawal by Subject|0|||
163368639|NCT03563157|590059304|FG000|Overall Study|Progressive Disease|2|||
163368640|NCT02942277|590059305|FG000|Year 1|Withdrawal by Subject|0|||
163368641|NCT02942277|590059306|FG001|Year 1|Withdrawal by Subject|0|||
163368642|NCT02942277|590059307|FG002|Year 1|Withdrawal by Subject|0|||
163368643|NCT02942277|590059308|FG003|Year 1|Withdrawal by Subject|0|||
163368644|NCT02942277|590059309|FG004|Year 1|Withdrawal by Subject|1|||
163368645|NCT02942277|590059310|FG005|Year 1|Withdrawal by Subject|3|||
163368646|NCT02942277|590059311|FG006|Year 1|Withdrawal by Subject|0|||
163368647|NCT02942277|590059312|FG007|Year 1|Withdrawal by Subject|1|||
163368648|NCT02942277|590059313|FG008|Year 1|Withdrawal by Subject|0|||
163368649|NCT02942277|590059314|FG009|Year 1|Withdrawal by Subject|0|||
163368650|NCT02942277|590059315|FG010|Year 1|Withdrawal by Subject|3|||
163368651|NCT02942277|590059305|FG000|Year 1|Travel|0|||
163368652|NCT02942277|590059306|FG001|Year 1|Travel|1|||
163368653|NCT02942277|590059307|FG002|Year 1|Travel|0|||
163368654|NCT02942277|590059308|FG003|Year 1|Travel|0|||
163368655|NCT02942277|590059309|FG004|Year 1|Travel|4|||
163368656|NCT02942277|590059310|FG005|Year 1|Travel|5|||
163368657|NCT02942277|590059311|FG006|Year 1|Travel|0|||
163368658|NCT02942277|590059312|FG007|Year 1|Travel|0|||
163368659|NCT02942277|590059313|FG008|Year 1|Travel|0|||
163368660|NCT02942277|590059314|FG009|Year 1|Travel|0|||
163368661|NCT02942277|590059315|FG010|Year 1|Travel|8|||
163368662|NCT02942277|590059305|FG000|Year 1|Joined Army|0|||
163368663|NCT02942277|590059306|FG001|Year 1|Joined Army|1|||
163413221|NCT00756938|590220888|FG003|Optional Extension|Adverse Event|1|||
163368664|NCT02942277|590059307|FG002|Year 1|Joined Army|0|||
163368665|NCT02942277|590059308|FG003|Year 1|Joined Army|0|||
163368666|NCT02942277|590059309|FG004|Year 1|Joined Army|0|||
163368667|NCT02942277|590059310|FG005|Year 1|Joined Army|0|||
163413222|NCT00094055|590220889|FG000|Overall Study|Adverse Event|11|||
163413223|NCT00094055|590220889|FG000|Overall Study|Death|4|||
163413224|NCT00094055|590220889|FG000|Overall Study|Lack of Efficacy|17|||
163368668|NCT02942277|590059311|FG006|Year 1|Joined Army|0|||
163368669|NCT02942277|590059312|FG007|Year 1|Joined Army|0|||
163368670|NCT02942277|590059313|FG008|Year 1|Joined Army|0|||
163368671|NCT02942277|590059314|FG009|Year 1|Joined Army|0|||
163368672|NCT02942277|590059315|FG010|Year 1|Joined Army|0|||
163368673|NCT02942277|590059305|FG000|Year 1|Subject met withdrawal criteria|0|||
163368674|NCT02942277|590059306|FG001|Year 1|Subject met withdrawal criteria|0|||
163368675|NCT02942277|590059307|FG002|Year 1|Subject met withdrawal criteria|0|||
163368676|NCT02942277|590059308|FG003|Year 1|Subject met withdrawal criteria|1|||
163368677|NCT02942277|590059309|FG004|Year 1|Subject met withdrawal criteria|0|||
163413225|NCT00094055|590220889|FG000|Overall Study|Lost to Follow-up|2|||
163413226|NCT00094055|590220889|FG000|Overall Study|progressive disease|2|||
163413227|NCT00094055|590220889|FG000|Overall Study|clinical progression|1|||
163413228|NCT00094055|590220889|FG000|Overall Study|roll-over to another study|14|||
163413229|NCT00094055|590220889|FG000|Overall Study|Withdrawal by Subject|9|||
163413230|NCT00441545|590220890|FG000|First Intervention|Adverse Event|6|||
163413231|NCT00441545|590220891|FG001|First Intervention|Adverse Event|5|||
163413232|NCT00441545|590220890|FG000|First Intervention|Protocol Violation|2|||
163413233|NCT00441545|590220891|FG001|First Intervention|Protocol Violation|2|||
163413234|NCT00441545|590220890|FG000|First Intervention|Withdrawal by Subject|3|||
163413235|NCT00441545|590220891|FG001|First Intervention|Withdrawal by Subject|3|||
163413236|NCT00441545|590220890|FG000|First Intervention|Kidney transplant|1|||
163413237|NCT00441545|590220891|FG001|First Intervention|Kidney transplant|1|||
163413238|NCT00441545|590220890|FG000|First Intervention|Lack of Efficacy|2|||
163413239|NCT00441545|590220891|FG001|First Intervention|Lack of Efficacy|0|||
163413240|NCT00441545|590220890|FG000|First Intervention|Subject exceeded safety criteria|0|||
163413241|NCT00441545|590220891|FG001|First Intervention|Subject exceeded safety criteria|1|||
163413242|NCT00441545|590220890|FG000|First Intervention|Subject met an exclusionary criteria|1|||
163413243|NCT00441545|590220891|FG001|First Intervention|Subject met an exclusionary criteria|0|||
163413244|NCT00441545|590220890|FG000|First Intervention|Extended hospitalization|1|||
163413245|NCT00441545|590220891|FG001|First Intervention|Extended hospitalization|0|||
163413246|NCT00441545|590220890|FG000|First Intervention|Site error|1|||
163413247|NCT00441545|590220891|FG001|First Intervention|Site error|0|||
163413248|NCT00441545|590220890|FG000|First Intervention|Sponsor's request|1|||
163413249|NCT00441545|590220891|FG001|First Intervention|Sponsor's request|0|||
163413250|NCT00441545|590220890|FG000|Second Intervention|Adverse Event|5|||
163413251|NCT00441545|590220891|FG001|Second Intervention|Adverse Event|2|||
163413252|NCT00441545|590220890|FG000|Second Intervention|Protocol Violation|4|||
163413253|NCT00441545|590220891|FG001|Second Intervention|Protocol Violation|1|||
163413254|NCT00441545|590220890|FG000|Second Intervention|Withdrawal by Subject|1|||
163413255|NCT00441545|590220891|FG001|Second Intervention|Withdrawal by Subject|1|||
163413256|NCT00441545|590220890|FG000|Second Intervention|Kidney Transplant|1|||
163413257|NCT00441545|590220891|FG001|Second Intervention|Kidney Transplant|1|||
163413258|NCT00441545|590220890|FG000|Second Intervention|Lack of Efficacy|0|||
163413259|NCT00441545|590220891|FG001|Second Intervention|Lack of Efficacy|1|||
163413260|NCT00441545|590220890|FG000|Second Intervention|Subject exceeded safety criteria|1|||
163413261|NCT00441545|590220891|FG001|Second Intervention|Subject exceeded safety criteria|0|||
163413262|NCT00441545|590220890|FG000|Second Intervention|Subject moved|0|||
163413263|NCT00441545|590220891|FG001|Second Intervention|Subject moved|1|||
163368678|NCT02942277|590059310|FG005|Year 1|Subject met withdrawal criteria|0|||
163368679|NCT02942277|590059311|FG006|Year 1|Subject met withdrawal criteria|0|||
163368680|NCT02942277|590059312|FG007|Year 1|Subject met withdrawal criteria|0|||
163368681|NCT02942277|590059313|FG008|Year 1|Subject met withdrawal criteria|0|||
163368682|NCT02942277|590059314|FG009|Year 1|Subject met withdrawal criteria|0|||
163368683|NCT02942277|590059315|FG010|Year 1|Subject met withdrawal criteria|0|||
163368684|NCT02942277|590059305|FG000|Year 1|Lost to Follow-up|0|||
163368685|NCT02942277|590059306|FG001|Year 1|Lost to Follow-up|0|||
163368686|NCT02942277|590059307|FG002|Year 1|Lost to Follow-up|0|||
163368687|NCT02942277|590059308|FG003|Year 1|Lost to Follow-up|0|||
163368688|NCT02942277|590059309|FG004|Year 1|Lost to Follow-up|1|||
163368689|NCT02942277|590059310|FG005|Year 1|Lost to Follow-up|0|||
163368690|NCT02942277|590059311|FG006|Year 1|Lost to Follow-up|0|||
163368691|NCT02942277|590059312|FG007|Year 1|Lost to Follow-up|0|||
163368692|NCT02942277|590059313|FG008|Year 1|Lost to Follow-up|0|||
163368693|NCT02942277|590059314|FG009|Year 1|Lost to Follow-up|0|||
163368694|NCT02942277|590059315|FG010|Year 1|Lost to Follow-up|2|||
163368695|NCT02942277|590059305|FG000|Year 1|Protocol Violation|0|||
163368696|NCT02942277|590059306|FG001|Year 1|Protocol Violation|0|||
163368697|NCT02942277|590059307|FG002|Year 1|Protocol Violation|0|||
163368698|NCT02942277|590059308|FG003|Year 1|Protocol Violation|0|||
163368699|NCT02942277|590059309|FG004|Year 1|Protocol Violation|1|||
163368700|NCT02942277|590059310|FG005|Year 1|Protocol Violation|1|||
163368701|NCT02942277|590059311|FG006|Year 1|Protocol Violation|0|||
163368702|NCT02942277|590059312|FG007|Year 1|Protocol Violation|0|||
163368703|NCT02942277|590059313|FG008|Year 1|Protocol Violation|0|||
163368704|NCT02942277|590059314|FG009|Year 1|Protocol Violation|0|||
163368705|NCT02942277|590059315|FG010|Year 1|Protocol Violation|2|||
163368706|NCT02942277|590059305|FG000|Year 1|Pregnancy|0|||
163368707|NCT02942277|590059306|FG001|Year 1|Pregnancy|0|||
163368708|NCT02942277|590059307|FG002|Year 1|Pregnancy|0|||
163368709|NCT02942277|590059308|FG003|Year 1|Pregnancy|0|||
163368710|NCT02942277|590059309|FG004|Year 1|Pregnancy|0|||
163368711|NCT02942277|590059310|FG005|Year 1|Pregnancy|1|||
163413264|NCT02347176|590220892|FG000|Overall Study|Lost to Follow-up|2|||
163413265|NCT02347176|590220893|FG001|Overall Study|Lost to Follow-up|3|||
163413266|NCT02347176|590220894|FG002|Overall Study|Lost to Follow-up|1|||
163368712|NCT02942277|590059311|FG006|Year 1|Pregnancy|0|||
163368713|NCT02942277|590059312|FG007|Year 1|Pregnancy|0|||
163368714|NCT02942277|590059313|FG008|Year 1|Pregnancy|0|||
163368715|NCT02942277|590059314|FG009|Year 1|Pregnancy|0|||
163368716|NCT02942277|590059315|FG010|Year 1|Pregnancy|0|||
163368717|NCT02942277|590059305|FG000|Year 2|Lost to Follow-up|0|||
163368718|NCT02942277|590059306|FG001|Year 2|Lost to Follow-up|0|||
163368719|NCT02942277|590059307|FG002|Year 2|Lost to Follow-up|0|||
163368720|NCT02942277|590059308|FG003|Year 2|Lost to Follow-up|0|||
163368721|NCT02942277|590059309|FG004|Year 2|Lost to Follow-up|2|||
163368722|NCT02942277|590059310|FG005|Year 2|Lost to Follow-up|1|||
163368723|NCT02942277|590059311|FG006|Year 2|Lost to Follow-up|0|||
163368724|NCT02942277|590059312|FG007|Year 2|Lost to Follow-up|0|||
163368725|NCT02942277|590059313|FG008|Year 2|Lost to Follow-up|0|||
163368726|NCT02942277|590059314|FG009|Year 2|Lost to Follow-up|0|||
163368727|NCT02942277|590059315|FG010|Year 2|Lost to Follow-up|0|||
163368728|NCT02942277|590059305|FG000|Year 2|Did not rescreen|0|||
163368729|NCT02942277|590059306|FG001|Year 2|Did not rescreen|0|||
163368730|NCT02942277|590059307|FG002|Year 2|Did not rescreen|1|||
163368731|NCT02942277|590059308|FG003|Year 2|Did not rescreen|1|||
163368732|NCT02942277|590059309|FG004|Year 2|Did not rescreen|9|||
163413267|NCT02347176|590220895|FG003|Overall Study|Lost to Follow-up|1|||
163413268|NCT02347176|590220892|FG000|Overall Study|Withdrawal by Subject|9|||
163413269|NCT02347176|590220893|FG001|Overall Study|Withdrawal by Subject|5|||
163413270|NCT02347176|590220894|FG002|Overall Study|Withdrawal by Subject|5|||
163413271|NCT02347176|590220895|FG003|Overall Study|Withdrawal by Subject|3|||
163368733|NCT02942277|590059310|FG005|Year 2|Did not rescreen|6|||
163368734|NCT02942277|590059311|FG006|Year 2|Did not rescreen|0|||
163368735|NCT02942277|590059312|FG007|Year 2|Did not rescreen|1|||
163368736|NCT02942277|590059313|FG008|Year 2|Did not rescreen|0|||
163368737|NCT02942277|590059314|FG009|Year 2|Did not rescreen|0|||
163368738|NCT02942277|590059315|FG010|Year 2|Did not rescreen|21|||
163368739|NCT02942277|590059305|FG000|Year 2|Met withdrawal criteria|0|||
163368740|NCT02942277|590059306|FG001|Year 2|Met withdrawal criteria|0|||
163368741|NCT02942277|590059307|FG002|Year 2|Met withdrawal criteria|0|||
163368742|NCT02942277|590059308|FG003|Year 2|Met withdrawal criteria|0|||
163368743|NCT02942277|590059309|FG004|Year 2|Met withdrawal criteria|1|||
163413272|NCT02347176|590220892|FG000|Overall Study|Other|1|||
163368744|NCT02942277|590059310|FG005|Year 2|Met withdrawal criteria|2|||
163368745|NCT02942277|590059311|FG006|Year 2|Met withdrawal criteria|0|||
163368746|NCT02942277|590059312|FG007|Year 2|Met withdrawal criteria|0|||
163368747|NCT02942277|590059313|FG008|Year 2|Met withdrawal criteria|0|||
163368748|NCT02942277|590059314|FG009|Year 2|Met withdrawal criteria|0|||
163368749|NCT02942277|590059315|FG010|Year 2|Met withdrawal criteria|1|||
163368750|NCT02942277|590059305|FG000|Year 2|Travel|0|||
163368751|NCT02942277|590059306|FG001|Year 2|Travel|1|||
163368752|NCT02942277|590059307|FG002|Year 2|Travel|0|||
163368753|NCT02942277|590059308|FG003|Year 2|Travel|0|||
163368754|NCT02942277|590059309|FG004|Year 2|Travel|0|||
163368755|NCT02942277|590059310|FG005|Year 2|Travel|1|||
163368756|NCT02942277|590059311|FG006|Year 2|Travel|0|||
163368757|NCT02942277|590059312|FG007|Year 2|Travel|0|||
163368758|NCT02942277|590059313|FG008|Year 2|Travel|0|||
163368759|NCT02942277|590059314|FG009|Year 2|Travel|1|||
163368760|NCT02942277|590059315|FG010|Year 2|Travel|3|||
163368761|NCT02942277|590059305|FG000|Year 2|Non-compliant|0|||
163368762|NCT02942277|590059306|FG001|Year 2|Non-compliant|0|||
163368763|NCT02942277|590059307|FG002|Year 2|Non-compliant|0|||
163368764|NCT02942277|590059308|FG003|Year 2|Non-compliant|0|||
163368765|NCT02942277|590059309|FG004|Year 2|Non-compliant|1|||
163368766|NCT02942277|590059310|FG005|Year 2|Non-compliant|1|||
163368767|NCT02942277|590059311|FG006|Year 2|Non-compliant|0|||
163368768|NCT02942277|590059312|FG007|Year 2|Non-compliant|0|||
163368769|NCT02942277|590059313|FG008|Year 2|Non-compliant|0|||
163368770|NCT02942277|590059314|FG009|Year 2|Non-compliant|0|||
163368771|NCT02942277|590059315|FG010|Year 2|Non-compliant|0|||
163368772|NCT02942277|590059305|FG000|Year 2|Withdrawal by Subject|0|||
163368773|NCT02942277|590059306|FG001|Year 2|Withdrawal by Subject|0|||
163368774|NCT02942277|590059307|FG002|Year 2|Withdrawal by Subject|0|||
163368775|NCT02942277|590059308|FG003|Year 2|Withdrawal by Subject|0|||
163413273|NCT02347176|590220893|FG001|Overall Study|Other|2|||
163413274|NCT02347176|590220894|FG002|Overall Study|Other|2|||
163413275|NCT02347176|590220895|FG003|Overall Study|Other|0|||
163368776|NCT02942277|590059309|FG004|Year 2|Withdrawal by Subject|0|||
163368777|NCT02942277|590059310|FG005|Year 2|Withdrawal by Subject|0|||
163368778|NCT02942277|590059311|FG006|Year 2|Withdrawal by Subject|1|||
163368779|NCT02942277|590059312|FG007|Year 2|Withdrawal by Subject|0|||
163368780|NCT02942277|590059313|FG008|Year 2|Withdrawal by Subject|0|||
163368781|NCT02942277|590059314|FG009|Year 2|Withdrawal by Subject|0|||
163368782|NCT02942277|590059315|FG010|Year 2|Withdrawal by Subject|0|||
163368783|NCT00565773|590059316|FG000|Overall Study|Withdrawal by Subject|1|||
163368784|NCT00565773|590059316|FG000|Overall Study|Physician Decision|1|||
163368785|NCT01240915|590059317|FG000|Overall Study|Adverse Event|0|||
163368786|NCT01240915|590059318|FG001|Overall Study|Adverse Event|0|||
163368787|NCT01240915|590059319|FG002|Overall Study|Adverse Event|0|||
163368788|NCT01240915|590059320|FG003|Overall Study|Adverse Event|1|||
163368789|NCT01240915|590059321|FG004|Overall Study|Adverse Event|0|||
163368790|NCT01240915|590059322|FG005|Overall Study|Adverse Event|2|||
163368791|NCT01240915|590059323|FG006|Overall Study|Adverse Event|0|||
163368792|NCT01240915|590059324|FG007|Overall Study|Adverse Event|0|||
163368793|NCT01240915|590059325|FG008|Overall Study|Adverse Event|1|||
163368794|NCT01240915|590059317|FG000|Overall Study|Lost to Follow-up|0|||
163368795|NCT01240915|590059318|FG001|Overall Study|Lost to Follow-up|0|||
163368796|NCT01240915|590059319|FG002|Overall Study|Lost to Follow-up|0|||
163368797|NCT01240915|590059320|FG003|Overall Study|Lost to Follow-up|0|||
163368798|NCT01240915|590059321|FG004|Overall Study|Lost to Follow-up|1|||
163368799|NCT01240915|590059322|FG005|Overall Study|Lost to Follow-up|1|||
163368800|NCT01240915|590059323|FG006|Overall Study|Lost to Follow-up|0|||
163368801|NCT01240915|590059324|FG007|Overall Study|Lost to Follow-up|1|||
163368802|NCT01240915|590059325|FG008|Overall Study|Lost to Follow-up|1|||
163368803|NCT01240915|590059317|FG000|Overall Study|Withdrawal by Subject|2|||
163368804|NCT01240915|590059318|FG001|Overall Study|Withdrawal by Subject|1|||
163368805|NCT01240915|590059319|FG002|Overall Study|Withdrawal by Subject|0|||
163368806|NCT01240915|590059320|FG003|Overall Study|Withdrawal by Subject|2|||
163368807|NCT01240915|590059321|FG004|Overall Study|Withdrawal by Subject|0|||
163368808|NCT01240915|590059322|FG005|Overall Study|Withdrawal by Subject|4|||
163368809|NCT01240915|590059323|FG006|Overall Study|Withdrawal by Subject|2|||
163368810|NCT01240915|590059324|FG007|Overall Study|Withdrawal by Subject|3|||
163368811|NCT01240915|590059325|FG008|Overall Study|Withdrawal by Subject|3|||
163368812|NCT01240915|590059317|FG000|Overall Study|Other|0|||
163368813|NCT01240915|590059318|FG001|Overall Study|Other|0|||
163368814|NCT01240915|590059319|FG002|Overall Study|Other|0|||
163368815|NCT01240915|590059320|FG003|Overall Study|Other|0|||
163368816|NCT01240915|590059321|FG004|Overall Study|Other|2|||
163368817|NCT01240915|590059322|FG005|Overall Study|Other|0|||
163368818|NCT01240915|590059323|FG006|Overall Study|Other|0|||
163368819|NCT01240915|590059324|FG007|Overall Study|Other|0|||
163368820|NCT01240915|590059325|FG008|Overall Study|Other|0|||
163368821|NCT01240915|590059317|FG000|Overall Study|Insufficient Clinical Response|0|||
163368822|NCT01240915|590059318|FG001|Overall Study|Insufficient Clinical Response|0|||
163368823|NCT01240915|590059319|FG002|Overall Study|Insufficient Clinical Response|0|||
163368824|NCT01240915|590059320|FG003|Overall Study|Insufficient Clinical Response|0|||
163368825|NCT01240915|590059321|FG004|Overall Study|Insufficient Clinical Response|1|||
163368826|NCT01240915|590059322|FG005|Overall Study|Insufficient Clinical Response|3|||
163368827|NCT01240915|590059323|FG006|Overall Study|Insufficient Clinical Response|6|||
163368828|NCT01240915|590059324|FG007|Overall Study|Insufficient Clinical Response|0|||
163368829|NCT01240915|590059325|FG008|Overall Study|Insufficient Clinical Response|3|||
163368830|NCT02574845|590059329|FG000|Overall Study|Consent withdrawn further participation|0|||
163368831|NCT02574845|590059330|FG001|Overall Study|Consent withdrawn further participation|0|||
163368832|NCT02574845|590059331|FG002|Overall Study|Consent withdrawn further participation|0|||
163368833|NCT02574845|590059332|FG003|Overall Study|Consent withdrawn further participation|0|||
163368834|NCT02574845|590059333|FG004|Overall Study|Consent withdrawn further participation|1|||
163368835|NCT02574845|590059334|FG005|Overall Study|Consent withdrawn further participation|0|||
163368836|NCT02574845|590059329|FG000|Overall Study|Adverse Event|0|||
163368837|NCT02574845|590059330|FG001|Overall Study|Adverse Event|1|||
163368838|NCT02574845|590059331|FG002|Overall Study|Adverse Event|0|||
163368839|NCT02574845|590059332|FG003|Overall Study|Adverse Event|0|||
163368840|NCT02574845|590059333|FG004|Overall Study|Adverse Event|0|||
163368841|NCT02574845|590059334|FG005|Overall Study|Adverse Event|1|||
163368842|NCT04313608|590059337|FG000|Overall Study|Death|12|||
163368843|NCT04313608|590059338|FG001|Overall Study|Death|3|||
163368844|NCT01867333|590059339|FG000|Overall Study|Withdrawal by Subject|1|||
163368845|NCT01867333|590059340|FG001|Overall Study|Withdrawal by Subject|0|||
163368846|NCT01867333|590059339|FG000|Overall Study|Adverse Event|1|||
163368847|NCT01867333|590059340|FG001|Overall Study|Adverse Event|0|||
163368848|NCT01867333|590059339|FG000|Overall Study|Participant choice|1|||
163368849|NCT01867333|590059340|FG001|Overall Study|Participant choice|2|||
163368850|NCT01867333|590059339|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
163368851|NCT01867333|590059340|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
163368852|NCT01867333|590059339|FG000|Overall Study|Death|0|||
163368853|NCT01867333|590059340|FG001|Overall Study|Death|1|||
163368854|NCT01867333|590059339|FG000|Overall Study|Physician Decision|3|||
163368855|NCT01867333|590059340|FG001|Overall Study|Physician Decision|2|||
163368856|NCT01867333|590059339|FG000|Overall Study|Switched to alternative treatment|1|||
163368857|NCT01867333|590059340|FG001|Overall Study|Switched to alternative treatment|0|||
163368858|NCT01145898|590059341|FG000|3-year Treatment|medication change by treating physician|3|||
163368859|NCT01145898|590059342|FG001|3-year Treatment|medication change by treating physician|16|||
163368860|NCT00879775|590059343|FG000|Overall Study|Lost to Follow-up|2|||
163368861|NCT00879775|590059344|FG001|Overall Study|Lost to Follow-up|1|||
163368862|NCT02440425|590059345|FG000|Overall Study|Death likely due to disease progression|1|||
163368863|NCT02440425|590059345|FG000|Overall Study|Withdrawal by Subject|2|||
163368864|NCT02440425|590059345|FG000|Overall Study|Adverse Event|1|||
163368865|NCT02440425|590059345|FG000|Overall Study|Adverse Event/Ineligible|1|||
163368866|NCT03101462|590059346|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
163368867|NCT03101462|590059347|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
163368868|NCT01669577|590059350|FG000|Overall Study|Death|22|||
163368869|NCT01669577|590059350|FG000|Overall Study|Lost to Follow-up|78|||
163368870|NCT01669577|590059350|FG000|Overall Study|Physician Decision|34|||
163368871|NCT03309813|590059351|FG000|Main Randomized Study|Withdrawal by Subject|1|||
163368872|NCT03309813|590059352|FG001|Main Randomized Study|Withdrawal by Subject|0|||
163368873|NCT01327846|590059353|FG000|Core Phase|Subject decision (vital status: missing)|1|||
163368874|NCT01327846|590059354|FG001|Core Phase|Subject decision (vital status: missing)|2|||
163368875|NCT01327846|590059355|FG002|Core Phase|Subject decision (vital status: missing)|2|||
163368876|NCT01327846|590059356|FG003|Core Phase|Subject decision (vital status: missing)|1|||
163368877|NCT01327846|590059353|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
163368878|NCT01327846|590059354|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
163368879|NCT01327846|590059355|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
163368880|NCT01327846|590059356|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
163368881|NCT01327846|590059353|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
163368882|NCT01327846|590059354|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
163368883|NCT01327846|590059355|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
163368884|NCT01327846|590059356|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
163368885|NCT01327846|590059353|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
163368886|NCT01327846|590059354|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
163368887|NCT01327846|590059355|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
163368888|NCT01327846|590059356|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
163368889|NCT01327846|590059353|FG000|Core Phase|Lost to Follow-up|3|||
163368890|NCT01327846|590059354|FG001|Core Phase|Lost to Follow-up|3|||
163368891|NCT01327846|590059355|FG002|Core Phase|Lost to Follow-up|4|||
163368892|NCT01327846|590059356|FG003|Core Phase|Lost to Follow-up|5|||
163368893|NCT01327846|590059353|FG000|Extension Phase|Study terminated by sponsor|1073|||
163368894|NCT01327846|590059354|FG001|Extension Phase|Study terminated by sponsor|1124|||
163368895|NCT01327846|590059355|FG002|Extension Phase|Study terminated by sponsor|1067|||
163368896|NCT01327846|590059356|FG003|Extension Phase|Study terminated by sponsor|1660|||
163368897|NCT01327846|590059353|FG000|Extension Phase|Withdrawal by Subject|20|||
163368898|NCT01327846|590059354|FG001|Extension Phase|Withdrawal by Subject|13|||
163368899|NCT01327846|590059355|FG002|Extension Phase|Withdrawal by Subject|19|||
163368900|NCT01327846|590059356|FG003|Extension Phase|Withdrawal by Subject|37|||
163368901|NCT01327846|590059353|FG000|Extension Phase|Lost to Follow-up|4|||
163368902|NCT01327846|590059354|FG001|Extension Phase|Lost to Follow-up|3|||
163368903|NCT01327846|590059355|FG002|Extension Phase|Lost to Follow-up|4|||
163368904|NCT01327846|590059356|FG003|Extension Phase|Lost to Follow-up|7|||
163368905|NCT01327846|590059353|FG000|Extension Phase|Technical Problems|2|||
163368906|NCT01327846|590059354|FG001|Extension Phase|Technical Problems|4|||
163368907|NCT01327846|590059355|FG002|Extension Phase|Technical Problems|2|||
163368908|NCT01327846|590059356|FG003|Extension Phase|Technical Problems|2|||
163368909|NCT04343976|590059358|FG000|Overall Study|Withdrawal by Subject|0|||
163368910|NCT04343976|590059359|FG001|Overall Study|Withdrawal by Subject|1|||
163368911|NCT02807883|590059360|FG000|Overall Study|Withdrawal by Subject|2|||
163368912|NCT04608773|590059361|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
163368913|NCT04608773|590059362|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
163368914|NCT04608773|590059361|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
163368915|NCT04608773|590059362|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
163368916|NCT04608773|590059361|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
163368917|NCT04608773|590059362|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
163368918|NCT04608773|590059361|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
163368919|NCT04608773|590059362|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
163368920|NCT04608773|590059361|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
163368921|NCT04608773|590059362|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
163368922|NCT02833077|590059363|FG000|Overall Study|Adverse Event|1|||
163368923|NCT02833077|590059364|FG001|Overall Study|Adverse Event|2|||
163368924|NCT02833077|590059363|FG000|Overall Study|Lost to Follow-up|10|||
163368925|NCT02833077|590059364|FG001|Overall Study|Lost to Follow-up|1|||
163368926|NCT02833077|590059363|FG000|Overall Study|Personal Reasons|6|||
163368927|NCT02833077|590059364|FG001|Overall Study|Personal Reasons|4|||
163368928|NCT02833077|590059363|FG000|Overall Study|Protocol Deviation|0|||
163368929|NCT02833077|590059364|FG001|Overall Study|Protocol Deviation|1|||
163368930|NCT00972322|590059365|FG000|Overall Study|Adverse Event|2|||
163368931|NCT00972322|590059366|FG001|Overall Study|Adverse Event|1|||
163368932|NCT00972322|590059365|FG000|Overall Study|Positive drug screen|0|||
163368933|NCT00972322|590059366|FG001|Overall Study|Positive drug screen|1|||
163368934|NCT00972322|590059365|FG000|Overall Study|Lost to Follow-up|0|||
163368935|NCT00972322|590059366|FG001|Overall Study|Lost to Follow-up|1|||
163368936|NCT00972322|590059365|FG000|Overall Study|Consistently high glucose values|1|||
163368937|NCT00972322|590059366|FG001|Overall Study|Consistently high glucose values|0|||
163368938|NCT00316017|590059367|FG000|Overall Study|Protocol Violation|11|||
163368939|NCT00316017|590059368|FG001|Overall Study|Protocol Violation|13|||
163368940|NCT00316017|590059369|FG002|Overall Study|Protocol Violation|19|||
163368941|NCT00623805|590059374|FG000|Overall Study|Adverse Event|9|||
163368942|NCT00623805|590059375|FG001|Overall Study|Adverse Event|6|||
163368943|NCT00623805|590059374|FG000|Overall Study|Death|2|||
163368944|NCT00623805|590059375|FG001|Overall Study|Death|0|||
163368945|NCT00623805|590059374|FG000|Overall Study|Lack of Efficacy|3|||
163368946|NCT00623805|590059375|FG001|Overall Study|Lack of Efficacy|7|||
163368947|NCT00623805|590059374|FG000|Overall Study|Lost to Follow-up|2|||
163368948|NCT00623805|590059375|FG001|Overall Study|Lost to Follow-up|2|||
163368949|NCT00623805|590059374|FG000|Overall Study|Protocol Violation|1|||
163368950|NCT00623805|590059375|FG001|Overall Study|Protocol Violation|1|||
163368951|NCT00623805|590059374|FG000|Overall Study|Reason not Specified|3|||
163368952|NCT00623805|590059375|FG001|Overall Study|Reason not Specified|6|||
163368953|NCT02671500|590059376|FG000|Overall Study|Lack of Efficacy|12|||
163368954|NCT02671500|590059376|FG000|Overall Study|Lost to Follow-up|2|||
163368955|NCT05235269|590059378|FG000|Overall Study|Adverse Event|1|||
163368956|NCT05235269|590059378|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
163368957|NCT05235269|590059378|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
163368958|NCT03361865|590059379|FG000|Overall Study|Death|17|||
163368959|NCT03361865|590059380|FG001|Overall Study|Death|18|||
163368960|NCT03361865|590059379|FG000|Overall Study|Physician Decision|1|||
163368961|NCT03361865|590059380|FG001|Overall Study|Physician Decision|9|||
163368962|NCT03361865|590059379|FG000|Overall Study|Withdrawal by Subject|1|||
163368963|NCT03361865|590059380|FG001|Overall Study|Withdrawal by Subject|0|||
163368964|NCT03852719|590059381|FG000|Overall Study|Withdrawal of consent|8|||
163368965|NCT03852719|590059382|FG001|Overall Study|Withdrawal of consent|8|||
163368966|NCT03852719|590059383|FG002|Overall Study|Withdrawal of consent|9|||
163368967|NCT03852719|590059381|FG000|Overall Study|Physician Decision|5|||
163368968|NCT03852719|590059382|FG001|Overall Study|Physician Decision|4|||
163368969|NCT03852719|590059383|FG002|Overall Study|Physician Decision|1|||
163368970|NCT03852719|590059381|FG000|Overall Study|Pregnancy|2|||
163368971|NCT03852719|590059382|FG001|Overall Study|Pregnancy|1|||
163368972|NCT03852719|590059383|FG002|Overall Study|Pregnancy|0|||
163368973|NCT03852719|590059381|FG000|Overall Study|Death|1|||
163368974|NCT03852719|590059382|FG001|Overall Study|Death|0|||
163368975|NCT03852719|590059383|FG002|Overall Study|Death|0|||
163368976|NCT03852719|590059381|FG000|Overall Study|Reason not Specified|3|||
163368977|NCT03852719|590059382|FG001|Overall Study|Reason not Specified|3|||
163368978|NCT03852719|590059383|FG002|Overall Study|Reason not Specified|5|||
163368979|NCT03852719|590059381|FG000|Overall Study|Adverse Event|2|||
163368980|NCT03852719|590059382|FG001|Overall Study|Adverse Event|1|||
163368981|NCT03852719|590059383|FG002|Overall Study|Adverse Event|4|||
163368982|NCT03852719|590059381|FG000|Overall Study|Progressive disease|1|||
163368983|NCT03852719|590059382|FG001|Overall Study|Progressive disease|4|||
163368984|NCT03852719|590059383|FG002|Overall Study|Progressive disease|1|||
163368985|NCT03852719|590059381|FG000|Overall Study|Lost to Follow-up|1|||
163368986|NCT03852719|590059382|FG001|Overall Study|Lost to Follow-up|0|||
163368987|NCT03852719|590059383|FG002|Overall Study|Lost to Follow-up|0|||
163368988|NCT03810235|590059384|FG000|Overall Study|Withdrawal by Subject|2|||
163368989|NCT03810235|590059385|FG001|Overall Study|Withdrawal by Subject|0|||
163368990|NCT04201262|590059386|FG000|Primary Treatment Period|Adverse Event|1|||
163368991|NCT04201262|590059387|FG001|Primary Treatment Period|Adverse Event|2|||
163368992|NCT04201262|590059386|FG000|Primary Treatment Period|Physician Decision|1|||
163368993|NCT04201262|590059387|FG001|Primary Treatment Period|Physician Decision|1|||
163368994|NCT04201262|590059386|FG000|Long-term Extension Period|Death|1|||
163368995|NCT04201262|590059387|FG001|Long-term Extension Period|Death|0|||
163368996|NCT01647542|590059389|FG000|Overall Study|Major Protocol Deviation|1|||
163368997|NCT01647542|590059390|FG001|Overall Study|Major Protocol Deviation|0|||
163368998|NCT01647542|590059391|FG002|Overall Study|Major Protocol Deviation|0|||
163368999|NCT01647542|590059389|FG000|Overall Study|Adverse Event|4|||
163369000|NCT01647542|590059390|FG001|Overall Study|Adverse Event|5|||
163369001|NCT01647542|590059391|FG002|Overall Study|Adverse Event|4|||
163369002|NCT01647542|590059389|FG000|Overall Study|Lost to Follow-up|0|||
163369003|NCT01647542|590059390|FG001|Overall Study|Lost to Follow-up|2|||
163369004|NCT01647542|590059391|FG002|Overall Study|Lost to Follow-up|2|||
163369005|NCT01647542|590059389|FG000|Overall Study|Withdrawal by Subject|6|||
163369006|NCT01647542|590059390|FG001|Overall Study|Withdrawal by Subject|4|||
163369007|NCT01647542|590059391|FG002|Overall Study|Withdrawal by Subject|0|||
163369008|NCT01647542|590059389|FG000|Overall Study|Study Termination|64|||
163369009|NCT01647542|590059390|FG001|Overall Study|Study Termination|61|||
163369010|NCT01647542|590059391|FG002|Overall Study|Study Termination|65|||
163369011|NCT01647542|590059389|FG000|Overall Study|Lack of Efficacy|1|||
163369012|NCT01647542|590059390|FG001|Overall Study|Lack of Efficacy|1|||
163369013|NCT01647542|590059391|FG002|Overall Study|Lack of Efficacy|0|||
163369014|NCT01647542|590059389|FG000|Overall Study|Death|0|||
163369015|NCT01647542|590059390|FG001|Overall Study|Death|0|||
163369016|NCT01647542|590059391|FG002|Overall Study|Death|1|||
163369017|NCT03682185|590059394|FG000|Overall Study|Lost to Follow-up|4|||
163369018|NCT03682185|590059395|FG001|Overall Study|Lost to Follow-up|7|||
163369019|NCT03682185|590059396|FG002|Overall Study|Lost to Follow-up|4|||
163369020|NCT03682185|590059397|FG003|Overall Study|Lost to Follow-up|7|||
163369021|NCT03682185|590059398|FG004|Overall Study|Lost to Follow-up|1|||
163369022|NCT03682185|590059394|FG000|Overall Study|Withdrawal by Subject|7|||
163369023|NCT03682185|590059395|FG001|Overall Study|Withdrawal by Subject|3|||
163369024|NCT03682185|590059396|FG002|Overall Study|Withdrawal by Subject|7|||
163369025|NCT03682185|590059397|FG003|Overall Study|Withdrawal by Subject|3|||
163369026|NCT03682185|590059398|FG004|Overall Study|Withdrawal by Subject|0|||
163369027|NCT06926673|590059399|FG000|Overall Study|Lost to Follow-up|0|||
163369028|NCT06926673|590059400|FG001|Overall Study|Lost to Follow-up|0|||
163369029|NCT06926673|590059401|FG002|Overall Study|Lost to Follow-up|0|||
163369030|NCT06926673|590059402|FG003|Overall Study|Lost to Follow-up|1|||
163369031|NCT06926673|590059403|FG004|Overall Study|Lost to Follow-up|0|||
163369032|NCT06926673|590059404|FG005|Overall Study|Lost to Follow-up|0|||
163369033|NCT06926673|590059405|FG006|Overall Study|Lost to Follow-up|0|||
163369034|NCT06926673|590059399|FG000|Overall Study|Physician Decision|0|||
163369035|NCT06926673|590059400|FG001|Overall Study|Physician Decision|0|||
163369036|NCT06926673|590059401|FG002|Overall Study|Physician Decision|0|||
163369037|NCT06926673|590059402|FG003|Overall Study|Physician Decision|0|||
163369038|NCT06926673|590059403|FG004|Overall Study|Physician Decision|0|||
163369039|NCT06926673|590059404|FG005|Overall Study|Physician Decision|0|||
163369040|NCT06926673|590059405|FG006|Overall Study|Physician Decision|1|||
163369041|NCT06926673|590059399|FG000|Overall Study|Withdrawal by Subject|0|||
163369042|NCT06926673|590059400|FG001|Overall Study|Withdrawal by Subject|3|||
163369043|NCT06926673|590059401|FG002|Overall Study|Withdrawal by Subject|2|||
163369044|NCT06926673|590059402|FG003|Overall Study|Withdrawal by Subject|1|||
163369045|NCT06926673|590059403|FG004|Overall Study|Withdrawal by Subject|0|||
163369046|NCT06926673|590059404|FG005|Overall Study|Withdrawal by Subject|2|||
163369047|NCT06926673|590059405|FG006|Overall Study|Withdrawal by Subject|0|||
163369048|NCT01967147|590060665|FG000|Overall Study|Adverse Event|5|||
163369049|NCT01967147|590060666|FG001|Overall Study|Adverse Event|2|||
163369050|NCT01967147|590060665|FG000|Overall Study|Lack of Efficacy|1|||
163369051|NCT01967147|590060666|FG001|Overall Study|Lack of Efficacy|4|||
163369052|NCT01967147|590060665|FG000|Overall Study|Lost to Follow-up|1|||
163369053|NCT01967147|590060666|FG001|Overall Study|Lost to Follow-up|2|||
163369054|NCT01967147|590060665|FG000|Overall Study|Withdrawal by Subject|2|||
163369055|NCT01967147|590060666|FG001|Overall Study|Withdrawal by Subject|4|||
163369056|NCT01967147|590060665|FG000|Overall Study|Non-compliance with Study Drug|0|||
163369057|NCT01967147|590060666|FG001|Overall Study|Non-compliance with Study Drug|3|||
163369058|NCT01967147|590060665|FG000|Overall Study|Other|4|||
163369059|NCT01967147|590060666|FG001|Overall Study|Other|5|||
163369060|NCT03843554|590060667|FG000|Overall Study|Physician Decision|0|||
163369061|NCT03843554|590060668|FG001|Overall Study|Physician Decision|2|||
163369062|NCT02218606|590060670|FG000|Overall Study|Adverse Event|1|||
163369063|NCT02218606|590060671|FG001|Overall Study|Adverse Event|1|||
163369064|NCT02218606|590060670|FG000|Overall Study|Death|15|||
163369065|NCT02218606|590060671|FG001|Overall Study|Death|28|||
163369066|NCT02218606|590060670|FG000|Overall Study|Physician Decision|0|||
163369067|NCT02218606|590060671|FG001|Overall Study|Physician Decision|1|||
163369068|NCT02218606|590060670|FG000|Overall Study|Withdrawal by Subject|4|||
163369069|NCT02218606|590060671|FG001|Overall Study|Withdrawal by Subject|0|||
163369070|NCT02218606|590060670|FG000|Overall Study|Noncompliance|1|||
163369071|NCT02218606|590060671|FG001|Overall Study|Noncompliance|0|||
163369072|NCT02218606|590060670|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
163369073|NCT02218606|590060671|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
163369074|NCT02218606|590060670|FG000|Overall Study|Other|2|||
163369075|NCT02218606|590060671|FG001|Overall Study|Other|1|||
163369076|NCT02218606|590060670|FG000|Overall Study|Never started treatment|0|||
163369077|NCT02218606|590060671|FG001|Overall Study|Never started treatment|1|||
163369078|NCT00890695|590060672|FG000|Overall Study|Protocol Violation|1|||
163369079|NCT00890695|590060673|FG001|Overall Study|Protocol Violation|0|||
163369080|NCT04396366|590060676|FG000|Overall Study|Adverse Event|1|||
163369081|NCT04396366|590060677|FG001|Overall Study|Adverse Event|0|||
163369082|NCT02187159|590060682|FG000|Overall Study|Protocol Violation|4|||
163369083|NCT02187159|590060683|FG001|Overall Study|Protocol Violation|6|||
163369084|NCT02187159|590060684|FG002|Overall Study|Protocol Violation|3|||
163369085|NCT02187159|590060685|FG003|Overall Study|Protocol Violation|4|||
163369086|NCT02187159|590060682|FG000|Overall Study|Lack of Efficacy|10|||
163369087|NCT02187159|590060683|FG001|Overall Study|Lack of Efficacy|5|||
163369088|NCT02187159|590060684|FG002|Overall Study|Lack of Efficacy|4|||
163369089|NCT02187159|590060685|FG003|Overall Study|Lack of Efficacy|7|||
163369090|NCT02187159|590060682|FG000|Overall Study|Adverse Event|28|||
163369091|NCT02187159|590060683|FG001|Overall Study|Adverse Event|33|||
163369092|NCT02187159|590060684|FG002|Overall Study|Adverse Event|42|||
163369093|NCT02187159|590060685|FG003|Overall Study|Adverse Event|50|||
163369094|NCT02187159|590060682|FG000|Overall Study|Withdrawal by Subject|24|||
163369095|NCT02187159|590060683|FG001|Overall Study|Withdrawal by Subject|28|||
163369096|NCT02187159|590060684|FG002|Overall Study|Withdrawal by Subject|25|||
163369097|NCT02187159|590060685|FG003|Overall Study|Withdrawal by Subject|26|||
163369098|NCT02187159|590060682|FG000|Overall Study|Other|3|||
163369099|NCT02187159|590060683|FG001|Overall Study|Other|7|||
163369100|NCT02187159|590060684|FG002|Overall Study|Other|3|||
163369101|NCT02187159|590060685|FG003|Overall Study|Other|9|||
163369102|NCT01283152|590060686|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
163369103|NCT01283152|590060687|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
163369104|NCT01283152|590060686|FG000|Overall Study|Refused HESA|1|||
163369105|NCT01283152|590060687|FG001|Overall Study|Refused HESA|0|||
163369106|NCT00567567|590060688|FG000|Overall Study|Adverse Event|0|||
163369107|NCT00567567|590060689|FG001|Overall Study|Adverse Event|2|||
163369108|NCT00567567|590060690|FG002|Overall Study|Adverse Event|5|||
163369109|NCT00567567|590060688|FG000|Overall Study|Death|8|||
163369110|NCT00567567|590060689|FG001|Overall Study|Death|1|||
163369111|NCT00567567|590060690|FG002|Overall Study|Death|5|||
163369112|NCT00567567|590060688|FG000|Overall Study|Lack of Efficacy|16|||
163369113|NCT00567567|590060689|FG001|Overall Study|Lack of Efficacy|17|||
163369114|NCT00567567|590060690|FG002|Overall Study|Lack of Efficacy|48|||
163369115|NCT00567567|590060688|FG000|Overall Study|Lost to Follow-up|0|||
163369116|NCT00567567|590060689|FG001|Overall Study|Lost to Follow-up|0|||
163369117|NCT00567567|590060690|FG002|Overall Study|Lost to Follow-up|1|||
163369118|NCT00567567|590060688|FG000|Overall Study|Physician Decision|16|||
163369119|NCT00567567|590060689|FG001|Overall Study|Physician Decision|18|||
163369120|NCT00567567|590060690|FG002|Overall Study|Physician Decision|84|||
163369121|NCT00567567|590060688|FG000|Overall Study|Withdrawal by Subject|0|||
163369122|NCT00567567|590060689|FG001|Overall Study|Withdrawal by Subject|0|||
163369123|NCT00567567|590060690|FG002|Overall Study|Withdrawal by Subject|2|||
163369124|NCT00567567|590060688|FG000|Overall Study|Ineligible|4|||
163369125|NCT00567567|590060689|FG001|Overall Study|Ineligible|0|||
163369126|NCT00567567|590060690|FG002|Overall Study|Ineligible|9|||
163369127|NCT00567567|590060688|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
163369128|NCT00567567|590060689|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
163369129|NCT00567567|590060690|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
163369130|NCT00567567|590060688|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
163369131|NCT00567567|590060689|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
163369132|NCT00567567|590060690|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
163369133|NCT00567567|590060688|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
163369134|NCT00567567|590060689|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
163369135|NCT00567567|590060690|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
163369136|NCT03433677|590060691|FG000|Period 1|Protocol Violation|1|||
163369137|NCT03433677|590060692|FG001|Period 1|Protocol Violation|0|||
163369138|NCT03433677|590060691|FG000|Period 2|Withdrawal by Subject|1|||
163369139|NCT03433677|590060692|FG001|Period 2|Withdrawal by Subject|1|||
163369140|NCT03330405|590060693|FG000|Overall Study|Other|1|||
163369141|NCT03330405|590060694|FG001|Overall Study|Other|3|||
163369142|NCT03330405|590060695|FG002|Overall Study|Other|1|||
163369143|NCT03330405|590060696|FG003|Overall Study|Other|0|||
163369144|NCT03330405|590060697|FG004|Overall Study|Other|2|||
163369145|NCT03330405|590060698|FG005|Overall Study|Other|0|||
163369146|NCT03330405|590060699|FG006|Overall Study|Other|1|||
163369147|NCT03330405|590060700|FG007|Overall Study|Other|0|||
163369148|NCT03330405|590060701|FG008|Overall Study|Other|0|||
163369149|NCT03330405|590060702|FG009|Overall Study|Other|0|||
163369150|NCT03330405|590060703|FG010|Overall Study|Other|0|||
163369151|NCT03330405|590060693|FG000|Overall Study|Progressive disease|8|||
163369152|NCT03330405|590060694|FG001|Overall Study|Progressive disease|27|||
163369153|NCT03330405|590060695|FG002|Overall Study|Progressive disease|4|||
163369154|NCT03330405|590060696|FG003|Overall Study|Progressive disease|18|||
163369155|NCT03330405|590060697|FG004|Overall Study|Progressive disease|16|||
163369156|NCT03330405|590060698|FG005|Overall Study|Progressive disease|14|||
163369157|NCT03330405|590060699|FG006|Overall Study|Progressive disease|7|||
163369158|NCT03330405|590060700|FG007|Overall Study|Progressive disease|29|||
163369159|NCT03330405|590060701|FG008|Overall Study|Progressive disease|9|||
163369160|NCT03330405|590060702|FG009|Overall Study|Progressive disease|11|||
163369161|NCT03330405|590060703|FG010|Overall Study|Progressive disease|5|||
163369162|NCT03330405|590060693|FG000|Overall Study|Withdrawal by Subject|1|||
163369163|NCT03330405|590060694|FG001|Overall Study|Withdrawal by Subject|4|||
163369164|NCT03330405|590060695|FG002|Overall Study|Withdrawal by Subject|0|||
163369165|NCT03330405|590060696|FG003|Overall Study|Withdrawal by Subject|1|||
163369166|NCT03330405|590060697|FG004|Overall Study|Withdrawal by Subject|1|||
163369167|NCT03330405|590060698|FG005|Overall Study|Withdrawal by Subject|1|||
163369168|NCT03330405|590060699|FG006|Overall Study|Withdrawal by Subject|0|||
163369169|NCT03330405|590060700|FG007|Overall Study|Withdrawal by Subject|2|||
163369170|NCT03330405|590060701|FG008|Overall Study|Withdrawal by Subject|2|||
163369171|NCT03330405|590060702|FG009|Overall Study|Withdrawal by Subject|1|||
163369172|NCT03330405|590060703|FG010|Overall Study|Withdrawal by Subject|1|||
163369173|NCT03330405|590060693|FG000|Overall Study|Global deterioration of health status|2|||
163369174|NCT03330405|590060694|FG001|Overall Study|Global deterioration of health status|3|||
163369175|NCT03330405|590060695|FG002|Overall Study|Global deterioration of health status|0|||
163369176|NCT03330405|590060696|FG003|Overall Study|Global deterioration of health status|2|||
163369177|NCT03330405|590060697|FG004|Overall Study|Global deterioration of health status|3|||
163369178|NCT03330405|590060698|FG005|Overall Study|Global deterioration of health status|3|||
163369179|NCT03330405|590060699|FG006|Overall Study|Global deterioration of health status|0|||
163369180|NCT03330405|590060700|FG007|Overall Study|Global deterioration of health status|2|||
163369181|NCT03330405|590060701|FG008|Overall Study|Global deterioration of health status|8|||
163369182|NCT03330405|590060702|FG009|Overall Study|Global deterioration of health status|4|||
163369183|NCT03330405|590060703|FG010|Overall Study|Global deterioration of health status|1|||
163369184|NCT03330405|590060693|FG000|Overall Study|Adverse Event|0|||
163369185|NCT03330405|590060694|FG001|Overall Study|Adverse Event|1|||
163369186|NCT03330405|590060695|FG002|Overall Study|Adverse Event|0|||
163369187|NCT03330405|590060696|FG003|Overall Study|Adverse Event|1|||
163369188|NCT03330405|590060697|FG004|Overall Study|Adverse Event|1|||
163369189|NCT03330405|590060698|FG005|Overall Study|Adverse Event|1|||
163369190|NCT03330405|590060699|FG006|Overall Study|Adverse Event|3|||
163369191|NCT03330405|590060700|FG007|Overall Study|Adverse Event|4|||
163369192|NCT03330405|590060701|FG008|Overall Study|Adverse Event|2|||
163369193|NCT03330405|590060702|FG009|Overall Study|Adverse Event|2|||
163369194|NCT03330405|590060703|FG010|Overall Study|Adverse Event|2|||
163369195|NCT03330405|590060693|FG000|Overall Study|Death|0|||
163369196|NCT03330405|590060694|FG001|Overall Study|Death|4|||
163369197|NCT03330405|590060695|FG002|Overall Study|Death|0|||
163369198|NCT03330405|590060696|FG003|Overall Study|Death|0|||
163369199|NCT03330405|590060697|FG004|Overall Study|Death|0|||
163369200|NCT03330405|590060698|FG005|Overall Study|Death|1|||
163369201|NCT03330405|590060699|FG006|Overall Study|Death|0|||
163369202|NCT03330405|590060700|FG007|Overall Study|Death|2|||
163369203|NCT03330405|590060701|FG008|Overall Study|Death|0|||
163369204|NCT03330405|590060702|FG009|Overall Study|Death|0|||
163369205|NCT03330405|590060703|FG010|Overall Study|Death|0|||
163369206|NCT03330405|590060693|FG000|Overall Study|Physician Decision|0|||
163369207|NCT03330405|590060694|FG001|Overall Study|Physician Decision|0|||
163369208|NCT03330405|590060695|FG002|Overall Study|Physician Decision|0|||
163369209|NCT03330405|590060696|FG003|Overall Study|Physician Decision|0|||
163369210|NCT03330405|590060697|FG004|Overall Study|Physician Decision|0|||
163369211|NCT03330405|590060698|FG005|Overall Study|Physician Decision|0|||
163369212|NCT03330405|590060699|FG006|Overall Study|Physician Decision|0|||
163369213|NCT03330405|590060700|FG007|Overall Study|Physician Decision|1|||
163369214|NCT03330405|590060701|FG008|Overall Study|Physician Decision|0|||
163369215|NCT03330405|590060702|FG009|Overall Study|Physician Decision|0|||
163369216|NCT03330405|590060703|FG010|Overall Study|Physician Decision|0|||
163369217|NCT03482466|590060704|FG000|Overall Study|Protocol Violation|2|||
163369218|NCT04833127|590060705|FG000|Overall Study|Lost to Follow-up|1|||
163369219|NCT04833127|590060706|FG001|Overall Study|Lost to Follow-up|1|||
163369220|NCT01736189|590060707|FG000|Overall Study|Violation of registration criteria|41|||
163369221|NCT01736189|590060707|FG000|Overall Study|Protocol Violation|4|||
163369222|NCT01736189|590060707|FG000|Overall Study|Criteria and protocol violations|1|||
163369223|NCT01499303|590060708|FG000|Overall Study|Ongoing|2|||
163369224|NCT01499303|590060709|FG001|Overall Study|Ongoing|1|||
163369225|NCT01499303|590060708|FG000|Overall Study|Withdrawal by Subject|0|||
163369226|NCT01499303|590060709|FG001|Overall Study|Withdrawal by Subject|1|||
163369227|NCT01499303|590060708|FG000|Overall Study|Adverse Event|1|||
163369228|NCT01499303|590060709|FG001|Overall Study|Adverse Event|4|||
163369229|NCT01499303|590060708|FG000|Overall Study|Other|0|||
163369230|NCT01499303|590060709|FG001|Overall Study|Other|1|||
163369231|NCT01896557|590060710|FG000|Clopidogrel Alone|Adverse Event|1|||
163369232|NCT01896557|590060711|FG001|Clopidogrel Alone|Adverse Event|0|||
163369233|NCT01896557|590060710|FG000|Clopidogrel + GI Protector|low adherence|1|||
163369234|NCT01896557|590060711|FG001|Clopidogrel + GI Protector|low adherence|1|||
163369235|NCT01896557|590060710|FG000|Clopidogrel + GI Protector|Reading error|1|||
163369236|NCT01896557|590060711|FG001|Clopidogrel + GI Protector|Reading error|3|||
163369237|NCT02383940|590060712|FG000|Overall Study|Adverse Event|1|||
163369238|NCT02383940|590060713|FG001|Overall Study|Adverse Event|0|||
163369239|NCT02383940|590060712|FG000|Overall Study|Lost to Follow-up|2|||
163369240|NCT02383940|590060713|FG001|Overall Study|Lost to Follow-up|2|||
163369241|NCT02383940|590060712|FG000|Overall Study|Physician Decision|2|||
163369242|NCT02383940|590060713|FG001|Overall Study|Physician Decision|0|||
163369243|NCT02383940|590060712|FG000|Overall Study|Withdrawal by Subject|1|||
163369244|NCT02383940|590060713|FG001|Overall Study|Withdrawal by Subject|1|||
163369245|NCT02383940|590060712|FG000|Overall Study|Randomized but not treated|2|||
163369246|NCT02383940|590060713|FG001|Overall Study|Randomized but not treated|0|||
163369247|NCT02383940|590060712|FG000|Overall Study|Other than specified above|1|||
163369248|NCT02383940|590060713|FG001|Overall Study|Other than specified above|0|||
163369249|NCT01517295|590060714|FG000|Overall Study|Physician Decision|1|||
163369250|NCT01517295|590060715|FG001|Overall Study|Physician Decision|0|||
163369251|NCT01353859|590060716|FG000|Overall Study|Adverse Event|3|||
163369252|NCT01353859|590060716|FG000|Overall Study|Lack of Efficacy|1|||
163369253|NCT03853551|590060717|FG000|Overall Study|Death|2|||
163369254|NCT03853551|590060717|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
163369255|NCT01923467|590060720|FG000|Overall Study|Lost to Follow-up|62|||
163369256|NCT01923467|590060720|FG000|Overall Study|Subject non-interest|479|||
163369257|NCT01075958|590060721|FG000|Overall Study|Blood sample could not be obtained|44|||
163369258|NCT01696045|590060727|FG000|Overall Study|Study drug toxicity|1|||
163369259|NCT01696045|590060728|FG001|Overall Study|Study drug toxicity|5|||
163369260|NCT01696045|590060727|FG000|Overall Study|Disease progression|2|||
163369261|NCT01696045|590060728|FG001|Overall Study|Disease progression|2|||
163369262|NCT01559129|590060729|FG000|Treatment Phase|Adverse Event|0|||
163369263|NCT01559129|590060730|FG001|Treatment Phase|Adverse Event|2|||
163369264|NCT01559129|590060729|FG000|Treatment Phase|Progressive Disease|1|||
163369265|NCT01559129|590060730|FG001|Treatment Phase|Progressive Disease|1|||
163369266|NCT01559129|590060729|FG000|Treatment Phase|Lack of Efficacy|0|||
163369267|NCT01559129|590060730|FG001|Treatment Phase|Lack of Efficacy|1|||
163369268|NCT01559129|590060729|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
163369269|NCT01559129|590060730|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
163369270|NCT01559129|590060729|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
163369271|NCT01559129|590060730|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
163369272|NCT01559129|590060729|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
163369273|NCT01559129|590060730|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
163369274|NCT01559129|590060729|FG000|Open-label Extension Period|Adverse Event|1|||
163369275|NCT01559129|590060730|FG001|Open-label Extension Period|Adverse Event|0|||
163369276|NCT01559129|590060729|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
163369277|NCT01559129|590060730|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
163369278|NCT03525392|590060731|FG000|Overall Study|Adverse Event|1|||
163369279|NCT03525392|590060732|FG001|Overall Study|Adverse Event|0|||
163369280|NCT03525392|590060733|FG002|Overall Study|Adverse Event|2|||
163369281|NCT03525392|590060734|FG003|Overall Study|Adverse Event|0|||
163369282|NCT03525392|590060735|FG004|Overall Study|Adverse Event|0|||
163369283|NCT03525392|590060731|FG000|Overall Study|Progressive disease|0|||
163369284|NCT03525392|590060732|FG001|Overall Study|Progressive disease|1|||
163369285|NCT03525392|590060733|FG002|Overall Study|Progressive disease|1|||
163369286|NCT03525392|590060734|FG003|Overall Study|Progressive disease|3|||
163369287|NCT03525392|590060735|FG004|Overall Study|Progressive disease|1|||
163369288|NCT00831129|590060738|FG000|Overall Study|Adverse Event|0|||
163369289|NCT00831129|590060739|FG001|Overall Study|Adverse Event|1|||
163369290|NCT00831129|590060738|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
163369291|NCT00831129|590060739|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
163369292|NCT00818779|590060741|FG000|Overall Study|Protocol Violation|1|||
163369293|NCT00818779|590060742|FG001|Overall Study|Protocol Violation|0|||
163369294|NCT00818779|590060741|FG000|Overall Study|Lost to Follow-up|1|||
163369295|NCT00818779|590060742|FG001|Overall Study|Lost to Follow-up|0|||
163369296|NCT00818779|590060741|FG000|Overall Study|Adverse Event|4|||
163369297|NCT00818779|590060742|FG001|Overall Study|Adverse Event|1|||
163369298|NCT00132873|590060743|FG000|Overall Study|Adverse Event|3|||
163369299|NCT00132873|590060743|FG000|Overall Study|Lost to Follow-up|1|||
163369300|NCT00132873|590060743|FG000|Overall Study|Lack of Efficacy|1|||
163369301|NCT00132873|590060743|FG000|Overall Study|Withdrawal by Subject|3|||
163369302|NCT00132873|590060743|FG000|Overall Study|Planned Pregnancy|1|||
163369303|NCT04276415|590060744|FG000|Overall Study|Adverse Event|0|||
163369304|NCT04276415|590060745|FG001|Overall Study|Adverse Event|0|||
163369305|NCT04276415|590060746|FG002|Overall Study|Adverse Event|0|||
163369306|NCT04276415|590060747|FG003|Overall Study|Adverse Event|3|||
163369307|NCT04276415|590060748|FG004|Overall Study|Adverse Event|0|||
163369308|NCT04276415|590060749|FG005|Overall Study|Adverse Event|0|||
163369309|NCT04276415|590060744|FG000|Overall Study|Clinical progression|1|||
163413276|NCT00939692|590220906|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
163369310|NCT04276415|590060745|FG001|Overall Study|Clinical progression|1|||
163369311|NCT04276415|590060746|FG002|Overall Study|Clinical progression|0|||
163369312|NCT04276415|590060747|FG003|Overall Study|Clinical progression|0|||
163369313|NCT04276415|590060748|FG004|Overall Study|Clinical progression|1|||
163369314|NCT04276415|590060749|FG005|Overall Study|Clinical progression|0|||
163369315|NCT04276415|590060744|FG000|Overall Study|Other|0|||
163369316|NCT04276415|590060745|FG001|Overall Study|Other|0|||
163369317|NCT04276415|590060746|FG002|Overall Study|Other|0|||
163369318|NCT04276415|590060747|FG003|Overall Study|Other|1|||
163369319|NCT04276415|590060748|FG004|Overall Study|Other|0|||
163369320|NCT04276415|590060749|FG005|Overall Study|Other|0|||
163369321|NCT04276415|590060744|FG000|Overall Study|Physician Decision|0|||
163369322|NCT04276415|590060745|FG001|Overall Study|Physician Decision|0|||
163369323|NCT04276415|590060746|FG002|Overall Study|Physician Decision|1|||
163369324|NCT04276415|590060747|FG003|Overall Study|Physician Decision|3|||
163369325|NCT04276415|590060748|FG004|Overall Study|Physician Decision|2|||
163369326|NCT04276415|590060749|FG005|Overall Study|Physician Decision|0|||
163369327|NCT04276415|590060744|FG000|Overall Study|Progressive disease|3|||
163369328|NCT04276415|590060745|FG001|Overall Study|Progressive disease|3|||
163369329|NCT04276415|590060746|FG002|Overall Study|Progressive disease|4|||
163369330|NCT04276415|590060747|FG003|Overall Study|Progressive disease|5|||
163369331|NCT04276415|590060748|FG004|Overall Study|Progressive disease|1|||
163369332|NCT04276415|590060749|FG005|Overall Study|Progressive disease|2|||
163369333|NCT04276415|590060744|FG000|Overall Study|Withdrawal by patient|0|||
163369334|NCT04276415|590060745|FG001|Overall Study|Withdrawal by patient|0|||
163369335|NCT04276415|590060746|FG002|Overall Study|Withdrawal by patient|0|||
163413277|NCT00939692|590220907|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
163369336|NCT04276415|590060747|FG003|Overall Study|Withdrawal by patient|1|||
163369337|NCT04276415|590060748|FG004|Overall Study|Withdrawal by patient|2|||
163369338|NCT04276415|590060749|FG005|Overall Study|Withdrawal by patient|0|||
163369339|NCT00208325|590060750|FG000|Overall Study|Death|18|||
163369340|NCT00208325|590060751|FG001|Overall Study|Death|19|||
163369341|NCT00208325|590060752|FG002|Overall Study|Death|7|||
163369342|NCT00208325|590060753|FG003|Overall Study|Death|5|||
163369343|NCT00208325|590060750|FG000|Overall Study|Withdrawal by Subject|0|||
163369344|NCT00208325|590060751|FG001|Overall Study|Withdrawal by Subject|1|||
163369345|NCT00208325|590060752|FG002|Overall Study|Withdrawal by Subject|0|||
163369346|NCT00208325|590060753|FG003|Overall Study|Withdrawal by Subject|0|||
163369347|NCT00208325|590060750|FG000|Overall Study|Revision|4|||
163369348|NCT00208325|590060751|FG001|Overall Study|Revision|1|||
163369349|NCT00208325|590060752|FG002|Overall Study|Revision|0|||
163369350|NCT00208325|590060753|FG003|Overall Study|Revision|4|||
163369351|NCT00208325|590060750|FG000|Overall Study|Lost to Follow-up|1|||
163369352|NCT00208325|590060751|FG001|Overall Study|Lost to Follow-up|0|||
163369353|NCT00208325|590060752|FG002|Overall Study|Lost to Follow-up|2|||
163369354|NCT00208325|590060753|FG003|Overall Study|Lost to Follow-up|0|||
163369355|NCT00208325|590060750|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
163369356|NCT00208325|590060751|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
163369357|NCT00208325|590060752|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
163369358|NCT00208325|590060753|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
163369359|NCT00208325|590060750|FG000|Overall Study|Does not wish to Continue in Study|5|||
163369360|NCT00208325|590060751|FG001|Overall Study|Does not wish to Continue in Study|8|||
163369361|NCT00208325|590060752|FG002|Overall Study|Does not wish to Continue in Study|3|||
163369362|NCT00208325|590060753|FG003|Overall Study|Does not wish to Continue in Study|2|||
163369363|NCT00208325|590060750|FG000|Overall Study|Other|2|||
163369364|NCT00208325|590060751|FG001|Overall Study|Other|1|||
163369365|NCT00208325|590060752|FG002|Overall Study|Other|1|||
163369366|NCT00208325|590060753|FG003|Overall Study|Other|0|||
163369367|NCT00208325|590060750|FG000|Overall Study|Mis-Randomized|17|||
163369368|NCT00208325|590060751|FG001|Overall Study|Mis-Randomized|20|||
163369369|NCT00208325|590060752|FG002|Overall Study|Mis-Randomized|0|||
163369370|NCT00208325|590060753|FG003|Overall Study|Mis-Randomized|0|||
163369371|NCT04662931|590060756|FG000|Overall Study|Withdrawal by Subject|17|||
163369372|NCT04662931|590060756|FG000|Overall Study|Death|3|||
163369373|NCT04662931|590060756|FG000|Overall Study|Lost to Follow-up|3|||
163369374|NCT04662931|590060756|FG000|Overall Study|Guardian Decision|1|||
163369375|NCT01254747|590060757|FG000|Overall Study|Unacceptable subjective vision|0|||
163369376|NCT01254747|590060758|FG001|Overall Study|Unacceptable subjective vision|0|||
163369377|NCT01254747|590060759|FG002|Overall Study|Unacceptable subjective vision|0|||
163369378|NCT01254747|590060760|FG003|Overall Study|Unacceptable subjective vision|2|||
163369379|NCT01254747|590060757|FG000|Overall Study|Difficult removal handling|0|||
163369380|NCT01254747|590060758|FG001|Overall Study|Difficult removal handling|0|||
163369381|NCT01254747|590060759|FG002|Overall Study|Difficult removal handling|1|||
163369382|NCT01254747|590060760|FG003|Overall Study|Difficult removal handling|0|||
163369383|NCT01254747|590060757|FG000|Overall Study|Symptoms and problems|0|||
163369384|NCT01254747|590060758|FG001|Overall Study|Symptoms and problems|2|||
163369385|NCT01254747|590060759|FG002|Overall Study|Symptoms and problems|1|||
163369386|NCT01254747|590060760|FG003|Overall Study|Symptoms and problems|0|||
163369387|NCT01254747|590060757|FG000|Overall Study|Lost to Follow-up|0|||
163369388|NCT01254747|590060758|FG001|Overall Study|Lost to Follow-up|0|||
163369389|NCT01254747|590060759|FG002|Overall Study|Lost to Follow-up|1|||
163369390|NCT01254747|590060760|FG003|Overall Study|Lost to Follow-up|0|||
163369391|NCT01254747|590060757|FG000|Overall Study|Biomicroscopy|0|||
163369392|NCT01254747|590060758|FG001|Overall Study|Biomicroscopy|0|||
163369393|NCT01254747|590060759|FG002|Overall Study|Biomicroscopy|1|||
163369394|NCT01254747|590060760|FG003|Overall Study|Biomicroscopy|0|||
163369395|NCT01254747|590060757|FG000|Overall Study|Discomfort|0|||
163369396|NCT01254747|590060758|FG001|Overall Study|Discomfort|4|||
163369397|NCT01254747|590060759|FG002|Overall Study|Discomfort|0|||
163369398|NCT01254747|590060760|FG003|Overall Study|Discomfort|0|||
163369399|NCT02406677|590060761|FG000|Overall Study|Death|16|||
163369400|NCT02406677|590060762|FG001|Overall Study|Death|8|||
163369401|NCT02406677|590060761|FG000|Overall Study|Discharged without P2Y12|1|||
163369402|NCT02406677|590060762|FG001|Overall Study|Discharged without P2Y12|3|||
163369403|NCT02406677|590060761|FG000|Overall Study|Discharged on prasugrel|283|||
163369404|NCT02406677|590060762|FG001|Overall Study|Discharged on prasugrel|587|||
163369405|NCT02406677|590060761|FG000|Overall Study|Withdrawal by Subject|1|||
163369406|NCT02406677|590060762|FG001|Overall Study|Withdrawal by Subject|0|||
163369407|NCT04531098|590060767|FG000|Stage I|Adverse Event|0|||
163369408|NCT04531098|590060768|FG001|Stage I|Adverse Event|0|||
163369409|NCT04531098|590060769|FG002|Stage I|Adverse Event|3|||
163369410|NCT04531098|590060767|FG000|Stage I|Protocol Violation|0|||
163369411|NCT04531098|590060768|FG001|Stage I|Protocol Violation|0|||
163369412|NCT04531098|590060769|FG002|Stage I|Protocol Violation|5|||
163369413|NCT04531098|590060767|FG000|Stage I|Withdrawal by Subject|0|||
163369414|NCT04531098|590060768|FG001|Stage I|Withdrawal by Subject|5|||
163369415|NCT04531098|590060769|FG002|Stage I|Withdrawal by Subject|10|||
163369416|NCT04531098|590060767|FG000|Stage II|Adverse Event|1|||
163369417|NCT04531098|590060768|FG001|Stage II|Adverse Event|2|||
163369418|NCT04531098|590060769|FG002|Stage II|Adverse Event|0|||
163369419|NCT04531098|590060767|FG000|Stage II|Protocol Violation|1|||
163369420|NCT04531098|590060768|FG001|Stage II|Protocol Violation|2|||
163369421|NCT04531098|590060769|FG002|Stage II|Protocol Violation|0|||
163369422|NCT04531098|590060767|FG000|Stage II|Withdrawal by Subject|3|||
163369423|NCT04531098|590060768|FG001|Stage II|Withdrawal by Subject|1|||
163369424|NCT04531098|590060769|FG002|Stage II|Withdrawal by Subject|0|||
163369425|NCT04531098|590060767|FG000|Stage II|Moved from study area|8|||
163369426|NCT04531098|590060768|FG001|Stage II|Moved from study area|5|||
163369427|NCT04531098|590060769|FG002|Stage II|Moved from study area|0|||
163369428|NCT00095498|590062865|FG000|Overall Study|Physician Decision|9|||
163369429|NCT00095498|590062866|FG001|Overall Study|Physician Decision|10|||
163369430|NCT00095498|590062867|FG002|Overall Study|Physician Decision|8|||
163369431|NCT00095498|590062865|FG000|Overall Study|Adverse Event|1|||
163369432|NCT00095498|590062866|FG001|Overall Study|Adverse Event|0|||
163369433|NCT00095498|590062867|FG002|Overall Study|Adverse Event|1|||
163369434|NCT00095498|590062865|FG000|Overall Study|Withdrawal by Subject|15|||
163369435|NCT00095498|590062866|FG001|Overall Study|Withdrawal by Subject|16|||
163369436|NCT00095498|590062867|FG002|Overall Study|Withdrawal by Subject|15|||
163369437|NCT00095498|590062865|FG000|Overall Study|Disease progression|0|||
163369438|NCT00095498|590062866|FG001|Overall Study|Disease progression|1|||
163369439|NCT00095498|590062867|FG002|Overall Study|Disease progression|1|||
163369440|NCT00095498|590062865|FG000|Overall Study|Ineligibility determined|3|||
163369441|NCT00095498|590062866|FG001|Overall Study|Ineligibility determined|0|||
163369442|NCT00095498|590062867|FG002|Overall Study|Ineligibility determined|2|||
163369443|NCT00095498|590062865|FG000|Overall Study|Lost to Follow-up|1|||
163369444|NCT00095498|590062866|FG001|Overall Study|Lost to Follow-up|1|||
163369445|NCT00095498|590062867|FG002|Overall Study|Lost to Follow-up|2|||
163369446|NCT00095498|590062865|FG000|Overall Study|Noncompliance|1|||
163369447|NCT00095498|590062866|FG001|Overall Study|Noncompliance|0|||
163369448|NCT00095498|590062867|FG002|Overall Study|Noncompliance|1|||
163369449|NCT00095498|590062865|FG000|Overall Study|Other|6|||
163369450|NCT00095498|590062866|FG001|Overall Study|Other|7|||
163369451|NCT00095498|590062867|FG002|Overall Study|Other|6|||
163369452|NCT00095498|590062865|FG000|Overall Study|Protocol Violation|0|||
163369453|NCT00095498|590062866|FG001|Overall Study|Protocol Violation|0|||
163369454|NCT00095498|590062867|FG002|Overall Study|Protocol Violation|1|||
163369455|NCT00095498|590062865|FG000|Overall Study|Requirement for alternative therapy|1|||
163369456|NCT00095498|590062866|FG001|Overall Study|Requirement for alternative therapy|0|||
163369457|NCT00095498|590062867|FG002|Overall Study|Requirement for alternative therapy|2|||
163369458|NCT05020327|590062869|FG000|Overall Study|Physician Decision|3|||
163369459|NCT05020327|590062870|FG001|Overall Study|Physician Decision|0|||
163369460|NCT05020327|590062871|FG002|Overall Study|Physician Decision|0|||
163369461|NCT05020327|590062869|FG000|Overall Study|Withdrawal by Subject|1|||
163369462|NCT05020327|590062870|FG001|Overall Study|Withdrawal by Subject|1|||
163369463|NCT05020327|590062871|FG002|Overall Study|Withdrawal by Subject|0|||
163369464|NCT05020327|590062869|FG000|Overall Study|personal/cultural, ineligible|12|||
163369465|NCT05020327|590062870|FG001|Overall Study|personal/cultural, ineligible|0|||
163369466|NCT05020327|590062871|FG002|Overall Study|personal/cultural, ineligible|0|||
163369467|NCT03002220|590062873|FG000|Overall Study|Lack of Efficacy|2|||
163369468|NCT03002220|590062873|FG000|Overall Study|Withdrawal by Subject|3|||
163369469|NCT03002220|590062873|FG000|Overall Study|Adverse Event|2|||
163369470|NCT03002220|590062873|FG000|Overall Study|Disease progression|13|||
163369471|NCT03002220|590062873|FG000|Overall Study|Physician Decision|1|||
163369472|NCT01015560|590062874|FG000|Overall Study|Adverse Event|1|||
163369473|NCT01015560|590062874|FG000|Overall Study|Not protocol specified|1|||
163369474|NCT01015560|590062874|FG000|Overall Study|Withdrawal by Subject|1|||
163369475|NCT03439254|590062877|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
163369476|NCT03439254|590062878|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
163369477|NCT03439254|590062879|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
163369478|NCT03439254|590062880|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
163369479|NCT03439254|590062881|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
163369480|NCT03439254|590062882|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
163369481|NCT03439254|590062877|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
163369482|NCT03439254|590062878|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
163369483|NCT03439254|590062879|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
163369484|NCT03439254|590062880|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
163369485|NCT03439254|590062881|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
163369486|NCT03439254|590062882|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
163369487|NCT03439254|590062877|FG000|Double-blind Phase (18 Months)|Death|1|||
163369488|NCT03439254|590062878|FG001|Double-blind Phase (18 Months)|Death|2|||
163369489|NCT03439254|590062879|FG002|Double-blind Phase (18 Months)|Death|2|||
163369490|NCT03439254|590062880|FG003|Double-blind Phase (18 Months)|Death|0|||
163369491|NCT03439254|590062881|FG004|Double-blind Phase (18 Months)|Death|0|||
163369492|NCT03439254|590062882|FG005|Double-blind Phase (18 Months)|Death|0|||
163369493|NCT03439254|590062877|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
163369494|NCT03439254|590062878|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
163369495|NCT03439254|590062879|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
163369496|NCT03439254|590062880|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
163369497|NCT03439254|590062881|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
163369498|NCT03439254|590062882|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
163369499|NCT03439254|590062877|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
163369500|NCT03439254|590062878|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
163369501|NCT03439254|590062879|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
163369502|NCT03439254|590062880|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
163369503|NCT03439254|590062881|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
163369504|NCT03439254|590062882|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
163369505|NCT03439254|590062877|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
163369506|NCT03439254|590062878|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
163369507|NCT03439254|590062879|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
163369508|NCT03439254|590062880|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
163369509|NCT03439254|590062881|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
163369510|NCT03439254|590062882|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
163369511|NCT03439254|590062877|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
163369512|NCT03439254|590062878|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
163369513|NCT03439254|590062879|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
163369514|NCT03439254|590062880|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
163369515|NCT03439254|590062881|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
163369516|NCT03439254|590062882|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
163369517|NCT03439254|590062877|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
163369518|NCT03439254|590062878|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
163369519|NCT03439254|590062879|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
163369520|NCT03439254|590062880|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
163369521|NCT03439254|590062881|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
163369522|NCT03439254|590062882|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
163369523|NCT03439254|590062877|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
163369524|NCT03439254|590062878|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
163369525|NCT03439254|590062879|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
163369526|NCT03439254|590062880|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
163369527|NCT03439254|590062881|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
163369528|NCT03439254|590062882|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
163369529|NCT03439254|590062877|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
163369530|NCT03439254|590062878|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
163369531|NCT03439254|590062879|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
163369532|NCT03439254|590062880|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
163369533|NCT03439254|590062881|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
163369534|NCT03439254|590062882|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
163369535|NCT03439254|590062877|FG000|Double-blind Phase (18 Months)|Site closure|0|||
163369536|NCT03439254|590062878|FG001|Double-blind Phase (18 Months)|Site closure|0|||
163369537|NCT03439254|590062879|FG002|Double-blind Phase (18 Months)|Site closure|1|||
163369538|NCT03439254|590062880|FG003|Double-blind Phase (18 Months)|Site closure|0|||
163369539|NCT03439254|590062881|FG004|Double-blind Phase (18 Months)|Site closure|0|||
163369540|NCT03439254|590062882|FG005|Double-blind Phase (18 Months)|Site closure|0|||
163369541|NCT03439254|590062877|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
163369542|NCT03439254|590062878|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
163369543|NCT03439254|590062879|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
163369544|NCT03439254|590062880|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
163369545|NCT03439254|590062881|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
163369546|NCT03439254|590062882|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
163369547|NCT03439254|590062877|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
163369548|NCT03439254|590062878|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
163369549|NCT03439254|590062879|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
163369550|NCT03439254|590062880|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
163369551|NCT03439254|590062881|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
163369552|NCT03439254|590062882|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
163369553|NCT03439254|590062877|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
163369554|NCT03439254|590062878|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
163369555|NCT03439254|590062879|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
163369556|NCT03439254|590062880|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
163369557|NCT03439254|590062881|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
163369558|NCT03439254|590062882|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
163369559|NCT03439254|590062877|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
163369560|NCT03439254|590062878|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
163369561|NCT03439254|590062879|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
163369562|NCT03439254|590062880|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
163369563|NCT03439254|590062881|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
163369564|NCT03439254|590062882|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
163369565|NCT03439254|590062877|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
163369566|NCT03439254|590062878|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
163369567|NCT03439254|590062879|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
163369568|NCT03439254|590062880|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
163369569|NCT03439254|590062881|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
163369570|NCT03439254|590062882|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
163369571|NCT03439254|590062877|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
163369572|NCT03439254|590062878|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
163369573|NCT03439254|590062879|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
163369574|NCT03439254|590062880|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
163369575|NCT03439254|590062881|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
163369576|NCT03439254|590062882|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
163369577|NCT03439254|590062877|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
163369578|NCT03439254|590062878|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
163369579|NCT03439254|590062879|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
163369580|NCT03439254|590062880|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
163369581|NCT03439254|590062881|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
163369582|NCT03439254|590062882|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
163369583|NCT03439254|590062877|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
163369584|NCT03439254|590062878|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
163369585|NCT03439254|590062879|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
163369586|NCT03439254|590062880|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
163369587|NCT03439254|590062881|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
163369588|NCT03439254|590062882|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
163369589|NCT03439254|590062877|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
163369590|NCT03439254|590062878|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
163369591|NCT03439254|590062879|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
163369592|NCT03439254|590062880|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
163369593|NCT03439254|590062881|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
163369594|NCT03439254|590062882|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
163369595|NCT03439254|590062877|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
163369596|NCT03439254|590062878|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
163369597|NCT03439254|590062879|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
163369598|NCT03439254|590062880|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
163369599|NCT03439254|590062881|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
163369600|NCT03439254|590062882|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
163369601|NCT03439254|590062877|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
163369602|NCT03439254|590062878|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
163369603|NCT03439254|590062879|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
163369604|NCT03439254|590062880|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
163369605|NCT03439254|590062881|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
163369606|NCT03439254|590062882|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
163369607|NCT03439254|590062877|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
163369608|NCT03439254|590062878|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
163369609|NCT03439254|590062879|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
163369610|NCT03439254|590062880|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
163369611|NCT03439254|590062881|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
163369612|NCT03439254|590062882|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
163369613|NCT00128102|590062885|FG000|Overall Study|Site Discontinued|3|||
163369614|NCT00128102|590062886|FG001|Overall Study|Site Discontinued|6|||
163369615|NCT00128102|590062885|FG000|Overall Study|Other|0|||
163369616|NCT00128102|590062886|FG001|Overall Study|Other|1|||
163369617|NCT00128102|590062885|FG000|Overall Study|Progressive Disease|255|||
163369618|NCT00128102|590062886|FG001|Overall Study|Progressive Disease|285|||
163369619|NCT00128102|590062885|FG000|Overall Study|Adverse Event|34|||
163369620|NCT00128102|590062886|FG001|Overall Study|Adverse Event|11|||
163369621|NCT00128102|590062885|FG000|Overall Study|Death|12|||
163413278|NCT00939692|590220906|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
163413279|NCT00939692|590220907|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
163413280|NCT01081795|590220908|FG000|Overall Study|Adverse Event|18|||
163413281|NCT01081795|590220909|FG001|Overall Study|Adverse Event|23|||
163413282|NCT01081795|590220910|FG002|Overall Study|Adverse Event|6|||
163413283|NCT01081795|590220908|FG000|Overall Study|Lack of Efficacy|7|||
163413284|NCT01081795|590220909|FG001|Overall Study|Lack of Efficacy|5|||
163413285|NCT01081795|590220910|FG002|Overall Study|Lack of Efficacy|19|||
163413286|NCT01081795|590220908|FG000|Overall Study|Subject's schedule|1|||
163413287|NCT01081795|590220909|FG001|Overall Study|Subject's schedule|1|||
163413288|NCT01081795|590220910|FG002|Overall Study|Subject's schedule|2|||
163369622|NCT00128102|590062886|FG001|Overall Study|Death|13|||
163369623|NCT00128102|590062885|FG000|Overall Study|Physician Decision|3|||
163369624|NCT00128102|590062886|FG001|Overall Study|Physician Decision|3|||
163369625|NCT00128102|590062885|FG000|Overall Study|Withdrawal by Subject|19|||
163369626|NCT00128102|590062886|FG001|Overall Study|Withdrawal by Subject|11|||
163369627|NCT00128102|590062885|FG000|Overall Study|Protocol Violation|2|||
163369628|NCT00128102|590062886|FG001|Overall Study|Protocol Violation|2|||
163369629|NCT01008410|590062892|FG000|Overall Study|Adverse Event|13|||
163369630|NCT01008410|590062893|FG001|Overall Study|Adverse Event|7|||
163369631|NCT01008410|590062892|FG000|Overall Study|Withdrawal by Subject|6|||
163369632|NCT01008410|590062893|FG001|Overall Study|Withdrawal by Subject|2|||
163369633|NCT01008410|590062892|FG000|Overall Study|Lost to Follow-up|1|||
163369634|NCT01008410|590062893|FG001|Overall Study|Lost to Follow-up|0|||
163369635|NCT01008410|590062892|FG000|Overall Study|Noncompliance|1|||
163369636|NCT01008410|590062893|FG001|Overall Study|Noncompliance|0|||
163369637|NCT01008410|590062892|FG000|Overall Study|Low Cortisol|2|||
163369638|NCT01008410|590062893|FG001|Overall Study|Low Cortisol|0|||
163369639|NCT01008410|590062892|FG000|Overall Study|Lack of Efficacy|2|||
163369640|NCT01008410|590062893|FG001|Overall Study|Lack of Efficacy|6|||
163369641|NCT01008410|590062892|FG000|Overall Study|Met Exclusion Criterion|0|||
163369642|NCT01008410|590062893|FG001|Overall Study|Met Exclusion Criterion|1|||
163369643|NCT00297427|590062896|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
163369644|NCT00297427|590062897|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
163369645|NCT00297427|590062896|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
163369646|NCT00297427|590062897|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
163369647|NCT00297427|590062896|FG000|Phase 1: Initial Intervention|Death|0|||
163369648|NCT00297427|590062897|FG001|Phase 1: Initial Intervention|Death|1|||
163369649|NCT00297427|590062896|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
163369650|NCT00297427|590062897|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
163369651|NCT00297427|590062896|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
163369652|NCT00297427|590062897|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
163369653|NCT00297427|590062896|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
163369654|NCT00297427|590062897|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
163369655|NCT00297427|590062896|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
163369656|NCT00297427|590062897|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
163369657|NCT00297427|590062896|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
163369658|NCT00297427|590062897|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
163369659|NCT01127893|590062898|FG000|Overall Study|Study Termination by the Sponsor|1|||
163369660|NCT01262677|590062899|FG000|Overall Study|Does not meet entrance criteria|0|||
163369661|NCT01262677|590062900|FG001|Overall Study|Does not meet entrance criteria|2|||
163369662|NCT01262677|590062901|FG002|Overall Study|Does not meet entrance criteria|0|||
163369663|NCT01262677|590062899|FG000|Overall Study|Insufficient clinical response|0|||
163369664|NCT01262677|590062900|FG001|Overall Study|Insufficient clinical response|0|||
163369665|NCT01262677|590062901|FG002|Overall Study|Insufficient clinical response|1|||
163369666|NCT01262677|590062899|FG000|Overall Study|Lost to Follow-up|1|||
163413289|NCT01081795|590220908|FG000|Overall Study|Revocation of informed consent|2|||
163369667|NCT01262677|590062900|FG001|Overall Study|Lost to Follow-up|0|||
163413290|NCT01081795|590220909|FG001|Overall Study|Revocation of informed consent|0|||
163413291|NCT01081795|590220910|FG002|Overall Study|Revocation of informed consent|0|||
163413292|NCT01081795|590220908|FG000|Overall Study|Ineligible for participation|1|||
163413293|NCT01081795|590220909|FG001|Overall Study|Ineligible for participation|0|||
163369668|NCT01262677|590062901|FG002|Overall Study|Lost to Follow-up|2|||
163369669|NCT01262677|590062899|FG000|Overall Study|No longer willing to participate|3|||
163369670|NCT01262677|590062900|FG001|Overall Study|No longer willing to participate|3|||
163413294|NCT01081795|590220910|FG002|Overall Study|Ineligible for participation|0|||
163369671|NCT01262677|590062901|FG002|Overall Study|No longer willing to participate|2|||
163369672|NCT01262677|590062899|FG000|Overall Study|Reason not provided|2|||
163369673|NCT01262677|590062900|FG001|Overall Study|Reason not provided|1|||
163369674|NCT01262677|590062901|FG002|Overall Study|Reason not provided|3|||
163369675|NCT01262677|590062899|FG000|Overall Study|Protocol Violation|0|||
163369676|NCT01262677|590062900|FG001|Overall Study|Protocol Violation|1|||
163369677|NCT01262677|590062901|FG002|Overall Study|Protocol Violation|1|||
163369678|NCT01262677|590062899|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
163369679|NCT01262677|590062900|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
163369680|NCT01262677|590062901|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
163369681|NCT00574873|590062902|FG000|Overall Study|Withdrawal by Subject|18|||
163369682|NCT00574873|590062903|FG001|Overall Study|Withdrawal by Subject|19|||
163369683|NCT00574873|590062902|FG000|Overall Study|Investigator request|18|||
163369684|NCT00574873|590062903|FG001|Overall Study|Investigator request|8|||
163369685|NCT00574873|590062902|FG000|Overall Study|Death|15|||
163369686|NCT00574873|590062903|FG001|Overall Study|Death|14|||
163369687|NCT00574873|590062902|FG000|Overall Study|Lost to Follow-up|14|||
163369688|NCT00574873|590062903|FG001|Overall Study|Lost to Follow-up|5|||
163369689|NCT00574873|590062902|FG000|Overall Study|Other|40|||
163369690|NCT00574873|590062903|FG001|Overall Study|Other|4|||
163369691|NCT00574873|590062902|FG000|Overall Study|Discontinuation of study by sponsor|5|||
163369692|NCT00574873|590062903|FG001|Overall Study|Discontinuation of study by sponsor|199|||
163369693|NCT00574873|590062902|FG000|Overall Study|Blank, site closed per local regulations|2|||
163369694|NCT00574873|590062903|FG001|Overall Study|Blank, site closed per local regulations|2|||
163369695|NCT00574873|590062902|FG000|Overall Study|Extension Study|126|||
163369696|NCT00574873|590062903|FG001|Overall Study|Extension Study|0|||
163369697|NCT03889704|590062905|FG000|Overall Study|Study terminated due to pandemic|1|||
163369698|NCT04552899|590062908|FG000|Overall Study|Adverse Event|4|||
163369699|NCT04552899|590062909|FG001|Overall Study|Adverse Event|3|||
163369700|NCT04552899|590062908|FG000|Overall Study|Death|4|||
163369701|NCT04552899|590062909|FG001|Overall Study|Death|4|||
163369702|NCT04552899|590062908|FG000|Overall Study|Lost to Follow-up|8|||
163369703|NCT04552899|590062909|FG001|Overall Study|Lost to Follow-up|13|||
163369704|NCT04552899|590062908|FG000|Overall Study|Lung Transplant|4|||
163369705|NCT04552899|590062909|FG001|Overall Study|Lung Transplant|3|||
163369706|NCT04552899|590062908|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
163369707|NCT04552899|590062909|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
163369708|NCT04552899|590062908|FG000|Overall Study|Physician Decision|3|||
163369709|NCT04552899|590062909|FG001|Overall Study|Physician Decision|4|||
163369710|NCT04552899|590062908|FG000|Overall Study|Study Terminated By Sponsor|237|||
163369711|NCT04552899|590062909|FG001|Overall Study|Study Terminated By Sponsor|239|||
163369712|NCT04552899|590062908|FG000|Overall Study|Withdrawal by Subject|15|||
163369713|NCT04552899|590062909|FG001|Overall Study|Withdrawal by Subject|17|||
163369714|NCT02591953|590062912|FG000|Overall Study|Lost to Follow-up|6|||
163369715|NCT02591953|590062913|FG001|Overall Study|Lost to Follow-up|6|||
163369716|NCT00461981|590062914|FG000|Overall Study|Lost to Follow-up|9|||
163369717|NCT00461981|590062915|FG001|Overall Study|Lost to Follow-up|6|||
163369718|NCT00461981|590062914|FG000|Overall Study|Withdrawal by Subject|2|||
163369719|NCT00461981|590062915|FG001|Overall Study|Withdrawal by Subject|3|||
163369720|NCT02060370|590062916|FG000|Overall Study|Physician Decision|1|||
163369721|NCT00731133|590062919|FG000|Overall Study|Withdrawal by Subject|10|||
163369722|NCT00943852|590062920|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163369723|NCT00943852|590062921|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163369724|NCT00943852|590062922|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163369725|NCT00943852|590062923|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
163369726|NCT00943852|590062924|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163369727|NCT00943852|590062925|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163369728|NCT00943852|590062926|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163369729|NCT00943852|590062927|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163369730|NCT00943852|590062928|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163369731|NCT00943852|590062929|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163369732|NCT00943852|590062920|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163369733|NCT00943852|590062921|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163369734|NCT00943852|590062922|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163369735|NCT00943852|590062923|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163369736|NCT00943852|590062924|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163369737|NCT00943852|590062925|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
163369738|NCT00943852|590062926|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163369739|NCT00943852|590062927|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163369740|NCT00943852|590062928|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163369741|NCT00943852|590062929|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163369742|NCT00943852|590062920|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163369743|NCT00943852|590062921|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163369744|NCT00943852|590062922|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163369745|NCT00943852|590062923|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163369746|NCT00943852|590062924|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163369747|NCT00943852|590062925|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163369748|NCT00943852|590062926|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
163369749|NCT00943852|590062927|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163369750|NCT00943852|590062928|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163369751|NCT00943852|590062929|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163369752|NCT00943852|590062920|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163369753|NCT00943852|590062921|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163369754|NCT00943852|590062922|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163369755|NCT00943852|590062923|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163369756|NCT00943852|590062924|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163369757|NCT00943852|590062925|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163369758|NCT00943852|590062926|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163369759|NCT00943852|590062927|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
163369760|NCT00943852|590062928|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163369761|NCT00943852|590062929|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163369762|NCT00943852|590062920|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
163369763|NCT00943852|590062921|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
163369764|NCT00943852|590062922|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
163369765|NCT00943852|590062923|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
163369766|NCT00943852|590062924|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
163369767|NCT00943852|590062925|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
163369768|NCT00943852|590062926|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
163369769|NCT00943852|590062927|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
163369770|NCT00943852|590062928|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
163369771|NCT00943852|590062929|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
163369772|NCT02672852|590062934|FG000|Part A1|Disease Worsening|1|||
163369773|NCT02672852|590062935|FG001|Part A1|Disease Worsening|0|||
163369774|NCT02672852|590062936|FG002|Part A1|Disease Worsening|0|||
163369775|NCT02672852|590062937|FG003|Part A1|Disease Worsening|0|||
163369776|NCT02672852|590062938|FG004|Part A1|Disease Worsening|0|||
163369777|NCT02672852|590062939|FG005|Part A1|Disease Worsening|0|||
163369778|NCT02672852|590062940|FG006|Part A1|Disease Worsening|0|||
163369779|NCT02672852|590062934|FG000|Part A1|Adverse Event|0|||
163369780|NCT02672852|590062935|FG001|Part A1|Adverse Event|1|||
163369781|NCT02672852|590062936|FG002|Part A1|Adverse Event|0|||
163369782|NCT02672852|590062937|FG003|Part A1|Adverse Event|0|||
163369783|NCT02672852|590062938|FG004|Part A1|Adverse Event|0|||
163369784|NCT02672852|590062939|FG005|Part A1|Adverse Event|0|||
163369785|NCT02672852|590062940|FG006|Part A1|Adverse Event|0|||
163369786|NCT02672852|590062934|FG000|Part A1|Lost to Follow-up|1|||
163369787|NCT02672852|590062935|FG001|Part A1|Lost to Follow-up|2|||
163369788|NCT02672852|590062936|FG002|Part A1|Lost to Follow-up|0|||
163369789|NCT02672852|590062937|FG003|Part A1|Lost to Follow-up|0|||
163369790|NCT02672852|590062938|FG004|Part A1|Lost to Follow-up|0|||
163369791|NCT02672852|590062939|FG005|Part A1|Lost to Follow-up|0|||
163369792|NCT02672852|590062940|FG006|Part A1|Lost to Follow-up|0|||
163369793|NCT02672852|590062934|FG000|Part A1|Withdrawal by Subject|1|||
163369794|NCT02672852|590062935|FG001|Part A1|Withdrawal by Subject|1|||
163369795|NCT02672852|590062936|FG002|Part A1|Withdrawal by Subject|0|||
163369796|NCT02672852|590062937|FG003|Part A1|Withdrawal by Subject|0|||
163369797|NCT02672852|590062938|FG004|Part A1|Withdrawal by Subject|0|||
163369798|NCT02672852|590062939|FG005|Part A1|Withdrawal by Subject|0|||
163369799|NCT02672852|590062940|FG006|Part A1|Withdrawal by Subject|0|||
163369800|NCT02672852|590062934|FG000|Part A2|Disease worsening|0|||
163369801|NCT02672852|590062935|FG001|Part A2|Disease worsening|0|||
163369802|NCT02672852|590062936|FG002|Part A2|Disease worsening|1|||
163369803|NCT02672852|590062937|FG003|Part A2|Disease worsening|0|||
163369804|NCT02672852|590062938|FG004|Part A2|Disease worsening|0|||
163369805|NCT02672852|590062939|FG005|Part A2|Disease worsening|0|||
163369806|NCT02672852|590062940|FG006|Part A2|Disease worsening|0|||
163369807|NCT02672852|590062934|FG000|Part A2|Adverse Event|0|||
163369808|NCT02672852|590062935|FG001|Part A2|Adverse Event|0|||
163369809|NCT02672852|590062936|FG002|Part A2|Adverse Event|3|||
163369810|NCT02672852|590062937|FG003|Part A2|Adverse Event|0|||
163369811|NCT02672852|590062938|FG004|Part A2|Adverse Event|0|||
163369812|NCT02672852|590062939|FG005|Part A2|Adverse Event|0|||
163369813|NCT02672852|590062940|FG006|Part A2|Adverse Event|0|||
163369814|NCT02672852|590062934|FG000|Part A2|Lost to Follow-up|0|||
163369815|NCT02672852|590062935|FG001|Part A2|Lost to Follow-up|0|||
163369816|NCT02672852|590062936|FG002|Part A2|Lost to Follow-up|2|||
163369817|NCT02672852|590062937|FG003|Part A2|Lost to Follow-up|0|||
163369818|NCT02672852|590062938|FG004|Part A2|Lost to Follow-up|0|||
163369819|NCT02672852|590062939|FG005|Part A2|Lost to Follow-up|0|||
163369820|NCT02672852|590062940|FG006|Part A2|Lost to Follow-up|0|||
163369821|NCT02672852|590062934|FG000|Part A2|Withdrawal by Subject|0|||
163369822|NCT02672852|590062935|FG001|Part A2|Withdrawal by Subject|0|||
163369823|NCT02672852|590062936|FG002|Part A2|Withdrawal by Subject|1|||
163369824|NCT02672852|590062937|FG003|Part A2|Withdrawal by Subject|0|||
163369825|NCT02672852|590062938|FG004|Part A2|Withdrawal by Subject|0|||
163369826|NCT02672852|590062939|FG005|Part A2|Withdrawal by Subject|0|||
163369827|NCT02672852|590062940|FG006|Part A2|Withdrawal by Subject|0|||
163369828|NCT02672852|590062934|FG000|Part A2|Other|0|||
163369829|NCT02672852|590062935|FG001|Part A2|Other|0|||
163369830|NCT02672852|590062936|FG002|Part A2|Other|3|||
163369831|NCT02672852|590062937|FG003|Part A2|Other|0|||
163369832|NCT02672852|590062938|FG004|Part A2|Other|0|||
163369833|NCT02672852|590062939|FG005|Part A2|Other|0|||
163369834|NCT02672852|590062940|FG006|Part A2|Other|0|||
163369835|NCT02672852|590062934|FG000|Part A2|Not entered in Part B|0|||
163369836|NCT02672852|590062935|FG001|Part A2|Not entered in Part B|0|||
163369837|NCT02672852|590062936|FG002|Part A2|Not entered in Part B|0|||
163369838|NCT02672852|590062937|FG003|Part A2|Not entered in Part B|4|||
163369839|NCT02672852|590062938|FG004|Part A2|Not entered in Part B|0|||
163369840|NCT02672852|590062939|FG005|Part A2|Not entered in Part B|0|||
163369841|NCT02672852|590062940|FG006|Part A2|Not entered in Part B|0|||
163369842|NCT02672852|590062934|FG000|Part B|Disease worsening|0|||
163369843|NCT02672852|590062935|FG001|Part B|Disease worsening|0|||
163369844|NCT02672852|590062936|FG002|Part B|Disease worsening|0|||
163369845|NCT02672852|590062937|FG003|Part B|Disease worsening|0|||
163369846|NCT02672852|590062938|FG004|Part B|Disease worsening|1|||
163369847|NCT02672852|590062939|FG005|Part B|Disease worsening|0|||
163369848|NCT02672852|590062940|FG006|Part B|Disease worsening|1|||
163369849|NCT02672852|590062934|FG000|Part B|Worsening pre-existing condition|0|||
163369850|NCT02672852|590062935|FG001|Part B|Worsening pre-existing condition|0|||
163369851|NCT02672852|590062936|FG002|Part B|Worsening pre-existing condition|0|||
163369852|NCT02672852|590062937|FG003|Part B|Worsening pre-existing condition|0|||
163369853|NCT02672852|590062938|FG004|Part B|Worsening pre-existing condition|0|||
163369854|NCT02672852|590062939|FG005|Part B|Worsening pre-existing condition|1|||
163369855|NCT02672852|590062940|FG006|Part B|Worsening pre-existing condition|0|||
163369856|NCT02672852|590062934|FG000|Part B|Other adverse event|0|||
163369857|NCT02672852|590062935|FG001|Part B|Other adverse event|0|||
163369858|NCT02672852|590062936|FG002|Part B|Other adverse event|0|||
163369859|NCT02672852|590062937|FG003|Part B|Other adverse event|0|||
163369860|NCT02672852|590062938|FG004|Part B|Other adverse event|3|||
163369861|NCT02672852|590062939|FG005|Part B|Other adverse event|5|||
163369862|NCT02672852|590062940|FG006|Part B|Other adverse event|1|||
163369863|NCT02672852|590062934|FG000|Part B|Lost to Follow-up|0|||
163369864|NCT02672852|590062935|FG001|Part B|Lost to Follow-up|0|||
163369865|NCT02672852|590062936|FG002|Part B|Lost to Follow-up|0|||
163369866|NCT02672852|590062937|FG003|Part B|Lost to Follow-up|0|||
163369867|NCT02672852|590062938|FG004|Part B|Lost to Follow-up|3|||
163369868|NCT02672852|590062939|FG005|Part B|Lost to Follow-up|4|||
163369869|NCT02672852|590062940|FG006|Part B|Lost to Follow-up|1|||
163369870|NCT02672852|590062934|FG000|Part B|Withdrawal by Subject|0|||
163369871|NCT02672852|590062935|FG001|Part B|Withdrawal by Subject|0|||
163369872|NCT02672852|590062936|FG002|Part B|Withdrawal by Subject|0|||
163369873|NCT02672852|590062937|FG003|Part B|Withdrawal by Subject|0|||
163369874|NCT02672852|590062938|FG004|Part B|Withdrawal by Subject|5|||
163369875|NCT02672852|590062939|FG005|Part B|Withdrawal by Subject|0|||
163369876|NCT02672852|590062940|FG006|Part B|Withdrawal by Subject|7|||
163369877|NCT02672852|590062934|FG000|Part B|Other|0|||
163369878|NCT02672852|590062935|FG001|Part B|Other|0|||
163369879|NCT02672852|590062936|FG002|Part B|Other|0|||
163369880|NCT02672852|590062937|FG003|Part B|Other|0|||
163369881|NCT02672852|590062938|FG004|Part B|Other|4|||
163369882|NCT02672852|590062939|FG005|Part B|Other|1|||
163369883|NCT02672852|590062940|FG006|Part B|Other|2|||
163369884|NCT01725126|590062943|FG000|Overall Study|Protocol Violation|0|||
163369885|NCT01725126|590062944|FG001|Overall Study|Protocol Violation|1|||
163369886|NCT01725126|590062945|FG002|Overall Study|Protocol Violation|0|||
163369887|NCT01725126|590062946|FG003|Overall Study|Protocol Violation|0|||
163369888|NCT01725126|590062947|FG004|Overall Study|Protocol Violation|0|||
163369889|NCT01725126|590062948|FG005|Overall Study|Protocol Violation|0|||
163369890|NCT01725126|590062943|FG000|Overall Study|Withdrawal by Subject|0|||
163369891|NCT01725126|590062944|FG001|Overall Study|Withdrawal by Subject|0|||
163369892|NCT01725126|590062945|FG002|Overall Study|Withdrawal by Subject|0|||
163369893|NCT01725126|590062946|FG003|Overall Study|Withdrawal by Subject|1|||
163369894|NCT01725126|590062947|FG004|Overall Study|Withdrawal by Subject|0|||
163369895|NCT01725126|590062948|FG005|Overall Study|Withdrawal by Subject|0|||
163369896|NCT02636725|590062949|FG000|Overall Study|Adverse Event|1|||
163369897|NCT04462289|590062954|FG000|Overall Study|Lost to Follow-up|4|||
163369898|NCT04462289|590062955|FG001|Overall Study|Lost to Follow-up|5|||
163369899|NCT04462289|590062954|FG000|Overall Study|Death|0|||
163369900|NCT04462289|590062955|FG001|Overall Study|Death|3|||
163369901|NCT04462289|590062954|FG000|Overall Study|Withdrawal by Subject|1|||
163369902|NCT04462289|590062955|FG001|Overall Study|Withdrawal by Subject|3|||
163369903|NCT01518153|590062956|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
163369904|NCT01518153|590062957|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
163369905|NCT01518153|590062958|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
163369906|NCT01518153|590062956|FG000|Stem Cell Transplant|Death|2|||
163369907|NCT01518153|590062957|FG001|Stem Cell Transplant|Death|0|||
163369908|NCT01518153|590062958|FG002|Stem Cell Transplant|Death|0|||
163369909|NCT01518153|590062956|FG000|Stem Cell Transplant|Secondary graft failure|1|||
163369910|NCT01518153|590062957|FG001|Stem Cell Transplant|Secondary graft failure|0|||
163369911|NCT01518153|590062958|FG002|Stem Cell Transplant|Secondary graft failure|0|||
163369912|NCT01518153|590062956|FG000|Stem Cell Transplant|Adverse Event|1|||
163369913|NCT01518153|590062957|FG001|Stem Cell Transplant|Adverse Event|0|||
163369914|NCT01518153|590062958|FG002|Stem Cell Transplant|Adverse Event|0|||
163369915|NCT01518153|590062956|FG000|Donor Lymphocyte Infusion|Death|0|||
163369916|NCT01518153|590062957|FG001|Donor Lymphocyte Infusion|Death|2|||
163369917|NCT01518153|590062958|FG002|Donor Lymphocyte Infusion|Death|1|||
163369918|NCT02145468|590062965|FG000|Overall Study|Withdrawal by Subject|5|||
163369919|NCT02145468|590062966|FG001|Overall Study|Withdrawal by Subject|8|||
163369920|NCT01803282|590062970|FG000|Overall Study|Progressive Disease|4|||
163369921|NCT01803282|590062971|FG001|Overall Study|Progressive Disease|3|||
163369922|NCT01803282|590062972|FG002|Overall Study|Progressive Disease|6|||
163369923|NCT01803282|590062973|FG003|Overall Study|Progressive Disease|22|||
163369924|NCT01803282|590062974|FG004|Overall Study|Progressive Disease|5|||
163369925|NCT01803282|590062975|FG005|Overall Study|Progressive Disease|8|||
163369926|NCT01803282|590062976|FG006|Overall Study|Progressive Disease|23|||
163369927|NCT01803282|590062977|FG007|Overall Study|Progressive Disease|24|||
163369928|NCT01803282|590062978|FG008|Overall Study|Progressive Disease|3|||
163369929|NCT01803282|590062979|FG009|Overall Study|Progressive Disease|29|||
163369930|NCT01803282|590062980|FG010|Overall Study|Progressive Disease|6|||
163369931|NCT01803282|590062981|FG011|Overall Study|Progressive Disease|11|||
163369932|NCT01803282|590062970|FG000|Overall Study|Death|0|||
163369933|NCT01803282|590062971|FG001|Overall Study|Death|0|||
163369934|NCT01803282|590062972|FG002|Overall Study|Death|0|||
163369935|NCT01803282|590062973|FG003|Overall Study|Death|0|||
163369936|NCT01803282|590062974|FG004|Overall Study|Death|2|||
163369937|NCT01803282|590062975|FG005|Overall Study|Death|1|||
163369938|NCT01803282|590062976|FG006|Overall Study|Death|1|||
163369939|NCT01803282|590062977|FG007|Overall Study|Death|5|||
163369940|NCT01803282|590062978|FG008|Overall Study|Death|1|||
163369941|NCT01803282|590062979|FG009|Overall Study|Death|1|||
163369942|NCT01803282|590062980|FG010|Overall Study|Death|0|||
163369943|NCT01803282|590062981|FG011|Overall Study|Death|0|||
163369944|NCT01803282|590062970|FG000|Overall Study|Withdrew Consent|0|||
163369945|NCT01803282|590062971|FG001|Overall Study|Withdrew Consent|0|||
163369946|NCT01803282|590062972|FG002|Overall Study|Withdrew Consent|0|||
163369947|NCT01803282|590062973|FG003|Overall Study|Withdrew Consent|6|||
163369948|NCT01803282|590062974|FG004|Overall Study|Withdrew Consent|1|||
163369949|NCT01803282|590062975|FG005|Overall Study|Withdrew Consent|0|||
163369950|NCT01803282|590062976|FG006|Overall Study|Withdrew Consent|8|||
163369951|NCT01803282|590062977|FG007|Overall Study|Withdrew Consent|3|||
163369952|NCT01803282|590062978|FG008|Overall Study|Withdrew Consent|1|||
163369953|NCT01803282|590062979|FG009|Overall Study|Withdrew Consent|5|||
163369954|NCT01803282|590062980|FG010|Overall Study|Withdrew Consent|0|||
163369955|NCT01803282|590062981|FG011|Overall Study|Withdrew Consent|1|||
163369956|NCT01803282|590062970|FG000|Overall Study|Investigator's Discretion|0|||
163369957|NCT01803282|590062971|FG001|Overall Study|Investigator's Discretion|0|||
163369958|NCT01803282|590062972|FG002|Overall Study|Investigator's Discretion|0|||
163369959|NCT01803282|590062973|FG003|Overall Study|Investigator's Discretion|7|||
163369960|NCT01803282|590062974|FG004|Overall Study|Investigator's Discretion|2|||
163369961|NCT01803282|590062975|FG005|Overall Study|Investigator's Discretion|1|||
163369962|NCT01803282|590062976|FG006|Overall Study|Investigator's Discretion|7|||
163369963|NCT01803282|590062977|FG007|Overall Study|Investigator's Discretion|10|||
163369964|NCT01803282|590062978|FG008|Overall Study|Investigator's Discretion|6|||
163369965|NCT01803282|590062979|FG009|Overall Study|Investigator's Discretion|7|||
163369966|NCT01803282|590062980|FG010|Overall Study|Investigator's Discretion|1|||
163369967|NCT01803282|590062981|FG011|Overall Study|Investigator's Discretion|0|||
163369968|NCT01803282|590062970|FG000|Overall Study|Adverse Event|0|||
163369969|NCT01803282|590062971|FG001|Overall Study|Adverse Event|0|||
163369970|NCT01803282|590062972|FG002|Overall Study|Adverse Event|0|||
163369971|NCT01803282|590062973|FG003|Overall Study|Adverse Event|0|||
163369972|NCT01803282|590062974|FG004|Overall Study|Adverse Event|0|||
163369973|NCT01803282|590062975|FG005|Overall Study|Adverse Event|0|||
163369974|NCT01803282|590062976|FG006|Overall Study|Adverse Event|1|||
163369975|NCT01803282|590062977|FG007|Overall Study|Adverse Event|2|||
163369976|NCT01803282|590062978|FG008|Overall Study|Adverse Event|0|||
163369977|NCT01803282|590062979|FG009|Overall Study|Adverse Event|1|||
163369978|NCT01803282|590062980|FG010|Overall Study|Adverse Event|0|||
163369979|NCT01803282|590062981|FG011|Overall Study|Adverse Event|3|||
163369980|NCT01803282|590062970|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163369981|NCT01803282|590062971|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163369982|NCT01803282|590062972|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163369983|NCT01803282|590062973|FG003|Overall Study|Non-Compliance with Study Drug|1|||
163369984|NCT01803282|590062974|FG004|Overall Study|Non-Compliance with Study Drug|0|||
163369985|NCT01803282|590062975|FG005|Overall Study|Non-Compliance with Study Drug|0|||
163369986|NCT01803282|590062976|FG006|Overall Study|Non-Compliance with Study Drug|0|||
163369987|NCT01803282|590062977|FG007|Overall Study|Non-Compliance with Study Drug|0|||
163369988|NCT01803282|590062978|FG008|Overall Study|Non-Compliance with Study Drug|0|||
163369989|NCT01803282|590062979|FG009|Overall Study|Non-Compliance with Study Drug|0|||
163369990|NCT01803282|590062980|FG010|Overall Study|Non-Compliance with Study Drug|0|||
163369991|NCT01803282|590062981|FG011|Overall Study|Non-Compliance with Study Drug|0|||
163369992|NCT01803282|590062970|FG000|Overall Study|Unknown Reason|0|||
163369993|NCT01803282|590062971|FG001|Overall Study|Unknown Reason|0|||
163369994|NCT01803282|590062972|FG002|Overall Study|Unknown Reason|0|||
163369995|NCT01803282|590062973|FG003|Overall Study|Unknown Reason|0|||
163369996|NCT01803282|590062974|FG004|Overall Study|Unknown Reason|0|||
163369997|NCT01803282|590062975|FG005|Overall Study|Unknown Reason|0|||
163369998|NCT01803282|590062976|FG006|Overall Study|Unknown Reason|0|||
163369999|NCT01803282|590062977|FG007|Overall Study|Unknown Reason|1|||
163370000|NCT01803282|590062978|FG008|Overall Study|Unknown Reason|0|||
163370001|NCT01803282|590062979|FG009|Overall Study|Unknown Reason|0|||
163370002|NCT01803282|590062980|FG010|Overall Study|Unknown Reason|0|||
163370003|NCT01803282|590062981|FG011|Overall Study|Unknown Reason|0|||
163370004|NCT01803282|590062970|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
163370005|NCT01803282|590062971|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
163370006|NCT01803282|590062972|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
163370007|NCT01803282|590062973|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
163370008|NCT01803282|590062974|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
163370009|NCT01803282|590062975|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
163370010|NCT01803282|590062976|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
163370011|NCT01803282|590062977|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
163370012|NCT01803282|590062978|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
163370013|NCT01803282|590062979|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
163370014|NCT01803282|590062980|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
163370015|NCT01803282|590062981|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
163370016|NCT01803282|590062970|FG000|Overall Study|Enrolled but Never Treated|0|||
163370017|NCT01803282|590062971|FG001|Overall Study|Enrolled but Never Treated|0|||
163370018|NCT01803282|590062972|FG002|Overall Study|Enrolled but Never Treated|0|||
163370019|NCT01803282|590062973|FG003|Overall Study|Enrolled but Never Treated|0|||
163370020|NCT01803282|590062974|FG004|Overall Study|Enrolled but Never Treated|1|||
163370021|NCT01803282|590062975|FG005|Overall Study|Enrolled but Never Treated|0|||
163370022|NCT01803282|590062976|FG006|Overall Study|Enrolled but Never Treated|1|||
163370023|NCT01803282|590062977|FG007|Overall Study|Enrolled but Never Treated|1|||
163370024|NCT01803282|590062978|FG008|Overall Study|Enrolled but Never Treated|0|||
163370025|NCT01803282|590062979|FG009|Overall Study|Enrolled but Never Treated|1|||
163370026|NCT01803282|590062980|FG010|Overall Study|Enrolled but Never Treated|0|||
163370027|NCT01803282|590062981|FG011|Overall Study|Enrolled but Never Treated|0|||
163370028|NCT00798434|590062986|FG000|Double-Blind|Adverse Event|22|||
163370029|NCT00798434|590062987|FG001|Double-Blind|Adverse Event|46|||
163370030|NCT00798434|590062986|FG000|Double-Blind|Death|0|||
163370031|NCT00798434|590062987|FG001|Double-Blind|Death|1|||
163370032|NCT00798434|590062986|FG000|Double-Blind|Lost to Follow-up|1|||
163370033|NCT00798434|590062987|FG001|Double-Blind|Lost to Follow-up|0|||
163370034|NCT00798434|590062986|FG000|Double-Blind|Lack of Efficacy|8|||
163370035|NCT00798434|590062987|FG001|Double-Blind|Lack of Efficacy|12|||
163370036|NCT00798434|590062986|FG000|Double-Blind|Withdrawal by Subject|17|||
163370037|NCT00798434|590062987|FG001|Double-Blind|Withdrawal by Subject|14|||
163370038|NCT00798434|590062986|FG000|Double-Blind|Protocol Violation|1|||
163370039|NCT00798434|590062987|FG001|Double-Blind|Protocol Violation|4|||
163370040|NCT00798434|590062986|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
163370041|NCT00798434|590062987|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
163370042|NCT00798434|590062986|FG000|Double-Blind|Other|1|||
163370043|NCT00798434|590062987|FG001|Double-Blind|Other|0|||
163370044|NCT00798434|590062986|FG000|Double-Blind|Not Treated|3|||
163370045|NCT00798434|590062987|FG001|Double-Blind|Not Treated|6|||
163370046|NCT00798434|590062986|FG000|Open-Label|Adverse Event|33|||
163370047|NCT00798434|590062987|FG001|Open-Label|Adverse Event|11|||
163370048|NCT00798434|590062986|FG000|Open-Label|Lack of Efficacy|5|||
163370049|NCT00798434|590062987|FG001|Open-Label|Lack of Efficacy|11|||
163370050|NCT00798434|590062986|FG000|Open-Label|Withdrawal by Subject|2|||
163370051|NCT00798434|590062987|FG001|Open-Label|Withdrawal by Subject|7|||
163370052|NCT00798434|590062986|FG000|Open-Label|Protocol Violation|1|||
163413295|NCT01081795|590220908|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
163370053|NCT00798434|590062987|FG001|Open-Label|Protocol Violation|0|||
163370054|NCT00798434|590062986|FG000|Open-Label|Other|1|||
163370055|NCT00798434|590062987|FG001|Open-Label|Other|2|||
163370056|NCT00798434|590062986|FG000|Open-Label|Not Treated|0|||
163370057|NCT00798434|590062987|FG001|Open-Label|Not Treated|1|||
163370058|NCT01217437|590062991|FG000|Overall Study|Adverse Event|0|||
163370059|NCT01217437|590062992|FG001|Overall Study|Adverse Event|8|||
163370060|NCT01217437|590062991|FG000|Overall Study|Death|5|||
163370061|NCT01217437|590062992|FG001|Overall Study|Death|0|||
163370062|NCT01217437|590062991|FG000|Overall Study|Lack of Efficacy|29|||
163370063|NCT01217437|590062992|FG001|Overall Study|Lack of Efficacy|25|||
163370064|NCT01217437|590062991|FG000|Overall Study|Physician Decision|8|||
163370065|NCT01217437|590062992|FG001|Overall Study|Physician Decision|5|||
163370066|NCT01217437|590062991|FG000|Overall Study|Withdrawal by Subject|0|||
163370067|NCT01217437|590062992|FG001|Overall Study|Withdrawal by Subject|2|||
163370068|NCT01217437|590062991|FG000|Overall Study|Ineligible|1|||
163370069|NCT01217437|590062992|FG001|Overall Study|Ineligible|1|||
163370070|NCT04908631|590062993|FG000|Overall Study|Lost to Follow-up|1|||
163370071|NCT04908631|590062993|FG000|Overall Study|Physician Decision|1|||
163370072|NCT04908631|590062993|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
163370073|NCT02336451|590062997|FG000|Overall Study|Adverse Event|1|||
163370074|NCT02336451|590062998|FG001|Overall Study|Adverse Event|2|||
163370075|NCT02336451|590062999|FG002|Overall Study|Adverse Event|0|||
163370076|NCT02336451|590063000|FG003|Overall Study|Adverse Event|6|||
163370077|NCT02336451|590063001|FG004|Overall Study|Adverse Event|4|||
163370078|NCT02336451|590062997|FG000|Overall Study|Death|6|||
163370079|NCT02336451|590062998|FG001|Overall Study|Death|2|||
163370080|NCT02336451|590062999|FG002|Overall Study|Death|3|||
163370081|NCT02336451|590063000|FG003|Overall Study|Death|6|||
163370082|NCT02336451|590063001|FG004|Overall Study|Death|6|||
163370083|NCT02336451|590062997|FG000|Overall Study|Physician Decision|9|||
163370084|NCT02336451|590062998|FG001|Overall Study|Physician Decision|6|||
163370085|NCT02336451|590062999|FG002|Overall Study|Physician Decision|7|||
163370086|NCT02336451|590063000|FG003|Overall Study|Physician Decision|16|||
163370087|NCT02336451|590063001|FG004|Overall Study|Physician Decision|3|||
163370088|NCT02336451|590062997|FG000|Overall Study|Progressive disease|23|||
163370089|NCT02336451|590062998|FG001|Overall Study|Progressive disease|26|||
163370090|NCT02336451|590062999|FG002|Overall Study|Progressive disease|2|||
163370091|NCT02336451|590063000|FG003|Overall Study|Progressive disease|14|||
163370092|NCT02336451|590063001|FG004|Overall Study|Progressive disease|4|||
163370093|NCT02336451|590062997|FG000|Overall Study|Protocol Violation|1|||
163370094|NCT02336451|590062998|FG001|Overall Study|Protocol Violation|0|||
163370095|NCT02336451|590062999|FG002|Overall Study|Protocol Violation|0|||
163370096|NCT02336451|590063000|FG003|Overall Study|Protocol Violation|0|||
163370097|NCT02336451|590063001|FG004|Overall Study|Protocol Violation|0|||
163370098|NCT02336451|590062997|FG000|Overall Study|Patient/guardian decision|2|||
163370099|NCT02336451|590062998|FG001|Overall Study|Patient/guardian decision|4|||
163370100|NCT02336451|590062999|FG002|Overall Study|Patient/guardian decision|0|||
163370101|NCT02336451|590063000|FG003|Overall Study|Patient/guardian decision|2|||
163413296|NCT01081795|590220909|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
163413297|NCT01081795|590220910|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
163413298|NCT01081795|590220908|FG000|Overall Study|Using drug with restricted days of use|2|||
163413299|NCT01081795|590220909|FG001|Overall Study|Using drug with restricted days of use|3|||
163413300|NCT01081795|590220910|FG002|Overall Study|Using drug with restricted days of use|2|||
163413301|NCT01081795|590220908|FG000|Overall Study|Other|1|||
163413302|NCT01081795|590220909|FG001|Overall Study|Other|2|||
163413303|NCT01081795|590220910|FG002|Overall Study|Other|0|||
163413304|NCT02462473|590220911|FG000|Overall Study|Death|1|||
163413305|NCT02462473|590220911|FG000|Overall Study|Other|3|||
163413306|NCT01536860|590220912|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
163370102|NCT02336451|590063001|FG004|Overall Study|Patient/guardian decision|1|||
163370103|NCT06655558|590063004|FG000|Overall Study|Protocol Violation|1|||
163413307|NCT01536860|590220913|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
163413308|NCT01536860|590220914|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
163413309|NCT01707693|590220915|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
163413310|NCT01707693|590220916|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
163413311|NCT01707693|590220915|FG000|Overall Study Allocation|Protocol Violation|4|||
163413312|NCT01707693|590220916|FG001|Overall Study Allocation|Protocol Violation|3|||
163413313|NCT01707693|590220915|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
163370104|NCT04893460|590063014|FG000|Overall Study|Lost to Follow-up|18|||
163370105|NCT03578887|590063015|FG000|Overall Study|Withdrawal by Subject|7|||
163413314|NCT01707693|590220916|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
163370106|NCT03578887|590063016|FG001|Overall Study|Withdrawal by Subject|2|||
163370107|NCT03578887|590063017|FG002|Overall Study|Withdrawal by Subject|1|||
163370108|NCT03578887|590063015|FG000|Overall Study|Lost to Follow-up|13|||
163370109|NCT03578887|590063016|FG001|Overall Study|Lost to Follow-up|1|||
163370110|NCT03578887|590063017|FG002|Overall Study|Lost to Follow-up|4|||
163370111|NCT03578887|590063015|FG000|Overall Study|Physician Decision|0|||
163370112|NCT03578887|590063016|FG001|Overall Study|Physician Decision|1|||
163370113|NCT03578887|590063017|FG002|Overall Study|Physician Decision|1|||
163370114|NCT01099215|590064473|FG000|Overall Study|Withdrawal by Subject|1|||
163370115|NCT01099215|590064474|FG001|Overall Study|Withdrawal by Subject|0|||
163370116|NCT01099215|590064473|FG000|Overall Study|Adverse Event|0|||
163370117|NCT01099215|590064474|FG001|Overall Study|Adverse Event|1|||
163370118|NCT00387426|590064476|FG000|Overall Study|Lack of Response|7|||
163370119|NCT00387426|590064476|FG000|Overall Study|Toxicities|4|||
163370120|NCT00387426|590064476|FG000|Overall Study|Disease Progression|3|||
163370121|NCT03203473|590064477|FG000|Induction Phase|Never started primary treatment|2|||
163370122|NCT03203473|590064478|FG001|Induction Phase|Never started primary treatment|0|||
163370123|NCT03203473|590064479|FG002|Induction Phase|Never started primary treatment|0|||
163370124|NCT03203473|590064477|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
163370125|NCT03203473|590064478|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
163370126|NCT03203473|590064479|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
163370127|NCT03203473|590064477|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
163370128|NCT03203473|590064478|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
163370129|NCT03203473|590064479|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
163370130|NCT03203473|590064477|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
163370131|NCT03203473|590064478|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
163370132|NCT03203473|590064479|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
163370133|NCT03203473|590064477|FG000|Arm Allocation Phase|started salvage therapy|0|||
163370134|NCT03203473|590064478|FG001|Arm Allocation Phase|started salvage therapy|5|||
163370135|NCT03203473|590064479|FG002|Arm Allocation Phase|started salvage therapy|0|||
163370136|NCT03203473|590064477|FG000|Arm Allocation Phase|Disease progression|0|||
163370137|NCT03203473|590064478|FG001|Arm Allocation Phase|Disease progression|0|||
163370138|NCT03203473|590064479|FG002|Arm Allocation Phase|Disease progression|37|||
163370139|NCT03203473|590064477|FG000|Arm Allocation Phase|Adverse Event|0|||
163370140|NCT03203473|590064478|FG001|Arm Allocation Phase|Adverse Event|0|||
163370141|NCT03203473|590064479|FG002|Arm Allocation Phase|Adverse Event|11|||
163370142|NCT03203473|590064477|FG000|Arm Allocation Phase|Physician Decision|0|||
163370143|NCT03203473|590064478|FG001|Arm Allocation Phase|Physician Decision|0|||
163370144|NCT03203473|590064479|FG002|Arm Allocation Phase|Physician Decision|3|||
163370145|NCT03203473|590064477|FG000|Arm Allocation Phase|Death|0|||
163370146|NCT03203473|590064478|FG001|Arm Allocation Phase|Death|0|||
163370147|NCT03203473|590064479|FG002|Arm Allocation Phase|Death|1|||
163370148|NCT03203473|590064477|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
163370149|NCT03203473|590064478|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
163370150|NCT03203473|590064479|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
163370151|NCT03203473|590064477|FG000|Arm Allocation Phase|Intercurrent illness|0|||
163370152|NCT03203473|590064478|FG001|Arm Allocation Phase|Intercurrent illness|0|||
163370153|NCT03203473|590064479|FG002|Arm Allocation Phase|Intercurrent illness|1|||
163370154|NCT03203473|590064477|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
163370155|NCT03203473|590064478|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
163370156|NCT03203473|590064479|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
163370157|NCT00215137|590064480|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
163370158|NCT00215137|590064481|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
163370159|NCT00215137|590064482|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
163370160|NCT00215137|590064480|FG000|Randomization Period|Lost to Follow-up|0|||
163370161|NCT00215137|590064481|FG001|Randomization Period|Lost to Follow-up|1|||
163370162|NCT00215137|590064482|FG002|Randomization Period|Lost to Follow-up|0|||
163370163|NCT00215137|590064480|FG000|Randomization Period|Withdrawal by Subject|0|||
163370164|NCT00215137|590064481|FG001|Randomization Period|Withdrawal by Subject|1|||
163370165|NCT00215137|590064482|FG002|Randomization Period|Withdrawal by Subject|0|||
163370166|NCT03333876|590064483|FG000|Screening Period|Screen Failure|4|||
163370167|NCT03333876|590064483|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
163370168|NCT03333876|590064483|FG000|Mandibular Advancement|Adverse Event|2|||
163370169|NCT03333876|590064483|FG000|Mandibular Advancement|Product Damage|2|||
163370170|NCT00166712|590064487|FG000|Overall Study|Death|0|||
163370171|NCT00166712|590064488|FG001|Overall Study|Death|1|||
163370172|NCT00166712|590064487|FG000|Overall Study|Adverse Event|1|||
163370173|NCT00166712|590064488|FG001|Overall Study|Adverse Event|0|||
163370174|NCT00166712|590064487|FG000|Overall Study|Withdrawal by Subject|1|||
163370175|NCT00166712|590064488|FG001|Overall Study|Withdrawal by Subject|2|||
163370176|NCT00166712|590064487|FG000|Overall Study|Physician Decision|0|||
163370177|NCT00166712|590064488|FG001|Overall Study|Physician Decision|2|||
163370178|NCT04684394|590064489|FG000|Overall Study|Death|1|||
163370179|NCT04684394|590064490|FG001|Overall Study|Death|2|||
163370180|NCT04684394|590064489|FG000|Overall Study|Lost to Follow-up|1|||
163370181|NCT04684394|590064490|FG001|Overall Study|Lost to Follow-up|0|||
163370182|NCT04684394|590064489|FG000|Overall Study|Withdrawal by Subject|2|||
163370183|NCT04684394|590064490|FG001|Overall Study|Withdrawal by Subject|0|||
163370184|NCT04684394|590064489|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
163370185|NCT04684394|590064490|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
163370186|NCT03986944|590064491|FG000|Overall Study|Adverse Event|1|||
163413315|NCT01707693|590220915|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
163413316|NCT01707693|590220916|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
163413317|NCT03115151|590220918|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
163413318|NCT03115151|590220919|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
163413319|NCT03115151|590220918|FG000|Overall Study|Epidural catheter removal|1|||
163413320|NCT03115151|590220919|FG001|Overall Study|Epidural catheter removal|0|||
163413321|NCT03115151|590220918|FG000|Overall Study|Withdrawal by Subject|0|||
163413322|NCT03115151|590220919|FG001|Overall Study|Withdrawal by Subject|1|||
163413323|NCT03115151|590220918|FG000|Overall Study|Intervention not received according to the protocol.|1|||
163413324|NCT03115151|590220919|FG001|Overall Study|Intervention not received according to the protocol.|1|||
163370187|NCT03986944|590064492|FG001|Overall Study|Adverse Event|2|||
163370188|NCT03986944|590064493|FG002|Overall Study|Adverse Event|3|||
163370189|NCT03986944|590064491|FG000|Overall Study|Protocol Violation|0|||
163370190|NCT03986944|590064492|FG001|Overall Study|Protocol Violation|1|||
163370191|NCT03986944|590064493|FG002|Overall Study|Protocol Violation|1|||
163370192|NCT03986944|590064491|FG000|Overall Study|Withdrawal by Subject|3|||
163370193|NCT03986944|590064492|FG001|Overall Study|Withdrawal by Subject|5|||
163370194|NCT03986944|590064493|FG002|Overall Study|Withdrawal by Subject|5|||
163413325|NCT03115151|590220918|FG000|Overall Study|Physician Decision|1|||
163413326|NCT03115151|590220919|FG001|Overall Study|Physician Decision|0|||
163413327|NCT03115151|590220918|FG000|Overall Study|Randomization not applied|1|||
163413328|NCT03115151|590220919|FG001|Overall Study|Randomization not applied|1|||
163413329|NCT01543087|590220922|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
163413330|NCT01543087|590220923|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
163413331|NCT01543087|590220924|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
163413332|NCT01543087|590220925|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
163413333|NCT01543087|590220926|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
163413334|NCT01543087|590220927|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
163413335|NCT01543087|590220922|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
163413336|NCT01543087|590220923|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
163413337|NCT01543087|590220924|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
163413338|NCT01543087|590220925|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
163413339|NCT01543087|590220926|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
163413340|NCT01543087|590220927|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
163413341|NCT01543087|590220922|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
163413342|NCT01543087|590220923|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
163413343|NCT01543087|590220924|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
163413344|NCT01543087|590220925|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
163413345|NCT01543087|590220926|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
163413346|NCT01543087|590220927|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
163413347|NCT01543087|590220922|FG000|Stage 1 (48 Months)|Other than specified|5|||
163413348|NCT01543087|590220923|FG001|Stage 1 (48 Months)|Other than specified|0|||
163370195|NCT03986944|590064491|FG000|Overall Study|Study termination|10|||
163370196|NCT03986944|590064492|FG001|Overall Study|Study termination|10|||
163370197|NCT03986944|590064493|FG002|Overall Study|Study termination|10|||
163370198|NCT03986944|590064491|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
163370199|NCT03986944|590064492|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
163370200|NCT03986944|590064493|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
163370201|NCT03986944|590064491|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
163370202|NCT03986944|590064492|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
163370203|NCT03986944|590064493|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
163370204|NCT00568178|590064494|FG000|Double Blind Base Study|Adverse Event|0|||
163370205|NCT00568178|590064495|FG001|Double Blind Base Study|Adverse Event|2|||
163370206|NCT00568178|590064496|FG002|Double Blind Base Study|Adverse Event|1|||
163370207|NCT00568178|590064497|FG003|Double Blind Base Study|Adverse Event|2|||
163370208|NCT00568178|590064498|FG004|Double Blind Base Study|Adverse Event|0|||
163370209|NCT00568178|590064499|FG005|Double Blind Base Study|Adverse Event|0|||
163370210|NCT00568178|590064494|FG000|Double Blind Base Study|Lost to Follow-up|1|||
163370211|NCT00568178|590064495|FG001|Double Blind Base Study|Lost to Follow-up|0|||
163370212|NCT00568178|590064496|FG002|Double Blind Base Study|Lost to Follow-up|0|||
163370213|NCT00568178|590064497|FG003|Double Blind Base Study|Lost to Follow-up|1|||
163370214|NCT00568178|590064498|FG004|Double Blind Base Study|Lost to Follow-up|0|||
163370215|NCT00568178|590064499|FG005|Double Blind Base Study|Lost to Follow-up|0|||
163370216|NCT00568178|590064494|FG000|Double Blind Base Study|Physician Decision|1|||
163370217|NCT00568178|590064495|FG001|Double Blind Base Study|Physician Decision|1|||
163370218|NCT00568178|590064496|FG002|Double Blind Base Study|Physician Decision|0|||
163370219|NCT00568178|590064497|FG003|Double Blind Base Study|Physician Decision|1|||
163413349|NCT01543087|590220924|FG002|Stage 1 (48 Months)|Other than specified|9|||
163413350|NCT01543087|590220925|FG003|Stage 1 (48 Months)|Other than specified|0|||
163413351|NCT01543087|590220926|FG004|Stage 1 (48 Months)|Other than specified|0|||
163370220|NCT00568178|590064498|FG004|Double Blind Base Study|Physician Decision|0|||
163370221|NCT00568178|590064499|FG005|Double Blind Base Study|Physician Decision|0|||
163370222|NCT00568178|590064494|FG000|Double Blind Base Study|Protocol Violation|3|||
163370223|NCT00568178|590064495|FG001|Double Blind Base Study|Protocol Violation|2|||
163370224|NCT00568178|590064496|FG002|Double Blind Base Study|Protocol Violation|0|||
163370225|NCT00568178|590064497|FG003|Double Blind Base Study|Protocol Violation|0|||
163370226|NCT00568178|590064498|FG004|Double Blind Base Study|Protocol Violation|0|||
163370227|NCT00568178|590064499|FG005|Double Blind Base Study|Protocol Violation|0|||
163370228|NCT00568178|590064494|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
163370229|NCT00568178|590064495|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
163370230|NCT00568178|590064496|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
163370231|NCT00568178|590064497|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
163370232|NCT00568178|590064498|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
163370233|NCT00568178|590064499|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
163370234|NCT00568178|590064494|FG000|Double Blind Base Study|Progressive Disease|0|||
163370235|NCT00568178|590064495|FG001|Double Blind Base Study|Progressive Disease|0|||
163370236|NCT00568178|590064496|FG002|Double Blind Base Study|Progressive Disease|0|||
163370237|NCT00568178|590064497|FG003|Double Blind Base Study|Progressive Disease|1|||
163370238|NCT00568178|590064498|FG004|Double Blind Base Study|Progressive Disease|0|||
163370239|NCT00568178|590064499|FG005|Double Blind Base Study|Progressive Disease|0|||
163370240|NCT00568178|590064494|FG000|Open Label Extension|Adverse Event|0|||
163370241|NCT00568178|590064495|FG001|Open Label Extension|Adverse Event|0|||
163370242|NCT00568178|590064496|FG002|Open Label Extension|Adverse Event|0|||
163370243|NCT00568178|590064497|FG003|Open Label Extension|Adverse Event|0|||
163370244|NCT00568178|590064498|FG004|Open Label Extension|Adverse Event|11|||
163370245|NCT00568178|590064499|FG005|Open Label Extension|Adverse Event|8|||
163370246|NCT00568178|590064494|FG000|Open Label Extension|Protocol Violation|0|||
163370247|NCT00568178|590064495|FG001|Open Label Extension|Protocol Violation|0|||
163370248|NCT00568178|590064496|FG002|Open Label Extension|Protocol Violation|0|||
163370249|NCT00568178|590064497|FG003|Open Label Extension|Protocol Violation|0|||
163370250|NCT00568178|590064498|FG004|Open Label Extension|Protocol Violation|1|||
163370251|NCT00568178|590064499|FG005|Open Label Extension|Protocol Violation|0|||
163370252|NCT00568178|590064494|FG000|Open Label Extension|Lost to Follow-up|0|||
163370253|NCT00568178|590064495|FG001|Open Label Extension|Lost to Follow-up|0|||
163370254|NCT00568178|590064496|FG002|Open Label Extension|Lost to Follow-up|0|||
163370255|NCT00568178|590064497|FG003|Open Label Extension|Lost to Follow-up|0|||
163370256|NCT00568178|590064498|FG004|Open Label Extension|Lost to Follow-up|6|||
163370257|NCT00568178|590064499|FG005|Open Label Extension|Lost to Follow-up|11|||
163370258|NCT00568178|590064494|FG000|Open Label Extension|Physician Decision|0|||
163370259|NCT00568178|590064495|FG001|Open Label Extension|Physician Decision|0|||
163370260|NCT00568178|590064496|FG002|Open Label Extension|Physician Decision|0|||
163370261|NCT00568178|590064497|FG003|Open Label Extension|Physician Decision|0|||
163370262|NCT00568178|590064498|FG004|Open Label Extension|Physician Decision|9|||
163370263|NCT00568178|590064499|FG005|Open Label Extension|Physician Decision|8|||
163370264|NCT00568178|590064494|FG000|Open Label Extension|Pregnancy|0|||
163370265|NCT00568178|590064495|FG001|Open Label Extension|Pregnancy|0|||
163370266|NCT00568178|590064496|FG002|Open Label Extension|Pregnancy|0|||
163370267|NCT00568178|590064497|FG003|Open Label Extension|Pregnancy|0|||
163370268|NCT00568178|590064498|FG004|Open Label Extension|Pregnancy|0|||
163370269|NCT00568178|590064499|FG005|Open Label Extension|Pregnancy|1|||
163370270|NCT00568178|590064494|FG000|Open Label Extension|Progressive Disease|0|||
163370271|NCT00568178|590064495|FG001|Open Label Extension|Progressive Disease|0|||
163370272|NCT00568178|590064496|FG002|Open Label Extension|Progressive Disease|0|||
163370273|NCT00568178|590064497|FG003|Open Label Extension|Progressive Disease|0|||
163370274|NCT00568178|590064498|FG004|Open Label Extension|Progressive Disease|3|||
163370275|NCT00568178|590064499|FG005|Open Label Extension|Progressive Disease|1|||
163370276|NCT00568178|590064494|FG000|Open Label Extension|Termination of Trial|0|||
163370277|NCT00568178|590064495|FG001|Open Label Extension|Termination of Trial|0|||
163370278|NCT00568178|590064496|FG002|Open Label Extension|Termination of Trial|0|||
163370279|NCT00568178|590064497|FG003|Open Label Extension|Termination of Trial|0|||
163370280|NCT00568178|590064498|FG004|Open Label Extension|Termination of Trial|45|||
163370281|NCT00568178|590064499|FG005|Open Label Extension|Termination of Trial|47|||
163370282|NCT00568178|590064494|FG000|Open Label Extension|Withdrawal by Subject|0|||
163370283|NCT00568178|590064495|FG001|Open Label Extension|Withdrawal by Subject|0|||
163370284|NCT00568178|590064496|FG002|Open Label Extension|Withdrawal by Subject|0|||
163370285|NCT00568178|590064497|FG003|Open Label Extension|Withdrawal by Subject|0|||
163370286|NCT00568178|590064498|FG004|Open Label Extension|Withdrawal by Subject|4|||
163370287|NCT00568178|590064499|FG005|Open Label Extension|Withdrawal by Subject|4|||
163370288|NCT01531673|590064500|FG000|Overall Study|Non-Compliance|0|||
163370289|NCT01531673|590064501|FG001|Overall Study|Non-Compliance|0|||
163370290|NCT01531673|590064502|FG002|Overall Study|Non-Compliance|0|||
163370291|NCT01531673|590064503|FG003|Overall Study|Non-Compliance|0|||
163370292|NCT01531673|590064504|FG004|Overall Study|Non-Compliance|0|||
163370293|NCT01531673|590064505|FG005|Overall Study|Non-Compliance|1|||
163413352|NCT01543087|590220927|FG005|Stage 1 (48 Months)|Other than specified|0|||
163413353|NCT01543087|590220922|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
163370294|NCT01531673|590064506|FG006|Overall Study|Non-Compliance|0|||
163370295|NCT01531673|590064507|FG007|Overall Study|Non-Compliance|0|||
163370296|NCT01531673|590064508|FG008|Overall Study|Non-Compliance|0|||
163370297|NCT01531673|590064509|FG009|Overall Study|Non-Compliance|0|||
163370298|NCT01531673|590064510|FG010|Overall Study|Non-Compliance|0|||
163370299|NCT01531673|590064511|FG011|Overall Study|Non-Compliance|0|||
163370300|NCT01531673|590064512|FG012|Overall Study|Non-Compliance|0|||
163413354|NCT01543087|590220923|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
163413355|NCT01543087|590220924|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
163413356|NCT01543087|590220925|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
163413357|NCT01543087|590220926|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
163413358|NCT01543087|590220927|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
163413359|NCT01543087|590220922|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
163413360|NCT01543087|590220923|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
163413361|NCT01543087|590220924|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
163413362|NCT01543087|590220925|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
163413363|NCT01543087|590220926|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
163413364|NCT01543087|590220927|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
163413365|NCT01543087|590220922|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
163413366|NCT01543087|590220923|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
163370301|NCT01531673|590064500|FG000|Overall Study|Adverse Event|0|||
163370302|NCT01531673|590064501|FG001|Overall Study|Adverse Event|1|||
163370303|NCT01531673|590064502|FG002|Overall Study|Adverse Event|0|||
163370304|NCT01531673|590064503|FG003|Overall Study|Adverse Event|0|||
163370305|NCT01531673|590064504|FG004|Overall Study|Adverse Event|0|||
163370306|NCT01531673|590064505|FG005|Overall Study|Adverse Event|0|||
163370307|NCT01531673|590064506|FG006|Overall Study|Adverse Event|0|||
163413367|NCT01543087|590220924|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
163413368|NCT01543087|590220925|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
163413369|NCT01543087|590220926|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
163413370|NCT01543087|590220927|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
163413371|NCT00143455|590220928|FG000|Cohort 1|Adverse Event|8|||
163413372|NCT00143455|590220929|FG001|Cohort 1|Adverse Event|4|||
163413373|NCT00143455|590220930|FG002|Cohort 1|Adverse Event|0|||
163413374|NCT00143455|590220931|FG003|Cohort 1|Adverse Event|0|||
163413375|NCT00143455|590220928|FG000|Cohort 1|Death|5|||
163413376|NCT00143455|590220929|FG001|Cohort 1|Death|2|||
163413377|NCT00143455|590220930|FG002|Cohort 1|Death|0|||
163413378|NCT00143455|590220931|FG003|Cohort 1|Death|0|||
163413379|NCT00143455|590220928|FG000|Cohort 1|Progressive Disease|0|||
163413380|NCT00143455|590220929|FG001|Cohort 1|Progressive Disease|6|||
163413381|NCT00143455|590220930|FG002|Cohort 1|Progressive Disease|0|||
163413382|NCT00143455|590220931|FG003|Cohort 1|Progressive Disease|0|||
163413383|NCT00143455|590220928|FG000|Cohort 1|Withdrawal by Subject|1|||
163413384|NCT00143455|590220929|FG001|Cohort 1|Withdrawal by Subject|4|||
163413385|NCT00143455|590220930|FG002|Cohort 1|Withdrawal by Subject|0|||
163413386|NCT00143455|590220931|FG003|Cohort 1|Withdrawal by Subject|0|||
163413387|NCT00143455|590220928|FG000|Cohort 1|Randomized But Not Treated|0|||
163413388|NCT00143455|590220929|FG001|Cohort 1|Randomized But Not Treated|1|||
163413389|NCT00143455|590220930|FG002|Cohort 1|Randomized But Not Treated|0|||
163413390|NCT00143455|590220931|FG003|Cohort 1|Randomized But Not Treated|0|||
163413391|NCT00143455|590220928|FG000|Cohort 2|Adverse Event|0|||
163413392|NCT00143455|590220929|FG001|Cohort 2|Adverse Event|0|||
163413393|NCT00143455|590220930|FG002|Cohort 2|Adverse Event|42|||
163413394|NCT00143455|590220931|FG003|Cohort 2|Adverse Event|30|||
163413395|NCT00143455|590220928|FG000|Cohort 2|No Longer Required Study Treatment|0|||
163370308|NCT01531673|590064507|FG007|Overall Study|Adverse Event|0|||
163413396|NCT00143455|590220929|FG001|Cohort 2|No Longer Required Study Treatment|0|||
163413397|NCT00143455|590220930|FG002|Cohort 2|No Longer Required Study Treatment|1|||
163413398|NCT00143455|590220931|FG003|Cohort 2|No Longer Required Study Treatment|0|||
163413399|NCT00143455|590220928|FG000|Cohort 2|Protocol Violation|0|||
163413400|NCT00143455|590220929|FG001|Cohort 2|Protocol Violation|0|||
163413401|NCT00143455|590220930|FG002|Cohort 2|Protocol Violation|1|||
163413402|NCT00143455|590220931|FG003|Cohort 2|Protocol Violation|1|||
163370309|NCT01531673|590064508|FG008|Overall Study|Adverse Event|0|||
163370310|NCT01531673|590064509|FG009|Overall Study|Adverse Event|0|||
163370311|NCT01531673|590064510|FG010|Overall Study|Adverse Event|0|||
163413403|NCT00143455|590220928|FG000|Cohort 2|Lost to Follow-up|0|||
163413404|NCT00143455|590220929|FG001|Cohort 2|Lost to Follow-up|0|||
163413405|NCT00143455|590220930|FG002|Cohort 2|Lost to Follow-up|1|||
163370312|NCT01531673|590064511|FG011|Overall Study|Adverse Event|0|||
163413406|NCT00143455|590220931|FG003|Cohort 2|Lost to Follow-up|4|||
163413407|NCT00143455|590220928|FG000|Cohort 2|Death|0|||
163413408|NCT00143455|590220929|FG001|Cohort 2|Death|0|||
163413409|NCT00143455|590220930|FG002|Cohort 2|Death|20|||
163370313|NCT01531673|590064512|FG012|Overall Study|Adverse Event|0|||
163413410|NCT00143455|590220931|FG003|Cohort 2|Death|12|||
163370314|NCT01531673|590064500|FG000|Overall Study|Lost to Follow-up|0|||
163370315|NCT01531673|590064501|FG001|Overall Study|Lost to Follow-up|0|||
163370316|NCT01531673|590064502|FG002|Overall Study|Lost to Follow-up|0|||
163370317|NCT01531673|590064503|FG003|Overall Study|Lost to Follow-up|0|||
163370318|NCT01531673|590064504|FG004|Overall Study|Lost to Follow-up|1|||
163370319|NCT01531673|590064505|FG005|Overall Study|Lost to Follow-up|0|||
163370320|NCT01531673|590064506|FG006|Overall Study|Lost to Follow-up|0|||
163370321|NCT01531673|590064507|FG007|Overall Study|Lost to Follow-up|0|||
163370322|NCT01531673|590064508|FG008|Overall Study|Lost to Follow-up|0|||
163370323|NCT01531673|590064509|FG009|Overall Study|Lost to Follow-up|0|||
163370324|NCT01531673|590064510|FG010|Overall Study|Lost to Follow-up|0|||
163370325|NCT01531673|590064511|FG011|Overall Study|Lost to Follow-up|0|||
163370326|NCT01531673|590064512|FG012|Overall Study|Lost to Follow-up|0|||
163370327|NCT01531673|590064500|FG000|Overall Study|Other|0|||
163370328|NCT01531673|590064501|FG001|Overall Study|Other|0|||
163370329|NCT01531673|590064502|FG002|Overall Study|Other|0|||
163370330|NCT01531673|590064503|FG003|Overall Study|Other|1|||
163370331|NCT01531673|590064504|FG004|Overall Study|Other|0|||
163370332|NCT01531673|590064505|FG005|Overall Study|Other|0|||
163370333|NCT01531673|590064506|FG006|Overall Study|Other|0|||
163370334|NCT01531673|590064507|FG007|Overall Study|Other|0|||
163370335|NCT01531673|590064508|FG008|Overall Study|Other|0|||
163370336|NCT01531673|590064509|FG009|Overall Study|Other|1|||
163370337|NCT01531673|590064510|FG010|Overall Study|Other|0|||
163370338|NCT01531673|590064511|FG011|Overall Study|Other|0|||
163370339|NCT01531673|590064512|FG012|Overall Study|Other|0|||
163370340|NCT01014208|590064513|FG000|Overall Study|Lost to Follow-up|2|||
163370341|NCT01014208|590064514|FG001|Overall Study|Lost to Follow-up|5|||
163370342|NCT01014208|590064513|FG000|Overall Study|Participant Withdrew Consent|12|||
163370343|NCT01014208|590064514|FG001|Overall Study|Participant Withdrew Consent|12|||
163370344|NCT01014208|590064513|FG000|Overall Study|Did Not Receive Study Drug|2|||
163370345|NCT01014208|590064514|FG001|Overall Study|Did Not Receive Study Drug|0|||
163370346|NCT01014208|590064513|FG000|Overall Study|Study Closed/terminated|78|||
163370347|NCT01014208|590064514|FG001|Overall Study|Study Closed/terminated|83|||
163370348|NCT01332630|590064515|FG000|Overall Study|Withdrawal by Subject|3|||
163370349|NCT04476251|590064518|FG000|Overall Study|Not treated|1|||
163370350|NCT01008553|590064519|FG000|Period 1 (Titration Period)|Physician Decision|2|||
163370351|NCT01008553|590064520|FG001|Period 1 (Titration Period)|Physician Decision|0|||
163370352|NCT01008553|590064521|FG002|Period 1 (Titration Period)|Physician Decision|0|||
163370353|NCT01008553|590064519|FG000|Period 1 (Titration Period)|Adverse Event|33|||
163370354|NCT01008553|590064520|FG001|Period 1 (Titration Period)|Adverse Event|0|||
163370355|NCT01008553|590064521|FG002|Period 1 (Titration Period)|Adverse Event|0|||
163370356|NCT01008553|590064519|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
163370357|NCT01008553|590064520|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
163370358|NCT01008553|590064521|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
163370359|NCT01008553|590064519|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
163370360|NCT01008553|590064520|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
163370361|NCT01008553|590064521|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
163370362|NCT01008553|590064519|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
163370363|NCT01008553|590064520|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
163370364|NCT01008553|590064521|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
163370365|NCT01008553|590064519|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
163370366|NCT01008553|590064520|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
163370367|NCT01008553|590064521|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
163370368|NCT01008553|590064519|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
163370369|NCT01008553|590064520|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
163370370|NCT01008553|590064521|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
163370371|NCT01008553|590064519|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
163370372|NCT01008553|590064520|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
163370373|NCT01008553|590064521|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
163370374|NCT01008553|590064519|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
163370375|NCT01008553|590064520|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
163370376|NCT01008553|590064521|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
163370377|NCT01008553|590064519|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
163370378|NCT01008553|590064520|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
163370379|NCT01008553|590064521|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
163370380|NCT01008553|590064519|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
163370381|NCT01008553|590064520|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
163370382|NCT01008553|590064521|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
163370383|NCT01008553|590064519|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
163370384|NCT01008553|590064520|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
163370385|NCT01008553|590064521|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
163370386|NCT01008553|590064519|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
163370387|NCT01008553|590064520|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
163370388|NCT01008553|590064521|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
163370389|NCT01008553|590064519|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
163370390|NCT01008553|590064520|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
163370391|NCT01008553|590064521|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
163370392|NCT00581555|590064522|FG000|Overall Study|Adverse Event|4|||
163370393|NCT00581555|590064523|FG001|Overall Study|Adverse Event|3|||
163370394|NCT00581555|590064522|FG000|Overall Study|Physician Decision|3|||
163370395|NCT00581555|590064523|FG001|Overall Study|Physician Decision|2|||
163370396|NCT00581555|590064522|FG000|Overall Study|Withdrawal by Subject|18|||
163370397|NCT00581555|590064523|FG001|Overall Study|Withdrawal by Subject|9|||
163370398|NCT00581555|590064522|FG000|Overall Study|Lost to Follow-up|2|||
163370399|NCT00581555|590064523|FG001|Overall Study|Lost to Follow-up|2|||
163370400|NCT00581555|590064522|FG000|Overall Study|Other reasons|16|||
163370401|NCT00581555|590064523|FG001|Overall Study|Other reasons|4|||
163370402|NCT02787044|590064524|FG000|Overall Study|Lost to Follow-up|15|||
163370403|NCT02787044|590064525|FG001|Overall Study|Lost to Follow-up|19|||
163370404|NCT01638429|590064526|FG000|Overall Study|Withdrawal by Subject|1|||
163370405|NCT02040584|590064527|FG000|Overall Study|Adverse Event|13|||
163370406|NCT02040584|590064528|FG001|Overall Study|Adverse Event|6|||
163370407|NCT02040584|590064527|FG000|Overall Study|Protocol Violation|9|||
163370408|NCT02040584|590064528|FG001|Overall Study|Protocol Violation|11|||
163370409|NCT02040584|590064527|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163370410|NCT02040584|590064528|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163370411|NCT02040584|590064527|FG000|Overall Study|Death|6|||
163370412|NCT02040584|590064528|FG001|Overall Study|Death|3|||
163370413|NCT02040584|590064527|FG000|Overall Study|Transplant rejection/retransplant|0|||
163370414|NCT02040584|590064528|FG001|Overall Study|Transplant rejection/retransplant|1|||
163370415|NCT02040584|590064527|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
163370416|NCT02040584|590064528|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
163370417|NCT02530970|590064544|FG000|Overall Study|Adverse Event|8|||
163370418|NCT02530970|590064544|FG000|Overall Study|Lost to Follow-up|88|||
163370419|NCT02530970|590064544|FG000|Overall Study|Physician Decision|5|||
163370420|NCT02530970|590064544|FG000|Overall Study|Withdrawal by Subject|14|||
163370421|NCT02530970|590064544|FG000|Overall Study|Death|6|||
163370422|NCT02530970|590064544|FG000|Overall Study|Hospitalization|1|||
163370423|NCT02530970|590064544|FG000|Overall Study|Insurance|2|||
163370424|NCT02530970|590064544|FG000|Overall Study|Explant|2|||
163370425|NCT02530970|590064544|FG000|Overall Study|Change in Provider|5|||
163370426|NCT02530970|590064544|FG000|Overall Study|Relocation|3|||
163370427|NCT00743431|590064548|FG000|Overall Study|Toxicity|6|||
163370428|NCT00743431|590064548|FG000|Overall Study|Tumor progression|56|||
163370429|NCT00743431|590064548|FG000|Overall Study|Withdrawal by Subject|13|||
163370430|NCT00743431|590064548|FG000|Overall Study|Death|9|||
163370431|NCT00743431|590064548|FG000|Overall Study|Reason for discontinuation not specified|29|||
163370432|NCT00743431|590064548|FG000|Overall Study|No documentation available|13|||
163370433|NCT03291288|590064549|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
163370434|NCT03291288|590064550|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
163370435|NCT03291288|590064549|FG000|Drug-drug Interaction Phase|Disease progression|1|||
163370436|NCT03291288|590064550|FG001|Drug-drug Interaction Phase|Disease progression|0|||
163370437|NCT03291288|590064549|FG000|Drug-drug Interaction Phase|Other|3|||
163370438|NCT03291288|590064550|FG001|Drug-drug Interaction Phase|Other|0|||
163370439|NCT03291288|590064549|FG000|Pexidartinib Only|Ongoing|0|||
163370440|NCT03291288|590064550|FG001|Pexidartinib Only|Ongoing|2|||
163370441|NCT04978493|590064551|FG000|Overall Study|No reason available|0|||
163370442|NCT04978493|590064552|FG001|Overall Study|No reason available|1|||
163370443|NCT04978493|590064551|FG000|Overall Study|Adverse Event|1|||
163370444|NCT04978493|590064552|FG001|Overall Study|Adverse Event|0|||
163370445|NCT01896726|590064553|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
163370446|NCT01896726|590064553|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
163370447|NCT01128114|590064554|FG000|Overall Study|Treatment Withdrawn|6|||
163370448|NCT01128114|590064554|FG000|Overall Study|Screening Failed|2|||
163370449|NCT02387970|590064555|FG000|Overall Study|Did not complete 1-year follow up|1|||
163370450|NCT02387970|590064556|FG001|Overall Study|Did not complete 1-year follow up|2|||
163370451|NCT02628028|590064557|FG000|Dosing Period|Withdrawal by Subject|0|||
163370452|NCT02628028|590064558|FG001|Dosing Period|Withdrawal by Subject|0|||
163370453|NCT02628028|590064559|FG002|Dosing Period|Withdrawal by Subject|1|||
163370454|NCT02628028|590064560|FG003|Dosing Period|Withdrawal by Subject|0|||
163370455|NCT02628028|590064561|FG004|Dosing Period|Withdrawal by Subject|2|||
163370456|NCT02628028|590064562|FG005|Dosing Period|Withdrawal by Subject|4|||
163370457|NCT02628028|590064563|FG006|Dosing Period|Withdrawal by Subject|1|||
163370458|NCT02628028|590064564|FG007|Dosing Period|Withdrawal by Subject|1|||
163370459|NCT02628028|590064557|FG000|Dosing Period|Adverse Event|0|||
163370460|NCT02628028|590064558|FG001|Dosing Period|Adverse Event|0|||
163370461|NCT02628028|590064559|FG002|Dosing Period|Adverse Event|0|||
163370462|NCT02628028|590064560|FG003|Dosing Period|Adverse Event|0|||
163370463|NCT02628028|590064561|FG004|Dosing Period|Adverse Event|2|||
163370464|NCT02628028|590064562|FG005|Dosing Period|Adverse Event|1|||
163370465|NCT02628028|590064563|FG006|Dosing Period|Adverse Event|3|||
163370466|NCT02628028|590064564|FG007|Dosing Period|Adverse Event|2|||
163370467|NCT02628028|590064557|FG000|Dosing Period|Death|0|||
163370468|NCT02628028|590064558|FG001|Dosing Period|Death|0|||
163370469|NCT02628028|590064559|FG002|Dosing Period|Death|0|||
163370470|NCT02628028|590064560|FG003|Dosing Period|Death|0|||
163370471|NCT02628028|590064561|FG004|Dosing Period|Death|0|||
163370472|NCT02628028|590064562|FG005|Dosing Period|Death|0|||
163370473|NCT02628028|590064563|FG006|Dosing Period|Death|0|||
163370474|NCT02628028|590064564|FG007|Dosing Period|Death|1|||
163370475|NCT02628028|590064557|FG000|Dosing Period|Lack of Efficacy|0|||
163370476|NCT02628028|590064558|FG001|Dosing Period|Lack of Efficacy|0|||
163370477|NCT02628028|590064559|FG002|Dosing Period|Lack of Efficacy|0|||
163370478|NCT02628028|590064560|FG003|Dosing Period|Lack of Efficacy|0|||
163370479|NCT02628028|590064561|FG004|Dosing Period|Lack of Efficacy|3|||
163370480|NCT02628028|590064562|FG005|Dosing Period|Lack of Efficacy|0|||
163370481|NCT02628028|590064563|FG006|Dosing Period|Lack of Efficacy|1|||
163370482|NCT02628028|590064564|FG007|Dosing Period|Lack of Efficacy|0|||
163370483|NCT02628028|590064557|FG000|Dosing Period|Study Terminated by Sponsor|0|||
163370484|NCT02628028|590064558|FG001|Dosing Period|Study Terminated by Sponsor|0|||
163370485|NCT02628028|590064559|FG002|Dosing Period|Study Terminated by Sponsor|0|||
163370486|NCT02628028|590064560|FG003|Dosing Period|Study Terminated by Sponsor|0|||
163370487|NCT02628028|590064561|FG004|Dosing Period|Study Terminated by Sponsor|7|||
163370488|NCT02628028|590064562|FG005|Dosing Period|Study Terminated by Sponsor|6|||
163370489|NCT02628028|590064563|FG006|Dosing Period|Study Terminated by Sponsor|7|||
163370490|NCT02628028|590064564|FG007|Dosing Period|Study Terminated by Sponsor|7|||
163370491|NCT02628028|590064557|FG000|Dosing Period|Physician Decision|0|||
163370492|NCT02628028|590064558|FG001|Dosing Period|Physician Decision|0|||
163370493|NCT02628028|590064559|FG002|Dosing Period|Physician Decision|0|||
163370494|NCT02628028|590064560|FG003|Dosing Period|Physician Decision|0|||
163370495|NCT02628028|590064561|FG004|Dosing Period|Physician Decision|0|||
163370496|NCT02628028|590064562|FG005|Dosing Period|Physician Decision|1|||
163370497|NCT02628028|590064563|FG006|Dosing Period|Physician Decision|0|||
163370498|NCT02628028|590064564|FG007|Dosing Period|Physician Decision|0|||
163370499|NCT02628028|590064557|FG000|Dosing Period|Site Terminated by Sponsor|0|||
163370500|NCT02628028|590064558|FG001|Dosing Period|Site Terminated by Sponsor|0|||
163370501|NCT02628028|590064559|FG002|Dosing Period|Site Terminated by Sponsor|0|||
163370502|NCT02628028|590064560|FG003|Dosing Period|Site Terminated by Sponsor|0|||
163370503|NCT02628028|590064561|FG004|Dosing Period|Site Terminated by Sponsor|0|||
163370504|NCT02628028|590064562|FG005|Dosing Period|Site Terminated by Sponsor|1|||
163370505|NCT02628028|590064563|FG006|Dosing Period|Site Terminated by Sponsor|1|||
163370506|NCT02628028|590064564|FG007|Dosing Period|Site Terminated by Sponsor|0|||
163370507|NCT02628028|590064557|FG000|Dosing Period|Lost to Follow-up|0|||
163370508|NCT02628028|590064558|FG001|Dosing Period|Lost to Follow-up|0|||
163370509|NCT02628028|590064559|FG002|Dosing Period|Lost to Follow-up|0|||
163370510|NCT02628028|590064560|FG003|Dosing Period|Lost to Follow-up|0|||
163370511|NCT02628028|590064561|FG004|Dosing Period|Lost to Follow-up|0|||
163370512|NCT02628028|590064562|FG005|Dosing Period|Lost to Follow-up|0|||
163370513|NCT02628028|590064563|FG006|Dosing Period|Lost to Follow-up|1|||
163370514|NCT02628028|590064564|FG007|Dosing Period|Lost to Follow-up|0|||
163370515|NCT02628028|590064557|FG000|Dosing Period|Other|0|||
163370516|NCT02628028|590064558|FG001|Dosing Period|Other|0|||
163370517|NCT02628028|590064559|FG002|Dosing Period|Other|0|||
163370518|NCT02628028|590064560|FG003|Dosing Period|Other|0|||
163370519|NCT02628028|590064561|FG004|Dosing Period|Other|2|||
163370520|NCT02628028|590064562|FG005|Dosing Period|Other|1|||
163370521|NCT02628028|590064563|FG006|Dosing Period|Other|2|||
163370522|NCT02628028|590064564|FG007|Dosing Period|Other|4|||
163370523|NCT02628028|590064557|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
163370524|NCT02628028|590064558|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
163370525|NCT02628028|590064559|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
163370526|NCT02628028|590064560|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
163370527|NCT02628028|590064561|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
163370528|NCT02628028|590064562|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
163370529|NCT02628028|590064563|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
163370530|NCT02628028|590064564|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
163370531|NCT02628028|590064557|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
163370532|NCT02628028|590064558|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
163370533|NCT02628028|590064559|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
163370534|NCT02628028|590064560|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
163370535|NCT02628028|590064561|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
163370536|NCT02628028|590064562|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
163370537|NCT02628028|590064563|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
163370538|NCT02628028|590064564|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
163370539|NCT02628028|590064557|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
163370540|NCT02628028|590064558|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
163370541|NCT02628028|590064559|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
163370542|NCT02628028|590064560|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
163370543|NCT02628028|590064561|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
163370544|NCT02628028|590064562|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
163370545|NCT02628028|590064563|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
163370546|NCT02628028|590064564|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
163370547|NCT02628028|590064557|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
163370548|NCT02628028|590064558|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
163370549|NCT02628028|590064559|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
163370550|NCT02628028|590064560|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
163370551|NCT02628028|590064561|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
163370552|NCT02628028|590064562|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
163370553|NCT02628028|590064563|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
163370554|NCT02628028|590064564|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
163370555|NCT02628028|590064557|FG000|Long-term Extension (LTE) Period|Other|0|||
163370556|NCT02628028|590064558|FG001|Long-term Extension (LTE) Period|Other|0|||
163370557|NCT02628028|590064559|FG002|Long-term Extension (LTE) Period|Other|0|||
163370558|NCT02628028|590064560|FG003|Long-term Extension (LTE) Period|Other|0|||
163370559|NCT02628028|590064561|FG004|Long-term Extension (LTE) Period|Other|0|||
163370560|NCT02628028|590064562|FG005|Long-term Extension (LTE) Period|Other|3|||
163370561|NCT02628028|590064563|FG006|Long-term Extension (LTE) Period|Other|4|||
163370562|NCT02628028|590064564|FG007|Long-term Extension (LTE) Period|Other|3|||
163370563|NCT00586612|590064565|FG000|Primary Phase|Protocol Violation|1|||
163370564|NCT00586612|590064566|FG001|Primary Phase|Protocol Violation|0|||
163370565|NCT00586612|590064565|FG000|Primary Phase|Lost to Follow-up|0|||
163370566|NCT00586612|590064566|FG001|Primary Phase|Lost to Follow-up|1|||
163370567|NCT00586612|590064565|FG000|Primary Phase|Withdrawal by Subject|0|||
163370568|NCT00586612|590064566|FG001|Primary Phase|Withdrawal by Subject|2|||
163370569|NCT00586612|590064565|FG000|Booster Phase|Lost to Follow-up|3|||
163370570|NCT00586612|590064566|FG001|Booster Phase|Lost to Follow-up|1|||
163370571|NCT01743989|590064567|FG000|Treatment Phase|Unstable MR4.0|0|||
163370572|NCT01743989|590064568|FG001|Treatment Phase|Unstable MR4.0|6|||
163370573|NCT01743989|590064569|FG002|Treatment Phase|Unstable MR4.0|263|||
163370574|NCT01743989|590064567|FG000|Treatment Phase|Adverse Event|0|||
163370575|NCT01743989|590064568|FG001|Treatment Phase|Adverse Event|4|||
163370576|NCT01743989|590064569|FG002|Treatment Phase|Adverse Event|67|||
163370577|NCT01743989|590064567|FG000|Treatment Phase|Withdrawal by Subject|1|||
163370578|NCT01743989|590064568|FG001|Treatment Phase|Withdrawal by Subject|3|||
163370579|NCT01743989|590064569|FG002|Treatment Phase|Withdrawal by Subject|28|||
163370580|NCT01743989|590064567|FG000|Treatment Phase|Death|0|||
163370581|NCT01743989|590064568|FG001|Treatment Phase|Death|1|||
163370582|NCT01743989|590064569|FG002|Treatment Phase|Death|3|||
163370583|NCT01743989|590064567|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
163370584|NCT01743989|590064568|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
163370585|NCT01743989|590064569|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
163370586|NCT01743989|590064567|FG000|Treatment Phase|Protocol deviation|0|||
163370587|NCT01743989|590064568|FG001|Treatment Phase|Protocol deviation|0|||
163370588|NCT01743989|590064569|FG002|Treatment Phase|Protocol deviation|3|||
163370589|NCT01743989|590064567|FG000|Treatment Phase|Pregnancy|0|||
163370590|NCT01743989|590064568|FG001|Treatment Phase|Pregnancy|0|||
163370591|NCT01743989|590064569|FG002|Treatment Phase|Pregnancy|2|||
163370592|NCT01743989|590064567|FG000|Treatment Phase|Lost to Follow-up|0|||
163370593|NCT01743989|590064568|FG001|Treatment Phase|Lost to Follow-up|0|||
163370594|NCT01743989|590064569|FG002|Treatment Phase|Lost to Follow-up|2|||
163370595|NCT01743989|590064567|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
163370596|NCT01743989|590064568|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
163370597|NCT01743989|590064569|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
163370598|NCT01743989|590064567|FG000|Treatment Phase|Administrative problems|0|||
163370599|NCT01743989|590064568|FG001|Treatment Phase|Administrative problems|0|||
163370600|NCT01743989|590064569|FG002|Treatment Phase|Administrative problems|1|||
163370601|NCT01743989|590064567|FG000|Treatment Phase|New cancer (CML) therapy|0|||
163370602|NCT01743989|590064568|FG001|Treatment Phase|New cancer (CML) therapy|1|||
163370603|NCT01743989|590064569|FG002|Treatment Phase|New cancer (CML) therapy|0|||
163370604|NCT01743989|590064567|FG000|Treatment Phase|Physician Decision|0|||
163370605|NCT01743989|590064568|FG001|Treatment Phase|Physician Decision|0|||
163370606|NCT01743989|590064569|FG002|Treatment Phase|Physician Decision|3|||
163370607|NCT01743989|590064567|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
163370608|NCT01743989|590064568|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
163370609|NCT01743989|590064569|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
163370610|NCT01743989|590064567|FG000|Treatment Phase|Not randomized by mistake|0|||
163370611|NCT01743989|590064568|FG001|Treatment Phase|Not randomized by mistake|0|||
163370612|NCT01743989|590064569|FG002|Treatment Phase|Not randomized by mistake|1|||
163370613|NCT01743989|590064567|FG000|Treatment Phase|Included by mistake|0|||
163370614|NCT01743989|590064568|FG001|Treatment Phase|Included by mistake|0|||
163370615|NCT01743989|590064569|FG002|Treatment Phase|Included by mistake|1|||
163370616|NCT01743989|590064567|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
163370617|NCT01743989|590064568|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
163370618|NCT01743989|590064569|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
163370619|NCT01743989|590064567|FG000|TFR Phase|Adverse Event|0|||
163370620|NCT01743989|590064568|FG001|TFR Phase|Adverse Event|1|||
163370621|NCT01743989|590064569|FG002|TFR Phase|Adverse Event|0|||
163370622|NCT01743989|590064567|FG000|TFR Phase|Lost to Follow-up|0|||
163370623|NCT01743989|590064568|FG001|TFR Phase|Lost to Follow-up|2|||
163370624|NCT01743989|590064569|FG002|TFR Phase|Lost to Follow-up|0|||
163370625|NCT01743989|590064567|FG000|TFR Phase|Physician Decision|0|||
163370626|NCT01743989|590064568|FG001|TFR Phase|Physician Decision|1|||
163370627|NCT01743989|590064569|FG002|TFR Phase|Physician Decision|0|||
163370628|NCT01743989|590064567|FG000|TFR Phase|Logistical problems|0|||
163370629|NCT01743989|590064568|FG001|TFR Phase|Logistical problems|2|||
163370630|NCT01743989|590064569|FG002|TFR Phase|Logistical problems|0|||
163370631|NCT01743989|590064567|FG000|TFR Phase|Protocol deviation|0|||
163370632|NCT01743989|590064568|FG001|TFR Phase|Protocol deviation|1|||
163370633|NCT01743989|590064569|FG002|TFR Phase|Protocol deviation|0|||
163370634|NCT01743989|590064567|FG000|TFR Phase|Withdrawal by Subject|0|||
163370635|NCT01743989|590064568|FG001|TFR Phase|Withdrawal by Subject|2|||
163370636|NCT01743989|590064569|FG002|TFR Phase|Withdrawal by Subject|0|||
163370637|NCT01743989|590064567|FG000|Re-treatment Phase|Adverse Event|8|||
163370638|NCT01743989|590064568|FG001|Re-treatment Phase|Adverse Event|4|||
163370639|NCT01743989|590064569|FG002|Re-treatment Phase|Adverse Event|0|||
163370640|NCT01743989|590064567|FG000|Re-treatment Phase|Death|1|||
163370641|NCT01743989|590064568|FG001|Re-treatment Phase|Death|1|||
163370642|NCT01743989|590064569|FG002|Re-treatment Phase|Death|0|||
163370643|NCT01743989|590064567|FG000|Re-treatment Phase|Administrative problems|1|||
163370644|NCT01743989|590064568|FG001|Re-treatment Phase|Administrative problems|1|||
163370645|NCT01743989|590064569|FG002|Re-treatment Phase|Administrative problems|0|||
163370646|NCT01743989|590064567|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
163370647|NCT01743989|590064568|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
163370648|NCT01743989|590064569|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
163370649|NCT01743989|590064567|FG000|Re-treatment Phase|Unstable MR|1|||
163370650|NCT01743989|590064568|FG001|Re-treatment Phase|Unstable MR|0|||
163370651|NCT01743989|590064569|FG002|Re-treatment Phase|Unstable MR|0|||
163370652|NCT01743989|590064567|FG000|Re-treatment Phase|Physician Decision|0|||
163370653|NCT01743989|590064568|FG001|Re-treatment Phase|Physician Decision|1|||
163370654|NCT01743989|590064569|FG002|Re-treatment Phase|Physician Decision|0|||
163370655|NCT01743989|590064567|FG000|Re-treatment Phase|Lost to Follow-up|0|||
163370656|NCT01743989|590064568|FG001|Re-treatment Phase|Lost to Follow-up|1|||
163370657|NCT01743989|590064569|FG002|Re-treatment Phase|Lost to Follow-up|0|||
163370658|NCT02235311|590064572|FG000|Overall Study|Lost to Follow-up|0|||
163370659|NCT02235311|590064573|FG001|Overall Study|Lost to Follow-up|1|||
163370660|NCT02235311|590064572|FG000|Overall Study|Protocol Violation|0|||
163370661|NCT02235311|590064573|FG001|Overall Study|Protocol Violation|1|||
163370662|NCT04655027|590064574|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
163370663|NCT04655027|590064575|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
163370664|NCT00658788|590064576|FG000|Overall Study|Adverse Event|11|||
163370665|NCT00658788|590064576|FG000|Overall Study|Withdrawal by Subject|13|||
163370666|NCT00658788|590064576|FG000|Overall Study|Lost to Follow-up|18|||
163370667|NCT00658788|590064576|FG000|Overall Study|Treatment Discontinuation|32|||
163370668|NCT00653523|590064577|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
163370669|NCT00653523|590064577|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
163370670|NCT00653523|590064577|FG000|Overall Study|Adverse Event|7|||
163370671|NCT00653523|590064577|FG000|Overall Study|Withdrawal by Subject|6|||
163370672|NCT00653523|590064577|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
163370673|NCT00653523|590064577|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
163370674|NCT05543707|590064582|FG000|Overall Study|Study drug non-compliance/|5|||
163370675|NCT05543707|590064583|FG001|Overall Study|Study drug non-compliance/|0|||
163370676|NCT05543707|590064582|FG000|Overall Study|Withdrawal by Subject|1|||
163370677|NCT05543707|590064583|FG001|Overall Study|Withdrawal by Subject|1|||
163370678|NCT05543707|590064582|FG000|Overall Study|Adverse Event|1|||
163370679|NCT05543707|590064583|FG001|Overall Study|Adverse Event|0|||
163370680|NCT05543707|590064582|FG000|Overall Study|concurrent illness|0|||
163370681|NCT05543707|590064583|FG001|Overall Study|concurrent illness|1|||
163370682|NCT05543707|590064582|FG000|Overall Study|Pregnancy|1|||
163413411|NCT00143455|590220928|FG000|Cohort 2|Progressive Disease|0|||
163370683|NCT05543707|590064583|FG001|Overall Study|Pregnancy|1|||
163370684|NCT00186888|590064584|FG000|Overall Study|Toxicity|0|||
163370685|NCT00186888|590064585|FG001|Overall Study|Toxicity|1|||
163413412|NCT00143455|590220929|FG001|Cohort 2|Progressive Disease|0|||
163370686|NCT00186888|590064586|FG002|Overall Study|Toxicity|0|||
163370687|NCT00186888|590064584|FG000|Overall Study|Relapse or progression of disease|4|||
163370688|NCT00186888|590064585|FG001|Overall Study|Relapse or progression of disease|2|||
163370689|NCT00186888|590064586|FG002|Overall Study|Relapse or progression of disease|0|||
163370690|NCT05511038|590064587|FG000|Overall|Withdrawal by Subject|5|||
163370691|NCT05511038|590064588|FG001|Overall|Withdrawal by Subject|3|||
163370692|NCT05511038|590064587|FG000|Overall|Screen Failure|20|||
163370693|NCT05511038|590064588|FG001|Overall|Screen Failure|1|||
163370694|NCT05511038|590064587|FG000|Overall|Physician Decision|3|||
163370695|NCT05511038|590064588|FG001|Overall|Physician Decision|0|||
163370696|NCT05511038|590064587|FG000|Overall|Lost to Follow-up|3|||
163370697|NCT05511038|590064588|FG001|Overall|Lost to Follow-up|0|||
163370698|NCT05511038|590064587|FG000|Overall|Death|1|||
163370699|NCT05511038|590064588|FG001|Overall|Death|0|||
163370700|NCT05511038|590064587|FG000|Screening|Withdrawal by Subject|1|||
163370701|NCT05511038|590064588|FG001|Screening|Withdrawal by Subject|0|||
163370702|NCT05511038|590064587|FG000|Screening|Lost to Follow Up (1 participant)|1|||
163370703|NCT05511038|590064588|FG001|Screening|Lost to Follow Up (1 participant)|0|||
163370704|NCT05511038|590064587|FG000|Screening|Screen Failure|3|||
163370705|NCT05511038|590064588|FG001|Screening|Screen Failure|0|||
163370706|NCT05511038|590064587|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
163370707|NCT05511038|590064588|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
163370708|NCT05511038|590064587|FG000|Treatment|Withdrawal by Subject|5|||
163370709|NCT05511038|590064588|FG001|Treatment|Withdrawal by Subject|3|||
163370710|NCT05511038|590064587|FG000|Treatment|Physician Decision|4|||
163370711|NCT05511038|590064588|FG001|Treatment|Physician Decision|0|||
163370712|NCT05511038|590064587|FG000|Treatment|Lost to Follow-up|2|||
163370713|NCT05511038|590064588|FG001|Treatment|Lost to Follow-up|0|||
163370714|NCT05511038|590064587|FG000|Treatment|Death|1|||
163370715|NCT05511038|590064588|FG001|Treatment|Death|0|||
163370716|NCT05511038|590064587|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
163370717|NCT05511038|590064588|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
163370718|NCT05511038|590064587|FG000|Treatment|Refuse by subject|1|||
163370719|NCT05511038|590064588|FG001|Treatment|Refuse by subject|0|||
163370720|NCT05511038|590064587|FG000|Treatment|Subject did not go to the site for visit|1|||
163370721|NCT05511038|590064588|FG001|Treatment|Subject did not go to the site for visit|0|||
163370722|NCT02108964|590064589|FG000|Overall Study|Progressive disease|15|||
163370723|NCT02108964|590064590|FG001|Overall Study|Progressive disease|31|||
163370724|NCT02108964|590064591|FG002|Overall Study|Progressive disease|54|||
163370725|NCT02108964|590064592|FG003|Overall Study|Progressive disease|7|||
163370726|NCT02108964|590064593|FG004|Overall Study|Progressive disease|20|||
163370727|NCT02108964|590064594|FG005|Overall Study|Progressive disease|4|||
163370728|NCT02108964|590064595|FG006|Overall Study|Progressive disease|6|||
163370729|NCT02108964|590064596|FG007|Overall Study|Progressive disease|33|||
163370730|NCT02108964|590064589|FG000|Overall Study|Physician Decision|1|||
163370731|NCT02108964|590064590|FG001|Overall Study|Physician Decision|5|||
163370732|NCT02108964|590064591|FG002|Overall Study|Physician Decision|7|||
163370733|NCT02108964|590064592|FG003|Overall Study|Physician Decision|1|||
163370734|NCT02108964|590064593|FG004|Overall Study|Physician Decision|2|||
163370735|NCT02108964|590064594|FG005|Overall Study|Physician Decision|1|||
163370736|NCT02108964|590064595|FG006|Overall Study|Physician Decision|1|||
163370737|NCT02108964|590064596|FG007|Overall Study|Physician Decision|3|||
163370738|NCT02108964|590064589|FG000|Overall Study|Adverse Event|0|||
163370739|NCT02108964|590064590|FG001|Overall Study|Adverse Event|0|||
163370740|NCT02108964|590064591|FG002|Overall Study|Adverse Event|4|||
163370741|NCT02108964|590064592|FG003|Overall Study|Adverse Event|0|||
163370742|NCT02108964|590064593|FG004|Overall Study|Adverse Event|1|||
163370743|NCT02108964|590064594|FG005|Overall Study|Adverse Event|0|||
163370744|NCT02108964|590064595|FG006|Overall Study|Adverse Event|3|||
163370745|NCT02108964|590064596|FG007|Overall Study|Adverse Event|2|||
163370746|NCT02108964|590064589|FG000|Overall Study|Death|1|||
163370747|NCT02108964|590064590|FG001|Overall Study|Death|1|||
163370748|NCT02108964|590064591|FG002|Overall Study|Death|4|||
163370749|NCT02108964|590064592|FG003|Overall Study|Death|0|||
163370750|NCT02108964|590064593|FG004|Overall Study|Death|3|||
163370751|NCT02108964|590064594|FG005|Overall Study|Death|0|||
163370752|NCT02108964|590064595|FG006|Overall Study|Death|0|||
163370753|NCT02108964|590064596|FG007|Overall Study|Death|2|||
163370754|NCT02108964|590064589|FG000|Overall Study|Subject/Guardian decision|0|||
163370755|NCT02108964|590064590|FG001|Overall Study|Subject/Guardian decision|1|||
163370756|NCT02108964|590064591|FG002|Overall Study|Subject/Guardian decision|4|||
163370757|NCT02108964|590064592|FG003|Overall Study|Subject/Guardian decision|0|||
163370758|NCT02108964|590064593|FG004|Overall Study|Subject/Guardian decision|2|||
163370759|NCT02108964|590064594|FG005|Overall Study|Subject/Guardian decision|0|||
163370760|NCT02108964|590064595|FG006|Overall Study|Subject/Guardian decision|1|||
163370761|NCT02108964|590064596|FG007|Overall Study|Subject/Guardian decision|2|||
163370762|NCT02108964|590064589|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
163370763|NCT02108964|590064590|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
163370764|NCT02108964|590064591|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
163384939|NCT00427895|590119250|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
163370765|NCT02108964|590064592|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
163370766|NCT02108964|590064593|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
163370767|NCT02108964|590064594|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
163370768|NCT02108964|590064595|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
163370769|NCT02108964|590064596|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
163370770|NCT03006848|590064597|FG000|Overall Study|Adverse Event|1|||
163370771|NCT03006848|590064597|FG000|Overall Study|Physician Decision|1|||
163370772|NCT03006848|590064597|FG000|Overall Study|Lack of Efficacy|16|||
163370773|NCT03086655|590064600|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
163370774|NCT03086655|590064601|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
163370775|NCT03086655|590064600|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
163370776|NCT03086655|590064601|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
163370777|NCT03086655|590064600|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
163370778|NCT03086655|590064601|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
163370779|NCT03086655|590064600|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
163370780|NCT03086655|590064601|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
163370781|NCT03086655|590064600|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
163370782|NCT03086655|590064601|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
163370783|NCT03086655|590064600|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
163370784|NCT03086655|590064601|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
163370785|NCT03086655|590064600|FG000|12 Month Follow-up = Final Assessment|Death|0|||
163370786|NCT03086655|590064601|FG001|12 Month Follow-up = Final Assessment|Death|1|||
163370787|NCT00384397|590064602|FG000|Overall Study|Adverse Event|0|||
163370788|NCT00384397|590064603|FG001|Overall Study|Adverse Event|1|||
163370789|NCT00384397|590064604|FG002|Overall Study|Adverse Event|2|||
163370790|NCT00384397|590064602|FG000|Overall Study|Protocol Violation|7|||
163370791|NCT00384397|590064603|FG001|Overall Study|Protocol Violation|15|||
163370792|NCT00384397|590064604|FG002|Overall Study|Protocol Violation|13|||
163370793|NCT00384397|590064602|FG000|Overall Study|Lost to Follow-up|11|||
163370794|NCT00384397|590064603|FG001|Overall Study|Lost to Follow-up|13|||
163370795|NCT00384397|590064604|FG002|Overall Study|Lost to Follow-up|3|||
163370796|NCT00384397|590064602|FG000|Overall Study|Withdrawal by Subject|14|||
163370797|NCT00384397|590064603|FG001|Overall Study|Withdrawal by Subject|17|||
163370798|NCT00384397|590064604|FG002|Overall Study|Withdrawal by Subject|15|||
163370799|NCT04531982|590064605|FG000|Overall Study|Withdrawal by Subject|10|||
163370800|NCT04531982|590064606|FG001|Overall Study|Withdrawal by Subject|11|||
163370801|NCT04531982|590064605|FG000|Overall Study|Adverse Event|6|||
163370802|NCT04531982|590064606|FG001|Overall Study|Adverse Event|14|||
163370803|NCT04531982|590064605|FG000|Overall Study|Protocol Violation|6|||
163370804|NCT04531982|590064606|FG001|Overall Study|Protocol Violation|9|||
163370805|NCT04531982|590064605|FG000|Overall Study|Non-compliance with study drug|3|||
163370806|NCT04531982|590064606|FG001|Overall Study|Non-compliance with study drug|2|||
163370807|NCT04531982|590064605|FG000|Overall Study|Use of prohibited medication|2|||
163370808|NCT04531982|590064606|FG001|Overall Study|Use of prohibited medication|0|||
163370809|NCT04531982|590064605|FG000|Overall Study|Lost to Follow-up|0|||
163370810|NCT04531982|590064606|FG001|Overall Study|Lost to Follow-up|1|||
163370811|NCT04531982|590064605|FG000|Overall Study|Geopolitical conflict|2|||
163370812|NCT04531982|590064606|FG001|Overall Study|Geopolitical conflict|0|||
163370813|NCT04531982|590064605|FG000|Overall Study|Lack of Efficacy|3|||
163370814|NCT04531982|590064606|FG001|Overall Study|Lack of Efficacy|1|||
163370815|NCT04998812|590064609|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
163370816|NCT04998812|590064610|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
163370817|NCT04998812|590064609|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
163370818|NCT04998812|590064610|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
163370819|NCT04998812|590064609|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
163370820|NCT04998812|590064610|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
163370821|NCT04998812|590064609|FG000|Vaccination Period|Ongoing in study|23|||
163370822|NCT04998812|590064610|FG001|Vaccination Period|Ongoing in study|23|||
163370823|NCT03524092|590064611|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
163370824|NCT03524092|590064612|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
163370825|NCT03524092|590064613|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
163370826|NCT03524092|590064614|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
163370827|NCT03524092|590064615|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
163370828|NCT03524092|590064616|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
163370829|NCT03524092|590064611|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
163370830|NCT03524092|590064612|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
163370831|NCT03524092|590064613|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
163370832|NCT03524092|590064614|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
163370833|NCT03524092|590064615|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
163370834|NCT03524092|590064616|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
163370835|NCT03524092|590064611|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
163370836|NCT03524092|590064612|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
163370837|NCT03524092|590064613|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
163370838|NCT03524092|590064614|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
163370839|NCT03524092|590064615|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
163370840|NCT03524092|590064616|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
163370841|NCT03524092|590064611|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
163370842|NCT03524092|590064612|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
163370843|NCT03524092|590064613|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
163370844|NCT03524092|590064614|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
163370845|NCT03524092|590064615|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
163370846|NCT03524092|590064616|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
163370847|NCT03524092|590064611|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
163370848|NCT03524092|590064612|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
163370849|NCT03524092|590064613|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
163370850|NCT03524092|590064614|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
163370851|NCT03524092|590064615|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
163370852|NCT03524092|590064616|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
163370853|NCT03524092|590064611|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
163370854|NCT03524092|590064612|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
163370855|NCT03524092|590064613|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
163370856|NCT03524092|590064614|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
163370857|NCT03524092|590064615|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
163370858|NCT03524092|590064616|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
163370859|NCT03524092|590064611|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
163370860|NCT03524092|590064612|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
163370861|NCT03524092|590064613|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
163370862|NCT03524092|590064614|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
163370863|NCT03524092|590064615|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
163370864|NCT03524092|590064616|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
163370865|NCT03524092|590064611|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
163370866|NCT03524092|590064612|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
163370867|NCT03524092|590064613|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
163370868|NCT03524092|590064614|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
163370869|NCT03524092|590064615|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
163370870|NCT03524092|590064616|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
163370871|NCT03524092|590064611|FG000|Loss of Response Rescue Period|Adverse Event|0|||
163370872|NCT03524092|590064612|FG001|Loss of Response Rescue Period|Adverse Event|0|||
163370873|NCT03524092|590064613|FG002|Loss of Response Rescue Period|Adverse Event|0|||
163370874|NCT03524092|590064614|FG003|Loss of Response Rescue Period|Adverse Event|2|||
163370875|NCT03524092|590064615|FG004|Loss of Response Rescue Period|Adverse Event|0|||
163370876|NCT03524092|590064616|FG005|Loss of Response Rescue Period|Adverse Event|0|||
163370877|NCT03524092|590064611|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
163370878|NCT03524092|590064612|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
163370879|NCT03524092|590064613|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
163370880|NCT03524092|590064614|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
163370881|NCT03524092|590064615|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
163370882|NCT03524092|590064616|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
163370883|NCT03524092|590064611|FG000|Loss of Response Rescue Period|Pregnancy|0|||
163370884|NCT03524092|590064612|FG001|Loss of Response Rescue Period|Pregnancy|0|||
163370885|NCT03524092|590064613|FG002|Loss of Response Rescue Period|Pregnancy|0|||
163370886|NCT03524092|590064614|FG003|Loss of Response Rescue Period|Pregnancy|1|||
163370887|NCT03524092|590064615|FG004|Loss of Response Rescue Period|Pregnancy|0|||
163370888|NCT03524092|590064616|FG005|Loss of Response Rescue Period|Pregnancy|0|||
163370889|NCT03524092|590064611|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
163370890|NCT03524092|590064612|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
163370891|NCT03524092|590064613|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
163370892|NCT03524092|590064614|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
163370893|NCT03524092|590064615|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
163370894|NCT03524092|590064616|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
163370895|NCT03524092|590064611|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
163370896|NCT03524092|590064612|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
163370897|NCT03524092|590064613|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
163370898|NCT03524092|590064614|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
163370899|NCT03524092|590064615|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
163413413|NCT00143455|590220930|FG002|Cohort 2|Progressive Disease|20|||
163413414|NCT00143455|590220931|FG003|Cohort 2|Progressive Disease|27|||
163413415|NCT00143455|590220928|FG000|Cohort 2|Withdrawal by Subject|0|||
163413416|NCT00143455|590220929|FG001|Cohort 2|Withdrawal by Subject|0|||
163413417|NCT00143455|590220930|FG002|Cohort 2|Withdrawal by Subject|13|||
163413418|NCT00143455|590220931|FG003|Cohort 2|Withdrawal by Subject|12|||
163413419|NCT00143455|590220928|FG000|Cohort 2|Other|0|||
163413420|NCT00143455|590220929|FG001|Cohort 2|Other|0|||
163413421|NCT00143455|590220930|FG002|Cohort 2|Other|7|||
163413422|NCT00143455|590220931|FG003|Cohort 2|Other|6|||
163413423|NCT00143455|590220928|FG000|Cohort 2|Randomized But Not Treated|0|||
163413424|NCT00143455|590220929|FG001|Cohort 2|Randomized But Not Treated|0|||
163413425|NCT00143455|590220930|FG002|Cohort 2|Randomized But Not Treated|1|||
163413426|NCT00143455|590220931|FG003|Cohort 2|Randomized But Not Treated|1|||
163413427|NCT02682901|590220932|FG000|Overall Study|Adverse Event|10|||
163413428|NCT02682901|590220933|FG001|Overall Study|Adverse Event|3|||
163413429|NCT02682901|590220932|FG000|Overall Study|Lack of Efficacy|0|||
163413430|NCT02682901|590220933|FG001|Overall Study|Lack of Efficacy|1|||
163413431|NCT03713944|590220934|FG000|Study Treatment|Patient non-compliance|1|||
163413432|NCT03713944|590220934|FG000|Study Treatment|Alternative Cancer Therapy|3|||
163413433|NCT03713944|590220934|FG000|Study Treatment|Disease Progression|18|||
163413434|NCT03713944|590220934|FG000|Study Treatment|AE/Side Effects/Complications|2|||
163413435|NCT03713944|590220934|FG000|Study Treatment|Death|2|||
163413436|NCT03713944|590220934|FG000|Study Treatment|Withdrawal by Subject|1|||
163413437|NCT03713944|590220934|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
163413438|NCT03713944|590220934|FG000|Study Treatment|Symptomatic Deterioration|2|||
163413439|NCT03713944|590220934|FG000|Follow up|Withdrawal by Subject|2|||
163413440|NCT03713944|590220934|FG000|Follow up|Death|11|||
163370900|NCT03524092|590064616|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
163370901|NCT03524092|590064611|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
163370902|NCT03524092|590064612|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
163370903|NCT03524092|590064613|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
163370904|NCT03524092|590064614|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
163370905|NCT03524092|590064615|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
163370906|NCT03524092|590064616|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
163370907|NCT03524092|590064611|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
163370908|NCT03524092|590064612|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
163370909|NCT03524092|590064613|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
163370910|NCT03524092|590064614|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
163370911|NCT03524092|590064615|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
163370912|NCT03524092|590064616|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
163370913|NCT03524092|590064611|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
163370914|NCT03524092|590064612|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
163370915|NCT03524092|590064613|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
163370916|NCT03524092|590064614|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
163370917|NCT03524092|590064615|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
163370918|NCT03524092|590064616|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
163370919|NCT03524092|590064611|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
163370920|NCT03524092|590064612|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
163370921|NCT03524092|590064613|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
163370922|NCT03524092|590064614|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
163370923|NCT03524092|590064615|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
163370924|NCT03524092|590064616|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
163370925|NCT03524092|590064611|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
163370926|NCT03524092|590064612|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
163370927|NCT03524092|590064613|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
163370928|NCT03524092|590064614|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
163370929|NCT03524092|590064615|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
163370930|NCT03524092|590064616|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
163370931|NCT03524092|590064611|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
163413441|NCT03713944|590220934|FG000|Follow up|Study Terminated|3|||
163413442|NCT00730639|590220949|FG000|Overall Study|Adverse Event|3|||
163413443|NCT00730639|590220950|FG001|Overall Study|Adverse Event|0|||
163413444|NCT00730639|590220951|FG002|Overall Study|Adverse Event|9|||
163413445|NCT00730639|590220952|FG003|Overall Study|Adverse Event|8|||
163413446|NCT00730639|590220953|FG004|Overall Study|Adverse Event|23|||
163413447|NCT00730639|590220949|FG000|Overall Study|Complete Response|0|||
163413448|NCT00730639|590220950|FG001|Overall Study|Complete Response|0|||
163413449|NCT00730639|590220951|FG002|Overall Study|Complete Response|2|||
163413450|NCT00730639|590220952|FG003|Overall Study|Complete Response|2|||
163413451|NCT00730639|590220953|FG004|Overall Study|Complete Response|1|||
163413452|NCT00730639|590220949|FG000|Overall Study|Completed Maximum Cycles|0|||
163413453|NCT00730639|590220950|FG001|Overall Study|Completed Maximum Cycles|0|||
163413454|NCT00730639|590220951|FG002|Overall Study|Completed Maximum Cycles|11|||
163413455|NCT00730639|590220952|FG003|Overall Study|Completed Maximum Cycles|3|||
163413456|NCT00730639|590220953|FG004|Overall Study|Completed Maximum Cycles|6|||
163413457|NCT00730639|590220949|FG000|Overall Study|Death|0|||
163413458|NCT00730639|590220950|FG001|Overall Study|Death|0|||
163413459|NCT00730639|590220951|FG002|Overall Study|Death|0|||
163413460|NCT00730639|590220952|FG003|Overall Study|Death|0|||
163413461|NCT00730639|590220953|FG004|Overall Study|Death|2|||
163413462|NCT00730639|590220949|FG000|Overall Study|Disease Progression|12|||
163413463|NCT00730639|590220950|FG001|Overall Study|Disease Progression|13|||
163413464|NCT00730639|590220951|FG002|Overall Study|Disease Progression|48|||
163413465|NCT00730639|590220952|FG003|Overall Study|Disease Progression|32|||
163413466|NCT00730639|590220953|FG004|Overall Study|Disease Progression|88|||
163413467|NCT00730639|590220949|FG000|Overall Study|non-specified|0|||
163413468|NCT00730639|590220950|FG001|Overall Study|non-specified|0|||
163413469|NCT00730639|590220951|FG002|Overall Study|non-specified|4|||
163413470|NCT00730639|590220952|FG003|Overall Study|non-specified|2|||
163413471|NCT00730639|590220953|FG004|Overall Study|non-specified|3|||
163413472|NCT00730639|590220949|FG000|Overall Study|Protocol Violation|0|||
163413473|NCT00730639|590220950|FG001|Overall Study|Protocol Violation|0|||
163413474|NCT00730639|590220951|FG002|Overall Study|Protocol Violation|1|||
163413475|NCT00730639|590220952|FG003|Overall Study|Protocol Violation|0|||
163413476|NCT00730639|590220953|FG004|Overall Study|Protocol Violation|0|||
163413477|NCT00730639|590220949|FG000|Overall Study|Withdrawal by Subject|0|||
163413478|NCT00730639|590220950|FG001|Overall Study|Withdrawal by Subject|0|||
163413479|NCT00730639|590220951|FG002|Overall Study|Withdrawal by Subject|6|||
163413480|NCT00730639|590220952|FG003|Overall Study|Withdrawal by Subject|3|||
163413481|NCT00730639|590220953|FG004|Overall Study|Withdrawal by Subject|4|||
163413482|NCT00730639|590220949|FG000|Overall Study|Treatment on-going|2|||
163413483|NCT00730639|590220950|FG001|Overall Study|Treatment on-going|5|||
163413484|NCT00730639|590220951|FG002|Overall Study|Treatment on-going|5|||
163413485|NCT00730639|590220952|FG003|Overall Study|Treatment on-going|4|||
163413486|NCT00730639|590220953|FG004|Overall Study|Treatment on-going|4|||
163413487|NCT02665286|590220956|FG000|Overall Study|Lost to Follow-up|3|||
163413488|NCT02665286|590220957|FG001|Overall Study|Lost to Follow-up|2|||
163413489|NCT02665286|590220958|FG002|Overall Study|Lost to Follow-up|1|||
163413490|NCT00848354|590220960|FG000|Phase 1|Adverse Event|5|||
163413491|NCT00848354|590220961|FG001|Phase 1|Adverse Event|4|||
163413492|NCT00848354|590220960|FG000|Phase 1|Discontinuation of study by sponsor|2|||
163413493|NCT00848354|590220961|FG001|Phase 1|Discontinuation of study by sponsor|1|||
163413494|NCT00848354|590220960|FG000|Phase 1|Failed to return|0|||
163413495|NCT00848354|590220961|FG001|Phase 1|Failed to return|1|||
163413496|NCT00848354|590220960|FG000|Phase 1|Lost to Follow-up|1|||
163413497|NCT00848354|590220961|FG001|Phase 1|Lost to Follow-up|1|||
163413498|NCT00848354|590220960|FG000|Phase 1|Unspecified Reason|1|||
163413499|NCT00848354|590220961|FG001|Phase 1|Unspecified Reason|1|||
163413500|NCT00848354|590220960|FG000|Phase 1|Protocol Violation|1|||
163413501|NCT00848354|590220961|FG001|Phase 1|Protocol Violation|1|||
163413502|NCT00848354|590220960|FG000|Phase 1|Withdrawal by Subject|2|||
163413503|NCT00848354|590220961|FG001|Phase 1|Withdrawal by Subject|4|||
163413504|NCT00848354|590220960|FG000|Phase 1|Lack of Efficacy|0|||
163413505|NCT00848354|590220961|FG001|Phase 1|Lack of Efficacy|1|||
163413506|NCT00848354|590220960|FG000|Phase 2 Year 1|Adverse Event|7|||
163413507|NCT00848354|590220961|FG001|Phase 2 Year 1|Adverse Event|2|||
163413508|NCT00848354|590220960|FG000|Phase 2 Year 1|Death|1|||
163413509|NCT00848354|590220961|FG001|Phase 2 Year 1|Death|0|||
163413510|NCT00848354|590220960|FG000|Phase 2 Year 1|Failed to Return|1|||
163413511|NCT00848354|590220961|FG001|Phase 2 Year 1|Failed to Return|1|||
163413512|NCT00848354|590220960|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
163413513|NCT00848354|590220961|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
163413514|NCT00848354|590220960|FG000|Phase 2 Year 1|Unspecified Reason|3|||
163413515|NCT00848354|590220961|FG001|Phase 2 Year 1|Unspecified Reason|0|||
163413516|NCT00848354|590220960|FG000|Phase 2 Year 1|Protocol Violation|4|||
163413517|NCT00848354|590220961|FG001|Phase 2 Year 1|Protocol Violation|1|||
163413518|NCT00848354|590220960|FG000|Phase 2 Year 1|Subject Request|1|||
163413519|NCT00848354|590220961|FG001|Phase 2 Year 1|Subject Request|2|||
163413520|NCT00848354|590220960|FG000|Phase 2 Year 2|Adverse Event|12|||
163413521|NCT00848354|590220961|FG001|Phase 2 Year 2|Adverse Event|2|||
163413522|NCT00848354|590220960|FG000|Phase 2 Year 2|Death|2|||
163413523|NCT00848354|590220961|FG001|Phase 2 Year 2|Death|0|||
163413524|NCT00848354|590220960|FG000|Phase 2 Year 2|Failed to return|3|||
163413525|NCT00848354|590220961|FG001|Phase 2 Year 2|Failed to return|0|||
163413526|NCT00848354|590220960|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
163413527|NCT00848354|590220961|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
163413528|NCT00848354|590220960|FG000|Phase 2 Year 2|Unspecified Reason|1|||
163413529|NCT00848354|590220961|FG001|Phase 2 Year 2|Unspecified Reason|0|||
163413530|NCT00848354|590220960|FG000|Phase 2 Year 2|Protocol Violation|1|||
163413531|NCT00848354|590220961|FG001|Phase 2 Year 2|Protocol Violation|1|||
163370932|NCT03524092|590064612|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
163370933|NCT03524092|590064613|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
163370934|NCT03524092|590064614|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
163370935|NCT03524092|590064615|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
163370936|NCT03524092|590064616|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
163370937|NCT03524092|590064611|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
163370938|NCT03524092|590064612|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
163370939|NCT03524092|590064613|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
163370940|NCT03524092|590064614|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
163370941|NCT03524092|590064615|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
163370942|NCT03524092|590064616|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
163370943|NCT03524092|590064611|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
163370944|NCT03524092|590064612|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
163370945|NCT03524092|590064613|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
163370946|NCT03524092|590064614|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
163370947|NCT03524092|590064615|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
163370948|NCT03524092|590064616|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
163370949|NCT03524092|590064611|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
163370950|NCT03524092|590064612|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
163370951|NCT03524092|590064613|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
163370952|NCT03524092|590064614|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
163370953|NCT03524092|590064615|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
163370954|NCT03524092|590064616|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
163370955|NCT03524092|590064611|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
163370956|NCT03524092|590064612|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
163370957|NCT03524092|590064613|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
163370958|NCT03524092|590064614|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
163370959|NCT03524092|590064615|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
163370960|NCT03524092|590064616|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
163370961|NCT04303780|590064617|FG000|Overall Study|Death|104|||
163370962|NCT04303780|590064618|FG001|Overall Study|Death|85|||
163370963|NCT04303780|590064617|FG000|Overall Study|Lost to Follow-up|5|||
163370964|NCT04303780|590064618|FG001|Overall Study|Lost to Follow-up|2|||
163370965|NCT04303780|590064617|FG000|Overall Study|Withdrawal by Subject|12|||
163370966|NCT04303780|590064618|FG001|Overall Study|Withdrawal by Subject|39|||
163370967|NCT04303780|590064617|FG000|Overall Study|Ongoing in study|50|||
163370968|NCT04303780|590064618|FG001|Overall Study|Ongoing in study|45|||
163370969|NCT03826030|590064619|FG000|Overall Study|Withdrawal by Subject|2|||
163370970|NCT03826030|590064620|FG001|Overall Study|Withdrawal by Subject|0|||
163370971|NCT03826030|590064621|FG002|Overall Study|Withdrawal by Subject|1|||
163370972|NCT03826030|590064619|FG000|Overall Study|Lost to Follow-up|1|||
163370973|NCT03826030|590064620|FG001|Overall Study|Lost to Follow-up|1|||
163370974|NCT03826030|590064621|FG002|Overall Study|Lost to Follow-up|1|||
163370975|NCT03826030|590064619|FG000|Overall Study|Too busy to return for visits|1|||
163370976|NCT03826030|590064620|FG001|Overall Study|Too busy to return for visits|0|||
163370977|NCT03826030|590064621|FG002|Overall Study|Too busy to return for visits|0|||
163370978|NCT01732822|590066443|FG000|Overall Study|Withdrawal by Subject|123|||
163370979|NCT01732822|590066444|FG001|Overall Study|Withdrawal by Subject|113|||
163370980|NCT02314780|590066445|FG000|Overall Study|organizational reasons|0|||
163370981|NCT02314780|590066446|FG001|Overall Study|organizational reasons|2|||
163370982|NCT02314780|590066447|FG002|Overall Study|organizational reasons|0|||
163370983|NCT02314780|590066445|FG000|Overall Study|Adverse Event|0|||
163370984|NCT02314780|590066446|FG001|Overall Study|Adverse Event|1|||
163370985|NCT02314780|590066447|FG002|Overall Study|Adverse Event|0|||
163370986|NCT01901432|590066448|FG000|Overall Study|Adverse Event|0|||
163370987|NCT01901432|590066449|FG001|Overall Study|Adverse Event|1|||
163370988|NCT01901432|590066450|FG002|Overall Study|Adverse Event|1|||
163370989|NCT01901432|590066451|FG003|Overall Study|Adverse Event|0|||
163370990|NCT01901432|590066452|FG004|Overall Study|Adverse Event|1|||
163370991|NCT01901432|590066448|FG000|Overall Study|Withdrawal by Subject|0|||
163370992|NCT01901432|590066449|FG001|Overall Study|Withdrawal by Subject|0|||
163370993|NCT01901432|590066450|FG002|Overall Study|Withdrawal by Subject|1|||
163370994|NCT01901432|590066451|FG003|Overall Study|Withdrawal by Subject|0|||
163370995|NCT01901432|590066452|FG004|Overall Study|Withdrawal by Subject|5|||
163370996|NCT01901432|590066448|FG000|Overall Study|Physician Decision|0|||
163370997|NCT01901432|590066449|FG001|Overall Study|Physician Decision|0|||
163370998|NCT01901432|590066450|FG002|Overall Study|Physician Decision|0|||
163370999|NCT01901432|590066451|FG003|Overall Study|Physician Decision|0|||
163413532|NCT00848354|590220960|FG000|Phase 2 Year 2|Subject Request|1|||
163413533|NCT00848354|590220961|FG001|Phase 2 Year 2|Subject Request|1|||
163371000|NCT01901432|590066452|FG004|Overall Study|Physician Decision|2|||
163371001|NCT01901432|590066448|FG000|Overall Study|Patient decision to stop study drug|0|||
163371002|NCT01901432|590066449|FG001|Overall Study|Patient decision to stop study drug|0|||
163371003|NCT01901432|590066450|FG002|Overall Study|Patient decision to stop study drug|0|||
163371004|NCT01901432|590066451|FG003|Overall Study|Patient decision to stop study drug|0|||
163371005|NCT01901432|590066452|FG004|Overall Study|Patient decision to stop study drug|1|||
163371006|NCT01077271|590066458|FG000|Overall Study|Parental desire|8|||
163371007|NCT01077271|590066458|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
163371008|NCT01077271|590066458|FG000|Overall Study|Noncompliance|2|||
163371009|NCT01077271|590066458|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
163371010|NCT01077271|590066458|FG000|Overall Study|Changed doctors|2|||
163371011|NCT01077271|590066458|FG000|Overall Study|Parents thought too many injections|2|||
163371012|NCT01077271|590066458|FG000|Overall Study|End of RSV season nearly reached|1|||
163371013|NCT01077271|590066458|FG000|Overall Study|Mother unconvinced of the necessity|1|||
163371014|NCT05816330|590066465|FG000|Overall Study|Withdrawal by Subject|4|||
163371015|NCT05816330|590066466|FG001|Overall Study|Withdrawal by Subject|1|||
163371016|NCT00201643|590066467|FG000|Overall Study|Withdrawal by Subject|5|||
163371017|NCT00201643|590066468|FG001|Overall Study|Withdrawal by Subject|4|||
163371018|NCT03446781|590066469|FG000|Overall Study|Lost to Follow-up|11|||
163371019|NCT03446781|590066470|FG001|Overall Study|Lost to Follow-up|5|||
163371020|NCT03446781|590066469|FG000|Overall Study|Withdrawal by Subject|9|||
163371021|NCT03446781|590066470|FG001|Overall Study|Withdrawal by Subject|7|||
163371022|NCT03446781|590066469|FG000|Overall Study|Adverse Event|8|||
163371023|NCT03446781|590066470|FG001|Overall Study|Adverse Event|2|||
163371024|NCT03446781|590066469|FG000|Overall Study|Protocol Violation|0|||
163371025|NCT03446781|590066470|FG001|Overall Study|Protocol Violation|3|||
163371026|NCT02898077|590066477|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
163371027|NCT02898077|590066478|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
163371028|NCT02898077|590066477|FG000|Overall Study|Lost to Follow-up|4|||
163371029|NCT02898077|590066478|FG001|Overall Study|Lost to Follow-up|3|||
163371030|NCT02898077|590066477|FG000|Overall Study|Physician Decision|0|||
163371031|NCT02898077|590066478|FG001|Overall Study|Physician Decision|2|||
163371032|NCT02898077|590066477|FG000|Overall Study|Sponsor Decision|32|||
163371033|NCT02898077|590066478|FG001|Overall Study|Sponsor Decision|13|||
163371034|NCT02898077|590066477|FG000|Overall Study|Withdrawal by Subject|6|||
163371035|NCT02898077|590066478|FG001|Overall Study|Withdrawal by Subject|3|||
163371036|NCT02898077|590066477|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
163371037|NCT02898077|590066478|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
163371038|NCT02898077|590066477|FG000|Overall Study|Ended extension period|3|||
163371039|NCT02898077|590066478|FG001|Overall Study|Ended extension period|0|||
163371040|NCT00996476|590066480|FG000|Overall Study|Withdrawal by Subject|1|||
163371041|NCT00996476|590066481|FG001|Overall Study|Withdrawal by Subject|2|||
163371042|NCT00996476|590066482|FG002|Overall Study|Withdrawal by Subject|1|||
163371043|NCT00996476|590066483|FG003|Overall Study|Withdrawal by Subject|0|||
163371044|NCT00996476|590066484|FG004|Overall Study|Withdrawal by Subject|1|||
163371045|NCT00996476|590066480|FG000|Overall Study|Adverse Event|0|||
163371046|NCT00996476|590066481|FG001|Overall Study|Adverse Event|1|||
163371047|NCT00996476|590066482|FG002|Overall Study|Adverse Event|0|||
163371048|NCT00996476|590066483|FG003|Overall Study|Adverse Event|0|||
163371049|NCT00996476|590066484|FG004|Overall Study|Adverse Event|1|||
163371050|NCT01802567|590066485|FG000|Overall Study|Withdrawal by Subject|2|||
163371051|NCT01802567|590066485|FG000|Overall Study|Physician Decision|1|||
163371052|NCT01802567|590066485|FG000|Overall Study|Lack of Efficacy|7|||
163371053|NCT01802567|590066485|FG000|Overall Study|Consented but did not start therapy|7|||
163371054|NCT01802567|590066485|FG000|Overall Study|Protocol Violation|1|||
163371055|NCT01940939|590066486|FG000|Overall Study|Withdrawal by Subject|2|||
163371056|NCT01940939|590066487|FG001|Overall Study|Withdrawal by Subject|8|||
163371057|NCT01470001|590066488|FG000|Overall Study|Lost to Follow-up|1|||
163371058|NCT01470001|590066489|FG001|Overall Study|Lost to Follow-up|1|||
163371059|NCT01470001|590066488|FG000|Overall Study|Physician Decision|2|||
163371060|NCT01470001|590066489|FG001|Overall Study|Physician Decision|0|||
163371061|NCT01470001|590066488|FG000|Overall Study|Withdrawal by Subject|2|||
163371062|NCT01470001|590066489|FG001|Overall Study|Withdrawal by Subject|1|||
163371063|NCT01895101|590066490|FG000|Overall Study|OPCAB procedure|1|||
163371064|NCT01895101|590066491|FG001|Overall Study|OPCAB procedure|1|||
163371065|NCT01895101|590066492|FG002|Overall Study|OPCAB procedure|3|||
163371066|NCT01895101|590066490|FG000|Overall Study|Withdrawal by Subject|0|||
163371067|NCT01895101|590066491|FG001|Overall Study|Withdrawal by Subject|1|||
163371068|NCT01895101|590066492|FG002|Overall Study|Withdrawal by Subject|2|||
163371069|NCT01895101|590066490|FG000|Overall Study|another study, enrolled in other study|0|||
163371070|NCT01895101|590066491|FG001|Overall Study|another study, enrolled in other study|1|||
163371071|NCT01895101|590066492|FG002|Overall Study|another study, enrolled in other study|0|||
163371072|NCT01895101|590066490|FG000|Overall Study|Death|0|||
163371073|NCT01895101|590066491|FG001|Overall Study|Death|1|||
163371074|NCT01895101|590066492|FG002|Overall Study|Death|0|||
163371075|NCT01895101|590066490|FG000|Overall Study|coagulation disorder|0|||
163413534|NCT00848354|590220960|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
163371076|NCT01895101|590066491|FG001|Overall Study|coagulation disorder|1|||
163371077|NCT01895101|590066492|FG002|Overall Study|coagulation disorder|0|||
163371078|NCT02182947|590066497|FG000|Overall Study|Withdrawal by Subject|7|||
163413535|NCT00848354|590220961|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
163413536|NCT00915343|590220964|FG000|Part B - Open Label Period|Treatment switch|0|||
163413537|NCT00915343|590220965|FG001|Part B - Open Label Period|Treatment switch|0|||
163413538|NCT00915343|590220966|FG002|Part B - Open Label Period|Treatment switch|1|||
163413539|NCT00915343|590220964|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
163413540|NCT00915343|590220965|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
163413541|NCT00915343|590220966|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
163413542|NCT02406781|590220967|FG000|Overall Study|Protocol Violation|2|||
163413543|NCT02406781|590220968|FG001|Overall Study|Protocol Violation|2|||
163413544|NCT02406781|590220969|FG002|Overall Study|Protocol Violation|2|||
163413545|NCT02406781|590220970|FG003|Overall Study|Protocol Violation|2|||
163413546|NCT02406781|590220971|FG004|Overall Study|Protocol Violation|1|||
163413547|NCT02406781|590220972|FG005|Overall Study|Protocol Violation|5|||
163413548|NCT02406781|590220973|FG006|Overall Study|Protocol Violation|3|||
163413549|NCT03505021|590220974|FG000|Overall Study|Protocol Violation|1|||
163413550|NCT03505021|590220975|FG001|Overall Study|Protocol Violation|0|||
163413551|NCT03505021|590220974|FG000|Overall Study|Death|9|||
163413552|NCT03505021|590220975|FG001|Overall Study|Death|8|||
163413553|NCT03505021|590220974|FG000|Overall Study|Consent withdrawn by subject|6|||
163413554|NCT03505021|590220975|FG001|Overall Study|Consent withdrawn by subject|1|||
163413555|NCT03505021|590220974|FG000|Overall Study|Lost to Follow-up|5|||
163413556|NCT03505021|590220975|FG001|Overall Study|Lost to Follow-up|3|||
163413557|NCT03505021|590220974|FG000|Overall Study|Adverse Event|26|||
163413558|NCT03505021|590220975|FG001|Overall Study|Adverse Event|9|||
163413559|NCT03505021|590220974|FG000|Overall Study|Disease progression|33|||
163413560|NCT03505021|590220975|FG001|Overall Study|Disease progression|17|||
163413561|NCT03505021|590220974|FG000|Overall Study|Other|11|||
163413562|NCT03505021|590220975|FG001|Overall Study|Other|5|||
163413563|NCT03505021|590220974|FG000|Overall Study|Personal reason|21|||
163413564|NCT03505021|590220975|FG001|Overall Study|Personal reason|12|||
163413565|NCT05280756|590222924|FG000|Overall Study|Lost to Follow-up|1|||
163413566|NCT05280756|590222925|FG001|Overall Study|Lost to Follow-up|1|||
163413567|NCT01299766|590222927|FG000|Overall Study|Death|5|||
163413568|NCT01299766|590222928|FG001|Overall Study|Death|4|||
163413569|NCT01299766|590222927|FG000|Overall Study|Withdrawal by Subject|29|||
163413570|NCT01299766|590222928|FG001|Overall Study|Withdrawal by Subject|19|||
163413571|NCT04002310|590222929|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
163413572|NCT04002310|590222930|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
163413573|NCT04002310|590222931|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
163413574|NCT04002310|590222932|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
163413575|NCT04002310|590222933|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
163413576|NCT00352534|590222934|FG000|Initial Staging|Ineligible|8|||
163413577|NCT00352534|590222935|FG001|Initial Staging|Ineligible|9|||
163413578|NCT00352534|590222936|FG002|Initial Staging|Ineligible|0|||
163413579|NCT00352534|590222937|FG003|Initial Staging|Ineligible|0|||
163413580|NCT00352534|590222938|FG004|Initial Staging|Ineligible|0|||
163413581|NCT00352534|590222939|FG005|Initial Staging|Ineligible|0|||
163413582|NCT00352534|590222940|FG006|Initial Staging|Ineligible|0|||
163413583|NCT00352534|590222934|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
163371079|NCT02182947|590066497|FG000|Overall Study|Lost to Follow-up|3|||
163371080|NCT02182947|590066497|FG000|Overall Study|Failed screening activities|8|||
163371081|NCT02236988|590066498|FG000|Overall Study|Lost to Follow-up|0|||
163371082|NCT02236988|590066499|FG001|Overall Study|Lost to Follow-up|0|||
163371083|NCT02236988|590066500|FG002|Overall Study|Lost to Follow-up|0|||
163371084|NCT02236988|590066501|FG003|Overall Study|Lost to Follow-up|1|||
163371085|NCT02236988|590066498|FG000|Overall Study|Unable to Comply with Study Visits|0|||
163371086|NCT02236988|590066499|FG001|Overall Study|Unable to Comply with Study Visits|0|||
163371087|NCT02236988|590066500|FG002|Overall Study|Unable to Comply with Study Visits|0|||
163413584|NCT00352534|590222935|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
163413585|NCT00352534|590222936|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
163371088|NCT02236988|590066501|FG003|Overall Study|Unable to Comply with Study Visits|2|||
163371089|NCT04308590|590066502|FG000|Overall Study|Adverse Event|12|||
163371090|NCT04308590|590066503|FG001|Overall Study|Adverse Event|2|||
163413586|NCT00352534|590222937|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
163413587|NCT00352534|590222938|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
163413588|NCT00352534|590222939|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
163413589|NCT00352534|590222940|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
163413590|NCT00352534|590222934|FG000|Final Risk Group Assignment|Physician Decision|0|||
163413591|NCT00352534|590222935|FG001|Final Risk Group Assignment|Physician Decision|0|||
163413592|NCT00352534|590222936|FG002|Final Risk Group Assignment|Physician Decision|0|||
163413593|NCT00352534|590222937|FG003|Final Risk Group Assignment|Physician Decision|0|||
163413594|NCT00352534|590222938|FG004|Final Risk Group Assignment|Physician Decision|0|||
163413595|NCT00352534|590222939|FG005|Final Risk Group Assignment|Physician Decision|8|||
163413596|NCT00352534|590222940|FG006|Final Risk Group Assignment|Physician Decision|0|||
163413597|NCT00352534|590222934|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
163413598|NCT00352534|590222935|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
163413599|NCT00352534|590222936|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
163413600|NCT00352534|590222937|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
163413601|NCT00352534|590222938|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
163413602|NCT00352534|590222939|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
163413603|NCT00352534|590222940|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
163413604|NCT00352534|590222934|FG000|Final Risk Group Assignment|Ineligible|0|||
163413605|NCT00352534|590222935|FG001|Final Risk Group Assignment|Ineligible|0|||
163413606|NCT00352534|590222936|FG002|Final Risk Group Assignment|Ineligible|3|||
163413607|NCT00352534|590222937|FG003|Final Risk Group Assignment|Ineligible|1|||
163413608|NCT00352534|590222938|FG004|Final Risk Group Assignment|Ineligible|0|||
163413609|NCT00352534|590222939|FG005|Final Risk Group Assignment|Ineligible|13|||
163413610|NCT00352534|590222940|FG006|Final Risk Group Assignment|Ineligible|0|||
163413611|NCT00352534|590222934|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
163413612|NCT00352534|590222935|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
163413613|NCT00352534|590222936|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
163413614|NCT00352534|590222937|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
163413615|NCT00352534|590222938|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
163413616|NCT00352534|590222939|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
163413617|NCT00352534|590222940|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
163413618|NCT00352534|590222934|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
163413619|NCT00352534|590222935|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
163413620|NCT00352534|590222936|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
163413621|NCT00352534|590222937|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
163413622|NCT00352534|590222938|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
163413623|NCT00352534|590222939|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
163413624|NCT00352534|590222940|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
163413625|NCT00352534|590222934|FG000|Final Risk Group Assignment|Death|0|||
163413626|NCT00352534|590222935|FG001|Final Risk Group Assignment|Death|0|||
163413627|NCT00352534|590222936|FG002|Final Risk Group Assignment|Death|0|||
163413628|NCT00352534|590222937|FG003|Final Risk Group Assignment|Death|0|||
163413629|NCT00352534|590222938|FG004|Final Risk Group Assignment|Death|0|||
163413630|NCT00352534|590222939|FG005|Final Risk Group Assignment|Death|2|||
163413631|NCT00352534|590222940|FG006|Final Risk Group Assignment|Death|0|||
163371091|NCT04308590|590066502|FG000|Overall Study|Withdrawal by Subject|10|||
163413632|NCT00544869|590222941|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
163413633|NCT00544869|590222942|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
163413634|NCT00544869|590222943|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
163413635|NCT00544869|590222941|FG000|Overall Study|Adverse Event|6|||
163413636|NCT00544869|590222942|FG001|Overall Study|Adverse Event|1|||
163413637|NCT00544869|590222943|FG002|Overall Study|Adverse Event|0|||
163413638|NCT00544869|590222941|FG000|Overall Study|Lack of Efficacy|1|||
163413639|NCT00544869|590222942|FG001|Overall Study|Lack of Efficacy|1|||
163413640|NCT00544869|590222943|FG002|Overall Study|Lack of Efficacy|0|||
163413641|NCT00544869|590222941|FG000|Overall Study|Physician Decision|2|||
163413642|NCT00544869|590222942|FG001|Overall Study|Physician Decision|0|||
163413643|NCT00544869|590222943|FG002|Overall Study|Physician Decision|0|||
163371092|NCT04308590|590066503|FG001|Overall Study|Withdrawal by Subject|4|||
163371093|NCT04308590|590066502|FG000|Overall Study|Death|1|||
163371094|NCT04308590|590066503|FG001|Overall Study|Death|0|||
163371095|NCT04308590|590066502|FG000|Overall Study|Lost to Follow-up|1|||
163371096|NCT04308590|590066503|FG001|Overall Study|Lost to Follow-up|1|||
163371097|NCT04308590|590066502|FG000|Overall Study|Physician Decision|1|||
163371098|NCT04308590|590066503|FG001|Overall Study|Physician Decision|0|||
163371099|NCT04308590|590066502|FG000|Overall Study|Subject does not want to continue with Pi|0|||
163371100|NCT04308590|590066503|FG001|Overall Study|Subject does not want to continue with Pi|1|||
163371101|NCT01156376|590066505|FG000|Overall Study|Adverse Event|1|||
163371102|NCT01156376|590066506|FG001|Overall Study|Adverse Event|0|||
163371103|NCT01156376|590066507|FG002|Overall Study|Adverse Event|1|||
163371104|NCT01156376|590066505|FG000|Overall Study|Withdrawal by Subject|0|||
163413644|NCT01072344|590222944|FG000|Overall Study|Relasped-reached end point|7|||
163413645|NCT01072344|590222945|FG001|Overall Study|Relasped-reached end point|12|||
163413646|NCT01072344|590222944|FG000|Overall Study|Protocol Violation|1|||
163413647|NCT01072344|590222945|FG001|Overall Study|Protocol Violation|2|||
163371105|NCT01156376|590066506|FG001|Overall Study|Withdrawal by Subject|0|||
163371106|NCT01156376|590066507|FG002|Overall Study|Withdrawal by Subject|3|||
163371107|NCT01493427|590066508|FG000|Overall Study|Adverse Event|10|||
163413648|NCT01072344|590222944|FG000|Overall Study|Lost to Follow-up|3|||
163413649|NCT01072344|590222945|FG001|Overall Study|Lost to Follow-up|4|||
163371108|NCT01493427|590066508|FG000|Overall Study|Personal Reasons|4|||
163413650|NCT02944448|590222949|FG000|Overall Study|Adverse Event|37|||
163413651|NCT02944448|590222950|FG001|Overall Study|Adverse Event|6|||
163413652|NCT02944448|590222949|FG000|Overall Study|Lack of Efficacy|8|||
163413653|NCT02944448|590222950|FG001|Overall Study|Lack of Efficacy|5|||
163413654|NCT02944448|590222949|FG000|Overall Study|Lost to Follow-up|3|||
163413655|NCT02944448|590222950|FG001|Overall Study|Lost to Follow-up|1|||
163413656|NCT02944448|590222949|FG000|Overall Study|Protocol Violation|25|||
163413657|NCT02944448|590222950|FG001|Overall Study|Protocol Violation|7|||
163413658|NCT02944448|590222949|FG000|Overall Study|Withdrawal by Subject|14|||
163413659|NCT02944448|590222950|FG001|Overall Study|Withdrawal by Subject|4|||
163413660|NCT02944448|590222949|FG000|Overall Study|Sponsor did not supply drug in time|0|||
163413661|NCT02944448|590222950|FG001|Overall Study|Sponsor did not supply drug in time|1|||
163413662|NCT02944448|590222949|FG000|Overall Study|Noncompliant with dosing|1|||
163413663|NCT02944448|590222950|FG001|Overall Study|Noncompliant with dosing|0|||
163413664|NCT02944448|590222949|FG000|Overall Study|Abnormal laboratory values|1|||
163413665|NCT02944448|590222950|FG001|Overall Study|Abnormal laboratory values|0|||
163413666|NCT00804687|590222951|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
163371109|NCT01493427|590066508|FG000|Overall Study|Lost to Follow-up|2|||
163371110|NCT01493427|590066508|FG000|Overall Study|Inability to Follow Instructions|2|||
163371111|NCT01493427|590066508|FG000|Overall Study|Other|2|||
163371112|NCT05775991|590066509|FG000|Overall Study|Withdrawal by Subject|0|||
163371113|NCT05775991|590066510|FG001|Overall Study|Withdrawal by Subject|0|||
163371114|NCT05775991|590066511|FG002|Overall Study|Withdrawal by Subject|2|||
163371115|NCT00939822|590066518|FG000|Overall Study|Lost to Follow-up|1|||
163371116|NCT00939822|590066519|FG001|Overall Study|Lost to Follow-up|0|||
163371117|NCT00939822|590066518|FG000|Overall Study|withdrew from study due to busy schedule|1|||
163371118|NCT00939822|590066519|FG001|Overall Study|withdrew from study due to busy schedule|1|||
163371119|NCT00939822|590066518|FG000|Overall Study|Mental health issues|0|||
163371120|NCT00939822|590066519|FG001|Overall Study|Mental health issues|2|||
163371121|NCT01072630|590066520|FG000|Overall Study|Adverse Event|11|||
163371122|NCT01072630|590066521|FG001|Overall Study|Adverse Event|19|||
163371123|NCT01072630|590066522|FG002|Overall Study|Adverse Event|2|||
163371124|NCT01072630|590066520|FG000|Overall Study|Lack of Efficacy|10|||
163371125|NCT01072630|590066521|FG001|Overall Study|Lack of Efficacy|10|||
163371126|NCT01072630|590066522|FG002|Overall Study|Lack of Efficacy|1|||
163371127|NCT01072630|590066520|FG000|Overall Study|Withdrawal by Subject|8|||
163371128|NCT01072630|590066521|FG001|Overall Study|Withdrawal by Subject|7|||
163371129|NCT01072630|590066522|FG002|Overall Study|Withdrawal by Subject|2|||
163371130|NCT01072630|590066520|FG000|Overall Study|Protocol Violation|10|||
163371131|NCT01072630|590066521|FG001|Overall Study|Protocol Violation|8|||
163371132|NCT01072630|590066522|FG002|Overall Study|Protocol Violation|4|||
163371133|NCT01072630|590066520|FG000|Overall Study|Lost to Follow-up|11|||
163371134|NCT01072630|590066521|FG001|Overall Study|Lost to Follow-up|11|||
163371135|NCT01072630|590066522|FG002|Overall Study|Lost to Follow-up|1|||
163371136|NCT01072630|590066520|FG000|Overall Study|Noncompliance with study medication|1|||
163371137|NCT01072630|590066521|FG001|Overall Study|Noncompliance with study medication|1|||
163371138|NCT01072630|590066522|FG002|Overall Study|Noncompliance with study medication|1|||
163371139|NCT01072630|590066520|FG000|Overall Study|Noncompliance with study procedures|1|||
163371140|NCT01072630|590066521|FG001|Overall Study|Noncompliance with study procedures|2|||
163371141|NCT01072630|590066522|FG002|Overall Study|Noncompliance with study procedures|1|||
163371142|NCT01072630|590066520|FG000|Overall Study|Other|3|||
163371143|NCT01072630|590066521|FG001|Overall Study|Other|2|||
163371144|NCT01072630|590066522|FG002|Overall Study|Other|1|||
163371145|NCT02683785|590066523|FG000|Overall Study|Withdrawal by Subject|1|||
163371146|NCT02683785|590066524|FG001|Overall Study|Withdrawal by Subject|1|||
163371147|NCT02683785|590066523|FG000|Overall Study|Lost to Follow-up|0|||
163371148|NCT02683785|590066524|FG001|Overall Study|Lost to Follow-up|1|||
163371149|NCT02683785|590066523|FG000|Overall Study|Adverse Event|0|||
163371150|NCT02683785|590066524|FG001|Overall Study|Adverse Event|2|||
163371151|NCT00416195|590066525|FG000|Overall Study|Adverse Event|1|||
163371152|NCT00416195|590066526|FG001|Overall Study|Adverse Event|2|||
163371153|NCT00416195|590066525|FG000|Overall Study|Protocol Violation|1|||
163371154|NCT00416195|590066526|FG001|Overall Study|Protocol Violation|1|||
163371155|NCT00416195|590066525|FG000|Overall Study|Other|0|||
163371156|NCT00416195|590066526|FG001|Overall Study|Other|1|||
163371157|NCT01305408|590066527|FG000|Overall Study|Adverse Event|10|||
163371158|NCT01305408|590066528|FG001|Overall Study|Adverse Event|7|||
163371159|NCT01305408|590066527|FG000|Overall Study|Lack of Efficacy|3|||
163371160|NCT01305408|590066528|FG001|Overall Study|Lack of Efficacy|4|||
163371161|NCT01305408|590066527|FG000|Overall Study|Withdrawal by Subject|9|||
163413667|NCT00804687|590222952|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
163413668|NCT00804687|590222953|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
163413669|NCT00804687|590222954|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
163413670|NCT00804687|590222955|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
163413671|NCT00804687|590222956|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
163371162|NCT01305408|590066528|FG001|Overall Study|Withdrawal by Subject|9|||
163371163|NCT01305408|590066527|FG000|Overall Study|Protocol Violation|4|||
163371164|NCT01305408|590066528|FG001|Overall Study|Protocol Violation|6|||
163371165|NCT01305408|590066527|FG000|Overall Study|Lost to Follow-up|5|||
163371166|NCT01305408|590066528|FG001|Overall Study|Lost to Follow-up|3|||
163371167|NCT01305408|590066527|FG000|Overall Study|Noncompliance with study medication|0|||
163371168|NCT01305408|590066528|FG001|Overall Study|Noncompliance with study medication|1|||
163371169|NCT01305408|590066527|FG000|Overall Study|Noncompliance with study procedures|0|||
163371170|NCT01305408|590066528|FG001|Overall Study|Noncompliance with study procedures|1|||
163371171|NCT01305408|590066527|FG000|Overall Study|Other|1|||
163413672|NCT00804687|590222951|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
163371172|NCT01305408|590066528|FG001|Overall Study|Other|0|||
163371173|NCT01877239|590066529|FG000|Overall Study|Adverse Event|4|||
163371174|NCT01877239|590066529|FG000|Overall Study|Disease Remission|1|||
163371175|NCT01877239|590066529|FG000|Overall Study|Withdrawal by Subject|4|||
163371176|NCT01877239|590066529|FG000|Overall Study|Other|2|||
163371177|NCT01877239|590066529|FG000|Overall Study|Lack of Efficacy|4|||
163371178|NCT01877239|590066529|FG000|Overall Study|Data not available|35|||
163371179|NCT01283516|590066533|FG000|Overall Study|Adverse Event|0|||
163371180|NCT01283516|590066534|FG001|Overall Study|Adverse Event|0|||
163371181|NCT01283516|590066535|FG002|Overall Study|Adverse Event|0|||
163371182|NCT01283516|590066536|FG003|Overall Study|Adverse Event|0|||
163371183|NCT01283516|590066537|FG004|Overall Study|Adverse Event|0|||
163371184|NCT01283516|590066538|FG005|Overall Study|Adverse Event|0|||
163371185|NCT01283516|590066539|FG006|Overall Study|Adverse Event|2|||
163371186|NCT01283516|590066540|FG007|Overall Study|Adverse Event|0|||
163371187|NCT01283516|590066541|FG008|Overall Study|Adverse Event|28|||
163371188|NCT01283516|590066533|FG000|Overall Study|Death|0|||
163371189|NCT01283516|590066534|FG001|Overall Study|Death|0|||
163371190|NCT01283516|590066535|FG002|Overall Study|Death|0|||
163371191|NCT01283516|590066536|FG003|Overall Study|Death|0|||
163371192|NCT01283516|590066537|FG004|Overall Study|Death|0|||
163371193|NCT01283516|590066538|FG005|Overall Study|Death|1|||
163371194|NCT01283516|590066539|FG006|Overall Study|Death|0|||
163371195|NCT01283516|590066540|FG007|Overall Study|Death|1|||
163371196|NCT01283516|590066541|FG008|Overall Study|Death|12|||
163371197|NCT01283516|590066533|FG000|Overall Study|Disease Progression|2|||
163371198|NCT01283516|590066534|FG001|Overall Study|Disease Progression|2|||
163371199|NCT01283516|590066535|FG002|Overall Study|Disease Progression|3|||
163371200|NCT01283516|590066536|FG003|Overall Study|Disease Progression|3|||
163371201|NCT01283516|590066537|FG004|Overall Study|Disease Progression|13|||
163371202|NCT01283516|590066538|FG005|Overall Study|Disease Progression|8|||
163371203|NCT01283516|590066539|FG006|Overall Study|Disease Progression|6|||
163371204|NCT01283516|590066540|FG007|Overall Study|Disease Progression|3|||
163371205|NCT01283516|590066541|FG008|Overall Study|Disease Progression|139|||
163371206|NCT01283516|590066533|FG000|Overall Study|Withdrawal by Subject|0|||
163371207|NCT01283516|590066534|FG001|Overall Study|Withdrawal by Subject|0|||
163371208|NCT01283516|590066535|FG002|Overall Study|Withdrawal by Subject|0|||
163371209|NCT01283516|590066536|FG003|Overall Study|Withdrawal by Subject|0|||
163371210|NCT01283516|590066537|FG004|Overall Study|Withdrawal by Subject|1|||
163371211|NCT01283516|590066538|FG005|Overall Study|Withdrawal by Subject|0|||
163371212|NCT01283516|590066539|FG006|Overall Study|Withdrawal by Subject|1|||
163371213|NCT01283516|590066540|FG007|Overall Study|Withdrawal by Subject|0|||
163371214|NCT01283516|590066541|FG008|Overall Study|Withdrawal by Subject|36|||
163371215|NCT01283516|590066533|FG000|Overall Study|Administrative problems|0|||
163371216|NCT01283516|590066534|FG001|Overall Study|Administrative problems|0|||
163371217|NCT01283516|590066535|FG002|Overall Study|Administrative problems|0|||
163371218|NCT01283516|590066536|FG003|Overall Study|Administrative problems|0|||
163371219|NCT01283516|590066537|FG004|Overall Study|Administrative problems|0|||
163371220|NCT01283516|590066538|FG005|Overall Study|Administrative problems|1|||
163371221|NCT01283516|590066539|FG006|Overall Study|Administrative problems|1|||
163371222|NCT01283516|590066540|FG007|Overall Study|Administrative problems|1|||
163371223|NCT01283516|590066541|FG008|Overall Study|Administrative problems|39|||
163371224|NCT01283516|590066533|FG000|Overall Study|Lost to Follow-up|0|||
163371225|NCT01283516|590066534|FG001|Overall Study|Lost to Follow-up|0|||
163371226|NCT01283516|590066535|FG002|Overall Study|Lost to Follow-up|0|||
163371227|NCT01283516|590066536|FG003|Overall Study|Lost to Follow-up|0|||
163371228|NCT01283516|590066537|FG004|Overall Study|Lost to Follow-up|0|||
163371229|NCT01283516|590066538|FG005|Overall Study|Lost to Follow-up|0|||
163371230|NCT01283516|590066539|FG006|Overall Study|Lost to Follow-up|0|||
163371231|NCT01283516|590066540|FG007|Overall Study|Lost to Follow-up|0|||
163371232|NCT01283516|590066541|FG008|Overall Study|Lost to Follow-up|1|||
163371233|NCT00444275|590066544|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
163371234|NCT00444275|590066545|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
163371235|NCT00444275|590066546|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
163371236|NCT00444275|590066547|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
163371237|NCT00444275|590066548|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
163371238|NCT00444275|590066544|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
163371239|NCT00444275|590066545|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
163371240|NCT00444275|590066546|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
163413673|NCT00804687|590222952|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
163413674|NCT00804687|590222953|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
163413675|NCT00804687|590222954|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
163371241|NCT00444275|590066547|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
163371242|NCT00444275|590066548|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
163371243|NCT00444275|590066544|FG000|Maintenance Treatment Phase|Adverse Event|0|||
163371244|NCT00444275|590066545|FG001|Maintenance Treatment Phase|Adverse Event|0|||
163371245|NCT00444275|590066546|FG002|Maintenance Treatment Phase|Adverse Event|3|||
163371246|NCT00444275|590066547|FG003|Maintenance Treatment Phase|Adverse Event|2|||
163371247|NCT00444275|590066548|FG004|Maintenance Treatment Phase|Adverse Event|13|||
163371248|NCT00444275|590066544|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
163371249|NCT00444275|590066545|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
163413676|NCT00804687|590222955|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
163413677|NCT00804687|590222956|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
163413678|NCT00804687|590222951|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
163413679|NCT00804687|590222952|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
163413680|NCT00804687|590222953|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
163413681|NCT00804687|590222954|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
163413682|NCT00804687|590222955|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
163413683|NCT00804687|590222956|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
163413684|NCT00804687|590222951|FG000|Period 5: Treatment Period|Positive drug test|1|||
163413685|NCT00804687|590222952|FG001|Period 5: Treatment Period|Positive drug test|0|||
163413686|NCT00804687|590222953|FG002|Period 5: Treatment Period|Positive drug test|0|||
163413687|NCT00804687|590222954|FG003|Period 5: Treatment Period|Positive drug test|0|||
163413688|NCT00804687|590222955|FG004|Period 5: Treatment Period|Positive drug test|0|||
163413689|NCT00804687|590222956|FG005|Period 5: Treatment Period|Positive drug test|0|||
163413690|NCT00805740|590222960|FG000|Overall Study|Death|7|||
163413691|NCT00805740|590222961|FG001|Overall Study|Death|4|||
163413692|NCT00805740|590222960|FG000|Overall Study|Withdrawal by Subject|1|||
163413693|NCT00805740|590222961|FG001|Overall Study|Withdrawal by Subject|0|||
163413694|NCT00805740|590222960|FG000|Overall Study|Lost to Follow-up|1|||
163413695|NCT00805740|590222961|FG001|Overall Study|Lost to Follow-up|0|||
163413696|NCT00805740|590222960|FG000|Overall Study|Randomized, but not treated|2|||
163413697|NCT00805740|590222961|FG001|Overall Study|Randomized, but not treated|0|||
163413698|NCT05227690|590222966|FG000|Overall Study|Adverse Event|5|||
163413699|NCT05227690|590222967|FG001|Overall Study|Adverse Event|6|||
163413700|NCT05227690|590222968|FG002|Overall Study|Adverse Event|10|||
163413701|NCT05227690|590222966|FG000|Overall Study|Lack of Efficacy|2|||
163413702|NCT05227690|590222967|FG001|Overall Study|Lack of Efficacy|4|||
163413703|NCT05227690|590222968|FG002|Overall Study|Lack of Efficacy|1|||
163413704|NCT05227690|590222966|FG000|Overall Study|Physician Decision|6|||
163413705|NCT05227690|590222967|FG001|Overall Study|Physician Decision|0|||
163413706|NCT05227690|590222968|FG002|Overall Study|Physician Decision|4|||
163413707|NCT05227690|590222966|FG000|Overall Study|Withdrawal of consent|28|||
163413708|NCT05227690|590222967|FG001|Overall Study|Withdrawal of consent|27|||
163413709|NCT05227690|590222968|FG002|Overall Study|Withdrawal of consent|21|||
163413710|NCT05227690|590222966|FG000|Overall Study|Other, not specified|2|||
163413711|NCT05227690|590222967|FG001|Overall Study|Other, not specified|2|||
163413712|NCT05227690|590222968|FG002|Overall Study|Other, not specified|1|||
163413713|NCT00975156|590222969|FG000|Overall Study|Protocol Violation|0|||
163413714|NCT00975156|590222970|FG001|Overall Study|Protocol Violation|1|||
163413715|NCT02634580|590222971|FG000|Double-blind Treatment Period|Subject Request|1|||
163413716|NCT02634580|590222972|FG001|Double-blind Treatment Period|Subject Request|0|||
163413717|NCT02634580|590222973|FG002|Double-blind Treatment Period|Subject Request|1|||
163413718|NCT02634580|590222974|FG003|Double-blind Treatment Period|Subject Request|1|||
163413719|NCT02634580|590222971|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
163413720|NCT02634580|590222972|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
163413721|NCT02634580|590222973|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
163413722|NCT02634580|590222974|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
163413723|NCT02908880|590222976|FG000|Overall Study|Lost to Follow-up|4|||
163371250|NCT00444275|590066546|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
163413724|NCT02908880|590222976|FG000|Overall Study|Explantation of the device|1|||
163413725|NCT02908880|590222976|FG000|Overall Study|Withdrawal by Subject|17|||
163413726|NCT02908880|590222976|FG000|Overall Study|Death|5|||
163413727|NCT00424827|590222981|FG000|Overall Study|Adverse Event|1|||
163413728|NCT00491179|590222982|FG000|Overall Study|Adverse Event|5|||
163413729|NCT00491179|590222983|FG001|Overall Study|Adverse Event|1|||
163413730|NCT00491179|590222982|FG000|Overall Study|Withdrawal by Subject|2|||
163413731|NCT00491179|590222983|FG001|Overall Study|Withdrawal by Subject|1|||
163413732|NCT02009878|590222984|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
163413733|NCT02009878|590222985|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
163413734|NCT02009878|590222986|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
163413735|NCT01491178|590222989|FG000|Overall Study|Adverse Event|1016|||
163371251|NCT00444275|590066547|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
163371252|NCT00444275|590066548|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
163371253|NCT00444275|590066544|FG000|Maintenance Treatment Phase|Patient's wish|0|||
163371254|NCT00444275|590066545|FG001|Maintenance Treatment Phase|Patient's wish|0|||
163371255|NCT00444275|590066546|FG002|Maintenance Treatment Phase|Patient's wish|19|||
163371256|NCT00444275|590066547|FG003|Maintenance Treatment Phase|Patient's wish|9|||
163371257|NCT00444275|590066548|FG004|Maintenance Treatment Phase|Patient's wish|20|||
163371258|NCT00444275|590066544|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
163371259|NCT00444275|590066545|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
163371260|NCT00444275|590066546|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
163371261|NCT00444275|590066547|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
163371262|NCT00444275|590066548|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
163371263|NCT00444275|590066544|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
163371264|NCT00444275|590066545|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
163371265|NCT00444275|590066546|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
163371266|NCT00444275|590066547|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
163371267|NCT00444275|590066548|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
163371268|NCT04187326|590066549|FG000|Overall Study|Lost to Follow-up|2|||
163371269|NCT04187326|590066550|FG001|Overall Study|Lost to Follow-up|1|||
163371270|NCT04187326|590066549|FG000|Overall Study|Computer error- task was only partially completed.|0|||
163371271|NCT04187326|590066550|FG001|Overall Study|Computer error- task was only partially completed.|1|||
163371272|NCT00283244|590066551|FG000|Overall Study|Adverse Event|0|||
163371273|NCT00283244|590066552|FG001|Overall Study|Adverse Event|8|||
163371274|NCT00283244|590066553|FG002|Overall Study|Adverse Event|11|||
163371275|NCT00283244|590066551|FG000|Overall Study|Death|4|||
163371276|NCT00283244|590066552|FG001|Overall Study|Death|3|||
163371277|NCT00283244|590066553|FG002|Overall Study|Death|2|||
163371278|NCT00283244|590066551|FG000|Overall Study|Lack of Efficacy|8|||
163371279|NCT00283244|590066552|FG001|Overall Study|Lack of Efficacy|32|||
163371280|NCT00283244|590066553|FG002|Overall Study|Lack of Efficacy|26|||
163371281|NCT00283244|590066551|FG000|Overall Study|Withdrawal by Subject|1|||
163371282|NCT00283244|590066552|FG001|Overall Study|Withdrawal by Subject|2|||
163371283|NCT00283244|590066553|FG002|Overall Study|Withdrawal by Subject|2|||
163371284|NCT00283244|590066551|FG000|Overall Study|Physician Decision|0|||
163371285|NCT00283244|590066552|FG001|Overall Study|Physician Decision|0|||
163371286|NCT00283244|590066553|FG002|Overall Study|Physician Decision|1|||
163371287|NCT00283244|590066551|FG000|Overall Study|Medical illness (other complicating dz)|4|||
163371288|NCT00283244|590066552|FG001|Overall Study|Medical illness (other complicating dz)|3|||
163371289|NCT00283244|590066553|FG002|Overall Study|Medical illness (other complicating dz)|6|||
163371290|NCT00283244|590066551|FG000|Overall Study|Clinical deterioration|1|||
163371291|NCT00283244|590066552|FG001|Overall Study|Clinical deterioration|3|||
163371292|NCT00283244|590066553|FG002|Overall Study|Clinical deterioration|3|||
163371293|NCT05543187|590066556|FG000|Overall Study|Ongoing|3|||
163371294|NCT05543187|590066557|FG001|Overall Study|Ongoing|2|||
163371295|NCT04777864|590066558|FG000|Overall Study|Lost to Follow-up|8|||
163371296|NCT04777864|590066559|FG001|Overall Study|Lost to Follow-up|19|||
163371297|NCT02344290|590066563|FG000|Overall Study|Withdrawal by Subject|315|||
163371298|NCT02344290|590066564|FG001|Overall Study|Withdrawal by Subject|324|||
163371299|NCT02344290|590066563|FG000|Overall Study|Lost to Follow-up|258|||
163371300|NCT02344290|590066564|FG001|Overall Study|Lost to Follow-up|249|||
163371301|NCT02344290|590066563|FG000|Overall Study|Unable to get to clinic|69|||
163371302|NCT02344290|590066564|FG001|Overall Study|Unable to get to clinic|60|||
163371303|NCT02344290|590066563|FG000|Overall Study|Physician Decision|25|||
163371304|NCT02344290|590066564|FG001|Overall Study|Physician Decision|25|||
163371305|NCT02344290|590066563|FG000|Overall Study|Site Closure|15|||
163371306|NCT02344290|590066564|FG001|Overall Study|Site Closure|19|||
163371307|NCT02344290|590066563|FG000|Overall Study|Other|5|||
163371308|NCT02344290|590066564|FG001|Overall Study|Other|3|||
163371309|NCT06748729|590066566|FG000|Overall Study|Withdrawal by Subject|1|||
163371310|NCT00379288|590068454|FG000|Overall Study|Adverse Event|5|||
163371311|NCT00379288|590068455|FG001|Overall Study|Adverse Event|6|||
163371312|NCT00379288|590068456|FG002|Overall Study|Adverse Event|2|||
163371313|NCT00379288|590068457|FG003|Overall Study|Adverse Event|0|||
163371314|NCT00379288|590068454|FG000|Overall Study|Treatment Failure|0|||
163413736|NCT01491178|590222989|FG000|Overall Study|Improvement of NVAF|210|||
163413737|NCT01491178|590222989|FG000|Overall Study|To conduct invasive treatment|59|||
163371315|NCT00379288|590068455|FG001|Overall Study|Treatment Failure|1|||
163371316|NCT00379288|590068456|FG002|Overall Study|Treatment Failure|0|||
163371317|NCT00379288|590068457|FG003|Overall Study|Treatment Failure|1|||
163371318|NCT00379288|590068454|FG000|Overall Study|Lost to Follow-up|3|||
163371319|NCT00379288|590068455|FG001|Overall Study|Lost to Follow-up|3|||
163371320|NCT00379288|590068456|FG002|Overall Study|Lost to Follow-up|2|||
163371321|NCT00379288|590068457|FG003|Overall Study|Lost to Follow-up|0|||
163371322|NCT00379288|590068454|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
163371323|NCT00379288|590068455|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
163371324|NCT00379288|590068456|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
163371325|NCT00379288|590068457|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
163371326|NCT00379288|590068454|FG000|Overall Study|Subject withdrew-related to study drug|1|||
163371327|NCT00379288|590068455|FG001|Overall Study|Subject withdrew-related to study drug|0|||
163371328|NCT00379288|590068456|FG002|Overall Study|Subject withdrew-related to study drug|0|||
163371329|NCT00379288|590068457|FG003|Overall Study|Subject withdrew-related to study drug|1|||
163371330|NCT00379288|590068454|FG000|Overall Study|Noncompliance with protocol|8|||
163371331|NCT00379288|590068455|FG001|Overall Study|Noncompliance with protocol|6|||
163371332|NCT00379288|590068456|FG002|Overall Study|Noncompliance with protocol|2|||
163371333|NCT00379288|590068457|FG003|Overall Study|Noncompliance with protocol|1|||
163371334|NCT00379288|590068454|FG000|Overall Study|Did not meet protocol eligibility|0|||
163371335|NCT00379288|590068455|FG001|Overall Study|Did not meet protocol eligibility|1|||
163371336|NCT00379288|590068456|FG002|Overall Study|Did not meet protocol eligibility|0|||
163371337|NCT00379288|590068457|FG003|Overall Study|Did not meet protocol eligibility|2|||
163371338|NCT00379288|590068454|FG000|Overall Study|Administrative|2|||
163371339|NCT00379288|590068455|FG001|Overall Study|Administrative|2|||
163371340|NCT00379288|590068456|FG002|Overall Study|Administrative|0|||
163371341|NCT00379288|590068457|FG003|Overall Study|Administrative|1|||
163371342|NCT00591370|590068458|FG000|Overall Study|Not Treated|2|||
163371343|NCT01183260|590068459|FG000|Overall Study|Intraop screen failure|2|||
163371344|NCT01183260|590068460|FG001|Overall Study|Intraop screen failure|0|||
163371345|NCT01183260|590068459|FG000|Overall Study|Withdrawal by Subject|1|||
163371346|NCT01183260|590068460|FG001|Overall Study|Withdrawal by Subject|1|||
163371347|NCT01183260|590068459|FG000|Overall Study|Revised within 30 days|0|||
163371348|NCT01183260|590068460|FG001|Overall Study|Revised within 30 days|1|||
163371349|NCT01183260|590068459|FG000|Overall Study|Death|1|||
163371350|NCT01183260|590068460|FG001|Overall Study|Death|0|||
163371351|NCT01202903|590068462|FG000|Overall Study|Administrative Probelms|1|||
163371352|NCT01202903|590068463|FG001|Overall Study|Administrative Probelms|4|||
163371353|NCT01202903|590068462|FG000|Overall Study|Protocol Violation|0|||
163371354|NCT01202903|590068463|FG001|Overall Study|Protocol Violation|1|||
163371355|NCT01202903|590068462|FG000|Overall Study|Death|1|||
163371356|NCT01202903|590068463|FG001|Overall Study|Death|0|||
163371357|NCT01202903|590068462|FG000|Overall Study|Lost to Follow-up|1|||
163371358|NCT01202903|590068463|FG001|Overall Study|Lost to Follow-up|1|||
163371359|NCT01202903|590068462|FG000|Overall Study|Lack of Efficacy|1|||
163371360|NCT01202903|590068463|FG001|Overall Study|Lack of Efficacy|3|||
163371361|NCT01202903|590068462|FG000|Overall Study|Adverse Event|3|||
163371362|NCT01202903|590068463|FG001|Overall Study|Adverse Event|3|||
163371363|NCT01202903|590068462|FG000|Overall Study|Withdrawal by Subject|4|||
163371364|NCT01202903|590068463|FG001|Overall Study|Withdrawal by Subject|4|||
163371365|NCT01302080|590068464|FG000|Overall Study|Withdrew Consent|92|||
163371366|NCT01302080|590068465|FG001|Overall Study|Withdrew Consent|39|||
163371367|NCT01302080|590068464|FG000|Overall Study|Patient/Family Moved|28|||
163371368|NCT01302080|590068465|FG001|Overall Study|Patient/Family Moved|3|||
163371369|NCT01302080|590068464|FG000|Overall Study|Lost to Follow-up|192|||
163371370|NCT01302080|590068465|FG001|Overall Study|Lost to Follow-up|93|||
163371371|NCT01302080|590068464|FG000|Overall Study|Death|1|||
163371372|NCT01302080|590068465|FG001|Overall Study|Death|0|||
163371373|NCT01302080|590068464|FG000|Overall Study|Other|52|||
163371374|NCT01302080|590068465|FG001|Overall Study|Other|8|||
163371375|NCT01302080|590068464|FG000|Overall Study|Reason Missing For Discontinuation|1|||
163371376|NCT01302080|590068465|FG001|Overall Study|Reason Missing For Discontinuation|0|||
163371377|NCT00837694|590068466|FG000|Overall Study|Lost to Follow-up|2|||
163371378|NCT00837694|590068467|FG001|Overall Study|Lost to Follow-up|0|||
163371379|NCT00837694|590068468|FG002|Overall Study|Lost to Follow-up|2|||
163371380|NCT00837694|590068469|FG003|Overall Study|Lost to Follow-up|1|||
163371381|NCT00837694|590068470|FG004|Overall Study|Lost to Follow-up|1|||
163371382|NCT00837694|590068471|FG005|Overall Study|Lost to Follow-up|1|||
163371383|NCT00095056|590068474|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
163371384|NCT00095056|590068475|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
163371385|NCT00095056|590068474|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
163371386|NCT00095056|590068475|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
163371387|NCT00095056|590068474|FG000|Phase A (Weeks 0-12)|Death|1|||
163371388|NCT00095056|590068475|FG001|Phase A (Weeks 0-12)|Death|0|||
163371389|NCT00095056|590068474|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
163371390|NCT00095056|590068475|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
163371391|NCT00095056|590068474|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
163371392|NCT00095056|590068475|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
163371393|NCT00095056|590068474|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
163371394|NCT00095056|590068475|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
163371395|NCT00095056|590068474|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
163371396|NCT00095056|590068475|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
163371397|NCT00095056|590068474|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
163371398|NCT00095056|590068475|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
163371399|NCT00095056|590068474|FG000|Phase B (Weeks 12-54)|Death|3|||
163371400|NCT00095056|590068475|FG001|Phase B (Weeks 12-54)|Death|1|||
163371401|NCT00095056|590068474|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
163371402|NCT00095056|590068475|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
163371403|NCT00095056|590068474|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
163371404|NCT00095056|590068475|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
163371405|NCT00306670|590068476|FG000|Overall Study|patients recruited; Genentech, the st|0|||
163371406|NCT00306670|590068477|FG001|Overall Study|patients recruited; Genentech, the st|2|||
163371407|NCT00503139|590068481|FG000|Overall Study|Case Report Forms were not collected|4|||
163371408|NCT00503139|590068481|FG000|Overall Study|Protocol Violation|4|||
163371409|NCT00091169|590068485|FG000|Overall Study|Disease progression|3|||
163371410|NCT00091169|590068486|FG001|Overall Study|Disease progression|1|||
163371411|NCT00091169|590068485|FG000|Overall Study|Adverse Event|11|||
163371412|NCT00091169|590068486|FG001|Overall Study|Adverse Event|17|||
163371413|NCT00091169|590068485|FG000|Overall Study|Death|4|||
163371414|NCT00091169|590068486|FG001|Overall Study|Death|1|||
163371415|NCT00091169|590068485|FG000|Overall Study|Withdrawal by Subject|10|||
163371416|NCT00091169|590068486|FG001|Overall Study|Withdrawal by Subject|13|||
163371417|NCT00091169|590068485|FG000|Overall Study|Other|3|||
163371418|NCT00091169|590068486|FG001|Overall Study|Other|4|||
163371419|NCT00091169|590068485|FG000|Overall Study|Not start protocol therapy|26|||
163371420|NCT00091169|590068486|FG001|Overall Study|Not start protocol therapy|17|||
163371421|NCT02735577|590068487|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
163371422|NCT02735577|590068487|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
163371423|NCT00833833|590068488|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
163371424|NCT00833833|590068489|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
163371425|NCT00833833|590068490|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
163371426|NCT00833833|590068491|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
163371427|NCT00833833|590068492|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
163371428|NCT00833833|590068493|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
163371429|NCT00833833|590068488|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
163371430|NCT00833833|590068489|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
163371431|NCT00833833|590068490|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
163371432|NCT00833833|590068491|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
163371433|NCT00833833|590068492|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
163371434|NCT00833833|590068493|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
163371435|NCT00833833|590068488|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
163371436|NCT00833833|590068489|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
163371437|NCT00833833|590068490|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
163371438|NCT00833833|590068491|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
163371439|NCT00833833|590068492|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
163371440|NCT00833833|590068493|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
163371441|NCT00833833|590068488|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
163371442|NCT00833833|590068489|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
163371443|NCT00833833|590068490|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
163371444|NCT00833833|590068491|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
163371445|NCT00833833|590068492|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
163371446|NCT00833833|590068493|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
163371447|NCT00833833|590068488|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
163371448|NCT00833833|590068489|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163371449|NCT00833833|590068490|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
163371450|NCT00833833|590068491|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163371451|NCT00833833|590068492|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163371452|NCT00833833|590068493|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163371453|NCT00833833|590068488|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
163371454|NCT00833833|590068489|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
163371455|NCT00833833|590068490|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
163371456|NCT00833833|590068491|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
163371457|NCT00833833|590068492|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
163371458|NCT00833833|590068493|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
163371459|NCT00833833|590068488|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
163371460|NCT00833833|590068489|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
163371461|NCT00833833|590068490|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
163371462|NCT00833833|590068491|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
163371463|NCT00833833|590068492|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
163371464|NCT00833833|590068493|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
163371465|NCT00833833|590068488|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
163371466|NCT00833833|590068489|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
163371467|NCT00833833|590068490|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
163371468|NCT00833833|590068491|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
163371469|NCT00833833|590068492|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
163371470|NCT00833833|590068493|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
163371471|NCT00833833|590068488|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
163371472|NCT00833833|590068489|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
163371473|NCT00833833|590068490|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
163371474|NCT00833833|590068491|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
163371475|NCT00833833|590068492|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
163371476|NCT00833833|590068493|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
163371477|NCT00833833|590068488|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163371478|NCT00833833|590068489|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163371479|NCT00833833|590068490|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163371480|NCT00833833|590068491|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163371481|NCT00833833|590068492|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
163371482|NCT00833833|590068493|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
163371483|NCT00833833|590068488|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
163371484|NCT00833833|590068489|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
163371485|NCT00833833|590068490|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
163371486|NCT00833833|590068491|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
163371487|NCT00833833|590068492|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
163371488|NCT00833833|590068493|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
163371489|NCT00833833|590068488|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
163371490|NCT00833833|590068489|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
163371491|NCT00833833|590068490|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
163371492|NCT00833833|590068491|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
163371493|NCT00833833|590068492|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
163371494|NCT00833833|590068493|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
163371495|NCT00833833|590068488|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
163371496|NCT00833833|590068489|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
163371497|NCT00833833|590068490|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
163371498|NCT00833833|590068491|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
163371499|NCT00833833|590068492|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
163371500|NCT00833833|590068493|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
163371501|NCT02040259|590068494|FG000|Overall Study|Death|280|||
163371502|NCT02040259|590068494|FG000|Overall Study|Lost to Follow-up|76|||
163371503|NCT02040259|590068494|FG000|Overall Study|Assessment not completed|3|||
163371504|NCT02040259|590068494|FG000|Overall Study|Withdrawal by Subject|4|||
163371505|NCT00316602|590068504|FG000|Overall Study|Withdrawal by Subject|3|||
163371506|NCT00316602|590068505|FG001|Overall Study|Withdrawal by Subject|2|||
163371507|NCT00316602|590068504|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
163371508|NCT00316602|590068505|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
163371509|NCT00316602|590068504|FG000|Overall Study|Adverse Event|1|||
163371510|NCT00316602|590068505|FG001|Overall Study|Adverse Event|0|||
163371511|NCT00316602|590068504|FG000|Overall Study|Other|3|||
163371512|NCT00316602|590068505|FG001|Overall Study|Other|6|||
163371513|NCT01142232|590068506|FG000|Overall Study|Adverse Event|1|||
163371514|NCT01142232|590068507|FG001|Overall Study|Adverse Event|2|||
163371515|NCT01142232|590068508|FG002|Overall Study|Adverse Event|1|||
163371516|NCT01142232|590068509|FG003|Overall Study|Adverse Event|0|||
163371517|NCT01142232|590068510|FG004|Overall Study|Adverse Event|4|||
163371518|NCT01142232|590068506|FG000|Overall Study|Death|0|||
163371519|NCT01142232|590068507|FG001|Overall Study|Death|0|||
163371520|NCT01142232|590068508|FG002|Overall Study|Death|0|||
163371521|NCT01142232|590068509|FG003|Overall Study|Death|0|||
163371522|NCT01142232|590068510|FG004|Overall Study|Death|1|||
163371523|NCT01142232|590068506|FG000|Overall Study|Disease Progression|2|||
163371524|NCT01142232|590068507|FG001|Overall Study|Disease Progression|0|||
163371525|NCT01142232|590068508|FG002|Overall Study|Disease Progression|1|||
163371526|NCT01142232|590068509|FG003|Overall Study|Disease Progression|2|||
163371527|NCT01142232|590068510|FG004|Overall Study|Disease Progression|12|||
163371528|NCT01142232|590068506|FG000|Overall Study|Withdrawal by Subject|0|||
163371529|NCT01142232|590068507|FG001|Overall Study|Withdrawal by Subject|0|||
163371530|NCT01142232|590068508|FG002|Overall Study|Withdrawal by Subject|0|||
163371531|NCT01142232|590068509|FG003|Overall Study|Withdrawal by Subject|1|||
163371532|NCT01142232|590068510|FG004|Overall Study|Withdrawal by Subject|3|||
163371533|NCT01142232|590068506|FG000|Overall Study|Physician Decision|0|||
163371534|NCT01142232|590068507|FG001|Overall Study|Physician Decision|1|||
163371535|NCT01142232|590068508|FG002|Overall Study|Physician Decision|0|||
163371536|NCT01142232|590068509|FG003|Overall Study|Physician Decision|2|||
163371537|NCT01142232|590068510|FG004|Overall Study|Physician Decision|10|||
163371538|NCT01142232|590068506|FG000|Overall Study|Alternative Therapy|0|||
163371539|NCT01142232|590068507|FG001|Overall Study|Alternative Therapy|1|||
163371540|NCT01142232|590068508|FG002|Overall Study|Alternative Therapy|1|||
163371541|NCT01142232|590068509|FG003|Overall Study|Alternative Therapy|0|||
163371542|NCT01142232|590068510|FG004|Overall Study|Alternative Therapy|1|||
163371543|NCT01142232|590068506|FG000|Overall Study|Off Trt for other complicating disease|0|||
163371544|NCT01142232|590068507|FG001|Overall Study|Off Trt for other complicating disease|0|||
163371545|NCT01142232|590068508|FG002|Overall Study|Off Trt for other complicating disease|0|||
163371546|NCT01142232|590068509|FG003|Overall Study|Off Trt for other complicating disease|0|||
163371547|NCT01142232|590068510|FG004|Overall Study|Off Trt for other complicating disease|1|||
163371548|NCT01142232|590068506|FG000|Overall Study|Noncompliance|0|||
163371549|NCT01142232|590068507|FG001|Overall Study|Noncompliance|0|||
163371550|NCT01142232|590068508|FG002|Overall Study|Noncompliance|0|||
163371551|NCT01142232|590068509|FG003|Overall Study|Noncompliance|0|||
163371552|NCT01142232|590068510|FG004|Overall Study|Noncompliance|2|||
163371553|NCT00626990|590068511|FG000|Overall Study|Lack of Efficacy|6|||
163371554|NCT00626990|590068512|FG001|Overall Study|Lack of Efficacy|7|||
163371555|NCT00626990|590068513|FG002|Overall Study|Lack of Efficacy|49|||
163371556|NCT00626990|590068514|FG003|Overall Study|Lack of Efficacy|40|||
163371557|NCT00626990|590068511|FG000|Overall Study|Adverse Event|1|||
163371558|NCT00626990|590068512|FG001|Overall Study|Adverse Event|7|||
163371559|NCT00626990|590068513|FG002|Overall Study|Adverse Event|14|||
163371560|NCT00626990|590068514|FG003|Overall Study|Adverse Event|28|||
163371561|NCT00626990|590068511|FG000|Overall Study|Death|0|||
163371562|NCT00626990|590068512|FG001|Overall Study|Death|1|||
163371563|NCT00626990|590068513|FG002|Overall Study|Death|0|||
163371564|NCT00626990|590068514|FG003|Overall Study|Death|0|||
163371565|NCT00626990|590068511|FG000|Overall Study|Withdrawal by Subject|3|||
163371566|NCT00626990|590068512|FG001|Overall Study|Withdrawal by Subject|1|||
163371567|NCT00626990|590068513|FG002|Overall Study|Withdrawal by Subject|5|||
163371568|NCT00626990|590068514|FG003|Overall Study|Withdrawal by Subject|11|||
163371569|NCT00626990|590068511|FG000|Overall Study|Protocol Violation|0|||
163371570|NCT00626990|590068512|FG001|Overall Study|Protocol Violation|1|||
163371571|NCT00626990|590068513|FG002|Overall Study|Protocol Violation|1|||
163371572|NCT00626990|590068514|FG003|Overall Study|Protocol Violation|0|||
163371573|NCT00626990|590068511|FG000|Overall Study|Various different reasons/missing|4|||
163371574|NCT00626990|590068512|FG001|Overall Study|Various different reasons/missing|8|||
163371575|NCT00626990|590068513|FG002|Overall Study|Various different reasons/missing|8|||
163371576|NCT00626990|590068514|FG003|Overall Study|Various different reasons/missing|16|||
163371577|NCT04138576|590068519|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
163371578|NCT04410523|590068524|FG000|Overall Study|Study terminated by sponsor|1|||
163371579|NCT04410523|590068525|FG001|Overall Study|Study terminated by sponsor|3|||
163371580|NCT04410523|590068526|FG002|Overall Study|Study terminated by sponsor|2|||
163371581|NCT04410523|590068527|FG003|Overall Study|Study terminated by sponsor|6|||
163371582|NCT04410523|590068528|FG004|Overall Study|Study terminated by sponsor|3|||
163371583|NCT04410523|590068529|FG005|Overall Study|Study terminated by sponsor|4|||
163371584|NCT04410523|590068524|FG000|Overall Study|Adverse Event|1|||
163371585|NCT04410523|590068525|FG001|Overall Study|Adverse Event|0|||
163371586|NCT04410523|590068526|FG002|Overall Study|Adverse Event|0|||
163371587|NCT04410523|590068527|FG003|Overall Study|Adverse Event|0|||
163371588|NCT04410523|590068528|FG004|Overall Study|Adverse Event|0|||
163371589|NCT04410523|590068529|FG005|Overall Study|Adverse Event|2|||
163371590|NCT04410523|590068524|FG000|Overall Study|Lost to Follow-up|0|||
163371591|NCT04410523|590068525|FG001|Overall Study|Lost to Follow-up|1|||
163371592|NCT04410523|590068526|FG002|Overall Study|Lost to Follow-up|0|||
163371593|NCT04410523|590068527|FG003|Overall Study|Lost to Follow-up|0|||
163371594|NCT04410523|590068528|FG004|Overall Study|Lost to Follow-up|0|||
163371595|NCT04410523|590068529|FG005|Overall Study|Lost to Follow-up|0|||
163371596|NCT04410523|590068524|FG000|Overall Study|Physician Decision|0|||
163371597|NCT04410523|590068525|FG001|Overall Study|Physician Decision|1|||
163371598|NCT04410523|590068526|FG002|Overall Study|Physician Decision|0|||
163371599|NCT04410523|590068527|FG003|Overall Study|Physician Decision|0|||
163371600|NCT04410523|590068528|FG004|Overall Study|Physician Decision|0|||
163371601|NCT04410523|590068529|FG005|Overall Study|Physician Decision|0|||
163371602|NCT04410523|590068524|FG000|Overall Study|Pregnancy|0|||
163371603|NCT04410523|590068525|FG001|Overall Study|Pregnancy|0|||
163371604|NCT04410523|590068526|FG002|Overall Study|Pregnancy|0|||
163371605|NCT04410523|590068527|FG003|Overall Study|Pregnancy|0|||
163371606|NCT04410523|590068528|FG004|Overall Study|Pregnancy|0|||
163371607|NCT04410523|590068529|FG005|Overall Study|Pregnancy|1|||
163371608|NCT04410523|590068524|FG000|Overall Study|Protocol deviation|0|||
163371609|NCT04410523|590068525|FG001|Overall Study|Protocol deviation|0|||
163371610|NCT04410523|590068526|FG002|Overall Study|Protocol deviation|0|||
163371611|NCT04410523|590068527|FG003|Overall Study|Protocol deviation|0|||
163371612|NCT04410523|590068528|FG004|Overall Study|Protocol deviation|0|||
163413738|NCT01491178|590222989|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
163371613|NCT04410523|590068529|FG005|Overall Study|Protocol deviation|2|||
163371614|NCT04410523|590068524|FG000|Overall Study|Subject decision|2|||
163371615|NCT04410523|590068525|FG001|Overall Study|Subject decision|0|||
163371616|NCT04410523|590068526|FG002|Overall Study|Subject decision|0|||
163371617|NCT04410523|590068527|FG003|Overall Study|Subject decision|1|||
163371618|NCT04410523|590068528|FG004|Overall Study|Subject decision|0|||
163371619|NCT04410523|590068529|FG005|Overall Study|Subject decision|1|||
163371620|NCT00490490|590068530|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
163371621|NCT00490490|590068530|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
163371622|NCT03268603|590068531|FG000|Overall Study|Withdrawal by Subject|6|||
163371623|NCT03268603|590068531|FG000|Overall Study|Physician Decision|1|||
163371624|NCT03268603|590068531|FG000|Overall Study|Withdrawn due to disease progression|2|||
163371625|NCT04939701|590068532|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
163371626|NCT04939701|590068533|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
163371627|NCT04939701|590068534|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
163371628|NCT04939701|590068532|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
163371629|NCT04939701|590068533|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
163371630|NCT04939701|590068534|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
163371631|NCT04939701|590068532|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
163371632|NCT04939701|590068533|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
163371633|NCT04939701|590068534|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
163371634|NCT04939701|590068532|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
163371635|NCT04939701|590068533|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
163371636|NCT04939701|590068534|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
163371637|NCT04939701|590068532|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
163371638|NCT04939701|590068533|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
163371639|NCT04939701|590068534|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
163371640|NCT04939701|590068532|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
163371641|NCT04939701|590068533|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
163371642|NCT04939701|590068534|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
163371643|NCT04939701|590068532|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
163371644|NCT04939701|590068533|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
163371645|NCT04939701|590068534|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
163371646|NCT00772330|590068535|FG000|Overall Study|Lost to Follow-up|3|||
163371647|NCT00734591|590068536|FG000|Screening for Prospective Period|Site did not participate|1604|||
163371648|NCT00734591|590068537|FG001|Screening for Prospective Period|Site did not participate|1488|||
163371649|NCT00734591|590068536|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
163371650|NCT00734591|590068537|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
163371651|NCT00734591|590068536|FG000|Prospective Period|Withdrawal by Subject|11|||
163413739|NCT01491178|590222989|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
163413740|NCT01491178|590222989|FG000|Overall Study|To take a contraindication|20|||
163413741|NCT01491178|590222989|FG000|Overall Study|Other than specified above|657|||
163413742|NCT05689047|590222990|FG000|Overall Study|Lost to Follow-up|0|||
163413743|NCT05689047|590222991|FG001|Overall Study|Lost to Follow-up|1|||
163413744|NCT05689047|590222990|FG000|Overall Study|Protocol Deviation|1|||
163413745|NCT05689047|590222991|FG001|Overall Study|Protocol Deviation|0|||
163413746|NCT01604512|590222992|FG000|Overall Study|Withdrawal by Subject|3|||
163413747|NCT01604512|590222992|FG000|Overall Study|Not treated|4|||
163413748|NCT03132636|590222993|FG000|Overall Study|Adverse Event|1|||
163413749|NCT03132636|590222994|FG001|Overall Study|Adverse Event|2|||
163413750|NCT03132636|590222993|FG000|Overall Study|Death|4|||
163413751|NCT03132636|590222994|FG001|Overall Study|Death|7|||
163413752|NCT03132636|590222993|FG000|Overall Study|Lost to Follow-up|3|||
163413753|NCT03132636|590222994|FG001|Overall Study|Lost to Follow-up|2|||
163413754|NCT03132636|590222993|FG000|Overall Study|Non compliance with protocol by participant|1|||
163413755|NCT03132636|590222994|FG001|Overall Study|Non compliance with protocol by participant|1|||
163413756|NCT03132636|590222993|FG000|Overall Study|Subject decision|1|||
163413757|NCT03132636|590222994|FG001|Overall Study|Subject decision|9|||
163413758|NCT03132636|590222993|FG000|Overall Study|Sponsor decision|0|||
163413759|NCT03132636|590222994|FG001|Overall Study|Sponsor decision|1|||
163413760|NCT03132636|590222993|FG000|Overall Study|Physician Decision|1|||
163413761|NCT03132636|590222994|FG001|Overall Study|Physician Decision|0|||
163413762|NCT03132636|590222993|FG000|Overall Study|Progressive disease|33|||
163413763|NCT03132636|590222994|FG001|Overall Study|Progressive disease|36|||
163413764|NCT03132636|590222993|FG000|Overall Study|Withdrawal of consent|2|||
163413765|NCT03132636|590222994|FG001|Overall Study|Withdrawal of consent|5|||
163413766|NCT03132636|590222993|FG000|Overall Study|Did not re-consent|1|||
163413767|NCT03132636|590222994|FG001|Overall Study|Did not re-consent|0|||
163413768|NCT03132636|590222993|FG000|Overall Study|Lost insurance coverage|1|||
163413769|NCT03132636|590222994|FG001|Overall Study|Lost insurance coverage|0|||
163371652|NCT00734591|590068537|FG001|Prospective Period|Withdrawal by Subject|9|||
163371653|NCT00734591|590068536|FG000|Prospective Period|Lost to Follow-up|37|||
163371654|NCT00734591|590068537|FG001|Prospective Period|Lost to Follow-up|33|||
163371655|NCT00734591|590068536|FG000|Prospective Period|Study Terminated|1|||
163371656|NCT00734591|590068537|FG001|Prospective Period|Study Terminated|0|||
163413770|NCT03132636|590222993|FG000|Overall Study|Related to radiological outcomes|0|||
163413771|NCT03132636|590222994|FG001|Overall Study|Related to radiological outcomes|1|||
163413772|NCT03132636|590222993|FG000|Overall Study|Unable to come to site for continued visits|0|||
163413773|NCT03132636|590222994|FG001|Overall Study|Unable to come to site for continued visits|1|||
163413782|NCT03083886|590222999|FG000|Overall Study|Withdrawal by Subject|51|||
163413783|NCT03083886|590223000|FG001|Overall Study|Withdrawal by Subject|73|||
163413784|NCT03083886|590223001|FG002|Overall Study|Withdrawal by Subject|104|||
163413785|NCT03083886|590222999|FG000|Overall Study|Missing Baseline data|43|||
163413786|NCT03083886|590223000|FG001|Overall Study|Missing Baseline data|42|||
163413787|NCT03083886|590223001|FG002|Overall Study|Missing Baseline data|31|||
163413788|NCT03083886|590222999|FG000|Overall Study|Investigator terminated|1|||
163413789|NCT03083886|590223000|FG001|Overall Study|Investigator terminated|6|||
163413790|NCT03083886|590223001|FG002|Overall Study|Investigator terminated|3|||
163371657|NCT00734591|590068536|FG000|Prospective Period|Other|2|||
163371658|NCT00734591|590068537|FG001|Prospective Period|Other|2|||
163371659|NCT03248882|590068540|FG000|Overall Study|Adverse Event|3|||
163371660|NCT03248882|590068541|FG001|Overall Study|Adverse Event|3|||
163371661|NCT03248882|590068542|FG002|Overall Study|Adverse Event|2|||
163371662|NCT03248882|590068543|FG003|Overall Study|Adverse Event|6|||
163371663|NCT03248882|590068544|FG004|Overall Study|Adverse Event|9|||
163371664|NCT03248882|590068540|FG000|Overall Study|Lost to Follow-up|0|||
163371665|NCT03248882|590068541|FG001|Overall Study|Lost to Follow-up|0|||
163371666|NCT03248882|590068542|FG002|Overall Study|Lost to Follow-up|0|||
163371667|NCT03248882|590068543|FG003|Overall Study|Lost to Follow-up|0|||
163371668|NCT03248882|590068544|FG004|Overall Study|Lost to Follow-up|1|||
163371669|NCT03248882|590068540|FG000|Overall Study|Protocol Violation|2|||
163371670|NCT03248882|590068541|FG001|Overall Study|Protocol Violation|0|||
163371671|NCT03248882|590068542|FG002|Overall Study|Protocol Violation|2|||
163371672|NCT03248882|590068543|FG003|Overall Study|Protocol Violation|0|||
163371673|NCT03248882|590068544|FG004|Overall Study|Protocol Violation|1|||
163371674|NCT03248882|590068540|FG000|Overall Study|Withdrawal by Subject|2|||
163371675|NCT03248882|590068541|FG001|Overall Study|Withdrawal by Subject|2|||
163371676|NCT03248882|590068542|FG002|Overall Study|Withdrawal by Subject|3|||
163371677|NCT03248882|590068543|FG003|Overall Study|Withdrawal by Subject|4|||
163371678|NCT03248882|590068544|FG004|Overall Study|Withdrawal by Subject|2|||
163371679|NCT01656200|590068545|FG000|Overall Study|Withdrawal by Subject|1|||
163371680|NCT01461811|590068546|FG000|Overall Study|Adverse Event|2|||
163371681|NCT01461811|590068547|FG001|Overall Study|Adverse Event|1|||
163371682|NCT01461811|590068546|FG000|Overall Study|Subject decision unrelated to an AE|1|||
163371683|NCT01461811|590068547|FG001|Overall Study|Subject decision unrelated to an AE|1|||
163371684|NCT01461811|590068546|FG000|Overall Study|Noncompliance|1|||
163371685|NCT01461811|590068547|FG001|Overall Study|Noncompliance|1|||
163371686|NCT03015129|590068548|FG000|Overall Study|Death|2|||
163371687|NCT03015129|590068549|FG001|Overall Study|Death|2|||
163371688|NCT03015129|590068548|FG000|Overall Study|Lost to Follow-up|0|||
163371689|NCT03015129|590068549|FG001|Overall Study|Lost to Follow-up|1|||
163371690|NCT03015129|590068548|FG000|Overall Study|Progression of disease|38|||
163371691|NCT03015129|590068549|FG001|Overall Study|Progression of disease|33|||
163371692|NCT03015129|590068548|FG000|Overall Study|Adverse Event|0|||
163371693|NCT03015129|590068549|FG001|Overall Study|Adverse Event|4|||
163371694|NCT05032872|590068550|FG000|Overall Study|Adverse Event|1|||
163371695|NCT05032872|590068551|FG001|Overall Study|Adverse Event|0|||
163371696|NCT05032872|590068550|FG000|Overall Study|Lost to Follow-up|2|||
163371697|NCT05032872|590068551|FG001|Overall Study|Lost to Follow-up|4|||
163371698|NCT05032872|590068550|FG000|Overall Study|Withdrawal by Subject|4|||
163371699|NCT05032872|590068551|FG001|Overall Study|Withdrawal by Subject|3|||
163371700|NCT00338962|590068552|FG000|Overall Study|Lost to Follow-up|3|||
163371701|NCT00338962|590068553|FG001|Overall Study|Lost to Follow-up|3|||
163371702|NCT00338962|590068554|FG002|Overall Study|Lost to Follow-up|2|||
163371703|NCT00338962|590068555|FG003|Overall Study|Lost to Follow-up|3|||
163371704|NCT00338962|590068552|FG000|Overall Study|Withdrawal by Subject|1|||
163371705|NCT00338962|590068553|FG001|Overall Study|Withdrawal by Subject|0|||
163371706|NCT00338962|590068554|FG002|Overall Study|Withdrawal by Subject|0|||
163371707|NCT00338962|590068555|FG003|Overall Study|Withdrawal by Subject|0|||
163371708|NCT00338962|590068552|FG000|Overall Study|No Transportation|2|||
163371709|NCT00338962|590068553|FG001|Overall Study|No Transportation|0|||
163371710|NCT00338962|590068554|FG002|Overall Study|No Transportation|0|||
163371711|NCT00338962|590068555|FG003|Overall Study|No Transportation|0|||
163371712|NCT00338962|590068552|FG000|Overall Study|Time Constraint|2|||
163371713|NCT00338962|590068553|FG001|Overall Study|Time Constraint|0|||
163371714|NCT00338962|590068554|FG002|Overall Study|Time Constraint|0|||
163371715|NCT00338962|590068555|FG003|Overall Study|Time Constraint|0|||
163371716|NCT00338962|590068552|FG000|Overall Study|Moved|0|||
163371717|NCT00338962|590068553|FG001|Overall Study|Moved|1|||
163371718|NCT00338962|590068554|FG002|Overall Study|Moved|0|||
163371719|NCT00338962|590068555|FG003|Overall Study|Moved|0|||
163371720|NCT00338962|590068552|FG000|Overall Study|Adverse Event|0|||
163413791|NCT01285908|590223004|FG000|Baseline Measurement|unable to insert catheter|1|||
163413792|NCT01285908|590223005|FG001|Baseline Measurement|unable to insert catheter|0|||
163413793|NCT01285908|590223006|FG002|Baseline Measurement|unable to insert catheter|0|||
163413794|NCT01285908|590223004|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
163413795|NCT01285908|590223005|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
163413796|NCT01285908|590223006|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
163413797|NCT01285908|590223004|FG000|Baseline Measurement|unable to tolerate procedure|1|||
163413798|NCT01285908|590223005|FG001|Baseline Measurement|unable to tolerate procedure|0|||
163413799|NCT01285908|590223006|FG002|Baseline Measurement|unable to tolerate procedure|0|||
163413800|NCT01562548|590223007|FG000|Overall Study|Lost to Follow-up|0|||
163413801|NCT01562548|590223008|FG001|Overall Study|Lost to Follow-up|0|||
163413802|NCT01562548|590223009|FG002|Overall Study|Lost to Follow-up|1|||
163413803|NCT01562548|590223010|FG003|Overall Study|Lost to Follow-up|0|||
163413804|NCT03655756|590223011|FG000|Overall Study|Death|1|||
163413805|NCT03529773|590223012|FG000|Overall Study|Adverse Event|0|||
163413806|NCT03529773|590223013|FG001|Overall Study|Adverse Event|0|||
163413807|NCT03529773|590223014|FG002|Overall Study|Adverse Event|0|||
163413808|NCT03529773|590223015|FG003|Overall Study|Adverse Event|0|||
163413809|NCT03529773|590223016|FG004|Overall Study|Adverse Event|0|||
163413810|NCT03529773|590223017|FG005|Overall Study|Adverse Event|0|||
163413811|NCT03529773|590223018|FG006|Overall Study|Adverse Event|0|||
163413812|NCT03529773|590223019|FG007|Overall Study|Adverse Event|0|||
163413813|NCT03529773|590223020|FG008|Overall Study|Adverse Event|0|||
163413814|NCT03529773|590223021|FG009|Overall Study|Adverse Event|0|||
163413815|NCT03529773|590223022|FG010|Overall Study|Adverse Event|0|||
163413816|NCT03529773|590223023|FG011|Overall Study|Adverse Event|0|||
163413817|NCT03529773|590223024|FG012|Overall Study|Adverse Event|0|||
163413818|NCT03529773|590223025|FG013|Overall Study|Adverse Event|0|||
163371721|NCT00338962|590068553|FG001|Overall Study|Adverse Event|0|||
163371722|NCT00338962|590068554|FG002|Overall Study|Adverse Event|2|||
163371723|NCT00338962|590068555|FG003|Overall Study|Adverse Event|0|||
163371724|NCT00338962|590068552|FG000|Overall Study|Poor Compliance|0|||
163371725|NCT00338962|590068553|FG001|Overall Study|Poor Compliance|0|||
163371726|NCT00338962|590068554|FG002|Overall Study|Poor Compliance|2|||
163371727|NCT00338962|590068555|FG003|Overall Study|Poor Compliance|0|||
163371728|NCT03733314|590068556|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
163371729|NCT03733314|590068557|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
163371730|NCT03733314|590068556|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
163413819|NCT03529773|590223026|FG014|Overall Study|Adverse Event|0|||
163413820|NCT03529773|590223027|FG015|Overall Study|Adverse Event|0|||
163413821|NCT03529773|590223028|FG016|Overall Study|Adverse Event|0|||
163413822|NCT03529773|590223029|FG017|Overall Study|Adverse Event|0|||
163413823|NCT03529773|590223030|FG018|Overall Study|Adverse Event|0|||
163413824|NCT03529773|590223031|FG019|Overall Study|Adverse Event|0|||
163413825|NCT03529773|590223032|FG020|Overall Study|Adverse Event|0|||
163371731|NCT03733314|590068557|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
163371732|NCT03733314|590068556|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
163371733|NCT03733314|590068557|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
163371734|NCT03733314|590068556|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
163371735|NCT03733314|590068557|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
163371736|NCT03733314|590068556|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
163371737|NCT03733314|590068557|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
163371738|NCT03733314|590068556|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
163371739|NCT03733314|590068557|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
163371740|NCT01598662|590068558|FG000|Overall Study|Lost to Follow-up|10|||
163371741|NCT01598662|590068559|FG001|Overall Study|Lost to Follow-up|17|||
163371742|NCT01598662|590068558|FG000|Overall Study|Physician Decision|1|||
163371743|NCT01598662|590068559|FG001|Overall Study|Physician Decision|2|||
163371744|NCT01598662|590068558|FG000|Overall Study|IUD expelled before month 6|0|||
163371745|NCT01598662|590068559|FG001|Overall Study|IUD expelled before month 6|2|||
163371746|NCT00910039|590068560|FG000|Overall Study|Physician Decision|1|||
163371747|NCT04155047|590068562|FG000|Overall Study|Adverse Event|1|||
163371748|NCT04155047|590068563|FG001|Overall Study|Adverse Event|0|||
163371749|NCT04155047|590068562|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
163371750|NCT04155047|590068563|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
163371751|NCT04514510|590068567|FG000|Overall Study|Lost to Follow-up|0|||
163413826|NCT03529773|590223033|FG021|Overall Study|Adverse Event|0|||
163413827|NCT03529773|590223034|FG022|Overall Study|Adverse Event|0|||
163413828|NCT03529773|590223035|FG023|Overall Study|Adverse Event|0|||
163413829|NCT03529773|590223036|FG024|Overall Study|Adverse Event|0|||
163413830|NCT03529773|590223037|FG025|Overall Study|Adverse Event|0|||
163371752|NCT04514510|590068568|FG001|Overall Study|Lost to Follow-up|1|||
163413831|NCT03529773|590223038|FG026|Overall Study|Adverse Event|0|||
163413832|NCT03529773|590223039|FG027|Overall Study|Adverse Event|0|||
163413833|NCT03529773|590223040|FG028|Overall Study|Adverse Event|0|||
163413834|NCT03529773|590223041|FG029|Overall Study|Adverse Event|0|||
163371753|NCT04514510|590068567|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
163371754|NCT04514510|590068568|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
163371755|NCT00821587|590068569|FG000|Overall Study|Physician Decision|0|||
163371756|NCT00821587|590068570|FG001|Overall Study|Physician Decision|1|||
163371757|NCT02781090|590068573|FG000|3-Month Follow-Up|Missed Visit|20|||
163371758|NCT02781090|590068574|FG001|3-Month Follow-Up|Missed Visit|20|||
163371759|NCT02781090|590068573|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
163371760|NCT02781090|590068574|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
163371761|NCT02781090|590068573|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
163371762|NCT02781090|590068574|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
163371763|NCT02781090|590068573|FG000|3-Month Follow-Up|Death|1|||
163371764|NCT02781090|590068574|FG001|3-Month Follow-Up|Death|0|||
163371765|NCT02781090|590068573|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
163371766|NCT02781090|590068574|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
163371767|NCT02781090|590068573|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
163371768|NCT02781090|590068574|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
163371769|NCT02781090|590068573|FG000|6-Month Follow-Up|Death|0|||
163371770|NCT02781090|590068574|FG001|6-Month Follow-Up|Death|1|||
163371771|NCT00643617|590068575|FG000|Overall Study|Death|6|||
163371772|NCT00643617|590068576|FG001|Overall Study|Death|9|||
163371773|NCT00643617|590068575|FG000|Overall Study|Lost to Follow-up|42|||
163371774|NCT00643617|590068576|FG001|Overall Study|Lost to Follow-up|51|||
163371775|NCT02075073|590068577|FG000|Overall Study|Withdrawal by Subject|0|||
163371776|NCT02075073|590068578|FG001|Overall Study|Withdrawal by Subject|1|||
163371777|NCT02075073|590068579|FG002|Overall Study|Withdrawal by Subject|0|||
163371778|NCT01208103|590068586|FG000|Overall Study|Adverse Event|1|||
163371779|NCT01208103|590068586|FG000|Overall Study|Withdrawal by Subject|1|||
163371780|NCT02770612|590068593|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
163413835|NCT03529773|590223042|FG030|Overall Study|Adverse Event|1|||
163413836|NCT03529773|590223043|FG031|Overall Study|Adverse Event|0|||
163413837|NCT03529773|590223044|FG032|Overall Study|Adverse Event|0|||
163413838|NCT03529773|590223045|FG033|Overall Study|Adverse Event|0|||
163413839|NCT03529773|590223046|FG034|Overall Study|Adverse Event|0|||
163413840|NCT03529773|590223047|FG035|Overall Study|Adverse Event|1|||
163371781|NCT02233803|590068594|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
163371782|NCT02233803|590068595|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
163371783|NCT02233803|590068594|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
163371784|NCT02233803|590068595|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
163371785|NCT02233803|590068594|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
163371786|NCT02233803|590068595|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
163371787|NCT02233803|590068594|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
163371788|NCT02233803|590068595|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
163371789|NCT02233803|590068594|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
163371790|NCT02233803|590068595|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
163371791|NCT02233803|590068594|FG000|Washout Period (4-Wks)|Physician Decision|1|||
163371792|NCT02233803|590068595|FG001|Washout Period (4-Wks)|Physician Decision|0|||
163371793|NCT02233803|590068594|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
163371794|NCT02233803|590068595|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
163371795|NCT02233803|590068594|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
163371796|NCT02233803|590068595|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
163371797|NCT02233803|590068594|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
163371798|NCT02233803|590068595|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
163371799|NCT03846453|590068596|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
163371800|NCT03846453|590068597|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
163371801|NCT03846453|590068598|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
163371802|NCT03846453|590068596|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
163371803|NCT03846453|590068597|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
163371804|NCT03846453|590068598|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
163371805|NCT03846453|590068596|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
163371806|NCT03846453|590068597|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
163371807|NCT03846453|590068598|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
163371808|NCT03846453|590068596|FG000|Placebo Run-in (14 Days)|Other|2|||
163371809|NCT03846453|590068597|FG001|Placebo Run-in (14 Days)|Other|0|||
163371810|NCT03846453|590068598|FG002|Placebo Run-in (14 Days)|Other|0|||
163413841|NCT03529773|590223048|FG036|Overall Study|Adverse Event|0|||
163371811|NCT03846453|590068596|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
163371812|NCT03846453|590068597|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
163371813|NCT03846453|590068598|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
163413842|NCT03529773|590223049|FG037|Overall Study|Adverse Event|0|||
163413843|NCT03529773|590223050|FG038|Overall Study|Adverse Event|1|||
163371814|NCT03846453|590068596|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
163371815|NCT03846453|590068597|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
163371816|NCT03846453|590068598|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
163413844|NCT03529773|590223051|FG039|Overall Study|Adverse Event|1|||
163371817|NCT03846453|590068596|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
163371818|NCT03846453|590068597|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
163371819|NCT03846453|590068598|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
163371820|NCT03846453|590068596|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
163371821|NCT03846453|590068597|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
163371822|NCT03846453|590068598|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
163371823|NCT03846453|590068596|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
163371824|NCT03846453|590068597|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
163371825|NCT03846453|590068598|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
163371826|NCT01989169|590068601|FG000|Period 2|Adverse Event|0|||
163371827|NCT01989169|590068602|FG001|Period 2|Adverse Event|1|||
163371828|NCT01114880|590068603|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
163371829|NCT01114880|590068604|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
163371830|NCT01114880|590068603|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
163371831|NCT01114880|590068604|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
163371832|NCT01114880|590068603|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
163371833|NCT01114880|590068604|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
163371834|NCT01114880|590068603|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
163371835|NCT01114880|590068604|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
163371836|NCT01114880|590068603|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
163371837|NCT01114880|590068604|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
163371838|NCT01114880|590068603|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
163371839|NCT01114880|590068604|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
163371840|NCT04531904|590068606|FG000|Overall Study|Lost to Follow-up|1|||
163371841|NCT04531904|590068606|FG000|Overall Study|Death|14|||
163371842|NCT02738853|590068609|FG000|Enrollment|Inclusion/Exclusion not met|21|||
163371843|NCT02738853|590068609|FG000|Enrollment|Withdrawal by Subject|3|||
163371844|NCT02738853|590068609|FG000|Enrollment|Subject treated with commercially available device|6|||
163371845|NCT02738853|590068609|FG000|Enrollment|Study Enrollment Closed|3|||
163371846|NCT02738853|590068609|FG000|Procedure|Death|1|||
163371847|NCT02738853|590068609|FG000|1 Month|Death|2|||
163371848|NCT02738853|590068609|FG000|6 Month|Death|4|||
163371849|NCT02738853|590068609|FG000|6 Month|Withdrawal by Subject|2|||
163371850|NCT02738853|590068609|FG000|1 Year|Death|6|||
163371851|NCT02738853|590068609|FG000|1 Year|Withdrawal by Subject|1|||
163371852|NCT02738853|590068609|FG000|2 Year|Death|2|||
163371853|NCT02738853|590068609|FG000|2 Year|Lost to Follow-up|1|||
163371854|NCT02738853|590068609|FG000|3 Year|Death|2|||
163371855|NCT02738853|590068609|FG000|3 Year|Withdrawal by Subject|1|||
163371856|NCT02738853|590068609|FG000|4 Year|Death|9|||
163371857|NCT02738853|590068609|FG000|5 Year|Lost to Follow-up|4|||
163371858|NCT03519997|590068610|FG000|Overall Study|Adverse Event|4|||
163371859|NCT03519997|590068610|FG000|Overall Study|Withdrawal by Subject|2|||
163371860|NCT03519997|590068610|FG000|Overall Study|Protocol Violation|1|||
163371861|NCT03361605|590068611|FG000|Overall Study|Analyzable data not available|3|||
163371862|NCT02906007|590068612|FG000|Overall Study|Physician Decision|0|||
163371863|NCT02906007|590068613|FG001|Overall Study|Physician Decision|0|||
163371864|NCT02906007|590068614|FG002|Overall Study|Physician Decision|1|||
163371865|NCT02906007|590068612|FG000|Overall Study|Died|1|||
163371866|NCT02906007|590068613|FG001|Overall Study|Died|0|||
163371867|NCT02906007|590068614|FG002|Overall Study|Died|0|||
163371868|NCT04696653|590068615|FG000|Overall Study|left organization|18|||
163371869|NCT04696653|590068615|FG000|Overall Study|Lost to Follow-up|3|||
163371870|NCT03520712|590068616|FG000|Overall Study|Early termination of the study by Sponsor|2|||
163371871|NCT04372121|590068617|FG000|Overall Study|Lost to Follow-up|0|||
163371872|NCT04372121|590068618|FG001|Overall Study|Lost to Follow-up|0|||
163371873|NCT04372121|590068619|FG002|Overall Study|Lost to Follow-up|0|||
163371874|NCT04372121|590068620|FG003|Overall Study|Lost to Follow-up|1|||
163371875|NCT04372121|590068617|FG000|Overall Study|Protocol Violation|0|||
163371876|NCT04372121|590068618|FG001|Overall Study|Protocol Violation|0|||
163371877|NCT04372121|590068619|FG002|Overall Study|Protocol Violation|1|||
163371878|NCT04372121|590068620|FG003|Overall Study|Protocol Violation|0|||
163371879|NCT04372121|590068617|FG000|Overall Study|Withdrawal by Subject|3|||
163371880|NCT04372121|590068618|FG001|Overall Study|Withdrawal by Subject|1|||
163371881|NCT04372121|590068619|FG002|Overall Study|Withdrawal by Subject|0|||
163371882|NCT04372121|590068620|FG003|Overall Study|Withdrawal by Subject|0|||
163371883|NCT04372121|590068617|FG000|Overall Study|Study termination|6|||
163371884|NCT04372121|590068618|FG001|Overall Study|Study termination|5|||
163371885|NCT04372121|590068619|FG002|Overall Study|Study termination|1|||
163371886|NCT04372121|590068620|FG003|Overall Study|Study termination|1|||
163371887|NCT04372121|590068617|FG000|Overall Study|Hysterectomy planned|1|||
163371888|NCT04372121|590068618|FG001|Overall Study|Hysterectomy planned|0|||
163371889|NCT04372121|590068619|FG002|Overall Study|Hysterectomy planned|0|||
163371890|NCT04372121|590068620|FG003|Overall Study|Hysterectomy planned|0|||
163371891|NCT03921723|590070206|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
163371892|NCT03921723|590070206|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
163371893|NCT03046121|590070208|FG000|Overall Study|Death|32|||
163371894|NCT03046121|590070209|FG001|Overall Study|Death|60|||
163371895|NCT03046121|590070208|FG000|Overall Study|Withdrawal by Subject|14|||
163371896|NCT03046121|590070209|FG001|Overall Study|Withdrawal by Subject|12|||
163371897|NCT03214640|590070210|FG000|Overall Study|Protocol Violation|1|||
163371898|NCT03214640|590070211|FG001|Overall Study|Protocol Violation|2|||
163371899|NCT03214640|590070212|FG002|Overall Study|Protocol Violation|1|||
163371900|NCT03214640|590070213|FG003|Overall Study|Protocol Violation|4|||
163371901|NCT00406692|590070221|FG000|Overall Study|Withdrawal by Subject|4|||
163371902|NCT00406692|590070221|FG000|Overall Study|Physician Decision|1|||
163371903|NCT00406692|590070221|FG000|Overall Study|Adverse Event|1|||
163371904|NCT00406692|590070221|FG000|Overall Study|Lack of Efficacy|1|||
163371905|NCT04488770|590070222|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163371906|NCT04488770|590070223|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163371907|NCT04488770|590070224|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163371908|NCT04488770|590070225|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
163371909|NCT04488770|590070226|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163371910|NCT04488770|590070227|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163371911|NCT04488770|590070228|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163371912|NCT04488770|590070229|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163371913|NCT04488770|590070230|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163371914|NCT04488770|590070231|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163371915|NCT04488770|590070232|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163371916|NCT04488770|590070233|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163371917|NCT04488770|590070234|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163371918|NCT04488770|590070222|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
163371919|NCT04488770|590070223|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163371920|NCT04488770|590070224|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163371921|NCT04488770|590070225|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163371922|NCT04488770|590070226|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163371923|NCT04488770|590070227|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163371924|NCT04488770|590070228|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163371925|NCT04488770|590070229|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163371926|NCT04488770|590070230|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163371927|NCT04488770|590070231|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163371928|NCT04488770|590070232|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163371929|NCT04488770|590070233|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163371930|NCT04488770|590070234|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163371931|NCT04488770|590070222|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163371932|NCT04488770|590070223|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163371933|NCT04488770|590070224|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163371934|NCT04488770|590070225|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163371935|NCT04488770|590070226|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163371936|NCT04488770|590070227|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
163371937|NCT04488770|590070228|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
163371938|NCT04488770|590070229|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163371939|NCT04488770|590070230|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163371940|NCT04488770|590070231|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163371941|NCT04488770|590070232|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163371942|NCT04488770|590070233|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163371943|NCT04488770|590070234|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163371944|NCT04488770|590070222|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163371945|NCT04488770|590070223|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163371946|NCT04488770|590070224|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163371947|NCT04488770|590070225|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163371948|NCT04488770|590070226|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
163371949|NCT04488770|590070227|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163371950|NCT04488770|590070228|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163371951|NCT04488770|590070229|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163371952|NCT04488770|590070230|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163371953|NCT04488770|590070231|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163371954|NCT04488770|590070232|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163371955|NCT04488770|590070233|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163371956|NCT04488770|590070234|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163371957|NCT03547739|590070235|FG000|Overall Study|Death|0|||
163371958|NCT03547739|590070236|FG001|Overall Study|Death|1|||
163413845|NCT03529773|590223012|FG000|Overall Study|Death|0|||
163413846|NCT03529773|590223013|FG001|Overall Study|Death|0|||
163413847|NCT03529773|590223014|FG002|Overall Study|Death|0|||
163413848|NCT03529773|590223015|FG003|Overall Study|Death|0|||
163413849|NCT03529773|590223016|FG004|Overall Study|Death|0|||
163413850|NCT03529773|590223017|FG005|Overall Study|Death|0|||
163413851|NCT03529773|590223018|FG006|Overall Study|Death|0|||
163413852|NCT03529773|590223019|FG007|Overall Study|Death|0|||
163413853|NCT03529773|590223020|FG008|Overall Study|Death|0|||
163413854|NCT03529773|590223021|FG009|Overall Study|Death|0|||
163413855|NCT03529773|590223022|FG010|Overall Study|Death|0|||
163413856|NCT03529773|590223023|FG011|Overall Study|Death|0|||
163413857|NCT03529773|590223024|FG012|Overall Study|Death|1|||
163413858|NCT03529773|590223025|FG013|Overall Study|Death|0|||
163413859|NCT03529773|590223026|FG014|Overall Study|Death|0|||
163413860|NCT03529773|590223027|FG015|Overall Study|Death|0|||
163413861|NCT03529773|590223028|FG016|Overall Study|Death|0|||
163413862|NCT03529773|590223029|FG017|Overall Study|Death|0|||
163413863|NCT03529773|590223030|FG018|Overall Study|Death|0|||
163413864|NCT03529773|590223031|FG019|Overall Study|Death|1|||
163413865|NCT03529773|590223032|FG020|Overall Study|Death|0|||
163413866|NCT03529773|590223033|FG021|Overall Study|Death|0|||
163413867|NCT03529773|590223034|FG022|Overall Study|Death|1|||
163413868|NCT03529773|590223035|FG023|Overall Study|Death|0|||
163413869|NCT03529773|590223036|FG024|Overall Study|Death|0|||
163413870|NCT03529773|590223037|FG025|Overall Study|Death|0|||
163413871|NCT03529773|590223038|FG026|Overall Study|Death|0|||
163413872|NCT03529773|590223039|FG027|Overall Study|Death|0|||
163413873|NCT03529773|590223040|FG028|Overall Study|Death|0|||
163413874|NCT03529773|590223041|FG029|Overall Study|Death|0|||
163413875|NCT03529773|590223042|FG030|Overall Study|Death|0|||
163413876|NCT03529773|590223043|FG031|Overall Study|Death|0|||
163413877|NCT03529773|590223044|FG032|Overall Study|Death|0|||
163413878|NCT03529773|590223045|FG033|Overall Study|Death|1|||
163413879|NCT03529773|590223046|FG034|Overall Study|Death|1|||
163413880|NCT03529773|590223047|FG035|Overall Study|Death|0|||
163413881|NCT03529773|590223048|FG036|Overall Study|Death|1|||
163413882|NCT03529773|590223049|FG037|Overall Study|Death|0|||
163413883|NCT03529773|590223050|FG038|Overall Study|Death|0|||
163413884|NCT03529773|590223051|FG039|Overall Study|Death|0|||
163413885|NCT03529773|590223012|FG000|Overall Study|Lost to Follow-up|0|||
163413886|NCT03529773|590223013|FG001|Overall Study|Lost to Follow-up|0|||
163413887|NCT03529773|590223014|FG002|Overall Study|Lost to Follow-up|1|||
163413888|NCT03529773|590223015|FG003|Overall Study|Lost to Follow-up|0|||
163413889|NCT03529773|590223016|FG004|Overall Study|Lost to Follow-up|1|||
163413890|NCT03529773|590223017|FG005|Overall Study|Lost to Follow-up|1|||
163413891|NCT03529773|590223018|FG006|Overall Study|Lost to Follow-up|0|||
163413892|NCT03529773|590223019|FG007|Overall Study|Lost to Follow-up|0|||
163413893|NCT03529773|590223020|FG008|Overall Study|Lost to Follow-up|0|||
163413894|NCT03529773|590223021|FG009|Overall Study|Lost to Follow-up|0|||
163413895|NCT03529773|590223022|FG010|Overall Study|Lost to Follow-up|0|||
163413896|NCT03529773|590223023|FG011|Overall Study|Lost to Follow-up|0|||
163413897|NCT03529773|590223024|FG012|Overall Study|Lost to Follow-up|0|||
163413898|NCT03529773|590223025|FG013|Overall Study|Lost to Follow-up|1|||
163413899|NCT03529773|590223026|FG014|Overall Study|Lost to Follow-up|4|||
163413900|NCT03529773|590223027|FG015|Overall Study|Lost to Follow-up|1|||
163413901|NCT03529773|590223028|FG016|Overall Study|Lost to Follow-up|1|||
163413902|NCT03529773|590223029|FG017|Overall Study|Lost to Follow-up|0|||
163413903|NCT03529773|590223030|FG018|Overall Study|Lost to Follow-up|1|||
163413904|NCT03529773|590223031|FG019|Overall Study|Lost to Follow-up|1|||
163413905|NCT03529773|590223032|FG020|Overall Study|Lost to Follow-up|2|||
163413906|NCT03529773|590223033|FG021|Overall Study|Lost to Follow-up|4|||
163413907|NCT03529773|590223034|FG022|Overall Study|Lost to Follow-up|3|||
163413908|NCT03529773|590223035|FG023|Overall Study|Lost to Follow-up|4|||
163413909|NCT03529773|590223036|FG024|Overall Study|Lost to Follow-up|3|||
163413910|NCT03529773|590223037|FG025|Overall Study|Lost to Follow-up|5|||
163413911|NCT03529773|590223038|FG026|Overall Study|Lost to Follow-up|5|||
163413912|NCT03529773|590223039|FG027|Overall Study|Lost to Follow-up|0|||
163413913|NCT03529773|590223040|FG028|Overall Study|Lost to Follow-up|0|||
163413914|NCT03529773|590223041|FG029|Overall Study|Lost to Follow-up|0|||
163413915|NCT03529773|590223042|FG030|Overall Study|Lost to Follow-up|1|||
163413916|NCT03529773|590223043|FG031|Overall Study|Lost to Follow-up|0|||
163413917|NCT03529773|590223044|FG032|Overall Study|Lost to Follow-up|0|||
163413918|NCT03529773|590223045|FG033|Overall Study|Lost to Follow-up|1|||
163413919|NCT03529773|590223046|FG034|Overall Study|Lost to Follow-up|1|||
163413920|NCT03529773|590223047|FG035|Overall Study|Lost to Follow-up|0|||
163413921|NCT03529773|590223048|FG036|Overall Study|Lost to Follow-up|0|||
163413922|NCT03529773|590223049|FG037|Overall Study|Lost to Follow-up|3|||
163413923|NCT03529773|590223050|FG038|Overall Study|Lost to Follow-up|1|||
163413924|NCT03529773|590223051|FG039|Overall Study|Lost to Follow-up|1|||
163413925|NCT03529773|590223012|FG000|Overall Study|No longer meets eligibility criteria|0|||
163413926|NCT03529773|590223013|FG001|Overall Study|No longer meets eligibility criteria|0|||
163413927|NCT03529773|590223014|FG002|Overall Study|No longer meets eligibility criteria|0|||
163413928|NCT03529773|590223015|FG003|Overall Study|No longer meets eligibility criteria|0|||
163413929|NCT03529773|590223016|FG004|Overall Study|No longer meets eligibility criteria|0|||
163371959|NCT03547739|590070237|FG002|Overall Study|Death|5|||
163371960|NCT03547739|590070235|FG000|Overall Study|Adverse Event|24|||
163371961|NCT03547739|590070236|FG001|Overall Study|Adverse Event|11|||
163371962|NCT03547739|590070237|FG002|Overall Study|Adverse Event|13|||
163371963|NCT03547739|590070235|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
163371964|NCT03547739|590070236|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
163371965|NCT03547739|590070237|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
163371966|NCT03547739|590070235|FG000|Overall Study|Lost to Follow-up|80|||
163371967|NCT03547739|590070236|FG001|Overall Study|Lost to Follow-up|84|||
163371968|NCT03547739|590070237|FG002|Overall Study|Lost to Follow-up|116|||
163371969|NCT00468143|590070238|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
163371970|NCT00468143|590070239|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
163371971|NCT00468143|590070238|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
163371972|NCT00468143|590070239|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
163371973|NCT01606670|590070242|FG000|Overall Study|Adverse Event|6|||
163371974|NCT01606670|590070242|FG000|Overall Study|Lack of Efficacy|2|||
163371975|NCT01606670|590070242|FG000|Overall Study|Lost to Follow-up|3|||
163371976|NCT01606670|590070242|FG000|Overall Study|Withdrawal by Subject|3|||
163371977|NCT01606670|590070242|FG000|Overall Study|Other Reason|2|||
163371978|NCT01696955|590070247|FG000|Main Study|Protocol Violation|1|||
163371979|NCT01696955|590070248|FG001|Main Study|Protocol Violation|0|||
163371980|NCT01696955|590070247|FG000|Main Study|Withdrawal by Subject|1|||
163371981|NCT01696955|590070248|FG001|Main Study|Withdrawal by Subject|1|||
163371982|NCT03192475|590070255|FG000|Overall Study|Death|0|||
163371983|NCT03192475|590070256|FG001|Overall Study|Death|1|||
163371984|NCT03192475|590070255|FG000|Overall Study|Lost to Follow-up|13|||
163371985|NCT03192475|590070256|FG001|Overall Study|Lost to Follow-up|8|||
163371986|NCT01641159|590070257|FG000|Overall Study|Lost to Follow-up|2|||
163371987|NCT01641159|590070258|FG001|Overall Study|Lost to Follow-up|1|||
163371988|NCT01641159|590070257|FG000|Overall Study|Withdrawal by Subject|0|||
163371989|NCT01641159|590070258|FG001|Overall Study|Withdrawal by Subject|1|||
163371990|NCT03980808|590070259|FG000|Overall Study|Lost to Follow-up|2|||
163371991|NCT03980808|590070260|FG001|Overall Study|Lost to Follow-up|2|||
163371992|NCT00798590|590070261|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
163371993|NCT00798590|590070262|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
163371994|NCT03653208|590070267|FG000|Overall Study|Withdrawal by Subject|0|||
163371995|NCT03653208|590070268|FG001|Overall Study|Withdrawal by Subject|0|||
163371996|NCT03653208|590070269|FG002|Overall Study|Withdrawal by Subject|0|||
163371997|NCT03653208|590070270|FG003|Overall Study|Withdrawal by Subject|0|||
163371998|NCT03653208|590070271|FG004|Overall Study|Withdrawal by Subject|1|||
163371999|NCT03653208|590070272|FG005|Overall Study|Withdrawal by Subject|0|||
163372000|NCT03653208|590070273|FG006|Overall Study|Withdrawal by Subject|0|||
163372001|NCT03653208|590070274|FG007|Overall Study|Withdrawal by Subject|1|||
163372002|NCT03653208|590070275|FG008|Overall Study|Withdrawal by Subject|1|||
163372003|NCT05330676|590070276|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
163372004|NCT05330676|590070277|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
163372005|NCT00436605|590070278|FG000|Overall Study|Protocol Violation|3|||
163372006|NCT00573859|590070283|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
163372007|NCT00573859|590070283|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
163372008|NCT02416453|590070284|FG000|Overall Study|Adverse Event|0|||
163372009|NCT02416453|590070285|FG001|Overall Study|Adverse Event|0|||
163372010|NCT02416453|590070286|FG002|Overall Study|Adverse Event|0|||
163372011|NCT02416453|590070287|FG003|Overall Study|Adverse Event|2|||
163372012|NCT02416453|590070288|FG004|Overall Study|Adverse Event|0|||
163372013|NCT02416453|590070289|FG005|Overall Study|Adverse Event|1|||
163372014|NCT02416453|590070290|FG006|Overall Study|Adverse Event|0|||
163372015|NCT02416453|590070291|FG007|Overall Study|Adverse Event|0|||
163372016|NCT02416453|590070292|FG008|Overall Study|Adverse Event|0|||
163372017|NCT02416453|590070293|FG009|Overall Study|Adverse Event|0|||
163372018|NCT02416453|590070294|FG010|Overall Study|Adverse Event|0|||
163372019|NCT02416453|590070284|FG000|Overall Study|Lost to Follow-up|1|||
163372020|NCT02416453|590070285|FG001|Overall Study|Lost to Follow-up|3|||
163372021|NCT02416453|590070286|FG002|Overall Study|Lost to Follow-up|0|||
163372022|NCT02416453|590070287|FG003|Overall Study|Lost to Follow-up|8|||
163372023|NCT02416453|590070288|FG004|Overall Study|Lost to Follow-up|0|||
163372024|NCT02416453|590070289|FG005|Overall Study|Lost to Follow-up|5|||
163372025|NCT02416453|590070290|FG006|Overall Study|Lost to Follow-up|1|||
163372026|NCT02416453|590070291|FG007|Overall Study|Lost to Follow-up|3|||
163372027|NCT02416453|590070292|FG008|Overall Study|Lost to Follow-up|1|||
163372028|NCT02416453|590070293|FG009|Overall Study|Lost to Follow-up|0|||
163372029|NCT02416453|590070294|FG010|Overall Study|Lost to Follow-up|0|||
163372030|NCT02416453|590070284|FG000|Overall Study|Physician Decision|0|||
163372031|NCT02416453|590070285|FG001|Overall Study|Physician Decision|0|||
163372032|NCT02416453|590070286|FG002|Overall Study|Physician Decision|0|||
163372033|NCT02416453|590070287|FG003|Overall Study|Physician Decision|0|||
163372034|NCT02416453|590070288|FG004|Overall Study|Physician Decision|0|||
163372035|NCT02416453|590070289|FG005|Overall Study|Physician Decision|1|||
163372036|NCT02416453|590070290|FG006|Overall Study|Physician Decision|1|||
163372037|NCT02416453|590070291|FG007|Overall Study|Physician Decision|1|||
163372038|NCT02416453|590070292|FG008|Overall Study|Physician Decision|0|||
163372039|NCT02416453|590070293|FG009|Overall Study|Physician Decision|0|||
163372040|NCT02416453|590070294|FG010|Overall Study|Physician Decision|0|||
163372041|NCT02416453|590070284|FG000|Overall Study|Withdrawal by Subject|2|||
163372042|NCT02416453|590070285|FG001|Overall Study|Withdrawal by Subject|0|||
163372043|NCT02416453|590070286|FG002|Overall Study|Withdrawal by Subject|0|||
163372044|NCT02416453|590070287|FG003|Overall Study|Withdrawal by Subject|5|||
163372045|NCT02416453|590070288|FG004|Overall Study|Withdrawal by Subject|1|||
163372046|NCT02416453|590070289|FG005|Overall Study|Withdrawal by Subject|8|||
163372047|NCT02416453|590070290|FG006|Overall Study|Withdrawal by Subject|0|||
163372048|NCT02416453|590070291|FG007|Overall Study|Withdrawal by Subject|8|||
163372049|NCT02416453|590070292|FG008|Overall Study|Withdrawal by Subject|4|||
163372050|NCT02416453|590070293|FG009|Overall Study|Withdrawal by Subject|0|||
163372051|NCT02416453|590070294|FG010|Overall Study|Withdrawal by Subject|0|||
163372052|NCT02416453|590070284|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163372053|NCT02416453|590070285|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163372054|NCT02416453|590070286|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
163372055|NCT02416453|590070287|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163372056|NCT02416453|590070288|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163372057|NCT02416453|590070289|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163372058|NCT02416453|590070290|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163372059|NCT02416453|590070291|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163372060|NCT02416453|590070292|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163372061|NCT02416453|590070293|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163372062|NCT02416453|590070294|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163372063|NCT02416453|590070284|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163372064|NCT02416453|590070285|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163372065|NCT02416453|590070286|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163372066|NCT02416453|590070287|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163372067|NCT02416453|590070288|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163372068|NCT02416453|590070289|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
163372069|NCT02416453|590070290|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163372070|NCT02416453|590070291|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163372071|NCT02416453|590070292|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163372072|NCT02416453|590070293|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163372073|NCT02416453|590070294|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163372074|NCT00368927|590070295|FG000|Overall Study|Lost to Follow-up|2|||
163372075|NCT00368927|590070296|FG001|Overall Study|Lost to Follow-up|0|||
163372076|NCT00368927|590070295|FG000|Overall Study|Adverse Event|1|||
163372077|NCT00368927|590070296|FG001|Overall Study|Adverse Event|1|||
163372078|NCT00368927|590070295|FG000|Overall Study|Withdrawal by Subject|1|||
163372079|NCT00368927|590070296|FG001|Overall Study|Withdrawal by Subject|2|||
163372080|NCT00368927|590070295|FG000|Overall Study|Physician Decision|1|||
163372081|NCT00368927|590070296|FG001|Overall Study|Physician Decision|0|||
163372082|NCT00886795|590070297|FG000|Overall Study|Lack of Efficacy|1|||
163372083|NCT01204710|590070300|FG000|Randomization Treatment|Lost to Follow-up|1|||
163372084|NCT01204710|590070301|FG001|Randomization Treatment|Lost to Follow-up|0|||
163372085|NCT01204710|590070300|FG000|Randomization Treatment|Withdrawal by Subject|6|||
163372086|NCT01204710|590070301|FG001|Randomization Treatment|Withdrawal by Subject|5|||
163372087|NCT01204710|590070300|FG000|Randomization Treatment|Physician Decision|3|||
163372088|NCT01204710|590070301|FG001|Randomization Treatment|Physician Decision|2|||
163372089|NCT01204710|590070300|FG000|Randomization Treatment|Entry criteria not met|0|||
163372090|NCT01204710|590070301|FG001|Randomization Treatment|Entry criteria not met|1|||
163372091|NCT01204710|590070300|FG000|Randomization Treatment|Adverse Event|4|||
163372092|NCT01204710|590070301|FG001|Randomization Treatment|Adverse Event|2|||
163372093|NCT01204710|590070300|FG000|Randomization Treatment|Sponsor Decision|0|||
163372094|NCT01204710|590070301|FG001|Randomization Treatment|Sponsor Decision|1|||
163372095|NCT01204710|590070300|FG000|Randomization Treatment|Worsening of General condition|0|||
163372096|NCT01204710|590070301|FG001|Randomization Treatment|Worsening of General condition|1|||
163372097|NCT01204710|590070300|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
163372098|NCT01204710|590070301|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
163372099|NCT01204710|590070300|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
163372100|NCT01204710|590070301|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
163372101|NCT01204710|590070300|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
163372102|NCT01204710|590070301|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
163372103|NCT01204710|590070300|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
163372104|NCT01204710|590070301|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
163372105|NCT00680992|590070302|FG000|Overall Study|Complete Resection (as per protocol)|25|||
163372106|NCT00680992|590070303|FG001|Overall Study|Complete Resection (as per protocol)|121|||
163372107|NCT00680992|590070304|FG002|Overall Study|Complete Resection (as per protocol)|0|||
163372108|NCT00680992|590070302|FG000|Overall Study|Administrative Decision|83|||
163372109|NCT00680992|590070303|FG001|Overall Study|Administrative Decision|42|||
163372110|NCT00680992|590070304|FG002|Overall Study|Administrative Decision|5|||
163372111|NCT00680992|590070302|FG000|Overall Study|End of Trial|32|||
163372112|NCT00680992|590070303|FG001|Overall Study|End of Trial|12|||
163372113|NCT00680992|590070304|FG002|Overall Study|End of Trial|3|||
163372114|NCT00680992|590070302|FG000|Overall Study|Withdrawal by Subject|33|||
163372115|NCT00680992|590070303|FG001|Overall Study|Withdrawal by Subject|11|||
163372116|NCT00680992|590070304|FG002|Overall Study|Withdrawal by Subject|1|||
163372117|NCT00680992|590070302|FG000|Overall Study|Adverse Event|21|||
163372118|NCT00680992|590070303|FG001|Overall Study|Adverse Event|19|||
163372119|NCT00680992|590070304|FG002|Overall Study|Adverse Event|1|||
163372120|NCT00680992|590070302|FG000|Overall Study|Other|19|||
163372121|NCT00680992|590070303|FG001|Overall Study|Other|14|||
163372122|NCT00680992|590070304|FG002|Overall Study|Other|1|||
163372123|NCT00680992|590070302|FG000|Overall Study|Disease Progression|21|||
163372124|NCT00680992|590070303|FG001|Overall Study|Disease Progression|9|||
163372125|NCT00680992|590070304|FG002|Overall Study|Disease Progression|0|||
163372126|NCT00680992|590070302|FG000|Overall Study|Lost to Follow-up|12|||
163372127|NCT00680992|590070303|FG001|Overall Study|Lost to Follow-up|14|||
163372128|NCT00680992|590070304|FG002|Overall Study|Lost to Follow-up|0|||
163372129|NCT00680992|590070302|FG000|Overall Study|Noncompliance|4|||
163372130|NCT00680992|590070303|FG001|Overall Study|Noncompliance|6|||
163372131|NCT00680992|590070304|FG002|Overall Study|Noncompliance|0|||
163372132|NCT00680992|590070302|FG000|Overall Study|Requirement for Alternative Therapy|8|||
163372133|NCT00680992|590070303|FG001|Overall Study|Requirement for Alternative Therapy|2|||
163372134|NCT00680992|590070304|FG002|Overall Study|Requirement for Alternative Therapy|0|||
163372135|NCT00680992|590070302|FG000|Overall Study|Pregnancy|5|||
163372136|NCT00680992|590070303|FG001|Overall Study|Pregnancy|0|||
163372137|NCT00680992|590070304|FG002|Overall Study|Pregnancy|1|||
163372138|NCT00680992|590070302|FG000|Overall Study|Death|5|||
163372139|NCT00680992|590070303|FG001|Overall Study|Death|1|||
163372140|NCT00680992|590070304|FG002|Overall Study|Death|0|||
163372141|NCT00680992|590070302|FG000|Overall Study|Ineligibility Determined|0|||
163372142|NCT00680992|590070303|FG001|Overall Study|Ineligibility Determined|1|||
163372143|NCT00680992|590070304|FG002|Overall Study|Ineligibility Determined|0|||
163372144|NCT03898167|590070305|FG000|Overall Study|Terminated phone call early|7|||
163372145|NCT03898167|590070306|FG001|Overall Study|Terminated phone call early|0|||
163372146|NCT03898167|590070307|FG002|Overall Study|Terminated phone call early|0|||
163372147|NCT03898167|590070305|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
163372148|NCT03898167|590070306|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
163372149|NCT03898167|590070307|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
163372150|NCT00151281|590070308|FG000|Overall Study|Not evaluable|3|||
163372151|NCT04047862|590070326|FG000|Overall Study|Death|0|||
163372152|NCT04047862|590070327|FG001|Overall Study|Death|0|||
163372153|NCT04047862|590070328|FG002|Overall Study|Death|4|||
163372154|NCT04047862|590070329|FG003|Overall Study|Death|7|||
163372155|NCT04047862|590070330|FG004|Overall Study|Death|2|||
163372156|NCT04047862|590070331|FG005|Overall Study|Death|4|||
163372157|NCT04047862|590070332|FG006|Overall Study|Death|3|||
163372158|NCT04047862|590070333|FG007|Overall Study|Death|24|||
163372159|NCT04047862|590070334|FG008|Overall Study|Death|24|||
163372160|NCT04047862|590070335|FG009|Overall Study|Death|22|||
163372161|NCT04047862|590070336|FG010|Overall Study|Death|35|||
163372162|NCT04047862|590070337|FG011|Overall Study|Death|18|||
163372163|NCT04047862|590070338|FG012|Overall Study|Death|14|||
163372164|NCT04047862|590070339|FG013|Overall Study|Death|6|||
163372165|NCT04047862|590070340|FG014|Overall Study|Death|19|||
163372166|NCT04047862|590070341|FG015|Overall Study|Death|42|||
163372167|NCT04047862|590070342|FG016|Overall Study|Death|9|||
163372168|NCT04047862|590070343|FG017|Overall Study|Death|8|||
163372169|NCT04047862|590070344|FG018|Overall Study|Death|10|||
163372170|NCT04047862|590070326|FG000|Overall Study|Withdrawal by Subject|0|||
163372171|NCT04047862|590070327|FG001|Overall Study|Withdrawal by Subject|0|||
163372172|NCT04047862|590070328|FG002|Overall Study|Withdrawal by Subject|0|||
163372173|NCT04047862|590070329|FG003|Overall Study|Withdrawal by Subject|5|||
163372174|NCT04047862|590070330|FG004|Overall Study|Withdrawal by Subject|2|||
163372175|NCT04047862|590070331|FG005|Overall Study|Withdrawal by Subject|0|||
163372176|NCT04047862|590070332|FG006|Overall Study|Withdrawal by Subject|1|||
163372177|NCT04047862|590070333|FG007|Overall Study|Withdrawal by Subject|0|||
163372178|NCT04047862|590070334|FG008|Overall Study|Withdrawal by Subject|4|||
163372179|NCT04047862|590070335|FG009|Overall Study|Withdrawal by Subject|4|||
163372180|NCT04047862|590070336|FG010|Overall Study|Withdrawal by Subject|4|||
163372181|NCT04047862|590070337|FG011|Overall Study|Withdrawal by Subject|2|||
163372182|NCT04047862|590070338|FG012|Overall Study|Withdrawal by Subject|3|||
163372183|NCT04047862|590070339|FG013|Overall Study|Withdrawal by Subject|0|||
163372184|NCT04047862|590070340|FG014|Overall Study|Withdrawal by Subject|9|||
163372185|NCT04047862|590070341|FG015|Overall Study|Withdrawal by Subject|5|||
163372186|NCT04047862|590070342|FG016|Overall Study|Withdrawal by Subject|1|||
163372187|NCT04047862|590070343|FG017|Overall Study|Withdrawal by Subject|3|||
163372188|NCT04047862|590070344|FG018|Overall Study|Withdrawal by Subject|1|||
163372189|NCT04047862|590070326|FG000|Overall Study|Lost to Follow-up|0|||
163372190|NCT04047862|590070327|FG001|Overall Study|Lost to Follow-up|0|||
163372191|NCT04047862|590070328|FG002|Overall Study|Lost to Follow-up|1|||
163372192|NCT04047862|590070329|FG003|Overall Study|Lost to Follow-up|0|||
163372193|NCT04047862|590070330|FG004|Overall Study|Lost to Follow-up|0|||
163372194|NCT04047862|590070331|FG005|Overall Study|Lost to Follow-up|0|||
163372195|NCT04047862|590070332|FG006|Overall Study|Lost to Follow-up|0|||
163372196|NCT04047862|590070333|FG007|Overall Study|Lost to Follow-up|1|||
163372197|NCT04047862|590070334|FG008|Overall Study|Lost to Follow-up|0|||
163372198|NCT04047862|590070335|FG009|Overall Study|Lost to Follow-up|1|||
163372199|NCT04047862|590070336|FG010|Overall Study|Lost to Follow-up|0|||
163372200|NCT04047862|590070337|FG011|Overall Study|Lost to Follow-up|3|||
163372201|NCT04047862|590070338|FG012|Overall Study|Lost to Follow-up|0|||
163372202|NCT04047862|590070339|FG013|Overall Study|Lost to Follow-up|0|||
163372203|NCT04047862|590070340|FG014|Overall Study|Lost to Follow-up|2|||
163372204|NCT04047862|590070341|FG015|Overall Study|Lost to Follow-up|2|||
163372205|NCT04047862|590070342|FG016|Overall Study|Lost to Follow-up|1|||
163372206|NCT04047862|590070343|FG017|Overall Study|Lost to Follow-up|0|||
163372207|NCT04047862|590070344|FG018|Overall Study|Lost to Follow-up|0|||
163372208|NCT04047862|590070326|FG000|Overall Study|Physician Decision|0|||
163372209|NCT04047862|590070327|FG001|Overall Study|Physician Decision|0|||
163372210|NCT04047862|590070328|FG002|Overall Study|Physician Decision|0|||
163372211|NCT04047862|590070329|FG003|Overall Study|Physician Decision|1|||
163372212|NCT04047862|590070330|FG004|Overall Study|Physician Decision|0|||
163372213|NCT04047862|590070331|FG005|Overall Study|Physician Decision|0|||
163372214|NCT04047862|590070332|FG006|Overall Study|Physician Decision|0|||
163372215|NCT04047862|590070333|FG007|Overall Study|Physician Decision|0|||
163372216|NCT04047862|590070334|FG008|Overall Study|Physician Decision|0|||
163372217|NCT04047862|590070335|FG009|Overall Study|Physician Decision|0|||
163372218|NCT04047862|590070336|FG010|Overall Study|Physician Decision|0|||
163372219|NCT04047862|590070337|FG011|Overall Study|Physician Decision|0|||
163372220|NCT04047862|590070338|FG012|Overall Study|Physician Decision|0|||
163372221|NCT04047862|590070339|FG013|Overall Study|Physician Decision|0|||
163372222|NCT04047862|590070340|FG014|Overall Study|Physician Decision|1|||
163372223|NCT04047862|590070341|FG015|Overall Study|Physician Decision|0|||
163372224|NCT04047862|590070342|FG016|Overall Study|Physician Decision|1|||
163372225|NCT04047862|590070343|FG017|Overall Study|Physician Decision|0|||
163372226|NCT04047862|590070344|FG018|Overall Study|Physician Decision|0|||
163372227|NCT04047862|590070326|FG000|Overall Study|Completed all Assessments|1|||
163372228|NCT04047862|590070327|FG001|Overall Study|Completed all Assessments|3|||
163372229|NCT04047862|590070328|FG002|Overall Study|Completed all Assessments|1|||
163372230|NCT04047862|590070329|FG003|Overall Study|Completed all Assessments|3|||
163372231|NCT04047862|590070330|FG004|Overall Study|Completed all Assessments|2|||
163372232|NCT04047862|590070331|FG005|Overall Study|Completed all Assessments|5|||
163372233|NCT04047862|590070332|FG006|Overall Study|Completed all Assessments|7|||
163372234|NCT04047862|590070333|FG007|Overall Study|Completed all Assessments|0|||
163372235|NCT04047862|590070334|FG008|Overall Study|Completed all Assessments|0|||
163372236|NCT04047862|590070335|FG009|Overall Study|Completed all Assessments|0|||
163372237|NCT04047862|590070336|FG010|Overall Study|Completed all Assessments|0|||
163372238|NCT04047862|590070337|FG011|Overall Study|Completed all Assessments|0|||
163372239|NCT04047862|590070338|FG012|Overall Study|Completed all Assessments|0|||
163372240|NCT04047862|590070339|FG013|Overall Study|Completed all Assessments|0|||
163372241|NCT04047862|590070340|FG014|Overall Study|Completed all Assessments|0|||
163372242|NCT04047862|590070341|FG015|Overall Study|Completed all Assessments|0|||
163372243|NCT04047862|590070342|FG016|Overall Study|Completed all Assessments|0|||
163372244|NCT04047862|590070343|FG017|Overall Study|Completed all Assessments|0|||
163372245|NCT04047862|590070344|FG018|Overall Study|Completed all Assessments|0|||
163372246|NCT04047862|590070326|FG000|Overall Study|Sponsor Decision|0|||
163372247|NCT04047862|590070327|FG001|Overall Study|Sponsor Decision|0|||
163372248|NCT04047862|590070328|FG002|Overall Study|Sponsor Decision|0|||
163372249|NCT04047862|590070329|FG003|Overall Study|Sponsor Decision|0|||
163372250|NCT04047862|590070330|FG004|Overall Study|Sponsor Decision|0|||
163372251|NCT04047862|590070331|FG005|Overall Study|Sponsor Decision|0|||
163372252|NCT04047862|590070332|FG006|Overall Study|Sponsor Decision|0|||
163372253|NCT04047862|590070333|FG007|Overall Study|Sponsor Decision|13|||
163372254|NCT04047862|590070334|FG008|Overall Study|Sponsor Decision|10|||
163372255|NCT04047862|590070335|FG009|Overall Study|Sponsor Decision|18|||
163372256|NCT04047862|590070336|FG010|Overall Study|Sponsor Decision|3|||
163372257|NCT04047862|590070337|FG011|Overall Study|Sponsor Decision|3|||
163372258|NCT04047862|590070338|FG012|Overall Study|Sponsor Decision|4|||
163372259|NCT04047862|590070339|FG013|Overall Study|Sponsor Decision|0|||
163372260|NCT04047862|590070340|FG014|Overall Study|Sponsor Decision|7|||
163372261|NCT04047862|590070341|FG015|Overall Study|Sponsor Decision|8|||
163372262|NCT04047862|590070342|FG016|Overall Study|Sponsor Decision|9|||
163372263|NCT04047862|590070343|FG017|Overall Study|Sponsor Decision|7|||
163372264|NCT04047862|590070344|FG018|Overall Study|Sponsor Decision|8|||
163372265|NCT04047862|590070326|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163372266|NCT04047862|590070327|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163372267|NCT04047862|590070328|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163372268|NCT04047862|590070329|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163372269|NCT04047862|590070330|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163372270|NCT04047862|590070331|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163372271|NCT04047862|590070332|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163372272|NCT04047862|590070333|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
163372273|NCT04047862|590070334|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
163372274|NCT04047862|590070335|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163372275|NCT04047862|590070336|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
163372276|NCT04047862|590070337|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163372277|NCT04047862|590070338|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163372278|NCT04047862|590070339|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163372279|NCT04047862|590070340|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
163372280|NCT04047862|590070341|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
163372281|NCT04047862|590070342|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
163372282|NCT04047862|590070343|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
163372283|NCT04047862|590070344|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
163372284|NCT04047862|590070326|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372285|NCT04047862|590070327|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372286|NCT04047862|590070328|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372287|NCT04047862|590070329|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372288|NCT04047862|590070330|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372289|NCT04047862|590070331|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372290|NCT04047862|590070332|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372291|NCT04047862|590070333|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372292|NCT04047862|590070334|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372293|NCT04047862|590070335|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372294|NCT04047862|590070336|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372295|NCT04047862|590070337|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372296|NCT04047862|590070338|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372297|NCT04047862|590070339|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372298|NCT04047862|590070340|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372299|NCT04047862|590070341|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
163372300|NCT04047862|590070342|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372301|NCT04047862|590070343|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163372302|NCT04047862|590070344|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
163372303|NCT04047862|590070326|FG000|Overall Study|Other|0|||
163372304|NCT04047862|590070327|FG001|Overall Study|Other|0|||
163372305|NCT04047862|590070328|FG002|Overall Study|Other|0|||
163372306|NCT04047862|590070329|FG003|Overall Study|Other|0|||
163372307|NCT04047862|590070330|FG004|Overall Study|Other|0|||
163372308|NCT04047862|590070331|FG005|Overall Study|Other|0|||
163372309|NCT04047862|590070332|FG006|Overall Study|Other|0|||
163372310|NCT04047862|590070333|FG007|Overall Study|Other|0|||
163372311|NCT04047862|590070334|FG008|Overall Study|Other|0|||
163372312|NCT04047862|590070335|FG009|Overall Study|Other|0|||
163372313|NCT04047862|590070336|FG010|Overall Study|Other|0|||
163372314|NCT04047862|590070337|FG011|Overall Study|Other|0|||
163372315|NCT04047862|590070338|FG012|Overall Study|Other|0|||
163372316|NCT04047862|590070339|FG013|Overall Study|Other|0|||
163372317|NCT04047862|590070340|FG014|Overall Study|Other|2|||
163372318|NCT04047862|590070341|FG015|Overall Study|Other|1|||
163372319|NCT04047862|590070342|FG016|Overall Study|Other|1|||
163372320|NCT04047862|590070343|FG017|Overall Study|Other|1|||
163372321|NCT04047862|590070344|FG018|Overall Study|Other|0|||
163372322|NCT04349631|590070351|FG000|Overall Study|Lost to Follow-up|3|||
163372323|NCT04349631|590070351|FG000|Overall Study|Withdrawal by Subject|7|||
163372324|NCT00640133|590072016|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
163372325|NCT00640133|590072017|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
163372326|NCT00640133|590072016|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
163372327|NCT00640133|590072017|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
163413930|NCT03529773|590223017|FG005|Overall Study|No longer meets eligibility criteria|0|||
163372328|NCT00640133|590072016|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
163372329|NCT00640133|590072017|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
163372330|NCT03896152|590072019|FG000|Overall Study|Patient/guardian decision|1|||
163372331|NCT03896152|590072020|FG001|Overall Study|Patient/guardian decision|1|||
163372332|NCT03896152|590072019|FG000|Overall Study|Adverse Event|0|||
163372333|NCT03896152|590072020|FG001|Overall Study|Adverse Event|1|||
163372334|NCT03896152|590072019|FG000|Overall Study|Physician Decision|1|||
163372335|NCT03896152|590072020|FG001|Overall Study|Physician Decision|0|||
163372336|NCT03896152|590072019|FG000|Overall Study|Technical problems|1|||
163372337|NCT03896152|590072020|FG001|Overall Study|Technical problems|0|||
163372338|NCT00224887|590072021|FG000|Overall Study|Pregnancy|6|||
163372339|NCT00224887|590072022|FG001|Overall Study|Pregnancy|6|||
163372340|NCT04032613|590072023|FG000|Overall Study|Did not complete post-program assessment|5|||
163372341|NCT04032613|590072024|FG001|Overall Study|Did not complete post-program assessment|2|||
163372342|NCT01659853|590072025|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
163372343|NCT01659853|590072026|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
163372344|NCT01659853|590072025|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
163372345|NCT01659853|590072026|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
163372346|NCT01365481|590072035|FG000|Overall Study|Adverse Event|6|||
163372347|NCT01365481|590072036|FG001|Overall Study|Adverse Event|9|||
163372348|NCT01365481|590072037|FG002|Overall Study|Adverse Event|0|||
163372349|NCT01365481|590072038|FG003|Overall Study|Adverse Event|2|||
163372350|NCT01365481|590072035|FG000|Overall Study|Withdrawal by Subject|0|||
163372351|NCT01365481|590072036|FG001|Overall Study|Withdrawal by Subject|2|||
163372352|NCT01365481|590072037|FG002|Overall Study|Withdrawal by Subject|1|||
163372353|NCT01365481|590072038|FG003|Overall Study|Withdrawal by Subject|1|||
163372354|NCT01365481|590072035|FG000|Overall Study|Lost to Follow-up|1|||
163372355|NCT01365481|590072036|FG001|Overall Study|Lost to Follow-up|1|||
163372356|NCT01365481|590072037|FG002|Overall Study|Lost to Follow-up|2|||
163372357|NCT01365481|590072038|FG003|Overall Study|Lost to Follow-up|3|||
163372358|NCT01365481|590072035|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163372359|NCT01365481|590072036|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163372360|NCT01365481|590072037|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163372361|NCT01365481|590072038|FG003|Overall Study|Abnormal laboratory value(s)|0|||
163372362|NCT01365481|590072035|FG000|Overall Study|Administrative problems|0|||
163372363|NCT01365481|590072036|FG001|Overall Study|Administrative problems|1|||
163372364|NCT01365481|590072037|FG002|Overall Study|Administrative problems|0|||
163372365|NCT01365481|590072038|FG003|Overall Study|Administrative problems|0|||
163372366|NCT01365481|590072035|FG000|Overall Study|Protocol deviation|0|||
163372367|NCT01365481|590072036|FG001|Overall Study|Protocol deviation|1|||
163372368|NCT01365481|590072037|FG002|Overall Study|Protocol deviation|0|||
163372369|NCT01365481|590072038|FG003|Overall Study|Protocol deviation|1|||
163372370|NCT01365481|590072035|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163372371|NCT01365481|590072036|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163372372|NCT01365481|590072037|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
163372373|NCT01365481|590072038|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
163372374|NCT00757627|590072039|FG000|Overall Study|Adverse Event|15|||
163372375|NCT00757627|590072039|FG000|Overall Study|Lack of Efficacy|10|||
163372376|NCT00757627|590072039|FG000|Overall Study|Lost to Follow-up|28|||
163372377|NCT00757627|590072039|FG000|Overall Study|Withdrawal by Subject|27|||
163372378|NCT00757627|590072039|FG000|Overall Study|Other|1|||
163372379|NCT00635661|590072044|FG000|Overall Study|Withdrawal by Subject|4|||
163372380|NCT00403767|590072050|FG000|Overall Study|Adverse Event|993|||
163372381|NCT00403767|590072051|FG001|Overall Study|Adverse Event|919|||
163372382|NCT00403767|590072050|FG000|Overall Study|Non-compliant with study medication|134|||
163372383|NCT00403767|590072051|FG001|Overall Study|Non-compliant with study medication|164|||
163372384|NCT00403767|590072050|FG000|Overall Study|Consent withdrawn|671|||
163372385|NCT00403767|590072051|FG001|Overall Study|Consent withdrawn|673|||
163372386|NCT00403767|590072050|FG000|Overall Study|Investigator dec./not protocol-related|191|||
163372387|NCT00403767|590072051|FG001|Overall Study|Investigator dec./not protocol-related|178|||
163372388|NCT00403767|590072050|FG000|Overall Study|Lost to Follow-up|6|||
163372389|NCT00403767|590072051|FG001|Overall Study|Lost to Follow-up|8|||
163372390|NCT00403767|590072050|FG000|Overall Study|Protocol Violation|142|||
163372391|NCT00403767|590072051|FG001|Overall Study|Protocol Violation|124|||
163372392|NCT00403767|590072050|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
163372393|NCT00403767|590072051|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
163372394|NCT00403767|590072050|FG000|Overall Study|Study terminated by sponsor|82|||
163372395|NCT00403767|590072051|FG001|Overall Study|Study terminated by sponsor|69|||
163372396|NCT00403767|590072050|FG000|Overall Study|Missing/incomplete data|1|||
163372397|NCT00403767|590072051|FG001|Overall Study|Missing/incomplete data|1|||
163372398|NCT02755818|590072052|FG000|Overall Study|Withdrawal by Subject|0|||
163372399|NCT02755818|590072053|FG001|Overall Study|Withdrawal by Subject|0|||
163372400|NCT02755818|590072054|FG002|Overall Study|Withdrawal by Subject|0|||
163372401|NCT02755818|590072055|FG003|Overall Study|Withdrawal by Subject|2|||
163372402|NCT02755818|590072052|FG000|Overall Study|withdrawal by PI|0|||
163372403|NCT02755818|590072053|FG001|Overall Study|withdrawal by PI|0|||
163372404|NCT02755818|590072054|FG002|Overall Study|withdrawal by PI|1|||
163372405|NCT02755818|590072055|FG003|Overall Study|withdrawal by PI|1|||
163372406|NCT03014011|590072056|FG000|First Intervention|Withdrawal by Subject|1|||
163372407|NCT03014011|590072057|FG001|First Intervention|Withdrawal by Subject|0|||
163372408|NCT03014011|590072056|FG000|Washout|Withdrawal by Subject|1|||
163372409|NCT03014011|590072057|FG001|Washout|Withdrawal by Subject|0|||
163372410|NCT01152814|590072058|FG000|Overall Study|Lost to Follow-up|2|||
163372411|NCT01280357|590072069|FG000|Overall Study|Excluded no internal monitoring|14|||
163372412|NCT01280357|590072069|FG000|Overall Study|IInsufficient data/No data supplied|12|||
163372413|NCT03284203|590072070|FG000|Overall Study|Lost to Follow-up|3|||
163372414|NCT02229851|590072071|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
163372415|NCT02229851|590072072|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
163372416|NCT02229851|590072073|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
163372417|NCT02229851|590072074|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
163372418|NCT02229851|590072075|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
163372419|NCT02229851|590072076|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
163372420|NCT02229851|590072077|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
163372421|NCT02229851|590072071|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
163372422|NCT02229851|590072072|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
163372423|NCT02229851|590072073|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
163372424|NCT02229851|590072074|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
163372425|NCT02229851|590072075|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
163372426|NCT02229851|590072076|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
163372427|NCT02229851|590072077|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
163372428|NCT02229851|590072071|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
163372429|NCT02229851|590072072|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
163372430|NCT02229851|590072073|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
163372431|NCT02229851|590072074|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
163372432|NCT02229851|590072075|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
163372433|NCT02229851|590072076|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
163372434|NCT02229851|590072077|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
163372435|NCT02229851|590072071|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
163372436|NCT02229851|590072072|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
163372437|NCT02229851|590072073|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
163372438|NCT02229851|590072074|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
163372439|NCT02229851|590072075|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
163372440|NCT02229851|590072076|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
163372441|NCT02229851|590072077|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
163372442|NCT02229851|590072071|FG000|Main Phase (Double-blind Phase)|Death|1|||
163372443|NCT02229851|590072072|FG001|Main Phase (Double-blind Phase)|Death|1|||
163372444|NCT02229851|590072073|FG002|Main Phase (Double-blind Phase)|Death|0|||
163372445|NCT02229851|590072074|FG003|Main Phase (Double-blind Phase)|Death|0|||
163372446|NCT02229851|590072075|FG004|Main Phase (Double-blind Phase)|Death|0|||
163372447|NCT02229851|590072076|FG005|Main Phase (Double-blind Phase)|Death|0|||
163372448|NCT02229851|590072077|FG006|Main Phase (Double-blind Phase)|Death|0|||
163372449|NCT02229851|590072071|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
163372450|NCT02229851|590072072|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
163372451|NCT02229851|590072073|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
163372452|NCT02229851|590072074|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
163372453|NCT02229851|590072075|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
163372454|NCT02229851|590072076|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
163372455|NCT02229851|590072077|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
163372456|NCT02229851|590072071|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
163372457|NCT02229851|590072072|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
163372458|NCT02229851|590072073|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
163372459|NCT02229851|590072074|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
163372460|NCT02229851|590072075|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
163372461|NCT02229851|590072076|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
163372462|NCT02229851|590072077|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
163372463|NCT02229851|590072071|FG000|Extension Phase (Open-label Phase)|Death|0|||
163372464|NCT02229851|590072072|FG001|Extension Phase (Open-label Phase)|Death|0|||
163372465|NCT02229851|590072073|FG002|Extension Phase (Open-label Phase)|Death|0|||
163372466|NCT02229851|590072074|FG003|Extension Phase (Open-label Phase)|Death|1|||
163372467|NCT02229851|590072075|FG004|Extension Phase (Open-label Phase)|Death|0|||
163372468|NCT02229851|590072076|FG005|Extension Phase (Open-label Phase)|Death|1|||
163372469|NCT02229851|590072077|FG006|Extension Phase (Open-label Phase)|Death|1|||
163372470|NCT03682302|590072080|FG000|Overall Study|Lost to Follow-up|1|||
163372471|NCT03682302|590072081|FG001|Overall Study|Lost to Follow-up|2|||
163372472|NCT03682302|590072082|FG002|Overall Study|Lost to Follow-up|0|||
163372473|NCT03682302|590072083|FG003|Overall Study|Lost to Follow-up|1|||
163372474|NCT03682302|590072080|FG000|Overall Study|Study drug was not administered|0|||
163372475|NCT03682302|590072081|FG001|Overall Study|Study drug was not administered|0|||
163372476|NCT03682302|590072082|FG002|Overall Study|Study drug was not administered|1|||
163372477|NCT03682302|590072083|FG003|Overall Study|Study drug was not administered|1|||
163372478|NCT03189745|590072085|FG000|Overall Study|Conflict in work schedule of participant|1|||
163413931|NCT03529773|590223018|FG006|Overall Study|No longer meets eligibility criteria|0|||
163413932|NCT03529773|590223019|FG007|Overall Study|No longer meets eligibility criteria|0|||
163413933|NCT03529773|590223020|FG008|Overall Study|No longer meets eligibility criteria|0|||
163413934|NCT03529773|590223021|FG009|Overall Study|No longer meets eligibility criteria|0|||
163413935|NCT03529773|590223022|FG010|Overall Study|No longer meets eligibility criteria|0|||
163413936|NCT03529773|590223023|FG011|Overall Study|No longer meets eligibility criteria|0|||
163413937|NCT03529773|590223024|FG012|Overall Study|No longer meets eligibility criteria|0|||
163413938|NCT03529773|590223025|FG013|Overall Study|No longer meets eligibility criteria|0|||
163413939|NCT03529773|590223026|FG014|Overall Study|No longer meets eligibility criteria|0|||
163413940|NCT03529773|590223027|FG015|Overall Study|No longer meets eligibility criteria|0|||
163413941|NCT03529773|590223028|FG016|Overall Study|No longer meets eligibility criteria|0|||
163413942|NCT03529773|590223029|FG017|Overall Study|No longer meets eligibility criteria|0|||
163413943|NCT03529773|590223030|FG018|Overall Study|No longer meets eligibility criteria|0|||
163413944|NCT03529773|590223031|FG019|Overall Study|No longer meets eligibility criteria|0|||
163413945|NCT03529773|590223032|FG020|Overall Study|No longer meets eligibility criteria|0|||
163413946|NCT03529773|590223033|FG021|Overall Study|No longer meets eligibility criteria|0|||
163413947|NCT03529773|590223034|FG022|Overall Study|No longer meets eligibility criteria|1|||
163413948|NCT03529773|590223035|FG023|Overall Study|No longer meets eligibility criteria|0|||
163413949|NCT03529773|590223036|FG024|Overall Study|No longer meets eligibility criteria|0|||
163413950|NCT03529773|590223037|FG025|Overall Study|No longer meets eligibility criteria|0|||
163413951|NCT03529773|590223038|FG026|Overall Study|No longer meets eligibility criteria|0|||
163413952|NCT03529773|590223039|FG027|Overall Study|No longer meets eligibility criteria|0|||
163413953|NCT03529773|590223040|FG028|Overall Study|No longer meets eligibility criteria|0|||
163413954|NCT03529773|590223041|FG029|Overall Study|No longer meets eligibility criteria|0|||
163413955|NCT03529773|590223042|FG030|Overall Study|No longer meets eligibility criteria|0|||
163413956|NCT03529773|590223043|FG031|Overall Study|No longer meets eligibility criteria|0|||
163413957|NCT03529773|590223044|FG032|Overall Study|No longer meets eligibility criteria|0|||
163413958|NCT03529773|590223045|FG033|Overall Study|No longer meets eligibility criteria|0|||
163413959|NCT03529773|590223046|FG034|Overall Study|No longer meets eligibility criteria|0|||
163413960|NCT03529773|590223047|FG035|Overall Study|No longer meets eligibility criteria|0|||
163413961|NCT03529773|590223048|FG036|Overall Study|No longer meets eligibility criteria|0|||
163413962|NCT03529773|590223049|FG037|Overall Study|No longer meets eligibility criteria|0|||
163413963|NCT03529773|590223050|FG038|Overall Study|No longer meets eligibility criteria|1|||
163413964|NCT03529773|590223051|FG039|Overall Study|No longer meets eligibility criteria|0|||
163413965|NCT03529773|590223012|FG000|Overall Study|Other|0|||
163413966|NCT03529773|590223013|FG001|Overall Study|Other|0|||
163413967|NCT03529773|590223014|FG002|Overall Study|Other|0|||
163413968|NCT03529773|590223015|FG003|Overall Study|Other|0|||
163413969|NCT03529773|590223016|FG004|Overall Study|Other|0|||
163413970|NCT03529773|590223017|FG005|Overall Study|Other|0|||
163413971|NCT03529773|590223018|FG006|Overall Study|Other|0|||
163413972|NCT03529773|590223019|FG007|Overall Study|Other|0|||
163413973|NCT03529773|590223020|FG008|Overall Study|Other|0|||
163413974|NCT03529773|590223021|FG009|Overall Study|Other|0|||
163413975|NCT03529773|590223022|FG010|Overall Study|Other|0|||
163413976|NCT03529773|590223023|FG011|Overall Study|Other|0|||
163413977|NCT03529773|590223024|FG012|Overall Study|Other|1|||
163413978|NCT03529773|590223025|FG013|Overall Study|Other|0|||
163413979|NCT03529773|590223026|FG014|Overall Study|Other|2|||
163413980|NCT03529773|590223027|FG015|Overall Study|Other|0|||
163413981|NCT03529773|590223028|FG016|Overall Study|Other|0|||
163413982|NCT03529773|590223029|FG017|Overall Study|Other|3|||
163413983|NCT03529773|590223030|FG018|Overall Study|Other|0|||
163413984|NCT03529773|590223031|FG019|Overall Study|Other|0|||
163413985|NCT03529773|590223032|FG020|Overall Study|Other|1|||
163413986|NCT03529773|590223033|FG021|Overall Study|Other|0|||
163413987|NCT03529773|590223034|FG022|Overall Study|Other|1|||
163413988|NCT03529773|590223035|FG023|Overall Study|Other|0|||
163413989|NCT03529773|590223036|FG024|Overall Study|Other|3|||
163413990|NCT03529773|590223037|FG025|Overall Study|Other|2|||
163413991|NCT03529773|590223038|FG026|Overall Study|Other|2|||
163413992|NCT03529773|590223039|FG027|Overall Study|Other|0|||
163413993|NCT03529773|590223040|FG028|Overall Study|Other|0|||
163413994|NCT03529773|590223041|FG029|Overall Study|Other|0|||
163413995|NCT03529773|590223042|FG030|Overall Study|Other|0|||
163413996|NCT03529773|590223043|FG031|Overall Study|Other|0|||
163413997|NCT03529773|590223044|FG032|Overall Study|Other|0|||
163413998|NCT03529773|590223045|FG033|Overall Study|Other|0|||
163413999|NCT03529773|590223046|FG034|Overall Study|Other|1|||
163414000|NCT03529773|590223047|FG035|Overall Study|Other|1|||
163414001|NCT03529773|590223048|FG036|Overall Study|Other|0|||
163414002|NCT03529773|590223049|FG037|Overall Study|Other|0|||
163414003|NCT03529773|590223050|FG038|Overall Study|Other|0|||
163414004|NCT03529773|590223051|FG039|Overall Study|Other|0|||
163414005|NCT03529773|590223012|FG000|Overall Study|Physician Decision|0|||
163414006|NCT03529773|590223013|FG001|Overall Study|Physician Decision|0|||
163372479|NCT03189745|590072086|FG001|Overall Study|Conflict in work schedule of participant|1|||
163372480|NCT01276379|590072087|FG000|Overall Study|Screening failure|40|||
163372481|NCT02729831|590072089|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
163372482|NCT02729831|590072090|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
163372483|NCT02729831|590072091|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
163372484|NCT02729831|590072092|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
163372485|NCT02729831|590072089|FG000|1 Week Post-visit|Lost to Follow-up|43|||
163372486|NCT02729831|590072090|FG001|1 Week Post-visit|Lost to Follow-up|40|||
163372487|NCT02729831|590072091|FG002|1 Week Post-visit|Lost to Follow-up|38|||
163372488|NCT02729831|590072092|FG003|1 Week Post-visit|Lost to Follow-up|36|||
163372489|NCT02729831|590072089|FG000|6 Month Follow-up|Lost to Follow-up|54|||
163372490|NCT02729831|590072090|FG001|6 Month Follow-up|Lost to Follow-up|51|||
163372491|NCT02729831|590072091|FG002|6 Month Follow-up|Lost to Follow-up|48|||
163372492|NCT02729831|590072092|FG003|6 Month Follow-up|Lost to Follow-up|42|||
163372493|NCT02729831|590072089|FG000|6 Month Follow-up|Death|1|||
163372494|NCT02729831|590072090|FG001|6 Month Follow-up|Death|3|||
163372495|NCT02729831|590072091|FG002|6 Month Follow-up|Death|0|||
163372496|NCT02729831|590072092|FG003|6 Month Follow-up|Death|1|||
163372497|NCT00864253|590072093|FG000|Overall Study|Adverse Event|56|||
163372498|NCT00864253|590072094|FG001|Overall Study|Adverse Event|11|||
163372499|NCT00864253|590072093|FG000|Overall Study|Unrelated Adverse Event|3|||
163372500|NCT00864253|590072094|FG001|Overall Study|Unrelated Adverse Event|1|||
163372501|NCT00864253|590072093|FG000|Overall Study|Physician Decision|11|||
163372502|NCT00864253|590072094|FG001|Overall Study|Physician Decision|15|||
163372503|NCT00864253|590072093|FG000|Overall Study|Protocol Violation|0|||
163372504|NCT00864253|590072094|FG001|Overall Study|Protocol Violation|2|||
163372505|NCT00864253|590072093|FG000|Overall Study|Lost to Follow-up|1|||
163372506|NCT00864253|590072094|FG001|Overall Study|Lost to Follow-up|1|||
163372507|NCT00864253|590072093|FG000|Overall Study|Withdrawal by Subject|18|||
163372508|NCT00864253|590072094|FG001|Overall Study|Withdrawal by Subject|18|||
163372509|NCT00864253|590072093|FG000|Overall Study|Death|1|||
163372510|NCT00864253|590072094|FG001|Overall Study|Death|0|||
163372511|NCT00864253|590072093|FG000|Overall Study|Ongoing|2|||
163372512|NCT00864253|590072094|FG001|Overall Study|Ongoing|3|||
163372513|NCT00864253|590072093|FG000|Overall Study|Untreated|7|||
163372514|NCT00864253|590072094|FG001|Overall Study|Untreated|7|||
163372515|NCT01111240|590072096|FG000|Overall Study|Adverse Event|190|||
163372516|NCT01111240|590072096|FG000|Overall Study|Lack of Efficacy|545|||
163372517|NCT01111240|590072096|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
163372518|NCT01111240|590072096|FG000|Overall Study|Other|312|||
163372519|NCT01747551|590072097|FG000|Overall Study|Progressive Disease|24|||
163372520|NCT01747551|590072098|FG001|Overall Study|Progressive Disease|17|||
163372521|NCT01747551|590072097|FG000|Overall Study|Death|3|||
163372522|NCT01747551|590072098|FG001|Overall Study|Death|1|||
163372523|NCT01747551|590072097|FG000|Overall Study|Adverse Event|7|||
163372524|NCT01747551|590072098|FG001|Overall Study|Adverse Event|1|||
163372525|NCT01747551|590072097|FG000|Overall Study|Prolonged Treatment Delay|2|||
163372526|NCT01747551|590072098|FG001|Overall Study|Prolonged Treatment Delay|0|||
163372527|NCT01747551|590072097|FG000|Overall Study|Withdrawal by Subject|3|||
163372528|NCT01747551|590072098|FG001|Overall Study|Withdrawal by Subject|1|||
163372529|NCT01747551|590072097|FG000|Overall Study|Physician Decision|2|||
163372530|NCT01747551|590072098|FG001|Overall Study|Physician Decision|1|||
163372531|NCT01747551|590072097|FG000|Overall Study|Other|2|||
163372532|NCT01747551|590072098|FG001|Overall Study|Other|0|||
163372533|NCT01609062|590072099|FG000|Extension Phase|Terminated by Sponsor|14|||
163372534|NCT01609062|590072100|FG001|Extension Phase|Terminated by Sponsor|9|||
163372535|NCT01609062|590072099|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
163372536|NCT01609062|590072100|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
163372537|NCT01609062|590072099|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
163372538|NCT01609062|590072100|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
163372539|NCT03842358|590072105|FG000|Overall Study|Poor DOT probe contact with breast|2|||
163372540|NCT03842358|590072105|FG000|Overall Study|DOT system problem|1|||
163372541|NCT03842358|590072105|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
163372542|NCT03842358|590072105|FG000|Overall Study|No biopsy after physician review|4|||
163372543|NCT03842358|590072105|FG000|Overall Study|Patient withdrew|2|||
163372544|NCT05384938|590072106|FG000|Overall Study|Withdrawal by Subject|8|||
163372545|NCT05384938|590072106|FG000|Overall Study|Lost to Follow-up|6|||
163372546|NCT05384938|590072106|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
163372547|NCT02626455|590072107|FG000|Overall Study|Other|1|||
163372548|NCT02626455|590072108|FG001|Overall Study|Other|1|||
163372549|NCT02626455|590072109|FG002|Overall Study|Other|0|||
163372550|NCT02626455|590072110|FG003|Overall Study|Other|0|||
163372551|NCT02626455|590072111|FG004|Overall Study|Other|0|||
163372552|NCT02626455|590072112|FG005|Overall Study|Other|17|||
163372553|NCT02626455|590072113|FG006|Overall Study|Other|23|||
163372554|NCT02626455|590072107|FG000|Overall Study|Withdrawal by Subject|1|||
163372555|NCT02626455|590072108|FG001|Overall Study|Withdrawal by Subject|0|||
163372556|NCT02626455|590072109|FG002|Overall Study|Withdrawal by Subject|0|||
163372557|NCT02626455|590072110|FG003|Overall Study|Withdrawal by Subject|0|||
163372558|NCT02626455|590072111|FG004|Overall Study|Withdrawal by Subject|0|||
163372559|NCT02626455|590072112|FG005|Overall Study|Withdrawal by Subject|10|||
163372560|NCT02626455|590072113|FG006|Overall Study|Withdrawal by Subject|6|||
163372561|NCT02626455|590072107|FG000|Overall Study|Physician Decision|0|||
163372562|NCT02626455|590072108|FG001|Overall Study|Physician Decision|2|||
163372563|NCT02626455|590072109|FG002|Overall Study|Physician Decision|2|||
163372564|NCT02626455|590072110|FG003|Overall Study|Physician Decision|2|||
163372565|NCT02626455|590072111|FG004|Overall Study|Physician Decision|1|||
163372566|NCT02626455|590072112|FG005|Overall Study|Physician Decision|10|||
163372567|NCT02626455|590072113|FG006|Overall Study|Physician Decision|3|||
163372568|NCT02626455|590072107|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
163372569|NCT02626455|590072108|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
163372570|NCT02626455|590072109|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
163372571|NCT02626455|590072110|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
163372572|NCT02626455|590072111|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
163372573|NCT02626455|590072112|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
163372574|NCT02626455|590072113|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
163372575|NCT02626455|590072107|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
163372576|NCT02626455|590072108|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
163372577|NCT02626455|590072109|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
163372578|NCT02626455|590072110|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
163372579|NCT02626455|590072111|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
163372580|NCT02626455|590072112|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
163372581|NCT02626455|590072113|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
163372582|NCT02626455|590072107|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
163372583|NCT02626455|590072108|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
163372584|NCT02626455|590072109|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
163372585|NCT02626455|590072110|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
163372586|NCT02626455|590072111|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
163372587|NCT02626455|590072112|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
163372588|NCT02626455|590072113|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
163372589|NCT02626455|590072107|FG000|Overall Study|Patient decision|0|||
163372590|NCT02626455|590072108|FG001|Overall Study|Patient decision|1|||
163372591|NCT02626455|590072109|FG002|Overall Study|Patient decision|0|||
163372592|NCT02626455|590072110|FG003|Overall Study|Patient decision|0|||
163372593|NCT02626455|590072111|FG004|Overall Study|Patient decision|1|||
163372594|NCT02626455|590072112|FG005|Overall Study|Patient decision|36|||
163372595|NCT02626455|590072113|FG006|Overall Study|Patient decision|22|||
163372596|NCT02626455|590072107|FG000|Overall Study|Protocol Violation|0|||
163372597|NCT02626455|590072108|FG001|Overall Study|Protocol Violation|0|||
163372598|NCT02626455|590072109|FG002|Overall Study|Protocol Violation|0|||
163372599|NCT02626455|590072110|FG003|Overall Study|Protocol Violation|0|||
163372600|NCT02626455|590072111|FG004|Overall Study|Protocol Violation|0|||
163372601|NCT02626455|590072112|FG005|Overall Study|Protocol Violation|0|||
163372602|NCT02626455|590072113|FG006|Overall Study|Protocol Violation|1|||
163372603|NCT02626455|590072107|FG000|Overall Study|Progressive disease - radiological progression|0|||
163372604|NCT02626455|590072108|FG001|Overall Study|Progressive disease - radiological progression|0|||
163372605|NCT02626455|590072109|FG002|Overall Study|Progressive disease - radiological progression|0|||
163372606|NCT02626455|590072110|FG003|Overall Study|Progressive disease - radiological progression|0|||
163372607|NCT02626455|590072111|FG004|Overall Study|Progressive disease - radiological progression|0|||
163372608|NCT02626455|590072112|FG005|Overall Study|Progressive disease - radiological progression|11|||
163372609|NCT02626455|590072113|FG006|Overall Study|Progressive disease - radiological progression|22|||
163372610|NCT02626455|590072107|FG000|Overall Study|Progressive disease - clinical progression|0|||
163372611|NCT02626455|590072108|FG001|Overall Study|Progressive disease - clinical progression|0|||
163372612|NCT02626455|590072109|FG002|Overall Study|Progressive disease - clinical progression|0|||
163372613|NCT02626455|590072110|FG003|Overall Study|Progressive disease - clinical progression|0|||
163372614|NCT02626455|590072111|FG004|Overall Study|Progressive disease - clinical progression|0|||
163372615|NCT02626455|590072112|FG005|Overall Study|Progressive disease - clinical progression|1|||
163372616|NCT02626455|590072113|FG006|Overall Study|Progressive disease - clinical progression|2|||
163372617|NCT02626455|590072107|FG000|Overall Study|Lost to Follow-up|0|||
163372618|NCT02626455|590072108|FG001|Overall Study|Lost to Follow-up|0|||
163372619|NCT02626455|590072109|FG002|Overall Study|Lost to Follow-up|0|||
163372620|NCT02626455|590072110|FG003|Overall Study|Lost to Follow-up|0|||
163372621|NCT02626455|590072111|FG004|Overall Study|Lost to Follow-up|0|||
163372622|NCT02626455|590072112|FG005|Overall Study|Lost to Follow-up|1|||
163372623|NCT02626455|590072113|FG006|Overall Study|Lost to Follow-up|0|||
163372624|NCT02626455|590072107|FG000|Overall Study|AE not associated with clinical disease progression|1|||
163372625|NCT02626455|590072108|FG001|Overall Study|AE not associated with clinical disease progression|1|||
163372626|NCT02626455|590072109|FG002|Overall Study|AE not associated with clinical disease progression|0|||
163372627|NCT02626455|590072110|FG003|Overall Study|AE not associated with clinical disease progression|2|||
163372628|NCT02626455|590072111|FG004|Overall Study|AE not associated with clinical disease progression|1|||
163372629|NCT02626455|590072112|FG005|Overall Study|AE not associated with clinical disease progression|65|||
163372630|NCT02626455|590072113|FG006|Overall Study|AE not associated with clinical disease progression|21|||
163372631|NCT02626455|590072107|FG000|Overall Study|AE associated with clinical disease progression|0|||
163372632|NCT02626455|590072108|FG001|Overall Study|AE associated with clinical disease progression|0|||
163372633|NCT02626455|590072109|FG002|Overall Study|AE associated with clinical disease progression|0|||
163372634|NCT02626455|590072110|FG003|Overall Study|AE associated with clinical disease progression|0|||
163372635|NCT02626455|590072111|FG004|Overall Study|AE associated with clinical disease progression|0|||
163372636|NCT02626455|590072112|FG005|Overall Study|AE associated with clinical disease progression|1|||
163372637|NCT02626455|590072113|FG006|Overall Study|AE associated with clinical disease progression|2|||
163372638|NCT02626455|590072107|FG000|Overall Study|Study intervention never administered|0|||
163372639|NCT02626455|590072108|FG001|Overall Study|Study intervention never administered|0|||
163372640|NCT02626455|590072109|FG002|Overall Study|Study intervention never administered|0|||
163372641|NCT02626455|590072110|FG003|Overall Study|Study intervention never administered|0|||
163372642|NCT02626455|590072111|FG004|Overall Study|Study intervention never administered|0|||
163372643|NCT02626455|590072112|FG005|Overall Study|Study intervention never administered|1|||
163372644|NCT02626455|590072113|FG006|Overall Study|Study intervention never administered|3|||
163372645|NCT06665919|590072114|FG000|Overall Study|Withdrawal by Subject|4|||
163372646|NCT06665919|590072115|FG001|Overall Study|Withdrawal by Subject|4|||
163372647|NCT06665919|590072116|FG002|Overall Study|Withdrawal by Subject|4|||
163372648|NCT06665919|590072114|FG000|Overall Study|Non-compliance to Treatment|4|||
163372649|NCT06665919|590072115|FG001|Overall Study|Non-compliance to Treatment|1|||
163372650|NCT06665919|590072116|FG002|Overall Study|Non-compliance to Treatment|6|||
163372651|NCT06665919|590072114|FG000|Overall Study|Lost to Follow-up|3|||
163372652|NCT06665919|590072115|FG001|Overall Study|Lost to Follow-up|0|||
163372653|NCT06665919|590072116|FG002|Overall Study|Lost to Follow-up|2|||
163372654|NCT06665919|590072114|FG000|Overall Study|Physician Decision|4|||
163372655|NCT06665919|590072115|FG001|Overall Study|Physician Decision|0|||
163372656|NCT06665919|590072116|FG002|Overall Study|Physician Decision|1|||
163372657|NCT05148962|590072117|FG000|Overall Study|Withdrawal by Subject|1|||
163372658|NCT05148962|590072118|FG001|Overall Study|Withdrawal by Subject|1|||
163372659|NCT05148962|590072119|FG002|Overall Study|Withdrawal by Subject|0|||
163372660|NCT05148962|590072120|FG003|Overall Study|Withdrawal by Subject|1|||
163372661|NCT05148962|590072121|FG004|Overall Study|Withdrawal by Subject|0|||
163372662|NCT05148962|590072117|FG000|Overall Study|Participant was early terminated per protocol|0|||
163372663|NCT05148962|590072118|FG001|Overall Study|Participant was early terminated per protocol|0|||
163372664|NCT05148962|590072119|FG002|Overall Study|Participant was early terminated per protocol|3|||
163372665|NCT05148962|590072120|FG003|Overall Study|Participant was early terminated per protocol|5|||
163372666|NCT05148962|590072121|FG004|Overall Study|Participant was early terminated per protocol|2|||
163372667|NCT05148962|590072117|FG000|Overall Study|Miscellaneous|0|||
163372668|NCT05148962|590072118|FG001|Overall Study|Miscellaneous|0|||
163372669|NCT05148962|590072119|FG002|Overall Study|Miscellaneous|0|||
163372670|NCT05148962|590072120|FG003|Overall Study|Miscellaneous|1|||
163372671|NCT05148962|590072121|FG004|Overall Study|Miscellaneous|0|||
163372672|NCT01200290|590072123|FG000|Treatment Period|Adverse Event|1|||
163372673|NCT01200290|590072123|FG000|Post-Treatment Follow-Up Period|Death|2|||
163372674|NCT01525238|590072124|FG000|Overall Study|Withdrawal by Subject|1|||
163372675|NCT01525238|590072125|FG001|Overall Study|Withdrawal by Subject|0|||
163372676|NCT01525238|590072126|FG002|Overall Study|Withdrawal by Subject|0|||
163372677|NCT00607724|590072127|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
163372678|NCT00607724|590072128|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
163372679|NCT00607724|590072129|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
163372680|NCT00607724|590072130|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
163372681|NCT00607724|590072131|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
163372682|NCT00607724|590072132|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
163372683|NCT00607724|590072133|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
163372684|NCT00607724|590072127|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
163372685|NCT00607724|590072128|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
163372686|NCT00607724|590072129|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
163372687|NCT00607724|590072130|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
163372688|NCT00607724|590072131|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
163372689|NCT00607724|590072132|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
163372690|NCT00607724|590072133|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
163372691|NCT00607724|590072127|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
163372692|NCT00607724|590072128|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
163372693|NCT00607724|590072129|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
163372694|NCT00607724|590072130|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
163372695|NCT00607724|590072131|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
163372696|NCT00607724|590072132|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
163372697|NCT00607724|590072133|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
163372698|NCT00607724|590072127|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
163372699|NCT00607724|590072128|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
163372700|NCT00607724|590072129|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
163372701|NCT00607724|590072130|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
163372702|NCT00607724|590072131|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
163372703|NCT00607724|590072132|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
163372704|NCT00607724|590072133|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
163372705|NCT00607724|590072127|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
163372706|NCT00607724|590072128|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
163372707|NCT00607724|590072129|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
163372708|NCT00607724|590072130|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
163372709|NCT00607724|590072131|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
163372710|NCT00607724|590072132|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
163372711|NCT00607724|590072133|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
163372712|NCT01946529|590072139|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
163372713|NCT01946529|590072140|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
163372714|NCT01946529|590072141|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
163372715|NCT01946529|590072139|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
163372716|NCT01946529|590072140|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
163372717|NCT01946529|590072141|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
163372718|NCT00775463|590073876|FG000|Overall Study|Withdrawal by Subject|0|||
163372719|NCT00775463|590073877|FG001|Overall Study|Withdrawal by Subject|1|||
163372720|NCT00775463|590073876|FG000|Overall Study|Adverse Event|7|||
163372721|NCT00775463|590073877|FG001|Overall Study|Adverse Event|9|||
163372722|NCT00775463|590073876|FG000|Overall Study|Protocol Violation|2|||
163372723|NCT00775463|590073877|FG001|Overall Study|Protocol Violation|2|||
163372724|NCT00775463|590073876|FG000|Overall Study|Lost to Follow-up|1|||
163372725|NCT00775463|590073877|FG001|Overall Study|Lost to Follow-up|0|||
163372726|NCT00775463|590073876|FG000|Overall Study|Lack of Efficacy|1|||
163372727|NCT00775463|590073877|FG001|Overall Study|Lack of Efficacy|1|||
163372728|NCT01789567|590073878|FG000|Overall Study|Death|6|||
163372729|NCT01994837|590073879|FG000|Overall Study|Progressive disease per protocol|23|||
163372730|NCT01994837|590073879|FG000|Overall Study|Adv event related to progressive disease|3|||
163372731|NCT01994837|590073879|FG000|Overall Study|Fatal progressive disease|2|||
163372732|NCT01994837|590073879|FG000|Overall Study|Adverse event not related to progression|1|||
163372733|NCT01994837|590073879|FG000|Overall Study|Chose palliative care|1|||
163372734|NCT01994837|590073879|FG000|Overall Study|Proceeded to transplant|1|||
163372735|NCT01994837|590073879|FG000|Overall Study|Removed from study due to no response|1|||
163372736|NCT03900416|590073881|FG000|Six Week Follow-up|Lost to Follow-up|1|||
163372737|NCT03900416|590073882|FG001|Six Week Follow-up|Lost to Follow-up|0|||
163372738|NCT03900416|590073881|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
163372739|NCT03900416|590073882|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
163372740|NCT03900416|590073881|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
163372741|NCT03900416|590073882|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
163372742|NCT03900416|590073881|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
163372743|NCT03900416|590073882|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
163372744|NCT03900416|590073881|FG000|Twelve Week Follow-up|Adverse Event|1|||
163372745|NCT03900416|590073882|FG001|Twelve Week Follow-up|Adverse Event|1|||
163372746|NCT03900416|590073881|FG000|Six Month Follow-up|Lost to Follow-up|4|||
163372747|NCT03900416|590073882|FG001|Six Month Follow-up|Lost to Follow-up|3|||
163372748|NCT03900416|590073881|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
163372749|NCT03900416|590073882|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
163372750|NCT03207451|590073885|FG000|Overall Study|scheduling conflict|1|||
163372751|NCT03207451|590073886|FG001|Overall Study|scheduling conflict|0|||
163372752|NCT03207451|590073887|FG002|Overall Study|scheduling conflict|2|||
163372753|NCT03207451|590073888|FG003|Overall Study|scheduling conflict|2|||
163372754|NCT03207451|590073885|FG000|Overall Study|Adverse Event|0|||
163372755|NCT03207451|590073886|FG001|Overall Study|Adverse Event|0|||
163372756|NCT03207451|590073887|FG002|Overall Study|Adverse Event|0|||
163372757|NCT03207451|590073888|FG003|Overall Study|Adverse Event|1|||
163372758|NCT00436852|590073889|FG000|Overall Study|Death|23|||
163372759|NCT00436852|590073890|FG001|Overall Study|Death|34|||
163372760|NCT00436852|590073889|FG000|Overall Study|Lack of Efficacy|9|||
163372761|NCT00436852|590073890|FG001|Overall Study|Lack of Efficacy|7|||
163372762|NCT00436852|590073889|FG000|Overall Study|Withdrawal by Subject|2|||
163372763|NCT00436852|590073890|FG001|Overall Study|Withdrawal by Subject|4|||
163372764|NCT00436852|590073889|FG000|Overall Study|Ineligible|1|||
163372765|NCT00436852|590073890|FG001|Overall Study|Ineligible|0|||
163372766|NCT00370682|590073891|FG000|Overall Study|Moved from area|0|||
163372767|NCT00370682|590073892|FG001|Overall Study|Moved from area|2|||
163372768|NCT00370682|590073893|FG002|Overall Study|Moved from area|0|||
163372769|NCT00370682|590073891|FG000|Overall Study|Lost to Follow-up|0|||
163372770|NCT00370682|590073892|FG001|Overall Study|Lost to Follow-up|1|||
163372771|NCT00370682|590073893|FG002|Overall Study|Lost to Follow-up|1|||
163372772|NCT03167359|590073894|FG000|Overall Study|Physician Decision|1|||
163372773|NCT03167359|590073894|FG000|Overall Study|Lost to Follow-up|1|||
163372774|NCT03339583|590073895|FG000|First Intervention (14 Days)|Adverse Event|1|||
163372775|NCT03339583|590073896|FG001|First Intervention (14 Days)|Adverse Event|0|||
163372776|NCT03339583|590073895|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
163372777|NCT03339583|590073896|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
163372778|NCT03339583|590073895|FG000|Second Intervention (14 Days)|Adverse Event|0|||
163372779|NCT03339583|590073896|FG001|Second Intervention (14 Days)|Adverse Event|1|||
163372780|NCT03339583|590073895|FG000|Follow-up (14 Days)|Physician Decision|6|||
163372781|NCT03339583|590073896|FG001|Follow-up (14 Days)|Physician Decision|3|||
163372782|NCT02141620|590073897|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
163372783|NCT02141620|590073898|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
163372784|NCT03651622|590073899|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
163372785|NCT03651622|590073900|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
163372786|NCT03651622|590073901|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
163372787|NCT03651622|590073899|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
163372788|NCT03651622|590073900|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
163372789|NCT03651622|590073901|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
163372790|NCT03651622|590073899|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
163372791|NCT03651622|590073900|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
163414007|NCT03529773|590223014|FG002|Overall Study|Physician Decision|0|||
163414008|NCT03529773|590223015|FG003|Overall Study|Physician Decision|0|||
163414009|NCT03529773|590223016|FG004|Overall Study|Physician Decision|0|||
163414010|NCT03529773|590223017|FG005|Overall Study|Physician Decision|0|||
163414011|NCT03529773|590223018|FG006|Overall Study|Physician Decision|0|||
163414012|NCT03529773|590223019|FG007|Overall Study|Physician Decision|0|||
163414013|NCT03529773|590223020|FG008|Overall Study|Physician Decision|0|||
163414014|NCT03529773|590223021|FG009|Overall Study|Physician Decision|0|||
163414015|NCT03529773|590223022|FG010|Overall Study|Physician Decision|0|||
163414016|NCT03529773|590223023|FG011|Overall Study|Physician Decision|0|||
163414017|NCT03529773|590223024|FG012|Overall Study|Physician Decision|0|||
163414018|NCT03529773|590223025|FG013|Overall Study|Physician Decision|0|||
163414019|NCT03529773|590223026|FG014|Overall Study|Physician Decision|0|||
163414020|NCT03529773|590223027|FG015|Overall Study|Physician Decision|0|||
163414021|NCT03529773|590223028|FG016|Overall Study|Physician Decision|0|||
163414022|NCT03529773|590223029|FG017|Overall Study|Physician Decision|0|||
163414023|NCT03529773|590223030|FG018|Overall Study|Physician Decision|0|||
163414024|NCT03529773|590223031|FG019|Overall Study|Physician Decision|1|||
163414025|NCT03529773|590223032|FG020|Overall Study|Physician Decision|1|||
163414026|NCT03529773|590223033|FG021|Overall Study|Physician Decision|0|||
163414027|NCT03529773|590223034|FG022|Overall Study|Physician Decision|0|||
163414028|NCT03529773|590223035|FG023|Overall Study|Physician Decision|0|||
163414029|NCT03529773|590223036|FG024|Overall Study|Physician Decision|0|||
163414030|NCT03529773|590223037|FG025|Overall Study|Physician Decision|0|||
163414031|NCT03529773|590223038|FG026|Overall Study|Physician Decision|0|||
163414032|NCT03529773|590223039|FG027|Overall Study|Physician Decision|0|||
163414033|NCT03529773|590223040|FG028|Overall Study|Physician Decision|0|||
163414034|NCT03529773|590223041|FG029|Overall Study|Physician Decision|0|||
163414035|NCT03529773|590223042|FG030|Overall Study|Physician Decision|0|||
163414036|NCT03529773|590223043|FG031|Overall Study|Physician Decision|0|||
163414037|NCT03529773|590223044|FG032|Overall Study|Physician Decision|0|||
163414038|NCT03529773|590223045|FG033|Overall Study|Physician Decision|0|||
163414039|NCT03529773|590223046|FG034|Overall Study|Physician Decision|0|||
163414040|NCT03529773|590223047|FG035|Overall Study|Physician Decision|0|||
163414041|NCT03529773|590223048|FG036|Overall Study|Physician Decision|0|||
163414042|NCT03529773|590223049|FG037|Overall Study|Physician Decision|0|||
163372792|NCT03651622|590073901|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
163372793|NCT03651622|590073899|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
163372794|NCT03651622|590073900|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
163372795|NCT03651622|590073901|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
163372796|NCT03651622|590073899|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
163372797|NCT03651622|590073900|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
163372798|NCT03651622|590073901|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
163414043|NCT03529773|590223050|FG038|Overall Study|Physician Decision|0|||
163414044|NCT03529773|590223051|FG039|Overall Study|Physician Decision|0|||
163414045|NCT03529773|590223012|FG000|Overall Study|Protocol Violation|0|||
163414046|NCT03529773|590223013|FG001|Overall Study|Protocol Violation|0|||
163414047|NCT03529773|590223014|FG002|Overall Study|Protocol Violation|0|||
163414048|NCT03529773|590223015|FG003|Overall Study|Protocol Violation|0|||
163414049|NCT03529773|590223016|FG004|Overall Study|Protocol Violation|0|||
163414050|NCT03529773|590223017|FG005|Overall Study|Protocol Violation|0|||
163414051|NCT03529773|590223018|FG006|Overall Study|Protocol Violation|0|||
163414052|NCT03529773|590223019|FG007|Overall Study|Protocol Violation|0|||
163372799|NCT01519089|590073902|FG000|Overall Study|Adverse Event|4|||
163372800|NCT01519089|590073903|FG001|Overall Study|Adverse Event|4|||
163372801|NCT01519089|590073902|FG000|Overall Study|Lack of Efficacy|0|||
163372802|NCT01519089|590073903|FG001|Overall Study|Lack of Efficacy|2|||
163372803|NCT01519089|590073902|FG000|Overall Study|Lost to Follow-up|1|||
163372804|NCT01519089|590073903|FG001|Overall Study|Lost to Follow-up|0|||
163372805|NCT01519089|590073902|FG000|Overall Study|Withdrawal by Subject|0|||
163372806|NCT01519089|590073903|FG001|Overall Study|Withdrawal by Subject|2|||
163372807|NCT01519089|590073902|FG000|Overall Study|Other|2|||
163372808|NCT01519089|590073903|FG001|Overall Study|Other|6|||
163372809|NCT01519089|590073902|FG000|Overall Study|Not received study drug|0|||
163372810|NCT01519089|590073903|FG001|Overall Study|Not received study drug|1|||
163372811|NCT00307684|590073904|FG000|Open Label Phase|Lack of Efficacy|0|||
163372812|NCT00307684|590073905|FG001|Open Label Phase|Lack of Efficacy|0|||
163372813|NCT00307684|590073906|FG002|Open Label Phase|Lack of Efficacy|3|||
163372814|NCT00307684|590073904|FG000|Open Label Phase|Adverse Event|0|||
163372815|NCT00307684|590073905|FG001|Open Label Phase|Adverse Event|0|||
163372816|NCT00307684|590073906|FG002|Open Label Phase|Adverse Event|16|||
163372817|NCT00307684|590073904|FG000|Open Label Phase|Withdrawal by Subject|0|||
163372818|NCT00307684|590073905|FG001|Open Label Phase|Withdrawal by Subject|0|||
163372819|NCT00307684|590073906|FG002|Open Label Phase|Withdrawal by Subject|15|||
163372820|NCT00307684|590073904|FG000|Open Label Phase|Lost to Follow-up|0|||
163372821|NCT00307684|590073905|FG001|Open Label Phase|Lost to Follow-up|0|||
163372822|NCT00307684|590073906|FG002|Open Label Phase|Lost to Follow-up|11|||
163372823|NCT00307684|590073904|FG000|Open Label Phase|non compliance|0|||
163372824|NCT00307684|590073905|FG001|Open Label Phase|non compliance|0|||
163372825|NCT00307684|590073906|FG002|Open Label Phase|non compliance|5|||
163372826|NCT00307684|590073904|FG000|Open Label Phase|other|0|||
163372827|NCT00307684|590073905|FG001|Open Label Phase|other|0|||
163372828|NCT00307684|590073906|FG002|Open Label Phase|other|6|||
163372829|NCT00307684|590073904|FG000|Double Blind Phase|Lack of Efficacy|2|||
163372830|NCT00307684|590073905|FG001|Double Blind Phase|Lack of Efficacy|5|||
163372831|NCT00307684|590073906|FG002|Double Blind Phase|Lack of Efficacy|0|||
163372832|NCT00730275|590073907|FG000|Overall Study|Withdrawal by Subject|0|||
163372833|NCT00730275|590073908|FG001|Overall Study|Withdrawal by Subject|0|||
163372834|NCT00730275|590073909|FG002|Overall Study|Withdrawal by Subject|0|||
163372835|NCT00730275|590073910|FG003|Overall Study|Withdrawal by Subject|1|||
163372836|NCT00356408|590073911|FG000|Overall Study|Adverse Event|9|||
163372837|NCT00356408|590073911|FG000|Overall Study|Lack of Efficacy|36|||
163372838|NCT00356408|590073911|FG000|Overall Study|Lost to Follow-up|2|||
163372839|NCT00356408|590073911|FG000|Overall Study|Withdrawal by Subject|6|||
163372840|NCT00356408|590073911|FG000|Overall Study|Other: Principal investigator discretion|3|||
163372841|NCT00356408|590073911|FG000|Overall Study|Other: Sponsor request|1|||
163372842|NCT00356408|590073911|FG000|Overall Study|Other: Azathioprine stopped|1|||
163372843|NCT00356408|590073911|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
163372844|NCT00356408|590073911|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
163372845|NCT05487586|590073916|FG000|Overall Study|Death|22|||
163372846|NCT05487586|590073916|FG000|Overall Study|Physician Decision|1|||
163372847|NCT05487586|590073916|FG000|Overall Study|Transfer to another hospital|4|||
163372848|NCT05487586|590073916|FG000|Overall Study|Other|1|||
163372849|NCT01744392|590073918|FG000|Overall Study|Physician Decision|1|||
163372850|NCT00299494|590073921|FG000|Overall Study|Withdrawal by Subject|0|||
163372851|NCT00299494|590073922|FG001|Overall Study|Withdrawal by Subject|0|||
163372852|NCT00299494|590073923|FG002|Overall Study|Withdrawal by Subject|0|||
163372853|NCT00299494|590073924|FG003|Overall Study|Withdrawal by Subject|3|||
163372854|NCT00299494|590073925|FG004|Overall Study|Withdrawal by Subject|1|||
163372855|NCT00299494|590073926|FG005|Overall Study|Withdrawal by Subject|4|||
163372856|NCT00299494|590073921|FG000|Overall Study|Physician Decision|0|||
163372857|NCT00299494|590073922|FG001|Overall Study|Physician Decision|0|||
163372858|NCT00299494|590073923|FG002|Overall Study|Physician Decision|0|||
163372859|NCT00299494|590073924|FG003|Overall Study|Physician Decision|0|||
163372860|NCT00299494|590073925|FG004|Overall Study|Physician Decision|1|||
163372861|NCT00299494|590073926|FG005|Overall Study|Physician Decision|0|||
163372862|NCT00299494|590073921|FG000|Overall Study|Death|3|||
163372863|NCT00299494|590073922|FG001|Overall Study|Death|1|||
163372864|NCT00299494|590073923|FG002|Overall Study|Death|4|||
163372865|NCT00299494|590073924|FG003|Overall Study|Death|6|||
163372866|NCT00299494|590073925|FG004|Overall Study|Death|18|||
163372867|NCT00299494|590073926|FG005|Overall Study|Death|19|||
163372868|NCT00299494|590073921|FG000|Overall Study|Lost to Follow-up|0|||
163372869|NCT00299494|590073922|FG001|Overall Study|Lost to Follow-up|0|||
163372870|NCT00299494|590073923|FG002|Overall Study|Lost to Follow-up|0|||
163372871|NCT00299494|590073924|FG003|Overall Study|Lost to Follow-up|0|||
163372872|NCT00299494|590073925|FG004|Overall Study|Lost to Follow-up|3|||
163372873|NCT00299494|590073926|FG005|Overall Study|Lost to Follow-up|1|||
163372874|NCT00299494|590073921|FG000|Overall Study|Other - Unspecified|0|||
163372875|NCT00299494|590073922|FG001|Overall Study|Other - Unspecified|0|||
163372876|NCT00299494|590073923|FG002|Overall Study|Other - Unspecified|0|||
163372877|NCT00299494|590073924|FG003|Overall Study|Other - Unspecified|0|||
163414053|NCT03529773|590223020|FG008|Overall Study|Protocol Violation|0|||
163414054|NCT03529773|590223021|FG009|Overall Study|Protocol Violation|0|||
163414055|NCT03529773|590223022|FG010|Overall Study|Protocol Violation|0|||
163414056|NCT03529773|590223023|FG011|Overall Study|Protocol Violation|0|||
163414057|NCT03529773|590223024|FG012|Overall Study|Protocol Violation|0|||
163414058|NCT03529773|590223025|FG013|Overall Study|Protocol Violation|0|||
163372878|NCT00299494|590073925|FG004|Overall Study|Other - Unspecified|3|||
163372879|NCT00299494|590073926|FG005|Overall Study|Other - Unspecified|1|||
163372880|NCT00299494|590073921|FG000|Overall Study|Other - site closure|0|||
163372881|NCT00299494|590073922|FG001|Overall Study|Other - site closure|0|||
163372882|NCT00299494|590073923|FG002|Overall Study|Other - site closure|0|||
163372883|NCT00299494|590073924|FG003|Overall Study|Other - site closure|1|||
163372884|NCT00299494|590073925|FG004|Overall Study|Other - site closure|1|||
163372885|NCT00299494|590073926|FG005|Overall Study|Other - site closure|1|||
163414059|NCT03529773|590223026|FG014|Overall Study|Protocol Violation|0|||
163414060|NCT03529773|590223027|FG015|Overall Study|Protocol Violation|0|||
163414061|NCT03529773|590223028|FG016|Overall Study|Protocol Violation|0|||
163414062|NCT03529773|590223029|FG017|Overall Study|Protocol Violation|0|||
163414063|NCT03529773|590223030|FG018|Overall Study|Protocol Violation|0|||
163414064|NCT03529773|590223031|FG019|Overall Study|Protocol Violation|0|||
163414065|NCT03529773|590223032|FG020|Overall Study|Protocol Violation|0|||
163414066|NCT03529773|590223033|FG021|Overall Study|Protocol Violation|0|||
163414067|NCT03529773|590223034|FG022|Overall Study|Protocol Violation|0|||
163414068|NCT03529773|590223035|FG023|Overall Study|Protocol Violation|0|||
163414069|NCT03529773|590223036|FG024|Overall Study|Protocol Violation|0|||
163414070|NCT03529773|590223037|FG025|Overall Study|Protocol Violation|0|||
163414071|NCT03529773|590223038|FG026|Overall Study|Protocol Violation|0|||
163414072|NCT03529773|590223039|FG027|Overall Study|Protocol Violation|0|||
163414073|NCT03529773|590223040|FG028|Overall Study|Protocol Violation|0|||
163414074|NCT03529773|590223041|FG029|Overall Study|Protocol Violation|0|||
163414075|NCT03529773|590223042|FG030|Overall Study|Protocol Violation|1|||
163414076|NCT03529773|590223043|FG031|Overall Study|Protocol Violation|0|||
163414077|NCT03529773|590223044|FG032|Overall Study|Protocol Violation|0|||
163414078|NCT03529773|590223045|FG033|Overall Study|Protocol Violation|0|||
163414079|NCT03529773|590223046|FG034|Overall Study|Protocol Violation|0|||
163414080|NCT03529773|590223047|FG035|Overall Study|Protocol Violation|0|||
163414081|NCT03529773|590223048|FG036|Overall Study|Protocol Violation|0|||
163414082|NCT03529773|590223049|FG037|Overall Study|Protocol Violation|0|||
163414083|NCT03529773|590223050|FG038|Overall Study|Protocol Violation|0|||
163414084|NCT03529773|590223051|FG039|Overall Study|Protocol Violation|0|||
163414085|NCT03529773|590223012|FG000|Overall Study|Withdrawal by Subject|0|||
163414086|NCT03529773|590223013|FG001|Overall Study|Withdrawal by Subject|0|||
163414087|NCT03529773|590223014|FG002|Overall Study|Withdrawal by Subject|0|||
163414088|NCT03529773|590223015|FG003|Overall Study|Withdrawal by Subject|0|||
163414089|NCT03529773|590223016|FG004|Overall Study|Withdrawal by Subject|0|||
163414090|NCT03529773|590223017|FG005|Overall Study|Withdrawal by Subject|0|||
163414091|NCT03529773|590223018|FG006|Overall Study|Withdrawal by Subject|0|||
163414092|NCT03529773|590223019|FG007|Overall Study|Withdrawal by Subject|1|||
163414093|NCT03529773|590223020|FG008|Overall Study|Withdrawal by Subject|0|||
163414094|NCT03529773|590223021|FG009|Overall Study|Withdrawal by Subject|1|||
163414095|NCT03529773|590223022|FG010|Overall Study|Withdrawal by Subject|1|||
163414096|NCT03529773|590223023|FG011|Overall Study|Withdrawal by Subject|0|||
163414097|NCT03529773|590223024|FG012|Overall Study|Withdrawal by Subject|0|||
163414098|NCT03529773|590223025|FG013|Overall Study|Withdrawal by Subject|0|||
163414099|NCT03529773|590223026|FG014|Overall Study|Withdrawal by Subject|0|||
163414100|NCT03529773|590223027|FG015|Overall Study|Withdrawal by Subject|3|||
163414101|NCT03529773|590223028|FG016|Overall Study|Withdrawal by Subject|0|||
163414102|NCT03529773|590223029|FG017|Overall Study|Withdrawal by Subject|2|||
163414103|NCT03529773|590223030|FG018|Overall Study|Withdrawal by Subject|3|||
163414104|NCT03529773|590223031|FG019|Overall Study|Withdrawal by Subject|1|||
163414105|NCT03529773|590223032|FG020|Overall Study|Withdrawal by Subject|3|||
163414106|NCT03529773|590223033|FG021|Overall Study|Withdrawal by Subject|1|||
163372886|NCT01417104|590073930|FG000|Overall Study|Withdrawal by Subject|5|||
163372887|NCT01417104|590073931|FG001|Overall Study|Withdrawal by Subject|1|||
163372888|NCT01417104|590073930|FG000|Overall Study|Failure to make contact|0|||
163414107|NCT03529773|590223034|FG022|Overall Study|Withdrawal by Subject|1|||
163414108|NCT03529773|590223035|FG023|Overall Study|Withdrawal by Subject|2|||
163414109|NCT03529773|590223036|FG024|Overall Study|Withdrawal by Subject|2|||
163414110|NCT03529773|590223037|FG025|Overall Study|Withdrawal by Subject|4|||
163414111|NCT03529773|590223038|FG026|Overall Study|Withdrawal by Subject|2|||
163414112|NCT03529773|590223039|FG027|Overall Study|Withdrawal by Subject|1|||
163414113|NCT03529773|590223040|FG028|Overall Study|Withdrawal by Subject|1|||
163414114|NCT03529773|590223041|FG029|Overall Study|Withdrawal by Subject|0|||
163414115|NCT03529773|590223042|FG030|Overall Study|Withdrawal by Subject|0|||
163414116|NCT03529773|590223043|FG031|Overall Study|Withdrawal by Subject|0|||
163414117|NCT03529773|590223044|FG032|Overall Study|Withdrawal by Subject|0|||
163414118|NCT03529773|590223045|FG033|Overall Study|Withdrawal by Subject|0|||
163414119|NCT03529773|590223046|FG034|Overall Study|Withdrawal by Subject|1|||
163372889|NCT01417104|590073931|FG001|Overall Study|Failure to make contact|1|||
163372890|NCT01417104|590073930|FG000|Overall Study|Adverse Event|1|||
163372891|NCT01417104|590073931|FG001|Overall Study|Adverse Event|0|||
163372892|NCT03223662|590073932|FG000|Overall Study|Physician Decision|1|||
163372893|NCT03223662|590073932|FG000|Overall Study|Study closure|1|||
163372894|NCT00528931|590073933|FG000|Overall Study|Lost to Follow-up|1|||
163372895|NCT00992225|590073934|FG000|Overall Study|Entry Criteria Not Met|8|||
163372896|NCT00992225|590073934|FG000|Overall Study|Adverse Event|2|||
163372897|NCT03122223|590073935|FG000|Overall Study|Withdrawal by Subject|2|||
163372898|NCT03122223|590073936|FG001|Overall Study|Withdrawal by Subject|2|||
163372899|NCT03122223|590073937|FG002|Overall Study|Withdrawal by Subject|1|||
163372900|NCT03122223|590073938|FG003|Overall Study|Withdrawal by Subject|0|||
163372901|NCT03122223|590073935|FG000|Overall Study|Lost to Follow-up|0|||
163372902|NCT03122223|590073936|FG001|Overall Study|Lost to Follow-up|2|||
163372903|NCT03122223|590073937|FG002|Overall Study|Lost to Follow-up|2|||
163372904|NCT03122223|590073938|FG003|Overall Study|Lost to Follow-up|0|||
163372905|NCT03122223|590073935|FG000|Overall Study|Participant unable to adhere|1|||
163372906|NCT03122223|590073936|FG001|Overall Study|Participant unable to adhere|1|||
163372907|NCT03122223|590073937|FG002|Overall Study|Participant unable to adhere|1|||
163372908|NCT03122223|590073938|FG003|Overall Study|Participant unable to adhere|0|||
163372909|NCT03466073|590073939|FG000|Overall Study|Death|1|||
163372910|NCT03466073|590073940|FG001|Overall Study|Death|0|||
163372911|NCT03466073|590073941|FG002|Overall Study|Death|0|||
163372912|NCT03466073|590073942|FG003|Overall Study|Death|0|||
163372913|NCT03466073|590073943|FG004|Overall Study|Death|0|||
163372914|NCT03466073|590073944|FG005|Overall Study|Death|1|||
163372915|NCT02285153|590073945|FG000|Overall Study|Adverse Event|1|||
163372916|NCT02285153|590073946|FG001|Overall Study|Adverse Event|0|||
163372917|NCT01489891|590073948|FG000|Overall Study|Endoscopy failure|1|||
163372918|NCT01489891|590073949|FG001|Overall Study|Endoscopy failure|0|||
163372919|NCT00532493|590073950|FG000|Overall Study|Death|1|||
163372920|NCT00532493|590073951|FG001|Overall Study|Death|1|||
163372921|NCT00532493|590073950|FG000|Overall Study|Lost to Follow-up|10|||
163372922|NCT00532493|590073951|FG001|Overall Study|Lost to Follow-up|7|||
163372923|NCT00532493|590073950|FG000|Overall Study|Withdrawal by Subject|7|||
163372924|NCT00532493|590073951|FG001|Overall Study|Withdrawal by Subject|9|||
163372925|NCT00532493|590073950|FG000|Overall Study|Physician Decision|1|||
163372926|NCT00532493|590073951|FG001|Overall Study|Physician Decision|6|||
163372927|NCT00532493|590073950|FG000|Overall Study|Adverse Event|6|||
163372928|NCT00532493|590073951|FG001|Overall Study|Adverse Event|5|||
163372929|NCT00532493|590073950|FG000|Overall Study|Protocol Deviation|1|||
163372930|NCT00532493|590073951|FG001|Overall Study|Protocol Deviation|0|||
163372931|NCT00532493|590073950|FG000|Overall Study|Subject Moved Away|3|||
163372932|NCT00532493|590073951|FG001|Overall Study|Subject Moved Away|1|||
163372933|NCT00532493|590073950|FG000|Overall Study|Contraindicative Medication|1|||
163372934|NCT00532493|590073951|FG001|Overall Study|Contraindicative Medication|0|||
163372935|NCT02045875|590073955|FG000|Overall Study|Lost to Follow-up|3|||
163372936|NCT02045875|590073956|FG001|Overall Study|Lost to Follow-up|0|||
163372937|NCT02045875|590073955|FG000|Overall Study|Withdrawal by Subject|4|||
163372938|NCT02045875|590073956|FG001|Overall Study|Withdrawal by Subject|3|||
163372939|NCT00948766|590073957|FG000|Core Study|Adverse Event|73|||
163372940|NCT00948766|590073958|FG001|Core Study|Adverse Event|51|||
163372941|NCT00948766|590073957|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
163372942|NCT00948766|590073958|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
163372943|NCT00948766|590073957|FG000|Core Study|Patient Withdrew Consent|27|||
163372944|NCT00948766|590073958|FG001|Core Study|Patient Withdrew Consent|46|||
163372945|NCT00948766|590073957|FG000|Core Study|Lost to Follow-up|3|||
163372946|NCT00948766|590073958|FG001|Core Study|Lost to Follow-up|2|||
163372947|NCT00948766|590073957|FG000|Core Study|Administrative Problems|2|||
163372948|NCT00948766|590073958|FG001|Core Study|Administrative Problems|2|||
163372949|NCT00948766|590073957|FG000|Core Study|Death|1|||
163372950|NCT00948766|590073958|FG001|Core Study|Death|1|||
163372951|NCT00948766|590073957|FG000|Core Study|Protocol Deviation|8|||
163372952|NCT00948766|590073958|FG001|Core Study|Protocol Deviation|10|||
163372953|NCT00948766|590073957|FG000|Extension Study|Adverse Event|43|||
163372954|NCT00948766|590073958|FG001|Extension Study|Adverse Event|0|||
163372955|NCT00948766|590073957|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
163372956|NCT00948766|590073958|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
163372957|NCT00948766|590073957|FG000|Extension Study|Study Drug No Longer Required|1|||
163372958|NCT00948766|590073958|FG001|Extension Study|Study Drug No Longer Required|0|||
163372959|NCT00948766|590073957|FG000|Extension Study|Patient Withdrew Consent|32|||
163372960|NCT00948766|590073958|FG001|Extension Study|Patient Withdrew Consent|0|||
163372961|NCT00948766|590073957|FG000|Extension Study|Lost to Follow-up|8|||
163372962|NCT00948766|590073958|FG001|Extension Study|Lost to Follow-up|0|||
163372963|NCT00948766|590073957|FG000|Extension Study|Administrative Problems|1|||
163372964|NCT00948766|590073958|FG001|Extension Study|Administrative Problems|0|||
163372965|NCT00948766|590073957|FG000|Extension Study|Death|4|||
163372966|NCT00948766|590073958|FG001|Extension Study|Death|0|||
163372967|NCT03459443|590073961|FG000|Overall Study|Lack of Efficacy|3|||
163372968|NCT03459443|590073961|FG000|Overall Study|Adverse Event|1|||
163372969|NCT03459443|590073961|FG000|Overall Study|Sponsor's decision to close the study|18|||
163372970|NCT02153073|590073962|FG000|Overall Study|Case Report Forms Uncollected|230|||
163372971|NCT02153073|590073962|FG000|Overall Study|Protocol Deviation|68|||
163372972|NCT03702231|590073963|FG000|Overall Study|Withdrawal by Subject|1|||
163372973|NCT03702231|590073964|FG001|Overall Study|Withdrawal by Subject|0|||
163372974|NCT03702231|590073965|FG002|Overall Study|Withdrawal by Subject|0|||
163372975|NCT03702231|590073963|FG000|Overall Study|Protocol Violation|0|||
163372976|NCT03702231|590073964|FG001|Overall Study|Protocol Violation|0|||
163372977|NCT03702231|590073965|FG002|Overall Study|Protocol Violation|1|||
163372978|NCT03702231|590073963|FG000|Overall Study|Change in CLL Treatment|0|||
163372979|NCT03702231|590073964|FG001|Overall Study|Change in CLL Treatment|0|||
163372980|NCT03702231|590073965|FG002|Overall Study|Change in CLL Treatment|1|||
163372981|NCT03702231|590073963|FG000|Overall Study|COVID Pandemic|1|||
163372982|NCT03702231|590073964|FG001|Overall Study|COVID Pandemic|4|||
163372983|NCT03702231|590073965|FG002|Overall Study|COVID Pandemic|1|||
163372984|NCT03702231|590073963|FG000|Overall Study|Non-compliance|0|||
163372985|NCT03702231|590073964|FG001|Overall Study|Non-compliance|0|||
163372986|NCT03702231|590073965|FG002|Overall Study|Non-compliance|1|||
163372987|NCT01278173|590073966|FG000|Overall Study|Lack of Efficacy|13|||
163372988|NCT01278173|590073966|FG000|Overall Study|Adverse Event|8|||
163372989|NCT01278173|590073966|FG000|Overall Study|Administrative or other reason|4|||
163372990|NCT01278173|590073966|FG000|Overall Study|Protocol Violation|1|||
163372991|NCT01278173|590073966|FG000|Overall Study|Withdrawal by Subject|1|||
163372992|NCT02270515|590073967|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
163372993|NCT02270515|590073967|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
163372994|NCT02270515|590073967|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
163372995|NCT02270515|590073967|FG000|Intervention Period 1: 0-6 Months|Death|7|||
163372996|NCT02270515|590073967|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
163414120|NCT03529773|590223047|FG035|Overall Study|Withdrawal by Subject|2|||
163414121|NCT03529773|590223048|FG036|Overall Study|Withdrawal by Subject|0|||
163414122|NCT03529773|590223049|FG037|Overall Study|Withdrawal by Subject|2|||
163414123|NCT03529773|590223050|FG038|Overall Study|Withdrawal by Subject|1|||
163414124|NCT03529773|590223051|FG039|Overall Study|Withdrawal by Subject|1|||
163414125|NCT03529773|590223012|FG000|Overall Study|Screen Failure|0|||
163414126|NCT03529773|590223013|FG001|Overall Study|Screen Failure|0|||
163414127|NCT03529773|590223014|FG002|Overall Study|Screen Failure|0|||
163414128|NCT03529773|590223015|FG003|Overall Study|Screen Failure|0|||
163414129|NCT03529773|590223016|FG004|Overall Study|Screen Failure|0|||
163414130|NCT03529773|590223017|FG005|Overall Study|Screen Failure|0|||
163414131|NCT03529773|590223018|FG006|Overall Study|Screen Failure|0|||
163414132|NCT03529773|590223019|FG007|Overall Study|Screen Failure|0|||
163414133|NCT03529773|590223020|FG008|Overall Study|Screen Failure|0|||
163414134|NCT03529773|590223021|FG009|Overall Study|Screen Failure|0|||
163414135|NCT03529773|590223022|FG010|Overall Study|Screen Failure|0|||
163414136|NCT03529773|590223023|FG011|Overall Study|Screen Failure|0|||
163414137|NCT03529773|590223024|FG012|Overall Study|Screen Failure|0|||
163414138|NCT03529773|590223025|FG013|Overall Study|Screen Failure|0|||
163414139|NCT03529773|590223026|FG014|Overall Study|Screen Failure|0|||
163414140|NCT03529773|590223027|FG015|Overall Study|Screen Failure|0|||
163414141|NCT03529773|590223028|FG016|Overall Study|Screen Failure|0|||
163414142|NCT03529773|590223029|FG017|Overall Study|Screen Failure|0|||
163414143|NCT03529773|590223030|FG018|Overall Study|Screen Failure|0|||
163414144|NCT03529773|590223031|FG019|Overall Study|Screen Failure|0|||
163414145|NCT03529773|590223032|FG020|Overall Study|Screen Failure|0|||
163414146|NCT03529773|590223033|FG021|Overall Study|Screen Failure|0|||
163414147|NCT03529773|590223034|FG022|Overall Study|Screen Failure|0|||
163414148|NCT03529773|590223035|FG023|Overall Study|Screen Failure|0|||
163414149|NCT03529773|590223036|FG024|Overall Study|Screen Failure|0|||
163414150|NCT03529773|590223037|FG025|Overall Study|Screen Failure|0|||
163414151|NCT03529773|590223038|FG026|Overall Study|Screen Failure|0|||
163414152|NCT03529773|590223039|FG027|Overall Study|Screen Failure|0|||
163414153|NCT03529773|590223040|FG028|Overall Study|Screen Failure|0|||
163414154|NCT03529773|590223041|FG029|Overall Study|Screen Failure|0|||
163414155|NCT03529773|590223042|FG030|Overall Study|Screen Failure|0|||
163414156|NCT03529773|590223043|FG031|Overall Study|Screen Failure|0|||
163414157|NCT03529773|590223044|FG032|Overall Study|Screen Failure|0|||
163414158|NCT03529773|590223045|FG033|Overall Study|Screen Failure|0|||
163372997|NCT02270515|590073967|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
163372998|NCT02270515|590073967|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
163372999|NCT02270515|590073967|FG000|Intervention Period 2: 6-12 Months|Death|5|||
163373000|NCT02270515|590073967|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
163414159|NCT03529773|590223046|FG034|Overall Study|Screen Failure|0|||
163414160|NCT03529773|590223047|FG035|Overall Study|Screen Failure|0|||
163414161|NCT03529773|590223048|FG036|Overall Study|Screen Failure|1|||
163414162|NCT03529773|590223049|FG037|Overall Study|Screen Failure|1|||
163414163|NCT03529773|590223050|FG038|Overall Study|Screen Failure|0|||
163373001|NCT02270515|590073967|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
163373002|NCT02270515|590073967|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
163373003|NCT02270515|590073967|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
163373004|NCT02270515|590073967|FG000|Intervention Period 3: 12-18 Months|Death|3|||
163373005|NCT02270515|590073967|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
163373006|NCT01607476|590073970|FG000|Overall Study|Withdrawal by Subject|1|||
163373007|NCT01607476|590073971|FG001|Overall Study|Withdrawal by Subject|0|||
163373008|NCT01607476|590073972|FG002|Overall Study|Withdrawal by Subject|1|||
163373009|NCT01607476|590073970|FG000|Overall Study|Lost to Follow-up|0|||
163373010|NCT01607476|590073971|FG001|Overall Study|Lost to Follow-up|0|||
163373011|NCT01607476|590073972|FG002|Overall Study|Lost to Follow-up|2|||
163373012|NCT04445987|590073973|FG000|Overall Study|Adverse Event|0|||
163373013|NCT04445987|590073974|FG001|Overall Study|Adverse Event|0|||
163373014|NCT04445987|590073975|FG002|Overall Study|Adverse Event|1|||
163373015|NCT04445987|590073976|FG003|Overall Study|Adverse Event|0|||
163373016|NCT04445987|590073977|FG004|Overall Study|Adverse Event|4|||
163373017|NCT04445987|590073978|FG005|Overall Study|Adverse Event|0|||
163373018|NCT04445987|590073973|FG000|Overall Study|Lost to Follow-up|4|||
163373019|NCT04445987|590073974|FG001|Overall Study|Lost to Follow-up|3|||
163373020|NCT04445987|590073975|FG002|Overall Study|Lost to Follow-up|1|||
163373021|NCT04445987|590073976|FG003|Overall Study|Lost to Follow-up|1|||
163373022|NCT04445987|590073977|FG004|Overall Study|Lost to Follow-up|29|||
163373023|NCT04445987|590073978|FG005|Overall Study|Lost to Follow-up|0|||
163373024|NCT04445987|590073973|FG000|Overall Study|Physician Decision|0|||
163373025|NCT04445987|590073974|FG001|Overall Study|Physician Decision|0|||
163373026|NCT04445987|590073975|FG002|Overall Study|Physician Decision|0|||
163373027|NCT04445987|590073976|FG003|Overall Study|Physician Decision|0|||
163373028|NCT04445987|590073977|FG004|Overall Study|Physician Decision|1|||
163373029|NCT04445987|590073978|FG005|Overall Study|Physician Decision|0|||
163373030|NCT04445987|590073973|FG000|Overall Study|Protocol Violation|1|||
163373031|NCT04445987|590073974|FG001|Overall Study|Protocol Violation|0|||
163373032|NCT04445987|590073975|FG002|Overall Study|Protocol Violation|0|||
163373033|NCT04445987|590073976|FG003|Overall Study|Protocol Violation|0|||
163373034|NCT04445987|590073977|FG004|Overall Study|Protocol Violation|2|||
163373035|NCT04445987|590073978|FG005|Overall Study|Protocol Violation|0|||
163373036|NCT04445987|590073973|FG000|Overall Study|Withdrawal by Subject|4|||
163373037|NCT04445987|590073974|FG001|Overall Study|Withdrawal by Subject|0|||
163373038|NCT04445987|590073975|FG002|Overall Study|Withdrawal by Subject|1|||
163373039|NCT04445987|590073976|FG003|Overall Study|Withdrawal by Subject|0|||
163373040|NCT04445987|590073977|FG004|Overall Study|Withdrawal by Subject|18|||
163373041|NCT04445987|590073978|FG005|Overall Study|Withdrawal by Subject|1|||
163373042|NCT04445987|590073973|FG000|Overall Study|Other reason|0|||
163373043|NCT04445987|590073974|FG001|Overall Study|Other reason|0|||
163373044|NCT04445987|590073975|FG002|Overall Study|Other reason|1|||
163373045|NCT04445987|590073976|FG003|Overall Study|Other reason|0|||
163373046|NCT04445987|590073977|FG004|Overall Study|Other reason|2|||
163373047|NCT04445987|590073978|FG005|Overall Study|Other reason|0|||
163373048|NCT02091206|590073979|FG000|Treatment Period|Adverse Event|0|||
163373049|NCT02091206|590073980|FG001|Treatment Period|Adverse Event|1|||
163373050|NCT02091206|590073981|FG002|Treatment Period|Adverse Event|0|||
163373051|NCT02091206|590073982|FG003|Treatment Period|Adverse Event|0|||
163373052|NCT02091206|590073979|FG000|Treatment Period|Met withdrawal criteria|0|||
163373053|NCT02091206|590073980|FG001|Treatment Period|Met withdrawal criteria|0|||
163373054|NCT02091206|590073981|FG002|Treatment Period|Met withdrawal criteria|1|||
163373055|NCT02091206|590073982|FG003|Treatment Period|Met withdrawal criteria|0|||
163373056|NCT02091206|590073979|FG000|Taper Period|Participant refused study drug|1|||
163373057|NCT02091206|590073980|FG001|Taper Period|Participant refused study drug|0|||
163373058|NCT02091206|590073981|FG002|Taper Period|Participant refused study drug|0|||
163373059|NCT02091206|590073982|FG003|Taper Period|Participant refused study drug|1|||
163373060|NCT02091206|590073979|FG000|Taper Period|Lost to Follow-up|0|||
163373061|NCT02091206|590073980|FG001|Taper Period|Lost to Follow-up|0|||
163373062|NCT02091206|590073981|FG002|Taper Period|Lost to Follow-up|0|||
163373063|NCT02091206|590073982|FG003|Taper Period|Lost to Follow-up|1|||
163373064|NCT03772587|590073988|FG000|Overall Study|COVID-19|0|||
163414164|NCT03529773|590223051|FG039|Overall Study|Screen Failure|1|||
163414165|NCT03529773|590223012|FG000|Overall Study|Randomized but not vaccinated|0|||
163373065|NCT03772587|590073989|FG001|Overall Study|COVID-19|0|||
163373066|NCT03772587|590073990|FG002|Overall Study|COVID-19|1|||
163373067|NCT03772587|590073991|FG003|Overall Study|COVID-19|1|||
163373068|NCT03772587|590073992|FG004|Overall Study|COVID-19|0|||
163373069|NCT03772587|590073988|FG000|Overall Study|Withdrawal by Subject|1|||
163373070|NCT03772587|590073989|FG001|Overall Study|Withdrawal by Subject|0|||
163373071|NCT03772587|590073990|FG002|Overall Study|Withdrawal by Subject|0|||
163373072|NCT03772587|590073991|FG003|Overall Study|Withdrawal by Subject|0|||
163373073|NCT03772587|590073992|FG004|Overall Study|Withdrawal by Subject|0|||
163373074|NCT02297139|590073993|FG000|Overall Study|Disease progression|0|||
163373075|NCT02297139|590073994|FG001|Overall Study|Disease progression|1|||
163414166|NCT03529773|590223013|FG001|Overall Study|Randomized but not vaccinated|0|||
163373076|NCT02297139|590073993|FG000|Overall Study|Study drug toxicity|0|||
163373077|NCT02297139|590073994|FG001|Overall Study|Study drug toxicity|4|||
163373078|NCT02297139|590073993|FG000|Overall Study|Participant request to discontinue study treatment|0|||
163373079|NCT02297139|590073994|FG001|Overall Study|Participant request to discontinue study treatment|1|||
163373080|NCT02297139|590073993|FG000|Overall Study|Maximum clinical benefit|1|||
163373081|NCT02297139|590073994|FG001|Overall Study|Maximum clinical benefit|0|||
163373082|NCT02297139|590073993|FG000|Overall Study|Administrative reason by sponsor|0|||
163373083|NCT02297139|590073994|FG001|Overall Study|Administrative reason by sponsor|2|||
163373084|NCT02297139|590073993|FG000|Overall Study|Other reasons|0|||
163373085|NCT02297139|590073994|FG001|Overall Study|Other reasons|8|||
163373086|NCT05051462|590074000|FG000|Overall Study|Lost to Follow-up|1|||
163373087|NCT05051462|590074001|FG001|Overall Study|Lost to Follow-up|8|||
163373088|NCT05051462|590074000|FG000|Overall Study|Withdrawal by Subject|1|||
163373089|NCT05051462|590074001|FG001|Overall Study|Withdrawal by Subject|0|||
163373090|NCT05051462|590074000|FG000|Overall Study|Protocol Violation|0|||
163373091|NCT05051462|590074001|FG001|Overall Study|Protocol Violation|2|||
163373092|NCT02425904|590074002|FG000|Overall Study|Lost to Follow-up|1|||
163373093|NCT02425904|590074003|FG001|Overall Study|Lost to Follow-up|0|||
163373094|NCT02425904|590074002|FG000|Overall Study|Withdrawal by Subject|2|||
163373095|NCT02425904|590074003|FG001|Overall Study|Withdrawal by Subject|0|||
163373096|NCT02425904|590074002|FG000|Overall Study|Death|0|||
163373097|NCT02425904|590074003|FG001|Overall Study|Death|3|||
163373098|NCT05260021|590074004|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
163373099|NCT05260021|590074005|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
163373100|NCT05260021|590074006|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
163373101|NCT05260021|590074004|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
163373102|NCT05260021|590074005|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
163373103|NCT05260021|590074006|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
163373104|NCT05260021|590074004|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
163373105|NCT05260021|590074005|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
163373106|NCT05260021|590074006|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
163373107|NCT05260021|590074004|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
163373108|NCT05260021|590074005|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
163373109|NCT05260021|590074006|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
163373110|NCT05260021|590074004|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
163373111|NCT05260021|590074005|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
163373112|NCT05260021|590074006|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
163414167|NCT03529773|590223014|FG002|Overall Study|Randomized but not vaccinated|0|||
163414168|NCT03529773|590223015|FG003|Overall Study|Randomized but not vaccinated|0|||
163414169|NCT03529773|590223016|FG004|Overall Study|Randomized but not vaccinated|0|||
163414170|NCT03529773|590223017|FG005|Overall Study|Randomized but not vaccinated|0|||
163414171|NCT03529773|590223018|FG006|Overall Study|Randomized but not vaccinated|0|||
163414172|NCT03529773|590223019|FG007|Overall Study|Randomized but not vaccinated|0|||
163414173|NCT03529773|590223020|FG008|Overall Study|Randomized but not vaccinated|0|||
163414174|NCT03529773|590223021|FG009|Overall Study|Randomized but not vaccinated|0|||
163414175|NCT03529773|590223022|FG010|Overall Study|Randomized but not vaccinated|0|||
163414176|NCT03529773|590223023|FG011|Overall Study|Randomized but not vaccinated|0|||
163414177|NCT03529773|590223024|FG012|Overall Study|Randomized but not vaccinated|0|||
163414178|NCT03529773|590223025|FG013|Overall Study|Randomized but not vaccinated|0|||
163414179|NCT03529773|590223026|FG014|Overall Study|Randomized but not vaccinated|0|||
163414180|NCT03529773|590223027|FG015|Overall Study|Randomized but not vaccinated|0|||
163414181|NCT03529773|590223028|FG016|Overall Study|Randomized but not vaccinated|0|||
163414182|NCT03529773|590223029|FG017|Overall Study|Randomized but not vaccinated|1|||
163414183|NCT03529773|590223030|FG018|Overall Study|Randomized but not vaccinated|0|||
163414184|NCT03529773|590223031|FG019|Overall Study|Randomized but not vaccinated|0|||
163414185|NCT03529773|590223032|FG020|Overall Study|Randomized but not vaccinated|0|||
163414186|NCT03529773|590223033|FG021|Overall Study|Randomized but not vaccinated|0|||
163414187|NCT03529773|590223034|FG022|Overall Study|Randomized but not vaccinated|0|||
163414188|NCT03529773|590223035|FG023|Overall Study|Randomized but not vaccinated|0|||
163414189|NCT03529773|590223036|FG024|Overall Study|Randomized but not vaccinated|0|||
163414190|NCT03529773|590223037|FG025|Overall Study|Randomized but not vaccinated|0|||
163414191|NCT03529773|590223038|FG026|Overall Study|Randomized but not vaccinated|0|||
163414192|NCT03529773|590223039|FG027|Overall Study|Randomized but not vaccinated|1|||
163414193|NCT03529773|590223040|FG028|Overall Study|Randomized but not vaccinated|0|||
163373113|NCT05597787|590074007|FG000|Overall Study|Withdrawal by Subject|0|||
163373114|NCT05597787|590074008|FG001|Overall Study|Withdrawal by Subject|0|||
163373115|NCT05597787|590074009|FG002|Overall Study|Withdrawal by Subject|1|||
163373116|NCT01144377|590074011|FG000|52 Week Treatment Period|Adverse Event|0|||
163414194|NCT03529773|590223041|FG029|Overall Study|Randomized but not vaccinated|0|||
163414195|NCT03529773|590223042|FG030|Overall Study|Randomized but not vaccinated|0|||
163414196|NCT03529773|590223043|FG031|Overall Study|Randomized but not vaccinated|0|||
163373117|NCT01144377|590074012|FG001|52 Week Treatment Period|Adverse Event|0|||
163373118|NCT01144377|590074013|FG002|52 Week Treatment Period|Adverse Event|3|||
163373119|NCT01144377|590074014|FG003|52 Week Treatment Period|Adverse Event|2|||
163373120|NCT01144377|590074015|FG004|52 Week Treatment Period|Adverse Event|1|||
163373121|NCT01144377|590074011|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
163373122|NCT01144377|590074012|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
163373123|NCT01144377|590074013|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
163373124|NCT01144377|590074014|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
163373125|NCT01144377|590074015|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
163373126|NCT01144377|590074011|FG000|52 Week Treatment Period|Protocol Violation|0|||
163373127|NCT01144377|590074012|FG001|52 Week Treatment Period|Protocol Violation|0|||
163373128|NCT01144377|590074013|FG002|52 Week Treatment Period|Protocol Violation|0|||
163373129|NCT01144377|590074014|FG003|52 Week Treatment Period|Protocol Violation|0|||
163373130|NCT01144377|590074015|FG004|52 Week Treatment Period|Protocol Violation|1|||
163373131|NCT01144377|590074011|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
163373132|NCT01144377|590074012|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
163373133|NCT01144377|590074013|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
163373134|NCT01144377|590074014|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
163373135|NCT01144377|590074015|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
163373136|NCT01144377|590074011|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
163373137|NCT01144377|590074012|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
163373138|NCT01144377|590074013|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
163373139|NCT01144377|590074014|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
163373140|NCT01144377|590074015|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
163373141|NCT01144377|590074011|FG000|52 Week Treatment Period|Sponsor Decision|0|||
163373142|NCT01144377|590074012|FG001|52 Week Treatment Period|Sponsor Decision|0|||
163373143|NCT01144377|590074013|FG002|52 Week Treatment Period|Sponsor Decision|0|||
163373144|NCT01144377|590074014|FG003|52 Week Treatment Period|Sponsor Decision|0|||
163373145|NCT01144377|590074015|FG004|52 Week Treatment Period|Sponsor Decision|1|||
163373146|NCT01144377|590074011|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
163373147|NCT01144377|590074012|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
163373148|NCT01144377|590074013|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
163373149|NCT01144377|590074014|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
163373150|NCT01144377|590074015|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
163373151|NCT01144377|590074011|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
163373152|NCT01144377|590074012|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
163373153|NCT01144377|590074013|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
163373154|NCT01144377|590074014|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
163373155|NCT01144377|590074015|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
163373156|NCT01144377|590074011|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
163373157|NCT01144377|590074012|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
163373158|NCT01144377|590074013|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
163373159|NCT01144377|590074014|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
163414197|NCT03529773|590223044|FG032|Overall Study|Randomized but not vaccinated|0|||
163414198|NCT03529773|590223045|FG033|Overall Study|Randomized but not vaccinated|0|||
163414199|NCT03529773|590223046|FG034|Overall Study|Randomized but not vaccinated|0|||
163414200|NCT03529773|590223047|FG035|Overall Study|Randomized but not vaccinated|0|||
163414201|NCT03529773|590223048|FG036|Overall Study|Randomized but not vaccinated|0|||
163414202|NCT03529773|590223049|FG037|Overall Study|Randomized but not vaccinated|0|||
163414203|NCT03529773|590223050|FG038|Overall Study|Randomized but not vaccinated|0|||
163414204|NCT03529773|590223051|FG039|Overall Study|Randomized but not vaccinated|0|||
163414205|NCT03237065|590223053|FG000|Overall Study|Adverse Event|0|||
163414206|NCT03237065|590223054|FG001|Overall Study|Adverse Event|2|||
163414207|NCT03237065|590223053|FG000|Overall Study|Protocol Violation|0|||
163414208|NCT03237065|590223054|FG001|Overall Study|Protocol Violation|1|||
163414209|NCT03237065|590223053|FG000|Overall Study|Withdrawal by Subject|3|||
163414210|NCT03237065|590223054|FG001|Overall Study|Withdrawal by Subject|0|||
163414211|NCT03237065|590223053|FG000|Overall Study|Lost to Follow-up|1|||
163414212|NCT03237065|590223054|FG001|Overall Study|Lost to Follow-up|0|||
163414213|NCT03237065|590223053|FG000|Overall Study|Unable to obtain venous access|0|||
163414214|NCT03237065|590223054|FG001|Overall Study|Unable to obtain venous access|1|||
163414215|NCT00209339|590223055|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
163373160|NCT01144377|590074015|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
163373161|NCT01214642|590074016|FG000|Overall Study|Progressive Disease|3|||
163373162|NCT01214642|590074017|FG001|Overall Study|Progressive Disease|2|||
163373163|NCT01214642|590074018|FG002|Overall Study|Progressive Disease|3|||
163373164|NCT01214642|590074019|FG003|Overall Study|Progressive Disease|5|||
163414216|NCT00209339|590223055|FG000|At 12 Months Follow-up|Death|1|||
163414217|NCT00209339|590223055|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
163414218|NCT00209339|590223055|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
163414219|NCT00209339|590223055|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
163373165|NCT01214642|590074020|FG004|Overall Study|Progressive Disease|5|||
163373166|NCT01214642|590074021|FG005|Overall Study|Progressive Disease|3|||
163373167|NCT01214642|590074022|FG006|Overall Study|Progressive Disease|5|||
163373168|NCT01214642|590074023|FG007|Overall Study|Progressive Disease|3|||
163373169|NCT01214642|590074024|FG008|Overall Study|Progressive Disease|10|||
163373170|NCT01214642|590074025|FG009|Overall Study|Progressive Disease|2|||
163373171|NCT01214642|590074026|FG010|Overall Study|Progressive Disease|1|||
163373172|NCT01214642|590074027|FG011|Overall Study|Progressive Disease|4|||
163373173|NCT01214642|590074016|FG000|Overall Study|Adverse Event|0|||
163373174|NCT01214642|590074017|FG001|Overall Study|Adverse Event|1|||
163373175|NCT01214642|590074018|FG002|Overall Study|Adverse Event|0|||
163373176|NCT01214642|590074019|FG003|Overall Study|Adverse Event|0|||
163373177|NCT01214642|590074020|FG004|Overall Study|Adverse Event|0|||
163373178|NCT01214642|590074021|FG005|Overall Study|Adverse Event|0|||
163373179|NCT01214642|590074022|FG006|Overall Study|Adverse Event|1|||
163373180|NCT01214642|590074023|FG007|Overall Study|Adverse Event|0|||
163373181|NCT01214642|590074024|FG008|Overall Study|Adverse Event|0|||
163373182|NCT01214642|590074025|FG009|Overall Study|Adverse Event|1|||
163373183|NCT01214642|590074026|FG010|Overall Study|Adverse Event|1|||
163373184|NCT01214642|590074027|FG011|Overall Study|Adverse Event|0|||
163373185|NCT01214642|590074016|FG000|Overall Study|Death|0|||
163373186|NCT01214642|590074017|FG001|Overall Study|Death|0|||
163373187|NCT01214642|590074018|FG002|Overall Study|Death|1|||
163373188|NCT01214642|590074019|FG003|Overall Study|Death|0|||
163373189|NCT01214642|590074020|FG004|Overall Study|Death|0|||
163373190|NCT01214642|590074021|FG005|Overall Study|Death|0|||
163373191|NCT01214642|590074022|FG006|Overall Study|Death|0|||
163373192|NCT01214642|590074023|FG007|Overall Study|Death|0|||
163373193|NCT01214642|590074024|FG008|Overall Study|Death|0|||
163373194|NCT01214642|590074025|FG009|Overall Study|Death|0|||
163373195|NCT01214642|590074026|FG010|Overall Study|Death|1|||
163373196|NCT01214642|590074027|FG011|Overall Study|Death|0|||
163373197|NCT01214642|590074016|FG000|Overall Study|Withdrawal by Subject|0|||
163373198|NCT01214642|590074017|FG001|Overall Study|Withdrawal by Subject|0|||
163373199|NCT01214642|590074018|FG002|Overall Study|Withdrawal by Subject|1|||
163373200|NCT01214642|590074019|FG003|Overall Study|Withdrawal by Subject|0|||
163373201|NCT01214642|590074020|FG004|Overall Study|Withdrawal by Subject|0|||
163373202|NCT01214642|590074021|FG005|Overall Study|Withdrawal by Subject|0|||
163373203|NCT01214642|590074022|FG006|Overall Study|Withdrawal by Subject|0|||
163373204|NCT01214642|590074023|FG007|Overall Study|Withdrawal by Subject|0|||
163373205|NCT01214642|590074024|FG008|Overall Study|Withdrawal by Subject|3|||
163373206|NCT01214642|590074025|FG009|Overall Study|Withdrawal by Subject|1|||
163373207|NCT01214642|590074026|FG010|Overall Study|Withdrawal by Subject|1|||
163373208|NCT01214642|590074027|FG011|Overall Study|Withdrawal by Subject|0|||
163373209|NCT01214642|590074016|FG000|Overall Study|Physician Decision|0|||
163373210|NCT01214642|590074017|FG001|Overall Study|Physician Decision|0|||
163373211|NCT01214642|590074018|FG002|Overall Study|Physician Decision|1|||
163373212|NCT01214642|590074019|FG003|Overall Study|Physician Decision|1|||
163373213|NCT01214642|590074020|FG004|Overall Study|Physician Decision|1|||
163373214|NCT01214642|590074021|FG005|Overall Study|Physician Decision|0|||
163373215|NCT01214642|590074022|FG006|Overall Study|Physician Decision|0|||
163373216|NCT01214642|590074023|FG007|Overall Study|Physician Decision|0|||
163373217|NCT01214642|590074024|FG008|Overall Study|Physician Decision|0|||
163373218|NCT01214642|590074025|FG009|Overall Study|Physician Decision|0|||
163373219|NCT01214642|590074026|FG010|Overall Study|Physician Decision|0|||
163373220|NCT01214642|590074027|FG011|Overall Study|Physician Decision|2|||
163373221|NCT01241604|590074028|FG000|Screening Period|Screen Failure|3|||
163373222|NCT01241604|590074029|FG001|Screening Period|Screen Failure|0|||
163373223|NCT01241604|590074030|FG002|Screening Period|Screen Failure|0|||
163373224|NCT02980731|590075336|FG000|Overall Study|Death|63|||
163373225|NCT02980731|590075336|FG000|Overall Study|Withdrawal by Subject|6|||
163373226|NCT02980731|590075336|FG000|Overall Study|Lost to Follow-up|5|||
163373227|NCT02980731|590075336|FG000|Overall Study|Study terminated by Sponsor|4|||
163373228|NCT02980731|590075336|FG000|Overall Study|Completed survival follow-up period|65|||
163373229|NCT02980731|590075336|FG000|Overall Study|COVID-19 infection|1|||
163373230|NCT02980731|590075336|FG000|Overall Study|Other, not specified|66|||
163373231|NCT03037931|590075337|FG000|Overall Study|Death|354|||
163373232|NCT03037931|590075338|FG001|Overall Study|Death|367|||
163373233|NCT03037931|590075337|FG000|Overall Study|Lost to Follow-up|7|||
163373234|NCT03037931|590075338|FG001|Overall Study|Lost to Follow-up|4|||
163373235|NCT03037931|590075337|FG000|Overall Study|Withdrawal by Subject|48|||
163373236|NCT03037931|590075338|FG001|Overall Study|Withdrawal by Subject|41|||
163373237|NCT02075476|590075339|FG000|Overall Study|Death|2|||
163373238|NCT02075476|590075340|FG001|Overall Study|Death|2|||
163373239|NCT02075476|590075339|FG000|Overall Study|Lost to Follow-up|1|||
163373240|NCT02075476|590075340|FG001|Overall Study|Lost to Follow-up|3|||
163373241|NCT02731690|590075341|FG000|Overall Study|Adverse Event|1|||
163373242|NCT02731690|590075341|FG000|Overall Study|Withdrawal by Subject|3|||
163373243|NCT02731690|590075341|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
163373244|NCT00872989|590075342|FG000|Overall Study|Adverse Event|7|||
163373245|NCT00872989|590075343|FG001|Overall Study|Adverse Event|15|||
163373246|NCT00872989|590075342|FG000|Overall Study|Withdrawal by Subject|8|||
163373247|NCT00872989|590075343|FG001|Overall Study|Withdrawal by Subject|5|||
163373248|NCT00872989|590075342|FG000|Overall Study|Progression/relapse|47|||
163373249|NCT00872989|590075343|FG001|Overall Study|Progression/relapse|35|||
163373250|NCT00872989|590075342|FG000|Overall Study|Not protocol specified|3|||
163373251|NCT00872989|590075343|FG001|Overall Study|Not protocol specified|8|||
163373252|NCT02407990|590075344|FG000|Overall Study|Death|2|||
163373253|NCT02407990|590075345|FG001|Overall Study|Death|22|||
163373254|NCT02407990|590075346|FG002|Overall Study|Death|23|||
163373255|NCT02407990|590075347|FG003|Overall Study|Death|7|||
163373256|NCT02407990|590075348|FG004|Overall Study|Death|17|||
163373257|NCT02407990|590075349|FG005|Overall Study|Death|16|||
163373258|NCT02407990|590075350|FG006|Overall Study|Death|10|||
163373259|NCT02407990|590075351|FG007|Overall Study|Death|248|||
163373260|NCT02407990|590075344|FG000|Overall Study|Lost to Follow-up|0|||
163373261|NCT02407990|590075345|FG001|Overall Study|Lost to Follow-up|1|||
163373262|NCT02407990|590075346|FG002|Overall Study|Lost to Follow-up|0|||
163373263|NCT02407990|590075347|FG003|Overall Study|Lost to Follow-up|0|||
163373264|NCT02407990|590075348|FG004|Overall Study|Lost to Follow-up|0|||
163373265|NCT02407990|590075349|FG005|Overall Study|Lost to Follow-up|0|||
163373266|NCT02407990|590075350|FG006|Overall Study|Lost to Follow-up|0|||
163373267|NCT02407990|590075351|FG007|Overall Study|Lost to Follow-up|17|||
163373268|NCT02407990|590075344|FG000|Overall Study|Progressive Disease|0|||
163373269|NCT02407990|590075345|FG001|Overall Study|Progressive Disease|0|||
163373270|NCT02407990|590075346|FG002|Overall Study|Progressive Disease|0|||
163373271|NCT02407990|590075347|FG003|Overall Study|Progressive Disease|0|||
163373272|NCT02407990|590075348|FG004|Overall Study|Progressive Disease|0|||
163373273|NCT02407990|590075349|FG005|Overall Study|Progressive Disease|0|||
163373274|NCT02407990|590075350|FG006|Overall Study|Progressive Disease|0|||
163373275|NCT02407990|590075351|FG007|Overall Study|Progressive Disease|1|||
163373276|NCT02407990|590075344|FG000|Overall Study|Withdrawal by Subject|0|||
163373277|NCT02407990|590075345|FG001|Overall Study|Withdrawal by Subject|0|||
163373278|NCT02407990|590075346|FG002|Overall Study|Withdrawal by Subject|0|||
163373279|NCT02407990|590075347|FG003|Overall Study|Withdrawal by Subject|0|||
163373280|NCT02407990|590075348|FG004|Overall Study|Withdrawal by Subject|1|||
163373281|NCT02407990|590075349|FG005|Overall Study|Withdrawal by Subject|0|||
163373282|NCT02407990|590075350|FG006|Overall Study|Withdrawal by Subject|0|||
163373283|NCT02407990|590075351|FG007|Overall Study|Withdrawal by Subject|30|||
163373284|NCT02407990|590075344|FG000|Overall Study|Study Terminated by Sponsor|1|||
163373285|NCT02407990|590075345|FG001|Overall Study|Study Terminated by Sponsor|3|||
163373286|NCT02407990|590075346|FG002|Overall Study|Study Terminated by Sponsor|3|||
163373287|NCT02407990|590075347|FG003|Overall Study|Study Terminated by Sponsor|0|||
163373288|NCT02407990|590075348|FG004|Overall Study|Study Terminated by Sponsor|3|||
163373289|NCT02407990|590075349|FG005|Overall Study|Study Terminated by Sponsor|4|||
163373290|NCT02407990|590075350|FG006|Overall Study|Study Terminated by Sponsor|3|||
163373291|NCT02407990|590075351|FG007|Overall Study|Study Terminated by Sponsor|37|||
163373292|NCT02407990|590075344|FG000|Overall Study|Logistics|0|||
163373293|NCT02407990|590075345|FG001|Overall Study|Logistics|0|||
163373294|NCT02407990|590075346|FG002|Overall Study|Logistics|0|||
163373295|NCT02407990|590075347|FG003|Overall Study|Logistics|0|||
163373296|NCT02407990|590075348|FG004|Overall Study|Logistics|0|||
163373297|NCT02407990|590075349|FG005|Overall Study|Logistics|0|||
163373298|NCT02407990|590075350|FG006|Overall Study|Logistics|0|||
163373299|NCT02407990|590075351|FG007|Overall Study|Logistics|1|||
163373300|NCT02407990|590075344|FG000|Overall Study|Rolled into long-term extension study|0|||
163373301|NCT02407990|590075345|FG001|Overall Study|Rolled into long-term extension study|0|||
163373302|NCT02407990|590075346|FG002|Overall Study|Rolled into long-term extension study|0|||
163373303|NCT02407990|590075347|FG003|Overall Study|Rolled into long-term extension study|0|||
163373304|NCT02407990|590075348|FG004|Overall Study|Rolled into long-term extension study|0|||
163373305|NCT02407990|590075349|FG005|Overall Study|Rolled into long-term extension study|0|||
163373306|NCT02407990|590075350|FG006|Overall Study|Rolled into long-term extension study|0|||
163373307|NCT02407990|590075351|FG007|Overall Study|Rolled into long-term extension study|1|||
163373308|NCT01238900|590075352|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
163373309|NCT01238900|590075352|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
163373310|NCT03241927|590075353|FG000|Overall Study|study terminated|1|||
163373311|NCT03241927|590075354|FG001|Overall Study|study terminated|0|||
163373312|NCT03573583|590075355|FG000|Overall Study|Lost to Follow-up|1|||
163373313|NCT03573583|590075356|FG001|Overall Study|Lost to Follow-up|0|||
163373314|NCT03573583|590075355|FG000|Overall Study|Withdrawal by Subject|1|||
163373315|NCT03573583|590075356|FG001|Overall Study|Withdrawal by Subject|1|||
163373316|NCT01198756|590075357|FG000|Overall Study|Adverse Event|0|||
163373317|NCT01198756|590075358|FG001|Overall Study|Adverse Event|0|||
163373318|NCT01198756|590075359|FG002|Overall Study|Adverse Event|0|||
163373319|NCT01198756|590075360|FG003|Overall Study|Adverse Event|1|||
163373320|NCT01198756|590075357|FG000|Overall Study|Protocol Violation|0|||
163373321|NCT01198756|590075358|FG001|Overall Study|Protocol Violation|0|||
163373322|NCT01198756|590075359|FG002|Overall Study|Protocol Violation|0|||
163373323|NCT01198756|590075360|FG003|Overall Study|Protocol Violation|2|||
163373324|NCT01198756|590075357|FG000|Overall Study|Withdrawal by Subject|9|||
163373325|NCT01198756|590075358|FG001|Overall Study|Withdrawal by Subject|4|||
163373326|NCT01198756|590075359|FG002|Overall Study|Withdrawal by Subject|7|||
163373327|NCT01198756|590075360|FG003|Overall Study|Withdrawal by Subject|5|||
163373328|NCT01198756|590075357|FG000|Overall Study|Lost to Follow-up|29|||
163373329|NCT01198756|590075358|FG001|Overall Study|Lost to Follow-up|36|||
163373330|NCT01198756|590075359|FG002|Overall Study|Lost to Follow-up|23|||
163373331|NCT01198756|590075360|FG003|Overall Study|Lost to Follow-up|18|||
163373332|NCT02915302|590075363|FG000|Overall Study|Adverse Event|3|||
163373333|NCT02915302|590075364|FG001|Overall Study|Adverse Event|0|||
163373334|NCT02915302|590075363|FG000|Overall Study|Protocol Violation|20|||
163373335|NCT02915302|590075364|FG001|Overall Study|Protocol Violation|27|||
163373336|NCT02915302|590075363|FG000|Overall Study|Lost to Follow-up|19|||
163373337|NCT02915302|590075364|FG001|Overall Study|Lost to Follow-up|22|||
163373338|NCT02915302|590075363|FG000|Overall Study|Withdrawal by Subject|22|||
163373339|NCT02915302|590075364|FG001|Overall Study|Withdrawal by Subject|29|||
163373340|NCT02915302|590075363|FG000|Overall Study|Other|1|||
163373341|NCT02915302|590075364|FG001|Overall Study|Other|0|||
163373342|NCT04343872|590075367|FG000|Overall Study|Lost to Follow-up|6|||
163373343|NCT04343872|590075368|FG001|Overall Study|Lost to Follow-up|3|||
163373344|NCT01850446|590075369|FG000|Overall Study|Lack of Efficacy|1|||
163373345|NCT01850446|590075370|FG001|Overall Study|Lack of Efficacy|0|||
163373346|NCT01850446|590075369|FG000|Overall Study|Withdrawal by Subject|4|||
163373347|NCT01850446|590075370|FG001|Overall Study|Withdrawal by Subject|0|||
163373348|NCT01850446|590075369|FG000|Overall Study|Protocol Violation|0|||
163373349|NCT01850446|590075370|FG001|Overall Study|Protocol Violation|2|||
163373350|NCT00591721|590075371|FG000|Overall Study|Withdrawal by Subject|10|||
163373351|NCT00591721|590075372|FG001|Overall Study|Withdrawal by Subject|10|||
163373352|NCT00591721|590075371|FG000|Overall Study|Lost to Follow-up|1|||
163373353|NCT00591721|590075372|FG001|Overall Study|Lost to Follow-up|4|||
163373354|NCT00591721|590075371|FG000|Overall Study|Intervention not received|10|||
163373355|NCT00591721|590075372|FG001|Overall Study|Intervention not received|8|||
163373356|NCT01119105|590075373|FG000|Overall Study|Withdrawal by Subject|1|||
163373357|NCT01119105|590075374|FG001|Overall Study|Withdrawal by Subject|1|||
163373358|NCT01119105|590075375|FG002|Overall Study|Withdrawal by Subject|1|||
163373359|NCT01119105|590075373|FG000|Overall Study|Lost to Follow-up|0|||
163373360|NCT01119105|590075374|FG001|Overall Study|Lost to Follow-up|2|||
163373361|NCT01119105|590075375|FG002|Overall Study|Lost to Follow-up|5|||
163373362|NCT01119105|590075373|FG000|Overall Study|Adverse Event|1|||
163373363|NCT01119105|590075374|FG001|Overall Study|Adverse Event|0|||
163373364|NCT01119105|590075375|FG002|Overall Study|Adverse Event|1|||
163373365|NCT01119105|590075373|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
163373366|NCT01119105|590075374|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
163373367|NCT01119105|590075375|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
163373368|NCT01119105|590075373|FG000|Overall Study|Other|1|||
163373369|NCT01119105|590075374|FG001|Overall Study|Other|1|||
163373370|NCT01119105|590075375|FG002|Overall Study|Other|0|||
163373371|NCT01639495|590075376|FG000|Overall Study|Lost to Follow-up|6|||
163373372|NCT01639495|590075376|FG000|Overall Study|Consented but didn't have study catheter|4|||
163373373|NCT01639495|590075376|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
163373374|NCT01639495|590075376|FG000|Overall Study|No radiofrequency energy applied|2|||
163373375|NCT02366468|590075380|FG000|Overall Study|Adverse Event|2|||
163373376|NCT02366468|590075381|FG001|Overall Study|Adverse Event|0|||
163373377|NCT02366468|590075380|FG000|Overall Study|Withdrawal by Subject|1|||
163373378|NCT02366468|590075381|FG001|Overall Study|Withdrawal by Subject|5|||
163373379|NCT02366468|590075380|FG000|Overall Study|Lost to Follow-up|2|||
163373380|NCT02366468|590075381|FG001|Overall Study|Lost to Follow-up|0|||
163373381|NCT02366468|590075380|FG000|Overall Study|Death|1|||
163373382|NCT02366468|590075381|FG001|Overall Study|Death|2|||
163373383|NCT02366468|590075380|FG000|Overall Study|Other|0|||
163373384|NCT02366468|590075381|FG001|Overall Study|Other|2|||
163373385|NCT05540717|590075384|FG000|Overall Study|Lost to Follow-up|2|||
163373386|NCT05540717|590075385|FG001|Overall Study|Lost to Follow-up|5|||
163373387|NCT05540717|590075384|FG000|Overall Study|Withdrawal by Subject|6|||
163373388|NCT05540717|590075385|FG001|Overall Study|Withdrawal by Subject|6|||
163373389|NCT05540717|590075384|FG000|Overall Study|Sponsor request|1|||
163373390|NCT05540717|590075385|FG001|Overall Study|Sponsor request|0|||
163373391|NCT05540717|590075384|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
163373392|NCT05540717|590075385|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
163373393|NCT05540717|590075384|FG000|Overall Study|Other|0|||
163373394|NCT05540717|590075385|FG001|Overall Study|Other|1|||
163373395|NCT01144052|590075386|FG000|Overall Study|Withdrawal by Subject|1|||
163373396|NCT01144052|590075387|FG001|Overall Study|Withdrawal by Subject|1|||
163373397|NCT03836716|590075391|FG000|Overall Study|Adverse Event|3|||
163373398|NCT03836716|590075391|FG000|Overall Study|Death|22|||
163373399|NCT03836716|590075391|FG000|Overall Study|Withdrawal by Subject|8|||
163373400|NCT03836716|590075391|FG000|Overall Study|Study terminated by sponsor|87|||
163373401|NCT01879722|590075392|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
163414220|NCT00209339|590223055|FG000|At 24 Months Follow-up|Death|1|||
163414221|NCT00209339|590223055|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
163414222|NCT00209339|590223055|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
163414223|NCT00209339|590223055|FG000|At 4 Years Follow-up|Death|1|||
163414224|NCT00209339|590223055|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
163414225|NCT00209339|590223055|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
163414226|NCT00209339|590223055|FG000|At 5 Years Follow-up|Death|1|||
163414227|NCT02062658|590223057|FG000|Overall Study|Withdrawal by Subject|1|||
163414228|NCT02062658|590223057|FG000|Overall Study|Lack of Efficacy|1|||
163414229|NCT00257010|590223062|FG000|Overall Study|Lack of Efficacy|11|||
163414230|NCT00257010|590223062|FG000|Overall Study|Lost to Follow-up|53|||
163414231|NCT00257010|590223062|FG000|Overall Study|Withdrawal by Subject|34|||
163414232|NCT00257010|590223062|FG000|Overall Study|Adverse Event|10|||
163414233|NCT00257010|590223062|FG000|Overall Study|various|11|||
163414234|NCT00257010|590223062|FG000|Overall Study|no headache reported|9|||
163414235|NCT02574637|590223063|FG000|Double-blind Period|Adverse Event|1|||
163414236|NCT02574637|590223064|FG001|Double-blind Period|Adverse Event|0|||
163414237|NCT02574637|590223065|FG002|Double-blind Period|Adverse Event|0|||
163414238|NCT02574637|590223066|FG003|Double-blind Period|Adverse Event|0|||
163414239|NCT02574637|590223067|FG004|Double-blind Period|Adverse Event|0|||
163414240|NCT02574637|590223068|FG005|Double-blind Period|Adverse Event|0|||
163414241|NCT02574637|590223069|FG006|Double-blind Period|Adverse Event|0|||
163414242|NCT02574637|590223070|FG007|Double-blind Period|Adverse Event|0|||
163414243|NCT02574637|590223071|FG008|Double-blind Period|Adverse Event|0|||
163414244|NCT02574637|590223072|FG009|Double-blind Period|Adverse Event|0|||
163414245|NCT02574637|590223063|FG000|Double-blind Period|Lack of Efficacy|0|||
163414246|NCT02574637|590223064|FG001|Double-blind Period|Lack of Efficacy|0|||
163414247|NCT02574637|590223065|FG002|Double-blind Period|Lack of Efficacy|2|||
163414248|NCT02574637|590223066|FG003|Double-blind Period|Lack of Efficacy|0|||
163414249|NCT02574637|590223067|FG004|Double-blind Period|Lack of Efficacy|0|||
163414250|NCT02574637|590223068|FG005|Double-blind Period|Lack of Efficacy|0|||
163414251|NCT02574637|590223069|FG006|Double-blind Period|Lack of Efficacy|0|||
163414252|NCT02574637|590223070|FG007|Double-blind Period|Lack of Efficacy|0|||
163414253|NCT02574637|590223071|FG008|Double-blind Period|Lack of Efficacy|0|||
163414254|NCT02574637|590223072|FG009|Double-blind Period|Lack of Efficacy|0|||
163414255|NCT02574637|590223063|FG000|Double-blind Period|Protocol Deviation|1|||
163414256|NCT02574637|590223064|FG001|Double-blind Period|Protocol Deviation|0|||
163373402|NCT01879722|590075393|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
163373403|NCT01879722|590075394|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
163373404|NCT01879722|590075395|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
163373405|NCT01879722|590075396|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
163373406|NCT01879722|590075397|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
163373407|NCT01879722|590075398|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
163373408|NCT01879722|590075399|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
163373409|NCT01879722|590075400|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
163373410|NCT01879722|590075401|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
163373411|NCT01879722|590075392|FG000|Overall Study|Voluntary Withdrawal|0|||
163373412|NCT01879722|590075393|FG001|Overall Study|Voluntary Withdrawal|0|||
163373413|NCT01879722|590075394|FG002|Overall Study|Voluntary Withdrawal|0|||
163373414|NCT01879722|590075395|FG003|Overall Study|Voluntary Withdrawal|0|||
163373415|NCT01879722|590075396|FG004|Overall Study|Voluntary Withdrawal|0|||
163373416|NCT01879722|590075397|FG005|Overall Study|Voluntary Withdrawal|0|||
163373417|NCT01879722|590075398|FG006|Overall Study|Voluntary Withdrawal|0|||
163414257|NCT02574637|590223065|FG002|Double-blind Period|Protocol Deviation|0|||
163414258|NCT02574637|590223066|FG003|Double-blind Period|Protocol Deviation|0|||
163414259|NCT02574637|590223067|FG004|Double-blind Period|Protocol Deviation|0|||
163373418|NCT01879722|590075399|FG007|Overall Study|Voluntary Withdrawal|0|||
163414260|NCT02574637|590223068|FG005|Double-blind Period|Protocol Deviation|0|||
163414261|NCT02574637|590223069|FG006|Double-blind Period|Protocol Deviation|0|||
163414262|NCT02574637|590223070|FG007|Double-blind Period|Protocol Deviation|0|||
163414263|NCT02574637|590223071|FG008|Double-blind Period|Protocol Deviation|0|||
163373419|NCT01879722|590075400|FG008|Overall Study|Voluntary Withdrawal|1|||
163414264|NCT02574637|590223072|FG009|Double-blind Period|Protocol Deviation|0|||
163414265|NCT02574637|590223063|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
163373420|NCT01879722|590075401|FG009|Overall Study|Voluntary Withdrawal|0|||
163373421|NCT01983254|590075402|FG000|Overall Study|Death|6|||
163373422|NCT01983254|590075403|FG001|Overall Study|Death|6|||
163373423|NCT01983254|590075402|FG000|Overall Study|Lost to Follow-up|17|||
163373424|NCT01983254|590075403|FG001|Overall Study|Lost to Follow-up|16|||
163373425|NCT01983254|590075402|FG000|Overall Study|too ill|11|||
163373426|NCT01983254|590075403|FG001|Overall Study|too ill|8|||
163414266|NCT02574637|590223064|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
163414267|NCT02574637|590223065|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
163414268|NCT02574637|590223066|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
163414269|NCT02574637|590223067|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
163373427|NCT00037830|590075406|FG000|Overall Study|Adverse Event|2|||
163373428|NCT00037830|590075407|FG001|Overall Study|Adverse Event|0|||
163373429|NCT00037830|590075408|FG002|Overall Study|Adverse Event|0|||
163373430|NCT00037830|590075406|FG000|Overall Study|Withdrawal by Subject|4|||
163373431|NCT00037830|590075407|FG001|Overall Study|Withdrawal by Subject|5|||
163373432|NCT00037830|590075408|FG002|Overall Study|Withdrawal by Subject|1|||
163373433|NCT00037830|590075406|FG000|Overall Study|Protocol Violation|2|||
163373434|NCT00037830|590075407|FG001|Overall Study|Protocol Violation|2|||
163373435|NCT00037830|590075408|FG002|Overall Study|Protocol Violation|0|||
163373436|NCT00037830|590075406|FG000|Overall Study|Unrelated Medical Problem|2|||
163373437|NCT00037830|590075407|FG001|Overall Study|Unrelated Medical Problem|0|||
163373438|NCT00037830|590075408|FG002|Overall Study|Unrelated Medical Problem|0|||
163373439|NCT03582943|590075411|FG000|Allocated to Groups|Withdrawal by Subject|1|||
163373440|NCT03582943|590075412|FG001|Allocated to Groups|Withdrawal by Subject|1|||
163373441|NCT03582943|590075411|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
163373442|NCT03582943|590075412|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
163373443|NCT03582943|590075411|FG000|Analyzed|Protocol Violation|4|||
163373444|NCT03582943|590075412|FG001|Analyzed|Protocol Violation|1|||
163373445|NCT01631227|590075415|FG000|Overall Study|withdrawn consent|27|||
163373446|NCT01631227|590075416|FG001|Overall Study|withdrawn consent|21|||
163373447|NCT01631227|590075415|FG000|Overall Study|Adverse Event|1|||
163373448|NCT01631227|590075416|FG001|Overall Study|Adverse Event|0|||
163373449|NCT01631227|590075415|FG000|Overall Study|administrative|2|||
163373450|NCT01631227|590075416|FG001|Overall Study|administrative|1|||
163373451|NCT01153321|590075417|FG000|Overall Study|Development of study withdrawal criteria|0|||
163373452|NCT01153321|590075418|FG001|Overall Study|Development of study withdrawal criteria|1|||
163373453|NCT01153321|590075417|FG000|Overall Study|Withdrawal by Subject|0|||
163373454|NCT01153321|590075418|FG001|Overall Study|Withdrawal by Subject|1|||
163373455|NCT01153321|590075417|FG000|Overall Study|Adverse Event|1|||
163373456|NCT01153321|590075418|FG001|Overall Study|Adverse Event|1|||
163373457|NCT01177800|590075420|FG000|Overall Study|Adverse Event|9|||
163373458|NCT01177800|590075421|FG001|Overall Study|Adverse Event|3|||
163373459|NCT01177800|590075420|FG000|Overall Study|Protocol Violation|0|||
163373460|NCT01177800|590075421|FG001|Overall Study|Protocol Violation|1|||
163373461|NCT01177800|590075420|FG000|Overall Study|Physician Decision|1|||
163373462|NCT01177800|590075421|FG001|Overall Study|Physician Decision|0|||
163373463|NCT01177800|590075420|FG000|Overall Study|Withdrawal of informed consent|0|||
163373464|NCT01177800|590075421|FG001|Overall Study|Withdrawal of informed consent|1|||
163373465|NCT03527550|590075422|FG000|Overall Study|Lost to Follow-up|4|||
163373466|NCT03527550|590075423|FG001|Overall Study|Lost to Follow-up|2|||
163373467|NCT03527550|590075422|FG000|Overall Study|Withdrawal by Subject|4|||
163373468|NCT03527550|590075423|FG001|Overall Study|Withdrawal by Subject|1|||
163373469|NCT03527550|590075422|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
163373470|NCT03527550|590075423|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
163373471|NCT03053518|590075428|FG000|Overall Study|Withdrawal by Subject|3|||
163373472|NCT03053518|590075428|FG000|Overall Study|Lost to Follow-up|2|||
163373473|NCT03053518|590075428|FG000|Overall Study|Ineligible|5|||
163373474|NCT02683876|590075429|FG000|Overall Study|samples damaged during shipping|2|||
163373475|NCT02683876|590075430|FG001|Overall Study|samples damaged during shipping|0|||
163373476|NCT01232738|590075431|FG000|Overall Study|Death|3|||
163373477|NCT01232738|590075431|FG000|Overall Study|Physician Decision|2|||
163373478|NCT01232738|590075431|FG000|Overall Study|Lost to Follow-up|1|||
163373479|NCT01232738|590075431|FG000|Overall Study|Withdrawal by Subject|2|||
163373480|NCT01232738|590075431|FG000|Overall Study|Adverse Event|5|||
163373481|NCT03231800|590075436|FG000|Overall Study|Lost to Follow-up|0|||
163373482|NCT03231800|590075437|FG001|Overall Study|Lost to Follow-up|2|||
163373483|NCT03231800|590075436|FG000|Overall Study|Protocol Violation|1|||
163373484|NCT03231800|590075437|FG001|Overall Study|Protocol Violation|1|||
163373485|NCT03231800|590075436|FG000|Overall Study|reason not provided|2|||
163373486|NCT03231800|590075437|FG001|Overall Study|reason not provided|0|||
163373487|NCT00488475|590075438|FG000|Overall Study|Other|1754|||
163373488|NCT00400725|590075449|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
163373489|NCT00400725|590075450|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
163373490|NCT00400725|590075451|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
163373491|NCT00400725|590075449|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
163373492|NCT00400725|590075450|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
163373493|NCT00400725|590075451|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
163373494|NCT00400725|590075449|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
163373495|NCT00400725|590075450|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
163373496|NCT00400725|590075451|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
163373497|NCT00400725|590075449|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
163373498|NCT00400725|590075450|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
163373499|NCT00400725|590075451|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
163373500|NCT00400725|590075449|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
163373501|NCT00400725|590075450|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
163373502|NCT00400725|590075451|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
163373503|NCT00400725|590075449|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
163373504|NCT00400725|590075450|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
163373505|NCT00400725|590075451|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
163373506|NCT00400725|590075449|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
163373507|NCT00400725|590075450|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
163373508|NCT00400725|590075451|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
163373509|NCT00400725|590075449|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
163373510|NCT00400725|590075450|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
163373511|NCT00400725|590075451|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
163373512|NCT00400725|590075449|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
163373513|NCT00400725|590075450|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
163373514|NCT00400725|590075451|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
163373515|NCT01593787|590075452|FG000|Overall Study|Adverse Event|1|||
163373516|NCT01593787|590075453|FG001|Overall Study|Adverse Event|0|||
163373517|NCT01593787|590075454|FG002|Overall Study|Adverse Event|0|||
163373518|NCT01133418|590075457|FG000|Overall Study|Lost to Follow-up|5|||
163373519|NCT01133418|590075458|FG001|Overall Study|Lost to Follow-up|6|||
163373520|NCT04150068|590075459|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
163373521|NCT04150068|590075460|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
163373522|NCT04150068|590075461|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
163373523|NCT04150068|590075459|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
163373524|NCT04150068|590075460|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
163373525|NCT04150068|590075461|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
163373526|NCT05316701|590075462|FG000|Overall Study|Adverse Event|0|||
163373527|NCT05316701|590075463|FG001|Overall Study|Adverse Event|1|||
163373528|NCT05316701|590075462|FG000|Overall Study|Death|3|||
163373529|NCT05316701|590075463|FG001|Overall Study|Death|9|||
163373530|NCT05316701|590075462|FG000|Overall Study|Lost to Follow-up|1|||
163373531|NCT05316701|590075463|FG001|Overall Study|Lost to Follow-up|0|||
163373532|NCT05316701|590075462|FG000|Overall Study|Physician Decision|1|||
163373533|NCT05316701|590075463|FG001|Overall Study|Physician Decision|4|||
163373534|NCT05316701|590075462|FG000|Overall Study|Withdrawal by Subject|3|||
163373535|NCT05316701|590075463|FG001|Overall Study|Withdrawal by Subject|5|||
163373536|NCT05316701|590075462|FG000|Overall Study|Progression/Relapse|14|||
163373537|NCT05316701|590075463|FG001|Overall Study|Progression/Relapse|9|||
163373538|NCT05316701|590075462|FG000|Overall Study|Received Standard of Care|1|||
163373539|NCT05316701|590075463|FG001|Overall Study|Received Standard of Care|0|||
163373540|NCT05316701|590075462|FG000|Overall Study|Ongoing|70|||
163373541|NCT05316701|590075463|FG001|Overall Study|Ongoing|64|||
163373542|NCT04679935|590075464|FG000|Overall Study|Death|0|||
163373543|NCT04679935|590075465|FG001|Overall Study|Death|1|||
163373544|NCT00969709|590077114|FG000|Overall Study|Adverse Event|3|||
163373545|NCT00969709|590077115|FG001|Overall Study|Adverse Event|13|||
163373546|NCT00969709|590077116|FG002|Overall Study|Adverse Event|26|||
163373547|NCT00969709|590077117|FG003|Overall Study|Adverse Event|12|||
163373548|NCT00969709|590077114|FG000|Overall Study|Lack of Efficacy|7|||
163373549|NCT00969709|590077115|FG001|Overall Study|Lack of Efficacy|4|||
163373550|NCT00969709|590077116|FG002|Overall Study|Lack of Efficacy|1|||
163373551|NCT00969709|590077117|FG003|Overall Study|Lack of Efficacy|3|||
163373552|NCT00969709|590077114|FG000|Overall Study|Protocol Violation|9|||
163373553|NCT00969709|590077115|FG001|Overall Study|Protocol Violation|5|||
163373554|NCT00969709|590077116|FG002|Overall Study|Protocol Violation|9|||
163373555|NCT00969709|590077117|FG003|Overall Study|Protocol Violation|10|||
163373556|NCT00969709|590077114|FG000|Overall Study|Withdrawal by Subject|9|||
163373557|NCT00969709|590077115|FG001|Overall Study|Withdrawal by Subject|12|||
163373558|NCT00969709|590077116|FG002|Overall Study|Withdrawal by Subject|11|||
163373559|NCT00969709|590077117|FG003|Overall Study|Withdrawal by Subject|23|||
163373560|NCT00969709|590077114|FG000|Overall Study|Lost to Follow-up|10|||
163373561|NCT00969709|590077115|FG001|Overall Study|Lost to Follow-up|14|||
163373562|NCT00969709|590077116|FG002|Overall Study|Lost to Follow-up|8|||
163373563|NCT00969709|590077117|FG003|Overall Study|Lost to Follow-up|15|||
163373564|NCT00969709|590077114|FG000|Overall Study|Other reasons|0|||
163373565|NCT00969709|590077115|FG001|Overall Study|Other reasons|0|||
163373566|NCT00969709|590077116|FG002|Overall Study|Other reasons|3|||
163373567|NCT00969709|590077117|FG003|Overall Study|Other reasons|0|||
163373568|NCT02516332|590077118|FG000|Overall Study|Withdrawal by Subject|2|||
163373569|NCT02516332|590077119|FG001|Overall Study|Withdrawal by Subject|1|||
163373570|NCT02516332|590077120|FG002|Overall Study|Withdrawal by Subject|2|||
163373571|NCT03695237|590077121|FG000|Overall Study|Withdrawal by Subject|1|||
163373572|NCT03695237|590077122|FG001|Overall Study|Withdrawal by Subject|3|||
163373573|NCT03695237|590077121|FG000|Overall Study|Lost to Follow-up|1|||
163373574|NCT03695237|590077122|FG001|Overall Study|Lost to Follow-up|2|||
163373575|NCT03695237|590077121|FG000|Overall Study|Other, Not Specified|8|||
163373576|NCT03695237|590077122|FG001|Overall Study|Other, Not Specified|2|||
163373577|NCT00055601|590077123|FG000|Overall Study|Protocol Violation|1|||
163414270|NCT02574637|590223068|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
163373578|NCT00055601|590077124|FG001|Overall Study|Protocol Violation|1|||
163373579|NCT00055601|590077123|FG000|Overall Study|No protocol treatment received|1|||
163373580|NCT00055601|590077124|FG001|Overall Study|No protocol treatment received|1|||
163373581|NCT02217332|590077125|FG000|Overall Study|Adverse Event|3|||
163373582|NCT02217332|590077125|FG000|Overall Study|Dose interruption >1 month|1|||
163373583|NCT02217332|590077125|FG000|Overall Study|Protocol Violation (eligibility)|1|||
163373584|NCT02217332|590077125|FG000|Overall Study|Withdrawal by Subject|1|||
163373585|NCT02217332|590077125|FG000|Overall Study|Lost to Follow-up|1|||
163373586|NCT00127205|590077128|FG000|Overall Study|Adverse Event|228|||
163373587|NCT00127205|590077129|FG001|Overall Study|Adverse Event|387|||
163373588|NCT00127205|590077130|FG002|Overall Study|Adverse Event|273|||
163373589|NCT00127205|590077128|FG000|Overall Study|Death|8|||
163373590|NCT00127205|590077129|FG001|Overall Study|Death|6|||
163373591|NCT00127205|590077130|FG002|Overall Study|Death|5|||
163373592|NCT00127205|590077128|FG000|Overall Study|Withdrawal by Subject|318|||
163373593|NCT00127205|590077129|FG001|Overall Study|Withdrawal by Subject|310|||
163373594|NCT00127205|590077130|FG002|Overall Study|Withdrawal by Subject|172|||
163373595|NCT00127205|590077128|FG000|Overall Study|Other-non protocol specified|142|||
163373596|NCT00127205|590077129|FG001|Overall Study|Other-non protocol specified|129|||
163373597|NCT00127205|590077130|FG002|Overall Study|Other-non protocol specified|77|||
163373598|NCT00127205|590077128|FG000|Overall Study|Data not reported|6|||
163373599|NCT00127205|590077129|FG001|Overall Study|Data not reported|10|||
163373600|NCT00127205|590077130|FG002|Overall Study|Data not reported|1|||
163373601|NCT00127205|590077128|FG000|Overall Study|Progression|127|||
163373602|NCT00127205|590077129|FG001|Overall Study|Progression|131|||
163373603|NCT00127205|590077130|FG002|Overall Study|Progression|84|||
163373604|NCT01327495|590077131|FG000|Overall Study|Adverse Event|2|||
163373605|NCT01327495|590077132|FG001|Overall Study|Adverse Event|1|||
163373606|NCT01327495|590077133|FG002|Overall Study|Adverse Event|1|||
163373607|NCT01327495|590077134|FG003|Overall Study|Adverse Event|0|||
163373608|NCT01327495|590077135|FG004|Overall Study|Adverse Event|0|||
163373609|NCT01327495|590077136|FG005|Overall Study|Adverse Event|2|||
163373610|NCT01327495|590077131|FG000|Overall Study|Withdrawal by Subject|0|||
163373611|NCT01327495|590077132|FG001|Overall Study|Withdrawal by Subject|1|||
163373612|NCT01327495|590077133|FG002|Overall Study|Withdrawal by Subject|1|||
163373613|NCT01327495|590077134|FG003|Overall Study|Withdrawal by Subject|0|||
163373614|NCT01327495|590077135|FG004|Overall Study|Withdrawal by Subject|1|||
163373615|NCT01327495|590077136|FG005|Overall Study|Withdrawal by Subject|0|||
163373616|NCT01327495|590077131|FG000|Overall Study|Physician Decision|0|||
163373617|NCT01327495|590077132|FG001|Overall Study|Physician Decision|0|||
163373618|NCT01327495|590077133|FG002|Overall Study|Physician Decision|0|||
163373619|NCT01327495|590077134|FG003|Overall Study|Physician Decision|0|||
163373620|NCT01327495|590077135|FG004|Overall Study|Physician Decision|2|||
163373621|NCT01327495|590077136|FG005|Overall Study|Physician Decision|0|||
163373622|NCT03377699|590077140|FG000|Overall Study|Withdrawal by Subject|2|||
163373623|NCT03377699|590077141|FG001|Overall Study|Withdrawal by Subject|9|||
163373624|NCT03377699|590077140|FG000|Overall Study|Lost to Follow-up|1|||
163373625|NCT03377699|590077141|FG001|Overall Study|Lost to Follow-up|1|||
163373626|NCT03377699|590077140|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
163373627|NCT03377699|590077141|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
163373628|NCT03377699|590077140|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
163373629|NCT03377699|590077141|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
163373630|NCT03377699|590077140|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
163373631|NCT03377699|590077141|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
163373632|NCT03377699|590077140|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
163373633|NCT03377699|590077141|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
163373634|NCT02580305|590077142|FG000|Overall Study|Adverse Event|15|||
163373635|NCT02580305|590077143|FG001|Overall Study|Adverse Event|19|||
163373636|NCT02580305|590077144|FG002|Overall Study|Adverse Event|10|||
163373637|NCT02580305|590077142|FG000|Overall Study|Lack of Efficacy|5|||
163373638|NCT02580305|590077143|FG001|Overall Study|Lack of Efficacy|0|||
163373639|NCT02580305|590077144|FG002|Overall Study|Lack of Efficacy|2|||
163373640|NCT02580305|590077142|FG000|Overall Study|Protocol Violation|4|||
163373641|NCT02580305|590077143|FG001|Overall Study|Protocol Violation|9|||
163373642|NCT02580305|590077144|FG002|Overall Study|Protocol Violation|6|||
163373643|NCT02580305|590077142|FG000|Overall Study|Lost to Follow-up|4|||
163373644|NCT02580305|590077143|FG001|Overall Study|Lost to Follow-up|4|||
163373645|NCT02580305|590077144|FG002|Overall Study|Lost to Follow-up|2|||
163373646|NCT02580305|590077142|FG000|Overall Study|Withdrawal by Subject|11|||
163373647|NCT02580305|590077143|FG001|Overall Study|Withdrawal by Subject|9|||
163373648|NCT02580305|590077144|FG002|Overall Study|Withdrawal by Subject|7|||
163373649|NCT02580305|590077142|FG000|Overall Study|Randomized in error and never treated|4|||
163373650|NCT02580305|590077143|FG001|Overall Study|Randomized in error and never treated|8|||
163373651|NCT02580305|590077144|FG002|Overall Study|Randomized in error and never treated|5|||
163373652|NCT00700427|590077145|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
163373653|NCT00700427|590077146|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
163373654|NCT00700427|590077147|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
163373655|NCT00700427|590077148|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
163373656|NCT00700427|590077149|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
163373657|NCT00700427|590077145|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
163373658|NCT00700427|590077146|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
163373659|NCT00700427|590077147|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
163373660|NCT00700427|590077148|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
163373661|NCT00700427|590077149|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
163373662|NCT00700427|590077145|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
163373663|NCT00700427|590077146|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
163373664|NCT00700427|590077147|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
163373665|NCT00700427|590077148|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
163373666|NCT00700427|590077149|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
163373667|NCT00700427|590077145|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
163373668|NCT00700427|590077146|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
163373669|NCT00700427|590077147|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
163373670|NCT00700427|590077148|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
163373671|NCT00700427|590077149|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
163373672|NCT00700427|590077145|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
163373673|NCT00700427|590077146|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
163373674|NCT00700427|590077147|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
163373675|NCT00700427|590077148|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
163373676|NCT00700427|590077149|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
163373677|NCT00700427|590077145|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
163373678|NCT00700427|590077146|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
163373679|NCT00700427|590077147|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
163373680|NCT00700427|590077148|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
163373681|NCT00700427|590077149|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
163373682|NCT00700427|590077145|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
163373683|NCT00700427|590077146|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
163373684|NCT00700427|590077147|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
163373685|NCT00700427|590077148|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
163373686|NCT00700427|590077149|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
163373687|NCT00700427|590077145|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
163373688|NCT00700427|590077146|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
163373689|NCT00700427|590077147|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
163373690|NCT00700427|590077148|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
163373691|NCT00700427|590077149|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
163373692|NCT00700427|590077145|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
163373693|NCT00700427|590077146|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
163373694|NCT00700427|590077147|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
163373695|NCT00700427|590077148|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
163373696|NCT00700427|590077149|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
163373697|NCT00700427|590077145|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
163373698|NCT00700427|590077146|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
163373699|NCT00700427|590077147|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
163373700|NCT00700427|590077148|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
163373701|NCT00700427|590077149|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
163373702|NCT00700427|590077145|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
163373703|NCT00700427|590077146|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
163373704|NCT00700427|590077147|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
163373705|NCT00700427|590077148|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
163373706|NCT00700427|590077149|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
163373707|NCT00700427|590077145|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
163373708|NCT00700427|590077146|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
163373709|NCT00700427|590077147|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
163373710|NCT00700427|590077148|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
163373711|NCT00700427|590077149|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
163373712|NCT00700427|590077145|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
163373713|NCT00700427|590077146|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
163373714|NCT00700427|590077147|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
163373715|NCT00700427|590077148|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
163373716|NCT00700427|590077149|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
163373717|NCT00700427|590077145|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
163373718|NCT00700427|590077146|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
163373719|NCT00700427|590077147|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
163373720|NCT00700427|590077148|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
163373721|NCT00700427|590077149|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
163373722|NCT00700427|590077145|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
163373723|NCT00700427|590077146|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
163373724|NCT00700427|590077147|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
163373725|NCT00700427|590077148|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
163373726|NCT00700427|590077149|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
163373727|NCT00700427|590077145|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
163373728|NCT00700427|590077146|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
163373729|NCT00700427|590077147|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
163373730|NCT00700427|590077148|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
163373731|NCT00700427|590077149|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
163373732|NCT00700427|590077145|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
163373733|NCT00700427|590077146|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
163373734|NCT00700427|590077147|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
163373735|NCT00700427|590077148|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
163373736|NCT00700427|590077149|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
163373737|NCT00700427|590077145|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
163373738|NCT00700427|590077146|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
163373739|NCT00700427|590077147|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
163373740|NCT00700427|590077148|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
163373741|NCT00700427|590077149|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
163373742|NCT00700427|590077145|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
163373743|NCT00700427|590077146|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
163373744|NCT00700427|590077147|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
163373745|NCT00700427|590077148|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
163373746|NCT00700427|590077149|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
163373747|NCT00700427|590077145|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
163373748|NCT00700427|590077146|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
163373749|NCT00700427|590077147|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
163373750|NCT00700427|590077148|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
163373751|NCT00700427|590077149|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
163373752|NCT00700427|590077145|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
163373753|NCT00700427|590077146|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
163373754|NCT00700427|590077147|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
163373755|NCT00700427|590077148|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
163373756|NCT00700427|590077149|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
163373757|NCT00700427|590077145|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
163373758|NCT00700427|590077146|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
163373759|NCT00700427|590077147|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
163373760|NCT00700427|590077148|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
163373761|NCT00700427|590077149|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
163373762|NCT00700427|590077145|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
163373763|NCT00700427|590077146|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
163373764|NCT00700427|590077147|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
163373765|NCT00700427|590077148|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
163373766|NCT00700427|590077149|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
163373767|NCT00700427|590077145|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
163373768|NCT00700427|590077146|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
163373769|NCT00700427|590077147|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
163373770|NCT00700427|590077148|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
163373771|NCT00700427|590077149|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
163373772|NCT00700427|590077145|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
163373773|NCT00700427|590077146|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
163373774|NCT00700427|590077147|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
163373775|NCT00700427|590077148|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
163373776|NCT00700427|590077149|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
163373777|NCT00700427|590077145|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
163373778|NCT00700427|590077146|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
163373779|NCT00700427|590077147|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
163373780|NCT00700427|590077148|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
163373781|NCT00700427|590077149|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
163373782|NCT00700427|590077145|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
163373783|NCT00700427|590077146|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
163373784|NCT00700427|590077147|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
163373785|NCT00700427|590077148|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
163373786|NCT00700427|590077149|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
163373787|NCT00700427|590077145|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
163373788|NCT00700427|590077146|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
163373789|NCT00700427|590077147|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
163373790|NCT00700427|590077148|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
163373791|NCT00700427|590077149|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
163373792|NCT00700427|590077145|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
163373793|NCT00700427|590077146|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
163373794|NCT00700427|590077147|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
163373795|NCT00700427|590077148|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
163373796|NCT00700427|590077149|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
163373797|NCT00700427|590077145|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
163373798|NCT00700427|590077146|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
163373799|NCT00700427|590077147|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
163373800|NCT00700427|590077148|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
163373801|NCT00700427|590077149|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
163373802|NCT00700427|590077145|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
163373803|NCT00700427|590077146|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
163373804|NCT00700427|590077147|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
163373805|NCT00700427|590077148|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
163373806|NCT00700427|590077149|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
163373807|NCT00700427|590077145|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
163373808|NCT00700427|590077146|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
163373809|NCT00700427|590077147|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
163373810|NCT00700427|590077148|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
163373811|NCT00700427|590077149|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
163373812|NCT00700427|590077145|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
163373813|NCT00700427|590077146|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
163373814|NCT00700427|590077147|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
163373815|NCT00700427|590077148|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
163373816|NCT00700427|590077149|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
163373817|NCT00700427|590077145|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
163373818|NCT00700427|590077146|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
163373819|NCT00700427|590077147|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
163373820|NCT00700427|590077148|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
163373821|NCT00700427|590077149|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
163373822|NCT00700427|590077145|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
163373823|NCT00700427|590077146|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
163373824|NCT00700427|590077147|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
163373825|NCT00700427|590077148|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
163373826|NCT00700427|590077149|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
163373827|NCT00700427|590077145|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
163373828|NCT00700427|590077146|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
163373829|NCT00700427|590077147|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
163373830|NCT00700427|590077148|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
163373831|NCT00700427|590077149|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
163373832|NCT00700427|590077145|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
163373833|NCT00700427|590077146|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
163373834|NCT00700427|590077147|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
163373835|NCT00700427|590077148|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
163373836|NCT00700427|590077149|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
163373837|NCT00700427|590077145|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
163373838|NCT00700427|590077146|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
163373839|NCT00700427|590077147|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
163373840|NCT00700427|590077148|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
163373841|NCT00700427|590077149|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
163373842|NCT05560243|590077150|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
163373843|NCT05870228|590077152|FG000|Overall Study|Lost to Follow-up|2|||
163373844|NCT05870228|590077153|FG001|Overall Study|Lost to Follow-up|0|||
163373845|NCT05870228|590077152|FG000|Overall Study|Withdrawal by Subject|1|||
163373846|NCT05870228|590077153|FG001|Overall Study|Withdrawal by Subject|0|||
163373847|NCT00859222|590077155|FG000|Overall Study|Adverse Event|2|||
163373848|NCT00859222|590077156|FG001|Overall Study|Adverse Event|3|||
163373849|NCT00859222|590077157|FG002|Overall Study|Adverse Event|6|||
163373850|NCT00859222|590077158|FG003|Overall Study|Adverse Event|24|||
163373851|NCT00859222|590077159|FG004|Overall Study|Adverse Event|15|||
163373852|NCT00859222|590077155|FG000|Overall Study|DLT|1|||
163373853|NCT00859222|590077156|FG001|Overall Study|DLT|0|||
163373854|NCT00859222|590077157|FG002|Overall Study|DLT|0|||
163373855|NCT00859222|590077158|FG003|Overall Study|DLT|0|||
163373856|NCT00859222|590077159|FG004|Overall Study|DLT|0|||
163373857|NCT04075994|590077166|FG000|Overall Study|Withdrawal by Subject|8|||
163373858|NCT04075994|590077167|FG001|Overall Study|Withdrawal by Subject|9|||
163373859|NCT04075994|590077166|FG000|Overall Study|Adverse Event|2|||
163373860|NCT04075994|590077167|FG001|Overall Study|Adverse Event|2|||
163373861|NCT04075994|590077166|FG000|Overall Study|Investigator withdrew|3|||
163373862|NCT04075994|590077167|FG001|Overall Study|Investigator withdrew|1|||
163373863|NCT00252577|590077171|FG000|Overall Study|Lost to Follow-up|20|||
163373864|NCT00560066|590077174|FG000|Overall Study|Death|2|||
163373865|NCT00560066|590077175|FG001|Overall Study|Death|1|||
163373866|NCT00560066|590077174|FG000|Overall Study|Withdrawal by Subject|0|||
163373867|NCT00560066|590077175|FG001|Overall Study|Withdrawal by Subject|3|||
163373868|NCT00560066|590077174|FG000|Overall Study|Lost to Follow-up|4|||
163373869|NCT00560066|590077175|FG001|Overall Study|Lost to Follow-up|10|||
163373870|NCT00560066|590077174|FG000|Overall Study|Protocol Violation|0|||
163373871|NCT00560066|590077175|FG001|Overall Study|Protocol Violation|1|||
163373872|NCT00560066|590077174|FG000|Overall Study|Administrative reason|0|||
163373873|NCT00560066|590077175|FG001|Overall Study|Administrative reason|5|||
163373874|NCT00560066|590077174|FG000|Overall Study|Missing primary reason|0|||
163373875|NCT00560066|590077175|FG001|Overall Study|Missing primary reason|2|||
163373876|NCT02797080|590077176|FG000|Overall Study|Lost to Follow-up|1|||
163373877|NCT02797080|590077176|FG000|Overall Study|Withdrawal by Subject|1|||
163373880|NCT00951015|590077178|FG000|Randomization Phase 96 Week|Adverse Event|1|||
163373881|NCT00951015|590077179|FG001|Randomization Phase 96 Week|Adverse Event|1|||
163373882|NCT00951015|590077180|FG002|Randomization Phase 96 Week|Adverse Event|2|||
163373883|NCT00951015|590077181|FG003|Randomization Phase 96 Week|Adverse Event|5|||
163373884|NCT00951015|590077182|FG004|Randomization Phase 96 Week|Adverse Event|0|||
163373885|NCT00951015|590077178|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
163373886|NCT00951015|590077179|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
163373887|NCT00951015|590077180|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
163373888|NCT00951015|590077181|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
163373889|NCT00951015|590077182|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
163373890|NCT00951015|590077178|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
163373891|NCT00951015|590077179|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
163373892|NCT00951015|590077180|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
163373893|NCT00951015|590077181|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
163373894|NCT00951015|590077182|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
163373895|NCT00951015|590077178|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
163373896|NCT00951015|590077179|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
163373897|NCT00951015|590077180|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
163373898|NCT00951015|590077181|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
163373899|NCT00951015|590077182|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
163373900|NCT00951015|590077178|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
163373901|NCT00951015|590077179|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
163373902|NCT00951015|590077180|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
163373903|NCT00951015|590077181|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
163373904|NCT00951015|590077182|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
163373905|NCT00951015|590077178|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
163373906|NCT00951015|590077179|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
163373907|NCT00951015|590077180|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
163373908|NCT00951015|590077181|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
163373909|NCT00951015|590077182|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
163373910|NCT00951015|590077178|FG000|Open-label Phase|Adverse Event|0|||
163373911|NCT00951015|590077179|FG001|Open-label Phase|Adverse Event|0|||
163373912|NCT00951015|590077180|FG002|Open-label Phase|Adverse Event|0|||
163373913|NCT00951015|590077181|FG003|Open-label Phase|Adverse Event|0|||
163373914|NCT00951015|590077182|FG004|Open-label Phase|Adverse Event|3|||
163373915|NCT00951015|590077178|FG000|Open-label Phase|Lack of Efficacy|0|||
163373916|NCT00951015|590077179|FG001|Open-label Phase|Lack of Efficacy|0|||
163373917|NCT00951015|590077180|FG002|Open-label Phase|Lack of Efficacy|0|||
163373918|NCT00951015|590077181|FG003|Open-label Phase|Lack of Efficacy|0|||
163373919|NCT00951015|590077182|FG004|Open-label Phase|Lack of Efficacy|1|||
163373920|NCT00951015|590077178|FG000|Open-label Phase|Protocol Violation|0|||
163373921|NCT00951015|590077179|FG001|Open-label Phase|Protocol Violation|0|||
163373922|NCT00951015|590077180|FG002|Open-label Phase|Protocol Violation|0|||
163373923|NCT00951015|590077181|FG003|Open-label Phase|Protocol Violation|0|||
163373924|NCT00951015|590077182|FG004|Open-label Phase|Protocol Violation|12|||
163373925|NCT00951015|590077178|FG000|Open-label Phase|Lost to Follow-up|0|||
163373926|NCT00951015|590077179|FG001|Open-label Phase|Lost to Follow-up|0|||
163373927|NCT00951015|590077180|FG002|Open-label Phase|Lost to Follow-up|0|||
163373928|NCT00951015|590077181|FG003|Open-label Phase|Lost to Follow-up|0|||
163373929|NCT00951015|590077182|FG004|Open-label Phase|Lost to Follow-up|12|||
163373930|NCT00951015|590077178|FG000|Open-label Phase|Withdrawal by Subject|0|||
163373931|NCT00951015|590077179|FG001|Open-label Phase|Withdrawal by Subject|0|||
163373932|NCT00951015|590077180|FG002|Open-label Phase|Withdrawal by Subject|0|||
163373933|NCT00951015|590077181|FG003|Open-label Phase|Withdrawal by Subject|0|||
163373934|NCT00951015|590077182|FG004|Open-label Phase|Withdrawal by Subject|14|||
163373935|NCT00951015|590077178|FG000|Open-label Phase|Physician Decision|0|||
163373936|NCT00951015|590077179|FG001|Open-label Phase|Physician Decision|0|||
163373937|NCT00951015|590077180|FG002|Open-label Phase|Physician Decision|0|||
163373938|NCT00951015|590077181|FG003|Open-label Phase|Physician Decision|0|||
163373939|NCT00951015|590077182|FG004|Open-label Phase|Physician Decision|8|||
163373940|NCT01416389|590077183|FG000|Overall Study|Lost to Follow-up|1|||
163373941|NCT01416389|590077184|FG001|Overall Study|Lost to Follow-up|0|||
163373942|NCT01416389|590077183|FG000|Overall Study|Started New Therapy|2|||
163373943|NCT01416389|590077184|FG001|Overall Study|Started New Therapy|0|||
163373944|NCT00929110|590077191|FG000|Overall Study|Adverse Event|40|||
163373945|NCT00929110|590077192|FG001|Overall Study|Adverse Event|29|||
163373946|NCT00929110|590077193|FG002|Overall Study|Adverse Event|18|||
163373947|NCT00929110|590077191|FG000|Overall Study|Subject withdrew consent|40|||
163373948|NCT00929110|590077192|FG001|Overall Study|Subject withdrew consent|23|||
163373949|NCT00929110|590077193|FG002|Overall Study|Subject withdrew consent|26|||
163373950|NCT00929110|590077191|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
163373951|NCT00929110|590077192|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
163373952|NCT00929110|590077193|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
163373953|NCT00929110|590077191|FG000|Overall Study|Lost to Follow-up|7|||
163373954|NCT00929110|590077192|FG001|Overall Study|Lost to Follow-up|7|||
163373955|NCT00929110|590077193|FG002|Overall Study|Lost to Follow-up|3|||
163373956|NCT00929110|590077191|FG000|Overall Study|Protocol deviation|5|||
163373957|NCT00929110|590077192|FG001|Overall Study|Protocol deviation|2|||
163373958|NCT00929110|590077193|FG002|Overall Study|Protocol deviation|4|||
163373959|NCT00929110|590077191|FG000|Overall Study|Administrative problems|4|||
163373960|NCT00929110|590077192|FG001|Overall Study|Administrative problems|1|||
163373961|NCT00929110|590077193|FG002|Overall Study|Administrative problems|2|||
163373962|NCT00929110|590077191|FG000|Overall Study|Death|2|||
163373963|NCT00929110|590077192|FG001|Overall Study|Death|2|||
163373964|NCT00929110|590077193|FG002|Overall Study|Death|2|||
163373965|NCT00929110|590077191|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163373966|NCT00929110|590077192|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163373967|NCT00929110|590077193|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163373968|NCT00929110|590077191|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163373969|NCT00929110|590077192|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163373970|NCT00929110|590077193|FG002|Overall Study|Abnormal test procedure result(s)|1|||
163373971|NCT00929110|590077191|FG000|Overall Study|Patient inability to use the device|0|||
163373972|NCT00929110|590077192|FG001|Overall Study|Patient inability to use the device|1|||
163373973|NCT00929110|590077193|FG002|Overall Study|Patient inability to use the device|0|||
163373974|NCT01163292|590077196|FG000|Overall Study|Lack of Efficacy|9|||
163373975|NCT01163292|590077197|FG001|Overall Study|Lack of Efficacy|0|||
163373976|NCT01163292|590077196|FG000|Overall Study|Adverse Event|6|||
163373977|NCT01163292|590077197|FG001|Overall Study|Adverse Event|0|||
163373978|NCT01163292|590077196|FG000|Overall Study|Initiation of biological therapy|0|||
163373979|NCT01163292|590077197|FG001|Overall Study|Initiation of biological therapy|15|||
163373980|NCT01163292|590077196|FG000|Overall Study|Sufficient response to adalimumab|8|||
163373981|NCT01163292|590077197|FG001|Overall Study|Sufficient response to adalimumab|0|||
163373982|NCT01163292|590077196|FG000|Overall Study|Refusal to receive adalimumab|7|||
163373983|NCT01163292|590077197|FG001|Overall Study|Refusal to receive adalimumab|0|||
163373984|NCT01163292|590077196|FG000|Overall Study|Economic reasons|6|||
163373985|NCT01163292|590077197|FG001|Overall Study|Economic reasons|0|||
163373986|NCT01163292|590077196|FG000|Overall Study|No further visits|5|||
163373987|NCT01163292|590077197|FG001|Overall Study|No further visits|7|||
163373988|NCT02535091|590077198|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
163373989|NCT02535091|590077199|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
163373990|NCT02535091|590077200|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
163373991|NCT02535091|590077198|FG000|Overall Study|Withdrawal by Subject|14|||
163373992|NCT02535091|590077199|FG001|Overall Study|Withdrawal by Subject|5|||
163373993|NCT02535091|590077200|FG002|Overall Study|Withdrawal by Subject|121|||
163414271|NCT02574637|590223069|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
163373994|NCT02535091|590077198|FG000|Overall Study|Adverse Event|9|||
163373995|NCT02535091|590077199|FG001|Overall Study|Adverse Event|4|||
163373996|NCT02535091|590077200|FG002|Overall Study|Adverse Event|170|||
163373997|NCT02535091|590077198|FG000|Overall Study|Other|4|||
163373998|NCT02535091|590077199|FG001|Overall Study|Other|3|||
163373999|NCT02535091|590077200|FG002|Overall Study|Other|81|||
163374000|NCT02535091|590077198|FG000|Overall Study|Lost to Follow-up|0|||
163374001|NCT02535091|590077199|FG001|Overall Study|Lost to Follow-up|1|||
163374002|NCT02535091|590077200|FG002|Overall Study|Lost to Follow-up|19|||
163374003|NCT02535091|590077198|FG000|Overall Study|Protocol Violation|0|||
163374004|NCT02535091|590077199|FG001|Overall Study|Protocol Violation|1|||
163374005|NCT02535091|590077200|FG002|Overall Study|Protocol Violation|11|||
163374006|NCT02535091|590077198|FG000|Overall Study|Pregnancy|0|||
163374007|NCT02535091|590077199|FG001|Overall Study|Pregnancy|0|||
163374008|NCT02535091|590077200|FG002|Overall Study|Pregnancy|7|||
163374009|NCT02643472|590077204|FG000|Overall Study|Death|2|||
163374010|NCT02643472|590077205|FG001|Overall Study|Death|5|||
163374011|NCT02643472|590077204|FG000|Overall Study|Withdrawal by Subject|3|||
163374012|NCT02643472|590077205|FG001|Overall Study|Withdrawal by Subject|2|||
163374013|NCT02643472|590077204|FG000|Overall Study|Protocol Violation|0|||
163374014|NCT02643472|590077205|FG001|Overall Study|Protocol Violation|1|||
163374015|NCT02643472|590077204|FG000|Overall Study|Lost to Follow-up|22|||
163374016|NCT02643472|590077205|FG001|Overall Study|Lost to Follow-up|26|||
163374017|NCT01259089|590077206|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
163374018|NCT01259089|590077207|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
163374019|NCT01259089|590077208|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
163374020|NCT01259089|590077209|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
163374021|NCT01259089|590077210|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
163374022|NCT01259089|590077211|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
163374023|NCT01259089|590077206|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
163374024|NCT01259089|590077207|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
163374025|NCT01259089|590077208|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
163374026|NCT01259089|590077209|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
163374027|NCT01259089|590077210|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
163374028|NCT01259089|590077211|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
163374029|NCT01259089|590077206|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
163374030|NCT01259089|590077207|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
163374031|NCT01259089|590077208|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
163374032|NCT01259089|590077209|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
163374033|NCT01259089|590077210|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
163374034|NCT01259089|590077211|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
163374035|NCT01259089|590077206|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
163374036|NCT01259089|590077207|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
163374037|NCT01259089|590077208|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
163414272|NCT02574637|590223070|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
163414273|NCT02574637|590223071|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
163414274|NCT02574637|590223072|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
163414275|NCT02574637|590223063|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
163414276|NCT02574637|590223064|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
163414277|NCT02574637|590223065|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
163374038|NCT01259089|590077209|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
163374039|NCT01259089|590077210|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
163374040|NCT01259089|590077211|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
163374041|NCT01259089|590077206|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
163374042|NCT01259089|590077207|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
163374043|NCT01259089|590077208|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
163374044|NCT01259089|590077209|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
163374045|NCT01259089|590077210|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
163374046|NCT01259089|590077211|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
163374047|NCT01259089|590077206|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
163374048|NCT01259089|590077207|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
163414278|NCT02574637|590223066|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
163414279|NCT02574637|590223067|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
163414280|NCT02574637|590223068|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
163374049|NCT01259089|590077208|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
163374050|NCT01259089|590077209|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
163374051|NCT01259089|590077210|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
163374052|NCT01259089|590077211|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
163414281|NCT02574637|590223069|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
163414282|NCT02574637|590223070|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
163414283|NCT02574637|590223071|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
163414284|NCT02574637|590223072|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
163374053|NCT01259089|590077206|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
163374054|NCT01259089|590077207|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
163374055|NCT01259089|590077208|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
163374056|NCT01259089|590077209|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
163374057|NCT01259089|590077210|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
163374058|NCT01259089|590077211|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
163374059|NCT01259089|590077206|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
163374060|NCT01259089|590077207|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
163374061|NCT01259089|590077208|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
163374062|NCT01259089|590077209|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
163374063|NCT01259089|590077210|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
163374064|NCT01259089|590077211|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
163374065|NCT01259089|590077206|FG000|Survival Follow up for Two Years|Death|3|||
163374066|NCT01259089|590077207|FG001|Survival Follow up for Two Years|Death|2|||
163374067|NCT01259089|590077208|FG002|Survival Follow up for Two Years|Death|2|||
163374068|NCT01259089|590077209|FG003|Survival Follow up for Two Years|Death|3|||
163374069|NCT01259089|590077210|FG004|Survival Follow up for Two Years|Death|6|||
163374070|NCT01259089|590077211|FG005|Survival Follow up for Two Years|Death|13|||
163374071|NCT01259089|590077206|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
163374072|NCT01259089|590077207|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
163374073|NCT01259089|590077208|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
163374074|NCT01259089|590077209|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
163374075|NCT01259089|590077210|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
163374076|NCT01259089|590077211|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
163374077|NCT01259089|590077206|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
163374078|NCT01259089|590077207|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
163374079|NCT01259089|590077208|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
163374080|NCT01259089|590077209|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
163374081|NCT01259089|590077210|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
163374082|NCT01259089|590077211|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
163374083|NCT01258595|590077216|FG000|Overall Study|Lost to Follow-up|1|||
163374084|NCT01258595|590077217|FG001|Overall Study|Lost to Follow-up|0|||
163374085|NCT01258595|590077216|FG000|Overall Study|Withdrawal by Subject|0|||
163374086|NCT01258595|590077217|FG001|Overall Study|Withdrawal by Subject|1|||
163374087|NCT01215188|590077218|FG000|Overall Study|Lost to Follow-up|22|||
163374088|NCT01215188|590077219|FG001|Overall Study|Lost to Follow-up|22|||
163374089|NCT01215188|590077220|FG002|Overall Study|Lost to Follow-up|16|||
163374090|NCT01215188|590077218|FG000|Overall Study|Adverse Event|1|||
163374091|NCT01215188|590077219|FG001|Overall Study|Adverse Event|1|||
163374092|NCT01215188|590077220|FG002|Overall Study|Adverse Event|3|||
163374093|NCT01215188|590077218|FG000|Overall Study|Physician Decision|2|||
163374094|NCT01215188|590077219|FG001|Overall Study|Physician Decision|1|||
163374095|NCT01215188|590077220|FG002|Overall Study|Physician Decision|0|||
163374096|NCT01215188|590077218|FG000|Overall Study|Lack of Efficacy|0|||
163374097|NCT01215188|590077219|FG001|Overall Study|Lack of Efficacy|0|||
163374098|NCT01215188|590077220|FG002|Overall Study|Lack of Efficacy|1|||
163374099|NCT01215188|590077218|FG000|Overall Study|Protocol Violation|1|||
163374100|NCT01215188|590077219|FG001|Overall Study|Protocol Violation|1|||
163374101|NCT01215188|590077220|FG002|Overall Study|Protocol Violation|1|||
163374102|NCT01215188|590077218|FG000|Overall Study|Withdrawal by Subject|32|||
163374103|NCT01215188|590077219|FG001|Overall Study|Withdrawal by Subject|34|||
163374104|NCT01215188|590077220|FG002|Overall Study|Withdrawal by Subject|31|||
163374105|NCT02310100|590077221|FG000|Overall Study|Physician Decision|3|||
163374106|NCT02310100|590077221|FG000|Overall Study|Withdrawal by Subject|10|||
163374107|NCT02310100|590077221|FG000|Overall Study|Enrollment closure|1|||
163374108|NCT02310100|590077221|FG000|Overall Study|Unapproved ablation operator|1|||
163374109|NCT02310100|590077221|FG000|Overall Study|Visit compliance|1|||
163374110|NCT02310100|590077221|FG000|Overall Study|Lost to Follow-up|2|||
163374111|NCT00688870|590077225|FG000|Infant Series|Parent or legal guardian request|4|||
163374112|NCT00688870|590077226|FG001|Infant Series|Parent or legal guardian request|0|||
163374113|NCT01151410|590077230|FG000|Overall Study|Withdrawal by Subject|3|||
163374114|NCT01151410|590077231|FG001|Overall Study|Withdrawal by Subject|5|||
163374115|NCT01151410|590077230|FG000|Overall Study|Lost to Follow-up|3|||
163374116|NCT01151410|590077231|FG001|Overall Study|Lost to Follow-up|4|||
163374117|NCT01151410|590077230|FG000|Overall Study|Adverse Event|1|||
163414285|NCT02574637|590223063|FG000|Double-blind Period|Reason Not Specified|0|||
163374118|NCT01151410|590077231|FG001|Overall Study|Adverse Event|2|||
163374119|NCT01151410|590077230|FG000|Overall Study|Protocol deviation|2|||
163374120|NCT01151410|590077231|FG001|Overall Study|Protocol deviation|1|||
163374121|NCT01151410|590077230|FG000|Overall Study|Administrative problems|1|||
163374122|NCT01151410|590077231|FG001|Overall Study|Administrative problems|1|||
163414286|NCT02574637|590223064|FG001|Double-blind Period|Reason Not Specified|0|||
163414287|NCT02574637|590223065|FG002|Double-blind Period|Reason Not Specified|0|||
163374123|NCT01151410|590077230|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163374124|NCT01151410|590077231|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163374125|NCT01151410|590077230|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163374126|NCT01151410|590077231|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163374127|NCT01253018|590077232|FG000|Overall Study|Lost to Follow-up|1|||
163374128|NCT01253018|590077233|FG001|Overall Study|Lost to Follow-up|1|||
163374129|NCT01253018|590077232|FG000|Overall Study|Robot Repair Issues|2|||
163374130|NCT01253018|590077233|FG001|Overall Study|Robot Repair Issues|0|||
163374131|NCT01253018|590077232|FG000|Overall Study|Withdrawal by Subject|1|||
163374132|NCT01253018|590077233|FG001|Overall Study|Withdrawal by Subject|1|||
163374133|NCT00744757|590077234|FG000|Overall Study|Objective disease progression|7|||
163374134|NCT00744757|590077234|FG000|Overall Study|Physician Decision|5|||
163374135|NCT00744757|590077234|FG000|Overall Study|Withdrawal by Subject|1|||
163374136|NCT00744757|590077234|FG000|Overall Study|Death|6|||
163374137|NCT00744757|590077234|FG000|Overall Study|Adverse Event|2|||
163374138|NCT01820585|590077235|FG000|Overall Study|Adverse Event|9|||
163374139|NCT01820585|590077236|FG001|Overall Study|Adverse Event|13|||
163414288|NCT02574637|590223066|FG003|Double-blind Period|Reason Not Specified|1|||
163414289|NCT02574637|590223067|FG004|Double-blind Period|Reason Not Specified|0|||
163414290|NCT02574637|590223068|FG005|Double-blind Period|Reason Not Specified|0|||
163414291|NCT02574637|590223069|FG006|Double-blind Period|Reason Not Specified|0|||
163414292|NCT02574637|590223070|FG007|Double-blind Period|Reason Not Specified|0|||
163414293|NCT02574637|590223071|FG008|Double-blind Period|Reason Not Specified|0|||
163374140|NCT01820585|590077237|FG002|Overall Study|Adverse Event|23|||
163374141|NCT01820585|590077238|FG003|Overall Study|Adverse Event|34|||
163374142|NCT01820585|590077235|FG000|Overall Study|Lack of Efficacy|9|||
163374143|NCT01820585|590077236|FG001|Overall Study|Lack of Efficacy|7|||
163374144|NCT01820585|590077237|FG002|Overall Study|Lack of Efficacy|5|||
163374145|NCT01820585|590077238|FG003|Overall Study|Lack of Efficacy|1|||
163374146|NCT01820585|590077235|FG000|Overall Study|Withdrawal by Subject|3|||
163374147|NCT01820585|590077236|FG001|Overall Study|Withdrawal by Subject|7|||
163374148|NCT01820585|590077237|FG002|Overall Study|Withdrawal by Subject|3|||
163374149|NCT01820585|590077238|FG003|Overall Study|Withdrawal by Subject|8|||
163374150|NCT01820585|590077235|FG000|Overall Study|Lost to Follow-up|3|||
163374151|NCT01820585|590077236|FG001|Overall Study|Lost to Follow-up|3|||
163374152|NCT01820585|590077237|FG002|Overall Study|Lost to Follow-up|0|||
163374153|NCT01820585|590077238|FG003|Overall Study|Lost to Follow-up|3|||
163374154|NCT01820585|590077235|FG000|Overall Study|Protocol Violation|3|||
163374155|NCT01820585|590077236|FG001|Overall Study|Protocol Violation|1|||
163374156|NCT01820585|590077237|FG002|Overall Study|Protocol Violation|1|||
163374157|NCT01820585|590077238|FG003|Overall Study|Protocol Violation|1|||
163374158|NCT01820585|590077235|FG000|Overall Study|Subject non-compliance|0|||
163414294|NCT02574637|590223072|FG009|Double-blind Period|Reason Not Specified|0|||
163414295|NCT02574637|590223063|FG000|Open-label (OL) Period|Adverse Event|0|||
163414296|NCT02574637|590223064|FG001|Open-label (OL) Period|Adverse Event|0|||
163414297|NCT02574637|590223065|FG002|Open-label (OL) Period|Adverse Event|0|||
163414298|NCT02574637|590223066|FG003|Open-label (OL) Period|Adverse Event|0|||
163414299|NCT02574637|590223067|FG004|Open-label (OL) Period|Adverse Event|0|||
163414300|NCT02574637|590223068|FG005|Open-label (OL) Period|Adverse Event|0|||
163414301|NCT02574637|590223069|FG006|Open-label (OL) Period|Adverse Event|0|||
163414302|NCT02574637|590223070|FG007|Open-label (OL) Period|Adverse Event|0|||
163414303|NCT02574637|590223071|FG008|Open-label (OL) Period|Adverse Event|1|||
163414304|NCT02574637|590223072|FG009|Open-label (OL) Period|Adverse Event|0|||
163414305|NCT02574637|590223063|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
163414306|NCT02574637|590223064|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
163414307|NCT02574637|590223065|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
163374159|NCT01820585|590077236|FG001|Overall Study|Subject non-compliance|0|||
163374160|NCT01820585|590077237|FG002|Overall Study|Subject non-compliance|1|||
163374161|NCT01820585|590077238|FG003|Overall Study|Subject non-compliance|2|||
163374162|NCT01820585|590077235|FG000|Overall Study|at sponsor request|0|||
163374163|NCT01820585|590077236|FG001|Overall Study|at sponsor request|0|||
163374164|NCT01820585|590077237|FG002|Overall Study|at sponsor request|1|||
163414308|NCT02574637|590223066|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
163414309|NCT02574637|590223067|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
163374165|NCT01820585|590077238|FG003|Overall Study|at sponsor request|0|||
163374166|NCT01820585|590077235|FG000|Overall Study|Pregnancy|0|||
163414310|NCT02574637|590223068|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
163414311|NCT02574637|590223069|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
163414312|NCT02574637|590223070|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
163374167|NCT01820585|590077236|FG001|Overall Study|Pregnancy|1|||
163374168|NCT01820585|590077237|FG002|Overall Study|Pregnancy|0|||
163374169|NCT01820585|590077238|FG003|Overall Study|Pregnancy|0|||
163374170|NCT01712659|590077239|FG000|Dose Escalation|Physician Decision|0|||
163374171|NCT01712659|590077240|FG001|Dose Escalation|Physician Decision|1|||
163374172|NCT01712659|590077241|FG002|Dose Escalation|Physician Decision|0|||
163414313|NCT02574637|590223071|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
163374173|NCT01712659|590077242|FG003|Dose Escalation|Physician Decision|0|||
163374174|NCT01712659|590077243|FG004|Dose Escalation|Physician Decision|0|||
163374175|NCT01712659|590077239|FG000|Dose Escalation|Unable to take study drug|0|||
163374176|NCT01712659|590077240|FG001|Dose Escalation|Unable to take study drug|1|||
163374177|NCT01712659|590077241|FG002|Dose Escalation|Unable to take study drug|0|||
163374178|NCT01712659|590077242|FG003|Dose Escalation|Unable to take study drug|0|||
163374179|NCT01712659|590077243|FG004|Dose Escalation|Unable to take study drug|0|||
163374180|NCT01712659|590077239|FG000|Dose Expansion|Early disease progression|1|||
163374181|NCT01712659|590077240|FG001|Dose Expansion|Early disease progression|0|||
163374182|NCT01712659|590077241|FG002|Dose Expansion|Early disease progression|0|||
163374183|NCT01712659|590077242|FG003|Dose Expansion|Early disease progression|0|||
163374184|NCT01712659|590077243|FG004|Dose Expansion|Early disease progression|0|||
163374185|NCT01712659|590077239|FG000|Dose Expansion|Physician Decision|1|||
163374186|NCT01712659|590077240|FG001|Dose Expansion|Physician Decision|0|||
163374187|NCT01712659|590077241|FG002|Dose Expansion|Physician Decision|0|||
163374188|NCT01712659|590077242|FG003|Dose Expansion|Physician Decision|0|||
163374189|NCT01712659|590077243|FG004|Dose Expansion|Physician Decision|0|||
163374190|NCT00548262|590077244|FG000|Overall Study|Death|21|||
163374191|NCT00548262|590077244|FG000|Overall Study|Adverse Event|2|||
163374192|NCT00548262|590077244|FG000|Overall Study|Lack of Efficacy|4|||
163374193|NCT00548262|590077244|FG000|Overall Study|Lost to Follow-up|1|||
163374194|NCT00548262|590077244|FG000|Overall Study|Other|3|||
163374195|NCT00548262|590077244|FG000|Overall Study|Withdrawal by Subject|1|||
163374196|NCT01769326|590077250|FG000|Overall Study|Lost to Follow-up|1|||
163374197|NCT01769326|590077251|FG001|Overall Study|Lost to Follow-up|2|||
163374198|NCT01769326|590077252|FG002|Overall Study|Lost to Follow-up|0|||
163374199|NCT01769326|590077253|FG003|Overall Study|Lost to Follow-up|0|||
163374200|NCT01769326|590077250|FG000|Overall Study|unrelated injry|1|||
163374201|NCT01769326|590077251|FG001|Overall Study|unrelated injry|1|||
163374202|NCT01769326|590077252|FG002|Overall Study|unrelated injry|0|||
163374203|NCT01769326|590077253|FG003|Overall Study|unrelated injry|0|||
163374204|NCT01769326|590077250|FG000|Overall Study|got a job|0|||
163374205|NCT01769326|590077251|FG001|Overall Study|got a job|1|||
163374206|NCT01769326|590077252|FG002|Overall Study|got a job|0|||
163374207|NCT01769326|590077253|FG003|Overall Study|got a job|0|||
163374208|NCT01769326|590077250|FG000|Overall Study|Got sick and could not complete study|0|||
163374209|NCT01769326|590077251|FG001|Overall Study|Got sick and could not complete study|0|||
163374210|NCT01769326|590077252|FG002|Overall Study|Got sick and could not complete study|1|||
163374211|NCT01769326|590077253|FG003|Overall Study|Got sick and could not complete study|0|||
163374212|NCT01036438|590077254|FG000|Overall Study|Adverse Event|7|||
163374213|NCT01036438|590077255|FG001|Overall Study|Adverse Event|8|||
163374214|NCT01036438|590077254|FG000|Overall Study|Death|0|||
163374215|NCT01036438|590077255|FG001|Overall Study|Death|1|||
163374216|NCT01036438|590077254|FG000|Overall Study|No effect of study treatment|3|||
163374217|NCT01036438|590077255|FG001|Overall Study|No effect of study treatment|1|||
163374218|NCT00888927|590077256|FG000|Overall Study|Adverse Event|0|||
163374219|NCT00888927|590077257|FG001|Overall Study|Adverse Event|0|||
163374220|NCT00888927|590077258|FG002|Overall Study|Adverse Event|0|||
163374221|NCT00888927|590077259|FG003|Overall Study|Adverse Event|1|||
163374222|NCT00888927|590077256|FG000|Overall Study|Withdrawal of consent|0|||
163374223|NCT00888927|590077257|FG001|Overall Study|Withdrawal of consent|0|||
163374224|NCT00888927|590077258|FG002|Overall Study|Withdrawal of consent|0|||
163374225|NCT00888927|590077259|FG003|Overall Study|Withdrawal of consent|1|||
163374226|NCT03592745|590077260|FG000|Overall Study|Adverse Event|0|||
163374227|NCT03592745|590077261|FG001|Overall Study|Adverse Event|2|||
163374228|NCT03592745|590077260|FG000|Overall Study|Lost to Follow-up|2|||
163374229|NCT03592745|590077261|FG001|Overall Study|Lost to Follow-up|0|||
163374230|NCT03592745|590077260|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
163374231|NCT03592745|590077261|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
163374232|NCT00293059|590077262|FG000|Overall Study|Adverse Event|12|||
163374233|NCT00293059|590077263|FG001|Overall Study|Adverse Event|4|||
163374234|NCT00293059|590077262|FG000|Overall Study|Lack of Efficacy|2|||
163374235|NCT00293059|590077263|FG001|Overall Study|Lack of Efficacy|0|||
163374236|NCT00293059|590077262|FG000|Overall Study|Lost to Follow-up|2|||
163374237|NCT00293059|590077263|FG001|Overall Study|Lost to Follow-up|3|||
163374238|NCT00293059|590077262|FG000|Overall Study|Pregnancy|1|||
163374239|NCT00293059|590077263|FG001|Overall Study|Pregnancy|1|||
163374240|NCT00293059|590077262|FG000|Overall Study|Protocol Violation|2|||
163374241|NCT00293059|590077263|FG001|Overall Study|Protocol Violation|0|||
163374242|NCT00293059|590077262|FG000|Overall Study|Withdrawal by Subject|11|||
163374243|NCT00293059|590077263|FG001|Overall Study|Withdrawal by Subject|5|||
163374244|NCT00293059|590077262|FG000|Overall Study|Participant moved out of state|1|||
163374245|NCT00293059|590077263|FG001|Overall Study|Participant moved out of state|0|||
163374246|NCT00293059|590077262|FG000|Overall Study|Participant stopped study drug|1|||
163374247|NCT00293059|590077263|FG001|Overall Study|Participant stopped study drug|0|||
163374248|NCT00293059|590077262|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
163374249|NCT00293059|590077263|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
163374250|NCT00293059|590077262|FG000|Overall Study|missing|3|||
163374251|NCT00293059|590077263|FG001|Overall Study|missing|5|||
163374252|NCT04362189|590077267|FG000|Overall Study|Lost to Follow-up|0|||
163374253|NCT04362189|590077268|FG001|Overall Study|Lost to Follow-up|1|||
163374254|NCT04362189|590077267|FG000|Overall Study|Withdrawal by Subject|1|||
163374255|NCT04362189|590077268|FG001|Overall Study|Withdrawal by Subject|0|||
163374256|NCT04362189|590077267|FG000|Overall Study|FDA Clinical Hold|7|||
163374257|NCT04362189|590077268|FG001|Overall Study|FDA Clinical Hold|2|||
163374258|NCT04362189|590077267|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
163374259|NCT04362189|590077268|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
163374260|NCT04362189|590077267|FG000|Overall Study|Adverse Event|0|||
163374261|NCT04362189|590077268|FG001|Overall Study|Adverse Event|2|||
163374262|NCT04362189|590077267|FG000|Overall Study|Death|4|||
163374263|NCT04362189|590077268|FG001|Overall Study|Death|1|||
163374264|NCT02111681|590077269|FG000|Overall Study|Death|5|||
163374265|NCT02111681|590077269|FG000|Overall Study|Lack of Efficacy|2|||
163374266|NCT02111681|590077269|FG000|Overall Study|Progression of disease|4|||
163374267|NCT03981861|590077270|FG000|Overall Study|Withdrawal by Subject|3|||
163374268|NCT02914275|590079209|FG000|Overall Study|Lost to Follow-up|84|||
163374269|NCT02914275|590079210|FG001|Overall Study|Lost to Follow-up|29|||
163374270|NCT02914275|590079209|FG000|Overall Study|Withdrawal by Subject|26|||
163374271|NCT02914275|590079210|FG001|Overall Study|Withdrawal by Subject|10|||
163374272|NCT02914275|590079209|FG000|Overall Study|Protocol Violation|1|||
163374273|NCT02914275|590079210|FG001|Overall Study|Protocol Violation|1|||
163374274|NCT02914275|590079209|FG000|Overall Study|Physician Decision|3|||
163374275|NCT02914275|590079210|FG001|Overall Study|Physician Decision|1|||
163374276|NCT02914275|590079209|FG000|Overall Study|Other|4|||
163374277|NCT02914275|590079210|FG001|Overall Study|Other|1|||
163374278|NCT02914275|590079209|FG000|Overall Study|Excluded due to invalid informed consent|3|||
163374279|NCT02914275|590079210|FG001|Overall Study|Excluded due to invalid informed consent|0|||
163374280|NCT00923260|590079211|FG000|Overall Study|Lost to Follow-up|1|||
163374281|NCT00923260|590079212|FG001|Overall Study|Lost to Follow-up|1|||
163374282|NCT02134977|590079225|FG000|Overall Study|Protocol Deviation|102|||
163374283|NCT03828747|590079226|FG000|Double-Blind Treatment Period|Adverse Event|6|||
163374284|NCT03828747|590079227|FG001|Double-Blind Treatment Period|Adverse Event|6|||
163374285|NCT03828747|590079226|FG000|Double-Blind Treatment Period|Death|1|||
163374286|NCT03828747|590079227|FG001|Double-Blind Treatment Period|Death|1|||
163374287|NCT03828747|590079226|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163374288|NCT03828747|590079227|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
163374289|NCT03828747|590079226|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
163374290|NCT03828747|590079227|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
163374291|NCT03828747|590079226|FG000|Double-Blind Treatment Period|Physician Decision|1|||
163374292|NCT03828747|590079227|FG001|Double-Blind Treatment Period|Physician Decision|4|||
163374293|NCT03828747|590079226|FG000|Double-Blind Treatment Period|Various reasons|5|||
163374294|NCT03828747|590079227|FG001|Double-Blind Treatment Period|Various reasons|3|||
163374295|NCT03828747|590079226|FG000|Open-Label Extension|Adverse Event|9|||
163374296|NCT03828747|590079227|FG001|Open-Label Extension|Adverse Event|7|||
163374297|NCT03828747|590079226|FG000|Open-Label Extension|Death|0|||
163374298|NCT03828747|590079227|FG001|Open-Label Extension|Death|2|||
163374299|NCT03828747|590079226|FG000|Open-Label Extension|Lost to Follow-up|4|||
163374300|NCT03828747|590079227|FG001|Open-Label Extension|Lost to Follow-up|0|||
163374301|NCT03828747|590079226|FG000|Open-Label Extension|Withdrawal by Subject|31|||
163374302|NCT03828747|590079227|FG001|Open-Label Extension|Withdrawal by Subject|30|||
163374303|NCT03828747|590079226|FG000|Open-Label Extension|Various reasons|4|||
163374304|NCT03828747|590079227|FG001|Open-Label Extension|Various reasons|4|||
163374305|NCT03828747|590079226|FG000|Open-Label Extension|Physician Decision|6|||
163374306|NCT03828747|590079227|FG001|Open-Label Extension|Physician Decision|2|||
163374307|NCT01658150|590079228|FG000|Overall Study|Withdrawal by Subject|1|||
163374308|NCT04187989|590079229|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
163374309|NCT04187989|590079230|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
163374310|NCT04187989|590079229|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
163374311|NCT04187989|590079230|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
163374312|NCT03646656|590079231|FG000|Overall Study|Lost to Follow-up|1|||
163374313|NCT03646656|590079232|FG001|Overall Study|Lost to Follow-up|0|||
163374314|NCT03646656|590079231|FG000|Overall Study|Withdrawal by Subject|2|||
163374315|NCT03646656|590079232|FG001|Overall Study|Withdrawal by Subject|0|||
163374316|NCT03507777|590079233|FG000|Overall Study|Lost to Follow-up|5|||
163374317|NCT03507777|590079234|FG001|Overall Study|Lost to Follow-up|7|||
163374318|NCT03507777|590079233|FG000|Overall Study|Withdrawal by Subject|6|||
163374319|NCT03507777|590079234|FG001|Overall Study|Withdrawal by Subject|11|||
163374320|NCT03507777|590079233|FG000|Overall Study|Death|30|||
163374321|NCT03507777|590079234|FG001|Overall Study|Death|44|||
163374322|NCT03507777|590079233|FG000|Overall Study|Other Reasons|3|||
163374323|NCT03507777|590079234|FG001|Overall Study|Other Reasons|8|||
163374324|NCT00446043|590079235|FG000|Overall Study|Adverse Event|9|||
163374325|NCT00446043|590079235|FG000|Overall Study|Withdrawal by Subject|70|||
163374326|NCT00446043|590079235|FG000|Overall Study|Protocol Violation|2|||
163374327|NCT00446043|590079235|FG000|Overall Study|Lost to Follow-up|42|||
163374328|NCT00446043|590079235|FG000|Overall Study|Pregnancy|2|||
163374329|NCT02071290|590079240|FG000|Overall Study|Death|1|||
163374330|NCT02071290|590079241|FG001|Overall Study|Death|0|||
163374331|NCT02071290|590079240|FG000|Overall Study|Withdrawal by Subject|0|||
163374332|NCT02071290|590079241|FG001|Overall Study|Withdrawal by Subject|1|||
163374333|NCT02071290|590079240|FG000|Overall Study|Protocol Violation|3|||
163374334|NCT02071290|590079241|FG001|Overall Study|Protocol Violation|5|||
163374335|NCT02071290|590079240|FG000|Overall Study|Physician Decision|0|||
163374336|NCT02071290|590079241|FG001|Overall Study|Physician Decision|1|||
163374337|NCT00964886|590079250|FG000|Overall Study|Lost to Follow-up|2|||
163374338|NCT00964886|590079251|FG001|Overall Study|Lost to Follow-up|2|||
163374339|NCT00964886|590079252|FG002|Overall Study|Lost to Follow-up|6|||
163374340|NCT00964886|590079253|FG003|Overall Study|Lost to Follow-up|4|||
163374341|NCT00964886|590079250|FG000|Overall Study|Withdrawal by Subject|6|||
163374342|NCT00964886|590079251|FG001|Overall Study|Withdrawal by Subject|2|||
163374343|NCT00964886|590079252|FG002|Overall Study|Withdrawal by Subject|5|||
163374344|NCT00964886|590079253|FG003|Overall Study|Withdrawal by Subject|3|||
163374345|NCT00964886|590079250|FG000|Overall Study|Adverse Event|3|||
163374346|NCT00964886|590079251|FG001|Overall Study|Adverse Event|1|||
163374347|NCT00964886|590079252|FG002|Overall Study|Adverse Event|5|||
163374348|NCT00964886|590079253|FG003|Overall Study|Adverse Event|2|||
163374349|NCT00964886|590079250|FG000|Overall Study|Protocol Violation|0|||
163374350|NCT00964886|590079251|FG001|Overall Study|Protocol Violation|2|||
163374351|NCT00964886|590079252|FG002|Overall Study|Protocol Violation|0|||
163374352|NCT00964886|590079253|FG003|Overall Study|Protocol Violation|0|||
163374353|NCT01871805|590079257|FG000|Phase I|Death|7|||
163374354|NCT01871805|590079258|FG001|Phase I|Death|4|||
163374355|NCT01871805|590079259|FG002|Phase I|Death|6|||
163374356|NCT01871805|590079260|FG003|Phase I|Death|2|||
163374357|NCT01871805|590079261|FG004|Phase I|Death|9|||
163374358|NCT01871805|590079262|FG005|Phase I|Death|0|||
163374359|NCT01871805|590079257|FG000|Phase I|Alive in Survival Follow-up|0|||
163374360|NCT01871805|590079258|FG001|Phase I|Alive in Survival Follow-up|2|||
163374361|NCT01871805|590079259|FG002|Phase I|Alive in Survival Follow-up|4|||
163374362|NCT01871805|590079260|FG003|Phase I|Alive in Survival Follow-up|5|||
163374363|NCT01871805|590079261|FG004|Phase I|Alive in Survival Follow-up|4|||
163374364|NCT01871805|590079262|FG005|Phase I|Alive in Survival Follow-up|0|||
163374365|NCT01871805|590079257|FG000|Phase I|Lost to Follow-up|0|||
163374366|NCT01871805|590079258|FG001|Phase I|Lost to Follow-up|1|||
163374367|NCT01871805|590079259|FG002|Phase I|Lost to Follow-up|3|||
163374368|NCT01871805|590079260|FG003|Phase I|Lost to Follow-up|0|||
163374369|NCT01871805|590079261|FG004|Phase I|Lost to Follow-up|0|||
163374370|NCT01871805|590079262|FG005|Phase I|Lost to Follow-up|0|||
163374371|NCT01871805|590079257|FG000|Phase II|Death|0|||
163374372|NCT01871805|590079258|FG001|Phase II|Death|0|||
163374373|NCT01871805|590079259|FG002|Phase II|Death|0|||
163374374|NCT01871805|590079260|FG003|Phase II|Death|0|||
163374375|NCT01871805|590079261|FG004|Phase II|Death|0|||
163374376|NCT01871805|590079262|FG005|Phase II|Death|45|||
163374377|NCT01871805|590079257|FG000|Phase II|Alive in Survival Follow-up|0|||
163374378|NCT01871805|590079258|FG001|Phase II|Alive in Survival Follow-up|0|||
163374379|NCT01871805|590079259|FG002|Phase II|Alive in Survival Follow-up|0|||
163374380|NCT01871805|590079260|FG003|Phase II|Alive in Survival Follow-up|0|||
163374381|NCT01871805|590079261|FG004|Phase II|Alive in Survival Follow-up|0|||
163374382|NCT01871805|590079262|FG005|Phase II|Alive in Survival Follow-up|29|||
163374383|NCT01871805|590079257|FG000|Phase II|Lost to Follow-up|0|||
163374384|NCT01871805|590079258|FG001|Phase II|Lost to Follow-up|0|||
163374385|NCT01871805|590079259|FG002|Phase II|Lost to Follow-up|0|||
163374386|NCT01871805|590079260|FG003|Phase II|Lost to Follow-up|0|||
163374387|NCT01871805|590079261|FG004|Phase II|Lost to Follow-up|0|||
163374388|NCT01871805|590079262|FG005|Phase II|Lost to Follow-up|13|||
163374389|NCT00941070|590079265|FG000|Overall Study|Patient non-compliant|1|||
163374390|NCT03500159|590079266|FG000|Overall Study|Study Terminated|2|||
163374391|NCT03500159|590079267|FG001|Overall Study|Study Terminated|1|||
163374392|NCT03484273|590079272|FG000|Overall Study|Equipment Malfunction|1|||
163374393|NCT03484273|590079272|FG000|Overall Study|Data excluded from analysis|1|||
163374394|NCT00468104|590079273|FG000|First Intervention|Protocol Violation|2|||
163374395|NCT00468104|590079274|FG001|First Intervention|Protocol Violation|1|||
163374396|NCT00468104|590079273|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
163374397|NCT00468104|590079274|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
163374398|NCT00468104|590079273|FG000|First Intervention|died within 3 weeks|1|||
163374399|NCT00468104|590079274|FG001|First Intervention|died within 3 weeks|0|||
163374400|NCT00468104|590079273|FG000|First Intervention|malposition/blocked chest tube tube|2|||
163374401|NCT00468104|590079274|FG001|First Intervention|malposition/blocked chest tube tube|0|||
163374402|NCT00468104|590079273|FG000|First Intervention|large lung mass with minimal effusion|1|||
163374403|NCT00468104|590079274|FG001|First Intervention|large lung mass with minimal effusion|0|||
163374404|NCT00468104|590079273|FG000|First Intervention|associated prolonged pneumothorax|1|||
163374405|NCT00468104|590079274|FG001|First Intervention|associated prolonged pneumothorax|0|||
163374406|NCT00468104|590079273|FG000|First Intervention|trapped lung|1|||
163374407|NCT00468104|590079274|FG001|First Intervention|trapped lung|0|||
163374408|NCT00468104|590079273|FG000|Second Intervention|Withdrawal by Subject|5|||
163374409|NCT00468104|590079274|FG001|Second Intervention|Withdrawal by Subject|2|||
163374410|NCT00468104|590079273|FG000|Second Intervention|discarded for malposition of chest tube|0|||
163374411|NCT00468104|590079274|FG001|Second Intervention|discarded for malposition of chest tube|2|||
163374412|NCT01263665|590079276|FG000|Overall Study|Withdrew Consent|1|||
163374413|NCT01263665|590079276|FG000|Overall Study|Lost to Follow-up|3|||
163374414|NCT01263665|590079276|FG000|Overall Study|Death|2|||
163374415|NCT01263665|590079276|FG000|Overall Study|Amputation above the ankle|1|||
163374416|NCT01263665|590079276|FG000|Overall Study|Surgical Bypass|2|||
163374417|NCT00324675|590079279|FG000|Overall Study|Adverse Event|1|||
163374418|NCT00324675|590079280|FG001|Overall Study|Adverse Event|0|||
163374419|NCT01941719|590079283|FG000|Overall Study|Lost to Follow-up|20|||
163374420|NCT01941719|590079284|FG001|Overall Study|Lost to Follow-up|19|||
163374421|NCT00381615|590079285|FG000|Overall Study|Withdrawal by Subject|1|||
163374422|NCT00381615|590079286|FG001|Overall Study|Withdrawal by Subject|3|||
163374423|NCT00381615|590079287|FG002|Overall Study|Withdrawal by Subject|0|||
163374424|NCT00381615|590079288|FG003|Overall Study|Withdrawal by Subject|1|||
163374425|NCT00381615|590079285|FG000|Overall Study|Lost to Follow-up|3|||
163374426|NCT00381615|590079286|FG001|Overall Study|Lost to Follow-up|2|||
163374427|NCT00381615|590079287|FG002|Overall Study|Lost to Follow-up|0|||
163374428|NCT00381615|590079288|FG003|Overall Study|Lost to Follow-up|1|||
163374429|NCT00381615|590079285|FG000|Overall Study|Protocol Violation|0|||
163374430|NCT00381615|590079286|FG001|Overall Study|Protocol Violation|0|||
163374431|NCT00381615|590079287|FG002|Overall Study|Protocol Violation|1|||
163374432|NCT00381615|590079288|FG003|Overall Study|Protocol Violation|0|||
163374433|NCT03819634|590079291|FG000|Overall Study|Physician Decision|2|||
163374434|NCT00958841|590079292|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163374435|NCT00958841|590079292|FG000|Overall Study|Abnormal test procedure result(s)|3|||
163374436|NCT00958841|590079292|FG000|Overall Study|Administrative problems|1|||
163374437|NCT00958841|590079292|FG000|Overall Study|Adverse Event|8|||
163374438|NCT00958841|590079292|FG000|Overall Study|New cancer therapy|5|||
163374439|NCT00958841|590079292|FG000|Overall Study|Withdrawal by Subject|1|||
163374440|NCT00958841|590079292|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
163374441|NCT00958841|590079292|FG000|Overall Study|Completed M6/did not enter extension|27|||
163374442|NCT00958841|590079292|FG000|Overall Study|Discontinued prior to M*|28|||
163374443|NCT01125514|590079294|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
163374444|NCT01125514|590079294|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
163374445|NCT01125514|590079294|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
163374446|NCT01125514|590079294|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
163374447|NCT01125514|590079294|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
163374448|NCT01125514|590079294|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
163374449|NCT00858364|590079295|FG000|Overall Study|Administrative Decision|3|||
163374450|NCT00858364|590079296|FG001|Overall Study|Administrative Decision|2|||
163374451|NCT00858364|590079295|FG000|Overall Study|Adverse Event|5|||
163374452|NCT00858364|590079296|FG001|Overall Study|Adverse Event|2|||
163374453|NCT00858364|590079295|FG000|Overall Study|Withdrawal by Subject|44|||
163374454|NCT00858364|590079296|FG001|Overall Study|Withdrawal by Subject|118|||
163374455|NCT00858364|590079295|FG000|Overall Study|Ineligibility Determined|1|||
163374456|NCT00858364|590079296|FG001|Overall Study|Ineligibility Determined|10|||
163374457|NCT00858364|590079295|FG000|Overall Study|Lost to Follow-up|24|||
163374458|NCT00858364|590079296|FG001|Overall Study|Lost to Follow-up|54|||
163374459|NCT00858364|590079295|FG000|Overall Study|Noncompliance|3|||
163374460|NCT00858364|590079296|FG001|Overall Study|Noncompliance|4|||
163374461|NCT00858364|590079295|FG000|Overall Study|Protocol Deviation|0|||
163374462|NCT00858364|590079296|FG001|Overall Study|Protocol Deviation|2|||
163374463|NCT00858364|590079295|FG000|Overall Study|Other|9|||
163374464|NCT00858364|590079296|FG001|Overall Study|Other|17|||
163374465|NCT00858364|590079295|FG000|Overall Study|Missing|1|||
163374466|NCT00858364|590079296|FG001|Overall Study|Missing|1|||
163374467|NCT00858364|590079295|FG000|Overall Study|Still on-study|114|||
163374468|NCT00858364|590079296|FG001|Overall Study|Still on-study|247|||
163374469|NCT01655693|590079300|FG000|Overall Study|Progression of Disease|92|||
163374470|NCT01655693|590079301|FG001|Overall Study|Progression of Disease|76|||
163374471|NCT01655693|590079302|FG002|Overall Study|Progression of Disease|58|||
163374472|NCT01655693|590079300|FG000|Overall Study|Death|8|||
163374473|NCT01655693|590079301|FG001|Overall Study|Death|9|||
163374474|NCT01655693|590079302|FG002|Overall Study|Death|12|||
163374475|NCT01655693|590079300|FG000|Overall Study|Serious Adverse Event|3|||
163374476|NCT01655693|590079301|FG001|Overall Study|Serious Adverse Event|15|||
163374477|NCT01655693|590079302|FG002|Overall Study|Serious Adverse Event|11|||
163374478|NCT01655693|590079300|FG000|Overall Study|Withdrawal by Subject|3|||
163374479|NCT01655693|590079301|FG001|Overall Study|Withdrawal by Subject|2|||
163374480|NCT01655693|590079302|FG002|Overall Study|Withdrawal by Subject|20|||
163374481|NCT01655693|590079300|FG000|Overall Study|Adverse Event|3|||
163374482|NCT01655693|590079301|FG001|Overall Study|Adverse Event|11|||
163374483|NCT01655693|590079302|FG002|Overall Study|Adverse Event|3|||
163374484|NCT01655693|590079300|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
163374485|NCT01655693|590079301|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
163374486|NCT01655693|590079302|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
163374487|NCT01655693|590079300|FG000|Overall Study|Non-Compliance|0|||
163374488|NCT01655693|590079301|FG001|Overall Study|Non-Compliance|0|||
163374489|NCT01655693|590079302|FG002|Overall Study|Non-Compliance|7|||
163374490|NCT01655693|590079300|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
163374491|NCT01655693|590079301|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
163374492|NCT01655693|590079302|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
163374493|NCT01655693|590079300|FG000|Overall Study|Protocol Violation|1|||
163374494|NCT01655693|590079301|FG001|Overall Study|Protocol Violation|0|||
163374495|NCT01655693|590079302|FG002|Overall Study|Protocol Violation|3|||
163374496|NCT01655693|590079300|FG000|Overall Study|Lost to Follow-up|1|||
163374497|NCT01655693|590079301|FG001|Overall Study|Lost to Follow-up|0|||
163374498|NCT01655693|590079302|FG002|Overall Study|Lost to Follow-up|1|||
163374499|NCT01655693|590079300|FG000|Overall Study|Screening Failure|1|||
163374500|NCT01655693|590079301|FG001|Overall Study|Screening Failure|0|||
163374501|NCT01655693|590079302|FG002|Overall Study|Screening Failure|0|||
163374502|NCT01655693|590079300|FG000|Overall Study|Other|8|||
163374503|NCT01655693|590079301|FG001|Overall Study|Other|6|||
163374504|NCT01655693|590079302|FG002|Overall Study|Other|15|||
163374505|NCT01012414|590079306|FG000|Overall Study|Withdrawal by Subject|2|||
163374506|NCT01012414|590079306|FG000|Overall Study|Lost to Follow-up|1|||
163374507|NCT01012414|590079306|FG000|Overall Study|Trial was stopped before completed|7|||
163374508|NCT02601300|590079307|FG000|Induction Phase|Lack of Efficacy|2|||
163374509|NCT02601300|590079307|FG000|Induction Phase|Protocol Violation|1|||
163374510|NCT02601300|590079307|FG000|Extension Phase|Withdrawal by Subject|3|||
163374511|NCT02601300|590079307|FG000|Extension Phase|Adverse Event|4|||
163374512|NCT02601300|590079307|FG000|Extension Phase|Lack of Efficacy|10|||
163374513|NCT00291642|590079312|FG000|Overall Study|Adverse Event|1|||
163374514|NCT00291642|590079313|FG001|Overall Study|Adverse Event|0|||
163374515|NCT00291642|590079314|FG002|Overall Study|Adverse Event|1|||
163374516|NCT00291642|590079315|FG003|Overall Study|Adverse Event|0|||
163374517|NCT00291642|590079316|FG004|Overall Study|Adverse Event|1|||
163374518|NCT00291642|590079312|FG000|Overall Study|Patient missed visit|0|||
163374519|NCT00291642|590079313|FG001|Overall Study|Patient missed visit|0|||
163374520|NCT00291642|590079314|FG002|Overall Study|Patient missed visit|1|||
163374521|NCT00291642|590079315|FG003|Overall Study|Patient missed visit|0|||
163374522|NCT00291642|590079316|FG004|Overall Study|Patient missed visit|0|||
163374523|NCT00291642|590079312|FG000|Overall Study|Intake of prohibited medication|1|||
163374524|NCT00291642|590079313|FG001|Overall Study|Intake of prohibited medication|0|||
163374525|NCT00291642|590079314|FG002|Overall Study|Intake of prohibited medication|0|||
163374526|NCT00291642|590079315|FG003|Overall Study|Intake of prohibited medication|0|||
163374527|NCT00291642|590079316|FG004|Overall Study|Intake of prohibited medication|0|||
163374528|NCT02544451|590079320|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
163374529|NCT02544451|590079321|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
163374530|NCT02544451|590079322|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
163374531|NCT02544451|590079323|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
163374532|NCT02544451|590079320|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
163374533|NCT02544451|590079321|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
163374534|NCT02544451|590079322|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
163374535|NCT02544451|590079323|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
163374536|NCT02544451|590079320|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
163374537|NCT02544451|590079321|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
163374538|NCT02544451|590079322|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
163374539|NCT02544451|590079323|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
163374540|NCT02544451|590079320|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
163374541|NCT02544451|590079321|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
163374542|NCT02544451|590079322|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
163374543|NCT02544451|590079323|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
163414314|NCT02574637|590223072|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
163414315|NCT02574637|590223063|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
163414316|NCT02574637|590223064|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
163414317|NCT02574637|590223065|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
163414318|NCT02574637|590223066|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
163374544|NCT02544451|590079320|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
163374545|NCT02544451|590079321|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
163374546|NCT02544451|590079322|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
163374547|NCT02544451|590079323|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
163374548|NCT02544451|590079320|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
163374549|NCT02544451|590079321|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
163374550|NCT02544451|590079322|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
163374551|NCT02544451|590079323|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
163374552|NCT03001076|590079327|FG000|Overall Study|Withdrawal by patient|2|||
163374553|NCT03001076|590079328|FG001|Overall Study|Withdrawal by patient|0|||
163374554|NCT03001076|590079327|FG000|Overall Study|Other|1|||
163374555|NCT03001076|590079328|FG001|Overall Study|Other|0|||
163374556|NCT03001076|590079327|FG000|Overall Study|Adverse Event|3|||
163374557|NCT03001076|590079328|FG001|Overall Study|Adverse Event|3|||
163374558|NCT03001076|590079327|FG000|Overall Study|Sponsor decision|1|||
163374559|NCT03001076|590079328|FG001|Overall Study|Sponsor decision|0|||
163374560|NCT03001076|590079327|FG000|Overall Study|Lost to Follow-up|0|||
163374561|NCT03001076|590079328|FG001|Overall Study|Lost to Follow-up|2|||
163374562|NCT04602221|590079329|FG000|Overall Study|Discontinuation of trial treatment|0|||
163374563|NCT04602221|590079330|FG001|Overall Study|Discontinuation of trial treatment|0|||
163374564|NCT04602221|590079331|FG002|Overall Study|Discontinuation of trial treatment|1|||
163374565|NCT04602221|590079332|FG003|Overall Study|Discontinuation of trial treatment|0|||
163374566|NCT04602221|590079333|FG004|Overall Study|Discontinuation of trial treatment|0|||
163374567|NCT04602221|590079334|FG005|Overall Study|Discontinuation of trial treatment|0|||
163374568|NCT04602221|590079335|FG006|Overall Study|Discontinuation of trial treatment|0|||
163374569|NCT04602221|590079336|FG007|Overall Study|Discontinuation of trial treatment|0|||
163374570|NCT04602221|590079337|FG008|Overall Study|Discontinuation of trial treatment|0|||
163374571|NCT04602221|590079338|FG009|Overall Study|Discontinuation of trial treatment|0|||
163374572|NCT04602221|590079339|FG010|Overall Study|Discontinuation of trial treatment|0|||
163374573|NCT04602221|590079340|FG011|Overall Study|Discontinuation of trial treatment|0|||
163374574|NCT04602221|590079341|FG012|Overall Study|Discontinuation of trial treatment|0|||
163374575|NCT04602221|590079342|FG013|Overall Study|Discontinuation of trial treatment|0|||
163374576|NCT04602221|590079343|FG014|Overall Study|Discontinuation of trial treatment|0|||
163374577|NCT04602221|590079344|FG015|Overall Study|Discontinuation of trial treatment|0|||
163374578|NCT04602221|590079345|FG016|Overall Study|Discontinuation of trial treatment|0|||
163374579|NCT04602221|590079346|FG017|Overall Study|Discontinuation of trial treatment|0|||
163374580|NCT04602221|590079329|FG000|Overall Study|Other than listed|0|||
163374581|NCT04602221|590079330|FG001|Overall Study|Other than listed|0|||
163374582|NCT04602221|590079331|FG002|Overall Study|Other than listed|0|||
163374583|NCT04602221|590079332|FG003|Overall Study|Other than listed|0|||
163374584|NCT04602221|590079333|FG004|Overall Study|Other than listed|0|||
163374585|NCT04602221|590079334|FG005|Overall Study|Other than listed|0|||
163374586|NCT04602221|590079335|FG006|Overall Study|Other than listed|0|||
163374587|NCT04602221|590079336|FG007|Overall Study|Other than listed|0|||
163374588|NCT04602221|590079337|FG008|Overall Study|Other than listed|0|||
163374589|NCT04602221|590079338|FG009|Overall Study|Other than listed|0|||
163374590|NCT04602221|590079339|FG010|Overall Study|Other than listed|0|||
163374591|NCT04602221|590079340|FG011|Overall Study|Other than listed|0|||
163374592|NCT04602221|590079341|FG012|Overall Study|Other than listed|0|||
163374593|NCT04602221|590079342|FG013|Overall Study|Other than listed|0|||
163374594|NCT04602221|590079343|FG014|Overall Study|Other than listed|0|||
163374595|NCT04602221|590079344|FG015|Overall Study|Other than listed|1|||
163374596|NCT04602221|590079345|FG016|Overall Study|Other than listed|0|||
163374597|NCT04602221|590079346|FG017|Overall Study|Other than listed|1|||
163374598|NCT04602221|590079329|FG000|Overall Study|Withdrawal by Subject|0|||
163374599|NCT04602221|590079330|FG001|Overall Study|Withdrawal by Subject|0|||
163374600|NCT04602221|590079331|FG002|Overall Study|Withdrawal by Subject|0|||
163374601|NCT04602221|590079332|FG003|Overall Study|Withdrawal by Subject|0|||
163374602|NCT04602221|590079333|FG004|Overall Study|Withdrawal by Subject|0|||
163374603|NCT04602221|590079334|FG005|Overall Study|Withdrawal by Subject|0|||
163374604|NCT04602221|590079335|FG006|Overall Study|Withdrawal by Subject|0|||
163374605|NCT04602221|590079336|FG007|Overall Study|Withdrawal by Subject|0|||
163374606|NCT04602221|590079337|FG008|Overall Study|Withdrawal by Subject|0|||
163374607|NCT04602221|590079338|FG009|Overall Study|Withdrawal by Subject|0|||
163374608|NCT04602221|590079339|FG010|Overall Study|Withdrawal by Subject|0|||
163374609|NCT04602221|590079340|FG011|Overall Study|Withdrawal by Subject|0|||
163374610|NCT04602221|590079341|FG012|Overall Study|Withdrawal by Subject|1|||
163374611|NCT04602221|590079342|FG013|Overall Study|Withdrawal by Subject|0|||
163374612|NCT04602221|590079343|FG014|Overall Study|Withdrawal by Subject|0|||
163374613|NCT04602221|590079344|FG015|Overall Study|Withdrawal by Subject|0|||
163374614|NCT04602221|590079345|FG016|Overall Study|Withdrawal by Subject|0|||
163374615|NCT04602221|590079346|FG017|Overall Study|Withdrawal by Subject|0|||
163374616|NCT04602221|590079329|FG000|Overall Study|Lost to Follow-up|0|||
163374617|NCT04602221|590079330|FG001|Overall Study|Lost to Follow-up|0|||
163374618|NCT04602221|590079331|FG002|Overall Study|Lost to Follow-up|0|||
163374619|NCT04602221|590079332|FG003|Overall Study|Lost to Follow-up|0|||
163374620|NCT04602221|590079333|FG004|Overall Study|Lost to Follow-up|0|||
163374621|NCT04602221|590079334|FG005|Overall Study|Lost to Follow-up|1|||
163374622|NCT04602221|590079335|FG006|Overall Study|Lost to Follow-up|0|||
163374623|NCT04602221|590079336|FG007|Overall Study|Lost to Follow-up|0|||
163374624|NCT04602221|590079337|FG008|Overall Study|Lost to Follow-up|0|||
163374625|NCT04602221|590079338|FG009|Overall Study|Lost to Follow-up|0|||
163374626|NCT04602221|590079339|FG010|Overall Study|Lost to Follow-up|0|||
163374627|NCT04602221|590079340|FG011|Overall Study|Lost to Follow-up|0|||
163374628|NCT04602221|590079341|FG012|Overall Study|Lost to Follow-up|0|||
163374629|NCT04602221|590079342|FG013|Overall Study|Lost to Follow-up|0|||
163374630|NCT04602221|590079343|FG014|Overall Study|Lost to Follow-up|0|||
163374631|NCT04602221|590079344|FG015|Overall Study|Lost to Follow-up|0|||
163374632|NCT04602221|590079345|FG016|Overall Study|Lost to Follow-up|0|||
163374633|NCT04602221|590079346|FG017|Overall Study|Lost to Follow-up|0|||
163374634|NCT00844532|590079348|FG000|Overall Study|Death|16|||
163374635|NCT00844532|590079348|FG000|Overall Study|Withdrawal by Subject|16|||
163374636|NCT00844532|590079348|FG000|Overall Study|Lost to Follow-up|7|||
163374637|NCT02576587|590079349|FG000|Baseline|Equipment failure|0|||
163374638|NCT02576587|590079350|FG001|Baseline|Equipment failure|1|||
163374639|NCT02576587|590079349|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
163374640|NCT02576587|590079350|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
163374641|NCT02576587|590079349|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
163374642|NCT02576587|590079350|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
163374643|NCT02576587|590079349|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
163374644|NCT02576587|590079350|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
163374645|NCT01080716|590079351|FG000|Part 1|Physician Decision|1|||
163374646|NCT01080716|590079352|FG001|Part 1|Physician Decision|0|||
163374647|NCT01080716|590079353|FG002|Part 1|Physician Decision|0|||
163374648|NCT01080716|590079354|FG003|Part 1|Physician Decision|0|||
163374649|NCT01056718|590079355|FG000|Overall Study|Withdrawal by Subject|2|||
163374650|NCT01056718|590079355|FG000|Overall Study|Ischemia on baseline stress test|1|||
163374651|NCT03590366|590079356|FG000|Overall Study|Adverse Event|0|||
163374652|NCT03590366|590079357|FG001|Overall Study|Adverse Event|3|||
163374653|NCT03590366|590079356|FG000|Overall Study|Lost to Follow-up|3|||
163374654|NCT03590366|590079357|FG001|Overall Study|Lost to Follow-up|3|||
163374655|NCT03590366|590079356|FG000|Overall Study|Withdrawal by Subject|0|||
163374656|NCT03590366|590079357|FG001|Overall Study|Withdrawal by Subject|2|||
163374657|NCT00738894|590079358|FG000|Overall Study|Lost to Follow-up|23|||
163374658|NCT00738894|590079359|FG001|Overall Study|Lost to Follow-up|13|||
163374659|NCT00738894|590079358|FG000|Overall Study|Withdrawal by Subject|10|||
163374660|NCT00738894|590079359|FG001|Overall Study|Withdrawal by Subject|15|||
163374661|NCT00738894|590079358|FG000|Overall Study|Physician Decision|4|||
163374662|NCT00738894|590079359|FG001|Overall Study|Physician Decision|5|||
163374663|NCT00738894|590079358|FG000|Overall Study|Death|2|||
163374664|NCT00738894|590079359|FG001|Overall Study|Death|0|||
163374665|NCT05017103|590079360|FG000|Overall Study|Death|2|||
163374666|NCT02656329|590079361|FG000|Overall Study|Lost to Follow-up|2|||
163374667|NCT02656329|590079362|FG001|Overall Study|Lost to Follow-up|3|||
163374668|NCT02656329|590079361|FG000|Overall Study|Withdrawal by Subject|7|||
163374669|NCT02656329|590079362|FG001|Overall Study|Withdrawal by Subject|6|||
163374670|NCT02656329|590079361|FG000|Overall Study|Study termination by Sponsor|150|||
163374671|NCT02656329|590079362|FG001|Overall Study|Study termination by Sponsor|142|||
163374672|NCT02656329|590079361|FG000|Overall Study|Other than specified above|5|||
163374673|NCT02656329|590079362|FG001|Overall Study|Other than specified above|6|||
163374674|NCT01081665|590079364|FG000|Overall Study|Death|41|||
163374675|NCT01081665|590079364|FG000|Overall Study|Lost to Follow-up|18|||
163374676|NCT01081665|590079364|FG000|Overall Study|Withdrawal by Subject|17|||
163374677|NCT01081665|590079364|FG000|Overall Study|Change of dialysis unit|10|||
163374678|NCT01081665|590079364|FG000|Overall Study|Regulation of iPTH|5|||
163374679|NCT01081665|590079364|FG000|Overall Study|Change in renal replacement therapy|2|||
163374680|NCT01081665|590079364|FG000|Overall Study|Adverse Event|1|||
163374681|NCT01081665|590079364|FG000|Overall Study|Lack of Efficacy|1|||
163374682|NCT03541174|590081088|FG000|Part 1 Double-Blind|Adverse Event|6|||
163374683|NCT03541174|590081089|FG001|Part 1 Double-Blind|Adverse Event|5|||
163374684|NCT03541174|590081090|FG002|Part 1 Double-Blind|Adverse Event|2|||
163374685|NCT03541174|590081091|FG003|Part 1 Double-Blind|Adverse Event|0|||
163374686|NCT03541174|590081092|FG004|Part 1 Double-Blind|Adverse Event|0|||
163374687|NCT03541174|590081093|FG005|Part 1 Double-Blind|Adverse Event|0|||
163374688|NCT03541174|590081088|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
163374689|NCT03541174|590081089|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
163374690|NCT03541174|590081090|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
163374691|NCT03541174|590081091|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
163374692|NCT03541174|590081092|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
163374693|NCT03541174|590081093|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
163374694|NCT03541174|590081088|FG000|Part 1 Double-Blind|Other reasons|3|||
163374695|NCT03541174|590081089|FG001|Part 1 Double-Blind|Other reasons|2|||
163374696|NCT03541174|590081090|FG002|Part 1 Double-Blind|Other reasons|3|||
163374697|NCT03541174|590081091|FG003|Part 1 Double-Blind|Other reasons|0|||
163374698|NCT03541174|590081092|FG004|Part 1 Double-Blind|Other reasons|0|||
163374699|NCT03541174|590081093|FG005|Part 1 Double-Blind|Other reasons|0|||
163374700|NCT03541174|590081088|FG000|Part 2 Single-Blind|Adverse Event|0|||
163374701|NCT03541174|590081089|FG001|Part 2 Single-Blind|Adverse Event|0|||
163374702|NCT03541174|590081090|FG002|Part 2 Single-Blind|Adverse Event|0|||
163374703|NCT03541174|590081091|FG003|Part 2 Single-Blind|Adverse Event|25|||
163374704|NCT03541174|590081092|FG004|Part 2 Single-Blind|Adverse Event|0|||
163374705|NCT03541174|590081093|FG005|Part 2 Single-Blind|Adverse Event|0|||
163374706|NCT03541174|590081088|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
163374707|NCT03541174|590081089|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
163374708|NCT03541174|590081090|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
163374709|NCT03541174|590081091|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
163374710|NCT03541174|590081092|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
163374711|NCT03541174|590081093|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
163374712|NCT03541174|590081088|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
163374713|NCT03541174|590081089|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
163374714|NCT03541174|590081090|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
163374715|NCT03541174|590081091|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
163374716|NCT03541174|590081092|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
163374717|NCT03541174|590081093|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
163374718|NCT03541174|590081088|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
163374719|NCT03541174|590081089|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
163374720|NCT03541174|590081090|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
163374721|NCT03541174|590081091|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
163374722|NCT03541174|590081092|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
163374723|NCT03541174|590081093|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
163374724|NCT03541174|590081088|FG000|Part 2 Single-Blind|Death|0|||
163374725|NCT03541174|590081089|FG001|Part 2 Single-Blind|Death|0|||
163374726|NCT03541174|590081090|FG002|Part 2 Single-Blind|Death|0|||
163374727|NCT03541174|590081091|FG003|Part 2 Single-Blind|Death|5|||
163374728|NCT03541174|590081092|FG004|Part 2 Single-Blind|Death|0|||
163374729|NCT03541174|590081093|FG005|Part 2 Single-Blind|Death|0|||
163374730|NCT03541174|590081088|FG000|Part 2 Single-Blind|Pregnancy|0|||
163374731|NCT03541174|590081089|FG001|Part 2 Single-Blind|Pregnancy|0|||
163374732|NCT03541174|590081090|FG002|Part 2 Single-Blind|Pregnancy|0|||
163374733|NCT03541174|590081091|FG003|Part 2 Single-Blind|Pregnancy|1|||
163374734|NCT03541174|590081092|FG004|Part 2 Single-Blind|Pregnancy|0|||
163374735|NCT03541174|590081093|FG005|Part 2 Single-Blind|Pregnancy|0|||
163374736|NCT03541174|590081088|FG000|Part 2 Single-Blind|Other reasons|0|||
163374737|NCT03541174|590081089|FG001|Part 2 Single-Blind|Other reasons|0|||
163374738|NCT03541174|590081090|FG002|Part 2 Single-Blind|Other reasons|0|||
163374739|NCT03541174|590081091|FG003|Part 2 Single-Blind|Other reasons|32|||
163374740|NCT03541174|590081092|FG004|Part 2 Single-Blind|Other reasons|0|||
163374741|NCT03541174|590081093|FG005|Part 2 Single-Blind|Other reasons|0|||
163374742|NCT03541174|590081088|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
163374743|NCT03541174|590081089|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
163374744|NCT03541174|590081090|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
163374745|NCT03541174|590081091|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
163374746|NCT03541174|590081092|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
163374747|NCT03541174|590081093|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
163374748|NCT03541174|590081088|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
163374749|NCT03541174|590081089|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
163374750|NCT03541174|590081090|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
163374751|NCT03541174|590081091|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
163374752|NCT03541174|590081092|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
163374753|NCT03541174|590081093|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
163374754|NCT03541174|590081088|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
163374755|NCT03541174|590081089|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
163374756|NCT03541174|590081090|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
163374757|NCT03541174|590081091|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
163374758|NCT03541174|590081092|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
163374759|NCT03541174|590081093|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
163374760|NCT03541174|590081088|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
163374761|NCT03541174|590081089|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
163374762|NCT03541174|590081090|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
163374763|NCT03541174|590081091|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
163374764|NCT03541174|590081092|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
163374765|NCT03541174|590081093|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
163374766|NCT03541174|590081088|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
163374767|NCT03541174|590081089|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
163374768|NCT03541174|590081090|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
163374769|NCT03541174|590081091|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
163374770|NCT03541174|590081092|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
163374771|NCT03541174|590081093|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
163374772|NCT00605215|590081094|FG000|Overall Study|Death|0|||
163374773|NCT00605215|590081095|FG001|Overall Study|Death|0|||
163374774|NCT00605215|590081096|FG002|Overall Study|Death|1|||
163374775|NCT00605215|590081094|FG000|Overall Study|Adverse Event|19|||
163374776|NCT00605215|590081095|FG001|Overall Study|Adverse Event|21|||
163374777|NCT00605215|590081096|FG002|Overall Study|Adverse Event|26|||
163374778|NCT00605215|590081094|FG000|Overall Study|Refusal to sign the re-consent form|8|||
163374779|NCT00605215|590081095|FG001|Overall Study|Refusal to sign the re-consent form|3|||
163374780|NCT00605215|590081096|FG002|Overall Study|Refusal to sign the re-consent form|3|||
163374781|NCT00605215|590081094|FG000|Overall Study|Withdrawal by Subject|39|||
163374782|NCT00605215|590081095|FG001|Overall Study|Withdrawal by Subject|37|||
163374783|NCT00605215|590081096|FG002|Overall Study|Withdrawal by Subject|27|||
163374784|NCT00605215|590081094|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
163374785|NCT00605215|590081095|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
163374786|NCT00605215|590081096|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
163374787|NCT00605215|590081094|FG000|Overall Study|Protocol Violation|3|||
163374788|NCT00605215|590081095|FG001|Overall Study|Protocol Violation|4|||
163374789|NCT00605215|590081096|FG002|Overall Study|Protocol Violation|1|||
163374790|NCT00605215|590081094|FG000|Overall Study|Pregnancy|8|||
163374791|NCT00605215|590081095|FG001|Overall Study|Pregnancy|5|||
163374792|NCT00605215|590081096|FG002|Overall Study|Pregnancy|4|||
163374793|NCT00605215|590081094|FG000|Overall Study|Lost to Follow-up|8|||
163374794|NCT00605215|590081095|FG001|Overall Study|Lost to Follow-up|5|||
163374795|NCT00605215|590081096|FG002|Overall Study|Lost to Follow-up|2|||
163374796|NCT00605215|590081094|FG000|Overall Study|Other than specified|0|||
163374797|NCT00605215|590081095|FG001|Overall Study|Other than specified|2|||
163374798|NCT00605215|590081096|FG002|Overall Study|Other than specified|1|||
163374799|NCT00275262|590081097|FG000|Overall Study|Adverse Event|2|||
163374800|NCT00275262|590081098|FG001|Overall Study|Adverse Event|0|||
163374801|NCT00275262|590081097|FG000|Overall Study|Disease progression|2|||
163374802|NCT00275262|590081098|FG001|Overall Study|Disease progression|5|||
163374803|NCT00275262|590081097|FG000|Overall Study|Lost to Follow-up|0|||
163374804|NCT00275262|590081098|FG001|Overall Study|Lost to Follow-up|2|||
163374805|NCT00275262|590081097|FG000|Overall Study|Protocol Violation|0|||
163374806|NCT00275262|590081098|FG001|Overall Study|Protocol Violation|2|||
163374807|NCT00275262|590081097|FG000|Overall Study|Death|1|||
163374808|NCT00275262|590081098|FG001|Overall Study|Death|0|||
163374809|NCT00275262|590081097|FG000|Overall Study|Started Chemotherapy|1|||
163374810|NCT00275262|590081098|FG001|Overall Study|Started Chemotherapy|0|||
163374811|NCT04058366|590081101|FG000|Overall Study|Adverse Event|14|||
163374812|NCT04058366|590081101|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
163374813|NCT04058366|590081101|FG000|Overall Study|Commercial drug is available for participants|6|||
163374814|NCT04058366|590081101|FG000|Overall Study|Death|1|||
163374815|NCT04058366|590081101|FG000|Overall Study|Other non-compliance|2|||
163374816|NCT04058366|590081101|FG000|Overall Study|Other|6|||
163374817|NCT02738203|590081102|FG000|Overall Study|Failed IUD Insertion|2|||
163374818|NCT02738203|590081103|FG001|Overall Study|Failed IUD Insertion|2|||
163374819|NCT02738203|590081102|FG000|Overall Study|Protocol Violation|0|||
163374820|NCT02738203|590081103|FG001|Overall Study|Protocol Violation|1|||
163374821|NCT05087979|590081104|FG000|Overall Study|Converted to general anesthesia|1|||
163374822|NCT05087979|590081105|FG001|Overall Study|Converted to general anesthesia|0|||
163374823|NCT01227577|590081108|FG000|Overall Study|Protocol deviation|3|||
163374824|NCT01227577|590081108|FG000|Overall Study|Death|3|||
163374825|NCT01227577|590081108|FG000|Overall Study|Administrative problems|2|||
163374826|NCT01227577|590081108|FG000|Overall Study|Lost to Follow-up|1|||
163374827|NCT01227577|590081108|FG000|Overall Study|Withdrawal by Subject|4|||
163374828|NCT01227577|590081108|FG000|Overall Study|Lack of Efficacy|5|||
163374829|NCT01227577|590081108|FG000|Overall Study|Adverse Event|17|||
163374830|NCT03809429|590081109|FG000|Overall Study|Withdrawal by Subject|7|||
163374831|NCT03809429|590081110|FG001|Overall Study|Withdrawal by Subject|3|||
163374832|NCT03809429|590081109|FG000|Overall Study|Adverse Event|6|||
163374833|NCT03809429|590081110|FG001|Overall Study|Adverse Event|9|||
163374834|NCT03809429|590081109|FG000|Overall Study|COVID-19|3|||
163374835|NCT03809429|590081110|FG001|Overall Study|COVID-19|1|||
163374836|NCT03809429|590081109|FG000|Overall Study|Participant was discontinued by investigator|12|||
163374837|NCT03809429|590081110|FG001|Overall Study|Participant was discontinued by investigator|7|||
163374838|NCT00194987|590081111|FG000|Overall Study|Withdrawal by Subject|0|||
163374839|NCT00194987|590081112|FG001|Overall Study|Withdrawal by Subject|3|||
163374840|NCT01664598|590081113|FG000|Overall Study|Sponsor Decision|1|||
163374841|NCT01664598|590081113|FG000|Overall Study|Withdrawal of Informed Consent|4|||
163374842|NCT01664598|590081113|FG000|Overall Study|Adverse Event|1|||
163374843|NCT02245737|590081118|FG000|Overall Study|Adverse Event|23|||
163374844|NCT02245737|590081119|FG001|Overall Study|Adverse Event|26|||
163374845|NCT02245737|590081120|FG002|Overall Study|Adverse Event|33|||
163374846|NCT02245737|590081118|FG000|Overall Study|Condition Worsened|9|||
163374847|NCT02245737|590081119|FG001|Overall Study|Condition Worsened|10|||
163374848|NCT02245737|590081120|FG002|Overall Study|Condition Worsened|9|||
163374849|NCT02245737|590081118|FG000|Overall Study|Death|2|||
163374850|NCT02245737|590081119|FG001|Overall Study|Death|4|||
163374851|NCT02245737|590081120|FG002|Overall Study|Death|4|||
163374852|NCT02245737|590081118|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
163374853|NCT02245737|590081119|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
163374854|NCT02245737|590081120|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
163374855|NCT02245737|590081118|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
163374856|NCT02245737|590081119|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
163374857|NCT02245737|590081120|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
163374858|NCT02245737|590081118|FG000|Overall Study|Lost to Follow-up|2|||
163374859|NCT02245737|590081119|FG001|Overall Study|Lost to Follow-up|5|||
163374860|NCT02245737|590081120|FG002|Overall Study|Lost to Follow-up|4|||
163374861|NCT02245737|590081118|FG000|Overall Study|Other-determined by Investigator|9|||
163374862|NCT02245737|590081119|FG001|Overall Study|Other-determined by Investigator|10|||
163374863|NCT02245737|590081120|FG002|Overall Study|Other-determined by Investigator|10|||
163374864|NCT02245737|590081118|FG000|Overall Study|Physician Decision|6|||
163374865|NCT02245737|590081119|FG001|Overall Study|Physician Decision|3|||
163374866|NCT02245737|590081120|FG002|Overall Study|Physician Decision|6|||
163374867|NCT02245737|590081118|FG000|Overall Study|Protocol Violation|3|||
163374868|NCT02245737|590081119|FG001|Overall Study|Protocol Violation|2|||
163374869|NCT02245737|590081120|FG002|Overall Study|Protocol Violation|3|||
163374870|NCT02245737|590081118|FG000|Overall Study|Withdrawal by Subject|40|||
163374871|NCT02245737|590081119|FG001|Overall Study|Withdrawal by Subject|41|||
163374872|NCT02245737|590081120|FG002|Overall Study|Withdrawal by Subject|44|||
163374873|NCT02245737|590081118|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
163374874|NCT02245737|590081119|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
163374875|NCT02245737|590081120|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
163374876|NCT02245737|590081118|FG000|Overall Study|Sponsor Decision|445|||
163374877|NCT02245737|590081119|FG001|Overall Study|Sponsor Decision|430|||
163374878|NCT02245737|590081120|FG002|Overall Study|Sponsor Decision|432|||
163374879|NCT00836745|590081124|FG000|Overall Study|Death|2|||
163374880|NCT00836745|590081124|FG000|Overall Study|Lost to Follow-up|10|||
163374881|NCT00836745|590081124|FG000|Overall Study|Adverse Event|3|||
163374882|NCT00836745|590081124|FG000|Overall Study|Objective progression or relapse|4|||
163374883|NCT00836745|590081124|FG000|Overall Study|Other|2|||
163374884|NCT01239043|590081127|FG000|Overall Study|Protocol Violation|2|||
163374885|NCT01239043|590081128|FG001|Overall Study|Protocol Violation|1|||
163374886|NCT02929329|590081131|FG000|Overall Study|Withdrawal by Subject|24|||
163374887|NCT02929329|590081132|FG001|Overall Study|Withdrawal by Subject|21|||
163374888|NCT02929329|590081131|FG000|Overall Study|Lost to Follow-up|26|||
163374889|NCT02929329|590081132|FG001|Overall Study|Lost to Follow-up|20|||
163374890|NCT02929329|590081131|FG000|Overall Study|Death|1054|||
163374891|NCT02929329|590081132|FG001|Overall Study|Death|1051|||
163374892|NCT02121301|590081133|FG000|Overall Study|Protocol Violation|1|||
163374893|NCT02121301|590081134|FG001|Overall Study|Protocol Violation|4|||
163374894|NCT02121301|590081135|FG002|Overall Study|Protocol Violation|1|||
163374895|NCT00434213|590081141|FG000|Overall Study|Adverse Event|12|||
163374896|NCT00434213|590081141|FG000|Overall Study|Lack of Efficacy|9|||
163374897|NCT00434213|590081141|FG000|Overall Study|Lost to Follow-up|14|||
163374898|NCT00434213|590081141|FG000|Overall Study|Withdrawal by Subject|7|||
163374899|NCT00434213|590081141|FG000|Overall Study|Protocol Violation|3|||
163374900|NCT00434213|590081141|FG000|Overall Study|Unable to comply with study visit window|2|||
163374901|NCT00434213|590081141|FG000|Overall Study|Application site reaction|1|||
163374902|NCT00434213|590081141|FG000|Overall Study|Non-compliant to study schedule|1|||
163374903|NCT01699503|590081142|FG000|Overall Study|Death|31|||
163374904|NCT01699503|590081143|FG001|Overall Study|Death|40|||
163374905|NCT01699503|590081142|FG000|Overall Study|Withdrawal by Subject|65|||
163374906|NCT01699503|590081143|FG001|Overall Study|Withdrawal by Subject|57|||
163374907|NCT01699503|590081142|FG000|Overall Study|Lost to Follow-up|121|||
163374908|NCT01699503|590081143|FG001|Overall Study|Lost to Follow-up|117|||
163374909|NCT01699503|590081142|FG000|Overall Study|Excluded due to quality|783|||
163374910|NCT01699503|590081143|FG001|Overall Study|Excluded due to quality|791|||
163374911|NCT01639560|590081146|FG000|Overall Study|Withdrawal by Subject|9|||
163374912|NCT01639560|590081147|FG001|Overall Study|Withdrawal by Subject|14|||
163374913|NCT01639560|590081146|FG000|Overall Study|Lack of Efficacy|1|||
163374914|NCT01639560|590081147|FG001|Overall Study|Lack of Efficacy|2|||
163374915|NCT01639560|590081146|FG000|Overall Study|Lost to Follow-up|9|||
163374916|NCT01639560|590081147|FG001|Overall Study|Lost to Follow-up|11|||
163374917|NCT01639560|590081146|FG000|Overall Study|Adverse Event|0|||
163374918|NCT01639560|590081147|FG001|Overall Study|Adverse Event|2|||
163374919|NCT00774930|590081149|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
163374920|NCT00774930|590081150|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
163374921|NCT00774930|590081149|FG000|DB Phase|Adverse Event|1|||
163374922|NCT00774930|590081150|FG001|DB Phase|Adverse Event|2|||
163374923|NCT00774930|590081149|FG000|DB Phase|Subject Decision|1|||
163374924|NCT00774930|590081150|FG001|DB Phase|Subject Decision|5|||
163374925|NCT00774930|590081149|FG000|DB Phase|Sponsor Decision|0|||
163374926|NCT00774930|590081150|FG001|DB Phase|Sponsor Decision|1|||
163374927|NCT00774930|590081149|FG000|DB Phase|Disease Progression|1|||
163374928|NCT00774930|590081150|FG001|DB Phase|Disease Progression|1|||
163374929|NCT00774930|590081149|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
163374930|NCT00774930|590081150|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
163374931|NCT00774930|590081149|FG000|IOL Phase|Adverse Event|1|||
163374932|NCT00774930|590081150|FG001|IOL Phase|Adverse Event|1|||
163374933|NCT00774930|590081149|FG000|IOL Phase|Subject Decision|4|||
163374934|NCT00774930|590081150|FG001|IOL Phase|Subject Decision|3|||
163374935|NCT00774930|590081149|FG000|IOL Phase|Physician Decision|3|||
163374936|NCT00774930|590081150|FG001|IOL Phase|Physician Decision|2|||
163374937|NCT00774930|590081149|FG000|IOL Phase|Sponsor Decision|1|||
163374938|NCT00774930|590081150|FG001|IOL Phase|Sponsor Decision|0|||
163374939|NCT00774930|590081149|FG000|IOL Phase|Disease Progression|2|||
163374940|NCT00774930|590081150|FG001|IOL Phase|Disease Progression|1|||
163374941|NCT00774930|590081149|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
163374942|NCT00774930|590081150|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
163374943|NCT00774930|590081149|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
163374944|NCT00774930|590081150|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
163374945|NCT00774930|590081149|FG000|IOL Phase|Other|1|||
163374946|NCT00774930|590081150|FG001|IOL Phase|Other|0|||
163374947|NCT00774930|590081149|FG000|IOL Phase|Brain radiation|0|||
163374948|NCT00774930|590081150|FG001|IOL Phase|Brain radiation|1|||
163374949|NCT00774930|590081149|FG000|LTOLE Phase|Adverse Event|7|||
163374950|NCT00774930|590081150|FG001|LTOLE Phase|Adverse Event|3|||
163374951|NCT00774930|590081149|FG000|LTOLE Phase|Subject decision|0|||
163374952|NCT00774930|590081150|FG001|LTOLE Phase|Subject decision|5|||
163374953|NCT00774930|590081149|FG000|LTOLE Phase|Physician Decision|4|||
163374954|NCT00774930|590081150|FG001|LTOLE Phase|Physician Decision|1|||
163374955|NCT00774930|590081149|FG000|LTOLE Phase|Sponsor decision|2|||
163374956|NCT00774930|590081150|FG001|LTOLE Phase|Sponsor decision|1|||
163374957|NCT00774930|590081149|FG000|LTOLE Phase|Disease Progression|2|||
163374958|NCT00774930|590081150|FG001|LTOLE Phase|Disease Progression|5|||
163374959|NCT00774930|590081149|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
163374960|NCT00774930|590081150|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
163374961|NCT00774930|590081149|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
163374962|NCT00774930|590081150|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
163374963|NCT00766363|590081151|FG000|Overall Study|Withdrawal by Subject|1|||
163374964|NCT00766363|590081152|FG001|Overall Study|Withdrawal by Subject|0|||
163374965|NCT00766363|590081153|FG002|Overall Study|Withdrawal by Subject|0|||
163374966|NCT00766363|590081154|FG003|Overall Study|Withdrawal by Subject|0|||
163374967|NCT00766363|590081151|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
163374968|NCT00766363|590081152|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
163374969|NCT00766363|590081153|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
163374970|NCT00766363|590081154|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
163374971|NCT03020576|590081159|FG000|Overall Study|Withdrawal by Subject|1|||
163374972|NCT03020576|590081160|FG001|Overall Study|Withdrawal by Subject|2|||
163374973|NCT03292432|590081161|FG000|Overall Study|Lost to Follow-up|11|||
163374974|NCT03292432|590081162|FG001|Overall Study|Lost to Follow-up|8|||
163374975|NCT03292432|590081161|FG000|Overall Study|Death|2|||
163374976|NCT03292432|590081162|FG001|Overall Study|Death|1|||
163374977|NCT03292432|590081161|FG000|Overall Study|Withdrawal by Subject|1|||
163374978|NCT03292432|590081162|FG001|Overall Study|Withdrawal by Subject|2|||
163374979|NCT03292432|590081161|FG000|Overall Study|Site closed before any data collected|1|||
163374980|NCT03292432|590081162|FG001|Overall Study|Site closed before any data collected|0|||
163374981|NCT00911937|590081163|FG000|Overall Study|Death|1|||
163374982|NCT00911937|590081164|FG001|Overall Study|Death|0|||
163374983|NCT00911937|590081163|FG000|Overall Study|Lost to Follow-up|8|||
163374984|NCT00911937|590081164|FG001|Overall Study|Lost to Follow-up|5|||
163374985|NCT00911937|590081163|FG000|Overall Study|Withdrawal by Subject|10|||
163374986|NCT00911937|590081164|FG001|Overall Study|Withdrawal by Subject|7|||
163374987|NCT00911937|590081163|FG000|Overall Study|Withdrawn due to pregnancy|1|||
163374988|NCT00911937|590081164|FG001|Overall Study|Withdrawn due to pregnancy|0|||
163374989|NCT00911937|590081163|FG000|Overall Study|Adverse Event|11|||
163374990|NCT00911937|590081164|FG001|Overall Study|Adverse Event|25|||
163374991|NCT00911937|590081163|FG000|Overall Study|Lack of Efficacy|11|||
163374992|NCT00911937|590081164|FG001|Overall Study|Lack of Efficacy|6|||
163374993|NCT00911937|590081163|FG000|Overall Study|Did not meet inclusion criteria|9|||
163374994|NCT00911937|590081164|FG001|Overall Study|Did not meet inclusion criteria|11|||
163374995|NCT00911937|590081163|FG000|Overall Study|Protocol Violation|14|||
163374996|NCT00911937|590081164|FG001|Overall Study|Protocol Violation|23|||
163374997|NCT00911937|590081163|FG000|Overall Study|Randomized but not treated|13|||
163374998|NCT00911937|590081164|FG001|Overall Study|Randomized but not treated|13|||
163374999|NCT00911937|590081163|FG000|Overall Study|Other|9|||
163375000|NCT00911937|590081164|FG001|Overall Study|Other|5|||
163375001|NCT01498679|590081165|FG000|Overall Study|Adverse Event|1|||
163375002|NCT01498679|590081166|FG001|Overall Study|Adverse Event|4|||
163375003|NCT01498679|590081165|FG000|Overall Study|Lack of Efficacy|72|||
163375004|NCT01498679|590081166|FG001|Overall Study|Lack of Efficacy|12|||
163375005|NCT01498679|590081165|FG000|Overall Study|Protocol Violation|4|||
163375006|NCT01498679|590081166|FG001|Overall Study|Protocol Violation|0|||
163375007|NCT01498679|590081165|FG000|Overall Study|Physician Decision|0|||
163375008|NCT01498679|590081166|FG001|Overall Study|Physician Decision|2|||
163375009|NCT01498679|590081165|FG000|Overall Study|Withdrawal by Subject|12|||
163375010|NCT01498679|590081166|FG001|Overall Study|Withdrawal by Subject|4|||
163375011|NCT00424385|590081168|FG000|Cohort 0|Withdrawal by Subject|5|||
163375012|NCT00424385|590081168|FG000|Cohort 0|Physician Decision|1|||
163414319|NCT02574637|590223067|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
163375013|NCT00424385|590081168|FG000|Cohort 1|Withdrawal by Subject|1|||
163375014|NCT02057523|590081169|FG000|Overall Study|Withdrawal by Subject|1|||
163375015|NCT02057523|590081169|FG000|Overall Study|Lack of Efficacy|1|||
163375016|NCT03174431|590081172|FG000|Overall Study|Withdrawal by Subject|14|||
163375017|NCT03174431|590081173|FG001|Overall Study|Withdrawal by Subject|11|||
163375018|NCT03174431|590081172|FG000|Overall Study|alternative treatment|2|||
163375019|NCT03174431|590081173|FG001|Overall Study|alternative treatment|0|||
163375020|NCT03174431|590081172|FG000|Overall Study|Lost to Follow-up|1|||
163375021|NCT03174431|590081173|FG001|Overall Study|Lost to Follow-up|5|||
163375022|NCT02706899|590081181|FG000|Overall Study|Withdrawal by Subject|1|||
163375023|NCT02706899|590081182|FG001|Overall Study|Withdrawal by Subject|0|||
163375024|NCT02706899|590081181|FG000|Overall Study|Death|8|||
163375025|NCT02706899|590081182|FG001|Overall Study|Death|0|||
163375026|NCT02706899|590081181|FG000|Overall Study|Study Termination by Sponsor|4|||
163375027|NCT02706899|590081182|FG001|Overall Study|Study Termination by Sponsor|6|||
163375028|NCT00633880|590081185|FG000|Open Label Titration|Lack of Efficacy|1|||
163375029|NCT00633880|590081186|FG001|Open Label Titration|Lack of Efficacy|0|||
163375030|NCT00633880|590081187|FG002|Open Label Titration|Lack of Efficacy|0|||
163375031|NCT00633880|590081185|FG000|Open Label Titration|Adverse Event|13|||
163375032|NCT00633880|590081186|FG001|Open Label Titration|Adverse Event|0|||
163375033|NCT00633880|590081187|FG002|Open Label Titration|Adverse Event|0|||
163375034|NCT00633880|590081185|FG000|Open Label Titration|Treatment Failure|55|||
163375035|NCT00633880|590081186|FG001|Open Label Titration|Treatment Failure|0|||
163375036|NCT00633880|590081187|FG002|Open Label Titration|Treatment Failure|0|||
163375037|NCT00633880|590081185|FG000|Open Label Titration|Protocol Violation|6|||
163375038|NCT00633880|590081186|FG001|Open Label Titration|Protocol Violation|0|||
163375039|NCT00633880|590081187|FG002|Open Label Titration|Protocol Violation|0|||
163375040|NCT00633880|590081185|FG000|Open Label Titration|Physician Decision|1|||
163375041|NCT00633880|590081186|FG001|Open Label Titration|Physician Decision|0|||
163375042|NCT00633880|590081187|FG002|Open Label Titration|Physician Decision|0|||
163375043|NCT00633880|590081185|FG000|Open Label Titration|Withdrawal by Subject|4|||
163414320|NCT02574637|590223068|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
163414321|NCT02574637|590223069|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
163414322|NCT02574637|590223070|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
163414323|NCT02574637|590223071|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
163414324|NCT02574637|590223072|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
163414325|NCT00699907|590223077|FG000|Overall Study|Withdrawal by Subject|2|||
163414326|NCT00699907|590223078|FG001|Overall Study|Withdrawal by Subject|1|||
163414327|NCT00699907|590223079|FG002|Overall Study|Withdrawal by Subject|0|||
163414328|NCT00699907|590223077|FG000|Overall Study|No usable sample|0|||
163414329|NCT00699907|590223078|FG001|Overall Study|No usable sample|9|||
163414330|NCT00699907|590223079|FG002|Overall Study|No usable sample|8|||
163414331|NCT02161211|590223080|FG000|Overall Study|Lost to Follow-up|21|||
163414332|NCT02161211|590223081|FG001|Overall Study|Lost to Follow-up|27|||
163414333|NCT02161211|590223082|FG002|Overall Study|Lost to Follow-up|21|||
163414334|NCT02161211|590223080|FG000|Overall Study|Dropped|12|||
163414335|NCT02161211|590223081|FG001|Overall Study|Dropped|5|||
163414336|NCT02161211|590223082|FG002|Overall Study|Dropped|9|||
163414337|NCT01164722|590223084|FG000|Overall Study|Adverse Event|0|||
163414338|NCT01164722|590223085|FG001|Overall Study|Adverse Event|1|||
163414339|NCT01164722|590223084|FG000|Overall Study|Withdrawal by Subject|3|||
163375044|NCT00633880|590081186|FG001|Open Label Titration|Withdrawal by Subject|0|||
163375045|NCT00633880|590081187|FG002|Open Label Titration|Withdrawal by Subject|0|||
163375046|NCT01413503|590081189|FG000|Overall Study|Lost to Follow-up|1|||
163375047|NCT02546921|590081190|FG000|Overall Study|Adverse Event|0|||
163375048|NCT02546921|590081191|FG001|Overall Study|Adverse Event|5|||
163375049|NCT02546921|590081192|FG002|Overall Study|Adverse Event|2|||
163375050|NCT02546921|590081193|FG003|Overall Study|Adverse Event|0|||
163375051|NCT02546921|590081194|FG004|Overall Study|Adverse Event|0|||
163375052|NCT02546921|590081195|FG005|Overall Study|Adverse Event|0|||
163375053|NCT02546921|590081196|FG006|Overall Study|Adverse Event|0|||
163375054|NCT02546921|590081190|FG000|Overall Study|Evidence of Disease Progression|1|||
163414340|NCT01164722|590223085|FG001|Overall Study|Withdrawal by Subject|4|||
163414341|NCT01164722|590223084|FG000|Overall Study|Lost to Follow-up|3|||
163414342|NCT01164722|590223085|FG001|Overall Study|Lost to Follow-up|6|||
163375055|NCT02546921|590081191|FG001|Overall Study|Evidence of Disease Progression|0|||
163375056|NCT02546921|590081192|FG002|Overall Study|Evidence of Disease Progression|0|||
163375057|NCT02546921|590081193|FG003|Overall Study|Evidence of Disease Progression|0|||
163375058|NCT02546921|590081194|FG004|Overall Study|Evidence of Disease Progression|1|||
163375059|NCT02546921|590081195|FG005|Overall Study|Evidence of Disease Progression|0|||
163375060|NCT02546921|590081196|FG006|Overall Study|Evidence of Disease Progression|0|||
163375061|NCT02546921|590081190|FG000|Overall Study|Patient Choice|0|||
163414343|NCT01164722|590223084|FG000|Overall Study|met protocol criteria for non-treatment|11|||
163414344|NCT01164722|590223085|FG001|Overall Study|met protocol criteria for non-treatment|1|||
163414345|NCT01164722|590223084|FG000|Overall Study|enrolled on other study, concomitant med|1|||
163375062|NCT02546921|590081191|FG001|Overall Study|Patient Choice|1|||
163375063|NCT02546921|590081192|FG002|Overall Study|Patient Choice|0|||
163375064|NCT02546921|590081193|FG003|Overall Study|Patient Choice|0|||
163375065|NCT02546921|590081194|FG004|Overall Study|Patient Choice|0|||
163375066|NCT02546921|590081195|FG005|Overall Study|Patient Choice|1|||
163375067|NCT02546921|590081196|FG006|Overall Study|Patient Choice|0|||
163375068|NCT01373151|590081197|FG000|Period 1|Lack of Efficacy|3|||
163375069|NCT01373151|590081198|FG001|Period 1|Lack of Efficacy|0|||
163375070|NCT01373151|590081199|FG002|Period 1|Lack of Efficacy|0|||
163375071|NCT01373151|590081200|FG003|Period 1|Lack of Efficacy|0|||
163375072|NCT01373151|590081201|FG004|Period 1|Lack of Efficacy|1|||
163375073|NCT01373151|590081202|FG005|Period 1|Lack of Efficacy|0|||
163375074|NCT01373151|590081203|FG006|Period 1|Lack of Efficacy|0|||
163375075|NCT01373151|590081197|FG000|Period 1|Adverse Event|0|||
163375076|NCT01373151|590081198|FG001|Period 1|Adverse Event|0|||
163375077|NCT01373151|590081199|FG002|Period 1|Adverse Event|1|||
163375078|NCT01373151|590081200|FG003|Period 1|Adverse Event|0|||
163375079|NCT01373151|590081201|FG004|Period 1|Adverse Event|4|||
163375080|NCT01373151|590081202|FG005|Period 1|Adverse Event|3|||
163375081|NCT01373151|590081203|FG006|Period 1|Adverse Event|0|||
163375082|NCT01373151|590081197|FG000|Period 1|Withdrawal by Subject|2|||
163375083|NCT01373151|590081198|FG001|Period 1|Withdrawal by Subject|0|||
163375084|NCT01373151|590081199|FG002|Period 1|Withdrawal by Subject|3|||
163375085|NCT01373151|590081200|FG003|Period 1|Withdrawal by Subject|1|||
163375086|NCT01373151|590081201|FG004|Period 1|Withdrawal by Subject|0|||
163375087|NCT01373151|590081202|FG005|Period 1|Withdrawal by Subject|1|||
163375088|NCT01373151|590081203|FG006|Period 1|Withdrawal by Subject|0|||
163375089|NCT01373151|590081197|FG000|Period 2|Lack of Efficacy|9|||
163375090|NCT01373151|590081198|FG001|Period 2|Lack of Efficacy|0|||
163375091|NCT01373151|590081199|FG002|Period 2|Lack of Efficacy|0|||
163375092|NCT01373151|590081200|FG003|Period 2|Lack of Efficacy|1|||
163375093|NCT01373151|590081201|FG004|Period 2|Lack of Efficacy|2|||
163375094|NCT01373151|590081202|FG005|Period 2|Lack of Efficacy|0|||
163375095|NCT01373151|590081203|FG006|Period 2|Lack of Efficacy|3|||
163375096|NCT01373151|590081197|FG000|Period 2|Adverse Event|0|||
163375097|NCT01373151|590081198|FG001|Period 2|Adverse Event|0|||
163375098|NCT01373151|590081199|FG002|Period 2|Adverse Event|3|||
163375099|NCT01373151|590081200|FG003|Period 2|Adverse Event|3|||
163375100|NCT01373151|590081201|FG004|Period 2|Adverse Event|0|||
163375101|NCT01373151|590081202|FG005|Period 2|Adverse Event|0|||
163375102|NCT01373151|590081203|FG006|Period 2|Adverse Event|1|||
163375103|NCT01373151|590081197|FG000|Period 2|subject request to discontinue|0|||
163375104|NCT01373151|590081198|FG001|Period 2|subject request to discontinue|1|||
163375105|NCT01373151|590081199|FG002|Period 2|subject request to discontinue|0|||
163375106|NCT01373151|590081200|FG003|Period 2|subject request to discontinue|0|||
163375107|NCT01373151|590081201|FG004|Period 2|subject request to discontinue|0|||
163375108|NCT01373151|590081202|FG005|Period 2|subject request to discontinue|0|||
163375109|NCT01373151|590081203|FG006|Period 2|subject request to discontinue|0|||
163375110|NCT01373151|590081197|FG000|Period 2|Withdrawal by Subject|0|||
163375111|NCT01373151|590081198|FG001|Period 2|Withdrawal by Subject|0|||
163375112|NCT01373151|590081199|FG002|Period 2|Withdrawal by Subject|0|||
163375113|NCT01373151|590081200|FG003|Period 2|Withdrawal by Subject|1|||
163375114|NCT01373151|590081201|FG004|Period 2|Withdrawal by Subject|0|||
163375115|NCT01373151|590081202|FG005|Period 2|Withdrawal by Subject|0|||
163375116|NCT01373151|590081203|FG006|Period 2|Withdrawal by Subject|0|||
163375117|NCT01373151|590081197|FG000|Period 2|Other|0|||
163375118|NCT01373151|590081198|FG001|Period 2|Other|0|||
163375119|NCT01373151|590081199|FG002|Period 2|Other|1|||
163375120|NCT01373151|590081200|FG003|Period 2|Other|0|||
163375121|NCT01373151|590081201|FG004|Period 2|Other|0|||
163375122|NCT01373151|590081202|FG005|Period 2|Other|0|||
163375123|NCT01373151|590081203|FG006|Period 2|Other|1|||
163375124|NCT03026075|590081207|FG000|Overall Study|Physician Decision|1|||
163375125|NCT03381339|590081210|FG000|Overall Study|Protocol Violation|4|||
163375126|NCT03381339|590081211|FG001|Overall Study|Protocol Violation|3|||
163375127|NCT03381339|590081210|FG000|Overall Study|Lost to Follow-up|0|||
163375128|NCT03381339|590081211|FG001|Overall Study|Lost to Follow-up|1|||
163414346|NCT01164722|590223085|FG001|Overall Study|enrolled on other study, concomitant med|3|||
163375129|NCT03117998|590081212|FG000|Overall Study|Adverse Event|1|||
163375130|NCT03117998|590081213|FG001|Overall Study|Adverse Event|0|||
163375131|NCT03117998|590081214|FG002|Overall Study|Adverse Event|0|||
163375132|NCT03117998|590081215|FG003|Overall Study|Adverse Event|0|||
163375133|NCT03117998|590081216|FG004|Overall Study|Adverse Event|0|||
163375134|NCT03117998|590081217|FG005|Overall Study|Adverse Event|0|||
163375135|NCT03117998|590081212|FG000|Overall Study|Withdrawal by Subject|0|||
163375136|NCT03117998|590081213|FG001|Overall Study|Withdrawal by Subject|0|||
163375137|NCT03117998|590081214|FG002|Overall Study|Withdrawal by Subject|2|||
163375138|NCT03117998|590081215|FG003|Overall Study|Withdrawal by Subject|3|||
163375139|NCT03117998|590081216|FG004|Overall Study|Withdrawal by Subject|3|||
163375140|NCT03117998|590081217|FG005|Overall Study|Withdrawal by Subject|0|||
163375141|NCT03117998|590081212|FG000|Overall Study|Physician Decision|0|||
163375142|NCT03117998|590081213|FG001|Overall Study|Physician Decision|1|||
163375143|NCT03117998|590081214|FG002|Overall Study|Physician Decision|1|||
163375144|NCT03117998|590081215|FG003|Overall Study|Physician Decision|0|||
163375145|NCT03117998|590081216|FG004|Overall Study|Physician Decision|0|||
163375146|NCT03117998|590081217|FG005|Overall Study|Physician Decision|0|||
163375147|NCT03117998|590081212|FG000|Overall Study|Lost to Follow-up|0|||
163375148|NCT03117998|590081213|FG001|Overall Study|Lost to Follow-up|0|||
163375149|NCT03117998|590081214|FG002|Overall Study|Lost to Follow-up|0|||
163375150|NCT03117998|590081215|FG003|Overall Study|Lost to Follow-up|1|||
163375151|NCT03117998|590081216|FG004|Overall Study|Lost to Follow-up|4|||
163375152|NCT03117998|590081217|FG005|Overall Study|Lost to Follow-up|0|||
163375153|NCT03117998|590081212|FG000|Overall Study|Subject noncompliance|0|||
163375154|NCT03117998|590081213|FG001|Overall Study|Subject noncompliance|0|||
163375155|NCT03117998|590081214|FG002|Overall Study|Subject noncompliance|1|||
163375156|NCT03117998|590081215|FG003|Overall Study|Subject noncompliance|0|||
163375157|NCT03117998|590081216|FG004|Overall Study|Subject noncompliance|0|||
163375158|NCT03117998|590081217|FG005|Overall Study|Subject noncompliance|2|||
163375159|NCT03117998|590081212|FG000|Overall Study|Protocol Violation|0|||
163375160|NCT03117998|590081213|FG001|Overall Study|Protocol Violation|0|||
163375161|NCT03117998|590081214|FG002|Overall Study|Protocol Violation|0|||
163375162|NCT03117998|590081215|FG003|Overall Study|Protocol Violation|0|||
163375163|NCT03117998|590081216|FG004|Overall Study|Protocol Violation|0|||
163375164|NCT03117998|590081217|FG005|Overall Study|Protocol Violation|1|||
163375165|NCT04927247|590081218|FG000|Overall Study|Other|2|||
163375166|NCT04927247|590081219|FG001|Overall Study|Other|1|||
163375167|NCT04927247|590081218|FG000|Overall Study|Physician Decision|0|||
163414347|NCT03889639|590223087|FG000|Overall Study|Withdrawal by Subject|0|||
163414348|NCT03889639|590223088|FG001|Overall Study|Withdrawal by Subject|0|||
163414349|NCT03889639|590223089|FG002|Overall Study|Withdrawal by Subject|0|||
163414350|NCT03889639|590223090|FG003|Overall Study|Withdrawal by Subject|0|||
163414351|NCT03889639|590223091|FG004|Overall Study|Withdrawal by Subject|0|||
163414352|NCT03889639|590223092|FG005|Overall Study|Withdrawal by Subject|0|||
163414353|NCT03889639|590223093|FG006|Overall Study|Withdrawal by Subject|0|||
163414354|NCT03889639|590223094|FG007|Overall Study|Withdrawal by Subject|1|||
163414355|NCT01703858|590223095|FG000|Overall Study|Withdrawal by Subject|0|||
163414356|NCT01703858|590223096|FG001|Overall Study|Withdrawal by Subject|1|||
163414357|NCT01703858|590223097|FG002|Overall Study|Withdrawal by Subject|0|||
163414358|NCT02556255|590223098|FG000|Overall Study|Lost to Follow-up|4|||
163414359|NCT00993031|590223099|FG000|Overall Study|Death|0|||
163414360|NCT00993031|590223100|FG001|Overall Study|Death|1|||
163414361|NCT00993031|590223099|FG000|Overall Study|Physician Decision|0|||
163414362|NCT00993031|590223100|FG001|Overall Study|Physician Decision|2|||
163414363|NCT00993031|590223099|FG000|Overall Study|Withdrawal by Subject|3|||
163414364|NCT00993031|590223100|FG001|Overall Study|Withdrawal by Subject|3|||
163414365|NCT00993031|590223099|FG000|Overall Study|Lost to Follow-up|19|||
163414366|NCT00993031|590223100|FG001|Overall Study|Lost to Follow-up|13|||
163414367|NCT01834729|590223104|FG000|Overall Study|Did not return bowel diaries|0|||
163414368|NCT01834729|590223105|FG001|Overall Study|Did not return bowel diaries|0|||
163414369|NCT01834729|590223106|FG002|Overall Study|Did not return bowel diaries|3|||
163414370|NCT01834729|590223107|FG003|Overall Study|Did not return bowel diaries|0|||
163414371|NCT01834729|590223104|FG000|Overall Study|Withdrawal by Subject|1|||
163414372|NCT01834729|590223105|FG001|Overall Study|Withdrawal by Subject|1|||
163375168|NCT04927247|590081219|FG001|Overall Study|Physician Decision|1|||
163375169|NCT04927247|590081218|FG000|Overall Study|Adverse Event|1|||
163375170|NCT04927247|590081219|FG001|Overall Study|Adverse Event|0|||
163375171|NCT02001064|590081221|FG000|Overall Study|Withdrawal by Subject|2|||
163375172|NCT02001064|590081222|FG001|Overall Study|Withdrawal by Subject|1|||
163375173|NCT01468181|590081224|FG000|Overall Study|Adverse Event|8|||
163375174|NCT01468181|590081225|FG001|Overall Study|Adverse Event|1|||
163375175|NCT01468181|590081226|FG002|Overall Study|Adverse Event|6|||
163375176|NCT01468181|590081227|FG003|Overall Study|Adverse Event|2|||
163375177|NCT01468181|590081228|FG004|Overall Study|Adverse Event|2|||
163375178|NCT01468181|590081224|FG000|Overall Study|Protocol Violation|2|||
163375179|NCT01468181|590081225|FG001|Overall Study|Protocol Violation|0|||
163375180|NCT01468181|590081226|FG002|Overall Study|Protocol Violation|1|||
163375181|NCT01468181|590081227|FG003|Overall Study|Protocol Violation|0|||
163375182|NCT01468181|590081228|FG004|Overall Study|Protocol Violation|1|||
163375183|NCT01468181|590081224|FG000|Overall Study|Physician Decision|0|||
163375184|NCT01468181|590081225|FG001|Overall Study|Physician Decision|0|||
163375185|NCT01468181|590081226|FG002|Overall Study|Physician Decision|0|||
163375186|NCT01468181|590081227|FG003|Overall Study|Physician Decision|1|||
163375187|NCT01468181|590081228|FG004|Overall Study|Physician Decision|1|||
163375188|NCT01468181|590081224|FG000|Overall Study|Lost to Follow-up|0|||
163375189|NCT01468181|590081225|FG001|Overall Study|Lost to Follow-up|0|||
163375190|NCT01468181|590081226|FG002|Overall Study|Lost to Follow-up|1|||
163375191|NCT01468181|590081227|FG003|Overall Study|Lost to Follow-up|0|||
163375192|NCT01468181|590081228|FG004|Overall Study|Lost to Follow-up|1|||
163414373|NCT01834729|590223106|FG002|Overall Study|Withdrawal by Subject|0|||
163414374|NCT01834729|590223107|FG003|Overall Study|Withdrawal by Subject|0|||
163414375|NCT01834729|590223104|FG000|Overall Study|Adverse Event|0|||
163375193|NCT01468181|590081224|FG000|Overall Study|Withdrawal by Subject|0|||
163375194|NCT01468181|590081225|FG001|Overall Study|Withdrawal by Subject|1|||
163375195|NCT01468181|590081226|FG002|Overall Study|Withdrawal by Subject|0|||
163375196|NCT01468181|590081227|FG003|Overall Study|Withdrawal by Subject|0|||
163375197|NCT01468181|590081228|FG004|Overall Study|Withdrawal by Subject|0|||
163375198|NCT00545753|590081232|FG000|Overall Study|Withdrawal by Subject|0|||
163375199|NCT00545753|590081233|FG001|Overall Study|Withdrawal by Subject|1|||
163375200|NCT00545753|590081234|FG002|Overall Study|Withdrawal by Subject|10|||
163375201|NCT00545753|590081232|FG000|Overall Study|Lost to Follow-up|13|||
163375202|NCT00545753|590081233|FG001|Overall Study|Lost to Follow-up|3|||
163375203|NCT00545753|590081234|FG002|Overall Study|Lost to Follow-up|12|||
163375204|NCT00545753|590081232|FG000|Overall Study|Protocol Violation|3|||
163414376|NCT01834729|590223105|FG001|Overall Study|Adverse Event|0|||
163414377|NCT01834729|590223106|FG002|Overall Study|Adverse Event|0|||
163414378|NCT01834729|590223107|FG003|Overall Study|Adverse Event|2|||
163414379|NCT04673786|590223109|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
163414380|NCT04673786|590223110|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
163414381|NCT04673786|590223111|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
163414382|NCT04673786|590223109|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
163414383|NCT04673786|590223110|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
163414384|NCT04673786|590223111|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
163414385|NCT04673786|590223109|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
163414386|NCT04673786|590223110|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
163414387|NCT04673786|590223111|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
163414388|NCT04673786|590223109|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
163414389|NCT04673786|590223110|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
163414390|NCT04673786|590223111|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
163414391|NCT04673786|590223109|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
163414392|NCT04673786|590223110|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
163414393|NCT04673786|590223111|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
163414394|NCT04673786|590223109|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
163414395|NCT04673786|590223110|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
163414396|NCT04673786|590223111|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
163414397|NCT01325428|590223112|FG000|Part A|Progressive disease according to RECIST|9|||
163414398|NCT01325428|590223112|FG000|Part A|Clinical signs, symptoms of progression|2|||
163414399|NCT01325428|590223112|FG000|Part A|Other adverse event|1|||
163414400|NCT01325428|590223112|FG000|Part A|Refused continue taking trial medication|2|||
163414401|NCT01325428|590223112|FG000|Part A|Other reason not defined above|2|||
163414402|NCT01325428|590223112|FG000|Part B|Refused continue taking trial medication|2|||
163414403|NCT01325428|590223112|FG000|Part B|Other reason not defined above|1|||
163414404|NCT00725075|590223113|FG000|Overall Study|Use of Excluded Medication|0|||
163414405|NCT00725075|590223114|FG001|Overall Study|Use of Excluded Medication|1|||
163414406|NCT00725075|590223115|FG002|Overall Study|Use of Excluded Medication|0|||
163414407|NCT00725075|590223113|FG000|Overall Study|Protocol Violation|0|||
163414408|NCT00725075|590223114|FG001|Overall Study|Protocol Violation|0|||
163414409|NCT00725075|590223115|FG002|Overall Study|Protocol Violation|1|||
163414410|NCT00725075|590223113|FG000|Overall Study|Lost to Follow-up|1|||
163414411|NCT00725075|590223114|FG001|Overall Study|Lost to Follow-up|0|||
163414412|NCT00725075|590223115|FG002|Overall Study|Lost to Follow-up|0|||
163414413|NCT00725075|590223113|FG000|Overall Study|Withdrawal by Subject|4|||
163414414|NCT00725075|590223114|FG001|Overall Study|Withdrawal by Subject|5|||
163414415|NCT00725075|590223115|FG002|Overall Study|Withdrawal by Subject|4|||
163414416|NCT00725075|590223113|FG000|Overall Study|Adverse Event|2|||
163414417|NCT00725075|590223114|FG001|Overall Study|Adverse Event|1|||
163375205|NCT00545753|590081233|FG001|Overall Study|Protocol Violation|1|||
163375206|NCT00545753|590081234|FG002|Overall Study|Protocol Violation|4|||
163375207|NCT00513305|590081235|FG000|Overall Study|Adverse Event|6|||
163375208|NCT00513305|590081236|FG001|Overall Study|Adverse Event|2|||
163375209|NCT00513305|590081235|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
163375210|NCT00513305|590081236|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
163375211|NCT00513305|590081235|FG000|Overall Study|Lack of Efficacy|8|||
163414418|NCT00725075|590223115|FG002|Overall Study|Adverse Event|1|||
163414419|NCT00725075|590223113|FG000|Overall Study|Worsening of Disease|2|||
163414420|NCT00725075|590223114|FG001|Overall Study|Worsening of Disease|1|||
163414421|NCT00725075|590223115|FG002|Overall Study|Worsening of Disease|2|||
163414422|NCT00725075|590223113|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
163414423|NCT00725075|590223114|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
163414424|NCT00725075|590223115|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
163375212|NCT00513305|590081236|FG001|Overall Study|Lack of Efficacy|13|||
163414425|NCT00725075|590223113|FG000|Overall Study|Other|1|||
163414426|NCT00725075|590223114|FG001|Overall Study|Other|0|||
163414427|NCT00725075|590223115|FG002|Overall Study|Other|0|||
163414428|NCT01298492|590223116|FG000|Overall Study|Death|2|||
163414429|NCT01298492|590223116|FG000|Overall Study|Insufficient Clinical Response|22|||
163414430|NCT01298492|590223116|FG000|Overall Study|Lost to Follow-up|12|||
163375213|NCT00513305|590081235|FG000|Overall Study|Withdrawal by Subject|1|||
163375214|NCT00513305|590081236|FG001|Overall Study|Withdrawal by Subject|2|||
163375215|NCT00513305|590081235|FG000|Overall Study|Disease progression|8|||
163375216|NCT00513305|590081236|FG001|Overall Study|Disease progression|5|||
163375217|NCT00513305|590081235|FG000|Overall Study|Eligible for stem cell transplant|1|||
163375218|NCT00513305|590081236|FG001|Overall Study|Eligible for stem cell transplant|0|||
163375219|NCT00513305|590081235|FG000|Overall Study|Hematologic counts did not recover|1|||
163375220|NCT00513305|590081236|FG001|Overall Study|Hematologic counts did not recover|0|||
163375221|NCT00513305|590081235|FG000|Overall Study|Physician Decision|1|||
163375222|NCT00513305|590081236|FG001|Overall Study|Physician Decision|0|||
163375223|NCT00513305|590081235|FG000|Overall Study|Persistent hypocellularity|0|||
163375224|NCT00513305|590081236|FG001|Overall Study|Persistent hypocellularity|1|||
163375225|NCT00513305|590081235|FG000|Overall Study|Sponsor Decision|0|||
163375226|NCT00513305|590081236|FG001|Overall Study|Sponsor Decision|2|||
163375227|NCT01262027|590081238|FG000|Overall Study|Adverse Event|1|||
163375228|NCT01262027|590081238|FG000|Overall Study|Withdrawal by Subject|3|||
163375229|NCT01262027|590081238|FG000|Overall Study|Protocol Violation|1|||
163375230|NCT01011153|590081242|FG000|Overall Study|Less than 78 cases completed|8|||
163375231|NCT01011153|590081243|FG001|Overall Study|Less than 78 cases completed|11|||
163375232|NCT01011153|590081244|FG002|Overall Study|Less than 78 cases completed|9|||
163375233|NCT03014479|590081249|FG000|Overall Study|Adverse Event|0|||
163375234|NCT03014479|590081250|FG001|Overall Study|Adverse Event|1|||
163375235|NCT03014479|590081249|FG000|Overall Study|Voluntary Withdrawal|0|||
163375236|NCT03014479|590081250|FG001|Overall Study|Voluntary Withdrawal|2|||
163375237|NCT03014479|590081249|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
163375238|NCT03014479|590081250|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
163375239|NCT01081132|590081256|FG000|Overall Study|Lack of Efficacy|25|||
163375240|NCT01081132|590081257|FG001|Overall Study|Lack of Efficacy|9|||
163375241|NCT01081132|590081256|FG000|Overall Study|Withdrawal by Subject|13|||
163375242|NCT01081132|590081257|FG001|Overall Study|Withdrawal by Subject|16|||
163375243|NCT01081132|590081256|FG000|Overall Study|Lost to Follow-up|4|||
163375244|NCT01081132|590081257|FG001|Overall Study|Lost to Follow-up|11|||
163375245|NCT01081132|590081256|FG000|Overall Study|Adverse Event|3|||
163375246|NCT01081132|590081257|FG001|Overall Study|Adverse Event|9|||
163375247|NCT01081132|590081256|FG000|Overall Study|Non Compliance|4|||
163375248|NCT01081132|590081257|FG001|Overall Study|Non Compliance|2|||
163375249|NCT01081132|590081256|FG000|Overall Study|Lack Of Compliance|0|||
163375250|NCT01081132|590081257|FG001|Overall Study|Lack Of Compliance|1|||
163375251|NCT01081132|590081256|FG000|Overall Study|Missed Visits|1|||
163375252|NCT01081132|590081257|FG001|Overall Study|Missed Visits|1|||
163375253|NCT01081132|590081256|FG000|Overall Study|Stopped Taking Meds|2|||
163375254|NCT01081132|590081257|FG001|Overall Study|Stopped Taking Meds|0|||
163375255|NCT01081132|590081256|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
163375256|NCT01081132|590081257|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
163375257|NCT01081132|590081256|FG000|Overall Study|Declined Taper Phase|0|||
163375258|NCT01081132|590081257|FG001|Overall Study|Declined Taper Phase|1|||
163375259|NCT01081132|590081256|FG000|Overall Study|Protocol Violation|3|||
163375260|NCT01081132|590081257|FG001|Overall Study|Protocol Violation|1|||
163375261|NCT03973931|590081258|FG000|Overall Study|Lost to Follow-up|47|||
163375262|NCT03973931|590081259|FG001|Overall Study|Lost to Follow-up|63|||
163375263|NCT03973931|590081260|FG002|Overall Study|Lost to Follow-up|51|||
163375264|NCT03973931|590081261|FG003|Overall Study|Lost to Follow-up|54|||
163375265|NCT03973931|590081258|FG000|Overall Study|opted out|6|||
163375266|NCT03973931|590081259|FG001|Overall Study|opted out|5|||
163375267|NCT03973931|590081260|FG002|Overall Study|opted out|5|||
163375268|NCT03973931|590081261|FG003|Overall Study|opted out|1|||
163375269|NCT00432666|590082790|FG000|Main Period|Adverse Event|1|||
163375270|NCT00432666|590082791|FG001|Main Period|Adverse Event|1|||
163375271|NCT00432666|590082790|FG000|Main Period|Consent Withdrawn|1|||
163375272|NCT00432666|590082791|FG001|Main Period|Consent Withdrawn|0|||
163375273|NCT00432666|590082790|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
163375274|NCT00432666|590082791|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
163375275|NCT00432666|590082790|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
163375276|NCT00432666|590082791|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
163375277|NCT00432666|590082790|FG000|Open-Label Extension Period|Adverse Event|5|||
163375278|NCT00432666|590082791|FG001|Open-Label Extension Period|Adverse Event|0|||
163375279|NCT00432666|590082790|FG000|Open-Label Extension Period|Consent withdrawn|10|||
163375280|NCT00432666|590082791|FG001|Open-Label Extension Period|Consent withdrawn|0|||
163375281|NCT00432666|590082790|FG000|Open-Label Extension Period|Physician Decision|3|||
163375282|NCT00432666|590082791|FG001|Open-Label Extension Period|Physician Decision|0|||
163375283|NCT00978627|590082792|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
163375284|NCT00978627|590082793|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
163375285|NCT00978627|590082792|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
163375286|NCT00978627|590082793|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
163375287|NCT00978627|590082792|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
163375288|NCT00978627|590082793|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
163375289|NCT00978627|590082792|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
163414431|NCT01298492|590223116|FG000|Overall Study|Withdrawal by Subject|47|||
163414432|NCT01298492|590223116|FG000|Overall Study|Other (Unspecified)|7|||
163414433|NCT01298492|590223116|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
163414434|NCT01298492|590223116|FG000|Overall Study|Protocol Violation|2|||
163414435|NCT01298492|590223116|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
163414436|NCT01298492|590223116|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
163414437|NCT02340663|590223117|FG000|Overall Study|Lost to Follow-up|1|||
163414438|NCT02340663|590223118|FG001|Overall Study|Lost to Follow-up|0|||
163414439|NCT02340663|590223117|FG000|Overall Study|Protocol Violation|1|||
163414440|NCT02340663|590223118|FG001|Overall Study|Protocol Violation|0|||
163414441|NCT02340663|590223117|FG000|Overall Study|Withdrawal by Subject|3|||
163414442|NCT02340663|590223118|FG001|Overall Study|Withdrawal by Subject|1|||
163414443|NCT02902120|590223119|FG000|Overall Study|Lack of Efficacy|1|||
163414444|NCT01353703|590223121|FG000|Overall Study|Migrated/moved from study area|1|||
163414445|NCT01353703|590223122|FG001|Overall Study|Migrated/moved from study area|0|||
163414446|NCT03298022|590223123|FG000|Overall Study|Lack of Efficacy|4|||
163414447|NCT03298022|590223123|FG000|Overall Study|Withdrawal by Subject|7|||
163414448|NCT03298022|590223123|FG000|Overall Study|Adverse Event|1|||
163414449|NCT03298022|590223123|FG000|Overall Study|disease relapse|1|||
163414450|NCT03694925|590223124|FG000|Overall Study|Inadequate laboratory testing|0|||
163414451|NCT03694925|590223125|FG001|Overall Study|Inadequate laboratory testing|3|||
163414452|NCT03694925|590223126|FG002|Overall Study|Inadequate laboratory testing|0|||
163424273|NCT00885365|590258214|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
163424274|NCT00885365|590258215|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
163424275|NCT00885365|590258214|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
163424276|NCT00885365|590258215|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
163424277|NCT01824979|590258216|FG000|Overall Study|Withdrawal by Subject|5|||
163424278|NCT01824979|590258217|FG001|Overall Study|Withdrawal by Subject|0|||
163424279|NCT01824979|590258216|FG000|Overall Study|Physician Decision|2|||
163424280|NCT01824979|590258217|FG001|Overall Study|Physician Decision|0|||
163424281|NCT01824979|590258216|FG000|Overall Study|Protocol Violation|6|||
163424282|NCT01824979|590258217|FG001|Overall Study|Protocol Violation|13|||
163424283|NCT01756456|590258221|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
163375290|NCT00978627|590082793|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
163375291|NCT00978627|590082792|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
163375292|NCT00978627|590082793|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
163375293|NCT00978627|590082792|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
163375294|NCT00978627|590082793|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
163375295|NCT00978627|590082792|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
163375296|NCT00978627|590082793|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
163375297|NCT00978627|590082792|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
163375298|NCT00978627|590082793|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
163375299|NCT00978627|590082792|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
163375300|NCT00978627|590082793|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
163375301|NCT01506453|590082794|FG000|Overall Study|Withdrawal prior to treatment|0|||
163375302|NCT01506453|590082795|FG001|Overall Study|Withdrawal prior to treatment|2|||
163375303|NCT00603304|590082812|FG000|Overall Study|Lost to Follow-up|5|||
163375304|NCT00603304|590082813|FG001|Overall Study|Lost to Follow-up|7|||
163375305|NCT00603304|590082812|FG000|Overall Study|Withdrawal by Subject|8|||
163375306|NCT00603304|590082813|FG001|Overall Study|Withdrawal by Subject|5|||
163375307|NCT00603304|590082812|FG000|Overall Study|Protocol Violation|1|||
163375308|NCT00603304|590082813|FG001|Overall Study|Protocol Violation|0|||
163375309|NCT00603304|590082812|FG000|Overall Study|Adverse Event|4|||
163375310|NCT00603304|590082813|FG001|Overall Study|Adverse Event|2|||
163375311|NCT00603304|590082812|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
163375312|NCT00603304|590082813|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
163375313|NCT00603304|590082812|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
163375314|NCT00603304|590082813|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
163375315|NCT00603304|590082812|FG000|Overall Study|Exclusionary Medication|2|||
163375316|NCT00603304|590082813|FG001|Overall Study|Exclusionary Medication|3|||
163375317|NCT00603304|590082812|FG000|Overall Study|Non-Compliant|0|||
163375318|NCT00603304|590082813|FG001|Overall Study|Non-Compliant|1|||
163375319|NCT00603304|590082812|FG000|Overall Study|Moved Away|0|||
163375320|NCT00603304|590082813|FG001|Overall Study|Moved Away|2|||
163375321|NCT00603304|590082812|FG000|Overall Study|Other|2|||
163375322|NCT00603304|590082813|FG001|Overall Study|Other|0|||
163375323|NCT00603304|590082812|FG000|Overall Study|Patient Decision|2|||
163375324|NCT00603304|590082813|FG001|Overall Study|Patient Decision|0|||
163375325|NCT01076192|590082814|FG000|Overall Study|Other|197|||
163375326|NCT01290315|590082815|FG000|Overall Study|Adverse Event|0|||
163375327|NCT01290315|590082816|FG001|Overall Study|Adverse Event|0|||
163375328|NCT01290315|590082817|FG002|Overall Study|Adverse Event|0|||
163375329|NCT01290315|590082818|FG003|Overall Study|Adverse Event|3|||
163375330|NCT01290315|590082815|FG000|Overall Study|Selection criteria/compliance|2|||
163424284|NCT01756456|590258222|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
163375331|NCT01290315|590082816|FG001|Overall Study|Selection criteria/compliance|1|||
163375332|NCT01290315|590082817|FG002|Overall Study|Selection criteria/compliance|0|||
163375333|NCT01290315|590082818|FG003|Overall Study|Selection criteria/compliance|2|||
163375334|NCT01290315|590082815|FG000|Overall Study|Lost to Follow-up|0|||
163375335|NCT01290315|590082816|FG001|Overall Study|Lost to Follow-up|1|||
163375336|NCT01290315|590082817|FG002|Overall Study|Lost to Follow-up|0|||
163375337|NCT01290315|590082818|FG003|Overall Study|Lost to Follow-up|0|||
163375338|NCT01290315|590082815|FG000|Overall Study|Withdrawal by Subject|1|||
163375339|NCT01290315|590082816|FG001|Overall Study|Withdrawal by Subject|1|||
163375340|NCT01290315|590082817|FG002|Overall Study|Withdrawal by Subject|0|||
163375341|NCT01290315|590082818|FG003|Overall Study|Withdrawal by Subject|0|||
163375342|NCT03725085|590082819|FG000|Overall Study|Lost to Follow-up|2|||
163375343|NCT00705679|590082820|FG000|Overall Study|Adverse Event|1|||
163375344|NCT00705679|590082821|FG001|Overall Study|Adverse Event|1|||
163375345|NCT00705679|590082822|FG002|Overall Study|Adverse Event|0|||
163375346|NCT00705679|590082823|FG003|Overall Study|Adverse Event|0|||
163375347|NCT00705679|590082824|FG004|Overall Study|Adverse Event|0|||
163375348|NCT00705679|590082820|FG000|Overall Study|Death|0|||
163375349|NCT00705679|590082821|FG001|Overall Study|Death|0|||
163375350|NCT00705679|590082822|FG002|Overall Study|Death|3|||
163375351|NCT00705679|590082823|FG003|Overall Study|Death|2|||
163375352|NCT00705679|590082824|FG004|Overall Study|Death|1|||
163375353|NCT00705679|590082820|FG000|Overall Study|Lost to Follow-up|32|||
163375354|NCT00705679|590082821|FG001|Overall Study|Lost to Follow-up|60|||
163375355|NCT00705679|590082822|FG002|Overall Study|Lost to Follow-up|44|||
163375356|NCT00705679|590082823|FG003|Overall Study|Lost to Follow-up|30|||
163375357|NCT00705679|590082824|FG004|Overall Study|Lost to Follow-up|35|||
163375358|NCT00705679|590082820|FG000|Overall Study|Physician Decision|0|||
163375359|NCT00705679|590082821|FG001|Overall Study|Physician Decision|1|||
163375360|NCT00705679|590082822|FG002|Overall Study|Physician Decision|0|||
163375361|NCT00705679|590082823|FG003|Overall Study|Physician Decision|1|||
163375362|NCT00705679|590082824|FG004|Overall Study|Physician Decision|0|||
163375363|NCT00705679|590082820|FG000|Overall Study|Withdrawal by Subject|32|||
163375364|NCT00705679|590082821|FG001|Overall Study|Withdrawal by Subject|77|||
163375365|NCT00705679|590082822|FG002|Overall Study|Withdrawal by Subject|68|||
163375366|NCT00705679|590082823|FG003|Overall Study|Withdrawal by Subject|47|||
163375367|NCT00705679|590082824|FG004|Overall Study|Withdrawal by Subject|33|||
163375368|NCT03527173|590082825|FG000|Overall Study|Lost to Follow-up|4|||
163375369|NCT03527173|590082826|FG001|Overall Study|Lost to Follow-up|2|||
163375370|NCT03527173|590082825|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
163375371|NCT03527173|590082826|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
163375372|NCT03527173|590082825|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
163375373|NCT03527173|590082826|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
163375374|NCT03527173|590082825|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
163375375|NCT03527173|590082826|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163375376|NCT01248780|590082827|FG000|Overall Study|Lack of Efficacy|2|||
163375377|NCT01248780|590082828|FG001|Overall Study|Lack of Efficacy|0|||
163375378|NCT01248780|590082827|FG000|Overall Study|Lost to Follow-up|0|||
163375379|NCT01248780|590082828|FG001|Overall Study|Lost to Follow-up|1|||
163375380|NCT01248780|590082827|FG000|Overall Study|Death|0|||
163375381|NCT01248780|590082828|FG001|Overall Study|Death|1|||
163375382|NCT01248780|590082827|FG000|Overall Study|Adverse Event|2|||
163375383|NCT01248780|590082828|FG001|Overall Study|Adverse Event|7|||
163375384|NCT01248780|590082827|FG000|Overall Study|Protocol Violation|1|||
163375385|NCT01248780|590082828|FG001|Overall Study|Protocol Violation|1|||
163375386|NCT01248780|590082827|FG000|Overall Study|Withdrawal by Subject|4|||
163375387|NCT01248780|590082828|FG001|Overall Study|Withdrawal by Subject|4|||
163375388|NCT01248780|590082827|FG000|Overall Study|Not treated|0|||
163375389|NCT01248780|590082828|FG001|Overall Study|Not treated|1|||
163375390|NCT04214600|590082829|FG000|Overall Study|Lost to Follow-up|9|||
163375391|NCT04214600|590082830|FG001|Overall Study|Lost to Follow-up|14|||
163375392|NCT00896051|590082831|FG000|Overall Study|Adverse Event|2|||
163375393|NCT00896051|590082832|FG001|Overall Study|Adverse Event|1|||
163375394|NCT00896051|590082831|FG000|Overall Study|Lost to Follow-up|3|||
163375395|NCT00896051|590082832|FG001|Overall Study|Lost to Follow-up|2|||
163375396|NCT00896051|590082831|FG000|Overall Study|Withdrawal by Subject|3|||
163375397|NCT00896051|590082832|FG001|Overall Study|Withdrawal by Subject|2|||
163375398|NCT00896051|590082831|FG000|Overall Study|Subject noncompliant|1|||
163375399|NCT00896051|590082832|FG001|Overall Study|Subject noncompliant|3|||
163375400|NCT00896051|590082831|FG000|Overall Study|Other|1|||
163375401|NCT00896051|590082832|FG001|Overall Study|Other|1|||
163375402|NCT02935452|590082833|FG000|Overall Study|work and life commintment|3|||
163375403|NCT02935452|590082834|FG001|Overall Study|work and life commintment|1|||
163375404|NCT01813929|590082836|FG000|Overall Study|Withdrawal by Subject|0|||
163375405|NCT01813929|590082837|FG001|Overall Study|Withdrawal by Subject|1|||
163375406|NCT00007345|590082838|FG000|Overall Study|Refused further treatment|0|||
163375407|NCT00007345|590082839|FG001|Overall Study|Refused further treatment|7|||
163375408|NCT00007345|590082838|FG000|Overall Study|Switched to alternative treatment|0|||
163414453|NCT03087955|590225272|FG000|Overall Study|Death|4|||
163414454|NCT03087955|590225273|FG001|Overall Study|Death|0|||
163414455|NCT03087955|590225272|FG000|Overall Study|Lack of Efficacy|2|||
163414456|NCT03087955|590225273|FG001|Overall Study|Lack of Efficacy|0|||
163414457|NCT03087955|590225272|FG000|Overall Study|Lost to Follow-up|1|||
163414458|NCT03087955|590225273|FG001|Overall Study|Lost to Follow-up|0|||
163414459|NCT04484285|590225274|FG000|Overall Study|Unable to operate stimulator|3|||
163414460|NCT04484285|590225275|FG001|Overall Study|Unable to operate stimulator|0|||
163414461|NCT06272370|590225276|FG000|Overall Study|Lost to Follow-up|0|||
163414462|NCT06272370|590225277|FG001|Overall Study|Lost to Follow-up|3|||
163414463|NCT06272370|590225278|FG002|Overall Study|Lost to Follow-up|1|||
163414464|NCT06272370|590225279|FG003|Overall Study|Lost to Follow-up|1|||
163414465|NCT02527707|590225286|FG000|Overall Study|Adverse Event|1|||
163414466|NCT02527707|590225286|FG000|Overall Study|Adverse Event|1|||
163414467|NCT02090855|590225287|FG000|Overall Study|no evaluable Standard of Truth results|2|||
163414468|NCT00619502|590225299|FG000|Overall Study|Lost to Follow-up|8|||
163414469|NCT00619502|590225300|FG001|Overall Study|Lost to Follow-up|10|||
163414470|NCT01354028|590225301|FG000|Overall Study|Physician Decision|0|||
163414471|NCT01354028|590225302|FG001|Overall Study|Physician Decision|2|||
163414472|NCT01354028|590225301|FG000|Overall Study|Discharged before study start|2|||
163414473|NCT01354028|590225302|FG001|Overall Study|Discharged before study start|2|||
163414474|NCT01354028|590225301|FG000|Overall Study|No quiet alert state|0|||
163414475|NCT01354028|590225302|FG001|Overall Study|No quiet alert state|1|||
163414476|NCT03968419|590225305|FG000|Treatment Period|Adverse Event|0|||
163414477|NCT03968419|590225306|FG001|Treatment Period|Adverse Event|0|||
163414478|NCT03968419|590225307|FG002|Treatment Period|Adverse Event|1|||
163414479|NCT03968419|590225305|FG000|Safety Follow-up Period|Death|3|||
163414480|NCT03968419|590225306|FG001|Safety Follow-up Period|Death|2|||
163414481|NCT03968419|590225307|FG002|Safety Follow-up Period|Death|1|||
163414482|NCT03968419|590225305|FG000|Safety Follow-up Period|Subject Decision|2|||
163414483|NCT03968419|590225306|FG001|Safety Follow-up Period|Subject Decision|1|||
163414484|NCT03968419|590225307|FG002|Safety Follow-up Period|Subject Decision|0|||
163414485|NCT02968810|590225308|FG000|Overall Study|Lost to Follow-up|1|||
163414486|NCT02968810|590225309|FG001|Overall Study|Lost to Follow-up|0|||
163414487|NCT02968810|590225308|FG000|Overall Study|Physician Decision|1|||
163414488|NCT02968810|590225309|FG001|Overall Study|Physician Decision|0|||
163414489|NCT02968810|590225308|FG000|Overall Study|Withdrawal by Subject|1|||
163414490|NCT02968810|590225309|FG001|Overall Study|Withdrawal by Subject|3|||
163414491|NCT02968810|590225308|FG000|Overall Study|Disease Progression|0|||
163414492|NCT02968810|590225309|FG001|Overall Study|Disease Progression|1|||
163414493|NCT01641939|590225312|FG000|Overall Study|Death|90|||
163414494|NCT01641939|590225313|FG001|Overall Study|Death|187|||
163414495|NCT01641939|590225314|FG002|Overall Study|Death|61|||
163414496|NCT01641939|590225312|FG000|Overall Study|Lost to Follow-up|3|||
163414497|NCT01641939|590225313|FG001|Overall Study|Lost to Follow-up|2|||
163414498|NCT01641939|590225314|FG002|Overall Study|Lost to Follow-up|1|||
163414499|NCT01641939|590225312|FG000|Overall Study|Withdrawal by Subject|14|||
163414500|NCT01641939|590225313|FG001|Overall Study|Withdrawal by Subject|11|||
163414501|NCT01641939|590225314|FG002|Overall Study|Withdrawal by Subject|5|||
163414502|NCT01641939|590225312|FG000|Overall Study|Study Terminated by Sponsor|10|||
163414503|NCT01641939|590225313|FG001|Overall Study|Study Terminated by Sponsor|28|||
163414504|NCT01641939|590225314|FG002|Overall Study|Study Terminated by Sponsor|3|||
163414505|NCT02894840|590225315|FG000|Overall Study|Lost to Follow-up|1|||
163414506|NCT02894840|590225316|FG001|Overall Study|Lost to Follow-up|0|||
163414507|NCT02894840|590225317|FG002|Overall Study|Lost to Follow-up|3|||
163414508|NCT02894840|590225318|FG003|Overall Study|Lost to Follow-up|0|||
163414509|NCT00716976|590225319|FG000|Overall Study|Adverse Event|2|||
163414510|NCT00716976|590225320|FG001|Overall Study|Adverse Event|0|||
163414511|NCT00716976|590225319|FG000|Overall Study|Death|1|||
163414512|NCT00716976|590225320|FG001|Overall Study|Death|0|||
163414513|NCT00716976|590225319|FG000|Overall Study|Physician Decision|2|||
163414514|NCT00716976|590225320|FG001|Overall Study|Physician Decision|2|||
163414515|NCT00716976|590225319|FG000|Overall Study|Withdrawal by Subject|5|||
163414516|NCT00716976|590225320|FG001|Overall Study|Withdrawal by Subject|1|||
163414517|NCT00716976|590225319|FG000|Overall Study|Premature discontinuation cisplatin|5|||
163414518|NCT00716976|590225320|FG001|Overall Study|Premature discontinuation cisplatin|4|||
163414519|NCT00716976|590225319|FG000|Overall Study|Radiation during protocol|1|||
163414520|NCT00716976|590225320|FG001|Overall Study|Radiation during protocol|0|||
163414521|NCT00716976|590225319|FG000|Overall Study|Ineligibles|4|||
163414522|NCT00716976|590225320|FG001|Overall Study|Ineligibles|2|||
163414523|NCT05499559|590225324|FG000|Overall Study|Lost to Follow-up|467|||
163414524|NCT02971202|590225331|FG000|Overall Study|Pregnancy|1|||
163414525|NCT02971202|590225332|FG001|Overall Study|Pregnancy|0|||
163414526|NCT02971202|590225333|FG002|Overall Study|Pregnancy|0|||
163414527|NCT02971202|590225331|FG000|Overall Study|screen fail after consent|1|||
163414528|NCT02971202|590225332|FG001|Overall Study|screen fail after consent|0|||
163414529|NCT02971202|590225333|FG002|Overall Study|screen fail after consent|1|||
163414530|NCT03472560|590225334|FG000|Overall Study|Subject transfer to continuation protocol|0|||
163414531|NCT03472560|590225335|FG001|Overall Study|Subject transfer to continuation protocol|1|||
163414532|NCT03472560|590225334|FG000|Overall Study|Withdrawal by Subject|4|||
163414533|NCT03472560|590225335|FG001|Overall Study|Withdrawal by Subject|0|||
163414534|NCT03472560|590225334|FG000|Overall Study|Progressive disease|24|||
163414535|NCT03472560|590225335|FG001|Overall Study|Progressive disease|8|||
163414536|NCT03472560|590225334|FG000|Overall Study|Physician Decision|1|||
163414537|NCT03472560|590225335|FG001|Overall Study|Physician Decision|0|||
163414538|NCT03472560|590225334|FG000|Overall Study|Death|7|||
163414539|NCT03472560|590225335|FG001|Overall Study|Death|4|||
163414540|NCT03472560|590225334|FG000|Overall Study|Adverse Event|5|||
163414541|NCT03472560|590225335|FG001|Overall Study|Adverse Event|3|||
163414542|NCT03472560|590225334|FG000|Overall Study|Global deterioration of health status|0|||
163414543|NCT03472560|590225335|FG001|Overall Study|Global deterioration of health status|4|||
163414544|NCT01946178|590225336|FG000|Overall Study|Pregnancy|1|||
163414545|NCT01946178|590225336|FG000|Overall Study|Lost to Follow-up|1|||
163414546|NCT01534676|590225342|FG000|Overall Study|Study closed due to poor enrollment|2|||
163414547|NCT01534676|590225343|FG001|Overall Study|Study closed due to poor enrollment|1|||
163414548|NCT05425563|590225346|FG000|Overall Study|Withdrawal by Subject|17|||
163414549|NCT01001702|590225347|FG000|Overall Study|Lost to Follow-up|7|||
163414550|NCT01001702|590225347|FG000|Overall Study|Adverse Event|7|||
163414551|NCT01001702|590225347|FG000|Overall Study|Sponsor Discontinued Study|4|||
163414552|NCT01001702|590225347|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
163414553|NCT01001702|590225347|FG000|Overall Study|Investigator withdrew Subject|10|||
163414554|NCT01001702|590225347|FG000|Overall Study|Withdrawal by Subject|19|||
163414555|NCT01001702|590225347|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
163414556|NCT00584233|590225350|FG000|Overall Study|Withdrawal by Subject|5|||
163414557|NCT00584233|590225350|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
163414558|NCT02494596|590225351|FG000|Overall Study|Insufficient Therapeutic Response|3|||
163414559|NCT02494596|590225352|FG001|Overall Study|Insufficient Therapeutic Response|3|||
163414560|NCT02494596|590225353|FG002|Overall Study|Insufficient Therapeutic Response|1|||
163414561|NCT02494596|590225351|FG000|Overall Study|Adverse Event|0|||
163414562|NCT02494596|590225352|FG001|Overall Study|Adverse Event|1|||
163414563|NCT02494596|590225353|FG002|Overall Study|Adverse Event|0|||
163414564|NCT02494596|590225351|FG000|Overall Study|Refused Treatment|0|||
163414565|NCT02494596|590225352|FG001|Overall Study|Refused Treatment|1|||
163414566|NCT02494596|590225353|FG002|Overall Study|Refused Treatment|0|||
163414567|NCT02222714|590225354|FG000|Overall Study|Death|0|||
163414568|NCT02222714|590225355|FG001|Overall Study|Death|2|||
163414569|NCT02222714|590225356|FG002|Overall Study|Death|3|||
163414570|NCT02222714|590225357|FG003|Overall Study|Death|4|||
163414571|NCT02222714|590225358|FG004|Overall Study|Death|6|||
163414572|NCT02222714|590225354|FG000|Overall Study|Withdrawal by Subject|0|||
163414573|NCT02222714|590225355|FG001|Overall Study|Withdrawal by Subject|0|||
163414574|NCT02222714|590225356|FG002|Overall Study|Withdrawal by Subject|1|||
163414575|NCT02222714|590225357|FG003|Overall Study|Withdrawal by Subject|0|||
163414576|NCT02222714|590225358|FG004|Overall Study|Withdrawal by Subject|1|||
163414577|NCT00159432|590225359|FG000|Overall Study|Adverse Event|1|||
163414578|NCT00159432|590225359|FG000|Overall Study|Death|1|||
163414579|NCT00159432|590225359|FG000|Overall Study|Lack of Efficacy|8|||
163414580|NCT04537208|590225360|FG000|Overall Study|Adverse Event|0|||
163375409|NCT00007345|590082839|FG001|Overall Study|Switched to alternative treatment|3|||
163375410|NCT00007345|590082838|FG000|Overall Study|Intercurrent illness|1|||
163375411|NCT00007345|590082839|FG001|Overall Study|Intercurrent illness|0|||
163375412|NCT00007345|590082838|FG000|Overall Study|Death on study|1|||
163375413|NCT00007345|590082839|FG001|Overall Study|Death on study|1|||
163375414|NCT04433585|590082840|FG000|Overall Study|Withdrawal by Subject|15|||
163375415|NCT04433585|590082841|FG001|Overall Study|Withdrawal by Subject|3|||
163414581|NCT04537208|590225361|FG001|Overall Study|Adverse Event|0|||
163414582|NCT04537208|590225362|FG002|Overall Study|Adverse Event|0|||
163414583|NCT04537208|590225363|FG003|Overall Study|Adverse Event|0|||
163414584|NCT04537208|590225364|FG004|Overall Study|Adverse Event|0|||
163414585|NCT04537208|590225365|FG005|Overall Study|Adverse Event|0|||
163414586|NCT04537208|590225366|FG006|Overall Study|Adverse Event|0|||
163375416|NCT04433585|590082842|FG002|Overall Study|Withdrawal by Subject|15|||
163414587|NCT04537208|590225367|FG007|Overall Study|Adverse Event|0|||
163414588|NCT04537208|590225368|FG008|Overall Study|Adverse Event|1|||
163414589|NCT04537208|590225369|FG009|Overall Study|Adverse Event|0|||
163414590|NCT04537208|590225370|FG010|Overall Study|Adverse Event|0|||
163414591|NCT04537208|590225360|FG000|Overall Study|Protocol deviation|0|||
163414592|NCT04537208|590225361|FG001|Overall Study|Protocol deviation|0|||
163414593|NCT04537208|590225362|FG002|Overall Study|Protocol deviation|2|||
163414594|NCT04537208|590225363|FG003|Overall Study|Protocol deviation|0|||
163414595|NCT04537208|590225364|FG004|Overall Study|Protocol deviation|0|||
163414596|NCT04537208|590225365|FG005|Overall Study|Protocol deviation|2|||
163414597|NCT04537208|590225366|FG006|Overall Study|Protocol deviation|4|||
163414598|NCT04537208|590225367|FG007|Overall Study|Protocol deviation|0|||
163414599|NCT04537208|590225368|FG008|Overall Study|Protocol deviation|1|||
163414600|NCT04537208|590225369|FG009|Overall Study|Protocol deviation|0|||
163375417|NCT04433585|590082843|FG003|Overall Study|Withdrawal by Subject|6|||
163375418|NCT04433585|590082840|FG000|Overall Study|Adverse Event|10|||
163375419|NCT04433585|590082841|FG001|Overall Study|Adverse Event|4|||
163375420|NCT04433585|590082842|FG002|Overall Study|Adverse Event|1|||
163375421|NCT04433585|590082843|FG003|Overall Study|Adverse Event|0|||
163375422|NCT04433585|590082840|FG000|Overall Study|Due to the conflict in Ukraine|2|||
163375423|NCT04433585|590082841|FG001|Overall Study|Due to the conflict in Ukraine|1|||
163375424|NCT04433585|590082842|FG002|Overall Study|Due to the conflict in Ukraine|1|||
163375425|NCT04433585|590082843|FG003|Overall Study|Due to the conflict in Ukraine|2|||
163375426|NCT04433585|590082840|FG000|Overall Study|Physician Decision|1|||
163375427|NCT04433585|590082841|FG001|Overall Study|Physician Decision|2|||
163375428|NCT04433585|590082842|FG002|Overall Study|Physician Decision|0|||
163375429|NCT04433585|590082843|FG003|Overall Study|Physician Decision|0|||
163375430|NCT04433585|590082840|FG000|Overall Study|Lost to Follow-up|1|||
163375431|NCT04433585|590082841|FG001|Overall Study|Lost to Follow-up|1|||
163375432|NCT04433585|590082842|FG002|Overall Study|Lost to Follow-up|1|||
163375433|NCT04433585|590082843|FG003|Overall Study|Lost to Follow-up|0|||
163375434|NCT04433585|590082840|FG000|Overall Study|Lack of Efficacy|0|||
163375435|NCT04433585|590082841|FG001|Overall Study|Lack of Efficacy|1|||
163375436|NCT04433585|590082842|FG002|Overall Study|Lack of Efficacy|1|||
163375437|NCT04433585|590082843|FG003|Overall Study|Lack of Efficacy|1|||
163375438|NCT04433585|590082840|FG000|Overall Study|Death|0|||
163375439|NCT04433585|590082841|FG001|Overall Study|Death|1|||
163375440|NCT04433585|590082842|FG002|Overall Study|Death|0|||
163375441|NCT04433585|590082843|FG003|Overall Study|Death|0|||
163375442|NCT04988867|590082854|FG000|Overall Study|Study terminated by Sponsor|12|||
163375443|NCT04988867|590082854|FG000|Overall Study|Adverse Event|2|||
163375444|NCT04988867|590082854|FG000|Overall Study|Study drug noncompliance|1|||
163375445|NCT01097707|590082857|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
163375446|NCT01097707|590082858|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
163375447|NCT01097707|590082859|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
163375448|NCT01097707|590082860|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
163375449|NCT01097707|590082861|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
163375450|NCT01097707|590082857|FG000|Overall Study|Adverse Event|4|||
163375451|NCT01097707|590082858|FG001|Overall Study|Adverse Event|2|||
163375452|NCT01097707|590082859|FG002|Overall Study|Adverse Event|3|||
163375453|NCT01097707|590082860|FG003|Overall Study|Adverse Event|1|||
163375454|NCT01097707|590082861|FG004|Overall Study|Adverse Event|3|||
163375455|NCT01097707|590082857|FG000|Overall Study|Entry Criteria Not Met|2|||
163375456|NCT01097707|590082858|FG001|Overall Study|Entry Criteria Not Met|1|||
163375457|NCT01097707|590082859|FG002|Overall Study|Entry Criteria Not Met|1|||
163375458|NCT01097707|590082860|FG003|Overall Study|Entry Criteria Not Met|0|||
163375459|NCT01097707|590082861|FG004|Overall Study|Entry Criteria Not Met|1|||
163375460|NCT01097707|590082857|FG000|Overall Study|Lack of Efficacy|1|||
163375461|NCT01097707|590082858|FG001|Overall Study|Lack of Efficacy|0|||
163375462|NCT01097707|590082859|FG002|Overall Study|Lack of Efficacy|0|||
163375463|NCT01097707|590082860|FG003|Overall Study|Lack of Efficacy|1|||
163375464|NCT01097707|590082861|FG004|Overall Study|Lack of Efficacy|0|||
163375465|NCT01097707|590082857|FG000|Overall Study|Lost to Follow-up|1|||
163375466|NCT01097707|590082858|FG001|Overall Study|Lost to Follow-up|1|||
163375467|NCT01097707|590082859|FG002|Overall Study|Lost to Follow-up|2|||
163375468|NCT01097707|590082860|FG003|Overall Study|Lost to Follow-up|0|||
163375469|NCT01097707|590082861|FG004|Overall Study|Lost to Follow-up|3|||
163375470|NCT01097707|590082857|FG000|Overall Study|Protocol Violation|2|||
163375471|NCT01097707|590082858|FG001|Overall Study|Protocol Violation|2|||
163375472|NCT01097707|590082859|FG002|Overall Study|Protocol Violation|3|||
163375473|NCT01097707|590082860|FG003|Overall Study|Protocol Violation|2|||
163375474|NCT01097707|590082861|FG004|Overall Study|Protocol Violation|2|||
163375475|NCT01097707|590082857|FG000|Overall Study|Sponsor Decision|31|||
163375476|NCT01097707|590082858|FG001|Overall Study|Sponsor Decision|31|||
163375477|NCT01097707|590082859|FG002|Overall Study|Sponsor Decision|34|||
163375478|NCT01097707|590082860|FG003|Overall Study|Sponsor Decision|35|||
163375479|NCT01097707|590082861|FG004|Overall Study|Sponsor Decision|36|||
163375480|NCT01097707|590082857|FG000|Overall Study|Withdrawal by Subject|3|||
163375481|NCT01097707|590082858|FG001|Overall Study|Withdrawal by Subject|6|||
163375482|NCT01097707|590082859|FG002|Overall Study|Withdrawal by Subject|1|||
163375483|NCT01097707|590082860|FG003|Overall Study|Withdrawal by Subject|4|||
163375484|NCT01097707|590082861|FG004|Overall Study|Withdrawal by Subject|3|||
163375485|NCT01097707|590082857|FG000|Overall Study|Reason unknown|0|||
163375486|NCT01097707|590082858|FG001|Overall Study|Reason unknown|0|||
163375487|NCT01097707|590082859|FG002|Overall Study|Reason unknown|0|||
163375488|NCT01097707|590082860|FG003|Overall Study|Reason unknown|0|||
163375489|NCT01097707|590082861|FG004|Overall Study|Reason unknown|1|||
163375490|NCT03212989|590082862|FG000|Overall Study|Physician Decision|8|||
163375491|NCT03775434|590082863|FG000|Overall Study|Adverse Event|2|||
163375492|NCT03775434|590082863|FG000|Overall Study|Withdrawal by Subject|1|||
163375493|NCT03047395|590082864|FG000|Overall Study|Adverse Event|142|||
163375494|NCT03047395|590082864|FG000|Overall Study|Withdrawal by Subject|155|||
163375495|NCT03047395|590082864|FG000|Overall Study|Lost to Follow-up|144|||
163375496|NCT03047395|590082864|FG000|Overall Study|COVID-19 Infection|2|||
163375497|NCT03047395|590082864|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
163375498|NCT03047395|590082864|FG000|Overall Study|Other, Not Specified|117|||
163375499|NCT04811131|590082871|FG000|Overall Study|Adverse Event|0|||
163375500|NCT04811131|590082872|FG001|Overall Study|Adverse Event|0|||
163375501|NCT04811131|590082873|FG002|Overall Study|Adverse Event|1|||
163375502|NCT04811131|590082874|FG003|Overall Study|Adverse Event|0|||
163375503|NCT04811131|590082871|FG000|Overall Study|Lack of Efficacy|0|||
163375504|NCT04811131|590082872|FG001|Overall Study|Lack of Efficacy|0|||
163375505|NCT04811131|590082873|FG002|Overall Study|Lack of Efficacy|0|||
163375506|NCT04811131|590082874|FG003|Overall Study|Lack of Efficacy|1|||
163375507|NCT04811131|590082871|FG000|Overall Study|Lost to Follow-up|0|||
163375508|NCT04811131|590082872|FG001|Overall Study|Lost to Follow-up|1|||
163375509|NCT04811131|590082873|FG002|Overall Study|Lost to Follow-up|0|||
163375510|NCT04811131|590082874|FG003|Overall Study|Lost to Follow-up|0|||
163375511|NCT04811131|590082871|FG000|Overall Study|Sponsor request|31|||
163375512|NCT04811131|590082872|FG001|Overall Study|Sponsor request|35|||
163375513|NCT04811131|590082873|FG002|Overall Study|Sponsor request|27|||
163375514|NCT04811131|590082874|FG003|Overall Study|Sponsor request|10|||
163375515|NCT04811131|590082871|FG000|Overall Study|Withdrawal by Subject|3|||
163375516|NCT04811131|590082872|FG001|Overall Study|Withdrawal by Subject|1|||
163375517|NCT04811131|590082873|FG002|Overall Study|Withdrawal by Subject|3|||
163375518|NCT04811131|590082874|FG003|Overall Study|Withdrawal by Subject|1|||
163375519|NCT00620282|590082882|FG000|Overall Study|Adverse Event|0|||
163375520|NCT00620282|590082883|FG001|Overall Study|Adverse Event|1|||
163375521|NCT00620282|590082884|FG002|Overall Study|Adverse Event|0|||
163375522|NCT00620282|590082882|FG000|Overall Study|Arterial line unable to be placed|0|||
163375523|NCT00620282|590082883|FG001|Overall Study|Arterial line unable to be placed|0|||
163375524|NCT00620282|590082884|FG002|Overall Study|Arterial line unable to be placed|1|||
163375525|NCT00620282|590082882|FG000|Overall Study|Withdrawal by Subject|0|||
163375526|NCT00620282|590082883|FG001|Overall Study|Withdrawal by Subject|1|||
163375527|NCT00620282|590082884|FG002|Overall Study|Withdrawal by Subject|0|||
163375528|NCT02217475|590082885|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
163375529|NCT02217475|590082886|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
163375530|NCT02217475|590082887|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
163375531|NCT02217475|590082885|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
163375532|NCT02217475|590082886|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
163375533|NCT02217475|590082887|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
163375534|NCT02217475|590082885|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
163375535|NCT02217475|590082886|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
163375536|NCT02217475|590082887|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
163375537|NCT02217475|590082885|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
163375538|NCT02217475|590082886|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
163375539|NCT02217475|590082887|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
163375540|NCT02217475|590082885|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
163375541|NCT02217475|590082886|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
163375542|NCT02217475|590082887|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
163375543|NCT02217475|590082885|FG000|Discontinued After Period 1|Adverse Event|1|||
163375544|NCT02217475|590082886|FG001|Discontinued After Period 1|Adverse Event|2|||
163375545|NCT02217475|590082887|FG002|Discontinued After Period 1|Adverse Event|0|||
163375546|NCT02217475|590082885|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
163375547|NCT02217475|590082886|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
163375548|NCT02217475|590082887|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
163375549|NCT02217475|590082885|FG000|Discontinued After Period 1|Physician Decision|0|||
163375550|NCT02217475|590082886|FG001|Discontinued After Period 1|Physician Decision|0|||
163375551|NCT02217475|590082887|FG002|Discontinued After Period 1|Physician Decision|1|||
163375552|NCT02217475|590082885|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
163375553|NCT02217475|590082886|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
163375554|NCT02217475|590082887|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
163375555|NCT02217475|590082885|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
163375556|NCT02217475|590082886|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
163375557|NCT02217475|590082887|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
163375558|NCT02217475|590082885|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
163375559|NCT02217475|590082886|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
163375560|NCT02217475|590082887|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
163375561|NCT02217475|590082885|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
163375562|NCT02217475|590082886|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
163375563|NCT02217475|590082887|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
163375564|NCT02217475|590082885|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
163375565|NCT02217475|590082886|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
163375566|NCT02217475|590082887|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
163375567|NCT01127763|590082888|FG000|Overall Study|Adverse Event|2|||
163375568|NCT01127763|590082888|FG000|Overall Study|Withdrawal by Subject|1|||
163414601|NCT04537208|590225370|FG010|Overall Study|Protocol deviation|2|||
163414602|NCT04537208|590225360|FG000|Overall Study|Withdrawal by Subject|4|||
163414603|NCT04537208|590225361|FG001|Overall Study|Withdrawal by Subject|2|||
163414604|NCT04537208|590225362|FG002|Overall Study|Withdrawal by Subject|1|||
163414605|NCT04537208|590225363|FG003|Overall Study|Withdrawal by Subject|3|||
163414606|NCT04537208|590225364|FG004|Overall Study|Withdrawal by Subject|5|||
163414607|NCT04537208|590225365|FG005|Overall Study|Withdrawal by Subject|1|||
163414608|NCT04537208|590225366|FG006|Overall Study|Withdrawal by Subject|6|||
163414609|NCT04537208|590225367|FG007|Overall Study|Withdrawal by Subject|1|||
163414610|NCT04537208|590225368|FG008|Overall Study|Withdrawal by Subject|7|||
163414611|NCT04537208|590225369|FG009|Overall Study|Withdrawal by Subject|2|||
163414612|NCT04537208|590225370|FG010|Overall Study|Withdrawal by Subject|4|||
163414613|NCT04537208|590225360|FG000|Overall Study|Lost to Follow-up|4|||
163414614|NCT04537208|590225361|FG001|Overall Study|Lost to Follow-up|1|||
163414615|NCT04537208|590225362|FG002|Overall Study|Lost to Follow-up|3|||
163414616|NCT04537208|590225363|FG003|Overall Study|Lost to Follow-up|4|||
163414617|NCT04537208|590225364|FG004|Overall Study|Lost to Follow-up|3|||
163414618|NCT04537208|590225365|FG005|Overall Study|Lost to Follow-up|2|||
163414619|NCT04537208|590225366|FG006|Overall Study|Lost to Follow-up|3|||
163414620|NCT04537208|590225367|FG007|Overall Study|Lost to Follow-up|2|||
163414621|NCT04537208|590225368|FG008|Overall Study|Lost to Follow-up|7|||
163414622|NCT04537208|590225369|FG009|Overall Study|Lost to Follow-up|2|||
163414623|NCT04537208|590225370|FG010|Overall Study|Lost to Follow-up|2|||
163414624|NCT03286842|590225371|FG000|Overall Study|Patients rolled over to another study|80|||
163414625|NCT03178487|590225375|FG000|Period 1|Adverse Event|1|||
163414626|NCT03178487|590225376|FG001|Period 1|Adverse Event|2|||
163414627|NCT03178487|590225375|FG000|Period 1|Withdrawal by Subject|2|||
163414628|NCT03178487|590225376|FG001|Period 1|Withdrawal by Subject|1|||
163414629|NCT03178487|590225375|FG000|Period 1|Lost to Follow-up|1|||
163414630|NCT03178487|590225376|FG001|Period 1|Lost to Follow-up|0|||
163414631|NCT03178487|590225375|FG000|Period 1|Other|0|||
163414632|NCT03178487|590225376|FG001|Period 1|Other|1|||
163414633|NCT03178487|590225375|FG000|Period 2|Adverse Event|4|||
163414634|NCT03178487|590225376|FG001|Period 2|Adverse Event|4|||
163375569|NCT01127763|590082888|FG000|Overall Study|Physician Decision|2|||
163375570|NCT04738292|590082893|FG000|Overall Study|Death|1|||
163375571|NCT03181789|590082895|FG000|Overall Study|Withdrawal by Subject|0|||
163375572|NCT03181789|590082896|FG001|Overall Study|Withdrawal by Subject|1|||
163375573|NCT03181789|590082897|FG002|Overall Study|Withdrawal by Subject|1|||
163375574|NCT03181789|590082898|FG003|Overall Study|Withdrawal by Subject|0|||
163375575|NCT03181789|590082895|FG000|Overall Study|Lost to Follow-up|7|||
163375576|NCT03181789|590082896|FG001|Overall Study|Lost to Follow-up|1|||
163375577|NCT03181789|590082897|FG002|Overall Study|Lost to Follow-up|0|||
163414635|NCT03178487|590225375|FG000|Period 2|Withdrawal by Subject|6|||
163414636|NCT03178487|590225376|FG001|Period 2|Withdrawal by Subject|6|||
163414637|NCT03178487|590225375|FG000|Period 2|Lost to Follow-up|2|||
163414638|NCT03178487|590225376|FG001|Period 2|Lost to Follow-up|2|||
163414639|NCT03178487|590225375|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
163414640|NCT03178487|590225376|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
163414641|NCT03178487|590225375|FG000|Period 2|Other|8|||
163414642|NCT03178487|590225376|FG001|Period 2|Other|7|||
163414643|NCT00704964|590225382|FG000|Overall Study|Not completed on time|328|||
163414644|NCT02161562|590225383|FG000|Overall Study|Withdrawal by Subject|5|||
163414645|NCT02161562|590225384|FG001|Overall Study|Withdrawal by Subject|8|||
163414646|NCT02161562|590225383|FG000|Overall Study|Protocol Violation|9|||
163375578|NCT03181789|590082898|FG003|Overall Study|Lost to Follow-up|0|||
163375579|NCT03181789|590082895|FG000|Overall Study|Participant unable to adhere to visit|0|||
163375580|NCT03181789|590082896|FG001|Overall Study|Participant unable to adhere to visit|1|||
163375581|NCT03181789|590082897|FG002|Overall Study|Participant unable to adhere to visit|0|||
163375582|NCT03181789|590082898|FG003|Overall Study|Participant unable to adhere to visit|0|||
163375583|NCT01131182|590082899|FG000|Overall Study|Withdrawal by Subject|1|||
163375584|NCT01131182|590082900|FG001|Overall Study|Withdrawal by Subject|1|||
163375585|NCT01131182|590082899|FG000|Overall Study|Lost to Follow-up|14|||
163375586|NCT01131182|590082900|FG001|Overall Study|Lost to Follow-up|15|||
163414647|NCT02161562|590225384|FG001|Overall Study|Protocol Violation|4|||
163414648|NCT02161562|590225383|FG000|Overall Study|Pregnancy|1|||
163414649|NCT02161562|590225384|FG001|Overall Study|Pregnancy|2|||
163414650|NCT02161562|590225383|FG000|Overall Study|Lost to Follow-up|3|||
163414651|NCT02161562|590225384|FG001|Overall Study|Lost to Follow-up|1|||
163375587|NCT01131182|590082899|FG000|Overall Study|Other Reason|1|||
163375588|NCT01131182|590082900|FG001|Overall Study|Other Reason|0|||
163375589|NCT00735475|590082901|FG000|Overall Study|Adverse Event|0|||
163375590|NCT00735475|590082902|FG001|Overall Study|Adverse Event|1|||
163375591|NCT00735475|590082901|FG000|Overall Study|Death|1|||
163414652|NCT02161562|590225383|FG000|Overall Study|Lack of Efficacy|4|||
163414653|NCT02161562|590225384|FG001|Overall Study|Lack of Efficacy|1|||
163414654|NCT02161562|590225383|FG000|Overall Study|Adverse Event|1|||
163414655|NCT02161562|590225384|FG001|Overall Study|Adverse Event|1|||
163414656|NCT02161562|590225383|FG000|Overall Study|Participant moved back to home country|1|||
163375592|NCT00735475|590082902|FG001|Overall Study|Death|1|||
163375593|NCT00735475|590082901|FG000|Overall Study|Lost to Follow-up|3|||
163375594|NCT00735475|590082902|FG001|Overall Study|Lost to Follow-up|3|||
163375595|NCT00735475|590082901|FG000|Overall Study|Physician Decision|0|||
163375596|NCT00735475|590082902|FG001|Overall Study|Physician Decision|1|||
163375597|NCT00735475|590082901|FG000|Overall Study|Withdrawal by Subject|4|||
163375598|NCT00735475|590082902|FG001|Overall Study|Withdrawal by Subject|5|||
163414657|NCT02161562|590225384|FG001|Overall Study|Participant moved back to home country|0|||
163414658|NCT02161562|590225383|FG000|Overall Study|Withdrew due to being out of the country|1|||
163414659|NCT02161562|590225384|FG001|Overall Study|Withdrew due to being out of the country|0|||
163414660|NCT02161562|590225383|FG000|Overall Study|Participant moved out of province|1|||
163414661|NCT02161562|590225384|FG001|Overall Study|Participant moved out of province|0|||
163414662|NCT00197054|590225391|FG000|Overall Study|Withdrawal by Subject|9|||
163414663|NCT00197054|590225392|FG001|Overall Study|Withdrawal by Subject|3|||
163414664|NCT00197054|590225393|FG002|Overall Study|Withdrawal by Subject|3|||
163414665|NCT00197054|590225391|FG000|Overall Study|Moved from area|7|||
163414666|NCT00197054|590225392|FG001|Overall Study|Moved from area|14|||
163414667|NCT00197054|590225393|FG002|Overall Study|Moved from area|9|||
163414668|NCT00197054|590225391|FG000|Overall Study|Lost to Follow-up|1|||
163414669|NCT00197054|590225392|FG001|Overall Study|Lost to Follow-up|4|||
163414670|NCT00197054|590225393|FG002|Overall Study|Lost to Follow-up|0|||
163414671|NCT01163786|590225394|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
163414672|NCT01163786|590225394|FG000|Treatment With Bortezomib|Adverse Event|2|||
163414673|NCT01163786|590225394|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
163414674|NCT03021642|590225401|FG000|Washout Period (21 Days)|Adverse Event|1|||
163414675|NCT03021642|590225402|FG001|Washout Period (21 Days)|Adverse Event|1|||
163414676|NCT01192347|590225403|FG000|Overall Study|Death|3|||
163414677|NCT01192347|590225403|FG000|Overall Study|Lost to Follow-up|3|||
163414678|NCT01192347|590225403|FG000|Overall Study|Withdrawal by Subject|1|||
163414679|NCT01192347|590225403|FG000|Overall Study|Adverse Event|1|||
163414680|NCT01192347|590225403|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
163414681|NCT01192347|590225403|FG000|Overall Study|Patient seen in different hospital|1|||
163414682|NCT01192347|590225403|FG000|Overall Study|Patient not visiting hospital regularly|1|||
163414683|NCT01192347|590225403|FG000|Overall Study|Patient did not show up for visits|1|||
163414684|NCT00090545|590225404|FG000|Overall Study|Disease progression on study|21|||
163414685|NCT00090545|590225405|FG001|Overall Study|Disease progression on study|17|||
163414686|NCT00090545|590225404|FG000|Overall Study|Refused further treatment|1|||
163414687|NCT00090545|590225405|FG001|Overall Study|Refused further treatment|4|||
163414688|NCT00090545|590225404|FG000|Overall Study|Death|0|||
163414689|NCT00090545|590225405|FG001|Overall Study|Death|1|||
163414690|NCT00090545|590225404|FG000|Overall Study|Adverse Event|0|||
163414691|NCT00090545|590225405|FG001|Overall Study|Adverse Event|2|||
163414692|NCT02474082|590225406|FG000|Overall Study|Adverse Event|2|||
163414693|NCT02474082|590225407|FG001|Overall Study|Adverse Event|32|||
163414694|NCT02474082|590225406|FG000|Overall Study|Withdrawal of informed consent|1|||
163414695|NCT02474082|590225407|FG001|Overall Study|Withdrawal of informed consent|11|||
163414696|NCT02474082|590225406|FG000|Overall Study|Lost to Follow-up|2|||
163414697|NCT02474082|590225407|FG001|Overall Study|Lost to Follow-up|2|||
163414698|NCT02474082|590225406|FG000|Overall Study|Dose tapering not achieved|0|||
163414699|NCT02474082|590225407|FG001|Overall Study|Dose tapering not achieved|4|||
163414700|NCT02474082|590225406|FG000|Overall Study|Participant/guardian decision|1|||
163414701|NCT02474082|590225407|FG001|Overall Study|Participant/guardian decision|2|||
163414702|NCT02474082|590225406|FG000|Overall Study|Non-compliance with study treatment|0|||
163375599|NCT02442336|590082903|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
163375600|NCT02442336|590082903|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
163375601|NCT02442336|590082903|FG000|Overall Study|Lost to Follow-up|11|||
163375602|NCT05086276|590082904|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
163414703|NCT02474082|590225407|FG001|Overall Study|Non-compliance with study treatment|2|||
163414704|NCT02474082|590225406|FG000|Overall Study|Protocol deviation|0|||
163414705|NCT02474082|590225407|FG001|Overall Study|Protocol deviation|1|||
163414706|NCT04317274|590225410|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
163414707|NCT04317274|590225411|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
163414708|NCT04317274|590225412|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
163414709|NCT04317274|590225413|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
163414710|NCT00430508|590225414|FG000|Overall Study|Adverse Event|2|||
163414711|NCT00430508|590225415|FG001|Overall Study|Adverse Event|3|||
163375603|NCT05086276|590082905|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
163375604|NCT00777088|590082906|FG000|Overall Study|PED Treatment not attempted|1|||
163414712|NCT00430508|590225416|FG002|Overall Study|Adverse Event|5|||
163414713|NCT00430508|590225417|FG003|Overall Study|Adverse Event|3|||
163414714|NCT00430508|590225414|FG000|Overall Study|Withdrawal by Subject|0|||
163375605|NCT02101385|590082907|FG000|Study Treatment|Disease Progression|9|||
163375606|NCT02101385|590082908|FG001|Study Treatment|Disease Progression|3|||
163414715|NCT00430508|590225415|FG001|Overall Study|Withdrawal by Subject|1|||
163414716|NCT00430508|590225416|FG002|Overall Study|Withdrawal by Subject|1|||
163414717|NCT00430508|590225417|FG003|Overall Study|Withdrawal by Subject|1|||
163414718|NCT00430508|590225414|FG000|Overall Study|responder at visit 4|0|||
163414719|NCT00430508|590225415|FG001|Overall Study|responder at visit 4|0|||
163414720|NCT00430508|590225416|FG002|Overall Study|responder at visit 4|2|||
163414721|NCT00430508|590225417|FG003|Overall Study|responder at visit 4|0|||
163414722|NCT00430508|590225414|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
163414723|NCT00430508|590225415|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
163414724|NCT00430508|590225416|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
163414725|NCT00430508|590225417|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
163414726|NCT00430508|590225414|FG000|Overall Study|Other|1|||
163414727|NCT00430508|590225415|FG001|Overall Study|Other|1|||
163414728|NCT00430508|590225416|FG002|Overall Study|Other|3|||
163414729|NCT00430508|590225417|FG003|Overall Study|Other|0|||
163375607|NCT02101385|590082907|FG000|Study Treatment|Alternative therapy|0|||
163375608|NCT02101385|590082908|FG001|Study Treatment|Alternative therapy|1|||
163375609|NCT02101385|590082907|FG000|Study Treatment|No treatment, per protocol criteria|0|||
163375610|NCT02101385|590082908|FG001|Study Treatment|No treatment, per protocol criteria|4|||
163375611|NCT02101385|590082907|FG000|Study Treatment|Patient Non compliance|0|||
163375612|NCT02101385|590082908|FG001|Study Treatment|Patient Non compliance|2|||
163375613|NCT02101385|590082907|FG000|Study Treatment|Withdrawal by Subject|5|||
163375614|NCT02101385|590082908|FG001|Study Treatment|Withdrawal by Subject|2|||
163375615|NCT02101385|590082907|FG000|Study Treatment|screen failure|1|||
163375616|NCT02101385|590082908|FG001|Study Treatment|screen failure|0|||
163375617|NCT02101385|590082907|FG000|Study Treatment|AE/Side Effects/Complications|8|||
163375618|NCT02101385|590082908|FG001|Study Treatment|AE/Side Effects/Complications|0|||
163375619|NCT02101385|590082907|FG000|Study Treatment|Lost to Follow-up|1|||
163375620|NCT02101385|590082908|FG001|Study Treatment|Lost to Follow-up|0|||
163375621|NCT02101385|590082907|FG000|Study Treatment|Disease Progression before treatment|1|||
163375622|NCT02101385|590082908|FG001|Study Treatment|Disease Progression before treatment|0|||
163375623|NCT02101385|590082907|FG000|Study Treatment|Death|1|||
163375624|NCT02101385|590082908|FG001|Study Treatment|Death|0|||
163375625|NCT02101385|590082907|FG000|Follow up|Lost to Follow-up|4|||
163375626|NCT02101385|590082908|FG001|Follow up|Lost to Follow-up|9|||
163375627|NCT02101385|590082907|FG000|Follow up|Refused to follow up|5|||
163375628|NCT02101385|590082908|FG001|Follow up|Refused to follow up|4|||
163375629|NCT02101385|590082907|FG000|Follow up|Death|21|||
163375630|NCT02101385|590082908|FG001|Follow up|Death|39|||
163375631|NCT02101385|590082907|FG000|Follow up|study completed|33|||
163375632|NCT02101385|590082908|FG001|Follow up|study completed|52|||
163375633|NCT02101385|590082907|FG000|Follow up|screen failure|2|||
163375634|NCT02101385|590082908|FG001|Follow up|screen failure|0|||
163375635|NCT02101385|590082907|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
163375636|NCT02101385|590082908|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
163375637|NCT02101385|590082907|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
163375638|NCT02101385|590082908|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
163375639|NCT02101385|590082907|FG000|Follow up|Withdrawal by Subject|2|||
163375640|NCT02101385|590082908|FG001|Follow up|Withdrawal by Subject|2|||
163375641|NCT02101385|590082907|FG000|Follow up|PI requested closure of site|0|||
163375642|NCT02101385|590082908|FG001|Follow up|PI requested closure of site|5|||
163375643|NCT02489968|590082911|FG000|Open-label Treatment Period|Adverse Event|14|||
163375644|NCT02489968|590082912|FG001|Open-label Treatment Period|Adverse Event|7|||
163375645|NCT02489968|590082913|FG002|Open-label Treatment Period|Adverse Event|0|||
163375646|NCT02489968|590082914|FG003|Open-label Treatment Period|Adverse Event|0|||
163375647|NCT02489968|590082915|FG004|Open-label Treatment Period|Adverse Event|0|||
163375648|NCT02489968|590082916|FG005|Open-label Treatment Period|Adverse Event|0|||
163375649|NCT02489968|590082911|FG000|Open-label Treatment Period|Protocol Violation|2|||
163375650|NCT02489968|590082912|FG001|Open-label Treatment Period|Protocol Violation|2|||
163375651|NCT02489968|590082913|FG002|Open-label Treatment Period|Protocol Violation|0|||
163375652|NCT02489968|590082914|FG003|Open-label Treatment Period|Protocol Violation|0|||
163375653|NCT02489968|590082915|FG004|Open-label Treatment Period|Protocol Violation|0|||
163375654|NCT02489968|590082916|FG005|Open-label Treatment Period|Protocol Violation|0|||
163414730|NCT00288080|590225424|FG000|Overall Study|Withdrawal by Subject|1|||
163414731|NCT00288080|590225425|FG001|Overall Study|Withdrawal by Subject|3|||
163414732|NCT00288080|590225424|FG000|Overall Study|Protocol Violation|25|||
163414733|NCT00288080|590225425|FG001|Overall Study|Protocol Violation|20|||
163375655|NCT02489968|590082911|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
163375656|NCT02489968|590082912|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
163375657|NCT02489968|590082913|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
163375658|NCT02489968|590082914|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
163375659|NCT02489968|590082915|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
163414734|NCT03403192|590225426|FG000|Overall Study|Lost to Follow-up|1|||
163414735|NCT03403192|590225427|FG001|Overall Study|Lost to Follow-up|2|||
163414736|NCT03403192|590225428|FG002|Overall Study|Lost to Follow-up|0|||
163414737|NCT03403192|590225429|FG003|Overall Study|Lost to Follow-up|0|||
163414738|NCT03403192|590225426|FG000|Overall Study|Unable to respond|0|||
163414739|NCT03403192|590225427|FG001|Overall Study|Unable to respond|1|||
163414740|NCT03403192|590225428|FG002|Overall Study|Unable to respond|0|||
163414741|NCT03403192|590225429|FG003|Overall Study|Unable to respond|0|||
163414742|NCT03403192|590225426|FG000|Overall Study|Incomplete|3|||
163414743|NCT03403192|590225427|FG001|Overall Study|Incomplete|1|||
163414744|NCT03403192|590225428|FG002|Overall Study|Incomplete|3|||
163414745|NCT03403192|590225429|FG003|Overall Study|Incomplete|6|||
163414746|NCT04849780|590225431|FG000|Period 1|Covid-19 Related|1|||
163414747|NCT04849780|590225432|FG001|Period 1|Covid-19 Related|0|||
163414748|NCT04849780|590225431|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
163414749|NCT04849780|590225432|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
163414750|NCT04849780|590225431|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
163414751|NCT04849780|590225432|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
163414752|NCT00087646|590225433|FG000|Overall Study|Adverse Event|37|||
163414753|NCT00087646|590225434|FG001|Overall Study|Adverse Event|6|||
163414754|NCT00087646|590225435|FG002|Overall Study|Adverse Event|18|||
163414755|NCT00087646|590225436|FG003|Overall Study|Adverse Event|20|||
163414756|NCT00087646|590225433|FG000|Overall Study|Death|0|||
163414757|NCT00087646|590225434|FG001|Overall Study|Death|1|||
163414758|NCT00087646|590225435|FG002|Overall Study|Death|0|||
163414759|NCT00087646|590225436|FG003|Overall Study|Death|0|||
163414760|NCT00087646|590225433|FG000|Overall Study|Withdrawal by Subject|6|||
163414761|NCT00087646|590225434|FG001|Overall Study|Withdrawal by Subject|1|||
163414762|NCT00087646|590225435|FG002|Overall Study|Withdrawal by Subject|2|||
163414763|NCT00087646|590225436|FG003|Overall Study|Withdrawal by Subject|2|||
163414764|NCT00087646|590225433|FG000|Overall Study|Insufficient therapeutic response|64|||
163414765|NCT00087646|590225434|FG001|Overall Study|Insufficient therapeutic response|24|||
163414766|NCT00087646|590225435|FG002|Overall Study|Insufficient therapeutic response|38|||
163414767|NCT00087646|590225436|FG003|Overall Study|Insufficient therapeutic response|51|||
163414768|NCT00087646|590225433|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
163414769|NCT00087646|590225434|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
163414770|NCT00087646|590225435|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
163414771|NCT00087646|590225436|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
163414772|NCT00087646|590225433|FG000|Overall Study|Failure to Return|5|||
163414773|NCT00087646|590225434|FG001|Overall Study|Failure to Return|2|||
163414774|NCT00087646|590225435|FG002|Overall Study|Failure to Return|2|||
163414775|NCT00087646|590225436|FG003|Overall Study|Failure to Return|3|||
163414776|NCT00087646|590225433|FG000|Overall Study|Administrative/Other|6|||
163414777|NCT00087646|590225434|FG001|Overall Study|Administrative/Other|1|||
163414778|NCT00087646|590225435|FG002|Overall Study|Administrative/Other|1|||
163414779|NCT00087646|590225436|FG003|Overall Study|Administrative/Other|2|||
163414780|NCT00087646|590225433|FG000|Overall Study|Other Protocol Violation|3|||
163414781|NCT00087646|590225434|FG001|Overall Study|Other Protocol Violation|1|||
163414782|NCT00087646|590225435|FG002|Overall Study|Other Protocol Violation|0|||
163414783|NCT00087646|590225436|FG003|Overall Study|Other Protocol Violation|0|||
163414784|NCT00087646|590225433|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
163414785|NCT00087646|590225434|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
163414786|NCT00087646|590225435|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
163414787|NCT00087646|590225436|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
163414788|NCT01422239|590225439|FG000|Overall Study|Lost to Follow-up|4|||
163414789|NCT01422239|590225440|FG001|Overall Study|Lost to Follow-up|3|||
163414790|NCT03033875|590225445|FG000|Overall Study|Withdrawal by Subject|5|||
163414791|NCT03033875|590225446|FG001|Overall Study|Withdrawal by Subject|9|||
163414792|NCT03033875|590225447|FG002|Overall Study|Withdrawal by Subject|4|||
163414793|NCT03033875|590225445|FG000|Overall Study|Other|14|||
163414794|NCT03033875|590225446|FG001|Overall Study|Other|15|||
163414795|NCT03033875|590225447|FG002|Overall Study|Other|8|||
163414796|NCT03595553|590225448|FG000|Overall Study|Withdrawal by Subject|20|||
163414797|NCT03595553|590225449|FG001|Overall Study|Withdrawal by Subject|8|||
163414798|NCT03595553|590225448|FG000|Overall Study|Physician Decision|3|||
163414799|NCT03595553|590225449|FG001|Overall Study|Physician Decision|2|||
163414800|NCT03595553|590225448|FG000|Overall Study|Adverse Event|2|||
163414801|NCT03595553|590225449|FG001|Overall Study|Adverse Event|5|||
163414802|NCT03595553|590225448|FG000|Overall Study|Death|24|||
163414803|NCT03595553|590225449|FG001|Overall Study|Death|22|||
163414804|NCT03595553|590225448|FG000|Overall Study|Lost to Follow-up|6|||
163414805|NCT03595553|590225449|FG001|Overall Study|Lost to Follow-up|7|||
163414806|NCT03595553|590225448|FG000|Overall Study|Other as indicated in CSR|3|||
163414807|NCT03595553|590225449|FG001|Overall Study|Other as indicated in CSR|3|||
163414808|NCT03595553|590225448|FG000|Overall Study|Sponsor Decision|0|||
163414809|NCT03595553|590225449|FG001|Overall Study|Sponsor Decision|1|||
163414810|NCT03467958|590225450|FG000|Overall Study|Adverse Event|20|||
163414811|NCT03467958|590225451|FG001|Overall Study|Adverse Event|32|||
163414812|NCT03467958|590225452|FG002|Overall Study|Adverse Event|5|||
163414813|NCT03467958|590225453|FG003|Overall Study|Adverse Event|3|||
163414814|NCT03467958|590225454|FG004|Overall Study|Adverse Event|3|||
163414815|NCT03467958|590225455|FG005|Overall Study|Adverse Event|3|||
163414816|NCT03467958|590225456|FG006|Overall Study|Adverse Event|6|||
163414817|NCT03467958|590225457|FG007|Overall Study|Adverse Event|5|||
163414818|NCT03467958|590225458|FG008|Overall Study|Adverse Event|0|||
163414819|NCT03467958|590225450|FG000|Overall Study|Lack of Efficacy|59|||
163414820|NCT03467958|590225451|FG001|Overall Study|Lack of Efficacy|120|||
163414821|NCT03467958|590225452|FG002|Overall Study|Lack of Efficacy|6|||
163414822|NCT03467958|590225453|FG003|Overall Study|Lack of Efficacy|9|||
163414823|NCT03467958|590225454|FG004|Overall Study|Lack of Efficacy|8|||
163414824|NCT03467958|590225455|FG005|Overall Study|Lack of Efficacy|9|||
163414825|NCT03467958|590225456|FG006|Overall Study|Lack of Efficacy|11|||
163414826|NCT03467958|590225457|FG007|Overall Study|Lack of Efficacy|9|||
163414827|NCT03467958|590225458|FG008|Overall Study|Lack of Efficacy|3|||
163414828|NCT03467958|590225450|FG000|Overall Study|Lost to Follow-up|1|||
163414829|NCT03467958|590225451|FG001|Overall Study|Lost to Follow-up|2|||
163414830|NCT03467958|590225452|FG002|Overall Study|Lost to Follow-up|1|||
163414831|NCT03467958|590225453|FG003|Overall Study|Lost to Follow-up|0|||
163414832|NCT03467958|590225454|FG004|Overall Study|Lost to Follow-up|4|||
163414833|NCT03467958|590225455|FG005|Overall Study|Lost to Follow-up|0|||
163375660|NCT02489968|590082916|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
163375661|NCT02489968|590082911|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
163375662|NCT02489968|590082912|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
163375663|NCT02489968|590082913|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
163375664|NCT02489968|590082914|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
163375665|NCT02489968|590082915|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
163375666|NCT02489968|590082916|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
163375667|NCT02489968|590082911|FG000|Open-label Treatment Period|Other than specified above|204|||
163375668|NCT02489968|590082912|FG001|Open-label Treatment Period|Other than specified above|189|||
163375669|NCT02489968|590082913|FG002|Open-label Treatment Period|Other than specified above|0|||
163375670|NCT02489968|590082914|FG003|Open-label Treatment Period|Other than specified above|0|||
163375671|NCT02489968|590082915|FG004|Open-label Treatment Period|Other than specified above|0|||
163375672|NCT02489968|590082916|FG005|Open-label Treatment Period|Other than specified above|0|||
163375673|NCT02489968|590082911|FG000|Double-blind Treatment Period|Adverse Event|0|||
163375674|NCT02489968|590082912|FG001|Double-blind Treatment Period|Adverse Event|0|||
163375675|NCT02489968|590082913|FG002|Double-blind Treatment Period|Adverse Event|2|||
163375676|NCT02489968|590082914|FG003|Double-blind Treatment Period|Adverse Event|6|||
163414834|NCT03467958|590225456|FG006|Overall Study|Lost to Follow-up|0|||
163414835|NCT03467958|590225457|FG007|Overall Study|Lost to Follow-up|0|||
163414836|NCT03467958|590225458|FG008|Overall Study|Lost to Follow-up|0|||
163414837|NCT03467958|590225450|FG000|Overall Study|Other reasons|8|||
163414838|NCT03467958|590225451|FG001|Overall Study|Other reasons|14|||
163414839|NCT03467958|590225452|FG002|Overall Study|Other reasons|2|||
163414840|NCT03467958|590225453|FG003|Overall Study|Other reasons|1|||
163414841|NCT03467958|590225454|FG004|Overall Study|Other reasons|4|||
163414842|NCT03467958|590225455|FG005|Overall Study|Other reasons|0|||
163414843|NCT03467958|590225456|FG006|Overall Study|Other reasons|1|||
163414844|NCT03467958|590225457|FG007|Overall Study|Other reasons|0|||
163414845|NCT03467958|590225458|FG008|Overall Study|Other reasons|1|||
163414846|NCT03467958|590225450|FG000|Overall Study|Pregnancy|1|||
163414847|NCT03467958|590225451|FG001|Overall Study|Pregnancy|0|||
163414848|NCT03467958|590225452|FG002|Overall Study|Pregnancy|0|||
163414849|NCT03467958|590225453|FG003|Overall Study|Pregnancy|0|||
163414850|NCT03467958|590225454|FG004|Overall Study|Pregnancy|0|||
163414851|NCT03467958|590225455|FG005|Overall Study|Pregnancy|1|||
163414852|NCT03467958|590225456|FG006|Overall Study|Pregnancy|0|||
163414853|NCT03467958|590225457|FG007|Overall Study|Pregnancy|0|||
163414854|NCT03467958|590225458|FG008|Overall Study|Pregnancy|0|||
163414855|NCT03467958|590225450|FG000|Overall Study|Study terminated by sponsor|65|||
163414856|NCT03467958|590225451|FG001|Overall Study|Study terminated by sponsor|117|||
163414857|NCT03467958|590225452|FG002|Overall Study|Study terminated by sponsor|45|||
163375677|NCT02489968|590082915|FG004|Double-blind Treatment Period|Adverse Event|4|||
163414858|NCT03467958|590225453|FG003|Overall Study|Study terminated by sponsor|64|||
163414859|NCT03467958|590225454|FG004|Overall Study|Study terminated by sponsor|66|||
163414860|NCT03467958|590225455|FG005|Overall Study|Study terminated by sponsor|17|||
163375678|NCT02489968|590082916|FG005|Double-blind Treatment Period|Adverse Event|5|||
163375679|NCT02489968|590082911|FG000|Double-blind Treatment Period|Protocol Violation|0|||
163414861|NCT03467958|590225456|FG006|Overall Study|Study terminated by sponsor|11|||
163414862|NCT03467958|590225457|FG007|Overall Study|Study terminated by sponsor|5|||
163414863|NCT03467958|590225458|FG008|Overall Study|Study terminated by sponsor|5|||
163414864|NCT03467958|590225450|FG000|Overall Study|Withdrawal by Subject|25|||
163414865|NCT03467958|590225451|FG001|Overall Study|Withdrawal by Subject|44|||
163414866|NCT03467958|590225452|FG002|Overall Study|Withdrawal by Subject|7|||
163414867|NCT03467958|590225453|FG003|Overall Study|Withdrawal by Subject|8|||
163414868|NCT03467958|590225454|FG004|Overall Study|Withdrawal by Subject|6|||
163375680|NCT02489968|590082912|FG001|Double-blind Treatment Period|Protocol Violation|0|||
163375681|NCT02489968|590082913|FG002|Double-blind Treatment Period|Protocol Violation|0|||
163375682|NCT02489968|590082914|FG003|Double-blind Treatment Period|Protocol Violation|0|||
163375683|NCT02489968|590082915|FG004|Double-blind Treatment Period|Protocol Violation|1|||
163375684|NCT02489968|590082916|FG005|Double-blind Treatment Period|Protocol Violation|1|||
163375685|NCT02489968|590082911|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
163375686|NCT02489968|590082912|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
163375687|NCT02489968|590082913|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
163375688|NCT02489968|590082914|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
163375689|NCT02489968|590082915|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
163375690|NCT02489968|590082916|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
163375691|NCT02489968|590082911|FG000|Double-blind Treatment Period|Other than specified above|0|||
163375692|NCT02489968|590082912|FG001|Double-blind Treatment Period|Other than specified above|0|||
163375693|NCT02489968|590082913|FG002|Double-blind Treatment Period|Other than specified above|0|||
163375694|NCT02489968|590082914|FG003|Double-blind Treatment Period|Other than specified above|0|||
163375695|NCT02489968|590082915|FG004|Double-blind Treatment Period|Other than specified above|1|||
163375696|NCT02489968|590082916|FG005|Double-blind Treatment Period|Other than specified above|0|||
163375697|NCT01982448|590082921|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
163375698|NCT01982448|590082922|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
163375699|NCT01982448|590082921|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
163375700|NCT01982448|590082922|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
163375701|NCT01982448|590082921|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
163375702|NCT01982448|590082922|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
163375703|NCT01982448|590082921|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
163375704|NCT01982448|590082922|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
163375705|NCT02594163|590084234|FG000|Treatment Period|Progressive disease|2|||
163375706|NCT02594163|590084235|FG001|Treatment Period|Progressive disease|3|||
163375707|NCT02594163|590084234|FG000|Treatment Period|Adverse Event|1|||
163375708|NCT02594163|590084235|FG001|Treatment Period|Adverse Event|5|||
163375709|NCT02594163|590084234|FG000|Treatment Period|Physician Decision|1|||
163375710|NCT02594163|590084235|FG001|Treatment Period|Physician Decision|3|||
163375711|NCT02594163|590084234|FG000|Treatment Period|Study termination by sponsor|2|||
163375712|NCT02594163|590084235|FG001|Treatment Period|Study termination by sponsor|1|||
163375713|NCT02594163|590084234|FG000|Treatment Period|Other, Non-AE|1|||
163375714|NCT02594163|590084235|FG001|Treatment Period|Other, Non-AE|0|||
163375715|NCT02594163|590084234|FG000|Follow-up Period|Withdrawal by Subject|0|||
163375716|NCT02594163|590084235|FG001|Follow-up Period|Withdrawal by Subject|1|||
163375717|NCT02594163|590084234|FG000|Follow-up Period|Study Termination by Sponsor|6|||
163375718|NCT02594163|590084235|FG001|Follow-up Period|Study Termination by Sponsor|4|||
163375719|NCT02594163|590084234|FG000|Follow-up Period|Lost to Follow-up|1|||
163375720|NCT02594163|590084235|FG001|Follow-up Period|Lost to Follow-up|0|||
163375721|NCT02594163|590084234|FG000|Follow-up Period|Death|2|||
163375722|NCT02594163|590084235|FG001|Follow-up Period|Death|5|||
163375723|NCT02594163|590084234|FG000|Follow-up Period|Adverse Event|0|||
163375724|NCT02594163|590084235|FG001|Follow-up Period|Adverse Event|1|||
163375725|NCT02594163|590084234|FG000|Follow-up Period|Progressive Disease|2|||
163375726|NCT02594163|590084235|FG001|Follow-up Period|Progressive Disease|0|||
163375727|NCT02594163|590084234|FG000|Follow-up Period|Physician Decision|0|||
163375728|NCT02594163|590084235|FG001|Follow-up Period|Physician Decision|1|||
163375729|NCT01342341|590084236|FG000|Overall Study|Lost to Follow-up|4|||
163375730|NCT01342341|590084237|FG001|Overall Study|Lost to Follow-up|4|||
163375731|NCT01022268|590084240|FG000|Overall Study|Withdrawal by Subject|1|||
163375732|NCT01022268|590084241|FG001|Overall Study|Withdrawal by Subject|0|||
163375733|NCT01022268|590084240|FG000|Overall Study|Withdrawal by Subject|1|||
163375734|NCT01022268|590084241|FG001|Overall Study|Withdrawal by Subject|0|||
163375735|NCT01034176|590084242|FG000|Overall Study|Physician Decision|2|||
163375736|NCT01034176|590084243|FG001|Overall Study|Physician Decision|0|||
163375737|NCT01034176|590084242|FG000|Overall Study|Withdrawal by Subject|0|||
163375738|NCT01034176|590084243|FG001|Overall Study|Withdrawal by Subject|1|||
163375739|NCT01034176|590084242|FG000|Overall Study|Lost to Follow-up|0|||
163375740|NCT01034176|590084243|FG001|Overall Study|Lost to Follow-up|1|||
163375741|NCT02704754|590084245|FG000|Overall Study|Lost to Follow-up|1|||
163375742|NCT02704754|590084246|FG001|Overall Study|Lost to Follow-up|1|||
163375743|NCT02704754|590084245|FG000|Overall Study|Lack of Efficacy|1|||
163375744|NCT02704754|590084246|FG001|Overall Study|Lack of Efficacy|0|||
163375745|NCT02704754|590084245|FG000|Overall Study|Withdrawal by Subject|1|||
163375746|NCT02704754|590084246|FG001|Overall Study|Withdrawal by Subject|0|||
163375747|NCT00423943|590084249|FG000|Overall Study|Withdrawal by Subject|3|||
163375748|NCT00423943|590084250|FG001|Overall Study|Withdrawal by Subject|1|||
163375749|NCT03730480|590084251|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
163375750|NCT04097301|590084254|FG000|Overall Study|Death|1|||
163375751|NCT04097301|590084254|FG000|Overall Study|Withdrawal by Subject|1|||
163375752|NCT04097301|590084254|FG000|Overall Study|Screening Failure|5|||
163375753|NCT01403610|590084261|FG000|Overall Study|Withdrawal by Subject|2|||
163375754|NCT01403610|590084262|FG001|Overall Study|Withdrawal by Subject|0|||
163375755|NCT01403610|590084263|FG002|Overall Study|Withdrawal by Subject|0|||
163375756|NCT01403610|590084264|FG003|Overall Study|Withdrawal by Subject|0|||
163375757|NCT01403610|590084261|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
163375758|NCT01403610|590084262|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
163375759|NCT01403610|590084263|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
163375760|NCT01403610|590084264|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
163375761|NCT00901186|590084265|FG000|Overall Study|Lack of Efficacy|0|||
163375762|NCT00901186|590084266|FG001|Overall Study|Lack of Efficacy|1|||
163375763|NCT00901186|590084265|FG000|Overall Study|Abnormal laboratory values|0|||
163375764|NCT00901186|590084266|FG001|Overall Study|Abnormal laboratory values|1|||
163375765|NCT00901186|590084265|FG000|Overall Study|Lost to Follow-up|2|||
163375766|NCT00901186|590084266|FG001|Overall Study|Lost to Follow-up|0|||
163375767|NCT00901186|590084265|FG000|Overall Study|Adverse Event|2|||
163375768|NCT00901186|590084266|FG001|Overall Study|Adverse Event|4|||
163375769|NCT00901186|590084265|FG000|Overall Study|Administration problems|0|||
163375770|NCT00901186|590084266|FG001|Overall Study|Administration problems|1|||
163375771|NCT00901186|590084265|FG000|Overall Study|Protocol deviations|5|||
163375772|NCT00901186|590084266|FG001|Overall Study|Protocol deviations|4|||
163375773|NCT00107120|590084267|FG000|Overall Study|Adverse Event|4|||
163375774|NCT00107120|590084268|FG001|Overall Study|Adverse Event|1|||
163375775|NCT00107120|590084267|FG000|Overall Study|Lack of Efficacy|5|||
163375776|NCT00107120|590084268|FG001|Overall Study|Lack of Efficacy|5|||
163375777|NCT00107120|590084267|FG000|Overall Study|Protocol Violation|3|||
163375778|NCT00107120|590084268|FG001|Overall Study|Protocol Violation|0|||
163375779|NCT00107120|590084267|FG000|Overall Study|Withdrawal by Subject|8|||
163375780|NCT00107120|590084268|FG001|Overall Study|Withdrawal by Subject|9|||
163375781|NCT00107120|590084267|FG000|Overall Study|Lost to Follow-up|8|||
163375782|NCT00107120|590084268|FG001|Overall Study|Lost to Follow-up|6|||
163375783|NCT00107120|590084267|FG000|Overall Study|Pregnancy|0|||
163375784|NCT00107120|590084268|FG001|Overall Study|Pregnancy|1|||
163375785|NCT00107120|590084267|FG000|Overall Study|moving away from site|1|||
163375786|NCT00107120|590084268|FG001|Overall Study|moving away from site|1|||
163375787|NCT00107120|590084267|FG000|Overall Study|death of parent|0|||
163375788|NCT00107120|590084268|FG001|Overall Study|death of parent|1|||
163375789|NCT01635920|590084271|FG000|Overall Study|Adverse Event|1|||
163375790|NCT01635920|590084272|FG001|Overall Study|Adverse Event|0|||
163375791|NCT01635920|590084271|FG000|Overall Study|Lost to Follow-up|0|||
163375792|NCT01635920|590084272|FG001|Overall Study|Lost to Follow-up|1|||
163375793|NCT01635920|590084271|FG000|Overall Study|Subject decision|2|||
163375794|NCT01635920|590084272|FG001|Overall Study|Subject decision|0|||
163375795|NCT00158860|590084289|FG000|Overall Study|Adverse Event|3|||
163375796|NCT00158860|590084290|FG001|Overall Study|Adverse Event|6|||
163375797|NCT00158860|590084289|FG000|Overall Study|Lost to Follow-up|11|||
163375798|NCT00158860|590084290|FG001|Overall Study|Lost to Follow-up|17|||
163375799|NCT00158860|590084289|FG000|Overall Study|Protocol Violation|8|||
163375800|NCT00158860|590084290|FG001|Overall Study|Protocol Violation|23|||
163375801|NCT00158860|590084289|FG000|Overall Study|Withdrawal by Subject|7|||
163375802|NCT00158860|590084290|FG001|Overall Study|Withdrawal by Subject|17|||
163375803|NCT00158860|590084289|FG000|Overall Study|MOVING OUT OF STATE|1|||
163375804|NCT00158860|590084290|FG001|Overall Study|MOVING OUT OF STATE|0|||
163375805|NCT00158860|590084289|FG000|Overall Study|Pregnancy|3|||
163375806|NCT00158860|590084290|FG001|Overall Study|Pregnancy|3|||
163375807|NCT00158860|590084289|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
163375808|NCT00158860|590084290|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
163375809|NCT00158860|590084289|FG000|Overall Study|SPONSOR REQUEST|0|||
163375810|NCT00158860|590084290|FG001|Overall Study|SPONSOR REQUEST|1|||
163375811|NCT00158860|590084289|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
163375812|NCT00158860|590084290|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
163375813|NCT00158860|590084289|FG000|Overall Study|Closed per sponsor|0|||
163375814|NCT00158860|590084290|FG001|Overall Study|Closed per sponsor|1|||
163375815|NCT04638920|590084291|FG000|Overall Study|Withdrawal by Subject|5|||
163375816|NCT01801735|590084292|FG000|Overall Study|Adverse Event|79|||
163375817|NCT01801735|590084292|FG000|Overall Study|Lack of Efficacy|28|||
163375818|NCT01801735|590084292|FG000|Overall Study|Withdrawal by Subject|27|||
163375819|NCT01801735|590084292|FG000|Overall Study|Protocol Violation|25|||
163375820|NCT01801735|590084292|FG000|Overall Study|Lost to Follow-up|15|||
163375821|NCT01801735|590084292|FG000|Overall Study|Non-compliance with Trial Drug|13|||
163375822|NCT01801735|590084292|FG000|Overall Study|Physician Decision|3|||
163375823|NCT01801735|590084292|FG000|Overall Study|Death|1|||
163375824|NCT01801735|590084292|FG000|Overall Study|Other, including site closure|19|||
163375825|NCT01435616|590084293|FG000|Overall Study|Adverse Event|39|||
163375826|NCT01435616|590084294|FG001|Overall Study|Adverse Event|21|||
163375827|NCT01435616|590084293|FG000|Overall Study|Death|7|||
163375828|NCT01435616|590084294|FG001|Overall Study|Death|2|||
163375829|NCT01435616|590084293|FG000|Overall Study|Lost to Follow-up|22|||
163375830|NCT01435616|590084294|FG001|Overall Study|Lost to Follow-up|13|||
163414869|NCT03467958|590225455|FG005|Overall Study|Withdrawal by Subject|8|||
163414870|NCT03467958|590225456|FG006|Overall Study|Withdrawal by Subject|4|||
163414871|NCT03467958|590225457|FG007|Overall Study|Withdrawal by Subject|1|||
163414872|NCT03467958|590225458|FG008|Overall Study|Withdrawal by Subject|4|||
163414873|NCT02286947|590225459|FG000|Overall Study|Withdrawal by Subject|2|||
163414874|NCT01687712|590225460|FG000|Cycle 1|Not Biochemically Pregnant|386|||
163414875|NCT01687712|590225461|FG001|Cycle 1|Not Biochemically Pregnant|348|||
163414876|NCT01687712|590225460|FG000|Cycle 1|Early Pregnancy Loss|43|||
163414877|NCT01687712|590225461|FG001|Cycle 1|Early Pregnancy Loss|60|||
163414878|NCT01687712|590225460|FG000|Cycle 1|Ectopic Pregnancy|5|||
163414879|NCT01687712|590225461|FG001|Cycle 1|Ectopic Pregnancy|5|||
163414880|NCT01687712|590225460|FG000|Cycle 1|Heterotropic Pregnancy|1|||
163414881|NCT01687712|590225461|FG001|Cycle 1|Heterotropic Pregnancy|0|||
163414882|NCT01687712|590225460|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
163414883|NCT01687712|590225461|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
163414884|NCT01687712|590225460|FG000|Cycle 1|Abortion|3|||
163414885|NCT01687712|590225461|FG001|Cycle 1|Abortion|0|||
163414886|NCT01687712|590225460|FG000|Cycle 1|Intrauterine Fetal Death|0|||
163414887|NCT01687712|590225461|FG001|Cycle 1|Intrauterine Fetal Death|1|||
163414888|NCT01687712|590225460|FG000|Cycle 1|Lost to Follow-up|1|||
163414889|NCT01687712|590225461|FG001|Cycle 1|Lost to Follow-up|1|||
163414890|NCT01687712|590225460|FG000|Cycle 2|Not Biochemically Pregnant|74|||
163414891|NCT01687712|590225461|FG001|Cycle 2|Not Biochemically Pregnant|77|||
163414892|NCT01687712|590225460|FG000|Cycle 2|Early Pregnancy Loss|18|||
163414893|NCT01687712|590225461|FG001|Cycle 2|Early Pregnancy Loss|16|||
163414894|NCT01687712|590225460|FG000|Cycle 2|Ectopic Pregnancy|0|||
163414895|NCT01687712|590225461|FG001|Cycle 2|Ectopic Pregnancy|1|||
163414896|NCT01687712|590225460|FG000|Cycle 2|Still Birth|1|||
163414897|NCT01687712|590225461|FG001|Cycle 2|Still Birth|0|||
163414898|NCT01687712|590225460|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
163414899|NCT01687712|590225461|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
163414900|NCT01687712|590225460|FG000|Cycle 3|Not Biochemically Pregnant|21|||
163414901|NCT01687712|590225461|FG001|Cycle 3|Not Biochemically Pregnant|22|||
163414902|NCT01687712|590225460|FG000|Cycle 3|Early Pregnancy Loss|1|||
163414903|NCT01687712|590225461|FG001|Cycle 3|Early Pregnancy Loss|2|||
163414904|NCT01687712|590225460|FG000|Cycle 3|Ectopic Pregnancy|1|||
163414905|NCT01687712|590225461|FG001|Cycle 3|Ectopic Pregnancy|0|||
163414906|NCT01687712|590225460|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
163414907|NCT01687712|590225461|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
163414908|NCT00516737|590225466|FG000|Overall Study|Lost to Follow-up|2|||
163414909|NCT00516737|590225467|FG001|Overall Study|Lost to Follow-up|0|||
163414910|NCT00516737|590225466|FG000|Overall Study|Physician Decision|0|||
163414911|NCT00516737|590225467|FG001|Overall Study|Physician Decision|1|||
163414912|NCT00516737|590225466|FG000|Overall Study|Withdrawal by Subject|0|||
163414913|NCT00516737|590225467|FG001|Overall Study|Withdrawal by Subject|1|||
163414914|NCT00516737|590225466|FG000|Overall Study|Lack of Qualifying Event|9|||
163414915|NCT00516737|590225467|FG001|Overall Study|Lack of Qualifying Event|6|||
163414916|NCT00512798|590225468|FG000|Overall Study|Death|0|||
163414917|NCT00512798|590225469|FG001|Overall Study|Death|3|||
163414918|NCT00512798|590225468|FG000|Overall Study|Adverse Event|2|||
163414919|NCT00512798|590225469|FG001|Overall Study|Adverse Event|4|||
163414920|NCT00512798|590225468|FG000|Overall Study|Progression of disease|14|||
163414921|NCT00512798|590225469|FG001|Overall Study|Progression of disease|20|||
163414922|NCT00512798|590225468|FG000|Overall Study|Withdrawal by Subject|3|||
163414923|NCT00512798|590225469|FG001|Overall Study|Withdrawal by Subject|0|||
163414924|NCT03551743|590225471|FG000|Overall Study|Adverse Event|1|||
163414925|NCT03551743|590225472|FG001|Overall Study|Adverse Event|0|||
163414926|NCT03551743|590225473|FG002|Overall Study|Adverse Event|0|||
163414927|NCT03551743|590225474|FG003|Overall Study|Adverse Event|0|||
163414928|NCT03551743|590225471|FG000|Overall Study|Withdrawal by Subject|1|||
163414929|NCT03551743|590225472|FG001|Overall Study|Withdrawal by Subject|0|||
163414930|NCT03551743|590225473|FG002|Overall Study|Withdrawal by Subject|0|||
163414931|NCT03551743|590225474|FG003|Overall Study|Withdrawal by Subject|0|||
163414932|NCT02317562|590225475|FG000|Overall Study|Physician Decision|1|||
163414933|NCT02317562|590225475|FG000|Overall Study|early termination of the study|8|||
163414934|NCT02317562|590225475|FG000|Overall Study|Lack of Efficacy|4|||
163414935|NCT02317562|590225475|FG000|Overall Study|Withdrawal by Subject|1|||
163414936|NCT00911989|590225476|FG000|Overall Study|Adverse Event|1|||
163414937|NCT03434977|590225477|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
163414938|NCT03434977|590225478|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
163414939|NCT01145066|590225479|FG000|Overall Study|To resume NSAIDs|2|||
163414940|NCT01145066|590225480|FG001|Overall Study|To resume NSAIDs|2|||
163414941|NCT01145066|590225481|FG002|Overall Study|To resume NSAIDs|1|||
163414942|NCT01145066|590225479|FG000|Overall Study|Non-related surgery|0|||
163414943|NCT01145066|590225480|FG001|Overall Study|Non-related surgery|0|||
163414944|NCT01145066|590225481|FG002|Overall Study|Non-related surgery|1|||
163414945|NCT01145066|590225479|FG000|Overall Study|Withdrawal by Subject|0|||
163414946|NCT01145066|590225480|FG001|Overall Study|Withdrawal by Subject|0|||
163414947|NCT01145066|590225481|FG002|Overall Study|Withdrawal by Subject|2|||
163414948|NCT01145066|590225479|FG000|Overall Study|To start new med|1|||
163414949|NCT01145066|590225480|FG001|Overall Study|To start new med|0|||
163414950|NCT01145066|590225481|FG002|Overall Study|To start new med|0|||
163414951|NCT01145066|590225479|FG000|Overall Study|problems swallowing capsule|1|||
163414952|NCT01145066|590225480|FG001|Overall Study|problems swallowing capsule|0|||
163414953|NCT01145066|590225481|FG002|Overall Study|problems swallowing capsule|0|||
163414954|NCT01145066|590225479|FG000|Overall Study|Abdominal discomfort|0|||
163414955|NCT01145066|590225480|FG001|Overall Study|Abdominal discomfort|1|||
163414956|NCT01145066|590225481|FG002|Overall Study|Abdominal discomfort|0|||
163414957|NCT01145066|590225479|FG000|Overall Study|Low platelet count|0|||
163414958|NCT01145066|590225480|FG001|Overall Study|Low platelet count|1|||
163414959|NCT01145066|590225481|FG002|Overall Study|Low platelet count|0|||
163414960|NCT03920670|590225482|FG000|Overall Study|Protocol Violation|2|||
163414961|NCT03920670|590225483|FG001|Overall Study|Protocol Violation|2|||
163414962|NCT03920670|590225482|FG000|Overall Study|Adverse Event|1|||
163414963|NCT03920670|590225483|FG001|Overall Study|Adverse Event|0|||
163414964|NCT02363478|590226919|FG000|Overall Study|Lost to Follow-up|4|||
163414965|NCT02363478|590226919|FG000|Overall Study|Adverse Event|4|||
163414966|NCT00930059|590226920|FG000|Overall Study|Death|1|||
163414967|NCT00930059|590226921|FG001|Overall Study|Death|0|||
163414968|NCT00930059|590226920|FG000|Overall Study|Did not meet entrance criteria|1|||
163414969|NCT00930059|590226921|FG001|Overall Study|Did not meet entrance criteria|1|||
163414970|NCT00930059|590226920|FG000|Overall Study|Withdrawal by Subject|3|||
163414971|NCT00930059|590226921|FG001|Overall Study|Withdrawal by Subject|4|||
163414972|NCT00930059|590226920|FG000|Overall Study|Other|1|||
163414973|NCT00930059|590226921|FG001|Overall Study|Other|0|||
163414974|NCT00930059|590226920|FG000|Overall Study|1 site terminated by sponsor|1|||
163414975|NCT00930059|590226921|FG001|Overall Study|1 site terminated by sponsor|1|||
163414976|NCT00930059|590226920|FG000|Overall Study|Adverse Event|1|||
163414977|NCT00930059|590226921|FG001|Overall Study|Adverse Event|6|||
163414978|NCT01916980|590226925|FG000|Overall Study|Adverse Event|4|||
163414979|NCT01916980|590226926|FG001|Overall Study|Adverse Event|2|||
163414980|NCT01916980|590226925|FG000|Overall Study|Lack of Efficacy|2|||
163414981|NCT01916980|590226926|FG001|Overall Study|Lack of Efficacy|2|||
163414982|NCT01916980|590226925|FG000|Overall Study|Withdrawal by Subject|1|||
163414983|NCT01916980|590226926|FG001|Overall Study|Withdrawal by Subject|0|||
163414984|NCT00546364|590226927|FG000|Overall Study|Disease progression|5|||
163414985|NCT00546364|590226928|FG001|Overall Study|Disease progression|11|||
163414986|NCT00546364|590226929|FG002|Overall Study|Disease progression|8|||
163414987|NCT00546364|590226927|FG000|Overall Study|Completed and off treatment|1|||
163414988|NCT00546364|590226928|FG001|Overall Study|Completed and off treatment|0|||
163414989|NCT00546364|590226929|FG002|Overall Study|Completed and off treatment|2|||
163414990|NCT00546364|590226927|FG000|Overall Study|Administrative reason by sponsor|1|||
163414991|NCT00546364|590226928|FG001|Overall Study|Administrative reason by sponsor|0|||
163414992|NCT00546364|590226929|FG002|Overall Study|Administrative reason by sponsor|0|||
163414993|NCT00546364|590226927|FG000|Overall Study|Poor compliance/noncompliance|0|||
163414994|NCT00546364|590226928|FG001|Overall Study|Poor compliance/noncompliance|0|||
163414995|NCT00546364|590226929|FG002|Overall Study|Poor compliance/noncompliance|1|||
163414996|NCT00546364|590226927|FG000|Overall Study|No longer meets study criteria|1|||
163414997|NCT00546364|590226928|FG001|Overall Study|No longer meets study criteria|1|||
163414998|NCT00546364|590226929|FG002|Overall Study|No longer meets study criteria|0|||
163414999|NCT00546364|590226927|FG000|Overall Study|Withdrawal by Subject|5|||
163415000|NCT00546364|590226928|FG001|Overall Study|Withdrawal by Subject|6|||
163415001|NCT00546364|590226929|FG002|Overall Study|Withdrawal by Subject|3|||
163415002|NCT00546364|590226927|FG000|Overall Study|Prior taxotere|1|||
163415003|NCT00546364|590226928|FG001|Overall Study|Prior taxotere|0|||
163415004|NCT00546364|590226929|FG002|Overall Study|Prior taxotere|0|||
163415005|NCT00546364|590226927|FG000|Overall Study|Mixed response|1|||
163415006|NCT00546364|590226928|FG001|Overall Study|Mixed response|0|||
163415007|NCT00546364|590226929|FG002|Overall Study|Mixed response|0|||
163415008|NCT00546364|590226927|FG000|Overall Study|Palliative treatment|1|||
163415009|NCT00546364|590226928|FG001|Overall Study|Palliative treatment|0|||
163415010|NCT00546364|590226929|FG002|Overall Study|Palliative treatment|1|||
163415011|NCT00546364|590226927|FG000|Overall Study|Target lesions resected|1|||
163415012|NCT00546364|590226928|FG001|Overall Study|Target lesions resected|0|||
163415013|NCT00546364|590226929|FG002|Overall Study|Target lesions resected|0|||
163415014|NCT00546364|590226927|FG000|Overall Study|Physician Decision|0|||
163415015|NCT00546364|590226928|FG001|Overall Study|Physician Decision|0|||
163415016|NCT00546364|590226929|FG002|Overall Study|Physician Decision|1|||
163415017|NCT00546364|590226927|FG000|Overall Study|Sponsor decision|0|||
163415018|NCT00546364|590226928|FG001|Overall Study|Sponsor decision|0|||
163415019|NCT00546364|590226929|FG002|Overall Study|Sponsor decision|1|||
163415020|NCT03064763|590226930|FG000|Overall Study|Lost to Follow-up|1|||
163415021|NCT03064763|590226930|FG000|Overall Study|Death|8|||
163415022|NCT00935883|590226933|FG000|Treatment Period|Physician Decision|1|||
163415023|NCT00935883|590226934|FG001|Treatment Period|Physician Decision|0|||
163415024|NCT00935883|590226933|FG000|Treatment Period|Withdrawal by Subject|0|||
163415025|NCT00935883|590226934|FG001|Treatment Period|Withdrawal by Subject|2|||
163415026|NCT04033367|590226939|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
163415027|NCT04033367|590226940|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
163415028|NCT04033367|590226939|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
163415029|NCT04033367|590226940|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
163415030|NCT04033367|590226939|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
163415031|NCT04033367|590226940|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
163415032|NCT04033367|590226939|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
163415033|NCT04033367|590226940|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
163415034|NCT02723201|590226941|FG000|Second Intervention Period|Protocol Violation|1|||
163415035|NCT02723201|590226942|FG001|Second Intervention Period|Protocol Violation|0|||
163415036|NCT02723201|590226943|FG002|Second Intervention Period|Protocol Violation|0|||
163415037|NCT02723201|590226941|FG000|Second Intervention Period|Adverse Event|1|||
163415038|NCT02723201|590226942|FG001|Second Intervention Period|Adverse Event|0|||
163415039|NCT02723201|590226943|FG002|Second Intervention Period|Adverse Event|0|||
163415040|NCT02415712|590226946|FG000|Overall Study|Protocol Violation|16|||
163415041|NCT01537211|590226948|FG000|Overall Study|Lost to Follow-up|0|||
163415042|NCT01537211|590226949|FG001|Overall Study|Lost to Follow-up|1|||
163375831|NCT01435616|590084293|FG000|Overall Study|Protocol Violation|16|||
163375832|NCT01435616|590084294|FG001|Overall Study|Protocol Violation|13|||
163375833|NCT01435616|590084293|FG000|Overall Study|Withdrawal by Subject|66|||
163375834|NCT01435616|590084294|FG001|Overall Study|Withdrawal by Subject|24|||
163415043|NCT02624492|590226967|FG000|Overall Study|Adverse Event|2|||
163415044|NCT02624492|590226968|FG001|Overall Study|Adverse Event|2|||
163375835|NCT01435616|590084293|FG000|Overall Study|Physician Decision|20|||
163375836|NCT01435616|590084294|FG001|Overall Study|Physician Decision|7|||
163375837|NCT01435616|590084293|FG000|Overall Study|Sponsor Decision|1|||
163375838|NCT01435616|590084294|FG001|Overall Study|Sponsor Decision|0|||
163375839|NCT00371683|590084296|FG000|DB Treatment Period-Randomized Patients|Death|1|||
163375840|NCT00371683|590084297|FG001|DB Treatment Period-Randomized Patients|Death|1|||
163375841|NCT00371683|590084296|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
163375842|NCT00371683|590084297|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
163375843|NCT00371683|590084296|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
163375844|NCT00371683|590084297|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
163375845|NCT00371683|590084296|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
163375846|NCT00371683|590084297|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
163375847|NCT00371683|590084296|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
163375848|NCT00371683|590084297|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
163375849|NCT00371683|590084296|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
163375850|NCT00371683|590084297|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
163375851|NCT00371683|590084296|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
163375852|NCT00371683|590084297|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
163375853|NCT00371683|590084296|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
163375854|NCT00371683|590084297|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
163375855|NCT00371683|590084296|FG000|Follow-Up Period - Randomized Patients|Death|0|||
163375856|NCT00371683|590084297|FG001|Follow-Up Period - Randomized Patients|Death|2|||
163375857|NCT00371683|590084296|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
163375858|NCT00371683|590084297|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
163375859|NCT00371683|590084296|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
163375860|NCT00371683|590084297|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
163375861|NCT01237587|590084298|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
163375862|NCT01237587|590084299|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
163375863|NCT01237587|590084298|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
163375864|NCT01237587|590084299|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
163375865|NCT01237587|590084298|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
163375866|NCT01237587|590084299|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
163375867|NCT01237587|590084298|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
163375868|NCT01237587|590084299|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
163375869|NCT01237587|590084298|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
163375870|NCT01237587|590084299|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
163375871|NCT01237587|590084298|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
163375872|NCT01237587|590084299|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
163375873|NCT01237587|590084298|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
163375874|NCT01237587|590084299|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
163375875|NCT01237587|590084298|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
163375876|NCT01237587|590084299|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
163375877|NCT01237587|590084298|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
163375878|NCT01237587|590084299|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
163375879|NCT01237587|590084298|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
163375880|NCT01237587|590084299|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
163375881|NCT01237587|590084298|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
163375882|NCT01237587|590084299|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
163375883|NCT01237587|590084298|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
163375884|NCT01237587|590084299|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
163375885|NCT01237587|590084298|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
163375886|NCT01237587|590084299|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
163375887|NCT01237587|590084298|FG000|Taper Phase|Adverse Event|0|||
163375888|NCT01237587|590084299|FG001|Taper Phase|Adverse Event|2|||
163375889|NCT01237587|590084298|FG000|Taper Phase|Protocol Violation|2|||
163375890|NCT01237587|590084299|FG001|Taper Phase|Protocol Violation|0|||
163375891|NCT01237587|590084298|FG000|Taper Phase|Lack of Efficacy|2|||
163375892|NCT01237587|590084299|FG001|Taper Phase|Lack of Efficacy|5|||
163375893|NCT01237587|590084298|FG000|Taper Phase|Parent/Guardian Decision|0|||
163375894|NCT01237587|590084299|FG001|Taper Phase|Parent/Guardian Decision|2|||
163375895|NCT01237587|590084298|FG000|Taper Phase|Sponsor Decision|1|||
163375896|NCT01237587|590084299|FG001|Taper Phase|Sponsor Decision|0|||
163375897|NCT01237587|590084298|FG000|Taper Phase|Withdrawal by Subject|0|||
163375898|NCT01237587|590084299|FG001|Taper Phase|Withdrawal by Subject|1|||
163375899|NCT01011387|590084301|FG000|Overall Study|Withdrawal by Subject|3|||
163375900|NCT01011387|590084301|FG000|Overall Study|Adverse Event|2|||
163375901|NCT01011387|590084301|FG000|Overall Study|Protocol Violation|1|||
163375902|NCT01139580|590084302|FG000|Overall Study|Adverse Event|5|||
163375903|NCT01139580|590084303|FG001|Overall Study|Adverse Event|4|||
163375904|NCT01139580|590084302|FG000|Overall Study|Lost to Follow-up|9|||
163375905|NCT01139580|590084303|FG001|Overall Study|Lost to Follow-up|1|||
163375906|NCT01139580|590084302|FG000|Overall Study|Lack of Efficacy|0|||
163375907|NCT01139580|590084303|FG001|Overall Study|Lack of Efficacy|2|||
163375908|NCT01139580|590084302|FG000|Overall Study|Withdrawal by Subject|6|||
163375909|NCT01139580|590084303|FG001|Overall Study|Withdrawal by Subject|9|||
163375910|NCT01139580|590084302|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
163375911|NCT01139580|590084303|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
163375912|NCT01139580|590084302|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
163375913|NCT01139580|590084303|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
163375914|NCT01139580|590084302|FG000|Overall Study|Misrandomized|1|||
163375915|NCT01139580|590084303|FG001|Overall Study|Misrandomized|0|||
163375916|NCT01139580|590084302|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
163375917|NCT01139580|590084303|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
163375918|NCT01139580|590084302|FG000|Overall Study|Participant Randomization in Error|0|||
163375919|NCT01139580|590084303|FG001|Overall Study|Participant Randomization in Error|1|||
163375920|NCT01285609|590084304|FG000|Randomized|Progressive Disease|41|||
163375921|NCT01285609|590084305|FG001|Randomized|Progressive Disease|61|||
163375922|NCT01285609|590084304|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
163375923|NCT01285609|590084305|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
163375924|NCT01285609|590084304|FG000|Randomized|Study Drug Toxicity|13|||
163375925|NCT01285609|590084305|FG001|Randomized|Study Drug Toxicity|14|||
163375926|NCT01285609|590084304|FG000|Randomized|Death|5|||
163375927|NCT01285609|590084305|FG001|Randomized|Death|7|||
163375928|NCT01285609|590084304|FG000|Randomized|Withdrawal by Subject|8|||
163375929|NCT01285609|590084305|FG001|Randomized|Withdrawal by Subject|11|||
163375930|NCT01285609|590084304|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
163375931|NCT01285609|590084305|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
163375932|NCT01285609|590084304|FG000|Randomized|Undisclosed Reasons|1|||
163375933|NCT01285609|590084305|FG001|Randomized|Undisclosed Reasons|0|||
163375934|NCT01285609|590084304|FG000|Randomized|Randomized but not Treated|4|||
163375935|NCT01285609|590084305|FG001|Randomized|Randomized but not Treated|4|||
163375936|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
163375937|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
163375938|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
163375939|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
163375940|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
163375941|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
163375942|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
163375943|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
163375944|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Death|11|||
163375945|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Death|3|||
163375946|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
163375947|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
163375948|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Not Reported|0|||
163375949|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Not Reported|2|||
163375950|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
163375951|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
163415045|NCT02624492|590226969|FG002|Overall Study|Adverse Event|2|||
163415046|NCT02624492|590226967|FG000|Overall Study|Progressive disease|0|||
163415047|NCT02624492|590226968|FG001|Overall Study|Progressive disease|2|||
163415048|NCT02624492|590226969|FG002|Overall Study|Progressive disease|3|||
163415049|NCT00343512|590226970|FG000|Overall Study|Withdrawal by Subject|2|||
163415050|NCT02971670|590226971|FG000|Overall Study|Withdrawal by Subject|4|||
163415051|NCT02971670|590226972|FG001|Overall Study|Withdrawal by Subject|1|||
163415052|NCT02971670|590226973|FG002|Overall Study|Withdrawal by Subject|1|||
163415053|NCT02971670|590226974|FG003|Overall Study|Withdrawal by Subject|2|||
163415054|NCT01127165|590226975|FG000|Overall Study|Adverse Event|2|||
163415055|NCT01127165|590226976|FG001|Overall Study|Adverse Event|2|||
163415056|NCT01127165|590226975|FG000|Overall Study|Lack of Efficacy|10|||
163415057|NCT01127165|590226976|FG001|Overall Study|Lack of Efficacy|8|||
163415058|NCT01127165|590226975|FG000|Overall Study|Lost to Follow-up|3|||
163415059|NCT01127165|590226976|FG001|Overall Study|Lost to Follow-up|5|||
163415060|NCT01127165|590226975|FG000|Overall Study|Withdrawal by Subject|1|||
163415061|NCT01127165|590226976|FG001|Overall Study|Withdrawal by Subject|3|||
163415062|NCT01127165|590226975|FG000|Overall Study|Protocol Violation|0|||
163415063|NCT01127165|590226976|FG001|Overall Study|Protocol Violation|1|||
163415064|NCT00379795|590226977|FG000|Overall Study|Death|31|||
163415065|NCT00379795|590226978|FG001|Overall Study|Death|8|||
163415066|NCT00379795|590226979|FG002|Overall Study|Death|6|||
163415067|NCT00379795|590226980|FG003|Overall Study|Death|4|||
163415068|NCT00379795|590226981|FG004|Overall Study|Death|7|||
163415069|NCT00379795|590226977|FG000|Overall Study|Adverse Event|17|||
163415070|NCT00379795|590226978|FG001|Overall Study|Adverse Event|3|||
163415071|NCT00379795|590226979|FG002|Overall Study|Adverse Event|3|||
163415072|NCT00379795|590226980|FG003|Overall Study|Adverse Event|1|||
163415073|NCT00379795|590226981|FG004|Overall Study|Adverse Event|4|||
163415074|NCT00379795|590226977|FG000|Overall Study|Lost to Follow-up|8|||
163415075|NCT00379795|590226978|FG001|Overall Study|Lost to Follow-up|1|||
163415076|NCT00379795|590226979|FG002|Overall Study|Lost to Follow-up|2|||
163415077|NCT00379795|590226980|FG003|Overall Study|Lost to Follow-up|1|||
163415078|NCT00379795|590226981|FG004|Overall Study|Lost to Follow-up|4|||
163415079|NCT00379795|590226977|FG000|Overall Study|Physician Decision|25|||
163415080|NCT00379795|590226978|FG001|Overall Study|Physician Decision|0|||
163415081|NCT00379795|590226979|FG002|Overall Study|Physician Decision|2|||
163415082|NCT00379795|590226980|FG003|Overall Study|Physician Decision|2|||
163415083|NCT00379795|590226981|FG004|Overall Study|Physician Decision|2|||
163415084|NCT00379795|590226977|FG000|Overall Study|Withdrawal by Subject|94|||
163415085|NCT00379795|590226978|FG001|Overall Study|Withdrawal by Subject|11|||
163415086|NCT00379795|590226979|FG002|Overall Study|Withdrawal by Subject|19|||
163415087|NCT00379795|590226980|FG003|Overall Study|Withdrawal by Subject|7|||
163415088|NCT00379795|590226981|FG004|Overall Study|Withdrawal by Subject|14|||
163415089|NCT00379795|590226977|FG000|Overall Study|Subject non-compliance|7|||
163415090|NCT00379795|590226978|FG001|Overall Study|Subject non-compliance|2|||
163415091|NCT00379795|590226979|FG002|Overall Study|Subject non-compliance|0|||
163415092|NCT00379795|590226980|FG003|Overall Study|Subject non-compliance|0|||
163415093|NCT00379795|590226981|FG004|Overall Study|Subject non-compliance|1|||
163415094|NCT00379795|590226977|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
163415095|NCT00379795|590226978|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
163415096|NCT00379795|590226979|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
163415097|NCT00379795|590226980|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
163415098|NCT00379795|590226981|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
163415099|NCT00379795|590226977|FG000|Overall Study|Subjects condition mandated intervention|34|||
163415100|NCT00379795|590226978|FG001|Overall Study|Subjects condition mandated intervention|9|||
163415101|NCT00379795|590226979|FG002|Overall Study|Subjects condition mandated intervention|7|||
163415102|NCT00379795|590226980|FG003|Overall Study|Subjects condition mandated intervention|5|||
163415103|NCT00379795|590226981|FG004|Overall Study|Subjects condition mandated intervention|7|||
163415104|NCT00379795|590226977|FG000|Overall Study|Sponsor's decision|257|||
163415105|NCT00379795|590226978|FG001|Overall Study|Sponsor's decision|17|||
163415106|NCT00379795|590226979|FG002|Overall Study|Sponsor's decision|54|||
163415107|NCT00379795|590226980|FG003|Overall Study|Sponsor's decision|47|||
163415108|NCT00379795|590226981|FG004|Overall Study|Sponsor's decision|10|||
163415109|NCT00763321|590226982|FG000|Open-label Period|Adverse Event|24|||
163415110|NCT00763321|590226983|FG001|Open-label Period|Adverse Event|0|||
163415111|NCT00763321|590226984|FG002|Open-label Period|Adverse Event|0|||
163415112|NCT00763321|590226982|FG000|Open-label Period|Lost to Follow-up|14|||
163415113|NCT00763321|590226983|FG001|Open-label Period|Lost to Follow-up|0|||
163415114|NCT00763321|590226984|FG002|Open-label Period|Lost to Follow-up|0|||
163415115|NCT00763321|590226982|FG000|Open-label Period|Withdrawal by Subject|7|||
163415116|NCT00763321|590226983|FG001|Open-label Period|Withdrawal by Subject|0|||
163415117|NCT00763321|590226984|FG002|Open-label Period|Withdrawal by Subject|0|||
163415118|NCT00763321|590226982|FG000|Open-label Period|Subject noncompliant|7|||
163415119|NCT00763321|590226983|FG001|Open-label Period|Subject noncompliant|0|||
163415120|NCT00763321|590226984|FG002|Open-label Period|Subject noncompliant|0|||
163415121|NCT00763321|590226982|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
163415122|NCT00763321|590226983|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
163375952|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
163375953|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
163375954|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
163375955|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
163375956|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
163375957|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
163375958|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
163375959|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
163375960|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
163375961|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
163375962|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
163375963|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
163375964|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
163375965|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
163375966|NCT01285609|590084304|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
163375967|NCT01285609|590084305|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
163375968|NCT01285609|590084304|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
163375969|NCT01285609|590084305|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
163375970|NCT01142115|590084306|FG000|First Intervention|Lack of Efficacy|1|||
163375971|NCT01142115|590084307|FG001|First Intervention|Lack of Efficacy|1|||
163375972|NCT01142115|590084306|FG000|First Intervention|Adverse Event|1|||
163375973|NCT01142115|590084307|FG001|First Intervention|Adverse Event|0|||
163375974|NCT03208036|590084308|FG000|Baseline Assessment|Withdrawal by Subject|1|||
163375975|NCT03208036|590084309|FG001|Baseline Assessment|Withdrawal by Subject|1|||
163375976|NCT03208036|590084308|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
163375977|NCT03208036|590084309|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
163375978|NCT03208036|590084308|FG000|Intervention|Withdrawal by Subject|3|||
163375979|NCT03208036|590084309|FG001|Intervention|Withdrawal by Subject|2|||
163375980|NCT03208036|590084308|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
163375981|NCT03208036|590084309|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
163375982|NCT00700778|590084310|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
163375983|NCT00350103|590084316|FG000|Overall Study|Adverse Event|12|||
163375984|NCT00350103|590084317|FG001|Overall Study|Adverse Event|29|||
163375985|NCT00350103|590084318|FG002|Overall Study|Adverse Event|17|||
163375986|NCT00350103|590084316|FG000|Overall Study|Lack of Efficacy|5|||
163375987|NCT00350103|590084317|FG001|Overall Study|Lack of Efficacy|1|||
163375988|NCT00350103|590084318|FG002|Overall Study|Lack of Efficacy|3|||
163375989|NCT00350103|590084316|FG000|Overall Study|Withdrawal by Subject|6|||
163375990|NCT00350103|590084317|FG001|Overall Study|Withdrawal by Subject|6|||
163375991|NCT00350103|590084318|FG002|Overall Study|Withdrawal by Subject|8|||
163375992|NCT00350103|590084316|FG000|Overall Study|Protocol Violation|0|||
163375993|NCT00350103|590084317|FG001|Overall Study|Protocol Violation|0|||
163375994|NCT00350103|590084318|FG002|Overall Study|Protocol Violation|1|||
163375995|NCT00350103|590084316|FG000|Overall Study|Unsatisfactory Compliance|2|||
163375996|NCT00350103|590084317|FG001|Overall Study|Unsatisfactory Compliance|2|||
163375997|NCT00350103|590084318|FG002|Overall Study|Unsatisfactory Compliance|1|||
163375998|NCT00350103|590084316|FG000|Overall Study|Investigator´s decision|1|||
163375999|NCT00350103|590084317|FG001|Overall Study|Investigator´s decision|1|||
163376000|NCT00350103|590084318|FG002|Overall Study|Investigator´s decision|0|||
163376001|NCT00350103|590084316|FG000|Overall Study|Exclusion criteria met|0|||
163376002|NCT00350103|590084317|FG001|Overall Study|Exclusion criteria met|0|||
163376003|NCT00350103|590084318|FG002|Overall Study|Exclusion criteria met|1|||
163376004|NCT00350103|590084316|FG000|Overall Study|Patient relocated|0|||
163376005|NCT00350103|590084317|FG001|Overall Study|Patient relocated|0|||
163376006|NCT00350103|590084318|FG002|Overall Study|Patient relocated|1|||
163376007|NCT00350103|590084316|FG000|Overall Study|Need for prohibited medication|1|||
163376008|NCT00350103|590084317|FG001|Overall Study|Need for prohibited medication|0|||
163376009|NCT00350103|590084318|FG002|Overall Study|Need for prohibited medication|0|||
163376010|NCT00350103|590084316|FG000|Overall Study|Personal reasons|0|||
163376011|NCT00350103|590084317|FG001|Overall Study|Personal reasons|0|||
163376012|NCT00350103|590084318|FG002|Overall Study|Personal reasons|1|||
163376013|NCT00350103|590084316|FG000|Overall Study|Patient stopped feeling pain|1|||
163376014|NCT00350103|590084317|FG001|Overall Study|Patient stopped feeling pain|0|||
163376015|NCT00350103|590084318|FG002|Overall Study|Patient stopped feeling pain|0|||
163376016|NCT00350103|590084316|FG000|Overall Study|PR greater than 250ms|0|||
163376017|NCT00350103|590084317|FG001|Overall Study|PR greater than 250ms|0|||
163376018|NCT00350103|590084318|FG002|Overall Study|PR greater than 250ms|1|||
163376019|NCT00350103|590084316|FG000|Overall Study|Wrong calculation of QT interval|0|||
163376020|NCT00350103|590084317|FG001|Overall Study|Wrong calculation of QT interval|0|||
163376021|NCT00350103|590084318|FG002|Overall Study|Wrong calculation of QT interval|1|||
163376022|NCT00350103|590084316|FG000|Overall Study|Sponsor mistake|1|||
163415123|NCT00763321|590226984|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
163376023|NCT00350103|590084317|FG001|Overall Study|Sponsor mistake|0|||
163376024|NCT00350103|590084318|FG002|Overall Study|Sponsor mistake|0|||
163376025|NCT00350103|590084316|FG000|Overall Study|Randomization mistake|0|||
163376026|NCT00350103|590084317|FG001|Overall Study|Randomization mistake|1|||
163376027|NCT00350103|590084318|FG002|Overall Study|Randomization mistake|1|||
163376028|NCT00350103|590084316|FG000|Overall Study|Sponsor´s decision|0|||
163376029|NCT00350103|590084317|FG001|Overall Study|Sponsor´s decision|1|||
163376030|NCT00350103|590084318|FG002|Overall Study|Sponsor´s decision|0|||
163376031|NCT00350103|590084316|FG000|Overall Study|Lost, Reason unknown|1|||
163376032|NCT00350103|590084317|FG001|Overall Study|Lost, Reason unknown|1|||
163376033|NCT00350103|590084318|FG002|Overall Study|Lost, Reason unknown|0|||
163376034|NCT01879553|590084319|FG000|Overall Study|Withdrawal by Subject|1|||
163376035|NCT01879553|590084320|FG001|Overall Study|Withdrawal by Subject|0|||
163376036|NCT02559895|590084321|FG000|Overall Study|Adverse Event|3|||
163376037|NCT02559895|590084322|FG001|Overall Study|Adverse Event|3|||
163376038|NCT02559895|590084323|FG002|Overall Study|Adverse Event|2|||
163376039|NCT02559895|590084324|FG003|Overall Study|Adverse Event|1|||
163376040|NCT02559895|590084321|FG000|Overall Study|Lack of Efficacy|2|||
163376041|NCT02559895|590084322|FG001|Overall Study|Lack of Efficacy|3|||
163376042|NCT02559895|590084323|FG002|Overall Study|Lack of Efficacy|2|||
163376043|NCT02559895|590084324|FG003|Overall Study|Lack of Efficacy|8|||
163376044|NCT02559895|590084321|FG000|Overall Study|Lost to Follow-up|22|||
163376045|NCT02559895|590084322|FG001|Overall Study|Lost to Follow-up|16|||
163376046|NCT02559895|590084323|FG002|Overall Study|Lost to Follow-up|12|||
163376047|NCT02559895|590084324|FG003|Overall Study|Lost to Follow-up|17|||
163376048|NCT02559895|590084321|FG000|Overall Study|Physician Decision|1|||
163376049|NCT02559895|590084322|FG001|Overall Study|Physician Decision|1|||
163376050|NCT02559895|590084323|FG002|Overall Study|Physician Decision|3|||
163376051|NCT02559895|590084324|FG003|Overall Study|Physician Decision|0|||
163376052|NCT02559895|590084321|FG000|Overall Study|Withdrawal by Subject|16|||
163376053|NCT02559895|590084322|FG001|Overall Study|Withdrawal by Subject|9|||
163376054|NCT02559895|590084323|FG002|Overall Study|Withdrawal by Subject|20|||
163376055|NCT02559895|590084324|FG003|Overall Study|Withdrawal by Subject|9|||
163376056|NCT02559895|590084321|FG000|Overall Study|Study Burden|10|||
163376057|NCT02559895|590084322|FG001|Overall Study|Study Burden|16|||
163376058|NCT02559895|590084323|FG002|Overall Study|Study Burden|12|||
163376059|NCT02559895|590084324|FG003|Overall Study|Study Burden|22|||
163376060|NCT02559895|590084321|FG000|Overall Study|Other|1|||
163376061|NCT02559895|590084322|FG001|Overall Study|Other|5|||
163376062|NCT02559895|590084323|FG002|Overall Study|Other|3|||
163376063|NCT02559895|590084324|FG003|Overall Study|Other|3|||
163376064|NCT00320528|590084325|FG000|Study Period II|Adverse Event|3|||
163376065|NCT00320528|590084326|FG001|Study Period II|Adverse Event|4|||
163376066|NCT00320528|590084327|FG002|Study Period II|Adverse Event|8|||
163376067|NCT00320528|590084325|FG000|Study Period II|Parent/Caregiver Decision|8|||
163376068|NCT00320528|590084326|FG001|Study Period II|Parent/Caregiver Decision|3|||
163376069|NCT00320528|590084327|FG002|Study Period II|Parent/Caregiver Decision|11|||
163376070|NCT00320528|590084325|FG000|Study Period II|Withdrawal by Subject|0|||
163376071|NCT00320528|590084326|FG001|Study Period II|Withdrawal by Subject|1|||
163376072|NCT00320528|590084327|FG002|Study Period II|Withdrawal by Subject|1|||
163376073|NCT00320528|590084325|FG000|Study Period II|Entry Criteria Exclusion|0|||
163376074|NCT00320528|590084326|FG001|Study Period II|Entry Criteria Exclusion|2|||
163376075|NCT00320528|590084327|FG002|Study Period II|Entry Criteria Exclusion|2|||
163376076|NCT00320528|590084325|FG000|Study Period III|Adverse Event|1|||
163376077|NCT00320528|590084326|FG001|Study Period III|Adverse Event|0|||
163376078|NCT00320528|590084327|FG002|Study Period III|Adverse Event|0|||
163376079|NCT00320528|590084325|FG000|Study Period III|Lost to Follow-up|1|||
163376080|NCT00320528|590084326|FG001|Study Period III|Lost to Follow-up|0|||
163376081|NCT00320528|590084327|FG002|Study Period III|Lost to Follow-up|0|||
163376082|NCT00320528|590084325|FG000|Study Period III|Withdrawal by Subject|1|||
163376083|NCT00320528|590084326|FG001|Study Period III|Withdrawal by Subject|1|||
163376084|NCT00320528|590084327|FG002|Study Period III|Withdrawal by Subject|2|||
163376085|NCT00320528|590084325|FG000|Study Period III|Lack of Efficacy|2|||
163376086|NCT00320528|590084326|FG001|Study Period III|Lack of Efficacy|0|||
163376087|NCT00320528|590084327|FG002|Study Period III|Lack of Efficacy|0|||
163376088|NCT00320528|590084325|FG000|Study Period III|Parent/Caregiver Decision|14|||
163376089|NCT00320528|590084326|FG001|Study Period III|Parent/Caregiver Decision|3|||
163376090|NCT00320528|590084327|FG002|Study Period III|Parent/Caregiver Decision|11|||
163376091|NCT00320528|590084325|FG000|Study Period III|Protocol Violation|0|||
163376092|NCT00320528|590084326|FG001|Study Period III|Protocol Violation|1|||
163376093|NCT00320528|590084327|FG002|Study Period III|Protocol Violation|0|||
163376094|NCT00320528|590084325|FG000|Study Period III|Physician Decision|0|||
163376095|NCT00320528|590084326|FG001|Study Period III|Physician Decision|1|||
163376096|NCT00320528|590084327|FG002|Study Period III|Physician Decision|2|||
163376097|NCT00320528|590084325|FG000|Study Period III|Sponsor Decision|0|||
163376098|NCT00320528|590084326|FG001|Study Period III|Sponsor Decision|0|||
163376099|NCT00320528|590084327|FG002|Study Period III|Sponsor Decision|1|||
163415124|NCT00763321|590226982|FG000|Open-label Period|Lack of Efficacy|2|||
163415125|NCT00763321|590226983|FG001|Open-label Period|Lack of Efficacy|0|||
163415126|NCT00763321|590226984|FG002|Open-label Period|Lack of Efficacy|0|||
163415127|NCT00763321|590226982|FG000|Open-label Period|Other|4|||
163415128|NCT00763321|590226983|FG001|Open-label Period|Other|0|||
163415129|NCT00763321|590226984|FG002|Open-label Period|Other|0|||
163415130|NCT00763321|590226982|FG000|Double-blind Period|Lack of Efficacy|0|||
163415131|NCT00763321|590226983|FG001|Double-blind Period|Lack of Efficacy|9|||
163415132|NCT00763321|590226984|FG002|Double-blind Period|Lack of Efficacy|17|||
163415133|NCT00763321|590226982|FG000|Double-blind Period|Adverse Event|0|||
163415134|NCT00763321|590226983|FG001|Double-blind Period|Adverse Event|4|||
163415135|NCT00763321|590226984|FG002|Double-blind Period|Adverse Event|4|||
163415136|NCT00763321|590226982|FG000|Double-blind Period|Lost to Follow-up|0|||
163415137|NCT00763321|590226983|FG001|Double-blind Period|Lost to Follow-up|4|||
163415138|NCT00763321|590226984|FG002|Double-blind Period|Lost to Follow-up|2|||
163415139|NCT00763321|590226982|FG000|Double-blind Period|Withdrawal by Subject|0|||
163415140|NCT00763321|590226983|FG001|Double-blind Period|Withdrawal by Subject|2|||
163415141|NCT00763321|590226984|FG002|Double-blind Period|Withdrawal by Subject|3|||
163415142|NCT00763321|590226982|FG000|Double-blind Period|Other|0|||
163415143|NCT00763321|590226983|FG001|Double-blind Period|Other|2|||
163415144|NCT00763321|590226984|FG002|Double-blind Period|Other|3|||
163415145|NCT01064167|590226985|FG000|Overall Study|Protocol Violation|14|||
163415146|NCT01064167|590226986|FG001|Overall Study|Protocol Violation|15|||
163415147|NCT01060059|590226991|FG000|Overall Study|Adverse Event|1|||
163415148|NCT01060059|590226992|FG001|Overall Study|Adverse Event|1|||
163415149|NCT01060059|590226991|FG000|Overall Study|Death|2|||
163415150|NCT01060059|590226992|FG001|Overall Study|Death|3|||
163415151|NCT01060059|590226991|FG000|Overall Study|Lost to Follow-up|18|||
163415152|NCT01060059|590226992|FG001|Overall Study|Lost to Follow-up|34|||
163415153|NCT01060059|590226991|FG000|Overall Study|entry criteria not met|4|||
163415154|NCT01060059|590226992|FG001|Overall Study|entry criteria not met|3|||
163415155|NCT01060059|590226991|FG000|Overall Study|Withdrawal by Subject|35|||
163415156|NCT01060059|590226992|FG001|Overall Study|Withdrawal by Subject|23|||
163415157|NCT01060059|590226991|FG000|Overall Study|lack of glycemic control|2|||
163415158|NCT01060059|590226992|FG001|Overall Study|lack of glycemic control|1|||
163415159|NCT01060059|590226991|FG000|Overall Study|lack of compliance|5|||
163415160|NCT01060059|590226992|FG001|Overall Study|lack of compliance|2|||
163415161|NCT01816243|590226995|FG000|Overall Study|Adverse Event|6|||
163415162|NCT01816243|590226995|FG000|Overall Study|Lost to Follow-up|1|||
163415163|NCT01816243|590226995|FG000|Overall Study|Lack of Efficacy|1|||
163415164|NCT01816243|590226995|FG000|Overall Study|Not eligible for the study|1|||
163415165|NCT01816243|590226995|FG000|Overall Study|Amputation|3|||
163415166|NCT01920711|590226996|FG000|Overall Study|Death|347|||
163415167|NCT01920711|590226997|FG001|Overall Study|Death|356|||
163415168|NCT01920711|590226996|FG000|Overall Study|Lost to Follow-up|13|||
163415169|NCT01920711|590226997|FG001|Overall Study|Lost to Follow-up|14|||
163415170|NCT01920711|590226996|FG000|Overall Study|Withdrawal by Subject|4|||
163415171|NCT01920711|590226997|FG001|Overall Study|Withdrawal by Subject|3|||
163415172|NCT03891901|590226998|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
163415173|NCT03891901|590226999|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
163415174|NCT03891901|590227000|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
163415175|NCT03891901|590227001|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
163415176|NCT03891901|590227002|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
163415177|NCT03891901|590227003|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
163415178|NCT03891901|590227004|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
163415179|NCT03891901|590227005|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
163415180|NCT03891901|590227006|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
163415181|NCT03891901|590226998|FG000|Overall Study|Adverse Event|2|||
163415182|NCT03891901|590226999|FG001|Overall Study|Adverse Event|2|||
163415183|NCT03891901|590227000|FG002|Overall Study|Adverse Event|0|||
163415184|NCT03891901|590227001|FG003|Overall Study|Adverse Event|0|||
163415185|NCT03891901|590227002|FG004|Overall Study|Adverse Event|0|||
163415186|NCT03891901|590227003|FG005|Overall Study|Adverse Event|0|||
163415187|NCT03891901|590227004|FG006|Overall Study|Adverse Event|0|||
163415188|NCT03891901|590227005|FG007|Overall Study|Adverse Event|0|||
163415189|NCT03891901|590227006|FG008|Overall Study|Adverse Event|0|||
163415190|NCT03891901|590226998|FG000|Overall Study|Poor venous access|1|||
163415191|NCT03891901|590226999|FG001|Overall Study|Poor venous access|0|||
163415192|NCT03891901|590227000|FG002|Overall Study|Poor venous access|0|||
163415193|NCT03891901|590227001|FG003|Overall Study|Poor venous access|0|||
163415194|NCT03891901|590227002|FG004|Overall Study|Poor venous access|0|||
163415195|NCT03891901|590227003|FG005|Overall Study|Poor venous access|0|||
163415196|NCT03891901|590227004|FG006|Overall Study|Poor venous access|0|||
163415197|NCT03891901|590227005|FG007|Overall Study|Poor venous access|0|||
163415198|NCT03891901|590227006|FG008|Overall Study|Poor venous access|0|||
163415199|NCT03891901|590226998|FG000|Overall Study|Withdrawal by Subject|0|||
163415200|NCT03891901|590226999|FG001|Overall Study|Withdrawal by Subject|2|||
163376100|NCT00320528|590084325|FG000|Study Period III|Atomoxetine Commercially Available|68|||
163376101|NCT00320528|590084326|FG001|Study Period III|Atomoxetine Commercially Available|25|||
163376102|NCT00320528|590084327|FG002|Study Period III|Atomoxetine Commercially Available|90|||
163376103|NCT04828837|590084328|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
163376104|NCT04828837|590084329|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
163376105|NCT04828837|590084328|FG000|Overall Study|Lost to Follow-up|2|||
163376106|NCT04828837|590084329|FG001|Overall Study|Lost to Follow-up|6|||
163376107|NCT04828837|590084328|FG000|Overall Study|Lack of Efficacy|1|||
163376108|NCT04828837|590084329|FG001|Overall Study|Lack of Efficacy|0|||
163376109|NCT04828837|590084328|FG000|Overall Study|Admitted due to pneumothorax.|1|||
163376110|NCT04828837|590084329|FG001|Overall Study|Admitted due to pneumothorax.|0|||
163376111|NCT04828837|590084328|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
163376112|NCT04828837|590084329|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
163376113|NCT01397422|590084330|FG000|Overall Study|Adverse Event|0|||
163376114|NCT01397422|590084331|FG001|Overall Study|Adverse Event|3|||
163376115|NCT01397422|590084332|FG002|Overall Study|Adverse Event|3|||
163376116|NCT01397422|590084333|FG003|Overall Study|Adverse Event|8|||
163376117|NCT01397422|590084330|FG000|Overall Study|Withdrawal by Subject|1|||
163376118|NCT01397422|590084331|FG001|Overall Study|Withdrawal by Subject|0|||
163376119|NCT01397422|590084332|FG002|Overall Study|Withdrawal by Subject|0|||
163376120|NCT01397422|590084333|FG003|Overall Study|Withdrawal by Subject|0|||
163376121|NCT01397422|590084330|FG000|Overall Study|Increased bradykinesia related to PD|1|||
163376122|NCT01397422|590084331|FG001|Overall Study|Increased bradykinesia related to PD|0|||
163376123|NCT01397422|590084332|FG002|Overall Study|Increased bradykinesia related to PD|0|||
163376124|NCT01397422|590084333|FG003|Overall Study|Increased bradykinesia related to PD|0|||
163376125|NCT04540887|590084339|FG000|Overall Study|Withdrawal by Subject|2|||
163376126|NCT00760474|590084340|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
163376127|NCT00760474|590084341|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
163376128|NCT00760474|590084340|FG000|Placebo Washout Period|Other|0|||
163376129|NCT00760474|590084341|FG001|Placebo Washout Period|Other|1|||
163376130|NCT00760474|590084340|FG000|Period 2 (P2)|Lost to Follow-up|1|||
163376131|NCT00760474|590084341|FG001|Period 2 (P2)|Lost to Follow-up|0|||
163376132|NCT00760474|590084340|FG000|Period 2 (P2)|Adverse Event|0|||
163376133|NCT00760474|590084341|FG001|Period 2 (P2)|Adverse Event|1|||
163376134|NCT04664400|590084342|FG000|Overall Study|Withdrawal by Subject|2|||
163376135|NCT03762200|590084346|FG000|Overall Study|Death|2|||
163376136|NCT03738423|590084347|FG000|Overall Study|Withdrawal by Subject|9|||
163376137|NCT03738423|590084348|FG001|Overall Study|Withdrawal by Subject|12|||
163376138|NCT03738423|590084349|FG002|Overall Study|Withdrawal by Subject|9|||
163376139|NCT03738423|590084350|FG003|Overall Study|Withdrawal by Subject|12|||
163376140|NCT03738423|590084351|FG004|Overall Study|Withdrawal by Subject|10|||
163376141|NCT03738423|590084347|FG000|Overall Study|Lack of Efficacy|3|||
163376142|NCT03738423|590084348|FG001|Overall Study|Lack of Efficacy|1|||
163376143|NCT03738423|590084349|FG002|Overall Study|Lack of Efficacy|1|||
163376144|NCT03738423|590084350|FG003|Overall Study|Lack of Efficacy|1|||
163376145|NCT03738423|590084351|FG004|Overall Study|Lack of Efficacy|2|||
163376146|NCT03738423|590084347|FG000|Overall Study|Lost to Follow-up|1|||
163376147|NCT03738423|590084348|FG001|Overall Study|Lost to Follow-up|0|||
163376148|NCT03738423|590084349|FG002|Overall Study|Lost to Follow-up|1|||
163376149|NCT03738423|590084350|FG003|Overall Study|Lost to Follow-up|1|||
163376150|NCT03738423|590084351|FG004|Overall Study|Lost to Follow-up|0|||
163376151|NCT03738423|590084347|FG000|Overall Study|Protocol Violation|1|||
163376152|NCT03738423|590084348|FG001|Overall Study|Protocol Violation|0|||
163376153|NCT03738423|590084349|FG002|Overall Study|Protocol Violation|0|||
163376154|NCT03738423|590084350|FG003|Overall Study|Protocol Violation|0|||
163376155|NCT03738423|590084351|FG004|Overall Study|Protocol Violation|1|||
163376156|NCT03738423|590084347|FG000|Overall Study|Physician Decision|0|||
163376157|NCT03738423|590084348|FG001|Overall Study|Physician Decision|0|||
163376158|NCT03738423|590084349|FG002|Overall Study|Physician Decision|1|||
163376159|NCT03738423|590084350|FG003|Overall Study|Physician Decision|0|||
163376160|NCT03738423|590084351|FG004|Overall Study|Physician Decision|1|||
163376161|NCT03738423|590084347|FG000|Overall Study|Death|0|||
163376162|NCT03738423|590084348|FG001|Overall Study|Death|0|||
163376163|NCT03738423|590084349|FG002|Overall Study|Death|0|||
163376164|NCT03738423|590084350|FG003|Overall Study|Death|0|||
163376165|NCT03738423|590084351|FG004|Overall Study|Death|1|||
163376166|NCT03738423|590084347|FG000|Overall Study|Randomized but never treated|0|||
163376167|NCT03738423|590084348|FG001|Overall Study|Randomized but never treated|0|||
163376168|NCT03738423|590084349|FG002|Overall Study|Randomized but never treated|1|||
163376169|NCT03738423|590084350|FG003|Overall Study|Randomized but never treated|1|||
163376170|NCT03738423|590084351|FG004|Overall Study|Randomized but never treated|0|||
163376171|NCT02592876|590084357|FG000|Overall Study|Withdrawal by Subject|3|||
163376172|NCT02592876|590084358|FG001|Overall Study|Withdrawal by Subject|3|||
163376173|NCT02592876|590084357|FG000|Overall Study|Study Termination by Sponsor|32|||
163376174|NCT02592876|590084358|FG001|Overall Study|Study Termination by Sponsor|27|||
163376175|NCT02592876|590084357|FG000|Overall Study|Lost to Follow-up|0|||
163376176|NCT02592876|590084358|FG001|Overall Study|Lost to Follow-up|1|||
163376177|NCT02592876|590084357|FG000|Overall Study|Death|6|||
163376178|NCT02592876|590084358|FG001|Overall Study|Death|9|||
163376179|NCT01865747|590084359|FG000|Overall Study (ITT)|Adverse Event|32|||
163376180|NCT01865747|590084360|FG001|Overall Study (ITT)|Adverse Event|31|||
163376181|NCT01865747|590084359|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
163376182|NCT01865747|590084360|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
163376183|NCT01865747|590084359|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
163376184|NCT01865747|590084360|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
163376185|NCT01865747|590084359|FG000|Overall Study (ITT)|Protocol Violation|1|||
163376186|NCT01865747|590084360|FG001|Overall Study (ITT)|Protocol Violation|1|||
163376187|NCT01865747|590084359|FG000|Overall Study (ITT)|Physician Decision|5|||
163376188|NCT01865747|590084360|FG001|Overall Study (ITT)|Physician Decision|2|||
163376189|NCT01865747|590084359|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
163376190|NCT01865747|590084360|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
163376191|NCT01865747|590084359|FG000|Overall Study (ITT)|Sponsor Decision|0|||
163376192|NCT01865747|590084360|FG001|Overall Study (ITT)|Sponsor Decision|1|||
163376193|NCT01865747|590084359|FG000|Overall Study (ITT)|Progressive Disease|122|||
163376194|NCT01865747|590084360|FG001|Overall Study (ITT)|Progressive Disease|158|||
163376195|NCT01865747|590084359|FG000|Overall Study (ITT)|Reason Not Provided|0|||
163376196|NCT01865747|590084360|FG001|Overall Study (ITT)|Reason Not Provided|1|||
163376197|NCT01865747|590084359|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
163376198|NCT01865747|590084360|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
163376199|NCT01865747|590084359|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
163376200|NCT01865747|590084360|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
163376201|NCT01865747|590084359|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
163376202|NCT01865747|590084360|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
163376203|NCT01865747|590084359|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
163376204|NCT01865747|590084360|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
163376205|NCT01865747|590084359|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
163376206|NCT01865747|590084360|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
163376207|NCT01865747|590084359|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
163376208|NCT01865747|590084360|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
163376209|NCT01865747|590084359|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
163376210|NCT01865747|590084360|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
163376211|NCT01865747|590084359|FG000|Primary Intent to Treat (PITT)|Other|0|||
163376212|NCT01865747|590084360|FG001|Primary Intent to Treat (PITT)|Other|1|||
163376213|NCT00867308|590084361|FG000|Overall Study|Death|1|||
163376214|NCT00867308|590084362|FG001|Overall Study|Death|0|||
163376215|NCT00867308|590084361|FG000|Overall Study|Adverse Event|1|||
163376216|NCT00867308|590084362|FG001|Overall Study|Adverse Event|4|||
163376217|NCT00867308|590084361|FG000|Overall Study|Lack of Efficacy|6|||
163376218|NCT00867308|590084362|FG001|Overall Study|Lack of Efficacy|12|||
163376219|NCT00867308|590084361|FG000|Overall Study|Withdrawal by Subject|1|||
163376220|NCT00867308|590084362|FG001|Overall Study|Withdrawal by Subject|2|||
163376221|NCT00611975|590084365|FG000|Overall Study|Withdrawal by Subject|3|||
163376222|NCT00611975|590084366|FG001|Overall Study|Withdrawal by Subject|7|||
163376223|NCT00611975|590084365|FG000|Overall Study|Pregnancy|2|||
163376224|NCT00611975|590084366|FG001|Overall Study|Pregnancy|1|||
163376225|NCT04625413|590084367|FG000|Overall Study|Hospice|2|||
163376226|NCT04625413|590084367|FG000|Overall Study|Distress|1|||
163376227|NCT04625413|590084367|FG000|Overall Study|Not feeling well|1|||
163376228|NCT05618912|590084371|FG000|Overall Study|Lost to Follow-up|14|||
163376229|NCT05618912|590084372|FG001|Overall Study|Lost to Follow-up|19|||
163376230|NCT00734097|590086320|FG000|Screening|Protocol Violation|12|||
163376231|NCT00734097|590086320|FG000|Screening|Withdrawal by Subject|5|||
163376232|NCT00734097|590086320|FG000|Screening|Lost to Follow-up|2|||
163376233|NCT00734097|590086320|FG000|Screening|Unconfirmed pregnancy|1|||
163376234|NCT00734097|590086320|FG000|Open Label|Lost to Follow-up|7|||
163376235|NCT00734097|590086320|FG000|Open Label|Withdrawal by Subject|5|||
163376236|NCT00734097|590086320|FG000|Open Label|Protocol Violation|4|||
163376237|NCT02233543|590086323|FG000|Period 1|Withdrawal by Subject|1|||
163376238|NCT02233543|590086324|FG001|Period 1|Withdrawal by Subject|0|||
163376239|NCT02233543|590086323|FG000|Period 1|Participants required other treatment.|2|||
163376240|NCT02233543|590086324|FG001|Period 1|Participants required other treatment.|3|||
163376241|NCT02233543|590086323|FG000|Period 2|Adverse Event|1|||
163376242|NCT02233543|590086324|FG001|Period 2|Adverse Event|0|||
163376243|NCT02233543|590086323|FG000|Period 2|Participant required other treatment.|0|||
163376244|NCT02233543|590086324|FG001|Period 2|Participant required other treatment.|1|||
163376245|NCT02233543|590086323|FG000|Period 2|COPD exacerbation|1|||
163376246|NCT02233543|590086324|FG001|Period 2|COPD exacerbation|0|||
163376247|NCT01302067|590086325|FG000|Overall Study|Death|0|||
163376248|NCT01302067|590086326|FG001|Overall Study|Death|0|||
163376249|NCT01302067|590086327|FG002|Overall Study|Death|1|||
163376250|NCT01302067|590086325|FG000|Overall Study|Physician Decision|9|||
163376251|NCT01302067|590086326|FG001|Overall Study|Physician Decision|5|||
163376252|NCT01302067|590086327|FG002|Overall Study|Physician Decision|14|||
163415201|NCT03891901|590227000|FG002|Overall Study|Withdrawal by Subject|0|||
163415202|NCT03891901|590227001|FG003|Overall Study|Withdrawal by Subject|0|||
163415203|NCT03891901|590227002|FG004|Overall Study|Withdrawal by Subject|0|||
163415204|NCT03891901|590227003|FG005|Overall Study|Withdrawal by Subject|0|||
163415205|NCT03891901|590227004|FG006|Overall Study|Withdrawal by Subject|0|||
163415206|NCT03891901|590227005|FG007|Overall Study|Withdrawal by Subject|0|||
163415207|NCT03891901|590227006|FG008|Overall Study|Withdrawal by Subject|0|||
163415208|NCT04949841|590227022|FG000|Overall Study|Adverse Event|7|||
163415209|NCT04949841|590227022|FG000|Overall Study|Death|1|||
163415210|NCT04949841|590227022|FG000|Overall Study|Withdrawal by Subject|52|||
163415211|NCT04949841|590227022|FG000|Overall Study|Pregnancy|4|||
163415212|NCT04949841|590227022|FG000|Overall Study|Lost to Follow-up|9|||
163415213|NCT04949841|590227022|FG000|Overall Study|Lack of Efficacy|55|||
163415214|NCT04949841|590227022|FG000|Overall Study|Various reasons|9|||
163415215|NCT04820309|590227023|FG000|Overall Study|Adverse Event|96|||
163415216|NCT04820309|590227023|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
163415217|NCT04820309|590227023|FG000|Overall Study|Consent Withdrawn|93|||
163415218|NCT04820309|590227023|FG000|Overall Study|failure to adhere to protocol|32|||
163415219|NCT04820309|590227023|FG000|Overall Study|alcohol or drug use|6|||
163415220|NCT04820309|590227023|FG000|Overall Study|Lost to Follow-up|46|||
163415221|NCT04820309|590227023|FG000|Overall Study|Death|2|||
163415222|NCT04820309|590227023|FG000|Overall Study|Pregnancy|1|||
163376253|NCT01302067|590086325|FG000|Overall Study|Lack of Efficacy|8|||
163376254|NCT01302067|590086326|FG001|Overall Study|Lack of Efficacy|4|||
163376255|NCT01302067|590086327|FG002|Overall Study|Lack of Efficacy|2|||
163376256|NCT01302067|590086325|FG000|Overall Study|Lost to Follow-up|9|||
163376257|NCT01302067|590086326|FG001|Overall Study|Lost to Follow-up|4|||
163376258|NCT01302067|590086327|FG002|Overall Study|Lost to Follow-up|15|||
163376259|NCT01302067|590086325|FG000|Overall Study|Withdrawal by Subject|13|||
163376260|NCT01302067|590086326|FG001|Overall Study|Withdrawal by Subject|6|||
163376261|NCT01302067|590086327|FG002|Overall Study|Withdrawal by Subject|10|||
163376262|NCT01302067|590086325|FG000|Overall Study|Other|1|||
163376263|NCT01302067|590086326|FG001|Overall Study|Other|1|||
163376264|NCT01302067|590086327|FG002|Overall Study|Other|3|||
163376265|NCT01302067|590086325|FG000|Overall Study|Protocol Violation|11|||
163376266|NCT01302067|590086326|FG001|Overall Study|Protocol Violation|0|||
163376267|NCT01302067|590086327|FG002|Overall Study|Protocol Violation|8|||
163376268|NCT01302067|590086325|FG000|Overall Study|Adverse Event|27|||
163376269|NCT01302067|590086326|FG001|Overall Study|Adverse Event|14|||
163376270|NCT01302067|590086327|FG002|Overall Study|Adverse Event|45|||
163376271|NCT00266227|590086330|FG000|Initial Treatment|Adverse Event|0|||
163376272|NCT00266227|590086331|FG001|Initial Treatment|Adverse Event|0|||
163376273|NCT00266227|590086332|FG002|Initial Treatment|Adverse Event|13|||
163376274|NCT00266227|590086330|FG000|Initial Treatment|Lost to Follow-up|0|||
163376275|NCT00266227|590086331|FG001|Initial Treatment|Lost to Follow-up|0|||
163376276|NCT00266227|590086332|FG002|Initial Treatment|Lost to Follow-up|6|||
163376277|NCT00266227|590086330|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
163376278|NCT00266227|590086331|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
163376279|NCT00266227|590086332|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
163376280|NCT00266227|590086330|FG000|Initial Treatment|Physician decision to withdraw|0|||
163376281|NCT00266227|590086331|FG001|Initial Treatment|Physician decision to withdraw|0|||
163376282|NCT00266227|590086332|FG002|Initial Treatment|Physician decision to withdraw|12|||
163376283|NCT00266227|590086330|FG000|Initial Treatment|Pregnancy|0|||
163376284|NCT00266227|590086331|FG001|Initial Treatment|Pregnancy|0|||
163376285|NCT00266227|590086332|FG002|Initial Treatment|Pregnancy|1|||
163376286|NCT00266227|590086330|FG000|Retreatment: Up to Week 48|Death|1|||
163376287|NCT00266227|590086331|FG001|Retreatment: Up to Week 48|Death|0|||
163376288|NCT00266227|590086332|FG002|Retreatment: Up to Week 48|Death|0|||
163376289|NCT00266227|590086330|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
163376290|NCT00266227|590086331|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
163376291|NCT00266227|590086332|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
163376292|NCT00266227|590086330|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
163376293|NCT00266227|590086331|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
163376294|NCT00266227|590086332|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
163376295|NCT00266227|590086330|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
163376296|NCT00266227|590086331|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
163376297|NCT00266227|590086332|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
163376298|NCT00266227|590086330|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
163376299|NCT00266227|590086331|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
163376300|NCT00266227|590086332|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
163415223|NCT04820309|590227023|FG000|Overall Study|Other reasons|12|||
163415224|NCT04202679|590227027|FG000|Overall Study|Adverse Event|2|||
163415225|NCT04202679|590227028|FG001|Overall Study|Adverse Event|0|||
163415226|NCT04202679|590227027|FG000|Overall Study|Poor compliance to protocol|1|||
163415227|NCT04202679|590227028|FG001|Overall Study|Poor compliance to protocol|0|||
163415228|NCT04202679|590227027|FG000|Overall Study|Withdrawal by Subject|23|||
163415229|NCT04202679|590227028|FG001|Overall Study|Withdrawal by Subject|6|||
163415230|NCT01250379|590227029|FG000|Overall Study|Death|141|||
163415231|NCT01250379|590227030|FG001|Overall Study|Death|148|||
163415232|NCT01250379|590227029|FG000|Overall Study|Withdrawal by Subject|32|||
163415233|NCT01250379|590227030|FG001|Overall Study|Withdrawal by Subject|20|||
163415234|NCT01250379|590227029|FG000|Overall Study|Physician Decision|11|||
163415235|NCT01250379|590227030|FG001|Overall Study|Physician Decision|3|||
163415236|NCT01250379|590227029|FG000|Overall Study|Protocol Violation|2|||
163415237|NCT01250379|590227030|FG001|Overall Study|Protocol Violation|8|||
163415238|NCT01250379|590227029|FG000|Overall Study|Lost to Follow-up|9|||
163415239|NCT01250379|590227030|FG001|Overall Study|Lost to Follow-up|6|||
163415240|NCT01250379|590227029|FG000|Overall Study|Adverse Event|5|||
163415241|NCT01250379|590227030|FG001|Overall Study|Adverse Event|4|||
163415242|NCT01250379|590227029|FG000|Overall Study|Other|0|||
163415243|NCT01250379|590227030|FG001|Overall Study|Other|4|||
163415244|NCT01250379|590227029|FG000|Overall Study|Participant noncompliance|2|||
163415245|NCT01250379|590227030|FG001|Overall Study|Participant noncompliance|0|||
163415246|NCT03864653|590227031|FG000|Overall Study|Withdrawal by Subject|1|||
163415247|NCT01984268|590227032|FG000|Overall Study|Study Terminated|15|||
163415248|NCT01314716|590227033|FG000|Double-Blind Phase|Randomized but not treated|1|||
163415249|NCT01314716|590227034|FG001|Double-Blind Phase|Randomized but not treated|1|||
163415250|NCT01314716|590227033|FG000|Double-Blind Phase|Adverse Event|10|||
163415251|NCT01314716|590227034|FG001|Double-Blind Phase|Adverse Event|4|||
163415252|NCT01314716|590227033|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
163376301|NCT00266227|590086330|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
163376302|NCT00266227|590086331|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
163376303|NCT00266227|590086332|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
163376304|NCT00266227|590086330|FG000|Retreatment: Week 48 to Week 72|Death|1|||
163376305|NCT00266227|590086331|FG001|Retreatment: Week 48 to Week 72|Death|1|||
163376306|NCT00266227|590086332|FG002|Retreatment: Week 48 to Week 72|Death|0|||
163376307|NCT00266227|590086330|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
163376308|NCT00266227|590086331|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
163376309|NCT00266227|590086332|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
163376310|NCT00266227|590086330|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
163376311|NCT00266227|590086331|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
163376312|NCT00266227|590086332|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
163376313|NCT00266227|590086330|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
163376314|NCT00266227|590086331|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
163376315|NCT00266227|590086332|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
163376316|NCT00266227|590086330|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
163376317|NCT00266227|590086331|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
163376318|NCT00266227|590086332|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
163376319|NCT02924428|590086333|FG000|Overall Study|Adverse Event|1|||
163376320|NCT02924428|590086334|FG001|Overall Study|Adverse Event|0|||
163376321|NCT02924428|590086333|FG000|Overall Study|Physician Decision|1|||
163376322|NCT02924428|590086334|FG001|Overall Study|Physician Decision|0|||
163376323|NCT02924428|590086333|FG000|Overall Study|Lost to Follow-up|2|||
163376324|NCT02924428|590086334|FG001|Overall Study|Lost to Follow-up|4|||
163376325|NCT02924428|590086333|FG000|Overall Study|Pregnancy|0|||
163376326|NCT02924428|590086334|FG001|Overall Study|Pregnancy|1|||
163376327|NCT02680002|590086335|FG000|Overall Study|Lost to Follow-up|5|||
163376328|NCT02680002|590086336|FG001|Overall Study|Lost to Follow-up|1|||
163376329|NCT02680002|590086337|FG002|Overall Study|Lost to Follow-up|4|||
163376330|NCT02680002|590086338|FG003|Overall Study|Lost to Follow-up|2|||
163376331|NCT02680002|590086339|FG004|Overall Study|Lost to Follow-up|0|||
163376332|NCT02680002|590086340|FG005|Overall Study|Lost to Follow-up|2|||
163376333|NCT02680002|590086335|FG000|Overall Study|Physician Decision|5|||
163376334|NCT02680002|590086336|FG001|Overall Study|Physician Decision|1|||
163376335|NCT02680002|590086337|FG002|Overall Study|Physician Decision|1|||
163376336|NCT02680002|590086338|FG003|Overall Study|Physician Decision|1|||
163376337|NCT02680002|590086339|FG004|Overall Study|Physician Decision|1|||
163376338|NCT02680002|590086340|FG005|Overall Study|Physician Decision|1|||
163376339|NCT02680002|590086335|FG000|Overall Study|Protocol Violation|1|||
163376340|NCT02680002|590086336|FG001|Overall Study|Protocol Violation|0|||
163376341|NCT02680002|590086337|FG002|Overall Study|Protocol Violation|1|||
163376342|NCT02680002|590086338|FG003|Overall Study|Protocol Violation|0|||
163376343|NCT02680002|590086339|FG004|Overall Study|Protocol Violation|1|||
163376344|NCT02680002|590086340|FG005|Overall Study|Protocol Violation|2|||
163376345|NCT02680002|590086335|FG000|Overall Study|Withdrawal by Subject|0|||
163376346|NCT02680002|590086336|FG001|Overall Study|Withdrawal by Subject|0|||
163376347|NCT02680002|590086337|FG002|Overall Study|Withdrawal by Subject|1|||
163376348|NCT02680002|590086338|FG003|Overall Study|Withdrawal by Subject|0|||
163415253|NCT01314716|590227034|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
163415254|NCT01314716|590227033|FG000|Double-Blind Phase|Lost to Follow-up|0|||
163415255|NCT01314716|590227034|FG001|Double-Blind Phase|Lost to Follow-up|1|||
163415256|NCT01314716|590227033|FG000|Double-Blind Phase|Sponsor request|1|||
163415257|NCT01314716|590227034|FG001|Double-Blind Phase|Sponsor request|2|||
163415258|NCT01314716|590227033|FG000|Double-Blind Phase|Physician Decision|0|||
163415259|NCT01314716|590227034|FG001|Double-Blind Phase|Physician Decision|1|||
163415260|NCT01314716|590227033|FG000|Open-Label Phase|Adverse Event|4|||
163415261|NCT01314716|590227034|FG001|Open-Label Phase|Adverse Event|6|||
163415262|NCT01314716|590227033|FG000|Open-Label Phase|Withdrawal by Subject|1|||
163415263|NCT01314716|590227034|FG001|Open-Label Phase|Withdrawal by Subject|2|||
163415264|NCT01314716|590227033|FG000|Open-Label Phase|Physician Decision|5|||
163415265|NCT01314716|590227034|FG001|Open-Label Phase|Physician Decision|4|||
163415266|NCT01928381|590227038|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
163415267|NCT01928381|590227039|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
163415268|NCT01928381|590227040|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
163415269|NCT01928381|590227041|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
163415270|NCT01928381|590227042|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
163415271|NCT01928381|590227043|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
163415272|NCT01928381|590227044|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
163415273|NCT01928381|590227038|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
163415274|NCT01928381|590227039|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
163415275|NCT01928381|590227040|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
163415276|NCT01928381|590227041|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
163415277|NCT01928381|590227042|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
163415278|NCT01928381|590227043|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
163415279|NCT01928381|590227044|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
163415280|NCT01928381|590227038|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
163415281|NCT01928381|590227039|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
163415282|NCT01928381|590227040|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
163415283|NCT01928381|590227041|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
163415284|NCT01928381|590227042|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
163415285|NCT01928381|590227043|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
163415286|NCT01928381|590227044|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
163415287|NCT01928381|590227038|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
163415288|NCT01928381|590227039|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
163415289|NCT01928381|590227040|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
163415290|NCT01928381|590227041|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
163415291|NCT01928381|590227042|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
163415292|NCT01928381|590227043|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
163415293|NCT01928381|590227044|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
163415294|NCT01928381|590227038|FG000|Part 1 - Pain Training|Protocol Violation|1|||
163415295|NCT01928381|590227039|FG001|Part 1 - Pain Training|Protocol Violation|0|||
163415296|NCT01928381|590227040|FG002|Part 1 - Pain Training|Protocol Violation|0|||
163415297|NCT01928381|590227041|FG003|Part 1 - Pain Training|Protocol Violation|0|||
163415298|NCT01928381|590227042|FG004|Part 1 - Pain Training|Protocol Violation|0|||
163415299|NCT01928381|590227043|FG005|Part 1 - Pain Training|Protocol Violation|0|||
163415300|NCT01928381|590227044|FG006|Part 1 - Pain Training|Protocol Violation|0|||
163415301|NCT01928381|590227038|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
163415302|NCT01928381|590227039|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
163415303|NCT01928381|590227040|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
163415304|NCT01928381|590227041|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
163415305|NCT01928381|590227042|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
163415306|NCT01928381|590227043|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
163415307|NCT01928381|590227044|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
163376349|NCT02680002|590086339|FG004|Overall Study|Withdrawal by Subject|2|||
163376350|NCT02680002|590086340|FG005|Overall Study|Withdrawal by Subject|2|||
163376351|NCT02680002|590086335|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
163376352|NCT02680002|590086336|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
163376353|NCT02680002|590086337|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
163376354|NCT02680002|590086338|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
163376355|NCT02680002|590086339|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
163376356|NCT02680002|590086340|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
163376357|NCT02680002|590086335|FG000|Overall Study|Other|0|||
163376358|NCT02680002|590086336|FG001|Overall Study|Other|1|||
163376359|NCT02680002|590086337|FG002|Overall Study|Other|0|||
163376360|NCT02680002|590086338|FG003|Overall Study|Other|0|||
163376361|NCT02680002|590086339|FG004|Overall Study|Other|1|||
163376362|NCT02680002|590086340|FG005|Overall Study|Other|0|||
163376363|NCT02680002|590086335|FG000|Overall Study|Adverse Event|0|||
163376364|NCT02680002|590086336|FG001|Overall Study|Adverse Event|0|||
163376365|NCT02680002|590086337|FG002|Overall Study|Adverse Event|0|||
163376366|NCT02680002|590086338|FG003|Overall Study|Adverse Event|0|||
163376367|NCT02680002|590086339|FG004|Overall Study|Adverse Event|1|||
163376368|NCT02680002|590086340|FG005|Overall Study|Adverse Event|2|||
163376369|NCT02480153|590086341|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
163415308|NCT01928381|590227038|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
163415309|NCT01928381|590227039|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
163415310|NCT01928381|590227040|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
163415311|NCT01928381|590227041|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
163415312|NCT01928381|590227042|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
163415313|NCT01928381|590227043|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
163415314|NCT01928381|590227044|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
163415315|NCT01928381|590227038|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
163415316|NCT01928381|590227039|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
163415317|NCT01928381|590227040|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
163415318|NCT01928381|590227041|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
163415319|NCT01928381|590227042|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
163415320|NCT01928381|590227043|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
163415321|NCT01928381|590227044|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
163415322|NCT01928381|590227038|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
163415323|NCT01928381|590227039|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
163415324|NCT01928381|590227040|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
163415325|NCT01928381|590227041|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
163415326|NCT01928381|590227042|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
163415327|NCT01928381|590227043|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
163415328|NCT01928381|590227044|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
163415329|NCT01928381|590227038|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
163415330|NCT01928381|590227039|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
163415331|NCT01928381|590227040|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
163415332|NCT01928381|590227041|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
163415333|NCT01928381|590227042|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
163415334|NCT01928381|590227043|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
163415335|NCT01928381|590227044|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
163415336|NCT01928381|590227038|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
163415337|NCT01928381|590227039|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
163415338|NCT01928381|590227040|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
163415339|NCT01928381|590227041|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
163415340|NCT01928381|590227042|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
163415341|NCT01928381|590227043|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
163415342|NCT01928381|590227044|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
163415343|NCT01928381|590227038|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
163415344|NCT01928381|590227039|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
163415345|NCT01928381|590227040|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
163415346|NCT01928381|590227041|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
163415347|NCT01928381|590227042|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
163415348|NCT01928381|590227043|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
163415349|NCT01928381|590227044|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
163415350|NCT01928381|590227038|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
163415351|NCT01928381|590227039|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
163415352|NCT01928381|590227040|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
163415353|NCT01928381|590227041|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
163415354|NCT01928381|590227042|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
163415355|NCT01928381|590227043|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
163415356|NCT01928381|590227044|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
163415357|NCT01928381|590227038|FG000|Washout First Intervention|Protocol Violation|0|||
163415358|NCT01928381|590227039|FG001|Washout First Intervention|Protocol Violation|0|||
163415359|NCT01928381|590227040|FG002|Washout First Intervention|Protocol Violation|0|||
163415360|NCT01928381|590227041|FG003|Washout First Intervention|Protocol Violation|0|||
163415361|NCT01928381|590227042|FG004|Washout First Intervention|Protocol Violation|1|||
163415362|NCT01928381|590227043|FG005|Washout First Intervention|Protocol Violation|0|||
163415363|NCT01928381|590227044|FG006|Washout First Intervention|Protocol Violation|0|||
163376370|NCT02480153|590086342|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
163376371|NCT02480153|590086343|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
163376372|NCT02480153|590086341|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
163376373|NCT02480153|590086342|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
163376374|NCT02480153|590086343|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
163376375|NCT02480153|590086341|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
163376376|NCT02480153|590086342|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
163376377|NCT02480153|590086343|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
163376378|NCT02480153|590086341|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
163376379|NCT02480153|590086342|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
163376380|NCT02480153|590086343|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
163376381|NCT02480153|590086341|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
163376382|NCT02480153|590086342|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
163376383|NCT02480153|590086343|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
163376384|NCT02480153|590086341|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
163376385|NCT02480153|590086342|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
163376386|NCT02480153|590086343|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
163376387|NCT02480153|590086341|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
163376388|NCT02480153|590086342|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
163376389|NCT02480153|590086343|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
163376390|NCT02480153|590086341|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
163376391|NCT02480153|590086342|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
163376392|NCT02480153|590086343|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
163376393|NCT02480153|590086341|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
163376394|NCT02480153|590086342|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
163376395|NCT02480153|590086343|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
163376396|NCT02480153|590086341|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
163376397|NCT02480153|590086342|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
163376398|NCT02480153|590086343|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
163376399|NCT02480153|590086341|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
163376400|NCT02480153|590086342|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
163376401|NCT02480153|590086343|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
163376402|NCT02480153|590086341|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
163376403|NCT02480153|590086342|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
163376404|NCT02480153|590086343|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
163376405|NCT02480153|590086341|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
163376406|NCT02480153|590086342|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
163376407|NCT02480153|590086343|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
163376408|NCT02480153|590086341|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
163376409|NCT02480153|590086342|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
163376410|NCT02480153|590086343|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
163376411|NCT02480153|590086341|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
163376412|NCT02480153|590086342|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
163376413|NCT02480153|590086343|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
163376414|NCT02480153|590086341|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
163376415|NCT02480153|590086342|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
163376416|NCT02480153|590086343|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
163376417|NCT02480153|590086341|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
163376418|NCT02480153|590086342|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
163376419|NCT02480153|590086343|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
163376420|NCT02480153|590086341|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
163376421|NCT02480153|590086342|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
163376422|NCT02480153|590086343|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
163376423|NCT03241225|590086345|FG000|Overall Study|Lost to Follow-up|2|||
163376424|NCT03241225|590086346|FG001|Overall Study|Lost to Follow-up|1|||
163376425|NCT03241225|590086345|FG000|Overall Study|Protocol Violation|4|||
163376426|NCT03241225|590086346|FG001|Overall Study|Protocol Violation|1|||
163376427|NCT03241225|590086345|FG000|Overall Study|Withdrawal by Subject|1|||
163376428|NCT03241225|590086346|FG001|Overall Study|Withdrawal by Subject|0|||
163376429|NCT00852540|590086349|FG000|Overall Study|Adverse Event|10|||
163376430|NCT00852540|590086350|FG001|Overall Study|Adverse Event|3|||
163376431|NCT00852540|590086349|FG000|Overall Study|Lack of Efficacy|15|||
163376432|NCT00852540|590086350|FG001|Overall Study|Lack of Efficacy|3|||
163376433|NCT00852540|590086349|FG000|Overall Study|Protocol Violation|1|||
163376434|NCT00852540|590086350|FG001|Overall Study|Protocol Violation|2|||
163376435|NCT00852540|590086349|FG000|Overall Study|Lost to Follow-up|2|||
163376436|NCT00852540|590086350|FG001|Overall Study|Lost to Follow-up|3|||
163376437|NCT00852540|590086349|FG000|Overall Study|Investigator Discretion|2|||
163376438|NCT00852540|590086350|FG001|Overall Study|Investigator Discretion|3|||
163376439|NCT00852540|590086349|FG000|Overall Study|Withdrawal by Subject|3|||
163376440|NCT00852540|590086350|FG001|Overall Study|Withdrawal by Subject|1|||
163376441|NCT00852540|590086349|FG000|Overall Study|Did Not Receive Study Drug|3|||
163376442|NCT00852540|590086350|FG001|Overall Study|Did Not Receive Study Drug|3|||
163376443|NCT02383056|590086353|FG000|Overall Study|Adverse Event|1|||
163376444|NCT02383056|590086354|FG001|Overall Study|Adverse Event|0|||
163376445|NCT02383056|590086353|FG000|Overall Study|Lost to Follow-up|0|||
163376446|NCT02383056|590086354|FG001|Overall Study|Lost to Follow-up|2|||
163376447|NCT01775475|590086358|FG000|Overall Study|Death|3|||
163376448|NCT01775475|590086359|FG001|Overall Study|Death|3|||
163415364|NCT01928381|590227038|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
163415365|NCT01928381|590227039|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
163415366|NCT01928381|590227040|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
163415367|NCT01928381|590227041|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
163415368|NCT01928381|590227042|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
163415369|NCT01928381|590227043|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
163415370|NCT01928381|590227044|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
163415371|NCT01928381|590227038|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
163415372|NCT01928381|590227039|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
163415373|NCT01928381|590227040|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
163415374|NCT01928381|590227041|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
163415375|NCT01928381|590227042|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
163415376|NCT01928381|590227043|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
163415377|NCT01928381|590227044|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
163415378|NCT02531646|590227045|FG000|Overall Study|equip. image processing issue|5|||
163415379|NCT02531646|590227046|FG001|Overall Study|equip. image processing issue|1|||
163415380|NCT02531646|590227047|FG002|Overall Study|equip. image processing issue|0|||
163415381|NCT00429585|590227048|FG000|Overall Study|Death|1|||
163415382|NCT00429585|590227049|FG001|Overall Study|Death|0|||
163415383|NCT00429585|590227048|FG000|Overall Study|Lost to Follow-up|27|||
163415384|NCT00429585|590227049|FG001|Overall Study|Lost to Follow-up|20|||
163415385|NCT00429585|590227048|FG000|Overall Study|Physician Decision|2|||
163415386|NCT00429585|590227049|FG001|Overall Study|Physician Decision|0|||
163415387|NCT01582308|590227050|FG000|Period 1|Withdrawal by Subject|0|||
163415388|NCT01582308|590227051|FG001|Period 1|Withdrawal by Subject|0|||
163415389|NCT01582308|590227052|FG002|Period 1|Withdrawal by Subject|0|||
163415390|NCT01582308|590227053|FG003|Period 1|Withdrawal by Subject|0|||
163415391|NCT01582308|590227054|FG004|Period 1|Withdrawal by Subject|0|||
163415392|NCT01582308|590227055|FG005|Period 1|Withdrawal by Subject|0|||
163415393|NCT01582308|590227056|FG006|Period 1|Withdrawal by Subject|1|||
163415394|NCT01582308|590227057|FG007|Period 1|Withdrawal by Subject|0|||
163415395|NCT01582308|590227058|FG008|Period 1|Withdrawal by Subject|0|||
163415396|NCT01582308|590227059|FG009|Period 1|Withdrawal by Subject|0|||
163415397|NCT01582308|590227050|FG000|10-day Washout Following Period 1|Physician Decision|0|||
163415398|NCT01582308|590227051|FG001|10-day Washout Following Period 1|Physician Decision|0|||
163415399|NCT01582308|590227052|FG002|10-day Washout Following Period 1|Physician Decision|0|||
163415400|NCT01582308|590227053|FG003|10-day Washout Following Period 1|Physician Decision|0|||
163415401|NCT01582308|590227054|FG004|10-day Washout Following Period 1|Physician Decision|1|||
163415402|NCT01582308|590227055|FG005|10-day Washout Following Period 1|Physician Decision|0|||
163415403|NCT01582308|590227056|FG006|10-day Washout Following Period 1|Physician Decision|0|||
163415404|NCT01582308|590227057|FG007|10-day Washout Following Period 1|Physician Decision|0|||
163415405|NCT01582308|590227058|FG008|10-day Washout Following Period 1|Physician Decision|0|||
163415406|NCT01582308|590227059|FG009|10-day Washout Following Period 1|Physician Decision|0|||
163415407|NCT01582308|590227050|FG000|Period 4|Physician Decision|1|||
163415408|NCT01582308|590227051|FG001|Period 4|Physician Decision|0|||
163415409|NCT01582308|590227052|FG002|Period 4|Physician Decision|0|||
163415410|NCT01582308|590227053|FG003|Period 4|Physician Decision|0|||
163415411|NCT01582308|590227054|FG004|Period 4|Physician Decision|0|||
163415412|NCT01582308|590227055|FG005|Period 4|Physician Decision|1|||
163415413|NCT01582308|590227056|FG006|Period 4|Physician Decision|0|||
163415414|NCT01582308|590227057|FG007|Period 4|Physician Decision|0|||
163415415|NCT01582308|590227058|FG008|Period 4|Physician Decision|0|||
163415416|NCT01582308|590227059|FG009|Period 4|Physician Decision|1|||
163415417|NCT00772668|590227065|FG000|Overall Study|Physician Decision|3|||
163415418|NCT01182428|590227066|FG000|Overall Study|Physician Decision|1|||
163415419|NCT01182428|590227067|FG001|Overall Study|Physician Decision|0|||
163415420|NCT01182428|590227066|FG000|Overall Study|Lost to Follow-up|9|||
163415421|NCT01182428|590227067|FG001|Overall Study|Lost to Follow-up|1|||
163415422|NCT01182428|590227066|FG000|Overall Study|Withdrawal by Subject|1|||
163415423|NCT01182428|590227067|FG001|Overall Study|Withdrawal by Subject|0|||
163415424|NCT03631706|590227069|FG000|Overall Study|Randomized, not treated|1|||
163415425|NCT03631706|590227070|FG001|Overall Study|Randomized, not treated|0|||
163415426|NCT01227902|590229448|FG000|Overall Study|Adverse Event|12|||
163415427|NCT01227902|590229449|FG001|Overall Study|Adverse Event|8|||
163415428|NCT01227902|590229450|FG002|Overall Study|Adverse Event|11|||
163415429|NCT01227902|590229451|FG003|Overall Study|Adverse Event|4|||
163415430|NCT01227902|590229448|FG000|Overall Study|Lack of Efficacy|1|||
163415431|NCT01227902|590229449|FG001|Overall Study|Lack of Efficacy|2|||
163415432|NCT01227902|590229450|FG002|Overall Study|Lack of Efficacy|2|||
163415433|NCT01227902|590229451|FG003|Overall Study|Lack of Efficacy|1|||
163415434|NCT01227902|590229448|FG000|Overall Study|Protocol Violation|1|||
163415435|NCT01227902|590229449|FG001|Overall Study|Protocol Violation|0|||
163415436|NCT01227902|590229450|FG002|Overall Study|Protocol Violation|0|||
163415437|NCT01227902|590229451|FG003|Overall Study|Protocol Violation|0|||
163415438|NCT01227902|590229448|FG000|Overall Study|Lost to Follow-up|0|||
163376449|NCT02074553|590086367|FG000|Intervention Period 1|Family Emergency|0|||
163376450|NCT02074553|590086368|FG001|Intervention Period 1|Family Emergency|0|||
163376451|NCT02074553|590086369|FG002|Intervention Period 1|Family Emergency|0|||
163376452|NCT02074553|590086370|FG003|Intervention Period 1|Family Emergency|1|||
163376453|NCT02074553|590086371|FG004|Intervention Period 1|Family Emergency|0|||
163376454|NCT02074553|590086372|FG005|Intervention Period 1|Family Emergency|0|||
163376455|NCT02074553|590086373|FG006|Intervention Period 1|Family Emergency|0|||
163376456|NCT02074553|590086374|FG007|Intervention Period 1|Family Emergency|0|||
163376457|NCT02074553|590086367|FG000|Washout Period 1|Adverse Event|1|||
163376458|NCT02074553|590086368|FG001|Washout Period 1|Adverse Event|0|||
163376459|NCT02074553|590086369|FG002|Washout Period 1|Adverse Event|0|||
163376460|NCT02074553|590086370|FG003|Washout Period 1|Adverse Event|0|||
163376461|NCT02074553|590086371|FG004|Washout Period 1|Adverse Event|0|||
163376462|NCT02074553|590086372|FG005|Washout Period 1|Adverse Event|0|||
163376463|NCT02074553|590086373|FG006|Washout Period 1|Adverse Event|0|||
163376464|NCT02074553|590086374|FG007|Washout Period 1|Adverse Event|0|||
163376465|NCT02074553|590086367|FG000|Washout Period 1|Physician Decision|0|||
163376466|NCT02074553|590086368|FG001|Washout Period 1|Physician Decision|0|||
163376467|NCT02074553|590086369|FG002|Washout Period 1|Physician Decision|0|||
163376468|NCT02074553|590086370|FG003|Washout Period 1|Physician Decision|1|||
163376469|NCT02074553|590086371|FG004|Washout Period 1|Physician Decision|0|||
163376470|NCT02074553|590086372|FG005|Washout Period 1|Physician Decision|0|||
163376471|NCT02074553|590086373|FG006|Washout Period 1|Physician Decision|0|||
163376472|NCT02074553|590086374|FG007|Washout Period 1|Physician Decision|0|||
163376473|NCT02074553|590086367|FG000|Washout Period 1|Other|0|||
163376474|NCT02074553|590086368|FG001|Washout Period 1|Other|0|||
163376475|NCT02074553|590086369|FG002|Washout Period 1|Other|0|||
163376476|NCT02074553|590086370|FG003|Washout Period 1|Other|0|||
163376477|NCT02074553|590086371|FG004|Washout Period 1|Other|0|||
163376478|NCT02074553|590086372|FG005|Washout Period 1|Other|1|||
163376479|NCT02074553|590086373|FG006|Washout Period 1|Other|0|||
163376480|NCT02074553|590086374|FG007|Washout Period 1|Other|0|||
163376481|NCT02074553|590086367|FG000|Washout Period 2|Adverse Event|0|||
163376482|NCT02074553|590086368|FG001|Washout Period 2|Adverse Event|0|||
163376483|NCT02074553|590086369|FG002|Washout Period 2|Adverse Event|0|||
163376484|NCT02074553|590086370|FG003|Washout Period 2|Adverse Event|0|||
163376485|NCT02074553|590086371|FG004|Washout Period 2|Adverse Event|0|||
163376486|NCT02074553|590086372|FG005|Washout Period 2|Adverse Event|0|||
163376487|NCT02074553|590086373|FG006|Washout Period 2|Adverse Event|1|||
163376488|NCT02074553|590086374|FG007|Washout Period 2|Adverse Event|0|||
163376489|NCT02074553|590086367|FG000|Washout Period 2|Physician Decision|0|||
163376490|NCT02074553|590086368|FG001|Washout Period 2|Physician Decision|0|||
163376491|NCT02074553|590086369|FG002|Washout Period 2|Physician Decision|0|||
163376492|NCT02074553|590086370|FG003|Washout Period 2|Physician Decision|0|||
163376493|NCT02074553|590086371|FG004|Washout Period 2|Physician Decision|0|||
163376494|NCT02074553|590086372|FG005|Washout Period 2|Physician Decision|1|||
163376495|NCT02074553|590086373|FG006|Washout Period 2|Physician Decision|0|||
163376496|NCT02074553|590086374|FG007|Washout Period 2|Physician Decision|0|||
163376497|NCT02074553|590086367|FG000|Washout Period 2|Lost to Follow-up|0|||
163376498|NCT02074553|590086368|FG001|Washout Period 2|Lost to Follow-up|0|||
163376499|NCT02074553|590086369|FG002|Washout Period 2|Lost to Follow-up|1|||
163376500|NCT02074553|590086370|FG003|Washout Period 2|Lost to Follow-up|0|||
163376501|NCT02074553|590086371|FG004|Washout Period 2|Lost to Follow-up|0|||
163376502|NCT02074553|590086372|FG005|Washout Period 2|Lost to Follow-up|0|||
163376503|NCT02074553|590086373|FG006|Washout Period 2|Lost to Follow-up|0|||
163376504|NCT02074553|590086374|FG007|Washout Period 2|Lost to Follow-up|0|||
163376505|NCT02074553|590086367|FG000|Washout Period 3|Physician Decision|0|||
163376506|NCT02074553|590086368|FG001|Washout Period 3|Physician Decision|0|||
163376507|NCT02074553|590086369|FG002|Washout Period 3|Physician Decision|0|||
163376508|NCT02074553|590086370|FG003|Washout Period 3|Physician Decision|0|||
163376509|NCT02074553|590086371|FG004|Washout Period 3|Physician Decision|0|||
163376510|NCT02074553|590086372|FG005|Washout Period 3|Physician Decision|0|||
163376511|NCT02074553|590086373|FG006|Washout Period 3|Physician Decision|0|||
163376512|NCT02074553|590086374|FG007|Washout Period 3|Physician Decision|1|||
163376513|NCT02342743|590086375|FG000|Baseline Period|Withdrawal by Subject|3|||
163376514|NCT02342743|590086375|FG000|Baseline Period|Lost to Follow-up|2|||
163376515|NCT02342743|590086375|FG000|Baseline Period|Change in prophylactic medication|3|||
163376516|NCT02342743|590086375|FG000|Baseline Period|Screening failure regarding baseline|7|||
163376517|NCT02342743|590086375|FG000|Treatment Period|Withdrawal by Subject|2|||
163376518|NCT02342743|590086375|FG000|Treatment Period|Lost to Follow-up|8|||
163376519|NCT02342743|590086375|FG000|Treatment Period|Change in prophylactic medication|1|||
163376520|NCT00686725|590086376|FG000|Overall Study|Adverse Event|1|||
163376521|NCT00686725|590086377|FG001|Overall Study|Adverse Event|1|||
163376522|NCT00686725|590086376|FG000|Overall Study|Progressive Disease|17|||
163376523|NCT00686725|590086377|FG001|Overall Study|Progressive Disease|23|||
163376524|NCT00686725|590086376|FG000|Overall Study|Lost to Follow-up|7|||
163376525|NCT00686725|590086377|FG001|Overall Study|Lost to Follow-up|5|||
163376526|NCT00686725|590086376|FG000|Overall Study|Death|6|||
163415439|NCT01227902|590229449|FG001|Overall Study|Lost to Follow-up|0|||
163415440|NCT01227902|590229450|FG002|Overall Study|Lost to Follow-up|1|||
163415441|NCT01227902|590229451|FG003|Overall Study|Lost to Follow-up|2|||
163415442|NCT01227902|590229448|FG000|Overall Study|Physician Decision|0|||
163415443|NCT01227902|590229449|FG001|Overall Study|Physician Decision|1|||
163415444|NCT01227902|590229450|FG002|Overall Study|Physician Decision|1|||
163415445|NCT01227902|590229451|FG003|Overall Study|Physician Decision|0|||
163415446|NCT01227902|590229448|FG000|Overall Study|Withdrawal by Subject|4|||
163415447|NCT01227902|590229449|FG001|Overall Study|Withdrawal by Subject|2|||
163415448|NCT01227902|590229450|FG002|Overall Study|Withdrawal by Subject|4|||
163415449|NCT01227902|590229451|FG003|Overall Study|Withdrawal by Subject|3|||
163415450|NCT02554929|590229452|FG000|Overall Study|Lost to Follow-up|4|||
163415451|NCT02554929|590229453|FG001|Overall Study|Lost to Follow-up|4|||
163415452|NCT02554929|590229452|FG000|Overall Study|Withdrawal by Subject|2|||
163415453|NCT02554929|590229453|FG001|Overall Study|Withdrawal by Subject|8|||
163415454|NCT00388947|590229454|FG000|Overall Study|Protocol Violation|47|||
163415455|NCT04660643|590229455|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
163415456|NCT04660643|590229456|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
163415457|NCT04660643|590229457|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
163415458|NCT04660643|590229455|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
163415459|NCT04660643|590229456|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
163415460|NCT04660643|590229457|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
163415461|NCT04660643|590229455|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
163415462|NCT04660643|590229456|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
163415463|NCT04660643|590229457|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
163415464|NCT04660643|590229455|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
163415465|NCT04660643|590229456|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
163415466|NCT04660643|590229457|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
163415467|NCT04660643|590229455|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
163415468|NCT04660643|590229456|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
163415469|NCT04660643|590229457|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
163415470|NCT04660643|590229455|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
163415471|NCT04660643|590229456|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
163415472|NCT04660643|590229457|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
163415473|NCT04660643|590229455|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
163415474|NCT04660643|590229456|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
163415475|NCT04660643|590229457|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
163415476|NCT04660643|590229455|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
163415477|NCT04660643|590229456|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
163415478|NCT04660643|590229457|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
163415479|NCT04660643|590229455|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
163415480|NCT04660643|590229456|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
163415481|NCT04660643|590229457|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
163415482|NCT04660643|590229455|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
163415483|NCT04660643|590229456|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
163415484|NCT04660643|590229457|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
163415485|NCT04660643|590229455|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
163415486|NCT04660643|590229456|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
163415487|NCT04660643|590229457|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
163415488|NCT04660643|590229455|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
163415489|NCT04660643|590229456|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
163415490|NCT04660643|590229457|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
163415491|NCT04660643|590229455|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
163415492|NCT04660643|590229456|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
163415493|NCT04660643|590229457|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
163415494|NCT04660643|590229455|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
163415495|NCT04660643|590229456|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
163415496|NCT04660643|590229457|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
163415497|NCT04660643|590229455|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
163415498|NCT04660643|590229456|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
163415499|NCT04660643|590229457|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
163415500|NCT04660643|590229455|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
163415501|NCT04660643|590229456|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
163415502|NCT04660643|590229457|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
163415503|NCT05162066|590229461|FG000|Overall Study|Adverse Event|1|||
163415504|NCT05162066|590229462|FG001|Overall Study|Adverse Event|0|||
163415505|NCT05162066|590229463|FG002|Overall Study|Adverse Event|0|||
163376527|NCT00686725|590086377|FG001|Overall Study|Death|3|||
163376528|NCT00686725|590086376|FG000|Overall Study|Withdrawal by Subject|13|||
163376529|NCT00686725|590086377|FG001|Overall Study|Withdrawal by Subject|4|||
163376530|NCT00686725|590086376|FG000|Overall Study|Protocol Violation|1|||
163376531|NCT00686725|590086377|FG001|Overall Study|Protocol Violation|3|||
163376532|NCT00686725|590086376|FG000|Overall Study|Other|1|||
163376533|NCT00686725|590086377|FG001|Overall Study|Other|3|||
163376534|NCT04875676|590086378|FG000|Overall Study|Lost to Follow-up|1|||
163376535|NCT04875676|590086379|FG001|Overall Study|Lost to Follow-up|0|||
163376536|NCT04875676|590086380|FG002|Overall Study|Lost to Follow-up|0|||
163376537|NCT03064035|590086381|FG000|Overall Study|Did not receive allocated intervention|4|||
163376538|NCT03064035|590086382|FG001|Overall Study|Did not receive allocated intervention|2|||
163376539|NCT03064035|590086381|FG000|Overall Study|Lost to Follow-up|1|||
163376540|NCT03064035|590086382|FG001|Overall Study|Lost to Follow-up|1|||
163376541|NCT03602066|590086383|FG000|Overall Study|Withdrawal by Subject|2|||
163376542|NCT03602066|590086384|FG001|Overall Study|Withdrawal by Subject|0|||
163376543|NCT03602066|590086383|FG000|Overall Study|Physician Decision|1|||
163376544|NCT03602066|590086384|FG001|Overall Study|Physician Decision|0|||
163376545|NCT00092495|590086385|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
163376546|NCT00092495|590086386|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
163376547|NCT00092495|590086387|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
163376548|NCT00092495|590086388|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
163376549|NCT00092495|590086389|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
163376550|NCT00092495|590086385|FG000|Base Study Vaccination Period|Extended|0|||
163376551|NCT00092495|590086386|FG001|Base Study Vaccination Period|Extended|0|||
163376552|NCT00092495|590086387|FG002|Base Study Vaccination Period|Extended|0|||
163376553|NCT00092495|590086388|FG003|Base Study Vaccination Period|Extended|1|||
163376554|NCT00092495|590086389|FG004|Base Study Vaccination Period|Extended|0|||
163376555|NCT00092495|590086385|FG000|Base Study Vaccination Period|*Clinical AE|1|||
163376556|NCT00092495|590086386|FG001|Base Study Vaccination Period|*Clinical AE|0|||
163376557|NCT00092495|590086387|FG002|Base Study Vaccination Period|*Clinical AE|1|||
163376558|NCT00092495|590086388|FG003|Base Study Vaccination Period|*Clinical AE|2|||
163376559|NCT00092495|590086389|FG004|Base Study Vaccination Period|*Clinical AE|0|||
163376560|NCT00092495|590086385|FG000|Base Study Vaccination Period|*Other reasons|1|||
163376561|NCT00092495|590086386|FG001|Base Study Vaccination Period|*Other reasons|0|||
163376562|NCT00092495|590086387|FG002|Base Study Vaccination Period|*Other reasons|0|||
163376563|NCT00092495|590086388|FG003|Base Study Vaccination Period|*Other reasons|1|||
163376564|NCT00092495|590086389|FG004|Base Study Vaccination Period|*Other reasons|0|||
163376565|NCT00092495|590086385|FG000|Base Study Vaccination Period|*Pregnancy|0|||
163376566|NCT00092495|590086386|FG001|Base Study Vaccination Period|*Pregnancy|2|||
163376567|NCT00092495|590086387|FG002|Base Study Vaccination Period|*Pregnancy|5|||
163376568|NCT00092495|590086388|FG003|Base Study Vaccination Period|*Pregnancy|7|||
163376569|NCT00092495|590086389|FG004|Base Study Vaccination Period|*Pregnancy|0|||
163376570|NCT00092495|590086385|FG000|Base Study Vaccination Period|Adverse Event|1|||
163376571|NCT00092495|590086386|FG001|Base Study Vaccination Period|Adverse Event|0|||
163376572|NCT00092495|590086387|FG002|Base Study Vaccination Period|Adverse Event|0|||
163376573|NCT00092495|590086388|FG003|Base Study Vaccination Period|Adverse Event|3|||
163376574|NCT00092495|590086389|FG004|Base Study Vaccination Period|Adverse Event|0|||
163376575|NCT00092495|590086385|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
163376576|NCT00092495|590086386|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
163376577|NCT00092495|590086387|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
163376578|NCT00092495|590086388|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
163376579|NCT00092495|590086389|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
163376580|NCT00092495|590086385|FG000|Base Study Vaccination Period|Moved|3|||
163376581|NCT00092495|590086386|FG001|Base Study Vaccination Period|Moved|1|||
163376582|NCT00092495|590086387|FG002|Base Study Vaccination Period|Moved|2|||
163376583|NCT00092495|590086388|FG003|Base Study Vaccination Period|Moved|2|||
163376584|NCT00092495|590086389|FG004|Base Study Vaccination Period|Moved|0|||
163376585|NCT00092495|590086385|FG000|Base Study Vaccination Period|Other|1|||
163376586|NCT00092495|590086386|FG001|Base Study Vaccination Period|Other|1|||
163376587|NCT00092495|590086387|FG002|Base Study Vaccination Period|Other|0|||
163376588|NCT00092495|590086388|FG003|Base Study Vaccination Period|Other|2|||
163376589|NCT00092495|590086389|FG004|Base Study Vaccination Period|Other|0|||
163376590|NCT00092495|590086385|FG000|Base Study Vaccination Period|Pregnancy|2|||
163376591|NCT00092495|590086386|FG001|Base Study Vaccination Period|Pregnancy|0|||
163376592|NCT00092495|590086387|FG002|Base Study Vaccination Period|Pregnancy|0|||
163376593|NCT00092495|590086388|FG003|Base Study Vaccination Period|Pregnancy|0|||
163376594|NCT00092495|590086389|FG004|Base Study Vaccination Period|Pregnancy|0|||
163376595|NCT00092495|590086385|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
163376596|NCT00092495|590086386|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
163376597|NCT00092495|590086387|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
163376598|NCT00092495|590086388|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
163376599|NCT00092495|590086389|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
163415506|NCT05162066|590229461|FG000|Overall Study|Perceived lack of efficacy|1|||
163415507|NCT05162066|590229462|FG001|Overall Study|Perceived lack of efficacy|0|||
163415508|NCT05162066|590229463|FG002|Overall Study|Perceived lack of efficacy|0|||
163415509|NCT01220414|590229464|FG000|Overall Study|Withdrawal by Subject|1|||
163415510|NCT01220414|590229465|FG001|Overall Study|Withdrawal by Subject|0|||
163415511|NCT01220414|590229466|FG002|Overall Study|Withdrawal by Subject|0|||
163415512|NCT01220414|590229467|FG003|Overall Study|Withdrawal by Subject|1|||
163415513|NCT00669617|590229470|FG000|Period 1|Withdrawal by Subject|0|||
163415514|NCT00669617|590229471|FG001|Period 1|Withdrawal by Subject|0|||
163415515|NCT00669617|590229472|FG002|Period 1|Withdrawal by Subject|1|||
163415516|NCT00669617|590229473|FG003|Period 1|Withdrawal by Subject|0|||
163415517|NCT00669617|590229474|FG004|Period 1|Withdrawal by Subject|0|||
163415518|NCT00669617|590229470|FG000|Period 1|Protocol Deviation|0|||
163415519|NCT00669617|590229471|FG001|Period 1|Protocol Deviation|0|||
163415520|NCT00669617|590229472|FG002|Period 1|Protocol Deviation|0|||
163415521|NCT00669617|590229473|FG003|Period 1|Protocol Deviation|0|||
163415522|NCT00669617|590229474|FG004|Period 1|Protocol Deviation|1|||
163415523|NCT00669617|590229470|FG000|Period 3|Lost to Follow-up|1|||
163415524|NCT00669617|590229471|FG001|Period 3|Lost to Follow-up|0|||
163415525|NCT00669617|590229472|FG002|Period 3|Lost to Follow-up|0|||
163415526|NCT00669617|590229473|FG003|Period 3|Lost to Follow-up|0|||
163415527|NCT00669617|590229474|FG004|Period 3|Lost to Follow-up|0|||
163415528|NCT00623831|590229475|FG000|Overall Study|Withdrawal by Subject|1|||
163415529|NCT00623831|590229476|FG001|Overall Study|Withdrawal by Subject|0|||
163415530|NCT00623831|590229475|FG000|Overall Study|Progressive Disease|0|||
163415531|NCT00623831|590229476|FG001|Overall Study|Progressive Disease|1|||
163415532|NCT01276821|590229477|FG000|Overall Study|Protocol Violation|0|||
163415533|NCT01276821|590229478|FG001|Overall Study|Protocol Violation|1|||
163415534|NCT00066690|590229479|FG000|Overall Study|Adverse Event|145|||
163415535|NCT00066690|590229480|FG001|Overall Study|Adverse Event|58|||
163415536|NCT00066690|590229481|FG002|Overall Study|Adverse Event|126|||
163415537|NCT00066690|590229479|FG000|Overall Study|Death|3|||
163415538|NCT00066690|590229480|FG001|Overall Study|Death|0|||
163415539|NCT00066690|590229481|FG002|Overall Study|Death|2|||
163415540|NCT00066690|590229479|FG000|Overall Study|Lack of Efficacy|114|||
163415541|NCT00066690|590229480|FG001|Overall Study|Lack of Efficacy|110|||
163415542|NCT00066690|590229481|FG002|Overall Study|Lack of Efficacy|76|||
163415543|NCT00066690|590229479|FG000|Overall Study|Lost to Follow-up|40|||
163415544|NCT00066690|590229480|FG001|Overall Study|Lost to Follow-up|21|||
163415545|NCT00066690|590229481|FG002|Overall Study|Lost to Follow-up|29|||
163376600|NCT00092495|590086385|FG000|Base Study Vaccination Period|Protocol Violation|1|||
163376601|NCT00092495|590086386|FG001|Base Study Vaccination Period|Protocol Violation|0|||
163376602|NCT00092495|590086387|FG002|Base Study Vaccination Period|Protocol Violation|0|||
163376603|NCT00092495|590086388|FG003|Base Study Vaccination Period|Protocol Violation|0|||
163376604|NCT00092495|590086389|FG004|Base Study Vaccination Period|Protocol Violation|0|||
163376605|NCT00092495|590086385|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
163376606|NCT00092495|590086386|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
163376607|NCT00092495|590086387|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
163376608|NCT00092495|590086388|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
163376609|NCT00092495|590086389|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
163376610|NCT00092495|590086385|FG000|Base Study Follow-up Period|Extended|0|||
163376611|NCT00092495|590086386|FG001|Base Study Follow-up Period|Extended|0|||
163376612|NCT00092495|590086387|FG002|Base Study Follow-up Period|Extended|1|||
163376613|NCT00092495|590086388|FG003|Base Study Follow-up Period|Extended|2|||
163376614|NCT00092495|590086389|FG004|Base Study Follow-up Period|Extended|0|||
163376615|NCT00092495|590086385|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
163376616|NCT00092495|590086386|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
163376617|NCT00092495|590086387|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
163376618|NCT00092495|590086388|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
163376619|NCT00092495|590086389|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
163376620|NCT00092495|590086385|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
163376621|NCT00092495|590086386|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
163376622|NCT00092495|590086387|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
163376623|NCT00092495|590086388|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
163376624|NCT00092495|590086389|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
163376625|NCT03103763|590086392|FG000|Overall Study|Death|15|||
163376626|NCT03103763|590086393|FG001|Overall Study|Death|5|||
163376627|NCT03103763|590086394|FG002|Overall Study|Death|5|||
163415546|NCT00066690|590229479|FG000|Overall Study|Withdrawal by Subject|50|||
163415547|NCT00066690|590229480|FG001|Overall Study|Withdrawal by Subject|55|||
163415548|NCT00066690|590229481|FG002|Overall Study|Withdrawal by Subject|49|||
163415549|NCT00066690|590229479|FG000|Overall Study|Treatment Ongoing|246|||
163415550|NCT00066690|590229480|FG001|Overall Study|Treatment Ongoing|278|||
163415551|NCT00066690|590229481|FG002|Overall Study|Treatment Ongoing|282|||
163415552|NCT00223496|590229482|FG000|Overall Study|screen failure|9|||
163415553|NCT00223496|590229482|FG000|Overall Study|Lost to Follow-up|4|||
163415554|NCT00223496|590229482|FG000|Overall Study|Lack of Efficacy|6|||
163415555|NCT00223496|590229482|FG000|Overall Study|Withdrawal by Subject|1|||
163415556|NCT00223496|590229482|FG000|Overall Study|Physician Decision|2|||
163376628|NCT03103763|590086392|FG000|Overall Study|Withdrawal by Subject|0|||
163376629|NCT03103763|590086393|FG001|Overall Study|Withdrawal by Subject|3|||
163376630|NCT03103763|590086394|FG002|Overall Study|Withdrawal by Subject|2|||
163376631|NCT00938470|590086395|FG000|Overall Study|Disease Progression|3|||
163376632|NCT00938470|590086396|FG001|Overall Study|Disease Progression|0|||
163376633|NCT00938470|590086395|FG000|Overall Study|Alternate Treatment|1|||
163376634|NCT00938470|590086396|FG001|Overall Study|Alternate Treatment|0|||
163376635|NCT00938470|590086395|FG000|Overall Study|Death|3|||
163376636|NCT00938470|590086396|FG001|Overall Study|Death|2|||
163376637|NCT00938470|590086395|FG000|Overall Study|Other Reason|0|||
163376638|NCT00938470|590086396|FG001|Overall Study|Other Reason|1|||
163376639|NCT02336178|590086397|FG000|Overall Study|Lost to Follow-up|1|||
163376640|NCT02336178|590086397|FG000|Overall Study|Protocol Violation|1|||
163376641|NCT02336178|590086397|FG000|Overall Study|Withdrawal by Subject|1|||
163376642|NCT02336178|590086397|FG000|Overall Study|Other|1|||
163376643|NCT03245151|590086398|FG000|Overall Study|Withdrawal by Subject|2|||
163376644|NCT03245151|590086399|FG001|Overall Study|Withdrawal by Subject|0|||
163376645|NCT03245151|590086400|FG002|Overall Study|Withdrawal by Subject|0|||
163376646|NCT03245151|590086401|FG003|Overall Study|Withdrawal by Subject|2|||
163376647|NCT03245151|590086402|FG004|Overall Study|Withdrawal by Subject|1|||
163376648|NCT03245151|590086398|FG000|Overall Study|Death|3|||
163376649|NCT03245151|590086399|FG001|Overall Study|Death|14|||
163376650|NCT03245151|590086400|FG002|Overall Study|Death|9|||
163376651|NCT03245151|590086401|FG003|Overall Study|Death|16|||
163376652|NCT03245151|590086402|FG004|Overall Study|Death|7|||
163376653|NCT03245151|590086398|FG000|Overall Study|Sponsor's decision|0|||
163376654|NCT03245151|590086399|FG001|Overall Study|Sponsor's decision|1|||
163376655|NCT03245151|590086400|FG002|Overall Study|Sponsor's decision|0|||
163376656|NCT03245151|590086401|FG003|Overall Study|Sponsor's decision|0|||
163376657|NCT03245151|590086402|FG004|Overall Study|Sponsor's decision|0|||
163376658|NCT01970345|590086403|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
163376659|NCT01970345|590086404|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
163376660|NCT01970345|590086403|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
163376661|NCT01970345|590086404|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
163376662|NCT01346475|590086405|FG000|First Intervention|Lost to Follow-up|4|||
163376663|NCT01346475|590086406|FG001|First Intervention|Lost to Follow-up|3|||
163376664|NCT01552603|590086407|FG000|Overall Study|Physician Decision|1|||
163376665|NCT00618618|590086408|FG000|Overall Study|Patient Request|0|||
163376666|NCT00618618|590086409|FG001|Overall Study|Patient Request|0|||
163376667|NCT00618618|590086410|FG002|Overall Study|Patient Request|2|||
163376668|NCT00618618|590086411|FG003|Overall Study|Patient Request|0|||
163376669|NCT00618618|590086408|FG000|Overall Study|Inability to Complete Study Procedures|0|||
163376670|NCT00618618|590086409|FG001|Overall Study|Inability to Complete Study Procedures|1|||
163376671|NCT00618618|590086410|FG002|Overall Study|Inability to Complete Study Procedures|0|||
163376672|NCT00618618|590086411|FG003|Overall Study|Inability to Complete Study Procedures|0|||
163376673|NCT00618618|590086408|FG000|Overall Study|Lost to Follow-up|3|||
163376674|NCT00618618|590086409|FG001|Overall Study|Lost to Follow-up|0|||
163376675|NCT00618618|590086410|FG002|Overall Study|Lost to Follow-up|0|||
163376676|NCT00618618|590086411|FG003|Overall Study|Lost to Follow-up|1|||
163376677|NCT00618618|590086408|FG000|Overall Study|Non-compliance|1|||
163376678|NCT00618618|590086409|FG001|Overall Study|Non-compliance|1|||
163376679|NCT00618618|590086410|FG002|Overall Study|Non-compliance|0|||
163376680|NCT00618618|590086411|FG003|Overall Study|Non-compliance|0|||
163376681|NCT00618618|590086408|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
163376682|NCT00618618|590086409|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
163376683|NCT00618618|590086410|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
163376684|NCT00618618|590086411|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
163376685|NCT00618618|590086408|FG000|Overall Study|Death|0|||
163376686|NCT00618618|590086409|FG001|Overall Study|Death|1|||
163376687|NCT00618618|590086410|FG002|Overall Study|Death|0|||
163376688|NCT00618618|590086411|FG003|Overall Study|Death|0|||
163376689|NCT00621777|590086415|FG000|Open Phase|Adverse Event|20|||
163376690|NCT00621777|590086416|FG001|Open Phase|Adverse Event|0|||
163376691|NCT00621777|590086415|FG000|Open Phase|Did not abstain during open phase|56|||
163376692|NCT00621777|590086416|FG001|Open Phase|Did not abstain during open phase|0|||
163376693|NCT00621777|590086415|FG000|Open Phase|Withdrawal by Subject|17|||
163376694|NCT00621777|590086416|FG001|Open Phase|Withdrawal by Subject|0|||
163376695|NCT00621777|590086415|FG000|Open Phase|administrative|13|||
163376696|NCT00621777|590086416|FG001|Open Phase|administrative|0|||
163376697|NCT00621777|590086415|FG000|Open Phase|Lost to Follow-up|10|||
163376698|NCT00621777|590086416|FG001|Open Phase|Lost to Follow-up|0|||
163376699|NCT00621777|590086415|FG000|Randomized Phase|Adverse Event|3|||
163376700|NCT00621777|590086416|FG001|Randomized Phase|Adverse Event|3|||
163376701|NCT00621777|590086415|FG000|Randomized Phase|Lost to Follow-up|3|||
163376702|NCT00621777|590086416|FG001|Randomized Phase|Lost to Follow-up|3|||
163376703|NCT00621777|590086415|FG000|Randomized Phase|Withdrawal by Subject|1|||
163415557|NCT02939131|590229485|FG000|Overall Study|Unable to get to clinic|6|||
163415558|NCT02939131|590229486|FG001|Overall Study|Unable to get to clinic|4|||
163415559|NCT02939131|590229485|FG000|Overall Study|Lost to Follow-up|2|||
163415560|NCT02939131|590229486|FG001|Overall Study|Lost to Follow-up|4|||
163415561|NCT02939131|590229485|FG000|Overall Study|severe debilitation|1|||
163415562|NCT02939131|590229486|FG001|Overall Study|severe debilitation|0|||
163415563|NCT02939131|590229485|FG000|Overall Study|Other|0|||
163415564|NCT02939131|590229486|FG001|Overall Study|Other|1|||
163415565|NCT02939131|590229485|FG000|Overall Study|not willing to adhere to protocol|2|||
163415566|NCT02939131|590229486|FG001|Overall Study|not willing to adhere to protocol|0|||
163415567|NCT03569202|590229487|FG000|Part 3|Physician Decision|1|||
163415568|NCT03569202|590229488|FG001|Part 3|Physician Decision|0|||
163415569|NCT03569202|590229487|FG000|Part 3|Other|1|||
163415570|NCT03569202|590229488|FG001|Part 3|Other|1|||
163415571|NCT00323557|590229489|FG000|Overall Study|Physician Decision|1|||
163415572|NCT00323557|590229490|FG001|Overall Study|Physician Decision|0|||
163415573|NCT00684515|590229491|FG000|Overall Study|Adverse Event|3|||
163415574|NCT00684515|590229492|FG001|Overall Study|Adverse Event|3|||
163415575|NCT00684515|590229493|FG002|Overall Study|Adverse Event|1|||
163415576|NCT00684515|590229491|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
163415577|NCT00684515|590229492|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
163415578|NCT00684515|590229493|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
163415579|NCT02450578|590229494|FG000|Overall Study|ECG abnormality so not treated|1|||
163415580|NCT02450578|590229495|FG001|Overall Study|ECG abnormality so not treated|0|||
163376704|NCT00621777|590086416|FG001|Randomized Phase|Withdrawal by Subject|9|||
163376705|NCT00621777|590086415|FG000|Randomized Phase|administrative|0|||
163376706|NCT00621777|590086416|FG001|Randomized Phase|administrative|3|||
163376707|NCT00621777|590086415|FG000|Randomized Phase|Death|0|||
163376708|NCT00621777|590086416|FG001|Randomized Phase|Death|1|||
163376709|NCT01236365|590086417|FG000|Overall Study|Lost to Follow-up|0|||
163376710|NCT01236365|590086418|FG001|Overall Study|Lost to Follow-up|2|||
163376711|NCT01236365|590086417|FG000|Overall Study|Moved Out of State|1|||
163376712|NCT01236365|590086418|FG001|Overall Study|Moved Out of State|0|||
163376713|NCT01236365|590086417|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
163376714|NCT01236365|590086418|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
163376715|NCT00558259|590086421|FG000|Overall Study|Adverse Event|50|||
163376716|NCT00558259|590086422|FG001|Overall Study|Adverse Event|81|||
163376717|NCT00558259|590086421|FG000|Overall Study|Protocol Violation|9|||
163376718|NCT00558259|590086422|FG001|Overall Study|Protocol Violation|5|||
163376719|NCT00558259|590086421|FG000|Overall Study|Withdrawal by Subject|12|||
163376720|NCT00558259|590086422|FG001|Overall Study|Withdrawal by Subject|13|||
163376721|NCT00700258|590086429|FG000|Overall Study|Premature discontinuation of documentation|136|||
163376722|NCT00700258|590086429|FG000|Overall Study|Type of study end not documented|1|||
163376723|NCT00700258|590086429|FG000|Overall Study|Lost to Follow-up|81|||
163376724|NCT00700258|590086429|FG000|Overall Study|Premature discontinuation of therapy|1013|||
163376725|NCT00473265|590086430|FG000|Overall Study|Unrelated adverse event|5|||
163376726|NCT00473265|590086430|FG000|Overall Study|Off treatment early|15|||
163376727|NCT02663518|590086433|FG000|Part 1: Phase 1a Escalation|Death|0|||
163376728|NCT02663518|590086434|FG001|Part 1: Phase 1a Escalation|Death|0|||
163376729|NCT02663518|590086435|FG002|Part 1: Phase 1a Escalation|Death|1|||
163376730|NCT02663518|590086436|FG003|Part 1: Phase 1a Escalation|Death|0|||
163376731|NCT02663518|590086437|FG004|Part 1: Phase 1a Escalation|Death|0|||
163376732|NCT02663518|590086438|FG005|Part 1: Phase 1a Escalation|Death|0|||
163376733|NCT02663518|590086439|FG006|Part 1: Phase 1a Escalation|Death|0|||
163376734|NCT02663518|590086440|FG007|Part 1: Phase 1a Escalation|Death|0|||
163376735|NCT02663518|590086441|FG008|Part 1: Phase 1a Escalation|Death|0|||
163376736|NCT02663518|590086442|FG009|Part 1: Phase 1a Escalation|Death|0|||
163376737|NCT02663518|590086443|FG010|Part 1: Phase 1a Escalation|Death|0|||
163376738|NCT02663518|590086444|FG011|Part 1: Phase 1a Escalation|Death|0|||
163376739|NCT02663518|590086445|FG012|Part 1: Phase 1a Escalation|Death|0|||
163376740|NCT02663518|590086446|FG013|Part 1: Phase 1a Escalation|Death|0|||
163376741|NCT02663518|590086433|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163376742|NCT02663518|590086434|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163376743|NCT02663518|590086435|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
163376744|NCT02663518|590086436|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163376745|NCT02663518|590086437|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163376746|NCT02663518|590086438|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163376747|NCT02663518|590086439|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163376748|NCT02663518|590086440|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163376749|NCT02663518|590086441|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163376750|NCT02663518|590086442|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163376751|NCT02663518|590086443|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163415581|NCT02450578|590229496|FG002|Overall Study|ECG abnormality so not treated|0|||
163415582|NCT02450578|590229497|FG003|Overall Study|ECG abnormality so not treated|0|||
163415583|NCT02167945|590229499|FG000|Overall Study|Adverse Event|16|||
163415584|NCT02167945|590229499|FG000|Overall Study|Withdrew Consent|42|||
163415585|NCT02167945|590229499|FG000|Overall Study|Lost to Follow-up|122|||
163415586|NCT02167945|590229499|FG000|Overall Study|COVID-19 logistical restrictions|6|||
163376752|NCT02663518|590086444|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163376753|NCT02663518|590086445|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163376754|NCT02663518|590086446|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163376755|NCT02663518|590086433|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
163376756|NCT02663518|590086434|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
163376757|NCT02663518|590086435|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
163376758|NCT02663518|590086436|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
163376759|NCT02663518|590086437|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163376760|NCT02663518|590086438|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163376761|NCT02663518|590086439|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163376762|NCT02663518|590086440|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163376763|NCT02663518|590086441|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163376764|NCT02663518|590086442|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163376765|NCT02663518|590086443|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163376766|NCT02663518|590086444|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163376767|NCT02663518|590086445|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163376768|NCT02663518|590086446|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163376769|NCT02663518|590086433|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
163376770|NCT02663518|590086434|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163376771|NCT02663518|590086435|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
163376772|NCT02663518|590086436|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
163376773|NCT02663518|590086437|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163376774|NCT02663518|590086438|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163376775|NCT02663518|590086439|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163376776|NCT02663518|590086440|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163376777|NCT02663518|590086441|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163376778|NCT02663518|590086442|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163376779|NCT02663518|590086443|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163376780|NCT02663518|590086444|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163376781|NCT02663518|590086445|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163376782|NCT02663518|590086446|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163376783|NCT02663518|590086433|FG000|Part 1: Phase 1a Escalation|Other|0|||
163376784|NCT02663518|590086434|FG001|Part 1: Phase 1a Escalation|Other|0|||
163376785|NCT02663518|590086435|FG002|Part 1: Phase 1a Escalation|Other|2|||
163376786|NCT02663518|590086436|FG003|Part 1: Phase 1a Escalation|Other|0|||
163376787|NCT02663518|590086437|FG004|Part 1: Phase 1a Escalation|Other|0|||
163376788|NCT02663518|590086438|FG005|Part 1: Phase 1a Escalation|Other|0|||
163376789|NCT02663518|590086439|FG006|Part 1: Phase 1a Escalation|Other|0|||
163376790|NCT02663518|590086440|FG007|Part 1: Phase 1a Escalation|Other|0|||
163376791|NCT02663518|590086441|FG008|Part 1: Phase 1a Escalation|Other|0|||
163376792|NCT02663518|590086442|FG009|Part 1: Phase 1a Escalation|Other|0|||
163376793|NCT02663518|590086443|FG010|Part 1: Phase 1a Escalation|Other|0|||
163376794|NCT02663518|590086444|FG011|Part 1: Phase 1a Escalation|Other|0|||
163376795|NCT02663518|590086445|FG012|Part 1: Phase 1a Escalation|Other|0|||
163376796|NCT02663518|590086446|FG013|Part 1: Phase 1a Escalation|Other|0|||
163376797|NCT02663518|590086433|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
163376798|NCT02663518|590086434|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
163376799|NCT02663518|590086435|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
163376800|NCT02663518|590086436|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
163376801|NCT02663518|590086437|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
163376802|NCT02663518|590086438|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
163376803|NCT02663518|590086439|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
163376804|NCT02663518|590086440|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
163376805|NCT02663518|590086441|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
163376806|NCT02663518|590086442|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
163376807|NCT02663518|590086443|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
163376808|NCT02663518|590086444|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
163376809|NCT02663518|590086445|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
163376810|NCT02663518|590086446|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
163376811|NCT02663518|590086433|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163376812|NCT02663518|590086434|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163376813|NCT02663518|590086435|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163376814|NCT02663518|590086436|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163376815|NCT02663518|590086437|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
163376816|NCT02663518|590086438|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163376817|NCT02663518|590086439|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
163376818|NCT02663518|590086440|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
163376819|NCT02663518|590086441|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163376820|NCT02663518|590086442|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163376821|NCT02663518|590086443|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163376822|NCT02663518|590086444|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163376823|NCT02663518|590086445|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163376824|NCT02663518|590086446|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163376825|NCT02663518|590086433|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163376826|NCT02663518|590086434|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163376827|NCT02663518|590086435|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163376828|NCT02663518|590086436|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163376829|NCT02663518|590086437|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
163376830|NCT02663518|590086438|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163376831|NCT02663518|590086439|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163376832|NCT02663518|590086440|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163376833|NCT02663518|590086441|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163376834|NCT02663518|590086442|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163376835|NCT02663518|590086443|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163376836|NCT02663518|590086444|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163376837|NCT02663518|590086445|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163376838|NCT02663518|590086446|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163376839|NCT02663518|590086433|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163376840|NCT02663518|590086434|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163376841|NCT02663518|590086435|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163376842|NCT02663518|590086436|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163376843|NCT02663518|590086437|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
163376844|NCT02663518|590086438|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
163376845|NCT02663518|590086439|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
163376846|NCT02663518|590086440|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
163376847|NCT02663518|590086441|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163376848|NCT02663518|590086442|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163376849|NCT02663518|590086443|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163376850|NCT02663518|590086444|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163376851|NCT02663518|590086445|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163376852|NCT02663518|590086446|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163376853|NCT02663518|590086433|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
163376854|NCT02663518|590086434|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
163376855|NCT02663518|590086435|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
163376856|NCT02663518|590086436|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
163376857|NCT02663518|590086437|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
163376858|NCT02663518|590086438|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
163376859|NCT02663518|590086439|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
163376860|NCT02663518|590086440|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
163376861|NCT02663518|590086441|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
163376862|NCT02663518|590086442|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
163376863|NCT02663518|590086443|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
163376864|NCT02663518|590086444|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
163376865|NCT02663518|590086445|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
163376866|NCT02663518|590086446|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
163376867|NCT02663518|590086433|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163376868|NCT02663518|590086434|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163376869|NCT02663518|590086435|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163376870|NCT02663518|590086436|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163376871|NCT02663518|590086437|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163376872|NCT02663518|590086438|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163376873|NCT02663518|590086439|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
163376874|NCT02663518|590086440|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163376875|NCT02663518|590086441|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163376876|NCT02663518|590086442|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163376877|NCT02663518|590086443|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163376878|NCT02663518|590086444|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163376879|NCT02663518|590086445|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163376880|NCT02663518|590086446|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163376881|NCT02663518|590086433|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
163376882|NCT02663518|590086434|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
163376883|NCT02663518|590086435|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
163376884|NCT02663518|590086436|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
163376885|NCT02663518|590086437|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
163376886|NCT02663518|590086438|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
163376887|NCT02663518|590086439|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
163376888|NCT02663518|590086440|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
163376889|NCT02663518|590086441|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
163376890|NCT02663518|590086442|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
163376891|NCT02663518|590086443|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
163376892|NCT02663518|590086444|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
163376893|NCT02663518|590086445|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
163376894|NCT02663518|590086446|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
163376895|NCT02663518|590086433|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163376896|NCT02663518|590086434|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163376897|NCT02663518|590086435|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163376898|NCT02663518|590086436|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163376899|NCT02663518|590086437|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163376900|NCT02663518|590086438|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163376901|NCT02663518|590086439|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163376902|NCT02663518|590086440|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163376903|NCT02663518|590086441|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163376904|NCT02663518|590086442|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163376905|NCT02663518|590086443|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163376906|NCT02663518|590086444|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163376907|NCT02663518|590086445|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
163376908|NCT02663518|590086446|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163376909|NCT02663518|590086433|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163376910|NCT02663518|590086434|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163376911|NCT02663518|590086435|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163376912|NCT02663518|590086436|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163376913|NCT02663518|590086437|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163376914|NCT02663518|590086438|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163376915|NCT02663518|590086439|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163376916|NCT02663518|590086440|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163376917|NCT02663518|590086441|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163376918|NCT02663518|590086442|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163376919|NCT02663518|590086443|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163376920|NCT02663518|590086444|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
163376921|NCT02663518|590086445|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163376922|NCT02663518|590086446|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163376923|NCT02663518|590086433|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163376924|NCT02663518|590086434|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163376925|NCT02663518|590086435|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163376926|NCT02663518|590086436|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163376927|NCT02663518|590086437|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163376928|NCT02663518|590086438|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163376929|NCT02663518|590086439|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163376930|NCT02663518|590086440|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163376931|NCT02663518|590086441|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163376932|NCT02663518|590086442|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
163376933|NCT02663518|590086443|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163376934|NCT02663518|590086444|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
163376935|NCT02663518|590086445|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
163376936|NCT02663518|590086446|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
163376937|NCT02663518|590086433|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
163376938|NCT02663518|590086434|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
163376939|NCT02663518|590086435|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
163376940|NCT02663518|590086436|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
163376941|NCT02663518|590086437|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
163376942|NCT02663518|590086438|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
163376943|NCT02663518|590086439|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
163376944|NCT02663518|590086440|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
163376945|NCT02663518|590086441|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
163376946|NCT02663518|590086442|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
163376947|NCT02663518|590086443|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
163376948|NCT02663518|590086444|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
163376949|NCT02663518|590086445|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
163376950|NCT02663518|590086446|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
163376951|NCT02663518|590086433|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163376952|NCT02663518|590086434|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163376953|NCT02663518|590086435|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163376954|NCT02663518|590086436|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163376955|NCT02663518|590086437|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163376956|NCT02663518|590086438|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163415587|NCT02167945|590229499|FG000|Overall Study|Other, not specified|63|||
163415588|NCT00132730|590229500|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
163415589|NCT00132730|590229501|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
163415590|NCT00132730|590229502|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
163415591|NCT00132730|590229503|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
163415592|NCT00132730|590229504|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
163415593|NCT00132730|590229505|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
163415594|NCT00132730|590229500|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
163415595|NCT00132730|590229501|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
163415596|NCT00132730|590229502|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
163415597|NCT00132730|590229503|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
163415598|NCT00132730|590229504|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
163415599|NCT00132730|590229505|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
163415600|NCT00132730|590229500|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
163415601|NCT00132730|590229501|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
163415602|NCT00132730|590229502|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
163415603|NCT00132730|590229503|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
163415604|NCT00132730|590229504|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
163415605|NCT00132730|590229505|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
163415606|NCT00132730|590229500|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
163415607|NCT00132730|590229501|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
163415608|NCT00132730|590229502|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
163415609|NCT00132730|590229503|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
163415610|NCT00132730|590229504|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
163415611|NCT00132730|590229505|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
163415612|NCT00132730|590229500|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
163415613|NCT00132730|590229501|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
163415614|NCT00132730|590229502|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
163415615|NCT00132730|590229503|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
163415616|NCT00132730|590229504|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
163415617|NCT00132730|590229505|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
163415618|NCT00132730|590229500|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
163415619|NCT00132730|590229501|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
163415620|NCT00132730|590229502|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
163415621|NCT00132730|590229503|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
163415622|NCT00132730|590229504|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
163415623|NCT00132730|590229505|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
163415624|NCT00132730|590229500|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
163415625|NCT00132730|590229501|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
163415626|NCT00132730|590229502|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
163415627|NCT00132730|590229503|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
163415628|NCT00132730|590229504|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
163415629|NCT00132730|590229505|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
163415630|NCT00132730|590229500|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
163415631|NCT00132730|590229501|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
163415632|NCT00132730|590229502|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
163415633|NCT00132730|590229503|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
163415634|NCT00132730|590229504|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
163415635|NCT00132730|590229505|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
163415636|NCT00132730|590229500|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
163415637|NCT00132730|590229501|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
163415638|NCT00132730|590229502|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
163415639|NCT00132730|590229503|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
163415640|NCT00132730|590229504|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
163415641|NCT00132730|590229505|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
163415642|NCT00132730|590229500|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
163415643|NCT00132730|590229501|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
163415644|NCT00132730|590229502|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
163415645|NCT00132730|590229503|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
163415646|NCT00132730|590229504|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
163415647|NCT00132730|590229505|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
163415648|NCT00132730|590229500|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
163376957|NCT02663518|590086439|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163415649|NCT00132730|590229501|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
163415650|NCT00132730|590229502|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
163415651|NCT00132730|590229503|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
163415652|NCT00132730|590229504|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
163415653|NCT00132730|590229505|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
163415654|NCT00132730|590229500|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
163415655|NCT00132730|590229501|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
163415656|NCT00132730|590229502|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
163415657|NCT00132730|590229503|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
163415658|NCT00132730|590229504|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
163415659|NCT00132730|590229505|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
163415660|NCT00094757|590229506|FG000|Overall Study|Adverse Event|11|||
163415661|NCT00094757|590229507|FG001|Overall Study|Adverse Event|9|||
163415662|NCT00094757|590229508|FG002|Overall Study|Adverse Event|6|||
163415663|NCT00094757|590229506|FG000|Overall Study|Lack of Efficacy|11|||
163415664|NCT00094757|590229507|FG001|Overall Study|Lack of Efficacy|15|||
163415665|NCT00094757|590229508|FG002|Overall Study|Lack of Efficacy|8|||
163415666|NCT00094757|590229506|FG000|Overall Study|Lost to Follow-up|3|||
163376958|NCT02663518|590086440|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163376959|NCT02663518|590086441|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163376960|NCT02663518|590086442|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163376961|NCT02663518|590086443|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163376962|NCT02663518|590086444|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163376963|NCT02663518|590086445|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
163376964|NCT02663518|590086446|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163376965|NCT00006011|590086450|FG000|Overall Study|Disease progression|13|||
163376966|NCT00006011|590086451|FG001|Overall Study|Disease progression|6|||
163376967|NCT00006011|590086452|FG002|Overall Study|Disease progression|26|||
163376968|NCT00006011|590086450|FG000|Overall Study|Refused further treatment|15|||
163376969|NCT00006011|590086451|FG001|Overall Study|Refused further treatment|13|||
163376970|NCT00006011|590086452|FG002|Overall Study|Refused further treatment|26|||
163376971|NCT00006011|590086450|FG000|Overall Study|Adverse Event|15|||
163376972|NCT00006011|590086451|FG001|Overall Study|Adverse Event|39|||
163376973|NCT00006011|590086452|FG002|Overall Study|Adverse Event|5|||
163376974|NCT00006011|590086450|FG000|Overall Study|Death|0|||
163376975|NCT00006011|590086451|FG001|Overall Study|Death|1|||
163376976|NCT00006011|590086452|FG002|Overall Study|Death|2|||
163376977|NCT00006011|590086450|FG000|Overall Study|Other|4|||
163376978|NCT00006011|590086451|FG001|Overall Study|Other|2|||
163376979|NCT00006011|590086452|FG002|Overall Study|Other|5|||
163376980|NCT00006011|590086450|FG000|Overall Study|Ineligible|18|||
163376981|NCT00006011|590086451|FG001|Overall Study|Ineligible|16|||
163376982|NCT00006011|590086452|FG002|Overall Study|Ineligible|9|||
163376983|NCT01004848|590086453|FG000|Overall Study|Lost to Follow-up|55|||
163376984|NCT01004848|590086454|FG001|Overall Study|Lost to Follow-up|45|||
163376985|NCT01236534|590086460|FG000|Overall Study|Adverse Event|3|||
163376986|NCT01236534|590086461|FG001|Overall Study|Adverse Event|0|||
163376987|NCT01844687|590086462|FG000|Visit 1|Protocol Violation|3|||
163376988|NCT01844687|590086462|FG000|Visit 1|Lost to Follow-up|5|||
163376989|NCT01844687|590086462|FG000|Visit 2|Withdrawal by Subject|1|||
163376990|NCT01844687|590086462|FG000|Visit 2|Protocol Violation|1|||
163376991|NCT01844687|590086462|FG000|Visit 3|Lost to Follow-up|1|||
163376992|NCT01844687|590086462|FG000|Visit 3|Withdrawal by Subject|3|||
163376993|NCT01844687|590086462|FG000|Visit 3|child care problems|1|||
163376994|NCT01844687|590086462|FG000|Visit 4|Pregnancy|1|||
163376995|NCT01844687|590086462|FG000|Visit 4|Lost to Follow-up|1|||
163376996|NCT01844687|590086462|FG000|Visit 4|Withdrawal by Subject|2|||
163376997|NCT03215810|590086467|FG000|Overall Study|Still responding to nivolumab|1|||
163376998|NCT03215810|590086467|FG000|Overall Study|Insufficient TIL growth|1|||
163376999|NCT03215810|590086467|FG000|Overall Study|Decline in performance status|1|||
163377000|NCT03215810|590086467|FG000|Overall Study|Withdrawal by Subject|1|||
163415667|NCT00094757|590229507|FG001|Overall Study|Lost to Follow-up|5|||
163415668|NCT00094757|590229508|FG002|Overall Study|Lost to Follow-up|6|||
163377001|NCT01773291|590088085|FG000|Overall Study|Protocol Violation|1|||
163377002|NCT01773291|590088086|FG001|Overall Study|Protocol Violation|0|||
163377003|NCT01773291|590088087|FG002|Overall Study|Protocol Violation|0|||
163377004|NCT01773291|590088085|FG000|Overall Study|Withdrawal by Subject|0|||
163377005|NCT01773291|590088086|FG001|Overall Study|Withdrawal by Subject|0|||
163377006|NCT01773291|590088087|FG002|Overall Study|Withdrawal by Subject|1|||
163377007|NCT00203476|590088088|FG000|Overall Study|Lost to Follow-up|1|||
163377008|NCT00203476|590088089|FG001|Overall Study|Lost to Follow-up|0|||
163377009|NCT00203476|590088090|FG002|Overall Study|Lost to Follow-up|0|||
163377010|NCT00203476|590088088|FG000|Overall Study|Withdrawal by Subject|0|||
163377011|NCT00203476|590088089|FG001|Overall Study|Withdrawal by Subject|1|||
163377012|NCT00203476|590088090|FG002|Overall Study|Withdrawal by Subject|0|||
163377013|NCT03310268|590088091|FG000|Overall Study|(Not specified)|1|||
163377014|NCT03310268|590088092|FG001|Overall Study|(Not specified)|5|||
163377015|NCT03310268|590088093|FG002|Overall Study|(Not specified)|0|||
163377016|NCT04797650|590088094|FG000|Overall Study|Reason Not Specified|5|||
163377017|NCT04797650|590088095|FG001|Overall Study|Reason Not Specified|12|||
163377018|NCT04797650|590088096|FG002|Overall Study|Reason Not Specified|5|||
163377019|NCT04797650|590088094|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
163377020|NCT04797650|590088095|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
163377021|NCT04797650|590088096|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
163377022|NCT04797650|590088094|FG000|Overall Study|Lack of Efficacy|1|||
163377023|NCT04797650|590088095|FG001|Overall Study|Lack of Efficacy|0|||
163377024|NCT04797650|590088096|FG002|Overall Study|Lack of Efficacy|1|||
163377025|NCT04797650|590088094|FG000|Overall Study|Non-compliance with Study Drug|0|||
163377026|NCT04797650|590088095|FG001|Overall Study|Non-compliance with Study Drug|0|||
163377027|NCT04797650|590088096|FG002|Overall Study|Non-compliance with Study Drug|2|||
163377028|NCT04797650|590088094|FG000|Overall Study|Lost to Follow-up|4|||
163377029|NCT04797650|590088095|FG001|Overall Study|Lost to Follow-up|6|||
163377030|NCT04797650|590088096|FG002|Overall Study|Lost to Follow-up|1|||
163377031|NCT04772898|590088099|FG000|Overall Study|Withdrawal by Subject|0|||
163377032|NCT04772898|590088100|FG001|Overall Study|Withdrawal by Subject|1|||
163377033|NCT00309959|590088102|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
163377034|NCT02937454|590088103|FG000|Overall Study|Adverse Event|0|||
163377035|NCT02937454|590088104|FG001|Overall Study|Adverse Event|1|||
163377036|NCT02937454|590088103|FG000|Overall Study|Death|98|||
163377037|NCT02937454|590088104|FG001|Overall Study|Death|95|||
163377038|NCT02937454|590088103|FG000|Overall Study|Lost to Follow-up|1|||
163377039|NCT02937454|590088104|FG001|Overall Study|Lost to Follow-up|1|||
163377040|NCT02937454|590088103|FG000|Overall Study|Physician Decision|0|||
163377041|NCT02937454|590088104|FG001|Overall Study|Physician Decision|1|||
163377042|NCT02937454|590088103|FG000|Overall Study|Protocol Violation|6|||
163377043|NCT02937454|590088104|FG001|Overall Study|Protocol Violation|10|||
163377044|NCT02937454|590088103|FG000|Overall Study|Withdrawal by Subject|27|||
163377045|NCT02937454|590088104|FG001|Overall Study|Withdrawal by Subject|15|||
163377046|NCT02937454|590088103|FG000|Overall Study|Other|8|||
163377047|NCT02937454|590088104|FG001|Overall Study|Other|5|||
163377048|NCT01253304|590088105|FG000|Overall Study|Adverse Event|0|||
163377049|NCT01253304|590088106|FG001|Overall Study|Adverse Event|0|||
163377050|NCT01253304|590088107|FG002|Overall Study|Adverse Event|0|||
163377051|NCT01253304|590088108|FG003|Overall Study|Adverse Event|1|||
163377052|NCT01888900|590088116|FG000|Overall Study|failed treatment|0|||
163377053|NCT01888900|590088117|FG001|Overall Study|failed treatment|2|||
163377054|NCT01160289|590088118|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
163377055|NCT01160289|590088119|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
163377056|NCT01160289|590088120|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
163377057|NCT01160289|590088121|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
163377058|NCT01160289|590088122|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
163377059|NCT01160289|590088123|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
163377060|NCT01160289|590088118|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
163377061|NCT01160289|590088119|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
163377062|NCT01160289|590088120|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
163377063|NCT01160289|590088121|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
163377064|NCT01160289|590088122|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
163377065|NCT01160289|590088123|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
163377066|NCT01160289|590088118|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
163377067|NCT01160289|590088119|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
163377068|NCT01160289|590088120|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
163377069|NCT01160289|590088121|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
163377070|NCT01160289|590088122|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
163377071|NCT01160289|590088123|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
163377072|NCT01160289|590088118|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
163377073|NCT01160289|590088119|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
163377074|NCT01160289|590088120|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
163377075|NCT01160289|590088121|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
163377076|NCT01160289|590088122|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
163377077|NCT01160289|590088123|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
163377078|NCT01160289|590088118|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
163377079|NCT01160289|590088119|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
163377080|NCT01160289|590088120|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
163377081|NCT01160289|590088121|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
163377082|NCT01160289|590088122|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
163377083|NCT01160289|590088123|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
163415669|NCT00094757|590229506|FG000|Overall Study|Patient Moved|2|||
163377084|NCT01160289|590088118|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
163377085|NCT01160289|590088119|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
163377086|NCT01160289|590088120|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
163377087|NCT01160289|590088121|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
163377088|NCT01160289|590088122|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
163377089|NCT01160289|590088123|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
163377090|NCT01160289|590088118|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
163377091|NCT01160289|590088119|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
163377092|NCT01160289|590088120|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
163377093|NCT01160289|590088121|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
163377094|NCT01160289|590088122|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
163377095|NCT01160289|590088123|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
163377096|NCT01160289|590088118|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
163377097|NCT01160289|590088119|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
163377098|NCT01160289|590088120|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
163377099|NCT01160289|590088121|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
163377100|NCT01160289|590088122|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
163377101|NCT01160289|590088123|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
163377102|NCT01160289|590088118|FG000|Post-Randomization Period|Adverse Event|0|||
163377103|NCT01160289|590088119|FG001|Post-Randomization Period|Adverse Event|4|||
163377104|NCT01160289|590088120|FG002|Post-Randomization Period|Adverse Event|4|||
163377105|NCT01160289|590088121|FG003|Post-Randomization Period|Adverse Event|2|||
163377106|NCT01160289|590088122|FG004|Post-Randomization Period|Adverse Event|0|||
163377107|NCT01160289|590088123|FG005|Post-Randomization Period|Adverse Event|0|||
163377108|NCT01160289|590088118|FG000|Post-Randomization Period|Death|0|||
163377109|NCT01160289|590088119|FG001|Post-Randomization Period|Death|0|||
163377110|NCT01160289|590088120|FG002|Post-Randomization Period|Death|0|||
163377111|NCT01160289|590088121|FG003|Post-Randomization Period|Death|1|||
163377112|NCT01160289|590088122|FG004|Post-Randomization Period|Death|0|||
163377113|NCT01160289|590088123|FG005|Post-Randomization Period|Death|0|||
163377114|NCT01160289|590088118|FG000|Post-Randomization Period|Lack of Efficacy|0|||
163377115|NCT01160289|590088119|FG001|Post-Randomization Period|Lack of Efficacy|1|||
163377116|NCT01160289|590088120|FG002|Post-Randomization Period|Lack of Efficacy|0|||
163377117|NCT01160289|590088121|FG003|Post-Randomization Period|Lack of Efficacy|3|||
163377118|NCT01160289|590088122|FG004|Post-Randomization Period|Lack of Efficacy|0|||
163377119|NCT01160289|590088123|FG005|Post-Randomization Period|Lack of Efficacy|0|||
163377120|NCT01160289|590088118|FG000|Post-Randomization Period|Lost to Follow-up|0|||
163377121|NCT01160289|590088119|FG001|Post-Randomization Period|Lost to Follow-up|3|||
163377122|NCT01160289|590088120|FG002|Post-Randomization Period|Lost to Follow-up|2|||
163377123|NCT01160289|590088121|FG003|Post-Randomization Period|Lost to Follow-up|5|||
163377124|NCT01160289|590088122|FG004|Post-Randomization Period|Lost to Follow-up|3|||
163377125|NCT01160289|590088123|FG005|Post-Randomization Period|Lost to Follow-up|4|||
163377126|NCT01160289|590088118|FG000|Post-Randomization Period|Physician Decision|0|||
163377127|NCT01160289|590088119|FG001|Post-Randomization Period|Physician Decision|0|||
163377128|NCT01160289|590088120|FG002|Post-Randomization Period|Physician Decision|1|||
163377129|NCT01160289|590088121|FG003|Post-Randomization Period|Physician Decision|0|||
163377130|NCT01160289|590088122|FG004|Post-Randomization Period|Physician Decision|0|||
163377131|NCT01160289|590088123|FG005|Post-Randomization Period|Physician Decision|0|||
163377132|NCT01160289|590088118|FG000|Post-Randomization Period|Protocol Violation|0|||
163377133|NCT01160289|590088119|FG001|Post-Randomization Period|Protocol Violation|4|||
163377134|NCT01160289|590088120|FG002|Post-Randomization Period|Protocol Violation|2|||
163377135|NCT01160289|590088121|FG003|Post-Randomization Period|Protocol Violation|0|||
163377136|NCT01160289|590088122|FG004|Post-Randomization Period|Protocol Violation|1|||
163377137|NCT01160289|590088123|FG005|Post-Randomization Period|Protocol Violation|3|||
163377138|NCT01160289|590088118|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
163377139|NCT01160289|590088119|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
163377140|NCT01160289|590088120|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
163377141|NCT01160289|590088121|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
163377142|NCT01160289|590088122|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
163377143|NCT01160289|590088123|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
163377144|NCT01160289|590088118|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
163377145|NCT01160289|590088119|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
163377146|NCT01160289|590088120|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
163377147|NCT01160289|590088121|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
163377148|NCT01160289|590088122|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
163377149|NCT01160289|590088123|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
163377150|NCT01160289|590088118|FG000|Post-Randomization Period|Sponsor Decision|0|||
163377151|NCT01160289|590088119|FG001|Post-Randomization Period|Sponsor Decision|1|||
163377152|NCT01160289|590088120|FG002|Post-Randomization Period|Sponsor Decision|0|||
163377153|NCT01160289|590088121|FG003|Post-Randomization Period|Sponsor Decision|0|||
163377154|NCT01160289|590088122|FG004|Post-Randomization Period|Sponsor Decision|0|||
163377155|NCT01160289|590088123|FG005|Post-Randomization Period|Sponsor Decision|0|||
163377156|NCT01156792|590088128|FG000|Overall Study|Adverse Event|1|||
163377157|NCT01156792|590088128|FG000|Overall Study|Lack of Efficacy|36|||
163377158|NCT01156792|590088128|FG000|Overall Study|Protocol Violation|6|||
163377159|NCT01156792|590088128|FG000|Overall Study|Lost to Follow-up|3|||
163377160|NCT01156792|590088128|FG000|Overall Study|Physician Decision|3|||
163377161|NCT01156792|590088128|FG000|Overall Study|Withdrawal by Subject|9|||
163377162|NCT01156792|590088128|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
163377163|NCT00768079|590088129|FG000|Overall Study|Lost to Follow-up|2|||
163377164|NCT00768079|590088130|FG001|Overall Study|Lost to Follow-up|0|||
163377165|NCT00768079|590088131|FG002|Overall Study|Lost to Follow-up|4|||
163377166|NCT00768079|590088129|FG000|Overall Study|Participant incarcerated|0|||
163377167|NCT00768079|590088130|FG001|Overall Study|Participant incarcerated|1|||
163377168|NCT00768079|590088131|FG002|Overall Study|Participant incarcerated|0|||
163377169|NCT03271021|590088132|FG000|Overall Study|Adverse Event|3|||
163377170|NCT03271021|590088133|FG001|Overall Study|Adverse Event|2|||
163377171|NCT03271021|590088132|FG000|Overall Study|Withdrawal by Subject|36|||
163377172|NCT03271021|590088133|FG001|Overall Study|Withdrawal by Subject|53|||
163377173|NCT03271021|590088132|FG000|Overall Study|Lost to Follow-up|34|||
163377174|NCT03271021|590088133|FG001|Overall Study|Lost to Follow-up|39|||
163377175|NCT03271021|590088132|FG000|Overall Study|Protocol Violation|6|||
163377176|NCT03271021|590088133|FG001|Overall Study|Protocol Violation|4|||
163377177|NCT03271021|590088132|FG000|Overall Study|Abnormal Lab Results|1|||
163377178|NCT03271021|590088133|FG001|Overall Study|Abnormal Lab Results|0|||
163377179|NCT03271021|590088132|FG000|Overall Study|Miscellaneous|9|||
163377180|NCT03271021|590088133|FG001|Overall Study|Miscellaneous|8|||
163377181|NCT01474434|590088134|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
163377182|NCT01474434|590088135|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
163377183|NCT01474434|590088136|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
163377184|NCT01474434|590088137|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
163377185|NCT01474434|590088134|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
163377186|NCT01474434|590088135|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
163377187|NCT01474434|590088136|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
163377188|NCT01474434|590088137|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
163377189|NCT01474434|590088134|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
163377190|NCT01474434|590088135|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
163377191|NCT01474434|590088136|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
163377192|NCT01474434|590088137|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
163377193|NCT02207569|590088140|FG000|1-Month|Death|6|||
163377194|NCT02207569|590088140|FG000|1-Month|Withdrawal by Subject|2|||
163377195|NCT02207569|590088140|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
163377196|NCT02207569|590088140|FG000|6-Month|Death|8|||
163377197|NCT02207569|590088140|FG000|6-Month|Withdrawal by Subject|2|||
163377198|NCT02207569|590088140|FG000|12-Month|Death|14|||
163377199|NCT02207569|590088140|FG000|12-Month|Withdrawal by Subject|2|||
163377200|NCT02207569|590088140|FG000|24-Month|Death|23|||
163377201|NCT02207569|590088140|FG000|24-Month|Withdrawal by Subject|3|||
163377202|NCT02207569|590088140|FG000|36-Month|Death|23|||
163377203|NCT02207569|590088140|FG000|36-Month|Withdrawal by Subject|4|||
163377204|NCT02207569|590088140|FG000|48-Month|Death|25|||
163377205|NCT02207569|590088140|FG000|48-Month|Withdrawal by Subject|2|||
163377206|NCT02207569|590088140|FG000|48-Month|Lost to Follow-up|4|||
163377207|NCT02207569|590088140|FG000|60-Month|Death|1|||
163377208|NCT02207569|590088140|FG000|60-Month|Lost to Follow-up|1|||
163377209|NCT02207569|590088140|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
163377210|NCT02207569|590088140|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
163377211|NCT02585232|590088141|FG000|Overall Study|Lost to Follow-up|8|||
163377212|NCT02585232|590088142|FG001|Overall Study|Lost to Follow-up|8|||
163377213|NCT02585232|590088141|FG000|Overall Study|Withdrawal by Subject|4|||
163377214|NCT02585232|590088142|FG001|Overall Study|Withdrawal by Subject|8|||
163377215|NCT01157676|590088150|FG000|Randomization|Death|1|||
163377216|NCT01157676|590088151|FG001|Randomization|Death|1|||
163377217|NCT01157676|590088150|FG000|Randomization|unresectable|2|||
163377218|NCT01157676|590088151|FG001|Randomization|unresectable|3|||
163377219|NCT01157676|590088150|FG000|Randomization|Withdrawal by Subject|17|||
163377220|NCT01157676|590088151|FG001|Randomization|Withdrawal by Subject|13|||
163377221|NCT01157676|590088150|FG000|Randomization|Physician Decision|1|||
163377222|NCT01157676|590088151|FG001|Randomization|Physician Decision|0|||
163377223|NCT01157676|590088150|FG000|Surgery|underwent open cystectomy|0|||
163377224|NCT01157676|590088151|FG001|Surgery|underwent open cystectomy|4|||
163377225|NCT01157676|590088150|FG000|Surgery|converted to open procedure|0|||
163377226|NCT01157676|590088151|FG001|Surgery|converted to open procedure|5|||
163377227|NCT01157676|590088150|FG000|Surgery|underwent robotic cystectomy|1|||
163377228|NCT01157676|590088151|FG001|Surgery|underwent robotic cystectomy|0|||
163415670|NCT00094757|590229507|FG001|Overall Study|Patient Moved|1|||
163415671|NCT00094757|590229508|FG002|Overall Study|Patient Moved|1|||
163415672|NCT00094757|590229506|FG000|Overall Study|Protocol Violation|8|||
163415673|NCT00094757|590229507|FG001|Overall Study|Protocol Violation|5|||
163415674|NCT00094757|590229508|FG002|Overall Study|Protocol Violation|3|||
163415675|NCT00094757|590229506|FG000|Overall Study|Withdrawal by Subject|14|||
163415676|NCT00094757|590229507|FG001|Overall Study|Withdrawal by Subject|21|||
163415677|NCT00094757|590229508|FG002|Overall Study|Withdrawal by Subject|5|||
163415678|NCT00094757|590229506|FG000|Overall Study|Other|3|||
163415679|NCT00094757|590229507|FG001|Overall Study|Other|3|||
163415680|NCT00094757|590229508|FG002|Overall Study|Other|1|||
163415681|NCT00094757|590229506|FG000|Overall Study|Protocol specified discontinuation|1|||
163415682|NCT00094757|590229507|FG001|Overall Study|Protocol specified discontinuation|3|||
163415683|NCT00094757|590229508|FG002|Overall Study|Protocol specified discontinuation|0|||
163415684|NCT02623335|590229509|FG000|Overall Study|Death|8|||
163415685|NCT02623335|590229510|FG001|Overall Study|Death|7|||
163415686|NCT02623335|590229509|FG000|Overall Study|Lost to Follow-up|15|||
163415687|NCT02623335|590229510|FG001|Overall Study|Lost to Follow-up|23|||
163415688|NCT02623335|590229509|FG000|Overall Study|Withdrawal by Subject|2|||
163415689|NCT02623335|590229510|FG001|Overall Study|Withdrawal by Subject|5|||
163415690|NCT02623335|590229509|FG000|Overall Study|Protocol Violation|2|||
163415691|NCT02623335|590229510|FG001|Overall Study|Protocol Violation|1|||
163415692|NCT01463098|590229511|FG000|Part A (11 Days)|Participant Choice|2|||
163415693|NCT01463098|590229512|FG001|Part A (11 Days)|Participant Choice|0|||
163415694|NCT01463098|590229513|FG002|Part A (11 Days)|Participant Choice|0|||
163415695|NCT01463098|590229514|FG003|Part A (11 Days)|Participant Choice|0|||
163415696|NCT01463098|590229515|FG004|Part A (11 Days)|Participant Choice|0|||
163415697|NCT01463098|590229516|FG005|Part A (11 Days)|Participant Choice|0|||
163415698|NCT01463098|590229517|FG006|Part A (11 Days)|Participant Choice|0|||
163415699|NCT01463098|590229518|FG007|Part A (11 Days)|Participant Choice|0|||
163415700|NCT01463098|590229519|FG008|Part A (11 Days)|Participant Choice|1|||
163415701|NCT01463098|590229520|FG009|Part A (11 Days)|Participant Choice|0|||
163415702|NCT01463098|590229521|FG010|Part A (11 Days)|Participant Choice|0|||
163415703|NCT01463098|590229522|FG011|Part A (11 Days)|Participant Choice|0|||
163415704|NCT01463098|590229523|FG012|Part A (11 Days)|Participant Choice|0|||
163415705|NCT01463098|590229524|FG013|Part A (11 Days)|Participant Choice|0|||
163415706|NCT01463098|590229511|FG000|Part A (11 Days)|Lost to Follow-up|0|||
163415707|NCT01463098|590229512|FG001|Part A (11 Days)|Lost to Follow-up|0|||
163415708|NCT01463098|590229513|FG002|Part A (11 Days)|Lost to Follow-up|0|||
163415709|NCT01463098|590229514|FG003|Part A (11 Days)|Lost to Follow-up|0|||
163415710|NCT01463098|590229515|FG004|Part A (11 Days)|Lost to Follow-up|1|||
163415711|NCT01463098|590229516|FG005|Part A (11 Days)|Lost to Follow-up|0|||
163415712|NCT01463098|590229517|FG006|Part A (11 Days)|Lost to Follow-up|0|||
163415713|NCT01463098|590229518|FG007|Part A (11 Days)|Lost to Follow-up|0|||
163415714|NCT01463098|590229519|FG008|Part A (11 Days)|Lost to Follow-up|0|||
163415715|NCT01463098|590229520|FG009|Part A (11 Days)|Lost to Follow-up|0|||
163415716|NCT01463098|590229521|FG010|Part A (11 Days)|Lost to Follow-up|0|||
163415717|NCT01463098|590229522|FG011|Part A (11 Days)|Lost to Follow-up|0|||
163415718|NCT01463098|590229523|FG012|Part A (11 Days)|Lost to Follow-up|0|||
163415719|NCT01463098|590229524|FG013|Part A (11 Days)|Lost to Follow-up|0|||
163415720|NCT01463098|590229511|FG000|Part B (11 Days)|Participant Choice|0|||
163415721|NCT01463098|590229512|FG001|Part B (11 Days)|Participant Choice|0|||
163415722|NCT01463098|590229513|FG002|Part B (11 Days)|Participant Choice|0|||
163415723|NCT01463098|590229514|FG003|Part B (11 Days)|Participant Choice|0|||
163415724|NCT01463098|590229515|FG004|Part B (11 Days)|Participant Choice|0|||
163415725|NCT01463098|590229516|FG005|Part B (11 Days)|Participant Choice|0|||
163415726|NCT01463098|590229517|FG006|Part B (11 Days)|Participant Choice|0|||
163415727|NCT01463098|590229518|FG007|Part B (11 Days)|Participant Choice|0|||
163415728|NCT01463098|590229519|FG008|Part B (11 Days)|Participant Choice|0|||
163415729|NCT01463098|590229520|FG009|Part B (11 Days)|Participant Choice|0|||
163415730|NCT01463098|590229521|FG010|Part B (11 Days)|Participant Choice|0|||
163415731|NCT01463098|590229522|FG011|Part B (11 Days)|Participant Choice|1|||
163415732|NCT01463098|590229523|FG012|Part B (11 Days)|Participant Choice|0|||
163415733|NCT01463098|590229524|FG013|Part B (11 Days)|Participant Choice|0|||
163415734|NCT00395967|590229525|FG000|Treatment Period|Failed Mobilization|1|||
163415735|NCT00395967|590229525|FG000|Follow-up Period|Death|1|||
163415736|NCT00395967|590229525|FG000|Follow-up Period|Lost to Follow-up|1|||
163415737|NCT01262976|590229526|FG000|Up to Month 2|Serious Adverse Event|0|||
163415738|NCT01262976|590229527|FG001|Up to Month 2|Serious Adverse Event|0|||
163415739|NCT01262976|590229528|FG002|Up to Month 2|Serious Adverse Event|1|||
163415740|NCT01262976|590229529|FG003|Up to Month 2|Serious Adverse Event|0|||
163415741|NCT01262976|590229530|FG004|Up to Month 2|Serious Adverse Event|0|||
163415742|NCT01262976|590229531|FG005|Up to Month 2|Serious Adverse Event|0|||
163415743|NCT01262976|590229526|FG000|Up to Month 2|Withdrawal by Subject|1|||
163415744|NCT01262976|590229527|FG001|Up to Month 2|Withdrawal by Subject|0|||
163415745|NCT01262976|590229528|FG002|Up to Month 2|Withdrawal by Subject|0|||
163415746|NCT01262976|590229529|FG003|Up to Month 2|Withdrawal by Subject|0|||
163415747|NCT01262976|590229530|FG004|Up to Month 2|Withdrawal by Subject|0|||
163415748|NCT01262976|590229531|FG005|Up to Month 2|Withdrawal by Subject|0|||
163415749|NCT01262976|590229526|FG000|Up to Month 2|Migrated/moved from study area|0|||
163415750|NCT01262976|590229527|FG001|Up to Month 2|Migrated/moved from study area|1|||
163415751|NCT01262976|590229528|FG002|Up to Month 2|Migrated/moved from study area|0|||
163415752|NCT01262976|590229529|FG003|Up to Month 2|Migrated/moved from study area|0|||
163415753|NCT01262976|590229530|FG004|Up to Month 2|Migrated/moved from study area|1|||
163415754|NCT01262976|590229531|FG005|Up to Month 2|Migrated/moved from study area|1|||
163415755|NCT01262976|590229526|FG000|Up to Month 2|Lost to Follow-up|1|||
163415756|NCT01262976|590229527|FG001|Up to Month 2|Lost to Follow-up|0|||
163415757|NCT01262976|590229528|FG002|Up to Month 2|Lost to Follow-up|0|||
163415758|NCT01262976|590229529|FG003|Up to Month 2|Lost to Follow-up|1|||
163415759|NCT01262976|590229530|FG004|Up to Month 2|Lost to Follow-up|1|||
163415760|NCT01262976|590229531|FG005|Up to Month 2|Lost to Follow-up|1|||
163415761|NCT01262976|590229526|FG000|Up to Month 2|Other|1|||
163415762|NCT01262976|590229527|FG001|Up to Month 2|Other|0|||
163415763|NCT01262976|590229528|FG002|Up to Month 2|Other|0|||
163415764|NCT01262976|590229529|FG003|Up to Month 2|Other|1|||
163415765|NCT01262976|590229530|FG004|Up to Month 2|Other|0|||
163415766|NCT01262976|590229531|FG005|Up to Month 2|Other|2|||
163415767|NCT01262976|590229526|FG000|Up to Month 7|Serious Adverse Event|0|||
163415768|NCT01262976|590229527|FG001|Up to Month 7|Serious Adverse Event|0|||
163415769|NCT01262976|590229528|FG002|Up to Month 7|Serious Adverse Event|2|||
163415770|NCT01262976|590229529|FG003|Up to Month 7|Serious Adverse Event|0|||
163415771|NCT01262976|590229530|FG004|Up to Month 7|Serious Adverse Event|0|||
163415772|NCT01262976|590229531|FG005|Up to Month 7|Serious Adverse Event|0|||
163415773|NCT01262976|590229526|FG000|Up to Month 7|Withdrawal by Subject|1|||
163415774|NCT01262976|590229527|FG001|Up to Month 7|Withdrawal by Subject|0|||
163415775|NCT01262976|590229528|FG002|Up to Month 7|Withdrawal by Subject|0|||
163415776|NCT01262976|590229529|FG003|Up to Month 7|Withdrawal by Subject|0|||
163415777|NCT01262976|590229530|FG004|Up to Month 7|Withdrawal by Subject|0|||
163415778|NCT01262976|590229531|FG005|Up to Month 7|Withdrawal by Subject|0|||
163415779|NCT01262976|590229526|FG000|Up to Month 7|Migrated/moved from study area|0|||
163415780|NCT01262976|590229527|FG001|Up to Month 7|Migrated/moved from study area|0|||
163415781|NCT01262976|590229528|FG002|Up to Month 7|Migrated/moved from study area|1|||
163415782|NCT01262976|590229529|FG003|Up to Month 7|Migrated/moved from study area|3|||
163415783|NCT01262976|590229530|FG004|Up to Month 7|Migrated/moved from study area|1|||
163415784|NCT01262976|590229531|FG005|Up to Month 7|Migrated/moved from study area|1|||
163415785|NCT01262976|590229526|FG000|Up to Month 7|Lost to Follow-up|1|||
163415786|NCT01262976|590229527|FG001|Up to Month 7|Lost to Follow-up|0|||
163415787|NCT01262976|590229528|FG002|Up to Month 7|Lost to Follow-up|1|||
163415788|NCT01262976|590229529|FG003|Up to Month 7|Lost to Follow-up|3|||
163415789|NCT01262976|590229530|FG004|Up to Month 7|Lost to Follow-up|1|||
163415790|NCT01262976|590229531|FG005|Up to Month 7|Lost to Follow-up|3|||
163415791|NCT01262976|590229526|FG000|Up to Month 7|Other|3|||
163415792|NCT01262976|590229527|FG001|Up to Month 7|Other|0|||
163415793|NCT01262976|590229528|FG002|Up to Month 7|Other|2|||
163377229|NCT00682890|590088152|FG000|Overall Study|Lost to Follow-up|1|||
163377230|NCT00682890|590088153|FG001|Overall Study|Lost to Follow-up|1|||
163377231|NCT00682890|590088152|FG000|Overall Study|subject moved away|0|||
163377232|NCT00682890|590088153|FG001|Overall Study|subject moved away|1|||
163377233|NCT00682890|590088152|FG000|Overall Study|heavy menstrual bleeding|1|||
163377234|NCT00682890|590088153|FG001|Overall Study|heavy menstrual bleeding|0|||
163377235|NCT00141219|590088157|FG000|Overall Study|Protocol violations|5|||
163377236|NCT00141219|590088158|FG001|Overall Study|Protocol violations|4|||
163377237|NCT00141219|590088157|FG000|Overall Study|Adverse Event|8|||
163377238|NCT00141219|590088158|FG001|Overall Study|Adverse Event|6|||
163377239|NCT00141219|590088157|FG000|Overall Study|Lack of Efficacy|5|||
163377240|NCT00141219|590088158|FG001|Overall Study|Lack of Efficacy|4|||
163377241|NCT00141219|590088157|FG000|Overall Study|Withdrawal by Subject|6|||
163377242|NCT00141219|590088158|FG001|Overall Study|Withdrawal by Subject|2|||
163377243|NCT01577745|590088159|FG000|Overall Study|Withdrawal by Subject|0|||
163377244|NCT01577745|590088160|FG001|Overall Study|Withdrawal by Subject|1|||
163377245|NCT01577745|590088161|FG002|Overall Study|Withdrawal by Subject|0|||
163377246|NCT01577745|590088162|FG003|Overall Study|Withdrawal by Subject|3|||
163377247|NCT01577745|590088163|FG004|Overall Study|Withdrawal by Subject|2|||
163377248|NCT01577745|590088164|FG005|Overall Study|Withdrawal by Subject|0|||
163377249|NCT01577745|590088159|FG000|Overall Study|Death|3|||
163377250|NCT01577745|590088160|FG001|Overall Study|Death|2|||
163377251|NCT01577745|590088161|FG002|Overall Study|Death|2|||
163377252|NCT01577745|590088162|FG003|Overall Study|Death|1|||
163377253|NCT01577745|590088163|FG004|Overall Study|Death|1|||
163377254|NCT01577745|590088164|FG005|Overall Study|Death|3|||
163377255|NCT01577745|590088159|FG000|Overall Study|Physician Decision|0|||
163415794|NCT01262976|590229529|FG003|Up to Month 7|Other|0|||
163377256|NCT01577745|590088160|FG001|Overall Study|Physician Decision|0|||
163377257|NCT01577745|590088161|FG002|Overall Study|Physician Decision|0|||
163415795|NCT01262976|590229530|FG004|Up to Month 7|Other|0|||
163415796|NCT01262976|590229531|FG005|Up to Month 7|Other|0|||
163415797|NCT01262976|590229526|FG000|Up to Year 1|Serious Adverse Event|0|||
163415798|NCT01262976|590229527|FG001|Up to Year 1|Serious Adverse Event|0|||
163415799|NCT01262976|590229528|FG002|Up to Year 1|Serious Adverse Event|2|||
163415800|NCT01262976|590229529|FG003|Up to Year 1|Serious Adverse Event|0|||
163415801|NCT01262976|590229530|FG004|Up to Year 1|Serious Adverse Event|0|||
163415802|NCT01262976|590229531|FG005|Up to Year 1|Serious Adverse Event|0|||
163415803|NCT01262976|590229526|FG000|Up to Year 1|Withdrawal by Subject|1|||
163415804|NCT01262976|590229527|FG001|Up to Year 1|Withdrawal by Subject|0|||
163415805|NCT01262976|590229528|FG002|Up to Year 1|Withdrawal by Subject|0|||
163415806|NCT01262976|590229529|FG003|Up to Year 1|Withdrawal by Subject|0|||
163415807|NCT01262976|590229530|FG004|Up to Year 1|Withdrawal by Subject|0|||
163415808|NCT01262976|590229531|FG005|Up to Year 1|Withdrawal by Subject|0|||
163415809|NCT01262976|590229526|FG000|Up to Year 1|Migrated/moved from study area|1|||
163415810|NCT01262976|590229527|FG001|Up to Year 1|Migrated/moved from study area|0|||
163415811|NCT01262976|590229528|FG002|Up to Year 1|Migrated/moved from study area|0|||
163415812|NCT01262976|590229529|FG003|Up to Year 1|Migrated/moved from study area|3|||
163415813|NCT01262976|590229530|FG004|Up to Year 1|Migrated/moved from study area|3|||
163415814|NCT01262976|590229531|FG005|Up to Year 1|Migrated/moved from study area|2|||
163415815|NCT01262976|590229526|FG000|Up to Year 1|Lost to Follow-up|4|||
163415816|NCT01262976|590229527|FG001|Up to Year 1|Lost to Follow-up|0|||
163415817|NCT01262976|590229528|FG002|Up to Year 1|Lost to Follow-up|0|||
163415818|NCT01262976|590229529|FG003|Up to Year 1|Lost to Follow-up|1|||
163415819|NCT01262976|590229530|FG004|Up to Year 1|Lost to Follow-up|6|||
163415820|NCT01262976|590229531|FG005|Up to Year 1|Lost to Follow-up|5|||
163415821|NCT01262976|590229526|FG000|Up to Year 1|Other|3|||
163415822|NCT01262976|590229527|FG001|Up to Year 1|Other|1|||
163415823|NCT01262976|590229528|FG002|Up to Year 1|Other|0|||
163415824|NCT01262976|590229529|FG003|Up to Year 1|Other|0|||
163415825|NCT01262976|590229530|FG004|Up to Year 1|Other|2|||
163415826|NCT01262976|590229531|FG005|Up to Year 1|Other|1|||
163415827|NCT01262976|590229526|FG000|Up to Year 1|Subjects with unknown completion status|0|||
163415828|NCT01262976|590229527|FG001|Up to Year 1|Subjects with unknown completion status|0|||
163415829|NCT01262976|590229528|FG002|Up to Year 1|Subjects with unknown completion status|1|||
163415830|NCT01262976|590229529|FG003|Up to Year 1|Subjects with unknown completion status|0|||
163415831|NCT01262976|590229530|FG004|Up to Year 1|Subjects with unknown completion status|0|||
163415832|NCT01262976|590229531|FG005|Up to Year 1|Subjects with unknown completion status|1|||
163415833|NCT01262976|590229526|FG000|Up to Year 2|Serious Adverse Event|0|||
163415834|NCT01262976|590229527|FG001|Up to Year 2|Serious Adverse Event|0|||
163415835|NCT01262976|590229528|FG002|Up to Year 2|Serious Adverse Event|2|||
163415836|NCT01262976|590229529|FG003|Up to Year 2|Serious Adverse Event|0|||
163415837|NCT01262976|590229530|FG004|Up to Year 2|Serious Adverse Event|0|||
163415838|NCT01262976|590229531|FG005|Up to Year 2|Serious Adverse Event|0|||
163415839|NCT01262976|590229526|FG000|Up to Year 2|Withdrawal by Subject|1|||
163415840|NCT01262976|590229527|FG001|Up to Year 2|Withdrawal by Subject|0|||
163415841|NCT01262976|590229528|FG002|Up to Year 2|Withdrawal by Subject|0|||
163415842|NCT01262976|590229529|FG003|Up to Year 2|Withdrawal by Subject|0|||
163415843|NCT01262976|590229530|FG004|Up to Year 2|Withdrawal by Subject|0|||
163415844|NCT01262976|590229531|FG005|Up to Year 2|Withdrawal by Subject|0|||
163415845|NCT01262976|590229526|FG000|Up to Year 2|Migrated/moved from study area|0|||
163415846|NCT01262976|590229527|FG001|Up to Year 2|Migrated/moved from study area|0|||
163415847|NCT01262976|590229528|FG002|Up to Year 2|Migrated/moved from study area|0|||
163415848|NCT01262976|590229529|FG003|Up to Year 2|Migrated/moved from study area|2|||
163415849|NCT01262976|590229530|FG004|Up to Year 2|Migrated/moved from study area|1|||
163415850|NCT01262976|590229531|FG005|Up to Year 2|Migrated/moved from study area|2|||
163377258|NCT01577745|590088162|FG003|Overall Study|Physician Decision|1|||
163377259|NCT01577745|590088163|FG004|Overall Study|Physician Decision|1|||
163377260|NCT01577745|590088164|FG005|Overall Study|Physician Decision|0|||
163377261|NCT01577745|590088159|FG000|Overall Study|Lost to Follow-up|0|||
163377262|NCT01577745|590088160|FG001|Overall Study|Lost to Follow-up|0|||
163377263|NCT01577745|590088161|FG002|Overall Study|Lost to Follow-up|0|||
163377264|NCT01577745|590088162|FG003|Overall Study|Lost to Follow-up|0|||
163377265|NCT01577745|590088163|FG004|Overall Study|Lost to Follow-up|0|||
163377266|NCT01577745|590088164|FG005|Overall Study|Lost to Follow-up|1|||
163415851|NCT01262976|590229526|FG000|Up to Year 2|Lost to Follow-up|1|||
163415852|NCT01262976|590229527|FG001|Up to Year 2|Lost to Follow-up|1|||
163415853|NCT01262976|590229528|FG002|Up to Year 2|Lost to Follow-up|2|||
163415854|NCT01262976|590229529|FG003|Up to Year 2|Lost to Follow-up|2|||
163415855|NCT01262976|590229530|FG004|Up to Year 2|Lost to Follow-up|3|||
163415856|NCT01262976|590229531|FG005|Up to Year 2|Lost to Follow-up|3|||
163415857|NCT01262976|590229526|FG000|Up to Year 2|Subjects with unknown completion status|0|||
163415858|NCT01262976|590229527|FG001|Up to Year 2|Subjects with unknown completion status|0|||
163415859|NCT01262976|590229528|FG002|Up to Year 2|Subjects with unknown completion status|1|||
163377267|NCT01577745|590088159|FG000|Overall Study|Alternative Therapy|0|||
163377268|NCT01577745|590088160|FG001|Overall Study|Alternative Therapy|0|||
163377269|NCT01577745|590088161|FG002|Overall Study|Alternative Therapy|0|||
163377270|NCT01577745|590088162|FG003|Overall Study|Alternative Therapy|1|||
163377271|NCT01577745|590088163|FG004|Overall Study|Alternative Therapy|1|||
163377272|NCT01577745|590088164|FG005|Overall Study|Alternative Therapy|0|||
163377273|NCT00468559|590088166|FG000|Open-label Treatment Phase|Adverse Event|5|||
163377274|NCT00468559|590088167|FG001|Open-label Treatment Phase|Adverse Event|0|||
163377275|NCT00468559|590088168|FG002|Open-label Treatment Phase|Adverse Event|0|||
163377276|NCT00468559|590088166|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
163377277|NCT00468559|590088167|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
163377278|NCT00468559|590088168|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
163377279|NCT00468559|590088166|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
163377280|NCT00468559|590088167|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
163377281|NCT00468559|590088168|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
163377282|NCT00468559|590088166|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
163377283|NCT00468559|590088167|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
163377284|NCT00468559|590088168|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
163377285|NCT00468559|590088166|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
163377286|NCT00468559|590088167|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
163377287|NCT00468559|590088168|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
163377288|NCT02971761|590088169|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
163377289|NCT02624791|590088170|FG000|Overall Study|Withdrawal by Subject|2|||
163377290|NCT02624791|590088171|FG001|Overall Study|Withdrawal by Subject|0|||
163377291|NCT02624791|590088172|FG002|Overall Study|Withdrawal by Subject|0|||
163377292|NCT02624791|590088173|FG003|Overall Study|Withdrawal by Subject|0|||
163377293|NCT02624791|590088174|FG004|Overall Study|Withdrawal by Subject|0|||
163377294|NCT02624791|590088175|FG005|Overall Study|Withdrawal by Subject|0|||
163377295|NCT01146782|590088179|FG000|Screening Cohort|Screen Failure|187|||
163377296|NCT01146782|590088179|FG000|Screening Cohort|Lost to Follow-up|4|||
163377297|NCT01146782|590088179|FG000|Screening Cohort|Physician Decision|1|||
163377298|NCT01146782|590088179|FG000|Screening Cohort|Withdrawal by Subject|29|||
163377299|NCT01146782|590088179|FG000|Safety Cohort|Screen Failure|61|||
163377300|NCT01146782|590088179|FG000|Safety Cohort|Withdrawal by Subject|4|||
163377301|NCT01146782|590088179|FG000|Safety Cohort|Control AHI <5|4|||
163377302|NCT01146782|590088179|FG000|Safety Cohort|TST <4 hrs|14|||
163377303|NCT01146782|590088179|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
163377304|NCT01146782|590088179|FG000|Primary Endpoint Cohort|Physician Decision|1|||
163377305|NCT01605916|590088180|FG000|Overall Study|Adverse Event|1|||
163377306|NCT01605916|590088181|FG001|Overall Study|Adverse Event|0|||
163377307|NCT01605916|590088182|FG002|Overall Study|Adverse Event|0|||
163377308|NCT01605916|590088183|FG003|Overall Study|Adverse Event|1|||
163377309|NCT01605916|590088184|FG004|Overall Study|Adverse Event|0|||
163377310|NCT01605916|590088180|FG000|Overall Study|Lack of Efficacy|2|||
163377311|NCT01605916|590088181|FG001|Overall Study|Lack of Efficacy|3|||
163377312|NCT01605916|590088182|FG002|Overall Study|Lack of Efficacy|3|||
163377313|NCT01605916|590088183|FG003|Overall Study|Lack of Efficacy|5|||
163377314|NCT01605916|590088184|FG004|Overall Study|Lack of Efficacy|4|||
163377315|NCT01605916|590088180|FG000|Overall Study|Withdrawal by Subject|1|||
163377316|NCT01605916|590088181|FG001|Overall Study|Withdrawal by Subject|1|||
163377317|NCT01605916|590088182|FG002|Overall Study|Withdrawal by Subject|0|||
163377318|NCT01605916|590088183|FG003|Overall Study|Withdrawal by Subject|0|||
163377319|NCT01605916|590088184|FG004|Overall Study|Withdrawal by Subject|2|||
163377320|NCT02842151|590088187|FG000|Overall Study|Adverse Event|1|||
163377321|NCT02842151|590088187|FG000|Overall Study|Subject moved too far away|1|||
163377322|NCT00438672|590088188|FG000|Overall Study|Lost to Follow-up|7|||
163377323|NCT00438672|590088189|FG001|Overall Study|Lost to Follow-up|9|||
163377324|NCT03965351|590088192|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
163377325|NCT03965351|590088193|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
163377326|NCT03965351|590088192|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
163377327|NCT03965351|590088193|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
163377328|NCT02217501|590088200|FG000|Overall Study|Death|3|||
163377329|NCT02217501|590088201|FG001|Overall Study|Death|4|||
163377330|NCT01394978|590088202|FG000|Overall Study|Withdrawal by Subject|2|||
163377331|NCT01394978|590088203|FG001|Overall Study|Withdrawal by Subject|4|||
163377332|NCT01394978|590088202|FG000|Overall Study|Lost to Follow-up|13|||
163377333|NCT01394978|590088203|FG001|Overall Study|Lost to Follow-up|20|||
163377334|NCT01394978|590088202|FG000|Overall Study|Death|6|||
163377335|NCT01394978|590088203|FG001|Overall Study|Death|7|||
163377336|NCT02019667|590088204|FG000|First Intervention (6 Months)|Adverse Event|0|||
163377337|NCT02019667|590088205|FG001|First Intervention (6 Months)|Adverse Event|1|||
163377338|NCT02019667|590088204|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
163377339|NCT02019667|590088205|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
163377340|NCT02019667|590088204|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
163377341|NCT02019667|590088205|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
163377342|NCT02432196|590088209|FG000|Overall Study|Exit - did not receive study device|1|||
163377343|NCT02432196|590088209|FG000|Overall Study|Death|2|||
163377344|NCT02432196|590088209|FG000|Overall Study|Reoperation|3|||
163377345|NCT01942785|590088215|FG000|Overall Study|Adverse Event|2|||
163377346|NCT01942785|590088215|FG000|Overall Study|Withdrawal by Subject|1|||
163377347|NCT01942785|590088215|FG000|Overall Study|Protocol Violation|1|||
163377348|NCT05038163|590088224|FG000|Stage 1|Did not complete survey|374|||
163377349|NCT05038163|590088225|FG001|Stage 1|Did not complete survey|0|||
163377350|NCT05038163|590088226|FG002|Stage 1|Did not complete survey|0|||
163377351|NCT05038163|590088227|FG003|Stage 1|Did not complete survey|0|||
163377352|NCT05038163|590088228|FG004|Stage 1|Did not complete survey|0|||
163377353|NCT05038163|590088229|FG005|Stage 1|Did not complete survey|0|||
163377354|NCT05038163|590088224|FG000|Stage 2|Did not complete Stage 2 survey|0|||
163377355|NCT05038163|590088225|FG001|Stage 2|Did not complete Stage 2 survey|29|||
163377356|NCT05038163|590088226|FG002|Stage 2|Did not complete Stage 2 survey|30|||
163377357|NCT05038163|590088227|FG003|Stage 2|Did not complete Stage 2 survey|24|||
163377358|NCT05038163|590088228|FG004|Stage 2|Did not complete Stage 2 survey|21|||
163377359|NCT05038163|590088229|FG005|Stage 2|Did not complete Stage 2 survey|100|||
163377360|NCT01905150|590088231|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
163377361|NCT01905150|590088232|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
163377362|NCT05453201|590088233|FG000|Overall Study|Withdrawal by Subject|1|||
163377363|NCT03562975|590088234|FG000|Overall Study|Death|1|||
163377364|NCT03562975|590088234|FG000|Overall Study|Lost to Follow-up|1|||
163377365|NCT03562975|590088234|FG000|Overall Study|Withdrawal by Subject|1|||
163377366|NCT01934790|590088235|FG000|Treatment|Adverse Event|3|||
163377367|NCT01934790|590088235|FG000|Treatment|Clinical progression|6|||
163377368|NCT01934790|590088235|FG000|Treatment|Radiological progression|4|||
163377369|NCT01934790|590088235|FG000|Treatment|Withdrawal by Subject|2|||
163377370|NCT01934790|590088235|FG000|Treatment|Study drug never administered|1|||
163377371|NCT01934790|590088235|FG000|Active Follow up|Death|20|||
163377372|NCT01934790|590088235|FG000|Active Follow up|Physician Decision|2|||
163377373|NCT01934790|590088235|FG000|Active Follow up|Progressive disease|1|||
163377374|NCT01934790|590088235|FG000|Active Follow up|Other reason|1|||
163377375|NCT00552929|590088238|FG000|Overall Study|Lost to Follow-up|0|||
163377376|NCT00552929|590088239|FG001|Overall Study|Lost to Follow-up|0|||
163377377|NCT00552929|590088240|FG002|Overall Study|Lost to Follow-up|0|||
163377378|NCT00552929|590088241|FG003|Overall Study|Lost to Follow-up|0|||
163377379|NCT00552929|590088242|FG004|Overall Study|Lost to Follow-up|0|||
163377380|NCT00552929|590088243|FG005|Overall Study|Lost to Follow-up|0|||
163377381|NCT00552929|590088244|FG006|Overall Study|Lost to Follow-up|0|||
163377382|NCT00552929|590088245|FG007|Overall Study|Lost to Follow-up|0|||
163377383|NCT00552929|590088246|FG008|Overall Study|Lost to Follow-up|1|||
163377384|NCT00552929|590088247|FG009|Overall Study|Lost to Follow-up|0|||
163377385|NCT00552929|590088238|FG000|Overall Study|Not Eligible|0|||
163377386|NCT00552929|590088239|FG001|Overall Study|Not Eligible|0|||
163377387|NCT00552929|590088240|FG002|Overall Study|Not Eligible|0|||
163377388|NCT00552929|590088241|FG003|Overall Study|Not Eligible|0|||
163377389|NCT00552929|590088242|FG004|Overall Study|Not Eligible|0|||
163377390|NCT00552929|590088243|FG005|Overall Study|Not Eligible|1|||
163377391|NCT00552929|590088244|FG006|Overall Study|Not Eligible|0|||
163377392|NCT00552929|590088245|FG007|Overall Study|Not Eligible|0|||
163377393|NCT00552929|590088246|FG008|Overall Study|Not Eligible|0|||
163377394|NCT00552929|590088247|FG009|Overall Study|Not Eligible|0|||
163377395|NCT01147536|590088248|FG000|Overall Study|Administrative study close|2|||
163377396|NCT01147536|590088248|FG000|Overall Study|Death|1|||
163377397|NCT01758900|590088251|FG000|Overall Study|difficulty for further intubation|7|||
163377398|NCT01758900|590088252|FG001|Overall Study|difficulty for further intubation|8|||
163377399|NCT02631577|590088253|FG000|Overall Study|Death|1|||
163377400|NCT02631577|590088254|FG001|Overall Study|Death|7|||
163377401|NCT02631577|590088253|FG000|Overall Study|Withdrawal by Subject|0|||
163377402|NCT02631577|590088254|FG001|Overall Study|Withdrawal by Subject|3|||
163377403|NCT04577001|590088257|FG000|Overall Study|Subject became ineligible|0|||
163377404|NCT04577001|590088258|FG001|Overall Study|Subject became ineligible|1|||
163377405|NCT03647488|590089772|FG000|Overall Study|Progressive disease|10|||
163377406|NCT03647488|590089773|FG001|Overall Study|Progressive disease|0|||
163377407|NCT03647488|590089774|FG002|Overall Study|Progressive disease|0|||
163377408|NCT03647488|590089772|FG000|Overall Study|Adverse Event|5|||
163377409|NCT03647488|590089773|FG001|Overall Study|Adverse Event|0|||
163377410|NCT03647488|590089774|FG002|Overall Study|Adverse Event|0|||
163377411|NCT03647488|590089772|FG000|Overall Study|Clinical progression|2|||
163377412|NCT03647488|590089773|FG001|Overall Study|Clinical progression|0|||
163377413|NCT03647488|590089774|FG002|Overall Study|Clinical progression|0|||
163377414|NCT03647488|590089772|FG000|Overall Study|Participant refused to take investigational product|1|||
163377415|NCT03647488|590089773|FG001|Overall Study|Participant refused to take investigational product|0|||
163377416|NCT03647488|590089774|FG002|Overall Study|Participant refused to take investigational product|0|||
163377417|NCT00812331|590089775|FG000|Overall Study|Adverse Event|1|||
163377418|NCT00812331|590089776|FG001|Overall Study|Adverse Event|0|||
163377419|NCT00812331|590089777|FG002|Overall Study|Adverse Event|0|||
163377420|NCT00812331|590089778|FG003|Overall Study|Adverse Event|0|||
163377421|NCT00812331|590089779|FG004|Overall Study|Adverse Event|0|||
163415860|NCT01262976|590229529|FG003|Up to Year 2|Subjects with unknown completion status|0|||
163415861|NCT01262976|590229530|FG004|Up to Year 2|Subjects with unknown completion status|0|||
163415862|NCT01262976|590229531|FG005|Up to Year 2|Subjects with unknown completion status|0|||
163415863|NCT01262976|590229526|FG000|Up to Year 2|Other|3|||
163415864|NCT01262976|590229527|FG001|Up to Year 2|Other|0|||
163415865|NCT01262976|590229528|FG002|Up to Year 2|Other|0|||
163415866|NCT01262976|590229529|FG003|Up to Year 2|Other|0|||
163415867|NCT01262976|590229530|FG004|Up to Year 2|Other|0|||
163415868|NCT01262976|590229531|FG005|Up to Year 2|Other|0|||
163415869|NCT01262976|590229526|FG000|Up to Year 3|Serious Adverse Event|0|||
163415870|NCT01262976|590229527|FG001|Up to Year 3|Serious Adverse Event|0|||
163415871|NCT01262976|590229528|FG002|Up to Year 3|Serious Adverse Event|2|||
163415872|NCT01262976|590229529|FG003|Up to Year 3|Serious Adverse Event|0|||
163415873|NCT01262976|590229530|FG004|Up to Year 3|Serious Adverse Event|0|||
163415874|NCT01262976|590229531|FG005|Up to Year 3|Serious Adverse Event|0|||
163415875|NCT01262976|590229526|FG000|Up to Year 3|Withdrawal by Subject|1|||
163415876|NCT01262976|590229527|FG001|Up to Year 3|Withdrawal by Subject|0|||
163415877|NCT01262976|590229528|FG002|Up to Year 3|Withdrawal by Subject|0|||
163415878|NCT01262976|590229529|FG003|Up to Year 3|Withdrawal by Subject|0|||
163415879|NCT01262976|590229530|FG004|Up to Year 3|Withdrawal by Subject|0|||
163415880|NCT01262976|590229531|FG005|Up to Year 3|Withdrawal by Subject|0|||
163415881|NCT01262976|590229526|FG000|Up to Year 3|Migrated/moved from study area|0|||
163415882|NCT01262976|590229527|FG001|Up to Year 3|Migrated/moved from study area|0|||
163415883|NCT01262976|590229528|FG002|Up to Year 3|Migrated/moved from study area|0|||
163415884|NCT01262976|590229529|FG003|Up to Year 3|Migrated/moved from study area|2|||
163415885|NCT01262976|590229530|FG004|Up to Year 3|Migrated/moved from study area|1|||
163415886|NCT01262976|590229531|FG005|Up to Year 3|Migrated/moved from study area|1|||
163415887|NCT01262976|590229526|FG000|Up to Year 3|Lost to Follow-up|2|||
163415888|NCT01262976|590229527|FG001|Up to Year 3|Lost to Follow-up|2|||
163415889|NCT01262976|590229528|FG002|Up to Year 3|Lost to Follow-up|4|||
163415890|NCT01262976|590229529|FG003|Up to Year 3|Lost to Follow-up|3|||
163415891|NCT01262976|590229530|FG004|Up to Year 3|Lost to Follow-up|1|||
163415892|NCT01262976|590229531|FG005|Up to Year 3|Lost to Follow-up|3|||
163415893|NCT01262976|590229526|FG000|Up to Year 3|Subjects with unknown completion status|0|||
163415894|NCT01262976|590229527|FG001|Up to Year 3|Subjects with unknown completion status|0|||
163415895|NCT01262976|590229528|FG002|Up to Year 3|Subjects with unknown completion status|1|||
163415896|NCT01262976|590229529|FG003|Up to Year 3|Subjects with unknown completion status|0|||
163415897|NCT01262976|590229530|FG004|Up to Year 3|Subjects with unknown completion status|0|||
163415898|NCT01262976|590229531|FG005|Up to Year 3|Subjects with unknown completion status|0|||
163415899|NCT01262976|590229526|FG000|Up to Year 3|Other|3|||
163415900|NCT01262976|590229527|FG001|Up to Year 3|Other|0|||
163415901|NCT01262976|590229528|FG002|Up to Year 3|Other|0|||
163415902|NCT01262976|590229529|FG003|Up to Year 3|Other|0|||
163415903|NCT01262976|590229530|FG004|Up to Year 3|Other|0|||
163415904|NCT01262976|590229531|FG005|Up to Year 3|Other|0|||
163415905|NCT01528787|590229532|FG000|Overall Study|Withdrawal by Subject|0|||
163415906|NCT01528787|590229533|FG001|Overall Study|Withdrawal by Subject|0|||
163415907|NCT01528787|590229534|FG002|Overall Study|Withdrawal by Subject|0|||
163415908|NCT01528787|590229535|FG003|Overall Study|Withdrawal by Subject|1|||
163415909|NCT01528787|590229532|FG000|Overall Study|Family Emergency|0|||
163415910|NCT01528787|590229533|FG001|Overall Study|Family Emergency|0|||
163415911|NCT01528787|590229534|FG002|Overall Study|Family Emergency|1|||
163415912|NCT01528787|590229535|FG003|Overall Study|Family Emergency|0|||
163415913|NCT03433781|590229543|FG000|Overall Study|Progression of Disease|1|||
163415914|NCT03433781|590229544|FG001|Overall Study|Progression of Disease|0|||
163415915|NCT03433781|590229545|FG002|Overall Study|Progression of Disease|0|||
163415916|NCT03433781|590229543|FG000|Overall Study|Physician Decision|0|||
163377422|NCT03694275|590089780|FG000|Overall Study|Adverse Event|0|||
163377423|NCT03694275|590089781|FG001|Overall Study|Adverse Event|1|||
163377424|NCT03694275|590089780|FG000|Overall Study|Reason not Specified|0|||
163415917|NCT03433781|590229544|FG001|Overall Study|Physician Decision|1|||
163415918|NCT03433781|590229545|FG002|Overall Study|Physician Decision|0|||
163415919|NCT02400255|590229546|FG000|Overall Study|Relapse|4|||
163377425|NCT03694275|590089781|FG001|Overall Study|Reason not Specified|1|||
163377426|NCT00153062|590089785|FG000|Overall Study|Death|360|||
163377427|NCT00153062|590089786|FG001|Overall Study|Death|352|||
163377428|NCT00153062|590089787|FG002|Overall Study|Death|369|||
163377429|NCT00153062|590089788|FG003|Overall Study|Death|365|||
163377430|NCT00153062|590089785|FG000|Overall Study|Withdrawal by Subject|14|||
163377431|NCT00153062|590089786|FG001|Overall Study|Withdrawal by Subject|30|||
163377432|NCT00153062|590089787|FG002|Overall Study|Withdrawal by Subject|27|||
163377433|NCT00153062|590089788|FG003|Overall Study|Withdrawal by Subject|28|||
163377434|NCT00153062|590089785|FG000|Overall Study|Lost to Follow-up|12|||
163377435|NCT00153062|590089786|FG001|Overall Study|Lost to Follow-up|20|||
163377436|NCT00153062|590089787|FG002|Overall Study|Lost to Follow-up|15|||
163377437|NCT00153062|590089788|FG003|Overall Study|Lost to Follow-up|16|||
163415920|NCT02400255|590229547|FG001|Overall Study|Relapse|1|||
163415921|NCT02400255|590229548|FG002|Overall Study|Relapse|1|||
163415922|NCT02400255|590229549|FG003|Overall Study|Relapse|2|||
163415923|NCT02400255|590229546|FG000|Overall Study|Adverse Event|6|||
163415924|NCT02400255|590229547|FG001|Overall Study|Adverse Event|3|||
163415925|NCT02400255|590229548|FG002|Overall Study|Adverse Event|0|||
163415926|NCT02400255|590229549|FG003|Overall Study|Adverse Event|0|||
163415927|NCT02400255|590229546|FG000|Overall Study|Physician Decision|6|||
163415928|NCT02400255|590229547|FG001|Overall Study|Physician Decision|0|||
163415929|NCT02400255|590229548|FG002|Overall Study|Physician Decision|0|||
163415930|NCT02400255|590229549|FG003|Overall Study|Physician Decision|0|||
163415931|NCT02400255|590229546|FG000|Overall Study|Loss of insurance|1|||
163415932|NCT02400255|590229547|FG001|Overall Study|Loss of insurance|0|||
163415933|NCT02400255|590229548|FG002|Overall Study|Loss of insurance|0|||
163415934|NCT02400255|590229549|FG003|Overall Study|Loss of insurance|0|||
163415935|NCT02568046|590229550|FG000|Overall Study|Adverse Event|0|||
163415936|NCT02568046|590229551|FG001|Overall Study|Adverse Event|1|||
163415937|NCT02568046|590229550|FG000|Overall Study|Death|2|||
163415938|NCT02568046|590229551|FG001|Overall Study|Death|0|||
163377438|NCT00153062|590089785|FG000|Overall Study|Adverse Event|0|||
163377439|NCT00153062|590089786|FG001|Overall Study|Adverse Event|1|||
163377440|NCT00153062|590089787|FG002|Overall Study|Adverse Event|1|||
163377441|NCT00153062|590089788|FG003|Overall Study|Adverse Event|0|||
163377442|NCT00153062|590089785|FG000|Overall Study|Protocol Violation|0|||
163377443|NCT00153062|590089786|FG001|Overall Study|Protocol Violation|2|||
163377444|NCT00153062|590089787|FG002|Overall Study|Protocol Violation|1|||
163377445|NCT00153062|590089788|FG003|Overall Study|Protocol Violation|1|||
163377446|NCT00153062|590089785|FG000|Overall Study|No disposition data available|1|||
163377447|NCT00153062|590089786|FG001|Overall Study|No disposition data available|1|||
163377448|NCT00153062|590089787|FG002|Overall Study|No disposition data available|1|||
163377449|NCT00153062|590089788|FG003|Overall Study|No disposition data available|1|||
163377450|NCT00153062|590089785|FG000|Overall Study|Other|0|||
163377451|NCT00153062|590089786|FG001|Overall Study|Other|0|||
163377452|NCT00153062|590089787|FG002|Overall Study|Other|1|||
163377453|NCT00153062|590089788|FG003|Overall Study|Other|0|||
163377454|NCT02359877|590089789|FG000|Overall Study|Withdrawal by Subject|1|||
163377455|NCT02359877|590089790|FG001|Overall Study|Withdrawal by Subject|0|||
163377456|NCT02359877|590089791|FG002|Overall Study|Withdrawal by Subject|0|||
163377457|NCT02359877|590089792|FG003|Overall Study|Withdrawal by Subject|2|||
163377458|NCT02359877|590089789|FG000|Overall Study|Adverse Event|0|||
163377459|NCT02359877|590089790|FG001|Overall Study|Adverse Event|0|||
163377460|NCT02359877|590089791|FG002|Overall Study|Adverse Event|0|||
163377461|NCT02359877|590089792|FG003|Overall Study|Adverse Event|1|||
163377462|NCT00910689|590089804|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
163377463|NCT00910689|590089805|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
163377464|NCT00910689|590089806|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
163377465|NCT00910689|590089807|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
163377466|NCT00910689|590089804|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
163377467|NCT00910689|590089805|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
163377468|NCT00910689|590089806|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
163377469|NCT00910689|590089807|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
163377470|NCT00910689|590089804|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
163377471|NCT00910689|590089805|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
163377472|NCT00910689|590089806|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
163377473|NCT00910689|590089807|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
163377474|NCT00910689|590089804|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
163415939|NCT02568046|590229550|FG000|Overall Study|Progressive Disease|1|||
163415940|NCT02568046|590229551|FG001|Overall Study|Progressive Disease|0|||
163415941|NCT02568046|590229550|FG000|Overall Study|Withdrawal by Subject|2|||
163377475|NCT00910689|590089805|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
163415942|NCT02568046|590229551|FG001|Overall Study|Withdrawal by Subject|1|||
163415943|NCT02568046|590229550|FG000|Overall Study|Other Events|0|||
163415944|NCT02568046|590229551|FG001|Overall Study|Other Events|1|||
163377476|NCT00910689|590089806|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
163377477|NCT00910689|590089807|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
163377478|NCT00910689|590089804|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
163377479|NCT00910689|590089805|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
163377480|NCT00910689|590089806|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
163377481|NCT00910689|590089807|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
163415945|NCT02809833|590229552|FG000|Overall Study|Death|3|||
163415946|NCT02809833|590229552|FG000|Overall Study|Intolerance|54|||
163415947|NCT02809833|590229552|FG000|Overall Study|Lack of Efficacy|89|||
163415948|NCT02809833|590229552|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
163415949|NCT02809833|590229552|FG000|Overall Study|Noncompliance|1|||
163415950|NCT02809833|590229552|FG000|Overall Study|Withdrawal by Subject|34|||
163415951|NCT02809833|590229552|FG000|Overall Study|Lost to Follow-up|35|||
163415952|NCT02809833|590229552|FG000|Overall Study|Adverse Event (AE)|24|||
163415953|NCT02809833|590229552|FG000|Overall Study|Other|5|||
163415954|NCT02809833|590229552|FG000|Overall Study|Missing Information|52|||
163377482|NCT00910689|590089804|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
163377483|NCT00910689|590089805|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
163415955|NCT00523991|590229555|FG000|Overall Study|Adverse Event|6|||
163415956|NCT00523991|590229556|FG001|Overall Study|Adverse Event|5|||
163415957|NCT00523991|590229555|FG000|Overall Study|Protocol Violation|1|||
163415958|NCT00523991|590229556|FG001|Overall Study|Protocol Violation|4|||
163415959|NCT00523991|590229555|FG000|Overall Study|Lost to Follow-up|4|||
163415960|NCT00523991|590229556|FG001|Overall Study|Lost to Follow-up|1|||
163415961|NCT00523991|590229555|FG000|Overall Study|Withdrawal by Subject|7|||
163415962|NCT00523991|590229556|FG001|Overall Study|Withdrawal by Subject|17|||
163415963|NCT00523991|590229555|FG000|Overall Study|Other reason (not specified)|3|||
163415964|NCT00523991|590229556|FG001|Overall Study|Other reason (not specified)|0|||
163415965|NCT00193063|590229558|FG000|Overall Study|Lack of Efficacy|3|||
163415966|NCT00193063|590229558|FG000|Overall Study|Adverse Event|1|||
163415967|NCT03261531|590229559|FG000|Overall Study|Withdrawal by Subject|4|||
163415968|NCT00744874|590229561|FG000|Overall Study|Lost to Follow-up|1|||
163415969|NCT00744874|590229561|FG000|Overall Study|Withdrawal by Subject|1|||
163415970|NCT00744874|590229561|FG000|Overall Study|Study Device not available at procedure|1|||
163415971|NCT00744874|590229561|FG000|Overall Study|Unable to accomodate schedule|1|||
163415972|NCT03175549|590229564|FG000|Overall Study|Lost to Follow-up|2|||
163415973|NCT03175549|590229565|FG001|Overall Study|Lost to Follow-up|2|||
163415974|NCT03175549|590229564|FG000|Overall Study|Medication non-compliance|2|||
163415975|NCT03175549|590229565|FG001|Overall Study|Medication non-compliance|2|||
163415976|NCT02435849|590229566|FG000|Overall Study|Death|23|||
163415977|NCT02435849|590229567|FG001|Overall Study|Death|0|||
163415978|NCT02435849|590229566|FG000|Overall Study|Lack of Efficacy|10|||
163415979|NCT02435849|590229567|FG001|Overall Study|Lack of Efficacy|0|||
163415980|NCT02435849|590229566|FG000|Overall Study|New therapy for study indication|8|||
163415981|NCT02435849|590229567|FG001|Overall Study|New therapy for study indication|0|||
163415982|NCT02435849|590229566|FG000|Overall Study|Subject/guardian decision|5|||
163415983|NCT02435849|590229567|FG001|Overall Study|Subject/guardian decision|1|||
163415984|NCT02435849|590229566|FG000|Overall Study|Lost to Follow-up|1|||
163415985|NCT02435849|590229567|FG001|Overall Study|Lost to Follow-up|0|||
163377484|NCT00910689|590089806|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
163377485|NCT00910689|590089807|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
163377486|NCT00910689|590089804|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
163377487|NCT00910689|590089805|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
163377488|NCT00910689|590089806|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
163377489|NCT00910689|590089807|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
163377490|NCT00910689|590089804|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
163377491|NCT00910689|590089805|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
163377492|NCT00910689|590089806|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
163377493|NCT00910689|590089807|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
163377494|NCT00910689|590089804|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
163377495|NCT00910689|590089805|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
163377496|NCT00910689|590089806|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
163377497|NCT00910689|590089807|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
163377498|NCT00910689|590089804|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
163377499|NCT00910689|590089805|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
163377500|NCT00910689|590089806|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
163377501|NCT00910689|590089807|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
163377502|NCT00910689|590089804|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
163377503|NCT00910689|590089805|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
163377504|NCT00910689|590089806|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
163377505|NCT00910689|590089807|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
163377506|NCT00910689|590089804|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
163377507|NCT00910689|590089805|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
163377508|NCT00910689|590089806|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
163377509|NCT00910689|590089807|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
163377510|NCT00910689|590089804|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
163377511|NCT00910689|590089805|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
163415986|NCT02435849|590229566|FG000|Overall Study|Physician Decision|1|||
163415987|NCT02435849|590229567|FG001|Overall Study|Physician Decision|0|||
163415988|NCT02486757|590229568|FG000|Overall Study|Lost to Follow-up|1|||
163415989|NCT02793232|590229569|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
163415990|NCT02793232|590229570|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
163415991|NCT02793232|590229571|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
163415992|NCT02793232|590229572|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
163415993|NCT02793232|590229573|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
163415994|NCT02793232|590229574|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
163415995|NCT02793232|590229575|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
163415996|NCT02793232|590229576|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
163415997|NCT02793232|590229577|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
163415998|NCT02387580|590229580|FG000|Overall Study|Withdrawal by Subject|0|||
163415999|NCT02387580|590229581|FG001|Overall Study|Withdrawal by Subject|0|||
163416000|NCT02387580|590229582|FG002|Overall Study|Withdrawal by Subject|0|||
163416001|NCT02387580|590229583|FG003|Overall Study|Withdrawal by Subject|1|||
163416002|NCT02387580|590229584|FG004|Overall Study|Withdrawal by Subject|0|||
163416003|NCT02387580|590229585|FG005|Overall Study|Withdrawal by Subject|0|||
163416004|NCT03984305|590229587|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
163416005|NCT03984305|590229588|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
163416006|NCT03984305|590229587|FG000|Overall Study|Withdrawal by Subject|3|||
163416007|NCT03984305|590229588|FG001|Overall Study|Withdrawal by Subject|3|||
163416008|NCT03984305|590229587|FG000|Overall Study|Lost to Follow-up|1|||
163416009|NCT03984305|590229588|FG001|Overall Study|Lost to Follow-up|0|||
163416010|NCT02883244|590229589|FG000|Overall Study|Lost to Follow-up|0|||
163416011|NCT02883244|590229590|FG001|Overall Study|Lost to Follow-up|1|||
163416012|NCT03979274|590229601|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163416013|NCT03979274|590229602|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163416014|NCT02301403|590229603|FG000|Overall Study|Withdrawal by Subject|28|||
163416015|NCT02301403|590229604|FG001|Overall Study|Withdrawal by Subject|41|||
163416016|NCT02302963|590229605|FG000|Overall Study|Withdrawal by Subject|2|||
163416017|NCT02302963|590229606|FG001|Overall Study|Withdrawal by Subject|1|||
163416018|NCT02302963|590229605|FG000|Overall Study|Steroid injection|0|||
163416019|NCT02302963|590229606|FG001|Overall Study|Steroid injection|1|||
163416020|NCT02302963|590229605|FG000|Overall Study|Physician Decision|1|||
163416021|NCT02302963|590229606|FG001|Overall Study|Physician Decision|0|||
163416022|NCT01614093|590229609|FG000|Overall Study|Withdrawal by Subject|1|||
163416023|NCT00603915|590229610|FG000|Overall Study|Physician Decision|1|||
163416024|NCT03064841|590229611|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
163416025|NCT03064841|590229611|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
163416026|NCT03064841|590229611|FG000|Overall Study|Screen failure|2|||
163416027|NCT00573794|590229612|FG000|Overall Study|Adverse Event|81|||
163416028|NCT00573794|590229612|FG000|Overall Study|Withdrew Consent|90|||
163416029|NCT00573794|590229612|FG000|Overall Study|Lost to Follow-up|13|||
163416030|NCT00573794|590229612|FG000|Overall Study|Protocol Violation|6|||
163416031|NCT00573794|590229612|FG000|Overall Study|Lack of Efficacy|94|||
163416032|NCT00573794|590229612|FG000|Overall Study|Other|46|||
163416033|NCT01724528|590229622|FG000|Overall Study|Death|3|||
163416034|NCT01724528|590229623|FG001|Overall Study|Death|0|||
163416035|NCT01724528|590229622|FG000|Overall Study|Withdrawal by Subject|0|||
163416036|NCT01724528|590229623|FG001|Overall Study|Withdrawal by Subject|2|||
163416037|NCT01724528|590229622|FG000|Overall Study|Protocol Violation|0|||
163416038|NCT01724528|590229623|FG001|Overall Study|Protocol Violation|1|||
163416039|NCT01724528|590229622|FG000|Overall Study|Patient refused to attend last visit|1|||
163416040|NCT01724528|590229623|FG001|Overall Study|Patient refused to attend last visit|0|||
163377512|NCT00910689|590089806|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
163377513|NCT00910689|590089807|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
163377514|NCT00910689|590089804|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
163377515|NCT00910689|590089805|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
163377516|NCT00910689|590089806|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
163377517|NCT00910689|590089807|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
163377518|NCT00910689|590089804|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
163377519|NCT00910689|590089805|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
163377520|NCT00910689|590089806|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
163377521|NCT00910689|590089807|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
163377522|NCT00910689|590089804|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
163377523|NCT00910689|590089805|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
163416041|NCT02183519|590229627|FG000|Overall Study|computer error|3|||
163416042|NCT02183519|590229628|FG001|Overall Study|computer error|0|||
163416043|NCT02183519|590229627|FG000|Overall Study|Did not respond to cough inducter|0|||
163416044|NCT02183519|590229628|FG001|Overall Study|Did not respond to cough inducter|3|||
163416045|NCT04556617|590229631|FG000|Overall Study|progressive disease|0|||
163416046|NCT04556617|590229632|FG001|Overall Study|progressive disease|2|||
163416047|NCT04556617|590229633|FG002|Overall Study|progressive disease|2|||
163416048|NCT04556617|590229634|FG003|Overall Study|progressive disease|1|||
163416049|NCT04556617|590229635|FG004|Overall Study|progressive disease|1|||
163416050|NCT04556617|590229631|FG000|Overall Study|Physician Decision|0|||
163416051|NCT04556617|590229632|FG001|Overall Study|Physician Decision|0|||
163416052|NCT04556617|590229633|FG002|Overall Study|Physician Decision|2|||
163416053|NCT04556617|590229634|FG003|Overall Study|Physician Decision|0|||
163416054|NCT04556617|590229635|FG004|Overall Study|Physician Decision|0|||
163416055|NCT04556617|590229631|FG000|Overall Study|Adverse Event|0|||
163416056|NCT04556617|590229632|FG001|Overall Study|Adverse Event|0|||
163416057|NCT04556617|590229633|FG002|Overall Study|Adverse Event|2|||
163416058|NCT04556617|590229634|FG003|Overall Study|Adverse Event|3|||
163416059|NCT04556617|590229635|FG004|Overall Study|Adverse Event|0|||
163416060|NCT04556617|590229631|FG000|Overall Study|Withdrawal by Subject|0|||
163416061|NCT04556617|590229632|FG001|Overall Study|Withdrawal by Subject|2|||
163416062|NCT04556617|590229633|FG002|Overall Study|Withdrawal by Subject|1|||
163416063|NCT04556617|590229634|FG003|Overall Study|Withdrawal by Subject|1|||
163416064|NCT04556617|590229635|FG004|Overall Study|Withdrawal by Subject|0|||
163416065|NCT04556617|590229631|FG000|Overall Study|PSA increase|0|||
163416066|NCT04556617|590229632|FG001|Overall Study|PSA increase|1|||
163377524|NCT00910689|590089806|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
163377525|NCT00910689|590089807|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
163377526|NCT00910689|590089804|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
163416067|NCT04556617|590229633|FG002|Overall Study|PSA increase|0|||
163416068|NCT04556617|590229634|FG003|Overall Study|PSA increase|0|||
163416069|NCT04556617|590229635|FG004|Overall Study|PSA increase|0|||
163416070|NCT04556617|590229631|FG000|Overall Study|Sponsor study termination|1|||
163416071|NCT04556617|590229632|FG001|Overall Study|Sponsor study termination|0|||
163416072|NCT04556617|590229633|FG002|Overall Study|Sponsor study termination|0|||
163416073|NCT04556617|590229634|FG003|Overall Study|Sponsor study termination|0|||
163416074|NCT04556617|590229635|FG004|Overall Study|Sponsor study termination|0|||
163416075|NCT05902364|590229640|FG000|Overall Study|Adverse Event|1|||
163416076|NCT05902364|590229641|FG001|Overall Study|Adverse Event|0|||
163416077|NCT02270242|590229642|FG000|Overall Study|Withdrawal by Subject|18|||
163416078|NCT02270242|590229643|FG001|Overall Study|Withdrawal by Subject|25|||
163416079|NCT02270242|590229642|FG000|Overall Study|Lost to Follow-up|41|||
163416080|NCT02270242|590229643|FG001|Overall Study|Lost to Follow-up|27|||
163416081|NCT02270242|590229642|FG000|Overall Study|Physician Decision|0|||
163416082|NCT02270242|590229643|FG001|Overall Study|Physician Decision|1|||
163416083|NCT04187092|590230998|FG000|Overall Study|Lost to Follow-up|1|||
163416084|NCT04187092|590230999|FG001|Overall Study|Lost to Follow-up|1|||
163416085|NCT04187092|590230998|FG000|Overall Study|Withdrawal by Subject|1|||
163416086|NCT04187092|590230999|FG001|Overall Study|Withdrawal by Subject|1|||
163416087|NCT04187092|590230998|FG000|Overall Study|Adverse Event|0|||
163416088|NCT04187092|590230999|FG001|Overall Study|Adverse Event|1|||
163416089|NCT01748071|590231002|FG000|Overall Study|Adverse Event|2|||
163416090|NCT01748071|590231003|FG001|Overall Study|Adverse Event|2|||
163416091|NCT01748071|590231004|FG002|Overall Study|Adverse Event|0|||
163416092|NCT03068325|590231005|FG000|Overall Study|Lost to Follow-up|5|||
163416093|NCT01445535|590231008|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
163416094|NCT01445535|590231009|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
163416095|NCT01445535|590231010|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
163416096|NCT01445535|590231011|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
163416097|NCT01445535|590231008|FG000|Overall Study|Disease progression|1|||
163416098|NCT01445535|590231009|FG001|Overall Study|Disease progression|0|||
163416099|NCT01445535|590231010|FG002|Overall Study|Disease progression|1|||
163416100|NCT01445535|590231011|FG003|Overall Study|Disease progression|0|||
163416101|NCT01445535|590231008|FG000|Overall Study|PI discretion|0|||
163416102|NCT01445535|590231009|FG001|Overall Study|PI discretion|0|||
163416103|NCT01445535|590231010|FG002|Overall Study|PI discretion|0|||
163416104|NCT01445535|590231011|FG003|Overall Study|PI discretion|1|||
163416105|NCT00420511|590231019|FG000|Overall Study|Adverse Event|1|||
163416106|NCT00420511|590231020|FG001|Overall Study|Adverse Event|1|||
163416107|NCT00420511|590231019|FG000|Overall Study|Lost to Follow-up|1|||
163416108|NCT00420511|590231020|FG001|Overall Study|Lost to Follow-up|0|||
163416109|NCT01668654|590231021|FG000|Overall Study|Study Closed/Terminated|3|||
163416110|NCT01668654|590231021|FG000|Overall Study|Withdrawal by Subject|1|||
163416111|NCT00454779|590231022|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
163416112|NCT00454779|590231023|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
163416113|NCT00454779|590231022|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
163416114|NCT00454779|590231023|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
163416115|NCT00454779|590231022|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
163416116|NCT00454779|590231023|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
163416117|NCT00454779|590231022|FG000|First-line Treatment Phase|Protocol Violation|0|||
163416118|NCT00454779|590231023|FG001|First-line Treatment Phase|Protocol Violation|1|||
163416119|NCT00454779|590231022|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
163416120|NCT00454779|590231023|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
163416121|NCT00454779|590231022|FG000|First-line Treatment Phase|Ongoing|1|||
163377527|NCT00910689|590089805|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
163377528|NCT00910689|590089806|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
163377529|NCT00910689|590089807|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
163377530|NCT00910689|590089804|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
163377531|NCT00910689|590089805|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
163377532|NCT00910689|590089806|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
163377533|NCT00910689|590089807|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
163416122|NCT00454779|590231023|FG001|First-line Treatment Phase|Ongoing|0|||
163416123|NCT00454779|590231022|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
163416124|NCT00454779|590231023|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
163377534|NCT00910689|590089804|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
163377535|NCT00910689|590089805|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
163377536|NCT00910689|590089806|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
163377537|NCT00910689|590089807|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
163377538|NCT00910689|590089804|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
163377539|NCT00910689|590089805|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
163377540|NCT00910689|590089806|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
163377541|NCT00910689|590089807|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
163377542|NCT00910689|590089804|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
163377543|NCT00910689|590089805|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
163377544|NCT00910689|590089806|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
163377545|NCT00910689|590089807|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
163377546|NCT01290029|590089810|FG000|Overall Study|Other|2|||
163377547|NCT00189488|590089811|FG000|Overall Study|Ineligibility determined|1|||
163377548|NCT00189488|590089812|FG001|Overall Study|Ineligibility determined|0|||
163377549|NCT00189488|590089811|FG000|Overall Study|Protocol deviation|2|||
163377550|NCT00189488|590089812|FG001|Overall Study|Protocol deviation|1|||
163377551|NCT00189488|590089811|FG000|Overall Study|Adverse Event|2|||
163377552|NCT00189488|590089812|FG001|Overall Study|Adverse Event|1|||
163377553|NCT00189488|590089811|FG000|Overall Study|Withdrawal by Subject|2|||
163377554|NCT00189488|590089812|FG001|Overall Study|Withdrawal by Subject|6|||
163377555|NCT00189488|590089811|FG000|Overall Study|Disease progression|2|||
163377556|NCT00189488|590089812|FG001|Overall Study|Disease progression|4|||
163377557|NCT00189488|590089811|FG000|Overall Study|Administrative Decision|0|||
163377558|NCT00189488|590089812|FG001|Overall Study|Administrative Decision|2|||
163377559|NCT00189488|590089811|FG000|Overall Study|Death|5|||
163377560|NCT00189488|590089812|FG001|Overall Study|Death|8|||
163377561|NCT00189488|590089811|FG000|Overall Study|Other|1|||
163377562|NCT00189488|590089812|FG001|Overall Study|Other|0|||
163377563|NCT00616902|590089815|FG000|Overall Study|Termination of study|6|||
163377564|NCT00616902|590089816|FG001|Overall Study|Termination of study|6|||
163377565|NCT01877837|590089817|FG000|Overall Study|Lost to Follow-up|1|||
163377566|NCT01877837|590089817|FG000|Overall Study|Ineligible|4|||
163377567|NCT00645801|590089818|FG000|Overall Study|unclear if patient took all the medication.|1|||
163377568|NCT00645801|590089819|FG001|Overall Study|unclear if patient took all the medication.|0|||
163377569|NCT00645801|590089818|FG000|Overall Study|Lost to Follow-up|19|||
163377570|NCT00645801|590089819|FG001|Overall Study|Lost to Follow-up|15|||
163377571|NCT00759915|590089820|FG000|Overall Study|Withdrawal by Subject|1|||
163377572|NCT00759915|590089821|FG001|Overall Study|Withdrawal by Subject|0|||
163377573|NCT00759915|590089820|FG000|Overall Study|Adverse Event|0|||
163377574|NCT00759915|590089821|FG001|Overall Study|Adverse Event|1|||
163377575|NCT00932113|590089824|FG000|Overall Study|Lost to Follow-up|1|||
163377576|NCT00932113|590089825|FG001|Overall Study|Lost to Follow-up|0|||
163377577|NCT01143038|590089826|FG000|Overall Study|Withdrawal by Subject|4|||
163377578|NCT01143038|590089826|FG000|Overall Study|Requirement for alternative therapy|5|||
163377579|NCT01143038|590089826|FG000|Overall Study|Adverse Event|3|||
163377580|NCT01143038|590089826|FG000|Overall Study|Lost to Follow-up|2|||
163377581|NCT01143038|590089826|FG000|Overall Study|Protocol Deviation|1|||
163377582|NCT01143038|590089826|FG000|Overall Study|Death|1|||
163377583|NCT00657020|590089827|FG000|PERIOD 1|Adverse Event|0|||
163377584|NCT00657020|590089828|FG001|PERIOD 1|Adverse Event|1|||
163377585|NCT01183234|590089829|FG000|First Intervention|Adverse Event|1|||
163377586|NCT01183234|590089830|FG001|First Intervention|Adverse Event|0|||
163377587|NCT02029846|590089833|FG000|Overall Study|n=1 each arm|1|||
163377588|NCT02029846|590089834|FG001|Overall Study|n=1 each arm|1|||
163377589|NCT00370331|590089835|FG000|Overall Study|Adverse Event|4|||
163377590|NCT00370331|590089836|FG001|Overall Study|Adverse Event|13|||
163377591|NCT00370331|590089835|FG000|Overall Study|Withdrawal by Subject|2|||
163377592|NCT00370331|590089836|FG001|Overall Study|Withdrawal by Subject|4|||
163377593|NCT00370331|590089835|FG000|Overall Study|Lost to Follow-up|0|||
163377594|NCT00370331|590089836|FG001|Overall Study|Lost to Follow-up|3|||
163377595|NCT00370331|590089835|FG000|Overall Study|Lack of Efficacy|0|||
163377596|NCT00370331|590089836|FG001|Overall Study|Lack of Efficacy|1|||
163377597|NCT00370331|590089835|FG000|Overall Study|Non-compliance|0|||
163377598|NCT00370331|590089836|FG001|Overall Study|Non-compliance|1|||
163377599|NCT00370331|590089835|FG000|Overall Study|Protocol Violation|1|||
163377600|NCT00370331|590089836|FG001|Overall Study|Protocol Violation|1|||
163377601|NCT00993668|590089838|FG000|Single-Blind Period|Adverse Event|1|||
163377602|NCT00993668|590089839|FG001|Single-Blind Period|Adverse Event|1|||
163377603|NCT00993668|590089838|FG000|Single-Blind Period|Lack of Efficacy|0|||
163377604|NCT00993668|590089839|FG001|Single-Blind Period|Lack of Efficacy|1|||
163377605|NCT00993668|590089838|FG000|Single-Blind Period|Lost to Follow-up|3|||
163377606|NCT00993668|590089839|FG001|Single-Blind Period|Lost to Follow-up|1|||
163377607|NCT00993668|590089838|FG000|Open-Label Period|Adverse Event|9|||
163377608|NCT00993668|590089839|FG001|Open-Label Period|Adverse Event|8|||
163377609|NCT00993668|590089838|FG000|Open-Label Period|Lack of Efficacy|4|||
163377610|NCT00993668|590089839|FG001|Open-Label Period|Lack of Efficacy|3|||
163416125|NCT00454779|590231022|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
163416126|NCT00454779|590231023|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
163416127|NCT00454779|590231022|FG000|Second-line Treatment Phase|Ongoing|0|||
163416128|NCT00454779|590231023|FG001|Second-line Treatment Phase|Ongoing|1|||
163416129|NCT01337973|590231025|FG000|Overall Study|Lost to Follow-up|2|||
163416130|NCT01337973|590231026|FG001|Overall Study|Lost to Follow-up|4|||
163416131|NCT01337973|590231027|FG002|Overall Study|Lost to Follow-up|3|||
163416132|NCT01337973|590231025|FG000|Overall Study|Death|1|||
163416133|NCT01337973|590231026|FG001|Overall Study|Death|2|||
163416134|NCT01337973|590231027|FG002|Overall Study|Death|1|||
163416135|NCT01337973|590231025|FG000|Overall Study|Withdrawal by Subject|10|||
163416136|NCT01337973|590231026|FG001|Overall Study|Withdrawal by Subject|8|||
163416137|NCT01337973|590231027|FG002|Overall Study|Withdrawal by Subject|4|||
163416138|NCT01337973|590231025|FG000|Overall Study|missing data on primary outcome|3|||
163416139|NCT01337973|590231026|FG001|Overall Study|missing data on primary outcome|1|||
163416140|NCT01337973|590231027|FG002|Overall Study|missing data on primary outcome|3|||
163416141|NCT03634800|590231028|FG000|Overall Study|Adverse Event|1|||
163416142|NCT03634800|590231028|FG000|Overall Study|Disease Progression|4|||
163416143|NCT03634800|590231028|FG000|Overall Study|Withdrawal by Subject|1|||
163416144|NCT01114529|590231029|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
163416145|NCT01114529|590231030|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
163416146|NCT01114529|590231031|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
163416147|NCT01114529|590231029|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
163416148|NCT01114529|590231030|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
163416149|NCT01114529|590231031|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
163416150|NCT01114529|590231029|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
163416151|NCT01114529|590231030|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
163416152|NCT01114529|590231031|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
163416153|NCT01114529|590231029|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
163416154|NCT01114529|590231030|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
163416155|NCT01114529|590231031|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
163416156|NCT01114529|590231029|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
163416157|NCT01114529|590231030|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
163416158|NCT01114529|590231031|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
163416159|NCT01114529|590231029|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
163416160|NCT01114529|590231030|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
163416161|NCT01114529|590231031|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
163416162|NCT01114529|590231029|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
163416163|NCT01114529|590231030|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
163416164|NCT01114529|590231031|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
163416165|NCT01114529|590231029|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
163416166|NCT01114529|590231030|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
163416167|NCT01114529|590231031|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
163416168|NCT01114529|590231029|FG000|Completed Study Medication at Month 24|Death|2|||
163416169|NCT01114529|590231030|FG001|Completed Study Medication at Month 24|Death|1|||
163416170|NCT01114529|590231031|FG002|Completed Study Medication at Month 24|Death|2|||
163416171|NCT01114529|590231029|FG000|Completed Study Medication at Month 24|Graft loss|0|||
163416172|NCT01114529|590231030|FG001|Completed Study Medication at Month 24|Graft loss|2|||
163416173|NCT01114529|590231031|FG002|Completed Study Medication at Month 24|Graft loss|0|||
163416174|NCT01114529|590231029|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
163377611|NCT00993668|590089838|FG000|Open-Label Period|Withdrawal by Subject|4|||
163377612|NCT00993668|590089839|FG001|Open-Label Period|Withdrawal by Subject|3|||
163377613|NCT00993668|590089838|FG000|Open-Label Period|Lost to Follow-up|6|||
163377614|NCT00993668|590089839|FG001|Open-Label Period|Lost to Follow-up|1|||
163377615|NCT02313233|590089842|FG000|Overall Study|Withdrawal by Subject|1|||
163377616|NCT02313233|590089843|FG001|Overall Study|Withdrawal by Subject|2|||
163377617|NCT02313233|590089842|FG000|Overall Study|Administrative reason|1|||
163377618|NCT02313233|590089843|FG001|Overall Study|Administrative reason|1|||
163377619|NCT02095951|590089844|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
163377620|NCT02095951|590089845|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
163377621|NCT03618823|590089846|FG000|Overall Study|Lost to Follow-up|63|||
163377622|NCT03618823|590089847|FG001|Overall Study|Lost to Follow-up|61|||
163377623|NCT05383508|590089848|FG000|Overall Study|Withdrawal by Subject|1|||
163377624|NCT05383508|590089849|FG001|Overall Study|Withdrawal by Subject|0|||
163377625|NCT05383508|590089850|FG002|Overall Study|Withdrawal by Subject|1|||
163377626|NCT05383508|590089851|FG003|Overall Study|Withdrawal by Subject|1|||
163377627|NCT05383508|590089852|FG004|Overall Study|Withdrawal by Subject|2|||
163377628|NCT05383508|590089853|FG005|Overall Study|Withdrawal by Subject|0|||
163377629|NCT01621568|590089855|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
163377630|NCT01621568|590089856|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
163377631|NCT01621568|590089855|FG000|Week 5-6 No Treatment|Death|1|||
163377632|NCT01621568|590089856|FG001|Week 5-6 No Treatment|Death|0|||
163377633|NCT02930226|590089857|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
163377634|NCT02930226|590089858|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
163377635|NCT02930226|590089859|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
163377636|NCT02930226|590089860|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
163377637|NCT02930226|590089861|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
163377638|NCT02930226|590089862|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
163377639|NCT02224690|590089866|FG000|Overall Study|Adverse Event|8|||
163377640|NCT02224690|590089867|FG001|Overall Study|Adverse Event|1|||
163377641|NCT02224690|590089866|FG000|Overall Study|Met Withdrawal Criteria|4|||
163377642|NCT02224690|590089867|FG001|Overall Study|Met Withdrawal Criteria|0|||
163377643|NCT02224690|590089866|FG000|Overall Study|Use of G-tube|1|||
163377644|NCT02224690|590089867|FG001|Overall Study|Use of G-tube|0|||
163377645|NCT02224690|590089866|FG000|Overall Study|Did not meet eligibility criteria|1|||
163377646|NCT02224690|590089867|FG001|Overall Study|Did not meet eligibility criteria|0|||
163377647|NCT01506609|590089869|FG000|Overall Study|Adverse Event Related to Progression|0|||
163377648|NCT01506609|590089870|FG001|Overall Study|Adverse Event Related to Progression|0|||
163377649|NCT01506609|590089871|FG002|Overall Study|Adverse Event Related to Progression|0|||
163377650|NCT01506609|590089872|FG003|Overall Study|Adverse Event Related to Progression|3|||
163377651|NCT01506609|590089873|FG004|Overall Study|Adverse Event Related to Progression|7|||
163377652|NCT01506609|590089874|FG005|Overall Study|Adverse Event Related to Progression|3|||
163377653|NCT01506609|590089869|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
163377654|NCT01506609|590089870|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
163377655|NCT01506609|590089871|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
163377656|NCT01506609|590089872|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
163377657|NCT01506609|590089873|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
163377658|NCT01506609|590089874|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
163377659|NCT01506609|590089869|FG000|Overall Study|Withdrawal by Subject|0|||
163377660|NCT01506609|590089870|FG001|Overall Study|Withdrawal by Subject|0|||
163377661|NCT01506609|590089871|FG002|Overall Study|Withdrawal by Subject|0|||
163377662|NCT01506609|590089872|FG003|Overall Study|Withdrawal by Subject|9|||
163377663|NCT01506609|590089873|FG004|Overall Study|Withdrawal by Subject|7|||
163377664|NCT01506609|590089874|FG005|Overall Study|Withdrawal by Subject|7|||
163377665|NCT01506609|590089869|FG000|Overall Study|Lost to Follow-up|0|||
163377666|NCT01506609|590089870|FG001|Overall Study|Lost to Follow-up|0|||
163377667|NCT01506609|590089871|FG002|Overall Study|Lost to Follow-up|0|||
163377668|NCT01506609|590089872|FG003|Overall Study|Lost to Follow-up|1|||
163377669|NCT01506609|590089873|FG004|Overall Study|Lost to Follow-up|2|||
163377670|NCT01506609|590089874|FG005|Overall Study|Lost to Follow-up|0|||
163377671|NCT01506609|590089869|FG000|Overall Study|Sponsor Discontinued Study|0|||
163377672|NCT01506609|590089870|FG001|Overall Study|Sponsor Discontinued Study|0|||
163377673|NCT01506609|590089871|FG002|Overall Study|Sponsor Discontinued Study|0|||
163377674|NCT01506609|590089872|FG003|Overall Study|Sponsor Discontinued Study|2|||
163377675|NCT01506609|590089873|FG004|Overall Study|Sponsor Discontinued Study|2|||
163377676|NCT01506609|590089874|FG005|Overall Study|Sponsor Discontinued Study|0|||
163377677|NCT01506609|590089869|FG000|Overall Study|Progressive Disease per Protocol|1|||
163377678|NCT01506609|590089870|FG001|Overall Study|Progressive Disease per Protocol|0|||
163377679|NCT01506609|590089871|FG002|Overall Study|Progressive Disease per Protocol|0|||
163377680|NCT01506609|590089872|FG003|Overall Study|Progressive Disease per Protocol|64|||
163377681|NCT01506609|590089873|FG004|Overall Study|Progressive Disease per Protocol|57|||
163377682|NCT01506609|590089874|FG005|Overall Study|Progressive Disease per Protocol|74|||
163377683|NCT01506609|590089869|FG000|Overall Study|Other, Not Specified|0|||
163377684|NCT01506609|590089870|FG001|Overall Study|Other, Not Specified|0|||
163377685|NCT01506609|590089871|FG002|Overall Study|Other, Not Specified|0|||
163377686|NCT01506609|590089872|FG003|Overall Study|Other, Not Specified|10|||
163377687|NCT01506609|590089873|FG004|Overall Study|Other, Not Specified|7|||
163377688|NCT01506609|590089874|FG005|Overall Study|Other, Not Specified|3|||
163377689|NCT01506609|590089869|FG000|Overall Study|Missing / Unknown Reason|1|||
163377690|NCT01506609|590089870|FG001|Overall Study|Missing / Unknown Reason|0|||
163377691|NCT01506609|590089871|FG002|Overall Study|Missing / Unknown Reason|1|||
163377692|NCT01506609|590089872|FG003|Overall Study|Missing / Unknown Reason|4|||
163377693|NCT01506609|590089873|FG004|Overall Study|Missing / Unknown Reason|4|||
163377694|NCT01506609|590089874|FG005|Overall Study|Missing / Unknown Reason|2|||
163377695|NCT01990560|590089881|FG000|Overall Study|Withdrawal by Subject|1|||
163377696|NCT02325557|590089882|FG000|Overall Study|Progressive disease|1|||
163377697|NCT02325557|590089883|FG001|Overall Study|Progressive disease|0|||
163377698|NCT02325557|590089884|FG002|Overall Study|Progressive disease|0|||
163377699|NCT02325557|590089885|FG003|Overall Study|Progressive disease|0|||
163377700|NCT02325557|590089882|FG000|Overall Study|Withdrawal by Subject|4|||
163377701|NCT02325557|590089883|FG001|Overall Study|Withdrawal by Subject|0|||
163416175|NCT01114529|590231030|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
163416176|NCT01114529|590231031|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
163416177|NCT01114529|590231029|FG000|Completed Study Medication at Month 24|Missing|2|||
163416178|NCT01114529|590231030|FG001|Completed Study Medication at Month 24|Missing|0|||
163416179|NCT01114529|590231031|FG002|Completed Study Medication at Month 24|Missing|0|||
163416180|NCT01114529|590231029|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
163416181|NCT01114529|590231030|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
163416182|NCT01114529|590231031|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
163416183|NCT01114529|590231029|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
163416184|NCT01114529|590231030|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
163416185|NCT01114529|590231031|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
163416186|NCT01114529|590231029|FG000|Completed Study Phase at Month 24|Death|8|||
163377702|NCT02325557|590089884|FG002|Overall Study|Withdrawal by Subject|0|||
163377703|NCT02325557|590089885|FG003|Overall Study|Withdrawal by Subject|15|||
163377704|NCT02325557|590089882|FG000|Overall Study|Death|5|||
163377705|NCT02325557|590089883|FG001|Overall Study|Death|1|||
163377706|NCT02325557|590089884|FG002|Overall Study|Death|1|||
163377707|NCT02325557|590089885|FG003|Overall Study|Death|16|||
163377708|NCT02325557|590089882|FG000|Overall Study|Lost to Follow-up|0|||
163377709|NCT02325557|590089883|FG001|Overall Study|Lost to Follow-up|0|||
163377710|NCT02325557|590089884|FG002|Overall Study|Lost to Follow-up|1|||
163377711|NCT02325557|590089885|FG003|Overall Study|Lost to Follow-up|1|||
163377712|NCT02325557|590089882|FG000|Overall Study|Other|0|||
163377713|NCT02325557|590089883|FG001|Overall Study|Other|0|||
163377714|NCT02325557|590089884|FG002|Overall Study|Other|0|||
163377715|NCT02325557|590089885|FG003|Overall Study|Other|5|||
163377716|NCT02703259|590089889|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
163377717|NCT02703259|590089890|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
163377718|NCT02703259|590089889|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
163377719|NCT02703259|590089890|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
163377720|NCT02703259|590089889|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
163377721|NCT02703259|590089890|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
163377722|NCT01153958|590089891|FG000|Overall Study|Study Terminated|36|||
163377723|NCT01153958|590089892|FG001|Overall Study|Study Terminated|32|||
163377724|NCT00895154|590089894|FG000|Overall Study|Lost to Follow-up|1|||
163377725|NCT00895154|590089895|FG001|Overall Study|Lost to Follow-up|1|||
163377726|NCT00895154|590089894|FG000|Overall Study|Withdrawal by Subject|0|||
163377727|NCT00895154|590089895|FG001|Overall Study|Withdrawal by Subject|1|||
163377728|NCT00470366|590089896|FG000|Overall Study|Adverse Event|3|||
163377729|NCT00470366|590089896|FG000|Overall Study|Poor compliance|1|||
163377730|NCT01021215|590089897|FG000|Overall Study|Lost to Follow-up|3|||
163377731|NCT01021215|590089898|FG001|Overall Study|Lost to Follow-up|0|||
163377732|NCT01103362|590089901|FG000|Overall Study|study terminated|596|||
163377733|NCT01688830|590089905|FG000|Overall Study|Lost to Follow-up|0|||
163377734|NCT01688830|590089906|FG001|Overall Study|Lost to Follow-up|0|||
163377735|NCT01688830|590089907|FG002|Overall Study|Lost to Follow-up|0|||
163377736|NCT01688830|590089908|FG003|Overall Study|Lost to Follow-up|0|||
163377737|NCT01688830|590089909|FG004|Overall Study|Lost to Follow-up|0|||
163377738|NCT01688830|590089910|FG005|Overall Study|Lost to Follow-up|0|||
163377739|NCT01688830|590089911|FG006|Overall Study|Lost to Follow-up|0|||
163416187|NCT01114529|590231030|FG001|Completed Study Phase at Month 24|Death|5|||
163416188|NCT01114529|590231031|FG002|Completed Study Phase at Month 24|Death|4|||
163416189|NCT01114529|590231029|FG000|Completed Study Phase at Month 24|Other|2|||
163416190|NCT01114529|590231030|FG001|Completed Study Phase at Month 24|Other|0|||
163377740|NCT01688830|590089912|FG007|Overall Study|Lost to Follow-up|0|||
163377741|NCT01688830|590089913|FG008|Overall Study|Lost to Follow-up|0|||
163377742|NCT01688830|590089914|FG009|Overall Study|Lost to Follow-up|0|||
163377743|NCT01688830|590089915|FG010|Overall Study|Lost to Follow-up|1|||
163377744|NCT01688830|590089916|FG011|Overall Study|Lost to Follow-up|0|||
163377745|NCT01688830|590089917|FG012|Overall Study|Lost to Follow-up|0|||
163377746|NCT01688830|590089918|FG013|Overall Study|Lost to Follow-up|0|||
163377747|NCT01688830|590089919|FG014|Overall Study|Lost to Follow-up|0|||
163377748|NCT01688830|590089920|FG015|Overall Study|Lost to Follow-up|0|||
163377749|NCT01688830|590089921|FG016|Overall Study|Lost to Follow-up|0|||
163377750|NCT01688830|590089922|FG017|Overall Study|Lost to Follow-up|0|||
163377751|NCT01688830|590089923|FG018|Overall Study|Lost to Follow-up|0|||
163377752|NCT01688830|590089924|FG019|Overall Study|Lost to Follow-up|0|||
163377753|NCT01688830|590089925|FG020|Overall Study|Lost to Follow-up|0|||
163377754|NCT00935818|590089926|FG000|Overall Study|Withdrawal by Subject|45|||
163416191|NCT01114529|590231031|FG002|Completed Study Phase at Month 24|Other|0|||
163377755|NCT00935818|590089927|FG001|Overall Study|Withdrawal by Subject|50|||
163377756|NCT00935818|590089926|FG000|Overall Study|Lost to Follow-up|40|||
163377757|NCT00935818|590089927|FG001|Overall Study|Lost to Follow-up|42|||
163377758|NCT00935818|590089926|FG000|Overall Study|Adverse Event|6|||
163377759|NCT00935818|590089927|FG001|Overall Study|Adverse Event|7|||
163377760|NCT00935818|590089926|FG000|Overall Study|Physician Decision|0|||
163377761|NCT00935818|590089927|FG001|Overall Study|Physician Decision|1|||
163377762|NCT00604825|590089928|FG000|Overall Study|Adverse Event|2|||
163377763|NCT00604825|590089929|FG001|Overall Study|Adverse Event|6|||
163377764|NCT00604825|590089930|FG002|Overall Study|Adverse Event|7|||
163377765|NCT00604825|590089931|FG003|Overall Study|Adverse Event|4|||
163377766|NCT00604825|590089928|FG000|Overall Study|Lost to Follow-up|0|||
163377767|NCT00604825|590089929|FG001|Overall Study|Lost to Follow-up|3|||
163377768|NCT00604825|590089930|FG002|Overall Study|Lost to Follow-up|1|||
163377769|NCT00604825|590089931|FG003|Overall Study|Lost to Follow-up|0|||
163377770|NCT00604825|590089928|FG000|Overall Study|Protocol Violation|0|||
163377771|NCT00604825|590089929|FG001|Overall Study|Protocol Violation|1|||
163377772|NCT00604825|590089930|FG002|Overall Study|Protocol Violation|0|||
163377773|NCT00604825|590089931|FG003|Overall Study|Protocol Violation|0|||
163377774|NCT00604825|590089928|FG000|Overall Study|Withdrawal by Subject|4|||
163377775|NCT00604825|590089929|FG001|Overall Study|Withdrawal by Subject|3|||
163377776|NCT00604825|590089930|FG002|Overall Study|Withdrawal by Subject|5|||
163377777|NCT00604825|590089931|FG003|Overall Study|Withdrawal by Subject|5|||
163377778|NCT00604825|590089928|FG000|Overall Study|Lack of Efficacy|3|||
163377779|NCT00604825|590089929|FG001|Overall Study|Lack of Efficacy|2|||
163377780|NCT00604825|590089930|FG002|Overall Study|Lack of Efficacy|1|||
163377781|NCT00604825|590089931|FG003|Overall Study|Lack of Efficacy|0|||
163377782|NCT00604825|590089928|FG000|Overall Study|Did not meet eligibility criteria|0|||
163377783|NCT00604825|590089929|FG001|Overall Study|Did not meet eligibility criteria|0|||
163377784|NCT00604825|590089930|FG002|Overall Study|Did not meet eligibility criteria|2|||
163377785|NCT00604825|590089931|FG003|Overall Study|Did not meet eligibility criteria|0|||
163377786|NCT00604825|590089928|FG000|Overall Study|Physician Decision|0|||
163377787|NCT00604825|590089929|FG001|Overall Study|Physician Decision|0|||
163377788|NCT00604825|590089930|FG002|Overall Study|Physician Decision|0|||
163377789|NCT00604825|590089931|FG003|Overall Study|Physician Decision|1|||
163377790|NCT00604825|590089928|FG000|Overall Study|Exclusion criterion met|0|||
163377791|NCT00604825|590089929|FG001|Overall Study|Exclusion criterion met|0|||
163377792|NCT00604825|590089930|FG002|Overall Study|Exclusion criterion met|0|||
163377793|NCT00604825|590089931|FG003|Overall Study|Exclusion criterion met|1|||
163377794|NCT03465904|590089932|FG000|Overall Study|Withdrawal by Subject|9|||
163377795|NCT03465904|590089933|FG001|Overall Study|Withdrawal by Subject|5|||
163377796|NCT03465904|590089932|FG000|Overall Study|Lost to Follow-up|11|||
163377797|NCT03465904|590089933|FG001|Overall Study|Lost to Follow-up|9|||
163377798|NCT03465904|590089932|FG000|Overall Study|Protocol Violation|20|||
163377799|NCT03465904|590089933|FG001|Overall Study|Protocol Violation|15|||
163377800|NCT01305200|590089934|FG000|Overall Study|Physician Decision|4|||
163377801|NCT01305200|590089935|FG001|Overall Study|Physician Decision|6|||
163377802|NCT01305200|590089936|FG002|Overall Study|Physician Decision|1|||
163377803|NCT01305200|590089934|FG000|Overall Study|Withdrawal by Subject|24|||
163377804|NCT01305200|590089935|FG001|Overall Study|Withdrawal by Subject|21|||
163377805|NCT01305200|590089936|FG002|Overall Study|Withdrawal by Subject|1|||
163377806|NCT01305200|590089934|FG000|Overall Study|Ineligible|1|||
163377807|NCT01305200|590089935|FG001|Overall Study|Ineligible|2|||
163377808|NCT01305200|590089936|FG002|Overall Study|Ineligible|1|||
163377809|NCT01305200|590089934|FG000|Overall Study|Death|0|||
163377810|NCT01305200|590089935|FG001|Overall Study|Death|2|||
163377811|NCT01305200|590089936|FG002|Overall Study|Death|0|||
163377812|NCT05593445|590089937|FG000|12-Week DBVC Period|Adverse Event|1|||
163377813|NCT05593445|590089938|FG001|12-Week DBVC Period|Adverse Event|0|||
163377814|NCT05593445|590089939|FG002|12-Week DBVC Period|Adverse Event|0|||
163377815|NCT05593445|590089940|FG003|12-Week DBVC Period|Adverse Event|0|||
163377816|NCT05593445|590089937|FG000|12-Week DBVC Period|Physician Decision|0|||
163377817|NCT05593445|590089938|FG001|12-Week DBVC Period|Physician Decision|1|||
163377818|NCT05593445|590089939|FG002|12-Week DBVC Period|Physician Decision|0|||
163377819|NCT05593445|590089940|FG003|12-Week DBVC Period|Physician Decision|0|||
163377820|NCT05593445|590089937|FG000|12-Week DBVC Period|Protocol Violation|0|||
163377821|NCT05593445|590089938|FG001|12-Week DBVC Period|Protocol Violation|1|||
163377822|NCT05593445|590089939|FG002|12-Week DBVC Period|Protocol Violation|0|||
163377823|NCT05593445|590089940|FG003|12-Week DBVC Period|Protocol Violation|0|||
163377824|NCT05593445|590089937|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
163377825|NCT05593445|590089938|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
163377826|NCT05593445|590089939|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
163377827|NCT05593445|590089940|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
163377828|NCT05593445|590089937|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
163377829|NCT05593445|590089938|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
163377830|NCT05593445|590089939|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
163377831|NCT05593445|590089940|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
163377832|NCT05593445|590089937|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
163377833|NCT05593445|590089938|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
163377834|NCT05593445|590089939|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
163377835|NCT05593445|590089940|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
163377836|NCT05593445|590089937|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
163377837|NCT05593445|590089938|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
163377838|NCT05593445|590089939|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
163377839|NCT05593445|590089940|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
163377840|NCT05593445|590089937|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
163377841|NCT05593445|590089938|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
163377842|NCT05593445|590089939|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
163377843|NCT05593445|590089940|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
163377844|NCT05559476|590089941|FG000|Overall Study|Adverse Event|2|||
163377845|NCT05559476|590089942|FG001|Overall Study|Adverse Event|0|||
163377846|NCT05559476|590089941|FG000|Overall Study|Lost to Follow-up|13|||
163377847|NCT05559476|590089942|FG001|Overall Study|Lost to Follow-up|12|||
163377848|NCT05559476|590089941|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
163377849|NCT05559476|590089942|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
163377850|NCT05559476|590089941|FG000|Overall Study|Other|0|||
163377851|NCT05559476|590089942|FG001|Overall Study|Other|2|||
163377852|NCT00925353|590089943|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
163377853|NCT02349425|590093062|FG000|Period 1|Adverse Event|1|||
163377854|NCT02349425|590093063|FG001|Period 1|Adverse Event|1|||
163377855|NCT02349425|590093064|FG002|Period 1|Adverse Event|0|||
163377856|NCT02349425|590093065|FG003|Period 1|Adverse Event|0|||
163377857|NCT02349425|590093062|FG000|Period 2|Adverse Event|0|||
163377858|NCT02349425|590093063|FG001|Period 2|Adverse Event|1|||
163377859|NCT02349425|590093064|FG002|Period 2|Adverse Event|1|||
163377860|NCT02349425|590093065|FG003|Period 2|Adverse Event|0|||
163377861|NCT01190514|590093066|FG000|First Intervention (Period 1)|Adverse Event|1|||
163377862|NCT01190514|590093067|FG001|First Intervention (Period 1)|Adverse Event|0|||
163377863|NCT01190514|590093068|FG002|First Intervention (Period 1)|Adverse Event|0|||
163377864|NCT01190514|590093069|FG003|First Intervention (Period 1)|Adverse Event|0|||
163377865|NCT01190514|590093066|FG000|Third Intervention (Period 3)|Adverse Event|1|||
163377866|NCT01190514|590093067|FG001|Third Intervention (Period 3)|Adverse Event|0|||
163377867|NCT01190514|590093068|FG002|Third Intervention (Period 3)|Adverse Event|0|||
163377868|NCT01190514|590093069|FG003|Third Intervention (Period 3)|Adverse Event|0|||
163377869|NCT00512317|590093070|FG000|Overall Study|Insufficient clinical response|36|||
163377870|NCT00512317|590093070|FG000|Overall Study|Withdrawal by Subject|23|||
163377871|NCT00512317|590093070|FG000|Overall Study|Sponsor closure of study|21|||
163377872|NCT00512317|590093070|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
163377873|NCT00512317|590093070|FG000|Overall Study|Adverse Event|13|||
163377874|NCT00512317|590093070|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
163377875|NCT00512317|590093070|FG000|Overall Study|Lost to Follow-up|2|||
163377876|NCT00512317|590093070|FG000|Overall Study|Other|2|||
163377877|NCT00706433|590093073|FG000|Overall Study|Lost to Follow-up|3|||
163377878|NCT00706433|590093074|FG001|Overall Study|Lost to Follow-up|1|||
163377879|NCT00706433|590093075|FG002|Overall Study|Lost to Follow-up|6|||
163377880|NCT00706433|590093076|FG003|Overall Study|Lost to Follow-up|0|||
163377881|NCT00706433|590093073|FG000|Overall Study|Withdrawal by Subject|1|||
163377882|NCT00706433|590093074|FG001|Overall Study|Withdrawal by Subject|2|||
163377883|NCT00706433|590093075|FG002|Overall Study|Withdrawal by Subject|3|||
163377884|NCT00706433|590093076|FG003|Overall Study|Withdrawal by Subject|1|||
163377885|NCT00706433|590093073|FG000|Overall Study|Adverse Event|0|||
163377886|NCT00706433|590093074|FG001|Overall Study|Adverse Event|0|||
163377887|NCT00706433|590093075|FG002|Overall Study|Adverse Event|1|||
163377888|NCT00706433|590093076|FG003|Overall Study|Adverse Event|0|||
163377889|NCT00706433|590093073|FG000|Overall Study|Protocol Violation|1|||
163377890|NCT00706433|590093074|FG001|Overall Study|Protocol Violation|0|||
163377891|NCT00706433|590093075|FG002|Overall Study|Protocol Violation|0|||
163377892|NCT00706433|590093076|FG003|Overall Study|Protocol Violation|0|||
163377893|NCT00706433|590093073|FG000|Overall Study|new job|0|||
163377894|NCT00706433|590093074|FG001|Overall Study|new job|0|||
163377895|NCT00706433|590093075|FG002|Overall Study|new job|0|||
163377896|NCT00706433|590093076|FG003|Overall Study|new job|1|||
163377897|NCT04101318|590093078|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
163377898|NCT04101318|590093079|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
163377899|NCT04101318|590093078|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
163377900|NCT04101318|590093079|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
163377901|NCT04101318|590093078|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
163377902|NCT04101318|590093079|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
163377903|NCT00717067|590093080|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
163377904|NCT00717067|590093081|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
163377905|NCT00717067|590093082|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
163377906|NCT00717067|590093083|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
163377907|NCT00717067|590093084|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
163377908|NCT02090959|590093085|FG000|Overall Study|Withdrawal by Subject|10|||
163377909|NCT02090959|590093085|FG000|Overall Study|Adverse Event|1|||
163377910|NCT02090959|590093085|FG000|Overall Study|Investigator decision|2|||
163377911|NCT02090959|590093085|FG000|Overall Study|Study termination|6|||
163377912|NCT02090959|590093085|FG000|Overall Study|Enrolled but not treated|1|||
163377913|NCT02090959|590093085|FG000|Overall Study|Transfer for compassionate use medicine|4|||
163416192|NCT01114529|590231029|FG000|Completed Study Phase at Month 24|Missing|2|||
163416193|NCT01114529|590231030|FG001|Completed Study Phase at Month 24|Missing|0|||
163416194|NCT01114529|590231031|FG002|Completed Study Phase at Month 24|Missing|0|||
163416195|NCT04428411|590231034|FG000|Overall Study|Lost to Follow-up|114|||
163416196|NCT00634569|590231035|FG000|Overall Study|Withdrawal by Subject|0|||
163416197|NCT00634569|590231036|FG001|Overall Study|Withdrawal by Subject|4|||
163416198|NCT00634569|590231035|FG000|Overall Study|Physician Decision|0|||
163416199|NCT00634569|590231036|FG001|Overall Study|Physician Decision|1|||
163416200|NCT02918019|590231037|FG000|Overall Study|Death|0|||
163416201|NCT02918019|590231038|FG001|Overall Study|Death|0|||
163416202|NCT02918019|590231039|FG002|Overall Study|Death|1|||
163416203|NCT02918019|590231040|FG003|Overall Study|Death|0|||
163416204|NCT02918019|590231037|FG000|Overall Study|Lost to Follow-up|1|||
163416205|NCT02918019|590231038|FG001|Overall Study|Lost to Follow-up|1|||
163416206|NCT02918019|590231039|FG002|Overall Study|Lost to Follow-up|0|||
163416207|NCT02918019|590231040|FG003|Overall Study|Lost to Follow-up|1|||
163416208|NCT02918019|590231037|FG000|Overall Study|Principal investigator request|0|||
163416209|NCT02918019|590231038|FG001|Overall Study|Principal investigator request|0|||
163416210|NCT02918019|590231039|FG002|Overall Study|Principal investigator request|0|||
163416211|NCT02918019|590231040|FG003|Overall Study|Principal investigator request|1|||
163416212|NCT02918019|590231037|FG000|Overall Study|Physician Decision|1|||
163416213|NCT02918019|590231038|FG001|Overall Study|Physician Decision|3|||
163416214|NCT02918019|590231039|FG002|Overall Study|Physician Decision|2|||
163416215|NCT02918019|590231040|FG003|Overall Study|Physician Decision|0|||
163416216|NCT02918019|590231037|FG000|Overall Study|Protocol deviation|1|||
163416217|NCT02918019|590231038|FG001|Overall Study|Protocol deviation|1|||
163416218|NCT02918019|590231039|FG002|Overall Study|Protocol deviation|0|||
163416219|NCT02918019|590231040|FG003|Overall Study|Protocol deviation|2|||
163416220|NCT02918019|590231037|FG000|Overall Study|Withdrawal by Subject|3|||
163416221|NCT02918019|590231038|FG001|Overall Study|Withdrawal by Subject|4|||
163416222|NCT02918019|590231039|FG002|Overall Study|Withdrawal by Subject|6|||
163416223|NCT02918019|590231040|FG003|Overall Study|Withdrawal by Subject|4|||
163416224|NCT02918019|590231037|FG000|Overall Study|Adverse Event|0|||
163416225|NCT02918019|590231038|FG001|Overall Study|Adverse Event|1|||
163416226|NCT02918019|590231039|FG002|Overall Study|Adverse Event|0|||
163416227|NCT02918019|590231040|FG003|Overall Study|Adverse Event|1|||
163416228|NCT01212185|590231041|FG000|Overall Study|Protocol Violation|2|||
163416229|NCT01212185|590231042|FG001|Overall Study|Protocol Violation|1|||
163416230|NCT03555266|590231043|FG000|Overall Study|Protocol Violation|6|||
163416231|NCT03555266|590231044|FG001|Overall Study|Protocol Violation|4|||
163416232|NCT01699087|590231045|FG000|Overall Study|Lost to Follow-up|7|||
163416233|NCT01699087|590231045|FG000|Overall Study|Screen failure (prior to treatment)|15|||
163416234|NCT01699087|590231045|FG000|Overall Study|Unable to make future visits|2|||
163416235|NCT03370770|590231046|FG000|Overall Study|Patient was followed in another hospital center|1|||
163416236|NCT03370770|590231046|FG000|Overall Study|Progressive Disease|98|||
163416237|NCT03370770|590231046|FG000|Overall Study|Adverse Event|2|||
163416238|NCT03370770|590231046|FG000|Overall Study|Death|5|||
163416239|NCT00797823|590231051|FG000|First Period (Initial Randomization)|Physician Decision|1|||
163416240|NCT00797823|590231052|FG001|First Period (Initial Randomization)|Physician Decision|0|||
163416241|NCT00797823|590231053|FG002|First Period (Initial Randomization)|Physician Decision|0|||
163416242|NCT00408694|590231054|FG000|Overall Study|Ineligible|1|||
163416243|NCT00408694|590231054|FG000|Overall Study|No protocol treatment|1|||
163416244|NCT01700192|590231055|FG000|Overall Study|Adverse Event|73|||
163416245|NCT01700192|590231056|FG001|Overall Study|Adverse Event|18|||
163416246|NCT01700192|590231055|FG000|Overall Study|Lack of Efficacy|1|||
163416247|NCT01700192|590231056|FG001|Overall Study|Lack of Efficacy|0|||
163416248|NCT01700192|590231055|FG000|Overall Study|Lost to Follow-up|42|||
163416249|NCT01700192|590231056|FG001|Overall Study|Lost to Follow-up|29|||
163416250|NCT01700192|590231055|FG000|Overall Study|Noncompliance with study drug|0|||
163416251|NCT01700192|590231056|FG001|Overall Study|Noncompliance with study drug|5|||
163416252|NCT01700192|590231055|FG000|Overall Study|Physician Decision|2|||
163416253|NCT01700192|590231056|FG001|Overall Study|Physician Decision|3|||
163416254|NCT01700192|590231055|FG000|Overall Study|Pregnancy|1|||
163416255|NCT01700192|590231056|FG001|Overall Study|Pregnancy|4|||
163416256|NCT01700192|590231055|FG000|Overall Study|Progressive disease|1|||
163416257|NCT01700192|590231056|FG001|Overall Study|Progressive disease|0|||
163416258|NCT01700192|590231055|FG000|Overall Study|Protocol Violation|3|||
163416259|NCT01700192|590231056|FG001|Overall Study|Protocol Violation|4|||
163416260|NCT01700192|590231055|FG000|Overall Study|Technical problems|0|||
163416261|NCT01700192|590231056|FG001|Overall Study|Technical problems|1|||
163416262|NCT01700192|590231055|FG000|Overall Study|Withdrawal by Subject|56|||
163416263|NCT01700192|590231056|FG001|Overall Study|Withdrawal by Subject|64|||
163416264|NCT01700192|590231055|FG000|Overall Study|Never received study drug|1|||
163416265|NCT01700192|590231056|FG001|Overall Study|Never received study drug|0|||
163416266|NCT01017952|590231061|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
163416267|NCT01017952|590231062|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
163416268|NCT01017952|590231063|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
163377914|NCT02090959|590093085|FG000|Overall Study|Move to medical need program|3|||
163377915|NCT02090959|590093085|FG000|Overall Study|Entered in to other study|34|||
163377916|NCT02090959|590093085|FG000|Overall Study|Switched to commercial supply|88|||
163377917|NCT02090959|590093085|FG000|Overall Study|Other than specified|2|||
163377918|NCT00522873|590093086|FG000|Overall Study|Adverse Event|41|||
163377919|NCT00522873|590093087|FG001|Overall Study|Adverse Event|26|||
163377920|NCT00522873|590093086|FG000|Overall Study|Withdrawal by Subject|20|||
163377921|NCT00522873|590093087|FG001|Overall Study|Withdrawal by Subject|9|||
163377922|NCT00522873|590093086|FG000|Overall Study|Protocol Violation|14|||
163377923|NCT00522873|590093087|FG001|Overall Study|Protocol Violation|4|||
163377924|NCT00522873|590093086|FG000|Overall Study|Lost to Follow-up|11|||
163377925|NCT00522873|590093087|FG001|Overall Study|Lost to Follow-up|3|||
163377926|NCT00522873|590093086|FG000|Overall Study|Personal Reasons|8|||
163377927|NCT00522873|590093087|FG001|Overall Study|Personal Reasons|1|||
163377928|NCT00522873|590093086|FG000|Overall Study|Medication Errors|1|||
163377929|NCT00522873|590093087|FG001|Overall Study|Medication Errors|1|||
163377930|NCT00522873|590093086|FG000|Overall Study|Never Received Medication|1|||
163377931|NCT00522873|590093087|FG001|Overall Study|Never Received Medication|0|||
163377932|NCT02966301|590093088|FG000|Overall Study|Death|2|||
163377933|NCT02966301|590093088|FG000|Overall Study|Withdrawal by Subject|1|||
163377934|NCT00822172|590093092|FG000|Overall Study|Adverse Event|10|||
163377935|NCT00822172|590093093|FG001|Overall Study|Adverse Event|12|||
163377936|NCT00822172|590093092|FG000|Overall Study|Death|1|||
163377937|NCT00822172|590093093|FG001|Overall Study|Death|0|||
163377938|NCT00822172|590093092|FG000|Overall Study|Lost to Follow-up|3|||
163377939|NCT00822172|590093093|FG001|Overall Study|Lost to Follow-up|1|||
163377940|NCT00822172|590093092|FG000|Overall Study|Withdrawal by Subject|1|||
163377941|NCT00822172|590093093|FG001|Overall Study|Withdrawal by Subject|4|||
163377942|NCT00822172|590093092|FG000|Overall Study|site closed|0|||
163377943|NCT00822172|590093093|FG001|Overall Study|site closed|1|||
163377944|NCT00822172|590093092|FG000|Overall Study|Other|0|||
163377945|NCT00822172|590093093|FG001|Overall Study|Other|1|||
163377946|NCT01375114|590093096|FG000|Overall Study|Lost to Follow-up|1|||
163377947|NCT01375114|590093097|FG001|Overall Study|Lost to Follow-up|0|||
163377948|NCT01375114|590093098|FG002|Overall Study|Lost to Follow-up|1|||
163377949|NCT01375114|590093096|FG000|Overall Study|Disease Progression|3|||
163377950|NCT01375114|590093097|FG001|Overall Study|Disease Progression|2|||
163377951|NCT01375114|590093098|FG002|Overall Study|Disease Progression|2|||
163377952|NCT01375114|590093096|FG000|Overall Study|Patient Changed Mind|0|||
163377953|NCT01375114|590093097|FG001|Overall Study|Patient Changed Mind|0|||
163377954|NCT01375114|590093098|FG002|Overall Study|Patient Changed Mind|2|||
163377955|NCT01375114|590093096|FG000|Overall Study|Pruritus|0|||
163377956|NCT01375114|590093097|FG001|Overall Study|Pruritus|0|||
163377957|NCT01375114|590093098|FG002|Overall Study|Pruritus|1|||
163377958|NCT01375114|590093096|FG000|Overall Study|Restlessness|0|||
163377959|NCT01375114|590093097|FG001|Overall Study|Restlessness|0|||
163377960|NCT01375114|590093098|FG002|Overall Study|Restlessness|1|||
163377961|NCT01375114|590093096|FG000|Overall Study|Diarrhea|0|||
163377962|NCT01375114|590093097|FG001|Overall Study|Diarrhea|0|||
163377963|NCT01375114|590093098|FG002|Overall Study|Diarrhea|1|||
163377964|NCT01375114|590093096|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
163377965|NCT01375114|590093097|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
163377966|NCT01375114|590093098|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
163377967|NCT01375114|590093096|FG000|Overall Study|Nausea|0|||
163377968|NCT01375114|590093097|FG001|Overall Study|Nausea|1|||
163377969|NCT01375114|590093098|FG002|Overall Study|Nausea|0|||
163377970|NCT01375114|590093096|FG000|Overall Study|Increased AST/ALT|0|||
163377971|NCT01375114|590093097|FG001|Overall Study|Increased AST/ALT|1|||
163377972|NCT01375114|590093098|FG002|Overall Study|Increased AST/ALT|0|||
163377973|NCT01375114|590093096|FG000|Overall Study|Vaginal Hemorrhage|0|||
163377974|NCT01375114|590093097|FG001|Overall Study|Vaginal Hemorrhage|1|||
163377975|NCT01375114|590093098|FG002|Overall Study|Vaginal Hemorrhage|0|||
163377976|NCT01375114|590093096|FG000|Overall Study|Family problem|0|||
163377977|NCT01375114|590093097|FG001|Overall Study|Family problem|1|||
163377978|NCT01375114|590093098|FG002|Overall Study|Family problem|0|||
163377979|NCT01375114|590093096|FG000|Overall Study|Protocol Violation|2|||
163377980|NCT01375114|590093097|FG001|Overall Study|Protocol Violation|0|||
163377981|NCT01375114|590093098|FG002|Overall Study|Protocol Violation|0|||
163377982|NCT01859988|590093099|FG000|Overall Study|Withdrawal by Subject|6|||
163377983|NCT01859988|590093100|FG001|Overall Study|Withdrawal by Subject|3|||
163377984|NCT01859988|590093101|FG002|Overall Study|Withdrawal by Subject|4|||
163377985|NCT01859988|590093102|FG003|Overall Study|Withdrawal by Subject|3|||
163377986|NCT01859988|590093103|FG004|Overall Study|Withdrawal by Subject|2|||
163377987|NCT01859988|590093104|FG005|Overall Study|Withdrawal by Subject|2|||
163377988|NCT01859988|590093099|FG000|Overall Study|Lack of Efficacy|1|||
163377989|NCT01859988|590093100|FG001|Overall Study|Lack of Efficacy|1|||
163377990|NCT01859988|590093101|FG002|Overall Study|Lack of Efficacy|5|||
163377991|NCT01859988|590093102|FG003|Overall Study|Lack of Efficacy|0|||
163377992|NCT01859988|590093103|FG004|Overall Study|Lack of Efficacy|7|||
163377993|NCT01859988|590093104|FG005|Overall Study|Lack of Efficacy|9|||
163377994|NCT01859988|590093099|FG000|Overall Study|Physician Decision|1|||
163377995|NCT01859988|590093100|FG001|Overall Study|Physician Decision|3|||
163377996|NCT01859988|590093101|FG002|Overall Study|Physician Decision|1|||
163377997|NCT01859988|590093102|FG003|Overall Study|Physician Decision|3|||
163377998|NCT01859988|590093103|FG004|Overall Study|Physician Decision|4|||
163377999|NCT01859988|590093104|FG005|Overall Study|Physician Decision|1|||
163378000|NCT01859988|590093099|FG000|Overall Study|Adverse Event|2|||
163378001|NCT01859988|590093100|FG001|Overall Study|Adverse Event|1|||
163378002|NCT01859988|590093101|FG002|Overall Study|Adverse Event|3|||
163378003|NCT01859988|590093102|FG003|Overall Study|Adverse Event|1|||
163378004|NCT01859988|590093103|FG004|Overall Study|Adverse Event|2|||
163378005|NCT01859988|590093104|FG005|Overall Study|Adverse Event|2|||
163378006|NCT01859988|590093099|FG000|Overall Study|Lost to Follow-up|1|||
163378007|NCT01859988|590093100|FG001|Overall Study|Lost to Follow-up|2|||
163378008|NCT01859988|590093101|FG002|Overall Study|Lost to Follow-up|3|||
163378009|NCT01859988|590093102|FG003|Overall Study|Lost to Follow-up|0|||
163378010|NCT01859988|590093103|FG004|Overall Study|Lost to Follow-up|3|||
163378011|NCT01859988|590093104|FG005|Overall Study|Lost to Follow-up|2|||
163378012|NCT01859988|590093099|FG000|Overall Study|Protocol Violation|0|||
163378013|NCT01859988|590093100|FG001|Overall Study|Protocol Violation|0|||
163378014|NCT01859988|590093101|FG002|Overall Study|Protocol Violation|1|||
163378015|NCT01859988|590093102|FG003|Overall Study|Protocol Violation|0|||
163378016|NCT01859988|590093103|FG004|Overall Study|Protocol Violation|0|||
163378017|NCT01859988|590093104|FG005|Overall Study|Protocol Violation|0|||
163378018|NCT01859988|590093099|FG000|Overall Study|Other than specified above|0|||
163378019|NCT01859988|590093100|FG001|Overall Study|Other than specified above|2|||
163378020|NCT01859988|590093101|FG002|Overall Study|Other than specified above|11|||
163378021|NCT01859988|590093102|FG003|Overall Study|Other than specified above|3|||
163378022|NCT01859988|590093103|FG004|Overall Study|Other than specified above|5|||
163378023|NCT01859988|590093104|FG005|Overall Study|Other than specified above|3|||
163378024|NCT00652327|590093105|FG000|Overall Study|Adverse Event|0|||
163378025|NCT00652327|590093106|FG001|Overall Study|Adverse Event|2|||
163378026|NCT00652327|590093105|FG000|Overall Study|Lost to Follow-up|0|||
163378027|NCT00652327|590093106|FG001|Overall Study|Lost to Follow-up|3|||
163378028|NCT00564889|590093107|FG000|Overall Study|Death|7|||
163378029|NCT00564889|590093107|FG000|Overall Study|Adverse Event|12|||
163378030|NCT00564889|590093107|FG000|Overall Study|Alternative treatment|3|||
163378031|NCT00564889|590093107|FG000|Overall Study|Disease progression|3|||
163378032|NCT00564889|590093107|FG000|Overall Study|Other, not specified|4|||
163378033|NCT00635427|590093108|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
163378034|NCT00635427|590093109|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
163378035|NCT00635427|590093110|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
163378036|NCT00635427|590093111|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
163378037|NCT00635427|590093112|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
163378038|NCT00635427|590093108|FG000|Overall Study|Death|0|||
163378039|NCT00635427|590093109|FG001|Overall Study|Death|0|||
163378040|NCT00635427|590093110|FG002|Overall Study|Death|0|||
163378041|NCT00635427|590093111|FG003|Overall Study|Death|1|||
163378042|NCT00635427|590093112|FG004|Overall Study|Death|0|||
163378043|NCT00635427|590093108|FG000|Overall Study|Termination Of Study By Sponsor|12|||
163378044|NCT00635427|590093109|FG001|Overall Study|Termination Of Study By Sponsor|6|||
163378045|NCT00635427|590093110|FG002|Overall Study|Termination Of Study By Sponsor|10|||
163378046|NCT00635427|590093111|FG003|Overall Study|Termination Of Study By Sponsor|6|||
163378047|NCT00635427|590093112|FG004|Overall Study|Termination Of Study By Sponsor|6|||
163378048|NCT00635427|590093108|FG000|Overall Study|Withdrawal Of Consent|0|||
163378049|NCT00635427|590093109|FG001|Overall Study|Withdrawal Of Consent|0|||
163378050|NCT00635427|590093110|FG002|Overall Study|Withdrawal Of Consent|0|||
163378051|NCT00635427|590093111|FG003|Overall Study|Withdrawal Of Consent|2|||
163378052|NCT00635427|590093112|FG004|Overall Study|Withdrawal Of Consent|2|||
163378053|NCT05753670|590093113|FG000|Overall Study|Withdrawal by Subject|6|||
163378054|NCT05753670|590093114|FG001|Overall Study|Withdrawal by Subject|8|||
163378055|NCT05753670|590093113|FG000|Overall Study|Protocol Violation|3|||
163378056|NCT05753670|590093114|FG001|Overall Study|Protocol Violation|1|||
163378057|NCT00577473|590093117|FG000|Overall Study|Protocol Violation|1|||
163378058|NCT00577473|590093118|FG001|Overall Study|Protocol Violation|4|||
163378059|NCT00577473|590093117|FG000|Overall Study|Adverse Event|8|||
163378060|NCT00577473|590093118|FG001|Overall Study|Adverse Event|5|||
163378061|NCT00577473|590093117|FG000|Overall Study|Withdrawal by Subject|2|||
163378062|NCT00577473|590093118|FG001|Overall Study|Withdrawal by Subject|6|||
163378063|NCT00577473|590093117|FG000|Overall Study|Physician Decision|2|||
163378064|NCT00577473|590093118|FG001|Overall Study|Physician Decision|2|||
163378065|NCT00577473|590093117|FG000|Overall Study|Lack of Efficacy|8|||
163378066|NCT00577473|590093118|FG001|Overall Study|Lack of Efficacy|7|||
163378067|NCT02595073|590093119|FG000|Overall Study|Progressive Disease|0|||
163378068|NCT02595073|590093120|FG001|Overall Study|Progressive Disease|1|||
163378069|NCT02595073|590093119|FG000|Overall Study|Protocol Violation|2|||
163378070|NCT02595073|590093120|FG001|Overall Study|Protocol Violation|0|||
163378071|NCT01324440|590093121|FG000|Overall Study|Subject moved|0|||
163416269|NCT01017952|590231064|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
163416270|NCT01017952|590231065|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
163416271|NCT01017952|590231061|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
163416272|NCT01017952|590231062|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
163416273|NCT01017952|590231063|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
163416274|NCT01017952|590231064|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
163416275|NCT01017952|590231065|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
163416276|NCT01017952|590231061|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
163416277|NCT01017952|590231062|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
163416278|NCT01017952|590231063|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
163416279|NCT01017952|590231064|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
163416280|NCT01017952|590231065|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
163416281|NCT01017952|590231061|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
163416282|NCT01017952|590231062|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
163416283|NCT01017952|590231063|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
163416284|NCT01017952|590231064|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
163416285|NCT01017952|590231065|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
163416286|NCT01017952|590231061|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
163416287|NCT01017952|590231062|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
163416288|NCT01017952|590231063|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
163416289|NCT01017952|590231064|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
163416290|NCT01017952|590231065|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
163416291|NCT01017952|590231061|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
163416292|NCT01017952|590231062|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
163416293|NCT01017952|590231063|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
163416294|NCT01017952|590231064|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
163416295|NCT01017952|590231065|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
163416296|NCT01017952|590231061|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
163416297|NCT01017952|590231062|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
163416298|NCT01017952|590231063|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
163416299|NCT01017952|590231064|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
163416300|NCT01017952|590231065|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
163416301|NCT01017952|590231061|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
163416302|NCT01017952|590231062|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
163416303|NCT01017952|590231063|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
163416304|NCT01017952|590231064|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
163416305|NCT01017952|590231065|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
163416306|NCT01017952|590231061|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
163416307|NCT01017952|590231062|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
163416308|NCT01017952|590231063|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
163416309|NCT01017952|590231064|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
163416310|NCT01017952|590231065|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
163416311|NCT01017952|590231061|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
163416312|NCT01017952|590231062|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
163416313|NCT01017952|590231063|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
163416314|NCT01017952|590231064|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
163416315|NCT01017952|590231065|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
163416316|NCT01017952|590231061|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
163378072|NCT01324440|590093122|FG001|Overall Study|Subject moved|1|||
163378073|NCT02884908|590093128|FG000|Overall Study|Lost to Follow-up|13|||
163378074|NCT02884908|590093129|FG001|Overall Study|Lost to Follow-up|18|||
163378075|NCT01293487|590093133|FG000|Overall Study|Lost to Follow-up|0|||
163378076|NCT01293487|590093134|FG001|Overall Study|Lost to Follow-up|0|||
163378077|NCT01293487|590093135|FG002|Overall Study|Lost to Follow-up|0|||
163378078|NCT01293487|590093136|FG003|Overall Study|Lost to Follow-up|1|||
163378079|NCT01293487|590093137|FG004|Overall Study|Lost to Follow-up|0|||
163378080|NCT01293487|590093138|FG005|Overall Study|Lost to Follow-up|0|||
163378081|NCT01293487|590093139|FG006|Overall Study|Lost to Follow-up|0|||
163378082|NCT01293487|590093140|FG007|Overall Study|Lost to Follow-up|0|||
163378083|NCT01293487|590093133|FG000|Overall Study|Withdrawal by Subject|0|||
163378084|NCT01293487|590093134|FG001|Overall Study|Withdrawal by Subject|0|||
163378085|NCT01293487|590093135|FG002|Overall Study|Withdrawal by Subject|0|||
163378086|NCT01293487|590093136|FG003|Overall Study|Withdrawal by Subject|0|||
163378087|NCT01293487|590093137|FG004|Overall Study|Withdrawal by Subject|0|||
163378088|NCT01293487|590093138|FG005|Overall Study|Withdrawal by Subject|0|||
163378089|NCT01293487|590093139|FG006|Overall Study|Withdrawal by Subject|0|||
163378090|NCT01293487|590093140|FG007|Overall Study|Withdrawal by Subject|2|||
163378091|NCT04860297|590093141|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
163416317|NCT01017952|590231062|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
163416318|NCT01017952|590231063|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
163416319|NCT01017952|590231064|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
163416320|NCT01017952|590231065|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
163416321|NCT01017952|590231061|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
163416322|NCT01017952|590231062|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
163416323|NCT01017952|590231063|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
163416324|NCT01017952|590231064|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
163416325|NCT01017952|590231065|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
163416326|NCT01017952|590231061|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163416327|NCT01017952|590231062|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
163416328|NCT01017952|590231063|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
163416329|NCT01017952|590231064|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
163416330|NCT01017952|590231065|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
163416331|NCT01017952|590231061|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
163416332|NCT01017952|590231062|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
163416333|NCT01017952|590231063|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
163416334|NCT01017952|590231064|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
163416335|NCT01017952|590231065|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
163416336|NCT00352105|590231067|FG000|Overall Study|Death|5|||
163416337|NCT00352105|590231067|FG000|Overall Study|Withdrawal by Subject|5|||
163416338|NCT00352105|590231067|FG000|Overall Study|Lack of Efficacy|9|||
163416339|NCT00352105|590231067|FG000|Overall Study|Adverse Event|19|||
163416340|NCT00352105|590231067|FG000|Overall Study|Protocol Violation|2|||
163416341|NCT02979431|590231070|FG000|Overall Study|Parent/guardian withdrew consent|2|||
163416342|NCT02979431|590231071|FG001|Overall Study|Parent/guardian withdrew consent|1|||
163416343|NCT02979431|590231072|FG002|Overall Study|Parent/guardian withdrew consent|1|||
163416344|NCT02979431|590231073|FG003|Overall Study|Parent/guardian withdrew consent|1|||
163416345|NCT02979431|590231070|FG000|Overall Study|Randomized but received no study drug|1|||
163416346|NCT02979431|590231071|FG001|Overall Study|Randomized but received no study drug|1|||
163416347|NCT02979431|590231072|FG002|Overall Study|Randomized but received no study drug|0|||
163416348|NCT02979431|590231073|FG003|Overall Study|Randomized but received no study drug|0|||
163416349|NCT02979431|590231070|FG000|Overall Study|Adverse Event|0|||
163416350|NCT02979431|590231071|FG001|Overall Study|Adverse Event|0|||
163416351|NCT02979431|590231072|FG002|Overall Study|Adverse Event|1|||
163416352|NCT02979431|590231073|FG003|Overall Study|Adverse Event|0|||
163416353|NCT02979431|590231070|FG000|Overall Study|Subject left country after Day14|1|||
163416354|NCT02979431|590231071|FG001|Overall Study|Subject left country after Day14|0|||
163416355|NCT02979431|590231072|FG002|Overall Study|Subject left country after Day14|0|||
163416356|NCT02979431|590231073|FG003|Overall Study|Subject left country after Day14|0|||
163416357|NCT01656434|590231074|FG000|Overall Study|Adverse Event|199|||
163416358|NCT01656434|590231075|FG001|Overall Study|Adverse Event|63|||
163416359|NCT01656434|590231074|FG000|Overall Study|Enrollment terminated at trial site|2|||
163416360|NCT01656434|590231075|FG001|Overall Study|Enrollment terminated at trial site|0|||
163416361|NCT01656434|590231074|FG000|Overall Study|Lost to Follow-up|309|||
163416362|NCT01656434|590231075|FG001|Overall Study|Lost to Follow-up|76|||
163416363|NCT01656434|590231074|FG000|Overall Study|Site discontinued study participation|24|||
163416364|NCT01656434|590231075|FG001|Overall Study|Site discontinued study participation|9|||
163416365|NCT01656434|590231074|FG000|Overall Study|Screen failure|2|||
163416366|NCT01656434|590231075|FG001|Overall Study|Screen failure|0|||
163416367|NCT01656434|590231074|FG000|Overall Study|Protocol Violation|7|||
163416368|NCT01656434|590231075|FG001|Overall Study|Protocol Violation|0|||
163416369|NCT01656434|590231074|FG000|Overall Study|Pregnancy wish|18|||
163416370|NCT01656434|590231075|FG001|Overall Study|Pregnancy wish|6|||
163416371|NCT01656434|590231074|FG000|Overall Study|Pregnancy|45|||
163416372|NCT01656434|590231075|FG001|Overall Study|Pregnancy|10|||
163416373|NCT01656434|590231074|FG000|Overall Study|Physician Decision|7|||
163416374|NCT01656434|590231075|FG001|Overall Study|Physician Decision|2|||
163416375|NCT01656434|590231074|FG000|Overall Study|Non-compliance with study drug|48|||
163416376|NCT01656434|590231075|FG001|Overall Study|Non-compliance with study drug|9|||
163416377|NCT01656434|590231074|FG000|Overall Study|Study terminated by sponsor|1501|||
163416378|NCT01656434|590231075|FG001|Overall Study|Study terminated by sponsor|348|||
163416379|NCT01656434|590231074|FG000|Overall Study|Participant discontinued; drug related|13|||
163416380|NCT01656434|590231075|FG001|Overall Study|Participant discontinued; drug related|4|||
163416381|NCT01656434|590231074|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
163416382|NCT01656434|590231075|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
163416383|NCT01656434|590231074|FG000|Overall Study|Non-compliance with protocol|39|||
163416384|NCT01656434|590231075|FG001|Overall Study|Non-compliance with protocol|15|||
163416385|NCT01656434|590231074|FG000|Overall Study|Participant moved|40|||
163416386|NCT01656434|590231075|FG001|Overall Study|Participant moved|12|||
163378092|NCT04860297|590093142|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
163378093|NCT04860297|590093143|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
163378094|NCT04860297|590093144|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
163378095|NCT04860297|590093145|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
163378096|NCT04860297|590093146|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
163378097|NCT04860297|590093147|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
163378098|NCT04860297|590093148|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
163378099|NCT04860297|590093141|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
163378100|NCT04860297|590093142|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
163378101|NCT04860297|590093143|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
163378102|NCT04860297|590093144|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
163378103|NCT04860297|590093145|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
163378104|NCT04860297|590093146|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
163378105|NCT04860297|590093147|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
163378106|NCT04860297|590093148|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
163378107|NCT04860297|590093141|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
163378108|NCT04860297|590093142|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
163378109|NCT04860297|590093143|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
163378110|NCT04860297|590093144|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
163378111|NCT04860297|590093145|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
163378112|NCT04860297|590093146|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
163378113|NCT04860297|590093147|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
163378114|NCT04860297|590093148|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
163378115|NCT04860297|590093141|FG000|Part B (Booster Dose)|Other Than Specified|0|||
163378116|NCT04860297|590093142|FG001|Part B (Booster Dose)|Other Than Specified|0|||
163378117|NCT04860297|590093143|FG002|Part B (Booster Dose)|Other Than Specified|0|||
163378118|NCT04860297|590093144|FG003|Part B (Booster Dose)|Other Than Specified|0|||
163378119|NCT04860297|590093145|FG004|Part B (Booster Dose)|Other Than Specified|0|||
163378120|NCT04860297|590093146|FG005|Part B (Booster Dose)|Other Than Specified|1|||
163378121|NCT04860297|590093147|FG006|Part B (Booster Dose)|Other Than Specified|1|||
163378122|NCT04860297|590093148|FG007|Part B (Booster Dose)|Other Than Specified|0|||
163378123|NCT04860297|590093141|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
163378124|NCT04860297|590093142|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
163378125|NCT04860297|590093143|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
163378126|NCT04860297|590093144|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
163378127|NCT04860297|590093145|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
163378128|NCT04860297|590093146|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
163378129|NCT04860297|590093147|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
163378130|NCT04860297|590093148|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
163378131|NCT04860297|590093141|FG000|Part B (Booster Dose)|Death|0|||
163378132|NCT04860297|590093142|FG001|Part B (Booster Dose)|Death|0|||
163378133|NCT04860297|590093143|FG002|Part B (Booster Dose)|Death|0|||
163378134|NCT04860297|590093144|FG003|Part B (Booster Dose)|Death|0|||
163378135|NCT04860297|590093145|FG004|Part B (Booster Dose)|Death|1|||
163378136|NCT04860297|590093146|FG005|Part B (Booster Dose)|Death|2|||
163378137|NCT04860297|590093147|FG006|Part B (Booster Dose)|Death|1|||
163378138|NCT04860297|590093148|FG007|Part B (Booster Dose)|Death|0|||
163378139|NCT04860297|590093141|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
163378140|NCT04860297|590093142|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
163378141|NCT04860297|590093143|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
163378142|NCT04860297|590093144|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
163378143|NCT04860297|590093145|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
163378144|NCT04860297|590093146|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
163378145|NCT04860297|590093147|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
163378146|NCT04860297|590093148|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
163378147|NCT00862719|590093149|FG000|Overall Study|Disease Progression|5|||
163378148|NCT00862719|590093150|FG001|Overall Study|Disease Progression|0|||
163378149|NCT00862719|590093151|FG002|Overall Study|Disease Progression|1|||
163378150|NCT00862719|590093152|FG003|Overall Study|Disease Progression|0|||
163378151|NCT00862719|590093149|FG000|Overall Study|Death|5|||
163378152|NCT00862719|590093150|FG001|Overall Study|Death|6|||
163378153|NCT00862719|590093151|FG002|Overall Study|Death|1|||
163378154|NCT00862719|590093152|FG003|Overall Study|Death|1|||
163378155|NCT00862719|590093149|FG000|Overall Study|Engraftment failure|0|||
163378156|NCT00862719|590093150|FG001|Overall Study|Engraftment failure|0|||
163378157|NCT00862719|590093151|FG002|Overall Study|Engraftment failure|1|||
163378158|NCT00862719|590093152|FG003|Overall Study|Engraftment failure|0|||
163378159|NCT00862719|590093149|FG000|Overall Study|Veno-Occlusive Disease|0|||
163378160|NCT00862719|590093150|FG001|Overall Study|Veno-Occlusive Disease|0|||
163378161|NCT00862719|590093151|FG002|Overall Study|Veno-Occlusive Disease|1|||
163378162|NCT00862719|590093152|FG003|Overall Study|Veno-Occlusive Disease|0|||
163378163|NCT01642251|590093153|FG000|Overall Study|Progressive disease|0|||
163378164|NCT01642251|590093154|FG001|Overall Study|Progressive disease|0|||
163378165|NCT01642251|590093155|FG002|Overall Study|Progressive disease|3|||
163378166|NCT01642251|590093156|FG003|Overall Study|Progressive disease|3|||
163378167|NCT01642251|590093153|FG000|Overall Study|Adverse Event|0|||
163378168|NCT01642251|590093154|FG001|Overall Study|Adverse Event|0|||
163378169|NCT01642251|590093155|FG002|Overall Study|Adverse Event|5|||
163378170|NCT01642251|590093156|FG003|Overall Study|Adverse Event|4|||
163378171|NCT01642251|590093153|FG000|Overall Study|Death|0|||
163378172|NCT01642251|590093154|FG001|Overall Study|Death|0|||
163378173|NCT01642251|590093155|FG002|Overall Study|Death|1|||
163378174|NCT01642251|590093156|FG003|Overall Study|Death|3|||
163378175|NCT01642251|590093153|FG000|Overall Study|Withdrawal by Subject|0|||
163378176|NCT01642251|590093154|FG001|Overall Study|Withdrawal by Subject|0|||
163378177|NCT01642251|590093155|FG002|Overall Study|Withdrawal by Subject|1|||
163378178|NCT01642251|590093156|FG003|Overall Study|Withdrawal by Subject|3|||
163378179|NCT01642251|590093153|FG000|Overall Study|Alternative therapy|0|||
163378180|NCT01642251|590093154|FG001|Overall Study|Alternative therapy|0|||
163378181|NCT01642251|590093155|FG002|Overall Study|Alternative therapy|0|||
163378182|NCT01642251|590093156|FG003|Overall Study|Alternative therapy|2|||
163378183|NCT01642251|590093153|FG000|Overall Study|Other complicating disease|0|||
163378184|NCT01642251|590093154|FG001|Overall Study|Other complicating disease|0|||
163378185|NCT01642251|590093155|FG002|Overall Study|Other complicating disease|1|||
163378186|NCT01642251|590093156|FG003|Overall Study|Other complicating disease|0|||
163378187|NCT01642251|590093153|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
163378188|NCT01642251|590093154|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
163378189|NCT01642251|590093155|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
163378190|NCT01642251|590093156|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
163378191|NCT00998790|590093157|FG000|Overall Study|Withdrawal by Subject|21|||
163378192|NCT01993927|590093158|FG000|Overall Study|Case Report Forms Uncollected|18|||
163378193|NCT01993927|590093158|FG000|Overall Study|Protocol Violation|11|||
163378194|NCT00287690|590093161|FG000|Overall Study|Protocol Violation|20|||
163378195|NCT00287690|590093162|FG001|Overall Study|Protocol Violation|26|||
163378196|NCT02414932|590093163|FG000|Overall Study|Withdrawal by Subject|2|||
163378197|NCT02414932|590093164|FG001|Overall Study|Withdrawal by Subject|3|||
163378198|NCT02414932|590093163|FG000|Overall Study|Adverse Event|1|||
163378199|NCT02414932|590093164|FG001|Overall Study|Adverse Event|0|||
163378200|NCT00540046|590093165|FG000|Overall Study|Lost to Follow-up|33|||
163378201|NCT00540046|590093166|FG001|Overall Study|Lost to Follow-up|23|||
163378202|NCT00185965|590093174|FG000|Overall Study|Adverse Event|0|||
163378203|NCT00185965|590093175|FG001|Overall Study|Adverse Event|1|||
163378204|NCT02533531|590093176|FG000|Overall Study|Device did not turn on|1|||
163378205|NCT03814187|590093177|FG000|Overall Study|Sponsor's Administrative Decision|0|||
163378206|NCT03814187|590093178|FG001|Overall Study|Sponsor's Administrative Decision|0|||
163378207|NCT03814187|590093179|FG002|Overall Study|Sponsor's Administrative Decision|272|||
163378208|NCT03814187|590093177|FG000|Overall Study|Death|80|||
163378209|NCT03814187|590093178|FG001|Overall Study|Death|81|||
163378210|NCT03814187|590093179|FG002|Overall Study|Death|4|||
163378211|NCT03814187|590093177|FG000|Overall Study|Withdrew Consent|77|||
163378212|NCT03814187|590093178|FG001|Overall Study|Withdrew Consent|78|||
163378213|NCT03814187|590093179|FG002|Overall Study|Withdrew Consent|2|||
163378214|NCT03814187|590093177|FG000|Overall Study|Lost to Follow-up|47|||
163378215|NCT03814187|590093178|FG001|Overall Study|Lost to Follow-up|52|||
163378216|NCT03814187|590093179|FG002|Overall Study|Lost to Follow-up|1|||
163378217|NCT03814187|590093177|FG000|Overall Study|Adverse Event|22|||
163378218|NCT03814187|590093178|FG001|Overall Study|Adverse Event|23|||
163378219|NCT03814187|590093179|FG002|Overall Study|Adverse Event|0|||
163378220|NCT03814187|590093177|FG000|Overall Study|Physician Decision|7|||
163378221|NCT03814187|590093178|FG001|Overall Study|Physician Decision|4|||
163378222|NCT03814187|590093179|FG002|Overall Study|Physician Decision|2|||
163378223|NCT03814187|590093177|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
163378224|NCT03814187|590093178|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
163378225|NCT03814187|590093179|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
163378226|NCT03814187|590093177|FG000|Overall Study|Other reasons|34|||
163378227|NCT03814187|590093178|FG001|Overall Study|Other reasons|40|||
163378228|NCT03814187|590093179|FG002|Overall Study|Other reasons|2|||
163378229|NCT02047903|590093180|FG000|Overall Study|Adverse Event|14|||
163378230|NCT02047903|590093180|FG000|Overall Study|Serious adverse event|10|||
163378231|NCT02047903|590093180|FG000|Overall Study|Withdrawal by Subject|16|||
163378232|NCT02047903|590093180|FG000|Overall Study|Lost to Follow-up|4|||
163378233|NCT02047903|590093180|FG000|Overall Study|Reason not listed|6|||
163378234|NCT02047903|590093180|FG000|Overall Study|Not Treated|9|||
163378235|NCT00513604|590093184|FG000|Overall Study|Not treated|2|||
163378236|NCT00513604|590093185|FG001|Overall Study|Not treated|0|||
163378237|NCT00513604|590093186|FG002|Overall Study|Not treated|1|||
163378238|NCT00513604|590093187|FG003|Overall Study|Not treated|0|||
163378239|NCT00513604|590093188|FG004|Overall Study|Not treated|0|||
163378240|NCT00513604|590093184|FG000|Overall Study|Death during treatment|0|||
163378241|NCT00513604|590093185|FG001|Overall Study|Death during treatment|3|||
163378242|NCT00513604|590093186|FG002|Overall Study|Death during treatment|2|||
163378243|NCT00513604|590093187|FG003|Overall Study|Death during treatment|0|||
163378244|NCT00513604|590093188|FG004|Overall Study|Death during treatment|0|||
163378245|NCT01014533|590093189|FG000|Overall Study|Protocol Violation|3|||
163378246|NCT01014533|590093190|FG001|Overall Study|Protocol Violation|2|||
163378247|NCT01014533|590093189|FG000|Overall Study|Withdrawal by Subject|2|||
163378248|NCT01014533|590093190|FG001|Overall Study|Withdrawal by Subject|0|||
163378249|NCT01014533|590093189|FG000|Overall Study|unable to come to appointment|0|||
163378250|NCT01014533|590093190|FG001|Overall Study|unable to come to appointment|3|||
163378251|NCT00412061|590093191|FG000|Double Blind Phase|Disease Progression|101|||
163378252|NCT00412061|590093192|FG001|Double Blind Phase|Disease Progression|154|||
163378253|NCT00412061|590093191|FG000|Double Blind Phase|Adverse Event|61|||
163378254|NCT00412061|590093192|FG001|Double Blind Phase|Adverse Event|16|||
163378255|NCT00412061|590093191|FG000|Double Blind Phase|Final Primary Analysis|26|||
163378256|NCT00412061|590093192|FG001|Double Blind Phase|Final Primary Analysis|14|||
163378257|NCT00412061|590093191|FG000|Double Blind Phase|Withdrawal by Subject|18|||
163378258|NCT00412061|590093192|FG001|Double Blind Phase|Withdrawal by Subject|20|||
163378259|NCT00412061|590093191|FG000|Double Blind Phase|Death|6|||
163378260|NCT00412061|590093192|FG001|Double Blind Phase|Death|3|||
163378261|NCT00412061|590093191|FG000|Double Blind Phase|Protocol Violation|3|||
163378262|NCT00412061|590093192|FG001|Double Blind Phase|Protocol Violation|4|||
163378263|NCT00412061|590093191|FG000|Double Blind Phase|New Cander Therapy|1|||
163378264|NCT00412061|590093192|FG001|Double Blind Phase|New Cander Therapy|1|||
163378265|NCT00412061|590093191|FG000|Double Blind Phase|Lost to Follow-up|0|||
163378266|NCT00412061|590093192|FG001|Double Blind Phase|Lost to Follow-up|1|||
163378267|NCT00412061|590093191|FG000|Open Label Phase|Disease Progression|0|||
163378268|NCT00412061|590093192|FG001|Open Label Phase|Disease Progression|86|||
163378269|NCT00412061|590093191|FG000|Open Label Phase|Adverse Event|0|||
163378270|NCT00412061|590093192|FG001|Open Label Phase|Adverse Event|46|||
163378271|NCT00412061|590093191|FG000|Open Label Phase|Withdrawal by Subject|0|||
163378272|NCT00412061|590093192|FG001|Open Label Phase|Withdrawal by Subject|15|||
163378273|NCT00412061|590093191|FG000|Open Label Phase|Administrative Problems|0|||
163378274|NCT00412061|590093192|FG001|Open Label Phase|Administrative Problems|13|||
163378275|NCT00412061|590093191|FG000|Open Label Phase|Death|0|||
163378276|NCT00412061|590093192|FG001|Open Label Phase|Death|7|||
163378277|NCT00412061|590093191|FG000|Open Label Phase|Lost to Follow-up|0|||
163378278|NCT00412061|590093192|FG001|Open Label Phase|Lost to Follow-up|2|||
163378279|NCT00412061|590093191|FG000|Open Label Phase|New Cancer Therapy|0|||
163378280|NCT00412061|590093192|FG001|Open Label Phase|New Cancer Therapy|1|||
163378281|NCT02689518|590093193|FG000|Overall Study|Withdrawal by Subject|3|||
163378282|NCT01942590|590093196|FG000|Overall Study|Withdrawal by Subject|0|||
163378283|NCT01942590|590093197|FG001|Overall Study|Withdrawal by Subject|1|||
163378284|NCT01942590|590093196|FG000|Overall Study|Adverse Event|1|||
163378285|NCT01942590|590093197|FG001|Overall Study|Adverse Event|0|||
163378286|NCT02433340|590093198|FG000|Overall Study|Adverse Event|0|||
163378287|NCT02433340|590093199|FG001|Overall Study|Adverse Event|0|||
163378288|NCT02433340|590093200|FG002|Overall Study|Adverse Event|1|||
163378289|NCT02433340|590093201|FG003|Overall Study|Adverse Event|0|||
163378290|NCT02433340|590093198|FG000|Overall Study|Withdrawal by Subject|1|||
163378291|NCT02433340|590093199|FG001|Overall Study|Withdrawal by Subject|0|||
163378292|NCT02433340|590093200|FG002|Overall Study|Withdrawal by Subject|1|||
163378293|NCT02433340|590093201|FG003|Overall Study|Withdrawal by Subject|2|||
163378294|NCT02433340|590093198|FG000|Overall Study|Lost to Follow-up|0|||
163378295|NCT02433340|590093199|FG001|Overall Study|Lost to Follow-up|1|||
163378296|NCT02433340|590093200|FG002|Overall Study|Lost to Follow-up|0|||
163378297|NCT02433340|590093201|FG003|Overall Study|Lost to Follow-up|0|||
163378298|NCT02433340|590093198|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
163378299|NCT02433340|590093199|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
163378300|NCT02433340|590093200|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
163378301|NCT02433340|590093201|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
163378302|NCT02433340|590093198|FG000|Overall Study|Other|0|||
163378303|NCT02433340|590093199|FG001|Overall Study|Other|1|||
163378304|NCT02433340|590093200|FG002|Overall Study|Other|0|||
163378305|NCT02433340|590093201|FG003|Overall Study|Other|0|||
163378306|NCT01226095|590093202|FG000|Overall Study|Poor compliance|1|||
163378307|NCT04822597|590093207|FG000|Overall Study|Withdrawal by Subject|0|||
163378308|NCT04822597|590093208|FG001|Overall Study|Withdrawal by Subject|1|||
163378309|NCT04822597|590093209|FG002|Overall Study|Withdrawal by Subject|1|||
163378310|NCT04822597|590093210|FG003|Overall Study|Withdrawal by Subject|0|||
163378311|NCT04822597|590093207|FG000|Overall Study|Physician Decision|0|||
163378312|NCT04822597|590093208|FG001|Overall Study|Physician Decision|0|||
163378313|NCT04822597|590093209|FG002|Overall Study|Physician Decision|1|||
163378314|NCT04822597|590093210|FG003|Overall Study|Physician Decision|1|||
163378315|NCT04822597|590093207|FG000|Overall Study|Subject withdrawn after enrollment|0|||
163378316|NCT04822597|590093208|FG001|Overall Study|Subject withdrawn after enrollment|1|||
163378317|NCT04822597|590093209|FG002|Overall Study|Subject withdrawn after enrollment|0|||
163378318|NCT04822597|590093210|FG003|Overall Study|Subject withdrawn after enrollment|1|||
163378319|NCT04822597|590093207|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
163378320|NCT04822597|590093208|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
163378321|NCT04822597|590093209|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
163378322|NCT04822597|590093210|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
163378323|NCT00911768|590093217|FG000|Overall Study|Protocol Violation|5|||
163378324|NCT00911768|590093218|FG001|Overall Study|Protocol Violation|4|||
163378325|NCT00911768|590093217|FG000|Overall Study|Withdrawal by Subject|1|||
163378326|NCT00911768|590093218|FG001|Overall Study|Withdrawal by Subject|0|||
163378327|NCT02859324|590093220|FG000|Overall Study|Death|4|||
163378328|NCT02859324|590093221|FG001|Overall Study|Death|6|||
163378329|NCT02859324|590093222|FG002|Overall Study|Death|5|||
163378330|NCT02859324|590093220|FG000|Overall Study|Other reasons|3|||
163378331|NCT02859324|590093221|FG001|Overall Study|Other reasons|3|||
163378332|NCT02859324|590093222|FG002|Overall Study|Other reasons|0|||
163378333|NCT02665338|590093224|FG000|Overall Study|Withdrawal by Subject|0|||
163378334|NCT02665338|590093225|FG001|Overall Study|Withdrawal by Subject|1|||
163378335|NCT00998335|590093226|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
163378336|NCT00998335|590093227|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
163378337|NCT05110690|590093228|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
163378338|NCT05110690|590093228|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
163378339|NCT05110690|590093228|FG000|Completion of Intervention|Lost to Follow-up|1|||
163378340|NCT05110690|590093228|FG000|Completion of Intervention|Death|1|||
163378341|NCT05110690|590093228|FG000|Completion of Intervention|Withdrawal by Subject|2|||
163378342|NCT02502799|590094786|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
163378343|NCT02502799|590094787|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
163378344|NCT02502799|590094788|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
163378345|NCT02502799|590094789|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
163378346|NCT02502799|590094786|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
163378347|NCT02502799|590094787|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
163378348|NCT02502799|590094788|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
163378349|NCT02502799|590094789|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
163378350|NCT02502799|590094786|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
163378351|NCT02502799|590094787|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
163378352|NCT02502799|590094788|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
163378353|NCT02502799|590094789|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
163378354|NCT02502799|590094786|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
163378355|NCT02502799|590094787|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
163378356|NCT02502799|590094788|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
163378357|NCT02502799|590094789|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
163378358|NCT02502799|590094786|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
163378359|NCT02502799|590094787|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
163378360|NCT02502799|590094788|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
163378361|NCT02502799|590094789|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
163378362|NCT01589237|590094794|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
163378363|NCT01589237|590094795|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
163378364|NCT01589237|590094796|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
163378365|NCT01589237|590094797|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
163378366|NCT01589237|590094794|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
163378367|NCT01589237|590094795|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
163378368|NCT01589237|590094796|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
163378369|NCT01589237|590094797|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
163378370|NCT01589237|590094794|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
163378371|NCT01589237|590094795|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
163378372|NCT01589237|590094796|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
163378373|NCT01589237|590094797|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
163378374|NCT01589237|590094794|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
163378375|NCT01589237|590094795|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
163378376|NCT01589237|590094796|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
163378377|NCT01589237|590094797|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
163378378|NCT00117845|590094798|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
163378379|NCT03207009|590094799|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
163378380|NCT01491672|590094800|FG000|Overall Study|Lost to Follow-up|0|||
163378381|NCT01491672|590094801|FG001|Overall Study|Lost to Follow-up|4|||
163378382|NCT01491672|590094802|FG002|Overall Study|Lost to Follow-up|1|||
163378383|NCT01491672|590094800|FG000|Overall Study|Withdrawal by Subject|6|||
163378384|NCT01491672|590094801|FG001|Overall Study|Withdrawal by Subject|7|||
163378385|NCT01491672|590094802|FG002|Overall Study|Withdrawal by Subject|0|||
163378386|NCT01491672|590094800|FG000|Overall Study|Adverse Event|8|||
163378387|NCT01491672|590094801|FG001|Overall Study|Adverse Event|10|||
163378388|NCT01491672|590094802|FG002|Overall Study|Adverse Event|4|||
163378389|NCT01491672|590094800|FG000|Overall Study|Disease progression|42|||
163378390|NCT01491672|590094801|FG001|Overall Study|Disease progression|34|||
163378391|NCT01491672|590094802|FG002|Overall Study|Disease progression|6|||
163378392|NCT01491672|590094800|FG000|Overall Study|Protocol deviation|0|||
163378393|NCT01491672|590094801|FG001|Overall Study|Protocol deviation|1|||
163378394|NCT01491672|590094802|FG002|Overall Study|Protocol deviation|0|||
163378395|NCT01491672|590094800|FG000|Overall Study|Death|0|||
163378396|NCT01491672|590094801|FG001|Overall Study|Death|4|||
163378397|NCT01491672|590094802|FG002|Overall Study|Death|0|||
163378398|NCT00642772|590094807|FG000|Overall Study|Lost to Follow-up|3|||
163378399|NCT00642772|590094807|FG000|Overall Study|Withdrawal by Subject|7|||
163378400|NCT02947087|590094808|FG000|Overall Study|Withdrawal by Subject|3|||
163378401|NCT02947087|590094809|FG001|Overall Study|Withdrawal by Subject|2|||
163378402|NCT00545051|590094810|FG000|Overall Study|Adverse Event|7|||
163378403|NCT00545051|590094811|FG001|Overall Study|Adverse Event|3|||
163378404|NCT00545051|590094810|FG000|Overall Study|Death|1|||
163378405|NCT00545051|590094811|FG001|Overall Study|Death|0|||
163378406|NCT00545051|590094810|FG000|Overall Study|Violation of inclusion/exclusion|0|||
163378407|NCT00545051|590094811|FG001|Overall Study|Violation of inclusion/exclusion|2|||
163378408|NCT00545051|590094810|FG000|Overall Study|Protocol Violation|1|||
163378409|NCT00545051|590094811|FG001|Overall Study|Protocol Violation|0|||
163378410|NCT00545051|590094810|FG000|Overall Study|Withdrawal by Subject|0|||
163378411|NCT00545051|590094811|FG001|Overall Study|Withdrawal by Subject|1|||
163378412|NCT00545051|590094810|FG000|Overall Study|Administrative reasons|0|||
163378413|NCT00545051|590094811|FG001|Overall Study|Administrative reasons|1|||
163378414|NCT04256629|590094818|FG000|Overall Study|Adverse Event|0|||
163378415|NCT04256629|590094819|FG001|Overall Study|Adverse Event|0|||
163378416|NCT04256629|590094820|FG002|Overall Study|Adverse Event|0|||
163378417|NCT04256629|590094821|FG003|Overall Study|Adverse Event|0|||
163378418|NCT04256629|590094822|FG004|Overall Study|Adverse Event|0|||
163378419|NCT04256629|590094823|FG005|Overall Study|Adverse Event|1|||
163378420|NCT04256629|590094818|FG000|Overall Study|Protocol Violation|0|||
163378421|NCT04256629|590094819|FG001|Overall Study|Protocol Violation|1|||
163378422|NCT04256629|590094820|FG002|Overall Study|Protocol Violation|0|||
163378423|NCT04256629|590094821|FG003|Overall Study|Protocol Violation|0|||
163378424|NCT04256629|590094822|FG004|Overall Study|Protocol Violation|0|||
163378425|NCT04256629|590094823|FG005|Overall Study|Protocol Violation|0|||
163378426|NCT01383499|590094824|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
163378427|NCT01383499|590094825|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
163378428|NCT01383499|590094826|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
163378429|NCT01383499|590094827|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
163378430|NCT00477334|590094828|FG000|Overall Study|Discontinued prior to taking study drug|106|||
163378431|NCT00477334|590094829|FG001|Overall Study|Discontinued prior to taking study drug|53|||
163378432|NCT00477334|590094828|FG000|Overall Study|Adverse Event|1|||
163378433|NCT00477334|590094829|FG001|Overall Study|Adverse Event|2|||
163378434|NCT00477334|590094828|FG000|Overall Study|Withdrawal by Subject|2|||
163378435|NCT00477334|590094829|FG001|Overall Study|Withdrawal by Subject|1|||
163378436|NCT00477334|590094828|FG000|Overall Study|Lost to Follow-up|15|||
163378437|NCT00477334|590094829|FG001|Overall Study|Lost to Follow-up|4|||
163378438|NCT00477334|590094828|FG000|Overall Study|Administrative Problems|39|||
163378439|NCT00477334|590094829|FG001|Overall Study|Administrative Problems|15|||
163378440|NCT00477334|590094828|FG000|Overall Study|Protocol Violation|7|||
163378441|NCT00477334|590094829|FG001|Overall Study|Protocol Violation|1|||
163378442|NCT04745026|590094833|FG000|Overall Study|Physician Decision|1|||
163378443|NCT04745026|590094834|FG001|Overall Study|Physician Decision|0|||
163378444|NCT04745026|590094833|FG000|Overall Study|Adverse Event|2|||
163378445|NCT04745026|590094834|FG001|Overall Study|Adverse Event|2|||
163378446|NCT04745026|590094833|FG000|Overall Study|Protocol Violation|1|||
163378447|NCT04745026|590094834|FG001|Overall Study|Protocol Violation|3|||
163378448|NCT04745026|590094833|FG000|Overall Study|Lost to Follow-up|4|||
163378449|NCT04745026|590094834|FG001|Overall Study|Lost to Follow-up|3|||
163378450|NCT04745026|590094833|FG000|Overall Study|Withdrawal by Subject|5|||
163378451|NCT04745026|590094834|FG001|Overall Study|Withdrawal by Subject|5|||
163378452|NCT02292927|590094837|FG000|Overall Study|Protocol Violation|13|||
163378453|NCT02292927|590094838|FG001|Overall Study|Protocol Violation|7|||
163378454|NCT01656733|590094839|FG000|Overall Study|No permission to collect birth outcomes|0|||
163378455|NCT01656733|590094840|FG001|Overall Study|No permission to collect birth outcomes|1|||
163378456|NCT01656733|590094839|FG000|Overall Study|Delivery at another hospital|0|||
163378457|NCT01656733|590094840|FG001|Overall Study|Delivery at another hospital|2|||
163378458|NCT01656733|590094839|FG000|Overall Study|Spontaneous abortion|0|||
163416387|NCT01656434|590231074|FG000|Overall Study|Participant withdrew consent|28|||
163378459|NCT01656733|590094840|FG001|Overall Study|Spontaneous abortion|1|||
163378460|NCT01415531|590094842|FG000|Overall Study|Adverse Event|7|||
163378461|NCT01415531|590094843|FG001|Overall Study|Adverse Event|10|||
163378462|NCT01415531|590094842|FG000|Overall Study|Lack of Efficacy|3|||
163378463|NCT01415531|590094843|FG001|Overall Study|Lack of Efficacy|2|||
163378464|NCT01415531|590094842|FG000|Overall Study|Protocol Violation|0|||
163378465|NCT01415531|590094843|FG001|Overall Study|Protocol Violation|1|||
163378466|NCT01415531|590094842|FG000|Overall Study|Withdrawal by Subject|5|||
163378467|NCT01415531|590094843|FG001|Overall Study|Withdrawal by Subject|4|||
163378468|NCT01415531|590094842|FG000|Overall Study|Lost to Follow-up|6|||
163378469|NCT01415531|590094843|FG001|Overall Study|Lost to Follow-up|14|||
163378470|NCT01415531|590094842|FG000|Overall Study|Lack of Compliance|1|||
163378471|NCT01415531|590094843|FG001|Overall Study|Lack of Compliance|4|||
163378472|NCT01415531|590094842|FG000|Overall Study|Other Reasons|3|||
163378473|NCT01415531|590094843|FG001|Overall Study|Other Reasons|2|||
163378474|NCT00122460|590094844|FG000|Overall Study|investigational study phase ongoing|7|||
163416388|NCT01656434|590231075|FG001|Overall Study|Participant withdrew consent|9|||
163416389|NCT01656434|590231074|FG000|Overall Study|Withdrawal by Subject|64|||
163416390|NCT01656434|590231075|FG001|Overall Study|Withdrawal by Subject|7|||
163416391|NCT02435914|590231076|FG000|Overall Study|Ocular Adverse Event|1|||
163416392|NCT02435914|590231077|FG001|Overall Study|Ocular Adverse Event|0|||
163416393|NCT02435914|590231078|FG002|Overall Study|Ocular Adverse Event|0|||
163416394|NCT02435914|590231079|FG003|Overall Study|Ocular Adverse Event|0|||
163416395|NCT02435914|590231076|FG000|Overall Study|Withdrawal by Subject|0|||
163416396|NCT02435914|590231077|FG001|Overall Study|Withdrawal by Subject|1|||
163416397|NCT02435914|590231078|FG002|Overall Study|Withdrawal by Subject|0|||
163416398|NCT02435914|590231079|FG003|Overall Study|Withdrawal by Subject|0|||
163416399|NCT02435914|590231076|FG000|Overall Study|Other Miscellaneous Reason|0|||
163416400|NCT02435914|590231077|FG001|Overall Study|Other Miscellaneous Reason|0|||
163416401|NCT02435914|590231078|FG002|Overall Study|Other Miscellaneous Reason|1|||
163416402|NCT02435914|590231079|FG003|Overall Study|Other Miscellaneous Reason|0|||
163416403|NCT01405053|590231085|FG000|Overall Study|Adverse Event|3|||
163416404|NCT01405053|590231086|FG001|Overall Study|Adverse Event|0|||
163416405|NCT01405053|590231085|FG000|Overall Study|Lost to Follow-up|0|||
163416406|NCT01405053|590231086|FG001|Overall Study|Lost to Follow-up|1|||
163416407|NCT01405053|590231085|FG000|Overall Study|Participant choice|2|||
163416408|NCT01405053|590231086|FG001|Overall Study|Participant choice|1|||
163416409|NCT01405053|590231085|FG000|Overall Study|Inadequate therapeutic effect|2|||
163416410|NCT01405053|590231086|FG001|Overall Study|Inadequate therapeutic effect|1|||
163416411|NCT01405053|590231085|FG000|Overall Study|Withdrawal by Subject|3|||
163416412|NCT01405053|590231086|FG001|Overall Study|Withdrawal by Subject|4|||
163416413|NCT01405053|590231085|FG000|Overall Study|Other|0|||
163416414|NCT01405053|590231086|FG001|Overall Study|Other|1|||
163416415|NCT00130286|590231089|FG000|Overall Study|Withdrawal by Subject|0|||
163416416|NCT00130286|590231090|FG001|Overall Study|Withdrawal by Subject|1|||
163416417|NCT00130286|590231091|FG002|Overall Study|Withdrawal by Subject|2|||
163416418|NCT00130286|590231092|FG003|Overall Study|Withdrawal by Subject|2|||
163416419|NCT00130286|590231089|FG000|Overall Study|Adverse Event|0|||
163416420|NCT00130286|590231090|FG001|Overall Study|Adverse Event|0|||
163416421|NCT00130286|590231091|FG002|Overall Study|Adverse Event|2|||
163416422|NCT00130286|590231092|FG003|Overall Study|Adverse Event|0|||
163416423|NCT00130286|590231089|FG000|Overall Study|Missing lab specimens|0|||
163416424|NCT00130286|590231090|FG001|Overall Study|Missing lab specimens|2|||
163416425|NCT00130286|590231091|FG002|Overall Study|Missing lab specimens|0|||
163416426|NCT00130286|590231092|FG003|Overall Study|Missing lab specimens|0|||
163416427|NCT01818726|590231098|FG000|Overall Study|Administrative reasons|5|||
163416428|NCT01818726|590231099|FG001|Overall Study|Administrative reasons|1|||
163416429|NCT01818726|590231098|FG000|Overall Study|Withdrawal by Subject|0|||
163416430|NCT01818726|590231099|FG001|Overall Study|Withdrawal by Subject|1|||
163416431|NCT01818726|590231098|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
163416432|NCT01818726|590231099|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
163416433|NCT00357500|590231100|FG000|Overall Study|Adverse Event|3|||
163416434|NCT00357500|590231100|FG000|Overall Study|Withdrawal by Subject|5|||
163416435|NCT00357500|590231100|FG000|Overall Study|Progressive Disease|65|||
163416436|NCT00357500|590231100|FG000|Overall Study|Not Started Protocol Therapy|4|||
163416437|NCT00993928|590231101|FG000|Overall Study|Withdrawal by Subject|4|||
163416438|NCT00993928|590231102|FG001|Overall Study|Withdrawal by Subject|7|||
163416439|NCT00993928|590231101|FG000|Overall Study|ineligible|1|||
163416440|NCT00993928|590231102|FG001|Overall Study|ineligible|0|||
163416441|NCT02154087|590231105|FG000|Overall Study|Study Termination|1|||
163416442|NCT05574062|590231107|FG000|Pre Run-In|Screening failure|3|||
163416443|NCT05574062|590231108|FG001|Pre Run-In|Screening failure|0|||
163416444|NCT05574062|590231109|FG002|Pre Run-In|Screening failure|0|||
163416445|NCT05574062|590231110|FG003|Pre Run-In|Screening failure|0|||
163416446|NCT05574062|590231111|FG004|Pre Run-In|Screening failure|0|||
163416447|NCT05574062|590231107|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
163416448|NCT05574062|590231108|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
163416449|NCT05574062|590231109|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
163416450|NCT05574062|590231110|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
163416451|NCT05574062|590231111|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
163378475|NCT00122460|590094845|FG001|Overall Study|investigational study phase ongoing|1|||
163378476|NCT02962960|590094846|FG000|Overall Study|Withdrawal by Subject|1|||
163378477|NCT02962960|590094847|FG001|Overall Study|Withdrawal by Subject|1|||
163416452|NCT05574062|590231107|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
163416453|NCT05574062|590231108|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
163378478|NCT02962960|590094848|FG002|Overall Study|Withdrawal by Subject|0|||
163378479|NCT02962960|590094846|FG000|Overall Study|Adverse Event|1|||
163378480|NCT02962960|590094847|FG001|Overall Study|Adverse Event|1|||
163378481|NCT02962960|590094848|FG002|Overall Study|Adverse Event|0|||
163378482|NCT02962960|590094846|FG000|Overall Study|Protocol Violation|1|||
163378483|NCT02962960|590094847|FG001|Overall Study|Protocol Violation|0|||
163378484|NCT02962960|590094848|FG002|Overall Study|Protocol Violation|0|||
163378485|NCT01236339|590094849|FG000|Overall Study|Termination of study by sponsor|11|||
163378486|NCT01236339|590094850|FG001|Overall Study|Termination of study by sponsor|13|||
163378487|NCT02054741|590094851|FG000|Overall Study|Protocol Violation|13|||
163378488|NCT02054741|590094852|FG001|Overall Study|Protocol Violation|2|||
163378489|NCT02054741|590094851|FG000|Overall Study|Withdrawal by Subject|10|||
163378490|NCT02054741|590094852|FG001|Overall Study|Withdrawal by Subject|5|||
163378491|NCT02054741|590094851|FG000|Overall Study|Death|94|||
163378492|NCT02054741|590094852|FG001|Overall Study|Death|90|||
163378493|NCT02054741|590094851|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
163378494|NCT02054741|590094852|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
163378495|NCT00394082|590094853|FG000|Overall Study|Unacceptable toxicity|15|||
163378496|NCT00394082|590094853|FG000|Overall Study|Adverse Event|4|||
163378497|NCT00394082|590094853|FG000|Overall Study|Physician Decision|4|||
163378498|NCT00394082|590094853|FG000|Overall Study|Withdrawal by Subject|2|||
163378499|NCT00394082|590094853|FG000|Overall Study|Other|1|||
163378500|NCT02344004|590094855|FG000|Overall Study|Adverse Event|11|||
163378501|NCT02344004|590094856|FG001|Overall Study|Adverse Event|1|||
163378502|NCT02344004|590094855|FG000|Overall Study|Death|9|||
163378503|NCT02344004|590094856|FG001|Overall Study|Death|7|||
163378504|NCT02344004|590094855|FG000|Overall Study|Physician Decision|4|||
163378505|NCT02344004|590094856|FG001|Overall Study|Physician Decision|1|||
163378506|NCT02344004|590094855|FG000|Overall Study|Withdrawal by Subject|22|||
163378507|NCT02344004|590094856|FG001|Overall Study|Withdrawal by Subject|5|||
163378508|NCT02344004|590094855|FG000|Overall Study|Rescue Medication|2|||
163378509|NCT02344004|590094856|FG001|Overall Study|Rescue Medication|0|||
163378510|NCT02344004|590094855|FG000|Overall Study|Other Not Specified|12|||
163378511|NCT02344004|590094856|FG001|Overall Study|Other Not Specified|0|||
163378512|NCT02344004|590094855|FG000|Overall Study|Protocol Violation|1|||
163378513|NCT02344004|590094856|FG001|Overall Study|Protocol Violation|0|||
163378514|NCT01768117|590094857|FG000|Overall Study|Lost to Follow-up|1|||
163378515|NCT01768117|590094857|FG000|Overall Study|Withdrawal by Subject|2|||
163378516|NCT01768117|590094857|FG000|Overall Study|Protocol Violation|3|||
163378517|NCT01945060|590094858|FG000|Overall Study|Lost to follow up|1|||
163378518|NCT01945060|590094859|FG001|Overall Study|Lost to follow up|0|||
163378519|NCT01945060|590094858|FG000|Overall Study|Distress related to IV access|0|||
163378520|NCT01945060|590094859|FG001|Overall Study|Distress related to IV access|1|||
163378521|NCT00138671|590094860|FG000|Overall Study|Death|0|||
163378522|NCT00138671|590094861|FG001|Overall Study|Death|3|||
163378523|NCT00138671|590094860|FG000|Overall Study|Adverse Event|6|||
163378524|NCT00138671|590094861|FG001|Overall Study|Adverse Event|3|||
163378525|NCT00138671|590094860|FG000|Overall Study|Lost to Follow-up|1|||
163378526|NCT00138671|590094861|FG001|Overall Study|Lost to Follow-up|2|||
163378527|NCT00138671|590094860|FG000|Overall Study|Withdrawal by Subject|3|||
163378528|NCT00138671|590094861|FG001|Overall Study|Withdrawal by Subject|5|||
163378529|NCT00138671|590094860|FG000|Overall Study|Other|3|||
163378530|NCT00138671|590094861|FG001|Overall Study|Other|3|||
163378531|NCT01488487|590094864|FG000|Overall Study|Adverse Event|6|||
163378532|NCT01488487|590094864|FG000|Overall Study|Death|1|||
163378533|NCT01488487|590094864|FG000|Overall Study|Withdrawal by Subject|2|||
163378534|NCT02084056|590094865|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
163378535|NCT02084056|590094866|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
163378536|NCT02084056|590094867|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
163378537|NCT02084056|590094868|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
163378538|NCT02084056|590094865|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
163378539|NCT02084056|590094866|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
163378540|NCT02084056|590094867|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
163378541|NCT02084056|590094868|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
163378542|NCT00395460|590094869|FG000|Overall Study|Withdrawal by Subject|1|||
163378543|NCT00395460|590094870|FG001|Overall Study|Withdrawal by Subject|0|||
163378544|NCT00938860|590094878|FG000|Overall Study|Adverse Event|2|||
163378545|NCT00938860|590094879|FG001|Overall Study|Adverse Event|1|||
163378546|NCT00938860|590094878|FG000|Overall Study|Abnormal laboratory values|2|||
163378547|NCT00938860|590094879|FG001|Overall Study|Abnormal laboratory values|2|||
163378548|NCT00938860|590094878|FG000|Overall Study|Withdrawal by Subject|11|||
163378549|NCT00938860|590094879|FG001|Overall Study|Withdrawal by Subject|8|||
163378550|NCT00938860|590094878|FG000|Overall Study|Lost to Follow-up|4|||
163378551|NCT00938860|590094879|FG001|Overall Study|Lost to Follow-up|4|||
163378552|NCT00938860|590094878|FG000|Overall Study|Administration problems|2|||
163378553|NCT00938860|590094879|FG001|Overall Study|Administration problems|0|||
163378554|NCT00938860|590094878|FG000|Overall Study|Death|1|||
163378555|NCT00938860|590094879|FG001|Overall Study|Death|1|||
163378556|NCT00938860|590094878|FG000|Overall Study|Protocol Violation|3|||
163378557|NCT00938860|590094879|FG001|Overall Study|Protocol Violation|1|||
163378558|NCT01605019|590094880|FG000|Overall Study|pt did not meet transplant endpoint|3|||
163378559|NCT01605019|590094881|FG001|Overall Study|pt did not meet transplant endpoint|0|||
163378560|NCT04223830|590094885|FG000|Overall Study|Lost to Follow-up|9|||
163378561|NCT04223830|590094885|FG000|Overall Study|Adverse Event|1|||
163378562|NCT00324116|590094886|FG000|Overall Study|Adverse Event|5|||
163378563|NCT00324116|590094886|FG000|Overall Study|Lack of Efficacy|17|||
163378564|NCT00324116|590094886|FG000|Overall Study|Withdrawal by Subject|5|||
163378565|NCT00324116|590094886|FG000|Overall Study|Other|5|||
163378566|NCT01806623|590094887|FG000|Overall Study|Withdrawal by Subject|1|||
163378567|NCT01806623|590094887|FG000|Overall Study|Adverse Event|1|||
163378568|NCT01806623|590094887|FG000|Overall Study|Did not meet the inclusion criteria|56|||
163378569|NCT01737827|590094888|FG000|Overall Study|Adverse Event|3|||
163378570|NCT01737827|590094889|FG001|Overall Study|Adverse Event|6|||
163378571|NCT01737827|590094890|FG002|Overall Study|Adverse Event|0|||
163378572|NCT01737827|590094888|FG000|Overall Study|Lost to Follow-up|0|||
163378573|NCT01737827|590094889|FG001|Overall Study|Lost to Follow-up|1|||
163378574|NCT01737827|590094890|FG002|Overall Study|Lost to Follow-up|0|||
163378575|NCT01737827|590094888|FG000|Overall Study|Physician Decision|0|||
163378576|NCT01737827|590094889|FG001|Overall Study|Physician Decision|2|||
163378577|NCT01737827|590094890|FG002|Overall Study|Physician Decision|0|||
163378578|NCT01737827|590094888|FG000|Overall Study|Progressive Disease|5|||
163378579|NCT01737827|590094889|FG001|Overall Study|Progressive Disease|16|||
163378580|NCT01737827|590094890|FG002|Overall Study|Progressive Disease|2|||
163378581|NCT01737827|590094888|FG000|Overall Study|Study Terminated by Sponsor|0|||
163378582|NCT01737827|590094889|FG001|Overall Study|Study Terminated by Sponsor|1|||
163378583|NCT01737827|590094890|FG002|Overall Study|Study Terminated by Sponsor|0|||
163378584|NCT01737827|590094888|FG000|Overall Study|Subject/Guardian Decision|0|||
163378585|NCT01737827|590094889|FG001|Overall Study|Subject/Guardian Decision|2|||
163378586|NCT01737827|590094890|FG002|Overall Study|Subject/Guardian Decision|0|||
163378587|NCT01451827|590094891|FG000|Overall Study|Adverse Event|2|||
163378588|NCT01451827|590094892|FG001|Overall Study|Adverse Event|0|||
163378589|NCT01451827|590094893|FG002|Overall Study|Adverse Event|1|||
163378590|NCT01451827|590094894|FG003|Overall Study|Adverse Event|1|||
163378591|NCT01451827|590094891|FG000|Overall Study|Protocol deviation|1|||
163378592|NCT01451827|590094892|FG001|Overall Study|Protocol deviation|0|||
163378593|NCT01451827|590094893|FG002|Overall Study|Protocol deviation|0|||
163378594|NCT01451827|590094894|FG003|Overall Study|Protocol deviation|0|||
163378595|NCT01451827|590094891|FG000|Overall Study|Lost to Follow-up|0|||
163378596|NCT01451827|590094892|FG001|Overall Study|Lost to Follow-up|3|||
163378597|NCT01451827|590094893|FG002|Overall Study|Lost to Follow-up|0|||
163378598|NCT01451827|590094894|FG003|Overall Study|Lost to Follow-up|2|||
163378599|NCT01451827|590094891|FG000|Overall Study|Participant met withdrawal criteria|0|||
163378600|NCT01451827|590094892|FG001|Overall Study|Participant met withdrawal criteria|2|||
163378601|NCT01451827|590094893|FG002|Overall Study|Participant met withdrawal criteria|0|||
163378602|NCT01451827|590094894|FG003|Overall Study|Participant met withdrawal criteria|0|||
163378603|NCT01451827|590094891|FG000|Overall Study|Withdrawal by Subject|0|||
163378604|NCT01451827|590094892|FG001|Overall Study|Withdrawal by Subject|0|||
163378605|NCT01451827|590094893|FG002|Overall Study|Withdrawal by Subject|1|||
163378606|NCT01451827|590094894|FG003|Overall Study|Withdrawal by Subject|1|||
163378607|NCT01964924|590094895|FG000|Trametinib Monotherapy|Progression|19|||
163378608|NCT01964924|590094896|FG001|Trametinib Monotherapy|Progression|0|||
163378609|NCT01528345|590094897|FG000|Overall Study|Adverse Event|10|||
163378610|NCT01528345|590094898|FG001|Overall Study|Adverse Event|1|||
163378611|NCT01528345|590094897|FG000|Overall Study|Death|1|||
163378612|NCT01528345|590094898|FG001|Overall Study|Death|1|||
163378613|NCT01528345|590094897|FG000|Overall Study|Non-compliance with study treatment|1|||
163378614|NCT01528345|590094898|FG001|Overall Study|Non-compliance with study treatment|0|||
163378615|NCT01528345|590094897|FG000|Overall Study|Progressive Disease|26|||
163378616|NCT01528345|590094898|FG001|Overall Study|Progressive Disease|40|||
163378617|NCT01528345|590094897|FG000|Overall Study|Study Terminated by Sponsor|4|||
163378618|NCT01528345|590094898|FG001|Overall Study|Study Terminated by Sponsor|8|||
163378619|NCT01528345|590094897|FG000|Overall Study|Subject/Guardian Decision|5|||
163378620|NCT01528345|590094898|FG001|Overall Study|Subject/Guardian Decision|0|||
163378621|NCT01034163|590094899|FG000|Overall Study|Treatment completed as per protocol|8|||
163378622|NCT01034163|590094900|FG001|Overall Study|Treatment completed as per protocol|7|||
163378623|NCT01034163|590094899|FG000|Overall Study|Withdrawal by Subject|8|||
163378624|NCT01034163|590094900|FG001|Overall Study|Withdrawal by Subject|2|||
163378625|NCT01034163|590094899|FG000|Overall Study|Protocol deviation|1|||
163378626|NCT01034163|590094900|FG001|Overall Study|Protocol deviation|0|||
163378627|NCT01034163|590094899|FG000|Overall Study|Disease progression|3|||
163378628|NCT01034163|590094900|FG001|Overall Study|Disease progression|4|||
163378629|NCT01034163|590094899|FG000|Overall Study|Adverse Event|6|||
163378630|NCT01034163|590094900|FG001|Overall Study|Adverse Event|0|||
163378631|NCT01034163|590094899|FG000|Overall Study|Administrative problems|0|||
163378632|NCT01034163|590094900|FG001|Overall Study|Administrative problems|1|||
163378633|NCT01034163|590094899|FG000|Overall Study|Abnormal laboratory value|1|||
163378634|NCT01034163|590094900|FG001|Overall Study|Abnormal laboratory value|0|||
163378635|NCT00528645|590094901|FG000|Overall Study|Adverse Event|3|||
163378636|NCT00296400|590094902|FG000|Overall Study|Adverse Event|7|||
163378637|NCT00296400|590094903|FG001|Overall Study|Adverse Event|7|||
163378638|NCT00296400|590094904|FG002|Overall Study|Adverse Event|7|||
163378639|NCT00296400|590094902|FG000|Overall Study|Withdrawal by Subject|5|||
163378640|NCT00296400|590094903|FG001|Overall Study|Withdrawal by Subject|6|||
163378641|NCT00296400|590094904|FG002|Overall Study|Withdrawal by Subject|2|||
163378642|NCT00296400|590094902|FG000|Overall Study|Incorrect enrollment|2|||
163378643|NCT00296400|590094903|FG001|Overall Study|Incorrect enrollment|0|||
163378644|NCT00296400|590094904|FG002|Overall Study|Incorrect enrollment|0|||
163378645|NCT00296400|590094902|FG000|Overall Study|Protocol Violation|1|||
163378646|NCT00296400|590094903|FG001|Overall Study|Protocol Violation|1|||
163378647|NCT00296400|590094904|FG002|Overall Study|Protocol Violation|1|||
163378648|NCT00296400|590094902|FG000|Overall Study|Lost to Follow-up|1|||
163378649|NCT00296400|590094903|FG001|Overall Study|Lost to Follow-up|1|||
163378650|NCT00296400|590094904|FG002|Overall Study|Lost to Follow-up|2|||
163378651|NCT00296400|590094902|FG000|Overall Study|Study specific discontinuation criteria|0|||
163378652|NCT00296400|590094903|FG001|Overall Study|Study specific discontinuation criteria|0|||
163378653|NCT00296400|590094904|FG002|Overall Study|Study specific discontinuation criteria|1|||
163378654|NCT00296400|590094902|FG000|Overall Study|Visit 10 was performed earlier|0|||
163378655|NCT00296400|590094903|FG001|Overall Study|Visit 10 was performed earlier|1|||
163378656|NCT00296400|590094904|FG002|Overall Study|Visit 10 was performed earlier|0|||
163378657|NCT00296400|590094902|FG000|Overall Study|Pregnancy|1|||
163378658|NCT00296400|590094903|FG001|Overall Study|Pregnancy|2|||
163378659|NCT00296400|590094904|FG002|Overall Study|Pregnancy|0|||
163378660|NCT03406078|590094907|FG000|Overall Study|Death|1|||
163378661|NCT03406078|590094908|FG001|Overall Study|Death|0|||
163378662|NCT03406078|590094907|FG000|Overall Study|Lost to Follow-up|0|||
163378663|NCT03406078|590094908|FG001|Overall Study|Lost to Follow-up|1|||
163378664|NCT03406078|590094907|FG000|Overall Study|Withdrawal by Subject|5|||
163378665|NCT03406078|590094908|FG001|Overall Study|Withdrawal by Subject|2|||
163378666|NCT03538301|590094911|FG000|Overall Study|Adverse Event|1|||
163378667|NCT03538301|590094912|FG001|Overall Study|Adverse Event|4|||
163378668|NCT03538301|590094913|FG002|Overall Study|Adverse Event|4|||
163378669|NCT03538301|590094911|FG000|Overall Study|Death|1|||
163378670|NCT03538301|590094912|FG001|Overall Study|Death|1|||
163378671|NCT03538301|590094913|FG002|Overall Study|Death|0|||
163378672|NCT03538301|590094911|FG000|Overall Study|Physician Decision|0|||
163378673|NCT03538301|590094912|FG001|Overall Study|Physician Decision|1|||
163378674|NCT03538301|590094913|FG002|Overall Study|Physician Decision|0|||
163378675|NCT03538301|590094911|FG000|Overall Study|Protocol Violation|0|||
163378676|NCT03538301|590094912|FG001|Overall Study|Protocol Violation|0|||
163378677|NCT03538301|590094913|FG002|Overall Study|Protocol Violation|1|||
163378678|NCT03538301|590094911|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
163378679|NCT03538301|590094912|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
163378680|NCT03538301|590094913|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
163378681|NCT03616977|590094914|FG000|Period 1|Physician Decision|0|||
163378682|NCT03616977|590094915|FG001|Period 1|Physician Decision|1|||
163378683|NCT03616977|590094914|FG000|Period 3|Adverse Event|1|||
163378684|NCT03616977|590094915|FG001|Period 3|Adverse Event|1|||
163378685|NCT00591851|590094916|FG000|Overall Study|Withdrawal by Subject|3|||
163378686|NCT00591851|590094916|FG000|Overall Study|Adverse Event|2|||
163378687|NCT00591851|590094916|FG000|Overall Study|Progressive Disease|1|||
163378688|NCT00515853|590094917|FG000|Overall Study|Lost to Follow-up|9|||
163378689|NCT00515853|590094918|FG001|Overall Study|Lost to Follow-up|13|||
163378690|NCT00515853|590094917|FG000|Overall Study|Withdrawal by Subject|6|||
163378691|NCT00515853|590094918|FG001|Overall Study|Withdrawal by Subject|4|||
163378692|NCT03798691|590094923|FG000|Overall Study|Lost to Follow-up|2|||
163378693|NCT03798691|590094924|FG001|Overall Study|Lost to Follow-up|2|||
163378694|NCT01586910|590096895|FG000|Overall Study|Death|4|||
163378695|NCT01586910|590096896|FG001|Overall Study|Death|4|||
163378696|NCT01586910|590096895|FG000|Overall Study|Withdrawal by Subject|6|||
163378697|NCT01586910|590096896|FG001|Overall Study|Withdrawal by Subject|43|||
163378698|NCT01586910|590096895|FG000|Overall Study|Physician withdrew Subject|5|||
163378699|NCT01586910|590096896|FG001|Overall Study|Physician withdrew Subject|24|||
163378700|NCT00953407|590096897|FG000|Overall Study|Failed inclusion criteria|1|||
163378701|NCT00953407|590096898|FG001|Overall Study|Failed inclusion criteria|1|||
163378702|NCT00953407|590096899|FG002|Overall Study|Failed inclusion criteria|1|||
163378703|NCT00953407|590096900|FG003|Overall Study|Failed inclusion criteria|1|||
163378704|NCT00953407|590096901|FG004|Overall Study|Failed inclusion criteria|1|||
163378705|NCT00953407|590096897|FG000|Overall Study|Lost to Follow-up|0|||
163378706|NCT00953407|590096898|FG001|Overall Study|Lost to Follow-up|0|||
163378707|NCT00953407|590096899|FG002|Overall Study|Lost to Follow-up|0|||
163378708|NCT00953407|590096900|FG003|Overall Study|Lost to Follow-up|1|||
163378709|NCT00953407|590096901|FG004|Overall Study|Lost to Follow-up|0|||
163378710|NCT02186223|590096902|FG000|Overall Study|Not eligible for device placement|6|||
163416454|NCT05574062|590231109|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
163416455|NCT05574062|590231110|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
163416456|NCT05574062|590231111|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
163416457|NCT05574062|590231107|FG000|Continuation Phase Period 1|Physician Decision|1|||
163416458|NCT05574062|590231108|FG001|Continuation Phase Period 1|Physician Decision|0|||
163416459|NCT05574062|590231109|FG002|Continuation Phase Period 1|Physician Decision|0|||
163416460|NCT05574062|590231110|FG003|Continuation Phase Period 1|Physician Decision|0|||
163416461|NCT05574062|590231111|FG004|Continuation Phase Period 1|Physician Decision|0|||
163416462|NCT05574062|590231107|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
163416463|NCT05574062|590231108|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
163416464|NCT05574062|590231109|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
163416465|NCT05574062|590231110|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
163416466|NCT05574062|590231111|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
163416467|NCT05574062|590231107|FG000|Continuation Phase Period 1|Adverse Event|1|||
163416468|NCT05574062|590231108|FG001|Continuation Phase Period 1|Adverse Event|0|||
163416469|NCT05574062|590231109|FG002|Continuation Phase Period 1|Adverse Event|0|||
163416470|NCT05574062|590231110|FG003|Continuation Phase Period 1|Adverse Event|0|||
163416471|NCT05574062|590231111|FG004|Continuation Phase Period 1|Adverse Event|0|||
163416472|NCT05574062|590231107|FG000|Continuation Phase Period 1|Death|1|||
163416473|NCT05574062|590231108|FG001|Continuation Phase Period 1|Death|0|||
163416474|NCT05574062|590231109|FG002|Continuation Phase Period 1|Death|0|||
163416475|NCT05574062|590231110|FG003|Continuation Phase Period 1|Death|0|||
163416476|NCT05574062|590231111|FG004|Continuation Phase Period 1|Death|0|||
163416477|NCT05574062|590231107|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
163416478|NCT05574062|590231108|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
163416479|NCT05574062|590231109|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
163416480|NCT05574062|590231110|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
163416481|NCT05574062|590231111|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
163416482|NCT05702736|590231113|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
163416483|NCT05702736|590231114|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
163416484|NCT05702736|590231113|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
163416485|NCT05702736|590231114|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
163416486|NCT04811716|590231130|FG000|Overall Study|Withdrawal by Subject|2|||
163416487|NCT04811716|590231131|FG001|Overall Study|Withdrawal by Subject|0|||
163416488|NCT02321436|590231132|FG000|Overall Study|Withdrawal by Subject|1|||
163416489|NCT02321436|590231133|FG001|Overall Study|Withdrawal by Subject|0|||
163416490|NCT02321436|590231132|FG000|Overall Study|Lost to Follow-up|0|||
163416491|NCT02321436|590231133|FG001|Overall Study|Lost to Follow-up|1|||
163416492|NCT03355300|590231134|FG000|Overall Study|Physician Decision|0|||
163416493|NCT03355300|590231135|FG001|Overall Study|Physician Decision|1|||
163416494|NCT03355300|590231134|FG000|Overall Study|Lack of Efficacy|2|||
163416495|NCT03355300|590231135|FG001|Overall Study|Lack of Efficacy|1|||
163416496|NCT03355300|590231134|FG000|Overall Study|Other reason|1|||
163416497|NCT03355300|590231135|FG001|Overall Study|Other reason|0|||
163416498|NCT00546052|590231136|FG000|Overall Study|Adverse Event|47|||
163416499|NCT00546052|590231136|FG000|Overall Study|Lost to Follow-up|144|||
163416500|NCT00546052|590231136|FG000|Overall Study|Protocol Violation|9|||
163416501|NCT00546052|590231136|FG000|Overall Study|Withdrawal by Subject|20|||
163416502|NCT00546052|590231136|FG000|Overall Study|Non Compliance|7|||
163416503|NCT01031446|590231139|FG000|Overall Study|Disease Progression|38|||
163416504|NCT01031446|590231139|FG000|Overall Study|Adverse Event|9|||
163416505|NCT01031446|590231139|FG000|Overall Study|Physician Decision|4|||
163416506|NCT01031446|590231139|FG000|Overall Study|Withdrawal by Subject|3|||
163416507|NCT01031446|590231139|FG000|Overall Study|Still on treatment|1|||
163416508|NCT01877083|590231140|FG000|Treatment Phase|Disease Progression|10|||
163416509|NCT01877083|590231140|FG000|Treatment Phase|Clinical Progression|1|||
163416510|NCT01877083|590231140|FG000|Treatment Phase|Adverse Event|6|||
163416511|NCT01877083|590231140|FG000|Treatment Phase|Withdrawal by Subject|2|||
163416512|NCT01877083|590231140|FG000|Treatment Phase|Lost to Follow-up|1|||
163416513|NCT01877083|590231140|FG000|Extension Phase|Disease Progression|3|||
163416514|NCT01877083|590231140|FG000|Extension Phase|Adverse Event|2|||
163416515|NCT00684957|590231143|FG000|Overall Study|Withdrawal by Subject|1|||
163416516|NCT00684957|590231144|FG001|Overall Study|Withdrawal by Subject|1|||
163416517|NCT00684957|590231143|FG000|Overall Study|Lost to Follow-up|1|||
163416518|NCT00684957|590231144|FG001|Overall Study|Lost to Follow-up|0|||
163416519|NCT04341948|590231145|FG000|Overall Study|Adverse Event|0|||
163416520|NCT04341948|590231146|FG001|Overall Study|Adverse Event|1|||
163416521|NCT04341948|590231145|FG000|Overall Study|Lost to Follow-up|6|||
163416522|NCT04341948|590231146|FG001|Overall Study|Lost to Follow-up|1|||
163416523|NCT04341948|590231145|FG000|Overall Study|Physician Decision|1|||
163416524|NCT04341948|590231146|FG001|Overall Study|Physician Decision|2|||
163416525|NCT04341948|590231145|FG000|Overall Study|Withdrawal by Participant|6|||
163416526|NCT04341948|590231146|FG001|Overall Study|Withdrawal by Participant|3|||
163416527|NCT04341948|590231145|FG000|Overall Study|Lack of compliance by Participant|1|||
163416528|NCT04341948|590231146|FG001|Overall Study|Lack of compliance by Participant|0|||
163378711|NCT02186223|590096902|FG000|Overall Study|Unable to obtain femoral access|3|||
163378712|NCT02186223|590096902|FG000|Overall Study|Death|3|||
163378713|NCT02186223|590096902|FG000|Overall Study|Device in place less than 48 hours|9|||
163378714|NCT00252733|590096903|FG000|Overall Study|Withdrawal by Subject|73|||
163378715|NCT00252733|590096904|FG001|Overall Study|Withdrawal by Subject|67|||
163378716|NCT00252733|590096903|FG000|Overall Study|Death|7|||
163378717|NCT00252733|590096904|FG001|Overall Study|Death|5|||
163378718|NCT00252733|590096903|FG000|Overall Study|Lost to Follow-up|12|||
163378719|NCT00252733|590096904|FG001|Overall Study|Lost to Follow-up|6|||
163378720|NCT00252733|590096903|FG000|Overall Study|Multiple Reasons|14|||
163378721|NCT00252733|590096904|FG001|Overall Study|Multiple Reasons|14|||
163378722|NCT01111474|590096905|FG000|Overall Study|Lost to Follow-up|12|||
163378723|NCT00618982|590096906|FG000|Overall Study|Adverse Event|23|||
163378724|NCT00618982|590096906|FG000|Overall Study|Withdrawal by Subject|1|||
163378725|NCT00618982|590096906|FG000|Overall Study|Protocol Violation|1|||
163378726|NCT00618982|590096906|FG000|Overall Study|ongoing, still treated with study med.|25|||
163378727|NCT04289051|590096907|FG000|Overall Study|Lost to Follow-up|0|||
163378728|NCT04289051|590096908|FG001|Overall Study|Lost to Follow-up|0|||
163378729|NCT04289051|590096909|FG002|Overall Study|Lost to Follow-up|2|||
163378730|NCT00156819|590096910|FG000|Overall Study|Lost to Follow-up|1|||
163378731|NCT00156819|590096911|FG001|Overall Study|Lost to Follow-up|1|||
163378732|NCT00156819|590096912|FG002|Overall Study|Lost to Follow-up|3|||
163378733|NCT01689337|590096913|FG000|Overall Study|Study Discontinuation|1|||
163378734|NCT05398237|590096918|FG000|Overall Study|Withdrawal by Subject|1|||
163378735|NCT01312857|590096921|FG000|Overall Study|Adverse Event|1|||
163378736|NCT01312857|590096922|FG001|Overall Study|Adverse Event|1|||
163378737|NCT01312857|590096921|FG000|Overall Study|Lost to Follow-up|2|||
163378738|NCT01312857|590096922|FG001|Overall Study|Lost to Follow-up|0|||
163378739|NCT01312857|590096921|FG000|Overall Study|Physician Decision|3|||
163378740|NCT01312857|590096922|FG001|Overall Study|Physician Decision|0|||
163378741|NCT01312857|590096921|FG000|Overall Study|Withdrawal by Subject|2|||
163378742|NCT01312857|590096922|FG001|Overall Study|Withdrawal by Subject|0|||
163378743|NCT01248065|590096923|FG000|Overall Study|Lost to Follow-up|3|||
163378744|NCT01248065|590096924|FG001|Overall Study|Lost to Follow-up|5|||
163378745|NCT01248065|590096923|FG000|Overall Study|Withdrawal by Subject|14|||
163378746|NCT01248065|590096924|FG001|Overall Study|Withdrawal by Subject|11|||
163378747|NCT01248065|590096923|FG000|Overall Study|Adverse Event|3|||
163378748|NCT01248065|590096924|FG001|Overall Study|Adverse Event|0|||
163378749|NCT01248065|590096923|FG000|Overall Study|Third treatment failure event|3|||
163378750|NCT01248065|590096924|FG001|Overall Study|Third treatment failure event|1|||
163378751|NCT01248065|590096923|FG000|Overall Study|Other|3|||
163378752|NCT01248065|590096924|FG001|Overall Study|Other|5|||
163378753|NCT02781844|590096930|FG000|Treatment Period 1|Adverse Event|0|||
163378754|NCT02781844|590096931|FG001|Treatment Period 1|Adverse Event|0|||
163378755|NCT02781844|590096932|FG002|Treatment Period 1|Adverse Event|0|||
163378756|NCT02781844|590096933|FG003|Treatment Period 1|Adverse Event|0|||
163378757|NCT02781844|590096934|FG004|Treatment Period 1|Adverse Event|0|||
163378758|NCT02781844|590096935|FG005|Treatment Period 1|Adverse Event|1|||
163378759|NCT02781844|590096936|FG006|Treatment Period 1|Adverse Event|0|||
163378760|NCT02781844|590096937|FG007|Treatment Period 1|Adverse Event|0|||
163378761|NCT00321373|590096938|FG000|Overall Study|Adverse Event|0|||
163378762|NCT00321373|590096939|FG001|Overall Study|Adverse Event|0|||
163378763|NCT00321373|590096940|FG002|Overall Study|Adverse Event|1|||
163378764|NCT00321373|590096938|FG000|Overall Study|Lost to Follow-up|1|||
163378765|NCT00321373|590096939|FG001|Overall Study|Lost to Follow-up|0|||
163378766|NCT00321373|590096940|FG002|Overall Study|Lost to Follow-up|1|||
163378767|NCT00321373|590096938|FG000|Overall Study|Withdrawal by Subject|1|||
163378768|NCT00321373|590096939|FG001|Overall Study|Withdrawal by Subject|0|||
163378769|NCT00321373|590096940|FG002|Overall Study|Withdrawal by Subject|0|||
163378770|NCT00321373|590096938|FG000|Overall Study|Other|0|||
163378771|NCT00321373|590096939|FG001|Overall Study|Other|0|||
163378772|NCT00321373|590096940|FG002|Overall Study|Other|1|||
163378773|NCT01774487|590096941|FG000|Overall Study|Did not tolerate taste|4|||
163378774|NCT01774487|590096942|FG001|Overall Study|Did not tolerate taste|4|||
163378775|NCT02572882|590096947|FG000|Overall Study|Withdrawal by Subject|1|||
163378776|NCT02572882|590096947|FG000|Overall Study|Participant received kidney transplant|1|||
163378777|NCT04275089|590096948|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
163378778|NCT01079663|590096951|FG000|Overall Study|Adverse Event|0|||
163378779|NCT01079663|590096952|FG001|Overall Study|Adverse Event|2|||
163378780|NCT01079663|590096951|FG000|Overall Study|Protocol Violation|0|||
163378781|NCT01079663|590096952|FG001|Overall Study|Protocol Violation|2|||
163378782|NCT03606668|590096953|FG000|Overall Study|Screen Failure|1|||
163378783|NCT03606668|590096953|FG000|Overall Study|Lost to Follow-up|1|||
163378784|NCT01014143|590096957|FG000|Second Intervention|Lost to Follow-up|2|||
163378785|NCT01014143|590096958|FG001|Second Intervention|Lost to Follow-up|0|||
163378786|NCT01014143|590096959|FG002|Second Intervention|Lost to Follow-up|0|||
163378787|NCT02354508|590096960|FG000|Period 1: Core Phase|Adverse Event|1|||
163378788|NCT02354508|590096961|FG001|Period 1: Core Phase|Adverse Event|1|||
163378789|NCT02354508|590096962|FG002|Period 1: Core Phase|Adverse Event|2|||
163416529|NCT03406897|590231147|FG000|Overall Study|Lost to Follow-up|1|||
163378790|NCT02354508|590096960|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
163378791|NCT02354508|590096961|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
163378792|NCT02354508|590096962|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
163378793|NCT02354508|590096960|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
163378794|NCT02354508|590096961|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
163378795|NCT02354508|590096962|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
163378796|NCT02354508|590096960|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
163378797|NCT02354508|590096961|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
163378798|NCT02354508|590096962|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
163378799|NCT02354508|590096960|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
163378800|NCT02354508|590096961|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
163378801|NCT02354508|590096962|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
163378802|NCT02354508|590096960|FG000|Period 2: Extension Phase|Physician Decision|5|||
163378803|NCT02354508|590096961|FG001|Period 2: Extension Phase|Physician Decision|0|||
163378804|NCT02354508|590096962|FG002|Period 2: Extension Phase|Physician Decision|1|||
163378805|NCT02354508|590096960|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
163378806|NCT02354508|590096961|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
163378807|NCT02354508|590096962|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
163378808|NCT02354508|590096960|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
163378809|NCT02354508|590096961|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
163378810|NCT02354508|590096962|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
163378811|NCT02354508|590096960|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
163378812|NCT02354508|590096961|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
163378813|NCT02354508|590096962|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
163378814|NCT00461032|590096966|FG000|Overall Study|Adverse Event|5|||
163378815|NCT00461032|590096967|FG001|Overall Study|Adverse Event|6|||
163378816|NCT00461032|590096966|FG000|Overall Study|Lack of Efficacy|5|||
163378817|NCT00461032|590096967|FG001|Overall Study|Lack of Efficacy|1|||
163378818|NCT00461032|590096966|FG000|Overall Study|Lost to Follow-up|7|||
163378819|NCT00461032|590096967|FG001|Overall Study|Lost to Follow-up|12|||
163378820|NCT00461032|590096966|FG000|Overall Study|Protocol Violation|4|||
163378821|NCT00461032|590096967|FG001|Overall Study|Protocol Violation|4|||
163378822|NCT00461032|590096966|FG000|Overall Study|Withdrawal by Subject|7|||
163378823|NCT00461032|590096967|FG001|Overall Study|Withdrawal by Subject|15|||
163378824|NCT00461032|590096966|FG000|Overall Study|Patient Moved or Relocated|2|||
163378825|NCT00461032|590096967|FG001|Overall Study|Patient Moved or Relocated|1|||
163378826|NCT00461032|590096966|FG000|Overall Study|Other|7|||
163378827|NCT00461032|590096967|FG001|Overall Study|Other|5|||
163378828|NCT04447846|590096968|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
163378829|NCT00297232|590096970|FG000|Overall Study|Lack of Efficacy|7|||
163378830|NCT00297232|590096970|FG000|Overall Study|Lost to Follow-up|10|||
163378831|NCT00297232|590096970|FG000|Overall Study|Adverse Event|63|||
163378832|NCT00297232|590096970|FG000|Overall Study|Voluntary Withdrawal|120|||
163378833|NCT00297232|590096970|FG000|Overall Study|Subject was Noncompliant|9|||
163378834|NCT00297232|590096970|FG000|Overall Study|Death|9|||
163378835|NCT00297232|590096970|FG000|Overall Study|Anti-natalizumab Positive|8|||
163378836|NCT00297232|590096970|FG000|Overall Study|Switched to Commercial Tysabri|22|||
163378837|NCT00297232|590096970|FG000|Overall Study|Disease Progression|8|||
163378838|NCT00297232|590096970|FG000|Overall Study|Fear of PML|10|||
163378839|NCT00297232|590096970|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
163378840|NCT00297232|590096970|FG000|Overall Study|Miscellaneous|5|||
163378841|NCT00297232|590096970|FG000|Overall Study|Sponsor Decision|34|||
163378842|NCT00297232|590096970|FG000|Overall Study|Subject Relocated|7|||
163378843|NCT00297232|590096970|FG000|Overall Study|Subject Withdrew Consent|37|||
163378844|NCT00297232|590096970|FG000|Overall Study|Persistently Positive Antibodies|11|||
163378845|NCT00297232|590096970|FG000|Overall Study|Investigator Withdrew From Program|19|||
163378846|NCT00297232|590096970|FG000|Overall Study|Did Not Enroll to Week 264|34|||
163416530|NCT03406897|590231148|FG001|Overall Study|Lost to Follow-up|2|||
163416531|NCT03406897|590231147|FG000|Overall Study|Withdrawal by Subject|4|||
163378847|NCT00297232|590096970|FG000|Overall Study|Did Not Enroll to Week 480|17|||
163378848|NCT00297232|590096970|FG000|Overall Study|No data available after Week 264|161|||
163378849|NCT00297232|590096970|FG000|Overall Study|Other|1|||
163378850|NCT03536143|590096973|FG000|Overall Study|Early termination, Sponsor decision|1|||
163378851|NCT01878214|590096974|FG000|Overall Study|Withdrawal by Subject|18|||
163378852|NCT01878214|590096975|FG001|Overall Study|Withdrawal by Subject|7|||
163378853|NCT01878214|590096974|FG000|Overall Study|Death|0|||
163378854|NCT01878214|590096975|FG001|Overall Study|Death|1|||
163378855|NCT01878214|590096974|FG000|Overall Study|Lost to Follow-up|35|||
163378856|NCT01878214|590096975|FG001|Overall Study|Lost to Follow-up|36|||
163378857|NCT03038438|590096976|FG000|Overall Study|Death|3|||
163378858|NCT03038438|590096976|FG000|Overall Study|Lost to Follow-up|8|||
163416532|NCT03406897|590231148|FG001|Overall Study|Withdrawal by Subject|4|||
163416533|NCT03406897|590231147|FG000|Overall Study|Physician Decision|0|||
163416534|NCT03406897|590231148|FG001|Overall Study|Physician Decision|1|||
163416535|NCT05900115|590232418|FG000|Overall Study|Lost to Follow-up|129|||
163416536|NCT05900115|590232419|FG001|Overall Study|Lost to Follow-up|98|||
163416537|NCT01602341|590232420|FG000|Overall Study|Adverse Event|0|||
163416538|NCT01602341|590232421|FG001|Overall Study|Adverse Event|1|||
163416539|NCT02152345|590232422|FG000|Overall Study|Case Cancellations|2|||
163416540|NCT02152345|590232423|FG001|Overall Study|Case Cancellations|4|||
163416541|NCT02152345|590232422|FG000|Overall Study|Withdrawal by Subject|2|||
163416542|NCT02152345|590232423|FG001|Overall Study|Withdrawal by Subject|1|||
163416543|NCT02324270|590232425|FG000|Overall Study|Withdrawal by Subject|0|||
163416544|NCT02324270|590232426|FG001|Overall Study|Withdrawal by Subject|1|||
163416545|NCT02324270|590232427|FG002|Overall Study|Withdrawal by Subject|0|||
163416546|NCT02324270|590232425|FG000|Overall Study|Lost to Follow-up|4|||
163416547|NCT02324270|590232426|FG001|Overall Study|Lost to Follow-up|3|||
163416548|NCT02324270|590232427|FG002|Overall Study|Lost to Follow-up|4|||
163416549|NCT02324270|590232425|FG000|Overall Study|Protocol Violation|0|||
163416550|NCT02324270|590232426|FG001|Overall Study|Protocol Violation|1|||
163416551|NCT02324270|590232427|FG002|Overall Study|Protocol Violation|1|||
163416552|NCT02324270|590232425|FG000|Overall Study|Non Compliance with Study Drug|1|||
163416553|NCT02324270|590232426|FG001|Overall Study|Non Compliance with Study Drug|2|||
163416554|NCT02324270|590232427|FG002|Overall Study|Non Compliance with Study Drug|0|||
163416555|NCT03521791|590232428|FG000|Overall Study|Protocol Violation|7|||
163416556|NCT03521791|590232429|FG001|Overall Study|Protocol Violation|17|||
163416557|NCT00680836|590232430|FG000|Overall Study|Withdrawal by Subject|3|||
163416558|NCT00680836|590232431|FG001|Overall Study|Withdrawal by Subject|0|||
163416559|NCT00680836|590232430|FG000|Overall Study|Lost to Follow-up|3|||
163416560|NCT00680836|590232431|FG001|Overall Study|Lost to Follow-up|1|||
163416561|NCT00680836|590232430|FG000|Overall Study|Physician Decision|2|||
163416562|NCT00680836|590232431|FG001|Overall Study|Physician Decision|1|||
163416563|NCT03786432|590232432|FG000|Overall Study|Screen Failure after consent|1|||
163416564|NCT03786432|590232432|FG000|Overall Study|Lost to Follow-up|4|||
163416565|NCT03786432|590232432|FG000|Overall Study|did not complete 12 month CT scan|1|||
163416566|NCT03038308|590232433|FG000|Overall Study|Surgical resection|1|||
163416567|NCT03038308|590232433|FG000|Overall Study|Withdrawal by Subject|2|||
163416568|NCT03038308|590232433|FG000|Overall Study|Lost to Follow-up|1|||
163416569|NCT01475734|590232435|FG000|Overall Study|Withdrawal by Subject|1|||
163416570|NCT01475734|590232436|FG001|Overall Study|Withdrawal by Subject|0|||
163416571|NCT01475734|590232435|FG000|Overall Study|Protocol Violation|1|||
163416572|NCT01475734|590232436|FG001|Overall Study|Protocol Violation|0|||
163416573|NCT01475734|590232435|FG000|Overall Study|Physician Decision|0|||
163416574|NCT01475734|590232436|FG001|Overall Study|Physician Decision|1|||
163416575|NCT00771472|590232437|FG000|Overall Study|Physician Decision|2|||
163416576|NCT00771472|590232438|FG001|Overall Study|Physician Decision|3|||
163416577|NCT00771472|590232437|FG000|Overall Study|Progressive Disease|3|||
163416578|NCT00771472|590232438|FG001|Overall Study|Progressive Disease|1|||
163416579|NCT00771472|590232437|FG000|Overall Study|Protocol Violation|1|||
163416580|NCT00771472|590232438|FG001|Overall Study|Protocol Violation|0|||
163416581|NCT00667576|590232444|FG000|Overall Study|Withdrawal by Subject|1|||
163416582|NCT00667576|590232445|FG001|Overall Study|Withdrawal by Subject|0|||
163416583|NCT00667576|590232446|FG002|Overall Study|Withdrawal by Subject|1|||
163416584|NCT00667576|590232447|FG003|Overall Study|Withdrawal by Subject|1|||
163416585|NCT00667576|590232448|FG004|Overall Study|Withdrawal by Subject|1|||
163416586|NCT00667576|590232444|FG000|Overall Study|Adverse Event|1|||
163416587|NCT00667576|590232445|FG001|Overall Study|Adverse Event|1|||
163416588|NCT00667576|590232446|FG002|Overall Study|Adverse Event|0|||
163416589|NCT00667576|590232447|FG003|Overall Study|Adverse Event|0|||
163416590|NCT00667576|590232448|FG004|Overall Study|Adverse Event|0|||
163416591|NCT00667576|590232444|FG000|Overall Study|Lost to Follow-up|0|||
163416592|NCT00667576|590232445|FG001|Overall Study|Lost to Follow-up|0|||
163416593|NCT00667576|590232446|FG002|Overall Study|Lost to Follow-up|1|||
163416594|NCT00667576|590232447|FG003|Overall Study|Lost to Follow-up|0|||
163416595|NCT00667576|590232448|FG004|Overall Study|Lost to Follow-up|0|||
163416596|NCT00667576|590232444|FG000|Overall Study|Protocol Violation|0|||
163416597|NCT00667576|590232445|FG001|Overall Study|Protocol Violation|0|||
163416598|NCT00667576|590232446|FG002|Overall Study|Protocol Violation|0|||
163416599|NCT00667576|590232447|FG003|Overall Study|Protocol Violation|1|||
163416600|NCT00667576|590232448|FG004|Overall Study|Protocol Violation|0|||
163416601|NCT00667576|590232444|FG000|Overall Study|Physician Decision|0|||
163416602|NCT00667576|590232445|FG001|Overall Study|Physician Decision|0|||
163416603|NCT00667576|590232446|FG002|Overall Study|Physician Decision|0|||
163416604|NCT00667576|590232447|FG003|Overall Study|Physician Decision|1|||
163416605|NCT00667576|590232448|FG004|Overall Study|Physician Decision|0|||
163416606|NCT00667576|590232444|FG000|Overall Study|Missed Visit|0|||
163416607|NCT00667576|590232445|FG001|Overall Study|Missed Visit|0|||
163416608|NCT00667576|590232446|FG002|Overall Study|Missed Visit|0|||
163416609|NCT00667576|590232447|FG003|Overall Study|Missed Visit|1|||
163416610|NCT00667576|590232448|FG004|Overall Study|Missed Visit|0|||
163416611|NCT00568555|590232455|FG000|Overall Study|Withdrawal by Subject|1|||
163416612|NCT00568555|590232456|FG001|Overall Study|Withdrawal by Subject|1|||
163416613|NCT01231555|590232457|FG000|Overall Study|Study terminated|8|||
163416614|NCT01231555|590232458|FG001|Overall Study|Study terminated|5|||
163416615|NCT01231555|590232459|FG002|Overall Study|Study terminated|8|||
163416616|NCT01231555|590232457|FG000|Overall Study|Withdrawal by Subject|0|||
163416617|NCT01231555|590232458|FG001|Overall Study|Withdrawal by Subject|2|||
163416618|NCT01231555|590232459|FG002|Overall Study|Withdrawal by Subject|0|||
163416619|NCT00700180|590232461|FG000|Overall Study|Death|99|||
163416620|NCT00700180|590232462|FG001|Overall Study|Death|114|||
163416621|NCT00700180|590232461|FG000|Overall Study|Alive on treatment|5|||
163416622|NCT00700180|590232462|FG001|Overall Study|Alive on treatment|3|||
163416623|NCT00700180|590232461|FG000|Overall Study|Alive in follow-up|46|||
163416624|NCT00700180|590232462|FG001|Overall Study|Alive in follow-up|27|||
163416625|NCT00700180|590232461|FG000|Overall Study|Lost to Follow-up|4|||
163416626|NCT00700180|590232462|FG001|Overall Study|Lost to Follow-up|5|||
163416627|NCT03588741|590232463|FG000|Overall Study|Withdrawal by Subject|1|||
163416628|NCT02288247|590232464|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
163416629|NCT02288247|590232465|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
163416630|NCT02288247|590232464|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
163416631|NCT02288247|590232465|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
163416632|NCT02288247|590232464|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
163416633|NCT02288247|590232465|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
163416634|NCT02288247|590232464|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
163416635|NCT02288247|590232465|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
163416636|NCT02288247|590232464|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
163416637|NCT02288247|590232465|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
163378859|NCT03038438|590096976|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
163378860|NCT03038438|590096976|FG000|Overall Study|Withdrawal by Subject|5|||
163378861|NCT03038438|590096976|FG000|Overall Study|No 36-Month Follow-Up|18|||
163378862|NCT01174160|590096977|FG000|Overall Study|Adverse Event|1|||
163378863|NCT01174160|590096978|FG001|Overall Study|Adverse Event|0|||
163378864|NCT01174160|590096977|FG000|Overall Study|Lost to Follow-up|1|||
163378865|NCT01174160|590096978|FG001|Overall Study|Lost to Follow-up|0|||
163378866|NCT01174160|590096977|FG000|Overall Study|Physician Decision|1|||
163378867|NCT01174160|590096978|FG001|Overall Study|Physician Decision|0|||
163378868|NCT01174160|590096977|FG000|Overall Study|Protocol Violation|4|||
163378869|NCT01174160|590096978|FG001|Overall Study|Protocol Violation|6|||
163378870|NCT01174160|590096977|FG000|Overall Study|Withdrawal by Subject|1|||
163378871|NCT01174160|590096978|FG001|Overall Study|Withdrawal by Subject|0|||
163378872|NCT03406260|590096981|FG000|Period 1|Adverse Event|0|||
163378873|NCT03406260|590096982|FG001|Period 1|Adverse Event|0|||
163416638|NCT02288247|590232464|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
163416639|NCT02288247|590232465|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
163416640|NCT02288247|590232464|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
163416641|NCT02288247|590232465|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
163416642|NCT02288247|590232464|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
163416643|NCT02288247|590232465|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
163416644|NCT02288247|590232464|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
163416645|NCT02288247|590232465|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
163416646|NCT02288247|590232464|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
163416647|NCT02288247|590232465|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
163416648|NCT02288247|590232464|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
163416649|NCT02288247|590232465|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
163416650|NCT02288247|590232464|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
163416651|NCT02288247|590232465|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
163378874|NCT03406260|590096983|FG002|Period 1|Adverse Event|0|||
163416652|NCT02288247|590232464|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
163416653|NCT02288247|590232465|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
163416654|NCT02288247|590232464|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
163416655|NCT02288247|590232465|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
163416656|NCT02288247|590232464|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
163416657|NCT02288247|590232465|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
163416658|NCT02288247|590232464|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
163416659|NCT02288247|590232465|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
163416660|NCT02817087|590232466|FG000|Overall Study|Withdrawal by Subject|2|||
163416661|NCT02817087|590232467|FG001|Overall Study|Withdrawal by Subject|0|||
163416662|NCT04871711|590232468|FG000|Overall Study|Withdrawal by Subject|11|||
163416663|NCT04871711|590232469|FG001|Overall Study|Withdrawal by Subject|5|||
163416664|NCT04871711|590232468|FG000|Overall Study|Lack of Efficacy|5|||
163378875|NCT03406260|590096984|FG003|Period 1|Adverse Event|0|||
163378876|NCT03406260|590096985|FG004|Period 1|Adverse Event|1|||
163378877|NCT03406260|590096986|FG005|Period 1|Adverse Event|0|||
163378878|NCT00871780|590096987|FG000|Overall Study|Enrolled But Not Treated|6|||
163378879|NCT00871780|590096987|FG000|Overall Study|Withdrawal by Subject|9|||
163378880|NCT00871780|590096987|FG000|Overall Study|Adverse Event|6|||
163378881|NCT00871780|590096987|FG000|Overall Study|Voluntary Discontinuation|4|||
163378882|NCT00871780|590096987|FG000|Overall Study|Death|1|||
163378883|NCT00871780|590096987|FG000|Overall Study|Physician Decision|1|||
163378884|NCT01029652|590096991|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
163378885|NCT01029652|590096992|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
163378886|NCT01029652|590096991|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
163378887|NCT01029652|590096992|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
163378888|NCT01029652|590096991|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
163378889|NCT01029652|590096992|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
163378890|NCT01029652|590096991|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
163378891|NCT01029652|590096992|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
163378892|NCT01029652|590096991|FG000|Core Study (0-12 Weeks)|Death|0|||
163378893|NCT01029652|590096992|FG001|Core Study (0-12 Weeks)|Death|1|||
163378894|NCT01029652|590096991|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
163378895|NCT01029652|590096992|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
163378896|NCT01029652|590096991|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
163378897|NCT01029652|590096992|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
163378898|NCT01029652|590096991|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
163378899|NCT01029652|590096992|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
163378900|NCT01029652|590096991|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
163378901|NCT01029652|590096992|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
163378902|NCT01029652|590096991|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
163378903|NCT01029652|590096992|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
163378904|NCT01029652|590096991|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
163378905|NCT01029652|590096992|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
163378906|NCT01029652|590096991|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
163378907|NCT01029652|590096992|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
163378908|NCT05767021|590096993|FG000|Overall Study|Adverse Event|2|||
163378909|NCT05767021|590096993|FG000|Overall Study|Protocol Deviation|1|||
163378910|NCT05767021|590096993|FG000|Overall Study|Withdrawal by Subject|1|||
163378911|NCT05767021|590096993|FG000|Overall Study|Physician Decision|1|||
163378912|NCT05767021|590096993|FG000|Overall Study|Lack of Efficacy|11|||
163378913|NCT05767021|590096993|FG000|Overall Study|Assigned Treatment by Mistake|1|||
163378914|NCT00523640|590096998|FG000|Overall Study|Death|1|||
163378915|NCT06377488|590096999|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
163378916|NCT06377488|590096999|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
163378917|NCT06377488|590096999|FG000|Overall Study|Protocol Violation|1|||
163378918|NCT06377488|590096999|FG000|Overall Study|Lost to Follow-up|1|||
163378919|NCT06377488|590096999|FG000|Overall Study|Incorrect Lens Dispensed|2|||
163378920|NCT02399254|590097002|FG000|Overall Study|Physician Decision|2|||
163378921|NCT02334423|590097003|FG000|Overall Study|Protocol Violation|10|||
163378922|NCT02334423|590097004|FG001|Overall Study|Protocol Violation|3|||
163378923|NCT01076647|590097007|FG000|Overall Study|Adverse Event|4|||
163378924|NCT01076647|590097008|FG001|Overall Study|Adverse Event|1|||
163378925|NCT01076647|590097007|FG000|Overall Study|Lack of Efficacy|0|||
163378926|NCT01076647|590097008|FG001|Overall Study|Lack of Efficacy|1|||
163378927|NCT01076647|590097007|FG000|Overall Study|Protocol Violation|7|||
163378928|NCT01076647|590097008|FG001|Overall Study|Protocol Violation|9|||
163378929|NCT01076647|590097007|FG000|Overall Study|Withdrawal criteria|2|||
163378930|NCT01076647|590097008|FG001|Overall Study|Withdrawal criteria|2|||
163378931|NCT01076647|590097007|FG000|Overall Study|Unclassified|12|||
163378932|NCT01076647|590097008|FG001|Overall Study|Unclassified|12|||
163378933|NCT03545503|590097011|FG000|Overall Study|Protocol Violation|14|||
163378934|NCT03545503|590097012|FG001|Overall Study|Protocol Violation|16|||
163378935|NCT04494256|590097013|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
163378936|NCT04494256|590097014|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
163378937|NCT04494256|590097015|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
163378938|NCT04494256|590097016|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
163378939|NCT04494256|590097017|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
163378940|NCT04494256|590097018|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
163378941|NCT04494256|590097019|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
163378942|NCT04494256|590097013|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
163378943|NCT04494256|590097014|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
163378944|NCT04494256|590097015|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
163378945|NCT04494256|590097016|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
163378946|NCT04494256|590097017|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
163378947|NCT04494256|590097018|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
163378948|NCT04494256|590097019|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
163416665|NCT04871711|590232469|FG001|Overall Study|Lack of Efficacy|7|||
163416666|NCT04871711|590232468|FG000|Overall Study|Adverse Event|2|||
163416667|NCT04871711|590232469|FG001|Overall Study|Adverse Event|6|||
163416668|NCT04871711|590232468|FG000|Overall Study|Various reasons|2|||
163416669|NCT04871711|590232469|FG001|Overall Study|Various reasons|1|||
163416670|NCT04871711|590232468|FG000|Overall Study|Lost to Follow-up|0|||
163416671|NCT04871711|590232469|FG001|Overall Study|Lost to Follow-up|2|||
163416672|NCT01665144|590232470|FG000|Core Part|Withdrawal by Subject|96|||
163416673|NCT01665144|590232471|FG001|Core Part|Withdrawal by Subject|77|||
163416674|NCT01665144|590232472|FG002|Core Part|Withdrawal by Subject|0|||
163416675|NCT01665144|590232470|FG000|Core Part|Adverse Event|45|||
163416676|NCT01665144|590232471|FG001|Core Part|Adverse Event|18|||
163416677|NCT01665144|590232472|FG002|Core Part|Adverse Event|0|||
163416678|NCT01665144|590232470|FG000|Core Part|Lack of Efficacy|16|||
163416679|NCT01665144|590232471|FG001|Core Part|Lack of Efficacy|11|||
163416680|NCT01665144|590232472|FG002|Core Part|Lack of Efficacy|0|||
163416681|NCT01665144|590232470|FG000|Core Part|Lost to Follow-up|9|||
163416682|NCT01665144|590232471|FG001|Core Part|Lost to Follow-up|8|||
163416683|NCT01665144|590232472|FG002|Core Part|Lost to Follow-up|0|||
163416684|NCT01665144|590232470|FG000|Core Part|Physician Decision|13|||
163416685|NCT01665144|590232471|FG001|Core Part|Physician Decision|1|||
163416686|NCT01665144|590232472|FG002|Core Part|Physician Decision|0|||
163416687|NCT01665144|590232470|FG000|Core Part|Progressive disease|8|||
163416688|NCT01665144|590232471|FG001|Core Part|Progressive disease|4|||
163416689|NCT01665144|590232472|FG002|Core Part|Progressive disease|0|||
163416690|NCT01665144|590232470|FG000|Core Part|Non-compliance with study treatment|5|||
163416691|NCT01665144|590232471|FG001|Core Part|Non-compliance with study treatment|0|||
163416692|NCT01665144|590232472|FG002|Core Part|Non-compliance with study treatment|0|||
163416693|NCT01665144|590232470|FG000|Core Part|Death|3|||
163416694|NCT01665144|590232471|FG001|Core Part|Death|1|||
163416695|NCT01665144|590232472|FG002|Core Part|Death|0|||
163416696|NCT01665144|590232470|FG000|Core Part|Protocol deviation|3|||
163416697|NCT01665144|590232471|FG001|Core Part|Protocol deviation|1|||
163416698|NCT01665144|590232472|FG002|Core Part|Protocol deviation|0|||
163416699|NCT01665144|590232470|FG000|Core Part|New therapy for study indication|2|||
163416700|NCT01665144|590232471|FG001|Core Part|New therapy for study indication|1|||
163416701|NCT01665144|590232472|FG002|Core Part|New therapy for study indication|0|||
163416702|NCT01665144|590232470|FG000|Core Part|Technical problems|2|||
163416703|NCT01665144|590232471|FG001|Core Part|Technical problems|0|||
163416704|NCT01665144|590232472|FG002|Core Part|Technical problems|0|||
163416705|NCT01665144|590232470|FG000|Extension Part|Patient/guardian decision|180|||
163416706|NCT01665144|590232471|FG001|Extension Part|Patient/guardian decision|0|||
163416707|NCT01665144|590232472|FG002|Extension Part|Patient/guardian decision|98|||
163416708|NCT01665144|590232470|FG000|Extension Part|Adverse Event|104|||
163416709|NCT01665144|590232471|FG001|Extension Part|Adverse Event|0|||
163416710|NCT01665144|590232472|FG002|Extension Part|Adverse Event|59|||
163416711|NCT01665144|590232470|FG000|Extension Part|Study closed early|42|||
163416712|NCT01665144|590232471|FG001|Extension Part|Study closed early|0|||
163416713|NCT01665144|590232472|FG002|Extension Part|Study closed early|19|||
163416714|NCT01665144|590232470|FG000|Extension Part|Progressive disease|36|||
163416715|NCT01665144|590232471|FG001|Extension Part|Progressive disease|0|||
163416716|NCT01665144|590232472|FG002|Extension Part|Progressive disease|14|||
163416717|NCT01665144|590232470|FG000|Extension Part|Lack of Efficacy|37|||
163416718|NCT01665144|590232471|FG001|Extension Part|Lack of Efficacy|0|||
163416719|NCT01665144|590232472|FG002|Extension Part|Lack of Efficacy|12|||
163416720|NCT01665144|590232470|FG000|Extension Part|Physician Decision|29|||
163416721|NCT01665144|590232471|FG001|Extension Part|Physician Decision|0|||
163416722|NCT01665144|590232472|FG002|Extension Part|Physician Decision|13|||
163416723|NCT01665144|590232470|FG000|Extension Part|Technical problems|20|||
163416724|NCT01665144|590232471|FG001|Extension Part|Technical problems|0|||
163416725|NCT01665144|590232472|FG002|Extension Part|Technical problems|8|||
163416726|NCT01665144|590232470|FG000|Extension Part|Death|20|||
163416727|NCT01665144|590232471|FG001|Extension Part|Death|0|||
163416728|NCT01665144|590232472|FG002|Extension Part|Death|4|||
163416729|NCT01665144|590232470|FG000|Extension Part|Missing|12|||
163416730|NCT01665144|590232471|FG001|Extension Part|Missing|0|||
163416731|NCT01665144|590232472|FG002|Extension Part|Missing|6|||
163416732|NCT01665144|590232470|FG000|Extension Part|Lost to Follow-up|9|||
163416733|NCT01665144|590232471|FG001|Extension Part|Lost to Follow-up|0|||
163416734|NCT01665144|590232472|FG002|Extension Part|Lost to Follow-up|5|||
163416735|NCT01665144|590232470|FG000|Extension Part|New therapy for study indication|3|||
163416736|NCT01665144|590232471|FG001|Extension Part|New therapy for study indication|0|||
163416737|NCT01665144|590232472|FG002|Extension Part|New therapy for study indication|2|||
163416738|NCT01665144|590232470|FG000|Extension Part|Protocol deviation|3|||
163416739|NCT01665144|590232471|FG001|Extension Part|Protocol deviation|0|||
163416740|NCT01665144|590232472|FG002|Extension Part|Protocol deviation|0|||
163416741|NCT01972074|590232479|FG000|Overall Study|Adverse Event|4|||
163416742|NCT01972074|590232480|FG001|Overall Study|Adverse Event|1|||
163416743|NCT01972074|590232481|FG002|Overall Study|Adverse Event|0|||
163416744|NCT01972074|590232479|FG000|Overall Study|Lack of Efficacy|1|||
163378949|NCT04494256|590097013|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
163378950|NCT04494256|590097014|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
163378951|NCT04494256|590097015|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
163378952|NCT04494256|590097016|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
163378953|NCT04494256|590097017|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
163378954|NCT04494256|590097018|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
163378955|NCT04494256|590097019|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
163378956|NCT04494256|590097013|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163378957|NCT04494256|590097014|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163378958|NCT04494256|590097015|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163378959|NCT04494256|590097016|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
163378960|NCT04494256|590097017|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
163378961|NCT04494256|590097018|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163378962|NCT04494256|590097019|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163378963|NCT04494256|590097013|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
163378964|NCT04494256|590097014|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
163378965|NCT04494256|590097015|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
163378966|NCT04494256|590097016|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
163378967|NCT04494256|590097017|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
163378968|NCT04494256|590097018|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
163378969|NCT04494256|590097019|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
163378970|NCT04494256|590097013|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
163378971|NCT04494256|590097014|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
163378972|NCT04494256|590097015|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
163378973|NCT04494256|590097016|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
163378974|NCT04494256|590097017|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
163378975|NCT04494256|590097018|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
163378976|NCT04494256|590097019|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
163378977|NCT04494256|590097013|FG000|Part 2: Open Label Period|Death|0|||
163378978|NCT04494256|590097014|FG001|Part 2: Open Label Period|Death|0|||
163378979|NCT04494256|590097015|FG002|Part 2: Open Label Period|Death|0|||
163378980|NCT04494256|590097016|FG003|Part 2: Open Label Period|Death|0|||
163378981|NCT04494256|590097017|FG004|Part 2: Open Label Period|Death|0|||
163378982|NCT04494256|590097018|FG005|Part 2: Open Label Period|Death|4|||
163378983|NCT04494256|590097019|FG006|Part 2: Open Label Period|Death|2|||
163378984|NCT04494256|590097013|FG000|Part 2: Open Label Period|Adverse Event|0|||
163378985|NCT04494256|590097014|FG001|Part 2: Open Label Period|Adverse Event|0|||
163378986|NCT04494256|590097015|FG002|Part 2: Open Label Period|Adverse Event|0|||
163378987|NCT04494256|590097016|FG003|Part 2: Open Label Period|Adverse Event|0|||
163378988|NCT04494256|590097017|FG004|Part 2: Open Label Period|Adverse Event|0|||
163378989|NCT04494256|590097018|FG005|Part 2: Open Label Period|Adverse Event|0|||
163378990|NCT04494256|590097019|FG006|Part 2: Open Label Period|Adverse Event|2|||
163378991|NCT04494256|590097013|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
163378992|NCT04494256|590097014|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
163378993|NCT04494256|590097015|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
163378994|NCT04494256|590097016|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
163378995|NCT04494256|590097017|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
163378996|NCT04494256|590097018|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
163378997|NCT04494256|590097019|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
163378998|NCT04494256|590097013|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
163378999|NCT04494256|590097014|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
163379000|NCT04494256|590097015|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
163379001|NCT04494256|590097016|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
163379002|NCT04494256|590097017|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
163379003|NCT04494256|590097018|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
163379004|NCT04494256|590097019|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
163379005|NCT04494256|590097013|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
163379006|NCT04494256|590097014|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
163379007|NCT04494256|590097015|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
163379008|NCT04494256|590097016|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
163379009|NCT04494256|590097017|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
163379010|NCT04494256|590097018|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
163379011|NCT04494256|590097019|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
163379012|NCT04494256|590097013|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163416745|NCT01972074|590232480|FG001|Overall Study|Lack of Efficacy|1|||
163416746|NCT01972074|590232481|FG002|Overall Study|Lack of Efficacy|0|||
163416747|NCT01972074|590232479|FG000|Overall Study|Lost to Follow-up|0|||
163416748|NCT01972074|590232480|FG001|Overall Study|Lost to Follow-up|1|||
163416749|NCT01972074|590232481|FG002|Overall Study|Lost to Follow-up|1|||
163416750|NCT01972074|590232479|FG000|Overall Study|Withdrawal by Subject|1|||
163416751|NCT01972074|590232480|FG001|Overall Study|Withdrawal by Subject|1|||
163416752|NCT01972074|590232481|FG002|Overall Study|Withdrawal by Subject|1|||
163416753|NCT01972074|590232479|FG000|Overall Study|Scanner Unavailable|0|||
163416754|NCT01972074|590232480|FG001|Overall Study|Scanner Unavailable|0|||
163416755|NCT01972074|590232481|FG002|Overall Study|Scanner Unavailable|1|||
163416756|NCT02319044|590232482|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
163416757|NCT02319044|590232483|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
163416758|NCT02319044|590232484|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
163416759|NCT02319044|590232482|FG000|Overall Study|Withdrawal by Subject|3|||
163416760|NCT02319044|590232483|FG001|Overall Study|Withdrawal by Subject|3|||
163416761|NCT02319044|590232484|FG002|Overall Study|Withdrawal by Subject|6|||
163416762|NCT02319044|590232482|FG000|Overall Study|Condition under investigation worsened|100|||
163416763|NCT02319044|590232483|FG001|Overall Study|Condition under investigation worsened|50|||
163416764|NCT02319044|590232484|FG002|Overall Study|Condition under investigation worsened|46|||
163416765|NCT02319044|590232482|FG000|Overall Study|Adverse Event|17|||
163416766|NCT02319044|590232483|FG001|Overall Study|Adverse Event|2|||
163416767|NCT02319044|590232484|FG002|Overall Study|Adverse Event|8|||
163416768|NCT02319044|590232482|FG000|Overall Study|Study specific discontinuation criteria|2|||
163416769|NCT02319044|590232483|FG001|Overall Study|Study specific discontinuation criteria|2|||
163416770|NCT02319044|590232484|FG002|Overall Study|Study specific discontinuation criteria|1|||
163416771|NCT02319044|590232482|FG000|Overall Study|Not treated|0|||
163416772|NCT02319044|590232483|FG001|Overall Study|Not treated|2|||
163416773|NCT02319044|590232484|FG002|Overall Study|Not treated|2|||
163416774|NCT03687502|590232489|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
163416775|NCT03687502|590232489|FG000|Overall Study|Lumason not available|1|||
163416776|NCT00486278|590232490|FG000|Overall Study|Adverse Event|5|||
163416777|NCT00486278|590232490|FG000|Overall Study|Withdrawal by Subject|2|||
163416778|NCT00486278|590232490|FG000|Overall Study|Physician Decision|2|||
163416779|NCT01777581|590232496|FG000|Overall Study|Lost to Follow-up|1|||
163416780|NCT01777581|590232497|FG001|Overall Study|Lost to Follow-up|1|||
163416781|NCT01777581|590232496|FG000|Overall Study|Adverse Event|2|||
163416782|NCT01777581|590232497|FG001|Overall Study|Adverse Event|0|||
163416783|NCT01777581|590232496|FG000|Overall Study|Lack of Efficacy|0|||
163416784|NCT01777581|590232497|FG001|Overall Study|Lack of Efficacy|1|||
163416785|NCT02887521|590232500|FG000|Overall Study|Withdrawal by Subject|0|||
163416786|NCT02887521|590232501|FG001|Overall Study|Withdrawal by Subject|3|||
163416787|NCT00695565|590232502|FG000|Overall Study|Lost to Follow-up|4|||
163416788|NCT00695565|590232503|FG001|Overall Study|Lost to Follow-up|4|||
163416789|NCT00695565|590232502|FG000|Overall Study|Adverse Event|3|||
163416790|NCT00695565|590232503|FG001|Overall Study|Adverse Event|1|||
163416791|NCT00695565|590232502|FG000|Overall Study|Protocol Violation|3|||
163416792|NCT00695565|590232503|FG001|Overall Study|Protocol Violation|1|||
163416793|NCT00695565|590232502|FG000|Overall Study|Withdrawal by Subject|1|||
163416794|NCT00695565|590232503|FG001|Overall Study|Withdrawal by Subject|1|||
163416795|NCT00695565|590232502|FG000|Overall Study|Lack of Efficacy|1|||
163416796|NCT00695565|590232503|FG001|Overall Study|Lack of Efficacy|1|||
163416797|NCT00695565|590232502|FG000|Overall Study|Subject did not follow instructions|1|||
163416798|NCT00695565|590232503|FG001|Overall Study|Subject did not follow instructions|1|||
163416799|NCT01462266|590232504|FG000|Overall Study|Adverse Event|7|||
163416800|NCT01462266|590232505|FG001|Overall Study|Adverse Event|6|||
163416801|NCT01462266|590232504|FG000|Overall Study|Death|2|||
163416802|NCT01462266|590232505|FG001|Overall Study|Death|1|||
163416803|NCT01462266|590232504|FG000|Overall Study|Lack of Efficacy|0|||
163416804|NCT01462266|590232505|FG001|Overall Study|Lack of Efficacy|2|||
163416805|NCT01462266|590232504|FG000|Overall Study|Lost to Follow-up|4|||
163416806|NCT01462266|590232505|FG001|Overall Study|Lost to Follow-up|3|||
163416807|NCT01462266|590232504|FG000|Overall Study|Non-compliance with study drug|3|||
163416808|NCT01462266|590232505|FG001|Overall Study|Non-compliance with study drug|0|||
163416809|NCT01462266|590232504|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
163416810|NCT01462266|590232505|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
163416811|NCT01462266|590232504|FG000|Overall Study|Physician Decision|2|||
163416812|NCT01462266|590232505|FG001|Overall Study|Physician Decision|5|||
163416813|NCT01462266|590232504|FG000|Overall Study|Protocol Violation|1|||
163416814|NCT01462266|590232505|FG001|Overall Study|Protocol Violation|3|||
163416815|NCT01462266|590232504|FG000|Overall Study|Withdrawal by Subject|7|||
163416816|NCT01462266|590232505|FG001|Overall Study|Withdrawal by Subject|2|||
163416817|NCT01462266|590232504|FG000|Overall Study|Screen failure|1|||
163416818|NCT01462266|590232505|FG001|Overall Study|Screen failure|1|||
163416819|NCT01106846|590232506|FG000|Overall Study|Change in surgical procedure|0|||
163416820|NCT01106846|590232507|FG001|Overall Study|Change in surgical procedure|1|||
163379013|NCT04494256|590097014|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163379014|NCT04494256|590097015|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163379015|NCT04494256|590097016|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163379016|NCT04494256|590097017|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163379017|NCT04494256|590097018|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
163379018|NCT04494256|590097019|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
163379019|NCT04494256|590097013|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
163379020|NCT04494256|590097014|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
163379021|NCT04494256|590097015|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
163379022|NCT04494256|590097016|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
163379023|NCT04494256|590097017|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
163379024|NCT04494256|590097018|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
163379025|NCT04494256|590097019|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
163379026|NCT00262951|590097020|FG000|Overall Study|Progressive disease/relapse|3|||
163379027|NCT00262951|590097020|FG000|Overall Study|Adverse Event|7|||
163379028|NCT00262951|590097020|FG000|Overall Study|Death|1|||
163379029|NCT00262951|590097020|FG000|Overall Study|Withdrawal by Subject|1|||
163379030|NCT00262951|590097020|FG000|Overall Study|Alternative treatment|3|||
163379031|NCT00262951|590097020|FG000|Overall Study|Off treatment for other disease|1|||
163379032|NCT02483585|590097021|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
163379033|NCT02483585|590097022|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
163379034|NCT02483585|590097021|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
163379035|NCT02483585|590097022|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
163379036|NCT02483585|590097021|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
163379037|NCT02483585|590097022|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
163379038|NCT02483585|590097021|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
163379039|NCT02483585|590097022|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
163379040|NCT02483585|590097021|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
163379041|NCT02483585|590097022|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
163379042|NCT02483585|590097021|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
163379043|NCT02483585|590097022|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
163379044|NCT02483585|590097021|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
163379045|NCT02483585|590097022|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
163379046|NCT00825916|590097026|FG000|Overall Study|Lost to Follow-up|4|||
163379047|NCT00825916|590097027|FG001|Overall Study|Lost to Follow-up|2|||
163379048|NCT00825916|590097028|FG002|Overall Study|Lost to Follow-up|1|||
163379049|NCT01778023|590097029|FG000|Overall Study|Withdrawal by Subject|0|||
163379050|NCT01778023|590097030|FG001|Overall Study|Withdrawal by Subject|3|||
163379051|NCT01098097|590097031|FG000|Overall Study|Adverse Event|17|||
163379052|NCT01098097|590097031|FG000|Overall Study|Lost to Follow-up|18|||
163379053|NCT01098097|590097031|FG000|Overall Study|Status unknown|16|||
163379054|NCT01098097|590097031|FG000|Overall Study|No reason reported|31|||
163379055|NCT01000636|590097032|FG000|Overall Study|Withdrawal by Subject|1|||
163379056|NCT01000636|590097032|FG000|Overall Study|Adverse Event|1|||
163379057|NCT00577577|590097034|FG000|Overall Study|Adverse Event|3|||
163379058|NCT00577577|590097035|FG001|Overall Study|Adverse Event|2|||
163379059|NCT00577577|590097034|FG000|Overall Study|Lost to Follow-up|1|||
163379060|NCT00577577|590097035|FG001|Overall Study|Lost to Follow-up|0|||
163379061|NCT00577577|590097034|FG000|Overall Study|Protocol Violation|0|||
163379062|NCT00577577|590097035|FG001|Overall Study|Protocol Violation|3|||
163379063|NCT00577577|590097034|FG000|Overall Study|Transportation|1|||
163379064|NCT00577577|590097035|FG001|Overall Study|Transportation|0|||
163379065|NCT01090427|590097036|FG000|After Controlled Period|Death|0|||
163379066|NCT01090427|590097037|FG001|After Controlled Period|Death|0|||
163379067|NCT01090427|590097038|FG002|After Controlled Period|Death|0|||
163379068|NCT01090427|590097039|FG003|After Controlled Period|Death|0|||
163379069|NCT01090427|590097040|FG004|After Controlled Period|Death|0|||
163379070|NCT01090427|590097041|FG005|After Controlled Period|Death|1|||
163379071|NCT01090427|590097042|FG006|After Controlled Period|Death|0|||
163379072|NCT01090427|590097036|FG000|After Controlled Period|Lack of Efficacy|0|||
163379073|NCT01090427|590097037|FG001|After Controlled Period|Lack of Efficacy|0|||
163379074|NCT01090427|590097038|FG002|After Controlled Period|Lack of Efficacy|0|||
163379075|NCT01090427|590097039|FG003|After Controlled Period|Lack of Efficacy|0|||
163379076|NCT01090427|590097040|FG004|After Controlled Period|Lack of Efficacy|0|||
163379077|NCT01090427|590097041|FG005|After Controlled Period|Lack of Efficacy|3|||
163379078|NCT01090427|590097042|FG006|After Controlled Period|Lack of Efficacy|2|||
163379079|NCT01090427|590097036|FG000|After Controlled Period|Adverse Event|0|||
163379080|NCT01090427|590097037|FG001|After Controlled Period|Adverse Event|0|||
163379081|NCT01090427|590097038|FG002|After Controlled Period|Adverse Event|0|||
163379082|NCT01090427|590097039|FG003|After Controlled Period|Adverse Event|2|||
163379083|NCT01090427|590097040|FG004|After Controlled Period|Adverse Event|0|||
163379084|NCT01090427|590097041|FG005|After Controlled Period|Adverse Event|1|||
163416821|NCT03110900|590232508|FG000|Overall Study|Sponsor withdrew|1|||
163416822|NCT03110900|590232509|FG001|Overall Study|Sponsor withdrew|1|||
163416823|NCT00644787|590232510|FG000|Period 1: Titration Phase|Adverse Event|11|||
163416824|NCT00644787|590232511|FG001|Period 1: Titration Phase|Adverse Event|0|||
163416825|NCT00644787|590232512|FG002|Period 1: Titration Phase|Adverse Event|0|||
163416826|NCT00644787|590232510|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
163416827|NCT00644787|590232511|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
163416828|NCT00644787|590232512|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
163416829|NCT00644787|590232510|FG000|Period 1: Titration Phase|Physician Decision|1|||
163416830|NCT00644787|590232511|FG001|Period 1: Titration Phase|Physician Decision|0|||
163416831|NCT00644787|590232512|FG002|Period 1: Titration Phase|Physician Decision|0|||
163416832|NCT00644787|590232510|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
163416833|NCT00644787|590232511|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
163416834|NCT00644787|590232512|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
163416835|NCT00644787|590232510|FG000|Period 1: Titration Phase|Worsening of complications|1|||
163416836|NCT00644787|590232511|FG001|Period 1: Titration Phase|Worsening of complications|0|||
163416837|NCT00644787|590232512|FG002|Period 1: Titration Phase|Worsening of complications|0|||
163416838|NCT00644787|590232510|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
163416839|NCT00644787|590232511|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
163416840|NCT00644787|590232512|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
163416841|NCT00644787|590232510|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
163416842|NCT00644787|590232511|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
163416843|NCT00644787|590232512|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
163416844|NCT00644787|590232510|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
163379085|NCT01090427|590097042|FG006|After Controlled Period|Adverse Event|0|||
163379086|NCT01154010|590097043|FG000|Overall Study|Lost to Follow-up|0|||
163379087|NCT01154010|590097044|FG001|Overall Study|Lost to Follow-up|1|||
163379088|NCT02413333|590097050|FG000|Period 1|Adverse Event|1|||
163379089|NCT02413333|590097051|FG001|Period 1|Adverse Event|0|||
163379090|NCT02413333|590097050|FG000|Period 1|Reason Not Specified|0|||
163379091|NCT02413333|590097051|FG001|Period 1|Reason Not Specified|1|||
163379092|NCT02413333|590097050|FG000|Period 2|Protocol Deviation|1|||
163379093|NCT02413333|590097051|FG001|Period 2|Protocol Deviation|0|||
163379094|NCT01465347|590097052|FG000|Overall Study|Withdrawal by Subject|1|||
163379095|NCT01465347|590097053|FG001|Overall Study|Withdrawal by Subject|1|||
163379096|NCT01465347|590097052|FG000|Overall Study|Physician Decision|0|||
163379097|NCT01465347|590097053|FG001|Overall Study|Physician Decision|1|||
163379098|NCT01465347|590097052|FG000|Overall Study|Admitted to hospice|0|||
163379099|NCT01465347|590097053|FG001|Overall Study|Admitted to hospice|1|||
163379100|NCT00906945|590097054|FG000|Overall Study|Found to be not eligible|0|||
163379101|NCT00906945|590097055|FG001|Overall Study|Found to be not eligible|0|||
163379102|NCT00906945|590097056|FG002|Overall Study|Found to be not eligible|0|||
163379103|NCT00906945|590097057|FG003|Overall Study|Found to be not eligible|1|||
163379104|NCT00906945|590097058|FG004|Overall Study|Found to be not eligible|1|||
163379105|NCT00906945|590097059|FG005|Overall Study|Found to be not eligible|1|||
163379106|NCT00906945|590097054|FG000|Overall Study|Physician Decision|0|||
163379107|NCT00906945|590097055|FG001|Overall Study|Physician Decision|0|||
163379108|NCT00906945|590097056|FG002|Overall Study|Physician Decision|0|||
163379109|NCT00906945|590097057|FG003|Overall Study|Physician Decision|0|||
163379110|NCT00906945|590097058|FG004|Overall Study|Physician Decision|0|||
163379111|NCT00906945|590097059|FG005|Overall Study|Physician Decision|1|||
163379112|NCT02996474|590097060|FG000|Overall Study|Physician Decision|5|||
163379113|NCT01210664|590097062|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
163379114|NCT01210664|590097063|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
163379115|NCT01210664|590097064|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
163379116|NCT01210664|590097065|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
163379117|NCT01210664|590097062|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
163379118|NCT01210664|590097063|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
163379119|NCT01210664|590097064|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
163379120|NCT01210664|590097065|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
163379121|NCT01210664|590097062|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
163416845|NCT00644787|590232511|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
163416846|NCT00644787|590232512|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
163416847|NCT00644787|590232510|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
163416848|NCT00644787|590232511|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
163416849|NCT00644787|590232512|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
163416850|NCT00644787|590232510|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
163416851|NCT00644787|590232511|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
163416852|NCT00644787|590232512|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
163416853|NCT00644787|590232510|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
163416854|NCT00644787|590232511|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
163416855|NCT00644787|590232512|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
163416856|NCT00644787|590232510|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
163416857|NCT00644787|590232511|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
163379122|NCT01210664|590097063|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
163379123|NCT01210664|590097064|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
163379124|NCT01210664|590097065|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
163379125|NCT01853644|590097066|FG000|Registration and Treatment Start|Did not start treatment|1|||
163379126|NCT01853644|590097066|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
163379127|NCT01853644|590097066|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
163379128|NCT01853644|590097066|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
163379129|NCT01853644|590097066|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
163379130|NCT01853644|590097066|FG000|Continued Treatment After First Response|Adverse Event|2|||
163379131|NCT01853644|590097066|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
163379132|NCT02891837|590097067|FG000|Overall Study|Lost to Follow-up|2|||
163379133|NCT02891837|590097068|FG001|Overall Study|Lost to Follow-up|0|||
163379134|NCT02891837|590097067|FG000|Overall Study|Withdrawal by Subject|1|||
163379135|NCT02891837|590097068|FG001|Overall Study|Withdrawal by Subject|0|||
163379136|NCT00943111|590097069|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
163379137|NCT00943111|590097070|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
163379138|NCT00943111|590097071|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
163379139|NCT00943111|590097069|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
163379140|NCT00943111|590097070|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
163379141|NCT00943111|590097071|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
163379142|NCT00943111|590097069|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
163379143|NCT00943111|590097070|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
163379144|NCT00943111|590097071|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
163379145|NCT00943111|590097069|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
163379146|NCT00943111|590097070|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
163379147|NCT00943111|590097071|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
163379148|NCT00943111|590097069|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
163379149|NCT00943111|590097070|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
163379150|NCT00943111|590097071|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
163379151|NCT00943111|590097069|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
163379152|NCT00943111|590097070|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
163379153|NCT00943111|590097071|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
163379154|NCT00943111|590097069|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
163379155|NCT00943111|590097070|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
163379156|NCT00943111|590097071|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
163379157|NCT00943111|590097069|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
163379158|NCT00943111|590097070|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
163379159|NCT00943111|590097071|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
163379160|NCT02502097|590099458|FG000|Period 1|Adverse Event|0|||
163379161|NCT02502097|590099459|FG001|Period 1|Adverse Event|0|||
163379162|NCT02502097|590099460|FG002|Period 1|Adverse Event|1|||
163379163|NCT02502097|590099461|FG003|Period 1|Adverse Event|0|||
163379164|NCT02502097|590099458|FG000|Wash Out Period|Adverse Event|0|||
163379165|NCT02502097|590099459|FG001|Wash Out Period|Adverse Event|1|||
163379166|NCT02502097|590099460|FG002|Wash Out Period|Adverse Event|1|||
163379167|NCT02502097|590099461|FG003|Wash Out Period|Adverse Event|1|||
163379168|NCT02502097|590099458|FG000|Period 2|Adverse Event|0|||
163379169|NCT02502097|590099459|FG001|Period 2|Adverse Event|0|||
163379170|NCT02502097|590099460|FG002|Period 2|Adverse Event|1|||
163379171|NCT02502097|590099461|FG003|Period 2|Adverse Event|0|||
163379172|NCT02874924|590099462|FG000|Overall Study|Adverse Event|2|||
163379173|NCT02874924|590099463|FG001|Overall Study|Adverse Event|0|||
163379174|NCT02874924|590099464|FG002|Overall Study|Adverse Event|0|||
163379175|NCT02874924|590099462|FG000|Overall Study|Withdrawal by Subject|1|||
163379176|NCT02874924|590099463|FG001|Overall Study|Withdrawal by Subject|0|||
163379177|NCT02874924|590099464|FG002|Overall Study|Withdrawal by Subject|0|||
163379178|NCT02808143|590099467|FG000|Maintenance Phase|Disease recurrence|1|||
163379179|NCT02808143|590099468|FG001|Maintenance Phase|Disease recurrence|3|||
163379180|NCT02808143|590099467|FG000|Maintenance Phase|Disease progression|1|||
163379181|NCT02808143|590099468|FG001|Maintenance Phase|Disease progression|2|||
163379182|NCT02808143|590099467|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
163379183|NCT02808143|590099468|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
163379184|NCT02808143|590099467|FG000|Survival Follow-Up|Disease recurrence|0|||
163379185|NCT02808143|590099468|FG001|Survival Follow-Up|Disease recurrence|2|||
163379186|NCT02808143|590099467|FG000|Survival Follow-Up|Adverse Event|0|||
163379187|NCT02808143|590099468|FG001|Survival Follow-Up|Adverse Event|1|||
163379188|NCT02808143|590099467|FG000|Survival Follow-Up|Death|1|||
163416858|NCT00644787|590232512|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
163379189|NCT02808143|590099468|FG001|Survival Follow-Up|Death|0|||
163379190|NCT01874431|590099469|FG000|Overall Study|Physician Decision|0|||
163379191|NCT01874431|590099470|FG001|Overall Study|Physician Decision|0|||
163379192|NCT01874431|590099471|FG002|Overall Study|Physician Decision|1|||
163379193|NCT01874431|590099472|FG003|Overall Study|Physician Decision|0|||
163379194|NCT01874431|590099473|FG004|Overall Study|Physician Decision|0|||
163379195|NCT01874431|590099474|FG005|Overall Study|Physician Decision|0|||
163379196|NCT01874431|590099475|FG006|Overall Study|Physician Decision|0|||
163379197|NCT01874431|590099476|FG007|Overall Study|Physician Decision|0|||
163379198|NCT01874431|590099469|FG000|Overall Study|Adverse Event|5|||
163379199|NCT01874431|590099470|FG001|Overall Study|Adverse Event|4|||
163379200|NCT01874431|590099471|FG002|Overall Study|Adverse Event|6|||
163379201|NCT01874431|590099472|FG003|Overall Study|Adverse Event|5|||
163379202|NCT01874431|590099473|FG004|Overall Study|Adverse Event|2|||
163379203|NCT01874431|590099474|FG005|Overall Study|Adverse Event|8|||
163379204|NCT01874431|590099475|FG006|Overall Study|Adverse Event|2|||
163379205|NCT01874431|590099476|FG007|Overall Study|Adverse Event|3|||
163379206|NCT01874431|590099469|FG000|Overall Study|Protocol Violation|1|||
163379207|NCT01874431|590099470|FG001|Overall Study|Protocol Violation|1|||
163379208|NCT01874431|590099471|FG002|Overall Study|Protocol Violation|1|||
163379209|NCT01874431|590099472|FG003|Overall Study|Protocol Violation|0|||
163379210|NCT01874431|590099473|FG004|Overall Study|Protocol Violation|3|||
163379211|NCT01874431|590099474|FG005|Overall Study|Protocol Violation|2|||
163379212|NCT01874431|590099475|FG006|Overall Study|Protocol Violation|1|||
163379213|NCT01874431|590099476|FG007|Overall Study|Protocol Violation|1|||
163379214|NCT01874431|590099469|FG000|Overall Study|Non-compliance|0|||
163379215|NCT01874431|590099470|FG001|Overall Study|Non-compliance|0|||
163379216|NCT01874431|590099471|FG002|Overall Study|Non-compliance|0|||
163379217|NCT01874431|590099472|FG003|Overall Study|Non-compliance|0|||
163379218|NCT01874431|590099473|FG004|Overall Study|Non-compliance|1|||
163379219|NCT01874431|590099474|FG005|Overall Study|Non-compliance|0|||
163379220|NCT01874431|590099475|FG006|Overall Study|Non-compliance|1|||
163379221|NCT01874431|590099476|FG007|Overall Study|Non-compliance|0|||
163379222|NCT01874431|590099469|FG000|Overall Study|Logistical difficulties|0|||
163379223|NCT01874431|590099470|FG001|Overall Study|Logistical difficulties|0|||
163379224|NCT01874431|590099471|FG002|Overall Study|Logistical difficulties|0|||
163379225|NCT01874431|590099472|FG003|Overall Study|Logistical difficulties|0|||
163379226|NCT01874431|590099473|FG004|Overall Study|Logistical difficulties|0|||
163379227|NCT01874431|590099474|FG005|Overall Study|Logistical difficulties|0|||
163379228|NCT01874431|590099475|FG006|Overall Study|Logistical difficulties|1|||
163379229|NCT01874431|590099476|FG007|Overall Study|Logistical difficulties|0|||
163379230|NCT01874431|590099469|FG000|Overall Study|Withdrawal by Subject|0|||
163379231|NCT01874431|590099470|FG001|Overall Study|Withdrawal by Subject|0|||
163379232|NCT01874431|590099471|FG002|Overall Study|Withdrawal by Subject|1|||
163379233|NCT01874431|590099472|FG003|Overall Study|Withdrawal by Subject|2|||
163379234|NCT01874431|590099473|FG004|Overall Study|Withdrawal by Subject|1|||
163379235|NCT01874431|590099474|FG005|Overall Study|Withdrawal by Subject|1|||
163379236|NCT01874431|590099475|FG006|Overall Study|Withdrawal by Subject|3|||
163379237|NCT01874431|590099476|FG007|Overall Study|Withdrawal by Subject|0|||
163379238|NCT01874431|590099469|FG000|Overall Study|Sponsor decision|0|||
163379239|NCT01874431|590099470|FG001|Overall Study|Sponsor decision|0|||
163379240|NCT01874431|590099471|FG002|Overall Study|Sponsor decision|0|||
163379241|NCT01874431|590099472|FG003|Overall Study|Sponsor decision|0|||
163379242|NCT01874431|590099473|FG004|Overall Study|Sponsor decision|1|||
163379243|NCT01874431|590099474|FG005|Overall Study|Sponsor decision|0|||
163379244|NCT01874431|590099475|FG006|Overall Study|Sponsor decision|0|||
163379245|NCT01874431|590099476|FG007|Overall Study|Sponsor decision|0|||
163379246|NCT01874431|590099469|FG000|Overall Study|Lost to Follow-up|0|||
163379247|NCT01874431|590099470|FG001|Overall Study|Lost to Follow-up|0|||
163379248|NCT01874431|590099471|FG002|Overall Study|Lost to Follow-up|1|||
163379249|NCT01874431|590099472|FG003|Overall Study|Lost to Follow-up|0|||
163379250|NCT01874431|590099473|FG004|Overall Study|Lost to Follow-up|0|||
163379251|NCT01874431|590099474|FG005|Overall Study|Lost to Follow-up|0|||
163379252|NCT01874431|590099475|FG006|Overall Study|Lost to Follow-up|0|||
163379253|NCT01874431|590099476|FG007|Overall Study|Lost to Follow-up|0|||
163379254|NCT03718533|590099478|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
163379255|NCT03718533|590099478|FG000|Overall Study|Protocol deviation|1|||
163379256|NCT03718533|590099478|FG000|Overall Study|Disease progression|1|||
163379257|NCT03718533|590099478|FG000|Overall Study|Relapse|1|||
163379258|NCT03718533|590099478|FG000|Overall Study|Physician Decision|2|||
163379259|NCT03718533|590099478|FG000|Overall Study|Physician Decision and Adverse Event|1|||
163379260|NCT02257567|590099481|FG000|Overall Study|Adverse Event|0|||
163379261|NCT02257567|590099482|FG001|Overall Study|Adverse Event|0|||
163379262|NCT02257567|590099483|FG002|Overall Study|Adverse Event|0|||
163379263|NCT02257567|590099484|FG003|Overall Study|Adverse Event|1|||
163379264|NCT02257567|590099485|FG004|Overall Study|Adverse Event|1|||
163379265|NCT02257567|590099486|FG005|Overall Study|Adverse Event|0|||
163379266|NCT02257567|590099487|FG006|Overall Study|Adverse Event|0|||
163379267|NCT02257567|590099488|FG007|Overall Study|Adverse Event|0|||
163379268|NCT02257567|590099489|FG008|Overall Study|Adverse Event|1|||
163379269|NCT02257567|590099490|FG009|Overall Study|Adverse Event|0|||
163379270|NCT02257567|590099491|FG010|Overall Study|Adverse Event|0|||
163379271|NCT02257567|590099481|FG000|Overall Study|Death|2|||
163379272|NCT02257567|590099482|FG001|Overall Study|Death|2|||
163379273|NCT02257567|590099483|FG002|Overall Study|Death|2|||
163379274|NCT02257567|590099484|FG003|Overall Study|Death|4|||
163379275|NCT02257567|590099485|FG004|Overall Study|Death|15|||
163379276|NCT02257567|590099486|FG005|Overall Study|Death|11|||
163379277|NCT02257567|590099487|FG006|Overall Study|Death|26|||
163379278|NCT02257567|590099488|FG007|Overall Study|Death|30|||
163379279|NCT02257567|590099489|FG008|Overall Study|Death|2|||
163379280|NCT02257567|590099490|FG009|Overall Study|Death|18|||
163379281|NCT02257567|590099491|FG010|Overall Study|Death|65|||
163379282|NCT02257567|590099481|FG000|Overall Study|Lost to Follow-up|0|||
163379283|NCT02257567|590099482|FG001|Overall Study|Lost to Follow-up|0|||
163379284|NCT02257567|590099483|FG002|Overall Study|Lost to Follow-up|0|||
163379285|NCT02257567|590099484|FG003|Overall Study|Lost to Follow-up|0|||
163379286|NCT02257567|590099485|FG004|Overall Study|Lost to Follow-up|2|||
163379287|NCT02257567|590099486|FG005|Overall Study|Lost to Follow-up|2|||
163379288|NCT02257567|590099487|FG006|Overall Study|Lost to Follow-up|0|||
163379289|NCT02257567|590099488|FG007|Overall Study|Lost to Follow-up|0|||
163379290|NCT02257567|590099489|FG008|Overall Study|Lost to Follow-up|0|||
163379291|NCT02257567|590099490|FG009|Overall Study|Lost to Follow-up|1|||
163379292|NCT02257567|590099491|FG010|Overall Study|Lost to Follow-up|1|||
163379293|NCT02257567|590099481|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163379294|NCT02257567|590099482|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163379295|NCT02257567|590099483|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163379296|NCT02257567|590099484|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163379297|NCT02257567|590099485|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
163379298|NCT02257567|590099486|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163379299|NCT02257567|590099487|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
163379300|NCT02257567|590099488|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163379301|NCT02257567|590099489|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163379302|NCT02257567|590099490|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163379303|NCT02257567|590099491|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163379304|NCT02257567|590099481|FG000|Overall Study|Physician Decision|0|||
163379305|NCT02257567|590099482|FG001|Overall Study|Physician Decision|0|||
163379306|NCT02257567|590099483|FG002|Overall Study|Physician Decision|0|||
163379307|NCT02257567|590099484|FG003|Overall Study|Physician Decision|0|||
163379308|NCT02257567|590099485|FG004|Overall Study|Physician Decision|0|||
163379309|NCT02257567|590099486|FG005|Overall Study|Physician Decision|0|||
163379310|NCT02257567|590099487|FG006|Overall Study|Physician Decision|0|||
163379311|NCT02257567|590099488|FG007|Overall Study|Physician Decision|2|||
163379312|NCT02257567|590099489|FG008|Overall Study|Physician Decision|0|||
163379313|NCT02257567|590099490|FG009|Overall Study|Physician Decision|1|||
163379314|NCT02257567|590099491|FG010|Overall Study|Physician Decision|0|||
163379315|NCT02257567|590099481|FG000|Overall Study|Withdrawal by Subject|0|||
163379316|NCT02257567|590099482|FG001|Overall Study|Withdrawal by Subject|0|||
163379317|NCT02257567|590099483|FG002|Overall Study|Withdrawal by Subject|2|||
163379318|NCT02257567|590099484|FG003|Overall Study|Withdrawal by Subject|0|||
163379319|NCT02257567|590099485|FG004|Overall Study|Withdrawal by Subject|0|||
163379320|NCT02257567|590099486|FG005|Overall Study|Withdrawal by Subject|6|||
163379321|NCT02257567|590099487|FG006|Overall Study|Withdrawal by Subject|6|||
163379322|NCT02257567|590099488|FG007|Overall Study|Withdrawal by Subject|6|||
163379323|NCT02257567|590099489|FG008|Overall Study|Withdrawal by Subject|1|||
163379324|NCT02257567|590099490|FG009|Overall Study|Withdrawal by Subject|1|||
163379325|NCT02257567|590099491|FG010|Overall Study|Withdrawal by Subject|10|||
163379326|NCT00946101|590099492|FG000|Overall Study|Lost to Follow-up|2|||
163379327|NCT00946101|590099493|FG001|Overall Study|Lost to Follow-up|1|||
163379328|NCT00946101|590099492|FG000|Overall Study|Withdrawal of consent|2|||
163379329|NCT00946101|590099493|FG001|Overall Study|Withdrawal of consent|0|||
163379330|NCT00946101|590099492|FG000|Overall Study|Physician Decision|0|||
163379331|NCT00946101|590099493|FG001|Overall Study|Physician Decision|1|||
163379332|NCT00495586|590099494|FG000|Overall Study|Withdrawal by Subject|4|||
163379333|NCT00495586|590099495|FG001|Overall Study|Withdrawal by Subject|4|||
163379334|NCT01590017|590099496|FG000|Overall Study|Adverse Event|1|||
163379335|NCT01590017|590099496|FG000|Overall Study|Withdrawal by Subject|1|||
163379336|NCT01590017|590099496|FG000|Overall Study|Lack of Efficacy|1|||
163379337|NCT01590017|590099496|FG000|Overall Study|Physician Decision|1|||
163379338|NCT02038543|590099497|FG000|Overall Study|Screen Failure|0|||
163379339|NCT02038543|590099498|FG001|Overall Study|Screen Failure|0|||
163379340|NCT02038543|590099499|FG002|Overall Study|Screen Failure|0|||
163379341|NCT02038543|590099500|FG003|Overall Study|Screen Failure|1|||
163379342|NCT02038543|590099497|FG000|Overall Study|Withdrawal by Subject|0|||
163379343|NCT02038543|590099498|FG001|Overall Study|Withdrawal by Subject|0|||
163379344|NCT02038543|590099499|FG002|Overall Study|Withdrawal by Subject|0|||
163379345|NCT02038543|590099500|FG003|Overall Study|Withdrawal by Subject|1|||
163379346|NCT00093808|590099501|FG000|Overall Study|Cancel participation before receiving tx|1|||
163379347|NCT00093808|590099501|FG000|Overall Study|Protocol Violation|1|||
163379348|NCT02647866|590099502|FG000|Overall Study|Adverse Event|0|||
163379349|NCT02647866|590099503|FG001|Overall Study|Adverse Event|0|||
163379350|NCT02647866|590099504|FG002|Overall Study|Adverse Event|2|||
163379351|NCT02647866|590099505|FG003|Overall Study|Adverse Event|2|||
163379352|NCT02647866|590099506|FG004|Overall Study|Adverse Event|1|||
163379353|NCT02647866|590099502|FG000|Overall Study|Disease Worsening|3|||
163379354|NCT02647866|590099503|FG001|Overall Study|Disease Worsening|1|||
163379355|NCT02647866|590099504|FG002|Overall Study|Disease Worsening|0|||
163379356|NCT02647866|590099505|FG003|Overall Study|Disease Worsening|0|||
163379357|NCT02647866|590099506|FG004|Overall Study|Disease Worsening|1|||
163379358|NCT02647866|590099502|FG000|Overall Study|Withdrawal by Subject|1|||
163379359|NCT02647866|590099503|FG001|Overall Study|Withdrawal by Subject|1|||
163379360|NCT02647866|590099504|FG002|Overall Study|Withdrawal by Subject|2|||
163379361|NCT02647866|590099505|FG003|Overall Study|Withdrawal by Subject|4|||
163379362|NCT02647866|590099506|FG004|Overall Study|Withdrawal by Subject|4|||
163379363|NCT02647866|590099502|FG000|Overall Study|Physician Decision|0|||
163379364|NCT02647866|590099503|FG001|Overall Study|Physician Decision|1|||
163379365|NCT02647866|590099504|FG002|Overall Study|Physician Decision|1|||
163379366|NCT02647866|590099505|FG003|Overall Study|Physician Decision|0|||
163379367|NCT02647866|590099506|FG004|Overall Study|Physician Decision|2|||
163379368|NCT02647866|590099502|FG000|Overall Study|Death|0|||
163379369|NCT02647866|590099503|FG001|Overall Study|Death|1|||
163379370|NCT02647866|590099504|FG002|Overall Study|Death|0|||
163379371|NCT02647866|590099505|FG003|Overall Study|Death|0|||
163379372|NCT02647866|590099506|FG004|Overall Study|Death|0|||
163379373|NCT02647866|590099502|FG000|Overall Study|Subject moved to different country|1|||
163379374|NCT02647866|590099503|FG001|Overall Study|Subject moved to different country|0|||
163379375|NCT02647866|590099504|FG002|Overall Study|Subject moved to different country|0|||
163379376|NCT02647866|590099505|FG003|Overall Study|Subject moved to different country|0|||
163379377|NCT02647866|590099506|FG004|Overall Study|Subject moved to different country|0|||
163379378|NCT02527343|590099507|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
163379379|NCT02527343|590099508|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
163379380|NCT02527343|590099509|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
163379381|NCT02527343|590099510|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
163379382|NCT02527343|590099511|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
163379383|NCT02527343|590099512|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
163379384|NCT02527343|590099507|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
163379385|NCT02527343|590099508|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
163379386|NCT02527343|590099509|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
163379387|NCT02527343|590099510|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
163379388|NCT02527343|590099511|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
163379389|NCT02527343|590099512|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
163379390|NCT02527343|590099507|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
163379391|NCT02527343|590099508|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
163379392|NCT02527343|590099509|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
163379393|NCT02527343|590099510|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
163379394|NCT02527343|590099511|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
163379395|NCT02527343|590099512|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
163379396|NCT02527343|590099507|FG000|RT Period: Weeks 1 to 52|Other|4|||
163379397|NCT02527343|590099508|FG001|RT Period: Weeks 1 to 52|Other|3|||
163379398|NCT02527343|590099509|FG002|RT Period: Weeks 1 to 52|Other|0|||
163379399|NCT02527343|590099510|FG003|RT Period: Weeks 1 to 52|Other|0|||
163379400|NCT02527343|590099511|FG004|RT Period: Weeks 1 to 52|Other|0|||
163379401|NCT02527343|590099512|FG005|RT Period: Weeks 1 to 52|Other|0|||
163379402|NCT02527343|590099507|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
163379403|NCT02527343|590099508|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
163379404|NCT02527343|590099509|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
163379405|NCT02527343|590099510|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
163379406|NCT02527343|590099511|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
163379407|NCT02527343|590099512|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
163379408|NCT02527343|590099507|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
163379409|NCT02527343|590099508|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
163379410|NCT02527343|590099509|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
163379411|NCT02527343|590099510|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
163379412|NCT02527343|590099511|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
163379413|NCT02527343|590099512|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
163379414|NCT02527343|590099507|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
163379415|NCT02527343|590099508|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
163379416|NCT02527343|590099509|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
163379417|NCT02527343|590099510|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
163379418|NCT02527343|590099511|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
163379419|NCT02527343|590099512|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
163379420|NCT02527343|590099507|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
163379421|NCT02527343|590099508|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
163379422|NCT02527343|590099509|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
163379423|NCT02527343|590099510|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
163379424|NCT02527343|590099511|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
163379425|NCT02527343|590099512|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
163379426|NCT02527343|590099507|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
163379427|NCT02527343|590099508|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
163379428|NCT02527343|590099509|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
163379429|NCT02527343|590099510|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
163379430|NCT02527343|590099511|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
163379431|NCT02527343|590099512|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
163379432|NCT02527343|590099507|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
163379433|NCT02527343|590099508|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
163379434|NCT02527343|590099509|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
163379435|NCT02527343|590099510|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
163379436|NCT02527343|590099511|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
163379437|NCT02527343|590099512|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
163379438|NCT02527343|590099507|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
163379439|NCT02527343|590099508|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
163379440|NCT02527343|590099509|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
163379441|NCT02527343|590099510|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
163379442|NCT02527343|590099511|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
163379443|NCT02527343|590099512|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
163379444|NCT02527343|590099507|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
163379445|NCT02527343|590099508|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
163379446|NCT02527343|590099509|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
163379447|NCT02527343|590099510|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
163379448|NCT02527343|590099511|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
163379449|NCT02527343|590099512|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
163379450|NCT02527343|590099507|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
163379451|NCT02527343|590099508|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
163379452|NCT02527343|590099509|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
163379453|NCT02527343|590099510|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
163379454|NCT02527343|590099511|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
163379455|NCT02527343|590099512|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
163379456|NCT04426851|590099513|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
163379457|NCT04426851|590099514|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
163379458|NCT04426851|590099513|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
163379459|NCT04426851|590099514|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
163379460|NCT03625895|590099516|FG000|Overall Study|Protocol Violation|585|||
163379461|NCT03256851|590099517|FG000|Overall Study|Withdrawal by Subject|1|||
163379462|NCT03256851|590099518|FG001|Overall Study|Withdrawal by Subject|0|||
163379463|NCT01065844|590099519|FG000|Overall Study|Adverse Event|5|||
163379464|NCT02081417|590099520|FG000|Overall Study|Lost to Follow-up|26|||
163379465|NCT02081417|590099521|FG001|Overall Study|Lost to Follow-up|23|||
163379466|NCT02081417|590099520|FG000|Overall Study|Moved Away|1|||
163379467|NCT02081417|590099521|FG001|Overall Study|Moved Away|2|||
163379468|NCT02081417|590099520|FG000|Overall Study|Incarcerated|2|||
163379469|NCT02081417|590099521|FG001|Overall Study|Incarcerated|2|||
163379470|NCT02081417|590099520|FG000|Overall Study|Death|4|||
163379471|NCT02081417|590099521|FG001|Overall Study|Death|3|||
163379472|NCT02081417|590099520|FG000|Overall Study|Withdrawal by Subject|4|||
163379473|NCT02081417|590099521|FG001|Overall Study|Withdrawal by Subject|0|||
163379474|NCT02081417|590099520|FG000|Overall Study|Admitted to Residential Treatment|2|||
163379475|NCT02081417|590099521|FG001|Overall Study|Admitted to Residential Treatment|0|||
163379476|NCT02081417|590099520|FG000|Overall Study|Did not start treatment|17|||
163379477|NCT02081417|590099521|FG001|Overall Study|Did not start treatment|21|||
163379478|NCT01502631|590099529|FG000|Overall Study|Adverse Event|5|||
163379479|NCT01502631|590099530|FG001|Overall Study|Adverse Event|8|||
163379480|NCT01502631|590099529|FG000|Overall Study|Lost to Follow-up|2|||
163379481|NCT01502631|590099530|FG001|Overall Study|Lost to Follow-up|2|||
163379482|NCT01502631|590099529|FG000|Overall Study|Participant withdrew consent|2|||
163379483|NCT01502631|590099530|FG001|Overall Study|Participant withdrew consent|4|||
163379484|NCT01502631|590099529|FG000|Overall Study|Participant non-compliant|1|||
163379485|NCT01502631|590099530|FG001|Overall Study|Participant non-compliant|0|||
163379486|NCT01502631|590099529|FG000|Overall Study|Investigator's decision|0|||
163379487|NCT01502631|590099530|FG001|Overall Study|Investigator's decision|1|||
163379488|NCT01502631|590099529|FG000|Overall Study|Other|10|||
163379489|NCT01502631|590099530|FG001|Overall Study|Other|5|||
163379490|NCT02424734|590099534|FG000|Overall Study|Treatment stopped to be discharged home|2|||
163379491|NCT02424734|590099535|FG001|Overall Study|Treatment stopped to be discharged home|2|||
163379492|NCT02424734|590099536|FG002|Overall Study|Treatment stopped to be discharged home|0|||
163379493|NCT01445301|590099537|FG000|Overall Study|Adverse Event|15|||
163379494|NCT01445301|590099538|FG001|Overall Study|Adverse Event|25|||
163379495|NCT01445301|590099539|FG002|Overall Study|Adverse Event|4|||
163379496|NCT01445301|590099537|FG000|Overall Study|Lack of Efficacy|0|||
163379497|NCT01445301|590099538|FG001|Overall Study|Lack of Efficacy|1|||
163379498|NCT01445301|590099539|FG002|Overall Study|Lack of Efficacy|0|||
163379499|NCT01445301|590099537|FG000|Overall Study|Protocol Violation|1|||
163379500|NCT01445301|590099538|FG001|Overall Study|Protocol Violation|0|||
163379501|NCT01445301|590099539|FG002|Overall Study|Protocol Violation|0|||
163379502|NCT01445301|590099537|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
163379503|NCT01445301|590099538|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
163379504|NCT01445301|590099539|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
163379505|NCT01445301|590099537|FG000|Overall Study|Physician Decision|0|||
163379506|NCT01445301|590099538|FG001|Overall Study|Physician Decision|2|||
163379507|NCT01445301|590099539|FG002|Overall Study|Physician Decision|0|||
163379508|NCT01445301|590099537|FG000|Overall Study|Withdrawal by Subject|5|||
163379509|NCT01445301|590099538|FG001|Overall Study|Withdrawal by Subject|6|||
163379510|NCT01445301|590099539|FG002|Overall Study|Withdrawal by Subject|4|||
163379511|NCT00752557|590099540|FG000|Overall Study|Withdrawal by Subject|4|||
163379512|NCT00752557|590099541|FG001|Overall Study|Withdrawal by Subject|3|||
163379513|NCT00752557|590099542|FG002|Overall Study|Withdrawal by Subject|3|||
163379514|NCT00752557|590099540|FG000|Overall Study|Unspecified resaons|0|||
163379515|NCT00752557|590099541|FG001|Overall Study|Unspecified resaons|2|||
163379516|NCT00752557|590099542|FG002|Overall Study|Unspecified resaons|2|||
163379517|NCT00752557|590099540|FG000|Overall Study|Lost to Follow-up|1|||
163379518|NCT00752557|590099541|FG001|Overall Study|Lost to Follow-up|0|||
163379519|NCT00752557|590099542|FG002|Overall Study|Lost to Follow-up|1|||
163379520|NCT02150343|590099543|FG000|Overall Study|Adverse Event|2|||
163379521|NCT02150343|590099544|FG001|Overall Study|Adverse Event|0|||
163379522|NCT02150343|590099545|FG002|Overall Study|Adverse Event|1|||
163379523|NCT02150343|590099546|FG003|Overall Study|Adverse Event|1|||
163379524|NCT02150343|590099543|FG000|Overall Study|Withdrawal by Subject|13|||
163379525|NCT02150343|590099544|FG001|Overall Study|Withdrawal by Subject|10|||
163379526|NCT02150343|590099545|FG002|Overall Study|Withdrawal by Subject|9|||
163379527|NCT02150343|590099546|FG003|Overall Study|Withdrawal by Subject|4|||
163379528|NCT02150343|590099543|FG000|Overall Study|Lost to Follow-up|4|||
163379529|NCT02150343|590099544|FG001|Overall Study|Lost to Follow-up|4|||
163379530|NCT02150343|590099545|FG002|Overall Study|Lost to Follow-up|2|||
163379531|NCT02150343|590099546|FG003|Overall Study|Lost to Follow-up|3|||
163379532|NCT02150343|590099543|FG000|Overall Study|Other|2|||
163379533|NCT02150343|590099544|FG001|Overall Study|Other|6|||
163379534|NCT02150343|590099545|FG002|Overall Study|Other|0|||
163379535|NCT02150343|590099546|FG003|Overall Study|Other|2|||
163379536|NCT00190749|590099547|FG000|Overall Study|Lost to Follow-up|8|||
163379537|NCT00190749|590099548|FG001|Overall Study|Lost to Follow-up|11|||
163379538|NCT00190749|590099547|FG000|Overall Study|Withdrawal by Subject|10|||
163379539|NCT00190749|590099548|FG001|Overall Study|Withdrawal by Subject|6|||
163379540|NCT00190749|590099547|FG000|Overall Study|Protocol Violation|5|||
163379541|NCT00190749|590099548|FG001|Overall Study|Protocol Violation|4|||
163379542|NCT00190749|590099547|FG000|Overall Study|Adverse Event|0|||
163379543|NCT00190749|590099548|FG001|Overall Study|Adverse Event|5|||
163379544|NCT00190749|590099547|FG000|Overall Study|Lack of Efficacy|2|||
163379545|NCT00190749|590099548|FG001|Overall Study|Lack of Efficacy|3|||
163379546|NCT00190749|590099547|FG000|Overall Study|Reason Not Specified|0|||
163379547|NCT00190749|590099548|FG001|Overall Study|Reason Not Specified|2|||
163379548|NCT00190749|590099547|FG000|Overall Study|Sponsor Decision|1|||
163379549|NCT00190749|590099548|FG001|Overall Study|Sponsor Decision|0|||
163379550|NCT00439231|590099549|FG000|Overall Study|Lack of Efficacy|28|||
163379551|NCT04493502|590099550|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
163379552|NCT04493502|590099551|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
163379553|NCT04493502|590099550|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
163379554|NCT04493502|590099551|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
163379555|NCT04493502|590099550|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
163379556|NCT04493502|590099551|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
163379557|NCT04493502|590099550|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
163379558|NCT04493502|590099551|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
163379559|NCT04493502|590099550|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
163379560|NCT04493502|590099551|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
163379561|NCT04493502|590099550|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
163416859|NCT03048422|590232515|FG000|Overall Study|Death|1|||
163416860|NCT03048422|590232516|FG001|Overall Study|Death|0|||
163416861|NCT03048422|590232517|FG002|Overall Study|Death|0|||
163416862|NCT03048422|590232515|FG000|Overall Study|Lost to Follow-up|5|||
163416863|NCT03048422|590232516|FG001|Overall Study|Lost to Follow-up|0|||
163416864|NCT03048422|590232517|FG002|Overall Study|Lost to Follow-up|1|||
163416865|NCT03048422|590232515|FG000|Overall Study|Withdrawal by Subject|5|||
163416866|NCT03048422|590232516|FG001|Overall Study|Withdrawal by Subject|7|||
163416867|NCT03048422|590232517|FG002|Overall Study|Withdrawal by Subject|4|||
163416868|NCT03048422|590232515|FG000|Overall Study|Moved|3|||
163416869|NCT03048422|590232516|FG001|Overall Study|Moved|2|||
163416870|NCT03048422|590232517|FG002|Overall Study|Moved|2|||
163416871|NCT03048422|590232515|FG000|Overall Study|Noncompliant with Study Requirements|2|||
163416872|NCT03048422|590232516|FG001|Overall Study|Noncompliant with Study Requirements|1|||
163416873|NCT03048422|590232517|FG002|Overall Study|Noncompliant with Study Requirements|2|||
163416874|NCT03048422|590232515|FG000|Overall Study|Not Able to Get to Clinic|1|||
163416875|NCT03048422|590232516|FG001|Overall Study|Not Able to Get to Clinic|0|||
163416876|NCT03048422|590232517|FG002|Overall Study|Not Able to Get to Clinic|0|||
163416877|NCT02482129|590232519|FG000|Overall Study|Adverse Event-prior to treatment|0|||
163416878|NCT02482129|590232520|FG001|Overall Study|Adverse Event-prior to treatment|1|||
163416879|NCT02482129|590232519|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
163416880|NCT02482129|590232520|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
163416881|NCT02482129|590232519|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
163416882|NCT02482129|590232520|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
163416883|NCT02482129|590232519|FG000|Overall Study|Criteria not met-prior to treatment|1|||
163416884|NCT02482129|590232520|FG001|Overall Study|Criteria not met-prior to treatment|0|||
163416885|NCT02482129|590232519|FG000|Overall Study|Adverse Event|1|||
163416886|NCT02482129|590232520|FG001|Overall Study|Adverse Event|0|||
163416887|NCT02482129|590232519|FG000|Overall Study|Withdrawal by Subject|2|||
163416888|NCT02482129|590232520|FG001|Overall Study|Withdrawal by Subject|0|||
163416889|NCT02482129|590232519|FG000|Overall Study|Criteria not met|1|||
163416890|NCT02482129|590232520|FG001|Overall Study|Criteria not met|0|||
163416891|NCT02320487|590232528|FG000|Overall Study|Reason not Specified|1|||
163416892|NCT02320487|590232528|FG000|Overall Study|Physician Decision|5|||
163416893|NCT02320487|590232528|FG000|Overall Study|Withdrawal by Subject|1|||
163416894|NCT02320487|590232528|FG000|Overall Study|Death|3|||
163416895|NCT02320487|590232528|FG000|Overall Study|Adverse Event|11|||
163416896|NCT03344003|590232529|FG000|Overall Study|Switched to alternative treatment|1|||
163416897|NCT03344003|590232530|FG001|Overall Study|Switched to alternative treatment|0|||
163416898|NCT03344003|590232529|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
163416899|NCT03344003|590232530|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
163416900|NCT02949128|590233925|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
163416901|NCT02949128|590233925|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
163416902|NCT02949128|590233925|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
163416903|NCT02949128|590233925|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
163416904|NCT02949128|590233925|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
163416905|NCT02949128|590233925|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
163416906|NCT02949128|590233925|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
163416907|NCT02949128|590233925|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
163416908|NCT02949128|590233925|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
163416909|NCT02949128|590233925|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
163416910|NCT00880750|590233928|FG000|First Intervention|Adverse Event|1|||
163416911|NCT00880750|590233929|FG001|First Intervention|Adverse Event|0|||
163416912|NCT00880750|590233928|FG000|First Intervention|Unable to collect urine|4|||
163416913|NCT00880750|590233929|FG001|First Intervention|Unable to collect urine|0|||
163416914|NCT00880750|590233928|FG000|First Intervention|Non-compliance with meals|0|||
163416915|NCT00880750|590233929|FG001|First Intervention|Non-compliance with meals|1|||
163416916|NCT00880750|590233928|FG000|First Intervention|Withdrawal by Subject|2|||
163416917|NCT00880750|590233929|FG001|First Intervention|Withdrawal by Subject|0|||
163416918|NCT00880750|590233928|FG000|First Intervention|Lost to Follow-up|2|||
163416919|NCT00880750|590233929|FG001|First Intervention|Lost to Follow-up|0|||
163416920|NCT00880750|590233928|FG000|Second Intervention|Withdrawal by Subject|2|||
163416921|NCT00880750|590233929|FG001|Second Intervention|Withdrawal by Subject|2|||
163416922|NCT00880750|590233928|FG000|Second Intervention|Protocol Violation|1|||
163416923|NCT00880750|590233929|FG001|Second Intervention|Protocol Violation|0|||
163416924|NCT00880750|590233928|FG000|Second Intervention|Unable to collect urine|1|||
163416925|NCT00880750|590233929|FG001|Second Intervention|Unable to collect urine|0|||
163416926|NCT00483327|590233939|FG000|Overall Study|Adverse Event|1|||
163416927|NCT00483327|590233939|FG000|Overall Study|Withdrawal by Subject|3|||
163416928|NCT00483327|590233939|FG000|Overall Study|Lost to Follow-up|4|||
163416929|NCT00483327|590233939|FG000|Overall Study|Patient Non Compliance|2|||
163416930|NCT00670007|590233940|FG000|Overall Study|Drug abuse|1|||
163416931|NCT00670007|590233940|FG000|Overall Study|Lung transplant|1|||
163416932|NCT00670007|590233940|FG000|Overall Study|Travel/Vacation|1|||
163416933|NCT00670007|590233940|FG000|Overall Study|Adverse event, serious fatal|1|||
163416934|NCT00670007|590233940|FG000|Overall Study|Adverse Event|1|||
163416935|NCT00670007|590233940|FG000|Overall Study|Withdrawal by Subject|4|||
163416936|NCT00618722|590233941|FG000|Overall Study|Refusal of Treatment|0|||
163416937|NCT00618722|590233942|FG001|Overall Study|Refusal of Treatment|0|||
163416938|NCT00618722|590233943|FG002|Overall Study|Refusal of Treatment|1|||
163416939|NCT00618722|590233944|FG003|Overall Study|Refusal of Treatment|0|||
163416940|NCT00618722|590233941|FG000|Overall Study|Patient Request|1|||
163416941|NCT00618722|590233942|FG001|Overall Study|Patient Request|1|||
163416942|NCT00618722|590233943|FG002|Overall Study|Patient Request|1|||
163416943|NCT00618722|590233944|FG003|Overall Study|Patient Request|1|||
163416944|NCT00618722|590233941|FG000|Overall Study|Inability to Complete Study Procedure|0|||
163416945|NCT00618722|590233942|FG001|Overall Study|Inability to Complete Study Procedure|1|||
163416946|NCT00618722|590233943|FG002|Overall Study|Inability to Complete Study Procedure|0|||
163416947|NCT00618722|590233944|FG003|Overall Study|Inability to Complete Study Procedure|0|||
163416948|NCT00618722|590233941|FG000|Overall Study|Lost to Follow-up|2|||
163416949|NCT00618722|590233942|FG001|Overall Study|Lost to Follow-up|0|||
163416950|NCT00618722|590233943|FG002|Overall Study|Lost to Follow-up|0|||
163416951|NCT00618722|590233944|FG003|Overall Study|Lost to Follow-up|2|||
163416952|NCT00618722|590233941|FG000|Overall Study|Miscellaneous Reasons|0|||
163416953|NCT00618722|590233942|FG001|Overall Study|Miscellaneous Reasons|0|||
163416954|NCT00618722|590233943|FG002|Overall Study|Miscellaneous Reasons|1|||
163416955|NCT00618722|590233944|FG003|Overall Study|Miscellaneous Reasons|1|||
163416956|NCT00925600|590233945|FG000|Overall Study|Withdrawal by Subject|16|||
163416957|NCT00925600|590233946|FG001|Overall Study|Withdrawal by Subject|14|||
163416958|NCT00925600|590233945|FG000|Overall Study|Death|4|||
163416959|NCT00925600|590233946|FG001|Overall Study|Death|3|||
163379562|NCT04493502|590099551|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
163379563|NCT04493502|590099550|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
163379564|NCT04493502|590099551|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
163379565|NCT04493502|590099550|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
163379566|NCT04493502|590099551|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
163379567|NCT04493502|590099550|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
163379568|NCT04493502|590099551|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
163379569|NCT04493502|590099550|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
163379570|NCT04493502|590099551|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
163379571|NCT04493502|590099550|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
163379572|NCT04493502|590099551|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
163379573|NCT04493502|590099550|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
163379574|NCT04493502|590099551|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
163379575|NCT04493502|590099550|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
163379576|NCT04493502|590099551|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
163379577|NCT02891408|590099552|FG000|Overall Study|Lost to Follow-up|0|||
163379578|NCT02891408|590099553|FG001|Overall Study|Lost to Follow-up|0|||
163379579|NCT02891408|590099554|FG002|Overall Study|Lost to Follow-up|1|||
163379580|NCT02891408|590099555|FG003|Overall Study|Lost to Follow-up|0|||
163379581|NCT02891408|590099556|FG004|Overall Study|Lost to Follow-up|0|||
163379582|NCT02891408|590099557|FG005|Overall Study|Lost to Follow-up|0|||
163379583|NCT02891408|590099558|FG006|Overall Study|Lost to Follow-up|0|||
163379584|NCT00709852|590099559|FG000|Period 1|Adverse Event|2|||
163379585|NCT00709852|590099560|FG001|Period 1|Adverse Event|0|||
163379586|NCT00709852|590099559|FG000|Period 1|Withdrawal by Subject|4|||
163379587|NCT00709852|590099560|FG001|Period 1|Withdrawal by Subject|2|||
163379588|NCT00709852|590099559|FG000|Period 1|Protocol Violation|1|||
163379589|NCT00709852|590099560|FG001|Period 1|Protocol Violation|0|||
163379590|NCT00709852|590099559|FG000|Period 1|Defective scanner|0|||
163379591|NCT00709852|590099560|FG001|Period 1|Defective scanner|1|||
163379592|NCT00709852|590099559|FG000|Period 1|Lost to Follow-up|1|||
163379593|NCT00709852|590099560|FG001|Period 1|Lost to Follow-up|0|||
163379594|NCT00709852|590099559|FG000|Period 2|Protocol Violation|4|||
163379595|NCT00709852|590099560|FG001|Period 2|Protocol Violation|1|||
163379596|NCT00709852|590099559|FG000|Period 2|Adverse Event|1|||
163379597|NCT00709852|590099560|FG001|Period 2|Adverse Event|1|||
163379598|NCT00709852|590099559|FG000|Period 2|Lost to Follow-up|1|||
163416960|NCT00925600|590233945|FG000|Overall Study|Lost to Follow-up|2|||
163416961|NCT00925600|590233946|FG001|Overall Study|Lost to Follow-up|2|||
163416962|NCT00925600|590233945|FG000|Overall Study|Disease Progression|1|||
163416963|NCT00925600|590233946|FG001|Overall Study|Disease Progression|3|||
163379599|NCT00709852|590099560|FG001|Period 2|Lost to Follow-up|0|||
163379600|NCT00709852|590099559|FG000|Period 2|No 72-hour follow-up|3|||
163379601|NCT00709852|590099560|FG001|Period 2|No 72-hour follow-up|0|||
163379602|NCT01048671|590099561|FG000|Overall Study|Protocol Violation|0|||
163416964|NCT00925600|590233945|FG000|Overall Study|Administrative Decision|1|||
163416965|NCT00925600|590233946|FG001|Overall Study|Administrative Decision|1|||
163416966|NCT00925600|590233945|FG000|Overall Study|Noncompliance|2|||
163416967|NCT00925600|590233946|FG001|Overall Study|Noncompliance|0|||
163416968|NCT00925600|590233945|FG000|Overall Study|Ineligibility Determined|2|||
163416969|NCT00925600|590233946|FG001|Overall Study|Ineligibility Determined|0|||
163416970|NCT00925600|590233945|FG000|Overall Study|Protocol Deviation|0|||
163416971|NCT00925600|590233946|FG001|Overall Study|Protocol Deviation|1|||
163416972|NCT00925600|590233945|FG000|Overall Study|Requirement for Alternative Therapy|0|||
163416973|NCT00925600|590233946|FG001|Overall Study|Requirement for Alternative Therapy|1|||
163416974|NCT00925600|590233945|FG000|Overall Study|Other|3|||
163416975|NCT00925600|590233946|FG001|Overall Study|Other|1|||
163416976|NCT00925600|590233945|FG000|Overall Study|Adverse Event|1|||
163416977|NCT00925600|590233946|FG001|Overall Study|Adverse Event|2|||
163416978|NCT00127127|590233951|FG000|Overall Study|Adverse Event|0|||
163416979|NCT00127127|590233952|FG001|Overall Study|Adverse Event|2|||
163416980|NCT00127127|590233953|FG002|Overall Study|Adverse Event|0|||
163416981|NCT00127127|590233954|FG003|Overall Study|Adverse Event|1|||
163416982|NCT00127127|590233951|FG000|Overall Study|Lack of Efficacy|1|||
163416983|NCT00127127|590233952|FG001|Overall Study|Lack of Efficacy|3|||
163416984|NCT00127127|590233953|FG002|Overall Study|Lack of Efficacy|0|||
163416985|NCT00127127|590233954|FG003|Overall Study|Lack of Efficacy|2|||
163416986|NCT00200057|590233955|FG000|Overall Study|Lack of Efficacy|3|||
163416987|NCT00200057|590233955|FG000|Overall Study|Exited due to terminal illness of PI|2|||
163416988|NCT00200057|590233955|FG000|Overall Study|Withdrawal by Subject|1|||
163416989|NCT00200057|590233955|FG000|Overall Study|Change in medical condition|1|||
163416990|NCT00200057|590233955|FG000|Overall Study|Infection|1|||
163416991|NCT00200057|590233955|FG000|Overall Study|Death|1|||
163416992|NCT01059448|590233957|FG000|Overall Study|Adverse Event|1|||
163416993|NCT01059448|590233958|FG001|Overall Study|Adverse Event|3|||
163416994|NCT01059448|590233959|FG002|Overall Study|Adverse Event|0|||
163416995|NCT01059448|590233960|FG003|Overall Study|Adverse Event|1|||
163416996|NCT01059448|590233957|FG000|Overall Study|Withdrawal by Subject|2|||
163416997|NCT01059448|590233958|FG001|Overall Study|Withdrawal by Subject|0|||
163416998|NCT01059448|590233959|FG002|Overall Study|Withdrawal by Subject|2|||
163416999|NCT01059448|590233960|FG003|Overall Study|Withdrawal by Subject|4|||
163417000|NCT01059448|590233957|FG000|Overall Study|Disease Progression|2|||
163417001|NCT01059448|590233958|FG001|Overall Study|Disease Progression|1|||
163417002|NCT01059448|590233959|FG002|Overall Study|Disease Progression|4|||
163417003|NCT01059448|590233960|FG003|Overall Study|Disease Progression|2|||
163417004|NCT01059448|590233957|FG000|Overall Study|Administrative Decision|43|||
163417005|NCT01059448|590233958|FG001|Overall Study|Administrative Decision|49|||
163417006|NCT01059448|590233959|FG002|Overall Study|Administrative Decision|45|||
163417007|NCT01059448|590233960|FG003|Overall Study|Administrative Decision|46|||
163417008|NCT01059448|590233957|FG000|Overall Study|Lost to Follow-up|0|||
163417009|NCT01059448|590233958|FG001|Overall Study|Lost to Follow-up|0|||
163417010|NCT01059448|590233959|FG002|Overall Study|Lost to Follow-up|2|||
163417011|NCT01059448|590233960|FG003|Overall Study|Lost to Follow-up|0|||
163417012|NCT01059448|590233957|FG000|Overall Study|Death|0|||
163417013|NCT01059448|590233958|FG001|Overall Study|Death|1|||
163417014|NCT01059448|590233959|FG002|Overall Study|Death|0|||
163417015|NCT01059448|590233960|FG003|Overall Study|Death|0|||
163417016|NCT01059448|590233957|FG000|Overall Study|Other|1|||
163417017|NCT01059448|590233958|FG001|Overall Study|Other|1|||
163379603|NCT01048671|590099562|FG001|Overall Study|Protocol Violation|1|||
163379604|NCT01048671|590099563|FG002|Overall Study|Protocol Violation|1|||
163379605|NCT05249829|590099564|FG000|Overall Study|Participant Relocation|0|||
163379606|NCT05249829|590099565|FG001|Overall Study|Participant Relocation|1|||
163379607|NCT05249829|590099566|FG002|Overall Study|Participant Relocation|2|||
163379608|NCT05249829|590099567|FG003|Overall Study|Participant Relocation|2|||
163379609|NCT05249829|590099564|FG000|Overall Study|Withdrawal by Subject|9|||
163379610|NCT05249829|590099565|FG001|Overall Study|Withdrawal by Subject|17|||
163379611|NCT05249829|590099566|FG002|Overall Study|Withdrawal by Subject|40|||
163379612|NCT05249829|590099567|FG003|Overall Study|Withdrawal by Subject|35|||
163379613|NCT05249829|590099564|FG000|Overall Study|Physician Decision|1|||
163379614|NCT05249829|590099565|FG001|Overall Study|Physician Decision|0|||
163379615|NCT05249829|590099566|FG002|Overall Study|Physician Decision|0|||
163379616|NCT05249829|590099567|FG003|Overall Study|Physician Decision|0|||
163417018|NCT01059448|590233959|FG002|Overall Study|Other|0|||
163417019|NCT01059448|590233960|FG003|Overall Study|Other|1|||
163417020|NCT01390389|590233961|FG000|Overall Study|Withdrawal by Subject|2|||
163417021|NCT01390389|590233962|FG001|Overall Study|Withdrawal by Subject|0|||
163417022|NCT01390389|590233961|FG000|Overall Study|Screen Fail|2|||
163417023|NCT01390389|590233962|FG001|Overall Study|Screen Fail|1|||
163379617|NCT05249829|590099564|FG000|Overall Study|Lost to Follow-up|16|||
163417024|NCT00778830|590233963|FG000|Overall Study|Ongoing at data cut-off|0|||
163417025|NCT00778830|590233964|FG001|Overall Study|Ongoing at data cut-off|1|||
163417026|NCT03593915|590233965|FG000|Overall Study|Adverse Event|0|||
163417027|NCT03593915|590233966|FG001|Overall Study|Adverse Event|0|||
163417028|NCT03593915|590233967|FG002|Overall Study|Adverse Event|0|||
163417029|NCT03593915|590233968|FG003|Overall Study|Adverse Event|1|||
163417030|NCT03593915|590233969|FG004|Overall Study|Adverse Event|0|||
163417031|NCT03593915|590233970|FG005|Overall Study|Adverse Event|0|||
163417032|NCT03593915|590233965|FG000|Overall Study|Physician Decision|0|||
163417033|NCT03593915|590233966|FG001|Overall Study|Physician Decision|0|||
163417034|NCT03593915|590233967|FG002|Overall Study|Physician Decision|0|||
163417035|NCT03593915|590233968|FG003|Overall Study|Physician Decision|0|||
163417036|NCT03593915|590233969|FG004|Overall Study|Physician Decision|0|||
163417037|NCT03593915|590233970|FG005|Overall Study|Physician Decision|1|||
163417038|NCT05512949|590233971|FG000|Overall Study|Lost to Follow-up|4|||
163417039|NCT05512949|590233972|FG001|Overall Study|Lost to Follow-up|6|||
163417040|NCT05512949|590233973|FG002|Overall Study|Lost to Follow-up|2|||
163417041|NCT05512949|590233971|FG000|Overall Study|Protocol Violation|0|||
163417042|NCT05512949|590233972|FG001|Overall Study|Protocol Violation|0|||
163417043|NCT05512949|590233973|FG002|Overall Study|Protocol Violation|1|||
163417044|NCT05512949|590233971|FG000|Overall Study|Withdrawal by Subject|1|||
163417045|NCT05512949|590233972|FG001|Overall Study|Withdrawal by Subject|1|||
163417046|NCT05512949|590233973|FG002|Overall Study|Withdrawal by Subject|2|||
163417047|NCT05512949|590233971|FG000|Overall Study|Completion status unknown|1|||
163417048|NCT05512949|590233972|FG001|Overall Study|Completion status unknown|3|||
163417049|NCT05512949|590233973|FG002|Overall Study|Completion status unknown|0|||
163417050|NCT01583179|590233974|FG000|Overall Study|Screen failure|1|||
163417051|NCT01583179|590233975|FG001|Overall Study|Screen failure|2|||
163417052|NCT01246206|590233976|FG000|Overall Study|Patient did not receive study regiments.|1|||
163417053|NCT02002975|590233977|FG000|Overall Study|Case Report Forms Uncollected|135|||
163417054|NCT02002975|590233977|FG000|Overall Study|Protocol Deviation|437|||
163417055|NCT03988907|590233978|FG000|Overall Study|Unable to complete visit|0|||
163417056|NCT03988907|590233979|FG001|Overall Study|Unable to complete visit|1|||
163417057|NCT02810964|590233980|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
163417058|NCT02810964|590233981|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
163417059|NCT02810964|590233980|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
163417060|NCT02810964|590233981|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
163417061|NCT02810964|590233980|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
163417062|NCT02810964|590233981|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
163417063|NCT02810964|590233980|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
163417064|NCT02810964|590233981|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
163417065|NCT03523351|590233982|FG000|Overall Study|Death|13|||
163417066|NCT03523351|590233983|FG001|Overall Study|Death|11|||
163417067|NCT03523351|590233982|FG000|Overall Study|Lost to Follow-up|2|||
163417068|NCT03523351|590233983|FG001|Overall Study|Lost to Follow-up|3|||
163417069|NCT03523351|590233982|FG000|Overall Study|Withdrawal by Subject|4|||
163417070|NCT03523351|590233983|FG001|Overall Study|Withdrawal by Subject|0|||
163417071|NCT03523351|590233982|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
163417072|NCT03523351|590233983|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
163417073|NCT03609619|590233984|FG000|Overall Study|Adverse Event|1|||
163417074|NCT03609619|590233985|FG001|Overall Study|Adverse Event|0|||
163417075|NCT03609619|590233984|FG000|Overall Study|Lack of Efficacy|1|||
163417076|NCT03609619|590233985|FG001|Overall Study|Lack of Efficacy|2|||
163417077|NCT03609619|590233984|FG000|Overall Study|Protocol Violation|5|||
163417078|NCT03609619|590233985|FG001|Overall Study|Protocol Violation|0|||
163417079|NCT03609619|590233984|FG000|Overall Study|Withdrawal by Subject|2|||
163417080|NCT03609619|590233985|FG001|Overall Study|Withdrawal by Subject|3|||
163417081|NCT03609619|590233984|FG000|Overall Study|Lost to Follow-up|1|||
163417082|NCT03609619|590233985|FG001|Overall Study|Lost to Follow-up|1|||
163417083|NCT00688909|590233986|FG000|Overall Study|Adverse Event|28|||
163417084|NCT00688909|590233986|FG000|Overall Study|Patient withdrew consent|2|||
163417085|NCT00688909|590233986|FG000|Overall Study|Administrative problems|1|||
163417086|NCT00688909|590233986|FG000|Overall Study|Protocol Violation|2|||
163417087|NCT02472847|590233988|FG000|Overall Study|Withdrawal by Subject|1|||
163417088|NCT02472847|590233989|FG001|Overall Study|Withdrawal by Subject|5|||
163417089|NCT04656990|590233990|FG000|Baseline|pandemic|20|||
163417090|NCT04656990|590233991|FG001|Baseline|pandemic|24|||
163417091|NCT04656990|590233990|FG000|Follow Up Period|Lost to Follow-up|61|||
163417092|NCT04656990|590233991|FG001|Follow Up Period|Lost to Follow-up|73|||
163417093|NCT03244059|590233992|FG000|Specific Aim 1|Physician Decision|1|||
163417094|NCT03244059|590233993|FG001|Specific Aim 1|Physician Decision|0|||
163417095|NCT03244059|590233992|FG000|Specific Aim 2|Physician Decision|1|||
163417096|NCT03244059|590233993|FG001|Specific Aim 2|Physician Decision|0|||
163417097|NCT01613326|590233995|FG000|Overall Study|Adverse Event|7|||
163417098|NCT01613326|590233996|FG001|Overall Study|Adverse Event|5|||
163417099|NCT01613326|590233995|FG000|Overall Study|Withdrawal by Subject|3|||
163417100|NCT01613326|590233996|FG001|Overall Study|Withdrawal by Subject|4|||
163417101|NCT01613326|590233995|FG000|Overall Study|Abnormal test procedure result(s)|2|||
163417102|NCT01613326|590233996|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163417103|NCT01613326|590233995|FG000|Overall Study|inability to use device|1|||
163417104|NCT01613326|590233996|FG001|Overall Study|inability to use device|0|||
163417105|NCT01613326|590233995|FG000|Overall Study|Lack of Efficacy|0|||
163417106|NCT01613326|590233996|FG001|Overall Study|Lack of Efficacy|1|||
163379618|NCT05249829|590099565|FG001|Overall Study|Lost to Follow-up|16|||
163379619|NCT05249829|590099566|FG002|Overall Study|Lost to Follow-up|57|||
163379620|NCT05249829|590099567|FG003|Overall Study|Lost to Follow-up|60|||
163379621|NCT05249829|590099564|FG000|Overall Study|Adverse Event|2|||
163379622|NCT05249829|590099565|FG001|Overall Study|Adverse Event|2|||
163379623|NCT05249829|590099566|FG002|Overall Study|Adverse Event|2|||
163379624|NCT05249829|590099567|FG003|Overall Study|Adverse Event|2|||
163379625|NCT05249829|590099564|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
163379626|NCT05249829|590099565|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
163379627|NCT05249829|590099566|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
163379628|NCT05249829|590099567|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
163379629|NCT05249829|590099564|FG000|Overall Study|Protocol Violation|2|||
163379630|NCT05249829|590099565|FG001|Overall Study|Protocol Violation|0|||
163379631|NCT05249829|590099566|FG002|Overall Study|Protocol Violation|5|||
163379632|NCT05249829|590099567|FG003|Overall Study|Protocol Violation|3|||
163379633|NCT05249829|590099564|FG000|Overall Study|Death|0|||
163379634|NCT05249829|590099565|FG001|Overall Study|Death|1|||
163379635|NCT05249829|590099566|FG002|Overall Study|Death|2|||
163379636|NCT05249829|590099567|FG003|Overall Study|Death|4|||
163379637|NCT00196976|590099568|FG000|Primary Study|Migrated from study area|0|||
163379638|NCT00196976|590099569|FG001|Primary Study|Migrated from study area|0|||
163379639|NCT00196976|590099570|FG002|Primary Study|Migrated from study area|0|||
163379640|NCT00196976|590099571|FG003|Primary Study|Migrated from study area|0|||
163379641|NCT00196976|590099572|FG004|Primary Study|Migrated from study area|0|||
163379642|NCT00196976|590099573|FG005|Primary Study|Migrated from study area|0|||
163379643|NCT00196976|590099574|FG006|Primary Study|Migrated from study area|0|||
163379644|NCT00196976|590099575|FG007|Primary Study|Migrated from study area|1|||
163379645|NCT00196976|590099576|FG008|Primary Study|Migrated from study area|0|||
163379646|NCT00196976|590099577|FG009|Primary Study|Migrated from study area|0|||
163379647|NCT00196976|590099578|FG010|Primary Study|Migrated from study area|0|||
163379648|NCT00196976|590099579|FG011|Primary Study|Migrated from study area|0|||
163379649|NCT00196976|590099580|FG012|Primary Study|Migrated from study area|0|||
163379650|NCT00196976|590099581|FG013|Primary Study|Migrated from study area|0|||
163379651|NCT00196976|590099568|FG000|Primary Study|Protocol Violation|0|||
163379652|NCT00196976|590099569|FG001|Primary Study|Protocol Violation|1|||
163379653|NCT00196976|590099570|FG002|Primary Study|Protocol Violation|1|||
163379654|NCT00196976|590099571|FG003|Primary Study|Protocol Violation|0|||
163379655|NCT00196976|590099572|FG004|Primary Study|Protocol Violation|0|||
163379656|NCT00196976|590099573|FG005|Primary Study|Protocol Violation|0|||
163379657|NCT00196976|590099574|FG006|Primary Study|Protocol Violation|0|||
163379658|NCT00196976|590099575|FG007|Primary Study|Protocol Violation|0|||
163379659|NCT00196976|590099576|FG008|Primary Study|Protocol Violation|0|||
163379660|NCT00196976|590099577|FG009|Primary Study|Protocol Violation|0|||
163379661|NCT00196976|590099578|FG010|Primary Study|Protocol Violation|0|||
163379662|NCT00196976|590099579|FG011|Primary Study|Protocol Violation|0|||
163379663|NCT00196976|590099580|FG012|Primary Study|Protocol Violation|0|||
163379664|NCT00196976|590099581|FG013|Primary Study|Protocol Violation|0|||
163379665|NCT00196976|590099568|FG000|Primary Study|Withdrawal by Subject|1|||
163379666|NCT00196976|590099569|FG001|Primary Study|Withdrawal by Subject|0|||
163379667|NCT00196976|590099570|FG002|Primary Study|Withdrawal by Subject|1|||
163379668|NCT00196976|590099571|FG003|Primary Study|Withdrawal by Subject|1|||
163379669|NCT00196976|590099572|FG004|Primary Study|Withdrawal by Subject|2|||
163379670|NCT00196976|590099573|FG005|Primary Study|Withdrawal by Subject|1|||
163379671|NCT00196976|590099574|FG006|Primary Study|Withdrawal by Subject|0|||
163379672|NCT00196976|590099575|FG007|Primary Study|Withdrawal by Subject|0|||
163379673|NCT00196976|590099576|FG008|Primary Study|Withdrawal by Subject|0|||
163379674|NCT00196976|590099577|FG009|Primary Study|Withdrawal by Subject|1|||
163379675|NCT00196976|590099578|FG010|Primary Study|Withdrawal by Subject|0|||
163379676|NCT00196976|590099579|FG011|Primary Study|Withdrawal by Subject|0|||
163379677|NCT00196976|590099580|FG012|Primary Study|Withdrawal by Subject|0|||
163379678|NCT00196976|590099581|FG013|Primary Study|Withdrawal by Subject|0|||
163379679|NCT00196976|590099568|FG000|Primary Study|Lost to Follow-up|0|||
163379680|NCT00196976|590099569|FG001|Primary Study|Lost to Follow-up|0|||
163379681|NCT00196976|590099570|FG002|Primary Study|Lost to Follow-up|0|||
163379682|NCT00196976|590099571|FG003|Primary Study|Lost to Follow-up|0|||
163379683|NCT00196976|590099572|FG004|Primary Study|Lost to Follow-up|1|||
163379684|NCT00196976|590099573|FG005|Primary Study|Lost to Follow-up|1|||
163379685|NCT00196976|590099574|FG006|Primary Study|Lost to Follow-up|0|||
163379686|NCT00196976|590099575|FG007|Primary Study|Lost to Follow-up|2|||
163379687|NCT00196976|590099576|FG008|Primary Study|Lost to Follow-up|0|||
163379688|NCT00196976|590099577|FG009|Primary Study|Lost to Follow-up|0|||
163379689|NCT00196976|590099578|FG010|Primary Study|Lost to Follow-up|0|||
163379690|NCT00196976|590099579|FG011|Primary Study|Lost to Follow-up|0|||
163379691|NCT00196976|590099580|FG012|Primary Study|Lost to Follow-up|0|||
163379692|NCT00196976|590099581|FG013|Primary Study|Lost to Follow-up|0|||
163379693|NCT00196976|590099568|FG000|Primary Study|Other|0|||
163379694|NCT00196976|590099569|FG001|Primary Study|Other|0|||
163379695|NCT00196976|590099570|FG002|Primary Study|Other|2|||
163379696|NCT00196976|590099571|FG003|Primary Study|Other|0|||
163379697|NCT00196976|590099572|FG004|Primary Study|Other|0|||
163379698|NCT00196976|590099573|FG005|Primary Study|Other|0|||
163379699|NCT00196976|590099574|FG006|Primary Study|Other|0|||
163379700|NCT00196976|590099575|FG007|Primary Study|Other|0|||
163379701|NCT00196976|590099576|FG008|Primary Study|Other|0|||
163379702|NCT00196976|590099577|FG009|Primary Study|Other|0|||
163379703|NCT00196976|590099578|FG010|Primary Study|Other|0|||
163379704|NCT00196976|590099579|FG011|Primary Study|Other|0|||
163379705|NCT00196976|590099580|FG012|Primary Study|Other|0|||
163379706|NCT00196976|590099581|FG013|Primary Study|Other|0|||
163379707|NCT00196976|590099568|FG000|Booster Study|Withdrawal by Subject|0|||
163379708|NCT00196976|590099569|FG001|Booster Study|Withdrawal by Subject|0|||
163379709|NCT00196976|590099570|FG002|Booster Study|Withdrawal by Subject|0|||
163379710|NCT00196976|590099571|FG003|Booster Study|Withdrawal by Subject|0|||
163379711|NCT00196976|590099572|FG004|Booster Study|Withdrawal by Subject|0|||
163379712|NCT00196976|590099573|FG005|Booster Study|Withdrawal by Subject|0|||
163379713|NCT00196976|590099574|FG006|Booster Study|Withdrawal by Subject|0|||
163379714|NCT00196976|590099575|FG007|Booster Study|Withdrawal by Subject|0|||
163379715|NCT00196976|590099576|FG008|Booster Study|Withdrawal by Subject|0|||
163379716|NCT00196976|590099577|FG009|Booster Study|Withdrawal by Subject|0|||
163379717|NCT00196976|590099578|FG010|Booster Study|Withdrawal by Subject|1|||
163379718|NCT00196976|590099579|FG011|Booster Study|Withdrawal by Subject|0|||
163379719|NCT00196976|590099580|FG012|Booster Study|Withdrawal by Subject|0|||
163379720|NCT00196976|590099581|FG013|Booster Study|Withdrawal by Subject|0|||
163379721|NCT00196976|590099568|FG000|Booster Study|Lost to Follow-up|0|||
163379722|NCT00196976|590099569|FG001|Booster Study|Lost to Follow-up|0|||
163379723|NCT00196976|590099570|FG002|Booster Study|Lost to Follow-up|0|||
163379724|NCT00196976|590099571|FG003|Booster Study|Lost to Follow-up|0|||
163379725|NCT00196976|590099572|FG004|Booster Study|Lost to Follow-up|0|||
163379726|NCT00196976|590099573|FG005|Booster Study|Lost to Follow-up|0|||
163379727|NCT00196976|590099574|FG006|Booster Study|Lost to Follow-up|0|||
163379728|NCT00196976|590099575|FG007|Booster Study|Lost to Follow-up|0|||
163379729|NCT00196976|590099576|FG008|Booster Study|Lost to Follow-up|0|||
163379730|NCT00196976|590099577|FG009|Booster Study|Lost to Follow-up|0|||
163379731|NCT00196976|590099578|FG010|Booster Study|Lost to Follow-up|1|||
163379732|NCT00196976|590099579|FG011|Booster Study|Lost to Follow-up|2|||
163379733|NCT00196976|590099580|FG012|Booster Study|Lost to Follow-up|0|||
163379734|NCT00196976|590099581|FG013|Booster Study|Lost to Follow-up|0|||
163379735|NCT01535560|590099583|FG000|Overall Study|Adverse Event|12|||
163379736|NCT01535560|590099584|FG001|Overall Study|Adverse Event|7|||
163379737|NCT01535560|590099583|FG000|Overall Study|Lost to Follow-up|1|||
163379738|NCT01535560|590099584|FG001|Overall Study|Lost to Follow-up|3|||
163379739|NCT01535560|590099583|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
163379740|NCT01535560|590099584|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
163379741|NCT01535560|590099583|FG000|Overall Study|Treatment Failure|21|||
163379742|NCT01535560|590099584|FG001|Overall Study|Treatment Failure|83|||
163379743|NCT01535560|590099583|FG000|Overall Study|Other|0|||
163379744|NCT01535560|590099584|FG001|Overall Study|Other|1|||
163379745|NCT01535560|590099583|FG000|Overall Study|Randomized in Error|0|||
163379746|NCT01535560|590099584|FG001|Overall Study|Randomized in Error|1|||
163379747|NCT02009761|590099585|FG000|Overall Study|Adverse Event|4|||
163379748|NCT00825825|590099588|FG000|First Medication Period (14 Days)|Adverse Event|1|||
163379749|NCT00825825|590099589|FG001|First Medication Period (14 Days)|Adverse Event|0|||
163379750|NCT00825825|590099590|FG002|First Medication Period (14 Days)|Adverse Event|0|||
163379751|NCT00825825|590099591|FG003|First Medication Period (14 Days)|Adverse Event|0|||
163379752|NCT00825825|590099592|FG004|First Medication Period (14 Days)|Adverse Event|0|||
163379753|NCT00825825|590099593|FG005|First Medication Period (14 Days)|Adverse Event|1|||
163379754|NCT00825825|590099588|FG000|First Medication Period (14 Days)|Physician Decision|2|||
163379755|NCT00825825|590099589|FG001|First Medication Period (14 Days)|Physician Decision|0|||
163379756|NCT00825825|590099590|FG002|First Medication Period (14 Days)|Physician Decision|1|||
163379757|NCT00825825|590099591|FG003|First Medication Period (14 Days)|Physician Decision|0|||
163379758|NCT00825825|590099592|FG004|First Medication Period (14 Days)|Physician Decision|0|||
163379759|NCT00825825|590099593|FG005|First Medication Period (14 Days)|Physician Decision|1|||
163379760|NCT00825825|590099588|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
163379761|NCT00825825|590099589|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
163379762|NCT00825825|590099590|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
163379763|NCT00825825|590099591|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
163379764|NCT00825825|590099592|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
163379765|NCT00825825|590099593|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
163379766|NCT00825825|590099588|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
163379767|NCT00825825|590099589|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
163379768|NCT00825825|590099590|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
163379769|NCT00825825|590099591|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
163379770|NCT00825825|590099592|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
163379771|NCT00825825|590099593|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
163379772|NCT00825825|590099588|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
163379773|NCT00825825|590099589|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
163379774|NCT00825825|590099590|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
163379775|NCT00825825|590099591|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
163379776|NCT00825825|590099592|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
163379777|NCT00825825|590099593|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
163379778|NCT00825825|590099588|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
163379779|NCT00825825|590099589|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
163379780|NCT00825825|590099590|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
163379781|NCT00825825|590099591|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
163379782|NCT00825825|590099592|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
163379783|NCT00825825|590099593|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
163379784|NCT00825825|590099588|FG000|Third Medication Period (14 Days)|poor data quality|0|||
163379785|NCT00825825|590099589|FG001|Third Medication Period (14 Days)|poor data quality|1|||
163379786|NCT00825825|590099590|FG002|Third Medication Period (14 Days)|poor data quality|0|||
163379787|NCT00825825|590099591|FG003|Third Medication Period (14 Days)|poor data quality|0|||
163379788|NCT00825825|590099592|FG004|Third Medication Period (14 Days)|poor data quality|0|||
163379789|NCT00825825|590099593|FG005|Third Medication Period (14 Days)|poor data quality|0|||
163379790|NCT02649946|590099599|FG000|Overall Study|Withdrawal by Subject|1|||
163379791|NCT02649946|590099600|FG001|Overall Study|Withdrawal by Subject|1|||
163379792|NCT02649946|590099599|FG000|Overall Study|Death|7|||
163379793|NCT02649946|590099600|FG001|Overall Study|Death|9|||
163379794|NCT02649946|590099599|FG000|Overall Study|Physician Decision|1|||
163379795|NCT02649946|590099600|FG001|Overall Study|Physician Decision|0|||
163379796|NCT02649946|590099599|FG000|Overall Study|Lost to Follow-up|2|||
163379797|NCT02649946|590099600|FG001|Overall Study|Lost to Follow-up|1|||
163379798|NCT02649946|590099599|FG000|Overall Study|Erroneously enrolled|1|||
163379799|NCT02649946|590099600|FG001|Overall Study|Erroneously enrolled|0|||
163379800|NCT02649946|590099599|FG000|Overall Study|Missed 6-month follow-up visit|0|||
163379801|NCT02649946|590099600|FG001|Overall Study|Missed 6-month follow-up visit|4|||
163379802|NCT01178385|590099601|FG000|Overall Study|Withdrawal by Subject|2|||
163379803|NCT01178385|590099602|FG001|Overall Study|Withdrawal by Subject|0|||
163379804|NCT00985946|590099603|FG000|Overall Study|Lost to Follow-up|6|||
163379805|NCT00985946|590099603|FG000|Overall Study|Withdrawal by Subject|1|||
163379806|NCT05924945|590099607|FG000|Overall Study|Withdrawal by Subject|3|||
163379807|NCT05924945|590099608|FG001|Overall Study|Withdrawal by Subject|4|||
163379808|NCT00928018|590099621|FG000|Overall Study|Withdrawal by Subject|1|||
163379809|NCT00928018|590099622|FG001|Overall Study|Withdrawal by Subject|0|||
163379810|NCT02008877|590099623|FG000|Overall Study|Inevaluable|0|||
163379811|NCT02008877|590099624|FG001|Overall Study|Inevaluable|1|||
163379812|NCT02008877|590099625|FG002|Overall Study|Inevaluable|0|||
163379813|NCT00847808|590099626|FG000|Overall Study|Adverse Event|7|||
163379814|NCT00847808|590099626|FG000|Overall Study|Protocol Violation|1|||
163379815|NCT00847808|590099626|FG000|Overall Study|Lost to Follow-up|1|||
163379816|NCT00847808|590099626|FG000|Overall Study|Withdrawal by Subject|4|||
163379817|NCT00847808|590099626|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
163379818|NCT00847808|590099626|FG000|Overall Study|Participant Took Excluded Medication|1|||
163379819|NCT05000931|590099636|FG000|Overall Study|Lost to Follow-up|1|||
163379820|NCT05326815|590099637|FG000|Overall Study|Withdrawal by Subject|3|||
163379821|NCT05326815|590099637|FG000|Overall Study|Did not complete required labs|6|||
163379822|NCT05326815|590099637|FG000|Overall Study|Screen fail- abnormal labs|5|||
163379823|NCT00979134|590099638|FG000|Overall Study|Disease progression|18|||
163379824|NCT00979134|590099639|FG001|Overall Study|Disease progression|2|||
163379825|NCT00979134|590099640|FG002|Overall Study|Disease progression|5|||
163379826|NCT00979134|590099638|FG000|Overall Study|Adverse Event|0|||
163379827|NCT00979134|590099639|FG001|Overall Study|Adverse Event|0|||
163379828|NCT00979134|590099640|FG002|Overall Study|Adverse Event|2|||
163379829|NCT00979134|590099638|FG000|Overall Study|Withdrawal by Subject|1|||
163379830|NCT00979134|590099639|FG001|Overall Study|Withdrawal by Subject|1|||
163379831|NCT00979134|590099640|FG002|Overall Study|Withdrawal by Subject|2|||
163379832|NCT00979134|590099638|FG000|Overall Study|Lost to Follow-up|2|||
163379833|NCT00979134|590099639|FG001|Overall Study|Lost to Follow-up|2|||
163379834|NCT00979134|590099640|FG002|Overall Study|Lost to Follow-up|0|||
163379835|NCT00979134|590099638|FG000|Overall Study|Death|4|||
163379836|NCT00979134|590099639|FG001|Overall Study|Death|0|||
163379837|NCT00979134|590099640|FG002|Overall Study|Death|26|||
163379838|NCT00979134|590099638|FG000|Overall Study|Other|8|||
163379839|NCT00979134|590099639|FG001|Overall Study|Other|1|||
163379840|NCT00979134|590099640|FG002|Overall Study|Other|5|||
163379841|NCT05172050|590099641|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
163379842|NCT05172050|590099642|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
163379843|NCT05172050|590099643|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
163379844|NCT05172050|590099641|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
163379845|NCT05172050|590099642|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
163379846|NCT05172050|590099643|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
163379847|NCT05172050|590099641|FG000|Overall Study|Other|2|||
163379848|NCT05172050|590099642|FG001|Overall Study|Other|2|||
163379849|NCT05172050|590099643|FG002|Overall Study|Other|1|||
163379850|NCT04617275|590099648|FG000|Treatment Period|Adverse Event|1|||
163379851|NCT04617275|590099649|FG001|Treatment Period|Adverse Event|6|||
163379852|NCT04617275|590099650|FG002|Treatment Period|Adverse Event|4|||
163379853|NCT04617275|590099651|FG003|Treatment Period|Adverse Event|6|||
163379854|NCT04617275|590099652|FG004|Treatment Period|Adverse Event|7|||
163379855|NCT04617275|590099653|FG005|Treatment Period|Adverse Event|8|||
163379856|NCT04617275|590099654|FG006|Treatment Period|Adverse Event|0|||
163379857|NCT04617275|590099655|FG007|Treatment Period|Adverse Event|12|||
163379858|NCT04617275|590099648|FG000|Treatment Period|Lost to Follow-up|0|||
163379859|NCT04617275|590099649|FG001|Treatment Period|Lost to Follow-up|0|||
163379860|NCT04617275|590099650|FG002|Treatment Period|Lost to Follow-up|2|||
163379861|NCT04617275|590099651|FG003|Treatment Period|Lost to Follow-up|0|||
163379862|NCT04617275|590099652|FG004|Treatment Period|Lost to Follow-up|0|||
163379863|NCT04617275|590099653|FG005|Treatment Period|Lost to Follow-up|3|||
163379864|NCT04617275|590099654|FG006|Treatment Period|Lost to Follow-up|0|||
163379865|NCT04617275|590099655|FG007|Treatment Period|Lost to Follow-up|2|||
163379866|NCT04617275|590099648|FG000|Treatment Period|No longer meets eligibility criteria|0|||
163379867|NCT04617275|590099649|FG001|Treatment Period|No longer meets eligibility criteria|0|||
163379868|NCT04617275|590099650|FG002|Treatment Period|No longer meets eligibility criteria|0|||
163379869|NCT04617275|590099651|FG003|Treatment Period|No longer meets eligibility criteria|1|||
163379870|NCT04617275|590099652|FG004|Treatment Period|No longer meets eligibility criteria|0|||
163379871|NCT04617275|590099653|FG005|Treatment Period|No longer meets eligibility criteria|0|||
163379872|NCT04617275|590099654|FG006|Treatment Period|No longer meets eligibility criteria|0|||
163379873|NCT04617275|590099655|FG007|Treatment Period|No longer meets eligibility criteria|0|||
163379874|NCT04617275|590099648|FG000|Treatment Period|Other|0|||
163379875|NCT04617275|590099649|FG001|Treatment Period|Other|1|||
163379876|NCT04617275|590099650|FG002|Treatment Period|Other|0|||
163379877|NCT04617275|590099651|FG003|Treatment Period|Other|0|||
163379878|NCT04617275|590099652|FG004|Treatment Period|Other|0|||
163379879|NCT04617275|590099653|FG005|Treatment Period|Other|0|||
163379880|NCT04617275|590099654|FG006|Treatment Period|Other|0|||
163379881|NCT04617275|590099655|FG007|Treatment Period|Other|0|||
163379882|NCT04617275|590099648|FG000|Treatment Period|Withdrawal by Subject|2|||
163379883|NCT04617275|590099649|FG001|Treatment Period|Withdrawal by Subject|0|||
163379884|NCT04617275|590099650|FG002|Treatment Period|Withdrawal by Subject|0|||
163379885|NCT04617275|590099651|FG003|Treatment Period|Withdrawal by Subject|2|||
163379886|NCT04617275|590099652|FG004|Treatment Period|Withdrawal by Subject|2|||
163379887|NCT04617275|590099653|FG005|Treatment Period|Withdrawal by Subject|0|||
163379888|NCT04617275|590099654|FG006|Treatment Period|Withdrawal by Subject|1|||
163379889|NCT04617275|590099655|FG007|Treatment Period|Withdrawal by Subject|2|||
163379890|NCT04617275|590099648|FG000|Follow-up Period|Adverse Event|1|||
163379891|NCT04617275|590099649|FG001|Follow-up Period|Adverse Event|1|||
163379892|NCT04617275|590099650|FG002|Follow-up Period|Adverse Event|2|||
163379893|NCT04617275|590099651|FG003|Follow-up Period|Adverse Event|3|||
163379894|NCT04617275|590099652|FG004|Follow-up Period|Adverse Event|4|||
163379895|NCT04617275|590099653|FG005|Follow-up Period|Adverse Event|3|||
163379896|NCT04617275|590099654|FG006|Follow-up Period|Adverse Event|0|||
163379897|NCT04617275|590099655|FG007|Follow-up Period|Adverse Event|3|||
163379898|NCT04617275|590099648|FG000|Follow-up Period|Lost to Follow-up|0|||
163379899|NCT04617275|590099649|FG001|Follow-up Period|Lost to Follow-up|1|||
163379900|NCT04617275|590099650|FG002|Follow-up Period|Lost to Follow-up|2|||
163379901|NCT04617275|590099651|FG003|Follow-up Period|Lost to Follow-up|0|||
163379902|NCT04617275|590099652|FG004|Follow-up Period|Lost to Follow-up|0|||
163379903|NCT04617275|590099653|FG005|Follow-up Period|Lost to Follow-up|4|||
163379904|NCT04617275|590099654|FG006|Follow-up Period|Lost to Follow-up|0|||
163379905|NCT04617275|590099655|FG007|Follow-up Period|Lost to Follow-up|3|||
163379906|NCT04617275|590099648|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
163379907|NCT04617275|590099649|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
163379908|NCT04617275|590099650|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
163379909|NCT04617275|590099651|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
163379910|NCT04617275|590099652|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
163379911|NCT04617275|590099653|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
163379912|NCT04617275|590099654|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
163379913|NCT04617275|590099655|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
163379914|NCT04617275|590099648|FG000|Follow-up Period|Other|0|||
163379915|NCT04617275|590099649|FG001|Follow-up Period|Other|1|||
163379916|NCT04617275|590099650|FG002|Follow-up Period|Other|0|||
163379917|NCT04617275|590099651|FG003|Follow-up Period|Other|0|||
163379918|NCT04617275|590099652|FG004|Follow-up Period|Other|0|||
163379919|NCT04617275|590099653|FG005|Follow-up Period|Other|0|||
163379920|NCT04617275|590099654|FG006|Follow-up Period|Other|0|||
163379921|NCT04617275|590099655|FG007|Follow-up Period|Other|0|||
163379922|NCT04617275|590099648|FG000|Follow-up Period|Withdrawal by Subject|2|||
163379923|NCT04617275|590099649|FG001|Follow-up Period|Withdrawal by Subject|0|||
163379924|NCT04617275|590099650|FG002|Follow-up Period|Withdrawal by Subject|0|||
163379925|NCT04617275|590099651|FG003|Follow-up Period|Withdrawal by Subject|2|||
163379926|NCT04617275|590099652|FG004|Follow-up Period|Withdrawal by Subject|2|||
163379927|NCT04617275|590099653|FG005|Follow-up Period|Withdrawal by Subject|0|||
163379928|NCT04617275|590099654|FG006|Follow-up Period|Withdrawal by Subject|1|||
163379929|NCT04617275|590099655|FG007|Follow-up Period|Withdrawal by Subject|2|||
163379930|NCT04227704|590099656|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
163379931|NCT04227704|590099657|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
163379932|NCT04227704|590099658|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
163379933|NCT04227704|590099656|FG000|Overall Study|due to C/S being cancelled|1|||
163379934|NCT04227704|590099657|FG001|Overall Study|due to C/S being cancelled|0|||
163379935|NCT04227704|590099658|FG002|Overall Study|due to C/S being cancelled|0|||
163379936|NCT00729378|590101381|FG000|Baseline|Did not complete study measurements|72|||
163379937|NCT00729378|590101382|FG001|Baseline|Did not complete study measurements|33|||
163379938|NCT00729378|590101381|FG000|Baseline|Withdrawal by Subject|66|||
163379939|NCT00729378|590101382|FG001|Baseline|Withdrawal by Subject|59|||
163379940|NCT00729378|590101381|FG000|12-months|Lost to Follow-up|100|||
163379941|NCT00729378|590101382|FG001|12-months|Lost to Follow-up|65|||
163379942|NCT00729378|590101381|FG000|24-months|Lost to Follow-up|72|||
163379943|NCT00729378|590101382|FG001|24-months|Lost to Follow-up|51|||
163379944|NCT00729378|590101381|FG000|36-months|Lost to Follow-up|15|||
163379945|NCT00729378|590101382|FG001|36-months|Lost to Follow-up|6|||
163379946|NCT00484289|590101392|FG000|Long Term Phase|Adverse Event|1|||
163379947|NCT00484289|590101393|FG001|Long Term Phase|Adverse Event|17|||
163379948|NCT00484289|590101394|FG002|Long Term Phase|Adverse Event|5|||
163379949|NCT00484289|590101392|FG000|Long Term Phase|Withdrawal by Subject|0|||
163379950|NCT00484289|590101393|FG001|Long Term Phase|Withdrawal by Subject|7|||
163379951|NCT00484289|590101394|FG002|Long Term Phase|Withdrawal by Subject|6|||
163379952|NCT00484289|590101392|FG000|Long Term Phase|Inadequate response|2|||
163379953|NCT00484289|590101393|FG001|Long Term Phase|Inadequate response|7|||
163379954|NCT00484289|590101394|FG002|Long Term Phase|Inadequate response|4|||
163379955|NCT00484289|590101392|FG000|Long Term Phase|Other Reason|0|||
163379956|NCT00484289|590101393|FG001|Long Term Phase|Other Reason|5|||
163379957|NCT00484289|590101394|FG002|Long Term Phase|Other Reason|1|||
163379958|NCT00484289|590101392|FG000|Post Marketing Phase|Adverse Event|0|||
163379959|NCT00484289|590101393|FG001|Post Marketing Phase|Adverse Event|1|||
163379960|NCT00484289|590101394|FG002|Post Marketing Phase|Adverse Event|0|||
163379961|NCT00690443|590101395|FG000|Overall Study|Adverse Event|1|||
163379962|NCT00690443|590101396|FG001|Overall Study|Adverse Event|2|||
163379963|NCT01776541|590101402|FG000|Overall Study|Administrative Reason|6|||
163379964|NCT01776541|590101403|FG001|Overall Study|Administrative Reason|2|||
163379965|NCT01776541|590101402|FG000|Overall Study|Death|4|||
163379966|NCT01776541|590101403|FG001|Overall Study|Death|0|||
163379967|NCT01776541|590101402|FG000|Overall Study|Lost to Follow-up|27|||
163379968|NCT01776541|590101403|FG001|Overall Study|Lost to Follow-up|48|||
163379969|NCT01776541|590101402|FG000|Overall Study|Unclassified|5|||
163379970|NCT01776541|590101403|FG001|Overall Study|Unclassified|4|||
163379971|NCT01776541|590101402|FG000|Overall Study|Protocol Violation|2|||
163379972|NCT01776541|590101403|FG001|Overall Study|Protocol Violation|1|||
163379973|NCT01776541|590101402|FG000|Overall Study|Withdrawal by Subject|12|||
163379974|NCT01776541|590101403|FG001|Overall Study|Withdrawal by Subject|20|||
163379975|NCT00903006|590101406|FG000|Overall Study|Withdrawal by Subject|2|||
163379976|NCT00903006|590101407|FG001|Overall Study|Withdrawal by Subject|0|||
163379977|NCT00903006|590101408|FG002|Overall Study|Withdrawal by Subject|0|||
163379978|NCT00903006|590101409|FG003|Overall Study|Withdrawal by Subject|0|||
163379979|NCT00903006|590101406|FG000|Overall Study|Progressive Disease|0|||
163379980|NCT00903006|590101407|FG001|Overall Study|Progressive Disease|3|||
163379981|NCT00903006|590101408|FG002|Overall Study|Progressive Disease|1|||
163379982|NCT00903006|590101409|FG003|Overall Study|Progressive Disease|0|||
163379983|NCT03405792|590101410|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
163379984|NCT03405792|590101411|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
163379985|NCT03405792|590101410|FG000|Overall Study|o Did not receive pembrolizumab|1|||
163379986|NCT03405792|590101411|FG001|Overall Study|o Did not receive pembrolizumab|0|||
163379987|NCT01347762|590101412|FG000|Overall Study|Lost to Follow-up|0|||
163379988|NCT01347762|590101413|FG001|Overall Study|Lost to Follow-up|1|||
163379989|NCT01347762|590101414|FG002|Overall Study|Lost to Follow-up|6|||
163379990|NCT01347762|590101415|FG003|Overall Study|Lost to Follow-up|5|||
163379991|NCT01347762|590101412|FG000|Overall Study|Withdrawal by Subject|4|||
163379992|NCT01347762|590101413|FG001|Overall Study|Withdrawal by Subject|1|||
163379993|NCT01347762|590101414|FG002|Overall Study|Withdrawal by Subject|3|||
163379994|NCT01347762|590101415|FG003|Overall Study|Withdrawal by Subject|3|||
163379995|NCT02319525|590101416|FG000|Overall Study|Withdrawal by Subject|2|||
163379996|NCT02319525|590101417|FG001|Overall Study|Withdrawal by Subject|1|||
163379997|NCT02729753|590101424|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
163379998|NCT02729753|590101425|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
163379999|NCT02842827|590101426|FG000|Overall Study|Adverse Event|0|||
163380000|NCT02842827|590101427|FG001|Overall Study|Adverse Event|1|||
163380001|NCT02842827|590101428|FG002|Overall Study|Adverse Event|0|||
163380002|NCT02842827|590101429|FG003|Overall Study|Adverse Event|1|||
163380003|NCT02842827|590101430|FG004|Overall Study|Adverse Event|0|||
163380004|NCT02842827|590101431|FG005|Overall Study|Adverse Event|1|||
163380005|NCT02842827|590101432|FG006|Overall Study|Adverse Event|0|||
163380006|NCT02842827|590101433|FG007|Overall Study|Adverse Event|0|||
163380007|NCT02842827|590101426|FG000|Overall Study|Death|1|||
163380008|NCT02842827|590101427|FG001|Overall Study|Death|0|||
163380009|NCT02842827|590101428|FG002|Overall Study|Death|2|||
163380010|NCT02842827|590101429|FG003|Overall Study|Death|3|||
163380011|NCT02842827|590101430|FG004|Overall Study|Death|2|||
163380012|NCT02842827|590101431|FG005|Overall Study|Death|1|||
163380013|NCT02842827|590101432|FG006|Overall Study|Death|0|||
163380014|NCT02842827|590101433|FG007|Overall Study|Death|4|||
163380015|NCT02842827|590101426|FG000|Overall Study|Physician Decision|1|||
163380016|NCT02842827|590101427|FG001|Overall Study|Physician Decision|3|||
163380017|NCT02842827|590101428|FG002|Overall Study|Physician Decision|0|||
163380018|NCT02842827|590101429|FG003|Overall Study|Physician Decision|0|||
163380019|NCT02842827|590101430|FG004|Overall Study|Physician Decision|1|||
163380020|NCT02842827|590101431|FG005|Overall Study|Physician Decision|4|||
163380021|NCT02842827|590101432|FG006|Overall Study|Physician Decision|2|||
163380022|NCT02842827|590101433|FG007|Overall Study|Physician Decision|1|||
163380023|NCT02842827|590101426|FG000|Overall Study|Protocol Defined Disease Progression|0|||
163380024|NCT02842827|590101427|FG001|Overall Study|Protocol Defined Disease Progression|0|||
163380025|NCT02842827|590101428|FG002|Overall Study|Protocol Defined Disease Progression|0|||
163380026|NCT02842827|590101429|FG003|Overall Study|Protocol Defined Disease Progression|0|||
163380027|NCT02842827|590101430|FG004|Overall Study|Protocol Defined Disease Progression|0|||
163380028|NCT02842827|590101431|FG005|Overall Study|Protocol Defined Disease Progression|1|||
163380029|NCT02842827|590101432|FG006|Overall Study|Protocol Defined Disease Progression|0|||
163380030|NCT02842827|590101433|FG007|Overall Study|Protocol Defined Disease Progression|0|||
163380031|NCT02842827|590101426|FG000|Overall Study|Participant Withdrawal of Consent|1|||
163380032|NCT02842827|590101427|FG001|Overall Study|Participant Withdrawal of Consent|2|||
163380033|NCT02842827|590101428|FG002|Overall Study|Participant Withdrawal of Consent|2|||
163380034|NCT02842827|590101429|FG003|Overall Study|Participant Withdrawal of Consent|2|||
163380035|NCT02842827|590101430|FG004|Overall Study|Participant Withdrawal of Consent|2|||
163380036|NCT02842827|590101431|FG005|Overall Study|Participant Withdrawal of Consent|1|||
163380037|NCT02842827|590101432|FG006|Overall Study|Participant Withdrawal of Consent|2|||
163380038|NCT02842827|590101433|FG007|Overall Study|Participant Withdrawal of Consent|1|||
163380039|NCT01815138|590101434|FG000|Overall Study|Withdrawal by Subject|0|||
163380040|NCT01815138|590101435|FG001|Overall Study|Withdrawal by Subject|1|||
163380041|NCT01815138|590101434|FG000|Overall Study|Physician Decision|8|||
163380042|NCT01815138|590101435|FG001|Overall Study|Physician Decision|5|||
163380043|NCT00950950|590101437|FG000|Overall Study|Adverse Event|1|||
163380044|NCT00950950|590101438|FG001|Overall Study|Adverse Event|0|||
163380045|NCT00950950|590101437|FG000|Overall Study|Withdrawal by Subject|0|||
163380046|NCT00950950|590101438|FG001|Overall Study|Withdrawal by Subject|1|||
163380047|NCT01047293|590101439|FG000|Overall Study|DLT criteria not fulfilled|1|||
163380048|NCT01047293|590101440|FG001|Overall Study|DLT criteria not fulfilled|1|||
163380049|NCT01047293|590101441|FG002|Overall Study|DLT criteria not fulfilled|0|||
163380050|NCT01047293|590101442|FG003|Overall Study|DLT criteria not fulfilled|0|||
163380051|NCT00757783|590101443|FG000|Overall Study|Adverse Event|0|||
163380052|NCT00757783|590101444|FG001|Overall Study|Adverse Event|2|||
163380053|NCT00757783|590101443|FG000|Overall Study|Lost to Follow-up|1|||
163380054|NCT00757783|590101444|FG001|Overall Study|Lost to Follow-up|1|||
163380055|NCT00757783|590101443|FG000|Overall Study|Protocol Violation|1|||
163380056|NCT00757783|590101444|FG001|Overall Study|Protocol Violation|0|||
163380057|NCT00757783|590101443|FG000|Overall Study|Withdrawal by Subject|2|||
163380058|NCT00757783|590101444|FG001|Overall Study|Withdrawal by Subject|1|||
163380059|NCT00757783|590101443|FG000|Overall Study|Other|1|||
163380060|NCT00757783|590101444|FG001|Overall Study|Other|2|||
163380061|NCT02372136|590101445|FG000|Overall Study|Death|3|||
163380062|NCT02372136|590101446|FG001|Overall Study|Death|1|||
163380063|NCT02679508|590101447|FG000|Healing Phase|Protocol Violation|1|||
163380064|NCT02679508|590101448|FG001|Healing Phase|Protocol Violation|1|||
163380065|NCT02679508|590101447|FG000|Healing Phase|Lost to Follow-up|1|||
163380066|NCT02679508|590101448|FG001|Healing Phase|Lost to Follow-up|0|||
163380067|NCT02679508|590101447|FG000|Maintenance Phase|Adverse Event|12|||
163380068|NCT02679508|590101448|FG001|Maintenance Phase|Adverse Event|2|||
163380069|NCT02679508|590101447|FG000|Maintenance Phase|Lost to Follow-up|0|||
163380070|NCT02679508|590101448|FG001|Maintenance Phase|Lost to Follow-up|1|||
163380071|NCT02679508|590101447|FG000|Maintenance Phase|Withdrawal by Subject|15|||
163380072|NCT02679508|590101448|FG001|Maintenance Phase|Withdrawal by Subject|8|||
163380073|NCT02679508|590101447|FG000|Maintenance Phase|Other|5|||
163380074|NCT02679508|590101448|FG001|Maintenance Phase|Other|4|||
163380075|NCT01588496|590101449|FG000|Overall Study|Withdrawal by Subject|0|||
163380076|NCT01588496|590101450|FG001|Overall Study|Withdrawal by Subject|1|||
163417107|NCT01613326|590233995|FG000|Overall Study|Lost to Follow-up|0|||
163417108|NCT01613326|590233996|FG001|Overall Study|Lost to Follow-up|1|||
163417109|NCT01613326|590233995|FG000|Overall Study|Administrative|0|||
163417110|NCT01613326|590233996|FG001|Overall Study|Administrative|2|||
163417111|NCT01613326|590233995|FG000|Overall Study|Protocol Violation|0|||
163417112|NCT01613326|590233996|FG001|Overall Study|Protocol Violation|1|||
163417113|NCT01940484|590233997|FG000|Overall Study|Withdrawal by Subject|3|||
163417114|NCT01940484|590233997|FG000|Overall Study|Underwent transplantation|4|||
163417115|NCT01940484|590233997|FG000|Overall Study|Death|2|||
163417116|NCT01940484|590233997|FG000|Overall Study|Adverse Event|1|||
163417117|NCT01705691|590233999|FG000|Overall Study|Death|1|||
163417118|NCT01705691|590234000|FG001|Overall Study|Death|2|||
163417119|NCT01705691|590233999|FG000|Overall Study|Withdrawal by Subject|1|||
163417120|NCT01705691|590234000|FG001|Overall Study|Withdrawal by Subject|2|||
163417121|NCT01705691|590233999|FG000|Overall Study|Lost to Follow-up|1|||
163417122|NCT01705691|590234000|FG001|Overall Study|Lost to Follow-up|1|||
163417123|NCT01705691|590233999|FG000|Overall Study|Other|0|||
163417124|NCT01705691|590234000|FG001|Overall Study|Other|1|||
163417125|NCT02658448|590234001|FG000|Overall Study|Lost to Follow-up|1|||
163417126|NCT03106779|590234002|FG000|Overall Study|Lack of Efficacy|33|||
163417127|NCT03106779|590234003|FG001|Overall Study|Lack of Efficacy|24|||
163417128|NCT03106779|590234002|FG000|Overall Study|Adverse Event|8|||
163417129|NCT03106779|590234003|FG001|Overall Study|Adverse Event|16|||
163417130|NCT03106779|590234002|FG000|Overall Study|Physician Decision|10|||
163417131|NCT03106779|590234003|FG001|Overall Study|Physician Decision|6|||
163417132|NCT03106779|590234002|FG000|Overall Study|Patient/guardian decision|4|||
163417133|NCT03106779|590234003|FG001|Overall Study|Patient/guardian decision|3|||
163417134|NCT03106779|590234002|FG000|Overall Study|Progressive disease|1|||
163417135|NCT03106779|590234003|FG001|Overall Study|Progressive disease|3|||
163417136|NCT03106779|590234002|FG000|Overall Study|Lost to Follow-up|1|||
163417137|NCT03106779|590234003|FG001|Overall Study|Lost to Follow-up|2|||
163417138|NCT03106779|590234002|FG000|Overall Study|Death|1|||
163417139|NCT03106779|590234003|FG001|Overall Study|Death|0|||
163417140|NCT03106779|590234002|FG000|Overall Study|Protocol Violation|1|||
163417141|NCT03106779|590234003|FG001|Overall Study|Protocol Violation|0|||
163417142|NCT03106779|590234002|FG000|Overall Study|Not treated|1|||
163417143|NCT03106779|590234003|FG001|Overall Study|Not treated|0|||
163417144|NCT04233229|590234004|FG000|Overall Study|Withdrawal by Subject|0|||
163417145|NCT04233229|590234005|FG001|Overall Study|Withdrawal by Subject|1|||
163417146|NCT04233229|590234004|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
163417147|NCT04233229|590234005|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
163417148|NCT04233229|590234004|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
163417149|NCT04233229|590234005|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
163417150|NCT04652804|590234006|FG000|Overall Study|Ineligible post randomization|1|||
163417151|NCT04652804|590234007|FG001|Overall Study|Ineligible post randomization|0|||
163417152|NCT04652804|590234008|FG002|Overall Study|Ineligible post randomization|1|||
163417153|NCT04652804|590234009|FG003|Overall Study|Ineligible post randomization|0|||
163417154|NCT04652804|590234010|FG004|Overall Study|Ineligible post randomization|1|||
163417155|NCT04652804|590234011|FG005|Overall Study|Ineligible post randomization|1|||
163417156|NCT04652804|590234006|FG000|Overall Study|Missing SVR lab results|2|||
163417157|NCT04652804|590234007|FG001|Overall Study|Missing SVR lab results|0|||
163417158|NCT04652804|590234008|FG002|Overall Study|Missing SVR lab results|0|||
163417159|NCT04652804|590234009|FG003|Overall Study|Missing SVR lab results|0|||
163417160|NCT04652804|590234010|FG004|Overall Study|Missing SVR lab results|0|||
163417161|NCT04652804|590234011|FG005|Overall Study|Missing SVR lab results|0|||
163417162|NCT00584194|590234012|FG000|Overall Study|Other|135|||
163417163|NCT04093531|590234013|FG000|Overall Study|failed screening|4|||
163417164|NCT03665285|590234014|FG000|Overall Study|Started New Anticancer Treatment|1|||
163417165|NCT03665285|590234015|FG001|Overall Study|Started New Anticancer Treatment|1|||
163417166|NCT03665285|590234016|FG002|Overall Study|Started New Anticancer Treatment|2|||
163417167|NCT03665285|590234017|FG003|Overall Study|Started New Anticancer Treatment|4|||
163417168|NCT03665285|590234018|FG004|Overall Study|Started New Anticancer Treatment|1|||
163417169|NCT03665285|590234019|FG005|Overall Study|Started New Anticancer Treatment|1|||
163417170|NCT03665285|590234020|FG006|Overall Study|Started New Anticancer Treatment|2|||
163417171|NCT03665285|590234021|FG007|Overall Study|Started New Anticancer Treatment|15|||
163417172|NCT03665285|590234022|FG008|Overall Study|Started New Anticancer Treatment|1|||
163417173|NCT03665285|590234014|FG000|Overall Study|Disease Progression|0|||
163417174|NCT03665285|590234015|FG001|Overall Study|Disease Progression|0|||
163417175|NCT03665285|590234016|FG002|Overall Study|Disease Progression|3|||
163417176|NCT03665285|590234017|FG003|Overall Study|Disease Progression|1|||
163417177|NCT03665285|590234018|FG004|Overall Study|Disease Progression|0|||
163417178|NCT03665285|590234019|FG005|Overall Study|Disease Progression|0|||
163417179|NCT03665285|590234020|FG006|Overall Study|Disease Progression|0|||
163417180|NCT03665285|590234021|FG007|Overall Study|Disease Progression|7|||
163417181|NCT03665285|590234022|FG008|Overall Study|Disease Progression|1|||
163417182|NCT03665285|590234014|FG000|Overall Study|Hospice|0|||
163417183|NCT03665285|590234015|FG001|Overall Study|Hospice|0|||
163380077|NCT01588496|590101451|FG002|Overall Study|Withdrawal by Subject|0|||
163380078|NCT03143166|590101452|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
163380079|NCT02003573|590101456|FG000|Overall Study|Progressive disease|2|||
163380080|NCT02003573|590101457|FG001|Overall Study|Progressive disease|0|||
163380081|NCT02003573|590101458|FG002|Overall Study|Progressive disease|1|||
163380082|NCT02003573|590101456|FG000|Overall Study|Other Adverse event|0|||
163380083|NCT02003573|590101457|FG001|Overall Study|Other Adverse event|1|||
163380084|NCT02003573|590101458|FG002|Overall Study|Other Adverse event|1|||
163380085|NCT02003573|590101456|FG000|Overall Study|Refuse to take trial medication|0|||
163380086|NCT02003573|590101457|FG001|Overall Study|Refuse to take trial medication|1|||
163380087|NCT02003573|590101458|FG002|Overall Study|Refuse to take trial medication|1|||
163380088|NCT02003573|590101456|FG000|Overall Study|Other than specified|1|||
163380089|NCT02003573|590101457|FG001|Overall Study|Other than specified|2|||
163380090|NCT02003573|590101458|FG002|Overall Study|Other than specified|3|||
163380091|NCT03683823|590101465|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
163380092|NCT03683823|590101466|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
163380093|NCT03683823|590101465|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
163380094|NCT03683823|590101466|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
163380095|NCT03683823|590101465|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
163380096|NCT03683823|590101466|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
163380097|NCT05026710|590101468|FG000|Overall Study|No longer met eligibility criteria|3|||
163380098|NCT05026710|590101469|FG001|Overall Study|No longer met eligibility criteria|1|||
163380099|NCT00994682|590101470|FG000|Double Bilnd|Withdrawal by Subject|5|||
163380100|NCT00994682|590101471|FG001|Double Bilnd|Withdrawal by Subject|6|||
163380101|NCT00994682|590101470|FG000|Double Bilnd|Lost to Follow-up|3|||
163380102|NCT00994682|590101471|FG001|Double Bilnd|Lost to Follow-up|3|||
163380103|NCT00994682|590101470|FG000|Double Bilnd|Adverse Event|1|||
163380104|NCT00994682|590101471|FG001|Double Bilnd|Adverse Event|0|||
163380105|NCT00994682|590101470|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
163380106|NCT00994682|590101471|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
163380107|NCT00994682|590101470|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
163380108|NCT00994682|590101471|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
163380109|NCT00994682|590101470|FG000|Pioglitazone Open Label|Physician Decision|6|||
163380110|NCT00994682|590101471|FG001|Pioglitazone Open Label|Physician Decision|1|||
163380111|NCT01323972|590101472|FG000|Overall Study|Withdrawal by Subject|1|||
163380112|NCT01323972|590101473|FG001|Overall Study|Withdrawal by Subject|0|||
163380113|NCT01323972|590101474|FG002|Overall Study|Withdrawal by Subject|1|||
163380114|NCT01323972|590101475|FG003|Overall Study|Withdrawal by Subject|0|||
163380115|NCT01323972|590101472|FG000|Overall Study|Migrated/moved from study area|1|||
163380116|NCT01323972|590101473|FG001|Overall Study|Migrated/moved from study area|2|||
163380117|NCT01323972|590101474|FG002|Overall Study|Migrated/moved from study area|0|||
163380118|NCT01323972|590101475|FG003|Overall Study|Migrated/moved from study area|0|||
163380119|NCT01323972|590101472|FG000|Overall Study|Lost to Follow-up|0|||
163380120|NCT01323972|590101473|FG001|Overall Study|Lost to Follow-up|1|||
163380121|NCT01323972|590101474|FG002|Overall Study|Lost to Follow-up|1|||
163380122|NCT01323972|590101475|FG003|Overall Study|Lost to Follow-up|1|||
163380123|NCT03218397|590101476|FG000|Overall Study|Prior positive blood culture|8|||
163380124|NCT03218397|590101477|FG001|Overall Study|Prior positive blood culture|13|||
163380125|NCT03218397|590101476|FG000|Overall Study|Comfort care|8|||
163380126|NCT03218397|590101477|FG001|Overall Study|Comfort care|5|||
163380127|NCT03218397|590101476|FG000|Overall Study|Comfort care and positive blood culture|1|||
163380128|NCT03218397|590101477|FG001|Overall Study|Comfort care and positive blood culture|0|||
163380129|NCT03218397|590101476|FG000|Overall Study|Comfort care and mixed culture|0|||
163380130|NCT03218397|590101477|FG001|Overall Study|Comfort care and mixed culture|1|||
163380131|NCT03218397|590101476|FG000|Overall Study|Mixed culture|2|||
163380132|NCT03218397|590101477|FG001|Overall Study|Mixed culture|2|||
163380133|NCT03218397|590101476|FG000|Overall Study|Inaccessible hospital records|2|||
163380134|NCT03218397|590101477|FG001|Overall Study|Inaccessible hospital records|5|||
163380135|NCT03218397|590101476|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
163380136|NCT03218397|590101477|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
163380137|NCT03218397|590101476|FG000|Overall Study|Randomized during laboratory off hours|2|||
163380138|NCT03218397|590101477|FG001|Overall Study|Randomized during laboratory off hours|1|||
163380139|NCT01796548|590101480|FG000|Overall Study|Lost to Follow-up|1|||
163380140|NCT01796548|590101480|FG000|Overall Study|Other|2|||
163380141|NCT01049217|590101483|FG000|Overall Study|Adverse Event|2|||
163380142|NCT01049217|590101484|FG001|Overall Study|Adverse Event|1|||
163380143|NCT01049217|590101483|FG000|Overall Study|Lack of Efficacy|1|||
163380144|NCT01049217|590101484|FG001|Overall Study|Lack of Efficacy|1|||
163380145|NCT01049217|590101483|FG000|Overall Study|Lost to Follow-up|3|||
163380146|NCT01049217|590101484|FG001|Overall Study|Lost to Follow-up|8|||
163380147|NCT01049217|590101483|FG000|Overall Study|Withdrawal by Subject|4|||
163380148|NCT01049217|590101484|FG001|Overall Study|Withdrawal by Subject|3|||
163380149|NCT01049217|590101483|FG000|Overall Study|Protocol Violation|1|||
163380150|NCT01049217|590101484|FG001|Overall Study|Protocol Violation|3|||
163417184|NCT03665285|590234016|FG002|Overall Study|Hospice|0|||
163417185|NCT03665285|590234017|FG003|Overall Study|Hospice|0|||
163417186|NCT03665285|590234018|FG004|Overall Study|Hospice|0|||
163417187|NCT03665285|590234019|FG005|Overall Study|Hospice|0|||
163417188|NCT03665285|590234020|FG006|Overall Study|Hospice|0|||
163417189|NCT03665285|590234021|FG007|Overall Study|Hospice|2|||
163417190|NCT03665285|590234022|FG008|Overall Study|Hospice|0|||
163417191|NCT03665285|590234014|FG000|Overall Study|Withdrawal by Subject|0|||
163417192|NCT03665285|590234015|FG001|Overall Study|Withdrawal by Subject|0|||
163417193|NCT03665285|590234016|FG002|Overall Study|Withdrawal by Subject|0|||
163417194|NCT03665285|590234017|FG003|Overall Study|Withdrawal by Subject|0|||
163417195|NCT03665285|590234018|FG004|Overall Study|Withdrawal by Subject|1|||
163417196|NCT03665285|590234019|FG005|Overall Study|Withdrawal by Subject|0|||
163417197|NCT03665285|590234020|FG006|Overall Study|Withdrawal by Subject|0|||
163417198|NCT03665285|590234021|FG007|Overall Study|Withdrawal by Subject|2|||
163417199|NCT03665285|590234022|FG008|Overall Study|Withdrawal by Subject|0|||
163417200|NCT03665285|590234014|FG000|Overall Study|Physician Decision|0|||
163417201|NCT03665285|590234015|FG001|Overall Study|Physician Decision|0|||
163417202|NCT03665285|590234016|FG002|Overall Study|Physician Decision|0|||
163417203|NCT03665285|590234017|FG003|Overall Study|Physician Decision|0|||
163417204|NCT03665285|590234018|FG004|Overall Study|Physician Decision|0|||
163417205|NCT03665285|590234019|FG005|Overall Study|Physician Decision|0|||
163417206|NCT03665285|590234020|FG006|Overall Study|Physician Decision|0|||
163417207|NCT03665285|590234021|FG007|Overall Study|Physician Decision|2|||
163417208|NCT03665285|590234022|FG008|Overall Study|Physician Decision|0|||
163417209|NCT01235962|590234023|FG000|Overall Study|Withdrawal by Subject|20|||
163417210|NCT01235962|590234024|FG001|Overall Study|Withdrawal by Subject|19|||
163417211|NCT01235962|590234025|FG002|Overall Study|Withdrawal by Subject|62|||
163417212|NCT01235962|590234026|FG003|Overall Study|Withdrawal by Subject|49|||
163417213|NCT01235962|590234023|FG000|Overall Study|Lost to Follow-up|21|||
163417214|NCT01235962|590234024|FG001|Overall Study|Lost to Follow-up|16|||
163417215|NCT01235962|590234025|FG002|Overall Study|Lost to Follow-up|47|||
163417216|NCT01235962|590234026|FG003|Overall Study|Lost to Follow-up|32|||
163417217|NCT01235962|590234023|FG000|Overall Study|Physician Decision|5|||
163417218|NCT01235962|590234024|FG001|Overall Study|Physician Decision|0|||
163417219|NCT01235962|590234025|FG002|Overall Study|Physician Decision|9|||
163417220|NCT01235962|590234026|FG003|Overall Study|Physician Decision|5|||
163417221|NCT03543410|590234027|FG000|Overall Study|Adverse Event|10|||
163417222|NCT03543410|590234028|FG001|Overall Study|Adverse Event|8|||
163417223|NCT03543410|590234029|FG002|Overall Study|Adverse Event|2|||
163417224|NCT03543410|590234027|FG000|Overall Study|Lack of Efficacy|0|||
163417225|NCT03543410|590234028|FG001|Overall Study|Lack of Efficacy|1|||
163417226|NCT03543410|590234029|FG002|Overall Study|Lack of Efficacy|0|||
163417227|NCT03543410|590234027|FG000|Overall Study|Lost to Follow-up|0|||
163417228|NCT03543410|590234028|FG001|Overall Study|Lost to Follow-up|1|||
163380151|NCT01049217|590101483|FG000|Overall Study|Pregnancy|1|||
163380152|NCT01049217|590101484|FG001|Overall Study|Pregnancy|0|||
163380153|NCT01049217|590101483|FG000|Overall Study|Study Terminated by Sponsor|43|||
163380154|NCT01049217|590101484|FG001|Overall Study|Study Terminated by Sponsor|43|||
163380155|NCT01049217|590101483|FG000|Overall Study|Other|1|||
163380156|NCT01049217|590101484|FG001|Overall Study|Other|2|||
163380157|NCT01049217|590101483|FG000|Overall Study|Randomized but not Treated|0|||
163380158|NCT01049217|590101484|FG001|Overall Study|Randomized but not Treated|2|||
163380159|NCT00126503|590101485|FG000|Overall Study|disease progression|23|||
163380160|NCT00126503|590101486|FG001|Overall Study|disease progression|14|||
163380161|NCT00126503|590101485|FG000|Overall Study|Withdrawal by Subject|0|||
163380162|NCT00126503|590101486|FG001|Overall Study|Withdrawal by Subject|1|||
163380163|NCT00126503|590101485|FG000|Overall Study|alternative therapy|1|||
163380164|NCT00126503|590101486|FG001|Overall Study|alternative therapy|1|||
163417229|NCT03543410|590234029|FG002|Overall Study|Lost to Follow-up|0|||
163417230|NCT03543410|590234027|FG000|Overall Study|Withdrawal by Subject|5|||
163417231|NCT03543410|590234028|FG001|Overall Study|Withdrawal by Subject|2|||
163380165|NCT00126503|590101485|FG000|Overall Study|other complicating disease|4|||
163380166|NCT00126503|590101486|FG001|Overall Study|other complicating disease|1|||
163380167|NCT00126503|590101485|FG000|Overall Study|Death|3|||
163380168|NCT00126503|590101486|FG001|Overall Study|Death|0|||
163380169|NCT00126503|590101485|FG000|Overall Study|Adverse Event|13|||
163417232|NCT03543410|590234029|FG002|Overall Study|Withdrawal by Subject|8|||
163417233|NCT03543410|590234027|FG000|Overall Study|Protocol Violation|0|||
163417234|NCT03543410|590234028|FG001|Overall Study|Protocol Violation|1|||
163417235|NCT03543410|590234029|FG002|Overall Study|Protocol Violation|0|||
163417236|NCT03543410|590234027|FG000|Overall Study|Due to COVID-19|4|||
163380170|NCT00126503|590101486|FG001|Overall Study|Adverse Event|3|||
163380171|NCT00126503|590101485|FG000|Overall Study|non-compliant|1|||
163380172|NCT00126503|590101486|FG001|Overall Study|non-compliant|0|||
163417237|NCT03543410|590234028|FG001|Overall Study|Due to COVID-19|0|||
163417238|NCT03543410|590234029|FG002|Overall Study|Due to COVID-19|2|||
163417239|NCT03543410|590234027|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
163417240|NCT03543410|590234028|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
163417241|NCT03543410|590234029|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
163380173|NCT00126503|590101485|FG000|Overall Study|Physician Decision|2|||
163380174|NCT00126503|590101486|FG001|Overall Study|Physician Decision|1|||
163380175|NCT00589121|590101487|FG000|Overall Study|Protocol Violation|2|||
163380176|NCT00589121|590101488|FG001|Overall Study|Protocol Violation|6|||
163380177|NCT00589121|590101487|FG000|Overall Study|No protocol treatment received|0|||
163380178|NCT00589121|590101488|FG001|Overall Study|No protocol treatment received|1|||
163380179|NCT02495792|590101489|FG000|Overall Study|Lost to Follow-up|5|||
163380180|NCT02495792|590101490|FG001|Overall Study|Lost to Follow-up|9|||
163380181|NCT02495792|590101489|FG000|Overall Study|Protocol Violation|32|||
163380182|NCT02495792|590101490|FG001|Overall Study|Protocol Violation|31|||
163380183|NCT03519971|590101491|FG000|Overall Study|Death|142|||
163380184|NCT03519971|590101492|FG001|Overall Study|Death|69|||
163380185|NCT03519971|590101491|FG000|Overall Study|Lost to Follow-up|0|||
163417242|NCT03543410|590234027|FG000|Overall Study|Not Due to COVID-19|2|||
163417243|NCT03543410|590234028|FG001|Overall Study|Not Due to COVID-19|0|||
163417244|NCT03543410|590234029|FG002|Overall Study|Not Due to COVID-19|1|||
163417245|NCT01580397|590234030|FG000|Overall Study|Lack of Efficacy|14|||
163417246|NCT01727258|590234031|FG000|Overall Study|Adverse Event|0|||
163417247|NCT01727258|590234032|FG001|Overall Study|Adverse Event|2|||
163417248|NCT01727258|590234033|FG002|Overall Study|Adverse Event|0|||
163417249|NCT01727258|590234031|FG000|Overall Study|Noncompliance with Study Drug|0|||
163417250|NCT01727258|590234032|FG001|Overall Study|Noncompliance with Study Drug|0|||
163417251|NCT01727258|590234033|FG002|Overall Study|Noncompliance with Study Drug|1|||
163417252|NCT01727258|590234031|FG000|Overall Study|Withdrawal by Subject|1|||
163417253|NCT01727258|590234032|FG001|Overall Study|Withdrawal by Subject|1|||
163417254|NCT01727258|590234033|FG002|Overall Study|Withdrawal by Subject|0|||
163417255|NCT01727258|590234031|FG000|Overall Study|Lost to Follow-up|1|||
163417256|NCT01727258|590234032|FG001|Overall Study|Lost to Follow-up|0|||
163417257|NCT01727258|590234033|FG002|Overall Study|Lost to Follow-up|0|||
163417258|NCT01318122|590234034|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163417259|NCT01318122|590234035|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163417260|NCT01318122|590234036|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
163417261|NCT01318122|590234037|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
163417262|NCT01318122|590234034|FG000|Enrolled - Long-Term Extension Study|Other|1|||
163417263|NCT01318122|590234035|FG001|Enrolled - Long-Term Extension Study|Other|0|||
163417264|NCT01318122|590234036|FG002|Enrolled - Long-Term Extension Study|Other|0|||
163417265|NCT01318122|590234037|FG003|Enrolled - Long-Term Extension Study|Other|0|||
163417266|NCT01318122|590234034|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
163417267|NCT01318122|590234035|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
163417268|NCT01318122|590234036|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
163417269|NCT01318122|590234037|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
163417270|NCT01318122|590234034|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
163417271|NCT01318122|590234035|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163417272|NCT01318122|590234036|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163417273|NCT01318122|590234037|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163417274|NCT01318122|590234034|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
163417275|NCT01318122|590234035|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
163417276|NCT01318122|590234036|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163417277|NCT01318122|590234037|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
163417278|NCT01318122|590234034|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
163417279|NCT01318122|590234035|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
163417280|NCT01318122|590234036|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
163417281|NCT01318122|590234037|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
163417282|NCT00820755|590234038|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
163417283|NCT00820755|590234039|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
163417284|NCT00820755|590234040|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
163417285|NCT00820755|590234038|FG000|Period 1: Combination Therapy Phase|Death|28|||
163417286|NCT00820755|590234039|FG001|Period 1: Combination Therapy Phase|Death|0|||
163417287|NCT00820755|590234040|FG002|Period 1: Combination Therapy Phase|Death|0|||
163380186|NCT03519971|590101492|FG001|Overall Study|Lost to Follow-up|1|||
163380187|NCT03519971|590101491|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
163380188|NCT03519971|590101492|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
163380189|NCT03519971|590101491|FG000|Overall Study|Withdrawal by Subject|3|||
163380190|NCT03519971|590101492|FG001|Overall Study|Withdrawal by Subject|2|||
163380191|NCT03519971|590101491|FG000|Overall Study|Other|1|||
163380192|NCT03519971|590101492|FG001|Overall Study|Other|0|||
163417288|NCT00820755|590234038|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
163417289|NCT00820755|590234039|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
163417290|NCT00820755|590234040|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
163417291|NCT00820755|590234038|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
163380193|NCT00925132|590101493|FG000|Overall Study|Withdrawal by Subject|2|||
163380194|NCT00925132|590101494|FG001|Overall Study|Withdrawal by Subject|0|||
163380195|NCT00925132|590101495|FG002|Overall Study|Withdrawal by Subject|0|||
163380196|NCT00925132|590101496|FG003|Overall Study|Withdrawal by Subject|0|||
163380197|NCT00925132|590101497|FG004|Overall Study|Withdrawal by Subject|1|||
163380198|NCT00925132|590101493|FG000|Overall Study|Removed due to disease progression|0|||
163380199|NCT00925132|590101494|FG001|Overall Study|Removed due to disease progression|0|||
163380200|NCT00925132|590101495|FG002|Overall Study|Removed due to disease progression|0|||
163380201|NCT00925132|590101496|FG003|Overall Study|Removed due to disease progression|0|||
163380202|NCT00925132|590101497|FG004|Overall Study|Removed due to disease progression|4|||
163380203|NCT02545933|590101498|FG000|Overall Study|Adverse Event|3|||
163380204|NCT02545933|590101499|FG001|Overall Study|Adverse Event|0|||
163380205|NCT02545933|590101500|FG002|Overall Study|Adverse Event|0|||
163380206|NCT02545933|590101498|FG000|Overall Study|Withdrawal by Subject|2|||
163380207|NCT02545933|590101499|FG001|Overall Study|Withdrawal by Subject|3|||
163380208|NCT02545933|590101500|FG002|Overall Study|Withdrawal by Subject|3|||
163380209|NCT02545933|590101498|FG000|Overall Study|Protocol Violation|1|||
163380210|NCT02545933|590101499|FG001|Overall Study|Protocol Violation|0|||
163380211|NCT02545933|590101500|FG002|Overall Study|Protocol Violation|1|||
163380212|NCT03149549|590101501|FG000|Study Discontinuation--Treatment Period|Death|0|||
163380213|NCT03149549|590101502|FG001|Study Discontinuation--Treatment Period|Death|0|||
163380214|NCT03149549|590101503|FG002|Study Discontinuation--Treatment Period|Death|0|||
163380215|NCT03149549|590101504|FG003|Study Discontinuation--Treatment Period|Death|1|||
163380216|NCT03149549|590101505|FG004|Study Discontinuation--Treatment Period|Death|2|||
163380217|NCT03149549|590101506|FG005|Study Discontinuation--Treatment Period|Death|1|||
163380218|NCT03149549|590101507|FG006|Study Discontinuation--Treatment Period|Death|1|||
163380219|NCT03149549|590101508|FG007|Study Discontinuation--Treatment Period|Death|2|||
163380220|NCT03149549|590101509|FG008|Study Discontinuation--Treatment Period|Death|4|||
163380221|NCT03149549|590101510|FG009|Study Discontinuation--Treatment Period|Death|1|||
163380222|NCT03149549|590101511|FG010|Study Discontinuation--Treatment Period|Death|0|||
163380223|NCT03149549|590101512|FG011|Study Discontinuation--Treatment Period|Death|0|||
163380224|NCT03149549|590101513|FG012|Study Discontinuation--Treatment Period|Death|1|||
163380225|NCT03149549|590101501|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163380226|NCT03149549|590101502|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163380227|NCT03149549|590101503|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163380228|NCT03149549|590101504|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163380229|NCT03149549|590101505|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163380230|NCT03149549|590101506|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163380231|NCT03149549|590101507|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163380232|NCT03149549|590101508|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
163380233|NCT03149549|590101509|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163380234|NCT03149549|590101510|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163380235|NCT03149549|590101511|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163380236|NCT03149549|590101512|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163380237|NCT03149549|590101513|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
163380238|NCT03149549|590101501|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
163380239|NCT03149549|590101502|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
163380240|NCT03149549|590101503|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
163380241|NCT03149549|590101504|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
163380242|NCT03149549|590101505|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
163380243|NCT03149549|590101506|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
163380244|NCT03149549|590101507|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
163380245|NCT03149549|590101508|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
163380246|NCT03149549|590101509|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
163380247|NCT03149549|590101510|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
163380248|NCT03149549|590101511|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
163380249|NCT03149549|590101512|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
163380250|NCT03149549|590101513|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
163380251|NCT03149549|590101501|FG000|Study Discontinuation--Treatment Period|Other|0|||
163380252|NCT03149549|590101502|FG001|Study Discontinuation--Treatment Period|Other|0|||
163380253|NCT03149549|590101503|FG002|Study Discontinuation--Treatment Period|Other|0|||
163380254|NCT03149549|590101504|FG003|Study Discontinuation--Treatment Period|Other|0|||
163380255|NCT03149549|590101505|FG004|Study Discontinuation--Treatment Period|Other|0|||
163380256|NCT03149549|590101506|FG005|Study Discontinuation--Treatment Period|Other|0|||
163380257|NCT03149549|590101507|FG006|Study Discontinuation--Treatment Period|Other|0|||
163380258|NCT03149549|590101508|FG007|Study Discontinuation--Treatment Period|Other|1|||
163380259|NCT03149549|590101509|FG008|Study Discontinuation--Treatment Period|Other|0|||
163380260|NCT03149549|590101510|FG009|Study Discontinuation--Treatment Period|Other|1|||
163380261|NCT03149549|590101511|FG010|Study Discontinuation--Treatment Period|Other|0|||
163380262|NCT03149549|590101512|FG011|Study Discontinuation--Treatment Period|Other|0|||
163380263|NCT03149549|590101513|FG012|Study Discontinuation--Treatment Period|Other|0|||
163380264|NCT03149549|590101501|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163380265|NCT03149549|590101502|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163380266|NCT03149549|590101503|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163380267|NCT03149549|590101504|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163380268|NCT03149549|590101505|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163417292|NCT00820755|590234039|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
163417293|NCT00820755|590234040|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
163417294|NCT00820755|590234038|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
163417295|NCT00820755|590234039|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
163417296|NCT00820755|590234040|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
163417297|NCT00820755|590234038|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
163417298|NCT00820755|590234039|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
163417299|NCT00820755|590234040|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
163417300|NCT00820755|590234038|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
163417301|NCT00820755|590234039|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
163417302|NCT00820755|590234040|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
163417303|NCT00820755|590234038|FG000|Period 1: Combination Therapy Phase|Other|11|||
163417304|NCT00820755|590234039|FG001|Period 1: Combination Therapy Phase|Other|0|||
163417305|NCT00820755|590234040|FG002|Period 1: Combination Therapy Phase|Other|0|||
163417306|NCT00820755|590234038|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
163417307|NCT00820755|590234039|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
163417308|NCT00820755|590234040|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
163417309|NCT01486199|590234041|FG000|Two Year Period Between Study Days|Physician Decision|1|||
163417310|NCT01486199|590234042|FG001|Two Year Period Between Study Days|Physician Decision|0|||
163417311|NCT03604445|590234046|FG000|Overall Study|Death|0|||
163417312|NCT03604445|590234047|FG001|Overall Study|Death|0|||
163417313|NCT03604445|590234048|FG002|Overall Study|Death|0|||
163417314|NCT03604445|590234049|FG003|Overall Study|Death|0|||
163417315|NCT03604445|590234050|FG004|Overall Study|Death|0|||
163417316|NCT03604445|590234051|FG005|Overall Study|Death|0|||
163417317|NCT03604445|590234052|FG006|Overall Study|Death|0|||
163417318|NCT03604445|590234053|FG007|Overall Study|Death|0|||
163417319|NCT03604445|590234054|FG008|Overall Study|Death|1|||
163417320|NCT03604445|590234046|FG000|Overall Study|Withdrawal by Subject|0|||
163417321|NCT03604445|590234047|FG001|Overall Study|Withdrawal by Subject|0|||
163417322|NCT03604445|590234048|FG002|Overall Study|Withdrawal by Subject|0|||
163417323|NCT03604445|590234049|FG003|Overall Study|Withdrawal by Subject|0|||
163417324|NCT03604445|590234050|FG004|Overall Study|Withdrawal by Subject|0|||
163417325|NCT03604445|590234051|FG005|Overall Study|Withdrawal by Subject|0|||
163417326|NCT03604445|590234052|FG006|Overall Study|Withdrawal by Subject|1|||
163417327|NCT03604445|590234053|FG007|Overall Study|Withdrawal by Subject|0|||
163417328|NCT03604445|590234054|FG008|Overall Study|Withdrawal by Subject|0|||
163417329|NCT03604445|590234046|FG000|Overall Study|Missing visit|0|||
163417330|NCT03604445|590234047|FG001|Overall Study|Missing visit|0|||
163417331|NCT03604445|590234048|FG002|Overall Study|Missing visit|0|||
163417332|NCT03604445|590234049|FG003|Overall Study|Missing visit|0|||
163417333|NCT03604445|590234050|FG004|Overall Study|Missing visit|0|||
163417334|NCT03604445|590234051|FG005|Overall Study|Missing visit|1|||
163417335|NCT03604445|590234052|FG006|Overall Study|Missing visit|0|||
163417336|NCT03604445|590234053|FG007|Overall Study|Missing visit|1|||
163417337|NCT03604445|590234054|FG008|Overall Study|Missing visit|0|||
163417338|NCT03604445|590234046|FG000|Overall Study|Adverse Event|0|||
163417339|NCT03604445|590234047|FG001|Overall Study|Adverse Event|0|||
163417340|NCT03604445|590234048|FG002|Overall Study|Adverse Event|0|||
163417341|NCT03604445|590234049|FG003|Overall Study|Adverse Event|1|||
163417342|NCT03604445|590234050|FG004|Overall Study|Adverse Event|0|||
163417343|NCT03604445|590234051|FG005|Overall Study|Adverse Event|0|||
163417344|NCT03604445|590234052|FG006|Overall Study|Adverse Event|0|||
163417345|NCT03604445|590234053|FG007|Overall Study|Adverse Event|0|||
163380269|NCT03149549|590101506|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
163380270|NCT03149549|590101507|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
163380271|NCT03149549|590101508|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163417346|NCT03604445|590234054|FG008|Overall Study|Adverse Event|1|||
163417347|NCT02154425|590234055|FG000|Screening Period|Adverse Event|1|||
163417348|NCT00480857|590234058|FG000|Overall Study|Lack of Efficacy|2|||
163417349|NCT00611247|590234061|FG000|Overall Study|Death|1|||
163417350|NCT00611247|590234062|FG001|Overall Study|Death|5|||
163417351|NCT00611247|590234061|FG000|Overall Study|Lack of Efficacy|1|||
163417352|NCT00611247|590234062|FG001|Overall Study|Lack of Efficacy|16|||
163417353|NCT02551159|590234065|FG000|Overall Study|Death|352|||
163417354|NCT02551159|590234066|FG001|Overall Study|Death|174|||
163417355|NCT02551159|590234067|FG002|Overall Study|Death|161|||
163417356|NCT02551159|590234065|FG000|Overall Study|Withdrawal by Subject|8|||
163380272|NCT03149549|590101509|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
163380273|NCT03149549|590101510|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163380274|NCT03149549|590101511|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163380275|NCT03149549|590101512|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163380276|NCT03149549|590101513|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163380277|NCT03149549|590101501|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163380278|NCT03149549|590101502|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163380279|NCT03149549|590101503|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163380280|NCT03149549|590101504|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163380281|NCT03149549|590101505|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
163380282|NCT03149549|590101506|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163380283|NCT03149549|590101507|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163380284|NCT03149549|590101508|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
163380285|NCT03149549|590101509|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
163380286|NCT03149549|590101510|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163380287|NCT03149549|590101511|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163380288|NCT03149549|590101512|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
163380289|NCT03149549|590101513|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
163380290|NCT03149549|590101501|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
163380291|NCT03149549|590101502|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
163380292|NCT03149549|590101503|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
163380293|NCT03149549|590101504|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
163380294|NCT03149549|590101505|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
163380295|NCT03149549|590101506|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
163380296|NCT03149549|590101507|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
163380297|NCT03149549|590101508|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
163380298|NCT03149549|590101509|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
163380299|NCT03149549|590101510|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
163380300|NCT03149549|590101511|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
163380301|NCT03149549|590101512|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
163380302|NCT03149549|590101513|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
163380303|NCT03149549|590101501|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
163380304|NCT03149549|590101502|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
163380305|NCT03149549|590101503|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
163380306|NCT03149549|590101504|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
163380307|NCT03149549|590101505|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
163380308|NCT03149549|590101506|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
163380309|NCT03149549|590101507|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
163380310|NCT03149549|590101508|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
163380311|NCT03149549|590101509|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
163380312|NCT03149549|590101510|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
163380313|NCT03149549|590101511|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
163380314|NCT03149549|590101512|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
163380315|NCT03149549|590101513|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
163380316|NCT03149549|590101501|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
163380317|NCT03149549|590101502|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
163380318|NCT03149549|590101503|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
163380319|NCT03149549|590101504|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
163380320|NCT03149549|590101505|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
163380321|NCT03149549|590101506|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
163380322|NCT03149549|590101507|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
163380323|NCT03149549|590101508|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
163380324|NCT03149549|590101509|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
163380325|NCT03149549|590101510|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
163380326|NCT03149549|590101511|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
163380327|NCT03149549|590101512|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
163380328|NCT03149549|590101513|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
163380329|NCT03141905|590101514|FG000|Overall Study|Death|3|||
163380330|NCT03141905|590101515|FG001|Overall Study|Death|2|||
163380331|NCT03141905|590101514|FG000|Overall Study|Withdrawal by Subject|1|||
163380332|NCT03141905|590101515|FG001|Overall Study|Withdrawal by Subject|0|||
163380333|NCT03141905|590101514|FG000|Overall Study|Lost to Follow-up|3|||
163380334|NCT03141905|590101515|FG001|Overall Study|Lost to Follow-up|7|||
163380335|NCT03141905|590101514|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
163380336|NCT03141905|590101515|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
163380337|NCT05180500|590101516|FG000|Overall Study|Adverse Event|1|||
163380338|NCT05180500|590101517|FG001|Overall Study|Adverse Event|0|||
163380339|NCT05180500|590101516|FG000|Overall Study|Withdrawal by Subject|2|||
163380340|NCT05180500|590101517|FG001|Overall Study|Withdrawal by Subject|0|||
163380341|NCT04927884|590101522|FG000|Overall Study|Progressive Disease|2|||
163380342|NCT01775124|590101523|FG000|Core Period|Disease Progression|0|||
163380343|NCT01775124|590101524|FG001|Core Period|Disease Progression|1|||
163380344|NCT01775124|590101523|FG000|Core Period|Physician Decision|1|||
163380345|NCT01775124|590101524|FG001|Core Period|Physician Decision|1|||
163380346|NCT01775124|590101523|FG000|Core Period|Death|0|||
163380347|NCT01775124|590101524|FG001|Core Period|Death|1|||
163380348|NCT01775124|590101523|FG000|Core Period|Administrative problems|1|||
163380349|NCT01775124|590101524|FG001|Core Period|Administrative problems|0|||
163380350|NCT01775124|590101523|FG000|Core Period|Withdrawal by Subject|4|||
163380351|NCT01775124|590101524|FG001|Core Period|Withdrawal by Subject|2|||
163380352|NCT01775124|590101523|FG000|Core Period|Adverse Event|5|||
163380353|NCT01775124|590101524|FG001|Core Period|Adverse Event|5|||
163380354|NCT01775124|590101523|FG000|Extension Period|Adverse Event|3|||
163380355|NCT01775124|590101524|FG001|Extension Period|Adverse Event|2|||
163380356|NCT01775124|590101523|FG000|Extension Period|Physician Decision|0|||
163380357|NCT01775124|590101524|FG001|Extension Period|Physician Decision|2|||
163380358|NCT01775124|590101523|FG000|Extension Period|Administrative problems|0|||
163380359|NCT01775124|590101524|FG001|Extension Period|Administrative problems|1|||
163380360|NCT01775124|590101523|FG000|Extension Period|Lost to Follow-up|0|||
163380361|NCT01775124|590101524|FG001|Extension Period|Lost to Follow-up|1|||
163380362|NCT01775124|590101523|FG000|Extension Period|Withdrawal by Subject|9|||
163380363|NCT01775124|590101524|FG001|Extension Period|Withdrawal by Subject|12|||
163380364|NCT05917470|590101525|FG000|Overall Study|Progressive Disease|1|||
163380365|NCT05917470|590101526|FG001|Overall Study|Progressive Disease|1|||
163380366|NCT05917470|590101527|FG002|Overall Study|Progressive Disease|2|||
163380367|NCT05917470|590101528|FG003|Overall Study|Progressive Disease|3|||
163380368|NCT05917470|590101529|FG004|Overall Study|Progressive Disease|1|||
163380369|NCT05917470|590101530|FG005|Overall Study|Progressive Disease|1|||
163380370|NCT05917470|590101531|FG006|Overall Study|Progressive Disease|0|||
163380371|NCT05917470|590101532|FG007|Overall Study|Progressive Disease|0|||
163380372|NCT05917470|590101525|FG000|Overall Study|Withdrawal by Subject|0|||
163380373|NCT05917470|590101526|FG001|Overall Study|Withdrawal by Subject|0|||
163380374|NCT05917470|590101527|FG002|Overall Study|Withdrawal by Subject|1|||
163380375|NCT05917470|590101528|FG003|Overall Study|Withdrawal by Subject|0|||
163380376|NCT05917470|590101529|FG004|Overall Study|Withdrawal by Subject|0|||
163380377|NCT05917470|590101530|FG005|Overall Study|Withdrawal by Subject|0|||
163380378|NCT05917470|590101531|FG006|Overall Study|Withdrawal by Subject|0|||
163380379|NCT05917470|590101532|FG007|Overall Study|Withdrawal by Subject|0|||
163380380|NCT05917470|590101525|FG000|Overall Study|Sponsor Decision|0|||
163380381|NCT05917470|590101526|FG001|Overall Study|Sponsor Decision|0|||
163380382|NCT05917470|590101527|FG002|Overall Study|Sponsor Decision|1|||
163380383|NCT05917470|590101528|FG003|Overall Study|Sponsor Decision|0|||
163380384|NCT05917470|590101529|FG004|Overall Study|Sponsor Decision|2|||
163380385|NCT05917470|590101530|FG005|Overall Study|Sponsor Decision|1|||
163380386|NCT05917470|590101531|FG006|Overall Study|Sponsor Decision|3|||
163380387|NCT05917470|590101532|FG007|Overall Study|Sponsor Decision|3|||
163380388|NCT05917470|590101525|FG000|Overall Study|Adverse Event|0|||
163380389|NCT05917470|590101526|FG001|Overall Study|Adverse Event|0|||
163380390|NCT05917470|590101527|FG002|Overall Study|Adverse Event|0|||
163380391|NCT05917470|590101528|FG003|Overall Study|Adverse Event|0|||
163380392|NCT05917470|590101529|FG004|Overall Study|Adverse Event|0|||
163380393|NCT05917470|590101530|FG005|Overall Study|Adverse Event|1|||
163380394|NCT05917470|590101531|FG006|Overall Study|Adverse Event|0|||
163380395|NCT05917470|590101532|FG007|Overall Study|Adverse Event|0|||
163380396|NCT02317432|590101533|FG000|Overall Study|Death|4|||
163380397|NCT02317432|590101534|FG001|Overall Study|Death|1|||
163380398|NCT02317432|590101533|FG000|Overall Study|Lost to Follow-up|0|||
163380399|NCT02317432|590101534|FG001|Overall Study|Lost to Follow-up|5|||
163380400|NCT02317432|590101533|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
163380401|NCT02317432|590101534|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
163380402|NCT01328717|590103726|FG000|Overall Study|Adverse Event|1|||
163380403|NCT00346268|590103727|FG000|Overall Study|Adverse Event|1|||
163380404|NCT00346268|590103728|FG001|Overall Study|Adverse Event|0|||
163380405|NCT00346268|590103727|FG000|Overall Study|Protocol Violation|1|||
163380406|NCT00346268|590103728|FG001|Overall Study|Protocol Violation|0|||
163380407|NCT00346268|590103727|FG000|Overall Study|Participant refused|0|||
163380408|NCT00346268|590103728|FG001|Overall Study|Participant refused|3|||
163380409|NCT01036763|590103729|FG000|Overall Study|Adverse Event|25|||
163380410|NCT01036763|590103729|FG000|Overall Study|Lost to Follow-up|28|||
163380411|NCT01036763|590103729|FG000|Overall Study|Other reason (not specified)|40|||
163380412|NCT01177722|590103732|FG000|Overall Study|Serious Adverse Event|0|||
163380413|NCT01177722|590103733|FG001|Overall Study|Serious Adverse Event|0|||
163380414|NCT01177722|590103734|FG002|Overall Study|Serious Adverse Event|1|||
163380415|NCT01177722|590103735|FG003|Overall Study|Serious Adverse Event|0|||
163417357|NCT02551159|590234066|FG001|Overall Study|Withdrawal by Subject|5|||
163417358|NCT02551159|590234067|FG002|Overall Study|Withdrawal by Subject|16|||
163417359|NCT02551159|590234065|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
163417360|NCT02551159|590234066|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
163417361|NCT02551159|590234067|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
163417362|NCT00243659|590234068|FG000|Overall Study|Withdrawal by Subject|1|||
163417363|NCT00243659|590234069|FG001|Overall Study|Withdrawal by Subject|1|||
163417364|NCT00243659|590234068|FG000|Overall Study|Protocol Violation|1|||
163417365|NCT00243659|590234069|FG001|Overall Study|Protocol Violation|2|||
163417366|NCT06098729|590234070|FG000|Overall Study|Withdrawal by Subject|1|||
163417367|NCT01890421|590234076|FG000|Overall Study|Adverse Event|1|||
163417368|NCT01890421|590234076|FG000|Overall Study|Other reason|10|||
163417369|NCT02026063|590234082|FG000|Overall Study|Physician Decision|0|||
163417370|NCT02026063|590234083|FG001|Overall Study|Physician Decision|10|||
163417371|NCT02026063|590234082|FG000|Overall Study|Noncompliance with Study Drug|1|||
163417372|NCT02026063|590234083|FG001|Overall Study|Noncompliance with Study Drug|1|||
163417373|NCT02026063|590234082|FG000|Overall Study|Withdrawal of Consent|1|||
163417374|NCT02026063|590234083|FG001|Overall Study|Withdrawal of Consent|6|||
163417375|NCT02026063|590234082|FG000|Overall Study|Adverse Event|5|||
163417376|NCT02026063|590234083|FG001|Overall Study|Adverse Event|20|||
163417377|NCT02026063|590234082|FG000|Overall Study|Lack of Efficacy|0|||
163417378|NCT02026063|590234083|FG001|Overall Study|Lack of Efficacy|4|||
163417379|NCT02026063|590234082|FG000|Overall Study|Lost to Follow-up|0|||
163417380|NCT02026063|590234083|FG001|Overall Study|Lost to Follow-up|1|||
163417381|NCT02026063|590234082|FG000|Overall Study|Reason not Specified|2|||
163417382|NCT02026063|590234083|FG001|Overall Study|Reason not Specified|7|||
163417383|NCT05499520|590235962|FG000|Overall Study|Lost to Follow-up|0|||
163417384|NCT05499520|590235963|FG001|Overall Study|Lost to Follow-up|0|||
163417385|NCT05499520|590235964|FG002|Overall Study|Lost to Follow-up|38|||
163417386|NCT05499520|590235965|FG003|Overall Study|Lost to Follow-up|41|||
163417387|NCT05499520|590235966|FG004|Overall Study|Lost to Follow-up|46|||
163417388|NCT05499520|590235967|FG005|Overall Study|Lost to Follow-up|0|||
163417389|NCT05499520|590235968|FG006|Overall Study|Lost to Follow-up|31|||
163417390|NCT05499520|590235969|FG007|Overall Study|Lost to Follow-up|45|||
163417391|NCT05499520|590235970|FG008|Overall Study|Lost to Follow-up|42|||
163417392|NCT05499520|590235971|FG009|Overall Study|Lost to Follow-up|0|||
163417393|NCT05499520|590235972|FG010|Overall Study|Lost to Follow-up|0|||
163417394|NCT05499520|590235973|FG011|Overall Study|Lost to Follow-up|37|||
163417395|NCT05499520|590235974|FG012|Overall Study|Lost to Follow-up|53|||
163417396|NCT05499520|590235975|FG013|Overall Study|Lost to Follow-up|49|||
163417397|NCT05499520|590235976|FG014|Overall Study|Lost to Follow-up|0|||
163417398|NCT05499520|590235977|FG015|Overall Study|Lost to Follow-up|36|||
163417399|NCT05499520|590235978|FG016|Overall Study|Lost to Follow-up|58|||
163417400|NCT05499520|590235979|FG017|Overall Study|Lost to Follow-up|53|||
163417401|NCT00793793|590235980|FG000|Overall Study|Adverse Event|0|||
163380416|NCT01177722|590103732|FG000|Overall Study|Protocol Violation|0|||
163380417|NCT01177722|590103733|FG001|Overall Study|Protocol Violation|0|||
163380418|NCT01177722|590103734|FG002|Overall Study|Protocol Violation|1|||
163380419|NCT01177722|590103735|FG003|Overall Study|Protocol Violation|0|||
163380420|NCT01177722|590103732|FG000|Overall Study|Lost to Follow-up|3|||
163380421|NCT01177722|590103733|FG001|Overall Study|Lost to Follow-up|4|||
163380422|NCT01177722|590103734|FG002|Overall Study|Lost to Follow-up|3|||
163380423|NCT01177722|590103735|FG003|Overall Study|Lost to Follow-up|1|||
163380424|NCT01177722|590103732|FG000|Overall Study|Withdrawal by Subject|10|||
163380425|NCT01177722|590103733|FG001|Overall Study|Withdrawal by Subject|6|||
163380426|NCT01177722|590103734|FG002|Overall Study|Withdrawal by Subject|4|||
163380427|NCT01177722|590103735|FG003|Overall Study|Withdrawal by Subject|6|||
163380428|NCT02831387|590103736|FG000|Overall Study|Withdrawal by Subject|1|||
163380429|NCT02831387|590103737|FG001|Overall Study|Withdrawal by Subject|1|||
163380430|NCT02831387|590103736|FG000|Overall Study|Discontinued due to stock recovery|0|||
163380431|NCT02831387|590103737|FG001|Overall Study|Discontinued due to stock recovery|1|||
163380432|NCT00192647|590103738|FG000|Overall Study|Death|1|||
163380433|NCT00192647|590103739|FG001|Overall Study|Death|1|||
163380434|NCT00192647|590103738|FG000|Overall Study|Adverse Event|35|||
163380435|NCT00192647|590103739|FG001|Overall Study|Adverse Event|29|||
163380436|NCT00192647|590103738|FG000|Overall Study|Laboratory Test Abnormality|4|||
163380437|NCT00192647|590103739|FG001|Overall Study|Laboratory Test Abnormality|2|||
163380438|NCT00192647|590103738|FG000|Overall Study|Insufficient Therapeutic Response|53|||
163380439|NCT00192647|590103739|FG001|Overall Study|Insufficient Therapeutic Response|83|||
163417402|NCT00793793|590235981|FG001|Overall Study|Adverse Event|0|||
163417403|NCT00793793|590235982|FG002|Overall Study|Adverse Event|1|||
163417404|NCT00793793|590235983|FG003|Overall Study|Adverse Event|1|||
163417405|NCT00793793|590235984|FG004|Overall Study|Adverse Event|0|||
163417406|NCT00793793|590235985|FG005|Overall Study|Adverse Event|1|||
163417407|NCT00793793|590235986|FG006|Overall Study|Adverse Event|2|||
163417408|NCT00793793|590235987|FG007|Overall Study|Adverse Event|0|||
163417409|NCT00793793|590235988|FG008|Overall Study|Adverse Event|0|||
163417410|NCT00793793|590235989|FG009|Overall Study|Adverse Event|0|||
163380440|NCT00192647|590103738|FG000|Overall Study|Entry Criteria Violation|6|||
163380441|NCT00192647|590103739|FG001|Overall Study|Entry Criteria Violation|6|||
163380442|NCT00192647|590103738|FG000|Overall Study|Protocol Violation|3|||
163380443|NCT00192647|590103739|FG001|Overall Study|Protocol Violation|1|||
163380444|NCT00192647|590103738|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
163380445|NCT00192647|590103739|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
163380446|NCT00192647|590103738|FG000|Overall Study|Failure to Return|11|||
163380447|NCT00192647|590103739|FG001|Overall Study|Failure to Return|13|||
163380448|NCT00192647|590103738|FG000|Overall Study|Other/Administrative|5|||
163380449|NCT00192647|590103739|FG001|Overall Study|Other/Administrative|3|||
163380450|NCT01828073|590103740|FG000|Overall Study|Lost to Follow-up|1|||
163380451|NCT01828073|590103741|FG001|Overall Study|Lost to Follow-up|2|||
163380452|NCT05220254|590103746|FG000|Overall Study|Withdrawal by Subject|4|||
163380453|NCT05220254|590103746|FG000|Overall Study|Removed due to ineligibility|1|||
163380454|NCT05220254|590103746|FG000|Overall Study|Lost to Follow-up|7|||
163380455|NCT01557283|590103749|FG000|Overall Study|Lost to Follow-up|7|||
163380456|NCT01557283|590103749|FG000|Overall Study|Non-responder|19|||
163380457|NCT01557283|590103749|FG000|Overall Study|Adverse Event|7|||
163380458|NCT01557283|590103749|FG000|Overall Study|Lack of Efficacy|1|||
163380459|NCT01557283|590103749|FG000|Overall Study|Non-compliance|1|||
163380460|NCT01557283|590103749|FG000|Overall Study|Withdrawal by Subject|1|||
163380461|NCT01557283|590103749|FG000|Overall Study|Participant's weight too high for dose|1|||
163380462|NCT01557283|590103749|FG000|Overall Study|Worsening of psoriasis|1|||
163380463|NCT01557283|590103749|FG000|Overall Study|Other|6|||
163380464|NCT01765192|590103750|FG000|Treatment Period 1|Adverse Event|0|||
163380465|NCT01765192|590103751|FG001|Treatment Period 1|Adverse Event|1|||
163380466|NCT01765192|590103750|FG000|Washout Period|Voluntary Withdrawal|1|||
163380467|NCT01765192|590103751|FG001|Washout Period|Voluntary Withdrawal|1|||
163380468|NCT01765192|590103750|FG000|Washout Period|Reason not specified|1|||
163380469|NCT01765192|590103751|FG001|Washout Period|Reason not specified|0|||
163380470|NCT01765192|590103750|FG000|Treatment Period 2|Reason not specified|0|||
163380471|NCT01765192|590103751|FG001|Treatment Period 2|Reason not specified|2|||
163380472|NCT01765192|590103750|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
163380473|NCT01765192|590103751|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
163380474|NCT01016977|590103754|FG000|Overall Study|Lost to Follow-up|1|||
163380475|NCT01016977|590103755|FG001|Overall Study|Lost to Follow-up|0|||
163380476|NCT01016977|590103754|FG000|Overall Study|Withdrawal by Subject|2|||
163380477|NCT01016977|590103755|FG001|Overall Study|Withdrawal by Subject|2|||
163380478|NCT02080221|590103756|FG000|Overall Study|Withdrawal by Subject|1|||
163380479|NCT02080221|590103756|FG000|Overall Study|Clinical Progression of Disease|1|||
163380480|NCT03184870|590103762|FG000|Initial Treatment|Death|6|||
163380481|NCT03184870|590103763|FG001|Initial Treatment|Death|6|||
163380482|NCT03184870|590103764|FG002|Initial Treatment|Death|8|||
163380483|NCT03184870|590103765|FG003|Initial Treatment|Death|8|||
163380484|NCT03184870|590103766|FG004|Initial Treatment|Death|6|||
163380485|NCT03184870|590103767|FG005|Initial Treatment|Death|6|||
163380486|NCT03184870|590103768|FG006|Initial Treatment|Death|6|||
163380487|NCT03184870|590103769|FG007|Initial Treatment|Death|7|||
163380488|NCT03184870|590103770|FG008|Initial Treatment|Death|1|||
163380489|NCT03184870|590103771|FG009|Initial Treatment|Death|2|||
163380490|NCT03184870|590103772|FG010|Initial Treatment|Death|26|||
163380491|NCT03184870|590103773|FG011|Initial Treatment|Death|28|||
163380492|NCT03184870|590103774|FG012|Initial Treatment|Death|10|||
163380493|NCT03184870|590103775|FG013|Initial Treatment|Death|33|||
163380494|NCT03184870|590103776|FG014|Initial Treatment|Death|34|||
163380495|NCT03184870|590103777|FG015|Initial Treatment|Death|26|||
163380496|NCT03184870|590103778|FG016|Initial Treatment|Death|20|||
163380497|NCT03184870|590103779|FG017|Initial Treatment|Death|18|||
163380498|NCT03184870|590103762|FG000|Initial Treatment|Other Reasons|2|||
163380499|NCT03184870|590103763|FG001|Initial Treatment|Other Reasons|2|||
163380500|NCT03184870|590103764|FG002|Initial Treatment|Other Reasons|0|||
163380501|NCT03184870|590103765|FG003|Initial Treatment|Other Reasons|1|||
163380502|NCT03184870|590103766|FG004|Initial Treatment|Other Reasons|0|||
163380503|NCT03184870|590103767|FG005|Initial Treatment|Other Reasons|0|||
163380504|NCT03184870|590103768|FG006|Initial Treatment|Other Reasons|0|||
163380505|NCT03184870|590103769|FG007|Initial Treatment|Other Reasons|2|||
163380506|NCT03184870|590103770|FG008|Initial Treatment|Other Reasons|0|||
163380507|NCT03184870|590103771|FG009|Initial Treatment|Other Reasons|0|||
163380508|NCT03184870|590103772|FG010|Initial Treatment|Other Reasons|4|||
163380509|NCT03184870|590103773|FG011|Initial Treatment|Other Reasons|2|||
163380510|NCT03184870|590103774|FG012|Initial Treatment|Other Reasons|2|||
163380511|NCT03184870|590103775|FG013|Initial Treatment|Other Reasons|0|||
163380512|NCT03184870|590103776|FG014|Initial Treatment|Other Reasons|0|||
163380513|NCT03184870|590103777|FG015|Initial Treatment|Other Reasons|1|||
163380514|NCT03184870|590103778|FG016|Initial Treatment|Other Reasons|0|||
163380515|NCT03184870|590103779|FG017|Initial Treatment|Other Reasons|2|||
163380516|NCT03184870|590103762|FG000|Initial Treatment|Lost to Follow-up|2|||
163380517|NCT03184870|590103763|FG001|Initial Treatment|Lost to Follow-up|0|||
163380518|NCT03184870|590103764|FG002|Initial Treatment|Lost to Follow-up|0|||
163380519|NCT03184870|590103765|FG003|Initial Treatment|Lost to Follow-up|1|||
163380520|NCT03184870|590103766|FG004|Initial Treatment|Lost to Follow-up|1|||
163380521|NCT03184870|590103767|FG005|Initial Treatment|Lost to Follow-up|1|||
163380522|NCT03184870|590103768|FG006|Initial Treatment|Lost to Follow-up|0|||
163380523|NCT03184870|590103769|FG007|Initial Treatment|Lost to Follow-up|2|||
163380524|NCT03184870|590103770|FG008|Initial Treatment|Lost to Follow-up|0|||
163380525|NCT03184870|590103771|FG009|Initial Treatment|Lost to Follow-up|0|||
163380526|NCT03184870|590103772|FG010|Initial Treatment|Lost to Follow-up|2|||
163380527|NCT03184870|590103773|FG011|Initial Treatment|Lost to Follow-up|0|||
163380528|NCT03184870|590103774|FG012|Initial Treatment|Lost to Follow-up|2|||
163380529|NCT03184870|590103775|FG013|Initial Treatment|Lost to Follow-up|2|||
163380530|NCT03184870|590103776|FG014|Initial Treatment|Lost to Follow-up|0|||
163380531|NCT03184870|590103777|FG015|Initial Treatment|Lost to Follow-up|0|||
163380532|NCT03184870|590103778|FG016|Initial Treatment|Lost to Follow-up|2|||
163380533|NCT03184870|590103779|FG017|Initial Treatment|Lost to Follow-up|2|||
163380534|NCT03184870|590103762|FG000|Initial Treatment|Withdrawal by Subject|0|||
163380535|NCT03184870|590103763|FG001|Initial Treatment|Withdrawal by Subject|0|||
163380536|NCT03184870|590103764|FG002|Initial Treatment|Withdrawal by Subject|2|||
163380537|NCT03184870|590103765|FG003|Initial Treatment|Withdrawal by Subject|1|||
163380538|NCT03184870|590103766|FG004|Initial Treatment|Withdrawal by Subject|1|||
163380539|NCT03184870|590103767|FG005|Initial Treatment|Withdrawal by Subject|0|||
163380540|NCT03184870|590103768|FG006|Initial Treatment|Withdrawal by Subject|1|||
163380541|NCT03184870|590103769|FG007|Initial Treatment|Withdrawal by Subject|0|||
163380542|NCT03184870|590103770|FG008|Initial Treatment|Withdrawal by Subject|0|||
163380543|NCT03184870|590103771|FG009|Initial Treatment|Withdrawal by Subject|0|||
163380544|NCT03184870|590103772|FG010|Initial Treatment|Withdrawal by Subject|0|||
163380545|NCT03184870|590103773|FG011|Initial Treatment|Withdrawal by Subject|2|||
163380546|NCT03184870|590103774|FG012|Initial Treatment|Withdrawal by Subject|3|||
163380547|NCT03184870|590103775|FG013|Initial Treatment|Withdrawal by Subject|0|||
163380548|NCT03184870|590103776|FG014|Initial Treatment|Withdrawal by Subject|1|||
163380549|NCT03184870|590103777|FG015|Initial Treatment|Withdrawal by Subject|5|||
163380550|NCT03184870|590103778|FG016|Initial Treatment|Withdrawal by Subject|2|||
163380551|NCT03184870|590103779|FG017|Initial Treatment|Withdrawal by Subject|2|||
163380552|NCT03184870|590103762|FG000|Initial Treatment|Moved to crossover treatment|0|||
163380553|NCT03184870|590103763|FG001|Initial Treatment|Moved to crossover treatment|0|||
163380554|NCT03184870|590103764|FG002|Initial Treatment|Moved to crossover treatment|0|||
163380555|NCT03184870|590103765|FG003|Initial Treatment|Moved to crossover treatment|0|||
163380556|NCT03184870|590103766|FG004|Initial Treatment|Moved to crossover treatment|0|||
163380557|NCT03184870|590103767|FG005|Initial Treatment|Moved to crossover treatment|0|||
163380558|NCT03184870|590103768|FG006|Initial Treatment|Moved to crossover treatment|0|||
163380559|NCT03184870|590103769|FG007|Initial Treatment|Moved to crossover treatment|0|||
163380560|NCT03184870|590103770|FG008|Initial Treatment|Moved to crossover treatment|0|||
163380561|NCT03184870|590103771|FG009|Initial Treatment|Moved to crossover treatment|0|||
163380562|NCT03184870|590103772|FG010|Initial Treatment|Moved to crossover treatment|0|||
163380563|NCT03184870|590103773|FG011|Initial Treatment|Moved to crossover treatment|0|||
163380564|NCT03184870|590103774|FG012|Initial Treatment|Moved to crossover treatment|9|||
163380565|NCT03184870|590103775|FG013|Initial Treatment|Moved to crossover treatment|0|||
163380566|NCT03184870|590103776|FG014|Initial Treatment|Moved to crossover treatment|0|||
163380567|NCT03184870|590103777|FG015|Initial Treatment|Moved to crossover treatment|0|||
163380568|NCT03184870|590103778|FG016|Initial Treatment|Moved to crossover treatment|0|||
163380569|NCT03184870|590103779|FG017|Initial Treatment|Moved to crossover treatment|0|||
163380570|NCT03184870|590103762|FG000|Crossover Treatment|Other reasons|0|||
163380571|NCT03184870|590103763|FG001|Crossover Treatment|Other reasons|0|||
163380572|NCT03184870|590103764|FG002|Crossover Treatment|Other reasons|0|||
163380573|NCT03184870|590103765|FG003|Crossover Treatment|Other reasons|0|||
163380574|NCT03184870|590103766|FG004|Crossover Treatment|Other reasons|0|||
163380575|NCT03184870|590103767|FG005|Crossover Treatment|Other reasons|0|||
163380576|NCT03184870|590103768|FG006|Crossover Treatment|Other reasons|0|||
163380577|NCT03184870|590103769|FG007|Crossover Treatment|Other reasons|0|||
163380578|NCT03184870|590103770|FG008|Crossover Treatment|Other reasons|0|||
163380579|NCT03184870|590103771|FG009|Crossover Treatment|Other reasons|0|||
163380580|NCT03184870|590103772|FG010|Crossover Treatment|Other reasons|0|||
163380581|NCT03184870|590103773|FG011|Crossover Treatment|Other reasons|0|||
163380582|NCT03184870|590103774|FG012|Crossover Treatment|Other reasons|0|||
163380583|NCT03184870|590103775|FG013|Crossover Treatment|Other reasons|0|||
163380584|NCT03184870|590103776|FG014|Crossover Treatment|Other reasons|0|||
163380585|NCT03184870|590103777|FG015|Crossover Treatment|Other reasons|0|||
163380586|NCT03184870|590103778|FG016|Crossover Treatment|Other reasons|0|||
163380587|NCT03184870|590103779|FG017|Crossover Treatment|Other reasons|2|||
163380588|NCT03184870|590103762|FG000|Crossover Treatment|Death|0|||
163380589|NCT03184870|590103763|FG001|Crossover Treatment|Death|0|||
163380590|NCT03184870|590103764|FG002|Crossover Treatment|Death|0|||
163380591|NCT03184870|590103765|FG003|Crossover Treatment|Death|0|||
163380592|NCT03184870|590103766|FG004|Crossover Treatment|Death|0|||
163380593|NCT03184870|590103767|FG005|Crossover Treatment|Death|0|||
163380594|NCT03184870|590103768|FG006|Crossover Treatment|Death|0|||
163380595|NCT03184870|590103769|FG007|Crossover Treatment|Death|0|||
163380596|NCT03184870|590103770|FG008|Crossover Treatment|Death|0|||
163380597|NCT03184870|590103771|FG009|Crossover Treatment|Death|0|||
163380598|NCT03184870|590103772|FG010|Crossover Treatment|Death|0|||
163380599|NCT03184870|590103773|FG011|Crossover Treatment|Death|0|||
163380600|NCT03184870|590103774|FG012|Crossover Treatment|Death|0|||
163380601|NCT03184870|590103775|FG013|Crossover Treatment|Death|0|||
163380602|NCT03184870|590103776|FG014|Crossover Treatment|Death|0|||
163380603|NCT03184870|590103777|FG015|Crossover Treatment|Death|0|||
163380604|NCT03184870|590103778|FG016|Crossover Treatment|Death|0|||
163380605|NCT03184870|590103779|FG017|Crossover Treatment|Death|7|||
163380606|NCT05081388|590103780|FG000|Overall Study|Adverse Event|1|||
163380607|NCT05081388|590103781|FG001|Overall Study|Adverse Event|0|||
163380608|NCT05081388|590103782|FG002|Overall Study|Adverse Event|0|||
163380609|NCT05081388|590103783|FG003|Overall Study|Adverse Event|0|||
163380610|NCT05081388|590103784|FG004|Overall Study|Adverse Event|0|||
163380611|NCT05081388|590103780|FG000|Overall Study|Lost to Follow-up|0|||
163380612|NCT05081388|590103781|FG001|Overall Study|Lost to Follow-up|1|||
163380613|NCT05081388|590103782|FG002|Overall Study|Lost to Follow-up|0|||
163380614|NCT05081388|590103783|FG003|Overall Study|Lost to Follow-up|0|||
163380615|NCT05081388|590103784|FG004|Overall Study|Lost to Follow-up|0|||
163380616|NCT05081388|590103780|FG000|Overall Study|Subject decision|0|||
163380617|NCT05081388|590103781|FG001|Overall Study|Subject decision|0|||
163380618|NCT05081388|590103782|FG002|Overall Study|Subject decision|0|||
163380619|NCT05081388|590103783|FG003|Overall Study|Subject decision|1|||
163380620|NCT05081388|590103784|FG004|Overall Study|Subject decision|0|||
163380621|NCT03786783|590103785|FG000|Overall Study|Death|1|||
163380622|NCT03786783|590103785|FG000|Overall Study|Physician Decision|6|||
163380623|NCT03786783|590103785|FG000|Overall Study|Withdrawal by Subject|2|||
163380624|NCT03786783|590103785|FG000|Overall Study|Disease Progression|7|||
163380625|NCT03786783|590103785|FG000|Overall Study|Patient/Parent Refusal|4|||
163380626|NCT04279392|590103788|FG000|Overall Study|Physician Decision|1|||
163380627|NCT04279392|590103789|FG001|Overall Study|Physician Decision|0|||
163380628|NCT01981473|590103790|FG000|Overall Study|Incorrect diagnosis of RA|0|||
163380629|NCT01981473|590103791|FG001|Overall Study|Incorrect diagnosis of RA|0|||
163380630|NCT01981473|590103792|FG002|Overall Study|Incorrect diagnosis of RA|1|||
163380631|NCT01981473|590103790|FG000|Overall Study|Received treatment for < 6 months|0|||
163380632|NCT01981473|590103791|FG001|Overall Study|Received treatment for < 6 months|0|||
163380633|NCT01981473|590103792|FG002|Overall Study|Received treatment for < 6 months|1|||
163380634|NCT01981473|590103790|FG000|Overall Study|Received treatment for >24 months|2|||
163380635|NCT01981473|590103791|FG001|Overall Study|Received treatment for >24 months|0|||
163380636|NCT01981473|590103792|FG002|Overall Study|Received treatment for >24 months|6|||
163380637|NCT00738582|590103793|FG000|Combination Therapy|Completed Combination Therapy|1|||
163380638|NCT00738582|590103794|FG001|Combination Therapy|Completed Combination Therapy|0|||
163380639|NCT00738582|590103793|FG000|Combination Therapy|Physician Decision|1|||
163380640|NCT00738582|590103794|FG001|Combination Therapy|Physician Decision|0|||
163380641|NCT00738582|590103793|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
163380642|NCT00738582|590103794|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
163380643|NCT00738582|590103793|FG000|Combination Therapy|Other|5|||
163380644|NCT00738582|590103794|FG001|Combination Therapy|Other|0|||
163380645|NCT00738582|590103793|FG000|Combination Therapy|Adverse Event|16|||
163380646|NCT00738582|590103794|FG001|Combination Therapy|Adverse Event|0|||
163380647|NCT00738582|590103793|FG000|Combination Therapy|Progressive Disease|9|||
163380648|NCT00738582|590103794|FG001|Combination Therapy|Progressive Disease|0|||
163380649|NCT00738582|590103793|FG000|Maintenance Therapy|Other|0|||
163380650|NCT00738582|590103794|FG001|Maintenance Therapy|Other|2|||
163380651|NCT00738582|590103793|FG000|Maintenance Therapy|Adverse Event|0|||
163380652|NCT00738582|590103794|FG001|Maintenance Therapy|Adverse Event|6|||
163380653|NCT00738582|590103793|FG000|Maintenance Therapy|Progressive Disease|0|||
163380654|NCT00738582|590103794|FG001|Maintenance Therapy|Progressive Disease|47|||
163380655|NCT00738582|590103793|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
163380656|NCT00738582|590103794|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
163380657|NCT02518490|590103801|FG000|Overall Study|Withdrawal by Subject|1|||
163380658|NCT02518490|590103802|FG001|Overall Study|Withdrawal by Subject|1|||
163380659|NCT00346632|590103803|FG000|Overall Study|Progressive Disease|2|||
163380660|NCT00346632|590103804|FG001|Overall Study|Progressive Disease|2|||
163380661|NCT00346632|590103805|FG002|Overall Study|Progressive Disease|4|||
163380662|NCT00346632|590103806|FG003|Overall Study|Progressive Disease|3|||
163380663|NCT00346632|590103807|FG004|Overall Study|Progressive Disease|3|||
163380664|NCT00346632|590103808|FG005|Overall Study|Progressive Disease|1|||
163380665|NCT00346632|590103809|FG006|Overall Study|Progressive Disease|2|||
163380666|NCT00346632|590103810|FG007|Overall Study|Progressive Disease|2|||
163380667|NCT00346632|590103811|FG008|Overall Study|Progressive Disease|2|||
163380668|NCT00346632|590103812|FG009|Overall Study|Progressive Disease|2|||
163380669|NCT00346632|590103803|FG000|Overall Study|Adverse Event|0|||
163380670|NCT00346632|590103804|FG001|Overall Study|Adverse Event|0|||
163380671|NCT00346632|590103805|FG002|Overall Study|Adverse Event|0|||
163380672|NCT00346632|590103806|FG003|Overall Study|Adverse Event|0|||
163380673|NCT00346632|590103807|FG004|Overall Study|Adverse Event|1|||
163380674|NCT00346632|590103808|FG005|Overall Study|Adverse Event|1|||
163380675|NCT00346632|590103809|FG006|Overall Study|Adverse Event|1|||
163380676|NCT00346632|590103810|FG007|Overall Study|Adverse Event|0|||
163380677|NCT00346632|590103811|FG008|Overall Study|Adverse Event|0|||
163380678|NCT00346632|590103812|FG009|Overall Study|Adverse Event|0|||
163380679|NCT00346632|590103803|FG000|Overall Study|Death|0|||
163380680|NCT00346632|590103804|FG001|Overall Study|Death|0|||
163380681|NCT00346632|590103805|FG002|Overall Study|Death|1|||
163380682|NCT00346632|590103806|FG003|Overall Study|Death|0|||
163380683|NCT00346632|590103807|FG004|Overall Study|Death|0|||
163380684|NCT00346632|590103808|FG005|Overall Study|Death|0|||
163380685|NCT00346632|590103809|FG006|Overall Study|Death|0|||
163380686|NCT00346632|590103810|FG007|Overall Study|Death|0|||
163380687|NCT00346632|590103811|FG008|Overall Study|Death|0|||
163380688|NCT00346632|590103812|FG009|Overall Study|Death|0|||
163380689|NCT00346632|590103803|FG000|Overall Study|Protocol Violation|0|||
163380690|NCT00346632|590103804|FG001|Overall Study|Protocol Violation|0|||
163380691|NCT00346632|590103805|FG002|Overall Study|Protocol Violation|0|||
163380692|NCT00346632|590103806|FG003|Overall Study|Protocol Violation|0|||
163380693|NCT00346632|590103807|FG004|Overall Study|Protocol Violation|0|||
163380694|NCT00346632|590103808|FG005|Overall Study|Protocol Violation|0|||
163380695|NCT00346632|590103809|FG006|Overall Study|Protocol Violation|1|||
163380696|NCT00346632|590103810|FG007|Overall Study|Protocol Violation|0|||
163380697|NCT00346632|590103811|FG008|Overall Study|Protocol Violation|0|||
163380698|NCT00346632|590103812|FG009|Overall Study|Protocol Violation|0|||
163380699|NCT00346632|590103803|FG000|Overall Study|Withdrawal by Subject|0|||
163380700|NCT00346632|590103804|FG001|Overall Study|Withdrawal by Subject|0|||
163380701|NCT00346632|590103805|FG002|Overall Study|Withdrawal by Subject|0|||
163380702|NCT00346632|590103806|FG003|Overall Study|Withdrawal by Subject|0|||
163380703|NCT00346632|590103807|FG004|Overall Study|Withdrawal by Subject|0|||
163380704|NCT00346632|590103808|FG005|Overall Study|Withdrawal by Subject|0|||
163380705|NCT00346632|590103809|FG006|Overall Study|Withdrawal by Subject|1|||
163380706|NCT00346632|590103810|FG007|Overall Study|Withdrawal by Subject|0|||
163380707|NCT00346632|590103811|FG008|Overall Study|Withdrawal by Subject|0|||
163380708|NCT00346632|590103812|FG009|Overall Study|Withdrawal by Subject|0|||
163380709|NCT00346632|590103803|FG000|Overall Study|Switched to alternative treatment|0|||
163380710|NCT00346632|590103804|FG001|Overall Study|Switched to alternative treatment|0|||
163380711|NCT00346632|590103805|FG002|Overall Study|Switched to alternative treatment|1|||
163380712|NCT00346632|590103806|FG003|Overall Study|Switched to alternative treatment|0|||
163380713|NCT00346632|590103807|FG004|Overall Study|Switched to alternative treatment|0|||
163380714|NCT00346632|590103808|FG005|Overall Study|Switched to alternative treatment|0|||
163380715|NCT00346632|590103809|FG006|Overall Study|Switched to alternative treatment|0|||
163380716|NCT00346632|590103810|FG007|Overall Study|Switched to alternative treatment|0|||
163380717|NCT00346632|590103811|FG008|Overall Study|Switched to alternative treatment|0|||
163380718|NCT00346632|590103812|FG009|Overall Study|Switched to alternative treatment|0|||
163380719|NCT00346632|590103803|FG000|Overall Study|Not Stated|1|||
163380720|NCT00346632|590103804|FG001|Overall Study|Not Stated|1|||
163380721|NCT00346632|590103805|FG002|Overall Study|Not Stated|0|||
163380722|NCT00346632|590103806|FG003|Overall Study|Not Stated|0|||
163380723|NCT00346632|590103807|FG004|Overall Study|Not Stated|0|||
163380724|NCT00346632|590103808|FG005|Overall Study|Not Stated|0|||
163380725|NCT00346632|590103809|FG006|Overall Study|Not Stated|0|||
163380726|NCT00346632|590103810|FG007|Overall Study|Not Stated|2|||
163380727|NCT00346632|590103811|FG008|Overall Study|Not Stated|2|||
163380728|NCT00346632|590103812|FG009|Overall Study|Not Stated|1|||
163380729|NCT00918580|590103813|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
163380730|NCT00918580|590103813|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
163380731|NCT00918580|590103813|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
163380732|NCT00918580|590103813|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
163380733|NCT00918580|590103813|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
163380734|NCT00918580|590103813|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
163380735|NCT00918580|590103813|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
163380736|NCT04882995|590103814|FG000|Overall Study|Withdrawal by Subject|1|||
163380737|NCT04882995|590103815|FG001|Overall Study|Withdrawal by Subject|2|||
163380738|NCT04882995|590103814|FG000|Overall Study|Protocol Violation|4|||
163380739|NCT04882995|590103815|FG001|Overall Study|Protocol Violation|4|||
163380740|NCT04882995|590103814|FG000|Overall Study|Surgery postponed due to COVID|1|||
163380741|NCT04882995|590103815|FG001|Overall Study|Surgery postponed due to COVID|1|||
163380742|NCT03587974|590103816|FG000|Overall Study|caregiver demented, care recipient died|3|||
163380743|NCT03587974|590103817|FG001|Overall Study|caregiver demented, care recipient died|3|||
163380744|NCT03587974|590103816|FG000|Overall Study|Withdrawal by Subject|2|||
163380745|NCT03587974|590103817|FG001|Overall Study|Withdrawal by Subject|1|||
163380746|NCT03486457|590103818|FG000|Up to Month 3|Adverse Event|2|||
163380747|NCT03486457|590103819|FG001|Up to Month 3|Adverse Event|5|||
163417411|NCT00793793|590235990|FG010|Overall Study|Adverse Event|0|||
163380748|NCT03486457|590103818|FG000|Up to Month 3|Lack of Efficacy|1|||
163380749|NCT03486457|590103819|FG001|Up to Month 3|Lack of Efficacy|0|||
163380750|NCT03486457|590103818|FG000|Up to Month 3|Withdrawal by Subject|1|||
163380751|NCT03486457|590103819|FG001|Up to Month 3|Withdrawal by Subject|0|||
163380752|NCT03486457|590103818|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
163380753|NCT03486457|590103819|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
163380754|NCT03486457|590103818|FG000|Up to Month 3|Other|1|||
163380755|NCT03486457|590103819|FG001|Up to Month 3|Other|0|||
163380756|NCT03486457|590103818|FG000|Month 3 to Month 6|Adverse Event|2|||
163380757|NCT03486457|590103819|FG001|Month 3 to Month 6|Adverse Event|0|||
163380758|NCT03486457|590103818|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
163380759|NCT03486457|590103819|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
163380760|NCT03486457|590103818|FG000|Month 3 to Month 6|Pregnancy|0|||
163380761|NCT03486457|590103819|FG001|Month 3 to Month 6|Pregnancy|1|||
163380762|NCT03486457|590103818|FG000|Month 3 to Month 6|Other|1|||
163380763|NCT03486457|590103819|FG001|Month 3 to Month 6|Other|0|||
163380764|NCT00372229|590103820|FG000|Study Phase|Graft loss|0|||
163380765|NCT00372229|590103821|FG001|Study Phase|Graft loss|3|||
163380766|NCT00372229|590103820|FG000|Study Phase|Protocol Violation|3|||
163380767|NCT00372229|590103821|FG001|Study Phase|Protocol Violation|4|||
163380768|NCT00372229|590103820|FG000|Study Phase|Consent withdrawn|16|||
163380769|NCT00372229|590103821|FG001|Study Phase|Consent withdrawn|14|||
163380770|NCT00372229|590103820|FG000|Study Phase|Refused treatment/did not cooperate|3|||
163380771|NCT00372229|590103821|FG001|Study Phase|Refused treatment/did not cooperate|1|||
163380772|NCT00372229|590103820|FG000|Study Phase|Death|3|||
163380773|NCT00372229|590103821|FG001|Study Phase|Death|2|||
163380774|NCT00372229|590103820|FG000|Study Phase|Reason not specified|3|||
163380775|NCT00372229|590103821|FG001|Study Phase|Reason not specified|2|||
163380776|NCT00372229|590103820|FG000|Study Phase|Lost to Follow-up|3|||
163380777|NCT00372229|590103821|FG001|Study Phase|Lost to Follow-up|3|||
163380778|NCT00372229|590103820|FG000|Follow-Up Phase|Graft loss|8|||
163380779|NCT00372229|590103821|FG001|Follow-Up Phase|Graft loss|7|||
163380780|NCT00372229|590103820|FG000|Follow-Up Phase|Consent withdrawn|13|||
163380781|NCT00372229|590103821|FG001|Follow-Up Phase|Consent withdrawn|19|||
163380782|NCT00372229|590103820|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
163380783|NCT00372229|590103821|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
163380784|NCT00372229|590103820|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
163380785|NCT00372229|590103821|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
163380786|NCT00372229|590103820|FG000|Follow-Up Phase|Death|9|||
163380787|NCT00372229|590103821|FG001|Follow-Up Phase|Death|12|||
163380788|NCT00372229|590103820|FG000|Follow-Up Phase|Administrative|1|||
163380789|NCT00372229|590103821|FG001|Follow-Up Phase|Administrative|0|||
163380790|NCT00372229|590103820|FG000|Follow-Up Phase|Reason not specified|2|||
163380791|NCT00372229|590103821|FG001|Follow-Up Phase|Reason not specified|3|||
163380792|NCT00372229|590103820|FG000|Follow-Up Phase|Lost to Follow-up|12|||
163380793|NCT00372229|590103821|FG001|Follow-Up Phase|Lost to Follow-up|10|||
163380794|NCT03235284|590103822|FG000|Overall Study|Adverse Event|1|||
163380795|NCT03235284|590103823|FG001|Overall Study|Adverse Event|2|||
163380796|NCT03235284|590103824|FG002|Overall Study|Adverse Event|1|||
163380798|NCT01382706|590103826|FG000|Overall Study|Adverse Event|1|||
163380799|NCT01382706|590103826|FG000|Overall Study|Withdrawal by Subject|1|||
163380800|NCT04055090|590103827|FG000|Overall Study|screen failure|1|||
163380801|NCT04055090|590103828|FG001|Overall Study|screen failure|0|||
163380802|NCT04055090|590103827|FG000|Overall Study|Withdrawal by Subject|1|||
163380803|NCT04055090|590103828|FG001|Overall Study|Withdrawal by Subject|0|||
163380804|NCT05478499|590103831|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
163380805|NCT05478499|590103832|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
163380806|NCT05478499|590103831|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
163380807|NCT05478499|590103832|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
163380808|NCT05478499|590103831|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
163380809|NCT05478499|590103832|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
163380810|NCT05478499|590103831|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
163380811|NCT05478499|590103832|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
163380812|NCT05478499|590103831|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
163380813|NCT05478499|590103832|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
163380814|NCT05478499|590103831|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
163380815|NCT05478499|590103832|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
163380816|NCT05478499|590103831|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
163380817|NCT05478499|590103832|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
163380818|NCT05478499|590103831|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
163380819|NCT05478499|590103832|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
163380820|NCT05478499|590103831|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
163380821|NCT05478499|590103832|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
163380822|NCT05478499|590103831|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
163380823|NCT05478499|590103832|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
163380824|NCT05478499|590103831|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
163380825|NCT05478499|590103832|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
163380826|NCT00249002|590103833|FG000|Overall Study|Adverse Event|2|||
163380827|NCT00249002|590103833|FG000|Overall Study|Study cancellation|3|||
163380828|NCT00249002|590103833|FG000|Overall Study|Other|2|||
163380829|NCT00552240|590103837|FG000|Overall Study|Adverse Event|9|||
163380830|NCT00552240|590103838|FG001|Overall Study|Adverse Event|9|||
163380831|NCT00552240|590103837|FG000|Overall Study|Protocol Violation|1|||
163380832|NCT00552240|590103838|FG001|Overall Study|Protocol Violation|1|||
163380833|NCT00552240|590103837|FG000|Overall Study|Lost to Follow-up|5|||
163380834|NCT00552240|590103838|FG001|Overall Study|Lost to Follow-up|6|||
163380835|NCT00552240|590103837|FG000|Overall Study|Withdrawal by Subject|2|||
163380836|NCT00552240|590103838|FG001|Overall Study|Withdrawal by Subject|2|||
163380837|NCT00552240|590103837|FG000|Overall Study|Lack of Efficacy|6|||
163380838|NCT00552240|590103838|FG001|Overall Study|Lack of Efficacy|0|||
163380839|NCT00552240|590103837|FG000|Overall Study|Other|1|||
163380840|NCT00552240|590103838|FG001|Overall Study|Other|0|||
163380841|NCT02679573|590103839|FG000|Overall Study|Adverse Event|13|||
163380842|NCT02679573|590103840|FG001|Overall Study|Adverse Event|6|||
163380843|NCT02679573|590103839|FG000|Overall Study|Lack of Efficacy|12|||
163380844|NCT02679573|590103840|FG001|Overall Study|Lack of Efficacy|15|||
163380845|NCT02679573|590103839|FG000|Overall Study|Could not complete required study visits|6|||
163380846|NCT02679573|590103840|FG001|Overall Study|Could not complete required study visits|2|||
163380847|NCT02679573|590103839|FG000|Overall Study|Withdrawal by Subject|2|||
163380848|NCT02679573|590103840|FG001|Overall Study|Withdrawal by Subject|9|||
163380849|NCT02679573|590103839|FG000|Overall Study|Death|2|||
163380850|NCT02679573|590103840|FG001|Overall Study|Death|0|||
163380851|NCT02679573|590103839|FG000|Overall Study|Physician Decision|2|||
163380852|NCT02679573|590103840|FG001|Overall Study|Physician Decision|4|||
163380853|NCT02679573|590103839|FG000|Overall Study|Lost to Follow-up|0|||
163380854|NCT02679573|590103840|FG001|Overall Study|Lost to Follow-up|3|||
163380855|NCT02476279|590103841|FG000|Overall Study|Lost to Follow-up|1|||
163380856|NCT02476279|590103842|FG001|Overall Study|Lost to Follow-up|1|||
163380857|NCT02128542|590103843|FG000|Overall Study|Lost to Follow-up|3|||
163380858|NCT02128542|590103844|FG001|Overall Study|Lost to Follow-up|0|||
163380859|NCT02128542|590103843|FG000|Overall Study|Withdrew Consent|1|||
163380860|NCT02128542|590103844|FG001|Overall Study|Withdrew Consent|0|||
163380861|NCT01411215|590103848|FG000|Overall Study|Adverse Event|1|||
163380862|NCT01411215|590103849|FG001|Overall Study|Adverse Event|2|||
163380863|NCT01411215|590103848|FG000|Overall Study|Lack of Efficacy|2|||
163380864|NCT01411215|590103849|FG001|Overall Study|Lack of Efficacy|4|||
163380865|NCT01411215|590103848|FG000|Overall Study|Lost to Follow-up|12|||
163380866|NCT01411215|590103849|FG001|Overall Study|Lost to Follow-up|18|||
163380867|NCT01411215|590103848|FG000|Overall Study|Did not meet entrance criteria|0|||
163380868|NCT01411215|590103849|FG001|Overall Study|Did not meet entrance criteria|1|||
163380869|NCT01411215|590103848|FG000|Overall Study|Study terminated by sponsor|2|||
163380870|NCT01411215|590103849|FG001|Overall Study|Study terminated by sponsor|15|||
163380871|NCT01411215|590103848|FG000|Overall Study|Protocol Violation|3|||
163380872|NCT01411215|590103849|FG001|Overall Study|Protocol Violation|5|||
163380873|NCT01411215|590103848|FG000|Overall Study|Withdrawal by Subject|34|||
163380874|NCT01411215|590103849|FG001|Overall Study|Withdrawal by Subject|21|||
163380875|NCT01411215|590103848|FG000|Overall Study|Other|12|||
163380876|NCT01411215|590103849|FG001|Overall Study|Other|17|||
163380877|NCT01411215|590103848|FG000|Overall Study|Screen failure|0|||
163380878|NCT01411215|590103849|FG001|Overall Study|Screen failure|1|||
163380879|NCT03451162|590103852|FG000|Overall Study|Lost to Follow-up|1|||
163380880|NCT03451162|590103853|FG001|Overall Study|Lost to Follow-up|0|||
163380881|NCT03451162|590103854|FG002|Overall Study|Lost to Follow-up|0|||
163380882|NCT03451162|590103855|FG003|Overall Study|Lost to Follow-up|0|||
163380883|NCT03451162|590103856|FG004|Overall Study|Lost to Follow-up|0|||
163380884|NCT03451162|590103852|FG000|Overall Study|Physician Decision|0|||
163380885|NCT03451162|590103853|FG001|Overall Study|Physician Decision|1|||
163380886|NCT03451162|590103854|FG002|Overall Study|Physician Decision|0|||
163380887|NCT03451162|590103855|FG003|Overall Study|Physician Decision|0|||
163380888|NCT03451162|590103856|FG004|Overall Study|Physician Decision|0|||
163380889|NCT03451162|590103852|FG000|Overall Study|Withdrawal by Subject|1|||
163380890|NCT03451162|590103853|FG001|Overall Study|Withdrawal by Subject|1|||
163380891|NCT03451162|590103854|FG002|Overall Study|Withdrawal by Subject|0|||
163380892|NCT03451162|590103855|FG003|Overall Study|Withdrawal by Subject|0|||
163380893|NCT03451162|590103856|FG004|Overall Study|Withdrawal by Subject|0|||
163380894|NCT01952054|590103857|FG000|Overall Study|Physician Decision|1|||
163380895|NCT01100034|590103858|FG000|Overall Study|Lost to Follow-up|11|||
163417412|NCT00793793|590235991|FG011|Overall Study|Adverse Event|2|||
163417413|NCT00793793|590235980|FG000|Overall Study|Protocol Violation|0|||
163417414|NCT00793793|590235981|FG001|Overall Study|Protocol Violation|0|||
163380896|NCT01100034|590103858|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
163380897|NCT01100034|590103858|FG000|Overall Study|Withdrawal by Subject|4|||
163380898|NCT01100034|590103858|FG000|Overall Study|Sponsor decision|21|||
163380899|NCT01100034|590103858|FG000|Overall Study|Participated in another clinical trial|1|||
163380900|NCT01100034|590103858|FG000|Overall Study|Participants moved to another hospital|4|||
163380901|NCT01100034|590103858|FG000|Overall Study|Site closed due to non-responsiveness|1|||
163380902|NCT00402597|590103859|FG000|Overall Study|Death|15|||
163380903|NCT00402597|590103860|FG001|Overall Study|Death|7|||
163380904|NCT00402597|590103861|FG002|Overall Study|Death|6|||
163380905|NCT00402597|590103862|FG003|Overall Study|Death|4|||
163380906|NCT00402597|590103863|FG004|Overall Study|Death|6|||
163380907|NCT00402597|590103859|FG000|Overall Study|Adverse Event|81|||
163380908|NCT00402597|590103860|FG001|Overall Study|Adverse Event|18|||
163380909|NCT00402597|590103861|FG002|Overall Study|Adverse Event|106|||
163380910|NCT00402597|590103862|FG003|Overall Study|Adverse Event|39|||
163380911|NCT00402597|590103863|FG004|Overall Study|Adverse Event|71|||
163380912|NCT00402597|590103859|FG000|Overall Study|Lost to Follow-up|8|||
163380913|NCT00402597|590103860|FG001|Overall Study|Lost to Follow-up|1|||
163380914|NCT00402597|590103861|FG002|Overall Study|Lost to Follow-up|8|||
163380915|NCT00402597|590103862|FG003|Overall Study|Lost to Follow-up|2|||
163380916|NCT00402597|590103863|FG004|Overall Study|Lost to Follow-up|3|||
163380917|NCT00402597|590103859|FG000|Overall Study|Withdrawal by Subject|57|||
163380918|NCT00402597|590103860|FG001|Overall Study|Withdrawal by Subject|16|||
163380919|NCT00402597|590103861|FG002|Overall Study|Withdrawal by Subject|65|||
163380920|NCT00402597|590103862|FG003|Overall Study|Withdrawal by Subject|15|||
163380921|NCT00402597|590103863|FG004|Overall Study|Withdrawal by Subject|24|||
163380922|NCT00402597|590103859|FG000|Overall Study|reason not specified|30|||
163380923|NCT00402597|590103860|FG001|Overall Study|reason not specified|4|||
163380924|NCT00402597|590103861|FG002|Overall Study|reason not specified|27|||
163380925|NCT00402597|590103862|FG003|Overall Study|reason not specified|14|||
163380926|NCT00402597|590103863|FG004|Overall Study|reason not specified|20|||
163380927|NCT01831856|590103864|FG000|Overall Study|Adverse Event|5|||
163380928|NCT01831856|590103865|FG001|Overall Study|Adverse Event|8|||
163380929|NCT01831856|590103864|FG000|Overall Study|Lack of Efficacy|13|||
163380930|NCT01831856|590103865|FG001|Overall Study|Lack of Efficacy|11|||
163380931|NCT01831856|590103864|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
163380932|NCT01831856|590103865|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
163380933|NCT05208866|590103867|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
163380934|NCT00836095|590103870|FG000|Overall Study|Physician Decision|0|||
163380935|NCT00836095|590103871|FG001|Overall Study|Physician Decision|3|||
163380936|NCT01602562|590103873|FG000|Overall Study|Adverse Event|3|||
163380937|NCT01602562|590103874|FG001|Overall Study|Adverse Event|1|||
163380938|NCT01602562|590103873|FG000|Overall Study|Physician Decision|1|||
163380939|NCT01602562|590103874|FG001|Overall Study|Physician Decision|1|||
163380940|NCT01602562|590103873|FG000|Overall Study|Withdrawal by Subject|1|||
163380941|NCT01602562|590103874|FG001|Overall Study|Withdrawal by Subject|1|||
163380942|NCT04964414|590103875|FG000|Overall Study|Lost to Follow-up|10|||
163380943|NCT04964414|590103876|FG001|Overall Study|Lost to Follow-up|8|||
163380944|NCT04964414|590103875|FG000|Overall Study|Withdrawal by Subject|1|||
163380945|NCT04964414|590103876|FG001|Overall Study|Withdrawal by Subject|1|||
163380946|NCT00232544|590103877|FG000|Overall Study|Lost to Follow-up|20|||
163380947|NCT00232544|590103878|FG001|Overall Study|Lost to Follow-up|15|||
163380948|NCT00116753|590103879|FG000|Overall Study|Adverse Event|16|||
163380949|NCT00116753|590103880|FG001|Overall Study|Adverse Event|10|||
163380950|NCT00116753|590103881|FG002|Overall Study|Adverse Event|7|||
163380951|NCT00116753|590103879|FG000|Overall Study|Withdrawal by Subject|11|||
163380952|NCT00116753|590103880|FG001|Overall Study|Withdrawal by Subject|12|||
163380953|NCT00116753|590103881|FG002|Overall Study|Withdrawal by Subject|8|||
163380954|NCT00116753|590103879|FG000|Overall Study|Lost to Follow-up|0|||
163380955|NCT00116753|590103880|FG001|Overall Study|Lost to Follow-up|2|||
163380956|NCT00116753|590103881|FG002|Overall Study|Lost to Follow-up|1|||
163380957|NCT00116753|590103879|FG000|Overall Study|Protocol Violation|0|||
163380958|NCT00116753|590103880|FG001|Overall Study|Protocol Violation|0|||
163380959|NCT00116753|590103881|FG002|Overall Study|Protocol Violation|1|||
163380960|NCT00116753|590103879|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
163380961|NCT00116753|590103880|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
163380962|NCT00116753|590103881|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
163380963|NCT00116753|590103879|FG000|Overall Study|Disease Progression|3|||
163380964|NCT00116753|590103880|FG001|Overall Study|Disease Progression|4|||
163380965|NCT00116753|590103881|FG002|Overall Study|Disease Progression|3|||
163380966|NCT00116753|590103879|FG000|Overall Study|Abnormal Echocardiogram|0|||
163380967|NCT00116753|590103880|FG001|Overall Study|Abnormal Echocardiogram|0|||
163380968|NCT00116753|590103881|FG002|Overall Study|Abnormal Echocardiogram|1|||
163380969|NCT00116753|590103879|FG000|Overall Study|Progressive Parkinson's Disease|1|||
163380970|NCT00116753|590103880|FG001|Overall Study|Progressive Parkinson's Disease|0|||
163380971|NCT00116753|590103881|FG002|Overall Study|Progressive Parkinson's Disease|0|||
163380972|NCT00116753|590103879|FG000|Overall Study|Dosing Error|0|||
163380973|NCT00116753|590103880|FG001|Overall Study|Dosing Error|1|||
163380974|NCT00116753|590103881|FG002|Overall Study|Dosing Error|0|||
163380975|NCT01200589|590103882|FG000|Overall Study|Withdrawal by Subject|13|||
163380976|NCT01200589|590103883|FG001|Overall Study|Withdrawal by Subject|11|||
163380977|NCT01200589|590103882|FG000|Overall Study|Physician Decision|2|||
163380978|NCT01200589|590103883|FG001|Overall Study|Physician Decision|2|||
163380979|NCT01200589|590103882|FG000|Overall Study|Lost to Follow-up|5|||
163380980|NCT01200589|590103883|FG001|Overall Study|Lost to Follow-up|4|||
163380981|NCT01200589|590103882|FG000|Overall Study|Study terminated|170|||
163380982|NCT01200589|590103883|FG001|Overall Study|Study terminated|172|||
163380983|NCT00986973|590103884|FG000|Overall Study|Withdrawn by study team|1|||
163380984|NCT00598273|590103885|FG000|Overall Study|Adverse Event|4|||
163380985|NCT00598273|590103886|FG001|Overall Study|Adverse Event|5|||
163380986|NCT00598273|590103887|FG002|Overall Study|Adverse Event|2|||
163380987|NCT00598273|590103885|FG000|Overall Study|Death|6|||
163380988|NCT00598273|590103886|FG001|Overall Study|Death|12|||
163380989|NCT00598273|590103887|FG002|Overall Study|Death|8|||
163380990|NCT00598273|590103885|FG000|Overall Study|Lost to Follow-up|8|||
163380991|NCT00598273|590103886|FG001|Overall Study|Lost to Follow-up|3|||
163380992|NCT00598273|590103887|FG002|Overall Study|Lost to Follow-up|5|||
163380993|NCT00598273|590103885|FG000|Overall Study|Physician Decision|0|||
163380994|NCT00598273|590103886|FG001|Overall Study|Physician Decision|0|||
163380995|NCT00598273|590103887|FG002|Overall Study|Physician Decision|1|||
163380996|NCT00598273|590103885|FG000|Overall Study|Withdrawal by Subject|12|||
163380997|NCT00598273|590103886|FG001|Overall Study|Withdrawal by Subject|10|||
163380998|NCT00598273|590103887|FG002|Overall Study|Withdrawal by Subject|10|||
163380999|NCT00598273|590103885|FG000|Overall Study|Noncompliance|3|||
163381000|NCT00598273|590103886|FG001|Overall Study|Noncompliance|2|||
163381001|NCT00598273|590103887|FG002|Overall Study|Noncompliance|3|||
163381002|NCT00598273|590103885|FG000|Overall Study|Relocation|0|||
163381003|NCT00598273|590103886|FG001|Overall Study|Relocation|2|||
163417415|NCT00793793|590235982|FG002|Overall Study|Protocol Violation|0|||
163417416|NCT00793793|590235983|FG003|Overall Study|Protocol Violation|1|||
163381004|NCT00598273|590103887|FG002|Overall Study|Relocation|4|||
163381005|NCT00598273|590103885|FG000|Overall Study|Renal transplant|1|||
163381006|NCT00598273|590103886|FG001|Overall Study|Renal transplant|0|||
163381007|NCT00598273|590103887|FG002|Overall Study|Renal transplant|1|||
163381008|NCT00598273|590103885|FG000|Overall Study|Site elected to close|1|||
163381009|NCT00598273|590103886|FG001|Overall Study|Site elected to close|0|||
163381010|NCT00598273|590103887|FG002|Overall Study|Site elected to close|0|||
163381011|NCT00598273|590103885|FG000|Overall Study|Started dialysis|6|||
163381012|NCT00598273|590103886|FG001|Overall Study|Started dialysis|4|||
163381013|NCT00598273|590103887|FG002|Overall Study|Started dialysis|5|||
163381014|NCT01590082|590103888|FG000|Overall Study|Withdrawal by Subject|1|||
163381015|NCT01590082|590103889|FG001|Overall Study|Withdrawal by Subject|0|||
163381016|NCT01590082|590103888|FG000|Overall Study|Ineligible|1|||
163381017|NCT01590082|590103889|FG001|Overall Study|Ineligible|0|||
163381018|NCT02549196|590103890|FG000|Overall Study|Protocol Violation|0|||
163381019|NCT02549196|590103891|FG001|Overall Study|Protocol Violation|0|||
163381020|NCT02549196|590103892|FG002|Overall Study|Protocol Violation|0|||
163381021|NCT02549196|590103893|FG003|Overall Study|Protocol Violation|1|||
163381022|NCT02549196|590103890|FG000|Overall Study|Withdrawal by Subject|1|||
163381023|NCT02549196|590103891|FG001|Overall Study|Withdrawal by Subject|0|||
163381024|NCT02549196|590103892|FG002|Overall Study|Withdrawal by Subject|1|||
163381025|NCT02549196|590103893|FG003|Overall Study|Withdrawal by Subject|0|||
163381026|NCT01442779|590103894|FG000|Overall Study|Withdrawal by Subject|3|||
163381027|NCT01442779|590103894|FG000|Overall Study|Death|3|||
163381028|NCT01442779|590103894|FG000|Overall Study|Non-compliance|1|||
163381029|NCT05195489|590105871|FG000|Overall Study|Lost to Follow-up|1|||
163381030|NCT05195489|590105872|FG001|Overall Study|Lost to Follow-up|0|||
163381031|NCT05195489|590105871|FG000|Overall Study|Protocol Violation|0|||
163381032|NCT05195489|590105872|FG001|Overall Study|Protocol Violation|2|||
163381033|NCT05195489|590105871|FG000|Overall Study|Withdrawal by Subject|1|||
163381034|NCT05195489|590105872|FG001|Overall Study|Withdrawal by Subject|1|||
163381035|NCT05195489|590105871|FG000|Overall Study|Removed|0|||
163381036|NCT05195489|590105872|FG001|Overall Study|Removed|1|||
163381037|NCT00409773|590105874|FG000|Overall Study|Adverse Event|3|||
163381038|NCT00409773|590105875|FG001|Overall Study|Adverse Event|4|||
163381039|NCT00409773|590105876|FG002|Overall Study|Adverse Event|4|||
163381040|NCT00409773|590105877|FG003|Overall Study|Adverse Event|2|||
163381041|NCT00409773|590105878|FG004|Overall Study|Adverse Event|6|||
163381042|NCT00409773|590105874|FG000|Overall Study|Lost to Follow-up|6|||
163381043|NCT00409773|590105875|FG001|Overall Study|Lost to Follow-up|1|||
163381044|NCT00409773|590105876|FG002|Overall Study|Lost to Follow-up|2|||
163381045|NCT00409773|590105877|FG003|Overall Study|Lost to Follow-up|3|||
163381046|NCT00409773|590105878|FG004|Overall Study|Lost to Follow-up|1|||
163381047|NCT00409773|590105874|FG000|Overall Study|Physician Decision|0|||
163381048|NCT00409773|590105875|FG001|Overall Study|Physician Decision|0|||
163381049|NCT00409773|590105876|FG002|Overall Study|Physician Decision|0|||
163381050|NCT00409773|590105877|FG003|Overall Study|Physician Decision|2|||
163381051|NCT00409773|590105878|FG004|Overall Study|Physician Decision|0|||
163381052|NCT00409773|590105874|FG000|Overall Study|Protocol Violation|0|||
163381053|NCT00409773|590105875|FG001|Overall Study|Protocol Violation|2|||
163381054|NCT00409773|590105876|FG002|Overall Study|Protocol Violation|3|||
163381055|NCT00409773|590105877|FG003|Overall Study|Protocol Violation|3|||
163381056|NCT00409773|590105878|FG004|Overall Study|Protocol Violation|1|||
163381057|NCT00409773|590105874|FG000|Overall Study|Withdrawal by Subject|0|||
163381058|NCT00409773|590105875|FG001|Overall Study|Withdrawal by Subject|0|||
163381059|NCT00409773|590105876|FG002|Overall Study|Withdrawal by Subject|0|||
163417417|NCT00793793|590235984|FG004|Overall Study|Protocol Violation|0|||
163417418|NCT00793793|590235985|FG005|Overall Study|Protocol Violation|0|||
163417419|NCT00793793|590235986|FG006|Overall Study|Protocol Violation|0|||
163417420|NCT00793793|590235987|FG007|Overall Study|Protocol Violation|0|||
163417421|NCT00793793|590235988|FG008|Overall Study|Protocol Violation|0|||
163417422|NCT00793793|590235989|FG009|Overall Study|Protocol Violation|0|||
163417423|NCT00793793|590235990|FG010|Overall Study|Protocol Violation|0|||
163417424|NCT00793793|590235991|FG011|Overall Study|Protocol Violation|0|||
163417425|NCT00793793|590235980|FG000|Overall Study|Lost to Follow-up|0|||
163417426|NCT00793793|590235981|FG001|Overall Study|Lost to Follow-up|0|||
163417427|NCT00793793|590235982|FG002|Overall Study|Lost to Follow-up|1|||
163417428|NCT00793793|590235983|FG003|Overall Study|Lost to Follow-up|0|||
163417429|NCT00793793|590235984|FG004|Overall Study|Lost to Follow-up|0|||
163417430|NCT00793793|590235985|FG005|Overall Study|Lost to Follow-up|0|||
163417431|NCT00793793|590235986|FG006|Overall Study|Lost to Follow-up|0|||
163417432|NCT00793793|590235987|FG007|Overall Study|Lost to Follow-up|0|||
163417433|NCT00793793|590235988|FG008|Overall Study|Lost to Follow-up|1|||
163417434|NCT00793793|590235989|FG009|Overall Study|Lost to Follow-up|3|||
163417435|NCT00793793|590235990|FG010|Overall Study|Lost to Follow-up|1|||
163417436|NCT00793793|590235991|FG011|Overall Study|Lost to Follow-up|0|||
163417437|NCT00793793|590235980|FG000|Overall Study|Withdrawal by Subject|0|||
163417438|NCT00793793|590235981|FG001|Overall Study|Withdrawal by Subject|0|||
163417439|NCT00793793|590235982|FG002|Overall Study|Withdrawal by Subject|0|||
163417440|NCT00793793|590235983|FG003|Overall Study|Withdrawal by Subject|0|||
163417441|NCT00793793|590235984|FG004|Overall Study|Withdrawal by Subject|1|||
163417442|NCT00793793|590235985|FG005|Overall Study|Withdrawal by Subject|0|||
163417443|NCT00793793|590235986|FG006|Overall Study|Withdrawal by Subject|0|||
163417444|NCT00793793|590235987|FG007|Overall Study|Withdrawal by Subject|0|||
163417445|NCT00793793|590235988|FG008|Overall Study|Withdrawal by Subject|1|||
163417446|NCT00793793|590235989|FG009|Overall Study|Withdrawal by Subject|0|||
163417447|NCT00793793|590235990|FG010|Overall Study|Withdrawal by Subject|0|||
163417448|NCT00793793|590235991|FG011|Overall Study|Withdrawal by Subject|0|||
163417449|NCT00793793|590235980|FG000|Overall Study|reason not specified|0|||
163417450|NCT00793793|590235981|FG001|Overall Study|reason not specified|1|||
163417451|NCT00793793|590235982|FG002|Overall Study|reason not specified|0|||
163417452|NCT00793793|590235983|FG003|Overall Study|reason not specified|1|||
163417453|NCT00793793|590235984|FG004|Overall Study|reason not specified|1|||
163417454|NCT00793793|590235985|FG005|Overall Study|reason not specified|1|||
163417455|NCT00793793|590235986|FG006|Overall Study|reason not specified|2|||
163417456|NCT00793793|590235987|FG007|Overall Study|reason not specified|0|||
163417457|NCT00793793|590235988|FG008|Overall Study|reason not specified|7|||
163417458|NCT00793793|590235989|FG009|Overall Study|reason not specified|6|||
163417459|NCT00793793|590235990|FG010|Overall Study|reason not specified|2|||
163417460|NCT00793793|590235991|FG011|Overall Study|reason not specified|4|||
163417461|NCT00840827|590235992|FG000|Overall Study|Adverse Event|1|||
163417462|NCT00840827|590235992|FG000|Overall Study|Lack of Efficacy|4|||
163417463|NCT00840827|590235992|FG000|Overall Study|Physician Decision|1|||
163417464|NCT01482910|590235994|FG000|Overall Study|Adverse Event|6|||
163417465|NCT01482910|590235995|FG001|Overall Study|Adverse Event|5|||
163417466|NCT01482910|590235994|FG000|Overall Study|Lost to Follow-up|0|||
163417467|NCT01482910|590235995|FG001|Overall Study|Lost to Follow-up|1|||
163417468|NCT01482910|590235994|FG000|Overall Study|Protocol Violation|1|||
163417469|NCT01482910|590235995|FG001|Overall Study|Protocol Violation|1|||
163417470|NCT01482910|590235994|FG000|Overall Study|Withdrawal by Subject|7|||
163417471|NCT01482910|590235995|FG001|Overall Study|Withdrawal by Subject|2|||
163417472|NCT01482910|590235994|FG000|Overall Study|Death|1|||
163417473|NCT01482910|590235995|FG001|Overall Study|Death|0|||
163417474|NCT00331409|590235996|FG000|Overall Study|Lack of Efficacy|4|||
163417475|NCT02614079|590235997|FG000|Overall Study|Withdrawal by Subject|1|||
163417476|NCT01058096|590235998|FG000|Double-blind Treatment Phase|Adverse Event|11|||
163417477|NCT01058096|590235999|FG001|Double-blind Treatment Phase|Adverse Event|15|||
163417478|NCT01058096|590235998|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
163417479|NCT01058096|590235999|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
163417480|NCT01058096|590235998|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
163417481|NCT01058096|590235999|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
163417482|NCT01058096|590235998|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
163417483|NCT01058096|590235999|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
163417484|NCT01058096|590235998|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
163417485|NCT01058096|590235999|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
163417486|NCT01058096|590235998|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
163417487|NCT01058096|590235999|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
163417488|NCT04451330|590236000|FG000|Overall Study|Adverse Event|1|||
163417489|NCT04451330|590236001|FG001|Overall Study|Adverse Event|2|||
163417490|NCT04451330|590236000|FG000|Overall Study|Lost to Follow-up|5|||
163417491|NCT04451330|590236001|FG001|Overall Study|Lost to Follow-up|0|||
163417492|NCT04451330|590236000|FG000|Overall Study|Withdrawal by Subject|3|||
163417493|NCT04451330|590236001|FG001|Overall Study|Withdrawal by Subject|1|||
163381060|NCT00409773|590105877|FG003|Overall Study|Withdrawal by Subject|2|||
163381061|NCT00409773|590105878|FG004|Overall Study|Withdrawal by Subject|1|||
163381062|NCT00409773|590105874|FG000|Overall Study|Lack of Eligibility|0|||
163381063|NCT00409773|590105875|FG001|Overall Study|Lack of Eligibility|0|||
163381064|NCT00409773|590105876|FG002|Overall Study|Lack of Eligibility|0|||
163381065|NCT00409773|590105877|FG003|Overall Study|Lack of Eligibility|0|||
163381066|NCT00409773|590105878|FG004|Overall Study|Lack of Eligibility|1|||
163381067|NCT01201343|590105879|FG000|Overall Study|Adverse Event|6|||
163381068|NCT01201343|590105879|FG000|Overall Study|Withdrawal by Subject|5|||
163381069|NCT01201343|590105879|FG000|Overall Study|Lost to Follow-up|2|||
163381070|NCT01201343|590105879|FG000|Overall Study|Lack of Efficacy|2|||
163381071|NCT01201343|590105879|FG000|Overall Study|Participant wrongly included in trial|1|||
163381072|NCT01201343|590105879|FG000|Overall Study|Randomized, not treated|3|||
163381073|NCT01919814|590105880|FG000|Overall Study|Adverse Event|1|||
163381074|NCT01919814|590105881|FG001|Overall Study|Adverse Event|0|||
163381075|NCT01919814|590105880|FG000|Overall Study|Protocol Violation|1|||
163381076|NCT01919814|590105881|FG001|Overall Study|Protocol Violation|0|||
163381077|NCT01919814|590105880|FG000|Overall Study|Withdrawal by Subject|1|||
163381078|NCT01919814|590105881|FG001|Overall Study|Withdrawal by Subject|0|||
163381079|NCT02164383|590105882|FG000|Overall Study|Lost to Follow-up|1|||
163381080|NCT02164383|590105883|FG001|Overall Study|Lost to Follow-up|0|||
163381081|NCT01672723|590105884|FG000|First Intervention|Adverse Event|3|||
163381082|NCT01672723|590105885|FG001|First Intervention|Adverse Event|0|||
163381083|NCT00743275|590105886|FG000|Overall Study|Protocol Violation|0|||
163381084|NCT00743275|590105887|FG001|Overall Study|Protocol Violation|1|||
163381085|NCT03057977|590105891|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
163381086|NCT03057977|590105892|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
163381087|NCT03057977|590105891|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
163381088|NCT03057977|590105892|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
163381089|NCT03057977|590105891|FG000|Discontinuation From Treatment|Protocol Violation|6|||
163381090|NCT03057977|590105892|FG001|Discontinuation From Treatment|Protocol Violation|5|||
163381091|NCT03057977|590105891|FG000|Discontinuation From Treatment|Not treated|4|||
163381092|NCT03057977|590105892|FG001|Discontinuation From Treatment|Not treated|0|||
163381093|NCT03057977|590105891|FG000|Discontinuation From Treatment|Adverse Event|343|||
163381094|NCT03057977|590105892|FG001|Discontinuation From Treatment|Adverse Event|337|||
163381095|NCT03057977|590105891|FG000|Discontinuation From Treatment|Reason Unknown|0|||
163381096|NCT03057977|590105892|FG001|Discontinuation From Treatment|Reason Unknown|1|||
163381097|NCT03057977|590105891|FG000|Discontinuation From Treatment|Personal Reasons|1|||
163381098|NCT03057977|590105892|FG001|Discontinuation From Treatment|Personal Reasons|1|||
163381099|NCT03057977|590105891|FG000|Discontinuation From Treatment|Unblinded medication|1|||
163381100|NCT03057977|590105892|FG001|Discontinuation From Treatment|Unblinded medication|0|||
163381101|NCT03057977|590105891|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
163381102|NCT03057977|590105892|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
163381103|NCT03057977|590105891|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
163381104|NCT03057977|590105892|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
163381105|NCT03057977|590105891|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
163381106|NCT03057977|590105892|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
163381107|NCT03057977|590105891|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
163381108|NCT03057977|590105892|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
163381109|NCT03057977|590105891|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
163381110|NCT03057977|590105892|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
163381111|NCT03057977|590105891|FG000|Discontinuation From Treatment|Not attending study visit|3|||
163381112|NCT03057977|590105892|FG001|Discontinuation From Treatment|Not attending study visit|10|||
163417494|NCT04451330|590236000|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163417495|NCT04451330|590236001|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163417496|NCT04451330|590236000|FG000|Overall Study|Other than specified|0|||
163381113|NCT03057977|590105891|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
163381114|NCT03057977|590105892|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
163381115|NCT03057977|590105891|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
163381116|NCT03057977|590105892|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
163381117|NCT03057977|590105891|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
163381118|NCT03057977|590105892|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
163381119|NCT03057977|590105891|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
163381120|NCT03057977|590105892|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
163381121|NCT03057977|590105891|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
163381122|NCT03057977|590105892|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
163381123|NCT01201317|590105893|FG000|Overall Study|Withdrawal by Subject|5|||
163381124|NCT01201317|590105894|FG001|Overall Study|Withdrawal by Subject|0|||
163381125|NCT01201317|590105895|FG002|Overall Study|Withdrawal by Subject|3|||
163417497|NCT04451330|590236001|FG001|Overall Study|Other than specified|1|||
163417498|NCT05099640|590236002|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
163417499|NCT05099640|590236003|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
163417500|NCT05099640|590236004|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
163417501|NCT05099640|590236002|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
163417502|NCT05099640|590236003|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
163417503|NCT05099640|590236004|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
163417504|NCT05099640|590236002|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
163417505|NCT05099640|590236003|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
163417506|NCT05099640|590236004|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
163417507|NCT05099640|590236002|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
163417508|NCT05099640|590236003|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
163417509|NCT05099640|590236004|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
163417510|NCT05099640|590236002|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
163417511|NCT05099640|590236003|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
163417512|NCT05099640|590236004|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
163417513|NCT05099640|590236002|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
163417514|NCT05099640|590236003|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
163417515|NCT05099640|590236004|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
163417516|NCT00179959|590236005|FG000|Overall Study|Lost to Follow-up|3|||
163417517|NCT00179959|590236006|FG001|Overall Study|Lost to Follow-up|1|||
163417518|NCT00179959|590236005|FG000|Overall Study|Withdrawal by Subject|3|||
163417519|NCT00179959|590236006|FG001|Overall Study|Withdrawal by Subject|2|||
163417520|NCT01552681|590236011|FG000|Overall Study|Withdrawal by Subject|4|||
163417521|NCT01552681|590236012|FG001|Overall Study|Withdrawal by Subject|0|||
163417522|NCT01552681|590236011|FG000|Overall Study|Physician Decision|1|||
163417523|NCT01552681|590236012|FG001|Overall Study|Physician Decision|0|||
163417524|NCT01552681|590236011|FG000|Overall Study|Subject moved away|0|||
163417525|NCT01552681|590236012|FG001|Overall Study|Subject moved away|1|||
163417526|NCT03075163|590236013|FG000|Overall Study|not eligible for treatment limb|138|||
163417527|NCT03075163|590236014|FG001|Overall Study|not eligible for treatment limb|138|||
163417528|NCT00236080|590236015|FG000|Overall Study|Adverse Event|0|||
163417529|NCT00236080|590236016|FG001|Overall Study|Adverse Event|0|||
163417530|NCT00236080|590236017|FG002|Overall Study|Adverse Event|3|||
163417531|NCT00236080|590236018|FG003|Overall Study|Adverse Event|1|||
163417532|NCT00236080|590236019|FG004|Overall Study|Adverse Event|0|||
163417533|NCT00236080|590236015|FG000|Overall Study|Lost to Follow-up|0|||
163417534|NCT00236080|590236016|FG001|Overall Study|Lost to Follow-up|1|||
163417535|NCT00236080|590236017|FG002|Overall Study|Lost to Follow-up|0|||
163417536|NCT00236080|590236018|FG003|Overall Study|Lost to Follow-up|0|||
163417537|NCT00236080|590236019|FG004|Overall Study|Lost to Follow-up|0|||
163417538|NCT00236080|590236015|FG000|Overall Study|Physician Decision|1|||
163417539|NCT00236080|590236016|FG001|Overall Study|Physician Decision|0|||
163417540|NCT00236080|590236017|FG002|Overall Study|Physician Decision|1|||
163417541|NCT00236080|590236018|FG003|Overall Study|Physician Decision|1|||
163417542|NCT00236080|590236019|FG004|Overall Study|Physician Decision|1|||
163417543|NCT00236080|590236015|FG000|Overall Study|Withdrawal by Subject|1|||
163417544|NCT00236080|590236016|FG001|Overall Study|Withdrawal by Subject|0|||
163417545|NCT00236080|590236017|FG002|Overall Study|Withdrawal by Subject|0|||
163417546|NCT00236080|590236018|FG003|Overall Study|Withdrawal by Subject|0|||
163417547|NCT00236080|590236019|FG004|Overall Study|Withdrawal by Subject|0|||
163417548|NCT00236080|590236015|FG000|Overall Study|Miscellaneous|0|||
163417549|NCT00236080|590236016|FG001|Overall Study|Miscellaneous|0|||
163417550|NCT00236080|590236017|FG002|Overall Study|Miscellaneous|1|||
163417551|NCT00236080|590236018|FG003|Overall Study|Miscellaneous|0|||
163417552|NCT00236080|590236019|FG004|Overall Study|Miscellaneous|0|||
163417553|NCT01214044|590236020|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
163381126|NCT01201317|590105893|FG000|Overall Study|Adverse Event|2|||
163381127|NCT01201317|590105894|FG001|Overall Study|Adverse Event|2|||
163381128|NCT01201317|590105895|FG002|Overall Study|Adverse Event|2|||
163381129|NCT01201317|590105893|FG000|Overall Study|Screen failure|1|||
163381130|NCT01201317|590105894|FG001|Overall Study|Screen failure|1|||
163381131|NCT01201317|590105895|FG002|Overall Study|Screen failure|0|||
163381132|NCT01201317|590105893|FG000|Overall Study|Protocol Violation|0|||
163381133|NCT01201317|590105894|FG001|Overall Study|Protocol Violation|1|||
163417554|NCT01214044|590236020|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
163417555|NCT01214044|590236020|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
163381134|NCT01201317|590105895|FG002|Overall Study|Protocol Violation|1|||
163417556|NCT01214044|590236020|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
163417557|NCT01214044|590236020|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
163417558|NCT01214044|590236020|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
163381135|NCT01201317|590105893|FG000|Overall Study|Death|0|||
163381136|NCT01201317|590105894|FG001|Overall Study|Death|1|||
163381137|NCT01201317|590105895|FG002|Overall Study|Death|0|||
163417559|NCT04698525|590236021|FG000|Overall Study|Lost to Follow-up|1|||
163417560|NCT04698525|590236022|FG001|Overall Study|Lost to Follow-up|2|||
163417561|NCT04698525|590236021|FG000|Overall Study|Three suffered of Covid-19|2|||
163417562|NCT04698525|590236022|FG001|Overall Study|Three suffered of Covid-19|1|||
163417563|NCT01961544|590236023|FG000|Overall Study|Protocol Violation|1|||
163417564|NCT01961544|590236023|FG000|Overall Study|Withdrawal by Subject|7|||
163381138|NCT01201317|590105893|FG000|Overall Study|Study-specific withdrawal criteria|0|||
163381139|NCT01201317|590105894|FG001|Overall Study|Study-specific withdrawal criteria|0|||
163381140|NCT01201317|590105895|FG002|Overall Study|Study-specific withdrawal criteria|1|||
163381141|NCT01201317|590105893|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
163381142|NCT01201317|590105894|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
163381143|NCT01201317|590105895|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
163381144|NCT01201317|590105893|FG000|Overall Study|Decrease in renal function|0|||
163381145|NCT01201317|590105894|FG001|Overall Study|Decrease in renal function|1|||
163381146|NCT01201317|590105895|FG002|Overall Study|Decrease in renal function|0|||
163381147|NCT01201317|590105893|FG000|Overall Study|Lack of Efficacy|1|||
163381148|NCT01201317|590105894|FG001|Overall Study|Lack of Efficacy|0|||
163381149|NCT01201317|590105895|FG002|Overall Study|Lack of Efficacy|0|||
163381150|NCT01201317|590105893|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
163381151|NCT01201317|590105894|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
163381152|NCT01201317|590105895|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
163381153|NCT01350336|590105896|FG000|Overall Study|Lost to Follow-up|31|||
163381154|NCT01350336|590105896|FG000|Overall Study|Withdrawal by Subject|14|||
163381155|NCT01350336|590105896|FG000|Overall Study|Physician Decision|8|||
163417565|NCT01961544|590236023|FG000|Overall Study|Adverse Event|1|||
163417566|NCT01961544|590236023|FG000|Overall Study|Physician Decision|2|||
163417567|NCT01961544|590236023|FG000|Overall Study|Poor Tolerance|1|||
163417568|NCT01961544|590236023|FG000|Overall Study|Aggravation of Steral Pain|1|||
163417569|NCT03157531|590236026|FG000|Overall Study|Death|2|||
163417570|NCT03157531|590236026|FG000|Overall Study|Lost to Follow-up|4|||
163417571|NCT02211261|590236034|FG000|Overall Study|Withdrawal by Subject|0|||
163417572|NCT02211261|590236035|FG001|Overall Study|Withdrawal by Subject|0|||
163417573|NCT02211261|590236036|FG002|Overall Study|Withdrawal by Subject|1|||
163417574|NCT02211261|590236037|FG003|Overall Study|Withdrawal by Subject|0|||
163417575|NCT02211261|590236038|FG004|Overall Study|Withdrawal by Subject|2|||
163417576|NCT02211261|590236039|FG005|Overall Study|Withdrawal by Subject|0|||
163417577|NCT02211261|590236040|FG006|Overall Study|Withdrawal by Subject|0|||
163417578|NCT02211261|590236041|FG007|Overall Study|Withdrawal by Subject|0|||
163417579|NCT02211261|590236042|FG008|Overall Study|Withdrawal by Subject|0|||
163417580|NCT02211261|590236043|FG009|Overall Study|Withdrawal by Subject|0|||
163417581|NCT02211261|590236044|FG010|Overall Study|Withdrawal by Subject|0|||
163417582|NCT02211261|590236034|FG000|Overall Study|Other|0|||
163417583|NCT02211261|590236035|FG001|Overall Study|Other|0|||
163417584|NCT02211261|590236036|FG002|Overall Study|Other|0|||
163417585|NCT02211261|590236037|FG003|Overall Study|Other|0|||
163417586|NCT02211261|590236038|FG004|Overall Study|Other|0|||
163417587|NCT02211261|590236039|FG005|Overall Study|Other|1|||
163417588|NCT02211261|590236040|FG006|Overall Study|Other|0|||
163417589|NCT02211261|590236041|FG007|Overall Study|Other|0|||
163417590|NCT02211261|590236042|FG008|Overall Study|Other|0|||
163417591|NCT02211261|590236043|FG009|Overall Study|Other|2|||
163417592|NCT02211261|590236044|FG010|Overall Study|Other|0|||
163417593|NCT02211261|590236034|FG000|Overall Study|Lost to Follow-up|0|||
163417594|NCT02211261|590236035|FG001|Overall Study|Lost to Follow-up|0|||
163417595|NCT02211261|590236036|FG002|Overall Study|Lost to Follow-up|0|||
163417596|NCT02211261|590236037|FG003|Overall Study|Lost to Follow-up|0|||
163417597|NCT02211261|590236038|FG004|Overall Study|Lost to Follow-up|0|||
163417598|NCT02211261|590236039|FG005|Overall Study|Lost to Follow-up|0|||
163417599|NCT02211261|590236040|FG006|Overall Study|Lost to Follow-up|0|||
163417600|NCT02211261|590236041|FG007|Overall Study|Lost to Follow-up|1|||
163417601|NCT02211261|590236042|FG008|Overall Study|Lost to Follow-up|0|||
163417602|NCT02211261|590236043|FG009|Overall Study|Lost to Follow-up|0|||
163417603|NCT02211261|590236044|FG010|Overall Study|Lost to Follow-up|0|||
163417604|NCT01573910|590236045|FG000|Overall Study|Adverse Event|4|||
163417605|NCT01573910|590236046|FG001|Overall Study|Adverse Event|4|||
163417606|NCT01573910|590236045|FG000|Overall Study|Lost to Follow-up|2|||
163417607|NCT01573910|590236046|FG001|Overall Study|Lost to Follow-up|1|||
163417608|NCT01573910|590236045|FG000|Overall Study|Withdrawal by Subject|0|||
163417609|NCT01573910|590236046|FG001|Overall Study|Withdrawal by Subject|1|||
163417610|NCT01573910|590236045|FG000|Overall Study|Protocol Violation|3|||
163381156|NCT01350336|590105896|FG000|Overall Study|Death|4|||
163381157|NCT02795429|590105898|FG000|Overall Study|Adverse Event|1|||
163417611|NCT01573910|590236046|FG001|Overall Study|Protocol Violation|0|||
163417612|NCT01573910|590236045|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
163417613|NCT01573910|590236046|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
163417614|NCT02251912|590236047|FG000|Overall Study|Withdrawal by Subject|2|||
163381158|NCT02795429|590105899|FG001|Overall Study|Adverse Event|2|||
163381159|NCT02795429|590105900|FG002|Overall Study|Adverse Event|1|||
163381160|NCT02795429|590105901|FG003|Overall Study|Adverse Event|2|||
163381161|NCT02795429|590105902|FG004|Overall Study|Adverse Event|1|||
163381162|NCT02795429|590105898|FG000|Overall Study|Death|1|||
163381163|NCT02795429|590105899|FG001|Overall Study|Death|0|||
163381164|NCT02795429|590105900|FG002|Overall Study|Death|1|||
163381165|NCT02795429|590105901|FG003|Overall Study|Death|2|||
163381166|NCT02795429|590105902|FG004|Overall Study|Death|1|||
163381167|NCT02795429|590105898|FG000|Overall Study|Physician Decision|0|||
163381168|NCT02795429|590105899|FG001|Overall Study|Physician Decision|0|||
163381169|NCT02795429|590105900|FG002|Overall Study|Physician Decision|2|||
163381170|NCT02795429|590105901|FG003|Overall Study|Physician Decision|1|||
163381171|NCT02795429|590105902|FG004|Overall Study|Physician Decision|5|||
163381172|NCT02795429|590105898|FG000|Overall Study|Progressive disease|3|||
163381173|NCT02795429|590105899|FG001|Overall Study|Progressive disease|7|||
163381174|NCT02795429|590105900|FG002|Overall Study|Progressive disease|6|||
163381175|NCT02795429|590105901|FG003|Overall Study|Progressive disease|26|||
163381176|NCT02795429|590105902|FG004|Overall Study|Progressive disease|20|||
163381177|NCT02795429|590105898|FG000|Overall Study|Subject/guardian decision|1|||
163381178|NCT02795429|590105899|FG001|Overall Study|Subject/guardian decision|1|||
163381179|NCT02795429|590105900|FG002|Overall Study|Subject/guardian decision|1|||
163381180|NCT02795429|590105901|FG003|Overall Study|Subject/guardian decision|1|||
163381181|NCT02795429|590105902|FG004|Overall Study|Subject/guardian decision|3|||
163381182|NCT02079610|590105903|FG000|Overall Study|Withdrawal by Subject|1|||
163381183|NCT02079610|590105904|FG001|Overall Study|Withdrawal by Subject|1|||
163381184|NCT04776148|590105905|FG000|Overall Study|Death|249|||
163381185|NCT04776148|590105906|FG001|Overall Study|Death|260|||
163381186|NCT04776148|590105905|FG000|Overall Study|Lost to Follow-up|0|||
163381187|NCT04776148|590105906|FG001|Overall Study|Lost to Follow-up|1|||
163381188|NCT04776148|590105905|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163381189|NCT04776148|590105906|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163381190|NCT04776148|590105905|FG000|Overall Study|Withdrawal by Subject|3|||
163381191|NCT04776148|590105906|FG001|Overall Study|Withdrawal by Subject|4|||
163381192|NCT04776148|590105905|FG000|Overall Study|Sponsor Decision|30|||
163381193|NCT04776148|590105906|FG001|Overall Study|Sponsor Decision|15|||
163381194|NCT01052103|590105907|FG000|Overall Study|Adverse Event|10|||
163381195|NCT01052103|590105908|FG001|Overall Study|Adverse Event|6|||
163381196|NCT01052103|590105907|FG000|Overall Study|Entry Criteria Not Met|3|||
163381197|NCT01052103|590105908|FG001|Overall Study|Entry Criteria Not Met|1|||
163381198|NCT01052103|590105907|FG000|Overall Study|Lost to Follow-up|3|||
163381199|NCT01052103|590105908|FG001|Overall Study|Lost to Follow-up|5|||
163381200|NCT01052103|590105907|FG000|Overall Study|Protocol Violation|10|||
163381201|NCT01052103|590105908|FG001|Overall Study|Protocol Violation|4|||
163381202|NCT01052103|590105907|FG000|Overall Study|Scheduling conflict|2|||
163381203|NCT01052103|590105908|FG001|Overall Study|Scheduling conflict|1|||
163381204|NCT01052103|590105907|FG000|Overall Study|Sponsor Decision|2|||
163381205|NCT01052103|590105908|FG001|Overall Study|Sponsor Decision|0|||
163381206|NCT01052103|590105907|FG000|Overall Study|Withdrawal by Subject|3|||
163381207|NCT01052103|590105908|FG001|Overall Study|Withdrawal by Subject|6|||
163381208|NCT01052103|590105907|FG000|Overall Study|Perceived Lack of Efficacy|1|||
163381209|NCT01052103|590105908|FG001|Overall Study|Perceived Lack of Efficacy|0|||
163381210|NCT00666679|590105909|FG000|First Intervention|Lost to Follow-up|1|||
163381211|NCT00666679|590105910|FG001|First Intervention|Lost to Follow-up|0|||
163381212|NCT00666679|590105909|FG000|First Intervention|Protocol Violation|1|||
163381213|NCT00666679|590105910|FG001|First Intervention|Protocol Violation|0|||
163381214|NCT00666679|590105909|FG000|First Intervention|Withdrawal by Subject|1|||
163381215|NCT00666679|590105910|FG001|First Intervention|Withdrawal by Subject|0|||
163381216|NCT00666679|590105909|FG000|First Intervention|Randomized did not start treatment|1|||
163381217|NCT00666679|590105910|FG001|First Intervention|Randomized did not start treatment|1|||
163381218|NCT00666679|590105909|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
163381219|NCT00666679|590105910|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
163381220|NCT00666679|590105909|FG000|Washout Period of 1 Week|Protocol Violation|0|||
163381221|NCT00666679|590105910|FG001|Washout Period of 1 Week|Protocol Violation|1|||
163381222|NCT00666679|590105909|FG000|Second Intervention|Adverse Event|1|||
163381223|NCT00666679|590105910|FG001|Second Intervention|Adverse Event|0|||
163381224|NCT00666679|590105909|FG000|Second Intervention|Death|0|||
163381225|NCT00666679|590105910|FG001|Second Intervention|Death|1|||
163381226|NCT00211185|590105911|FG000|Overall Study|Death|2|||
163381227|NCT00211185|590105911|FG000|Overall Study|Disease progression|7|||
163381228|NCT00211185|590105911|FG000|Overall Study|Withdrawal by Subject|6|||
163381229|NCT00211185|590105911|FG000|Overall Study|Physician Decision|5|||
163381230|NCT03658668|590105914|FG000|Overall Study|Time Commitment|1|||
163381231|NCT03658668|590105915|FG001|Overall Study|Time Commitment|1|||
163381232|NCT03305731|590105916|FG000|Overall Study|Protocol Violation|1|||
163381233|NCT04634825|590105917|FG000|Overall Study|Death|10|||
163381234|NCT04634825|590105918|FG001|Overall Study|Death|3|||
163381235|NCT04634825|590105917|FG000|Overall Study|Lost to Follow-up|1|||
163381236|NCT04634825|590105918|FG001|Overall Study|Lost to Follow-up|0|||
163381237|NCT04634825|590105917|FG000|Overall Study|Study terminated by sponsor|35|||
163381238|NCT04634825|590105918|FG001|Overall Study|Study terminated by sponsor|11|||
163381239|NCT04634825|590105917|FG000|Overall Study|Withdrawal by Subject|2|||
163381240|NCT04634825|590105918|FG001|Overall Study|Withdrawal by Subject|0|||
163381241|NCT01136772|590105921|FG000|Overall Study|Adverse Event|15|||
163381242|NCT01136772|590105922|FG001|Overall Study|Adverse Event|14|||
163381243|NCT01136772|590105921|FG000|Overall Study|Lack of Efficacy|42|||
163381244|NCT01136772|590105922|FG001|Overall Study|Lack of Efficacy|39|||
163381245|NCT01136772|590105921|FG000|Overall Study|Administrative|14|||
163381246|NCT01136772|590105922|FG001|Overall Study|Administrative|12|||
163381247|NCT01136772|590105921|FG000|Overall Study|Withdrawal by Subject|33|||
163381248|NCT01136772|590105922|FG001|Overall Study|Withdrawal by Subject|36|||
163381249|NCT01136772|590105921|FG000|Overall Study|Did not receive injection|10|||
163381250|NCT01136772|590105922|FG001|Overall Study|Did not receive injection|7|||
163381251|NCT01136772|590105921|FG000|Overall Study|Did not follow up after first injection|2|||
163381252|NCT01136772|590105922|FG001|Overall Study|Did not follow up after first injection|2|||
163381253|NCT01127139|590105923|FG000|Overall Study|Adverse Event|40|||
163381254|NCT01127139|590105923|FG000|Overall Study|Incompliance|12|||
163381255|NCT01127139|590105923|FG000|Overall Study|Lack of Efficacy|4|||
163381256|NCT01127139|590105923|FG000|Overall Study|Reason not specified|1|||
163381257|NCT03881553|590105929|FG000|Overall Study|Discharged prior to participation|1|||
163381258|NCT03881553|590105930|FG001|Overall Study|Discharged prior to participation|1|||
163381259|NCT03881553|590105931|FG002|Overall Study|Discharged prior to participation|0|||
163381260|NCT03881553|590105929|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
163381261|NCT03881553|590105930|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
163381262|NCT03881553|590105931|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
163381263|NCT01718353|590105932|FG000|Overall Study|Lost to Follow-up|0|||
163381264|NCT01718353|590105933|FG001|Overall Study|Lost to Follow-up|1|||
163381265|NCT01718353|590105932|FG000|Overall Study|Principal Investigator's Decision|10|||
163381266|NCT01718353|590105933|FG001|Overall Study|Principal Investigator's Decision|4|||
163381267|NCT01718353|590105932|FG000|Overall Study|Randomized but not treated|2|||
163381268|NCT01718353|590105933|FG001|Overall Study|Randomized but not treated|0|||
163381269|NCT01959516|590105934|FG000|Epoch 1|Adverse Event|4|||
163381270|NCT01959516|590105935|FG001|Epoch 1|Adverse Event|1|||
163381271|NCT01959516|590105934|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
163381272|NCT01959516|590105935|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
163381273|NCT01959516|590105934|FG000|Epoch 1|Subject withdrew consent|3|||
163381274|NCT01959516|590105935|FG001|Epoch 1|Subject withdrew consent|2|||
163381275|NCT01959516|590105934|FG000|Epoch 1|Administrative problems|1|||
163381276|NCT01959516|590105935|FG001|Epoch 1|Administrative problems|0|||
163381277|NCT01959516|590105934|FG000|Epoch 1|Use of prohibited treatment|1|||
163381278|NCT01959516|590105935|FG001|Epoch 1|Use of prohibited treatment|0|||
163381279|NCT01959516|590105934|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
163381280|NCT01959516|590105935|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
163381281|NCT01959516|590105934|FG000|Epoch 1|Protocol deviation|0|||
163381282|NCT01959516|590105935|FG001|Epoch 1|Protocol deviation|1|||
163381283|NCT01959516|590105934|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
163381284|NCT01959516|590105935|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
163381285|NCT01959516|590105934|FG000|Epoch 2|Subject withdrew consent|1|||
163381286|NCT01959516|590105935|FG001|Epoch 2|Subject withdrew consent|0|||
163381287|NCT01959516|590105934|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
163381288|NCT01959516|590105935|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
163381289|NCT02581631|590105946|FG000|Overall Study|Disease progression|29|||
163381290|NCT02581631|590105947|FG001|Overall Study|Disease progression|19|||
163381291|NCT02581631|590105948|FG002|Overall Study|Disease progression|13|||
163381292|NCT02581631|590105949|FG003|Overall Study|Disease progression|5|||
163381293|NCT02581631|590105950|FG004|Overall Study|Disease progression|8|||
163381294|NCT02581631|590105946|FG000|Overall Study|Study drug toxicity|4|||
163381295|NCT02581631|590105947|FG001|Overall Study|Study drug toxicity|6|||
163381296|NCT02581631|590105948|FG002|Overall Study|Study drug toxicity|7|||
163381297|NCT02581631|590105949|FG003|Overall Study|Study drug toxicity|0|||
163381298|NCT02581631|590105950|FG004|Overall Study|Study drug toxicity|3|||
163381299|NCT02581631|590105946|FG000|Overall Study|AE unrelated to study drug|3|||
163381300|NCT02581631|590105947|FG001|Overall Study|AE unrelated to study drug|1|||
163381301|NCT02581631|590105948|FG002|Overall Study|AE unrelated to study drug|1|||
163381302|NCT02581631|590105949|FG003|Overall Study|AE unrelated to study drug|0|||
163381303|NCT02581631|590105950|FG004|Overall Study|AE unrelated to study drug|2|||
163381304|NCT02581631|590105946|FG000|Overall Study|Request to discontinue|1|||
163381305|NCT02581631|590105947|FG001|Overall Study|Request to discontinue|0|||
163381306|NCT02581631|590105948|FG002|Overall Study|Request to discontinue|3|||
163381307|NCT02581631|590105949|FG003|Overall Study|Request to discontinue|0|||
163381308|NCT02581631|590105950|FG004|Overall Study|Request to discontinue|1|||
163381309|NCT02581631|590105946|FG000|Overall Study|participant withdrew consent|3|||
163381310|NCT02581631|590105947|FG001|Overall Study|participant withdrew consent|0|||
163381311|NCT02581631|590105948|FG002|Overall Study|participant withdrew consent|1|||
163381312|NCT02581631|590105949|FG003|Overall Study|participant withdrew consent|0|||
163381313|NCT02581631|590105950|FG004|Overall Study|participant withdrew consent|0|||
163381314|NCT02581631|590105946|FG000|Overall Study|Maximum clinical benefit|1|||
163381315|NCT02581631|590105947|FG001|Overall Study|Maximum clinical benefit|7|||
163381316|NCT02581631|590105948|FG002|Overall Study|Maximum clinical benefit|1|||
163381317|NCT02581631|590105949|FG003|Overall Study|Maximum clinical benefit|3|||
163381318|NCT02581631|590105950|FG004|Overall Study|Maximum clinical benefit|13|||
163381319|NCT02581631|590105946|FG000|Overall Study|Other Reasons|1|||
163381320|NCT02581631|590105947|FG001|Overall Study|Other Reasons|0|||
163381321|NCT02581631|590105948|FG002|Overall Study|Other Reasons|2|||
163381322|NCT02581631|590105949|FG003|Overall Study|Other Reasons|2|||
163381323|NCT02581631|590105950|FG004|Overall Study|Other Reasons|3|||
163381324|NCT02581631|590105946|FG000|Overall Study|Poor/Non-Compliance|0|||
163381325|NCT02581631|590105947|FG001|Overall Study|Poor/Non-Compliance|0|||
163381326|NCT02581631|590105948|FG002|Overall Study|Poor/Non-Compliance|1|||
163381327|NCT02581631|590105949|FG003|Overall Study|Poor/Non-Compliance|0|||
163381328|NCT02581631|590105950|FG004|Overall Study|Poor/Non-Compliance|0|||
163381329|NCT01759368|590105951|FG000|Overall Study|Lost to Follow-up|1|||
163381330|NCT01759368|590105952|FG001|Overall Study|Lost to Follow-up|0|||
163381331|NCT01191268|590105953|FG000|Overall Study|Withdrawal by Subject|19|||
163381332|NCT01191268|590105954|FG001|Overall Study|Withdrawal by Subject|25|||
163381333|NCT01191268|590105955|FG002|Overall Study|Withdrawal by Subject|21|||
163381334|NCT01191268|590105953|FG000|Overall Study|Adverse Event|21|||
163381335|NCT01191268|590105954|FG001|Overall Study|Adverse Event|13|||
163381336|NCT01191268|590105955|FG002|Overall Study|Adverse Event|8|||
163381337|NCT01191268|590105953|FG000|Overall Study|Physician Decision|6|||
163381338|NCT01191268|590105954|FG001|Overall Study|Physician Decision|8|||
163381339|NCT01191268|590105955|FG002|Overall Study|Physician Decision|9|||
163381340|NCT01191268|590105953|FG000|Overall Study|Lost to Follow-up|8|||
163381341|NCT01191268|590105954|FG001|Overall Study|Lost to Follow-up|5|||
163381342|NCT01191268|590105955|FG002|Overall Study|Lost to Follow-up|9|||
163381343|NCT01191268|590105953|FG000|Overall Study|Entry Criteria Not Met|3|||
163381344|NCT01191268|590105954|FG001|Overall Study|Entry Criteria Not Met|1|||
163381345|NCT01191268|590105955|FG002|Overall Study|Entry Criteria Not Met|1|||
163381346|NCT01191268|590105953|FG000|Overall Study|Death|0|||
163381347|NCT01191268|590105954|FG001|Overall Study|Death|1|||
163381348|NCT01191268|590105955|FG002|Overall Study|Death|3|||
163381349|NCT01191268|590105953|FG000|Overall Study|Protocol Violation|1|||
163381350|NCT01191268|590105954|FG001|Overall Study|Protocol Violation|0|||
163381351|NCT01191268|590105955|FG002|Overall Study|Protocol Violation|1|||
163381352|NCT01191268|590105953|FG000|Overall Study|Sponsor Decision|0|||
163381353|NCT01191268|590105954|FG001|Overall Study|Sponsor Decision|2|||
163381354|NCT01191268|590105955|FG002|Overall Study|Sponsor Decision|0|||
163381355|NCT00336895|590105956|FG000|Overall Study|diarrhea|1|||
163381356|NCT00336895|590105956|FG000|Overall Study|nausea and upset stomach|1|||
163381357|NCT00336895|590105956|FG000|Overall Study|Physician Decision|1|||
163381358|NCT00336895|590105956|FG000|Overall Study|screen failed|1|||
163381359|NCT01959334|590105957|FG000|Second Dose|Adverse Event|1|||
163381360|NCT01959334|590105958|FG001|Second Dose|Adverse Event|0|||
163381361|NCT01959334|590105957|FG000|Third Dose|Adverse Event|0|||
163381362|NCT01959334|590105958|FG001|Third Dose|Adverse Event|1|||
163381363|NCT01313689|590105959|FG000|24-Week Randomization 1|Adverse Event|10|||
163381364|NCT01313689|590105960|FG001|24-Week Randomization 1|Adverse Event|5|||
163381365|NCT01313689|590105961|FG002|24-Week Randomization 1|Adverse Event|0|||
163381366|NCT01313689|590105962|FG003|24-Week Randomization 1|Adverse Event|0|||
163381367|NCT01313689|590105963|FG004|24-Week Randomization 1|Adverse Event|0|||
163381368|NCT01313689|590105959|FG000|24-Week Randomization 1|Physician Decision|4|||
163381369|NCT01313689|590105960|FG001|24-Week Randomization 1|Physician Decision|5|||
163381370|NCT01313689|590105961|FG002|24-Week Randomization 1|Physician Decision|0|||
163381371|NCT01313689|590105962|FG003|24-Week Randomization 1|Physician Decision|0|||
163381372|NCT01313689|590105963|FG004|24-Week Randomization 1|Physician Decision|0|||
163381373|NCT01313689|590105959|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
163381374|NCT01313689|590105960|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
163381375|NCT01313689|590105961|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
163381376|NCT01313689|590105962|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
163381377|NCT01313689|590105963|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
163381378|NCT01313689|590105959|FG000|24-Week Randomization 2|Adverse Event|0|||
163381379|NCT01313689|590105960|FG001|24-Week Randomization 2|Adverse Event|0|||
163381380|NCT01313689|590105961|FG002|24-Week Randomization 2|Adverse Event|2|||
163381381|NCT01313689|590105962|FG003|24-Week Randomization 2|Adverse Event|0|||
163381382|NCT01313689|590105963|FG004|24-Week Randomization 2|Adverse Event|8|||
163381383|NCT01313689|590105959|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
163381384|NCT01313689|590105960|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
163381385|NCT01313689|590105961|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
163381386|NCT01313689|590105962|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
163381387|NCT01313689|590105963|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
163381388|NCT01313689|590105959|FG000|24-Week Randomization 2|Physician Decision|0|||
163381389|NCT01313689|590105960|FG001|24-Week Randomization 2|Physician Decision|0|||
163381390|NCT01313689|590105961|FG002|24-Week Randomization 2|Physician Decision|0|||
163381391|NCT01313689|590105962|FG003|24-Week Randomization 2|Physician Decision|0|||
163381392|NCT01313689|590105963|FG004|24-Week Randomization 2|Physician Decision|4|||
163381393|NCT01768637|590105964|FG000|Overall Study|Lost to Follow-up|2|||
163381394|NCT01768637|590105965|FG001|Overall Study|Lost to Follow-up|7|||
163381395|NCT01768637|590105964|FG000|Overall Study|Difficult blood draw|1|||
163381396|NCT01768637|590105965|FG001|Overall Study|Difficult blood draw|0|||
163381397|NCT01054170|590105966|FG000|Overall Study|Protocol Violation|1|||
163381398|NCT01054170|590105967|FG001|Overall Study|Protocol Violation|0|||
163381399|NCT01054170|590105966|FG000|Overall Study|Withdrawal by Subject|3|||
163381400|NCT01054170|590105967|FG001|Overall Study|Withdrawal by Subject|2|||
163381401|NCT01054170|590105966|FG000|Overall Study|Adverse Event|0|||
163381402|NCT01054170|590105967|FG001|Overall Study|Adverse Event|4|||
163381403|NCT02951767|590105968|FG000|Overall Study|Study Terminated By Sponsor|9|||
163381404|NCT02951767|590105968|FG000|Overall Study|Withdrawal by Subject|11|||
163381405|NCT02951767|590105968|FG000|Overall Study|Death|96|||
163381406|NCT02951767|590105968|FG000|Overall Study|Lost to Follow-up|2|||
163381407|NCT02951767|590105968|FG000|Overall Study|Physician Decision|1|||
163381408|NCT01337115|590105972|FG000|Overall Study|Protocol Violation|2|||
163381409|NCT01337115|590105973|FG001|Overall Study|Protocol Violation|0|||
163381410|NCT03426267|590105982|FG000|Overall Study|Physician Decision|1|||
163381411|NCT03426267|590105983|FG001|Overall Study|Physician Decision|4|||
163381412|NCT03426267|590105982|FG000|Overall Study|Lost to Follow-up|1|||
163381413|NCT03426267|590105983|FG001|Overall Study|Lost to Follow-up|0|||
163381414|NCT03426267|590105982|FG000|Overall Study|Withdrawal by Subject|4|||
163381415|NCT03426267|590105983|FG001|Overall Study|Withdrawal by Subject|10|||
163381416|NCT03426267|590105982|FG000|Overall Study|Protocol Violation|1|||
163381417|NCT03426267|590105983|FG001|Overall Study|Protocol Violation|3|||
163381418|NCT03426267|590105982|FG000|Overall Study|Adverse Event|9|||
163381419|NCT03426267|590105983|FG001|Overall Study|Adverse Event|27|||
163381420|NCT03426267|590105982|FG000|Overall Study|Prohibited Treatment Intake|2|||
163381421|NCT03426267|590105983|FG001|Overall Study|Prohibited Treatment Intake|3|||
163381422|NCT03426267|590105982|FG000|Overall Study|Lack of Efficacy|0|||
163381423|NCT03426267|590105983|FG001|Overall Study|Lack of Efficacy|25|||
163381424|NCT03426267|590105982|FG000|Overall Study|other|3|||
163381425|NCT03426267|590105983|FG001|Overall Study|other|0|||
163381426|NCT00609765|590105984|FG000|Overall Study|Study ended prior to 12 months|1|||
163381427|NCT02054520|590105991|FG000|Overall Study|Adverse Event|1|||
163381428|NCT02054520|590105992|FG001|Overall Study|Adverse Event|4|||
163381429|NCT02054520|590105993|FG002|Overall Study|Adverse Event|2|||
163381430|NCT02054520|590105994|FG003|Overall Study|Adverse Event|1|||
163381431|NCT02054520|590105995|FG004|Overall Study|Adverse Event|1|||
163381432|NCT02054520|590105996|FG005|Overall Study|Adverse Event|0|||
163381433|NCT02054520|590105991|FG000|Overall Study|Lack of Efficacy|7|||
163381434|NCT02054520|590105992|FG001|Overall Study|Lack of Efficacy|0|||
163381435|NCT02054520|590105993|FG002|Overall Study|Lack of Efficacy|2|||
163381436|NCT02054520|590105994|FG003|Overall Study|Lack of Efficacy|1|||
163381437|NCT02054520|590105995|FG004|Overall Study|Lack of Efficacy|3|||
163381438|NCT02054520|590105996|FG005|Overall Study|Lack of Efficacy|2|||
163381439|NCT02054520|590105991|FG000|Overall Study|Withdrawal by Subject|1|||
163381440|NCT02054520|590105992|FG001|Overall Study|Withdrawal by Subject|0|||
163381441|NCT02054520|590105993|FG002|Overall Study|Withdrawal by Subject|0|||
163381442|NCT02054520|590105994|FG003|Overall Study|Withdrawal by Subject|2|||
163381443|NCT02054520|590105995|FG004|Overall Study|Withdrawal by Subject|1|||
163381444|NCT02054520|590105996|FG005|Overall Study|Withdrawal by Subject|0|||
163381445|NCT02054520|590105991|FG000|Overall Study|Physician Decision|0|||
163381446|NCT02054520|590105992|FG001|Overall Study|Physician Decision|1|||
163381447|NCT02054520|590105993|FG002|Overall Study|Physician Decision|0|||
163381448|NCT02054520|590105994|FG003|Overall Study|Physician Decision|1|||
163381449|NCT02054520|590105995|FG004|Overall Study|Physician Decision|0|||
163381450|NCT02054520|590105996|FG005|Overall Study|Physician Decision|1|||
163381451|NCT02054520|590105991|FG000|Overall Study|Study terminated by Sponsor|0|||
163381452|NCT02054520|590105992|FG001|Overall Study|Study terminated by Sponsor|0|||
163381453|NCT02054520|590105993|FG002|Overall Study|Study terminated by Sponsor|2|||
163417615|NCT02251912|590236048|FG001|Overall Study|Withdrawal by Subject|3|||
163417616|NCT02251912|590236047|FG000|Overall Study|Adverse Event|0|||
163417617|NCT02251912|590236048|FG001|Overall Study|Adverse Event|2|||
163381454|NCT02054520|590105994|FG003|Overall Study|Study terminated by Sponsor|1|||
163381455|NCT02054520|590105995|FG004|Overall Study|Study terminated by Sponsor|0|||
163381456|NCT02054520|590105996|FG005|Overall Study|Study terminated by Sponsor|0|||
163381457|NCT02027623|590105997|FG000|Overall Study|Lost to Follow-up|3|||
163381458|NCT02027623|590105998|FG001|Overall Study|Lost to Follow-up|3|||
163381459|NCT02027623|590105997|FG000|Overall Study|Withdrawal by Subject|6|||
163381460|NCT02027623|590105998|FG001|Overall Study|Withdrawal by Subject|9|||
163381461|NCT01272804|590106001|FG000|Overall Study|Adverse Event|1|||
163381462|NCT01272804|590106002|FG001|Overall Study|Adverse Event|0|||
163381463|NCT01272804|590106003|FG002|Overall Study|Adverse Event|0|||
163381464|NCT01272804|590106004|FG003|Overall Study|Adverse Event|0|||
163381465|NCT01272804|590106005|FG004|Overall Study|Adverse Event|2|||
163381466|NCT01272804|590106006|FG005|Overall Study|Adverse Event|1|||
163381467|NCT03801915|590106007|FG000|Overall Study|Screen failure|0|||
163381468|NCT03801915|590106008|FG001|Overall Study|Screen failure|0|||
163381469|NCT03801915|590106009|FG002|Overall Study|Screen failure|1|||
163381470|NCT03801915|590106007|FG000|Overall Study|Ineligible|1|||
163381471|NCT03801915|590106008|FG001|Overall Study|Ineligible|0|||
163381472|NCT03801915|590106009|FG002|Overall Study|Ineligible|0|||
163381473|NCT03801915|590106007|FG000|Overall Study|Physician Decision|2|||
163381474|NCT03801915|590106008|FG001|Overall Study|Physician Decision|1|||
163381475|NCT03801915|590106009|FG002|Overall Study|Physician Decision|0|||
163381476|NCT02308020|590106010|FG000|Overall Study|Lost to Follow-up|1|||
163381477|NCT02308020|590106011|FG001|Overall Study|Lost to Follow-up|7|||
163381478|NCT02308020|590106012|FG002|Overall Study|Lost to Follow-up|0|||
163381479|NCT02308020|590106013|FG003|Overall Study|Lost to Follow-up|0|||
163381480|NCT02308020|590106014|FG004|Overall Study|Lost to Follow-up|1|||
163381481|NCT02308020|590106015|FG005|Overall Study|Lost to Follow-up|2|||
163381482|NCT02308020|590106010|FG000|Overall Study|Sponsor Decision|0|||
163381483|NCT02308020|590106011|FG001|Overall Study|Sponsor Decision|8|||
163381484|NCT02308020|590106012|FG002|Overall Study|Sponsor Decision|0|||
163381485|NCT02308020|590106013|FG003|Overall Study|Sponsor Decision|2|||
163381486|NCT02308020|590106014|FG004|Overall Study|Sponsor Decision|2|||
163381487|NCT02308020|590106015|FG005|Overall Study|Sponsor Decision|1|||
163381488|NCT02308020|590106010|FG000|Overall Study|Withdrawal by Subject|3|||
163381489|NCT02308020|590106011|FG001|Overall Study|Withdrawal by Subject|5|||
163381490|NCT02308020|590106012|FG002|Overall Study|Withdrawal by Subject|3|||
163381491|NCT02308020|590106013|FG003|Overall Study|Withdrawal by Subject|2|||
163381492|NCT02308020|590106014|FG004|Overall Study|Withdrawal by Subject|1|||
163381493|NCT02308020|590106015|FG005|Overall Study|Withdrawal by Subject|2|||
163381494|NCT03265938|590106016|FG000|Overall Study|Withdrawal by Subject|1|||
163381495|NCT03265938|590106016|FG000|Overall Study|Physician Decision|1|||
163381496|NCT03265938|590106016|FG000|Overall Study|friable mass|6|||
163381497|NCT01211288|590106017|FG000|Overall Study|Lost to Follow-up|1|||
163381498|NCT01211288|590106018|FG001|Overall Study|Lost to Follow-up|1|||
163381499|NCT01551212|590106019|FG000|Overall Study|Graft loss/Retransplantation|0|||
163381500|NCT01551212|590106020|FG001|Overall Study|Graft loss/Retransplantation|1|||
163381501|NCT01551212|590106019|FG000|Overall Study|Administrative problems|1|||
163381502|NCT01551212|590106020|FG001|Overall Study|Administrative problems|2|||
163381503|NCT01551212|590106019|FG000|Overall Study|Lost to Follow-up|0|||
163381504|NCT01551212|590106020|FG001|Overall Study|Lost to Follow-up|1|||
163381505|NCT01551212|590106019|FG000|Overall Study|Protocol Violation|0|||
163381506|NCT01551212|590106020|FG001|Overall Study|Protocol Violation|1|||
163381507|NCT01551212|590106019|FG000|Overall Study|Withdrawal by Subject|0|||
163381508|NCT01551212|590106020|FG001|Overall Study|Withdrawal by Subject|7|||
163381509|NCT01551212|590106019|FG000|Overall Study|Death|2|||
163381510|NCT01551212|590106020|FG001|Overall Study|Death|4|||
163381511|NCT01551212|590106019|FG000|Overall Study|Never Received Study Treatment|2|||
163381512|NCT01551212|590106020|FG001|Overall Study|Never Received Study Treatment|4|||
163381513|NCT00705523|590106021|FG000|Overall Study|Lost to Follow-up|2|||
163381514|NCT00705523|590106022|FG001|Overall Study|Lost to Follow-up|3|||
163381515|NCT02471833|590106023|FG000|Overall Study|Lost to Follow-up|1|||
163381516|NCT02471833|590106024|FG001|Overall Study|Lost to Follow-up|0|||
163381517|NCT02471833|590106025|FG002|Overall Study|Lost to Follow-up|0|||
163381518|NCT02471833|590106023|FG000|Overall Study|Withdrawal by Subject|2|||
163381519|NCT02471833|590106024|FG001|Overall Study|Withdrawal by Subject|1|||
163381520|NCT02471833|590106025|FG002|Overall Study|Withdrawal by Subject|5|||
163381521|NCT02673515|590106026|FG000|Overall Study|Lack of motivation|2|||
163381522|NCT02673515|590106027|FG001|Overall Study|Lack of motivation|1|||
163381523|NCT02523599|590106030|FG000|Overall Study|Adverse Event|1|||
163381524|NCT02523599|590106031|FG001|Overall Study|Adverse Event|0|||
163381525|NCT02523599|590106030|FG000|Overall Study|Physician Decision|1|||
163417618|NCT00268242|590236050|FG000|Overall Study|Death|1|||
163417619|NCT02175680|590236051|FG000|Overall Study|non-compliance|1|||
163381526|NCT02523599|590106031|FG001|Overall Study|Physician Decision|0|||
163381527|NCT02523599|590106030|FG000|Overall Study|Lost to Follow-up|4|||
163381528|NCT02523599|590106031|FG001|Overall Study|Lost to Follow-up|1|||
163381529|NCT02523599|590106030|FG000|Overall Study|Did not return for Day 30 visit|2|||
163381530|NCT02523599|590106031|FG001|Overall Study|Did not return for Day 30 visit|0|||
163381531|NCT01892540|590106032|FG000|Overall Study|Did not complete PET/MRI|0|||
163381532|NCT01892540|590106033|FG001|Overall Study|Did not complete PET/MRI|0|||
163381533|NCT01892540|590106034|FG002|Overall Study|Did not complete PET/MRI|2|||
163381534|NCT01892540|590106032|FG000|Overall Study|Did not fit in scanner|0|||
163381535|NCT01892540|590106033|FG001|Overall Study|Did not fit in scanner|0|||
163381536|NCT01892540|590106034|FG002|Overall Study|Did not fit in scanner|1|||
163381537|NCT01370590|590106035|FG000|Period 1|Adverse Event|8|||
163381538|NCT01370590|590106036|FG001|Period 1|Adverse Event|4|||
163381539|NCT01370590|590106035|FG000|Period 1|Lost to Follow-up|2|||
163381540|NCT01370590|590106036|FG001|Period 1|Lost to Follow-up|2|||
163381541|NCT01370590|590106035|FG000|Period 1|Protocol Violation|2|||
163381542|NCT01370590|590106036|FG001|Period 1|Protocol Violation|2|||
163381543|NCT01370590|590106035|FG000|Period 1|Withdrawal by Subject|4|||
163381544|NCT01370590|590106036|FG001|Period 1|Withdrawal by Subject|2|||
163381545|NCT01370590|590106035|FG000|Period 1|Could not access randomization system|0|||
163381546|NCT01370590|590106036|FG001|Period 1|Could not access randomization system|1|||
163381547|NCT01370590|590106035|FG000|Crossover Washout Period|Adverse Event|1|||
163381548|NCT01370590|590106036|FG001|Crossover Washout Period|Adverse Event|4|||
163381549|NCT01370590|590106035|FG000|Crossover Washout Period|Lost to Follow-up|2|||
163381550|NCT01370590|590106036|FG001|Crossover Washout Period|Lost to Follow-up|0|||
163381551|NCT01370590|590106035|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
163381552|NCT01370590|590106036|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
163381553|NCT01370590|590106035|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
163381554|NCT01370590|590106036|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
163381555|NCT01370590|590106035|FG000|Period 2|Adverse Event|0|||
163381556|NCT01370590|590106036|FG001|Period 2|Adverse Event|1|||
163381557|NCT01370590|590106035|FG000|Period 2|Withdrawal by Subject|1|||
163381558|NCT01370590|590106036|FG001|Period 2|Withdrawal by Subject|1|||
163381559|NCT03110224|590106037|FG000|Overall Study|Death|3|||
163381560|NCT03110224|590106037|FG000|Overall Study|Lost to Follow-up|132|||
163381561|NCT03110224|590106037|FG000|Overall Study|Physician Decision|2|||
163381562|NCT03110224|590106037|FG000|Overall Study|Site Closed by Physician|35|||
163381563|NCT03110224|590106037|FG000|Overall Study|Site Closed by Sponsor|202|||
163381564|NCT03110224|590106037|FG000|Overall Study|Withdrawal by Subject|9|||
163381565|NCT00727311|590106038|FG000|Overall Study|Did not receive drug|316|||
163381566|NCT00727311|590106038|FG000|Overall Study|Missing end of therapy data|205|||
163381567|NCT00727311|590106038|FG000|Overall Study|Adverse Event|58|||
163381568|NCT00727311|590106038|FG000|Overall Study|Lack of Efficacy|242|||
163381569|NCT00727311|590106038|FG000|Overall Study|Lost to Follow-up|73|||
163381570|NCT00727311|590106038|FG000|Overall Study|Withdrawal by Subject|77|||
163381571|NCT00727311|590106038|FG000|Overall Study|Other|97|||
163381572|NCT00727311|590106038|FG000|Overall Study|Multiple reasons|39|||
163381573|NCT03992846|590106039|FG000|Overall Study|Adverse Event|8|||
163381574|NCT03992846|590106040|FG001|Overall Study|Adverse Event|6|||
163381575|NCT03992846|590106041|FG002|Overall Study|Adverse Event|3|||
163381576|NCT03992846|590106039|FG000|Overall Study|Lost to Follow-up|0|||
163381577|NCT03992846|590106040|FG001|Overall Study|Lost to Follow-up|1|||
163381578|NCT03992846|590106041|FG002|Overall Study|Lost to Follow-up|1|||
163381579|NCT03992846|590106039|FG000|Overall Study|Pregnancy|2|||
163381580|NCT03992846|590106040|FG001|Overall Study|Pregnancy|0|||
163381581|NCT03992846|590106041|FG002|Overall Study|Pregnancy|1|||
163381582|NCT03992846|590106039|FG000|Overall Study|Protocol Violation|1|||
163381583|NCT03992846|590106040|FG001|Overall Study|Protocol Violation|2|||
163381584|NCT03992846|590106041|FG002|Overall Study|Protocol Violation|0|||
163381585|NCT03992846|590106039|FG000|Overall Study|Withdrawal by Subject|8|||
163381586|NCT03992846|590106040|FG001|Overall Study|Withdrawal by Subject|10|||
163381587|NCT03992846|590106041|FG002|Overall Study|Withdrawal by Subject|20|||
163381588|NCT03992846|590106039|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
163381589|NCT03992846|590106040|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
163381590|NCT03992846|590106041|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
163381591|NCT00031551|590107801|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
163381592|NCT00031551|590107802|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
163381593|NCT01440374|590107805|FG000|Part 1: Open-label Phase|Adverse Event|5|||
163381594|NCT01440374|590107806|FG001|Part 1: Open-label Phase|Adverse Event|0|||
163381595|NCT01440374|590107807|FG002|Part 1: Open-label Phase|Adverse Event|0|||
163381596|NCT01440374|590107808|FG003|Part 1: Open-label Phase|Adverse Event|0|||
163381597|NCT01440374|590107805|FG000|Part 1: Open-label Phase|Physician Decision|1|||
163381598|NCT01440374|590107806|FG001|Part 1: Open-label Phase|Physician Decision|0|||
163381599|NCT01440374|590107807|FG002|Part 1: Open-label Phase|Physician Decision|0|||
163381600|NCT01440374|590107808|FG003|Part 1: Open-label Phase|Physician Decision|0|||
163381601|NCT01440374|590107805|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
163381602|NCT01440374|590107806|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
163381603|NCT01440374|590107807|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
163381604|NCT01440374|590107808|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
163381605|NCT01440374|590107805|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
163381606|NCT01440374|590107806|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
163381607|NCT01440374|590107807|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
163381608|NCT01440374|590107808|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
163381609|NCT01440374|590107805|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
163381610|NCT01440374|590107806|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
163381611|NCT01440374|590107807|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
163381612|NCT01440374|590107808|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
163381613|NCT01440374|590107805|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
163381614|NCT01440374|590107806|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
163381615|NCT01440374|590107807|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
163381616|NCT01440374|590107808|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
163381617|NCT01440374|590107805|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
163381618|NCT01440374|590107806|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
163381619|NCT01440374|590107807|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
163381620|NCT01440374|590107808|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
163381621|NCT01440374|590107805|FG000|Part 2; Double-blind Phase|Not treated|0|||
163381622|NCT01440374|590107806|FG001|Part 2; Double-blind Phase|Not treated|0|||
163381623|NCT01440374|590107807|FG002|Part 2; Double-blind Phase|Not treated|1|||
163381624|NCT01440374|590107808|FG003|Part 2; Double-blind Phase|Not treated|0|||
163381625|NCT01440374|590107805|FG000|Part 3: Extension|Withdrawal by Subject|0|||
163381626|NCT01440374|590107806|FG001|Part 3: Extension|Withdrawal by Subject|0|||
163381627|NCT01440374|590107807|FG002|Part 3: Extension|Withdrawal by Subject|0|||
163381628|NCT01440374|590107808|FG003|Part 3: Extension|Withdrawal by Subject|5|||
163381629|NCT01440374|590107805|FG000|Part 3: Extension|Adverse Event|0|||
163381630|NCT01440374|590107806|FG001|Part 3: Extension|Adverse Event|0|||
163381631|NCT01440374|590107807|FG002|Part 3: Extension|Adverse Event|0|||
163381632|NCT01440374|590107808|FG003|Part 3: Extension|Adverse Event|13|||
163381633|NCT01440374|590107805|FG000|Part 3: Extension|Physician Decision|0|||
163381634|NCT01440374|590107806|FG001|Part 3: Extension|Physician Decision|0|||
163381635|NCT01440374|590107807|FG002|Part 3: Extension|Physician Decision|0|||
163381636|NCT01440374|590107808|FG003|Part 3: Extension|Physician Decision|14|||
163381637|NCT04812548|590107809|FG000|Overall Study|Adverse Event|2|||
163381638|NCT04812548|590107810|FG001|Overall Study|Adverse Event|7|||
163381639|NCT04812548|590107809|FG000|Overall Study|HSCT Planned|2|||
163381640|NCT04812548|590107810|FG001|Overall Study|HSCT Planned|3|||
163381641|NCT04812548|590107809|FG000|Overall Study|Progressive Disease|0|||
163381642|NCT04812548|590107810|FG001|Overall Study|Progressive Disease|2|||
163381643|NCT04812548|590107809|FG000|Overall Study|Death|0|||
163381644|NCT04812548|590107810|FG001|Overall Study|Death|1|||
163381645|NCT04812548|590107809|FG000|Overall Study|Post Study Access to Treatment|0|||
163381646|NCT04812548|590107810|FG001|Overall Study|Post Study Access to Treatment|1|||
163381647|NCT04812548|590107809|FG000|Overall Study|Withdrawal by Subject|0|||
163381648|NCT04812548|590107810|FG001|Overall Study|Withdrawal by Subject|1|||
163381649|NCT04812548|590107809|FG000|Overall Study|Physician Decision|1|||
163381650|NCT04812548|590107810|FG001|Overall Study|Physician Decision|0|||
163381651|NCT02141984|590107813|FG000|Overall Study|Lack of Efficacy|2|||
163381652|NCT00876928|590107816|FG000|Overall Study|Lost to Follow-up|2|||
163381653|NCT00876928|590107817|FG001|Overall Study|Lost to Follow-up|5|||
163381654|NCT00876928|590107816|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
163381655|NCT00876928|590107817|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
163381656|NCT01716117|590107818|FG000|Overall Study|Death|5|||
163381657|NCT01716117|590107819|FG001|Overall Study|Death|2|||
163381658|NCT01716117|590107818|FG000|Overall Study|Withdrawal by Subject|2|||
163381659|NCT01716117|590107819|FG001|Overall Study|Withdrawal by Subject|0|||
163381660|NCT03645057|590107821|FG000|Randomization to Baseline|Lost to Follow-up|1|||
163381661|NCT03645057|590107822|FG001|Randomization to Baseline|Lost to Follow-up|0|||
163381662|NCT03645057|590107823|FG002|Randomization to Baseline|Lost to Follow-up|1|||
163381663|NCT03645057|590107824|FG003|Randomization to Baseline|Lost to Follow-up|0|||
163381664|NCT03645057|590107821|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
163381665|NCT03645057|590107822|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
163381666|NCT03645057|590107823|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
163381667|NCT03645057|590107824|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
163381668|NCT03645057|590107821|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
163381669|NCT03645057|590107822|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
163381670|NCT03645057|590107823|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
163381671|NCT03645057|590107824|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
163381672|NCT03645057|590107821|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
163381673|NCT03645057|590107822|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
163381674|NCT03645057|590107823|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
163381675|NCT03645057|590107824|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
163381676|NCT01171807|590107828|FG000|Overall Study|Treatment failure|2|||
163381677|NCT01171807|590107829|FG001|Overall Study|Treatment failure|4|||
163381678|NCT01171807|590107828|FG000|Overall Study|Non compliance|1|||
163381679|NCT01171807|590107829|FG001|Overall Study|Non compliance|0|||
163381680|NCT01171807|590107828|FG000|Overall Study|Lost to Follow-up|3|||
163381681|NCT01171807|590107829|FG001|Overall Study|Lost to Follow-up|0|||
163381682|NCT01901341|590107830|FG000|Overall Study|Adverse Event|4|||
163381683|NCT01901341|590107831|FG001|Overall Study|Adverse Event|2|||
163381684|NCT01901341|590107830|FG000|Overall Study|Lack of Efficacy|0|||
163381685|NCT01901341|590107831|FG001|Overall Study|Lack of Efficacy|2|||
163381686|NCT01901341|590107830|FG000|Overall Study|Lost to Follow-up|0|||
163381687|NCT01901341|590107831|FG001|Overall Study|Lost to Follow-up|1|||
163381688|NCT01901341|590107830|FG000|Overall Study|Protocol Violation|2|||
163381689|NCT01901341|590107831|FG001|Overall Study|Protocol Violation|0|||
163381690|NCT01901341|590107830|FG000|Overall Study|Study Terminated by Sponsor|13|||
163381691|NCT01901341|590107831|FG001|Overall Study|Study Terminated by Sponsor|15|||
163381692|NCT01901341|590107830|FG000|Overall Study|Withdrawal by Subject|1|||
163381693|NCT01901341|590107831|FG001|Overall Study|Withdrawal by Subject|1|||
163381694|NCT04964388|590107832|FG000|Overall Study|Lost to Follow-up|3|||
163381695|NCT04964388|590107833|FG001|Overall Study|Lost to Follow-up|2|||
163381696|NCT00250679|590107834|FG000|Overall Study|Adverse Event|12|||
163381697|NCT00250679|590107835|FG001|Overall Study|Adverse Event|15|||
163381698|NCT00250679|590107836|FG002|Overall Study|Adverse Event|16|||
163381699|NCT00250679|590107834|FG000|Overall Study|Protocol Violation|2|||
163381700|NCT00250679|590107835|FG001|Overall Study|Protocol Violation|4|||
163381701|NCT00250679|590107836|FG002|Overall Study|Protocol Violation|3|||
163381702|NCT00250679|590107834|FG000|Overall Study|Withdrawal by Subject|15|||
163381703|NCT00250679|590107835|FG001|Overall Study|Withdrawal by Subject|18|||
163381704|NCT00250679|590107836|FG002|Overall Study|Withdrawal by Subject|15|||
163381705|NCT00250679|590107834|FG000|Overall Study|Lost to Follow-up|3|||
163381706|NCT00250679|590107835|FG001|Overall Study|Lost to Follow-up|4|||
163381707|NCT00250679|590107836|FG002|Overall Study|Lost to Follow-up|2|||
163381708|NCT00250679|590107834|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
163381709|NCT00250679|590107835|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
163381710|NCT00250679|590107836|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
163381711|NCT00250679|590107834|FG000|Overall Study|Lack of Efficacy|0|||
163381712|NCT00250679|590107835|FG001|Overall Study|Lack of Efficacy|1|||
163381713|NCT00250679|590107836|FG002|Overall Study|Lack of Efficacy|3|||
163381714|NCT00250679|590107834|FG000|Overall Study|Technical Holter issues|1|||
163381715|NCT00250679|590107835|FG001|Overall Study|Technical Holter issues|0|||
163381716|NCT00250679|590107836|FG002|Overall Study|Technical Holter issues|2|||
163381717|NCT00250679|590107834|FG000|Overall Study|Moved|1|||
163381718|NCT00250679|590107835|FG001|Overall Study|Moved|1|||
163381719|NCT00250679|590107836|FG002|Overall Study|Moved|0|||
163381720|NCT00250679|590107834|FG000|Overall Study|Non-compliance|1|||
163381721|NCT00250679|590107835|FG001|Overall Study|Non-compliance|1|||
163381722|NCT00250679|590107836|FG002|Overall Study|Non-compliance|0|||
163381723|NCT00250679|590107834|FG000|Overall Study|various single events: hip surgery,diary|3|||
163381724|NCT00250679|590107835|FG001|Overall Study|various single events: hip surgery,diary|1|||
163381725|NCT00250679|590107836|FG002|Overall Study|various single events: hip surgery,diary|1|||
163381726|NCT00448279|590107838|FG000|Overall Study|Lost to Follow-up|2|||
163381727|NCT00448279|590107839|FG001|Overall Study|Lost to Follow-up|2|||
163381728|NCT00448279|590107838|FG000|Overall Study|Adverse Event|1|||
163381729|NCT00448279|590107839|FG001|Overall Study|Adverse Event|1|||
163381730|NCT00448279|590107838|FG000|Overall Study|Disease progression|16|||
163381731|NCT00448279|590107839|FG001|Overall Study|Disease progression|18|||
163381732|NCT00448279|590107838|FG000|Overall Study|Withdrawal by Subject|4|||
163381733|NCT00448279|590107839|FG001|Overall Study|Withdrawal by Subject|3|||
163381734|NCT00448279|590107838|FG000|Overall Study|Other|6|||
163381735|NCT00448279|590107839|FG001|Overall Study|Other|4|||
163381736|NCT00448279|590107838|FG000|Overall Study|Protocol Violation|0|||
163381737|NCT00448279|590107839|FG001|Overall Study|Protocol Violation|1|||
163381738|NCT03907410|590107840|FG000|Overall Study|Lost to Follow-up|4|||
163381739|NCT03907410|590107841|FG001|Overall Study|Lost to Follow-up|1|||
163381740|NCT03907410|590107842|FG002|Overall Study|Lost to Follow-up|1|||
163381741|NCT03907410|590107840|FG000|Overall Study|Lost to follow-up and research burden|0|||
163381742|NCT03907410|590107841|FG001|Overall Study|Lost to follow-up and research burden|0|||
163381743|NCT03907410|590107842|FG002|Overall Study|Lost to follow-up and research burden|1|||
163381744|NCT01155375|590107843|FG000|Overall Study|Adverse Event|1|||
163381745|NCT01155375|590107844|FG001|Overall Study|Adverse Event|0|||
163381746|NCT00757588|590107845|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
163381747|NCT00757588|590107846|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
163381748|NCT00757588|590107845|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
163381749|NCT00757588|590107846|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
163381750|NCT00757588|590107845|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
163381751|NCT00757588|590107846|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
163381752|NCT00757588|590107845|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
163381753|NCT00757588|590107846|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
163381754|NCT00757588|590107845|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
163381755|NCT00757588|590107846|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
163381756|NCT00757588|590107845|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
163381757|NCT00757588|590107846|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
163381758|NCT00757588|590107845|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
163381759|NCT00757588|590107846|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
163381760|NCT00757588|590107845|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
163381761|NCT00757588|590107846|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
163381762|NCT00757588|590107845|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
163381763|NCT00757588|590107846|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
163381764|NCT00757588|590107845|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
163381765|NCT00757588|590107846|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
163381766|NCT00757588|590107845|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
163381767|NCT00757588|590107846|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
163381768|NCT00757588|590107845|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
163381769|NCT00757588|590107846|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
163381770|NCT00757588|590107845|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
163381771|NCT00757588|590107846|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
163381772|NCT00757588|590107845|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
163381773|NCT00757588|590107846|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
163381774|NCT00757588|590107845|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
163381775|NCT00757588|590107846|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
163381776|NCT00757588|590107845|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
163381777|NCT00757588|590107846|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
163381778|NCT02563522|590107847|FG000|Overall Study|Adverse Event|2|||
163381779|NCT02563522|590107848|FG001|Overall Study|Adverse Event|3|||
163381780|NCT02563522|590107847|FG000|Overall Study|Lost to Follow-up|1|||
163381781|NCT02563522|590107848|FG001|Overall Study|Lost to Follow-up|0|||
163381782|NCT02563522|590107847|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
163381783|NCT02563522|590107848|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
163381784|NCT04874415|590107852|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163381785|NCT04874415|590107853|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163381786|NCT04874415|590107854|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163417620|NCT02175680|590236051|FG000|Overall Study|other non-medical reason|1|||
163417621|NCT01913483|590236052|FG000|Overall Study|Withdrawal by Subject|1|||
163417622|NCT01913483|590236053|FG001|Overall Study|Withdrawal by Subject|2|||
163417623|NCT01913483|590236052|FG000|Overall Study|Lost to Follow-up|6|||
163417624|NCT01913483|590236053|FG001|Overall Study|Lost to Follow-up|3|||
163417625|NCT01913483|590236052|FG000|Overall Study|Death|14|||
163417626|NCT01913483|590236053|FG001|Overall Study|Death|17|||
163381787|NCT04874415|590107855|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163381788|NCT04874415|590107856|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163381789|NCT04874415|590107857|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163381790|NCT04874415|590107858|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
163381791|NCT04874415|590107859|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163381792|NCT04874415|590107860|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
163381793|NCT04874415|590107861|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
163381794|NCT04874415|590107862|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163381795|NCT04874415|590107863|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
163381796|NCT04874415|590107864|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
163381797|NCT04874415|590107865|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163381798|NCT04874415|590107866|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
163381799|NCT04874415|590107867|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
163381800|NCT04874415|590107852|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
163381801|NCT04874415|590107853|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
163381802|NCT04874415|590107854|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
163381803|NCT04874415|590107855|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
163381804|NCT04874415|590107856|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
163381805|NCT04874415|590107857|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
163381806|NCT04874415|590107858|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
163381807|NCT04874415|590107859|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
163381808|NCT04874415|590107860|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
163381809|NCT04874415|590107861|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
163381810|NCT04874415|590107862|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
163381811|NCT04874415|590107863|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
163381812|NCT04874415|590107864|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
163381813|NCT04874415|590107865|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
163381814|NCT04874415|590107866|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
163381815|NCT04874415|590107867|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
163381816|NCT04874415|590107852|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163381817|NCT04874415|590107853|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163381818|NCT04874415|590107854|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163381819|NCT04874415|590107855|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163381820|NCT04874415|590107856|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
163381821|NCT04874415|590107857|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163381822|NCT04874415|590107858|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163381823|NCT04874415|590107859|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163417627|NCT03969888|590236054|FG000|Overall Study|Never Received Study Drug|0|||
163417628|NCT03969888|590236055|FG001|Overall Study|Never Received Study Drug|0|||
163417629|NCT03969888|590236056|FG002|Overall Study|Never Received Study Drug|1|||
163417630|NCT03969888|590236057|FG003|Overall Study|Never Received Study Drug|0|||
163417631|NCT03969888|590236058|FG004|Overall Study|Never Received Study Drug|0|||
163381824|NCT04874415|590107860|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163381825|NCT04874415|590107861|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163381826|NCT04874415|590107862|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163381827|NCT04874415|590107863|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163381828|NCT04874415|590107864|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163381829|NCT04874415|590107865|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163381830|NCT04874415|590107866|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163381831|NCT04874415|590107867|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163381832|NCT00881608|590107868|FG000|Overall Study|Study prematurely terminated|11|||
163381833|NCT00701220|590107869|FG000|Overall Study|Withdrawal by Subject|0|||
163381834|NCT00701220|590107870|FG001|Overall Study|Withdrawal by Subject|2|||
163381835|NCT00701220|590107869|FG000|Overall Study|Protocol Violation|2|||
163381836|NCT00701220|590107870|FG001|Overall Study|Protocol Violation|0|||
163381837|NCT05559099|590107873|FG000|Overall Study|Death|5|||
163381838|NCT05559099|590107874|FG001|Overall Study|Death|4|||
163381839|NCT05559099|590107873|FG000|Overall Study|Lost to Follow-up|0|||
163381840|NCT05559099|590107874|FG001|Overall Study|Lost to Follow-up|2|||
163381841|NCT05559099|590107873|FG000|Overall Study|Adverse Event|1|||
163381842|NCT05559099|590107874|FG001|Overall Study|Adverse Event|1|||
163381843|NCT04018092|590107875|FG000|Overall Study|Withdrawal by Subject|1|||
163381844|NCT04018092|590107876|FG001|Overall Study|Withdrawal by Subject|1|||
163381845|NCT04018092|590107875|FG000|Overall Study|Withdrawal by Subject|1|||
163381846|NCT04018092|590107876|FG001|Overall Study|Withdrawal by Subject|1|||
163381847|NCT06469242|590107877|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
163381848|NCT06469242|590107878|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
163381849|NCT06469242|590107877|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
163381850|NCT06469242|590107878|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
163381851|NCT01205152|590107879|FG000|Overall Study|Death|1|||
163381852|NCT00069108|590107880|FG000|Overall Study|Withdrawal by Subject|5|||
163381853|NCT00069108|590107881|FG001|Overall Study|Withdrawal by Subject|9|||
163381854|NCT00069108|590107880|FG000|Overall Study|Adverse Event|64|||
163381855|NCT00069108|590107881|FG001|Overall Study|Adverse Event|42|||
163381856|NCT00069108|590107880|FG000|Overall Study|Death|6|||
163381857|NCT00069108|590107881|FG001|Overall Study|Death|6|||
163381858|NCT00069108|590107880|FG000|Overall Study|Administration|15|||
163381859|NCT00069108|590107881|FG001|Overall Study|Administration|4|||
163381860|NCT00069108|590107880|FG000|Overall Study|Insufficient therapy|117|||
163381861|NCT00069108|590107881|FG001|Overall Study|Insufficient therapy|144|||
163381862|NCT00069108|590107880|FG000|Overall Study|Violation criteria|1|||
163381863|NCT00069108|590107881|FG001|Overall Study|Violation criteria|4|||
163381864|NCT00069108|590107880|FG000|Overall Study|Refused treatment|5|||
163381865|NCT00069108|590107881|FG001|Overall Study|Refused treatment|10|||
163381866|NCT02783768|590107882|FG000|Overall Study|Lost to Follow-up|1|||
163381867|NCT02783768|590107883|FG001|Overall Study|Lost to Follow-up|0|||
163381868|NCT02208999|590107884|FG000|Overall Study|Lost to Follow-up|1|||
163381869|NCT00319839|590107885|FG000|Overall Study|Adverse Event|5|||
163381870|NCT00319839|590107885|FG000|Overall Study|Withdrawal by Subject|1|||
163381871|NCT00986674|590107886|FG000|Overall Study|Lack of Efficacy|28|||
163381872|NCT00986674|590107887|FG001|Overall Study|Lack of Efficacy|25|||
163381873|NCT00986674|590107888|FG002|Overall Study|Lack of Efficacy|23|||
163381874|NCT00986674|590107886|FG000|Overall Study|Adverse Event|4|||
163381875|NCT00986674|590107887|FG001|Overall Study|Adverse Event|8|||
163381876|NCT00986674|590107888|FG002|Overall Study|Adverse Event|9|||
163381877|NCT00986674|590107886|FG000|Overall Study|Death|5|||
163381878|NCT00986674|590107887|FG001|Overall Study|Death|0|||
163381879|NCT00986674|590107888|FG002|Overall Study|Death|4|||
163381880|NCT00986674|590107886|FG000|Overall Study|Withdrawal by Subject|6|||
163381881|NCT00986674|590107887|FG001|Overall Study|Withdrawal by Subject|2|||
163381882|NCT00986674|590107888|FG002|Overall Study|Withdrawal by Subject|1|||
163381883|NCT00986674|590107886|FG000|Overall Study|alternative therapy|0|||
163381884|NCT00986674|590107887|FG001|Overall Study|alternative therapy|0|||
163381885|NCT00986674|590107888|FG002|Overall Study|alternative therapy|1|||
163381886|NCT00986674|590107886|FG000|Overall Study|not start protocol therapy|4|||
163381887|NCT00986674|590107887|FG001|Overall Study|not start protocol therapy|3|||
163381888|NCT00986674|590107888|FG002|Overall Study|not start protocol therapy|1|||
163381889|NCT00986674|590107886|FG000|Overall Study|unknown/not specify|0|||
163381890|NCT00986674|590107887|FG001|Overall Study|unknown/not specify|7|||
163381891|NCT00986674|590107888|FG002|Overall Study|unknown/not specify|9|||
163381892|NCT01853137|590107889|FG000|Overall Study|Lost to Follow-up|4|||
163381893|NCT01853137|590107890|FG001|Overall Study|Lost to Follow-up|1|||
163381894|NCT01037244|590107891|FG000|Overall Study|Adverse Event|3|||
163381895|NCT01037244|590107892|FG001|Overall Study|Adverse Event|2|||
163381896|NCT01037244|590107893|FG002|Overall Study|Adverse Event|6|||
163381897|NCT01037244|590107894|FG003|Overall Study|Adverse Event|3|||
163381898|NCT01037244|590107891|FG000|Overall Study|Lack of Efficacy|1|||
163381899|NCT01037244|590107892|FG001|Overall Study|Lack of Efficacy|1|||
163381900|NCT01037244|590107893|FG002|Overall Study|Lack of Efficacy|0|||
163381901|NCT01037244|590107894|FG003|Overall Study|Lack of Efficacy|1|||
163381902|NCT01037244|590107891|FG000|Overall Study|Lost to Follow-up|3|||
163381903|NCT01037244|590107892|FG001|Overall Study|Lost to Follow-up|3|||
163381904|NCT01037244|590107893|FG002|Overall Study|Lost to Follow-up|4|||
163381905|NCT01037244|590107894|FG003|Overall Study|Lost to Follow-up|4|||
163381906|NCT01037244|590107891|FG000|Overall Study|Withdrawal by Subject|1|||
163381907|NCT01037244|590107892|FG001|Overall Study|Withdrawal by Subject|5|||
163381908|NCT01037244|590107893|FG002|Overall Study|Withdrawal by Subject|3|||
163381909|NCT01037244|590107894|FG003|Overall Study|Withdrawal by Subject|5|||
163381910|NCT01037244|590107891|FG000|Overall Study|Partner Withdrew Consent|2|||
163381911|NCT01037244|590107892|FG001|Overall Study|Partner Withdrew Consent|1|||
163381912|NCT01037244|590107893|FG002|Overall Study|Partner Withdrew Consent|0|||
163381913|NCT01037244|590107894|FG003|Overall Study|Partner Withdrew Consent|0|||
163381914|NCT01037244|590107891|FG000|Overall Study|Various|3|||
163381915|NCT01037244|590107892|FG001|Overall Study|Various|2|||
163381916|NCT01037244|590107893|FG002|Overall Study|Various|1|||
163381917|NCT01037244|590107894|FG003|Overall Study|Various|1|||
163381918|NCT00690820|590107895|FG000|Period 1|Withdrawal by Subject|0|||
163381919|NCT00690820|590107896|FG001|Period 1|Withdrawal by Subject|1|||
163381920|NCT00848926|590107897|FG000|Treatment Period|Progressive disease|45|||
163381921|NCT00848926|590107897|FG000|Treatment Period|Adverse Event|20|||
163381922|NCT00848926|590107897|FG000|Treatment Period|Physician Decision|12|||
163381923|NCT00848926|590107897|FG000|Treatment Period|Withdrawal by Subject|7|||
163381924|NCT00848926|590107897|FG000|Follow-up Period|Lost to Follow-up|7|||
163381925|NCT00848926|590107897|FG000|Follow-up Period|Withdrawal by Subject|3|||
163381926|NCT00848926|590107897|FG000|Follow-up Period|Other|2|||
163381927|NCT00903630|590107898|FG000|Phase 2|Adverse Event|0|||
163381928|NCT00903630|590107899|FG001|Phase 2|Adverse Event|0|||
163381929|NCT00903630|590107900|FG002|Phase 2|Adverse Event|1|||
163381930|NCT04025580|590107901|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
163381931|NCT04025580|590107902|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
163381932|NCT04025580|590107903|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
163381933|NCT02216357|590107904|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
163381934|NCT02216357|590107905|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
163381935|NCT01790126|590107907|FG000|Overall Study|PSA Progression|12|||
163381936|NCT01790126|590107908|FG001|Overall Study|PSA Progression|16|||
163381937|NCT01790126|590107909|FG002|Overall Study|PSA Progression|16|||
163381938|NCT01790126|590107907|FG000|Overall Study|Other|5|||
163381939|NCT01790126|590107908|FG001|Overall Study|Other|4|||
163381940|NCT01790126|590107909|FG002|Overall Study|Other|8|||
163381941|NCT01790126|590107907|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
163381942|NCT01790126|590107908|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
163381943|NCT01790126|590107909|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
163381944|NCT01790126|590107907|FG000|Overall Study|Withdrawal by Physician|1|||
163381945|NCT01790126|590107908|FG001|Overall Study|Withdrawal by Physician|1|||
163381946|NCT01790126|590107909|FG002|Overall Study|Withdrawal by Physician|2|||
163381947|NCT01790126|590107907|FG000|Overall Study|Withdrawal by Subject|3|||
163381948|NCT01790126|590107908|FG001|Overall Study|Withdrawal by Subject|1|||
163381949|NCT01790126|590107909|FG002|Overall Study|Withdrawal by Subject|2|||
163381950|NCT01790126|590107907|FG000|Overall Study|Lost to Follow-up|1|||
163381951|NCT01790126|590107908|FG001|Overall Study|Lost to Follow-up|0|||
163417632|NCT03969888|590236059|FG005|Overall Study|Never Received Study Drug|0|||
163417633|NCT03969888|590236060|FG006|Overall Study|Never Received Study Drug|1|||
163417634|NCT03969888|590236061|FG007|Overall Study|Never Received Study Drug|0|||
163417635|NCT03969888|590236054|FG000|Overall Study|Reason Not Specified|0|||
163417636|NCT03969888|590236055|FG001|Overall Study|Reason Not Specified|0|||
163417637|NCT03969888|590236056|FG002|Overall Study|Reason Not Specified|0|||
163417638|NCT03969888|590236057|FG003|Overall Study|Reason Not Specified|0|||
163417639|NCT03969888|590236058|FG004|Overall Study|Reason Not Specified|0|||
163417640|NCT03969888|590236059|FG005|Overall Study|Reason Not Specified|0|||
163417641|NCT03969888|590236060|FG006|Overall Study|Reason Not Specified|0|||
163381952|NCT01790126|590107909|FG002|Overall Study|Lost to Follow-up|1|||
163417642|NCT03969888|590236061|FG007|Overall Study|Reason Not Specified|1|||
163417643|NCT04062214|590236064|FG000|Week 12|Death|1|||
163417644|NCT04062214|590236065|FG001|Week 12|Death|1|||
163417645|NCT04062214|590236064|FG000|Week 12|Withdrawal by Subject|14|||
163417646|NCT04062214|590236065|FG001|Week 12|Withdrawal by Subject|13|||
163381953|NCT01790126|590107907|FG000|Overall Study|Adverse Event|0|||
163417647|NCT04062214|590236064|FG000|Week 12|Lost to Follow-up|55|||
163417648|NCT04062214|590236065|FG001|Week 12|Lost to Follow-up|68|||
163381954|NCT01790126|590107908|FG001|Overall Study|Adverse Event|2|||
163417649|NCT04062214|590236064|FG000|Week 12|Intermittent missing|31|||
163417650|NCT04062214|590236065|FG001|Week 12|Intermittent missing|29|||
163381955|NCT01790126|590107909|FG002|Overall Study|Adverse Event|0|||
163381956|NCT01790126|590107907|FG000|Overall Study|Death|2|||
163381957|NCT01790126|590107908|FG001|Overall Study|Death|0|||
163381958|NCT01790126|590107909|FG002|Overall Study|Death|0|||
163417651|NCT04062214|590236064|FG000|Week 36|Withdrawal by Subject|4|||
163381959|NCT01790126|590107907|FG000|Overall Study|Radiographic Progression|3|||
163381960|NCT01790126|590107908|FG001|Overall Study|Radiographic Progression|1|||
163381961|NCT01790126|590107909|FG002|Overall Study|Radiographic Progression|0|||
163381962|NCT00455325|590107910|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
163381963|NCT00455325|590107911|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
163381964|NCT00455325|590107912|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
163381965|NCT00455325|590107913|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
163381966|NCT00455325|590107910|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
163381967|NCT00455325|590107911|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
163381968|NCT00455325|590107912|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
163381969|NCT00455325|590107913|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
163381970|NCT00455325|590107910|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
163381971|NCT00455325|590107911|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
163381972|NCT00455325|590107912|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
163381973|NCT00455325|590107913|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
163381974|NCT00455325|590107910|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
163381975|NCT00455325|590107911|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
163381976|NCT00455325|590107912|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
163381977|NCT00455325|590107913|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
163381978|NCT00455325|590107910|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
163381979|NCT00455325|590107911|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
163381980|NCT00455325|590107912|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
163381981|NCT00455325|590107913|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
163381982|NCT00455325|590107910|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
163381983|NCT00455325|590107911|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
163381984|NCT00455325|590107912|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
163381985|NCT00455325|590107913|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
163381986|NCT00455325|590107910|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
163381987|NCT00455325|590107911|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
163381988|NCT00455325|590107912|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
163381989|NCT00455325|590107913|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
163381990|NCT02435966|590107914|FG000|Overall Study|Withdrawal by Subject|0|||
163381991|NCT02435966|590107915|FG001|Overall Study|Withdrawal by Subject|1|||
163381992|NCT02435966|590107916|FG002|Overall Study|Withdrawal by Subject|0|||
163381993|NCT00928746|590107917|FG000|Overall Study|Adverse Event|2|||
163381994|NCT00928746|590107917|FG000|Overall Study|Protocol Violation|1|||
163381995|NCT00928746|590107917|FG000|Overall Study|Withdrawal by Subject|1|||
163381996|NCT00928746|590107917|FG000|Overall Study|Other|2|||
163381997|NCT02745392|590107922|FG000|Overall Study|Lost to Follow-up|0|||
163381998|NCT02745392|590107923|FG001|Overall Study|Lost to Follow-up|1|||
163381999|NCT02745392|590107924|FG002|Overall Study|Lost to Follow-up|0|||
163382000|NCT02745392|590107925|FG003|Overall Study|Lost to Follow-up|0|||
163382001|NCT02004353|590107930|FG000|Overall Study|Voluntary participation|1334|||
163382002|NCT02481947|590107940|FG000|Overall Study|Withdrawal by Subject|24|||
163382003|NCT02481947|590107941|FG001|Overall Study|Withdrawal by Subject|10|||
163382004|NCT02481947|590107940|FG000|Overall Study|Lost to Follow-up|11|||
163382005|NCT02481947|590107941|FG001|Overall Study|Lost to Follow-up|5|||
163382006|NCT02481947|590107940|FG000|Overall Study|Adverse Event|6|||
163382007|NCT02481947|590107941|FG001|Overall Study|Adverse Event|11|||
163382008|NCT02481947|590107940|FG000|Overall Study|Physician Decision|4|||
163382009|NCT02481947|590107941|FG001|Overall Study|Physician Decision|5|||
163382010|NCT02481947|590107940|FG000|Overall Study|Protocol Violation|1|||
163382011|NCT02481947|590107941|FG001|Overall Study|Protocol Violation|5|||
163382012|NCT01007448|590107942|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
163382013|NCT01007448|590107943|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
163382014|NCT01007448|590107942|FG000|Overall Study|Staph Skin Infection Flare|1|||
163382015|NCT01007448|590107943|FG001|Overall Study|Staph Skin Infection Flare|0|||
163382016|NCT01007448|590107942|FG000|Overall Study|Participant Leaving the Country|1|||
163382017|NCT01007448|590107943|FG001|Overall Study|Participant Leaving the Country|0|||
163382018|NCT01007448|590107942|FG000|Overall Study|Participant Given Prohibited Medication|1|||
163382019|NCT01007448|590107943|FG001|Overall Study|Participant Given Prohibited Medication|0|||
163382020|NCT01007448|590107942|FG000|Overall Study|Progressive Disease|1|||
163382021|NCT01007448|590107943|FG001|Overall Study|Progressive Disease|2|||
163382022|NCT01007448|590107942|FG000|Overall Study|Lack of Efficacy|2|||
163382023|NCT01007448|590107943|FG001|Overall Study|Lack of Efficacy|0|||
163382024|NCT01007448|590107942|FG000|Overall Study|Withdrawal by Subject|2|||
163382025|NCT01007448|590107943|FG001|Overall Study|Withdrawal by Subject|3|||
163382026|NCT01007448|590107942|FG000|Overall Study|Adverse Event|1|||
163382027|NCT01007448|590107943|FG001|Overall Study|Adverse Event|4|||
163382028|NCT02751320|590107944|FG000|Overall Study|Adverse Event|2|||
163382029|NCT02751320|590107944|FG000|Overall Study|Withdrawal by Subject|1|||
163417652|NCT04062214|590236065|FG001|Week 36|Withdrawal by Subject|5|||
163382030|NCT03426605|590107945|FG000|Overall Study|AML relapse or progression|2|||
163382031|NCT03426605|590107946|FG001|Overall Study|AML relapse or progression|1|||
163382032|NCT03426605|590107947|FG002|Overall Study|AML relapse or progression|2|||
163382033|NCT03426605|590107948|FG003|Overall Study|AML relapse or progression|2|||
163382034|NCT03426605|590107945|FG000|Overall Study|Treatment failure|3|||
163382035|NCT03426605|590107946|FG001|Overall Study|Treatment failure|2|||
163382036|NCT03426605|590107947|FG002|Overall Study|Treatment failure|0|||
163382037|NCT03426605|590107948|FG003|Overall Study|Treatment failure|0|||
163382038|NCT03426605|590107945|FG000|Overall Study|Adverse Event|1|||
163382039|NCT03426605|590107946|FG001|Overall Study|Adverse Event|0|||
163382040|NCT03426605|590107947|FG002|Overall Study|Adverse Event|1|||
163382041|NCT03426605|590107948|FG003|Overall Study|Adverse Event|1|||
163382042|NCT03426605|590107945|FG000|Overall Study|Withdrawal by Subject|0|||
163382043|NCT03426605|590107946|FG001|Overall Study|Withdrawal by Subject|0|||
163382044|NCT03426605|590107947|FG002|Overall Study|Withdrawal by Subject|1|||
163382045|NCT03426605|590107948|FG003|Overall Study|Withdrawal by Subject|1|||
163382046|NCT01886378|590107949|FG000|Overall Study|Adverse Event|1|||
163382047|NCT01886378|590107949|FG000|Overall Study|Withdrawal by Subject|4|||
163382048|NCT01270971|590107950|FG000|Overall Study|Withdrawal by Subject|24|||
163382049|NCT01270971|590107951|FG001|Overall Study|Withdrawal by Subject|11|||
163382050|NCT01270971|590107950|FG000|Overall Study|Lost to Follow-up|18|||
163382051|NCT01270971|590107951|FG001|Overall Study|Lost to Follow-up|5|||
163382052|NCT01270971|590107950|FG000|Overall Study|Adverse Event|1|||
163382053|NCT01270971|590107951|FG001|Overall Study|Adverse Event|2|||
163382054|NCT01270971|590107950|FG000|Overall Study|Non compliance|2|||
163382055|NCT01270971|590107951|FG001|Overall Study|Non compliance|2|||
163382056|NCT01270971|590107950|FG000|Overall Study|Non-specific|7|||
163382057|NCT01270971|590107951|FG001|Overall Study|Non-specific|3|||
163382058|NCT04217590|590107960|FG000|Overall Study|Other|1|||
163382059|NCT04217590|590107961|FG001|Overall Study|Other|1|||
163382060|NCT04217590|590107960|FG000|Overall Study|Withdrawal by Subject|3|||
163382061|NCT04217590|590107961|FG001|Overall Study|Withdrawal by Subject|1|||
163382062|NCT04217590|590107960|FG000|Overall Study|Death|0|||
163382063|NCT04217590|590107961|FG001|Overall Study|Death|1|||
163382064|NCT02232243|590107964|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
163382065|NCT02232243|590107965|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
163382066|NCT02232243|590107966|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
163382067|NCT01395888|590107967|FG000|2-week Run-in Period|Adverse Event|2|||
163382068|NCT01395888|590107968|FG001|2-week Run-in Period|Adverse Event|0|||
163382069|NCT01395888|590107969|FG002|2-week Run-in Period|Adverse Event|0|||
163382070|NCT01395888|590107967|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
163382071|NCT01395888|590107968|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
163382072|NCT01395888|590107969|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
163382073|NCT01395888|590107967|FG000|2-week Run-in Period|Lost to Follow-up|1|||
163382074|NCT01395888|590107968|FG001|2-week Run-in Period|Lost to Follow-up|0|||
163382075|NCT01395888|590107969|FG002|2-week Run-in Period|Lost to Follow-up|0|||
163382076|NCT01395888|590107967|FG000|2-week Run-in Period|Protocol Violation|2|||
163382077|NCT01395888|590107968|FG001|2-week Run-in Period|Protocol Violation|0|||
163382078|NCT01395888|590107969|FG002|2-week Run-in Period|Protocol Violation|0|||
163382079|NCT01395888|590107967|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
163382080|NCT01395888|590107968|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
163382081|NCT01395888|590107969|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
163382082|NCT01395888|590107967|FG000|Treatment Period (TP)|Adverse Event|0|||
163382083|NCT01395888|590107968|FG001|Treatment Period (TP)|Adverse Event|7|||
163382084|NCT01395888|590107969|FG002|Treatment Period (TP)|Adverse Event|6|||
163382085|NCT01395888|590107967|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
163382086|NCT01395888|590107968|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
163382087|NCT01395888|590107969|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
163382088|NCT01395888|590107967|FG000|Treatment Period (TP)|Protocol Violation|0|||
163382089|NCT01395888|590107968|FG001|Treatment Period (TP)|Protocol Violation|1|||
163382090|NCT01395888|590107969|FG002|Treatment Period (TP)|Protocol Violation|5|||
163382091|NCT01395888|590107967|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
163382092|NCT01395888|590107968|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
163382093|NCT01395888|590107969|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
163382094|NCT01395888|590107967|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
163382095|NCT01395888|590107968|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
163382096|NCT01395888|590107969|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
163382097|NCT01946438|590107970|FG000|Overall Study|Adverse Event|0|||
163382098|NCT01946438|590107971|FG001|Overall Study|Adverse Event|0|||
163382099|NCT01946438|590107972|FG002|Overall Study|Adverse Event|0|||
163382100|NCT01946438|590107973|FG003|Overall Study|Adverse Event|1|||
163382101|NCT01946438|590107970|FG000|Overall Study|Serious Adverse event|1|||
163382102|NCT01946438|590107971|FG001|Overall Study|Serious Adverse event|0|||
163382103|NCT01946438|590107972|FG002|Overall Study|Serious Adverse event|0|||
163382104|NCT01946438|590107973|FG003|Overall Study|Serious Adverse event|0|||
163382105|NCT01946438|590107970|FG000|Overall Study|Protocol Violation|0|||
163382106|NCT01946438|590107971|FG001|Overall Study|Protocol Violation|0|||
163382107|NCT01946438|590107972|FG002|Overall Study|Protocol Violation|1|||
163382108|NCT01946438|590107973|FG003|Overall Study|Protocol Violation|0|||
163382109|NCT01946438|590107970|FG000|Overall Study|Withdrawal by Subject|1|||
163382110|NCT01946438|590107971|FG001|Overall Study|Withdrawal by Subject|0|||
163382111|NCT01946438|590107972|FG002|Overall Study|Withdrawal by Subject|0|||
163382112|NCT01946438|590107973|FG003|Overall Study|Withdrawal by Subject|0|||
163382113|NCT02457559|590107974|FG000|Overall Study|Progressive Disease|1|||
163382114|NCT02457559|590107975|FG001|Overall Study|Progressive Disease|2|||
163382115|NCT02457559|590107976|FG002|Overall Study|Progressive Disease|3|||
163382116|NCT02457559|590107977|FG003|Overall Study|Progressive Disease|0|||
163382117|NCT02457559|590107978|FG004|Overall Study|Progressive Disease|0|||
163382118|NCT02457559|590107979|FG005|Overall Study|Progressive Disease|2|||
163382119|NCT02457559|590107980|FG006|Overall Study|Progressive Disease|1|||
163382120|NCT02457559|590107981|FG007|Overall Study|Progressive Disease|0|||
163382121|NCT02457559|590107982|FG008|Overall Study|Progressive Disease|1|||
163382122|NCT02457559|590107983|FG009|Overall Study|Progressive Disease|1|||
163382123|NCT02457559|590107984|FG010|Overall Study|Progressive Disease|1|||
163382124|NCT02457559|590107974|FG000|Overall Study|Investigator's Discretion|0|||
163382125|NCT02457559|590107975|FG001|Overall Study|Investigator's Discretion|0|||
163382126|NCT02457559|590107976|FG002|Overall Study|Investigator's Discretion|2|||
163382127|NCT02457559|590107977|FG003|Overall Study|Investigator's Discretion|0|||
163382128|NCT02457559|590107978|FG004|Overall Study|Investigator's Discretion|1|||
163382129|NCT02457559|590107979|FG005|Overall Study|Investigator's Discretion|0|||
163382130|NCT02457559|590107980|FG006|Overall Study|Investigator's Discretion|1|||
163382131|NCT02457559|590107981|FG007|Overall Study|Investigator's Discretion|0|||
163382132|NCT02457559|590107982|FG008|Overall Study|Investigator's Discretion|1|||
163382133|NCT02457559|590107983|FG009|Overall Study|Investigator's Discretion|0|||
163382134|NCT02457559|590107984|FG010|Overall Study|Investigator's Discretion|1|||
163382135|NCT02457559|590107974|FG000|Overall Study|Adverse Event|0|||
163382136|NCT02457559|590107975|FG001|Overall Study|Adverse Event|1|||
163382137|NCT02457559|590107976|FG002|Overall Study|Adverse Event|2|||
163382138|NCT02457559|590107977|FG003|Overall Study|Adverse Event|0|||
163382139|NCT02457559|590107978|FG004|Overall Study|Adverse Event|0|||
163382140|NCT02457559|590107979|FG005|Overall Study|Adverse Event|0|||
163382141|NCT02457559|590107980|FG006|Overall Study|Adverse Event|0|||
163382142|NCT02457559|590107981|FG007|Overall Study|Adverse Event|0|||
163382143|NCT02457559|590107982|FG008|Overall Study|Adverse Event|0|||
163382144|NCT02457559|590107983|FG009|Overall Study|Adverse Event|0|||
163382145|NCT02457559|590107984|FG010|Overall Study|Adverse Event|0|||
163382146|NCT02457559|590107974|FG000|Overall Study|Reason not Specified|1|||
163382147|NCT02457559|590107975|FG001|Overall Study|Reason not Specified|0|||
163382148|NCT02457559|590107976|FG002|Overall Study|Reason not Specified|0|||
163382149|NCT02457559|590107977|FG003|Overall Study|Reason not Specified|0|||
163382150|NCT02457559|590107978|FG004|Overall Study|Reason not Specified|0|||
163382151|NCT02457559|590107979|FG005|Overall Study|Reason not Specified|0|||
163382152|NCT02457559|590107980|FG006|Overall Study|Reason not Specified|0|||
163382153|NCT02457559|590107981|FG007|Overall Study|Reason not Specified|0|||
163382154|NCT02457559|590107982|FG008|Overall Study|Reason not Specified|0|||
163382155|NCT02457559|590107983|FG009|Overall Study|Reason not Specified|2|||
163382156|NCT02457559|590107984|FG010|Overall Study|Reason not Specified|0|||
163382157|NCT02457559|590107974|FG000|Overall Study|Death|0|||
163382158|NCT02457559|590107975|FG001|Overall Study|Death|0|||
163382159|NCT02457559|590107976|FG002|Overall Study|Death|0|||
163382160|NCT02457559|590107977|FG003|Overall Study|Death|0|||
163382161|NCT02457559|590107978|FG004|Overall Study|Death|0|||
163382162|NCT02457559|590107979|FG005|Overall Study|Death|0|||
163382163|NCT02457559|590107980|FG006|Overall Study|Death|0|||
163382164|NCT02457559|590107981|FG007|Overall Study|Death|0|||
163382165|NCT02457559|590107982|FG008|Overall Study|Death|1|||
163382166|NCT02457559|590107983|FG009|Overall Study|Death|1|||
163382167|NCT02457559|590107984|FG010|Overall Study|Death|0|||
163382168|NCT02412371|590107985|FG000|Overall Study|Withdrawal by Subject|0|||
163382169|NCT02412371|590107986|FG001|Overall Study|Withdrawal by Subject|2|||
163382170|NCT02412371|590107987|FG002|Overall Study|Withdrawal by Subject|0|||
163382171|NCT02412371|590107988|FG003|Overall Study|Withdrawal by Subject|1|||
163382172|NCT02412371|590107989|FG004|Overall Study|Withdrawal by Subject|1|||
163382173|NCT02412371|590107990|FG005|Overall Study|Withdrawal by Subject|0|||
163382174|NCT02412371|590107985|FG000|Overall Study|Sponsor Discontinued Study|1|||
163382175|NCT02412371|590107986|FG001|Overall Study|Sponsor Discontinued Study|4|||
163382176|NCT02412371|590107987|FG002|Overall Study|Sponsor Discontinued Study|6|||
163382177|NCT02412371|590107988|FG003|Overall Study|Sponsor Discontinued Study|4|||
163382178|NCT02412371|590107989|FG004|Overall Study|Sponsor Discontinued Study|5|||
163382179|NCT02412371|590107990|FG005|Overall Study|Sponsor Discontinued Study|0|||
163382180|NCT02412371|590107985|FG000|Overall Study|Death|4|||
163382181|NCT02412371|590107986|FG001|Overall Study|Death|2|||
163382182|NCT02412371|590107987|FG002|Overall Study|Death|1|||
163382183|NCT02412371|590107988|FG003|Overall Study|Death|3|||
163382184|NCT02412371|590107989|FG004|Overall Study|Death|5|||
163382185|NCT02412371|590107990|FG005|Overall Study|Death|2|||
163382186|NCT02412371|590107985|FG000|Overall Study|Other|2|||
163382187|NCT02412371|590107986|FG001|Overall Study|Other|1|||
163382188|NCT02412371|590107987|FG002|Overall Study|Other|0|||
163382189|NCT02412371|590107988|FG003|Overall Study|Other|0|||
163382190|NCT02412371|590107989|FG004|Overall Study|Other|1|||
163382191|NCT02412371|590107990|FG005|Overall Study|Other|3|||
163382192|NCT03169101|590107991|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
163382193|NCT03169101|590107992|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
163382194|NCT03169101|590107993|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
163382195|NCT03169101|590107994|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
163382196|NCT02641496|590107995|FG000|Overall Study|Lost to Follow-up|13|||
163382197|NCT02641496|590107996|FG001|Overall Study|Lost to Follow-up|12|||
163382198|NCT02641496|590107995|FG000|Overall Study|Withdrawal by Subject|1|||
163382199|NCT02641496|590107996|FG001|Overall Study|Withdrawal by Subject|0|||
163382200|NCT05590884|590107999|FG000|Overall Study|Withdrawal by Subject|1|||
163382201|NCT05590884|590108000|FG001|Overall Study|Withdrawal by Subject|0|||
163382202|NCT05590884|590108001|FG002|Overall Study|Withdrawal by Subject|0|||
163382203|NCT00171704|590109680|FG000|Overall Study|Adverse Event|24|||
163382204|NCT00171704|590109681|FG001|Overall Study|Adverse Event|33|||
163382205|NCT00171704|590109680|FG000|Overall Study|Disease Progression|14|||
163382206|NCT00171704|590109681|FG001|Overall Study|Disease Progression|9|||
163382207|NCT00171704|590109680|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
163382208|NCT00171704|590109681|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
163382209|NCT00171704|590109680|FG000|Overall Study|Administrative Problems|2|||
163382210|NCT00171704|590109681|FG001|Overall Study|Administrative Problems|1|||
163382211|NCT00171704|590109680|FG000|Overall Study|Death|2|||
163382212|NCT00171704|590109681|FG001|Overall Study|Death|2|||
163382213|NCT00171704|590109680|FG000|Overall Study|Withdrawal by Subject|1|||
163382214|NCT00171704|590109681|FG001|Overall Study|Withdrawal by Subject|3|||
163382215|NCT00171704|590109680|FG000|Overall Study|Protocol Violation|0|||
163382216|NCT00171704|590109681|FG001|Overall Study|Protocol Violation|1|||
163382217|NCT00320541|590109683|FG000|Overall Study|Adverse Event|21|||
163382218|NCT00320541|590109684|FG001|Overall Study|Adverse Event|19|||
163382219|NCT00320541|590109683|FG000|Overall Study|Protocol Violation|0|||
163382220|NCT00320541|590109684|FG001|Overall Study|Protocol Violation|1|||
163382221|NCT00320541|590109683|FG000|Overall Study|Withdrawal by Subject|12|||
163382222|NCT00320541|590109684|FG001|Overall Study|Withdrawal by Subject|16|||
163382223|NCT00320541|590109683|FG000|Overall Study|Physician Decision|9|||
163382224|NCT00320541|590109684|FG001|Overall Study|Physician Decision|13|||
163382225|NCT00320541|590109683|FG000|Overall Study|Other|3|||
163382226|NCT00320541|590109684|FG001|Overall Study|Other|4|||
163382227|NCT00320541|590109683|FG000|Overall Study|Sponsor Decision|2|||
163382228|NCT00320541|590109684|FG001|Overall Study|Sponsor Decision|1|||
163382229|NCT00320541|590109683|FG000|Overall Study|Death due to Study Disease|1|||
163382230|NCT00320541|590109684|FG001|Overall Study|Death due to Study Disease|3|||
163382231|NCT00320541|590109683|FG000|Overall Study|Death due to Adverse Event(s)|1|||
163382232|NCT00320541|590109684|FG001|Overall Study|Death due to Adverse Event(s)|0|||
163382233|NCT00320541|590109683|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
163382234|NCT00320541|590109684|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
163382235|NCT01620255|590109690|FG000|Overall Study|Withdrawal by Subject|4|||
163382236|NCT01620255|590109691|FG001|Overall Study|Withdrawal by Subject|1|||
163382237|NCT01620255|590109692|FG002|Overall Study|Withdrawal by Subject|1|||
163382238|NCT01620255|590109693|FG003|Overall Study|Withdrawal by Subject|2|||
163382239|NCT01620255|590109694|FG004|Overall Study|Withdrawal by Subject|4|||
163382240|NCT01620255|590109690|FG000|Overall Study|Participant underwent fecal transplant|0|||
163382241|NCT01620255|590109691|FG001|Overall Study|Participant underwent fecal transplant|0|||
163382242|NCT01620255|590109692|FG002|Overall Study|Participant underwent fecal transplant|1|||
163382243|NCT01620255|590109693|FG003|Overall Study|Participant underwent fecal transplant|0|||
163382244|NCT01620255|590109694|FG004|Overall Study|Participant underwent fecal transplant|0|||
163382245|NCT01620255|590109690|FG000|Overall Study|Non-compliance|0|||
163382246|NCT01620255|590109691|FG001|Overall Study|Non-compliance|1|||
163382247|NCT01620255|590109692|FG002|Overall Study|Non-compliance|0|||
163382248|NCT01620255|590109693|FG003|Overall Study|Non-compliance|0|||
163382249|NCT01620255|590109694|FG004|Overall Study|Non-compliance|0|||
163382250|NCT01620255|590109690|FG000|Overall Study|Adverse Event|0|||
163382251|NCT01620255|590109691|FG001|Overall Study|Adverse Event|4|||
163382252|NCT01620255|590109692|FG002|Overall Study|Adverse Event|0|||
163417653|NCT04062214|590236064|FG000|Week 36|Lost to Follow-up|50|||
163382253|NCT01620255|590109693|FG003|Overall Study|Adverse Event|1|||
163382254|NCT01620255|590109694|FG004|Overall Study|Adverse Event|1|||
163382255|NCT01620255|590109690|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
163382256|NCT01620255|590109691|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
163382257|NCT01620255|590109692|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
163417654|NCT04062214|590236065|FG001|Week 36|Lost to Follow-up|46|||
163382258|NCT01620255|590109693|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
163382259|NCT01620255|590109694|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
163382260|NCT01873495|590109701|FG000|Overall Study|Withdrawal by Subject|1|||
163382261|NCT01873495|590109701|FG000|Overall Study|Physician Decision|3|||
163417655|NCT04062214|590236064|FG000|Week 36|Death|0|||
163382262|NCT01873495|590109701|FG000|Overall Study|Adverse Event|1|||
163382263|NCT01873495|590109701|FG000|Overall Study|Removed for Transplantation|1|||
163382264|NCT01873495|590109701|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
163382265|NCT04335812|590109702|FG000|Overall Study|Withdrawal by Subject|1|||
163382266|NCT04335812|590109703|FG001|Overall Study|Withdrawal by Subject|3|||
163382267|NCT04335812|590109702|FG000|Overall Study|Lost to Follow-up|12|||
163382268|NCT04335812|590109703|FG001|Overall Study|Lost to Follow-up|12|||
163382269|NCT04335812|590109702|FG000|Overall Study|Did not engage in the intervention|22|||
163382270|NCT04335812|590109703|FG001|Overall Study|Did not engage in the intervention|18|||
163382271|NCT03864146|590109707|FG000|Overall Study|Lost to Follow-up|14|||
163382272|NCT03864146|590109708|FG001|Overall Study|Lost to Follow-up|23|||
163382273|NCT03864146|590109707|FG000|Overall Study|Withdrawal by Subject|3|||
163382274|NCT03864146|590109708|FG001|Overall Study|Withdrawal by Subject|2|||
163382275|NCT00799513|590109709|FG000|Overall Study|Physician Decision|1|||
163382276|NCT00799513|590109709|FG000|Overall Study|Adverse Event|1|||
163382277|NCT05062759|590109712|FG000|Overall Study|Death|0|||
163382278|NCT05062759|590109713|FG001|Overall Study|Death|1|||
163382279|NCT05062759|590109712|FG000|Overall Study|Lost to Follow-up|1|||
163382280|NCT05062759|590109713|FG001|Overall Study|Lost to Follow-up|0|||
163382281|NCT04981366|590109714|FG000|Overall Study|Withdrawal by Subject|5|||
163382282|NCT04981366|590109715|FG001|Overall Study|Withdrawal by Subject|4|||
163382283|NCT04981366|590109716|FG002|Overall Study|Withdrawal by Subject|8|||
163382284|NCT04981366|590109714|FG000|Overall Study|Health issues unrelated to the trial|1|||
163382285|NCT04981366|590109715|FG001|Overall Study|Health issues unrelated to the trial|2|||
163382286|NCT04981366|590109716|FG002|Overall Study|Health issues unrelated to the trial|0|||
163382287|NCT04371198|590109717|FG000|Overall Study|inadequate sample|4|||
163382288|NCT01112306|590109718|FG000|Overall Study|Death|175|||
163382289|NCT01112306|590109718|FG000|Overall Study|Lost to Follow-up|9|||
163382290|NCT01112306|590109718|FG000|Overall Study|Withdrawal by Subject|31|||
163382291|NCT01112306|590109718|FG000|Overall Study|Other|70|||
163382292|NCT03214094|590109719|FG000|Overall Study|Case Report Forms Uncollected|14|||
163417656|NCT04062214|590236065|FG001|Week 36|Death|1|||
163417657|NCT00464178|590236068|FG000|Overall Study|Protocol Violation|1|||
163417658|NCT00464178|590236068|FG000|Overall Study|Withdrawal by Subject|1|||
163417659|NCT04506294|590236071|FG000|Overall Study|Lost to Follow-up|70|||
163417660|NCT04506294|590236072|FG001|Overall Study|Lost to Follow-up|20|||
163417661|NCT04506294|590236071|FG000|Overall Study|Withdrawal by Subject|16|||
163417662|NCT04506294|590236072|FG001|Overall Study|Withdrawal by Subject|2|||
163417663|NCT01469000|590236078|FG000|Overall Study|Withdrawal by Subject|16|||
163417664|NCT01469000|590236079|FG001|Overall Study|Withdrawal by Subject|3|||
163417665|NCT01469000|590236078|FG000|Overall Study|Sponsor Decision|4|||
163382293|NCT03214094|590109719|FG000|Overall Study|Protocol Deviation|46|||
163382294|NCT00655486|590109725|FG000|Overall Study|Adverse Event|10|||
163382295|NCT00655486|590109725|FG000|Overall Study|Lack of Efficacy|8|||
163382296|NCT00655486|590109725|FG000|Overall Study|Withdrawal by Subject|4|||
163382297|NCT00655486|590109725|FG000|Overall Study|Protocol Violation|1|||
163382298|NCT00655486|590109725|FG000|Overall Study|Unsatisfactory compliance|2|||
163382299|NCT00655486|590109725|FG000|Overall Study|Other: Pregnancy|1|||
163382300|NCT00655486|590109725|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
163382301|NCT00655486|590109725|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
163382302|NCT00310037|590109726|FG000|Overall Study|Adverse Event|7|||
163382303|NCT00310037|590109727|FG001|Overall Study|Adverse Event|14|||
163382304|NCT00310037|590109726|FG000|Overall Study|Withdrawal by Subject|4|||
163417666|NCT01469000|590236079|FG001|Overall Study|Sponsor Decision|1|||
163417667|NCT00769119|590236082|FG000|Overall Study|Voluntary discontinuation|0|||
163417668|NCT00769119|590236083|FG001|Overall Study|Voluntary discontinuation|2|||
163417669|NCT00769119|590236082|FG000|Overall Study|Adverse Event|1|||
163417670|NCT00769119|590236083|FG001|Overall Study|Adverse Event|1|||
163417671|NCT00769119|590236082|FG000|Overall Study|Disallowed medication|1|||
163382305|NCT00310037|590109727|FG001|Overall Study|Withdrawal by Subject|3|||
163382306|NCT00310037|590109726|FG000|Overall Study|Progression|6|||
163382307|NCT00310037|590109727|FG001|Overall Study|Progression|0|||
163382308|NCT00310037|590109726|FG000|Overall Study|Non-protocol treatment|1|||
163382309|NCT00310037|590109727|FG001|Overall Study|Non-protocol treatment|0|||
163382310|NCT04218084|590109738|FG000|Overall Study|Adverse Event|7|||
163382311|NCT04218084|590109739|FG001|Overall Study|Adverse Event|2|||
163382312|NCT04218084|590109738|FG000|Overall Study|Withdrawal of Consent|4|||
163382313|NCT04218084|590109739|FG001|Overall Study|Withdrawal of Consent|5|||
163382314|NCT04218084|590109738|FG000|Overall Study|Physician Decision|1|||
163382315|NCT04218084|590109739|FG001|Overall Study|Physician Decision|1|||
163382316|NCT04218084|590109738|FG000|Overall Study|Lost to Follow-up|1|||
163382317|NCT04218084|590109739|FG001|Overall Study|Lost to Follow-up|1|||
163382318|NCT04218084|590109738|FG000|Overall Study|Non-compliance with study drug|1|||
163417672|NCT00769119|590236083|FG001|Overall Study|Disallowed medication|0|||
163417673|NCT01116544|590236086|FG000|Overall Study|Protocol Violation|1|||
163417674|NCT01116544|590236087|FG001|Overall Study|Protocol Violation|0|||
163417675|NCT01116544|590236086|FG000|Overall Study|Withdrawal by Subject|1|||
163417676|NCT01116544|590236087|FG001|Overall Study|Withdrawal by Subject|1|||
163382319|NCT04218084|590109739|FG001|Overall Study|Non-compliance with study drug|1|||
163382320|NCT04218084|590109738|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
163382321|NCT04218084|590109739|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
163382322|NCT04218084|590109738|FG000|Overall Study|Other|0|||
163382323|NCT04218084|590109739|FG001|Overall Study|Other|1|||
163382324|NCT04218084|590109738|FG000|Overall Study|Ongoing at data cut-off date|62|||
163382325|NCT04218084|590109739|FG001|Overall Study|Ongoing at data cut-off date|58|||
163382326|NCT05041101|590109740|FG000|Overall Study|Adverse Event|1|||
163382327|NCT05041101|590109741|FG001|Overall Study|Adverse Event|0|||
163382328|NCT05041101|590109742|FG002|Overall Study|Adverse Event|0|||
163382329|NCT05041101|590109740|FG000|Overall Study|Diease Progression|5|||
163382330|NCT05041101|590109741|FG001|Overall Study|Diease Progression|0|||
163382331|NCT05041101|590109742|FG002|Overall Study|Diease Progression|0|||
163382332|NCT00842985|590109743|FG000|Screening|Did not meet entrance requirements|27|||
163382333|NCT00842985|590109743|FG000|First Intervention|Withdrawal by Subject|3|||
163382334|NCT00842985|590109743|FG000|First Intervention|Protocol Violation|3|||
163382335|NCT00842985|590109743|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
163382336|NCT00842985|590109743|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
163382337|NCT01122862|590109744|FG000|Period 1|Protocol Violation|0|||
163382338|NCT01122862|590109745|FG001|Period 1|Protocol Violation|1|||
163382339|NCT01122862|590109746|FG002|Period 1|Protocol Violation|0|||
163382340|NCT01122862|590109744|FG000|Period 2|Adverse Event|0|||
163382341|NCT01122862|590109745|FG001|Period 2|Adverse Event|0|||
163382342|NCT01122862|590109746|FG002|Period 2|Adverse Event|1|||
163382343|NCT00966277|590109749|FG000|Overall Study|Withdrawal by Subject|3|||
163382344|NCT00966277|590109750|FG001|Overall Study|Withdrawal by Subject|0|||
163382345|NCT00966277|590109749|FG000|Overall Study|Ineligible|1|||
163382346|NCT00966277|590109750|FG001|Overall Study|Ineligible|3|||
163382347|NCT00966277|590109749|FG000|Overall Study|Treatment Plan Changed|0|||
163382348|NCT00966277|590109750|FG001|Overall Study|Treatment Plan Changed|1|||
163382349|NCT01249274|590109751|FG000|Overall Study|Lost to Follow-up|3|||
163382350|NCT01249274|590109752|FG001|Overall Study|Lost to Follow-up|4|||
163382351|NCT01249274|590109751|FG000|Overall Study|Received inpatient substance treatment|1|||
163382352|NCT01249274|590109752|FG001|Overall Study|Received inpatient substance treatment|2|||
163382353|NCT01498653|590109753|FG000|Overall Study|Adverse Event|2|||
163382354|NCT01498653|590109754|FG001|Overall Study|Adverse Event|2|||
163382355|NCT01498653|590109753|FG000|Overall Study|Lack of Efficacy|12|||
163382356|NCT01498653|590109754|FG001|Overall Study|Lack of Efficacy|26|||
163382357|NCT01498653|590109753|FG000|Overall Study|Protocol Violation|0|||
163382358|NCT01498653|590109754|FG001|Overall Study|Protocol Violation|4|||
163382359|NCT01498653|590109753|FG000|Overall Study|Lost to Follow-up|1|||
163382360|NCT01498653|590109754|FG001|Overall Study|Lost to Follow-up|0|||
163382361|NCT01498653|590109753|FG000|Overall Study|Physician Decision|2|||
163382362|NCT01498653|590109754|FG001|Overall Study|Physician Decision|0|||
163382363|NCT01498653|590109753|FG000|Overall Study|Withdrawal by Subject|2|||
163382364|NCT01498653|590109754|FG001|Overall Study|Withdrawal by Subject|3|||
163382365|NCT02070588|590109760|FG000|Overall Study|Withdrawal by Subject|29|||
163382366|NCT02070588|590109761|FG001|Overall Study|Withdrawal by Subject|1|||
163382367|NCT02070588|590109762|FG002|Overall Study|Withdrawal by Subject|0|||
163382368|NCT02070588|590109760|FG000|Overall Study|Writhdrawal due to early termination|9|||
163382369|NCT02070588|590109761|FG001|Overall Study|Writhdrawal due to early termination|0|||
163382370|NCT02070588|590109762|FG002|Overall Study|Writhdrawal due to early termination|0|||
163417677|NCT05168267|590236088|FG000|Overall Study|Withdrawal by Subject|2|||
163417678|NCT05168267|590236089|FG001|Overall Study|Withdrawal by Subject|1|||
163417679|NCT05168267|590236088|FG000|Overall Study|Withdrawn by Therapist|1|||
163417680|NCT05168267|590236089|FG001|Overall Study|Withdrawn by Therapist|1|||
163417681|NCT05168267|590236088|FG000|Overall Study|Left Facility|1|||
163417682|NCT05168267|590236089|FG001|Overall Study|Left Facility|0|||
163417683|NCT02937350|590236090|FG000|Overall Study|Withdrawal by Subject|0|||
163417684|NCT02937350|590236091|FG001|Overall Study|Withdrawal by Subject|1|||
163382371|NCT02070588|590109760|FG000|Overall Study|Adverse Event|1|||
163382372|NCT02070588|590109761|FG001|Overall Study|Adverse Event|0|||
163382373|NCT02070588|590109762|FG002|Overall Study|Adverse Event|0|||
163382374|NCT03421431|590109763|FG000|Overall Study|Adverse Event|2|||
163382375|NCT03421431|590109764|FG001|Overall Study|Adverse Event|1|||
163382376|NCT03421431|590109765|FG002|Overall Study|Adverse Event|12|||
163382377|NCT03421431|590109763|FG000|Overall Study|Lost to Follow-up|1|||
163382378|NCT03421431|590109764|FG001|Overall Study|Lost to Follow-up|1|||
163382379|NCT03421431|590109765|FG002|Overall Study|Lost to Follow-up|1|||
163382380|NCT03421431|590109763|FG000|Overall Study|Withdrawal by Subject|3|||
163382381|NCT03421431|590109764|FG001|Overall Study|Withdrawal by Subject|2|||
163382382|NCT03421431|590109765|FG002|Overall Study|Withdrawal by Subject|1|||
163382383|NCT03421431|590109763|FG000|Overall Study|Protocol Violation|0|||
163382384|NCT03421431|590109764|FG001|Overall Study|Protocol Violation|1|||
163382385|NCT03421431|590109765|FG002|Overall Study|Protocol Violation|0|||
163417685|NCT02937350|590236092|FG002|Overall Study|Withdrawal by Subject|0|||
163417686|NCT02419508|590236093|FG000|Overall Study|Adverse Event|9|||
163417687|NCT02419508|590236094|FG001|Overall Study|Adverse Event|3|||
163382386|NCT03421431|590109763|FG000|Overall Study|Participant met Stopping Rules|0|||
163382387|NCT03421431|590109764|FG001|Overall Study|Participant met Stopping Rules|1|||
163382388|NCT03421431|590109765|FG002|Overall Study|Participant met Stopping Rules|0|||
163382389|NCT00141726|590109770|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
163382390|NCT00235326|590109775|FG000|Overall Study|Lost to Follow-up|746|||
163382391|NCT00235326|590109776|FG001|Overall Study|Lost to Follow-up|1400|||
163382392|NCT01477333|590109778|FG000|Overall Study|Adverse Event|1|||
163382393|NCT01477333|590109778|FG000|Overall Study|Withdrawal by Subject|1|||
163382394|NCT01477333|590109778|FG000|Overall Study|Clinical Deterioration|1|||
163382395|NCT01178671|590109779|FG000|Overall Study|Adverse Event|4|||
163382396|NCT01178671|590109780|FG001|Overall Study|Adverse Event|6|||
163382397|NCT01178671|590109779|FG000|Overall Study|Protocol Violation|1|||
163382398|NCT01178671|590109780|FG001|Overall Study|Protocol Violation|1|||
163382399|NCT01178671|590109779|FG000|Overall Study|Lack of Efficacy|0|||
163382400|NCT01178671|590109780|FG001|Overall Study|Lack of Efficacy|1|||
163382401|NCT01178671|590109779|FG000|Overall Study|Lost to Follow-up|3|||
163382402|NCT01178671|590109780|FG001|Overall Study|Lost to Follow-up|1|||
163382403|NCT01178671|590109779|FG000|Overall Study|Physician Decision|4|||
163382404|NCT01178671|590109780|FG001|Overall Study|Physician Decision|6|||
163382405|NCT04620811|590109781|FG000|Overall Study|Withdrawal by Subject|18|||
163382406|NCT04620811|590109782|FG001|Overall Study|Withdrawal by Subject|15|||
163382407|NCT04620811|590109781|FG000|Overall Study|Adverse Event|6|||
163382408|NCT04620811|590109782|FG001|Overall Study|Adverse Event|11|||
163382409|NCT04620811|590109781|FG000|Overall Study|Lost to Follow-up|4|||
163382410|NCT04620811|590109782|FG001|Overall Study|Lost to Follow-up|8|||
163382411|NCT04620811|590109781|FG000|Overall Study|Physician Decision|1|||
163382412|NCT04620811|590109782|FG001|Overall Study|Physician Decision|4|||
163382413|NCT04620811|590109781|FG000|Overall Study|Sponsor Decision|0|||
163382414|NCT04620811|590109782|FG001|Overall Study|Sponsor Decision|1|||
163382415|NCT04620811|590109781|FG000|Overall Study|Elevation of ALT or AST|1|||
163382416|NCT04620811|590109782|FG001|Overall Study|Elevation of ALT or AST|0|||
163382417|NCT04620811|590109781|FG000|Overall Study|Other|3|||
163382418|NCT04620811|590109782|FG001|Overall Study|Other|5|||
163382419|NCT01078675|590109783|FG000|Overall Study|Withdrawal by Subject|7|||
163382420|NCT01078675|590109784|FG001|Overall Study|Withdrawal by Subject|3|||
163382421|NCT01078675|590109783|FG000|Overall Study|Protocol Violation|56|||
163382422|NCT01078675|590109784|FG001|Overall Study|Protocol Violation|0|||
163382423|NCT01078675|590109783|FG000|Overall Study|Provided in CRF for specific reasons|2|||
163382424|NCT01078675|590109784|FG001|Overall Study|Provided in CRF for specific reasons|3|||
163382425|NCT01078675|590109783|FG000|Overall Study|Adverse Event|3|||
163382426|NCT01078675|590109784|FG001|Overall Study|Adverse Event|0|||
163382427|NCT02513303|590109786|FG000|Overall Study|Withdrawal by Subject|9|||
163417688|NCT02419508|590236093|FG000|Overall Study|Withdrawal by Subject|1|||
163417689|NCT02419508|590236094|FG001|Overall Study|Withdrawal by Subject|0|||
163417690|NCT02419508|590236093|FG000|Overall Study|Other - Reason not specified|0|||
163417691|NCT02419508|590236094|FG001|Overall Study|Other - Reason not specified|1|||
163417692|NCT01738971|590236103|FG000|Overall Study|Lost to Follow-up|19|||
163417693|NCT01738971|590236104|FG001|Overall Study|Lost to Follow-up|30|||
163417694|NCT01738971|590236105|FG002|Overall Study|Lost to Follow-up|17|||
163417695|NCT04698629|590236113|FG000|Overall Study|Adverse Event|1|||
163417696|NCT06228586|590236118|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
163417697|NCT06228586|590236119|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
163417698|NCT00865020|590236130|FG000|Overall Study|Withdrawal by Subject|22|||
163417699|NCT00865020|590236131|FG001|Overall Study|Withdrawal by Subject|16|||
163417700|NCT00865020|590236130|FG000|Overall Study|Adverse Event|9|||
163417701|NCT00865020|590236131|FG001|Overall Study|Adverse Event|14|||
163417702|NCT00865020|590236130|FG000|Overall Study|Abnormal test procedure result(s)|6|||
163382428|NCT02513303|590109787|FG001|Overall Study|Withdrawal by Subject|7|||
163382429|NCT02513303|590109788|FG002|Overall Study|Withdrawal by Subject|2|||
163417703|NCT00865020|590236131|FG001|Overall Study|Abnormal test procedure result(s)|8|||
163417704|NCT00865020|590236130|FG000|Overall Study|Lost to Follow-up|6|||
163382430|NCT02513303|590109786|FG000|Overall Study|Lost to Follow-up|2|||
163382431|NCT02513303|590109787|FG001|Overall Study|Lost to Follow-up|4|||
163382432|NCT02513303|590109788|FG002|Overall Study|Lost to Follow-up|0|||
163382433|NCT02513303|590109786|FG000|Overall Study|Adverse Event|0|||
163417705|NCT00865020|590236131|FG001|Overall Study|Lost to Follow-up|4|||
163417706|NCT00865020|590236130|FG000|Overall Study|Protocol deviation|4|||
163382434|NCT02513303|590109787|FG001|Overall Study|Adverse Event|1|||
163382435|NCT02513303|590109788|FG002|Overall Study|Adverse Event|0|||
163382436|NCT02513303|590109786|FG000|Overall Study|Physician Decision|1|||
163382437|NCT02513303|590109787|FG001|Overall Study|Physician Decision|1|||
163382438|NCT02513303|590109788|FG002|Overall Study|Physician Decision|0|||
163382439|NCT02513303|590109786|FG000|Overall Study|Death|8|||
163417707|NCT00865020|590236131|FG001|Overall Study|Protocol deviation|1|||
163417708|NCT00865020|590236130|FG000|Overall Study|Administrative problems|0|||
163382440|NCT02513303|590109787|FG001|Overall Study|Death|4|||
163382441|NCT02513303|590109788|FG002|Overall Study|Death|2|||
163382442|NCT01691768|590109789|FG000|Overall Study|Death|0|||
163417709|NCT00865020|590236131|FG001|Overall Study|Administrative problems|2|||
163417710|NCT00865020|590236130|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163417711|NCT00865020|590236131|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163417712|NCT00865020|590236130|FG000|Overall Study|Death|0|||
163417713|NCT00865020|590236131|FG001|Overall Study|Death|1|||
163417714|NCT00865020|590236130|FG000|Overall Study|Randomized but discontinued|2|||
163417715|NCT00865020|590236131|FG001|Overall Study|Randomized but discontinued|4|||
163417716|NCT01891643|590238085|FG000|Overall Study|Adverse event unrelated to study drug|2|||
163417717|NCT01891643|590238086|FG001|Overall Study|Adverse event unrelated to study drug|5|||
163417718|NCT01891643|590238085|FG000|Overall Study|Disease Progression|4|||
163417719|NCT01891643|590238086|FG001|Overall Study|Disease Progression|3|||
163417720|NCT01891643|590238085|FG000|Overall Study|Study Drug Toxicity|3|||
163417721|NCT01891643|590238086|FG001|Overall Study|Study Drug Toxicity|0|||
163417722|NCT01891643|590238085|FG000|Overall Study|Maximum Clinical Benefit|0|||
163417723|NCT01891643|590238086|FG001|Overall Study|Maximum Clinical Benefit|1|||
163417724|NCT01891643|590238085|FG000|Overall Study|Poor/Non-compliance|0|||
163417725|NCT01891643|590238086|FG001|Overall Study|Poor/Non-compliance|1|||
163417726|NCT01891643|590238085|FG000|Overall Study|Participant request to discontinue|1|||
163417727|NCT01891643|590238086|FG001|Overall Study|Participant request to discontinue|0|||
163417728|NCT04047797|590238089|FG000|Overall Study|Progressive Disease|1|||
163417729|NCT01430442|590238090|FG000|Overall Study|Subject Withdrew Consent|3|||
163417730|NCT01430442|590238091|FG001|Overall Study|Subject Withdrew Consent|0|||
163417731|NCT01430442|590238092|FG002|Overall Study|Subject Withdrew Consent|1|||
163417732|NCT01430442|590238093|FG003|Overall Study|Subject Withdrew Consent|0|||
163417733|NCT01430442|590238094|FG004|Overall Study|Subject Withdrew Consent|2|||
163417734|NCT01430442|590238095|FG005|Overall Study|Subject Withdrew Consent|1|||
163417735|NCT01430442|590238096|FG006|Overall Study|Subject Withdrew Consent|5|||
163417736|NCT01430442|590238097|FG007|Overall Study|Subject Withdrew Consent|2|||
163382443|NCT01691768|590109790|FG001|Overall Study|Death|2|||
163382444|NCT01691768|590109789|FG000|Overall Study|Lost to Follow-up|4|||
163382445|NCT01691768|590109790|FG001|Overall Study|Lost to Follow-up|3|||
163382446|NCT01691768|590109789|FG000|Overall Study|Withdrawal by Subject|10|||
163382447|NCT01691768|590109790|FG001|Overall Study|Withdrawal by Subject|9|||
163382448|NCT01691768|590109789|FG000|Overall Study|Relocated|0|||
163382449|NCT01691768|590109790|FG001|Overall Study|Relocated|1|||
163382450|NCT01691768|590109789|FG000|Overall Study|Investigator decision|1|||
163382451|NCT01691768|590109790|FG001|Overall Study|Investigator decision|1|||
163382452|NCT01920854|590109794|FG000|Overall Study|Withdrawal by Subject|1|||
163382453|NCT01920854|590109795|FG001|Overall Study|Withdrawal by Subject|0|||
163382454|NCT01920854|590109796|FG002|Overall Study|Withdrawal by Subject|0|||
163382455|NCT01920854|590109797|FG003|Overall Study|Withdrawal by Subject|0|||
163382456|NCT01920854|590109798|FG004|Overall Study|Withdrawal by Subject|1|||
163382457|NCT01920854|590109799|FG005|Overall Study|Withdrawal by Subject|0|||
163382458|NCT01920854|590109800|FG006|Overall Study|Withdrawal by Subject|1|||
163382459|NCT00679627|590109801|FG000|Overall Study|Death|41|||
163382460|NCT00679627|590109802|FG001|Overall Study|Death|29|||
163382461|NCT00679627|590109801|FG000|Overall Study|Adverse Event|43|||
163382462|NCT00679627|590109802|FG001|Overall Study|Adverse Event|53|||
163382463|NCT00679627|590109801|FG000|Overall Study|Withdrawal by Subject|168|||
163382464|NCT00679627|590109802|FG001|Overall Study|Withdrawal by Subject|172|||
163382465|NCT00679627|590109801|FG000|Overall Study|Lost to Follow-up|22|||
163382466|NCT00679627|590109802|FG001|Overall Study|Lost to Follow-up|26|||
163382467|NCT00679627|590109801|FG000|Overall Study|Early Study Closure|425|||
163382468|NCT00679627|590109802|FG001|Overall Study|Early Study Closure|405|||
163382469|NCT03513588|590109806|FG000|Overall Study|Lost to Follow-up|0|||
163382470|NCT03513588|590109807|FG001|Overall Study|Lost to Follow-up|1|||
163382471|NCT03513588|590109808|FG002|Overall Study|Lost to Follow-up|1|||
163382472|NCT03513588|590109806|FG000|Overall Study|Study dosing paused by sponsor|1|||
163382473|NCT03513588|590109807|FG001|Overall Study|Study dosing paused by sponsor|1|||
163382474|NCT03513588|590109808|FG002|Overall Study|Study dosing paused by sponsor|0|||
163382475|NCT03513588|590109806|FG000|Overall Study|Death|0|||
163382476|NCT03513588|590109807|FG001|Overall Study|Death|0|||
163417737|NCT01430442|590238090|FG000|Overall Study|Lost to Follow-up|2|||
163417738|NCT01430442|590238091|FG001|Overall Study|Lost to Follow-up|0|||
163417739|NCT01430442|590238092|FG002|Overall Study|Lost to Follow-up|1|||
163417740|NCT01430442|590238093|FG003|Overall Study|Lost to Follow-up|2|||
163382477|NCT03513588|590109808|FG002|Overall Study|Death|1|||
163382478|NCT03333837|590109809|FG000|Overall Study|Adverse Event|2|||
163382479|NCT03333837|590109810|FG001|Overall Study|Adverse Event|1|||
163382480|NCT03333837|590109811|FG002|Overall Study|Adverse Event|1|||
163382481|NCT03333837|590109812|FG003|Overall Study|Adverse Event|1|||
163417741|NCT01430442|590238094|FG004|Overall Study|Lost to Follow-up|2|||
163417742|NCT01430442|590238095|FG005|Overall Study|Lost to Follow-up|1|||
163417743|NCT01430442|590238096|FG006|Overall Study|Lost to Follow-up|5|||
163417744|NCT01430442|590238097|FG007|Overall Study|Lost to Follow-up|1|||
163417745|NCT01430442|590238090|FG000|Overall Study|Pregnancy|1|||
163382482|NCT03333837|590109813|FG004|Overall Study|Adverse Event|0|||
163382483|NCT03333837|590109809|FG000|Overall Study|Caregiver withdrew|0|||
163382484|NCT03333837|590109810|FG001|Overall Study|Caregiver withdrew|2|||
163382485|NCT03333837|590109811|FG002|Overall Study|Caregiver withdrew|1|||
163382486|NCT03333837|590109812|FG003|Overall Study|Caregiver withdrew|0|||
163382487|NCT03333837|590109813|FG004|Overall Study|Caregiver withdrew|0|||
163382488|NCT03333837|590109809|FG000|Overall Study|Withdrawal by Subject|0|||
163382489|NCT03333837|590109810|FG001|Overall Study|Withdrawal by Subject|0|||
163382490|NCT03333837|590109811|FG002|Overall Study|Withdrawal by Subject|1|||
163382491|NCT03333837|590109812|FG003|Overall Study|Withdrawal by Subject|1|||
163382492|NCT03333837|590109813|FG004|Overall Study|Withdrawal by Subject|3|||
163382493|NCT03333837|590109809|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
163382494|NCT03333837|590109810|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
163382495|NCT03333837|590109811|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
163382496|NCT03333837|590109812|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
163382497|NCT03333837|590109813|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
163382498|NCT01013285|590109814|FG000|Overall Study|Death|48|||
163382499|NCT01013285|590109815|FG001|Overall Study|Death|89|||
163382500|NCT00704405|590109816|FG000|Overall Study (NC Population)|Adverse Event|1|||
163382501|NCT00704405|590109817|FG001|Overall Study (NC Population)|Adverse Event|0|||
163382502|NCT00704405|590109818|FG002|Overall Study (NC Population)|Adverse Event|0|||
163382503|NCT00704405|590109819|FG003|Overall Study (NC Population)|Adverse Event|0|||
163382504|NCT00704405|590109820|FG004|Overall Study (NC Population)|Adverse Event|0|||
163382505|NCT00704405|590109816|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
163382506|NCT00704405|590109817|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
163382507|NCT00704405|590109818|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
163382508|NCT00704405|590109819|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
163382509|NCT00704405|590109820|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
163382510|NCT00704405|590109816|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
163382511|NCT00704405|590109817|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
163382512|NCT00704405|590109818|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
163382513|NCT00704405|590109819|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
163382514|NCT00704405|590109820|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
163382515|NCT00704405|590109816|FG000|Overall Study (NC Population)|Other|0|||
163382516|NCT00704405|590109817|FG001|Overall Study (NC Population)|Other|0|||
163382517|NCT00704405|590109818|FG002|Overall Study (NC Population)|Other|0|||
163382518|NCT00704405|590109819|FG003|Overall Study (NC Population)|Other|0|||
163382519|NCT00704405|590109820|FG004|Overall Study (NC Population)|Other|1|||
163382520|NCT00704405|590109816|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
163382521|NCT00704405|590109817|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
163382522|NCT00704405|590109818|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
163382523|NCT00704405|590109819|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
163382524|NCT00704405|590109820|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
163382525|NCT00704405|590109816|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
163382526|NCT00704405|590109817|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
163382527|NCT00704405|590109818|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
163382528|NCT00704405|590109819|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
163382529|NCT00704405|590109820|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
163382530|NCT02374671|590109821|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
163382531|NCT02374671|590109822|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
163382532|NCT02374671|590109823|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
163382533|NCT02374671|590109821|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
163382534|NCT02374671|590109822|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
163382535|NCT02374671|590109823|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
163382536|NCT02374671|590109821|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
163382537|NCT02374671|590109822|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
163382538|NCT02374671|590109823|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
163382539|NCT02374671|590109821|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
163382540|NCT02374671|590109822|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
163382541|NCT02374671|590109823|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
163382542|NCT02374671|590109821|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
163382543|NCT02374671|590109822|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
163382544|NCT02374671|590109823|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
163382545|NCT04134845|590109832|FG000|Overall Study|withdrawl by PI|12|||
163382546|NCT04134845|590109833|FG001|Overall Study|withdrawl by PI|5|||
163382547|NCT03440320|590111766|FG000|Overall Study|Withdrawal by Subject|0|||
163382548|NCT03440320|590111767|FG001|Overall Study|Withdrawal by Subject|1|||
163382549|NCT01912456|590111768|FG000|Period 1|Physician Decision|0|||
163382550|NCT01912456|590111769|FG001|Period 1|Physician Decision|0|||
163382551|NCT01912456|590111770|FG002|Period 1|Physician Decision|1|||
163382552|NCT01912456|590111771|FG003|Period 1|Physician Decision|0|||
163382553|NCT01912456|590111768|FG000|Period 1|non-compliance|1|||
163382554|NCT01912456|590111769|FG001|Period 1|non-compliance|0|||
163382555|NCT01912456|590111770|FG002|Period 1|non-compliance|0|||
163382556|NCT01912456|590111771|FG003|Period 1|non-compliance|1|||
163382557|NCT01912456|590111768|FG000|Period 1|Adverse Event|1|||
163382558|NCT01912456|590111769|FG001|Period 1|Adverse Event|0|||
163382559|NCT01912456|590111770|FG002|Period 1|Adverse Event|0|||
163382560|NCT01912456|590111771|FG003|Period 1|Adverse Event|1|||
163382561|NCT01912456|590111768|FG000|Period 1|Withdrawal by Subject|0|||
163382562|NCT01912456|590111769|FG001|Period 1|Withdrawal by Subject|1|||
163382563|NCT01912456|590111770|FG002|Period 1|Withdrawal by Subject|1|||
163382564|NCT01912456|590111771|FG003|Period 1|Withdrawal by Subject|1|||
163382565|NCT01912456|590111768|FG000|Period 2|Lack of Efficacy|0|||
163382566|NCT01912456|590111769|FG001|Period 2|Lack of Efficacy|2|||
163382567|NCT01912456|590111770|FG002|Period 2|Lack of Efficacy|0|||
163382568|NCT01912456|590111771|FG003|Period 2|Lack of Efficacy|0|||
163382569|NCT01912456|590111768|FG000|Period 2|Adverse Event|0|||
163382570|NCT01912456|590111769|FG001|Period 2|Adverse Event|0|||
163382571|NCT01912456|590111770|FG002|Period 2|Adverse Event|0|||
163382572|NCT01912456|590111771|FG003|Period 2|Adverse Event|1|||
163382573|NCT01340196|590111772|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
163382574|NCT00816400|590111781|FG000|Overall Study|Death|2|||
163382575|NCT00816400|590111782|FG001|Overall Study|Death|3|||
163382576|NCT00816400|590111783|FG002|Overall Study|Death|3|||
163382577|NCT00816400|590111784|FG003|Overall Study|Death|3|||
163382578|NCT00816400|590111785|FG004|Overall Study|Death|2|||
163382579|NCT00816400|590111786|FG005|Overall Study|Death|3|||
163382580|NCT00816400|590111787|FG006|Overall Study|Death|2|||
163382581|NCT00816400|590111788|FG007|Overall Study|Death|5|||
163382582|NCT00816400|590111789|FG008|Overall Study|Death|6|||
163382583|NCT00816400|590111781|FG000|Overall Study|In hospice care at the end of the study|0|||
163382584|NCT00816400|590111782|FG001|Overall Study|In hospice care at the end of the study|0|||
163382585|NCT00816400|590111783|FG002|Overall Study|In hospice care at the end of the study|2|||
163382586|NCT00816400|590111784|FG003|Overall Study|In hospice care at the end of the study|0|||
163382587|NCT00816400|590111785|FG004|Overall Study|In hospice care at the end of the study|0|||
163382588|NCT00816400|590111786|FG005|Overall Study|In hospice care at the end of the study|0|||
163382589|NCT00816400|590111787|FG006|Overall Study|In hospice care at the end of the study|0|||
163382590|NCT00816400|590111788|FG007|Overall Study|In hospice care at the end of the study|0|||
163382591|NCT00816400|590111789|FG008|Overall Study|In hospice care at the end of the study|0|||
163382592|NCT00440999|590111800|FG000|Overall Study|Adverse Event|0|||
163382593|NCT00440999|590111801|FG001|Overall Study|Adverse Event|2|||
163382594|NCT00440999|590111800|FG000|Overall Study|Lack of Efficacy|6|||
163382595|NCT00440999|590111801|FG001|Overall Study|Lack of Efficacy|7|||
163382596|NCT00440999|590111800|FG000|Overall Study|Lost to Follow-up|19|||
163382597|NCT00440999|590111801|FG001|Overall Study|Lost to Follow-up|12|||
163382598|NCT00440999|590111800|FG000|Overall Study|Protocol Violation|1|||
163382599|NCT00440999|590111801|FG001|Overall Study|Protocol Violation|0|||
163382600|NCT00440999|590111800|FG000|Overall Study|Withdrawal by Subject|2|||
163382601|NCT00440999|590111801|FG001|Overall Study|Withdrawal by Subject|5|||
163382602|NCT00440999|590111800|FG000|Overall Study|Subjets missed the visit|1|||
163382603|NCT00440999|590111801|FG001|Overall Study|Subjets missed the visit|0|||
163382604|NCT00440999|590111800|FG000|Overall Study|Mixed infection at entry|1|||
163382605|NCT00440999|590111801|FG001|Overall Study|Mixed infection at entry|0|||
163382606|NCT00440999|590111800|FG000|Overall Study|P. falciparum malaria|5|||
163382607|NCT00440999|590111801|FG001|Overall Study|P. falciparum malaria|14|||
163382608|NCT00440999|590111800|FG000|Overall Study|Subj left hosp without inform staff|0|||
163382609|NCT00440999|590111801|FG001|Overall Study|Subj left hosp without inform staff|1|||
163382610|NCT03401229|590111802|FG000|Overall Study|Lost to Follow-up|2|||
163382611|NCT03401229|590111803|FG001|Overall Study|Lost to Follow-up|1|||
163382612|NCT03401229|590111802|FG000|Overall Study|Other|1|||
163382613|NCT03401229|590111803|FG001|Overall Study|Other|3|||
163382614|NCT03401229|590111802|FG000|Overall Study|Adverse Event|8|||
163382615|NCT03401229|590111803|FG001|Overall Study|Adverse Event|6|||
163382616|NCT03401229|590111802|FG000|Overall Study|Withdrawal by Subject|29|||
163382617|NCT03401229|590111803|FG001|Overall Study|Withdrawal by Subject|26|||
163417746|NCT01430442|590238091|FG001|Overall Study|Pregnancy|0|||
163382618|NCT03401229|590111802|FG000|Overall Study|COVID-19|0|||
163382619|NCT03401229|590111803|FG001|Overall Study|COVID-19|1|||
163382620|NCT05333224|590111804|FG000|Overall Study - Infants|Lost to Follow-up|1|||
163382621|NCT05333224|590111805|FG001|Overall Study - Infants|Lost to Follow-up|1|||
163382622|NCT01776424|590111809|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
163382623|NCT01776424|590111810|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
163382624|NCT01776424|590111811|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
163382625|NCT01776424|590111809|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
163382626|NCT01776424|590111810|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
163382627|NCT01776424|590111811|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
163382628|NCT01776424|590111809|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
163382629|NCT01776424|590111810|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
163382630|NCT01776424|590111811|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
163382631|NCT01776424|590111809|FG000|LTOLE Part (Open Label)|Refused|5|||
163382632|NCT01776424|590111810|FG001|LTOLE Part (Open Label)|Refused|2|||
163382633|NCT01776424|590111811|FG002|LTOLE Part (Open Label)|Refused|11|||
163382634|NCT01776424|590111809|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
163382635|NCT01776424|590111810|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
163382636|NCT01776424|590111811|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
163382637|NCT00819390|590111813|FG000|Overall Study|Lost to Follow-up|1|||
163382638|NCT00819390|590111814|FG001|Overall Study|Lost to Follow-up|1|||
163382639|NCT00819390|590111815|FG002|Overall Study|Lost to Follow-up|0|||
163382640|NCT00819390|590111816|FG003|Overall Study|Lost to Follow-up|0|||
163382641|NCT00819390|590111813|FG000|Overall Study|Withdrawal by Subject|2|||
163382642|NCT00819390|590111814|FG001|Overall Study|Withdrawal by Subject|0|||
163382643|NCT00819390|590111815|FG002|Overall Study|Withdrawal by Subject|0|||
163382644|NCT00819390|590111816|FG003|Overall Study|Withdrawal by Subject|0|||
163382645|NCT00819390|590111813|FG000|Overall Study|Adverse Event|0|||
163382646|NCT00819390|590111814|FG001|Overall Study|Adverse Event|0|||
163382647|NCT00819390|590111815|FG002|Overall Study|Adverse Event|1|||
163382648|NCT00819390|590111816|FG003|Overall Study|Adverse Event|0|||
163382649|NCT02294227|590111817|FG000|Overall Study|Death|0|||
163382650|NCT02294227|590111818|FG001|Overall Study|Death|0|||
163382651|NCT02294227|590111819|FG002|Overall Study|Death|1|||
163382652|NCT02294227|590111817|FG000|Overall Study|Subject/Guardian Decision|6|||
163382653|NCT02294227|590111818|FG001|Overall Study|Subject/Guardian Decision|3|||
163382654|NCT02294227|590111819|FG002|Overall Study|Subject/Guardian Decision|7|||
163382655|NCT02294227|590111817|FG000|Overall Study|Physician Decision|1|||
163382656|NCT02294227|590111818|FG001|Overall Study|Physician Decision|2|||
163382657|NCT02294227|590111819|FG002|Overall Study|Physician Decision|1|||
163382658|NCT02294227|590111817|FG000|Overall Study|Lost to Follow-up|1|||
163382659|NCT02294227|590111818|FG001|Overall Study|Lost to Follow-up|0|||
163382660|NCT02294227|590111819|FG002|Overall Study|Lost to Follow-up|0|||
163382661|NCT02294227|590111817|FG000|Overall Study|Lack of Efficacy|11|||
163382662|NCT02294227|590111818|FG001|Overall Study|Lack of Efficacy|12|||
163382663|NCT02294227|590111819|FG002|Overall Study|Lack of Efficacy|8|||
163382664|NCT02294227|590111817|FG000|Overall Study|Adverse Event|6|||
163382665|NCT02294227|590111818|FG001|Overall Study|Adverse Event|8|||
163382666|NCT02294227|590111819|FG002|Overall Study|Adverse Event|2|||
163382667|NCT00887432|590111820|FG000|Overall Study|Start Excluded Therapy|3|||
163382668|NCT00887432|590111821|FG001|Overall Study|Start Excluded Therapy|0|||
163382669|NCT00887432|590111820|FG000|Overall Study|Did not complete treatment|6|||
163382670|NCT00887432|590111821|FG001|Overall Study|Did not complete treatment|8|||
163382671|NCT00887432|590111820|FG000|Overall Study|Protocol Violation|2|||
163382672|NCT00887432|590111821|FG001|Overall Study|Protocol Violation|3|||
163382673|NCT00887432|590111820|FG000|Overall Study|Withdrawal by Subject|3|||
163382674|NCT00887432|590111821|FG001|Overall Study|Withdrawal by Subject|2|||
163382675|NCT00887432|590111820|FG000|Overall Study|Lost to Follow-up|1|||
163382676|NCT00887432|590111821|FG001|Overall Study|Lost to Follow-up|0|||
163382677|NCT00887432|590111820|FG000|Overall Study|No reason provided|0|||
163382678|NCT00887432|590111821|FG001|Overall Study|No reason provided|1|||
163382679|NCT00899548|590111822|FG000|Overall Study|Physician Decision|3|||
163382680|NCT00551460|590111823|FG000|Overall Study|Adverse Event|1|||
163382681|NCT00551460|590111823|FG000|Overall Study|Withdrawal by Subject|1|||
163382682|NCT00551460|590111823|FG000|Overall Study|Physician Decision|1|||
163382683|NCT00551460|590111823|FG000|Overall Study|Death|7|||
163382684|NCT00551460|590111823|FG000|Overall Study|Ineligible|4|||
163382685|NCT00551460|590111823|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
163382686|NCT00448123|590111824|FG000|Overall Study|Lost to Follow-up|9|||
163382687|NCT00448123|590111825|FG001|Overall Study|Lost to Follow-up|6|||
163382688|NCT00448123|590111824|FG000|Overall Study|Physician Decision|6|||
163382689|NCT00448123|590111825|FG001|Overall Study|Physician Decision|6|||
163382690|NCT00818649|590111826|FG000|Overall Study|Declining performance status|2|||
163382691|NCT00818649|590111826|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
163382692|NCT00818649|590111826|FG000|Overall Study|Adverse Event|1|||
163382693|NCT01275131|590111827|FG000|Period 1|Withdrawal by Subject|1|||
163382694|NCT01275131|590111828|FG001|Period 1|Withdrawal by Subject|0|||
163382695|NCT01275131|590111829|FG002|Period 1|Withdrawal by Subject|3|||
163382696|NCT01275131|590111830|FG003|Period 1|Withdrawal by Subject|2|||
163382697|NCT01275131|590111827|FG000|Period 1|Physician Decision|1|||
163382698|NCT01275131|590111828|FG001|Period 1|Physician Decision|0|||
163382699|NCT01275131|590111829|FG002|Period 1|Physician Decision|0|||
163382700|NCT01275131|590111830|FG003|Period 1|Physician Decision|0|||
163382701|NCT01275131|590111827|FG000|Period 2 (Crossover)|Adverse Event|0|||
163382702|NCT01275131|590111828|FG001|Period 2 (Crossover)|Adverse Event|1|||
163382703|NCT01275131|590111829|FG002|Period 2 (Crossover)|Adverse Event|0|||
163382704|NCT01275131|590111830|FG003|Period 2 (Crossover)|Adverse Event|0|||
163382705|NCT01275131|590111827|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
163382706|NCT01275131|590111828|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
163382707|NCT01275131|590111829|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
163382708|NCT01275131|590111830|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
163382709|NCT02112708|590111835|FG000|Baseline|Physician Decision|16|||
163382710|NCT02112708|590111836|FG001|Baseline|Physician Decision|11|||
163382711|NCT02112708|590111835|FG000|Baseline|Lost to Follow-up|12|||
163382712|NCT02112708|590111836|FG001|Baseline|Lost to Follow-up|0|||
163382713|NCT02112708|590111835|FG000|4 Month|Death|0|||
163382714|NCT02112708|590111836|FG001|4 Month|Death|1|||
163382715|NCT02112708|590111835|FG000|4 Month|Withdrawal by Subject|12|||
163382716|NCT02112708|590111836|FG001|4 Month|Withdrawal by Subject|0|||
163382717|NCT00953745|590111837|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
163382718|NCT00953745|590111838|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
163382719|NCT00953745|590111837|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
163382720|NCT00953745|590111838|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
163382721|NCT00953745|590111837|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
163382722|NCT00953745|590111838|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
163382723|NCT00953745|590111837|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
163382724|NCT00953745|590111838|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
163382725|NCT00953745|590111837|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
163382726|NCT00953745|590111838|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
163382727|NCT00953745|590111837|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
163382728|NCT00953745|590111838|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
163382729|NCT00490724|590111839|FG000|Period I|Physician Decision|0|||
163382730|NCT00490724|590111840|FG001|Period I|Physician Decision|0|||
163382731|NCT00490724|590111841|FG002|Period I|Physician Decision|1|||
163382732|NCT00490724|590111839|FG000|Period II|Treatment Discontinuation|3|||
163382733|NCT00490724|590111840|FG001|Period II|Treatment Discontinuation|1|||
163382734|NCT00490724|590111841|FG002|Period II|Treatment Discontinuation|3|||
163382735|NCT00903682|590111844|FG000|Overall Study|Adverse Event|6|||
163382736|NCT00903682|590111845|FG001|Overall Study|Adverse Event|13|||
163382737|NCT00903682|590111844|FG000|Overall Study|Lost to Follow-up|1|||
163382738|NCT00903682|590111845|FG001|Overall Study|Lost to Follow-up|0|||
163382739|NCT00903682|590111844|FG000|Overall Study|Withdrawal by Subject|5|||
163382740|NCT00903682|590111845|FG001|Overall Study|Withdrawal by Subject|0|||
163382741|NCT00903682|590111844|FG000|Overall Study|Pregnancy|0|||
163382742|NCT00903682|590111845|FG001|Overall Study|Pregnancy|1|||
163382743|NCT00903682|590111844|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
163382744|NCT00903682|590111845|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
163382745|NCT00903682|590111844|FG000|Overall Study|Subject Non-Compliant|1|||
163382746|NCT00903682|590111845|FG001|Overall Study|Subject Non-Compliant|0|||
163382747|NCT00903682|590111844|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
163382748|NCT00903682|590111845|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
163382749|NCT00903682|590111844|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
163382750|NCT00903682|590111845|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
163382751|NCT03866473|590111846|FG000|Phase 1|Death|1|||
163382752|NCT03866473|590111847|FG001|Phase 1|Death|0|||
163382753|NCT03866473|590111846|FG000|Phase 2|Death|0|||
163382754|NCT03866473|590111847|FG001|Phase 2|Death|2|||
163382755|NCT03866473|590111846|FG000|Phase 2|Dropped|1|||
163382756|NCT03866473|590111847|FG001|Phase 2|Dropped|1|||
163382757|NCT03866473|590111846|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
163382758|NCT03866473|590111847|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
163382759|NCT03110185|590111848|FG000|Overall Study|Death|0|||
163382760|NCT03110185|590111849|FG001|Overall Study|Death|1|||
163382761|NCT03110185|590111848|FG000|Overall Study|Withdrawal by Subject|2|||
163382762|NCT03110185|590111849|FG001|Overall Study|Withdrawal by Subject|7|||
163382763|NCT03110185|590111848|FG000|Overall Study|Time Constraints|0|||
163382764|NCT03110185|590111849|FG001|Overall Study|Time Constraints|6|||
163382765|NCT03110185|590111848|FG000|Overall Study|Conflict with care|5|||
163382766|NCT03110185|590111849|FG001|Overall Study|Conflict with care|12|||
163382767|NCT03110185|590111848|FG000|Overall Study|Protocol Violation|1|||
163382768|NCT03110185|590111849|FG001|Overall Study|Protocol Violation|4|||
163382769|NCT03110185|590111848|FG000|Overall Study|MRI Incompatible|2|||
163382770|NCT03110185|590111849|FG001|Overall Study|MRI Incompatible|0|||
163382771|NCT03110185|590111848|FG000|Overall Study|Patient Refusal|0|||
163382772|NCT03110185|590111849|FG001|Overall Study|Patient Refusal|1|||
163382773|NCT00600886|590111850|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
163382774|NCT00600886|590111851|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
163382775|NCT00600886|590111850|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
163382776|NCT00600886|590111851|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
163382777|NCT00600886|590111850|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
163382778|NCT00600886|590111851|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
163382779|NCT00600886|590111850|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
163382780|NCT00600886|590111851|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
163382781|NCT00600886|590111850|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
163382782|NCT00600886|590111851|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
163382783|NCT00600886|590111850|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
163382784|NCT00600886|590111851|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
163382785|NCT00600886|590111850|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
163382786|NCT00600886|590111851|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
163382787|NCT00600886|590111850|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
163382788|NCT00600886|590111851|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
163382789|NCT00600886|590111850|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
163382790|NCT00600886|590111851|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
163382791|NCT00600886|590111850|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
163382792|NCT00600886|590111851|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
163382793|NCT00600886|590111850|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
163382794|NCT00600886|590111851|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
163382795|NCT00600886|590111850|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
163382796|NCT00600886|590111851|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
163382797|NCT00600886|590111850|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
163382798|NCT00600886|590111851|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
163382799|NCT00600886|590111850|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
163382800|NCT00600886|590111851|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
163382801|NCT00600886|590111850|FG000|Extension - Same Treatment (FAS)|Death|1|||
163382802|NCT00600886|590111851|FG001|Extension - Same Treatment (FAS)|Death|1|||
163382803|NCT00600886|590111850|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
163382804|NCT00600886|590111851|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
163382805|NCT00600886|590111850|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
163382806|NCT00600886|590111851|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
163382807|NCT00600886|590111850|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
163382808|NCT00600886|590111851|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
163382809|NCT00600886|590111850|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
163382810|NCT00600886|590111851|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
163382811|NCT00600886|590111850|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
163382812|NCT00600886|590111851|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
163382813|NCT00600886|590111850|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
163382814|NCT00600886|590111851|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
163382815|NCT00600886|590111850|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
163382816|NCT00600886|590111851|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
163382817|NCT00600886|590111850|FG000|Extension - After Crossover (CAS)|Death|1|||
163382818|NCT00600886|590111851|FG001|Extension - After Crossover (CAS)|Death|0|||
163382819|NCT02053792|590111852|FG000|Overall Study|Physician Decision|0|||
163382820|NCT02053792|590111853|FG001|Overall Study|Physician Decision|1|||
163382821|NCT02053792|590111852|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
163382822|NCT02053792|590111853|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
163382823|NCT02053792|590111852|FG000|Overall Study|Lack of Efficacy|1|||
163382824|NCT02053792|590111853|FG001|Overall Study|Lack of Efficacy|0|||
163382825|NCT02053792|590111852|FG000|Overall Study|Adverse Event|1|||
163382826|NCT02053792|590111853|FG001|Overall Study|Adverse Event|0|||
163382827|NCT02053792|590111852|FG000|Overall Study|Withdrawal by Subject|2|||
163382828|NCT02053792|590111853|FG001|Overall Study|Withdrawal by Subject|2|||
163382829|NCT02053792|590111852|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
163382830|NCT02053792|590111853|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
163382831|NCT02053792|590111852|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
163382832|NCT02053792|590111853|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
163382833|NCT03075410|590111854|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
163382834|NCT03075410|590111855|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
163382835|NCT03075410|590111856|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
163382836|NCT03075410|590111857|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
163382837|NCT03075410|590111858|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
163382838|NCT03075410|590111859|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
163382839|NCT03075410|590111860|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
163382840|NCT03075410|590111861|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
163382841|NCT03075410|590111862|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
163382842|NCT03075410|590111854|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
163382843|NCT03075410|590111855|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163382844|NCT03075410|590111856|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163382845|NCT03075410|590111857|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163382846|NCT03075410|590111858|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163382847|NCT03075410|590111859|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163417747|NCT01430442|590238092|FG002|Overall Study|Pregnancy|0|||
163382848|NCT03075410|590111860|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163382849|NCT03075410|590111861|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163382850|NCT03075410|590111862|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163382851|NCT01427751|590111863|FG000|Overall Study|Adverse Event|18|||
163382852|NCT01427751|590111864|FG001|Overall Study|Adverse Event|2|||
163382853|NCT01427751|590111863|FG000|Overall Study|No further treatment benefit expected|5|||
163382854|NCT01427751|590111864|FG001|Overall Study|No further treatment benefit expected|1|||
163382855|NCT01427751|590111863|FG000|Overall Study|Lost to Follow-up|3|||
163382856|NCT01427751|590111864|FG001|Overall Study|Lost to Follow-up|1|||
163382857|NCT01427751|590111863|FG000|Overall Study|Withdrawal of consent|2|||
163382858|NCT01427751|590111864|FG001|Overall Study|Withdrawal of consent|2|||
163382859|NCT01427751|590111863|FG000|Overall Study|Protocol Violation|6|||
163382860|NCT01427751|590111864|FG001|Overall Study|Protocol Violation|4|||
163382861|NCT01427751|590111863|FG000|Overall Study|Death|2|||
163382862|NCT01427751|590111864|FG001|Overall Study|Death|0|||
163382863|NCT01427751|590111863|FG000|Overall Study|Other miscellaneous reasons|6|||
163382864|NCT01427751|590111864|FG001|Overall Study|Other miscellaneous reasons|4|||
163382865|NCT01028027|590111865|FG000|Overall Study|Lost to Follow-up|4|||
163382866|NCT01028027|590111866|FG001|Overall Study|Lost to Follow-up|1|||
163382867|NCT01028027|590111865|FG000|Overall Study|Withdrawal by Subject|5|||
163382868|NCT01028027|590111866|FG001|Overall Study|Withdrawal by Subject|3|||
163382869|NCT01028027|590111865|FG000|Overall Study|Adverse Event|4|||
163382870|NCT01028027|590111866|FG001|Overall Study|Adverse Event|7|||
163382871|NCT01028027|590111865|FG000|Overall Study|Protocol Violation|3|||
163382872|NCT01028027|590111866|FG001|Overall Study|Protocol Violation|1|||
163382873|NCT01028027|590111865|FG000|Overall Study|Lack of Efficacy|0|||
163382874|NCT01028027|590111866|FG001|Overall Study|Lack of Efficacy|1|||
163382875|NCT00368992|590111877|FG000|Overall Study|Ineligible|5|||
163382876|NCT00368992|590111877|FG000|Overall Study|Refused treatment|3|||
163382877|NCT00368992|590111877|FG000|Overall Study|Lack of Efficacy|63|||
163382878|NCT00368992|590111877|FG000|Overall Study|Adverse Event|26|||
163382879|NCT00368992|590111877|FG000|Overall Study|Death|4|||
163382880|NCT00368992|590111877|FG000|Overall Study|Other|9|||
163382881|NCT00790751|590111884|FG000|Overall Study|Protocol non-compliance|16|||
163382882|NCT00790751|590111885|FG001|Overall Study|Protocol non-compliance|16|||
163382883|NCT00790751|590111886|FG002|Overall Study|Protocol non-compliance|10|||
163382884|NCT00790751|590111887|FG003|Overall Study|Protocol non-compliance|11|||
163382885|NCT00790751|590111884|FG000|Overall Study|Lost to Follow-up|4|||
163382886|NCT00790751|590111885|FG001|Overall Study|Lost to Follow-up|9|||
163382887|NCT00790751|590111886|FG002|Overall Study|Lost to Follow-up|4|||
163382888|NCT00790751|590111887|FG003|Overall Study|Lost to Follow-up|5|||
163382889|NCT00790751|590111884|FG000|Overall Study|Adverse Event|5|||
163382890|NCT00790751|590111885|FG001|Overall Study|Adverse Event|3|||
163382891|NCT00790751|590111886|FG002|Overall Study|Adverse Event|5|||
163382892|NCT00790751|590111887|FG003|Overall Study|Adverse Event|4|||
163382893|NCT00790751|590111884|FG000|Overall Study|Requirement for restricted medication|0|||
163382894|NCT00790751|590111885|FG001|Overall Study|Requirement for restricted medication|2|||
163382895|NCT00790751|590111886|FG002|Overall Study|Requirement for restricted medication|0|||
163382896|NCT00790751|590111887|FG003|Overall Study|Requirement for restricted medication|0|||
163382897|NCT00790751|590111884|FG000|Overall Study|Death|0|||
163382898|NCT00790751|590111885|FG001|Overall Study|Death|0|||
163382899|NCT00790751|590111886|FG002|Overall Study|Death|1|||
163382900|NCT00790751|590111887|FG003|Overall Study|Death|0|||
163382901|NCT00790751|590111884|FG000|Overall Study|Physician Decision|0|||
163382902|NCT00790751|590111885|FG001|Overall Study|Physician Decision|0|||
163382903|NCT00790751|590111886|FG002|Overall Study|Physician Decision|0|||
163382904|NCT00790751|590111887|FG003|Overall Study|Physician Decision|1|||
163382905|NCT04443153|590111890|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
163382906|NCT04443153|590111891|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
163382907|NCT04443153|590111890|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
163382908|NCT04443153|590111891|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
163382909|NCT04443153|590111890|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
163382910|NCT04443153|590111891|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
163382911|NCT04443153|590111890|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
163382912|NCT04443153|590111891|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
163382913|NCT01078454|590111895|FG000|Overall Study|Adverse Event|1|||
163382914|NCT01078454|590111896|FG001|Overall Study|Adverse Event|1|||
163382915|NCT01078454|590111895|FG000|Overall Study|Death|0|||
163382916|NCT01078454|590111896|FG001|Overall Study|Death|1|||
163382917|NCT04737187|590111897|FG000|Overall Study|Switched to marketed drug|32|||
163382918|NCT04737187|590111898|FG001|Overall Study|Switched to marketed drug|4|||
163382919|NCT04737187|590111897|FG000|Overall Study|Radiological Progressive Disease|145|||
163382920|NCT04737187|590111898|FG001|Overall Study|Radiological Progressive Disease|146|||
163382921|NCT04737187|590111897|FG000|Overall Study|Clinical Progressive Disease|20|||
163382922|NCT04737187|590111898|FG001|Overall Study|Clinical Progressive Disease|20|||
163382923|NCT04737187|590111897|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
163417748|NCT01430442|590238093|FG003|Overall Study|Pregnancy|0|||
163417749|NCT01430442|590238094|FG004|Overall Study|Pregnancy|0|||
163417750|NCT01430442|590238095|FG005|Overall Study|Pregnancy|1|||
163417751|NCT01430442|590238096|FG006|Overall Study|Pregnancy|0|||
163417752|NCT01430442|590238097|FG007|Overall Study|Pregnancy|0|||
163417753|NCT01430442|590238090|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
163417754|NCT01430442|590238091|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
163417755|NCT01430442|590238092|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
163417756|NCT01430442|590238093|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
163417757|NCT01430442|590238094|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
163417758|NCT01430442|590238095|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
163417759|NCT01430442|590238096|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
163417760|NCT01430442|590238097|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
163417761|NCT00947531|590238102|FG000|Overall Study|Withdrawal by Subject|10|||
163417762|NCT00947531|590238103|FG001|Overall Study|Withdrawal by Subject|7|||
163417763|NCT00947531|590238102|FG000|Overall Study|Administrative Reason|0|||
163417764|NCT00947531|590238103|FG001|Overall Study|Administrative Reason|1|||
163417765|NCT00947531|590238102|FG000|Overall Study|Adverse Event|2|||
163417766|NCT00947531|590238103|FG001|Overall Study|Adverse Event|2|||
163417767|NCT00947531|590238102|FG000|Overall Study|Lack of Efficacy|1|||
163417768|NCT00947531|590238103|FG001|Overall Study|Lack of Efficacy|0|||
163417769|NCT00947531|590238102|FG000|Overall Study|Other|1|||
163417770|NCT00947531|590238103|FG001|Overall Study|Other|1|||
163417771|NCT01773421|590238105|FG000|Treatment Phase|Other|0|||
163417772|NCT01773421|590238106|FG001|Treatment Phase|Other|0|||
163417773|NCT01773421|590238107|FG002|Treatment Phase|Other|2|||
163417774|NCT01773421|590238108|FG003|Treatment Phase|Other|0|||
163417775|NCT01773421|590238109|FG004|Treatment Phase|Other|0|||
163417776|NCT01773421|590238110|FG005|Treatment Phase|Other|0|||
163417777|NCT01773421|590238111|FG006|Treatment Phase|Other|0|||
163417778|NCT01773421|590238105|FG000|Treatment Phase|Adverse Event|0|||
163417779|NCT01773421|590238106|FG001|Treatment Phase|Adverse Event|0|||
163417780|NCT01773421|590238107|FG002|Treatment Phase|Adverse Event|3|||
163417781|NCT01773421|590238108|FG003|Treatment Phase|Adverse Event|1|||
163417782|NCT01773421|590238109|FG004|Treatment Phase|Adverse Event|0|||
163417783|NCT01773421|590238110|FG005|Treatment Phase|Adverse Event|0|||
163417784|NCT01773421|590238111|FG006|Treatment Phase|Adverse Event|0|||
163417785|NCT01773421|590238105|FG000|Treatment Phase|Withdrawal by Subject|0|||
163417786|NCT01773421|590238106|FG001|Treatment Phase|Withdrawal by Subject|0|||
163417787|NCT01773421|590238107|FG002|Treatment Phase|Withdrawal by Subject|1|||
163417788|NCT01773421|590238108|FG003|Treatment Phase|Withdrawal by Subject|1|||
163417789|NCT01773421|590238109|FG004|Treatment Phase|Withdrawal by Subject|0|||
163417790|NCT01773421|590238110|FG005|Treatment Phase|Withdrawal by Subject|0|||
163417791|NCT01773421|590238111|FG006|Treatment Phase|Withdrawal by Subject|0|||
163417792|NCT01773421|590238105|FG000|Extension Phase|Other|0|||
163417793|NCT01773421|590238106|FG001|Extension Phase|Other|0|||
163417794|NCT01773421|590238107|FG002|Extension Phase|Other|0|||
163417795|NCT01773421|590238108|FG003|Extension Phase|Other|0|||
163417796|NCT01773421|590238109|FG004|Extension Phase|Other|1|||
163417797|NCT01773421|590238110|FG005|Extension Phase|Other|2|||
163417798|NCT01773421|590238111|FG006|Extension Phase|Other|0|||
163417799|NCT01773421|590238105|FG000|Extension Phase|Adverse Event|0|||
163417800|NCT01773421|590238106|FG001|Extension Phase|Adverse Event|0|||
163417801|NCT01773421|590238107|FG002|Extension Phase|Adverse Event|0|||
163417802|NCT01773421|590238108|FG003|Extension Phase|Adverse Event|0|||
163417803|NCT01773421|590238109|FG004|Extension Phase|Adverse Event|2|||
163417804|NCT01773421|590238110|FG005|Extension Phase|Adverse Event|0|||
163417805|NCT01773421|590238111|FG006|Extension Phase|Adverse Event|0|||
163417806|NCT02327260|590238112|FG000|Overall Study|Lost to Follow-up|2|||
163417807|NCT02327260|590238113|FG001|Overall Study|Lost to Follow-up|3|||
163417808|NCT02327260|590238114|FG002|Overall Study|Lost to Follow-up|2|||
163417809|NCT02327260|590238112|FG000|Overall Study|invalid phone number|1|||
163417810|NCT02327260|590238113|FG001|Overall Study|invalid phone number|1|||
163417811|NCT02327260|590238114|FG002|Overall Study|invalid phone number|0|||
163417812|NCT02327260|590238112|FG000|Overall Study|non-adherence to protocol|2|||
163417813|NCT02327260|590238113|FG001|Overall Study|non-adherence to protocol|0|||
163417814|NCT02327260|590238114|FG002|Overall Study|non-adherence to protocol|0|||
163417815|NCT02327260|590238112|FG000|Overall Study|cognitive concerns|1|||
163417816|NCT02327260|590238113|FG001|Overall Study|cognitive concerns|0|||
163417817|NCT02327260|590238114|FG002|Overall Study|cognitive concerns|0|||
163417818|NCT03502330|590238115|FG000|Overall Study|Adverse Event|2|||
163417819|NCT03502330|590238116|FG001|Overall Study|Adverse Event|1|||
163417820|NCT03502330|590238117|FG002|Overall Study|Adverse Event|0|||
163417821|NCT03502330|590238118|FG003|Overall Study|Adverse Event|0|||
163417822|NCT03502330|590238119|FG004|Overall Study|Adverse Event|1|||
163417823|NCT03502330|590238120|FG005|Overall Study|Adverse Event|0|||
163417824|NCT03502330|590238121|FG006|Overall Study|Adverse Event|1|||
163417825|NCT03502330|590238122|FG007|Overall Study|Adverse Event|1|||
163417826|NCT03502330|590238123|FG008|Overall Study|Adverse Event|0|||
163417827|NCT03502330|590238115|FG000|Overall Study|Lack of Efficacy|1|||
163417828|NCT03502330|590238116|FG001|Overall Study|Lack of Efficacy|5|||
163417829|NCT03502330|590238117|FG002|Overall Study|Lack of Efficacy|3|||
163417830|NCT03502330|590238118|FG003|Overall Study|Lack of Efficacy|5|||
163417831|NCT03502330|590238119|FG004|Overall Study|Lack of Efficacy|1|||
163417832|NCT03502330|590238120|FG005|Overall Study|Lack of Efficacy|5|||
163417833|NCT03502330|590238121|FG006|Overall Study|Lack of Efficacy|5|||
163417834|NCT03502330|590238122|FG007|Overall Study|Lack of Efficacy|6|||
163417835|NCT03502330|590238123|FG008|Overall Study|Lack of Efficacy|0|||
163417836|NCT03502330|590238115|FG000|Overall Study|Physician Decision|0|||
163417837|NCT03502330|590238116|FG001|Overall Study|Physician Decision|0|||
163417838|NCT03502330|590238117|FG002|Overall Study|Physician Decision|0|||
163417839|NCT03502330|590238118|FG003|Overall Study|Physician Decision|0|||
163417840|NCT03502330|590238119|FG004|Overall Study|Physician Decision|1|||
163417841|NCT03502330|590238120|FG005|Overall Study|Physician Decision|0|||
163417842|NCT03502330|590238121|FG006|Overall Study|Physician Decision|0|||
163417843|NCT03502330|590238122|FG007|Overall Study|Physician Decision|0|||
163417844|NCT03502330|590238123|FG008|Overall Study|Physician Decision|0|||
163417845|NCT03502330|590238115|FG000|Overall Study|Withdrawal by Subject|0|||
163417846|NCT03502330|590238116|FG001|Overall Study|Withdrawal by Subject|0|||
163417847|NCT03502330|590238117|FG002|Overall Study|Withdrawal by Subject|0|||
163417848|NCT03502330|590238118|FG003|Overall Study|Withdrawal by Subject|0|||
163417849|NCT03502330|590238119|FG004|Overall Study|Withdrawal by Subject|0|||
163417850|NCT03502330|590238120|FG005|Overall Study|Withdrawal by Subject|1|||
163417851|NCT03502330|590238121|FG006|Overall Study|Withdrawal by Subject|0|||
163417852|NCT03502330|590238122|FG007|Overall Study|Withdrawal by Subject|1|||
163417853|NCT03502330|590238123|FG008|Overall Study|Withdrawal by Subject|0|||
163417854|NCT03502330|590238115|FG000|Overall Study|Death|0|||
163417855|NCT03502330|590238116|FG001|Overall Study|Death|0|||
163417856|NCT03502330|590238117|FG002|Overall Study|Death|0|||
163417857|NCT03502330|590238118|FG003|Overall Study|Death|0|||
163417858|NCT03502330|590238119|FG004|Overall Study|Death|0|||
163417859|NCT03502330|590238120|FG005|Overall Study|Death|0|||
163417860|NCT03502330|590238121|FG006|Overall Study|Death|2|||
163417861|NCT03502330|590238122|FG007|Overall Study|Death|0|||
163417862|NCT03502330|590238123|FG008|Overall Study|Death|0|||
163417863|NCT02804763|590238127|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
163417864|NCT02804763|590238128|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
163417865|NCT02804763|590238129|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
163417866|NCT02804763|590238130|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
163417867|NCT02804763|590238127|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
163417868|NCT02804763|590238128|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
163417869|NCT02804763|590238129|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
163417870|NCT02804763|590238130|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
163417871|NCT02804763|590238127|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
163417872|NCT02804763|590238128|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
163417873|NCT02804763|590238129|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
163417874|NCT02804763|590238130|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
163417875|NCT02804763|590238127|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
163417876|NCT02804763|590238128|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
163417877|NCT02804763|590238129|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
163417878|NCT02804763|590238130|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
163417879|NCT02804763|590238127|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
163417880|NCT02804763|590238128|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
163417881|NCT02804763|590238129|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
163417882|NCT02804763|590238130|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
163417883|NCT02804763|590238127|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
163417884|NCT02804763|590238128|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
163417885|NCT02804763|590238129|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
163417886|NCT02804763|590238130|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
163417887|NCT01400932|590238135|FG000|Overall Study|Adverse Event|10|||
163417888|NCT01400932|590238136|FG001|Overall Study|Adverse Event|5|||
163417889|NCT01400932|590238135|FG000|Overall Study|Lack of Efficacy|0|||
163417890|NCT01400932|590238136|FG001|Overall Study|Lack of Efficacy|3|||
163417891|NCT01400932|590238135|FG000|Overall Study|Withdrawal by Subject|2|||
163417892|NCT01400932|590238136|FG001|Overall Study|Withdrawal by Subject|6|||
163417893|NCT01400932|590238135|FG000|Overall Study|Lost to Follow-up|1|||
163417894|NCT01400932|590238136|FG001|Overall Study|Lost to Follow-up|0|||
163417895|NCT01400932|590238135|FG000|Overall Study|Protocol Deviation|0|||
163417896|NCT01400932|590238136|FG001|Overall Study|Protocol Deviation|1|||
163417897|NCT01400932|590238135|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
163417898|NCT01400932|590238136|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
163417899|NCT00860158|590238137|FG000|Overall Study|Study Terminated|1|||
163417900|NCT00282243|590238138|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
163417901|NCT00282243|590238138|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
163417902|NCT00282243|590238138|FG000|Extension Treatment Period|Adverse Event|15|||
163417903|NCT00282243|590238138|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
163417904|NCT00282243|590238138|FG000|Extension Treatment Period|Non-compliance|2|||
163417905|NCT00282243|590238138|FG000|Extension Treatment Period|Physician Decision|1|||
163417906|NCT01070329|590238139|FG000|Overall Study|Adverse Event|13|||
163417907|NCT01070329|590238140|FG001|Overall Study|Adverse Event|10|||
163417908|NCT01070329|590238139|FG000|Overall Study|Lost to Follow-up|22|||
163417909|NCT01070329|590238140|FG001|Overall Study|Lost to Follow-up|12|||
163417910|NCT01070329|590238139|FG000|Overall Study|Withdrawal by Subject|9|||
163417911|NCT01070329|590238140|FG001|Overall Study|Withdrawal by Subject|11|||
163417912|NCT01070329|590238139|FG000|Overall Study|Protocol Violation|3|||
163417913|NCT01070329|590238140|FG001|Overall Study|Protocol Violation|8|||
163417914|NCT01070329|590238139|FG000|Overall Study|Lack of Efficacy|2|||
163417915|NCT01070329|590238140|FG001|Overall Study|Lack of Efficacy|6|||
163417916|NCT01070329|590238139|FG000|Overall Study|Physician Decision|2|||
163417917|NCT01070329|590238140|FG001|Overall Study|Physician Decision|1|||
163417918|NCT01070329|590238139|FG000|Overall Study|Entry Criteria Not Met|1|||
163417919|NCT01070329|590238140|FG001|Overall Study|Entry Criteria Not Met|0|||
163417920|NCT01070329|590238139|FG000|Overall Study|Sponsor Decision|0|||
163417921|NCT01070329|590238140|FG001|Overall Study|Sponsor Decision|1|||
163417922|NCT02863848|590238141|FG000|Overall Study|Lost to Follow-up|1|||
163417923|NCT02863848|590238142|FG001|Overall Study|Lost to Follow-up|1|||
163417924|NCT02863848|590238141|FG000|Overall Study|Protocol Violation|1|||
163417925|NCT02863848|590238142|FG001|Overall Study|Protocol Violation|2|||
163417926|NCT03980938|590238146|FG000|Treatment Period 1|Study Terminated|1|||
163417927|NCT03980938|590238147|FG001|Treatment Period 1|Study Terminated|1|||
163417928|NCT03980938|590238146|FG000|Treatment Period 2|Study Terminated|2|||
163417929|NCT03980938|590238147|FG001|Treatment Period 2|Study Terminated|2|||
163417930|NCT03706365|590238149|FG000|Overall Study|Lost to Follow-up|7|||
163417931|NCT03706365|590238150|FG001|Overall Study|Lost to Follow-up|0|||
163417932|NCT03706365|590238149|FG000|Overall Study|Withdrawal by Subject|17|||
163382924|NCT04737187|590111898|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
163382925|NCT04737187|590111897|FG000|Overall Study|Adverse Event|16|||
163382926|NCT04737187|590111898|FG001|Overall Study|Adverse Event|16|||
163382927|NCT04737187|590111897|FG000|Overall Study|Physician Decision|2|||
163382928|NCT04737187|590111898|FG001|Overall Study|Physician Decision|0|||
163382929|NCT04737187|590111897|FG000|Overall Study|Withdrawal by Subject|5|||
163382930|NCT04737187|590111898|FG001|Overall Study|Withdrawal by Subject|8|||
163382931|NCT05227703|590111899|FG000|Overall Study|Adverse Event|2|||
163382932|NCT05227703|590111900|FG001|Overall Study|Adverse Event|6|||
163382933|NCT05227703|590111901|FG002|Overall Study|Adverse Event|4|||
163382934|NCT05227703|590111899|FG000|Overall Study|Lack of Efficacy|4|||
163382935|NCT05227703|590111900|FG001|Overall Study|Lack of Efficacy|0|||
163382936|NCT05227703|590111901|FG002|Overall Study|Lack of Efficacy|1|||
163382937|NCT05227703|590111899|FG000|Overall Study|Physician Decision|2|||
163382938|NCT05227703|590111900|FG001|Overall Study|Physician Decision|2|||
163382939|NCT05227703|590111901|FG002|Overall Study|Physician Decision|1|||
163382940|NCT05227703|590111899|FG000|Overall Study|Protocol Violation|2|||
163382941|NCT05227703|590111900|FG001|Overall Study|Protocol Violation|1|||
163382942|NCT05227703|590111901|FG002|Overall Study|Protocol Violation|0|||
163382943|NCT05227703|590111899|FG000|Overall Study|Withdrawal by Subject|17|||
163382944|NCT05227703|590111900|FG001|Overall Study|Withdrawal by Subject|26|||
163382945|NCT05227703|590111901|FG002|Overall Study|Withdrawal by Subject|32|||
163382946|NCT05227703|590111899|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
163382947|NCT05227703|590111900|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
163382948|NCT05227703|590111901|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
163382949|NCT05227703|590111899|FG000|Overall Study|Other|1|||
163382950|NCT05227703|590111900|FG001|Overall Study|Other|1|||
163382951|NCT05227703|590111901|FG002|Overall Study|Other|0|||
163382952|NCT03464097|590111908|FG000|Overall Study|Withdrawal by Subject|15|||
163382953|NCT03464097|590111909|FG001|Overall Study|Withdrawal by Subject|13|||
163382954|NCT03464097|590111910|FG002|Overall Study|Withdrawal by Subject|11|||
163382955|NCT03464097|590111908|FG000|Overall Study|Study terminated by sponsor|47|||
163382956|NCT03464097|590111909|FG001|Overall Study|Study terminated by sponsor|44|||
163382957|NCT03464097|590111910|FG002|Overall Study|Study terminated by sponsor|40|||
163382958|NCT03464097|590111908|FG000|Overall Study|Pregnancy|0|||
163417933|NCT03706365|590238150|FG001|Overall Study|Withdrawal by Subject|15|||
163417934|NCT03706365|590238149|FG000|Overall Study|On Study Treatment|51|||
163417935|NCT03706365|590238150|FG001|Overall Study|On Study Treatment|51|||
163417936|NCT00605267|590238151|FG000|Overall Study|Adverse Event|0|||
163417937|NCT00605267|590238152|FG001|Overall Study|Adverse Event|1|||
163417938|NCT00605267|590238151|FG000|Overall Study|Lack of Efficacy|1|||
163417939|NCT00605267|590238152|FG001|Overall Study|Lack of Efficacy|5|||
163382959|NCT03464097|590111909|FG001|Overall Study|Pregnancy|1|||
163382960|NCT03464097|590111910|FG002|Overall Study|Pregnancy|0|||
163382961|NCT03464097|590111908|FG000|Overall Study|Other reasons|5|||
163382962|NCT03464097|590111909|FG001|Overall Study|Other reasons|12|||
163417940|NCT00605267|590238151|FG000|Overall Study|Withdrawal by Subject|2|||
163417941|NCT00605267|590238152|FG001|Overall Study|Withdrawal by Subject|3|||
163417942|NCT04557384|590238154|FG000|Overall Study|Study Terminated by Sponsor|1|||
163417943|NCT04557384|590238154|FG000|Overall Study|Death|1|||
163417944|NCT01505894|590238158|FG000|Overall Study|Adverse Event|1|||
163417945|NCT01505894|590238159|FG001|Overall Study|Adverse Event|0|||
163417946|NCT01505894|590238160|FG002|Overall Study|Adverse Event|0|||
163417947|NCT01505894|590238161|FG003|Overall Study|Adverse Event|0|||
163417948|NCT01505894|590238162|FG004|Overall Study|Adverse Event|0|||
163417949|NCT01505894|590238163|FG005|Overall Study|Adverse Event|0|||
163417950|NCT01505894|590238164|FG006|Overall Study|Adverse Event|0|||
163417951|NCT01505894|590238165|FG007|Overall Study|Adverse Event|0|||
163417952|NCT01505894|590238166|FG008|Overall Study|Adverse Event|0|||
163417953|NCT01505894|590238158|FG000|Overall Study|Other than specified|0|||
163417954|NCT01505894|590238159|FG001|Overall Study|Other than specified|0|||
163417955|NCT01505894|590238160|FG002|Overall Study|Other than specified|0|||
163417956|NCT01505894|590238161|FG003|Overall Study|Other than specified|0|||
163417957|NCT01505894|590238162|FG004|Overall Study|Other than specified|1|||
163417958|NCT01505894|590238163|FG005|Overall Study|Other than specified|0|||
163417959|NCT01505894|590238164|FG006|Overall Study|Other than specified|0|||
163417960|NCT01505894|590238165|FG007|Overall Study|Other than specified|0|||
163417961|NCT01505894|590238166|FG008|Overall Study|Other than specified|0|||
163417962|NCT00254566|590238168|FG000|Overall Study|Death|1|||
163417963|NCT00254566|590238169|FG001|Overall Study|Death|0|||
163417964|NCT00254566|590238168|FG000|Overall Study|Adverse Event|5|||
163417965|NCT00254566|590238169|FG001|Overall Study|Adverse Event|4|||
163417966|NCT00254566|590238168|FG000|Overall Study|Lack of Efficacy|12|||
163417967|NCT00254566|590238169|FG001|Overall Study|Lack of Efficacy|9|||
163417968|NCT00254566|590238168|FG000|Overall Study|Other|1|||
163417969|NCT00254566|590238169|FG001|Overall Study|Other|5|||
163417970|NCT00254566|590238168|FG000|Overall Study|Withdrawal by Subject|5|||
163417971|NCT00254566|590238169|FG001|Overall Study|Withdrawal by Subject|6|||
163417972|NCT00254566|590238168|FG000|Overall Study|Lost to Follow-up|7|||
163417973|NCT00254566|590238169|FG001|Overall Study|Lost to Follow-up|2|||
163417974|NCT00059202|590238171|FG000|Overall Study|Withdrawal by Subject|5|||
163417975|NCT00059202|590238172|FG001|Overall Study|Withdrawal by Subject|9|||
163417976|NCT00059202|590238171|FG000|Overall Study|Protocol Violation|1|||
163417977|NCT00059202|590238172|FG001|Overall Study|Protocol Violation|3|||
163417978|NCT00059202|590238171|FG000|Overall Study|drug toxicity|0|||
163417979|NCT00059202|590238172|FG001|Overall Study|drug toxicity|3|||
163417980|NCT04088409|590238175|FG000|Part A|Withdrawal by Subject|2|||
163417981|NCT04088409|590238176|FG001|Part A|Withdrawal by Subject|1|||
163417982|NCT04088409|590238175|FG000|Part A|Did Not Meet Randomization Criteria|2|||
163417983|NCT04088409|590238176|FG001|Part A|Did Not Meet Randomization Criteria|0|||
163417984|NCT04088409|590238175|FG000|Part A|Lack of Efficacy|9|||
163417985|NCT04088409|590238176|FG001|Part A|Lack of Efficacy|0|||
163417986|NCT04088409|590238175|FG000|Part A|Lost to Follow-up|1|||
163417987|NCT04088409|590238176|FG001|Part A|Lost to Follow-up|0|||
163417988|NCT04088409|590238175|FG000|Part A|Adverse Event|1|||
163417989|NCT04088409|590238176|FG001|Part A|Adverse Event|0|||
163417990|NCT04088409|590238175|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
163417991|NCT04088409|590238176|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
163417992|NCT04088409|590238175|FG000|Part B|Ongoing Treatment|10|||
163417993|NCT04088409|590238176|FG001|Part B|Ongoing Treatment|0|||
163417994|NCT00841763|590238177|FG000|Overall Study|Withdrawal by Subject|60|||
163417995|NCT00841763|590238178|FG001|Overall Study|Withdrawal by Subject|17|||
163417996|NCT00841763|590238179|FG002|Overall Study|Withdrawal by Subject|4|||
163417997|NCT00841763|590238180|FG003|Overall Study|Withdrawal by Subject|1|||
163417998|NCT00841763|590238177|FG000|Overall Study|Adverse Event|9|||
163417999|NCT00841763|590238178|FG001|Overall Study|Adverse Event|10|||
163418000|NCT00841763|590238179|FG002|Overall Study|Adverse Event|3|||
163418001|NCT00841763|590238180|FG003|Overall Study|Adverse Event|2|||
163418002|NCT00841763|590238177|FG000|Overall Study|Lost to Follow-up|63|||
163418003|NCT00841763|590238178|FG001|Overall Study|Lost to Follow-up|25|||
163418004|NCT00841763|590238179|FG002|Overall Study|Lost to Follow-up|0|||
163418005|NCT00841763|590238180|FG003|Overall Study|Lost to Follow-up|0|||
163418006|NCT00841763|590238177|FG000|Overall Study|Protocol Violation|20|||
163418007|NCT00841763|590238178|FG001|Overall Study|Protocol Violation|3|||
163418008|NCT00841763|590238179|FG002|Overall Study|Protocol Violation|1|||
163418009|NCT00841763|590238180|FG003|Overall Study|Protocol Violation|0|||
163418010|NCT00841763|590238177|FG000|Overall Study|Administrative Reasons|3|||
163418011|NCT00841763|590238178|FG001|Overall Study|Administrative Reasons|1|||
163418012|NCT00841763|590238179|FG002|Overall Study|Administrative Reasons|0|||
163418013|NCT00841763|590238180|FG003|Overall Study|Administrative Reasons|0|||
163418014|NCT00841763|590238177|FG000|Overall Study|Unable to Classify|7|||
163418015|NCT00841763|590238178|FG001|Overall Study|Unable to Classify|1|||
163418016|NCT00841763|590238179|FG002|Overall Study|Unable to Classify|0|||
163418017|NCT00841763|590238180|FG003|Overall Study|Unable to Classify|0|||
163418018|NCT00400400|590238181|FG000|Overall Study|Adverse Event|9|||
163382963|NCT03464097|590111910|FG002|Overall Study|Other reasons|14|||
163382964|NCT03464097|590111908|FG000|Overall Study|Lost to Follow-up|0|||
163382965|NCT03464097|590111909|FG001|Overall Study|Lost to Follow-up|1|||
163382966|NCT03464097|590111910|FG002|Overall Study|Lost to Follow-up|1|||
163382967|NCT03464097|590111908|FG000|Overall Study|Lack of Efficacy|11|||
163382968|NCT03464097|590111909|FG001|Overall Study|Lack of Efficacy|18|||
163382969|NCT03464097|590111910|FG002|Overall Study|Lack of Efficacy|30|||
163382970|NCT03464097|590111908|FG000|Overall Study|Death|1|||
163382971|NCT03464097|590111909|FG001|Overall Study|Death|0|||
163382972|NCT03464097|590111910|FG002|Overall Study|Death|0|||
163382973|NCT03464097|590111908|FG000|Overall Study|Adverse Event|13|||
163382974|NCT03464097|590111909|FG001|Overall Study|Adverse Event|6|||
163382975|NCT03464097|590111910|FG002|Overall Study|Adverse Event|8|||
163382976|NCT03035201|590111911|FG000|Overall Study|Death|9|||
163382977|NCT03035201|590111912|FG001|Overall Study|Death|12|||
163382978|NCT03035201|590111913|FG002|Overall Study|Death|9|||
163382979|NCT03035201|590111914|FG003|Overall Study|Death|10|||
163382980|NCT03035201|590111911|FG000|Overall Study|Withdrawal by Subject|51|||
163382981|NCT03035201|590111912|FG001|Overall Study|Withdrawal by Subject|49|||
163382982|NCT03035201|590111913|FG002|Overall Study|Withdrawal by Subject|37|||
163382983|NCT03035201|590111914|FG003|Overall Study|Withdrawal by Subject|46|||
163382984|NCT03035201|590111911|FG000|Overall Study|Lost to Follow-up|67|||
163382985|NCT03035201|590111912|FG001|Overall Study|Lost to Follow-up|51|||
163382986|NCT03035201|590111913|FG002|Overall Study|Lost to Follow-up|64|||
163382987|NCT03035201|590111914|FG003|Overall Study|Lost to Follow-up|69|||
163382988|NCT03727438|590111921|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
163382989|NCT03727438|590111922|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
163382990|NCT03727438|590111921|FG000|Intervention Period|Excluded (health)|1|||
163382991|NCT03727438|590111922|FG001|Intervention Period|Excluded (health)|0|||
163382992|NCT03727438|590111921|FG000|Intervention Period|Withdrawal by Subject|3|||
163382993|NCT03727438|590111922|FG001|Intervention Period|Withdrawal by Subject|1|||
163382994|NCT03727438|590111921|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
163382995|NCT03727438|590111922|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
163382996|NCT03727438|590111921|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
163382997|NCT03727438|590111922|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
163382998|NCT03727438|590111921|FG000|8 Week Assessment|Withdrawal by Subject|6|||
163382999|NCT03727438|590111922|FG001|8 Week Assessment|Withdrawal by Subject|1|||
163383000|NCT03727438|590111921|FG000|6 mo Assessment|did not complete assessment|10|||
163383001|NCT03727438|590111922|FG001|6 mo Assessment|did not complete assessment|11|||
163383002|NCT06729606|590111923|FG000|Overall Study|Adverse Event|0|||
163383003|NCT06729606|590111924|FG001|Overall Study|Adverse Event|2|||
163383004|NCT06729606|590111923|FG000|Overall Study|Death|1|||
163383005|NCT06729606|590111924|FG001|Overall Study|Death|0|||
163383006|NCT06729606|590111923|FG000|Overall Study|Physician Decision|0|||
163383007|NCT06729606|590111924|FG001|Overall Study|Physician Decision|1|||
163383008|NCT06729606|590111923|FG000|Overall Study|Withdrawal by Subject|2|||
163383009|NCT06729606|590111924|FG001|Overall Study|Withdrawal by Subject|4|||
163383010|NCT00001962|590113604|FG000|Overall Study|Lack of Efficacy|18|||
163383011|NCT00001962|590113604|FG000|Overall Study|Lack of Accrual|6|||
163383012|NCT00001962|590113604|FG000|Overall Study|Death|1|||
163383013|NCT00001962|590113604|FG000|Overall Study|Lost to Follow-up|2|||
163383014|NCT00001962|590113604|FG000|Overall Study|Adverse Event|1|||
163383015|NCT00604279|590113610|FG000|Overall Study|Lack of Efficacy|22|||
163383016|NCT00604279|590113611|FG001|Overall Study|Lack of Efficacy|9|||
163383017|NCT00604279|590113610|FG000|Overall Study|Lost to Follow-up|9|||
163383018|NCT00604279|590113611|FG001|Overall Study|Lost to Follow-up|14|||
163383019|NCT00604279|590113610|FG000|Overall Study|Pregnancy|2|||
163383020|NCT00604279|590113611|FG001|Overall Study|Pregnancy|0|||
163383021|NCT00604279|590113610|FG000|Overall Study|Protocol Violation|3|||
163383022|NCT00604279|590113611|FG001|Overall Study|Protocol Violation|1|||
163383023|NCT00604279|590113610|FG000|Overall Study|Withdrawal by Subject|16|||
163383024|NCT00604279|590113611|FG001|Overall Study|Withdrawal by Subject|5|||
163383025|NCT00604279|590113610|FG000|Overall Study|Adverse Event|4|||
163383026|NCT00604279|590113611|FG001|Overall Study|Adverse Event|5|||
163383027|NCT00604279|590113610|FG000|Overall Study|Other|8|||
163383028|NCT00604279|590113611|FG001|Overall Study|Other|4|||
163383029|NCT03938545|590113612|FG000|Overall Study|Lost to Follow-up|0|||
163383030|NCT03938545|590113613|FG001|Overall Study|Lost to Follow-up|0|||
163383031|NCT03938545|590113614|FG002|Overall Study|Lost to Follow-up|0|||
163383032|NCT03938545|590113615|FG003|Overall Study|Lost to Follow-up|1|||
163383033|NCT03938545|590113612|FG000|Overall Study|Non-compliance with study drug|0|||
163383034|NCT03938545|590113613|FG001|Overall Study|Non-compliance with study drug|0|||
163383035|NCT03938545|590113614|FG002|Overall Study|Non-compliance with study drug|1|||
163383036|NCT03938545|590113615|FG003|Overall Study|Non-compliance with study drug|0|||
163383037|NCT03938545|590113612|FG000|Overall Study|Pregnancy|1|||
163383038|NCT03938545|590113613|FG001|Overall Study|Pregnancy|0|||
163383039|NCT03938545|590113614|FG002|Overall Study|Pregnancy|0|||
163383040|NCT03938545|590113615|FG003|Overall Study|Pregnancy|0|||
163418019|NCT00400400|590238182|FG001|Overall Study|Adverse Event|8|||
163418020|NCT00400400|590238181|FG000|Overall Study|Protocol Violation|2|||
163418021|NCT00400400|590238182|FG001|Overall Study|Protocol Violation|0|||
163418022|NCT00400400|590238181|FG000|Overall Study|Withdrawal by Subject|1|||
163418023|NCT00400400|590238182|FG001|Overall Study|Withdrawal by Subject|3|||
163418024|NCT00400400|590238181|FG000|Overall Study|Administrative Problem|1|||
163418025|NCT00400400|590238182|FG001|Overall Study|Administrative Problem|0|||
163418026|NCT00400400|590238181|FG000|Overall Study|Lost to Follow-up|0|||
163418027|NCT00400400|590238182|FG001|Overall Study|Lost to Follow-up|1|||
163418028|NCT00400400|590238181|FG000|Overall Study|Did not receive study drug|1|||
163418029|NCT00400400|590238182|FG001|Overall Study|Did not receive study drug|3|||
163418030|NCT00648167|590238183|FG000|Overall Study|Adverse Event|6|||
163418031|NCT00648167|590238183|FG000|Overall Study|unable to swallow tablets|1|||
163418032|NCT01688050|590238184|FG000|Overall Study|Death|7|||
163418033|NCT01688050|590238184|FG000|Overall Study|Conversion to open repair|1|||
163418034|NCT01688050|590238184|FG000|Overall Study|Lost to Follow-up|13|||
163418035|NCT01688050|590238184|FG000|Overall Study|Withdrawal by Subject|10|||
163418036|NCT00927368|590238185|FG000|Overall Study|enrollment in another study|1|||
163418037|NCT00927368|590238186|FG001|Overall Study|enrollment in another study|1|||
163418038|NCT00927368|590238187|FG002|Overall Study|enrollment in another study|2|||
163418039|NCT00927368|590238185|FG000|Overall Study|Lost to Follow-up|4|||
163418040|NCT00927368|590238186|FG001|Overall Study|Lost to Follow-up|0|||
163418041|NCT00927368|590238187|FG002|Overall Study|Lost to Follow-up|0|||
163418042|NCT00927368|590238185|FG000|Overall Study|equipment failure|1|||
163418043|NCT00927368|590238186|FG001|Overall Study|equipment failure|0|||
163418044|NCT00927368|590238187|FG002|Overall Study|equipment failure|0|||
163418045|NCT00927368|590238185|FG000|Overall Study|ineligible post randomization|0|||
163418046|NCT00927368|590238186|FG001|Overall Study|ineligible post randomization|3|||
163418047|NCT00927368|590238187|FG002|Overall Study|ineligible post randomization|1|||
163418048|NCT00927368|590238185|FG000|Overall Study|cancellation of surgery|0|||
163418049|NCT00927368|590238186|FG001|Overall Study|cancellation of surgery|1|||
163418050|NCT00927368|590238187|FG002|Overall Study|cancellation of surgery|2|||
163418051|NCT00191451|590238193|FG000|Overall Study|Withdrawal by Subject|2|||
163418052|NCT00191451|590238194|FG001|Overall Study|Withdrawal by Subject|3|||
163418053|NCT00191451|590238195|FG002|Overall Study|Withdrawal by Subject|5|||
163418054|NCT00191451|590238193|FG000|Overall Study|Physician Decision|2|||
163418055|NCT00191451|590238194|FG001|Overall Study|Physician Decision|9|||
163418056|NCT00191451|590238195|FG002|Overall Study|Physician Decision|6|||
163418057|NCT00191451|590238193|FG000|Overall Study|Sponsor Decision|1|||
163418058|NCT00191451|590238194|FG001|Overall Study|Sponsor Decision|0|||
163383041|NCT03938545|590113612|FG000|Overall Study|Study terminated by sponsor|6|||
163383042|NCT03938545|590113613|FG001|Overall Study|Study terminated by sponsor|4|||
163383043|NCT03938545|590113614|FG002|Overall Study|Study terminated by sponsor|2|||
163383044|NCT03938545|590113615|FG003|Overall Study|Study terminated by sponsor|4|||
163383045|NCT03938545|590113612|FG000|Overall Study|Withdrawal by Subject|0|||
163383046|NCT03938545|590113613|FG001|Overall Study|Withdrawal by Subject|1|||
163383047|NCT03938545|590113614|FG002|Overall Study|Withdrawal by Subject|0|||
163383048|NCT03938545|590113615|FG003|Overall Study|Withdrawal by Subject|0|||
163383049|NCT03938545|590113612|FG000|Overall Study|Adverse Event|1|||
163383050|NCT03938545|590113613|FG001|Overall Study|Adverse Event|0|||
163383051|NCT03938545|590113614|FG002|Overall Study|Adverse Event|0|||
163383052|NCT03938545|590113615|FG003|Overall Study|Adverse Event|0|||
163383053|NCT00355056|590113616|FG000|Randomization Period|Early Termination|4|||
163383054|NCT00355056|590113617|FG001|Randomization Period|Early Termination|6|||
163383055|NCT01060540|590113618|FG000|Overall Study|Withdrawal by Subject|10|||
163383056|NCT01060540|590113619|FG001|Overall Study|Withdrawal by Subject|20|||
163383057|NCT01060540|590113618|FG000|Overall Study|Lost to Follow-up|52|||
163383058|NCT01060540|590113619|FG001|Overall Study|Lost to Follow-up|43|||
163383059|NCT01060540|590113618|FG000|Overall Study|Death|2|||
163383060|NCT01060540|590113619|FG001|Overall Study|Death|1|||
163383061|NCT01060540|590113618|FG000|Overall Study|Physician Decision|0|||
163383062|NCT01060540|590113619|FG001|Overall Study|Physician Decision|1|||
163383063|NCT02647320|590113623|FG000|Overall Study|Adverse Event|0|||
163383064|NCT02647320|590113624|FG001|Overall Study|Adverse Event|1|||
163418059|NCT00191451|590238195|FG002|Overall Study|Sponsor Decision|0|||
163383065|NCT02647320|590113625|FG002|Overall Study|Adverse Event|3|||
163418060|NCT00191451|590238193|FG000|Overall Study|Ineligible|0|||
163418061|NCT00191451|590238194|FG001|Overall Study|Ineligible|1|||
163418062|NCT00191451|590238195|FG002|Overall Study|Ineligible|0|||
163418063|NCT00191451|590238193|FG000|Overall Study|Reason Not Specified|2|||
163418064|NCT00191451|590238194|FG001|Overall Study|Reason Not Specified|1|||
163418065|NCT00191451|590238195|FG002|Overall Study|Reason Not Specified|3|||
163418066|NCT00272987|590238203|FG000|Overall Study|Adverse Event|1|||
163418067|NCT00272987|590238204|FG001|Overall Study|Adverse Event|0|||
163418068|NCT00272987|590238205|FG002|Overall Study|Adverse Event|0|||
163383066|NCT02647320|590113626|FG003|Overall Study|Adverse Event|2|||
163383067|NCT02647320|590113627|FG004|Overall Study|Adverse Event|1|||
163383068|NCT02647320|590113623|FG000|Overall Study|Protocol Violation|0|||
163418069|NCT00272987|590238203|FG000|Overall Study|Lost to Follow-up|3|||
163418070|NCT00272987|590238204|FG001|Overall Study|Lost to Follow-up|1|||
163418071|NCT00272987|590238205|FG002|Overall Study|Lost to Follow-up|1|||
163418072|NCT00272987|590238203|FG000|Overall Study|Withdrawal by Subject|1|||
163418073|NCT00272987|590238204|FG001|Overall Study|Withdrawal by Subject|0|||
163418074|NCT00272987|590238205|FG002|Overall Study|Withdrawal by Subject|3|||
163418075|NCT00272987|590238203|FG000|Overall Study|Sponsor Terminated study|0|||
163418076|NCT00272987|590238204|FG001|Overall Study|Sponsor Terminated study|1|||
163418077|NCT00272987|590238205|FG002|Overall Study|Sponsor Terminated study|1|||
163418078|NCT00272987|590238203|FG000|Overall Study|Disease progression|1|||
163418079|NCT00272987|590238204|FG001|Overall Study|Disease progression|1|||
163418080|NCT00272987|590238205|FG002|Overall Study|Disease progression|2|||
163418081|NCT00272987|590238203|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
163418082|NCT00272987|590238204|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
163418083|NCT00272987|590238205|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
163418084|NCT00272987|590238203|FG000|Overall Study|Death|1|||
163418085|NCT00272987|590238204|FG001|Overall Study|Death|0|||
163418086|NCT00272987|590238205|FG002|Overall Study|Death|0|||
163418087|NCT03222349|590238210|FG000|Overall Study|Treatment B not done|5|||
163418088|NCT03222349|590238211|FG001|Overall Study|Treatment B not done|0|||
163418089|NCT03222349|590238210|FG000|Overall Study|Lost to Follow-up|1|||
163418090|NCT03222349|590238211|FG001|Overall Study|Lost to Follow-up|2|||
163418091|NCT03222349|590238210|FG000|Overall Study|Withdrawal by Subject|1|||
163418092|NCT03222349|590238211|FG001|Overall Study|Withdrawal by Subject|0|||
163418093|NCT03222349|590238210|FG000|Overall Study|Treatment A not done|0|||
163418094|NCT03222349|590238211|FG001|Overall Study|Treatment A not done|5|||
163418095|NCT03222349|590238210|FG000|Overall Study|Study terminated by sponsor|1|||
163418096|NCT03222349|590238211|FG001|Overall Study|Study terminated by sponsor|0|||
163418097|NCT03739528|590238214|FG000|Overall Study|Not treated|8|||
163418098|NCT03739528|590238215|FG001|Overall Study|Not treated|12|||
163418099|NCT03739528|590238214|FG000|Overall Study|Treatment and study discontinued|6|||
163418100|NCT03739528|590238215|FG001|Overall Study|Treatment and study discontinued|2|||
163418101|NCT03739528|590238214|FG000|Overall Study|Treatment discontinued + study completed|1|||
163418102|NCT03739528|590238215|FG001|Overall Study|Treatment discontinued + study completed|3|||
163383069|NCT02647320|590113624|FG001|Overall Study|Protocol Violation|0|||
163383070|NCT02647320|590113625|FG002|Overall Study|Protocol Violation|3|||
163383071|NCT02647320|590113626|FG003|Overall Study|Protocol Violation|0|||
163383072|NCT02647320|590113627|FG004|Overall Study|Protocol Violation|0|||
163383073|NCT02647320|590113623|FG000|Overall Study|Withdrawal by Subject|7|||
163383074|NCT02647320|590113624|FG001|Overall Study|Withdrawal by Subject|4|||
163383075|NCT02647320|590113625|FG002|Overall Study|Withdrawal by Subject|2|||
163383076|NCT02647320|590113626|FG003|Overall Study|Withdrawal by Subject|2|||
163383077|NCT02647320|590113627|FG004|Overall Study|Withdrawal by Subject|7|||
163383078|NCT02647320|590113623|FG000|Overall Study|Persistent hyperglycemia|0|||
163383079|NCT02647320|590113624|FG001|Overall Study|Persistent hyperglycemia|1|||
163383080|NCT02647320|590113625|FG002|Overall Study|Persistent hyperglycemia|1|||
163383081|NCT02647320|590113626|FG003|Overall Study|Persistent hyperglycemia|1|||
163383082|NCT02647320|590113627|FG004|Overall Study|Persistent hyperglycemia|1|||
163383083|NCT02647320|590113623|FG000|Overall Study|Study terminated by sponsor|1|||
163383084|NCT02647320|590113624|FG001|Overall Study|Study terminated by sponsor|1|||
163383085|NCT02647320|590113625|FG002|Overall Study|Study terminated by sponsor|1|||
163383086|NCT02647320|590113626|FG003|Overall Study|Study terminated by sponsor|1|||
163383087|NCT02647320|590113627|FG004|Overall Study|Study terminated by sponsor|2|||
163383088|NCT02647320|590113623|FG000|Overall Study|Reason not provided|0|||
163383089|NCT02647320|590113624|FG001|Overall Study|Reason not provided|0|||
163383090|NCT02647320|590113625|FG002|Overall Study|Reason not provided|1|||
163383091|NCT02647320|590113626|FG003|Overall Study|Reason not provided|0|||
163383092|NCT02647320|590113627|FG004|Overall Study|Reason not provided|2|||
163383093|NCT02647320|590113623|FG000|Overall Study|Lost to Follow-up|1|||
163383094|NCT02647320|590113624|FG001|Overall Study|Lost to Follow-up|1|||
163383095|NCT02647320|590113625|FG002|Overall Study|Lost to Follow-up|0|||
163383096|NCT02647320|590113626|FG003|Overall Study|Lost to Follow-up|0|||
163383097|NCT02647320|590113627|FG004|Overall Study|Lost to Follow-up|0|||
163383098|NCT02647320|590113623|FG000|Overall Study|Develop anemia|1|||
163383099|NCT02647320|590113624|FG001|Overall Study|Develop anemia|0|||
163418103|NCT04303000|590238216|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
163418104|NCT04303000|590238217|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
163418105|NCT04303000|590238218|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
163418106|NCT05655377|590238219|FG000|Overall Study|Withdrawal by Subject|2|||
163418107|NCT03118947|590238222|FG000|Overall Study|Adverse Event|7|||
163418108|NCT03118947|590238222|FG000|Overall Study|Death|3|||
163383100|NCT02647320|590113625|FG002|Overall Study|Develop anemia|0|||
163383101|NCT02647320|590113626|FG003|Overall Study|Develop anemia|0|||
163383102|NCT02647320|590113627|FG004|Overall Study|Develop anemia|0|||
163383103|NCT02647320|590113623|FG000|Overall Study|Lack of Efficacy|0|||
163383104|NCT02647320|590113624|FG001|Overall Study|Lack of Efficacy|0|||
163383105|NCT02647320|590113625|FG002|Overall Study|Lack of Efficacy|0|||
163383106|NCT02647320|590113626|FG003|Overall Study|Lack of Efficacy|1|||
163383107|NCT02647320|590113627|FG004|Overall Study|Lack of Efficacy|0|||
163383108|NCT02647320|590113623|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
163383109|NCT02647320|590113624|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
163383110|NCT02647320|590113625|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
163383111|NCT02647320|590113626|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
163383112|NCT02647320|590113627|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
163383113|NCT00596427|590113628|FG000|Overall Study|Withdrawal by Subject|2|||
163383114|NCT00596427|590113629|FG001|Overall Study|Withdrawal by Subject|2|||
163383115|NCT00596427|590113628|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
163383116|NCT00596427|590113629|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
163383117|NCT00596427|590113628|FG000|Overall Study|Protocol Violation|1|||
163383118|NCT00596427|590113629|FG001|Overall Study|Protocol Violation|0|||
163383119|NCT02401867|590113630|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
163383120|NCT02401867|590113630|FG000|Analysis|Cervical assay could not be conducted|9|||
163383121|NCT01650246|590113631|FG000|Overall Study|Adverse Event|23|||
163383122|NCT01650246|590113631|FG000|Overall Study|Protocol Violation|5|||
163383123|NCT01650246|590113631|FG000|Overall Study|Sponsor terminated study|53|||
163383124|NCT01650246|590113631|FG000|Overall Study|Lost to Follow-up|5|||
163383125|NCT01650246|590113631|FG000|Overall Study|Withdrawal by Subject|26|||
163383126|NCT01650246|590113631|FG000|Overall Study|Death|1|||
163383127|NCT01650246|590113631|FG000|Overall Study|Lack of Efficacy|30|||
163383128|NCT00081770|590113632|FG000|Overall Study|Adverse Event|130|||
163383129|NCT00081770|590113633|FG001|Overall Study|Adverse Event|98|||
163383130|NCT00081770|590113634|FG002|Overall Study|Adverse Event|136|||
163383131|NCT00081770|590113632|FG000|Overall Study|Lack of Efficacy|262|||
163383132|NCT00081770|590113633|FG001|Overall Study|Lack of Efficacy|357|||
163383133|NCT00081770|590113634|FG002|Overall Study|Lack of Efficacy|211|||
163383134|NCT00081770|590113632|FG000|Overall Study|Lost to Follow-up|45|||
163383135|NCT00081770|590113633|FG001|Overall Study|Lost to Follow-up|34|||
163383136|NCT00081770|590113634|FG002|Overall Study|Lost to Follow-up|45|||
163383137|NCT00081770|590113632|FG000|Overall Study|Protocol Violation|15|||
163383138|NCT00081770|590113633|FG001|Overall Study|Protocol Violation|10|||
163383139|NCT00081770|590113634|FG002|Overall Study|Protocol Violation|10|||
163383140|NCT00081770|590113632|FG000|Overall Study|Withdrawal by Subject|45|||
163383141|NCT00081770|590113633|FG001|Overall Study|Withdrawal by Subject|40|||
163383142|NCT00081770|590113634|FG002|Overall Study|Withdrawal by Subject|42|||
163383143|NCT00081770|590113632|FG000|Overall Study|Did not meet protocol eligibility|2|||
163383144|NCT00081770|590113633|FG001|Overall Study|Did not meet protocol eligibility|0|||
163383145|NCT00081770|590113634|FG002|Overall Study|Did not meet protocol eligibility|3|||
163383146|NCT00081770|590113632|FG000|Overall Study|Administrative|1|||
163383147|NCT00081770|590113633|FG001|Overall Study|Administrative|0|||
163383148|NCT00081770|590113634|FG002|Overall Study|Administrative|1|||
163383149|NCT00081770|590113632|FG000|Overall Study|Other|2|||
163383150|NCT00081770|590113633|FG001|Overall Study|Other|7|||
163383151|NCT00081770|590113634|FG002|Overall Study|Other|8|||
163383152|NCT03435497|590113636|FG000|Overall Study|Lost to Follow-up|1|||
163383153|NCT03435497|590113637|FG001|Overall Study|Lost to Follow-up|0|||
163383154|NCT03435497|590113636|FG000|Overall Study|Death|1|||
163383155|NCT03435497|590113637|FG001|Overall Study|Death|0|||
163383156|NCT03435497|590113636|FG000|Overall Study|Withdrawal by Subject|0|||
163383157|NCT03435497|590113637|FG001|Overall Study|Withdrawal by Subject|4|||
163383158|NCT03435497|590113636|FG000|Overall Study|Wrong survey administered|0|||
163383159|NCT03435497|590113637|FG001|Overall Study|Wrong survey administered|2|||
163383160|NCT01072877|590113638|FG000|Overall Study|Lost to Follow-up|1|||
163383161|NCT01072877|590113639|FG001|Overall Study|Lost to Follow-up|1|||
163383162|NCT01072877|590113640|FG002|Overall Study|Lost to Follow-up|0|||
163383163|NCT01072877|590113641|FG003|Overall Study|Lost to Follow-up|2|||
163383164|NCT01072877|590113642|FG004|Overall Study|Lost to Follow-up|0|||
163383165|NCT00601419|590113643|FG000|Overall Study|Lost to Follow-up|3|||
163383166|NCT00601419|590113643|FG000|Overall Study|Missed Visits|1|||
163383167|NCT04281004|590113654|FG000|Overall Study|Physician Decision|1|||
163383168|NCT04281004|590113655|FG001|Overall Study|Physician Decision|0|||
163383169|NCT00701779|590113656|FG000|Overall Study|Adverse Event|6|||
163383170|NCT00701779|590113656|FG000|Overall Study|Lost to Follow-up|1|||
163383171|NCT00701779|590113656|FG000|Overall Study|Withdrawal by Subject|2|||
163383172|NCT02245672|590113657|FG000|Overall Study|Adverse Event|4|||
163383173|NCT02245672|590113658|FG001|Overall Study|Adverse Event|4|||
163383174|NCT02245672|590113659|FG002|Overall Study|Adverse Event|4|||
163383175|NCT02245672|590113657|FG000|Overall Study|Lost to Follow-up|3|||
163383176|NCT02245672|590113658|FG001|Overall Study|Lost to Follow-up|5|||
163383177|NCT02245672|590113659|FG002|Overall Study|Lost to Follow-up|1|||
163383178|NCT02245672|590113657|FG000|Overall Study|Withdrawal by Subject|6|||
163383179|NCT02245672|590113658|FG001|Overall Study|Withdrawal by Subject|3|||
163383180|NCT02245672|590113659|FG002|Overall Study|Withdrawal by Subject|0|||
163383181|NCT02245672|590113657|FG000|Overall Study|Randomized in error (not treated)|0|||
163383182|NCT02245672|590113658|FG001|Overall Study|Randomized in error (not treated)|1|||
163383183|NCT02245672|590113659|FG002|Overall Study|Randomized in error (not treated)|0|||
163383184|NCT00971932|590113662|FG000|Overall Study|Withdrawal by Subject|1|||
163383185|NCT00971932|590113662|FG000|Overall Study|Investigator's decision|2|||
163383186|NCT00971932|590113662|FG000|Overall Study|Ongoing|4|||
163383187|NCT01217957|590113663|FG000|Phase 1|Withdrawal by Patient|1|||
163383188|NCT01217957|590113664|FG001|Phase 1|Withdrawal by Patient|0|||
163383189|NCT01217957|590113665|FG002|Phase 1|Withdrawal by Patient|1|||
163383190|NCT01217957|590113666|FG003|Phase 1|Withdrawal by Patient|1|||
163383191|NCT01217957|590113667|FG004|Phase 1|Withdrawal by Patient|0|||
163383192|NCT01217957|590113663|FG000|Phase 2|Withdrawal by Patient|0|||
163383193|NCT01217957|590113664|FG001|Phase 2|Withdrawal by Patient|0|||
163383194|NCT01217957|590113665|FG002|Phase 2|Withdrawal by Patient|0|||
163383195|NCT01217957|590113666|FG003|Phase 2|Withdrawal by Patient|0|||
163383196|NCT01217957|590113667|FG004|Phase 2|Withdrawal by Patient|1|||
163383197|NCT01640054|590113669|FG000|Overall Study|Study-specific disc criteria|1|||
163383198|NCT01640054|590113669|FG000|Overall Study|Lack of Efficacy|3|||
163383199|NCT01640054|590113669|FG000|Overall Study|Adverse Event|2|||
163383200|NCT01206777|590113670|FG000|Overall Study|Death|1|||
163383201|NCT01206777|590113670|FG000|Overall Study|Adverse Event|1|||
163383202|NCT02382016|590113671|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
163383203|NCT02382016|590113672|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
163383204|NCT02382016|590113671|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
163383205|NCT02382016|590113672|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
163383206|NCT02382016|590113671|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
163383207|NCT02382016|590113672|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
163383208|NCT02382016|590113671|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
163383209|NCT02382016|590113672|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
163383210|NCT02382016|590113671|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
163383211|NCT02382016|590113672|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
163383212|NCT02382016|590113671|FG000|Open-label (OL) Treatment Period|Death|4|||
163383213|NCT02382016|590113672|FG001|Open-label (OL) Treatment Period|Death|0|||
163383214|NCT02382016|590113671|FG000|OL Extension Period|Physician Decision|3|||
163383215|NCT02382016|590113672|FG001|OL Extension Period|Physician Decision|0|||
163383216|NCT02382016|590113671|FG000|OL Extension Period|Death|2|||
163383217|NCT02382016|590113672|FG001|OL Extension Period|Death|0|||
163383218|NCT02382016|590113671|FG000|OL Extension Period|Withdrawal by Subject|1|||
163383219|NCT02382016|590113672|FG001|OL Extension Period|Withdrawal by Subject|0|||
163383220|NCT00730171|590113677|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
163383221|NCT00730171|590113677|FG000|Overall Study|Adverse Event|193|||
163383222|NCT00730171|590113677|FG000|Overall Study|Protocol Violation|48|||
163383223|NCT00730171|590113677|FG000|Overall Study|Withdrawal by Subject|202|||
163383224|NCT00730171|590113677|FG000|Overall Study|Lost to Follow-up|121|||
163383225|NCT00730171|590113677|FG000|Overall Study|Insufficient Therapeutic Response|141|||
163383226|NCT00730171|590113677|FG000|Overall Study|Other|61|||
163383227|NCT01729156|590113678|FG000|Overall Study|Withdrawal by Subject|1|||
163383228|NCT01729156|590113679|FG001|Overall Study|Withdrawal by Subject|0|||
163383229|NCT01729156|590113680|FG002|Overall Study|Withdrawal by Subject|0|||
163383230|NCT01256658|590113683|FG000|Period 1|Lost to Follow-up|837|||
163383231|NCT01256658|590113684|FG001|Period 1|Lost to Follow-up|661|||
163383232|NCT01256658|590113683|FG000|Period 1|Withdrawal by Subject|35|||
163383233|NCT01256658|590113684|FG001|Period 1|Withdrawal by Subject|43|||
163383234|NCT01256658|590113683|FG000|Period 1|Death|48|||
163383235|NCT01256658|590113684|FG001|Period 1|Death|44|||
163383236|NCT00719563|590113685|FG000|Overall Study|Adverse Event|16|||
163383237|NCT00719563|590113686|FG001|Overall Study|Adverse Event|13|||
163383238|NCT00719563|590113685|FG000|Overall Study|Medical condition changed|3|||
163383239|NCT00719563|590113686|FG001|Overall Study|Medical condition changed|5|||
163383240|NCT00719563|590113685|FG000|Overall Study|Lack of Efficacy|3|||
163383241|NCT00719563|590113686|FG001|Overall Study|Lack of Efficacy|7|||
163383242|NCT00719563|590113685|FG000|Overall Study|Personal reasons|6|||
163383243|NCT00719563|590113686|FG001|Overall Study|Personal reasons|7|||
163383244|NCT00719563|590113685|FG000|Overall Study|Unknown reasons|4|||
163383245|NCT00719563|590113686|FG001|Overall Study|Unknown reasons|6|||
163383246|NCT00719563|590113685|FG000|Overall Study|Noncompliant|1|||
163383247|NCT00719563|590113686|FG001|Overall Study|Noncompliant|1|||
163383248|NCT00719563|590113685|FG000|Overall Study|Lost to Follow-up|5|||
163383249|NCT00719563|590113686|FG001|Overall Study|Lost to Follow-up|3|||
163383250|NCT02120625|590113691|FG000|Overall Study|Physician Decision|2|||
163383251|NCT04363801|590113692|FG000|Overall Study|Death|18|||
163383252|NCT04363801|590113693|FG001|Overall Study|Death|14|||
163383253|NCT04363801|590113694|FG002|Overall Study|Death|16|||
163383254|NCT04363801|590113695|FG003|Overall Study|Death|48|||
163383255|NCT04363801|590113696|FG004|Overall Study|Death|38|||
163383256|NCT04363801|590113692|FG000|Overall Study|Withdrawal by Subject|1|||
163383257|NCT04363801|590113693|FG001|Overall Study|Withdrawal by Subject|6|||
163383258|NCT04363801|590113694|FG002|Overall Study|Withdrawal by Subject|1|||
163383259|NCT04363801|590113695|FG003|Overall Study|Withdrawal by Subject|4|||
163383260|NCT04363801|590113696|FG004|Overall Study|Withdrawal by Subject|14|||
163383261|NCT04363801|590113692|FG000|Overall Study|Sponsor Decision|6|||
163418109|NCT03118947|590238222|FG000|Overall Study|Lack of Efficacy|4|||
163383262|NCT04363801|590113693|FG001|Overall Study|Sponsor Decision|4|||
163383263|NCT04363801|590113694|FG002|Overall Study|Sponsor Decision|10|||
163383264|NCT04363801|590113695|FG003|Overall Study|Sponsor Decision|33|||
163383265|NCT04363801|590113696|FG004|Overall Study|Sponsor Decision|32|||
163383266|NCT04363801|590113692|FG000|Overall Study|Lost to Follow-up|0|||
163383267|NCT04363801|590113693|FG001|Overall Study|Lost to Follow-up|0|||
163383268|NCT04363801|590113694|FG002|Overall Study|Lost to Follow-up|1|||
163383269|NCT04363801|590113695|FG003|Overall Study|Lost to Follow-up|0|||
163383270|NCT04363801|590113696|FG004|Overall Study|Lost to Follow-up|1|||
163383271|NCT01146054|590113697|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
163383272|NCT01146054|590113697|FG000|Overall Study|Rapid tumor progression|2|||
163383273|NCT01146054|590113697|FG000|Overall Study|Other illness precluded treatment|2|||
163383274|NCT01146054|590113697|FG000|Overall Study|Lost to Follow-up|1|||
163383275|NCT02901041|590113700|FG000|Overall Study|Withdrawal by PI|4|||
163383276|NCT02901041|590113701|FG001|Overall Study|Withdrawal by PI|8|||
163383277|NCT02901041|590113700|FG000|Overall Study|Withdrawal by Subject|7|||
163383278|NCT02901041|590113701|FG001|Overall Study|Withdrawal by Subject|3|||
163383279|NCT00762970|590113702|FG000|Overall Study|Withdrawal by Subject|7|||
163383280|NCT00762970|590113703|FG001|Overall Study|Withdrawal by Subject|4|||
163383281|NCT00762970|590113704|FG002|Overall Study|Withdrawal by Subject|0|||
163383282|NCT00762970|590113702|FG000|Overall Study|Protocol Violation|3|||
163383283|NCT00762970|590113703|FG001|Overall Study|Protocol Violation|1|||
163383284|NCT00762970|590113704|FG002|Overall Study|Protocol Violation|1|||
163383285|NCT00762970|590113702|FG000|Overall Study|Lost to Follow-up|1|||
163383286|NCT00762970|590113703|FG001|Overall Study|Lost to Follow-up|2|||
163383287|NCT00762970|590113704|FG002|Overall Study|Lost to Follow-up|0|||
163383288|NCT00762970|590113702|FG000|Overall Study|Difficulty of handling lens|1|||
163383289|NCT00762970|590113703|FG001|Overall Study|Difficulty of handling lens|2|||
163383290|NCT00762970|590113704|FG002|Overall Study|Difficulty of handling lens|0|||
163383291|NCT01480674|590113705|FG000|Overall Study|Death|23|||
163383292|NCT01480674|590113705|FG000|Overall Study|Lost to Follow-up|2|||
163383293|NCT01480674|590113705|FG000|Overall Study|visit not done|10|||
163383294|NCT00975507|590113706|FG000|Overall Study|Adverse Event|1|||
163383295|NCT00975507|590113707|FG001|Overall Study|Adverse Event|0|||
163383296|NCT00975507|590113706|FG000|Overall Study|Lost to Follow-up|7|||
163383297|NCT00975507|590113707|FG001|Overall Study|Lost to Follow-up|1|||
163383298|NCT00975507|590113706|FG000|Overall Study|Protocol Violation|2|||
163383299|NCT00975507|590113707|FG001|Overall Study|Protocol Violation|0|||
163418110|NCT03118947|590238222|FG000|Overall Study|Non-compliance with study drug|1|||
163418111|NCT03118947|590238222|FG000|Overall Study|Protocol Violation|2|||
163418112|NCT03118947|590238222|FG000|Overall Study|Withdrawal by Subject|3|||
163418113|NCT03118947|590238222|FG000|Overall Study|Withdrawal by caregiver|3|||
163418114|NCT03118947|590238222|FG000|Overall Study|Change in patient's living situation|4|||
163418115|NCT03118947|590238222|FG000|Overall Study|Lost to Follow-up|2|||
163418116|NCT02769624|590238223|FG000|Overall Study|Lost to Follow-up|0|||
163418117|NCT02769624|590238224|FG001|Overall Study|Lost to Follow-up|1|||
163418118|NCT01987908|590238233|FG000|Placebo Lead-in Period|Adverse Event|2|||
163418119|NCT01987908|590238234|FG001|Placebo Lead-in Period|Adverse Event|0|||
163418120|NCT01987908|590238235|FG002|Placebo Lead-in Period|Adverse Event|0|||
163418121|NCT01987908|590238233|FG000|Placebo Lead-in Period|Physician Decision|2|||
163418122|NCT01987908|590238234|FG001|Placebo Lead-in Period|Physician Decision|0|||
163418123|NCT01987908|590238235|FG002|Placebo Lead-in Period|Physician Decision|0|||
163418124|NCT01987908|590238233|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
163418125|NCT01987908|590238234|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
163418126|NCT01987908|590238235|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
163418127|NCT01987908|590238233|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
163418128|NCT01987908|590238234|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
163383300|NCT00975507|590113706|FG000|Overall Study|Withdrawal by Subject|10|||
163383301|NCT00975507|590113707|FG001|Overall Study|Withdrawal by Subject|3|||
163383302|NCT03249714|590113708|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
163383303|NCT03249714|590113709|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
163383304|NCT03249714|590113708|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
163383305|NCT03249714|590113709|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
163418129|NCT01987908|590238235|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
163418130|NCT01987908|590238233|FG000|Treatment Period|Adverse Event|0|||
163383306|NCT03249714|590113708|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
163418131|NCT01987908|590238234|FG001|Treatment Period|Adverse Event|1|||
163383307|NCT03249714|590113709|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
163418132|NCT01987908|590238235|FG002|Treatment Period|Adverse Event|1|||
163418133|NCT01987908|590238233|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
163418134|NCT01987908|590238234|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
163418135|NCT01987908|590238235|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
163418136|NCT01987908|590238233|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
163383308|NCT03249714|590113708|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
163383309|NCT03249714|590113709|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
163383310|NCT03818204|590113710|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383311|NCT03818204|590113711|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383312|NCT03818204|590113712|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383313|NCT03818204|590113713|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383314|NCT03818204|590113714|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
163383315|NCT03818204|590113715|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383316|NCT03818204|590113716|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383317|NCT03818204|590113717|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383318|NCT03818204|590113718|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383319|NCT03818204|590113719|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383320|NCT03818204|590113720|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383321|NCT03818204|590113721|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383322|NCT03818204|590113722|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383323|NCT03818204|590113723|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
163383324|NCT03818204|590113724|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383325|NCT03818204|590113725|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383326|NCT03818204|590113726|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383327|NCT03818204|590113727|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383328|NCT03818204|590113728|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163383329|NCT03818204|590113710|FG000|Overall Study|Physician Decision|0|||
163383330|NCT03818204|590113711|FG001|Overall Study|Physician Decision|0|||
163383331|NCT03818204|590113712|FG002|Overall Study|Physician Decision|0|||
163383332|NCT03818204|590113713|FG003|Overall Study|Physician Decision|0|||
163383333|NCT03818204|590113714|FG004|Overall Study|Physician Decision|0|||
163383334|NCT03818204|590113715|FG005|Overall Study|Physician Decision|0|||
163383335|NCT03818204|590113716|FG006|Overall Study|Physician Decision|0|||
163383336|NCT03818204|590113717|FG007|Overall Study|Physician Decision|0|||
163383337|NCT03818204|590113718|FG008|Overall Study|Physician Decision|0|||
163383338|NCT03818204|590113719|FG009|Overall Study|Physician Decision|0|||
163383339|NCT03818204|590113720|FG010|Overall Study|Physician Decision|0|||
163383340|NCT03818204|590113721|FG011|Overall Study|Physician Decision|0|||
163383341|NCT03818204|590113722|FG012|Overall Study|Physician Decision|0|||
163383342|NCT03818204|590113723|FG013|Overall Study|Physician Decision|0|||
163383343|NCT03818204|590113724|FG014|Overall Study|Physician Decision|1|||
163383344|NCT03818204|590113725|FG015|Overall Study|Physician Decision|0|||
163383345|NCT03818204|590113726|FG016|Overall Study|Physician Decision|0|||
163383346|NCT03818204|590113727|FG017|Overall Study|Physician Decision|0|||
163383347|NCT03818204|590113728|FG018|Overall Study|Physician Decision|0|||
163383348|NCT00887250|590113731|FG000|Overall Study|Adverse Event|3|||
163383349|NCT00887250|590113732|FG001|Overall Study|Adverse Event|0|||
163383350|NCT00887250|590113733|FG002|Overall Study|Adverse Event|7|||
163383351|NCT00887250|590113731|FG000|Overall Study|Lack of Efficacy|9|||
163383352|NCT00887250|590113732|FG001|Overall Study|Lack of Efficacy|6|||
163383353|NCT00887250|590113733|FG002|Overall Study|Lack of Efficacy|1|||
163383354|NCT00887250|590113731|FG000|Overall Study|Lost to Follow-up|2|||
163383355|NCT00887250|590113732|FG001|Overall Study|Lost to Follow-up|3|||
163383356|NCT00887250|590113733|FG002|Overall Study|Lost to Follow-up|1|||
163383357|NCT00887250|590113731|FG000|Overall Study|Protocol Violation|2|||
163383358|NCT00887250|590113732|FG001|Overall Study|Protocol Violation|2|||
163383359|NCT00887250|590113733|FG002|Overall Study|Protocol Violation|1|||
163383360|NCT00887250|590113731|FG000|Overall Study|Withdrawal by Subject|2|||
163383361|NCT00887250|590113732|FG001|Overall Study|Withdrawal by Subject|1|||
163383362|NCT00887250|590113733|FG002|Overall Study|Withdrawal by Subject|2|||
163383363|NCT00887250|590113731|FG000|Overall Study|Patient uncooperative|0|||
163383364|NCT00887250|590113732|FG001|Overall Study|Patient uncooperative|0|||
163383365|NCT00887250|590113733|FG002|Overall Study|Patient uncooperative|1|||
163383366|NCT05754333|590113734|FG000|Overall Study|Miscellaneous|3|||
163383367|NCT05754333|590113735|FG001|Overall Study|Miscellaneous|0|||
163383368|NCT05754333|590113736|FG002|Overall Study|Miscellaneous|0|||
163383369|NCT05754333|590113737|FG003|Overall Study|Miscellaneous|0|||
163383370|NCT05754333|590113734|FG000|Overall Study|Lost to Follow-up|2|||
163383371|NCT05754333|590113735|FG001|Overall Study|Lost to Follow-up|1|||
163383372|NCT05754333|590113736|FG002|Overall Study|Lost to Follow-up|0|||
163383373|NCT05754333|590113737|FG003|Overall Study|Lost to Follow-up|1|||
163383374|NCT00879762|590113738|FG000|Overall Study|Lost to Follow-up|3|||
163383375|NCT00879762|590113739|FG001|Overall Study|Lost to Follow-up|1|||
163383376|NCT04754477|590113742|FG000|Overall Study|Withdrawal by Subject|1|||
163383377|NCT02427464|590113745|FG000|Overall Study|Adverse Event|6|||
163383378|NCT02427464|590113746|FG001|Overall Study|Adverse Event|1|||
163383379|NCT02427464|590113745|FG000|Overall Study|Lost to Follow-up|16|||
163383380|NCT02427464|590113746|FG001|Overall Study|Lost to Follow-up|5|||
163383381|NCT02427464|590113745|FG000|Overall Study|Physician Decision|2|||
163383382|NCT02427464|590113746|FG001|Overall Study|Physician Decision|0|||
163383383|NCT02427464|590113745|FG000|Overall Study|Withdrawal by Subject|10|||
163383384|NCT02427464|590113746|FG001|Overall Study|Withdrawal by Subject|8|||
163383385|NCT02427464|590113745|FG000|Overall Study|Noncompliance|16|||
163383386|NCT02427464|590113746|FG001|Overall Study|Noncompliance|10|||
163383387|NCT02572843|590113750|FG000|Accrual|Brain metastasis retrospectively detected|1|||
163383388|NCT02572843|590113750|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
163383389|NCT02572843|590113750|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
163383390|NCT02572843|590113750|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
163383391|NCT02572843|590113750|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
163383392|NCT02572843|590113750|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
163383393|NCT02572843|590113750|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
163383394|NCT02572843|590113750|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
163383395|NCT02572843|590113750|FG000|Surgery|lost to follow up|7|||
163383396|NCT02572843|590113750|FG000|Surgery|Death|1|||
163383397|NCT03756129|590113751|FG000|Overall Study|Adverse Event|1|||
163383398|NCT03756129|590113752|FG001|Overall Study|Adverse Event|1|||
163383399|NCT03756129|590113753|FG002|Overall Study|Adverse Event|0|||
163383400|NCT03756129|590113754|FG003|Overall Study|Adverse Event|2|||
163383401|NCT03756129|590113755|FG004|Overall Study|Adverse Event|0|||
163383402|NCT03756129|590113756|FG005|Overall Study|Adverse Event|0|||
163383403|NCT03756129|590113751|FG000|Overall Study|Withdrawal by Subject|2|||
163383404|NCT03756129|590113752|FG001|Overall Study|Withdrawal by Subject|1|||
163383405|NCT03756129|590113753|FG002|Overall Study|Withdrawal by Subject|3|||
163383406|NCT03756129|590113754|FG003|Overall Study|Withdrawal by Subject|1|||
163383407|NCT03756129|590113755|FG004|Overall Study|Withdrawal by Subject|1|||
163383408|NCT03756129|590113756|FG005|Overall Study|Withdrawal by Subject|3|||
163383409|NCT03756129|590113751|FG000|Overall Study|Lost to Follow-up|0|||
163383410|NCT03756129|590113752|FG001|Overall Study|Lost to Follow-up|0|||
163383411|NCT03756129|590113753|FG002|Overall Study|Lost to Follow-up|0|||
163383412|NCT03756129|590113754|FG003|Overall Study|Lost to Follow-up|0|||
163383413|NCT03756129|590113755|FG004|Overall Study|Lost to Follow-up|0|||
163383414|NCT03756129|590113756|FG005|Overall Study|Lost to Follow-up|1|||
163383415|NCT03756129|590113751|FG000|Overall Study|Physician Decision|0|||
163383416|NCT03756129|590113752|FG001|Overall Study|Physician Decision|0|||
163383417|NCT03756129|590113753|FG002|Overall Study|Physician Decision|0|||
163383418|NCT03756129|590113754|FG003|Overall Study|Physician Decision|0|||
163383419|NCT03756129|590113755|FG004|Overall Study|Physician Decision|0|||
163383420|NCT03756129|590113756|FG005|Overall Study|Physician Decision|1|||
163383421|NCT04469270|590113757|FG000|Overall Study|Adverse Event|2|||
163383422|NCT04469270|590113758|FG001|Overall Study|Adverse Event|0|||
163383423|NCT04469270|590113757|FG000|Overall Study|Lost to Follow-up|4|||
163383424|NCT04469270|590113758|FG001|Overall Study|Lost to Follow-up|3|||
163383425|NCT04469270|590113757|FG000|Overall Study|Withdrawal by Subject|7|||
163383426|NCT04469270|590113758|FG001|Overall Study|Withdrawal by Subject|3|||
163383427|NCT04469270|590113757|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
163383428|NCT04469270|590113758|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
163383429|NCT04469270|590113757|FG000|Overall Study|missing|1|||
163383430|NCT04469270|590113758|FG001|Overall Study|missing|0|||
163383431|NCT03432260|590113759|FG000|Overall Study|Lost to Follow-up|1|||
163383432|NCT03432260|590113760|FG001|Overall Study|Lost to Follow-up|1|||
163383433|NCT03432260|590113761|FG002|Overall Study|Lost to Follow-up|0|||
163383434|NCT03432260|590113762|FG003|Overall Study|Lost to Follow-up|0|||
163383435|NCT03432260|590113763|FG004|Overall Study|Lost to Follow-up|1|||
163383436|NCT02186847|590113765|FG000|Overall Study|Protocol Violation|3|||
163383437|NCT02186847|590113766|FG001|Overall Study|Protocol Violation|0|||
163383438|NCT05328167|590113767|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
163383439|NCT05328167|590113767|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
163383440|NCT00345293|590113768|FG000|Overall Study|Unable to access line for sample|1|||
163383441|NCT00345293|590113769|FG001|Overall Study|Unable to access line for sample|0|||
163383442|NCT00345293|590113768|FG000|Overall Study|Withdrawal by Subject|1|||
163383443|NCT00345293|590113769|FG001|Overall Study|Withdrawal by Subject|0|||
163383444|NCT01307579|590113770|FG000|Overall Study|Death|3|||
163383445|NCT01307579|590113771|FG001|Overall Study|Death|6|||
163383446|NCT01307579|590113770|FG000|Overall Study|Physician Decision|26|||
163383447|NCT01307579|590113771|FG001|Overall Study|Physician Decision|29|||
163383448|NCT01307579|590113770|FG000|Overall Study|Withdrawal by Subject|7|||
163383449|NCT01307579|590113771|FG001|Overall Study|Withdrawal by Subject|3|||
163383450|NCT01307579|590113770|FG000|Overall Study|Institutional diagnosis of IFD|21|||
163383451|NCT01307579|590113771|FG001|Overall Study|Institutional diagnosis of IFD|36|||
163383452|NCT01307579|590113770|FG000|Overall Study|Begin conditioning for HSCT|42|||
163383453|NCT01307579|590113771|FG001|Overall Study|Begin conditioning for HSCT|44|||
163383454|NCT01307579|590113770|FG000|Overall Study|Refractory or relapsed AML|38|||
163383455|NCT01307579|590113771|FG001|Overall Study|Refractory or relapsed AML|23|||
163383456|NCT01307579|590113770|FG000|Overall Study|Ineligible|3|||
163383457|NCT01307579|590113771|FG001|Overall Study|Ineligible|4|||
163383458|NCT03170349|590113774|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
163383459|NCT03170349|590113774|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
163383460|NCT03170349|590113774|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
163383461|NCT03170349|590113774|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
163383462|NCT03170349|590113774|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
163383463|NCT03170349|590113774|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
163383464|NCT03170349|590113774|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
163383465|NCT03170349|590113774|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
163383466|NCT03170349|590113774|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
163383467|NCT03170349|590113774|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
163383468|NCT03170349|590113774|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
163383469|NCT03170349|590113774|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
163383470|NCT03170349|590113774|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
163383471|NCT03170349|590113774|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
163383472|NCT03170349|590113774|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
163383473|NCT03170349|590113774|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
163383474|NCT02101034|590115650|FG000|Overall Study|Enrolled but did not start treatment|0|||
163383475|NCT02101034|590115651|FG001|Overall Study|Enrolled but did not start treatment|0|||
163383476|NCT02101034|590115652|FG002|Overall Study|Enrolled but did not start treatment|1|||
163383477|NCT02101034|590115653|FG003|Overall Study|Enrolled but did not start treatment|0|||
163383478|NCT02101034|590115654|FG004|Overall Study|Enrolled but did not start treatment|0|||
163383479|NCT00995020|590115655|FG000|Overall Study|margin analysis not performed|2|||
163383480|NCT00995020|590115656|FG001|Overall Study|margin analysis not performed|5|||
163383481|NCT00995020|590115655|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
163383482|NCT00995020|590115656|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
163383483|NCT01614197|590115657|FG000|Overall Study|Withdrawal by Subject|0|||
163383484|NCT01614197|590115658|FG001|Overall Study|Withdrawal by Subject|1|||
163383485|NCT01614197|590115659|FG002|Overall Study|Withdrawal by Subject|0|||
163383486|NCT01614197|590115660|FG003|Overall Study|Withdrawal by Subject|0|||
163383487|NCT00876694|590115662|FG000|Overall Study|Adverse Event|10|||
163383488|NCT00876694|590115663|FG001|Overall Study|Adverse Event|7|||
163383489|NCT00876694|590115662|FG000|Overall Study|Subject withdrew consent|6|||
163383490|NCT00876694|590115663|FG001|Overall Study|Subject withdrew consent|4|||
163383491|NCT00876694|590115662|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163383492|NCT00876694|590115663|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163383493|NCT00876694|590115662|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163383494|NCT00876694|590115663|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163383495|NCT00876694|590115662|FG000|Overall Study|Administrative problems|1|||
163383496|NCT00876694|590115663|FG001|Overall Study|Administrative problems|1|||
163383497|NCT00876694|590115662|FG000|Overall Study|Death|1|||
163383498|NCT00876694|590115663|FG001|Overall Study|Death|0|||
163383499|NCT00288509|590115664|FG000|Treatment Cycle 1|Adverse Event|1|||
163383500|NCT00288509|590115664|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
163383501|NCT00288509|590115664|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
163383502|NCT00288509|590115664|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
163383503|NCT00288509|590115664|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
163383504|NCT00288509|590115664|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
163383505|NCT00288509|590115664|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
163383506|NCT00288509|590115664|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
163383507|NCT00288509|590115664|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
163383508|NCT00288509|590115664|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
163383509|NCT00288509|590115664|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
163383510|NCT00288509|590115664|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
163383511|NCT00288509|590115664|FG000|Treatment Cycle 4|Physician Decision|4|||
163383512|NCT00288509|590115664|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
163383513|NCT00084266|590115665|FG000|Overall Study|Death|42|||
163383514|NCT00084266|590115666|FG001|Overall Study|Death|39|||
163383515|NCT00084266|590115665|FG000|Overall Study|Adverse Event|8|||
163383516|NCT00084266|590115666|FG001|Overall Study|Adverse Event|5|||
163383517|NCT00084266|590115665|FG000|Overall Study|Lack of Efficacy|2|||
163383518|NCT00084266|590115666|FG001|Overall Study|Lack of Efficacy|4|||
163383519|NCT00084266|590115665|FG000|Overall Study|Lost to Follow-up|5|||
163383520|NCT00084266|590115666|FG001|Overall Study|Lost to Follow-up|3|||
163383521|NCT00084266|590115665|FG000|Overall Study|Participant not willing to participate|3|||
163383522|NCT00084266|590115666|FG001|Overall Study|Participant not willing to participate|8|||
163383523|NCT00084266|590115665|FG000|Overall Study|Other|360|||
163383524|NCT00084266|590115666|FG001|Overall Study|Other|344|||
163383525|NCT00084266|590115665|FG000|Overall Study|Randomized not treated|21|||
163383526|NCT00084266|590115666|FG001|Overall Study|Randomized not treated|20|||
163383527|NCT01215422|590115667|FG000|Overall Study|Relocation|1|||
163383528|NCT01215422|590115668|FG001|Overall Study|Relocation|0|||
163383529|NCT01215422|590115669|FG002|Overall Study|Relocation|0|||
163418137|NCT01987908|590238234|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
163418138|NCT01987908|590238235|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
163418139|NCT01869348|590238237|FG000|Overall Study|Withdrawal by Subject|1|||
163418140|NCT01869348|590238238|FG001|Overall Study|Withdrawal by Subject|1|||
163418141|NCT01728779|590238239|FG000|Overall Study|Withdrawal by Subject|1|||
163418142|NCT02789657|590238240|FG000|Overall Study|Withdrawal by Subject|2|||
163418143|NCT02789657|590238241|FG001|Overall Study|Withdrawal by Subject|0|||
163418144|NCT02789657|590238242|FG002|Overall Study|Withdrawal by Subject|0|||
163418145|NCT02789657|590238243|FG003|Overall Study|Withdrawal by Subject|0|||
163418146|NCT01925209|590238244|FG000|Treatment Epoch|Physician Decision|1|||
163418147|NCT01925209|590238245|FG001|Treatment Epoch|Physician Decision|0|||
163418148|NCT01925209|590238246|FG002|Treatment Epoch|Physician Decision|0|||
163418149|NCT01925209|590238247|FG003|Treatment Epoch|Physician Decision|0|||
163418150|NCT01925209|590238244|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
163418151|NCT01925209|590238245|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
163418152|NCT01925209|590238246|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
163418153|NCT01925209|590238247|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
163418154|NCT01925209|590238244|FG000|Treatment Epoch|Death|1|||
163418155|NCT01925209|590238245|FG001|Treatment Epoch|Death|0|||
163418156|NCT01925209|590238246|FG002|Treatment Epoch|Death|0|||
163418157|NCT01925209|590238247|FG003|Treatment Epoch|Death|0|||
163418158|NCT01925209|590238244|FG000|Treatment Epoch|Protocol deviation|0|||
163418159|NCT01925209|590238245|FG001|Treatment Epoch|Protocol deviation|0|||
163418160|NCT01925209|590238246|FG002|Treatment Epoch|Protocol deviation|1|||
163418161|NCT01925209|590238247|FG003|Treatment Epoch|Protocol deviation|1|||
163418162|NCT01925209|590238244|FG000|Treatment Epoch|Withdrawal by Subject|4|||
163418163|NCT01925209|590238245|FG001|Treatment Epoch|Withdrawal by Subject|3|||
163418164|NCT01925209|590238246|FG002|Treatment Epoch|Withdrawal by Subject|3|||
163418165|NCT01925209|590238247|FG003|Treatment Epoch|Withdrawal by Subject|2|||
163418166|NCT01925209|590238244|FG000|Treatment Epoch|Adverse Event|3|||
163418167|NCT01925209|590238245|FG001|Treatment Epoch|Adverse Event|5|||
163418168|NCT01925209|590238246|FG002|Treatment Epoch|Adverse Event|3|||
163418169|NCT01925209|590238247|FG003|Treatment Epoch|Adverse Event|1|||
163418170|NCT01925209|590238244|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
163418171|NCT01925209|590238245|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
163418172|NCT01925209|590238246|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
163418173|NCT01925209|590238247|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
163418174|NCT01925209|590238244|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
163418175|NCT01925209|590238245|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
163418176|NCT01925209|590238246|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
163418177|NCT01925209|590238247|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
163418178|NCT01925209|590238244|FG000|Follow-up|Adverse Event|1|||
163418179|NCT01925209|590238245|FG001|Follow-up|Adverse Event|4|||
163418180|NCT01925209|590238246|FG002|Follow-up|Adverse Event|0|||
163418181|NCT01925209|590238247|FG003|Follow-up|Adverse Event|1|||
163418182|NCT01925209|590238244|FG000|Follow-up|Physician Decision|0|||
163418183|NCT01925209|590238245|FG001|Follow-up|Physician Decision|0|||
163418184|NCT01925209|590238246|FG002|Follow-up|Physician Decision|1|||
163418185|NCT01925209|590238247|FG003|Follow-up|Physician Decision|0|||
163418186|NCT01925209|590238244|FG000|Follow-up|Non-compliance with study treatment|0|||
163418187|NCT01925209|590238245|FG001|Follow-up|Non-compliance with study treatment|0|||
163418188|NCT01925209|590238246|FG002|Follow-up|Non-compliance with study treatment|0|||
163418189|NCT01925209|590238247|FG003|Follow-up|Non-compliance with study treatment|1|||
163418190|NCT01925209|590238244|FG000|Follow-up|Withdrawal by Subject|0|||
163418191|NCT01925209|590238245|FG001|Follow-up|Withdrawal by Subject|2|||
163383530|NCT01215422|590115670|FG003|Overall Study|Relocation|0|||
163383531|NCT01215422|590115667|FG000|Overall Study|Failed intubations|0|||
163383532|NCT01215422|590115668|FG001|Overall Study|Failed intubations|0|||
163383533|NCT01215422|590115669|FG002|Overall Study|Failed intubations|3|||
163383534|NCT01215422|590115670|FG003|Overall Study|Failed intubations|8|||
163383535|NCT01215422|590115667|FG000|Overall Study|Did not complete all intubations|7|||
163383536|NCT01215422|590115668|FG001|Overall Study|Did not complete all intubations|0|||
163383537|NCT01215422|590115669|FG002|Overall Study|Did not complete all intubations|0|||
163418192|NCT01925209|590238246|FG002|Follow-up|Withdrawal by Subject|0|||
163418193|NCT01925209|590238247|FG003|Follow-up|Withdrawal by Subject|2|||
163418194|NCT00448708|590238248|FG000|Overall Study|Death|21|||
163418195|NCT00448708|590238249|FG001|Overall Study|Death|17|||
163418196|NCT00448708|590238248|FG000|Overall Study|Withdrawal by Subject|8|||
163383538|NCT01215422|590115670|FG003|Overall Study|Did not complete all intubations|0|||
163418197|NCT00448708|590238249|FG001|Overall Study|Withdrawal by Subject|4|||
163418198|NCT00448708|590238248|FG000|Overall Study|Lost to Follow-up|6|||
163418199|NCT00448708|590238249|FG001|Overall Study|Lost to Follow-up|8|||
163418200|NCT00448708|590238248|FG000|Overall Study|not listed|0|||
163418201|NCT00448708|590238249|FG001|Overall Study|not listed|2|||
163418202|NCT01299727|590238250|FG000|Overall Study|Withdrawal by Subject|1|||
163418203|NCT01299727|590238251|FG001|Overall Study|Withdrawal by Subject|0|||
163418204|NCT01299727|590238252|FG002|Overall Study|Withdrawal by Subject|0|||
163383539|NCT01386788|590115673|FG000|Overall Study|Lost to Follow-up|2|||
163383540|NCT00462865|590115674|FG000|Overall Study|Adverse Event|1|||
163383541|NCT06336603|590115676|FG000|Overall Study|Withdrawal by Subject|1|||
163383542|NCT06336603|590115676|FG000|Overall Study|Lost to Follow-up|2|||
163418205|NCT01299727|590238250|FG000|Overall Study|Adverse Event|0|||
163418206|NCT01299727|590238251|FG001|Overall Study|Adverse Event|0|||
163418207|NCT01299727|590238252|FG002|Overall Study|Adverse Event|1|||
163418208|NCT01299727|590238250|FG000|Overall Study|Completed the Treatment Period|3|||
163418209|NCT01299727|590238251|FG001|Overall Study|Completed the Treatment Period|4|||
163418210|NCT01299727|590238252|FG002|Overall Study|Completed the Treatment Period|3|||
163418211|NCT03882424|590238253|FG000|Overall Study|Lost to Follow-up|3|||
163418212|NCT03882424|590238254|FG001|Overall Study|Lost to Follow-up|0|||
163418213|NCT03882424|590238255|FG002|Overall Study|Lost to Follow-up|0|||
163418214|NCT03882424|590238253|FG000|Overall Study|schedule conflict|1|||
163418215|NCT03882424|590238254|FG001|Overall Study|schedule conflict|0|||
163418216|NCT03882424|590238255|FG002|Overall Study|schedule conflict|0|||
163418217|NCT02772757|590238257|FG000|Overall Study|Withdrawal by Subject|1|||
163418218|NCT02772757|590238258|FG001|Overall Study|Withdrawal by Subject|0|||
163418219|NCT02772757|590238259|FG002|Overall Study|Withdrawal by Subject|1|||
163418220|NCT02772757|590238257|FG000|Overall Study|Protocol Violation|0|||
163418221|NCT02772757|590238258|FG001|Overall Study|Protocol Violation|0|||
163418222|NCT02772757|590238259|FG002|Overall Study|Protocol Violation|1|||
163418223|NCT02772757|590238257|FG000|Overall Study|Physician Decision|0|||
163418224|NCT02772757|590238258|FG001|Overall Study|Physician Decision|3|||
163418225|NCT02772757|590238259|FG002|Overall Study|Physician Decision|3|||
163418226|NCT00510276|590238268|FG000|Acute Double-Blind Phase|Adverse Event|21|||
163418227|NCT00510276|590238269|FG001|Acute Double-Blind Phase|Adverse Event|6|||
163418228|NCT00510276|590238268|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
163418229|NCT00510276|590238269|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
163383543|NCT01295034|590115680|FG000|Overall Study|Lost to Follow-up|5|||
163383544|NCT01295034|590115681|FG001|Overall Study|Lost to Follow-up|5|||
163383545|NCT00824161|590115683|FG000|Overall Study|Withdrawal by Subject|1|||
163383546|NCT00824161|590115683|FG000|Overall Study|Screen Failure|1|||
163383547|NCT01774110|590115688|FG000|Overall Study|Lost to Follow-up|7|||
163383548|NCT00063154|590115689|FG000|Overall Study|Disease progression|27|||
163383549|NCT00063154|590115689|FG000|Overall Study|Adverse Event|2|||
163383550|NCT00063154|590115689|FG000|Overall Study|Physician Decision|10|||
163383551|NCT00063154|590115689|FG000|Overall Study|Death|3|||
163383552|NCT00063154|590115689|FG000|Overall Study|Reason unspecified|1|||
163383553|NCT00063154|590115689|FG000|Overall Study|Did not receive treatment|8|||
163383554|NCT02699983|590115691|FG000|Overall Study|Withdrawal by Subject|1|||
163383555|NCT02699983|590115692|FG001|Overall Study|Withdrawal by Subject|0|||
163383556|NCT03575143|590115693|FG000|Overall Study|Lost to Follow-up|0|||
163383557|NCT03575143|590115694|FG001|Overall Study|Lost to Follow-up|0|||
163383558|NCT03575143|590115695|FG002|Overall Study|Lost to Follow-up|4|||
163383559|NCT03575143|590115693|FG000|Overall Study|Withdrawal by Subject|0|||
163383560|NCT03575143|590115694|FG001|Overall Study|Withdrawal by Subject|0|||
163383561|NCT03575143|590115695|FG002|Overall Study|Withdrawal by Subject|5|||
163383562|NCT03575143|590115693|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
163383563|NCT03575143|590115694|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
163383564|NCT03575143|590115695|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
163383565|NCT01259726|590115698|FG000|Overall Study|Death|1|||
163383566|NCT01259726|590115699|FG001|Overall Study|Death|0|||
163383567|NCT01259726|590115700|FG002|Overall Study|Death|0|||
163383568|NCT01259726|590115701|FG003|Overall Study|Death|0|||
163383569|NCT01259726|590115698|FG000|Overall Study|Physician Decision|2|||
163383570|NCT01259726|590115699|FG001|Overall Study|Physician Decision|0|||
163383571|NCT01259726|590115700|FG002|Overall Study|Physician Decision|1|||
163383572|NCT01259726|590115701|FG003|Overall Study|Physician Decision|1|||
163383573|NCT01259726|590115698|FG000|Overall Study|Withdrawal by Subject|1|||
163383574|NCT01259726|590115699|FG001|Overall Study|Withdrawal by Subject|3|||
163383575|NCT01259726|590115700|FG002|Overall Study|Withdrawal by Subject|2|||
163383576|NCT01259726|590115701|FG003|Overall Study|Withdrawal by Subject|1|||
163418230|NCT00510276|590238268|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
163418231|NCT00510276|590238269|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
163418232|NCT00510276|590238268|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
163418233|NCT00510276|590238269|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
163418234|NCT00510276|590238268|FG000|Acute Double-Blind Phase|Physician Decision|0|||
163418235|NCT00510276|590238269|FG001|Acute Double-Blind Phase|Physician Decision|3|||
163418236|NCT00510276|590238268|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
163418237|NCT00510276|590238269|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
163383577|NCT01259726|590115698|FG000|Overall Study|Lost to Follow-up|1|||
163383578|NCT01259726|590115699|FG001|Overall Study|Lost to Follow-up|1|||
163418238|NCT00510276|590238268|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
163383579|NCT01259726|590115700|FG002|Overall Study|Lost to Follow-up|1|||
163383580|NCT01259726|590115701|FG003|Overall Study|Lost to Follow-up|3|||
163418239|NCT00510276|590238269|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
163418240|NCT00510276|590238268|FG000|Acute Double-Blind Phase|Subject Decision|26|||
163418241|NCT00510276|590238269|FG001|Acute Double-Blind Phase|Subject Decision|28|||
163418242|NCT00510276|590238268|FG000|Extension Open-Label Phase|Adverse Event|9|||
163418243|NCT00510276|590238269|FG001|Extension Open-Label Phase|Adverse Event|18|||
163418244|NCT00510276|590238268|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
163418245|NCT00510276|590238269|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
163418246|NCT00510276|590238268|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
163418247|NCT00510276|590238269|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
163418248|NCT00510276|590238268|FG000|Extension Open-Label Phase|Physician Decision|2|||
163418249|NCT00510276|590238269|FG001|Extension Open-Label Phase|Physician Decision|3|||
163418250|NCT00510276|590238268|FG000|Extension Open-Label Phase|Protocol Violation|0|||
163418251|NCT00510276|590238269|FG001|Extension Open-Label Phase|Protocol Violation|1|||
163418252|NCT00510276|590238268|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
163418253|NCT00510276|590238269|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
163418254|NCT00510276|590238268|FG000|Extension Open-Label Phase|Subject Decision|7|||
163418255|NCT00510276|590238269|FG001|Extension Open-Label Phase|Subject Decision|9|||
163418256|NCT00441792|590238270|FG000|Overall Study|Lost to Follow-up|0|||
163418257|NCT00441792|590238271|FG001|Overall Study|Lost to Follow-up|2|||
163418258|NCT01731678|590238272|FG000|Overall Study|Withdrawal by Subject|3|||
163418259|NCT01731678|590238272|FG000|Overall Study|Did not meet inclusion criteria|1|||
163418260|NCT01731678|590238272|FG000|Overall Study|RMT too high, making TMS difficult|3|||
163418261|NCT00888355|590238275|FG000|Overall Study|Adverse Event|10|||
163418262|NCT00888355|590238276|FG001|Overall Study|Adverse Event|0|||
163418263|NCT00888355|590238277|FG002|Overall Study|Adverse Event|3|||
163418264|NCT00888355|590238278|FG003|Overall Study|Adverse Event|3|||
163418265|NCT00888355|590238275|FG000|Overall Study|Lack of Efficacy|9|||
163418266|NCT00888355|590238276|FG001|Overall Study|Lack of Efficacy|2|||
163418267|NCT00888355|590238277|FG002|Overall Study|Lack of Efficacy|5|||
163418268|NCT00888355|590238278|FG003|Overall Study|Lack of Efficacy|2|||
163418269|NCT00888355|590238275|FG000|Overall Study|Lost to Follow-up|0|||
163418270|NCT00888355|590238276|FG001|Overall Study|Lost to Follow-up|2|||
163418271|NCT00888355|590238277|FG002|Overall Study|Lost to Follow-up|2|||
163418272|NCT00888355|590238278|FG003|Overall Study|Lost to Follow-up|0|||
163418273|NCT00888355|590238275|FG000|Overall Study|Protocol Violation|3|||
163418274|NCT00888355|590238276|FG001|Overall Study|Protocol Violation|2|||
163418275|NCT00888355|590238277|FG002|Overall Study|Protocol Violation|1|||
163418276|NCT00888355|590238278|FG003|Overall Study|Protocol Violation|2|||
163418277|NCT00888355|590238275|FG000|Overall Study|Withdrawal by Subject|0|||
163418278|NCT00888355|590238276|FG001|Overall Study|Withdrawal by Subject|3|||
163418279|NCT00888355|590238277|FG002|Overall Study|Withdrawal by Subject|1|||
163418280|NCT00888355|590238278|FG003|Overall Study|Withdrawal by Subject|3|||
163418281|NCT00772629|590240003|FG000|Overall Study|Subject was not vaccinated|1|||
163418282|NCT00772629|590240004|FG001|Overall Study|Subject was not vaccinated|0|||
163418283|NCT00132041|590240010|FG000|Baseline|Ineligible|6|||
163418284|NCT00132041|590240010|FG000|3 Months Post Ablation|Transplant|1|||
163418285|NCT00132041|590240010|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
163418286|NCT00132041|590240010|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
163418287|NCT00132041|590240010|FG000|6 Months Post Ablation|Death|2|||
163418288|NCT00132041|590240010|FG000|6 Months Post Ablation|Transplant|6|||
163418289|NCT00132041|590240010|FG000|9 Months Post Ablation|Death|1|||
163418290|NCT00132041|590240010|FG000|9 Months Post Ablation|Transplant|1|||
163418291|NCT00132041|590240010|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
163418292|NCT00132041|590240010|FG000|12 Months Post Ablation|Death|1|||
163418293|NCT00132041|590240010|FG000|12 Months Post Ablation|Transplant|1|||
163418294|NCT00132041|590240010|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
163418295|NCT00132041|590240010|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
163418296|NCT00132041|590240010|FG000|15 Months Post Ablation|Death|1|||
163418297|NCT00132041|590240010|FG000|15 Months Post Ablation|Transplant|5|||
163418298|NCT00132041|590240010|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
163418299|NCT00132041|590240010|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
163418300|NCT00132041|590240010|FG000|18 Months Post Ablation|Transplant|1|||
163418301|NCT00132041|590240010|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
163418302|NCT00132041|590240010|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
163418303|NCT01171820|590240012|FG000|Overall Study|Death|3|||
163418304|NCT01171820|590240013|FG001|Overall Study|Death|3|||
163418305|NCT01171820|590240012|FG000|Overall Study|Lost to Follow-up|0|||
163418306|NCT01171820|590240013|FG001|Overall Study|Lost to Follow-up|1|||
163418307|NCT01171820|590240012|FG000|Overall Study|Withdrawal by Subject|2|||
163418308|NCT01171820|590240013|FG001|Overall Study|Withdrawal by Subject|0|||
163418309|NCT01171820|590240012|FG000|Overall Study|Physician Decision|0|||
163418310|NCT01171820|590240013|FG001|Overall Study|Physician Decision|1|||
163418311|NCT01171820|590240012|FG000|Overall Study|1-Year Missed Visit|1|||
163418312|NCT01171820|590240013|FG001|Overall Study|1-Year Missed Visit|1|||
163418313|NCT03969875|590240014|FG000|Overall Study|did not receive allocated intervention|3|||
163418314|NCT03969875|590240015|FG001|Overall Study|did not receive allocated intervention|3|||
163383581|NCT01211197|590115703|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163383582|NCT01211197|590115704|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163383583|NCT01211197|590115705|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
163383584|NCT01211197|590115706|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163383585|NCT01211197|590115707|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163383586|NCT01211197|590115708|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163383587|NCT01211197|590115703|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
163383588|NCT01211197|590115704|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
163383589|NCT01211197|590115705|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
163383590|NCT01211197|590115706|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
163383591|NCT01211197|590115707|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
163383592|NCT01211197|590115708|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
163383593|NCT00261846|590115709|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
163383594|NCT00261846|590115710|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
163383595|NCT00261846|590115711|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
163383596|NCT00261846|590115712|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163383597|NCT00261846|590115713|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163383598|NCT00261846|590115714|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163383599|NCT00261846|590115715|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163383600|NCT00261846|590115716|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163383601|NCT00261846|590115717|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163383602|NCT00261846|590115718|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163383603|NCT00261846|590115719|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163383604|NCT00261846|590115720|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163383605|NCT00261846|590115709|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163383606|NCT00261846|590115710|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163383607|NCT00261846|590115711|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163383608|NCT00261846|590115712|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
163383609|NCT00261846|590115713|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163383610|NCT00261846|590115714|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163383611|NCT00261846|590115715|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163383612|NCT00261846|590115716|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163383613|NCT00261846|590115717|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
163383614|NCT00261846|590115718|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163383615|NCT00261846|590115719|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163383616|NCT00261846|590115720|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163383617|NCT00261846|590115709|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
163383618|NCT00261846|590115710|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
163383619|NCT00261846|590115711|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
163383620|NCT00261846|590115712|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
163383621|NCT00261846|590115713|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
163383622|NCT00261846|590115714|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
163383623|NCT00261846|590115715|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
163383624|NCT00261846|590115716|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
163383625|NCT00261846|590115717|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
163383626|NCT00261846|590115718|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
163383627|NCT00261846|590115719|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
163383628|NCT00261846|590115720|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
163383629|NCT00261846|590115709|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
163383630|NCT00261846|590115710|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
163383631|NCT00261846|590115711|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
163383632|NCT00261846|590115712|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
163383633|NCT00261846|590115713|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
163383634|NCT00261846|590115714|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
163383635|NCT00261846|590115715|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
163383636|NCT00261846|590115716|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
163383637|NCT00261846|590115717|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
163383638|NCT00261846|590115718|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
163383639|NCT00261846|590115719|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
163383640|NCT00261846|590115720|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
163383641|NCT00261846|590115709|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
163383642|NCT00261846|590115710|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
163383643|NCT00261846|590115711|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
163383644|NCT00261846|590115712|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
163383645|NCT00261846|590115713|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
163383646|NCT00261846|590115714|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
163383647|NCT00261846|590115715|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
163383648|NCT00261846|590115716|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
163383649|NCT00261846|590115717|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
163418315|NCT03969875|590240016|FG002|Overall Study|did not receive allocated intervention|4|||
163418316|NCT03969875|590240014|FG000|Overall Study|Protocol Violation|4|||
163418317|NCT03969875|590240015|FG001|Overall Study|Protocol Violation|2|||
163418318|NCT03969875|590240016|FG002|Overall Study|Protocol Violation|2|||
163418319|NCT00167245|590240017|FG000|Overall Study|Lost to Follow-up|20|||
163418320|NCT00167245|590240018|FG001|Overall Study|Lost to Follow-up|31|||
163418321|NCT00167245|590240017|FG000|Overall Study|Withdrawal by Subject|5|||
163418322|NCT00167245|590240018|FG001|Overall Study|Withdrawal by Subject|8|||
163418323|NCT00167245|590240017|FG000|Overall Study|Incarcerated|3|||
163418324|NCT00167245|590240018|FG001|Overall Study|Incarcerated|2|||
163418325|NCT00167245|590240017|FG000|Overall Study|Drowsy|1|||
163418326|NCT00167245|590240018|FG001|Overall Study|Drowsy|0|||
163418327|NCT01871090|590240019|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
163418328|NCT01871090|590240020|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
163418329|NCT01871090|590240019|FG000|Overall Study|Interrogation not completed correctly|1|||
163418330|NCT01871090|590240020|FG001|Overall Study|Interrogation not completed correctly|0|||
163418331|NCT01871090|590240019|FG000|Overall Study|Subject Non-Compliance|0|||
163418332|NCT01871090|590240020|FG001|Overall Study|Subject Non-Compliance|1|||
163418333|NCT02911688|590240024|FG000|Washout|Lost to Follow-up|1|||
163418334|NCT02911688|590240025|FG001|Washout|Lost to Follow-up|1|||
163418335|NCT02911688|590240024|FG000|Washout|Withdrawal by Subject|0|||
163418336|NCT02911688|590240025|FG001|Washout|Withdrawal by Subject|1|||
163418337|NCT01307033|590240028|FG000|8-week Double-blind Period|Adverse Event|2|||
163418338|NCT01307033|590240029|FG001|8-week Double-blind Period|Adverse Event|0|||
163418339|NCT01307033|590240030|FG002|8-week Double-blind Period|Adverse Event|0|||
163383650|NCT00261846|590115718|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
163418340|NCT01307033|590240031|FG003|8-week Double-blind Period|Adverse Event|0|||
163418341|NCT01307033|590240028|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
163418342|NCT01307033|590240029|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
163418343|NCT01307033|590240030|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
163418344|NCT01307033|590240031|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
163418345|NCT01307033|590240028|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
163418346|NCT01307033|590240029|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
163418347|NCT01307033|590240030|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
163418348|NCT01307033|590240031|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
163418349|NCT01307033|590240028|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
163418350|NCT01307033|590240029|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
163418351|NCT01307033|590240030|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
163418352|NCT01307033|590240031|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
163418353|NCT01307033|590240028|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
163418354|NCT01307033|590240029|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
163418355|NCT01307033|590240030|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
163418356|NCT01307033|590240031|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
163383651|NCT00261846|590115719|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
163383652|NCT00261846|590115720|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
163383653|NCT00261846|590115709|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
163383654|NCT00261846|590115710|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
163383655|NCT00261846|590115711|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
163383656|NCT00261846|590115712|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
163383657|NCT00261846|590115713|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
163383658|NCT00261846|590115714|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
163383659|NCT00261846|590115715|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
163383660|NCT00261846|590115716|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
163383661|NCT00261846|590115717|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
163383662|NCT00261846|590115718|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
163383663|NCT00261846|590115719|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
163383664|NCT00261846|590115720|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
163418357|NCT01307033|590240028|FG000|44-week Open-label Extension|Adverse Event|0|||
163418358|NCT01307033|590240029|FG001|44-week Open-label Extension|Adverse Event|0|||
163418359|NCT01307033|590240030|FG002|44-week Open-label Extension|Adverse Event|2|||
163418360|NCT01307033|590240031|FG003|44-week Open-label Extension|Adverse Event|1|||
163418361|NCT01307033|590240028|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
163418362|NCT01307033|590240029|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
163418363|NCT01307033|590240030|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
163418364|NCT01307033|590240031|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
163418365|NCT01307033|590240028|FG000|44-week Open-label Extension|Physician Decision|0|||
163383665|NCT00261846|590115709|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
163383666|NCT00261846|590115710|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
163383667|NCT00261846|590115711|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
163383668|NCT00261846|590115712|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
163383669|NCT00261846|590115713|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
163383670|NCT00261846|590115714|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
163383671|NCT00261846|590115715|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
163383672|NCT00261846|590115716|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
163383673|NCT00261846|590115717|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
163383674|NCT00261846|590115718|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
163383675|NCT00261846|590115719|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
163383676|NCT00261846|590115720|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
163383677|NCT04781387|590115723|FG000|Overall Study|Withdrawal by Subject|1|||
163383678|NCT04781387|590115724|FG001|Overall Study|Withdrawal by Subject|0|||
163383679|NCT04781387|590115725|FG002|Overall Study|Withdrawal by Subject|1|||
163383680|NCT04781387|590115723|FG000|Overall Study|Lost to Follow-up|1|||
163383681|NCT04781387|590115724|FG001|Overall Study|Lost to Follow-up|0|||
163383682|NCT04781387|590115725|FG002|Overall Study|Lost to Follow-up|0|||
163383683|NCT01636960|590115726|FG000|Induction Phase|Adverse Event|2|||
163383684|NCT01636960|590115726|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
163383685|NCT01636960|590115726|FG000|Maintenance Phase|Adverse Event|3|||
163383686|NCT01636960|590115726|FG000|Maintenance Phase|Progressive disease|1|||
163383687|NCT01209780|590115727|FG000|Overall Study|Adverse Event|0|||
163383688|NCT01209780|590115728|FG001|Overall Study|Adverse Event|1|||
163383689|NCT01209780|590115729|FG002|Overall Study|Adverse Event|0|||
163383690|NCT01209780|590115730|FG003|Overall Study|Adverse Event|0|||
163383691|NCT01209780|590115731|FG004|Overall Study|Adverse Event|0|||
163383692|NCT01209780|590115727|FG000|Overall Study|Withdrawal by Subject|9|||
163383693|NCT01209780|590115728|FG001|Overall Study|Withdrawal by Subject|2|||
163383694|NCT01209780|590115729|FG002|Overall Study|Withdrawal by Subject|1|||
163383695|NCT01209780|590115730|FG003|Overall Study|Withdrawal by Subject|1|||
163383696|NCT01209780|590115731|FG004|Overall Study|Withdrawal by Subject|0|||
163383697|NCT01209780|590115727|FG000|Overall Study|Lost to Follow-up|17|||
163383698|NCT01209780|590115728|FG001|Overall Study|Lost to Follow-up|12|||
163383699|NCT01209780|590115729|FG002|Overall Study|Lost to Follow-up|3|||
163383700|NCT01209780|590115730|FG003|Overall Study|Lost to Follow-up|9|||
163383701|NCT01209780|590115731|FG004|Overall Study|Lost to Follow-up|4|||
163383702|NCT01209780|590115727|FG000|Overall Study|Protocol Violation|0|||
163383703|NCT01209780|590115728|FG001|Overall Study|Protocol Violation|1|||
163383704|NCT01209780|590115729|FG002|Overall Study|Protocol Violation|0|||
163383705|NCT01209780|590115730|FG003|Overall Study|Protocol Violation|0|||
163383706|NCT01209780|590115731|FG004|Overall Study|Protocol Violation|0|||
163383707|NCT01209780|590115727|FG000|Overall Study|Inappropriate enrollment|0|||
163383708|NCT01209780|590115728|FG001|Overall Study|Inappropriate enrollment|2|||
163383709|NCT01209780|590115729|FG002|Overall Study|Inappropriate enrollment|0|||
163383710|NCT01209780|590115730|FG003|Overall Study|Inappropriate enrollment|0|||
163383711|NCT01209780|590115731|FG004|Overall Study|Inappropriate enrollment|1|||
163383712|NCT01745848|590115732|FG000|Overall Study|Adverse Event|6|||
163383713|NCT02318797|590115736|FG000|Overall Study|Death|3|||
163383714|NCT02318797|590115737|FG001|Overall Study|Death|6|||
163383715|NCT02318797|590115736|FG000|Overall Study|Lost to Follow-up|85|||
163383716|NCT02318797|590115737|FG001|Overall Study|Lost to Follow-up|96|||
163383717|NCT02709096|590115742|FG000|Overall Study|non-compliance|1|||
163383718|NCT02709096|590115743|FG001|Overall Study|non-compliance|1|||
163383719|NCT00505284|590115744|FG000|Overall Study|Adverse Event|3|||
163383720|NCT00505284|590115745|FG001|Overall Study|Adverse Event|7|||
163383721|NCT00505284|590115746|FG002|Overall Study|Adverse Event|9|||
163383722|NCT00505284|590115747|FG003|Overall Study|Adverse Event|14|||
163383723|NCT00505284|590115748|FG004|Overall Study|Adverse Event|22|||
163383724|NCT00505284|590115744|FG000|Overall Study|Protocol Violation|0|||
163383725|NCT00505284|590115745|FG001|Overall Study|Protocol Violation|1|||
163383726|NCT00505284|590115746|FG002|Overall Study|Protocol Violation|1|||
163383727|NCT00505284|590115747|FG003|Overall Study|Protocol Violation|0|||
163383728|NCT00505284|590115748|FG004|Overall Study|Protocol Violation|0|||
163383729|NCT00505284|590115744|FG000|Overall Study|Withdrawal by Subject|2|||
163383730|NCT00505284|590115745|FG001|Overall Study|Withdrawal by Subject|6|||
163383731|NCT00505284|590115746|FG002|Overall Study|Withdrawal by Subject|1|||
163383732|NCT00505284|590115747|FG003|Overall Study|Withdrawal by Subject|0|||
163383733|NCT00505284|590115748|FG004|Overall Study|Withdrawal by Subject|6|||
163383734|NCT00505284|590115744|FG000|Overall Study|Lack of Efficacy|0|||
163383735|NCT00505284|590115745|FG001|Overall Study|Lack of Efficacy|1|||
163383736|NCT00505284|590115746|FG002|Overall Study|Lack of Efficacy|1|||
163383737|NCT00505284|590115747|FG003|Overall Study|Lack of Efficacy|1|||
163383738|NCT00505284|590115748|FG004|Overall Study|Lack of Efficacy|1|||
163383739|NCT00505284|590115744|FG000|Overall Study|Physician Decision|0|||
163383740|NCT00505284|590115745|FG001|Overall Study|Physician Decision|1|||
163383741|NCT00505284|590115746|FG002|Overall Study|Physician Decision|0|||
163383742|NCT00505284|590115747|FG003|Overall Study|Physician Decision|0|||
163383743|NCT00505284|590115748|FG004|Overall Study|Physician Decision|0|||
163383744|NCT00505284|590115744|FG000|Overall Study|Other|5|||
163383745|NCT00505284|590115745|FG001|Overall Study|Other|0|||
163383746|NCT00505284|590115746|FG002|Overall Study|Other|0|||
163383747|NCT00505284|590115747|FG003|Overall Study|Other|4|||
163383748|NCT00505284|590115748|FG004|Overall Study|Other|4|||
163383749|NCT00940108|590115749|FG000|Overall Study|Adverse Event|2|||
163383750|NCT00940108|590115750|FG001|Overall Study|Adverse Event|4|||
163418366|NCT01307033|590240029|FG001|44-week Open-label Extension|Physician Decision|0|||
163418367|NCT01307033|590240030|FG002|44-week Open-label Extension|Physician Decision|1|||
163418368|NCT01307033|590240031|FG003|44-week Open-label Extension|Physician Decision|0|||
163418369|NCT01307033|590240028|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
163418370|NCT01307033|590240029|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
163418371|NCT01307033|590240030|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
163418372|NCT01307033|590240031|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
163418373|NCT01307033|590240028|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
163418374|NCT01307033|590240029|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
163418375|NCT01307033|590240030|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
163418376|NCT01307033|590240031|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
163418377|NCT01307033|590240028|FG000|44-week Open-label Extension|Death|0|||
163418378|NCT01307033|590240029|FG001|44-week Open-label Extension|Death|0|||
163418379|NCT01307033|590240030|FG002|44-week Open-label Extension|Death|0|||
163418380|NCT01307033|590240031|FG003|44-week Open-label Extension|Death|1|||
163418381|NCT01793792|590240032|FG000|Overall Study|Death|5|||
163418382|NCT01793792|590240032|FG000|Overall Study|Lost to Follow-up|5|||
163418383|NCT01793792|590240032|FG000|Overall Study|Withdrawal by Subject|1|||
163418384|NCT01793792|590240032|FG000|Overall Study|Device Not Implanted|1|||
163418385|NCT00851903|590240035|FG000|Overall Study|Withdrawal by Subject|2|||
163418386|NCT00270894|590240036|FG000|Overall Study|Adverse Event|1|||
163418387|NCT00270894|590240036|FG000|Overall Study|Withdrawal by Subject|1|||
163418388|NCT02487108|590240042|FG000|Overall Study|Adverse Event|1|||
163418389|NCT02487108|590240043|FG001|Overall Study|Adverse Event|6|||
163418390|NCT02487108|590240044|FG002|Overall Study|Adverse Event|12|||
163418391|NCT02487108|590240045|FG003|Overall Study|Adverse Event|6|||
163418392|NCT02487108|590240042|FG000|Overall Study|Withdrawal by Subject|8|||
163418393|NCT02487108|590240043|FG001|Overall Study|Withdrawal by Subject|5|||
163418394|NCT02487108|590240044|FG002|Overall Study|Withdrawal by Subject|5|||
163418395|NCT02487108|590240045|FG003|Overall Study|Withdrawal by Subject|0|||
163418396|NCT02487108|590240042|FG000|Overall Study|Non-compliance to study medication|3|||
163418397|NCT02487108|590240043|FG001|Overall Study|Non-compliance to study medication|2|||
163418398|NCT02487108|590240044|FG002|Overall Study|Non-compliance to study medication|5|||
163418399|NCT02487108|590240045|FG003|Overall Study|Non-compliance to study medication|4|||
163418400|NCT02487108|590240042|FG000|Overall Study|Protocol Violation|1|||
163418401|NCT02487108|590240043|FG001|Overall Study|Protocol Violation|1|||
163418402|NCT02487108|590240044|FG002|Overall Study|Protocol Violation|2|||
163418403|NCT02487108|590240045|FG003|Overall Study|Protocol Violation|0|||
163418404|NCT02487108|590240042|FG000|Overall Study|Non-compliance to study procedures|0|||
163418405|NCT02487108|590240043|FG001|Overall Study|Non-compliance to study procedures|0|||
163418406|NCT02487108|590240044|FG002|Overall Study|Non-compliance to study procedures|0|||
163418407|NCT02487108|590240045|FG003|Overall Study|Non-compliance to study procedures|1|||
163418408|NCT02487108|590240042|FG000|Overall Study|Other than specified|3|||
163418409|NCT02487108|590240043|FG001|Overall Study|Other than specified|2|||
163418410|NCT02487108|590240044|FG002|Overall Study|Other than specified|2|||
163418411|NCT02487108|590240045|FG003|Overall Study|Other than specified|0|||
163418412|NCT00469612|590240046|FG000|Overall Study|Study terminated before data collected|2|||
163418413|NCT00469612|590240047|FG001|Overall Study|Study terminated before data collected|0|||
163418414|NCT00883493|590240048|FG000|Overall Study|Adverse Event|11|||
163418415|NCT00883493|590240049|FG001|Overall Study|Adverse Event|12|||
163418416|NCT00883493|590240048|FG000|Overall Study|Lack of Efficacy|4|||
163418417|NCT00883493|590240049|FG001|Overall Study|Lack of Efficacy|3|||
163418418|NCT00883493|590240048|FG000|Overall Study|Lost to Follow-up|7|||
163418419|NCT00883493|590240049|FG001|Overall Study|Lost to Follow-up|6|||
163418420|NCT00883493|590240048|FG000|Overall Study|Withdrawal by Subject|11|||
163418421|NCT00883493|590240049|FG001|Overall Study|Withdrawal by Subject|20|||
163418422|NCT00883493|590240048|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
163418423|NCT00883493|590240049|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
163418424|NCT00883493|590240048|FG000|Overall Study|Study specific disc. criteria|2|||
163418425|NCT00883493|590240049|FG001|Overall Study|Study specific disc. criteria|0|||
163418426|NCT00883493|590240048|FG000|Overall Study|Other|5|||
163418427|NCT00883493|590240049|FG001|Overall Study|Other|3|||
163418428|NCT01622569|590240050|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
163418429|NCT01622569|590240051|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
163418430|NCT01622569|590240052|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
163418431|NCT01622569|590240053|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
163418432|NCT01622569|590240050|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
163418433|NCT01622569|590240051|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
163418434|NCT01622569|590240052|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
163418435|NCT01622569|590240053|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
163418436|NCT01622569|590240050|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
163418437|NCT01622569|590240051|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
163383751|NCT00940108|590115751|FG002|Overall Study|Adverse Event|0|||
163383752|NCT00940108|590115752|FG003|Overall Study|Adverse Event|2|||
163383753|NCT00940108|590115749|FG000|Overall Study|Withdrew Consent|2|||
163383754|NCT00940108|590115750|FG001|Overall Study|Withdrew Consent|1|||
163383755|NCT00940108|590115751|FG002|Overall Study|Withdrew Consent|0|||
163383756|NCT00940108|590115752|FG003|Overall Study|Withdrew Consent|1|||
163383757|NCT00940108|590115749|FG000|Overall Study|Dose 2 contraindicated|1|||
163383758|NCT00940108|590115750|FG001|Overall Study|Dose 2 contraindicated|1|||
163383759|NCT00940108|590115751|FG002|Overall Study|Dose 2 contraindicated|0|||
163383760|NCT00940108|590115752|FG003|Overall Study|Dose 2 contraindicated|1|||
163383761|NCT00940108|590115749|FG000|Overall Study|Declined further vaccination|0|||
163383762|NCT00940108|590115750|FG001|Overall Study|Declined further vaccination|1|||
163383763|NCT00940108|590115751|FG002|Overall Study|Declined further vaccination|3|||
163383764|NCT00940108|590115752|FG003|Overall Study|Declined further vaccination|0|||
163383765|NCT00940108|590115749|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
163383766|NCT00940108|590115750|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
163383767|NCT00940108|590115751|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
163383768|NCT00940108|590115752|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
163383769|NCT00940108|590115749|FG000|Overall Study|Viral illness after Dose 1|0|||
163383770|NCT00940108|590115750|FG001|Overall Study|Viral illness after Dose 1|1|||
163383771|NCT00940108|590115751|FG002|Overall Study|Viral illness after Dose 1|0|||
163383772|NCT00940108|590115752|FG003|Overall Study|Viral illness after Dose 1|0|||
163383773|NCT00940108|590115749|FG000|Overall Study|Diagnosed with H1N1|0|||
163383774|NCT00940108|590115750|FG001|Overall Study|Diagnosed with H1N1|0|||
163383775|NCT00940108|590115751|FG002|Overall Study|Diagnosed with H1N1|0|||
163383776|NCT00940108|590115752|FG003|Overall Study|Diagnosed with H1N1|1|||
163383777|NCT01740323|590115753|FG000|Overall Study|Adverse Event|1|||
163383778|NCT01740323|590115754|FG001|Overall Study|Adverse Event|0|||
163383779|NCT01740323|590115753|FG000|Overall Study|Randomized but did not take study drug|1|||
163383780|NCT01740323|590115754|FG001|Overall Study|Randomized but did not take study drug|0|||
163383781|NCT06338462|590115755|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
163383782|NCT00928447|590115756|FG000|Overall Study|Withdrawal by Subject|1|||
163383783|NCT00928447|590115756|FG000|Overall Study|Investigator's decision|1|||
163383784|NCT03581825|590115758|FG000|Period 1|Lens Discomfort|1|||
163383785|NCT03581825|590115759|FG001|Period 1|Lens Discomfort|0|||
163383786|NCT03581825|590115758|FG000|Period 2|Unsatisfactory Vision to Test|0|||
163383787|NCT03581825|590115759|FG001|Period 2|Unsatisfactory Vision to Test|1|||
163383788|NCT00585195|590115761|FG000|Overall Study|Adverse Event|0|||
163383789|NCT00585195|590115762|FG001|Overall Study|Adverse Event|0|||
163383790|NCT00585195|590115763|FG002|Overall Study|Adverse Event|0|||
163383791|NCT00585195|590115764|FG003|Overall Study|Adverse Event|0|||
163383792|NCT00585195|590115765|FG004|Overall Study|Adverse Event|2|||
163383793|NCT00585195|590115766|FG005|Overall Study|Adverse Event|1|||
163383794|NCT00585195|590115767|FG006|Overall Study|Adverse Event|0|||
163383795|NCT00585195|590115768|FG007|Overall Study|Adverse Event|1|||
163383796|NCT00585195|590115769|FG008|Overall Study|Adverse Event|0|||
163383797|NCT00585195|590115770|FG009|Overall Study|Adverse Event|0|||
163383798|NCT00585195|590115771|FG010|Overall Study|Adverse Event|3|||
163383799|NCT00585195|590115772|FG011|Overall Study|Adverse Event|0|||
163383800|NCT00585195|590115773|FG012|Overall Study|Adverse Event|8|||
163383801|NCT00585195|590115774|FG013|Overall Study|Adverse Event|6|||
163383802|NCT00585195|590115775|FG014|Overall Study|Adverse Event|4|||
163383803|NCT00585195|590115776|FG015|Overall Study|Adverse Event|1|||
163383804|NCT00585195|590115777|FG016|Overall Study|Adverse Event|14|||
163383805|NCT00585195|590115778|FG017|Overall Study|Adverse Event|9|||
163383806|NCT00585195|590115779|FG018|Overall Study|Adverse Event|2|||
163383807|NCT00585195|590115780|FG019|Overall Study|Adverse Event|3|||
163383808|NCT00585195|590115781|FG020|Overall Study|Adverse Event|1|||
163383809|NCT00585195|590115761|FG000|Overall Study|Progressive Disease|2|||
163383810|NCT00585195|590115762|FG001|Overall Study|Progressive Disease|2|||
163383811|NCT00585195|590115763|FG002|Overall Study|Progressive Disease|5|||
163383812|NCT00585195|590115764|FG003|Overall Study|Progressive Disease|4|||
163383813|NCT00585195|590115765|FG004|Overall Study|Progressive Disease|6|||
163383814|NCT00585195|590115766|FG005|Overall Study|Progressive Disease|4|||
163383815|NCT00585195|590115767|FG006|Overall Study|Progressive Disease|6|||
163383816|NCT00585195|590115768|FG007|Overall Study|Progressive Disease|3|||
163383817|NCT00585195|590115769|FG008|Overall Study|Progressive Disease|0|||
163383818|NCT00585195|590115770|FG009|Overall Study|Progressive Disease|5|||
163383819|NCT00585195|590115771|FG010|Overall Study|Progressive Disease|2|||
163383820|NCT00585195|590115772|FG011|Overall Study|Progressive Disease|25|||
163383821|NCT00585195|590115773|FG012|Overall Study|Progressive Disease|29|||
163383822|NCT00585195|590115774|FG013|Overall Study|Progressive Disease|26|||
163383823|NCT00585195|590115775|FG014|Overall Study|Progressive Disease|21|||
163383824|NCT00585195|590115776|FG015|Overall Study|Progressive Disease|12|||
163383825|NCT00585195|590115777|FG016|Overall Study|Progressive Disease|94|||
163383826|NCT00585195|590115778|FG017|Overall Study|Progressive Disease|42|||
163383827|NCT00585195|590115779|FG018|Overall Study|Progressive Disease|4|||
163383828|NCT00585195|590115780|FG019|Overall Study|Progressive Disease|9|||
163383829|NCT00585195|590115781|FG020|Overall Study|Progressive Disease|8|||
163383830|NCT00585195|590115761|FG000|Overall Study|Withdrawal by Subject|1|||
163383831|NCT00585195|590115762|FG001|Overall Study|Withdrawal by Subject|1|||
163418438|NCT01622569|590240052|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
163418439|NCT01622569|590240053|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
163418440|NCT01622569|590240050|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
163418441|NCT01622569|590240051|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
163418442|NCT01622569|590240052|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
163418443|NCT01622569|590240053|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
163418444|NCT01622569|590240050|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
163418445|NCT01622569|590240051|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
163418446|NCT01622569|590240052|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
163418447|NCT01622569|590240053|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
163418448|NCT01622569|590240050|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
163418449|NCT01622569|590240051|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
163418450|NCT01622569|590240052|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
163418451|NCT01622569|590240053|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
163418452|NCT01622569|590240050|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
163418453|NCT01622569|590240051|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
163418454|NCT01622569|590240052|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
163418455|NCT01622569|590240053|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
163418456|NCT01622569|590240050|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
163418457|NCT01622569|590240051|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
163418458|NCT01622569|590240052|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
163418459|NCT01622569|590240053|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
163418460|NCT02522767|590240054|FG000|Double-blind|Withdrawal by Subject|8|||
163418461|NCT02522767|590240055|FG001|Double-blind|Withdrawal by Subject|11|||
163418462|NCT02522767|590240054|FG000|Double-blind|Lost to Follow-up|1|||
163418463|NCT02522767|590240055|FG001|Double-blind|Lost to Follow-up|0|||
163418464|NCT02522767|590240054|FG000|Double-blind|Adverse Event|1|||
163418465|NCT02522767|590240055|FG001|Double-blind|Adverse Event|10|||
163418466|NCT02522767|590240054|FG000|Double-blind|Protocol Violation|0|||
163418467|NCT02522767|590240055|FG001|Double-blind|Protocol Violation|1|||
163418468|NCT02522767|590240054|FG000|Double-blind|Lack of Efficacy|0|||
163418469|NCT02522767|590240055|FG001|Double-blind|Lack of Efficacy|2|||
163418470|NCT02522767|590240054|FG000|Double-blind|Protocol Deviation|1|||
163383832|NCT00585195|590115763|FG002|Overall Study|Withdrawal by Subject|2|||
163383833|NCT00585195|590115764|FG003|Overall Study|Withdrawal by Subject|2|||
163383834|NCT00585195|590115765|FG004|Overall Study|Withdrawal by Subject|0|||
163383835|NCT00585195|590115766|FG005|Overall Study|Withdrawal by Subject|0|||
163383836|NCT00585195|590115767|FG006|Overall Study|Withdrawal by Subject|0|||
163383837|NCT00585195|590115768|FG007|Overall Study|Withdrawal by Subject|1|||
163383838|NCT00585195|590115769|FG008|Overall Study|Withdrawal by Subject|0|||
163383839|NCT00585195|590115770|FG009|Overall Study|Withdrawal by Subject|0|||
163383840|NCT00585195|590115771|FG010|Overall Study|Withdrawal by Subject|3|||
163383841|NCT00585195|590115772|FG011|Overall Study|Withdrawal by Subject|8|||
163383842|NCT00585195|590115773|FG012|Overall Study|Withdrawal by Subject|15|||
163383843|NCT00585195|590115774|FG013|Overall Study|Withdrawal by Subject|0|||
163383844|NCT00585195|590115775|FG014|Overall Study|Withdrawal by Subject|3|||
163383845|NCT00585195|590115776|FG015|Overall Study|Withdrawal by Subject|0|||
163383846|NCT00585195|590115777|FG016|Overall Study|Withdrawal by Subject|7|||
163383847|NCT00585195|590115778|FG017|Overall Study|Withdrawal by Subject|1|||
163383848|NCT00585195|590115779|FG018|Overall Study|Withdrawal by Subject|2|||
163383849|NCT00585195|590115780|FG019|Overall Study|Withdrawal by Subject|2|||
163383850|NCT00585195|590115781|FG020|Overall Study|Withdrawal by Subject|0|||
163383851|NCT00585195|590115761|FG000|Overall Study|Other|0|||
163383852|NCT00585195|590115762|FG001|Overall Study|Other|1|||
163383853|NCT00585195|590115763|FG002|Overall Study|Other|1|||
163383854|NCT00585195|590115764|FG003|Overall Study|Other|1|||
163383855|NCT00585195|590115765|FG004|Overall Study|Other|0|||
163383856|NCT00585195|590115766|FG005|Overall Study|Other|1|||
163418471|NCT02522767|590240055|FG001|Double-blind|Protocol Deviation|0|||
163418472|NCT02522767|590240054|FG000|Open-label|Withdrawal by Subject|2|||
163418473|NCT02522767|590240055|FG001|Open-label|Withdrawal by Subject|3|||
163418474|NCT02522767|590240054|FG000|Open-label|Lost to Follow-up|0|||
163418475|NCT02522767|590240055|FG001|Open-label|Lost to Follow-up|1|||
163418476|NCT02522767|590240054|FG000|Open-label|Adverse Event|2|||
163418477|NCT02522767|590240055|FG001|Open-label|Adverse Event|1|||
163418478|NCT02522767|590240054|FG000|Open-label|Lack of Efficacy|1|||
163418479|NCT02522767|590240055|FG001|Open-label|Lack of Efficacy|1|||
163383857|NCT00585195|590115767|FG006|Overall Study|Other|0|||
163383858|NCT00585195|590115768|FG007|Overall Study|Other|0|||
163383859|NCT00585195|590115769|FG008|Overall Study|Other|2|||
163383860|NCT00585195|590115770|FG009|Overall Study|Other|1|||
163383861|NCT00585195|590115771|FG010|Overall Study|Other|0|||
163383862|NCT00585195|590115772|FG011|Overall Study|Other|19|||
163383863|NCT00585195|590115773|FG012|Overall Study|Other|24|||
163383864|NCT00585195|590115774|FG013|Overall Study|Other|7|||
163383865|NCT00585195|590115775|FG014|Overall Study|Other|11|||
163383866|NCT00585195|590115776|FG015|Overall Study|Other|3|||
163383867|NCT00585195|590115777|FG016|Overall Study|Other|28|||
163383868|NCT00585195|590115778|FG017|Overall Study|Other|12|||
163383869|NCT00585195|590115779|FG018|Overall Study|Other|10|||
163383870|NCT00585195|590115780|FG019|Overall Study|Other|4|||
163383871|NCT00585195|590115781|FG020|Overall Study|Other|2|||
163383872|NCT00585195|590115761|FG000|Overall Study|Randomized not treated|0|||
163383873|NCT00585195|590115762|FG001|Overall Study|Randomized not treated|0|||
163383874|NCT00585195|590115763|FG002|Overall Study|Randomized not treated|1|||
163383875|NCT00585195|590115764|FG003|Overall Study|Randomized not treated|0|||
163383876|NCT00585195|590115765|FG004|Overall Study|Randomized not treated|1|||
163383877|NCT00585195|590115766|FG005|Overall Study|Randomized not treated|0|||
163383878|NCT00585195|590115767|FG006|Overall Study|Randomized not treated|1|||
163383879|NCT00585195|590115768|FG007|Overall Study|Randomized not treated|0|||
163383880|NCT00585195|590115769|FG008|Overall Study|Randomized not treated|0|||
163383881|NCT00585195|590115770|FG009|Overall Study|Randomized not treated|0|||
163383882|NCT00585195|590115771|FG010|Overall Study|Randomized not treated|2|||
163383883|NCT00585195|590115772|FG011|Overall Study|Randomized not treated|0|||
163383884|NCT00585195|590115773|FG012|Overall Study|Randomized not treated|0|||
163383885|NCT00585195|590115774|FG013|Overall Study|Randomized not treated|0|||
163383886|NCT00585195|590115775|FG014|Overall Study|Randomized not treated|0|||
163383887|NCT00585195|590115776|FG015|Overall Study|Randomized not treated|1|||
163383888|NCT00585195|590115777|FG016|Overall Study|Randomized not treated|0|||
163383889|NCT00585195|590115778|FG017|Overall Study|Randomized not treated|1|||
163383890|NCT00585195|590115779|FG018|Overall Study|Randomized not treated|3|||
163383891|NCT00585195|590115780|FG019|Overall Study|Randomized not treated|0|||
163383892|NCT00585195|590115781|FG020|Overall Study|Randomized not treated|2|||
163383893|NCT00585195|590115761|FG000|Overall Study|Death|0|||
163383894|NCT00585195|590115762|FG001|Overall Study|Death|0|||
163383895|NCT00585195|590115763|FG002|Overall Study|Death|0|||
163383896|NCT00585195|590115764|FG003|Overall Study|Death|0|||
163383897|NCT00585195|590115765|FG004|Overall Study|Death|0|||
163383898|NCT00585195|590115766|FG005|Overall Study|Death|0|||
163383899|NCT00585195|590115767|FG006|Overall Study|Death|0|||
163383900|NCT00585195|590115768|FG007|Overall Study|Death|0|||
163383901|NCT00585195|590115769|FG008|Overall Study|Death|1|||
163383902|NCT00585195|590115770|FG009|Overall Study|Death|0|||
163383903|NCT00585195|590115771|FG010|Overall Study|Death|1|||
163383904|NCT00585195|590115772|FG011|Overall Study|Death|1|||
163383905|NCT00585195|590115773|FG012|Overall Study|Death|7|||
163383906|NCT00585195|590115774|FG013|Overall Study|Death|2|||
163383907|NCT00585195|590115775|FG014|Overall Study|Death|8|||
163383908|NCT00585195|590115776|FG015|Overall Study|Death|2|||
163383909|NCT00585195|590115777|FG016|Overall Study|Death|11|||
163383910|NCT00585195|590115778|FG017|Overall Study|Death|0|||
163383911|NCT00585195|590115779|FG018|Overall Study|Death|0|||
163383912|NCT00585195|590115780|FG019|Overall Study|Death|0|||
163383913|NCT00585195|590115781|FG020|Overall Study|Death|1|||
163383914|NCT00585195|590115761|FG000|Overall Study|Lost to Follow-up|0|||
163383915|NCT00585195|590115762|FG001|Overall Study|Lost to Follow-up|0|||
163383916|NCT00585195|590115763|FG002|Overall Study|Lost to Follow-up|0|||
163383917|NCT00585195|590115764|FG003|Overall Study|Lost to Follow-up|0|||
163383918|NCT00585195|590115765|FG004|Overall Study|Lost to Follow-up|0|||
163383919|NCT00585195|590115766|FG005|Overall Study|Lost to Follow-up|0|||
163383920|NCT00585195|590115767|FG006|Overall Study|Lost to Follow-up|0|||
163383921|NCT00585195|590115768|FG007|Overall Study|Lost to Follow-up|0|||
163383922|NCT00585195|590115769|FG008|Overall Study|Lost to Follow-up|0|||
163383923|NCT00585195|590115770|FG009|Overall Study|Lost to Follow-up|0|||
163383924|NCT00585195|590115771|FG010|Overall Study|Lost to Follow-up|0|||
163383925|NCT00585195|590115772|FG011|Overall Study|Lost to Follow-up|0|||
163383926|NCT00585195|590115773|FG012|Overall Study|Lost to Follow-up|1|||
163383927|NCT00585195|590115774|FG013|Overall Study|Lost to Follow-up|0|||
163383928|NCT00585195|590115775|FG014|Overall Study|Lost to Follow-up|0|||
163383929|NCT00585195|590115776|FG015|Overall Study|Lost to Follow-up|0|||
163383930|NCT00585195|590115777|FG016|Overall Study|Lost to Follow-up|0|||
163383931|NCT00585195|590115778|FG017|Overall Study|Lost to Follow-up|2|||
163383932|NCT00585195|590115779|FG018|Overall Study|Lost to Follow-up|0|||
163383933|NCT00585195|590115780|FG019|Overall Study|Lost to Follow-up|0|||
163383934|NCT00585195|590115781|FG020|Overall Study|Lost to Follow-up|0|||
163383935|NCT00585195|590115761|FG000|Overall Study|Site Terminated by Sponsor|0|||
163383936|NCT00585195|590115762|FG001|Overall Study|Site Terminated by Sponsor|0|||
163383937|NCT00585195|590115763|FG002|Overall Study|Site Terminated by Sponsor|0|||
163383938|NCT00585195|590115764|FG003|Overall Study|Site Terminated by Sponsor|0|||
163383939|NCT00585195|590115765|FG004|Overall Study|Site Terminated by Sponsor|0|||
163383940|NCT00585195|590115766|FG005|Overall Study|Site Terminated by Sponsor|0|||
163383941|NCT00585195|590115767|FG006|Overall Study|Site Terminated by Sponsor|0|||
163418480|NCT02522767|590240054|FG000|Open-label|Protocol Violation|0|||
163418481|NCT02522767|590240055|FG001|Open-label|Protocol Violation|1|||
163418482|NCT00548548|590240056|FG000|Overall Study|Death|345|||
163418483|NCT00548548|590240057|FG001|Overall Study|Death|348|||
163418484|NCT00548548|590240056|FG000|Overall Study|Lost to Follow-up|17|||
163418485|NCT00548548|590240057|FG001|Overall Study|Lost to Follow-up|18|||
163418486|NCT01848145|590240058|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
163418487|NCT01848145|590240058|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
163418488|NCT01848145|590240058|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
163418489|NCT01848145|590240058|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
163418490|NCT01848145|590240058|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
163418491|NCT01848145|590240058|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
163418492|NCT01848145|590240058|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
163418493|NCT00364689|590240059|FG000|Overall Study|Lost to Follow-up|1|||
163418494|NCT03683394|590240062|FG000|Overall Study|Withdrawal by Subject|4|||
163418495|NCT03683394|590240063|FG001|Overall Study|Withdrawal by Subject|8|||
163418496|NCT03683394|590240062|FG000|Overall Study|Lost to Follow-up|7|||
163418497|NCT03683394|590240063|FG001|Overall Study|Lost to Follow-up|0|||
163418498|NCT03683394|590240062|FG000|Overall Study|Death|3|||
163418499|NCT03683394|590240063|FG001|Overall Study|Death|1|||
163418500|NCT02239263|590240064|FG000|Overall Study|Protocol Violation|6|||
163418501|NCT01109940|590240065|FG000|Overall Study|Administrative problems|2|||
163418502|NCT01109940|590240066|FG001|Overall Study|Administrative problems|0|||
163418503|NCT01109940|590240067|FG002|Overall Study|Administrative problems|0|||
163418504|NCT01109940|590240068|FG003|Overall Study|Administrative problems|0|||
163418505|NCT01109940|590240065|FG000|Overall Study|Serious Adverse Event|2|||
163418506|NCT01109940|590240066|FG001|Overall Study|Serious Adverse Event|1|||
163418507|NCT01109940|590240067|FG002|Overall Study|Serious Adverse Event|0|||
163418508|NCT01109940|590240068|FG003|Overall Study|Serious Adverse Event|0|||
163418509|NCT01109940|590240065|FG000|Overall Study|Lost to Follow-up|1|||
163418510|NCT01109940|590240066|FG001|Overall Study|Lost to Follow-up|0|||
163418511|NCT01109940|590240067|FG002|Overall Study|Lost to Follow-up|0|||
163418512|NCT01109940|590240068|FG003|Overall Study|Lost to Follow-up|0|||
163418513|NCT01109940|590240065|FG000|Overall Study|Patient withdrew consent|1|||
163418514|NCT01109940|590240066|FG001|Overall Study|Patient withdrew consent|1|||
163418515|NCT01109940|590240067|FG002|Overall Study|Patient withdrew consent|0|||
163418516|NCT01109940|590240068|FG003|Overall Study|Patient withdrew consent|0|||
163418517|NCT01109940|590240065|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163418518|NCT01109940|590240066|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163418519|NCT01109940|590240067|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
163418520|NCT01109940|590240068|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
163418521|NCT00354601|590240072|FG000|Overall Study|Protocol Violation|1|||
163418522|NCT00354601|590240072|FG000|Overall Study|progression|1|||
163418523|NCT02471716|590240073|FG000|Overall Study|Withdrawal by Subject|0|||
163418524|NCT02471716|590240074|FG001|Overall Study|Withdrawal by Subject|1|||
163418525|NCT02471716|590240075|FG002|Overall Study|Withdrawal by Subject|0|||
163418526|NCT02471716|590240076|FG003|Overall Study|Withdrawal by Subject|2|||
163418527|NCT02471716|590240077|FG004|Overall Study|Withdrawal by Subject|5|||
163418528|NCT02471716|590240073|FG000|Overall Study|Study Terminiated by sponsor|0|||
163418529|NCT02471716|590240074|FG001|Overall Study|Study Terminiated by sponsor|0|||
163418530|NCT02471716|590240075|FG002|Overall Study|Study Terminiated by sponsor|0|||
163418531|NCT02471716|590240076|FG003|Overall Study|Study Terminiated by sponsor|1|||
163418532|NCT02471716|590240077|FG004|Overall Study|Study Terminiated by sponsor|0|||
163418533|NCT02471716|590240073|FG000|Overall Study|Lost to Follow-up|0|||
163418534|NCT02471716|590240074|FG001|Overall Study|Lost to Follow-up|0|||
163418535|NCT02471716|590240075|FG002|Overall Study|Lost to Follow-up|0|||
163418536|NCT02471716|590240076|FG003|Overall Study|Lost to Follow-up|3|||
163418537|NCT02471716|590240077|FG004|Overall Study|Lost to Follow-up|2|||
163418538|NCT02471716|590240073|FG000|Overall Study|Death|0|||
163418539|NCT02471716|590240074|FG001|Overall Study|Death|0|||
163418540|NCT02471716|590240075|FG002|Overall Study|Death|0|||
163418541|NCT02471716|590240076|FG003|Overall Study|Death|1|||
163418542|NCT02471716|590240077|FG004|Overall Study|Death|0|||
163418543|NCT02471716|590240073|FG000|Overall Study|Other|0|||
163418544|NCT02471716|590240074|FG001|Overall Study|Other|0|||
163418545|NCT02471716|590240075|FG002|Overall Study|Other|0|||
163418546|NCT02471716|590240076|FG003|Overall Study|Other|8|||
163418547|NCT02471716|590240077|FG004|Overall Study|Other|9|||
163418548|NCT01838044|590240093|FG000|Overall Study|Adverse Event|4|||
163418549|NCT01838044|590240094|FG001|Overall Study|Adverse Event|6|||
163418550|NCT01838044|590240093|FG000|Overall Study|Protocol Violation|3|||
163418551|NCT01838044|590240094|FG001|Overall Study|Protocol Violation|3|||
163418552|NCT01838044|590240093|FG000|Overall Study|Withdrawal by Subject|0|||
163418553|NCT01838044|590240094|FG001|Overall Study|Withdrawal by Subject|2|||
163418554|NCT01838044|590240093|FG000|Overall Study|Insufficient clinical response|1|||
163418555|NCT01838044|590240094|FG001|Overall Study|Insufficient clinical response|2|||
163418556|NCT01838044|590240093|FG000|Overall Study|Medication error without associated AE|0|||
163418557|NCT01838044|590240094|FG001|Overall Study|Medication error without associated AE|1|||
163383942|NCT00585195|590115768|FG007|Overall Study|Site Terminated by Sponsor|0|||
163383943|NCT00585195|590115769|FG008|Overall Study|Site Terminated by Sponsor|0|||
163383944|NCT00585195|590115770|FG009|Overall Study|Site Terminated by Sponsor|0|||
163383945|NCT00585195|590115771|FG010|Overall Study|Site Terminated by Sponsor|0|||
163383946|NCT00585195|590115772|FG011|Overall Study|Site Terminated by Sponsor|0|||
163383947|NCT00585195|590115773|FG012|Overall Study|Site Terminated by Sponsor|1|||
163383948|NCT00585195|590115774|FG013|Overall Study|Site Terminated by Sponsor|0|||
163383949|NCT00585195|590115775|FG014|Overall Study|Site Terminated by Sponsor|0|||
163383950|NCT00585195|590115776|FG015|Overall Study|Site Terminated by Sponsor|0|||
163383951|NCT00585195|590115777|FG016|Overall Study|Site Terminated by Sponsor|0|||
163383952|NCT00585195|590115778|FG017|Overall Study|Site Terminated by Sponsor|0|||
163383953|NCT00585195|590115779|FG018|Overall Study|Site Terminated by Sponsor|0|||
163383954|NCT00585195|590115780|FG019|Overall Study|Site Terminated by Sponsor|0|||
163383955|NCT00585195|590115781|FG020|Overall Study|Site Terminated by Sponsor|0|||
163383956|NCT00585195|590115761|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
163383957|NCT00585195|590115762|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
163383958|NCT00585195|590115763|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
163383959|NCT00585195|590115764|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
163383960|NCT00585195|590115765|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
163383961|NCT00585195|590115766|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
163383962|NCT00585195|590115767|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
163383963|NCT00585195|590115768|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
163383964|NCT00585195|590115769|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
163383965|NCT00585195|590115770|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
163383966|NCT00585195|590115771|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
163383967|NCT00585195|590115772|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
163383968|NCT00585195|590115773|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
163383969|NCT00585195|590115774|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
163383970|NCT00585195|590115775|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
163383971|NCT00585195|590115776|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
163383972|NCT00585195|590115777|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
163383973|NCT00585195|590115778|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
163383974|NCT00585195|590115779|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
163383975|NCT00585195|590115780|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
163383976|NCT00585195|590115781|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
163383977|NCT00770341|590115782|FG000|Overall Study|Did not meet eligibility criteria|1|||
163383978|NCT00770341|590115783|FG001|Overall Study|Did not meet eligibility criteria|0|||
163383979|NCT00770341|590115784|FG002|Overall Study|Did not meet eligibility criteria|0|||
163383980|NCT00770341|590115782|FG000|Overall Study|Withdrawal by Subject|0|||
163383981|NCT00770341|590115783|FG001|Overall Study|Withdrawal by Subject|1|||
163383982|NCT00770341|590115784|FG002|Overall Study|Withdrawal by Subject|0|||
163383983|NCT00770341|590115782|FG000|Overall Study|Clinical Adverse Event|3|||
163383984|NCT00770341|590115783|FG001|Overall Study|Clinical Adverse Event|1|||
163383985|NCT00770341|590115784|FG002|Overall Study|Clinical Adverse Event|2|||
163383986|NCT00770341|590115782|FG000|Overall Study|Laboratory adverse event|3|||
163383987|NCT00770341|590115783|FG001|Overall Study|Laboratory adverse event|3|||
163383988|NCT00770341|590115784|FG002|Overall Study|Laboratory adverse event|0|||
163383989|NCT00770341|590115782|FG000|Overall Study|Lack of Efficacy|3|||
163383990|NCT00770341|590115783|FG001|Overall Study|Lack of Efficacy|0|||
163383991|NCT00770341|590115784|FG002|Overall Study|Lack of Efficacy|1|||
163383992|NCT00770341|590115782|FG000|Overall Study|Other|1|||
163383993|NCT00770341|590115783|FG001|Overall Study|Other|0|||
163383994|NCT00770341|590115784|FG002|Overall Study|Other|0|||
163383995|NCT00770341|590115782|FG000|Overall Study|Not treated|1|||
163383996|NCT00770341|590115783|FG001|Overall Study|Not treated|0|||
163383997|NCT00770341|590115784|FG002|Overall Study|Not treated|0|||
163383998|NCT02739360|590115785|FG000|Overall Study|Adverse Event|1|||
163383999|NCT02739360|590115785|FG000|Overall Study|Study terminated by Sponsor|2|||
163384000|NCT02533570|590115786|FG000|Overall Study|Adverse Event|0|||
163384001|NCT02533570|590115787|FG001|Overall Study|Adverse Event|1|||
163384002|NCT02533570|590115788|FG002|Overall Study|Adverse Event|1|||
163384003|NCT01163916|590115790|FG000|Overall Study|Withdrawal by Subject|2|||
163384004|NCT01163916|590115791|FG001|Overall Study|Withdrawal by Subject|0|||
163384005|NCT01163916|590115792|FG002|Overall Study|Withdrawal by Subject|2|||
163384006|NCT01163916|590115790|FG000|Overall Study|Adverse Event|2|||
163384007|NCT01163916|590115791|FG001|Overall Study|Adverse Event|0|||
163384008|NCT01163916|590115792|FG002|Overall Study|Adverse Event|1|||
163384009|NCT01163916|590115790|FG000|Overall Study|Lack of Efficacy|2|||
163384010|NCT01163916|590115791|FG001|Overall Study|Lack of Efficacy|0|||
163418558|NCT01838044|590240093|FG000|Overall Study|Lost to Follow-up|0|||
163418559|NCT01838044|590240094|FG001|Overall Study|Lost to Follow-up|2|||
163384011|NCT01163916|590115792|FG002|Overall Study|Lack of Efficacy|1|||
163384012|NCT01163916|590115790|FG000|Overall Study|Other|24|||
163384013|NCT01163916|590115791|FG001|Overall Study|Other|4|||
163384014|NCT01163916|590115792|FG002|Overall Study|Other|16|||
163384015|NCT00529958|590115793|FG000|2-Year Follow-up|Lost to Follow-up|1|||
163384016|NCT00529958|590115794|FG001|2-Year Follow-up|Lost to Follow-up|2|||
163384017|NCT00529958|590115795|FG002|2-Year Follow-up|Lost to Follow-up|2|||
163384018|NCT00529958|590115793|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
163384019|NCT00529958|590115794|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
163384020|NCT00529958|590115795|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
163384021|NCT00529958|590115793|FG000|5-Year Follow-up|Lost to Follow-up|2|||
163384022|NCT00529958|590115794|FG001|5-Year Follow-up|Lost to Follow-up|3|||
163384023|NCT00529958|590115795|FG002|5-Year Follow-up|Lost to Follow-up|1|||
163384024|NCT00529958|590115793|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
163384025|NCT00529958|590115794|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
163384026|NCT00529958|590115795|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
163384027|NCT02337751|590115796|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
163384028|NCT02337751|590115797|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
163384029|NCT02337751|590115796|FG000|Overall Study|Voluntary Withdrawal|6|||
163384030|NCT02337751|590115797|FG001|Overall Study|Voluntary Withdrawal|8|||
163384031|NCT02337751|590115796|FG000|Overall Study|Lack of Efficacy|2|||
163384032|NCT02337751|590115797|FG001|Overall Study|Lack of Efficacy|5|||
163384033|NCT02337751|590115796|FG000|Overall Study|Investigator's Judgement|1|||
163384034|NCT02337751|590115797|FG001|Overall Study|Investigator's Judgement|0|||
163384035|NCT01340651|590115798|FG000|Overall Study|Adverse Event|3|||
163384036|NCT01340651|590115798|FG000|Overall Study|Consent Withdrawn|2|||
163384037|NCT01340651|590115798|FG000|Overall Study|Commercial Supply per Sponsor|12|||
163384038|NCT01315353|590115799|FG000|Overall Study|Death|2|||
163384039|NCT01315353|590115800|FG001|Overall Study|Death|1|||
163384040|NCT01315353|590115801|FG002|Overall Study|Death|0|||
163384041|NCT01315353|590115799|FG000|Overall Study|Withdrawal by Subject|2|||
163384042|NCT01315353|590115800|FG001|Overall Study|Withdrawal by Subject|6|||
163384043|NCT01315353|590115801|FG002|Overall Study|Withdrawal by Subject|1|||
163384044|NCT01315353|590115799|FG000|Overall Study|Lost to Follow-up|13|||
163384045|NCT01315353|590115800|FG001|Overall Study|Lost to Follow-up|6|||
163384046|NCT01315353|590115801|FG002|Overall Study|Lost to Follow-up|6|||
163384047|NCT01315353|590115799|FG000|Overall Study|Unwilling to adhere to requirements|5|||
163384048|NCT01315353|590115800|FG001|Overall Study|Unwilling to adhere to requirements|5|||
163384049|NCT01315353|590115801|FG002|Overall Study|Unwilling to adhere to requirements|4|||
163384050|NCT01315353|590115799|FG000|Overall Study|Site closing|7|||
163384051|NCT01315353|590115800|FG001|Overall Study|Site closing|4|||
163384052|NCT01315353|590115801|FG002|Overall Study|Site closing|0|||
163384053|NCT01315353|590115799|FG000|Overall Study|Taken off study by site in error|0|||
163384054|NCT01315353|590115800|FG001|Overall Study|Taken off study by site in error|1|||
163384055|NCT01315353|590115801|FG002|Overall Study|Taken off study by site in error|0|||
163384056|NCT01315353|590115799|FG000|Overall Study|Inadvertent randomization/assignment|0|||
163384057|NCT01315353|590115800|FG001|Overall Study|Inadvertent randomization/assignment|0|||
163384058|NCT01315353|590115801|FG002|Overall Study|Inadvertent randomization/assignment|2|||
163384059|NCT01009580|590115802|FG000|Overall Study|Adverse Event|4|||
163384060|NCT01009580|590115803|FG001|Overall Study|Adverse Event|4|||
163384061|NCT01009580|590115802|FG000|Overall Study|Lack of Efficacy|0|||
163384062|NCT01009580|590115803|FG001|Overall Study|Lack of Efficacy|1|||
163384063|NCT01009580|590115802|FG000|Overall Study|Protocol Violation|2|||
163384064|NCT01009580|590115803|FG001|Overall Study|Protocol Violation|3|||
163384065|NCT01009580|590115802|FG000|Overall Study|Withdrawal Criteria|4|||
163384066|NCT01009580|590115803|FG001|Overall Study|Withdrawal Criteria|6|||
163384067|NCT01009580|590115802|FG000|Overall Study|Unclassified|17|||
163384068|NCT01009580|590115803|FG001|Overall Study|Unclassified|21|||
163384069|NCT05572021|590115806|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
163384070|NCT05572021|590115807|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
163384071|NCT03319849|590115808|FG000|Overall Study|Adverse Event|1|||
163384072|NCT03319849|590115809|FG001|Overall Study|Adverse Event|0|||
163384073|NCT03319849|590115808|FG000|Overall Study|Physician Decision|0|||
163384074|NCT03319849|590115809|FG001|Overall Study|Physician Decision|1|||
163384075|NCT03319849|590115808|FG000|Overall Study|Withdrawal by Subject|0|||
163384076|NCT03319849|590115809|FG001|Overall Study|Withdrawal by Subject|1|||
163384077|NCT03319849|590115808|FG000|Overall Study|COVID-19|0|||
163384078|NCT03319849|590115809|FG001|Overall Study|COVID-19|1|||
163384079|NCT03319849|590115808|FG000|Overall Study|Other|1|||
163384080|NCT03319849|590115809|FG001|Overall Study|Other|2|||
163384081|NCT03319849|590115808|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
163384082|NCT03319849|590115809|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
163384083|NCT03319849|590115808|FG000|Overall Study|Lost to Follow-up|0|||
163384084|NCT03319849|590115809|FG001|Overall Study|Lost to Follow-up|2|||
163384085|NCT00112047|590115814|FG000|Randomized Phase|Lost to Follow-up|26|||
163384086|NCT00112047|590115815|FG001|Randomized Phase|Lost to Follow-up|33|||
163384087|NCT00112047|590115814|FG000|Randomized Phase|Adverse Event|10|||
163384088|NCT00112047|590115815|FG001|Randomized Phase|Adverse Event|10|||
163384089|NCT00112047|590115814|FG000|Randomized Phase|Withrawal of consent|10|||
163384090|NCT00112047|590115815|FG001|Randomized Phase|Withrawal of consent|18|||
163384091|NCT00112047|590115814|FG000|Randomized Phase|Sub-optimal virological response|3|||
163384092|NCT00112047|590115815|FG001|Randomized Phase|Sub-optimal virological response|13|||
163384093|NCT00112047|590115814|FG000|Randomized Phase|Noncompliance|8|||
163384094|NCT00112047|590115815|FG001|Randomized Phase|Noncompliance|4|||
163384095|NCT00112047|590115814|FG000|Randomized Phase|Protocol Violation|2|||
163384096|NCT00112047|590115815|FG001|Randomized Phase|Protocol Violation|0|||
163384097|NCT00112047|590115814|FG000|Randomized Phase|Pregnancy|3|||
163384098|NCT00112047|590115815|FG001|Randomized Phase|Pregnancy|1|||
163384099|NCT00112047|590115814|FG000|Randomized Phase|Death|1|||
163384100|NCT00112047|590115815|FG001|Randomized Phase|Death|3|||
163384101|NCT00112047|590115814|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
163384102|NCT00112047|590115815|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
163384103|NCT00112047|590115814|FG000|Randomized Phase|Inability to swallow pills|0|||
163384104|NCT00112047|590115815|FG001|Randomized Phase|Inability to swallow pills|1|||
163384105|NCT00112047|590115814|FG000|Randomized Phase|Incarceration|3|||
163384106|NCT00112047|590115815|FG001|Randomized Phase|Incarceration|2|||
163384107|NCT00112047|590115814|FG000|Randomized Phase|Moved out of State|0|||
163384108|NCT00112047|590115815|FG001|Randomized Phase|Moved out of State|1|||
163384109|NCT00112047|590115814|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
163384110|NCT00112047|590115815|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
163384111|NCT00112047|590115814|FG000|Randomized Phase|High Hepatitis B DNA|0|||
163384112|NCT00112047|590115815|FG001|Randomized Phase|High Hepatitis B DNA|1|||
163384113|NCT00112047|590115814|FG000|Atripla Phase|Adverse Event|2|||
163384114|NCT00112047|590115815|FG001|Atripla Phase|Adverse Event|1|||
163384115|NCT00112047|590115814|FG000|Atripla Phase|Lost to Follow-up|5|||
163384116|NCT00112047|590115815|FG001|Atripla Phase|Lost to Follow-up|7|||
163384117|NCT00112047|590115814|FG000|Atripla Phase|Pregnancy|0|||
163384118|NCT00112047|590115815|FG001|Atripla Phase|Pregnancy|1|||
163384119|NCT00112047|590115814|FG000|Atripla Phase|Death|0|||
163384120|NCT00112047|590115815|FG001|Atripla Phase|Death|2|||
163384121|NCT00112047|590115814|FG000|Atripla Phase|Withdrew consent|7|||
163384122|NCT00112047|590115815|FG001|Atripla Phase|Withdrew consent|7|||
163384123|NCT00112047|590115814|FG000|Atripla Phase|Sub-optimal virological response|0|||
163384124|NCT00112047|590115815|FG001|Atripla Phase|Sub-optimal virological response|1|||
163384125|NCT00112047|590115814|FG000|Atripla Phase|Non-compliance|1|||
163384126|NCT00112047|590115815|FG001|Atripla Phase|Non-compliance|0|||
163384127|NCT00112047|590115814|FG000|Atripla Phase|Other|3|||
163384128|NCT00112047|590115815|FG001|Atripla Phase|Other|1|||
163384129|NCT04873232|590115819|FG000|Overall Study|Lost to Follow-up|1|||
163384130|NCT04873232|590115820|FG001|Overall Study|Lost to Follow-up|4|||
163384131|NCT04873232|590115819|FG000|Overall Study|Withdrawal by Subject|1|||
163384132|NCT04873232|590115820|FG001|Overall Study|Withdrawal by Subject|0|||
163384133|NCT05677893|590117312|FG000|Overall Study|Withdrawal by Subject|0|||
163384134|NCT05677893|590117313|FG001|Overall Study|Withdrawal by Subject|0|||
163384135|NCT05677893|590117314|FG002|Overall Study|Withdrawal by Subject|0|||
163384136|NCT05677893|590117315|FG003|Overall Study|Withdrawal by Subject|0|||
163384137|NCT05677893|590117316|FG004|Overall Study|Withdrawal by Subject|1|||
163384138|NCT05677893|590117317|FG005|Overall Study|Withdrawal by Subject|1|||
163384139|NCT05677893|590117318|FG006|Overall Study|Withdrawal by Subject|0|||
163384140|NCT05677893|590117312|FG000|Overall Study|Others|1|||
163384141|NCT05677893|590117313|FG001|Overall Study|Others|0|||
163384142|NCT05677893|590117314|FG002|Overall Study|Others|0|||
163384143|NCT05677893|590117315|FG003|Overall Study|Others|0|||
163384144|NCT05677893|590117316|FG004|Overall Study|Others|0|||
163384145|NCT05677893|590117317|FG005|Overall Study|Others|0|||
163384146|NCT05677893|590117318|FG006|Overall Study|Others|0|||
163384147|NCT03217266|590117319|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
163384148|NCT03217266|590117320|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
163384149|NCT03217266|590117321|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
163384150|NCT03217266|590117322|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
163384151|NCT03217266|590117319|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
163384152|NCT03217266|590117320|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
163384153|NCT03217266|590117321|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
163384154|NCT03217266|590117322|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
163384155|NCT03217266|590117319|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
163384156|NCT03217266|590117320|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
163384157|NCT03217266|590117321|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
163384158|NCT03217266|590117322|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
163384159|NCT01101477|590117324|FG000|Overall Study|Protocol Violation|5|||
163384160|NCT01101477|590117325|FG001|Overall Study|Protocol Violation|3|||
163384161|NCT01101477|590117326|FG002|Overall Study|Protocol Violation|1|||
163384162|NCT01222507|590117327|FG000|Overall Study|Physician Decision|1|||
163384163|NCT01222507|590117327|FG000|Overall Study|Withdrawal by Subject|1|||
163384164|NCT01786174|590117332|FG000|Overall Study|Discontinued Study Drug|2|||
163384165|NCT01786174|590117333|FG001|Overall Study|Discontinued Study Drug|0|||
163384166|NCT03442985|590117334|FG000|Overall Study|Sponsor Request|55|||
163384167|NCT03442985|590117335|FG001|Overall Study|Sponsor Request|60|||
163384168|NCT03442985|590117336|FG002|Overall Study|Sponsor Request|54|||
163384169|NCT03442985|590117334|FG000|Overall Study|Lost to Follow-up|5|||
163384170|NCT03442985|590117335|FG001|Overall Study|Lost to Follow-up|2|||
163384171|NCT03442985|590117336|FG002|Overall Study|Lost to Follow-up|7|||
163384172|NCT03442985|590117334|FG000|Overall Study|Withdrawal by Subject|2|||
163384173|NCT03442985|590117335|FG001|Overall Study|Withdrawal by Subject|3|||
163384174|NCT03442985|590117336|FG002|Overall Study|Withdrawal by Subject|4|||
163384175|NCT03442985|590117334|FG000|Overall Study|Adverse Event|0|||
163384176|NCT03442985|590117335|FG001|Overall Study|Adverse Event|1|||
163384177|NCT03442985|590117336|FG002|Overall Study|Adverse Event|0|||
163384178|NCT02598557|590117341|FG000|Overall Study|Withdrawal by Subject|1|||
163384179|NCT02598557|590117342|FG001|Overall Study|Withdrawal by Subject|0|||
163384180|NCT02598557|590117343|FG002|Overall Study|Withdrawal by Subject|1|||
163384181|NCT02598557|590117341|FG000|Overall Study|Participant did not start treatment|2|||
163384182|NCT02598557|590117342|FG001|Overall Study|Participant did not start treatment|1|||
163384183|NCT02598557|590117343|FG002|Overall Study|Participant did not start treatment|1|||
163384184|NCT02598557|590117341|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
163384185|NCT02598557|590117342|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
163384186|NCT02598557|590117343|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
163384187|NCT02598557|590117341|FG000|Overall Study|Adverse Event|1|||
163384188|NCT02598557|590117342|FG001|Overall Study|Adverse Event|1|||
163384189|NCT02598557|590117343|FG002|Overall Study|Adverse Event|0|||
163384190|NCT02864381|590117344|FG000|Overall Study|Death|58|||
163384191|NCT02864381|590117345|FG001|Overall Study|Death|61|||
163384192|NCT02864381|590117344|FG000|Overall Study|Withdrew Consent|5|||
163384193|NCT02864381|590117345|FG001|Overall Study|Withdrew Consent|6|||
163384194|NCT02864381|590117344|FG000|Overall Study|Reason Unknown|7|||
163384195|NCT02864381|590117345|FG001|Overall Study|Reason Unknown|3|||
163384196|NCT02864381|590117344|FG000|Overall Study|Lost to Follow-up|1|||
163384197|NCT02864381|590117345|FG001|Overall Study|Lost to Follow-up|1|||
163384198|NCT02864381|590117344|FG000|Overall Study|Investigator's Discretion|1|||
163384199|NCT02864381|590117345|FG001|Overall Study|Investigator's Discretion|0|||
163384200|NCT02864381|590117344|FG000|Overall Study|Protocol Violation|0|||
163384201|NCT02864381|590117345|FG001|Overall Study|Protocol Violation|1|||
163384202|NCT02986334|590117346|FG000|Overall Study|Withdrawal by Subject|0|||
163384203|NCT02986334|590117347|FG001|Overall Study|Withdrawal by Subject|1|||
163384204|NCT02986334|590117348|FG002|Overall Study|Withdrawal by Subject|2|||
163384205|NCT02986334|590117346|FG000|Overall Study|Lost to Follow-up|1|||
163384206|NCT02986334|590117347|FG001|Overall Study|Lost to Follow-up|2|||
163384207|NCT02986334|590117348|FG002|Overall Study|Lost to Follow-up|1|||
163384208|NCT02986334|590117346|FG000|Overall Study|Adverse Event|0|||
163384209|NCT02986334|590117347|FG001|Overall Study|Adverse Event|2|||
163384210|NCT02986334|590117348|FG002|Overall Study|Adverse Event|1|||
163384211|NCT02986334|590117346|FG000|Overall Study|non compliance in phone ratings|2|||
163384212|NCT02986334|590117347|FG001|Overall Study|non compliance in phone ratings|1|||
163384213|NCT02986334|590117348|FG002|Overall Study|non compliance in phone ratings|2|||
163384214|NCT02986334|590117346|FG000|Overall Study|undisclosed comorbidities|0|||
163384215|NCT02986334|590117347|FG001|Overall Study|undisclosed comorbidities|1|||
163384216|NCT02986334|590117348|FG002|Overall Study|undisclosed comorbidities|1|||
163384217|NCT04142450|590117349|FG000|Overall Study|Screen Failure|1|||
163384218|NCT04142450|590117349|FG000|Overall Study|Lost to Follow-up|1|||
163384219|NCT00120406|590117350|FG000|Overall Study|Death|9|||
163384220|NCT00120406|590117351|FG001|Overall Study|Death|4|||
163384221|NCT00120406|590117350|FG000|Overall Study|Withdrawal by Subject|5|||
163384222|NCT00120406|590117351|FG001|Overall Study|Withdrawal by Subject|7|||
163384223|NCT00120406|590117350|FG000|Overall Study|Lost to Follow-up|5|||
163384224|NCT00120406|590117351|FG001|Overall Study|Lost to Follow-up|2|||
163384225|NCT00120406|590117350|FG000|Overall Study|received non-study stent|0|||
163384226|NCT00120406|590117351|FG001|Overall Study|received non-study stent|2|||
163384227|NCT00120406|590117350|FG000|Overall Study|patient moved but has not withdrawn|0|||
163384228|NCT00120406|590117351|FG001|Overall Study|patient moved but has not withdrawn|1|||
163384229|NCT00667355|590117354|FG000|Overall Study|Adverse Event|5|||
163384230|NCT00667355|590117354|FG000|Overall Study|Lost to Follow-up|1|||
163384231|NCT00667355|590117354|FG000|Overall Study|Other reason was not specified|5|||
163384232|NCT01313637|590117355|FG000|Overall Study|Adverse Event|17|||
163384233|NCT01313637|590117356|FG001|Overall Study|Adverse Event|24|||
163384234|NCT01313637|590117357|FG002|Overall Study|Adverse Event|25|||
163384235|NCT01313637|590117358|FG003|Overall Study|Adverse Event|18|||
163384236|NCT01313637|590117355|FG000|Overall Study|Lack of Efficacy|44|||
163384237|NCT01313637|590117356|FG001|Overall Study|Lack of Efficacy|38|||
163384238|NCT01313637|590117357|FG002|Overall Study|Lack of Efficacy|37|||
163384239|NCT01313637|590117358|FG003|Overall Study|Lack of Efficacy|24|||
163384240|NCT01313637|590117355|FG000|Overall Study|Protocol Violation|4|||
163384241|NCT01313637|590117356|FG001|Overall Study|Protocol Violation|3|||
163384242|NCT01313637|590117357|FG002|Overall Study|Protocol Violation|11|||
163384243|NCT01313637|590117358|FG003|Overall Study|Protocol Violation|5|||
163384244|NCT01313637|590117355|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
163384245|NCT01313637|590117356|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
163384246|NCT01313637|590117357|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
163384247|NCT01313637|590117358|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
163384248|NCT01313637|590117355|FG000|Overall Study|Lost to Follow-up|0|||
163384249|NCT01313637|590117356|FG001|Overall Study|Lost to Follow-up|2|||
163384250|NCT01313637|590117357|FG002|Overall Study|Lost to Follow-up|1|||
163384251|NCT01313637|590117358|FG003|Overall Study|Lost to Follow-up|3|||
163384252|NCT01313637|590117355|FG000|Overall Study|Withdrawal by Subject|11|||
163384253|NCT01313637|590117356|FG001|Overall Study|Withdrawal by Subject|13|||
163384254|NCT01313637|590117357|FG002|Overall Study|Withdrawal by Subject|18|||
163384255|NCT01313637|590117358|FG003|Overall Study|Withdrawal by Subject|15|||
163384256|NCT00795951|590117359|FG000|Overall Study|Lost to Follow-up|1|||
163384257|NCT00795951|590117359|FG000|Overall Study|Withdrawal by Subject|1|||
163384258|NCT00655863|590117361|FG000|Overall Study|Lost to Follow-up|0|||
163384259|NCT00655863|590117362|FG001|Overall Study|Lost to Follow-up|0|||
163384260|NCT00655863|590117363|FG002|Overall Study|Lost to Follow-up|1|||
163384261|NCT01138007|590117364|FG000|Overall Study|Adverse Event|4|||
163384262|NCT01138007|590117365|FG001|Overall Study|Adverse Event|12|||
163384263|NCT01138007|590117366|FG002|Overall Study|Adverse Event|9|||
163384264|NCT01138007|590117364|FG000|Overall Study|Lack of Efficacy|2|||
163384265|NCT01138007|590117365|FG001|Overall Study|Lack of Efficacy|0|||
163384266|NCT01138007|590117366|FG002|Overall Study|Lack of Efficacy|6|||
163384267|NCT01138007|590117364|FG000|Overall Study|Protocol Violation|2|||
163384268|NCT01138007|590117365|FG001|Overall Study|Protocol Violation|3|||
163384269|NCT01138007|590117366|FG002|Overall Study|Protocol Violation|2|||
163384270|NCT01138007|590117364|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
163384271|NCT01138007|590117365|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
163384272|NCT01138007|590117366|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
163384273|NCT01138007|590117364|FG000|Overall Study|Lost to Follow-up|3|||
163384274|NCT01138007|590117365|FG001|Overall Study|Lost to Follow-up|3|||
163384275|NCT01138007|590117366|FG002|Overall Study|Lost to Follow-up|5|||
163384276|NCT01138007|590117364|FG000|Overall Study|Physician Decision|0|||
163384277|NCT01138007|590117365|FG001|Overall Study|Physician Decision|5|||
163384278|NCT01138007|590117366|FG002|Overall Study|Physician Decision|3|||
163384279|NCT01138007|590117364|FG000|Overall Study|Withdrawal by Subject|5|||
163384280|NCT01138007|590117365|FG001|Overall Study|Withdrawal by Subject|6|||
163384281|NCT01138007|590117366|FG002|Overall Study|Withdrawal by Subject|15|||
163384282|NCT01323647|590117371|FG000|Overall Study|Migrated/moved from study area|2|||
163384283|NCT01323647|590117372|FG001|Overall Study|Migrated/moved from study area|0|||
163384284|NCT01323647|590117371|FG000|Overall Study|Withdrawal by Subject|5|||
163384285|NCT01323647|590117372|FG001|Overall Study|Withdrawal by Subject|0|||
163384286|NCT01323647|590117371|FG000|Overall Study|Lost to Follow-up|2|||
163384287|NCT01323647|590117372|FG001|Overall Study|Lost to Follow-up|0|||
163384288|NCT00712673|590117373|FG000|Overall Study|Adverse Event|3|||
163384289|NCT00712673|590117374|FG001|Overall Study|Adverse Event|3|||
163384290|NCT00712673|590117375|FG002|Overall Study|Adverse Event|21|||
163384291|NCT00712673|590117376|FG003|Overall Study|Adverse Event|26|||
163384292|NCT00712673|590117373|FG000|Overall Study|Lack of Efficacy|2|||
163384293|NCT00712673|590117374|FG001|Overall Study|Lack of Efficacy|8|||
163384294|NCT00712673|590117375|FG002|Overall Study|Lack of Efficacy|8|||
163384295|NCT00712673|590117376|FG003|Overall Study|Lack of Efficacy|6|||
163384296|NCT00712673|590117373|FG000|Overall Study|Poor Compliance to Protocol|3|||
163384297|NCT00712673|590117374|FG001|Overall Study|Poor Compliance to Protocol|3|||
163384298|NCT00712673|590117375|FG002|Overall Study|Poor Compliance to Protocol|4|||
163384299|NCT00712673|590117376|FG003|Overall Study|Poor Compliance to Protocol|16|||
163384300|NCT00712673|590117373|FG000|Overall Study|Lost to Follow-up|1|||
163384301|NCT00712673|590117374|FG001|Overall Study|Lost to Follow-up|0|||
163384302|NCT00712673|590117375|FG002|Overall Study|Lost to Follow-up|2|||
163384303|NCT00712673|590117376|FG003|Overall Study|Lost to Follow-up|0|||
163384304|NCT00712673|590117373|FG000|Overall Study|Withdrawal by Subject|6|||
163384305|NCT00712673|590117374|FG001|Overall Study|Withdrawal by Subject|7|||
163384306|NCT00712673|590117375|FG002|Overall Study|Withdrawal by Subject|15|||
163384307|NCT00712673|590117376|FG003|Overall Study|Withdrawal by Subject|20|||
163384308|NCT00712673|590117373|FG000|Overall Study|Familial and Personal Reasons|5|||
163384309|NCT00712673|590117374|FG001|Overall Study|Familial and Personal Reasons|0|||
163384310|NCT00712673|590117375|FG002|Overall Study|Familial and Personal Reasons|5|||
163384311|NCT00712673|590117376|FG003|Overall Study|Familial and Personal Reasons|2|||
163384312|NCT00712673|590117373|FG000|Overall Study|Investigator's Decision|1|||
163384313|NCT00712673|590117374|FG001|Overall Study|Investigator's Decision|0|||
163384314|NCT00712673|590117375|FG002|Overall Study|Investigator's Decision|0|||
163384315|NCT00712673|590117376|FG003|Overall Study|Investigator's Decision|0|||
163384316|NCT00712673|590117373|FG000|Overall Study|Protocol Violation|0|||
163384317|NCT00712673|590117374|FG001|Overall Study|Protocol Violation|0|||
163384318|NCT00712673|590117375|FG002|Overall Study|Protocol Violation|2|||
163384319|NCT00712673|590117376|FG003|Overall Study|Protocol Violation|0|||
163384320|NCT02768870|590117377|FG000|Overall Study|Death|1|||
163384321|NCT02768870|590117377|FG000|Overall Study|Reoperation|6|||
163384322|NCT02768870|590117377|FG000|Overall Study|Lost to Follow-up|1|||
163384323|NCT02768870|590117377|FG000|Overall Study|Exit|4|||
163384324|NCT02963610|590117378|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
163384325|NCT02203695|590117379|FG000|Overall Study|Patient withdrew consent|1|||
163384326|NCT02203695|590117380|FG001|Overall Study|Patient withdrew consent|1|||
163384327|NCT02203695|590117379|FG000|Overall Study|Started non-study treatment|1|||
163384328|NCT02203695|590117380|FG001|Overall Study|Started non-study treatment|0|||
163384329|NCT00846391|590117381|FG000|Overall Study|Physician Decision|0|||
163384330|NCT00846391|590117382|FG001|Overall Study|Physician Decision|0|||
163384331|NCT00846391|590117383|FG002|Overall Study|Physician Decision|1|||
163384332|NCT00846391|590117381|FG000|Overall Study|Study Terminated by Sponsor|1|||
163384333|NCT00846391|590117382|FG001|Overall Study|Study Terminated by Sponsor|2|||
163384334|NCT00846391|590117383|FG002|Overall Study|Study Terminated by Sponsor|2|||
163384335|NCT01580969|590117386|FG000|Overall Study|Physician Decision|3|||
163384336|NCT01580969|590117387|FG001|Overall Study|Physician Decision|0|||
163384337|NCT01580969|590117388|FG002|Overall Study|Physician Decision|0|||
163384338|NCT02019927|590117391|FG000|Overall Study|Lost to Follow-up|2|||
163384339|NCT02019927|590117392|FG001|Overall Study|Lost to Follow-up|4|||
163384340|NCT02019927|590117393|FG002|Overall Study|Lost to Follow-up|1|||
163384341|NCT02019927|590117394|FG003|Overall Study|Lost to Follow-up|2|||
163384342|NCT02019927|590117395|FG004|Overall Study|Lost to Follow-up|3|||
163384343|NCT02019927|590117396|FG005|Overall Study|Lost to Follow-up|1|||
163384344|NCT03181451|590117397|FG000|Overall Study|Adverse Event|0|||
163384345|NCT03181451|590117398|FG001|Overall Study|Adverse Event|1|||
163384346|NCT03181451|590117399|FG002|Overall Study|Adverse Event|0|||
163384347|NCT03181451|590117397|FG000|Overall Study|Withdrawal by Subject|0|||
163384348|NCT03181451|590117398|FG001|Overall Study|Withdrawal by Subject|1|||
163384349|NCT03181451|590117399|FG002|Overall Study|Withdrawal by Subject|0|||
163384350|NCT01259284|590117406|FG000|Overall Study|Study Termination|2|||
163384351|NCT01259284|590117407|FG001|Overall Study|Study Termination|0|||
163384352|NCT01259284|590117408|FG002|Overall Study|Study Termination|0|||
163384353|NCT00069238|590117409|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
163384354|NCT00069238|590117410|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
163384355|NCT00069238|590117411|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
163384356|NCT00069238|590117409|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
163384357|NCT00069238|590117410|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
163384358|NCT00069238|590117411|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
163384359|NCT00069238|590117409|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
163384360|NCT00069238|590117410|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
163384361|NCT00069238|590117411|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
163384362|NCT01001832|590117412|FG000|Short-term Period|Adverse Event|2|||
163384363|NCT01001832|590117413|FG001|Short-term Period|Adverse Event|3|||
163384364|NCT01001832|590117412|FG000|Long-term Period|Adverse Event|2|||
163384365|NCT01001832|590117413|FG001|Long-term Period|Adverse Event|1|||
163384366|NCT01001832|590117412|FG000|Long-term Period|Withdrawal by Subject|1|||
163384367|NCT01001832|590117413|FG001|Long-term Period|Withdrawal by Subject|0|||
163384368|NCT01001832|590117412|FG000|Long-term Period|Lack of Efficacy|0|||
163384369|NCT01001832|590117413|FG001|Long-term Period|Lack of Efficacy|2|||
163384370|NCT01001832|590117412|FG000|Long-term Period|Other|1|||
163384371|NCT01001832|590117413|FG001|Long-term Period|Other|2|||
163384372|NCT01001832|590117412|FG000|Follow-up Period|Withdrawal by Subject|1|||
163384373|NCT01001832|590117413|FG001|Follow-up Period|Withdrawal by Subject|0|||
163384374|NCT01001832|590117412|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
163384375|NCT01001832|590117413|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
163384376|NCT01001832|590117412|FG000|Follow-up Period|Other|2|||
163384377|NCT01001832|590117413|FG001|Follow-up Period|Other|1|||
163384378|NCT00926211|590117420|FG000|Overall Study|Lost to Follow-up|1|||
163384379|NCT01012713|590117421|FG000|Overall Study|Lack of Efficacy|3|||
163384380|NCT01242800|590117422|FG000|Overall Study|Patient refusal|0|||
163384381|NCT01242800|590117423|FG001|Overall Study|Patient refusal|10|||
163384382|NCT01242800|590117422|FG000|Overall Study|Physician Decision|0|||
163384383|NCT01242800|590117423|FG001|Overall Study|Physician Decision|1|||
163384384|NCT01242800|590117422|FG000|Overall Study|Disease progression|0|||
163384385|NCT01242800|590117423|FG001|Overall Study|Disease progression|3|||
163384386|NCT01242800|590117422|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
163384387|NCT01242800|590117423|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
163384388|NCT01242800|590117422|FG000|Overall Study|Reasons not reported|0|||
163384389|NCT01242800|590117423|FG001|Overall Study|Reasons not reported|4|||
163384390|NCT00511901|590117427|FG000|Overall Study|Withdrawal by Subject|1|||
163384391|NCT00511901|590117428|FG001|Overall Study|Withdrawal by Subject|3|||
163384392|NCT02447172|590117429|FG000|Overall Study|Adverse Event|11|||
163384393|NCT02447172|590117430|FG001|Overall Study|Adverse Event|8|||
163384394|NCT02447172|590117431|FG002|Overall Study|Adverse Event|7|||
163384395|NCT02447172|590117429|FG000|Overall Study|Death|3|||
163384396|NCT02447172|590117430|FG001|Overall Study|Death|1|||
163384397|NCT02447172|590117431|FG002|Overall Study|Death|0|||
163384398|NCT02447172|590117429|FG000|Overall Study|Protocol Violation|2|||
163384399|NCT02447172|590117430|FG001|Overall Study|Protocol Violation|1|||
163384400|NCT02447172|590117431|FG002|Overall Study|Protocol Violation|2|||
163384401|NCT02447172|590117429|FG000|Overall Study|Lost to Follow-up|7|||
163384402|NCT02447172|590117430|FG001|Overall Study|Lost to Follow-up|4|||
163384403|NCT02447172|590117431|FG002|Overall Study|Lost to Follow-up|4|||
163384404|NCT02447172|590117429|FG000|Overall Study|Withdrawal by Subject|5|||
163384405|NCT02447172|590117430|FG001|Overall Study|Withdrawal by Subject|1|||
163384406|NCT02447172|590117431|FG002|Overall Study|Withdrawal by Subject|3|||
163384407|NCT02447172|590117429|FG000|Overall Study|protocol specific treatment unrelated|3|||
163384408|NCT02447172|590117430|FG001|Overall Study|protocol specific treatment unrelated|0|||
163384409|NCT02447172|590117431|FG002|Overall Study|protocol specific treatment unrelated|2|||
163384410|NCT00983931|590117435|FG000|14 Day Washout Period|Physician Decision|1|||
163384411|NCT02409368|590117440|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
163384412|NCT02409368|590117441|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
163384413|NCT02409368|590117442|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
163384414|NCT02409368|590117443|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
163384415|NCT02409368|590117440|FG000|ECOG Reclassification|Death|1|||
163384416|NCT02409368|590117441|FG001|ECOG Reclassification|Death|5|||
163384417|NCT02409368|590117442|FG002|ECOG Reclassification|Death|0|||
163384418|NCT02409368|590117443|FG003|ECOG Reclassification|Death|0|||
163384419|NCT02409368|590117440|FG000|ECOG Reclassification|Disease Progression|113|||
163384420|NCT02409368|590117441|FG001|ECOG Reclassification|Disease Progression|382|||
163384421|NCT02409368|590117442|FG002|ECOG Reclassification|Disease Progression|70|||
163384422|NCT02409368|590117443|FG003|ECOG Reclassification|Disease Progression|1|||
163384423|NCT02409368|590117440|FG000|ECOG Reclassification|Lost to Follow-up|1|||
163384424|NCT02409368|590117441|FG001|ECOG Reclassification|Lost to Follow-up|5|||
163384425|NCT02409368|590117442|FG002|ECOG Reclassification|Lost to Follow-up|0|||
163384426|NCT02409368|590117443|FG003|ECOG Reclassification|Lost to Follow-up|0|||
163384427|NCT02409368|590117440|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
163384428|NCT02409368|590117441|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
163384429|NCT02409368|590117442|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
163384430|NCT02409368|590117443|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
163384431|NCT02409368|590117440|FG000|ECOG Reclassification|Poor/non-compliance|0|||
163384432|NCT02409368|590117441|FG001|ECOG Reclassification|Poor/non-compliance|3|||
163384433|NCT02409368|590117442|FG002|ECOG Reclassification|Poor/non-compliance|2|||
163384434|NCT02409368|590117443|FG003|ECOG Reclassification|Poor/non-compliance|0|||
163384435|NCT02409368|590117440|FG000|ECOG Reclassification|Study drug toxicity|17|||
163384436|NCT02409368|590117441|FG001|ECOG Reclassification|Study drug toxicity|42|||
163384437|NCT02409368|590117442|FG002|ECOG Reclassification|Study drug toxicity|7|||
163384438|NCT02409368|590117443|FG003|ECOG Reclassification|Study drug toxicity|0|||
163384439|NCT02409368|590117440|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
163384440|NCT02409368|590117441|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
163384441|NCT02409368|590117442|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
163384442|NCT02409368|590117443|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
163384443|NCT02409368|590117440|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
163384444|NCT02409368|590117441|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
163384445|NCT02409368|590117442|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
163384446|NCT02409368|590117443|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
163384447|NCT02409368|590117440|FG000|ECOG Reclassification|Participant withdrew consent|2|||
163384448|NCT02409368|590117441|FG001|ECOG Reclassification|Participant withdrew consent|3|||
163384449|NCT02409368|590117442|FG002|ECOG Reclassification|Participant withdrew consent|4|||
163384450|NCT02409368|590117443|FG003|ECOG Reclassification|Participant withdrew consent|0|||
163384451|NCT02409368|590117440|FG000|ECOG Reclassification|Other Reasons|5|||
163384452|NCT02409368|590117441|FG001|ECOG Reclassification|Other Reasons|26|||
163384453|NCT02409368|590117442|FG002|ECOG Reclassification|Other Reasons|2|||
163384454|NCT02409368|590117443|FG003|ECOG Reclassification|Other Reasons|0|||
163384455|NCT02409368|590117440|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
163384456|NCT02409368|590117441|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
163384457|NCT02409368|590117442|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
163384458|NCT02409368|590117443|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
163384459|NCT01296347|590117444|FG000|Allocation|Withdrawal by Subject|1|||
163384460|NCT01296347|590117445|FG001|Allocation|Withdrawal by Subject|2|||
163384461|NCT01296347|590117444|FG000|Allocation|Lack of Efficacy|1|||
163384462|NCT01296347|590117445|FG001|Allocation|Lack of Efficacy|2|||
163384463|NCT01296347|590117444|FG000|Allocation|not received infusion|1|||
163384464|NCT01296347|590117445|FG001|Allocation|not received infusion|0|||
163384465|NCT01296347|590117444|FG000|6 Week Follow up|Death|0|||
163384466|NCT01296347|590117445|FG001|6 Week Follow up|Death|1|||
163384467|NCT01296347|590117444|FG000|3 Month Follow up|Death|1|||
163384468|NCT01296347|590117445|FG001|3 Month Follow up|Death|0|||
163384469|NCT01296347|590117444|FG000|3 Month Follow up|Lost to Follow-up|0|||
163384470|NCT01296347|590117445|FG001|3 Month Follow up|Lost to Follow-up|1|||
163384471|NCT01296347|590117444|FG000|6 Month Follow up|Death|2|||
163384472|NCT01296347|590117445|FG001|6 Month Follow up|Death|1|||
163384473|NCT01296347|590117444|FG000|6 Month Follow up|Lost to Follow-up|0|||
163384474|NCT01296347|590117445|FG001|6 Month Follow up|Lost to Follow-up|1|||
163384475|NCT01296347|590117444|FG000|12 Month Follow up|Lost to Follow-up|3|||
163384476|NCT01296347|590117445|FG001|12 Month Follow up|Lost to Follow-up|1|||
163384477|NCT01296347|590117444|FG000|12 Month Follow up|Death|1|||
163384478|NCT01296347|590117445|FG001|12 Month Follow up|Death|1|||
163384479|NCT01296347|590117444|FG000|12 Month Follow up|Withdrawal by Subject|0|||
163384480|NCT01296347|590117445|FG001|12 Month Follow up|Withdrawal by Subject|1|||
163384481|NCT03343301|590117446|FG000|Overall Study|Withdrawal by Subject|1|||
163384482|NCT03343301|590117447|FG001|Overall Study|Withdrawal by Subject|1|||
163384483|NCT03343301|590117446|FG000|Overall Study|Death|0|||
163384484|NCT03343301|590117447|FG001|Overall Study|Death|2|||
163384485|NCT03343301|590117446|FG000|Overall Study|Other|0|||
163384486|NCT03343301|590117447|FG001|Overall Study|Other|6|||
163384487|NCT03343301|590117446|FG000|Overall Study|Missing|2|||
163384488|NCT03343301|590117447|FG001|Overall Study|Missing|0|||
163384489|NCT02668185|590117450|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
163384490|NCT02668185|590117451|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
163384491|NCT02668185|590117450|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
163384492|NCT02668185|590117451|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
163384493|NCT02668185|590117450|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
163384494|NCT02668185|590117451|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
163384495|NCT02668185|590117450|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
163384496|NCT02668185|590117451|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
163384497|NCT01013597|590117452|FG000|Overall Study|Withdrawal by Subject|1|||
163384498|NCT02678247|590117453|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
163384499|NCT02678247|590117454|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
163384500|NCT02678247|590117453|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
163384501|NCT02678247|590117454|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
163384502|NCT02678247|590117453|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
163384503|NCT02678247|590117454|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
163384504|NCT02678247|590117453|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
163384505|NCT02678247|590117454|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
163384506|NCT02678247|590117453|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
163384507|NCT02678247|590117454|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
163384508|NCT02678247|590117453|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
163384509|NCT02678247|590117454|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
163384510|NCT01390181|590119150|FG000|Overall Study|Lost to Follow-up|1|||
163384511|NCT01390181|590119150|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
163384512|NCT00720941|590119155|FG000|Overall Study|Protocol Violation|1|||
163384513|NCT00720941|590119156|FG001|Overall Study|Protocol Violation|2|||
163384514|NCT00720941|590119155|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
163384515|NCT00720941|590119156|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
163384516|NCT00720941|590119155|FG000|Overall Study|Lost to Follow-up|20|||
163384517|NCT00720941|590119156|FG001|Overall Study|Lost to Follow-up|15|||
163384518|NCT00720941|590119155|FG000|Overall Study|Physician Decision|14|||
163384519|NCT00720941|590119156|FG001|Overall Study|Physician Decision|12|||
163384520|NCT00720941|590119155|FG000|Overall Study|Withdrawal by Subject|29|||
163384521|NCT00720941|590119156|FG001|Overall Study|Withdrawal by Subject|36|||
163384522|NCT03511053|590119157|FG000|Overall Study|Withdrawal by Subject|1|||
163384523|NCT03628898|590119159|FG000|Overall Study|Device deficiency|1|||
163384524|NCT00985166|590119160|FG000|Overall Study|Lost to Follow-up|3|||
163384525|NCT00985166|590119161|FG001|Overall Study|Lost to Follow-up|2|||
163384526|NCT00985166|590119162|FG002|Overall Study|Lost to Follow-up|2|||
163384527|NCT00985166|590119160|FG000|Overall Study|Withdrawal by Subject|3|||
163384528|NCT00985166|590119161|FG001|Overall Study|Withdrawal by Subject|2|||
163384529|NCT00985166|590119162|FG002|Overall Study|Withdrawal by Subject|0|||
163384530|NCT00985166|590119160|FG000|Overall Study|Test not done|2|||
163384531|NCT00985166|590119161|FG001|Overall Study|Test not done|0|||
163384532|NCT00985166|590119162|FG002|Overall Study|Test not done|4|||
163384533|NCT00985166|590119160|FG000|Overall Study|Other|1|||
163384534|NCT00985166|590119161|FG001|Overall Study|Other|0|||
163384535|NCT00985166|590119162|FG002|Overall Study|Other|1|||
163384536|NCT00300781|590119163|FG000|Overall Study|Disease Progression|55|||
163384537|NCT00300781|590119164|FG001|Overall Study|Disease Progression|52|||
163384538|NCT00300781|590119163|FG000|Overall Study|Adverse Event|5|||
163384539|NCT00300781|590119164|FG001|Overall Study|Adverse Event|6|||
163384540|NCT00300781|590119163|FG000|Overall Study|Withdrawal by Subject|1|||
163384541|NCT00300781|590119164|FG001|Overall Study|Withdrawal by Subject|2|||
163384542|NCT00300781|590119163|FG000|Overall Study|Physician Decision|1|||
163384543|NCT00300781|590119164|FG001|Overall Study|Physician Decision|0|||
163384544|NCT00300781|590119163|FG000|Overall Study|Not Recorded|0|||
163384545|NCT00300781|590119164|FG001|Overall Study|Not Recorded|1|||
163384546|NCT00300781|590119163|FG000|Overall Study|Symptomatic Deterioration|1|||
163384547|NCT00300781|590119164|FG001|Overall Study|Symptomatic Deterioration|0|||
163384548|NCT00300781|590119163|FG000|Overall Study|Lost to Follow-up|0|||
163384549|NCT00300781|590119164|FG001|Overall Study|Lost to Follow-up|1|||
163384550|NCT00567268|590119167|FG000|Overall Study|Protocol Violation|7|||
163384551|NCT00567268|590119167|FG000|Overall Study|Lost to Follow-up|36|||
163384552|NCT00567268|590119167|FG000|Overall Study|No Visit After First Day of Treatment|2|||
163384553|NCT00567268|590119167|FG000|Overall Study|No Drug Administration|4|||
163384554|NCT00567268|590119167|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
163384555|NCT00294554|590119168|FG000|Overall Study|Lack of Efficacy|0|||
163384556|NCT00294554|590119169|FG001|Overall Study|Lack of Efficacy|1|||
163384557|NCT00294554|590119168|FG000|Overall Study|Physician Decision|0|||
163384558|NCT00294554|590119169|FG001|Overall Study|Physician Decision|1|||
163384559|NCT03548987|590119172|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
163384560|NCT03548987|590119173|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
163384561|NCT03548987|590119172|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
163384562|NCT03548987|590119173|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
163384563|NCT03548987|590119172|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
163384564|NCT03548987|590119173|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
163384565|NCT03548987|590119172|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
163384566|NCT03548987|590119173|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
163384567|NCT03548987|590119172|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
163384568|NCT03548987|590119173|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
163384569|NCT03548987|590119172|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
163384570|NCT03548987|590119173|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
163384571|NCT03548987|590119172|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
163384572|NCT03548987|590119173|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
163384573|NCT03548987|590119172|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
163384574|NCT03548987|590119173|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
163384575|NCT03548987|590119172|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
163384576|NCT03548987|590119173|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
163384577|NCT03548987|590119172|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
163384578|NCT03548987|590119173|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
163384579|NCT03548987|590119172|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
163384580|NCT03548987|590119173|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
163384581|NCT03548987|590119172|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
163384582|NCT03548987|590119173|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
163384583|NCT03548987|590119172|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
163384584|NCT03548987|590119173|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
163384585|NCT03548987|590119172|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
163384586|NCT03548987|590119173|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
163384587|NCT04572841|590119174|FG000|Overall Study|Adverse Event|1|||
163384588|NCT04572841|590119175|FG001|Overall Study|Adverse Event|1|||
163384589|NCT04572841|590119174|FG000|Overall Study|Withdrawal by Subject|2|||
163384590|NCT04572841|590119175|FG001|Overall Study|Withdrawal by Subject|1|||
163384591|NCT04661878|590119176|FG000|Overall Study|Lost to Follow-up|6|||
163384592|NCT04661878|590119177|FG001|Overall Study|Lost to Follow-up|5|||
163384593|NCT03603028|590119178|FG000|Overall Study|Withdrawal by Subject|1|||
163384594|NCT00640016|590119181|FG000|Overall Study|Withdrawal by Subject|0|||
163384595|NCT00640016|590119182|FG001|Overall Study|Withdrawal by Subject|1|||
163384596|NCT00640016|590119183|FG002|Overall Study|Withdrawal by Subject|0|||
163384597|NCT00640016|590119184|FG003|Overall Study|Withdrawal by Subject|0|||
163384598|NCT00640016|590119181|FG000|Overall Study|Study termination|2|||
163384599|NCT00640016|590119182|FG001|Overall Study|Study termination|1|||
163384600|NCT00640016|590119183|FG002|Overall Study|Study termination|3|||
163384601|NCT00640016|590119184|FG003|Overall Study|Study termination|2|||
163384602|NCT00640016|590119181|FG000|Overall Study|Adverse Event|0|||
163384603|NCT00640016|590119182|FG001|Overall Study|Adverse Event|0|||
163384604|NCT00640016|590119183|FG002|Overall Study|Adverse Event|0|||
163384605|NCT00640016|590119184|FG003|Overall Study|Adverse Event|1|||
163384606|NCT01287065|590119185|FG000|Treatment Period 1|Adverse Event|0|||
163384607|NCT01287065|590119186|FG001|Treatment Period 1|Adverse Event|0|||
163384608|NCT01287065|590119187|FG002|Treatment Period 1|Adverse Event|0|||
163418560|NCT00330187|590240095|FG000|Overall Study|Lost to Follow-up|12|||
163384609|NCT01287065|590119188|FG003|Treatment Period 1|Adverse Event|0|||
163384610|NCT01287065|590119189|FG004|Treatment Period 1|Adverse Event|1|||
163384611|NCT01287065|590119190|FG005|Treatment Period 1|Adverse Event|0|||
163384612|NCT01287065|590119185|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163384613|NCT01287065|590119186|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163384614|NCT01287065|590119187|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163384615|NCT01287065|590119188|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163384616|NCT01287065|590119189|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163384617|NCT01287065|590119190|FG005|Treatment Period 1|Withdrawal by Subject|1|||
163384618|NCT01326533|590119196|FG000|Overall Study|Lost to Follow-up|2|||
163384619|NCT01326533|590119197|FG001|Overall Study|Lost to Follow-up|0|||
163384620|NCT01326533|590119196|FG000|Overall Study|Withdrawal by Subject|1|||
163384621|NCT01326533|590119197|FG001|Overall Study|Withdrawal by Subject|0|||
163384622|NCT01326533|590119196|FG000|Overall Study|Adverse Event|1|||
163384623|NCT01326533|590119197|FG001|Overall Study|Adverse Event|0|||
163384624|NCT03353350|590119198|FG000|30-week Core Treatment Period|Protocol Violation|1|||
163384625|NCT03353350|590119199|FG001|30-week Core Treatment Period|Protocol Violation|1|||
163384626|NCT03353350|590119200|FG002|30-week Core Treatment Period|Protocol Violation|1|||
163384627|NCT03353350|590119201|FG003|30-week Core Treatment Period|Protocol Violation|0|||
163384628|NCT03353350|590119198|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
163384629|NCT03353350|590119199|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
163384630|NCT03353350|590119200|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
163384631|NCT03353350|590119201|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
163384632|NCT03353350|590119198|FG000|30-week Core Treatment Period|Adverse Event|0|||
163384633|NCT03353350|590119199|FG001|30-week Core Treatment Period|Adverse Event|4|||
163384634|NCT03353350|590119200|FG002|30-week Core Treatment Period|Adverse Event|2|||
163384635|NCT03353350|590119201|FG003|30-week Core Treatment Period|Adverse Event|3|||
163384636|NCT03353350|590119198|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
163384637|NCT03353350|590119199|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
163384638|NCT03353350|590119200|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
163384639|NCT03353350|590119201|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
163384640|NCT03353350|590119198|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
163384641|NCT03353350|590119199|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
163384642|NCT03353350|590119200|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
163384643|NCT03353350|590119201|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
163384644|NCT03353350|590119198|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
163384645|NCT03353350|590119199|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
163384646|NCT03353350|590119200|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
163384647|NCT03353350|590119201|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
163384648|NCT03353350|590119198|FG000|26-week Treatment Extension Period|Adverse Event|1|||
163384649|NCT03353350|590119199|FG001|26-week Treatment Extension Period|Adverse Event|0|||
163384650|NCT03353350|590119200|FG002|26-week Treatment Extension Period|Adverse Event|0|||
163384651|NCT03353350|590119201|FG003|26-week Treatment Extension Period|Adverse Event|1|||
163384652|NCT03353350|590119198|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
163384653|NCT03353350|590119199|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
163384654|NCT03353350|590119200|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
163384655|NCT03353350|590119201|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
163384656|NCT01032382|590119202|FG000|Overall Study|Disease dissemination|1|||
163384657|NCT01032382|590119203|FG001|Overall Study|Disease dissemination|1|||
163384658|NCT01032382|590119202|FG000|Overall Study|Treatment failure|3|||
163384659|NCT01032382|590119203|FG001|Overall Study|Treatment failure|1|||
163384660|NCT01032382|590119202|FG000|Overall Study|Index lesion relapse|1|||
163384661|NCT01032382|590119203|FG001|Overall Study|Index lesion relapse|3|||
163384662|NCT00985153|590119204|FG000|Overall Study|Lost to Follow-up|16|||
163384663|NCT00985153|590119205|FG001|Overall Study|Lost to Follow-up|19|||
163384664|NCT00985153|590119206|FG002|Overall Study|Lost to Follow-up|17|||
163384665|NCT00985153|590119207|FG003|Overall Study|Lost to Follow-up|20|||
163384666|NCT00985153|590119204|FG000|Overall Study|Protocol Violation|3|||
163384667|NCT00985153|590119205|FG001|Overall Study|Protocol Violation|2|||
163384668|NCT00985153|590119206|FG002|Overall Study|Protocol Violation|4|||
163384669|NCT00985153|590119207|FG003|Overall Study|Protocol Violation|3|||
163384670|NCT00985153|590119204|FG000|Overall Study|Withdrawal by Subject|6|||
163384671|NCT00985153|590119205|FG001|Overall Study|Withdrawal by Subject|11|||
163384672|NCT00985153|590119206|FG002|Overall Study|Withdrawal by Subject|11|||
163384673|NCT00985153|590119207|FG003|Overall Study|Withdrawal by Subject|10|||
163384674|NCT00985153|590119204|FG000|Overall Study|Missed One or More Bleeds|7|||
163384675|NCT00985153|590119205|FG001|Overall Study|Missed One or More Bleeds|7|||
163384676|NCT00985153|590119206|FG002|Overall Study|Missed One or More Bleeds|8|||
163384677|NCT00985153|590119207|FG003|Overall Study|Missed One or More Bleeds|10|||
163384678|NCT00985153|590119204|FG000|Overall Study|Incomplete Safety Follow-up|3|||
163384679|NCT00985153|590119205|FG001|Overall Study|Incomplete Safety Follow-up|5|||
163384680|NCT00985153|590119206|FG002|Overall Study|Incomplete Safety Follow-up|4|||
163384681|NCT00985153|590119207|FG003|Overall Study|Incomplete Safety Follow-up|4|||
163384682|NCT01679405|590119209|FG000|Overall Study|Death|2|||
163384683|NCT01679405|590119210|FG001|Overall Study|Death|5|||
163384684|NCT04508023|590119211|FG000|Overall Study|Withdrawal by Subject|1|||
163384685|NCT04508023|590119212|FG001|Overall Study|Withdrawal by Subject|2|||
163384686|NCT01668667|590119221|FG000|Overall Study|Adverse Event|3|||
163384687|NCT01668667|590119222|FG001|Overall Study|Adverse Event|6|||
163384688|NCT01668667|590119223|FG002|Overall Study|Adverse Event|4|||
163384689|NCT01668667|590119224|FG003|Overall Study|Adverse Event|4|||
163384690|NCT01668667|590119221|FG000|Overall Study|Lack of Efficacy|3|||
163384691|NCT01668667|590119222|FG001|Overall Study|Lack of Efficacy|2|||
163384692|NCT01668667|590119223|FG002|Overall Study|Lack of Efficacy|2|||
163384693|NCT01668667|590119224|FG003|Overall Study|Lack of Efficacy|3|||
163384694|NCT01668667|590119221|FG000|Overall Study|Protocol Violation|6|||
163384695|NCT01668667|590119222|FG001|Overall Study|Protocol Violation|10|||
163384696|NCT01668667|590119223|FG002|Overall Study|Protocol Violation|12|||
163384697|NCT01668667|590119224|FG003|Overall Study|Protocol Violation|5|||
163384698|NCT01668667|590119221|FG000|Overall Study|Lost to Follow-up|9|||
163384699|NCT01668667|590119222|FG001|Overall Study|Lost to Follow-up|4|||
163384700|NCT01668667|590119223|FG002|Overall Study|Lost to Follow-up|7|||
163384701|NCT01668667|590119224|FG003|Overall Study|Lost to Follow-up|6|||
163384702|NCT01668667|590119221|FG000|Overall Study|Physician Decision|3|||
163384703|NCT01668667|590119222|FG001|Overall Study|Physician Decision|0|||
163384704|NCT01668667|590119223|FG002|Overall Study|Physician Decision|1|||
163384705|NCT01668667|590119224|FG003|Overall Study|Physician Decision|0|||
163384706|NCT01668667|590119221|FG000|Overall Study|Withdrawal by Subject|7|||
163384707|NCT01668667|590119222|FG001|Overall Study|Withdrawal by Subject|4|||
163384708|NCT01668667|590119223|FG002|Overall Study|Withdrawal by Subject|5|||
163384709|NCT01668667|590119224|FG003|Overall Study|Withdrawal by Subject|5|||
163384710|NCT02988622|590119225|FG000|Overall Study|Lost to Follow-up|17|||
163384711|NCT03562247|590119226|FG000|Overall Study|Lost to Follow-up|3|||
163384712|NCT03562247|590119227|FG001|Overall Study|Lost to Follow-up|1|||
163384713|NCT03562247|590119228|FG002|Overall Study|Lost to Follow-up|1|||
163384714|NCT01281969|590119231|FG000|Overall Study|not randomized didn't meet criteria|0|||
163384715|NCT01281969|590119232|FG001|Overall Study|not randomized didn't meet criteria|0|||
163384716|NCT01281969|590119233|FG002|Overall Study|not randomized didn't meet criteria|7|||
163384717|NCT01281969|590119231|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
163384718|NCT01281969|590119232|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
163384719|NCT01281969|590119233|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
163384720|NCT01281969|590119231|FG000|Overall Study|not randomized, child consent not given|0|||
163384721|NCT01281969|590119232|FG001|Overall Study|not randomized, child consent not given|0|||
163384722|NCT01281969|590119233|FG002|Overall Study|not randomized, child consent not given|2|||
163384723|NCT04640077|590119234|FG000|Period 1|Withdrawal by Subject|4|||
163384724|NCT04640077|590119235|FG001|Period 1|Withdrawal by Subject|5|||
163384725|NCT04640077|590119236|FG002|Period 1|Withdrawal by Subject|0|||
163384726|NCT04640077|590119234|FG000|Period 1|Adverse Event|1|||
163384727|NCT04640077|590119235|FG001|Period 1|Adverse Event|1|||
163384728|NCT04640077|590119236|FG002|Period 1|Adverse Event|0|||
163384729|NCT04640077|590119234|FG000|Period 1|Screen Failure|2|||
163384730|NCT04640077|590119235|FG001|Period 1|Screen Failure|0|||
163384731|NCT04640077|590119236|FG002|Period 1|Screen Failure|0|||
163384732|NCT04640077|590119234|FG000|Period 2|Withdrawal by Subject|0|||
163384733|NCT04640077|590119235|FG001|Period 2|Withdrawal by Subject|0|||
163384734|NCT04640077|590119236|FG002|Period 2|Withdrawal by Subject|18|||
163384735|NCT04640077|590119234|FG000|Period 2|Adverse Event|0|||
163384736|NCT04640077|590119235|FG001|Period 2|Adverse Event|0|||
163384737|NCT04640077|590119236|FG002|Period 2|Adverse Event|6|||
163384738|NCT04640077|590119234|FG000|Period 2|Lost to Follow-up|0|||
163384739|NCT04640077|590119235|FG001|Period 2|Lost to Follow-up|0|||
163384740|NCT04640077|590119236|FG002|Period 2|Lost to Follow-up|2|||
163384741|NCT04640077|590119234|FG000|Period 2|Death|0|||
163384742|NCT04640077|590119235|FG001|Period 2|Death|0|||
163384743|NCT04640077|590119236|FG002|Period 2|Death|2|||
163384744|NCT04640077|590119234|FG000|Period 2|Progressive Disease|0|||
163384745|NCT04640077|590119235|FG001|Period 2|Progressive Disease|0|||
163384746|NCT04640077|590119236|FG002|Period 2|Progressive Disease|1|||
163384747|NCT04640077|590119234|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
163384748|NCT04640077|590119235|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
163384749|NCT04640077|590119236|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
163384750|NCT02240693|590119237|FG000|Overall Study|Adverse Event|0|||
163384751|NCT02240693|590119238|FG001|Overall Study|Adverse Event|0|||
163384752|NCT02240693|590119239|FG002|Overall Study|Adverse Event|0|||
163384753|NCT02240693|590119240|FG003|Overall Study|Adverse Event|0|||
163384754|NCT02240693|590119241|FG004|Overall Study|Adverse Event|1|||
163384755|NCT02240693|590119237|FG000|Overall Study|Withdrawal by Subject|0|||
163384756|NCT02240693|590119238|FG001|Overall Study|Withdrawal by Subject|0|||
163384757|NCT02240693|590119239|FG002|Overall Study|Withdrawal by Subject|2|||
163384758|NCT02240693|590119240|FG003|Overall Study|Withdrawal by Subject|1|||
163384759|NCT02240693|590119241|FG004|Overall Study|Withdrawal by Subject|0|||
163384760|NCT02240693|590119237|FG000|Overall Study|Other than specified|0|||
163384761|NCT02240693|590119238|FG001|Overall Study|Other than specified|0|||
163384762|NCT02240693|590119239|FG002|Overall Study|Other than specified|2|||
163384763|NCT02240693|590119240|FG003|Overall Study|Other than specified|0|||
163384764|NCT02240693|590119241|FG004|Overall Study|Other than specified|0|||
163384765|NCT02041520|590119242|FG000|Overall Study|Adverse Event|2|||
163384766|NCT02041520|590119243|FG001|Overall Study|Adverse Event|1|||
163384767|NCT02041520|590119242|FG000|Overall Study|Withdrawal by Subject|3|||
163418561|NCT00330187|590240096|FG001|Overall Study|Lost to Follow-up|13|||
163418562|NCT00330187|590240097|FG002|Overall Study|Lost to Follow-up|14|||
163418563|NCT00330187|590240098|FG003|Overall Study|Lost to Follow-up|10|||
163418564|NCT00330187|590240095|FG000|Overall Study|Withdrawal by Subject|8|||
163418565|NCT00330187|590240096|FG001|Overall Study|Withdrawal by Subject|5|||
163418566|NCT00330187|590240097|FG002|Overall Study|Withdrawal by Subject|4|||
163418567|NCT00330187|590240098|FG003|Overall Study|Withdrawal by Subject|4|||
163418568|NCT01162421|590240106|FG000|Overall Study|Did not receive study drug|2|||
163418569|NCT01162421|590240107|FG001|Overall Study|Did not receive study drug|1|||
163418570|NCT01162421|590240106|FG000|Overall Study|Adverse Event|2|||
163418571|NCT01162421|590240107|FG001|Overall Study|Adverse Event|5|||
163418572|NCT01162421|590240106|FG000|Overall Study|Lost to Follow-up|0|||
163418573|NCT01162421|590240107|FG001|Overall Study|Lost to Follow-up|2|||
163418574|NCT01162421|590240106|FG000|Overall Study|Lack of Efficacy|2|||
163418575|NCT01162421|590240107|FG001|Overall Study|Lack of Efficacy|2|||
163418576|NCT01162421|590240106|FG000|Overall Study|Other|2|||
163418577|NCT01162421|590240107|FG001|Overall Study|Other|3|||
163418578|NCT01133171|590240113|FG000|Overall Study|Withdrawal by Subject|1|||
163418579|NCT01133171|590240114|FG001|Overall Study|Withdrawal by Subject|2|||
163418580|NCT01133171|590240115|FG002|Overall Study|Withdrawal by Subject|0|||
163418581|NCT02526550|590240116|FG000|Overall Study|Lost to Follow-up|1|||
163418582|NCT00091832|590240118|FG000|Overall Study|Physician Decision|1|||
163418583|NCT00091832|590240119|FG001|Overall Study|Physician Decision|0|||
163418584|NCT00091832|590240120|FG002|Overall Study|Physician Decision|0|||
163418585|NCT00091832|590240121|FG003|Overall Study|Physician Decision|0|||
163418586|NCT00091832|590240122|FG004|Overall Study|Physician Decision|0|||
163418587|NCT00091832|590240123|FG005|Overall Study|Physician Decision|0|||
163418588|NCT00091832|590240118|FG000|Overall Study|Adverse Event|0|||
163418589|NCT00091832|590240119|FG001|Overall Study|Adverse Event|0|||
163418590|NCT00091832|590240120|FG002|Overall Study|Adverse Event|0|||
163418591|NCT00091832|590240121|FG003|Overall Study|Adverse Event|1|||
163418592|NCT00091832|590240122|FG004|Overall Study|Adverse Event|3|||
163418593|NCT00091832|590240123|FG005|Overall Study|Adverse Event|0|||
163418594|NCT00091832|590240118|FG000|Overall Study|Withdrawal by Subject|4|||
163418595|NCT00091832|590240119|FG001|Overall Study|Withdrawal by Subject|5|||
163418596|NCT00091832|590240120|FG002|Overall Study|Withdrawal by Subject|0|||
163418597|NCT00091832|590240121|FG003|Overall Study|Withdrawal by Subject|1|||
163418598|NCT00091832|590240122|FG004|Overall Study|Withdrawal by Subject|3|||
163418599|NCT00091832|590240123|FG005|Overall Study|Withdrawal by Subject|1|||
163418600|NCT00091832|590240118|FG000|Overall Study|Death|6|||
163418601|NCT00091832|590240119|FG001|Overall Study|Death|4|||
163418602|NCT00091832|590240120|FG002|Overall Study|Death|5|||
163418603|NCT00091832|590240121|FG003|Overall Study|Death|8|||
163418604|NCT00091832|590240122|FG004|Overall Study|Death|5|||
163418605|NCT00091832|590240123|FG005|Overall Study|Death|6|||
163418606|NCT00091832|590240118|FG000|Overall Study|Disease Progression|2|||
163418607|NCT00091832|590240119|FG001|Overall Study|Disease Progression|0|||
163418608|NCT00091832|590240120|FG002|Overall Study|Disease Progression|0|||
163418609|NCT00091832|590240121|FG003|Overall Study|Disease Progression|1|||
163418610|NCT00091832|590240122|FG004|Overall Study|Disease Progression|1|||
163418611|NCT00091832|590240123|FG005|Overall Study|Disease Progression|2|||
163418612|NCT00091832|590240118|FG000|Overall Study|Ineligibility Determined|0|||
163418613|NCT00091832|590240119|FG001|Overall Study|Ineligibility Determined|0|||
163418614|NCT00091832|590240120|FG002|Overall Study|Ineligibility Determined|1|||
163418615|NCT00091832|590240121|FG003|Overall Study|Ineligibility Determined|0|||
163418616|NCT00091832|590240122|FG004|Overall Study|Ineligibility Determined|1|||
163418617|NCT00091832|590240123|FG005|Overall Study|Ineligibility Determined|0|||
163418618|NCT00091832|590240118|FG000|Overall Study|Lost to Follow-up|1|||
163418619|NCT00091832|590240119|FG001|Overall Study|Lost to Follow-up|0|||
163418620|NCT00091832|590240120|FG002|Overall Study|Lost to Follow-up|3|||
163418621|NCT00091832|590240121|FG003|Overall Study|Lost to Follow-up|3|||
163418622|NCT00091832|590240122|FG004|Overall Study|Lost to Follow-up|2|||
163418623|NCT00091832|590240123|FG005|Overall Study|Lost to Follow-up|1|||
163418624|NCT00091832|590240118|FG000|Overall Study|Noncompliance|0|||
163418625|NCT00091832|590240119|FG001|Overall Study|Noncompliance|1|||
163418626|NCT00091832|590240120|FG002|Overall Study|Noncompliance|0|||
163418627|NCT00091832|590240121|FG003|Overall Study|Noncompliance|0|||
163418628|NCT00091832|590240122|FG004|Overall Study|Noncompliance|0|||
163418629|NCT00091832|590240123|FG005|Overall Study|Noncompliance|0|||
163418630|NCT00091832|590240118|FG000|Overall Study|Other|0|||
163418631|NCT00091832|590240119|FG001|Overall Study|Other|1|||
163418632|NCT00091832|590240120|FG002|Overall Study|Other|2|||
163418633|NCT00091832|590240121|FG003|Overall Study|Other|0|||
163418634|NCT00091832|590240122|FG004|Overall Study|Other|0|||
163418635|NCT00091832|590240123|FG005|Overall Study|Other|0|||
163418636|NCT00091832|590240118|FG000|Overall Study|Protocol Violation|0|||
163418637|NCT00091832|590240119|FG001|Overall Study|Protocol Violation|0|||
163418638|NCT00091832|590240120|FG002|Overall Study|Protocol Violation|1|||
163418639|NCT00091832|590240121|FG003|Overall Study|Protocol Violation|0|||
163418640|NCT00091832|590240122|FG004|Overall Study|Protocol Violation|0|||
163418641|NCT00091832|590240123|FG005|Overall Study|Protocol Violation|1|||
163418642|NCT03434379|590240126|FG000|Global Period|Lost to Follow-up|3|||
163418643|NCT03434379|590240127|FG001|Global Period|Lost to Follow-up|6|||
163418644|NCT03434379|590240128|FG002|Global Period|Lost to Follow-up|0|||
163418645|NCT03434379|590240129|FG003|Global Period|Lost to Follow-up|0|||
163418646|NCT03434379|590240126|FG000|Global Period|Death|115|||
163418647|NCT03434379|590240127|FG001|Global Period|Death|228|||
163418648|NCT03434379|590240128|FG002|Global Period|Death|0|||
163418649|NCT03434379|590240129|FG003|Global Period|Death|0|||
163418650|NCT03434379|590240126|FG000|Global Period|Withdrawal by Subject|20|||
163418651|NCT03434379|590240127|FG001|Global Period|Withdrawal by Subject|21|||
163418652|NCT03434379|590240128|FG002|Global Period|Withdrawal by Subject|0|||
163418653|NCT03434379|590240129|FG003|Global Period|Withdrawal by Subject|0|||
163418654|NCT03434379|590240126|FG000|Global Period|Reason Unspecified|0|||
163418655|NCT03434379|590240127|FG001|Global Period|Reason Unspecified|1|||
163418656|NCT03434379|590240128|FG002|Global Period|Reason Unspecified|0|||
163418657|NCT03434379|590240129|FG003|Global Period|Reason Unspecified|0|||
163418658|NCT03434379|590240126|FG000|Global Period|Study Ended by Sponsor|26|||
163418659|NCT03434379|590240127|FG001|Global Period|Study Ended by Sponsor|80|||
163418660|NCT03434379|590240128|FG002|Global Period|Study Ended by Sponsor|0|||
163418661|NCT03434379|590240129|FG003|Global Period|Study Ended by Sponsor|0|||
163418662|NCT03434379|590240126|FG000|Global Period|Physician Decision|1|||
163418663|NCT03434379|590240127|FG001|Global Period|Physician Decision|0|||
163418664|NCT03434379|590240128|FG002|Global Period|Physician Decision|0|||
163418665|NCT03434379|590240129|FG003|Global Period|Physician Decision|0|||
163418666|NCT03434379|590240126|FG000|China Extension Period|Lost to Follow-up|0|||
163418667|NCT03434379|590240127|FG001|China Extension Period|Lost to Follow-up|0|||
163418668|NCT03434379|590240128|FG002|China Extension Period|Lost to Follow-up|2|||
163418669|NCT03434379|590240129|FG003|China Extension Period|Lost to Follow-up|3|||
163418670|NCT03434379|590240126|FG000|China Extension Period|Death|0|||
163418671|NCT03434379|590240127|FG001|China Extension Period|Death|0|||
163418672|NCT03434379|590240128|FG002|China Extension Period|Death|46|||
163418673|NCT03434379|590240129|FG003|China Extension Period|Death|88|||
163418674|NCT03434379|590240126|FG000|China Extension Period|Withdrawal by Subject|0|||
163418675|NCT03434379|590240127|FG001|China Extension Period|Withdrawal by Subject|0|||
163418676|NCT03434379|590240128|FG002|China Extension Period|Withdrawal by Subject|8|||
163418677|NCT03434379|590240129|FG003|China Extension Period|Withdrawal by Subject|6|||
163418678|NCT03434379|590240126|FG000|China Extension Period|Study Ended by Sponsor|0|||
163418679|NCT03434379|590240127|FG001|China Extension Period|Study Ended by Sponsor|0|||
163418680|NCT03434379|590240128|FG002|China Extension Period|Study Ended by Sponsor|5|||
163418681|NCT03434379|590240129|FG003|China Extension Period|Study Ended by Sponsor|36|||
163418682|NCT00686647|590240133|FG000|Overall Study|Lost to Follow-up|1|||
163418683|NCT00686647|590240133|FG000|Overall Study|Death|1|||
163418684|NCT00578643|590240134|FG000|Overall Study|Death|1|||
163418685|NCT00578643|590240134|FG000|Overall Study|Lost to Follow-up|1|||
163418686|NCT01725750|590240135|FG000|Overall Study|Adverse Event|1|||
163418687|NCT01725750|590240136|FG001|Overall Study|Adverse Event|0|||
163418688|NCT01725750|590240135|FG000|Overall Study|Lost to Follow-up|1|||
163418689|NCT01725750|590240136|FG001|Overall Study|Lost to Follow-up|1|||
163418690|NCT01725750|590240135|FG000|Overall Study|Withdrawal by Subject|0|||
163418691|NCT01725750|590240136|FG001|Overall Study|Withdrawal by Subject|9|||
163418692|NCT03179436|590240138|FG000|Overall Study|Withdrawal by Subject|1|||
163418693|NCT03179436|590240139|FG001|Overall Study|Withdrawal by Subject|0|||
163418694|NCT03179436|590240140|FG002|Overall Study|Withdrawal by Subject|0|||
163418695|NCT03179436|590240141|FG003|Overall Study|Withdrawal by Subject|4|||
163418696|NCT03179436|590240142|FG004|Overall Study|Withdrawal by Subject|2|||
163418697|NCT03179436|590240143|FG005|Overall Study|Withdrawal by Subject|2|||
163418698|NCT03179436|590240144|FG006|Overall Study|Withdrawal by Subject|5|||
163418699|NCT03179436|590240145|FG007|Overall Study|Withdrawal by Subject|0|||
163418700|NCT03179436|590240146|FG008|Overall Study|Withdrawal by Subject|3|||
163418701|NCT03179436|590240147|FG009|Overall Study|Withdrawal by Subject|0|||
163418702|NCT03179436|590240148|FG010|Overall Study|Withdrawal by Subject|0|||
163418703|NCT03179436|590240149|FG011|Overall Study|Withdrawal by Subject|0|||
163418704|NCT03179436|590240138|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163418705|NCT03179436|590240139|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163418706|NCT03179436|590240140|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163418707|NCT03179436|590240141|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163418708|NCT03179436|590240142|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
163418709|NCT03179436|590240143|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
163418710|NCT03179436|590240144|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
163418711|NCT03179436|590240145|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
163418712|NCT03179436|590240146|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
163418713|NCT03179436|590240147|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
163418714|NCT03179436|590240148|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
163418715|NCT03179436|590240149|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
163418716|NCT03179436|590240138|FG000|Overall Study|Sponsor Decision|0|||
163418717|NCT03179436|590240139|FG001|Overall Study|Sponsor Decision|0|||
163384768|NCT02041520|590119243|FG001|Overall Study|Withdrawal by Subject|4|||
163384769|NCT02041520|590119242|FG000|Overall Study|Protocol Violation|1|||
163384770|NCT02041520|590119243|FG001|Overall Study|Protocol Violation|0|||
163384771|NCT02041520|590119242|FG000|Overall Study|Lost to Follow-up|0|||
163384772|NCT02041520|590119243|FG001|Overall Study|Lost to Follow-up|1|||
163384773|NCT02041520|590119242|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
163384774|NCT02041520|590119243|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
163384775|NCT00413972|590119244|FG000|Overall Study|Adverse Event|2|||
163384776|NCT00413972|590119245|FG001|Overall Study|Adverse Event|1|||
163384777|NCT00413972|590119246|FG002|Overall Study|Adverse Event|0|||
163384778|NCT00413972|590119247|FG003|Overall Study|Adverse Event|0|||
163384779|NCT00413972|590119244|FG000|Overall Study|Lost to Follow-up|1|||
163384780|NCT00413972|590119245|FG001|Overall Study|Lost to Follow-up|2|||
163384781|NCT00413972|590119246|FG002|Overall Study|Lost to Follow-up|1|||
163384782|NCT00413972|590119247|FG003|Overall Study|Lost to Follow-up|0|||
163384783|NCT00413972|590119244|FG000|Overall Study|Withdrawal by Subject|4|||
163384784|NCT00413972|590119245|FG001|Overall Study|Withdrawal by Subject|5|||
163384785|NCT00413972|590119246|FG002|Overall Study|Withdrawal by Subject|7|||
163384786|NCT00413972|590119247|FG003|Overall Study|Withdrawal by Subject|2|||
163384787|NCT00413972|590119244|FG000|Overall Study|Protocol Violation|0|||
163384788|NCT00413972|590119245|FG001|Overall Study|Protocol Violation|0|||
163384789|NCT00413972|590119246|FG002|Overall Study|Protocol Violation|2|||
163384790|NCT00413972|590119247|FG003|Overall Study|Protocol Violation|0|||
163384791|NCT00413972|590119244|FG000|Overall Study|Other|0|||
163384792|NCT00413972|590119245|FG001|Overall Study|Other|0|||
163384793|NCT00413972|590119246|FG002|Overall Study|Other|0|||
163384794|NCT00413972|590119247|FG003|Overall Study|Other|1|||
163384795|NCT00427895|590119250|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
163384796|NCT00427895|590119251|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
163384797|NCT00427895|590119252|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
163384798|NCT00427895|590119253|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
163384799|NCT00427895|590119254|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
163384800|NCT00427895|590119255|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
163384801|NCT00427895|590119256|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
163384802|NCT00427895|590119257|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
163384803|NCT00427895|590119250|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
163384804|NCT00427895|590119251|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
163384805|NCT00427895|590119252|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
163384806|NCT00427895|590119253|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
163384807|NCT00427895|590119254|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
163384808|NCT00427895|590119255|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
163384809|NCT00427895|590119256|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
163384810|NCT00427895|590119257|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
163384811|NCT00427895|590119250|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
163384812|NCT00427895|590119251|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
163384813|NCT00427895|590119252|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
163384814|NCT00427895|590119253|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
163384815|NCT00427895|590119254|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
163384816|NCT00427895|590119255|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
163384817|NCT00427895|590119256|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
163384818|NCT00427895|590119257|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
163384819|NCT00427895|590119250|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
163384820|NCT00427895|590119251|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
163384821|NCT00427895|590119252|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
163384822|NCT00427895|590119253|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
163384823|NCT00427895|590119254|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
163384824|NCT00427895|590119255|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
163384825|NCT00427895|590119256|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
163384826|NCT00427895|590119257|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
163384827|NCT00427895|590119250|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
163384828|NCT00427895|590119251|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
163384829|NCT00427895|590119252|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
163384830|NCT00427895|590119253|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
163384831|NCT00427895|590119254|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
163384832|NCT00427895|590119255|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
163384833|NCT00427895|590119256|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
163384834|NCT00427895|590119257|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
163384835|NCT00427895|590119250|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
163384836|NCT00427895|590119251|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
163384837|NCT00427895|590119252|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
163384838|NCT00427895|590119253|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
163384839|NCT00427895|590119254|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
163418718|NCT03179436|590240140|FG002|Overall Study|Sponsor Decision|1|||
163418719|NCT03179436|590240141|FG003|Overall Study|Sponsor Decision|3|||
163418720|NCT03179436|590240142|FG004|Overall Study|Sponsor Decision|9|||
163418721|NCT03179436|590240143|FG005|Overall Study|Sponsor Decision|7|||
163418722|NCT03179436|590240144|FG006|Overall Study|Sponsor Decision|2|||
163418723|NCT03179436|590240145|FG007|Overall Study|Sponsor Decision|4|||
163418724|NCT03179436|590240146|FG008|Overall Study|Sponsor Decision|23|||
163418725|NCT03179436|590240147|FG009|Overall Study|Sponsor Decision|6|||
163418726|NCT03179436|590240148|FG010|Overall Study|Sponsor Decision|7|||
163418727|NCT03179436|590240149|FG011|Overall Study|Sponsor Decision|5|||
163418728|NCT03179436|590240138|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
163418729|NCT03179436|590240139|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
163418730|NCT03179436|590240140|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
163418731|NCT03179436|590240141|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
163418732|NCT03179436|590240142|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
163418733|NCT03179436|590240143|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
163418734|NCT03179436|590240144|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
163418735|NCT03179436|590240145|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
163418736|NCT03179436|590240146|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
163418737|NCT03179436|590240147|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
163418738|NCT03179436|590240148|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
163418739|NCT03179436|590240149|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
163418740|NCT03179436|590240138|FG000|Overall Study|Lost to Follow-up|1|||
163418741|NCT03179436|590240139|FG001|Overall Study|Lost to Follow-up|0|||
163418742|NCT03179436|590240140|FG002|Overall Study|Lost to Follow-up|0|||
163418743|NCT03179436|590240141|FG003|Overall Study|Lost to Follow-up|1|||
163418744|NCT03179436|590240142|FG004|Overall Study|Lost to Follow-up|0|||
163418745|NCT03179436|590240143|FG005|Overall Study|Lost to Follow-up|1|||
163418746|NCT03179436|590240144|FG006|Overall Study|Lost to Follow-up|0|||
163418747|NCT03179436|590240145|FG007|Overall Study|Lost to Follow-up|0|||
163418748|NCT03179436|590240146|FG008|Overall Study|Lost to Follow-up|1|||
163418749|NCT03179436|590240147|FG009|Overall Study|Lost to Follow-up|1|||
163384840|NCT00427895|590119255|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
163384841|NCT00427895|590119256|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
163384842|NCT00427895|590119257|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
163384843|NCT00427895|590119250|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
163384844|NCT00427895|590119251|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
163384845|NCT00427895|590119252|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
163384846|NCT00427895|590119253|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
163384847|NCT00427895|590119254|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
163384848|NCT00427895|590119255|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
163384849|NCT00427895|590119256|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
163384850|NCT00427895|590119257|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
163384851|NCT00427895|590119250|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
163384852|NCT00427895|590119251|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
163384853|NCT00427895|590119252|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
163384854|NCT00427895|590119253|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
163384855|NCT00427895|590119254|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
163384856|NCT00427895|590119255|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
163384857|NCT00427895|590119256|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
163384858|NCT00427895|590119257|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
163384859|NCT00427895|590119250|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
163384860|NCT00427895|590119251|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
163384861|NCT00427895|590119252|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
163384862|NCT00427895|590119253|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
163384863|NCT00427895|590119254|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
163384864|NCT00427895|590119255|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
163384865|NCT00427895|590119256|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
163384866|NCT00427895|590119257|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
163384867|NCT00427895|590119250|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
163384868|NCT00427895|590119251|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
163384869|NCT00427895|590119252|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
163384870|NCT00427895|590119253|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
163384871|NCT00427895|590119254|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
163384872|NCT00427895|590119255|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
163418750|NCT03179436|590240148|FG010|Overall Study|Lost to Follow-up|0|||
163418751|NCT03179436|590240149|FG011|Overall Study|Lost to Follow-up|0|||
163418752|NCT03179436|590240138|FG000|Overall Study|Death|12|||
163418753|NCT03179436|590240139|FG001|Overall Study|Death|17|||
163418754|NCT03179436|590240140|FG002|Overall Study|Death|7|||
163418755|NCT03179436|590240141|FG003|Overall Study|Death|32|||
163418756|NCT03179436|590240142|FG004|Overall Study|Death|29|||
163418757|NCT03179436|590240143|FG005|Overall Study|Death|30|||
163418758|NCT03179436|590240144|FG006|Overall Study|Death|33|||
163418759|NCT03179436|590240145|FG007|Overall Study|Death|9|||
163418760|NCT03179436|590240146|FG008|Overall Study|Death|84|||
163418761|NCT03179436|590240147|FG009|Overall Study|Death|33|||
163418762|NCT03179436|590240148|FG010|Overall Study|Death|22|||
163418763|NCT03179436|590240149|FG011|Overall Study|Death|15|||
163418764|NCT01634555|590240150|FG000|Overall Study|Adverse Event|3|||
163418765|NCT01634555|590240150|FG000|Overall Study|Physician Decision|1|||
163418766|NCT01506882|590240151|FG000|Overall Study|Lack of Efficacy|4|||
163418767|NCT01506882|590240152|FG001|Overall Study|Lack of Efficacy|3|||
163418768|NCT01506882|590240151|FG000|Overall Study|Lost to Follow-up|1|||
163418769|NCT01506882|590240152|FG001|Overall Study|Lost to Follow-up|0|||
163418770|NCT01506882|590240151|FG000|Overall Study|Withdrawal by Subject|9|||
163418771|NCT01506882|590240152|FG001|Overall Study|Withdrawal by Subject|3|||
163418772|NCT01506882|590240151|FG000|Overall Study|SAE, non-fatal|2|||
163418773|NCT01506882|590240152|FG001|Overall Study|SAE, non-fatal|0|||
163418774|NCT01506882|590240151|FG000|Overall Study|AE, non-serious non-fatal|3|||
163418775|NCT01506882|590240152|FG001|Overall Study|AE, non-serious non-fatal|1|||
163418776|NCT01506882|590240151|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
163418777|NCT01506882|590240152|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
163418778|NCT01506882|590240151|FG000|Overall Study|Other Reason|2|||
163418779|NCT01506882|590240152|FG001|Overall Study|Other Reason|0|||
163418780|NCT04025632|590242537|FG000|Overall Study|Adverse Event|1|||
163418781|NCT04025632|590242538|FG001|Overall Study|Adverse Event|1|||
163418782|NCT04025632|590242537|FG000|Overall Study|Withdrawal by Subject|1|||
163418783|NCT04025632|590242538|FG001|Overall Study|Withdrawal by Subject|1|||
163418784|NCT04025632|590242537|FG000|Overall Study|Study Terminated by Sponsor|10|||
163418785|NCT04025632|590242538|FG001|Overall Study|Study Terminated by Sponsor|9|||
163418786|NCT04025632|590242537|FG000|Overall Study|Physician Decision|3|||
163418787|NCT04025632|590242538|FG001|Overall Study|Physician Decision|1|||
163418788|NCT00376961|590242539|FG000|Initial Registration|Adverse Event|1|||
163418789|NCT00376961|590242540|FG001|Initial Registration|Adverse Event|0|||
163418790|NCT00376961|590242539|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
163418791|NCT00376961|590242540|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
163418792|NCT00376961|590242539|FG000|Initial Registration|Progression/relapse|1|||
163418793|NCT00376961|590242540|FG001|Initial Registration|Progression/relapse|0|||
163418794|NCT00376961|590242539|FG000|Initial Registration|Ineligible|3|||
163418795|NCT00376961|590242540|FG001|Initial Registration|Ineligible|0|||
163418796|NCT00376961|590242539|FG000|Maintenance|Adverse Event|0|||
163418797|NCT00376961|590242540|FG001|Maintenance|Adverse Event|1|||
163418798|NCT00376961|590242539|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
163418799|NCT00376961|590242540|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
163418800|NCT00376961|590242539|FG000|Maintenance|Progression/relapse|0|||
163418801|NCT00376961|590242540|FG001|Maintenance|Progression/relapse|18|||
163418802|NCT00376961|590242539|FG000|Maintenance|Ineligible|0|||
163418803|NCT00376961|590242540|FG001|Maintenance|Ineligible|3|||
163418804|NCT02591615|590242542|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
163418805|NCT02591615|590242543|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
163418806|NCT02591615|590242544|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
163418807|NCT02591615|590242545|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
163418808|NCT02591615|590242542|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
163418809|NCT02591615|590242543|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
163418810|NCT02591615|590242544|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
163418811|NCT02591615|590242545|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
163418812|NCT02591615|590242542|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
163418813|NCT02591615|590242543|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
163418814|NCT02591615|590242544|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
163418815|NCT02591615|590242545|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
163418816|NCT02591615|590242542|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
163418817|NCT02591615|590242543|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
163418818|NCT02591615|590242544|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
163418819|NCT02591615|590242545|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
163418820|NCT02591615|590242542|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
163418821|NCT02591615|590242543|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
163418822|NCT02591615|590242544|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
163418823|NCT02591615|590242545|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
163418824|NCT02591615|590242542|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
163418825|NCT02591615|590242543|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
163418826|NCT02591615|590242544|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
163418827|NCT02591615|590242545|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
163418828|NCT02591615|590242542|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
163418829|NCT02591615|590242543|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
163418830|NCT02591615|590242544|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
163418831|NCT02591615|590242545|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
163418832|NCT02591615|590242542|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
163418833|NCT02591615|590242543|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
163418834|NCT02591615|590242544|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
163418835|NCT02591615|590242545|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
163418836|NCT02591615|590242542|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
163418837|NCT02591615|590242543|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
163418838|NCT02591615|590242544|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
163418839|NCT02591615|590242545|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
163418840|NCT02591615|590242542|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
163418841|NCT02591615|590242543|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
163418842|NCT02591615|590242544|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
163418843|NCT02591615|590242545|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
163418844|NCT02591615|590242542|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
163418845|NCT02591615|590242543|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
163418846|NCT02591615|590242544|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
163418847|NCT02591615|590242545|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
163418848|NCT02591615|590242542|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
163418849|NCT02591615|590242543|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
163418850|NCT02591615|590242544|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
163418851|NCT02591615|590242545|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
163418852|NCT02591615|590242542|FG000|Maintenance MK-3475|Adverse Event|0|||
163418853|NCT02591615|590242543|FG001|Maintenance MK-3475|Adverse Event|3|||
163418854|NCT02591615|590242544|FG002|Maintenance MK-3475|Adverse Event|1|||
163418855|NCT02591615|590242545|FG003|Maintenance MK-3475|Adverse Event|2|||
163418856|NCT02591615|590242542|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
163418857|NCT02591615|590242543|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
163418858|NCT02591615|590242544|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
163418859|NCT02591615|590242545|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
163418860|NCT02591615|590242542|FG000|Maintenance MK-3475|Death|0|||
163418861|NCT02591615|590242543|FG001|Maintenance MK-3475|Death|1|||
163418862|NCT02591615|590242544|FG002|Maintenance MK-3475|Death|1|||
163418863|NCT02591615|590242545|FG003|Maintenance MK-3475|Death|0|||
163418864|NCT02591615|590242542|FG000|Maintenance MK-3475|Physician discretion|0|||
163418865|NCT02591615|590242543|FG001|Maintenance MK-3475|Physician discretion|0|||
163418866|NCT02591615|590242544|FG002|Maintenance MK-3475|Physician discretion|1|||
163418867|NCT02591615|590242545|FG003|Maintenance MK-3475|Physician discretion|0|||
163418868|NCT02591615|590242542|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
163418869|NCT02591615|590242543|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
163418870|NCT02591615|590242544|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
163418871|NCT02591615|590242545|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
163418872|NCT02591615|590242542|FG000|Maintenance MK-3475|In active treatment|2|||
163418873|NCT02591615|590242543|FG001|Maintenance MK-3475|In active treatment|0|||
163418874|NCT02591615|590242544|FG002|Maintenance MK-3475|In active treatment|0|||
163418875|NCT02591615|590242545|FG003|Maintenance MK-3475|In active treatment|1|||
163418876|NCT00686127|590242548|FG000|Overall Study|Withdrawal by Subject|14|||
163418877|NCT00686127|590242549|FG001|Overall Study|Withdrawal by Subject|6|||
163418878|NCT05195528|590242550|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
163418879|NCT05195528|590242551|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
163418880|NCT05195528|590242552|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
163418881|NCT05195528|590242553|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
163418882|NCT05195528|590242554|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
163418883|NCT05195528|590242550|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
163418884|NCT05195528|590242551|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
163418885|NCT05195528|590242552|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
163418886|NCT05195528|590242553|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
163418887|NCT05195528|590242554|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
163418888|NCT05195528|590242550|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
163418889|NCT05195528|590242551|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
163418890|NCT05195528|590242552|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
163418891|NCT05195528|590242553|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
163418892|NCT05195528|590242554|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
163418893|NCT05195528|590242550|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
163418894|NCT05195528|590242551|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
163418895|NCT05195528|590242552|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
163384873|NCT00427895|590119256|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
163384874|NCT00427895|590119257|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
163384875|NCT00427895|590119250|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
163384876|NCT00427895|590119251|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
163384877|NCT00427895|590119252|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
163384878|NCT00427895|590119253|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
163384879|NCT00427895|590119254|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
163384880|NCT00427895|590119255|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
163384881|NCT00427895|590119256|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
163384882|NCT00427895|590119257|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
163384883|NCT00427895|590119250|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
163384884|NCT00427895|590119251|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
163384885|NCT00427895|590119252|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
163384886|NCT00427895|590119253|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
163384887|NCT00427895|590119254|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
163418896|NCT05195528|590242553|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
163418897|NCT05195528|590242554|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
163418898|NCT05195528|590242550|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
163418899|NCT05195528|590242551|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
163418900|NCT05195528|590242552|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
163418901|NCT05195528|590242553|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
163418902|NCT05195528|590242554|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
163418903|NCT05195528|590242550|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
163418904|NCT05195528|590242551|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
163418905|NCT05195528|590242552|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
163418906|NCT05195528|590242553|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
163418907|NCT05195528|590242554|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
163418908|NCT05195528|590242550|FG000|Placebo-controlled Treatment Period|Other|0|||
163418909|NCT05195528|590242551|FG001|Placebo-controlled Treatment Period|Other|0|||
163418910|NCT05195528|590242552|FG002|Placebo-controlled Treatment Period|Other|1|||
163418911|NCT05195528|590242553|FG003|Placebo-controlled Treatment Period|Other|0|||
163418912|NCT05195528|590242554|FG004|Placebo-controlled Treatment Period|Other|0|||
163418913|NCT05195528|590242550|FG000|Extension Period|PTE or AE or SAE|0|||
163418914|NCT05195528|590242551|FG001|Extension Period|PTE or AE or SAE|4|||
163418915|NCT05195528|590242552|FG002|Extension Period|PTE or AE or SAE|5|||
163418916|NCT05195528|590242553|FG003|Extension Period|PTE or AE or SAE|4|||
163418917|NCT05195528|590242554|FG004|Extension Period|PTE or AE or SAE|4|||
163418918|NCT05195528|590242550|FG000|Extension Period|Protocol Violation|0|||
163418919|NCT05195528|590242551|FG001|Extension Period|Protocol Violation|2|||
163418920|NCT05195528|590242552|FG002|Extension Period|Protocol Violation|1|||
163418921|NCT05195528|590242553|FG003|Extension Period|Protocol Violation|0|||
163418922|NCT05195528|590242554|FG004|Extension Period|Protocol Violation|1|||
163418923|NCT05195528|590242550|FG000|Extension Period|Lost to Follow-up|0|||
163418924|NCT05195528|590242551|FG001|Extension Period|Lost to Follow-up|6|||
163418925|NCT05195528|590242552|FG002|Extension Period|Lost to Follow-up|13|||
163418926|NCT05195528|590242553|FG003|Extension Period|Lost to Follow-up|3|||
163418927|NCT05195528|590242554|FG004|Extension Period|Lost to Follow-up|7|||
163418928|NCT05195528|590242550|FG000|Extension Period|Withdrawal by Subject|0|||
163418929|NCT05195528|590242551|FG001|Extension Period|Withdrawal by Subject|12|||
163418930|NCT05195528|590242552|FG002|Extension Period|Withdrawal by Subject|9|||
163418931|NCT05195528|590242553|FG003|Extension Period|Withdrawal by Subject|6|||
163418932|NCT05195528|590242554|FG004|Extension Period|Withdrawal by Subject|5|||
163418933|NCT05195528|590242550|FG000|Extension Period|Lack of Efficacy|0|||
163418934|NCT05195528|590242551|FG001|Extension Period|Lack of Efficacy|3|||
163418935|NCT05195528|590242552|FG002|Extension Period|Lack of Efficacy|0|||
163418936|NCT05195528|590242553|FG003|Extension Period|Lack of Efficacy|0|||
163418937|NCT05195528|590242554|FG004|Extension Period|Lack of Efficacy|2|||
163418938|NCT05195528|590242550|FG000|Extension Period|Not Treated|0|||
163418939|NCT05195528|590242551|FG001|Extension Period|Not Treated|0|||
163418940|NCT05195528|590242552|FG002|Extension Period|Not Treated|2|||
163418941|NCT05195528|590242553|FG003|Extension Period|Not Treated|3|||
163418942|NCT05195528|590242554|FG004|Extension Period|Not Treated|0|||
163418943|NCT05195528|590242550|FG000|Extension Period|Other|0|||
163418944|NCT05195528|590242551|FG001|Extension Period|Other|1|||
163418945|NCT05195528|590242552|FG002|Extension Period|Other|1|||
163418946|NCT05195528|590242553|FG003|Extension Period|Other|0|||
163418947|NCT05195528|590242554|FG004|Extension Period|Other|0|||
163418948|NCT01552902|590242555|FG000|Overall Study|Adverse Event|1|||
163418949|NCT01552902|590242556|FG001|Overall Study|Adverse Event|15|||
163418950|NCT01552902|590242557|FG002|Overall Study|Adverse Event|14|||
163418951|NCT01552902|590242555|FG000|Overall Study|Protocol Violation|3|||
163418952|NCT01552902|590242556|FG001|Overall Study|Protocol Violation|3|||
163418953|NCT01552902|590242557|FG002|Overall Study|Protocol Violation|3|||
163418954|NCT01552902|590242555|FG000|Overall Study|Lack of Efficacy|4|||
163418955|NCT01552902|590242556|FG001|Overall Study|Lack of Efficacy|3|||
163418956|NCT01552902|590242557|FG002|Overall Study|Lack of Efficacy|1|||
163418957|NCT01552902|590242555|FG000|Overall Study|Withdrawal by Subject|1|||
163418958|NCT01552902|590242556|FG001|Overall Study|Withdrawal by Subject|9|||
163418959|NCT01552902|590242557|FG002|Overall Study|Withdrawal by Subject|6|||
163418960|NCT01552902|590242555|FG000|Overall Study|Lost to Follow-up|1|||
163418961|NCT01552902|590242556|FG001|Overall Study|Lost to Follow-up|3|||
163418962|NCT01552902|590242557|FG002|Overall Study|Lost to Follow-up|6|||
163418963|NCT01552902|590242555|FG000|Overall Study|Other|3|||
163418964|NCT01552902|590242556|FG001|Overall Study|Other|4|||
163418965|NCT01552902|590242557|FG002|Overall Study|Other|3|||
163418966|NCT02720757|590242558|FG000|Overall Study|Other reason|5|||
163418967|NCT02720757|590242558|FG000|Overall Study|Loss of contact|4|||
163418968|NCT02720757|590242558|FG000|Overall Study|Informed consent withdrawal|1|||
163418969|NCT02720757|590242558|FG000|Overall Study|Patients wish to withdraw|2|||
163418970|NCT02720757|590242558|FG000|Overall Study|Missing|3|||
163418971|NCT02720757|590242558|FG000|Overall Study|General exclusion|3|||
163418972|NCT00168831|590242560|FG000|Overall Study|Adverse Event|36|||
163418973|NCT00168831|590242561|FG001|Overall Study|Adverse Event|47|||
163418974|NCT00168831|590242562|FG002|Overall Study|Adverse Event|74|||
163418975|NCT00168831|590242560|FG000|Overall Study|Lost to Follow-up|5|||
163418976|NCT00168831|590242561|FG001|Overall Study|Lost to Follow-up|6|||
163418977|NCT00168831|590242562|FG002|Overall Study|Lost to Follow-up|4|||
163418978|NCT00168831|590242560|FG000|Overall Study|Withdrawal by Subject|7|||
163418979|NCT00168831|590242561|FG001|Overall Study|Withdrawal by Subject|14|||
163418980|NCT00168831|590242562|FG002|Overall Study|Withdrawal by Subject|19|||
163418981|NCT00168831|590242560|FG000|Overall Study|Protocol Violation|6|||
163418982|NCT00168831|590242561|FG001|Overall Study|Protocol Violation|11|||
163418983|NCT00168831|590242562|FG002|Overall Study|Protocol Violation|11|||
163418984|NCT00168831|590242560|FG000|Overall Study|Other|6|||
163418985|NCT00168831|590242561|FG001|Overall Study|Other|3|||
163418986|NCT00168831|590242562|FG002|Overall Study|Other|6|||
163418987|NCT04173741|590242564|FG000|Overall Study|IVC measurement cannot be done|1|||
163418988|NCT04173741|590242565|FG001|Overall Study|IVC measurement cannot be done|1|||
163418989|NCT02357420|590242566|FG000|Overall Study|Adverse Event|3|||
163418990|NCT02357420|590242567|FG001|Overall Study|Adverse Event|3|||
163418991|NCT02357420|590242568|FG002|Overall Study|Adverse Event|8|||
163418992|NCT02357420|590242569|FG003|Overall Study|Adverse Event|9|||
163418993|NCT02357420|590242566|FG000|Overall Study|Investigator Decision|1|||
163418994|NCT02357420|590242567|FG001|Overall Study|Investigator Decision|0|||
163418995|NCT02357420|590242568|FG002|Overall Study|Investigator Decision|0|||
163418996|NCT02357420|590242569|FG003|Overall Study|Investigator Decision|0|||
163418997|NCT02357420|590242566|FG000|Overall Study|Prohibited Medication|1|||
163418998|NCT02357420|590242567|FG001|Overall Study|Prohibited Medication|1|||
163418999|NCT02357420|590242568|FG002|Overall Study|Prohibited Medication|0|||
163419000|NCT02357420|590242569|FG003|Overall Study|Prohibited Medication|0|||
163419001|NCT02357420|590242566|FG000|Overall Study|Protocol Non-compliance|0|||
163419002|NCT02357420|590242567|FG001|Overall Study|Protocol Non-compliance|0|||
163419003|NCT02357420|590242568|FG002|Overall Study|Protocol Non-compliance|0|||
163419004|NCT02357420|590242569|FG003|Overall Study|Protocol Non-compliance|1|||
163419005|NCT02357420|590242566|FG000|Overall Study|Withdrawn Consent|4|||
163419006|NCT02357420|590242567|FG001|Overall Study|Withdrawn Consent|8|||
163419007|NCT02357420|590242568|FG002|Overall Study|Withdrawn Consent|6|||
163419008|NCT02357420|590242569|FG003|Overall Study|Withdrawn Consent|6|||
163419009|NCT02357420|590242566|FG000|Overall Study|Lost to Follow-up|3|||
163419010|NCT02357420|590242567|FG001|Overall Study|Lost to Follow-up|0|||
163419011|NCT02357420|590242568|FG002|Overall Study|Lost to Follow-up|2|||
163419012|NCT02357420|590242569|FG003|Overall Study|Lost to Follow-up|3|||
163419013|NCT03617705|590242570|FG000|Overall Study|Withdrawal by Subject|2|||
163419014|NCT03617705|590242570|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
163419015|NCT03617705|590242570|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
163419016|NCT03502187|590242571|FG000|Overall Study|Withdrawal by Subject|4|||
163419017|NCT03502187|590242572|FG001|Overall Study|Withdrawal by Subject|3|||
163419018|NCT03502187|590242573|FG002|Overall Study|Withdrawal by Subject|3|||
163419019|NCT03502187|590242571|FG000|Overall Study|Lost to Follow-up|5|||
163419020|NCT03502187|590242572|FG001|Overall Study|Lost to Follow-up|4|||
163419021|NCT03502187|590242573|FG002|Overall Study|Lost to Follow-up|5|||
163419022|NCT00214461|590242574|FG000|Overall Study|Adverse Event|0|||
163419023|NCT00214461|590242575|FG001|Overall Study|Adverse Event|0|||
163419024|NCT00214461|590242576|FG002|Overall Study|Adverse Event|1|||
163419025|NCT00214461|590242577|FG003|Overall Study|Adverse Event|1|||
163419026|NCT00214461|590242574|FG000|Overall Study|Withdrawal by Subject|0|||
163419027|NCT00214461|590242575|FG001|Overall Study|Withdrawal by Subject|0|||
163419028|NCT00214461|590242576|FG002|Overall Study|Withdrawal by Subject|1|||
163419029|NCT00214461|590242577|FG003|Overall Study|Withdrawal by Subject|0|||
163419030|NCT06118385|590242578|FG000|Overall Study|Protocol Violation|0|||
163419031|NCT06118385|590242579|FG001|Overall Study|Protocol Violation|0|||
163419032|NCT06118385|590242580|FG002|Overall Study|Protocol Violation|0|||
163419033|NCT06118385|590242581|FG003|Overall Study|Protocol Violation|0|||
163419034|NCT06118385|590242582|FG004|Overall Study|Protocol Violation|0|||
163419035|NCT06118385|590242583|FG005|Overall Study|Protocol Violation|0|||
163419036|NCT06118385|590242584|FG006|Overall Study|Protocol Violation|0|||
163419037|NCT06118385|590242585|FG007|Overall Study|Protocol Violation|0|||
163419038|NCT06118385|590242586|FG008|Overall Study|Protocol Violation|1|||
163419039|NCT06118385|590242587|FG009|Overall Study|Protocol Violation|0|||
163419040|NCT06118385|590242588|FG010|Overall Study|Protocol Violation|0|||
163419041|NCT06118385|590242589|FG011|Overall Study|Protocol Violation|0|||
163419042|NCT06118385|590242578|FG000|Overall Study|Out-of-range blood tests|0|||
163419043|NCT06118385|590242579|FG001|Overall Study|Out-of-range blood tests|0|||
163419044|NCT06118385|590242580|FG002|Overall Study|Out-of-range blood tests|0|||
163419045|NCT06118385|590242581|FG003|Overall Study|Out-of-range blood tests|0|||
163419046|NCT06118385|590242582|FG004|Overall Study|Out-of-range blood tests|0|||
163419047|NCT06118385|590242583|FG005|Overall Study|Out-of-range blood tests|0|||
163419048|NCT06118385|590242584|FG006|Overall Study|Out-of-range blood tests|0|||
163419049|NCT06118385|590242585|FG007|Overall Study|Out-of-range blood tests|0|||
163419050|NCT06118385|590242586|FG008|Overall Study|Out-of-range blood tests|1|||
163419051|NCT06118385|590242587|FG009|Overall Study|Out-of-range blood tests|0|||
163419052|NCT06118385|590242588|FG010|Overall Study|Out-of-range blood tests|0|||
163419053|NCT06118385|590242589|FG011|Overall Study|Out-of-range blood tests|0|||
163419054|NCT01554579|590242590|FG000|Overall Study|Adverse Event|6|||
163419055|NCT01554579|590242591|FG001|Overall Study|Adverse Event|25|||
163419056|NCT01554579|590242590|FG000|Overall Study|Lack of Efficacy|2|||
163419057|NCT01554579|590242591|FG001|Overall Study|Lack of Efficacy|1|||
163419058|NCT01554579|590242590|FG000|Overall Study|Withdrawal by Subject|2|||
163419059|NCT01554579|590242591|FG001|Overall Study|Withdrawal by Subject|1|||
163419060|NCT00234039|590242592|FG000|Overall Study|Adverse Event|2|||
163419061|NCT00234039|590242592|FG000|Overall Study|Progression/relapse|34|||
163419062|NCT00234039|590242592|FG000|Overall Study|Other - Not Protocol Specified|3|||
163419063|NCT00234039|590242592|FG000|Overall Study|Ineligible|9|||
163419064|NCT00234039|590242592|FG000|Overall Study|No Protocol Treatment Received|2|||
163419065|NCT01808612|590242593|FG000|Treatment Period|Adverse Event|8|||
163419066|NCT01808612|590242594|FG001|Treatment Period|Adverse Event|4|||
163419067|NCT01808612|590242595|FG002|Treatment Period|Adverse Event|3|||
163419068|NCT01808612|590242593|FG000|Treatment Period|Lost to Follow-up|2|||
163419069|NCT01808612|590242594|FG001|Treatment Period|Lost to Follow-up|2|||
163419070|NCT01808612|590242595|FG002|Treatment Period|Lost to Follow-up|1|||
163419071|NCT01808612|590242593|FG000|Treatment Period|Protocol Violation|1|||
163419072|NCT01808612|590242594|FG001|Treatment Period|Protocol Violation|0|||
163419073|NCT01808612|590242595|FG002|Treatment Period|Protocol Violation|0|||
163419074|NCT01808612|590242593|FG000|Treatment Period|Withdrawal by Subject|1|||
163419075|NCT01808612|590242594|FG001|Treatment Period|Withdrawal by Subject|0|||
163419076|NCT01808612|590242595|FG002|Treatment Period|Withdrawal by Subject|4|||
163419077|NCT01808612|590242593|FG000|Treatment Period|Physician Decision|1|||
163419078|NCT01808612|590242594|FG001|Treatment Period|Physician Decision|0|||
163419079|NCT01808612|590242595|FG002|Treatment Period|Physician Decision|4|||
163419080|NCT01808612|590242593|FG000|Treatment Period|Sponsor Decision|1|||
163419081|NCT01808612|590242594|FG001|Treatment Period|Sponsor Decision|0|||
163419082|NCT01808612|590242595|FG002|Treatment Period|Sponsor Decision|0|||
163419083|NCT01808612|590242593|FG000|Treatment Period|Lack of Efficacy|1|||
163419084|NCT01808612|590242594|FG001|Treatment Period|Lack of Efficacy|1|||
163419085|NCT01808612|590242595|FG002|Treatment Period|Lack of Efficacy|2|||
163419086|NCT01808612|590242593|FG000|Discontinuation Period|Adverse Event|1|||
163419087|NCT01808612|590242594|FG001|Discontinuation Period|Adverse Event|0|||
163419088|NCT01808612|590242595|FG002|Discontinuation Period|Adverse Event|0|||
163419089|NCT01808612|590242593|FG000|Discontinuation Period|Physician Decision|1|||
163419090|NCT01808612|590242594|FG001|Discontinuation Period|Physician Decision|0|||
163419091|NCT01808612|590242595|FG002|Discontinuation Period|Physician Decision|0|||
163419092|NCT01808612|590242593|FG000|Discontinuation Period|Lost to Follow-up|0|||
163419093|NCT01808612|590242594|FG001|Discontinuation Period|Lost to Follow-up|1|||
163419094|NCT01808612|590242595|FG002|Discontinuation Period|Lost to Follow-up|0|||
163419095|NCT03072160|590242598|FG000|Overall Study|Adverse Event|3|||
163419096|NCT03072160|590242599|FG001|Overall Study|Adverse Event|1|||
163419097|NCT03072160|590242598|FG000|Overall Study|Refused further treatment|6|||
163419098|NCT03072160|590242599|FG001|Overall Study|Refused further treatment|1|||
163419099|NCT03072160|590242598|FG000|Overall Study|Physician Decision|1|||
163419100|NCT03072160|590242599|FG001|Overall Study|Physician Decision|0|||
163419101|NCT03072160|590242598|FG000|Overall Study|Disease progression on study|1|||
163419102|NCT03072160|590242599|FG001|Overall Study|Disease progression on study|1|||
163419103|NCT03072160|590242598|FG000|Overall Study|No contact|0|||
163419104|NCT03072160|590242599|FG001|Overall Study|No contact|1|||
163419105|NCT01046695|590242600|FG000|Overall Study|Subject had a pacemaker|0|||
163419106|NCT01046695|590242601|FG001|Overall Study|Subject had a pacemaker|1|||
163419107|NCT01046695|590242600|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
163419108|NCT01046695|590242601|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
163419109|NCT04426695|590242602|FG000|Overall Study|Death|2|||
163419110|NCT04426695|590242603|FG001|Overall Study|Death|0|||
163419111|NCT04426695|590242604|FG002|Overall Study|Death|1|||
163419112|NCT04426695|590242605|FG003|Overall Study|Death|27|||
163419113|NCT04426695|590242606|FG004|Overall Study|Death|25|||
163419114|NCT04426695|590242607|FG005|Overall Study|Death|21|||
163419115|NCT04426695|590242608|FG006|Overall Study|Death|42|||
163419116|NCT04426695|590242609|FG007|Overall Study|Death|23|||
163419117|NCT04426695|590242610|FG008|Overall Study|Death|37|||
163419118|NCT04426695|590242611|FG009|Overall Study|Death|14|||
163419119|NCT04426695|590242612|FG010|Overall Study|Death|8|||
163419120|NCT04426695|590242613|FG011|Overall Study|Death|7|||
163419121|NCT04426695|590242614|FG012|Overall Study|Death|13|||
163419122|NCT04426695|590242615|FG013|Overall Study|Death|25|||
163419123|NCT04426695|590242616|FG014|Overall Study|Death|19|||
163419124|NCT04426695|590242617|FG015|Overall Study|Death|7|||
163419125|NCT04426695|590242618|FG016|Overall Study|Death|8|||
163419126|NCT04426695|590242619|FG017|Overall Study|Death|4|||
163419127|NCT04426695|590242602|FG000|Overall Study|Lost to Follow-up|2|||
163419128|NCT04426695|590242603|FG001|Overall Study|Lost to Follow-up|4|||
163419129|NCT04426695|590242604|FG002|Overall Study|Lost to Follow-up|1|||
163419130|NCT04426695|590242605|FG003|Overall Study|Lost to Follow-up|19|||
163419131|NCT04426695|590242606|FG004|Overall Study|Lost to Follow-up|10|||
163419132|NCT04426695|590242607|FG005|Overall Study|Lost to Follow-up|14|||
163419133|NCT04426695|590242608|FG006|Overall Study|Lost to Follow-up|5|||
163419134|NCT04426695|590242609|FG007|Overall Study|Lost to Follow-up|14|||
163419135|NCT04426695|590242610|FG008|Overall Study|Lost to Follow-up|10|||
163419136|NCT04426695|590242611|FG009|Overall Study|Lost to Follow-up|11|||
163419137|NCT04426695|590242612|FG010|Overall Study|Lost to Follow-up|12|||
163419138|NCT04426695|590242613|FG011|Overall Study|Lost to Follow-up|6|||
163419139|NCT04426695|590242614|FG012|Overall Study|Lost to Follow-up|2|||
163419140|NCT04426695|590242615|FG013|Overall Study|Lost to Follow-up|2|||
163419141|NCT04426695|590242616|FG014|Overall Study|Lost to Follow-up|2|||
163419142|NCT04426695|590242617|FG015|Overall Study|Lost to Follow-up|0|||
163419143|NCT04426695|590242618|FG016|Overall Study|Lost to Follow-up|0|||
163419144|NCT04426695|590242619|FG017|Overall Study|Lost to Follow-up|0|||
163419145|NCT04426695|590242602|FG000|Overall Study|Participant Decision|1|||
163419146|NCT04426695|590242603|FG001|Overall Study|Participant Decision|2|||
163419147|NCT04426695|590242604|FG002|Overall Study|Participant Decision|2|||
163419148|NCT04426695|590242605|FG003|Overall Study|Participant Decision|12|||
163419149|NCT04426695|590242606|FG004|Overall Study|Participant Decision|18|||
163419150|NCT04426695|590242607|FG005|Overall Study|Participant Decision|22|||
163419151|NCT04426695|590242608|FG006|Overall Study|Participant Decision|13|||
163419152|NCT04426695|590242609|FG007|Overall Study|Participant Decision|13|||
163419153|NCT04426695|590242610|FG008|Overall Study|Participant Decision|10|||
163419154|NCT04426695|590242611|FG009|Overall Study|Participant Decision|15|||
163419155|NCT04426695|590242612|FG010|Overall Study|Participant Decision|16|||
163419156|NCT04426695|590242613|FG011|Overall Study|Participant Decision|17|||
163419157|NCT04426695|590242614|FG012|Overall Study|Participant Decision|2|||
163419158|NCT04426695|590242615|FG013|Overall Study|Participant Decision|1|||
163419159|NCT04426695|590242616|FG014|Overall Study|Participant Decision|2|||
163419160|NCT04426695|590242617|FG015|Overall Study|Participant Decision|0|||
163419161|NCT04426695|590242618|FG016|Overall Study|Participant Decision|0|||
163419162|NCT04426695|590242619|FG017|Overall Study|Participant Decision|0|||
163419163|NCT04426695|590242602|FG000|Overall Study|Adverse Event|0|||
163419164|NCT04426695|590242603|FG001|Overall Study|Adverse Event|0|||
163419165|NCT04426695|590242604|FG002|Overall Study|Adverse Event|0|||
163419166|NCT04426695|590242605|FG003|Overall Study|Adverse Event|0|||
163419167|NCT04426695|590242606|FG004|Overall Study|Adverse Event|0|||
163419168|NCT04426695|590242607|FG005|Overall Study|Adverse Event|0|||
163419169|NCT04426695|590242608|FG006|Overall Study|Adverse Event|0|||
163419170|NCT04426695|590242609|FG007|Overall Study|Adverse Event|1|||
163419171|NCT04426695|590242610|FG008|Overall Study|Adverse Event|0|||
163419172|NCT04426695|590242611|FG009|Overall Study|Adverse Event|0|||
163419173|NCT04426695|590242612|FG010|Overall Study|Adverse Event|1|||
163419174|NCT04426695|590242613|FG011|Overall Study|Adverse Event|1|||
163419175|NCT04426695|590242614|FG012|Overall Study|Adverse Event|0|||
163419176|NCT04426695|590242615|FG013|Overall Study|Adverse Event|0|||
163419177|NCT04426695|590242616|FG014|Overall Study|Adverse Event|0|||
163419178|NCT04426695|590242617|FG015|Overall Study|Adverse Event|0|||
163419179|NCT04426695|590242618|FG016|Overall Study|Adverse Event|0|||
163419180|NCT04426695|590242619|FG017|Overall Study|Adverse Event|0|||
163419181|NCT04426695|590242602|FG000|Overall Study|Sponsor Request|0|||
163419182|NCT04426695|590242603|FG001|Overall Study|Sponsor Request|0|||
163419183|NCT04426695|590242604|FG002|Overall Study|Sponsor Request|0|||
163419184|NCT04426695|590242605|FG003|Overall Study|Sponsor Request|0|||
163419185|NCT04426695|590242606|FG004|Overall Study|Sponsor Request|0|||
163419186|NCT04426695|590242607|FG005|Overall Study|Sponsor Request|0|||
163419187|NCT04426695|590242608|FG006|Overall Study|Sponsor Request|1|||
163419188|NCT04426695|590242609|FG007|Overall Study|Sponsor Request|0|||
163419189|NCT04426695|590242610|FG008|Overall Study|Sponsor Request|0|||
163419190|NCT04426695|590242611|FG009|Overall Study|Sponsor Request|0|||
163419191|NCT04426695|590242612|FG010|Overall Study|Sponsor Request|0|||
163419192|NCT04426695|590242613|FG011|Overall Study|Sponsor Request|0|||
163419193|NCT04426695|590242614|FG012|Overall Study|Sponsor Request|0|||
163419194|NCT04426695|590242615|FG013|Overall Study|Sponsor Request|0|||
163419195|NCT04426695|590242616|FG014|Overall Study|Sponsor Request|0|||
163419196|NCT04426695|590242617|FG015|Overall Study|Sponsor Request|0|||
163419197|NCT04426695|590242618|FG016|Overall Study|Sponsor Request|0|||
163419198|NCT04426695|590242619|FG017|Overall Study|Sponsor Request|0|||
163419199|NCT04426695|590242602|FG000|Overall Study|Physician Decision|0|||
163419200|NCT04426695|590242603|FG001|Overall Study|Physician Decision|0|||
163419201|NCT04426695|590242604|FG002|Overall Study|Physician Decision|0|||
163419202|NCT04426695|590242605|FG003|Overall Study|Physician Decision|0|||
163419203|NCT04426695|590242606|FG004|Overall Study|Physician Decision|0|||
163419204|NCT04426695|590242607|FG005|Overall Study|Physician Decision|0|||
163419205|NCT04426695|590242608|FG006|Overall Study|Physician Decision|0|||
163419206|NCT04426695|590242609|FG007|Overall Study|Physician Decision|0|||
163419207|NCT04426695|590242610|FG008|Overall Study|Physician Decision|0|||
163419208|NCT04426695|590242611|FG009|Overall Study|Physician Decision|1|||
163419209|NCT04426695|590242612|FG010|Overall Study|Physician Decision|0|||
163419210|NCT04426695|590242613|FG011|Overall Study|Physician Decision|0|||
163419211|NCT04426695|590242614|FG012|Overall Study|Physician Decision|1|||
163419212|NCT04426695|590242615|FG013|Overall Study|Physician Decision|0|||
163419213|NCT04426695|590242616|FG014|Overall Study|Physician Decision|0|||
163419214|NCT04426695|590242617|FG015|Overall Study|Physician Decision|0|||
163419215|NCT04426695|590242618|FG016|Overall Study|Physician Decision|0|||
163419216|NCT04426695|590242619|FG017|Overall Study|Physician Decision|0|||
163419217|NCT04426695|590242602|FG000|Overall Study|Randomized but Never Treated|3|||
163419218|NCT04426695|590242603|FG001|Overall Study|Randomized but Never Treated|1|||
163419219|NCT04426695|590242604|FG002|Overall Study|Randomized but Never Treated|0|||
163419220|NCT04426695|590242605|FG003|Overall Study|Randomized but Never Treated|4|||
163419221|NCT04426695|590242606|FG004|Overall Study|Randomized but Never Treated|5|||
163419222|NCT04426695|590242607|FG005|Overall Study|Randomized but Never Treated|5|||
163419223|NCT04426695|590242608|FG006|Overall Study|Randomized but Never Treated|4|||
163419224|NCT04426695|590242609|FG007|Overall Study|Randomized but Never Treated|6|||
163419225|NCT04426695|590242610|FG008|Overall Study|Randomized but Never Treated|6|||
163419226|NCT04426695|590242611|FG009|Overall Study|Randomized but Never Treated|3|||
163419227|NCT04426695|590242612|FG010|Overall Study|Randomized but Never Treated|3|||
163419228|NCT04426695|590242613|FG011|Overall Study|Randomized but Never Treated|6|||
163419229|NCT04426695|590242614|FG012|Overall Study|Randomized but Never Treated|1|||
163419230|NCT04426695|590242615|FG013|Overall Study|Randomized but Never Treated|2|||
163419231|NCT04426695|590242616|FG014|Overall Study|Randomized but Never Treated|0|||
163419232|NCT04426695|590242617|FG015|Overall Study|Randomized but Never Treated|0|||
163419233|NCT04426695|590242618|FG016|Overall Study|Randomized but Never Treated|0|||
163419234|NCT04426695|590242619|FG017|Overall Study|Randomized but Never Treated|0|||
163419235|NCT00559273|590242620|FG000|Correction Period (20 Weeks)|Death|3|||
163419236|NCT00559273|590242621|FG001|Correction Period (20 Weeks)|Death|4|||
163419237|NCT00559273|590242620|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
163419238|NCT00559273|590242621|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
163419239|NCT00559273|590242620|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
163419240|NCT00559273|590242621|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
163419241|NCT00559273|590242620|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
163419242|NCT00559273|590242621|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
163419243|NCT00559273|590242620|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
163419244|NCT00559273|590242621|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
163419245|NCT00559273|590242620|FG000|Evaluation Period (8 Weeks)|Death|1|||
163419246|NCT00559273|590242621|FG001|Evaluation Period (8 Weeks)|Death|3|||
163419247|NCT00559273|590242620|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
163419248|NCT00559273|590242621|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
163419249|NCT00559273|590242620|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
163419250|NCT00559273|590242621|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
163419251|NCT00559273|590242620|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
163419252|NCT00559273|590242621|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
163419253|NCT03653390|590242625|FG000|Overall Study|Lost to Follow-up|12|||
163419254|NCT03653390|590242626|FG001|Overall Study|Lost to Follow-up|8|||
163419255|NCT03653390|590242627|FG002|Overall Study|Lost to Follow-up|7|||
163419256|NCT03653390|590242625|FG000|Overall Study|Withdrawal by Subject|6|||
163419257|NCT03653390|590242626|FG001|Overall Study|Withdrawal by Subject|1|||
163419258|NCT03653390|590242627|FG002|Overall Study|Withdrawal by Subject|1|||
163419259|NCT03653390|590242625|FG000|Overall Study|Death|1|||
163419260|NCT03653390|590242626|FG001|Overall Study|Death|0|||
163419261|NCT03653390|590242627|FG002|Overall Study|Death|0|||
163419262|NCT03653390|590242625|FG000|Overall Study|Paper Survey Lost|1|||
163419263|NCT03653390|590242626|FG001|Overall Study|Paper Survey Lost|0|||
163419264|NCT03653390|590242627|FG002|Overall Study|Paper Survey Lost|0|||
163419265|NCT00849667|590242630|FG000|Overall Study|Withdrawal by Subject|16|||
163419266|NCT00849667|590242631|FG001|Overall Study|Withdrawal by Subject|33|||
163419267|NCT00849667|590242632|FG002|Overall Study|Withdrawal by Subject|35|||
163419268|NCT00849667|590242630|FG000|Overall Study|Lost to Follow-up|8|||
163419269|NCT00849667|590242631|FG001|Overall Study|Lost to Follow-up|8|||
163419270|NCT00849667|590242632|FG002|Overall Study|Lost to Follow-up|8|||
163419271|NCT00849667|590242630|FG000|Overall Study|Adverse Event|1|||
163419272|NCT00849667|590242631|FG001|Overall Study|Adverse Event|2|||
163419273|NCT00849667|590242632|FG002|Overall Study|Adverse Event|0|||
163419274|NCT00849667|590242630|FG000|Overall Study|Other|18|||
163419275|NCT00849667|590242631|FG001|Overall Study|Other|19|||
163419276|NCT00849667|590242632|FG002|Overall Study|Other|18|||
163419277|NCT00849667|590242630|FG000|Overall Study|Progressive disease|119|||
163419278|NCT00849667|590242631|FG001|Overall Study|Progressive disease|100|||
163419279|NCT00849667|590242632|FG002|Overall Study|Progressive disease|112|||
163419280|NCT00849667|590242630|FG000|Overall Study|Sponsor decision|208|||
163419281|NCT00849667|590242631|FG001|Overall Study|Sponsor decision|204|||
163419282|NCT00849667|590242632|FG002|Overall Study|Sponsor decision|190|||
163419283|NCT00849667|590242630|FG000|Overall Study|Investigator discretion|0|||
163419284|NCT00849667|590242631|FG001|Overall Study|Investigator discretion|0|||
163419285|NCT00849667|590242632|FG002|Overall Study|Investigator discretion|1|||
163419286|NCT00189462|590242633|FG000|Overall Study|Lack of Efficacy|5|||
163419287|NCT00189462|590242634|FG001|Overall Study|Lack of Efficacy|1|||
163419288|NCT00189462|590242633|FG000|Overall Study|Lost to Follow-up|18|||
163419289|NCT00189462|590242634|FG001|Overall Study|Lost to Follow-up|20|||
163419290|NCT00553462|590242637|FG000|Overall Study|Adverse Event|4|||
163419291|NCT00553462|590242637|FG000|Overall Study|Progression|4|||
163419292|NCT00553462|590242637|FG000|Overall Study|Withdrawal by Subject|5|||
163419293|NCT00553462|590242637|FG000|Overall Study|Physician Decision|1|||
163419294|NCT01262625|590242638|FG000|Overall Study|Administrative Error|1|||
163419295|NCT01262625|590242639|FG001|Overall Study|Administrative Error|1|||
163419296|NCT01262625|590242638|FG000|Overall Study|Site Closed|1|||
163419297|NCT01262625|590242639|FG001|Overall Study|Site Closed|0|||
163419298|NCT00110994|590242640|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
163419299|NCT00110994|590242641|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
163419300|NCT00110994|590242640|FG000|Double-blind (DB) Treatment|Death|1|||
163419301|NCT00110994|590242641|FG001|Double-blind (DB) Treatment|Death|0|||
163419302|NCT00110994|590242640|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
163419303|NCT00110994|590242641|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
163419304|NCT00110994|590242640|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
163419305|NCT00110994|590242641|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
163419306|NCT00110994|590242640|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
163419307|NCT00110994|590242641|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
163419308|NCT00110994|590242640|FG000|Double-blind (DB) Treatment|other reasons|2|||
163419309|NCT00110994|590242641|FG001|Double-blind (DB) Treatment|other reasons|3|||
163419310|NCT00110994|590242640|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
163419311|NCT00110994|590242641|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
163419312|NCT00110994|590242640|FG000|Active Follow-up|Other reasons|0|||
163419313|NCT00110994|590242641|FG001|Active Follow-up|Other reasons|2|||
163419314|NCT00110994|590242640|FG000|Long Term Follow-up|Death|19|||
163419315|NCT00110994|590242641|FG001|Long Term Follow-up|Death|17|||
163419316|NCT04398732|590242642|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
163419317|NCT01500057|590242650|FG000|Overall Study|Lost to Follow-up|6|||
163419318|NCT01500057|590242651|FG001|Overall Study|Lost to Follow-up|4|||
163419319|NCT02318784|590242654|FG000|Overall Study|Adverse Event|13|||
163419320|NCT02318784|590242654|FG000|Overall Study|Death|2|||
163419321|NCT02318784|590242654|FG000|Overall Study|Progressive Disease|37|||
163419322|NCT02318784|590242654|FG000|Overall Study|Withdrawal by Subject|10|||
163419323|NCT03603652|590242659|FG000|Overall Study|Death|2|||
163419324|NCT03213366|590242664|FG000|Overall Study|Lost to Follow-up|9|||
163419325|NCT03213366|590242665|FG001|Overall Study|Lost to Follow-up|4|||
163419326|NCT02532855|590242666|FG000|Overall Study|Lost to Follow-up|4|||
163419327|NCT02532855|590242667|FG001|Overall Study|Lost to Follow-up|3|||
163419328|NCT02532855|590242666|FG000|Overall Study|Withdrawal by Subject|4|||
163419329|NCT02532855|590242667|FG001|Overall Study|Withdrawal by Subject|8|||
163419330|NCT00666926|590242668|FG000|Overall Study|Adverse Event|0|||
163419331|NCT00666926|590242669|FG001|Overall Study|Adverse Event|0|||
163419332|NCT00666926|590242670|FG002|Overall Study|Adverse Event|0|||
163419333|NCT00666926|590242671|FG003|Overall Study|Adverse Event|0|||
163419334|NCT00666926|590242672|FG004|Overall Study|Adverse Event|0|||
163419335|NCT00666926|590242673|FG005|Overall Study|Adverse Event|0|||
163419336|NCT00666926|590242674|FG006|Overall Study|Adverse Event|0|||
163419337|NCT00666926|590242675|FG007|Overall Study|Adverse Event|0|||
163419338|NCT00666926|590242676|FG008|Overall Study|Adverse Event|0|||
163419339|NCT00666926|590242677|FG009|Overall Study|Adverse Event|2|||
163419340|NCT00666926|590242678|FG010|Overall Study|Adverse Event|2|||
163419341|NCT00666926|590242679|FG011|Overall Study|Adverse Event|2|||
163419342|NCT00666926|590242680|FG012|Overall Study|Adverse Event|0|||
163419343|NCT00666926|590242681|FG013|Overall Study|Adverse Event|1|||
163419344|NCT00666926|590242682|FG014|Overall Study|Adverse Event|0|||
163419345|NCT00666926|590242683|FG015|Overall Study|Adverse Event|0|||
163419346|NCT00666926|590242668|FG000|Overall Study|Laboratory abnormality|0|||
163419347|NCT00666926|590242669|FG001|Overall Study|Laboratory abnormality|0|||
163419348|NCT00666926|590242670|FG002|Overall Study|Laboratory abnormality|0|||
163419349|NCT00666926|590242671|FG003|Overall Study|Laboratory abnormality|0|||
163419350|NCT00666926|590242672|FG004|Overall Study|Laboratory abnormality|0|||
163419351|NCT00666926|590242673|FG005|Overall Study|Laboratory abnormality|0|||
163419352|NCT00666926|590242674|FG006|Overall Study|Laboratory abnormality|0|||
163419353|NCT00666926|590242675|FG007|Overall Study|Laboratory abnormality|0|||
163419354|NCT00666926|590242676|FG008|Overall Study|Laboratory abnormality|0|||
163419355|NCT00666926|590242677|FG009|Overall Study|Laboratory abnormality|0|||
163419356|NCT00666926|590242678|FG010|Overall Study|Laboratory abnormality|1|||
163419357|NCT00666926|590242679|FG011|Overall Study|Laboratory abnormality|0|||
163419358|NCT00666926|590242680|FG012|Overall Study|Laboratory abnormality|0|||
163419359|NCT00666926|590242681|FG013|Overall Study|Laboratory abnormality|0|||
163419360|NCT00666926|590242682|FG014|Overall Study|Laboratory abnormality|0|||
163419361|NCT00666926|590242683|FG015|Overall Study|Laboratory abnormality|1|||
163419362|NCT00666926|590242668|FG000|Overall Study|Lack of Efficacy|0|||
163419363|NCT00666926|590242669|FG001|Overall Study|Lack of Efficacy|0|||
163419364|NCT00666926|590242670|FG002|Overall Study|Lack of Efficacy|0|||
163419365|NCT00666926|590242671|FG003|Overall Study|Lack of Efficacy|0|||
163419366|NCT00666926|590242672|FG004|Overall Study|Lack of Efficacy|0|||
163419367|NCT00666926|590242673|FG005|Overall Study|Lack of Efficacy|1|||
163419368|NCT00666926|590242674|FG006|Overall Study|Lack of Efficacy|0|||
163419369|NCT00666926|590242675|FG007|Overall Study|Lack of Efficacy|0|||
163419370|NCT00666926|590242676|FG008|Overall Study|Lack of Efficacy|0|||
163419371|NCT00666926|590242677|FG009|Overall Study|Lack of Efficacy|0|||
163419372|NCT00666926|590242678|FG010|Overall Study|Lack of Efficacy|0|||
163419373|NCT00666926|590242679|FG011|Overall Study|Lack of Efficacy|1|||
163419374|NCT00666926|590242680|FG012|Overall Study|Lack of Efficacy|0|||
163419375|NCT00666926|590242681|FG013|Overall Study|Lack of Efficacy|0|||
163419376|NCT00666926|590242682|FG014|Overall Study|Lack of Efficacy|0|||
163419377|NCT00666926|590242683|FG015|Overall Study|Lack of Efficacy|0|||
163419378|NCT00666926|590242668|FG000|Overall Study|Lost to Follow-up|0|||
163419379|NCT00666926|590242669|FG001|Overall Study|Lost to Follow-up|0|||
163419380|NCT00666926|590242670|FG002|Overall Study|Lost to Follow-up|0|||
163419381|NCT00666926|590242671|FG003|Overall Study|Lost to Follow-up|1|||
163419382|NCT00666926|590242672|FG004|Overall Study|Lost to Follow-up|0|||
163419383|NCT00666926|590242673|FG005|Overall Study|Lost to Follow-up|0|||
163419384|NCT00666926|590242674|FG006|Overall Study|Lost to Follow-up|0|||
163419385|NCT00666926|590242675|FG007|Overall Study|Lost to Follow-up|0|||
163419386|NCT00666926|590242676|FG008|Overall Study|Lost to Follow-up|0|||
163419387|NCT00666926|590242677|FG009|Overall Study|Lost to Follow-up|0|||
163419388|NCT00666926|590242678|FG010|Overall Study|Lost to Follow-up|0|||
163419389|NCT00666926|590242679|FG011|Overall Study|Lost to Follow-up|0|||
163419390|NCT00666926|590242680|FG012|Overall Study|Lost to Follow-up|0|||
163419391|NCT00666926|590242681|FG013|Overall Study|Lost to Follow-up|0|||
163419392|NCT00666926|590242682|FG014|Overall Study|Lost to Follow-up|0|||
163419393|NCT00666926|590242683|FG015|Overall Study|Lost to Follow-up|0|||
163419394|NCT00666926|590242668|FG000|Overall Study|Other|2|||
163419395|NCT00666926|590242669|FG001|Overall Study|Other|4|||
163419396|NCT00666926|590242670|FG002|Overall Study|Other|3|||
163419397|NCT00666926|590242671|FG003|Overall Study|Other|3|||
163419398|NCT00666926|590242672|FG004|Overall Study|Other|3|||
163419399|NCT00666926|590242673|FG005|Overall Study|Other|3|||
163419400|NCT00666926|590242674|FG006|Overall Study|Other|4|||
163419401|NCT00666926|590242675|FG007|Overall Study|Other|0|||
163419402|NCT00666926|590242676|FG008|Overall Study|Other|3|||
163419403|NCT00666926|590242677|FG009|Overall Study|Other|5|||
163419404|NCT00666926|590242678|FG010|Overall Study|Other|3|||
163419405|NCT00666926|590242679|FG011|Overall Study|Other|26|||
163419406|NCT00666926|590242680|FG012|Overall Study|Other|3|||
163419407|NCT00666926|590242681|FG013|Overall Study|Other|2|||
163419408|NCT00666926|590242682|FG014|Overall Study|Other|4|||
163419409|NCT00666926|590242683|FG015|Overall Study|Other|4|||
163419410|NCT00666926|590242668|FG000|Overall Study|Withdrawal by Subject|0|||
163419411|NCT00666926|590242669|FG001|Overall Study|Withdrawal by Subject|0|||
163419412|NCT00666926|590242670|FG002|Overall Study|Withdrawal by Subject|0|||
163419413|NCT00666926|590242671|FG003|Overall Study|Withdrawal by Subject|0|||
163419414|NCT00666926|590242672|FG004|Overall Study|Withdrawal by Subject|0|||
163419415|NCT00666926|590242673|FG005|Overall Study|Withdrawal by Subject|0|||
163419416|NCT00666926|590242674|FG006|Overall Study|Withdrawal by Subject|0|||
163419417|NCT00666926|590242675|FG007|Overall Study|Withdrawal by Subject|1|||
163419418|NCT00666926|590242676|FG008|Overall Study|Withdrawal by Subject|0|||
163419419|NCT00666926|590242677|FG009|Overall Study|Withdrawal by Subject|3|||
163419420|NCT00666926|590242678|FG010|Overall Study|Withdrawal by Subject|0|||
163419421|NCT00666926|590242679|FG011|Overall Study|Withdrawal by Subject|3|||
163419422|NCT00666926|590242680|FG012|Overall Study|Withdrawal by Subject|0|||
163419423|NCT00666926|590242681|FG013|Overall Study|Withdrawal by Subject|1|||
163419424|NCT00666926|590242682|FG014|Overall Study|Withdrawal by Subject|3|||
163419425|NCT00666926|590242683|FG015|Overall Study|Withdrawal by Subject|3|||
163419426|NCT00666926|590242668|FG000|Overall Study|Death|0|||
163419427|NCT00666926|590242669|FG001|Overall Study|Death|0|||
163419428|NCT00666926|590242670|FG002|Overall Study|Death|0|||
163419429|NCT00666926|590242671|FG003|Overall Study|Death|0|||
163419430|NCT00666926|590242672|FG004|Overall Study|Death|0|||
163419431|NCT00666926|590242673|FG005|Overall Study|Death|0|||
163419432|NCT00666926|590242674|FG006|Overall Study|Death|0|||
163419433|NCT00666926|590242675|FG007|Overall Study|Death|0|||
163419434|NCT00666926|590242676|FG008|Overall Study|Death|0|||
163419435|NCT00666926|590242677|FG009|Overall Study|Death|0|||
163419436|NCT00666926|590242678|FG010|Overall Study|Death|0|||
163419437|NCT00666926|590242679|FG011|Overall Study|Death|1|||
163419438|NCT00666926|590242680|FG012|Overall Study|Death|0|||
163419439|NCT00666926|590242681|FG013|Overall Study|Death|0|||
163419440|NCT00666926|590242682|FG014|Overall Study|Death|0|||
163419441|NCT00666926|590242683|FG015|Overall Study|Death|0|||
163419442|NCT01960855|590242686|FG000|Overall Study|Subject noncompliant|1|||
163419443|NCT01960855|590242687|FG001|Overall Study|Subject noncompliant|0|||
163419444|NCT01960855|590242688|FG002|Overall Study|Subject noncompliant|0|||
163419445|NCT01960855|590242689|FG003|Overall Study|Subject noncompliant|0|||
163419446|NCT01960855|590242690|FG004|Overall Study|Subject noncompliant|0|||
163419447|NCT01960855|590242686|FG000|Overall Study|Adverse Event|2|||
163419448|NCT01960855|590242687|FG001|Overall Study|Adverse Event|0|||
163419449|NCT01960855|590242688|FG002|Overall Study|Adverse Event|6|||
163419450|NCT01960855|590242689|FG003|Overall Study|Adverse Event|2|||
163419451|NCT01960855|590242690|FG004|Overall Study|Adverse Event|2|||
163419452|NCT01960855|590242686|FG000|Overall Study|Lack of Efficacy|1|||
163419453|NCT01960855|590242687|FG001|Overall Study|Lack of Efficacy|1|||
163419454|NCT01960855|590242688|FG002|Overall Study|Lack of Efficacy|0|||
163419455|NCT01960855|590242689|FG003|Overall Study|Lack of Efficacy|0|||
163419456|NCT01960855|590242690|FG004|Overall Study|Lack of Efficacy|0|||
163419457|NCT01960855|590242686|FG000|Overall Study|Other|2|||
163419458|NCT01960855|590242687|FG001|Overall Study|Other|1|||
163419459|NCT01960855|590242688|FG002|Overall Study|Other|1|||
163419460|NCT01960855|590242689|FG003|Overall Study|Other|1|||
163419461|NCT01960855|590242690|FG004|Overall Study|Other|0|||
163419462|NCT01960855|590242686|FG000|Overall Study|Consent withdrawn by subject|3|||
163419463|NCT01960855|590242687|FG001|Overall Study|Consent withdrawn by subject|1|||
163419464|NCT01960855|590242688|FG002|Overall Study|Consent withdrawn by subject|2|||
163419465|NCT01960855|590242689|FG003|Overall Study|Consent withdrawn by subject|1|||
163419466|NCT01960855|590242690|FG004|Overall Study|Consent withdrawn by subject|1|||
163419467|NCT01960855|590242686|FG000|Overall Study|Lost to Follow-up|2|||
163419468|NCT01960855|590242687|FG001|Overall Study|Lost to Follow-up|1|||
163419469|NCT01960855|590242688|FG002|Overall Study|Lost to Follow-up|0|||
163419470|NCT01960855|590242689|FG003|Overall Study|Lost to Follow-up|0|||
163419471|NCT01960855|590242690|FG004|Overall Study|Lost to Follow-up|2|||
163419472|NCT01879410|590242691|FG000|Overall Study|Adverse Event|9|||
163419473|NCT01879410|590242692|FG001|Overall Study|Adverse Event|14|||
163419474|NCT01879410|590242691|FG000|Overall Study|Lack of Efficacy|4|||
163419475|NCT01879410|590242692|FG001|Overall Study|Lack of Efficacy|6|||
163419476|NCT01879410|590242691|FG000|Overall Study|Protocol Violation|1|||
163419477|NCT01879410|590242692|FG001|Overall Study|Protocol Violation|7|||
163419478|NCT01879410|590242691|FG000|Overall Study|Lost to Follow-up|2|||
163419479|NCT01879410|590242692|FG001|Overall Study|Lost to Follow-up|1|||
163419480|NCT01879410|590242691|FG000|Overall Study|Withdrawal by Subject|7|||
163419481|NCT01879410|590242692|FG001|Overall Study|Withdrawal by Subject|8|||
163419482|NCT01879410|590242691|FG000|Overall Study|Randomised in Error|1|||
163419483|NCT01879410|590242692|FG001|Overall Study|Randomised in Error|2|||
163419484|NCT02058147|590242693|FG000|Overall Study|Randomized but not treated|0|||
163419485|NCT02058147|590242694|FG001|Overall Study|Randomized but not treated|0|||
163419486|NCT02058147|590242695|FG002|Overall Study|Randomized but not treated|1|||
163419487|NCT02058147|590242693|FG000|Overall Study|Adverse Event|12|||
163419488|NCT02058147|590242694|FG001|Overall Study|Adverse Event|9|||
163419489|NCT02058147|590242695|FG002|Overall Study|Adverse Event|21|||
163419490|NCT02058147|590242693|FG000|Overall Study|Lack of Efficacy|1|||
163419491|NCT02058147|590242694|FG001|Overall Study|Lack of Efficacy|0|||
163419492|NCT02058147|590242695|FG002|Overall Study|Lack of Efficacy|3|||
163419493|NCT02058147|590242693|FG000|Overall Study|Poor compliance to protocol|8|||
163419494|NCT02058147|590242694|FG001|Overall Study|Poor compliance to protocol|9|||
163419495|NCT02058147|590242695|FG002|Overall Study|Poor compliance to protocol|4|||
163419496|NCT02058147|590242693|FG000|Overall Study|Other than specified|8|||
163419497|NCT02058147|590242694|FG001|Overall Study|Other than specified|9|||
163419498|NCT02058147|590242695|FG002|Overall Study|Other than specified|0|||
163419499|NCT00773279|590242697|FG000|Period 1|Adverse Event|2|||
163419500|NCT00773279|590242698|FG001|Period 1|Adverse Event|1|||
163419501|NCT00773279|590242697|FG000|Period 1|Lack of Efficacy|0|||
163419502|NCT00773279|590242698|FG001|Period 1|Lack of Efficacy|2|||
163419503|NCT00773279|590242697|FG000|Period 1|Unclassified|5|||
163419504|NCT00773279|590242698|FG001|Period 1|Unclassified|1|||
163419505|NCT00773279|590242697|FG000|Period 2|Adverse Event|0|||
163419506|NCT00773279|590242698|FG001|Period 2|Adverse Event|1|||
163419507|NCT00773279|590242697|FG000|Period 2|Lack of Efficacy|1|||
163419508|NCT00773279|590242698|FG001|Period 2|Lack of Efficacy|0|||
163419509|NCT00773279|590242697|FG000|Period 2|Protocol Violation|0|||
163419510|NCT00773279|590242698|FG001|Period 2|Protocol Violation|3|||
163419511|NCT00773279|590242697|FG000|Period 2|Unclassified|2|||
163419512|NCT00773279|590242698|FG001|Period 2|Unclassified|2|||
163419513|NCT04178772|590242699|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
163419514|NCT04178772|590242699|FG000|Overall Study|study terminated early due to COVID-19|7|||
163419515|NCT01737931|590242700|FG000|Overall Study|Withdrawal by Subject|0|||
163419516|NCT01737931|590242701|FG001|Overall Study|Withdrawal by Subject|1|||
163419517|NCT01737931|590242702|FG002|Overall Study|Withdrawal by Subject|1|||
163419518|NCT01737931|590242700|FG000|Overall Study|Physician Decision|0|||
163419519|NCT01737931|590242701|FG001|Overall Study|Physician Decision|1|||
163419520|NCT01737931|590242702|FG002|Overall Study|Physician Decision|0|||
163419521|NCT04897867|590242703|FG000|Overall Study|Withdrawal of Consent|1|||
163419522|NCT04897867|590242703|FG000|Overall Study|Pregnancy|1|||
163419523|NCT04897867|590242703|FG000|Overall Study|Lost to Follow-up|7|||
163419524|NCT04897867|590242703|FG000|Overall Study|Reason not Specified|2|||
163419525|NCT01948830|590242704|FG000|Overall Study|Physician Decision|1|||
163419526|NCT01948830|590242705|FG001|Overall Study|Physician Decision|3|||
163419527|NCT01948830|590242704|FG000|Overall Study|Protocol deviation|1|||
163419528|NCT01948830|590242705|FG001|Overall Study|Protocol deviation|2|||
163419529|NCT01948830|590242704|FG000|Overall Study|Lost to Follow-up|5|||
163419530|NCT01948830|590242705|FG001|Overall Study|Lost to Follow-up|4|||
163419531|NCT01948830|590242704|FG000|Overall Study|Withdrawal by Subject|14|||
163419532|NCT01948830|590242705|FG001|Overall Study|Withdrawal by Subject|17|||
163419533|NCT01948830|590242704|FG000|Overall Study|Adverse Event|9|||
163419534|NCT01948830|590242705|FG001|Overall Study|Adverse Event|2|||
163419535|NCT01948830|590242704|FG000|Overall Study|Death|3|||
163419536|NCT01948830|590242705|FG001|Overall Study|Death|4|||
163419537|NCT01145560|590242706|FG000|Overall Study|Withdrawal by Subject|2|||
163419538|NCT01145560|590242707|FG001|Overall Study|Withdrawal by Subject|1|||
163419539|NCT01145560|590242708|FG002|Overall Study|Withdrawal by Subject|0|||
163419540|NCT01145560|590242706|FG000|Overall Study|Lost to Follow-up|1|||
163419541|NCT01145560|590242707|FG001|Overall Study|Lost to Follow-up|1|||
163419542|NCT01145560|590242708|FG002|Overall Study|Lost to Follow-up|1|||
163419543|NCT01145560|590242706|FG000|Overall Study|No study drug by 24h after organ failure|1|||
163419544|NCT01145560|590242707|FG001|Overall Study|No study drug by 24h after organ failure|0|||
163419545|NCT01145560|590242708|FG002|Overall Study|No study drug by 24h after organ failure|0|||
163419546|NCT01145560|590242706|FG000|Overall Study|Accidental unblinding of study treatment|0|||
163419547|NCT01145560|590242707|FG001|Overall Study|Accidental unblinding of study treatment|1|||
163419548|NCT01145560|590242708|FG002|Overall Study|Accidental unblinding of study treatment|0|||
163419549|NCT01145560|590242706|FG000|Overall Study|False insurance information|0|||
163419550|NCT01145560|590242707|FG001|Overall Study|False insurance information|1|||
163419551|NCT01145560|590242708|FG002|Overall Study|False insurance information|0|||
163419552|NCT01145560|590242706|FG000|Overall Study|Withdrawal of therapy|0|||
163419553|NCT01145560|590242707|FG001|Overall Study|Withdrawal of therapy|0|||
163419554|NCT01145560|590242708|FG002|Overall Study|Withdrawal of therapy|1|||
163419555|NCT00712348|590242709|FG000|Overall Study|Withdrawal by Subject|1|||
163419556|NCT01557166|590242715|FG000|Overall Study|Adverse Event|20|||
163419557|NCT01557166|590242716|FG001|Overall Study|Adverse Event|6|||
163419558|NCT01557166|590242715|FG000|Overall Study|Lack of Efficacy|2|||
163419559|NCT01557166|590242716|FG001|Overall Study|Lack of Efficacy|1|||
163419560|NCT01557166|590242715|FG000|Overall Study|Protocol Violation|8|||
163419561|NCT01557166|590242716|FG001|Overall Study|Protocol Violation|5|||
163419562|NCT01557166|590242715|FG000|Overall Study|Withdrawn consent|12|||
163419563|NCT01557166|590242716|FG001|Overall Study|Withdrawn consent|20|||
163419564|NCT01557166|590242715|FG000|Overall Study|Target dose not tolerated|1|||
163419565|NCT01557166|590242716|FG001|Overall Study|Target dose not tolerated|0|||
163419566|NCT01557166|590242715|FG000|Overall Study|Psychiatric disorder|1|||
163419567|NCT01557166|590242716|FG001|Overall Study|Psychiatric disorder|0|||
163419568|NCT01557166|590242715|FG000|Overall Study|Unclassified|2|||
163419569|NCT01557166|590242716|FG001|Overall Study|Unclassified|5|||
163419570|NCT01465659|590242717|FG000|Completed 1 Cycle of Treatment|Death|0|||
163419571|NCT01465659|590242718|FG001|Completed 1 Cycle of Treatment|Death|1|||
163419572|NCT01465659|590242719|FG002|Completed 1 Cycle of Treatment|Death|0|||
163419573|NCT01465659|590242720|FG003|Completed 1 Cycle of Treatment|Death|0|||
163419574|NCT01465659|590242717|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
163419575|NCT01465659|590242718|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
163419576|NCT01465659|590242719|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
163419577|NCT01465659|590242720|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
163419578|NCT01465659|590242717|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
163419579|NCT01465659|590242718|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
163419580|NCT01465659|590242719|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
163419581|NCT01465659|590242720|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
163419582|NCT01465659|590242717|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
163419583|NCT01465659|590242718|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
163419584|NCT01465659|590242719|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
163419585|NCT01465659|590242720|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
163419586|NCT01465659|590242717|FG000|Completed Follow for 1 Year|Death|6|||
163419587|NCT01465659|590242718|FG001|Completed Follow for 1 Year|Death|3|||
163419588|NCT01465659|590242719|FG002|Completed Follow for 1 Year|Death|2|||
163419589|NCT01465659|590242720|FG003|Completed Follow for 1 Year|Death|4|||
163419590|NCT02411747|590242721|FG000|Overall Study|Withdrawal by Subject|1|||
163419591|NCT02411747|590242722|FG001|Overall Study|Withdrawal by Subject|0|||
163419592|NCT02411747|590242721|FG000|Overall Study|Protocol Violation|2|||
163419593|NCT02411747|590242722|FG001|Overall Study|Protocol Violation|4|||
163419594|NCT02149810|590242723|FG000|Overall Study|Physician Decision|1|||
163419595|NCT02149810|590242724|FG001|Overall Study|Physician Decision|2|||
163419596|NCT02149810|590242723|FG000|Overall Study|Lost to Follow-up|2|||
163419597|NCT02149810|590242724|FG001|Overall Study|Lost to Follow-up|1|||
163419598|NCT02149810|590242723|FG000|Overall Study|Withdrawal by Subject|5|||
163419599|NCT02149810|590242724|FG001|Overall Study|Withdrawal by Subject|1|||
163419600|NCT00428597|590242725|FG000|Overall Study|Randomized but not treated|3|||
163419601|NCT00428597|590242726|FG001|Overall Study|Randomized but not treated|3|||
163419602|NCT00428597|590242725|FG000|Overall Study|Objective Progression or Relapse|19|||
163419603|NCT00428597|590242726|FG001|Overall Study|Objective Progression or Relapse|47|||
163419604|NCT00428597|590242725|FG000|Overall Study|Study Terminated by Sponsor|41|||
163419605|NCT00428597|590242726|FG001|Overall Study|Study Terminated by Sponsor|16|||
163419606|NCT00428597|590242725|FG000|Overall Study|Adverse Event|15|||
163419607|NCT00428597|590242726|FG001|Overall Study|Adverse Event|7|||
163419608|NCT00428597|590242725|FG000|Overall Study|Global Deterioration of Health Status|1|||
163419609|NCT00428597|590242726|FG001|Overall Study|Global Deterioration of Health Status|5|||
163419610|NCT00428597|590242725|FG000|Overall Study|Protocol Violation|2|||
163419611|NCT00428597|590242726|FG001|Overall Study|Protocol Violation|1|||
163419612|NCT00428597|590242725|FG000|Overall Study|Withdrawal by Subject|2|||
163419613|NCT00428597|590242726|FG001|Overall Study|Withdrawal by Subject|1|||
163419614|NCT00428597|590242725|FG000|Overall Study|Other|1|||
163419615|NCT00428597|590242726|FG001|Overall Study|Other|1|||
163419616|NCT00428597|590242725|FG000|Overall Study|Lost to Follow-up|0|||
163419617|NCT00428597|590242726|FG001|Overall Study|Lost to Follow-up|1|||
163419618|NCT00428597|590242725|FG000|Overall Study|Pregnancy|1|||
163419619|NCT00428597|590242726|FG001|Overall Study|Pregnancy|0|||
163419620|NCT00428597|590242725|FG000|Overall Study|Death|1|||
163419621|NCT00428597|590242726|FG001|Overall Study|Death|3|||
163419622|NCT00675597|590242727|FG000|Overall Study|Withdrawal by Subject|3|||
163419623|NCT00560755|590242729|FG000|Overall Study|Protocol Violation|15|||
163419624|NCT00560755|590242729|FG000|Overall Study|Withdrawal by Subject|26|||
163419625|NCT00560755|590242729|FG000|Overall Study|Lost to Follow-up|9|||
163419626|NCT00560755|590242729|FG000|Overall Study|Adverse Event|8|||
163419627|NCT00560755|590242729|FG000|Overall Study|Physician Decision|2|||
163419628|NCT03828487|590242732|FG000|Overall Study|Physician Decision|1|||
163419629|NCT02474329|590242737|FG000|Overall Study|Withdraw or did not contribute data.|13|||
163419630|NCT01356589|590242738|FG000|Overall Study|Enrolled, but not treated|3|||
163419631|NCT01356589|590242738|FG000|Overall Study|Dose data not recorded|2|||
163419632|NCT02447848|590242739|FG000|Overall Study|Patient discharged|3|||
163419633|NCT02447848|590242739|FG000|Overall Study|Lack of Efficacy|4|||
163419634|NCT02447848|590242739|FG000|Overall Study|Withdrawal by Subject|4|||
163419635|NCT02663895|590244527|FG000|Overall Study|Adverse Event|3|||
163419636|NCT02663895|590244527|FG000|Overall Study|Physician Decision|2|||
163419637|NCT02663895|590244527|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
163419638|NCT02663895|590244527|FG000|Overall Study|Withdrawal by Subject|1|||
163419639|NCT00809328|590244528|FG000|Overall Study|Lack of Efficacy|18|||
163419640|NCT00809328|590244528|FG000|Overall Study|Adverse Event|6|||
163419641|NCT00809328|590244528|FG000|Overall Study|Protocol Violation|3|||
163419642|NCT00809328|590244528|FG000|Overall Study|Withdrawal by Subject|2|||
163419643|NCT00008385|590244529|FG000|Overall Study|Off treatment reasons not reported|79|||
163419644|NCT00008385|590244530|FG001|Overall Study|Off treatment reasons not reported|70|||
163419645|NCT00008385|590244529|FG000|Overall Study|Progressive disease|52|||
163419646|NCT00008385|590244530|FG001|Overall Study|Progressive disease|117|||
163419647|NCT00008385|590244529|FG000|Overall Study|Adverse Event|8|||
163419648|NCT00008385|590244530|FG001|Overall Study|Adverse Event|20|||
163419649|NCT00008385|590244529|FG000|Overall Study|Death|12|||
163419650|NCT00008385|590244530|FG001|Overall Study|Death|18|||
163419651|NCT00008385|590244529|FG000|Overall Study|Withdrawal by Subject|67|||
163419652|NCT00008385|590244530|FG001|Overall Study|Withdrawal by Subject|157|||
163419653|NCT00008385|590244529|FG000|Overall Study|Start non-protocol therapy|3|||
163419654|NCT00008385|590244530|FG001|Overall Study|Start non-protocol therapy|1|||
163419655|NCT00008385|590244529|FG000|Overall Study|Other complicating disease|17|||
163419656|NCT00008385|590244530|FG001|Overall Study|Other complicating disease|30|||
163419657|NCT00008385|590244529|FG000|Overall Study|Maximum dose reached|0|||
163419658|NCT00008385|590244530|FG001|Overall Study|Maximum dose reached|2|||
163419659|NCT00008385|590244529|FG000|Overall Study|Other|105|||
163419660|NCT00008385|590244530|FG001|Overall Study|Other|212|||
163419661|NCT00008385|590244529|FG000|Overall Study|Not start protocol therapy|44|||
163419662|NCT00008385|590244530|FG001|Overall Study|Not start protocol therapy|175|||
163419663|NCT00365989|590244533|FG000|Overall Study|Withdrawal by Subject|1|||
163419664|NCT00365989|590244533|FG000|Overall Study|Non-compliance|1|||
163419665|NCT00317044|590244534|FG000|Overall Study|Protocol Violation|28|||
163419666|NCT00317044|590244535|FG001|Overall Study|Protocol Violation|22|||
163419667|NCT00317044|590244536|FG002|Overall Study|Protocol Violation|20|||
163419668|NCT00317044|590244534|FG000|Overall Study|Adverse Event|4|||
163419669|NCT00317044|590244535|FG001|Overall Study|Adverse Event|7|||
163419670|NCT00317044|590244536|FG002|Overall Study|Adverse Event|4|||
163419671|NCT00317044|590244534|FG000|Overall Study|Withdrawal by Subject|10|||
163419672|NCT00317044|590244535|FG001|Overall Study|Withdrawal by Subject|7|||
163419673|NCT00317044|590244536|FG002|Overall Study|Withdrawal by Subject|12|||
163419674|NCT00317044|590244534|FG000|Overall Study|Lost to Follow-up|0|||
163419675|NCT00317044|590244535|FG001|Overall Study|Lost to Follow-up|2|||
163419676|NCT00317044|590244536|FG002|Overall Study|Lost to Follow-up|3|||
163419677|NCT00317044|590244534|FG000|Overall Study|Multiple Reasons|6|||
163419678|NCT00317044|590244535|FG001|Overall Study|Multiple Reasons|2|||
163419679|NCT00317044|590244536|FG002|Overall Study|Multiple Reasons|6|||
163419680|NCT04317690|590244539|FG000|Overall Study|did not have complete information for primary outcome|0|||
163419681|NCT04317690|590244540|FG001|Overall Study|did not have complete information for primary outcome|4|||
163419682|NCT04317690|590244541|FG002|Overall Study|did not have complete information for primary outcome|0|||
163419683|NCT04317690|590244542|FG003|Overall Study|did not have complete information for primary outcome|2|||
163419684|NCT04317690|590244543|FG004|Overall Study|did not have complete information for primary outcome|0|||
163419685|NCT02318095|590244544|FG000|Overall Study|Adverse Event|1|||
163419686|NCT00600171|590244547|FG000|Overall Study|Adverse Event|0|||
163419687|NCT00600171|590244548|FG001|Overall Study|Adverse Event|1|||
163419688|NCT00600171|590244549|FG002|Overall Study|Adverse Event|0|||
163419689|NCT00600171|590244550|FG003|Overall Study|Adverse Event|0|||
163419690|NCT00600171|590244551|FG004|Overall Study|Adverse Event|1|||
163419691|NCT00600171|590244552|FG005|Overall Study|Adverse Event|0|||
163419692|NCT00600171|590244547|FG000|Overall Study|Lack of Efficacy|9|||
163419693|NCT00600171|590244548|FG001|Overall Study|Lack of Efficacy|12|||
163419694|NCT00600171|590244549|FG002|Overall Study|Lack of Efficacy|3|||
163419695|NCT00600171|590244550|FG003|Overall Study|Lack of Efficacy|5|||
163419696|NCT00600171|590244551|FG004|Overall Study|Lack of Efficacy|4|||
163419697|NCT00600171|590244552|FG005|Overall Study|Lack of Efficacy|0|||
163419698|NCT00600171|590244547|FG000|Overall Study|Protocol Violation|1|||
163419699|NCT00600171|590244548|FG001|Overall Study|Protocol Violation|2|||
163419700|NCT00600171|590244549|FG002|Overall Study|Protocol Violation|0|||
163419701|NCT00600171|590244550|FG003|Overall Study|Protocol Violation|1|||
163419702|NCT00600171|590244551|FG004|Overall Study|Protocol Violation|0|||
163419703|NCT00600171|590244552|FG005|Overall Study|Protocol Violation|0|||
163419704|NCT00600171|590244547|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
163419705|NCT00600171|590244548|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
163419706|NCT00600171|590244549|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
163419707|NCT00600171|590244550|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
163419708|NCT00600171|590244551|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
163419709|NCT00600171|590244552|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
163419710|NCT00600171|590244547|FG000|Overall Study|Withdrawal by Subject|3|||
163419711|NCT00600171|590244548|FG001|Overall Study|Withdrawal by Subject|0|||
163419712|NCT00600171|590244549|FG002|Overall Study|Withdrawal by Subject|0|||
163419713|NCT00600171|590244550|FG003|Overall Study|Withdrawal by Subject|1|||
163419714|NCT00600171|590244551|FG004|Overall Study|Withdrawal by Subject|1|||
163419715|NCT00600171|590244552|FG005|Overall Study|Withdrawal by Subject|1|||
163419716|NCT00600171|590244547|FG000|Overall Study|Physician Decision|0|||
163419717|NCT00600171|590244548|FG001|Overall Study|Physician Decision|1|||
163419718|NCT00600171|590244549|FG002|Overall Study|Physician Decision|0|||
163419719|NCT00600171|590244550|FG003|Overall Study|Physician Decision|1|||
163419720|NCT00600171|590244551|FG004|Overall Study|Physician Decision|0|||
163419721|NCT00600171|590244552|FG005|Overall Study|Physician Decision|2|||
163419722|NCT00600171|590244547|FG000|Overall Study|Lost to Follow-up|0|||
163419723|NCT00600171|590244548|FG001|Overall Study|Lost to Follow-up|0|||
163419724|NCT00600171|590244549|FG002|Overall Study|Lost to Follow-up|0|||
163419725|NCT00600171|590244550|FG003|Overall Study|Lost to Follow-up|1|||
163419726|NCT00600171|590244551|FG004|Overall Study|Lost to Follow-up|0|||
163419727|NCT00600171|590244552|FG005|Overall Study|Lost to Follow-up|0|||
163419728|NCT02367521|590244553|FG000|Overall Study|severe headache after intervention|2|||
163419729|NCT02367521|590244554|FG001|Overall Study|severe headache after intervention|0|||
163419730|NCT02367521|590244553|FG000|Overall Study|unable to find transportation|2|||
163419731|NCT02367521|590244554|FG001|Overall Study|unable to find transportation|0|||
163419732|NCT00542191|590244555|FG000|Overall Study|Death|3|||
163419733|NCT01014585|590244566|FG000|Overall Study|Adverse Event|0|||
163419734|NCT01014585|590244567|FG001|Overall Study|Adverse Event|2|||
163419735|NCT01014585|590244568|FG002|Overall Study|Adverse Event|0|||
163419736|NCT01014585|590244569|FG003|Overall Study|Adverse Event|3|||
163419737|NCT01014585|590244566|FG000|Overall Study|Withdrawal by Subject|2|||
163419738|NCT01014585|590244567|FG001|Overall Study|Withdrawal by Subject|0|||
163419739|NCT01014585|590244568|FG002|Overall Study|Withdrawal by Subject|1|||
163419740|NCT01014585|590244569|FG003|Overall Study|Withdrawal by Subject|3|||
163419741|NCT01014585|590244566|FG000|Overall Study|Lost to Follow-up|0|||
163419742|NCT01014585|590244567|FG001|Overall Study|Lost to Follow-up|0|||
163419743|NCT01014585|590244568|FG002|Overall Study|Lost to Follow-up|0|||
163419744|NCT01014585|590244569|FG003|Overall Study|Lost to Follow-up|2|||
163419745|NCT01014585|590244566|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
163419746|NCT01014585|590244567|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
163419747|NCT01014585|590244568|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
163419748|NCT01014585|590244569|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
163419749|NCT00508391|590244573|FG000|First Treatment|Withdrawal by Subject|6|||
163419750|NCT00508391|590244574|FG001|First Treatment|Withdrawal by Subject|3|||
163419751|NCT00508391|590244573|FG000|Second Treatment|Withdrawal by Subject|2|||
163419752|NCT00508391|590244574|FG001|Second Treatment|Withdrawal by Subject|0|||
163419753|NCT00880256|590244578|FG000|Overall Study|Lost to Follow-up|28|||
163419754|NCT02041962|590244579|FG000|Overall Study|Lost Aetna Coverage|43|||
163419755|NCT02041962|590244580|FG001|Overall Study|Lost Aetna Coverage|40|||
163419756|NCT02041962|590244579|FG000|Overall Study|Death|1|||
163419757|NCT02041962|590244580|FG001|Overall Study|Death|1|||
163419758|NCT02041962|590244579|FG000|Overall Study|Lost to Follow-up|37|||
163419759|NCT02041962|590244580|FG001|Overall Study|Lost to Follow-up|32|||
163419760|NCT02041962|590244579|FG000|Overall Study|Withdrawal by Subject|0|||
163419761|NCT02041962|590244580|FG001|Overall Study|Withdrawal by Subject|11|||
163419762|NCT01686568|590244581|FG000|Main Study|Withdrawal by Subject|1|||
163419763|NCT01686568|590244582|FG001|Main Study|Withdrawal by Subject|3|||
163419764|NCT01686568|590244581|FG000|Main Study|Noncompliance with protocol|0|||
163419765|NCT01686568|590244582|FG001|Main Study|Noncompliance with protocol|1|||
163419766|NCT01686568|590244581|FG000|Main Study|Liver enzymes above range of exclusion|1|||
163419767|NCT01686568|590244582|FG001|Main Study|Liver enzymes above range of exclusion|0|||
163419768|NCT01686568|590244581|FG000|Sub-Study|Not consented for sub-study|2|||
163419769|NCT01686568|590244582|FG001|Sub-Study|Not consented for sub-study|2|||
163419770|NCT01481896|590244586|FG000|Overall Study|Lost to Follow-up|12|||
163419771|NCT00364182|590244587|FG000|First Intervention|Secondary prophylaxis|1|||
163419772|NCT00364182|590244588|FG001|First Intervention|Secondary prophylaxis|0|||
163419773|NCT00364182|590244589|FG002|First Intervention|Secondary prophylaxis|0|||
163419774|NCT00364182|590244587|FG000|First Intervention|Withdrawal by Subject|2|||
163419775|NCT00364182|590244588|FG001|First Intervention|Withdrawal by Subject|0|||
163419776|NCT00364182|590244589|FG002|First Intervention|Withdrawal by Subject|0|||
163419777|NCT00364182|590244587|FG000|Second Intervention|non-compliance|0|||
163419778|NCT00364182|590244588|FG001|Second Intervention|non-compliance|1|||
163419779|NCT00364182|590244589|FG002|Second Intervention|non-compliance|1|||
163419780|NCT00364182|590244587|FG000|Second Intervention|Protocol Violation|0|||
163419781|NCT00364182|590244588|FG001|Second Intervention|Protocol Violation|1|||
163419782|NCT00364182|590244589|FG002|Second Intervention|Protocol Violation|0|||
163419783|NCT00364182|590244587|FG000|Second Intervention|Adverse Event|0|||
163419784|NCT00364182|590244588|FG001|Second Intervention|Adverse Event|0|||
163419785|NCT00364182|590244589|FG002|Second Intervention|Adverse Event|1|||
163419786|NCT00364182|590244587|FG000|Third Intervention|non-compliance|0|||
163419787|NCT00364182|590244588|FG001|Third Intervention|non-compliance|1|||
163419788|NCT00364182|590244589|FG002|Third Intervention|non-compliance|0|||
163419789|NCT00364182|590244587|FG000|Third Intervention|Lost to Follow-up|0|||
163419790|NCT00364182|590244588|FG001|Third Intervention|Lost to Follow-up|0|||
163419791|NCT00364182|590244589|FG002|Third Intervention|Lost to Follow-up|1|||
163419792|NCT03336502|590244591|FG000|Overall Study|Physician Decision|0|||
163419793|NCT03336502|590244592|FG001|Overall Study|Physician Decision|1|||
163419794|NCT03336502|590244591|FG000|Overall Study|Prohibited Drugs|1|||
163419795|NCT03336502|590244592|FG001|Overall Study|Prohibited Drugs|1|||
163419796|NCT03336502|590244591|FG000|Overall Study|Death|1|||
163419797|NCT03336502|590244592|FG001|Overall Study|Death|2|||
163419798|NCT03336502|590244591|FG000|Overall Study|Adverse Event|2|||
163419799|NCT03336502|590244592|FG001|Overall Study|Adverse Event|5|||
163419800|NCT02928952|590244593|FG000|Overall Study|Lost to Follow-up|5|||
163419801|NCT02928952|590244594|FG001|Overall Study|Lost to Follow-up|5|||
163419802|NCT02928952|590244593|FG000|Overall Study|Withdrawal by Subject|5|||
163419803|NCT02928952|590244594|FG001|Overall Study|Withdrawal by Subject|1|||
163419804|NCT02928952|590244593|FG000|Overall Study|Physician Decision|0|||
163419805|NCT02928952|590244594|FG001|Overall Study|Physician Decision|1|||
163419806|NCT02601573|590244595|FG000|Overall Study|Lost to Follow-up|0|||
163419807|NCT02601573|590244596|FG001|Overall Study|Lost to Follow-up|3|||
163419808|NCT02601573|590244597|FG002|Overall Study|Lost to Follow-up|1|||
163419809|NCT02601573|590244598|FG003|Overall Study|Lost to Follow-up|0|||
163419810|NCT02601573|590244599|FG004|Overall Study|Lost to Follow-up|2|||
163419811|NCT02601573|590244595|FG000|Overall Study|Withdrawal by Subject|0|||
163419812|NCT02601573|590244596|FG001|Overall Study|Withdrawal by Subject|1|||
163419813|NCT02601573|590244597|FG002|Overall Study|Withdrawal by Subject|0|||
163419814|NCT02601573|590244598|FG003|Overall Study|Withdrawal by Subject|1|||
163419815|NCT02601573|590244599|FG004|Overall Study|Withdrawal by Subject|0|||
163419816|NCT01850615|590244600|FG000|Overall Study|Protocol Violation|4|||
163419817|NCT01850615|590244601|FG001|Overall Study|Protocol Violation|1|||
163419818|NCT01850615|590244600|FG000|Overall Study|Adverse Event|2|||
163419819|NCT01850615|590244601|FG001|Overall Study|Adverse Event|1|||
163419820|NCT01850615|590244600|FG000|Overall Study|Withdrawal by Subject|3|||
163419821|NCT01850615|590244601|FG001|Overall Study|Withdrawal by Subject|1|||
163419822|NCT01850615|590244600|FG000|Overall Study|Lost to Follow-up|0|||
163419823|NCT01850615|590244601|FG001|Overall Study|Lost to Follow-up|1|||
163419824|NCT01850615|590244600|FG000|Overall Study|Unclassified|0|||
163419825|NCT01850615|590244601|FG001|Overall Study|Unclassified|1|||
163419826|NCT00974220|590244602|FG000|Treatment Period 1|Adverse Event|2|||
163419827|NCT00974220|590244603|FG001|Treatment Period 1|Adverse Event|1|||
163419828|NCT00974220|590244602|FG000|Treatment Period 1|noncompliant subjects|0|||
163419829|NCT00974220|590244603|FG001|Treatment Period 1|noncompliant subjects|1|||
163419830|NCT00706628|590244604|FG000|Overall Study|Other Adverse Event|16|||
163419831|NCT00706628|590244605|FG001|Overall Study|Other Adverse Event|5|||
163419832|NCT00706628|590244606|FG002|Overall Study|Other Adverse Event|5|||
163419833|NCT00706628|590244607|FG003|Overall Study|Other Adverse Event|2|||
163419834|NCT00706628|590244604|FG000|Overall Study|Non compliant with protocol|0|||
163419835|NCT00706628|590244605|FG001|Overall Study|Non compliant with protocol|1|||
163419836|NCT00706628|590244606|FG002|Overall Study|Non compliant with protocol|0|||
163419837|NCT00706628|590244607|FG003|Overall Study|Non compliant with protocol|0|||
163419838|NCT00706628|590244604|FG000|Overall Study|Consent withdrawn|6|||
163419839|NCT00706628|590244605|FG001|Overall Study|Consent withdrawn|1|||
163419840|NCT00706628|590244606|FG002|Overall Study|Consent withdrawn|3|||
163419841|NCT00706628|590244607|FG003|Overall Study|Consent withdrawn|0|||
163419842|NCT00706628|590244604|FG000|Overall Study|Progressive disease|20|||
163419843|NCT00706628|590244605|FG001|Overall Study|Progressive disease|13|||
163419844|NCT00706628|590244606|FG002|Overall Study|Progressive disease|8|||
163419845|NCT00706628|590244607|FG003|Overall Study|Progressive disease|1|||
163419846|NCT00706628|590244604|FG000|Overall Study|Other than those stated above|4|||
163419847|NCT00706628|590244605|FG001|Overall Study|Other than those stated above|0|||
163419848|NCT00706628|590244606|FG002|Overall Study|Other than those stated above|0|||
163419849|NCT00706628|590244607|FG003|Overall Study|Other than those stated above|0|||
163419850|NCT00706628|590244604|FG000|Overall Study|Not treated|1|||
163419851|NCT00706628|590244605|FG001|Overall Study|Not treated|1|||
163419852|NCT00706628|590244606|FG002|Overall Study|Not treated|0|||
163419853|NCT00706628|590244607|FG003|Overall Study|Not treated|0|||
163419854|NCT02921425|590244608|FG000|Overall Study|Protocol Violation|9|||
163419855|NCT01227967|590244609|FG000|Overall Study|Protocol Violation|3|||
163419856|NCT01227967|590244610|FG001|Overall Study|Protocol Violation|1|||
163419857|NCT01227967|590244609|FG000|Overall Study|Death|0|||
163419858|NCT01227967|590244610|FG001|Overall Study|Death|1|||
163419859|NCT01227967|590244609|FG000|Overall Study|Lost to Follow-up|8|||
163419860|NCT01227967|590244610|FG001|Overall Study|Lost to Follow-up|3|||
163419861|NCT01227967|590244609|FG000|Overall Study|Withdrawal by Subject|4|||
163419862|NCT01227967|590244610|FG001|Overall Study|Withdrawal by Subject|3|||
163419863|NCT01227967|590244609|FG000|Overall Study|Physician Decision|0|||
163419864|NCT01227967|590244610|FG001|Overall Study|Physician Decision|1|||
163419865|NCT01227967|590244609|FG000|Overall Study|Never Started Treatment|0|||
163419866|NCT01227967|590244610|FG001|Overall Study|Never Started Treatment|4|||
163419867|NCT01227967|590244609|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
163419868|NCT01227967|590244610|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
163419869|NCT03403400|590244611|FG000|Overall Study|Lost to Follow-up|1|||
163419870|NCT03403400|590244612|FG001|Overall Study|Lost to Follow-up|0|||
163419871|NCT03403400|590244613|FG002|Overall Study|Lost to Follow-up|1|||
163419872|NCT03403400|590244611|FG000|Overall Study|Hospitalization|1|||
163419873|NCT03403400|590244612|FG001|Overall Study|Hospitalization|0|||
163419874|NCT03403400|590244613|FG002|Overall Study|Hospitalization|0|||
163419875|NCT03403400|590244611|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
163419876|NCT03403400|590244612|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
163419877|NCT03403400|590244613|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
163419878|NCT01107444|590244617|FG000|Overall Study|Withdrawal by Subject|8|||
163419879|NCT01107444|590244618|FG001|Overall Study|Withdrawal by Subject|12|||
163419880|NCT01107444|590244617|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
163419881|NCT01107444|590244618|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
163419882|NCT02266433|590244622|FG000|Overall Study|Lost to Follow-up|54|||
163419883|NCT02266433|590244623|FG001|Overall Study|Lost to Follow-up|46|||
163419884|NCT02266433|590244622|FG000|Overall Study|Withdrawal by Subject|5|||
163419885|NCT02266433|590244623|FG001|Overall Study|Withdrawal by Subject|7|||
163419886|NCT00737529|590244627|FG000|Overall Study|Disease Progression|95|||
163419887|NCT00737529|590244627|FG000|Overall Study|Adverse Event|24|||
163419888|NCT00737529|590244627|FG000|Overall Study|Withdrawal by Subject|5|||
163419889|NCT00737529|590244627|FG000|Overall Study|Death|4|||
163419890|NCT00737529|590244627|FG000|Overall Study|Protocol Violation|1|||
163419891|NCT00737529|590244627|FG000|Overall Study|Other|4|||
163419892|NCT03310970|590244628|FG000|Overall Study|Withdrawal by Subject|0|||
163419893|NCT03310970|590244629|FG001|Overall Study|Withdrawal by Subject|1|||
163419894|NCT01446419|590244630|FG000|Overall Study|Death|1|||
163419895|NCT01446419|590244631|FG001|Overall Study|Death|0|||
163419896|NCT01446419|590244630|FG000|Overall Study|Withdrawal by Subject|1|||
163419897|NCT01446419|590244631|FG001|Overall Study|Withdrawal by Subject|1|||
163419898|NCT01446419|590244630|FG000|Overall Study|Terminated per protocol|3|||
163419899|NCT01446419|590244631|FG001|Overall Study|Terminated per protocol|0|||
163419900|NCT00946309|590244632|FG000|Overall Study|Protocol Violation|1|||
163419901|NCT00946309|590244633|FG001|Overall Study|Protocol Violation|0|||
163419902|NCT00946309|590244632|FG000|Overall Study|Lost to Follow-up|0|||
163419903|NCT00946309|590244633|FG001|Overall Study|Lost to Follow-up|1|||
163419904|NCT00946309|590244632|FG000|Overall Study|Procedure cancelled/discontinued|0|||
163419905|NCT00946309|590244633|FG001|Overall Study|Procedure cancelled/discontinued|3|||
163419906|NCT05032950|590244650|FG000|Overall Study|Adverse Event|0|||
163419907|NCT05032950|590244651|FG001|Overall Study|Adverse Event|0|||
163419908|NCT05032950|590244652|FG002|Overall Study|Adverse Event|1|||
163419909|NCT05032950|590244653|FG003|Overall Study|Adverse Event|1|||
163419910|NCT05032950|590244654|FG004|Overall Study|Adverse Event|0|||
163419911|NCT05032950|590244655|FG005|Overall Study|Adverse Event|0|||
163419912|NCT02959814|590244656|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
163419913|NCT02959814|590244656|FG000|Overall Study|Excluded based on anatomical criteria|2|||
163419914|NCT02959814|590244656|FG000|Overall Study|Protocol Violation|7|||
163419915|NCT02959814|590244656|FG000|Overall Study|FFR not measured|2|||
163419916|NCT02959814|590244656|FG000|Overall Study|In-procedure QFR not computed|6|||
163419917|NCT02959814|590244656|FG000|Overall Study|Excluded by FFR core-lab|24|||
163419918|NCT04343651|590244660|FG000|Overall Study|Physician Decision|2|||
163419919|NCT04343651|590244661|FG001|Overall Study|Physician Decision|1|||
163419920|NCT04343651|590244660|FG000|Overall Study|Lost to Follow-up|2|||
163419921|NCT04343651|590244661|FG001|Overall Study|Lost to Follow-up|1|||
163419922|NCT04343651|590244660|FG000|Overall Study|Protocol Violation|4|||
163419923|NCT04343651|590244661|FG001|Overall Study|Protocol Violation|6|||
163419924|NCT04343651|590244660|FG000|Overall Study|Missing|3|||
163419925|NCT04343651|590244661|FG001|Overall Study|Missing|9|||
163419926|NCT04343651|590244660|FG000|Overall Study|Withdrawal by Subject|0|||
163419927|NCT04343651|590244661|FG001|Overall Study|Withdrawal by Subject|4|||
163419928|NCT04343651|590244660|FG000|Overall Study|Death|0|||
163419929|NCT04343651|590244661|FG001|Overall Study|Death|1|||
163419930|NCT04343651|590244660|FG000|Overall Study|Did not start treatment|1|||
163419931|NCT04343651|590244661|FG001|Overall Study|Did not start treatment|1|||
163419932|NCT04343651|590244660|FG000|Overall Study|Patient did not complete visits 3-6|0|||
163419933|NCT04343651|590244661|FG001|Overall Study|Patient did not complete visits 3-6|1|||
163419934|NCT01583374|590244665|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
163419935|NCT01583374|590244666|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
163419936|NCT01583374|590244667|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
163419937|NCT01583374|590244668|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163419938|NCT01583374|590244669|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163419939|NCT01583374|590244670|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163419940|NCT01583374|590244671|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163419941|NCT01583374|590244672|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163419942|NCT01583374|590244673|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163419943|NCT01583374|590244665|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
163419944|NCT01583374|590244666|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
163419945|NCT01583374|590244667|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
163419946|NCT01583374|590244668|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163419947|NCT01583374|590244669|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163419948|NCT01583374|590244670|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163419949|NCT01583374|590244671|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163419950|NCT01583374|590244672|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163419951|NCT01583374|590244673|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163419952|NCT01583374|590244665|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
163419953|NCT01583374|590244666|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
163419954|NCT01583374|590244667|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163419955|NCT01583374|590244668|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163419956|NCT01583374|590244669|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163419957|NCT01583374|590244670|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163419958|NCT01583374|590244671|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163419959|NCT01583374|590244672|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163419960|NCT01583374|590244673|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163419961|NCT01583374|590244665|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
163419962|NCT01583374|590244666|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
163419963|NCT01583374|590244667|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
163419964|NCT01583374|590244668|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163419965|NCT01583374|590244669|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163419966|NCT01583374|590244670|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163419967|NCT01583374|590244671|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163419968|NCT01583374|590244672|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163419969|NCT01583374|590244673|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163419970|NCT01583374|590244665|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
163419971|NCT01583374|590244666|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
163419972|NCT01583374|590244667|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
163419973|NCT01583374|590244668|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
163419974|NCT01583374|590244669|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
163419975|NCT01583374|590244670|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
163419976|NCT01583374|590244671|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
163419977|NCT01583374|590244672|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
163419978|NCT01583374|590244673|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
163419979|NCT01583374|590244665|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163419980|NCT01583374|590244666|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163419981|NCT01583374|590244667|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
163419982|NCT01583374|590244668|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163419983|NCT01583374|590244669|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163419984|NCT01583374|590244670|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163419985|NCT01583374|590244671|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163419986|NCT01583374|590244672|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163419987|NCT01583374|590244673|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163419988|NCT01583374|590244665|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
163419989|NCT01583374|590244666|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
163419990|NCT01583374|590244667|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
163419991|NCT01583374|590244668|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
163419992|NCT01583374|590244669|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
163419993|NCT01583374|590244670|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
163419994|NCT01583374|590244671|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
163419995|NCT01583374|590244672|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
163419996|NCT01583374|590244673|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
163419997|NCT01583374|590244665|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163419998|NCT01583374|590244666|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163419999|NCT01583374|590244667|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163420000|NCT01583374|590244668|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163420001|NCT01583374|590244669|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163420002|NCT01583374|590244670|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163420003|NCT01583374|590244671|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163420004|NCT01583374|590244672|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
163420005|NCT01583374|590244673|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163420006|NCT01583374|590244665|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
163420007|NCT01583374|590244666|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
163420008|NCT01583374|590244667|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
163420009|NCT01583374|590244668|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
163420010|NCT01583374|590244669|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
163420011|NCT01583374|590244670|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
163420012|NCT01583374|590244671|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
163420013|NCT01583374|590244672|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
163420014|NCT01583374|590244673|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
163420015|NCT01583374|590244665|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
163420016|NCT01583374|590244666|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
163420017|NCT01583374|590244667|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
163420018|NCT01583374|590244668|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
163420019|NCT01583374|590244669|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
163420020|NCT01583374|590244670|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
163420021|NCT01583374|590244671|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
163420022|NCT01583374|590244672|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
163420023|NCT01583374|590244673|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
163420024|NCT01583374|590244665|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
163420025|NCT01583374|590244666|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
163420026|NCT01583374|590244667|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
163420027|NCT01583374|590244668|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
163420028|NCT01583374|590244669|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
163420029|NCT01583374|590244670|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
163420030|NCT01583374|590244671|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
163420031|NCT01583374|590244672|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
163420032|NCT01583374|590244673|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
163420033|NCT01583374|590244665|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
163420034|NCT01583374|590244666|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
163420035|NCT01583374|590244667|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
163420036|NCT01583374|590244668|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
163420037|NCT01583374|590244669|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
163420038|NCT01583374|590244670|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
163420039|NCT01583374|590244671|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
163420040|NCT01583374|590244672|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
163420041|NCT01583374|590244673|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
163420042|NCT01583374|590244665|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
163420043|NCT01583374|590244666|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
163420044|NCT01583374|590244667|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
163420045|NCT01583374|590244668|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
163420046|NCT01583374|590244669|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
163420047|NCT01583374|590244670|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
163420048|NCT01583374|590244671|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
163420049|NCT01583374|590244672|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
163420050|NCT01583374|590244673|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
163420051|NCT01583374|590244665|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
163420052|NCT01583374|590244666|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
163420053|NCT01583374|590244667|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
163420054|NCT01583374|590244668|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
163420055|NCT01583374|590244669|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
163420056|NCT01583374|590244670|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
163420057|NCT01583374|590244671|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
163420058|NCT01583374|590244672|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
163420059|NCT01583374|590244673|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
163420060|NCT01583374|590244665|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
163420061|NCT01583374|590244666|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
163420062|NCT01583374|590244667|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
163420063|NCT01583374|590244668|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
163420064|NCT01583374|590244669|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
163420065|NCT01583374|590244670|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
163420066|NCT01583374|590244671|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
163420067|NCT01583374|590244672|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
163420068|NCT01583374|590244673|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
163420069|NCT01583374|590244665|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
163420070|NCT01583374|590244666|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
163420071|NCT01583374|590244667|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
163420072|NCT01583374|590244668|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
163420073|NCT01583374|590244669|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
163420074|NCT01583374|590244670|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
163420075|NCT01583374|590244671|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
163420076|NCT01583374|590244672|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
163420077|NCT01583374|590244673|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
163420078|NCT01583374|590244665|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
163420079|NCT01583374|590244666|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
163420080|NCT01583374|590244667|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
163420081|NCT01583374|590244668|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
163420082|NCT01583374|590244669|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
163420083|NCT01583374|590244670|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
163420084|NCT01583374|590244671|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
163420085|NCT01583374|590244672|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
163420086|NCT01583374|590244673|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
163420087|NCT01583374|590244665|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
163420088|NCT01583374|590244666|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
163420089|NCT01583374|590244667|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
163420090|NCT01583374|590244668|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
163420091|NCT01583374|590244669|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
163420092|NCT01583374|590244670|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
163420093|NCT01583374|590244671|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
163420094|NCT01583374|590244672|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
163420095|NCT01583374|590244673|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
163420096|NCT01583374|590244665|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
163420097|NCT01583374|590244666|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
163420098|NCT01583374|590244667|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
163420099|NCT01583374|590244668|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
163420100|NCT01583374|590244669|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
163420101|NCT01583374|590244670|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
163420102|NCT01583374|590244671|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
163420103|NCT01583374|590244672|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
163420104|NCT01583374|590244673|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
163420105|NCT01292057|590244674|FG000|Overall Study|Protocol Violation|1|||
163420106|NCT01292057|590244675|FG001|Overall Study|Protocol Violation|1|||
163420107|NCT01292057|590244674|FG000|Overall Study|Lost to Follow-up|1|||
163420108|NCT01292057|590244675|FG001|Overall Study|Lost to Follow-up|1|||
163420109|NCT02307370|590244678|FG000|Overall Study|Death|5|||
163420110|NCT02307370|590244678|FG000|Overall Study|Lost to Follow-up|1|||
163420111|NCT02307370|590244678|FG000|Overall Study|Withdrawal by Subject|1|||
163420112|NCT02307370|590244678|FG000|Overall Study|Declined Addendum ICF|6|||
163420113|NCT02307370|590244678|FG000|Overall Study|No response during telephone contact|5|||
163420114|NCT02307370|590244678|FG000|Overall Study|Protocol Violation|1|||
163420115|NCT03219164|590246852|FG000|Overall Study|Study Terminated by Sponsor|16|||
163420116|NCT03219164|590246853|FG001|Overall Study|Study Terminated by Sponsor|12|||
163420117|NCT03219164|590246852|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
163420118|NCT03219164|590246853|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
163420119|NCT03219164|590246852|FG000|Overall Study|Lost to Follow-up|1|||
163420120|NCT03219164|590246853|FG001|Overall Study|Lost to Follow-up|1|||
163420121|NCT03219164|590246852|FG000|Overall Study|Adverse Event|1|||
163420122|NCT03219164|590246853|FG001|Overall Study|Adverse Event|0|||
163420123|NCT03219164|590246852|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163420124|NCT03219164|590246853|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163420125|NCT03219164|590246852|FG000|Overall Study|Protocol Violation|0|||
163420126|NCT03219164|590246853|FG001|Overall Study|Protocol Violation|1|||
163420127|NCT03219164|590246852|FG000|Overall Study|Withdrew Assent|1|||
163420128|NCT03219164|590246853|FG001|Overall Study|Withdrew Assent|0|||
163420129|NCT01097629|590246861|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
163420130|NCT01097629|590246862|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
163420131|NCT01097629|590246863|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
163420132|NCT01097629|590246864|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
163420133|NCT01097629|590246865|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
163420134|NCT01097629|590246866|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
163420135|NCT01097629|590246867|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
163420136|NCT01097629|590246868|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
163420137|NCT01097629|590246861|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
163420138|NCT01097629|590246862|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
163420139|NCT01097629|590246863|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
163420140|NCT01097629|590246864|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
163420141|NCT01097629|590246865|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
163420142|NCT01097629|590246866|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
163420143|NCT01097629|590246867|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
163420144|NCT01097629|590246868|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
163420145|NCT01097629|590246861|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
163420146|NCT01097629|590246862|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
163420147|NCT01097629|590246863|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
163420148|NCT01097629|590246864|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
163420149|NCT01097629|590246865|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
163420150|NCT01097629|590246866|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
163420151|NCT01097629|590246867|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
163420152|NCT01097629|590246868|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
163420153|NCT01097629|590246861|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
163420154|NCT01097629|590246862|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
163420155|NCT01097629|590246863|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
163420156|NCT01097629|590246864|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163420157|NCT01097629|590246865|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163420158|NCT01097629|590246866|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163420159|NCT01097629|590246867|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163420160|NCT01097629|590246868|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163420161|NCT01097629|590246861|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
163420162|NCT01097629|590246862|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
163420163|NCT01097629|590246863|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
163420164|NCT01097629|590246864|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
163420165|NCT01097629|590246865|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
163420166|NCT01097629|590246866|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
163420167|NCT01097629|590246867|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
163420168|NCT01097629|590246868|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
163420169|NCT01097629|590246861|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
163420170|NCT01097629|590246862|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
163420171|NCT01097629|590246863|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163420172|NCT01097629|590246864|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163420173|NCT01097629|590246865|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163420174|NCT01097629|590246866|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163420175|NCT01097629|590246867|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163420176|NCT01097629|590246868|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163420177|NCT01097629|590246861|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
163420178|NCT01097629|590246862|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
163420179|NCT01097629|590246863|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
163420180|NCT01097629|590246864|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163420181|NCT01097629|590246865|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163420182|NCT01097629|590246866|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163420183|NCT01097629|590246867|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163420184|NCT01097629|590246868|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163420185|NCT01097629|590246861|FG000|DB RO Phase|Withdrawal by Subject|0|||
163420186|NCT01097629|590246862|FG001|DB RO Phase|Withdrawal by Subject|0|||
163420187|NCT01097629|590246863|FG002|DB RO Phase|Withdrawal by Subject|0|||
163420188|NCT01097629|590246864|FG003|DB RO Phase|Withdrawal by Subject|0|||
163420189|NCT01097629|590246865|FG004|DB RO Phase|Withdrawal by Subject|0|||
163420190|NCT01097629|590246866|FG005|DB RO Phase|Withdrawal by Subject|0|||
163420191|NCT01097629|590246867|FG006|DB RO Phase|Withdrawal by Subject|0|||
163420192|NCT01097629|590246868|FG007|DB RO Phase|Withdrawal by Subject|1|||
163420193|NCT01097629|590246861|FG000|DB RO Phase|Protocol Violation|0|||
163420194|NCT01097629|590246862|FG001|DB RO Phase|Protocol Violation|0|||
163420195|NCT01097629|590246863|FG002|DB RO Phase|Protocol Violation|0|||
163420196|NCT01097629|590246864|FG003|DB RO Phase|Protocol Violation|1|||
163420197|NCT01097629|590246865|FG004|DB RO Phase|Protocol Violation|0|||
163420198|NCT01097629|590246866|FG005|DB RO Phase|Protocol Violation|1|||
163420199|NCT01097629|590246867|FG006|DB RO Phase|Protocol Violation|1|||
163420200|NCT01097629|590246868|FG007|DB RO Phase|Protocol Violation|0|||
163420201|NCT01097629|590246861|FG000|DB RO Phase|Lost to Follow-up|0|||
163420202|NCT01097629|590246862|FG001|DB RO Phase|Lost to Follow-up|0|||
163420203|NCT01097629|590246863|FG002|DB RO Phase|Lost to Follow-up|0|||
163420204|NCT01097629|590246864|FG003|DB RO Phase|Lost to Follow-up|0|||
163420205|NCT01097629|590246865|FG004|DB RO Phase|Lost to Follow-up|0|||
163420206|NCT01097629|590246866|FG005|DB RO Phase|Lost to Follow-up|0|||
163420207|NCT01097629|590246867|FG006|DB RO Phase|Lost to Follow-up|2|||
163420208|NCT01097629|590246868|FG007|DB RO Phase|Lost to Follow-up|0|||
163420209|NCT00956943|590246869|FG000|Overall Study|Lost to Follow-up|9|||
163420210|NCT00956943|590246870|FG001|Overall Study|Lost to Follow-up|10|||
163420211|NCT02613208|590246871|FG000|Overall Study|Withdrawal by Subject|1|||
163420212|NCT02613208|590246871|FG000|Overall Study|Change of address|2|||
163420213|NCT02613208|590246871|FG000|Overall Study|Physician Decision|2|||
163420214|NCT02613208|590246871|FG000|Overall Study|Lost to Follow-up|5|||
163420215|NCT02613208|590246871|FG000|Overall Study|Death|37|||
163420216|NCT01524991|590246872|FG000|Overall Study|Adverse Event|12|||
163420217|NCT01524991|590246872|FG000|Overall Study|Death|1|||
163420218|NCT01524991|590246872|FG000|Overall Study|Disease ProgressionDu|17|||
163420219|NCT01524991|590246872|FG000|Overall Study|Other complicating disease|1|||
163420220|NCT01524991|590246872|FG000|Overall Study|Withdrawal by Subject|2|||
163420221|NCT01524991|590246872|FG000|Overall Study|Symptomatic Deterioration|1|||
163420222|NCT04574999|590246875|FG000|Overall Study|Adverse Event|1|||
163420223|NCT04574999|590246876|FG001|Overall Study|Adverse Event|0|||
163420224|NCT04574999|590246875|FG000|Overall Study|Lack of Efficacy|2|||
163420225|NCT04574999|590246876|FG001|Overall Study|Lack of Efficacy|3|||
163420226|NCT04574999|590246875|FG000|Overall Study|Protocol Violation|1|||
163420227|NCT04574999|590246876|FG001|Overall Study|Protocol Violation|0|||
163420228|NCT04574999|590246875|FG000|Overall Study|Withdrawal by Subject|2|||
163420229|NCT04574999|590246876|FG001|Overall Study|Withdrawal by Subject|2|||
163420230|NCT04574999|590246875|FG000|Overall Study|Lost to Follow-up|1|||
163420231|NCT04574999|590246876|FG001|Overall Study|Lost to Follow-up|0|||
163420232|NCT04574999|590246875|FG000|Overall Study|Personal problems|1|||
163420233|NCT04574999|590246876|FG001|Overall Study|Personal problems|0|||
163420234|NCT04574999|590246875|FG000|Overall Study|Previous planned surgery|1|||
163420235|NCT04574999|590246876|FG001|Overall Study|Previous planned surgery|0|||
163420236|NCT00206726|590246878|FG000|Overall Study|Delayed recovery of blood counts|1|||
163420237|NCT00206726|590246878|FG000|Overall Study|Progressive disease or relapsed disease|18|||
163420238|NCT00206726|590246878|FG000|Overall Study|Placed on new protocol|1|||
163420239|NCT00206726|590246878|FG000|Overall Study|Bone marrow transplant|1|||
163420240|NCT00206726|590246878|FG000|Overall Study|Adverse Event|17|||
163420241|NCT00206726|590246878|FG000|Overall Study|Death|4|||
163420242|NCT00206726|590246878|FG000|Overall Study|Protocol Violation|1|||
163420243|NCT00206726|590246878|FG000|Overall Study|Withdrawal by Subject|8|||
163420244|NCT05148884|590246879|FG000|Overall Study|Withdrawal by Subject|3|||
163420245|NCT05148884|590246880|FG001|Overall Study|Withdrawal by Subject|0|||
163420246|NCT05148884|590246879|FG000|Overall Study|Deep brain stimulation operation|0|||
163420247|NCT05148884|590246880|FG001|Overall Study|Deep brain stimulation operation|1|||
163420248|NCT01341457|590246881|FG000|Overall Study|Adverse Event|2|||
163420249|NCT01341457|590246882|FG001|Overall Study|Adverse Event|0|||
163420250|NCT00832819|590246885|FG000|Overall Study|Adverse Event|0|||
163420251|NCT00832819|590246886|FG001|Overall Study|Adverse Event|1|||
163420252|NCT00832819|590246887|FG002|Overall Study|Adverse Event|0|||
163420253|NCT00832819|590246885|FG000|Overall Study|Protocol Violation|0|||
163420254|NCT00832819|590246886|FG001|Overall Study|Protocol Violation|0|||
163420255|NCT00832819|590246887|FG002|Overall Study|Protocol Violation|1|||
163420256|NCT01717638|590246888|FG000|Overall Study|Lost to Follow-up|0|||
163420257|NCT01717638|590246889|FG001|Overall Study|Lost to Follow-up|0|||
163420258|NCT01717638|590246890|FG002|Overall Study|Lost to Follow-up|0|||
163420259|NCT01717638|590246891|FG003|Overall Study|Lost to Follow-up|0|||
163420260|NCT01717638|590246892|FG004|Overall Study|Lost to Follow-up|0|||
163420261|NCT01717638|590246893|FG005|Overall Study|Lost to Follow-up|1|||
163420262|NCT01717638|590246894|FG006|Overall Study|Lost to Follow-up|0|||
163420263|NCT01717638|590246895|FG007|Overall Study|Lost to Follow-up|0|||
163420264|NCT01717638|590246896|FG008|Overall Study|Lost to Follow-up|0|||
163420265|NCT01717638|590246897|FG009|Overall Study|Lost to Follow-up|0|||
163420266|NCT01717638|590246898|FG010|Overall Study|Lost to Follow-up|0|||
163420267|NCT01717638|590246899|FG011|Overall Study|Lost to Follow-up|0|||
163420268|NCT01717638|590246900|FG012|Overall Study|Lost to Follow-up|0|||
163420269|NCT01717638|590246888|FG000|Overall Study|Father in hospital|0|||
163420270|NCT01717638|590246889|FG001|Overall Study|Father in hospital|0|||
163420271|NCT01717638|590246890|FG002|Overall Study|Father in hospital|0|||
163420272|NCT01717638|590246891|FG003|Overall Study|Father in hospital|0|||
163420273|NCT01717638|590246892|FG004|Overall Study|Father in hospital|0|||
163420274|NCT01717638|590246893|FG005|Overall Study|Father in hospital|0|||
163420275|NCT01717638|590246894|FG006|Overall Study|Father in hospital|0|||
163420276|NCT01717638|590246895|FG007|Overall Study|Father in hospital|0|||
163420277|NCT01717638|590246896|FG008|Overall Study|Father in hospital|0|||
163420278|NCT01717638|590246897|FG009|Overall Study|Father in hospital|0|||
163420279|NCT01717638|590246898|FG010|Overall Study|Father in hospital|0|||
163420280|NCT01717638|590246899|FG011|Overall Study|Father in hospital|0|||
163420281|NCT01717638|590246900|FG012|Overall Study|Father in hospital|1|||
163420282|NCT01717638|590246888|FG000|Overall Study|Withdrawal by Subject|0|||
163420283|NCT01717638|590246889|FG001|Overall Study|Withdrawal by Subject|1|||
163420284|NCT01717638|590246890|FG002|Overall Study|Withdrawal by Subject|1|||
163420285|NCT01717638|590246891|FG003|Overall Study|Withdrawal by Subject|0|||
163420286|NCT01717638|590246892|FG004|Overall Study|Withdrawal by Subject|1|||
163420287|NCT01717638|590246893|FG005|Overall Study|Withdrawal by Subject|0|||
163420288|NCT01717638|590246894|FG006|Overall Study|Withdrawal by Subject|2|||
163420289|NCT01717638|590246895|FG007|Overall Study|Withdrawal by Subject|1|||
163420290|NCT01717638|590246896|FG008|Overall Study|Withdrawal by Subject|2|||
163420291|NCT01717638|590246897|FG009|Overall Study|Withdrawal by Subject|1|||
163420292|NCT01717638|590246898|FG010|Overall Study|Withdrawal by Subject|0|||
163420293|NCT01717638|590246899|FG011|Overall Study|Withdrawal by Subject|0|||
163420294|NCT01717638|590246900|FG012|Overall Study|Withdrawal by Subject|18|||
163420295|NCT01719757|590246901|FG000|Overall Study|Adverse Event|38|||
163420296|NCT01719757|590246901|FG000|Overall Study|Withdrawal by Subject|15|||
163420297|NCT01719757|590246901|FG000|Overall Study|Lost to Follow-up|20|||
163420298|NCT01719757|590246901|FG000|Overall Study|Protocol Violation|1|||
163420299|NCT01719757|590246901|FG000|Overall Study|well controlled pain|27|||
163420300|NCT02626338|590246902|FG000|Overall Study|Lack of Efficacy|3|||
163420301|NCT02626338|590246903|FG001|Overall Study|Lack of Efficacy|2|||
163420302|NCT02626338|590246904|FG002|Overall Study|Lack of Efficacy|0|||
163420303|NCT03312218|590246910|FG000|Overall Study|Never signed in to access the app|54|||
163420304|NCT03312218|590246911|FG001|Overall Study|Never signed in to access the app|58|||
163420305|NCT01901224|590246912|FG000|Overall Study|study was not funded and terminated|2|||
163420306|NCT06441877|590246913|FG000|Overall Study|Withdrawal by Subject|0|||
163420307|NCT06441877|590246914|FG001|Overall Study|Withdrawal by Subject|2|||
163420308|NCT06441877|590246915|FG002|Overall Study|Withdrawal by Subject|0|||
163420309|NCT06441877|590246916|FG003|Overall Study|Withdrawal by Subject|0|||
163420310|NCT05742984|590246917|FG000|Overall Study|Adverse Event|0|||
163420311|NCT05742984|590246918|FG001|Overall Study|Adverse Event|0|||
163420312|NCT05742984|590246919|FG002|Overall Study|Adverse Event|1|||
163420313|NCT05742984|590246920|FG003|Overall Study|Adverse Event|0|||
163420314|NCT05742984|590246921|FG004|Overall Study|Adverse Event|1|||
163420315|NCT05742984|590246922|FG005|Overall Study|Adverse Event|1|||
163420316|NCT05742984|590246917|FG000|Overall Study|Withdrawal by Subject|0|||
163420317|NCT05742984|590246918|FG001|Overall Study|Withdrawal by Subject|1|||
163420318|NCT05742984|590246919|FG002|Overall Study|Withdrawal by Subject|0|||
163420319|NCT05742984|590246920|FG003|Overall Study|Withdrawal by Subject|0|||
163420320|NCT05742984|590246921|FG004|Overall Study|Withdrawal by Subject|0|||
163420321|NCT05742984|590246922|FG005|Overall Study|Withdrawal by Subject|2|||
163420322|NCT02162862|590246923|FG000|Overall Study|Lost to Follow-up|0|||
163420323|NCT02162862|590246924|FG001|Overall Study|Lost to Follow-up|11|||
163420324|NCT02162862|590246925|FG002|Overall Study|Lost to Follow-up|0|||
163420325|NCT02162862|590246923|FG000|Overall Study|Subject did not feel the med was needed|0|||
163420326|NCT02162862|590246924|FG001|Overall Study|Subject did not feel the med was needed|0|||
163420327|NCT02162862|590246925|FG002|Overall Study|Subject did not feel the med was needed|4|||
163420328|NCT03116113|590246926|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
163420329|NCT03116113|590246927|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
163420330|NCT03116113|590246928|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
163420331|NCT03116113|590246929|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
163420332|NCT03116113|590246930|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
163420333|NCT03116113|590246931|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
163420334|NCT03116113|590246932|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
163420335|NCT03116113|590246933|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
163420336|NCT03116113|590246934|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
163420337|NCT02159807|590246935|FG000|Overall Study|Adverse Event|0|||
163420338|NCT02159807|590246936|FG001|Overall Study|Adverse Event|0|||
163420339|NCT02159807|590246937|FG002|Overall Study|Adverse Event|1|||
163420340|NCT02159807|590246935|FG000|Overall Study|No CSF|1|||
163420341|NCT02159807|590246936|FG001|Overall Study|No CSF|1|||
163420342|NCT02159807|590246937|FG002|Overall Study|No CSF|1|||
163420343|NCT02159807|590246935|FG000|Overall Study|elevated blood pressure|0|||
163420344|NCT02159807|590246936|FG001|Overall Study|elevated blood pressure|0|||
163420345|NCT02159807|590246937|FG002|Overall Study|elevated blood pressure|1|||
163420346|NCT00950170|590246938|FG000|Overall Study|Parent/Legal Guardian Request|1|||
163420347|NCT00950170|590246938|FG000|Overall Study|Adverse Event|2|||
163420348|NCT00950170|590246938|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
163420349|NCT01254669|590246941|FG000|Overall Study|Withdrawal by Subject|0|||
163420350|NCT01254669|590246942|FG001|Overall Study|Withdrawal by Subject|1|||
163420351|NCT01254669|590246941|FG000|Overall Study|time constraint|2|||
163420352|NCT01254669|590246942|FG001|Overall Study|time constraint|2|||
163420353|NCT01254669|590246941|FG000|Overall Study|called to clinic during intervention|1|||
163420354|NCT01254669|590246942|FG001|Overall Study|called to clinic during intervention|1|||
163420355|NCT00103012|590246946|FG000|Overall Study|Withdrawal by Subject|2|||
163420356|NCT00103012|590246947|FG001|Overall Study|Withdrawal by Subject|1|||
163420357|NCT00103012|590246948|FG002|Overall Study|Withdrawal by Subject|2|||
163420358|NCT00103012|590246946|FG000|Overall Study|Pregnancy|1|||
163420359|NCT00103012|590246947|FG001|Overall Study|Pregnancy|0|||
163420360|NCT00103012|590246948|FG002|Overall Study|Pregnancy|0|||
163420361|NCT00103012|590246946|FG000|Overall Study|Adverse Event|0|||
163420362|NCT00103012|590246947|FG001|Overall Study|Adverse Event|0|||
163420363|NCT00103012|590246948|FG002|Overall Study|Adverse Event|1|||
163420364|NCT00103012|590246946|FG000|Overall Study|Subject non-compliant with medications|0|||
163420365|NCT00103012|590246947|FG001|Overall Study|Subject non-compliant with medications|0|||
163420366|NCT00103012|590246948|FG002|Overall Study|Subject non-compliant with medications|1|||
163420367|NCT00393718|590246958|FG000|Overall Study|Adverse Event|20|||
163420368|NCT00393718|590246959|FG001|Overall Study|Adverse Event|8|||
163420369|NCT00393718|590246958|FG000|Overall Study|Protocol Violation|1|||
163420370|NCT00393718|590246959|FG001|Overall Study|Protocol Violation|2|||
163420371|NCT00393718|590246958|FG000|Overall Study|Lack of Efficacy|10|||
163420372|NCT00393718|590246959|FG001|Overall Study|Lack of Efficacy|9|||
163420373|NCT00393718|590246958|FG000|Overall Study|Hypoglycaemia|3|||
163420374|NCT00393718|590246959|FG001|Overall Study|Hypoglycaemia|2|||
163420375|NCT00393718|590246958|FG000|Overall Study|Subject decision|5|||
163420376|NCT00393718|590246959|FG001|Overall Study|Subject decision|0|||
163420377|NCT00393718|590246958|FG000|Overall Study|Withdrawal of consent|2|||
163420378|NCT00393718|590246959|FG001|Overall Study|Withdrawal of consent|1|||
163420379|NCT00393718|590246958|FG000|Overall Study|Missed measurement|1|||
163420380|NCT00393718|590246959|FG001|Overall Study|Missed measurement|0|||
163420381|NCT00393718|590246958|FG000|Overall Study|Move|1|||
163420382|NCT00393718|590246959|FG001|Overall Study|Move|0|||
163420383|NCT01084551|590246961|FG000|Overall Study|Adverse Event|2|||
163420384|NCT01084551|590246962|FG001|Overall Study|Adverse Event|9|||
163420385|NCT01084551|590246963|FG002|Overall Study|Adverse Event|4|||
163420386|NCT01084551|590246961|FG000|Overall Study|Lack of Efficacy|2|||
163420387|NCT01084551|590246962|FG001|Overall Study|Lack of Efficacy|0|||
163420388|NCT01084551|590246963|FG002|Overall Study|Lack of Efficacy|1|||
163420389|NCT01084551|590246961|FG000|Overall Study|Withdrawal by Subject|2|||
163420390|NCT01084551|590246962|FG001|Overall Study|Withdrawal by Subject|1|||
163420391|NCT01084551|590246963|FG002|Overall Study|Withdrawal by Subject|0|||
163420392|NCT01084551|590246961|FG000|Overall Study|Protocol Violation|2|||
163420393|NCT01084551|590246962|FG001|Overall Study|Protocol Violation|4|||
163420394|NCT01084551|590246963|FG002|Overall Study|Protocol Violation|0|||
163420395|NCT01084551|590246961|FG000|Overall Study|Lost to Follow-up|0|||
163420396|NCT01084551|590246962|FG001|Overall Study|Lost to Follow-up|0|||
163420397|NCT01084551|590246963|FG002|Overall Study|Lost to Follow-up|3|||
163420398|NCT01084551|590246961|FG000|Overall Study|Physician Decision|1|||
163420399|NCT01084551|590246962|FG001|Overall Study|Physician Decision|0|||
163420400|NCT01084551|590246963|FG002|Overall Study|Physician Decision|0|||
163420401|NCT03902080|590246964|FG000|Overall Study|Adverse Event|17|||
163420402|NCT03902080|590246965|FG001|Overall Study|Adverse Event|15|||
163420403|NCT03902080|590246964|FG000|Overall Study|Withdrawal by Subject|28|||
163420404|NCT03902080|590246965|FG001|Overall Study|Withdrawal by Subject|35|||
163420405|NCT03902080|590246964|FG000|Overall Study|Lost to Follow-up|6|||
163420406|NCT03902080|590246965|FG001|Overall Study|Lost to Follow-up|7|||
163420407|NCT03902080|590246964|FG000|Overall Study|Other|3|||
163420408|NCT03902080|590246965|FG001|Overall Study|Other|5|||
163420409|NCT03902080|590246964|FG000|Overall Study|Non compliance|4|||
163420410|NCT03902080|590246965|FG001|Overall Study|Non compliance|3|||
163420411|NCT03902080|590246964|FG000|Overall Study|Physician Decision|5|||
163420412|NCT03902080|590246965|FG001|Overall Study|Physician Decision|1|||
163420413|NCT03902080|590246964|FG000|Overall Study|Protocol Violation|3|||
163420414|NCT03902080|590246965|FG001|Overall Study|Protocol Violation|3|||
163420415|NCT03902080|590246964|FG000|Overall Study|Lack of Efficacy|1|||
163420416|NCT03902080|590246965|FG001|Overall Study|Lack of Efficacy|3|||
163420417|NCT03902080|590246964|FG000|Overall Study|Withdrawn prior to dosing|0|||
163420418|NCT03902080|590246965|FG001|Overall Study|Withdrawn prior to dosing|1|||
163420419|NCT01703000|590246966|FG000|Overall Study|Death|1|||
163420420|NCT00289913|590246967|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163420421|NCT00289913|590246968|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
163420422|NCT00289913|590246969|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163420423|NCT00289913|590246970|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163420424|NCT00289913|590246971|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163420425|NCT00289913|590246967|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
163420426|NCT00289913|590246968|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
163420427|NCT00289913|590246969|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
163420428|NCT00289913|590246970|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
163420429|NCT00289913|590246971|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
163420430|NCT00289913|590246967|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
163420431|NCT00289913|590246968|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
163420432|NCT00289913|590246969|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
163420433|NCT00289913|590246970|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
163420434|NCT00289913|590246971|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
163420435|NCT00289913|590246967|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
163420436|NCT00289913|590246968|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
163420437|NCT00289913|590246969|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
163420438|NCT00289913|590246970|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
163420439|NCT00289913|590246971|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
163420440|NCT00289913|590246967|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163420441|NCT00289913|590246968|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163420442|NCT00289913|590246969|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163420443|NCT00289913|590246970|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
163420444|NCT00289913|590246971|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163420445|NCT00289913|590246967|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
163420446|NCT00289913|590246968|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
163420447|NCT00289913|590246969|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
163420448|NCT00289913|590246970|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
163420449|NCT00289913|590246971|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
163420450|NCT00289913|590246967|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
163420451|NCT00289913|590246968|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
163420452|NCT00289913|590246969|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
163420453|NCT00289913|590246970|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
163420454|NCT00289913|590246971|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
163420455|NCT00289913|590246967|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
163420456|NCT00289913|590246968|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
163420457|NCT00289913|590246969|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
163420458|NCT00289913|590246970|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
163420459|NCT00289913|590246971|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
163420460|NCT00289913|590246967|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
163420461|NCT00289913|590246968|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
163420462|NCT00289913|590246969|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
163420463|NCT00289913|590246970|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
163420464|NCT00289913|590246971|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
163420465|NCT00289913|590246967|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163420466|NCT00289913|590246968|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163420467|NCT00289913|590246969|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
163420468|NCT00289913|590246970|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163420469|NCT00289913|590246971|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163420470|NCT00289913|590246967|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
163420471|NCT00289913|590246968|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
163420472|NCT00289913|590246969|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
163420473|NCT00289913|590246970|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
163420474|NCT00289913|590246971|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
163420475|NCT00289913|590246967|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
163420476|NCT00289913|590246968|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
163420477|NCT00289913|590246969|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
163420478|NCT00289913|590246970|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
163420479|NCT00289913|590246971|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
163420480|NCT00289913|590246967|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
163420481|NCT00289913|590246968|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
163420482|NCT00289913|590246969|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
163420483|NCT00289913|590246970|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
163420484|NCT00289913|590246971|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
163420485|NCT00289913|590246967|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
163420486|NCT00289913|590246968|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163420487|NCT00289913|590246969|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
163420488|NCT00289913|590246970|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163420489|NCT00289913|590246971|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163420490|NCT00289913|590246967|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
163420491|NCT00289913|590246968|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
163420492|NCT00289913|590246969|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
163420493|NCT00289913|590246970|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
163420494|NCT00289913|590246971|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
163420495|NCT00289913|590246967|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
163420496|NCT00289913|590246968|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
163420497|NCT00289913|590246969|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
163420498|NCT00289913|590246970|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
163420499|NCT00289913|590246971|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
163420500|NCT00289913|590246967|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
163420501|NCT00289913|590246968|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
163420502|NCT00289913|590246969|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
163420503|NCT00289913|590246970|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
163420504|NCT00289913|590246971|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
163420505|NCT00289913|590246967|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
163420506|NCT00289913|590246968|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
163420507|NCT00289913|590246969|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
163420508|NCT00289913|590246970|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
163420509|NCT00289913|590246971|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
163420510|NCT00289913|590246967|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
163420511|NCT00289913|590246968|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
163420512|NCT00289913|590246969|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
163420513|NCT00289913|590246970|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
163420514|NCT00289913|590246971|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
163420515|NCT00289913|590246967|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
163420516|NCT00289913|590246968|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
163420517|NCT00289913|590246969|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
163420518|NCT00289913|590246970|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
163420519|NCT00289913|590246971|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
163420520|NCT00289913|590246967|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
163420521|NCT00289913|590246968|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
163420522|NCT00289913|590246969|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
163420523|NCT00289913|590246970|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
163420524|NCT00289913|590246971|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
163420525|NCT00289913|590246967|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
163420526|NCT00289913|590246968|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
163420527|NCT00289913|590246969|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
163420528|NCT00289913|590246970|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
163420529|NCT00289913|590246971|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
163420530|NCT00289913|590246967|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
163420531|NCT00289913|590246968|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
163420532|NCT00289913|590246969|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
163420533|NCT00289913|590246970|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
163420534|NCT00289913|590246971|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
163420535|NCT00289913|590246967|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163420536|NCT00289913|590246968|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
163420537|NCT00289913|590246969|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163420538|NCT00289913|590246970|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163420539|NCT00289913|590246971|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163420540|NCT00289913|590246967|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
163420541|NCT00289913|590246968|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
163420542|NCT00289913|590246969|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
163420543|NCT00289913|590246970|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
163420544|NCT00289913|590246971|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
163420545|NCT00289913|590246967|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
163420546|NCT00289913|590246968|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
163420547|NCT00289913|590246969|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
163420548|NCT00289913|590246970|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
163420549|NCT00289913|590246971|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
163420550|NCT00289913|590246967|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163420551|NCT00289913|590246968|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163420552|NCT00289913|590246969|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163420553|NCT00289913|590246970|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163420554|NCT00289913|590246971|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
163420555|NCT00289913|590246967|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
163420556|NCT00289913|590246968|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
163420557|NCT00289913|590246969|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
163420558|NCT00289913|590246970|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
163420559|NCT00289913|590246971|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
163420560|NCT00289913|590246967|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
163420561|NCT00289913|590246968|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
163420562|NCT00289913|590246969|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
163420563|NCT00289913|590246970|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
163420564|NCT00289913|590246971|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
163420565|NCT00289913|590246967|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
163420566|NCT00289913|590246968|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
163420567|NCT00289913|590246969|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
163420568|NCT00289913|590246970|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
163420569|NCT00289913|590246971|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
163420570|NCT00289913|590246967|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
163420571|NCT00289913|590246968|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
163420572|NCT00289913|590246969|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
163420573|NCT00289913|590246970|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
163420574|NCT00289913|590246971|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
163420575|NCT03822884|590246972|FG000|Overall Study|Withdrawal by Subject|0|||
163420576|NCT03822884|590246973|FG001|Overall Study|Withdrawal by Subject|0|||
163420577|NCT03822884|590246974|FG002|Overall Study|Withdrawal by Subject|0|||
163420578|NCT03822884|590246975|FG003|Overall Study|Withdrawal by Subject|0|||
163420579|NCT03822884|590246976|FG004|Overall Study|Withdrawal by Subject|1|||
163420580|NCT03822884|590246977|FG005|Overall Study|Withdrawal by Subject|0|||
163420581|NCT00434967|590246980|FG000|Overall Study|Adverse Event|2|||
163420582|NCT00434967|590246981|FG001|Overall Study|Adverse Event|4|||
163420583|NCT00434967|590246982|FG002|Overall Study|Adverse Event|3|||
163420584|NCT00434967|590246983|FG003|Overall Study|Adverse Event|3|||
163420585|NCT00434967|590246980|FG000|Overall Study|Lost to Follow-up|0|||
163420586|NCT00434967|590246981|FG001|Overall Study|Lost to Follow-up|0|||
163420587|NCT00434967|590246982|FG002|Overall Study|Lost to Follow-up|1|||
163420588|NCT00434967|590246983|FG003|Overall Study|Lost to Follow-up|0|||
163420589|NCT00434967|590246980|FG000|Overall Study|Withdrawal by Subject|2|||
163420590|NCT00434967|590246981|FG001|Overall Study|Withdrawal by Subject|2|||
163420591|NCT00434967|590246982|FG002|Overall Study|Withdrawal by Subject|4|||
163420592|NCT00434967|590246983|FG003|Overall Study|Withdrawal by Subject|6|||
163420593|NCT00434967|590246980|FG000|Overall Study|Randomized in error|0|||
163420594|NCT00434967|590246981|FG001|Overall Study|Randomized in error|0|||
163420595|NCT00434967|590246982|FG002|Overall Study|Randomized in error|0|||
163420596|NCT00434967|590246983|FG003|Overall Study|Randomized in error|1|||
163420597|NCT00434967|590246980|FG000|Overall Study|Protocol Violation|0|||
163420598|NCT00434967|590246981|FG001|Overall Study|Protocol Violation|1|||
163420599|NCT00434967|590246982|FG002|Overall Study|Protocol Violation|0|||
163420600|NCT00434967|590246983|FG003|Overall Study|Protocol Violation|1|||
163420601|NCT00434967|590246980|FG000|Overall Study|Physician Decision|1|||
163420602|NCT00434967|590246981|FG001|Overall Study|Physician Decision|1|||
163420603|NCT00434967|590246982|FG002|Overall Study|Physician Decision|1|||
163420604|NCT00434967|590246983|FG003|Overall Study|Physician Decision|0|||
163420605|NCT00434967|590246980|FG000|Overall Study|Patient Disposition Challenges|2|||
163420606|NCT00434967|590246981|FG001|Overall Study|Patient Disposition Challenges|0|||
163420607|NCT00434967|590246982|FG002|Overall Study|Patient Disposition Challenges|0|||
163420608|NCT00434967|590246983|FG003|Overall Study|Patient Disposition Challenges|3|||
163420609|NCT01279057|590246984|FG000|Overall Study|Adverse Event|1|||
163420610|NCT01279057|590246985|FG001|Overall Study|Adverse Event|0|||
163420611|NCT01279057|590246986|FG002|Overall Study|Adverse Event|1|||
163420612|NCT01279057|590246984|FG000|Overall Study|Insufficient therapeutic response|0|||
163420613|NCT01279057|590246985|FG001|Overall Study|Insufficient therapeutic response|0|||
163420614|NCT01279057|590246986|FG002|Overall Study|Insufficient therapeutic response|1|||
163420615|NCT01279057|590246984|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
163420616|NCT01279057|590246985|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
163420617|NCT01279057|590246986|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
163420618|NCT01279057|590246984|FG000|Overall Study|Withdrew consent|2|||
163420619|NCT01279057|590246985|FG001|Overall Study|Withdrew consent|0|||
163420620|NCT01279057|590246986|FG002|Overall Study|Withdrew consent|1|||
163420621|NCT01279057|590246984|FG000|Overall Study|Pregnancy|0|||
163420622|NCT01279057|590246985|FG001|Overall Study|Pregnancy|1|||
163420623|NCT01279057|590246986|FG002|Overall Study|Pregnancy|0|||
163420624|NCT01279057|590246984|FG000|Overall Study|Other|3|||
163420625|NCT01279057|590246985|FG001|Overall Study|Other|3|||
163420626|NCT01279057|590246986|FG002|Overall Study|Other|0|||
163420627|NCT01427309|590246988|FG000|Overall Study|Lost to Follow-up|130|||
163420628|NCT01427309|590246989|FG001|Overall Study|Lost to Follow-up|145|||
163420629|NCT01427309|590246990|FG002|Overall Study|Lost to Follow-up|122|||
163420630|NCT01427309|590246991|FG003|Overall Study|Lost to Follow-up|135|||
163420631|NCT01427309|590246988|FG000|Overall Study|Protocol Violation|42|||
163420632|NCT01427309|590246989|FG001|Overall Study|Protocol Violation|69|||
163420633|NCT01427309|590246990|FG002|Overall Study|Protocol Violation|125|||
163420634|NCT01427309|590246991|FG003|Overall Study|Protocol Violation|124|||
163420635|NCT01427309|590246988|FG000|Overall Study|Adverse Event|0|||
163420636|NCT01427309|590246989|FG001|Overall Study|Adverse Event|0|||
163420637|NCT01427309|590246990|FG002|Overall Study|Adverse Event|3|||
163420638|NCT01427309|590246991|FG003|Overall Study|Adverse Event|1|||
163420639|NCT01427309|590246988|FG000|Overall Study|Serious adverse event|52|||
163420640|NCT01427309|590246989|FG001|Overall Study|Serious adverse event|45|||
163420641|NCT01427309|590246990|FG002|Overall Study|Serious adverse event|50|||
163420642|NCT01427309|590246991|FG003|Overall Study|Serious adverse event|61|||
163420643|NCT01427309|590246988|FG000|Overall Study|Withdrawal by Subject|148|||
163420644|NCT01427309|590246989|FG001|Overall Study|Withdrawal by Subject|148|||
163420645|NCT01427309|590246990|FG002|Overall Study|Withdrawal by Subject|61|||
163420646|NCT01427309|590246991|FG003|Overall Study|Withdrawal by Subject|55|||
163420647|NCT00849017|590246994|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
163420648|NCT00849017|590246995|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
163420649|NCT00849017|590246996|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
163420650|NCT00849017|590246994|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
163420651|NCT00849017|590246995|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
163420652|NCT00849017|590246996|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
163420653|NCT00849017|590246994|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
163420654|NCT00849017|590246995|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
163420655|NCT00849017|590246996|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
163420656|NCT00849017|590246994|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
163420657|NCT00849017|590246995|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
163420658|NCT00849017|590246996|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
163420659|NCT00849017|590246994|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
163420660|NCT00849017|590246995|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
163420661|NCT00849017|590246996|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
163420662|NCT00849017|590246994|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
163420663|NCT00849017|590246995|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
163420664|NCT00849017|590246996|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
163420665|NCT00849017|590246994|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
163420666|NCT00849017|590246995|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
163420667|NCT00849017|590246996|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
163420668|NCT00849017|590246994|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
163420669|NCT00849017|590246995|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
163420670|NCT00849017|590246996|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
163420671|NCT00849017|590246994|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
163420672|NCT00849017|590246995|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
163420673|NCT00849017|590246996|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
163420674|NCT00849017|590246994|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
163420675|NCT00849017|590246995|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
163420676|NCT00849017|590246996|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
163420677|NCT00849017|590246994|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
163420678|NCT00849017|590246995|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
163420679|NCT00849017|590246996|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
163420680|NCT00849017|590246994|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
163420681|NCT00849017|590246995|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
163420682|NCT00849017|590246996|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
163420683|NCT00849017|590246994|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
163420684|NCT00849017|590246995|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
163420685|NCT00849017|590246996|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
163420686|NCT00849017|590246994|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
163420687|NCT00849017|590246995|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
163420688|NCT00849017|590246996|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
163420689|NCT00849017|590246994|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
163420690|NCT00849017|590246995|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
163420691|NCT00849017|590246996|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
163420692|NCT00849017|590246994|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
163420693|NCT00849017|590246995|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
163420694|NCT00849017|590246996|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
163420695|NCT00849017|590246994|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
163420696|NCT00849017|590246995|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
163420697|NCT00849017|590246996|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
163420698|NCT00849017|590246994|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
163420699|NCT00849017|590246995|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
163420700|NCT00849017|590246996|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
163420701|NCT00849017|590246994|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
163420702|NCT00849017|590246995|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
163420703|NCT00849017|590246996|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
163420704|NCT02913313|590246997|FG000|Overall Study|DISEASE PROGRESSION|1|||
163420705|NCT02913313|590246998|FG001|Overall Study|DISEASE PROGRESSION|2|||
163420706|NCT02913313|590246999|FG002|Overall Study|DISEASE PROGRESSION|2|||
163420707|NCT02913313|590247000|FG003|Overall Study|DISEASE PROGRESSION|4|||
163420708|NCT02913313|590247001|FG004|Overall Study|DISEASE PROGRESSION|6|||
163420709|NCT02913313|590247002|FG005|Overall Study|DISEASE PROGRESSION|4|||
163420710|NCT02913313|590247003|FG006|Overall Study|DISEASE PROGRESSION|19|||
163420711|NCT02913313|590247004|FG007|Overall Study|DISEASE PROGRESSION|3|||
163420712|NCT02913313|590247005|FG008|Overall Study|DISEASE PROGRESSION|4|||
163420713|NCT02913313|590247006|FG009|Overall Study|DISEASE PROGRESSION|4|||
163420714|NCT02913313|590247007|FG010|Overall Study|DISEASE PROGRESSION|11|||
163420715|NCT02913313|590247008|FG011|Overall Study|DISEASE PROGRESSION|5|||
163420716|NCT02913313|590247009|FG012|Overall Study|DISEASE PROGRESSION|14|||
163420717|NCT02913313|590247010|FG013|Overall Study|DISEASE PROGRESSION|3|||
163420718|NCT02913313|590246997|FG000|Overall Study|Not Reported|0|||
163420719|NCT02913313|590246998|FG001|Overall Study|Not Reported|0|||
163420720|NCT02913313|590246999|FG002|Overall Study|Not Reported|0|||
163420721|NCT02913313|590247000|FG003|Overall Study|Not Reported|0|||
163420722|NCT02913313|590247001|FG004|Overall Study|Not Reported|1|||
163420723|NCT02913313|590247002|FG005|Overall Study|Not Reported|0|||
163420724|NCT02913313|590247003|FG006|Overall Study|Not Reported|0|||
163420725|NCT02913313|590247004|FG007|Overall Study|Not Reported|0|||
163420726|NCT02913313|590247005|FG008|Overall Study|Not Reported|0|||
163420727|NCT02913313|590247006|FG009|Overall Study|Not Reported|0|||
163420728|NCT02913313|590247007|FG010|Overall Study|Not Reported|4|||
163420729|NCT02913313|590247008|FG011|Overall Study|Not Reported|0|||
163420730|NCT02913313|590247009|FG012|Overall Study|Not Reported|0|||
163420731|NCT02913313|590247010|FG013|Overall Study|Not Reported|0|||
163420732|NCT02913313|590246997|FG000|Overall Study|Other reasons|0|||
163420733|NCT02913313|590246998|FG001|Overall Study|Other reasons|0|||
163420734|NCT02913313|590246999|FG002|Overall Study|Other reasons|0|||
163420735|NCT02913313|590247000|FG003|Overall Study|Other reasons|0|||
163420736|NCT02913313|590247001|FG004|Overall Study|Other reasons|1|||
163420737|NCT02913313|590247002|FG005|Overall Study|Other reasons|0|||
163420738|NCT02913313|590247003|FG006|Overall Study|Other reasons|0|||
163420739|NCT02913313|590247004|FG007|Overall Study|Other reasons|0|||
163420740|NCT02913313|590247005|FG008|Overall Study|Other reasons|0|||
163420741|NCT02913313|590247006|FG009|Overall Study|Other reasons|0|||
163420742|NCT02913313|590247007|FG010|Overall Study|Other reasons|1|||
163420743|NCT02913313|590247008|FG011|Overall Study|Other reasons|0|||
163420744|NCT02913313|590247009|FG012|Overall Study|Other reasons|0|||
163420745|NCT02913313|590247010|FG013|Overall Study|Other reasons|0|||
163420746|NCT02913313|590246997|FG000|Overall Study|Withdrawal by Subject|0|||
163420747|NCT02913313|590246998|FG001|Overall Study|Withdrawal by Subject|0|||
163420748|NCT02913313|590246999|FG002|Overall Study|Withdrawal by Subject|1|||
163420749|NCT02913313|590247000|FG003|Overall Study|Withdrawal by Subject|0|||
163420750|NCT02913313|590247001|FG004|Overall Study|Withdrawal by Subject|0|||
163420751|NCT02913313|590247002|FG005|Overall Study|Withdrawal by Subject|0|||
163420752|NCT02913313|590247003|FG006|Overall Study|Withdrawal by Subject|1|||
163420753|NCT02913313|590247004|FG007|Overall Study|Withdrawal by Subject|1|||
163420754|NCT02913313|590247005|FG008|Overall Study|Withdrawal by Subject|0|||
163420755|NCT02913313|590247006|FG009|Overall Study|Withdrawal by Subject|0|||
163420756|NCT02913313|590247007|FG010|Overall Study|Withdrawal by Subject|1|||
163420757|NCT02913313|590247008|FG011|Overall Study|Withdrawal by Subject|0|||
163420758|NCT02913313|590247009|FG012|Overall Study|Withdrawal by Subject|0|||
163420759|NCT02913313|590247010|FG013|Overall Study|Withdrawal by Subject|0|||
163420760|NCT02913313|590246997|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163420761|NCT02913313|590246998|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163420762|NCT02913313|590246999|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163420763|NCT02913313|590247000|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163420764|NCT02913313|590247001|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163420765|NCT02913313|590247002|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163420766|NCT02913313|590247003|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163420767|NCT02913313|590247004|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163420768|NCT02913313|590247005|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163420769|NCT02913313|590247006|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163420770|NCT02913313|590247007|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
163420771|NCT02913313|590247008|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163420772|NCT02913313|590247009|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
163420773|NCT02913313|590247010|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
163420774|NCT02913313|590246997|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
163420775|NCT02913313|590246998|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
163420776|NCT02913313|590246999|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
163420777|NCT02913313|590247000|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
163420778|NCT02913313|590247001|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
163420779|NCT02913313|590247002|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
163420780|NCT02913313|590247003|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
163420781|NCT02913313|590247004|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
163420782|NCT02913313|590247005|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
163420783|NCT02913313|590247006|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
163420784|NCT02913313|590247007|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
163420785|NCT02913313|590247008|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
163420786|NCT02913313|590247009|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
163420787|NCT02913313|590247010|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
163420788|NCT01061008|590247011|FG000|Overall Study|Badiocephalic fistula failed|3|||
163420789|NCT01061008|590247012|FG001|Overall Study|Badiocephalic fistula failed|2|||
163420790|NCT01061008|590247011|FG000|Overall Study|Death|1|||
163420791|NCT01061008|590247012|FG001|Overall Study|Death|0|||
163420792|NCT01061008|590247011|FG000|Overall Study|Withdrawal by Subject|1|||
163420793|NCT01061008|590247012|FG001|Overall Study|Withdrawal by Subject|3|||
163420794|NCT01061008|590247011|FG000|Overall Study|Unable to exercise following surgery|1|||
163420795|NCT01061008|590247012|FG001|Overall Study|Unable to exercise following surgery|0|||
163420796|NCT01061008|590247011|FG000|Overall Study|Adverse Event|0|||
163420797|NCT01061008|590247012|FG001|Overall Study|Adverse Event|1|||
163420798|NCT02024971|590247015|FG000|Overall Study|Data Not Available|30|||
163420799|NCT02024971|590247015|FG000|Overall Study|Lost to Follow-up|6|||
163420800|NCT02908100|590247016|FG000|Overall Study|Adverse Event|7|||
163420801|NCT02908100|590247017|FG001|Overall Study|Adverse Event|6|||
163420802|NCT02908100|590247018|FG002|Overall Study|Adverse Event|9|||
163420803|NCT02908100|590247016|FG000|Overall Study|Death|2|||
163420804|NCT02908100|590247017|FG001|Overall Study|Death|0|||
163420805|NCT02908100|590247018|FG002|Overall Study|Death|0|||
163420806|NCT02908100|590247016|FG000|Overall Study|Lack of Efficacy|2|||
163420807|NCT02908100|590247017|FG001|Overall Study|Lack of Efficacy|3|||
163420808|NCT02908100|590247018|FG002|Overall Study|Lack of Efficacy|3|||
163420809|NCT02908100|590247016|FG000|Overall Study|Lost to Follow-up|0|||
163420810|NCT02908100|590247017|FG001|Overall Study|Lost to Follow-up|1|||
163420811|NCT02908100|590247018|FG002|Overall Study|Lost to Follow-up|2|||
163420812|NCT02908100|590247016|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163420813|NCT02908100|590247017|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163420814|NCT02908100|590247018|FG002|Overall Study|Non-Compliance With Study Drug|2|||
163420815|NCT02908100|590247016|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
163420816|NCT02908100|590247017|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
163420817|NCT02908100|590247018|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
163420818|NCT02908100|590247016|FG000|Overall Study|Physician Decision|0|||
163420819|NCT02908100|590247017|FG001|Overall Study|Physician Decision|1|||
163420820|NCT02908100|590247018|FG002|Overall Study|Physician Decision|0|||
163420821|NCT02908100|590247016|FG000|Overall Study|Pregnancy|1|||
163420822|NCT02908100|590247017|FG001|Overall Study|Pregnancy|2|||
163420823|NCT02908100|590247018|FG002|Overall Study|Pregnancy|0|||
163420824|NCT02908100|590247016|FG000|Overall Study|Withdrawal by Subject|8|||
163420825|NCT02908100|590247017|FG001|Overall Study|Withdrawal by Subject|7|||
163420826|NCT02908100|590247018|FG002|Overall Study|Withdrawal by Subject|5|||
163420827|NCT02908100|590247016|FG000|Overall Study|Randomised in Error|1|||
163420828|NCT02908100|590247017|FG001|Overall Study|Randomised in Error|0|||
163420829|NCT02908100|590247018|FG002|Overall Study|Randomised in Error|0|||
163420830|NCT05254418|590247020|FG000|Overall Study|Adverse Event|2|||
163420831|NCT02631538|590247023|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
163420832|NCT02631538|590247024|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
163420833|NCT02631538|590247025|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
163420834|NCT02631538|590247026|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
163420835|NCT02631538|590247023|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
163420836|NCT02631538|590247024|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
163420837|NCT02631538|590247025|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
163420838|NCT02631538|590247026|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
163420839|NCT02631538|590247023|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
163420840|NCT02631538|590247024|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
163420841|NCT02631538|590247025|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
163420842|NCT02631538|590247026|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
163420843|NCT02631538|590247023|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
163420844|NCT02631538|590247024|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
163420845|NCT02631538|590247025|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
163420846|NCT02631538|590247026|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
163420847|NCT02631538|590247023|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
163420848|NCT02631538|590247024|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
163420849|NCT02631538|590247025|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
163420850|NCT02631538|590247026|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
163420851|NCT02631538|590247023|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
163420852|NCT02631538|590247024|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
163420853|NCT02631538|590247025|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
163420854|NCT02631538|590247026|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
163420855|NCT00440726|590247027|FG000|Phase 1|Dose-Limiting Toxicity|0|||
163420856|NCT00440726|590247028|FG001|Phase 1|Dose-Limiting Toxicity|1|||
163420857|NCT00440726|590247029|FG002|Phase 1|Dose-Limiting Toxicity|0|||
163420858|NCT00440726|590247027|FG000|Phase 1|Physician Decision|1|||
163420859|NCT00440726|590247028|FG001|Phase 1|Physician Decision|0|||
163420860|NCT00440726|590247029|FG002|Phase 1|Physician Decision|0|||
163420861|NCT00440726|590247027|FG000|Phase 2|Death|0|||
163420862|NCT00440726|590247028|FG001|Phase 2|Death|0|||
163420863|NCT00440726|590247029|FG002|Phase 2|Death|1|||
163420864|NCT00440726|590247027|FG000|Phase 2|Adverse Event|0|||
163420865|NCT00440726|590247028|FG001|Phase 2|Adverse Event|0|||
163420866|NCT00440726|590247029|FG002|Phase 2|Adverse Event|1|||
163420867|NCT04067518|590247030|FG000|Overall Study|Adverse Event|1|||
163420868|NCT04067518|590247031|FG001|Overall Study|Adverse Event|3|||
163420869|NCT04067518|590247030|FG000|Overall Study|Screen failures|0|||
163420870|NCT04067518|590247031|FG001|Overall Study|Screen failures|1|||
163420871|NCT04067518|590247030|FG000|Overall Study|Enrolled but not treated|0|||
163420872|NCT04067518|590247031|FG001|Overall Study|Enrolled but not treated|1|||
163420873|NCT00110019|590247032|FG000|Overall Study|Lack of Efficacy|253|||
163420874|NCT00110019|590247033|FG001|Overall Study|Lack of Efficacy|285|||
163420875|NCT00110019|590247032|FG000|Overall Study|Adverse Event|61|||
163420876|NCT00110019|590247033|FG001|Overall Study|Adverse Event|40|||
163420877|NCT00110019|590247032|FG000|Overall Study|Death|13|||
163420878|NCT00110019|590247033|FG001|Overall Study|Death|15|||
163420879|NCT00110019|590247032|FG000|Overall Study|Withdrawal by Subject|21|||
163420880|NCT00110019|590247033|FG001|Overall Study|Withdrawal by Subject|9|||
163420881|NCT00110019|590247032|FG000|Overall Study|alternative therapy|5|||
163420882|NCT00110019|590247033|FG001|Overall Study|alternative therapy|1|||
163420883|NCT00110019|590247032|FG000|Overall Study|complicating disease|1|||
163420884|NCT00110019|590247033|FG001|Overall Study|complicating disease|1|||
163420885|NCT00110019|590247032|FG000|Overall Study|symptom deterioration|13|||
163420886|NCT00110019|590247033|FG001|Overall Study|symptom deterioration|16|||
163420887|NCT00110019|590247032|FG000|Overall Study|Not start protocol therapy|17|||
163420888|NCT00110019|590247033|FG001|Overall Study|Not start protocol therapy|16|||
163420889|NCT00110019|590247032|FG000|Overall Study|other reasons|22|||
163420890|NCT00110019|590247033|FG001|Overall Study|other reasons|30|||
163420891|NCT04276207|590247037|FG000|Period 1|Withdrawal by Subject|0|||
163420892|NCT04276207|590247038|FG001|Period 1|Withdrawal by Subject|1|||
163420893|NCT01256177|590247039|FG000|Overall Study|Withdrawal by Subject|23|||
163420894|NCT01256177|590247040|FG001|Overall Study|Withdrawal by Subject|22|||
163420895|NCT01256177|590247039|FG000|Overall Study|Lost to Follow-up|2|||
163420896|NCT01256177|590247040|FG001|Overall Study|Lost to Follow-up|2|||
163420897|NCT01256177|590247039|FG000|Overall Study|Adverse Event|8|||
163420898|NCT01256177|590247040|FG001|Overall Study|Adverse Event|9|||
163420899|NCT01256177|590247039|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
163420900|NCT01256177|590247040|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
163420901|NCT01256177|590247039|FG000|Overall Study|Condition under Investigation Worsened|1|||
163420902|NCT01256177|590247040|FG001|Overall Study|Condition under Investigation Worsened|0|||
163420903|NCT01256177|590247039|FG000|Overall Study|Lack of Efficacy|11|||
163420904|NCT01256177|590247040|FG001|Overall Study|Lack of Efficacy|2|||
163420905|NCT01256177|590247039|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
163420906|NCT01256177|590247040|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
163420907|NCT03624946|590247041|FG000|Overall Study|Lost to Follow-up|0|||
163420908|NCT03624946|590247042|FG001|Overall Study|Lost to Follow-up|1|||
163420909|NCT00862251|590247046|FG000|Overall Study|Adverse Event|8|||
163420910|NCT00862251|590247047|FG001|Overall Study|Adverse Event|3|||
163420911|NCT00862251|590247048|FG002|Overall Study|Adverse Event|1|||
163420912|NCT00862251|590247046|FG000|Overall Study|Lost to Follow-up|0|||
163420913|NCT00862251|590247047|FG001|Overall Study|Lost to Follow-up|0|||
163420914|NCT00862251|590247048|FG002|Overall Study|Lost to Follow-up|1|||
163420915|NCT00862251|590247046|FG000|Overall Study|Protocol Violation|2|||
163420916|NCT00862251|590247047|FG001|Overall Study|Protocol Violation|0|||
163420917|NCT00862251|590247048|FG002|Overall Study|Protocol Violation|1|||
163420918|NCT00862251|590247046|FG000|Overall Study|Withdrawal by Subject|9|||
163420919|NCT00862251|590247047|FG001|Overall Study|Withdrawal by Subject|2|||
163420920|NCT00862251|590247048|FG002|Overall Study|Withdrawal by Subject|6|||
163420921|NCT02796755|590247049|FG000|Overall Study|Adverse Event|2|||
163420922|NCT02796755|590247050|FG001|Overall Study|Adverse Event|0|||
163420923|NCT00675025|590247051|FG000|Overall Study|Study Terminated by Sponsor|38|||
163420924|NCT00675025|590247052|FG001|Overall Study|Study Terminated by Sponsor|42|||
163420925|NCT00675025|590247051|FG000|Overall Study|Adverse Event|6|||
163420926|NCT00675025|590247052|FG001|Overall Study|Adverse Event|11|||
163420927|NCT00675025|590247051|FG000|Overall Study|Lost to Follow-up|6|||
163420928|NCT00675025|590247052|FG001|Overall Study|Lost to Follow-up|4|||
163420929|NCT00675025|590247051|FG000|Overall Study|Withdrawal by Subject|4|||
163420930|NCT00675025|590247052|FG001|Overall Study|Withdrawal by Subject|6|||
163420931|NCT00944034|590247054|FG000|Overall Study|Inappropriate enrollment|0|||
163420932|NCT00944034|590247055|FG001|Overall Study|Inappropriate enrollment|1|||
163420933|NCT00944034|590247056|FG002|Overall Study|Inappropriate enrollment|0|||
163420934|NCT00944034|590247057|FG003|Overall Study|Inappropriate enrollment|1|||
163420935|NCT00944034|590247058|FG004|Overall Study|Inappropriate enrollment|2|||
163420936|NCT00944034|590247059|FG005|Overall Study|Inappropriate enrollment|1|||
163420937|NCT00944034|590247060|FG006|Overall Study|Inappropriate enrollment|0|||
163420938|NCT00944034|590247061|FG007|Overall Study|Inappropriate enrollment|0|||
163420939|NCT00944034|590247062|FG008|Overall Study|Inappropriate enrollment|1|||
163420940|NCT00944034|590247063|FG009|Overall Study|Inappropriate enrollment|1|||
163420941|NCT00944034|590247064|FG010|Overall Study|Inappropriate enrollment|0|||
163420942|NCT00944034|590247065|FG011|Overall Study|Inappropriate enrollment|0|||
163420943|NCT00944034|590247054|FG000|Overall Study|Withdrawal by Subject|3|||
163420944|NCT00944034|590247055|FG001|Overall Study|Withdrawal by Subject|2|||
163420945|NCT00944034|590247056|FG002|Overall Study|Withdrawal by Subject|6|||
163420946|NCT00944034|590247057|FG003|Overall Study|Withdrawal by Subject|2|||
163420947|NCT00944034|590247058|FG004|Overall Study|Withdrawal by Subject|5|||
163420948|NCT00944034|590247059|FG005|Overall Study|Withdrawal by Subject|8|||
163420949|NCT00944034|590247060|FG006|Overall Study|Withdrawal by Subject|2|||
163420950|NCT00944034|590247061|FG007|Overall Study|Withdrawal by Subject|2|||
163420951|NCT00944034|590247062|FG008|Overall Study|Withdrawal by Subject|3|||
163420952|NCT00944034|590247063|FG009|Overall Study|Withdrawal by Subject|4|||
163420953|NCT00944034|590247064|FG010|Overall Study|Withdrawal by Subject|0|||
163420954|NCT00944034|590247065|FG011|Overall Study|Withdrawal by Subject|4|||
163420955|NCT00944034|590247054|FG000|Overall Study|Lost to Follow-up|0|||
163420956|NCT00944034|590247055|FG001|Overall Study|Lost to Follow-up|4|||
163420957|NCT00944034|590247056|FG002|Overall Study|Lost to Follow-up|2|||
163420958|NCT00944034|590247057|FG003|Overall Study|Lost to Follow-up|0|||
163420959|NCT00944034|590247058|FG004|Overall Study|Lost to Follow-up|5|||
163420960|NCT00944034|590247059|FG005|Overall Study|Lost to Follow-up|7|||
163420961|NCT00944034|590247060|FG006|Overall Study|Lost to Follow-up|0|||
163420962|NCT00944034|590247061|FG007|Overall Study|Lost to Follow-up|1|||
163420963|NCT00944034|590247062|FG008|Overall Study|Lost to Follow-up|5|||
163420964|NCT00944034|590247063|FG009|Overall Study|Lost to Follow-up|1|||
163420965|NCT00944034|590247064|FG010|Overall Study|Lost to Follow-up|1|||
163420966|NCT00944034|590247065|FG011|Overall Study|Lost to Follow-up|0|||
163420967|NCT00944034|590247054|FG000|Overall Study|Death|0|||
163420968|NCT00944034|590247055|FG001|Overall Study|Death|0|||
163420969|NCT00944034|590247056|FG002|Overall Study|Death|1|||
163420970|NCT00944034|590247057|FG003|Overall Study|Death|0|||
163420971|NCT00944034|590247058|FG004|Overall Study|Death|0|||
163420972|NCT00944034|590247059|FG005|Overall Study|Death|0|||
163420973|NCT00944034|590247060|FG006|Overall Study|Death|0|||
163420974|NCT00944034|590247061|FG007|Overall Study|Death|0|||
163420975|NCT00944034|590247062|FG008|Overall Study|Death|0|||
163420976|NCT00944034|590247063|FG009|Overall Study|Death|0|||
163420977|NCT00944034|590247064|FG010|Overall Study|Death|0|||
163420978|NCT00944034|590247065|FG011|Overall Study|Death|0|||
163420979|NCT00944034|590247054|FG000|Overall Study|Protocol Violation|2|||
163420980|NCT00944034|590247055|FG001|Overall Study|Protocol Violation|0|||
163420981|NCT00944034|590247056|FG002|Overall Study|Protocol Violation|0|||
163420982|NCT00944034|590247057|FG003|Overall Study|Protocol Violation|1|||
163420983|NCT00944034|590247058|FG004|Overall Study|Protocol Violation|2|||
163420984|NCT00944034|590247059|FG005|Overall Study|Protocol Violation|3|||
163420985|NCT00944034|590247060|FG006|Overall Study|Protocol Violation|0|||
163420986|NCT00944034|590247061|FG007|Overall Study|Protocol Violation|1|||
163420987|NCT00944034|590247062|FG008|Overall Study|Protocol Violation|1|||
163420988|NCT00944034|590247063|FG009|Overall Study|Protocol Violation|4|||
163420989|NCT00944034|590247064|FG010|Overall Study|Protocol Violation|0|||
163420990|NCT00944034|590247065|FG011|Overall Study|Protocol Violation|0|||
163420991|NCT00944034|590247054|FG000|Overall Study|Unable to classify|0|||
163420992|NCT00944034|590247055|FG001|Overall Study|Unable to classify|0|||
163420993|NCT00944034|590247056|FG002|Overall Study|Unable to classify|0|||
163420994|NCT00944034|590247057|FG003|Overall Study|Unable to classify|0|||
163420995|NCT00944034|590247058|FG004|Overall Study|Unable to classify|0|||
163420996|NCT00944034|590247059|FG005|Overall Study|Unable to classify|1|||
163420997|NCT00944034|590247060|FG006|Overall Study|Unable to classify|1|||
163420998|NCT00944034|590247061|FG007|Overall Study|Unable to classify|1|||
163420999|NCT00944034|590247062|FG008|Overall Study|Unable to classify|0|||
163421000|NCT00944034|590247063|FG009|Overall Study|Unable to classify|0|||
163421001|NCT00944034|590247064|FG010|Overall Study|Unable to classify|0|||
163421002|NCT00944034|590247065|FG011|Overall Study|Unable to classify|0|||
163421003|NCT00944034|590247054|FG000|Overall Study|Administrative reason|0|||
163421004|NCT00944034|590247055|FG001|Overall Study|Administrative reason|0|||
163421005|NCT00944034|590247056|FG002|Overall Study|Administrative reason|0|||
163421006|NCT00944034|590247057|FG003|Overall Study|Administrative reason|0|||
163421007|NCT00944034|590247058|FG004|Overall Study|Administrative reason|0|||
163421008|NCT00944034|590247059|FG005|Overall Study|Administrative reason|0|||
163421009|NCT00944034|590247060|FG006|Overall Study|Administrative reason|1|||
163421010|NCT00944034|590247061|FG007|Overall Study|Administrative reason|0|||
163421011|NCT00944034|590247062|FG008|Overall Study|Administrative reason|0|||
163421012|NCT00944034|590247063|FG009|Overall Study|Administrative reason|0|||
163421013|NCT00944034|590247064|FG010|Overall Study|Administrative reason|0|||
163421014|NCT00944034|590247065|FG011|Overall Study|Administrative reason|0|||
163421015|NCT01596257|590247066|FG000|Overall Study|Inadequate Collection|23|||
163421016|NCT01596257|590247067|FG001|Overall Study|Inadequate Collection|19|||
163421017|NCT00531960|590247068|FG000|Overall Study|Adverse Event|5|||
163421018|NCT00531960|590247069|FG001|Overall Study|Adverse Event|4|||
163421019|NCT00531960|590247068|FG000|Overall Study|Death|3|||
163421020|NCT00531960|590247069|FG001|Overall Study|Death|2|||
163421021|NCT00531960|590247068|FG000|Overall Study|Lack of Efficacy|42|||
163421022|NCT00531960|590247069|FG001|Overall Study|Lack of Efficacy|41|||
163421023|NCT00531960|590247068|FG000|Overall Study|Violation of Selection Criteria|2|||
163421024|NCT00531960|590247069|FG001|Overall Study|Violation of Selection Criteria|0|||
163421025|NCT00531960|590247068|FG000|Overall Study|Refused Treatment|5|||
163421026|NCT00531960|590247069|FG001|Overall Study|Refused Treatment|6|||
163421027|NCT00531960|590247068|FG000|Overall Study|Other|4|||
163421028|NCT00531960|590247069|FG001|Overall Study|Other|10|||
163421029|NCT04258579|590247070|FG000|Overall Study|Withdrawal by Subject|7|||
163421030|NCT04258579|590247070|FG000|Overall Study|Lost to Follow-up|3|||
163421031|NCT04258579|590247070|FG000|Overall Study|Protocol Violation|2|||
163421032|NCT04258579|590247070|FG000|Overall Study|Adverse Event|1|||
163421033|NCT04007159|590247071|FG000|Induction Phase|(missed study visits)|16|||
163421034|NCT04007159|590247071|FG000|Induction Phase|Withdrawal by Subject|4|||
163421035|NCT04007159|590247071|FG000|Induction Phase|Adverse Event|2|||
163421036|NCT04007159|590247071|FG000|Challenge Phase|missed study visits|3|||
163421037|NCT00331006|590247073|FG000|Screening Phase|Withdrawal by Subject|1|||
163421038|NCT00331006|590247073|FG000|Screening Phase|enrollment halted|1|||
163421039|NCT00331006|590247073|FG000|Screening Phase|Lost to Follow-up|1|||
163421040|NCT00331006|590247073|FG000|Screening Phase|Ineligible for treatment phase|4|||
163421041|NCT00331006|590247073|FG000|Treatment Phase|Withdrawal by Subject|1|||
163421042|NCT00331006|590247073|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
163421043|NCT00331006|590247073|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
163421044|NCT03804684|590247074|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
163421045|NCT03804684|590247075|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
163421046|NCT01225562|590247076|FG000|Overall Study|Withdrawal by Subject|52|||
163421047|NCT01225562|590247077|FG001|Overall Study|Withdrawal by Subject|50|||
163421048|NCT01225562|590247078|FG002|Overall Study|Withdrawal by Subject|52|||
163421049|NCT01225562|590247076|FG000|Overall Study|Lost to Follow-up|3|||
163421050|NCT01225562|590247077|FG001|Overall Study|Lost to Follow-up|6|||
163421051|NCT01225562|590247078|FG002|Overall Study|Lost to Follow-up|1|||
163421052|NCT01375764|590247079|FG000|Overall Study|Lost to Follow-up|0|||
163421053|NCT01375764|590247080|FG001|Overall Study|Lost to Follow-up|1|||
163421054|NCT01375764|590247081|FG002|Overall Study|Lost to Follow-up|0|||
163421055|NCT01375764|590247082|FG003|Overall Study|Lost to Follow-up|0|||
163421056|NCT01375764|590247083|FG004|Overall Study|Lost to Follow-up|0|||
163421057|NCT01375764|590247079|FG000|Overall Study|Withdrawal by Subject|2|||
163421058|NCT01375764|590247080|FG001|Overall Study|Withdrawal by Subject|0|||
163421059|NCT01375764|590247081|FG002|Overall Study|Withdrawal by Subject|0|||
163421060|NCT01375764|590247082|FG003|Overall Study|Withdrawal by Subject|0|||
163421061|NCT01375764|590247083|FG004|Overall Study|Withdrawal by Subject|1|||
163421062|NCT01375764|590247079|FG000|Overall Study|Other|0|||
163421063|NCT01375764|590247080|FG001|Overall Study|Other|0|||
163421064|NCT01375764|590247081|FG002|Overall Study|Other|0|||
163421065|NCT01375764|590247082|FG003|Overall Study|Other|1|||
163421066|NCT01375764|590247083|FG004|Overall Study|Other|0|||
163421067|NCT02732951|590248555|FG000|Overall Study|Other than listed|1|||
163421068|NCT02732951|590248556|FG001|Overall Study|Other than listed|0|||
163421069|NCT02732951|590248555|FG000|Overall Study|Lost to Follow-up|0|||
163421070|NCT02732951|590248556|FG001|Overall Study|Lost to Follow-up|1|||
163421071|NCT02732951|590248555|FG000|Overall Study|Adverse Event|4|||
163421072|NCT02732951|590248556|FG001|Overall Study|Adverse Event|4|||
163421073|NCT02732951|590248555|FG000|Overall Study|Protocol Violation|0|||
163421074|NCT02732951|590248556|FG001|Overall Study|Protocol Violation|1|||
163421075|NCT01974817|590248557|FG000|Overall Study|Death|4|||
163421076|NCT01974817|590248557|FG000|Overall Study|Lost to Follow-up|2|||
163421077|NCT01974817|590248557|FG000|Overall Study|Protocol Violation|2|||
163421078|NCT05047523|590248562|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
163421079|NCT05047523|590248563|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
163421080|NCT05047523|590248564|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
163421081|NCT05047523|590248565|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
163421082|NCT05047523|590248566|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
163421083|NCT05047523|590248567|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
163421084|NCT05047523|590248562|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
163421085|NCT05047523|590248563|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
163421086|NCT05047523|590248564|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
163421087|NCT05047523|590248565|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
163421088|NCT05047523|590248566|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
163421089|NCT05047523|590248567|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
163421090|NCT05047523|590248562|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
163421091|NCT05047523|590248563|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
163421092|NCT05047523|590248564|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
163421093|NCT05047523|590248565|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
163421094|NCT05047523|590248566|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
163421095|NCT05047523|590248567|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
163421096|NCT05047523|590248562|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
163421097|NCT05047523|590248563|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163421098|NCT05047523|590248564|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163421099|NCT05047523|590248565|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163421100|NCT05047523|590248566|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163421101|NCT05047523|590248567|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163421102|NCT05047523|590248562|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
163421103|NCT05047523|590248563|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
163421104|NCT05047523|590248564|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
163421105|NCT05047523|590248565|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
163421106|NCT05047523|590248566|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
163421107|NCT05047523|590248567|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
163421108|NCT05047523|590248562|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
163421109|NCT05047523|590248563|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
163421110|NCT05047523|590248564|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
163421111|NCT05047523|590248565|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
163421112|NCT05047523|590248566|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
163421113|NCT05047523|590248567|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
163421114|NCT03658889|590248568|FG000|Overall Study|Protocol Violation|2|||
163421115|NCT03658889|590248569|FG001|Overall Study|Protocol Violation|0|||
163421116|NCT04188197|590248572|FG000|Overall Study|Lost to Follow-up|4|||
163421117|NCT04188197|590248573|FG001|Overall Study|Lost to Follow-up|1|||
163421118|NCT04188197|590248572|FG000|Overall Study|Withdrawal by Subject|1|||
163421119|NCT04188197|590248573|FG001|Overall Study|Withdrawal by Subject|1|||
163421120|NCT04188197|590248572|FG000|Overall Study|Pregnancy|0|||
163421121|NCT04188197|590248573|FG001|Overall Study|Pregnancy|1|||
163421122|NCT01805180|590248574|FG000|Lead-in Donor Phase|screen failure|1|||
163421123|NCT01805180|590248575|FG001|Lead-in Donor Phase|screen failure|0|||
163421124|NCT01805180|590248576|FG002|Lead-in Donor Phase|screen failure|0|||
163421125|NCT04684420|590248581|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163421126|NCT04684420|590248582|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163421127|NCT04684420|590248583|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
163421128|NCT04684420|590248584|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
163421129|NCT04684420|590248581|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
163421130|NCT04684420|590248582|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
163421131|NCT04684420|590248583|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
163421132|NCT04684420|590248584|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
163421133|NCT00463476|590248585|FG000|Overall Study|Withdrawal by Subject|1|||
163421134|NCT00463476|590248586|FG001|Overall Study|Withdrawal by Subject|2|||
163421135|NCT00463476|590248585|FG000|Overall Study|Lost to Follow-up|1|||
163421136|NCT00463476|590248586|FG001|Overall Study|Lost to Follow-up|1|||
163421137|NCT00928070|590248589|FG000|Overall Study|Lost to Follow-up|1|||
163421138|NCT00928070|590248590|FG001|Overall Study|Lost to Follow-up|2|||
163421139|NCT00928070|590248589|FG000|Overall Study|Withdrawal by Subject|10|||
163421140|NCT00928070|590248590|FG001|Overall Study|Withdrawal by Subject|3|||
163421141|NCT00928070|590248589|FG000|Overall Study|Adverse Event|14|||
163421142|NCT00928070|590248590|FG001|Overall Study|Adverse Event|26|||
163421143|NCT00928070|590248589|FG000|Overall Study|Lack of Efficacy|9|||
163421144|NCT00928070|590248590|FG001|Overall Study|Lack of Efficacy|5|||
163421145|NCT00928070|590248589|FG000|Overall Study|Did not meet entrance criteria|16|||
163421146|NCT00928070|590248590|FG001|Overall Study|Did not meet entrance criteria|9|||
163421147|NCT00928070|590248589|FG000|Overall Study|Protocol Violation|6|||
163421148|NCT00928070|590248590|FG001|Overall Study|Protocol Violation|5|||
163421149|NCT00928070|590248589|FG000|Overall Study|Randomized but not treated|2|||
163421150|NCT00928070|590248590|FG001|Overall Study|Randomized but not treated|2|||
163421151|NCT00928070|590248589|FG000|Overall Study|Other|5|||
163421152|NCT00928070|590248590|FG001|Overall Study|Other|5|||
163421153|NCT02690194|590248593|FG000|Overall Study|Withdrawal by Subject|1|||
163421154|NCT02690194|590248594|FG001|Overall Study|Withdrawal by Subject|4|||
163421155|NCT02690194|590248595|FG002|Overall Study|Withdrawal by Subject|0|||
163421156|NCT00624520|590248596|FG000|Overall Study|Withdrawal by Subject|12|||
163421157|NCT00624520|590248597|FG001|Overall Study|Withdrawal by Subject|7|||
163421158|NCT00624520|590248596|FG000|Overall Study|Death|0|||
163421159|NCT00624520|590248597|FG001|Overall Study|Death|1|||
163421160|NCT00556426|590248601|FG000|Overall Study|Withdrawal by Subject|3|||
163421161|NCT00556426|590248601|FG000|Overall Study|Death|6|||
163421162|NCT01570244|590248605|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
163421163|NCT00238264|590248609|FG000|Overall Study|Death|7|||
163421164|NCT00238264|590248609|FG000|Overall Study|Lost to Follow-up|18|||
163421165|NCT00238264|590248609|FG000|Overall Study|Withdrawal by Subject|4|||
163421166|NCT00238264|590248609|FG000|Overall Study|Ineligible|7|||
163421167|NCT00713219|590248610|FG000|Overall Study|Death|1|||
163421168|NCT00713219|590248610|FG000|Overall Study|Protocol Violation|1|||
163421169|NCT03183128|590248611|FG000|Overall Study|Adverse Event|1|||
163421170|NCT03183128|590248612|FG001|Overall Study|Adverse Event|2|||
163421171|NCT03183128|590248611|FG000|Overall Study|Withdrawal by Subject|1|||
163421172|NCT03183128|590248612|FG001|Overall Study|Withdrawal by Subject|8|||
163421173|NCT03183128|590248611|FG000|Overall Study|Protocol Violation|2|||
163421174|NCT03183128|590248612|FG001|Overall Study|Protocol Violation|0|||
163421175|NCT03183128|590248611|FG000|Overall Study|Lack of Efficacy|4|||
163421176|NCT03183128|590248612|FG001|Overall Study|Lack of Efficacy|27|||
163421177|NCT03183128|590248611|FG000|Overall Study|Lost to Follow-up|1|||
163421178|NCT03183128|590248612|FG001|Overall Study|Lost to Follow-up|0|||
163421179|NCT03183128|590248611|FG000|Overall Study|Death|2|||
163421180|NCT03183128|590248612|FG001|Overall Study|Death|0|||
163421181|NCT03183128|590248611|FG000|Overall Study|Physician Decision|1|||
163421182|NCT03183128|590248612|FG001|Overall Study|Physician Decision|0|||
163421183|NCT02978222|590248613|FG000|Overall Study|Withdrawal by Subject|2|||
163421184|NCT02978222|590248614|FG001|Overall Study|Withdrawal by Subject|2|||
163421185|NCT02978222|590248613|FG000|Overall Study|Physician Decision|2|||
163421186|NCT02978222|590248614|FG001|Overall Study|Physician Decision|0|||
163421187|NCT02978222|590248613|FG000|Overall Study|Adverse Event|0|||
163421188|NCT02978222|590248614|FG001|Overall Study|Adverse Event|1|||
163421189|NCT02978222|590248613|FG000|Overall Study|Death|1|||
163421190|NCT02978222|590248614|FG001|Overall Study|Death|0|||
163421191|NCT02978222|590248613|FG000|Overall Study|Disease Progression|32|||
163421192|NCT02978222|590248614|FG001|Overall Study|Disease Progression|32|||
163421193|NCT02978222|590248613|FG000|Overall Study|Early Study Termination|24|||
163421194|NCT02978222|590248614|FG001|Overall Study|Early Study Termination|21|||
163421195|NCT03258814|590248615|FG000|Overall Study|Early Termination|4|||
163421196|NCT03258814|590248616|FG001|Overall Study|Early Termination|3|||
163421197|NCT03258814|590248617|FG002|Overall Study|Early Termination|10|||
163421198|NCT01413958|590248618|FG000|Overall Study|Lost to Follow-up|0|||
163421199|NCT01413958|590248619|FG001|Overall Study|Lost to Follow-up|1|||
163421200|NCT02908516|590248620|FG000|Overall Study|Study Terminated|3|||
163421201|NCT02908516|590248621|FG001|Overall Study|Study Terminated|3|||
163421202|NCT00348140|590248624|FG000|Overall Study|Adverse Event|46|||
163421203|NCT00348140|590248625|FG001|Overall Study|Adverse Event|49|||
163421204|NCT00348140|590248626|FG002|Overall Study|Adverse Event|78|||
163421205|NCT00348140|590248624|FG000|Overall Study|Lost to Follow-up|4|||
163421206|NCT00348140|590248625|FG001|Overall Study|Lost to Follow-up|4|||
163421207|NCT00348140|590248626|FG002|Overall Study|Lost to Follow-up|4|||
163421208|NCT00348140|590248624|FG000|Overall Study|Protocol Violation|12|||
163421209|NCT00348140|590248625|FG001|Overall Study|Protocol Violation|13|||
163421210|NCT00348140|590248626|FG002|Overall Study|Protocol Violation|14|||
163421211|NCT00348140|590248624|FG000|Overall Study|Withdrawal by Subject|32|||
163421212|NCT00348140|590248625|FG001|Overall Study|Withdrawal by Subject|40|||
163421213|NCT00348140|590248626|FG002|Overall Study|Withdrawal by Subject|40|||
163421214|NCT00348140|590248624|FG000|Overall Study|Non-compliance|8|||
163421215|NCT00348140|590248625|FG001|Overall Study|Non-compliance|13|||
163421216|NCT00348140|590248626|FG002|Overall Study|Non-compliance|5|||
163421217|NCT00348140|590248624|FG000|Overall Study|Participant at risk due to study drug|2|||
163421218|NCT00348140|590248625|FG001|Overall Study|Participant at risk due to study drug|0|||
163421219|NCT00348140|590248626|FG002|Overall Study|Participant at risk due to study drug|0|||
163421220|NCT00348140|590248624|FG000|Overall Study|Conditional medication increased dose|1|||
163421221|NCT00348140|590248625|FG001|Overall Study|Conditional medication increased dose|0|||
163421222|NCT00348140|590248626|FG002|Overall Study|Conditional medication increased dose|0|||
163421223|NCT00348140|590248624|FG000|Overall Study|Caregiver related|4|||
163421224|NCT00348140|590248625|FG001|Overall Study|Caregiver related|7|||
163421225|NCT00348140|590248626|FG002|Overall Study|Caregiver related|3|||
163421226|NCT00348140|590248624|FG000|Overall Study|Participant hospitalised|3|||
163421227|NCT00348140|590248625|FG001|Overall Study|Participant hospitalised|0|||
163421228|NCT00348140|590248626|FG002|Overall Study|Participant hospitalised|0|||
163421229|NCT00348140|590248624|FG000|Overall Study|Efficacy related|1|||
163421230|NCT00348140|590248625|FG001|Overall Study|Efficacy related|1|||
163421231|NCT00348140|590248626|FG002|Overall Study|Efficacy related|0|||
163421232|NCT00348140|590248624|FG000|Overall Study|Administration related|3|||
163421233|NCT00348140|590248625|FG001|Overall Study|Administration related|1|||
163421234|NCT00348140|590248626|FG002|Overall Study|Administration related|1|||
163421235|NCT00348140|590248624|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
163421236|NCT00348140|590248625|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
163421237|NCT00348140|590248626|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
163421238|NCT00348140|590248624|FG000|Overall Study|Participant unwell|1|||
163421239|NCT00348140|590248625|FG001|Overall Study|Participant unwell|0|||
163421240|NCT00348140|590248626|FG002|Overall Study|Participant unwell|0|||
163421241|NCT00348140|590248624|FG000|Overall Study|Screen failure|1|||
163421242|NCT00348140|590248625|FG001|Overall Study|Screen failure|0|||
163421243|NCT00348140|590248626|FG002|Overall Study|Screen failure|0|||
163421244|NCT00348140|590248624|FG000|Overall Study|Investigator decided to discontinue|4|||
163421245|NCT00348140|590248625|FG001|Overall Study|Investigator decided to discontinue|1|||
163421246|NCT00348140|590248626|FG002|Overall Study|Investigator decided to discontinue|4|||
163421247|NCT00348140|590248624|FG000|Overall Study|Decided to discontinue on their own|1|||
163421248|NCT00348140|590248625|FG001|Overall Study|Decided to discontinue on their own|4|||
163421249|NCT00348140|590248626|FG002|Overall Study|Decided to discontinue on their own|1|||
163421250|NCT00348140|590248624|FG000|Overall Study|Use of prohibited drug|1|||
163421251|NCT00348140|590248625|FG001|Overall Study|Use of prohibited drug|0|||
163421252|NCT00348140|590248626|FG002|Overall Study|Use of prohibited drug|2|||
163421253|NCT00348140|590248624|FG000|Overall Study|Disease progression|1|||
163421254|NCT00348140|590248625|FG001|Overall Study|Disease progression|2|||
163421255|NCT00348140|590248626|FG002|Overall Study|Disease progression|5|||
163421256|NCT00348140|590248624|FG000|Overall Study|Increased risk of cardiac infarction|0|||
163421257|NCT00348140|590248625|FG001|Overall Study|Increased risk of cardiac infarction|1|||
163421258|NCT00348140|590248626|FG002|Overall Study|Increased risk of cardiac infarction|0|||
163421259|NCT00348140|590248624|FG000|Overall Study|Serious adverse event|0|||
163421260|NCT00348140|590248625|FG001|Overall Study|Serious adverse event|1|||
163421261|NCT00348140|590248626|FG002|Overall Study|Serious adverse event|0|||
163421262|NCT00348140|590248624|FG000|Overall Study|Abnormal ECG|0|||
163421263|NCT00348140|590248625|FG001|Overall Study|Abnormal ECG|1|||
163421264|NCT00348140|590248626|FG002|Overall Study|Abnormal ECG|3|||
163421265|NCT00348140|590248624|FG000|Overall Study|Participant died|0|||
163421266|NCT00348140|590248625|FG001|Overall Study|Participant died|1|||
163421267|NCT00348140|590248626|FG002|Overall Study|Participant died|0|||
163421268|NCT00348140|590248624|FG000|Overall Study|Exclusion criteria met|0|||
163421269|NCT00348140|590248625|FG001|Overall Study|Exclusion criteria met|0|||
163421270|NCT00348140|590248626|FG002|Overall Study|Exclusion criteria met|1|||
163421271|NCT00348140|590248624|FG000|Overall Study|Memory declined|0|||
163421272|NCT00348140|590248625|FG001|Overall Study|Memory declined|0|||
163421273|NCT00348140|590248626|FG002|Overall Study|Memory declined|1|||
163421274|NCT02909153|590248631|FG000|Overall Study|Withdrawal by Subject|0|||
163421275|NCT02909153|590248632|FG001|Overall Study|Withdrawal by Subject|1|||
163421276|NCT02909153|590248633|FG002|Overall Study|Withdrawal by Subject|0|||
163421277|NCT02909153|590248634|FG003|Overall Study|Withdrawal by Subject|0|||
163421278|NCT02909153|590248635|FG004|Overall Study|Withdrawal by Subject|0|||
163421279|NCT01273064|590248636|FG000|Overall Study|Adverse Event|5|||
163421280|NCT01273064|590248637|FG001|Overall Study|Adverse Event|1|||
163421281|NCT01273064|590248638|FG002|Overall Study|Adverse Event|3|||
163421282|NCT01273064|590248639|FG003|Overall Study|Adverse Event|2|||
163421283|NCT01273064|590248640|FG004|Overall Study|Adverse Event|1|||
163421284|NCT01273064|590248636|FG000|Overall Study|Withdrawal by Subject|4|||
163421285|NCT01273064|590248637|FG001|Overall Study|Withdrawal by Subject|2|||
163421286|NCT01273064|590248638|FG002|Overall Study|Withdrawal by Subject|2|||
163421287|NCT01273064|590248639|FG003|Overall Study|Withdrawal by Subject|2|||
163421288|NCT01273064|590248640|FG004|Overall Study|Withdrawal by Subject|0|||
163421289|NCT01273064|590248636|FG000|Overall Study|Study Termination|13|||
163421290|NCT01273064|590248637|FG001|Overall Study|Study Termination|27|||
163421291|NCT01273064|590248638|FG002|Overall Study|Study Termination|26|||
163421292|NCT01273064|590248639|FG003|Overall Study|Study Termination|16|||
163421293|NCT01273064|590248640|FG004|Overall Study|Study Termination|8|||
163421294|NCT01273064|590248636|FG000|Overall Study|Lost to Follow-up|1|||
163421295|NCT01273064|590248637|FG001|Overall Study|Lost to Follow-up|0|||
163421296|NCT01273064|590248638|FG002|Overall Study|Lost to Follow-up|0|||
163421297|NCT01273064|590248639|FG003|Overall Study|Lost to Follow-up|0|||
163421298|NCT01273064|590248640|FG004|Overall Study|Lost to Follow-up|0|||
163421299|NCT01273064|590248636|FG000|Overall Study|Physician Decision|0|||
163421300|NCT01273064|590248637|FG001|Overall Study|Physician Decision|0|||
163421301|NCT01273064|590248638|FG002|Overall Study|Physician Decision|0|||
163421302|NCT01273064|590248639|FG003|Overall Study|Physician Decision|0|||
163421303|NCT01273064|590248640|FG004|Overall Study|Physician Decision|1|||
163421304|NCT04666038|590248641|FG000|Overall Study|Progressive Disease|2|||
163421305|NCT04666038|590248642|FG001|Overall Study|Progressive Disease|0|||
163421306|NCT04666038|590248641|FG000|Overall Study|Death|38|||
163421307|NCT04666038|590248642|FG001|Overall Study|Death|32|||
163421308|NCT04666038|590248641|FG000|Overall Study|Withdrawal by Subject|10|||
163421309|NCT04666038|590248642|FG001|Overall Study|Withdrawal by Subject|19|||
163421310|NCT04666038|590248641|FG000|Overall Study|Lost to Follow-up|0|||
163421311|NCT04666038|590248642|FG001|Overall Study|Lost to Follow-up|2|||
163421312|NCT04666038|590248641|FG000|Overall Study|On Study Treatment|46|||
163421313|NCT04666038|590248642|FG001|Overall Study|On Study Treatment|5|||
163421314|NCT04666038|590248641|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
163421315|NCT04666038|590248642|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
163421316|NCT02867761|590248646|FG000|Overall Study|Participant withdrawn by investigator|0|||
163421317|NCT02867761|590248647|FG001|Overall Study|Participant withdrawn by investigator|1|||
163421318|NCT02867761|590248646|FG000|Overall Study|Lost to Follow-up|25|||
163421319|NCT02867761|590248647|FG001|Overall Study|Lost to Follow-up|18|||
163421320|NCT02867761|590248646|FG000|Overall Study|Unable to complete protocol|3|||
163421321|NCT02867761|590248647|FG001|Overall Study|Unable to complete protocol|7|||
163421322|NCT02445586|590248650|FG000|Overall Study|Death|14|||
163421323|NCT02445586|590248650|FG000|Overall Study|Withdrawal by Subject|13|||
163421324|NCT02445586|590248650|FG000|Overall Study|Disease Progression|10|||
163421325|NCT02445586|590248650|FG000|Overall Study|Protocol Violation|1|||
163421326|NCT02445586|590248650|FG000|Overall Study|Medical Condition|1|||
163421327|NCT01194440|590248651|FG000|Baseline (First Dose)|Reason not specified|4|||
163421328|NCT01194440|590248651|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
163421329|NCT01194440|590248651|FG000|Baseline (First Dose)|Change in therapy|1|||
163421330|NCT01194440|590248651|FG000|Baseline (First Dose)|Adverse Event|1|||
163421331|NCT01194440|590248651|FG000|6-months (2nd Dose)|Change in therapy|4|||
163421332|NCT01931059|590248652|FG000|Day 1|Pregnancy|0|||
163421333|NCT01931059|590248653|FG001|Day 1|Pregnancy|1|||
163421334|NCT01931059|590248652|FG000|Day3|Lost to Follow-up|1|||
163421335|NCT01931059|590248653|FG001|Day3|Lost to Follow-up|0|||
163421336|NCT02675075|590248654|FG000|Overall Study|Lost to Follow-up|3|||
163421337|NCT02675075|590248655|FG001|Overall Study|Lost to Follow-up|0|||
163421338|NCT02292212|590248656|FG000|ViE Phase|Withdrawal by Subject|1|||
163421339|NCT02292212|590248656|FG000|ViE Phase|Protocol Violation|2|||
163421340|NCT01176916|590248657|FG000|Overall Study|Adverse Event|61|||
163421341|NCT01176916|590248657|FG000|Overall Study|Death|1|||
163421342|NCT01176916|590248657|FG000|Overall Study|Lost to Follow-up|15|||
163421343|NCT01176916|590248657|FG000|Overall Study|Objective progression or relapse|17|||
163421344|NCT01176916|590248657|FG000|Overall Study|Protocol Violation|24|||
163421345|NCT01176916|590248657|FG000|Overall Study|Withdrawal by Subject|37|||
163421346|NCT01176916|590248657|FG000|Overall Study|Other|6|||
163421347|NCT01176916|590248657|FG000|Overall Study|Withdrawal prior to Treatment|6|||
163421348|NCT03158220|590248660|FG000|Overall Study|Screen Failure|0|||
163421349|NCT03158220|590248661|FG001|Overall Study|Screen Failure|1|||
163421350|NCT03158220|590248660|FG000|Overall Study|Withdrawal by Subject|8|||
163421351|NCT03158220|590248661|FG001|Overall Study|Withdrawal by Subject|9|||
163421352|NCT03158220|590248660|FG000|Overall Study|Status unknown|0|||
163421353|NCT03158220|590248661|FG001|Overall Study|Status unknown|1|||
163421354|NCT03158220|590248660|FG000|Overall Study|Lost to Follow-up|8|||
163421355|NCT03158220|590248661|FG001|Overall Study|Lost to Follow-up|5|||
163421356|NCT03158220|590248660|FG000|Overall Study|Physician Decision|1|||
163421357|NCT03158220|590248661|FG001|Overall Study|Physician Decision|0|||
163421358|NCT03887130|590248665|FG000|Overall Study|Progressive disease|23|||
163421359|NCT03887130|590248666|FG001|Overall Study|Progressive disease|14|||
163421360|NCT03887130|590248667|FG002|Overall Study|Progressive disease|7|||
163421361|NCT03887130|590248665|FG000|Overall Study|Protocol Violation|3|||
163421362|NCT03887130|590248666|FG001|Overall Study|Protocol Violation|1|||
163421363|NCT03887130|590248667|FG002|Overall Study|Protocol Violation|2|||
163421364|NCT03887130|590248665|FG000|Overall Study|Drug related toxicity|7|||
163421365|NCT03887130|590248666|FG001|Overall Study|Drug related toxicity|7|||
163421366|NCT03887130|590248667|FG002|Overall Study|Drug related toxicity|13|||
163421367|NCT03887130|590248665|FG000|Overall Study|Non drug related toxicity|3|||
163421368|NCT03887130|590248666|FG001|Overall Study|Non drug related toxicity|0|||
163421369|NCT03887130|590248667|FG002|Overall Study|Non drug related toxicity|0|||
163421370|NCT03887130|590248665|FG000|Overall Study|Death|2|||
163421371|NCT03887130|590248666|FG001|Overall Study|Death|2|||
163421372|NCT03887130|590248667|FG002|Overall Study|Death|1|||
163421373|NCT03887130|590248665|FG000|Overall Study|Withdrawal by Subject|7|||
163421374|NCT03887130|590248666|FG001|Overall Study|Withdrawal by Subject|6|||
163421375|NCT03887130|590248667|FG002|Overall Study|Withdrawal by Subject|11|||
163421376|NCT03887130|590248665|FG000|Overall Study|other reason|6|||
163421377|NCT03887130|590248666|FG001|Overall Study|other reason|20|||
163421378|NCT03887130|590248667|FG002|Overall Study|other reason|17|||
163421379|NCT00705263|590248668|FG000|Overall Study|Withdrawal by Subject|2|||
163421380|NCT02899156|590248669|FG000|Overall Study|Death|1|||
163421381|NCT02899156|590248670|FG001|Overall Study|Death|0|||
163421382|NCT02899156|590248669|FG000|Overall Study|Physician Decision|0|||
163421383|NCT02899156|590248670|FG001|Overall Study|Physician Decision|1|||
163421384|NCT00484315|590248672|FG000|12-Month Clinical Follow-up|Death|6|||
163421385|NCT00484315|590248673|FG001|12-Month Clinical Follow-up|Death|2|||
163421386|NCT00484315|590248672|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
163421387|NCT00484315|590248673|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
163421388|NCT00484315|590248672|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
163421389|NCT00484315|590248673|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
163421390|NCT00484315|590248672|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
163421391|NCT00484315|590248673|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
163421392|NCT00484315|590248672|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
163421393|NCT00484315|590248673|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
163421394|NCT00484315|590248672|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
163421395|NCT00484315|590248673|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
163421396|NCT00484315|590248672|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
163421397|NCT00484315|590248673|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
163421398|NCT01990261|590248674|FG000|Overall Study|Death Before Treatment Start|2|||
163421399|NCT01990261|590248674|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
163421400|NCT01990261|590248674|FG000|Overall Study|Death From other Causes|1|||
163421401|NCT01990261|590248674|FG000|Overall Study|Disease Progression (PD)|8|||
163421402|NCT01990261|590248674|FG000|Overall Study|PD Before Treatment Start|1|||
163421403|NCT01990261|590248674|FG000|Overall Study|Dossier not Approved|1|||
163421404|NCT01990261|590248674|FG000|Overall Study|Lost to Follow-up|2|||
163421405|NCT01078805|590248675|FG000|Overall Study|Clinically significant abnormal lab|5|||
163421406|NCT01078805|590248675|FG000|Overall Study|Death|134|||
163421407|NCT01078805|590248675|FG000|Overall Study|Lost to Follow-up|676|||
163421408|NCT01078805|590248675|FG000|Overall Study|Physician Decision|169|||
163421409|NCT01078805|590248675|FG000|Overall Study|Serious adverse event|26|||
163421410|NCT01078805|590248675|FG000|Overall Study|Sponsor decision|46|||
163421411|NCT01078805|590248675|FG000|Overall Study|Withdrawal by Subject|739|||
163421412|NCT01078805|590248675|FG000|Overall Study|Other|173|||
163421413|NCT01078805|590248675|FG000|Overall Study|Didn't take study drug|82|||
163421414|NCT01609842|590248676|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
163421415|NCT01609842|590248677|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
163421416|NCT04722991|590248678|FG000|Overall Study|Adverse Event|12|||
163421417|NCT04722991|590248679|FG001|Overall Study|Adverse Event|4|||
163421418|NCT04722991|590248678|FG000|Overall Study|Death|2|||
163421419|NCT04722991|590248679|FG001|Overall Study|Death|0|||
163421420|NCT04722991|590248678|FG000|Overall Study|Lost to Follow-up|1|||
163421421|NCT04722991|590248679|FG001|Overall Study|Lost to Follow-up|1|||
163421422|NCT04722991|590248678|FG000|Overall Study|Withdrawal cirterion met|2|||
163421423|NCT04722991|590248679|FG001|Overall Study|Withdrawal cirterion met|2|||
163421424|NCT04722991|590248678|FG000|Overall Study|Other|1|||
163421425|NCT04722991|590248679|FG001|Overall Study|Other|0|||
163421426|NCT04722991|590248678|FG000|Overall Study|Non-compliance|0|||
163421427|NCT04722991|590248679|FG001|Overall Study|Non-compliance|1|||
163421428|NCT04722991|590248678|FG000|Overall Study|Withdrawal by Subject|0|||
163421429|NCT04722991|590248679|FG001|Overall Study|Withdrawal by Subject|1|||
163421430|NCT03186989|590248680|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
163421431|NCT03186989|590248681|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
163421432|NCT03186989|590248682|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
163421433|NCT03186989|590248683|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
163421434|NCT03186989|590248684|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
163421435|NCT03186989|590248685|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
163421436|NCT03186989|590248686|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
163421437|NCT03186989|590248687|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
163421438|NCT03186989|590248688|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
163421439|NCT03186989|590248689|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
163421440|NCT03186989|590248690|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
163421441|NCT03186989|590248680|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163421442|NCT03186989|590248681|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163421443|NCT03186989|590248682|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163421444|NCT03186989|590248683|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163421445|NCT03186989|590248684|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163421446|NCT03186989|590248685|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
163421447|NCT03186989|590248686|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163421448|NCT03186989|590248687|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163421449|NCT03186989|590248688|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163421450|NCT03186989|590248689|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163421451|NCT03186989|590248690|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163421452|NCT03186989|590248680|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163421453|NCT03186989|590248681|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163421454|NCT03186989|590248682|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163421455|NCT03186989|590248683|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163421456|NCT03186989|590248684|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163421457|NCT03186989|590248685|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163421458|NCT03186989|590248686|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
163421459|NCT03186989|590248687|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163421460|NCT03186989|590248688|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163421461|NCT03186989|590248689|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163421462|NCT03186989|590248690|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163421463|NCT03186989|590248680|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
163421464|NCT03186989|590248681|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
163421465|NCT03186989|590248682|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
163421466|NCT03186989|590248683|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
163421467|NCT03186989|590248684|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
163421468|NCT03186989|590248685|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
163421469|NCT03186989|590248686|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
163421470|NCT03186989|590248687|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
163421471|NCT03186989|590248688|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
163421472|NCT03186989|590248689|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
163421473|NCT03186989|590248690|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
163421474|NCT02246621|590248694|FG000|Overall Study|Withdrawal by Subject|28|||
163421475|NCT02246621|590248695|FG001|Overall Study|Withdrawal by Subject|16|||
163421476|NCT02246621|590248694|FG000|Overall Study|Lost to Follow-up|1|||
163421477|NCT02246621|590248695|FG001|Overall Study|Lost to Follow-up|0|||
163421478|NCT02246621|590248694|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
163421479|NCT02246621|590248695|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
163421480|NCT00821678|590248696|FG000|Overall Study|Withdrawal by Subject|8|||
163421481|NCT00821678|590248697|FG001|Overall Study|Withdrawal by Subject|0|||
163421482|NCT00821678|590248696|FG000|Overall Study|Lost to Follow-up|13|||
163421483|NCT00821678|590248697|FG001|Overall Study|Lost to Follow-up|12|||
163421484|NCT00821678|590248696|FG000|Overall Study|Death|0|||
163421485|NCT00821678|590248697|FG001|Overall Study|Death|2|||
163421486|NCT03641560|590248698|FG000|Overall Study|Withdrawal by Subject|6|||
163421487|NCT03641560|590248698|FG000|Overall Study|Progressive disease|40|||
163421488|NCT03641560|590248698|FG000|Overall Study|Death|6|||
163421489|NCT04439279|590250804|FG000|Overall Study|Adverse Event|7|||
163421490|NCT04439279|590250804|FG000|Overall Study|Death|4|||
163421491|NCT04439279|590250804|FG000|Overall Study|Disease progression|17|||
163421492|NCT04439279|590250804|FG000|Overall Study|Complicating disease|3|||
163421493|NCT04439279|590250804|FG000|Overall Study|Withdrawal by Subject|2|||
163421494|NCT04439279|590250804|FG000|Overall Study|Ineligible|1|||
163421495|NCT04439279|590250804|FG000|Overall Study|Treatment still ongoing|1|||
163421496|NCT02031679|590250805|FG000|Overall Study|Protocol Violation|0|||
163421497|NCT02031679|590250806|FG001|Overall Study|Protocol Violation|1|||
163421498|NCT02031679|590250805|FG000|Overall Study|Lack of Efficacy|0|||
163421499|NCT02031679|590250806|FG001|Overall Study|Lack of Efficacy|1|||
163421500|NCT00110305|590250807|FG000|Overall Study|Adverse Event|46|||
163421501|NCT00110305|590250808|FG001|Overall Study|Adverse Event|13|||
163421502|NCT00110305|590250807|FG000|Overall Study|Sponsors Decision|1|||
163421503|NCT00110305|590250808|FG001|Overall Study|Sponsors Decision|0|||
163421504|NCT00110305|590250807|FG000|Overall Study|Subject Non-Compliant|9|||
163421505|NCT00110305|590250808|FG001|Overall Study|Subject Non-Compliant|2|||
163421506|NCT00110305|590250807|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
163421507|NCT00110305|590250808|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
163421508|NCT00110305|590250807|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
163421509|NCT00110305|590250808|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
163421510|NCT00110305|590250807|FG000|Overall Study|Protocol Violation|0|||
163421511|NCT00110305|590250808|FG001|Overall Study|Protocol Violation|1|||
163421512|NCT00110305|590250807|FG000|Overall Study|Withdrawal by Subject|7|||
163421513|NCT00110305|590250808|FG001|Overall Study|Withdrawal by Subject|7|||
163421514|NCT00110305|590250807|FG000|Overall Study|Lost to Follow-up|20|||
163421515|NCT00110305|590250808|FG001|Overall Study|Lost to Follow-up|3|||
163421516|NCT00110305|590250807|FG000|Overall Study|Other|8|||
163421517|NCT00110305|590250808|FG001|Overall Study|Other|2|||
163421518|NCT01609933|590250810|FG000|Overall Study|Adverse Event|1|||
163421519|NCT01609933|590250810|FG000|Overall Study|Withdrawal by Subject|3|||
163421520|NCT00224016|590250811|FG000|Titration Period|Withdrawal by Subject|0|||
163421521|NCT00224016|590250812|FG001|Titration Period|Withdrawal by Subject|1|||
163421522|NCT00224016|590250811|FG000|Titration Period|Lost to Follow-up|1|||
163421523|NCT00224016|590250812|FG001|Titration Period|Lost to Follow-up|0|||
163421524|NCT00224016|590250811|FG000|Maintenance Period|Withdrawal by Subject|2|||
163421525|NCT00224016|590250812|FG001|Maintenance Period|Withdrawal by Subject|0|||
163421526|NCT00224016|590250811|FG000|Maintenance Period|Lost to Follow-up|0|||
163421527|NCT00224016|590250812|FG001|Maintenance Period|Lost to Follow-up|1|||
163421528|NCT01252966|590250813|FG000|Overall Study|Lost to Follow-up|16|||
163421529|NCT01252966|590250814|FG001|Overall Study|Lost to Follow-up|10|||
163421530|NCT01252966|590250813|FG000|Overall Study|Withdrawal by Subject|7|||
163421531|NCT01252966|590250814|FG001|Overall Study|Withdrawal by Subject|3|||
163421532|NCT05019131|590250822|FG000|Overall Study|Lost to Follow-up|0|||
163421533|NCT05019131|590250823|FG001|Overall Study|Lost to Follow-up|3|||
163421534|NCT02360098|590250824|FG000|Overall Study|Physician Decision|7|||
163421535|NCT02054702|590250828|FG000|Overall Study|Lost to Follow-up|3|||
163421536|NCT02054702|590250829|FG001|Overall Study|Lost to Follow-up|5|||
163421537|NCT02054702|590250828|FG000|Overall Study|Adverse Event|3|||
163421538|NCT02054702|590250829|FG001|Overall Study|Adverse Event|1|||
163421539|NCT02054702|590250828|FG000|Overall Study|Met Withdrawal Criteria|4|||
163421540|NCT02054702|590250829|FG001|Overall Study|Met Withdrawal Criteria|1|||
163421541|NCT02054702|590250828|FG000|Overall Study|Physician Decision|0|||
163421542|NCT02054702|590250829|FG001|Overall Study|Physician Decision|1|||
163421543|NCT02054702|590250828|FG000|Overall Study|Withdrawal by Subject|14|||
163421544|NCT02054702|590250829|FG001|Overall Study|Withdrawal by Subject|4|||
163421545|NCT03486392|590250830|FG000|Overall Study|Lost to Follow-up|0|||
163421546|NCT03486392|590250831|FG001|Overall Study|Lost to Follow-up|0|||
163421547|NCT03486392|590250832|FG002|Overall Study|Lost to Follow-up|8|||
163421548|NCT03486392|590250833|FG003|Overall Study|Lost to Follow-up|5|||
163421549|NCT03486392|590250834|FG004|Overall Study|Lost to Follow-up|2|||
163421550|NCT03486392|590250830|FG000|Overall Study|Withdrawal by Subject|3|||
163421551|NCT03486392|590250831|FG001|Overall Study|Withdrawal by Subject|0|||
163421552|NCT03486392|590250832|FG002|Overall Study|Withdrawal by Subject|6|||
163421553|NCT03486392|590250833|FG003|Overall Study|Withdrawal by Subject|4|||
163421554|NCT03486392|590250834|FG004|Overall Study|Withdrawal by Subject|1|||
163421555|NCT03486392|590250830|FG000|Overall Study|Death|0|||
163421556|NCT03486392|590250831|FG001|Overall Study|Death|0|||
163421557|NCT03486392|590250832|FG002|Overall Study|Death|0|||
163421558|NCT03486392|590250833|FG003|Overall Study|Death|0|||
163421559|NCT03486392|590250834|FG004|Overall Study|Death|1|||
163421560|NCT02347631|590250835|FG000|First Intervention (2 Months)|Adverse Event|1|||
163421561|NCT02347631|590250836|FG001|First Intervention (2 Months)|Adverse Event|1|||
163421562|NCT02347631|590250835|FG000|First Intervention (2 Months)|Pregnancy|1|||
163421563|NCT02347631|590250836|FG001|First Intervention (2 Months)|Pregnancy|0|||
163421564|NCT02347631|590250835|FG000|First Intervention (2 Months)|Moved out of area|0|||
163421565|NCT02347631|590250836|FG001|First Intervention (2 Months)|Moved out of area|2|||
163421566|NCT02347631|590250835|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
163421567|NCT02347631|590250836|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
163421568|NCT02347631|590250835|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
163421569|NCT02347631|590250836|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
163421570|NCT02347631|590250835|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
163421571|NCT02347631|590250836|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
163421572|NCT02347631|590250835|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
163421573|NCT02347631|590250836|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
163421574|NCT02347631|590250835|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
163421575|NCT02347631|590250836|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
163421576|NCT02304926|590250838|FG000|Overall Study|Lost to Follow-up|2|||
163421577|NCT02304926|590250839|FG001|Overall Study|Lost to Follow-up|1|||
163421578|NCT02076165|590250840|FG000|Overall Study|Lost to Follow-up|7|||
163421579|NCT02076165|590250841|FG001|Overall Study|Lost to Follow-up|5|||
163421580|NCT02076165|590250840|FG000|Overall Study|Refused follow-up assessment|1|||
163421581|NCT02076165|590250841|FG001|Overall Study|Refused follow-up assessment|1|||
163421582|NCT02429856|590250842|FG000|Overall Study|Death|12|||
163421583|NCT02429856|590250843|FG001|Overall Study|Death|13|||
163421584|NCT02429856|590250842|FG000|Overall Study|Lost to Follow-up|6|||
163421585|NCT02429856|590250843|FG001|Overall Study|Lost to Follow-up|5|||
163421586|NCT02429856|590250842|FG000|Overall Study|Withdrawal by Subject|1|||
163421587|NCT02429856|590250843|FG001|Overall Study|Withdrawal by Subject|1|||
163421588|NCT01950819|590250844|FG000|Overall Study|Graft Loss|35|||
163421589|NCT01950819|590250845|FG001|Overall Study|Graft Loss|30|||
163421590|NCT01950819|590250844|FG000|Overall Study|Death|29|||
163421591|NCT01950819|590250845|FG001|Overall Study|Death|34|||
163421592|NCT01950819|590250844|FG000|Overall Study|Subject / Gardian decision|54|||
163421593|NCT01950819|590250845|FG001|Overall Study|Subject / Gardian decision|51|||
163421594|NCT01950819|590250844|FG000|Overall Study|technical problems|2|||
163421595|NCT01950819|590250845|FG001|Overall Study|technical problems|0|||
163421596|NCT01950819|590250844|FG000|Overall Study|Pregnancy|0|||
163421597|NCT01950819|590250845|FG001|Overall Study|Pregnancy|2|||
163421598|NCT01950819|590250844|FG000|Overall Study|Lost to Follow-up|9|||
163421599|NCT01950819|590250845|FG001|Overall Study|Lost to Follow-up|17|||
163421600|NCT04134494|590250846|FG000|Overall Study|Lost to Follow-up|2|||
163421601|NCT00781365|590250847|FG000|Overall Study|Withdrawal by Subject|13|||
163421602|NCT00781365|590250848|FG001|Overall Study|Withdrawal by Subject|8|||
163421603|NCT00781365|590250847|FG000|Overall Study|Did Not Attend Visit|20|||
163421604|NCT00781365|590250848|FG001|Overall Study|Did Not Attend Visit|28|||
163421605|NCT00781365|590250847|FG000|Overall Study|Language barrier|1|||
163421606|NCT00781365|590250848|FG001|Overall Study|Language barrier|0|||
163421607|NCT01360645|590250853|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
163421608|NCT01360645|590250854|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
163421609|NCT01360645|590250855|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
163421610|NCT01360645|590250856|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
163421611|NCT01360645|590250853|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
163421612|NCT01360645|590250854|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
163421613|NCT01360645|590250855|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
163421614|NCT01360645|590250856|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
163421615|NCT01360645|590250853|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
163421616|NCT01360645|590250854|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
163421617|NCT01360645|590250855|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
163421618|NCT01360645|590250856|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
163421619|NCT01360645|590250853|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
163421620|NCT01360645|590250854|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
163421621|NCT01360645|590250855|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
163421622|NCT01360645|590250856|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
163421623|NCT01360645|590250853|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
163421624|NCT01360645|590250854|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
163421625|NCT01360645|590250855|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
163421626|NCT01360645|590250856|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
163421627|NCT01360645|590250853|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
163421628|NCT01360645|590250854|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
163421629|NCT01360645|590250855|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
163421630|NCT01360645|590250856|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
163421631|NCT01360645|590250853|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
163421632|NCT01360645|590250854|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
163421633|NCT01360645|590250855|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
163421634|NCT01360645|590250856|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
163421635|NCT01360645|590250853|FG000|Phase B (6 Weeks)|Adverse Event|0|||
163421636|NCT01360645|590250854|FG001|Phase B (6 Weeks)|Adverse Event|6|||
163421637|NCT01360645|590250855|FG002|Phase B (6 Weeks)|Adverse Event|0|||
163421638|NCT01360645|590250856|FG003|Phase B (6 Weeks)|Adverse Event|0|||
163421639|NCT01360645|590250853|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
163421640|NCT01360645|590250854|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
163421641|NCT01360645|590250855|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
163421642|NCT01360645|590250856|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
163421643|NCT01360645|590250853|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
163421644|NCT01360645|590250854|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
163421645|NCT01360645|590250855|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
163421646|NCT01360645|590250856|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
163421647|NCT01360645|590250853|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
163421648|NCT01360645|590250854|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
163421649|NCT01360645|590250855|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
163421650|NCT01360645|590250856|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
163421651|NCT01360645|590250853|FG000|Phase A+|Lost to Follow-up|0|||
163421652|NCT01360645|590250854|FG001|Phase A+|Lost to Follow-up|0|||
163421653|NCT01360645|590250855|FG002|Phase A+|Lost to Follow-up|0|||
163421654|NCT01360645|590250856|FG003|Phase A+|Lost to Follow-up|7|||
163421655|NCT01360645|590250853|FG000|Phase A+|Adverse Event|0|||
163421656|NCT01360645|590250854|FG001|Phase A+|Adverse Event|0|||
163421657|NCT01360645|590250855|FG002|Phase A+|Adverse Event|0|||
163421658|NCT01360645|590250856|FG003|Phase A+|Adverse Event|2|||
163421659|NCT01360645|590250853|FG000|Phase A+|Met Withdrawal Criteria|0|||
163421660|NCT01360645|590250854|FG001|Phase A+|Met Withdrawal Criteria|0|||
163421661|NCT01360645|590250855|FG002|Phase A+|Met Withdrawal Criteria|0|||
163421662|NCT01360645|590250856|FG003|Phase A+|Met Withdrawal Criteria|4|||
163421663|NCT01360645|590250853|FG000|Phase A+|Physician Decision|0|||
163421664|NCT01360645|590250854|FG001|Phase A+|Physician Decision|0|||
163421665|NCT01360645|590250855|FG002|Phase A+|Physician Decision|0|||
163421666|NCT01360645|590250856|FG003|Phase A+|Physician Decision|2|||
163421667|NCT01360645|590250853|FG000|Phase A+|Withdrawal by Subject|0|||
163421668|NCT01360645|590250854|FG001|Phase A+|Withdrawal by Subject|0|||
163421669|NCT01360645|590250855|FG002|Phase A+|Withdrawal by Subject|0|||
163421670|NCT01360645|590250856|FG003|Phase A+|Withdrawal by Subject|5|||
163421671|NCT01360645|590250853|FG000|Phase A+|Protocol Deviation|0|||
163421672|NCT01360645|590250854|FG001|Phase A+|Protocol Deviation|0|||
163421673|NCT01360645|590250855|FG002|Phase A+|Protocol Deviation|0|||
163421674|NCT01360645|590250856|FG003|Phase A+|Protocol Deviation|4|||
163421675|NCT03371355|590250863|FG000|Overall Study|Investigator judgment|0|||
163421676|NCT03371355|590250864|FG001|Overall Study|Investigator judgment|0|||
163421677|NCT03371355|590250865|FG002|Overall Study|Investigator judgment|1|||
163421678|NCT03371355|590250866|FG003|Overall Study|Investigator judgment|1|||
163421679|NCT03371355|590250863|FG000|Overall Study|Voluntary withdrawal|1|||
163421680|NCT03371355|590250864|FG001|Overall Study|Voluntary withdrawal|0|||
163421681|NCT03371355|590250865|FG002|Overall Study|Voluntary withdrawal|1|||
163421682|NCT03371355|590250866|FG003|Overall Study|Voluntary withdrawal|2|||
163421683|NCT03371355|590250863|FG000|Overall Study|Adverse Event|0|||
163421684|NCT03371355|590250864|FG001|Overall Study|Adverse Event|1|||
163421685|NCT03371355|590250865|FG002|Overall Study|Adverse Event|2|||
163421686|NCT03371355|590250866|FG003|Overall Study|Adverse Event|3|||
163421687|NCT03371355|590250863|FG000|Overall Study|Reason not Specified|0|||
163421688|NCT03371355|590250864|FG001|Overall Study|Reason not Specified|1|||
163421689|NCT03371355|590250865|FG002|Overall Study|Reason not Specified|0|||
163421690|NCT03371355|590250866|FG003|Overall Study|Reason not Specified|1|||
163421691|NCT00868790|590250867|FG000|Period 1|Adverse Event|1|||
163421692|NCT00868790|590250868|FG001|Period 1|Adverse Event|0|||
163421693|NCT00868790|590250869|FG002|Period 1|Adverse Event|0|||
163421694|NCT00868790|590250870|FG003|Period 1|Adverse Event|0|||
163421695|NCT00868790|590250871|FG004|Period 1|Adverse Event|0|||
163421696|NCT00868790|590250872|FG005|Period 1|Adverse Event|0|||
163421697|NCT00868790|590250873|FG006|Period 1|Adverse Event|0|||
163421698|NCT00868790|590250874|FG007|Period 1|Adverse Event|3|||
163421699|NCT00868790|590250875|FG008|Period 1|Adverse Event|1|||
163421700|NCT00868790|590250876|FG009|Period 1|Adverse Event|0|||
163421701|NCT00868790|590250877|FG010|Period 1|Adverse Event|0|||
163421702|NCT00868790|590250878|FG011|Period 1|Adverse Event|0|||
163421703|NCT00868790|590250879|FG012|Period 1|Adverse Event|0|||
163421704|NCT00868790|590250880|FG013|Period 1|Adverse Event|1|||
163421705|NCT00868790|590250867|FG000|Period 1|Protocol Violation|1|||
163421706|NCT00868790|590250868|FG001|Period 1|Protocol Violation|0|||
163421707|NCT00868790|590250869|FG002|Period 1|Protocol Violation|0|||
163421708|NCT00868790|590250870|FG003|Period 1|Protocol Violation|0|||
163421709|NCT00868790|590250871|FG004|Period 1|Protocol Violation|0|||
163421710|NCT00868790|590250872|FG005|Period 1|Protocol Violation|0|||
163421711|NCT00868790|590250873|FG006|Period 1|Protocol Violation|0|||
163421712|NCT00868790|590250874|FG007|Period 1|Protocol Violation|0|||
163421713|NCT00868790|590250875|FG008|Period 1|Protocol Violation|0|||
163421714|NCT00868790|590250876|FG009|Period 1|Protocol Violation|0|||
163421715|NCT00868790|590250877|FG010|Period 1|Protocol Violation|0|||
163421716|NCT00868790|590250878|FG011|Period 1|Protocol Violation|0|||
163421717|NCT00868790|590250879|FG012|Period 1|Protocol Violation|0|||
163421718|NCT00868790|590250880|FG013|Period 1|Protocol Violation|0|||
163421719|NCT00868790|590250867|FG000|Period 1|Withdrawal by Subject|0|||
163421720|NCT00868790|590250868|FG001|Period 1|Withdrawal by Subject|1|||
163421721|NCT00868790|590250869|FG002|Period 1|Withdrawal by Subject|0|||
163421722|NCT00868790|590250870|FG003|Period 1|Withdrawal by Subject|0|||
163421723|NCT00868790|590250871|FG004|Period 1|Withdrawal by Subject|0|||
163421724|NCT00868790|590250872|FG005|Period 1|Withdrawal by Subject|0|||
163421725|NCT00868790|590250873|FG006|Period 1|Withdrawal by Subject|0|||
163421726|NCT00868790|590250874|FG007|Period 1|Withdrawal by Subject|0|||
163421727|NCT00868790|590250875|FG008|Period 1|Withdrawal by Subject|0|||
163421728|NCT00868790|590250876|FG009|Period 1|Withdrawal by Subject|0|||
163421729|NCT00868790|590250877|FG010|Period 1|Withdrawal by Subject|0|||
163421730|NCT00868790|590250878|FG011|Period 1|Withdrawal by Subject|0|||
163421731|NCT00868790|590250879|FG012|Period 1|Withdrawal by Subject|0|||
163421732|NCT00868790|590250880|FG013|Period 1|Withdrawal by Subject|1|||
163421733|NCT00868790|590250867|FG000|Period 1|Abnormal Triglycerides|0|||
163421734|NCT00868790|590250868|FG001|Period 1|Abnormal Triglycerides|0|||
163421735|NCT00868790|590250869|FG002|Period 1|Abnormal Triglycerides|0|||
163421736|NCT00868790|590250870|FG003|Period 1|Abnormal Triglycerides|0|||
163421737|NCT00868790|590250871|FG004|Period 1|Abnormal Triglycerides|1|||
163421738|NCT00868790|590250872|FG005|Period 1|Abnormal Triglycerides|0|||
163421739|NCT00868790|590250873|FG006|Period 1|Abnormal Triglycerides|0|||
163421740|NCT00868790|590250874|FG007|Period 1|Abnormal Triglycerides|0|||
163421741|NCT00868790|590250875|FG008|Period 1|Abnormal Triglycerides|0|||
163421742|NCT00868790|590250876|FG009|Period 1|Abnormal Triglycerides|0|||
163421743|NCT00868790|590250877|FG010|Period 1|Abnormal Triglycerides|0|||
163421744|NCT00868790|590250878|FG011|Period 1|Abnormal Triglycerides|0|||
163421745|NCT00868790|590250879|FG012|Period 1|Abnormal Triglycerides|0|||
163421746|NCT00868790|590250880|FG013|Period 1|Abnormal Triglycerides|0|||
163421747|NCT00868790|590250867|FG000|Period 1|Lost to Follow-up|0|||
163421748|NCT00868790|590250868|FG001|Period 1|Lost to Follow-up|0|||
163421749|NCT00868790|590250869|FG002|Period 1|Lost to Follow-up|0|||
163421750|NCT00868790|590250870|FG003|Period 1|Lost to Follow-up|0|||
163421751|NCT00868790|590250871|FG004|Period 1|Lost to Follow-up|0|||
163421752|NCT00868790|590250872|FG005|Period 1|Lost to Follow-up|1|||
163421753|NCT00868790|590250873|FG006|Period 1|Lost to Follow-up|0|||
163421754|NCT00868790|590250874|FG007|Period 1|Lost to Follow-up|0|||
163421755|NCT00868790|590250875|FG008|Period 1|Lost to Follow-up|0|||
163421756|NCT00868790|590250876|FG009|Period 1|Lost to Follow-up|0|||
163421757|NCT00868790|590250877|FG010|Period 1|Lost to Follow-up|0|||
163421758|NCT00868790|590250878|FG011|Period 1|Lost to Follow-up|0|||
163421759|NCT00868790|590250879|FG012|Period 1|Lost to Follow-up|0|||
163421760|NCT00868790|590250880|FG013|Period 1|Lost to Follow-up|0|||
163421761|NCT00868790|590250867|FG000|Period 2|Adverse Event|0|||
163421762|NCT00868790|590250868|FG001|Period 2|Adverse Event|0|||
163421763|NCT00868790|590250869|FG002|Period 2|Adverse Event|0|||
163421764|NCT00868790|590250870|FG003|Period 2|Adverse Event|0|||
163421765|NCT00868790|590250871|FG004|Period 2|Adverse Event|0|||
163421766|NCT00868790|590250872|FG005|Period 2|Adverse Event|0|||
163421767|NCT00868790|590250873|FG006|Period 2|Adverse Event|0|||
163421768|NCT00868790|590250874|FG007|Period 2|Adverse Event|0|||
163421769|NCT00868790|590250875|FG008|Period 2|Adverse Event|1|||
163421770|NCT00868790|590250876|FG009|Period 2|Adverse Event|0|||
163421771|NCT00868790|590250877|FG010|Period 2|Adverse Event|0|||
163421772|NCT00868790|590250878|FG011|Period 2|Adverse Event|0|||
163421773|NCT00868790|590250879|FG012|Period 2|Adverse Event|0|||
163421774|NCT00868790|590250880|FG013|Period 2|Adverse Event|0|||
163421775|NCT00868790|590250867|FG000|Period 2|Lost to Follow-up|0|||
163421776|NCT00868790|590250868|FG001|Period 2|Lost to Follow-up|1|||
163421777|NCT00868790|590250869|FG002|Period 2|Lost to Follow-up|0|||
163421778|NCT00868790|590250870|FG003|Period 2|Lost to Follow-up|0|||
163421779|NCT00868790|590250871|FG004|Period 2|Lost to Follow-up|0|||
163421780|NCT00868790|590250872|FG005|Period 2|Lost to Follow-up|1|||
163421781|NCT00868790|590250873|FG006|Period 2|Lost to Follow-up|0|||
163421782|NCT00868790|590250874|FG007|Period 2|Lost to Follow-up|0|||
163421783|NCT00868790|590250875|FG008|Period 2|Lost to Follow-up|0|||
163421784|NCT00868790|590250876|FG009|Period 2|Lost to Follow-up|0|||
163421785|NCT00868790|590250877|FG010|Period 2|Lost to Follow-up|0|||
163421786|NCT00868790|590250878|FG011|Period 2|Lost to Follow-up|0|||
163421787|NCT00868790|590250879|FG012|Period 2|Lost to Follow-up|0|||
163421788|NCT00868790|590250880|FG013|Period 2|Lost to Follow-up|0|||
163421789|NCT00868790|590250867|FG000|Period 2|Withdrawal by Subject|0|||
163421790|NCT00868790|590250868|FG001|Period 2|Withdrawal by Subject|0|||
163421791|NCT00868790|590250869|FG002|Period 2|Withdrawal by Subject|0|||
163421792|NCT00868790|590250870|FG003|Period 2|Withdrawal by Subject|0|||
163421793|NCT00868790|590250871|FG004|Period 2|Withdrawal by Subject|0|||
163421794|NCT00868790|590250872|FG005|Period 2|Withdrawal by Subject|0|||
163421795|NCT00868790|590250873|FG006|Period 2|Withdrawal by Subject|0|||
163421796|NCT00868790|590250874|FG007|Period 2|Withdrawal by Subject|0|||
163421797|NCT00868790|590250875|FG008|Period 2|Withdrawal by Subject|1|||
163421798|NCT00868790|590250876|FG009|Period 2|Withdrawal by Subject|0|||
163421799|NCT00868790|590250877|FG010|Period 2|Withdrawal by Subject|0|||
163421800|NCT00868790|590250878|FG011|Period 2|Withdrawal by Subject|0|||
163421801|NCT00868790|590250879|FG012|Period 2|Withdrawal by Subject|0|||
163421802|NCT00868790|590250880|FG013|Period 2|Withdrawal by Subject|1|||
163421803|NCT00868790|590250867|FG000|Period 3|Adverse Event|0|||
163421804|NCT00868790|590250868|FG001|Period 3|Adverse Event|0|||
163421805|NCT00868790|590250869|FG002|Period 3|Adverse Event|0|||
163421806|NCT00868790|590250870|FG003|Period 3|Adverse Event|0|||
163421807|NCT00868790|590250871|FG004|Period 3|Adverse Event|0|||
163421808|NCT00868790|590250872|FG005|Period 3|Adverse Event|0|||
163421809|NCT00868790|590250873|FG006|Period 3|Adverse Event|0|||
163421810|NCT00868790|590250874|FG007|Period 3|Adverse Event|0|||
163421811|NCT00868790|590250875|FG008|Period 3|Adverse Event|0|||
163421812|NCT00868790|590250876|FG009|Period 3|Adverse Event|1|||
163421813|NCT00868790|590250877|FG010|Period 3|Adverse Event|0|||
163421814|NCT00868790|590250878|FG011|Period 3|Adverse Event|0|||
163421815|NCT00868790|590250879|FG012|Period 3|Adverse Event|0|||
163421816|NCT00868790|590250880|FG013|Period 3|Adverse Event|0|||
163421817|NCT00868790|590250867|FG000|Period 3|Protocol Violation|0|||
163421818|NCT00868790|590250868|FG001|Period 3|Protocol Violation|0|||
163421819|NCT00868790|590250869|FG002|Period 3|Protocol Violation|0|||
163421820|NCT00868790|590250870|FG003|Period 3|Protocol Violation|0|||
163421821|NCT00868790|590250871|FG004|Period 3|Protocol Violation|0|||
163421822|NCT00868790|590250872|FG005|Period 3|Protocol Violation|0|||
163421823|NCT00868790|590250873|FG006|Period 3|Protocol Violation|0|||
163421824|NCT00868790|590250874|FG007|Period 3|Protocol Violation|0|||
163421825|NCT00868790|590250875|FG008|Period 3|Protocol Violation|0|||
163421826|NCT00868790|590250876|FG009|Period 3|Protocol Violation|0|||
163421827|NCT00868790|590250877|FG010|Period 3|Protocol Violation|1|||
163421828|NCT00868790|590250878|FG011|Period 3|Protocol Violation|0|||
163421829|NCT00868790|590250879|FG012|Period 3|Protocol Violation|0|||
163421830|NCT00868790|590250880|FG013|Period 3|Protocol Violation|0|||
163421831|NCT00868790|590250867|FG000|Period 3|Study Terminated by Sponsor|0|||
163421832|NCT00868790|590250868|FG001|Period 3|Study Terminated by Sponsor|0|||
163421833|NCT00868790|590250869|FG002|Period 3|Study Terminated by Sponsor|0|||
163421834|NCT00868790|590250870|FG003|Period 3|Study Terminated by Sponsor|1|||
163421835|NCT00868790|590250871|FG004|Period 3|Study Terminated by Sponsor|0|||
163421836|NCT00868790|590250872|FG005|Period 3|Study Terminated by Sponsor|0|||
163421837|NCT00868790|590250873|FG006|Period 3|Study Terminated by Sponsor|0|||
163421838|NCT00868790|590250874|FG007|Period 3|Study Terminated by Sponsor|0|||
163421839|NCT00868790|590250875|FG008|Period 3|Study Terminated by Sponsor|0|||
163421840|NCT00868790|590250876|FG009|Period 3|Study Terminated by Sponsor|0|||
163421841|NCT00868790|590250877|FG010|Period 3|Study Terminated by Sponsor|0|||
163421842|NCT00868790|590250878|FG011|Period 3|Study Terminated by Sponsor|0|||
163421843|NCT00868790|590250879|FG012|Period 3|Study Terminated by Sponsor|0|||
163421844|NCT00868790|590250880|FG013|Period 3|Study Terminated by Sponsor|0|||
163421845|NCT00868790|590250867|FG000|Period 4|Adverse Event|0|||
163421846|NCT00868790|590250868|FG001|Period 4|Adverse Event|0|||
163421847|NCT00868790|590250869|FG002|Period 4|Adverse Event|0|||
163421848|NCT00868790|590250870|FG003|Period 4|Adverse Event|0|||
163421849|NCT00868790|590250871|FG004|Period 4|Adverse Event|0|||
163421850|NCT00868790|590250872|FG005|Period 4|Adverse Event|0|||
163421851|NCT00868790|590250873|FG006|Period 4|Adverse Event|0|||
163421852|NCT00868790|590250874|FG007|Period 4|Adverse Event|1|||
163421853|NCT00868790|590250875|FG008|Period 4|Adverse Event|0|||
163421854|NCT00868790|590250876|FG009|Period 4|Adverse Event|0|||
163421855|NCT00868790|590250877|FG010|Period 4|Adverse Event|1|||
163421856|NCT00868790|590250878|FG011|Period 4|Adverse Event|0|||
163421857|NCT00868790|590250879|FG012|Period 4|Adverse Event|1|||
163421858|NCT00868790|590250880|FG013|Period 4|Adverse Event|0|||
163421859|NCT00868790|590250867|FG000|Period 4|Lost to Follow-up|0|||
163421860|NCT00868790|590250868|FG001|Period 4|Lost to Follow-up|0|||
163421861|NCT00868790|590250869|FG002|Period 4|Lost to Follow-up|0|||
163421862|NCT00868790|590250870|FG003|Period 4|Lost to Follow-up|0|||
163421863|NCT00868790|590250871|FG004|Period 4|Lost to Follow-up|0|||
163421864|NCT00868790|590250872|FG005|Period 4|Lost to Follow-up|0|||
163421865|NCT00868790|590250873|FG006|Period 4|Lost to Follow-up|0|||
163421866|NCT00868790|590250874|FG007|Period 4|Lost to Follow-up|1|||
163421867|NCT00868790|590250875|FG008|Period 4|Lost to Follow-up|0|||
163421868|NCT00868790|590250876|FG009|Period 4|Lost to Follow-up|0|||
163421869|NCT00868790|590250877|FG010|Period 4|Lost to Follow-up|0|||
163421870|NCT00868790|590250878|FG011|Period 4|Lost to Follow-up|0|||
163421871|NCT00868790|590250879|FG012|Period 4|Lost to Follow-up|0|||
163421872|NCT00868790|590250880|FG013|Period 4|Lost to Follow-up|0|||
163421873|NCT00868790|590250867|FG000|Period 4|Study Terminated by Sponsor|2|||
163421874|NCT00868790|590250868|FG001|Period 4|Study Terminated by Sponsor|0|||
163421875|NCT00868790|590250869|FG002|Period 4|Study Terminated by Sponsor|0|||
163421876|NCT00868790|590250870|FG003|Period 4|Study Terminated by Sponsor|0|||
163421877|NCT00868790|590250871|FG004|Period 4|Study Terminated by Sponsor|0|||
163421878|NCT00868790|590250872|FG005|Period 4|Study Terminated by Sponsor|0|||
163421879|NCT00868790|590250873|FG006|Period 4|Study Terminated by Sponsor|0|||
163421880|NCT00868790|590250874|FG007|Period 4|Study Terminated by Sponsor|1|||
163421881|NCT00868790|590250875|FG008|Period 4|Study Terminated by Sponsor|2|||
163421882|NCT00868790|590250876|FG009|Period 4|Study Terminated by Sponsor|0|||
163421883|NCT00868790|590250877|FG010|Period 4|Study Terminated by Sponsor|2|||
163421884|NCT00868790|590250878|FG011|Period 4|Study Terminated by Sponsor|1|||
163421885|NCT00868790|590250879|FG012|Period 4|Study Terminated by Sponsor|0|||
163421886|NCT00868790|590250880|FG013|Period 4|Study Terminated by Sponsor|1|||
163421887|NCT00868790|590250867|FG000|Period 4|Abnormal ALT/AST|0|||
163421888|NCT00868790|590250868|FG001|Period 4|Abnormal ALT/AST|0|||
163421889|NCT00868790|590250869|FG002|Period 4|Abnormal ALT/AST|1|||
163421890|NCT00868790|590250870|FG003|Period 4|Abnormal ALT/AST|0|||
163421891|NCT00868790|590250871|FG004|Period 4|Abnormal ALT/AST|0|||
163421892|NCT00868790|590250872|FG005|Period 4|Abnormal ALT/AST|0|||
163421893|NCT00868790|590250873|FG006|Period 4|Abnormal ALT/AST|0|||
163421894|NCT00868790|590250874|FG007|Period 4|Abnormal ALT/AST|0|||
163421895|NCT00868790|590250875|FG008|Period 4|Abnormal ALT/AST|0|||
163421896|NCT00868790|590250876|FG009|Period 4|Abnormal ALT/AST|0|||
163421897|NCT00868790|590250877|FG010|Period 4|Abnormal ALT/AST|0|||
163421898|NCT00868790|590250878|FG011|Period 4|Abnormal ALT/AST|0|||
163421899|NCT00868790|590250879|FG012|Period 4|Abnormal ALT/AST|0|||
163421900|NCT00868790|590250880|FG013|Period 4|Abnormal ALT/AST|0|||
163421901|NCT00868790|590250867|FG000|Post-study|Withdrawal by Subject|0|||
163421902|NCT00868790|590250868|FG001|Post-study|Withdrawal by Subject|0|||
163421903|NCT00868790|590250869|FG002|Post-study|Withdrawal by Subject|0|||
163421904|NCT00868790|590250870|FG003|Post-study|Withdrawal by Subject|0|||
163421905|NCT00868790|590250871|FG004|Post-study|Withdrawal by Subject|1|||
163421906|NCT00868790|590250872|FG005|Post-study|Withdrawal by Subject|0|||
163421907|NCT00868790|590250873|FG006|Post-study|Withdrawal by Subject|0|||
163421908|NCT00868790|590250874|FG007|Post-study|Withdrawal by Subject|0|||
163421909|NCT00868790|590250875|FG008|Post-study|Withdrawal by Subject|0|||
163421910|NCT00868790|590250876|FG009|Post-study|Withdrawal by Subject|0|||
163421911|NCT00868790|590250877|FG010|Post-study|Withdrawal by Subject|0|||
163421912|NCT00868790|590250878|FG011|Post-study|Withdrawal by Subject|0|||
163421913|NCT00868790|590250879|FG012|Post-study|Withdrawal by Subject|0|||
163421914|NCT00868790|590250880|FG013|Post-study|Withdrawal by Subject|0|||
163421915|NCT00868790|590250867|FG000|Post-study|Excluded Medication|0|||
163421916|NCT00868790|590250868|FG001|Post-study|Excluded Medication|0|||
163421917|NCT00868790|590250869|FG002|Post-study|Excluded Medication|0|||
163421918|NCT00868790|590250870|FG003|Post-study|Excluded Medication|0|||
163421919|NCT00868790|590250871|FG004|Post-study|Excluded Medication|0|||
163421920|NCT00868790|590250872|FG005|Post-study|Excluded Medication|0|||
163421921|NCT00868790|590250873|FG006|Post-study|Excluded Medication|0|||
163421922|NCT00868790|590250874|FG007|Post-study|Excluded Medication|2|||
163421923|NCT00868790|590250875|FG008|Post-study|Excluded Medication|0|||
163421924|NCT00868790|590250876|FG009|Post-study|Excluded Medication|1|||
163421925|NCT00868790|590250877|FG010|Post-study|Excluded Medication|0|||
163421926|NCT00868790|590250878|FG011|Post-study|Excluded Medication|0|||
163421927|NCT00868790|590250879|FG012|Post-study|Excluded Medication|0|||
163421928|NCT00868790|590250880|FG013|Post-study|Excluded Medication|0|||
163421929|NCT03595280|590250885|FG000|Overall Study|Lost to Follow-up|6|||
163421930|NCT03595280|590250886|FG001|Overall Study|Lost to Follow-up|9|||
163421931|NCT03595280|590250887|FG002|Overall Study|Lost to Follow-up|15|||
163421932|NCT02658812|590250888|FG000|Overall Study|Disease Progression|7|||
163421933|NCT02658812|590250888|FG000|Overall Study|Unrelated to study treatment|1|||
163421934|NCT02658812|590250888|FG000|Overall Study|Adverse Event|1|||
163421935|NCT01512264|590250891|FG000|Overall Study|Lost to Follow-up|0|||
163421936|NCT01512264|590250892|FG001|Overall Study|Lost to Follow-up|0|||
163421937|NCT01512264|590250893|FG002|Overall Study|Lost to Follow-up|0|||
163421938|NCT01512264|590250894|FG003|Overall Study|Lost to Follow-up|1|||
163421939|NCT00854828|590250895|FG000|Overall Study|Death|1|||
163421940|NCT00854828|590250896|FG001|Overall Study|Death|0|||
163421941|NCT00854828|590250897|FG002|Overall Study|Death|0|||
163421942|NCT00854828|590250898|FG003|Overall Study|Death|0|||
163421943|NCT00854828|590250895|FG000|Overall Study|Withdrawal by Subject|1|||
163421944|NCT00854828|590250896|FG001|Overall Study|Withdrawal by Subject|1|||
163421945|NCT00854828|590250897|FG002|Overall Study|Withdrawal by Subject|0|||
163421946|NCT00854828|590250898|FG003|Overall Study|Withdrawal by Subject|9|||
163421947|NCT00854828|590250895|FG000|Overall Study|Missed 24mo visit|1|||
163421948|NCT00854828|590250896|FG001|Overall Study|Missed 24mo visit|1|||
163421949|NCT00854828|590250897|FG002|Overall Study|Missed 24mo visit|8|||
163421950|NCT00854828|590250898|FG003|Overall Study|Missed 24mo visit|8|||
163421951|NCT04957290|590250908|FG000|Overall Study|Progressive disease|3|||
163421952|NCT04957290|590250909|FG001|Overall Study|Progressive disease|3|||
163421953|NCT04957290|590250910|FG002|Overall Study|Progressive disease|2|||
163421954|NCT04957290|590250911|FG003|Overall Study|Progressive disease|0|||
163421955|NCT04957290|590250912|FG004|Overall Study|Progressive disease|0|||
163421956|NCT04957290|590250913|FG005|Overall Study|Progressive disease|0|||
163421957|NCT04957290|590250908|FG000|Overall Study|Withdrawal by Subject|1|||
163421958|NCT04957290|590250909|FG001|Overall Study|Withdrawal by Subject|0|||
163421959|NCT04957290|590250910|FG002|Overall Study|Withdrawal by Subject|1|||
163421960|NCT04957290|590250911|FG003|Overall Study|Withdrawal by Subject|0|||
163421961|NCT04957290|590250912|FG004|Overall Study|Withdrawal by Subject|0|||
163421962|NCT04957290|590250913|FG005|Overall Study|Withdrawal by Subject|0|||
163421963|NCT04957290|590250908|FG000|Overall Study|Death|0|||
163421964|NCT04957290|590250909|FG001|Overall Study|Death|2|||
163421965|NCT04957290|590250910|FG002|Overall Study|Death|1|||
163421966|NCT04957290|590250911|FG003|Overall Study|Death|0|||
163421967|NCT04957290|590250912|FG004|Overall Study|Death|0|||
163421968|NCT04957290|590250913|FG005|Overall Study|Death|0|||
163421969|NCT04957290|590250908|FG000|Overall Study|non compliance with study drug|0|||
163421970|NCT04957290|590250909|FG001|Overall Study|non compliance with study drug|1|||
163421971|NCT04957290|590250910|FG002|Overall Study|non compliance with study drug|0|||
163421972|NCT04957290|590250911|FG003|Overall Study|non compliance with study drug|0|||
163421973|NCT04957290|590250912|FG004|Overall Study|non compliance with study drug|0|||
163421974|NCT04957290|590250913|FG005|Overall Study|non compliance with study drug|0|||
163421975|NCT04957290|590250908|FG000|Overall Study|none specified.|0|||
163421976|NCT04957290|590250909|FG001|Overall Study|none specified.|1|||
163421977|NCT04957290|590250910|FG002|Overall Study|none specified.|2|||
163421978|NCT04957290|590250911|FG003|Overall Study|none specified.|0|||
163421979|NCT04957290|590250912|FG004|Overall Study|none specified.|0|||
163421980|NCT04957290|590250913|FG005|Overall Study|none specified.|0|||
163421981|NCT04957290|590250908|FG000|Overall Study|unacceptable toxicity|0|||
163421982|NCT04957290|590250909|FG001|Overall Study|unacceptable toxicity|0|||
163421983|NCT04957290|590250910|FG002|Overall Study|unacceptable toxicity|1|||
163421984|NCT04957290|590250911|FG003|Overall Study|unacceptable toxicity|0|||
163421985|NCT04957290|590250912|FG004|Overall Study|unacceptable toxicity|0|||
163421986|NCT04957290|590250913|FG005|Overall Study|unacceptable toxicity|0|||
163421987|NCT04957290|590250908|FG000|Overall Study|Adverse Event|0|||
163421988|NCT04957290|590250909|FG001|Overall Study|Adverse Event|0|||
163421989|NCT04957290|590250910|FG002|Overall Study|Adverse Event|1|||
163421990|NCT04957290|590250911|FG003|Overall Study|Adverse Event|0|||
163421991|NCT04957290|590250912|FG004|Overall Study|Adverse Event|0|||
163421992|NCT04957290|590250913|FG005|Overall Study|Adverse Event|0|||
163421993|NCT04957290|590250908|FG000|Overall Study|study terminated by sponsor|0|||
163421994|NCT04957290|590250909|FG001|Overall Study|study terminated by sponsor|0|||
163421995|NCT04957290|590250910|FG002|Overall Study|study terminated by sponsor|2|||
163421996|NCT04957290|590250911|FG003|Overall Study|study terminated by sponsor|0|||
163421997|NCT04957290|590250912|FG004|Overall Study|study terminated by sponsor|0|||
163421998|NCT04957290|590250913|FG005|Overall Study|study terminated by sponsor|0|||
163421999|NCT00896532|590250914|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422000|NCT00896532|590250915|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422001|NCT00896532|590250916|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422002|NCT00896532|590250917|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
163422003|NCT00896532|590250918|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422004|NCT00896532|590250919|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
163422005|NCT00896532|590250920|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422006|NCT00896532|590250921|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422007|NCT00896532|590250922|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422008|NCT00896532|590250923|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422009|NCT00896532|590250924|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422010|NCT00896532|590250925|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422011|NCT00896532|590250926|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422012|NCT00896532|590250927|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422013|NCT00896532|590250928|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422014|NCT00896532|590250929|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422015|NCT00896532|590250930|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422016|NCT00896532|590250931|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422017|NCT00896532|590250932|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422018|NCT00896532|590250933|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422019|NCT00896532|590250934|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422020|NCT00896532|590250935|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422021|NCT00896532|590250936|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163422022|NCT00896532|590250914|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
163422023|NCT00896532|590250915|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
163422024|NCT00896532|590250916|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
163422025|NCT00896532|590250917|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
163422026|NCT00896532|590250918|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
163422027|NCT00896532|590250919|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
163422028|NCT00896532|590250920|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
163422029|NCT00896532|590250921|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422030|NCT00896532|590250922|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422031|NCT00896532|590250923|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422032|NCT00896532|590250924|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422033|NCT00896532|590250925|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422034|NCT00896532|590250926|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422035|NCT00896532|590250927|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422036|NCT00896532|590250928|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422037|NCT00896532|590250929|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422038|NCT00896532|590250930|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422039|NCT00896532|590250931|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422040|NCT00896532|590250932|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422041|NCT00896532|590250933|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422042|NCT00896532|590250934|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422043|NCT00896532|590250935|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422044|NCT00896532|590250936|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163422045|NCT00896532|590250914|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
163422046|NCT00896532|590250915|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
163422047|NCT00896532|590250916|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
163422048|NCT00896532|590250917|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
163422049|NCT00896532|590250918|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
163422050|NCT00896532|590250919|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
163422051|NCT00896532|590250920|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
163422052|NCT00896532|590250921|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
163422053|NCT00896532|590250922|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163422054|NCT00896532|590250923|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163422055|NCT00896532|590250924|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163422056|NCT00896532|590250925|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163422057|NCT00896532|590250926|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163422058|NCT00896532|590250927|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163422059|NCT00896532|590250928|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163422060|NCT00896532|590250929|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163422061|NCT00896532|590250930|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163422062|NCT00896532|590250931|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163422063|NCT00896532|590250932|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163422064|NCT00896532|590250933|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163422065|NCT00896532|590250934|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163422066|NCT00896532|590250935|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163422067|NCT00896532|590250936|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163422068|NCT00896532|590250914|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422069|NCT00896532|590250915|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422070|NCT00896532|590250916|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
163422071|NCT00896532|590250917|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422072|NCT00896532|590250918|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
163422073|NCT00896532|590250919|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422074|NCT00896532|590250920|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422075|NCT00896532|590250921|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422076|NCT00896532|590250922|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422077|NCT00896532|590250923|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422078|NCT00896532|590250924|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422079|NCT00896532|590250925|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422080|NCT00896532|590250926|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422081|NCT00896532|590250927|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422082|NCT00896532|590250928|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422083|NCT00896532|590250929|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422084|NCT00896532|590250930|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422085|NCT00896532|590250931|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422086|NCT00896532|590250932|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422087|NCT00896532|590250933|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422088|NCT00896532|590250934|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422089|NCT00896532|590250935|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422090|NCT00896532|590250936|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163422091|NCT00896532|590250914|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
163422092|NCT00896532|590250915|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422093|NCT00896532|590250916|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422094|NCT00896532|590250917|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
163422095|NCT00896532|590250918|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422096|NCT00896532|590250919|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422097|NCT00896532|590250920|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422098|NCT00896532|590250921|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422099|NCT00896532|590250922|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422100|NCT00896532|590250923|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422101|NCT00896532|590250924|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422102|NCT00896532|590250925|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422103|NCT00896532|590250926|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422104|NCT00896532|590250927|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422105|NCT00896532|590250928|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422106|NCT00896532|590250929|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422107|NCT00896532|590250930|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422108|NCT00896532|590250931|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422109|NCT00896532|590250932|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422110|NCT00896532|590250933|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422111|NCT00896532|590250934|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422112|NCT00896532|590250935|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422113|NCT00896532|590250936|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163422114|NCT00896532|590250914|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422115|NCT00896532|590250915|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422116|NCT00896532|590250916|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
163422117|NCT00896532|590250917|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422118|NCT00896532|590250918|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422119|NCT00896532|590250919|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422120|NCT00896532|590250920|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422121|NCT00896532|590250921|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422122|NCT00896532|590250922|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422123|NCT00896532|590250923|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422124|NCT00896532|590250924|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422125|NCT00896532|590250925|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422126|NCT00896532|590250926|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422127|NCT00896532|590250927|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422128|NCT00896532|590250928|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422129|NCT00896532|590250929|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422130|NCT00896532|590250930|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422131|NCT00896532|590250931|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422132|NCT00896532|590250932|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422133|NCT00896532|590250933|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422134|NCT00896532|590250934|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422135|NCT00896532|590250935|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422136|NCT00896532|590250936|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163422137|NCT00896532|590250914|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422138|NCT00896532|590250915|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422139|NCT00896532|590250916|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
163422140|NCT00896532|590250917|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422141|NCT00896532|590250918|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422142|NCT00896532|590250919|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422143|NCT00896532|590250920|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422144|NCT00896532|590250921|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422145|NCT00896532|590250922|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422146|NCT00896532|590250923|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422147|NCT00896532|590250924|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422148|NCT00896532|590250925|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422149|NCT00896532|590250926|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422150|NCT00896532|590250927|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422151|NCT00896532|590250928|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422152|NCT00896532|590250929|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422153|NCT00896532|590250930|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422154|NCT00896532|590250931|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422155|NCT00896532|590250932|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422156|NCT00896532|590250933|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422157|NCT00896532|590250934|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422158|NCT00896532|590250935|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422159|NCT00896532|590250936|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163422160|NCT00896532|590250914|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422161|NCT00896532|590250915|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422162|NCT00896532|590250916|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422163|NCT00896532|590250917|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
163422164|NCT00896532|590250918|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422165|NCT00896532|590250919|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422166|NCT00896532|590250920|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422167|NCT00896532|590250921|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422168|NCT00896532|590250922|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422169|NCT00896532|590250923|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422170|NCT00896532|590250924|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422171|NCT00896532|590250925|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422172|NCT00896532|590250926|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422173|NCT00896532|590250927|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422174|NCT00896532|590250928|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422175|NCT00896532|590250929|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422176|NCT00896532|590250930|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422177|NCT00896532|590250931|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422178|NCT00896532|590250932|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422179|NCT00896532|590250933|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422180|NCT00896532|590250934|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422181|NCT00896532|590250935|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422182|NCT00896532|590250936|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163422183|NCT00896532|590250914|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422184|NCT00896532|590250915|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
163422185|NCT00896532|590250916|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422186|NCT00896532|590250917|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
163422187|NCT00896532|590250918|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
163422188|NCT00896532|590250919|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422189|NCT00896532|590250920|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422190|NCT00896532|590250921|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422191|NCT00896532|590250922|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422192|NCT00896532|590250923|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422193|NCT00896532|590250924|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422194|NCT00896532|590250925|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422195|NCT00896532|590250926|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422196|NCT00896532|590250927|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422197|NCT00896532|590250928|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422198|NCT00896532|590250929|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422199|NCT00896532|590250930|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422200|NCT00896532|590250931|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422201|NCT00896532|590250932|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422202|NCT00896532|590250933|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422203|NCT00896532|590250934|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422204|NCT00896532|590250935|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422205|NCT00896532|590250936|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163422206|NCT00896532|590250914|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422207|NCT00896532|590250915|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422208|NCT00896532|590250916|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422209|NCT00896532|590250917|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422210|NCT00896532|590250918|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422211|NCT00896532|590250919|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422212|NCT00896532|590250920|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422213|NCT00896532|590250921|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422214|NCT00896532|590250922|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
163422215|NCT00896532|590250923|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422216|NCT00896532|590250924|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422217|NCT00896532|590250925|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422218|NCT00896532|590250926|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422219|NCT00896532|590250927|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422220|NCT00896532|590250928|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422221|NCT00896532|590250929|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422222|NCT00896532|590250930|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422223|NCT00896532|590250931|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422224|NCT00896532|590250932|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422225|NCT00896532|590250933|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422226|NCT00896532|590250934|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422227|NCT00896532|590250935|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422228|NCT00896532|590250936|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163422229|NCT00896532|590250914|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422230|NCT00896532|590250915|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422231|NCT00896532|590250916|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422232|NCT00896532|590250917|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422233|NCT00896532|590250918|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422234|NCT00896532|590250919|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422235|NCT00896532|590250920|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422236|NCT00896532|590250921|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422237|NCT00896532|590250922|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422238|NCT00896532|590250923|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422239|NCT00896532|590250924|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422240|NCT00896532|590250925|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422241|NCT00896532|590250926|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
163422242|NCT00896532|590250927|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422243|NCT00896532|590250928|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422244|NCT00896532|590250929|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422245|NCT00896532|590250930|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422246|NCT00896532|590250931|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422247|NCT00896532|590250932|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422248|NCT00896532|590250933|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422249|NCT00896532|590250934|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422250|NCT00896532|590250935|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422251|NCT00896532|590250936|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163422252|NCT00896532|590250914|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422253|NCT00896532|590250915|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422254|NCT00896532|590250916|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422255|NCT00896532|590250917|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422256|NCT00896532|590250918|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422257|NCT00896532|590250919|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422258|NCT00896532|590250920|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422259|NCT00896532|590250921|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422260|NCT00896532|590250922|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422261|NCT00896532|590250923|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422262|NCT00896532|590250924|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
163422263|NCT00896532|590250925|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422264|NCT00896532|590250926|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
163422265|NCT00896532|590250927|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422266|NCT00896532|590250928|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422267|NCT00896532|590250929|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422268|NCT00896532|590250930|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422269|NCT00896532|590250931|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422270|NCT00896532|590250932|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422271|NCT00896532|590250933|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422272|NCT00896532|590250934|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422273|NCT00896532|590250935|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422274|NCT00896532|590250936|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163422275|NCT00896532|590250914|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422276|NCT00896532|590250915|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422277|NCT00896532|590250916|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422278|NCT00896532|590250917|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422279|NCT00896532|590250918|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422280|NCT00896532|590250919|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422281|NCT00896532|590250920|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422282|NCT00896532|590250921|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422283|NCT00896532|590250922|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422284|NCT00896532|590250923|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422285|NCT00896532|590250924|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422286|NCT00896532|590250925|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422287|NCT00896532|590250926|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
163422288|NCT00896532|590250927|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
163422289|NCT00896532|590250928|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422290|NCT00896532|590250929|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422291|NCT00896532|590250930|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422292|NCT00896532|590250931|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422293|NCT00896532|590250932|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422294|NCT00896532|590250933|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422295|NCT00896532|590250934|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422296|NCT00896532|590250935|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422297|NCT00896532|590250936|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163422298|NCT00896532|590250914|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
163422299|NCT00896532|590250915|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
163422300|NCT00896532|590250916|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
163422301|NCT00896532|590250917|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
163422302|NCT00896532|590250918|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
163422303|NCT00896532|590250919|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
163422304|NCT00896532|590250920|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
163422305|NCT00896532|590250921|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
163422306|NCT00896532|590250922|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
163422307|NCT00896532|590250923|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
163422308|NCT00896532|590250924|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
163422309|NCT00896532|590250925|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
163422310|NCT00896532|590250926|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
163422311|NCT00896532|590250927|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
163422312|NCT00896532|590250928|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
163422313|NCT00896532|590250929|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
163422314|NCT00896532|590250930|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
163422315|NCT00896532|590250931|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
163422316|NCT00896532|590250932|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
163422317|NCT00896532|590250933|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
163422318|NCT00896532|590250934|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
163422319|NCT00896532|590250935|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
163422320|NCT00896532|590250936|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
163422321|NCT00896532|590250914|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422322|NCT00896532|590250915|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422323|NCT00896532|590250916|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422324|NCT00896532|590250917|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422325|NCT00896532|590250918|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422326|NCT00896532|590250919|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422327|NCT00896532|590250920|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422328|NCT00896532|590250921|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422329|NCT00896532|590250922|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422330|NCT00896532|590250923|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422331|NCT00896532|590250924|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422332|NCT00896532|590250925|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422333|NCT00896532|590250926|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422334|NCT00896532|590250927|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422335|NCT00896532|590250928|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422336|NCT00896532|590250929|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
163422337|NCT00896532|590250930|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
163422338|NCT00896532|590250931|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422339|NCT00896532|590250932|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422340|NCT00896532|590250933|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422341|NCT00896532|590250934|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422342|NCT00896532|590250935|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422343|NCT00896532|590250936|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163422344|NCT00896532|590250914|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422345|NCT00896532|590250915|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422346|NCT00896532|590250916|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422347|NCT00896532|590250917|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422348|NCT00896532|590250918|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422349|NCT00896532|590250919|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422350|NCT00896532|590250920|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422351|NCT00896532|590250921|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422352|NCT00896532|590250922|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422353|NCT00896532|590250923|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422354|NCT00896532|590250924|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422355|NCT00896532|590250925|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422356|NCT00896532|590250926|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422357|NCT00896532|590250927|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422358|NCT00896532|590250928|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422359|NCT00896532|590250929|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
163422360|NCT00896532|590250930|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
163422361|NCT00896532|590250931|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
163422362|NCT00896532|590250932|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422363|NCT00896532|590250933|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422364|NCT00896532|590250934|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422365|NCT00896532|590250935|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422366|NCT00896532|590250936|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163422367|NCT00896532|590250914|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422368|NCT00896532|590250915|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422369|NCT00896532|590250916|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422370|NCT00896532|590250917|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422371|NCT00896532|590250918|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422372|NCT00896532|590250919|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422373|NCT00896532|590250920|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422374|NCT00896532|590250921|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422375|NCT00896532|590250922|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422376|NCT00896532|590250923|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422377|NCT00896532|590250924|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422378|NCT00896532|590250925|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422379|NCT00896532|590250926|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422380|NCT00896532|590250927|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422381|NCT00896532|590250928|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422382|NCT00896532|590250929|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422383|NCT00896532|590250930|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
163422384|NCT00896532|590250931|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422385|NCT00896532|590250932|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422386|NCT00896532|590250933|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422387|NCT00896532|590250934|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422388|NCT00896532|590250935|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422389|NCT00896532|590250936|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163422390|NCT00896532|590250914|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
163422391|NCT00896532|590250915|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
163422392|NCT00896532|590250916|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
163422393|NCT00896532|590250917|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
163422394|NCT00896532|590250918|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
163422395|NCT00896532|590250919|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
163422396|NCT00896532|590250920|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
163422397|NCT00896532|590250921|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
163422398|NCT00896532|590250922|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
163422399|NCT00896532|590250923|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
163422400|NCT00896532|590250924|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
163422401|NCT00896532|590250925|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
163422402|NCT00896532|590250926|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
163422403|NCT00896532|590250927|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
163422404|NCT00896532|590250928|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
163422405|NCT00896532|590250929|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
163422406|NCT00896532|590250930|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
163422407|NCT00896532|590250931|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
163422408|NCT00896532|590250932|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
163422409|NCT00896532|590250933|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
163422410|NCT00896532|590250934|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
163422411|NCT00896532|590250935|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
163422412|NCT00896532|590250936|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
163422413|NCT00896532|590250914|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422414|NCT00896532|590250915|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422415|NCT00896532|590250916|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422416|NCT00896532|590250917|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422417|NCT00896532|590250918|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422418|NCT00896532|590250919|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422419|NCT00896532|590250920|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422420|NCT00896532|590250921|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422421|NCT00896532|590250922|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422422|NCT00896532|590250923|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422423|NCT00896532|590250924|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422424|NCT00896532|590250925|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422425|NCT00896532|590250926|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422426|NCT00896532|590250927|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422427|NCT00896532|590250928|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422428|NCT00896532|590250929|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422429|NCT00896532|590250930|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
163422430|NCT00896532|590250931|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422431|NCT00896532|590250932|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422432|NCT00896532|590250933|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422433|NCT00896532|590250934|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422434|NCT00896532|590250935|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422435|NCT00896532|590250936|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163422436|NCT00896532|590250914|FG000|Months 48-72: Follow-on Phase|Death|0|||
163422437|NCT00896532|590250915|FG001|Months 48-72: Follow-on Phase|Death|0|||
163422438|NCT00896532|590250916|FG002|Months 48-72: Follow-on Phase|Death|0|||
163422439|NCT00896532|590250917|FG003|Months 48-72: Follow-on Phase|Death|0|||
163422440|NCT00896532|590250918|FG004|Months 48-72: Follow-on Phase|Death|0|||
163422441|NCT00896532|590250919|FG005|Months 48-72: Follow-on Phase|Death|0|||
163422442|NCT00896532|590250920|FG006|Months 48-72: Follow-on Phase|Death|0|||
163422443|NCT00896532|590250921|FG007|Months 48-72: Follow-on Phase|Death|0|||
163422444|NCT00896532|590250922|FG008|Months 48-72: Follow-on Phase|Death|0|||
163422445|NCT00896532|590250923|FG009|Months 48-72: Follow-on Phase|Death|0|||
163422446|NCT00896532|590250924|FG010|Months 48-72: Follow-on Phase|Death|0|||
163422447|NCT00896532|590250925|FG011|Months 48-72: Follow-on Phase|Death|0|||
163422448|NCT00896532|590250926|FG012|Months 48-72: Follow-on Phase|Death|0|||
163422449|NCT00896532|590250927|FG013|Months 48-72: Follow-on Phase|Death|0|||
163422450|NCT00896532|590250928|FG014|Months 48-72: Follow-on Phase|Death|0|||
163422451|NCT00896532|590250929|FG015|Months 48-72: Follow-on Phase|Death|0|||
163422452|NCT00896532|590250930|FG016|Months 48-72: Follow-on Phase|Death|0|||
163422453|NCT00896532|590250931|FG017|Months 48-72: Follow-on Phase|Death|0|||
163422454|NCT00896532|590250932|FG018|Months 48-72: Follow-on Phase|Death|1|||
163422455|NCT00896532|590250933|FG019|Months 48-72: Follow-on Phase|Death|0|||
163422456|NCT00896532|590250934|FG020|Months 48-72: Follow-on Phase|Death|0|||
163422457|NCT00896532|590250935|FG021|Months 48-72: Follow-on Phase|Death|0|||
163422458|NCT00896532|590250936|FG022|Months 48-72: Follow-on Phase|Death|0|||
163422459|NCT00896532|590250914|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422460|NCT00896532|590250915|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422461|NCT00896532|590250916|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422462|NCT00896532|590250917|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422463|NCT00896532|590250918|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422464|NCT00896532|590250919|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422465|NCT00896532|590250920|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422466|NCT00896532|590250921|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422467|NCT00896532|590250922|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422468|NCT00896532|590250923|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422469|NCT00896532|590250924|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422470|NCT00896532|590250925|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422471|NCT00896532|590250926|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422472|NCT00896532|590250927|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422473|NCT00896532|590250928|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422474|NCT00896532|590250929|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422475|NCT00896532|590250930|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422476|NCT00896532|590250931|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422477|NCT00896532|590250932|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422478|NCT00896532|590250933|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422479|NCT00896532|590250934|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422480|NCT00896532|590250935|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
163422481|NCT00896532|590250936|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163422482|NCT00896532|590250914|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422483|NCT00896532|590250915|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422484|NCT00896532|590250916|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422485|NCT00896532|590250917|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422486|NCT00896532|590250918|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422487|NCT00896532|590250919|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422488|NCT00896532|590250920|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422489|NCT00896532|590250921|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422490|NCT00896532|590250922|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422491|NCT00896532|590250923|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422492|NCT00896532|590250924|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422493|NCT00896532|590250925|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422494|NCT00896532|590250926|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422495|NCT00896532|590250927|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422496|NCT00896532|590250928|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422497|NCT00896532|590250929|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422498|NCT00896532|590250930|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422499|NCT00896532|590250931|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422500|NCT00896532|590250932|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422501|NCT00896532|590250933|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422502|NCT00896532|590250934|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422503|NCT00896532|590250935|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
163422504|NCT00896532|590250936|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163422505|NCT01282229|590250937|FG000|Overall Study|Protocol Violation|2|||
163422506|NCT01671280|590250938|FG000|Overall Study|Withdrawal by Subject|2|||
163422507|NCT00996203|590250939|FG000|Overall Study|Adverse Event|3|||
163422508|NCT00996203|590250939|FG000|Overall Study|Lost to Follow-up|1|||
163422509|NCT00996203|590250939|FG000|Overall Study|Lack of Efficacy|1|||
163422510|NCT00996203|590250939|FG000|Overall Study|Protocol Violation|2|||
163422511|NCT01959165|590250940|FG000|Overall Study|Adverse Event|0|||
163422512|NCT01959165|590250941|FG001|Overall Study|Adverse Event|0|||
163422513|NCT01959165|590250942|FG002|Overall Study|Adverse Event|0|||
163422514|NCT01959165|590250943|FG003|Overall Study|Adverse Event|1|||
163422515|NCT01959165|590250940|FG000|Overall Study|Lack of Efficacy|1|||
163422516|NCT01959165|590250941|FG001|Overall Study|Lack of Efficacy|0|||
163422517|NCT01959165|590250942|FG002|Overall Study|Lack of Efficacy|0|||
163422518|NCT01959165|590250943|FG003|Overall Study|Lack of Efficacy|0|||
163422519|NCT01959165|590250940|FG000|Overall Study|overdose|0|||
163422520|NCT01959165|590250941|FG001|Overall Study|overdose|0|||
163422521|NCT01959165|590250942|FG002|Overall Study|overdose|0|||
163422522|NCT01959165|590250943|FG003|Overall Study|overdose|1|||
163422523|NCT01959165|590250940|FG000|Overall Study|Welfare recipient|0|||
163422524|NCT01959165|590250941|FG001|Overall Study|Welfare recipient|1|||
163422525|NCT01959165|590250942|FG002|Overall Study|Welfare recipient|0|||
163422526|NCT01959165|590250943|FG003|Overall Study|Welfare recipient|0|||
163422527|NCT03686969|590250944|FG000|Overall Study|Study terminated|1|||
163422528|NCT03686969|590250945|FG001|Overall Study|Study terminated|0|||
163422529|NCT00848120|590250947|FG000|Overall Study|Adverse Event|1|||
163422530|NCT01988090|590250959|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
163422531|NCT01988090|590250960|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
163422532|NCT01988090|590250959|FG000|Start Treament After Randomization|Protocol Violation|0|||
163422533|NCT01988090|590250960|FG001|Start Treament After Randomization|Protocol Violation|1|||
163422534|NCT01988090|590250959|FG000|Complete Study After Start|Withdrawal by Subject|2|||
163422535|NCT01988090|590250960|FG001|Complete Study After Start|Withdrawal by Subject|0|||
163422536|NCT01988090|590250959|FG000|Complete Study After Start|Protocol Violation|1|||
163422537|NCT01988090|590250960|FG001|Complete Study After Start|Protocol Violation|1|||
163422538|NCT01961115|590250964|FG000|Overall Study|Disease Progression|1|||
163422539|NCT01961115|590250965|FG001|Overall Study|Disease Progression|0|||
163422540|NCT01961115|590250966|FG002|Overall Study|Disease Progression|3|||
163422541|NCT01961115|590250964|FG000|Overall Study|Adverse Event|1|||
163422542|NCT01961115|590250965|FG001|Overall Study|Adverse Event|0|||
163422543|NCT01961115|590250966|FG002|Overall Study|Adverse Event|1|||
163422544|NCT01439945|590250971|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
163422545|NCT01439945|590250972|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
163422546|NCT01439945|590250973|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
163422547|NCT01439945|590250974|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
163422548|NCT01439945|590250971|FG000|Double-Blind Treatment Phase|Ineligible|1|||
163422549|NCT01439945|590250972|FG001|Double-Blind Treatment Phase|Ineligible|2|||
163422550|NCT01439945|590250973|FG002|Double-Blind Treatment Phase|Ineligible|0|||
163422551|NCT01439945|590250974|FG003|Double-Blind Treatment Phase|Ineligible|1|||
163422552|NCT04082663|590250975|FG000|Overall Study|Adverse Event|6|||
163422553|NCT04082663|590250975|FG000|Overall Study|Lost to Follow-up|1|||
163422554|NCT00927563|590250976|FG000|Overall Study|Lost to Follow-up|1|||
163422555|NCT00927563|590250976|FG000|Overall Study|Withdrawal by Subject|1|||
163422556|NCT02497001|590250979|FG000|Overall Study|Lost to Follow-up|10|||
163422557|NCT02497001|590250980|FG001|Overall Study|Lost to Follow-up|2|||
163422558|NCT02497001|590250981|FG002|Overall Study|Lost to Follow-up|0|||
163422559|NCT02497001|590250982|FG003|Overall Study|Lost to Follow-up|2|||
163422560|NCT02497001|590250979|FG000|Overall Study|Adverse Event|28|||
163422561|NCT02497001|590250980|FG001|Overall Study|Adverse Event|30|||
163422562|NCT02497001|590250981|FG002|Overall Study|Adverse Event|11|||
163422563|NCT02497001|590250982|FG003|Overall Study|Adverse Event|11|||
163422564|NCT02497001|590250979|FG000|Overall Study|Withdrawal by Subject|14|||
163422565|NCT02497001|590250980|FG001|Overall Study|Withdrawal by Subject|37|||
163422566|NCT02497001|590250981|FG002|Overall Study|Withdrawal by Subject|19|||
163422567|NCT02497001|590250982|FG003|Overall Study|Withdrawal by Subject|15|||
163422568|NCT02497001|590250979|FG000|Overall Study|Physician Decision|5|||
163422569|NCT02497001|590250980|FG001|Overall Study|Physician Decision|11|||
163422570|NCT02497001|590250981|FG002|Overall Study|Physician Decision|5|||
163422571|NCT02497001|590250982|FG003|Overall Study|Physician Decision|1|||
163422572|NCT02497001|590250979|FG000|Overall Study|subjects that were not treated|1|||
163422573|NCT02497001|590250980|FG001|Overall Study|subjects that were not treated|2|||
163422574|NCT02497001|590250981|FG002|Overall Study|subjects that were not treated|2|||
163422575|NCT02497001|590250982|FG003|Overall Study|subjects that were not treated|1|||
163422576|NCT02497001|590250979|FG000|Overall Study|Major Protocol Deviation|3|||
163422577|NCT02497001|590250980|FG001|Overall Study|Major Protocol Deviation|4|||
163422578|NCT02497001|590250981|FG002|Overall Study|Major Protocol Deviation|4|||
163422579|NCT02497001|590250982|FG003|Overall Study|Major Protocol Deviation|4|||
163422580|NCT02497001|590250979|FG000|Overall Study|Lack of Efficacy|10|||
163422581|NCT02497001|590250980|FG001|Overall Study|Lack of Efficacy|16|||
163422582|NCT02497001|590250981|FG002|Overall Study|Lack of Efficacy|6|||
163422583|NCT02497001|590250982|FG003|Overall Study|Lack of Efficacy|6|||
163422584|NCT02497001|590250979|FG000|Overall Study|Protocol Violation|3|||
163422585|NCT02497001|590250980|FG001|Overall Study|Protocol Violation|1|||
163422586|NCT02497001|590250981|FG002|Overall Study|Protocol Violation|3|||
163422587|NCT02497001|590250982|FG003|Overall Study|Protocol Violation|1|||
163422588|NCT05501119|590250983|FG000|Overall Study|Withdrawal by Subject|2|||
163422589|NCT05501119|590250983|FG000|Overall Study|Lost to Follow-up|5|||
163422590|NCT01752023|590250984|FG000|Overall Study|Physician Decision|2|||
163422591|NCT01752023|590250985|FG001|Overall Study|Physician Decision|1|||
163422592|NCT02542072|590250986|FG000|First Intervention (1 Month)|Adverse Event|1|||
163422593|NCT02542072|590250987|FG001|First Intervention (1 Month)|Adverse Event|1|||
163422594|NCT02542072|590250986|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
163422595|NCT02542072|590250987|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
163422596|NCT02542072|590250986|FG000|First Intervention (1 Month)|Lens discomfort|1|||
163422597|NCT02542072|590250987|FG001|First Intervention (1 Month)|Lens discomfort|2|||
163422598|NCT02542072|590250986|FG000|First Intervention (1 Month)|Protocol Violation|1|||
163422599|NCT02542072|590250987|FG001|First Intervention (1 Month)|Protocol Violation|0|||
163422600|NCT02542072|590250986|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
163422601|NCT02542072|590250987|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
163422602|NCT02542072|590250986|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
163422603|NCT02542072|590250987|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
163422604|NCT02440581|590250993|FG000|Overall Study|Death|0|||
163422605|NCT02440581|590250994|FG001|Overall Study|Death|0|||
163422606|NCT02440581|590250995|FG002|Overall Study|Death|7|||
163422607|NCT02440581|590250996|FG003|Overall Study|Death|5|||
163422608|NCT02440581|590250993|FG000|Overall Study|Transplanted|1|||
163422609|NCT02440581|590250994|FG001|Overall Study|Transplanted|0|||
163422610|NCT02440581|590250995|FG002|Overall Study|Transplanted|3|||
163422611|NCT02440581|590250996|FG003|Overall Study|Transplanted|2|||
163422612|NCT02440581|590250993|FG000|Overall Study|Withdrawal by Subject|4|||
163422613|NCT02440581|590250994|FG001|Overall Study|Withdrawal by Subject|11|||
163422614|NCT02440581|590250995|FG002|Overall Study|Withdrawal by Subject|3|||
163422615|NCT02440581|590250996|FG003|Overall Study|Withdrawal by Subject|7|||
163422616|NCT00654498|590250997|FG000|Overall Study|Not Treated|1|||
163422617|NCT00654498|590250998|FG001|Overall Study|Not Treated|0|||
163422618|NCT00654498|590250997|FG000|Overall Study|Adverse Event|6|||
163422619|NCT00654498|590250998|FG001|Overall Study|Adverse Event|1|||
163422620|NCT00654498|590250997|FG000|Overall Study|Protocol Violation|1|||
163422621|NCT00654498|590250998|FG001|Overall Study|Protocol Violation|1|||
163422622|NCT00654498|590250997|FG000|Overall Study|Lost to Follow-up|1|||
163422623|NCT00654498|590250998|FG001|Overall Study|Lost to Follow-up|5|||
163422624|NCT00654498|590250997|FG000|Overall Study|Withdrawal by Subject|1|||
163422625|NCT00654498|590250998|FG001|Overall Study|Withdrawal by Subject|0|||
163422626|NCT00654498|590250997|FG000|Overall Study|Other reason not defined above|4|||
163422627|NCT00654498|590250998|FG001|Overall Study|Other reason not defined above|5|||
163422628|NCT01468987|590250999|FG000|Overall Study|Adverse Event|12|||
163422629|NCT01468987|590251000|FG001|Overall Study|Adverse Event|9|||
163422630|NCT01468987|590250999|FG000|Overall Study|Death|4|||
163422631|NCT01468987|590251000|FG001|Overall Study|Death|1|||
163422632|NCT01468987|590250999|FG000|Overall Study|Lost to Follow-up|10|||
163422633|NCT01468987|590251000|FG001|Overall Study|Lost to Follow-up|5|||
163422634|NCT01468987|590250999|FG000|Overall Study|Protocol Violation|8|||
163422635|NCT01468987|590251000|FG001|Overall Study|Protocol Violation|2|||
163422636|NCT01468987|590250999|FG000|Overall Study|Withdrawal by Subject|28|||
163422637|NCT01468987|590251000|FG001|Overall Study|Withdrawal by Subject|28|||
163422638|NCT01468987|590250999|FG000|Overall Study|Physician Decision|8|||
163422639|NCT01468987|590251000|FG001|Overall Study|Physician Decision|15|||
163422640|NCT01468987|590250999|FG000|Overall Study|Sponsor Decision|1|||
163422641|NCT01468987|590251000|FG001|Overall Study|Sponsor Decision|0|||
163422642|NCT00787787|590251001|FG000|Overall Study|Lack of Efficacy|4|||
163422643|NCT00787787|590251001|FG000|Overall Study|Adverse Event|3|||
163422644|NCT00943683|590251002|FG000|Overall Study|Adverse Event|3|||
163422645|NCT00943683|590251003|FG001|Overall Study|Adverse Event|3|||
163422646|NCT00943683|590251002|FG000|Overall Study|Lost to Follow-up|1|||
163422647|NCT00943683|590251003|FG001|Overall Study|Lost to Follow-up|1|||
163422648|NCT00943683|590251002|FG000|Overall Study|Protocol Violation|1|||
163422649|NCT00943683|590251003|FG001|Overall Study|Protocol Violation|2|||
163422650|NCT00943683|590251002|FG000|Overall Study|Withdrawal by Subject|1|||
163422651|NCT00943683|590251003|FG001|Overall Study|Withdrawal by Subject|0|||
163422652|NCT00943683|590251002|FG000|Overall Study|Patient Moved|1|||
163422653|NCT00943683|590251003|FG001|Overall Study|Patient Moved|0|||
163422654|NCT01245673|590251004|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
163422655|NCT01445678|590251012|FG000|Overall Study|Adverse Event|12|||
163422656|NCT01445678|590251013|FG001|Overall Study|Adverse Event|8|||
163422657|NCT01445678|590251012|FG000|Overall Study|Lack of Efficacy|0|||
163422658|NCT01445678|590251013|FG001|Overall Study|Lack of Efficacy|2|||
163422659|NCT01445678|590251012|FG000|Overall Study|Lost to Follow-up|8|||
163422660|NCT01445678|590251013|FG001|Overall Study|Lost to Follow-up|5|||
163422661|NCT01445678|590251012|FG000|Overall Study|Protocol Violation|1|||
163422662|NCT01445678|590251013|FG001|Overall Study|Protocol Violation|1|||
163422663|NCT01445678|590251012|FG000|Overall Study|Withdrawal by Subject|9|||
163422664|NCT01445678|590251013|FG001|Overall Study|Withdrawal by Subject|5|||
163422665|NCT01459614|590251016|FG000|Overall Study|Adverse Event|1|||
163422666|NCT01459614|590251017|FG001|Overall Study|Adverse Event|0|||
163422667|NCT01565980|590251018|FG000|Overall Study|Death|1|||
163422668|NCT01565980|590251019|FG001|Overall Study|Death|0|||
163422669|NCT01565980|590251018|FG000|Overall Study|Lost to Follow-up|1|||
163422670|NCT01565980|590251019|FG001|Overall Study|Lost to Follow-up|0|||
163422671|NCT01565980|590251018|FG000|Overall Study|health complications|1|||
163422672|NCT01565980|590251019|FG001|Overall Study|health complications|1|||
163422673|NCT01565980|590251018|FG000|Overall Study|stopped medical treatment|1|||
163422674|NCT01565980|590251019|FG001|Overall Study|stopped medical treatment|0|||
163422675|NCT01565980|590251018|FG000|Overall Study|Withdrawal by Subject|0|||
163422676|NCT01565980|590251019|FG001|Overall Study|Withdrawal by Subject|3|||
163422677|NCT02078219|590251022|FG000|Overall Study|Other|2|||
163422678|NCT02078219|590251023|FG001|Overall Study|Other|2|||
163422679|NCT02078219|590251024|FG002|Overall Study|Other|3|||
163422680|NCT02078219|590251025|FG003|Overall Study|Other|0|||
163422681|NCT02078219|590251026|FG004|Overall Study|Other|1|||
163422682|NCT02078219|590251022|FG000|Overall Study|Withdrawal by Subject|0|||
163422683|NCT02078219|590251023|FG001|Overall Study|Withdrawal by Subject|1|||
163422684|NCT02078219|590251024|FG002|Overall Study|Withdrawal by Subject|0|||
163422685|NCT02078219|590251025|FG003|Overall Study|Withdrawal by Subject|1|||
163422686|NCT02078219|590251026|FG004|Overall Study|Withdrawal by Subject|1|||
163422687|NCT02078219|590251022|FG000|Overall Study|Protocol Violation|0|||
163422688|NCT02078219|590251023|FG001|Overall Study|Protocol Violation|0|||
163422689|NCT02078219|590251024|FG002|Overall Study|Protocol Violation|0|||
163422690|NCT02078219|590251025|FG003|Overall Study|Protocol Violation|1|||
163422691|NCT02078219|590251026|FG004|Overall Study|Protocol Violation|0|||
163422692|NCT02078219|590251022|FG000|Overall Study|Death|0|||
163422693|NCT02078219|590251023|FG001|Overall Study|Death|0|||
163422694|NCT02078219|590251024|FG002|Overall Study|Death|0|||
163422695|NCT02078219|590251025|FG003|Overall Study|Death|1|||
163422696|NCT02078219|590251026|FG004|Overall Study|Death|0|||
163422697|NCT02078219|590251022|FG000|Overall Study|Adverse Event|1|||
163422698|NCT02078219|590251023|FG001|Overall Study|Adverse Event|1|||
163422699|NCT02078219|590251024|FG002|Overall Study|Adverse Event|3|||
163422700|NCT02078219|590251025|FG003|Overall Study|Adverse Event|1|||
163422701|NCT02078219|590251026|FG004|Overall Study|Adverse Event|0|||
163422702|NCT03283085|590251032|FG000|Overall Study|Adverse Event|18|||
163422703|NCT03283085|590251033|FG001|Overall Study|Adverse Event|3|||
163422704|NCT03283085|590251034|FG002|Overall Study|Adverse Event|13|||
163422705|NCT03283085|590251035|FG003|Overall Study|Adverse Event|0|||
163422706|NCT03283085|590251036|FG004|Overall Study|Adverse Event|0|||
163422707|NCT03283085|590251037|FG005|Overall Study|Adverse Event|5|||
163422708|NCT03283085|590251032|FG000|Overall Study|Death|0|||
163422709|NCT03283085|590251033|FG001|Overall Study|Death|0|||
163422710|NCT03283085|590251034|FG002|Overall Study|Death|3|||
163422711|NCT03283085|590251035|FG003|Overall Study|Death|1|||
163422712|NCT03283085|590251036|FG004|Overall Study|Death|0|||
163422713|NCT03283085|590251037|FG005|Overall Study|Death|0|||
163422714|NCT03283085|590251032|FG000|Overall Study|Withdrawal by Subject|42|||
163422715|NCT03283085|590251033|FG001|Overall Study|Withdrawal by Subject|21|||
163422716|NCT03283085|590251034|FG002|Overall Study|Withdrawal by Subject|66|||
163422717|NCT03283085|590251035|FG003|Overall Study|Withdrawal by Subject|3|||
163422718|NCT03283085|590251036|FG004|Overall Study|Withdrawal by Subject|3|||
163422719|NCT03283085|590251037|FG005|Overall Study|Withdrawal by Subject|5|||
163422720|NCT03283085|590251032|FG000|Overall Study|Physician Decision|14|||
163422721|NCT03283085|590251033|FG001|Overall Study|Physician Decision|8|||
163422722|NCT03283085|590251034|FG002|Overall Study|Physician Decision|19|||
163422723|NCT03283085|590251035|FG003|Overall Study|Physician Decision|0|||
163422724|NCT03283085|590251036|FG004|Overall Study|Physician Decision|0|||
163422725|NCT03283085|590251037|FG005|Overall Study|Physician Decision|2|||
163422726|NCT03283085|590251032|FG000|Overall Study|Site Terminated by Sponsor|1|||
163422727|NCT03283085|590251033|FG001|Overall Study|Site Terminated by Sponsor|0|||
163422728|NCT03283085|590251034|FG002|Overall Study|Site Terminated by Sponsor|3|||
163422729|NCT03283085|590251035|FG003|Overall Study|Site Terminated by Sponsor|0|||
163422730|NCT03283085|590251036|FG004|Overall Study|Site Terminated by Sponsor|0|||
163422731|NCT03283085|590251037|FG005|Overall Study|Site Terminated by Sponsor|0|||
163422732|NCT03283085|590251032|FG000|Overall Study|Lost to Follow-up|2|||
163422733|NCT03283085|590251033|FG001|Overall Study|Lost to Follow-up|0|||
163422734|NCT03283085|590251034|FG002|Overall Study|Lost to Follow-up|2|||
163422735|NCT03283085|590251035|FG003|Overall Study|Lost to Follow-up|0|||
163422736|NCT03283085|590251036|FG004|Overall Study|Lost to Follow-up|0|||
163422737|NCT03283085|590251037|FG005|Overall Study|Lost to Follow-up|1|||
163422738|NCT03283085|590251032|FG000|Overall Study|Pregnancy|0|||
163422739|NCT03283085|590251033|FG001|Overall Study|Pregnancy|0|||
163422740|NCT03283085|590251034|FG002|Overall Study|Pregnancy|1|||
163422741|NCT03283085|590251035|FG003|Overall Study|Pregnancy|0|||
163422742|NCT03283085|590251036|FG004|Overall Study|Pregnancy|0|||
163422743|NCT03283085|590251037|FG005|Overall Study|Pregnancy|0|||
163422744|NCT03283085|590251032|FG000|Overall Study|Lack of Efficacy|12|||
163422745|NCT03283085|590251033|FG001|Overall Study|Lack of Efficacy|6|||
163422746|NCT03283085|590251034|FG002|Overall Study|Lack of Efficacy|24|||
163422747|NCT03283085|590251035|FG003|Overall Study|Lack of Efficacy|1|||
163422748|NCT03283085|590251036|FG004|Overall Study|Lack of Efficacy|1|||
163422749|NCT03283085|590251037|FG005|Overall Study|Lack of Efficacy|0|||
163422750|NCT03283085|590251032|FG000|Overall Study|Reason not Specified|0|||
163422751|NCT03283085|590251033|FG001|Overall Study|Reason not Specified|4|||
163422752|NCT03283085|590251034|FG002|Overall Study|Reason not Specified|8|||
163422753|NCT03283085|590251035|FG003|Overall Study|Reason not Specified|0|||
163422754|NCT03283085|590251036|FG004|Overall Study|Reason not Specified|0|||
163422755|NCT03283085|590251037|FG005|Overall Study|Reason not Specified|1|||
163422756|NCT00891202|590251038|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
163422757|NCT00891202|590251039|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
163422758|NCT00891202|590251040|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
163422759|NCT00891202|590251041|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
163422760|NCT00891202|590251038|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
163422761|NCT00891202|590251039|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
163422762|NCT00891202|590251040|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
163422763|NCT00891202|590251041|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
163422764|NCT00891202|590251038|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
163422765|NCT00891202|590251039|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
163422766|NCT00891202|590251040|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
163422767|NCT00891202|590251041|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
163422768|NCT00891202|590251038|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
163422769|NCT00891202|590251039|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
163422770|NCT00891202|590251040|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
163422771|NCT00891202|590251041|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
163422772|NCT02689492|590252847|FG000|Overall Study|Lost to Follow-up|61|||
163422773|NCT02689492|590252847|FG000|Overall Study|Withdrawal by Subject|11|||
163422774|NCT02689492|590252847|FG000|Overall Study|Death|9|||
163422775|NCT02689492|590252847|FG000|Overall Study|Physician Decision|2|||
163422776|NCT02689492|590252847|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
163422777|NCT02689492|590252847|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
163422778|NCT02689492|590252847|FG000|Overall Study|Other than listed|1|||
163422779|NCT01750918|590252848|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
163422780|NCT01750918|590252849|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
163422781|NCT01750918|590252850|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
163422782|NCT01750918|590252851|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
163422783|NCT01750918|590252852|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
163422784|NCT01750918|590252853|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
163422785|NCT01750918|590252854|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
163422786|NCT01750918|590252855|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
163422787|NCT01750918|590252848|FG000|Overall Study|Lost to Follow-up|0|||
163422788|NCT01750918|590252849|FG001|Overall Study|Lost to Follow-up|0|||
163422789|NCT01750918|590252850|FG002|Overall Study|Lost to Follow-up|2|||
163422790|NCT01750918|590252851|FG003|Overall Study|Lost to Follow-up|2|||
163422791|NCT01750918|590252852|FG004|Overall Study|Lost to Follow-up|0|||
163422792|NCT01750918|590252853|FG005|Overall Study|Lost to Follow-up|0|||
163422793|NCT01750918|590252854|FG006|Overall Study|Lost to Follow-up|0|||
163422794|NCT01750918|590252855|FG007|Overall Study|Lost to Follow-up|1|||
163422795|NCT01750918|590252848|FG000|Overall Study|Withdrawal by Subject|0|||
163422796|NCT01750918|590252849|FG001|Overall Study|Withdrawal by Subject|0|||
163422797|NCT01750918|590252850|FG002|Overall Study|Withdrawal by Subject|1|||
163422798|NCT01750918|590252851|FG003|Overall Study|Withdrawal by Subject|2|||
163422799|NCT01750918|590252852|FG004|Overall Study|Withdrawal by Subject|1|||
163422800|NCT01750918|590252853|FG005|Overall Study|Withdrawal by Subject|1|||
163422801|NCT01750918|590252854|FG006|Overall Study|Withdrawal by Subject|2|||
163422802|NCT01750918|590252855|FG007|Overall Study|Withdrawal by Subject|2|||
163422803|NCT02338843|590252861|FG000|Overall Study|Adverse Event|2|||
163422804|NCT02338843|590252862|FG001|Overall Study|Adverse Event|1|||
163422805|NCT02338843|590252861|FG000|Overall Study|Death|40|||
163422806|NCT02338843|590252862|FG001|Overall Study|Death|53|||
163422807|NCT02338843|590252861|FG000|Overall Study|Physician Decision|1|||
163422808|NCT02338843|590252862|FG001|Overall Study|Physician Decision|0|||
163422809|NCT02338843|590252861|FG000|Overall Study|Withdrawal by Subject|0|||
163422810|NCT02338843|590252862|FG001|Overall Study|Withdrawal by Subject|2|||
163422811|NCT02338843|590252861|FG000|Overall Study|Subject Recovered|0|||
163422812|NCT02338843|590252862|FG001|Overall Study|Subject Recovered|2|||
163422813|NCT02338843|590252861|FG000|Overall Study|Discontinued prior to randomizat|1|||
163422814|NCT02338843|590252862|FG001|Overall Study|Discontinued prior to randomizat|0|||
163422815|NCT00398112|590252881|FG000|Overall Study|Adverse Event|4|||
163422816|NCT00398112|590252881|FG000|Overall Study|Disease progression|9|||
163422817|NCT00398112|590252881|FG000|Overall Study|Alternative treatment|1|||
163422818|NCT00398112|590252881|FG000|Overall Study|Withdrawal by Subject|3|||
163422819|NCT00398112|590252881|FG000|Overall Study|Death|1|||
163422820|NCT00582556|590252882|FG000|Overall Study|Withdrawal by Subject|0|||
163422821|NCT00582556|590252883|FG001|Overall Study|Withdrawal by Subject|1|||
163422822|NCT00582556|590252884|FG002|Overall Study|Withdrawal by Subject|1|||
163422823|NCT00582556|590252882|FG000|Overall Study|Physician Decision|0|||
163422824|NCT00582556|590252883|FG001|Overall Study|Physician Decision|0|||
163422825|NCT00582556|590252884|FG002|Overall Study|Physician Decision|1|||
163422826|NCT01993888|590252885|FG000|Overall Study|Death|1|||
163422827|NCT01993888|590252886|FG001|Overall Study|Death|1|||
163422828|NCT01993888|590252885|FG000|Overall Study|Lost to Follow-up|1|||
163422829|NCT01993888|590252886|FG001|Overall Study|Lost to Follow-up|1|||
163422830|NCT01993888|590252885|FG000|Overall Study|Withdrawal by Subject|0|||
163422831|NCT01993888|590252886|FG001|Overall Study|Withdrawal by Subject|1|||
163422832|NCT03124459|590252887|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
163422833|NCT03124459|590252888|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
163422834|NCT03124459|590252889|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
163422835|NCT03124459|590252890|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
163422836|NCT03124459|590252891|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
163422837|NCT03124459|590252892|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
163422838|NCT03124459|590252887|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
163422839|NCT03124459|590252888|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
163422840|NCT03124459|590252889|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
163422841|NCT03124459|590252890|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
163422842|NCT03124459|590252891|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
163422843|NCT03124459|590252892|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
163422844|NCT03124459|590252887|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
163422845|NCT03124459|590252888|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
163422846|NCT03124459|590252889|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
163422847|NCT03124459|590252890|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
163422848|NCT03124459|590252891|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
163422849|NCT03124459|590252892|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
163422850|NCT03124459|590252887|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
163422851|NCT03124459|590252888|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
163422852|NCT03124459|590252889|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
163422853|NCT03124459|590252890|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
163422854|NCT03124459|590252891|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
163422855|NCT03124459|590252892|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
163422856|NCT03124459|590252887|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
163422857|NCT03124459|590252888|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
163422858|NCT03124459|590252889|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
163422859|NCT03124459|590252890|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
163422860|NCT03124459|590252891|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
163422861|NCT03124459|590252892|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
163422862|NCT03124459|590252887|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
163422863|NCT03124459|590252888|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
163422864|NCT03124459|590252889|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
163422865|NCT03124459|590252890|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
163422866|NCT03124459|590252891|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
163422867|NCT03124459|590252892|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
163422868|NCT00522392|590252893|FG000|Overall Study|Disease progression|0|||
163422869|NCT00522392|590252894|FG001|Overall Study|Disease progression|3|||
163422870|NCT00522392|590252893|FG000|Overall Study|Adverse Event|7|||
163422871|NCT00522392|590252894|FG001|Overall Study|Adverse Event|7|||
163422872|NCT00522392|590252893|FG000|Overall Study|Withdrawal by Subject|1|||
163422873|NCT00522392|590252894|FG001|Overall Study|Withdrawal by Subject|1|||
163422874|NCT00522392|590252893|FG000|Overall Study|Physician Decision|0|||
163422875|NCT00522392|590252894|FG001|Overall Study|Physician Decision|1|||
163422876|NCT00522392|590252893|FG000|Overall Study|Non-compliance|0|||
163422877|NCT00522392|590252894|FG001|Overall Study|Non-compliance|1|||
163422878|NCT03932812|590252895|FG000|Overall Study|Lost to Follow-up|12|||
163422879|NCT03932812|590252896|FG001|Overall Study|Lost to Follow-up|14|||
163422880|NCT03932812|590252895|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
163422881|NCT03932812|590252896|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
163422882|NCT00430755|590252899|FG000|Overall Study|Withdrawal by Subject|53|||
163422883|NCT01154101|590252900|FG000|Overall Study|Adverse Event|0|||
163422884|NCT01154101|590252901|FG001|Overall Study|Adverse Event|2|||
163422885|NCT01154101|590252902|FG002|Overall Study|Adverse Event|1|||
163422886|NCT01154101|590252903|FG003|Overall Study|Adverse Event|1|||
163422887|NCT01154101|590252904|FG004|Overall Study|Adverse Event|0|||
163422888|NCT01154101|590252900|FG000|Overall Study|Lost to Follow-up|0|||
163422889|NCT01154101|590252901|FG001|Overall Study|Lost to Follow-up|1|||
163422890|NCT01154101|590252902|FG002|Overall Study|Lost to Follow-up|0|||
163422891|NCT01154101|590252903|FG003|Overall Study|Lost to Follow-up|1|||
163422892|NCT01154101|590252904|FG004|Overall Study|Lost to Follow-up|0|||
163422893|NCT01154101|590252900|FG000|Overall Study|Withdrawal by Subject|0|||
163422894|NCT01154101|590252901|FG001|Overall Study|Withdrawal by Subject|1|||
163422895|NCT01154101|590252902|FG002|Overall Study|Withdrawal by Subject|2|||
163422896|NCT01154101|590252903|FG003|Overall Study|Withdrawal by Subject|0|||
163422897|NCT01154101|590252904|FG004|Overall Study|Withdrawal by Subject|1|||
163422898|NCT03575104|590252905|FG000|Overall Study|Adverse Event|4|||
163422899|NCT03575104|590252906|FG001|Overall Study|Adverse Event|3|||
163422900|NCT03575104|590252907|FG002|Overall Study|Adverse Event|4|||
163422901|NCT03575104|590252905|FG000|Overall Study|Withdrawal by Subject|13|||
163422902|NCT03575104|590252906|FG001|Overall Study|Withdrawal by Subject|16|||
163422903|NCT03575104|590252907|FG002|Overall Study|Withdrawal by Subject|11|||
163422904|NCT03575104|590252905|FG000|Overall Study|Other reasons|6|||
163422905|NCT03575104|590252906|FG001|Overall Study|Other reasons|8|||
163422906|NCT03575104|590252907|FG002|Overall Study|Other reasons|6|||
163422907|NCT03575104|590252905|FG000|Overall Study|Lost to Follow-up|1|||
163422908|NCT03575104|590252906|FG001|Overall Study|Lost to Follow-up|2|||
163422909|NCT03575104|590252907|FG002|Overall Study|Lost to Follow-up|1|||
163422910|NCT03293654|590252914|FG000|Overall Study|Lost to Follow-up|0|||
163422911|NCT03293654|590252915|FG001|Overall Study|Lost to Follow-up|1|||
163422912|NCT03293654|590252916|FG002|Overall Study|Lost to Follow-up|0|||
163422913|NCT01919307|590252917|FG000|Overall Study|Withdrawal by Subject|9|||
163422914|NCT05052723|590252919|FG000|Overall Study|Death|19|||
163422915|NCT02771522|590252921|FG000|Overall Study|Lost to Follow-up|3|||
163422916|NCT02771522|590252921|FG000|Overall Study|Withdrawal by Subject|2|||
163422917|NCT02771522|590252921|FG000|Overall Study|No white spot lesions|3|||
163422918|NCT03049449|590252924|FG000|Overall Study|Did not receive treatment.|0|||
163422919|NCT03049449|590252925|FG001|Overall Study|Did not receive treatment.|0|||
163422920|NCT03049449|590252926|FG002|Overall Study|Did not receive treatment.|0|||
163422921|NCT03049449|590252927|FG003|Overall Study|Did not receive treatment.|0|||
163422922|NCT03049449|590252928|FG004|Overall Study|Did not receive treatment.|0|||
163422923|NCT03049449|590252929|FG005|Overall Study|Did not receive treatment.|0|||
163422924|NCT03049449|590252930|FG006|Overall Study|Did not receive treatment.|0|||
163422925|NCT03049449|590252931|FG007|Overall Study|Did not receive treatment.|0|||
163422926|NCT03049449|590252932|FG008|Overall Study|Did not receive treatment.|1|||
163422927|NCT03049449|590252933|FG009|Overall Study|Did not receive treatment.|0|||
163422928|NCT03049449|590252924|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
163422929|NCT03049449|590252925|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
163422930|NCT03049449|590252926|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
163422931|NCT03049449|590252927|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
163422932|NCT03049449|590252928|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
163422933|NCT03049449|590252929|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
163422934|NCT03049449|590252930|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
163422935|NCT03049449|590252931|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
163422936|NCT03049449|590252932|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
163422937|NCT03049449|590252933|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
163422938|NCT03049449|590252924|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
163422939|NCT03049449|590252925|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
163422940|NCT03049449|590252926|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
163422941|NCT03049449|590252927|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
163422942|NCT03049449|590252928|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
163422943|NCT03049449|590252929|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
163422944|NCT03049449|590252930|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
163422945|NCT03049449|590252931|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
163422946|NCT03049449|590252932|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
163422947|NCT03049449|590252933|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
163422948|NCT01262898|590252941|FG000|Overall Study|Protocol Violation|1|||
163422949|NCT01262898|590252942|FG001|Overall Study|Protocol Violation|1|||
163422950|NCT01262898|590252943|FG002|Overall Study|Protocol Violation|0|||
163422951|NCT01262898|590252944|FG003|Overall Study|Protocol Violation|0|||
163422952|NCT01262898|590252941|FG000|Overall Study|Lost to Follow-up|1|||
163422953|NCT01262898|590252942|FG001|Overall Study|Lost to Follow-up|0|||
163422954|NCT01262898|590252943|FG002|Overall Study|Lost to Follow-up|0|||
163422955|NCT01262898|590252944|FG003|Overall Study|Lost to Follow-up|0|||
163422956|NCT01262898|590252941|FG000|Overall Study|Withdrawal by Subject|1|||
163422957|NCT01262898|590252942|FG001|Overall Study|Withdrawal by Subject|1|||
163422958|NCT01262898|590252943|FG002|Overall Study|Withdrawal by Subject|0|||
163422959|NCT01262898|590252944|FG003|Overall Study|Withdrawal by Subject|0|||
163422960|NCT02388295|590252951|FG000|Dose Escalation Week 1|Adverse Event|1|||
163422961|NCT02388295|590252952|FG001|Dose Escalation Week 1|Adverse Event|2|||
163422962|NCT02388295|590252953|FG002|Dose Escalation Week 1|Adverse Event|1|||
163422963|NCT02388295|590252951|FG000|Dose Escalation Week 1|Determined not eligible|1|||
163422964|NCT02388295|590252952|FG001|Dose Escalation Week 1|Determined not eligible|1|||
163422965|NCT02388295|590252953|FG002|Dose Escalation Week 1|Determined not eligible|1|||
163422966|NCT02388295|590252951|FG000|Dose Escalation Week 2|Protocol Violation|0|||
163422967|NCT02388295|590252952|FG001|Dose Escalation Week 2|Protocol Violation|1|||
163422968|NCT02388295|590252953|FG002|Dose Escalation Week 2|Protocol Violation|0|||
163422969|NCT02388295|590252951|FG000|Dose Escalation Week 2|Determined not eligible|1|||
163422970|NCT02388295|590252952|FG001|Dose Escalation Week 2|Determined not eligible|1|||
163422971|NCT02388295|590252953|FG002|Dose Escalation Week 2|Determined not eligible|1|||
163422972|NCT02388295|590252951|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
163422973|NCT02388295|590252952|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
163422974|NCT02388295|590252953|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
163422975|NCT01551693|590252954|FG000|Overall Study|Disease Progression|1|||
163422976|NCT01551693|590252955|FG001|Overall Study|Disease Progression|0|||
163422977|NCT01551693|590252954|FG000|Overall Study|Adverse Event|0|||
163422978|NCT01551693|590252955|FG001|Overall Study|Adverse Event|1|||
163422979|NCT01551693|590252954|FG000|Overall Study|Withdrawal by Subject|0|||
163422980|NCT01551693|590252955|FG001|Overall Study|Withdrawal by Subject|1|||
163422981|NCT01295125|590252960|FG000|Overall Study|Study stopped prematurely|9|||
163422982|NCT00891735|590252961|FG000|Overall Study|Adverse Event|2|||
163422983|NCT00891735|590252962|FG001|Overall Study|Adverse Event|0|||
163422984|NCT00891735|590252963|FG002|Overall Study|Adverse Event|2|||
163422985|NCT00891735|590252964|FG003|Overall Study|Adverse Event|0|||
163422986|NCT00891735|590252961|FG000|Overall Study|Death|8|||
163422987|NCT00891735|590252962|FG001|Overall Study|Death|5|||
163422988|NCT00891735|590252963|FG002|Overall Study|Death|4|||
163422989|NCT00891735|590252964|FG003|Overall Study|Death|5|||
163422990|NCT00891735|590252961|FG000|Overall Study|Lost to Follow-up|2|||
163422991|NCT00891735|590252962|FG001|Overall Study|Lost to Follow-up|2|||
163422992|NCT00891735|590252963|FG002|Overall Study|Lost to Follow-up|2|||
163422993|NCT00891735|590252964|FG003|Overall Study|Lost to Follow-up|2|||
163422994|NCT00891735|590252961|FG000|Overall Study|Physician's decision to withdraw patient|1|||
163422995|NCT00891735|590252962|FG001|Overall Study|Physician's decision to withdraw patient|0|||
163422996|NCT00891735|590252963|FG002|Overall Study|Physician's decision to withdraw patient|0|||
163422997|NCT00891735|590252964|FG003|Overall Study|Physician's decision to withdraw patient|0|||
163422998|NCT00891735|590252961|FG000|Overall Study|Patient's decision to withdraw|4|||
163422999|NCT00891735|590252962|FG001|Overall Study|Patient's decision to withdraw|9|||
163423000|NCT00891735|590252963|FG002|Overall Study|Patient's decision to withdraw|4|||
163423001|NCT00891735|590252964|FG003|Overall Study|Patient's decision to withdraw|8|||
163423002|NCT01355289|590252965|FG000|Core Study|Adverse Event, Non-Fatal|1|||
163423003|NCT01355289|590252966|FG001|Core Study|Adverse Event, Non-Fatal|0|||
163423004|NCT01355289|590252967|FG002|Core Study|Adverse Event, Non-Fatal|0|||
163423005|NCT01355289|590252968|FG003|Core Study|Adverse Event, Non-Fatal|0|||
163423006|NCT01355289|590252969|FG004|Core Study|Adverse Event, Non-Fatal|0|||
163423007|NCT01355289|590252965|FG000|Core Study|Inadequate Therapeutic Effect|0|||
163423008|NCT01355289|590252966|FG001|Core Study|Inadequate Therapeutic Effect|0|||
163423009|NCT01355289|590252967|FG002|Core Study|Inadequate Therapeutic Effect|0|||
163423010|NCT01355289|590252968|FG003|Core Study|Inadequate Therapeutic Effect|1|||
163423011|NCT01355289|590252969|FG004|Core Study|Inadequate Therapeutic Effect|0|||
163423012|NCT01355289|590252965|FG000|Core Study|Other|0|||
163423013|NCT01355289|590252966|FG001|Core Study|Other|0|||
163423014|NCT01355289|590252967|FG002|Core Study|Other|0|||
163423015|NCT01355289|590252968|FG003|Core Study|Other|1|||
163423016|NCT01355289|590252969|FG004|Core Study|Other|0|||
163423017|NCT01355289|590252965|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
163423018|NCT01355289|590252966|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
163423019|NCT01355289|590252967|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
163423020|NCT01355289|590252968|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
163423021|NCT01355289|590252969|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
163423022|NCT01355289|590252965|FG000|Open Label Extension|Lost to Follow-up|0|||
163423023|NCT01355289|590252966|FG001|Open Label Extension|Lost to Follow-up|0|||
163423024|NCT01355289|590252967|FG002|Open Label Extension|Lost to Follow-up|0|||
163423025|NCT01355289|590252968|FG003|Open Label Extension|Lost to Follow-up|0|||
163423026|NCT01355289|590252969|FG004|Open Label Extension|Lost to Follow-up|1|||
163423027|NCT01355289|590252965|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
163423028|NCT01355289|590252966|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
163423029|NCT01355289|590252967|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
163423030|NCT01355289|590252968|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
163423031|NCT01355289|590252969|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
163423032|NCT01355289|590252965|FG000|Open Label Extension|Other|0|||
163423033|NCT01355289|590252966|FG001|Open Label Extension|Other|0|||
163423034|NCT01355289|590252967|FG002|Open Label Extension|Other|0|||
163423035|NCT01355289|590252968|FG003|Open Label Extension|Other|0|||
163423036|NCT01355289|590252969|FG004|Open Label Extension|Other|3|||
163423037|NCT00802360|590252972|FG000|Overall Study|Stimulation failure|4|||
163423038|NCT00802360|590252973|FG001|Overall Study|Stimulation failure|0|||
163423039|NCT00802360|590252974|FG002|Overall Study|Stimulation failure|3|||
163423040|NCT00802360|590252975|FG003|Overall Study|Stimulation failure|3|||
163423041|NCT00802360|590252972|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
163423042|NCT00802360|590252973|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
163423043|NCT00802360|590252974|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
163423044|NCT00802360|590252975|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
163423045|NCT00802360|590252972|FG000|Overall Study|Cycle cancelled|0|||
163423046|NCT00802360|590252973|FG001|Overall Study|Cycle cancelled|1|||
163423047|NCT00802360|590252974|FG002|Overall Study|Cycle cancelled|1|||
163423048|NCT00802360|590252975|FG003|Overall Study|Cycle cancelled|1|||
163423049|NCT00802360|590252972|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
163423050|NCT00802360|590252973|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
163423051|NCT00802360|590252974|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
163423052|NCT00802360|590252975|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
163423053|NCT00802360|590252972|FG000|Overall Study|No positive serum pregnancy|17|||
163423054|NCT00802360|590252973|FG001|Overall Study|No positive serum pregnancy|20|||
163423055|NCT00802360|590252974|FG002|Overall Study|No positive serum pregnancy|14|||
163423056|NCT00802360|590252975|FG003|Overall Study|No positive serum pregnancy|10|||
163423057|NCT00802360|590252972|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
163423058|NCT00802360|590252973|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
163423059|NCT00802360|590252974|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
163423060|NCT00802360|590252975|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
163423061|NCT00802360|590252972|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
163423062|NCT00802360|590252973|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
163423063|NCT00802360|590252974|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
163423064|NCT00802360|590252975|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
163423065|NCT00802360|590252972|FG000|Overall Study|Other|2|||
163423066|NCT00802360|590252973|FG001|Overall Study|Other|3|||
163423067|NCT00802360|590252974|FG002|Overall Study|Other|6|||
163423068|NCT00802360|590252975|FG003|Overall Study|Other|3|||
163423069|NCT03838484|590252986|FG000|Overall Study|Lost to Follow-up|0|||
163423070|NCT03838484|590252987|FG001|Overall Study|Lost to Follow-up|1|||
163423071|NCT03838484|590252988|FG002|Overall Study|Lost to Follow-up|0|||
163423072|NCT03838484|590252989|FG003|Overall Study|Lost to Follow-up|0|||
163423073|NCT01900002|590252990|FG000|Overall Study|Withdrawal by Subject|2|||
163423074|NCT01900002|590252990|FG000|Overall Study|ineligible for Y-90|4|||
163423075|NCT01614964|590252991|FG000|Overall Study|Withdrawal by Subject|2|||
163423076|NCT01614964|590252992|FG001|Overall Study|Withdrawal by Subject|0|||
163423077|NCT01614964|590252991|FG000|Overall Study|Lost to Follow-up|3|||
163423078|NCT01614964|590252992|FG001|Overall Study|Lost to Follow-up|0|||
163423079|NCT00860470|590253001|FG000|Overall Study|Death|6|||
163423080|NCT00860470|590253002|FG001|Overall Study|Death|10|||
163423081|NCT00860470|590253001|FG000|Overall Study|Moved away|8|||
163423082|NCT00860470|590253002|FG001|Overall Study|Moved away|10|||
163423083|NCT00860470|590253001|FG000|Overall Study|Lost to Follow-up|34|||
163423084|NCT00860470|590253002|FG001|Overall Study|Lost to Follow-up|39|||
163423085|NCT00888238|590253004|FG000|Washout Period After Period 2|Adverse Event|0|||
163423086|NCT00888238|590253005|FG001|Washout Period After Period 2|Adverse Event|0|||
163423087|NCT00888238|590253006|FG002|Washout Period After Period 2|Adverse Event|1|||
163423088|NCT01032629|590253008|FG000|Overall Study|Closed Site|21|||
163423089|NCT01032629|590253009|FG001|Overall Study|Closed Site|18|||
163423090|NCT01032629|590253010|FG002|Overall Study|Closed Site|16|||
163423091|NCT01032629|590253008|FG000|Overall Study|Withdrawal by Subject|50|||
163423092|NCT01032629|590253009|FG001|Overall Study|Withdrawal by Subject|36|||
163423093|NCT01032629|590253010|FG002|Overall Study|Withdrawal by Subject|35|||
163423094|NCT01032629|590253008|FG000|Overall Study|Lost to Follow-up|74|||
163423095|NCT01032629|590253009|FG001|Overall Study|Lost to Follow-up|47|||
163423096|NCT01032629|590253010|FG002|Overall Study|Lost to Follow-up|37|||
163423097|NCT01662648|590253011|FG000|Overall Study|Death|1|||
163423098|NCT01662648|590253012|FG001|Overall Study|Death|3|||
163423099|NCT01662648|590253011|FG000|Overall Study|Adverse Event|40|||
163423100|NCT01662648|590253012|FG001|Overall Study|Adverse Event|37|||
163423101|NCT01662648|590253011|FG000|Overall Study|Lack of Efficacy|17|||
163423102|NCT01662648|590253012|FG001|Overall Study|Lack of Efficacy|16|||
163423103|NCT01662648|590253011|FG000|Overall Study|Participant ineligible to continue trial|1|||
163423104|NCT01662648|590253012|FG001|Overall Study|Participant ineligible to continue trial|1|||
163423105|NCT01662648|590253011|FG000|Overall Study|Lost to Follow-up|24|||
163423106|NCT01662648|590253012|FG001|Overall Study|Lost to Follow-up|36|||
163423107|NCT01662648|590253011|FG000|Overall Study|Withdrawal by Subject|36|||
163423108|NCT01662648|590253012|FG001|Overall Study|Withdrawal by Subject|53|||
163423109|NCT01662648|590253011|FG000|Overall Study|Participant non-compliant|16|||
163423110|NCT01662648|590253012|FG001|Overall Study|Participant non-compliant|20|||
163423111|NCT01662648|590253011|FG000|Overall Study|Other|8|||
163423112|NCT01662648|590253012|FG001|Overall Study|Other|11|||
163423113|NCT01662648|590253011|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
163423114|NCT01662648|590253012|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
163423115|NCT01662648|590253011|FG000|Overall Study|LOE and other reason unspecified|1|||
163423116|NCT01662648|590253012|FG001|Overall Study|LOE and other reason unspecified|0|||
163423117|NCT01662648|590253011|FG000|Overall Study|LOE and Participant non-compliant|0|||
163423118|NCT01662648|590253012|FG001|Overall Study|LOE and Participant non-compliant|1|||
163423119|NCT00619957|590253014|FG000|Month 24 Double-Blind|Adverse Event|9|||
163423120|NCT00619957|590253015|FG001|Month 24 Double-Blind|Adverse Event|7|||
163423121|NCT00619957|590253014|FG000|Month 24 Double-Blind|Protocol Violation|1|||
163423122|NCT00619957|590253015|FG001|Month 24 Double-Blind|Protocol Violation|0|||
163423123|NCT00619957|590253014|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
163423124|NCT00619957|590253015|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
163423125|NCT00619957|590253014|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
163423126|NCT00619957|590253015|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
163423127|NCT00619957|590253014|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
163423128|NCT00619957|590253015|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
163423129|NCT00619957|590253014|FG000|Month 48 Open-Label|Adverse Event|4|||
163423130|NCT00619957|590253015|FG001|Month 48 Open-Label|Adverse Event|4|||
163423131|NCT00619957|590253014|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
163423132|NCT00619957|590253015|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
163423133|NCT00619957|590253014|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
163423134|NCT00619957|590253015|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
163423135|NCT00723957|590253016|FG000|Overall Study|Adverse event unrelated to study drug|1|||
163423136|NCT00723957|590253017|FG001|Overall Study|Adverse event unrelated to study drug|4|||
163423137|NCT00723957|590253016|FG000|Overall Study|Death|3|||
163423138|NCT00723957|590253017|FG001|Overall Study|Death|4|||
163423139|NCT00723957|590253016|FG000|Overall Study|Disease progression|27|||
163423140|NCT00723957|590253017|FG001|Overall Study|Disease progression|25|||
163423141|NCT00723957|590253016|FG000|Overall Study|Maximum clinical benefit|4|||
163423142|NCT00723957|590253017|FG001|Overall Study|Maximum clinical benefit|5|||
163423143|NCT00723957|590253016|FG000|Overall Study|Investigator decision|1|||
163423144|NCT00723957|590253017|FG001|Overall Study|Investigator decision|1|||
163423145|NCT00723957|590253016|FG000|Overall Study|Study drug toxicity|4|||
163423146|NCT00723957|590253017|FG001|Overall Study|Study drug toxicity|6|||
163423147|NCT00723957|590253016|FG000|Overall Study|Withdrawal by Subject|7|||
163423148|NCT00723957|590253017|FG001|Overall Study|Withdrawal by Subject|5|||
163423149|NCT00723957|590253016|FG000|Overall Study|Reason not analyzed|1|||
163423150|NCT00723957|590253017|FG001|Overall Study|Reason not analyzed|0|||
163423151|NCT00723957|590253016|FG000|Overall Study|Never received treatment|3|||
163423152|NCT00723957|590253017|FG001|Overall Study|Never received treatment|3|||
163423153|NCT01763164|590253018|FG000|Treatment Phase|Participant/Guardian decision|26|||
163423154|NCT01763164|590253019|FG001|Treatment Phase|Participant/Guardian decision|14|||
163423155|NCT01763164|590253018|FG000|Treatment Phase|Protocol Violation|1|||
163423156|NCT01763164|590253019|FG001|Treatment Phase|Protocol Violation|1|||
163423157|NCT01763164|590253018|FG000|Treatment Phase|Progressive Disease|142|||
163423158|NCT01763164|590253019|FG001|Treatment Phase|Progressive Disease|76|||
163423159|NCT01763164|590253018|FG000|Treatment Phase|Physician Decision|24|||
163423160|NCT01763164|590253019|FG001|Treatment Phase|Physician Decision|13|||
163423161|NCT01763164|590253018|FG000|Treatment Phase|Death|10|||
163423162|NCT01763164|590253019|FG001|Treatment Phase|Death|1|||
163423163|NCT01763164|590253018|FG000|Treatment Phase|Adverse Event|66|||
163423164|NCT01763164|590253019|FG001|Treatment Phase|Adverse Event|8|||
163423165|NCT01763164|590253018|FG000|Treatment Phase|Randomized but not Treated|0|||
163423166|NCT01763164|590253019|FG001|Treatment Phase|Randomized but not Treated|19|||
163423167|NCT01763164|590253018|FG000|Treatment Phase|Other|0|||
163423168|NCT01763164|590253019|FG001|Treatment Phase|Other|1|||
163423169|NCT01763164|590253018|FG000|Follow up Phase|New therapy for study indication|12|||
163423170|NCT01763164|590253019|FG001|Follow up Phase|New therapy for study indication|3|||
163423171|NCT01763164|590253018|FG000|Follow up Phase|Death|21|||
163423172|NCT01763164|590253019|FG001|Follow up Phase|Death|4|||
163423173|NCT01763164|590253018|FG000|Follow up Phase|Subject/guardian decision|9|||
163423174|NCT01763164|590253019|FG001|Follow up Phase|Subject/guardian decision|2|||
163423175|NCT01763164|590253018|FG000|Follow up Phase|Progressive disease|127|||
163423176|NCT01763164|590253019|FG001|Follow up Phase|Progressive disease|62|||
163423177|NCT01763164|590253018|FG000|Follow up Phase|Physician Decision|10|||
163423178|NCT01763164|590253019|FG001|Follow up Phase|Physician Decision|3|||
163423179|NCT01763164|590253018|FG000|Follow up Phase|Lost to Follow-up|1|||
163423180|NCT01763164|590253019|FG001|Follow up Phase|Lost to Follow-up|0|||
163423181|NCT01763164|590253018|FG000|Follow up Phase|Adverse Event|17|||
163423182|NCT01763164|590253019|FG001|Follow up Phase|Adverse Event|1|||
163423183|NCT01264939|590253020|FG000|Overall Study|Adverse Event|1|||
163423184|NCT01264939|590253021|FG001|Overall Study|Adverse Event|3|||
163423185|NCT01264939|590253020|FG000|Overall Study|Lost to Follow-up|0|||
163423186|NCT01264939|590253021|FG001|Overall Study|Lost to Follow-up|3|||
163423187|NCT01264939|590253020|FG000|Overall Study|Physician Decision|1|||
163423188|NCT01264939|590253021|FG001|Overall Study|Physician Decision|1|||
163423189|NCT01264939|590253020|FG000|Overall Study|Patient/Guardian Decision|8|||
163423190|NCT01264939|590253021|FG001|Overall Study|Patient/Guardian Decision|10|||
163423191|NCT01264939|590253020|FG000|Overall Study|Disease Progression|8|||
163423192|NCT01264939|590253021|FG001|Overall Study|Disease Progression|11|||
163423193|NCT02965378|590253022|FG000|Overall Study|Progression|16|||
163423194|NCT02965378|590253023|FG001|Overall Study|Progression|4|||
163423195|NCT02965378|590253022|FG000|Overall Study|Adverse Event|5|||
163423196|NCT02965378|590253023|FG001|Overall Study|Adverse Event|2|||
163423197|NCT02965378|590253022|FG000|Overall Study|Death|2|||
163423198|NCT02965378|590253023|FG001|Overall Study|Death|0|||
163423199|NCT02965378|590253022|FG000|Overall Study|Refusal|2|||
163423200|NCT02965378|590253023|FG001|Overall Study|Refusal|1|||
163423201|NCT02965378|590253022|FG000|Overall Study|Not protocol specified|0|||
163423202|NCT02965378|590253023|FG001|Overall Study|Not protocol specified|2|||
163423203|NCT04964258|590253024|FG000|Overall Study|Lost to Follow-up|1|||
163423204|NCT04964258|590253025|FG001|Overall Study|Lost to Follow-up|0|||
163423205|NCT04964258|590253026|FG002|Overall Study|Lost to Follow-up|0|||
163423206|NCT04964258|590253027|FG003|Overall Study|Lost to Follow-up|0|||
163423207|NCT04964258|590253028|FG004|Overall Study|Lost to Follow-up|0|||
163423208|NCT04964258|590253029|FG005|Overall Study|Lost to Follow-up|1|||
163423209|NCT04964258|590253030|FG006|Overall Study|Lost to Follow-up|0|||
163423210|NCT04964258|590253031|FG007|Overall Study|Lost to Follow-up|0|||
163423211|NCT04964258|590253032|FG008|Overall Study|Lost to Follow-up|0|||
163423212|NCT04964258|590253033|FG009|Overall Study|Lost to Follow-up|0|||
163423213|NCT04964258|590253034|FG010|Overall Study|Lost to Follow-up|0|||
163423214|NCT01384292|590253037|FG000|Part B|Severe non-compliance to protocol|1|||
163423215|NCT01384292|590253038|FG001|Part B|Severe non-compliance to protocol|0|||
163423216|NCT01384292|590253039|FG002|Part B|Severe non-compliance to protocol|0|||
163423217|NCT01171612|590253041|FG000|Overall Study|Lost to Follow-up|51|||
163423218|NCT01285349|590253042|FG000|Overall Study|Lost to Follow-up|27|||
163423219|NCT01285349|590253043|FG001|Overall Study|Lost to Follow-up|20|||
163423220|NCT01285349|590253044|FG002|Overall Study|Lost to Follow-up|27|||
163423221|NCT00565617|590253045|FG000|Overall Study|Withdrawal by Subject|1|||
163423222|NCT03040024|590253046|FG000|Overall Study|Adverse Event|0|||
163423223|NCT03040024|590253047|FG001|Overall Study|Adverse Event|1|||
163423224|NCT03040024|590253048|FG002|Overall Study|Adverse Event|0|||
163423225|NCT03040024|590253046|FG000|Overall Study|Death|0|||
163423226|NCT03040024|590253047|FG001|Overall Study|Death|1|||
163423227|NCT03040024|590253048|FG002|Overall Study|Death|0|||
163423228|NCT03040024|590253046|FG000|Overall Study|Physician Decision|0|||
163423229|NCT03040024|590253047|FG001|Overall Study|Physician Decision|0|||
163423230|NCT03040024|590253048|FG002|Overall Study|Physician Decision|1|||
163423231|NCT01526148|590253050|FG000|Overall Study|Adverse Event|6|||
163423232|NCT01526148|590253051|FG001|Overall Study|Adverse Event|5|||
163423233|NCT01526148|590253050|FG000|Overall Study|Lost to Follow-up|3|||
163423234|NCT01526148|590253051|FG001|Overall Study|Lost to Follow-up|6|||
163423235|NCT01526148|590253050|FG000|Overall Study|Withdrawal by Subject|2|||
163423236|NCT01526148|590253051|FG001|Overall Study|Withdrawal by Subject|0|||
163423237|NCT01526148|590253050|FG000|Overall Study|Unstable Medical Condition|1|||
163423238|NCT01526148|590253051|FG001|Overall Study|Unstable Medical Condition|0|||
163423239|NCT01526148|590253050|FG000|Overall Study|Unable to discontinue concomitant med|1|||
163423240|NCT01526148|590253051|FG001|Overall Study|Unable to discontinue concomitant med|0|||
163423241|NCT01526148|590253050|FG000|Overall Study|Moved out of state|1|||
163423242|NCT01526148|590253051|FG001|Overall Study|Moved out of state|0|||
163423243|NCT01526148|590253050|FG000|Overall Study|Incarcerated|0|||
163423244|NCT01526148|590253051|FG001|Overall Study|Incarcerated|2|||
163423245|NCT01173653|590253052|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
163423246|NCT01173653|590253053|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
163423247|NCT03529409|590253064|FG000|Randomized|Lost to Follow-up|0|||
163423248|NCT03529409|590253065|FG001|Randomized|Lost to Follow-up|0|||
163423249|NCT03529409|590253066|FG002|Randomized|Lost to Follow-up|4|||
163423250|NCT03529409|590253064|FG000|Randomized|Excluded|0|||
163423251|NCT03529409|590253065|FG001|Randomized|Excluded|0|||
163423252|NCT03529409|590253066|FG002|Randomized|Excluded|1|||
163423253|NCT03529409|590253064|FG000|Post-treatment Assessment|Death|1|||
163423254|NCT03529409|590253065|FG001|Post-treatment Assessment|Death|0|||
163423255|NCT03529409|590253066|FG002|Post-treatment Assessment|Death|0|||
163423256|NCT03529409|590253064|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
163423257|NCT03529409|590253065|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
163423258|NCT03529409|590253066|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
163423259|NCT03529409|590253064|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
163423260|NCT03529409|590253065|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
163423261|NCT03529409|590253066|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
163423262|NCT03529409|590253064|FG000|Follow-up Assessment|Death|1|||
163423263|NCT03529409|590253065|FG001|Follow-up Assessment|Death|0|||
163423264|NCT03529409|590253066|FG002|Follow-up Assessment|Death|0|||
163423265|NCT03529409|590253064|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
163423266|NCT03529409|590253065|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
163423267|NCT03529409|590253066|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
163423268|NCT01497262|590253067|FG000|Overall Study|Abnormal Lab Values|4|||
163423269|NCT01497262|590253067|FG000|Overall Study|Abnormal Test Procedure Result|1|||
163423270|NCT01497262|590253067|FG000|Overall Study|Physician Decision|1|||
163423271|NCT01497262|590253067|FG000|Overall Study|Withdrawal by Subject|2|||
163423272|NCT01497262|590253067|FG000|Overall Study|Adverse Event|2|||
163423273|NCT01497262|590253067|FG000|Overall Study|Protocol Violation|1|||
163423274|NCT06001307|590254500|FG000|Overall Study|Lost to Follow-up|1|||
163423275|NCT06001307|590254501|FG001|Overall Study|Lost to Follow-up|2|||
163423276|NCT03532100|590254504|FG000|Overall Study|Intervention malfunction|1|||
163423277|NCT03896581|590254505|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
163423278|NCT03896581|590254506|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
163423279|NCT03896581|590254505|FG000|Overall Study|Withdrawal by Subject|4|||
163423280|NCT03896581|590254506|FG001|Overall Study|Withdrawal by Subject|1|||
163423281|NCT03896581|590254505|FG000|Overall Study|Lost to Follow-up|1|||
163423282|NCT03896581|590254506|FG001|Overall Study|Lost to Follow-up|0|||
163423283|NCT03896581|590254505|FG000|Overall Study|Lack of Efficacy|2|||
163423284|NCT03896581|590254506|FG001|Overall Study|Lack of Efficacy|1|||
163423285|NCT03896581|590254505|FG000|Overall Study|Adverse event, non-fatal|0|||
163423286|NCT03896581|590254506|FG001|Overall Study|Adverse event, non-fatal|2|||
163423287|NCT00162773|590254513|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
163423288|NCT02660580|590254518|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
163423289|NCT02660580|590254519|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
163423290|NCT02660580|590254520|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
163423291|NCT02660580|590254521|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
163423292|NCT02660580|590254522|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
163423293|NCT02660580|590254518|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
163423294|NCT02660580|590254519|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
163423295|NCT02660580|590254520|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
163423296|NCT02660580|590254521|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
163423297|NCT02660580|590254522|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
163423298|NCT02660580|590254518|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
163423299|NCT02660580|590254519|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
163423300|NCT02660580|590254520|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
163423301|NCT02660580|590254521|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
163423302|NCT02660580|590254522|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
163423303|NCT02660580|590254518|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
163423304|NCT02660580|590254519|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
163423305|NCT02660580|590254520|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
163423306|NCT02660580|590254521|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
163423307|NCT02660580|590254522|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
163423308|NCT02660580|590254518|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
163423309|NCT02660580|590254519|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
163423310|NCT02660580|590254520|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
163423311|NCT02660580|590254521|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
163423312|NCT02660580|590254522|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
163423313|NCT02660580|590254518|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
163423314|NCT02660580|590254519|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
163423315|NCT02660580|590254520|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
163423316|NCT02660580|590254521|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
163423317|NCT02660580|590254522|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
163423318|NCT02660580|590254518|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
163423319|NCT02660580|590254519|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
163423320|NCT02660580|590254520|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
163423321|NCT02660580|590254521|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
163423322|NCT02660580|590254522|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
163423323|NCT02660580|590254518|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
163423324|NCT02660580|590254519|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
163423325|NCT02660580|590254520|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
163423326|NCT02660580|590254521|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
163423327|NCT02660580|590254522|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
163423328|NCT02660580|590254518|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
163423329|NCT02660580|590254519|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
163423330|NCT02660580|590254520|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
163423331|NCT02660580|590254521|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
163423332|NCT02660580|590254522|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
163423333|NCT02660580|590254518|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
163423334|NCT02660580|590254519|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
163423335|NCT02660580|590254520|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
163423336|NCT02660580|590254521|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
163423337|NCT02660580|590254522|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
163423338|NCT02660580|590254518|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
163423339|NCT02660580|590254519|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
163423340|NCT02660580|590254520|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
163423341|NCT02660580|590254521|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
163423342|NCT02660580|590254522|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
163423343|NCT02660580|590254518|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
163423344|NCT02660580|590254519|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
163423345|NCT02660580|590254520|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
163423346|NCT02660580|590254521|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
163423347|NCT02660580|590254522|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
163423348|NCT02660580|590254518|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
163423349|NCT02660580|590254519|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
163423350|NCT02660580|590254520|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
163423351|NCT02660580|590254521|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
163423352|NCT02660580|590254522|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
163423353|NCT05415449|590254523|FG000|Overall Study|Lost to Follow-up|2|||
163423354|NCT05415449|590254523|FG000|Overall Study|Withdrawal by Subject|4|||
163423355|NCT02185521|590254526|FG000|Overall Study|Withdrawal by Subject|1|||
163423356|NCT02185521|590254526|FG000|Overall Study|Protocol Violation|1|||
163423357|NCT01028352|590254530|FG000|Overall Study|Ineligible due to baseline average pain|5|||
163423358|NCT01028352|590254530|FG000|Overall Study|Withdrawal by Subject|1|||
163423359|NCT01903876|590254531|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
163423360|NCT01903876|590254532|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
163423361|NCT01903876|590254531|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
163423362|NCT01903876|590254532|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
163423363|NCT00826748|590254543|FG000|Overall Study|Withdrawal by Subject|0|||
163423364|NCT00826748|590254544|FG001|Overall Study|Withdrawal by Subject|0|||
163423365|NCT00826748|590254545|FG002|Overall Study|Withdrawal by Subject|2|||
163423366|NCT00826748|590254543|FG000|Overall Study|Physician Decision|0|||
163423367|NCT00826748|590254544|FG001|Overall Study|Physician Decision|0|||
163423368|NCT00826748|590254545|FG002|Overall Study|Physician Decision|1|||
163423369|NCT00826748|590254543|FG000|Overall Study|Samples Did Not pass QC|0|||
163423370|NCT00826748|590254544|FG001|Overall Study|Samples Did Not pass QC|0|||
163423371|NCT00826748|590254545|FG002|Overall Study|Samples Did Not pass QC|1|||
163423372|NCT02300129|590254547|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
163423373|NCT02300129|590254548|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
163423374|NCT02300129|590254549|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
163423375|NCT02300129|590254550|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
163423376|NCT02300129|590254547|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
163423377|NCT02300129|590254548|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
163423378|NCT02300129|590254549|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
163423379|NCT02300129|590254550|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
163423380|NCT02300129|590254547|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
163423381|NCT02300129|590254548|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
163423382|NCT02300129|590254549|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
163423383|NCT02300129|590254550|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
163423384|NCT01887912|590254551|FG000|Overall Study|Serious adverse event|400|||
163423385|NCT01887912|590254552|FG001|Overall Study|Serious adverse event|198|||
163423386|NCT01887912|590254551|FG000|Overall Study|Other Adverse Event|34|||
163423387|NCT01887912|590254552|FG001|Overall Study|Other Adverse Event|15|||
163423388|NCT01887912|590254551|FG000|Overall Study|Protocol Violation|67|||
163423389|NCT01887912|590254552|FG001|Overall Study|Protocol Violation|37|||
163423390|NCT01887912|590254551|FG000|Overall Study|Lost to Follow-up|163|||
163423391|NCT01887912|590254552|FG001|Overall Study|Lost to Follow-up|74|||
163423392|NCT01887912|590254551|FG000|Overall Study|Withdrawal by Subject|606|||
163423393|NCT01887912|590254552|FG001|Overall Study|Withdrawal by Subject|349|||
163423394|NCT01887912|590254551|FG000|Overall Study|Other|122|||
163423395|NCT01887912|590254552|FG001|Overall Study|Other|58|||
163423396|NCT04462536|590254553|FG000|Overall Study|Withdrawal by Subject|3|||
163423397|NCT04462536|590254554|FG001|Overall Study|Withdrawal by Subject|9|||
163423398|NCT04462536|590254553|FG000|Overall Study|Lost to Follow-up|2|||
163423399|NCT04462536|590254554|FG001|Overall Study|Lost to Follow-up|4|||
163423400|NCT02747927|590254555|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
163423401|NCT02747927|590254556|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
163423402|NCT02747927|590254555|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
163423403|NCT02747927|590254556|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
163423404|NCT02747927|590254555|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
163423405|NCT02747927|590254556|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
163423406|NCT02747927|590254555|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
163423407|NCT02747927|590254556|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
163423408|NCT02747927|590254555|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
163423409|NCT02747927|590254556|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
163423410|NCT02747927|590254555|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
163423411|NCT02747927|590254556|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
163423412|NCT02747927|590254555|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
163423413|NCT02747927|590254556|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
163423414|NCT02747927|590254555|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
163423415|NCT02747927|590254556|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
163423416|NCT02747927|590254555|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
163423417|NCT02747927|590254556|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
163423418|NCT02747927|590254555|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
163423419|NCT02747927|590254556|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
163423420|NCT02747927|590254555|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
163423421|NCT02747927|590254556|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
163423422|NCT02747927|590254555|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
163423423|NCT02747927|590254556|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
163423424|NCT02747927|590254555|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
163423425|NCT02747927|590254556|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
163423426|NCT02747927|590254555|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
163423427|NCT02747927|590254556|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
163423428|NCT02747927|590254555|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
163423429|NCT02747927|590254556|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
163423430|NCT02747927|590254555|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
163423431|NCT02747927|590254556|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
163423432|NCT02747927|590254555|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
163423433|NCT02747927|590254556|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
163423434|NCT02747927|590254555|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
163423435|NCT02747927|590254556|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
163423436|NCT02747927|590254555|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
163423437|NCT02747927|590254556|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
163423438|NCT02747927|590254555|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
163423439|NCT02747927|590254556|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
163423440|NCT02747927|590254555|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
163423441|NCT02747927|590254556|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
163423442|NCT02747927|590254555|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
163423443|NCT02747927|590254556|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
163423444|NCT02747927|590254555|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
163423445|NCT02747927|590254556|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
163423446|NCT02747927|590254555|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
163423447|NCT02747927|590254556|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
163423448|NCT02747927|590254555|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
163423449|NCT02747927|590254556|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
163423450|NCT02747927|590254555|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
163423451|NCT02747927|590254556|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
163423452|NCT02747927|590254555|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
163423453|NCT02747927|590254556|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
163423454|NCT02747927|590254555|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
163423455|NCT02747927|590254556|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
163423456|NCT02747927|590254555|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
163423457|NCT02747927|590254556|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
163423458|NCT02747927|590254555|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
163423459|NCT02747927|590254556|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
163423460|NCT02747927|590254555|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
163423461|NCT02747927|590254556|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
163423462|NCT02747927|590254555|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
163423463|NCT02747927|590254556|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
163423464|NCT00450580|590254559|FG000|Overall Study|Adverse Event|5|||
163423465|NCT00450580|590254560|FG001|Overall Study|Adverse Event|7|||
163423466|NCT00450580|590254559|FG000|Overall Study|Lost to Follow-up|4|||
163423467|NCT00450580|590254560|FG001|Overall Study|Lost to Follow-up|5|||
163423468|NCT00450580|590254559|FG000|Overall Study|Withdrawal by Subject|2|||
163423469|NCT00450580|590254560|FG001|Overall Study|Withdrawal by Subject|2|||
163423470|NCT00450580|590254559|FG000|Overall Study|Protocol Violation|1|||
163423471|NCT00450580|590254560|FG001|Overall Study|Protocol Violation|1|||
163423472|NCT00450580|590254559|FG000|Overall Study|Protocol-defined virologic failure|1|||
163423473|NCT00450580|590254560|FG001|Overall Study|Protocol-defined virologic failure|0|||
163423474|NCT00450580|590254559|FG000|Overall Study|Could not comply with scheduled visits|1|||
163423475|NCT00450580|590254560|FG001|Overall Study|Could not comply with scheduled visits|0|||
163423476|NCT00450580|590254559|FG000|Overall Study|Patient went to Brazil|1|||
163423477|NCT00450580|590254560|FG001|Overall Study|Patient went to Brazil|0|||
163423478|NCT00450580|590254559|FG000|Overall Study|Patient could not swallow Norvir|1|||
163423479|NCT00450580|590254560|FG001|Overall Study|Patient could not swallow Norvir|0|||
163423480|NCT00450580|590254559|FG000|Overall Study|Withdrawal due to pregnancy|0|||
163423481|NCT00450580|590254560|FG001|Overall Study|Withdrawal due to pregnancy|1|||
163423482|NCT00332709|590254569|FG000|Overall Study|Adverse Event|11|||
163423483|NCT00332709|590254570|FG001|Overall Study|Adverse Event|14|||
163423484|NCT00332709|590254569|FG000|Overall Study|Withdrawal by Subject|2|||
163423485|NCT00332709|590254570|FG001|Overall Study|Withdrawal by Subject|3|||
163423486|NCT00332709|590254569|FG000|Overall Study|Lost to Follow-up|2|||
163423487|NCT00332709|590254570|FG001|Overall Study|Lost to Follow-up|0|||
163423488|NCT00332709|590254569|FG000|Overall Study|Administrative Problems|0|||
163423489|NCT00332709|590254570|FG001|Overall Study|Administrative Problems|3|||
163423490|NCT00332709|590254569|FG000|Overall Study|Abnormal test procedure result|1|||
163423491|NCT00332709|590254570|FG001|Overall Study|Abnormal test procedure result|0|||
163423492|NCT03480802|590254571|FG000|Overall Study|Lost to Follow-up|5|||
163423493|NCT03480802|590254572|FG001|Overall Study|Lost to Follow-up|1|||
163423494|NCT03480802|590254571|FG000|Overall Study|Withdrawal by Subject|2|||
163423495|NCT03480802|590254572|FG001|Overall Study|Withdrawal by Subject|1|||
163423496|NCT03480802|590254571|FG000|Overall Study|Relocated|0|||
163423497|NCT03480802|590254572|FG001|Overall Study|Relocated|1|||
163423498|NCT01409928|590254573|FG000|Overall Study|Physician Decision|12|||
163423499|NCT00988247|590254574|FG000|Overall Study|Adverse Event|17|||
163423500|NCT00988247|590254575|FG001|Overall Study|Adverse Event|3|||
163423501|NCT00988247|590254574|FG000|Overall Study|Withdrawal by Subject|44|||
163423502|NCT00988247|590254575|FG001|Overall Study|Withdrawal by Subject|13|||
163423503|NCT00988247|590254574|FG000|Overall Study|Pregnancy|1|||
163423504|NCT00988247|590254575|FG001|Overall Study|Pregnancy|2|||
163423505|NCT00988247|590254574|FG000|Overall Study|Lost to Follow-up|11|||
163423506|NCT00988247|590254575|FG001|Overall Study|Lost to Follow-up|2|||
163423507|NCT00988247|590254574|FG000|Overall Study|Protocol Violation|4|||
163423508|NCT00988247|590254575|FG001|Overall Study|Protocol Violation|5|||
163423509|NCT00988247|590254574|FG000|Overall Study|Sponsor requested withdrawal|3|||
163423510|NCT00988247|590254575|FG001|Overall Study|Sponsor requested withdrawal|1|||
163423511|NCT00988247|590254574|FG000|Overall Study|Other|3|||
163423512|NCT00988247|590254575|FG001|Overall Study|Other|0|||
163423513|NCT02661594|590254576|FG000|Overall Study|Protocol Violation|1|||
163423514|NCT02661594|590254577|FG001|Overall Study|Protocol Violation|0|||
163423515|NCT02661594|590254578|FG002|Overall Study|Protocol Violation|1|||
163423516|NCT02661594|590254579|FG003|Overall Study|Protocol Violation|0|||
163423517|NCT01169779|590254584|FG000|Overall Study|Adverse Event|3|||
163423518|NCT01169779|590254585|FG001|Overall Study|Adverse Event|11|||
163423519|NCT01169779|590254584|FG000|Overall Study|Lack of Efficacy|1|||
163423520|NCT01169779|590254585|FG001|Overall Study|Lack of Efficacy|0|||
163423521|NCT01169779|590254584|FG000|Overall Study|Protocol Violation|1|||
163423522|NCT01169779|590254585|FG001|Overall Study|Protocol Violation|1|||
163423523|NCT01169779|590254584|FG000|Overall Study|Withdrawal by Subject|3|||
163423524|NCT01169779|590254585|FG001|Overall Study|Withdrawal by Subject|2|||
163423525|NCT01169779|590254584|FG000|Overall Study|Familial and personal reasons|3|||
163423526|NCT01169779|590254585|FG001|Overall Study|Familial and personal reasons|3|||
163423527|NCT00432237|590254588|FG000|Overall Study|Adverse Event|0|||
163423528|NCT00432237|590254589|FG001|Overall Study|Adverse Event|0|||
163423529|NCT00432237|590254590|FG002|Overall Study|Adverse Event|0|||
163423530|NCT00432237|590254591|FG003|Overall Study|Adverse Event|1|||
163423531|NCT00432237|590254588|FG000|Overall Study|Lack of Efficacy|0|||
163423532|NCT00432237|590254589|FG001|Overall Study|Lack of Efficacy|0|||
163423533|NCT00432237|590254590|FG002|Overall Study|Lack of Efficacy|0|||
163423534|NCT00432237|590254591|FG003|Overall Study|Lack of Efficacy|1|||
163423535|NCT00432237|590254588|FG000|Overall Study|Lost to Follow-up|10|||
163423536|NCT00432237|590254589|FG001|Overall Study|Lost to Follow-up|10|||
163423537|NCT00432237|590254590|FG002|Overall Study|Lost to Follow-up|18|||
163423538|NCT00432237|590254591|FG003|Overall Study|Lost to Follow-up|18|||
163423539|NCT00432237|590254588|FG000|Overall Study|Physician Decision|1|||
163423540|NCT00432237|590254589|FG001|Overall Study|Physician Decision|3|||
163423541|NCT00432237|590254590|FG002|Overall Study|Physician Decision|2|||
163423542|NCT00432237|590254591|FG003|Overall Study|Physician Decision|1|||
163423543|NCT00432237|590254588|FG000|Overall Study|Pregnancy|0|||
163423544|NCT00432237|590254589|FG001|Overall Study|Pregnancy|1|||
163423545|NCT00432237|590254590|FG002|Overall Study|Pregnancy|0|||
163423546|NCT00432237|590254591|FG003|Overall Study|Pregnancy|0|||
163423547|NCT00432237|590254588|FG000|Overall Study|Protocol Violation|13|||
163423548|NCT00432237|590254589|FG001|Overall Study|Protocol Violation|10|||
163423549|NCT00432237|590254590|FG002|Overall Study|Protocol Violation|11|||
163423550|NCT00432237|590254591|FG003|Overall Study|Protocol Violation|8|||
163423551|NCT00432237|590254588|FG000|Overall Study|Withdrawal by Subject|5|||
163423552|NCT00432237|590254589|FG001|Overall Study|Withdrawal by Subject|6|||
163423553|NCT00432237|590254590|FG002|Overall Study|Withdrawal by Subject|9|||
163423554|NCT00432237|590254591|FG003|Overall Study|Withdrawal by Subject|11|||
163423555|NCT00432237|590254588|FG000|Overall Study|Lack of Qualifying Event|38|||
163423556|NCT00432237|590254589|FG001|Overall Study|Lack of Qualifying Event|71|||
163423557|NCT00432237|590254590|FG002|Overall Study|Lack of Qualifying Event|69|||
163423558|NCT00432237|590254591|FG003|Overall Study|Lack of Qualifying Event|84|||
163423559|NCT01354132|590254592|FG000|Randomization|Physician Decision|1|||
163423560|NCT01354132|590254593|FG001|Randomization|Physician Decision|0|||
163423561|NCT01354132|590254592|FG000|Randomization|Withdrawal by Subject|0|||
163423562|NCT01354132|590254593|FG001|Randomization|Withdrawal by Subject|1|||
163423563|NCT01354132|590254592|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
163423564|NCT01354132|590254593|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
163423565|NCT01354132|590254592|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
163423566|NCT01354132|590254593|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
163423567|NCT01354132|590254592|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
163423568|NCT01354132|590254593|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
163423569|NCT00191854|590254596|FG000|Overall Study|Death|26|||
163423570|NCT00191854|590254597|FG001|Overall Study|Death|23|||
163423571|NCT00191854|590254598|FG002|Overall Study|Death|29|||
163423572|NCT00191854|590254596|FG000|Overall Study|Lost to Follow-up|7|||
163423573|NCT00191854|590254597|FG001|Overall Study|Lost to Follow-up|5|||
163423574|NCT00191854|590254598|FG002|Overall Study|Lost to Follow-up|5|||
163423575|NCT00191854|590254596|FG000|Overall Study|Withdrawal by Subject|4|||
163423576|NCT00191854|590254597|FG001|Overall Study|Withdrawal by Subject|2|||
163423577|NCT00191854|590254598|FG002|Overall Study|Withdrawal by Subject|3|||
163423578|NCT00191854|590254596|FG000|Overall Study|Sponsor Decision|0|||
163423579|NCT00191854|590254597|FG001|Overall Study|Sponsor Decision|0|||
163423580|NCT00191854|590254598|FG002|Overall Study|Sponsor Decision|1|||
163423581|NCT00191854|590254596|FG000|Overall Study|Screen Failure|0|||
163423582|NCT00191854|590254597|FG001|Overall Study|Screen Failure|0|||
163423583|NCT00191854|590254598|FG002|Overall Study|Screen Failure|1|||
163423584|NCT03898063|590254601|FG000|Overall Study|Withdrawal by Subject|10|||
163423585|NCT03898063|590254602|FG001|Overall Study|Withdrawal by Subject|8|||
163423586|NCT03430986|590254603|FG000|24-week Control Period|Adverse Event|1|||
163423587|NCT03430986|590254604|FG001|24-week Control Period|Adverse Event|0|||
163423588|NCT03430986|590254603|FG000|24-week Control Period|Lost to Follow-up|2|||
163423589|NCT03430986|590254604|FG001|24-week Control Period|Lost to Follow-up|2|||
163423590|NCT03430986|590254603|FG000|24-week Control Period|Withdrawal by Participant|5|||
163423591|NCT03430986|590254604|FG001|24-week Control Period|Withdrawal by Participant|0|||
163423592|NCT03430986|590254603|FG000|24-week Control Period|Protocol Deviation|0|||
163423593|NCT03430986|590254604|FG001|24-week Control Period|Protocol Deviation|2|||
163423594|NCT03430986|590254603|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
163423595|NCT03430986|590254604|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
163423596|NCT03430986|590254603|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
163423597|NCT03430986|590254604|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
163423598|NCT01889602|590254608|FG000|First Intervention|Adverse Event|1|||
163423599|NCT01889602|590254609|FG001|First Intervention|Adverse Event|1|||
163423600|NCT01889602|590254610|FG002|First Intervention|Adverse Event|1|||
163423601|NCT01889602|590254608|FG000|First Intervention|Protocol Violation|0|||
163423602|NCT01889602|590254609|FG001|First Intervention|Protocol Violation|1|||
163423603|NCT01889602|590254610|FG002|First Intervention|Protocol Violation|1|||
163423604|NCT01889602|590254608|FG000|First Intervention|Study ending|0|||
163423605|NCT01889602|590254609|FG001|First Intervention|Study ending|1|||
163423606|NCT01889602|590254610|FG002|First Intervention|Study ending|0|||
163423607|NCT01889602|590254608|FG000|Second Intervention|Adverse Event|0|||
163423608|NCT01889602|590254609|FG001|Second Intervention|Adverse Event|0|||
163423609|NCT01889602|590254610|FG002|Second Intervention|Adverse Event|1|||
163423610|NCT01889602|590254608|FG000|Second Intervention|Study ending|1|||
163423611|NCT01889602|590254609|FG001|Second Intervention|Study ending|0|||
163423612|NCT01889602|590254610|FG002|Second Intervention|Study ending|0|||
163423613|NCT01889602|590254608|FG000|Second Intervention|Withdrawal by Subject|0|||
163423614|NCT01889602|590254609|FG001|Second Intervention|Withdrawal by Subject|0|||
163423615|NCT01889602|590254610|FG002|Second Intervention|Withdrawal by Subject|1|||
163423616|NCT01889602|590254608|FG000|Third Intervention|Protocol Violation|1|||
163423617|NCT01889602|590254609|FG001|Third Intervention|Protocol Violation|0|||
163423618|NCT01889602|590254610|FG002|Third Intervention|Protocol Violation|0|||
163423619|NCT01889602|590254608|FG000|Third Intervention|Withdrawal by Subject|2|||
163423620|NCT01889602|590254609|FG001|Third Intervention|Withdrawal by Subject|2|||
163423621|NCT01889602|590254610|FG002|Third Intervention|Withdrawal by Subject|0|||
163423622|NCT00961961|590254611|FG000|Phase I|Withdrawal by Subject|7|||
163423623|NCT00961961|590254612|FG001|Phase I|Withdrawal by Subject|0|||
163423624|NCT00961961|590254613|FG002|Phase I|Withdrawal by Subject|0|||
163423625|NCT00961961|590254614|FG003|Phase I|Withdrawal by Subject|0|||
163423626|NCT00961961|590254611|FG000|Phase I|Lost to Follow-up|10|||
163423627|NCT00961961|590254612|FG001|Phase I|Lost to Follow-up|0|||
163423628|NCT00961961|590254613|FG002|Phase I|Lost to Follow-up|0|||
163423629|NCT00961961|590254614|FG003|Phase I|Lost to Follow-up|0|||
163423630|NCT00961961|590254611|FG000|Phase I|Lack of Efficacy|94|||
163423631|NCT00961961|590254612|FG001|Phase I|Lack of Efficacy|0|||
163423632|NCT00961961|590254613|FG002|Phase I|Lack of Efficacy|0|||
163423633|NCT00961961|590254614|FG003|Phase I|Lack of Efficacy|0|||
163423634|NCT00961961|590254611|FG000|Phase I|Adverse Event|7|||
163423635|NCT00961961|590254612|FG001|Phase I|Adverse Event|0|||
163423636|NCT00961961|590254613|FG002|Phase I|Adverse Event|0|||
163423637|NCT00961961|590254614|FG003|Phase I|Adverse Event|0|||
163423638|NCT00961961|590254611|FG000|Phase I|Physician Decision|8|||
163423639|NCT00961961|590254612|FG001|Phase I|Physician Decision|0|||
163423640|NCT00961961|590254613|FG002|Phase I|Physician Decision|0|||
163423641|NCT00961961|590254614|FG003|Phase I|Physician Decision|0|||
163423642|NCT00961961|590254611|FG000|Phase II|Lost to Follow-up|0|||
163423643|NCT00961961|590254612|FG001|Phase II|Lost to Follow-up|0|||
163423644|NCT00961961|590254613|FG002|Phase II|Lost to Follow-up|10|||
163423645|NCT00961961|590254614|FG003|Phase II|Lost to Follow-up|7|||
163423646|NCT00961961|590254611|FG000|Phase II|Adverse Event|0|||
163423647|NCT00961961|590254612|FG001|Phase II|Adverse Event|0|||
163423648|NCT00961961|590254613|FG002|Phase II|Adverse Event|0|||
163423649|NCT00961961|590254614|FG003|Phase II|Adverse Event|1|||
163423650|NCT00961961|590254611|FG000|Phase II|Physician Decision|0|||
163423651|NCT00961961|590254612|FG001|Phase II|Physician Decision|0|||
163423652|NCT00961961|590254613|FG002|Phase II|Physician Decision|1|||
163423653|NCT00961961|590254614|FG003|Phase II|Physician Decision|0|||
163423654|NCT00961961|590254611|FG000|Phase II|Withdrawal by Subject|0|||
163423655|NCT00961961|590254612|FG001|Phase II|Withdrawal by Subject|0|||
163423656|NCT00961961|590254613|FG002|Phase II|Withdrawal by Subject|1|||
163423657|NCT00961961|590254614|FG003|Phase II|Withdrawal by Subject|0|||
163423658|NCT01412957|590254615|FG000|Overall Study|Withdrawal by Subject|6|||
163423659|NCT01412957|590254616|FG001|Overall Study|Withdrawal by Subject|22|||
163423660|NCT01412957|590254615|FG000|Overall Study|Lost to Follow-up|7|||
163423661|NCT01412957|590254616|FG001|Overall Study|Lost to Follow-up|2|||
163423662|NCT01412957|590254615|FG000|Overall Study|Death|136|||
163423663|NCT01412957|590254616|FG001|Overall Study|Death|133|||
163423664|NCT01926626|590254636|FG000|Overall Study|Withdrawal by Subject|15|||
163423665|NCT01926626|590254636|FG000|Overall Study|Lost to Follow-up|7|||
163423666|NCT03636906|590254637|FG000|Overall Study|Adverse Event|0|||
163423667|NCT03636906|590254638|FG001|Overall Study|Adverse Event|0|||
163423668|NCT03636906|590254639|FG002|Overall Study|Adverse Event|1|||
163423669|NCT03636906|590254637|FG000|Overall Study|Lost to Follow-up|1|||
163423670|NCT03636906|590254638|FG001|Overall Study|Lost to Follow-up|0|||
163423671|NCT03636906|590254639|FG002|Overall Study|Lost to Follow-up|0|||
163423672|NCT03636906|590254637|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
163424285|NCT01756456|590258223|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
163423673|NCT03636906|590254638|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
163423674|NCT03636906|590254639|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
163423675|NCT03636906|590254637|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
163423676|NCT03636906|590254638|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163423677|NCT03636906|590254639|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
163423678|NCT03636906|590254637|FG000|Overall Study|Other|0|||
163423679|NCT03636906|590254638|FG001|Overall Study|Other|0|||
163423680|NCT03636906|590254639|FG002|Overall Study|Other|1|||
163423681|NCT02292771|590254645|FG000|Overall Study|Withdrawal by Subject|2|||
163423682|NCT02292771|590254646|FG001|Overall Study|Withdrawal by Subject|1|||
163423683|NCT02292771|590254645|FG000|Overall Study|Lost to Follow-up|2|||
163423684|NCT02292771|590254646|FG001|Overall Study|Lost to Follow-up|1|||
163423685|NCT04280081|590254648|FG000|Overall Study|Adverse Event|4|||
163423686|NCT04280081|590254648|FG000|Overall Study|Death|2|||
163423687|NCT04280081|590254648|FG000|Overall Study|Progressive Disease|6|||
163423688|NCT01468311|590254649|FG000|Overall Study|mobilization failure|1|||
163423689|NCT01468311|590254649|FG000|Overall Study|Withdrawal by Subject|1|||
163423690|NCT04854499|590256163|FG000|Overall Study|Study Terminated by Sponsor|5|||
163423691|NCT04854499|590256164|FG001|Overall Study|Study Terminated by Sponsor|27|||
163423692|NCT04854499|590256165|FG002|Overall Study|Study Terminated by Sponsor|28|||
163423693|NCT04854499|590256166|FG003|Overall Study|Study Terminated by Sponsor|19|||
163423694|NCT04854499|590256167|FG004|Overall Study|Study Terminated by Sponsor|1|||
163423695|NCT04854499|590256168|FG005|Overall Study|Study Terminated by Sponsor|10|||
163423696|NCT04854499|590256163|FG000|Overall Study|Death|1|||
163423697|NCT04854499|590256164|FG001|Overall Study|Death|23|||
163423698|NCT04854499|590256165|FG002|Overall Study|Death|21|||
163423699|NCT04854499|590256166|FG003|Overall Study|Death|7|||
163423700|NCT04854499|590256167|FG004|Overall Study|Death|6|||
163423701|NCT04854499|590256168|FG005|Overall Study|Death|24|||
163423702|NCT04854499|590256163|FG000|Overall Study|Investigator's Discretion|0|||
163423703|NCT04854499|590256164|FG001|Overall Study|Investigator's Discretion|1|||
163423704|NCT04854499|590256165|FG002|Overall Study|Investigator's Discretion|3|||
163423705|NCT04854499|590256166|FG003|Overall Study|Investigator's Discretion|4|||
163423706|NCT04854499|590256167|FG004|Overall Study|Investigator's Discretion|1|||
163423707|NCT04854499|590256168|FG005|Overall Study|Investigator's Discretion|5|||
163423708|NCT04854499|590256163|FG000|Overall Study|Withdrew Consent|0|||
163423709|NCT04854499|590256164|FG001|Overall Study|Withdrew Consent|1|||
163423710|NCT04854499|590256165|FG002|Overall Study|Withdrew Consent|2|||
163423711|NCT04854499|590256166|FG003|Overall Study|Withdrew Consent|2|||
163423712|NCT04854499|590256167|FG004|Overall Study|Withdrew Consent|0|||
163423713|NCT04854499|590256168|FG005|Overall Study|Withdrew Consent|1|||
163423714|NCT04854499|590256163|FG000|Overall Study|Lost to Follow-up|0|||
163423715|NCT04854499|590256164|FG001|Overall Study|Lost to Follow-up|0|||
163423716|NCT04854499|590256165|FG002|Overall Study|Lost to Follow-up|0|||
163423717|NCT04854499|590256166|FG003|Overall Study|Lost to Follow-up|0|||
163423718|NCT04854499|590256167|FG004|Overall Study|Lost to Follow-up|0|||
163423719|NCT04854499|590256168|FG005|Overall Study|Lost to Follow-up|1|||
163423720|NCT01933932|590256175|FG000|Overall Study|Death|173|||
163423721|NCT01933932|590256176|FG001|Overall Study|Death|163|||
163423722|NCT01933932|590256175|FG000|Overall Study|Withdrawal by Subject|11|||
163423723|NCT01933932|590256176|FG001|Overall Study|Withdrawal by Subject|14|||
163423724|NCT01933932|590256175|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163423725|NCT01933932|590256176|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163423726|NCT02601950|590256177|FG000|Overall Study|Participant enrolled in rollover study|0|||
163423727|NCT02601950|590256178|FG001|Overall Study|Participant enrolled in rollover study|0|||
163423728|NCT02601950|590256179|FG002|Overall Study|Participant enrolled in rollover study|1|||
163423729|NCT02601950|590256180|FG003|Overall Study|Participant enrolled in rollover study|0|||
163423730|NCT02601950|590256181|FG004|Overall Study|Participant enrolled in rollover study|1|||
163423731|NCT02601950|590256182|FG005|Overall Study|Participant enrolled in rollover study|1|||
163423732|NCT02601950|590256183|FG006|Overall Study|Participant enrolled in rollover study|1|||
163423733|NCT02601950|590256184|FG007|Overall Study|Participant enrolled in rollover study|0|||
163423734|NCT02601950|590256177|FG000|Overall Study|Disease progression - radiological|21|||
163423735|NCT02601950|590256178|FG001|Overall Study|Disease progression - radiological|26|||
163423736|NCT02601950|590256179|FG002|Overall Study|Disease progression - radiological|22|||
163423737|NCT02601950|590256180|FG003|Overall Study|Disease progression - radiological|11|||
163423738|NCT02601950|590256181|FG004|Overall Study|Disease progression - radiological|46|||
163423739|NCT02601950|590256182|FG005|Overall Study|Disease progression - radiological|52|||
163423740|NCT02601950|590256183|FG006|Overall Study|Disease progression - radiological|7|||
163423741|NCT02601950|590256184|FG007|Overall Study|Disease progression - radiological|5|||
163423742|NCT02601950|590256177|FG000|Overall Study|Disease progression - clinical|3|||
163423743|NCT02601950|590256178|FG001|Overall Study|Disease progression - clinical|5|||
163423744|NCT02601950|590256179|FG002|Overall Study|Disease progression - clinical|4|||
163423745|NCT02601950|590256180|FG003|Overall Study|Disease progression - clinical|2|||
163423746|NCT02601950|590256181|FG004|Overall Study|Disease progression - clinical|6|||
163423747|NCT02601950|590256182|FG005|Overall Study|Disease progression - clinical|6|||
163423748|NCT02601950|590256183|FG006|Overall Study|Disease progression - clinical|5|||
163423749|NCT02601950|590256184|FG007|Overall Study|Disease progression - clinical|1|||
163423750|NCT02601950|590256177|FG000|Overall Study|Death|6|||
163423751|NCT02601950|590256178|FG001|Overall Study|Death|0|||
163423752|NCT02601950|590256179|FG002|Overall Study|Death|3|||
163423753|NCT02601950|590256180|FG003|Overall Study|Death|1|||
163423754|NCT02601950|590256181|FG004|Overall Study|Death|4|||
163423755|NCT02601950|590256182|FG005|Overall Study|Death|1|||
163423756|NCT02601950|590256183|FG006|Overall Study|Death|0|||
163423757|NCT02601950|590256184|FG007|Overall Study|Death|0|||
163423758|NCT02601950|590256177|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
163423759|NCT02601950|590256178|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
163423760|NCT02601950|590256179|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
163423761|NCT02601950|590256180|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
163423762|NCT02601950|590256181|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
163423763|NCT02601950|590256182|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
163423764|NCT02601950|590256183|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
163423765|NCT02601950|590256184|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
163423766|NCT02601950|590256177|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
163423767|NCT02601950|590256178|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
163423768|NCT02601950|590256179|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
163423769|NCT02601950|590256180|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
163423770|NCT02601950|590256181|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
163423771|NCT02601950|590256182|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
163423772|NCT02601950|590256183|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
163423773|NCT02601950|590256184|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
163423774|NCT02601950|590256177|FG000|Overall Study|Non-compliance|0|||
163423775|NCT02601950|590256178|FG001|Overall Study|Non-compliance|1|||
163423776|NCT02601950|590256179|FG002|Overall Study|Non-compliance|0|||
163423777|NCT02601950|590256180|FG003|Overall Study|Non-compliance|0|||
163423778|NCT02601950|590256181|FG004|Overall Study|Non-compliance|0|||
163423779|NCT02601950|590256182|FG005|Overall Study|Non-compliance|1|||
163423780|NCT02601950|590256183|FG006|Overall Study|Non-compliance|1|||
163423781|NCT02601950|590256184|FG007|Overall Study|Non-compliance|0|||
163423782|NCT02601950|590256177|FG000|Overall Study|Participant refused further study treatment|0|||
163423783|NCT02601950|590256178|FG001|Overall Study|Participant refused further study treatment|1|||
163423784|NCT02601950|590256179|FG002|Overall Study|Participant refused further study treatment|1|||
163423785|NCT02601950|590256180|FG003|Overall Study|Participant refused further study treatment|0|||
163423786|NCT02601950|590256181|FG004|Overall Study|Participant refused further study treatment|2|||
163423787|NCT02601950|590256182|FG005|Overall Study|Participant refused further study treatment|2|||
163423788|NCT02601950|590256183|FG006|Overall Study|Participant refused further study treatment|2|||
163423789|NCT02601950|590256184|FG007|Overall Study|Participant refused further study treatment|1|||
163423790|NCT02601950|590256177|FG000|Overall Study|Investigator discretion|1|||
163423791|NCT02601950|590256178|FG001|Overall Study|Investigator discretion|0|||
163423792|NCT02601950|590256179|FG002|Overall Study|Investigator discretion|1|||
163423793|NCT02601950|590256180|FG003|Overall Study|Investigator discretion|0|||
163423794|NCT02601950|590256181|FG004|Overall Study|Investigator discretion|1|||
163423795|NCT02601950|590256182|FG005|Overall Study|Investigator discretion|1|||
163423796|NCT02601950|590256183|FG006|Overall Study|Investigator discretion|1|||
163423797|NCT02601950|590256184|FG007|Overall Study|Investigator discretion|0|||
163423798|NCT02601950|590256177|FG000|Overall Study|Other|0|||
163423799|NCT02601950|590256178|FG001|Overall Study|Other|0|||
163423800|NCT02601950|590256179|FG002|Overall Study|Other|0|||
163423801|NCT02601950|590256180|FG003|Overall Study|Other|0|||
163423802|NCT02601950|590256181|FG004|Overall Study|Other|2|||
163423803|NCT02601950|590256182|FG005|Overall Study|Other|2|||
163423804|NCT02601950|590256183|FG006|Overall Study|Other|1|||
163423805|NCT02601950|590256184|FG007|Overall Study|Other|0|||
163423806|NCT02157883|590256185|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
163423807|NCT02157883|590256185|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
163423808|NCT02157883|590256185|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
163423809|NCT02157883|590256185|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
163423810|NCT02157883|590256185|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
163423811|NCT01701258|590256186|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
163423812|NCT01701258|590256187|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
163423813|NCT01701258|590256188|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
163423814|NCT01701258|590256189|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
163423815|NCT01701258|590256190|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
163423816|NCT01701258|590256191|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
163423817|NCT01701258|590256192|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
163423818|NCT01701258|590256193|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
163423819|NCT01701258|590256194|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
163423820|NCT01701258|590256195|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
163423821|NCT01701258|590256196|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
163423822|NCT01701258|590256197|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
163423823|NCT01701258|590256198|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
163423824|NCT01701258|590256186|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
163423825|NCT01701258|590256187|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
163423826|NCT01701258|590256188|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
163423827|NCT01701258|590256189|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
163423828|NCT01701258|590256190|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
163423829|NCT01701258|590256191|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
163423830|NCT01701258|590256192|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
163423831|NCT01701258|590256193|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
163423832|NCT01701258|590256194|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
163423833|NCT01701258|590256195|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
163423834|NCT01701258|590256196|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
163423835|NCT01701258|590256197|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
163423836|NCT01701258|590256198|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
163423837|NCT01701258|590256186|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
163423838|NCT01701258|590256187|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
163423839|NCT01701258|590256188|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
163423840|NCT01701258|590256189|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
163423841|NCT01701258|590256190|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
163423842|NCT01701258|590256191|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
163423843|NCT01701258|590256192|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
163423844|NCT01701258|590256193|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
163423845|NCT01701258|590256194|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
163423846|NCT01701258|590256195|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
163423847|NCT01701258|590256196|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
163423848|NCT01701258|590256197|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
163423849|NCT01701258|590256198|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
163423850|NCT01701258|590256186|FG000|Assessment and Scheduling|Investigator Terminated|2|||
163423851|NCT01701258|590256187|FG001|Assessment and Scheduling|Investigator Terminated|0|||
163423852|NCT01701258|590256188|FG002|Assessment and Scheduling|Investigator Terminated|0|||
163423853|NCT01701258|590256189|FG003|Assessment and Scheduling|Investigator Terminated|0|||
163423854|NCT01701258|590256190|FG004|Assessment and Scheduling|Investigator Terminated|0|||
163423855|NCT01701258|590256191|FG005|Assessment and Scheduling|Investigator Terminated|0|||
163423856|NCT01701258|590256192|FG006|Assessment and Scheduling|Investigator Terminated|0|||
163423857|NCT01701258|590256193|FG007|Assessment and Scheduling|Investigator Terminated|0|||
163423858|NCT01701258|590256194|FG008|Assessment and Scheduling|Investigator Terminated|0|||
163423859|NCT01701258|590256195|FG009|Assessment and Scheduling|Investigator Terminated|0|||
163423860|NCT01701258|590256196|FG010|Assessment and Scheduling|Investigator Terminated|0|||
163423861|NCT01701258|590256197|FG011|Assessment and Scheduling|Investigator Terminated|0|||
163423862|NCT01701258|590256198|FG012|Assessment and Scheduling|Investigator Terminated|0|||
163423863|NCT01323478|590256199|FG000|Overall Study|Adverse Event|7|||
163423864|NCT01323478|590256199|FG000|Overall Study|Lack of Efficacy|4|||
163423865|NCT01323478|590256199|FG000|Overall Study|Non-compliance With Study Product|3|||
163423866|NCT01323478|590256199|FG000|Overall Study|Protocol Violation|1|||
163423867|NCT01323478|590256199|FG000|Overall Study|Withdrawal of Consent|1|||
163423868|NCT01323478|590256199|FG000|Overall Study|Administrative or Other Reasons|8|||
163423869|NCT00934102|590256203|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
163423870|NCT00934102|590256204|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
163423871|NCT00934102|590256205|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
163423872|NCT00792298|590256206|FG000|Treatment Period 1|Adverse Event|0|||
163423873|NCT00792298|590256207|FG001|Treatment Period 1|Adverse Event|1|||
163423874|NCT00792298|590256208|FG002|Treatment Period 1|Adverse Event|0|||
163423875|NCT00792298|590256209|FG003|Treatment Period 1|Adverse Event|1|||
163423876|NCT00792298|590256210|FG004|Treatment Period 1|Adverse Event|0|||
163423877|NCT00792298|590256211|FG005|Treatment Period 1|Adverse Event|1|||
163423878|NCT00792298|590256212|FG006|Treatment Period 1|Adverse Event|1|||
163423879|NCT00792298|590256213|FG007|Treatment Period 1|Adverse Event|0|||
163423880|NCT00792298|590256206|FG000|Treatment Period 1|Lack of Efficacy|0|||
163423881|NCT00792298|590256207|FG001|Treatment Period 1|Lack of Efficacy|0|||
163423882|NCT00792298|590256208|FG002|Treatment Period 1|Lack of Efficacy|1|||
163423883|NCT00792298|590256209|FG003|Treatment Period 1|Lack of Efficacy|0|||
163423884|NCT00792298|590256210|FG004|Treatment Period 1|Lack of Efficacy|0|||
163423885|NCT00792298|590256211|FG005|Treatment Period 1|Lack of Efficacy|0|||
163423886|NCT00792298|590256212|FG006|Treatment Period 1|Lack of Efficacy|0|||
163423887|NCT00792298|590256213|FG007|Treatment Period 1|Lack of Efficacy|0|||
163423888|NCT00792298|590256206|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163423889|NCT00792298|590256207|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163423890|NCT00792298|590256208|FG002|Treatment Period 1|Withdrawal by Subject|1|||
163423891|NCT00792298|590256209|FG003|Treatment Period 1|Withdrawal by Subject|2|||
163423892|NCT00792298|590256210|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163423893|NCT00792298|590256211|FG005|Treatment Period 1|Withdrawal by Subject|2|||
163423894|NCT00792298|590256212|FG006|Treatment Period 1|Withdrawal by Subject|1|||
163423895|NCT00792298|590256213|FG007|Treatment Period 1|Withdrawal by Subject|0|||
163423896|NCT00792298|590256206|FG000|Treatment Period 1|Lost to Follow-up|0|||
163423897|NCT00792298|590256207|FG001|Treatment Period 1|Lost to Follow-up|0|||
163423898|NCT00792298|590256208|FG002|Treatment Period 1|Lost to Follow-up|0|||
163423899|NCT00792298|590256209|FG003|Treatment Period 1|Lost to Follow-up|0|||
163423900|NCT00792298|590256210|FG004|Treatment Period 1|Lost to Follow-up|0|||
163423901|NCT00792298|590256211|FG005|Treatment Period 1|Lost to Follow-up|0|||
163423902|NCT00792298|590256212|FG006|Treatment Period 1|Lost to Follow-up|1|||
163423903|NCT00792298|590256213|FG007|Treatment Period 1|Lost to Follow-up|0|||
163423904|NCT00792298|590256206|FG000|Treatment Period 1|Physician Decision|0|||
163423905|NCT00792298|590256207|FG001|Treatment Period 1|Physician Decision|0|||
163423906|NCT00792298|590256208|FG002|Treatment Period 1|Physician Decision|0|||
163423907|NCT00792298|590256209|FG003|Treatment Period 1|Physician Decision|1|||
163423908|NCT00792298|590256210|FG004|Treatment Period 1|Physician Decision|0|||
163423909|NCT00792298|590256211|FG005|Treatment Period 1|Physician Decision|0|||
163423910|NCT00792298|590256212|FG006|Treatment Period 1|Physician Decision|1|||
163423911|NCT00792298|590256213|FG007|Treatment Period 1|Physician Decision|0|||
163423912|NCT00792298|590256206|FG000|Treatment Period 1|Protocol Violation|0|||
163423913|NCT00792298|590256207|FG001|Treatment Period 1|Protocol Violation|0|||
163423914|NCT00792298|590256208|FG002|Treatment Period 1|Protocol Violation|0|||
163423915|NCT00792298|590256209|FG003|Treatment Period 1|Protocol Violation|0|||
163423916|NCT00792298|590256210|FG004|Treatment Period 1|Protocol Violation|0|||
163423917|NCT00792298|590256211|FG005|Treatment Period 1|Protocol Violation|0|||
163423918|NCT00792298|590256212|FG006|Treatment Period 1|Protocol Violation|0|||
163423919|NCT00792298|590256213|FG007|Treatment Period 1|Protocol Violation|1|||
163423920|NCT00792298|590256206|FG000|Washout|Adverse Event|0|||
163423921|NCT00792298|590256207|FG001|Washout|Adverse Event|0|||
163423922|NCT00792298|590256208|FG002|Washout|Adverse Event|0|||
163423923|NCT00792298|590256209|FG003|Washout|Adverse Event|0|||
163423924|NCT00792298|590256210|FG004|Washout|Adverse Event|0|||
163423925|NCT00792298|590256211|FG005|Washout|Adverse Event|1|||
163423926|NCT00792298|590256212|FG006|Washout|Adverse Event|0|||
163423927|NCT00792298|590256213|FG007|Washout|Adverse Event|0|||
163423928|NCT00792298|590256206|FG000|Washout|Withdrawal by Subject|0|||
163423929|NCT00792298|590256207|FG001|Washout|Withdrawal by Subject|0|||
163423930|NCT00792298|590256208|FG002|Washout|Withdrawal by Subject|1|||
163423931|NCT00792298|590256209|FG003|Washout|Withdrawal by Subject|0|||
163423932|NCT00792298|590256210|FG004|Washout|Withdrawal by Subject|0|||
163423933|NCT00792298|590256211|FG005|Washout|Withdrawal by Subject|1|||
163423934|NCT00792298|590256212|FG006|Washout|Withdrawal by Subject|0|||
163423935|NCT00792298|590256213|FG007|Washout|Withdrawal by Subject|0|||
163423936|NCT00792298|590256206|FG000|Treatment Period 2|Lack of Efficacy|0|||
163423937|NCT00792298|590256207|FG001|Treatment Period 2|Lack of Efficacy|0|||
163423938|NCT00792298|590256208|FG002|Treatment Period 2|Lack of Efficacy|0|||
163423939|NCT00792298|590256209|FG003|Treatment Period 2|Lack of Efficacy|0|||
163423940|NCT00792298|590256210|FG004|Treatment Period 2|Lack of Efficacy|1|||
163423941|NCT00792298|590256211|FG005|Treatment Period 2|Lack of Efficacy|0|||
163423942|NCT00792298|590256212|FG006|Treatment Period 2|Lack of Efficacy|0|||
163423943|NCT00792298|590256213|FG007|Treatment Period 2|Lack of Efficacy|0|||
163423944|NCT00792298|590256206|FG000|Treatment Period 2|Physician Decision|0|||
163423945|NCT00792298|590256207|FG001|Treatment Period 2|Physician Decision|0|||
163423946|NCT00792298|590256208|FG002|Treatment Period 2|Physician Decision|0|||
163423947|NCT00792298|590256209|FG003|Treatment Period 2|Physician Decision|0|||
163423948|NCT00792298|590256210|FG004|Treatment Period 2|Physician Decision|0|||
163423949|NCT00792298|590256211|FG005|Treatment Period 2|Physician Decision|0|||
163423950|NCT00792298|590256212|FG006|Treatment Period 2|Physician Decision|1|||
163423951|NCT00792298|590256213|FG007|Treatment Period 2|Physician Decision|0|||
163423952|NCT00792298|590256206|FG000|Treatment Period 2|Pregnancy|0|||
163423953|NCT00792298|590256207|FG001|Treatment Period 2|Pregnancy|0|||
163423954|NCT00792298|590256208|FG002|Treatment Period 2|Pregnancy|1|||
163423955|NCT00792298|590256209|FG003|Treatment Period 2|Pregnancy|0|||
163423956|NCT00792298|590256210|FG004|Treatment Period 2|Pregnancy|0|||
163423957|NCT00792298|590256211|FG005|Treatment Period 2|Pregnancy|0|||
163423958|NCT00792298|590256212|FG006|Treatment Period 2|Pregnancy|0|||
163423959|NCT00792298|590256213|FG007|Treatment Period 2|Pregnancy|0|||
163423960|NCT00792298|590256206|FG000|Treatment Period 2|Withdrawal by Subject|1|||
163423961|NCT00792298|590256207|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163423962|NCT00792298|590256208|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163423963|NCT00792298|590256209|FG003|Treatment Period 2|Withdrawal by Subject|2|||
163423964|NCT00792298|590256210|FG004|Treatment Period 2|Withdrawal by Subject|1|||
163423965|NCT00792298|590256211|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163423966|NCT00792298|590256212|FG006|Treatment Period 2|Withdrawal by Subject|0|||
163423967|NCT00792298|590256213|FG007|Treatment Period 2|Withdrawal by Subject|2|||
163423968|NCT00486603|590256219|FG000|Overall Study|Withdrawal by Subject|1|||
163423969|NCT00486603|590256220|FG001|Overall Study|Withdrawal by Subject|0|||
163423970|NCT00486603|590256221|FG002|Overall Study|Withdrawal by Subject|0|||
163423971|NCT00486603|590256222|FG003|Overall Study|Withdrawal by Subject|0|||
163423972|NCT00486603|590256223|FG004|Overall Study|Withdrawal by Subject|0|||
163423973|NCT00486603|590256219|FG000|Overall Study|Physician Decision|0|||
163423974|NCT00486603|590256220|FG001|Overall Study|Physician Decision|1|||
163423975|NCT00486603|590256221|FG002|Overall Study|Physician Decision|0|||
163423976|NCT00486603|590256222|FG003|Overall Study|Physician Decision|0|||
163423977|NCT00486603|590256223|FG004|Overall Study|Physician Decision|0|||
163423978|NCT02649634|590256224|FG000|Overall Study|Withdrawal by Subject|3|||
163423979|NCT02649634|590256225|FG001|Overall Study|Withdrawal by Subject|5|||
163423980|NCT02649634|590256224|FG000|Overall Study|Lost to Follow-up|0|||
163423981|NCT02649634|590256225|FG001|Overall Study|Lost to Follow-up|1|||
163423982|NCT01670994|590256228|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
163423983|NCT01670994|590256229|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
163423984|NCT01670994|590256228|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
163423985|NCT01670994|590256229|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
163423986|NCT01670994|590256228|FG000|Overall Study|Patient experienced DLT|0|||
163423987|NCT01670994|590256229|FG001|Overall Study|Patient experienced DLT|1|||
163423988|NCT00763009|590256230|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
163423989|NCT01111604|590256231|FG000|Overall Study|Lost to Follow-up|0|||
163423990|NCT01111604|590256232|FG001|Overall Study|Lost to Follow-up|0|||
163423991|NCT01111604|590256233|FG002|Overall Study|Lost to Follow-up|1|||
163423992|NCT01111604|590256231|FG000|Overall Study|Withdrew Consent|3|||
163423993|NCT01111604|590256232|FG001|Overall Study|Withdrew Consent|0|||
163423994|NCT01111604|590256233|FG002|Overall Study|Withdrew Consent|2|||
163423995|NCT01111604|590256231|FG000|Overall Study|Withdrawal by Subject|2|||
163423996|NCT01111604|590256232|FG001|Overall Study|Withdrawal by Subject|0|||
163423997|NCT01111604|590256233|FG002|Overall Study|Withdrawal by Subject|0|||
163423998|NCT01111604|590256231|FG000|Overall Study|Death|1|||
163423999|NCT01111604|590256232|FG001|Overall Study|Death|0|||
163424000|NCT01111604|590256233|FG002|Overall Study|Death|0|||
163424001|NCT01111604|590256231|FG000|Overall Study|Met Exclusion Criteria|2|||
163424002|NCT01111604|590256232|FG001|Overall Study|Met Exclusion Criteria|0|||
163424003|NCT01111604|590256233|FG002|Overall Study|Met Exclusion Criteria|0|||
163424004|NCT02013544|590256236|FG000|Overall Study|Adverse Event|5|||
163424005|NCT02013544|590256237|FG001|Overall Study|Adverse Event|5|||
163424006|NCT02013544|590256236|FG000|Overall Study|Lost to Follow-up|2|||
163424007|NCT02013544|590256237|FG001|Overall Study|Lost to Follow-up|3|||
163424008|NCT02013544|590256236|FG000|Overall Study|Withdrawal by Subject|2|||
163424009|NCT02013544|590256237|FG001|Overall Study|Withdrawal by Subject|8|||
163424010|NCT02013544|590256236|FG000|Overall Study|Physician Decision|0|||
163424011|NCT02013544|590256237|FG001|Overall Study|Physician Decision|1|||
163424012|NCT02013544|590256236|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
163424013|NCT02013544|590256237|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
163424014|NCT02706938|590256244|FG000|First Period, 6 Weeks|Adverse Event|8|||
163424015|NCT02706938|590256245|FG001|First Period, 6 Weeks|Adverse Event|0|||
163424016|NCT02706938|590256244|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
163424017|NCT02706938|590256245|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
163424018|NCT02706938|590256244|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
163424019|NCT02706938|590256245|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
163424020|NCT02706938|590256244|FG000|Second Period, 6 Weeks|Adverse Event|0|||
163424021|NCT02706938|590256245|FG001|Second Period, 6 Weeks|Adverse Event|7|||
163424022|NCT02706938|590256244|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
163424023|NCT02706938|590256245|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
163424024|NCT02868892|590256246|FG000|Overall Study|Investigator left site and no follow-up|6|||
163424025|NCT01360996|590256257|FG000|Overall Study|Withdrawal by Subject|4|||
163424026|NCT01360996|590256258|FG001|Overall Study|Withdrawal by Subject|3|||
163424027|NCT01360996|590256259|FG002|Overall Study|Withdrawal by Subject|2|||
163424028|NCT01360996|590256257|FG000|Overall Study|Noncompliant|2|||
163424029|NCT01360996|590256258|FG001|Overall Study|Noncompliant|0|||
163424030|NCT01360996|590256259|FG002|Overall Study|Noncompliant|0|||
163424031|NCT03377634|590256260|FG000|Study Period|Adverse Event|1|||
163424032|NCT03377634|590256261|FG001|Study Period|Adverse Event|0|||
163424033|NCT03377634|590256260|FG000|Study Period|Withdrawal by Subject|1|||
163424034|NCT03377634|590256261|FG001|Study Period|Withdrawal by Subject|0|||
163424035|NCT01454076|590256262|FG000|Overall Study|Other|2|||
163424036|NCT01454076|590256263|FG001|Overall Study|Other|0|||
163424037|NCT01454076|590256264|FG002|Overall Study|Other|0|||
163424038|NCT01454076|590256265|FG003|Overall Study|Other|1|||
163424039|NCT01454076|590256266|FG004|Overall Study|Other|2|||
163424040|NCT01454076|590256262|FG000|Overall Study|Withdrawal by Subject|3|||
163424041|NCT01454076|590256263|FG001|Overall Study|Withdrawal by Subject|4|||
163424042|NCT01454076|590256264|FG002|Overall Study|Withdrawal by Subject|2|||
163424043|NCT01454076|590256265|FG003|Overall Study|Withdrawal by Subject|1|||
163424044|NCT01454076|590256266|FG004|Overall Study|Withdrawal by Subject|2|||
163424045|NCT01454076|590256262|FG000|Overall Study|Adverse Event|8|||
163424046|NCT01454076|590256263|FG001|Overall Study|Adverse Event|2|||
163424047|NCT01454076|590256264|FG002|Overall Study|Adverse Event|7|||
163424048|NCT01454076|590256265|FG003|Overall Study|Adverse Event|0|||
163424049|NCT01454076|590256266|FG004|Overall Study|Adverse Event|2|||
163424050|NCT04525703|590256267|FG000|Overall Study|Lost to Follow-up|6|||
163424051|NCT04525703|590256268|FG001|Overall Study|Lost to Follow-up|15|||
163424052|NCT04525703|590256269|FG002|Overall Study|Lost to Follow-up|8|||
163424053|NCT00291551|590256275|FG000|Overall Study|Death|7|||
163424054|NCT00291551|590256275|FG000|Overall Study|Withdrawal by Subject|6|||
163424055|NCT02452762|590256276|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
163424056|NCT02452762|590256277|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
163424057|NCT02452762|590256276|FG000|Overall Study|Withdrawal by Subject|1|||
163424058|NCT02452762|590256277|FG001|Overall Study|Withdrawal by Subject|0|||
163424059|NCT00584870|590256278|FG000|Overall Study|Adverse Event|4|||
163424060|NCT00584870|590256279|FG001|Overall Study|Adverse Event|3|||
163424061|NCT00584870|590256280|FG002|Overall Study|Adverse Event|2|||
163424062|NCT00584870|590256278|FG000|Overall Study|Lost to Follow-up|4|||
163424063|NCT00584870|590256279|FG001|Overall Study|Lost to Follow-up|1|||
163424064|NCT00584870|590256280|FG002|Overall Study|Lost to Follow-up|1|||
163424065|NCT00584870|590256278|FG000|Overall Study|Lack of Efficacy|7|||
163424066|NCT00584870|590256279|FG001|Overall Study|Lack of Efficacy|14|||
163424067|NCT00584870|590256280|FG002|Overall Study|Lack of Efficacy|8|||
163424068|NCT00584870|590256278|FG000|Overall Study|Withdrawal by Subject|10|||
163424069|NCT00584870|590256279|FG001|Overall Study|Withdrawal by Subject|5|||
163424070|NCT00584870|590256280|FG002|Overall Study|Withdrawal by Subject|3|||
163424071|NCT00584870|590256278|FG000|Overall Study|Protocol Violation|1|||
163424072|NCT00584870|590256279|FG001|Overall Study|Protocol Violation|1|||
163424073|NCT00584870|590256280|FG002|Overall Study|Protocol Violation|2|||
163424074|NCT00584870|590256278|FG000|Overall Study|Did not met entrance criteria|1|||
163424075|NCT00584870|590256279|FG001|Overall Study|Did not met entrance criteria|0|||
163424076|NCT00584870|590256280|FG002|Overall Study|Did not met entrance criteria|0|||
163424077|NCT00584870|590256278|FG000|Overall Study|Other|2|||
163424078|NCT00584870|590256279|FG001|Overall Study|Other|0|||
163424079|NCT00584870|590256280|FG002|Overall Study|Other|0|||
163424080|NCT00584870|590256278|FG000|Overall Study|Randomized but not treated|0|||
163424081|NCT00584870|590256279|FG001|Overall Study|Randomized but not treated|1|||
163424082|NCT00584870|590256280|FG002|Overall Study|Randomized but not treated|2|||
163424083|NCT00631137|590256281|FG000|Overall Study|Withdrawal by Subject|1|||
163424084|NCT00631137|590256282|FG001|Overall Study|Withdrawal by Subject|0|||
163424085|NCT03682120|590256283|FG000|Overall Study|Lost to Follow-up|11|||
163424086|NCT03682120|590256284|FG001|Overall Study|Lost to Follow-up|4|||
163424087|NCT03682120|590256285|FG002|Overall Study|Lost to Follow-up|5|||
163424088|NCT03682120|590256286|FG003|Overall Study|Lost to Follow-up|2|||
163424089|NCT03682120|590256283|FG000|Overall Study|Physician Decision|1|||
163424090|NCT03682120|590256284|FG001|Overall Study|Physician Decision|0|||
163424091|NCT03682120|590256285|FG002|Overall Study|Physician Decision|0|||
163424092|NCT03682120|590256286|FG003|Overall Study|Physician Decision|0|||
163424093|NCT03682120|590256283|FG000|Overall Study|Withdrawal by Subject|1|||
163424094|NCT03682120|590256284|FG001|Overall Study|Withdrawal by Subject|2|||
163424095|NCT03682120|590256285|FG002|Overall Study|Withdrawal by Subject|3|||
163424096|NCT03682120|590256286|FG003|Overall Study|Withdrawal by Subject|0|||
163424097|NCT03682120|590256283|FG000|Overall Study|Death|0|||
163424098|NCT03682120|590256284|FG001|Overall Study|Death|1|||
163424099|NCT03682120|590256285|FG002|Overall Study|Death|0|||
163424100|NCT03682120|590256286|FG003|Overall Study|Death|0|||
163424101|NCT03682120|590256283|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
163424102|NCT03682120|590256284|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
163424103|NCT03682120|590256285|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
163424104|NCT03682120|590256286|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
163424105|NCT01015833|590256287|FG000|Overall Study|Death|1|||
163424106|NCT01015833|590256288|FG001|Overall Study|Death|0|||
163424107|NCT01015833|590256287|FG000|Overall Study|Withdrawal by Subject|3|||
163424108|NCT01015833|590256288|FG001|Overall Study|Withdrawal by Subject|2|||
163424109|NCT01015833|590256287|FG000|Overall Study|Adverse Event|0|||
163424110|NCT01015833|590256288|FG001|Overall Study|Adverse Event|1|||
163424111|NCT01015833|590256287|FG000|Overall Study|Physician Decision|2|||
163424112|NCT01015833|590256288|FG001|Overall Study|Physician Decision|0|||
163424113|NCT01015833|590256287|FG000|Overall Study|Symptomatic deterioration|0|||
163424114|NCT01015833|590256288|FG001|Overall Study|Symptomatic deterioration|1|||
163424115|NCT01015833|590256287|FG000|Overall Study|Other|5|||
163424116|NCT01015833|590256288|FG001|Overall Study|Other|1|||
163424117|NCT01015833|590256287|FG000|Overall Study|Motor Vehicle Accidents|1|||
163424118|NCT01015833|590256288|FG001|Overall Study|Motor Vehicle Accidents|0|||
163424119|NCT01015833|590256287|FG000|Overall Study|Did not start treatment|1|||
163424120|NCT01015833|590256288|FG001|Overall Study|Did not start treatment|0|||
163424121|NCT02040142|590256293|FG000|Overall Study|Lost to Follow-up|5|||
163424122|NCT02040142|590256293|FG000|Overall Study|Death|17|||
163424123|NCT02040142|590256293|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
163424124|NCT04752384|590256294|FG000|Overall Study|Withdrawal by Subject|1|||
163424125|NCT04752384|590256294|FG000|Overall Study|Death|1|||
163424126|NCT04439331|590256301|FG000|Overall Study|Never Start Protocol Therapy|2|||
163424127|NCT04439331|590256301|FG000|Overall Study|Ineligible|2|||
163424128|NCT04439331|590256301|FG000|Overall Study|Mutation Status Not Confirmed|1|||
163424129|NCT04439331|590256301|FG000|Overall Study|Adverse Event|1|||
163424130|NCT04439331|590256301|FG000|Overall Study|Death|1|||
163424131|NCT04439331|590256301|FG000|Overall Study|Disease Progression|20|||
163424132|NCT04439331|590256301|FG000|Overall Study|Withdrawal by Subject|6|||
163424133|NCT04439331|590256301|FG000|Overall Study|Physician Decision|1|||
163424134|NCT04439331|590256301|FG000|Overall Study|Other Complicating Disease|1|||
163424135|NCT04370509|590256303|FG000|Overall Study|Adverse Event|1|||
163424136|NCT04370509|590256304|FG001|Overall Study|Adverse Event|0|||
163424137|NCT04370509|590256303|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
163424138|NCT04370509|590256304|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
163424139|NCT04743856|590256305|FG000|Overall Study|Lost to Follow-up|6|||
163424140|NCT04743856|590256306|FG001|Overall Study|Lost to Follow-up|7|||
163424141|NCT04743856|590256305|FG000|Overall Study|Withdrawal by Subject|1|||
163424142|NCT04743856|590256306|FG001|Overall Study|Withdrawal by Subject|0|||
163424143|NCT04696861|590256307|FG000|Overall Study|Death|1|||
163424144|NCT04696861|590256308|FG001|Overall Study|Death|0|||
163424145|NCT04696861|590256307|FG000|Overall Study|Lost to Follow-up|3|||
163424146|NCT04696861|590256308|FG001|Overall Study|Lost to Follow-up|0|||
163424147|NCT04439188|590256309|FG000|Overall Study|Ineligible|3|||
163424148|NCT04439188|590256309|FG000|Overall Study|Adverse Event|4|||
163424149|NCT04439188|590256309|FG000|Overall Study|Death|1|||
163424150|NCT04439188|590256309|FG000|Overall Study|Disease Progression|25|||
163424151|NCT04439188|590256309|FG000|Overall Study|Withdrawal by Subject|2|||
163424152|NCT00413959|590256310|FG000|Overall Study|Pt had only one cycle.|1|||
163424153|NCT01870739|590256313|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
163424154|NCT01870739|590256314|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
163424155|NCT01870739|590256313|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
163424156|NCT01870739|590256314|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
163424157|NCT01870739|590256313|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
163424158|NCT01870739|590256314|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
163424159|NCT01870739|590256313|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
163424160|NCT01870739|590256314|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
163424161|NCT01870739|590256313|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
163424162|NCT01870739|590256314|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
163424163|NCT01870739|590256313|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
163424164|NCT01870739|590256314|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
163424165|NCT01870739|590256313|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
163424166|NCT01870739|590256314|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
163424167|NCT02425098|590256315|FG000|Overall Study|Lost to Follow-up|7|||
163424168|NCT02425098|590256316|FG001|Overall Study|Lost to Follow-up|7|||
163424169|NCT02425098|590256315|FG000|Overall Study|Withdrawal by Subject|4|||
163424170|NCT02425098|590256316|FG001|Overall Study|Withdrawal by Subject|8|||
163424171|NCT02425098|590256315|FG000|Overall Study|Pregnancy|2|||
163424172|NCT02425098|590256316|FG001|Overall Study|Pregnancy|0|||
163424173|NCT02425098|590256315|FG000|Overall Study|Reason not Specified|0|||
163424174|NCT02425098|590256316|FG001|Overall Study|Reason not Specified|1|||
163424175|NCT00960076|590258180|FG000|Overall Study|Adverse Event|1|||
163424176|NCT00960076|590258181|FG001|Overall Study|Adverse Event|7|||
163424177|NCT00960076|590258180|FG000|Overall Study|No longer met study criteria|1|||
163424178|NCT00960076|590258181|FG001|Overall Study|No longer met study criteria|5|||
163424179|NCT00960076|590258180|FG000|Overall Study|Withdrawal by Subject|1|||
163424180|NCT00960076|590258181|FG001|Overall Study|Withdrawal by Subject|2|||
163424181|NCT00960076|590258180|FG000|Overall Study|Lost to Follow-up|3|||
163424182|NCT00960076|590258181|FG001|Overall Study|Lost to Follow-up|3|||
163424183|NCT00960076|590258180|FG000|Overall Study|Severe non-compliance to protocol|1|||
163424184|NCT00960076|590258181|FG001|Overall Study|Severe non-compliance to protocol|2|||
163424185|NCT00960076|590258180|FG000|Overall Study|Hyperglycemia|1|||
163424186|NCT00960076|590258181|FG001|Overall Study|Hyperglycemia|5|||
163424187|NCT00960076|590258180|FG000|Overall Study|Did not attend the termination visit|0|||
163424188|NCT00960076|590258181|FG001|Overall Study|Did not attend the termination visit|1|||
163424189|NCT02029976|590258182|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
163424190|NCT02029976|590258183|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
163424191|NCT02029976|590258182|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
163424192|NCT02029976|590258183|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
163424193|NCT02029976|590258182|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
163424194|NCT02029976|590258183|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
163424195|NCT02029976|590258182|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
163424196|NCT02029976|590258183|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
163424197|NCT03263806|590258184|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
163424198|NCT03263806|590258185|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
163424199|NCT03263806|590258184|FG000|Overall Study|Withdrawal by Subject|0|||
163424200|NCT03263806|590258185|FG001|Overall Study|Withdrawal by Subject|1|||
163424201|NCT03263806|590258184|FG000|Overall Study|Study Termination|5|||
163424202|NCT03263806|590258185|FG001|Overall Study|Study Termination|6|||
163424203|NCT04840667|590258186|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
163424204|NCT01445171|590258187|FG000|Overall Study|Lost to Follow-up|11|||
163424205|NCT01445171|590258187|FG000|Overall Study|Withdrawal by Subject|16|||
163424206|NCT01445171|590258187|FG000|Overall Study|Death|51|||
163424207|NCT01445171|590258187|FG000|Overall Study|Subjects declined to return for followup|9|||
163424208|NCT01445171|590258187|FG000|Overall Study|Consented but did not receive device|8|||
163424209|NCT00023322|590258188|FG000|Overall Study|Lost to Follow-up|1|||
163424210|NCT05194345|590258191|FG000|Overall Study|Withdrawal by Subject|6|||
163424211|NCT05194345|590258192|FG001|Overall Study|Withdrawal by Subject|4|||
163424212|NCT05194345|590258193|FG002|Overall Study|Withdrawal by Subject|0|||
163424213|NCT05194345|590258191|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
163424214|NCT05194345|590258192|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
163424215|NCT05194345|590258193|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
163424216|NCT02612909|590258194|FG000|Phase 2|Withdrawal by Subject|2|||
163424217|NCT02612909|590258195|FG001|Phase 2|Withdrawal by Subject|5|||
163424218|NCT02612909|590258196|FG002|Phase 2|Withdrawal by Subject|0|||
163424219|NCT02612909|590258197|FG003|Phase 2|Withdrawal by Subject|0|||
163424220|NCT02612909|590258198|FG004|Phase 2|Withdrawal by Subject|0|||
163424221|NCT02612909|590258194|FG000|Phase 2|Pregnancy|0|||
163424222|NCT02612909|590258195|FG001|Phase 2|Pregnancy|0|||
163424223|NCT02612909|590258196|FG002|Phase 2|Pregnancy|1|||
163424224|NCT02612909|590258197|FG003|Phase 2|Pregnancy|0|||
163424225|NCT02612909|590258198|FG004|Phase 2|Pregnancy|0|||
163424226|NCT02612909|590258194|FG000|Phase 3|Withdrawal by Subject|0|||
163424227|NCT02612909|590258195|FG001|Phase 3|Withdrawal by Subject|0|||
163424228|NCT02612909|590258196|FG002|Phase 3|Withdrawal by Subject|0|||
163424229|NCT02612909|590258197|FG003|Phase 3|Withdrawal by Subject|1|||
163424230|NCT02612909|590258198|FG004|Phase 3|Withdrawal by Subject|0|||
163424231|NCT05067127|590258203|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
163424232|NCT05067127|590258204|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
163424233|NCT05067127|590258205|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
163424234|NCT05067127|590258206|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
163424235|NCT05067127|590258203|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
163424236|NCT05067127|590258204|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
163424237|NCT05067127|590258205|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
163424238|NCT05067127|590258206|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
163424239|NCT05067127|590258203|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
163424240|NCT05067127|590258204|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
163424241|NCT05067127|590258205|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
163424242|NCT05067127|590258206|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
163424243|NCT05067127|590258203|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
163424244|NCT05067127|590258204|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
163424245|NCT05067127|590258205|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
163424246|NCT05067127|590258206|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
163424247|NCT05067127|590258203|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
163424248|NCT05067127|590258204|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
163424249|NCT05067127|590258205|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
163424250|NCT05067127|590258206|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
163424251|NCT05067127|590258203|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
163424252|NCT05067127|590258204|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
163424253|NCT05067127|590258205|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
163424254|NCT05067127|590258206|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
163424255|NCT05067127|590258203|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
163424256|NCT05067127|590258204|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
163424257|NCT05067127|590258205|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
163424258|NCT05067127|590258206|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
163424259|NCT03615222|590258208|FG000|Overall Study|Ineligible|26|||
163424260|NCT03615222|590258208|FG000|Overall Study|Withdrawal by Subject|7|||
163424261|NCT03615222|590258208|FG000|Overall Study|Death|1|||
163424262|NCT03304522|590258211|FG000|Overall Study|Adverse Event|0|||
163424263|NCT03304522|590258212|FG001|Overall Study|Adverse Event|4|||
163424264|NCT03304522|590258211|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
163424265|NCT03304522|590258212|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
163424266|NCT03304522|590258211|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
163424286|NCT01756456|590258224|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
163424287|NCT01756456|590258225|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
163424288|NCT01756456|590258226|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
163424289|NCT01756456|590258221|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
163424290|NCT01756456|590258222|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
163424291|NCT01756456|590258223|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
163424292|NCT01756456|590258224|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
163424293|NCT01756456|590258225|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
163424294|NCT01756456|590258226|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
163424295|NCT01756456|590258221|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
163424296|NCT01756456|590258222|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
163424297|NCT01756456|590258223|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
163424298|NCT01756456|590258224|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
163424299|NCT01756456|590258225|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
163424300|NCT01756456|590258226|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
163424301|NCT01756456|590258221|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
163424302|NCT01756456|590258222|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
163424303|NCT01756456|590258223|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
163424304|NCT01756456|590258224|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
163424305|NCT01756456|590258225|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
163424306|NCT01756456|590258226|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
163424307|NCT01756456|590258221|FG000|Treatment Period: Phase I/II|Other causes|0|||
163424308|NCT01756456|590258222|FG001|Treatment Period: Phase I/II|Other causes|0|||
163424309|NCT01756456|590258223|FG002|Treatment Period: Phase I/II|Other causes|0|||
163424310|NCT01756456|590258224|FG003|Treatment Period: Phase I/II|Other causes|1|||
163424311|NCT01756456|590258225|FG004|Treatment Period: Phase I/II|Other causes|2|||
163424312|NCT01756456|590258226|FG005|Treatment Period: Phase I/II|Other causes|2|||
163424313|NCT01756456|590258221|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
163424314|NCT01756456|590258222|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
163424315|NCT01756456|590258223|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
163424316|NCT01756456|590258224|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
163424317|NCT01756456|590258225|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
163424318|NCT01756456|590258226|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
163424319|NCT01756456|590258221|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
163424320|NCT01756456|590258222|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
163424321|NCT01756456|590258223|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
163424322|NCT01756456|590258224|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
163424323|NCT01756456|590258225|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
163424324|NCT01756456|590258226|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
163424325|NCT01756456|590258221|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
163424326|NCT01756456|590258222|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
163424327|NCT01756456|590258223|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
163424328|NCT01756456|590258224|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
163424329|NCT01756456|590258225|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
163424330|NCT01756456|590258226|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
163424331|NCT01756456|590258221|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
163424332|NCT01756456|590258222|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
163424333|NCT01756456|590258223|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
163424334|NCT01756456|590258224|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
163424335|NCT01756456|590258225|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
163424336|NCT01756456|590258226|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
163424337|NCT01756456|590258221|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
163424338|NCT01756456|590258222|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
163424339|NCT01756456|590258223|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
163424340|NCT01756456|590258224|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
163424341|NCT01756456|590258225|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
163424342|NCT01756456|590258226|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
163424343|NCT01756456|590258221|FG000|Follow Up Period Phase I/II|Other causes|0|||
163424344|NCT01756456|590258222|FG001|Follow Up Period Phase I/II|Other causes|0|||
163424345|NCT01756456|590258223|FG002|Follow Up Period Phase I/II|Other causes|0|||
163424346|NCT01756456|590258224|FG003|Follow Up Period Phase I/II|Other causes|1|||
163424347|NCT01756456|590258225|FG004|Follow Up Period Phase I/II|Other causes|3|||
163424348|NCT01756456|590258226|FG005|Follow Up Period Phase I/II|Other causes|5|||
163424349|NCT00813995|590258227|FG000|Overall Study|Clinical adverse event|9|||
163424350|NCT00813995|590258228|FG001|Overall Study|Clinical adverse event|3|||
163424351|NCT00813995|590258227|FG000|Overall Study|Laboratory adverse event|0|||
163424352|NCT00813995|590258228|FG001|Overall Study|Laboratory adverse event|2|||
163424353|NCT00813995|590258227|FG000|Overall Study|Lack of Efficacy|1|||
163424354|NCT00813995|590258228|FG001|Overall Study|Lack of Efficacy|0|||
163424355|NCT00813995|590258227|FG000|Overall Study|Lost to Follow-up|4|||
163424356|NCT00813995|590258228|FG001|Overall Study|Lost to Follow-up|2|||
163424357|NCT00813995|590258227|FG000|Overall Study|Other reason|2|||
163424358|NCT00813995|590258228|FG001|Overall Study|Other reason|2|||
163424359|NCT00813995|590258227|FG000|Overall Study|Protocol Violation|3|||
163424360|NCT00813995|590258228|FG001|Overall Study|Protocol Violation|2|||
163424361|NCT00813995|590258227|FG000|Overall Study|Subject moved|4|||
163424362|NCT00813995|590258228|FG001|Overall Study|Subject moved|0|||
163424363|NCT00813995|590258227|FG000|Overall Study|Withdrawal by Subject|0|||
163424364|NCT00813995|590258228|FG001|Overall Study|Withdrawal by Subject|5|||
163424365|NCT03094195|590258229|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
163424366|NCT03094195|590258230|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
163424367|NCT03094195|590258231|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
163424368|NCT03094195|590258232|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
163424369|NCT03094195|590258233|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
163424370|NCT03094195|590258234|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
163424371|NCT03094195|590258235|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
163424372|NCT03094195|590258236|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
163424373|NCT03094195|590258229|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
163424374|NCT03094195|590258230|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
163424375|NCT03094195|590258231|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
163424376|NCT03094195|590258232|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
163424377|NCT03094195|590258233|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
163424378|NCT03094195|590258234|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
163424379|NCT03094195|590258235|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
163424380|NCT03094195|590258236|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
163424381|NCT03094195|590258229|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
163424382|NCT03094195|590258230|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
163424383|NCT03094195|590258231|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
163424384|NCT03094195|590258232|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
163424385|NCT03094195|590258233|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
163424386|NCT03094195|590258234|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
163424387|NCT03094195|590258235|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
163424388|NCT03094195|590258236|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
163424389|NCT03094195|590258229|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
163424390|NCT03094195|590258230|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
163424391|NCT03094195|590258231|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
163424392|NCT03094195|590258232|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
163424393|NCT03094195|590258233|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
163424394|NCT03094195|590258234|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
163424395|NCT03094195|590258235|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
163424396|NCT03094195|590258236|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
163424397|NCT01651780|590258237|FG000|Overall Study|Physician decision: No 30-day visit|2|||
163424398|NCT01651780|590258238|FG001|Overall Study|Physician decision: No 30-day visit|1|||
163424399|NCT01651780|590258237|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
163424400|NCT01651780|590258238|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
163424401|NCT01651780|590258237|FG000|Overall Study|Withdrawal by Subject|2|||
163424402|NCT01651780|590258238|FG001|Overall Study|Withdrawal by Subject|0|||
163424403|NCT01651780|590258237|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
163424404|NCT01651780|590258238|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163424405|NCT01651780|590258237|FG000|Overall Study|Lost to Follow-up|1|||
163424406|NCT01651780|590258238|FG001|Overall Study|Lost to Follow-up|2|||
163424407|NCT01651780|590258237|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
163424408|NCT01651780|590258238|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
163424409|NCT00054132|590258239|FG000|Overall Study|Not Treated|1|||
163424410|NCT03029832|590258240|FG000|Overall Study|Safety Follow-Up Completed|2|||
163424411|NCT03029832|590258241|FG001|Overall Study|Safety Follow-Up Completed|0|||
163424412|NCT03029832|590258240|FG000|Overall Study|Death due to Disease Progression|1|||
163424413|NCT03029832|590258241|FG001|Overall Study|Death due to Disease Progression|0|||
163424414|NCT03029832|590258240|FG000|Overall Study|Study Terminated By Sponsor|1|||
163424415|NCT03029832|590258241|FG001|Overall Study|Study Terminated By Sponsor|1|||
163424416|NCT01412229|590258242|FG000|Overall Study|Physician Decision|1|||
163424417|NCT00454207|590258243|FG000|Overall Study|Adverse Event|3|||
163424418|NCT00454207|590258244|FG001|Overall Study|Adverse Event|1|||
163424419|NCT00454207|590258243|FG000|Overall Study|Lack of Efficacy|1|||
163424420|NCT00454207|590258244|FG001|Overall Study|Lack of Efficacy|0|||
163424421|NCT00454207|590258243|FG000|Overall Study|Protocol Violation|0|||
163424422|NCT00454207|590258244|FG001|Overall Study|Protocol Violation|1|||
163424423|NCT02116621|590258248|FG000|Baseline|Withdrawal by Subject|0|||
163424424|NCT02116621|590258249|FG001|Baseline|Withdrawal by Subject|4|||
163424425|NCT02116621|590258248|FG000|Three Month Follow-up|Death|1|||
163424426|NCT02116621|590258249|FG001|Three Month Follow-up|Death|1|||
163424427|NCT02116621|590258248|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
163424428|NCT02116621|590258249|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
163424429|NCT02116621|590258248|FG000|Three Month Follow-up|Lost to Follow-up|0|||
163424430|NCT02116621|590258249|FG001|Three Month Follow-up|Lost to Follow-up|1|||
163424431|NCT02116621|590258248|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
163424432|NCT02116621|590258249|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
163424433|NCT02116621|590258248|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
163424434|NCT02116621|590258249|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
163424435|NCT02116621|590258248|FG000|Six Month Follow-up|Lost to Follow-up|2|||
163424436|NCT02116621|590258249|FG001|Six Month Follow-up|Lost to Follow-up|1|||
163424437|NCT02116621|590258248|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
163424438|NCT02116621|590258249|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
163424439|NCT02116621|590258248|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
163424440|NCT02116621|590258249|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
163424441|NCT02116621|590258248|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
163424442|NCT02116621|590258249|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
163424443|NCT02116621|590258248|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
163424444|NCT02116621|590258249|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
163424445|NCT02116621|590258248|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
163424446|NCT02116621|590258249|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
163424447|NCT04223609|590258250|FG000|Overall Study|Adverse Event|0|||
163424448|NCT04223609|590258251|FG001|Overall Study|Adverse Event|1|||
163424449|NCT04223609|590258250|FG000|Overall Study|Missed last visit|0|||
163424450|NCT04223609|590258251|FG001|Overall Study|Missed last visit|1|||
163424451|NCT03437447|590258252|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163424452|NCT03437447|590258253|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163424453|NCT03437447|590258254|FG002|Treatment Period 1|Withdrawal by Subject|1|||
163424454|NCT00591734|590258257|FG000|Overall Study|Lack of Efficacy|35|||
163424455|NCT00591734|590258257|FG000|Overall Study|Adverse Event|5|||
163424456|NCT00591734|590258257|FG000|Overall Study|Physician Decision|5|||
163424457|NCT00591734|590258257|FG000|Overall Study|Intercurrent Illness|8|||
163424458|NCT01551745|590258258|FG000|Overall Study|Withdrawal by Subject|1|||
163424459|NCT01551745|590258258|FG000|Overall Study|Disease Progression|2|||
163424460|NCT01661790|590258259|FG000|Overall Study|Lost to Follow-up|0|||
163424461|NCT01661790|590258260|FG001|Overall Study|Lost to Follow-up|2|||
163424462|NCT02048904|590258263|FG000|Overall Study|Withdrawal by Subject|7|||
163424463|NCT02048904|590258263|FG000|Overall Study|Physician Decision|70|||
163424464|NCT01813890|590258265|FG000|Overall Study|Adverse Event|0|||
163424465|NCT01813890|590258266|FG001|Overall Study|Adverse Event|3|||
163424466|NCT01813890|590258267|FG002|Overall Study|Adverse Event|4|||
163424467|NCT01813890|590258265|FG000|Overall Study|Lack of Efficacy|9|||
163424468|NCT01813890|590258266|FG001|Overall Study|Lack of Efficacy|1|||
163424469|NCT01813890|590258267|FG002|Overall Study|Lack of Efficacy|2|||
163424470|NCT04482647|590258268|FG000|Overall Study|Time constraints|2|||
163424471|NCT04482647|590258268|FG000|Overall Study|Health issues|1|||
163424472|NCT04482647|590258268|FG000|Overall Study|Death in the family|1|||
163424473|NCT04482647|590258268|FG000|Overall Study|Disliked the intervention|1|||
163424474|NCT04482647|590258268|FG000|Overall Study|No reasons specified|7|||
163424475|NCT03952559|590258269|FG000|Double Blind Treatment Period|Adverse Event|0|||
163424476|NCT03952559|590258270|FG001|Double Blind Treatment Period|Adverse Event|2|||
163424477|NCT03952559|590258271|FG002|Double Blind Treatment Period|Adverse Event|1|||
163424478|NCT03952559|590258272|FG003|Double Blind Treatment Period|Adverse Event|0|||
163424479|NCT03952559|590258273|FG004|Double Blind Treatment Period|Adverse Event|1|||
163424480|NCT03952559|590258269|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
163424481|NCT03952559|590258270|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
163424482|NCT03952559|590258271|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
163424483|NCT03952559|590258272|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
163424484|NCT03952559|590258273|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
163424485|NCT03952559|590258269|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
163424486|NCT03952559|590258270|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
163424487|NCT03952559|590258271|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
163424488|NCT03952559|590258272|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
163424489|NCT03952559|590258273|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
163424490|NCT03952559|590258269|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
163424491|NCT03952559|590258270|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
163424492|NCT03952559|590258271|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
163424493|NCT03952559|590258272|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
163424494|NCT03952559|590258273|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
163424495|NCT01986062|590258276|FG000|Overall Study|Lost to Follow-up|1|||
163424496|NCT01986062|590258277|FG001|Overall Study|Lost to Follow-up|0|||
163424497|NCT01986062|590258276|FG000|Overall Study|Withdrawal by Subject|0|||
163424498|NCT01986062|590258277|FG001|Overall Study|Withdrawal by Subject|1|||
163424499|NCT03538743|590258278|FG000|Overall Study|Adverse Event|0|||
163424500|NCT03538743|590258279|FG001|Overall Study|Adverse Event|0|||
163424501|NCT03538743|590258280|FG002|Overall Study|Adverse Event|1|||
163424502|NCT03538743|590258281|FG003|Overall Study|Adverse Event|1|||
163424503|NCT03538743|590258282|FG004|Overall Study|Adverse Event|0|||
163424504|NCT03538743|590258283|FG005|Overall Study|Adverse Event|0|||
163424505|NCT03538743|590258284|FG006|Overall Study|Adverse Event|0|||
163424506|NCT03538743|590258285|FG007|Overall Study|Adverse Event|0|||
163424507|NCT03538743|590258286|FG008|Overall Study|Adverse Event|0|||
163424508|NCT03538743|590258278|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
163424509|NCT03538743|590258279|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
163424510|NCT03538743|590258280|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
163424511|NCT03538743|590258281|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
163424512|NCT03538743|590258282|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
163424513|NCT03538743|590258283|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
163424514|NCT03538743|590258284|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
163424515|NCT03538743|590258285|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
163424516|NCT03538743|590258286|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
163424517|NCT03538743|590258278|FG000|Overall Study|Withdrawal by Subject|0|||
163424518|NCT03538743|590258279|FG001|Overall Study|Withdrawal by Subject|0|||
163424519|NCT03538743|590258280|FG002|Overall Study|Withdrawal by Subject|0|||
163424520|NCT03538743|590258281|FG003|Overall Study|Withdrawal by Subject|1|||
163424521|NCT03538743|590258282|FG004|Overall Study|Withdrawal by Subject|0|||
163424522|NCT03538743|590258283|FG005|Overall Study|Withdrawal by Subject|0|||
163424523|NCT03538743|590258284|FG006|Overall Study|Withdrawal by Subject|0|||
163424524|NCT03538743|590258285|FG007|Overall Study|Withdrawal by Subject|0|||
163424525|NCT03538743|590258286|FG008|Overall Study|Withdrawal by Subject|0|||
163424526|NCT01827384|590258289|FG000|Overall Study|Switched to alternative treatment|0|||
163424527|NCT01827384|590258290|FG001|Overall Study|Switched to alternative treatment|0|||
163424528|NCT01827384|590258291|FG002|Overall Study|Switched to alternative treatment|0|||
163424529|NCT01827384|590258292|FG003|Overall Study|Switched to alternative treatment|0|||
163424530|NCT01827384|590258293|FG004|Overall Study|Switched to alternative treatment|0|||
163424531|NCT01827384|590258294|FG005|Overall Study|Switched to alternative treatment|0|||
163424532|NCT01827384|590258295|FG006|Overall Study|Switched to alternative treatment|0|||
163424533|NCT01827384|590258296|FG007|Overall Study|Switched to alternative treatment|0|||
163424534|NCT01827384|590258297|FG008|Overall Study|Switched to alternative treatment|0|||
163424535|NCT01827384|590258298|FG009|Overall Study|Switched to alternative treatment|0|||
163424536|NCT01827384|590258299|FG010|Overall Study|Switched to alternative treatment|0|||
163424537|NCT01827384|590258300|FG011|Overall Study|Switched to alternative treatment|0|||
163424538|NCT01827384|590258301|FG012|Overall Study|Switched to alternative treatment|0|||
163424539|NCT01827384|590258302|FG013|Overall Study|Switched to alternative treatment|2|||
163424540|NCT01827384|590258289|FG000|Overall Study|Disease progression before treatment|0|||
163424541|NCT01827384|590258290|FG001|Overall Study|Disease progression before treatment|0|||
163424542|NCT01827384|590258291|FG002|Overall Study|Disease progression before treatment|0|||
163424543|NCT01827384|590258292|FG003|Overall Study|Disease progression before treatment|0|||
163424544|NCT01827384|590258293|FG004|Overall Study|Disease progression before treatment|0|||
163424545|NCT01827384|590258294|FG005|Overall Study|Disease progression before treatment|0|||
163424546|NCT01827384|590258295|FG006|Overall Study|Disease progression before treatment|0|||
163424547|NCT01827384|590258296|FG007|Overall Study|Disease progression before treatment|0|||
163424548|NCT01827384|590258297|FG008|Overall Study|Disease progression before treatment|0|||
163424549|NCT01827384|590258298|FG009|Overall Study|Disease progression before treatment|0|||
163424550|NCT01827384|590258299|FG010|Overall Study|Disease progression before treatment|0|||
163424551|NCT01827384|590258300|FG011|Overall Study|Disease progression before treatment|0|||
163424552|NCT01827384|590258301|FG012|Overall Study|Disease progression before treatment|0|||
163424553|NCT01827384|590258302|FG013|Overall Study|Disease progression before treatment|4|||
163424554|NCT01827384|590258289|FG000|Overall Study|Ineligible|0|||
163424555|NCT01827384|590258290|FG001|Overall Study|Ineligible|0|||
163424556|NCT01827384|590258291|FG002|Overall Study|Ineligible|0|||
163424557|NCT01827384|590258292|FG003|Overall Study|Ineligible|0|||
163424558|NCT01827384|590258293|FG004|Overall Study|Ineligible|0|||
163424559|NCT01827384|590258294|FG005|Overall Study|Ineligible|0|||
163424560|NCT01827384|590258295|FG006|Overall Study|Ineligible|0|||
163424561|NCT01827384|590258296|FG007|Overall Study|Ineligible|0|||
163424562|NCT01827384|590258297|FG008|Overall Study|Ineligible|0|||
163424563|NCT01827384|590258298|FG009|Overall Study|Ineligible|0|||
163424564|NCT01827384|590258299|FG010|Overall Study|Ineligible|0|||
163424565|NCT01827384|590258300|FG011|Overall Study|Ineligible|0|||
163424566|NCT01827384|590258301|FG012|Overall Study|Ineligible|0|||
163424567|NCT01827384|590258302|FG013|Overall Study|Ineligible|19|||
163424568|NCT01827384|590258289|FG000|Overall Study|Participant died before treatment|0|||
163424569|NCT01827384|590258290|FG001|Overall Study|Participant died before treatment|0|||
163424570|NCT01827384|590258291|FG002|Overall Study|Participant died before treatment|0|||
163424571|NCT01827384|590258292|FG003|Overall Study|Participant died before treatment|0|||
163424572|NCT01827384|590258293|FG004|Overall Study|Participant died before treatment|0|||
163424573|NCT01827384|590258294|FG005|Overall Study|Participant died before treatment|0|||
163424574|NCT01827384|590258295|FG006|Overall Study|Participant died before treatment|0|||
163424575|NCT01827384|590258296|FG007|Overall Study|Participant died before treatment|0|||
163424576|NCT01827384|590258297|FG008|Overall Study|Participant died before treatment|0|||
163424577|NCT01827384|590258298|FG009|Overall Study|Participant died before treatment|0|||
163424578|NCT01827384|590258299|FG010|Overall Study|Participant died before treatment|0|||
163424579|NCT01827384|590258300|FG011|Overall Study|Participant died before treatment|0|||
163424580|NCT01827384|590258301|FG012|Overall Study|Participant died before treatment|0|||
163424581|NCT01827384|590258302|FG013|Overall Study|Participant died before treatment|5|||
163424582|NCT01827384|590258289|FG000|Overall Study|Insufficient tumor cells|0|||
163424583|NCT01827384|590258290|FG001|Overall Study|Insufficient tumor cells|0|||
163424584|NCT01827384|590258291|FG002|Overall Study|Insufficient tumor cells|0|||
163424585|NCT01827384|590258292|FG003|Overall Study|Insufficient tumor cells|0|||
163424586|NCT01827384|590258293|FG004|Overall Study|Insufficient tumor cells|0|||
163424587|NCT01827384|590258294|FG005|Overall Study|Insufficient tumor cells|0|||
163424588|NCT01827384|590258295|FG006|Overall Study|Insufficient tumor cells|0|||
163424589|NCT01827384|590258296|FG007|Overall Study|Insufficient tumor cells|0|||
163424590|NCT01827384|590258297|FG008|Overall Study|Insufficient tumor cells|0|||
163424591|NCT01827384|590258298|FG009|Overall Study|Insufficient tumor cells|0|||
163424592|NCT01827384|590258299|FG010|Overall Study|Insufficient tumor cells|0|||
163424593|NCT01827384|590258300|FG011|Overall Study|Insufficient tumor cells|0|||
163424594|NCT01827384|590258301|FG012|Overall Study|Insufficient tumor cells|0|||
163424595|NCT01827384|590258302|FG013|Overall Study|Insufficient tumor cells|13|||
163424596|NCT01827384|590258289|FG000|Overall Study|No actionable mutation|0|||
163424597|NCT01827384|590258290|FG001|Overall Study|No actionable mutation|0|||
163424598|NCT01827384|590258291|FG002|Overall Study|No actionable mutation|0|||
163424599|NCT01827384|590258292|FG003|Overall Study|No actionable mutation|0|||
163424600|NCT01827384|590258293|FG004|Overall Study|No actionable mutation|0|||
163424601|NCT01827384|590258294|FG005|Overall Study|No actionable mutation|0|||
163424602|NCT01827384|590258295|FG006|Overall Study|No actionable mutation|0|||
163424603|NCT01827384|590258296|FG007|Overall Study|No actionable mutation|0|||
163424604|NCT01827384|590258297|FG008|Overall Study|No actionable mutation|0|||
163424605|NCT01827384|590258298|FG009|Overall Study|No actionable mutation|0|||
163424606|NCT01827384|590258299|FG010|Overall Study|No actionable mutation|0|||
163424607|NCT01827384|590258300|FG011|Overall Study|No actionable mutation|0|||
163424608|NCT01827384|590258301|FG012|Overall Study|No actionable mutation|0|||
163424609|NCT01827384|590258302|FG013|Overall Study|No actionable mutation|73|||
163424610|NCT01827384|590258289|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
163424611|NCT01827384|590258290|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
163424612|NCT01827384|590258291|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
163424613|NCT01827384|590258292|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
163424614|NCT01827384|590258293|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
163424615|NCT01827384|590258294|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
163424616|NCT01827384|590258295|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
163424617|NCT01827384|590258296|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
163424618|NCT01827384|590258297|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
163424619|NCT01827384|590258298|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
163424620|NCT01827384|590258299|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
163424621|NCT01827384|590258300|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
163424622|NCT01827384|590258301|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
163424623|NCT01827384|590258302|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
163424624|NCT00630331|590258304|FG000|Overall Study|Death|2|||
163424625|NCT00630331|590258305|FG001|Overall Study|Death|1|||
163424626|NCT00630331|590258306|FG002|Overall Study|Death|1|||
163424627|NCT00630331|590258304|FG000|Overall Study|Adverse Event|1|||
163424628|NCT00630331|590258305|FG001|Overall Study|Adverse Event|0|||
163424629|NCT00630331|590258306|FG002|Overall Study|Adverse Event|0|||
163424630|NCT00630331|590258304|FG000|Overall Study|Withdrawal by Subject|12|||
163424631|NCT00630331|590258305|FG001|Overall Study|Withdrawal by Subject|7|||
163424632|NCT00630331|590258306|FG002|Overall Study|Withdrawal by Subject|5|||
163424633|NCT00630331|590258304|FG000|Overall Study|Lost to Follow-up|175|||
163424634|NCT00630331|590258305|FG001|Overall Study|Lost to Follow-up|143|||
163424635|NCT00630331|590258306|FG002|Overall Study|Lost to Follow-up|170|||
163424636|NCT00630331|590258304|FG000|Overall Study|Inappropriate enrollment|3|||
163424637|NCT00630331|590258305|FG001|Overall Study|Inappropriate enrollment|6|||
163424638|NCT00630331|590258306|FG002|Overall Study|Inappropriate enrollment|3|||
163424639|NCT00630331|590258304|FG000|Overall Study|Unable to classify|9|||
163424640|NCT00630331|590258305|FG001|Overall Study|Unable to classify|4|||
163424641|NCT00630331|590258306|FG002|Overall Study|Unable to classify|3|||
163424642|NCT00630331|590258304|FG000|Overall Study|Protocol Violation|4|||
163424643|NCT00630331|590258305|FG001|Overall Study|Protocol Violation|5|||
163424644|NCT00630331|590258306|FG002|Overall Study|Protocol Violation|6|||
163424645|NCT01929135|590258314|FG000|Overall Study|Lost to Follow-up|1|||
163424646|NCT01929135|590258315|FG001|Overall Study|Lost to Follow-up|1|||
163424647|NCT01955707|590258318|FG000|Overall Study|Adverse Event|1|||
163424648|NCT01955707|590258319|FG001|Overall Study|Adverse Event|2|||
163424649|NCT01955707|590258318|FG000|Overall Study|Lost to Follow-up|2|||
163424650|NCT01955707|590258319|FG001|Overall Study|Lost to Follow-up|1|||
163424651|NCT01955707|590258318|FG000|Overall Study|Withdrawal by Subject|0|||
163424652|NCT01955707|590258319|FG001|Overall Study|Withdrawal by Subject|3|||
163424653|NCT01955707|590258318|FG000|Overall Study|Death|13|||
163424654|NCT01955707|590258319|FG001|Overall Study|Death|14|||
163424655|NCT01955707|590258318|FG000|Overall Study|Other|4|||
163424656|NCT01955707|590258319|FG001|Overall Study|Other|2|||
163424657|NCT01817790|590258324|FG000|Overall Study|Adverse Event|0|||
163424658|NCT01817790|590258325|FG001|Overall Study|Adverse Event|2|||
163424659|NCT01817790|590258324|FG000|Overall Study|Lost to Follow-up|0|||
163424660|NCT01817790|590258325|FG001|Overall Study|Lost to Follow-up|1|||
163424661|NCT01817790|590258324|FG000|Overall Study|Protocol Violation|2|||
163424662|NCT01817790|590258325|FG001|Overall Study|Protocol Violation|1|||
163424663|NCT01817790|590258324|FG000|Overall Study|Withdrawal by Subject|1|||
163424664|NCT01817790|590258325|FG001|Overall Study|Withdrawal by Subject|3|||
163424665|NCT01817790|590258324|FG000|Overall Study|Other: Could not attend appointment|1|||
163424666|NCT01817790|590258325|FG001|Overall Study|Other: Could not attend appointment|1|||
163424667|NCT01671345|590258326|FG000|Overall Study|Lost to Follow-up|10|||
163424668|NCT01671345|590258327|FG001|Overall Study|Lost to Follow-up|6|||
163424669|NCT01671345|590258326|FG000|Overall Study|visit with non-participating physician|3|||
163424670|NCT01671345|590258327|FG001|Overall Study|visit with non-participating physician|3|||
163424671|NCT02847598|590258330|FG000|Overall Study|Adverse Event|0|||
163424672|NCT02847598|590258331|FG001|Overall Study|Adverse Event|0|||
163424673|NCT02847598|590258332|FG002|Overall Study|Adverse Event|0|||
163424674|NCT02847598|590258333|FG003|Overall Study|Adverse Event|0|||
163424675|NCT02847598|590258334|FG004|Overall Study|Adverse Event|0|||
163424676|NCT02847598|590258335|FG005|Overall Study|Adverse Event|0|||
163424677|NCT02847598|590258336|FG006|Overall Study|Adverse Event|0|||
163424678|NCT02847598|590258337|FG007|Overall Study|Adverse Event|1|||
163424679|NCT02847598|590258330|FG000|Overall Study|Consent withdrawn|2|||
163424680|NCT02847598|590258331|FG001|Overall Study|Consent withdrawn|0|||
163424681|NCT02847598|590258332|FG002|Overall Study|Consent withdrawn|0|||
163424682|NCT02847598|590258333|FG003|Overall Study|Consent withdrawn|4|||
163424683|NCT02847598|590258334|FG004|Overall Study|Consent withdrawn|3|||
163424684|NCT02847598|590258335|FG005|Overall Study|Consent withdrawn|2|||
163424685|NCT02847598|590258336|FG006|Overall Study|Consent withdrawn|1|||
163424686|NCT02847598|590258337|FG007|Overall Study|Consent withdrawn|3|||
163424687|NCT02847598|590258330|FG000|Overall Study|Death|3|||
163424688|NCT02847598|590258331|FG001|Overall Study|Death|0|||
163424689|NCT02847598|590258332|FG002|Overall Study|Death|0|||
163424690|NCT02847598|590258333|FG003|Overall Study|Death|0|||
163424691|NCT02847598|590258334|FG004|Overall Study|Death|0|||
163424692|NCT02847598|590258335|FG005|Overall Study|Death|0|||
163424693|NCT02847598|590258336|FG006|Overall Study|Death|0|||
163424694|NCT02847598|590258337|FG007|Overall Study|Death|0|||
163424695|NCT02847598|590258330|FG000|Overall Study|Lost to Follow-up|0|||
163424696|NCT02847598|590258331|FG001|Overall Study|Lost to Follow-up|0|||
163424697|NCT02847598|590258332|FG002|Overall Study|Lost to Follow-up|0|||
163424698|NCT02847598|590258333|FG003|Overall Study|Lost to Follow-up|0|||
163424699|NCT02847598|590258334|FG004|Overall Study|Lost to Follow-up|0|||
163424700|NCT02847598|590258335|FG005|Overall Study|Lost to Follow-up|1|||
163424701|NCT02847598|590258336|FG006|Overall Study|Lost to Follow-up|1|||
163424702|NCT02847598|590258337|FG007|Overall Study|Lost to Follow-up|0|||
163424703|NCT03690869|590258338|FG000|Overall Study|Adverse Event|0|||
163424704|NCT03690869|590258339|FG001|Overall Study|Adverse Event|0|||
163424705|NCT03690869|590258340|FG002|Overall Study|Adverse Event|0|||
163424706|NCT03690869|590258341|FG003|Overall Study|Adverse Event|1|||
163424707|NCT03690869|590258342|FG004|Overall Study|Adverse Event|0|||
163424708|NCT03690869|590258343|FG005|Overall Study|Adverse Event|0|||
163424709|NCT03690869|590258344|FG006|Overall Study|Adverse Event|0|||
163424710|NCT03690869|590258345|FG007|Overall Study|Adverse Event|1|||
163424711|NCT03690869|590258346|FG008|Overall Study|Adverse Event|0|||
163424712|NCT03690869|590258347|FG009|Overall Study|Adverse Event|1|||
163424713|NCT03690869|590258338|FG000|Overall Study|Death|1|||
163424714|NCT03690869|590258339|FG001|Overall Study|Death|1|||
163424715|NCT03690869|590258340|FG002|Overall Study|Death|1|||
163424716|NCT03690869|590258341|FG003|Overall Study|Death|4|||
163424717|NCT03690869|590258342|FG004|Overall Study|Death|2|||
163424718|NCT03690869|590258343|FG005|Overall Study|Death|5|||
163424719|NCT03690869|590258344|FG006|Overall Study|Death|3|||
163424720|NCT03690869|590258345|FG007|Overall Study|Death|2|||
163424721|NCT03690869|590258346|FG008|Overall Study|Death|0|||
163424722|NCT03690869|590258347|FG009|Overall Study|Death|3|||
163424723|NCT03690869|590258338|FG000|Overall Study|Lost to Follow-up|0|||
163424724|NCT03690869|590258339|FG001|Overall Study|Lost to Follow-up|0|||
163424725|NCT03690869|590258340|FG002|Overall Study|Lost to Follow-up|1|||
163424726|NCT03690869|590258341|FG003|Overall Study|Lost to Follow-up|0|||
163424727|NCT03690869|590258342|FG004|Overall Study|Lost to Follow-up|0|||
163424728|NCT03690869|590258343|FG005|Overall Study|Lost to Follow-up|0|||
163424729|NCT03690869|590258344|FG006|Overall Study|Lost to Follow-up|0|||
163424730|NCT03690869|590258345|FG007|Overall Study|Lost to Follow-up|0|||
163424731|NCT03690869|590258346|FG008|Overall Study|Lost to Follow-up|0|||
163424732|NCT03690869|590258347|FG009|Overall Study|Lost to Follow-up|0|||
163424733|NCT03690869|590258338|FG000|Overall Study|Other Treatment|1|||
163424734|NCT03690869|590258339|FG001|Overall Study|Other Treatment|1|||
163424735|NCT03690869|590258340|FG002|Overall Study|Other Treatment|1|||
163424736|NCT03690869|590258341|FG003|Overall Study|Other Treatment|2|||
163424737|NCT03690869|590258342|FG004|Overall Study|Other Treatment|3|||
163424738|NCT03690869|590258343|FG005|Overall Study|Other Treatment|1|||
163424739|NCT03690869|590258344|FG006|Overall Study|Other Treatment|2|||
163424740|NCT03690869|590258345|FG007|Overall Study|Other Treatment|7|||
163424741|NCT03690869|590258346|FG008|Overall Study|Other Treatment|0|||
163424742|NCT03690869|590258347|FG009|Overall Study|Other Treatment|3|||
163424743|NCT03690869|590258338|FG000|Overall Study|Physician Decision|0|||
163424744|NCT03690869|590258339|FG001|Overall Study|Physician Decision|1|||
163424745|NCT03690869|590258340|FG002|Overall Study|Physician Decision|0|||
163424746|NCT03690869|590258341|FG003|Overall Study|Physician Decision|0|||
163424747|NCT03690869|590258342|FG004|Overall Study|Physician Decision|0|||
163424748|NCT03690869|590258343|FG005|Overall Study|Physician Decision|0|||
163424749|NCT03690869|590258344|FG006|Overall Study|Physician Decision|0|||
163424750|NCT03690869|590258345|FG007|Overall Study|Physician Decision|0|||
163424751|NCT03690869|590258346|FG008|Overall Study|Physician Decision|0|||
163424752|NCT03690869|590258347|FG009|Overall Study|Physician Decision|0|||
163424753|NCT03690869|590258338|FG000|Overall Study|Progressive Disease|1|||
163424754|NCT03690869|590258339|FG001|Overall Study|Progressive Disease|2|||
163424755|NCT03690869|590258340|FG002|Overall Study|Progressive Disease|0|||
163424756|NCT03690869|590258341|FG003|Overall Study|Progressive Disease|1|||
163424757|NCT03690869|590258342|FG004|Overall Study|Progressive Disease|0|||
163424758|NCT03690869|590258343|FG005|Overall Study|Progressive Disease|0|||
163424759|NCT03690869|590258344|FG006|Overall Study|Progressive Disease|0|||
163424760|NCT03690869|590258345|FG007|Overall Study|Progressive Disease|0|||
163424761|NCT03690869|590258346|FG008|Overall Study|Progressive Disease|1|||
163424762|NCT03690869|590258347|FG009|Overall Study|Progressive Disease|1|||
163424763|NCT03690869|590258338|FG000|Overall Study|Subject Decision|0|||
163424764|NCT03690869|590258339|FG001|Overall Study|Subject Decision|0|||
163424765|NCT03690869|590258340|FG002|Overall Study|Subject Decision|0|||
163424766|NCT03690869|590258341|FG003|Overall Study|Subject Decision|1|||
163424767|NCT03690869|590258342|FG004|Overall Study|Subject Decision|0|||
163424768|NCT03690869|590258343|FG005|Overall Study|Subject Decision|0|||
163424769|NCT03690869|590258344|FG006|Overall Study|Subject Decision|0|||
163424770|NCT03690869|590258345|FG007|Overall Study|Subject Decision|1|||
163424771|NCT03690869|590258346|FG008|Overall Study|Subject Decision|0|||
163424772|NCT03690869|590258347|FG009|Overall Study|Subject Decision|0|||
163424773|NCT03797001|590259680|FG000|Overall Study|Withdrawn due to COVID19|4|||
163424774|NCT03797001|590259681|FG001|Overall Study|Withdrawn due to COVID19|0|||
163424775|NCT03797001|590259680|FG000|Overall Study|Withdrawal by Subject|7|||
163424776|NCT03797001|590259681|FG001|Overall Study|Withdrawal by Subject|6|||
163424777|NCT03797001|590259680|FG000|Overall Study|Adverse Event|0|||
163424778|NCT03797001|590259681|FG001|Overall Study|Adverse Event|1|||
163424779|NCT00500266|590259682|FG000|Overall Study|Death|3|||
163424780|NCT00500266|590259682|FG000|Overall Study|Lost to Follow-up|3|||
163424781|NCT00500266|590259682|FG000|Overall Study|Withdrawal by Subject|3|||
163424782|NCT00500266|590259682|FG000|Overall Study|Assigned, not treated|4|||
163424783|NCT01552057|590259684|FG000|Overall Study|Adverse Event|14|||
163424784|NCT01552057|590259685|FG001|Overall Study|Adverse Event|15|||
163424785|NCT01552057|590259684|FG000|Overall Study|Lack of Efficacy|8|||
163424786|NCT01552057|590259685|FG001|Overall Study|Lack of Efficacy|23|||
163424787|NCT01552057|590259684|FG000|Overall Study|Withdrawal by Subject|5|||
163424788|NCT01552057|590259685|FG001|Overall Study|Withdrawal by Subject|8|||
163424789|NCT01552057|590259684|FG000|Overall Study|Entry Criteria Not Met|2|||
163424790|NCT01552057|590259685|FG001|Overall Study|Entry Criteria Not Met|2|||
163424791|NCT01552057|590259684|FG000|Overall Study|Physician Decision|1|||
163424792|NCT01552057|590259685|FG001|Overall Study|Physician Decision|0|||
163424793|NCT03895203|590259686|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
163424794|NCT03895203|590259687|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
163424795|NCT03895203|590259688|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
163424796|NCT03895203|590259689|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
163424797|NCT03895203|590259690|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
163424798|NCT03895203|590259691|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
163424799|NCT03895203|590259686|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
163424800|NCT03895203|590259687|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
163424801|NCT03895203|590259688|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
163424802|NCT03895203|590259689|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
163424803|NCT03895203|590259690|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
163424804|NCT03895203|590259691|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
163424805|NCT03895203|590259686|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
163424806|NCT03895203|590259687|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
163424807|NCT03895203|590259688|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
163424808|NCT03895203|590259689|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
163424809|NCT03895203|590259690|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
163424810|NCT03895203|590259691|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
163424811|NCT03895203|590259686|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
163424812|NCT03895203|590259687|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
163424813|NCT03895203|590259688|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
163424814|NCT03895203|590259689|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
163424815|NCT03895203|590259690|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
163424816|NCT03895203|590259691|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
163424817|NCT03895203|590259686|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
163424818|NCT03895203|590259687|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
163424819|NCT03895203|590259688|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
163424820|NCT03895203|590259689|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
163424821|NCT03895203|590259690|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
163424822|NCT03895203|590259691|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
163424823|NCT03895203|590259686|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
163424824|NCT03895203|590259687|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
163424825|NCT03895203|590259688|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
163424826|NCT03895203|590259689|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
163424827|NCT03895203|590259690|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
163424828|NCT03895203|590259691|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
163424829|NCT03895203|590259686|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
163424830|NCT03895203|590259687|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
163424831|NCT03895203|590259688|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
163424832|NCT03895203|590259689|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
163424833|NCT03895203|590259690|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
163424834|NCT03895203|590259691|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
163424835|NCT03895203|590259686|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
163424836|NCT03895203|590259687|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
163424837|NCT03895203|590259688|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
163424838|NCT03895203|590259689|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
163424839|NCT03895203|590259690|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
163424840|NCT03895203|590259691|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
163424841|NCT03895203|590259686|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
163424842|NCT03895203|590259687|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
163424843|NCT03895203|590259688|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
163424844|NCT03895203|590259689|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
163424845|NCT03895203|590259690|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
163424846|NCT03895203|590259691|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
163424847|NCT03895203|590259686|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
163424848|NCT03895203|590259687|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
163424849|NCT03895203|590259688|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
163424850|NCT03895203|590259689|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
163424851|NCT03895203|590259690|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
163424852|NCT03895203|590259691|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
163424853|NCT03895203|590259686|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
163424854|NCT03895203|590259687|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
163424855|NCT03895203|590259688|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
163424856|NCT03895203|590259689|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
163424857|NCT03895203|590259690|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
163424858|NCT03895203|590259691|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
163424859|NCT03895203|590259686|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
163424860|NCT03895203|590259687|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
163424861|NCT03895203|590259688|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
163424862|NCT03895203|590259689|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
163424863|NCT03895203|590259690|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
163424864|NCT03895203|590259691|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
163424865|NCT03895203|590259686|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
163424866|NCT03895203|590259687|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
163424867|NCT03895203|590259688|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
163424868|NCT03895203|590259689|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
163424869|NCT03895203|590259690|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
163424870|NCT03895203|590259691|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
163424871|NCT03895203|590259686|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
163424872|NCT03895203|590259687|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
163424873|NCT03895203|590259688|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
163424874|NCT03895203|590259689|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
163424875|NCT03895203|590259690|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
163424876|NCT03895203|590259691|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
163424877|NCT04572633|590259692|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
163424878|NCT03155997|590259695|FG000|Overall Study|Withdrawal by Subject|119|||
163424879|NCT03155997|590259696|FG001|Overall Study|Withdrawal by Subject|134|||
163424880|NCT03155997|590259695|FG000|Overall Study|Lost to Follow-up|12|||
163424881|NCT03155997|590259696|FG001|Overall Study|Lost to Follow-up|13|||
163424882|NCT03155997|590259695|FG000|Overall Study|Missing disposition data|0|||
163424883|NCT03155997|590259696|FG001|Overall Study|Missing disposition data|1|||
163424884|NCT03155997|590259695|FG000|Overall Study|On study treatment|2027|||
163424885|NCT03155997|590259696|FG001|Overall Study|On study treatment|2074|||
163424886|NCT03514914|590259698|FG000|Overall Study|Death|3|||
163424887|NCT03514914|590259699|FG001|Overall Study|Death|3|||
163424888|NCT03514914|590259698|FG000|Overall Study|Lost to Follow-up|117|||
163424889|NCT03514914|590259699|FG001|Overall Study|Lost to Follow-up|89|||
163424890|NCT02507349|590259706|FG000|Overall Study|Death|12|||
163424891|NCT02507349|590259707|FG001|Overall Study|Death|16|||
163424892|NCT02507349|590259706|FG000|Overall Study|Withdrawal by Subject|1|||
163424893|NCT02507349|590259707|FG001|Overall Study|Withdrawal by Subject|1|||
163424894|NCT02507349|590259706|FG000|Overall Study|Lost to Follow-up|174|||
163424895|NCT02507349|590259707|FG001|Overall Study|Lost to Follow-up|144|||
163424896|NCT02700984|590259708|FG000|Overall Study|Death|2|||
163424897|NCT02700984|590259709|FG001|Overall Study|Death|1|||
163424898|NCT02700984|590259708|FG000|Overall Study|Lost to Follow-up|2|||
163424899|NCT02700984|590259709|FG001|Overall Study|Lost to Follow-up|1|||
163424900|NCT02700984|590259708|FG000|Overall Study|Physician Decision|0|||
163424901|NCT02700984|590259709|FG001|Overall Study|Physician Decision|1|||
163424902|NCT02700984|590259708|FG000|Overall Study|Withdrawal by Subject|8|||
163424903|NCT02700984|590259709|FG001|Overall Study|Withdrawal by Subject|9|||
163424904|NCT02700984|590259708|FG000|Overall Study|Reason not specified|3|||
163424905|NCT02700984|590259709|FG001|Overall Study|Reason not specified|2|||
163424906|NCT00473876|590259710|FG000|Overall Study|Lost to Follow-up|3|||
163424907|NCT00473876|590259711|FG001|Overall Study|Lost to Follow-up|1|||
163424908|NCT00727402|590259712|FG000|Overall Study|Physician Decision|116|||
163424909|NCT02949830|590259714|FG000|Overall Study|Adverse Event|1|||
163424910|NCT02949830|590259714|FG000|Overall Study|Withdrawal by Subject|1|||
163424911|NCT01290887|590259715|FG000|Overall Study|Adverse Event|6|||
163424912|NCT01290887|590259716|FG001|Overall Study|Adverse Event|11|||
163424913|NCT01290887|590259715|FG000|Overall Study|Lack of Efficacy|4|||
163424914|NCT01290887|590259716|FG001|Overall Study|Lack of Efficacy|5|||
163424915|NCT01290887|590259715|FG000|Overall Study|Withdrawal by Subject|26|||
163424916|NCT01290887|590259716|FG001|Overall Study|Withdrawal by Subject|32|||
163424917|NCT01290887|590259715|FG000|Overall Study|Protocol Violation|2|||
163424918|NCT01290887|590259716|FG001|Overall Study|Protocol Violation|1|||
163424919|NCT01290887|590259715|FG000|Overall Study|Lost to Follow-up|4|||
163424920|NCT01290887|590259716|FG001|Overall Study|Lost to Follow-up|4|||
163424921|NCT01290887|590259715|FG000|Overall Study|Non-compliance to study procedures|0|||
163424922|NCT01290887|590259716|FG001|Overall Study|Non-compliance to study procedures|1|||
163424923|NCT01290887|590259715|FG000|Overall Study|Non-compliance to study medications|1|||
163424924|NCT01290887|590259716|FG001|Overall Study|Non-compliance to study medications|0|||
163424925|NCT01290887|590259715|FG000|Overall Study|Sponsor closure of study|420|||
163424926|NCT01290887|590259716|FG001|Overall Study|Sponsor closure of study|476|||
163424927|NCT01290887|590259715|FG000|Overall Study|Other|3|||
163424928|NCT01290887|590259716|FG001|Overall Study|Other|6|||
163424929|NCT01628926|590259717|FG000|Overall Study|Adverse Event|13|||
163424930|NCT01628926|590259718|FG001|Overall Study|Adverse Event|11|||
163424931|NCT01628926|590259719|FG002|Overall Study|Adverse Event|9|||
163424932|NCT01628926|590259717|FG000|Overall Study|Lack of Efficacy|2|||
163424933|NCT01628926|590259718|FG001|Overall Study|Lack of Efficacy|1|||
163424934|NCT01628926|590259719|FG002|Overall Study|Lack of Efficacy|5|||
163424935|NCT01628926|590259717|FG000|Overall Study|Withdrawal by Subject|6|||
163424936|NCT01628926|590259718|FG001|Overall Study|Withdrawal by Subject|4|||
163424937|NCT01628926|590259719|FG002|Overall Study|Withdrawal by Subject|2|||
163424938|NCT01628926|590259717|FG000|Overall Study|Protocol Violation|0|||
163424939|NCT01628926|590259718|FG001|Overall Study|Protocol Violation|1|||
163424940|NCT01628926|590259719|FG002|Overall Study|Protocol Violation|0|||
163424941|NCT01628926|590259717|FG000|Overall Study|Discontinuation criteria|3|||
163424942|NCT01628926|590259718|FG001|Overall Study|Discontinuation criteria|4|||
163424943|NCT01628926|590259719|FG002|Overall Study|Discontinuation criteria|0|||
163424944|NCT01628926|590259717|FG000|Overall Study|Physician Decision|2|||
163424945|NCT01628926|590259718|FG001|Overall Study|Physician Decision|2|||
163424946|NCT01628926|590259719|FG002|Overall Study|Physician Decision|1|||
163424947|NCT04373460|590259720|FG000|Overall Study|Did not receive tranfusion|18|||
163424948|NCT04373460|590259721|FG001|Overall Study|Did not receive tranfusion|26|||
163424949|NCT01672957|590259722|FG000|Overall Study|Protocol Violation|48|||
163424950|NCT01672957|590259722|FG000|Overall Study|Death|2|||
163424951|NCT01672957|590259722|FG000|Overall Study|ICF Signed After Transplantation|5|||
163424952|NCT01795547|590259725|FG000|Overall Study|Adverse Event|16|||
163424953|NCT01795547|590259726|FG001|Overall Study|Adverse Event|27|||
163424954|NCT01795547|590259725|FG000|Overall Study|Lack of Efficacy|8|||
163424955|NCT01795547|590259726|FG001|Overall Study|Lack of Efficacy|3|||
163424956|NCT01795547|590259725|FG000|Overall Study|Protocol Violation|6|||
163424957|NCT01795547|590259726|FG001|Overall Study|Protocol Violation|4|||
163424958|NCT01795547|590259725|FG000|Overall Study|Lost to Follow-up|2|||
163424959|NCT01795547|590259726|FG001|Overall Study|Lost to Follow-up|5|||
163424960|NCT01795547|590259725|FG000|Overall Study|Withdrawal of consent|7|||
163424961|NCT01795547|590259726|FG001|Overall Study|Withdrawal of consent|12|||
163424962|NCT01795547|590259725|FG000|Overall Study|Not Treated|4|||
163424963|NCT01795547|590259726|FG001|Overall Study|Not Treated|10|||
163424964|NCT01795547|590259725|FG000|Overall Study|Non-compliance with IMP|1|||
163424965|NCT01795547|590259726|FG001|Overall Study|Non-compliance with IMP|1|||
163424966|NCT01795547|590259725|FG000|Overall Study|Others|4|||
163424967|NCT01795547|590259726|FG001|Overall Study|Others|1|||
163424968|NCT01795547|590259725|FG000|Overall Study|Not stated|0|||
163424969|NCT01795547|590259726|FG001|Overall Study|Not stated|1|||
163424970|NCT00642642|590259727|FG000|Treatment & Follow Up|Adverse Event|2|||
163424971|NCT00642642|590259727|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
163424972|NCT00642642|590259727|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
163424973|NCT00151892|590259728|FG000|Overall Study|Lack of Efficacy|50|||
163424974|NCT00151892|590259729|FG001|Overall Study|Lack of Efficacy|57|||
163424975|NCT00151892|590259728|FG000|Overall Study|Patient request|10|||
163424976|NCT00151892|590259729|FG001|Overall Study|Patient request|7|||
163424977|NCT00151892|590259728|FG000|Overall Study|Lost to Follow-up|5|||
163424978|NCT00151892|590259729|FG001|Overall Study|Lost to Follow-up|10|||
163424979|NCT00151892|590259728|FG000|Overall Study|Adverse Event|6|||
163424980|NCT00151892|590259729|FG001|Overall Study|Adverse Event|3|||
163424981|NCT00151892|590259728|FG000|Overall Study|Protocol Violation|3|||
163424982|NCT00151892|590259729|FG001|Overall Study|Protocol Violation|3|||
163424983|NCT00151892|590259728|FG000|Overall Study|Non-compliance|0|||
163424984|NCT00151892|590259729|FG001|Overall Study|Non-compliance|1|||
163424985|NCT00151892|590259728|FG000|Overall Study|Pregnancy|0|||
163424986|NCT00151892|590259729|FG001|Overall Study|Pregnancy|1|||
163424987|NCT00151892|590259728|FG000|Overall Study|Did not return for a visit|1|||
163424988|NCT00151892|590259729|FG001|Overall Study|Did not return for a visit|0|||
163424989|NCT00151892|590259728|FG000|Overall Study|Used prohibited corticosteroids|1|||
163424990|NCT00151892|590259729|FG001|Overall Study|Used prohibited corticosteroids|0|||
163424991|NCT00151892|590259728|FG000|Overall Study|Lack of study medication at center|0|||
163424992|NCT00151892|590259729|FG001|Overall Study|Lack of study medication at center|1|||
163424993|NCT03440944|590259732|FG000|Overall Study|Physician Decision|1|||
163424994|NCT03440944|590259733|FG001|Overall Study|Physician Decision|0|||
163424995|NCT03440944|590259732|FG000|Overall Study|No Acceptable Vasculature|0|||
163424996|NCT03440944|590259733|FG001|Overall Study|No Acceptable Vasculature|1|||
163424997|NCT04672083|590259734|FG000|Overall Study|Lost to Follow-up|1|||
163424998|NCT04672083|590259735|FG001|Overall Study|Lost to Follow-up|0|||
163424999|NCT04672083|590259736|FG002|Overall Study|Lost to Follow-up|0|||
163425000|NCT04672083|590259737|FG003|Overall Study|Lost to Follow-up|0|||
163425001|NCT04672083|590259738|FG004|Overall Study|Lost to Follow-up|0|||
163425002|NCT02764541|590259739|FG000|Overall Study|Withdrawal by Subject|0|||
163425003|NCT02764541|590259740|FG001|Overall Study|Withdrawal by Subject|0|||
163425004|NCT02764541|590259741|FG002|Overall Study|Withdrawal by Subject|0|||
163425005|NCT02764541|590259742|FG003|Overall Study|Withdrawal by Subject|0|||
163425006|NCT02764541|590259743|FG004|Overall Study|Withdrawal by Subject|1|||
163425007|NCT02764541|590259744|FG005|Overall Study|Withdrawal by Subject|1|||
163425008|NCT02764541|590259745|FG006|Overall Study|Withdrawal by Subject|0|||
163425009|NCT02764541|590259746|FG007|Overall Study|Withdrawal by Subject|1|||
163425010|NCT02764541|590259739|FG000|Overall Study|Adverse Event|1|||
163425011|NCT02764541|590259740|FG001|Overall Study|Adverse Event|0|||
163425012|NCT02764541|590259741|FG002|Overall Study|Adverse Event|0|||
163425013|NCT02764541|590259742|FG003|Overall Study|Adverse Event|0|||
163425014|NCT02764541|590259743|FG004|Overall Study|Adverse Event|0|||
163425015|NCT02764541|590259744|FG005|Overall Study|Adverse Event|0|||
163425016|NCT02764541|590259745|FG006|Overall Study|Adverse Event|1|||
163425017|NCT02764541|590259746|FG007|Overall Study|Adverse Event|0|||
163425018|NCT02764541|590259739|FG000|Overall Study|Metastasis|1|||
163425019|NCT02764541|590259740|FG001|Overall Study|Metastasis|0|||
163425020|NCT02764541|590259741|FG002|Overall Study|Metastasis|0|||
163425021|NCT02764541|590259742|FG003|Overall Study|Metastasis|0|||
163425022|NCT02764541|590259743|FG004|Overall Study|Metastasis|0|||
163425023|NCT02764541|590259744|FG005|Overall Study|Metastasis|0|||
163425024|NCT02764541|590259745|FG006|Overall Study|Metastasis|0|||
163425025|NCT02764541|590259746|FG007|Overall Study|Metastasis|0|||
163425026|NCT02764541|590259739|FG000|Overall Study|Disease progression|1|||
163425027|NCT02764541|590259740|FG001|Overall Study|Disease progression|1|||
163425028|NCT02764541|590259741|FG002|Overall Study|Disease progression|0|||
163425029|NCT02764541|590259742|FG003|Overall Study|Disease progression|0|||
163425030|NCT02764541|590259743|FG004|Overall Study|Disease progression|0|||
163425031|NCT02764541|590259744|FG005|Overall Study|Disease progression|0|||
163425032|NCT02764541|590259745|FG006|Overall Study|Disease progression|0|||
163425033|NCT02764541|590259746|FG007|Overall Study|Disease progression|1|||
163425034|NCT02764541|590259739|FG000|Overall Study|Protocol Violation|0|||
163425035|NCT02764541|590259740|FG001|Overall Study|Protocol Violation|0|||
163425036|NCT02764541|590259741|FG002|Overall Study|Protocol Violation|0|||
163425037|NCT02764541|590259742|FG003|Overall Study|Protocol Violation|1|||
163425038|NCT02764541|590259743|FG004|Overall Study|Protocol Violation|0|||
163425039|NCT02764541|590259744|FG005|Overall Study|Protocol Violation|1|||
163425040|NCT02764541|590259745|FG006|Overall Study|Protocol Violation|0|||
163425041|NCT02764541|590259746|FG007|Overall Study|Protocol Violation|0|||
163425042|NCT02764541|590259739|FG000|Overall Study|Physician Decision|0|||
163425043|NCT02764541|590259740|FG001|Overall Study|Physician Decision|0|||
163425044|NCT02764541|590259741|FG002|Overall Study|Physician Decision|0|||
163425045|NCT02764541|590259742|FG003|Overall Study|Physician Decision|1|||
163425046|NCT02764541|590259743|FG004|Overall Study|Physician Decision|0|||
163425047|NCT02764541|590259744|FG005|Overall Study|Physician Decision|0|||
163425048|NCT02764541|590259745|FG006|Overall Study|Physician Decision|0|||
163425049|NCT02764541|590259746|FG007|Overall Study|Physician Decision|1|||
163425050|NCT02764541|590259739|FG000|Overall Study|Three Cycles completed before surgery|0|||
163425051|NCT02764541|590259740|FG001|Overall Study|Three Cycles completed before surgery|0|||
163425052|NCT02764541|590259741|FG002|Overall Study|Three Cycles completed before surgery|0|||
163425053|NCT02764541|590259742|FG003|Overall Study|Three Cycles completed before surgery|1|||
163425054|NCT02764541|590259743|FG004|Overall Study|Three Cycles completed before surgery|0|||
163425055|NCT02764541|590259744|FG005|Overall Study|Three Cycles completed before surgery|0|||
163425056|NCT02764541|590259745|FG006|Overall Study|Three Cycles completed before surgery|0|||
163425057|NCT02764541|590259746|FG007|Overall Study|Three Cycles completed before surgery|0|||
163425058|NCT02764541|590259739|FG000|Overall Study|Patient Compliance|0|||
163425059|NCT02764541|590259740|FG001|Overall Study|Patient Compliance|0|||
163425060|NCT02764541|590259741|FG002|Overall Study|Patient Compliance|1|||
163425061|NCT02764541|590259742|FG003|Overall Study|Patient Compliance|0|||
163425062|NCT02764541|590259743|FG004|Overall Study|Patient Compliance|0|||
163425063|NCT02764541|590259744|FG005|Overall Study|Patient Compliance|0|||
163425064|NCT02764541|590259745|FG006|Overall Study|Patient Compliance|0|||
163425065|NCT02764541|590259746|FG007|Overall Study|Patient Compliance|0|||
163425066|NCT02764541|590259739|FG000|Overall Study|Death|0|||
163425067|NCT02764541|590259740|FG001|Overall Study|Death|0|||
163425068|NCT02764541|590259741|FG002|Overall Study|Death|0|||
163425069|NCT02764541|590259742|FG003|Overall Study|Death|0|||
163425070|NCT02764541|590259743|FG004|Overall Study|Death|0|||
163425071|NCT02764541|590259744|FG005|Overall Study|Death|0|||
163425072|NCT02764541|590259745|FG006|Overall Study|Death|1|||
163425073|NCT02764541|590259746|FG007|Overall Study|Death|0|||
163425074|NCT02764541|590259739|FG000|Overall Study|Insurance reasons|0|||
163425075|NCT02764541|590259740|FG001|Overall Study|Insurance reasons|0|||
163425076|NCT02764541|590259741|FG002|Overall Study|Insurance reasons|0|||
163425077|NCT02764541|590259742|FG003|Overall Study|Insurance reasons|0|||
163425078|NCT02764541|590259743|FG004|Overall Study|Insurance reasons|0|||
163425079|NCT02764541|590259744|FG005|Overall Study|Insurance reasons|0|||
163425080|NCT02764541|590259745|FG006|Overall Study|Insurance reasons|1|||
163425081|NCT02764541|590259746|FG007|Overall Study|Insurance reasons|0|||
163425082|NCT00749190|590259749|FG000|Overall Study|Adverse Event|0|||
163425083|NCT00749190|590259750|FG001|Overall Study|Adverse Event|2|||
163425084|NCT00749190|590259751|FG002|Overall Study|Adverse Event|0|||
163425085|NCT00749190|590259752|FG003|Overall Study|Adverse Event|4|||
163425086|NCT00749190|590259753|FG004|Overall Study|Adverse Event|0|||
163425087|NCT00749190|590259754|FG005|Overall Study|Adverse Event|3|||
163425088|NCT00749190|590259755|FG006|Overall Study|Adverse Event|0|||
163425089|NCT00749190|590259749|FG000|Overall Study|Lack of Efficacy|3|||
163425090|NCT00749190|590259750|FG001|Overall Study|Lack of Efficacy|1|||
163425091|NCT00749190|590259751|FG002|Overall Study|Lack of Efficacy|1|||
163425092|NCT00749190|590259752|FG003|Overall Study|Lack of Efficacy|0|||
163425093|NCT00749190|590259753|FG004|Overall Study|Lack of Efficacy|0|||
163425094|NCT00749190|590259754|FG005|Overall Study|Lack of Efficacy|1|||
163425095|NCT00749190|590259755|FG006|Overall Study|Lack of Efficacy|0|||
163425096|NCT00749190|590259749|FG000|Overall Study|Withdrawal by Subject|2|||
163425097|NCT00749190|590259750|FG001|Overall Study|Withdrawal by Subject|1|||
163425098|NCT00749190|590259751|FG002|Overall Study|Withdrawal by Subject|0|||
163425099|NCT00749190|590259752|FG003|Overall Study|Withdrawal by Subject|0|||
163425100|NCT00749190|590259753|FG004|Overall Study|Withdrawal by Subject|0|||
163425101|NCT00749190|590259754|FG005|Overall Study|Withdrawal by Subject|1|||
163425102|NCT00749190|590259755|FG006|Overall Study|Withdrawal by Subject|0|||
163425103|NCT00749190|590259749|FG000|Overall Study|Protocol Violation|0|||
163425104|NCT00749190|590259750|FG001|Overall Study|Protocol Violation|1|||
163425105|NCT00749190|590259751|FG002|Overall Study|Protocol Violation|0|||
163425106|NCT00749190|590259752|FG003|Overall Study|Protocol Violation|0|||
163425107|NCT00749190|590259753|FG004|Overall Study|Protocol Violation|0|||
163425108|NCT00749190|590259754|FG005|Overall Study|Protocol Violation|0|||
163425109|NCT00749190|590259755|FG006|Overall Study|Protocol Violation|1|||
163425110|NCT00749190|590259749|FG000|Overall Study|Other reason not defined above|0|||
163425111|NCT00749190|590259750|FG001|Overall Study|Other reason not defined above|0|||
163425112|NCT00749190|590259751|FG002|Overall Study|Other reason not defined above|0|||
163425113|NCT00749190|590259752|FG003|Overall Study|Other reason not defined above|1|||
163425114|NCT00749190|590259753|FG004|Overall Study|Other reason not defined above|0|||
163425115|NCT00749190|590259754|FG005|Overall Study|Other reason not defined above|0|||
163425116|NCT00749190|590259755|FG006|Overall Study|Other reason not defined above|0|||
163425117|NCT03726268|590259757|FG000|Overall Study|Physician Decision|2|||
163425118|NCT03726268|590259758|FG001|Overall Study|Physician Decision|8|||
163425119|NCT03726268|590259759|FG002|Overall Study|Physician Decision|6|||
163425120|NCT03726268|590259760|FG003|Overall Study|Physician Decision|3|||
163425121|NCT03726268|590259757|FG000|Overall Study|Withdrawal by Subject|11|||
163425122|NCT03726268|590259758|FG001|Overall Study|Withdrawal by Subject|5|||
163425123|NCT03726268|590259759|FG002|Overall Study|Withdrawal by Subject|9|||
163425124|NCT03726268|590259760|FG003|Overall Study|Withdrawal by Subject|8|||
163425125|NCT00490542|590259761|FG000|Overall Study|Lost to Follow-up|3|||
163425126|NCT00490542|590259762|FG001|Overall Study|Lost to Follow-up|0|||
163425127|NCT00490542|590259761|FG000|Overall Study|Adverse Event|3|||
163425128|NCT00490542|590259762|FG001|Overall Study|Adverse Event|3|||
163425129|NCT00490542|590259761|FG000|Overall Study|Lack of Efficacy|1|||
163425130|NCT00490542|590259762|FG001|Overall Study|Lack of Efficacy|1|||
163425131|NCT02875223|590259763|FG000|Overall Study|Other reasons|0|||
163425132|NCT02875223|590259764|FG001|Overall Study|Other reasons|0|||
163425133|NCT02875223|590259765|FG002|Overall Study|Other reasons|1|||
163425134|NCT02875223|590259766|FG003|Overall Study|Other reasons|0|||
163425135|NCT02875223|590259767|FG004|Overall Study|Other reasons|1|||
163425136|NCT02875223|590259768|FG005|Overall Study|Other reasons|2|||
163425137|NCT02875223|590259769|FG006|Overall Study|Other reasons|0|||
163425138|NCT02875223|590259770|FG007|Overall Study|Other reasons|2|||
163425139|NCT02875223|590259771|FG008|Overall Study|Other reasons|0|||
163425140|NCT02875223|590259772|FG009|Overall Study|Other reasons|0|||
163425141|NCT02875223|590259773|FG010|Overall Study|Other reasons|0|||
163425142|NCT02875223|590259774|FG011|Overall Study|Other reasons|0|||
163425143|NCT02875223|590259775|FG012|Overall Study|Other reasons|0|||
163425144|NCT02875223|590259763|FG000|Overall Study|Withdrawal by Subject|0|||
163425145|NCT02875223|590259764|FG001|Overall Study|Withdrawal by Subject|0|||
163425146|NCT02875223|590259765|FG002|Overall Study|Withdrawal by Subject|0|||
163425147|NCT02875223|590259766|FG003|Overall Study|Withdrawal by Subject|0|||
163425148|NCT02875223|590259767|FG004|Overall Study|Withdrawal by Subject|1|||
163425149|NCT02875223|590259768|FG005|Overall Study|Withdrawal by Subject|1|||
163425150|NCT02875223|590259769|FG006|Overall Study|Withdrawal by Subject|0|||
163425151|NCT02875223|590259770|FG007|Overall Study|Withdrawal by Subject|0|||
163425152|NCT02875223|590259771|FG008|Overall Study|Withdrawal by Subject|1|||
163425153|NCT02875223|590259772|FG009|Overall Study|Withdrawal by Subject|0|||
163425154|NCT02875223|590259773|FG010|Overall Study|Withdrawal by Subject|0|||
163425155|NCT02875223|590259774|FG011|Overall Study|Withdrawal by Subject|0|||
163425156|NCT02875223|590259775|FG012|Overall Study|Withdrawal by Subject|0|||
163425157|NCT02875223|590259763|FG000|Overall Study|Progressive disease|0|||
163425158|NCT02875223|590259764|FG001|Overall Study|Progressive disease|0|||
163425159|NCT02875223|590259765|FG002|Overall Study|Progressive disease|1|||
163425160|NCT02875223|590259766|FG003|Overall Study|Progressive disease|0|||
163425161|NCT02875223|590259767|FG004|Overall Study|Progressive disease|0|||
163425162|NCT02875223|590259768|FG005|Overall Study|Progressive disease|0|||
163425163|NCT02875223|590259769|FG006|Overall Study|Progressive disease|0|||
163425164|NCT02875223|590259770|FG007|Overall Study|Progressive disease|0|||
163425165|NCT02875223|590259771|FG008|Overall Study|Progressive disease|0|||
163425166|NCT02875223|590259772|FG009|Overall Study|Progressive disease|12|||
163425167|NCT02875223|590259773|FG010|Overall Study|Progressive disease|2|||
163425168|NCT02875223|590259774|FG011|Overall Study|Progressive disease|3|||
163425169|NCT02875223|590259775|FG012|Overall Study|Progressive disease|6|||
163425170|NCT02875223|590259763|FG000|Overall Study|Death|4|||
163425171|NCT02875223|590259764|FG001|Overall Study|Death|4|||
163425172|NCT02875223|590259765|FG002|Overall Study|Death|3|||
163425173|NCT02875223|590259766|FG003|Overall Study|Death|4|||
163425174|NCT02875223|590259767|FG004|Overall Study|Death|2|||
163425175|NCT02875223|590259768|FG005|Overall Study|Death|3|||
163425176|NCT02875223|590259769|FG006|Overall Study|Death|5|||
163425177|NCT02875223|590259770|FG007|Overall Study|Death|7|||
163425178|NCT02875223|590259771|FG008|Overall Study|Death|3|||
163425179|NCT02875223|590259772|FG009|Overall Study|Death|2|||
163425180|NCT02875223|590259773|FG010|Overall Study|Death|0|||
163425181|NCT02875223|590259774|FG011|Overall Study|Death|0|||
163425182|NCT02875223|590259775|FG012|Overall Study|Death|0|||
163425183|NCT02875223|590259763|FG000|Overall Study|Lost to Follow-up|0|||
163425184|NCT02875223|590259764|FG001|Overall Study|Lost to Follow-up|1|||
163425185|NCT02875223|590259765|FG002|Overall Study|Lost to Follow-up|1|||
163425186|NCT02875223|590259766|FG003|Overall Study|Lost to Follow-up|0|||
163425187|NCT02875223|590259767|FG004|Overall Study|Lost to Follow-up|1|||
163425188|NCT02875223|590259768|FG005|Overall Study|Lost to Follow-up|0|||
163425189|NCT02875223|590259769|FG006|Overall Study|Lost to Follow-up|1|||
163425190|NCT02875223|590259770|FG007|Overall Study|Lost to Follow-up|1|||
163425191|NCT02875223|590259771|FG008|Overall Study|Lost to Follow-up|0|||
163425192|NCT02875223|590259772|FG009|Overall Study|Lost to Follow-up|0|||
163425193|NCT02875223|590259773|FG010|Overall Study|Lost to Follow-up|0|||
163425194|NCT02875223|590259774|FG011|Overall Study|Lost to Follow-up|0|||
163425195|NCT02875223|590259775|FG012|Overall Study|Lost to Follow-up|0|||
163425196|NCT03136107|590259776|FG000|Overall Study|Other (Not specified)|1|||
163425197|NCT01707992|590259778|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
163425198|NCT01707992|590259779|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
163425199|NCT01707992|590259780|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
163425200|NCT01707992|590259781|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
163425201|NCT01707992|590259782|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
163425202|NCT01707992|590259783|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
163425203|NCT01707992|590259778|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
163425204|NCT01707992|590259779|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
163425205|NCT01707992|590259780|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
163425206|NCT01707992|590259781|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
163425207|NCT01707992|590259782|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
163425208|NCT01707992|590259783|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
163425209|NCT01707992|590259778|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
163425210|NCT01707992|590259779|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
163425211|NCT01707992|590259780|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
163425212|NCT01707992|590259781|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
163425213|NCT01707992|590259782|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
163425214|NCT01707992|590259783|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
163425215|NCT01707992|590259778|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
163425216|NCT01707992|590259779|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
163425217|NCT01707992|590259780|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
163425218|NCT01707992|590259781|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
163425219|NCT01707992|590259782|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
163425220|NCT01707992|590259783|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
163425221|NCT01707992|590259778|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
163425222|NCT01707992|590259779|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
163425223|NCT01707992|590259780|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
163425224|NCT01707992|590259781|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
163425225|NCT01707992|590259782|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
163425226|NCT01707992|590259783|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
163425227|NCT01707992|590259778|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
163425228|NCT01707992|590259779|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
163425229|NCT01707992|590259780|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
163425230|NCT01707992|590259781|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
163425231|NCT01707992|590259782|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
163425232|NCT01707992|590259783|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
163425233|NCT01707992|590259778|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
163425234|NCT01707992|590259779|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
163425235|NCT01707992|590259780|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
163425236|NCT01707992|590259781|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
163425237|NCT01707992|590259782|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
163425238|NCT01707992|590259783|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
163425239|NCT01707992|590259778|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
163425240|NCT01707992|590259779|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
163425241|NCT01707992|590259780|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
163425242|NCT01707992|590259781|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
163425243|NCT01707992|590259782|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
163425244|NCT01707992|590259783|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
163425245|NCT01707992|590259778|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
163425246|NCT01707992|590259779|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
163425247|NCT01707992|590259780|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
163425248|NCT01707992|590259781|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
163425249|NCT01707992|590259782|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
163425250|NCT01707992|590259783|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
163425251|NCT01707992|590259778|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
163425252|NCT01707992|590259779|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
163425253|NCT01707992|590259780|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
163425254|NCT01707992|590259781|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
163425255|NCT01707992|590259782|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
163425256|NCT01707992|590259783|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
163425257|NCT01707992|590259778|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
163425258|NCT01707992|590259779|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
163425259|NCT01707992|590259780|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
163425260|NCT01707992|590259781|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
163425261|NCT01707992|590259782|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
163425262|NCT01707992|590259783|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
163425263|NCT01707992|590259778|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
163425264|NCT01707992|590259779|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
163425265|NCT01707992|590259780|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
163425266|NCT01707992|590259781|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
163425267|NCT01707992|590259782|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
163425268|NCT01707992|590259783|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
163425269|NCT01707992|590259778|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
163425270|NCT01707992|590259779|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
163425271|NCT01707992|590259780|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
163425272|NCT01707992|590259781|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
163425273|NCT01707992|590259782|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
163425274|NCT01707992|590259783|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
163425275|NCT01707992|590259778|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
163425276|NCT01707992|590259779|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
163425277|NCT01707992|590259780|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
163425278|NCT01707992|590259781|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
163425279|NCT01707992|590259782|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
163425280|NCT01707992|590259783|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
163425281|NCT01707992|590259778|FG000|Active Treatment Phase (24 Months)|Death|0|||
163425282|NCT01707992|590259779|FG001|Active Treatment Phase (24 Months)|Death|0|||
163425283|NCT01707992|590259780|FG002|Active Treatment Phase (24 Months)|Death|0|||
163425284|NCT01707992|590259781|FG003|Active Treatment Phase (24 Months)|Death|2|||
163425285|NCT01707992|590259782|FG004|Active Treatment Phase (24 Months)|Death|0|||
163425286|NCT01707992|590259783|FG005|Active Treatment Phase (24 Months)|Death|0|||
163425287|NCT01707992|590259778|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
163425288|NCT01707992|590259779|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
163425289|NCT01707992|590259780|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
163425290|NCT01707992|590259781|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
163425291|NCT01707992|590259782|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
163425292|NCT01707992|590259783|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
163425293|NCT01707992|590259778|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
163425294|NCT01707992|590259779|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
163425295|NCT01707992|590259780|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
163425296|NCT01707992|590259781|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
163425297|NCT01707992|590259782|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
163425298|NCT01707992|590259783|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
163425299|NCT01707992|590259778|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
163425300|NCT01707992|590259779|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
163425301|NCT01707992|590259780|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
163425302|NCT01707992|590259781|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
163425303|NCT01707992|590259782|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
163425304|NCT01707992|590259783|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
163425305|NCT01707992|590259778|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
163425306|NCT01707992|590259779|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
163425307|NCT01707992|590259780|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
163425308|NCT01707992|590259781|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
163425309|NCT01707992|590259782|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
163425310|NCT01707992|590259783|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
163425311|NCT00998738|590259784|FG000|Overall Study|Uknown|1|||
163425312|NCT03498521|590259785|FG000|Overall Study|Death|227|||
163425313|NCT03498521|590259786|FG001|Overall Study|Death|79|||
163425314|NCT03498521|590259787|FG002|Overall Study|Death|84|||
163425315|NCT03498521|590259785|FG000|Overall Study|Exclusion criteria|1|||
163425316|NCT03498521|590259786|FG001|Overall Study|Exclusion criteria|0|||
163425317|NCT03498521|590259787|FG002|Overall Study|Exclusion criteria|0|||
163425318|NCT03498521|590259785|FG000|Overall Study|Lost to Follow-up|4|||
163425319|NCT03498521|590259786|FG001|Overall Study|Lost to Follow-up|3|||
163425320|NCT03498521|590259787|FG002|Overall Study|Lost to Follow-up|3|||
163425321|NCT03498521|590259785|FG000|Overall Study|No profile due to technical failure|1|||
163425322|NCT03498521|590259786|FG001|Overall Study|No profile due to technical failure|0|||
163425323|NCT03498521|590259787|FG002|Overall Study|No profile due to technical failure|0|||
163425324|NCT03498521|590259785|FG000|Overall Study|Physician Decision|3|||
163425325|NCT03498521|590259786|FG001|Overall Study|Physician Decision|1|||
163425326|NCT03498521|590259787|FG002|Overall Study|Physician Decision|0|||
163425327|NCT03498521|590259785|FG000|Overall Study|Withdrawal by Subject|11|||
163425328|NCT03498521|590259786|FG001|Overall Study|Withdrawal by Subject|6|||
163425329|NCT03498521|590259787|FG002|Overall Study|Withdrawal by Subject|2|||
163425330|NCT03498521|590259785|FG000|Overall Study|Study terminated by sponsor|79|||
163425331|NCT03498521|590259786|FG001|Overall Study|Study terminated by sponsor|21|||
163425332|NCT03498521|590259787|FG002|Overall Study|Study terminated by sponsor|4|||
163425333|NCT02848833|590259796|FG000|Overall Study|subject who are duplicated|1|||
163425334|NCT02848833|590259796|FG000|Overall Study|have not taken the study drug|11|||
163425335|NCT02848833|590259796|FG000|Overall Study|follow-up failure|6|||
163425336|NCT02848833|590259796|FG000|Overall Study|Protocol Violation|119|||
163425337|NCT04980391|590259797|FG000|Overall Study|Death|0|||
163425338|NCT04980391|590259798|FG001|Overall Study|Death|0|||
163425339|NCT04980391|590259799|FG002|Overall Study|Death|1|||
163425340|NCT04980391|590259800|FG003|Overall Study|Death|1|||
163425341|NCT04980391|590259797|FG000|Overall Study|Lost to Follow-up|3|||
163425342|NCT04980391|590259798|FG001|Overall Study|Lost to Follow-up|3|||
163425343|NCT04980391|590259799|FG002|Overall Study|Lost to Follow-up|2|||
163425344|NCT04980391|590259800|FG003|Overall Study|Lost to Follow-up|3|||
163425345|NCT04980391|590259797|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
163425346|NCT04980391|590259798|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
163425347|NCT04980391|590259799|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
163425348|NCT04980391|590259800|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
163425349|NCT04980391|590259797|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163425350|NCT04980391|590259798|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163425351|NCT04980391|590259799|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
163425352|NCT04980391|590259800|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163425353|NCT04980391|590259797|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
163425354|NCT04980391|590259798|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
163425355|NCT04980391|590259799|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
163425356|NCT04980391|590259800|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
163425357|NCT04167345|590259801|FG000|Overall Study|Other|1|||
163425358|NCT04167345|590259802|FG001|Overall Study|Other|1|||
163425359|NCT04167345|590259803|FG002|Overall Study|Other|0|||
163425360|NCT04167345|590259804|FG003|Overall Study|Other|0|||
163425361|NCT04167345|590259805|FG004|Overall Study|Other|0|||
163425362|NCT04375761|590262333|FG000|Overall Study|Death|1|||
163425363|NCT04375761|590262334|FG001|Overall Study|Death|2|||
163425364|NCT04375761|590262333|FG000|Overall Study|Lost to Follow-up|203|||
163425365|NCT04375761|590262334|FG001|Overall Study|Lost to Follow-up|380|||
163425366|NCT04375761|590262333|FG000|Overall Study|Withdrawal by Subject|47|||
163425367|NCT04375761|590262334|FG001|Overall Study|Withdrawal by Subject|98|||
163425368|NCT04375761|590262333|FG000|Overall Study|Noncompliance with study procedure|121|||
163425369|NCT04375761|590262334|FG001|Overall Study|Noncompliance with study procedure|251|||
163425370|NCT04375761|590262333|FG000|Overall Study|Reimbursement not enough|1|||
163425371|NCT04375761|590262334|FG001|Overall Study|Reimbursement not enough|2|||
163425372|NCT04375761|590262333|FG000|Overall Study|Unforeseen family circumstances|1|||
163425373|NCT04375761|590262334|FG001|Overall Study|Unforeseen family circumstances|3|||
163425374|NCT04375761|590262333|FG000|Overall Study|Test too painful|1|||
163425375|NCT04375761|590262334|FG001|Overall Study|Test too painful|1|||
163425376|NCT04375761|590262333|FG000|Overall Study|Moved|0|||
163425377|NCT04375761|590262334|FG001|Overall Study|Moved|2|||
163425378|NCT04375761|590262333|FG000|Overall Study|Nonresponsive|0|||
163425379|NCT04375761|590262334|FG001|Overall Study|Nonresponsive|5|||
163425380|NCT02251743|590262346|FG000|Overall Study|Withdrawal by Subject|1|||
163425381|NCT02251743|590262347|FG001|Overall Study|Withdrawal by Subject|1|||
163425382|NCT00824564|590262348|FG000|Overall Study|Lost to Follow-up|5|||
163425383|NCT00824564|590262349|FG001|Overall Study|Lost to Follow-up|7|||
163425384|NCT00824564|590262348|FG000|Overall Study|Withdrawal by Subject|1|||
163425385|NCT00824564|590262349|FG001|Overall Study|Withdrawal by Subject|1|||
163425386|NCT00824564|590262348|FG000|Overall Study|Other|1|||
163425387|NCT00824564|590262349|FG001|Overall Study|Other|2|||
163425388|NCT00824564|590262348|FG000|Overall Study|Randomized, but not treated|1|||
163425389|NCT00824564|590262349|FG001|Overall Study|Randomized, but not treated|0|||
163425390|NCT00476086|590262354|FG000|Overall Study|Alternative therapy|1|||
163425391|NCT00476086|590262354|FG000|Overall Study|Progressive Disease|4|||
163425392|NCT02900092|590262355|FG000|Overall Study|Adverse Event|1|||
163425393|NCT01389245|590262356|FG000|Overall Study|Protocol Violation|10|||
163425394|NCT01389245|590262356|FG000|Overall Study|Lost to Follow-up|3|||
163425395|NCT01389245|590262356|FG000|Overall Study|Withdrawal by Subject|2|||
163425396|NCT05540652|590262357|FG000|Overall Study|Withdrawal by Subject|1|||
163425397|NCT04454489|590262358|FG000|Overall Study|Disease progression|12|||
163425398|NCT04454489|590262358|FG000|Overall Study|Death|4|||
163425399|NCT04454489|590262358|FG000|Overall Study|Adverse Event|1|||
163425400|NCT04454489|590262358|FG000|Overall Study|Physician Decision|1|||
163425401|NCT00442598|590262361|FG000|Overall Study|Adverse Event|1|||
163425402|NCT00442598|590262362|FG001|Overall Study|Adverse Event|0|||
163425403|NCT00442598|590262363|FG002|Overall Study|Adverse Event|0|||
163425404|NCT00442598|590262361|FG000|Overall Study|Tumor progression|3|||
163425405|NCT00442598|590262362|FG001|Overall Study|Tumor progression|4|||
163425406|NCT00442598|590262363|FG002|Overall Study|Tumor progression|0|||
163425407|NCT00442598|590262361|FG000|Overall Study|Clinical deterioration|1|||
163425408|NCT00442598|590262362|FG001|Overall Study|Clinical deterioration|2|||
163425409|NCT00442598|590262363|FG002|Overall Study|Clinical deterioration|0|||
163425410|NCT00442598|590262361|FG000|Overall Study|CA125 progression|0|||
163425411|NCT00442598|590262362|FG001|Overall Study|CA125 progression|1|||
163425412|NCT00442598|590262363|FG002|Overall Study|CA125 progression|0|||
163425413|NCT00442598|590262361|FG000|Overall Study|Reduced creatinine clearance|1|||
163425414|NCT00442598|590262362|FG001|Overall Study|Reduced creatinine clearance|0|||
163425415|NCT00442598|590262363|FG002|Overall Study|Reduced creatinine clearance|0|||
163425416|NCT00442598|590262361|FG000|Overall Study|Death|0|||
163425417|NCT00442598|590262362|FG001|Overall Study|Death|1|||
163425418|NCT00442598|590262363|FG002|Overall Study|Death|0|||
163425419|NCT02886702|590262364|FG000|Overall Study|Other|4|||
163425420|NCT02886702|590262365|FG001|Overall Study|Other|3|||
163425421|NCT02886702|590262366|FG002|Overall Study|Other|9|||
163425422|NCT02886702|590262364|FG000|Overall Study|Withdrawal by Subject|24|||
163425423|NCT02886702|590262365|FG001|Overall Study|Withdrawal by Subject|18|||
163425424|NCT02886702|590262366|FG002|Overall Study|Withdrawal by Subject|22|||
163425425|NCT02886702|590262364|FG000|Overall Study|Significant Worsening of Condition|0|||
163425426|NCT02886702|590262365|FG001|Overall Study|Significant Worsening of Condition|1|||
163425427|NCT02886702|590262366|FG002|Overall Study|Significant Worsening of Condition|0|||
163425428|NCT02886702|590262364|FG000|Overall Study|Protocol Violation|2|||
163425429|NCT02886702|590262365|FG001|Overall Study|Protocol Violation|2|||
163425430|NCT02886702|590262366|FG002|Overall Study|Protocol Violation|1|||
163425431|NCT02886702|590262364|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163425432|NCT02886702|590262365|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163425433|NCT02886702|590262366|FG002|Overall Study|Non-Compliance With Study Drug|4|||
163425434|NCT02886702|590262364|FG000|Overall Study|Lost to Follow-up|11|||
163425435|NCT02886702|590262365|FG001|Overall Study|Lost to Follow-up|13|||
163425436|NCT02886702|590262366|FG002|Overall Study|Lost to Follow-up|8|||
163425437|NCT02886702|590262364|FG000|Overall Study|Lack of Efficacy|3|||
163425438|NCT02886702|590262365|FG001|Overall Study|Lack of Efficacy|4|||
163425439|NCT02886702|590262366|FG002|Overall Study|Lack of Efficacy|5|||
163425440|NCT02886702|590262364|FG000|Overall Study|Adverse Event|4|||
163425441|NCT02886702|590262365|FG001|Overall Study|Adverse Event|9|||
163425442|NCT02886702|590262366|FG002|Overall Study|Adverse Event|3|||
163425443|NCT02886702|590262364|FG000|Overall Study|Administrative Reasons|0|||
163425444|NCT02886702|590262365|FG001|Overall Study|Administrative Reasons|0|||
163425445|NCT02886702|590262366|FG002|Overall Study|Administrative Reasons|1|||
163425446|NCT01756274|590262376|FG000|Overall Study|Protocol Violation|2|||
163425447|NCT01756274|590262376|FG000|Overall Study|Laboratory error|1|||
163425448|NCT01147926|590262377|FG000|Overall Study|Subject Withdrew Consent|9|||
163425449|NCT01147926|590262378|FG001|Overall Study|Subject Withdrew Consent|10|||
163425450|NCT01147926|590262377|FG000|Overall Study|Adverse Event|7|||
163425451|NCT01147926|590262378|FG001|Overall Study|Adverse Event|6|||
163425452|NCT01147926|590262377|FG000|Overall Study|Subject Non-Compliant|5|||
163425453|NCT01147926|590262378|FG001|Overall Study|Subject Non-Compliant|4|||
163425454|NCT01147926|590262377|FG000|Overall Study|Principal investigator left hospital|1|||
163425455|NCT01147926|590262378|FG001|Overall Study|Principal investigator left hospital|3|||
163425456|NCT01147926|590262377|FG000|Overall Study|Selection criteria not met|3|||
163425457|NCT01147926|590262378|FG001|Overall Study|Selection criteria not met|1|||
163425458|NCT01147926|590262377|FG000|Overall Study|Lost to Follow-up|0|||
163425459|NCT01147926|590262378|FG001|Overall Study|Lost to Follow-up|2|||
163425460|NCT01147926|590262377|FG000|Overall Study|Sponsor's Decision|0|||
163425461|NCT01147926|590262378|FG001|Overall Study|Sponsor's Decision|1|||
163425462|NCT01147926|590262377|FG000|Overall Study|Lack of Efficacy|1|||
163425463|NCT01147926|590262378|FG001|Overall Study|Lack of Efficacy|0|||
163425464|NCT01147926|590262377|FG000|Overall Study|Too busy, no time for study|1|||
163425465|NCT01147926|590262378|FG001|Overall Study|Too busy, no time for study|0|||
163425466|NCT01147926|590262377|FG000|Overall Study|Went on holiday|0|||
163425467|NCT01147926|590262378|FG001|Overall Study|Went on holiday|1|||
163425468|NCT01147926|590262377|FG000|Overall Study|Colonoscopy result|0|||
163425469|NCT01147926|590262378|FG001|Overall Study|Colonoscopy result|1|||
163425470|NCT01085682|590262379|FG000|Overall Study|Withdrawal by Subject|25|||
163425471|NCT01085682|590262380|FG001|Overall Study|Withdrawal by Subject|25|||
163425472|NCT03926143|590262383|FG000|Overall Study|Physician Decision|3|||
163425473|NCT03926143|590262383|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
163425474|NCT03926143|590262383|FG000|Overall Study|Adverse Event|2|||
163425475|NCT03926143|590262383|FG000|Overall Study|Progressive disease|3|||
163425476|NCT02561156|590262389|FG000|Part 2|Adverse Event|0|||
163425477|NCT02561156|590262390|FG001|Part 2|Adverse Event|0|||
163425478|NCT02561156|590262391|FG002|Part 2|Adverse Event|0|||
163425479|NCT02561156|590262392|FG003|Part 2|Adverse Event|0|||
163425480|NCT02561156|590262393|FG004|Part 2|Adverse Event|0|||
163425481|NCT02561156|590262394|FG005|Part 2|Adverse Event|0|||
163425482|NCT02561156|590262395|FG006|Part 2|Adverse Event|0|||
163425483|NCT02561156|590262396|FG007|Part 2|Adverse Event|0|||
163425484|NCT02561156|590262397|FG008|Part 2|Adverse Event|0|||
163425485|NCT02561156|590262398|FG009|Part 2|Adverse Event|0|||
163425486|NCT02561156|590262399|FG010|Part 2|Adverse Event|0|||
163425487|NCT02561156|590262400|FG011|Part 2|Adverse Event|1|||
163425488|NCT02561156|590262401|FG012|Part 2|Adverse Event|0|||
163425489|NCT01071070|590262406|FG000|Overall Study|Adverse Event|0|||
163425490|NCT01071070|590262407|FG001|Overall Study|Adverse Event|3|||
163425491|NCT01071070|590262406|FG000|Overall Study|Withdrawal by Subject|1|||
163425492|NCT01071070|590262407|FG001|Overall Study|Withdrawal by Subject|0|||
163425493|NCT01071070|590262406|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
163425494|NCT01071070|590262407|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
163425495|NCT01071070|590262406|FG000|Overall Study|Hypercalcemia|1|||
163425496|NCT01071070|590262407|FG001|Overall Study|Hypercalcemia|0|||
163425497|NCT02207907|590262413|FG000|Overall Study|Lost to Follow-up|3|||
163425498|NCT02207907|590262414|FG001|Overall Study|Lost to Follow-up|1|||
163425499|NCT02207907|590262413|FG000|Overall Study|Withdrawal by Subject|5|||
163425500|NCT02207907|590262414|FG001|Overall Study|Withdrawal by Subject|6|||
163425501|NCT02207907|590262413|FG000|Overall Study|Did not meet study criteria|3|||
163425502|NCT02207907|590262414|FG001|Overall Study|Did not meet study criteria|0|||
163425503|NCT02207907|590262413|FG000|Overall Study|Pregnancy|0|||
163425504|NCT02207907|590262414|FG001|Overall Study|Pregnancy|1|||
163425505|NCT00158184|590262415|FG000|Overall Study|personal issues|3|||
163425506|NCT00158184|590262416|FG001|Overall Study|personal issues|1|||
163425507|NCT00158184|590262415|FG000|Overall Study|failed for follow unit/study rules|2|||
163425508|NCT00158184|590262416|FG001|Overall Study|failed for follow unit/study rules|0|||
163425509|NCT00158184|590262415|FG000|Overall Study|Adverse Event|1|||
163425510|NCT00158184|590262416|FG001|Overall Study|Adverse Event|1|||
163425511|NCT01025635|590262422|FG000|Overall Study|Withdrawal by Subject|6|||
163425512|NCT01025635|590262423|FG001|Overall Study|Withdrawal by Subject|7|||
163425513|NCT01025635|590262422|FG000|Overall Study|Protocol Violation|4|||
163425514|NCT01025635|590262423|FG001|Overall Study|Protocol Violation|2|||
163425515|NCT01025635|590262422|FG000|Overall Study|Lack of Efficacy|0|||
163425516|NCT01025635|590262423|FG001|Overall Study|Lack of Efficacy|1|||
163425517|NCT01025635|590262422|FG000|Overall Study|Lost to Follow-up|9|||
163425518|NCT01025635|590262423|FG001|Overall Study|Lost to Follow-up|13|||
163425519|NCT01025635|590262422|FG000|Overall Study|Reason not known|4|||
163425520|NCT01025635|590262423|FG001|Overall Study|Reason not known|2|||
163425521|NCT02393209|590262424|FG000|Overall Study|Study Terminated by Sponsor|1|||
163425522|NCT02393209|590262425|FG001|Overall Study|Study Terminated by Sponsor|1|||
163425523|NCT02393209|590262426|FG002|Overall Study|Study Terminated by Sponsor|0|||
163425524|NCT02393209|590262427|FG003|Overall Study|Study Terminated by Sponsor|0|||
163425525|NCT02393209|590262424|FG000|Overall Study|Withdrawal by Patient|1|||
163425526|NCT02393209|590262425|FG001|Overall Study|Withdrawal by Patient|0|||
163425527|NCT02393209|590262426|FG002|Overall Study|Withdrawal by Patient|0|||
163425528|NCT02393209|590262427|FG003|Overall Study|Withdrawal by Patient|0|||
163425529|NCT02393209|590262424|FG000|Overall Study|Death|2|||
163425530|NCT02393209|590262425|FG001|Overall Study|Death|2|||
163425531|NCT02393209|590262426|FG002|Overall Study|Death|0|||
163425532|NCT02393209|590262427|FG003|Overall Study|Death|0|||
163425533|NCT02393209|590262424|FG000|Overall Study|Death due to Disease Progression|2|||
163425534|NCT02393209|590262425|FG001|Overall Study|Death due to Disease Progression|2|||
163425535|NCT02393209|590262426|FG002|Overall Study|Death due to Disease Progression|0|||
163425536|NCT02393209|590262427|FG003|Overall Study|Death due to Disease Progression|0|||
163425537|NCT02393209|590262424|FG000|Overall Study|Death from Legionella Infection|0|||
163425538|NCT02393209|590262425|FG001|Overall Study|Death from Legionella Infection|1|||
163425539|NCT02393209|590262426|FG002|Overall Study|Death from Legionella Infection|0|||
163425540|NCT02393209|590262427|FG003|Overall Study|Death from Legionella Infection|0|||
163425541|NCT02393209|590262424|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
163425542|NCT02393209|590262425|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
163425543|NCT02393209|590262426|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
163425544|NCT02393209|590262427|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
163425545|NCT02393209|590262424|FG000|Overall Study|Lost to Follow-up|0|||
163425546|NCT02393209|590262425|FG001|Overall Study|Lost to Follow-up|1|||
163425547|NCT02393209|590262426|FG002|Overall Study|Lost to Follow-up|0|||
163425548|NCT02393209|590262427|FG003|Overall Study|Lost to Follow-up|0|||
163425549|NCT00755079|590262428|FG000|Overall Study|Lost to Follow-up|1|||
163425550|NCT00755079|590262429|FG001|Overall Study|Lost to Follow-up|3|||
163425551|NCT00755079|590262428|FG000|Overall Study|Adverse Event|0|||
163425552|NCT00755079|590262429|FG001|Overall Study|Adverse Event|1|||
163425553|NCT00755079|590262428|FG000|Overall Study|Withdrawal by Subject|0|||
163425554|NCT00755079|590262429|FG001|Overall Study|Withdrawal by Subject|2|||
163425555|NCT03751111|590262430|FG000|Overall Study|Lack of Efficacy|9|||
163425556|NCT03751111|590262431|FG001|Overall Study|Lack of Efficacy|30|||
163425557|NCT03751111|590262430|FG000|Overall Study|Adverse Event|3|||
163425558|NCT03751111|590262431|FG001|Overall Study|Adverse Event|2|||
163425559|NCT03545282|590262432|FG000|Overall Study|Lost to Follow-up|15|||
163425560|NCT03545282|590262433|FG001|Overall Study|Lost to Follow-up|10|||
163425561|NCT03545282|590262432|FG000|Overall Study|Withdrawal by Subject|2|||
163425562|NCT03545282|590262433|FG001|Overall Study|Withdrawal by Subject|2|||
163425563|NCT00929240|590262434|FG000|Initial Treatment Phase|Adverse Event|31|||
163425564|NCT00929240|590262435|FG001|Initial Treatment Phase|Adverse Event|0|||
163425565|NCT00929240|590262436|FG002|Initial Treatment Phase|Adverse Event|0|||
163425566|NCT00929240|590262434|FG000|Initial Treatment Phase|Disease progression|41|||
163425567|NCT00929240|590262435|FG001|Initial Treatment Phase|Disease progression|0|||
163425568|NCT00929240|590262436|FG002|Initial Treatment Phase|Disease progression|0|||
163425569|NCT00929240|590262434|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
163425570|NCT00929240|590262435|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
163425571|NCT00929240|590262436|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
163425572|NCT00929240|590262434|FG000|Initial Treatment Phase|Protocol Violation|5|||
163425573|NCT00929240|590262435|FG001|Initial Treatment Phase|Protocol Violation|0|||
163425574|NCT00929240|590262436|FG002|Initial Treatment Phase|Protocol Violation|0|||
163425575|NCT00929240|590262434|FG000|Initial Treatment Phase|Death|2|||
163425576|NCT00929240|590262435|FG001|Initial Treatment Phase|Death|0|||
163425577|NCT00929240|590262436|FG002|Initial Treatment Phase|Death|0|||
163425578|NCT00929240|590262434|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
163425579|NCT00929240|590262435|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
163425580|NCT00929240|590262436|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
163425581|NCT00929240|590262434|FG000|Initial Treatment Phase|Physician Decision|4|||
163425582|NCT00929240|590262435|FG001|Initial Treatment Phase|Physician Decision|0|||
163425583|NCT00929240|590262436|FG002|Initial Treatment Phase|Physician Decision|0|||
163425584|NCT00929240|590262434|FG000|Maintenance Phase|Disease progression|0|||
163425585|NCT00929240|590262435|FG001|Maintenance Phase|Disease progression|73|||
163425586|NCT00929240|590262436|FG002|Maintenance Phase|Disease progression|60|||
163425587|NCT00929240|590262434|FG000|Maintenance Phase|Adverse Event|0|||
163425588|NCT00929240|590262435|FG001|Maintenance Phase|Adverse Event|9|||
163425589|NCT00929240|590262436|FG002|Maintenance Phase|Adverse Event|12|||
163425590|NCT00929240|590262434|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163425591|NCT00929240|590262435|FG001|Maintenance Phase|Withdrawal by Subject|2|||
163425592|NCT00929240|590262436|FG002|Maintenance Phase|Withdrawal by Subject|6|||
163425593|NCT00929240|590262434|FG000|Maintenance Phase|Protocol Violation|0|||
163425594|NCT00929240|590262435|FG001|Maintenance Phase|Protocol Violation|1|||
163425595|NCT00929240|590262436|FG002|Maintenance Phase|Protocol Violation|0|||
163425596|NCT00929240|590262434|FG000|Maintenance Phase|Health authority/Study termination|0|||
163425597|NCT00929240|590262435|FG001|Maintenance Phase|Health authority/Study termination|1|||
163425598|NCT00929240|590262436|FG002|Maintenance Phase|Health authority/Study termination|2|||
163425599|NCT00929240|590262434|FG000|Maintenance Phase|Physician Decision|0|||
163425600|NCT00929240|590262435|FG001|Maintenance Phase|Physician Decision|2|||
163425601|NCT00929240|590262436|FG002|Maintenance Phase|Physician Decision|1|||
163425602|NCT00929240|590262434|FG000|Maintenance Phase|Change of treatment|0|||
163425603|NCT00929240|590262435|FG001|Maintenance Phase|Change of treatment|4|||
163425604|NCT00929240|590262436|FG002|Maintenance Phase|Change of treatment|0|||
163425605|NCT00929240|590262434|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
163425606|NCT00929240|590262435|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
163425607|NCT00929240|590262436|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
163425608|NCT00929240|590262434|FG000|Maintenance Phase|Participant not treated|0|||
163425609|NCT00929240|590262435|FG001|Maintenance Phase|Participant not treated|2|||
163425610|NCT00929240|590262436|FG002|Maintenance Phase|Participant not treated|0|||
163425611|NCT02582671|590262437|FG000|Overall Study|Failure to return|1|||
163425612|NCT02582671|590262437|FG000|Overall Study|Other, not specified|1|||
163425613|NCT01287104|590262442|FG000|Overall Study|Patient developed progressive disease|1|||
163425614|NCT01287104|590262443|FG001|Overall Study|Patient developed progressive disease|1|||
163425615|NCT01287104|590262444|FG002|Overall Study|Patient developed progressive disease|3|||
163425616|NCT01287104|590262445|FG003|Overall Study|Patient developed progressive disease|2|||
163425617|NCT01287104|590262442|FG000|Overall Study|Donor anaphylaxis|0|||
163425618|NCT01287104|590262443|FG001|Overall Study|Donor anaphylaxis|1|||
163425619|NCT01287104|590262444|FG002|Overall Study|Donor anaphylaxis|0|||
163425620|NCT01287104|590262445|FG003|Overall Study|Donor anaphylaxis|1|||
163425621|NCT01287104|590262442|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
163425622|NCT01287104|590262443|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
163425623|NCT01287104|590262444|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
163425624|NCT01287104|590262445|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
163425625|NCT01287104|590262442|FG000|Overall Study|Low donor chimerism|0|||
163425626|NCT01287104|590262443|FG001|Overall Study|Low donor chimerism|1|||
163425627|NCT01287104|590262444|FG002|Overall Study|Low donor chimerism|0|||
163425628|NCT01287104|590262445|FG003|Overall Study|Low donor chimerism|0|||
163425629|NCT01287104|590262442|FG000|Overall Study|NK cells did not meet release criteria|0|||
163425630|NCT01287104|590262443|FG001|Overall Study|NK cells did not meet release criteria|1|||
163425631|NCT01287104|590262444|FG002|Overall Study|NK cells did not meet release criteria|0|||
163425632|NCT01287104|590262445|FG003|Overall Study|NK cells did not meet release criteria|0|||
163425633|NCT01276288|590262450|FG000|Overall Study|Adverse Event|1|||
163425634|NCT01276288|590262451|FG001|Overall Study|Adverse Event|1|||
163425635|NCT01276288|590262452|FG002|Overall Study|Adverse Event|0|||
163425636|NCT01276288|590262453|FG003|Overall Study|Adverse Event|0|||
163425637|NCT01276288|590262450|FG000|Overall Study|not treated|1|||
163425638|NCT01276288|590262451|FG001|Overall Study|not treated|0|||
163425639|NCT01276288|590262452|FG002|Overall Study|not treated|0|||
163425640|NCT01276288|590262453|FG003|Overall Study|not treated|0|||
163425641|NCT01478958|590262460|FG000|Overall Study|Withdrawal by Subject|1|||
163425642|NCT01478958|590262461|FG001|Overall Study|Withdrawal by Subject|1|||
163425643|NCT01478958|590262462|FG002|Overall Study|Withdrawal by Subject|1|||
163425644|NCT01478958|590262460|FG000|Overall Study|Weight loss|1|||
163425645|NCT01478958|590262461|FG001|Overall Study|Weight loss|0|||
163425646|NCT01478958|590262462|FG002|Overall Study|Weight loss|0|||
163425647|NCT01478958|590262460|FG000|Overall Study|Re-located|0|||
163425648|NCT01478958|590262461|FG001|Overall Study|Re-located|1|||
163425649|NCT01478958|590262462|FG002|Overall Study|Re-located|0|||
163425650|NCT01478958|590262460|FG000|Overall Study|Unable to comply|0|||
163425651|NCT01478958|590262461|FG001|Overall Study|Unable to comply|0|||
163425652|NCT01478958|590262462|FG002|Overall Study|Unable to comply|2|||
163425653|NCT00629083|590262463|FG000|Overall Study|Adverse Event|0|||
163425654|NCT00629083|590262464|FG001|Overall Study|Adverse Event|2|||
163425655|NCT00629083|590262463|FG000|Overall Study|Lack of Efficacy|3|||
163425656|NCT00629083|590262464|FG001|Overall Study|Lack of Efficacy|1|||
163425657|NCT00629083|590262463|FG000|Overall Study|Withdrawal by Subject|10|||
163425658|NCT00629083|590262464|FG001|Overall Study|Withdrawal by Subject|2|||
163425659|NCT00629083|590262463|FG000|Overall Study|Lost to Follow-up|12|||
163425660|NCT00629083|590262464|FG001|Overall Study|Lost to Follow-up|8|||
163425661|NCT00629083|590262463|FG000|Overall Study|Moved out of country/state|2|||
163425662|NCT00629083|590262464|FG001|Overall Study|Moved out of country/state|1|||
163425663|NCT00629083|590262463|FG000|Overall Study|Refused to return for 12 month visit|1|||
163425664|NCT00629083|590262464|FG001|Overall Study|Refused to return for 12 month visit|0|||
163425665|NCT01193686|590262465|FG000|Overall Study|Withdrawal by Subject|4|||
163425666|NCT01193686|590262466|FG001|Overall Study|Withdrawal by Subject|1|||
163425667|NCT01193686|590262465|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
163425668|NCT01193686|590262466|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
163425669|NCT03401749|590262467|FG000|Overall Study|Lost to Follow-up|20|||
163425670|NCT03401749|590262468|FG001|Overall Study|Lost to Follow-up|16|||
163425671|NCT03401749|590262469|FG002|Overall Study|Lost to Follow-up|26|||
163425672|NCT01147809|590262472|FG000|Phase I (168 Days)|Adverse Event|0|||
163425673|NCT01147809|590262473|FG001|Phase I (168 Days)|Adverse Event|0|||
163425674|NCT01147809|590262474|FG002|Phase I (168 Days)|Adverse Event|0|||
163425675|NCT01147809|590262475|FG003|Phase I (168 Days)|Adverse Event|1|||
163425676|NCT01147809|590262476|FG004|Phase I (168 Days)|Adverse Event|0|||
163425677|NCT01147809|590262477|FG005|Phase I (168 Days)|Adverse Event|0|||
163425678|NCT01147809|590262472|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
163425679|NCT01147809|590262473|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
163425680|NCT01147809|590262474|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
163425681|NCT01147809|590262475|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
163425682|NCT01147809|590262476|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
163425683|NCT01147809|590262477|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
163425684|NCT01147809|590262472|FG000|Phase I (168 Days)|Physician Decision|0|||
163425685|NCT01147809|590262473|FG001|Phase I (168 Days)|Physician Decision|1|||
162925342|NCT00602641|588428937|FG001|Overall Study|Other Complicating Disease|2|||
163425686|NCT01147809|590262474|FG002|Phase I (168 Days)|Physician Decision|2|||
163425687|NCT01147809|590262475|FG003|Phase I (168 Days)|Physician Decision|0|||
163425688|NCT01147809|590262476|FG004|Phase I (168 Days)|Physician Decision|0|||
163425689|NCT01147809|590262477|FG005|Phase I (168 Days)|Physician Decision|0|||
163425690|NCT01147809|590262472|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
163425691|NCT01147809|590262473|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
163425692|NCT01147809|590262474|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
163425693|NCT01147809|590262475|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
163425694|NCT01147809|590262476|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
163425695|NCT01147809|590262477|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
163425696|NCT01147809|590262472|FG000|Phase II (168 Days)|Adverse Event|0|||
163425697|NCT01147809|590262473|FG001|Phase II (168 Days)|Adverse Event|0|||
163425698|NCT01147809|590262474|FG002|Phase II (168 Days)|Adverse Event|0|||
163425699|NCT01147809|590262475|FG003|Phase II (168 Days)|Adverse Event|0|||
163425700|NCT01147809|590262476|FG004|Phase II (168 Days)|Adverse Event|3|||
163425701|NCT01147809|590262477|FG005|Phase II (168 Days)|Adverse Event|6|||
163425702|NCT01147809|590262472|FG000|Phase II (168 Days)|Protocol Violation|0|||
163425703|NCT01147809|590262473|FG001|Phase II (168 Days)|Protocol Violation|0|||
163425704|NCT01147809|590262474|FG002|Phase II (168 Days)|Protocol Violation|0|||
163425705|NCT01147809|590262475|FG003|Phase II (168 Days)|Protocol Violation|0|||
163425706|NCT01147809|590262476|FG004|Phase II (168 Days)|Protocol Violation|0|||
163425707|NCT01147809|590262477|FG005|Phase II (168 Days)|Protocol Violation|1|||
163425708|NCT01147809|590262472|FG000|Phase II (168 Days)|Physician Decision|0|||
163425709|NCT01147809|590262473|FG001|Phase II (168 Days)|Physician Decision|0|||
163425710|NCT01147809|590262474|FG002|Phase II (168 Days)|Physician Decision|0|||
163425711|NCT01147809|590262475|FG003|Phase II (168 Days)|Physician Decision|0|||
163425712|NCT01147809|590262476|FG004|Phase II (168 Days)|Physician Decision|5|||
163425713|NCT01147809|590262477|FG005|Phase II (168 Days)|Physician Decision|11|||
163425714|NCT01147809|590262472|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
163425715|NCT01147809|590262473|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
163425716|NCT01147809|590262474|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
163425717|NCT01147809|590262475|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
163425718|NCT01147809|590262476|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
163425719|NCT01147809|590262477|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
163425720|NCT01147809|590262472|FG000|Phase II (168 Days)|Ongoing|0|||
163425721|NCT01147809|590262473|FG001|Phase II (168 Days)|Ongoing|0|||
163425722|NCT01147809|590262474|FG002|Phase II (168 Days)|Ongoing|0|||
163425723|NCT01147809|590262475|FG003|Phase II (168 Days)|Ongoing|0|||
163425724|NCT01147809|590262476|FG004|Phase II (168 Days)|Ongoing|1|||
163425725|NCT01147809|590262477|FG005|Phase II (168 Days)|Ongoing|0|||
163425726|NCT01307423|590262478|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
163425727|NCT01307423|590262479|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
163425728|NCT01307423|590262480|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
163425729|NCT01307423|590262481|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163425730|NCT01307423|590262482|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163425731|NCT01307423|590262483|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163425732|NCT01307423|590262484|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163425733|NCT01307423|590262485|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163425734|NCT01307423|590262486|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163425735|NCT01307423|590262478|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
163425736|NCT01307423|590262479|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
163425737|NCT01307423|590262480|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
163425738|NCT01307423|590262481|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163425739|NCT01307423|590262482|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163425740|NCT01307423|590262483|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163425741|NCT01307423|590262484|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163425742|NCT01307423|590262485|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163425743|NCT01307423|590262486|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163425744|NCT01307423|590262478|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
163425745|NCT01307423|590262479|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
163425746|NCT01307423|590262480|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
163425747|NCT01307423|590262481|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163425748|NCT01307423|590262482|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163425749|NCT01307423|590262483|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163425750|NCT01307423|590262484|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163425751|NCT01307423|590262485|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163425752|NCT01307423|590262486|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163425753|NCT01307423|590262478|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163425754|NCT01307423|590262479|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163425755|NCT01307423|590262480|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
163425756|NCT01307423|590262481|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163425757|NCT01307423|590262482|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163425758|NCT01307423|590262483|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163425759|NCT01307423|590262484|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163425760|NCT01307423|590262485|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163425761|NCT01307423|590262486|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163425762|NCT01307423|590262478|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
163425763|NCT01307423|590262479|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
163425764|NCT01307423|590262480|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
163425765|NCT01307423|590262481|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163425766|NCT01307423|590262482|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163425767|NCT01307423|590262483|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163425768|NCT01307423|590262484|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163425769|NCT01307423|590262485|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163425770|NCT01307423|590262486|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163425771|NCT01307423|590262478|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
163425772|NCT01307423|590262479|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163425773|NCT01307423|590262480|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163425774|NCT01307423|590262481|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163425775|NCT01307423|590262482|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163425776|NCT01307423|590262483|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163425777|NCT01307423|590262484|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163425778|NCT01307423|590262485|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163425779|NCT01307423|590262486|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163425780|NCT01307423|590262478|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
163425781|NCT01307423|590262479|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
163425782|NCT01307423|590262480|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163425783|NCT01307423|590262481|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163425784|NCT01307423|590262482|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163425785|NCT01307423|590262483|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163425786|NCT01307423|590262484|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163425787|NCT01307423|590262485|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163425788|NCT01307423|590262486|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163425789|NCT01307423|590262478|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
163425790|NCT01307423|590262479|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
163425791|NCT01307423|590262480|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
163425792|NCT01307423|590262481|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
163425793|NCT01307423|590262482|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
163425794|NCT01307423|590262483|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
163425795|NCT01307423|590262484|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
163425796|NCT01307423|590262485|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
163425797|NCT01307423|590262486|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
163425798|NCT01307423|590262478|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
163425799|NCT01307423|590262479|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
163425800|NCT01307423|590262480|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
163425801|NCT01307423|590262481|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
163425802|NCT01307423|590262482|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
163425803|NCT01307423|590262483|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
163425804|NCT01307423|590262484|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
163425805|NCT01307423|590262485|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
163425806|NCT01307423|590262486|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
163425807|NCT01307423|590262478|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
163425808|NCT01307423|590262479|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
163425809|NCT01307423|590262480|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
163425810|NCT01307423|590262481|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
163425811|NCT01307423|590262482|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
163425812|NCT01307423|590262483|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
163425813|NCT01307423|590262484|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
163425814|NCT01307423|590262485|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
163425815|NCT01307423|590262486|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
163425816|NCT01307423|590262478|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163425817|NCT01307423|590262479|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163425818|NCT01307423|590262480|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163425819|NCT01307423|590262481|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163425820|NCT01307423|590262482|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163425821|NCT01307423|590262483|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
163425822|NCT01307423|590262484|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163425823|NCT01307423|590262485|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163425824|NCT01307423|590262486|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163425825|NCT01307423|590262478|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
163425826|NCT01307423|590262479|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
163425827|NCT01307423|590262480|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
163425828|NCT01307423|590262481|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
163425829|NCT01307423|590262482|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
163425830|NCT01307423|590262483|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
163425831|NCT01307423|590262484|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
163425832|NCT01307423|590262485|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
163425833|NCT01307423|590262486|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
163425834|NCT01307423|590262478|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163425835|NCT01307423|590262479|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163425836|NCT01307423|590262480|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163425837|NCT01307423|590262481|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
163425838|NCT01307423|590262482|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163425839|NCT01307423|590262483|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163425840|NCT01307423|590262484|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163425841|NCT01307423|590262485|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163425842|NCT01307423|590262486|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163425843|NCT01307423|590262478|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
163425844|NCT01307423|590262479|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
163425845|NCT01307423|590262480|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
163425846|NCT01307423|590262481|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
163425847|NCT01307423|590262482|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
163425848|NCT01307423|590262483|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
163425849|NCT01307423|590262484|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
163425850|NCT01307423|590262485|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
163425851|NCT01307423|590262486|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
163425852|NCT01307423|590262478|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163425853|NCT01307423|590262479|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163425854|NCT01307423|590262480|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163425855|NCT01307423|590262481|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163425856|NCT01307423|590262482|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163425857|NCT01307423|590262483|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
163425858|NCT01307423|590262484|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163425859|NCT01307423|590262485|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163425860|NCT01307423|590262486|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163425861|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163425862|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
163425863|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
163425864|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163425865|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163425866|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163425867|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163425868|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
163425869|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
163425870|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163425871|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
163425872|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
163425873|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163425874|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163425875|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163425876|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163425877|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
163425878|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
163425879|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163425880|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163425881|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
163425882|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163425883|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163425884|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163425885|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163425886|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163425887|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163425888|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163425889|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
163425890|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
163425891|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163425892|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163425893|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163425894|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163425895|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
163425896|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
163425897|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163425898|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
163425899|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163425900|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163425901|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163425902|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163425903|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163425904|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
163425905|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
163425906|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163425907|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
163425908|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
163425909|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163425910|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163425911|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163425912|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163425913|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
163425914|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
163425915|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163425916|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
163425917|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
163425918|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163425919|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163425920|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163425921|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163425922|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
163425923|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
163425924|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
163425925|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
163425926|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
163425927|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
163425928|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
163425929|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
163425930|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
163425931|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
163425932|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
163425933|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163425934|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
163425935|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
163425936|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163425937|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163425938|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163425939|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163425940|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
163425941|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
163425942|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163425943|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
163425944|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
163425945|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163425946|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163425947|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163425948|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163425949|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
163425950|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
163425951|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163425952|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
163425953|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163425954|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163425955|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163425956|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163425957|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163425958|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
163425959|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163425960|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163425961|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
163425962|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163425963|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163425964|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163425965|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163425966|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163425967|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163425968|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163425969|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163425970|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
163425971|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163425972|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163425973|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163425974|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163425975|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163425976|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163425977|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
163425978|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163425979|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
163425980|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
163425981|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163425982|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163425983|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163425984|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163425985|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
163425986|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
163425987|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163425988|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163425989|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
163425990|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163425991|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163425992|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163425993|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163425994|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163425995|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163425996|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163425997|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163425998|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163425999|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163426000|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163426001|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163426002|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163426003|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
163426004|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163426005|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163426006|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
163426007|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
163426008|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163426009|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163426010|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163426011|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163426012|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163426013|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
163426014|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163426015|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
163426016|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
163426017|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163426018|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163426019|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163426020|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163426021|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163426022|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163426023|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163426024|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
163426025|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
163426026|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163426027|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163426028|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163426029|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163426030|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163426031|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
163426032|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163426033|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
163426034|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163426035|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163426036|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163426037|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163426038|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163426039|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163426040|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163426041|NCT01307423|590262478|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163426042|NCT01307423|590262479|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163426043|NCT01307423|590262480|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
163426044|NCT01307423|590262481|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163426045|NCT01307423|590262482|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163426046|NCT01307423|590262483|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163426047|NCT01307423|590262484|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163426048|NCT01307423|590262485|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
163426049|NCT01307423|590262486|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
163426050|NCT03406962|590262489|FG000|Overall Study|Death|2|||
163426051|NCT03406962|590262489|FG000|Overall Study|Adverse Event|1|||
163426052|NCT03853694|590262490|FG000|Overall Study|Protocol Violation|3|||
163426053|NCT03853694|590262491|FG001|Overall Study|Protocol Violation|5|||
163426054|NCT03853694|590262492|FG002|Overall Study|Protocol Violation|3|||
163426055|NCT03853694|590262490|FG000|Overall Study|Delivered early|0|||
163426056|NCT03853694|590262491|FG001|Overall Study|Delivered early|1|||
163426057|NCT03853694|590262492|FG002|Overall Study|Delivered early|0|||
163426058|NCT03853694|590262490|FG000|Overall Study|not suitable to proceed|0|||
163426059|NCT03853694|590262491|FG001|Overall Study|not suitable to proceed|1|||
163426060|NCT03853694|590262492|FG002|Overall Study|not suitable to proceed|0|||
163426061|NCT03853694|590262490|FG000|Overall Study|difficult surgery|0|||
163426062|NCT03853694|590262491|FG001|Overall Study|difficult surgery|0|||
163426063|NCT03853694|590262492|FG002|Overall Study|difficult surgery|1|||
163426064|NCT03853694|590262490|FG000|Overall Study|Lost to Follow-up|0|||
163426065|NCT03853694|590262491|FG001|Overall Study|Lost to Follow-up|1|||
163426066|NCT03853694|590262492|FG002|Overall Study|Lost to Follow-up|0|||
163426067|NCT03853694|590262490|FG000|Overall Study|Withdrawal by Subject|0|||
163426068|NCT03853694|590262491|FG001|Overall Study|Withdrawal by Subject|1|||
163426069|NCT03853694|590262492|FG002|Overall Study|Withdrawal by Subject|0|||
163426070|NCT02209766|590262493|FG000|Overall Study|Withdrawal by Subject|0|||
163426071|NCT02209766|590262494|FG001|Overall Study|Withdrawal by Subject|0|||
163426072|NCT02209766|590262495|FG002|Overall Study|Withdrawal by Subject|0|||
163426073|NCT02209766|590262496|FG003|Overall Study|Withdrawal by Subject|1|||
163426074|NCT02209766|590262497|FG004|Overall Study|Withdrawal by Subject|0|||
163426075|NCT00805207|590262498|FG000|Overall Study|Protocol Violation|0|||
163426076|NCT00805207|590262499|FG001|Overall Study|Protocol Violation|0|||
163426077|NCT00805207|590262500|FG002|Overall Study|Protocol Violation|1|||
163426078|NCT00805207|590262501|FG003|Overall Study|Protocol Violation|0|||
163426079|NCT00805207|590262502|FG004|Overall Study|Protocol Violation|0|||
163426080|NCT00805207|590262503|FG005|Overall Study|Protocol Violation|0|||
163426081|NCT00805207|590262504|FG006|Overall Study|Protocol Violation|0|||
163426082|NCT00805207|590262505|FG007|Overall Study|Protocol Violation|0|||
163426083|NCT00805207|590262506|FG008|Overall Study|Protocol Violation|0|||
163426084|NCT00805207|590262498|FG000|Overall Study|Physician Decision|0|||
163426085|NCT00805207|590262499|FG001|Overall Study|Physician Decision|1|||
163426086|NCT00805207|590262500|FG002|Overall Study|Physician Decision|0|||
163426087|NCT00805207|590262501|FG003|Overall Study|Physician Decision|0|||
163426088|NCT00805207|590262502|FG004|Overall Study|Physician Decision|0|||
163426089|NCT00805207|590262503|FG005|Overall Study|Physician Decision|1|||
163426090|NCT00805207|590262504|FG006|Overall Study|Physician Decision|0|||
163426091|NCT00805207|590262505|FG007|Overall Study|Physician Decision|0|||
163426092|NCT00805207|590262506|FG008|Overall Study|Physician Decision|0|||
163426093|NCT00805207|590262498|FG000|Overall Study|Withdrawal by Subject|0|||
163426094|NCT00805207|590262499|FG001|Overall Study|Withdrawal by Subject|1|||
163426095|NCT00805207|590262500|FG002|Overall Study|Withdrawal by Subject|0|||
163426096|NCT00805207|590262501|FG003|Overall Study|Withdrawal by Subject|0|||
163426097|NCT00805207|590262502|FG004|Overall Study|Withdrawal by Subject|1|||
163426098|NCT00805207|590262503|FG005|Overall Study|Withdrawal by Subject|2|||
163426099|NCT00805207|590262504|FG006|Overall Study|Withdrawal by Subject|0|||
163426100|NCT00805207|590262505|FG007|Overall Study|Withdrawal by Subject|0|||
163426101|NCT00805207|590262506|FG008|Overall Study|Withdrawal by Subject|0|||
163426102|NCT00064701|590262507|FG000|One Year Post-transplant|Did not receive study drug|7|||
163426103|NCT00064701|590262508|FG001|One Year Post-transplant|Did not receive study drug|12|||
163426104|NCT00064701|590262509|FG002|One Year Post-transplant|Did not receive study drug|11|||
163426105|NCT00064701|590262507|FG000|One Year Post-transplant|Adverse Event|23|||
163426106|NCT00064701|590262508|FG001|One Year Post-transplant|Adverse Event|19|||
163426107|NCT00064701|590262509|FG002|One Year Post-transplant|Adverse Event|37|||
163426108|NCT00064701|590262507|FG000|One Year Post-transplant|Rejection|0|||
163426109|NCT00064701|590262508|FG001|One Year Post-transplant|Rejection|1|||
163426110|NCT00064701|590262509|FG002|One Year Post-transplant|Rejection|16|||
163426111|NCT00064701|590262507|FG000|One Year Post-transplant|Non-compliance|4|||
163426112|NCT00064701|590262508|FG001|One Year Post-transplant|Non-compliance|2|||
163426113|NCT00064701|590262509|FG002|One Year Post-transplant|Non-compliance|5|||
163426114|NCT00064701|590262507|FG000|One Year Post-transplant|Graft Failure|3|||
163426115|NCT00064701|590262508|FG001|One Year Post-transplant|Graft Failure|2|||
163426116|NCT00064701|590262509|FG002|One Year Post-transplant|Graft Failure|1|||
163426117|NCT00064701|590262507|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
163426118|NCT00064701|590262508|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
163426119|NCT00064701|590262509|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
163426120|NCT00064701|590262507|FG000|One Year Post-transplant|Lost to Follow-up|1|||
163426121|NCT00064701|590262508|FG001|One Year Post-transplant|Lost to Follow-up|0|||
163426122|NCT00064701|590262509|FG002|One Year Post-transplant|Lost to Follow-up|0|||
163426123|NCT00064701|590262507|FG000|One Year Post-transplant|Converted to rapamycin|1|||
163426124|NCT00064701|590262508|FG001|One Year Post-transplant|Converted to rapamycin|0|||
163426125|NCT00064701|590262509|FG002|One Year Post-transplant|Converted to rapamycin|0|||
163426126|NCT00064701|590262507|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
163426127|NCT00064701|590262508|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
163426128|NCT00064701|590262509|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
163426129|NCT00064701|590262507|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
163426130|NCT00064701|590262508|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
163426131|NCT00064701|590262509|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
163426132|NCT00064701|590262507|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
163426133|NCT00064701|590262508|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
163426134|NCT00064701|590262509|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
163426135|NCT00064701|590262507|FG000|One Year Post-transplant|Poor absorption|0|||
163426136|NCT00064701|590262508|FG001|One Year Post-transplant|Poor absorption|1|||
163426137|NCT00064701|590262509|FG002|One Year Post-transplant|Poor absorption|0|||
163426138|NCT00064701|590262507|FG000|One Year Post-transplant|Pancreas transplant|0|||
163426139|NCT00064701|590262508|FG001|One Year Post-transplant|Pancreas transplant|0|||
163426140|NCT00064701|590262509|FG002|One Year Post-transplant|Pancreas transplant|1|||
163426141|NCT00064701|590262507|FG000|Clinical Continuation Phase|Adverse Event|12|||
163426142|NCT00064701|590262508|FG001|Clinical Continuation Phase|Adverse Event|21|||
163426143|NCT00064701|590262509|FG002|Clinical Continuation Phase|Adverse Event|14|||
163426144|NCT00064701|590262507|FG000|Clinical Continuation Phase|Non-compliance|8|||
163426145|NCT00064701|590262508|FG001|Clinical Continuation Phase|Non-compliance|6|||
163426146|NCT00064701|590262509|FG002|Clinical Continuation Phase|Non-compliance|7|||
163426147|NCT00064701|590262507|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
163426148|NCT00064701|590262508|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
163426149|NCT00064701|590262509|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
163426150|NCT00064701|590262507|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
163426151|NCT00064701|590262508|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
163426152|NCT00064701|590262509|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
163426153|NCT00064701|590262507|FG000|Clinical Continuation Phase|Graft Failure|5|||
163426154|NCT00064701|590262508|FG001|Clinical Continuation Phase|Graft Failure|5|||
163426155|NCT00064701|590262509|FG002|Clinical Continuation Phase|Graft Failure|2|||
163426156|NCT00064701|590262507|FG000|Clinical Continuation Phase|Rejection|1|||
163426157|NCT00064701|590262508|FG001|Clinical Continuation Phase|Rejection|2|||
163426158|NCT00064701|590262509|FG002|Clinical Continuation Phase|Rejection|2|||
163426159|NCT00064701|590262507|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
163426160|NCT00064701|590262508|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
163426161|NCT00064701|590262509|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
163426162|NCT00064701|590262507|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
163426163|NCT00064701|590262508|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
163426164|NCT00064701|590262509|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
163426165|NCT00064701|590262507|FG000|Clinical Continuation Phase|Physician Decision|1|||
163426166|NCT00064701|590262508|FG001|Clinical Continuation Phase|Physician Decision|3|||
163426167|NCT00064701|590262509|FG002|Clinical Continuation Phase|Physician Decision|0|||
163426168|NCT00064701|590262507|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
163426169|NCT00064701|590262508|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
163426170|NCT00064701|590262509|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
163426171|NCT00064701|590262507|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
163426172|NCT00064701|590262508|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
163426173|NCT00064701|590262509|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
163426174|NCT00064701|590262507|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
163426175|NCT00064701|590262508|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
163426176|NCT00064701|590262509|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
163426177|NCT00064701|590262507|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
163426178|NCT00064701|590262508|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
163426179|NCT00064701|590262509|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
163426180|NCT00064701|590262507|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
163426181|NCT00064701|590262508|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
163426182|NCT00064701|590262509|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
163426183|NCT00064701|590262507|FG000|Clinical Continuation Phase|Patient opted out|0|||
163426184|NCT00064701|590262508|FG001|Clinical Continuation Phase|Patient opted out|0|||
163426185|NCT00064701|590262509|FG002|Clinical Continuation Phase|Patient opted out|1|||
163426186|NCT01818297|590262510|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
163426187|NCT01818297|590262511|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
163426188|NCT01818297|590262510|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
163426189|NCT01818297|590262511|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
163426190|NCT01818297|590262510|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
163426191|NCT01818297|590262511|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
163426192|NCT03308188|590262512|FG000|Overall Study|Withdrawal by Subject|0|||
163426193|NCT03308188|590262513|FG001|Overall Study|Withdrawal by Subject|3|||
163426194|NCT03308188|590262512|FG000|Overall Study|Death|0|||
163426195|NCT03308188|590262513|FG001|Overall Study|Death|1|||
163426196|NCT01791855|590262514|FG000|Overall Study|Adverse Event|0|||
163426197|NCT01791855|590262515|FG001|Overall Study|Adverse Event|0|||
163426198|NCT01791855|590262516|FG002|Overall Study|Adverse Event|0|||
163426199|NCT01791855|590262517|FG003|Overall Study|Adverse Event|1|||
163426200|NCT01791855|590262514|FG000|Overall Study|Randomized, not treated|0|||
163426201|NCT01791855|590262515|FG001|Overall Study|Randomized, not treated|1|||
163426202|NCT01791855|590262516|FG002|Overall Study|Randomized, not treated|0|||
163426203|NCT01791855|590262517|FG003|Overall Study|Randomized, not treated|0|||
163426204|NCT00481065|590262518|FG000|Overall Study|Adverse event or death|1|||
163426205|NCT00481065|590262519|FG001|Overall Study|Adverse event or death|1|||
163426206|NCT00481065|590262520|FG002|Overall Study|Adverse event or death|3|||
163426207|NCT00481065|590262521|FG003|Overall Study|Adverse event or death|0|||
163426208|NCT00481065|590262522|FG004|Overall Study|Adverse event or death|2|||
163426209|NCT00481065|590262523|FG005|Overall Study|Adverse event or death|0|||
163426210|NCT00481065|590262524|FG006|Overall Study|Adverse event or death|1|||
163426211|NCT00481065|590262525|FG007|Overall Study|Adverse event or death|1|||
163426212|NCT00481065|590262518|FG000|Overall Study|Withdrawal by Subject|11|||
163426213|NCT00481065|590262519|FG001|Overall Study|Withdrawal by Subject|12|||
163426214|NCT00481065|590262520|FG002|Overall Study|Withdrawal by Subject|7|||
163426215|NCT00481065|590262521|FG003|Overall Study|Withdrawal by Subject|11|||
163426216|NCT00481065|590262522|FG004|Overall Study|Withdrawal by Subject|13|||
163426217|NCT00481065|590262523|FG005|Overall Study|Withdrawal by Subject|12|||
163426218|NCT00481065|590262524|FG006|Overall Study|Withdrawal by Subject|9|||
163426219|NCT00481065|590262525|FG007|Overall Study|Withdrawal by Subject|10|||
163426220|NCT00481065|590262518|FG000|Overall Study|Lost to Follow-up|4|||
163426221|NCT00481065|590262519|FG001|Overall Study|Lost to Follow-up|2|||
163426222|NCT00481065|590262520|FG002|Overall Study|Lost to Follow-up|4|||
163426223|NCT00481065|590262521|FG003|Overall Study|Lost to Follow-up|3|||
163426224|NCT00481065|590262522|FG004|Overall Study|Lost to Follow-up|3|||
163426225|NCT00481065|590262523|FG005|Overall Study|Lost to Follow-up|3|||
163426226|NCT00481065|590262524|FG006|Overall Study|Lost to Follow-up|2|||
163426227|NCT00481065|590262525|FG007|Overall Study|Lost to Follow-up|5|||
163426228|NCT00481065|590262518|FG000|Overall Study|Inappropriate enrollment|4|||
163426229|NCT00481065|590262519|FG001|Overall Study|Inappropriate enrollment|0|||
163426230|NCT00481065|590262520|FG002|Overall Study|Inappropriate enrollment|2|||
163426231|NCT00481065|590262521|FG003|Overall Study|Inappropriate enrollment|0|||
163426232|NCT00481065|590262522|FG004|Overall Study|Inappropriate enrollment|2|||
163426233|NCT00481065|590262523|FG005|Overall Study|Inappropriate enrollment|1|||
163426234|NCT00481065|590262524|FG006|Overall Study|Inappropriate enrollment|0|||
163426235|NCT00481065|590262525|FG007|Overall Study|Inappropriate enrollment|1|||
163426236|NCT00481065|590262518|FG000|Overall Study|Administrative reason|0|||
163426237|NCT00481065|590262519|FG001|Overall Study|Administrative reason|0|||
163426238|NCT00481065|590262520|FG002|Overall Study|Administrative reason|0|||
163426239|NCT00481065|590262521|FG003|Overall Study|Administrative reason|0|||
163426240|NCT00481065|590262522|FG004|Overall Study|Administrative reason|0|||
163426241|NCT00481065|590262523|FG005|Overall Study|Administrative reason|2|||
163426242|NCT00481065|590262524|FG006|Overall Study|Administrative reason|1|||
163426243|NCT00481065|590262525|FG007|Overall Study|Administrative reason|0|||
163426244|NCT00481065|590262518|FG000|Overall Study|Protocol Violation|2|||
163426245|NCT00481065|590262519|FG001|Overall Study|Protocol Violation|1|||
163426246|NCT00481065|590262520|FG002|Overall Study|Protocol Violation|1|||
163426247|NCT00481065|590262521|FG003|Overall Study|Protocol Violation|1|||
163426248|NCT00481065|590262522|FG004|Overall Study|Protocol Violation|2|||
163426249|NCT00481065|590262523|FG005|Overall Study|Protocol Violation|6|||
163426250|NCT00481065|590262524|FG006|Overall Study|Protocol Violation|3|||
162925343|NCT00602641|588428936|FG000|Overall Study|Physician Decision|5|||
162925344|NCT00602641|588428937|FG001|Overall Study|Physician Decision|4|||
163426251|NCT00481065|590262525|FG007|Overall Study|Protocol Violation|2|||
163426252|NCT00481065|590262518|FG000|Overall Study|Unable to classify|0|||
163426253|NCT00481065|590262519|FG001|Overall Study|Unable to classify|1|||
163426254|NCT00481065|590262520|FG002|Overall Study|Unable to classify|2|||
163426255|NCT00481065|590262521|FG003|Overall Study|Unable to classify|0|||
163426256|NCT00481065|590262522|FG004|Overall Study|Unable to classify|1|||
163426257|NCT00481065|590262523|FG005|Overall Study|Unable to classify|0|||
163426258|NCT00481065|590262524|FG006|Overall Study|Unable to classify|0|||
163426259|NCT00481065|590262525|FG007|Overall Study|Unable to classify|0|||
163426260|NCT01709331|590262526|FG000|Overall Study|Adverse Event|1|||
163426261|NCT04439344|590262527|FG000|Overall Study|Never started threapy|3|||
163426262|NCT04439344|590262527|FG000|Overall Study|Ineligible|3|||
163426263|NCT04439344|590262527|FG000|Overall Study|Adverse Event|13|||
163426264|NCT04439344|590262527|FG000|Overall Study|Death|2|||
163426265|NCT04439344|590262527|FG000|Overall Study|Disease progression|29|||
163426266|NCT04439344|590262527|FG000|Overall Study|Withdrawal by Subject|2|||
163426267|NCT04439344|590262527|FG000|Overall Study|Alternative therapy|1|||
163426268|NCT00772447|590262528|FG000|Overall Study|Withdrawal by Subject|9|||
163426269|NCT00772447|590262529|FG001|Overall Study|Withdrawal by Subject|5|||
163426270|NCT00772447|590262528|FG000|Overall Study|Physician Decision|4|||
163426271|NCT00772447|590262529|FG001|Overall Study|Physician Decision|8|||
163426272|NCT00772447|590262528|FG000|Overall Study|Lost to Follow-up|2|||
163426273|NCT00772447|590262529|FG001|Overall Study|Lost to Follow-up|4|||
163426274|NCT00772447|590262528|FG000|Overall Study|incorrect enrolment|3|||
163426275|NCT00772447|590262529|FG001|Overall Study|incorrect enrolment|4|||
163426276|NCT00772447|590262528|FG000|Overall Study|Protocol Violation|0|||
163426277|NCT00772447|590262529|FG001|Overall Study|Protocol Violation|1|||
163426278|NCT00772447|590262528|FG000|Overall Study|all others|2|||
163426279|NCT00772447|590262529|FG001|Overall Study|all others|2|||
163426280|NCT03770403|590262535|FG000|Overall Study|Adverse Event|8|||
163426281|NCT03770403|590262535|FG000|Overall Study|Death|5|||
163426282|NCT03770403|590262535|FG000|Overall Study|Physician Decision|1|||
163426283|NCT03770403|590262535|FG000|Overall Study|Sponsor decision|1|||
163426284|NCT03770403|590262535|FG000|Overall Study|Study terminated by Sponsor|1|||
163426285|NCT03770403|590262535|FG000|Overall Study|Withdrawal by Subject|13|||
163426286|NCT03770403|590262535|FG000|Overall Study|Other|88|||
163426287|NCT03896295|590262536|FG000|Overall Study|Adverse Event|0|||
163426288|NCT03896295|590262537|FG001|Overall Study|Adverse Event|1|||
163426289|NCT03896295|590262536|FG000|Overall Study|COVID-19|7|||
163426290|NCT03896295|590262537|FG001|Overall Study|COVID-19|29|||
163426291|NCT01957137|590262538|FG000|Randomized Portion|Adverse Event|1|||
163426292|NCT01957137|590262538|FG000|Randomized Portion|Withdrawal by Subject|1|||
163426293|NCT02901431|590262551|FG000|PK Part|Adverse Event|0|||
163426294|NCT02901431|590262552|FG001|PK Part|Adverse Event|1|||
163426295|NCT02901431|590262553|FG002|PK Part|Adverse Event|0|||
163426296|NCT02901431|590262554|FG003|PK Part|Adverse Event|0|||
163426297|NCT02901431|590262555|FG004|PK Part|Adverse Event|0|||
163426298|NCT02901431|590262556|FG005|PK Part|Adverse Event|0|||
163426299|NCT02901431|590262557|FG006|PK Part|Adverse Event|0|||
163426300|NCT02901431|590262558|FG007|PK Part|Adverse Event|0|||
163426301|NCT02901431|590262559|FG008|PK Part|Adverse Event|0|||
163426302|NCT02901431|590262560|FG009|PK Part|Adverse Event|0|||
163426303|NCT02901431|590262561|FG010|PK Part|Adverse Event|0|||
163426304|NCT02901431|590262562|FG011|PK Part|Adverse Event|0|||
163426305|NCT02901431|590262563|FG012|PK Part|Adverse Event|0|||
163426306|NCT02901431|590262551|FG000|PK Part|Lost to Follow-up|0|||
163426307|NCT02901431|590262552|FG001|PK Part|Lost to Follow-up|0|||
163426308|NCT02901431|590262553|FG002|PK Part|Lost to Follow-up|1|||
163426309|NCT02901431|590262554|FG003|PK Part|Lost to Follow-up|0|||
163426310|NCT02901431|590262555|FG004|PK Part|Lost to Follow-up|0|||
163426311|NCT02901431|590262556|FG005|PK Part|Lost to Follow-up|0|||
163426312|NCT02901431|590262557|FG006|PK Part|Lost to Follow-up|0|||
163426313|NCT02901431|590262558|FG007|PK Part|Lost to Follow-up|0|||
163426314|NCT02901431|590262559|FG008|PK Part|Lost to Follow-up|0|||
163426315|NCT02901431|590262560|FG009|PK Part|Lost to Follow-up|0|||
163426316|NCT02901431|590262561|FG010|PK Part|Lost to Follow-up|0|||
163426317|NCT02901431|590262562|FG011|PK Part|Lost to Follow-up|0|||
163426318|NCT02901431|590262563|FG012|PK Part|Lost to Follow-up|0|||
163426319|NCT02901431|590262551|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
163426320|NCT02901431|590262552|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163426321|NCT02901431|590262553|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163426322|NCT02901431|590262554|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163426323|NCT02901431|590262555|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163426324|NCT02901431|590262556|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163426325|NCT02901431|590262557|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163426326|NCT02901431|590262558|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163426327|NCT02901431|590262559|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163426328|NCT02901431|590262560|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163426329|NCT02901431|590262561|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163426330|NCT02901431|590262562|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163426331|NCT02901431|590262563|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163426332|NCT02901431|590262551|FG000|PK Part|Pending dose confirmation|0|||
163426333|NCT02901431|590262552|FG001|PK Part|Pending dose confirmation|1|||
163426334|NCT02901431|590262553|FG002|PK Part|Pending dose confirmation|0|||
163426335|NCT02901431|590262554|FG003|PK Part|Pending dose confirmation|0|||
163426336|NCT02901431|590262555|FG004|PK Part|Pending dose confirmation|0|||
163426337|NCT02901431|590262556|FG005|PK Part|Pending dose confirmation|0|||
163426338|NCT02901431|590262557|FG006|PK Part|Pending dose confirmation|0|||
163426339|NCT02901431|590262558|FG007|PK Part|Pending dose confirmation|0|||
163426340|NCT02901431|590262559|FG008|PK Part|Pending dose confirmation|0|||
163426341|NCT02901431|590262560|FG009|PK Part|Pending dose confirmation|0|||
163426342|NCT02901431|590262561|FG010|PK Part|Pending dose confirmation|0|||
163426343|NCT02901431|590262562|FG011|PK Part|Pending dose confirmation|0|||
163426344|NCT02901431|590262563|FG012|PK Part|Pending dose confirmation|0|||
163426345|NCT02901431|590262551|FG000|PK Part|8 weeks of treatment ran out|2|||
163426346|NCT02901431|590262552|FG001|PK Part|8 weeks of treatment ran out|0|||
163426347|NCT02901431|590262553|FG002|PK Part|8 weeks of treatment ran out|0|||
163426348|NCT02901431|590262554|FG003|PK Part|8 weeks of treatment ran out|0|||
163426349|NCT02901431|590262555|FG004|PK Part|8 weeks of treatment ran out|0|||
163426350|NCT02901431|590262556|FG005|PK Part|8 weeks of treatment ran out|0|||
163426351|NCT02901431|590262557|FG006|PK Part|8 weeks of treatment ran out|0|||
163426352|NCT02901431|590262558|FG007|PK Part|8 weeks of treatment ran out|0|||
163426353|NCT02901431|590262559|FG008|PK Part|8 weeks of treatment ran out|0|||
163426354|NCT02901431|590262560|FG009|PK Part|8 weeks of treatment ran out|0|||
163426355|NCT02901431|590262561|FG010|PK Part|8 weeks of treatment ran out|0|||
163426356|NCT02901431|590262562|FG011|PK Part|8 weeks of treatment ran out|0|||
163426357|NCT02901431|590262563|FG012|PK Part|8 weeks of treatment ran out|0|||
163426358|NCT02901431|590262551|FG000|PK Part|Stopped treatment after 8 weeks|1|||
163426359|NCT02901431|590262552|FG001|PK Part|Stopped treatment after 8 weeks|0|||
163426360|NCT02901431|590262553|FG002|PK Part|Stopped treatment after 8 weeks|1|||
163426361|NCT02901431|590262554|FG003|PK Part|Stopped treatment after 8 weeks|0|||
163426362|NCT02901431|590262555|FG004|PK Part|Stopped treatment after 8 weeks|0|||
163426363|NCT02901431|590262556|FG005|PK Part|Stopped treatment after 8 weeks|0|||
163426364|NCT02901431|590262557|FG006|PK Part|Stopped treatment after 8 weeks|0|||
163426365|NCT02901431|590262558|FG007|PK Part|Stopped treatment after 8 weeks|0|||
163426366|NCT02901431|590262559|FG008|PK Part|Stopped treatment after 8 weeks|0|||
163426367|NCT02901431|590262560|FG009|PK Part|Stopped treatment after 8 weeks|0|||
163426368|NCT02901431|590262561|FG010|PK Part|Stopped treatment after 8 weeks|0|||
163426369|NCT02901431|590262562|FG011|PK Part|Stopped treatment after 8 weeks|0|||
163426370|NCT02901431|590262563|FG012|PK Part|Stopped treatment after 8 weeks|0|||
163426371|NCT02901431|590262551|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
163426372|NCT02901431|590262552|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163426373|NCT02901431|590262553|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
163426374|NCT02901431|590262554|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163426375|NCT02901431|590262555|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163426376|NCT02901431|590262556|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163426377|NCT02901431|590262557|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163426378|NCT02901431|590262558|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163426379|NCT02901431|590262559|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163426380|NCT02901431|590262560|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163426381|NCT02901431|590262561|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163426382|NCT02901431|590262562|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163426383|NCT02901431|590262563|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163426384|NCT02901431|590262551|FG000|PK Part|Discontinued per Sponsor|0|||
163426385|NCT02901431|590262552|FG001|PK Part|Discontinued per Sponsor|3|||
163426386|NCT02901431|590262553|FG002|PK Part|Discontinued per Sponsor|0|||
163426387|NCT02901431|590262554|FG003|PK Part|Discontinued per Sponsor|0|||
163426388|NCT02901431|590262555|FG004|PK Part|Discontinued per Sponsor|0|||
163426389|NCT02901431|590262556|FG005|PK Part|Discontinued per Sponsor|0|||
163426390|NCT02901431|590262557|FG006|PK Part|Discontinued per Sponsor|0|||
163426391|NCT02901431|590262558|FG007|PK Part|Discontinued per Sponsor|0|||
163426392|NCT02901431|590262559|FG008|PK Part|Discontinued per Sponsor|0|||
163426393|NCT02901431|590262560|FG009|PK Part|Discontinued per Sponsor|0|||
163426394|NCT02901431|590262561|FG010|PK Part|Discontinued per Sponsor|0|||
163426395|NCT02901431|590262562|FG011|PK Part|Discontinued per Sponsor|0|||
163426396|NCT02901431|590262563|FG012|PK Part|Discontinued per Sponsor|0|||
163426397|NCT02901431|590262551|FG000|PK Part|Withdrawal by Subject|1|||
163426398|NCT02901431|590262552|FG001|PK Part|Withdrawal by Subject|1|||
163426399|NCT02901431|590262553|FG002|PK Part|Withdrawal by Subject|3|||
163426400|NCT02901431|590262554|FG003|PK Part|Withdrawal by Subject|0|||
163426401|NCT02901431|590262555|FG004|PK Part|Withdrawal by Subject|0|||
163426402|NCT02901431|590262556|FG005|PK Part|Withdrawal by Subject|0|||
163426403|NCT02901431|590262557|FG006|PK Part|Withdrawal by Subject|0|||
163426404|NCT02901431|590262558|FG007|PK Part|Withdrawal by Subject|0|||
163426405|NCT02901431|590262559|FG008|PK Part|Withdrawal by Subject|0|||
163426406|NCT02901431|590262560|FG009|PK Part|Withdrawal by Subject|0|||
163426407|NCT02901431|590262561|FG010|PK Part|Withdrawal by Subject|0|||
163426408|NCT02901431|590262562|FG011|PK Part|Withdrawal by Subject|0|||
163426409|NCT02901431|590262563|FG012|PK Part|Withdrawal by Subject|0|||
163426410|NCT02901431|590262551|FG000|Main Treatment Part|Adverse Event|0|||
163426411|NCT02901431|590262552|FG001|Main Treatment Part|Adverse Event|0|||
163426412|NCT02901431|590262553|FG002|Main Treatment Part|Adverse Event|0|||
163426413|NCT02901431|590262554|FG003|Main Treatment Part|Adverse Event|3|||
163426414|NCT02901431|590262555|FG004|Main Treatment Part|Adverse Event|3|||
163426415|NCT02901431|590262556|FG005|Main Treatment Part|Adverse Event|4|||
163426416|NCT02901431|590262557|FG006|Main Treatment Part|Adverse Event|1|||
163426417|NCT02901431|590262558|FG007|Main Treatment Part|Adverse Event|0|||
163426418|NCT02901431|590262559|FG008|Main Treatment Part|Adverse Event|0|||
163426419|NCT02901431|590262560|FG009|Main Treatment Part|Adverse Event|0|||
163426420|NCT02901431|590262561|FG010|Main Treatment Part|Adverse Event|0|||
163426421|NCT02901431|590262562|FG011|Main Treatment Part|Adverse Event|0|||
163426422|NCT02901431|590262563|FG012|Main Treatment Part|Adverse Event|0|||
163426423|NCT02901431|590262551|FG000|Main Treatment Part|Lack of Efficacy|0|||
163426424|NCT02901431|590262552|FG001|Main Treatment Part|Lack of Efficacy|0|||
163426425|NCT02901431|590262553|FG002|Main Treatment Part|Lack of Efficacy|0|||
163426426|NCT02901431|590262554|FG003|Main Treatment Part|Lack of Efficacy|1|||
163426427|NCT02901431|590262555|FG004|Main Treatment Part|Lack of Efficacy|0|||
163426428|NCT02901431|590262556|FG005|Main Treatment Part|Lack of Efficacy|0|||
163426429|NCT02901431|590262557|FG006|Main Treatment Part|Lack of Efficacy|0|||
163426430|NCT02901431|590262558|FG007|Main Treatment Part|Lack of Efficacy|0|||
163426431|NCT02901431|590262559|FG008|Main Treatment Part|Lack of Efficacy|0|||
163426432|NCT02901431|590262560|FG009|Main Treatment Part|Lack of Efficacy|0|||
163426433|NCT02901431|590262561|FG010|Main Treatment Part|Lack of Efficacy|0|||
163426434|NCT02901431|590262562|FG011|Main Treatment Part|Lack of Efficacy|0|||
163426435|NCT02901431|590262563|FG012|Main Treatment Part|Lack of Efficacy|0|||
163426436|NCT02901431|590262551|FG000|Main Treatment Part|Lost to Follow-up|0|||
163426437|NCT02901431|590262552|FG001|Main Treatment Part|Lost to Follow-up|0|||
163426438|NCT02901431|590262553|FG002|Main Treatment Part|Lost to Follow-up|0|||
163426439|NCT02901431|590262554|FG003|Main Treatment Part|Lost to Follow-up|3|||
163426440|NCT02901431|590262555|FG004|Main Treatment Part|Lost to Follow-up|1|||
163426441|NCT02901431|590262556|FG005|Main Treatment Part|Lost to Follow-up|2|||
163426442|NCT02901431|590262557|FG006|Main Treatment Part|Lost to Follow-up|3|||
163426443|NCT02901431|590262558|FG007|Main Treatment Part|Lost to Follow-up|0|||
163426444|NCT02901431|590262559|FG008|Main Treatment Part|Lost to Follow-up|0|||
163426445|NCT02901431|590262560|FG009|Main Treatment Part|Lost to Follow-up|0|||
163426446|NCT02901431|590262561|FG010|Main Treatment Part|Lost to Follow-up|0|||
163426447|NCT02901431|590262562|FG011|Main Treatment Part|Lost to Follow-up|0|||
163426448|NCT02901431|590262563|FG012|Main Treatment Part|Lost to Follow-up|0|||
163426449|NCT02901431|590262551|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
163426450|NCT02901431|590262552|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
163426451|NCT02901431|590262553|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
163426452|NCT02901431|590262554|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
163426453|NCT02901431|590262555|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
163426454|NCT02901431|590262556|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
163426455|NCT02901431|590262557|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
163426456|NCT02901431|590262558|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
163426457|NCT02901431|590262559|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
163426458|NCT02901431|590262560|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
163426459|NCT02901431|590262561|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
163426460|NCT02901431|590262562|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
163426461|NCT02901431|590262563|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
163426462|NCT02901431|590262551|FG000|Main Treatment Part|Physician Decision|0|||
163426463|NCT02901431|590262552|FG001|Main Treatment Part|Physician Decision|0|||
163426464|NCT02901431|590262553|FG002|Main Treatment Part|Physician Decision|0|||
163426465|NCT02901431|590262554|FG003|Main Treatment Part|Physician Decision|1|||
163426466|NCT02901431|590262555|FG004|Main Treatment Part|Physician Decision|0|||
163426467|NCT02901431|590262556|FG005|Main Treatment Part|Physician Decision|0|||
163426468|NCT02901431|590262557|FG006|Main Treatment Part|Physician Decision|1|||
163426469|NCT02901431|590262558|FG007|Main Treatment Part|Physician Decision|0|||
163426470|NCT02901431|590262559|FG008|Main Treatment Part|Physician Decision|0|||
163426471|NCT02901431|590262560|FG009|Main Treatment Part|Physician Decision|0|||
163426472|NCT02901431|590262561|FG010|Main Treatment Part|Physician Decision|0|||
163426473|NCT02901431|590262562|FG011|Main Treatment Part|Physician Decision|0|||
163426474|NCT02901431|590262563|FG012|Main Treatment Part|Physician Decision|0|||
163426475|NCT02901431|590262551|FG000|Main Treatment Part|Withdrawal by Subject|0|||
163426476|NCT02901431|590262552|FG001|Main Treatment Part|Withdrawal by Subject|0|||
163426477|NCT02901431|590262553|FG002|Main Treatment Part|Withdrawal by Subject|0|||
163426478|NCT02901431|590262554|FG003|Main Treatment Part|Withdrawal by Subject|18|||
163426479|NCT02901431|590262555|FG004|Main Treatment Part|Withdrawal by Subject|3|||
163426480|NCT02901431|590262556|FG005|Main Treatment Part|Withdrawal by Subject|5|||
163426481|NCT02901431|590262557|FG006|Main Treatment Part|Withdrawal by Subject|6|||
163426482|NCT02901431|590262558|FG007|Main Treatment Part|Withdrawal by Subject|0|||
163426483|NCT02901431|590262559|FG008|Main Treatment Part|Withdrawal by Subject|0|||
163426484|NCT02901431|590262560|FG009|Main Treatment Part|Withdrawal by Subject|0|||
163426485|NCT02901431|590262561|FG010|Main Treatment Part|Withdrawal by Subject|0|||
163426486|NCT02901431|590262562|FG011|Main Treatment Part|Withdrawal by Subject|0|||
163426487|NCT02901431|590262563|FG012|Main Treatment Part|Withdrawal by Subject|0|||
163426488|NCT02901431|590262551|FG000|Open Label Part|Adverse Event|0|||
163426489|NCT02901431|590262552|FG001|Open Label Part|Adverse Event|0|||
163426490|NCT02901431|590262553|FG002|Open Label Part|Adverse Event|0|||
163426491|NCT02901431|590262554|FG003|Open Label Part|Adverse Event|0|||
163426492|NCT02901431|590262555|FG004|Open Label Part|Adverse Event|0|||
163426493|NCT02901431|590262556|FG005|Open Label Part|Adverse Event|0|||
163426494|NCT02901431|590262557|FG006|Open Label Part|Adverse Event|0|||
163426495|NCT02901431|590262558|FG007|Open Label Part|Adverse Event|0|||
163426496|NCT02901431|590262559|FG008|Open Label Part|Adverse Event|4|||
163426497|NCT02901431|590262560|FG009|Open Label Part|Adverse Event|4|||
163426498|NCT02901431|590262561|FG010|Open Label Part|Adverse Event|0|||
163426499|NCT02901431|590262562|FG011|Open Label Part|Adverse Event|4|||
163426500|NCT02901431|590262563|FG012|Open Label Part|Adverse Event|1|||
163426501|NCT02901431|590262551|FG000|Open Label Part|Lost to Follow-up|0|||
163426502|NCT02901431|590262552|FG001|Open Label Part|Lost to Follow-up|0|||
163426503|NCT02901431|590262553|FG002|Open Label Part|Lost to Follow-up|0|||
163426504|NCT02901431|590262554|FG003|Open Label Part|Lost to Follow-up|0|||
163426505|NCT02901431|590262555|FG004|Open Label Part|Lost to Follow-up|0|||
163426506|NCT02901431|590262556|FG005|Open Label Part|Lost to Follow-up|0|||
163426507|NCT02901431|590262557|FG006|Open Label Part|Lost to Follow-up|0|||
163426508|NCT02901431|590262558|FG007|Open Label Part|Lost to Follow-up|0|||
163426509|NCT02901431|590262559|FG008|Open Label Part|Lost to Follow-up|2|||
163426510|NCT02901431|590262560|FG009|Open Label Part|Lost to Follow-up|2|||
163426511|NCT02901431|590262561|FG010|Open Label Part|Lost to Follow-up|1|||
163426512|NCT02901431|590262562|FG011|Open Label Part|Lost to Follow-up|1|||
163426513|NCT02901431|590262563|FG012|Open Label Part|Lost to Follow-up|1|||
163426514|NCT02901431|590262551|FG000|Open Label Part|Physician Decision|0|||
163426515|NCT02901431|590262552|FG001|Open Label Part|Physician Decision|0|||
163426516|NCT02901431|590262553|FG002|Open Label Part|Physician Decision|0|||
163426517|NCT02901431|590262554|FG003|Open Label Part|Physician Decision|0|||
163426518|NCT02901431|590262555|FG004|Open Label Part|Physician Decision|0|||
163426519|NCT02901431|590262556|FG005|Open Label Part|Physician Decision|0|||
163426520|NCT02901431|590262557|FG006|Open Label Part|Physician Decision|0|||
163426521|NCT02901431|590262558|FG007|Open Label Part|Physician Decision|0|||
163426522|NCT02901431|590262559|FG008|Open Label Part|Physician Decision|1|||
163426523|NCT02901431|590262560|FG009|Open Label Part|Physician Decision|1|||
163426524|NCT02901431|590262561|FG010|Open Label Part|Physician Decision|0|||
163426525|NCT02901431|590262562|FG011|Open Label Part|Physician Decision|0|||
163426526|NCT02901431|590262563|FG012|Open Label Part|Physician Decision|0|||
163426527|NCT02901431|590262551|FG000|Open Label Part|Study Terminated By Sponsor|0|||
163426528|NCT02901431|590262552|FG001|Open Label Part|Study Terminated By Sponsor|0|||
163426529|NCT02901431|590262553|FG002|Open Label Part|Study Terminated By Sponsor|0|||
163426530|NCT02901431|590262554|FG003|Open Label Part|Study Terminated By Sponsor|0|||
163426531|NCT02901431|590262555|FG004|Open Label Part|Study Terminated By Sponsor|0|||
163426532|NCT02901431|590262556|FG005|Open Label Part|Study Terminated By Sponsor|0|||
163426533|NCT02901431|590262557|FG006|Open Label Part|Study Terminated By Sponsor|0|||
163426534|NCT02901431|590262558|FG007|Open Label Part|Study Terminated By Sponsor|0|||
163426535|NCT02901431|590262559|FG008|Open Label Part|Study Terminated By Sponsor|35|||
163426536|NCT02901431|590262560|FG009|Open Label Part|Study Terminated By Sponsor|12|||
163426537|NCT02901431|590262561|FG010|Open Label Part|Study Terminated By Sponsor|21|||
163426538|NCT02901431|590262562|FG011|Open Label Part|Study Terminated By Sponsor|31|||
163426539|NCT02901431|590262563|FG012|Open Label Part|Study Terminated By Sponsor|0|||
163426540|NCT02901431|590262551|FG000|Open Label Part|Withdrawal by Subject|0|||
163426541|NCT02901431|590262552|FG001|Open Label Part|Withdrawal by Subject|0|||
163426542|NCT02901431|590262553|FG002|Open Label Part|Withdrawal by Subject|0|||
163426543|NCT02901431|590262554|FG003|Open Label Part|Withdrawal by Subject|0|||
163426544|NCT02901431|590262555|FG004|Open Label Part|Withdrawal by Subject|0|||
163426545|NCT02901431|590262556|FG005|Open Label Part|Withdrawal by Subject|0|||
163426546|NCT02901431|590262557|FG006|Open Label Part|Withdrawal by Subject|0|||
163426547|NCT02901431|590262558|FG007|Open Label Part|Withdrawal by Subject|0|||
163426548|NCT02901431|590262559|FG008|Open Label Part|Withdrawal by Subject|6|||
163426549|NCT02901431|590262560|FG009|Open Label Part|Withdrawal by Subject|5|||
163426550|NCT02901431|590262561|FG010|Open Label Part|Withdrawal by Subject|7|||
163426551|NCT02901431|590262562|FG011|Open Label Part|Withdrawal by Subject|3|||
163426552|NCT02901431|590262563|FG012|Open Label Part|Withdrawal by Subject|1|||
163426553|NCT02500537|590262564|FG000|Overall Study|Death|2|||
163426554|NCT02500537|590262565|FG001|Overall Study|Death|0|||
163426555|NCT02500537|590262564|FG000|Overall Study|Lost to Follow-up|0|||
163426556|NCT02500537|590262565|FG001|Overall Study|Lost to Follow-up|1|||
163426557|NCT02500537|590262564|FG000|Overall Study|Withdrawal by Subject|1|||
163426558|NCT02500537|590262565|FG001|Overall Study|Withdrawal by Subject|0|||
163426559|NCT03832387|590262568|FG000|Overall Study|Protocol Violation|2|||
163426560|NCT03832387|590262569|FG001|Overall Study|Protocol Violation|6|||
163426561|NCT03832387|590262568|FG000|Overall Study|EXCLUSION CRITERIA|3|||
163426562|NCT03832387|590262569|FG001|Overall Study|EXCLUSION CRITERIA|1|||
163426563|NCT00355121|590262570|FG000|Overall Study|Did not receive study vaccine|1|||
163426564|NCT00355121|590262571|FG001|Overall Study|Did not receive study vaccine|0|||
163426565|NCT00355121|590262572|FG002|Overall Study|Did not receive study vaccine|1|||
163426566|NCT00355121|590262570|FG000|Overall Study|Adverse Event|0|||
163426567|NCT00355121|590262571|FG001|Overall Study|Adverse Event|1|||
163426568|NCT00355121|590262572|FG002|Overall Study|Adverse Event|0|||
163426569|NCT00355121|590262570|FG000|Overall Study|Protocol Violation|7|||
163426570|NCT00355121|590262571|FG001|Overall Study|Protocol Violation|9|||
163426571|NCT00355121|590262572|FG002|Overall Study|Protocol Violation|1|||
163426572|NCT00355121|590262570|FG000|Overall Study|Lost to Follow-up|4|||
163426573|NCT00355121|590262571|FG001|Overall Study|Lost to Follow-up|7|||
163426574|NCT00355121|590262572|FG002|Overall Study|Lost to Follow-up|1|||
163426575|NCT00355121|590262570|FG000|Overall Study|Withdrawal by Subject|9|||
163426576|NCT00355121|590262571|FG001|Overall Study|Withdrawal by Subject|10|||
163426577|NCT00355121|590262572|FG002|Overall Study|Withdrawal by Subject|2|||
163426578|NCT00355121|590262570|FG000|Overall Study|Serious adverse events|0|||
163426579|NCT00355121|590262571|FG001|Overall Study|Serious adverse events|2|||
163426580|NCT00355121|590262572|FG002|Overall Study|Serious adverse events|0|||
163426581|NCT00784758|590262573|FG000|Overall Study|Withdrawal by Subject|3|||
163426582|NCT00784758|590262574|FG001|Overall Study|Withdrawal by Subject|0|||
163426583|NCT00784758|590262573|FG000|Overall Study|Adverse Event|1|||
163426584|NCT00784758|590262574|FG001|Overall Study|Adverse Event|0|||
163426585|NCT00215150|590265130|FG000|Open Label Phase|Lost to Follow-up|7|||
163426586|NCT00215150|590265130|FG000|Open Label Phase|Withdrawal by Subject|1|||
163426587|NCT00215150|590265130|FG000|Open Label Phase|Did not complete a post base visit|13|||
163426588|NCT00215150|590265130|FG000|Open Label Phase|Did not meet randomization criteria|9|||
163426589|NCT00215150|590265130|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
163426590|NCT00215150|590265130|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
163426591|NCT00215150|590265130|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
163426592|NCT01287754|590265133|FG000|Overall Study|Death|2|||
163426593|NCT01287754|590265134|FG001|Overall Study|Death|12|||
163426594|NCT01287754|590265133|FG000|Overall Study|Lost to Follow-up|1|||
163426595|NCT01287754|590265134|FG001|Overall Study|Lost to Follow-up|6|||
163426596|NCT01287754|590265133|FG000|Overall Study|Protocol Violation|0|||
163426597|NCT01287754|590265134|FG001|Overall Study|Protocol Violation|3|||
163426598|NCT04439266|590265135|FG000|Overall Study|Ineligible|1|||
163426599|NCT04439266|590265135|FG000|Overall Study|Adverse Event|1|||
163426600|NCT04439266|590265135|FG000|Overall Study|Death|1|||
163426601|NCT04439266|590265135|FG000|Overall Study|Disease progression|1|||
163426602|NCT04439266|590265135|FG000|Overall Study|Still on treatment|1|||
163426603|NCT05027802|590265137|FG000|Overall Study|Adverse Event|2|||
163426604|NCT05027802|590265137|FG000|Overall Study|Withdrawal by Subject|18|||
163426605|NCT05027802|590265137|FG000|Overall Study|Death|2|||
163426606|NCT05027802|590265137|FG000|Overall Study|Other|1|||
163426607|NCT00001337|590265144|FG000|Overall Study|Switched to alternate treatment|2|||
163426608|NCT00001337|590265145|FG001|Overall Study|Switched to alternate treatment|2|||
163426609|NCT00001337|590265146|FG002|Overall Study|Switched to alternate treatment|0|||
163426610|NCT00001337|590265144|FG000|Overall Study|Refused further treatment|2|||
163426611|NCT00001337|590265145|FG001|Overall Study|Refused further treatment|1|||
163426612|NCT00001337|590265146|FG002|Overall Study|Refused further treatment|0|||
163426613|NCT00001337|590265144|FG000|Overall Study|Began other Tx|1|||
163426614|NCT00001337|590265145|FG001|Overall Study|Began other Tx|0|||
163426615|NCT00001337|590265146|FG002|Overall Study|Began other Tx|0|||
163426616|NCT00001337|590265144|FG000|Overall Study|Physician Decision|3|||
163426617|NCT00001337|590265145|FG001|Overall Study|Physician Decision|1|||
163426618|NCT00001337|590265146|FG002|Overall Study|Physician Decision|0|||
163426619|NCT00001337|590265144|FG000|Overall Study|Doesn't have NHL|0|||
163426620|NCT00001337|590265145|FG001|Overall Study|Doesn't have NHL|1|||
163426621|NCT00001337|590265146|FG002|Overall Study|Doesn't have NHL|0|||
163426622|NCT00001337|590265144|FG000|Overall Study|Non protocol tx needed|3|||
163426623|NCT00001337|590265145|FG001|Overall Study|Non protocol tx needed|1|||
163426624|NCT00001337|590265146|FG002|Overall Study|Non protocol tx needed|0|||
163426625|NCT00001337|590265144|FG000|Overall Study|Protocol change|1|||
163426626|NCT00001337|590265145|FG001|Overall Study|Protocol change|0|||
163426627|NCT00001337|590265146|FG002|Overall Study|Protocol change|0|||
163426628|NCT00001337|590265144|FG000|Overall Study|2nd primary disease|0|||
163426629|NCT00001337|590265145|FG001|Overall Study|2nd primary disease|0|||
163426630|NCT00001337|590265146|FG002|Overall Study|2nd primary disease|1|||
163426631|NCT00001337|590265144|FG000|Overall Study|Death during follow up period|9|||
163426632|NCT00001337|590265145|FG001|Overall Study|Death during follow up period|4|||
163426633|NCT00001337|590265146|FG002|Overall Study|Death during follow up period|0|||
163426634|NCT00001337|590265144|FG000|Overall Study|Death on study|19|||
163426635|NCT00001337|590265145|FG001|Overall Study|Death on study|9|||
163426636|NCT00001337|590265146|FG002|Overall Study|Death on study|0|||
163426637|NCT00001337|590265144|FG000|Overall Study|Disease progression during follow-up period|3|||
163426638|NCT00001337|590265145|FG001|Overall Study|Disease progression during follow-up period|1|||
163426639|NCT00001337|590265146|FG002|Overall Study|Disease progression during follow-up period|0|||
163426640|NCT00001337|590265144|FG000|Overall Study|Disease progression on study|33|||
163426641|NCT00001337|590265145|FG001|Overall Study|Disease progression on study|41|||
163426642|NCT00001337|590265146|FG002|Overall Study|Disease progression on study|0|||
163426643|NCT00001337|590265144|FG000|Overall Study|Lost to further follow-up|10|||
163426644|NCT00001337|590265145|FG001|Overall Study|Lost to further follow-up|6|||
163426645|NCT00001337|590265146|FG002|Overall Study|Lost to further follow-up|0|||
163426646|NCT00001337|590265144|FG000|Overall Study|2nd malignancy|1|||
163426647|NCT00001337|590265145|FG001|Overall Study|2nd malignancy|0|||
163426648|NCT00001337|590265146|FG002|Overall Study|2nd malignancy|0|||
163426649|NCT00001337|590265144|FG000|Overall Study|Treatment for second lymphoma|0|||
163426650|NCT00001337|590265145|FG001|Overall Study|Treatment for second lymphoma|1|||
163426651|NCT00001337|590265146|FG002|Overall Study|Treatment for second lymphoma|0|||
163426652|NCT00001337|590265144|FG000|Overall Study|Transfer to transplant|0|||
163426653|NCT00001337|590265145|FG001|Overall Study|Transfer to transplant|1|||
163426654|NCT00001337|590265146|FG002|Overall Study|Transfer to transplant|0|||
163426655|NCT06161012|590265147|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
163426656|NCT06161012|590265148|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
163426657|NCT00408005|590265153|FG000|Induction|Adverse Event|19|||
163426658|NCT00408005|590265154|FG001|Induction|Adverse Event|3|||
163426659|NCT00408005|590265155|FG002|Induction|Adverse Event|0|||
163426660|NCT00408005|590265156|FG003|Induction|Adverse Event|0|||
163426661|NCT00408005|590265157|FG004|Induction|Adverse Event|0|||
163426662|NCT00408005|590265158|FG005|Induction|Adverse Event|0|||
163426663|NCT00408005|590265159|FG006|Induction|Adverse Event|0|||
163426664|NCT00408005|590265160|FG007|Induction|Adverse Event|0|||
163426665|NCT00408005|590265153|FG000|Induction|Death|6|||
163426666|NCT00408005|590265154|FG001|Induction|Death|0|||
163426667|NCT00408005|590265155|FG002|Induction|Death|0|||
163426668|NCT00408005|590265156|FG003|Induction|Death|0|||
163426669|NCT00408005|590265157|FG004|Induction|Death|0|||
163426670|NCT00408005|590265158|FG005|Induction|Death|0|||
163426671|NCT00408005|590265159|FG006|Induction|Death|0|||
163426672|NCT00408005|590265160|FG007|Induction|Death|0|||
163426673|NCT00408005|590265153|FG000|Induction|Physician Decision|83|||
163426674|NCT00408005|590265154|FG001|Induction|Physician Decision|9|||
163426675|NCT00408005|590265155|FG002|Induction|Physician Decision|0|||
163426676|NCT00408005|590265156|FG003|Induction|Physician Decision|0|||
163426677|NCT00408005|590265157|FG004|Induction|Physician Decision|0|||
163426678|NCT00408005|590265158|FG005|Induction|Physician Decision|0|||
163426679|NCT00408005|590265159|FG006|Induction|Physician Decision|0|||
163426680|NCT00408005|590265160|FG007|Induction|Physician Decision|0|||
163426681|NCT00408005|590265153|FG000|Induction|Withdrawal by Subject|2|||
163426682|NCT00408005|590265154|FG001|Induction|Withdrawal by Subject|4|||
163426683|NCT00408005|590265155|FG002|Induction|Withdrawal by Subject|0|||
163426684|NCT00408005|590265156|FG003|Induction|Withdrawal by Subject|0|||
163426685|NCT00408005|590265157|FG004|Induction|Withdrawal by Subject|0|||
163426686|NCT00408005|590265158|FG005|Induction|Withdrawal by Subject|0|||
163426687|NCT00408005|590265159|FG006|Induction|Withdrawal by Subject|0|||
163426688|NCT00408005|590265160|FG007|Induction|Withdrawal by Subject|0|||
163426689|NCT00408005|590265153|FG000|Induction|Ineligible|33|||
163426690|NCT00408005|590265154|FG001|Induction|Ineligible|14|||
163426691|NCT00408005|590265155|FG002|Induction|Ineligible|0|||
163426692|NCT00408005|590265156|FG003|Induction|Ineligible|0|||
163426693|NCT00408005|590265157|FG004|Induction|Ineligible|0|||
163426694|NCT00408005|590265158|FG005|Induction|Ineligible|0|||
163426695|NCT00408005|590265159|FG006|Induction|Ineligible|0|||
163426696|NCT00408005|590265160|FG007|Induction|Ineligible|0|||
163426697|NCT00408005|590265153|FG000|Induction|Refusal of Further Protocol Therapy|225|||
163426698|NCT00408005|590265154|FG001|Induction|Refusal of Further Protocol Therapy|44|||
163426699|NCT00408005|590265155|FG002|Induction|Refusal of Further Protocol Therapy|0|||
163426700|NCT00408005|590265156|FG003|Induction|Refusal of Further Protocol Therapy|0|||
163426701|NCT00408005|590265157|FG004|Induction|Refusal of Further Protocol Therapy|0|||
163426702|NCT00408005|590265158|FG005|Induction|Refusal of Further Protocol Therapy|0|||
163426703|NCT00408005|590265159|FG006|Induction|Refusal of Further Protocol Therapy|0|||
163426704|NCT00408005|590265160|FG007|Induction|Refusal of Further Protocol Therapy|0|||
163426705|NCT00408005|590265153|FG000|Induction|Entered another COG therapeutic protocol|4|||
163426706|NCT00408005|590265154|FG001|Induction|Entered another COG therapeutic protocol|0|||
163426707|NCT00408005|590265155|FG002|Induction|Entered another COG therapeutic protocol|0|||
163426708|NCT00408005|590265156|FG003|Induction|Entered another COG therapeutic protocol|0|||
163426709|NCT00408005|590265157|FG004|Induction|Entered another COG therapeutic protocol|0|||
163426710|NCT00408005|590265158|FG005|Induction|Entered another COG therapeutic protocol|0|||
163426711|NCT00408005|590265159|FG006|Induction|Entered another COG therapeutic protocol|0|||
163426712|NCT00408005|590265160|FG007|Induction|Entered another COG therapeutic protocol|0|||
163426713|NCT00408005|590265153|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
163426714|NCT00408005|590265154|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
163426715|NCT00408005|590265155|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
163426716|NCT00408005|590265156|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
163426717|NCT00408005|590265157|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
163426718|NCT00408005|590265158|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
163426719|NCT00408005|590265159|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
163426720|NCT00408005|590265160|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
163426721|NCT00408005|590265153|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
163426722|NCT00408005|590265154|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
163426723|NCT00408005|590265155|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
163426724|NCT00408005|590265156|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
163426725|NCT00408005|590265157|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
163426726|NCT00408005|590265158|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
163426727|NCT00408005|590265159|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
163426728|NCT00408005|590265160|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
163426729|NCT00408005|590265153|FG000|Induction|Progressive Disease|0|||
163426730|NCT00408005|590265154|FG001|Induction|Progressive Disease|1|||
163426731|NCT00408005|590265155|FG002|Induction|Progressive Disease|0|||
163426732|NCT00408005|590265156|FG003|Induction|Progressive Disease|0|||
163426733|NCT00408005|590265157|FG004|Induction|Progressive Disease|0|||
163426734|NCT00408005|590265158|FG005|Induction|Progressive Disease|0|||
163426735|NCT00408005|590265159|FG006|Induction|Progressive Disease|0|||
163426736|NCT00408005|590265160|FG007|Induction|Progressive Disease|0|||
163426737|NCT00408005|590265153|FG000|Induction|Inevaluable|18|||
163426738|NCT00408005|590265154|FG001|Induction|Inevaluable|14|||
163426739|NCT00408005|590265155|FG002|Induction|Inevaluable|0|||
163426740|NCT00408005|590265156|FG003|Induction|Inevaluable|0|||
163426741|NCT00408005|590265157|FG004|Induction|Inevaluable|0|||
163426742|NCT00408005|590265158|FG005|Induction|Inevaluable|0|||
163426743|NCT00408005|590265159|FG006|Induction|Inevaluable|0|||
163426744|NCT00408005|590265160|FG007|Induction|Inevaluable|0|||
163426745|NCT00408005|590265153|FG000|Induction|Failed to Complete Randomization|3|||
163426746|NCT00408005|590265154|FG001|Induction|Failed to Complete Randomization|2|||
163426747|NCT00408005|590265155|FG002|Induction|Failed to Complete Randomization|0|||
163426748|NCT00408005|590265156|FG003|Induction|Failed to Complete Randomization|0|||
163426749|NCT00408005|590265157|FG004|Induction|Failed to Complete Randomization|0|||
163426750|NCT00408005|590265158|FG005|Induction|Failed to Complete Randomization|0|||
163426751|NCT00408005|590265159|FG006|Induction|Failed to Complete Randomization|0|||
163426752|NCT00408005|590265160|FG007|Induction|Failed to Complete Randomization|0|||
163426753|NCT00408005|590265153|FG000|Induction|Protocol Deviation|3|||
163426754|NCT00408005|590265154|FG001|Induction|Protocol Deviation|1|||
163426755|NCT00408005|590265155|FG002|Induction|Protocol Deviation|0|||
163426756|NCT00408005|590265156|FG003|Induction|Protocol Deviation|0|||
163426757|NCT00408005|590265157|FG004|Induction|Protocol Deviation|0|||
163426758|NCT00408005|590265158|FG005|Induction|Protocol Deviation|0|||
163426759|NCT00408005|590265159|FG006|Induction|Protocol Deviation|0|||
163426760|NCT00408005|590265160|FG007|Induction|Protocol Deviation|0|||
163426761|NCT00408005|590265153|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
163426762|NCT00408005|590265154|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
163426763|NCT00408005|590265155|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
163426764|NCT00408005|590265156|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
163426765|NCT00408005|590265157|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
163426766|NCT00408005|590265158|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
163426767|NCT00408005|590265159|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
163426768|NCT00408005|590265160|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
163426769|NCT00408005|590265153|FG000|Induction|Recurrent leukemia|1|||
163426770|NCT00408005|590265154|FG001|Induction|Recurrent leukemia|0|||
163426771|NCT00408005|590265155|FG002|Induction|Recurrent leukemia|0|||
163426772|NCT00408005|590265156|FG003|Induction|Recurrent leukemia|0|||
163426773|NCT00408005|590265157|FG004|Induction|Recurrent leukemia|0|||
163426774|NCT00408005|590265158|FG005|Induction|Recurrent leukemia|0|||
163426775|NCT00408005|590265159|FG006|Induction|Recurrent leukemia|0|||
163426776|NCT00408005|590265160|FG007|Induction|Recurrent leukemia|0|||
163426777|NCT00408005|590265153|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
163426778|NCT00408005|590265154|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
163426779|NCT00408005|590265155|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
163426780|NCT00408005|590265156|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
163426781|NCT00408005|590265157|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
163426782|NCT00408005|590265158|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
163426783|NCT00408005|590265159|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
163426784|NCT00408005|590265160|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
163426785|NCT00408005|590265153|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
163426786|NCT00408005|590265154|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
163426787|NCT00408005|590265155|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
163426788|NCT00408005|590265156|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
163426789|NCT00408005|590265157|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
163426790|NCT00408005|590265158|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
163426791|NCT00408005|590265159|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
163426792|NCT00408005|590265160|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
163426793|NCT00408005|590265153|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
163426794|NCT00408005|590265154|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
163426795|NCT00408005|590265155|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
163426796|NCT00408005|590265156|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
163426797|NCT00408005|590265157|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
163426798|NCT00408005|590265158|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
163426799|NCT00408005|590265159|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
163426800|NCT00408005|590265160|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
163426801|NCT00408005|590265153|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
163426802|NCT00408005|590265154|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
163426803|NCT00408005|590265155|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
163426804|NCT00408005|590265156|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
163426805|NCT00408005|590265157|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
163426806|NCT00408005|590265158|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
163426807|NCT00408005|590265159|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
163426808|NCT00408005|590265160|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
163426809|NCT00408005|590265153|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
163426810|NCT00408005|590265154|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
163426811|NCT00408005|590265155|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
163426812|NCT00408005|590265156|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
163426813|NCT00408005|590265157|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
163426814|NCT00408005|590265158|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
163426815|NCT00408005|590265159|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
163426816|NCT00408005|590265160|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
163426817|NCT00408005|590265153|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
163426818|NCT00408005|590265154|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
163426819|NCT00408005|590265155|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
163426820|NCT00408005|590265156|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
163426821|NCT00408005|590265157|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
163426822|NCT00408005|590265158|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
163426823|NCT00408005|590265159|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
163426824|NCT00408005|590265160|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
163426825|NCT00408005|590265153|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
163426826|NCT00408005|590265154|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
163426827|NCT00408005|590265155|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
163426828|NCT00408005|590265156|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
163426829|NCT00408005|590265157|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
163426830|NCT00408005|590265158|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
163426831|NCT00408005|590265159|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
163426832|NCT00408005|590265160|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
163426833|NCT00408005|590265153|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
163426834|NCT00408005|590265154|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
163426835|NCT00408005|590265155|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
163426836|NCT00408005|590265156|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
163426837|NCT00408005|590265157|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
163426838|NCT00408005|590265158|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
163426839|NCT00408005|590265159|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
163426840|NCT00408005|590265160|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
163426841|NCT00408005|590265153|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
163426842|NCT00408005|590265154|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
163426843|NCT00408005|590265155|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
163426844|NCT00408005|590265156|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
163426845|NCT00408005|590265157|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
163426846|NCT00408005|590265158|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
163426847|NCT00408005|590265159|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
163426848|NCT00408005|590265160|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
163426849|NCT00408005|590265153|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
163426850|NCT00408005|590265154|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
163426851|NCT00408005|590265155|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
163426852|NCT00408005|590265156|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
163426853|NCT00408005|590265157|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
163426854|NCT00408005|590265158|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
163426855|NCT00408005|590265159|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
163426856|NCT00408005|590265160|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
163426857|NCT00408005|590265153|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
163426858|NCT00408005|590265154|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
163426859|NCT00408005|590265155|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
163426860|NCT00408005|590265156|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
163426861|NCT00408005|590265157|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
163426862|NCT00408005|590265158|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
163426863|NCT00408005|590265159|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
163426864|NCT00408005|590265160|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
163426865|NCT00408005|590265153|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
163426866|NCT00408005|590265154|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
163426867|NCT00408005|590265155|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
163426868|NCT00408005|590265156|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
163426869|NCT00408005|590265157|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
163426870|NCT00408005|590265158|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
163426871|NCT00408005|590265159|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
163426872|NCT00408005|590265160|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
163426873|NCT00408005|590265153|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
163426874|NCT00408005|590265154|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
163426875|NCT00408005|590265155|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
163426876|NCT00408005|590265156|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
163426877|NCT00408005|590265157|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
163426878|NCT00408005|590265158|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
163426879|NCT00408005|590265159|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
163426880|NCT00408005|590265160|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
163426881|NCT00408005|590265153|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
163426882|NCT00408005|590265154|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
163426883|NCT00408005|590265155|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
163426884|NCT00408005|590265156|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
163426885|NCT00408005|590265157|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
163426886|NCT00408005|590265158|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
163426887|NCT00408005|590265159|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
163426888|NCT00408005|590265160|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
163426889|NCT05817045|590265161|FG000|Overall Study|Protocol Violation|0|||
163426890|NCT05817045|590265162|FG001|Overall Study|Protocol Violation|3|||
163426891|NCT05817045|590265161|FG000|Overall Study|Withdrawal by Subject|10|||
163426892|NCT05817045|590265162|FG001|Overall Study|Withdrawal by Subject|7|||
163426893|NCT05817045|590265161|FG000|Overall Study|Physician Decision|3|||
163426894|NCT05817045|590265162|FG001|Overall Study|Physician Decision|0|||
163426895|NCT05817045|590265161|FG000|Overall Study|Lost to Follow-up|0|||
163426896|NCT05817045|590265162|FG001|Overall Study|Lost to Follow-up|1|||
163426897|NCT05817045|590265161|FG000|Overall Study|Device Deficiency|1|||
163426898|NCT05817045|590265162|FG001|Overall Study|Device Deficiency|0|||
163426899|NCT05817045|590265161|FG000|Overall Study|System Error|1|||
163426900|NCT05817045|590265162|FG001|Overall Study|System Error|0|||
163426901|NCT01506141|590265163|FG000|Overall Study|Adverse Event|0|||
163426902|NCT01506141|590265164|FG001|Overall Study|Adverse Event|2|||
163426903|NCT01506141|590265163|FG000|Overall Study|Participation Terminated by Investigator|1|||
163426904|NCT01506141|590265164|FG001|Overall Study|Participation Terminated by Investigator|1|||
163426905|NCT01506141|590265163|FG000|Overall Study|Site Terminated by Sponsor|2|||
163426906|NCT01506141|590265164|FG001|Overall Study|Site Terminated by Sponsor|0|||
163426907|NCT01506141|590265163|FG000|Overall Study|Reason Not Specified|4|||
163426908|NCT01506141|590265164|FG001|Overall Study|Reason Not Specified|2|||
163426909|NCT04889209|590265165|FG000|All Cohorts Except 15E|Adverse Event|0|||
163426910|NCT04889209|590265166|FG001|All Cohorts Except 15E|Adverse Event|0|||
163426911|NCT04889209|590265167|FG002|All Cohorts Except 15E|Adverse Event|0|||
163426912|NCT04889209|590265168|FG003|All Cohorts Except 15E|Adverse Event|0|||
163426913|NCT04889209|590265169|FG004|All Cohorts Except 15E|Adverse Event|0|||
163426914|NCT04889209|590265170|FG005|All Cohorts Except 15E|Adverse Event|0|||
163426915|NCT04889209|590265171|FG006|All Cohorts Except 15E|Adverse Event|1|||
163426916|NCT04889209|590265172|FG007|All Cohorts Except 15E|Adverse Event|0|||
163426917|NCT04889209|590265173|FG008|All Cohorts Except 15E|Adverse Event|0|||
163426918|NCT04889209|590265174|FG009|All Cohorts Except 15E|Adverse Event|0|||
163426919|NCT04889209|590265175|FG010|All Cohorts Except 15E|Adverse Event|0|||
163426920|NCT04889209|590265176|FG011|All Cohorts Except 15E|Adverse Event|0|||
163426921|NCT04889209|590265177|FG012|All Cohorts Except 15E|Adverse Event|0|||
163426922|NCT04889209|590265178|FG013|All Cohorts Except 15E|Adverse Event|0|||
163426923|NCT04889209|590265179|FG014|All Cohorts Except 15E|Adverse Event|0|||
163426924|NCT04889209|590265180|FG015|All Cohorts Except 15E|Adverse Event|0|||
163426925|NCT04889209|590265181|FG016|All Cohorts Except 15E|Adverse Event|0|||
163426926|NCT04889209|590265182|FG017|All Cohorts Except 15E|Adverse Event|0|||
163426927|NCT04889209|590265165|FG000|All Cohorts Except 15E|Death|0|||
163426928|NCT04889209|590265166|FG001|All Cohorts Except 15E|Death|1|||
163426929|NCT04889209|590265167|FG002|All Cohorts Except 15E|Death|0|||
163426930|NCT04889209|590265168|FG003|All Cohorts Except 15E|Death|0|||
163426931|NCT04889209|590265169|FG004|All Cohorts Except 15E|Death|0|||
163426932|NCT04889209|590265170|FG005|All Cohorts Except 15E|Death|0|||
163426933|NCT04889209|590265171|FG006|All Cohorts Except 15E|Death|0|||
163426934|NCT04889209|590265172|FG007|All Cohorts Except 15E|Death|0|||
163426935|NCT04889209|590265173|FG008|All Cohorts Except 15E|Death|0|||
163426936|NCT04889209|590265174|FG009|All Cohorts Except 15E|Death|0|||
163426937|NCT04889209|590265175|FG010|All Cohorts Except 15E|Death|0|||
163426938|NCT04889209|590265176|FG011|All Cohorts Except 15E|Death|0|||
163426939|NCT04889209|590265177|FG012|All Cohorts Except 15E|Death|0|||
163426940|NCT04889209|590265178|FG013|All Cohorts Except 15E|Death|0|||
163426941|NCT04889209|590265179|FG014|All Cohorts Except 15E|Death|0|||
163426942|NCT04889209|590265180|FG015|All Cohorts Except 15E|Death|0|||
163426943|NCT04889209|590265181|FG016|All Cohorts Except 15E|Death|0|||
163426944|NCT04889209|590265182|FG017|All Cohorts Except 15E|Death|0|||
163426945|NCT04889209|590265165|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
163426946|NCT04889209|590265166|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
163426947|NCT04889209|590265167|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
163426948|NCT04889209|590265168|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
163426949|NCT04889209|590265169|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
163426950|NCT04889209|590265170|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
163426951|NCT04889209|590265171|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
163426952|NCT04889209|590265172|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
163426953|NCT04889209|590265173|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
163426954|NCT04889209|590265174|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
163426955|NCT04889209|590265175|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
163426956|NCT04889209|590265176|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
163426957|NCT04889209|590265177|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
163426958|NCT04889209|590265178|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
163426959|NCT04889209|590265179|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
163426960|NCT04889209|590265180|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
163426961|NCT04889209|590265181|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
163426962|NCT04889209|590265182|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
163426963|NCT04889209|590265165|FG000|All Cohorts Except 15E|Physician Decision|0|||
163426964|NCT04889209|590265166|FG001|All Cohorts Except 15E|Physician Decision|0|||
163426965|NCT04889209|590265167|FG002|All Cohorts Except 15E|Physician Decision|0|||
163426966|NCT04889209|590265168|FG003|All Cohorts Except 15E|Physician Decision|0|||
163426967|NCT04889209|590265169|FG004|All Cohorts Except 15E|Physician Decision|1|||
163426968|NCT04889209|590265170|FG005|All Cohorts Except 15E|Physician Decision|0|||
163426969|NCT04889209|590265171|FG006|All Cohorts Except 15E|Physician Decision|0|||
163426970|NCT04889209|590265172|FG007|All Cohorts Except 15E|Physician Decision|1|||
163426971|NCT04889209|590265173|FG008|All Cohorts Except 15E|Physician Decision|0|||
163426972|NCT04889209|590265174|FG009|All Cohorts Except 15E|Physician Decision|1|||
163426973|NCT04889209|590265175|FG010|All Cohorts Except 15E|Physician Decision|0|||
163426974|NCT04889209|590265176|FG011|All Cohorts Except 15E|Physician Decision|1|||
163426975|NCT04889209|590265177|FG012|All Cohorts Except 15E|Physician Decision|1|||
163426976|NCT04889209|590265178|FG013|All Cohorts Except 15E|Physician Decision|0|||
163426977|NCT04889209|590265179|FG014|All Cohorts Except 15E|Physician Decision|0|||
163426978|NCT04889209|590265180|FG015|All Cohorts Except 15E|Physician Decision|0|||
163426979|NCT04889209|590265181|FG016|All Cohorts Except 15E|Physician Decision|0|||
163426980|NCT04889209|590265182|FG017|All Cohorts Except 15E|Physician Decision|0|||
163426981|NCT04889209|590265165|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
163426982|NCT04889209|590265166|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
163426983|NCT04889209|590265167|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
163426984|NCT04889209|590265168|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
163426985|NCT04889209|590265169|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
163426986|NCT04889209|590265170|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
163426987|NCT04889209|590265171|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
163426988|NCT04889209|590265172|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
163426989|NCT04889209|590265173|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
163426990|NCT04889209|590265174|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
163426991|NCT04889209|590265175|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
163426992|NCT04889209|590265176|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
163426993|NCT04889209|590265177|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
163426994|NCT04889209|590265178|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
163426995|NCT04889209|590265179|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
163426996|NCT04889209|590265180|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
163426997|NCT04889209|590265181|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
163426998|NCT04889209|590265182|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
163426999|NCT04889209|590265165|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
163427000|NCT04889209|590265166|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
163427001|NCT04889209|590265167|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
163427002|NCT04889209|590265168|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
163427003|NCT04889209|590265169|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
163427004|NCT04889209|590265170|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
163427005|NCT04889209|590265171|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
163427006|NCT04889209|590265172|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
163427007|NCT04889209|590265173|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
163427008|NCT04889209|590265174|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
163427009|NCT04889209|590265175|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
163427010|NCT04889209|590265176|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
163427011|NCT04889209|590265177|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
163427012|NCT04889209|590265178|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
163427013|NCT04889209|590265179|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
163427014|NCT04889209|590265180|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
163427015|NCT04889209|590265181|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
163427016|NCT04889209|590265182|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
163427017|NCT04889209|590265165|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427018|NCT04889209|590265166|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427019|NCT04889209|590265167|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427020|NCT04889209|590265168|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
163427021|NCT04889209|590265169|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427022|NCT04889209|590265170|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427023|NCT04889209|590265171|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427024|NCT04889209|590265172|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427025|NCT04889209|590265173|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427026|NCT04889209|590265174|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427027|NCT04889209|590265175|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427028|NCT04889209|590265176|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427029|NCT04889209|590265177|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427030|NCT04889209|590265178|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427031|NCT04889209|590265179|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427032|NCT04889209|590265180|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427033|NCT04889209|590265181|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427034|NCT04889209|590265182|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163427035|NCT04889209|590265165|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
163427036|NCT04889209|590265166|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
163427037|NCT04889209|590265167|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
163427038|NCT04889209|590265168|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
163427039|NCT04889209|590265169|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
163427040|NCT04889209|590265170|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
163427041|NCT04889209|590265171|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
163427042|NCT04889209|590265172|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
163427043|NCT04889209|590265173|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
163427044|NCT04889209|590265174|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
163427045|NCT04889209|590265175|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
163427046|NCT04889209|590265176|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
163427047|NCT04889209|590265177|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
163427048|NCT04889209|590265178|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
163427049|NCT04889209|590265179|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
163427050|NCT04889209|590265180|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
163427051|NCT04889209|590265181|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
163427052|NCT04889209|590265182|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
163427053|NCT04889209|590265165|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427054|NCT04889209|590265166|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427055|NCT04889209|590265167|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427056|NCT04889209|590265168|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427057|NCT04889209|590265169|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427058|NCT04889209|590265170|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427059|NCT04889209|590265171|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427060|NCT04889209|590265172|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427061|NCT04889209|590265173|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427062|NCT04889209|590265174|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427063|NCT04889209|590265175|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427064|NCT04889209|590265176|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427065|NCT04889209|590265177|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427066|NCT04889209|590265178|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427067|NCT04889209|590265179|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427068|NCT04889209|590265180|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427069|NCT04889209|590265181|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
163427070|NCT04889209|590265182|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
163427071|NCT04889209|590265165|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427072|NCT04889209|590265166|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427073|NCT04889209|590265167|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427074|NCT04889209|590265168|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427075|NCT04889209|590265169|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427076|NCT04889209|590265170|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427077|NCT04889209|590265171|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427078|NCT04889209|590265172|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427079|NCT04889209|590265173|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427080|NCT04889209|590265174|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427081|NCT04889209|590265175|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427082|NCT04889209|590265176|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427083|NCT04889209|590265177|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427084|NCT04889209|590265178|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427085|NCT04889209|590265179|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427086|NCT04889209|590265180|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427087|NCT04889209|590265181|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
163427088|NCT04889209|590265182|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
163427089|NCT04889209|590265165|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427090|NCT04889209|590265166|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427091|NCT04889209|590265167|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427092|NCT04889209|590265168|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427093|NCT04889209|590265169|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427094|NCT04889209|590265170|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427095|NCT04889209|590265171|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427096|NCT04889209|590265172|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427097|NCT04889209|590265173|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427098|NCT04889209|590265174|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427099|NCT04889209|590265175|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427100|NCT04889209|590265176|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427101|NCT04889209|590265177|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427102|NCT04889209|590265178|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427103|NCT04889209|590265179|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
163427104|NCT04889209|590265180|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427105|NCT04889209|590265181|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427106|NCT04889209|590265182|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
163427107|NCT04607408|590265183|FG000|Overall Study|Lost to Follow-up|0|||
163427108|NCT04607408|590265184|FG001|Overall Study|Lost to Follow-up|0|||
163427109|NCT04607408|590265185|FG002|Overall Study|Lost to Follow-up|0|||
163427110|NCT04607408|590265186|FG003|Overall Study|Lost to Follow-up|1|||
163427111|NCT04607408|590265187|FG004|Overall Study|Lost to Follow-up|0|||
163427112|NCT04607408|590265183|FG000|Overall Study|Withdrawal by Subject|0|||
163427113|NCT04607408|590265184|FG001|Overall Study|Withdrawal by Subject|1|||
163427114|NCT04607408|590265185|FG002|Overall Study|Withdrawal by Subject|0|||
163427115|NCT04607408|590265186|FG003|Overall Study|Withdrawal by Subject|1|||
163427116|NCT04607408|590265187|FG004|Overall Study|Withdrawal by Subject|0|||
163427117|NCT05424276|590265194|FG000|Overall Study|Adverse Event|1|||
163427118|NCT05424276|590265195|FG001|Overall Study|Adverse Event|0|||
163427119|NCT05424276|590265196|FG002|Overall Study|Adverse Event|0|||
163427120|NCT05424276|590265197|FG003|Overall Study|Adverse Event|2|||
163427121|NCT05424276|590265194|FG000|Overall Study|Withdrawal by Subject|0|||
163427122|NCT05424276|590265195|FG001|Overall Study|Withdrawal by Subject|0|||
163427123|NCT05424276|590265196|FG002|Overall Study|Withdrawal by Subject|2|||
163427124|NCT05424276|590265197|FG003|Overall Study|Withdrawal by Subject|0|||
163427125|NCT05424276|590265194|FG000|Overall Study|Protocol Violation|0|||
163427126|NCT05424276|590265195|FG001|Overall Study|Protocol Violation|1|||
163427127|NCT05424276|590265196|FG002|Overall Study|Protocol Violation|0|||
163427128|NCT05424276|590265197|FG003|Overall Study|Protocol Violation|0|||
163427129|NCT05424276|590265194|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
163427130|NCT05424276|590265195|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
163427131|NCT05424276|590265196|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
163427132|NCT05424276|590265197|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
163427133|NCT01725165|590265198|FG000|Overall Study|Death|11|||
163427134|NCT01725165|590265199|FG001|Overall Study|Death|18|||
163427135|NCT05113940|590265202|FG000|Part A (18 Days)|Adverse Event|0|||
163427136|NCT05113940|590265203|FG001|Part A (18 Days)|Adverse Event|0|||
163427137|NCT05113940|590265204|FG002|Part A (18 Days)|Adverse Event|1|||
163427138|NCT05113940|590265205|FG003|Part A (18 Days)|Adverse Event|1|||
163427139|NCT05113940|590265206|FG004|Part A (18 Days)|Adverse Event|1|||
163427140|NCT05113940|590265207|FG005|Part A (18 Days)|Adverse Event|0|||
163427141|NCT05113940|590265208|FG006|Part A (18 Days)|Adverse Event|0|||
163427142|NCT05113940|590265209|FG007|Part A (18 Days)|Adverse Event|0|||
163427143|NCT05113940|590265210|FG008|Part A (18 Days)|Adverse Event|0|||
163427144|NCT05113940|590265211|FG009|Part A (18 Days)|Adverse Event|0|||
163427145|NCT05113940|590265212|FG010|Part A (18 Days)|Adverse Event|0|||
163427146|NCT05113940|590265213|FG011|Part A (18 Days)|Adverse Event|2|||
163427147|NCT05113940|590265214|FG012|Part A (18 Days)|Adverse Event|0|||
163427148|NCT05113940|590265215|FG013|Part A (18 Days)|Adverse Event|0|||
163427149|NCT05113940|590265216|FG014|Part A (18 Days)|Adverse Event|0|||
163427150|NCT05113940|590265202|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
163427151|NCT05113940|590265203|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
163427152|NCT05113940|590265204|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
163427153|NCT05113940|590265205|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
163427154|NCT05113940|590265206|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
163427155|NCT05113940|590265207|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
163427156|NCT05113940|590265208|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
163427157|NCT05113940|590265209|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
163427158|NCT05113940|590265210|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
163427159|NCT05113940|590265211|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
163427160|NCT05113940|590265212|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
163427161|NCT05113940|590265213|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
163427162|NCT05113940|590265214|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
163427163|NCT05113940|590265215|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
163427164|NCT05113940|590265216|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
163427165|NCT03619213|590265218|FG000|Overall Study|Lost to Follow-up|2|||
163427166|NCT03619213|590265219|FG001|Overall Study|Lost to Follow-up|1|||
163427167|NCT03619213|590265218|FG000|Overall Study|Withdrawal by Subject|8|||
163427168|NCT03619213|590265219|FG001|Overall Study|Withdrawal by Subject|10|||
163427169|NCT00382967|590265220|FG000|Overall Study|Protocol Violation|1|||
163427170|NCT00382967|590265221|FG001|Overall Study|Protocol Violation|1|||
163427171|NCT00501228|590265223|FG000|Overall Study|Withdrawal by Subject|1|||
163427172|NCT00461175|590265224|FG000|Overall Study|Protocol Violation|522|||
163427173|NCT00461175|590265225|FG001|Overall Study|Protocol Violation|365|||
163427174|NCT00316264|590265227|FG000|Overall Study|Lost to Follow-up|0|||
163427175|NCT00316264|590265228|FG001|Overall Study|Lost to Follow-up|1|||
163427176|NCT00316264|590265229|FG002|Overall Study|Lost to Follow-up|0|||
163427177|NCT00316264|590265227|FG000|Overall Study|Withdrawal of Consent|3|||
163427178|NCT00316264|590265228|FG001|Overall Study|Withdrawal of Consent|5|||
163427179|NCT00316264|590265229|FG002|Overall Study|Withdrawal of Consent|6|||
163427180|NCT00316264|590265227|FG000|Overall Study|Death|2|||
163427181|NCT00316264|590265228|FG001|Overall Study|Death|0|||
163427182|NCT00316264|590265229|FG002|Overall Study|Death|0|||
163427183|NCT00316264|590265227|FG000|Overall Study|Other|1|||
163427184|NCT00316264|590265228|FG001|Overall Study|Other|1|||
163427185|NCT00316264|590265229|FG002|Overall Study|Other|0|||
163427186|NCT02209506|590265232|FG000|Overall Study|Withdrawal by Subject|0|||
163427187|NCT02209506|590265233|FG001|Overall Study|Withdrawal by Subject|0|||
163427188|NCT02209506|590265234|FG002|Overall Study|Withdrawal by Subject|0|||
163427189|NCT02209506|590265235|FG003|Overall Study|Withdrawal by Subject|0|||
163427190|NCT02209506|590265236|FG004|Overall Study|Withdrawal by Subject|1|||
163427191|NCT02203149|590265237|FG000|Part 1|Adverse Event|0|||
163427192|NCT02203149|590265238|FG001|Part 1|Adverse Event|1|||
163427193|NCT02203149|590265239|FG002|Part 1|Adverse Event|0|||
163427194|NCT02203149|590265240|FG003|Part 1|Adverse Event|0|||
163427195|NCT02203149|590265241|FG004|Part 1|Adverse Event|0|||
163427196|NCT02203149|590265237|FG000|Part 2|Death|0|||
163427197|NCT02203149|590265238|FG001|Part 2|Death|0|||
163427198|NCT02203149|590265239|FG002|Part 2|Death|1|||
163427199|NCT02203149|590265240|FG003|Part 2|Death|1|||
163427200|NCT02203149|590265241|FG004|Part 2|Death|0|||
163427201|NCT02203149|590265237|FG000|Part 2|Withdrawal by Subject|0|||
163427202|NCT02203149|590265238|FG001|Part 2|Withdrawal by Subject|0|||
163427203|NCT02203149|590265239|FG002|Part 2|Withdrawal by Subject|0|||
163427204|NCT02203149|590265240|FG003|Part 2|Withdrawal by Subject|1|||
163427205|NCT02203149|590265241|FG004|Part 2|Withdrawal by Subject|0|||
163427206|NCT02203149|590265237|FG000|Part 2|Adverse Event|0|||
163427207|NCT02203149|590265238|FG001|Part 2|Adverse Event|0|||
163427208|NCT02203149|590265239|FG002|Part 2|Adverse Event|0|||
163427209|NCT02203149|590265240|FG003|Part 2|Adverse Event|1|||
163427210|NCT02203149|590265241|FG004|Part 2|Adverse Event|1|||
163427211|NCT02537678|590265242|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
163427212|NCT02537678|590265243|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
163427213|NCT02537678|590265242|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
163427214|NCT02537678|590265243|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
163427215|NCT02537678|590265242|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
163427216|NCT02537678|590265243|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
163427217|NCT02537678|590265242|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
163427218|NCT02537678|590265243|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
163427219|NCT02537678|590265242|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
163427220|NCT02537678|590265243|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
163427221|NCT02537678|590265242|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
163427222|NCT02537678|590265243|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
163427223|NCT02537678|590265242|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
163427224|NCT02537678|590265243|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
163427225|NCT04348851|590265244|FG000|Post-Test 1|Withdrawal by Subject|0|||
163427226|NCT04348851|590265245|FG001|Post-Test 1|Withdrawal by Subject|1|||
163427227|NCT04348851|590265246|FG002|Post-Test 1|Withdrawal by Subject|0|||
163427228|NCT04348851|590265247|FG003|Post-Test 1|Withdrawal by Subject|0|||
163427229|NCT04348851|590265244|FG000|Post-Test 1|Lost to Follow-up|0|||
163427230|NCT04348851|590265245|FG001|Post-Test 1|Lost to Follow-up|1|||
163427231|NCT04348851|590265246|FG002|Post-Test 1|Lost to Follow-up|0|||
163427232|NCT04348851|590265247|FG003|Post-Test 1|Lost to Follow-up|0|||
163427233|NCT04348851|590265244|FG000|Post-Test 2|Stroke survivor death|0|||
163427234|NCT04348851|590265245|FG001|Post-Test 2|Stroke survivor death|1|||
163427235|NCT04348851|590265246|FG002|Post-Test 2|Stroke survivor death|0|||
163427236|NCT04348851|590265247|FG003|Post-Test 2|Stroke survivor death|1|||
163427237|NCT00195650|590265248|FG000|Overall Study|Adverse Event|194|||
163427238|NCT00195650|590265248|FG000|Overall Study|Lack of Efficacy|99|||
163427239|NCT00195650|590265248|FG000|Overall Study|Withdrawal by Subject|67|||
163427240|NCT00195650|590265248|FG000|Overall Study|Lost to Follow-up|44|||
163427241|NCT00195650|590265248|FG000|Overall Study|Death|23|||
163427242|NCT00195650|590265248|FG000|Overall Study|Protocol Violation|15|||
163427243|NCT00195650|590265248|FG000|Overall Study|Administrative reasons|83|||
163427244|NCT00432809|590265249|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
163427245|NCT00432809|590265250|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
163427246|NCT00432809|590265251|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
163427247|NCT00432809|590265249|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
163427248|NCT00432809|590265250|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
163427249|NCT00432809|590265251|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
163427250|NCT01499290|590265252|FG000|Overall Study|Withdrawal by Subject|22|||
163427251|NCT01499290|590265253|FG001|Overall Study|Withdrawal by Subject|15|||
163427252|NCT01499290|590265252|FG000|Overall Study|Not specified in study report|11|||
163427253|NCT01499290|590265253|FG001|Overall Study|Not specified in study report|5|||
163427254|NCT01499290|590265252|FG000|Overall Study|Condition improved/subject recovered|1|||
163427255|NCT01499290|590265253|FG001|Overall Study|Condition improved/subject recovered|0|||
163427256|NCT01499290|590265252|FG000|Overall Study|Lack of Efficacy|7|||
163427257|NCT01499290|590265253|FG001|Overall Study|Lack of Efficacy|8|||
163427258|NCT01499290|590265252|FG000|Overall Study|Adverse Event|14|||
163427259|NCT01499290|590265253|FG001|Overall Study|Adverse Event|7|||
163427260|NCT00552110|590265254|FG000|Overall Study|Serious or Life-Threatening AE|0|||
163427261|NCT00552110|590265255|FG001|Overall Study|Serious or Life-Threatening AE|0|||
163427262|NCT00552110|590265256|FG002|Overall Study|Serious or Life-Threatening AE|1|||
163427263|NCT00552110|590265257|FG003|Overall Study|Serious or Life-Threatening AE|0|||
163427264|NCT00552110|590265258|FG004|Overall Study|Serious or Life-Threatening AE|0|||
163427265|NCT00552110|590265254|FG000|Overall Study|Lack of Efficacy|1|||
163427266|NCT00552110|590265255|FG001|Overall Study|Lack of Efficacy|0|||
163427267|NCT00552110|590265256|FG002|Overall Study|Lack of Efficacy|0|||
163427268|NCT00552110|590265257|FG003|Overall Study|Lack of Efficacy|1|||
163427269|NCT00552110|590265258|FG004|Overall Study|Lack of Efficacy|4|||
163427270|NCT00552110|590265254|FG000|Overall Study|Withdrawal by Subject|0|||
163427271|NCT00552110|590265255|FG001|Overall Study|Withdrawal by Subject|2|||
163427272|NCT00552110|590265256|FG002|Overall Study|Withdrawal by Subject|0|||
163427273|NCT00552110|590265257|FG003|Overall Study|Withdrawal by Subject|3|||
163427274|NCT00552110|590265258|FG004|Overall Study|Withdrawal by Subject|2|||
163427275|NCT00552110|590265254|FG000|Overall Study|Lost to Follow-up|0|||
163427276|NCT00552110|590265255|FG001|Overall Study|Lost to Follow-up|0|||
163427277|NCT00552110|590265256|FG002|Overall Study|Lost to Follow-up|0|||
163427278|NCT00552110|590265257|FG003|Overall Study|Lost to Follow-up|1|||
163427279|NCT00552110|590265258|FG004|Overall Study|Lost to Follow-up|1|||
163427280|NCT00552110|590265254|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
163427281|NCT00552110|590265255|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
163427282|NCT00552110|590265256|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
163427283|NCT00552110|590265257|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
163427284|NCT00552110|590265258|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
163427285|NCT00552110|590265254|FG000|Overall Study|Withdrawn per Sponsor|0|||
163427286|NCT00552110|590265255|FG001|Overall Study|Withdrawn per Sponsor|1|||
163427287|NCT00552110|590265256|FG002|Overall Study|Withdrawn per Sponsor|0|||
163427288|NCT00552110|590265257|FG003|Overall Study|Withdrawn per Sponsor|0|||
163427289|NCT00552110|590265258|FG004|Overall Study|Withdrawn per Sponsor|1|||
163427290|NCT00552110|590265254|FG000|Overall Study|Use of Prohibited Medication|1|||
163427291|NCT00552110|590265255|FG001|Overall Study|Use of Prohibited Medication|1|||
163427292|NCT00552110|590265256|FG002|Overall Study|Use of Prohibited Medication|0|||
163427293|NCT00552110|590265257|FG003|Overall Study|Use of Prohibited Medication|0|||
163427294|NCT00552110|590265258|FG004|Overall Study|Use of Prohibited Medication|0|||
163427295|NCT00552110|590265254|FG000|Overall Study|Delay of Study due to Relabeling|0|||
163427296|NCT00552110|590265255|FG001|Overall Study|Delay of Study due to Relabeling|0|||
163427297|NCT00552110|590265256|FG002|Overall Study|Delay of Study due to Relabeling|0|||
163427298|NCT00552110|590265257|FG003|Overall Study|Delay of Study due to Relabeling|1|||
163427299|NCT00552110|590265258|FG004|Overall Study|Delay of Study due to Relabeling|0|||
163427300|NCT00552110|590265254|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
163427301|NCT00552110|590265255|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
163427302|NCT00552110|590265256|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
163427303|NCT00552110|590265257|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
163427304|NCT00552110|590265258|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
163427305|NCT00552110|590265254|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
163427306|NCT00552110|590265255|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
163427307|NCT00552110|590265256|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
163427308|NCT00552110|590265257|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
163427309|NCT00552110|590265258|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
163427310|NCT00700804|590265259|FG000|Overall Study|Withdrawal by Subject|1|||
163427311|NCT00700804|590265260|FG001|Overall Study|Withdrawal by Subject|2|||
163427312|NCT00700804|590265259|FG000|Overall Study|Protocol Violation|1|||
163427313|NCT00700804|590265260|FG001|Overall Study|Protocol Violation|1|||
163427314|NCT00700804|590265259|FG000|Overall Study|Loose Stools|1|||
163427315|NCT00700804|590265260|FG001|Overall Study|Loose Stools|1|||
163427316|NCT05775289|590265261|FG000|Overall Study|Study Ongoing|20|||
163427317|NCT05775289|590265262|FG001|Overall Study|Study Ongoing|53|||
163427318|NCT05775289|590265263|FG002|Overall Study|Study Ongoing|15|||
163427319|NCT05775289|590265264|FG003|Overall Study|Study Ongoing|55|||
163427320|NCT05775289|590265261|FG000|Overall Study|Death|4|||
163427321|NCT05775289|590265262|FG001|Overall Study|Death|11|||
163427322|NCT05775289|590265263|FG002|Overall Study|Death|8|||
163427323|NCT05775289|590265264|FG003|Overall Study|Death|12|||
163427324|NCT05775289|590265261|FG000|Overall Study|Lost to Follow-up|0|||
163427325|NCT05775289|590265262|FG001|Overall Study|Lost to Follow-up|1|||
163427326|NCT05775289|590265263|FG002|Overall Study|Lost to Follow-up|0|||
163427327|NCT05775289|590265264|FG003|Overall Study|Lost to Follow-up|0|||
163427328|NCT05775289|590265261|FG000|Overall Study|Progressive Disease|0|||
163427329|NCT05775289|590265262|FG001|Overall Study|Progressive Disease|0|||
163427330|NCT05775289|590265263|FG002|Overall Study|Progressive Disease|1|||
163427331|NCT05775289|590265264|FG003|Overall Study|Progressive Disease|0|||
163427332|NCT05775289|590265261|FG000|Overall Study|Withdrawal by Subject|1|||
163427333|NCT05775289|590265262|FG001|Overall Study|Withdrawal by Subject|1|||
163427334|NCT05775289|590265263|FG002|Overall Study|Withdrawal by Subject|0|||
163427335|NCT05775289|590265264|FG003|Overall Study|Withdrawal by Subject|0|||
163427336|NCT02330419|590265269|FG000|Overall Study|Lost to Follow-up|3|||
163427337|NCT02330419|590265270|FG001|Overall Study|Lost to Follow-up|7|||
163427338|NCT01587989|590265275|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
163427339|NCT01587989|590265276|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
163427340|NCT01587989|590265277|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
163427341|NCT01587989|590265275|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
163427342|NCT01587989|590265276|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
163427343|NCT01587989|590265277|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
163427344|NCT01587989|590265275|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
163427345|NCT01587989|590265276|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
163427346|NCT01587989|590265277|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
163427347|NCT01587989|590265275|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
163427348|NCT01587989|590265276|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
163427349|NCT01587989|590265277|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
163427350|NCT01587989|590265275|FG000|Randomized Study Treatment|Screening failure|0|||
163427351|NCT01587989|590265276|FG001|Randomized Study Treatment|Screening failure|1|||
163427352|NCT01587989|590265277|FG002|Randomized Study Treatment|Screening failure|0|||
163427353|NCT01587989|590265275|FG000|Randomized Study Treatment|Physician Decision|0|||
163427354|NCT01587989|590265276|FG001|Randomized Study Treatment|Physician Decision|0|||
163427355|NCT01587989|590265277|FG002|Randomized Study Treatment|Physician Decision|1|||
163427356|NCT03313050|590265278|FG000|Stage 2: 12 Months|Adverse Event|0|||
163427357|NCT03313050|590265279|FG001|Stage 2: 12 Months|Adverse Event|0|||
163427358|NCT03313050|590265280|FG002|Stage 2: 12 Months|Adverse Event|0|||
163427359|NCT03313050|590265281|FG003|Stage 2: 12 Months|Adverse Event|1|||
163427360|NCT03313050|590265278|FG000|Stage 2: 12 Months|Death|0|||
163427361|NCT03313050|590265279|FG001|Stage 2: 12 Months|Death|0|||
163427362|NCT03313050|590265280|FG002|Stage 2: 12 Months|Death|3|||
163427363|NCT03313050|590265281|FG003|Stage 2: 12 Months|Death|0|||
163427364|NCT03313050|590265278|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
163427365|NCT03313050|590265279|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
163427366|NCT03313050|590265280|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
163427367|NCT03313050|590265281|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
163427368|NCT03313050|590265278|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
163427369|NCT03313050|590265279|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
163427370|NCT03313050|590265280|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
163427371|NCT03313050|590265281|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
163427372|NCT03313050|590265278|FG000|Stage 2: 12 Months|Protocol deviation|0|||
163427373|NCT03313050|590265279|FG001|Stage 2: 12 Months|Protocol deviation|0|||
163427374|NCT03313050|590265280|FG002|Stage 2: 12 Months|Protocol deviation|7|||
163427375|NCT03313050|590265281|FG003|Stage 2: 12 Months|Protocol deviation|7|||
163427376|NCT03313050|590265278|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
163427377|NCT03313050|590265279|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
163427378|NCT03313050|590265280|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
163427379|NCT03313050|590265281|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
163427380|NCT03313050|590265278|FG000|Stage 2: 12 Months|Other|0|||
163427381|NCT03313050|590265279|FG001|Stage 2: 12 Months|Other|0|||
163427382|NCT03313050|590265280|FG002|Stage 2: 12 Months|Other|0|||
163427383|NCT03313050|590265281|FG003|Stage 2: 12 Months|Other|1|||
163427384|NCT04211337|590265282|FG000|Overall Study|On Treatment|175|||
163427385|NCT04211337|590265283|FG001|Overall Study|On Treatment|40|||
163427386|NCT04211337|590265282|FG000|Overall Study|Withdrawal by Subject|0|||
163427387|NCT04211337|590265283|FG001|Overall Study|Withdrawal by Subject|2|||
163427388|NCT01291017|590265284|FG000|Overall Study|Lost to Follow-up|2|||
163427389|NCT01291017|590265284|FG000|Overall Study|Withdrawal by Subject|3|||
163427390|NCT05630846|590267576|FG000|Overall Study|Death|1|||
163427391|NCT05630846|590267577|FG001|Overall Study|Death|0|||
163427392|NCT05630846|590267578|FG002|Overall Study|Death|0|||
163427393|NCT05630846|590267579|FG003|Overall Study|Death|0|||
163427394|NCT05630846|590267576|FG000|Overall Study|Withdrawal by Subject|3|||
163427395|NCT05630846|590267577|FG001|Overall Study|Withdrawal by Subject|3|||
163427396|NCT05630846|590267578|FG002|Overall Study|Withdrawal by Subject|4|||
163427397|NCT05630846|590267579|FG003|Overall Study|Withdrawal by Subject|1|||
163427398|NCT05630846|590267576|FG000|Overall Study|Lost to Follow-up|6|||
163427399|NCT05630846|590267577|FG001|Overall Study|Lost to Follow-up|5|||
163427400|NCT05630846|590267578|FG002|Overall Study|Lost to Follow-up|2|||
163427401|NCT05630846|590267579|FG003|Overall Study|Lost to Follow-up|5|||
163427402|NCT05630846|590267576|FG000|Overall Study|Other|1|||
163427403|NCT05630846|590267577|FG001|Overall Study|Other|0|||
163427404|NCT05630846|590267578|FG002|Overall Study|Other|0|||
163427405|NCT05630846|590267579|FG003|Overall Study|Other|0|||
163427406|NCT01431287|590267581|FG000|Overall Study|not treated|0|||
163427407|NCT01431287|590267582|FG001|Overall Study|not treated|0|||
163427408|NCT01431287|590267583|FG002|Overall Study|not treated|1|||
163427409|NCT01431287|590267584|FG003|Overall Study|not treated|0|||
163427410|NCT01431287|590267585|FG004|Overall Study|not treated|0|||
163427411|NCT01431287|590267581|FG000|Overall Study|Adverse Event|59|||
163427412|NCT01431287|590267582|FG001|Overall Study|Adverse Event|57|||
163427413|NCT01431287|590267583|FG002|Overall Study|Adverse Event|53|||
163427414|NCT01431287|590267584|FG003|Overall Study|Adverse Event|33|||
163427415|NCT01431287|590267585|FG004|Overall Study|Adverse Event|41|||
163427416|NCT01431287|590267581|FG000|Overall Study|Non compliant with protocol|6|||
163427417|NCT01431287|590267582|FG001|Overall Study|Non compliant with protocol|6|||
163427418|NCT01431287|590267583|FG002|Overall Study|Non compliant with protocol|5|||
163427419|NCT01431287|590267584|FG003|Overall Study|Non compliant with protocol|6|||
163427420|NCT01431287|590267585|FG004|Overall Study|Non compliant with protocol|5|||
163427421|NCT01431287|590267581|FG000|Overall Study|Lost to Follow-up|0|||
163427422|NCT01431287|590267582|FG001|Overall Study|Lost to Follow-up|3|||
163427423|NCT01431287|590267583|FG002|Overall Study|Lost to Follow-up|2|||
163427424|NCT01431287|590267584|FG003|Overall Study|Lost to Follow-up|3|||
163427425|NCT01431287|590267585|FG004|Overall Study|Lost to Follow-up|1|||
163427426|NCT01431287|590267581|FG000|Overall Study|Consent withdrawn not due to AE|29|||
163427427|NCT01431287|590267582|FG001|Overall Study|Consent withdrawn not due to AE|30|||
163427428|NCT01431287|590267583|FG002|Overall Study|Consent withdrawn not due to AE|34|||
163427429|NCT01431287|590267584|FG003|Overall Study|Consent withdrawn not due to AE|19|||
163427430|NCT01431287|590267585|FG004|Overall Study|Consent withdrawn not due to AE|29|||
163427431|NCT01431287|590267581|FG000|Overall Study|not stated above|4|||
163427432|NCT01431287|590267582|FG001|Overall Study|not stated above|2|||
163427433|NCT01431287|590267583|FG002|Overall Study|not stated above|2|||
163427434|NCT01431287|590267584|FG003|Overall Study|not stated above|2|||
163427435|NCT01431287|590267585|FG004|Overall Study|not stated above|1|||
163427436|NCT03019549|590267586|FG000|Washout|DId not meet genotype criteria|11|||
163427437|NCT03019549|590267586|FG000|Period 2|Adverse Event|2|||
163427438|NCT03019549|590267586|FG000|Period 2|Physician Decision|2|||
163427439|NCT03019549|590267586|FG000|Period 2|Withdrawal by Subject|1|||
163427440|NCT04030195|590267587|FG000|Overall Study|Withdrawal by Subject|2|||
163427441|NCT04030195|590267588|FG001|Overall Study|Withdrawal by Subject|0|||
163427442|NCT04030195|590267589|FG002|Overall Study|Withdrawal by Subject|0|||
163427443|NCT01412879|590267590|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
163427444|NCT01412879|590267591|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
163427445|NCT01412879|590267592|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
163427446|NCT01412879|590267590|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
163427447|NCT01412879|590267591|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
163427448|NCT01412879|590267592|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
163427449|NCT01412879|590267590|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
163427450|NCT01412879|590267591|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
163427451|NCT01412879|590267592|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
163427452|NCT01412879|590267590|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
163427453|NCT01412879|590267591|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
163427454|NCT01412879|590267592|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
163427455|NCT01412879|590267590|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
163427456|NCT01412879|590267591|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
163427457|NCT01412879|590267592|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
163427458|NCT01056107|590267594|FG000|Overall Study|Withdrawal by Subject|0|||
163427459|NCT01056107|590267595|FG001|Overall Study|Withdrawal by Subject|1|||
163427460|NCT01056107|590267596|FG002|Overall Study|Withdrawal by Subject|3|||
163427461|NCT01056107|590267597|FG003|Overall Study|Withdrawal by Subject|0|||
163427462|NCT02091440|590267609|FG000|Overall Study|Death|2|||
163427463|NCT00278629|590267616|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
163427464|NCT03323749|590267617|FG000|Double-blind Period|Lost to Follow-up|4|||
163427465|NCT03323749|590267618|FG001|Double-blind Period|Lost to Follow-up|5|||
163427466|NCT03323749|590267617|FG000|Double-blind Period|Adverse Event|3|||
163427467|NCT03323749|590267618|FG001|Double-blind Period|Adverse Event|1|||
163427468|NCT03323749|590267617|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
163427469|NCT03323749|590267618|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
163427470|NCT03323749|590267617|FG000|Open-Label Period|Adverse Event|3|||
163427471|NCT03323749|590267618|FG001|Open-Label Period|Adverse Event|10|||
163427472|NCT03323749|590267617|FG000|Open-Label Period|Withdrawal by Subject|7|||
163427473|NCT03323749|590267618|FG001|Open-Label Period|Withdrawal by Subject|5|||
163427474|NCT01821963|590267619|FG000|Overall Study|Adverse Event|1|||
163427475|NCT00783289|590267620|FG000|Overall Study|Protocol Violation|0|||
163427476|NCT00783289|590267621|FG001|Overall Study|Protocol Violation|1|||
163427477|NCT00783289|590267622|FG002|Overall Study|Protocol Violation|0|||
163427478|NCT00783289|590267623|FG003|Overall Study|Protocol Violation|0|||
163427479|NCT00506389|590267624|FG000|In-treatment Period|Other|3|||
163427480|NCT00506389|590267625|FG001|In-treatment Period|Other|3|||
163427481|NCT00506389|590267626|FG002|In-treatment Period|Other|4|||
163427482|NCT00506389|590267624|FG000|In-treatment Period|Lost to Follow-up|0|||
163427483|NCT00506389|590267625|FG001|In-treatment Period|Lost to Follow-up|0|||
163427484|NCT00506389|590267626|FG002|In-treatment Period|Lost to Follow-up|1|||
163427485|NCT00506389|590267624|FG000|In-treatment Period|Lack of compliance|1|||
163427486|NCT00506389|590267625|FG001|In-treatment Period|Lack of compliance|0|||
163427487|NCT00506389|590267626|FG002|In-treatment Period|Lack of compliance|0|||
163427488|NCT00506389|590267624|FG000|In-treatment Period|Reasons not related to trial|4|||
163427489|NCT00506389|590267625|FG001|In-treatment Period|Reasons not related to trial|1|||
163427490|NCT00506389|590267626|FG002|In-treatment Period|Reasons not related to trial|0|||
163427491|NCT00506389|590267624|FG000|In-treatment Period|Withdrawal by Subject|3|||
163427492|NCT00506389|590267625|FG001|In-treatment Period|Withdrawal by Subject|3|||
163427493|NCT00506389|590267626|FG002|In-treatment Period|Withdrawal by Subject|4|||
163427494|NCT00506389|590267624|FG000|In-treatment Period|Lack of Efficacy|0|||
163427495|NCT00506389|590267625|FG001|In-treatment Period|Lack of Efficacy|2|||
163427496|NCT00506389|590267626|FG002|In-treatment Period|Lack of Efficacy|0|||
163427497|NCT00506389|590267624|FG000|In-treatment Period|Adverse Event|11|||
163427498|NCT00506389|590267625|FG001|In-treatment Period|Adverse Event|5|||
163427499|NCT00506389|590267626|FG002|In-treatment Period|Adverse Event|2|||
163427500|NCT00506389|590267624|FG000|In-treatment Period|Randomized but not treated|4|||
163427501|NCT00506389|590267625|FG001|In-treatment Period|Randomized but not treated|1|||
163427502|NCT00506389|590267626|FG002|In-treatment Period|Randomized but not treated|1|||
163427503|NCT05224258|590267628|FG000|Overall Study|Withdrawal by Subject|1|||
163427504|NCT05224258|590267629|FG001|Overall Study|Withdrawal by Subject|1|||
163427505|NCT05224258|590267628|FG000|Overall Study|Physician Decision|1|||
163427506|NCT05224258|590267629|FG001|Overall Study|Physician Decision|1|||
163427507|NCT05224258|590267628|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163427508|NCT05224258|590267629|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163427509|NCT05224258|590267628|FG000|Overall Study|Study Product No Longer in Use|1|||
163427510|NCT05224258|590267629|FG001|Overall Study|Study Product No Longer in Use|0|||
163427511|NCT05224258|590267628|FG000|Overall Study|Adverse Event|0|||
163427512|NCT05224258|590267629|FG001|Overall Study|Adverse Event|1|||
163427513|NCT05224258|590267628|FG000|Overall Study|Protocol Deviation|0|||
163427514|NCT05224258|590267629|FG001|Overall Study|Protocol Deviation|1|||
163427515|NCT03095703|590267631|FG000|Overall Study|Withdrawal by Subject|1|||
163427516|NCT03539432|590267632|FG000|Overall Study|Lost to Follow-up|0|||
163427517|NCT03539432|590267633|FG001|Overall Study|Lost to Follow-up|1|||
163427518|NCT01381094|590267634|FG000|Overall Study|Adverse Event|1|||
163427519|NCT01381094|590267635|FG001|Overall Study|Adverse Event|2|||
163427520|NCT01381094|590267636|FG002|Overall Study|Adverse Event|0|||
163427521|NCT01381094|590267637|FG003|Overall Study|Adverse Event|1|||
163427522|NCT01381094|590267638|FG004|Overall Study|Adverse Event|0|||
163427523|NCT01381094|590267634|FG000|Overall Study|Lost to Follow-up|0|||
163427524|NCT01381094|590267635|FG001|Overall Study|Lost to Follow-up|0|||
163427525|NCT01381094|590267636|FG002|Overall Study|Lost to Follow-up|0|||
163427526|NCT01381094|590267637|FG003|Overall Study|Lost to Follow-up|0|||
163427527|NCT01381094|590267638|FG004|Overall Study|Lost to Follow-up|1|||
163427528|NCT01381094|590267634|FG000|Overall Study|Withdrawal of informed consent|0|||
163427529|NCT01381094|590267635|FG001|Overall Study|Withdrawal of informed consent|1|||
163427530|NCT01381094|590267636|FG002|Overall Study|Withdrawal of informed consent|0|||
163427531|NCT01381094|590267637|FG003|Overall Study|Withdrawal of informed consent|0|||
163427532|NCT01381094|590267638|FG004|Overall Study|Withdrawal of informed consent|0|||
163427533|NCT01381094|590267634|FG000|Overall Study|Participant given Aranesp injection|1|||
163427534|NCT01381094|590267635|FG001|Overall Study|Participant given Aranesp injection|0|||
163427535|NCT01381094|590267636|FG002|Overall Study|Participant given Aranesp injection|0|||
163427536|NCT01381094|590267637|FG003|Overall Study|Participant given Aranesp injection|0|||
163427537|NCT01381094|590267638|FG004|Overall Study|Participant given Aranesp injection|0|||
163427538|NCT02443402|590267641|FG000|Overall Study|Withdrawal by Subject|3|||
163427539|NCT02443402|590267642|FG001|Overall Study|Withdrawal by Subject|1|||
163427540|NCT02443402|590267641|FG000|Overall Study|Screen Failure|1|||
163427541|NCT02443402|590267642|FG001|Overall Study|Screen Failure|2|||
163427542|NCT01934504|590267644|FG000|Overall Study|Protocol Deviation|0|||
163427543|NCT01934504|590267645|FG001|Overall Study|Protocol Deviation|0|||
163427544|NCT01934504|590267646|FG002|Overall Study|Protocol Deviation|0|||
163427545|NCT01934504|590267647|FG003|Overall Study|Protocol Deviation|2|||
163427546|NCT01934504|590267644|FG000|Overall Study|Study Terminated by Sponsor|1|||
163427547|NCT01934504|590267645|FG001|Overall Study|Study Terminated by Sponsor|0|||
163427548|NCT01934504|590267646|FG002|Overall Study|Study Terminated by Sponsor|5|||
163427549|NCT01934504|590267647|FG003|Overall Study|Study Terminated by Sponsor|5|||
163427550|NCT02665689|590267648|FG000|Overall Study|Adverse Event|1|||
163427551|NCT02665689|590267649|FG001|Overall Study|Adverse Event|0|||
163427552|NCT02665689|590267648|FG000|Overall Study|Trial termination|1|||
163427553|NCT02665689|590267649|FG001|Overall Study|Trial termination|1|||
163427554|NCT02665689|590267648|FG000|Overall Study|Lost to Follow-up|0|||
163427555|NCT02665689|590267649|FG001|Overall Study|Lost to Follow-up|1|||
163427556|NCT00996840|590267658|FG000|Overall Study|Adverse Event|0|||
163427557|NCT00996840|590267659|FG001|Overall Study|Adverse Event|1|||
163427558|NCT00996840|590267660|FG002|Overall Study|Adverse Event|0|||
163427559|NCT00996840|590267661|FG003|Overall Study|Adverse Event|0|||
163427560|NCT00996840|590267662|FG004|Overall Study|Adverse Event|0|||
163427561|NCT00996840|590267658|FG000|Overall Study|Physician Decision|0|||
163427562|NCT00996840|590267659|FG001|Overall Study|Physician Decision|0|||
163427563|NCT00996840|590267660|FG002|Overall Study|Physician Decision|1|||
163427564|NCT00996840|590267661|FG003|Overall Study|Physician Decision|1|||
163427565|NCT00996840|590267662|FG004|Overall Study|Physician Decision|2|||
163427566|NCT00996840|590267658|FG000|Overall Study|Withdrawal by Subject|1|||
163427567|NCT00996840|590267659|FG001|Overall Study|Withdrawal by Subject|1|||
163427568|NCT00996840|590267660|FG002|Overall Study|Withdrawal by Subject|0|||
163427569|NCT00996840|590267661|FG003|Overall Study|Withdrawal by Subject|0|||
163427570|NCT00996840|590267662|FG004|Overall Study|Withdrawal by Subject|0|||
163427571|NCT00603239|590267663|FG000|Overall Study|Adverse Event|4|||
163427572|NCT00603239|590267664|FG001|Overall Study|Adverse Event|1|||
163427573|NCT00603239|590267663|FG000|Overall Study|Entry criteria not met|0|||
163427574|NCT00603239|590267664|FG001|Overall Study|Entry criteria not met|1|||
163427575|NCT00603239|590267663|FG000|Overall Study|Loss of glucose control|3|||
163427576|NCT00603239|590267664|FG001|Overall Study|Loss of glucose control|0|||
163427577|NCT00603239|590267663|FG000|Overall Study|Lost to Follow-up|2|||
163427578|NCT00603239|590267664|FG001|Overall Study|Lost to Follow-up|1|||
163427579|NCT00603239|590267663|FG000|Overall Study|Physician Decision|2|||
163427580|NCT00603239|590267664|FG001|Overall Study|Physician Decision|0|||
163427581|NCT00603239|590267663|FG000|Overall Study|Protocol Violation|2|||
163427582|NCT00603239|590267664|FG001|Overall Study|Protocol Violation|0|||
163427583|NCT00603239|590267663|FG000|Overall Study|Subject decision|2|||
163427584|NCT00603239|590267664|FG001|Overall Study|Subject decision|1|||
163427585|NCT02292849|590267665|FG000|Overall Study|Lost to Follow-up|0|||
163427586|NCT02292849|590267666|FG001|Overall Study|Lost to Follow-up|2|||
163427587|NCT02292849|590267667|FG002|Overall Study|Lost to Follow-up|2|||
163427588|NCT02292849|590267665|FG000|Overall Study|Physician Decision|4|||
163427589|NCT02292849|590267666|FG001|Overall Study|Physician Decision|0|||
163427590|NCT02292849|590267667|FG002|Overall Study|Physician Decision|0|||
163427591|NCT02210780|590267669|FG000|Overall Study|Adverse Event|0|||
163427592|NCT02210780|590267670|FG001|Overall Study|Adverse Event|5|||
163427593|NCT02210780|590267669|FG000|Overall Study|Lost to Follow-up|2|||
163427594|NCT02210780|590267670|FG001|Overall Study|Lost to Follow-up|1|||
163427595|NCT02210780|590267669|FG000|Overall Study|Withdrawal by Subject|1|||
163427596|NCT02210780|590267670|FG001|Overall Study|Withdrawal by Subject|1|||
163427597|NCT02210780|590267669|FG000|Overall Study|Physician Decision|1|||
163427598|NCT02210780|590267670|FG001|Overall Study|Physician Decision|0|||
163427599|NCT02210780|590267669|FG000|Overall Study|Protocol Violation|1|||
163427600|NCT02210780|590267670|FG001|Overall Study|Protocol Violation|0|||
163427601|NCT02210780|590267669|FG000|Overall Study|Other than specified above|0|||
163427602|NCT02210780|590267670|FG001|Overall Study|Other than specified above|1|||
163427603|NCT01562028|590267671|FG000|Overall Study|Withdrawal by Subject|1|||
163427604|NCT01562028|590267672|FG001|Overall Study|Withdrawal by Subject|1|||
163427605|NCT01562028|590267671|FG000|Overall Study|Lost to Follow-up|2|||
163427606|NCT01562028|590267672|FG001|Overall Study|Lost to Follow-up|1|||
163427607|NCT00097539|590267673|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
163427608|NCT00097539|590267674|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
163427609|NCT00097539|590267675|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
163427610|NCT00097539|590267676|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
163427611|NCT00097539|590267677|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
163427612|NCT00097539|590267678|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
163427613|NCT00097539|590267679|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
163427614|NCT00097539|590267673|FG000|Overall Study|Withdrawal by Subject|925|||
163427615|NCT00097539|590267674|FG001|Overall Study|Withdrawal by Subject|323|||
163427616|NCT00097539|590267675|FG002|Overall Study|Withdrawal by Subject|346|||
163427617|NCT00097539|590267676|FG003|Overall Study|Withdrawal by Subject|217|||
163427618|NCT00097539|590267677|FG004|Overall Study|Withdrawal by Subject|68|||
163427619|NCT00097539|590267678|FG005|Overall Study|Withdrawal by Subject|229|||
163427620|NCT00097539|590267679|FG006|Overall Study|Withdrawal by Subject|3|||
163427621|NCT00097539|590267673|FG000|Overall Study|Participant Non-compliant|2140|||
163427622|NCT00097539|590267674|FG001|Overall Study|Participant Non-compliant|567|||
163427623|NCT00097539|590267675|FG002|Overall Study|Participant Non-compliant|1067|||
163427624|NCT00097539|590267676|FG003|Overall Study|Participant Non-compliant|353|||
163427625|NCT00097539|590267677|FG004|Overall Study|Participant Non-compliant|136|||
163427626|NCT00097539|590267678|FG005|Overall Study|Participant Non-compliant|543|||
163427627|NCT00097539|590267679|FG006|Overall Study|Participant Non-compliant|18|||
163427628|NCT00097539|590267673|FG000|Overall Study|Lack of Efficacy|249|||
163427629|NCT00097539|590267674|FG001|Overall Study|Lack of Efficacy|122|||
163427630|NCT00097539|590267675|FG002|Overall Study|Lack of Efficacy|202|||
163427631|NCT00097539|590267676|FG003|Overall Study|Lack of Efficacy|105|||
163427632|NCT00097539|590267677|FG004|Overall Study|Lack of Efficacy|45|||
163427633|NCT00097539|590267678|FG005|Overall Study|Lack of Efficacy|228|||
163427634|NCT00097539|590267679|FG006|Overall Study|Lack of Efficacy|5|||
163427635|NCT00097539|590267673|FG000|Overall Study|Adverse Event|78|||
163427636|NCT00097539|590267674|FG001|Overall Study|Adverse Event|133|||
163427637|NCT00097539|590267675|FG002|Overall Study|Adverse Event|37|||
163427638|NCT00097539|590267676|FG003|Overall Study|Adverse Event|27|||
163427639|NCT00097539|590267677|FG004|Overall Study|Adverse Event|30|||
163427640|NCT00097539|590267678|FG005|Overall Study|Adverse Event|59|||
163427641|NCT00097539|590267679|FG006|Overall Study|Adverse Event|1|||
163427642|NCT00097539|590267673|FG000|Overall Study|Death|2|||
163427643|NCT00097539|590267674|FG001|Overall Study|Death|7|||
163427644|NCT00097539|590267675|FG002|Overall Study|Death|0|||
163427645|NCT00097539|590267676|FG003|Overall Study|Death|0|||
163427646|NCT00097539|590267677|FG004|Overall Study|Death|1|||
163427647|NCT00097539|590267678|FG005|Overall Study|Death|3|||
163427648|NCT00097539|590267679|FG006|Overall Study|Death|0|||
163427649|NCT00097539|590267673|FG000|Overall Study|Reasons Other Than Above|3602|||
163427650|NCT00097539|590267674|FG001|Overall Study|Reasons Other Than Above|1382|||
163427651|NCT00097539|590267675|FG002|Overall Study|Reasons Other Than Above|1757|||
163427652|NCT00097539|590267676|FG003|Overall Study|Reasons Other Than Above|692|||
163427653|NCT00097539|590267677|FG004|Overall Study|Reasons Other Than Above|361|||
163427654|NCT00097539|590267678|FG005|Overall Study|Reasons Other Than Above|1244|||
163427655|NCT00097539|590267679|FG006|Overall Study|Reasons Other Than Above|34|||
163427656|NCT00097539|590267673|FG000|Overall Study|Reason not Specified|111|||
163427657|NCT00097539|590267674|FG001|Overall Study|Reason not Specified|49|||
163427658|NCT00097539|590267675|FG002|Overall Study|Reason not Specified|53|||
163427659|NCT00097539|590267676|FG003|Overall Study|Reason not Specified|21|||
163427660|NCT00097539|590267677|FG004|Overall Study|Reason not Specified|11|||
163427661|NCT00097539|590267678|FG005|Overall Study|Reason not Specified|40|||
163427662|NCT00097539|590267679|FG006|Overall Study|Reason not Specified|2|||
163427663|NCT04938648|590267680|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
163427664|NCT04938648|590267681|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
163427665|NCT04938648|590267680|FG000|Overall Study|Patient too ill|0|||
163427666|NCT04938648|590267681|FG001|Overall Study|Patient too ill|1|||
163427667|NCT04938648|590267680|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
163427668|NCT04938648|590267681|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
163427669|NCT04938648|590267680|FG000|Overall Study|Patient did not have memory problems|1|||
163427670|NCT04938648|590267681|FG001|Overall Study|Patient did not have memory problems|1|||
163427671|NCT04938648|590267680|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
163427672|NCT04938648|590267681|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
163427673|NCT04938648|590267680|FG000|Overall Study|Care partner could not be reached|0|||
163427674|NCT04938648|590267681|FG001|Overall Study|Care partner could not be reached|1|||
163427675|NCT04938648|590267680|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
163427676|NCT04938648|590267681|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
163427677|NCT04938648|590267680|FG000|Overall Study|Withdrawal by Subject|2|||
163427678|NCT04938648|590267681|FG001|Overall Study|Withdrawal by Subject|1|||
163427679|NCT00364793|590267682|FG000|Overall Study|Adverse Event|2|||
163427680|NCT00364793|590267683|FG001|Overall Study|Adverse Event|0|||
163427681|NCT00364793|590267684|FG002|Overall Study|Adverse Event|0|||
163427682|NCT00364793|590267685|FG003|Overall Study|Adverse Event|0|||
163427683|NCT00364793|590267682|FG000|Overall Study|Death|1|||
163427684|NCT00364793|590267683|FG001|Overall Study|Death|0|||
163427685|NCT00364793|590267684|FG002|Overall Study|Death|1|||
163427686|NCT00364793|590267685|FG003|Overall Study|Death|0|||
163427687|NCT00364793|590267682|FG000|Overall Study|Lack of Efficacy|3|||
163427688|NCT00364793|590267683|FG001|Overall Study|Lack of Efficacy|3|||
163427689|NCT00364793|590267684|FG002|Overall Study|Lack of Efficacy|1|||
163427690|NCT00364793|590267685|FG003|Overall Study|Lack of Efficacy|1|||
163427691|NCT00364793|590267682|FG000|Overall Study|Lost to Follow-up|1|||
163427692|NCT00364793|590267683|FG001|Overall Study|Lost to Follow-up|0|||
163427693|NCT00364793|590267684|FG002|Overall Study|Lost to Follow-up|2|||
163427694|NCT00364793|590267685|FG003|Overall Study|Lost to Follow-up|0|||
163427695|NCT00364793|590267682|FG000|Overall Study|Poor or non-compliance|1|||
163427696|NCT00364793|590267683|FG001|Overall Study|Poor or non-compliance|1|||
163427697|NCT00364793|590267684|FG002|Overall Study|Poor or non-compliance|0|||
163427698|NCT00364793|590267685|FG003|Overall Study|Poor or non-compliance|1|||
163427699|NCT00364793|590267682|FG000|Overall Study|No longer meets criteria|0|||
163427700|NCT00364793|590267683|FG001|Overall Study|No longer meets criteria|0|||
163427701|NCT00364793|590267684|FG002|Overall Study|No longer meets criteria|0|||
163427702|NCT00364793|590267685|FG003|Overall Study|No longer meets criteria|1|||
163427703|NCT00364793|590267682|FG000|Overall Study|Withdrawal by Subject|0|||
163427704|NCT00364793|590267683|FG001|Overall Study|Withdrawal by Subject|1|||
163427705|NCT00364793|590267684|FG002|Overall Study|Withdrawal by Subject|0|||
163427706|NCT00364793|590267685|FG003|Overall Study|Withdrawal by Subject|0|||
163427707|NCT05127486|590267686|FG000|Overall Study|Adverse Event|2|||
163427708|NCT05127486|590267687|FG001|Overall Study|Adverse Event|4|||
163427709|NCT05127486|590267686|FG000|Overall Study|Lack of Efficacy|1|||
163427710|NCT05127486|590267687|FG001|Overall Study|Lack of Efficacy|0|||
163427711|NCT05127486|590267686|FG000|Overall Study|Pregnancy|0|||
163427712|NCT05127486|590267687|FG001|Overall Study|Pregnancy|1|||
163427713|NCT05127486|590267686|FG000|Overall Study|Physician Decision|4|||
163427714|NCT05127486|590267687|FG001|Overall Study|Physician Decision|1|||
163427715|NCT05127486|590267686|FG000|Overall Study|Withdrawal by Subject|14|||
163427716|NCT05127486|590267687|FG001|Overall Study|Withdrawal by Subject|13|||
163427717|NCT05127486|590267686|FG000|Overall Study|Lost to Follow-up|5|||
163427718|NCT05127486|590267687|FG001|Overall Study|Lost to Follow-up|8|||
163427719|NCT00775021|590267691|FG000|First Intervention|Lost to Follow-up|1|||
163427720|NCT00775021|590267692|FG001|First Intervention|Lost to Follow-up|0|||
163427721|NCT00775021|590267691|FG000|Second Intervention|Adverse Event|0|||
163427722|NCT00775021|590267692|FG001|Second Intervention|Adverse Event|1|||
163427723|NCT00363415|590267693|FG000|Overall Study|Progressive Disease|196|||
163427724|NCT00363415|590267694|FG001|Overall Study|Progressive Disease|107|||
163427725|NCT00363415|590267693|FG000|Overall Study|Sponsor Decision|67|||
163427726|NCT00363415|590267694|FG001|Overall Study|Sponsor Decision|31|||
163427727|NCT00363415|590267693|FG000|Overall Study|Death|32|||
163427728|NCT00363415|590267694|FG001|Overall Study|Death|29|||
163427729|NCT00363415|590267693|FG000|Overall Study|Adverse Event|24|||
163427730|NCT00363415|590267694|FG001|Overall Study|Adverse Event|15|||
163427731|NCT00363415|590267693|FG000|Overall Study|Physician Decision|18|||
163427732|NCT00363415|590267694|FG001|Overall Study|Physician Decision|35|||
163427733|NCT00363415|590267693|FG000|Overall Study|Entry Criteria Not Met|11|||
163427734|NCT00363415|590267694|FG001|Overall Study|Entry Criteria Not Met|10|||
163427735|NCT00363415|590267693|FG000|Overall Study|Withdrawal by Subject|9|||
163427736|NCT00363415|590267694|FG001|Overall Study|Withdrawal by Subject|15|||
163427737|NCT00363415|590267693|FG000|Overall Study|Lost to Follow-up|3|||
163427738|NCT00363415|590267694|FG001|Overall Study|Lost to Follow-up|3|||
163427739|NCT00363415|590267693|FG000|Overall Study|Protocol Violation|1|||
163427740|NCT00363415|590267694|FG001|Overall Study|Protocol Violation|4|||
163427741|NCT02688647|590267713|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
163427742|NCT02688647|590267714|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
163427743|NCT02688647|590267713|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
163427744|NCT02688647|590267714|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
163427745|NCT02688647|590267713|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
163427746|NCT02688647|590267714|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
163427747|NCT02688647|590267713|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
163427748|NCT02688647|590267714|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
163427749|NCT02688647|590267713|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
163427750|NCT02688647|590267714|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
163427751|NCT02688647|590267713|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
163427752|NCT02688647|590267714|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
163427753|NCT02688647|590267713|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
163427754|NCT02688647|590267714|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
163427755|NCT02542267|590267715|FG000|Overall Study|Withdrawal by Subject|10|||
163427756|NCT02542267|590267715|FG000|Overall Study|Physician Decision|6|||
163427757|NCT02542267|590267715|FG000|Overall Study|Lost to Follow-up|4|||
163427758|NCT02542267|590267715|FG000|Overall Study|Death|13|||
163427759|NCT02542267|590267715|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
163427760|NCT02542267|590267715|FG000|Overall Study|Other|9|||
163427761|NCT03093402|590267716|FG000|Overall Study|Lost to Follow-up|1|||
163427762|NCT03093402|590267717|FG001|Overall Study|Lost to Follow-up|0|||
163427763|NCT03093402|590267718|FG002|Overall Study|Lost to Follow-up|0|||
163427764|NCT03093402|590267719|FG003|Overall Study|Lost to Follow-up|0|||
163427765|NCT03093402|590267716|FG000|Overall Study|Withdrawal by Subject|3|||
163427766|NCT03093402|590267717|FG001|Overall Study|Withdrawal by Subject|3|||
163427767|NCT03093402|590267718|FG002|Overall Study|Withdrawal by Subject|0|||
163427768|NCT03093402|590267719|FG003|Overall Study|Withdrawal by Subject|1|||
163427769|NCT03093402|590267716|FG000|Overall Study|Withdrew prior to dosing|2|||
163427770|NCT03093402|590267717|FG001|Overall Study|Withdrew prior to dosing|1|||
163427771|NCT03093402|590267718|FG002|Overall Study|Withdrew prior to dosing|2|||
163427772|NCT03093402|590267719|FG003|Overall Study|Withdrew prior to dosing|3|||
163427773|NCT03093402|590267716|FG000|Overall Study|Ineligible for study|1|||
163427774|NCT03093402|590267717|FG001|Overall Study|Ineligible for study|0|||
163427775|NCT03093402|590267718|FG002|Overall Study|Ineligible for study|0|||
163427776|NCT03093402|590267719|FG003|Overall Study|Ineligible for study|0|||
163427777|NCT03093402|590267716|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
163427778|NCT03093402|590267717|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
163427779|NCT03093402|590267718|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
163427780|NCT03093402|590267719|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
163427781|NCT01147497|590267724|FG000|Overall Study|failed insertion|2|||
163427782|NCT01147497|590267725|FG001|Overall Study|failed insertion|0|||
163427783|NCT02731742|590267726|FG000|Overall Study|Death|1|||
163427784|NCT02731742|590267727|FG001|Overall Study|Death|2|||
163427785|NCT02731742|590267728|FG002|Overall Study|Death|5|||
163427786|NCT02731742|590267729|FG003|Overall Study|Death|0|||
163427787|NCT02731742|590267726|FG000|Overall Study|Physician Decision|0|||
163427788|NCT02731742|590267727|FG001|Overall Study|Physician Decision|0|||
163427789|NCT02731742|590267728|FG002|Overall Study|Physician Decision|0|||
163427790|NCT02731742|590267729|FG003|Overall Study|Physician Decision|1|||
163427791|NCT02731742|590267726|FG000|Overall Study|Study Terminated by Sponsor|2|||
163427792|NCT02731742|590267727|FG001|Overall Study|Study Terminated by Sponsor|1|||
163427793|NCT02731742|590267728|FG002|Overall Study|Study Terminated by Sponsor|1|||
163427794|NCT02731742|590267729|FG003|Overall Study|Study Terminated by Sponsor|1|||
163427795|NCT04026568|590267730|FG000|Overall Study|study terminated|0|||
163427796|NCT04026568|590267731|FG001|Overall Study|study terminated|1|||
163427797|NCT01974323|590267732|FG000|Overall Study|Other Reasons|25|||
163427798|NCT01974323|590267733|FG001|Overall Study|Other Reasons|28|||
163427799|NCT01974323|590267732|FG000|Overall Study|Protocol Violation|2|||
163427800|NCT01974323|590267733|FG001|Overall Study|Protocol Violation|2|||
163427801|NCT01974323|590267732|FG000|Overall Study|Personal Reasons|15|||
163427802|NCT01974323|590267733|FG001|Overall Study|Personal Reasons|19|||
163427803|NCT01974323|590267732|FG000|Overall Study|Lost to Follow-up|45|||
163427804|NCT01974323|590267733|FG001|Overall Study|Lost to Follow-up|40|||
163427805|NCT01974323|590267732|FG000|Overall Study|Pregnancy|2|||
163427806|NCT01974323|590267733|FG001|Overall Study|Pregnancy|1|||
163427807|NCT01974323|590267732|FG000|Overall Study|Lack of Efficacy|1|||
163427808|NCT01974323|590267733|FG001|Overall Study|Lack of Efficacy|1|||
163427809|NCT01974323|590267732|FG000|Overall Study|Adverse Event|2|||
163427810|NCT01974323|590267733|FG001|Overall Study|Adverse Event|2|||
163427811|NCT00331760|590267734|FG000|Overall Study|Ineligible / no protocol treatment|15|||
163427812|NCT00331760|590267735|FG001|Overall Study|Ineligible / no protocol treatment|8|||
163427813|NCT00833092|590267736|FG000|Overall Study|Withdrawal by Subject|2|||
163427814|NCT00833092|590267737|FG001|Overall Study|Withdrawal by Subject|3|||
163427815|NCT00833092|590267736|FG000|Overall Study|Protocol Violation|2|||
163427816|NCT00833092|590267737|FG001|Overall Study|Protocol Violation|1|||
163427817|NCT00833092|590267736|FG000|Overall Study|Diarrhea|0|||
163427818|NCT00833092|590267737|FG001|Overall Study|Diarrhea|2|||
163427819|NCT00833092|590267736|FG000|Overall Study|constipation|0|||
163427820|NCT00833092|590267737|FG001|Overall Study|constipation|1|||
163427821|NCT00619229|590267740|FG000|Overall Study|Withdrawal by Subject|1|||
163427822|NCT00619229|590267741|FG001|Overall Study|Withdrawal by Subject|1|||
163427823|NCT00619229|590267740|FG000|Overall Study|Lost to Follow-up|1|||
163427824|NCT00619229|590267741|FG001|Overall Study|Lost to Follow-up|0|||
163427825|NCT00619229|590267740|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
163427826|NCT00619229|590267741|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
163427827|NCT00619229|590267740|FG000|Overall Study|Investigator planned Cataract Operation|1|||
163427828|NCT00619229|590267741|FG001|Overall Study|Investigator planned Cataract Operation|0|||
163427829|NCT03417440|590267742|FG000|Overall Study|Lost to Follow-up|0|||
163427830|NCT03417440|590267743|FG001|Overall Study|Lost to Follow-up|1|||
163427831|NCT03417440|590267744|FG002|Overall Study|Lost to Follow-up|0|||
163427832|NCT03417440|590267745|FG003|Overall Study|Lost to Follow-up|0|||
163427833|NCT03417440|590267746|FG004|Overall Study|Lost to Follow-up|1|||
163427834|NCT03417440|590267747|FG005|Overall Study|Lost to Follow-up|0|||
163427835|NCT03417440|590267748|FG006|Overall Study|Lost to Follow-up|0|||
163427836|NCT03417440|590267749|FG007|Overall Study|Lost to Follow-up|0|||
163427837|NCT03417440|590267742|FG000|Overall Study|Withdrawal by Subject|2|||
163427838|NCT03417440|590267743|FG001|Overall Study|Withdrawal by Subject|0|||
163427839|NCT03417440|590267744|FG002|Overall Study|Withdrawal by Subject|2|||
163427840|NCT03417440|590267745|FG003|Overall Study|Withdrawal by Subject|1|||
163427841|NCT03417440|590267746|FG004|Overall Study|Withdrawal by Subject|1|||
163427842|NCT03417440|590267747|FG005|Overall Study|Withdrawal by Subject|0|||
163427843|NCT03417440|590267748|FG006|Overall Study|Withdrawal by Subject|0|||
163427844|NCT03417440|590267749|FG007|Overall Study|Withdrawal by Subject|1|||
163427845|NCT00355264|590267750|FG000|Extension (Variable Duration)|Adverse Event|1|||
163427846|NCT00355264|590267750|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
163427847|NCT01451645|590267751|FG000|Overall Study|Protocol Violation|1|||
163427848|NCT01451645|590267752|FG001|Overall Study|Protocol Violation|0|||
163427849|NCT01451645|590267751|FG000|Overall Study|Adverse Event|0|||
163427850|NCT01451645|590267752|FG001|Overall Study|Adverse Event|3|||
163427851|NCT01451645|590267751|FG000|Overall Study|Withdrawal by Subject|4|||
163427852|NCT01451645|590267752|FG001|Overall Study|Withdrawal by Subject|2|||
163427853|NCT01451645|590267751|FG000|Overall Study|Lost to Follow-up|4|||
163427854|NCT01451645|590267752|FG001|Overall Study|Lost to Follow-up|3|||
163427855|NCT00963807|590267754|FG000|Overall Study|Physician Decision|2|||
163427856|NCT00963807|590267754|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
163427857|NCT00963807|590267754|FG000|Overall Study|Disease progression|15|||
163427858|NCT00075881|590269316|FG000|Overall Study|Lack of Efficacy|18|||
163427859|NCT00075881|590269316|FG000|Overall Study|Adverse Event|7|||
163427860|NCT00075881|590269316|FG000|Overall Study|Death|1|||
163427861|NCT00075881|590269316|FG000|Overall Study|Withdrawal by Subject|2|||
163427862|NCT00075881|590269316|FG000|Overall Study|Protocol Violation|4|||
163427863|NCT00075881|590269316|FG000|Overall Study|other complicating disease|3|||
163427864|NCT00075881|590269316|FG000|Overall Study|other|4|||
163427865|NCT00075881|590269316|FG000|Overall Study|missing data|2|||
163427866|NCT00075881|590269316|FG000|Overall Study|Ineligible|1|||
163427867|NCT00075881|590269316|FG000|Overall Study|never start protocol therapy|1|||
163427868|NCT02224664|590269317|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
163427869|NCT02224664|590269318|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
163427870|NCT02224664|590269319|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
163427871|NCT02224664|590269320|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
163427872|NCT02224664|590269321|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
163427873|NCT02224664|590269317|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
163427874|NCT02224664|590269318|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
163427875|NCT02224664|590269319|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
163427876|NCT02224664|590269320|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
163427877|NCT02224664|590269321|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
163427878|NCT02224664|590269317|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
163427879|NCT02224664|590269318|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
163427880|NCT02224664|590269319|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
163427881|NCT02224664|590269320|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
163427882|NCT02224664|590269321|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
163427883|NCT02109029|590269324|FG000|Part B|Adverse Event|0|||
163427884|NCT02109029|590269325|FG001|Part B|Adverse Event|0|||
163427885|NCT02109029|590269326|FG002|Part B|Adverse Event|0|||
163427886|NCT02109029|590269327|FG003|Part B|Adverse Event|0|||
163427887|NCT02109029|590269328|FG004|Part B|Adverse Event|1|||
163427888|NCT02109029|590269329|FG005|Part B|Adverse Event|1|||
163427889|NCT03195894|590269330|FG000|Overall Study|"An example is Started other treatment."|4|||
163427890|NCT03195894|590269331|FG001|Overall Study|"An example is Started other treatment."|5|||
163427891|NCT03195894|590269330|FG000|Overall Study|Withdrawal by Subject|15|||
163427892|NCT03195894|590269331|FG001|Overall Study|Withdrawal by Subject|4|||
163427893|NCT03195894|590269330|FG000|Overall Study|Lost to Follow-up|14|||
163427894|NCT03195894|590269331|FG001|Overall Study|Lost to Follow-up|19|||
163427895|NCT00377962|590269339|FG000|Core Study: 0-12 Months|Adverse Event|18|||
163427896|NCT00377962|590269340|FG001|Core Study: 0-12 Months|Adverse Event|2|||
163427897|NCT00377962|590269339|FG000|Core Study: 0-12 Months|Death|3|||
163427898|NCT00377962|590269340|FG001|Core Study: 0-12 Months|Death|0|||
163427899|NCT00377962|590269339|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
163427900|NCT00377962|590269340|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
163427901|NCT00377962|590269339|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
163427902|NCT00377962|590269340|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
163427903|NCT00377962|590269339|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
163427904|NCT00377962|590269340|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
163427905|NCT00377962|590269339|FG000|Extension Study: 12-24 Months|Death|1|||
163427906|NCT00377962|590269340|FG001|Extension Study: 12-24 Months|Death|1|||
163427907|NCT00377962|590269339|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
163427908|NCT00377962|590269340|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
163427909|NCT00377962|590269339|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
163427910|NCT00377962|590269340|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
163427911|NCT00377962|590269339|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
163427912|NCT00377962|590269340|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
163427913|NCT00496366|590269342|FG000|Overall Study|Death|1|||
163427914|NCT00260208|590269343|FG000|Overall Study|Subject withdrew consent|11|||
163427915|NCT00260208|590269344|FG001|Overall Study|Subject withdrew consent|7|||
163427916|NCT00260208|590269343|FG000|Overall Study|Lost to Follow-up|6|||
163427917|NCT00260208|590269344|FG001|Overall Study|Lost to Follow-up|1|||
163427918|NCT00260208|590269343|FG000|Overall Study|Death|12|||
163427919|NCT00260208|590269344|FG001|Overall Study|Death|10|||
163427920|NCT00260208|590269343|FG000|Overall Study|Missing|18|||
163427921|NCT00260208|590269344|FG001|Overall Study|Missing|16|||
163427922|NCT02966314|590269352|FG000|Overall Study|Lost to Follow-up|1|||
163427923|NCT02966314|590269353|FG001|Overall Study|Lost to Follow-up|0|||
163427924|NCT02582515|590269354|FG000|Overall Study|Withdrawal by Subject|0|||
163427925|NCT02582515|590269355|FG001|Overall Study|Withdrawal by Subject|1|||
163427926|NCT00828464|590269356|FG000|Overall Study|Withdrawal by Subject|1|||
163427927|NCT02197377|590269357|FG000|Overall Study|Insertion Failure|0|||
163427928|NCT02197377|590269358|FG001|Overall Study|Insertion Failure|3|||
163427929|NCT02786901|590269359|FG000|Overall Study|Adverse Event|1|||
163427930|NCT02786901|590269360|FG001|Overall Study|Adverse Event|1|||
163427931|NCT02786901|590269361|FG002|Overall Study|Adverse Event|2|||
163427932|NCT02786901|590269359|FG000|Overall Study|Physician Decision|1|||
163427933|NCT02786901|590269360|FG001|Overall Study|Physician Decision|0|||
163427934|NCT02786901|590269361|FG002|Overall Study|Physician Decision|0|||
163427935|NCT02786901|590269359|FG000|Overall Study|Rescue Therapy Use|71|||
163427936|NCT02786901|590269360|FG001|Overall Study|Rescue Therapy Use|49|||
163427937|NCT02786901|590269361|FG002|Overall Study|Rescue Therapy Use|33|||
163427938|NCT02786901|590269359|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
163427939|NCT02786901|590269360|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
163427940|NCT02786901|590269361|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
163427941|NCT02786901|590269359|FG000|Overall Study|Disallowed medication|1|||
163427942|NCT02786901|590269360|FG001|Overall Study|Disallowed medication|1|||
163427943|NCT02786901|590269361|FG002|Overall Study|Disallowed medication|0|||
163427944|NCT02786901|590269359|FG000|Overall Study|Randomized in error|2|||
163427945|NCT02786901|590269360|FG001|Overall Study|Randomized in error|0|||
163427946|NCT02786901|590269361|FG002|Overall Study|Randomized in error|1|||
163427947|NCT00466505|590269362|FG000|Overall Study|disease progression|13|||
163427948|NCT00466505|590269362|FG000|Overall Study|Adverse Event|4|||
163427949|NCT00699192|590269363|FG000|Overall Study|Missing|1|||
163427950|NCT00699192|590269364|FG001|Overall Study|Missing|1|||
163427951|NCT00699192|590269365|FG002|Overall Study|Missing|1|||
163427952|NCT00699192|590269363|FG000|Overall Study|Adverse Event|9|||
163427953|NCT00699192|590269364|FG001|Overall Study|Adverse Event|4|||
163427954|NCT00699192|590269365|FG002|Overall Study|Adverse Event|3|||
163427955|NCT00699192|590269363|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163427956|NCT00699192|590269364|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163427957|NCT00699192|590269365|FG002|Overall Study|Abnormal test procedure result(s)|1|||
163427958|NCT00699192|590269363|FG000|Overall Study|Lack of Efficacy|0|||
163427959|NCT00699192|590269364|FG001|Overall Study|Lack of Efficacy|0|||
163427960|NCT00699192|590269365|FG002|Overall Study|Lack of Efficacy|1|||
163427961|NCT00699192|590269363|FG000|Overall Study|Withdrawal by Subject|3|||
163427962|NCT00699192|590269364|FG001|Overall Study|Withdrawal by Subject|2|||
163427963|NCT00699192|590269365|FG002|Overall Study|Withdrawal by Subject|4|||
163427964|NCT00699192|590269363|FG000|Overall Study|Administrative problems|1|||
163427965|NCT00699192|590269364|FG001|Overall Study|Administrative problems|3|||
163427966|NCT00699192|590269365|FG002|Overall Study|Administrative problems|1|||
163427967|NCT00699192|590269363|FG000|Overall Study|Protocol Violation|2|||
163427968|NCT00699192|590269364|FG001|Overall Study|Protocol Violation|2|||
163427969|NCT00699192|590269365|FG002|Overall Study|Protocol Violation|0|||
163427970|NCT00826514|590269366|FG000|Overall Study|Adverse Event|1|||
163427971|NCT00826514|590269367|FG001|Overall Study|Adverse Event|1|||
163427972|NCT00826514|590269366|FG000|Overall Study|Lack of Efficacy|0|||
163427973|NCT00826514|590269367|FG001|Overall Study|Lack of Efficacy|1|||
163427974|NCT00826514|590269366|FG000|Overall Study|Withdrawal by Subject|2|||
163427975|NCT00826514|590269367|FG001|Overall Study|Withdrawal by Subject|3|||
163427976|NCT01773473|590269368|FG000|Overall Study|Adverse Event|3|||
163427977|NCT01773473|590269369|FG001|Overall Study|Adverse Event|2|||
163427978|NCT01773473|590269368|FG000|Overall Study|Protocol Violation|0|||
163427979|NCT01773473|590269369|FG001|Overall Study|Protocol Violation|4|||
163427980|NCT01773473|590269368|FG000|Overall Study|Physician Decision|3|||
163427981|NCT01773473|590269369|FG001|Overall Study|Physician Decision|5|||
163427982|NCT01773473|590269368|FG000|Overall Study|Sponsor Decision|2|||
163427983|NCT01773473|590269369|FG001|Overall Study|Sponsor Decision|0|||
163427984|NCT01773473|590269368|FG000|Overall Study|Lack of Efficacy|0|||
163427985|NCT01773473|590269369|FG001|Overall Study|Lack of Efficacy|1|||
163427986|NCT01773473|590269368|FG000|Overall Study|Non-Compliance with study drug|1|||
163427987|NCT01773473|590269369|FG001|Overall Study|Non-Compliance with study drug|4|||
163427988|NCT01773473|590269368|FG000|Overall Study|Withdrawal by Subject|5|||
163427989|NCT01773473|590269369|FG001|Overall Study|Withdrawal by Subject|3|||
163427990|NCT01773473|590269368|FG000|Overall Study|Lost to Follow-up|2|||
163427991|NCT01773473|590269369|FG001|Overall Study|Lost to Follow-up|0|||
163427992|NCT03663166|590269372|FG000|Overall Study|Withdrawal by Subject|1|||
163427993|NCT02620020|590269377|FG000|Overall Study|Adverse Event|8|||
163427994|NCT02620020|590269378|FG001|Overall Study|Adverse Event|4|||
163427995|NCT02620020|590269379|FG002|Overall Study|Adverse Event|3|||
163427996|NCT02620020|590269380|FG003|Overall Study|Adverse Event|5|||
163427997|NCT02620020|590269377|FG000|Overall Study|Lost to Follow-up|4|||
163427998|NCT02620020|590269378|FG001|Overall Study|Lost to Follow-up|8|||
163427999|NCT02620020|590269379|FG002|Overall Study|Lost to Follow-up|1|||
163428000|NCT02620020|590269380|FG003|Overall Study|Lost to Follow-up|4|||
163428001|NCT02620020|590269377|FG000|Overall Study|Physician Decision|7|||
163428002|NCT02620020|590269378|FG001|Overall Study|Physician Decision|4|||
163428003|NCT02620020|590269379|FG002|Overall Study|Physician Decision|3|||
163428004|NCT02620020|590269380|FG003|Overall Study|Physician Decision|4|||
163428005|NCT02620020|590269377|FG000|Overall Study|Protocol Violation|5|||
163428006|NCT02620020|590269378|FG001|Overall Study|Protocol Violation|2|||
163428007|NCT02620020|590269379|FG002|Overall Study|Protocol Violation|1|||
163428008|NCT02620020|590269380|FG003|Overall Study|Protocol Violation|1|||
163428009|NCT02620020|590269377|FG000|Overall Study|Withdrawal by Subject|20|||
163428010|NCT02620020|590269378|FG001|Overall Study|Withdrawal by Subject|16|||
163428011|NCT02620020|590269379|FG002|Overall Study|Withdrawal by Subject|17|||
163428012|NCT02620020|590269380|FG003|Overall Study|Withdrawal by Subject|12|||
163428013|NCT02620020|590269377|FG000|Overall Study|Death|0|||
163428014|NCT02620020|590269378|FG001|Overall Study|Death|1|||
163428015|NCT02620020|590269379|FG002|Overall Study|Death|0|||
163428016|NCT02620020|590269380|FG003|Overall Study|Death|0|||
163428017|NCT00098787|590269382|FG000|Overall Study|Never started treatment|3|||
163428018|NCT00098787|590269383|FG001|Overall Study|Never started treatment|2|||
163428019|NCT00098787|590269384|FG002|Overall Study|Never started treatment|1|||
163428020|NCT00098787|590269382|FG000|Overall Study|Ineligible|9|||
163428021|NCT00098787|590269383|FG001|Overall Study|Ineligible|7|||
163428022|NCT00098787|590269384|FG002|Overall Study|Ineligible|3|||
163428023|NCT00098787|590269382|FG000|Overall Study|Disease progression|28|||
163428024|NCT00098787|590269383|FG001|Overall Study|Disease progression|17|||
163428025|NCT00098787|590269384|FG002|Overall Study|Disease progression|23|||
163428026|NCT00098787|590269382|FG000|Overall Study|Adverse Event|8|||
163428027|NCT00098787|590269383|FG001|Overall Study|Adverse Event|17|||
163428028|NCT00098787|590269384|FG002|Overall Study|Adverse Event|8|||
163428029|NCT00098787|590269382|FG000|Overall Study|Death|6|||
163428030|NCT00098787|590269383|FG001|Overall Study|Death|1|||
163428031|NCT00098787|590269384|FG002|Overall Study|Death|0|||
163428032|NCT00098787|590269382|FG000|Overall Study|Withdrawal by Subject|4|||
163428033|NCT00098787|590269383|FG001|Overall Study|Withdrawal by Subject|12|||
163428034|NCT00098787|590269384|FG002|Overall Study|Withdrawal by Subject|6|||
163428035|NCT00098787|590269382|FG000|Overall Study|Alternative therapy|8|||
163428036|NCT00098787|590269383|FG001|Overall Study|Alternative therapy|13|||
163428037|NCT00098787|590269384|FG002|Overall Study|Alternative therapy|13|||
163428038|NCT00098787|590269382|FG000|Overall Study|Other|7|||
163428039|NCT00098787|590269383|FG001|Overall Study|Other|6|||
163428040|NCT00098787|590269384|FG002|Overall Study|Other|9|||
163428041|NCT00684814|590269385|FG000|Washout Period of 7 Days|Adverse Event|1|||
163428042|NCT00684814|590269386|FG001|Washout Period of 7 Days|Adverse Event|2|||
163428043|NCT00684814|590269385|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
163428044|NCT00684814|590269386|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
163428045|NCT00684814|590269385|FG000|Second Intervention|Adverse Event|1|||
163428046|NCT00684814|590269386|FG001|Second Intervention|Adverse Event|0|||
163428047|NCT05292755|590269387|FG000|Overall Study|Lost to Follow-up|5|||
163428048|NCT05292755|590269388|FG001|Overall Study|Lost to Follow-up|9|||
163428049|NCT04052139|590269389|FG000|Overall Study|Lost to Follow-up|2|||
163428050|NCT04052139|590269390|FG001|Overall Study|Lost to Follow-up|0|||
163428051|NCT04052139|590269391|FG002|Overall Study|Lost to Follow-up|0|||
163428052|NCT04052139|590269389|FG000|Overall Study|Withdrawal by Subject|1|||
163428053|NCT04052139|590269390|FG001|Overall Study|Withdrawal by Subject|0|||
163428054|NCT04052139|590269391|FG002|Overall Study|Withdrawal by Subject|0|||
163428055|NCT00707577|590269392|FG000|Overall Study|Withdrawal by Subject|3|||
163428056|NCT00707577|590269393|FG001|Overall Study|Withdrawal by Subject|2|||
163428057|NCT00707577|590269392|FG000|Overall Study|Lost to Follow-up|34|||
163428058|NCT00707577|590269393|FG001|Overall Study|Lost to Follow-up|25|||
163428059|NCT00707577|590269392|FG000|Overall Study|Left employment|13|||
163428060|NCT00707577|590269393|FG001|Overall Study|Left employment|10|||
163428061|NCT00707577|590269392|FG000|Overall Study|Pregnancy|4|||
163428062|NCT00707577|590269393|FG001|Overall Study|Pregnancy|1|||
163428063|NCT00190775|590269394|FG000|Overall Study|Adverse Event|57|||
163428064|NCT00190775|590269395|FG001|Overall Study|Adverse Event|22|||
163428065|NCT00190775|590269394|FG000|Overall Study|Satisfactory Response|1|||
163428066|NCT00190775|590269395|FG001|Overall Study|Satisfactory Response|0|||
163428067|NCT00190775|590269394|FG000|Overall Study|Lack of Efficacy|28|||
163428068|NCT00190775|590269395|FG001|Overall Study|Lack of Efficacy|32|||
163428069|NCT00190775|590269394|FG000|Overall Study|Lost to Follow-up|31|||
163428070|NCT00190775|590269395|FG001|Overall Study|Lost to Follow-up|23|||
163428071|NCT00190775|590269394|FG000|Overall Study|Participant Moved|0|||
163428072|NCT00190775|590269395|FG001|Overall Study|Participant Moved|1|||
163428073|NCT00190775|590269394|FG000|Overall Study|Withdrawal by Subject|24|||
163428074|NCT00190775|590269395|FG001|Overall Study|Withdrawal by Subject|13|||
163428075|NCT00190775|590269394|FG000|Overall Study|Sponsor Decision|1|||
163428076|NCT00190775|590269395|FG001|Overall Study|Sponsor Decision|0|||
163428077|NCT00190775|590269394|FG000|Overall Study|Physician Decision|3|||
163428078|NCT00190775|590269395|FG001|Overall Study|Physician Decision|0|||
163428079|NCT00190775|590269394|FG000|Overall Study|Noncompliance|3|||
163428080|NCT00190775|590269395|FG001|Overall Study|Noncompliance|5|||
163428081|NCT00190775|590269394|FG000|Overall Study|Protocol Violation|0|||
163428082|NCT00190775|590269395|FG001|Overall Study|Protocol Violation|1|||
163428083|NCT00190775|590269394|FG000|Overall Study|Exclusion Criteria Met|1|||
163428084|NCT00190775|590269395|FG001|Overall Study|Exclusion Criteria Met|3|||
163428085|NCT01794780|590269396|FG000|Overall Study|Adverse Event|0|||
163428086|NCT01794780|590269397|FG001|Overall Study|Adverse Event|1|||
163428087|NCT01794780|590269398|FG002|Overall Study|Adverse Event|2|||
163428088|NCT01794780|590269399|FG003|Overall Study|Adverse Event|0|||
163428089|NCT01794780|590269400|FG004|Overall Study|Adverse Event|0|||
163428090|NCT01794780|590269401|FG005|Overall Study|Adverse Event|0|||
163428091|NCT01794780|590269402|FG006|Overall Study|Adverse Event|0|||
163428092|NCT01794780|590269403|FG007|Overall Study|Adverse Event|0|||
163428093|NCT01794780|590269396|FG000|Overall Study|Death|0|||
163428094|NCT01794780|590269397|FG001|Overall Study|Death|2|||
163428095|NCT01794780|590269398|FG002|Overall Study|Death|14|||
163428096|NCT01794780|590269399|FG003|Overall Study|Death|1|||
163428097|NCT01794780|590269400|FG004|Overall Study|Death|0|||
163428098|NCT01794780|590269401|FG005|Overall Study|Death|9|||
163428099|NCT01794780|590269402|FG006|Overall Study|Death|4|||
163428100|NCT01794780|590269403|FG007|Overall Study|Death|0|||
163428101|NCT01794780|590269396|FG000|Overall Study|Lost to Follow-up|10|||
163428102|NCT01794780|590269397|FG001|Overall Study|Lost to Follow-up|64|||
163428103|NCT01794780|590269398|FG002|Overall Study|Lost to Follow-up|165|||
163428104|NCT01794780|590269399|FG003|Overall Study|Lost to Follow-up|53|||
163428105|NCT01794780|590269400|FG004|Overall Study|Lost to Follow-up|2|||
163428106|NCT01794780|590269401|FG005|Overall Study|Lost to Follow-up|99|||
163428107|NCT01794780|590269402|FG006|Overall Study|Lost to Follow-up|30|||
163428108|NCT01794780|590269403|FG007|Overall Study|Lost to Follow-up|5|||
163428109|NCT01794780|590269396|FG000|Overall Study|Withdrew informed consent|7|||
163428110|NCT01794780|590269397|FG001|Overall Study|Withdrew informed consent|17|||
163428111|NCT01794780|590269398|FG002|Overall Study|Withdrew informed consent|36|||
163428112|NCT01794780|590269399|FG003|Overall Study|Withdrew informed consent|9|||
163428113|NCT01794780|590269400|FG004|Overall Study|Withdrew informed consent|0|||
163428114|NCT01794780|590269401|FG005|Overall Study|Withdrew informed consent|48|||
163428115|NCT01794780|590269402|FG006|Overall Study|Withdrew informed consent|4|||
163428116|NCT01794780|590269403|FG007|Overall Study|Withdrew informed consent|3|||
163428117|NCT01794780|590269396|FG000|Overall Study|Other|0|||
163428118|NCT01794780|590269397|FG001|Overall Study|Other|12|||
163428119|NCT01794780|590269398|FG002|Overall Study|Other|25|||
163428120|NCT01794780|590269399|FG003|Overall Study|Other|20|||
163428121|NCT01794780|590269400|FG004|Overall Study|Other|1|||
163428122|NCT01794780|590269401|FG005|Overall Study|Other|24|||
163428123|NCT01794780|590269402|FG006|Overall Study|Other|4|||
163428124|NCT01794780|590269403|FG007|Overall Study|Other|1|||
163428125|NCT00519077|590269404|FG000|Overall Study|Death|6|||
163428126|NCT00519077|590269404|FG000|Overall Study|Other|2|||
163428127|NCT01967225|590269406|FG000|Overall Study|Adverse Event|3|||
163428128|NCT01967225|590269407|FG001|Overall Study|Adverse Event|1|||
163428129|NCT01967225|590269406|FG000|Overall Study|Withdrawal by Subject|2|||
163428130|NCT01967225|590269407|FG001|Overall Study|Withdrawal by Subject|1|||
163428131|NCT01967225|590269406|FG000|Overall Study|Lack of Efficacy|1|||
163428132|NCT01967225|590269407|FG001|Overall Study|Lack of Efficacy|1|||
163428133|NCT01967225|590269406|FG000|Overall Study|Switching to other therapy|2|||
163428134|NCT01967225|590269407|FG001|Overall Study|Switching to other therapy|0|||
163428135|NCT01967225|590269406|FG000|Overall Study|Protocol driven decision point|1|||
163428136|NCT01967225|590269407|FG001|Overall Study|Protocol driven decision point|0|||
163428137|NCT01967225|590269406|FG000|Overall Study|Logistical difficulties|1|||
163428138|NCT01967225|590269407|FG001|Overall Study|Logistical difficulties|0|||
163428139|NCT01967225|590269406|FG000|Overall Study|Protocol Violation|2|||
163428140|NCT01967225|590269407|FG001|Overall Study|Protocol Violation|0|||
163428141|NCT02286102|590269408|FG000|Overall Study|Screen Failure|1|||
163428142|NCT02286102|590269409|FG001|Overall Study|Screen Failure|1|||
163428143|NCT00327444|590269410|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
163428144|NCT00327444|590269411|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
163428145|NCT00327444|590269410|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
163428146|NCT00327444|590269411|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
163428147|NCT00327444|590269410|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
163428148|NCT00327444|590269411|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
163428149|NCT00327444|590269410|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
163428150|NCT00327444|590269411|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
163428151|NCT00327444|590269410|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
163428152|NCT00327444|590269411|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
163428153|NCT00327444|590269410|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
163428154|NCT00327444|590269411|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
163428155|NCT00327444|590269410|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
163428156|NCT00327444|590269411|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
163428157|NCT00327444|590269410|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
163428158|NCT00327444|590269411|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
163428159|NCT01658514|590269413|FG000|Overall Study|Protocol Violation|1|||
163428160|NCT01658514|590269414|FG001|Overall Study|Protocol Violation|0|||
163428161|NCT01658514|590269415|FG002|Overall Study|Protocol Violation|2|||
163428162|NCT00144170|590269417|FG000|Overall Study|Adverse Event|84|||
163428163|NCT00144170|590269418|FG001|Overall Study|Adverse Event|41|||
163428164|NCT00144170|590269417|FG000|Overall Study|Protocol Violation|23|||
163428165|NCT00144170|590269418|FG001|Overall Study|Protocol Violation|16|||
163428166|NCT00144170|590269417|FG000|Overall Study|Lost to Follow-up|5|||
163428167|NCT00144170|590269418|FG001|Overall Study|Lost to Follow-up|10|||
163428168|NCT00144170|590269417|FG000|Overall Study|Withdrawal by Subject|29|||
163428169|NCT00144170|590269418|FG001|Overall Study|Withdrawal by Subject|13|||
163428170|NCT00144170|590269417|FG000|Overall Study|Other reason not defined above|211|||
163428171|NCT00144170|590269418|FG001|Overall Study|Other reason not defined above|316|||
163428172|NCT00981526|590269419|FG000|Overall Study|Withdrawal by Subject|0|||
163428173|NCT00981526|590269420|FG001|Overall Study|Withdrawal by Subject|2|||
163428174|NCT00981526|590269419|FG000|Overall Study|Physician Decision|4|||
163428175|NCT00981526|590269420|FG001|Overall Study|Physician Decision|4|||
163428176|NCT00332202|590269421|FG000|Overall Study|Adverse Event|72|||
163428177|NCT00332202|590269422|FG001|Overall Study|Adverse Event|28|||
163428178|NCT00332202|590269421|FG000|Overall Study|Lost to Follow-up|2|||
163428179|NCT00332202|590269422|FG001|Overall Study|Lost to Follow-up|1|||
163428180|NCT00332202|590269421|FG000|Overall Study|Physician Decision|6|||
163428181|NCT00332202|590269422|FG001|Overall Study|Physician Decision|8|||
163428182|NCT00332202|590269421|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
163428183|NCT00332202|590269422|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
163428184|NCT00332202|590269421|FG000|Overall Study|Protocol Violation|7|||
163428185|NCT00332202|590269422|FG001|Overall Study|Protocol Violation|2|||
163428186|NCT00332202|590269421|FG000|Overall Study|Sponsor Decision|1|||
163428187|NCT00332202|590269422|FG001|Overall Study|Sponsor Decision|2|||
163428188|NCT00332202|590269421|FG000|Overall Study|Withdrawal by Subject|36|||
163428189|NCT00332202|590269422|FG001|Overall Study|Withdrawal by Subject|17|||
163428190|NCT00332202|590269421|FG000|Overall Study|Progressive Disease|106|||
163428191|NCT00332202|590269422|FG001|Overall Study|Progressive Disease|60|||
163428192|NCT00332202|590269421|FG000|Overall Study|Death|5|||
163428193|NCT00332202|590269422|FG001|Overall Study|Death|2|||
163428194|NCT00655928|590269423|FG000|Overall Study|Withdrawal by Subject|2|||
163428195|NCT00655928|590269424|FG001|Overall Study|Withdrawal by Subject|1|||
163428196|NCT00655928|590269423|FG000|Overall Study|Physician Decision|1|||
163428197|NCT00655928|590269424|FG001|Overall Study|Physician Decision|1|||
163428198|NCT02370121|590269425|FG000|Overall Study|Lost to Follow-up|1|||
163428199|NCT02370121|590269426|FG001|Overall Study|Lost to Follow-up|1|||
163428200|NCT02654002|590269433|FG000|Overall Study|Adverse Event|0|||
163428201|NCT02654002|590269434|FG001|Overall Study|Adverse Event|0|||
163428202|NCT02654002|590269435|FG002|Overall Study|Adverse Event|0|||
163428203|NCT02654002|590269436|FG003|Overall Study|Adverse Event|0|||
163428204|NCT02654002|590269437|FG004|Overall Study|Adverse Event|0|||
163428205|NCT02654002|590269438|FG005|Overall Study|Adverse Event|0|||
163428206|NCT02654002|590269439|FG006|Overall Study|Adverse Event|1|||
163428207|NCT02654002|590269440|FG007|Overall Study|Adverse Event|0|||
163428208|NCT02654002|590269441|FG008|Overall Study|Adverse Event|0|||
163428209|NCT02654002|590269433|FG000|Overall Study|Withdrew Consent|0|||
163428210|NCT02654002|590269434|FG001|Overall Study|Withdrew Consent|0|||
163428211|NCT02654002|590269435|FG002|Overall Study|Withdrew Consent|0|||
163428212|NCT02654002|590269436|FG003|Overall Study|Withdrew Consent|0|||
163428213|NCT02654002|590269437|FG004|Overall Study|Withdrew Consent|0|||
163428214|NCT02654002|590269438|FG005|Overall Study|Withdrew Consent|1|||
163428215|NCT02654002|590269439|FG006|Overall Study|Withdrew Consent|0|||
163428216|NCT02654002|590269440|FG007|Overall Study|Withdrew Consent|1|||
163428217|NCT02654002|590269441|FG008|Overall Study|Withdrew Consent|0|||
163428218|NCT05262764|590269445|FG000|Overall Study|Case report form not collected|9|||
163428219|NCT05262764|590269445|FG000|Overall Study|No patient visits after entry|23|||
163428220|NCT05262764|590269445|FG000|Overall Study|Registration rule not followed|2|||
163428221|NCT05262764|590269445|FG000|Overall Study|Patient of non-chronic heart failure|1|||
163428222|NCT00275561|590269446|FG000|Overall Study|Withdrawal by Subject|0|||
163428223|NCT00275561|590269447|FG001|Overall Study|Withdrawal by Subject|1|||
163428224|NCT00275561|590269446|FG000|Overall Study|Travel|1|||
163428225|NCT00275561|590269447|FG001|Overall Study|Travel|1|||
163428226|NCT00275561|590269446|FG000|Overall Study|Scheduling|1|||
163428227|NCT00275561|590269447|FG001|Overall Study|Scheduling|2|||
163428228|NCT00275561|590269446|FG000|Overall Study|Family Issues|0|||
163428229|NCT00275561|590269447|FG001|Overall Study|Family Issues|2|||
163428230|NCT01769105|590269452|FG000|First Intervention|Protocol Violation|2|||
163428231|NCT01769105|590269453|FG001|First Intervention|Protocol Violation|2|||
163428232|NCT01769105|590269452|FG000|Cross-over|Lost to Follow-up|5|||
163428233|NCT01769105|590269453|FG001|Cross-over|Lost to Follow-up|0|||
163428234|NCT01392183|590269454|FG000|First Drug Administration|Adverse Event|3|||
163428235|NCT01392183|590269455|FG001|First Drug Administration|Adverse Event|2|||
163428236|NCT01392183|590269454|FG000|First Drug Administration|Death|1|||
163428237|NCT01392183|590269455|FG001|First Drug Administration|Death|0|||
163428238|NCT01392183|590269454|FG000|First Drug Administration|Withdrawal by Subject|10|||
163428239|NCT01392183|590269455|FG001|First Drug Administration|Withdrawal by Subject|17|||
163428240|NCT00684177|590269460|FG000|Overall Study|Adverse Event|4|||
163428241|NCT00684177|590269461|FG001|Overall Study|Adverse Event|3|||
163428242|NCT00684177|590269460|FG000|Overall Study|Lack of Efficacy|10|||
163428243|NCT00684177|590269461|FG001|Overall Study|Lack of Efficacy|15|||
163428244|NCT00684177|590269460|FG000|Overall Study|Protocol Violation|1|||
163428245|NCT00684177|590269461|FG001|Overall Study|Protocol Violation|0|||
163428246|NCT00684177|590269460|FG000|Overall Study|Lost to Follow-up|2|||
163428247|NCT00684177|590269461|FG001|Overall Study|Lost to Follow-up|1|||
163428248|NCT00684177|590269460|FG000|Overall Study|Physician Decision|2|||
163428249|NCT00684177|590269461|FG001|Overall Study|Physician Decision|0|||
163428250|NCT00684177|590269460|FG000|Overall Study|Withdrawal by Subject|1|||
163428251|NCT00684177|590269461|FG001|Overall Study|Withdrawal by Subject|2|||
163428252|NCT00684177|590269460|FG000|Overall Study|Other|1|||
163428253|NCT00684177|590269461|FG001|Overall Study|Other|2|||
163428254|NCT00768222|590271200|FG000|Overall Study|Lost to Follow-up|1|||
163428255|NCT00768222|590271201|FG001|Overall Study|Lost to Follow-up|1|||
163428256|NCT00768222|590271200|FG000|Overall Study|Withdrawal by Subject|3|||
163428257|NCT00768222|590271201|FG001|Overall Study|Withdrawal by Subject|1|||
163428258|NCT00768222|590271200|FG000|Overall Study|Protocol Violation|0|||
163428259|NCT00768222|590271201|FG001|Overall Study|Protocol Violation|2|||
163428260|NCT03263091|590271203|FG000|OL Component|Withdrawal by Subject|1|||
163428261|NCT03263091|590271204|FG001|OL Component|Withdrawal by Subject|1|||
163428262|NCT03263091|590271205|FG002|OL Component|Withdrawal by Subject|0|||
163428263|NCT03263091|590271206|FG003|OL Component|Withdrawal by Subject|0|||
163428264|NCT03263091|590271207|FG004|OL Component|Withdrawal by Subject|0|||
163428265|NCT03263091|590271208|FG005|OL Component|Withdrawal by Subject|0|||
163428266|NCT03263091|590271203|FG000|OL Component|Physician Decision|0|||
163428267|NCT03263091|590271204|FG001|OL Component|Physician Decision|1|||
163428268|NCT03263091|590271205|FG002|OL Component|Physician Decision|2|||
163428269|NCT03263091|590271206|FG003|OL Component|Physician Decision|0|||
163428270|NCT03263091|590271207|FG004|OL Component|Physician Decision|0|||
163428271|NCT03263091|590271208|FG005|OL Component|Physician Decision|0|||
163428272|NCT03263091|590271203|FG000|OL Component|Death|1|||
163428273|NCT03263091|590271204|FG001|OL Component|Death|0|||
163428274|NCT03263091|590271205|FG002|OL Component|Death|0|||
163428275|NCT03263091|590271206|FG003|OL Component|Death|0|||
163428276|NCT03263091|590271207|FG004|OL Component|Death|0|||
163428277|NCT03263091|590271208|FG005|OL Component|Death|0|||
163428278|NCT03263091|590271203|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
163428279|NCT03263091|590271204|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
163428280|NCT03263091|590271205|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
163428281|NCT03263091|590271206|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
163428282|NCT03263091|590271207|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
163428283|NCT03263091|590271208|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
163428284|NCT03263091|590271203|FG000|OL High-EPO Component|Physician Decision|0|||
163428285|NCT03263091|590271204|FG001|OL High-EPO Component|Physician Decision|0|||
163428286|NCT03263091|590271205|FG002|OL High-EPO Component|Physician Decision|0|||
163428287|NCT03263091|590271206|FG003|OL High-EPO Component|Physician Decision|1|||
163428288|NCT03263091|590271207|FG004|OL High-EPO Component|Physician Decision|0|||
163428289|NCT03263091|590271208|FG005|OL High-EPO Component|Physician Decision|0|||
163428290|NCT03263091|590271203|FG000|OL High-EPO Component|Death|0|||
163428291|NCT03263091|590271204|FG001|OL High-EPO Component|Death|0|||
163428292|NCT03263091|590271205|FG002|OL High-EPO Component|Death|0|||
163428293|NCT03263091|590271206|FG003|OL High-EPO Component|Death|3|||
163428294|NCT03263091|590271207|FG004|OL High-EPO Component|Death|0|||
163428295|NCT03263091|590271208|FG005|OL High-EPO Component|Death|0|||
163428296|NCT03263091|590271203|FG000|DB Component|Withdrawal by Subject|0|||
163428297|NCT03263091|590271204|FG001|DB Component|Withdrawal by Subject|0|||
163428298|NCT03263091|590271205|FG002|DB Component|Withdrawal by Subject|0|||
163428299|NCT03263091|590271206|FG003|DB Component|Withdrawal by Subject|0|||
163428300|NCT03263091|590271207|FG004|DB Component|Withdrawal by Subject|22|||
163428301|NCT03263091|590271208|FG005|DB Component|Withdrawal by Subject|8|||
163428302|NCT03263091|590271203|FG000|DB Component|Physician Decision|0|||
163428303|NCT03263091|590271204|FG001|DB Component|Physician Decision|0|||
163428304|NCT03263091|590271205|FG002|DB Component|Physician Decision|0|||
163428305|NCT03263091|590271206|FG003|DB Component|Physician Decision|0|||
163428306|NCT03263091|590271207|FG004|DB Component|Physician Decision|3|||
163428307|NCT03263091|590271208|FG005|DB Component|Physician Decision|1|||
163428308|NCT03263091|590271203|FG000|DB Component|Adverse Event|0|||
163428309|NCT03263091|590271204|FG001|DB Component|Adverse Event|0|||
163428310|NCT03263091|590271205|FG002|DB Component|Adverse Event|0|||
163428311|NCT03263091|590271206|FG003|DB Component|Adverse Event|0|||
163428312|NCT03263091|590271207|FG004|DB Component|Adverse Event|2|||
163428313|NCT03263091|590271208|FG005|DB Component|Adverse Event|1|||
163428314|NCT03263091|590271203|FG000|DB Component|Lost to Follow-up|0|||
163428315|NCT03263091|590271204|FG001|DB Component|Lost to Follow-up|0|||
163428316|NCT03263091|590271205|FG002|DB Component|Lost to Follow-up|0|||
163428317|NCT03263091|590271206|FG003|DB Component|Lost to Follow-up|0|||
163428318|NCT03263091|590271207|FG004|DB Component|Lost to Follow-up|2|||
163428319|NCT03263091|590271208|FG005|DB Component|Lost to Follow-up|1|||
163428320|NCT03263091|590271203|FG000|DB Component|Death|0|||
163428321|NCT03263091|590271204|FG001|DB Component|Death|0|||
163428322|NCT03263091|590271205|FG002|DB Component|Death|0|||
163428323|NCT03263091|590271206|FG003|DB Component|Death|0|||
163428324|NCT03263091|590271207|FG004|DB Component|Death|7|||
163428325|NCT03263091|590271208|FG005|DB Component|Death|4|||
163428326|NCT03263091|590271203|FG000|DB Component|Other than specified|0|||
163428327|NCT03263091|590271204|FG001|DB Component|Other than specified|0|||
163428328|NCT03263091|590271205|FG002|DB Component|Other than specified|0|||
163428329|NCT03263091|590271206|FG003|DB Component|Other than specified|0|||
163428330|NCT03263091|590271207|FG004|DB Component|Other than specified|8|||
163428331|NCT03263091|590271208|FG005|DB Component|Other than specified|6|||
163428332|NCT00265941|590271212|FG000|Overall Study|Protocol Violation|22|||
163428333|NCT00265941|590271213|FG001|Overall Study|Protocol Violation|25|||
163428334|NCT00265941|590271212|FG000|Overall Study|Lost to Follow-up|1|||
163428335|NCT00265941|590271213|FG001|Overall Study|Lost to Follow-up|1|||
163428336|NCT01217606|590271225|FG000|Initial Treatment Phase|Other Reasons|0|||
163428337|NCT01217606|590271226|FG001|Initial Treatment Phase|Other Reasons|2|||
163428338|NCT01217606|590271225|FG000|Initial Treatment Phase|Protocol Violation|3|||
163428339|NCT01217606|590271226|FG001|Initial Treatment Phase|Protocol Violation|2|||
163428340|NCT01217606|590271225|FG000|Initial Treatment Phase|Personal Reasons|0|||
163428341|NCT01217606|590271226|FG001|Initial Treatment Phase|Personal Reasons|2|||
163428342|NCT01217606|590271225|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
163428343|NCT01217606|590271226|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
163428344|NCT01217606|590271225|FG000|Initial Treatment Phase|Adverse Event|10|||
163428345|NCT01217606|590271226|FG001|Initial Treatment Phase|Adverse Event|6|||
163428346|NCT01217606|590271225|FG000|9-Month Masked Extension|Adverse Event|3|||
163428347|NCT01217606|590271226|FG001|9-Month Masked Extension|Adverse Event|6|||
163428348|NCT01217606|590271225|FG000|9-Month Masked Extension|Other Reasons|4|||
163428349|NCT01217606|590271226|FG001|9-Month Masked Extension|Other Reasons|4|||
163428350|NCT01217606|590271225|FG000|9-Month Masked Extension|Personal Reasons|2|||
163428351|NCT01217606|590271226|FG001|9-Month Masked Extension|Personal Reasons|1|||
163428352|NCT01217606|590271225|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
163428353|NCT01217606|590271226|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
163428354|NCT01217606|590271225|FG000|9-Month Masked Extension|Pregnancy|1|||
163428355|NCT01217606|590271226|FG001|9-Month Masked Extension|Pregnancy|0|||
163428356|NCT01217606|590271225|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
163428357|NCT01217606|590271226|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
163428358|NCT02432807|590271233|FG000|Overall Study|Adverse Event|0|||
163428359|NCT02432807|590271234|FG001|Overall Study|Adverse Event|2|||
163428360|NCT02432807|590271233|FG000|Overall Study|Lost to Follow-up|1|||
163428361|NCT02432807|590271234|FG001|Overall Study|Lost to Follow-up|0|||
163428362|NCT02432807|590271233|FG000|Overall Study|Withdrawal by Subject|1|||
163428363|NCT02432807|590271234|FG001|Overall Study|Withdrawal by Subject|1|||
163428364|NCT02432807|590271233|FG000|Overall Study|Other|1|||
163428365|NCT02432807|590271234|FG001|Overall Study|Other|1|||
163428366|NCT03976401|590271235|FG000|Overall Study|Adverse Event|2|||
163428367|NCT03976401|590271236|FG001|Overall Study|Adverse Event|0|||
163428368|NCT03976401|590271237|FG002|Overall Study|Adverse Event|4|||
163428369|NCT03976401|590271238|FG003|Overall Study|Adverse Event|1|||
163428370|NCT03976401|590271239|FG004|Overall Study|Adverse Event|1|||
163428371|NCT03976401|590271240|FG005|Overall Study|Adverse Event|0|||
163428372|NCT03976401|590271235|FG000|Overall Study|Withdrawal by Subject|0|||
163428373|NCT03976401|590271236|FG001|Overall Study|Withdrawal by Subject|1|||
163428374|NCT03976401|590271237|FG002|Overall Study|Withdrawal by Subject|0|||
163428375|NCT03976401|590271238|FG003|Overall Study|Withdrawal by Subject|0|||
163428376|NCT03976401|590271239|FG004|Overall Study|Withdrawal by Subject|0|||
163428377|NCT03976401|590271240|FG005|Overall Study|Withdrawal by Subject|1|||
163428378|NCT03976401|590271235|FG000|Overall Study|Physician Decision|0|||
163428379|NCT03976401|590271236|FG001|Overall Study|Physician Decision|0|||
163428380|NCT03976401|590271237|FG002|Overall Study|Physician Decision|1|||
163428381|NCT03976401|590271238|FG003|Overall Study|Physician Decision|0|||
163428382|NCT03976401|590271239|FG004|Overall Study|Physician Decision|0|||
163428383|NCT03976401|590271240|FG005|Overall Study|Physician Decision|0|||
163428384|NCT03976401|590271235|FG000|Overall Study|Lost to Follow-up|1|||
163428385|NCT03976401|590271236|FG001|Overall Study|Lost to Follow-up|2|||
163428386|NCT03976401|590271237|FG002|Overall Study|Lost to Follow-up|0|||
163428387|NCT03976401|590271238|FG003|Overall Study|Lost to Follow-up|0|||
163428388|NCT03976401|590271239|FG004|Overall Study|Lost to Follow-up|0|||
163428389|NCT03976401|590271240|FG005|Overall Study|Lost to Follow-up|0|||
163428390|NCT03976401|590271235|FG000|Overall Study|Protocol Violation|0|||
163428391|NCT03976401|590271236|FG001|Overall Study|Protocol Violation|1|||
163428392|NCT03976401|590271237|FG002|Overall Study|Protocol Violation|0|||
163428393|NCT03976401|590271238|FG003|Overall Study|Protocol Violation|0|||
163428394|NCT03976401|590271239|FG004|Overall Study|Protocol Violation|0|||
163428395|NCT03976401|590271240|FG005|Overall Study|Protocol Violation|0|||
163428396|NCT03976401|590271235|FG000|Overall Study|Withdrew Consent|0|||
163428397|NCT03976401|590271236|FG001|Overall Study|Withdrew Consent|0|||
163428398|NCT03976401|590271237|FG002|Overall Study|Withdrew Consent|0|||
163428399|NCT03976401|590271238|FG003|Overall Study|Withdrew Consent|1|||
163428400|NCT03976401|590271239|FG004|Overall Study|Withdrew Consent|0|||
163428401|NCT03976401|590271240|FG005|Overall Study|Withdrew Consent|0|||
163428402|NCT04125680|590271242|FG000|Overall Study|Lost to Follow-up|15|||
163428403|NCT00391976|590271245|FG000|Overall Study|Adverse Event|0|||
163428404|NCT00391976|590271246|FG001|Overall Study|Adverse Event|0|||
163428405|NCT00391976|590271247|FG002|Overall Study|Adverse Event|1|||
163428406|NCT00391976|590271245|FG000|Overall Study|Withdrawal of consent|0|||
163428407|NCT00391976|590271246|FG001|Overall Study|Withdrawal of consent|1|||
163428408|NCT00391976|590271247|FG002|Overall Study|Withdrawal of consent|1|||
163428409|NCT00391976|590271245|FG000|Overall Study|Lost to Follow-up|1|||
163428410|NCT00391976|590271246|FG001|Overall Study|Lost to Follow-up|2|||
163428411|NCT00391976|590271247|FG002|Overall Study|Lost to Follow-up|0|||
163428412|NCT00391976|590271245|FG000|Overall Study|Inappropriate enrollment|1|||
163428413|NCT00391976|590271246|FG001|Overall Study|Inappropriate enrollment|1|||
163428414|NCT00391976|590271247|FG002|Overall Study|Inappropriate enrollment|0|||
163428415|NCT00391976|590271245|FG000|Overall Study|Protocol deviation/violation|4|||
163428416|NCT00391976|590271246|FG001|Overall Study|Protocol deviation/violation|2|||
163428417|NCT00391976|590271247|FG002|Overall Study|Protocol deviation/violation|1|||
163428418|NCT00391976|590271245|FG000|Overall Study|Recurrence/no eradication of infection|21|||
163428419|NCT00391976|590271246|FG001|Overall Study|Recurrence/no eradication of infection|19|||
163428420|NCT00391976|590271247|FG002|Overall Study|Recurrence/no eradication of infection|0|||
163428421|NCT00391976|590271245|FG000|Overall Study|Unable to classify|0|||
163428422|NCT00391976|590271246|FG001|Overall Study|Unable to classify|0|||
163428423|NCT00391976|590271247|FG002|Overall Study|Unable to classify|1|||
163428424|NCT00391976|590271245|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
163428425|NCT00391976|590271246|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
163428426|NCT00391976|590271247|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
163428427|NCT00049127|590271248|FG000|Overall Study|Withdrawal by Subject|0|||
163428428|NCT00049127|590271249|FG001|Overall Study|Withdrawal by Subject|0|||
163428429|NCT00049127|590271250|FG002|Overall Study|Withdrawal by Subject|1|||
163428430|NCT00049127|590271251|FG003|Overall Study|Withdrawal by Subject|0|||
163428431|NCT00049127|590271252|FG004|Overall Study|Withdrawal by Subject|0|||
163428432|NCT02725788|590271257|FG000|Overall Study|Lost to Follow-up|1|||
163428433|NCT02725788|590271258|FG001|Overall Study|Lost to Follow-up|1|||
163428434|NCT02725788|590271257|FG000|Overall Study|Protocol Violation|0|||
163428435|NCT02725788|590271258|FG001|Overall Study|Protocol Violation|1|||
163428436|NCT00474240|590271259|FG000|Overall Study|Withdrawal by Subject|1|||
163428437|NCT00474240|590271260|FG001|Overall Study|Withdrawal by Subject|1|||
163428438|NCT00474240|590271261|FG002|Overall Study|Withdrawal by Subject|0|||
163428439|NCT00474240|590271262|FG003|Overall Study|Withdrawal by Subject|2|||
163428440|NCT00474240|590271263|FG004|Overall Study|Withdrawal by Subject|3|||
163428441|NCT00474240|590271264|FG005|Overall Study|Withdrawal by Subject|1|||
163428442|NCT00474240|590271259|FG000|Overall Study|Adverse Event|0|||
163428443|NCT00474240|590271260|FG001|Overall Study|Adverse Event|0|||
163428444|NCT00474240|590271261|FG002|Overall Study|Adverse Event|9|||
163428445|NCT00474240|590271262|FG003|Overall Study|Adverse Event|14|||
163428446|NCT00474240|590271263|FG004|Overall Study|Adverse Event|5|||
163428447|NCT00474240|590271264|FG005|Overall Study|Adverse Event|16|||
163428448|NCT00474240|590271259|FG000|Overall Study|Removed due to lab value|0|||
163428449|NCT00474240|590271260|FG001|Overall Study|Removed due to lab value|0|||
163428450|NCT00474240|590271261|FG002|Overall Study|Removed due to lab value|0|||
163428451|NCT00474240|590271262|FG003|Overall Study|Removed due to lab value|0|||
163428452|NCT00474240|590271263|FG004|Overall Study|Removed due to lab value|0|||
163428453|NCT00474240|590271264|FG005|Overall Study|Removed due to lab value|1|||
163428454|NCT00502840|590271265|FG000|Overall Study|Adverse Event|5|||
163428455|NCT00502840|590271265|FG000|Overall Study|Additional or changed therapy|48|||
163428456|NCT00502840|590271265|FG000|Overall Study|Lack of Efficacy|11|||
163428457|NCT00502840|590271265|FG000|Overall Study|Protocol Violation|4|||
163428458|NCT00502840|590271265|FG000|Overall Study|Withdrawal by Subject|5|||
163428459|NCT00502840|590271265|FG000|Overall Study|Lost to Follow-up|6|||
163428460|NCT00502840|590271265|FG000|Overall Study|Administrative problems|1|||
163428461|NCT00502840|590271265|FG000|Overall Study|Other|20|||
163428462|NCT00809133|590271266|FG000|Overall Study|Progressive disease|2|||
163428463|NCT00809133|590271267|FG001|Overall Study|Progressive disease|5|||
163428464|NCT00809133|590271268|FG002|Overall Study|Progressive disease|5|||
163428465|NCT00809133|590271269|FG003|Overall Study|Progressive disease|3|||
163428466|NCT00809133|590271270|FG004|Overall Study|Progressive disease|4|||
163428467|NCT00809133|590271271|FG005|Overall Study|Progressive disease|1|||
163428468|NCT00809133|590271272|FG006|Overall Study|Progressive disease|3|||
163428469|NCT00809133|590271273|FG007|Overall Study|Progressive disease|3|||
163428470|NCT00809133|590271274|FG008|Overall Study|Progressive disease|3|||
163428471|NCT00809133|590271275|FG009|Overall Study|Progressive disease|9|||
163428472|NCT00809133|590271276|FG010|Overall Study|Progressive disease|5|||
163428473|NCT00809133|590271277|FG011|Overall Study|Progressive disease|7|||
163428474|NCT00809133|590271278|FG012|Overall Study|Progressive disease|5|||
163428475|NCT00809133|590271279|FG013|Overall Study|Progressive disease|4|||
163428476|NCT00809133|590271266|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163428477|NCT00809133|590271267|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163428478|NCT00809133|590271268|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163428479|NCT00809133|590271269|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163428480|NCT00809133|590271270|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163428481|NCT00809133|590271271|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
163428482|NCT00809133|590271272|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
163428483|NCT00809133|590271273|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
163428484|NCT00809133|590271274|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163428485|NCT00809133|590271275|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163428486|NCT00809133|590271276|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163428487|NCT00809133|590271277|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163428488|NCT00809133|590271278|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163428489|NCT00809133|590271279|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
163428490|NCT00809133|590271266|FG000|Overall Study|Other adverse event|1|||
163428491|NCT00809133|590271267|FG001|Overall Study|Other adverse event|1|||
163428492|NCT00809133|590271268|FG002|Overall Study|Other adverse event|1|||
163428493|NCT00809133|590271269|FG003|Overall Study|Other adverse event|0|||
163428494|NCT00809133|590271270|FG004|Overall Study|Other adverse event|0|||
163428495|NCT00809133|590271271|FG005|Overall Study|Other adverse event|3|||
163428496|NCT00809133|590271272|FG006|Overall Study|Other adverse event|2|||
163428497|NCT00809133|590271273|FG007|Overall Study|Other adverse event|4|||
163428498|NCT00809133|590271274|FG008|Overall Study|Other adverse event|0|||
163428499|NCT00809133|590271275|FG009|Overall Study|Other adverse event|0|||
163428500|NCT00809133|590271276|FG010|Overall Study|Other adverse event|1|||
163428501|NCT00809133|590271277|FG011|Overall Study|Other adverse event|1|||
163428502|NCT00809133|590271278|FG012|Overall Study|Other adverse event|0|||
163428503|NCT00809133|590271279|FG013|Overall Study|Other adverse event|1|||
163428504|NCT00809133|590271266|FG000|Overall Study|Lost to Follow-up|0|||
163428505|NCT00809133|590271267|FG001|Overall Study|Lost to Follow-up|0|||
163428506|NCT00809133|590271268|FG002|Overall Study|Lost to Follow-up|0|||
163428507|NCT00809133|590271269|FG003|Overall Study|Lost to Follow-up|0|||
163428508|NCT00809133|590271270|FG004|Overall Study|Lost to Follow-up|0|||
163428509|NCT00809133|590271271|FG005|Overall Study|Lost to Follow-up|1|||
163428510|NCT00809133|590271272|FG006|Overall Study|Lost to Follow-up|0|||
163428511|NCT00809133|590271273|FG007|Overall Study|Lost to Follow-up|0|||
163428512|NCT00809133|590271274|FG008|Overall Study|Lost to Follow-up|0|||
163428513|NCT00809133|590271275|FG009|Overall Study|Lost to Follow-up|0|||
163428514|NCT00809133|590271276|FG010|Overall Study|Lost to Follow-up|0|||
163428515|NCT00809133|590271277|FG011|Overall Study|Lost to Follow-up|0|||
163428516|NCT00809133|590271278|FG012|Overall Study|Lost to Follow-up|0|||
163428517|NCT00809133|590271279|FG013|Overall Study|Lost to Follow-up|0|||
163428518|NCT00809133|590271266|FG000|Overall Study|Consent withdrawn|0|||
163428519|NCT00809133|590271267|FG001|Overall Study|Consent withdrawn|0|||
163428520|NCT00809133|590271268|FG002|Overall Study|Consent withdrawn|0|||
163428521|NCT00809133|590271269|FG003|Overall Study|Consent withdrawn|0|||
163428522|NCT00809133|590271270|FG004|Overall Study|Consent withdrawn|1|||
163428523|NCT00809133|590271271|FG005|Overall Study|Consent withdrawn|0|||
163428524|NCT00809133|590271272|FG006|Overall Study|Consent withdrawn|0|||
163428525|NCT00809133|590271273|FG007|Overall Study|Consent withdrawn|0|||
163428526|NCT00809133|590271274|FG008|Overall Study|Consent withdrawn|0|||
163428527|NCT00809133|590271275|FG009|Overall Study|Consent withdrawn|0|||
163428528|NCT00809133|590271276|FG010|Overall Study|Consent withdrawn|0|||
163428529|NCT00809133|590271277|FG011|Overall Study|Consent withdrawn|0|||
163428530|NCT00809133|590271278|FG012|Overall Study|Consent withdrawn|0|||
163428531|NCT00809133|590271279|FG013|Overall Study|Consent withdrawn|0|||
163428532|NCT00809133|590271266|FG000|Overall Study|Other not mentioned above|0|||
163428533|NCT00809133|590271267|FG001|Overall Study|Other not mentioned above|1|||
163428534|NCT00809133|590271268|FG002|Overall Study|Other not mentioned above|0|||
163428535|NCT00809133|590271269|FG003|Overall Study|Other not mentioned above|0|||
163428536|NCT00809133|590271270|FG004|Overall Study|Other not mentioned above|0|||
163428537|NCT00809133|590271271|FG005|Overall Study|Other not mentioned above|1|||
163428538|NCT00809133|590271272|FG006|Overall Study|Other not mentioned above|0|||
163428539|NCT00809133|590271273|FG007|Overall Study|Other not mentioned above|0|||
163428540|NCT00809133|590271274|FG008|Overall Study|Other not mentioned above|0|||
163428541|NCT00809133|590271275|FG009|Overall Study|Other not mentioned above|0|||
163428542|NCT00809133|590271276|FG010|Overall Study|Other not mentioned above|0|||
163428543|NCT00809133|590271277|FG011|Overall Study|Other not mentioned above|0|||
163428544|NCT00809133|590271278|FG012|Overall Study|Other not mentioned above|0|||
163428545|NCT00809133|590271279|FG013|Overall Study|Other not mentioned above|0|||
163428546|NCT03093155|590271280|FG000|Overall Study|Not Eligible|1|||
163428547|NCT03093155|590271281|FG001|Overall Study|Not Eligible|0|||
163428548|NCT03093155|590271280|FG000|Overall Study|Withdrawal by Subject|0|||
163428549|NCT03093155|590271281|FG001|Overall Study|Withdrawal by Subject|1|||
163428550|NCT01700829|590271282|FG000|Overall Study|Withdrawal by Subject|1|||
163428551|NCT01700829|590271283|FG001|Overall Study|Withdrawal by Subject|1|||
163428552|NCT01075178|590271284|FG000|Subject Matching|eligible but not matched|130|||
163428553|NCT01075178|590271285|FG001|Subject Matching|eligible but not matched|403|||
163428554|NCT01075178|590271284|FG000|Subject Chart Review|died before chart review period|0|||
163428555|NCT01075178|590271285|FG001|Subject Chart Review|died before chart review period|2|||
163428556|NCT01075178|590271284|FG000|Subject Chart Review|no data collected due to site closure|3|||
163428557|NCT01075178|590271285|FG001|Subject Chart Review|no data collected due to site closure|4|||
163428558|NCT01075178|590271284|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
163428559|NCT01075178|590271285|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
163428560|NCT02983604|590271286|FG000|Overall Study|Enrolled but not Treated|0|||
163428561|NCT02983604|590271287|FG001|Overall Study|Enrolled but not Treated|0|||
163428562|NCT02983604|590271288|FG002|Overall Study|Enrolled but not Treated|1|||
163428563|NCT02983604|590271289|FG003|Overall Study|Enrolled but not Treated|0|||
163428564|NCT00607048|590271291|FG000|Overall Study|Adverse Event|0|||
163428565|NCT00607048|590271292|FG001|Overall Study|Adverse Event|1|||
163428566|NCT00607048|590271293|FG002|Overall Study|Adverse Event|0|||
163428567|NCT00607048|590271294|FG003|Overall Study|Adverse Event|0|||
163428568|NCT00607048|590271295|FG004|Overall Study|Adverse Event|4|||
163428569|NCT00607048|590271296|FG005|Overall Study|Adverse Event|0|||
163428570|NCT00607048|590271291|FG000|Overall Study|Global deterioration of health|1|||
163428571|NCT00607048|590271292|FG001|Overall Study|Global deterioration of health|0|||
163428572|NCT00607048|590271293|FG002|Overall Study|Global deterioration of health|0|||
163428573|NCT00607048|590271294|FG003|Overall Study|Global deterioration of health|0|||
163428574|NCT00607048|590271295|FG004|Overall Study|Global deterioration of health|0|||
163428575|NCT00607048|590271296|FG005|Overall Study|Global deterioration of health|0|||
163428576|NCT00607048|590271291|FG000|Overall Study|Objective disease progression - relapse|1|||
163428577|NCT00607048|590271292|FG001|Overall Study|Objective disease progression - relapse|2|||
163428578|NCT00607048|590271293|FG002|Overall Study|Objective disease progression - relapse|4|||
163428579|NCT00607048|590271294|FG003|Overall Study|Objective disease progression - relapse|2|||
163428580|NCT00607048|590271295|FG004|Overall Study|Objective disease progression - relapse|2|||
163428581|NCT00607048|590271296|FG005|Overall Study|Objective disease progression - relapse|2|||
163428582|NCT00607048|590271291|FG000|Overall Study|Withdrawal by Subject|0|||
163428583|NCT00607048|590271292|FG001|Overall Study|Withdrawal by Subject|0|||
163428584|NCT00607048|590271293|FG002|Overall Study|Withdrawal by Subject|0|||
163428585|NCT00607048|590271294|FG003|Overall Study|Withdrawal by Subject|1|||
163428586|NCT00607048|590271295|FG004|Overall Study|Withdrawal by Subject|0|||
163428587|NCT00607048|590271296|FG005|Overall Study|Withdrawal by Subject|2|||
163428588|NCT00607048|590271291|FG000|Overall Study|Other|1|||
163428589|NCT00607048|590271292|FG001|Overall Study|Other|1|||
163428590|NCT00607048|590271293|FG002|Overall Study|Other|0|||
163428591|NCT00607048|590271294|FG003|Overall Study|Other|0|||
163428592|NCT00607048|590271295|FG004|Overall Study|Other|0|||
163428593|NCT00607048|590271296|FG005|Overall Study|Other|1|||
163428594|NCT04336163|590271297|FG000|Overall Study|Lost to Follow-up|55|||
163428595|NCT04336163|590271298|FG001|Overall Study|Lost to Follow-up|0|||
163428596|NCT04927312|590271299|FG000|Overall Study|Adverse Event|1|||
163428597|NCT04927312|590271299|FG000|Overall Study|Death|1|||
163428598|NCT04927312|590271299|FG000|Overall Study|Withdrawal by Subject|1|||
163428599|NCT04927312|590271299|FG000|Overall Study|Other|1|||
163428600|NCT04919564|590271300|FG000|Overall Study|Lost to Follow-up|1|||
163428601|NCT04919564|590271301|FG001|Overall Study|Lost to Follow-up|0|||
163428602|NCT04919564|590271300|FG000|Overall Study|Physician Decision|1|||
163428603|NCT04919564|590271301|FG001|Overall Study|Physician Decision|1|||
163428604|NCT01241786|590271307|FG000|Overall Study|Lack of Efficacy|5|||
163428605|NCT03182738|590271330|FG000|Overall Study|Lost to Follow-up|9|||
163428606|NCT03182738|590271331|FG001|Overall Study|Lost to Follow-up|3|||
163428607|NCT03182738|590271330|FG000|Overall Study|Pregnancy|0|||
163428608|NCT03182738|590271331|FG001|Overall Study|Pregnancy|1|||
163428609|NCT03182738|590271330|FG000|Overall Study|Withdrawal by Subject|0|||
163428610|NCT03182738|590271331|FG001|Overall Study|Withdrawal by Subject|1|||
163428611|NCT00446030|590271332|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
163428612|NCT00446030|590271333|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
163428613|NCT00446030|590271332|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
163428614|NCT00446030|590271333|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
163428615|NCT00446030|590271332|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
163428616|NCT00446030|590271333|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
163428617|NCT00446030|590271332|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
163428618|NCT00446030|590271333|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
163428619|NCT00446030|590271332|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
163428620|NCT00446030|590271333|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
163428621|NCT00446030|590271332|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
163428622|NCT00446030|590271333|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
163428623|NCT00446030|590271332|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
163428624|NCT00446030|590271333|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
163428625|NCT00446030|590271332|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
163428626|NCT00446030|590271333|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
163428627|NCT00446030|590271332|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
163428628|NCT00446030|590271333|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
163428629|NCT00446030|590271332|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
163428630|NCT00446030|590271333|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
163428631|NCT00446030|590271332|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
163428632|NCT00446030|590271333|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
163428633|NCT00446030|590271332|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
163428634|NCT00446030|590271333|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
163428635|NCT00446030|590271332|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
163428636|NCT00446030|590271333|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
163428637|NCT00446030|590271332|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
163428638|NCT00446030|590271333|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
163428639|NCT00446030|590271332|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
163428640|NCT00446030|590271333|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
163428641|NCT00446030|590271332|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
163428642|NCT00446030|590271333|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
163428643|NCT00446030|590271332|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
163428644|NCT00446030|590271333|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
163428645|NCT00446030|590271332|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
163428646|NCT00446030|590271333|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
163428647|NCT00446030|590271332|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
163428648|NCT00446030|590271333|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
163428649|NCT02886715|590271337|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163428650|NCT02886715|590271338|FG001|Overall Study|Non-Compliance With Study Drug|2|||
163428651|NCT02886715|590271339|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163428652|NCT02886715|590271337|FG000|Overall Study|Adverse Event|4|||
163428653|NCT02886715|590271338|FG001|Overall Study|Adverse Event|2|||
163428654|NCT02886715|590271339|FG002|Overall Study|Adverse Event|0|||
163428655|NCT02886715|590271337|FG000|Overall Study|Lack of Efficacy|0|||
163428656|NCT02886715|590271338|FG001|Overall Study|Lack of Efficacy|2|||
163428657|NCT02886715|590271339|FG002|Overall Study|Lack of Efficacy|1|||
163428658|NCT02886715|590271337|FG000|Overall Study|Lost to Follow-up|29|||
163428659|NCT02886715|590271338|FG001|Overall Study|Lost to Follow-up|26|||
163428660|NCT02886715|590271339|FG002|Overall Study|Lost to Follow-up|10|||
163428661|NCT02886715|590271337|FG000|Overall Study|Pregnancy|1|||
163428662|NCT02886715|590271338|FG001|Overall Study|Pregnancy|1|||
163428663|NCT02886715|590271339|FG002|Overall Study|Pregnancy|1|||
163428664|NCT02886715|590271337|FG000|Overall Study|Protocol Violation|3|||
163428665|NCT02886715|590271338|FG001|Overall Study|Protocol Violation|2|||
163428666|NCT02886715|590271339|FG002|Overall Study|Protocol Violation|1|||
163428667|NCT02886715|590271337|FG000|Overall Study|Withdrawal by Subject|20|||
163428668|NCT02886715|590271338|FG001|Overall Study|Withdrawal by Subject|18|||
163428669|NCT02886715|590271339|FG002|Overall Study|Withdrawal by Subject|5|||
163428670|NCT02886715|590271337|FG000|Overall Study|missing|7|||
163428671|NCT02886715|590271338|FG001|Overall Study|missing|2|||
163428672|NCT02886715|590271339|FG002|Overall Study|missing|2|||
163428673|NCT00503399|590271340|FG000|Overall Study|Death|2|||
163428674|NCT00503399|590271341|FG001|Overall Study|Death|1|||
163428675|NCT00503399|590271340|FG000|Overall Study|Protocol Violation|1|||
163428676|NCT00503399|590271341|FG001|Overall Study|Protocol Violation|0|||
163428677|NCT00503399|590271340|FG000|Overall Study|Withdrawal by Subject|4|||
163428678|NCT00503399|590271341|FG001|Overall Study|Withdrawal by Subject|2|||
163428679|NCT00503399|590271340|FG000|Overall Study|Adverse Event|0|||
163428680|NCT00503399|590271341|FG001|Overall Study|Adverse Event|3|||
163428681|NCT00503399|590271340|FG000|Overall Study|Lost to Follow-up|0|||
163428682|NCT00503399|590271341|FG001|Overall Study|Lost to Follow-up|2|||
163428683|NCT01676961|590271342|FG000|Overall Study|Death|3|||
163428684|NCT01676961|590271342|FG000|Overall Study|Lost to Follow-up|1|||
163428685|NCT01676961|590271342|FG000|Overall Study|Withdrawal by Subject|1|||
163428686|NCT01128387|590271345|FG000|Overall Study|Physician Decision|0|||
163428687|NCT01128387|590271346|FG001|Overall Study|Physician Decision|1|||
163428688|NCT01535235|590271347|FG000|Overall Study|Adverse Event|1|||
163428689|NCT01535235|590271348|FG001|Overall Study|Adverse Event|0|||
163428690|NCT02499952|590271352|FG000|Overall Study|Lost to Follow-up|1|||
163428691|NCT02499952|590271352|FG000|Overall Study|Death|9|||
163428692|NCT02120417|590271353|FG000|Overall Study|Death|5|||
163428693|NCT02120417|590271354|FG001|Overall Study|Death|1|||
163428694|NCT02120417|590271353|FG000|Overall Study|Adverse Event|3|||
163428695|NCT02120417|590271354|FG001|Overall Study|Adverse Event|9|||
163428696|NCT02120417|590271353|FG000|Overall Study|Participant decision|4|||
163428697|NCT02120417|590271354|FG001|Overall Study|Participant decision|4|||
163428698|NCT02120417|590271353|FG000|Overall Study|Disease progression|41|||
163428699|NCT02120417|590271354|FG001|Overall Study|Disease progression|45|||
163428700|NCT02120417|590271353|FG000|Overall Study|Noncompliance with study treatment|0|||
163428701|NCT02120417|590271354|FG001|Overall Study|Noncompliance with study treatment|2|||
163428702|NCT02120417|590271353|FG000|Overall Study|Physician Decision|2|||
163428703|NCT02120417|590271354|FG001|Overall Study|Physician Decision|3|||
163428704|NCT02120417|590271353|FG000|Overall Study|Other unspecified|5|||
163428705|NCT02120417|590271354|FG001|Overall Study|Other unspecified|4|||
163428706|NCT00927485|590271355|FG000|Overall Study|Adverse Event|4|||
163428707|NCT00927485|590271356|FG001|Overall Study|Adverse Event|2|||
163428708|NCT00927485|590271355|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
163428709|NCT00927485|590271356|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
163428710|NCT01440101|590271357|FG000|Overall Study|Adverse Event|2|||
163428711|NCT01440101|590271358|FG001|Overall Study|Adverse Event|0|||
163428712|NCT01440101|590271359|FG002|Overall Study|Adverse Event|0|||
163428713|NCT01440101|590271357|FG000|Overall Study|Withdrawal by Subject|0|||
163428714|NCT01440101|590271358|FG001|Overall Study|Withdrawal by Subject|3|||
163428715|NCT01440101|590271359|FG002|Overall Study|Withdrawal by Subject|1|||
163428716|NCT01440101|590271357|FG000|Overall Study|Other|0|||
163428717|NCT01440101|590271358|FG001|Overall Study|Other|1|||
163428718|NCT01440101|590271359|FG002|Overall Study|Other|0|||
163428719|NCT02305563|590271363|FG000|Treatment Period|Disease progression|0|||
163428720|NCT02305563|590271364|FG001|Treatment Period|Disease progression|0|||
163428721|NCT02305563|590271365|FG002|Treatment Period|Disease progression|15|||
163428722|NCT02305563|590271366|FG003|Treatment Period|Disease progression|6|||
163428723|NCT02305563|590271367|FG004|Treatment Period|Disease progression|6|||
163428724|NCT02305563|590271363|FG000|Treatment Period|Study drug toxicity|0|||
163428725|NCT02305563|590271364|FG001|Treatment Period|Study drug toxicity|0|||
163428726|NCT02305563|590271365|FG002|Treatment Period|Study drug toxicity|0|||
163428727|NCT02305563|590271366|FG003|Treatment Period|Study drug toxicity|1|||
163428728|NCT02305563|590271367|FG004|Treatment Period|Study drug toxicity|2|||
163428729|NCT02305563|590271363|FG000|Treatment Period|Death|0|||
163428730|NCT02305563|590271364|FG001|Treatment Period|Death|0|||
163428731|NCT02305563|590271365|FG002|Treatment Period|Death|1|||
163428732|NCT02305563|590271366|FG003|Treatment Period|Death|2|||
163428733|NCT02305563|590271367|FG004|Treatment Period|Death|1|||
163428734|NCT02305563|590271363|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
163428735|NCT02305563|590271364|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
163428736|NCT02305563|590271365|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
163428737|NCT02305563|590271366|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
163428738|NCT02305563|590271367|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
163428739|NCT02305563|590271363|FG000|Treatment Period|Participant request to stop therapy|0|||
163428740|NCT02305563|590271364|FG001|Treatment Period|Participant request to stop therapy|2|||
163428741|NCT02305563|590271365|FG002|Treatment Period|Participant request to stop therapy|0|||
163428742|NCT02305563|590271366|FG003|Treatment Period|Participant request to stop therapy|1|||
163428743|NCT02305563|590271367|FG004|Treatment Period|Participant request to stop therapy|0|||
163428744|NCT02305563|590271363|FG000|Treatment Period|Participant withdrew consent|0|||
163428745|NCT02305563|590271364|FG001|Treatment Period|Participant withdrew consent|0|||
163428746|NCT02305563|590271365|FG002|Treatment Period|Participant withdrew consent|1|||
163428747|NCT02305563|590271366|FG003|Treatment Period|Participant withdrew consent|1|||
163428748|NCT02305563|590271367|FG004|Treatment Period|Participant withdrew consent|1|||
163428749|NCT02305563|590271363|FG000|Treatment Period|Maximum clinical benefit|0|||
163428750|NCT02305563|590271364|FG001|Treatment Period|Maximum clinical benefit|0|||
163428751|NCT02305563|590271365|FG002|Treatment Period|Maximum clinical benefit|0|||
163428752|NCT02305563|590271366|FG003|Treatment Period|Maximum clinical benefit|0|||
163428753|NCT02305563|590271367|FG004|Treatment Period|Maximum clinical benefit|1|||
163428754|NCT02305563|590271363|FG000|Treatment Period|Poor/non-compliance|0|||
163428755|NCT02305563|590271364|FG001|Treatment Period|Poor/non-compliance|0|||
163428756|NCT02305563|590271365|FG002|Treatment Period|Poor/non-compliance|0|||
163428757|NCT02305563|590271366|FG003|Treatment Period|Poor/non-compliance|0|||
163428758|NCT02305563|590271367|FG004|Treatment Period|Poor/non-compliance|1|||
163428759|NCT02305563|590271363|FG000|Treatment Period|Administrative reason by Sponsor|0|||
163428760|NCT02305563|590271364|FG001|Treatment Period|Administrative reason by Sponsor|0|||
163428761|NCT02305563|590271365|FG002|Treatment Period|Administrative reason by Sponsor|0|||
163428762|NCT02305563|590271366|FG003|Treatment Period|Administrative reason by Sponsor|0|||
163428763|NCT02305563|590271367|FG004|Treatment Period|Administrative reason by Sponsor|1|||
163428764|NCT02305563|590271363|FG000|Treatment Period|other reason|2|||
163428765|NCT02305563|590271364|FG001|Treatment Period|other reason|0|||
163428766|NCT02305563|590271365|FG002|Treatment Period|other reason|2|||
163428767|NCT02305563|590271366|FG003|Treatment Period|other reason|2|||
163428768|NCT02305563|590271367|FG004|Treatment Period|other reason|1|||
163428769|NCT02305563|590271363|FG000|Treatment Period|Randomized but not treated|0|||
163428770|NCT02305563|590271364|FG001|Treatment Period|Randomized but not treated|0|||
163428771|NCT02305563|590271365|FG002|Treatment Period|Randomized but not treated|0|||
163428772|NCT02305563|590271366|FG003|Treatment Period|Randomized but not treated|0|||
163428773|NCT02305563|590271367|FG004|Treatment Period|Randomized but not treated|2|||
163428774|NCT02305563|590271363|FG000|Treatment Period|added ULO, then disease progression|0|||
163428775|NCT02305563|590271364|FG001|Treatment Period|added ULO, then disease progression|0|||
163428776|NCT02305563|590271365|FG002|Treatment Period|added ULO, then disease progression|0|||
163428777|NCT02305563|590271366|FG003|Treatment Period|added ULO, then disease progression|0|||
163428778|NCT02305563|590271367|FG004|Treatment Period|added ULO, then disease progression|4|||
163428779|NCT02305563|590271363|FG000|Treatment Period|added ULO; then other reason|0|||
163428780|NCT02305563|590271364|FG001|Treatment Period|added ULO; then other reason|0|||
163428781|NCT02305563|590271365|FG002|Treatment Period|added ULO; then other reason|0|||
163428782|NCT02305563|590271366|FG003|Treatment Period|added ULO; then other reason|0|||
163428783|NCT02305563|590271367|FG004|Treatment Period|added ULO; then other reason|1|||
163428784|NCT02305563|590271363|FG000|Treatment Period|added ULO, then request to stop|0|||
163428785|NCT02305563|590271364|FG001|Treatment Period|added ULO, then request to stop|0|||
163428786|NCT02305563|590271365|FG002|Treatment Period|added ULO, then request to stop|0|||
163428787|NCT02305563|590271366|FG003|Treatment Period|added ULO, then request to stop|0|||
163428788|NCT02305563|590271367|FG004|Treatment Period|added ULO, then request to stop|1|||
163428789|NCT02305563|590271363|FG000|Follow-up Period|Death|0|||
163428790|NCT02305563|590271364|FG001|Follow-up Period|Death|0|||
163428791|NCT02305563|590271365|FG002|Follow-up Period|Death|5|||
163428792|NCT02305563|590271366|FG003|Follow-up Period|Death|4|||
163428793|NCT02305563|590271367|FG004|Follow-up Period|Death|7|||
163428794|NCT02305563|590271363|FG000|Follow-up Period|Participant withdrew consent|0|||
163428795|NCT02305563|590271364|FG001|Follow-up Period|Participant withdrew consent|0|||
163428796|NCT02305563|590271365|FG002|Follow-up Period|Participant withdrew consent|2|||
163428797|NCT02305563|590271366|FG003|Follow-up Period|Participant withdrew consent|1|||
163428798|NCT02305563|590271367|FG004|Follow-up Period|Participant withdrew consent|0|||
163428799|NCT02305563|590271363|FG000|Follow-up Period|other reason|0|||
163428800|NCT02305563|590271364|FG001|Follow-up Period|other reason|0|||
163428801|NCT02305563|590271365|FG002|Follow-up Period|other reason|0|||
163428802|NCT02305563|590271366|FG003|Follow-up Period|other reason|0|||
163428803|NCT02305563|590271367|FG004|Follow-up Period|other reason|1|||
163428804|NCT02305563|590271363|FG000|Follow-up Period|Followup no longer required per protocol|3|||
163428805|NCT02305563|590271364|FG001|Follow-up Period|Followup no longer required per protocol|3|||
163428806|NCT02305563|590271365|FG002|Follow-up Period|Followup no longer required per protocol|4|||
163428807|NCT02305563|590271366|FG003|Follow-up Period|Followup no longer required per protocol|1|||
163428808|NCT02305563|590271367|FG004|Follow-up Period|Followup no longer required per protocol|4|||
163428809|NCT01275222|590271369|FG000|Phase l by Treatment|Adverse Event|1|||
163428810|NCT01275222|590271370|FG001|Phase l by Treatment|Adverse Event|4|||
163428811|NCT01275222|590271371|FG002|Phase l by Treatment|Adverse Event|2|||
163428812|NCT01275222|590271372|FG003|Phase l by Treatment|Adverse Event|3|||
163428813|NCT01275222|590271373|FG004|Phase l by Treatment|Adverse Event|0|||
163428814|NCT01275222|590271374|FG005|Phase l by Treatment|Adverse Event|0|||
163428815|NCT01275222|590271369|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
163428816|NCT01275222|590271370|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
163428817|NCT01275222|590271371|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
163428818|NCT01275222|590271372|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
163428819|NCT01275222|590271373|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
163428820|NCT01275222|590271374|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
163428821|NCT01275222|590271369|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
163428822|NCT01275222|590271370|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
163428823|NCT01275222|590271371|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
163428824|NCT01275222|590271372|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
163428825|NCT01275222|590271373|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
163428826|NCT01275222|590271374|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
163428827|NCT01275222|590271369|FG000|Phase l by Treatment|Disease progression|12|||
163428828|NCT01275222|590271370|FG001|Phase l by Treatment|Disease progression|8|||
163428829|NCT01275222|590271371|FG002|Phase l by Treatment|Disease progression|2|||
163428830|NCT01275222|590271372|FG003|Phase l by Treatment|Disease progression|5|||
163428831|NCT01275222|590271373|FG004|Phase l by Treatment|Disease progression|0|||
163428832|NCT01275222|590271374|FG005|Phase l by Treatment|Disease progression|0|||
163428833|NCT01275222|590271369|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
163428834|NCT01275222|590271370|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
163428835|NCT01275222|590271371|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
163428836|NCT01275222|590271372|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
163428837|NCT01275222|590271373|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
163428838|NCT01275222|590271374|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
163428839|NCT01275222|590271369|FG000|Phase l by Treatment|Death|0|||
163428840|NCT01275222|590271370|FG001|Phase l by Treatment|Death|1|||
163428841|NCT01275222|590271371|FG002|Phase l by Treatment|Death|0|||
163428842|NCT01275222|590271372|FG003|Phase l by Treatment|Death|1|||
163428843|NCT01275222|590271373|FG004|Phase l by Treatment|Death|0|||
163428844|NCT01275222|590271374|FG005|Phase l by Treatment|Death|0|||
163428845|NCT01275222|590271369|FG000|Phase ll by Stratum|Adverse Event|0|||
163428846|NCT01275222|590271370|FG001|Phase ll by Stratum|Adverse Event|0|||
163428847|NCT01275222|590271371|FG002|Phase ll by Stratum|Adverse Event|0|||
163428848|NCT01275222|590271372|FG003|Phase ll by Stratum|Adverse Event|0|||
163428849|NCT01275222|590271373|FG004|Phase ll by Stratum|Adverse Event|2|||
163428850|NCT01275222|590271374|FG005|Phase ll by Stratum|Adverse Event|10|||
163428851|NCT01275222|590271369|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
163428852|NCT01275222|590271370|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
163428853|NCT01275222|590271371|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
163428854|NCT01275222|590271372|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
163428855|NCT01275222|590271373|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
163428856|NCT01275222|590271374|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
163428857|NCT01275222|590271369|FG000|Phase ll by Stratum|Disease progression|0|||
163428858|NCT01275222|590271370|FG001|Phase ll by Stratum|Disease progression|0|||
163428859|NCT01275222|590271371|FG002|Phase ll by Stratum|Disease progression|0|||
163428860|NCT01275222|590271372|FG003|Phase ll by Stratum|Disease progression|0|||
163428861|NCT01275222|590271373|FG004|Phase ll by Stratum|Disease progression|23|||
163428862|NCT01275222|590271374|FG005|Phase ll by Stratum|Disease progression|31|||
163428863|NCT01275222|590271369|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
163428864|NCT01275222|590271370|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
163428865|NCT01275222|590271371|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
163428866|NCT01275222|590271372|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
163428867|NCT01275222|590271373|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
163428868|NCT01275222|590271374|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
163428869|NCT01275222|590271369|FG000|Phase ll by Stratum|Death|0|||
163428870|NCT01275222|590271370|FG001|Phase ll by Stratum|Death|0|||
163428871|NCT01275222|590271371|FG002|Phase ll by Stratum|Death|0|||
163428872|NCT01275222|590271372|FG003|Phase ll by Stratum|Death|0|||
163428873|NCT01275222|590271373|FG004|Phase ll by Stratum|Death|1|||
163428874|NCT01275222|590271374|FG005|Phase ll by Stratum|Death|1|||
163428875|NCT00957853|590271375|FG000|Overall Study|Withdrawal by Subject|1|||
163428876|NCT00957853|590271376|FG001|Overall Study|Withdrawal by Subject|0|||
163428877|NCT00957853|590271377|FG002|Overall Study|Withdrawal by Subject|0|||
163428878|NCT02722044|590271379|FG000|Overall Study|Adverse Event|2|||
163428879|NCT02722044|590271379|FG000|Overall Study|Physician Decision|1|||
163428880|NCT02722044|590271379|FG000|Overall Study|Withdrawal by Subject|1|||
163428881|NCT02722044|590271379|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
163428882|NCT00609622|590271380|FG000|Overall Study|Adverse Event|14|||
163428883|NCT00609622|590271381|FG001|Overall Study|Adverse Event|10|||
163428884|NCT00609622|590271380|FG000|Overall Study|Withdrawal by Subject|4|||
163428885|NCT00609622|590271381|FG001|Overall Study|Withdrawal by Subject|20|||
163428886|NCT00609622|590271380|FG000|Overall Study|Death|1|||
163428887|NCT00609622|590271381|FG001|Overall Study|Death|4|||
163428888|NCT00609622|590271380|FG000|Overall Study|Protocol Violation|1|||
163428889|NCT00609622|590271381|FG001|Overall Study|Protocol Violation|1|||
163428890|NCT00609622|590271380|FG000|Overall Study|Objective progression or relapse|47|||
163428891|NCT00609622|590271381|FG001|Overall Study|Objective progression or relapse|41|||
163428892|NCT00609622|590271380|FG000|Overall Study|Study terminated by sponsor|16|||
163428893|NCT00609622|590271381|FG001|Overall Study|Study terminated by sponsor|3|||
163428894|NCT00609622|590271380|FG000|Overall Study|Other|7|||
163428895|NCT00609622|590271381|FG001|Overall Study|Other|14|||
163428896|NCT00609622|590271380|FG000|Overall Study|Global deterioration of health status|6|||
163428897|NCT00609622|590271381|FG001|Overall Study|Global deterioration of health status|2|||
163428898|NCT01237951|590271384|FG000|Overall Study|Death|1|||
163428899|NCT01708057|590271385|FG000|Overall Study|Withdrawal due to study termination.|1|||
163428900|NCT01708057|590271386|FG001|Overall Study|Withdrawal due to study termination.|1|||
163428901|NCT01708057|590271387|FG002|Overall Study|Withdrawal due to study termination.|1|||
163428902|NCT02970929|590271392|FG000|Overall Study|Adverse Event|18|||
163428903|NCT02970929|590271392|FG000|Overall Study|Lack of Efficacy|8|||
163428904|NCT02970929|590271392|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
163428905|NCT02970929|590271392|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
163428906|NCT02970929|590271392|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
163428907|NCT02970929|590271392|FG000|Overall Study|LOST TO FOLLOWUP|6|||
163428908|NCT02970929|590271392|FG000|Overall Study|MOVED OUT OF STATE|1|||
163428909|NCT02970929|590271392|FG000|Overall Study|Withdrawal by Subject|16|||
163428910|NCT00666562|590271395|FG000|Overall Study|Withdrawal by Subject|0|||
163428911|NCT00666562|590271396|FG001|Overall Study|Withdrawal by Subject|1|||
163428912|NCT00666562|590271397|FG002|Overall Study|Withdrawal by Subject|0|||
163428913|NCT00666562|590271395|FG000|Overall Study|Concomitant Medication|0|||
163428914|NCT00666562|590271396|FG001|Overall Study|Concomitant Medication|1|||
163428915|NCT00666562|590271397|FG002|Overall Study|Concomitant Medication|0|||
163428916|NCT03874234|590273075|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
163428917|NCT03874234|590273076|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
163428918|NCT03874234|590273077|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
163428919|NCT03874234|590273078|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
163428920|NCT03874234|590273079|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
163428921|NCT03874234|590273080|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
163428922|NCT03874234|590273081|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
163428923|NCT03874234|590273082|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
163428924|NCT03874234|590273083|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
163428925|NCT03874234|590273084|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
163428926|NCT03874234|590273085|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
163428927|NCT03874234|590273086|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
163428928|NCT03874234|590273087|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
163428929|NCT03874234|590273075|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
163428930|NCT03874234|590273076|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
163428931|NCT03874234|590273077|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
163428932|NCT03874234|590273078|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
163428933|NCT03874234|590273079|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
163428934|NCT03874234|590273080|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
163428935|NCT03874234|590273081|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
163428936|NCT03874234|590273082|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
163428937|NCT03874234|590273083|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
163428938|NCT03874234|590273084|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
163428939|NCT03874234|590273085|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
163428940|NCT03874234|590273086|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
163428941|NCT03874234|590273087|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
163428942|NCT03874234|590273075|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
163428943|NCT03874234|590273076|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
163428944|NCT03874234|590273077|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
163428945|NCT03874234|590273078|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
163428946|NCT03874234|590273079|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
163428947|NCT03874234|590273080|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
163428948|NCT03874234|590273081|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
163428949|NCT03874234|590273082|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
163428950|NCT03874234|590273083|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
163428951|NCT03874234|590273084|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
163428952|NCT03874234|590273085|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
163428953|NCT03874234|590273086|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
163428954|NCT03874234|590273087|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
163428955|NCT03874234|590273075|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
163428956|NCT03874234|590273076|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
163428957|NCT03874234|590273077|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
163428958|NCT03874234|590273078|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
163428959|NCT03874234|590273079|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
163428960|NCT03874234|590273080|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
163428961|NCT03874234|590273081|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
163428962|NCT03874234|590273082|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
163428963|NCT03874234|590273083|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
163428964|NCT03874234|590273084|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
163428965|NCT03874234|590273085|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
163428966|NCT03874234|590273086|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
163428967|NCT03874234|590273087|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
163428968|NCT03874234|590273075|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
163428969|NCT03874234|590273076|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
163428970|NCT03874234|590273077|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
163428971|NCT03874234|590273078|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
163428972|NCT03874234|590273079|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
163428973|NCT03874234|590273080|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
163428974|NCT03874234|590273081|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
163428975|NCT03874234|590273082|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
163428976|NCT03874234|590273083|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
163428977|NCT03874234|590273084|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
163428978|NCT03874234|590273085|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
163428979|NCT03874234|590273086|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
163428980|NCT03874234|590273087|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
163428981|NCT03874234|590273075|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
163428982|NCT03874234|590273076|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
163428983|NCT03874234|590273077|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
163428984|NCT03874234|590273078|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
163428985|NCT03874234|590273079|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
163428986|NCT03874234|590273080|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
163428987|NCT03874234|590273081|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
163428988|NCT03874234|590273082|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
163428989|NCT03874234|590273083|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
163428990|NCT03874234|590273084|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
163428991|NCT03874234|590273085|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
163428992|NCT03874234|590273086|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
163428993|NCT03874234|590273087|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
163428994|NCT03874234|590273075|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
163428995|NCT03874234|590273076|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
163428996|NCT03874234|590273077|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
163428997|NCT03874234|590273078|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
163428998|NCT03874234|590273079|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
163428999|NCT03874234|590273080|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
163429000|NCT03874234|590273081|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
163429001|NCT03874234|590273082|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
163429002|NCT03874234|590273083|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
163429003|NCT03874234|590273084|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
163429004|NCT03874234|590273085|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
163429005|NCT03874234|590273086|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
163429006|NCT03874234|590273087|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
163429007|NCT03874234|590273075|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
163429008|NCT03874234|590273076|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
163429009|NCT03874234|590273077|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
163429010|NCT03874234|590273078|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
163429011|NCT03874234|590273079|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
163429012|NCT03874234|590273080|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
163429013|NCT03874234|590273081|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
163429014|NCT03874234|590273082|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
163429015|NCT03874234|590273083|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
163429016|NCT03874234|590273084|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
163429017|NCT03874234|590273085|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
163429018|NCT03874234|590273086|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
163429019|NCT03874234|590273087|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
163429020|NCT03168867|590273093|FG000|Overall Study|Withdrawal by Subject|1|||
163429021|NCT03168867|590273094|FG001|Overall Study|Withdrawal by Subject|5|||
163429022|NCT03812510|590273095|FG000|Overall Study|Lost to Follow-up|39|||
163429023|NCT03812510|590273095|FG000|Overall Study|Withdrawal by Subject|42|||
163429024|NCT03812510|590273095|FG000|Overall Study|Physician Decision|2|||
163429025|NCT03812510|590273095|FG000|Overall Study|Study Terminated by Sponsor|9|||
163429026|NCT03812510|590273095|FG000|Overall Study|Did Not Start Study Medication|55|||
163429027|NCT03812510|590273095|FG000|Overall Study|Adverse Event|5|||
163429028|NCT00858832|590273096|FG000|Overall Study|became ineligible: delivered vaginally|1|||
163429029|NCT00858832|590273097|FG001|Overall Study|became ineligible: delivered vaginally|0|||
163429030|NCT00858832|590273096|FG000|Overall Study|Adverse Event|0|||
163429031|NCT00858832|590273097|FG001|Overall Study|Adverse Event|1|||
163429032|NCT05421754|590273102|FG000|Overall Study|Technical issue with sensor|1|||
163429033|NCT04433117|590273103|FG000|Overall Study|Withdrawal by Subject|1|||
163429034|NCT04433117|590273104|FG001|Overall Study|Withdrawal by Subject|0|||
163429035|NCT00824421|590273105|FG000|Overall Study|Adverse Event|6|||
163429036|NCT00824421|590273106|FG001|Overall Study|Adverse Event|6|||
163429037|NCT00824421|590273107|FG002|Overall Study|Adverse Event|6|||
163429038|NCT00824421|590273105|FG000|Overall Study|Death|0|||
163429039|NCT00824421|590273106|FG001|Overall Study|Death|1|||
163429040|NCT00824421|590273107|FG002|Overall Study|Death|0|||
163429041|NCT00824421|590273105|FG000|Overall Study|Lack of Efficacy|5|||
163429042|NCT00824421|590273106|FG001|Overall Study|Lack of Efficacy|7|||
163429043|NCT00824421|590273107|FG002|Overall Study|Lack of Efficacy|4|||
163429044|NCT00824421|590273105|FG000|Overall Study|Lost to Follow-up|2|||
163429045|NCT00824421|590273106|FG001|Overall Study|Lost to Follow-up|3|||
163429046|NCT00824421|590273107|FG002|Overall Study|Lost to Follow-up|0|||
163429047|NCT00824421|590273105|FG000|Overall Study|Pregnancy|1|||
163429048|NCT00824421|590273106|FG001|Overall Study|Pregnancy|0|||
163429049|NCT00824421|590273107|FG002|Overall Study|Pregnancy|1|||
163429050|NCT00824421|590273105|FG000|Overall Study|Withdrawal by Subject|2|||
163429051|NCT00824421|590273106|FG001|Overall Study|Withdrawal by Subject|3|||
163429052|NCT00824421|590273107|FG002|Overall Study|Withdrawal by Subject|3|||
163429053|NCT00824421|590273105|FG000|Overall Study|Randomized but not Treated|1|||
163429054|NCT00824421|590273106|FG001|Overall Study|Randomized but not Treated|1|||
163429055|NCT00824421|590273107|FG002|Overall Study|Randomized but not Treated|0|||
163429056|NCT00824421|590273105|FG000|Overall Study|Other|0|||
163429057|NCT00824421|590273106|FG001|Overall Study|Other|1|||
163429058|NCT00824421|590273107|FG002|Overall Study|Other|0|||
163429059|NCT00659438|590273109|FG000|Overall Study|Withdrawal by Subject|2|||
163429060|NCT00659438|590273110|FG001|Overall Study|Withdrawal by Subject|2|||
163429061|NCT00659438|590273109|FG000|Overall Study|Death|11|||
163429062|NCT00659438|590273110|FG001|Overall Study|Death|6|||
163429063|NCT00659438|590273109|FG000|Overall Study|Lost to Follow-up|1|||
163429064|NCT00659438|590273110|FG001|Overall Study|Lost to Follow-up|0|||
163429065|NCT00201851|590273111|FG000|Overall Study|Lost to Follow-up|2|||
163429066|NCT00201851|590273112|FG001|Overall Study|Lost to Follow-up|1|||
163429067|NCT00201851|590273113|FG002|Overall Study|Lost to Follow-up|0|||
163429068|NCT00201851|590273111|FG000|Overall Study|Ineligible post enrollment|6|||
163429069|NCT00201851|590273112|FG001|Overall Study|Ineligible post enrollment|1|||
163429070|NCT00201851|590273113|FG002|Overall Study|Ineligible post enrollment|1|||
163429071|NCT02469246|590273114|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
163429072|NCT02469246|590273115|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
163429073|NCT02469246|590273114|FG000|Double-Blind Phase|Adverse Event|12|||
163429074|NCT02469246|590273115|FG001|Double-Blind Phase|Adverse Event|9|||
163429075|NCT02469246|590273114|FG000|Double-Blind Phase|Death|2|||
163429076|NCT02469246|590273115|FG001|Double-Blind Phase|Death|0|||
163429077|NCT02469246|590273114|FG000|Double-Blind Phase|Lack of Efficacy|2|||
163429078|NCT02469246|590273115|FG001|Double-Blind Phase|Lack of Efficacy|1|||
163429079|NCT02469246|590273114|FG000|Double-Blind Phase|Investigator's Discretion|8|||
163429080|NCT02469246|590273115|FG001|Double-Blind Phase|Investigator's Discretion|8|||
163429081|NCT02469246|590273114|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
163429082|NCT02469246|590273115|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
163429083|NCT02469246|590273114|FG000|Double-Blind Phase|Protocol Violation|1|||
163429084|NCT02469246|590273115|FG001|Double-Blind Phase|Protocol Violation|1|||
163429085|NCT02469246|590273114|FG000|Double-Blind Phase|Withdrew Consent|25|||
163429086|NCT02469246|590273115|FG001|Double-Blind Phase|Withdrew Consent|25|||
163429087|NCT02469246|590273114|FG000|Double-Blind Phase|Lost to Follow-up|9|||
163429088|NCT02469246|590273115|FG001|Double-Blind Phase|Lost to Follow-up|5|||
163429089|NCT02690701|590273122|FG000|Treatment Period 1|Adverse Event|2|||
163429090|NCT02690701|590273123|FG001|Treatment Period 1|Adverse Event|2|||
163429091|NCT02690701|590273122|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163429092|NCT02690701|590273123|FG001|Treatment Period 1|Withdrawal by Subject|1|||
163429093|NCT02690701|590273122|FG000|Treatment Period 2|Adverse Event|2|||
163429094|NCT02690701|590273123|FG001|Treatment Period 2|Adverse Event|0|||
163429095|NCT02690701|590273122|FG000|Treatment Period 2|Lack of Efficacy|1|||
163429096|NCT02690701|590273123|FG001|Treatment Period 2|Lack of Efficacy|0|||
163429097|NCT02690701|590273122|FG000|Treatment Period 2|Lost to Follow-up|0|||
163429098|NCT02690701|590273123|FG001|Treatment Period 2|Lost to Follow-up|2|||
163429099|NCT02690701|590273122|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163429100|NCT02690701|590273123|FG001|Treatment Period 2|Withdrawal by Subject|2|||
163429101|NCT02690701|590273122|FG000|Treatment Period 2|Protocol Violation|0|||
163429102|NCT02690701|590273123|FG001|Treatment Period 2|Protocol Violation|1|||
163429103|NCT02700451|590273124|FG000|Overall Study|Protocol Violation|2|||
163429104|NCT02700451|590273125|FG001|Overall Study|Protocol Violation|2|||
163429105|NCT02700451|590273126|FG002|Overall Study|Protocol Violation|3|||
163429106|NCT02700451|590273124|FG000|Overall Study|Discontinued intervention|14|||
163429107|NCT02700451|590273125|FG001|Overall Study|Discontinued intervention|15|||
163429108|NCT02700451|590273126|FG002|Overall Study|Discontinued intervention|14|||
163429109|NCT00404092|590273132|FG000|Overall Study|Death|1|||
163429110|NCT00404092|590273133|FG001|Overall Study|Death|0|||
163429111|NCT00404092|590273134|FG002|Overall Study|Death|0|||
163429112|NCT00404092|590273135|FG003|Overall Study|Death|0|||
163429113|NCT00404092|590273132|FG000|Overall Study|Adverse Event|0|||
163429114|NCT00404092|590273133|FG001|Overall Study|Adverse Event|0|||
163429115|NCT00404092|590273134|FG002|Overall Study|Adverse Event|1|||
163429116|NCT00404092|590273135|FG003|Overall Study|Adverse Event|0|||
163429117|NCT02344576|590273141|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
163429118|NCT02344576|590273142|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
163429119|NCT02344576|590273143|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
163429120|NCT02344576|590273144|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
163429121|NCT02344576|590273141|FG000|1-Month Follow-Up|Death|13|||
163429122|NCT02344576|590273142|FG001|1-Month Follow-Up|Death|8|||
163429123|NCT02344576|590273143|FG002|1-Month Follow-Up|Death|0|||
163429124|NCT02344576|590273144|FG003|1-Month Follow-Up|Death|0|||
163429125|NCT02344576|590273141|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
163429126|NCT02344576|590273142|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
163429127|NCT02344576|590273143|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
163429128|NCT02344576|590273144|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
163429129|NCT02344576|590273141|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
163429130|NCT02344576|590273142|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
163429131|NCT02344576|590273143|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
163429132|NCT02344576|590273144|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
163429133|NCT02344576|590273141|FG000|6-Month Follow-Up|Death|14|||
163429134|NCT02344576|590273142|FG001|6-Month Follow-Up|Death|14|||
163429135|NCT02344576|590273143|FG002|6-Month Follow-Up|Death|0|||
163429136|NCT02344576|590273144|FG003|6-Month Follow-Up|Death|0|||
163429137|NCT02344576|590273141|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
163429138|NCT02344576|590273142|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
163429139|NCT02344576|590273143|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
163429140|NCT02344576|590273144|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
163429141|NCT02344576|590273141|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
163429142|NCT02344576|590273142|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
163429143|NCT02344576|590273143|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
163429144|NCT02344576|590273144|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
163429145|NCT04325503|590273146|FG000|Overall Study|Withdrawal by Subject|1|||
163429146|NCT04325503|590273146|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
163429147|NCT02337387|590273147|FG000|Overall Study|Adverse Event|0|||
163429148|NCT02337387|590273148|FG001|Overall Study|Adverse Event|1|||
163429149|NCT02337387|590273149|FG002|Overall Study|Adverse Event|0|||
163429150|NCT02337387|590273150|FG003|Overall Study|Adverse Event|0|||
163429151|NCT02337387|590273147|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
163429152|NCT02337387|590273148|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
163429153|NCT02337387|590273149|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
163429154|NCT02337387|590273150|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
163429155|NCT01642212|590273151|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
163429156|NCT01642212|590273152|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
163429157|NCT01642212|590273153|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
163429158|NCT01642212|590273154|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
163429159|NCT01642212|590273155|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
163429160|NCT01642212|590273151|FG000|Double-blind Treatment|Other|0|||
163429161|NCT01642212|590273152|FG001|Double-blind Treatment|Other|2|||
163429162|NCT01642212|590273153|FG002|Double-blind Treatment|Other|1|||
163429163|NCT01642212|590273154|FG003|Double-blind Treatment|Other|0|||
163429164|NCT01642212|590273155|FG004|Double-blind Treatment|Other|0|||
163429165|NCT01642212|590273151|FG000|Double-blind Treatment|Non-compliance|0|||
163429166|NCT01642212|590273152|FG001|Double-blind Treatment|Non-compliance|1|||
163429167|NCT01642212|590273153|FG002|Double-blind Treatment|Non-compliance|0|||
163429168|NCT01642212|590273154|FG003|Double-blind Treatment|Non-compliance|0|||
163429169|NCT01642212|590273155|FG004|Double-blind Treatment|Non-compliance|0|||
163429170|NCT01642212|590273151|FG000|Double-blind Treatment|Adverse Event|0|||
163429171|NCT01642212|590273152|FG001|Double-blind Treatment|Adverse Event|0|||
163429172|NCT01642212|590273153|FG002|Double-blind Treatment|Adverse Event|1|||
163429173|NCT01642212|590273154|FG003|Double-blind Treatment|Adverse Event|0|||
163429174|NCT01642212|590273155|FG004|Double-blind Treatment|Adverse Event|0|||
163429175|NCT01642212|590273151|FG000|Open-label Extension|Adverse Event|0|||
163429176|NCT01642212|590273152|FG001|Open-label Extension|Adverse Event|0|||
163429177|NCT01642212|590273153|FG002|Open-label Extension|Adverse Event|0|||
163429178|NCT01642212|590273154|FG003|Open-label Extension|Adverse Event|3|||
163429179|NCT01642212|590273155|FG004|Open-label Extension|Adverse Event|0|||
163429180|NCT01642212|590273151|FG000|Open-label Extension|Sponsor Decision|0|||
163429181|NCT01642212|590273152|FG001|Open-label Extension|Sponsor Decision|0|||
163429182|NCT01642212|590273153|FG002|Open-label Extension|Sponsor Decision|0|||
163429183|NCT01642212|590273154|FG003|Open-label Extension|Sponsor Decision|7|||
163429184|NCT01642212|590273155|FG004|Open-label Extension|Sponsor Decision|4|||
163429185|NCT01642212|590273151|FG000|Open-label Extension|Consent Withdrawn|0|||
163429186|NCT01642212|590273152|FG001|Open-label Extension|Consent Withdrawn|0|||
163429187|NCT01642212|590273153|FG002|Open-label Extension|Consent Withdrawn|0|||
163429188|NCT01642212|590273154|FG003|Open-label Extension|Consent Withdrawn|0|||
163429189|NCT01642212|590273155|FG004|Open-label Extension|Consent Withdrawn|2|||
163429190|NCT01642212|590273151|FG000|Open-label Extension|Lost to Follow-up|0|||
163429191|NCT01642212|590273152|FG001|Open-label Extension|Lost to Follow-up|0|||
163429192|NCT01642212|590273153|FG002|Open-label Extension|Lost to Follow-up|0|||
163429193|NCT01642212|590273154|FG003|Open-label Extension|Lost to Follow-up|0|||
163429194|NCT01642212|590273155|FG004|Open-label Extension|Lost to Follow-up|1|||
163429195|NCT01642212|590273151|FG000|Open-label Extension|Other|0|||
163429196|NCT01642212|590273152|FG001|Open-label Extension|Other|0|||
163429197|NCT01642212|590273153|FG002|Open-label Extension|Other|0|||
163429198|NCT01642212|590273154|FG003|Open-label Extension|Other|0|||
163429199|NCT01642212|590273155|FG004|Open-label Extension|Other|1|||
163429200|NCT01243268|590273157|FG000|Overall Study|Lost to Follow-up|4|||
163429201|NCT01243268|590273157|FG000|Overall Study|Protocol Violation|51|||
163429202|NCT01243268|590273157|FG000|Overall Study|Deviation with contract date|7|||
163429203|NCT01243268|590273157|FG000|Overall Study|Duplicate subject|2|||
163429204|NCT00702143|590273158|FG000|Overall Study|Lost to Follow-up|0|||
163429205|NCT00702143|590273159|FG001|Overall Study|Lost to Follow-up|0|||
163429206|NCT00702143|590273160|FG002|Overall Study|Lost to Follow-up|1|||
163429207|NCT03871491|590273163|FG000|Overall Study|Withdrawal by Subject|14|||
163429208|NCT03871491|590273164|FG001|Overall Study|Withdrawal by Subject|14|||
163429209|NCT03871491|590273165|FG002|Overall Study|Withdrawal by Subject|14|||
163429210|NCT03871491|590273166|FG003|Overall Study|Withdrawal by Subject|14|||
163429211|NCT03871491|590273163|FG000|Overall Study|Physician Decision|0|||
163429212|NCT03871491|590273164|FG001|Overall Study|Physician Decision|0|||
163429213|NCT03871491|590273165|FG002|Overall Study|Physician Decision|1|||
163429214|NCT03871491|590273166|FG003|Overall Study|Physician Decision|1|||
163429215|NCT03871491|590273163|FG000|Overall Study|Lost to Follow-up|50|||
163429216|NCT03871491|590273164|FG001|Overall Study|Lost to Follow-up|15|||
163429217|NCT03871491|590273165|FG002|Overall Study|Lost to Follow-up|36|||
163429218|NCT03871491|590273166|FG003|Overall Study|Lost to Follow-up|11|||
163429219|NCT05202808|590273167|FG000|Overall Study|Lost to Follow-up|3|||
163429220|NCT05202808|590273168|FG001|Overall Study|Lost to Follow-up|1|||
163429221|NCT04996797|590273169|FG000|Overall Study|Adverse Event|0|||
163429222|NCT04996797|590273170|FG001|Overall Study|Adverse Event|2|||
163429223|NCT04996797|590273171|FG002|Overall Study|Adverse Event|0|||
163429224|NCT04996797|590273172|FG003|Overall Study|Adverse Event|1|||
163429225|NCT04996797|590273169|FG000|Overall Study|Lack of Efficacy|0|||
163429226|NCT04996797|590273170|FG001|Overall Study|Lack of Efficacy|2|||
163429227|NCT04996797|590273171|FG002|Overall Study|Lack of Efficacy|0|||
163429228|NCT04996797|590273172|FG003|Overall Study|Lack of Efficacy|0|||
163429229|NCT04996797|590273169|FG000|Overall Study|Prohibited Medication|0|||
163429230|NCT04996797|590273170|FG001|Overall Study|Prohibited Medication|1|||
163429231|NCT04996797|590273171|FG002|Overall Study|Prohibited Medication|0|||
163429232|NCT04996797|590273172|FG003|Overall Study|Prohibited Medication|0|||
163429233|NCT04996797|590273169|FG000|Overall Study|Ongoing|68|||
163429234|NCT04996797|590273170|FG001|Overall Study|Ongoing|60|||
163429235|NCT04996797|590273171|FG002|Overall Study|Ongoing|22|||
163429236|NCT04996797|590273172|FG003|Overall Study|Ongoing|20|||
163429237|NCT04996797|590273169|FG000|Overall Study|Withdrawal by Subject|0|||
163429238|NCT04996797|590273170|FG001|Overall Study|Withdrawal by Subject|2|||
163429239|NCT04996797|590273171|FG002|Overall Study|Withdrawal by Subject|0|||
163429240|NCT04996797|590273172|FG003|Overall Study|Withdrawal by Subject|0|||
163429241|NCT02793544|590273173|FG000|Overall Study|Death|10|||
163429242|NCT02793544|590273174|FG001|Overall Study|Death|8|||
163429243|NCT02793544|590273173|FG000|Overall Study|Lost to Follow-up|2|||
163429244|NCT02793544|590273174|FG001|Overall Study|Lost to Follow-up|0|||
163429245|NCT02793544|590273173|FG000|Overall Study|Withdrawal by Subject|1|||
163429246|NCT02793544|590273174|FG001|Overall Study|Withdrawal by Subject|0|||
163429247|NCT02495948|590273179|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
163429248|NCT02495948|590273180|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
163429249|NCT02495948|590273179|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
163429250|NCT02495948|590273180|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
163429251|NCT00100048|590273181|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
163429252|NCT00100048|590273182|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
163429253|NCT00100048|590273183|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
163429254|NCT00100048|590273184|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
163429255|NCT00100048|590273185|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
163429256|NCT00100048|590273186|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
163429257|NCT00100048|590273181|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
163429258|NCT00100048|590273182|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
163429259|NCT00100048|590273183|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
163429260|NCT00100048|590273184|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
163429261|NCT00100048|590273185|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
163429262|NCT00100048|590273186|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
163429263|NCT00100048|590273181|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
163429264|NCT00100048|590273182|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
163429265|NCT00100048|590273183|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
163429266|NCT00100048|590273184|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
163429267|NCT00100048|590273185|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
163429268|NCT00100048|590273186|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
163429269|NCT00100048|590273181|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
163429270|NCT00100048|590273182|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
163429271|NCT00100048|590273183|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
163429272|NCT00100048|590273184|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
163429273|NCT00100048|590273185|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
163429274|NCT00100048|590273186|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
163429275|NCT00100048|590273181|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
163429276|NCT00100048|590273182|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
163429277|NCT00100048|590273183|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
163429278|NCT00100048|590273184|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
163429279|NCT00100048|590273185|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
163429280|NCT00100048|590273186|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
163429281|NCT00100048|590273181|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
163429282|NCT00100048|590273182|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
163429283|NCT00100048|590273183|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
163429284|NCT00100048|590273184|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
163429285|NCT00100048|590273185|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
163429286|NCT00100048|590273186|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
163429287|NCT00100048|590273181|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
163429288|NCT00100048|590273182|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
163429289|NCT00100048|590273183|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
163429290|NCT00100048|590273184|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
163429291|NCT00100048|590273185|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
163429292|NCT00100048|590273186|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
163429293|NCT00100048|590273181|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
163429294|NCT00100048|590273182|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
163429295|NCT00100048|590273183|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
163429296|NCT00100048|590273184|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
163429297|NCT00100048|590273185|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
163429298|NCT00100048|590273186|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
163429299|NCT00667277|590273188|FG000|Overall Study|Withdrawal by Subject|2|||
163429300|NCT02747004|590273189|FG000|Overall Study|Withdrawal by Subject|8|||
163429301|NCT02747004|590273190|FG001|Overall Study|Withdrawal by Subject|5|||
163429302|NCT02747004|590273191|FG002|Overall Study|Withdrawal by Subject|4|||
163429303|NCT02747004|590273189|FG000|Overall Study|Lost to Follow-up|1|||
163429304|NCT02747004|590273190|FG001|Overall Study|Lost to Follow-up|2|||
163429305|NCT02747004|590273191|FG002|Overall Study|Lost to Follow-up|2|||
163429306|NCT02747004|590273189|FG000|Overall Study|on study treatment/follow-up|48|||
163429307|NCT02747004|590273190|FG001|Overall Study|on study treatment/follow-up|42|||
163429308|NCT02747004|590273191|FG002|Overall Study|on study treatment/follow-up|41|||
163429309|NCT05087030|590273192|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
163429310|NCT05087030|590273193|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
163429311|NCT05087030|590273194|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
163429312|NCT05087030|590273195|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
163429313|NCT05087030|590273196|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
163429314|NCT05087030|590273192|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
163429315|NCT05087030|590273193|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
163429316|NCT05087030|590273194|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
163429317|NCT05087030|590273195|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
163429318|NCT05087030|590273196|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
163429319|NCT05087030|590273192|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
163429320|NCT05087030|590273193|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
163429321|NCT05087030|590273194|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
163429322|NCT05087030|590273195|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
163429323|NCT05087030|590273196|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
163429324|NCT05087030|590273192|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
163429325|NCT05087030|590273193|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
163429326|NCT05087030|590273194|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
163429327|NCT05087030|590273195|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
163429328|NCT05087030|590273196|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
163429329|NCT05087030|590273192|FG000|Main Period (Week 0 to Week 52)|Death|0|||
163429330|NCT05087030|590273193|FG001|Main Period (Week 0 to Week 52)|Death|1|||
163429331|NCT05087030|590273194|FG002|Main Period (Week 0 to Week 52)|Death|0|||
163429332|NCT05087030|590273195|FG003|Main Period (Week 0 to Week 52)|Death|0|||
163429333|NCT05087030|590273196|FG004|Main Period (Week 0 to Week 52)|Death|0|||
163429334|NCT05087030|590273192|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
163429335|NCT05087030|590273193|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
163429336|NCT05087030|590273194|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
163429337|NCT05087030|590273195|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
163429338|NCT05087030|590273196|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
163429339|NCT05087030|590273192|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
163429340|NCT05087030|590273193|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
163429341|NCT05087030|590273194|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
163429342|NCT05087030|590273195|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
163429343|NCT05087030|590273196|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
163429344|NCT05087030|590273192|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
163429345|NCT05087030|590273193|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
163429346|NCT05087030|590273194|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
163429347|NCT05087030|590273195|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
163429348|NCT05087030|590273196|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
163429349|NCT05087030|590273192|FG000|Main Period (Week 0 to Week 52)|Other|1|||
163429350|NCT05087030|590273193|FG001|Main Period (Week 0 to Week 52)|Other|2|||
163429351|NCT05087030|590273194|FG002|Main Period (Week 0 to Week 52)|Other|0|||
163429352|NCT05087030|590273195|FG003|Main Period (Week 0 to Week 52)|Other|0|||
163429353|NCT05087030|590273196|FG004|Main Period (Week 0 to Week 52)|Other|0|||
163429354|NCT05087030|590273192|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
163429355|NCT05087030|590273193|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
163429356|NCT05087030|590273194|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
163429357|NCT05087030|590273195|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
163429358|NCT05087030|590273196|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
163429359|NCT04885257|590273200|FG000|Overall Study|Withdrawal by Subject|1|||
163429360|NCT04885257|590273201|FG001|Overall Study|Withdrawal by Subject|0|||
163429361|NCT00818259|590273202|FG000|Part I|Withdrawal by Subject|1|||
163429362|NCT00818259|590273203|FG001|Part I|Withdrawal by Subject|0|||
163429363|NCT00818259|590273204|FG002|Part I|Withdrawal by Subject|0|||
163429364|NCT00818259|590273205|FG003|Part I|Withdrawal by Subject|0|||
163429365|NCT00818259|590273206|FG004|Part I|Withdrawal by Subject|0|||
163429366|NCT00818259|590273207|FG005|Part I|Withdrawal by Subject|0|||
163429367|NCT00818259|590273208|FG006|Part I|Withdrawal by Subject|0|||
163429368|NCT00818259|590273209|FG007|Part I|Withdrawal by Subject|0|||
163429369|NCT00818259|590273210|FG008|Part I|Withdrawal by Subject|0|||
163429370|NCT00818259|590273202|FG000|Part II|Physician Decision|0|||
163429371|NCT00818259|590273203|FG001|Part II|Physician Decision|0|||
163429372|NCT00818259|590273204|FG002|Part II|Physician Decision|1|||
163429373|NCT00818259|590273205|FG003|Part II|Physician Decision|0|||
163429374|NCT00818259|590273206|FG004|Part II|Physician Decision|0|||
163429375|NCT00818259|590273207|FG005|Part II|Physician Decision|0|||
163429376|NCT00818259|590273208|FG006|Part II|Physician Decision|0|||
163429377|NCT00818259|590273209|FG007|Part II|Physician Decision|0|||
163429378|NCT00818259|590273210|FG008|Part II|Physician Decision|0|||
163429379|NCT00818259|590273202|FG000|Part II|Lack of Efficacy|0|||
163429380|NCT00818259|590273203|FG001|Part II|Lack of Efficacy|0|||
163429381|NCT00818259|590273204|FG002|Part II|Lack of Efficacy|0|||
163429382|NCT00818259|590273205|FG003|Part II|Lack of Efficacy|1|||
163429383|NCT00818259|590273206|FG004|Part II|Lack of Efficacy|0|||
163429384|NCT00818259|590273207|FG005|Part II|Lack of Efficacy|0|||
163429385|NCT00818259|590273208|FG006|Part II|Lack of Efficacy|0|||
163429386|NCT00818259|590273209|FG007|Part II|Lack of Efficacy|0|||
163429387|NCT00818259|590273210|FG008|Part II|Lack of Efficacy|0|||
163429388|NCT00818259|590273202|FG000|Part II|Not Treated|0|||
163429389|NCT00818259|590273203|FG001|Part II|Not Treated|0|||
163429390|NCT00818259|590273204|FG002|Part II|Not Treated|0|||
163429391|NCT00818259|590273205|FG003|Part II|Not Treated|1|||
163429392|NCT00818259|590273206|FG004|Part II|Not Treated|0|||
163429393|NCT00818259|590273207|FG005|Part II|Not Treated|0|||
163429394|NCT00818259|590273208|FG006|Part II|Not Treated|0|||
163429395|NCT00818259|590273209|FG007|Part II|Not Treated|0|||
163429396|NCT00818259|590273210|FG008|Part II|Not Treated|0|||
163429397|NCT00818259|590273202|FG000|Part IV|Physician Decision|0|||
163429398|NCT00818259|590273203|FG001|Part IV|Physician Decision|0|||
163429399|NCT00818259|590273204|FG002|Part IV|Physician Decision|0|||
163429400|NCT00818259|590273205|FG003|Part IV|Physician Decision|0|||
163429401|NCT00818259|590273206|FG004|Part IV|Physician Decision|0|||
163429402|NCT00818259|590273207|FG005|Part IV|Physician Decision|1|||
163429403|NCT00818259|590273208|FG006|Part IV|Physician Decision|0|||
163429404|NCT00818259|590273209|FG007|Part IV|Physician Decision|0|||
163429405|NCT00818259|590273210|FG008|Part IV|Physician Decision|0|||
163429406|NCT00818259|590273202|FG000|Part V|Adverse Event|0|||
163429407|NCT00818259|590273203|FG001|Part V|Adverse Event|0|||
163429408|NCT00818259|590273204|FG002|Part V|Adverse Event|0|||
163429409|NCT00818259|590273205|FG003|Part V|Adverse Event|0|||
163429410|NCT00818259|590273206|FG004|Part V|Adverse Event|0|||
163429411|NCT00818259|590273207|FG005|Part V|Adverse Event|0|||
163429412|NCT00818259|590273208|FG006|Part V|Adverse Event|0|||
163429413|NCT00818259|590273209|FG007|Part V|Adverse Event|1|||
163429414|NCT00818259|590273210|FG008|Part V|Adverse Event|0|||
163429415|NCT04640766|590273211|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
163429416|NCT01024244|590274427|FG000|Overall Study|Adverse Event|1|||
163429417|NCT01024244|590274428|FG001|Overall Study|Adverse Event|2|||
163429418|NCT01024244|590274429|FG002|Overall Study|Adverse Event|0|||
163429419|NCT01024244|590274430|FG003|Overall Study|Adverse Event|1|||
163429420|NCT01024244|590274431|FG004|Overall Study|Adverse Event|2|||
163429421|NCT01024244|590274427|FG000|Overall Study|Entry Criteria Not Met|0|||
163429422|NCT01024244|590274428|FG001|Overall Study|Entry Criteria Not Met|1|||
163429423|NCT01024244|590274429|FG002|Overall Study|Entry Criteria Not Met|0|||
163429424|NCT01024244|590274430|FG003|Overall Study|Entry Criteria Not Met|0|||
163429425|NCT01024244|590274431|FG004|Overall Study|Entry Criteria Not Met|0|||
163429426|NCT01024244|590274427|FG000|Overall Study|Lack of Efficacy|1|||
163429427|NCT01024244|590274428|FG001|Overall Study|Lack of Efficacy|0|||
163429428|NCT01024244|590274429|FG002|Overall Study|Lack of Efficacy|0|||
163429429|NCT01024244|590274430|FG003|Overall Study|Lack of Efficacy|0|||
163429430|NCT01024244|590274431|FG004|Overall Study|Lack of Efficacy|0|||
163429431|NCT01024244|590274427|FG000|Overall Study|Protocol Violation|1|||
163429432|NCT01024244|590274428|FG001|Overall Study|Protocol Violation|0|||
163429433|NCT01024244|590274429|FG002|Overall Study|Protocol Violation|0|||
163429434|NCT01024244|590274430|FG003|Overall Study|Protocol Violation|0|||
163429435|NCT01024244|590274431|FG004|Overall Study|Protocol Violation|2|||
163429436|NCT01024244|590274427|FG000|Overall Study|Sponsor Decision|14|||
163429437|NCT01024244|590274428|FG001|Overall Study|Sponsor Decision|7|||
163429438|NCT01024244|590274429|FG002|Overall Study|Sponsor Decision|14|||
163429439|NCT01024244|590274430|FG003|Overall Study|Sponsor Decision|12|||
163429440|NCT01024244|590274431|FG004|Overall Study|Sponsor Decision|10|||
163429441|NCT01024244|590274427|FG000|Overall Study|Withdrawal by Subject|0|||
163429442|NCT01024244|590274428|FG001|Overall Study|Withdrawal by Subject|1|||
163429443|NCT01024244|590274429|FG002|Overall Study|Withdrawal by Subject|0|||
163429444|NCT01024244|590274430|FG003|Overall Study|Withdrawal by Subject|0|||
163429445|NCT01024244|590274431|FG004|Overall Study|Withdrawal by Subject|0|||
163429446|NCT01896232|590274435|FG000|Overall Study|Death|6|||
163429447|NCT01896232|590274436|FG001|Overall Study|Death|10|||
163429448|NCT01896232|590274435|FG000|Overall Study|Withdrawal by Subject|32|||
163429449|NCT01896232|590274436|FG001|Overall Study|Withdrawal by Subject|31|||
163429450|NCT01896232|590274435|FG000|Overall Study|Sponsor Decision|2|||
163429451|NCT01896232|590274436|FG001|Overall Study|Sponsor Decision|0|||
163429452|NCT01896232|590274435|FG000|Overall Study|Lost to Follow-up|9|||
163429453|NCT01896232|590274436|FG001|Overall Study|Lost to Follow-up|12|||
163429454|NCT00686205|590274437|FG000|Overall Study|Protocol Violation|127|||
163429455|NCT00686205|590274438|FG001|Overall Study|Protocol Violation|0|||
163429456|NCT00686205|590274437|FG000|Overall Study|Withdrawal by Subject|2|||
163429457|NCT00686205|590274438|FG001|Overall Study|Withdrawal by Subject|0|||
163429458|NCT00686205|590274437|FG000|Overall Study|Specimen handling procedure altered|5878|||
163429459|NCT00686205|590274438|FG001|Overall Study|Specimen handling procedure altered|0|||
163429460|NCT00686205|590274437|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
163429461|NCT00686205|590274438|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
163429462|NCT00942409|590274439|FG000|Overall Study|Lack of Efficacy|1|||
163429463|NCT00942409|590274439|FG000|Overall Study|study drug unavailable|2|||
163429464|NCT01697215|590274440|FG000|Overall Study|Physician Decision|5|||
163429465|NCT01697215|590274440|FG000|Overall Study|Malfunction|9|||
163429466|NCT01697215|590274440|FG000|Overall Study|CXR not available|9|||
163429467|NCT01929083|590274441|FG000|Intervention 1|Lost to Follow-up|2|||
163429468|NCT01929083|590274442|FG001|Intervention 1|Lost to Follow-up|0|||
163429469|NCT01929083|590274441|FG000|Intervention 1|Nonadherent to study medications|1|||
163429470|NCT01929083|590274442|FG001|Intervention 1|Nonadherent to study medications|0|||
163429471|NCT01929083|590274441|FG000|Intervention 2|Adverse Event|0|||
163429472|NCT01929083|590274442|FG001|Intervention 2|Adverse Event|1|||
163429473|NCT02599402|590274443|FG000|Overall Study|Disease progression|153|||
163429474|NCT02599402|590274443|FG000|Overall Study|Study drug toxicity|201|||
163429475|NCT02599402|590274443|FG000|Overall Study|Death|26|||
163429476|NCT02599402|590274443|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
163429477|NCT02599402|590274443|FG000|Overall Study|Participant request to discontinue study treatment|13|||
163429478|NCT02599402|590274443|FG000|Overall Study|Participant withdrew consent|5|||
163429479|NCT02599402|590274443|FG000|Overall Study|Lost to Follow-up|1|||
163429480|NCT02599402|590274443|FG000|Overall Study|Maximum Clinical Benefit|7|||
163429481|NCT02599402|590274443|FG000|Overall Study|Poor/non-compliance|1|||
163429482|NCT02599402|590274443|FG000|Overall Study|Pregnancy|1|||
163429483|NCT02599402|590274443|FG000|Overall Study|Participant no longer met study criteria|7|||
163429484|NCT02599402|590274443|FG000|Overall Study|Other Reasons|95|||
163429485|NCT02945657|590274444|FG000|Overall Study|Adverse Event|1|||
163429486|NCT02945657|590274444|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
163429487|NCT00087438|590274449|FG000|Overall Study|Ineligible / No protocol treatment|4|||
163429488|NCT00283387|590274450|FG000|First Intervention|Subject non-compliant|1|||
163429489|NCT00283387|590274451|FG001|First Intervention|Subject non-compliant|1|||
163429490|NCT00283387|590274450|FG000|First Intervention|Withdrawal by Subject|0|||
163429491|NCT00283387|590274451|FG001|First Intervention|Withdrawal by Subject|1|||
163429492|NCT05340504|590274452|FG000|Overall Study|Withdrawal by Subject|1|||
163429493|NCT05340504|590274453|FG001|Overall Study|Withdrawal by Subject|0|||
163429494|NCT03068715|590274457|FG000|Overall Study|No longer met inclusion criteria|1|||
163429495|NCT03068715|590274458|FG001|Overall Study|No longer met inclusion criteria|0|||
163429496|NCT00728416|590274459|FG000|Overall Study|Adverse Event|1|||
163429497|NCT00728416|590274460|FG001|Overall Study|Adverse Event|1|||
163429498|NCT00728416|590274459|FG000|Overall Study|Treatment Failure|0|||
163429499|NCT00728416|590274460|FG001|Overall Study|Treatment Failure|1|||
163429500|NCT00728416|590274459|FG000|Overall Study|Withdrawal by Subject|1|||
163429501|NCT00728416|590274460|FG001|Overall Study|Withdrawal by Subject|0|||
163429502|NCT00117312|590274461|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
163429503|NCT00117312|590274462|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
163429504|NCT00117312|590274463|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
163429505|NCT00117312|590274464|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
163429506|NCT00117312|590274461|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
163429507|NCT00117312|590274462|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
163429508|NCT00117312|590274463|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
163429509|NCT00117312|590274464|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
163429510|NCT00117312|590274461|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
163429511|NCT00117312|590274462|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
163429512|NCT00117312|590274463|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
163429513|NCT00117312|590274464|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
163429514|NCT00117312|590274461|FG000|Overall Study|Other|0|||
163429515|NCT00117312|590274462|FG001|Overall Study|Other|1|||
163429516|NCT00117312|590274463|FG002|Overall Study|Other|3|||
163429517|NCT00117312|590274464|FG003|Overall Study|Other|1|||
163429518|NCT00117312|590274461|FG000|Overall Study|Patient choice|0|||
163429519|NCT00117312|590274462|FG001|Overall Study|Patient choice|0|||
163429520|NCT00117312|590274463|FG002|Overall Study|Patient choice|2|||
163429521|NCT00117312|590274464|FG003|Overall Study|Patient choice|1|||
163429522|NCT00117312|590274461|FG000|Overall Study|Adverse Event|0|||
163429523|NCT00117312|590274462|FG001|Overall Study|Adverse Event|2|||
163429524|NCT00117312|590274463|FG002|Overall Study|Adverse Event|0|||
163429525|NCT00117312|590274464|FG003|Overall Study|Adverse Event|0|||
163429526|NCT00117312|590274461|FG000|Overall Study|Protocol Violation|0|||
163429527|NCT00117312|590274462|FG001|Overall Study|Protocol Violation|1|||
163429528|NCT00117312|590274463|FG002|Overall Study|Protocol Violation|3|||
163429529|NCT00117312|590274464|FG003|Overall Study|Protocol Violation|0|||
163429530|NCT00117312|590274461|FG000|Overall Study|PSA decrease <=50%|0|||
163429531|NCT00117312|590274462|FG001|Overall Study|PSA decrease <=50%|2|||
163429532|NCT00117312|590274463|FG002|Overall Study|PSA decrease <=50%|2|||
163429533|NCT00117312|590274464|FG003|Overall Study|PSA decrease <=50%|4|||
163429534|NCT00117312|590274461|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
163429535|NCT00117312|590274462|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
163429536|NCT00117312|590274463|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
163429537|NCT00117312|590274464|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
163429538|NCT00117312|590274461|FG000|Overall Study|Hepatic abnormality|0|||
163429539|NCT00117312|590274462|FG001|Overall Study|Hepatic abnormality|1|||
163429540|NCT00117312|590274463|FG002|Overall Study|Hepatic abnormality|0|||
163429541|NCT00117312|590274464|FG003|Overall Study|Hepatic abnormality|1|||
163429542|NCT00117312|590274461|FG000|Overall Study|Withdrawal by Subject|0|||
163429543|NCT00117312|590274462|FG001|Overall Study|Withdrawal by Subject|2|||
163429544|NCT00117312|590274463|FG002|Overall Study|Withdrawal by Subject|0|||
163429545|NCT00117312|590274464|FG003|Overall Study|Withdrawal by Subject|0|||
163429546|NCT01120626|590274465|FG000|Overall Study|Withdrawal by Subject|1|||
163429547|NCT01120626|590274466|FG001|Overall Study|Withdrawal by Subject|0|||
163429548|NCT00509106|590274468|FG000|Overall Study|Adverse Event|3|||
163429549|NCT00509106|590274469|FG001|Overall Study|Adverse Event|2|||
163429550|NCT00509106|590274468|FG000|Overall Study|Noncompliance|0|||
163429551|NCT00509106|590274469|FG001|Overall Study|Noncompliance|1|||
163429552|NCT00509106|590274468|FG000|Overall Study|At the request of sponsor/investigator|1|||
163429553|NCT00509106|590274469|FG001|Overall Study|At the request of sponsor/investigator|2|||
163429554|NCT00509106|590274468|FG000|Overall Study|Withdrew consent|4|||
163429555|NCT00509106|590274469|FG001|Overall Study|Withdrew consent|8|||
163429556|NCT00509106|590274468|FG000|Overall Study|Lost to Follow-up|16|||
163429557|NCT00509106|590274469|FG001|Overall Study|Lost to Follow-up|10|||
163429558|NCT00509106|590274468|FG000|Overall Study|Other|1|||
163429559|NCT00509106|590274469|FG001|Overall Study|Other|0|||
163429560|NCT00509106|590274468|FG000|Overall Study|Death|6|||
163429561|NCT00509106|590274469|FG001|Overall Study|Death|6|||
163429562|NCT03075839|590274475|FG000|Overall Study|Lost to Follow-up|4|||
163429563|NCT01051739|590274477|FG000|Overall Study|Death|3|||
163429564|NCT01051739|590274478|FG001|Overall Study|Death|3|||
163429565|NCT01051739|590274477|FG000|Overall Study|Withdrawal by Subject|25|||
163429566|NCT01051739|590274478|FG001|Overall Study|Withdrawal by Subject|10|||
163429567|NCT03527043|590274479|FG000|Overall Study|Withdrawal by Subject|1|||
163429568|NCT03527043|590274480|FG001|Overall Study|Withdrawal by Subject|0|||
163429569|NCT05089708|590274481|FG000|Overall Study|Lost to Follow-up|9|||
163429570|NCT05089708|590274482|FG001|Overall Study|Lost to Follow-up|7|||
163429571|NCT05089708|590274481|FG000|Overall Study|Withdrawal by Subject|3|||
163429572|NCT05089708|590274482|FG001|Overall Study|Withdrawal by Subject|1|||
163429573|NCT05089708|590274481|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
163429574|NCT05089708|590274482|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
163429575|NCT05089708|590274481|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
163429576|NCT05089708|590274482|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
163429577|NCT02500550|590274484|FG000|Overall Study|Death|7|||
163429578|NCT00636818|590274485|FG000|Overall Study|Adverse Event|1|||
163429579|NCT00636818|590274485|FG000|Overall Study|Lost to Follow-up|2|||
163429580|NCT00636818|590274485|FG000|Overall Study|Entry Criteria Exclusion|3|||
163429581|NCT00636818|590274485|FG000|Overall Study|Protocol Violation|1|||
163429582|NCT00636818|590274485|FG000|Overall Study|Withdrawal by Subject|4|||
163429583|NCT02201940|590274486|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
163429584|NCT02201940|590274487|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
163429585|NCT02201940|590274486|FG000|Overall Study|Lack of Efficacy|2|||
163429586|NCT02201940|590274487|FG001|Overall Study|Lack of Efficacy|113|||
163429587|NCT02201940|590274486|FG000|Overall Study|Lost to Follow-up|5|||
163429588|NCT02201940|590274487|FG001|Overall Study|Lost to Follow-up|0|||
163429589|NCT02201940|590274486|FG000|Overall Study|Withdrew Consent|2|||
163429590|NCT02201940|590274487|FG001|Overall Study|Withdrew Consent|1|||
163429591|NCT02201940|590274486|FG000|Overall Study|Investigator's Discretion|1|||
163429592|NCT02201940|590274487|FG001|Overall Study|Investigator's Discretion|1|||
163429593|NCT02201940|590274486|FG000|Overall Study|Death|1|||
163429594|NCT02201940|590274487|FG001|Overall Study|Death|0|||
163429595|NCT02201940|590274486|FG000|Overall Study|Adverse Event|0|||
163429596|NCT02201940|590274487|FG001|Overall Study|Adverse Event|1|||
163429597|NCT02604264|590274489|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
163429598|NCT02604264|590274490|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
163429599|NCT01511445|590274497|FG000|Overall Study|Lost to Follow-up|3|||
163429600|NCT01511445|590274498|FG001|Overall Study|Lost to Follow-up|1|||
163429601|NCT01511445|590274497|FG000|Overall Study|Protocol Violation|1|||
163429602|NCT01511445|590274498|FG001|Overall Study|Protocol Violation|3|||
163429603|NCT01511445|590274497|FG000|Overall Study|Protocol Violation|1|||
163429604|NCT01511445|590274498|FG001|Overall Study|Protocol Violation|0|||
163429605|NCT04091217|590274501|FG000|Overall Study|Lost to Follow-up|2|||
163429606|NCT01822561|590274502|FG000|Overall Study|Withdrawal by Subject|2|||
163429607|NCT01624142|590274503|FG000|Overall Study|Withdrawal by Subject|14|||
163429608|NCT01624142|590274504|FG001|Overall Study|Withdrawal by Subject|4|||
163429609|NCT01624142|590274503|FG000|Overall Study|Death|3|||
163429610|NCT01624142|590274504|FG001|Overall Study|Death|6|||
163429611|NCT01624142|590274503|FG000|Overall Study|Study Closure|12|||
163429612|NCT01624142|590274504|FG001|Overall Study|Study Closure|6|||
163429613|NCT01624142|590274503|FG000|Overall Study|Lost to Follow-up|2|||
163429614|NCT01624142|590274504|FG001|Overall Study|Lost to Follow-up|0|||
163429615|NCT01624142|590274503|FG000|Overall Study|Other|1|||
163429616|NCT01624142|590274504|FG001|Overall Study|Other|0|||
163429617|NCT04826900|590274505|FG000|Overall Study|Family factor|1|||
163429618|NCT04826900|590274506|FG001|Overall Study|Family factor|1|||
163429619|NCT02597062|590274508|FG000|Overall Study|Ineligible|1|||
163429620|NCT01053429|590274511|FG000|Overall Study|Adverse Event|64|||
163429621|NCT01053429|590274511|FG000|Overall Study|Other|309|||
163429622|NCT01697345|590274512|FG000|Overall Study|Withdrawal by Subject|1|||
163429623|NCT01976806|590274513|FG000|Overall Study|Lost to Follow-up|1|||
163429624|NCT01976806|590274514|FG001|Overall Study|Lost to Follow-up|4|||
163429625|NCT01976806|590274513|FG000|Overall Study|Adverse Event|1|||
163429626|NCT01976806|590274514|FG001|Overall Study|Adverse Event|1|||
163429627|NCT01976806|590274513|FG000|Overall Study|Withdrawal by Subject|1|||
163429628|NCT01976806|590274514|FG001|Overall Study|Withdrawal by Subject|1|||
163429629|NCT03929250|590274519|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
163429630|NCT03929250|590274520|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
163429631|NCT01523873|590274522|FG000|Overall Study|Protocol Violation|422|||
163429632|NCT00045032|590274527|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
163429633|NCT00045032|590274528|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
163429634|NCT00045032|590274529|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
163429635|NCT00045032|590274527|FG000|Overall Study|Death|22|||
163429636|NCT00045032|590274528|FG001|Overall Study|Death|24|||
163429637|NCT00045032|590274529|FG002|Overall Study|Death|17|||
163429638|NCT00045032|590274527|FG000|Overall Study|Insufficient Therapeutic Response|542|||
163429639|NCT00045032|590274528|FG001|Overall Study|Insufficient Therapeutic Response|437|||
163429640|NCT00045032|590274529|FG002|Overall Study|Insufficient Therapeutic Response|445|||
163429641|NCT00045032|590274527|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
163429642|NCT00045032|590274528|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
163429643|NCT00045032|590274529|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
163429644|NCT00045032|590274527|FG000|Overall Study|Other Protocol Violation|2|||
163429645|NCT00045032|590274528|FG001|Overall Study|Other Protocol Violation|0|||
163429646|NCT00045032|590274529|FG002|Overall Study|Other Protocol Violation|1|||
163429647|NCT00045032|590274527|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
163429648|NCT00045032|590274528|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
163429649|NCT00045032|590274529|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
163429650|NCT00045032|590274527|FG000|Overall Study|Failure to Return|57|||
163429651|NCT00045032|590274528|FG001|Overall Study|Failure to Return|62|||
163429652|NCT00045032|590274529|FG002|Overall Study|Failure to Return|61|||
163429653|NCT00045032|590274527|FG000|Overall Study|Other|93|||
163429654|NCT00045032|590274528|FG001|Overall Study|Other|84|||
163429655|NCT00045032|590274529|FG002|Overall Study|Other|105|||
163429656|NCT02582658|590274530|FG000|Overall Study|Failure to Return|10|||
163429657|NCT02582658|590274530|FG000|Overall Study|Insufficient Virological Response|2|||
163429658|NCT02582658|590274530|FG000|Overall Study|Withdrawn Consent|1|||
163429659|NCT02582658|590274530|FG000|Overall Study|Death|1|||
163429660|NCT02582658|590274530|FG000|Overall Study|Not further specified|11|||
163429661|NCT02581995|590274531|FG000|Overall Study|Unspecified other|3|||
163429662|NCT02581995|590274531|FG000|Overall Study|Adverse Event|6|||
163429663|NCT02581995|590274531|FG000|Overall Study|Lost to Follow-up|5|||
163429664|NCT02581995|590274531|FG000|Overall Study|Withdrawal by participant|12|||
163429665|NCT02581995|590274531|FG000|Overall Study|Physician Decision|1|||
163429666|NCT02581995|590274531|FG000|Overall Study|Death|4|||
163429667|NCT06119191|590274533|FG000|Overall Study|Adverse Event|0|||
163429668|NCT06119191|590274534|FG001|Overall Study|Adverse Event|1|||
163429669|NCT06119191|590274533|FG000|Overall Study|Protocol Violation|1|||
163429670|NCT06119191|590274534|FG001|Overall Study|Protocol Violation|0|||
163429671|NCT03528681|590276575|FG000|Open-Label Phase|Physician Decision|2|||
163429672|NCT03528681|590276576|FG001|Open-Label Phase|Physician Decision|0|||
163429673|NCT03528681|590276577|FG002|Open-Label Phase|Physician Decision|0|||
163429674|NCT03528681|590276578|FG003|Open-Label Phase|Physician Decision|0|||
163429675|NCT03528681|590276575|FG000|Open-Label Phase|Withdrawal by Subject|8|||
163429676|NCT03528681|590276576|FG001|Open-Label Phase|Withdrawal by Subject|0|||
163429677|NCT03528681|590276577|FG002|Open-Label Phase|Withdrawal by Subject|0|||
163429678|NCT03528681|590276578|FG003|Open-Label Phase|Withdrawal by Subject|0|||
163429679|NCT03528681|590276575|FG000|Open-Label Phase|(Not collected)|4|||
163429680|NCT03528681|590276576|FG001|Open-Label Phase|(Not collected)|0|||
163429681|NCT03528681|590276577|FG002|Open-Label Phase|(Not collected)|0|||
163429682|NCT03528681|590276578|FG003|Open-Label Phase|(Not collected)|0|||
163429683|NCT03528681|590276575|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
163429684|NCT03528681|590276576|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
163429685|NCT03528681|590276577|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
163429686|NCT03528681|590276578|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
163429687|NCT03528681|590276575|FG000|Randomized Treatment Phase|Physician Decision|0|||
163429688|NCT03528681|590276576|FG001|Randomized Treatment Phase|Physician Decision|5|||
163429689|NCT03528681|590276577|FG002|Randomized Treatment Phase|Physician Decision|1|||
163429690|NCT03528681|590276578|FG003|Randomized Treatment Phase|Physician Decision|2|||
163429691|NCT03528681|590276575|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
163429692|NCT03528681|590276576|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
163429693|NCT03528681|590276577|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
163429694|NCT03528681|590276578|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
163429695|NCT03528681|590276575|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
163429696|NCT03528681|590276576|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
163429697|NCT03528681|590276577|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
163429698|NCT03528681|590276578|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
163429699|NCT03528681|590276575|FG000|Randomized Treatment Phase|(Not collected)|0|||
163429700|NCT03528681|590276576|FG001|Randomized Treatment Phase|(Not collected)|4|||
163429701|NCT03528681|590276577|FG002|Randomized Treatment Phase|(Not collected)|6|||
163429702|NCT03528681|590276578|FG003|Randomized Treatment Phase|(Not collected)|5|||
163429703|NCT03518840|590276581|FG000|Overall Study|Lost to Follow-up|6|||
163429704|NCT00374556|590276584|FG000|Overall Study|Lost to Follow-up|1|||
163429705|NCT00374556|590276585|FG001|Overall Study|Lost to Follow-up|0|||
163429706|NCT00374556|590276584|FG000|Overall Study|Removed at baseline due to medical cond|0|||
163429707|NCT00374556|590276585|FG001|Overall Study|Removed at baseline due to medical cond|1|||
163429708|NCT00473694|590276586|FG000|Overall Study|Adverse Event|0|||
163429709|NCT00473694|590276587|FG001|Overall Study|Adverse Event|1|||
163429710|NCT00473694|590276588|FG002|Overall Study|Adverse Event|0|||
163429711|NCT00473694|590276589|FG003|Overall Study|Adverse Event|0|||
163429712|NCT00473694|590276586|FG000|Overall Study|Participants did not receive treatment|11|||
163429713|NCT00473694|590276587|FG001|Overall Study|Participants did not receive treatment|3|||
163429714|NCT00473694|590276588|FG002|Overall Study|Participants did not receive treatment|5|||
163429715|NCT00473694|590276589|FG003|Overall Study|Participants did not receive treatment|6|||
163429716|NCT00473694|590276586|FG000|Overall Study|Lost to Follow-up|0|||
163429717|NCT00473694|590276587|FG001|Overall Study|Lost to Follow-up|0|||
163429718|NCT00473694|590276588|FG002|Overall Study|Lost to Follow-up|0|||
163429719|NCT00473694|590276589|FG003|Overall Study|Lost to Follow-up|1|||
163429720|NCT02468193|590276590|FG000|Overall Study|Adverse Event|4|||
163429721|NCT02468193|590276590|FG000|Overall Study|Subject/ Guardian decision|2|||
163429722|NCT03816995|590276593|FG000|Overall Study|Withdrawal by Subject|3|||
163429723|NCT03816995|590276594|FG001|Overall Study|Withdrawal by Subject|1|||
163429724|NCT03816995|590276593|FG000|Overall Study|Cancelled Surgery|8|||
163429725|NCT03816995|590276594|FG001|Overall Study|Cancelled Surgery|12|||
163429726|NCT03816995|590276593|FG000|Overall Study|No wound protector used|11|||
163429727|NCT03816995|590276594|FG001|Overall Study|No wound protector used|17|||
163429728|NCT03816995|590276593|FG000|Overall Study|Protocol Violation|2|||
163429729|NCT03816995|590276594|FG001|Overall Study|Protocol Violation|3|||
163429730|NCT01485614|590276595|FG000|Randomization|Not Treated|1|||
163429731|NCT01485614|590276596|FG001|Randomization|Not Treated|0|||
163429732|NCT01485614|590276597|FG002|Randomization|Not Treated|0|||
163429733|NCT01485614|590276598|FG003|Randomization|Not Treated|0|||
163429734|NCT01485614|590276595|FG000|Weeks 0-20|Lost to Follow-up|2|||
163429735|NCT01485614|590276596|FG001|Weeks 0-20|Lost to Follow-up|0|||
163429736|NCT01485614|590276597|FG002|Weeks 0-20|Lost to Follow-up|0|||
163429737|NCT01485614|590276598|FG003|Weeks 0-20|Lost to Follow-up|0|||
163429738|NCT01485614|590276595|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
163429739|NCT01485614|590276596|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
163429740|NCT01485614|590276597|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
163429741|NCT01485614|590276598|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
163429742|NCT01485614|590276595|FG000|Weeks 0-20|Withdrawal by Subject|3|||
163429743|NCT01485614|590276596|FG001|Weeks 0-20|Withdrawal by Subject|2|||
163429744|NCT01485614|590276597|FG002|Weeks 0-20|Withdrawal by Subject|1|||
163429745|NCT01485614|590276598|FG003|Weeks 0-20|Withdrawal by Subject|0|||
163429746|NCT01485614|590276595|FG000|Weeks 20-54|Lost to Follow-up|4|||
163429747|NCT01485614|590276596|FG001|Weeks 20-54|Lost to Follow-up|3|||
163429748|NCT01485614|590276597|FG002|Weeks 20-54|Lost to Follow-up|1|||
163429749|NCT01485614|590276598|FG003|Weeks 20-54|Lost to Follow-up|0|||
163429750|NCT01485614|590276595|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
163429751|NCT01485614|590276596|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
163429752|NCT01485614|590276597|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
163429753|NCT01485614|590276598|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
163429754|NCT01485614|590276595|FG000|Weeks 20-54|Withdrawal by Subject|5|||
163429755|NCT01485614|590276596|FG001|Weeks 20-54|Withdrawal by Subject|3|||
163429756|NCT01485614|590276597|FG002|Weeks 20-54|Withdrawal by Subject|0|||
163429757|NCT01485614|590276598|FG003|Weeks 20-54|Withdrawal by Subject|0|||
163429758|NCT01503021|590276603|FG000|Overall Study|Adverse Event|7|||
163429759|NCT01503021|590276604|FG001|Overall Study|Adverse Event|6|||
163429760|NCT01503021|590276603|FG000|Overall Study|Death|0|||
163429761|NCT01503021|590276604|FG001|Overall Study|Death|2|||
163429762|NCT01503021|590276603|FG000|Overall Study|Lost to Follow-up|2|||
163429763|NCT01503021|590276604|FG001|Overall Study|Lost to Follow-up|0|||
163429764|NCT01503021|590276603|FG000|Overall Study|Physician Decision|3|||
163429765|NCT01503021|590276604|FG001|Overall Study|Physician Decision|0|||
163429766|NCT01503021|590276603|FG000|Overall Study|Protocol Violation|1|||
163429767|NCT01503021|590276604|FG001|Overall Study|Protocol Violation|3|||
163429768|NCT01503021|590276603|FG000|Overall Study|Withdrawal by Subject|9|||
163429769|NCT01503021|590276604|FG001|Overall Study|Withdrawal by Subject|8|||
163429770|NCT01503021|590276603|FG000|Overall Study|Moved, received transplant, etc.|5|||
163429771|NCT01503021|590276604|FG001|Overall Study|Moved, received transplant, etc.|7|||
163429772|NCT03941548|590276606|FG000|Overall Study|Adverse Event|0|||
163429773|NCT03941548|590276607|FG001|Overall Study|Adverse Event|1|||
163429774|NCT03941548|590276606|FG000|Overall Study|Lost to Follow-up|0|||
163429775|NCT03941548|590276607|FG001|Overall Study|Lost to Follow-up|1|||
163429776|NCT03941548|590276606|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
163429777|NCT03941548|590276607|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
163429778|NCT01242111|590276608|FG000|Overall Study|Adverse Event|1|||
163429779|NCT01242111|590276608|FG000|Overall Study|Withdrawal by Subject|1|||
163429780|NCT01242111|590276608|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
163429781|NCT00870688|590276609|FG000|Overall Study|Lost to Follow-up|2|||
163429782|NCT00870688|590276609|FG000|Overall Study|Death, Unrelated|1|||
163429783|NCT00870688|590276609|FG000|Overall Study|Granules in the Stools|1|||
163429784|NCT02015819|590276610|FG000|Overall Study|Rickham catheter was misaligned|0|||
163429785|NCT02015819|590276611|FG001|Overall Study|Rickham catheter was misaligned|0|||
163429786|NCT02015819|590276612|FG002|Overall Study|Rickham catheter was misaligned|0|||
163429787|NCT02015819|590276613|FG003|Overall Study|Rickham catheter was misaligned|1|||
163429788|NCT01486264|590276620|FG000|Overall Study|Death|1|||
163429789|NCT01486264|590276621|FG001|Overall Study|Death|1|||
163429790|NCT01486264|590276620|FG000|Overall Study|Adverse Event|3|||
163429791|NCT01486264|590276621|FG001|Overall Study|Adverse Event|3|||
163429792|NCT01486264|590276620|FG000|Overall Study|Lack of Efficacy|6|||
163429793|NCT01486264|590276621|FG001|Overall Study|Lack of Efficacy|10|||
163429794|NCT01486264|590276620|FG000|Overall Study|Withdrawal by Subject|7|||
163429795|NCT01486264|590276621|FG001|Overall Study|Withdrawal by Subject|18|||
163429796|NCT01486264|590276620|FG000|Overall Study|Physician Decision|1|||
163429797|NCT01486264|590276621|FG001|Overall Study|Physician Decision|1|||
163429798|NCT01486264|590276620|FG000|Overall Study|Protocol Violation|3|||
163429799|NCT01486264|590276621|FG001|Overall Study|Protocol Violation|0|||
163429800|NCT01486264|590276620|FG000|Overall Study|Lost to Follow-up|3|||
163429801|NCT01486264|590276621|FG001|Overall Study|Lost to Follow-up|2|||
163429802|NCT01486264|590276620|FG000|Overall Study|Other|5|||
163429803|NCT01486264|590276621|FG001|Overall Study|Other|11|||
163429804|NCT01486264|590276620|FG000|Overall Study|Not treated|0|||
163429805|NCT01486264|590276621|FG001|Overall Study|Not treated|1|||
163429806|NCT03584009|590276623|FG000|Overall Study|Death|25|||
163429807|NCT03584009|590276624|FG001|Overall Study|Death|18|||
163429808|NCT03584009|590276623|FG000|Overall Study|Lost to Follow-up|0|||
163429809|NCT03584009|590276624|FG001|Overall Study|Lost to Follow-up|1|||
163429810|NCT03584009|590276623|FG000|Overall Study|Physician Decision|1|||
163429811|NCT03584009|590276624|FG001|Overall Study|Physician Decision|1|||
163429812|NCT03584009|590276623|FG000|Overall Study|Study Terminated by Sponsor|22|||
163429813|NCT03584009|590276624|FG001|Overall Study|Study Terminated by Sponsor|30|||
163429814|NCT03584009|590276623|FG000|Overall Study|Withdrawal by Subject|3|||
163429815|NCT03584009|590276624|FG001|Overall Study|Withdrawal by Subject|2|||
163429816|NCT04112914|590276625|FG000|Overall Study|Lost to Follow-up|13|||
163429817|NCT04112914|590276626|FG001|Overall Study|Lost to Follow-up|9|||
163429818|NCT04112914|590276625|FG000|Overall Study|Withdrawal by Subject|1|||
163429819|NCT04112914|590276626|FG001|Overall Study|Withdrawal by Subject|0|||
163429820|NCT00768560|590276627|FG000|Intervention Set 1|Adverse Event|0|||
163429821|NCT00768560|590276628|FG001|Intervention Set 1|Adverse Event|1|||
163429822|NCT00768560|590276629|FG002|Intervention Set 1|Adverse Event|0|||
163429823|NCT00768560|590276630|FG003|Intervention Set 1|Adverse Event|0|||
163429824|NCT00768560|590276631|FG004|Intervention Set 1|Adverse Event|0|||
163429825|NCT00768560|590276632|FG005|Intervention Set 1|Adverse Event|0|||
163429826|NCT02635204|590276633|FG000|Overall Study|Adverse Event|1|||
163429827|NCT02635204|590276634|FG001|Overall Study|Adverse Event|0|||
163429828|NCT02635204|590276633|FG000|Overall Study|Lost to Follow-up|1|||
163429829|NCT02635204|590276634|FG001|Overall Study|Lost to Follow-up|1|||
163429830|NCT00389207|590276635|FG000|Overall Study|Adverse Event|26|||
163429831|NCT00389207|590276636|FG001|Overall Study|Adverse Event|32|||
163429832|NCT00389207|590276637|FG002|Overall Study|Adverse Event|10|||
163429833|NCT00389207|590276635|FG000|Overall Study|Protocol Violation|3|||
163429834|NCT00389207|590276636|FG001|Overall Study|Protocol Violation|1|||
163429835|NCT00389207|590276637|FG002|Overall Study|Protocol Violation|4|||
163429836|NCT00389207|590276635|FG000|Overall Study|Lost to Follow-up|12|||
163429837|NCT00389207|590276636|FG001|Overall Study|Lost to Follow-up|9|||
163429838|NCT00389207|590276637|FG002|Overall Study|Lost to Follow-up|7|||
163429839|NCT00389207|590276635|FG000|Overall Study|Withdrawal by Subject|5|||
163429840|NCT00389207|590276636|FG001|Overall Study|Withdrawal by Subject|7|||
163429841|NCT00389207|590276637|FG002|Overall Study|Withdrawal by Subject|11|||
163429842|NCT00389207|590276635|FG000|Overall Study|Other|17|||
163429843|NCT00389207|590276636|FG001|Overall Study|Other|23|||
163429844|NCT00389207|590276637|FG002|Overall Study|Other|9|||
163429845|NCT01772134|590276643|FG000|Overall Study|Adverse Event|6|||
163429846|NCT01772134|590276644|FG001|Overall Study|Adverse Event|5|||
163429847|NCT01772134|590276645|FG002|Overall Study|Adverse Event|10|||
163429848|NCT01772134|590276643|FG000|Overall Study|Withdrew Consent|3|||
163429849|NCT01772134|590276644|FG001|Overall Study|Withdrew Consent|1|||
163429850|NCT01772134|590276645|FG002|Overall Study|Withdrew Consent|5|||
163429851|NCT01772134|590276643|FG000|Overall Study|Lost to Follow-up|2|||
163429852|NCT01772134|590276644|FG001|Overall Study|Lost to Follow-up|0|||
163429853|NCT01772134|590276645|FG002|Overall Study|Lost to Follow-up|0|||
163429854|NCT01772134|590276643|FG000|Overall Study|Protocol Deviation|4|||
163429855|NCT01772134|590276644|FG001|Overall Study|Protocol Deviation|3|||
163429856|NCT01772134|590276645|FG002|Overall Study|Protocol Deviation|3|||
163429857|NCT01772134|590276643|FG000|Overall Study|Lack of Efficacy|11|||
163429858|NCT01772134|590276644|FG001|Overall Study|Lack of Efficacy|5|||
163429859|NCT01772134|590276645|FG002|Overall Study|Lack of Efficacy|3|||
163429860|NCT01772134|590276643|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
163429861|NCT01772134|590276644|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
163429862|NCT01772134|590276645|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
163429863|NCT01772134|590276643|FG000|Overall Study|Randomized Study Medication Not Received|2|||
163429864|NCT01772134|590276644|FG001|Overall Study|Randomized Study Medication Not Received|0|||
163429865|NCT01772134|590276645|FG002|Overall Study|Randomized Study Medication Not Received|1|||
163429866|NCT00594399|590276650|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
163429867|NCT00594399|590276651|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
163429868|NCT00594399|590276652|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
163429869|NCT00594399|590276650|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
163429870|NCT00594399|590276651|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
163429871|NCT00594399|590276652|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
163429872|NCT00594399|590276650|FG000|Initial 3 Month Counseling|Personal issues|2|||
163429873|NCT00594399|590276651|FG001|Initial 3 Month Counseling|Personal issues|0|||
163429874|NCT00594399|590276652|FG002|Initial 3 Month Counseling|Personal issues|0|||
163429875|NCT00594399|590276650|FG000|Initial 3 Month Counseling|Too busy|7|||
163429876|NCT00594399|590276651|FG001|Initial 3 Month Counseling|Too busy|1|||
163429877|NCT00594399|590276652|FG002|Initial 3 Month Counseling|Too busy|0|||
163429878|NCT00594399|590276650|FG000|Initial 3 Month Counseling|Pain|2|||
163429879|NCT00594399|590276651|FG001|Initial 3 Month Counseling|Pain|0|||
163429880|NCT00594399|590276652|FG002|Initial 3 Month Counseling|Pain|0|||
163429881|NCT00594399|590276650|FG000|Initial 3 Month Counseling|Moved|1|||
163429882|NCT00594399|590276651|FG001|Initial 3 Month Counseling|Moved|0|||
163429883|NCT00594399|590276652|FG002|Initial 3 Month Counseling|Moved|0|||
163429884|NCT00594399|590276650|FG000|Initial 3 Month Counseling|Family illness|1|||
163429885|NCT00594399|590276651|FG001|Initial 3 Month Counseling|Family illness|0|||
163429886|NCT00594399|590276652|FG002|Initial 3 Month Counseling|Family illness|0|||
163429887|NCT00594399|590276650|FG000|Rerandomization Arm 1 Only|Death|2|||
163429888|NCT00594399|590276651|FG001|Rerandomization Arm 1 Only|Death|1|||
163429889|NCT00594399|590276652|FG002|Rerandomization Arm 1 Only|Death|0|||
163429890|NCT00594399|590276650|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
163429891|NCT00594399|590276651|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
163429892|NCT00594399|590276652|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
163429893|NCT03830281|590276653|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
163429894|NCT03830281|590276654|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
163429895|NCT03830281|590276653|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
163429896|NCT03830281|590276654|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
163429897|NCT03830281|590276653|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
163429898|NCT03830281|590276654|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
163429899|NCT03830281|590276653|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
163429900|NCT03830281|590276654|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
163429901|NCT03830281|590276653|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
163429902|NCT03830281|590276654|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
163429903|NCT03830281|590276653|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
163429904|NCT03830281|590276654|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
163429905|NCT03830281|590276653|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
163429906|NCT03830281|590276654|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
163429907|NCT03830281|590276653|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
163429908|NCT03830281|590276654|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
163429909|NCT03830281|590276653|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
163429910|NCT03830281|590276654|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
163429911|NCT03293680|590276655|FG000|Overall Study|Death|1|||
163429912|NCT03293680|590276655|FG000|Overall Study|Did not meet inclusion criteria|8|||
163429913|NCT00922935|590276656|FG000|Overall Study|Protocol Violation|0|||
163429914|NCT00922935|590276657|FG001|Overall Study|Protocol Violation|3|||
163429915|NCT00922935|590276658|FG002|Overall Study|Protocol Violation|0|||
163429916|NCT00922935|590276656|FG000|Overall Study|Physician Decision|1|||
163429917|NCT00922935|590276657|FG001|Overall Study|Physician Decision|1|||
163429918|NCT00922935|590276658|FG002|Overall Study|Physician Decision|0|||
163429919|NCT00922935|590276656|FG000|Overall Study|Lost to Follow-up|0|||
163429920|NCT00922935|590276657|FG001|Overall Study|Lost to Follow-up|1|||
163429921|NCT00922935|590276658|FG002|Overall Study|Lost to Follow-up|0|||
163429922|NCT01491945|590276659|FG000|Overall Study|Death|30|||
163429923|NCT01491945|590276659|FG000|Overall Study|Withdrwan/LTF|16|||
163429924|NCT01491945|590276659|FG000|Overall Study|Conversion|4|||
163429925|NCT01491945|590276659|FG000|Overall Study|Missed Visit|1|||
163429926|NCT00074958|590276660|FG000|Overall Study|Adverse Event|1|||
163429927|NCT03192904|590276663|FG000|Overall Study|Physician Decision|3|||
163429928|NCT03192904|590276664|FG001|Overall Study|Physician Decision|1|||
163429929|NCT03192904|590276663|FG000|Overall Study|Lost to Follow-up|0|||
163429930|NCT03192904|590276664|FG001|Overall Study|Lost to Follow-up|1|||
163429931|NCT00709202|590276665|FG000|Overall Study|Withdrawal by Subject|6|||
163429932|NCT00709202|590276666|FG001|Overall Study|Withdrawal by Subject|6|||
163429933|NCT03133767|590276667|FG000|Overall Study|Lost to Follow-up|38|||
163429934|NCT03133767|590276668|FG001|Overall Study|Lost to Follow-up|24|||
163429935|NCT03133767|590276667|FG000|Overall Study|Protocol Violation|0|||
163429936|NCT03133767|590276668|FG001|Overall Study|Protocol Violation|1|||
163429937|NCT03301857|590276669|FG000|Overall Study|Death|0|||
163429938|NCT03301857|590276670|FG001|Overall Study|Death|2|||
163429939|NCT03301857|590276669|FG000|Overall Study|Lost to Follow-up|4|||
163429940|NCT03301857|590276670|FG001|Overall Study|Lost to Follow-up|2|||
163429941|NCT03301857|590276669|FG000|Overall Study|Decision by Sponsor|6|||
163429942|NCT03301857|590276670|FG001|Overall Study|Decision by Sponsor|0|||
163429943|NCT03301857|590276669|FG000|Overall Study|Withdrawal by Subject|12|||
163429944|NCT03301857|590276670|FG001|Overall Study|Withdrawal by Subject|4|||
163429945|NCT01856114|590276684|FG000|Overall Study|Withdrawal by Subject|1|||
163429946|NCT01856114|590276685|FG001|Overall Study|Withdrawal by Subject|0|||
163429947|NCT01856114|590276684|FG000|Overall Study|Adverse Event|1|||
163429948|NCT01856114|590276685|FG001|Overall Study|Adverse Event|0|||
163429949|NCT02853760|590276686|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
163429950|NCT02853760|590276687|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
163429951|NCT02853760|590276688|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
163429952|NCT02853760|590276689|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
163429953|NCT02853760|590276690|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
163429954|NCT02853760|590276691|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
163429955|NCT00488631|590276692|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
163429956|NCT00488631|590276693|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
163429957|NCT00488631|590276694|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
163429958|NCT00488631|590276695|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
163429959|NCT00488631|590276696|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
163429960|NCT00488631|590276697|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
163429961|NCT00488631|590276698|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
163429962|NCT00488631|590276699|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
163429963|NCT00488631|590276700|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
163429964|NCT00488631|590276701|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
163429965|NCT00488631|590276692|FG000|Double Blind Period (Week 0-54)|Death|0|||
163429966|NCT00488631|590276693|FG001|Double Blind Period (Week 0-54)|Death|0|||
163429967|NCT00488631|590276694|FG002|Double Blind Period (Week 0-54)|Death|0|||
163429968|NCT00488631|590276695|FG003|Double Blind Period (Week 0-54)|Death|0|||
163429969|NCT00488631|590276696|FG004|Double Blind Period (Week 0-54)|Death|0|||
163429970|NCT00488631|590276697|FG005|Double Blind Period (Week 0-54)|Death|1|||
163429971|NCT00488631|590276698|FG006|Double Blind Period (Week 0-54)|Death|0|||
163429972|NCT00488631|590276699|FG007|Double Blind Period (Week 0-54)|Death|0|||
163429973|NCT00488631|590276700|FG008|Double Blind Period (Week 0-54)|Death|0|||
163429974|NCT00488631|590276701|FG009|Double Blind Period (Week 0-54)|Death|0|||
163429975|NCT00488631|590276692|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
163429976|NCT00488631|590276693|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
163429977|NCT00488631|590276694|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
163429978|NCT00488631|590276695|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
163429979|NCT00488631|590276696|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
163429980|NCT00488631|590276697|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
163429981|NCT00488631|590276698|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
163429982|NCT00488631|590276699|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
163429983|NCT00488631|590276700|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
163429984|NCT00488631|590276701|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
163429985|NCT00488631|590276692|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
163429986|NCT00488631|590276693|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
163429987|NCT00488631|590276694|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
163429988|NCT00488631|590276695|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
163429989|NCT00488631|590276696|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
163429990|NCT00488631|590276697|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
163429991|NCT00488631|590276698|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
163429992|NCT00488631|590276699|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
163429993|NCT00488631|590276700|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
163429994|NCT00488631|590276701|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
163429995|NCT00488631|590276692|FG000|Double Blind Period (Week 0-54)|Other|6|||
163429996|NCT00488631|590276693|FG001|Double Blind Period (Week 0-54)|Other|12|||
163429997|NCT00488631|590276694|FG002|Double Blind Period (Week 0-54)|Other|10|||
163429998|NCT00488631|590276695|FG003|Double Blind Period (Week 0-54)|Other|11|||
163429999|NCT00488631|590276696|FG004|Double Blind Period (Week 0-54)|Other|14|||
163430000|NCT00488631|590276697|FG005|Double Blind Period (Week 0-54)|Other|34|||
163430001|NCT00488631|590276698|FG006|Double Blind Period (Week 0-54)|Other|0|||
163430002|NCT00488631|590276699|FG007|Double Blind Period (Week 0-54)|Other|0|||
163430003|NCT00488631|590276700|FG008|Double Blind Period (Week 0-54)|Other|0|||
163430004|NCT00488631|590276701|FG009|Double Blind Period (Week 0-54)|Other|0|||
163430005|NCT00488631|590276692|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
163430006|NCT00488631|590276693|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
163430007|NCT00488631|590276694|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
163430008|NCT00488631|590276695|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
163430009|NCT00488631|590276696|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
163430010|NCT00488631|590276697|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
163430011|NCT00488631|590276698|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
163430012|NCT00488631|590276699|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
163430013|NCT00488631|590276700|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
163430014|NCT00488631|590276701|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
163430015|NCT00488631|590276692|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
163430016|NCT00488631|590276693|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
163430017|NCT00488631|590276694|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
163430018|NCT00488631|590276695|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
163430019|NCT00488631|590276696|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
163430020|NCT00488631|590276697|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
163430021|NCT00488631|590276698|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
163430022|NCT00488631|590276699|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
163430023|NCT00488631|590276700|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
163430024|NCT00488631|590276701|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
163430025|NCT00488631|590276692|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
163430026|NCT00488631|590276693|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
163430027|NCT00488631|590276694|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
163430028|NCT00488631|590276695|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
163430029|NCT00488631|590276696|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
163430030|NCT00488631|590276697|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
163430031|NCT00488631|590276698|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
163430032|NCT00488631|590276699|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
163430033|NCT00488631|590276700|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
163430034|NCT00488631|590276701|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
163430035|NCT00488631|590276692|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
163430036|NCT00488631|590276693|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
163430037|NCT00488631|590276694|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
163430038|NCT00488631|590276695|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
163430039|NCT00488631|590276696|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
163430040|NCT00488631|590276697|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
163430041|NCT00488631|590276698|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
163430042|NCT00488631|590276699|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
163430043|NCT00488631|590276700|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
163430044|NCT00488631|590276701|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
163430045|NCT00488631|590276692|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
163430046|NCT00488631|590276693|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
163430047|NCT00488631|590276694|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
163430048|NCT00488631|590276695|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
163430049|NCT00488631|590276696|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
163430050|NCT00488631|590276697|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
163430051|NCT00488631|590276698|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
163430052|NCT00488631|590276699|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
163430053|NCT00488631|590276700|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
163430054|NCT00488631|590276701|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
163430055|NCT05300087|590276702|FG000|Overall Study|Withdrawal by Subject|0|||
163430056|NCT05300087|590276703|FG001|Overall Study|Withdrawal by Subject|1|||
163430057|NCT01444300|590276704|FG000|Overall Study|Adverse Event|4|||
163430058|NCT01444300|590276705|FG001|Overall Study|Adverse Event|0|||
163430059|NCT03248128|590276706|FG000|Overall Study|Lost to Follow-up|1|||
163430060|NCT03248128|590276707|FG001|Overall Study|Lost to Follow-up|0|||
163430061|NCT03248128|590276706|FG000|Overall Study|Withdrawal by Subject|16|||
163430062|NCT03248128|590276707|FG001|Overall Study|Withdrawal by Subject|14|||
163430063|NCT03248128|590276706|FG000|Overall Study|Site Closed|4|||
163430064|NCT03248128|590276707|FG001|Overall Study|Site Closed|3|||
163430065|NCT03248128|590276706|FG000|Overall Study|Randomized, but did not receive treatment|1|||
163430066|NCT03248128|590276707|FG001|Overall Study|Randomized, but did not receive treatment|3|||
163430067|NCT03372941|590276710|FG000|Overall Study|Lost to Follow-up|2|||
163430068|NCT03372941|590276711|FG001|Overall Study|Lost to Follow-up|4|||
163430069|NCT00741819|590276712|FG000|Overall Study|Adverse Event|3|||
163430070|NCT00741819|590276712|FG000|Overall Study|Withdrawal by Subject|3|||
163430071|NCT00741819|590276712|FG000|Overall Study|Death|1|||
163430072|NCT00741819|590276712|FG000|Overall Study|Disease progression|1|||
163430073|NCT01126580|590276713|FG000|Overall Study|Adverse Event|14|||
163430074|NCT01126580|590276714|FG001|Overall Study|Adverse Event|8|||
163430075|NCT01126580|590276715|FG002|Overall Study|Adverse Event|12|||
163430076|NCT01126580|590276713|FG000|Overall Study|Withdrawal by Subject|11|||
163430077|NCT01126580|590276714|FG001|Overall Study|Withdrawal by Subject|19|||
163430078|NCT01126580|590276715|FG002|Overall Study|Withdrawal by Subject|14|||
163430079|NCT01126580|590276713|FG000|Overall Study|Sponsor Decision|5|||
163430080|NCT01126580|590276714|FG001|Overall Study|Sponsor Decision|4|||
163430081|NCT01126580|590276715|FG002|Overall Study|Sponsor Decision|7|||
163430082|NCT01126580|590276713|FG000|Overall Study|Physician Decision|1|||
163430083|NCT01126580|590276714|FG001|Overall Study|Physician Decision|1|||
163430084|NCT01126580|590276715|FG002|Overall Study|Physician Decision|2|||
163430085|NCT01126580|590276713|FG000|Overall Study|Entry Criteria Not Met|1|||
163430086|NCT01126580|590276714|FG001|Overall Study|Entry Criteria Not Met|1|||
163430087|NCT01126580|590276715|FG002|Overall Study|Entry Criteria Not Met|2|||
163430088|NCT01126580|590276713|FG000|Overall Study|Lack of Efficacy|2|||
163430089|NCT01126580|590276714|FG001|Overall Study|Lack of Efficacy|3|||
163430090|NCT01126580|590276715|FG002|Overall Study|Lack of Efficacy|4|||
163430091|NCT01126580|590276713|FG000|Overall Study|Protocol Violation|0|||
163430092|NCT01126580|590276714|FG001|Overall Study|Protocol Violation|1|||
163430093|NCT01126580|590276715|FG002|Overall Study|Protocol Violation|2|||
163430094|NCT01126580|590276713|FG000|Overall Study|Lost to Follow-up|15|||
163430095|NCT01126580|590276714|FG001|Overall Study|Lost to Follow-up|13|||
163430096|NCT01126580|590276715|FG002|Overall Study|Lost to Follow-up|9|||
163430097|NCT01126580|590276713|FG000|Overall Study|Treatment Non-compliance|0|||
163430098|NCT01126580|590276714|FG001|Overall Study|Treatment Non-compliance|2|||
163430099|NCT01126580|590276715|FG002|Overall Study|Treatment Non-compliance|3|||
163430100|NCT01731002|590276725|FG000|Overall Study|Adverse Event|0|||
163430101|NCT01731002|590276726|FG001|Overall Study|Adverse Event|2|||
163430102|NCT01731002|590276727|FG002|Overall Study|Adverse Event|2|||
163430103|NCT01731002|590276725|FG000|Overall Study|Non-Compliant|0|||
163430104|NCT01731002|590276726|FG001|Overall Study|Non-Compliant|1|||
163430105|NCT01731002|590276727|FG002|Overall Study|Non-Compliant|0|||
163430106|NCT01731002|590276725|FG000|Overall Study|Lost to Follow-up|1|||
163430107|NCT01731002|590276726|FG001|Overall Study|Lost to Follow-up|0|||
163430108|NCT01731002|590276727|FG002|Overall Study|Lost to Follow-up|0|||
163430109|NCT01731002|590276725|FG000|Overall Study|Test Agent Discontinuation|0|||
163430110|NCT01731002|590276726|FG001|Overall Study|Test Agent Discontinuation|1|||
163430111|NCT01731002|590276727|FG002|Overall Study|Test Agent Discontinuation|0|||
163430112|NCT01731002|590276725|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
163430113|NCT01731002|590276726|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
163430114|NCT01731002|590276727|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
163430115|NCT01731002|590276725|FG000|Overall Study|Elevated IOP|1|||
163430116|NCT01731002|590276726|FG001|Overall Study|Elevated IOP|0|||
163430117|NCT01731002|590276727|FG002|Overall Study|Elevated IOP|0|||
163430118|NCT01731002|590276725|FG000|Overall Study|Inappropriate use of study medications|0|||
163430119|NCT01731002|590276726|FG001|Overall Study|Inappropriate use of study medications|0|||
163430120|NCT01731002|590276727|FG002|Overall Study|Inappropriate use of study medications|1|||
163430121|NCT00686543|590276728|FG000|Overall Study|Adverse Event|9|||
163430122|NCT00686543|590276729|FG001|Overall Study|Adverse Event|1|||
163430123|NCT00686543|590276730|FG002|Overall Study|Adverse Event|3|||
163430124|NCT00686543|590276731|FG003|Overall Study|Adverse Event|2|||
163430125|NCT00686543|590276728|FG000|Overall Study|Withdrawal by Subject|2|||
163430126|NCT00686543|590276729|FG001|Overall Study|Withdrawal by Subject|0|||
163430127|NCT00686543|590276730|FG002|Overall Study|Withdrawal by Subject|0|||
163430128|NCT00686543|590276731|FG003|Overall Study|Withdrawal by Subject|0|||
163430129|NCT00686543|590276728|FG000|Overall Study|Protocol Violation|3|||
163430130|NCT00686543|590276729|FG001|Overall Study|Protocol Violation|0|||
163430131|NCT00686543|590276730|FG002|Overall Study|Protocol Violation|2|||
163430132|NCT00686543|590276731|FG003|Overall Study|Protocol Violation|1|||
163430133|NCT00752986|590276732|FG000|Overall Study|Withdrawal by Subject|2|||
163430134|NCT00752986|590276733|FG001|Overall Study|Withdrawal by Subject|1|||
163430135|NCT00752986|590276734|FG002|Overall Study|Withdrawal by Subject|2|||
163430136|NCT00752986|590276732|FG000|Overall Study|Protocol Violation|3|||
163430137|NCT00752986|590276733|FG001|Overall Study|Protocol Violation|0|||
163430138|NCT00752986|590276734|FG002|Overall Study|Protocol Violation|0|||
163430139|NCT00924703|590276735|FG000|Overall Study|Withdrawal by Subject|11|||
163430140|NCT00924703|590276735|FG000|Overall Study|Physician Decision|5|||
163430141|NCT00924703|590276735|FG000|Overall Study|Lost to Follow-up|3|||
163430142|NCT00924703|590276735|FG000|Overall Study|Adverse Event|2|||
163430143|NCT00924703|590276735|FG000|Overall Study|Withdrawal by Sponsor|1|||
163430144|NCT02382133|590276738|FG000|Overall Study|Death|22|||
163430145|NCT02382133|590276738|FG000|Overall Study|transfer out of ICU|4|||
163430146|NCT02382133|590276738|FG000|Overall Study|Physician Decision|2|||
163430147|NCT02382133|590276738|FG000|Overall Study|arterial catheter loss|4|||
163430148|NCT02382133|590276738|FG000|Overall Study|pressure injury both sites|1|||
163430149|NCT04906707|590276739|FG000|Overall Study|Withdrawal by Subject|2|||
163430150|NCT04906707|590276740|FG001|Overall Study|Withdrawal by Subject|0|||
163430151|NCT04906707|590276739|FG000|Overall Study|Withdrawal due to PI decision|1|||
163430152|NCT04906707|590276740|FG001|Overall Study|Withdrawal due to PI decision|0|||
163430153|NCT04906707|590276739|FG000|Overall Study|Lost to Follow-up|0|||
163430154|NCT04906707|590276740|FG001|Overall Study|Lost to Follow-up|1|||
163430155|NCT04429022|590276746|FG000|Overall Study|Protocol Violation|18|||
163430156|NCT04429022|590276747|FG001|Overall Study|Protocol Violation|1|||
163430157|NCT04321343|590276748|FG000|Overall Study|Adverse Event|0|||
163430158|NCT04321343|590276749|FG001|Overall Study|Adverse Event|0|||
163430159|NCT04321343|590276750|FG002|Overall Study|Adverse Event|1|||
163430160|NCT04321343|590276751|FG003|Overall Study|Adverse Event|0|||
163430161|NCT04321343|590276748|FG000|Overall Study|Death|0|||
163430162|NCT04321343|590276749|FG001|Overall Study|Death|0|||
163430163|NCT04321343|590276750|FG002|Overall Study|Death|0|||
163430164|NCT04321343|590276751|FG003|Overall Study|Death|1|||
163430165|NCT04321343|590276748|FG000|Overall Study|Pregnancy|1|||
163430166|NCT04321343|590276749|FG001|Overall Study|Pregnancy|0|||
163430167|NCT04321343|590276750|FG002|Overall Study|Pregnancy|0|||
163430168|NCT04321343|590276751|FG003|Overall Study|Pregnancy|0|||
163430169|NCT04321343|590276748|FG000|Overall Study|Protocol Violation|1|||
163430170|NCT04321343|590276749|FG001|Overall Study|Protocol Violation|1|||
163430171|NCT04321343|590276750|FG002|Overall Study|Protocol Violation|1|||
163430172|NCT04321343|590276751|FG003|Overall Study|Protocol Violation|1|||
163430173|NCT04321343|590276748|FG000|Overall Study|Withdrawal by Subject|0|||
163430174|NCT04321343|590276749|FG001|Overall Study|Withdrawal by Subject|6|||
163430175|NCT04321343|590276750|FG002|Overall Study|Withdrawal by Subject|0|||
163430176|NCT04321343|590276751|FG003|Overall Study|Withdrawal by Subject|2|||
163430177|NCT04321343|590276748|FG000|Overall Study|Lost to Follow-up|2|||
163430178|NCT04321343|590276749|FG001|Overall Study|Lost to Follow-up|2|||
163430179|NCT04321343|590276750|FG002|Overall Study|Lost to Follow-up|1|||
163430180|NCT04321343|590276751|FG003|Overall Study|Lost to Follow-up|3|||
163430181|NCT03430310|590276752|FG000|Overall Study|Protocol Violation|2|||
163430182|NCT03430310|590276753|FG001|Overall Study|Protocol Violation|0|||
163430183|NCT03430310|590276752|FG000|Overall Study|Withdrawal by Subject|3|||
163430184|NCT03430310|590276753|FG001|Overall Study|Withdrawal by Subject|2|||
163430185|NCT03430310|590276752|FG000|Overall Study|COVID shutdown March 2020|0|||
163430186|NCT03430310|590276753|FG001|Overall Study|COVID shutdown March 2020|1|||
163430199|NCT02770807|590276756|FG000|Overall Study|Adverse Event|3|||
163430200|NCT02770807|590276757|FG001|Overall Study|Adverse Event|3|||
163430201|NCT02770807|590276758|FG002|Overall Study|Adverse Event|1|||
163430202|NCT02770807|590276756|FG000|Overall Study|Withdrawal by Subject|7|||
163430203|NCT02770807|590276757|FG001|Overall Study|Withdrawal by Subject|3|||
163430204|NCT02770807|590276758|FG002|Overall Study|Withdrawal by Subject|4|||
163430205|NCT02770807|590276756|FG000|Overall Study|Other|0|||
163430206|NCT02770807|590276757|FG001|Overall Study|Other|1|||
163430207|NCT02770807|590276758|FG002|Overall Study|Other|0|||
163430208|NCT02770807|590276756|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
163430209|NCT02770807|590276757|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
163430210|NCT02770807|590276758|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
163430211|NCT02770807|590276756|FG000|Overall Study|Physician Decision|0|||
163430212|NCT02770807|590276757|FG001|Overall Study|Physician Decision|0|||
163430213|NCT02770807|590276758|FG002|Overall Study|Physician Decision|1|||
163430214|NCT01084252|590278562|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
163430215|NCT01084252|590278563|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
163430216|NCT01084252|590278564|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
163430217|NCT01084252|590278565|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
163430218|NCT01084252|590278566|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
163430219|NCT01084252|590278567|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
163430220|NCT01084252|590278568|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
163430221|NCT01084252|590278569|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
163430222|NCT01084252|590278570|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
163430223|NCT01084252|590278571|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
163430224|NCT01084252|590278572|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
163430225|NCT01084252|590278573|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
163430226|NCT01084252|590278574|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
163430227|NCT01084252|590278575|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
163430228|NCT04909463|590278576|FG000|Overall Study|Withdrawal by Subject|0|||
163430229|NCT04909463|590278577|FG001|Overall Study|Withdrawal by Subject|1|||
163430230|NCT04909463|590278578|FG002|Overall Study|Withdrawal by Subject|0|||
163430231|NCT04909463|590278579|FG003|Overall Study|Withdrawal by Subject|0|||
163430232|NCT04909463|590278576|FG000|Overall Study|Lost to Follow-up|2|||
163430233|NCT04909463|590278577|FG001|Overall Study|Lost to Follow-up|1|||
163430234|NCT04909463|590278578|FG002|Overall Study|Lost to Follow-up|1|||
163430235|NCT04909463|590278579|FG003|Overall Study|Lost to Follow-up|0|||
163430236|NCT00853632|590278580|FG000|Overall Study|Death|88|||
163430237|NCT00853632|590278580|FG000|Overall Study|Withdrawal by Subject|45|||
163430238|NCT00853632|590278580|FG000|Overall Study|Lost to Follow-up|30|||
163430239|NCT00853632|590278580|FG000|Overall Study|Reoperation/Explant|17|||
163430240|NCT00853632|590278580|FG000|Overall Study|Exit with other reason|22|||
163430241|NCT04364854|590278581|FG000|Overall Study|Withdrawal by Subject|1|||
163430242|NCT04364854|590278582|FG001|Overall Study|Withdrawal by Subject|0|||
163430243|NCT04364854|590278583|FG002|Overall Study|Withdrawal by Subject|1|||
163430244|NCT04364854|590278584|FG003|Overall Study|Withdrawal by Subject|3|||
163430245|NCT04364854|590278581|FG000|Overall Study|Death|1|||
163430246|NCT04364854|590278582|FG001|Overall Study|Death|0|||
163430247|NCT04364854|590278583|FG002|Overall Study|Death|0|||
163430248|NCT04364854|590278584|FG003|Overall Study|Death|0|||
163430249|NCT04364854|590278581|FG000|Overall Study|Lost to Follow-up|0|||
163430250|NCT04364854|590278582|FG001|Overall Study|Lost to Follow-up|0|||
163430251|NCT04364854|590278583|FG002|Overall Study|Lost to Follow-up|0|||
163430252|NCT04364854|590278584|FG003|Overall Study|Lost to Follow-up|1|||
163430253|NCT04493619|590278586|FG000|Overall Study|Death|4|||
163430254|NCT04493619|590278587|FG001|Overall Study|Death|3|||
163430255|NCT04493619|590278588|FG002|Overall Study|Death|3|||
163430256|NCT04493619|590278589|FG003|Overall Study|Death|4|||
163430257|NCT04493619|590278586|FG000|Overall Study|Study discontinued early|10|||
163430258|NCT04493619|590278587|FG001|Overall Study|Study discontinued early|0|||
163430259|NCT04493619|590278588|FG002|Overall Study|Study discontinued early|4|||
163430260|NCT04493619|590278589|FG003|Overall Study|Study discontinued early|8|||
163430261|NCT04493619|590278586|FG000|Overall Study|Lost to Follow-up|0|||
163430262|NCT04493619|590278587|FG001|Overall Study|Lost to Follow-up|0|||
163430263|NCT04493619|590278588|FG002|Overall Study|Lost to Follow-up|0|||
163430264|NCT04493619|590278589|FG003|Overall Study|Lost to Follow-up|1|||
163430265|NCT01614457|590278599|FG000|Overall Study|Non-Compliance|1|||
163430266|NCT01614457|590278600|FG001|Overall Study|Non-Compliance|0|||
163430267|NCT01614457|590278599|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
163430268|NCT01614457|590278600|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
163430269|NCT02342171|590278601|FG000|Overall Study|Death|4|||
163430270|NCT02342171|590278602|FG001|Overall Study|Death|87|||
163430271|NCT02342171|590278601|FG000|Overall Study|Received favipiravir|10|||
163430272|NCT02342171|590278602|FG001|Overall Study|Received favipiravir|0|||
163430273|NCT02342171|590278601|FG000|Overall Study|Missing cycle treshold value|1|||
163430274|NCT02342171|590278602|FG001|Overall Study|Missing cycle treshold value|0|||
163430275|NCT02342171|590278601|FG000|Overall Study|Unknown outcome|0|||
163430276|NCT02342171|590278602|FG001|Overall Study|Unknown outcome|1|||
163430277|NCT02342171|590278601|FG000|Overall Study|Missing age data|0|||
163430278|NCT02342171|590278602|FG001|Overall Study|Missing age data|1|||
163430279|NCT00875420|590278607|FG000|Overall Study|Adverse Event|0|||
163430280|NCT00875420|590278608|FG001|Overall Study|Adverse Event|1|||
163430281|NCT00875420|590278609|FG002|Overall Study|Adverse Event|1|||
163430282|NCT00875420|590278610|FG003|Overall Study|Adverse Event|0|||
163430283|NCT00875420|590278611|FG004|Overall Study|Adverse Event|0|||
163430284|NCT00875420|590278607|FG000|Overall Study|Inability to complete study procedures|1|||
163430285|NCT00875420|590278608|FG001|Overall Study|Inability to complete study procedures|0|||
163430286|NCT00875420|590278609|FG002|Overall Study|Inability to complete study procedures|1|||
163430287|NCT00875420|590278610|FG003|Overall Study|Inability to complete study procedures|1|||
163430288|NCT00875420|590278611|FG004|Overall Study|Inability to complete study procedures|1|||
163430289|NCT00875420|590278607|FG000|Overall Study|Lost to Follow-up|1|||
163430290|NCT00875420|590278608|FG001|Overall Study|Lost to Follow-up|0|||
163430291|NCT00875420|590278609|FG002|Overall Study|Lost to Follow-up|0|||
163430292|NCT00875420|590278610|FG003|Overall Study|Lost to Follow-up|0|||
163430293|NCT00875420|590278611|FG004|Overall Study|Lost to Follow-up|0|||
163430294|NCT00875420|590278607|FG000|Overall Study|Personal reason|0|||
163430295|NCT00875420|590278608|FG001|Overall Study|Personal reason|0|||
163430296|NCT00875420|590278609|FG002|Overall Study|Personal reason|0|||
163430297|NCT00875420|590278610|FG003|Overall Study|Personal reason|0|||
163430298|NCT00875420|590278611|FG004|Overall Study|Personal reason|1|||
163430299|NCT00875420|590278607|FG000|Overall Study|Prohibited medication|0|||
163430300|NCT00875420|590278608|FG001|Overall Study|Prohibited medication|0|||
163430301|NCT00875420|590278609|FG002|Overall Study|Prohibited medication|0|||
163430302|NCT00875420|590278610|FG003|Overall Study|Prohibited medication|1|||
163430303|NCT00875420|590278611|FG004|Overall Study|Prohibited medication|0|||
163430304|NCT00875420|590278607|FG000|Overall Study|Sponsor decision|0|||
163430305|NCT00875420|590278608|FG001|Overall Study|Sponsor decision|1|||
163430306|NCT00875420|590278609|FG002|Overall Study|Sponsor decision|0|||
163430307|NCT00875420|590278610|FG003|Overall Study|Sponsor decision|0|||
163430308|NCT00875420|590278611|FG004|Overall Study|Sponsor decision|0|||
163430309|NCT00875420|590278607|FG000|Overall Study|Withdrawal by Subject|0|||
163430310|NCT00875420|590278608|FG001|Overall Study|Withdrawal by Subject|0|||
163430311|NCT00875420|590278609|FG002|Overall Study|Withdrawal by Subject|1|||
163430312|NCT00875420|590278610|FG003|Overall Study|Withdrawal by Subject|0|||
163430313|NCT00875420|590278611|FG004|Overall Study|Withdrawal by Subject|0|||
163430314|NCT00914628|590278612|FG000|Overall Study|Death|35|||
163430315|NCT00914628|590278613|FG001|Overall Study|Death|17|||
163430316|NCT00914628|590278612|FG000|Overall Study|Medical decision|4|||
163430317|NCT00914628|590278613|FG001|Overall Study|Medical decision|0|||
163430318|NCT00914628|590278612|FG000|Overall Study|Protocol Violation|1|||
163430319|NCT00914628|590278613|FG001|Overall Study|Protocol Violation|0|||
163430320|NCT00914628|590278612|FG000|Overall Study|Lack of Efficacy|1|||
163430321|NCT00914628|590278613|FG001|Overall Study|Lack of Efficacy|0|||
163430322|NCT00914628|590278612|FG000|Overall Study|non-randomized|1|||
163430323|NCT00914628|590278613|FG001|Overall Study|non-randomized|0|||
163430324|NCT00914628|590278612|FG000|Overall Study|Relapse|1|||
163430325|NCT00914628|590278613|FG001|Overall Study|Relapse|2|||
163430326|NCT00914628|590278612|FG000|Overall Study|Study terminated by Sponsor|14|||
163430327|NCT00914628|590278613|FG001|Overall Study|Study terminated by Sponsor|8|||
163430328|NCT00914628|590278612|FG000|Overall Study|Patients who did not receive a single dose|7|||
163430329|NCT00914628|590278613|FG001|Overall Study|Patients who did not receive a single dose|1|||
163430330|NCT00742781|590278614|FG000|Overall Study|Withdrawal by Subject|3|||
163430331|NCT01416181|590278615|FG000|Part 1|Other|10|||
163430332|NCT01416181|590278616|FG001|Part 1|Other|24|||
163430333|NCT01416181|590278615|FG000|Part 1|Death|0|||
163430334|NCT01416181|590278616|FG001|Part 1|Death|1|||
163430335|NCT01416181|590278615|FG000|Part 1|Investigator Decision|7|||
163430336|NCT01416181|590278616|FG001|Part 1|Investigator Decision|6|||
163430337|NCT01416181|590278615|FG000|Part 1|Withdrawal by Subject|74|||
163430338|NCT01416181|590278616|FG001|Part 1|Withdrawal by Subject|48|||
163430339|NCT01416181|590278615|FG000|Part 1|Lack of Efficacy|16|||
163430340|NCT01416181|590278616|FG001|Part 1|Lack of Efficacy|8|||
163430341|NCT01416181|590278615|FG000|Part 1|Lost to Follow-up|1|||
163430342|NCT01416181|590278616|FG001|Part 1|Lost to Follow-up|1|||
163430343|NCT01416181|590278615|FG000|Part 1|Adverse Event|15|||
163430344|NCT01416181|590278616|FG001|Part 1|Adverse Event|18|||
163430345|NCT01416181|590278615|FG000|Part 1|Ongoing in Follow-Up|14|||
163430346|NCT01416181|590278616|FG001|Part 1|Ongoing in Follow-Up|8|||
163430347|NCT01416181|590278615|FG000|Part 2|Adverse Event|11|||
163430348|NCT01416181|590278616|FG001|Part 2|Adverse Event|4|||
163430349|NCT01416181|590278615|FG000|Part 2|Other|234|||
163430350|NCT01416181|590278616|FG001|Part 2|Other|267|||
163430351|NCT01416181|590278615|FG000|Part 2|Investigator Decision|6|||
163430352|NCT01416181|590278616|FG001|Part 2|Investigator Decision|7|||
163430353|NCT01416181|590278615|FG000|Part 2|Withdrawal by Subject|14|||
163430354|NCT01416181|590278616|FG001|Part 2|Withdrawal by Subject|5|||
163430355|NCT01416181|590278615|FG000|Part 2|Lack of Efficacy|4|||
163430356|NCT01416181|590278616|FG001|Part 2|Lack of Efficacy|1|||
163430357|NCT01416181|590278615|FG000|Part 2|Lost to Follow-up|2|||
163430358|NCT01416181|590278616|FG001|Part 2|Lost to Follow-up|2|||
163430359|NCT01756157|590278617|FG000|First Intervention Period|Withdrawal by Subject|1|||
163430360|NCT01756157|590278618|FG001|First Intervention Period|Withdrawal by Subject|0|||
163430361|NCT01756157|590278617|FG000|First Intervention Period|Lost to Follow-up|0|||
163430362|NCT01756157|590278618|FG001|First Intervention Period|Lost to Follow-up|2|||
163430363|NCT02799381|590278621|FG000|Overall Study|Withdrew consent|3|||
163430364|NCT02799381|590278622|FG001|Overall Study|Withdrew consent|2|||
163430365|NCT02799381|590278621|FG000|Overall Study|Adverse Event|0|||
163430366|NCT02799381|590278622|FG001|Overall Study|Adverse Event|1|||
163430367|NCT02799381|590278621|FG000|Overall Study|Participant did not take any study drug|1|||
163430368|NCT02799381|590278622|FG001|Overall Study|Participant did not take any study drug|0|||
163430369|NCT02698410|590278625|FG000|Overall Study|Adverse Event|2|||
163430370|NCT02698410|590278625|FG000|Overall Study|Withdrawal by Subject|1|||
163430371|NCT02698410|590278625|FG000|Overall Study|Other|1|||
163430372|NCT03952130|590278626|FG000|Overall Study|Adverse Event|0|||
163430373|NCT03952130|590278627|FG001|Overall Study|Adverse Event|1|||
163430374|NCT03952130|590278626|FG000|Overall Study|Lost to Follow-up|1|||
163430375|NCT03952130|590278627|FG001|Overall Study|Lost to Follow-up|0|||
163430376|NCT03952130|590278626|FG000|Overall Study|Withdrawal by Subject|1|||
163430377|NCT03952130|590278627|FG001|Overall Study|Withdrawal by Subject|5|||
163430378|NCT01713348|590278628|FG000|Overall Study|Withdrawal by Subject|3|||
163430379|NCT01713348|590278629|FG001|Overall Study|Withdrawal by Subject|2|||
163430380|NCT01713348|590278630|FG002|Overall Study|Withdrawal by Subject|2|||
163430381|NCT01713348|590278631|FG003|Overall Study|Withdrawal by Subject|0|||
163430382|NCT01713348|590278628|FG000|Overall Study|Lost to Follow-up|1|||
163430383|NCT01713348|590278629|FG001|Overall Study|Lost to Follow-up|0|||
163430384|NCT01713348|590278630|FG002|Overall Study|Lost to Follow-up|0|||
163430385|NCT01713348|590278631|FG003|Overall Study|Lost to Follow-up|0|||
163430386|NCT02638012|590278632|FG000|Overall Study|Lost to Follow-up|1|||
163430387|NCT00621023|590278633|FG000|Overall Study|Death|5|||
163430388|NCT00621023|590278633|FG000|Overall Study|Follow up discontinued|1|||
163430389|NCT03199911|590278640|FG000|Overall Study|Lost to Follow-up|5|||
163430390|NCT03199911|590278641|FG001|Overall Study|Lost to Follow-up|5|||
163430391|NCT03199911|590278640|FG000|Overall Study|Did not proceed with surgery|2|||
163430392|NCT03199911|590278641|FG001|Overall Study|Did not proceed with surgery|1|||
163430393|NCT00486902|590278642|FG000|Overall Study|Withdrawal by Subject|1|||
163430394|NCT00486902|590278643|FG001|Overall Study|Withdrawal by Subject|2|||
163430395|NCT00486902|590278642|FG000|Overall Study|decision for postpartum tubal ligation|3|||
163430396|NCT00486902|590278643|FG001|Overall Study|decision for postpartum tubal ligation|1|||
163430397|NCT00486902|590278642|FG000|Overall Study|spinal anesthetic protocal violation|1|||
163430398|NCT00486902|590278643|FG001|Overall Study|spinal anesthetic protocal violation|1|||
163430399|NCT00486902|590278642|FG000|Overall Study|Did not meet inclusion criteria|1|||
163430400|NCT00486902|590278643|FG001|Overall Study|Did not meet inclusion criteria|0|||
163430401|NCT00486902|590278642|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
163430402|NCT00486902|590278643|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
163430403|NCT00541307|590278644|FG000|Overall Study|Death|5|||
163430404|NCT00541307|590278644|FG000|Overall Study|Physician Decision|3|||
163430405|NCT00541307|590278644|FG000|Overall Study|Withdrawal by Subject|6|||
163430406|NCT00541307|590278644|FG000|Overall Study|Lost to Follow-up|4|||
163430407|NCT00541307|590278644|FG000|Overall Study|Subject returned early (outside window)|1|||
163430408|NCT00541307|590278644|FG000|Overall Study|Surgical Bypass|5|||
163430409|NCT04331899|590278645|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
163430410|NCT04331899|590278646|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
163430411|NCT01062399|590278649|FG000|Overall Study|Protocol Violation|0|||
163430412|NCT01062399|590278650|FG001|Overall Study|Protocol Violation|1|||
163430413|NCT01062399|590278651|FG002|Overall Study|Protocol Violation|0|||
163430414|NCT01062399|590278652|FG003|Overall Study|Protocol Violation|6|||
163430415|NCT01062399|590278653|FG004|Overall Study|Protocol Violation|4|||
163430416|NCT02424539|590278654|FG000|Overall Study|Adverse Event|0|||
163430417|NCT02424539|590278655|FG001|Overall Study|Adverse Event|0|||
163430418|NCT02424539|590278656|FG002|Overall Study|Adverse Event|1|||
163430419|NCT02424539|590278654|FG000|Overall Study|Physician Decision|0|||
163430420|NCT02424539|590278655|FG001|Overall Study|Physician Decision|0|||
163430421|NCT02424539|590278656|FG002|Overall Study|Physician Decision|1|||
163430422|NCT02424539|590278654|FG000|Overall Study|Withdrawal by Subject|3|||
163430423|NCT02424539|590278655|FG001|Overall Study|Withdrawal by Subject|1|||
163430424|NCT02424539|590278656|FG002|Overall Study|Withdrawal by Subject|0|||
163430425|NCT02424539|590278654|FG000|Overall Study|Other: Reached stopping criteria|11|||
163430426|NCT02424539|590278655|FG001|Overall Study|Other: Reached stopping criteria|7|||
163430427|NCT02424539|590278656|FG002|Overall Study|Other: Reached stopping criteria|6|||
163430428|NCT04178590|590278657|FG000|Overall Study|Pregnancy|1|||
163430429|NCT04178590|590278657|FG000|Overall Study|Lost to Follow-up|1|||
163430430|NCT04723537|590278658|FG000|Overall Study|Withdrawal by Subject|3|||
163430431|NCT04723537|590278659|FG001|Overall Study|Withdrawal by Subject|0|||
163430432|NCT04723537|590278660|FG002|Overall Study|Withdrawal by Subject|0|||
163430433|NCT04723537|590278658|FG000|Overall Study|Physician Decision|0|||
163430434|NCT04723537|590278659|FG001|Overall Study|Physician Decision|0|||
163430435|NCT04723537|590278660|FG002|Overall Study|Physician Decision|1|||
163430436|NCT04723537|590278658|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
163430437|NCT04723537|590278659|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
163430438|NCT04723537|590278660|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
163430439|NCT01845025|590278661|FG000|Overall Study|Adverse Event|6|||
163430440|NCT01845025|590278662|FG001|Overall Study|Adverse Event|3|||
163430441|NCT01845025|590278661|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
163430442|NCT01845025|590278662|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163430443|NCT01845025|590278661|FG000|Overall Study|Withdrawal by Subject|48|||
163430444|NCT01845025|590278662|FG001|Overall Study|Withdrawal by Subject|44|||
163430445|NCT01845025|590278661|FG000|Overall Study|Lost to Follow-up|13|||
163430446|NCT01845025|590278662|FG001|Overall Study|Lost to Follow-up|13|||
163430447|NCT01845025|590278661|FG000|Overall Study|Administrative problems|8|||
163430448|NCT01845025|590278662|FG001|Overall Study|Administrative problems|8|||
163430449|NCT01845025|590278661|FG000|Overall Study|Death|2|||
163430450|NCT01845025|590278662|FG001|Overall Study|Death|0|||
163430451|NCT01845025|590278661|FG000|Overall Study|Protocol deviation|3|||
163430452|NCT01845025|590278662|FG001|Overall Study|Protocol deviation|6|||
163430453|NCT01845025|590278661|FG000|Overall Study|Missing|1|||
163430454|NCT01845025|590278662|FG001|Overall Study|Missing|1|||
163430455|NCT00733902|590278669|FG000|Overall Study|Death|0|||
163430456|NCT00733902|590278670|FG001|Overall Study|Death|0|||
163430457|NCT00733902|590278671|FG002|Overall Study|Death|0|||
163430458|NCT00733902|590278672|FG003|Overall Study|Death|1|||
163430459|NCT00733902|590278669|FG000|Overall Study|Adverse Event|3|||
163430460|NCT00733902|590278670|FG001|Overall Study|Adverse Event|4|||
163430461|NCT00733902|590278671|FG002|Overall Study|Adverse Event|7|||
163430462|NCT00733902|590278672|FG003|Overall Study|Adverse Event|11|||
163430463|NCT00733902|590278669|FG000|Overall Study|Lack of Efficacy|56|||
163430464|NCT00733902|590278670|FG001|Overall Study|Lack of Efficacy|21|||
163430465|NCT00733902|590278671|FG002|Overall Study|Lack of Efficacy|34|||
163430466|NCT00733902|590278672|FG003|Overall Study|Lack of Efficacy|23|||
163430467|NCT00733902|590278669|FG000|Overall Study|Protocol Violation|4|||
163430468|NCT00733902|590278670|FG001|Overall Study|Protocol Violation|6|||
163430469|NCT00733902|590278671|FG002|Overall Study|Protocol Violation|3|||
163430470|NCT00733902|590278672|FG003|Overall Study|Protocol Violation|3|||
163430471|NCT00733902|590278669|FG000|Overall Study|Withdrawal by Subject|10|||
163430472|NCT00733902|590278670|FG001|Overall Study|Withdrawal by Subject|5|||
163430473|NCT00733902|590278671|FG002|Overall Study|Withdrawal by Subject|4|||
163430474|NCT00733902|590278672|FG003|Overall Study|Withdrawal by Subject|16|||
163430475|NCT00733902|590278669|FG000|Overall Study|Entered extension study|89|||
163430476|NCT00733902|590278670|FG001|Overall Study|Entered extension study|124|||
163430477|NCT00733902|590278671|FG002|Overall Study|Entered extension study|111|||
163430478|NCT00733902|590278672|FG003|Overall Study|Entered extension study|109|||
163430479|NCT00733902|590278669|FG000|Overall Study|Randomized but not treated|2|||
163430480|NCT00733902|590278670|FG001|Overall Study|Randomized but not treated|2|||
163430481|NCT00733902|590278671|FG002|Overall Study|Randomized but not treated|2|||
163430482|NCT00733902|590278672|FG003|Overall Study|Randomized but not treated|1|||
163430483|NCT00813748|590278673|FG000|Skin Test Substudy|Physician Decision|0|||
163430484|NCT00813748|590278674|FG001|Skin Test Substudy|Physician Decision|1|||
163430485|NCT01829048|590278675|FG000|Overall Study|Withdrawal by Subject|0|||
163430486|NCT01829048|590278676|FG001|Overall Study|Withdrawal by Subject|0|||
163430487|NCT01829048|590278677|FG002|Overall Study|Withdrawal by Subject|0|||
163430488|NCT01829048|590278678|FG003|Overall Study|Withdrawal by Subject|2|||
163430489|NCT01829048|590278679|FG004|Overall Study|Withdrawal by Subject|0|||
163430490|NCT00504257|590278680|FG000|Overall Study|Withdrawal by Subject|2|||
163430491|NCT00504257|590278680|FG000|Overall Study|ineligible histology|2|||
163430492|NCT00500071|590278690|FG000|Screening and Washout Phase|Protocol Violation|1|||
163430493|NCT00500071|590278690|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
163430494|NCT00500071|590278690|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
163430495|NCT00500071|590278690|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
163430496|NCT00500071|590278690|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
163430497|NCT00500071|590278690|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
163430498|NCT00500071|590278690|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
163430499|NCT00424398|590278694|FG000|Overall Study|Withdrawal by Subject|2|||
163430500|NCT00424398|590278695|FG001|Overall Study|Withdrawal by Subject|1|||
163430501|NCT00424398|590278696|FG002|Overall Study|Withdrawal by Subject|0|||
163430502|NCT00424398|590278694|FG000|Overall Study|Subject met exclusion criteria|1|||
163430503|NCT00424398|590278695|FG001|Overall Study|Subject met exclusion criteria|0|||
163430504|NCT00424398|590278696|FG002|Overall Study|Subject met exclusion criteria|0|||
163430505|NCT01023789|590278697|FG000|3 - Year Visit|Death|29|||
163430506|NCT01023789|590278697|FG000|3 - Year Visit|Withdrawal of consent|1|||
163430507|NCT01023789|590278697|FG000|3 - Year Visit|Lost to Follow-up|13|||
163430520|NCT02698189|590278700|FG000|Overall Study|Physician Decision|3|||
163430521|NCT02698189|590278701|FG001|Overall Study|Physician Decision|0|||
163430522|NCT02698189|590278700|FG000|Overall Study|Progressive disease|0|||
163430523|NCT02698189|590278701|FG001|Overall Study|Progressive disease|5|||
163430524|NCT02698189|590278700|FG000|Overall Study|Study terminated by sponsor|0|||
163430525|NCT02698189|590278701|FG001|Overall Study|Study terminated by sponsor|1|||
163430526|NCT02240706|590278702|FG000|Overall Study|Lack of Efficacy|2|||
163430527|NCT02240706|590278703|FG001|Overall Study|Lack of Efficacy|2|||
163430528|NCT02240706|590278704|FG002|Overall Study|Lack of Efficacy|2|||
163430529|NCT02240706|590278705|FG003|Overall Study|Lack of Efficacy|2|||
163430530|NCT02240706|590278706|FG004|Overall Study|Lack of Efficacy|5|||
163430531|NCT02240706|590278707|FG005|Overall Study|Lack of Efficacy|0|||
163430532|NCT02240706|590278708|FG006|Overall Study|Lack of Efficacy|0|||
163430533|NCT02240706|590278702|FG000|Overall Study|Adverse Event|1|||
163430534|NCT02240706|590278703|FG001|Overall Study|Adverse Event|0|||
163430535|NCT02240706|590278704|FG002|Overall Study|Adverse Event|1|||
163430536|NCT02240706|590278705|FG003|Overall Study|Adverse Event|0|||
163430537|NCT02240706|590278706|FG004|Overall Study|Adverse Event|2|||
163430538|NCT02240706|590278707|FG005|Overall Study|Adverse Event|0|||
163430539|NCT02240706|590278708|FG006|Overall Study|Adverse Event|0|||
163430540|NCT02240706|590278702|FG000|Overall Study|Progressive disease|0|||
163430541|NCT02240706|590278703|FG001|Overall Study|Progressive disease|0|||
163430542|NCT02240706|590278704|FG002|Overall Study|Progressive disease|0|||
163430543|NCT02240706|590278705|FG003|Overall Study|Progressive disease|0|||
163430544|NCT02240706|590278706|FG004|Overall Study|Progressive disease|1|||
163430545|NCT02240706|590278707|FG005|Overall Study|Progressive disease|0|||
163430546|NCT02240706|590278708|FG006|Overall Study|Progressive disease|0|||
163430547|NCT02240706|590278702|FG000|Overall Study|Dose limiting toxicity|0|||
163430548|NCT02240706|590278703|FG001|Overall Study|Dose limiting toxicity|0|||
163430549|NCT02240706|590278704|FG002|Overall Study|Dose limiting toxicity|0|||
163430550|NCT02240706|590278705|FG003|Overall Study|Dose limiting toxicity|0|||
163430551|NCT02240706|590278706|FG004|Overall Study|Dose limiting toxicity|1|||
163430552|NCT02240706|590278707|FG005|Overall Study|Dose limiting toxicity|0|||
163430553|NCT02240706|590278708|FG006|Overall Study|Dose limiting toxicity|0|||
163430554|NCT02240706|590278702|FG000|Overall Study|Refused to continue taking medication|0|||
163430555|NCT02240706|590278703|FG001|Overall Study|Refused to continue taking medication|1|||
163430556|NCT02240706|590278704|FG002|Overall Study|Refused to continue taking medication|3|||
163430557|NCT02240706|590278705|FG003|Overall Study|Refused to continue taking medication|1|||
163430558|NCT02240706|590278706|FG004|Overall Study|Refused to continue taking medication|2|||
163430559|NCT02240706|590278707|FG005|Overall Study|Refused to continue taking medication|0|||
163430560|NCT02240706|590278708|FG006|Overall Study|Refused to continue taking medication|0|||
163430561|NCT02240706|590278702|FG000|Overall Study|Insurance billing concerns|0|||
163430562|NCT02240706|590278703|FG001|Overall Study|Insurance billing concerns|0|||
163430563|NCT02240706|590278704|FG002|Overall Study|Insurance billing concerns|0|||
163430564|NCT02240706|590278705|FG003|Overall Study|Insurance billing concerns|1|||
163430565|NCT02240706|590278706|FG004|Overall Study|Insurance billing concerns|0|||
163430566|NCT02240706|590278707|FG005|Overall Study|Insurance billing concerns|0|||
163430567|NCT02240706|590278708|FG006|Overall Study|Insurance billing concerns|0|||
163430568|NCT05502289|590278713|FG000|Period 1|Out Of Window|1|||
163430569|NCT05502289|590278714|FG001|Period 1|Out Of Window|0|||
163430570|NCT02333227|590278720|FG000|Overall Study|Lost to Follow-up|137|||
163430571|NCT02333227|590278721|FG001|Overall Study|Lost to Follow-up|106|||
163430572|NCT02333227|590278720|FG000|Overall Study|Pregnancy Interrupted|42|||
163430573|NCT02333227|590278721|FG001|Overall Study|Pregnancy Interrupted|89|||
163430574|NCT02333227|590278720|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
163430575|NCT02333227|590278721|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
163430576|NCT03459040|590278722|FG000|Overall Study|Death|8|||
163430577|NCT03459040|590278722|FG000|Overall Study|Withdrawal by Subject|1|||
163430578|NCT01914679|590278723|FG000|Overall Study|Lack of Efficacy|1|||
163430579|NCT01914679|590278723|FG000|Overall Study|Sponsor terminated study|4|||
163430580|NCT00256295|590278724|FG000|Overall Study|Withdrawal by Subject|3|||
163430581|NCT00256295|590278724|FG000|Overall Study|Death|1|||
163430582|NCT05369806|590278725|FG000|Overall Study|Lost to Follow-up|1|||
163430583|NCT01331161|590278727|FG000|Overall Study|Physician Decision|1|||
163430584|NCT01331161|590278728|FG001|Overall Study|Physician Decision|0|||
163430585|NCT01331161|590278727|FG000|Overall Study|Lost to Follow-up|0|||
163430586|NCT01331161|590278728|FG001|Overall Study|Lost to Follow-up|1|||
163430587|NCT01331161|590278727|FG000|Overall Study|Pregnancy|0|||
163430588|NCT01331161|590278728|FG001|Overall Study|Pregnancy|1|||
163430589|NCT03277196|590278730|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
163430590|NCT03277196|590278730|FG000|Overall Study|Lost to Follow-up|3|||
163430591|NCT03277196|590278730|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
163430592|NCT03277196|590278730|FG000|Overall Study|Other|2|||
163430593|NCT05738486|590281816|FG000|Overall Study|Continuing Study|194|||
163430594|NCT05738486|590281817|FG001|Overall Study|Continuing Study|196|||
163430595|NCT05738486|590281818|FG002|Overall Study|Continuing Study|193|||
163430596|NCT05738486|590281819|FG003|Overall Study|Continuing Study|191|||
163430597|NCT05738486|590281816|FG000|Overall Study|Withdrawal by Subject|8|||
163430598|NCT05738486|590281817|FG001|Overall Study|Withdrawal by Subject|5|||
163430599|NCT05738486|590281818|FG002|Overall Study|Withdrawal by Subject|7|||
163430600|NCT05738486|590281819|FG003|Overall Study|Withdrawal by Subject|13|||
163430601|NCT05738486|590281816|FG000|Overall Study|Adverse Event|4|||
163430602|NCT05738486|590281817|FG001|Overall Study|Adverse Event|6|||
163430603|NCT05738486|590281818|FG002|Overall Study|Adverse Event|4|||
163430604|NCT05738486|590281819|FG003|Overall Study|Adverse Event|5|||
163430605|NCT05738486|590281816|FG000|Overall Study|Physician Decision|0|||
163430606|NCT05738486|590281817|FG001|Overall Study|Physician Decision|2|||
163430607|NCT05738486|590281818|FG002|Overall Study|Physician Decision|4|||
163430608|NCT05738486|590281819|FG003|Overall Study|Physician Decision|1|||
163430609|NCT05738486|590281816|FG000|Overall Study|Lost to Follow-up|1|||
163430610|NCT05738486|590281817|FG001|Overall Study|Lost to Follow-up|1|||
163430611|NCT05738486|590281818|FG002|Overall Study|Lost to Follow-up|2|||
163430612|NCT05738486|590281819|FG003|Overall Study|Lost to Follow-up|1|||
163430613|NCT05738486|590281816|FG000|Overall Study|Participant was Non-ambulatory|0|||
163430614|NCT05738486|590281817|FG001|Overall Study|Participant was Non-ambulatory|0|||
163430615|NCT05738486|590281818|FG002|Overall Study|Participant was Non-ambulatory|1|||
163430616|NCT05738486|590281819|FG003|Overall Study|Participant was Non-ambulatory|0|||
163430617|NCT05738486|590281816|FG000|Overall Study|Participant had Poor Venous Access|0|||
163430618|NCT05738486|590281817|FG001|Overall Study|Participant had Poor Venous Access|0|||
163430619|NCT05738486|590281818|FG002|Overall Study|Participant had Poor Venous Access|0|||
163430620|NCT05738486|590281819|FG003|Overall Study|Participant had Poor Venous Access|1|||
163430621|NCT05738486|590281816|FG000|Overall Study|Assigned Treatment by Mistake|0|||
163430622|NCT05738486|590281817|FG001|Overall Study|Assigned Treatment by Mistake|0|||
163430623|NCT05738486|590281818|FG002|Overall Study|Assigned Treatment by Mistake|0|||
163430624|NCT05738486|590281819|FG003|Overall Study|Assigned Treatment by Mistake|1|||
163430625|NCT05738486|590281816|FG000|Overall Study|Death|0|||
163430626|NCT05738486|590281817|FG001|Overall Study|Death|0|||
163430627|NCT05738486|590281818|FG002|Overall Study|Death|1|||
163430628|NCT05738486|590281819|FG003|Overall Study|Death|0|||
163430629|NCT05738486|590281816|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
163430630|NCT05738486|590281817|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
163430631|NCT05738486|590281818|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
163430632|NCT05738486|590281819|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
163430633|NCT02017444|590281823|FG000|Overall Study|Physician Decision|1|||
163430634|NCT02017444|590281824|FG001|Overall Study|Physician Decision|0|||
163430635|NCT02017444|590281823|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
163430636|NCT02017444|590281824|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
163430637|NCT00886821|590281825|FG000|Stage 2|Adverse Event|0|||
163430638|NCT00886821|590281826|FG001|Stage 2|Adverse Event|0|||
163430639|NCT00886821|590281827|FG002|Stage 2|Adverse Event|0|||
163430640|NCT00886821|590281828|FG003|Stage 2|Adverse Event|0|||
163430641|NCT00886821|590281829|FG004|Stage 2|Adverse Event|0|||
163430642|NCT00886821|590281830|FG005|Stage 2|Adverse Event|0|||
163430643|NCT00886821|590281831|FG006|Stage 2|Adverse Event|0|||
163430644|NCT00886821|590281832|FG007|Stage 2|Adverse Event|0|||
163430645|NCT00886821|590281833|FG008|Stage 2|Adverse Event|0|||
163430646|NCT00886821|590281834|FG009|Stage 2|Adverse Event|0|||
163430647|NCT00886821|590281835|FG010|Stage 2|Adverse Event|0|||
163430648|NCT00886821|590281836|FG011|Stage 2|Adverse Event|1|||
163430649|NCT00886821|590281837|FG012|Stage 2|Adverse Event|3|||
163430650|NCT00886821|590281838|FG013|Stage 2|Adverse Event|0|||
163430651|NCT00886821|590281825|FG000|Stage 2|Lost to Follow-up|0|||
163430652|NCT00886821|590281826|FG001|Stage 2|Lost to Follow-up|0|||
163430653|NCT00886821|590281827|FG002|Stage 2|Lost to Follow-up|0|||
163430654|NCT00886821|590281828|FG003|Stage 2|Lost to Follow-up|0|||
163430655|NCT00886821|590281829|FG004|Stage 2|Lost to Follow-up|0|||
163430656|NCT00886821|590281830|FG005|Stage 2|Lost to Follow-up|0|||
163430657|NCT00886821|590281831|FG006|Stage 2|Lost to Follow-up|0|||
163430658|NCT00886821|590281832|FG007|Stage 2|Lost to Follow-up|0|||
163430659|NCT00886821|590281833|FG008|Stage 2|Lost to Follow-up|0|||
163430660|NCT00886821|590281834|FG009|Stage 2|Lost to Follow-up|0|||
163430661|NCT00886821|590281835|FG010|Stage 2|Lost to Follow-up|0|||
163430662|NCT00886821|590281836|FG011|Stage 2|Lost to Follow-up|0|||
163430663|NCT00886821|590281837|FG012|Stage 2|Lost to Follow-up|2|||
163430664|NCT00886821|590281838|FG013|Stage 2|Lost to Follow-up|1|||
163430665|NCT03716726|590281839|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
163430666|NCT03716726|590281840|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
163430667|NCT03716726|590281839|FG000|12 Months Followup|Lost to Follow-up|10|||
163430668|NCT03716726|590281840|FG001|12 Months Followup|Lost to Follow-up|17|||
163430669|NCT02579603|590281841|FG000|Overall Study|Not treated|1|||
163430670|NCT02579603|590281842|FG001|Overall Study|Not treated|0|||
163430671|NCT02579603|590281841|FG000|Overall Study|Adverse Event|2|||
163430672|NCT02579603|590281842|FG001|Overall Study|Adverse Event|2|||
163430673|NCT02579603|590281841|FG000|Overall Study|Other than stated|1|||
163430674|NCT02579603|590281842|FG001|Overall Study|Other than stated|0|||
163430675|NCT00469079|590281843|FG000|Overall Study|Lack of Efficacy|3|||
163430676|NCT00469079|590281844|FG001|Overall Study|Lack of Efficacy|8|||
163430677|NCT00469079|590281845|FG002|Overall Study|Lack of Efficacy|5|||
163430678|NCT00469079|590281843|FG000|Overall Study|Adverse Event|1|||
163430679|NCT00469079|590281844|FG001|Overall Study|Adverse Event|3|||
163430680|NCT00469079|590281845|FG002|Overall Study|Adverse Event|2|||
163430681|NCT00469079|590281843|FG000|Overall Study|Lost to Follow-up|4|||
163430682|NCT00469079|590281844|FG001|Overall Study|Lost to Follow-up|8|||
163430683|NCT00469079|590281845|FG002|Overall Study|Lost to Follow-up|10|||
163430684|NCT00469079|590281843|FG000|Overall Study|Withdrawal by Subject|1|||
163430685|NCT00469079|590281844|FG001|Overall Study|Withdrawal by Subject|2|||
163430686|NCT00469079|590281845|FG002|Overall Study|Withdrawal by Subject|2|||
163430687|NCT00469079|590281843|FG000|Overall Study|Ineligible|0|||
163430688|NCT00469079|590281844|FG001|Overall Study|Ineligible|1|||
163430689|NCT00469079|590281845|FG002|Overall Study|Ineligible|0|||
163430690|NCT00942162|590281846|FG000|Overall Study|Death|45|||
163430691|NCT00942162|590281847|FG001|Overall Study|Death|35|||
163430692|NCT00942162|590281848|FG002|Overall Study|Death|0|||
163430693|NCT00942162|590281846|FG000|Overall Study|Withdrawal by Subject|7|||
163430694|NCT00942162|590281847|FG001|Overall Study|Withdrawal by Subject|2|||
163430695|NCT00942162|590281848|FG002|Overall Study|Withdrawal by Subject|0|||
163430696|NCT00942162|590281846|FG000|Overall Study|Lost to Follow-up|4|||
163430697|NCT00942162|590281847|FG001|Overall Study|Lost to Follow-up|0|||
163430698|NCT00942162|590281848|FG002|Overall Study|Lost to Follow-up|0|||
163430699|NCT00942162|590281846|FG000|Overall Study|Other|14|||
163430700|NCT00942162|590281847|FG001|Overall Study|Other|13|||
163430701|NCT00942162|590281848|FG002|Overall Study|Other|2|||
163430702|NCT04419506|590281851|FG000|Overall Study|Adverse Event|0|||
163430703|NCT04419506|590281852|FG001|Overall Study|Adverse Event|10|||
163430704|NCT04419506|590281853|FG002|Overall Study|Adverse Event|0|||
163430705|NCT04419506|590281854|FG003|Overall Study|Adverse Event|3|||
163430706|NCT04419506|590281851|FG000|Overall Study|Withdrawal by Subject|0|||
163430707|NCT04419506|590281852|FG001|Overall Study|Withdrawal by Subject|0|||
163430708|NCT04419506|590281853|FG002|Overall Study|Withdrawal by Subject|0|||
163430709|NCT04419506|590281854|FG003|Overall Study|Withdrawal by Subject|1|||
163430710|NCT04419506|590281851|FG000|Overall Study|poor-compliance|0|||
163430711|NCT04419506|590281852|FG001|Overall Study|poor-compliance|0|||
163430712|NCT04419506|590281853|FG002|Overall Study|poor-compliance|0|||
163430713|NCT04419506|590281854|FG003|Overall Study|poor-compliance|1|||
163430714|NCT04329949|590281855|FG000|Overall Study|Death|36|||
163430715|NCT04329949|590281855|FG000|Overall Study|Withdrawal by Subject|4|||
163430716|NCT04329949|590281855|FG000|Overall Study|Termination of study by sponsor|3|||
163430717|NCT04645797|590281856|FG000|Overall Study|Disease Progression|3|||
163430718|NCT04645797|590281857|FG001|Overall Study|Disease Progression|3|||
163430719|NCT04645797|590281858|FG002|Overall Study|Disease Progression|1|||
163430720|NCT04645797|590281859|FG003|Overall Study|Disease Progression|0|||
163430721|NCT04645797|590281860|FG004|Overall Study|Disease Progression|0|||
163430722|NCT04645797|590281861|FG005|Overall Study|Disease Progression|0|||
163430723|NCT04645797|590281862|FG006|Overall Study|Disease Progression|0|||
163430724|NCT04645797|590281856|FG000|Overall Study|Death|3|||
163430725|NCT04645797|590281857|FG001|Overall Study|Death|1|||
163430726|NCT04645797|590281858|FG002|Overall Study|Death|0|||
163430727|NCT04645797|590281859|FG003|Overall Study|Death|0|||
163430728|NCT04645797|590281860|FG004|Overall Study|Death|0|||
163430729|NCT04645797|590281861|FG005|Overall Study|Death|0|||
163430730|NCT04645797|590281862|FG006|Overall Study|Death|0|||
163430731|NCT00345605|590281865|FG000|Arm 1|Adverse Event|0|||
163430732|NCT00345605|590281866|FG001|Arm 1|Adverse Event|1|||
163430733|NCT00345605|590281865|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
163430734|NCT00345605|590281866|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
163430735|NCT00817414|590281867|FG000|Overall Study|Adverse Event|1|||
163430736|NCT00817414|590281868|FG001|Overall Study|Adverse Event|1|||
163430737|NCT00817414|590281869|FG002|Overall Study|Adverse Event|1|||
163430738|NCT00817414|590281870|FG003|Overall Study|Adverse Event|0|||
163430739|NCT00817414|590281871|FG004|Overall Study|Adverse Event|0|||
163430740|NCT00817414|590281867|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
163430741|NCT00817414|590281868|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
163430742|NCT00817414|590281869|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
163430743|NCT00817414|590281870|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
163430744|NCT00817414|590281871|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
163430745|NCT00817414|590281867|FG000|Overall Study|Withdrawal by Subject|1|||
163430746|NCT00817414|590281868|FG001|Overall Study|Withdrawal by Subject|1|||
163430747|NCT00817414|590281869|FG002|Overall Study|Withdrawal by Subject|0|||
163430748|NCT00817414|590281870|FG003|Overall Study|Withdrawal by Subject|0|||
163430749|NCT00817414|590281871|FG004|Overall Study|Withdrawal by Subject|0|||
163430750|NCT00817414|590281867|FG000|Overall Study|Lost to Follow-up|0|||
163430751|NCT00817414|590281868|FG001|Overall Study|Lost to Follow-up|0|||
163430752|NCT00817414|590281869|FG002|Overall Study|Lost to Follow-up|1|||
163430753|NCT00817414|590281870|FG003|Overall Study|Lost to Follow-up|1|||
163430754|NCT00817414|590281871|FG004|Overall Study|Lost to Follow-up|1|||
163430755|NCT00817414|590281867|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
163430756|NCT00817414|590281868|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
163430757|NCT00817414|590281869|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
163430758|NCT00817414|590281870|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
163430759|NCT00817414|590281871|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
163430760|NCT00817414|590281867|FG000|Overall Study|Protocol Violation|0|||
163430761|NCT00817414|590281868|FG001|Overall Study|Protocol Violation|0|||
163430762|NCT00817414|590281869|FG002|Overall Study|Protocol Violation|0|||
163430763|NCT00817414|590281870|FG003|Overall Study|Protocol Violation|0|||
163430764|NCT00817414|590281871|FG004|Overall Study|Protocol Violation|1|||
163430765|NCT03717922|590281874|FG000|Overall Study|Lost to Follow-up|2|||
163430766|NCT03717922|590281875|FG001|Overall Study|Lost to Follow-up|2|||
163430767|NCT03126227|590281876|FG000|Overall Study|Adverse Event|43|||
163430768|NCT03126227|590281877|FG001|Overall Study|Adverse Event|4|||
163430769|NCT03126227|590281876|FG000|Overall Study|Death|0|||
163430770|NCT03126227|590281877|FG001|Overall Study|Death|1|||
163430771|NCT03126227|590281876|FG000|Overall Study|Lost to Follow-up|0|||
163430772|NCT03126227|590281877|FG001|Overall Study|Lost to Follow-up|1|||
163430773|NCT03126227|590281876|FG000|Overall Study|Physician Decision|2|||
163430774|NCT03126227|590281877|FG001|Overall Study|Physician Decision|0|||
163430775|NCT03126227|590281876|FG000|Overall Study|Protocol Violation|1|||
163430776|NCT03126227|590281877|FG001|Overall Study|Protocol Violation|0|||
163430777|NCT03126227|590281876|FG000|Overall Study|Withdrawal by Subject|19|||
163430778|NCT03126227|590281877|FG001|Overall Study|Withdrawal by Subject|3|||
163430779|NCT03126227|590281876|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
163430780|NCT03126227|590281877|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
163430781|NCT03126227|590281876|FG000|Overall Study|Lack of dosing compliance|2|||
163430782|NCT03126227|590281877|FG001|Overall Study|Lack of dosing compliance|0|||
163430783|NCT03126227|590281876|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
163430784|NCT03126227|590281877|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
163430785|NCT03126227|590281876|FG000|Overall Study|Scheduling conflict|1|||
163430786|NCT03126227|590281877|FG001|Overall Study|Scheduling conflict|0|||
163430787|NCT01126619|590281878|FG000|Overall Study|Not eligible for the study|2|||
163430788|NCT01126619|590281878|FG000|Overall Study|Investigator decision|4|||
163430789|NCT01126619|590281878|FG000|Overall Study|Serious adverse event|1|||
163430790|NCT01126619|590281878|FG000|Overall Study|Withdrawal by Subject|9|||
163430791|NCT01126619|590281878|FG000|Overall Study|Non-compliance|1|||
163430792|NCT04876391|590281879|FG000|Overall Study|Withdrawal by Subject|1|||
163430793|NCT04876391|590281880|FG001|Overall Study|Withdrawal by Subject|10|||
163430794|NCT04876391|590281879|FG000|Overall Study|Lost to Follow-up|2|||
163430795|NCT04876391|590281880|FG001|Overall Study|Lost to Follow-up|4|||
163430796|NCT04876391|590281879|FG000|Overall Study|Lack of Efficacy|0|||
163430797|NCT04876391|590281880|FG001|Overall Study|Lack of Efficacy|2|||
163430798|NCT04876391|590281879|FG000|Overall Study|Adverse Event|3|||
163430799|NCT04876391|590281880|FG001|Overall Study|Adverse Event|1|||
163430800|NCT04876391|590281879|FG000|Overall Study|Patient non-compliance|0|||
163430801|NCT04876391|590281880|FG001|Overall Study|Patient non-compliance|1|||
163430802|NCT04876391|590281879|FG000|Overall Study|Personal reasons|0|||
163430803|NCT04876391|590281880|FG001|Overall Study|Personal reasons|1|||
163430804|NCT04876391|590281879|FG000|Overall Study|Withdrawn as per protocol|2|||
163430805|NCT04876391|590281880|FG001|Overall Study|Withdrawn as per protocol|2|||
163430806|NCT01859403|590281885|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
163430807|NCT01859403|590281886|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
163430808|NCT01859403|590281885|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
163430809|NCT01859403|590281886|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
163430810|NCT01859403|590281885|FG000|Primary Endpoint Measure|Physician Decision|0|||
163430811|NCT01859403|590281886|FG001|Primary Endpoint Measure|Physician Decision|1|||
163430812|NCT01859403|590281885|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
163430813|NCT01859403|590281886|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
163430814|NCT00811252|590281887|FG000|Overall Study|Adverse Event|6|||
163430815|NCT00811252|590281888|FG001|Overall Study|Adverse Event|10|||
163430816|NCT00811252|590281889|FG002|Overall Study|Adverse Event|15|||
163430817|NCT00811252|590281887|FG000|Overall Study|Lack of Efficacy|7|||
163430818|NCT00811252|590281888|FG001|Overall Study|Lack of Efficacy|2|||
163430819|NCT00811252|590281889|FG002|Overall Study|Lack of Efficacy|0|||
163430820|NCT00811252|590281887|FG000|Overall Study|Protocol Violation|3|||
163430821|NCT00811252|590281888|FG001|Overall Study|Protocol Violation|3|||
163430822|NCT00811252|590281889|FG002|Overall Study|Protocol Violation|2|||
163430823|NCT00811252|590281887|FG000|Overall Study|Withdrawal of Consent|1|||
163430824|NCT00811252|590281888|FG001|Overall Study|Withdrawal of Consent|2|||
163430825|NCT00811252|590281889|FG002|Overall Study|Withdrawal of Consent|2|||
163430826|NCT00811252|590281887|FG000|Overall Study|Lost to Follow-up|0|||
163430827|NCT00811252|590281888|FG001|Overall Study|Lost to Follow-up|0|||
163430828|NCT00811252|590281889|FG002|Overall Study|Lost to Follow-up|2|||
163430829|NCT00811252|590281887|FG000|Overall Study|Administrative or Other Reasons|0|||
163430830|NCT00811252|590281888|FG001|Overall Study|Administrative or Other Reasons|3|||
163430831|NCT00811252|590281889|FG002|Overall Study|Administrative or Other Reasons|2|||
163430832|NCT01157117|590281890|FG000|Overall Study|Dosing Symptoms|0|||
163430833|NCT01157117|590281891|FG001|Overall Study|Dosing Symptoms|4|||
163430834|NCT01157117|590281892|FG002|Overall Study|Dosing Symptoms|0|||
163430835|NCT01157117|590281890|FG000|Overall Study|Withdrawal by Subject|4|||
163430836|NCT01157117|590281891|FG001|Overall Study|Withdrawal by Subject|1|||
163430837|NCT01157117|590281892|FG002|Overall Study|Withdrawal by Subject|1|||
163430838|NCT01157117|590281890|FG000|Overall Study|Lack of Efficacy|1|||
163430839|NCT01157117|590281891|FG001|Overall Study|Lack of Efficacy|1|||
163430840|NCT01157117|590281892|FG002|Overall Study|Lack of Efficacy|0|||
163430841|NCT01157117|590281890|FG000|Overall Study|Lost to Follow-up|0|||
163430842|NCT01157117|590281891|FG001|Overall Study|Lost to Follow-up|0|||
163430843|NCT01157117|590281892|FG002|Overall Study|Lost to Follow-up|1|||
163430844|NCT01157117|590281890|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
163430845|NCT01157117|590281891|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
163430846|NCT01157117|590281892|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
163430847|NCT01931865|590281896|FG000|Overall Study|Lost to Follow-up|2|||
163430848|NCT01931865|590281896|FG000|Overall Study|Withdrawal by Subject|2|||
163430849|NCT01121406|590281897|FG000|Overall Study|Progressive disease RECIST|44|||
163430850|NCT01121406|590281898|FG001|Overall Study|Progressive disease RECIST|28|||
163430851|NCT01121406|590281897|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
163430852|NCT01121406|590281898|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
163430853|NCT01121406|590281897|FG000|Overall Study|Other AE|3|||
163430854|NCT01121406|590281898|FG001|Overall Study|Other AE|10|||
163430855|NCT01121406|590281897|FG000|Overall Study|Non-compliant with protocol|0|||
163430856|NCT01121406|590281898|FG001|Overall Study|Non-compliant with protocol|2|||
163430857|NCT01121406|590281897|FG000|Overall Study|Lost to Follow-up|0|||
163430858|NCT01121406|590281898|FG001|Overall Study|Lost to Follow-up|1|||
163430859|NCT01121406|590281897|FG000|Overall Study|Refused continuation of study med.|1|||
163430860|NCT01121406|590281898|FG001|Overall Study|Refused continuation of study med.|2|||
163430861|NCT01121406|590281897|FG000|Overall Study|Reason other than specified above|2|||
163430862|NCT01121406|590281898|FG001|Overall Study|Reason other than specified above|6|||
163430863|NCT01121406|590281897|FG000|Overall Study|Not treated|1|||
163430864|NCT01121406|590281898|FG001|Overall Study|Not treated|0|||
163430865|NCT00892437|590281899|FG000|Randomized Phase|Randomized but not treated|6|||
163430866|NCT00892437|590281900|FG001|Randomized Phase|Randomized but not treated|0|||
163430867|NCT00892437|590281899|FG000|Randomized Phase|Adverse Event|2|||
163430868|NCT00892437|590281900|FG001|Randomized Phase|Adverse Event|2|||
163430869|NCT00892437|590281899|FG000|Randomized Phase|Lost to Follow-up|1|||
163430870|NCT00892437|590281900|FG001|Randomized Phase|Lost to Follow-up|3|||
163430871|NCT00892437|590281899|FG000|Randomized Phase|Investigator's Discretion|1|||
163430872|NCT00892437|590281900|FG001|Randomized Phase|Investigator's Discretion|0|||
163430873|NCT00892437|590281899|FG000|Randomized Phase|Withdrew Consent|1|||
163430874|NCT00892437|590281900|FG001|Randomized Phase|Withdrew Consent|0|||
163430875|NCT00892437|590281899|FG000|Open-Label Extension Phase|Adverse Event|4|||
163430876|NCT00892437|590281900|FG001|Open-Label Extension Phase|Adverse Event|2|||
163430877|NCT00892437|590281899|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
163430878|NCT00892437|590281900|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
163430879|NCT00892437|590281899|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
163430880|NCT00892437|590281900|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
163430881|NCT00892437|590281899|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
163430882|NCT00892437|590281900|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
163430883|NCT00892437|590281899|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
163430884|NCT00892437|590281900|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
163430885|NCT03185130|590281901|FG000|Overall Study|Withdrawal by Subject|0|||
163430886|NCT03185130|590281902|FG001|Overall Study|Withdrawal by Subject|2|||
163430887|NCT02286960|590281903|FG000|Overall Study|Lost to Follow-up|3|||
163430888|NCT02286960|590281904|FG001|Overall Study|Lost to Follow-up|3|||
163430889|NCT03596164|590281909|FG000|Overall Study|Adverse Event|0|||
163430890|NCT03596164|590281910|FG001|Overall Study|Adverse Event|1|||
163430891|NCT03596164|590281909|FG000|Overall Study|Death|1|||
163430892|NCT03596164|590281910|FG001|Overall Study|Death|0|||
163430893|NCT03427073|590281911|FG000|Overall Study|Disease Progression|1|||
163430894|NCT03427073|590281912|FG001|Overall Study|Disease Progression|1|||
163430895|NCT03427073|590281913|FG002|Overall Study|Disease Progression|1|||
163430896|NCT03427073|590281914|FG003|Overall Study|Disease Progression|3|||
163430897|NCT03427073|590281915|FG004|Overall Study|Disease Progression|3|||
163430898|NCT03427073|590281916|FG005|Overall Study|Disease Progression|4|||
163430899|NCT03427073|590281917|FG006|Overall Study|Disease Progression|2|||
163430900|NCT03427073|590281918|FG007|Overall Study|Disease Progression|3|||
163430901|NCT03427073|590281911|FG000|Overall Study|Physician Decision|0|||
163430902|NCT03427073|590281912|FG001|Overall Study|Physician Decision|0|||
163430903|NCT03427073|590281913|FG002|Overall Study|Physician Decision|0|||
163430904|NCT03427073|590281914|FG003|Overall Study|Physician Decision|0|||
163430905|NCT03427073|590281915|FG004|Overall Study|Physician Decision|0|||
163430906|NCT03427073|590281916|FG005|Overall Study|Physician Decision|0|||
163430907|NCT03427073|590281917|FG006|Overall Study|Physician Decision|1|||
163430908|NCT03427073|590281918|FG007|Overall Study|Physician Decision|1|||
163430909|NCT02835495|590281921|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
163430910|NCT02835495|590281922|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
163430911|NCT02835495|590281921|FG000|Overall Study|Declined in-person follow-up visit|4|||
163430912|NCT02835495|590281922|FG001|Overall Study|Declined in-person follow-up visit|2|||
163430913|NCT02580058|590281924|FG000|Overall Study|Adverse Event|16|||
163430914|NCT02580058|590281925|FG001|Overall Study|Adverse Event|30|||
163430915|NCT02580058|590281926|FG002|Overall Study|Adverse Event|20|||
163430916|NCT02580058|590281924|FG000|Overall Study|Death|4|||
163430917|NCT02580058|590281925|FG001|Overall Study|Death|4|||
163430918|NCT02580058|590281926|FG002|Overall Study|Death|5|||
163430919|NCT02580058|590281924|FG000|Overall Study|Physician Decision|1|||
163430920|NCT02580058|590281925|FG001|Overall Study|Physician Decision|3|||
163430921|NCT02580058|590281926|FG002|Overall Study|Physician Decision|11|||
163430922|NCT02580058|590281924|FG000|Overall Study|Other|5|||
163430923|NCT02580058|590281925|FG001|Overall Study|Other|1|||
163430924|NCT02580058|590281926|FG002|Overall Study|Other|3|||
163430925|NCT02580058|590281924|FG000|Overall Study|Withdrawal by Subject|4|||
163430926|NCT02580058|590281925|FG001|Overall Study|Withdrawal by Subject|7|||
163430927|NCT02580058|590281926|FG002|Overall Study|Withdrawal by Subject|31|||
163430928|NCT02580058|590281924|FG000|Overall Study|Global Deterioration of Health Status|19|||
163430929|NCT02580058|590281925|FG001|Overall Study|Global Deterioration of Health Status|18|||
163430930|NCT02580058|590281926|FG002|Overall Study|Global Deterioration of Health Status|24|||
163430931|NCT02580058|590281924|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
163430932|NCT02580058|590281925|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
163430933|NCT02580058|590281926|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
163430934|NCT02580058|590281924|FG000|Overall Study|Progressive Disease|137|||
163430935|NCT02580058|590281925|FG001|Overall Study|Progressive Disease|125|||
163430936|NCT02580058|590281926|FG002|Overall Study|Progressive Disease|94|||
163430937|NCT02580058|590281924|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163430938|NCT02580058|590281925|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163430939|NCT02580058|590281926|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163430940|NCT04283461|590281927|FG000|Overall Study|Enrolled in separate trial|0|||
163430941|NCT04283461|590281928|FG001|Overall Study|Enrolled in separate trial|0|||
163430942|NCT04283461|590281929|FG002|Overall Study|Enrolled in separate trial|8|||
163430943|NCT04283461|590281930|FG003|Overall Study|Enrolled in separate trial|13|||
163430944|NCT04283461|590281931|FG004|Overall Study|Enrolled in separate trial|12|||
163430945|NCT04283461|590281932|FG005|Overall Study|Enrolled in separate trial|0|||
163430946|NCT04283461|590281933|FG006|Overall Study|Enrolled in separate trial|0|||
163430947|NCT04283461|590281934|FG007|Overall Study|Enrolled in separate trial|8|||
163430948|NCT04283461|590281935|FG008|Overall Study|Enrolled in separate trial|0|||
163430949|NCT04283461|590281936|FG009|Overall Study|Enrolled in separate trial|0|||
163430950|NCT04283461|590281937|FG010|Overall Study|Enrolled in separate trial|0|||
163430951|NCT04283461|590281938|FG011|Overall Study|Enrolled in separate trial|7|||
163430952|NCT04283461|590281939|FG012|Overall Study|Enrolled in separate trial|0|||
163430953|NCT05490771|590281940|FG000|Overall Study|Disease progression|18|||
163430954|NCT05490771|590281940|FG000|Overall Study|Adverse Event|3|||
163430955|NCT05490771|590281940|FG000|Overall Study|Other complicating disease|1|||
163430956|NCT05490771|590281940|FG000|Overall Study|Withdrawal by Subject|3|||
163430957|NCT05490771|590281940|FG000|Overall Study|Physician Decision|1|||
163430958|NCT05490771|590281940|FG000|Overall Study|Still on treatment|2|||
163430959|NCT05490771|590281940|FG000|Overall Study|Never start protocol therapy|5|||
163430960|NCT05490771|590281940|FG000|Overall Study|Ineligible|2|||
163430961|NCT02115308|590281954|FG000|Overall Study|Safety Screening|2|||
163430962|NCT02115308|590281955|FG001|Overall Study|Safety Screening|2|||
163430963|NCT01309737|590281956|FG000|Week 0 to 16|Death|1|||
163430964|NCT01309737|590281957|FG001|Week 0 to 16|Death|0|||
163430965|NCT01309737|590281958|FG002|Week 0 to 16|Death|1|||
163430966|NCT01309737|590281959|FG003|Week 0 to 16|Death|0|||
163430967|NCT01309737|590281960|FG004|Week 0 to 16|Death|0|||
163430968|NCT01309737|590281956|FG000|Week 0 to 16|Adverse Event|11|||
163430969|NCT01309737|590281957|FG001|Week 0 to 16|Adverse Event|10|||
163430970|NCT01309737|590281958|FG002|Week 0 to 16|Adverse Event|5|||
163430971|NCT01309737|590281959|FG003|Week 0 to 16|Adverse Event|0|||
163430972|NCT01309737|590281960|FG004|Week 0 to 16|Adverse Event|0|||
163430973|NCT01309737|590281956|FG000|Week 0 to 16|Lack of Efficacy|15|||
163430974|NCT01309737|590281957|FG001|Week 0 to 16|Lack of Efficacy|2|||
163430975|NCT01309737|590281958|FG002|Week 0 to 16|Lack of Efficacy|24|||
163430976|NCT01309737|590281959|FG003|Week 0 to 16|Lack of Efficacy|0|||
163430977|NCT01309737|590281960|FG004|Week 0 to 16|Lack of Efficacy|0|||
163430978|NCT01309737|590281956|FG000|Week 0 to 16|Lost to Follow-up|7|||
163430979|NCT01309737|590281957|FG001|Week 0 to 16|Lost to Follow-up|8|||
163430980|NCT01309737|590281958|FG002|Week 0 to 16|Lost to Follow-up|3|||
163430981|NCT01309737|590281959|FG003|Week 0 to 16|Lost to Follow-up|0|||
163430982|NCT01309737|590281960|FG004|Week 0 to 16|Lost to Follow-up|0|||
163430983|NCT01309737|590281956|FG000|Week 0 to 16|Withdrawal by Subject|7|||
163430984|NCT01309737|590281957|FG001|Week 0 to 16|Withdrawal by Subject|6|||
163430985|NCT01309737|590281958|FG002|Week 0 to 16|Withdrawal by Subject|7|||
163430986|NCT01309737|590281959|FG003|Week 0 to 16|Withdrawal by Subject|0|||
163430987|NCT01309737|590281960|FG004|Week 0 to 16|Withdrawal by Subject|0|||
163430988|NCT01309737|590281956|FG000|Week 0 to 16|Other|10|||
163430989|NCT01309737|590281957|FG001|Week 0 to 16|Other|14|||
163430990|NCT01309737|590281958|FG002|Week 0 to 16|Other|4|||
163430991|NCT01309737|590281959|FG003|Week 0 to 16|Other|0|||
163430992|NCT01309737|590281960|FG004|Week 0 to 16|Other|0|||
163430993|NCT01309737|590281956|FG000|Week 0 to 16|Randomized, but not treated|1|||
163430994|NCT01309737|590281957|FG001|Week 0 to 16|Randomized, but not treated|0|||
163430995|NCT01309737|590281958|FG002|Week 0 to 16|Randomized, but not treated|0|||
163430996|NCT01309737|590281959|FG003|Week 0 to 16|Randomized, but not treated|0|||
163430997|NCT01309737|590281960|FG004|Week 0 to 16|Randomized, but not treated|0|||
163430998|NCT01309737|590281956|FG000|Week 16 to 52|Death|0|||
163430999|NCT01309737|590281957|FG001|Week 16 to 52|Death|0|||
163431000|NCT01309737|590281958|FG002|Week 16 to 52|Death|0|||
163431001|NCT01309737|590281959|FG003|Week 16 to 52|Death|0|||
163431002|NCT01309737|590281960|FG004|Week 16 to 52|Death|1|||
163431003|NCT01309737|590281956|FG000|Week 16 to 52|Adverse Event|7|||
163431004|NCT01309737|590281957|FG001|Week 16 to 52|Adverse Event|7|||
163431005|NCT01309737|590281958|FG002|Week 16 to 52|Adverse Event|0|||
163431006|NCT01309737|590281959|FG003|Week 16 to 52|Adverse Event|6|||
163431007|NCT01309737|590281960|FG004|Week 16 to 52|Adverse Event|5|||
163431008|NCT01309737|590281956|FG000|Week 16 to 52|Lack of Efficacy|107|||
163431009|NCT01309737|590281957|FG001|Week 16 to 52|Lack of Efficacy|76|||
163431010|NCT01309737|590281958|FG002|Week 16 to 52|Lack of Efficacy|0|||
163431011|NCT01309737|590281959|FG003|Week 16 to 52|Lack of Efficacy|25|||
163431012|NCT01309737|590281960|FG004|Week 16 to 52|Lack of Efficacy|21|||
163431013|NCT01309737|590281956|FG000|Week 16 to 52|Lost to Follow-up|4|||
163431014|NCT01309737|590281957|FG001|Week 16 to 52|Lost to Follow-up|2|||
163431015|NCT01309737|590281958|FG002|Week 16 to 52|Lost to Follow-up|0|||
163431016|NCT01309737|590281959|FG003|Week 16 to 52|Lost to Follow-up|1|||
163431017|NCT01309737|590281960|FG004|Week 16 to 52|Lost to Follow-up|4|||
163431018|NCT01309737|590281956|FG000|Week 16 to 52|Withdrawal by Subject|5|||
163431019|NCT01309737|590281957|FG001|Week 16 to 52|Withdrawal by Subject|6|||
163431020|NCT01309737|590281958|FG002|Week 16 to 52|Withdrawal by Subject|0|||
163431021|NCT01309737|590281959|FG003|Week 16 to 52|Withdrawal by Subject|0|||
163431022|NCT01309737|590281960|FG004|Week 16 to 52|Withdrawal by Subject|2|||
163431023|NCT01309737|590281956|FG000|Week 16 to 52|Other|10|||
163431024|NCT01309737|590281957|FG001|Week 16 to 52|Other|12|||
163431025|NCT01309737|590281958|FG002|Week 16 to 52|Other|0|||
163431026|NCT01309737|590281959|FG003|Week 16 to 52|Other|2|||
163431027|NCT01309737|590281960|FG004|Week 16 to 52|Other|0|||
163431028|NCT01442181|590281962|FG000|Overall Study|patient refused surgery|1|||
163431029|NCT01442181|590281963|FG001|Overall Study|patient refused surgery|0|||
163431030|NCT01442181|590281962|FG000|Overall Study|no insurance for surgery|1|||
163431031|NCT01442181|590281963|FG001|Overall Study|no insurance for surgery|0|||
163431032|NCT01442181|590281962|FG000|Overall Study|low ejection factor|0|||
163431033|NCT01442181|590281963|FG001|Overall Study|low ejection factor|1|||
163431034|NCT01442181|590281962|FG000|Overall Study|Lost to Follow-up|1|||
163431035|NCT01442181|590281963|FG001|Overall Study|Lost to Follow-up|1|||
163431036|NCT01442181|590281962|FG000|Overall Study|patient in an additional study|1|||
163431037|NCT01442181|590281963|FG001|Overall Study|patient in an additional study|0|||
163431038|NCT01442181|590281962|FG000|Overall Study|atrial fibrillation not noted|0|||
163431039|NCT01442181|590281963|FG001|Overall Study|atrial fibrillation not noted|1|||
163431040|NCT00749203|590281964|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
163431041|NCT00749203|590281965|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
163431042|NCT00749203|590281964|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
163431043|NCT00749203|590281965|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
163431044|NCT00749203|590281964|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
163431045|NCT00749203|590281965|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
163431046|NCT00749203|590281964|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
163431047|NCT00749203|590281965|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
163431048|NCT00749203|590281964|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
163431049|NCT00749203|590281965|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
163431050|NCT00749203|590281964|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
163431051|NCT00749203|590281965|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
163431052|NCT02034123|590281966|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
163431053|NCT02034123|590281967|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
163431054|NCT02034123|590281968|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
163431055|NCT02034123|590281969|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
163431056|NCT02034123|590281970|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
163431057|NCT02034123|590281971|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
163431058|NCT02034123|590281972|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
163431059|NCT02034123|590281973|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
163431060|NCT02034123|590281974|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
163431061|NCT02034123|590281975|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
163431062|NCT02034123|590281976|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
163431063|NCT02034123|590281977|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
163431064|NCT02034123|590281978|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
163431065|NCT02034123|590281979|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
163431066|NCT02034123|590281980|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
163431067|NCT02034123|590281981|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
163431068|NCT02034123|590281982|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
163431069|NCT02034123|590281983|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
163431070|NCT02034123|590281966|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431071|NCT02034123|590281967|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431072|NCT02034123|590281968|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431073|NCT02034123|590281969|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
163431074|NCT02034123|590281970|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431075|NCT02034123|590281971|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431076|NCT02034123|590281972|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431077|NCT02034123|590281973|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431078|NCT02034123|590281974|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431079|NCT02034123|590281975|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431080|NCT02034123|590281976|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431081|NCT02034123|590281977|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431082|NCT02034123|590281978|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431083|NCT02034123|590281979|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431084|NCT02034123|590281980|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431085|NCT02034123|590281981|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431086|NCT02034123|590281982|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431087|NCT02034123|590281983|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
163431088|NCT02034123|590281966|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431089|NCT02034123|590281967|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431090|NCT02034123|590281968|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431091|NCT02034123|590281969|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431092|NCT02034123|590281970|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431093|NCT02034123|590281971|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431094|NCT02034123|590281972|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431095|NCT02034123|590281973|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431096|NCT02034123|590281974|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
163431097|NCT02034123|590281975|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431098|NCT02034123|590281976|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431099|NCT02034123|590281977|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431100|NCT02034123|590281978|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431101|NCT02034123|590281979|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431102|NCT02034123|590281980|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431103|NCT02034123|590281981|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431104|NCT02034123|590281982|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431105|NCT02034123|590281983|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
163431106|NCT02034123|590281966|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431107|NCT02034123|590281967|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431108|NCT02034123|590281968|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431109|NCT02034123|590281969|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
163431110|NCT02034123|590281970|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
163431111|NCT02034123|590281971|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431112|NCT02034123|590281972|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431113|NCT02034123|590281973|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431114|NCT02034123|590281974|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431115|NCT02034123|590281975|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431116|NCT02034123|590281976|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431117|NCT02034123|590281977|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431118|NCT02034123|590281978|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431119|NCT02034123|590281979|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431120|NCT02034123|590281980|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431121|NCT02034123|590281981|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431122|NCT02034123|590281982|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431123|NCT02034123|590281983|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
163431124|NCT00246259|590281984|FG000|Overall Study|Other|3|||
163431125|NCT00246259|590281985|FG001|Overall Study|Other|3|||
163431126|NCT00246259|590281984|FG000|Overall Study|Not stable by Week 18|2|||
163431127|NCT00246259|590281985|FG001|Overall Study|Not stable by Week 18|1|||
163431128|NCT00246259|590281984|FG000|Overall Study|Participant non-compliant|4|||
163431129|NCT00246259|590281985|FG001|Overall Study|Participant non-compliant|9|||
163431130|NCT00246259|590281984|FG000|Overall Study|Lack of Efficacy|2|||
163431131|NCT00246259|590281985|FG001|Overall Study|Lack of Efficacy|2|||
163431132|NCT00246259|590281984|FG000|Overall Study|Investigator withdrew participant|2|||
163431133|NCT00246259|590281985|FG001|Overall Study|Investigator withdrew participant|0|||
163431134|NCT00246259|590281984|FG000|Overall Study|Adverse Event|5|||
163431135|NCT00246259|590281985|FG001|Overall Study|Adverse Event|0|||
163431136|NCT00246259|590281984|FG000|Overall Study|Lost to Follow-up|3|||
163431137|NCT00246259|590281985|FG001|Overall Study|Lost to Follow-up|4|||
163431138|NCT00246259|590281984|FG000|Overall Study|Withdrawal by Subject|5|||
163431139|NCT00246259|590281985|FG001|Overall Study|Withdrawal by Subject|1|||
163431140|NCT00246259|590281984|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
163431141|NCT00246259|590281985|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
163431142|NCT00855439|590281986|FG000|Overall Study|Withdrawal by Subject|2|||
163431143|NCT00855439|590281987|FG001|Overall Study|Withdrawal by Subject|0|||
163431144|NCT00855439|590281986|FG000|Overall Study|Pregnancy|1|||
163431145|NCT00855439|590281987|FG001|Overall Study|Pregnancy|0|||
163431146|NCT01564784|590281992|FG000|Overall Study|Other|1|||
163431147|NCT01564784|590281993|FG001|Overall Study|Other|0|||
163431148|NCT01564784|590281992|FG000|Overall Study|Subject refused further follow-up|1|||
163431149|NCT01564784|590281993|FG001|Overall Study|Subject refused further follow-up|6|||
163431150|NCT01564784|590281992|FG000|Overall Study|Lost to Follow-up|1|||
163431151|NCT01564784|590281993|FG001|Overall Study|Lost to Follow-up|1|||
163431152|NCT01564784|590281992|FG000|Overall Study|Death|131|||
163431153|NCT01564784|590281993|FG001|Overall Study|Death|126|||
163431154|NCT02272790|590281994|FG000|Overall Study|Physician Decision|0|||
163431155|NCT02272790|590281995|FG001|Overall Study|Physician Decision|1|||
163431156|NCT02272790|590281996|FG002|Overall Study|Physician Decision|0|||
163431157|NCT02272790|590281997|FG003|Overall Study|Physician Decision|0|||
163431158|NCT02272790|590281998|FG004|Overall Study|Physician Decision|0|||
163431159|NCT02272790|590281999|FG005|Overall Study|Physician Decision|0|||
163431160|NCT03022461|590282000|FG000|Overall Study|Death|3|||
163431161|NCT01982630|590282001|FG000|Overall Study|Adverse Event|2|||
163431162|NCT01982630|590282002|FG001|Overall Study|Adverse Event|0|||
163431163|NCT01982630|590282003|FG002|Overall Study|Adverse Event|1|||
163431164|NCT01982630|590282004|FG003|Overall Study|Adverse Event|0|||
163431165|NCT01982630|590282005|FG004|Overall Study|Adverse Event|1|||
163431166|NCT01982630|590282006|FG005|Overall Study|Adverse Event|2|||
163431167|NCT01982630|590282007|FG006|Overall Study|Adverse Event|1|||
163431168|NCT01982630|590282008|FG007|Overall Study|Adverse Event|0|||
163431169|NCT01982630|590282001|FG000|Overall Study|Physician Decision|1|||
163431170|NCT01982630|590282002|FG001|Overall Study|Physician Decision|0|||
163431171|NCT01982630|590282003|FG002|Overall Study|Physician Decision|2|||
163431172|NCT01982630|590282004|FG003|Overall Study|Physician Decision|1|||
163431173|NCT01982630|590282005|FG004|Overall Study|Physician Decision|2|||
163431174|NCT01982630|590282006|FG005|Overall Study|Physician Decision|0|||
163431175|NCT01982630|590282007|FG006|Overall Study|Physician Decision|0|||
163431176|NCT01982630|590282008|FG007|Overall Study|Physician Decision|0|||
163431177|NCT01982630|590282001|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
163431178|NCT01982630|590282002|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
163431179|NCT01982630|590282003|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
163431180|NCT01982630|590282004|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
163431181|NCT01982630|590282005|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
163431182|NCT01982630|590282006|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
163431183|NCT01982630|590282007|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
163431184|NCT01982630|590282008|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
163431185|NCT01982630|590282001|FG000|Overall Study|Withdrawal by Subject|0|||
163431186|NCT01982630|590282002|FG001|Overall Study|Withdrawal by Subject|0|||
163431187|NCT01982630|590282003|FG002|Overall Study|Withdrawal by Subject|0|||
163431188|NCT01982630|590282004|FG003|Overall Study|Withdrawal by Subject|0|||
163431189|NCT01982630|590282005|FG004|Overall Study|Withdrawal by Subject|0|||
163431190|NCT01982630|590282006|FG005|Overall Study|Withdrawal by Subject|1|||
163431191|NCT01982630|590282007|FG006|Overall Study|Withdrawal by Subject|0|||
163431192|NCT01982630|590282008|FG007|Overall Study|Withdrawal by Subject|0|||
163431193|NCT01076179|590282009|FG000|Overall Study|Withdrawal by Subject|1|||
163431194|NCT00986349|590282010|FG000|Overall Study|Unsuccessful implant procedure|3|||
163431195|NCT00986349|590282010|FG000|Overall Study|Adverse Event|2|||
163431196|NCT00986349|590282010|FG000|Overall Study|Physician Decision|1|||
163431197|NCT00986349|590282010|FG000|Overall Study|device migration|1|||
163431198|NCT02299934|590282011|FG000|Overall Study|Termination of study|13|||
163431199|NCT00561353|590282012|FG000|Overall Study|Subject reached a virologic endpoint|2|||
163431200|NCT00561353|590282013|FG001|Overall Study|Subject reached a virologic endpoint|1|||
163431201|NCT00561353|590282014|FG002|Overall Study|Subject reached a virologic endpoint|1|||
163431202|NCT00561353|590282015|FG003|Overall Study|Subject reached a virologic endpoint|4|||
163431203|NCT00561353|590282016|FG004|Overall Study|Subject reached a virologic endpoint|1|||
163431204|NCT00561353|590282017|FG005|Overall Study|Subject reached a virologic endpoint|3|||
163431205|NCT00561353|590282018|FG006|Overall Study|Subject reached a virologic endpoint|4|||
163431206|NCT00561353|590282019|FG007|Overall Study|Subject reached a virologic endpoint|4|||
163431207|NCT00561353|590282020|FG008|Overall Study|Subject reached a virologic endpoint|5|||
163431208|NCT00561353|590282021|FG009|Overall Study|Subject reached a virologic endpoint|0|||
163431209|NCT00561353|590282012|FG000|Overall Study|Subject ineligible to continue the trial|0|||
163431210|NCT00561353|590282013|FG001|Overall Study|Subject ineligible to continue the trial|0|||
163431211|NCT00561353|590282014|FG002|Overall Study|Subject ineligible to continue the trial|0|||
163431212|NCT00561353|590282015|FG003|Overall Study|Subject ineligible to continue the trial|0|||
163431213|NCT00561353|590282016|FG004|Overall Study|Subject ineligible to continue the trial|0|||
163431214|NCT00561353|590282017|FG005|Overall Study|Subject ineligible to continue the trial|1|||
163431215|NCT00561353|590282018|FG006|Overall Study|Subject ineligible to continue the trial|1|||
163431216|NCT00561353|590282019|FG007|Overall Study|Subject ineligible to continue the trial|0|||
163431217|NCT00561353|590282020|FG008|Overall Study|Subject ineligible to continue the trial|2|||
163431218|NCT00561353|590282021|FG009|Overall Study|Subject ineligible to continue the trial|1|||
163431219|NCT00561353|590282012|FG000|Overall Study|Other|1|||
163431220|NCT00561353|590282013|FG001|Overall Study|Other|0|||
163431221|NCT00561353|590282014|FG002|Overall Study|Other|1|||
163431222|NCT00561353|590282015|FG003|Overall Study|Other|0|||
163431223|NCT00561353|590282016|FG004|Overall Study|Other|0|||
163431224|NCT00561353|590282017|FG005|Overall Study|Other|2|||
163431225|NCT00561353|590282018|FG006|Overall Study|Other|0|||
163431226|NCT00561353|590282019|FG007|Overall Study|Other|0|||
163431227|NCT00561353|590282020|FG008|Overall Study|Other|0|||
163431228|NCT00561353|590282021|FG009|Overall Study|Other|0|||
163431229|NCT00561353|590282012|FG000|Overall Study|Adverse Event|0|||
163431230|NCT00561353|590282013|FG001|Overall Study|Adverse Event|0|||
163431231|NCT00561353|590282014|FG002|Overall Study|Adverse Event|0|||
163431232|NCT00561353|590282015|FG003|Overall Study|Adverse Event|2|||
163431233|NCT00561353|590282016|FG004|Overall Study|Adverse Event|0|||
163431234|NCT00561353|590282017|FG005|Overall Study|Adverse Event|0|||
163431235|NCT00561353|590282018|FG006|Overall Study|Adverse Event|1|||
163431236|NCT00561353|590282019|FG007|Overall Study|Adverse Event|0|||
163431237|NCT00561353|590282020|FG008|Overall Study|Adverse Event|0|||
163431238|NCT00561353|590282021|FG009|Overall Study|Adverse Event|1|||
163431239|NCT00561353|590282012|FG000|Overall Study|Lost to Follow-up|2|||
163431240|NCT00561353|590282013|FG001|Overall Study|Lost to Follow-up|0|||
163431241|NCT00561353|590282014|FG002|Overall Study|Lost to Follow-up|1|||
163431242|NCT00561353|590282015|FG003|Overall Study|Lost to Follow-up|0|||
163431243|NCT00561353|590282016|FG004|Overall Study|Lost to Follow-up|0|||
163431244|NCT00561353|590282017|FG005|Overall Study|Lost to Follow-up|0|||
163431245|NCT00561353|590282018|FG006|Overall Study|Lost to Follow-up|0|||
163431246|NCT00561353|590282019|FG007|Overall Study|Lost to Follow-up|0|||
163431247|NCT00561353|590282020|FG008|Overall Study|Lost to Follow-up|0|||
163431248|NCT00561353|590282021|FG009|Overall Study|Lost to Follow-up|0|||
163431249|NCT00561353|590282012|FG000|Overall Study|Withdrawal by Subject|0|||
163431250|NCT00561353|590282013|FG001|Overall Study|Withdrawal by Subject|2|||
163431251|NCT00561353|590282014|FG002|Overall Study|Withdrawal by Subject|0|||
163431252|NCT00561353|590282015|FG003|Overall Study|Withdrawal by Subject|0|||
163431253|NCT00561353|590282016|FG004|Overall Study|Withdrawal by Subject|0|||
163431254|NCT00561353|590282017|FG005|Overall Study|Withdrawal by Subject|0|||
163431255|NCT00561353|590282018|FG006|Overall Study|Withdrawal by Subject|0|||
163431256|NCT00561353|590282019|FG007|Overall Study|Withdrawal by Subject|0|||
163431257|NCT00561353|590282020|FG008|Overall Study|Withdrawal by Subject|0|||
163431258|NCT00561353|590282021|FG009|Overall Study|Withdrawal by Subject|0|||
163431259|NCT01273818|590282022|FG000|Overall Study|Physician Decision|13|||
163431260|NCT01273818|590282023|FG001|Overall Study|Physician Decision|2|||
163431261|NCT01273818|590282024|FG002|Overall Study|Physician Decision|9|||
163431262|NCT03934684|590282029|FG000|Overall Study|Participants continuing in study|11|||
163431263|NCT03934684|590282030|FG001|Overall Study|Participants continuing in study|4|||
163431264|NCT03934684|590282029|FG000|Overall Study|Discontinuation of carfilzomib|20|||
163431265|NCT03934684|590282030|FG001|Overall Study|Discontinuation of carfilzomib|30|||
163431266|NCT03934684|590282029|FG000|Overall Study|Death|2|||
163431267|NCT03934684|590282030|FG001|Overall Study|Death|2|||
163431268|NCT03934684|590282029|FG000|Overall Study|Lost to Follow-up|2|||
163431269|NCT03934684|590282030|FG001|Overall Study|Lost to Follow-up|5|||
163431270|NCT03934684|590282029|FG000|Overall Study|Withdrawal by Subject|7|||
163431271|NCT03934684|590282030|FG001|Overall Study|Withdrawal by Subject|8|||
163431272|NCT01073943|590282031|FG000|Overall Study|Withdrawal by Subject|8|||
163431273|NCT01073943|590282032|FG001|Overall Study|Withdrawal by Subject|2|||
163431274|NCT01073943|590282031|FG000|Overall Study|Protocol Violation|2|||
163431275|NCT01073943|590282032|FG001|Overall Study|Protocol Violation|1|||
163431276|NCT01073943|590282031|FG000|Overall Study|Adverse Event|1|||
163431277|NCT01073943|590282032|FG001|Overall Study|Adverse Event|1|||
163431278|NCT01073943|590282031|FG000|Overall Study|Lost to Follow-up|0|||
163431279|NCT01073943|590282032|FG001|Overall Study|Lost to Follow-up|2|||
163431280|NCT01073943|590282031|FG000|Overall Study|Power outage; colonoscopy not done|1|||
163431281|NCT01073943|590282032|FG001|Overall Study|Power outage; colonoscopy not done|0|||
163431282|NCT01073943|590282031|FG000|Overall Study|Subject forgot|0|||
163431283|NCT01073943|590282032|FG001|Overall Study|Subject forgot|1|||
163431284|NCT01073943|590282031|FG000|Overall Study|Unable to return for follow-up|0|||
163431285|NCT01073943|590282032|FG001|Overall Study|Unable to return for follow-up|1|||
163431286|NCT01073943|590282031|FG000|Overall Study|Could not tolerate prep|1|||
163431287|NCT01073943|590282032|FG001|Overall Study|Could not tolerate prep|0|||
163431288|NCT00761215|590282033|FG000|Overall Study|Randomized but didn't receive drug|1|||
163431289|NCT00761215|590282034|FG001|Overall Study|Randomized but didn't receive drug|1|||
163431290|NCT00761215|590282035|FG002|Overall Study|Randomized but didn't receive drug|2|||
163431291|NCT00761215|590282033|FG000|Overall Study|Lost to Follow-up|6|||
163431292|NCT00761215|590282034|FG001|Overall Study|Lost to Follow-up|3|||
163431293|NCT00761215|590282035|FG002|Overall Study|Lost to Follow-up|6|||
163431294|NCT00761215|590282033|FG000|Overall Study|Withdrawal by Subject|1|||
163431295|NCT00761215|590282034|FG001|Overall Study|Withdrawal by Subject|0|||
163431296|NCT00761215|590282035|FG002|Overall Study|Withdrawal by Subject|0|||
163431297|NCT00761215|590282033|FG000|Overall Study|Bacteremia|1|||
163431298|NCT00761215|590282034|FG001|Overall Study|Bacteremia|0|||
163431299|NCT00761215|590282035|FG002|Overall Study|Bacteremia|0|||
163431300|NCT05662332|590282036|FG000|Overall Study|Death|3|||
163431301|NCT05662332|590282037|FG001|Overall Study|Death|3|||
163431302|NCT05662332|590282036|FG000|Overall Study|Lost to Follow-up|3|||
163431303|NCT05662332|590282037|FG001|Overall Study|Lost to Follow-up|8|||
163431304|NCT05662332|590282036|FG000|Overall Study|Physician Decision|1|||
163431305|NCT05662332|590282037|FG001|Overall Study|Physician Decision|2|||
163431306|NCT05662332|590282036|FG000|Overall Study|Protocol Deviation|2|||
163431307|NCT05662332|590282037|FG001|Overall Study|Protocol Deviation|1|||
163431308|NCT05662332|590282036|FG000|Overall Study|Withdrawal by Subject|14|||
163431309|NCT05662332|590282037|FG001|Overall Study|Withdrawal by Subject|14|||
163431310|NCT05662332|590282036|FG000|Overall Study|Assigned Treatment by Mistake|5|||
163431311|NCT05662332|590282037|FG001|Overall Study|Assigned Treatment by Mistake|7|||
163431312|NCT05662332|590282036|FG000|Overall Study|Non-compliance with study drug|4|||
163431313|NCT05662332|590282037|FG001|Overall Study|Non-compliance with study drug|1|||
163431314|NCT05662332|590282036|FG000|Overall Study|Due to Bariatric surgery|1|||
163431315|NCT05662332|590282037|FG001|Overall Study|Due to Bariatric surgery|0|||
163431316|NCT05662332|590282036|FG000|Overall Study|Subject Moving out of State|0|||
163431317|NCT05662332|590282037|FG001|Overall Study|Subject Moving out of State|1|||
163431318|NCT05662332|590282036|FG000|Overall Study|Subject Missed the Schedule|1|||
163431319|NCT05662332|590282037|FG001|Overall Study|Subject Missed the Schedule|0|||
163431320|NCT05662332|590282036|FG000|Overall Study|The Patient Moved to Another City|1|||
163431321|NCT05662332|590282037|FG001|Overall Study|The Patient Moved to Another City|0|||
163431322|NCT00947349|590282038|FG000|Triple Treatment Combination Period|Adverse Event|0|||
163431323|NCT00947349|590282039|FG001|Triple Treatment Combination Period|Adverse Event|1|||
163431324|NCT00947349|590282040|FG002|Triple Treatment Combination Period|Adverse Event|0|||
163431325|NCT00947349|590282041|FG003|Triple Treatment Combination Period|Adverse Event|0|||
163431326|NCT00947349|590282038|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
163431327|NCT00947349|590282039|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
163431328|NCT00947349|590282040|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
163431329|NCT00947349|590282041|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
163431330|NCT00947349|590282038|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
163431331|NCT00947349|590282039|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
163431332|NCT00947349|590282040|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
163431333|NCT00947349|590282041|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
163431334|NCT00947349|590282038|FG000|Overall Study Standard of Care|Other|0|||
163431335|NCT00947349|590282039|FG001|Overall Study Standard of Care|Other|0|||
163431336|NCT00947349|590282040|FG002|Overall Study Standard of Care|Other|0|||
163431337|NCT00947349|590282041|FG003|Overall Study Standard of Care|Other|1|||
163431338|NCT00538681|590282042|FG000|Overall Study|Progressive Disease|7|||
163431339|NCT00538681|590282043|FG001|Overall Study|Progressive Disease|0|||
163431340|NCT00538681|590282044|FG002|Overall Study|Progressive Disease|1|||
163431341|NCT00538681|590282045|FG003|Overall Study|Progressive Disease|0|||
163431342|NCT00538681|590282042|FG000|Overall Study|Sponsor Decision|1|||
163431343|NCT00538681|590282043|FG001|Overall Study|Sponsor Decision|3|||
163431344|NCT00538681|590282044|FG002|Overall Study|Sponsor Decision|8|||
163431345|NCT00538681|590282045|FG003|Overall Study|Sponsor Decision|9|||
163431346|NCT00538681|590282042|FG000|Overall Study|Adverse Event|1|||
163431347|NCT00538681|590282043|FG001|Overall Study|Adverse Event|1|||
163431348|NCT00538681|590282044|FG002|Overall Study|Adverse Event|1|||
163431349|NCT00538681|590282045|FG003|Overall Study|Adverse Event|0|||
163431350|NCT00538681|590282042|FG000|Overall Study|Death|0|||
163431351|NCT00538681|590282043|FG001|Overall Study|Death|0|||
163431352|NCT00538681|590282044|FG002|Overall Study|Death|1|||
163431353|NCT00538681|590282045|FG003|Overall Study|Death|1|||
163431354|NCT00538681|590282042|FG000|Overall Study|Investigator Decision|0|||
163431355|NCT00538681|590282043|FG001|Overall Study|Investigator Decision|0|||
163431356|NCT00538681|590282044|FG002|Overall Study|Investigator Decision|0|||
163431357|NCT00538681|590282045|FG003|Overall Study|Investigator Decision|1|||
163431358|NCT00628355|590282046|FG000|Overall Study|Withdrawal by Subject|1|||
163431359|NCT00628355|590282047|FG001|Overall Study|Withdrawal by Subject|1|||
163431360|NCT01446809|590282048|FG000|Overall Study|Adverse Event|0|||
163431361|NCT01446809|590282049|FG001|Overall Study|Adverse Event|0|||
163431362|NCT01446809|590282050|FG002|Overall Study|Adverse Event|1|||
163431363|NCT01446809|590282048|FG000|Overall Study|Failure to complete study procedures|0|||
163431364|NCT01446809|590282049|FG001|Overall Study|Failure to complete study procedures|0|||
163431365|NCT01446809|590282050|FG002|Overall Study|Failure to complete study procedures|1|||
163431366|NCT03395210|590283388|FG000|Overall Study|Other|0|||
163431367|NCT03395210|590283389|FG001|Overall Study|Other|0|||
163431368|NCT03395210|590283390|FG002|Overall Study|Other|0|||
163431369|NCT03395210|590283391|FG003|Overall Study|Other|0|||
163431370|NCT03395210|590283392|FG004|Overall Study|Other|1|||
163431371|NCT03395210|590283388|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
163431372|NCT03395210|590283389|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
163431373|NCT03395210|590283390|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
163431374|NCT03395210|590283391|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
163431375|NCT03395210|590283392|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
163431376|NCT03395210|590283388|FG000|Overall Study|Adverse Event|1|||
163431377|NCT03395210|590283389|FG001|Overall Study|Adverse Event|0|||
163431378|NCT03395210|590283390|FG002|Overall Study|Adverse Event|2|||
163431379|NCT03395210|590283391|FG003|Overall Study|Adverse Event|4|||
163431380|NCT03395210|590283392|FG004|Overall Study|Adverse Event|3|||
163431381|NCT03395210|590283388|FG000|Overall Study|Need of Rescue Medication|1|||
163431382|NCT03395210|590283389|FG001|Overall Study|Need of Rescue Medication|0|||
163431383|NCT03395210|590283390|FG002|Overall Study|Need of Rescue Medication|1|||
163431384|NCT03395210|590283391|FG003|Overall Study|Need of Rescue Medication|4|||
163431385|NCT03395210|590283392|FG004|Overall Study|Need of Rescue Medication|0|||
163431386|NCT03395210|590283388|FG000|Overall Study|Lack of Response|0|||
163431387|NCT03395210|590283389|FG001|Overall Study|Lack of Response|0|||
163431388|NCT03395210|590283390|FG002|Overall Study|Lack of Response|0|||
163431389|NCT03395210|590283391|FG003|Overall Study|Lack of Response|5|||
163431390|NCT03395210|590283392|FG004|Overall Study|Lack of Response|5|||
163431391|NCT03395210|590283388|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
163431392|NCT03395210|590283389|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
163431393|NCT03395210|590283390|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
163431394|NCT03395210|590283391|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
163431395|NCT03395210|590283392|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
163431396|NCT03395210|590283388|FG000|Overall Study|Participant Decision|1|||
163431397|NCT03395210|590283389|FG001|Overall Study|Participant Decision|1|||
163431398|NCT03395210|590283390|FG002|Overall Study|Participant Decision|0|||
163431399|NCT03395210|590283391|FG003|Overall Study|Participant Decision|4|||
163431400|NCT03395210|590283392|FG004|Overall Study|Participant Decision|0|||
163431401|NCT03395210|590283388|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
163431402|NCT03395210|590283389|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
163431403|NCT03395210|590283390|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
163431404|NCT03395210|590283391|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
163431405|NCT03395210|590283392|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
163431406|NCT01006356|590283393|FG000|Overall Study|Adverse Event|6|||
163431407|NCT01006356|590283393|FG000|Overall Study|Physician Decision|1|||
163431408|NCT01006356|590283393|FG000|Overall Study|Paticipants did not cooperate|6|||
163431409|NCT01006356|590283393|FG000|Overall Study|Withdrawal by Subject|1|||
163431410|NCT01006356|590283393|FG000|Overall Study|Choice by participants|2|||
163431411|NCT01006356|590283393|FG000|Overall Study|Protocol Violation|3|||
163431412|NCT01006356|590283393|FG000|Overall Study|Other|23|||
163431413|NCT03368859|590283400|FG000|Overall Study|Withdrew Consent|5|||
163431414|NCT03368859|590283401|FG001|Overall Study|Withdrew Consent|4|||
163431415|NCT03368859|590283400|FG000|Overall Study|Death|12|||
163431416|NCT03368859|590283401|FG001|Overall Study|Death|6|||
163431417|NCT03368859|590283400|FG000|Overall Study|Study terminated by Sponsor|18|||
163431418|NCT03368859|590283401|FG001|Overall Study|Study terminated by Sponsor|23|||
163431419|NCT03368859|590283400|FG000|Overall Study|Other|1|||
163431420|NCT03368859|590283401|FG001|Overall Study|Other|1|||
163431421|NCT02559505|590283407|FG000|Overall Study|Lost to Follow-up|23|||
163431422|NCT02559505|590283408|FG001|Overall Study|Lost to Follow-up|20|||
163431423|NCT02559505|590283407|FG000|Overall Study|Withdrawal by Subject|4|||
163431424|NCT02559505|590283408|FG001|Overall Study|Withdrawal by Subject|2|||
163431425|NCT03523585|590283409|FG000|Overall Study|Progressive Disease|174|||
163431426|NCT03523585|590283410|FG001|Overall Study|Progressive Disease|64|||
163431427|NCT03523585|590283411|FG002|Overall Study|Progressive Disease|77|||
163431428|NCT03523585|590283409|FG000|Overall Study|Adverse Event|74|||
163431429|NCT03523585|590283410|FG001|Overall Study|Adverse Event|5|||
163431430|NCT03523585|590283411|FG002|Overall Study|Adverse Event|9|||
163431431|NCT03523585|590283409|FG000|Overall Study|Withdrawal by Subject|30|||
163431432|NCT03523585|590283410|FG001|Overall Study|Withdrawal by Subject|11|||
163431433|NCT03523585|590283411|FG002|Overall Study|Withdrawal by Subject|6|||
163431434|NCT03523585|590283409|FG000|Overall Study|Clinical Progression|23|||
163431435|NCT03523585|590283410|FG001|Overall Study|Clinical Progression|5|||
163431436|NCT03523585|590283411|FG002|Overall Study|Clinical Progression|10|||
163431437|NCT03523585|590283409|FG000|Overall Study|Death|4|||
163431438|NCT03523585|590283410|FG001|Overall Study|Death|0|||
163431439|NCT03523585|590283411|FG002|Overall Study|Death|1|||
163431440|NCT03523585|590283409|FG000|Overall Study|Physician Decision|2|||
163431441|NCT03523585|590283410|FG001|Overall Study|Physician Decision|1|||
163431442|NCT03523585|590283411|FG002|Overall Study|Physician Decision|0|||
163431443|NCT03523585|590283409|FG000|Overall Study|Lost to Follow-up|1|||
163431444|NCT03523585|590283410|FG001|Overall Study|Lost to Follow-up|0|||
163431445|NCT03523585|590283411|FG002|Overall Study|Lost to Follow-up|0|||
163431446|NCT03523585|590283409|FG000|Overall Study|Miscellaneous|1|||
163431447|NCT03523585|590283410|FG001|Overall Study|Miscellaneous|0|||
163431448|NCT03523585|590283411|FG002|Overall Study|Miscellaneous|0|||
163431449|NCT03523585|590283409|FG000|Overall Study|Protocol Deviation|1|||
163431450|NCT03523585|590283410|FG001|Overall Study|Protocol Deviation|0|||
163431451|NCT03523585|590283411|FG002|Overall Study|Protocol Deviation|1|||
163431452|NCT03523585|590283409|FG000|Overall Study|Randomized But Not Treated|2|||
163431453|NCT03523585|590283410|FG001|Overall Study|Randomized But Not Treated|4|||
163431454|NCT03523585|590283411|FG002|Overall Study|Randomized But Not Treated|3|||
163431455|NCT02874794|590283414|FG000|Overall Study|Physician Decision|3|||
163431456|NCT02874794|590283415|FG001|Overall Study|Physician Decision|2|||
163431457|NCT02874794|590283414|FG000|Overall Study|Withdrawal by Subject|2|||
163431458|NCT02874794|590283415|FG001|Overall Study|Withdrawal by Subject|8|||
163431459|NCT02874794|590283414|FG000|Overall Study|Death|2|||
163431460|NCT02874794|590283415|FG001|Overall Study|Death|1|||
163431461|NCT01473004|590283416|FG000|Overall Study|Incomplete Lobar Treatment|1|||
163431462|NCT01473004|590283417|FG001|Overall Study|Incomplete Lobar Treatment|0|||
163431463|NCT00698516|590283418|FG000|Overall Study|Study Termination|2|||
163431464|NCT00698516|590283418|FG000|Overall Study|Withdrawal by Subject|3|||
163431465|NCT05882890|590283419|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
163431466|NCT00613314|590283422|FG000|Overall Study|Adverse Event|5|||
163431467|NCT00613314|590283422|FG000|Overall Study|Protocol Violation|14|||
163431468|NCT00613314|590283422|FG000|Overall Study|Lost to Follow-up|46|||
163431469|NCT00613314|590283422|FG000|Overall Study|Other reason not defined above|90|||
163431470|NCT03090191|590283423|FG000|Overall Study|Adverse Event|90|||
163431471|NCT03090191|590283424|FG001|Overall Study|Adverse Event|72|||
163431472|NCT03090191|590283423|FG000|Overall Study|Death|365|||
163431473|NCT03090191|590283424|FG001|Overall Study|Death|358|||
163431474|NCT03090191|590283423|FG000|Overall Study|Lost to Follow-up|382|||
163431475|NCT03090191|590283424|FG001|Overall Study|Lost to Follow-up|394|||
163431476|NCT03090191|590283423|FG000|Overall Study|Physician Decision|77|||
163431477|NCT03090191|590283424|FG001|Overall Study|Physician Decision|66|||
163431478|NCT03090191|590283423|FG000|Overall Study|Protocol Violation|43|||
163431479|NCT03090191|590283424|FG001|Overall Study|Protocol Violation|52|||
163431480|NCT03090191|590283423|FG000|Overall Study|Withdrawal by Subject|2160|||
163431481|NCT03090191|590283424|FG001|Overall Study|Withdrawal by Subject|2133|||
163431482|NCT03090191|590283423|FG000|Overall Study|Site terminated|7|||
163431483|NCT03090191|590283424|FG001|Overall Study|Site terminated|8|||
163431484|NCT03090191|590283423|FG000|Overall Study|Other|66|||
163431485|NCT03090191|590283424|FG001|Overall Study|Other|60|||
163431486|NCT03090191|590283423|FG000|Overall Study|Withdrawn before any study vaccination|43|||
163431487|NCT03090191|590283424|FG001|Overall Study|Withdrawn before any study vaccination|52|||
163431488|NCT01324830|590283427|FG000|Overall Study|Progressive Disease|3|||
163431489|NCT01324830|590283428|FG001|Overall Study|Progressive Disease|2|||
163431490|NCT01324830|590283429|FG002|Overall Study|Progressive Disease|3|||
163431491|NCT01324830|590283430|FG003|Overall Study|Progressive Disease|3|||
163431492|NCT01324830|590283431|FG004|Overall Study|Progressive Disease|6|||
163431493|NCT01324830|590283432|FG005|Overall Study|Progressive Disease|6|||
163431494|NCT01324830|590283433|FG006|Overall Study|Progressive Disease|3|||
163431495|NCT01324830|590283434|FG007|Overall Study|Progressive Disease|3|||
163431496|NCT01324830|590283435|FG008|Overall Study|Progressive Disease|3|||
163431497|NCT01324830|590283436|FG009|Overall Study|Progressive Disease|6|||
163431498|NCT01324830|590283437|FG010|Overall Study|Progressive Disease|2|||
163431499|NCT01324830|590283438|FG011|Overall Study|Progressive Disease|1|||
163431500|NCT01324830|590283439|FG012|Overall Study|Progressive Disease|1|||
163431501|NCT01324830|590283440|FG013|Overall Study|Progressive Disease|1|||
163431502|NCT01324830|590283441|FG014|Overall Study|Progressive Disease|1|||
163431503|NCT01324830|590283442|FG015|Overall Study|Progressive Disease|3|||
163431504|NCT01324830|590283443|FG016|Overall Study|Progressive Disease|2|||
163431505|NCT01324830|590283444|FG017|Overall Study|Progressive Disease|3|||
163431506|NCT01324830|590283445|FG018|Overall Study|Progressive Disease|4|||
163431507|NCT01324830|590283427|FG000|Overall Study|Dose limiting toxicity|0|||
163431508|NCT01324830|590283428|FG001|Overall Study|Dose limiting toxicity|0|||
163431509|NCT01324830|590283429|FG002|Overall Study|Dose limiting toxicity|0|||
163431510|NCT01324830|590283430|FG003|Overall Study|Dose limiting toxicity|0|||
163431511|NCT01324830|590283431|FG004|Overall Study|Dose limiting toxicity|1|||
163431512|NCT01324830|590283432|FG005|Overall Study|Dose limiting toxicity|0|||
163431513|NCT01324830|590283433|FG006|Overall Study|Dose limiting toxicity|0|||
163431514|NCT01324830|590283434|FG007|Overall Study|Dose limiting toxicity|0|||
163431515|NCT01324830|590283435|FG008|Overall Study|Dose limiting toxicity|0|||
163431516|NCT01324830|590283436|FG009|Overall Study|Dose limiting toxicity|0|||
163431517|NCT01324830|590283437|FG010|Overall Study|Dose limiting toxicity|0|||
163431518|NCT01324830|590283438|FG011|Overall Study|Dose limiting toxicity|0|||
163431519|NCT01324830|590283439|FG012|Overall Study|Dose limiting toxicity|0|||
163431520|NCT01324830|590283440|FG013|Overall Study|Dose limiting toxicity|0|||
163431521|NCT01324830|590283441|FG014|Overall Study|Dose limiting toxicity|0|||
163431522|NCT01324830|590283442|FG015|Overall Study|Dose limiting toxicity|0|||
163431523|NCT01324830|590283443|FG016|Overall Study|Dose limiting toxicity|1|||
163431524|NCT01324830|590283444|FG017|Overall Study|Dose limiting toxicity|1|||
163431525|NCT01324830|590283445|FG018|Overall Study|Dose limiting toxicity|1|||
163431526|NCT01324830|590283427|FG000|Overall Study|Reason not mentioned above|0|||
163431527|NCT01324830|590283428|FG001|Overall Study|Reason not mentioned above|0|||
163431528|NCT01324830|590283429|FG002|Overall Study|Reason not mentioned above|0|||
163431529|NCT01324830|590283430|FG003|Overall Study|Reason not mentioned above|0|||
163431530|NCT01324830|590283431|FG004|Overall Study|Reason not mentioned above|0|||
163431531|NCT01324830|590283432|FG005|Overall Study|Reason not mentioned above|0|||
163431532|NCT01324830|590283433|FG006|Overall Study|Reason not mentioned above|0|||
163431533|NCT01324830|590283434|FG007|Overall Study|Reason not mentioned above|0|||
163431534|NCT01324830|590283435|FG008|Overall Study|Reason not mentioned above|0|||
163431535|NCT01324830|590283436|FG009|Overall Study|Reason not mentioned above|0|||
163431536|NCT01324830|590283437|FG010|Overall Study|Reason not mentioned above|0|||
163431537|NCT01324830|590283438|FG011|Overall Study|Reason not mentioned above|0|||
163431538|NCT01324830|590283439|FG012|Overall Study|Reason not mentioned above|0|||
163431539|NCT01324830|590283440|FG013|Overall Study|Reason not mentioned above|0|||
163431540|NCT01324830|590283441|FG014|Overall Study|Reason not mentioned above|0|||
163431541|NCT01324830|590283442|FG015|Overall Study|Reason not mentioned above|0|||
163431542|NCT01324830|590283443|FG016|Overall Study|Reason not mentioned above|0|||
163431543|NCT01324830|590283444|FG017|Overall Study|Reason not mentioned above|1|||
163431544|NCT01324830|590283445|FG018|Overall Study|Reason not mentioned above|0|||
163431545|NCT01324830|590283427|FG000|Overall Study|Adverse Event, serious fatal|0|||
163431546|NCT01324830|590283428|FG001|Overall Study|Adverse Event, serious fatal|1|||
163431547|NCT01324830|590283429|FG002|Overall Study|Adverse Event, serious fatal|0|||
163431548|NCT01324830|590283430|FG003|Overall Study|Adverse Event, serious fatal|0|||
163431549|NCT01324830|590283431|FG004|Overall Study|Adverse Event, serious fatal|0|||
163431550|NCT01324830|590283432|FG005|Overall Study|Adverse Event, serious fatal|0|||
163431551|NCT01324830|590283433|FG006|Overall Study|Adverse Event, serious fatal|0|||
163431552|NCT01324830|590283434|FG007|Overall Study|Adverse Event, serious fatal|0|||
163431553|NCT01324830|590283435|FG008|Overall Study|Adverse Event, serious fatal|0|||
163431554|NCT01324830|590283436|FG009|Overall Study|Adverse Event, serious fatal|0|||
163431555|NCT01324830|590283437|FG010|Overall Study|Adverse Event, serious fatal|0|||
163431556|NCT01324830|590283438|FG011|Overall Study|Adverse Event, serious fatal|0|||
163431557|NCT01324830|590283439|FG012|Overall Study|Adverse Event, serious fatal|0|||
163431558|NCT01324830|590283440|FG013|Overall Study|Adverse Event, serious fatal|0|||
163431559|NCT01324830|590283441|FG014|Overall Study|Adverse Event, serious fatal|0|||
163431560|NCT01324830|590283442|FG015|Overall Study|Adverse Event, serious fatal|0|||
163431561|NCT01324830|590283443|FG016|Overall Study|Adverse Event, serious fatal|0|||
163431562|NCT01324830|590283444|FG017|Overall Study|Adverse Event, serious fatal|0|||
163431563|NCT01324830|590283445|FG018|Overall Study|Adverse Event, serious fatal|0|||
163431564|NCT01324830|590283427|FG000|Overall Study|Adverse Event, non-fatal|0|||
163431565|NCT01324830|590283428|FG001|Overall Study|Adverse Event, non-fatal|0|||
163431566|NCT01324830|590283429|FG002|Overall Study|Adverse Event, non-fatal|0|||
163431567|NCT01324830|590283430|FG003|Overall Study|Adverse Event, non-fatal|0|||
163431568|NCT01324830|590283431|FG004|Overall Study|Adverse Event, non-fatal|0|||
163431569|NCT01324830|590283432|FG005|Overall Study|Adverse Event, non-fatal|0|||
163431570|NCT01324830|590283433|FG006|Overall Study|Adverse Event, non-fatal|0|||
163431571|NCT01324830|590283434|FG007|Overall Study|Adverse Event, non-fatal|0|||
163431572|NCT01324830|590283435|FG008|Overall Study|Adverse Event, non-fatal|2|||
163431573|NCT01324830|590283436|FG009|Overall Study|Adverse Event, non-fatal|0|||
163431574|NCT01324830|590283437|FG010|Overall Study|Adverse Event, non-fatal|1|||
163431575|NCT01324830|590283438|FG011|Overall Study|Adverse Event, non-fatal|0|||
163431576|NCT01324830|590283439|FG012|Overall Study|Adverse Event, non-fatal|0|||
163431577|NCT01324830|590283440|FG013|Overall Study|Adverse Event, non-fatal|0|||
163431578|NCT01324830|590283441|FG014|Overall Study|Adverse Event, non-fatal|0|||
163431579|NCT01324830|590283442|FG015|Overall Study|Adverse Event, non-fatal|0|||
163431580|NCT01324830|590283443|FG016|Overall Study|Adverse Event, non-fatal|0|||
163431581|NCT01324830|590283444|FG017|Overall Study|Adverse Event, non-fatal|1|||
163431582|NCT01324830|590283445|FG018|Overall Study|Adverse Event, non-fatal|0|||
163431583|NCT01324830|590283427|FG000|Overall Study|Withdrawal by Subject|0|||
163431584|NCT01324830|590283428|FG001|Overall Study|Withdrawal by Subject|0|||
163431585|NCT01324830|590283429|FG002|Overall Study|Withdrawal by Subject|0|||
163431586|NCT01324830|590283430|FG003|Overall Study|Withdrawal by Subject|0|||
163431587|NCT01324830|590283431|FG004|Overall Study|Withdrawal by Subject|0|||
163431588|NCT01324830|590283432|FG005|Overall Study|Withdrawal by Subject|1|||
163431589|NCT01324830|590283433|FG006|Overall Study|Withdrawal by Subject|0|||
163431590|NCT01324830|590283434|FG007|Overall Study|Withdrawal by Subject|0|||
163431591|NCT01324830|590283435|FG008|Overall Study|Withdrawal by Subject|0|||
163431592|NCT01324830|590283436|FG009|Overall Study|Withdrawal by Subject|0|||
163431593|NCT01324830|590283437|FG010|Overall Study|Withdrawal by Subject|1|||
163431594|NCT01324830|590283438|FG011|Overall Study|Withdrawal by Subject|0|||
163431595|NCT01324830|590283439|FG012|Overall Study|Withdrawal by Subject|0|||
163431596|NCT01324830|590283440|FG013|Overall Study|Withdrawal by Subject|0|||
163431597|NCT01324830|590283441|FG014|Overall Study|Withdrawal by Subject|0|||
163431598|NCT01324830|590283442|FG015|Overall Study|Withdrawal by Subject|0|||
163431599|NCT01324830|590283443|FG016|Overall Study|Withdrawal by Subject|0|||
163431600|NCT01324830|590283444|FG017|Overall Study|Withdrawal by Subject|0|||
163431601|NCT01324830|590283445|FG018|Overall Study|Withdrawal by Subject|1|||
163431602|NCT01973283|590283446|FG000|Overall Study|Lost to Follow-up|4|||
163431603|NCT02586805|590283454|FG000|Overall Study|Withdrawal by Subject|3|||
163431604|NCT02586805|590283455|FG001|Overall Study|Withdrawal by Subject|1|||
163431605|NCT02586805|590283456|FG002|Overall Study|Withdrawal by Subject|1|||
163431606|NCT02586805|590283457|FG003|Overall Study|Withdrawal by Subject|2|||
163431607|NCT02586805|590283454|FG000|Overall Study|Adverse Event|2|||
163431608|NCT02586805|590283455|FG001|Overall Study|Adverse Event|0|||
163431609|NCT02586805|590283456|FG002|Overall Study|Adverse Event|1|||
163431610|NCT02586805|590283457|FG003|Overall Study|Adverse Event|0|||
163431611|NCT02586805|590283454|FG000|Overall Study|Lost to Follow-up|0|||
163431612|NCT02586805|590283455|FG001|Overall Study|Lost to Follow-up|0|||
163431613|NCT02586805|590283456|FG002|Overall Study|Lost to Follow-up|1|||
163431614|NCT02586805|590283457|FG003|Overall Study|Lost to Follow-up|0|||
163431615|NCT02586805|590283454|FG000|Overall Study|Physician Decision|1|||
163431616|NCT02586805|590283455|FG001|Overall Study|Physician Decision|0|||
163431617|NCT02586805|590283456|FG002|Overall Study|Physician Decision|0|||
163431618|NCT02586805|590283457|FG003|Overall Study|Physician Decision|0|||
163431619|NCT00472303|590283463|FG000|Titration Phase|Adverse Event|22|||
163431620|NCT00472303|590283464|FG001|Titration Phase|Adverse Event|12|||
163431621|NCT00472303|590283465|FG002|Titration Phase|Adverse Event|0|||
163431622|NCT00472303|590283463|FG000|Titration Phase|Death|4|||
163431623|NCT00472303|590283464|FG001|Titration Phase|Death|2|||
163431624|NCT00472303|590283465|FG002|Titration Phase|Death|0|||
163431625|NCT00472303|590283463|FG000|Titration Phase|Lack of Efficacy|10|||
163431626|NCT00472303|590283464|FG001|Titration Phase|Lack of Efficacy|0|||
163431627|NCT00472303|590283465|FG002|Titration Phase|Lack of Efficacy|0|||
163431628|NCT00472303|590283463|FG000|Titration Phase|Withdrawal by Subject|16|||
163431629|NCT00472303|590283464|FG001|Titration Phase|Withdrawal by Subject|13|||
163431630|NCT00472303|590283465|FG002|Titration Phase|Withdrawal by Subject|0|||
163431631|NCT00472303|590283463|FG000|Titration Phase|Trial Medication non-compliant|4|||
163431632|NCT00472303|590283464|FG001|Titration Phase|Trial Medication non-compliant|1|||
163431633|NCT00472303|590283465|FG002|Titration Phase|Trial Medication non-compliant|0|||
163431634|NCT00472303|590283463|FG000|Titration Phase|Other|3|||
163431635|NCT00472303|590283464|FG001|Titration Phase|Other|1|||
163431636|NCT00472303|590283465|FG002|Titration Phase|Other|0|||
163431637|NCT00472303|590283463|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
163431638|NCT00472303|590283464|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
163431639|NCT00472303|590283465|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
163431640|NCT00472303|590283463|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
163431641|NCT00472303|590283464|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
163431642|NCT00472303|590283465|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
163431643|NCT00472303|590283463|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
163431644|NCT00472303|590283464|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
163431645|NCT00472303|590283465|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
163431646|NCT00472303|590283463|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
163431647|NCT00472303|590283464|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
163431648|NCT00472303|590283465|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
163431649|NCT00472303|590283463|FG000|Discontinuations After Titration Phase|Other|5|||
163431650|NCT00472303|590283464|FG001|Discontinuations After Titration Phase|Other|0|||
163431651|NCT00472303|590283465|FG002|Discontinuations After Titration Phase|Other|0|||
163431652|NCT00472303|590283463|FG000|Maintenance Phase|Adverse Event|5|||
163431653|NCT00472303|590283464|FG001|Maintenance Phase|Adverse Event|6|||
163431654|NCT00472303|590283465|FG002|Maintenance Phase|Adverse Event|6|||
163431655|NCT00472303|590283463|FG000|Maintenance Phase|Death|3|||
163431656|NCT00472303|590283464|FG001|Maintenance Phase|Death|0|||
163431657|NCT00472303|590283465|FG002|Maintenance Phase|Death|2|||
163431658|NCT00472303|590283463|FG000|Maintenance Phase|Lack of Efficacy|2|||
163431659|NCT00472303|590283464|FG001|Maintenance Phase|Lack of Efficacy|2|||
163431660|NCT00472303|590283465|FG002|Maintenance Phase|Lack of Efficacy|4|||
163431661|NCT00472303|590283463|FG000|Maintenance Phase|Withdrawal by Subject|6|||
163431662|NCT00472303|590283464|FG001|Maintenance Phase|Withdrawal by Subject|7|||
163431663|NCT00472303|590283465|FG002|Maintenance Phase|Withdrawal by Subject|3|||
163431664|NCT00472303|590283463|FG000|Maintenance Phase|Trial medication non-compliant|0|||
163431665|NCT00472303|590283464|FG001|Maintenance Phase|Trial medication non-compliant|0|||
163431666|NCT00472303|590283465|FG002|Maintenance Phase|Trial medication non-compliant|1|||
163431667|NCT00472303|590283463|FG000|Maintenance Phase|Resolution of pain|0|||
163431668|NCT00472303|590283464|FG001|Maintenance Phase|Resolution of pain|0|||
163431669|NCT00472303|590283465|FG002|Maintenance Phase|Resolution of pain|1|||
163431670|NCT00472303|590283463|FG000|Maintenance Phase|Other|1|||
163431671|NCT00472303|590283464|FG001|Maintenance Phase|Other|1|||
163431672|NCT00472303|590283465|FG002|Maintenance Phase|Other|0|||
163431673|NCT03577990|590283483|FG000|Overall Study|Lost to Follow-up|4|||
163431674|NCT03577990|590283484|FG001|Overall Study|Lost to Follow-up|6|||
163431675|NCT03577990|590283483|FG000|Overall Study|Withdrawal by Subject|4|||
163431676|NCT03577990|590283484|FG001|Overall Study|Withdrawal by Subject|7|||
163431677|NCT01097044|590283494|FG000|Overall Study|Withdrawal by Subject|4|||
163431678|NCT01097044|590283495|FG001|Overall Study|Withdrawal by Subject|4|||
163431679|NCT01097044|590283494|FG000|Overall Study|Lost to Follow-up|1|||
163431680|NCT01097044|590283495|FG001|Overall Study|Lost to Follow-up|0|||
163431681|NCT01097044|590283494|FG000|Overall Study|Withdrawal by Sponsor|0|||
163431682|NCT01097044|590283495|FG001|Overall Study|Withdrawal by Sponsor|1|||
163431683|NCT01682044|590283496|FG000|Overall Study|Death|1|||
163431684|NCT01682044|590283496|FG000|Overall Study|Progression|3|||
163431685|NCT02452359|590283500|FG000|Overall Study|Adverse Event|1|||
163431686|NCT02452359|590283500|FG000|Overall Study|Lost to Follow-up|15|||
163431687|NCT02452359|590283500|FG000|Overall Study|Pregnancy|1|||
163431688|NCT02452359|590283500|FG000|Overall Study|Withdrawal by Subject|4|||
163431689|NCT03414359|590283501|FG000|Overall Study|Lack of Efficacy|1|||
163431690|NCT03414359|590283502|FG001|Overall Study|Lack of Efficacy|1|||
163431691|NCT03414359|590283501|FG000|Overall Study|Protocol Violation|0|||
163431692|NCT03414359|590283502|FG001|Overall Study|Protocol Violation|1|||
163431693|NCT04865731|590283505|FG000|Overall Study|Physician Decision|2|||
163431694|NCT04865731|590283506|FG001|Overall Study|Physician Decision|1|||
163431695|NCT04865731|590283505|FG000|Overall Study|Adverse Event|1|||
163431696|NCT04865731|590283506|FG001|Overall Study|Adverse Event|0|||
163431697|NCT04865731|590283505|FG000|Overall Study|Withdrawal by Subject|0|||
163431698|NCT04865731|590283506|FG001|Overall Study|Withdrawal by Subject|1|||
163431699|NCT00222105|590283511|FG000|Overall Study|Removed due to wrong diagnosis|1|||
163431700|NCT00222105|590283511|FG000|Overall Study|Withdrawal by Subject|1|||
163431701|NCT00222105|590283511|FG000|Overall Study|Adverse Event|8|||
163431702|NCT00222105|590283511|FG000|Overall Study|Treatment delays|2|||
163431703|NCT00222105|590283511|FG000|Overall Study|Death|2|||
163431704|NCT01672892|590285142|FG000|Overall Study|Protocol Violation|7|||
163431705|NCT01672892|590285143|FG001|Overall Study|Protocol Violation|3|||
163431706|NCT02981472|590285154|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
163431707|NCT02981472|590285155|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
163431708|NCT02981472|590285154|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
163431709|NCT02981472|590285155|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163431710|NCT02981472|590285154|FG000|Treatment Period|Adverse Event|6|||
163431711|NCT02981472|590285155|FG001|Treatment Period|Adverse Event|1|||
163431712|NCT02981472|590285154|FG000|Treatment Period|Participant withdrew consent|1|||
163431713|NCT02981472|590285155|FG001|Treatment Period|Participant withdrew consent|0|||
163431714|NCT02981472|590285154|FG000|Treatment Period|Lost to Follow-up|0|||
163431715|NCT02981472|590285155|FG001|Treatment Period|Lost to Follow-up|1|||
163431716|NCT01584024|590285162|FG000|Overall Study|Lost to Follow-up|10|||
163431717|NCT01584024|590285162|FG000|Overall Study|Withdrawal by Subject|3|||
163431718|NCT00719810|590285168|FG000|Overall Study|Adverse Event|0|||
163431719|NCT00719810|590285169|FG001|Overall Study|Adverse Event|2|||
163431720|NCT00719810|590285170|FG002|Overall Study|Adverse Event|3|||
163431721|NCT00719810|590285168|FG000|Overall Study|Lost to Follow-up|2|||
163431722|NCT00719810|590285169|FG001|Overall Study|Lost to Follow-up|0|||
163431723|NCT00719810|590285170|FG002|Overall Study|Lost to Follow-up|3|||
163431724|NCT00719810|590285168|FG000|Overall Study|Physician Decision|0|||
163431725|NCT00719810|590285169|FG001|Overall Study|Physician Decision|1|||
163431726|NCT00719810|590285170|FG002|Overall Study|Physician Decision|0|||
163431727|NCT00719810|590285168|FG000|Overall Study|Withdrawal by Subject|1|||
163431728|NCT00719810|590285169|FG001|Overall Study|Withdrawal by Subject|1|||
163431729|NCT00719810|590285170|FG002|Overall Study|Withdrawal by Subject|2|||
163431730|NCT04893265|590285193|FG000|Overall Study|Withdrawal by Subject|2|||
163431731|NCT04893265|590285194|FG001|Overall Study|Withdrawal by Subject|5|||
163431732|NCT04893265|590285193|FG000|Overall Study|Lost to Follow-up|0|||
163431733|NCT04893265|590285194|FG001|Overall Study|Lost to Follow-up|4|||
163431734|NCT02465034|590285196|FG000|Overall Study|Withdrawal by Subject|1|||
163431735|NCT02465034|590285197|FG001|Overall Study|Withdrawal by Subject|1|||
163431736|NCT02465034|590285196|FG000|Overall Study|Screen fail|2|||
163431737|NCT02465034|590285197|FG001|Overall Study|Screen fail|0|||
163431738|NCT02465034|590285196|FG000|Overall Study|Could not be scheduled for study visit|0|||
163431739|NCT02465034|590285197|FG001|Overall Study|Could not be scheduled for study visit|5|||
163431740|NCT00573131|590285198|FG000|Overall Study|Withdrawal by Subject|10|||
163431741|NCT00573131|590285199|FG001|Overall Study|Withdrawal by Subject|8|||
163431742|NCT02401256|590285205|FG000|Overall Study|Adverse Event|5|||
163431743|NCT02401256|590285205|FG000|Overall Study|Withdrawal by Subject|12|||
163431744|NCT00893789|590285207|FG000|Overall Study|Withdrawal by Subject|3|||
163431745|NCT00893789|590285208|FG001|Overall Study|Withdrawal by Subject|1|||
163431746|NCT00893789|590285209|FG002|Overall Study|Withdrawal by Subject|3|||
163431747|NCT00893789|590285210|FG003|Overall Study|Withdrawal by Subject|1|||
163431748|NCT00893789|590285207|FG000|Overall Study|Noncompliance With Study Drug|1|||
163431749|NCT00893789|590285208|FG001|Overall Study|Noncompliance With Study Drug|0|||
163431750|NCT00893789|590285209|FG002|Overall Study|Noncompliance With Study Drug|1|||
163431751|NCT00893789|590285210|FG003|Overall Study|Noncompliance With Study Drug|2|||
163431752|NCT00893789|590285207|FG000|Overall Study|Noncompliance With Study Procedures|1|||
163431753|NCT00893789|590285208|FG001|Overall Study|Noncompliance With Study Procedures|0|||
163431754|NCT00893789|590285209|FG002|Overall Study|Noncompliance With Study Procedures|0|||
163431755|NCT00893789|590285210|FG003|Overall Study|Noncompliance With Study Procedures|0|||
163431756|NCT00893789|590285207|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
163431757|NCT00893789|590285208|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
163431758|NCT00893789|590285209|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
163431759|NCT00893789|590285210|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
163431760|NCT00893789|590285207|FG000|Overall Study|Adverse Event|0|||
163431761|NCT00893789|590285208|FG001|Overall Study|Adverse Event|2|||
163431762|NCT00893789|590285209|FG002|Overall Study|Adverse Event|1|||
163431763|NCT00893789|590285210|FG003|Overall Study|Adverse Event|5|||
163431764|NCT00893789|590285207|FG000|Overall Study|Protocol Violation|0|||
163431765|NCT00893789|590285208|FG001|Overall Study|Protocol Violation|1|||
163431766|NCT00893789|590285209|FG002|Overall Study|Protocol Violation|1|||
163431767|NCT00893789|590285210|FG003|Overall Study|Protocol Violation|4|||
163431768|NCT00893789|590285207|FG000|Overall Study|Lost to Follow-up|0|||
163431769|NCT00893789|590285208|FG001|Overall Study|Lost to Follow-up|0|||
163431770|NCT00893789|590285209|FG002|Overall Study|Lost to Follow-up|0|||
163431771|NCT00893789|590285210|FG003|Overall Study|Lost to Follow-up|1|||
163431772|NCT02024464|590285211|FG000|Overall Study|Discontinued|5|||
163431773|NCT02024464|590285212|FG001|Overall Study|Discontinued|4|||
163431774|NCT02024464|590285211|FG000|Overall Study|Missed Visits|1|||
163431775|NCT02024464|590285212|FG001|Overall Study|Missed Visits|0|||
163431776|NCT02024464|590285211|FG000|Overall Study|Lost to Follow-up|4|||
163431777|NCT02024464|590285212|FG001|Overall Study|Lost to Follow-up|7|||
163431778|NCT01575548|590285217|FG000|Overall Study|Adverse Event|15|||
163431779|NCT01575548|590285218|FG001|Overall Study|Adverse Event|2|||
163431780|NCT01575548|590285217|FG000|Overall Study|Disease progression|12|||
163431781|NCT01575548|590285218|FG001|Overall Study|Disease progression|25|||
163431782|NCT01575548|590285217|FG000|Overall Study|Death|1|||
163431783|NCT01575548|590285218|FG001|Overall Study|Death|0|||
163431784|NCT01575548|590285217|FG000|Overall Study|Other complicating disease|1|||
163431785|NCT01575548|590285218|FG001|Overall Study|Other complicating disease|0|||
163431786|NCT01575548|590285217|FG000|Overall Study|Withdrawal by Subject|7|||
163431787|NCT01575548|590285218|FG001|Overall Study|Withdrawal by Subject|3|||
163431788|NCT01575548|590285217|FG000|Overall Study|Noncompliance|1|||
163431789|NCT01575548|590285218|FG001|Overall Study|Noncompliance|0|||
163431790|NCT01575548|590285217|FG000|Overall Study|Anticipated surgery|0|||
163431791|NCT01575548|590285218|FG001|Overall Study|Anticipated surgery|1|||
163431792|NCT01575548|590285217|FG000|Overall Study|Never started protocol therapy|3|||
163431793|NCT01575548|590285218|FG001|Overall Study|Never started protocol therapy|2|||
163431794|NCT03872180|590285221|FG000|Overall Study|Adverse Event|4|||
163431795|NCT03872180|590285221|FG000|Overall Study|Lack of Efficacy|2|||
163431796|NCT02750410|590285224|FG000|Double-Blind Treatment Period|Adverse Event|2|||
163431797|NCT02750410|590285225|FG001|Double-Blind Treatment Period|Adverse Event|2|||
163431798|NCT02750410|590285224|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163431799|NCT02750410|590285225|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
163431800|NCT02750410|590285224|FG000|Open-Label Extension Period|Adverse Event|5|||
163431801|NCT02750410|590285225|FG001|Open-Label Extension Period|Adverse Event|3|||
163431802|NCT02750410|590285224|FG000|Open-Label Extension Period|Protocol Violation|0|||
163431803|NCT02750410|590285225|FG001|Open-Label Extension Period|Protocol Violation|1|||
163431804|NCT02750410|590285224|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
163431805|NCT02750410|590285225|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
163431806|NCT02504541|590285226|FG000|Overall Study|Adverse Event|4|||
163431807|NCT02504541|590285226|FG000|Overall Study|Withdrawal by Subject|4|||
163431808|NCT02504541|590285226|FG000|Overall Study|Lost to Follow-up|1|||
163431809|NCT02504541|590285226|FG000|Overall Study|Met Stopping Criteria|1|||
163431810|NCT02504541|590285226|FG000|Overall Study|Protocol Violation|2|||
163431811|NCT02504541|590285226|FG000|Overall Study|Termination by Sponsor|1|||
163431812|NCT02504541|590285226|FG000|Overall Study|Other|2|||
163431813|NCT02504541|590285226|FG000|Overall Study|Multiple|5|||
163431814|NCT01531725|590285227|FG000|Overall Study|Protocol Violation|5|||
163431815|NCT03215277|590285228|FG000|Overall Study|Adverse Event|2|||
163431816|NCT03215277|590285229|FG001|Overall Study|Adverse Event|3|||
163431817|NCT03215277|590285228|FG000|Overall Study|Death|1|||
163431818|NCT03215277|590285229|FG001|Overall Study|Death|0|||
163431819|NCT03215277|590285228|FG000|Overall Study|Lost to Follow-up|0|||
163431820|NCT03215277|590285229|FG001|Overall Study|Lost to Follow-up|1|||
163431821|NCT03215277|590285228|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
163431822|NCT03215277|590285229|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
163431823|NCT02317510|590285230|FG000|Overall Study|Adverse Event|0|||
163431824|NCT02317510|590285231|FG001|Overall Study|Adverse Event|1|||
163431825|NCT01122927|590285232|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
163431826|NCT01122927|590285233|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
163431827|NCT01122927|590285232|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
163431828|NCT01122927|590285233|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
163431829|NCT01122927|590285232|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
163431830|NCT01122927|590285233|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
163431831|NCT01122927|590285232|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
163431832|NCT01122927|590285233|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
163431833|NCT01122927|590285232|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
163431834|NCT01122927|590285233|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
163431835|NCT01122927|590285232|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
163431836|NCT01122927|590285233|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
163431837|NCT01122927|590285232|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
163431838|NCT01122927|590285233|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
163431839|NCT01122927|590285232|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
163431840|NCT01122927|590285233|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
163431841|NCT01122927|590285232|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
163431842|NCT01122927|590285233|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
163431843|NCT01122927|590285232|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
163431844|NCT01122927|590285233|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
163431845|NCT01122927|590285232|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
163431846|NCT01122927|590285233|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
163431847|NCT01122927|590285232|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
163431848|NCT01122927|590285233|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
163431849|NCT01244737|590285234|FG000|Overall Study|Physician Decision|2|||
163431850|NCT01244737|590285235|FG001|Overall Study|Physician Decision|18|||
163431851|NCT01244737|590285236|FG002|Overall Study|Physician Decision|5|||
163431852|NCT01244737|590285234|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
163431853|NCT01244737|590285235|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
163431854|NCT01244737|590285236|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
163431855|NCT01244737|590285234|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
163431856|NCT01244737|590285235|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
163431857|NCT01244737|590285236|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
163431858|NCT01244737|590285234|FG000|Overall Study|MIB immunopathology results not available|3|||
163431859|NCT01244737|590285235|FG001|Overall Study|MIB immunopathology results not available|2|||
163431860|NCT01244737|590285236|FG002|Overall Study|MIB immunopathology results not available|0|||
163431861|NCT01244737|590285234|FG000|Overall Study|PET data failure|0|||
163431862|NCT01244737|590285235|FG001|Overall Study|PET data failure|1|||
163431863|NCT01244737|590285236|FG002|Overall Study|PET data failure|0|||
163431864|NCT01244737|590285234|FG000|Overall Study|Withdrawal by Subject|0|||
163431865|NCT01244737|590285235|FG001|Overall Study|Withdrawal by Subject|0|||
163431866|NCT01244737|590285236|FG002|Overall Study|Withdrawal by Subject|1|||
163431867|NCT00356915|590285241|FG000|Overall Study|Non compliance|1|||
163431868|NCT00356915|590285242|FG001|Overall Study|Non compliance|2|||
163431869|NCT00356915|590285243|FG002|Overall Study|Non compliance|1|||
163431870|NCT00356915|590285241|FG000|Overall Study|Protocol Violation|2|||
163431871|NCT00356915|590285242|FG001|Overall Study|Protocol Violation|3|||
163431872|NCT00356915|590285243|FG002|Overall Study|Protocol Violation|2|||
163431873|NCT00356915|590285241|FG000|Overall Study|Withdrawal by Subject|14|||
163431874|NCT00356915|590285242|FG001|Overall Study|Withdrawal by Subject|14|||
163431875|NCT00356915|590285243|FG002|Overall Study|Withdrawal by Subject|10|||
163431876|NCT00356915|590285241|FG000|Overall Study|Lack of Efficacy|0|||
163431877|NCT00356915|590285242|FG001|Overall Study|Lack of Efficacy|0|||
163431878|NCT00356915|590285243|FG002|Overall Study|Lack of Efficacy|3|||
163431879|NCT00356915|590285241|FG000|Overall Study|Lost to Follow-up|27|||
163431880|NCT00356915|590285242|FG001|Overall Study|Lost to Follow-up|34|||
163431881|NCT00356915|590285243|FG002|Overall Study|Lost to Follow-up|14|||
163431882|NCT00356915|590285241|FG000|Overall Study|Administrative Decision|0|||
163431883|NCT00356915|590285242|FG001|Overall Study|Administrative Decision|0|||
163431884|NCT00356915|590285243|FG002|Overall Study|Administrative Decision|1|||
163431885|NCT00356915|590285241|FG000|Overall Study|Physician Decision|0|||
163431886|NCT00356915|590285242|FG001|Overall Study|Physician Decision|2|||
163431887|NCT00356915|590285243|FG002|Overall Study|Physician Decision|0|||
163431888|NCT00356915|590285241|FG000|Overall Study|Adverse Event|21|||
163431889|NCT00356915|590285242|FG001|Overall Study|Adverse Event|31|||
163431890|NCT00356915|590285243|FG002|Overall Study|Adverse Event|8|||
163431891|NCT00356915|590285241|FG000|Overall Study|Miscellaneous reasons|11|||
163431892|NCT00356915|590285242|FG001|Overall Study|Miscellaneous reasons|8|||
163431893|NCT00356915|590285243|FG002|Overall Study|Miscellaneous reasons|3|||
163431894|NCT02371629|590285244|FG000|Overall Study|Patient decision|14|||
163431895|NCT02371629|590285245|FG001|Overall Study|Patient decision|10|||
163431896|NCT02371629|590285244|FG000|Overall Study|Adverse Event|8|||
163431897|NCT02371629|590285245|FG001|Overall Study|Adverse Event|8|||
163431898|NCT02371629|590285244|FG000|Overall Study|Physician Decision|2|||
163431899|NCT02371629|590285245|FG001|Overall Study|Physician Decision|3|||
163431900|NCT02371629|590285244|FG000|Overall Study|Death|1|||
163431901|NCT02371629|590285245|FG001|Overall Study|Death|1|||
163431902|NCT02371629|590285244|FG000|Overall Study|Noncompliance with study treatment|1|||
163431903|NCT02371629|590285245|FG001|Overall Study|Noncompliance with study treatment|0|||
163431904|NCT02371629|590285244|FG000|Overall Study|Lack of Efficacy|0|||
163431905|NCT02371629|590285245|FG001|Overall Study|Lack of Efficacy|2|||
163431906|NCT02371629|590285244|FG000|Overall Study|Protocol deviation|0|||
163431907|NCT02371629|590285245|FG001|Overall Study|Protocol deviation|1|||
163431908|NCT01193335|590285246|FG000|After Infant Series|Lost to Follow-up|1|||
163431909|NCT01193335|590285247|FG001|After Infant Series|Lost to Follow-up|2|||
163431910|NCT01193335|590285246|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
163431911|NCT01193335|590285247|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
163431912|NCT01193335|590285246|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
163431913|NCT01193335|590285247|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
163431914|NCT01193335|590285246|FG000|1-Year Follow-up|Lost to Follow-up|4|||
163431915|NCT01193335|590285247|FG001|1-Year Follow-up|Lost to Follow-up|0|||
163431916|NCT01193335|590285246|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
163431917|NCT01193335|590285247|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
163431918|NCT01193335|590285246|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
163431919|NCT01193335|590285247|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
163431920|NCT03486314|590285249|FG000|Part A|Adverse Event|1|||
163431921|NCT03486314|590285250|FG001|Part A|Adverse Event|0|||
163431922|NCT03486314|590285251|FG002|Part A|Adverse Event|0|||
163431923|NCT03486314|590285249|FG000|Part A|Symptomatic Deterioration|2|||
163431924|NCT03486314|590285250|FG001|Part A|Symptomatic Deterioration|0|||
163431925|NCT03486314|590285251|FG002|Part A|Symptomatic Deterioration|0|||
163431926|NCT01985321|590285252|FG000|Overall Study|Protocol Violation|4|||
163431927|NCT01985321|590285253|FG001|Overall Study|Protocol Violation|3|||
163431928|NCT01985321|590285252|FG000|Overall Study|Withdrawal by Subject|1|||
163431929|NCT01985321|590285253|FG001|Overall Study|Withdrawal by Subject|0|||
163431930|NCT01985321|590285252|FG000|Overall Study|Lost to Follow-up|5|||
163431931|NCT01985321|590285253|FG001|Overall Study|Lost to Follow-up|2|||
163431932|NCT01985321|590285252|FG000|Overall Study|Subject treated wrong type of sore|1|||
163431933|NCT01985321|590285253|FG001|Overall Study|Subject treated wrong type of sore|0|||
163431934|NCT01364467|590285254|FG000|Overall Study|Lost to Follow-up|1|||
163431935|NCT01364467|590285255|FG001|Overall Study|Lost to Follow-up|2|||
163431936|NCT03228186|590285256|FG000|Overall Study|Patient never started treatment|1|||
163431937|NCT03953118|590285257|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
163431938|NCT03953118|590285258|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
163431939|NCT02502864|590285261|FG000|Overall Study|Withdrawal by Subject|1|||
163431940|NCT04375878|590285263|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
163431941|NCT04375878|590285264|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
163431942|NCT04375878|590285265|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
163431943|NCT04375878|590285266|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
163431944|NCT04375878|590285267|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
163431945|NCT04375878|590285268|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
163431946|NCT04375878|590285263|FG000|Crossover First and Second Interventions|Adverse Event|0|||
163431947|NCT04375878|590285264|FG001|Crossover First and Second Interventions|Adverse Event|0|||
163431948|NCT04375878|590285265|FG002|Crossover First and Second Interventions|Adverse Event|1|||
163431949|NCT04375878|590285266|FG003|Crossover First and Second Interventions|Adverse Event|0|||
163431950|NCT04375878|590285267|FG004|Crossover First and Second Interventions|Adverse Event|0|||
163431951|NCT04375878|590285268|FG005|Crossover First and Second Interventions|Adverse Event|0|||
163431952|NCT04375878|590285263|FG000|Extension Phase|Withdrawal by Subject|0|||
163431953|NCT04375878|590285264|FG001|Extension Phase|Withdrawal by Subject|0|||
163431954|NCT04375878|590285265|FG002|Extension Phase|Withdrawal by Subject|0|||
163431955|NCT04375878|590285266|FG003|Extension Phase|Withdrawal by Subject|0|||
163431956|NCT04375878|590285267|FG004|Extension Phase|Withdrawal by Subject|1|||
163431957|NCT04375878|590285268|FG005|Extension Phase|Withdrawal by Subject|0|||
163431958|NCT00816036|590285269|FG000|Overall Study|Death|47|||
163431959|NCT00816036|590285270|FG001|Overall Study|Death|28|||
163431960|NCT00816036|590285269|FG000|Overall Study|Lost to Follow-up|75|||
163431961|NCT00816036|590285270|FG001|Overall Study|Lost to Follow-up|57|||
163431962|NCT00816036|590285269|FG000|Overall Study|Withdrawal by Subject|54|||
163431963|NCT00816036|590285270|FG001|Overall Study|Withdrawal by Subject|23|||
163431964|NCT01624194|590285271|FG000|Overall Study|Lost to Follow-up|1|||
163431965|NCT01624194|590285272|FG001|Overall Study|Lost to Follow-up|0|||
163431966|NCT01624194|590285271|FG000|Overall Study|Withdrawal by Subject|1|||
163431967|NCT01624194|590285272|FG001|Overall Study|Withdrawal by Subject|0|||
163431968|NCT03212261|590285276|FG000|Overall Study|Became ineligible d/t tech|2|||
163431969|NCT03212261|590285276|FG000|Overall Study|Tech Trouble- No first study visit|1|||
163431970|NCT03212261|590285276|FG000|Overall Study|Lost to Follow-up|7|||
163431971|NCT03212261|590285276|FG000|Overall Study|Family Emergency|1|||
163431972|NCT03212261|590285276|FG000|Overall Study|Too busy/ No time|5|||
163431973|NCT03815175|590285280|FG000|Overall Study|Subject Lost to Follow-up|6|||
163431974|NCT03815175|590285280|FG000|Overall Study|Subject Withdrew Consent|48|||
163431975|NCT03815175|590285280|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
163431976|NCT03815175|590285280|FG000|Overall Study|Death|86|||
163431977|NCT03815175|590285280|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
163431978|NCT03815175|590285280|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
163431979|NCT03815175|590285280|FG000|Overall Study|Other Status Change Reason|1|||
163431980|NCT03815175|590285280|FG000|Overall Study|Missed Visit|12|||
163431981|NCT02296840|590285285|FG000|Overall Study|Adverse Event|1|||
163431982|NCT02296840|590285286|FG001|Overall Study|Adverse Event|1|||
163431983|NCT02296840|590285285|FG000|Overall Study|Protocol Violation|2|||
163431984|NCT02296840|590285286|FG001|Overall Study|Protocol Violation|1|||
163431985|NCT02296840|590285285|FG000|Overall Study|Lost to Follow-up|6|||
163431986|NCT02296840|590285286|FG001|Overall Study|Lost to Follow-up|17|||
163431987|NCT02485717|590285292|FG000|Overall Study|Lost to Follow-up|6|||
163431988|NCT02485717|590285293|FG001|Overall Study|Lost to Follow-up|0|||
163431989|NCT02485717|590285294|FG002|Overall Study|Lost to Follow-up|0|||
163431990|NCT02485717|590285292|FG000|Overall Study|Withdrawal by Subject|0|||
163431991|NCT02485717|590285293|FG001|Overall Study|Withdrawal by Subject|0|||
163431992|NCT02485717|590285294|FG002|Overall Study|Withdrawal by Subject|1|||
163431993|NCT02485717|590285292|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
163431994|NCT02485717|590285293|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
163431995|NCT02485717|590285294|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
163431996|NCT02485717|590285292|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
163431997|NCT02485717|590285293|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
163431998|NCT02485717|590285294|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
163431999|NCT02827877|590285295|FG000|Overall Study|Withdrawal by Subject|1|||
163432000|NCT00519532|590285298|FG000|Overall Study|Adverse Event|11|||
163432001|NCT00519532|590285298|FG000|Overall Study|Withdrawal by Subject|5|||
163432002|NCT00519532|590285298|FG000|Overall Study|Lost to Follow-up|2|||
163432003|NCT03914300|590285299|FG000|Overall Study|Adverse Event|1|||
163432004|NCT00814710|590285300|FG000|Overall Study|Adverse Event|1|||
163432005|NCT00814710|590285301|FG001|Overall Study|Adverse Event|0|||
163432006|NCT00814710|590285300|FG000|Overall Study|Lost to Follow-up|7|||
163432007|NCT00814710|590285301|FG001|Overall Study|Lost to Follow-up|3|||
163432008|NCT01450540|590285307|FG000|Overall Study|Withdrawal by Subject|19|||
163432009|NCT01450540|590285308|FG001|Overall Study|Withdrawal by Subject|13|||
163432010|NCT01450540|590285307|FG000|Overall Study|protocol deviation|3|||
163432011|NCT01450540|590285308|FG001|Overall Study|protocol deviation|23|||
163432012|NCT00140855|590285309|FG000|Overall Study|Progressive disease|2|||
163432013|NCT03542682|590285310|FG000|Overall Study|COVID-19 Protocol|0|||
163432014|NCT03542682|590285311|FG001|Overall Study|COVID-19 Protocol|1|||
163432015|NCT04090164|590285321|FG000|Overall Study|incomplete data on file|245|||
163432016|NCT04090164|590285322|FG001|Overall Study|incomplete data on file|0|||
163432017|NCT03439345|590286823|FG000|Overall Study|Lost to Follow-up|0|||
163432018|NCT03439345|590286824|FG001|Overall Study|Lost to Follow-up|1|||
163432019|NCT03439345|590286823|FG000|Overall Study|Consent withdrawn|0|||
163432020|NCT03439345|590286824|FG001|Overall Study|Consent withdrawn|1|||
163432021|NCT05405166|590286825|FG000|Overall Study|Death|49|||
163432022|NCT05405166|590286826|FG001|Overall Study|Death|50|||
163432023|NCT05405166|590286825|FG000|Overall Study|Withdrawal by Subject|10|||
163432024|NCT05405166|590286826|FG001|Overall Study|Withdrawal by Subject|3|||
163432025|NCT05405166|590286825|FG000|Overall Study|Ongoing at the time of PCD|209|||
163432026|NCT05405166|590286826|FG001|Overall Study|Ongoing at the time of PCD|210|||
163432027|NCT03746080|590286827|FG000|Overall Study|In follow up|2|||
163432028|NCT03746080|590286827|FG000|Overall Study|Death|15|||
163432029|NCT01843374|590286828|FG000|Overall Study|Death|155|||
163432030|NCT01843374|590286829|FG001|Overall Study|Death|313|||
163432031|NCT01843374|590286828|FG000|Overall Study|Withdrawal by Subject|14|||
163432032|NCT01843374|590286829|FG001|Overall Study|Withdrawal by Subject|20|||
163432033|NCT01843374|590286828|FG000|Overall Study|Withdrawing due to Other reason|20|||
163432034|NCT01843374|590286829|FG001|Overall Study|Withdrawing due to Other reason|46|||
163432035|NCT01826214|590286833|FG000|Overall Study|Adverse Event|7|||
163432036|NCT01826214|590286834|FG001|Overall Study|Adverse Event|6|||
163432037|NCT01826214|590286833|FG000|Overall Study|Death|3|||
163432038|NCT01826214|590286834|FG001|Overall Study|Death|1|||
163432039|NCT01826214|590286833|FG000|Overall Study|Lost to Follow-up|1|||
163432040|NCT01826214|590286834|FG001|Overall Study|Lost to Follow-up|0|||
163432041|NCT01826214|590286833|FG000|Overall Study|Physician Decision|0|||
163432042|NCT01826214|590286834|FG001|Overall Study|Physician Decision|2|||
163432043|NCT01826214|590286833|FG000|Overall Study|Progressive disease|22|||
163432044|NCT01826214|590286834|FG001|Overall Study|Progressive disease|21|||
163432045|NCT01826214|590286833|FG000|Overall Study|Study terminated by Sponsor|0|||
163432046|NCT01826214|590286834|FG001|Overall Study|Study terminated by Sponsor|1|||
163432047|NCT01826214|590286833|FG000|Overall Study|Subject/guardian decision|2|||
163432048|NCT01826214|590286834|FG001|Overall Study|Subject/guardian decision|3|||
163432049|NCT00955110|590286835|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
163432050|NCT00955110|590286835|FG000|Treatment Phase|Adverse Event|2|||
163432051|NCT00955110|590286835|FG000|Treatment Phase|Administrative reasons|2|||
163432052|NCT00955110|590286835|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
163432053|NCT00955110|590286835|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
163432054|NCT02128490|590286836|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
163432055|NCT02128490|590286837|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
163432056|NCT02128490|590286838|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
163432057|NCT02128490|590286839|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
163432058|NCT02128490|590286840|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
163432059|NCT02128490|590286836|FG000|Overall Study|Major Protocol Deviation|1|||
163432060|NCT02128490|590286837|FG001|Overall Study|Major Protocol Deviation|2|||
163432061|NCT02128490|590286838|FG002|Overall Study|Major Protocol Deviation|0|||
163432062|NCT02128490|590286839|FG003|Overall Study|Major Protocol Deviation|2|||
163432063|NCT02128490|590286840|FG004|Overall Study|Major Protocol Deviation|2|||
163432064|NCT02128490|590286836|FG000|Overall Study|Lost to Follow-up|0|||
163432065|NCT02128490|590286837|FG001|Overall Study|Lost to Follow-up|0|||
163432066|NCT02128490|590286838|FG002|Overall Study|Lost to Follow-up|1|||
163432067|NCT02128490|590286839|FG003|Overall Study|Lost to Follow-up|1|||
163432068|NCT02128490|590286840|FG004|Overall Study|Lost to Follow-up|1|||
163432069|NCT02128490|590286836|FG000|Overall Study|Voluntary Withdrawal|3|||
163432070|NCT02128490|590286837|FG001|Overall Study|Voluntary Withdrawal|3|||
163432071|NCT02128490|590286838|FG002|Overall Study|Voluntary Withdrawal|1|||
163432072|NCT02128490|590286839|FG003|Overall Study|Voluntary Withdrawal|1|||
163432073|NCT02128490|590286840|FG004|Overall Study|Voluntary Withdrawal|2|||
163432074|NCT02128490|590286836|FG000|Overall Study|Lack of Efficacy|0|||
163432075|NCT02128490|590286837|FG001|Overall Study|Lack of Efficacy|1|||
163432076|NCT02128490|590286838|FG002|Overall Study|Lack of Efficacy|0|||
163432077|NCT02128490|590286839|FG003|Overall Study|Lack of Efficacy|0|||
163432078|NCT02128490|590286840|FG004|Overall Study|Lack of Efficacy|0|||
163432079|NCT02128490|590286836|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
163432080|NCT02128490|590286837|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
163432081|NCT02128490|590286838|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
163432082|NCT02128490|590286839|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
163432083|NCT02128490|590286840|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
163432084|NCT02128490|590286836|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163432085|NCT02128490|590286837|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163432086|NCT02128490|590286838|FG002|Overall Study|Other Miscellaneous Reasons|2|||
163432087|NCT02128490|590286839|FG003|Overall Study|Other Miscellaneous Reasons|1|||
163432088|NCT02128490|590286840|FG004|Overall Study|Other Miscellaneous Reasons|1|||
163432089|NCT02243176|590286841|FG000|Overall Study|Other reason|1|||
163432090|NCT02243176|590286842|FG001|Overall Study|Other reason|2|||
163432091|NCT02243176|590286841|FG000|Overall Study|protocol specified withdrawal critera|1|||
163432092|NCT02243176|590286842|FG001|Overall Study|protocol specified withdrawal critera|3|||
163432093|NCT02243176|590286841|FG000|Overall Study|Protocol Violation|2|||
163432094|NCT02243176|590286842|FG001|Overall Study|Protocol Violation|1|||
163432095|NCT02243176|590286841|FG000|Overall Study|Withdrawal by Subject|8|||
163432096|NCT02243176|590286842|FG001|Overall Study|Withdrawal by Subject|7|||
163432097|NCT02243176|590286841|FG000|Overall Study|Adverse Event|2|||
163432098|NCT02243176|590286842|FG001|Overall Study|Adverse Event|2|||
163432099|NCT03704051|590286848|FG000|Overall Study|Withdrawal by Subject|4|||
163432100|NCT03704051|590286849|FG001|Overall Study|Withdrawal by Subject|0|||
163432101|NCT03311126|590286852|FG000|Induction|Death|1|||
163432102|NCT03311126|590286852|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
163432103|NCT03113500|590286853|FG000|Overall Study|Withdrawal by Subject|1|||
163432104|NCT01348919|590286854|FG000|Overall Study|Adverse Event|3|||
163432105|NCT01348919|590286855|FG001|Overall Study|Adverse Event|1|||
163432106|NCT01348919|590286856|FG002|Overall Study|Adverse Event|0|||
163432107|NCT01348919|590286854|FG000|Overall Study|Withdrawal by Subject|0|||
163432108|NCT01348919|590286855|FG001|Overall Study|Withdrawal by Subject|1|||
163432109|NCT01348919|590286856|FG002|Overall Study|Withdrawal by Subject|0|||
163432110|NCT01348919|590286854|FG000|Overall Study|Disease progression|0|||
163432111|NCT01348919|590286855|FG001|Overall Study|Disease progression|1|||
163432112|NCT01348919|590286856|FG002|Overall Study|Disease progression|1|||
163432113|NCT02517515|590286859|FG000|Overall Study|Adverse Event|0|||
163432114|NCT02517515|590286860|FG001|Overall Study|Adverse Event|1|||
163432115|NCT02517515|590286859|FG000|Overall Study|Withdrew Consent|0|||
163432116|NCT02517515|590286860|FG001|Overall Study|Withdrew Consent|1|||
163432117|NCT02517515|590286859|FG000|Overall Study|Lost to Follow-up|1|||
163432118|NCT02517515|590286860|FG001|Overall Study|Lost to Follow-up|0|||
163432119|NCT02517515|590286859|FG000|Overall Study|Other|1|||
163432120|NCT02517515|590286860|FG001|Overall Study|Other|0|||
163432121|NCT03839524|590286862|FG000|Overall Study|Adverse Event|1|||
163432122|NCT02037919|590286868|FG000|Overall Study|Lost to Follow-up|30|||
163432123|NCT02037919|590286869|FG001|Overall Study|Lost to Follow-up|45|||
163432124|NCT00886938|590286870|FG000|Overall Study|Adverse Event|1|||
163432125|NCT00886938|590286870|FG000|Overall Study|Withdrawal by Subject|1|||
163432126|NCT00917384|590286871|FG000|Overall Study|Lost to Follow-up|4|||
163432127|NCT00917384|590286872|FG001|Overall Study|Lost to Follow-up|2|||
163432128|NCT00917384|590286871|FG000|Overall Study|Withdrawal by Subject|10|||
163432129|NCT00917384|590286872|FG001|Overall Study|Withdrawal by Subject|2|||
163432130|NCT01458340|590286875|FG000|Overall Study|Adverse Event|5|||
163432131|NCT01458340|590286876|FG001|Overall Study|Adverse Event|4|||
163432132|NCT01458340|590286877|FG002|Overall Study|Adverse Event|2|||
163432133|NCT01458340|590286875|FG000|Overall Study|Lost to Follow-up|3|||
163432134|NCT01458340|590286876|FG001|Overall Study|Lost to Follow-up|3|||
163432135|NCT01458340|590286877|FG002|Overall Study|Lost to Follow-up|10|||
163432136|NCT01458340|590286875|FG000|Overall Study|Miscellaneous|0|||
163432137|NCT01458340|590286876|FG001|Overall Study|Miscellaneous|1|||
163432138|NCT01458340|590286877|FG002|Overall Study|Miscellaneous|0|||
163432139|NCT01458340|590286875|FG000|Overall Study|Physician Decision|1|||
163432140|NCT01458340|590286876|FG001|Overall Study|Physician Decision|1|||
163432141|NCT01458340|590286877|FG002|Overall Study|Physician Decision|2|||
163432142|NCT01458340|590286875|FG000|Overall Study|Protocol Violation|6|||
163432143|NCT01458340|590286876|FG001|Overall Study|Protocol Violation|6|||
163432144|NCT01458340|590286877|FG002|Overall Study|Protocol Violation|5|||
163432145|NCT01458340|590286875|FG000|Overall Study|Withdrawal by Subject|12|||
163432146|NCT01458340|590286876|FG001|Overall Study|Withdrawal by Subject|6|||
163432147|NCT01458340|590286877|FG002|Overall Study|Withdrawal by Subject|4|||
163432148|NCT01021007|590286880|FG000|Overall Study|Lost to Follow-up|1|||
163432149|NCT01021007|590286881|FG001|Overall Study|Lost to Follow-up|1|||
163432150|NCT01021007|590286880|FG000|Overall Study|Adverse Event|1|||
163432151|NCT01021007|590286881|FG001|Overall Study|Adverse Event|3|||
163432152|NCT00947154|590286884|FG000|Overall Study|Lost to Follow-up|1|||
163432153|NCT03293030|590286887|FG000|Overall Study|Withdrawal by Subject|3|||
163432154|NCT04899271|590286888|FG000|Overall Study|Lost to Follow-up|1|||
163432155|NCT04899271|590286889|FG001|Overall Study|Lost to Follow-up|0|||
163432156|NCT04899271|590286888|FG000|Overall Study|Subject request/consent withdrawal|2|||
163432157|NCT04899271|590286889|FG001|Overall Study|Subject request/consent withdrawal|0|||
163432158|NCT00693706|590286890|FG000|Overall Study|Protocol Violation|0|||
163432159|NCT00693706|590286891|FG001|Overall Study|Protocol Violation|1|||
163432160|NCT00498173|590286892|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
163432161|NCT00498173|590286893|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
163432162|NCT00498173|590286894|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
163432163|NCT00095303|590286897|FG000|Main Study|Lost to Follow-up|91|||
163432164|NCT00095303|590286898|FG001|Main Study|Lost to Follow-up|87|||
163432165|NCT00095303|590286897|FG000|Follow Up Study|Lost to Follow-up|59|||
163432166|NCT00095303|590286898|FG001|Follow Up Study|Lost to Follow-up|58|||
163432167|NCT01634243|590286901|FG000|Overall Study|Adverse Event|5|||
163432168|NCT01634243|590286902|FG001|Overall Study|Adverse Event|5|||
163432169|NCT01634243|590286901|FG000|Overall Study|Lack of Efficacy|1|||
163432170|NCT01634243|590286902|FG001|Overall Study|Lack of Efficacy|0|||
163432171|NCT00613626|590286907|FG000|Overall Study|Ineligible|0|||
163432172|NCT00613626|590286908|FG001|Overall Study|Ineligible|1|||
163432173|NCT00613626|590286909|FG002|Overall Study|Ineligible|0|||
163432174|NCT00004980|590286910|FG000|Overall Study|Withdrawal by Subject|1|||
163432175|NCT00004980|590286911|FG001|Overall Study|Withdrawal by Subject|0|||
163432176|NCT00004980|590286910|FG000|Overall Study|memory difficulties|1|||
163432177|NCT00004980|590286911|FG001|Overall Study|memory difficulties|1|||
163432178|NCT00004980|590286910|FG000|Overall Study|Physician Decision|0|||
163432179|NCT00004980|590286911|FG001|Overall Study|Physician Decision|1|||
163432180|NCT01299025|590286912|FG000|Overall Study|Withdrawal by Subject|2|||
163432181|NCT01299025|590286913|FG001|Overall Study|Withdrawal by Subject|1|||
163432182|NCT01299025|590286912|FG000|Overall Study|Lost to Follow-up|1|||
163432183|NCT01299025|590286913|FG001|Overall Study|Lost to Follow-up|0|||
163432184|NCT05480514|590286914|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
163432185|NCT05480514|590286915|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
163432186|NCT05480514|590286914|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
163432187|NCT05480514|590286915|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
163432188|NCT05480514|590286914|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
163432189|NCT05480514|590286915|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
163432190|NCT05480514|590286914|FG000|Period 1|Covid-19 Related|1|||
163432191|NCT05480514|590286915|FG001|Period 1|Covid-19 Related|0|||
163432192|NCT05480514|590286914|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
163432193|NCT05480514|590286915|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
163432194|NCT01259466|590286921|FG000|Overall Study|Withdrawal by Subject|1|||
163432195|NCT01259466|590286922|FG001|Overall Study|Withdrawal by Subject|9|||
163432196|NCT00184054|590286924|FG000|Overall Study|Adverse Event|1|||
163432197|NCT00457639|590286925|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
163432198|NCT00457639|590286926|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
163432199|NCT00457639|590286925|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
163432200|NCT00457639|590286926|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
163432201|NCT00457639|590286925|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
163432202|NCT00457639|590286926|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
163432203|NCT03885284|590286927|FG000|Overall Study|Disease Progression|1|||
163432204|NCT03885284|590286928|FG001|Overall Study|Disease Progression|3|||
163432205|NCT03885284|590286927|FG000|Overall Study|Physician Decision|0|||
163432206|NCT03885284|590286928|FG001|Overall Study|Physician Decision|1|||
163432207|NCT02932267|590286931|FG000|Overall Study|Withdrawal by Subject|3|||
163432208|NCT02932267|590286931|FG000|Overall Study|Lost to Follow-up|4|||
163432209|NCT02932267|590286931|FG000|Overall Study|Pregnancy|1|||
163432210|NCT00840463|590286936|FG000|Overall Study|Adverse Event|1|||
163432211|NCT00840463|590286937|FG001|Overall Study|Adverse Event|0|||
163432212|NCT01887210|590286938|FG000|Overall Study|Withdrawal by Subject|1|||
163432213|NCT01887210|590286939|FG001|Overall Study|Withdrawal by Subject|3|||
163432214|NCT01887210|590286938|FG000|Overall Study|Lost to Follow-up|0|||
163432215|NCT01887210|590286939|FG001|Overall Study|Lost to Follow-up|1|||
163432216|NCT02515669|590286949|FG000|228 Week Open-Label Phase|Other|0|||
163432217|NCT02515669|590286950|FG001|228 Week Open-Label Phase|Other|0|||
163432218|NCT02515669|590286951|FG002|228 Week Open-Label Phase|Other|1|||
163432219|NCT02515669|590286952|FG003|228 Week Open-Label Phase|Other|4|||
163432220|NCT02515669|590286949|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
163432221|NCT02515669|590286950|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
163432222|NCT02515669|590286951|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
163432223|NCT02515669|590286952|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
163432224|NCT02515669|590286949|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
163432225|NCT02515669|590286950|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
163432226|NCT02515669|590286951|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
163432227|NCT02515669|590286952|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
163432228|NCT02515669|590286949|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
163432229|NCT02515669|590286950|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
163432230|NCT02515669|590286951|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
163432231|NCT02515669|590286952|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
163432232|NCT02515669|590286949|FG000|228 Week Open-Label Phase|Missing|0|||
163432233|NCT02515669|590286950|FG001|228 Week Open-Label Phase|Missing|2|||
163432234|NCT02515669|590286951|FG002|228 Week Open-Label Phase|Missing|2|||
163432235|NCT02515669|590286952|FG003|228 Week Open-Label Phase|Missing|2|||
163432236|NCT00957372|590286953|FG000|PART I|Lost to Follow-up|0|||
163432237|NCT00957372|590286954|FG001|PART I|Lost to Follow-up|0|||
163432238|NCT00957372|590286955|FG002|PART I|Lost to Follow-up|1|||
163432239|NCT00957372|590286956|FG003|PART I|Lost to Follow-up|0|||
163432240|NCT00957372|590286953|FG000|PART II|Withdrawal by Subject|0|||
163432241|NCT00957372|590286954|FG001|PART II|Withdrawal by Subject|0|||
163432242|NCT00957372|590286955|FG002|PART II|Withdrawal by Subject|0|||
163432243|NCT00957372|590286956|FG003|PART II|Withdrawal by Subject|8|||
163432244|NCT00957372|590286953|FG000|PART II|Physician Decision|0|||
163432245|NCT00957372|590286954|FG001|PART II|Physician Decision|0|||
163432246|NCT00957372|590286955|FG002|PART II|Physician Decision|0|||
163432247|NCT00957372|590286956|FG003|PART II|Physician Decision|1|||
163432248|NCT00957372|590286953|FG000|PART II|Pregnancy|0|||
163432249|NCT00957372|590286954|FG001|PART II|Pregnancy|0|||
163432250|NCT00957372|590286955|FG002|PART II|Pregnancy|0|||
163432251|NCT00957372|590286956|FG003|PART II|Pregnancy|1|||
163432252|NCT00957372|590286953|FG000|PART II|Not Know|0|||
163432253|NCT00957372|590286954|FG001|PART II|Not Know|0|||
163432254|NCT00957372|590286955|FG002|PART II|Not Know|0|||
163432255|NCT00957372|590286956|FG003|PART II|Not Know|20|||
163432256|NCT00957372|590286953|FG000|PART II|Adverse Event|0|||
163432257|NCT00957372|590286954|FG001|PART II|Adverse Event|0|||
163432258|NCT00957372|590286955|FG002|PART II|Adverse Event|0|||
163432259|NCT00957372|590286956|FG003|PART II|Adverse Event|10|||
163432260|NCT00957372|590286953|FG000|PART II|Patient non-compliance|0|||
163432261|NCT00957372|590286954|FG001|PART II|Patient non-compliance|0|||
163432262|NCT00957372|590286955|FG002|PART II|Patient non-compliance|0|||
163432263|NCT00957372|590286956|FG003|PART II|Patient non-compliance|4|||
163432264|NCT01444391|590286959|FG000|Overall Study|Death|1|||
163432265|NCT03750838|590286960|FG000|Overall Study|Lost to Follow-up|10|||
163432266|NCT03750838|590286961|FG001|Overall Study|Lost to Follow-up|6|||
163432267|NCT02032875|590286967|FG000|Treatment Period|Adverse Event|1|||
163432268|NCT02032875|590286968|FG001|Treatment Period|Adverse Event|0|||
163432269|NCT02032875|590286967|FG000|Treatment Period|Liver transplant, No extension needed|0|||
163432270|NCT02032875|590286968|FG001|Treatment Period|Liver transplant, No extension needed|1|||
163432271|NCT02032875|590286967|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
163432272|NCT02032875|590286968|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
163432273|NCT02032875|590286967|FG000|Follow-up Period|Death|0|||
163432274|NCT02032875|590286968|FG001|Follow-up Period|Death|1|||
163432275|NCT02032875|590286967|FG000|Follow-up Period|Virologic Relapse|3|||
163432276|NCT02032875|590286968|FG001|Follow-up Period|Virologic Relapse|10|||
163432277|NCT03191786|590286973|FG000|Overall Study|Death|236|||
163432278|NCT03191786|590286974|FG001|Overall Study|Death|127|||
163432279|NCT03191786|590286973|FG000|Overall Study|Lost to Follow-up|9|||
163432280|NCT03191786|590286974|FG001|Overall Study|Lost to Follow-up|3|||
163432281|NCT03191786|590286973|FG000|Overall Study|Physician Decision|1|||
163432282|NCT03191786|590286974|FG001|Overall Study|Physician Decision|0|||
163432283|NCT03191786|590286973|FG000|Overall Study|Moved to Post Trial Access Program|30|||
163432284|NCT03191786|590286974|FG001|Overall Study|Moved to Post Trial Access Program|5|||
163432285|NCT03191786|590286973|FG000|Overall Study|Withdrawal by Subject|26|||
163432286|NCT03191786|590286974|FG001|Overall Study|Withdrawal by Subject|16|||
163432287|NCT05847881|590286975|FG000|Overall Study|Principal Investigator Decision|8|||
163432288|NCT05847881|590286975|FG000|Overall Study|Withdrawal by Subject|2|||
163432289|NCT05781542|590288299|FG000|Overall Study|Lost to Follow-up|1|||
163432290|NCT05781542|590288300|FG001|Overall Study|Lost to Follow-up|0|||
163432291|NCT05781542|590288301|FG002|Overall Study|Lost to Follow-up|1|||
163432292|NCT01386385|590288306|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
163432293|NCT01386385|590288307|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
163432294|NCT01386385|590288308|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
163432295|NCT01386385|590288309|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
163432296|NCT01386385|590288310|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
163432297|NCT01386385|590288311|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
163432298|NCT01386385|590288312|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
163432299|NCT01386385|590288313|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
163432300|NCT01386385|590288306|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
163432301|NCT01386385|590288307|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
163432302|NCT01386385|590288308|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
163432303|NCT01386385|590288309|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
163432304|NCT01386385|590288310|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
163432305|NCT01386385|590288311|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
163432306|NCT01386385|590288312|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
163432307|NCT01386385|590288313|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
163432308|NCT01386385|590288306|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
163432309|NCT01386385|590288307|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
163432310|NCT01386385|590288308|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
163432311|NCT01386385|590288309|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
163432312|NCT01386385|590288310|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
163432313|NCT01386385|590288311|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
163432314|NCT01386385|590288312|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
163432315|NCT01386385|590288313|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
163432316|NCT01386385|590288306|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
163432317|NCT01386385|590288307|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
163432318|NCT01386385|590288308|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
163432319|NCT01386385|590288309|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
163432320|NCT01386385|590288310|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
163432321|NCT01386385|590288311|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
163432322|NCT01386385|590288312|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
163432323|NCT01386385|590288313|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
163432324|NCT01386385|590288306|FG000|Phase II Concurrent CRT|Adverse Event|0|||
163432325|NCT01386385|590288307|FG001|Phase II Concurrent CRT|Adverse Event|0|||
163432326|NCT01386385|590288308|FG002|Phase II Concurrent CRT|Adverse Event|0|||
163432327|NCT01386385|590288309|FG003|Phase II Concurrent CRT|Adverse Event|0|||
163432328|NCT01386385|590288310|FG004|Phase II Concurrent CRT|Adverse Event|0|||
163432329|NCT01386385|590288311|FG005|Phase II Concurrent CRT|Adverse Event|0|||
163432330|NCT01386385|590288312|FG006|Phase II Concurrent CRT|Adverse Event|3|||
163432331|NCT01386385|590288313|FG007|Phase II Concurrent CRT|Adverse Event|3|||
163432332|NCT01386385|590288306|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
163432333|NCT01386385|590288307|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
163432334|NCT01386385|590288308|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
163432335|NCT01386385|590288309|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
163432336|NCT01386385|590288310|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
163432337|NCT01386385|590288311|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
163432338|NCT01386385|590288312|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
163432339|NCT01386385|590288313|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
163432340|NCT01386385|590288306|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
163432341|NCT01386385|590288307|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
163432342|NCT01386385|590288308|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
163432343|NCT01386385|590288309|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
163432344|NCT01386385|590288310|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
163432345|NCT01386385|590288311|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
163432346|NCT01386385|590288312|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
163432347|NCT01386385|590288313|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
163432348|NCT01386385|590288306|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
163432349|NCT01386385|590288307|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
163432350|NCT01386385|590288308|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
163432351|NCT01386385|590288309|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
163432352|NCT01386385|590288310|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
163432353|NCT01386385|590288311|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
163432354|NCT01386385|590288312|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
163432355|NCT01386385|590288313|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
163432356|NCT01386385|590288306|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
163432357|NCT01386385|590288307|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
163432358|NCT01386385|590288308|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
163432359|NCT01386385|590288309|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
163432360|NCT01386385|590288310|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
163432361|NCT01386385|590288311|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
163432362|NCT01386385|590288312|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
163432363|NCT01386385|590288313|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
163432364|NCT03167619|590288321|FG000|Overall Study|Death|11|||
163432365|NCT03167619|590288322|FG001|Overall Study|Death|8|||
163432366|NCT03167619|590288321|FG000|Overall Study|Withdrawal by Subject|1|||
163432367|NCT03167619|590288322|FG001|Overall Study|Withdrawal by Subject|2|||
163432368|NCT03167619|590288321|FG000|Overall Study|Physician Decision|0|||
163432369|NCT03167619|590288322|FG001|Overall Study|Physician Decision|1|||
163432370|NCT06400238|590288326|FG000|Overall Study|Started Protocol Therapy|2|||
163432371|NCT06400238|590288326|FG000|Overall Study|Adverse Event|1|||
163432372|NCT06400238|590288326|FG000|Overall Study|Death|1|||
163432373|NCT06400238|590288326|FG000|Overall Study|Disease Progression|27|||
163432374|NCT06400238|590288326|FG000|Overall Study|Withdrawal by Subject|2|||
163432375|NCT06400238|590288326|FG000|Overall Study|Physician Decision|2|||
163432376|NCT01009463|590288329|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
163432377|NCT01009463|590288330|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
163432378|NCT01009463|590288331|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
163432379|NCT01009463|590288332|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
163432380|NCT01009463|590288333|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
163432381|NCT01009463|590288329|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
163432382|NCT01009463|590288330|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
163432383|NCT01009463|590288331|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
163432384|NCT01009463|590288332|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
163432385|NCT01009463|590288333|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
163432386|NCT01009463|590288329|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
163432387|NCT01009463|590288330|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
163432388|NCT01009463|590288331|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
163432389|NCT01009463|590288332|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
163432390|NCT01009463|590288333|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
163432391|NCT01009463|590288329|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
163432392|NCT01009463|590288330|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
163432393|NCT01009463|590288331|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
163432394|NCT01009463|590288332|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
163432395|NCT01009463|590288333|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
163432396|NCT01009463|590288329|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
163432397|NCT01009463|590288330|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
163432398|NCT01009463|590288331|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
163432399|NCT01009463|590288332|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
163432400|NCT01009463|590288333|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
163432401|NCT01009463|590288329|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
163432402|NCT01009463|590288330|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
163432403|NCT01009463|590288331|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
163432404|NCT01009463|590288332|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
163432405|NCT01009463|590288333|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
163432406|NCT01009463|590288329|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
163432407|NCT01009463|590288330|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
163432408|NCT01009463|590288331|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
163432409|NCT01009463|590288332|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
163432410|NCT01009463|590288333|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
163432411|NCT01009463|590288329|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
163432412|NCT01009463|590288330|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
163432413|NCT01009463|590288331|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
163432414|NCT01009463|590288332|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
163432415|NCT01009463|590288333|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
163432416|NCT01009463|590288329|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
163432417|NCT01009463|590288330|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
163432418|NCT01009463|590288331|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
163432419|NCT01009463|590288332|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
163432420|NCT01009463|590288333|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
163432421|NCT01009463|590288329|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
163432422|NCT01009463|590288330|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
163432423|NCT01009463|590288331|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
163432424|NCT01009463|590288332|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
163432425|NCT01009463|590288333|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
163432426|NCT01009463|590288329|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
163432427|NCT01009463|590288330|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
163432428|NCT01009463|590288331|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
163432429|NCT01009463|590288332|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
163432430|NCT01009463|590288333|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
163432431|NCT01009463|590288329|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163432432|NCT01009463|590288330|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
163432433|NCT01009463|590288331|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
163432434|NCT01009463|590288332|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
163432435|NCT01009463|590288333|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
163432436|NCT01009463|590288329|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
163432437|NCT01009463|590288330|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
163432438|NCT01009463|590288331|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
163432439|NCT01009463|590288332|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
163432440|NCT01009463|590288333|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
163432441|NCT04430348|590288334|FG000|Overall Study|Death|3|||
163432442|NCT04430348|590288335|FG001|Overall Study|Death|2|||
163432443|NCT04430348|590288336|FG002|Overall Study|Death|2|||
163432444|NCT04430348|590288337|FG003|Overall Study|Death|2|||
163432445|NCT04430348|590288338|FG004|Overall Study|Death|2|||
163432446|NCT04430348|590288339|FG005|Overall Study|Death|3|||
163432447|NCT04430348|590288334|FG000|Overall Study|Lost to Follow-up|0|||
163432448|NCT04430348|590288335|FG001|Overall Study|Lost to Follow-up|0|||
163432449|NCT04430348|590288336|FG002|Overall Study|Lost to Follow-up|0|||
163432450|NCT04430348|590288337|FG003|Overall Study|Lost to Follow-up|1|||
163432451|NCT04430348|590288338|FG004|Overall Study|Lost to Follow-up|0|||
163432452|NCT04430348|590288339|FG005|Overall Study|Lost to Follow-up|0|||
163432453|NCT04430348|590288334|FG000|Overall Study|Adverse Event|0|||
163432454|NCT04430348|590288335|FG001|Overall Study|Adverse Event|0|||
163432455|NCT04430348|590288336|FG002|Overall Study|Adverse Event|0|||
163432456|NCT04430348|590288337|FG003|Overall Study|Adverse Event|0|||
163432457|NCT04430348|590288338|FG004|Overall Study|Adverse Event|0|||
163432458|NCT04430348|590288339|FG005|Overall Study|Adverse Event|1|||
163432459|NCT04430348|590288334|FG000|Overall Study|Withdrawal by Subject|0|||
163432460|NCT04430348|590288335|FG001|Overall Study|Withdrawal by Subject|1|||
163432461|NCT04430348|590288336|FG002|Overall Study|Withdrawal by Subject|0|||
163432462|NCT04430348|590288337|FG003|Overall Study|Withdrawal by Subject|0|||
163432463|NCT04430348|590288338|FG004|Overall Study|Withdrawal by Subject|0|||
163432464|NCT04430348|590288339|FG005|Overall Study|Withdrawal by Subject|1|||
163432465|NCT04430348|590288334|FG000|Overall Study|Study Terminated by Sponsor|0|||
163432466|NCT04430348|590288335|FG001|Overall Study|Study Terminated by Sponsor|0|||
163432467|NCT04430348|590288336|FG002|Overall Study|Study Terminated by Sponsor|2|||
163432468|NCT04430348|590288337|FG003|Overall Study|Study Terminated by Sponsor|0|||
163432469|NCT04430348|590288338|FG004|Overall Study|Study Terminated by Sponsor|1|||
163432470|NCT04430348|590288339|FG005|Overall Study|Study Terminated by Sponsor|1|||
163432471|NCT05408858|590288344|FG000|Overall Study|no longer met eligibility criteria|1|||
163432472|NCT00384956|590288345|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
163432473|NCT00900796|590288347|FG000|Phase 1|Lacked sufficient information|4|||
163432474|NCT00900796|590288347|FG000|Phase 1|Missing information at Week 16|7|||
163432475|NCT00900796|590288347|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
163432476|NCT00900796|590288347|FG000|Phase 2|Lost to Follow-up|5|||
163432477|NCT00881205|590288349|FG000|Overall Study|Adverse Event|8|||
163432478|NCT00881205|590288350|FG001|Overall Study|Adverse Event|3|||
163432479|NCT00881205|590288349|FG000|Overall Study|Withdrawal by Subject|1|||
163432480|NCT00881205|590288350|FG001|Overall Study|Withdrawal by Subject|2|||
163432481|NCT00881205|590288349|FG000|Overall Study|Lost to Follow-up|0|||
163432482|NCT00881205|590288350|FG001|Overall Study|Lost to Follow-up|1|||
163432483|NCT00881205|590288349|FG000|Overall Study|Administrative problems|1|||
163432484|NCT00881205|590288350|FG001|Overall Study|Administrative problems|1|||
163432485|NCT00881205|590288349|FG000|Overall Study|Condition no longer requires drug|1|||
163432486|NCT00881205|590288350|FG001|Overall Study|Condition no longer requires drug|0|||
163432487|NCT02318602|590288354|FG000|Overall Study|Adverse Event|0|||
163432488|NCT02318602|590288355|FG001|Overall Study|Adverse Event|1|||
163432489|NCT02318602|590288356|FG002|Overall Study|Adverse Event|1|||
163432490|NCT02318602|590288354|FG000|Overall Study|Withdrawal by Subject|0|||
163432491|NCT02318602|590288355|FG001|Overall Study|Withdrawal by Subject|3|||
163432492|NCT02318602|590288356|FG002|Overall Study|Withdrawal by Subject|0|||
163432493|NCT02318602|590288354|FG000|Overall Study|Death|1|||
163432494|NCT02318602|590288355|FG001|Overall Study|Death|0|||
163432495|NCT02318602|590288356|FG002|Overall Study|Death|0|||
163432496|NCT02318602|590288354|FG000|Overall Study|Guardian decision to withdraw|0|||
163432497|NCT02318602|590288355|FG001|Overall Study|Guardian decision to withdraw|0|||
163432498|NCT02318602|590288356|FG002|Overall Study|Guardian decision to withdraw|1|||
163432499|NCT01733329|590288358|FG000|Overall Study|Protocol Violation|1|||
163432500|NCT01733329|590288359|FG001|Overall Study|Protocol Violation|1|||
163432501|NCT01733329|590288358|FG000|Overall Study|Uterine artery injury|1|||
163432502|NCT01733329|590288359|FG001|Overall Study|Uterine artery injury|0|||
163432503|NCT00730236|590288360|FG000|Overall Study|Adverse Event|4|||
163432504|NCT00730236|590288360|FG000|Overall Study|Withdrawal by Subject|1|||
163432505|NCT00730236|590288360|FG000|Overall Study|Non-compliance|1|||
163432506|NCT00542828|590288366|FG000|Overall Study|Physician Decision|1|||
163432507|NCT00542828|590288366|FG000|Overall Study|Need for Prohibited Treatment|3|||
163432508|NCT00542828|590288366|FG000|Overall Study|Study Prematurely Discontinued|7|||
163432509|NCT00542828|590288366|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
163432510|NCT00258154|590288367|FG000|Overall Study|Adverse Event|1|||
163432511|NCT00258154|590288368|FG001|Overall Study|Adverse Event|0|||
163432512|NCT00258154|590288367|FG000|Overall Study|Lost to Follow-up|0|||
163432513|NCT00258154|590288368|FG001|Overall Study|Lost to Follow-up|1|||
163432514|NCT00258154|590288367|FG000|Overall Study|Protocol Violation|2|||
163432515|NCT00258154|590288368|FG001|Overall Study|Protocol Violation|1|||
163432516|NCT00258154|590288367|FG000|Overall Study|Withdrawal by Subject|3|||
163432517|NCT00258154|590288368|FG001|Overall Study|Withdrawal by Subject|4|||
163432518|NCT00258154|590288367|FG000|Overall Study|Patient Moved|3|||
163432519|NCT00258154|590288368|FG001|Overall Study|Patient Moved|1|||
163432520|NCT05139030|590288369|FG000|Overall Study|Withdrawal by Subject|1|||
163432521|NCT05139030|590288370|FG001|Overall Study|Withdrawal by Subject|3|||
163432522|NCT05139030|590288369|FG000|Overall Study|Adverse Event|0|||
163432523|NCT05139030|590288370|FG001|Overall Study|Adverse Event|1|||
163432524|NCT05139030|590288369|FG000|Overall Study|Failure to meet continuation criteria|0|||
163432525|NCT05139030|590288370|FG001|Overall Study|Failure to meet continuation criteria|1|||
163432526|NCT00820040|590288375|FG000|Overall Study|Death|1|||
163432527|NCT00820040|590288375|FG000|Overall Study|Sponsor terminated study|1|||
163432528|NCT00820040|590288375|FG000|Overall Study|Screen failure|1|||
163432529|NCT01824602|590288377|FG000|Overall Study|Withdrawal by Subject|0|||
163432530|NCT01824602|590288378|FG001|Overall Study|Withdrawal by Subject|0|||
163432531|NCT01824602|590288379|FG002|Overall Study|Withdrawal by Subject|1|||
163432532|NCT01824602|590288380|FG003|Overall Study|Withdrawal by Subject|2|||
163432533|NCT01824602|590288377|FG000|Overall Study|Patient non-compliance|0|||
163432534|NCT01824602|590288378|FG001|Overall Study|Patient non-compliance|0|||
163432535|NCT01824602|590288379|FG002|Overall Study|Patient non-compliance|1|||
163432536|NCT01824602|590288380|FG003|Overall Study|Patient non-compliance|0|||
163432537|NCT01824602|590288377|FG000|Overall Study|Adverse Event|1|||
163432538|NCT01824602|590288378|FG001|Overall Study|Adverse Event|0|||
163432539|NCT01824602|590288379|FG002|Overall Study|Adverse Event|2|||
163432540|NCT01824602|590288380|FG003|Overall Study|Adverse Event|2|||
163432541|NCT01824602|590288377|FG000|Overall Study|Treatment failure|0|||
163432542|NCT01824602|590288378|FG001|Overall Study|Treatment failure|0|||
163432543|NCT01824602|590288379|FG002|Overall Study|Treatment failure|0|||
163432544|NCT01824602|590288380|FG003|Overall Study|Treatment failure|1|||
163432545|NCT02192359|590288383|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
163432546|NCT02192359|590288384|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
163432547|NCT02192359|590288385|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
163432548|NCT02192359|590288386|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
163432549|NCT02192359|590288383|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
163432550|NCT02192359|590288384|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
163432551|NCT02192359|590288385|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
163432552|NCT02192359|590288386|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
163432553|NCT02192359|590288383|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
163432554|NCT02192359|590288384|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
163432555|NCT02192359|590288385|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
163432556|NCT02192359|590288386|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
163432557|NCT02117687|590288394|FG000|Overall Study|Lost to Follow-up|0|||
163432558|NCT02117687|590288395|FG001|Overall Study|Lost to Follow-up|1|||
163432559|NCT02117687|590288394|FG000|Overall Study|Adverse Event|0|||
163432560|NCT02117687|590288395|FG001|Overall Study|Adverse Event|2|||
163432561|NCT02117687|590288394|FG000|Overall Study|Other Reasons|1|||
163432562|NCT02117687|590288395|FG001|Overall Study|Other Reasons|1|||
163432563|NCT00002850|590288397|FG000|Overall Study|Death|4|||
163432564|NCT00002850|590288398|FG001|Overall Study|Death|1|||
163432565|NCT00002850|590288399|FG002|Overall Study|Death|3|||
163432566|NCT00002850|590288397|FG000|Overall Study|Protocol Violation|1|||
163432567|NCT00002850|590288398|FG001|Overall Study|Protocol Violation|0|||
163432568|NCT00002850|590288399|FG002|Overall Study|Protocol Violation|1|||
163432569|NCT00002850|590288397|FG000|Overall Study|Withdrawal by Subject|0|||
163432570|NCT00002850|590288398|FG001|Overall Study|Withdrawal by Subject|1|||
163432571|NCT00002850|590288399|FG002|Overall Study|Withdrawal by Subject|0|||
163432572|NCT02006576|590288400|FG000|Overall Study|Withdrawal by Subject|4|||
163432573|NCT02006576|590288401|FG001|Overall Study|Withdrawal by Subject|6|||
163432574|NCT02006576|590288402|FG002|Overall Study|Withdrawal by Subject|2|||
163432575|NCT02006576|590288400|FG000|Overall Study|Death|0|||
163432576|NCT02006576|590288401|FG001|Overall Study|Death|0|||
163432577|NCT02006576|590288402|FG002|Overall Study|Death|1|||
163432578|NCT02006576|590288400|FG000|Overall Study|Lost to Follow-up|1|||
163432579|NCT02006576|590288401|FG001|Overall Study|Lost to Follow-up|0|||
163432580|NCT02006576|590288402|FG002|Overall Study|Lost to Follow-up|1|||
163432581|NCT02006576|590288400|FG000|Overall Study|Screen Failure, too sick, other|13|||
163432582|NCT02006576|590288401|FG001|Overall Study|Screen Failure, too sick, other|1|||
163432583|NCT02006576|590288402|FG002|Overall Study|Screen Failure, too sick, other|13|||
163432584|NCT00785577|590288403|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
163432585|NCT00785577|590288404|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
163432586|NCT00785577|590288405|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
163432587|NCT00785577|590288406|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
163432588|NCT00785577|590288407|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
163432589|NCT00785577|590288403|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
163432590|NCT00785577|590288404|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
163432591|NCT00785577|590288405|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
163432592|NCT00785577|590288406|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
163432593|NCT00785577|590288407|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
163432594|NCT00785577|590288403|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
163432595|NCT00785577|590288404|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
163432596|NCT00785577|590288405|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
163432597|NCT00785577|590288406|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
163432598|NCT00785577|590288407|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
163432599|NCT00785577|590288403|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
163432600|NCT00785577|590288404|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
163432601|NCT00785577|590288405|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
163432602|NCT00785577|590288406|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
163432603|NCT00785577|590288407|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
163432604|NCT00785577|590288403|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
163432605|NCT00785577|590288404|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
163432606|NCT00785577|590288405|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
163432607|NCT00785577|590288406|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
163432608|NCT00785577|590288407|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
163432609|NCT00785577|590288403|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
163432610|NCT00785577|590288404|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
163432611|NCT00785577|590288405|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
163432612|NCT00785577|590288406|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
163432613|NCT00785577|590288407|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
163432614|NCT00785577|590288403|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
163432615|NCT00785577|590288404|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
163432616|NCT00785577|590288405|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
163432617|NCT00785577|590288406|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
163432618|NCT00785577|590288407|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
163432619|NCT00785577|590288403|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
163432620|NCT00785577|590288404|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
163432621|NCT00785577|590288405|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
163432622|NCT00785577|590288406|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
163432623|NCT00785577|590288407|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
163432624|NCT00785577|590288403|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
163432625|NCT00785577|590288404|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
163432626|NCT00785577|590288405|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
163432627|NCT00785577|590288406|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
163432628|NCT00785577|590288407|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
163432629|NCT00785577|590288403|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
163432630|NCT00785577|590288404|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
163432631|NCT00785577|590288405|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
163432632|NCT00785577|590288406|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
163432633|NCT00785577|590288407|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
163432634|NCT01919411|590288408|FG000|Overall Study|Lost to Follow-up|2|||
163432635|NCT01919411|590288409|FG001|Overall Study|Lost to Follow-up|4|||
163432636|NCT01919411|590288408|FG000|Overall Study|Physician Decision|1|||
163432637|NCT01919411|590288409|FG001|Overall Study|Physician Decision|0|||
163432638|NCT01919411|590288408|FG000|Overall Study|Protocol Violation|2|||
163432639|NCT01919411|590288409|FG001|Overall Study|Protocol Violation|1|||
163432640|NCT00630032|590288415|FG000|Overall Study|Death|55|||
163432641|NCT00630032|590288416|FG001|Overall Study|Death|49|||
163432642|NCT00630032|590288415|FG000|Overall Study|Withdrawal by Subject|3|||
163432643|NCT00630032|590288416|FG001|Overall Study|Withdrawal by Subject|2|||
163432644|NCT00630032|590288415|FG000|Overall Study|Lost to Follow-up|18|||
163432645|NCT00630032|590288416|FG001|Overall Study|Lost to Follow-up|31|||
163432646|NCT00630032|590288415|FG000|Overall Study|Protocol Violation|1|||
163432647|NCT00630032|590288416|FG001|Overall Study|Protocol Violation|0|||
163432648|NCT00630032|590288415|FG000|Overall Study|Patient has moved|1|||
163432649|NCT00630032|590288416|FG001|Overall Study|Patient has moved|1|||
163432650|NCT00630032|590288415|FG000|Overall Study|Disease progression|1|||
163432651|NCT00630032|590288416|FG001|Overall Study|Disease progression|1|||
163432652|NCT00630032|590288415|FG000|Overall Study|End of monitoring in US centers|11|||
163432653|NCT00630032|590288416|FG001|Overall Study|End of monitoring in US centers|11|||
163432654|NCT02332915|590288419|FG000|Overall Study|Moved out of region|3|||
163432655|NCT02332915|590288420|FG001|Overall Study|Moved out of region|0|||
163432656|NCT02332915|590288419|FG000|Overall Study|Unrelated illness|1|||
163432657|NCT02332915|590288420|FG001|Overall Study|Unrelated illness|1|||
163432658|NCT02332915|590288419|FG000|Overall Study|Travel distance prohibitive|0|||
163432659|NCT02332915|590288420|FG001|Overall Study|Travel distance prohibitive|1|||
163432660|NCT02332915|590288419|FG000|Overall Study|did not meet inclusion criteria|2|||
163432661|NCT02332915|590288420|FG001|Overall Study|did not meet inclusion criteria|4|||
163432662|NCT01901328|590288424|FG000|Overall Study|Lost to Follow-up|1|||
163432663|NCT01901328|590288425|FG001|Overall Study|Lost to Follow-up|0|||
163432664|NCT01901328|590288424|FG000|Overall Study|Physician Decision|0|||
163432665|NCT01901328|590288425|FG001|Overall Study|Physician Decision|1|||
163432666|NCT01901328|590288424|FG000|Overall Study|Protocol Violation|1|||
163432667|NCT01901328|590288425|FG001|Overall Study|Protocol Violation|1|||
163432668|NCT01901328|590288424|FG000|Overall Study|Study Terminated by Sponsor|19|||
163432669|NCT01901328|590288425|FG001|Overall Study|Study Terminated by Sponsor|16|||
163432670|NCT01901328|590288424|FG000|Overall Study|Withdrawal by Subject|1|||
163432671|NCT01901328|590288425|FG001|Overall Study|Withdrawal by Subject|2|||
163432672|NCT01901328|590288424|FG000|Overall Study|Lack of Efficacy|0|||
163432673|NCT01901328|590288425|FG001|Overall Study|Lack of Efficacy|1|||
163432674|NCT03232073|590288426|FG000|Overall Study|Death|1|||
163432675|NCT03232073|590288427|FG001|Overall Study|Death|0|||
163432676|NCT03232073|590288426|FG000|Overall Study|Adverse Event|7|||
163432677|NCT03232073|590288427|FG001|Overall Study|Adverse Event|12|||
163432678|NCT03232073|590288426|FG000|Overall Study|Lost to Follow-up|6|||
163432679|NCT03232073|590288427|FG001|Overall Study|Lost to Follow-up|6|||
163432680|NCT03232073|590288426|FG000|Overall Study|Lack of Efficacy|10|||
163432681|NCT03232073|590288427|FG001|Overall Study|Lack of Efficacy|8|||
163432682|NCT03232073|590288426|FG000|Overall Study|Physician Decision|9|||
163432683|NCT03232073|590288427|FG001|Overall Study|Physician Decision|2|||
163432684|NCT03232073|590288426|FG000|Overall Study|Withdrawal by Subject|54|||
163432685|NCT03232073|590288427|FG001|Overall Study|Withdrawal by Subject|39|||
163432686|NCT04358458|590288428|FG000|Overall Study|Death|1|||
163432687|NCT04358458|590288429|FG001|Overall Study|Death|1|||
163432688|NCT04358458|590288430|FG002|Overall Study|Death|3|||
163432689|NCT04358458|590288431|FG003|Overall Study|Death|8|||
163432690|NCT04358458|590288432|FG004|Overall Study|Death|1|||
163432691|NCT04358458|590288433|FG005|Overall Study|Death|6|||
163432692|NCT04358458|590288434|FG006|Overall Study|Death|2|||
163432693|NCT04358458|590288435|FG007|Overall Study|Death|3|||
163432694|NCT04358458|590288428|FG000|Overall Study|Lost to Follow-up|0|||
163432695|NCT04358458|590288429|FG001|Overall Study|Lost to Follow-up|0|||
163432696|NCT04358458|590288430|FG002|Overall Study|Lost to Follow-up|0|||
163432697|NCT04358458|590288431|FG003|Overall Study|Lost to Follow-up|0|||
163432698|NCT04358458|590288432|FG004|Overall Study|Lost to Follow-up|0|||
163432699|NCT04358458|590288433|FG005|Overall Study|Lost to Follow-up|0|||
163432700|NCT04358458|590288434|FG006|Overall Study|Lost to Follow-up|0|||
163432701|NCT04358458|590288435|FG007|Overall Study|Lost to Follow-up|1|||
163432702|NCT04358458|590288428|FG000|Overall Study|Site is closing study participation|0|||
163432703|NCT04358458|590288429|FG001|Overall Study|Site is closing study participation|0|||
163432704|NCT04358458|590288430|FG002|Overall Study|Site is closing study participation|0|||
163432705|NCT04358458|590288431|FG003|Overall Study|Site is closing study participation|1|||
163432706|NCT04358458|590288432|FG004|Overall Study|Site is closing study participation|0|||
163432707|NCT04358458|590288433|FG005|Overall Study|Site is closing study participation|0|||
163432708|NCT04358458|590288434|FG006|Overall Study|Site is closing study participation|0|||
163432709|NCT04358458|590288435|FG007|Overall Study|Site is closing study participation|0|||
163432710|NCT04358458|590288428|FG000|Overall Study|Sponsor request|2|||
163432711|NCT04358458|590288429|FG001|Overall Study|Sponsor request|3|||
163432712|NCT04358458|590288430|FG002|Overall Study|Sponsor request|3|||
163432713|NCT04358458|590288431|FG003|Overall Study|Sponsor request|0|||
163432714|NCT04358458|590288432|FG004|Overall Study|Sponsor request|2|||
163432715|NCT04358458|590288433|FG005|Overall Study|Sponsor request|3|||
163432716|NCT04358458|590288434|FG006|Overall Study|Sponsor request|1|||
163432717|NCT04358458|590288435|FG007|Overall Study|Sponsor request|1|||
163432718|NCT04358458|590288428|FG000|Overall Study|Withdrawal by Subject|0|||
163432719|NCT04358458|590288429|FG001|Overall Study|Withdrawal by Subject|0|||
163432720|NCT04358458|590288430|FG002|Overall Study|Withdrawal by Subject|1|||
163432721|NCT04358458|590288431|FG003|Overall Study|Withdrawal by Subject|1|||
163432722|NCT04358458|590288432|FG004|Overall Study|Withdrawal by Subject|0|||
163432723|NCT04358458|590288433|FG005|Overall Study|Withdrawal by Subject|1|||
163432724|NCT04358458|590288434|FG006|Overall Study|Withdrawal by Subject|0|||
163432725|NCT04358458|590288435|FG007|Overall Study|Withdrawal by Subject|1|||
163432726|NCT02082184|590289693|FG000|Overall Study|Adverse Event|1|||
163432727|NCT02082184|590289694|FG001|Overall Study|Adverse Event|0|||
163432728|NCT02082184|590289693|FG000|Overall Study|Medical diagnosis|1|||
163432729|NCT02082184|590289694|FG001|Overall Study|Medical diagnosis|2|||
163432730|NCT02082184|590289693|FG000|Overall Study|Device associated symptoms|5|||
163432731|NCT02082184|590289694|FG001|Overall Study|Device associated symptoms|0|||
163432732|NCT02082184|590289693|FG000|Overall Study|Withdrawal by Subject|3|||
163432733|NCT02082184|590289694|FG001|Overall Study|Withdrawal by Subject|2|||
163432734|NCT02082184|590289693|FG000|Overall Study|Protocol Violation|0|||
163432735|NCT02082184|590289694|FG001|Overall Study|Protocol Violation|6|||
163432736|NCT02082184|590289693|FG000|Overall Study|Lost to Follow-up|0|||
163432737|NCT02082184|590289694|FG001|Overall Study|Lost to Follow-up|2|||
163432738|NCT02082184|590289693|FG000|Overall Study|Subject non-compliance|0|||
163432739|NCT02082184|590289694|FG001|Overall Study|Subject non-compliance|1|||
163432740|NCT01362322|590289697|FG000|Overall Study|Withdrawal by Subject|3|||
163432741|NCT01362322|590289698|FG001|Overall Study|Withdrawal by Subject|1|||
163432742|NCT01362322|590289697|FG000|Overall Study|Lost to Follow-up|2|||
163432743|NCT01362322|590289698|FG001|Overall Study|Lost to Follow-up|6|||
163432744|NCT02413398|590289699|FG000|Overall Study|Lost to Follow-up|2|||
163432745|NCT02413398|590289700|FG001|Overall Study|Lost to Follow-up|4|||
163432746|NCT02413398|590289699|FG000|Overall Study|Withdrawal by Subject|1|||
163432747|NCT02413398|590289700|FG001|Overall Study|Withdrawal by Subject|1|||
163432748|NCT02413398|590289699|FG000|Overall Study|Other Eligibility criteria|1|||
163432749|NCT02413398|590289700|FG001|Overall Study|Other Eligibility criteria|2|||
163432750|NCT01925703|590289703|FG000|Overall Study|Physician Decision|1|||
163432751|NCT01925703|590289703|FG000|Overall Study|Lost to Follow-up|2|||
163432752|NCT01925703|590289703|FG000|Overall Study|Discharge prior to full iron repletion|1|||
163432753|NCT02498652|590289708|FG000|Overall Study|Protocol Violation|0|||
163432754|NCT02498652|590289709|FG001|Overall Study|Protocol Violation|1|||
163432755|NCT01184989|590289714|FG000|Overall Study|Adverse Event|11|||
163432756|NCT01184989|590289714|FG000|Overall Study|Withdrawal by Subject|1|||
163432757|NCT00465569|590289715|FG000|Overall Study|persistent eczema during dose escalation|1|||
163432758|NCT00465569|590289716|FG001|Overall Study|persistent eczema during dose escalation|0|||
163432759|NCT00482001|590289718|FG000|Overall Study|Protocol Violation|1|||
163432760|NCT00482001|590289719|FG001|Overall Study|Protocol Violation|1|||
163432761|NCT04786210|590289720|FG000|Overall Study|Lost to Follow-up|2|||
163432762|NCT04786210|590289720|FG000|Overall Study|Withdrawal by Subject|4|||
163432763|NCT03826914|590289721|FG000|Overall Study|Withdrawal by Subject|1|||
163432764|NCT03826914|590289722|FG001|Overall Study|Withdrawal by Subject|1|||
163432765|NCT04334148|590289724|FG000|Overall Study|positive nasal swab at baseline|0|||
163432766|NCT04334148|590289725|FG001|Overall Study|positive nasal swab at baseline|1|||
163432767|NCT05370157|590289726|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
163432768|NCT05370157|590289727|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
163432769|NCT05370157|590289726|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
163432770|NCT05370157|590289727|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
163432771|NCT01508676|590289728|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
163432772|NCT01508676|590289729|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
163432773|NCT01508676|590289728|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
163432774|NCT01508676|590289729|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
163432775|NCT01508676|590289728|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
163432776|NCT01508676|590289729|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
163432777|NCT01508676|590289728|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
163432778|NCT01508676|590289729|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
163432779|NCT01508676|590289728|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
163432780|NCT01508676|590289729|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
163432781|NCT06129487|590289730|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
163432782|NCT06129487|590289731|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
163432783|NCT03772327|590289732|FG000|Overall Study|Lost to Follow-up|3|||
163432784|NCT03772327|590289733|FG001|Overall Study|Lost to Follow-up|4|||
163432785|NCT03772327|590289732|FG000|Overall Study|Withdrawal by Subject|2|||
163432786|NCT03772327|590289733|FG001|Overall Study|Withdrawal by Subject|3|||
163432787|NCT04689828|590289734|FG000|Overall Study|Subject decision|5|||
163432788|NCT04689828|590289735|FG001|Overall Study|Subject decision|5|||
163432789|NCT04689828|590289734|FG000|Overall Study|Adverse Event|12|||
163432790|NCT04689828|590289735|FG001|Overall Study|Adverse Event|12|||
163432791|NCT04689828|590289734|FG000|Overall Study|Physician Decision|24|||
163432792|NCT04689828|590289735|FG001|Overall Study|Physician Decision|32|||
163432793|NCT04689828|590289734|FG000|Overall Study|Progressive disease|54|||
163432794|NCT04689828|590289735|FG001|Overall Study|Progressive disease|173|||
163432795|NCT04689828|590289734|FG000|Overall Study|Death|0|||
163432796|NCT04689828|590289735|FG001|Overall Study|Death|1|||
163432797|NCT04689828|590289734|FG000|Overall Study|Lost to Follow-up|1|||
163432798|NCT04689828|590289735|FG001|Overall Study|Lost to Follow-up|0|||
163432799|NCT04689828|590289734|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
163432800|NCT04689828|590289735|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
163432801|NCT04689828|590289734|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
163432802|NCT04689828|590289735|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
163432803|NCT04689828|590289734|FG000|Overall Study|Participants not treated|7|||
163432804|NCT04689828|590289735|FG001|Overall Study|Participants not treated|2|||
163432805|NCT00195351|590289740|FG000|Overall Study|Lost to Follow-up|9|||
163432806|NCT00195351|590289741|FG001|Overall Study|Lost to Follow-up|9|||
163432807|NCT00195351|590289740|FG000|Overall Study|Withdrawal by Subject|6|||
163432808|NCT00195351|590289741|FG001|Overall Study|Withdrawal by Subject|3|||
163432809|NCT00195351|590289740|FG000|Overall Study|Protocol Deviation|3|||
163432810|NCT00195351|590289741|FG001|Overall Study|Protocol Deviation|2|||
163432811|NCT00195351|590289740|FG000|Overall Study|Death|3|||
163432812|NCT00195351|590289741|FG001|Overall Study|Death|1|||
163432813|NCT00195351|590289740|FG000|Overall Study|Lack of Efficacy|0|||
163432814|NCT00195351|590289741|FG001|Overall Study|Lack of Efficacy|1|||
163432815|NCT04332419|590289744|FG000|Overall Study|Withdrawal by Subject|1|||
163432816|NCT02493751|590289745|FG000|Overall Study|Withdrawal by Subject|2|||
163432817|NCT02493751|590289746|FG001|Overall Study|Withdrawal by Subject|8|||
163432818|NCT02493751|590289745|FG000|Overall Study|Death|6|||
163432819|NCT02493751|590289746|FG001|Overall Study|Death|13|||
163432820|NCT02493751|590289745|FG000|Overall Study|Lost to Follow-up|2|||
163432821|NCT02493751|590289746|FG001|Overall Study|Lost to Follow-up|3|||
163432822|NCT02493751|590289745|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
163432823|NCT02493751|590289746|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
163432824|NCT01480180|590289747|FG000|Main Phase|Withdrawal criteria|12|||
163432825|NCT01480180|590289748|FG001|Main Phase|Withdrawal criteria|1|||
163432826|NCT01480180|590289749|FG002|Main Phase|Withdrawal criteria|0|||
163432827|NCT01480180|590289750|FG003|Main Phase|Withdrawal criteria|0|||
163432828|NCT01480180|590289751|FG004|Main Phase|Withdrawal criteria|0|||
163432829|NCT01480180|590289752|FG005|Main Phase|Withdrawal criteria|0|||
163432830|NCT01480180|590289747|FG000|Main Phase|Lack of Efficacy|1|||
163432831|NCT01480180|590289748|FG001|Main Phase|Lack of Efficacy|0|||
163432832|NCT01480180|590289749|FG002|Main Phase|Lack of Efficacy|0|||
163432833|NCT01480180|590289750|FG003|Main Phase|Lack of Efficacy|0|||
163432834|NCT01480180|590289751|FG004|Main Phase|Lack of Efficacy|0|||
163432835|NCT01480180|590289752|FG005|Main Phase|Lack of Efficacy|0|||
163432836|NCT01480180|590289747|FG000|Main Phase|Non-compliance|3|||
163432837|NCT01480180|590289748|FG001|Main Phase|Non-compliance|0|||
163432838|NCT01480180|590289749|FG002|Main Phase|Non-compliance|0|||
163432839|NCT01480180|590289750|FG003|Main Phase|Non-compliance|0|||
163432840|NCT01480180|590289751|FG004|Main Phase|Non-compliance|0|||
163432841|NCT01480180|590289752|FG005|Main Phase|Non-compliance|0|||
163432842|NCT01480180|590289747|FG000|Main Phase|Unclassified|3|||
163432843|NCT01480180|590289748|FG001|Main Phase|Unclassified|0|||
163432844|NCT01480180|590289749|FG002|Main Phase|Unclassified|0|||
163432845|NCT01480180|590289750|FG003|Main Phase|Unclassified|0|||
163432846|NCT01480180|590289751|FG004|Main Phase|Unclassified|0|||
163432847|NCT01480180|590289752|FG005|Main Phase|Unclassified|0|||
163432848|NCT01480180|590289747|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
163432849|NCT01480180|590289748|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
163432850|NCT01480180|590289749|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
163432851|NCT01480180|590289750|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
163432852|NCT01480180|590289751|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
163432853|NCT01480180|590289752|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
163432854|NCT01480180|590289747|FG000|Extension Phase, Part 1|Unclassified|0|||
163432855|NCT01480180|590289748|FG001|Extension Phase, Part 1|Unclassified|0|||
163432856|NCT01480180|590289749|FG002|Extension Phase, Part 1|Unclassified|1|||
163432857|NCT01480180|590289750|FG003|Extension Phase, Part 1|Unclassified|0|||
163432858|NCT01480180|590289751|FG004|Extension Phase, Part 1|Unclassified|0|||
163432859|NCT01480180|590289752|FG005|Extension Phase, Part 1|Unclassified|0|||
163432860|NCT01480180|590289747|FG000|Extension Phase, Part 1|Adverse Event|0|||
163432861|NCT01480180|590289748|FG001|Extension Phase, Part 1|Adverse Event|0|||
163432862|NCT01480180|590289749|FG002|Extension Phase, Part 1|Adverse Event|4|||
163432863|NCT01480180|590289750|FG003|Extension Phase, Part 1|Adverse Event|1|||
163432864|NCT01480180|590289751|FG004|Extension Phase, Part 1|Adverse Event|0|||
163432865|NCT01480180|590289752|FG005|Extension Phase, Part 1|Adverse Event|0|||
163432866|NCT01480180|590289747|FG000|Extension Phase, Part 1|Change of treatment|0|||
163432867|NCT01480180|590289748|FG001|Extension Phase, Part 1|Change of treatment|0|||
163432868|NCT01480180|590289749|FG002|Extension Phase, Part 1|Change of treatment|0|||
163432869|NCT01480180|590289750|FG003|Extension Phase, Part 1|Change of treatment|9|||
163432870|NCT01480180|590289751|FG004|Extension Phase, Part 1|Change of treatment|0|||
163432871|NCT01480180|590289752|FG005|Extension Phase, Part 1|Change of treatment|0|||
163432872|NCT01480180|590289747|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
163432873|NCT01480180|590289748|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
163432874|NCT01480180|590289749|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
163432875|NCT01480180|590289750|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
163432876|NCT01480180|590289751|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
163432877|NCT01480180|590289752|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
163432878|NCT01480180|590289747|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
163432879|NCT01480180|590289748|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
163432880|NCT01480180|590289749|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
163432881|NCT01480180|590289750|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
163432882|NCT01480180|590289751|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
163432883|NCT01480180|590289752|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
163432884|NCT01480180|590289747|FG000|Extension Phase, Part 2|Unclassified|0|||
163432885|NCT01480180|590289748|FG001|Extension Phase, Part 2|Unclassified|0|||
163432886|NCT01480180|590289749|FG002|Extension Phase, Part 2|Unclassified|3|||
163432887|NCT01480180|590289750|FG003|Extension Phase, Part 2|Unclassified|1|||
163432888|NCT01480180|590289751|FG004|Extension Phase, Part 2|Unclassified|1|||
163432889|NCT01480180|590289752|FG005|Extension Phase, Part 2|Unclassified|0|||
163432890|NCT00519623|590289753|FG000|Overall Study|Adverse Event|1|||
163432891|NCT04222725|590289756|FG000|Overall Study|Adverse Event|0|||
163432892|NCT04222725|590289757|FG001|Overall Study|Adverse Event|1|||
163432893|NCT04222725|590289758|FG002|Overall Study|Adverse Event|0|||
163432894|NCT04222725|590289759|FG003|Overall Study|Adverse Event|0|||
163432895|NCT03819140|590289760|FG000|Overall Study|Lost to Follow-up|1|||
163432896|NCT03819140|590289761|FG001|Overall Study|Lost to Follow-up|2|||
163432897|NCT03819140|590289760|FG000|Overall Study|Withdrawal by Subject|3|||
163432898|NCT03819140|590289761|FG001|Overall Study|Withdrawal by Subject|2|||
163432899|NCT03819140|590289760|FG000|Overall Study|Adverse Event|0|||
163432900|NCT03819140|590289761|FG001|Overall Study|Adverse Event|1|||
163432901|NCT03819140|590289760|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
163432902|NCT03819140|590289761|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
163432903|NCT03819140|590289760|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
163432904|NCT03819140|590289761|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
163432905|NCT00104871|590289762|FG000|Overall Study|Not evaluable|1|||
163432906|NCT00658333|590289763|FG000|Overall Study|Adverse Event|2|||
163432907|NCT00658333|590289764|FG001|Overall Study|Adverse Event|1|||
163432908|NCT00828451|590289767|FG000|Overall Study|Death|2|||
163432909|NCT00828451|590289767|FG000|Overall Study|Lack of intravenous line|7|||
163432910|NCT00828451|590289767|FG000|Overall Study|Withdrawal by Subject|1|||
163432911|NCT00828451|590289767|FG000|Overall Study|Deterioration in clinical status|1|||
163432912|NCT03256539|590289768|FG000|Overall Study|Withdrawal by Subject|0|||
163432913|NCT03256539|590289769|FG001|Overall Study|Withdrawal by Subject|3|||
163432914|NCT03256539|590289768|FG000|Overall Study|Unexpected closure of study components|8|||
163432915|NCT03256539|590289769|FG001|Overall Study|Unexpected closure of study components|4|||
163432916|NCT05755438|590289772|FG000|12-week DBVC Period|Adverse Event|4|||
163432917|NCT05755438|590289773|FG001|12-week DBVC Period|Adverse Event|1|||
163432918|NCT05755438|590289772|FG000|12-week DBVC Period|Physician Decision|1|||
163432919|NCT05755438|590289773|FG001|12-week DBVC Period|Physician Decision|1|||
163432920|NCT05755438|590289772|FG000|12-week DBVC Period|Protocol Violation|4|||
163432921|NCT05755438|590289773|FG001|12-week DBVC Period|Protocol Violation|2|||
163432922|NCT05755438|590289772|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
163432923|NCT05755438|590289773|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
163432924|NCT05755438|590289772|FG000|12-week DBVC Period|Sponsor Decision|1|||
163432925|NCT05755438|590289773|FG001|12-week DBVC Period|Sponsor Decision|0|||
163432926|NCT05755438|590289772|FG000|40-week OLE Period|Adverse Event|0|||
163432927|NCT05755438|590289773|FG001|40-week OLE Period|Adverse Event|2|||
163432928|NCT05755438|590289772|FG000|40-week OLE Period|Lack of Efficacy|1|||
163432929|NCT05755438|590289773|FG001|40-week OLE Period|Lack of Efficacy|1|||
163432930|NCT05755438|590289772|FG000|40-week OLE Period|Lost to Follow-up|1|||
163432931|NCT05755438|590289773|FG001|40-week OLE Period|Lost to Follow-up|0|||
163432932|NCT05755438|590289772|FG000|40-week OLE Period|Physician Decision|1|||
163432933|NCT05755438|590289773|FG001|40-week OLE Period|Physician Decision|1|||
163432934|NCT05755438|590289772|FG000|40-week OLE Period|Protocol Violation|1|||
163432935|NCT05755438|590289773|FG001|40-week OLE Period|Protocol Violation|1|||
163432936|NCT05755438|590289772|FG000|40-week OLE Period|Withdrawal by Subject|6|||
163432937|NCT05755438|590289773|FG001|40-week OLE Period|Withdrawal by Subject|6|||
163432938|NCT05755438|590289772|FG000|40-week OLE Period|Sponsor Decision|3|||
163432939|NCT05755438|590289773|FG001|40-week OLE Period|Sponsor Decision|0|||
163432940|NCT05755438|590289772|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
163432941|NCT05755438|590289773|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
163432942|NCT05755438|590289772|FG000|40-week OLE Period|Ongoing|46|||
163432943|NCT05755438|590289773|FG001|40-week OLE Period|Ongoing|58|||
163432944|NCT01548638|590289778|FG000|Overall Study|Protocol Violation|3|||
163432945|NCT01548638|590289778|FG000|Overall Study|Withdrawal by Subject|1|||
163432946|NCT01476787|590289780|FG000|Treatment|Progression|64|||
163432947|NCT01476787|590289781|FG001|Treatment|Progression|71|||
163432948|NCT01476787|590289780|FG000|Treatment|Toxicity|44|||
163432949|NCT01476787|590289781|FG001|Treatment|Toxicity|16|||
163432950|NCT01476787|590289780|FG000|Treatment|Death|0|||
163432951|NCT01476787|590289781|FG001|Treatment|Death|1|||
163432952|NCT01476787|590289780|FG000|Treatment|Withdrawal by Subject|3|||
163432953|NCT01476787|590289781|FG001|Treatment|Withdrawal by Subject|14|||
163432954|NCT01476787|590289780|FG000|Treatment|Major protocol violation|1|||
163432955|NCT01476787|590289781|FG001|Treatment|Major protocol violation|6|||
163432956|NCT01476787|590289780|FG000|Treatment|Other reasons|10|||
163432957|NCT01476787|590289781|FG001|Treatment|Other reasons|22|||
163432958|NCT01476787|590289780|FG000|Treatment|Concurrent illness|12|||
163432959|NCT01476787|590289781|FG001|Treatment|Concurrent illness|9|||
163432960|NCT01476787|590289780|FG000|Treatment|Insufficient response|15|||
163432961|NCT01476787|590289781|FG001|Treatment|Insufficient response|3|||
163432962|NCT01476787|590289780|FG000|Treatment|Voluntary treatment discontinuation|8|||
163432963|NCT01476787|590289781|FG001|Treatment|Voluntary treatment discontinuation|4|||
163432964|NCT01687673|590289790|FG000|Overall Study|Physician Decision|1|||
163432965|NCT02234622|590289791|FG000|Overall Study|Withdrawal by Subject|16|||
163432966|NCT02234622|590289792|FG001|Overall Study|Withdrawal by Subject|22|||
163432967|NCT02234622|590289791|FG000|Overall Study|Lost to Follow-up|27|||
163432968|NCT02234622|590289792|FG001|Overall Study|Lost to Follow-up|14|||
163432969|NCT03476239|590289793|FG000|Overall Study|Withdrawal by Subject|10|||
163432970|NCT03476239|590289793|FG000|Overall Study|Death|80|||
163432971|NCT03476239|590289793|FG000|Overall Study|Lost to Follow-up|8|||
163432972|NCT00618956|590289794|FG000|Overall Study|Adverse Event|10|||
163432973|NCT00618956|590289795|FG001|Overall Study|Adverse Event|34|||
163432974|NCT00618956|590289794|FG000|Overall Study|Lack of Efficacy|2|||
163432975|NCT00618956|590289795|FG001|Overall Study|Lack of Efficacy|1|||
163432976|NCT00618956|590289794|FG000|Overall Study|Withdrawal by Subject|5|||
163432977|NCT00618956|590289795|FG001|Overall Study|Withdrawal by Subject|7|||
163432978|NCT00618956|590289794|FG000|Overall Study|Lost to Follow-up|4|||
163432979|NCT00618956|590289795|FG001|Overall Study|Lost to Follow-up|5|||
163432980|NCT00618956|590289794|FG000|Overall Study|Protocol Violation|2|||
163432981|NCT00618956|590289795|FG001|Overall Study|Protocol Violation|2|||
163432982|NCT00618956|590289794|FG000|Overall Study|did not meet criteria, non-compliance|2|||
163432983|NCT00618956|590289795|FG001|Overall Study|did not meet criteria, non-compliance|1|||
163432984|NCT03598777|590289796|FG000|Overall Study|Study Terminated by Sponsor|3|||
163432985|NCT03598777|590289797|FG001|Overall Study|Study Terminated by Sponsor|0|||
163432986|NCT03598777|590289798|FG002|Overall Study|Study Terminated by Sponsor|0|||
163432987|NCT03598777|590289799|FG003|Overall Study|Study Terminated by Sponsor|0|||
163432988|NCT03598777|590289800|FG004|Overall Study|Study Terminated by Sponsor|15|||
163432989|NCT03598777|590289796|FG000|Overall Study|Withdrawal by Subject|1|||
163432990|NCT03598777|590289797|FG001|Overall Study|Withdrawal by Subject|1|||
163432991|NCT03598777|590289798|FG002|Overall Study|Withdrawal by Subject|0|||
163432992|NCT03598777|590289799|FG003|Overall Study|Withdrawal by Subject|0|||
163432993|NCT03598777|590289800|FG004|Overall Study|Withdrawal by Subject|0|||
163432994|NCT03598777|590289796|FG000|Overall Study|Adverse Event|1|||
163432995|NCT03598777|590289797|FG001|Overall Study|Adverse Event|0|||
163432996|NCT03598777|590289798|FG002|Overall Study|Adverse Event|0|||
163432997|NCT03598777|590289799|FG003|Overall Study|Adverse Event|0|||
163432998|NCT03598777|590289800|FG004|Overall Study|Adverse Event|0|||
163432999|NCT03598777|590289796|FG000|Overall Study|Lost to Follow-up|1|||
163433000|NCT03598777|590289797|FG001|Overall Study|Lost to Follow-up|0|||
163433001|NCT03598777|590289798|FG002|Overall Study|Lost to Follow-up|0|||
163433002|NCT03598777|590289799|FG003|Overall Study|Lost to Follow-up|0|||
163433003|NCT03598777|590289800|FG004|Overall Study|Lost to Follow-up|0|||
163433004|NCT01650805|590289801|FG000|Overall Study|Withdrawal by Subject|1|||
163433005|NCT01650805|590289802|FG001|Overall Study|Withdrawal by Subject|0|||
163433006|NCT02403206|590289803|FG000|Overall Study|Lost to Follow-up|4|||
163433007|NCT02403206|590289804|FG001|Overall Study|Lost to Follow-up|3|||
163433008|NCT02403206|590289803|FG000|Overall Study|Physician Decision|2|||
163433009|NCT02403206|590289804|FG001|Overall Study|Physician Decision|0|||
163433010|NCT02403206|590289803|FG000|Overall Study|Withdrawal by Subject|3|||
163433011|NCT02403206|590289804|FG001|Overall Study|Withdrawal by Subject|3|||
163433012|NCT02403206|590289803|FG000|Overall Study|Reason not given|2|||
163433013|NCT02403206|590289804|FG001|Overall Study|Reason not given|4|||
163433014|NCT02462889|590289805|FG000|Overall Study|Withdrawal by Subject|2|||
163433015|NCT02462889|590289806|FG001|Overall Study|Withdrawal by Subject|6|||
163433016|NCT02462889|590289805|FG000|Overall Study|Death|1|||
163433017|NCT02462889|590289806|FG001|Overall Study|Death|5|||
163433018|NCT04636177|590289809|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
163433019|NCT04636177|590289810|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
163433020|NCT04636177|590289809|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
163433021|NCT04636177|590289810|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
163433022|NCT04636177|590289809|FG000|Single-arm portion|Withdrawal by Subject|1|||
163433023|NCT04636177|590289810|FG001|Single-arm portion|Withdrawal by Subject|0|||
163433024|NCT04636177|590289809|FG000|Single-arm portion|Adverse Event|1|||
163433025|NCT04636177|590289810|FG001|Single-arm portion|Adverse Event|0|||
163433026|NCT01981187|590291819|FG000|Overall Study|Participant/guardian decision|2|||
163433027|NCT01981187|590291819|FG000|Overall Study|Physician Decision|1|||
163433028|NCT01981187|590291819|FG000|Overall Study|Disease progression|2|||
163433029|NCT01981187|590291819|FG000|Overall Study|Adverse Event|7|||
163433030|NCT00443560|590291820|FG000|Overall Study|No intrathecal dose|58|||
163433031|NCT00443560|590291821|FG001|Overall Study|No intrathecal dose|26|||
163433032|NCT00443560|590291820|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
163433033|NCT00443560|590291821|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
163433034|NCT01943539|590291826|FG000|Overall Study|Non-compliance with at-home intervention|4|||
163433035|NCT01943539|590291827|FG001|Overall Study|Non-compliance with at-home intervention|0|||
163433036|NCT01494038|590291830|FG000|Overall Study|Protocol Violation|1|||
163433037|NCT01494038|590291831|FG001|Overall Study|Protocol Violation|1|||
163433038|NCT01494038|590291830|FG000|Overall Study|Lost to Follow-up|18|||
163433039|NCT01494038|590291831|FG001|Overall Study|Lost to Follow-up|20|||
163433040|NCT01494038|590291830|FG000|Overall Study|Withdrawal by Subject|44|||
163433041|NCT01494038|590291831|FG001|Overall Study|Withdrawal by Subject|34|||
163433042|NCT01494038|590291830|FG000|Overall Study|Not able to get to clinic|21|||
163433043|NCT01494038|590291831|FG001|Overall Study|Not able to get to clinic|15|||
163433044|NCT01494038|590291830|FG000|Overall Study|Not willing to adhere to reqs|2|||
163433045|NCT01494038|590291831|FG001|Overall Study|Not willing to adhere to reqs|9|||
163433046|NCT01494038|590291830|FG000|Overall Study|Death|2|||
163433047|NCT01494038|590291831|FG001|Overall Study|Death|4|||
163433048|NCT00537940|590291832|FG000|Overall Study|Adverse Event|20|||
163433049|NCT00537940|590291833|FG001|Overall Study|Adverse Event|19|||
163433050|NCT00537940|590291832|FG000|Overall Study|Lack of Efficacy|8|||
163433051|NCT00537940|590291833|FG001|Overall Study|Lack of Efficacy|16|||
163433052|NCT00537940|590291832|FG000|Overall Study|Lost to Follow-up|23|||
163433053|NCT00537940|590291833|FG001|Overall Study|Lost to Follow-up|29|||
163433054|NCT00537940|590291832|FG000|Overall Study|Withdrawal by Subject|113|||
163433055|NCT00537940|590291833|FG001|Overall Study|Withdrawal by Subject|95|||
163433056|NCT00537940|590291832|FG000|Overall Study|Protocol Violation|6|||
163433057|NCT00537940|590291833|FG001|Overall Study|Protocol Violation|4|||
163433058|NCT00537940|590291832|FG000|Overall Study|Pregnancy|1|||
163433059|NCT00537940|590291833|FG001|Overall Study|Pregnancy|1|||
163433060|NCT00537940|590291832|FG000|Overall Study|Study terminated by sponsor|2|||
163433061|NCT00537940|590291833|FG001|Overall Study|Study terminated by sponsor|3|||
163433062|NCT00537940|590291832|FG000|Overall Study|Other|10|||
163433063|NCT00537940|590291833|FG001|Overall Study|Other|12|||
163433064|NCT03715465|590291837|FG000|Overall Study|Withdrawal by Subject|1|||
163433065|NCT03715465|590291838|FG001|Overall Study|Withdrawal by Subject|2|||
163433066|NCT02138110|590291840|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
163433067|NCT02138110|590291840|FG000|Overall Scaffold Implantation|Death|3|||
163433068|NCT00430781|590291841|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
163433069|NCT00430781|590291842|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
163433070|NCT00430781|590291843|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
163433071|NCT00430781|590291841|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
163433072|NCT00430781|590291842|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
163433073|NCT00430781|590291843|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
163433074|NCT00430781|590291841|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
163433075|NCT00430781|590291842|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
163433076|NCT00430781|590291843|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
163433077|NCT00430781|590291841|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
163433078|NCT00430781|590291842|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
163433079|NCT00430781|590291843|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
163433080|NCT00430781|590291841|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
163433081|NCT00430781|590291842|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
163433082|NCT00430781|590291843|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
163433083|NCT00430781|590291841|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
163433084|NCT00430781|590291842|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
163433085|NCT00430781|590291843|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
163433086|NCT00430781|590291841|FG000|Interim Analysis; 11 February 2008|Death|0|||
163433087|NCT00430781|590291842|FG001|Interim Analysis; 11 February 2008|Death|1|||
163433088|NCT00430781|590291843|FG002|Interim Analysis; 11 February 2008|Death|0|||
163433089|NCT00430781|590291841|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
163433090|NCT00430781|590291842|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
163433091|NCT00430781|590291843|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
163433092|NCT00430781|590291841|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
163433093|NCT00430781|590291842|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
163433094|NCT00430781|590291843|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
163433095|NCT00430781|590291841|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
163433096|NCT00430781|590291842|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
163433097|NCT00430781|590291843|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
163433098|NCT00430781|590291841|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
163433099|NCT00430781|590291842|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
163433100|NCT00430781|590291843|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
163433101|NCT00430781|590291841|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
163433102|NCT00430781|590291842|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
163433103|NCT00430781|590291843|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
163433104|NCT00430781|590291841|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
163433105|NCT00430781|590291842|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
163433106|NCT00430781|590291843|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
163433107|NCT00430781|590291841|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
163433108|NCT00430781|590291842|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
163433109|NCT00430781|590291843|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
163433110|NCT00430781|590291841|FG000|Final Analysis; 31 July 2008|Other|0|||
163433111|NCT00430781|590291842|FG001|Final Analysis; 31 July 2008|Other|1|||
163433112|NCT00430781|590291843|FG002|Final Analysis; 31 July 2008|Other|0|||
163433113|NCT00430781|590291841|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
163433114|NCT00430781|590291842|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
163433115|NCT00430781|590291843|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
163433116|NCT00430781|590291841|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
163433117|NCT00430781|590291842|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
163433118|NCT00430781|590291843|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
163433119|NCT00430781|590291841|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
163433120|NCT00430781|590291842|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
163433121|NCT00430781|590291843|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
163433122|NCT00430781|590291841|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
163433123|NCT00430781|590291842|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
163433124|NCT00430781|590291843|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
163433125|NCT00430781|590291841|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
163433126|NCT00430781|590291842|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
163433127|NCT00430781|590291843|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
163433128|NCT00430781|590291841|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
163433129|NCT00430781|590291842|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
163433130|NCT00430781|590291843|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
163433131|NCT00430781|590291841|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
163433132|NCT00430781|590291842|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
163433133|NCT00430781|590291843|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
163433134|NCT02158533|590291845|FG000|Stage 1|Adverse Event|6|||
163433135|NCT02158533|590291846|FG001|Stage 1|Adverse Event|4|||
163433136|NCT02158533|590291847|FG002|Stage 1|Adverse Event|7|||
163433137|NCT02158533|590291848|FG003|Stage 1|Adverse Event|0|||
163433138|NCT02158533|590291849|FG004|Stage 1|Adverse Event|0|||
163433139|NCT02158533|590291850|FG005|Stage 1|Adverse Event|0|||
163433140|NCT02158533|590291845|FG000|Stage 1|Withdrawal by Subject|3|||
163433141|NCT02158533|590291846|FG001|Stage 1|Withdrawal by Subject|2|||
163433142|NCT02158533|590291847|FG002|Stage 1|Withdrawal by Subject|1|||
163433143|NCT02158533|590291848|FG003|Stage 1|Withdrawal by Subject|0|||
163433144|NCT02158533|590291849|FG004|Stage 1|Withdrawal by Subject|0|||
163433145|NCT02158533|590291850|FG005|Stage 1|Withdrawal by Subject|0|||
163433146|NCT02158533|590291845|FG000|Stage 1|Lack of Efficacy|1|||
163433147|NCT02158533|590291846|FG001|Stage 1|Lack of Efficacy|0|||
163433148|NCT02158533|590291847|FG002|Stage 1|Lack of Efficacy|0|||
163433149|NCT02158533|590291848|FG003|Stage 1|Lack of Efficacy|0|||
163433150|NCT02158533|590291849|FG004|Stage 1|Lack of Efficacy|0|||
163433151|NCT02158533|590291850|FG005|Stage 1|Lack of Efficacy|0|||
163433152|NCT02158533|590291845|FG000|Stage 1|Lost to Follow-up|3|||
163433153|NCT02158533|590291846|FG001|Stage 1|Lost to Follow-up|1|||
163433154|NCT02158533|590291847|FG002|Stage 1|Lost to Follow-up|0|||
163433155|NCT02158533|590291848|FG003|Stage 1|Lost to Follow-up|0|||
163433156|NCT02158533|590291849|FG004|Stage 1|Lost to Follow-up|0|||
163433157|NCT02158533|590291850|FG005|Stage 1|Lost to Follow-up|0|||
163433158|NCT02158533|590291845|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
163433159|NCT02158533|590291846|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
163433160|NCT02158533|590291847|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
163433161|NCT02158533|590291848|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
163433162|NCT02158533|590291849|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
163433163|NCT02158533|590291850|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
163433164|NCT02158533|590291845|FG000|Stage 1|Non-compliance with study visits|1|||
163433165|NCT02158533|590291846|FG001|Stage 1|Non-compliance with study visits|0|||
163433166|NCT02158533|590291847|FG002|Stage 1|Non-compliance with study visits|0|||
163433167|NCT02158533|590291848|FG003|Stage 1|Non-compliance with study visits|0|||
163433168|NCT02158533|590291849|FG004|Stage 1|Non-compliance with study visits|0|||
163433169|NCT02158533|590291850|FG005|Stage 1|Non-compliance with study visits|0|||
163433170|NCT02158533|590291845|FG000|Stage 2|Adverse Event|0|||
163433171|NCT02158533|590291846|FG001|Stage 2|Adverse Event|0|||
163433172|NCT02158533|590291847|FG002|Stage 2|Adverse Event|0|||
163433173|NCT02158533|590291848|FG003|Stage 2|Adverse Event|0|||
163433174|NCT02158533|590291849|FG004|Stage 2|Adverse Event|0|||
163433175|NCT02158533|590291850|FG005|Stage 2|Adverse Event|1|||
163433176|NCT02158533|590291845|FG000|Stage 2|Lack of Efficacy|0|||
163433177|NCT02158533|590291846|FG001|Stage 2|Lack of Efficacy|0|||
163433178|NCT02158533|590291847|FG002|Stage 2|Lack of Efficacy|0|||
163433179|NCT02158533|590291848|FG003|Stage 2|Lack of Efficacy|0|||
163433180|NCT02158533|590291849|FG004|Stage 2|Lack of Efficacy|1|||
163433181|NCT02158533|590291850|FG005|Stage 2|Lack of Efficacy|0|||
163433182|NCT02158533|590291845|FG000|Stage 2|Lost to Follow-up|0|||
163433183|NCT02158533|590291846|FG001|Stage 2|Lost to Follow-up|0|||
163433184|NCT02158533|590291847|FG002|Stage 2|Lost to Follow-up|0|||
163433185|NCT02158533|590291848|FG003|Stage 2|Lost to Follow-up|1|||
163433186|NCT02158533|590291849|FG004|Stage 2|Lost to Follow-up|1|||
163433187|NCT02158533|590291850|FG005|Stage 2|Lost to Follow-up|2|||
163433188|NCT02158533|590291845|FG000|Stage 2|Withdrawal by Subject|0|||
163433189|NCT02158533|590291846|FG001|Stage 2|Withdrawal by Subject|0|||
163433190|NCT02158533|590291847|FG002|Stage 2|Withdrawal by Subject|0|||
163433191|NCT02158533|590291848|FG003|Stage 2|Withdrawal by Subject|0|||
163433192|NCT02158533|590291849|FG004|Stage 2|Withdrawal by Subject|1|||
163433193|NCT02158533|590291850|FG005|Stage 2|Withdrawal by Subject|2|||
163433194|NCT02158533|590291845|FG000|Stage 2|Physician Decision|0|||
163433195|NCT02158533|590291846|FG001|Stage 2|Physician Decision|0|||
163433196|NCT02158533|590291847|FG002|Stage 2|Physician Decision|0|||
163433197|NCT02158533|590291848|FG003|Stage 2|Physician Decision|0|||
163433198|NCT02158533|590291849|FG004|Stage 2|Physician Decision|1|||
163433199|NCT02158533|590291850|FG005|Stage 2|Physician Decision|0|||
163433200|NCT02158533|590291845|FG000|Stage 2|Pregnancy|0|||
163433201|NCT02158533|590291846|FG001|Stage 2|Pregnancy|0|||
163433202|NCT02158533|590291847|FG002|Stage 2|Pregnancy|0|||
163433203|NCT02158533|590291848|FG003|Stage 2|Pregnancy|1|||
163433204|NCT02158533|590291849|FG004|Stage 2|Pregnancy|0|||
163433205|NCT02158533|590291850|FG005|Stage 2|Pregnancy|0|||
163433206|NCT02158533|590291845|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
163433207|NCT02158533|590291846|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
163433208|NCT02158533|590291847|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
163433209|NCT02158533|590291848|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
163433210|NCT02158533|590291849|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
163433211|NCT02158533|590291850|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
163433212|NCT02158533|590291845|FG000|Stage 2|Non-adherence with study visits|0|||
163433213|NCT02158533|590291846|FG001|Stage 2|Non-adherence with study visits|0|||
163433214|NCT02158533|590291847|FG002|Stage 2|Non-adherence with study visits|0|||
163433215|NCT02158533|590291848|FG003|Stage 2|Non-adherence with study visits|0|||
163433216|NCT02158533|590291849|FG004|Stage 2|Non-adherence with study visits|0|||
163433217|NCT02158533|590291850|FG005|Stage 2|Non-adherence with study visits|1|||
163433218|NCT01389128|590291859|FG000|Overall Study|Fetal distress|1|||
163433219|NCT01389128|590291860|FG001|Overall Study|Fetal distress|0|||
163433220|NCT01389128|590291859|FG000|Overall Study|Cervix dilation stop|1|||
163433221|NCT01389128|590291860|FG001|Overall Study|Cervix dilation stop|2|||
163433222|NCT01389128|590291859|FG000|Overall Study|Rapid labor evolution|3|||
163433223|NCT01389128|590291860|FG001|Overall Study|Rapid labor evolution|2|||
163433224|NCT01389128|590291859|FG000|Overall Study|Intolerance to procedure|0|||
163433225|NCT01389128|590291860|FG001|Overall Study|Intolerance to procedure|2|||
163433226|NCT01451515|590291861|FG000|Overall Study|Death|0|||
163433227|NCT01451515|590291862|FG001|Overall Study|Death|1|||
163433228|NCT01451515|590291863|FG002|Overall Study|Death|0|||
163433229|NCT01451515|590291861|FG000|Overall Study|Withdrawal by Subject|0|||
163433230|NCT01451515|590291862|FG001|Overall Study|Withdrawal by Subject|1|||
163433231|NCT01451515|590291863|FG002|Overall Study|Withdrawal by Subject|0|||
163433232|NCT01451515|590291861|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
163433233|NCT01451515|590291862|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
163433234|NCT01451515|590291863|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
163433235|NCT01451515|590291861|FG000|Overall Study|Relapse (except CNS)|1|||
163433236|NCT01451515|590291862|FG001|Overall Study|Relapse (except CNS)|1|||
163433237|NCT01451515|590291863|FG002|Overall Study|Relapse (except CNS)|0|||
163433238|NCT00174941|590291867|FG000|Overall Study|Adverse Event|1|||
163433239|NCT00174941|590291868|FG001|Overall Study|Adverse Event|10|||
163433240|NCT00174941|590291869|FG002|Overall Study|Adverse Event|2|||
163433241|NCT00174941|590291870|FG003|Overall Study|Adverse Event|13|||
163433242|NCT00174941|590291867|FG000|Overall Study|Protocol Violation|0|||
163433243|NCT00174941|590291868|FG001|Overall Study|Protocol Violation|1|||
163433244|NCT00174941|590291869|FG002|Overall Study|Protocol Violation|0|||
163433245|NCT00174941|590291870|FG003|Overall Study|Protocol Violation|1|||
163433246|NCT00174941|590291867|FG000|Overall Study|Lost to Follow-up|0|||
163433247|NCT00174941|590291868|FG001|Overall Study|Lost to Follow-up|3|||
163433248|NCT00174941|590291869|FG002|Overall Study|Lost to Follow-up|2|||
163433249|NCT00174941|590291870|FG003|Overall Study|Lost to Follow-up|5|||
163433250|NCT00174941|590291867|FG000|Overall Study|Personal Reason(s)|0|||
163433251|NCT00174941|590291868|FG001|Overall Study|Personal Reason(s)|14|||
163433252|NCT00174941|590291869|FG002|Overall Study|Personal Reason(s)|8|||
163433253|NCT00174941|590291870|FG003|Overall Study|Personal Reason(s)|22|||
163433254|NCT00174941|590291867|FG000|Overall Study|Gout Flare|0|||
163433255|NCT00174941|590291868|FG001|Overall Study|Gout Flare|4|||
163433256|NCT00174941|590291869|FG002|Overall Study|Gout Flare|4|||
163433257|NCT00174941|590291870|FG003|Overall Study|Gout Flare|8|||
163433258|NCT00174941|590291867|FG000|Overall Study|Reason Not Specified|1|||
163433259|NCT00174941|590291868|FG001|Overall Study|Reason Not Specified|6|||
163433260|NCT00174941|590291869|FG002|Overall Study|Reason Not Specified|2|||
163433261|NCT00174941|590291870|FG003|Overall Study|Reason Not Specified|9|||
163433262|NCT03230097|590291873|FG000|Overall Study|Adverse Event|2|||
163433263|NCT03230097|590291874|FG001|Overall Study|Adverse Event|1|||
163433264|NCT03230097|590291873|FG000|Overall Study|non-compliance|0|||
163433265|NCT03230097|590291874|FG001|Overall Study|non-compliance|1|||
163433266|NCT03230097|590291873|FG000|Overall Study|Lost to Follow-up|2|||
163433267|NCT03230097|590291874|FG001|Overall Study|Lost to Follow-up|4|||
163433268|NCT03230097|590291873|FG000|Overall Study|Withdrawal by Subject|7|||
163433269|NCT03230097|590291874|FG001|Overall Study|Withdrawal by Subject|3|||
163433270|NCT03230097|590291873|FG000|Overall Study|Trial termination|4|||
163433271|NCT03230097|590291874|FG001|Overall Study|Trial termination|5|||
163433272|NCT03230097|590291873|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
163433273|NCT03230097|590291874|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
163433274|NCT03230097|590291873|FG000|Overall Study|outcome event|0|||
163433275|NCT03230097|590291874|FG001|Overall Study|outcome event|1|||
163433276|NCT01588197|590291891|FG000|Overall Study|Lack of Efficacy|0|||
163433277|NCT01588197|590291892|FG001|Overall Study|Lack of Efficacy|1|||
163433278|NCT01588197|590291891|FG000|Overall Study|No MRI|1|||
163433279|NCT01588197|590291892|FG001|Overall Study|No MRI|0|||
163433280|NCT00635102|590291906|FG000|Overall Study|Withdrawal by Subject|7|||
163433281|NCT00635102|590291907|FG001|Overall Study|Withdrawal by Subject|8|||
163433282|NCT00440401|590291910|FG000|Overall Study|Adverse Event|2|||
163433283|NCT00440401|590291911|FG001|Overall Study|Adverse Event|1|||
163433284|NCT00440401|590291910|FG000|Overall Study|Other|2|||
163433285|NCT00440401|590291911|FG001|Overall Study|Other|5|||
163433286|NCT01938625|590291912|FG000|Overall Study|Withdrawal by Subject|0|||
163433287|NCT01938625|590291913|FG001|Overall Study|Withdrawal by Subject|1|||
163433288|NCT01938625|590291912|FG000|Overall Study|Adverse Event|0|||
163433289|NCT01938625|590291913|FG001|Overall Study|Adverse Event|1|||
163433290|NCT02088034|590291914|FG000|Overall Study|Lost to Follow-up|1|||
163433291|NCT02088034|590291915|FG001|Overall Study|Lost to Follow-up|1|||
163433292|NCT02088034|590291916|FG002|Overall Study|Lost to Follow-up|0|||
162925345|NCT00602641|588428936|FG000|Overall Study|Administrative Closure|1|||
163433293|NCT02088034|590291914|FG000|Overall Study|Pregnancy|2|||
163433294|NCT02088034|590291915|FG001|Overall Study|Pregnancy|1|||
163433295|NCT02088034|590291916|FG002|Overall Study|Pregnancy|2|||
163433296|NCT00091793|590291919|FG000|Overall Study|Adverse Event|1|||
163433297|NCT00091793|590291920|FG001|Overall Study|Adverse Event|2|||
163433298|NCT00091793|590291919|FG000|Overall Study|Withdrawal by Subject|10|||
163433299|NCT00091793|590291920|FG001|Overall Study|Withdrawal by Subject|15|||
163433300|NCT00091793|590291919|FG000|Overall Study|Ineligibility determined|2|||
163433301|NCT00091793|590291920|FG001|Overall Study|Ineligibility determined|0|||
163433302|NCT00091793|590291919|FG000|Overall Study|Lost to Follow-up|7|||
163433303|NCT00091793|590291920|FG001|Overall Study|Lost to Follow-up|5|||
163433304|NCT00091793|590291919|FG000|Overall Study|Noncompliance|2|||
163433305|NCT00091793|590291920|FG001|Overall Study|Noncompliance|0|||
163433306|NCT00091793|590291919|FG000|Overall Study|Other|2|||
163433307|NCT00091793|590291920|FG001|Overall Study|Other|0|||
163433308|NCT00308620|590291921|FG000|Overall Study|Death|1|||
163433309|NCT00308620|590291922|FG001|Overall Study|Death|1|||
163433310|NCT00308620|590291923|FG002|Overall Study|Death|0|||
163433311|NCT00308620|590291921|FG000|Overall Study|Lost to Follow-up|0|||
163433312|NCT00308620|590291922|FG001|Overall Study|Lost to Follow-up|0|||
163433313|NCT00308620|590291923|FG002|Overall Study|Lost to Follow-up|1|||
163433314|NCT02424149|590291924|FG000|Overall Study|surgery cancelled|2|||
163433315|NCT02424149|590291925|FG001|Overall Study|surgery cancelled|0|||
163433316|NCT02424149|590291924|FG000|Overall Study|Withdrawal by Subject|0|||
163433317|NCT02424149|590291925|FG001|Overall Study|Withdrawal by Subject|1|||
163433318|NCT05309083|590291926|FG000|Overall Study|Withdrawal by Subject|2|||
163433319|NCT01238120|590291927|FG000|Overall Study|Withdrawal by Subject|4|||
163433320|NCT01238120|590291928|FG001|Overall Study|Withdrawal by Subject|1|||
163433321|NCT01238120|590291929|FG002|Overall Study|Withdrawal by Subject|2|||
163433322|NCT01238120|590291930|FG003|Overall Study|Withdrawal by Subject|5|||
163433323|NCT01238120|590291927|FG000|Overall Study|Lost to Follow-up|2|||
163433324|NCT01238120|590291928|FG001|Overall Study|Lost to Follow-up|0|||
163433325|NCT01238120|590291929|FG002|Overall Study|Lost to Follow-up|1|||
163433326|NCT01238120|590291930|FG003|Overall Study|Lost to Follow-up|1|||
163433327|NCT01238120|590291927|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
163433328|NCT01238120|590291928|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
163433329|NCT01238120|590291929|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
163433330|NCT01238120|590291930|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
163433331|NCT02388776|590291931|FG000|Overall Study|Death|1|||
163433332|NCT02388776|590291931|FG000|Overall Study|Lost to Follow-up|1|||
163433333|NCT00845429|590291945|FG000|Overall Study|Protocol Violation|5|||
163433334|NCT00845429|590291946|FG001|Overall Study|Protocol Violation|4|||
163433335|NCT00845429|590291947|FG002|Overall Study|Protocol Violation|7|||
163433336|NCT00845429|590291945|FG000|Overall Study|Lost to Follow-up|7|||
163433337|NCT00845429|590291946|FG001|Overall Study|Lost to Follow-up|9|||
163433338|NCT00845429|590291947|FG002|Overall Study|Lost to Follow-up|10|||
163433339|NCT00845429|590291945|FG000|Overall Study|Withdrawal by Subject|2|||
163433340|NCT00845429|590291946|FG001|Overall Study|Withdrawal by Subject|2|||
163433341|NCT00845429|590291947|FG002|Overall Study|Withdrawal by Subject|2|||
163433342|NCT00845429|590291945|FG000|Overall Study|Serious adverse event|0|||
163433343|NCT00845429|590291946|FG001|Overall Study|Serious adverse event|0|||
163433344|NCT00845429|590291947|FG002|Overall Study|Serious adverse event|1|||
163433345|NCT00587223|590291950|FG000|Overall Study|Adverse Event|1|||
163433346|NCT03519178|590291951|FG000|PF-06873600 Treatment|Adverse Event|0|||
163433347|NCT03519178|590291952|FG001|PF-06873600 Treatment|Adverse Event|0|||
163433348|NCT03519178|590291953|FG002|PF-06873600 Treatment|Adverse Event|0|||
163433349|NCT03519178|590291954|FG003|PF-06873600 Treatment|Adverse Event|0|||
163433350|NCT03519178|590291955|FG004|PF-06873600 Treatment|Adverse Event|0|||
163433351|NCT03519178|590291956|FG005|PF-06873600 Treatment|Adverse Event|0|||
163433352|NCT03519178|590291957|FG006|PF-06873600 Treatment|Adverse Event|0|||
163433353|NCT03519178|590291958|FG007|PF-06873600 Treatment|Adverse Event|2|||
163433354|NCT03519178|590291959|FG008|PF-06873600 Treatment|Adverse Event|1|||
163433355|NCT03519178|590291960|FG009|PF-06873600 Treatment|Adverse Event|0|||
163433356|NCT03519178|590291961|FG010|PF-06873600 Treatment|Adverse Event|0|||
163433357|NCT03519178|590291962|FG011|PF-06873600 Treatment|Adverse Event|0|||
163433358|NCT03519178|590291963|FG012|PF-06873600 Treatment|Adverse Event|1|||
163433359|NCT03519178|590291964|FG013|PF-06873600 Treatment|Adverse Event|3|||
163433360|NCT03519178|590291965|FG014|PF-06873600 Treatment|Adverse Event|2|||
163433361|NCT03519178|590291951|FG000|PF-06873600 Treatment|Death|0|||
163433362|NCT03519178|590291952|FG001|PF-06873600 Treatment|Death|0|||
163433363|NCT03519178|590291953|FG002|PF-06873600 Treatment|Death|0|||
163433364|NCT03519178|590291954|FG003|PF-06873600 Treatment|Death|0|||
163433365|NCT03519178|590291955|FG004|PF-06873600 Treatment|Death|0|||
163433366|NCT03519178|590291956|FG005|PF-06873600 Treatment|Death|0|||
163433367|NCT03519178|590291957|FG006|PF-06873600 Treatment|Death|0|||
163433368|NCT03519178|590291958|FG007|PF-06873600 Treatment|Death|0|||
163433369|NCT03519178|590291959|FG008|PF-06873600 Treatment|Death|1|||
163433370|NCT03519178|590291960|FG009|PF-06873600 Treatment|Death|1|||
163433371|NCT03519178|590291961|FG010|PF-06873600 Treatment|Death|0|||
163433372|NCT03519178|590291962|FG011|PF-06873600 Treatment|Death|0|||
163433373|NCT03519178|590291963|FG012|PF-06873600 Treatment|Death|0|||
163433374|NCT03519178|590291964|FG013|PF-06873600 Treatment|Death|0|||
163433375|NCT03519178|590291965|FG014|PF-06873600 Treatment|Death|1|||
163433376|NCT03519178|590291951|FG000|PF-06873600 Treatment|Physician Decision|0|||
163433377|NCT03519178|590291952|FG001|PF-06873600 Treatment|Physician Decision|0|||
163433378|NCT03519178|590291953|FG002|PF-06873600 Treatment|Physician Decision|0|||
163433379|NCT03519178|590291954|FG003|PF-06873600 Treatment|Physician Decision|0|||
163433380|NCT03519178|590291955|FG004|PF-06873600 Treatment|Physician Decision|0|||
163433381|NCT03519178|590291956|FG005|PF-06873600 Treatment|Physician Decision|0|||
163433382|NCT03519178|590291957|FG006|PF-06873600 Treatment|Physician Decision|0|||
163433383|NCT03519178|590291958|FG007|PF-06873600 Treatment|Physician Decision|1|||
163433384|NCT03519178|590291959|FG008|PF-06873600 Treatment|Physician Decision|0|||
163433385|NCT03519178|590291960|FG009|PF-06873600 Treatment|Physician Decision|0|||
163433386|NCT03519178|590291961|FG010|PF-06873600 Treatment|Physician Decision|1|||
163433387|NCT03519178|590291962|FG011|PF-06873600 Treatment|Physician Decision|0|||
163433388|NCT03519178|590291963|FG012|PF-06873600 Treatment|Physician Decision|0|||
163433389|NCT03519178|590291964|FG013|PF-06873600 Treatment|Physician Decision|4|||
163433390|NCT03519178|590291965|FG014|PF-06873600 Treatment|Physician Decision|1|||
163433391|NCT03519178|590291951|FG000|PF-06873600 Treatment|Progressive disease|1|||
163433392|NCT03519178|590291952|FG001|PF-06873600 Treatment|Progressive disease|1|||
163433393|NCT03519178|590291953|FG002|PF-06873600 Treatment|Progressive disease|1|||
163433394|NCT03519178|590291954|FG003|PF-06873600 Treatment|Progressive disease|1|||
163433395|NCT03519178|590291955|FG004|PF-06873600 Treatment|Progressive disease|6|||
163433396|NCT03519178|590291956|FG005|PF-06873600 Treatment|Progressive disease|7|||
163433397|NCT03519178|590291957|FG006|PF-06873600 Treatment|Progressive disease|3|||
163433398|NCT03519178|590291958|FG007|PF-06873600 Treatment|Progressive disease|7|||
163433399|NCT03519178|590291959|FG008|PF-06873600 Treatment|Progressive disease|3|||
163433400|NCT03519178|590291960|FG009|PF-06873600 Treatment|Progressive disease|5|||
163433401|NCT03519178|590291961|FG010|PF-06873600 Treatment|Progressive disease|4|||
163433402|NCT03519178|590291962|FG011|PF-06873600 Treatment|Progressive disease|3|||
163433403|NCT03519178|590291963|FG012|PF-06873600 Treatment|Progressive disease|4|||
163433404|NCT03519178|590291964|FG013|PF-06873600 Treatment|Progressive disease|28|||
163433405|NCT03519178|590291965|FG014|PF-06873600 Treatment|Progressive disease|8|||
163433406|NCT03519178|590291951|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
163433407|NCT03519178|590291952|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
163433408|NCT03519178|590291953|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
163433409|NCT03519178|590291954|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
163433410|NCT03519178|590291955|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
163433411|NCT03519178|590291956|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
163433412|NCT03519178|590291957|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
163433413|NCT03519178|590291958|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
163433414|NCT03519178|590291959|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
163433415|NCT03519178|590291960|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
163433416|NCT03519178|590291961|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
163433417|NCT03519178|590291962|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
163433418|NCT03519178|590291963|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
163433419|NCT03519178|590291964|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
163433420|NCT03519178|590291965|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
163433421|NCT03519178|590291951|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
163433422|NCT03519178|590291952|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
163433423|NCT03519178|590291953|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
163433424|NCT03519178|590291954|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
163433425|NCT03519178|590291955|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
163433426|NCT03519178|590291956|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
163433427|NCT03519178|590291957|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
163433428|NCT03519178|590291958|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
163433429|NCT03519178|590291959|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
163433430|NCT03519178|590291960|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
163433431|NCT03519178|590291961|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
163433432|NCT03519178|590291962|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
163433433|NCT03519178|590291963|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
163433434|NCT03519178|590291964|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
163433435|NCT03519178|590291965|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
163433436|NCT03519178|590291951|FG000|PF-06873600 Treatment|Refused further treatment|0|||
163433437|NCT03519178|590291952|FG001|PF-06873600 Treatment|Refused further treatment|1|||
163433438|NCT03519178|590291953|FG002|PF-06873600 Treatment|Refused further treatment|0|||
163433439|NCT03519178|590291954|FG003|PF-06873600 Treatment|Refused further treatment|0|||
163433440|NCT03519178|590291955|FG004|PF-06873600 Treatment|Refused further treatment|1|||
163433441|NCT03519178|590291956|FG005|PF-06873600 Treatment|Refused further treatment|0|||
163433442|NCT03519178|590291957|FG006|PF-06873600 Treatment|Refused further treatment|0|||
163433443|NCT03519178|590291958|FG007|PF-06873600 Treatment|Refused further treatment|0|||
163433444|NCT03519178|590291959|FG008|PF-06873600 Treatment|Refused further treatment|0|||
163433445|NCT03519178|590291960|FG009|PF-06873600 Treatment|Refused further treatment|0|||
163433446|NCT03519178|590291961|FG010|PF-06873600 Treatment|Refused further treatment|0|||
163433447|NCT03519178|590291962|FG011|PF-06873600 Treatment|Refused further treatment|0|||
163433448|NCT03519178|590291963|FG012|PF-06873600 Treatment|Refused further treatment|0|||
163433449|NCT03519178|590291964|FG013|PF-06873600 Treatment|Refused further treatment|0|||
163433450|NCT03519178|590291965|FG014|PF-06873600 Treatment|Refused further treatment|1|||
163433451|NCT03519178|590291951|FG000|PF-06873600 Treatment|Other|0|||
163433452|NCT03519178|590291952|FG001|PF-06873600 Treatment|Other|0|||
163433453|NCT03519178|590291953|FG002|PF-06873600 Treatment|Other|0|||
163433454|NCT03519178|590291954|FG003|PF-06873600 Treatment|Other|0|||
163433455|NCT03519178|590291955|FG004|PF-06873600 Treatment|Other|0|||
163433456|NCT03519178|590291956|FG005|PF-06873600 Treatment|Other|0|||
163433457|NCT03519178|590291957|FG006|PF-06873600 Treatment|Other|0|||
163433458|NCT03519178|590291958|FG007|PF-06873600 Treatment|Other|0|||
163433459|NCT03519178|590291959|FG008|PF-06873600 Treatment|Other|1|||
163433460|NCT03519178|590291960|FG009|PF-06873600 Treatment|Other|0|||
163433461|NCT03519178|590291961|FG010|PF-06873600 Treatment|Other|0|||
163433462|NCT03519178|590291962|FG011|PF-06873600 Treatment|Other|0|||
163433463|NCT03519178|590291963|FG012|PF-06873600 Treatment|Other|0|||
163433464|NCT03519178|590291964|FG013|PF-06873600 Treatment|Other|1|||
163433465|NCT03519178|590291965|FG014|PF-06873600 Treatment|Other|3|||
163433466|NCT03519178|590291951|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
163433467|NCT03519178|590291952|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
163433468|NCT03519178|590291953|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
163433469|NCT03519178|590291954|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
163433470|NCT03519178|590291955|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
163433471|NCT03519178|590291956|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
163433472|NCT03519178|590291957|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
163433473|NCT03519178|590291958|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
163433474|NCT03519178|590291959|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
163433475|NCT03519178|590291960|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
163433476|NCT03519178|590291961|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
163433477|NCT03519178|590291962|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
163433478|NCT03519178|590291963|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
163433479|NCT03519178|590291964|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
163433480|NCT03519178|590291965|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
163433481|NCT03519178|590291951|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
163433482|NCT03519178|590291952|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
163433483|NCT03519178|590291953|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
163433484|NCT03519178|590291954|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
163433485|NCT03519178|590291955|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
163433486|NCT03519178|590291956|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
163433487|NCT03519178|590291957|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
163433488|NCT03519178|590291958|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
163433489|NCT03519178|590291959|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
163433490|NCT03519178|590291960|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
163433491|NCT03519178|590291961|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
163433492|NCT03519178|590291962|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
163433493|NCT03519178|590291963|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
163433494|NCT03519178|590291964|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
163433495|NCT03519178|590291965|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
163433496|NCT03519178|590291951|FG000|Fulvestrant. Treatment|Adverse Event|0|||
163433497|NCT03519178|590291952|FG001|Fulvestrant. Treatment|Adverse Event|0|||
163433498|NCT03519178|590291953|FG002|Fulvestrant. Treatment|Adverse Event|0|||
163433499|NCT03519178|590291954|FG003|Fulvestrant. Treatment|Adverse Event|0|||
163433500|NCT03519178|590291955|FG004|Fulvestrant. Treatment|Adverse Event|0|||
163433501|NCT03519178|590291956|FG005|Fulvestrant. Treatment|Adverse Event|0|||
163433502|NCT03519178|590291957|FG006|Fulvestrant. Treatment|Adverse Event|0|||
163433503|NCT03519178|590291958|FG007|Fulvestrant. Treatment|Adverse Event|0|||
163433504|NCT03519178|590291959|FG008|Fulvestrant. Treatment|Adverse Event|0|||
163433505|NCT03519178|590291960|FG009|Fulvestrant. Treatment|Adverse Event|0|||
163433506|NCT03519178|590291961|FG010|Fulvestrant. Treatment|Adverse Event|0|||
163433507|NCT03519178|590291962|FG011|Fulvestrant. Treatment|Adverse Event|0|||
163433508|NCT03519178|590291963|FG012|Fulvestrant. Treatment|Adverse Event|0|||
163433509|NCT03519178|590291964|FG013|Fulvestrant. Treatment|Adverse Event|1|||
163433510|NCT03519178|590291965|FG014|Fulvestrant. Treatment|Adverse Event|0|||
163433511|NCT03519178|590291951|FG000|Fulvestrant. Treatment|Death|0|||
163433512|NCT03519178|590291952|FG001|Fulvestrant. Treatment|Death|0|||
163433513|NCT03519178|590291953|FG002|Fulvestrant. Treatment|Death|0|||
163433514|NCT03519178|590291954|FG003|Fulvestrant. Treatment|Death|0|||
163433515|NCT03519178|590291955|FG004|Fulvestrant. Treatment|Death|0|||
163433516|NCT03519178|590291956|FG005|Fulvestrant. Treatment|Death|0|||
163433517|NCT03519178|590291957|FG006|Fulvestrant. Treatment|Death|0|||
163433518|NCT03519178|590291958|FG007|Fulvestrant. Treatment|Death|0|||
163433519|NCT03519178|590291959|FG008|Fulvestrant. Treatment|Death|0|||
163433520|NCT03519178|590291960|FG009|Fulvestrant. Treatment|Death|1|||
163433521|NCT03519178|590291961|FG010|Fulvestrant. Treatment|Death|0|||
163433522|NCT03519178|590291962|FG011|Fulvestrant. Treatment|Death|0|||
163433523|NCT03519178|590291963|FG012|Fulvestrant. Treatment|Death|0|||
163433524|NCT03519178|590291964|FG013|Fulvestrant. Treatment|Death|0|||
163433525|NCT03519178|590291965|FG014|Fulvestrant. Treatment|Death|1|||
163433526|NCT03519178|590291951|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
163433527|NCT03519178|590291952|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
163433528|NCT03519178|590291953|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
163433529|NCT03519178|590291954|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
163433530|NCT03519178|590291955|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
163433531|NCT03519178|590291956|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
163433532|NCT03519178|590291957|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
163433533|NCT03519178|590291958|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
163433534|NCT03519178|590291959|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
163433535|NCT03519178|590291960|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
163433536|NCT03519178|590291961|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
163433537|NCT03519178|590291962|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
163433538|NCT03519178|590291963|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
163433539|NCT03519178|590291964|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
163433540|NCT03519178|590291965|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
163433541|NCT03519178|590291951|FG000|Fulvestrant. Treatment|Physician Decision|0|||
163433542|NCT03519178|590291952|FG001|Fulvestrant. Treatment|Physician Decision|0|||
163433543|NCT03519178|590291953|FG002|Fulvestrant. Treatment|Physician Decision|0|||
163433544|NCT03519178|590291954|FG003|Fulvestrant. Treatment|Physician Decision|0|||
163433545|NCT03519178|590291955|FG004|Fulvestrant. Treatment|Physician Decision|0|||
163433546|NCT03519178|590291956|FG005|Fulvestrant. Treatment|Physician Decision|0|||
163433547|NCT03519178|590291957|FG006|Fulvestrant. Treatment|Physician Decision|0|||
163433548|NCT03519178|590291958|FG007|Fulvestrant. Treatment|Physician Decision|0|||
163433549|NCT03519178|590291959|FG008|Fulvestrant. Treatment|Physician Decision|0|||
163433550|NCT03519178|590291960|FG009|Fulvestrant. Treatment|Physician Decision|0|||
163433551|NCT03519178|590291961|FG010|Fulvestrant. Treatment|Physician Decision|0|||
163433552|NCT03519178|590291962|FG011|Fulvestrant. Treatment|Physician Decision|0|||
163433553|NCT03519178|590291963|FG012|Fulvestrant. Treatment|Physician Decision|0|||
163433554|NCT03519178|590291964|FG013|Fulvestrant. Treatment|Physician Decision|4|||
163433555|NCT03519178|590291965|FG014|Fulvestrant. Treatment|Physician Decision|2|||
163433556|NCT03519178|590291951|FG000|Fulvestrant. Treatment|Progressive disease|0|||
163433557|NCT03519178|590291952|FG001|Fulvestrant. Treatment|Progressive disease|0|||
163433558|NCT03519178|590291953|FG002|Fulvestrant. Treatment|Progressive disease|0|||
163433559|NCT03519178|590291954|FG003|Fulvestrant. Treatment|Progressive disease|0|||
163433560|NCT03519178|590291955|FG004|Fulvestrant. Treatment|Progressive disease|0|||
163433561|NCT03519178|590291956|FG005|Fulvestrant. Treatment|Progressive disease|0|||
163433562|NCT03519178|590291957|FG006|Fulvestrant. Treatment|Progressive disease|0|||
163433563|NCT03519178|590291958|FG007|Fulvestrant. Treatment|Progressive disease|0|||
163433564|NCT03519178|590291959|FG008|Fulvestrant. Treatment|Progressive disease|0|||
163433565|NCT03519178|590291960|FG009|Fulvestrant. Treatment|Progressive disease|5|||
163433566|NCT03519178|590291961|FG010|Fulvestrant. Treatment|Progressive disease|0|||
163433567|NCT03519178|590291962|FG011|Fulvestrant. Treatment|Progressive disease|0|||
163433568|NCT03519178|590291963|FG012|Fulvestrant. Treatment|Progressive disease|0|||
163433569|NCT03519178|590291964|FG013|Fulvestrant. Treatment|Progressive disease|30|||
163433570|NCT03519178|590291965|FG014|Fulvestrant. Treatment|Progressive disease|8|||
163433571|NCT03519178|590291951|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
163433572|NCT03519178|590291952|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
163433573|NCT03519178|590291953|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
163433574|NCT03519178|590291954|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
163433575|NCT03519178|590291955|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
163433576|NCT03519178|590291956|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
163433577|NCT03519178|590291957|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
163433578|NCT03519178|590291958|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
163433579|NCT03519178|590291959|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
163433580|NCT03519178|590291960|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
163433581|NCT03519178|590291961|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
163433582|NCT03519178|590291962|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
163433583|NCT03519178|590291963|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
163433584|NCT03519178|590291964|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
163433585|NCT03519178|590291965|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
163433586|NCT03519178|590291951|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
163433587|NCT03519178|590291952|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
163433588|NCT03519178|590291953|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
163433589|NCT03519178|590291954|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
163433590|NCT03519178|590291955|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
163433591|NCT03519178|590291956|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
163433592|NCT03519178|590291957|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
163433593|NCT03519178|590291958|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
163433594|NCT03519178|590291959|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
163433595|NCT03519178|590291960|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
163433596|NCT03519178|590291961|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
163433597|NCT03519178|590291962|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
163433598|NCT03519178|590291963|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
163433599|NCT03519178|590291964|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
163433600|NCT03519178|590291965|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
163433601|NCT03519178|590291951|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
163433602|NCT03519178|590291952|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
163433603|NCT03519178|590291953|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
163433604|NCT03519178|590291954|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
163433605|NCT03519178|590291955|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
163433606|NCT03519178|590291956|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
163433607|NCT03519178|590291957|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
163433608|NCT03519178|590291958|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
163433609|NCT03519178|590291959|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
163433610|NCT03519178|590291960|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
163433611|NCT03519178|590291961|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
163433612|NCT03519178|590291962|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
163433613|NCT03519178|590291963|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
163433614|NCT03519178|590291964|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
163433615|NCT03519178|590291965|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
163433616|NCT03519178|590291951|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
163433617|NCT03519178|590291952|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
163433618|NCT03519178|590291953|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
163433619|NCT03519178|590291954|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
163433620|NCT03519178|590291955|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
163433621|NCT03519178|590291956|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
163433622|NCT03519178|590291957|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
163433623|NCT03519178|590291958|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
163433624|NCT03519178|590291959|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
163433625|NCT03519178|590291960|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
163433626|NCT03519178|590291961|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
163433627|NCT03519178|590291962|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
163433628|NCT03519178|590291963|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
163433629|NCT03519178|590291964|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
163433630|NCT03519178|590291965|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
163433631|NCT03519178|590291951|FG000|Fulvestrant. Treatment|Other|0|||
163433632|NCT03519178|590291952|FG001|Fulvestrant. Treatment|Other|0|||
163433633|NCT03519178|590291953|FG002|Fulvestrant. Treatment|Other|0|||
163433634|NCT03519178|590291954|FG003|Fulvestrant. Treatment|Other|0|||
163433635|NCT03519178|590291955|FG004|Fulvestrant. Treatment|Other|0|||
163433636|NCT03519178|590291956|FG005|Fulvestrant. Treatment|Other|0|||
163433637|NCT03519178|590291957|FG006|Fulvestrant. Treatment|Other|0|||
163433638|NCT03519178|590291958|FG007|Fulvestrant. Treatment|Other|0|||
163433639|NCT03519178|590291959|FG008|Fulvestrant. Treatment|Other|0|||
163433640|NCT03519178|590291960|FG009|Fulvestrant. Treatment|Other|0|||
163433641|NCT03519178|590291961|FG010|Fulvestrant. Treatment|Other|0|||
163433642|NCT03519178|590291962|FG011|Fulvestrant. Treatment|Other|0|||
163433643|NCT03519178|590291963|FG012|Fulvestrant. Treatment|Other|0|||
163433644|NCT03519178|590291964|FG013|Fulvestrant. Treatment|Other|1|||
163433645|NCT03519178|590291965|FG014|Fulvestrant. Treatment|Other|3|||
163433646|NCT03519178|590291951|FG000|Letrozole Treatment|Physician Decision|0|||
163433647|NCT03519178|590291952|FG001|Letrozole Treatment|Physician Decision|0|||
163433648|NCT03519178|590291953|FG002|Letrozole Treatment|Physician Decision|0|||
163433649|NCT03519178|590291954|FG003|Letrozole Treatment|Physician Decision|0|||
163433650|NCT03519178|590291955|FG004|Letrozole Treatment|Physician Decision|0|||
163433651|NCT03519178|590291956|FG005|Letrozole Treatment|Physician Decision|0|||
163433652|NCT03519178|590291957|FG006|Letrozole Treatment|Physician Decision|0|||
163433653|NCT03519178|590291958|FG007|Letrozole Treatment|Physician Decision|0|||
163433654|NCT03519178|590291959|FG008|Letrozole Treatment|Physician Decision|0|||
163433655|NCT03519178|590291960|FG009|Letrozole Treatment|Physician Decision|0|||
163433656|NCT03519178|590291961|FG010|Letrozole Treatment|Physician Decision|1|||
163433657|NCT03519178|590291962|FG011|Letrozole Treatment|Physician Decision|0|||
163433658|NCT03519178|590291963|FG012|Letrozole Treatment|Physician Decision|0|||
163433659|NCT03519178|590291964|FG013|Letrozole Treatment|Physician Decision|0|||
163433660|NCT03519178|590291965|FG014|Letrozole Treatment|Physician Decision|0|||
163433661|NCT03519178|590291951|FG000|Letrozole Treatment|Progressive disease|0|||
163433662|NCT03519178|590291952|FG001|Letrozole Treatment|Progressive disease|0|||
163433663|NCT03519178|590291953|FG002|Letrozole Treatment|Progressive disease|0|||
163433664|NCT03519178|590291954|FG003|Letrozole Treatment|Progressive disease|0|||
163433665|NCT03519178|590291955|FG004|Letrozole Treatment|Progressive disease|0|||
163433666|NCT03519178|590291956|FG005|Letrozole Treatment|Progressive disease|0|||
163433667|NCT03519178|590291957|FG006|Letrozole Treatment|Progressive disease|0|||
163433668|NCT03519178|590291958|FG007|Letrozole Treatment|Progressive disease|0|||
163433669|NCT03519178|590291959|FG008|Letrozole Treatment|Progressive disease|0|||
163433670|NCT03519178|590291960|FG009|Letrozole Treatment|Progressive disease|0|||
163433671|NCT03519178|590291961|FG010|Letrozole Treatment|Progressive disease|4|||
163433672|NCT03519178|590291962|FG011|Letrozole Treatment|Progressive disease|0|||
163433673|NCT03519178|590291963|FG012|Letrozole Treatment|Progressive disease|0|||
163433674|NCT03519178|590291964|FG013|Letrozole Treatment|Progressive disease|0|||
163433675|NCT03519178|590291965|FG014|Letrozole Treatment|Progressive disease|0|||
163433676|NCT03519178|590291951|FG000|Letrozole Treatment|Global deterioration of health status|0|||
163433677|NCT03519178|590291952|FG001|Letrozole Treatment|Global deterioration of health status|0|||
163433678|NCT03519178|590291953|FG002|Letrozole Treatment|Global deterioration of health status|0|||
163433679|NCT03519178|590291954|FG003|Letrozole Treatment|Global deterioration of health status|0|||
163433680|NCT03519178|590291955|FG004|Letrozole Treatment|Global deterioration of health status|0|||
163433681|NCT03519178|590291956|FG005|Letrozole Treatment|Global deterioration of health status|0|||
163433682|NCT03519178|590291957|FG006|Letrozole Treatment|Global deterioration of health status|0|||
163433683|NCT03519178|590291958|FG007|Letrozole Treatment|Global deterioration of health status|0|||
163433684|NCT03519178|590291959|FG008|Letrozole Treatment|Global deterioration of health status|0|||
163433685|NCT03519178|590291960|FG009|Letrozole Treatment|Global deterioration of health status|0|||
163433686|NCT03519178|590291961|FG010|Letrozole Treatment|Global deterioration of health status|2|||
163433687|NCT03519178|590291962|FG011|Letrozole Treatment|Global deterioration of health status|0|||
163433688|NCT03519178|590291963|FG012|Letrozole Treatment|Global deterioration of health status|0|||
163433689|NCT03519178|590291964|FG013|Letrozole Treatment|Global deterioration of health status|0|||
163433690|NCT03519178|590291965|FG014|Letrozole Treatment|Global deterioration of health status|0|||
163433691|NCT03519178|590291951|FG000|Follow-Up|Death|0|||
163433692|NCT03519178|590291952|FG001|Follow-Up|Death|0|||
163433693|NCT03519178|590291953|FG002|Follow-Up|Death|0|||
163433694|NCT03519178|590291954|FG003|Follow-Up|Death|0|||
163433695|NCT03519178|590291955|FG004|Follow-Up|Death|0|||
163433696|NCT03519178|590291956|FG005|Follow-Up|Death|0|||
163433697|NCT03519178|590291957|FG006|Follow-Up|Death|0|||
163433698|NCT03519178|590291958|FG007|Follow-Up|Death|0|||
163433699|NCT03519178|590291959|FG008|Follow-Up|Death|3|||
163433700|NCT03519178|590291960|FG009|Follow-Up|Death|1|||
163433701|NCT03519178|590291961|FG010|Follow-Up|Death|0|||
163433702|NCT03519178|590291962|FG011|Follow-Up|Death|0|||
163433703|NCT03519178|590291963|FG012|Follow-Up|Death|2|||
163433704|NCT03519178|590291964|FG013|Follow-Up|Death|0|||
163433705|NCT03519178|590291965|FG014|Follow-Up|Death|0|||
163433706|NCT03519178|590291951|FG000|Follow-Up|Lost to Follow-up|0|||
163433707|NCT03519178|590291952|FG001|Follow-Up|Lost to Follow-up|0|||
163433708|NCT03519178|590291953|FG002|Follow-Up|Lost to Follow-up|0|||
163433709|NCT03519178|590291954|FG003|Follow-Up|Lost to Follow-up|0|||
163433710|NCT03519178|590291955|FG004|Follow-Up|Lost to Follow-up|0|||
163433711|NCT03519178|590291956|FG005|Follow-Up|Lost to Follow-up|3|||
163433712|NCT03519178|590291957|FG006|Follow-Up|Lost to Follow-up|1|||
163433713|NCT03519178|590291958|FG007|Follow-Up|Lost to Follow-up|4|||
163433714|NCT03519178|590291959|FG008|Follow-Up|Lost to Follow-up|1|||
163433715|NCT03519178|590291960|FG009|Follow-Up|Lost to Follow-up|0|||
163433716|NCT03519178|590291961|FG010|Follow-Up|Lost to Follow-up|0|||
163433717|NCT03519178|590291962|FG011|Follow-Up|Lost to Follow-up|0|||
163433718|NCT03519178|590291963|FG012|Follow-Up|Lost to Follow-up|0|||
163433719|NCT03519178|590291964|FG013|Follow-Up|Lost to Follow-up|0|||
163433720|NCT03519178|590291965|FG014|Follow-Up|Lost to Follow-up|0|||
163433721|NCT03519178|590291951|FG000|Follow-Up|Withdrawal by Subject|1|||
163433722|NCT03519178|590291952|FG001|Follow-Up|Withdrawal by Subject|2|||
163433723|NCT03519178|590291953|FG002|Follow-Up|Withdrawal by Subject|2|||
163433724|NCT03519178|590291954|FG003|Follow-Up|Withdrawal by Subject|3|||
163433725|NCT03519178|590291955|FG004|Follow-Up|Withdrawal by Subject|5|||
163433726|NCT03519178|590291956|FG005|Follow-Up|Withdrawal by Subject|1|||
163433727|NCT03519178|590291957|FG006|Follow-Up|Withdrawal by Subject|2|||
163433728|NCT03519178|590291958|FG007|Follow-Up|Withdrawal by Subject|6|||
163433729|NCT03519178|590291959|FG008|Follow-Up|Withdrawal by Subject|5|||
163433730|NCT03519178|590291960|FG009|Follow-Up|Withdrawal by Subject|2|||
163433731|NCT03519178|590291961|FG010|Follow-Up|Withdrawal by Subject|3|||
163433732|NCT03519178|590291962|FG011|Follow-Up|Withdrawal by Subject|5|||
163433733|NCT03519178|590291963|FG012|Follow-Up|Withdrawal by Subject|2|||
163433734|NCT03519178|590291964|FG013|Follow-Up|Withdrawal by Subject|0|||
163433735|NCT03519178|590291965|FG014|Follow-Up|Withdrawal by Subject|0|||
163433736|NCT03519178|590291951|FG000|Follow-Up|Other|0|||
163433737|NCT03519178|590291952|FG001|Follow-Up|Other|0|||
163433738|NCT03519178|590291953|FG002|Follow-Up|Other|0|||
163433739|NCT03519178|590291954|FG003|Follow-Up|Other|0|||
163433740|NCT03519178|590291955|FG004|Follow-Up|Other|0|||
163433741|NCT03519178|590291956|FG005|Follow-Up|Other|0|||
163433742|NCT03519178|590291957|FG006|Follow-Up|Other|0|||
163433743|NCT03519178|590291958|FG007|Follow-Up|Other|1|||
163433744|NCT03519178|590291959|FG008|Follow-Up|Other|0|||
163433745|NCT03519178|590291960|FG009|Follow-Up|Other|0|||
163433746|NCT03519178|590291961|FG010|Follow-Up|Other|0|||
163433747|NCT03519178|590291962|FG011|Follow-Up|Other|0|||
163433748|NCT03519178|590291963|FG012|Follow-Up|Other|0|||
163433749|NCT03519178|590291964|FG013|Follow-Up|Other|0|||
163433750|NCT03519178|590291965|FG014|Follow-Up|Other|0|||
163433751|NCT03519178|590291951|FG000|Long-term Follow-up|Death|0|||
163433752|NCT03519178|590291952|FG001|Long-term Follow-up|Death|0|||
163433753|NCT03519178|590291953|FG002|Long-term Follow-up|Death|0|||
163433754|NCT03519178|590291954|FG003|Long-term Follow-up|Death|0|||
163433755|NCT03519178|590291955|FG004|Long-term Follow-up|Death|0|||
163433756|NCT03519178|590291956|FG005|Long-term Follow-up|Death|0|||
163433757|NCT03519178|590291957|FG006|Long-term Follow-up|Death|0|||
163433758|NCT03519178|590291958|FG007|Long-term Follow-up|Death|0|||
163433759|NCT03519178|590291959|FG008|Long-term Follow-up|Death|0|||
163433760|NCT03519178|590291960|FG009|Long-term Follow-up|Death|0|||
163433761|NCT03519178|590291961|FG010|Long-term Follow-up|Death|0|||
163433762|NCT03519178|590291962|FG011|Long-term Follow-up|Death|0|||
163433763|NCT03519178|590291963|FG012|Long-term Follow-up|Death|0|||
163433764|NCT03519178|590291964|FG013|Long-term Follow-up|Death|4|||
163433765|NCT03519178|590291965|FG014|Long-term Follow-up|Death|4|||
163433766|NCT03519178|590291951|FG000|Long-term Follow-up|Lost to Follow-up|0|||
163433767|NCT03519178|590291952|FG001|Long-term Follow-up|Lost to Follow-up|0|||
163433768|NCT03519178|590291953|FG002|Long-term Follow-up|Lost to Follow-up|0|||
163433769|NCT03519178|590291954|FG003|Long-term Follow-up|Lost to Follow-up|0|||
163433770|NCT03519178|590291955|FG004|Long-term Follow-up|Lost to Follow-up|0|||
163433771|NCT03519178|590291956|FG005|Long-term Follow-up|Lost to Follow-up|0|||
163433772|NCT03519178|590291957|FG006|Long-term Follow-up|Lost to Follow-up|0|||
163433773|NCT03519178|590291958|FG007|Long-term Follow-up|Lost to Follow-up|0|||
163433774|NCT03519178|590291959|FG008|Long-term Follow-up|Lost to Follow-up|0|||
163433775|NCT03519178|590291960|FG009|Long-term Follow-up|Lost to Follow-up|0|||
163433776|NCT03519178|590291961|FG010|Long-term Follow-up|Lost to Follow-up|0|||
163433777|NCT03519178|590291962|FG011|Long-term Follow-up|Lost to Follow-up|0|||
163433778|NCT03519178|590291963|FG012|Long-term Follow-up|Lost to Follow-up|0|||
163433779|NCT03519178|590291964|FG013|Long-term Follow-up|Lost to Follow-up|1|||
163433780|NCT03519178|590291965|FG014|Long-term Follow-up|Lost to Follow-up|1|||
163433781|NCT03519178|590291951|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
163433782|NCT03519178|590291952|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
163433783|NCT03519178|590291953|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
163433784|NCT03519178|590291954|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
163433785|NCT03519178|590291955|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
163433786|NCT03519178|590291956|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
163433787|NCT03519178|590291957|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
163433788|NCT03519178|590291958|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
163433789|NCT03519178|590291959|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
163433790|NCT03519178|590291960|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
163433791|NCT03519178|590291961|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
163433792|NCT03519178|590291962|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
163433793|NCT03519178|590291963|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
163433794|NCT03519178|590291964|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
163433795|NCT03519178|590291965|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
163433796|NCT03519178|590291951|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
163433797|NCT03519178|590291952|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
163433798|NCT03519178|590291953|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
163433799|NCT03519178|590291954|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
163433800|NCT03519178|590291955|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
163433801|NCT03519178|590291956|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
163433802|NCT03519178|590291957|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
163433803|NCT03519178|590291958|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
163433804|NCT03519178|590291959|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
163433805|NCT03519178|590291960|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
163433806|NCT03519178|590291961|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
163433807|NCT03519178|590291962|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
163433808|NCT03519178|590291963|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
163433809|NCT03519178|590291964|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
163433810|NCT03519178|590291965|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
163433811|NCT03519178|590291951|FG000|Long-term Follow-up|Other|0|||
163433812|NCT03519178|590291952|FG001|Long-term Follow-up|Other|0|||
163433813|NCT03519178|590291953|FG002|Long-term Follow-up|Other|0|||
163433814|NCT03519178|590291954|FG003|Long-term Follow-up|Other|0|||
163433815|NCT03519178|590291955|FG004|Long-term Follow-up|Other|0|||
163433816|NCT03519178|590291956|FG005|Long-term Follow-up|Other|0|||
163433817|NCT03519178|590291957|FG006|Long-term Follow-up|Other|0|||
163433818|NCT03519178|590291958|FG007|Long-term Follow-up|Other|0|||
163433819|NCT03519178|590291959|FG008|Long-term Follow-up|Other|0|||
163433820|NCT03519178|590291960|FG009|Long-term Follow-up|Other|0|||
163433821|NCT03519178|590291961|FG010|Long-term Follow-up|Other|0|||
163433822|NCT03519178|590291962|FG011|Long-term Follow-up|Other|0|||
163433823|NCT03519178|590291963|FG012|Long-term Follow-up|Other|0|||
163433824|NCT03519178|590291964|FG013|Long-term Follow-up|Other|0|||
163433825|NCT03519178|590291965|FG014|Long-term Follow-up|Other|1|||
163433826|NCT03519178|590291951|FG000|Long-term Follow-up|Global deterioration of health status|0|||
163433827|NCT03519178|590291952|FG001|Long-term Follow-up|Global deterioration of health status|0|||
163433828|NCT03519178|590291953|FG002|Long-term Follow-up|Global deterioration of health status|0|||
163433829|NCT03519178|590291954|FG003|Long-term Follow-up|Global deterioration of health status|0|||
163433830|NCT03519178|590291955|FG004|Long-term Follow-up|Global deterioration of health status|0|||
163433831|NCT03519178|590291956|FG005|Long-term Follow-up|Global deterioration of health status|0|||
163433832|NCT03519178|590291957|FG006|Long-term Follow-up|Global deterioration of health status|0|||
163433833|NCT03519178|590291958|FG007|Long-term Follow-up|Global deterioration of health status|0|||
163433834|NCT03519178|590291959|FG008|Long-term Follow-up|Global deterioration of health status|0|||
163433835|NCT03519178|590291960|FG009|Long-term Follow-up|Global deterioration of health status|0|||
163433836|NCT03519178|590291961|FG010|Long-term Follow-up|Global deterioration of health status|0|||
163433837|NCT03519178|590291962|FG011|Long-term Follow-up|Global deterioration of health status|0|||
163433838|NCT03519178|590291963|FG012|Long-term Follow-up|Global deterioration of health status|0|||
163433839|NCT03519178|590291964|FG013|Long-term Follow-up|Global deterioration of health status|1|||
163433840|NCT03519178|590291965|FG014|Long-term Follow-up|Global deterioration of health status|0|||
163433841|NCT00144300|590291974|FG000|Overall Study|Adverse Event|18|||
163433842|NCT00144300|590291975|FG001|Overall Study|Adverse Event|16|||
163433843|NCT00144300|590291974|FG000|Overall Study|Protocol Violation|1|||
163433844|NCT00144300|590291975|FG001|Overall Study|Protocol Violation|3|||
163433845|NCT00144300|590291974|FG000|Overall Study|Lost to Follow-up|3|||
163433846|NCT00144300|590291975|FG001|Overall Study|Lost to Follow-up|0|||
163433847|NCT00144300|590291974|FG000|Overall Study|Withdrawal by Subject|6|||
163433848|NCT00144300|590291975|FG001|Overall Study|Withdrawal by Subject|6|||
163433849|NCT00144300|590291974|FG000|Overall Study|Other reason (not specified)|1|||
163433850|NCT00144300|590291975|FG001|Overall Study|Other reason (not specified)|3|||
163433851|NCT04070378|590291978|FG000|Overall Study|Withdrawal by Subject|2|||
163433852|NCT04070378|590291978|FG000|Overall Study|Screen Failure|6|||
163433853|NCT04070378|590291978|FG000|Overall Study|Physician Decision|1|||
163433854|NCT04070378|590291978|FG000|Overall Study|Adverse Event|1|||
163433855|NCT05165394|590293573|FG000|Overall Study|Withdrawal by Subject|5|||
163433856|NCT05165394|590293574|FG001|Overall Study|Withdrawal by Subject|1|||
163433857|NCT05165394|590293573|FG000|Overall Study|Lost to Follow-up|1|||
163433858|NCT05165394|590293574|FG001|Overall Study|Lost to Follow-up|2|||
163433859|NCT05165394|590293573|FG000|Overall Study|Other Than Specified|0|||
163433860|NCT05165394|590293574|FG001|Overall Study|Other Than Specified|1|||
163433861|NCT03705494|590293575|FG000|Overall Study|Lost to Follow-up|2|||
163433862|NCT03705494|590293576|FG001|Overall Study|Lost to Follow-up|1|||
163433863|NCT03705494|590293575|FG000|Overall Study|Withdrawal by Subject|5|||
163433864|NCT03705494|590293576|FG001|Overall Study|Withdrawal by Subject|2|||
163433865|NCT02495077|590293577|FG000|Overall Study|Adverse Event|0|||
163433866|NCT02495077|590293578|FG001|Overall Study|Adverse Event|1|||
163433867|NCT02495077|590293579|FG002|Overall Study|Adverse Event|1|||
163433868|NCT02495077|590293580|FG003|Overall Study|Adverse Event|0|||
163433869|NCT02495077|590293577|FG000|Overall Study|Death|3|||
163433870|NCT02495077|590293578|FG001|Overall Study|Death|5|||
163433871|NCT02495077|590293579|FG002|Overall Study|Death|0|||
163433872|NCT02495077|590293580|FG003|Overall Study|Death|0|||
163433873|NCT02495077|590293577|FG000|Overall Study|Lost to Follow-up|6|||
163433874|NCT02495077|590293578|FG001|Overall Study|Lost to Follow-up|4|||
163433875|NCT02495077|590293579|FG002|Overall Study|Lost to Follow-up|0|||
163433876|NCT02495077|590293580|FG003|Overall Study|Lost to Follow-up|0|||
163433877|NCT02495077|590293577|FG000|Overall Study|Physician Decision|2|||
163433878|NCT02495077|590293578|FG001|Overall Study|Physician Decision|1|||
163433879|NCT02495077|590293579|FG002|Overall Study|Physician Decision|4|||
163433880|NCT02495077|590293580|FG003|Overall Study|Physician Decision|0|||
163433881|NCT02495077|590293577|FG000|Overall Study|Protocol Violation|0|||
163433882|NCT02495077|590293578|FG001|Overall Study|Protocol Violation|1|||
163433883|NCT02495077|590293579|FG002|Overall Study|Protocol Violation|0|||
163433884|NCT02495077|590293580|FG003|Overall Study|Protocol Violation|0|||
163433885|NCT02495077|590293577|FG000|Overall Study|Screen Failure|0|||
163433886|NCT02495077|590293578|FG001|Overall Study|Screen Failure|0|||
163433887|NCT02495077|590293579|FG002|Overall Study|Screen Failure|0|||
162925346|NCT00602641|588428937|FG001|Overall Study|Administrative Closure|1|||
163433888|NCT02495077|590293580|FG003|Overall Study|Screen Failure|48|||
163433889|NCT02495077|590293577|FG000|Overall Study|Withdrawal by Subject|7|||
163433890|NCT02495077|590293578|FG001|Overall Study|Withdrawal by Subject|7|||
163433891|NCT02495077|590293579|FG002|Overall Study|Withdrawal by Subject|7|||
163433892|NCT02495077|590293580|FG003|Overall Study|Withdrawal by Subject|0|||
163433893|NCT02495077|590293577|FG000|Overall Study|Covid-19 research restrictions|1|||
163433894|NCT02495077|590293578|FG001|Overall Study|Covid-19 research restrictions|0|||
163433895|NCT02495077|590293579|FG002|Overall Study|Covid-19 research restrictions|0|||
163433896|NCT02495077|590293580|FG003|Overall Study|Covid-19 research restrictions|0|||
163433897|NCT02495077|590293577|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
163433898|NCT02495077|590293578|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
163433899|NCT02495077|590293579|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
163433900|NCT02495077|590293580|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
163433901|NCT02495077|590293577|FG000|Overall Study|Incarcerated|0|||
163433902|NCT02495077|590293578|FG001|Overall Study|Incarcerated|1|||
163433903|NCT02495077|590293579|FG002|Overall Study|Incarcerated|0|||
163433904|NCT02495077|590293580|FG003|Overall Study|Incarcerated|0|||
163433905|NCT02495077|590293577|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
163433906|NCT02495077|590293578|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
163433907|NCT02495077|590293579|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
163433908|NCT02495077|590293580|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
163433909|NCT02495077|590293577|FG000|Overall Study|Timing of transplant and randomization|0|||
163433910|NCT02495077|590293578|FG001|Overall Study|Timing of transplant and randomization|0|||
163433911|NCT02495077|590293579|FG002|Overall Study|Timing of transplant and randomization|5|||
163433912|NCT02495077|590293580|FG003|Overall Study|Timing of transplant and randomization|0|||
163433913|NCT02742649|590293581|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
163433914|NCT02742649|590293582|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
163433915|NCT02742649|590293583|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
163433916|NCT02742649|590293584|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
163433917|NCT02742649|590293585|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
163433918|NCT02742649|590293581|FG000|Double-Blind Treatment Period|Adverse Event|0|||
163433919|NCT02742649|590293582|FG001|Double-Blind Treatment Period|Adverse Event|1|||
163433920|NCT02742649|590293583|FG002|Double-Blind Treatment Period|Adverse Event|0|||
163433921|NCT02742649|590293584|FG003|Double-Blind Treatment Period|Adverse Event|0|||
163433922|NCT02742649|590293585|FG004|Double-Blind Treatment Period|Adverse Event|0|||
163433923|NCT02742649|590293581|FG000|Open-Label Period|Lost to Follow-up|0|||
163433924|NCT02742649|590293582|FG001|Open-Label Period|Lost to Follow-up|0|||
163433925|NCT02742649|590293583|FG002|Open-Label Period|Lost to Follow-up|0|||
163433926|NCT02742649|590293584|FG003|Open-Label Period|Lost to Follow-up|0|||
163433927|NCT02742649|590293585|FG004|Open-Label Period|Lost to Follow-up|1|||
163433928|NCT03937986|590293586|FG000|Overall Study|COVID-19 Pandemic|1|||
163433929|NCT02839746|590293587|FG000|Overall Study|Not met selection criteria|12|||
163433930|NCT02333331|590293588|FG000|Overall Study|Adverse Event|1|||
163433931|NCT02333331|590293589|FG001|Overall Study|Adverse Event|0|||
163433932|NCT02333331|590293590|FG002|Overall Study|Adverse Event|4|||
163433933|NCT02333331|590293591|FG003|Overall Study|Adverse Event|1|||
163433934|NCT02333331|590293588|FG000|Overall Study|Death|0|||
163433935|NCT02333331|590293589|FG001|Overall Study|Death|0|||
163433936|NCT02333331|590293590|FG002|Overall Study|Death|2|||
163433937|NCT02333331|590293591|FG003|Overall Study|Death|0|||
163433938|NCT02333331|590293588|FG000|Overall Study|Lost to Follow-up|0|||
163433939|NCT02333331|590293589|FG001|Overall Study|Lost to Follow-up|0|||
163433940|NCT02333331|590293590|FG002|Overall Study|Lost to Follow-up|1|||
163433941|NCT02333331|590293591|FG003|Overall Study|Lost to Follow-up|0|||
163433942|NCT02333331|590293588|FG000|Overall Study|Physician Decision|0|||
163433943|NCT02333331|590293589|FG001|Overall Study|Physician Decision|1|||
163433944|NCT02333331|590293590|FG002|Overall Study|Physician Decision|0|||
163433945|NCT02333331|590293591|FG003|Overall Study|Physician Decision|0|||
163433946|NCT02333331|590293588|FG000|Overall Study|Protocol Deviation|0|||
163433947|NCT02333331|590293589|FG001|Overall Study|Protocol Deviation|3|||
163433948|NCT02333331|590293590|FG002|Overall Study|Protocol Deviation|2|||
163433949|NCT02333331|590293591|FG003|Overall Study|Protocol Deviation|1|||
163433950|NCT02333331|590293588|FG000|Overall Study|Patient/Guardian Decision|1|||
163433951|NCT02333331|590293589|FG001|Overall Study|Patient/Guardian Decision|2|||
163433952|NCT02333331|590293590|FG002|Overall Study|Patient/Guardian Decision|9|||
163433953|NCT02333331|590293591|FG003|Overall Study|Patient/Guardian Decision|1|||
163433954|NCT00756002|590293603|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
163433955|NCT00756002|590293604|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
163433956|NCT00756002|590293603|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163433957|NCT00756002|590293604|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
163433958|NCT00756002|590293603|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
163433959|NCT00756002|590293604|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
163433960|NCT00756002|590293603|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
163433961|NCT00756002|590293604|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
163433962|NCT00756002|590293603|FG000|Double-Blind Treatment Period|Other|2|||
163433963|NCT00756002|590293604|FG001|Double-Blind Treatment Period|Other|2|||
163433964|NCT04329923|590293608|FG000|Overall Study|Withdrawal by Subject|1|||
163433965|NCT04329923|590293609|FG001|Overall Study|Withdrawal by Subject|4|||
163433966|NCT04329923|590293610|FG002|Overall Study|Withdrawal by Subject|1|||
163433967|NCT04329923|590293611|FG003|Overall Study|Withdrawal by Subject|1|||
163433968|NCT04329923|590293612|FG004|Overall Study|Withdrawal by Subject|1|||
163433969|NCT04329923|590293613|FG005|Overall Study|Withdrawal by Subject|1|||
163433970|NCT04329923|590293608|FG000|Overall Study|early termination of study|0|||
163433971|NCT04329923|590293609|FG001|Overall Study|early termination of study|0|||
163433972|NCT04329923|590293610|FG002|Overall Study|early termination of study|0|||
163433973|NCT04329923|590293611|FG003|Overall Study|early termination of study|0|||
163433974|NCT04329923|590293612|FG004|Overall Study|early termination of study|1|||
163433975|NCT04329923|590293613|FG005|Overall Study|early termination of study|2|||
163433976|NCT04329923|590293608|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
163433977|NCT04329923|590293609|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
163433978|NCT04329923|590293610|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
163433979|NCT04329923|590293611|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
163433980|NCT04329923|590293612|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
163433981|NCT04329923|590293613|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
163433982|NCT01272180|590293614|FG000|Overall Study|Adverse Event|0|||
163433983|NCT01272180|590293615|FG001|Overall Study|Adverse Event|0|||
163433984|NCT01272180|590293616|FG002|Overall Study|Adverse Event|1|||
163433985|NCT01272180|590293617|FG003|Overall Study|Adverse Event|0|||
163433986|NCT01272180|590293614|FG000|Overall Study|Withdrawal by Subject|2|||
163433987|NCT01272180|590293615|FG001|Overall Study|Withdrawal by Subject|6|||
163433988|NCT01272180|590293616|FG002|Overall Study|Withdrawal by Subject|3|||
163433989|NCT01272180|590293617|FG003|Overall Study|Withdrawal by Subject|2|||
163433990|NCT01272180|590293614|FG000|Overall Study|Lost to Follow-up|15|||
163433991|NCT01272180|590293615|FG001|Overall Study|Lost to Follow-up|14|||
163433992|NCT01272180|590293616|FG002|Overall Study|Lost to Follow-up|8|||
163433993|NCT01272180|590293617|FG003|Overall Study|Lost to Follow-up|10|||
163433994|NCT01272180|590293614|FG000|Overall Study|Inappropriate enrollment|0|||
163433995|NCT01272180|590293615|FG001|Overall Study|Inappropriate enrollment|0|||
163433996|NCT01272180|590293616|FG002|Overall Study|Inappropriate enrollment|1|||
163433997|NCT01272180|590293617|FG003|Overall Study|Inappropriate enrollment|1|||
163433998|NCT01272180|590293614|FG000|Overall Study|Protocol Violation|0|||
163433999|NCT01272180|590293615|FG001|Overall Study|Protocol Violation|1|||
163434000|NCT01272180|590293616|FG002|Overall Study|Protocol Violation|0|||
163434001|NCT01272180|590293617|FG003|Overall Study|Protocol Violation|1|||
163434002|NCT01702805|590293620|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
163434003|NCT01702805|590293621|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
163434004|NCT01702805|590293620|FG000|Overall Study|Incomplete Follow-up|18|||
163434005|NCT01702805|590293621|FG001|Overall Study|Incomplete Follow-up|15|||
163434006|NCT01702805|590293620|FG000|Overall Study|Vital Status Assessment Only|40|||
163434007|NCT01702805|590293621|FG001|Overall Study|Vital Status Assessment Only|39|||
163434008|NCT01702805|590293620|FG000|Overall Study|Lost to Follow-up|5|||
163434009|NCT01702805|590293621|FG001|Overall Study|Lost to Follow-up|5|||
163434010|NCT03056287|590293622|FG000|Overall Study|Withdrawal by Subject|0|||
163434011|NCT03056287|590293623|FG001|Overall Study|Withdrawal by Subject|1|||
163434012|NCT03056287|590293624|FG002|Overall Study|Withdrawal by Subject|0|||
163434013|NCT03056287|590293625|FG003|Overall Study|Withdrawal by Subject|0|||
163434014|NCT03056287|590293622|FG000|Overall Study|move out of area|0|||
163434015|NCT03056287|590293623|FG001|Overall Study|move out of area|0|||
163434016|NCT03056287|590293624|FG002|Overall Study|move out of area|1|||
163434017|NCT03056287|590293625|FG003|Overall Study|move out of area|1|||
163434018|NCT01844076|590293626|FG000|Overall Study|Adverse Event|1|||
163434019|NCT01844076|590293627|FG001|Overall Study|Adverse Event|0|||
163434020|NCT01844076|590293628|FG002|Overall Study|Adverse Event|0|||
163434021|NCT01844076|590293629|FG003|Overall Study|Adverse Event|0|||
163434022|NCT01844076|590293626|FG000|Overall Study|Withdrawal by Subject|1|||
163434023|NCT01844076|590293627|FG001|Overall Study|Withdrawal by Subject|0|||
163434024|NCT01844076|590293628|FG002|Overall Study|Withdrawal by Subject|0|||
163434025|NCT01844076|590293629|FG003|Overall Study|Withdrawal by Subject|0|||
163434026|NCT01937312|590293633|FG000|Overall Study|Adverse Event|10|||
163434027|NCT01937312|590293634|FG001|Overall Study|Adverse Event|1|||
163434028|NCT01937312|590293633|FG000|Overall Study|Lack of Efficacy|0|||
163434029|NCT01937312|590293634|FG001|Overall Study|Lack of Efficacy|1|||
163434030|NCT01937312|590293633|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
163434031|NCT01937312|590293634|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
163434032|NCT01025336|590293636|FG000|Overall Study|Protocol Violation|0|||
163434033|NCT01025336|590293637|FG001|Overall Study|Protocol Violation|0|||
163434034|NCT01025336|590293638|FG002|Overall Study|Protocol Violation|0|||
163434035|NCT01025336|590293639|FG003|Overall Study|Protocol Violation|2|||
163434036|NCT01025336|590293640|FG004|Overall Study|Protocol Violation|0|||
163434037|NCT01486238|590293649|FG000|Overall Study|Death|0|||
163434038|NCT01486238|590293650|FG001|Overall Study|Death|2|||
163434039|NCT01486238|590293649|FG000|Overall Study|Withdrawal by Subject|2|||
163434040|NCT01486238|590293650|FG001|Overall Study|Withdrawal by Subject|1|||
163434041|NCT01486238|590293649|FG000|Overall Study|Lost to Follow-up|0|||
163434042|NCT01486238|590293650|FG001|Overall Study|Lost to Follow-up|3|||
163434043|NCT03043365|590293651|FG000|Weeks 0 to Week 8|Adverse Event|1|||
163434044|NCT03043365|590293652|FG001|Weeks 0 to Week 8|Adverse Event|3|||
163434045|NCT03043365|590293651|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
163434046|NCT03043365|590293652|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
163434047|NCT03043365|590293651|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
163434048|NCT03043365|590293652|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
163434049|NCT02723630|590293653|FG000|Intervention Period 1|Adverse Event|1|||
163434050|NCT02723630|590293654|FG001|Intervention Period 1|Adverse Event|0|||
163434051|NCT02723630|590293655|FG002|Intervention Period 1|Adverse Event|0|||
163434052|NCT02723630|590293656|FG003|Intervention Period 1|Adverse Event|0|||
163434053|NCT02723630|590293657|FG004|Intervention Period 1|Adverse Event|0|||
163434054|NCT02723630|590293658|FG005|Intervention Period 1|Adverse Event|0|||
163434055|NCT02723630|590293653|FG000|Intervention Period 3|consumption of restricted item|0|||
163434056|NCT02723630|590293654|FG001|Intervention Period 3|consumption of restricted item|1|||
163434057|NCT02723630|590293655|FG002|Intervention Period 3|consumption of restricted item|0|||
163434058|NCT02723630|590293656|FG003|Intervention Period 3|consumption of restricted item|0|||
163434059|NCT02723630|590293657|FG004|Intervention Period 3|consumption of restricted item|0|||
163434060|NCT02723630|590293658|FG005|Intervention Period 3|consumption of restricted item|0|||
163434061|NCT00923091|590293664|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
163434062|NCT00923091|590293665|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
163434063|NCT00923091|590293666|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
163434064|NCT00923091|590293667|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
163434065|NCT00923091|590293668|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
163434066|NCT00923091|590293669|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
163434067|NCT00923091|590293670|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
163434068|NCT00923091|590293671|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
163434069|NCT00923091|590293672|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
163434070|NCT00923091|590293673|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
163434071|NCT00923091|590293674|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
163434072|NCT00923091|590293675|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
163434073|NCT00923091|590293676|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
163434074|NCT00923091|590293664|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
163434075|NCT00923091|590293665|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
163434076|NCT00923091|590293666|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
163434077|NCT00923091|590293667|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
163434078|NCT00923091|590293668|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
163434079|NCT00923091|590293669|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
163434080|NCT00923091|590293670|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
163434081|NCT00923091|590293671|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
163434082|NCT00923091|590293672|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
163434083|NCT00923091|590293673|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
163434084|NCT00923091|590293674|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
163434085|NCT00923091|590293675|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
163434086|NCT00923091|590293676|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
163434087|NCT00923091|590293664|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
163434088|NCT00923091|590293665|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
163434089|NCT00923091|590293666|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
163434090|NCT00923091|590293667|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
163434091|NCT00923091|590293668|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
163434092|NCT00923091|590293669|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
163434093|NCT00923091|590293670|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
163434094|NCT00923091|590293671|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
163434095|NCT00923091|590293672|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
163434096|NCT00923091|590293673|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
163434097|NCT00923091|590293674|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
163434098|NCT00923091|590293675|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
163434099|NCT00923091|590293676|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
163434100|NCT00923091|590293664|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
163434101|NCT00923091|590293665|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
163434102|NCT00923091|590293666|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
163434103|NCT00923091|590293667|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
163434104|NCT00923091|590293668|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
163434105|NCT00923091|590293669|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
163434106|NCT00923091|590293670|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
163434107|NCT00923091|590293671|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
163434108|NCT00923091|590293672|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
163434109|NCT00923091|590293673|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
163434110|NCT00923091|590293674|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
163434111|NCT00923091|590293675|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
163434112|NCT00923091|590293676|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
163434113|NCT00923091|590293664|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
163434114|NCT00923091|590293665|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
163434115|NCT00923091|590293666|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
163434116|NCT00923091|590293667|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
163434117|NCT00923091|590293668|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
163434118|NCT00923091|590293669|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
163434119|NCT00923091|590293670|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
163434120|NCT00923091|590293671|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
163434121|NCT00923091|590293672|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
163434122|NCT00923091|590293673|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
163434123|NCT00923091|590293674|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
163434124|NCT00923091|590293675|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
163434125|NCT00923091|590293676|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
163434126|NCT00923091|590293664|FG000|Period III (Single-Blind)|Adverse Event|5|||
163434127|NCT00923091|590293665|FG001|Period III (Single-Blind)|Adverse Event|0|||
163434128|NCT00923091|590293666|FG002|Period III (Single-Blind)|Adverse Event|0|||
163434129|NCT00923091|590293667|FG003|Period III (Single-Blind)|Adverse Event|0|||
163434130|NCT00923091|590293668|FG004|Period III (Single-Blind)|Adverse Event|0|||
163434131|NCT00923091|590293669|FG005|Period III (Single-Blind)|Adverse Event|0|||
163434132|NCT00923091|590293670|FG006|Period III (Single-Blind)|Adverse Event|0|||
163434133|NCT00923091|590293671|FG007|Period III (Single-Blind)|Adverse Event|0|||
163434134|NCT00923091|590293672|FG008|Period III (Single-Blind)|Adverse Event|0|||
163434135|NCT00923091|590293673|FG009|Period III (Single-Blind)|Adverse Event|0|||
163434136|NCT00923091|590293674|FG010|Period III (Single-Blind)|Adverse Event|0|||
163434137|NCT00923091|590293675|FG011|Period III (Single-Blind)|Adverse Event|0|||
163434138|NCT00923091|590293676|FG012|Period III (Single-Blind)|Adverse Event|0|||
163434139|NCT00923091|590293664|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
163434140|NCT00923091|590293665|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
163434141|NCT00923091|590293666|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
163434142|NCT00923091|590293667|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
163434143|NCT00923091|590293668|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
163434144|NCT00923091|590293669|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
163434145|NCT00923091|590293670|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
163434146|NCT00923091|590293671|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
163434147|NCT00923091|590293672|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
163434148|NCT00923091|590293673|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
163434149|NCT00923091|590293674|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
163434150|NCT00923091|590293675|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
163434151|NCT00923091|590293676|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
163434152|NCT00923091|590293664|FG000|Period III (Single-Blind)|Protocol Violation|3|||
163434153|NCT00923091|590293665|FG001|Period III (Single-Blind)|Protocol Violation|0|||
163434154|NCT00923091|590293666|FG002|Period III (Single-Blind)|Protocol Violation|0|||
163434155|NCT00923091|590293667|FG003|Period III (Single-Blind)|Protocol Violation|0|||
163434156|NCT00923091|590293668|FG004|Period III (Single-Blind)|Protocol Violation|0|||
163434157|NCT00923091|590293669|FG005|Period III (Single-Blind)|Protocol Violation|0|||
163434158|NCT00923091|590293670|FG006|Period III (Single-Blind)|Protocol Violation|0|||
163434159|NCT00923091|590293671|FG007|Period III (Single-Blind)|Protocol Violation|0|||
163434160|NCT00923091|590293672|FG008|Period III (Single-Blind)|Protocol Violation|0|||
163434161|NCT00923091|590293673|FG009|Period III (Single-Blind)|Protocol Violation|0|||
163434162|NCT00923091|590293674|FG010|Period III (Single-Blind)|Protocol Violation|0|||
163434163|NCT00923091|590293675|FG011|Period III (Single-Blind)|Protocol Violation|0|||
163434164|NCT00923091|590293676|FG012|Period III (Single-Blind)|Protocol Violation|0|||
163434165|NCT00923091|590293664|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
163434166|NCT00923091|590293665|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
163434167|NCT00923091|590293666|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
163434168|NCT00923091|590293667|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
163434169|NCT00923091|590293668|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
163434170|NCT00923091|590293669|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
163434171|NCT00923091|590293670|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
163434172|NCT00923091|590293671|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
163434173|NCT00923091|590293672|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
163434174|NCT00923091|590293673|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
163434175|NCT00923091|590293674|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
163434176|NCT00923091|590293675|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
163434177|NCT00923091|590293676|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
163434178|NCT00923091|590293664|FG000|Period IV (Double-Blind)|Adverse Event|2|||
163434179|NCT00923091|590293665|FG001|Period IV (Double-Blind)|Adverse Event|0|||
163434180|NCT00923091|590293666|FG002|Period IV (Double-Blind)|Adverse Event|0|||
163434181|NCT00923091|590293667|FG003|Period IV (Double-Blind)|Adverse Event|0|||
163434182|NCT00923091|590293668|FG004|Period IV (Double-Blind)|Adverse Event|0|||
163434183|NCT00923091|590293669|FG005|Period IV (Double-Blind)|Adverse Event|0|||
163434184|NCT00923091|590293670|FG006|Period IV (Double-Blind)|Adverse Event|0|||
163434185|NCT00923091|590293671|FG007|Period IV (Double-Blind)|Adverse Event|0|||
163434186|NCT00923091|590293672|FG008|Period IV (Double-Blind)|Adverse Event|0|||
163434187|NCT00923091|590293673|FG009|Period IV (Double-Blind)|Adverse Event|0|||
163434188|NCT00923091|590293674|FG010|Period IV (Double-Blind)|Adverse Event|0|||
163434189|NCT00923091|590293675|FG011|Period IV (Double-Blind)|Adverse Event|0|||
163434190|NCT00923091|590293676|FG012|Period IV (Double-Blind)|Adverse Event|0|||
163434191|NCT00923091|590293664|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
163434192|NCT00923091|590293665|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
163434193|NCT00923091|590293666|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
163434194|NCT00923091|590293667|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
163434195|NCT00923091|590293668|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
163434196|NCT00923091|590293669|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
163434197|NCT00923091|590293670|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
163434198|NCT00923091|590293671|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
163434199|NCT00923091|590293672|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
163434200|NCT00923091|590293673|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
163434201|NCT00923091|590293674|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
163434202|NCT00923091|590293675|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
163434203|NCT00923091|590293676|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
163434204|NCT00923091|590293664|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
163434205|NCT00923091|590293665|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
163434206|NCT00923091|590293666|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
163434207|NCT00923091|590293667|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
163434208|NCT00923091|590293668|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
163434209|NCT00923091|590293669|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
163434210|NCT00923091|590293670|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
163434211|NCT00923091|590293671|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
163434212|NCT00923091|590293672|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
163434213|NCT00923091|590293673|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
163434214|NCT00923091|590293674|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
163434215|NCT00923091|590293675|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
163434216|NCT00923091|590293676|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
163434217|NCT00923091|590293664|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
163434218|NCT00923091|590293665|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
163434219|NCT00923091|590293666|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
163434220|NCT00923091|590293667|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
163434221|NCT00923091|590293668|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
163434222|NCT00923091|590293669|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
163434223|NCT00923091|590293670|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
163434224|NCT00923091|590293671|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
163434225|NCT00923091|590293672|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
163434226|NCT00923091|590293673|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
163434227|NCT00923091|590293674|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
163434228|NCT00923091|590293675|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
163434229|NCT00923091|590293676|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
163434230|NCT00923091|590293664|FG000|Period V (Double -Blind)|Protocol Violation|0|||
163434231|NCT00923091|590293665|FG001|Period V (Double -Blind)|Protocol Violation|0|||
163434232|NCT00923091|590293666|FG002|Period V (Double -Blind)|Protocol Violation|0|||
163434233|NCT00923091|590293667|FG003|Period V (Double -Blind)|Protocol Violation|0|||
163434234|NCT00923091|590293668|FG004|Period V (Double -Blind)|Protocol Violation|0|||
163434235|NCT00923091|590293669|FG005|Period V (Double -Blind)|Protocol Violation|0|||
163434236|NCT00923091|590293670|FG006|Period V (Double -Blind)|Protocol Violation|0|||
163434237|NCT00923091|590293671|FG007|Period V (Double -Blind)|Protocol Violation|0|||
163434238|NCT00923091|590293672|FG008|Period V (Double -Blind)|Protocol Violation|0|||
163434239|NCT00923091|590293673|FG009|Period V (Double -Blind)|Protocol Violation|0|||
163434240|NCT00923091|590293674|FG010|Period V (Double -Blind)|Protocol Violation|0|||
163434241|NCT00923091|590293675|FG011|Period V (Double -Blind)|Protocol Violation|0|||
163434242|NCT00923091|590293676|FG012|Period V (Double -Blind)|Protocol Violation|1|||
163434243|NCT00923091|590293664|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
163434244|NCT00923091|590293665|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
163434245|NCT00923091|590293666|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
163434246|NCT00923091|590293667|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
163434247|NCT00923091|590293668|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
163434248|NCT00923091|590293669|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
163434249|NCT00923091|590293670|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
163434250|NCT00923091|590293671|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
163434251|NCT00923091|590293672|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
163434252|NCT00923091|590293673|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
163434253|NCT00923091|590293674|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
163434254|NCT00923091|590293675|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
163434255|NCT00923091|590293676|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
163434256|NCT00923091|590293664|FG000|Period VI (Open-Label)|Adverse Event|17|||
163434257|NCT00923091|590293665|FG001|Period VI (Open-Label)|Adverse Event|0|||
163434258|NCT00923091|590293666|FG002|Period VI (Open-Label)|Adverse Event|4|||
163434259|NCT00923091|590293667|FG003|Period VI (Open-Label)|Adverse Event|1|||
163434260|NCT00923091|590293668|FG004|Period VI (Open-Label)|Adverse Event|1|||
163434261|NCT00923091|590293669|FG005|Period VI (Open-Label)|Adverse Event|0|||
163434262|NCT00923091|590293670|FG006|Period VI (Open-Label)|Adverse Event|0|||
163434263|NCT00923091|590293671|FG007|Period VI (Open-Label)|Adverse Event|0|||
163434264|NCT00923091|590293672|FG008|Period VI (Open-Label)|Adverse Event|0|||
163434265|NCT00923091|590293673|FG009|Period VI (Open-Label)|Adverse Event|0|||
163434266|NCT00923091|590293674|FG010|Period VI (Open-Label)|Adverse Event|0|||
163434267|NCT00923091|590293675|FG011|Period VI (Open-Label)|Adverse Event|0|||
163434268|NCT00923091|590293676|FG012|Period VI (Open-Label)|Adverse Event|0|||
163434269|NCT00923091|590293664|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
163434270|NCT00923091|590293665|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
163434271|NCT00923091|590293666|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
163434272|NCT00923091|590293667|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
163434273|NCT00923091|590293668|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
163434274|NCT00923091|590293669|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
163434275|NCT00923091|590293670|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
163434276|NCT00923091|590293671|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
163434277|NCT00923091|590293672|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
163434278|NCT00923091|590293673|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
163434279|NCT00923091|590293674|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
163434280|NCT00923091|590293675|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
163434281|NCT00923091|590293676|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
163434282|NCT00923091|590293664|FG000|Period VI (Open-Label)|Protocol Violation|6|||
163434283|NCT00923091|590293665|FG001|Period VI (Open-Label)|Protocol Violation|1|||
163434284|NCT00923091|590293666|FG002|Period VI (Open-Label)|Protocol Violation|3|||
163434285|NCT00923091|590293667|FG003|Period VI (Open-Label)|Protocol Violation|1|||
163434286|NCT00923091|590293668|FG004|Period VI (Open-Label)|Protocol Violation|4|||
163434287|NCT00923091|590293669|FG005|Period VI (Open-Label)|Protocol Violation|0|||
163434288|NCT00923091|590293670|FG006|Period VI (Open-Label)|Protocol Violation|0|||
163434289|NCT00923091|590293671|FG007|Period VI (Open-Label)|Protocol Violation|0|||
163434290|NCT00923091|590293672|FG008|Period VI (Open-Label)|Protocol Violation|0|||
163434291|NCT00923091|590293673|FG009|Period VI (Open-Label)|Protocol Violation|0|||
163434292|NCT00923091|590293674|FG010|Period VI (Open-Label)|Protocol Violation|0|||
163434293|NCT00923091|590293675|FG011|Period VI (Open-Label)|Protocol Violation|0|||
163434294|NCT00923091|590293676|FG012|Period VI (Open-Label)|Protocol Violation|0|||
163434295|NCT00923091|590293664|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
163434296|NCT00923091|590293665|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
163434297|NCT00923091|590293666|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
163434298|NCT00923091|590293667|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
163434299|NCT00923091|590293668|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
163434300|NCT00923091|590293669|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
163434301|NCT00923091|590293670|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
163434302|NCT00923091|590293671|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
163434303|NCT00923091|590293672|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
163434304|NCT00923091|590293673|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
163434305|NCT00923091|590293674|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
163434306|NCT00923091|590293675|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
163434307|NCT00923091|590293676|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
163434308|NCT00923091|590293664|FG000|Period VI (Open-Label)|Other Reason|0|||
163434309|NCT00923091|590293665|FG001|Period VI (Open-Label)|Other Reason|0|||
163434310|NCT00923091|590293666|FG002|Period VI (Open-Label)|Other Reason|0|||
163434311|NCT00923091|590293667|FG003|Period VI (Open-Label)|Other Reason|1|||
163434312|NCT00923091|590293668|FG004|Period VI (Open-Label)|Other Reason|1|||
163434313|NCT00923091|590293669|FG005|Period VI (Open-Label)|Other Reason|0|||
163434314|NCT00923091|590293670|FG006|Period VI (Open-Label)|Other Reason|0|||
163434315|NCT00923091|590293671|FG007|Period VI (Open-Label)|Other Reason|0|||
163434316|NCT00923091|590293672|FG008|Period VI (Open-Label)|Other Reason|0|||
163434317|NCT00923091|590293673|FG009|Period VI (Open-Label)|Other Reason|0|||
163434318|NCT00923091|590293674|FG010|Period VI (Open-Label)|Other Reason|0|||
163434319|NCT00923091|590293675|FG011|Period VI (Open-Label)|Other Reason|0|||
163434320|NCT00923091|590293676|FG012|Period VI (Open-Label)|Other Reason|0|||
163434321|NCT04246047|590293680|FG000|Overall Study|Death|50|||
163434322|NCT04246047|590293681|FG001|Overall Study|Death|77|||
163434323|NCT04246047|590293680|FG000|Overall Study|Lost to Follow-up|1|||
163434324|NCT04246047|590293681|FG001|Overall Study|Lost to Follow-up|3|||
163434325|NCT04246047|590293680|FG000|Overall Study|Physician Decision|4|||
163434326|NCT04246047|590293681|FG001|Overall Study|Physician Decision|10|||
163434327|NCT04246047|590293680|FG000|Overall Study|Withdrawal by Subject|19|||
163434328|NCT04246047|590293681|FG001|Overall Study|Withdrawal by Subject|26|||
163434329|NCT04246047|590293680|FG000|Overall Study|Ongoing|169|||
163434330|NCT04246047|590293681|FG001|Overall Study|Ongoing|135|||
163434331|NCT00754390|590293684|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
163434332|NCT00754390|590293684|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
163434333|NCT00754390|590293684|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
163434334|NCT00754390|590293684|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
163434335|NCT00847613|590293685|FG000|Overall Study|Ongoing at cut-off date|250|||
163434336|NCT00847613|590293686|FG001|Overall Study|Ongoing at cut-off date|265|||
163434337|NCT00847613|590293687|FG002|Overall Study|Ongoing at cut-off date|64|||
163434338|NCT00847613|590293688|FG003|Overall Study|Ongoing at cut-off date|64|||
163434339|NCT00847613|590293685|FG000|Overall Study|Death|1|||
163434340|NCT00847613|590293686|FG001|Overall Study|Death|1|||
163434341|NCT00847613|590293687|FG002|Overall Study|Death|0|||
163434342|NCT00847613|590293688|FG003|Overall Study|Death|0|||
163434343|NCT00847613|590293685|FG000|Overall Study|Adverse Event|36|||
163434344|NCT00847613|590293686|FG001|Overall Study|Adverse Event|26|||
163434345|NCT00847613|590293687|FG002|Overall Study|Adverse Event|5|||
163434346|NCT00847613|590293688|FG003|Overall Study|Adverse Event|6|||
163434347|NCT00847613|590293685|FG000|Overall Study|Lack of Efficacy|7|||
163434348|NCT00847613|590293686|FG001|Overall Study|Lack of Efficacy|3|||
163434349|NCT00847613|590293687|FG002|Overall Study|Lack of Efficacy|3|||
163434350|NCT00847613|590293688|FG003|Overall Study|Lack of Efficacy|1|||
163434351|NCT00847613|590293685|FG000|Overall Study|Study terminated by Sponsor|1|||
163434352|NCT00847613|590293686|FG001|Overall Study|Study terminated by Sponsor|0|||
163434353|NCT00847613|590293687|FG002|Overall Study|Study terminated by Sponsor|2|||
163434354|NCT00847613|590293688|FG003|Overall Study|Study terminated by Sponsor|1|||
163434355|NCT00847613|590293685|FG000|Overall Study|Lost to Follow-up|5|||
163434356|NCT00847613|590293686|FG001|Overall Study|Lost to Follow-up|0|||
163434357|NCT00847613|590293687|FG002|Overall Study|Lost to Follow-up|0|||
163434358|NCT00847613|590293688|FG003|Overall Study|Lost to Follow-up|3|||
163434359|NCT00847613|590293685|FG000|Overall Study|Protocol Violation|6|||
163434360|NCT00847613|590293686|FG001|Overall Study|Protocol Violation|6|||
163434361|NCT00847613|590293687|FG002|Overall Study|Protocol Violation|3|||
163434362|NCT00847613|590293688|FG003|Overall Study|Protocol Violation|1|||
163434363|NCT00847613|590293685|FG000|Overall Study|Pregnancy|1|||
163434364|NCT00847613|590293686|FG001|Overall Study|Pregnancy|1|||
163434365|NCT00847613|590293687|FG002|Overall Study|Pregnancy|0|||
163434366|NCT00847613|590293688|FG003|Overall Study|Pregnancy|0|||
163434367|NCT00847613|590293685|FG000|Overall Study|Site closure|1|||
163434368|NCT00847613|590293686|FG001|Overall Study|Site closure|0|||
163434369|NCT00847613|590293687|FG002|Overall Study|Site closure|0|||
163434370|NCT00847613|590293688|FG003|Overall Study|Site closure|1|||
163434371|NCT00847613|590293685|FG000|Overall Study|Withdrawal by Subject|8|||
163434372|NCT00847613|590293686|FG001|Overall Study|Withdrawal by Subject|11|||
163434373|NCT00847613|590293687|FG002|Overall Study|Withdrawal by Subject|2|||
163434374|NCT00847613|590293688|FG003|Overall Study|Withdrawal by Subject|2|||
163434375|NCT00847613|590293685|FG000|Overall Study|Participant moved|4|||
163434376|NCT00847613|590293686|FG001|Overall Study|Participant moved|1|||
163434377|NCT00847613|590293687|FG002|Overall Study|Participant moved|0|||
163434378|NCT00847613|590293688|FG003|Overall Study|Participant moved|0|||
163434379|NCT00847613|590293685|FG000|Overall Study|Sponsor request|0|||
163434380|NCT00847613|590293686|FG001|Overall Study|Sponsor request|1|||
163434381|NCT00847613|590293687|FG002|Overall Study|Sponsor request|0|||
163434382|NCT00847613|590293688|FG003|Overall Study|Sponsor request|0|||
163434383|NCT00847613|590293685|FG000|Overall Study|Randomized, but not treated|0|||
163434384|NCT00847613|590293686|FG001|Overall Study|Randomized, but not treated|3|||
163434385|NCT00847613|590293687|FG002|Overall Study|Randomized, but not treated|0|||
163434386|NCT00847613|590293688|FG003|Overall Study|Randomized, but not treated|0|||
163434387|NCT00847613|590293685|FG000|Overall Study|Other|1|||
163434388|NCT00847613|590293686|FG001|Overall Study|Other|1|||
163434389|NCT00847613|590293687|FG002|Overall Study|Other|2|||
163434390|NCT00847613|590293688|FG003|Overall Study|Other|0|||
163434391|NCT02111369|590293689|FG000|Overall Study|Lost to Follow-up|2|||
163434392|NCT02111369|590293689|FG000|Overall Study|Withdrawal by Subject|1|||
163434393|NCT00624338|590293692|FG000|Overall Study|Adverse Event|14|||
163434394|NCT00624338|590293693|FG001|Overall Study|Adverse Event|14|||
163434395|NCT00624338|590293694|FG002|Overall Study|Adverse Event|18|||
163434396|NCT00624338|590293692|FG000|Overall Study|Lost to Follow-up|1|||
163434397|NCT00624338|590293693|FG001|Overall Study|Lost to Follow-up|0|||
163434398|NCT00624338|590293694|FG002|Overall Study|Lost to Follow-up|0|||
163434399|NCT00624338|590293692|FG000|Overall Study|Lack of Efficacy|11|||
163434400|NCT00624338|590293693|FG001|Overall Study|Lack of Efficacy|3|||
163434401|NCT00624338|590293694|FG002|Overall Study|Lack of Efficacy|14|||
163434402|NCT00624338|590293692|FG000|Overall Study|Protocol Violation|3|||
163434403|NCT00624338|590293693|FG001|Overall Study|Protocol Violation|3|||
163434404|NCT00624338|590293694|FG002|Overall Study|Protocol Violation|2|||
163434405|NCT00624338|590293692|FG000|Overall Study|Death|0|||
163434406|NCT00624338|590293693|FG001|Overall Study|Death|2|||
163434407|NCT00624338|590293694|FG002|Overall Study|Death|0|||
163434408|NCT00624338|590293692|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
163434409|NCT00624338|590293693|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
163434410|NCT00624338|590293694|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
163434411|NCT00624338|590293692|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
163434412|NCT00624338|590293693|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
163434413|NCT00624338|590293694|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
163434414|NCT00624338|590293692|FG000|Overall Study|Other|15|||
163434415|NCT00624338|590293693|FG001|Overall Study|Other|5|||
163434416|NCT00624338|590293694|FG002|Overall Study|Other|9|||
163434417|NCT00624338|590293692|FG000|Overall Study|Randomized but not treated|2|||
163434418|NCT00624338|590293693|FG001|Overall Study|Randomized but not treated|1|||
163434419|NCT00624338|590293694|FG002|Overall Study|Randomized but not treated|3|||
163434420|NCT00072189|590293701|FG000|Overall Study|Withdrawal by Subject|1|||
163434421|NCT01933672|590293703|FG000|Metformin Run-in Period|Adverse Event|1|||
163434422|NCT01933672|590293704|FG001|Metformin Run-in Period|Adverse Event|0|||
163434423|NCT01933672|590293705|FG002|Metformin Run-in Period|Adverse Event|0|||
163434424|NCT01933672|590293706|FG003|Metformin Run-in Period|Adverse Event|0|||
163434425|NCT01933672|590293707|FG004|Metformin Run-in Period|Adverse Event|0|||
163434426|NCT01933672|590293708|FG005|Metformin Run-in Period|Adverse Event|0|||
163434427|NCT01933672|590293709|FG006|Metformin Run-in Period|Adverse Event|0|||
163434428|NCT01933672|590293703|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
163434429|NCT01933672|590293704|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
163434430|NCT01933672|590293705|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
163434431|NCT01933672|590293706|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
163434432|NCT01933672|590293707|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
163434433|NCT01933672|590293708|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
163434434|NCT01933672|590293709|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
163434435|NCT01933672|590293703|FG000|Metformin Run-in Period|Other|5|||
163434436|NCT01933672|590293704|FG001|Metformin Run-in Period|Other|0|||
163434437|NCT01933672|590293705|FG002|Metformin Run-in Period|Other|0|||
163434438|NCT01933672|590293706|FG003|Metformin Run-in Period|Other|0|||
163434439|NCT01933672|590293707|FG004|Metformin Run-in Period|Other|0|||
163434440|NCT01933672|590293708|FG005|Metformin Run-in Period|Other|0|||
163434441|NCT01933672|590293709|FG006|Metformin Run-in Period|Other|0|||
163434442|NCT01933672|590293703|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
163434443|NCT01933672|590293704|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
163434444|NCT01933672|590293705|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
163434445|NCT01933672|590293706|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
163434446|NCT01933672|590293707|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
163434447|NCT01933672|590293708|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
163434448|NCT01933672|590293709|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
163434449|NCT01933672|590293703|FG000|First Intervention Period (12-16 Days)|Other|0|||
163434450|NCT01933672|590293704|FG001|First Intervention Period (12-16 Days)|Other|0|||
163434451|NCT01933672|590293705|FG002|First Intervention Period (12-16 Days)|Other|1|||
163434452|NCT01933672|590293706|FG003|First Intervention Period (12-16 Days)|Other|0|||
163434453|NCT01933672|590293707|FG004|First Intervention Period (12-16 Days)|Other|0|||
163434454|NCT01933672|590293708|FG005|First Intervention Period (12-16 Days)|Other|1|||
163434455|NCT01933672|590293709|FG006|First Intervention Period (12-16 Days)|Other|0|||
163434456|NCT01933672|590293703|FG000|Second Intervention Period (12-16 Days)|Other|0|||
163434457|NCT01933672|590293704|FG001|Second Intervention Period (12-16 Days)|Other|1|||
163434458|NCT01933672|590293705|FG002|Second Intervention Period (12-16 Days)|Other|1|||
163434459|NCT01933672|590293706|FG003|Second Intervention Period (12-16 Days)|Other|0|||
163434460|NCT01933672|590293707|FG004|Second Intervention Period (12-16 Days)|Other|0|||
163434461|NCT01933672|590293708|FG005|Second Intervention Period (12-16 Days)|Other|0|||
163434462|NCT01933672|590293709|FG006|Second Intervention Period (12-16 Days)|Other|0|||
163434463|NCT01933672|590293703|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
163434464|NCT01933672|590293704|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
163434465|NCT01933672|590293705|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
163434466|NCT01933672|590293706|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
163434467|NCT01933672|590293707|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
163434468|NCT01933672|590293708|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
163434469|NCT01933672|590293709|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
163434470|NCT01933672|590293703|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
163434471|NCT01933672|590293704|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
163434472|NCT01933672|590293705|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
163434473|NCT01933672|590293706|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
163434474|NCT01933672|590293707|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
163434475|NCT01933672|590293708|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
163434476|NCT01933672|590293709|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
163434477|NCT00524303|590293710|FG000|Overall Study|Lost to Follow-up|6|||
163434478|NCT00524303|590293711|FG001|Overall Study|Lost to Follow-up|0|||
163434479|NCT00524303|590293712|FG002|Overall Study|Lost to Follow-up|3|||
163434480|NCT00524303|590293710|FG000|Overall Study|Protocol Violation|0|||
163434481|NCT00524303|590293711|FG001|Overall Study|Protocol Violation|1|||
163434482|NCT00524303|590293712|FG002|Overall Study|Protocol Violation|1|||
163434483|NCT00524303|590293710|FG000|Overall Study|Withdrawal by Subject|3|||
163434484|NCT00524303|590293711|FG001|Overall Study|Withdrawal by Subject|0|||
163434485|NCT00524303|590293712|FG002|Overall Study|Withdrawal by Subject|4|||
163434486|NCT00524303|590293710|FG000|Overall Study|Death|0|||
163434487|NCT00524303|590293711|FG001|Overall Study|Death|2|||
163434488|NCT00524303|590293712|FG002|Overall Study|Death|3|||
163434489|NCT00524303|590293710|FG000|Overall Study|Adverse Event|1|||
163434490|NCT00524303|590293711|FG001|Overall Study|Adverse Event|2|||
163434491|NCT00524303|590293712|FG002|Overall Study|Adverse Event|3|||
163434492|NCT00524303|590293710|FG000|Overall Study|Did not Complete Study Dosing|1|||
163434493|NCT00524303|590293711|FG001|Overall Study|Did not Complete Study Dosing|0|||
163434494|NCT00524303|590293712|FG002|Overall Study|Did not Complete Study Dosing|0|||
163434495|NCT00524303|590293710|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
163434496|NCT00524303|590293711|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
163434497|NCT00524303|590293712|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
163434498|NCT00524303|590293710|FG000|Overall Study|Disease Progression|0|||
163434499|NCT00524303|590293711|FG001|Overall Study|Disease Progression|4|||
163434500|NCT00524303|590293712|FG002|Overall Study|Disease Progression|1|||
163434501|NCT00524303|590293710|FG000|Overall Study|Disease Recurrence|0|||
163434502|NCT00524303|590293711|FG001|Overall Study|Disease Recurrence|1|||
163434503|NCT00524303|590293712|FG002|Overall Study|Disease Recurrence|0|||
163434504|NCT00524303|590293710|FG000|Overall Study|Sponsor Request|0|||
163434505|NCT00524303|590293711|FG001|Overall Study|Sponsor Request|0|||
163434506|NCT00524303|590293712|FG002|Overall Study|Sponsor Request|1|||
163434507|NCT00524303|590293710|FG000|Overall Study|Physician Decision|0|||
163434508|NCT00524303|590293711|FG001|Overall Study|Physician Decision|0|||
163434509|NCT00524303|590293712|FG002|Overall Study|Physician Decision|1|||
163434510|NCT00524303|590293710|FG000|Overall Study|Completed 5 years|0|||
163434511|NCT00524303|590293711|FG001|Overall Study|Completed 5 years|0|||
163434512|NCT00524303|590293712|FG002|Overall Study|Completed 5 years|1|||
163434513|NCT00970294|590293716|FG000|Overall Study|Physician Decision|4|||
163434514|NCT00970294|590293716|FG000|Overall Study|Withdrawal by Subject|1|||
163434515|NCT01877655|590293719|FG000|Overall Study|Death|57|||
163434516|NCT01877655|590293720|FG001|Overall Study|Death|52|||
163434517|NCT01877655|590293719|FG000|Overall Study|Withdrawal by Subject|18|||
163434518|NCT01877655|590293720|FG001|Overall Study|Withdrawal by Subject|26|||
163434519|NCT01877655|590293719|FG000|Overall Study|Physician Decision|11|||
163434520|NCT01877655|590293720|FG001|Overall Study|Physician Decision|10|||
163434521|NCT01877655|590293719|FG000|Overall Study|Miscellaneous|4|||
163434522|NCT01877655|590293720|FG001|Overall Study|Miscellaneous|4|||
163434523|NCT01877655|590293719|FG000|Overall Study|Randomized but Never Received Drug|8|||
163434524|NCT01877655|590293720|FG001|Overall Study|Randomized but Never Received Drug|5|||
163434525|NCT00095121|590293721|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
163434526|NCT00095121|590293722|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
163434527|NCT00095121|590293721|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
163434528|NCT00095121|590293722|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
163434529|NCT03567187|590293726|FG000|Overall Study|Lost to Follow-up|18|||
163434530|NCT03497689|590293727|FG000|Overall Study|Adverse Event|2|||
163434531|NCT03497689|590293727|FG000|Overall Study|Death|1|||
163434532|NCT03497689|590293727|FG000|Overall Study|Physician Decision|1|||
163434533|NCT03497689|590293727|FG000|Overall Study|Withdrawal by Subject|1|||
163434534|NCT03497689|590293727|FG000|Overall Study|Protocol Violation|2|||
163434535|NCT05176847|590294582|FG000|Overall Study|Lost to Follow-up|23|||
163434536|NCT05176847|590294583|FG001|Overall Study|Lost to Follow-up|36|||
163434537|NCT05176847|590294582|FG000|Overall Study|Withdrawal by Subject|7|||
163434538|NCT05176847|590294583|FG001|Overall Study|Withdrawal by Subject|12|||
163434539|NCT05176847|590294582|FG000|Overall Study|Removed from analysis|1|||
163434540|NCT05176847|590294583|FG001|Overall Study|Removed from analysis|0|||
163434541|NCT02562235|590294584|FG000|Overall Study|Adverse Event|3|||
163434542|NCT05369208|590294585|FG000|Core Phase|Prohibited Medication Required|2|||
163434543|NCT05369208|590294585|FG000|Core Phase|Adverse Event|1|||
163434544|NCT05369208|590294585|FG000|Core Phase|Lack of Efficacy|1|||
163434545|NCT05441670|590294586|FG000|Overall Study|Two participants completed intervention but not post-test due to ICU admit and family challenges.|0|||
163434546|NCT05441670|590294587|FG001|Overall Study|Two participants completed intervention but not post-test due to ICU admit and family challenges.|2|||
163434547|NCT02089737|590294590|FG000|Overall Study|Survey form not completed|5|||
163434548|NCT02089737|590294590|FG000|Overall Study|Not treated|1|||
163434549|NCT00744055|590294591|FG000|Overall Study|Withdrawal by Subject|6|||
163434550|NCT00744055|590294592|FG001|Overall Study|Withdrawal by Subject|9|||
163434551|NCT00744055|590294591|FG000|Overall Study|Lack of Efficacy|0|||
163434552|NCT00744055|590294592|FG001|Overall Study|Lack of Efficacy|1|||
163434553|NCT00744055|590294591|FG000|Overall Study|Physician Decision|0|||
163434554|NCT00744055|590294592|FG001|Overall Study|Physician Decision|2|||
163434555|NCT00744055|590294591|FG000|Overall Study|Protocol Violation|1|||
163434556|NCT00744055|590294592|FG001|Overall Study|Protocol Violation|1|||
163434557|NCT00744055|590294591|FG000|Overall Study|Lost to Follow-up|0|||
163434558|NCT00744055|590294592|FG001|Overall Study|Lost to Follow-up|1|||
163434559|NCT05248945|590294593|FG000|Overall Study|Adverse Event|1|||
163434560|NCT05248945|590294593|FG000|Overall Study|Elevated Gamma-Glutamyl Transferase (GGT)|1|||
163434561|NCT05525975|590294594|FG000|Overall Study|Surgery cancellation|4|||
163434562|NCT05525975|590294595|FG001|Overall Study|Surgery cancellation|5|||
163434563|NCT05525975|590294594|FG000|Overall Study|didn't fill prescription|1|||
163434564|NCT05525975|590294595|FG001|Overall Study|didn't fill prescription|0|||
163434565|NCT05525975|590294594|FG000|Overall Study|Withdrawal by Subject|0|||
163434566|NCT05525975|590294595|FG001|Overall Study|Withdrawal by Subject|3|||
163434567|NCT01123889|590294596|FG000|Overall Study|Lost to Follow-up|3|||
163434568|NCT01123889|590294597|FG001|Overall Study|Lost to Follow-up|1|||
163434569|NCT05090423|590294598|FG000|Overall Study|Because of the covid-19|3|||
163434570|NCT05090423|590294599|FG001|Overall Study|Because of the covid-19|2|||
163434571|NCT05090423|590294598|FG000|Overall Study|repeated ankle sprain in daily of life|0|||
163434572|NCT05090423|590294599|FG001|Overall Study|repeated ankle sprain in daily of life|1|||
163434573|NCT05733286|590294600|FG000|Overall Study|Never received study drug|2|||
163434574|NCT05733286|590294601|FG001|Overall Study|Never received study drug|3|||
163434575|NCT00685178|590294604|FG000|Overall Study|Adverse Event|1|||
163434576|NCT00685178|590294605|FG001|Overall Study|Adverse Event|5|||
163434577|NCT00685178|590294606|FG002|Overall Study|Adverse Event|2|||
163434578|NCT00685178|590294607|FG003|Overall Study|Adverse Event|4|||
163434579|NCT00685178|590294604|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
163434580|NCT00685178|590294605|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
163434581|NCT00685178|590294606|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
163434582|NCT00685178|590294607|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
163434583|NCT00685178|590294604|FG000|Overall Study|voluntary study discharge|4|||
163434584|NCT00685178|590294605|FG001|Overall Study|voluntary study discharge|5|||
163434585|NCT00685178|590294606|FG002|Overall Study|voluntary study discharge|1|||
163434586|NCT00685178|590294607|FG003|Overall Study|voluntary study discharge|1|||
163434587|NCT00685178|590294604|FG000|Overall Study|incarcerated|1|||
163434588|NCT00685178|590294605|FG001|Overall Study|incarcerated|3|||
163434589|NCT00685178|590294606|FG002|Overall Study|incarcerated|7|||
163434590|NCT00685178|590294607|FG003|Overall Study|incarcerated|0|||
163434591|NCT00685178|590294604|FG000|Overall Study|administrative (disciplinary) discharge|0|||
163434592|NCT00685178|590294605|FG001|Overall Study|administrative (disciplinary) discharge|1|||
163434593|NCT00685178|590294606|FG002|Overall Study|administrative (disciplinary) discharge|0|||
163434594|NCT00685178|590294607|FG003|Overall Study|administrative (disciplinary) discharge|2|||
163434595|NCT00685178|590294604|FG000|Overall Study|Pregnancy|0|||
163434596|NCT00685178|590294605|FG001|Overall Study|Pregnancy|0|||
163434597|NCT00685178|590294606|FG002|Overall Study|Pregnancy|0|||
163434598|NCT00685178|590294607|FG003|Overall Study|Pregnancy|1|||
163434599|NCT05098015|590294611|FG000|Overall Study|Death|1|||
163434600|NCT05098015|590294612|FG001|Overall Study|Death|1|||
163434601|NCT05098015|590294613|FG002|Overall Study|Death|3|||
163434602|NCT05098015|590294614|FG003|Overall Study|Death|0|||
163434603|NCT05098015|590294611|FG000|Overall Study|Lost to Follow-up|1|||
163434604|NCT05098015|590294612|FG001|Overall Study|Lost to Follow-up|1|||
163434605|NCT05098015|590294613|FG002|Overall Study|Lost to Follow-up|3|||
163434606|NCT05098015|590294614|FG003|Overall Study|Lost to Follow-up|3|||
163434607|NCT05098015|590294611|FG000|Overall Study|Withdrawal by Subject|0|||
163434608|NCT05098015|590294612|FG001|Overall Study|Withdrawal by Subject|1|||
163434609|NCT05098015|590294613|FG002|Overall Study|Withdrawal by Subject|0|||
163434610|NCT05098015|590294614|FG003|Overall Study|Withdrawal by Subject|2|||
163434611|NCT01059812|590294622|FG000|Overall Study|Adverse Event|9|||
163434612|NCT01059812|590294623|FG001|Overall Study|Adverse Event|5|||
163434613|NCT01059812|590294622|FG000|Overall Study|Lack of Efficacy|2|||
163434614|NCT01059812|590294623|FG001|Overall Study|Lack of Efficacy|2|||
163434615|NCT01059812|590294622|FG000|Overall Study|Protocol Violation|3|||
163434616|NCT01059812|590294623|FG001|Overall Study|Protocol Violation|1|||
163434617|NCT01059812|590294622|FG000|Overall Study|Withdrawal Criteria|9|||
163434618|NCT01059812|590294623|FG001|Overall Study|Withdrawal Criteria|4|||
163434619|NCT01059812|590294622|FG000|Overall Study|Unclassified|14|||
163434620|NCT01059812|590294623|FG001|Overall Study|Unclassified|4|||
163434621|NCT05299892|590294624|FG000|Overall Study|Withdrawal by Subject|2|||
163434622|NCT00149214|590294625|FG000|Overall Study|Adverse Event|12|||
163434623|NCT00149214|590294626|FG001|Overall Study|Adverse Event|9|||
163434624|NCT00149214|590294625|FG000|Overall Study|Withdrawal by Subject|4|||
163434625|NCT00149214|590294626|FG001|Overall Study|Withdrawal by Subject|1|||
163434626|NCT00149214|590294625|FG000|Overall Study|Physician Decision|3|||
163434627|NCT00149214|590294626|FG001|Overall Study|Physician Decision|3|||
163434628|NCT00149214|590294625|FG000|Overall Study|Sponsor Decision|0|||
163434629|NCT00149214|590294626|FG001|Overall Study|Sponsor Decision|1|||
163434630|NCT00149214|590294625|FG000|Overall Study|Progressive Disease|7|||
163434631|NCT00149214|590294626|FG001|Overall Study|Progressive Disease|3|||
163434632|NCT03334214|590294627|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
163434633|NCT03334214|590294628|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
163434634|NCT03334214|590294627|FG000|Overall Study|Withdrawal by Subject|0|||
163434635|NCT03334214|590294628|FG001|Overall Study|Withdrawal by Subject|1|||
163434636|NCT03334214|590294627|FG000|Overall Study|Other|1|||
163434637|NCT03334214|590294628|FG001|Overall Study|Other|0|||
163434638|NCT05655832|590294632|FG000|Overall Study|Not mentioned|0|||
163434639|NCT05655832|590294633|FG001|Overall Study|Not mentioned|1|||
163434640|NCT05655832|590294632|FG000|Overall Study|Withdrawal by Subject|0|||
163434641|NCT05655832|590294633|FG001|Overall Study|Withdrawal by Subject|1|||
163434642|NCT05655832|590294632|FG000|Overall Study|Protocol non-compliance|0|||
163434643|NCT05655832|590294633|FG001|Overall Study|Protocol non-compliance|1|||
163434644|NCT04516967|590294636|FG000|Core Phase|Adverse Event|2|||
163434645|NCT04516967|590294637|FG001|Core Phase|Adverse Event|1|||
163434646|NCT04516967|590294638|FG002|Core Phase|Adverse Event|0|||
163434647|NCT04516967|590294636|FG000|Core Phase|Physician Decision|1|||
163434648|NCT04516967|590294637|FG001|Core Phase|Physician Decision|1|||
163434649|NCT04516967|590294638|FG002|Core Phase|Physician Decision|0|||
163434650|NCT04516967|590294636|FG000|Core Phase|Lack of Efficacy|7|||
163434651|NCT04516967|590294637|FG001|Core Phase|Lack of Efficacy|18|||
163434652|NCT04516967|590294638|FG002|Core Phase|Lack of Efficacy|0|||
163434653|NCT05916170|590294639|FG000|No Warning Control|Lost to Follow-up|12|||
163434654|NCT05916170|590294639|FG000|No Warning Control|Withdrawal by Subject|15|||
163434655|NCT05916170|590294639|FG000|No Warning Control|Noncompliance with protocol|1|||
163434656|NCT05916170|590294639|FG000|Health Warning Intervention|Lost to Follow-up|15|||
163434657|NCT05916170|590294639|FG000|Health Warning Intervention|Withdrawal by Subject|10|||
163434658|NCT05916170|590294639|FG000|Health Warning Intervention|Noncompliance with protocol|14|||
163434659|NCT04576949|590294640|FG000|Overall Study|Adverse Event|1|||
163434660|NCT04576949|590294641|FG001|Overall Study|Adverse Event|3|||
163434661|NCT04576949|590294642|FG002|Overall Study|Adverse Event|2|||
163434662|NCT04576949|590294640|FG000|Overall Study|Withdrawal by Subject|41|||
163434663|NCT04576949|590294641|FG001|Overall Study|Withdrawal by Subject|26|||
163434664|NCT04576949|590294642|FG002|Overall Study|Withdrawal by Subject|18|||
163434665|NCT04576949|590294640|FG000|Overall Study|Physician Decision|3|||
163434666|NCT04576949|590294641|FG001|Overall Study|Physician Decision|0|||
163434667|NCT04576949|590294642|FG002|Overall Study|Physician Decision|0|||
163434668|NCT04576949|590294640|FG000|Overall Study|Death|0|||
163434669|NCT04576949|590294641|FG001|Overall Study|Death|1|||
163434670|NCT04576949|590294642|FG002|Overall Study|Death|0|||
163434671|NCT04576949|590294640|FG000|Overall Study|Lost to Follow-up|29|||
163434672|NCT04576949|590294641|FG001|Overall Study|Lost to Follow-up|37|||
163434673|NCT04576949|590294642|FG002|Overall Study|Lost to Follow-up|24|||
163434674|NCT04576949|590294640|FG000|Overall Study|Other, Not Specified|2|||
163434675|NCT04576949|590294641|FG001|Overall Study|Other, Not Specified|3|||
163434676|NCT04576949|590294642|FG002|Overall Study|Other, Not Specified|1|||
163434677|NCT04576949|590294640|FG000|Overall Study|Other|1|||
163434678|NCT04576949|590294641|FG001|Overall Study|Other|0|||
163434679|NCT04576949|590294642|FG002|Overall Study|Other|0|||
163434680|NCT03556904|590294645|FG000|Overall Study|Disease Progression after treatment started|3|||
163434681|NCT03556904|590294646|FG001|Overall Study|Disease Progression after treatment started|3|||
163434682|NCT03556904|590294645|FG000|Overall Study|Sponsor Termination|2|||
163434683|NCT03556904|590294646|FG001|Overall Study|Sponsor Termination|2|||
163434684|NCT03556904|590294645|FG000|Overall Study|Physician Decision|2|||
163434685|NCT03556904|590294646|FG001|Overall Study|Physician Decision|0|||
163434686|NCT03556904|590294645|FG000|Overall Study|Withdrawal by Subject|1|||
163434687|NCT03556904|590294646|FG001|Overall Study|Withdrawal by Subject|0|||
163434688|NCT05243680|590294647|FG000|Overall Study|Adverse Event|1|||
163434689|NCT05243680|590294648|FG001|Overall Study|Adverse Event|1|||
163434690|NCT05243680|590294647|FG000|Overall Study|Lack of Efficacy|1|||
163434691|NCT05243680|590294648|FG001|Overall Study|Lack of Efficacy|1|||
163434692|NCT05243680|590294647|FG000|Overall Study|Lost to Follow-up|5|||
163434693|NCT05243680|590294648|FG001|Overall Study|Lost to Follow-up|4|||
163434694|NCT05243680|590294647|FG000|Overall Study|Physician Decision|1|||
163434695|NCT05243680|590294648|FG001|Overall Study|Physician Decision|0|||
163434696|NCT05243680|590294647|FG000|Overall Study|Withdrawal by Subject|3|||
163434697|NCT05243680|590294648|FG001|Overall Study|Withdrawal by Subject|10|||
163434698|NCT05243680|590294647|FG000|Overall Study|Data integrity and GCP violations|4|||
163434699|NCT05243680|590294648|FG001|Overall Study|Data integrity and GCP violations|8|||
163434700|NCT05642442|590294649|FG000|Overall Study|Adverse Event|0|||
163434701|NCT05642442|590294650|FG001|Overall Study|Adverse Event|1|||
163434702|NCT05642442|590294649|FG000|Overall Study|Lack of Efficacy|0|||
163434703|NCT05642442|590294650|FG001|Overall Study|Lack of Efficacy|1|||
163434704|NCT05642442|590294649|FG000|Overall Study|Withdrawal by Subject|13|||
163434705|NCT05642442|590294650|FG001|Overall Study|Withdrawal by Subject|9|||
163434706|NCT05642442|590294649|FG000|Overall Study|Other|5|||
163434707|NCT05642442|590294650|FG001|Overall Study|Other|2|||
163434708|NCT05642442|590294649|FG000|Overall Study|Lost to Follow-up|0|||
163434709|NCT05642442|590294650|FG001|Overall Study|Lost to Follow-up|1|||
163434710|NCT03794986|590294651|FG000|Overall Study|0 Sessions Attended|34|||
163434711|NCT03794986|590294652|FG001|Overall Study|0 Sessions Attended|37|||
163434712|NCT03794986|590294651|FG000|Overall Study|Withdrawal by Subject|4|||
163434713|NCT03794986|590294652|FG001|Overall Study|Withdrawal by Subject|6|||
163434714|NCT03794986|590294651|FG000|Overall Study|Protocol Violation|1|||
163434715|NCT03794986|590294652|FG001|Overall Study|Protocol Violation|0|||
163434716|NCT00550238|590294655|FG000|Overall Study|Adverse Event|88|||
163434717|NCT00550238|590294655|FG000|Overall Study|Death|34|||
163434718|NCT00550238|590294655|FG000|Overall Study|Disease progression|46|||
163434719|NCT00550238|590294655|FG000|Overall Study|Withdrawal by Subject|167|||
163434720|NCT00550238|590294655|FG000|Overall Study|Physician Decision|31|||
163434721|NCT00550238|590294655|FG000|Overall Study|Patient noncompliance|25|||
163434722|NCT00550238|590294655|FG000|Overall Study|Lost to Follow-up|13|||
163434723|NCT00550238|590294655|FG000|Overall Study|Sponsor decision|55|||
163434724|NCT05270265|590294658|FG000|Overall Study|Lost to Follow-up|0|||
163434725|NCT05270265|590294659|FG001|Overall Study|Lost to Follow-up|1|||
163434726|NCT05270265|590294660|FG002|Overall Study|Lost to Follow-up|0|||
163434727|NCT02296684|590294663|FG000|Overall Study|Withdrawal by Subject|0|||
163434728|NCT02296684|590294664|FG001|Overall Study|Withdrawal by Subject|1|||
163434729|NCT02296684|590294665|FG002|Overall Study|Withdrawal by Subject|1|||
163434730|NCT02296684|590294663|FG000|Overall Study|Death|2|||
163434731|NCT02296684|590294664|FG001|Overall Study|Death|0|||
163434732|NCT02296684|590294665|FG002|Overall Study|Death|0|||
163434733|NCT03734666|590295037|FG000|Overall Study|Other|7|||
163434734|NCT03734666|590295038|FG001|Overall Study|Other|4|||
163434735|NCT03734666|590295037|FG000|Overall Study|Lost to Follow-up|12|||
163434736|NCT03734666|590295038|FG001|Overall Study|Lost to Follow-up|12|||
163434737|NCT05866185|590295039|FG000|Overall Study|Lost to Follow-up|2|||
163434738|NCT05866185|590295040|FG001|Overall Study|Lost to Follow-up|4|||
163434739|NCT05866185|590295041|FG002|Overall Study|Lost to Follow-up|4|||
163434740|NCT05866185|590295042|FG003|Overall Study|Lost to Follow-up|6|||
163434741|NCT03246529|590295043|FG000|Core Study (until 100 d post-transplant)|Adverse Event|0|||
163434742|NCT03246529|590295044|FG001|Core Study (until 100 d post-transplant)|Adverse Event|2|||
163434743|NCT03246529|590295045|FG002|Core Study (until 100 d post-transplant)|Adverse Event|0|||
163434744|NCT03246529|590295043|FG000|Core Study (until 100 d post-transplant)|Lost to Follow-up|0|||
163434745|NCT03246529|590295044|FG001|Core Study (until 100 d post-transplant)|Lost to Follow-up|1|||
163434746|NCT03246529|590295045|FG002|Core Study (until 100 d post-transplant)|Lost to Follow-up|1|||
163434747|NCT03246529|590295043|FG000|Core Study (until 100 d post-transplant)|Other Reasons|0|||
163434748|NCT03246529|590295044|FG001|Core Study (until 100 d post-transplant)|Other Reasons|2|||
163434749|NCT03246529|590295045|FG002|Core Study (until 100 d post-transplant)|Other Reasons|2|||
163434750|NCT03246529|590295043|FG000|Core Study (until 100 d post-transplant)|Physician Decision|0|||
163434751|NCT03246529|590295044|FG001|Core Study (until 100 d post-transplant)|Physician Decision|0|||
163434752|NCT03246529|590295045|FG002|Core Study (until 100 d post-transplant)|Physician Decision|1|||
163434753|NCT03246529|590295043|FG000|Core Study (until 100 d post-transplant)|Withdrawal by Subject|0|||
163434754|NCT03246529|590295044|FG001|Core Study (until 100 d post-transplant)|Withdrawal by Subject|1|||
163434755|NCT03246529|590295045|FG002|Core Study (until 100 d post-transplant)|Withdrawal by Subject|4|||
163434756|NCT03246529|590295043|FG000|Follow-up period at 1 year FU Completion|Disease progression|2|||
163434757|NCT03246529|590295044|FG001|Follow-up period at 1 year FU Completion|Disease progression|1|||
163434758|NCT03246529|590295045|FG002|Follow-up period at 1 year FU Completion|Disease progression|1|||
163434759|NCT03246529|590295043|FG000|Follow-up period at 1 year FU Completion|Lost to Follow-up|1|||
163434760|NCT03246529|590295044|FG001|Follow-up period at 1 year FU Completion|Lost to Follow-up|3|||
163434761|NCT03246529|590295045|FG002|Follow-up period at 1 year FU Completion|Lost to Follow-up|0|||
163434762|NCT03246529|590295043|FG000|Follow-up period at 1 year FU Completion|Withdrawal by Subject|0|||
163434763|NCT03246529|590295044|FG001|Follow-up period at 1 year FU Completion|Withdrawal by Subject|3|||
163434764|NCT03246529|590295045|FG002|Follow-up period at 1 year FU Completion|Withdrawal by Subject|0|||
163434765|NCT03246529|590295043|FG000|Follow-up period at 1 year FU Completion|Death|0|||
163434766|NCT03246529|590295044|FG001|Follow-up period at 1 year FU Completion|Death|0|||
163434767|NCT03246529|590295045|FG002|Follow-up period at 1 year FU Completion|Death|1|||
163434768|NCT05561673|590295050|FG000|Overall Study|Lost to Follow-up|0|||
163434769|NCT05561673|590295051|FG001|Overall Study|Lost to Follow-up|1|||
163434770|NCT05561673|590295052|FG002|Overall Study|Lost to Follow-up|0|||
163434771|NCT05561673|590295053|FG003|Overall Study|Lost to Follow-up|1|||
163434772|NCT05561673|590295054|FG004|Overall Study|Lost to Follow-up|0|||
163434773|NCT05561673|590295050|FG000|Overall Study|Consent withdrawal, not due to (S)AE|0|||
163434774|NCT05561673|590295051|FG001|Overall Study|Consent withdrawal, not due to (S)AE|1|||
163434775|NCT05561673|590295052|FG002|Overall Study|Consent withdrawal, not due to (S)AE|0|||
163434776|NCT05561673|590295053|FG003|Overall Study|Consent withdrawal, not due to (S)AE|0|||
163434777|NCT05561673|590295054|FG004|Overall Study|Consent withdrawal, not due to (S)AE|0|||
163434778|NCT05561673|590295050|FG000|Overall Study|Other|1|||
163434779|NCT05561673|590295051|FG001|Overall Study|Other|0|||
163434780|NCT05561673|590295052|FG002|Overall Study|Other|1|||
163434781|NCT05561673|590295053|FG003|Overall Study|Other|0|||
163434782|NCT05561673|590295054|FG004|Overall Study|Other|0|||
163434783|NCT00001259|590296976|FG000|Study 2|Adverse Event|0|||
163434784|NCT00001259|590296977|FG001|Study 2|Adverse Event|0|||
163434785|NCT00001259|590296978|FG002|Study 2|Adverse Event|0|||
163434786|NCT00001259|590296979|FG003|Study 2|Adverse Event|0|||
163434787|NCT00001259|590296980|FG004|Study 2|Adverse Event|2|||
163434788|NCT00001259|590296981|FG005|Study 2|Adverse Event|0|||
163434789|NCT00001259|590296982|FG006|Study 2|Adverse Event|0|||
163434790|NCT01582282|590296983|FG000|Overall Study|Adverse Event|1|||
163434791|NCT01582282|590296984|FG001|Overall Study|Adverse Event|1|||
163434792|NCT01582282|590296985|FG002|Overall Study|Adverse Event|0|||
163434793|NCT01582282|590296983|FG000|Overall Study|Lost to Follow-up|1|||
163434794|NCT01582282|590296984|FG001|Overall Study|Lost to Follow-up|0|||
163434795|NCT01582282|590296985|FG002|Overall Study|Lost to Follow-up|0|||
163434796|NCT01582282|590296983|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
163434797|NCT01582282|590296984|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
163434798|NCT01582282|590296985|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
163434799|NCT04426630|590296987|FG000|Overall Study|Death|4|||
163434800|NCT04426630|590296987|FG000|Overall Study|Lost to Follow-up|2|||
163434801|NCT02786537|590296988|FG000|As Randomized|Adverse Event|0|||
163434802|NCT02786537|590296989|FG001|As Randomized|Adverse Event|11|||
163434803|NCT02786537|590296990|FG002|As Randomized|Adverse Event|0|||
163434804|NCT02786537|590296991|FG003|As Randomized|Adverse Event|4|||
163434805|NCT02786537|590296992|FG004|As Randomized|Adverse Event|6|||
163434806|NCT02786537|590296993|FG005|As Randomized|Adverse Event|2|||
163434807|NCT02786537|590296988|FG000|As Randomized|Lack of Efficacy|0|||
163434808|NCT02786537|590296989|FG001|As Randomized|Lack of Efficacy|0|||
163434809|NCT02786537|590296990|FG002|As Randomized|Lack of Efficacy|0|||
163434810|NCT02786537|590296991|FG003|As Randomized|Lack of Efficacy|1|||
163434811|NCT02786537|590296992|FG004|As Randomized|Lack of Efficacy|0|||
163434812|NCT02786537|590296993|FG005|As Randomized|Lack of Efficacy|0|||
163434813|NCT02786537|590296988|FG000|As Randomized|Withdrawal by Subject|1|||
163434814|NCT02786537|590296989|FG001|As Randomized|Withdrawal by Subject|2|||
163434815|NCT02786537|590296990|FG002|As Randomized|Withdrawal by Subject|0|||
163434816|NCT02786537|590296991|FG003|As Randomized|Withdrawal by Subject|1|||
163434817|NCT02786537|590296992|FG004|As Randomized|Withdrawal by Subject|1|||
163434818|NCT02786537|590296993|FG005|As Randomized|Withdrawal by Subject|0|||
163434819|NCT02786537|590296988|FG000|As Randomized|Death|0|||
163434820|NCT02786537|590296989|FG001|As Randomized|Death|2|||
163434821|NCT02786537|590296990|FG002|As Randomized|Death|0|||
163434822|NCT02786537|590296991|FG003|As Randomized|Death|3|||
163434823|NCT02786537|590296992|FG004|As Randomized|Death|1|||
163434824|NCT02786537|590296993|FG005|As Randomized|Death|0|||
163434825|NCT02786537|590296988|FG000|As Randomized|Non-compliance with study drug|1|||
163434826|NCT02786537|590296989|FG001|As Randomized|Non-compliance with study drug|11|||
163434827|NCT02786537|590296990|FG002|As Randomized|Non-compliance with study drug|0|||
163434828|NCT02786537|590296991|FG003|As Randomized|Non-compliance with study drug|1|||
163434829|NCT02786537|590296992|FG004|As Randomized|Non-compliance with study drug|0|||
163434830|NCT02786537|590296993|FG005|As Randomized|Non-compliance with study drug|1|||
163434831|NCT02786537|590296988|FG000|As Randomized|Lost to treatment follow-up|4|||
163434832|NCT02786537|590296989|FG001|As Randomized|Lost to treatment follow-up|32|||
163434833|NCT02786537|590296990|FG002|As Randomized|Lost to treatment follow-up|0|||
163434834|NCT02786537|590296991|FG003|As Randomized|Lost to treatment follow-up|24|||
163434835|NCT02786537|590296992|FG004|As Randomized|Lost to treatment follow-up|4|||
163434836|NCT02786537|590296993|FG005|As Randomized|Lost to treatment follow-up|4|||
163434837|NCT02786537|590296988|FG000|As Randomized|Incarceration|0|||
163434838|NCT02786537|590296989|FG001|As Randomized|Incarceration|1|||
163434839|NCT02786537|590296990|FG002|As Randomized|Incarceration|0|||
163434840|NCT02786537|590296991|FG003|As Randomized|Incarceration|0|||
163434841|NCT02786537|590296992|FG004|As Randomized|Incarceration|0|||
163434842|NCT02786537|590296993|FG005|As Randomized|Incarceration|0|||
163434843|NCT02786537|590296988|FG000|As Randomized|Opiate Dependency Relapse|0|||
163434844|NCT02786537|590296989|FG001|As Randomized|Opiate Dependency Relapse|1|||
163434845|NCT02786537|590296990|FG002|As Randomized|Opiate Dependency Relapse|0|||
163434846|NCT02786537|590296991|FG003|As Randomized|Opiate Dependency Relapse|0|||
163434847|NCT02786537|590296992|FG004|As Randomized|Opiate Dependency Relapse|0|||
163434848|NCT02786537|590296993|FG005|As Randomized|Opiate Dependency Relapse|0|||
163434849|NCT02786537|590296988|FG000|As Randomized|HCV drugs stolen from pt|0|||
163434850|NCT02786537|590296989|FG001|As Randomized|HCV drugs stolen from pt|1|||
163434851|NCT02786537|590296990|FG002|As Randomized|HCV drugs stolen from pt|0|||
163434852|NCT02786537|590296991|FG003|As Randomized|HCV drugs stolen from pt|0|||
163434853|NCT02786537|590296992|FG004|As Randomized|HCV drugs stolen from pt|0|||
163434854|NCT02786537|590296993|FG005|As Randomized|HCV drugs stolen from pt|0|||
163434855|NCT02786537|590296988|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
163434856|NCT02786537|590296989|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
163434857|NCT02786537|590296990|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
163434858|NCT02786537|590296991|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
163434859|NCT02786537|590296992|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
163434860|NCT02786537|590296993|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
163434861|NCT02786537|590296988|FG000|As Randomized|Subject lost insurance|0|||
163434862|NCT02786537|590296989|FG001|As Randomized|Subject lost insurance|0|||
163434863|NCT02786537|590296990|FG002|As Randomized|Subject lost insurance|0|||
163434864|NCT02786537|590296991|FG003|As Randomized|Subject lost insurance|1|||
163434865|NCT02786537|590296992|FG004|As Randomized|Subject lost insurance|0|||
163434866|NCT02786537|590296993|FG005|As Randomized|Subject lost insurance|0|||
163434867|NCT02786537|590296988|FG000|As Treated|Adverse Event|0|||
163434868|NCT02786537|590296989|FG001|As Treated|Adverse Event|11|||
163434869|NCT02786537|590296990|FG002|As Treated|Adverse Event|0|||
163434870|NCT02786537|590296991|FG003|As Treated|Adverse Event|4|||
163434871|NCT02786537|590296992|FG004|As Treated|Adverse Event|6|||
163434872|NCT02786537|590296993|FG005|As Treated|Adverse Event|2|||
163434873|NCT02786537|590296988|FG000|As Treated|Death|0|||
163434874|NCT02786537|590296989|FG001|As Treated|Death|2|||
163434875|NCT02786537|590296990|FG002|As Treated|Death|0|||
163434876|NCT02786537|590296991|FG003|As Treated|Death|3|||
163434877|NCT02786537|590296992|FG004|As Treated|Death|1|||
163434878|NCT02786537|590296993|FG005|As Treated|Death|0|||
163434879|NCT02786537|590296988|FG000|As Treated|Lack of Efficacy|0|||
163434880|NCT02786537|590296989|FG001|As Treated|Lack of Efficacy|0|||
163434881|NCT02786537|590296990|FG002|As Treated|Lack of Efficacy|0|||
163434882|NCT02786537|590296991|FG003|As Treated|Lack of Efficacy|1|||
163434883|NCT02786537|590296992|FG004|As Treated|Lack of Efficacy|0|||
163434884|NCT02786537|590296993|FG005|As Treated|Lack of Efficacy|0|||
163434885|NCT02786537|590296988|FG000|As Treated|Lost to Follow-up|4|||
163434886|NCT02786537|590296989|FG001|As Treated|Lost to Follow-up|32|||
163434887|NCT02786537|590296990|FG002|As Treated|Lost to Follow-up|0|||
163434888|NCT02786537|590296991|FG003|As Treated|Lost to Follow-up|25|||
163434889|NCT02786537|590296992|FG004|As Treated|Lost to Follow-up|4|||
163434890|NCT02786537|590296993|FG005|As Treated|Lost to Follow-up|4|||
163434891|NCT02786537|590296988|FG000|As Treated|Non-compliance with study drug|1|||
163434892|NCT02786537|590296989|FG001|As Treated|Non-compliance with study drug|11|||
163434893|NCT02786537|590296990|FG002|As Treated|Non-compliance with study drug|0|||
163434894|NCT02786537|590296991|FG003|As Treated|Non-compliance with study drug|1|||
163434895|NCT02786537|590296992|FG004|As Treated|Non-compliance with study drug|0|||
163434896|NCT02786537|590296993|FG005|As Treated|Non-compliance with study drug|1|||
163434897|NCT02786537|590296988|FG000|As Treated|Lost insurance|0|||
163434898|NCT02786537|590296989|FG001|As Treated|Lost insurance|0|||
163434899|NCT02786537|590296990|FG002|As Treated|Lost insurance|0|||
163434900|NCT02786537|590296991|FG003|As Treated|Lost insurance|1|||
163434901|NCT02786537|590296992|FG004|As Treated|Lost insurance|0|||
163434902|NCT02786537|590296993|FG005|As Treated|Lost insurance|0|||
163434903|NCT02786537|590296988|FG000|As Treated|Withdrawal by Subject|1|||
163434904|NCT02786537|590296989|FG001|As Treated|Withdrawal by Subject|2|||
163434905|NCT02786537|590296990|FG002|As Treated|Withdrawal by Subject|0|||
163434906|NCT02786537|590296991|FG003|As Treated|Withdrawal by Subject|0|||
163434907|NCT02786537|590296992|FG004|As Treated|Withdrawal by Subject|1|||
163434908|NCT02786537|590296993|FG005|As Treated|Withdrawal by Subject|0|||
163434909|NCT02786537|590296988|FG000|As Treated|Incarceration|0|||
163434910|NCT02786537|590296989|FG001|As Treated|Incarceration|1|||
163434911|NCT02786537|590296990|FG002|As Treated|Incarceration|0|||
163434912|NCT02786537|590296991|FG003|As Treated|Incarceration|0|||
163434913|NCT02786537|590296992|FG004|As Treated|Incarceration|0|||
163434914|NCT02786537|590296993|FG005|As Treated|Incarceration|0|||
163434915|NCT02786537|590296988|FG000|As Treated|Opiate dependency relapse|0|||
163434916|NCT02786537|590296989|FG001|As Treated|Opiate dependency relapse|1|||
163434917|NCT02786537|590296990|FG002|As Treated|Opiate dependency relapse|0|||
163434918|NCT02786537|590296991|FG003|As Treated|Opiate dependency relapse|0|||
163434919|NCT02786537|590296992|FG004|As Treated|Opiate dependency relapse|0|||
163434920|NCT02786537|590296993|FG005|As Treated|Opiate dependency relapse|0|||
163434921|NCT02786537|590296988|FG000|As Treated|Drugs stolen from patient|0|||
163434922|NCT02786537|590296989|FG001|As Treated|Drugs stolen from patient|1|||
163434923|NCT02786537|590296990|FG002|As Treated|Drugs stolen from patient|0|||
163434924|NCT02786537|590296991|FG003|As Treated|Drugs stolen from patient|0|||
163434925|NCT02786537|590296992|FG004|As Treated|Drugs stolen from patient|0|||
163434926|NCT02786537|590296993|FG005|As Treated|Drugs stolen from patient|0|||
163434927|NCT02786537|590296988|FG000|As Treated|Advised to stop tx after loss of meds|0|||
163434928|NCT02786537|590296989|FG001|As Treated|Advised to stop tx after loss of meds|1|||
163434929|NCT02786537|590296990|FG002|As Treated|Advised to stop tx after loss of meds|0|||
163434930|NCT02786537|590296991|FG003|As Treated|Advised to stop tx after loss of meds|0|||
163434931|NCT02786537|590296992|FG004|As Treated|Advised to stop tx after loss of meds|0|||
163434932|NCT02786537|590296993|FG005|As Treated|Advised to stop tx after loss of meds|0|||
163434933|NCT02413255|590296996|FG000|Overall Study|Voluntary Withdrawal|0|||
163434934|NCT02413255|590296997|FG001|Overall Study|Voluntary Withdrawal|0|||
163434935|NCT02413255|590296998|FG002|Overall Study|Voluntary Withdrawal|0|||
163434936|NCT02413255|590296999|FG003|Overall Study|Voluntary Withdrawal|0|||
163434937|NCT02413255|590297000|FG004|Overall Study|Voluntary Withdrawal|0|||
163434938|NCT02413255|590297001|FG005|Overall Study|Voluntary Withdrawal|0|||
163434939|NCT02413255|590297002|FG006|Overall Study|Voluntary Withdrawal|0|||
163434940|NCT02413255|590297003|FG007|Overall Study|Voluntary Withdrawal|0|||
163434941|NCT02413255|590297004|FG008|Overall Study|Voluntary Withdrawal|0|||
163434942|NCT02413255|590297005|FG009|Overall Study|Voluntary Withdrawal|0|||
163434943|NCT02413255|590297006|FG010|Overall Study|Voluntary Withdrawal|0|||
163434944|NCT02413255|590297007|FG011|Overall Study|Voluntary Withdrawal|0|||
163434945|NCT02413255|590297008|FG012|Overall Study|Voluntary Withdrawal|0|||
163434946|NCT02413255|590297009|FG013|Overall Study|Voluntary Withdrawal|0|||
163434947|NCT02413255|590297010|FG014|Overall Study|Voluntary Withdrawal|1|||
163434948|NCT02413255|590297011|FG015|Overall Study|Voluntary Withdrawal|0|||
163434949|NCT02413255|590297012|FG016|Overall Study|Voluntary Withdrawal|0|||
163434950|NCT00077623|590297013|FG000|Overall Study|Adverse Event|1|||
163434951|NCT00077623|590297014|FG001|Overall Study|Adverse Event|0|||
163434952|NCT00077623|590297015|FG002|Overall Study|Adverse Event|1|||
163434953|NCT00077623|590297013|FG000|Overall Study|Withdrawal by Subject|2|||
163434954|NCT00077623|590297014|FG001|Overall Study|Withdrawal by Subject|10|||
163434955|NCT00077623|590297015|FG002|Overall Study|Withdrawal by Subject|1|||
163434956|NCT00077623|590297013|FG000|Overall Study|Other-Non safety reason|18|||
163434957|NCT00077623|590297014|FG001|Overall Study|Other-Non safety reason|15|||
163434958|NCT00077623|590297015|FG002|Overall Study|Other-Non safety reason|19|||
163434959|NCT00077623|590297013|FG000|Overall Study|Insufficient therapeutic response|2|||
163434960|NCT00077623|590297014|FG001|Overall Study|Insufficient therapeutic response|0|||
163434961|NCT00077623|590297015|FG002|Overall Study|Insufficient therapeutic response|0|||
163434962|NCT00077623|590297013|FG000|Overall Study|Death|12|||
163434963|NCT00077623|590297014|FG001|Overall Study|Death|18|||
163434964|NCT00077623|590297015|FG002|Overall Study|Death|11|||
163434965|NCT00077623|590297013|FG000|Overall Study|Failure to return|1|||
163434966|NCT00077623|590297014|FG001|Overall Study|Failure to return|0|||
163434967|NCT00077623|590297015|FG002|Overall Study|Failure to return|0|||
163434968|NCT01334125|590297016|FG000|Overall Study|Lost to Follow-up|3|||
163434969|NCT01334125|590297017|FG001|Overall Study|Lost to Follow-up|3|||
163434970|NCT00882713|590297020|FG000|Overall Study|Adverse Event|2|||
163434971|NCT00882713|590297020|FG000|Overall Study|Death|3|||
163434972|NCT00882713|590297020|FG000|Overall Study|Administrative reasons|4|||
163434973|NCT00882713|590297020|FG000|Overall Study|refused treatment/withdrew consent|4|||
163434974|NCT00882713|590297020|FG000|Overall Study|Blood transfusion|2|||
163434975|NCT00882713|590297020|FG000|Overall Study|Insufficient therapeutic response|3|||
163434976|NCT00882713|590297020|FG000|Overall Study|Failure to return|2|||
163434977|NCT00882713|590297020|FG000|Overall Study|Other - Reasons|2|||
163434978|NCT00401973|590297023|FG000|Overall Study|Adverse Event|2|||
163434979|NCT00401973|590297024|FG001|Overall Study|Adverse Event|8|||
163434980|NCT00401973|590297025|FG002|Overall Study|Adverse Event|4|||
163434981|NCT00401973|590297023|FG000|Overall Study|Clinical Relapse|0|||
163434982|NCT00401973|590297024|FG001|Overall Study|Clinical Relapse|1|||
163434983|NCT00401973|590297025|FG002|Overall Study|Clinical Relapse|1|||
163434984|NCT00401973|590297023|FG000|Overall Study|Lack of Efficacy|0|||
163434985|NCT00401973|590297024|FG001|Overall Study|Lack of Efficacy|0|||
163434986|NCT00401973|590297025|FG002|Overall Study|Lack of Efficacy|3|||
163434987|NCT00401973|590297023|FG000|Overall Study|Lost to Follow-up|2|||
163434988|NCT00401973|590297024|FG001|Overall Study|Lost to Follow-up|2|||
163434989|NCT00401973|590297025|FG002|Overall Study|Lost to Follow-up|2|||
163434990|NCT00401973|590297023|FG000|Overall Study|Physician Decision|2|||
163434991|NCT00401973|590297024|FG001|Overall Study|Physician Decision|0|||
163434992|NCT00401973|590297025|FG002|Overall Study|Physician Decision|1|||
163434993|NCT00401973|590297023|FG000|Overall Study|Protocol Violation|1|||
163434994|NCT00401973|590297024|FG001|Overall Study|Protocol Violation|2|||
163434995|NCT00401973|590297025|FG002|Overall Study|Protocol Violation|3|||
163434996|NCT00401973|590297023|FG000|Overall Study|Sponsor Decision|0|||
163434997|NCT00401973|590297024|FG001|Overall Study|Sponsor Decision|1|||
163434998|NCT00401973|590297025|FG002|Overall Study|Sponsor Decision|0|||
163434999|NCT00401973|590297023|FG000|Overall Study|Withdrawal by Subject|4|||
163435000|NCT00401973|590297024|FG001|Overall Study|Withdrawal by Subject|12|||
163435001|NCT00401973|590297025|FG002|Overall Study|Withdrawal by Subject|9|||
163435002|NCT02584634|590297026|FG000|Overall Study|Adverse Event|3|||
163435003|NCT02584634|590297027|FG001|Overall Study|Adverse Event|5|||
163435004|NCT02584634|590297026|FG000|Overall Study|Death|0|||
163435005|NCT02584634|590297027|FG001|Overall Study|Death|1|||
163435006|NCT02584634|590297026|FG000|Overall Study|Lost to Follow-up|0|||
163435007|NCT02584634|590297027|FG001|Overall Study|Lost to Follow-up|1|||
163435008|NCT02584634|590297026|FG000|Overall Study|Physician Decision|1|||
163435009|NCT02584634|590297027|FG001|Overall Study|Physician Decision|2|||
163435010|NCT02584634|590297026|FG000|Overall Study|Progressive disease|7|||
163435011|NCT02584634|590297027|FG001|Overall Study|Progressive disease|15|||
163435012|NCT02584634|590297026|FG000|Overall Study|Withdrawal by Subject|1|||
163435013|NCT02584634|590297027|FG001|Overall Study|Withdrawal by Subject|1|||
163435014|NCT02584634|590297026|FG000|Overall Study|Other|0|||
163435015|NCT02584634|590297027|FG001|Overall Study|Other|6|||
163435016|NCT04075604|590297029|FG000|Overall Study|Adverse Event|0|||
163435017|NCT04075604|590297030|FG001|Overall Study|Adverse Event|0|||
163435018|NCT04075604|590297031|FG002|Overall Study|Adverse Event|3|||
163435019|NCT04075604|590297029|FG000|Overall Study|Participant request to discontinue study treatment|0|||
163435020|NCT04075604|590297030|FG001|Overall Study|Participant request to discontinue study treatment|0|||
163435021|NCT04075604|590297031|FG002|Overall Study|Participant request to discontinue study treatment|1|||
163435022|NCT04075604|590297029|FG000|Overall Study|Participant withdrew consent|0|||
163435023|NCT04075604|590297030|FG001|Overall Study|Participant withdrew consent|0|||
163435024|NCT04075604|590297031|FG002|Overall Study|Participant withdrew consent|1|||
163435025|NCT04075604|590297029|FG000|Overall Study|Other reasons|1|||
163435026|NCT04075604|590297030|FG001|Overall Study|Other reasons|0|||
163435027|NCT04075604|590297031|FG002|Overall Study|Other reasons|0|||
163435028|NCT04075604|590297029|FG000|Overall Study|Disease progression|0|||
163435029|NCT04075604|590297030|FG001|Overall Study|Disease progression|1|||
163435030|NCT04075604|590297031|FG002|Overall Study|Disease progression|0|||
163435031|NCT04075604|590297029|FG000|Overall Study|Study drug toxicity|0|||
163435032|NCT04075604|590297030|FG001|Overall Study|Study drug toxicity|5|||
163435033|NCT04075604|590297031|FG002|Overall Study|Study drug toxicity|1|||
163435034|NCT01050062|590297035|FG000|Overall Study|Adverse Event|75|||
163435035|NCT01050062|590297036|FG001|Overall Study|Adverse Event|22|||
163435036|NCT01050062|590297035|FG000|Overall Study|Lost to Follow-up|83|||
163435037|NCT01050062|590297036|FG001|Overall Study|Lost to Follow-up|35|||
163435038|NCT01050062|590297035|FG000|Overall Study|Lack of Efficacy|22|||
163435039|NCT01050062|590297036|FG001|Overall Study|Lack of Efficacy|35|||
163435040|NCT01050062|590297035|FG000|Overall Study|Physician Decision|74|||
163435041|NCT01050062|590297036|FG001|Overall Study|Physician Decision|9|||
163435042|NCT01050062|590297035|FG000|Overall Study|Others|17|||
163435043|NCT01050062|590297036|FG001|Overall Study|Others|11|||
163435044|NCT03894540|590297037|FG000|Overall Study|Adverse Event|0|||
163435045|NCT03894540|590297038|FG001|Overall Study|Adverse Event|0|||
163435046|NCT03894540|590297039|FG002|Overall Study|Adverse Event|0|||
163435047|NCT03894540|590297040|FG003|Overall Study|Adverse Event|0|||
163435048|NCT03894540|590297041|FG004|Overall Study|Adverse Event|1|||
163435049|NCT03894540|590297042|FG005|Overall Study|Adverse Event|0|||
163435050|NCT03894540|590297037|FG000|Overall Study|Withdrawal by Subject|0|||
163435051|NCT03894540|590297038|FG001|Overall Study|Withdrawal by Subject|0|||
163435052|NCT03894540|590297039|FG002|Overall Study|Withdrawal by Subject|0|||
163435053|NCT03894540|590297040|FG003|Overall Study|Withdrawal by Subject|0|||
163435054|NCT03894540|590297041|FG004|Overall Study|Withdrawal by Subject|1|||
163435055|NCT03894540|590297042|FG005|Overall Study|Withdrawal by Subject|0|||
163435056|NCT03894540|590297037|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
163435057|NCT03894540|590297038|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
163435058|NCT03894540|590297039|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
163435059|NCT03894540|590297040|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
163435060|NCT03894540|590297041|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
163435061|NCT03894540|590297042|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
163435062|NCT03894540|590297037|FG000|Overall Study|Progressive Disease Clinical|1|||
163435063|NCT03894540|590297038|FG001|Overall Study|Progressive Disease Clinical|1|||
163435064|NCT03894540|590297039|FG002|Overall Study|Progressive Disease Clinical|0|||
163435065|NCT03894540|590297040|FG003|Overall Study|Progressive Disease Clinical|1|||
163435066|NCT03894540|590297041|FG004|Overall Study|Progressive Disease Clinical|5|||
163435067|NCT03894540|590297042|FG005|Overall Study|Progressive Disease Clinical|1|||
163435068|NCT03894540|590297037|FG000|Overall Study|Study termination by sponsor|0|||
163435069|NCT03894540|590297038|FG001|Overall Study|Study termination by sponsor|0|||
163435070|NCT03894540|590297039|FG002|Overall Study|Study termination by sponsor|0|||
163435071|NCT03894540|590297040|FG003|Overall Study|Study termination by sponsor|0|||
163435072|NCT03894540|590297041|FG004|Overall Study|Study termination by sponsor|2|||
163435073|NCT03894540|590297042|FG005|Overall Study|Study termination by sponsor|0|||
163435074|NCT03000452|590297043|FG000|Treatment Period|Death|1|||
163435075|NCT03000452|590297043|FG000|Treatment Period|Progressive Disease (PD)|14|||
163435076|NCT03000452|590297043|FG000|Treatment Period|Physician Decision|1|||
163435077|NCT03000452|590297043|FG000|Treatment Period|Miscellaneous|2|||
163435078|NCT03000452|590297043|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
163435079|NCT03000452|590297043|FG000|Follow-Up Period|Death|3|||
163435080|NCT03000452|590297043|FG000|Follow-Up Period|Withdrawal by Subject|3|||
163435081|NCT00593112|590297044|FG000|Overall Study|Scan Anxiety|3|||
163435082|NCT00593112|590297045|FG001|Overall Study|Scan Anxiety|0|||
163435083|NCT00593112|590297044|FG000|Overall Study|Abnormal Scan|1|||
163435084|NCT00593112|590297045|FG001|Overall Study|Abnormal Scan|0|||
163435085|NCT00593112|590297044|FG000|Overall Study|Unreadable Scan|1|||
163435086|NCT00593112|590297045|FG001|Overall Study|Unreadable Scan|0|||
163435087|NCT00593112|590297044|FG000|Overall Study|Withdrawal by Subject|5|||
163435088|NCT00593112|590297045|FG001|Overall Study|Withdrawal by Subject|0|||
163435089|NCT00852930|590297046|FG000|Overall Study|Withdrawal by Subject|1|||
163435090|NCT00852930|590297047|FG001|Overall Study|Withdrawal by Subject|1|||
163435091|NCT00852930|590297048|FG002|Overall Study|Withdrawal by Subject|1|||
163435092|NCT00852930|590297046|FG000|Overall Study|Physician Decision|0|||
163435093|NCT00852930|590297047|FG001|Overall Study|Physician Decision|0|||
163435094|NCT00852930|590297048|FG002|Overall Study|Physician Decision|1|||
163435095|NCT00537745|590297049|FG000|Overall Study|Did not meet eligibility criteria|2|||
163435096|NCT00537745|590297049|FG000|Overall Study|Withdrawal by Subject|2|||
163435097|NCT00537745|590297049|FG000|Overall Study|Subject unable to provide Interlock info|1|||
163435098|NCT03700892|590297051|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
163435099|NCT03700892|590297052|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
163435100|NCT03700892|590297053|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
163435101|NCT00650585|590297054|FG000|Overall Study|Lost to Follow-up|505|||
163435102|NCT00650585|590297055|FG001|Overall Study|Lost to Follow-up|482|||
163435103|NCT00650585|590297054|FG000|Overall Study|No parental consent|935|||
163435104|NCT00650585|590297055|FG001|Overall Study|No parental consent|866|||
163435105|NCT00650585|590297054|FG000|Overall Study|Excluded/ruled ineligible|357|||
163435106|NCT00650585|590297055|FG001|Overall Study|Excluded/ruled ineligible|129|||
163435107|NCT02532543|590297056|FG000|Overall Study|Lost to Follow-up|0|||
163435108|NCT02532543|590297057|FG001|Overall Study|Lost to Follow-up|0|||
163435109|NCT02532543|590297058|FG002|Overall Study|Lost to Follow-up|1|||
163435110|NCT02532543|590297059|FG003|Overall Study|Lost to Follow-up|0|||
163435111|NCT00849212|590297060|FG000|Overall Study|Lack of Efficacy|1|||
163435112|NCT00849212|590297060|FG000|Overall Study|Withdrawal by Subject|3|||
163435113|NCT00849212|590297060|FG000|Overall Study|Adverse Event|2|||
163435114|NCT00849212|590297060|FG000|Overall Study|Miscellaneous|1|||
163435115|NCT02640612|590297061|FG000|Overall Study|Adverse Event|6|||
163435116|NCT02640612|590297062|FG001|Overall Study|Adverse Event|7|||
163435117|NCT02640612|590297063|FG002|Overall Study|Adverse Event|2|||
163435118|NCT02640612|590297061|FG000|Overall Study|Death|1|||
163435119|NCT02640612|590297062|FG001|Overall Study|Death|0|||
163435120|NCT02640612|590297063|FG002|Overall Study|Death|0|||
163435121|NCT02640612|590297061|FG000|Overall Study|Withdrawal by Subject|10|||
163435122|NCT02640612|590297062|FG001|Overall Study|Withdrawal by Subject|3|||
163435123|NCT02640612|590297063|FG002|Overall Study|Withdrawal by Subject|3|||
163435124|NCT02640612|590297061|FG000|Overall Study|Lost to Follow-up|4|||
163435125|NCT02640612|590297062|FG001|Overall Study|Lost to Follow-up|1|||
163435126|NCT02640612|590297063|FG002|Overall Study|Lost to Follow-up|1|||
163435127|NCT02640612|590297061|FG000|Overall Study|Protocol Violation|0|||
163435128|NCT02640612|590297062|FG001|Overall Study|Protocol Violation|2|||
163435129|NCT02640612|590297063|FG002|Overall Study|Protocol Violation|0|||
163435130|NCT02640612|590297061|FG000|Overall Study|Lack of Efficacy|1|||
163435131|NCT02640612|590297062|FG001|Overall Study|Lack of Efficacy|1|||
163435132|NCT02640612|590297063|FG002|Overall Study|Lack of Efficacy|0|||
163435133|NCT03472534|590297072|FG000|Overall Study|Withdrawal by Subject|9|||
163435134|NCT03472534|590297072|FG000|Overall Study|Adverse Event|2|||
163435135|NCT02614794|590297073|FG000|Overall Study|Death|258|||
163435136|NCT02614794|590297074|FG001|Overall Study|Death|151|||
163435137|NCT02614794|590297073|FG000|Overall Study|Study closure by Sponsor|119|||
163435138|NCT02614794|590297074|FG001|Overall Study|Study closure by Sponsor|45|||
163435139|NCT02614794|590297073|FG000|Overall Study|Withdrawal by Subject|24|||
163435140|NCT02614794|590297074|FG001|Overall Study|Withdrawal by Subject|5|||
163435141|NCT02614794|590297073|FG000|Overall Study|Lost to Follow-up|7|||
163435142|NCT02614794|590297074|FG001|Overall Study|Lost to Follow-up|0|||
163435143|NCT02614794|590297073|FG000|Overall Study|Physician Decision|1|||
163435144|NCT02614794|590297074|FG001|Overall Study|Physician Decision|1|||
163435145|NCT02614794|590297073|FG000|Overall Study|Hospital closure|1|||
163435146|NCT02614794|590297074|FG001|Overall Study|Hospital closure|0|||
163435147|NCT02117050|590297079|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
163435148|NCT00491530|590297080|FG000|Overall Study|Adverse Event|6|||
163435149|NCT00491530|590297081|FG001|Overall Study|Adverse Event|1|||
163435150|NCT00491530|590297082|FG002|Overall Study|Adverse Event|2|||
163435151|NCT00491530|590297080|FG000|Overall Study|Withdrawal by Subject|3|||
163435152|NCT00491530|590297081|FG001|Overall Study|Withdrawal by Subject|0|||
163435153|NCT00491530|590297082|FG002|Overall Study|Withdrawal by Subject|0|||
163435154|NCT00491530|590297080|FG000|Overall Study|Lost to Follow-up|3|||
163435155|NCT00491530|590297081|FG001|Overall Study|Lost to Follow-up|2|||
163435156|NCT00491530|590297082|FG002|Overall Study|Lost to Follow-up|2|||
163435157|NCT00491530|590297080|FG000|Overall Study|Lack of Efficacy|0|||
163435158|NCT00491530|590297081|FG001|Overall Study|Lack of Efficacy|1|||
163435159|NCT00491530|590297082|FG002|Overall Study|Lack of Efficacy|0|||
163435160|NCT00491530|590297080|FG000|Overall Study|Investigator Discretion|0|||
163435161|NCT00491530|590297081|FG001|Overall Study|Investigator Discretion|1|||
163435162|NCT00491530|590297082|FG002|Overall Study|Investigator Discretion|0|||
163435163|NCT00491530|590297080|FG000|Overall Study|Patient Request|0|||
163435164|NCT00491530|590297081|FG001|Overall Study|Patient Request|1|||
163435165|NCT00491530|590297082|FG002|Overall Study|Patient Request|0|||
163435166|NCT00491530|590297080|FG000|Overall Study|Use of Prohibited Medication|0|||
163435167|NCT00491530|590297081|FG001|Overall Study|Use of Prohibited Medication|0|||
163435168|NCT00491530|590297082|FG002|Overall Study|Use of Prohibited Medication|1|||
163435169|NCT01591330|590297083|FG000|Period 1|Adverse Event|1|||
163435170|NCT01591330|590297084|FG001|Period 1|Adverse Event|0|||
163435171|NCT01591330|590297085|FG002|Period 1|Adverse Event|0|||
163435172|NCT01591330|590297086|FG003|Period 1|Adverse Event|0|||
163435173|NCT01591330|590297083|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
163435174|NCT01591330|590297084|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
163435175|NCT01591330|590297085|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
163435176|NCT01591330|590297086|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
163435177|NCT01591330|590297083|FG000|Period 2|Adverse Event|1|||
163435178|NCT01591330|590297084|FG001|Period 2|Adverse Event|0|||
163435179|NCT01591330|590297085|FG002|Period 2|Adverse Event|0|||
163435180|NCT01591330|590297086|FG003|Period 2|Adverse Event|0|||
163435181|NCT01662999|590297087|FG000|Period 3|Withdrawal by Subject|0|||
163435182|NCT01662999|590297088|FG001|Period 3|Withdrawal by Subject|1|||
163435183|NCT01662999|590297089|FG002|Period 3|Withdrawal by Subject|0|||
163435184|NCT01662999|590297090|FG003|Period 3|Withdrawal by Subject|0|||
163435185|NCT01662999|590297091|FG004|Period 3|Withdrawal by Subject|0|||
163435186|NCT01662999|590297092|FG005|Period 3|Withdrawal by Subject|0|||
163435187|NCT00196937|590297093|FG000|Overall Study|Serious Adverse Event|1|||
163435188|NCT00196937|590297094|FG001|Overall Study|Serious Adverse Event|0|||
163435189|NCT00196937|590297095|FG002|Overall Study|Serious Adverse Event|0|||
163435190|NCT00196937|590297093|FG000|Overall Study|Non-serious adverse event|1|||
163435191|NCT00196937|590297094|FG001|Overall Study|Non-serious adverse event|1|||
163435192|NCT00196937|590297095|FG002|Overall Study|Non-serious adverse event|1|||
163435193|NCT00196937|590297093|FG000|Overall Study|Withdrawal by Subject|0|||
163435194|NCT00196937|590297094|FG001|Overall Study|Withdrawal by Subject|0|||
163435195|NCT00196937|590297095|FG002|Overall Study|Withdrawal by Subject|2|||
163435196|NCT00196937|590297093|FG000|Overall Study|Lost to Follow-up|4|||
163435197|NCT00196937|590297094|FG001|Overall Study|Lost to Follow-up|3|||
163435198|NCT00196937|590297095|FG002|Overall Study|Lost to Follow-up|3|||
163435199|NCT00196937|590297093|FG000|Overall Study|Other|3|||
163435200|NCT00196937|590297094|FG001|Overall Study|Other|1|||
163435201|NCT00196937|590297095|FG002|Overall Study|Other|1|||
163435202|NCT03368404|590297098|FG000|Overall Study|Adverse Event|2|||
163435203|NCT03368404|590297099|FG001|Overall Study|Adverse Event|1|||
163435204|NCT03368404|590297098|FG000|Overall Study|Withdrawal by Subject|1|||
163435205|NCT03368404|590297099|FG001|Overall Study|Withdrawal by Subject|1|||
163435206|NCT04725682|590297100|FG000|Overall Study|Withdrawal by Subject|7|||
163435207|NCT04725682|590297101|FG001|Overall Study|Withdrawal by Subject|5|||
163435208|NCT04725682|590297100|FG000|Overall Study|Failed to comply with the requirements|2|||
163435209|NCT04725682|590297101|FG001|Overall Study|Failed to comply with the requirements|1|||
163435210|NCT04725682|590297100|FG000|Overall Study|Adverse Event|1|||
163435211|NCT04725682|590297101|FG001|Overall Study|Adverse Event|1|||
163435212|NCT04725682|590297100|FG000|Overall Study|Death|0|||
163435213|NCT04725682|590297101|FG001|Overall Study|Death|1|||
163435214|NCT00964795|590297102|FG000|Overall Study|Withdrawal by Subject|79|||
163435215|NCT00964795|590297102|FG000|Overall Study|Adverse Event|12|||
163435216|NCT00964795|590297102|FG000|Overall Study|Death|14|||
163435217|NCT00964795|590297102|FG000|Overall Study|Lost to Follow-up|7|||
163435218|NCT00964795|590297102|FG000|Overall Study|Termination of Study by Sponsor|169|||
163435219|NCT00964795|590297102|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
163435220|NCT00964795|590297102|FG000|Overall Study|Other|23|||
163435221|NCT00586690|590297107|FG000|Overall Study|Death|2|||
163435222|NCT00586690|590297108|FG001|Overall Study|Death|0|||
163435223|NCT00586690|590297107|FG000|Overall Study|Disease Progression|10|||
163435224|NCT00586690|590297108|FG001|Overall Study|Disease Progression|0|||
163435225|NCT00586690|590297107|FG000|Overall Study|Adverse Event|1|||
163435226|NCT00586690|590297108|FG001|Overall Study|Adverse Event|0|||
163435227|NCT00586690|590297107|FG000|Overall Study|Lack of Efficacy|2|||
163435228|NCT00586690|590297108|FG001|Overall Study|Lack of Efficacy|0|||
163435229|NCT00586690|590297107|FG000|Overall Study|Lab can't accommodate|1|||
163435230|NCT00586690|590297108|FG001|Overall Study|Lab can't accommodate|0|||
163435231|NCT02973815|590297111|FG000|Post Intervention|Death|1|||
163435232|NCT02973815|590297112|FG001|Post Intervention|Death|0|||
163435233|NCT02973815|590297111|FG000|Post Intervention|Lost to Follow-up|7|||
163435234|NCT02973815|590297112|FG001|Post Intervention|Lost to Follow-up|24|||
163435235|NCT02973815|590297111|FG000|Follow-up|Lost to Follow-up|2|||
163435236|NCT02973815|590297112|FG001|Follow-up|Lost to Follow-up|0|||
163435237|NCT03478683|590297113|FG000|Overall Study|Adverse Event|5|||
163435238|NCT03478683|590297114|FG001|Overall Study|Adverse Event|3|||
163435239|NCT03478683|590297113|FG000|Overall Study|Lost to Follow-up|0|||
163435240|NCT03478683|590297114|FG001|Overall Study|Lost to Follow-up|5|||
163435241|NCT03478683|590297113|FG000|Overall Study|Physician Decision|1|||
163435242|NCT03478683|590297114|FG001|Overall Study|Physician Decision|3|||
163435243|NCT03478683|590297113|FG000|Overall Study|Withdrawal by Subject|7|||
163435244|NCT03478683|590297114|FG001|Overall Study|Withdrawal by Subject|7|||
163435245|NCT01607892|590297123|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
163435246|NCT01607892|590297124|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
163435247|NCT01607892|590297125|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
163435248|NCT01607892|590297126|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
163435249|NCT01607892|590297127|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
163435250|NCT01607892|590297123|FG000|Overall Study|Death|4|||
163435251|NCT01607892|590297124|FG001|Overall Study|Death|2|||
163435252|NCT01607892|590297125|FG002|Overall Study|Death|8|||
163435253|NCT01607892|590297126|FG003|Overall Study|Death|10|||
163435254|NCT01607892|590297127|FG004|Overall Study|Death|3|||
163435255|NCT01607892|590297123|FG000|Overall Study|Investigator discretion|2|||
163435256|NCT01607892|590297124|FG001|Overall Study|Investigator discretion|4|||
163435257|NCT01607892|590297125|FG002|Overall Study|Investigator discretion|4|||
163435258|NCT01607892|590297126|FG003|Overall Study|Investigator discretion|8|||
163435259|NCT01607892|590297127|FG004|Overall Study|Investigator discretion|0|||
163435260|NCT01607892|590297123|FG000|Overall Study|Other treatments became available|1|||
163435261|NCT01607892|590297124|FG001|Overall Study|Other treatments became available|1|||
163435262|NCT01607892|590297125|FG002|Overall Study|Other treatments became available|0|||
163435263|NCT01607892|590297126|FG003|Overall Study|Other treatments became available|0|||
163435264|NCT01607892|590297127|FG004|Overall Study|Other treatments became available|2|||
163435265|NCT01607892|590297123|FG000|Overall Study|Intercurrent illness|1|||
163435266|NCT01607892|590297124|FG001|Overall Study|Intercurrent illness|0|||
163435267|NCT01607892|590297125|FG002|Overall Study|Intercurrent illness|0|||
163435268|NCT01607892|590297126|FG003|Overall Study|Intercurrent illness|3|||
163435269|NCT01607892|590297127|FG004|Overall Study|Intercurrent illness|0|||
163435270|NCT01607892|590297123|FG000|Overall Study|Non-Compliance with study procedures|0|||
163435271|NCT01607892|590297124|FG001|Overall Study|Non-Compliance with study procedures|0|||
163435272|NCT01607892|590297125|FG002|Overall Study|Non-Compliance with study procedures|1|||
163435273|NCT01607892|590297126|FG003|Overall Study|Non-Compliance with study procedures|0|||
163435274|NCT01607892|590297127|FG004|Overall Study|Non-Compliance with study procedures|0|||
163435275|NCT01607892|590297123|FG000|Overall Study|Consent withdrawn by participant|9|||
163435276|NCT01607892|590297124|FG001|Overall Study|Consent withdrawn by participant|4|||
163435277|NCT01607892|590297125|FG002|Overall Study|Consent withdrawn by participant|24|||
163435278|NCT01607892|590297126|FG003|Overall Study|Consent withdrawn by participant|14|||
163435279|NCT01607892|590297127|FG004|Overall Study|Consent withdrawn by participant|4|||
163435280|NCT01607892|590297123|FG000|Overall Study|Disease progression|38|||
163435281|NCT01607892|590297124|FG001|Overall Study|Disease progression|13|||
163435282|NCT01607892|590297125|FG002|Overall Study|Disease progression|37|||
163435283|NCT01607892|590297126|FG003|Overall Study|Disease progression|57|||
163435284|NCT01607892|590297127|FG004|Overall Study|Disease progression|9|||
163435285|NCT01607892|590297123|FG000|Overall Study|Incidence or severity of Adverse events|3|||
163435286|NCT01607892|590297124|FG001|Overall Study|Incidence or severity of Adverse events|3|||
163435287|NCT01607892|590297125|FG002|Overall Study|Incidence or severity of Adverse events|7|||
163435288|NCT01607892|590297126|FG003|Overall Study|Incidence or severity of Adverse events|2|||
163435289|NCT01607892|590297127|FG004|Overall Study|Incidence or severity of Adverse events|6|||
163435290|NCT02273973|590297130|FG000|Overall Study|Adverse Event|4|||
163435291|NCT02273973|590297131|FG001|Overall Study|Adverse Event|0|||
163435292|NCT02273973|590297130|FG000|Overall Study|Withdrawal by Subject|2|||
163435293|NCT02273973|590297131|FG001|Overall Study|Withdrawal by Subject|3|||
163435294|NCT02273973|590297130|FG000|Overall Study|Death|1|||
163435295|NCT02273973|590297131|FG001|Overall Study|Death|0|||
163435296|NCT02273973|590297130|FG000|Overall Study|Non-compliance|1|||
163435297|NCT02273973|590297131|FG001|Overall Study|Non-compliance|0|||
163435298|NCT02273973|590297130|FG000|Overall Study|Protocol Violation|1|||
163435299|NCT02273973|590297131|FG001|Overall Study|Protocol Violation|0|||
163435300|NCT02273973|590297130|FG000|Overall Study|Progression of disease|0|||
163435301|NCT02273973|590297131|FG001|Overall Study|Progression of disease|2|||
163435302|NCT02273973|590297130|FG000|Overall Study|Lost to Follow-up|0|||
163435303|NCT02273973|590297131|FG001|Overall Study|Lost to Follow-up|1|||
163435304|NCT02273973|590297130|FG000|Overall Study|Physician Decision|0|||
163435305|NCT02273973|590297131|FG001|Overall Study|Physician Decision|1|||
163435306|NCT02273973|590297130|FG000|Overall Study|Reason not specified|0|||
163435307|NCT02273973|590297131|FG001|Overall Study|Reason not specified|1|||
163435308|NCT03022422|590297132|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
163435309|NCT03022422|590297133|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
163435310|NCT03022422|590297134|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
163435311|NCT03022422|590297135|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
163435312|NCT03022422|590297136|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
163435313|NCT03022422|590297137|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
163435314|NCT02104180|590297138|FG000|Overall Study|Protocol Violation|1|||
163435315|NCT02104180|590297139|FG001|Overall Study|Protocol Violation|0|||
163435316|NCT01676116|590297140|FG000|Overall Study|Withdrawal criteria|2|||
163435317|NCT01676116|590297141|FG001|Overall Study|Withdrawal criteria|14|||
163435318|NCT01676116|590297140|FG000|Overall Study|Adverse Event|1|||
163435319|NCT01676116|590297141|FG001|Overall Study|Adverse Event|2|||
163435320|NCT01676116|590297140|FG000|Overall Study|Unclassified|4|||
163435321|NCT01676116|590297141|FG001|Overall Study|Unclassified|10|||
163435322|NCT01676116|590297140|FG000|Overall Study|Protocol Violation|9|||
163435323|NCT01676116|590297141|FG001|Overall Study|Protocol Violation|3|||
163435324|NCT00793585|590297142|FG000|Overall Study|Adverse Event|1|||
163435325|NCT00793585|590297143|FG001|Overall Study|Adverse Event|1|||
163435326|NCT00793585|590297142|FG000|Overall Study|Protocol Violation|1|||
163435327|NCT00793585|590297143|FG001|Overall Study|Protocol Violation|2|||
163435328|NCT01769404|590297144|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
163435329|NCT01769404|590297145|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
163435330|NCT01769404|590297144|FG000|Treatment Period 1|Withdrawal by Subject|3|||
163435331|NCT01769404|590297145|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163435332|NCT01769404|590297144|FG000|Treatment Period 1|Sponsor decision|1|||
163435333|NCT01769404|590297145|FG001|Treatment Period 1|Sponsor decision|0|||
163435334|NCT01769404|590297144|FG000|Treatment Period 2|Sponsor decision|7|||
163435335|NCT01769404|590297145|FG001|Treatment Period 2|Sponsor decision|0|||
163435336|NCT01821677|590297146|FG000|Overall Study|Adverse Event|4|||
163435337|NCT01821677|590297147|FG001|Overall Study|Adverse Event|6|||
163435338|NCT01821677|590297148|FG002|Overall Study|Adverse Event|5|||
163435339|NCT01821677|590297146|FG000|Overall Study|Physician Decision|1|||
163435340|NCT01821677|590297147|FG001|Overall Study|Physician Decision|4|||
163435341|NCT01821677|590297148|FG002|Overall Study|Physician Decision|1|||
163435342|NCT01821677|590297146|FG000|Overall Study|Non-compliance|0|||
163435343|NCT01821677|590297147|FG001|Overall Study|Non-compliance|1|||
163435344|NCT01821677|590297148|FG002|Overall Study|Non-compliance|2|||
163435345|NCT01821677|590297146|FG000|Overall Study|Lost to Follow-up|2|||
163435346|NCT01821677|590297147|FG001|Overall Study|Lost to Follow-up|1|||
163435347|NCT01821677|590297148|FG002|Overall Study|Lost to Follow-up|3|||
163435348|NCT01821677|590297146|FG000|Overall Study|Protocol Violation|0|||
163435349|NCT01821677|590297147|FG001|Overall Study|Protocol Violation|0|||
163435350|NCT01821677|590297148|FG002|Overall Study|Protocol Violation|2|||
163435351|NCT01821677|590297146|FG000|Overall Study|Withdrawal by Subject|7|||
163435352|NCT01821677|590297147|FG001|Overall Study|Withdrawal by Subject|3|||
163435353|NCT01821677|590297148|FG002|Overall Study|Withdrawal by Subject|2|||
163435354|NCT01821677|590297146|FG000|Overall Study|Other|9|||
163435355|NCT01821677|590297147|FG001|Overall Study|Other|0|||
163435356|NCT01821677|590297148|FG002|Overall Study|Other|0|||
163435357|NCT00538733|590297149|FG000|Overall Study|Adverse Event|8|||
163435358|NCT00538733|590297149|FG000|Overall Study|Death|1|||
163435359|NCT00538733|590297149|FG000|Overall Study|declined to participate|2|||
163435360|NCT00538733|590297149|FG000|Overall Study|still on therapy|1|||
163435361|NCT04513158|590297165|FG000|Overall Study|Screen Failure|1|||
163435362|NCT05278104|590297166|FG000|Overall Study|Not treated|1|||
163435363|NCT05278104|590297167|FG001|Overall Study|Not treated|0|||
163435364|NCT05278104|590297166|FG000|Overall Study|Adverse Event|2|||
163435365|NCT05278104|590297167|FG001|Overall Study|Adverse Event|1|||
163435366|NCT05278104|590297166|FG000|Overall Study|Exclusion criteria not met|1|||
163435367|NCT05278104|590297167|FG001|Overall Study|Exclusion criteria not met|0|||
163435368|NCT02629393|590299145|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
163435369|NCT02629393|590299145|FG000|Overall Study|Physician Decision|1|||
163435370|NCT01269125|590299146|FG000|Overall Study|Adverse Event|3|||
163435371|NCT01269125|590299147|FG001|Overall Study|Adverse Event|5|||
163435372|NCT01269125|590299148|FG002|Overall Study|Adverse Event|0|||
163435373|NCT01269125|590299146|FG000|Overall Study|Lost to Follow-up|4|||
163435374|NCT01269125|590299147|FG001|Overall Study|Lost to Follow-up|0|||
163435375|NCT01269125|590299148|FG002|Overall Study|Lost to Follow-up|0|||
163435376|NCT00151411|590299149|FG000|Overall Study|Lost to Follow-up|15|||
163435377|NCT00151411|590299150|FG001|Overall Study|Lost to Follow-up|19|||
163435378|NCT00151411|590299149|FG000|Overall Study|Withdrawal by Subject|12|||
163435379|NCT00151411|590299150|FG001|Overall Study|Withdrawal by Subject|20|||
163435380|NCT00151411|590299149|FG000|Overall Study|Adverse Event|6|||
163435381|NCT00151411|590299150|FG001|Overall Study|Adverse Event|0|||
163435382|NCT00151411|590299149|FG000|Overall Study|Pregnancy|0|||
163435383|NCT00151411|590299150|FG001|Overall Study|Pregnancy|4|||
163435384|NCT00417612|590299151|FG000|Overall Study|Errant diagnosis|0|||
163435385|NCT00417612|590299152|FG001|Overall Study|Errant diagnosis|1|||
163435386|NCT00417612|590299151|FG000|Overall Study|Adverse Event|2|||
163435387|NCT00417612|590299152|FG001|Overall Study|Adverse Event|0|||
163435388|NCT00417612|590299151|FG000|Overall Study|Protocol Violation|0|||
163435389|NCT00417612|590299152|FG001|Overall Study|Protocol Violation|2|||
163435390|NCT00417612|590299151|FG000|Overall Study|Lost to Follow-up|1|||
163435391|NCT00417612|590299152|FG001|Overall Study|Lost to Follow-up|0|||
163435392|NCT01283581|590299153|FG000|Overall Study|Lost to Follow-up|8|||
163435393|NCT01283581|590299154|FG001|Overall Study|Lost to Follow-up|6|||
163435394|NCT01283581|590299155|FG002|Overall Study|Lost to Follow-up|8|||
163435395|NCT01283581|590299153|FG000|Overall Study|Withdrawal by Subject|2|||
163435396|NCT01283581|590299154|FG001|Overall Study|Withdrawal by Subject|5|||
163435397|NCT01283581|590299155|FG002|Overall Study|Withdrawal by Subject|2|||
163435398|NCT01283581|590299153|FG000|Overall Study|Adverse Event|1|||
163435399|NCT01283581|590299154|FG001|Overall Study|Adverse Event|1|||
163435400|NCT01283581|590299155|FG002|Overall Study|Adverse Event|4|||
163435401|NCT01283581|590299153|FG000|Overall Study|Physician Decision|0|||
163435402|NCT01283581|590299154|FG001|Overall Study|Physician Decision|1|||
163435403|NCT01283581|590299155|FG002|Overall Study|Physician Decision|2|||
163435404|NCT01283581|590299153|FG000|Overall Study|Protocol Violation|0|||
163435405|NCT01283581|590299154|FG001|Overall Study|Protocol Violation|1|||
163435406|NCT01283581|590299155|FG002|Overall Study|Protocol Violation|2|||
163435407|NCT01283581|590299153|FG000|Overall Study|Noncompliance|1|||
163435408|NCT01283581|590299154|FG001|Overall Study|Noncompliance|0|||
163435409|NCT01283581|590299155|FG002|Overall Study|Noncompliance|0|||
163435410|NCT01283581|590299153|FG000|Overall Study|Investigator unblinded|0|||
163435411|NCT01283581|590299154|FG001|Overall Study|Investigator unblinded|0|||
163435412|NCT01283581|590299155|FG002|Overall Study|Investigator unblinded|1|||
163435413|NCT01283581|590299153|FG000|Overall Study|"Early termination"|0|||
163435414|NCT01283581|590299154|FG001|Overall Study|"Early termination"|0|||
163435415|NCT01283581|590299155|FG002|Overall Study|"Early termination"|1|||
163435416|NCT05523362|590299156|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
163435417|NCT05523362|590299156|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
163435418|NCT05523362|590299156|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
163435419|NCT05523362|590299156|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
163435420|NCT02760602|590299157|FG000|Overall Study|Withdrawal by Subject|1|||
163435421|NCT02760602|590299158|FG001|Overall Study|Withdrawal by Subject|0|||
163435422|NCT02760602|590299157|FG000|Overall Study|Terminated by sponsor|12|||
163435423|NCT02760602|590299158|FG001|Overall Study|Terminated by sponsor|13|||
163435424|NCT01260181|590299162|FG000|Overall Study|Decision of Investigator|1|||
163435425|NCT03351244|590299163|FG000|Overall Study|Adverse Event|7|||
163435426|NCT03351244|590299164|FG001|Overall Study|Adverse Event|11|||
163435427|NCT03351244|590299165|FG002|Overall Study|Adverse Event|12|||
163435428|NCT03351244|590299163|FG000|Overall Study|Investigator's decision|0|||
163435429|NCT03351244|590299164|FG001|Overall Study|Investigator's decision|0|||
163435430|NCT03351244|590299165|FG002|Overall Study|Investigator's decision|2|||
163435431|NCT03351244|590299163|FG000|Overall Study|System error|0|||
163435432|NCT03351244|590299164|FG001|Overall Study|System error|0|||
163435433|NCT03351244|590299165|FG002|Overall Study|System error|2|||
163435434|NCT03351244|590299163|FG000|Overall Study|COVID-19 restrictions|3|||
163435435|NCT03351244|590299164|FG001|Overall Study|COVID-19 restrictions|0|||
163435436|NCT03351244|590299165|FG002|Overall Study|COVID-19 restrictions|1|||
163435437|NCT03351244|590299163|FG000|Overall Study|Non-compliance|2|||
163435438|NCT03351244|590299164|FG001|Overall Study|Non-compliance|5|||
163435439|NCT03351244|590299165|FG002|Overall Study|Non-compliance|0|||
163435440|NCT03351244|590299163|FG000|Overall Study|Withdrawal by Subject|11|||
163435441|NCT03351244|590299164|FG001|Overall Study|Withdrawal by Subject|16|||
163435442|NCT03351244|590299165|FG002|Overall Study|Withdrawal by Subject|13|||
163435443|NCT03351244|590299163|FG000|Overall Study|Lost to Follow-up|2|||
163435444|NCT03351244|590299164|FG001|Overall Study|Lost to Follow-up|6|||
163435445|NCT03351244|590299165|FG002|Overall Study|Lost to Follow-up|4|||
163435446|NCT03351244|590299163|FG000|Overall Study|Protocol Violation|2|||
163435447|NCT03351244|590299164|FG001|Overall Study|Protocol Violation|2|||
163435448|NCT03351244|590299165|FG002|Overall Study|Protocol Violation|0|||
163435449|NCT01165229|590299168|FG000|Overall Study|Serious Adverse Event|456|||
163435450|NCT01165229|590299169|FG001|Overall Study|Serious Adverse Event|487|||
163435451|NCT01165229|590299168|FG000|Overall Study|Non-Serious Adverse Event|47|||
163435452|NCT01165229|590299169|FG001|Overall Study|Non-Serious Adverse Event|15|||
163435453|NCT01165229|590299168|FG000|Overall Study|Protocol Violation|6|||
163435454|NCT01165229|590299169|FG001|Overall Study|Protocol Violation|8|||
163435455|NCT01165229|590299168|FG000|Overall Study|Withdrawal by Subject|387|||
163435456|NCT01165229|590299169|FG001|Overall Study|Withdrawal by Subject|396|||
163435457|NCT01165229|590299168|FG000|Overall Study|Migrated/moved from study area|51|||
163435458|NCT01165229|590299169|FG001|Overall Study|Migrated/moved from study area|46|||
163435459|NCT01165229|590299168|FG000|Overall Study|Lost to Follow-up|123|||
163435460|NCT01165229|590299169|FG001|Overall Study|Lost to Follow-up|133|||
163435461|NCT01165229|590299168|FG000|Overall Study|Suspected HZ Episode|2|||
163435462|NCT01165229|590299169|FG001|Overall Study|Suspected HZ Episode|2|||
163435463|NCT01165229|590299168|FG000|Overall Study|No reason from the subject|108|||
163435464|NCT01165229|590299169|FG001|Overall Study|No reason from the subject|102|||
163435465|NCT01165229|590299168|FG000|Overall Study|Unknown completion status|0|||
163435466|NCT01165229|590299169|FG001|Overall Study|Unknown completion status|1|||
163435467|NCT00474253|590299170|FG000|Overall Study|Withdrew consent|2|||
163435468|NCT00474253|590299171|FG001|Overall Study|Withdrew consent|0|||
163435469|NCT00474253|590299170|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
163435470|NCT00474253|590299171|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
163435471|NCT00474253|590299170|FG000|Overall Study|Lost to Follow-up|1|||
163435472|NCT00474253|590299171|FG001|Overall Study|Lost to Follow-up|0|||
163435473|NCT00474253|590299170|FG000|Overall Study|Discharged prior to study completion|0|||
163435474|NCT00474253|590299171|FG001|Overall Study|Discharged prior to study completion|1|||
163435475|NCT01357239|590299172|FG000|Stratum: All Patients|Adverse Event|0|||
163435476|NCT01357239|590299173|FG001|Stratum: All Patients|Adverse Event|0|||
163435477|NCT01357239|590299174|FG002|Stratum: All Patients|Adverse Event|1|||
163435478|NCT01357239|590299175|FG003|Stratum: All Patients|Adverse Event|1|||
163435479|NCT01357239|590299172|FG000|Stratum: All Patients|Subject withdrew consent|0|||
163435480|NCT01357239|590299173|FG001|Stratum: All Patients|Subject withdrew consent|0|||
163435481|NCT01357239|590299174|FG002|Stratum: All Patients|Subject withdrew consent|1|||
163435482|NCT01357239|590299175|FG003|Stratum: All Patients|Subject withdrew consent|1|||
163435483|NCT01357239|590299172|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
163435484|NCT01357239|590299173|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
163435485|NCT01357239|590299174|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
163435486|NCT01357239|590299175|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
163435487|NCT01357239|590299172|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
163435488|NCT01357239|590299173|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
163435489|NCT01357239|590299174|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
163435490|NCT01357239|590299175|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
163435491|NCT01357239|590299172|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
163435492|NCT01357239|590299173|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
163435493|NCT01357239|590299174|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
163435494|NCT01357239|590299175|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
163435495|NCT03133481|590299178|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
163435496|NCT03133481|590299179|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
163435497|NCT00637728|590299183|FG000|Double-blind Phase|Adverse Event|1|||
163435498|NCT00637728|590299184|FG001|Double-blind Phase|Adverse Event|0|||
163435499|NCT00637728|590299185|FG002|Double-blind Phase|Adverse Event|0|||
163435500|NCT00637728|590299183|FG000|Double-blind Phase|Non-compliance|2|||
163435501|NCT00637728|590299184|FG001|Double-blind Phase|Non-compliance|0|||
163435502|NCT00637728|590299185|FG002|Double-blind Phase|Non-compliance|0|||
163435503|NCT00637728|590299183|FG000|Double-blind Phase|Study Discontinued|1|||
163435504|NCT00637728|590299184|FG001|Double-blind Phase|Study Discontinued|1|||
163435505|NCT00637728|590299185|FG002|Double-blind Phase|Study Discontinued|0|||
163435506|NCT01873950|590299188|FG000|Period 5|Withdrawal by Subject|0|||
163435507|NCT01873950|590299189|FG001|Period 5|Withdrawal by Subject|0|||
163435508|NCT01873950|590299190|FG002|Period 5|Withdrawal by Subject|0|||
163435509|NCT01873950|590299191|FG003|Period 5|Withdrawal by Subject|1|||
163435510|NCT01873950|590299192|FG004|Period 5|Withdrawal by Subject|0|||
163435511|NCT05372315|590299194|FG000|Overall Study|Withdrawal by Subject|1|||
163435512|NCT05372315|590299195|FG001|Overall Study|Withdrawal by Subject|0|||
163435513|NCT01512368|590299197|FG000|Overall Study|Protocol Violation|3|||
163435514|NCT00328198|590299198|FG000|Treatment|Adverse Event|21|||
163435515|NCT00328198|590299198|FG000|Treatment|Death|1|||
163435516|NCT00328198|590299198|FG000|Treatment|Physician Decision|5|||
163435517|NCT00328198|590299198|FG000|Treatment|Withdrawal by Subject|5|||
163435518|NCT00328198|590299198|FG000|Treatment|Evidence of disease progression|2|||
163435519|NCT00328198|590299198|FG000|Treatment|Non-compliance|1|||
163435520|NCT00328198|590299198|FG000|Treatment|Confirmed complete response, MRD -|3|||
163435521|NCT00328198|590299198|FG000|Follow-up|Lost to Follow-up|4|||
163435522|NCT00328198|590299198|FG000|Follow-up|Death|31|||
163435523|NCT01570491|590299199|FG000|Overall Study|Lost to Follow-up|3|||
163435524|NCT01570491|590299200|FG001|Overall Study|Lost to Follow-up|1|||
163435525|NCT01570491|590299199|FG000|Overall Study|treatment: not given or discontinued|2|||
163435526|NCT01570491|590299200|FG001|Overall Study|treatment: not given or discontinued|0|||
163435527|NCT01720667|590299206|FG000|Overall Study|Adverse Event|1|||
163435528|NCT01720667|590299207|FG001|Overall Study|Adverse Event|1|||
163435529|NCT01720667|590299206|FG000|Overall Study|Withdrawal by Subject|3|||
163435530|NCT01720667|590299207|FG001|Overall Study|Withdrawal by Subject|0|||
163435531|NCT04407507|590299208|FG000|Overall Study|Withdrawal by Subject|0|||
163435532|NCT04407507|590299209|FG001|Overall Study|Withdrawal by Subject|1|||
163435533|NCT01499576|590299210|FG000|Overall Study|Physician Decision|12|||
163435534|NCT01499576|590299210|FG000|Overall Study|Withdrawal by Subject|9|||
163435535|NCT03396471|590299218|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
163435536|NCT03396471|590299218|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
163435537|NCT03396471|590299218|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
163435538|NCT03396471|590299218|FG000|Study Treatment - Up to 22 Months|Death|2|||
163435539|NCT03396471|590299218|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
163435540|NCT03396471|590299218|FG000|Follow up - Up to 2 Years|Death|9|||
163435541|NCT03396471|590299218|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
163435542|NCT03396471|590299218|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
163435543|NCT03396471|590299218|FG000|Follow up - Up to 2 Years|study terminated|1|||
163435544|NCT03396471|590299218|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
163435545|NCT03396471|590299218|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
163435546|NCT01319929|590299219|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
163435547|NCT01319929|590299220|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
163435548|NCT01319929|590299219|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
163435549|NCT01319929|590299220|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
163435550|NCT01319929|590299219|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
163435551|NCT01319929|590299220|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
163435552|NCT01319929|590299219|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
163435553|NCT01319929|590299220|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
163435554|NCT01319929|590299219|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
163435555|NCT01319929|590299220|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
163435556|NCT03237845|590299221|FG000|Overall Study|Adverse Event|0|||
163435557|NCT03237845|590299222|FG001|Overall Study|Adverse Event|1|||
163435558|NCT03237845|590299221|FG000|Overall Study|Lost to Follow-up|13|||
163435559|NCT03237845|590299222|FG001|Overall Study|Lost to Follow-up|10|||
163435560|NCT03237845|590299221|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
163435561|NCT03237845|590299222|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
163435562|NCT03237845|590299221|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
163435563|NCT03237845|590299222|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
163435564|NCT03237845|590299221|FG000|Overall Study|Physician Decision|1|||
163435565|NCT03237845|590299222|FG001|Overall Study|Physician Decision|2|||
163435566|NCT03237845|590299221|FG000|Overall Study|Pregnancy|1|||
163435567|NCT03237845|590299222|FG001|Overall Study|Pregnancy|0|||
163435568|NCT03237845|590299221|FG000|Overall Study|Protocol Deviation|0|||
163435569|NCT03237845|590299222|FG001|Overall Study|Protocol Deviation|1|||
163435570|NCT03237845|590299221|FG000|Overall Study|Technical Problems|8|||
163435571|NCT03237845|590299222|FG001|Overall Study|Technical Problems|1|||
163435572|NCT03237845|590299221|FG000|Overall Study|Withdrawal by Subject|3|||
163435573|NCT03237845|590299222|FG001|Overall Study|Withdrawal by Subject|3|||
163435574|NCT03237845|590299221|FG000|Overall Study|Other Reasons|4|||
163435575|NCT03237845|590299222|FG001|Overall Study|Other Reasons|0|||
163435576|NCT01221233|590299223|FG000|Overall Study|Withdrawal by Subject|3|||
163435577|NCT01221233|590299224|FG001|Overall Study|Withdrawal by Subject|1|||
163435578|NCT03865407|590299226|FG000|Overall Study|Adverse Event|1|||
163435579|NCT03865407|590299227|FG001|Overall Study|Adverse Event|0|||
163435580|NCT03865407|590299226|FG000|Overall Study|Withdrawal by Subject|1|||
163435581|NCT03865407|590299227|FG001|Overall Study|Withdrawal by Subject|0|||
163435582|NCT03865407|590299226|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
163435583|NCT03865407|590299227|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
163435584|NCT01645280|590299228|FG000|Overall Study|Death|0|||
163435585|NCT01645280|590299229|FG001|Overall Study|Death|1|||
163435586|NCT01645280|590299230|FG002|Overall Study|Death|0|||
163435587|NCT01645280|590299231|FG003|Overall Study|Death|0|||
163435588|NCT01645280|590299232|FG004|Overall Study|Death|0|||
163435589|NCT01645280|590299228|FG000|Overall Study|Withdrawal by Subject|4|||
163435590|NCT01645280|590299229|FG001|Overall Study|Withdrawal by Subject|0|||
163435591|NCT01645280|590299230|FG002|Overall Study|Withdrawal by Subject|2|||
163435592|NCT01645280|590299231|FG003|Overall Study|Withdrawal by Subject|4|||
163435593|NCT01645280|590299232|FG004|Overall Study|Withdrawal by Subject|5|||
163435594|NCT01645280|590299228|FG000|Overall Study|Lost to Follow-up|0|||
163435595|NCT01645280|590299229|FG001|Overall Study|Lost to Follow-up|0|||
163435596|NCT01645280|590299230|FG002|Overall Study|Lost to Follow-up|0|||
163435597|NCT01645280|590299231|FG003|Overall Study|Lost to Follow-up|2|||
163435598|NCT01645280|590299232|FG004|Overall Study|Lost to Follow-up|1|||
163435599|NCT01645280|590299228|FG000|Overall Study|Other|1|||
163435600|NCT01645280|590299229|FG001|Overall Study|Other|1|||
163435601|NCT01645280|590299230|FG002|Overall Study|Other|2|||
163435602|NCT01645280|590299231|FG003|Overall Study|Other|0|||
163435603|NCT01645280|590299232|FG004|Overall Study|Other|0|||
163435604|NCT01645280|590299228|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
163435605|NCT01645280|590299229|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
163435606|NCT01645280|590299230|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
163435607|NCT01645280|590299231|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
163435608|NCT01645280|590299232|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
163435609|NCT00234104|590299237|FG000|Overall Study|Adverse Event|4|||
163435610|NCT00234104|590299238|FG001|Overall Study|Adverse Event|0|||
163435611|NCT00234104|590299239|FG002|Overall Study|Adverse Event|3|||
163435612|NCT00234104|590299240|FG003|Overall Study|Adverse Event|5|||
163435613|NCT00234104|590299237|FG000|Overall Study|Protocol Violation|0|||
163435614|NCT00234104|590299238|FG001|Overall Study|Protocol Violation|0|||
163435615|NCT00234104|590299239|FG002|Overall Study|Protocol Violation|0|||
163435616|NCT00234104|590299240|FG003|Overall Study|Protocol Violation|1|||
163435617|NCT00234104|590299237|FG000|Overall Study|Physician Decision|0|||
163435618|NCT00234104|590299238|FG001|Overall Study|Physician Decision|1|||
163435619|NCT00234104|590299239|FG002|Overall Study|Physician Decision|2|||
163435620|NCT00234104|590299240|FG003|Overall Study|Physician Decision|2|||
163435621|NCT00546819|590299241|FG000|Overall Study|Adverse Event|2|||
163435622|NCT00546819|590299242|FG001|Overall Study|Adverse Event|3|||
163435623|NCT00546819|590299241|FG000|Overall Study|Lost to Follow-up|2|||
163435624|NCT00546819|590299242|FG001|Overall Study|Lost to Follow-up|1|||
163435625|NCT00546819|590299241|FG000|Overall Study|Withdrawal by Subject|4|||
163435626|NCT00546819|590299242|FG001|Overall Study|Withdrawal by Subject|2|||
163435627|NCT02052960|590299244|FG000|Overall Study|Adverse Event|19|||
163435628|NCT02052960|590299245|FG001|Overall Study|Adverse Event|17|||
163435629|NCT02052960|590299244|FG000|Overall Study|Protocol Violation|4|||
163435630|NCT02052960|590299245|FG001|Overall Study|Protocol Violation|3|||
163435631|NCT02052960|590299244|FG000|Overall Study|Withdrawal by Subject|6|||
163435632|NCT02052960|590299245|FG001|Overall Study|Withdrawal by Subject|11|||
163435633|NCT02052960|590299244|FG000|Overall Study|Other|25|||
163435634|NCT02052960|590299245|FG001|Overall Study|Other|15|||
163435635|NCT02460822|590299246|FG000|Overall Study|Withdrawal by Subject|1|||
163435636|NCT04045613|590299247|FG000|Overall Study|Adverse Event|2|||
163435637|NCT04045613|590299248|FG001|Overall Study|Adverse Event|2|||
163435638|NCT04045613|590299249|FG002|Overall Study|Adverse Event|1|||
163435639|NCT04045613|590299250|FG003|Overall Study|Adverse Event|1|||
163435640|NCT04045613|590299251|FG004|Overall Study|Adverse Event|0|||
163435641|NCT04045613|590299252|FG005|Overall Study|Adverse Event|0|||
163435642|NCT04045613|590299253|FG006|Overall Study|Adverse Event|1|||
163435643|NCT04045613|590299247|FG000|Overall Study|Withdrawal by Subject|0|||
163435644|NCT04045613|590299248|FG001|Overall Study|Withdrawal by Subject|5|||
163435645|NCT04045613|590299249|FG002|Overall Study|Withdrawal by Subject|0|||
163435646|NCT04045613|590299250|FG003|Overall Study|Withdrawal by Subject|0|||
163435647|NCT04045613|590299251|FG004|Overall Study|Withdrawal by Subject|0|||
163435648|NCT04045613|590299252|FG005|Overall Study|Withdrawal by Subject|1|||
163435649|NCT04045613|590299253|FG006|Overall Study|Withdrawal by Subject|0|||
163435650|NCT04045613|590299247|FG000|Overall Study|Physician Decision|2|||
163435651|NCT04045613|590299248|FG001|Overall Study|Physician Decision|0|||
163435652|NCT04045613|590299249|FG002|Overall Study|Physician Decision|0|||
163435653|NCT04045613|590299250|FG003|Overall Study|Physician Decision|0|||
163435654|NCT04045613|590299251|FG004|Overall Study|Physician Decision|1|||
163435655|NCT04045613|590299252|FG005|Overall Study|Physician Decision|0|||
163435656|NCT04045613|590299253|FG006|Overall Study|Physician Decision|0|||
163435657|NCT04045613|590299247|FG000|Overall Study|Death|3|||
163435658|NCT04045613|590299248|FG001|Overall Study|Death|0|||
163435659|NCT04045613|590299249|FG002|Overall Study|Death|0|||
163435660|NCT04045613|590299250|FG003|Overall Study|Death|0|||
163435661|NCT04045613|590299251|FG004|Overall Study|Death|0|||
163435662|NCT04045613|590299252|FG005|Overall Study|Death|0|||
163435663|NCT04045613|590299253|FG006|Overall Study|Death|1|||
163435664|NCT04045613|590299247|FG000|Overall Study|Other reasons|0|||
163435665|NCT04045613|590299248|FG001|Overall Study|Other reasons|1|||
163435666|NCT04045613|590299249|FG002|Overall Study|Other reasons|0|||
163435667|NCT04045613|590299250|FG003|Overall Study|Other reasons|0|||
163435668|NCT04045613|590299251|FG004|Overall Study|Other reasons|0|||
163435669|NCT04045613|590299252|FG005|Overall Study|Other reasons|0|||
163435670|NCT04045613|590299253|FG006|Overall Study|Other reasons|1|||
163435671|NCT04045613|590299247|FG000|Overall Study|Progressive disease: Clinical progression|1|||
163435672|NCT04045613|590299248|FG001|Overall Study|Progressive disease: Clinical progression|0|||
163435673|NCT04045613|590299249|FG002|Overall Study|Progressive disease: Clinical progression|3|||
163435674|NCT04045613|590299250|FG003|Overall Study|Progressive disease: Clinical progression|1|||
163435675|NCT04045613|590299251|FG004|Overall Study|Progressive disease: Clinical progression|1|||
163435676|NCT04045613|590299252|FG005|Overall Study|Progressive disease: Clinical progression|3|||
163435677|NCT04045613|590299253|FG006|Overall Study|Progressive disease: Clinical progression|3|||
163435678|NCT04045613|590299247|FG000|Overall Study|Progressive disease: Radiological progression|24|||
163435679|NCT04045613|590299248|FG001|Overall Study|Progressive disease: Radiological progression|6|||
163435680|NCT04045613|590299249|FG002|Overall Study|Progressive disease: Radiological progression|8|||
163435681|NCT04045613|590299250|FG003|Overall Study|Progressive disease: Radiological progression|0|||
163435682|NCT04045613|590299251|FG004|Overall Study|Progressive disease: Radiological progression|6|||
163435683|NCT04045613|590299252|FG005|Overall Study|Progressive disease: Radiological progression|6|||
163435684|NCT04045613|590299253|FG006|Overall Study|Progressive disease: Radiological progression|11|||
163435685|NCT01254344|590299261|FG000|Overall Study|Adverse Event|2|||
163435686|NCT01254344|590299262|FG001|Overall Study|Adverse Event|5|||
163435687|NCT01254344|590299261|FG000|Overall Study|Physician Decision|7|||
163435688|NCT01254344|590299262|FG001|Overall Study|Physician Decision|4|||
163435689|NCT01254344|590299261|FG000|Overall Study|Protocol Violation|1|||
163435690|NCT01254344|590299262|FG001|Overall Study|Protocol Violation|4|||
163435691|NCT01254344|590299261|FG000|Overall Study|Withdrawal by Subject|3|||
163435692|NCT01254344|590299262|FG001|Overall Study|Withdrawal by Subject|6|||
163435693|NCT00467649|590299263|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
163435694|NCT00467649|590299264|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
163435695|NCT00467649|590299265|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
163435696|NCT00467649|590299266|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
163435697|NCT00467649|590299267|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
163435698|NCT00467649|590299268|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
163435699|NCT00467649|590299263|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
163435700|NCT00467649|590299264|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
163435701|NCT00467649|590299265|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
163435702|NCT00467649|590299266|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
163435703|NCT00467649|590299267|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
163435704|NCT00467649|590299268|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
163435705|NCT00467649|590299263|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
163435706|NCT00467649|590299264|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
163435707|NCT00467649|590299265|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
163435708|NCT00467649|590299266|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
163435709|NCT00467649|590299267|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
163435710|NCT00467649|590299268|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
163435711|NCT00467649|590299263|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
163435712|NCT00467649|590299264|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
163435713|NCT00467649|590299265|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
163435714|NCT00467649|590299266|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
163435715|NCT00467649|590299267|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
163435716|NCT00467649|590299268|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
163435717|NCT00467649|590299263|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
163435718|NCT00467649|590299264|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
163435719|NCT00467649|590299265|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
163435720|NCT00467649|590299266|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
163435721|NCT00467649|590299267|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
163435722|NCT00467649|590299268|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
163435723|NCT00467649|590299263|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
163435724|NCT00467649|590299264|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
163435725|NCT00467649|590299265|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
163435726|NCT00467649|590299266|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
163435727|NCT00467649|590299267|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
163435728|NCT00467649|590299268|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
163435729|NCT00467649|590299263|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
163435730|NCT00467649|590299264|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
163435731|NCT00467649|590299265|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
163435732|NCT00467649|590299266|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
163435733|NCT00467649|590299267|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
163435734|NCT00467649|590299268|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
163435735|NCT03233048|590299271|FG000|Overall Study|Withdrawal by Subject|1|||
163435736|NCT01856673|590299272|FG000|Overall Study|Withdrawal by Subject|44|||
163435737|NCT01856673|590299273|FG001|Overall Study|Withdrawal by Subject|50|||
163435738|NCT01856673|590299274|FG002|Overall Study|Withdrawal by Subject|33|||
163435739|NCT01856673|590299272|FG000|Overall Study|Lost to Follow-up|31|||
163435740|NCT01856673|590299273|FG001|Overall Study|Lost to Follow-up|34|||
163435741|NCT01856673|590299274|FG002|Overall Study|Lost to Follow-up|0|||
163435742|NCT01856673|590299272|FG000|Overall Study|Unknown reasons|9|||
163435743|NCT01856673|590299273|FG001|Overall Study|Unknown reasons|0|||
163435744|NCT01856673|590299274|FG002|Overall Study|Unknown reasons|0|||
163435745|NCT01856673|590299272|FG000|Overall Study|Psychologist decision|1|||
163435746|NCT01856673|590299273|FG001|Overall Study|Psychologist decision|0|||
163435747|NCT01856673|590299274|FG002|Overall Study|Psychologist decision|0|||
163435748|NCT01856673|590299272|FG000|Overall Study|Paperwork errors|8|||
163435749|NCT01856673|590299273|FG001|Overall Study|Paperwork errors|0|||
163435750|NCT01856673|590299274|FG002|Overall Study|Paperwork errors|0|||
163435751|NCT01856673|590299272|FG000|Overall Study|Death|1|||
163435752|NCT01856673|590299273|FG001|Overall Study|Death|1|||
163435753|NCT01856673|590299274|FG002|Overall Study|Death|0|||
163435754|NCT01856673|590299272|FG000|Overall Study|Protocol Violation|1|||
163435755|NCT01856673|590299273|FG001|Overall Study|Protocol Violation|0|||
163435756|NCT01856673|590299274|FG002|Overall Study|Protocol Violation|1|||
163435757|NCT00883753|590299275|FG000|Overall Study|Adverse Event|37|||
163435758|NCT00883753|590299275|FG000|Overall Study|Death|2|||
163435759|NCT00883753|590299275|FG000|Overall Study|Insufficient therapeutic response|16|||
163435760|NCT00883753|590299275|FG000|Overall Study|Lost to Follow-up|4|||
163435761|NCT00883753|590299275|FG000|Overall Study|Violation of selection criteria at entry|7|||
163435762|NCT00883753|590299275|FG000|Overall Study|Protocol Violation|2|||
163435763|NCT00883753|590299275|FG000|Overall Study|Refused treatment|4|||
163435764|NCT00883753|590299275|FG000|Overall Study|Withdrew consent|10|||
163435765|NCT00883753|590299275|FG000|Overall Study|Investigator's decision|17|||
163435766|NCT00883753|590299275|FG000|Overall Study|Administrative/Other|8|||
163435767|NCT01396525|590299278|FG000|Overall Study|Withdrawal by Subject|8|||
163435768|NCT01396525|590299278|FG000|Overall Study|Death|14|||
163435769|NCT01396525|590299278|FG000|Overall Study|Lost to Follow-up|4|||
163435770|NCT03114969|590299279|FG000|Overall Study|Lost to Follow-up|0|||
163435771|NCT03114969|590299280|FG001|Overall Study|Lost to Follow-up|0|||
163435772|NCT03114969|590299281|FG002|Overall Study|Lost to Follow-up|3|||
163435773|NCT03114969|590299282|FG003|Overall Study|Lost to Follow-up|2|||
163435774|NCT03114969|590299283|FG004|Overall Study|Lost to Follow-up|0|||
163435775|NCT03114969|590299284|FG005|Overall Study|Lost to Follow-up|0|||
163435776|NCT03114969|590299285|FG006|Overall Study|Lost to Follow-up|0|||
163435777|NCT03114969|590299286|FG007|Overall Study|Lost to Follow-up|0|||
163435778|NCT03114969|590299287|FG008|Overall Study|Lost to Follow-up|0|||
163435779|NCT03114969|590299279|FG000|Overall Study|Adverse Event|0|||
163435780|NCT03114969|590299280|FG001|Overall Study|Adverse Event|0|||
163435781|NCT03114969|590299281|FG002|Overall Study|Adverse Event|1|||
163435782|NCT03114969|590299282|FG003|Overall Study|Adverse Event|0|||
163435783|NCT03114969|590299283|FG004|Overall Study|Adverse Event|0|||
163435784|NCT03114969|590299284|FG005|Overall Study|Adverse Event|1|||
163435785|NCT03114969|590299285|FG006|Overall Study|Adverse Event|1|||
163435786|NCT03114969|590299286|FG007|Overall Study|Adverse Event|0|||
163435787|NCT03114969|590299287|FG008|Overall Study|Adverse Event|2|||
163435788|NCT00971321|590299288|FG000|Up to Month 7|Withdrawal by Subject|1|||
163435789|NCT00971321|590299289|FG001|Up to Month 7|Withdrawal by Subject|0|||
163435790|NCT00971321|590299288|FG000|Up to Month 7|Migrated/moved from study area|3|||
163435791|NCT00971321|590299289|FG001|Up to Month 7|Migrated/moved from study area|2|||
163435792|NCT00971321|590299288|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
163435793|NCT00971321|590299289|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
163435794|NCT00971321|590299288|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
163435795|NCT00971321|590299289|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
163435796|NCT00971321|590299288|FG000|Up to Month 11-12|Lost to Follow-up|1|||
163435797|NCT00971321|590299289|FG001|Up to Month 11-12|Lost to Follow-up|0|||
163435798|NCT02436239|590299293|FG000|Open-Lable Treatment Period|Adverse Event|12|||
163435799|NCT02436239|590299294|FG001|Open-Lable Treatment Period|Adverse Event|3|||
163435800|NCT02436239|590299295|FG002|Open-Lable Treatment Period|Adverse Event|4|||
163435801|NCT02436239|590299296|FG003|Open-Lable Treatment Period|Adverse Event|2|||
163435802|NCT02436239|590299293|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
163435803|NCT02436239|590299294|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
163435804|NCT02436239|590299295|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
163435805|NCT02436239|590299296|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
163435806|NCT02436239|590299293|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
163435807|NCT02436239|590299294|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
163435808|NCT02436239|590299295|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
163435809|NCT02436239|590299296|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
163435810|NCT02436239|590299293|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
163435811|NCT02436239|590299294|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
163435812|NCT02436239|590299295|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
163435813|NCT02436239|590299296|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
163435814|NCT02436239|590299293|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
163435815|NCT02436239|590299294|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
163435816|NCT02436239|590299295|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
163435817|NCT02436239|590299296|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
163435818|NCT02436239|590299293|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
163435819|NCT02436239|590299294|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
163435820|NCT02436239|590299295|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
163435821|NCT02436239|590299296|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
163435822|NCT02436239|590299293|FG000|Open-Lable Treatment Period|Other Reason|1|||
163435823|NCT02436239|590299294|FG001|Open-Lable Treatment Period|Other Reason|1|||
163435824|NCT02436239|590299295|FG002|Open-Lable Treatment Period|Other Reason|0|||
163435825|NCT02436239|590299296|FG003|Open-Lable Treatment Period|Other Reason|0|||
163435826|NCT02436239|590299293|FG000|Down-Taper Period|Withdrawal by Subject|4|||
163435827|NCT02436239|590299294|FG001|Down-Taper Period|Withdrawal by Subject|4|||
163435828|NCT02436239|590299295|FG002|Down-Taper Period|Withdrawal by Subject|1|||
163435829|NCT02436239|590299296|FG003|Down-Taper Period|Withdrawal by Subject|2|||
163435830|NCT02168946|590299297|FG000|Overall Study|Adverse Event|8|||
163435831|NCT02168946|590299298|FG001|Overall Study|Adverse Event|5|||
163435832|NCT02168946|590299297|FG000|Overall Study|Lost to Follow-up|3|||
163435833|NCT02168946|590299298|FG001|Overall Study|Lost to Follow-up|0|||
163435834|NCT02168946|590299297|FG000|Overall Study|Subject unable to come back for visits|1|||
163435835|NCT02168946|590299298|FG001|Overall Study|Subject unable to come back for visits|0|||
163435836|NCT00450866|590299303|FG000|Overall Study|Adverse Event|0|||
163435837|NCT00450866|590299304|FG001|Overall Study|Adverse Event|1|||
163435838|NCT00450866|590299303|FG000|Overall Study|Withdrawal by Subject|5|||
163435839|NCT00450866|590299304|FG001|Overall Study|Withdrawal by Subject|2|||
163435840|NCT00450866|590299303|FG000|Overall Study|Death|1|||
163435841|NCT00450866|590299304|FG001|Overall Study|Death|0|||
163435842|NCT00450866|590299303|FG000|Overall Study|Physician Decision|1|||
163435843|NCT00450866|590299304|FG001|Overall Study|Physician Decision|0|||
163435844|NCT02675517|590299305|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
163435845|NCT02675517|590299305|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
163435846|NCT03443024|590299308|FG000|Overall Study|Adverse Event|2|||
163435847|NCT03443024|590299309|FG001|Overall Study|Adverse Event|4|||
163435848|NCT03443024|590299310|FG002|Overall Study|Adverse Event|3|||
163435849|NCT03443024|590299311|FG003|Overall Study|Adverse Event|1|||
163435850|NCT03443024|590299308|FG000|Overall Study|Lost to Follow-up|9|||
163435851|NCT03443024|590299309|FG001|Overall Study|Lost to Follow-up|9|||
163435852|NCT03443024|590299310|FG002|Overall Study|Lost to Follow-up|7|||
163435853|NCT03443024|590299311|FG003|Overall Study|Lost to Follow-up|5|||
163435854|NCT03443024|590299308|FG000|Overall Study|Withdrawal by Subject|8|||
163435855|NCT03443024|590299309|FG001|Overall Study|Withdrawal by Subject|15|||
163435856|NCT03443024|590299310|FG002|Overall Study|Withdrawal by Subject|9|||
163435857|NCT03443024|590299311|FG003|Overall Study|Withdrawal by Subject|23|||
163435858|NCT03443024|590299308|FG000|Overall Study|Physician Decision|1|||
163435859|NCT03443024|590299309|FG001|Overall Study|Physician Decision|2|||
163435860|NCT03443024|590299310|FG002|Overall Study|Physician Decision|0|||
163435861|NCT03443024|590299311|FG003|Overall Study|Physician Decision|1|||
163435862|NCT03443024|590299308|FG000|Overall Study|Sponsor Decision|1|||
163435863|NCT03443024|590299309|FG001|Overall Study|Sponsor Decision|1|||
163435864|NCT03443024|590299310|FG002|Overall Study|Sponsor Decision|0|||
163435865|NCT03443024|590299311|FG003|Overall Study|Sponsor Decision|0|||
163435866|NCT03443024|590299308|FG000|Overall Study|Protocol Deviation|0|||
163435867|NCT03443024|590299309|FG001|Overall Study|Protocol Deviation|0|||
163435868|NCT03443024|590299310|FG002|Overall Study|Protocol Deviation|0|||
163435869|NCT03443024|590299311|FG003|Overall Study|Protocol Deviation|2|||
163435870|NCT02782715|590299312|FG000|Overall Study|Withdrawal by Subject|1|||
163435871|NCT02453841|590299330|FG000|Overall Study|Protocol Violation|1|||
163435872|NCT02453841|590299330|FG000|Overall Study|Unable to obtain blood samples|2|||
163435873|NCT01751646|590299331|FG000|Overall Study|Lost to Follow-up|5|||
163435874|NCT01751646|590299332|FG001|Overall Study|Lost to Follow-up|1|||
163435875|NCT01751646|590299331|FG000|Overall Study|Withdrawal by Subject|0|||
163435876|NCT01751646|590299332|FG001|Overall Study|Withdrawal by Subject|4|||
163435877|NCT01751646|590299331|FG000|Overall Study|Starting hormone therapy|1|||
163435878|NCT01751646|590299332|FG001|Overall Study|Starting hormone therapy|0|||
163435879|NCT01751646|590299331|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
163435880|NCT01751646|590299332|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
163435881|NCT01751646|590299331|FG000|Overall Study|Inadvertent enrollment|1|||
163435882|NCT01751646|590299332|FG001|Overall Study|Inadvertent enrollment|1|||
163435883|NCT01751646|590299331|FG000|Overall Study|Moved out of the area|1|||
163435884|NCT01751646|590299332|FG001|Overall Study|Moved out of the area|5|||
163435885|NCT01751646|590299331|FG000|Overall Study|Inability to attend required visits|0|||
163435886|NCT01751646|590299332|FG001|Overall Study|Inability to attend required visits|1|||
163435887|NCT01751646|590299331|FG000|Overall Study|Off study due to multiple obligations|0|||
163435888|NCT01751646|590299332|FG001|Overall Study|Off study due to multiple obligations|1|||
163435889|NCT01751646|590299331|FG000|Overall Study|Fails to comply with study requirements|0|||
163435890|NCT01751646|590299332|FG001|Overall Study|Fails to comply with study requirements|1|||
163435891|NCT01751646|590299331|FG000|Overall Study|Childcare issues|1|||
163435892|NCT01751646|590299332|FG001|Overall Study|Childcare issues|1|||
163435893|NCT02190591|590299333|FG000|Overall Study|Withdrawal by Subject|1|||
163435894|NCT02190591|590299334|FG001|Overall Study|Withdrawal by Subject|8|||
163435895|NCT02190591|590299333|FG000|Overall Study|Protocol Violation|1|||
163435896|NCT02190591|590299334|FG001|Overall Study|Protocol Violation|0|||
163435897|NCT02190591|590299333|FG000|Overall Study|did not use peanut ball as instructed|0|||
163435898|NCT02190591|590299334|FG001|Overall Study|did not use peanut ball as instructed|2|||
163435899|NCT02190591|590299333|FG000|Overall Study|face presentation so she was ineligible|0|||
163435900|NCT02190591|590299334|FG001|Overall Study|face presentation so she was ineligible|1|||
163435901|NCT01151137|590299335|FG000|Overall Study|Death|15|||
163435902|NCT01151137|590299336|FG001|Overall Study|Death|27|||
163435903|NCT01151137|590299335|FG000|Overall Study|Lost to Follow-up|1|||
163435904|NCT01151137|590299336|FG001|Overall Study|Lost to Follow-up|1|||
163435905|NCT02277444|590299339|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
163435906|NCT02277444|590299339|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
163435907|NCT02277444|590299339|FG000|Treatment Period (Week 0-52)|Other|1|||
163435908|NCT02277444|590299339|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
163435909|NCT02277444|590299339|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
163435910|NCT02277444|590299339|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
163435911|NCT02277444|590299339|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
163435912|NCT02277444|590299339|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
163435913|NCT02277444|590299339|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
163435914|NCT02031146|590300572|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
163435915|NCT02031146|590300573|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
163435916|NCT02031146|590300574|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
163435917|NCT02031146|590300575|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
163435918|NCT02031146|590300576|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
163435919|NCT02031146|590300577|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
163435920|NCT02031146|590300578|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
163435921|NCT01486316|590300579|FG000|Overall Study|Device explanted with/without re-implant|3|||
163435922|NCT01486316|590300580|FG001|Overall Study|Device explanted with/without re-implant|2|||
163435923|NCT01486316|590300581|FG002|Overall Study|Device explanted with/without re-implant|0|||
163435924|NCT01486316|590300582|FG003|Overall Study|Device explanted with/without re-implant|2|||
163435925|NCT01486316|590300579|FG000|Overall Study|Not meeting eligibility criteria|0|||
163435926|NCT01486316|590300580|FG001|Overall Study|Not meeting eligibility criteria|0|||
163435927|NCT01486316|590300581|FG002|Overall Study|Not meeting eligibility criteria|1|||
163435928|NCT01486316|590300582|FG003|Overall Study|Not meeting eligibility criteria|0|||
163435929|NCT01486316|590300579|FG000|Overall Study|Withdrawal by Subject|1|||
163435930|NCT01486316|590300580|FG001|Overall Study|Withdrawal by Subject|0|||
163435931|NCT01486316|590300581|FG002|Overall Study|Withdrawal by Subject|3|||
163435932|NCT01486316|590300582|FG003|Overall Study|Withdrawal by Subject|0|||
163435933|NCT01486316|590300579|FG000|Overall Study|Physician Decision|0|||
163435934|NCT01486316|590300580|FG001|Overall Study|Physician Decision|0|||
163435935|NCT01486316|590300581|FG002|Overall Study|Physician Decision|1|||
163435936|NCT01486316|590300582|FG003|Overall Study|Physician Decision|0|||
163435937|NCT01486316|590300579|FG000|Overall Study|Death|0|||
163435938|NCT01486316|590300580|FG001|Overall Study|Death|1|||
163435939|NCT01486316|590300581|FG002|Overall Study|Death|0|||
163435940|NCT01486316|590300582|FG003|Overall Study|Death|0|||
163435941|NCT02452970|590300589|FG000|Overall Study|Adverse Event|1|||
163435942|NCT02100657|590300590|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
163435943|NCT02100657|590300591|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
163435944|NCT02100657|590300592|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
163435945|NCT02100657|590300590|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
163435946|NCT02100657|590300591|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
163435947|NCT02100657|590300592|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
163435948|NCT02100657|590300590|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
163435949|NCT02100657|590300591|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
163435950|NCT02100657|590300592|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
163435951|NCT02100657|590300590|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
163435952|NCT02100657|590300591|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
163435953|NCT02100657|590300592|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
163435954|NCT02100657|590300590|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
163435955|NCT02100657|590300591|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
163435956|NCT02100657|590300592|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
163435957|NCT02100657|590300590|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
163435958|NCT02100657|590300591|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
163435959|NCT02100657|590300592|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
163435960|NCT02100657|590300590|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
163435961|NCT02100657|590300591|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
163435962|NCT02100657|590300592|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
163435963|NCT02100657|590300590|FG000|Cohort 3: Dose Level 3|Death|0|||
163435964|NCT02100657|590300591|FG001|Cohort 3: Dose Level 3|Death|0|||
163435965|NCT02100657|590300592|FG002|Cohort 3: Dose Level 3|Death|1|||
163435966|NCT02100657|590300590|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
163435967|NCT02100657|590300591|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
163435968|NCT02100657|590300592|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
163435969|NCT02100657|590300590|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
163435970|NCT02100657|590300591|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
163435971|NCT02100657|590300592|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
163435972|NCT02100657|590300590|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
163435973|NCT02100657|590300591|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
163435974|NCT02100657|590300592|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
163435975|NCT02100657|590300590|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
163435976|NCT02100657|590300591|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
163435977|NCT02100657|590300592|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
163435978|NCT02100657|590300590|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
163435979|NCT02100657|590300591|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
163435980|NCT02100657|590300592|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
163435981|NCT02531035|590300593|FG000|Overall Study|Death|0|||
163435982|NCT02531035|590300594|FG001|Overall Study|Death|1|||
163435983|NCT02531035|590300593|FG000|Overall Study|Protocol Violation|1|||
163435984|NCT02531035|590300594|FG001|Overall Study|Protocol Violation|1|||
163435985|NCT02531035|590300593|FG000|Overall Study|Noncompliance with study drug|8|||
163435986|NCT02531035|590300594|FG001|Overall Study|Noncompliance with study drug|3|||
163435987|NCT02531035|590300593|FG000|Overall Study|Physician Decision|1|||
163435988|NCT02531035|590300594|FG001|Overall Study|Physician Decision|0|||
163435989|NCT02531035|590300593|FG000|Overall Study|Adverse Event|16|||
163435990|NCT02531035|590300594|FG001|Overall Study|Adverse Event|45|||
163435991|NCT02531035|590300593|FG000|Overall Study|Other|3|||
163435992|NCT02531035|590300594|FG001|Overall Study|Other|2|||
163435993|NCT02531035|590300593|FG000|Overall Study|Withdrawal by Subject|42|||
163435994|NCT02531035|590300594|FG001|Overall Study|Withdrawal by Subject|32|||
163435995|NCT02531035|590300593|FG000|Overall Study|Lost to Follow-up|8|||
163435996|NCT02531035|590300594|FG001|Overall Study|Lost to Follow-up|10|||
163435997|NCT02531035|590300593|FG000|Overall Study|Randomized, not treated|2|||
163435998|NCT02531035|590300594|FG001|Overall Study|Randomized, not treated|1|||
163435999|NCT01543490|590300596|FG000|Overall Study|Adverse Event|4|||
163436000|NCT01543490|590300597|FG001|Overall Study|Adverse Event|0|||
163436001|NCT01543490|590300596|FG000|Overall Study|Physician Decision|1|||
163436002|NCT01543490|590300597|FG001|Overall Study|Physician Decision|0|||
163436003|NCT01543490|590300596|FG000|Overall Study|Lack of Efficacy|3|||
163436004|NCT01543490|590300597|FG001|Overall Study|Lack of Efficacy|3|||
163436005|NCT01543490|590300596|FG000|Overall Study|Lost to Follow-up|5|||
163436006|NCT01543490|590300597|FG001|Overall Study|Lost to Follow-up|0|||
163436007|NCT01543490|590300596|FG000|Overall Study|Withdrawal by Subject|2|||
163436008|NCT01543490|590300597|FG001|Overall Study|Withdrawal by Subject|0|||
163436009|NCT01543490|590300596|FG000|Overall Study|Other-Various Administrative Reasons|1|||
163436010|NCT01543490|590300597|FG001|Overall Study|Other-Various Administrative Reasons|2|||
163436011|NCT01040832|590300602|FG000|Overall Study|Adverse Event|4|||
163436012|NCT01040832|590300603|FG001|Overall Study|Adverse Event|5|||
163436013|NCT01040832|590300602|FG000|Overall Study|Death|4|||
163436014|NCT01040832|590300603|FG001|Overall Study|Death|6|||
163436015|NCT01040832|590300602|FG000|Overall Study|Withdrawal by Subject|2|||
163436016|NCT01040832|590300603|FG001|Overall Study|Withdrawal by Subject|3|||
163436017|NCT01040832|590300602|FG000|Overall Study|Progressive disease|32|||
163436018|NCT01040832|590300603|FG001|Overall Study|Progressive disease|17|||
163436019|NCT01040832|590300602|FG000|Overall Study|Symptomatic deterioration|2|||
163436020|NCT01040832|590300603|FG001|Overall Study|Symptomatic deterioration|5|||
163436021|NCT01040832|590300602|FG000|Overall Study|Other|2|||
163436022|NCT01040832|590300603|FG001|Overall Study|Other|1|||
163436023|NCT01712438|590300604|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
163436024|NCT01712438|590300604|FG000|Overall Study|Ongoing ITI treatment|6|||
163436025|NCT01712438|590300604|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
163436026|NCT01712438|590300604|FG000|Overall Study|Prematurely Discontinued|25|||
163436027|NCT01335971|590300605|FG000|Overall Study|Withdrawal by Subject|1|||
163436028|NCT01335971|590300606|FG001|Overall Study|Withdrawal by Subject|0|||
163436029|NCT01335971|590300607|FG002|Overall Study|Withdrawal by Subject|0|||
163436030|NCT01335971|590300605|FG000|Overall Study|Did not complete bronchoscopy|1|||
163436031|NCT01335971|590300606|FG001|Overall Study|Did not complete bronchoscopy|1|||
163436032|NCT01335971|590300607|FG002|Overall Study|Did not complete bronchoscopy|1|||
163436033|NCT03849560|590300608|FG000|Overall Study|Withdrawal by Subject|1|||
163436034|NCT03849560|590300609|FG001|Overall Study|Withdrawal by Subject|0|||
163436035|NCT03849560|590300610|FG002|Overall Study|Withdrawal by Subject|0|||
163436036|NCT01633060|590300613|FG000|Randomization Phase|Protocol deviation|1|||
163436037|NCT01633060|590300614|FG001|Randomization Phase|Protocol deviation|2|||
163436038|NCT01633060|590300613|FG000|Randomization Phase|Technical problem|0|||
163436039|NCT01633060|590300614|FG001|Randomization Phase|Technical problem|1|||
163436040|NCT01633060|590300613|FG000|Treatment Phase|Adverse Event|24|||
163436041|NCT01633060|590300614|FG001|Treatment Phase|Adverse Event|3|||
163436042|NCT01633060|590300613|FG000|Treatment Phase|Lost to Follow-up|1|||
163436043|NCT01633060|590300614|FG001|Treatment Phase|Lost to Follow-up|0|||
163436044|NCT01633060|590300613|FG000|Treatment Phase|Physician Decision|16|||
163436045|NCT01633060|590300614|FG001|Treatment Phase|Physician Decision|7|||
163436046|NCT01633060|590300613|FG000|Treatment Phase|Progressive Disease|210|||
163436047|NCT01633060|590300614|FG001|Treatment Phase|Progressive Disease|120|||
163436048|NCT01633060|590300613|FG000|Treatment Phase|Protocol Deviation|1|||
163436049|NCT01633060|590300614|FG001|Treatment Phase|Protocol Deviation|0|||
163436050|NCT01633060|590300613|FG000|Treatment Phase|Study Terminated by sponsor|7|||
163436051|NCT01633060|590300614|FG001|Treatment Phase|Study Terminated by sponsor|3|||
163436052|NCT01633060|590300613|FG000|Treatment Phase|Subject/guardian decision|25|||
163436053|NCT01633060|590300614|FG001|Treatment Phase|Subject/guardian decision|4|||
163436054|NCT01633060|590300613|FG000|Treatment Phase|Death|4|||
163436055|NCT01633060|590300614|FG001|Treatment Phase|Death|3|||
163436056|NCT01633060|590300613|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
163436057|NCT01633060|590300614|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
163436058|NCT01633060|590300613|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
163436059|NCT01633060|590300614|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
163436060|NCT01633060|590300613|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
163436061|NCT01633060|590300614|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
163436062|NCT01633060|590300613|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
163436063|NCT01633060|590300614|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
163436064|NCT01633060|590300613|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
163436065|NCT01633060|590300614|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
163436066|NCT01633060|590300613|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
163436067|NCT01633060|590300614|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
163436068|NCT02859415|590300615|FG000|Overall Study|Physician Decision|1|||
163436069|NCT02859415|590300616|FG001|Overall Study|Physician Decision|0|||
163436070|NCT02859415|590300615|FG000|Overall Study|Off treatment due to cardiac event|0|||
163436071|NCT02859415|590300616|FG001|Overall Study|Off treatment due to cardiac event|1|||
163436072|NCT00414440|590300617|FG000|Core Period|Withdrawal by Subject|70|||
163436073|NCT00414440|590300618|FG001|Core Period|Withdrawal by Subject|32|||
163436074|NCT00414440|590300617|FG000|Extension Period|Lost to Follow-up|44|||
163436075|NCT00414440|590300618|FG001|Extension Period|Lost to Follow-up|52|||
163436076|NCT00414440|590300617|FG000|Extension Period|Did not consent to continue follow up|61|||
163436077|NCT00414440|590300618|FG001|Extension Period|Did not consent to continue follow up|54|||
163436078|NCT00414440|590300617|FG000|Extension Period|Other|1|||
163436079|NCT00414440|590300618|FG001|Extension Period|Other|1|||
163436080|NCT00414440|590300617|FG000|Extension Period|Administrative|16|||
163436081|NCT00414440|590300618|FG001|Extension Period|Administrative|16|||
163436082|NCT00414440|590300617|FG000|Extension Period|Death|1|||
163436083|NCT00414440|590300618|FG001|Extension Period|Death|2|||
163436084|NCT00414440|590300617|FG000|Extension Period|Withdrawal by Subject|9|||
163436085|NCT00414440|590300618|FG001|Extension Period|Withdrawal by Subject|7|||
163436086|NCT00414440|590300617|FG000|Extension Period|Not included in follow up period|18|||
163436087|NCT00414440|590300618|FG001|Extension Period|Not included in follow up period|8|||
163436088|NCT01743027|590300622|FG000|Overall Study|Adverse Event|2|||
163436089|NCT01743027|590300623|FG001|Overall Study|Adverse Event|0|||
163436090|NCT01743027|590300624|FG002|Overall Study|Adverse Event|0|||
163436091|NCT01743027|590300625|FG003|Overall Study|Adverse Event|0|||
163436092|NCT01743027|590300622|FG000|Overall Study|Lost to Follow-up|0|||
163436093|NCT01743027|590300623|FG001|Overall Study|Lost to Follow-up|0|||
163436094|NCT01743027|590300624|FG002|Overall Study|Lost to Follow-up|2|||
163436095|NCT01743027|590300625|FG003|Overall Study|Lost to Follow-up|0|||
163436096|NCT01743027|590300622|FG000|Overall Study|Progressive Disease|1|||
163436097|NCT01743027|590300623|FG001|Overall Study|Progressive Disease|4|||
163436098|NCT01743027|590300624|FG002|Overall Study|Progressive Disease|3|||
163436099|NCT01743027|590300625|FG003|Overall Study|Progressive Disease|0|||
163436100|NCT01743027|590300622|FG000|Overall Study|Protocol Violation|1|||
163436101|NCT01743027|590300623|FG001|Overall Study|Protocol Violation|1|||
163436102|NCT01743027|590300624|FG002|Overall Study|Protocol Violation|1|||
163436103|NCT01743027|590300625|FG003|Overall Study|Protocol Violation|0|||
163436104|NCT01743027|590300622|FG000|Overall Study|Withdrawal by Subject|1|||
163436105|NCT01743027|590300623|FG001|Overall Study|Withdrawal by Subject|0|||
163436106|NCT01743027|590300624|FG002|Overall Study|Withdrawal by Subject|3|||
163436107|NCT01743027|590300625|FG003|Overall Study|Withdrawal by Subject|1|||
163436108|NCT00138151|590300626|FG000|Overall Study|Withdrawal by Subject|3|||
163436109|NCT00138151|590300626|FG000|Overall Study|Physician Decision|1|||
163436110|NCT04925570|590300629|FG000|Overall Study|Protocol Violation|24|||
163436111|NCT04925570|590300630|FG001|Overall Study|Protocol Violation|30|||
163436112|NCT04925570|590300629|FG000|Overall Study|Withdrawal by Subject|0|||
163436113|NCT04925570|590300630|FG001|Overall Study|Withdrawal by Subject|2|||
163436114|NCT01088412|590300631|FG000|Overall Study|Adverse Event|38|||
163436115|NCT01088412|590300632|FG001|Overall Study|Adverse Event|0|||
163436116|NCT01088412|590300633|FG002|Overall Study|Adverse Event|0|||
163436117|NCT01088412|590300631|FG000|Overall Study|Death|42|||
163436118|NCT01088412|590300632|FG001|Overall Study|Death|6|||
163436119|NCT01088412|590300633|FG002|Overall Study|Death|0|||
163436120|NCT01088412|590300631|FG000|Overall Study|Other Reason per Case Report Form|2089|||
163436121|NCT01088412|590300632|FG001|Overall Study|Other Reason per Case Report Form|103|||
163436122|NCT01088412|590300633|FG002|Overall Study|Other Reason per Case Report Form|9|||
163436123|NCT01088412|590300631|FG000|Overall Study|Withdrawal by Subject|1761|||
163436124|NCT01088412|590300632|FG001|Overall Study|Withdrawal by Subject|25|||
163436125|NCT01088412|590300633|FG002|Overall Study|Withdrawal by Subject|1|||
163436126|NCT01088412|590300631|FG000|Overall Study|Received Another GH Product|79|||
163436127|NCT01088412|590300632|FG001|Overall Study|Received Another GH Product|0|||
163436128|NCT01088412|590300633|FG002|Overall Study|Received Another GH Product|0|||
163436129|NCT01088412|590300631|FG000|Overall Study|Participant Moved|601|||
163436130|NCT01088412|590300632|FG001|Overall Study|Participant Moved|21|||
163436131|NCT01088412|590300633|FG002|Overall Study|Participant Moved|2|||
163436132|NCT01088412|590300631|FG000|Overall Study|Physician Decision|1041|||
163436133|NCT01088412|590300632|FG001|Overall Study|Physician Decision|8|||
163436134|NCT01088412|590300633|FG002|Overall Study|Physician Decision|4|||
163436135|NCT01088412|590300631|FG000|Overall Study|Sponsor Decision|4467|||
163436136|NCT01088412|590300632|FG001|Overall Study|Sponsor Decision|79|||
163436137|NCT01088412|590300633|FG002|Overall Study|Sponsor Decision|23|||
163436138|NCT01088412|590300631|FG000|Overall Study|Third Party Required to Change Brand|487|||
163436139|NCT01088412|590300632|FG001|Overall Study|Third Party Required to Change Brand|0|||
163436140|NCT01088412|590300633|FG002|Overall Study|Third Party Required to Change Brand|0|||
163436141|NCT01088412|590300631|FG000|Overall Study|Lost to Follow-up|3052|||
163436142|NCT01088412|590300632|FG001|Overall Study|Lost to Follow-up|130|||
163436143|NCT01088412|590300633|FG002|Overall Study|Lost to Follow-up|11|||
163436144|NCT01088412|590300631|FG000|Overall Study|Study Summary Not Completed|4360|||
163436145|NCT01088412|590300632|FG001|Overall Study|Study Summary Not Completed|64|||
163436146|NCT01088412|590300633|FG002|Overall Study|Study Summary Not Completed|22|||
163436147|NCT00793104|590300634|FG000|Overall Study|Lost to Follow-up|1|||
163436148|NCT03494725|590300637|FG000|Overall Study|Withdrawal by Subject|0|||
163436149|NCT03494725|590300638|FG001|Overall Study|Withdrawal by Subject|2|||
163436150|NCT03494725|590300637|FG000|Overall Study|Antibiotic use|1|||
163436151|NCT03494725|590300638|FG001|Overall Study|Antibiotic use|0|||
163436152|NCT02619253|590300639|FG000|Overall Study|Adverse Event|0|||
163436153|NCT02619253|590300640|FG001|Overall Study|Adverse Event|0|||
163436154|NCT02619253|590300641|FG002|Overall Study|Adverse Event|1|||
163436155|NCT02619253|590300642|FG003|Overall Study|Adverse Event|1|||
163436156|NCT02619253|590300643|FG004|Overall Study|Adverse Event|3|||
163436157|NCT02619253|590300639|FG000|Overall Study|Alternative Therapy|0|||
163436158|NCT02619253|590300640|FG001|Overall Study|Alternative Therapy|0|||
163436159|NCT02619253|590300641|FG002|Overall Study|Alternative Therapy|1|||
163436160|NCT02619253|590300642|FG003|Overall Study|Alternative Therapy|0|||
163436161|NCT02619253|590300643|FG004|Overall Study|Alternative Therapy|0|||
163436162|NCT02619253|590300639|FG000|Overall Study|Death|0|||
163436163|NCT02619253|590300640|FG001|Overall Study|Death|0|||
163436164|NCT02619253|590300641|FG002|Overall Study|Death|0|||
163436165|NCT02619253|590300642|FG003|Overall Study|Death|1|||
163436166|NCT02619253|590300643|FG004|Overall Study|Death|0|||
163436167|NCT02619253|590300639|FG000|Overall Study|Disease Progression|4|||
163436168|NCT02619253|590300640|FG001|Overall Study|Disease Progression|2|||
163436169|NCT02619253|590300641|FG002|Overall Study|Disease Progression|8|||
163436170|NCT02619253|590300642|FG003|Overall Study|Disease Progression|9|||
163436171|NCT02619253|590300643|FG004|Overall Study|Disease Progression|10|||
163436172|NCT02619253|590300639|FG000|Overall Study|Needed a disqualifying therapy|0|||
163436173|NCT02619253|590300640|FG001|Overall Study|Needed a disqualifying therapy|0|||
163436174|NCT02619253|590300641|FG002|Overall Study|Needed a disqualifying therapy|1|||
163436175|NCT02619253|590300642|FG003|Overall Study|Needed a disqualifying therapy|0|||
163436176|NCT02619253|590300643|FG004|Overall Study|Needed a disqualifying therapy|0|||
163436177|NCT02619253|590300639|FG000|Overall Study|Transferred to hospice|0|||
163436178|NCT02619253|590300640|FG001|Overall Study|Transferred to hospice|0|||
163436179|NCT02619253|590300641|FG002|Overall Study|Transferred to hospice|1|||
163436180|NCT02619253|590300642|FG003|Overall Study|Transferred to hospice|0|||
163436181|NCT02619253|590300643|FG004|Overall Study|Transferred to hospice|0|||
163436182|NCT02619253|590300639|FG000|Overall Study|Physician Decision|0|||
163436183|NCT02619253|590300640|FG001|Overall Study|Physician Decision|1|||
163436184|NCT02619253|590300641|FG002|Overall Study|Physician Decision|2|||
163436185|NCT02619253|590300642|FG003|Overall Study|Physician Decision|3|||
163436186|NCT02619253|590300643|FG004|Overall Study|Physician Decision|0|||
163436187|NCT02619253|590300639|FG000|Overall Study|Withdrawal by Subject|0|||
163436188|NCT02619253|590300640|FG001|Overall Study|Withdrawal by Subject|1|||
163436189|NCT02619253|590300641|FG002|Overall Study|Withdrawal by Subject|0|||
163436190|NCT02619253|590300642|FG003|Overall Study|Withdrawal by Subject|0|||
163436191|NCT02619253|590300643|FG004|Overall Study|Withdrawal by Subject|2|||
163436192|NCT02111811|590300644|FG000|Treatment Phase|Lost to Follow-up|22|||
163436193|NCT02111811|590300645|FG001|Treatment Phase|Lost to Follow-up|18|||
163436194|NCT02111811|590300644|FG000|Treatment Phase|Death|2|||
163436195|NCT02111811|590300645|FG001|Treatment Phase|Death|0|||
163436196|NCT02111811|590300644|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
163436197|NCT02111811|590300645|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
163436198|NCT02111811|590300644|FG000|Follow up Period (Aim 2)|Death|2|||
163436199|NCT02111811|590300645|FG001|Follow up Period (Aim 2)|Death|0|||
163436200|NCT01359982|590300646|FG000|Overall Study|Adverse Event|2|||
163436201|NCT01359982|590300647|FG001|Overall Study|Adverse Event|0|||
163436202|NCT01359982|590300648|FG002|Overall Study|Adverse Event|0|||
163436203|NCT01359982|590300649|FG003|Overall Study|Adverse Event|1|||
163436204|NCT01359982|590300650|FG004|Overall Study|Adverse Event|0|||
163436205|NCT01359982|590300651|FG005|Overall Study|Adverse Event|0|||
163436206|NCT01359982|590300646|FG000|Overall Study|Death|1|||
163436207|NCT01359982|590300647|FG001|Overall Study|Death|0|||
163436208|NCT01359982|590300648|FG002|Overall Study|Death|0|||
163436209|NCT01359982|590300649|FG003|Overall Study|Death|0|||
163436210|NCT01359982|590300650|FG004|Overall Study|Death|0|||
163436211|NCT01359982|590300651|FG005|Overall Study|Death|0|||
163436212|NCT05593432|590300652|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
163436213|NCT05593432|590300653|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
163436214|NCT05593432|590300654|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
163436215|NCT05593432|590300655|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
163436216|NCT05593432|590300652|FG000|16-Week OLE Period|Lack of Efficacy|0|||
163436217|NCT05593432|590300653|FG001|16-Week OLE Period|Lack of Efficacy|0|||
163436218|NCT05593432|590300654|FG002|16-Week OLE Period|Lack of Efficacy|0|||
163436219|NCT05593432|590300655|FG003|16-Week OLE Period|Lack of Efficacy|1|||
163436220|NCT05593432|590300652|FG000|16-Week OLE Period|Lost to Follow-up|0|||
163436221|NCT05593432|590300653|FG001|16-Week OLE Period|Lost to Follow-up|0|||
163436222|NCT05593432|590300654|FG002|16-Week OLE Period|Lost to Follow-up|1|||
163436223|NCT05593432|590300655|FG003|16-Week OLE Period|Lost to Follow-up|2|||
163436224|NCT05593432|590300652|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
163436225|NCT05593432|590300653|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
163436226|NCT05593432|590300654|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
163436227|NCT05593432|590300655|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
163436228|NCT01450137|590300657|FG000|Up to Week 12|Adverse Event|2|||
163436229|NCT01450137|590300658|FG001|Up to Week 12|Adverse Event|1|||
163436230|NCT01450137|590300657|FG000|Up to Week 12|Withdrawal by Subject|0|||
163436231|NCT01450137|590300658|FG001|Up to Week 12|Withdrawal by Subject|2|||
163436232|NCT01450137|590300657|FG000|Week 12 to Study End|Death|0|||
163436233|NCT01450137|590300658|FG001|Week 12 to Study End|Death|1|||
163436234|NCT01450137|590300657|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
163436235|NCT01450137|590300658|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
163436236|NCT01926886|590300659|FG000|Overall Study|Administrative/other|1|||
163436237|NCT01926886|590300660|FG001|Overall Study|Administrative/other|0|||
163436238|NCT01926886|590300659|FG000|Overall Study|Adverse event/intercurrent illness|4|||
163436239|NCT01926886|590300660|FG001|Overall Study|Adverse event/intercurrent illness|0|||
163436240|NCT01926886|590300659|FG000|Overall Study|Disease progression/recurrence|4|||
163436241|NCT01926886|590300660|FG001|Overall Study|Disease progression/recurrence|0|||
163436242|NCT01926886|590300659|FG000|Overall Study|Withdrawal by Subject|15|||
163436243|NCT01926886|590300660|FG001|Overall Study|Withdrawal by Subject|0|||
163436244|NCT01926886|590300659|FG000|Overall Study|Failure to return|3|||
163436245|NCT01926886|590300660|FG001|Overall Study|Failure to return|0|||
163436246|NCT01926886|590300659|FG000|Overall Study|Recurrence of disease|1|||
163436247|NCT01926886|590300660|FG001|Overall Study|Recurrence of disease|0|||
163436248|NCT01926886|590300659|FG000|Overall Study|Progression of disease|2|||
163436249|NCT01926886|590300660|FG001|Overall Study|Progression of disease|0|||
163436250|NCT01926886|590300659|FG000|Overall Study|Death|1|||
163436251|NCT01926886|590300660|FG001|Overall Study|Death|0|||
163436252|NCT01926886|590300659|FG000|Overall Study|Did not cooperate|1|||
163436253|NCT01926886|590300660|FG001|Overall Study|Did not cooperate|0|||
163436254|NCT00069121|590300661|FG000|Overall Study|Death|286|||
163436255|NCT00069121|590300662|FG001|Overall Study|Death|242|||
163436256|NCT00069121|590300661|FG000|Overall Study|Withdrawal by Subject|18|||
163436257|NCT00069121|590300662|FG001|Overall Study|Withdrawal by Subject|20|||
163436258|NCT00069121|590300661|FG000|Overall Study|Lost to Follow-up|63|||
163436259|NCT00069121|590300662|FG001|Overall Study|Lost to Follow-up|63|||
163436260|NCT02986373|590300663|FG000|Overall Study|Adverse Event|4|||
163436261|NCT02986373|590300663|FG000|Overall Study|Lost to Follow-up|1|||
163436262|NCT02986373|590300663|FG000|Overall Study|Withdrawal by Subject|10|||
163436263|NCT02986373|590300663|FG000|Overall Study|Other|24|||
163436264|NCT04800315|590300664|FG000|Randomization|Did not receive study treatment|1|||
163436265|NCT04800315|590300665|FG001|Randomization|Did not receive study treatment|0|||
163436266|NCT04800315|590300666|FG002|Randomization|Did not receive study treatment|0|||
163436267|NCT04800315|590300667|FG003|Randomization|Did not receive study treatment|0|||
163436268|NCT04800315|590300664|FG000|Treatment Period|Adverse Event|4|||
163436269|NCT04800315|590300665|FG001|Treatment Period|Adverse Event|2|||
163436270|NCT04800315|590300666|FG002|Treatment Period|Adverse Event|1|||
163436271|NCT04800315|590300667|FG003|Treatment Period|Adverse Event|2|||
163436272|NCT04800315|590300664|FG000|Treatment Period|Lack of Efficacy|1|||
163436273|NCT04800315|590300665|FG001|Treatment Period|Lack of Efficacy|0|||
163436274|NCT04800315|590300666|FG002|Treatment Period|Lack of Efficacy|0|||
163436275|NCT04800315|590300667|FG003|Treatment Period|Lack of Efficacy|3|||
163436276|NCT04800315|590300664|FG000|Treatment Period|Lost to Follow-up|0|||
163436277|NCT04800315|590300665|FG001|Treatment Period|Lost to Follow-up|1|||
163436278|NCT04800315|590300666|FG002|Treatment Period|Lost to Follow-up|2|||
163436279|NCT04800315|590300667|FG003|Treatment Period|Lost to Follow-up|2|||
163436280|NCT04800315|590300664|FG000|Treatment Period|Withdrawal by participant|0|||
163436281|NCT04800315|590300665|FG001|Treatment Period|Withdrawal by participant|0|||
163436282|NCT04800315|590300666|FG002|Treatment Period|Withdrawal by participant|0|||
163436283|NCT04800315|590300667|FG003|Treatment Period|Withdrawal by participant|4|||
163436284|NCT04800315|590300664|FG000|Treatment Period|Other Reasons|0|||
163436285|NCT04800315|590300665|FG001|Treatment Period|Other Reasons|2|||
163436286|NCT04800315|590300666|FG002|Treatment Period|Other Reasons|0|||
163436287|NCT04800315|590300667|FG003|Treatment Period|Other Reasons|1|||
163436288|NCT00753922|590300668|FG000|Overall Study|Lost to Follow-up|155|||
163436289|NCT00753922|590300669|FG001|Overall Study|Lost to Follow-up|24|||
163436290|NCT00753922|590300670|FG002|Overall Study|Lost to Follow-up|28|||
163436291|NCT00753922|590300671|FG003|Overall Study|Lost to Follow-up|5|||
163436292|NCT00753922|590300668|FG000|Overall Study|Withdrawal by Subject|9|||
163436293|NCT00753922|590300669|FG001|Overall Study|Withdrawal by Subject|11|||
163436294|NCT00753922|590300670|FG002|Overall Study|Withdrawal by Subject|4|||
163436295|NCT00753922|590300671|FG003|Overall Study|Withdrawal by Subject|2|||
163436296|NCT00753922|590300668|FG000|Overall Study|Patient Non-compliance|55|||
163436297|NCT00753922|590300669|FG001|Overall Study|Patient Non-compliance|22|||
163436298|NCT00753922|590300670|FG002|Overall Study|Patient Non-compliance|14|||
163436299|NCT00753922|590300671|FG003|Overall Study|Patient Non-compliance|11|||
163436300|NCT00753922|590300668|FG000|Overall Study|Patients Not Completing Visit|11|||
163436301|NCT00753922|590300669|FG001|Overall Study|Patients Not Completing Visit|0|||
163436302|NCT00753922|590300670|FG002|Overall Study|Patients Not Completing Visit|1|||
163436303|NCT00753922|590300671|FG003|Overall Study|Patients Not Completing Visit|0|||
163436304|NCT00753922|590300668|FG000|Overall Study|Death|2|||
163436305|NCT00753922|590300669|FG001|Overall Study|Death|23|||
163436306|NCT00753922|590300670|FG002|Overall Study|Death|2|||
163436307|NCT00753922|590300671|FG003|Overall Study|Death|1|||
163436308|NCT00753922|590300668|FG000|Overall Study|Discontinuation Due to Explantation|14|||
163436309|NCT00753922|590300669|FG001|Overall Study|Discontinuation Due to Explantation|14|||
163436310|NCT00753922|590300670|FG002|Overall Study|Discontinuation Due to Explantation|14|||
163436311|NCT00753922|590300671|FG003|Overall Study|Discontinuation Due to Explantation|4|||
163436312|NCT02983292|590300676|FG000|Overall Study|Participant unwell & cannot travel|2|||
163436313|NCT02983292|590300676|FG000|Overall Study|Lost to Follow-up|3|||
163436314|NCT02983292|590300676|FG000|Overall Study|Participant withdrew consent|2|||
163436315|NCT02983292|590300676|FG000|Overall Study|Revision|7|||
163436316|NCT02983292|590300676|FG000|Overall Study|Death|1|||
163436317|NCT02983292|590300676|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
163436318|NCT02983292|590300676|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
163436319|NCT02983292|590300676|FG000|Overall Study|Participant relocation|1|||
163436320|NCT00857246|590300677|FG000|Induction Regimen|Adverse Event|1|||
163436321|NCT00857246|590300677|FG000|Induction Regimen|disease-related complications|1|||
163436322|NCT00857246|590300677|FG000|Induction Regimen|Withdrawal by Subject|1|||
163436323|NCT00857246|590300677|FG000|Surgery (Curative)|disease progression|6|||
163436324|NCT00857246|590300677|FG000|ChemoRT|Withdrawal by Subject|1|||
163436325|NCT00857246|590300677|FG000|ChemoRT|Adverse Event|2|||
163436326|NCT03851510|590300678|FG000|Overall Study|Screen Fail|1|||
163436327|NCT03851510|590300678|FG000|Overall Study|Adverse Event|1|||
163436328|NCT03851510|590300678|FG000|Overall Study|Withdrawal by Subject|1|||
163436329|NCT02426086|590300679|FG000|Overall Study|Death|33|||
163436330|NCT02426086|590300680|FG001|Overall Study|Death|36|||
163436331|NCT02426086|590300679|FG000|Overall Study|Lost to Follow-up|2|||
163436332|NCT02426086|590300680|FG001|Overall Study|Lost to Follow-up|0|||
163436333|NCT02426086|590300679|FG000|Overall Study|Study Terminated by Sponsor|5|||
163436334|NCT02426086|590300680|FG001|Overall Study|Study Terminated by Sponsor|14|||
163436335|NCT02426086|590300679|FG000|Overall Study|Withdrawal by Subject|8|||
163436336|NCT02426086|590300680|FG001|Overall Study|Withdrawal by Subject|9|||
163436337|NCT04542291|590300681|FG000|Overall Study|Adverse Event|1|||
163436338|NCT04542291|590300681|FG000|Overall Study|Physician Decision|2|||
163436339|NCT01287117|590300682|FG000|Overall Study|Adverse Event|2|||
163436340|NCT01287117|590300683|FG001|Overall Study|Adverse Event|1|||
163436341|NCT01287117|590300684|FG002|Overall Study|Adverse Event|1|||
163436342|NCT01287117|590300685|FG003|Overall Study|Adverse Event|1|||
163436343|NCT01287117|590300682|FG000|Overall Study|Lost to Follow-up|1|||
163436344|NCT01287117|590300683|FG001|Overall Study|Lost to Follow-up|1|||
163436345|NCT01287117|590300684|FG002|Overall Study|Lost to Follow-up|0|||
163436346|NCT01287117|590300685|FG003|Overall Study|Lost to Follow-up|0|||
163436347|NCT01287117|590300682|FG000|Overall Study|Physician Decision|0|||
163436348|NCT01287117|590300683|FG001|Overall Study|Physician Decision|1|||
163436349|NCT01287117|590300684|FG002|Overall Study|Physician Decision|1|||
163436350|NCT01287117|590300685|FG003|Overall Study|Physician Decision|1|||
163436351|NCT01287117|590300682|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
163436352|NCT01287117|590300683|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
163436353|NCT01287117|590300684|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
163436354|NCT01287117|590300685|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
163436355|NCT01287117|590300682|FG000|Overall Study|Disease Progression|10|||
163436356|NCT01287117|590300683|FG001|Overall Study|Disease Progression|5|||
163436357|NCT01287117|590300684|FG002|Overall Study|Disease Progression|6|||
163436358|NCT01287117|590300685|FG003|Overall Study|Disease Progression|5|||
163436359|NCT00035815|590300693|FG000|Overall Study|Withdrawal by Subject|17|||
163436360|NCT00035815|590300694|FG001|Overall Study|Withdrawal by Subject|11|||
163436361|NCT02606877|590300702|FG000|Overall Study|Adverse Event|3|||
163436362|NCT02606877|590300703|FG001|Overall Study|Adverse Event|0|||
163436363|NCT02606877|590300702|FG000|Overall Study|Non-compliance with protocol|0|||
163436364|NCT02606877|590300703|FG001|Overall Study|Non-compliance with protocol|1|||
163436365|NCT02606877|590300702|FG000|Overall Study|Other than listed above|1|||
163436366|NCT02606877|590300703|FG001|Overall Study|Other than listed above|0|||
163436367|NCT04952389|590300704|FG000|Overall Study|Withdrawal by Subject|8|||
163436368|NCT04952389|590300705|FG001|Overall Study|Withdrawal by Subject|4|||
163436369|NCT05635838|590302186|FG000|16-Week DBVC Period|Adverse Event|2|||
163436370|NCT05635838|590302187|FG001|16-Week DBVC Period|Adverse Event|0|||
163436371|NCT05635838|590302188|FG002|16-Week DBVC Period|Adverse Event|0|||
163436372|NCT05635838|590302189|FG003|16-Week DBVC Period|Adverse Event|0|||
163436373|NCT05635838|590302186|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
163436374|NCT05635838|590302187|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
163436375|NCT05635838|590302188|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
163436376|NCT05635838|590302189|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
163436377|NCT05635838|590302186|FG000|16-Week DBVC Period|Physician Decision|0|||
163436378|NCT05635838|590302187|FG001|16-Week DBVC Period|Physician Decision|1|||
163436379|NCT05635838|590302188|FG002|16-Week DBVC Period|Physician Decision|0|||
163436380|NCT05635838|590302189|FG003|16-Week DBVC Period|Physician Decision|0|||
163436381|NCT05635838|590302186|FG000|16-Week DBVC Period|Protocol Violation|1|||
163436382|NCT05635838|590302187|FG001|16-Week DBVC Period|Protocol Violation|0|||
163436383|NCT05635838|590302188|FG002|16-Week DBVC Period|Protocol Violation|0|||
163436384|NCT05635838|590302189|FG003|16-Week DBVC Period|Protocol Violation|0|||
163436385|NCT05635838|590302186|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
163436386|NCT05635838|590302187|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
163436387|NCT05635838|590302188|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
163436388|NCT05635838|590302189|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
163436389|NCT05635838|590302186|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
163436390|NCT05635838|590302187|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
163436391|NCT05635838|590302188|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
163436392|NCT05635838|590302189|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
163436393|NCT05635838|590302186|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
163436394|NCT05635838|590302187|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
163436395|NCT05635838|590302188|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
163436396|NCT05635838|590302189|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
163436397|NCT05635838|590302186|FG000|16-Week OLE Period|Adverse Event|0|||
163436398|NCT05635838|590302187|FG001|16-Week OLE Period|Adverse Event|0|||
163436399|NCT05635838|590302188|FG002|16-Week OLE Period|Adverse Event|0|||
163436400|NCT05635838|590302189|FG003|16-Week OLE Period|Adverse Event|2|||
163436401|NCT05635838|590302186|FG000|16-Week OLE Period|Lost to Follow-up|0|||
163436402|NCT05635838|590302187|FG001|16-Week OLE Period|Lost to Follow-up|0|||
163436403|NCT05635838|590302188|FG002|16-Week OLE Period|Lost to Follow-up|1|||
163436404|NCT05635838|590302189|FG003|16-Week OLE Period|Lost to Follow-up|3|||
163436405|NCT05635838|590302186|FG000|16-Week OLE Period|Physician Decision|0|||
163436406|NCT05635838|590302187|FG001|16-Week OLE Period|Physician Decision|0|||
163436407|NCT05635838|590302188|FG002|16-Week OLE Period|Physician Decision|0|||
163436408|NCT05635838|590302189|FG003|16-Week OLE Period|Physician Decision|1|||
163436409|NCT05635838|590302186|FG000|16-Week OLE Period|Protocol Violation|0|||
163436410|NCT05635838|590302187|FG001|16-Week OLE Period|Protocol Violation|0|||
163436411|NCT05635838|590302188|FG002|16-Week OLE Period|Protocol Violation|1|||
163436412|NCT05635838|590302189|FG003|16-Week OLE Period|Protocol Violation|1|||
163436413|NCT05635838|590302186|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
163436414|NCT05635838|590302187|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
163436415|NCT05635838|590302188|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
163436416|NCT05635838|590302189|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
163436417|NCT05635838|590302186|FG000|16-Week OLE Period|Pregnancy|0|||
163436418|NCT05635838|590302187|FG001|16-Week OLE Period|Pregnancy|0|||
163436419|NCT05635838|590302188|FG002|16-Week OLE Period|Pregnancy|1|||
163436420|NCT05635838|590302189|FG003|16-Week OLE Period|Pregnancy|0|||
163436421|NCT02699515|590302196|FG000|Overall Study|Death|3|||
163436422|NCT02699515|590302197|FG001|Overall Study|Death|3|||
163436423|NCT02699515|590302198|FG002|Overall Study|Death|3|||
163436424|NCT02699515|590302199|FG003|Overall Study|Death|23|||
163436425|NCT02699515|590302200|FG004|Overall Study|Death|22|||
163436426|NCT02699515|590302201|FG005|Overall Study|Death|23|||
163436427|NCT02699515|590302202|FG006|Overall Study|Death|3|||
163436428|NCT02699515|590302203|FG007|Overall Study|Death|5|||
163436429|NCT02699515|590302196|FG000|Overall Study|Withdrawal by Subject|0|||
163436430|NCT02699515|590302197|FG001|Overall Study|Withdrawal by Subject|0|||
163436431|NCT02699515|590302198|FG002|Overall Study|Withdrawal by Subject|3|||
163436432|NCT02699515|590302199|FG003|Overall Study|Withdrawal by Subject|1|||
163436433|NCT02699515|590302200|FG004|Overall Study|Withdrawal by Subject|5|||
163436434|NCT02699515|590302201|FG005|Overall Study|Withdrawal by Subject|3|||
163436435|NCT02699515|590302202|FG006|Overall Study|Withdrawal by Subject|0|||
163436436|NCT02699515|590302203|FG007|Overall Study|Withdrawal by Subject|1|||
163436437|NCT02699515|590302196|FG000|Overall Study|Other|1|||
163436438|NCT02699515|590302197|FG001|Overall Study|Other|0|||
163436439|NCT02699515|590302198|FG002|Overall Study|Other|1|||
163436440|NCT02699515|590302199|FG003|Overall Study|Other|6|||
163436441|NCT02699515|590302200|FG004|Overall Study|Other|4|||
163436442|NCT02699515|590302201|FG005|Overall Study|Other|3|||
163436443|NCT02699515|590302202|FG006|Overall Study|Other|0|||
163436444|NCT02699515|590302203|FG007|Overall Study|Other|0|||
163436445|NCT05243550|590302204|FG000|Overall Study|Ongoing in the Study|171|||
163436446|NCT05243550|590302204|FG000|Overall Study|Withdrawal by Subject|10|||
163436447|NCT05243550|590302204|FG000|Overall Study|Lost to Follow-up|7|||
163436448|NCT05243550|590302204|FG000|Overall Study|Adverse Event|3|||
163436449|NCT05243550|590302204|FG000|Overall Study|Noncompliance|1|||
163436450|NCT05243550|590302204|FG000|Overall Study|Physician Decision|1|||
163436451|NCT05243550|590302204|FG000|Overall Study|Other Reason|4|||
163436452|NCT05094154|590302208|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
163436453|NCT05094154|590302209|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
163436454|NCT05094154|590302208|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
163436455|NCT05094154|590302209|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
163436456|NCT01266148|590302216|FG000|Overall Study|Adverse Event|2|||
163436457|NCT01266148|590302217|FG001|Overall Study|Adverse Event|0|||
163436458|NCT01266148|590302216|FG000|Overall Study|Ongoing rejection|1|||
163436459|NCT01266148|590302217|FG001|Overall Study|Ongoing rejection|0|||
163436460|NCT01266148|590302216|FG000|Overall Study|2 2R rejections|1|||
163436461|NCT01266148|590302217|FG001|Overall Study|2 2R rejections|0|||
163436462|NCT01266148|590302216|FG000|Overall Study|Death|2|||
163436463|NCT01266148|590302217|FG001|Overall Study|Death|3|||
163436464|NCT01266148|590302216|FG000|Overall Study|missing mGFR value + AE|1|||
163436465|NCT01266148|590302217|FG001|Overall Study|missing mGFR value + AE|0|||
163436466|NCT02400346|590302220|FG000|Overall Study|Adverse Event|24|||
163436467|NCT02400346|590302220|FG000|Overall Study|Lack of Efficacy|9|||
163436468|NCT02400346|590302220|FG000|Overall Study|Non-compliance with IMP|1|||
163436469|NCT02400346|590302220|FG000|Overall Study|Withdrawal by Subject|7|||
163436470|NCT02400346|590302220|FG000|Overall Study|Administrative or other reason(s)|2|||
163436471|NCT02400346|590302220|FG000|Overall Study|Lost to Follow-up|1|||
163436472|NCT02767570|590302223|FG000|Overall Study|Lost to Follow-up|3|||
163436473|NCT02767570|590302224|FG001|Overall Study|Lost to Follow-up|0|||
163436474|NCT02767570|590302223|FG000|Overall Study|COVID shutdown|2|||
163436475|NCT02767570|590302224|FG001|Overall Study|COVID shutdown|5|||
163436476|NCT02767570|590302223|FG000|Overall Study|Increased pain|2|||
163436477|NCT02767570|590302224|FG001|Overall Study|Increased pain|0|||
163436478|NCT02767570|590302223|FG000|Overall Study|Withdrawal by Subject|1|||
163436479|NCT02767570|590302224|FG001|Overall Study|Withdrawal by Subject|3|||
163436480|NCT02767570|590302223|FG000|Overall Study|Unrelated medical issue|1|||
163436481|NCT02767570|590302224|FG001|Overall Study|Unrelated medical issue|1|||
163436482|NCT02767570|590302223|FG000|Overall Study|Received intra-articular injection|0|||
163436483|NCT02767570|590302224|FG001|Overall Study|Received intra-articular injection|1|||
163436484|NCT01981122|590302228|FG000|Overall Study|Withdrawal by Subject|0|||
163436485|NCT01981122|590302229|FG001|Overall Study|Withdrawal by Subject|2|||
163436486|NCT01981122|590302228|FG000|Overall Study|Protocol Violation|0|||
163436487|NCT01981122|590302229|FG001|Overall Study|Protocol Violation|1|||
163436488|NCT01981122|590302228|FG000|Overall Study|Lost to Follow-up|0|||
163436489|NCT01981122|590302229|FG001|Overall Study|Lost to Follow-up|1|||
163436490|NCT01981122|590302228|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
163436491|NCT01981122|590302229|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
163436492|NCT01981122|590302228|FG000|Overall Study|Death|14|||
163436493|NCT01981122|590302229|FG001|Overall Study|Death|15|||
163436494|NCT00089843|590302230|FG000|Overall Study|Withdrawal by Subject|1|||
163436495|NCT00089843|590302231|FG001|Overall Study|Withdrawal by Subject|4|||
163436496|NCT00089843|590302232|FG002|Overall Study|Withdrawal by Subject|5|||
163436497|NCT00089843|590302233|FG003|Overall Study|Withdrawal by Subject|6|||
163436498|NCT00089843|590302230|FG000|Overall Study|Physician Decision|1|||
163436499|NCT00089843|590302231|FG001|Overall Study|Physician Decision|0|||
163436500|NCT00089843|590302232|FG002|Overall Study|Physician Decision|0|||
163436501|NCT00089843|590302233|FG003|Overall Study|Physician Decision|1|||
163436502|NCT01330381|590302234|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
163436503|NCT01330381|590302235|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
163436504|NCT01330381|590302236|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
163436505|NCT01330381|590302234|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
163436506|NCT01330381|590302235|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
163436507|NCT01330381|590302236|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
163436508|NCT01330381|590302234|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
163436509|NCT01330381|590302235|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
163436510|NCT01330381|590302236|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
163436511|NCT01330381|590302234|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
163436512|NCT01330381|590302235|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
163436513|NCT01330381|590302236|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
163436514|NCT01330381|590302234|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
163436515|NCT01330381|590302235|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
163436516|NCT01330381|590302236|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
163436517|NCT01330381|590302234|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
163436518|NCT01330381|590302235|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
163436519|NCT01330381|590302236|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
163436520|NCT01330381|590302234|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
163436521|NCT01330381|590302235|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
163436522|NCT01330381|590302236|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
163436523|NCT01330381|590302234|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
163436524|NCT01330381|590302235|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
163436525|NCT01330381|590302236|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
163436526|NCT01330381|590302234|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
163436527|NCT01330381|590302235|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
163436528|NCT01330381|590302236|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
162925347|NCT00602641|588428936|FG000|Overall Study|Other|3|||
163436529|NCT01330381|590302234|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
163436530|NCT01330381|590302235|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
163436531|NCT01330381|590302236|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
163436532|NCT03846947|590302237|FG000|Overall Study|technical issues with imaging sequence|2|||
163436533|NCT03060577|590302238|FG000|Overall Study|Withdrawal by Subject|25|||
163436534|NCT03060577|590302239|FG001|Overall Study|Withdrawal by Subject|5|||
163436535|NCT03060577|590302238|FG000|Overall Study|Physician Decision|4|||
163436536|NCT03060577|590302239|FG001|Overall Study|Physician Decision|3|||
163436537|NCT03060577|590302238|FG000|Overall Study|Lost to Follow-up|3|||
163436538|NCT03060577|590302239|FG001|Overall Study|Lost to Follow-up|0|||
163436539|NCT03060577|590302238|FG000|Overall Study|Death|7|||
163436540|NCT03060577|590302239|FG001|Overall Study|Death|1|||
163436541|NCT03060577|590302238|FG000|Overall Study|Adverse Event|9|||
163436542|NCT03060577|590302239|FG001|Overall Study|Adverse Event|1|||
163436543|NCT03060577|590302238|FG000|Overall Study|Inclusion/Exclusion|1|||
163436544|NCT03060577|590302239|FG001|Overall Study|Inclusion/Exclusion|0|||
163436545|NCT03060577|590302238|FG000|Overall Study|Other|8|||
163436546|NCT03060577|590302239|FG001|Overall Study|Other|2|||
163436547|NCT03216265|590302240|FG000|Overall Study|Adverse Event|2|||
163436548|NCT03216265|590302241|FG001|Overall Study|Adverse Event|0|||
163436549|NCT03216265|590302242|FG002|Overall Study|Adverse Event|2|||
163436550|NCT03216265|590302240|FG000|Overall Study|Lost to Follow-up|0|||
163436551|NCT03216265|590302241|FG001|Overall Study|Lost to Follow-up|1|||
163436552|NCT03216265|590302242|FG002|Overall Study|Lost to Follow-up|0|||
163436553|NCT03216265|590302240|FG000|Overall Study|Withdrawal by Subject|0|||
163436554|NCT03216265|590302241|FG001|Overall Study|Withdrawal by Subject|0|||
163436555|NCT03216265|590302242|FG002|Overall Study|Withdrawal by Subject|1|||
163436556|NCT01306058|590302243|FG000|Overall Study|Death|1|||
163436557|NCT01306058|590302243|FG000|Overall Study|Enrolled but did not get treatment|1|||
163436558|NCT01539837|590302244|FG000|Overall Study|reduce neutrophil level|0|||
163436559|NCT01539837|590302245|FG001|Overall Study|reduce neutrophil level|1|||
163436560|NCT01539837|590302246|FG002|Overall Study|reduce neutrophil level|1|||
163436561|NCT01539837|590302244|FG000|Overall Study|bad compliance|0|||
163436562|NCT01539837|590302245|FG001|Overall Study|bad compliance|0|||
163436563|NCT01539837|590302246|FG002|Overall Study|bad compliance|1|||
163436564|NCT00849693|590302247|FG000|Acute Treatment Phase|Adverse Event|12|||
163436565|NCT00849693|590302248|FG001|Acute Treatment Phase|Adverse Event|7|||
163436566|NCT00849693|590302249|FG002|Acute Treatment Phase|Adverse Event|6|||
163436567|NCT00849693|590302250|FG003|Acute Treatment Phase|Adverse Event|4|||
163436568|NCT00849693|590302247|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
163436569|NCT00849693|590302248|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
163436570|NCT00849693|590302249|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
163436571|NCT00849693|590302250|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
163436572|NCT00849693|590302247|FG000|Acute Treatment Phase|Protocol Violation|1|||
163436573|NCT00849693|590302248|FG001|Acute Treatment Phase|Protocol Violation|5|||
163436574|NCT00849693|590302249|FG002|Acute Treatment Phase|Protocol Violation|2|||
163436575|NCT00849693|590302250|FG003|Acute Treatment Phase|Protocol Violation|6|||
163436576|NCT00849693|590302247|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
163436577|NCT00849693|590302248|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
163436578|NCT00849693|590302249|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
163436579|NCT00849693|590302250|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
163436580|NCT00849693|590302247|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
163436581|NCT00849693|590302248|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
163436582|NCT00849693|590302249|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
163436583|NCT00849693|590302250|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
163436584|NCT00849693|590302247|FG000|Acute Treatment Phase|Physician Decision|2|||
163436585|NCT00849693|590302248|FG001|Acute Treatment Phase|Physician Decision|1|||
163436586|NCT00849693|590302249|FG002|Acute Treatment Phase|Physician Decision|2|||
163436587|NCT00849693|590302250|FG003|Acute Treatment Phase|Physician Decision|1|||
163436588|NCT00849693|590302247|FG000|Acute Treatment Phase|Sponsor decision|0|||
163436589|NCT00849693|590302248|FG001|Acute Treatment Phase|Sponsor decision|0|||
163436590|NCT00849693|590302249|FG002|Acute Treatment Phase|Sponsor decision|1|||
163436591|NCT00849693|590302250|FG003|Acute Treatment Phase|Sponsor decision|0|||
163436592|NCT00849693|590302247|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
163436593|NCT00849693|590302248|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
163436594|NCT00849693|590302249|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
163436595|NCT00849693|590302250|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
163436596|NCT00849693|590302247|FG000|Extension Phase|Adverse Event|4|||
163436597|NCT00849693|590302248|FG001|Extension Phase|Adverse Event|6|||
163436598|NCT00849693|590302249|FG002|Extension Phase|Adverse Event|3|||
163436599|NCT00849693|590302250|FG003|Extension Phase|Adverse Event|7|||
163436600|NCT00849693|590302247|FG000|Extension Phase|Lost to Follow-up|7|||
163436601|NCT00849693|590302248|FG001|Extension Phase|Lost to Follow-up|5|||
163436602|NCT00849693|590302249|FG002|Extension Phase|Lost to Follow-up|6|||
163436603|NCT00849693|590302250|FG003|Extension Phase|Lost to Follow-up|6|||
163436604|NCT00849693|590302247|FG000|Extension Phase|Protocol Violation|0|||
163436605|NCT00849693|590302248|FG001|Extension Phase|Protocol Violation|3|||
163436606|NCT00849693|590302249|FG002|Extension Phase|Protocol Violation|2|||
163436607|NCT00849693|590302250|FG003|Extension Phase|Protocol Violation|3|||
163436608|NCT00849693|590302247|FG000|Extension Phase|Withdrawal by Subject|6|||
163436609|NCT00849693|590302248|FG001|Extension Phase|Withdrawal by Subject|9|||
163436610|NCT00849693|590302249|FG002|Extension Phase|Withdrawal by Subject|10|||
163436611|NCT00849693|590302250|FG003|Extension Phase|Withdrawal by Subject|15|||
163436612|NCT00849693|590302247|FG000|Extension Phase|Parent or caregiver decision|9|||
163436613|NCT00849693|590302248|FG001|Extension Phase|Parent or caregiver decision|4|||
163436614|NCT00849693|590302249|FG002|Extension Phase|Parent or caregiver decision|10|||
163436615|NCT00849693|590302250|FG003|Extension Phase|Parent or caregiver decision|5|||
163436616|NCT00849693|590302247|FG000|Extension Phase|Physician Decision|1|||
163436617|NCT00849693|590302248|FG001|Extension Phase|Physician Decision|1|||
163436618|NCT00849693|590302249|FG002|Extension Phase|Physician Decision|2|||
163436619|NCT00849693|590302250|FG003|Extension Phase|Physician Decision|0|||
163436620|NCT00849693|590302247|FG000|Extension Phase|Sponsor decision|1|||
163436621|NCT00849693|590302248|FG001|Extension Phase|Sponsor decision|0|||
163436622|NCT00849693|590302249|FG002|Extension Phase|Sponsor decision|0|||
163436623|NCT00849693|590302250|FG003|Extension Phase|Sponsor decision|1|||
163436624|NCT00849693|590302247|FG000|Extension Phase|Lack of Efficacy|2|||
163436625|NCT00849693|590302248|FG001|Extension Phase|Lack of Efficacy|2|||
163436626|NCT00849693|590302249|FG002|Extension Phase|Lack of Efficacy|2|||
163436627|NCT00849693|590302250|FG003|Extension Phase|Lack of Efficacy|1|||
163436628|NCT01978912|590302253|FG000|Overall Study|Adverse Event|0|||
163436629|NCT01978912|590302254|FG001|Overall Study|Adverse Event|1|||
163436630|NCT01978912|590302255|FG002|Overall Study|Adverse Event|0|||
163436631|NCT01978912|590302256|FG003|Overall Study|Adverse Event|0|||
163436632|NCT01978912|590302253|FG000|Overall Study|Lost to Follow-up|1|||
163436633|NCT01978912|590302254|FG001|Overall Study|Lost to Follow-up|1|||
163436634|NCT01978912|590302255|FG002|Overall Study|Lost to Follow-up|0|||
163436635|NCT01978912|590302256|FG003|Overall Study|Lost to Follow-up|1|||
163436636|NCT01978912|590302253|FG000|Overall Study|Withdrawal by Subject|1|||
163436637|NCT01978912|590302254|FG001|Overall Study|Withdrawal by Subject|0|||
163436638|NCT01978912|590302255|FG002|Overall Study|Withdrawal by Subject|2|||
163436639|NCT01978912|590302256|FG003|Overall Study|Withdrawal by Subject|2|||
163436640|NCT01978912|590302253|FG000|Overall Study|Lumbar Surgery|1|||
163436641|NCT01978912|590302254|FG001|Overall Study|Lumbar Surgery|0|||
163436642|NCT01978912|590302255|FG002|Overall Study|Lumbar Surgery|1|||
163436643|NCT01978912|590302256|FG003|Overall Study|Lumbar Surgery|0|||
163436644|NCT01978912|590302253|FG000|Overall Study|Intradiscal Steroid Injection|0|||
163436645|NCT01978912|590302254|FG001|Overall Study|Intradiscal Steroid Injection|1|||
163436646|NCT01978912|590302255|FG002|Overall Study|Intradiscal Steroid Injection|0|||
163436647|NCT01978912|590302256|FG003|Overall Study|Intradiscal Steroid Injection|0|||
163436648|NCT00224107|590302257|FG000|Overall Study|Adverse Event|20|||
163436649|NCT00224107|590302258|FG001|Overall Study|Adverse Event|6|||
163436650|NCT00224107|590302257|FG000|Overall Study|Protocol Violation|2|||
163436651|NCT00224107|590302258|FG001|Overall Study|Protocol Violation|3|||
163436652|NCT00224107|590302257|FG000|Overall Study|Withdrawal by Subject|1|||
163436653|NCT00224107|590302258|FG001|Overall Study|Withdrawal by Subject|4|||
163436654|NCT00224107|590302257|FG000|Overall Study|Lack of Efficacy|2|||
163436655|NCT00224107|590302258|FG001|Overall Study|Lack of Efficacy|0|||
163436656|NCT00224107|590302257|FG000|Overall Study|Lost to Follow-up|4|||
163436657|NCT00224107|590302258|FG001|Overall Study|Lost to Follow-up|0|||
163436658|NCT00224107|590302257|FG000|Overall Study|Physician Decision|1|||
163436659|NCT00224107|590302258|FG001|Overall Study|Physician Decision|0|||
163436660|NCT00224107|590302257|FG000|Overall Study|Other|1|||
163436661|NCT00224107|590302258|FG001|Overall Study|Other|1|||
163436662|NCT01408537|590302261|FG000|Overall Study|Withdrawal by Subject|2|||
163436663|NCT01408537|590302261|FG000|Overall Study|Protocol Violation|3|||
163436664|NCT01408537|590302261|FG000|Overall Study|Lost to Follow-up|3|||
163436665|NCT00098345|590302266|FG000|Overall Study|Adverse Event|7|||
163436666|NCT00098345|590302266|FG000|Overall Study|Withdrawal by Subject|2|||
163436667|NCT00098345|590302266|FG000|Overall Study|progression|4|||
163436668|NCT01183858|590302267|FG000|Overall Study|Death not related to Progressive Disease|5|||
163436669|NCT01183858|590302268|FG001|Overall Study|Death not related to Progressive Disease|6|||
163436670|NCT01183858|590302267|FG000|Overall Study|Adverse Event|14|||
163436671|NCT01183858|590302268|FG001|Overall Study|Adverse Event|11|||
163436672|NCT01183858|590302267|FG000|Overall Study|Investigator's Decision|0|||
163436673|NCT01183858|590302268|FG001|Overall Study|Investigator's Decision|3|||
163436674|NCT01183858|590302267|FG000|Overall Study|Insufficient Therapeutic Response|2|||
163436675|NCT01183858|590302268|FG001|Overall Study|Insufficient Therapeutic Response|0|||
163436676|NCT01183858|590302267|FG000|Overall Study|Refused Treatment|1|||
163436677|NCT01183858|590302268|FG001|Overall Study|Refused Treatment|4|||
163436678|NCT01183858|590302267|FG000|Overall Study|Withdrew Consent|4|||
163436679|NCT01183858|590302268|FG001|Overall Study|Withdrew Consent|4|||
163436680|NCT01183858|590302267|FG000|Overall Study|Discontinued Smoking|3|||
163436681|NCT01183858|590302268|FG001|Overall Study|Discontinued Smoking|1|||
163436682|NCT01183858|590302267|FG000|Overall Study|Protocol Violation|1|||
163436683|NCT01183858|590302268|FG001|Overall Study|Protocol Violation|0|||
163436684|NCT01183858|590302267|FG000|Overall Study|Administrative/Other|6|||
163436685|NCT01183858|590302268|FG001|Overall Study|Administrative/Other|6|||
163436686|NCT01183858|590302267|FG000|Overall Study|Progressive Disease|112|||
163436687|NCT01183858|590302268|FG001|Overall Study|Progressive Disease|115|||
163436688|NCT01183858|590302267|FG000|Overall Study|Death related to Progressive Disease|4|||
163436689|NCT01183858|590302268|FG001|Overall Study|Death related to Progressive Disease|5|||
163436690|NCT01183858|590302267|FG000|Overall Study|Lost to Follow-up|1|||
163436691|NCT01183858|590302268|FG001|Overall Study|Lost to Follow-up|1|||
163436692|NCT01295905|590302271|FG000|Overall Study|Did not meet inclusion criteria|1|||
163436693|NCT01295905|590302272|FG001|Overall Study|Did not meet inclusion criteria|0|||
163436694|NCT01295905|590302271|FG000|Overall Study|Met exclusion criteria|1|||
163436695|NCT01295905|590302272|FG001|Overall Study|Met exclusion criteria|0|||
163436696|NCT03707977|590302273|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
163436697|NCT03707977|590302274|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
163436698|NCT03707977|590302275|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
163436699|NCT03707977|590302273|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
163436700|NCT03707977|590302274|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
163436701|NCT03707977|590302275|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
163436702|NCT03069690|590302276|FG000|Pregnancy Intervention|Pregnancy loss|9|||
163436703|NCT03069690|590302277|FG001|Pregnancy Intervention|Pregnancy loss|4|||
163436704|NCT03069690|590302278|FG002|Pregnancy Intervention|Pregnancy loss|0|||
163436705|NCT03069690|590302279|FG003|Pregnancy Intervention|Pregnancy loss|0|||
163436706|NCT03069690|590302280|FG004|Pregnancy Intervention|Pregnancy loss|0|||
163436707|NCT03069690|590302281|FG005|Pregnancy Intervention|Pregnancy loss|0|||
163436708|NCT03069690|590302276|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
163436709|NCT03069690|590302277|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
163436710|NCT03069690|590302278|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
163436711|NCT03069690|590302279|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
163436712|NCT03069690|590302280|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
163436713|NCT03069690|590302281|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
163436714|NCT03069690|590302276|FG000|Postpartum Intervention|Lost to Follow-up|0|||
163436715|NCT03069690|590302277|FG001|Postpartum Intervention|Lost to Follow-up|0|||
163436716|NCT03069690|590302278|FG002|Postpartum Intervention|Lost to Follow-up|5|||
163436717|NCT03069690|590302279|FG003|Postpartum Intervention|Lost to Follow-up|5|||
163436718|NCT03069690|590302280|FG004|Postpartum Intervention|Lost to Follow-up|2|||
163436719|NCT03069690|590302281|FG005|Postpartum Intervention|Lost to Follow-up|4|||
163436720|NCT02564120|590302282|FG000|Overall Study|Did not return release forms|160|||
163436721|NCT02564120|590302282|FG000|Overall Study|Death|58|||
163436722|NCT02564120|590302282|FG000|Overall Study|Withdrawal by Subject|204|||
163436723|NCT02564120|590302282|FG000|Overall Study|Other medical condition|24|||
163436724|NCT03842709|590302283|FG000|Overall Study|Withdrawal by Subject|3|||
163436725|NCT03842709|590302284|FG001|Overall Study|Withdrawal by Subject|3|||
163436726|NCT03842709|590302283|FG000|Overall Study|Lost to Follow-up|1|||
163436727|NCT03842709|590302284|FG001|Overall Study|Lost to Follow-up|0|||
163436728|NCT00641147|590302285|FG000|Completed 4 Months.|Physician Decision|1|||
163436729|NCT00641147|590302286|FG001|Completed 4 Months.|Physician Decision|0|||
163436730|NCT00641147|590302285|FG000|Completed 4 Months.|Adverse Event|1|||
163436731|NCT00641147|590302286|FG001|Completed 4 Months.|Adverse Event|0|||
163436732|NCT00641147|590302285|FG000|Completed 8 Months.|Physician Decision|2|||
163436733|NCT00641147|590302286|FG001|Completed 8 Months.|Physician Decision|1|||
163436734|NCT00641147|590302285|FG000|Completed 8 Months.|non compliance|1|||
163436735|NCT00641147|590302286|FG001|Completed 8 Months.|non compliance|0|||
163436736|NCT00641147|590302285|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
163436737|NCT00641147|590302286|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
163436738|NCT00641147|590302285|FG000|Completed 12 Months.|Physician Decision|1|||
163436739|NCT00641147|590302286|FG001|Completed 12 Months.|Physician Decision|1|||
163436740|NCT00641147|590302285|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
163436741|NCT00641147|590302286|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
163436742|NCT00641147|590302285|FG000|Completed 16 Months.|Physician Decision|1|||
163436743|NCT00641147|590302286|FG001|Completed 16 Months.|Physician Decision|0|||
163436744|NCT00641147|590302285|FG000|Completed 16 Months.|Lost to Follow-up|1|||
163436745|NCT00641147|590302286|FG001|Completed 16 Months.|Lost to Follow-up|0|||
163436746|NCT00791128|590302287|FG000|Overall Study|Adverse Event|4|||
163436747|NCT00791128|590302287|FG000|Overall Study|Device migration|2|||
163436748|NCT00791128|590302287|FG000|Overall Study|non-compliance by subject|2|||
163436749|NCT00791128|590302287|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
163436750|NCT01629667|590302288|FG000|Overall Study|Lost to Follow-up|0|||
163436751|NCT01629667|590302289|FG001|Overall Study|Lost to Follow-up|1|||
163436752|NCT01629667|590302290|FG002|Overall Study|Lost to Follow-up|1|||
163436753|NCT01629667|590302288|FG000|Overall Study|Withdrawal by Subject|31|||
163436754|NCT01629667|590302289|FG001|Overall Study|Withdrawal by Subject|20|||
163436755|NCT01629667|590302290|FG002|Overall Study|Withdrawal by Subject|28|||
163436756|NCT01629667|590302288|FG000|Overall Study|Death|1|||
163436757|NCT01629667|590302289|FG001|Overall Study|Death|5|||
163436758|NCT01629667|590302290|FG002|Overall Study|Death|3|||
163436759|NCT01629667|590302288|FG000|Overall Study|Randomized, not treated|2|||
163436760|NCT01629667|590302289|FG001|Overall Study|Randomized, not treated|1|||
163436761|NCT01629667|590302290|FG002|Overall Study|Randomized, not treated|0|||
163436762|NCT01629667|590302288|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
163436763|NCT01629667|590302289|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
163436764|NCT01629667|590302290|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
163436765|NCT01629667|590302288|FG000|Overall Study|Requiring lung transplant|2|||
163436766|NCT01629667|590302289|FG001|Overall Study|Requiring lung transplant|1|||
163436767|NCT01629667|590302290|FG002|Overall Study|Requiring lung transplant|3|||
163436768|NCT01629667|590302288|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
163436769|NCT01629667|590302289|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
163436770|NCT01629667|590302290|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
163436771|NCT01629667|590302288|FG000|Overall Study|Started other medicine|1|||
163436772|NCT01629667|590302289|FG001|Overall Study|Started other medicine|0|||
163436773|NCT01629667|590302290|FG002|Overall Study|Started other medicine|1|||
163436774|NCT01629667|590302288|FG000|Overall Study|Site error in safety follow-up|0|||
163436775|NCT01629667|590302289|FG001|Overall Study|Site error in safety follow-up|0|||
163436776|NCT01629667|590302290|FG002|Overall Study|Site error in safety follow-up|1|||
163436777|NCT01629667|590302288|FG000|Overall Study|Enrolled in another clinical study|0|||
163436778|NCT01629667|590302289|FG001|Overall Study|Enrolled in another clinical study|1|||
163436779|NCT01629667|590302290|FG002|Overall Study|Enrolled in another clinical study|0|||
163436780|NCT01629667|590302288|FG000|Overall Study|Code break|1|||
163436781|NCT01629667|590302289|FG001|Overall Study|Code break|0|||
163436782|NCT01629667|590302290|FG002|Overall Study|Code break|0|||
163436783|NCT00553059|590302291|FG000|Overall Study|Deemed ineligible|1|||
163436784|NCT00553059|590302292|FG001|Overall Study|Deemed ineligible|1|||
163436785|NCT00553059|590302291|FG000|Overall Study|Drug supply not available|0|||
163436786|NCT00553059|590302292|FG001|Overall Study|Drug supply not available|1|||
163436787|NCT00984659|590302293|FG000|2-week Run-in Period|Adverse Event|8|||
163436788|NCT00984659|590302294|FG001|2-week Run-in Period|Adverse Event|0|||
163436789|NCT00984659|590302295|FG002|2-week Run-in Period|Adverse Event|0|||
163436790|NCT00984659|590302296|FG003|2-week Run-in Period|Adverse Event|0|||
163436791|NCT00984659|590302293|FG000|2-week Run-in Period|Protocol Violation|5|||
163436792|NCT00984659|590302294|FG001|2-week Run-in Period|Protocol Violation|0|||
163436793|NCT00984659|590302295|FG002|2-week Run-in Period|Protocol Violation|0|||
163436794|NCT00984659|590302296|FG003|2-week Run-in Period|Protocol Violation|0|||
163436795|NCT00984659|590302293|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
163436796|NCT00984659|590302294|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
163436797|NCT00984659|590302295|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
163436798|NCT00984659|590302296|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
163436799|NCT00984659|590302293|FG000|2-week Run-in Period|Lost to Follow-up|3|||
163436800|NCT00984659|590302294|FG001|2-week Run-in Period|Lost to Follow-up|0|||
163436801|NCT00984659|590302295|FG002|2-week Run-in Period|Lost to Follow-up|0|||
163436802|NCT00984659|590302296|FG003|2-week Run-in Period|Lost to Follow-up|0|||
163436803|NCT00984659|590302293|FG000|2-week Run-in Period|Physician Decision|10|||
163436804|NCT00984659|590302294|FG001|2-week Run-in Period|Physician Decision|0|||
163436805|NCT00984659|590302295|FG002|2-week Run-in Period|Physician Decision|0|||
163436806|NCT00984659|590302296|FG003|2-week Run-in Period|Physician Decision|0|||
163436807|NCT00984659|590302293|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
163436808|NCT00984659|590302294|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
163436809|NCT00984659|590302295|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
163436810|NCT00984659|590302296|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
163436811|NCT00984659|590302293|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
163436812|NCT00984659|590302294|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
163436813|NCT00984659|590302295|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
163436814|NCT00984659|590302296|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
163436815|NCT00984659|590302293|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
163436816|NCT00984659|590302294|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
163436817|NCT00984659|590302295|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
163436818|NCT00984659|590302296|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
163436819|NCT00984659|590302293|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
163436820|NCT00984659|590302294|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
163436821|NCT00984659|590302295|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
163436822|NCT00984659|590302296|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
163436823|NCT00984659|590302293|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
163436824|NCT00984659|590302294|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
163436825|NCT00984659|590302295|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
163436826|NCT00984659|590302296|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
163436827|NCT00984659|590302293|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
163436828|NCT00984659|590302294|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
163436829|NCT00984659|590302295|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
163436830|NCT00984659|590302296|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
163436831|NCT00984659|590302293|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
163436832|NCT00984659|590302294|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
163436833|NCT00984659|590302295|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
163436834|NCT00984659|590302296|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
163436835|NCT01966731|590302297|FG000|Overall Study|Death|2|||
163436836|NCT01966731|590302297|FG000|Overall Study|Lost to Follow-up|1|||
163436837|NCT01966731|590302297|FG000|Overall Study|Physician Decision|2|||
163436838|NCT01966731|590302297|FG000|Overall Study|Follow up is not complete|600|||
163436839|NCT01966731|590302297|FG000|Overall Study|Screening Failure|29|||
163436840|NCT01966731|590302297|FG000|Overall Study|Found to be ineligible|1|||
163436841|NCT00592683|590302300|FG000|Overall Study|Found ineligible|0|||
163436842|NCT00592683|590302301|FG001|Overall Study|Found ineligible|1|||
163436843|NCT00592683|590302300|FG000|Overall Study|Withdrawal by Subject|1|||
163436844|NCT00592683|590302301|FG001|Overall Study|Withdrawal by Subject|0|||
163436845|NCT00592683|590302300|FG000|Overall Study|Adverse Event|0|||
163436846|NCT00592683|590302301|FG001|Overall Study|Adverse Event|2|||
163436847|NCT00592683|590302300|FG000|Overall Study|Protocol Violation|1|||
163436848|NCT00592683|590302301|FG001|Overall Study|Protocol Violation|0|||
163436849|NCT00592683|590302300|FG000|Overall Study|Study drug expired|1|||
163436850|NCT00592683|590302301|FG001|Overall Study|Study drug expired|0|||
163436851|NCT00592683|590302300|FG000|Overall Study|Other|1|||
163436852|NCT00592683|590302301|FG001|Overall Study|Other|0|||
163436853|NCT00592683|590302300|FG000|Overall Study|Lost to Follow-up|0|||
163436854|NCT00592683|590302301|FG001|Overall Study|Lost to Follow-up|1|||
163436855|NCT00201201|590302302|FG000|Overall Study|Death|0|||
163436856|NCT00201201|590302303|FG001|Overall Study|Death|2|||
163436857|NCT00201201|590302302|FG000|Overall Study|Withdrawal by Subject|5|||
163436858|NCT00201201|590302303|FG001|Overall Study|Withdrawal by Subject|5|||
163436859|NCT00891657|590302307|FG000|Overall Study|Withdrawal by Subject|1|||
163436860|NCT00891657|590302308|FG001|Overall Study|Withdrawal by Subject|1|||
163436861|NCT00537823|590302316|FG000|Overall Study|Adverse Event|2|||
163436862|NCT00537823|590302317|FG001|Overall Study|Adverse Event|0|||
163436863|NCT03455543|590302318|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
163436864|NCT03455543|590302319|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
163436865|NCT03455543|590302320|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
163436866|NCT03455543|590302318|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
163436867|NCT03455543|590302319|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
163436868|NCT03455543|590302320|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
163436869|NCT03455543|590302318|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
163436870|NCT03455543|590302319|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
163436871|NCT03455543|590302320|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
163436872|NCT03455543|590302318|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
163436873|NCT03455543|590302319|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
163436874|NCT03455543|590302320|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
163436875|NCT03455543|590302318|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
163436876|NCT03455543|590302319|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
163436877|NCT03455543|590302320|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
163436878|NCT03455543|590302318|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
163436879|NCT03455543|590302319|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
163436880|NCT03455543|590302320|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
163436881|NCT03455543|590302318|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
163436882|NCT03455543|590302319|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
163436883|NCT03455543|590302320|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
163436884|NCT03455543|590302318|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
163436885|NCT03455543|590302319|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
163436886|NCT03455543|590302320|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
163436887|NCT03455543|590302318|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
163436888|NCT03455543|590302319|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
163436889|NCT03455543|590302320|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
163436890|NCT00779038|590302321|FG000|Overall Study|Study Prematurely Terminated|13|||
163436891|NCT02717546|590302325|FG000|Overall Study|Lost to Follow-up|12|||
163436892|NCT00909090|590302326|FG000|Overall Study|Lost to Follow-up|17|||
163436893|NCT00909090|590302327|FG001|Overall Study|Lost to Follow-up|17|||
163436894|NCT02926573|590302329|FG000|Overall Study|Nausea|1|||
163436895|NCT02926573|590302330|FG001|Overall Study|Nausea|0|||
163436896|NCT02926573|590302329|FG000|Overall Study|Remain intubated|2|||
163436897|NCT02926573|590302330|FG001|Overall Study|Remain intubated|2|||
163436898|NCT02926573|590302329|FG000|Overall Study|Change in surgery plan|3|||
163436899|NCT02926573|590302330|FG001|Overall Study|Change in surgery plan|1|||
163436900|NCT02926573|590302329|FG000|Overall Study|Change to outpatient status|5|||
163436901|NCT02926573|590302330|FG001|Overall Study|Change to outpatient status|1|||
163436902|NCT02926573|590302329|FG000|Overall Study|Withdrawal by Subject|0|||
163436903|NCT02926573|590302330|FG001|Overall Study|Withdrawal by Subject|2|||
163436904|NCT02926573|590302329|FG000|Overall Study|Return to operating room|0|||
163436905|NCT02926573|590302330|FG001|Overall Study|Return to operating room|2|||
163436906|NCT02926573|590302329|FG000|Overall Study|Delirium|0|||
163436907|NCT02926573|590302330|FG001|Overall Study|Delirium|1|||
163436908|NCT03633331|590302340|FG000|Overall Study|Withdrawal by Subject|1|||
163436909|NCT01009294|590302341|FG000|Overall Study|Study discontinued by Sponsor|6|||
163436910|NCT03240081|590302342|FG000|Overall Study|Withdrawal by Subject|0|||
163436911|NCT03240081|590302343|FG001|Overall Study|Withdrawal by Subject|2|||
163436912|NCT03240081|590302342|FG000|Overall Study|Lost to Follow-up|0|||
163436913|NCT03240081|590302343|FG001|Overall Study|Lost to Follow-up|1|||
163436914|NCT00949650|590302344|FG000|Overall Study|Progressive disease|188|||
163436915|NCT00949650|590302345|FG001|Overall Study|Progressive disease|19|||
163436916|NCT00949650|590302344|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
163436917|NCT00949650|590302345|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
163436918|NCT00949650|590302344|FG000|Overall Study|Other Adverse Event (AE)|28|||
163436919|NCT00949650|590302345|FG001|Overall Study|Other Adverse Event (AE)|17|||
163436920|NCT00949650|590302344|FG000|Overall Study|Protocol Violation|1|||
163436921|NCT00949650|590302345|FG001|Overall Study|Protocol Violation|4|||
163436922|NCT00949650|590302344|FG000|Overall Study|Refusal to continue medication|7|||
163436923|NCT00949650|590302345|FG001|Overall Study|Refusal to continue medication|11|||
163436924|NCT00949650|590302344|FG000|Overall Study|Not treated|1|||
163436925|NCT00949650|590302345|FG001|Overall Study|Not treated|4|||
163436926|NCT00949650|590302344|FG000|Overall Study|Other not specified above|5|||
163436927|NCT00949650|590302345|FG001|Overall Study|Other not specified above|0|||
163436928|NCT04601272|590302348|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
163436929|NCT04601272|590302349|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
163436930|NCT04601272|590302350|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
163436931|NCT00940342|590302353|FG000|Overall Study|Adverse Event|0|||
163436932|NCT00940342|590302354|FG001|Overall Study|Adverse Event|2|||
163436933|NCT00940342|590302355|FG002|Overall Study|Adverse Event|1|||
163436934|NCT03249350|590302358|FG000|Overall Study|Participant did not initiate treatment|5|||
163436935|NCT03249350|590302359|FG001|Overall Study|Participant did not initiate treatment|8|||
163436936|NCT04168645|590303889|FG000|Overall Study|Lost to Follow-up|23|||
163436937|NCT04168645|590303890|FG001|Overall Study|Lost to Follow-up|28|||
163436938|NCT04168645|590303891|FG002|Overall Study|Lost to Follow-up|15|||
163436939|NCT04168645|590303892|FG003|Overall Study|Lost to Follow-up|12|||
163436940|NCT04168645|590303889|FG000|Overall Study|Death|1|||
163436941|NCT04168645|590303890|FG001|Overall Study|Death|1|||
163436942|NCT04168645|590303891|FG002|Overall Study|Death|0|||
163436943|NCT04168645|590303892|FG003|Overall Study|Death|0|||
163436944|NCT04168645|590303889|FG000|Overall Study|Withdrawal by Subject|5|||
163436945|NCT04168645|590303890|FG001|Overall Study|Withdrawal by Subject|2|||
163436946|NCT04168645|590303891|FG002|Overall Study|Withdrawal by Subject|2|||
163436947|NCT04168645|590303892|FG003|Overall Study|Withdrawal by Subject|2|||
163436948|NCT04168645|590303889|FG000|Overall Study|Administrative Withdrawal|3|||
163436949|NCT04168645|590303890|FG001|Overall Study|Administrative Withdrawal|1|||
163436950|NCT04168645|590303891|FG002|Overall Study|Administrative Withdrawal|1|||
163436951|NCT04168645|590303892|FG003|Overall Study|Administrative Withdrawal|3|||
163436952|NCT01853228|590303893|FG000|Phase 1|Lack of Efficacy|8|||
163436953|NCT01853228|590303894|FG001|Phase 1|Lack of Efficacy|0|||
163436954|NCT01853228|590303893|FG000|Phase 1|Other|1|||
163436955|NCT01853228|590303894|FG001|Phase 1|Other|0|||
163436956|NCT01853228|590303893|FG000|Phase 2|Physician Decision|0|||
163436957|NCT01853228|590303894|FG001|Phase 2|Physician Decision|1|||
163436958|NCT01853228|590303893|FG000|Phase 2|Proceed To Transplant|0|||
163436959|NCT01853228|590303894|FG001|Phase 2|Proceed To Transplant|3|||
163436960|NCT01853228|590303893|FG000|Phase 2|Lack of Efficacy|0|||
163436961|NCT01853228|590303894|FG001|Phase 2|Lack of Efficacy|4|||
163436962|NCT02114203|590303895|FG000|Overall Study|Adverse Event|0|||
163436963|NCT02114203|590303896|FG001|Overall Study|Adverse Event|1|||
163436964|NCT02114203|590303897|FG002|Overall Study|Adverse Event|0|||
163436965|NCT02114203|590303895|FG000|Overall Study|Withdrawal by Subject|0|||
163436966|NCT02114203|590303896|FG001|Overall Study|Withdrawal by Subject|1|||
163436967|NCT02114203|590303897|FG002|Overall Study|Withdrawal by Subject|0|||
163436968|NCT01518699|590303898|FG000|Period 2|Protocol Violation|1|||
163436969|NCT01518699|590303899|FG001|Period 2|Protocol Violation|1|||
163436970|NCT01518699|590303900|FG002|Period 2|Protocol Violation|0|||
163436971|NCT01518699|590303901|FG003|Period 2|Protocol Violation|0|||
163436972|NCT01518699|590303902|FG004|Period 2|Protocol Violation|0|||
163436973|NCT01518699|590303903|FG005|Period 2|Protocol Violation|0|||
163436974|NCT01518699|590303898|FG000|Period 2|Lost to Follow-up|0|||
163436975|NCT01518699|590303899|FG001|Period 2|Lost to Follow-up|1|||
163436976|NCT01518699|590303900|FG002|Period 2|Lost to Follow-up|0|||
163436977|NCT01518699|590303901|FG003|Period 2|Lost to Follow-up|0|||
163436978|NCT01518699|590303902|FG004|Period 2|Lost to Follow-up|0|||
163436979|NCT01518699|590303903|FG005|Period 2|Lost to Follow-up|0|||
163436980|NCT01518699|590303898|FG000|Period 2|Adverse Event|1|||
163436981|NCT01518699|590303899|FG001|Period 2|Adverse Event|0|||
163436982|NCT01518699|590303900|FG002|Period 2|Adverse Event|0|||
163436983|NCT01518699|590303901|FG003|Period 2|Adverse Event|0|||
163436984|NCT01518699|590303902|FG004|Period 2|Adverse Event|0|||
163436985|NCT01518699|590303903|FG005|Period 2|Adverse Event|0|||
163436986|NCT01300286|590303905|FG000|Overall Study|did not get dosed|1|||
163436987|NCT03635190|590303906|FG000|Overall Study|Lost to Follow-up|4|||
163436988|NCT03635190|590303906|FG000|Overall Study|Death|3|||
163436989|NCT03635190|590303906|FG000|Overall Study|Withdrawal by Subject|1|||
163436990|NCT03635190|590303906|FG000|Overall Study|Patient moved and did not return for follow up|1|||
163436991|NCT03692910|590303907|FG000|Overall Study|Lost to Follow-up|4|||
163436992|NCT03692910|590303908|FG001|Overall Study|Lost to Follow-up|0|||
163436993|NCT03692910|590303909|FG002|Overall Study|Lost to Follow-up|0|||
163436994|NCT03692910|590303907|FG000|Overall Study|Withdrawal by Subject|2|||
163436995|NCT03692910|590303908|FG001|Overall Study|Withdrawal by Subject|0|||
163436996|NCT03692910|590303909|FG002|Overall Study|Withdrawal by Subject|0|||
163436997|NCT01259492|590303914|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
163436998|NCT01259492|590303915|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
163436999|NCT01259492|590303916|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
163437000|NCT01259492|590303917|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
163437001|NCT01259492|590303914|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
163437002|NCT01259492|590303915|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
163437003|NCT01259492|590303916|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
163437004|NCT01259492|590303917|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
163437005|NCT01259492|590303914|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
163437006|NCT01259492|590303915|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
163437007|NCT01259492|590303916|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
163437008|NCT01259492|590303917|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
163437009|NCT01259492|590303914|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
163437010|NCT01259492|590303915|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
163437011|NCT01259492|590303916|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
163437012|NCT01259492|590303917|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
163437013|NCT01259492|590303914|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
163437014|NCT01259492|590303915|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
163437015|NCT01259492|590303916|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
163437016|NCT01259492|590303917|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
163437017|NCT01259492|590303914|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
163437018|NCT01259492|590303915|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
163437019|NCT01259492|590303916|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
163437020|NCT01259492|590303917|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
163437021|NCT01259492|590303914|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
163437022|NCT01259492|590303915|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
163437023|NCT01259492|590303916|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
163437024|NCT01259492|590303917|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
163437025|NCT01259492|590303914|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
163437026|NCT01259492|590303915|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
163437027|NCT01259492|590303916|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
163437028|NCT01259492|590303917|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
163437029|NCT01259492|590303914|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
163437030|NCT01259492|590303915|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
163437031|NCT01259492|590303916|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
163437032|NCT01259492|590303917|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
163437033|NCT01259492|590303914|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
163437034|NCT01259492|590303915|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
163437035|NCT01259492|590303916|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
163437036|NCT01259492|590303917|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
163437037|NCT01259492|590303914|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
163437038|NCT01259492|590303915|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
163437039|NCT01259492|590303916|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
163437040|NCT01259492|590303917|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
163437041|NCT01259492|590303914|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
163437042|NCT01259492|590303915|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
163437043|NCT01259492|590303916|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
163437044|NCT01259492|590303917|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
163437045|NCT01259492|590303914|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
163437046|NCT01259492|590303915|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
163437047|NCT01259492|590303916|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
163437048|NCT01259492|590303917|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
163437049|NCT01259492|590303914|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
163437050|NCT01259492|590303915|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
163437051|NCT01259492|590303916|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
163437052|NCT01259492|590303917|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
163437053|NCT01259492|590303914|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
163437054|NCT01259492|590303915|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
163437055|NCT01259492|590303916|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
163437056|NCT01259492|590303917|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
163437057|NCT01259492|590303914|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
163437058|NCT01259492|590303915|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
163437059|NCT01259492|590303916|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
163437060|NCT01259492|590303917|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
163437061|NCT01259492|590303914|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
163437062|NCT01259492|590303915|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
163437063|NCT01259492|590303916|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
163437064|NCT01259492|590303917|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
163437065|NCT01259492|590303914|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
163437066|NCT01259492|590303915|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
163437067|NCT01259492|590303916|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
163437068|NCT01259492|590303917|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
163437069|NCT01259492|590303914|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
163437070|NCT01259492|590303915|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
163437071|NCT01259492|590303916|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
163437072|NCT01259492|590303917|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
163437073|NCT01259492|590303914|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
163437074|NCT01259492|590303915|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
163437075|NCT01259492|590303916|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
163437076|NCT01259492|590303917|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
163437077|NCT00611455|590303930|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
163437078|NCT00611455|590303931|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
163437079|NCT00611455|590303932|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
163437080|NCT00611455|590303930|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
163437081|NCT00611455|590303931|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
163437082|NCT00611455|590303932|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
163437083|NCT00611455|590303930|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
163437084|NCT00611455|590303931|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
163437085|NCT00611455|590303932|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
163437086|NCT00611455|590303930|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
163437087|NCT00611455|590303931|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
163437088|NCT00611455|590303932|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163437089|NCT00611455|590303930|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
163437090|NCT00611455|590303931|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
163437091|NCT00611455|590303932|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
163437092|NCT00611455|590303930|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
163437093|NCT00611455|590303931|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
163437094|NCT00611455|590303932|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
163437095|NCT00611455|590303930|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
163437096|NCT00611455|590303931|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
163437097|NCT00611455|590303932|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
163437098|NCT00611455|590303930|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
163437099|NCT00611455|590303931|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
163437100|NCT00611455|590303932|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
163437101|NCT00611455|590303930|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
163437102|NCT00611455|590303931|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
163437103|NCT00611455|590303932|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
163437104|NCT00611455|590303930|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
163437105|NCT00611455|590303931|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
163437106|NCT00611455|590303932|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
163437107|NCT00611455|590303930|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
163437108|NCT00611455|590303931|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
163437109|NCT00611455|590303932|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
163437110|NCT00611455|590303930|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
163437111|NCT00611455|590303931|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
163437112|NCT00611455|590303932|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
163437113|NCT00611455|590303930|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
163437114|NCT00611455|590303931|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
163437115|NCT00611455|590303932|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
163437116|NCT00611455|590303930|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
163437117|NCT00611455|590303931|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
163437118|NCT00611455|590303932|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
163437119|NCT00611455|590303930|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
163437120|NCT00611455|590303931|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
163437121|NCT00611455|590303932|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
163437122|NCT00611455|590303930|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
163437123|NCT00611455|590303931|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
163437124|NCT00611455|590303932|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
163437125|NCT00611455|590303930|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
163437126|NCT00611455|590303931|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
163437127|NCT00611455|590303932|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
163437128|NCT00611455|590303930|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
163437129|NCT00611455|590303931|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
163437130|NCT00611455|590303932|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
163437131|NCT00611455|590303930|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
163437132|NCT00611455|590303931|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
163437133|NCT00611455|590303932|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
163437134|NCT00611455|590303930|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
163437135|NCT00611455|590303931|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
163437136|NCT00611455|590303932|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
163437137|NCT00611455|590303930|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
163437138|NCT00611455|590303931|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
163437139|NCT00611455|590303932|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
163437140|NCT03671369|590303933|FG000|Overall Study|Other|1|||
163437141|NCT03671369|590303933|FG000|Overall Study|Withdrawal by Subject|289|||
163437142|NCT03671369|590303933|FG000|Overall Study|Not willing to be vaccinated|1|||
163437143|NCT04382651|590303934|FG000|Overall Study|Death|26|||
163437144|NCT04382651|590303935|FG001|Overall Study|Death|23|||
163437145|NCT04382651|590303934|FG000|Overall Study|Lost to Follow-up|3|||
163437146|NCT04382651|590303935|FG001|Overall Study|Lost to Follow-up|4|||
163437147|NCT04382651|590303934|FG000|Overall Study|Withdrawal by Subject|2|||
163437148|NCT04382651|590303935|FG001|Overall Study|Withdrawal by Subject|0|||
163437149|NCT04382651|590303934|FG000|Overall Study|Physician Decision|0|||
163437150|NCT04382651|590303935|FG001|Overall Study|Physician Decision|1|||
163437151|NCT02732912|590303936|FG000|Overall Study|Discharged before night|2|||
163437152|NCT02732912|590303937|FG001|Overall Study|Discharged before night|6|||
163437153|NCT02732912|590303936|FG000|Overall Study|Incomplete completion of questionnaire|2|||
163437154|NCT02732912|590303937|FG001|Overall Study|Incomplete completion of questionnaire|3|||
163437155|NCT02732912|590303936|FG000|Overall Study|No outcome; discharged or refused|6|||
163437156|NCT02732912|590303937|FG001|Overall Study|No outcome; discharged or refused|9|||
163437157|NCT01507545|590303943|FG000|Overall Study|Withdrawal by Subject|6|||
163437158|NCT01507545|590303944|FG001|Overall Study|Withdrawal by Subject|2|||
163437159|NCT01507545|590303943|FG000|Overall Study|Lost to Follow-up|1|||
163437160|NCT01507545|590303944|FG001|Overall Study|Lost to Follow-up|0|||
163437161|NCT01507545|590303943|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
163437162|NCT01507545|590303944|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
163437163|NCT01507545|590303943|FG000|Overall Study|Progressive disease|60|||
163437164|NCT01507545|590303944|FG001|Overall Study|Progressive disease|27|||
163437165|NCT01507545|590303943|FG000|Overall Study|Other|6|||
163437166|NCT01507545|590303944|FG001|Overall Study|Other|4|||
163437167|NCT00790296|590303946|FG000|Overall Study|Did not meet study eligibility criteria|1|||
163437168|NCT00790296|590303947|FG001|Overall Study|Did not meet study eligibility criteria|1|||
163437169|NCT00790296|590303946|FG000|Overall Study|Adverse Event|0|||
163437170|NCT00790296|590303947|FG001|Overall Study|Adverse Event|1|||
163437171|NCT02612077|590303948|FG000|Overall Study|Adverse Event|3|||
163437172|NCT02612077|590303948|FG000|Overall Study|Withdrawal by Subject|9|||
163437173|NCT02612077|590303948|FG000|Overall Study|Protocol Violation|28|||
163437174|NCT02612077|590303948|FG000|Overall Study|Lost to Follow-up|20|||
163437175|NCT02612077|590303948|FG000|Overall Study|Death|377|||
163437176|NCT02612077|590303948|FG000|Overall Study|Moved or Changed Medical Team|23|||
163437177|NCT02612077|590303948|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
163437178|NCT02612077|590303948|FG000|Overall Study|Disease Progression|3|||
163437179|NCT02612077|590303948|FG000|Overall Study|Unknown reason|2|||
163437180|NCT01753518|590303949|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
163437181|NCT01753518|590303950|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
163437182|NCT01753518|590303949|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
163437183|NCT01753518|590303950|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
163437184|NCT01753518|590303949|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
163437185|NCT01753518|590303950|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
163437186|NCT01753518|590303949|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
163437187|NCT01753518|590303950|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
163437188|NCT01971476|590303951|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
163437189|NCT01971476|590303952|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
163437190|NCT01971476|590303953|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
163437191|NCT01971476|590303951|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
163437192|NCT01971476|590303952|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
163437193|NCT01971476|590303953|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
163437194|NCT01971476|590303951|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
163437195|NCT01971476|590303952|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
163437196|NCT01971476|590303953|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
163437197|NCT01716169|590303955|FG000|Overall Study|Adverse Event|1|||
163437198|NCT01716169|590303955|FG000|Overall Study|Lost to Follow-up|1|||
163437199|NCT01716169|590303955|FG000|Overall Study|Withdrawal by Subject|1|||
163437200|NCT01716169|590303955|FG000|Overall Study|inconsistent dressing application|1|||
163437201|NCT00553787|590303956|FG000|Overall Study|Adverse Event|34|||
163437202|NCT00553787|590303957|FG001|Overall Study|Adverse Event|21|||
163437203|NCT00553787|590303958|FG002|Overall Study|Adverse Event|67|||
163437204|NCT00553787|590303956|FG000|Overall Study|Lost to Follow-up|132|||
163437205|NCT00553787|590303957|FG001|Overall Study|Lost to Follow-up|44|||
163437206|NCT00553787|590303958|FG002|Overall Study|Lost to Follow-up|78|||
163437207|NCT00553787|590303956|FG000|Overall Study|Withdrawal by Subject|151|||
163437208|NCT00553787|590303957|FG001|Overall Study|Withdrawal by Subject|40|||
163437209|NCT00553787|590303958|FG002|Overall Study|Withdrawal by Subject|83|||
163437210|NCT00553787|590303956|FG000|Overall Study|Lack of Efficacy|31|||
163437211|NCT00553787|590303957|FG001|Overall Study|Lack of Efficacy|1|||
163437212|NCT00553787|590303958|FG002|Overall Study|Lack of Efficacy|3|||
163437213|NCT00553787|590303956|FG000|Overall Study|Pregnancy|0|||
163437214|NCT00553787|590303957|FG001|Overall Study|Pregnancy|1|||
163437215|NCT00553787|590303958|FG002|Overall Study|Pregnancy|2|||
163437216|NCT00553787|590303956|FG000|Overall Study|non compliance|4|||
163437217|NCT00553787|590303957|FG001|Overall Study|non compliance|0|||
163437218|NCT00553787|590303958|FG002|Overall Study|non compliance|11|||
163437219|NCT00553787|590303956|FG000|Overall Study|Requirement for restricted medication|8|||
163437220|NCT00553787|590303957|FG001|Overall Study|Requirement for restricted medication|7|||
163437221|NCT00553787|590303958|FG002|Overall Study|Requirement for restricted medication|5|||
163437222|NCT00553787|590303956|FG000|Overall Study|Other|18|||
163437223|NCT00553787|590303957|FG001|Overall Study|Other|10|||
163437224|NCT00553787|590303958|FG002|Overall Study|Other|13|||
163437225|NCT05121103|590303961|FG000|Overall Study|Progressive disease|2|||
163437226|NCT05121103|590303962|FG001|Overall Study|Progressive disease|1|||
163437227|NCT05121103|590303963|FG002|Overall Study|Progressive disease|6|||
163437228|NCT05121103|590303961|FG000|Overall Study|Physician Decision|2|||
163437229|NCT05121103|590303962|FG001|Overall Study|Physician Decision|1|||
163437230|NCT05121103|590303963|FG002|Overall Study|Physician Decision|0|||
163437231|NCT05121103|590303961|FG000|Overall Study|Withdrawal by Subject|0|||
163437232|NCT05121103|590303962|FG001|Overall Study|Withdrawal by Subject|1|||
163437233|NCT05121103|590303963|FG002|Overall Study|Withdrawal by Subject|0|||
163437234|NCT00514449|590303964|FG000|Overall Study|Withdrawal by Subject|1|||
163437235|NCT00514449|590303965|FG001|Overall Study|Withdrawal by Subject|2|||
163437236|NCT00514449|590303964|FG000|Overall Study|Protocol Violation|1|||
163437237|NCT00514449|590303965|FG001|Overall Study|Protocol Violation|2|||
163437238|NCT00514449|590303964|FG000|Overall Study|Lost to Follow-up|1|||
163437239|NCT00514449|590303965|FG001|Overall Study|Lost to Follow-up|0|||
163437240|NCT00301067|590303975|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
163437241|NCT00301067|590303976|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
163437242|NCT00301067|590303977|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
163437243|NCT00301067|590303978|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
163437244|NCT00301067|590303975|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
163437245|NCT00301067|590303976|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
163437246|NCT00301067|590303977|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
163437247|NCT00301067|590303978|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
163437248|NCT00301067|590303975|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
163437249|NCT00301067|590303976|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
163437250|NCT00301067|590303977|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
163437251|NCT00301067|590303978|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
163437252|NCT00301067|590303975|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
163437253|NCT00301067|590303976|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
163437254|NCT00301067|590303977|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
163437255|NCT00301067|590303978|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
163437256|NCT00301067|590303975|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
163437257|NCT00301067|590303976|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
163437258|NCT00301067|590303977|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
163437259|NCT00301067|590303978|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
163437260|NCT00301067|590303975|FG000|Follow up Until Death|Alive at last data cut point|1|||
163437261|NCT00301067|590303976|FG001|Follow up Until Death|Alive at last data cut point|0|||
163437262|NCT00301067|590303977|FG002|Follow up Until Death|Alive at last data cut point|0|||
163437263|NCT00301067|590303978|FG003|Follow up Until Death|Alive at last data cut point|1|||
163437264|NCT00149825|590303979|FG000|Overall Study|Intolerance to medication side effects|1|||
163437265|NCT00149825|590303980|FG001|Overall Study|Intolerance to medication side effects|2|||
163437266|NCT00149825|590303979|FG000|Overall Study|Time commitments|2|||
163437267|NCT00149825|590303980|FG001|Overall Study|Time commitments|1|||
163437268|NCT00149825|590303979|FG000|Overall Study|Not liking insomnia therapy|1|||
163437269|NCT00149825|590303980|FG001|Overall Study|Not liking insomnia therapy|0|||
163437270|NCT00149825|590303979|FG000|Overall Study|Other|1|||
163437271|NCT00149825|590303980|FG001|Overall Study|Other|0|||
163437272|NCT05897853|590303981|FG000|Overall Study|Lost to Follow-up|2|||
163437273|NCT05897853|590303982|FG001|Overall Study|Lost to Follow-up|0|||
163437274|NCT05897853|590303981|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
163437275|NCT05897853|590303982|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
163437276|NCT04458857|590303986|FG000|Overall Study|Adverse Event|0|||
163437277|NCT04458857|590303987|FG001|Overall Study|Adverse Event|1|||
163437278|NCT04458857|590303988|FG002|Overall Study|Adverse Event|0|||
163437279|NCT04458857|590303986|FG000|Overall Study|Withdrawal by Subject|2|||
163437280|NCT04458857|590303987|FG001|Overall Study|Withdrawal by Subject|0|||
163437281|NCT04458857|590303988|FG002|Overall Study|Withdrawal by Subject|0|||
163437282|NCT04458857|590303986|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163437283|NCT04458857|590303987|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163437284|NCT04458857|590303988|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163437285|NCT04458857|590303986|FG000|Overall Study|Non-compliance with study drug|0|||
163437286|NCT04458857|590303987|FG001|Overall Study|Non-compliance with study drug|1|||
163437287|NCT04458857|590303988|FG002|Overall Study|Non-compliance with study drug|0|||
163437288|NCT04458857|590303986|FG000|Overall Study|Lost to Follow-up|4|||
163437289|NCT04458857|590303987|FG001|Overall Study|Lost to Follow-up|1|||
163437290|NCT04458857|590303988|FG002|Overall Study|Lost to Follow-up|0|||
163437291|NCT02609399|590303989|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
163437292|NCT02609399|590303990|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
163437293|NCT02609399|590303989|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
163437294|NCT02609399|590303990|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
163437295|NCT02609399|590303989|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
163437296|NCT02609399|590303990|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
163437297|NCT00853905|590303992|FG000|Overall Study|Lost to Follow-up|1|||
163437298|NCT00853905|590303993|FG001|Overall Study|Lost to Follow-up|3|||
163437299|NCT00853905|590303992|FG000|Overall Study|Withdrawal by Subject|0|||
163437300|NCT00853905|590303993|FG001|Overall Study|Withdrawal by Subject|1|||
163437301|NCT00853905|590303992|FG000|Overall Study|never had surgery|1|||
163437302|NCT00853905|590303993|FG001|Overall Study|never had surgery|0|||
163437303|NCT00847561|590303996|FG000|Overall Study|Withdrawal by Subject|4|||
163437304|NCT00847561|590303997|FG001|Overall Study|Withdrawal by Subject|3|||
163437305|NCT00847561|590303996|FG000|Overall Study|Unable to schedule|9|||
163437306|NCT00847561|590303997|FG001|Overall Study|Unable to schedule|1|||
163437307|NCT01333189|590303998|FG000|Overall Study|Time constraints|1|||
163437308|NCT01333189|590303999|FG001|Overall Study|Time constraints|0|||
163437309|NCT01333189|590303998|FG000|Overall Study|Adverse Event|1|||
163437310|NCT01333189|590303999|FG001|Overall Study|Adverse Event|0|||
163437311|NCT01333189|590303998|FG000|Overall Study|Transportation difficulties|0|||
163437312|NCT01333189|590303999|FG001|Overall Study|Transportation difficulties|1|||
163437313|NCT01333189|590303998|FG000|Overall Study|Moved from region|0|||
163437314|NCT01333189|590303999|FG001|Overall Study|Moved from region|1|||
163437315|NCT01739595|590304001|FG000|Overall Study|Adverse Event|3|||
163437316|NCT01739595|590304002|FG001|Overall Study|Adverse Event|0|||
163437317|NCT01739595|590304003|FG002|Overall Study|Adverse Event|0|||
163437318|NCT01739595|590304001|FG000|Overall Study|Lost to Follow-up|2|||
163437319|NCT01739595|590304002|FG001|Overall Study|Lost to Follow-up|0|||
163437320|NCT01739595|590304003|FG002|Overall Study|Lost to Follow-up|0|||
163437321|NCT01739595|590304001|FG000|Overall Study|Withdrawal by Subject|2|||
163437322|NCT01739595|590304002|FG001|Overall Study|Withdrawal by Subject|1|||
163437323|NCT01739595|590304003|FG002|Overall Study|Withdrawal by Subject|2|||
163437324|NCT01739595|590304001|FG000|Overall Study|Eligibility issue|3|||
163437325|NCT01739595|590304002|FG001|Overall Study|Eligibility issue|0|||
163437326|NCT01739595|590304003|FG002|Overall Study|Eligibility issue|0|||
163437327|NCT01739595|590304001|FG000|Overall Study|Protocol Violation|1|||
163437328|NCT01739595|590304002|FG001|Overall Study|Protocol Violation|0|||
163437329|NCT01739595|590304003|FG002|Overall Study|Protocol Violation|0|||
163437330|NCT01739595|590304001|FG000|Overall Study|Lab assessment|1|||
163437331|NCT01739595|590304002|FG001|Overall Study|Lab assessment|0|||
163437332|NCT01739595|590304003|FG002|Overall Study|Lab assessment|0|||
163437333|NCT01739595|590304001|FG000|Overall Study|Drug discrepancy|1|||
163437334|NCT01739595|590304002|FG001|Overall Study|Drug discrepancy|0|||
163437335|NCT01739595|590304003|FG002|Overall Study|Drug discrepancy|0|||
163437336|NCT02725177|590304006|FG000|Overall Study|Physician Decision|4|||
163437337|NCT02725177|590304006|FG000|Overall Study|Adverse Event|1|||
163437338|NCT04285723|590304010|FG000|Overall Study|Subject decision|1|||
163437339|NCT04285723|590304011|FG001|Overall Study|Subject decision|2|||
163437340|NCT04285723|590304010|FG000|Overall Study|Physician Decision|1|||
163437341|NCT04285723|590304011|FG001|Overall Study|Physician Decision|0|||
163437342|NCT04285723|590304010|FG000|Overall Study|No efficiency|1|||
163437343|NCT04285723|590304011|FG001|Overall Study|No efficiency|0|||
163437344|NCT00778999|590304012|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
163437345|NCT00778999|590304013|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
163437346|NCT00778999|590304012|FG000|Overall Study|Did not receive recFSH|14|||
163437347|NCT00778999|590304013|FG001|Overall Study|Did not receive recFSH|20|||
163437348|NCT02032524|590304014|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
163437349|NCT02032524|590304015|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
163437350|NCT02032524|590304016|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
163437351|NCT02032524|590304017|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
163437352|NCT02032524|590304018|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
163437353|NCT02032524|590304019|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
163437354|NCT02032524|590304014|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
163437355|NCT02032524|590304015|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
163437356|NCT02032524|590304016|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
163437357|NCT02032524|590304017|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
163437358|NCT02032524|590304018|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
163437359|NCT02032524|590304019|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
163437360|NCT02032524|590304014|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
163437361|NCT02032524|590304015|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
163437362|NCT02032524|590304016|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
163437363|NCT02032524|590304017|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
163437364|NCT02032524|590304018|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
163437365|NCT02032524|590304019|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
163437366|NCT02032524|590304014|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
163437367|NCT02032524|590304015|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
163437368|NCT02032524|590304016|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
163437369|NCT02032524|590304017|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
163437370|NCT02032524|590304018|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
163437371|NCT02032524|590304019|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
163437372|NCT02032524|590304014|FG000|Period 2: LTS13769 Study|Other|0|||
163437373|NCT02032524|590304015|FG001|Period 2: LTS13769 Study|Other|0|||
163437374|NCT02032524|590304016|FG002|Period 2: LTS13769 Study|Other|0|||
163437375|NCT02032524|590304017|FG003|Period 2: LTS13769 Study|Other|0|||
163437376|NCT02032524|590304018|FG004|Period 2: LTS13769 Study|Other|0|||
163437377|NCT02032524|590304019|FG005|Period 2: LTS13769 Study|Other|1|||
163437378|NCT02903511|590304023|FG000|Overall Study|Withdrawal by Subject|1|||
163437379|NCT02903511|590304024|FG001|Overall Study|Withdrawal by Subject|0|||
163437380|NCT02903511|590304023|FG000|Overall Study|Lost to Follow-up|3|||
163437381|NCT02903511|590304024|FG001|Overall Study|Lost to Follow-up|2|||
163437382|NCT00969618|590304025|FG000|Overall Study|Adverse Event|29|||
163437383|NCT00969618|590304025|FG000|Overall Study|Entry Criteria Not Met|3|||
163437384|NCT00969618|590304025|FG000|Overall Study|Lack of Efficacy|2|||
163437385|NCT00969618|590304025|FG000|Overall Study|Lost to Follow-up|7|||
163437386|NCT00969618|590304025|FG000|Overall Study|Physician Decision|1|||
163437387|NCT00969618|590304025|FG000|Overall Study|Protocol Violation|9|||
163437388|NCT00969618|590304025|FG000|Overall Study|Withdrawal by Subject|27|||
163437389|NCT01089725|590304026|FG000|Overall Study|Adverse Event|1|||
163437390|NCT01089725|590304027|FG001|Overall Study|Adverse Event|1|||
163437391|NCT01089725|590304028|FG002|Overall Study|Adverse Event|0|||
163437392|NCT01089725|590304029|FG003|Overall Study|Adverse Event|0|||
163437393|NCT01089725|590304030|FG004|Overall Study|Adverse Event|2|||
163437394|NCT01089725|590304026|FG000|Overall Study|Lack of Efficacy|4|||
163437395|NCT01089725|590304027|FG001|Overall Study|Lack of Efficacy|3|||
163437396|NCT01089725|590304028|FG002|Overall Study|Lack of Efficacy|1|||
163437397|NCT01089725|590304029|FG003|Overall Study|Lack of Efficacy|0|||
163437398|NCT01089725|590304030|FG004|Overall Study|Lack of Efficacy|4|||
163437399|NCT01089725|590304026|FG000|Overall Study|Lost to Follow-up|2|||
163437400|NCT01089725|590304027|FG001|Overall Study|Lost to Follow-up|2|||
163437401|NCT01089725|590304028|FG002|Overall Study|Lost to Follow-up|0|||
163437402|NCT01089725|590304029|FG003|Overall Study|Lost to Follow-up|3|||
163437403|NCT01089725|590304030|FG004|Overall Study|Lost to Follow-up|0|||
163437404|NCT01089725|590304026|FG000|Overall Study|Protocol Violation|0|||
163437405|NCT01089725|590304027|FG001|Overall Study|Protocol Violation|0|||
163437406|NCT01089725|590304028|FG002|Overall Study|Protocol Violation|1|||
163437407|NCT01089725|590304029|FG003|Overall Study|Protocol Violation|1|||
163437408|NCT01089725|590304030|FG004|Overall Study|Protocol Violation|0|||
163437409|NCT01089725|590304026|FG000|Overall Study|Withdrawal by Subject|5|||
163437410|NCT01089725|590304027|FG001|Overall Study|Withdrawal by Subject|5|||
163437411|NCT01089725|590304028|FG002|Overall Study|Withdrawal by Subject|4|||
163437412|NCT01089725|590304029|FG003|Overall Study|Withdrawal by Subject|5|||
163437413|NCT01089725|590304030|FG004|Overall Study|Withdrawal by Subject|4|||
163437414|NCT01089725|590304026|FG000|Overall Study|Study Terminated by Sponsor|51|||
163437415|NCT01089725|590304027|FG001|Overall Study|Study Terminated by Sponsor|56|||
163437416|NCT01089725|590304028|FG002|Overall Study|Study Terminated by Sponsor|53|||
163437417|NCT01089725|590304029|FG003|Overall Study|Study Terminated by Sponsor|68|||
163437418|NCT01089725|590304030|FG004|Overall Study|Study Terminated by Sponsor|68|||
163437419|NCT01089725|590304026|FG000|Overall Study|Randomized, but not treated|0|||
163437420|NCT01089725|590304027|FG001|Overall Study|Randomized, but not treated|1|||
163437421|NCT01089725|590304028|FG002|Overall Study|Randomized, but not treated|2|||
163437422|NCT01089725|590304029|FG003|Overall Study|Randomized, but not treated|1|||
163437423|NCT01089725|590304030|FG004|Overall Study|Randomized, but not treated|2|||
163437424|NCT01089725|590304026|FG000|Overall Study|Other|3|||
163437425|NCT01089725|590304027|FG001|Overall Study|Other|0|||
163437426|NCT01089725|590304028|FG002|Overall Study|Other|0|||
163437427|NCT01089725|590304029|FG003|Overall Study|Other|1|||
163437428|NCT01089725|590304030|FG004|Overall Study|Other|0|||
163437429|NCT01894516|590305402|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
163437430|NCT01894516|590305403|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
163437431|NCT01894516|590305404|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
163437432|NCT01894516|590305405|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
163437433|NCT01894516|590305402|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
163437434|NCT01894516|590305403|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
163437435|NCT01894516|590305404|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
163437436|NCT01894516|590305405|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
163437437|NCT01894516|590305402|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
163437438|NCT01894516|590305403|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
163437439|NCT01894516|590305404|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
163437440|NCT01894516|590305405|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
163437441|NCT01894516|590305402|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
163437442|NCT01894516|590305403|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
163437443|NCT01894516|590305404|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
163437444|NCT01894516|590305405|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
163437445|NCT01894516|590305402|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
163437446|NCT01894516|590305403|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
163437447|NCT01894516|590305404|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
163437448|NCT01894516|590305405|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
163437449|NCT01894516|590305402|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
163437450|NCT01894516|590305403|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
163437451|NCT01894516|590305404|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
163437452|NCT01894516|590305405|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
163437453|NCT01894516|590305402|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
163437454|NCT01894516|590305403|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
163437455|NCT01894516|590305404|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
163437456|NCT01894516|590305405|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
163437457|NCT01894516|590305402|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
163437458|NCT01894516|590305403|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
163437459|NCT01894516|590305404|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
163437460|NCT01894516|590305405|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
163437461|NCT00375934|590305411|FG000|Overall Study|Adverse Event|1|||
163437462|NCT00375934|590305412|FG001|Overall Study|Adverse Event|1|||
163437463|NCT00375934|590305411|FG000|Overall Study|Withdrawal by Subject|2|||
163437464|NCT00375934|590305412|FG001|Overall Study|Withdrawal by Subject|2|||
163437465|NCT00375934|590305411|FG000|Overall Study|Lack of Efficacy|0|||
163437466|NCT00375934|590305412|FG001|Overall Study|Lack of Efficacy|2|||
163437467|NCT00375934|590305411|FG000|Overall Study|Physician Decision|0|||
163437468|NCT00375934|590305412|FG001|Overall Study|Physician Decision|1|||
163437469|NCT03191396|590305414|FG000|Overall Study|Lost to Follow-up|0|||
163437470|NCT03191396|590305415|FG001|Overall Study|Lost to Follow-up|3|||
163437471|NCT03191396|590305414|FG000|Overall Study|Withdrawal by Subject|3|||
163437472|NCT03191396|590305415|FG001|Overall Study|Withdrawal by Subject|2|||
163437473|NCT00893113|590305416|FG000|Overall Study|Lost to Follow-up|4|||
163437474|NCT00893113|590305417|FG001|Overall Study|Lost to Follow-up|8|||
163437475|NCT00893113|590305416|FG000|Overall Study|Early Termination|1|||
163437476|NCT00893113|590305417|FG001|Overall Study|Early Termination|1|||
163437477|NCT00893113|590305416|FG000|Overall Study|Withdrew Consent|8|||
163437478|NCT00893113|590305417|FG001|Overall Study|Withdrew Consent|7|||
163437479|NCT01240811|590305420|FG000|Overall Study|Physician Decision|0|||
163437480|NCT01240811|590305421|FG001|Overall Study|Physician Decision|1|||
163437481|NCT01240811|590305422|FG002|Overall Study|Physician Decision|0|||
163437482|NCT01240811|590305420|FG000|Overall Study|Withdrawal by Subject|0|||
163437483|NCT01240811|590305421|FG001|Overall Study|Withdrawal by Subject|0|||
163437484|NCT01240811|590305422|FG002|Overall Study|Withdrawal by Subject|1|||
163437485|NCT00486226|590305446|FG000|Overall Study|Death|3|||
163437486|NCT00486226|590305446|FG000|Overall Study|Adverse Event|1|||
163437487|NCT00486226|590305446|FG000|Overall Study|Withdrawal by Subject|1|||
163437488|NCT00486226|590305446|FG000|Overall Study|Lost to Follow-up|8|||
163437489|NCT00500149|590305453|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
163437490|NCT00500149|590305454|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
163437491|NCT00500149|590305453|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
163437492|NCT00500149|590305454|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
163437493|NCT00500149|590305453|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
163437494|NCT00500149|590305454|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
163437495|NCT00500149|590305453|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
163437496|NCT00500149|590305454|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
163437497|NCT00500149|590305453|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
163437498|NCT00500149|590305454|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
163437499|NCT00500149|590305453|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
163437500|NCT00500149|590305454|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
163437501|NCT00500149|590305453|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
163437502|NCT00500149|590305454|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
163437503|NCT01157169|590305455|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
163437504|NCT01157169|590305456|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
163437505|NCT01157169|590305455|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
163437506|NCT01157169|590305456|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
163437507|NCT02940886|590305457|FG000|Overall Study|Adverse Event|7|||
163437508|NCT02940886|590305458|FG001|Overall Study|Adverse Event|3|||
163437509|NCT02940886|590305457|FG000|Overall Study|Protocol Violation|0|||
163437510|NCT02940886|590305458|FG001|Overall Study|Protocol Violation|2|||
163437511|NCT02940886|590305457|FG000|Overall Study|Withdrawal by Subject|28|||
163437512|NCT02940886|590305458|FG001|Overall Study|Withdrawal by Subject|20|||
163437513|NCT02940886|590305457|FG000|Overall Study|Death|1|||
163437514|NCT02940886|590305458|FG001|Overall Study|Death|0|||
163437515|NCT02940886|590305457|FG000|Overall Study|Lack of Efficacy|1|||
163437516|NCT02940886|590305458|FG001|Overall Study|Lack of Efficacy|0|||
163437517|NCT02940886|590305457|FG000|Overall Study|Lost to Follow-up|49|||
163437518|NCT02940886|590305458|FG001|Overall Study|Lost to Follow-up|21|||
163437519|NCT02940886|590305457|FG000|Overall Study|Physician Decision|9|||
163437520|NCT02940886|590305458|FG001|Overall Study|Physician Decision|4|||
163437521|NCT02940886|590305457|FG000|Overall Study|Sponsor decision|0|||
163437522|NCT02940886|590305458|FG001|Overall Study|Sponsor decision|1|||
163437523|NCT02940886|590305457|FG000|Overall Study|No treatment|7|||
163437524|NCT02940886|590305458|FG001|Overall Study|No treatment|2|||
163437525|NCT02940886|590305457|FG000|Overall Study|Enrolment error|0|||
163437526|NCT02940886|590305458|FG001|Overall Study|Enrolment error|1|||
163437527|NCT03042611|590305459|FG000|Core Phase|Withdrawal by Subject|13|||
163437528|NCT03042611|590305460|FG001|Core Phase|Withdrawal by Subject|4|||
163437529|NCT03042611|590305461|FG002|Core Phase|Withdrawal by Subject|0|||
163437530|NCT03042611|590305462|FG003|Core Phase|Withdrawal by Subject|0|||
163437531|NCT03042611|590305459|FG000|Core Phase|Death|232|||
163437532|NCT03042611|590305460|FG001|Core Phase|Death|110|||
163437533|NCT03042611|590305461|FG002|Core Phase|Death|0|||
163437534|NCT03042611|590305462|FG003|Core Phase|Death|0|||
163437535|NCT03042611|590305459|FG000|Core Phase|Lost to Follow-up|4|||
163437536|NCT03042611|590305460|FG001|Core Phase|Lost to Follow-up|7|||
163437537|NCT03042611|590305461|FG002|Core Phase|Lost to Follow-up|0|||
163437538|NCT03042611|590305462|FG003|Core Phase|Lost to Follow-up|0|||
163437539|NCT03042611|590305459|FG000|Core Phase|Physician Decision|7|||
163437540|NCT03042611|590305460|FG001|Core Phase|Physician Decision|2|||
163437541|NCT03042611|590305461|FG002|Core Phase|Physician Decision|0|||
163437542|NCT03042611|590305462|FG003|Core Phase|Physician Decision|0|||
163437543|NCT03042611|590305459|FG000|Core Phase|Study Closed|0|||
163437544|NCT03042611|590305460|FG001|Core Phase|Study Closed|1|||
163437545|NCT03042611|590305461|FG002|Core Phase|Study Closed|0|||
163437546|NCT03042611|590305462|FG003|Core Phase|Study Closed|0|||
163437547|NCT03042611|590305459|FG000|Extension Phase|Death|0|||
163437548|NCT03042611|590305460|FG001|Extension Phase|Death|0|||
163437549|NCT03042611|590305461|FG002|Extension Phase|Death|34|||
163437550|NCT03042611|590305462|FG003|Extension Phase|Death|16|||
163437551|NCT03042611|590305459|FG000|Extension Phase|Lost to Follow-up|0|||
163437552|NCT03042611|590305460|FG001|Extension Phase|Lost to Follow-up|0|||
163437553|NCT03042611|590305461|FG002|Extension Phase|Lost to Follow-up|1|||
163437554|NCT03042611|590305462|FG003|Extension Phase|Lost to Follow-up|1|||
163437555|NCT03042611|590305459|FG000|Extension Phase|Study Closed|0|||
163437556|NCT03042611|590305460|FG001|Extension Phase|Study Closed|0|||
163437557|NCT03042611|590305461|FG002|Extension Phase|Study Closed|17|||
163437558|NCT03042611|590305462|FG003|Extension Phase|Study Closed|11|||
163437559|NCT00474630|590305463|FG000|Overall Study|Adverse Event|98|||
163437560|NCT00474630|590305464|FG001|Overall Study|Adverse Event|26|||
163437561|NCT00474630|590305463|FG000|Overall Study|Lost to Follow-up|22|||
163437562|NCT00474630|590305464|FG001|Overall Study|Lost to Follow-up|15|||
163437563|NCT00474630|590305463|FG000|Overall Study|Withdrawal by Subject|21|||
163437564|NCT00474630|590305464|FG001|Overall Study|Withdrawal by Subject|15|||
163437565|NCT00474630|590305463|FG000|Overall Study|Protocol Violation|3|||
163437566|NCT00474630|590305464|FG001|Overall Study|Protocol Violation|4|||
163437567|NCT00474630|590305463|FG000|Overall Study|Lack of Efficacy|5|||
163437568|NCT00474630|590305464|FG001|Overall Study|Lack of Efficacy|6|||
163437569|NCT00474630|590305463|FG000|Overall Study|Drug noncompliance, other|11|||
163437570|NCT00474630|590305464|FG001|Overall Study|Drug noncompliance, other|4|||
163437571|NCT02397655|590305470|FG000|Overall Study|data not completed|1301|||
163437572|NCT00545818|590305484|FG000|Overall Study|Protocol Violation|1|||
163437573|NCT00545818|590305485|FG001|Overall Study|Protocol Violation|0|||
163437574|NCT00545818|590305484|FG000|Overall Study|Adverse Event|1|||
163437575|NCT00545818|590305485|FG001|Overall Study|Adverse Event|1|||
163437576|NCT00545818|590305484|FG000|Overall Study|Lost to Follow-up|1|||
163437577|NCT00545818|590305485|FG001|Overall Study|Lost to Follow-up|6|||
163437578|NCT02623361|590305486|FG000|Overall Study|Protocol Violation|0|||
163437579|NCT02623361|590305487|FG001|Overall Study|Protocol Violation|1|||
163437580|NCT02623361|590305486|FG000|Overall Study|Withdrawal by Subject|0|||
163437581|NCT02623361|590305487|FG001|Overall Study|Withdrawal by Subject|1|||
163437582|NCT01873742|590305488|FG000|Overall Study|Lost to Follow-up|68|||
163437583|NCT01873742|590305489|FG001|Overall Study|Lost to Follow-up|76|||
163437584|NCT02498821|590305490|FG000|Overall Study|Screen failure|3|||
163437585|NCT02498821|590305491|FG001|Overall Study|Screen failure|5|||
163437586|NCT00942708|590305496|FG000|Overall Study|Withdrawal by Subject|1|||
163437587|NCT01457339|590305497|FG000|Period 3 (100 mg)|Adverse Event|0|||
163437588|NCT01457339|590305498|FG001|Period 3 (100 mg)|Adverse Event|1|||
163437589|NCT01457339|590305497|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
163437590|NCT01457339|590305498|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
163437591|NCT01457339|590305497|FG000|Period 6 (250 mg)|Family Emergency|1|||
163437592|NCT01457339|590305498|FG001|Period 6 (250 mg)|Family Emergency|0|||
163437593|NCT01457339|590305497|FG000|Period 6 (250 mg)|Personal appointment|0|||
163437594|NCT01457339|590305498|FG001|Period 6 (250 mg)|Personal appointment|1|||
163437595|NCT00995371|590305499|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
163437596|NCT00995371|590305500|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
163437597|NCT00306891|590305501|FG000|Part A|Withdrawal by Subject|1|||
163437598|NCT00306891|590305502|FG001|Part A|Withdrawal by Subject|1|||
163437599|NCT00306891|590305503|FG002|Part A|Withdrawal by Subject|0|||
163437600|NCT00306891|590305504|FG003|Part A|Withdrawal by Subject|0|||
163437601|NCT00306891|590305501|FG000|Part A|Condition under investigation worsened|2|||
163437602|NCT00306891|590305502|FG001|Part A|Condition under investigation worsened|2|||
163437603|NCT00306891|590305503|FG002|Part A|Condition under investigation worsened|0|||
163437604|NCT00306891|590305504|FG003|Part A|Condition under investigation worsened|0|||
163437605|NCT00306891|590305501|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
163437606|NCT00306891|590305502|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
163437607|NCT00306891|590305503|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
163437608|NCT00306891|590305504|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
163437609|NCT00306891|590305501|FG000|Part A|Partial bowel obstruction|1|||
163437610|NCT00306891|590305502|FG001|Part A|Partial bowel obstruction|0|||
163437611|NCT00306891|590305503|FG002|Part A|Partial bowel obstruction|0|||
163437612|NCT00306891|590305504|FG003|Part A|Partial bowel obstruction|0|||
163437613|NCT00306891|590305501|FG000|Part A|Reaccumul. of ascites following drainage|0|||
163437614|NCT00306891|590305502|FG001|Part A|Reaccumul. of ascites following drainage|1|||
163437615|NCT00306891|590305503|FG002|Part A|Reaccumul. of ascites following drainage|0|||
163437616|NCT00306891|590305504|FG003|Part A|Reaccumul. of ascites following drainage|0|||
163437617|NCT00306891|590305501|FG000|Part A|Suspicion of second malignancy|0|||
163437618|NCT00306891|590305502|FG001|Part A|Suspicion of second malignancy|1|||
163437619|NCT00306891|590305503|FG002|Part A|Suspicion of second malignancy|0|||
163437620|NCT00306891|590305504|FG003|Part A|Suspicion of second malignancy|0|||
163437621|NCT00306891|590305501|FG000|Part A|QTC interval outwith elig. criteria|1|||
163437622|NCT00306891|590305502|FG001|Part A|QTC interval outwith elig. criteria|0|||
163437623|NCT00306891|590305503|FG002|Part A|QTC interval outwith elig. criteria|0|||
163437624|NCT00306891|590305504|FG003|Part A|QTC interval outwith elig. criteria|0|||
163437625|NCT00306891|590305501|FG000|Part B|Death|0|||
163437626|NCT00306891|590305502|FG001|Part B|Death|0|||
163437627|NCT00306891|590305503|FG002|Part B|Death|1|||
163437628|NCT00306891|590305504|FG003|Part B|Death|2|||
163437629|NCT00306891|590305501|FG000|Part B|Adverse Event|0|||
163437630|NCT00306891|590305502|FG001|Part B|Adverse Event|0|||
163437631|NCT00306891|590305503|FG002|Part B|Adverse Event|5|||
163437632|NCT00306891|590305504|FG003|Part B|Adverse Event|5|||
163437633|NCT00306891|590305501|FG000|Part B|Withdrawal by Subject|0|||
163437634|NCT00306891|590305502|FG001|Part B|Withdrawal by Subject|0|||
163437635|NCT00306891|590305503|FG002|Part B|Withdrawal by Subject|3|||
163437636|NCT00306891|590305504|FG003|Part B|Withdrawal by Subject|1|||
163437637|NCT00306891|590305501|FG000|Part B|Condition under investigation worsened|0|||
163437638|NCT00306891|590305502|FG001|Part B|Condition under investigation worsened|0|||
163437639|NCT00306891|590305503|FG002|Part B|Condition under investigation worsened|2|||
163437640|NCT00306891|590305504|FG003|Part B|Condition under investigation worsened|8|||
163437641|NCT00306891|590305501|FG000|Part B|Development of study specific disc crit.|0|||
163437642|NCT00306891|590305502|FG001|Part B|Development of study specific disc crit.|0|||
163437643|NCT00306891|590305503|FG002|Part B|Development of study specific disc crit.|0|||
163437644|NCT00306891|590305504|FG003|Part B|Development of study specific disc crit.|1|||
163437645|NCT00673673|590305505|FG000|Overall Study|Progressive disease|27|||
163437646|NCT00673673|590305505|FG000|Overall Study|Adverse Event|4|||
163437647|NCT00673673|590305505|FG000|Overall Study|Withdrawal by Subject|3|||
163437648|NCT00673673|590305505|FG000|Overall Study|Investigators' discretion|2|||
163437649|NCT04538950|590305514|FG000|Overall Study|Pulmonary Issues|2|||
163437650|NCT04538950|590305514|FG000|Overall Study|illness|2|||
163437651|NCT04579393|590305517|FG000|Overall Study|Withdrawal by Subject|2|||
163437652|NCT04579393|590305518|FG001|Overall Study|Withdrawal by Subject|2|||
163437653|NCT04579393|590305517|FG000|Overall Study|Death|1|||
163437654|NCT04579393|590305518|FG001|Overall Study|Death|3|||
163437655|NCT01282814|590305521|FG000|First Intervention|Emesis During Dosing Interval|0|||
163437656|NCT01282814|590305522|FG001|First Intervention|Emesis During Dosing Interval|3|||
163437657|NCT01282814|590305521|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
163437658|NCT01282814|590305522|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
163437659|NCT02519231|590305525|FG000|Overall Study|Lost to Follow-up|2|||
163437660|NCT02519231|590305526|FG001|Overall Study|Lost to Follow-up|5|||
163437661|NCT02519231|590305525|FG000|Overall Study|Withdrawal by Subject|0|||
163437662|NCT02519231|590305526|FG001|Overall Study|Withdrawal by Subject|1|||
163437663|NCT02704429|590305527|FG000|Part A: 24 Weeks|Adverse Event|3|||
163437664|NCT02704429|590305528|FG001|Part A: 24 Weeks|Adverse Event|0|||
163437665|NCT02704429|590305527|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
163437666|NCT02704429|590305528|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
163437667|NCT00104104|590305529|FG000|Overall Study|Adverse Event|8|||
163437668|NCT00104104|590305530|FG001|Overall Study|Adverse Event|8|||
163437669|NCT00104104|590305529|FG000|Overall Study|Abnormal laboratory value(s)|20|||
163437670|NCT00104104|590305530|FG001|Overall Study|Abnormal laboratory value(s)|14|||
163437671|NCT00104104|590305529|FG000|Overall Study|Lack of Efficacy|0|||
163437672|NCT00104104|590305530|FG001|Overall Study|Lack of Efficacy|3|||
163437673|NCT00104104|590305529|FG000|Overall Study|Condition no longer requires study drug|7|||
163437674|NCT00104104|590305530|FG001|Overall Study|Condition no longer requires study drug|4|||
163437675|NCT00104104|590305529|FG000|Overall Study|Protocol Violation|5|||
163437676|NCT00104104|590305530|FG001|Overall Study|Protocol Violation|2|||
163437677|NCT00104104|590305529|FG000|Overall Study|Withdrawal by Subject|11|||
163437678|NCT00104104|590305530|FG001|Overall Study|Withdrawal by Subject|15|||
163437679|NCT00104104|590305529|FG000|Overall Study|Lost to Follow-up|3|||
163437680|NCT00104104|590305530|FG001|Overall Study|Lost to Follow-up|7|||
163437681|NCT00104104|590305529|FG000|Overall Study|Administrative problems|12|||
163437682|NCT00104104|590305530|FG001|Overall Study|Administrative problems|13|||
163437683|NCT00104104|590305529|FG000|Overall Study|Death|9|||
163437684|NCT00104104|590305530|FG001|Overall Study|Death|6|||
163437685|NCT00447421|590305532|FG000|Overall Study|Lack of Efficacy|1|||
163437686|NCT00447421|590305532|FG000|Overall Study|Adverse Event|3|||
163437687|NCT00447421|590305532|FG000|Overall Study|Sponsor Decision|2|||
163437688|NCT01707147|590305533|FG000|Overall Study|Administered Trajenta prior to contract|5|||
163437689|NCT01707147|590305533|FG000|Overall Study|Patients who have not taken Trajenta|1|||
163437690|NCT01707147|590305533|FG000|Overall Study|Follow-up failure|17|||
163437691|NCT01707147|590305533|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
163437692|NCT01326962|590305537|FG000|Overall Study|Adverse Event|1|||
163437693|NCT01326962|590305537|FG000|Overall Study|Withdrawal by Subject|1|||
163437694|NCT01326962|590305537|FG000|Overall Study|Lost to Follow-up|3|||
163437695|NCT01326962|590305537|FG000|Overall Study|Other|2|||
163437696|NCT02053246|590305538|FG000|Overall Study|Withdrawal by Subject|3|||
163437697|NCT02053246|590305538|FG000|Overall Study|Physician Decision|1|||
163437698|NCT02707757|590305539|FG000|Overall Study|Protocol Violation|3|||
163437699|NCT02707757|590305540|FG001|Overall Study|Protocol Violation|2|||
163437700|NCT02707757|590305539|FG000|Overall Study|Withdrawal by Subject|2|||
163437701|NCT02707757|590305540|FG001|Overall Study|Withdrawal by Subject|0|||
163437702|NCT02707757|590305539|FG000|Overall Study|Death|0|||
163437703|NCT02707757|590305540|FG001|Overall Study|Death|1|||
163437704|NCT02707757|590305539|FG000|Overall Study|Adverse Event|6|||
163437705|NCT02707757|590305540|FG001|Overall Study|Adverse Event|4|||
163437706|NCT02707757|590305539|FG000|Overall Study|Renal transplant/elective operation|1|||
163437707|NCT02707757|590305540|FG001|Overall Study|Renal transplant/elective operation|5|||
163437708|NCT01318902|590305541|FG000|Overall Study|Symptomatic Deterioration|0|||
163437709|NCT01318902|590305542|FG001|Overall Study|Symptomatic Deterioration|1|||
163437710|NCT01318902|590305543|FG002|Overall Study|Symptomatic Deterioration|1|||
163437711|NCT01318902|590305544|FG003|Overall Study|Symptomatic Deterioration|2|||
163437712|NCT01318902|590305541|FG000|Overall Study|Withdrawal by Patient|0|||
163437713|NCT01318902|590305542|FG001|Overall Study|Withdrawal by Patient|1|||
163437714|NCT01318902|590305543|FG002|Overall Study|Withdrawal by Patient|0|||
163437715|NCT01318902|590305544|FG003|Overall Study|Withdrawal by Patient|3|||
163437716|NCT01318902|590305541|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
163437717|NCT01318902|590305542|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
163437718|NCT01318902|590305543|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
163437719|NCT01318902|590305544|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
163437720|NCT01318902|590305541|FG000|Overall Study|Adverse Event|0|||
163437721|NCT01318902|590305542|FG001|Overall Study|Adverse Event|1|||
163437722|NCT01318902|590305543|FG002|Overall Study|Adverse Event|0|||
163437723|NCT01318902|590305544|FG003|Overall Study|Adverse Event|0|||
163437724|NCT01318902|590305541|FG000|Overall Study|Terminated by Sponsor|0|||
163437725|NCT01318902|590305542|FG001|Overall Study|Terminated by Sponsor|0|||
163437726|NCT01318902|590305543|FG002|Overall Study|Terminated by Sponsor|1|||
163437727|NCT01318902|590305544|FG003|Overall Study|Terminated by Sponsor|0|||
163437728|NCT00663858|590307572|FG000|Overall Study|Adverse Event|9|||
163437729|NCT00663858|590307573|FG001|Overall Study|Adverse Event|1|||
163437730|NCT00663858|590307574|FG002|Overall Study|Adverse Event|6|||
163437731|NCT00663858|590307572|FG000|Overall Study|Lack of Efficacy|5|||
163437732|NCT00663858|590307573|FG001|Overall Study|Lack of Efficacy|1|||
163437733|NCT00663858|590307574|FG002|Overall Study|Lack of Efficacy|3|||
163437734|NCT00663858|590307572|FG000|Overall Study|Withdrawal by Subject|7|||
163437735|NCT00663858|590307573|FG001|Overall Study|Withdrawal by Subject|3|||
163437736|NCT00663858|590307574|FG002|Overall Study|Withdrawal by Subject|3|||
163437737|NCT00663858|590307572|FG000|Overall Study|Protocol Violation|5|||
163437738|NCT00663858|590307573|FG001|Overall Study|Protocol Violation|3|||
163437739|NCT00663858|590307574|FG002|Overall Study|Protocol Violation|4|||
163437740|NCT00663858|590307572|FG000|Overall Study|Other|8|||
163437741|NCT00663858|590307573|FG001|Overall Study|Other|2|||
163437742|NCT00663858|590307574|FG002|Overall Study|Other|4|||
163437743|NCT00950690|590307577|FG000|Overall Study|Death|4|||
163437744|NCT00950690|590307577|FG000|Overall Study|Adverse Event|15|||
163437745|NCT00950690|590307577|FG000|Overall Study|Lack of Efficacy|22|||
163437746|NCT00950690|590307577|FG000|Overall Study|Lost to Follow-up|40|||
163437747|NCT00950690|590307577|FG000|Overall Study|Other|163|||
163437748|NCT01713036|590307578|FG000|Overall Study|Death|1|||
163437749|NCT00092547|590307579|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
163437750|NCT00092547|590307580|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
163437751|NCT00092547|590307581|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
163437752|NCT00092547|590307579|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
163437753|NCT00092547|590307580|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
163437754|NCT00092547|590307581|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
163437755|NCT00092547|590307579|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
163437756|NCT00092547|590307580|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
163437757|NCT00092547|590307581|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
163437758|NCT00092547|590307579|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
163437759|NCT00092547|590307580|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
163437760|NCT00092547|590307581|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
163437761|NCT00092547|590307579|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
163437762|NCT00092547|590307580|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
163437763|NCT00092547|590307581|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
163437764|NCT00092547|590307579|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
163437765|NCT00092547|590307580|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
163437766|NCT00092547|590307581|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
163437767|NCT00092547|590307579|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
163437768|NCT00092547|590307580|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
163437769|NCT00092547|590307581|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
163437770|NCT00092547|590307579|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
163437771|NCT00092547|590307580|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
163437772|NCT00092547|590307581|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
163437773|NCT00092547|590307579|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
163437774|NCT00092547|590307580|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
163437775|NCT00092547|590307581|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
163437776|NCT00092547|590307579|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
163437777|NCT00092547|590307580|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
163437778|NCT00092547|590307581|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
163437779|NCT00092547|590307579|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
163437780|NCT00092547|590307580|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
163437781|NCT00092547|590307581|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
163437782|NCT00092547|590307579|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
163437783|NCT00092547|590307580|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
163437784|NCT00092547|590307581|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
163437785|NCT00092547|590307579|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
163437786|NCT00092547|590307580|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
163437787|NCT00092547|590307581|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
163437788|NCT00092547|590307579|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
163437789|NCT00092547|590307580|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
163437790|NCT00092547|590307581|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
163437791|NCT00092547|590307579|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
163437792|NCT00092547|590307580|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
163437793|NCT00092547|590307581|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
163437794|NCT00092547|590307579|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
163437795|NCT00092547|590307580|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
163437796|NCT00092547|590307581|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
163437797|NCT00092547|590307579|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
163437798|NCT00092547|590307580|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
163437799|NCT00092547|590307581|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
163437800|NCT00092547|590307579|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
163437801|NCT00092547|590307580|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
163437802|NCT00092547|590307581|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
163437803|NCT00092547|590307579|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
163437804|NCT00092547|590307580|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
163437805|NCT00092547|590307581|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
163437806|NCT00092547|590307579|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
163437807|NCT00092547|590307580|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
163437808|NCT00092547|590307581|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
163437809|NCT00092547|590307579|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
163437810|NCT00092547|590307580|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
163437811|NCT00092547|590307581|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
163437812|NCT01166659|590307582|FG000|Overall Study|Subject Decision|8|||
163437813|NCT01166659|590307582|FG000|Overall Study|Investigator Decision|2|||
163437814|NCT01166659|590307582|FG000|Overall Study|Death|1|||
163437815|NCT01166659|590307582|FG000|Overall Study|Lost to Follow-up|1|||
163437816|NCT01166659|590307582|FG000|Overall Study|Study Closed at Site|1|||
163437817|NCT00958568|590307592|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
163437818|NCT00958568|590307593|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
163437819|NCT00958568|590307594|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
163437820|NCT00958568|590307595|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
163437821|NCT00958568|590307592|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
163437822|NCT00958568|590307593|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
163437823|NCT00958568|590307594|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
163437824|NCT00958568|590307595|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
163437825|NCT00958568|590307592|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
163437826|NCT00958568|590307593|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
163437827|NCT00958568|590307594|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
163437828|NCT00958568|590307595|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
163437829|NCT00958568|590307592|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
163437830|NCT00958568|590307593|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
163437831|NCT00958568|590307594|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
163437832|NCT00958568|590307595|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
163437833|NCT00958568|590307592|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
163437834|NCT00958568|590307593|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
163437835|NCT00958568|590307594|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
163437836|NCT00958568|590307595|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
163437837|NCT00958568|590307592|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
163437838|NCT00958568|590307593|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
163437839|NCT00958568|590307594|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
163437840|NCT00958568|590307595|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
163437841|NCT00958568|590307592|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
163437842|NCT00958568|590307593|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
163437843|NCT00958568|590307594|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
163437844|NCT00958568|590307595|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
163437845|NCT00958568|590307592|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
163437846|NCT00958568|590307593|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
163437847|NCT00958568|590307594|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
163437848|NCT00958568|590307595|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
163437849|NCT00958568|590307592|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
163437850|NCT00958568|590307593|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
163437851|NCT00958568|590307594|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
163437852|NCT00958568|590307595|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
163437853|NCT00958568|590307592|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
163437854|NCT00958568|590307593|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
163437855|NCT00958568|590307594|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
163437856|NCT00958568|590307595|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
163437857|NCT00958568|590307592|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
163437858|NCT00958568|590307593|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
163437859|NCT00958568|590307594|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
163437860|NCT00958568|590307595|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
163437861|NCT00958568|590307592|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
163437862|NCT00958568|590307593|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
163437863|NCT00958568|590307594|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
163437864|NCT00958568|590307595|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
163437865|NCT00958568|590307592|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
163437866|NCT00958568|590307593|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
163437867|NCT00958568|590307594|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
163437868|NCT00958568|590307595|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
163437869|NCT00958568|590307592|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
163437870|NCT00958568|590307593|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
163437871|NCT00958568|590307594|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
163437872|NCT00958568|590307595|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
163437873|NCT00958568|590307592|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
163437874|NCT00958568|590307593|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
163437875|NCT00958568|590307594|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
163437876|NCT00958568|590307595|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
163437877|NCT00958568|590307592|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
163437878|NCT00958568|590307593|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
163437879|NCT00958568|590307594|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
163437880|NCT00958568|590307595|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
163437881|NCT00958568|590307592|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
163437882|NCT00958568|590307593|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
163437883|NCT00958568|590307594|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
163437884|NCT00958568|590307595|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
163437885|NCT00958568|590307592|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
163437886|NCT00958568|590307593|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
163437887|NCT00958568|590307594|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
163437888|NCT00958568|590307595|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
163437889|NCT00958568|590307592|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
163437890|NCT00958568|590307593|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
163437891|NCT00958568|590307594|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
163437892|NCT00958568|590307595|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
163437893|NCT00958568|590307592|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
163437894|NCT00958568|590307593|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
163437895|NCT00958568|590307594|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
163437896|NCT00958568|590307595|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
163437897|NCT00958568|590307592|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
163437898|NCT00958568|590307593|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
163437899|NCT00958568|590307594|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
163437900|NCT00958568|590307595|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
163437901|NCT00958568|590307592|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
163437902|NCT00958568|590307593|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
163437903|NCT00958568|590307594|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
163437904|NCT00958568|590307595|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
163437905|NCT00958568|590307592|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
163437906|NCT00958568|590307593|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
163437907|NCT00958568|590307594|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
163437908|NCT00958568|590307595|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
163437909|NCT00958568|590307592|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
163437910|NCT00958568|590307593|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
163437911|NCT00958568|590307594|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
163437912|NCT00958568|590307595|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
163437913|NCT00958568|590307592|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
163437914|NCT00958568|590307593|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
163437915|NCT00958568|590307594|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
163437916|NCT00958568|590307595|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
163437917|NCT00958568|590307592|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
163437918|NCT00958568|590307593|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
163437919|NCT00958568|590307594|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
163437920|NCT00958568|590307595|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
163437921|NCT00958568|590307592|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
163437922|NCT00958568|590307593|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
163437923|NCT00958568|590307594|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
163437924|NCT00958568|590307595|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
163437925|NCT00958568|590307592|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
163437926|NCT00958568|590307593|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
163437927|NCT00958568|590307594|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
163437928|NCT00958568|590307595|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
163437929|NCT00958568|590307592|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
163437930|NCT00958568|590307593|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
163437931|NCT00958568|590307594|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
163437932|NCT00958568|590307595|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
163437933|NCT00915005|590307596|FG000|Overall Study|Withdrawal by Subject|4|||
163437934|NCT00915005|590307597|FG001|Overall Study|Withdrawal by Subject|4|||
163437935|NCT00915005|590307596|FG000|Overall Study|Patient preferred protons therapy|6|||
163437936|NCT00915005|590307597|FG001|Overall Study|Patient preferred protons therapy|0|||
163437937|NCT00915005|590307596|FG000|Overall Study|Insurance denial|3|||
163437938|NCT00915005|590307597|FG001|Overall Study|Insurance denial|15|||
163437939|NCT00589472|590307600|FG000|Overall Study|Adverse Event|1|||
163437940|NCT00117338|590307601|FG000|Overall Study|Adverse Event|0|||
163437941|NCT00117338|590307602|FG001|Overall Study|Adverse Event|1|||
163437942|NCT00117338|590307601|FG000|Overall Study|Protocol Violation|3|||
163437943|NCT00117338|590307602|FG001|Overall Study|Protocol Violation|2|||
163437944|NCT00117338|590307601|FG000|Overall Study|Withdrawal by Subject|1|||
163437945|NCT00117338|590307602|FG001|Overall Study|Withdrawal by Subject|0|||
163437946|NCT00117338|590307601|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
163437947|NCT00117338|590307602|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
163437948|NCT00117338|590307601|FG000|Overall Study|Lack of Efficacy|0|||
163437949|NCT00117338|590307602|FG001|Overall Study|Lack of Efficacy|1|||
163437950|NCT01380093|590307603|FG000|Naloxone Challenge Phase|Screen failures|21|||
163437951|NCT01380093|590307604|FG001|Naloxone Challenge Phase|Screen failures|0|||
163437952|NCT01380093|590307605|FG002|Naloxone Challenge Phase|Screen failures|0|||
163437953|NCT01380093|590307606|FG003|Naloxone Challenge Phase|Screen failures|0|||
163437954|NCT01380093|590307607|FG004|Naloxone Challenge Phase|Screen failures|0|||
163437955|NCT01380093|590307608|FG005|Naloxone Challenge Phase|Screen failures|0|||
163437956|NCT01380093|590307609|FG006|Naloxone Challenge Phase|Screen failures|0|||
163437957|NCT01380093|590307610|FG007|Naloxone Challenge Phase|Screen failures|0|||
163437958|NCT01380093|590307611|FG008|Naloxone Challenge Phase|Screen failures|0|||
163437959|NCT01380093|590307603|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
163437960|NCT01380093|590307604|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
163437961|NCT01380093|590307605|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
163437962|NCT01380093|590307606|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
163437963|NCT01380093|590307607|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
163437964|NCT01380093|590307608|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
163437965|NCT01380093|590307609|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
163437966|NCT01380093|590307610|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
163437967|NCT01380093|590307611|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
163437968|NCT01380093|590307603|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
163437969|NCT01380093|590307604|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
163437970|NCT01380093|590307605|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
163437971|NCT01380093|590307606|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
163437972|NCT01380093|590307607|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
163437973|NCT01380093|590307608|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
163437974|NCT01380093|590307609|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
163437975|NCT01380093|590307610|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
163437976|NCT01380093|590307611|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
163437977|NCT01380093|590307603|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
163437978|NCT01380093|590307604|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
163437979|NCT01380093|590307605|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
162925348|NCT00602641|588428937|FG001|Overall Study|Other|1|||
163437980|NCT01380093|590307606|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
163437981|NCT01380093|590307607|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
163437982|NCT01380093|590307608|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
163437983|NCT01380093|590307609|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
163437984|NCT01380093|590307610|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
163437985|NCT01380093|590307611|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
163437986|NCT01380093|590307603|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
163437987|NCT01380093|590307604|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
163437988|NCT01380093|590307605|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
163437989|NCT01380093|590307606|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
163437990|NCT01380093|590307607|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
163437991|NCT01380093|590307608|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
163437992|NCT01380093|590307609|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
163437993|NCT01380093|590307610|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
163437994|NCT01380093|590307611|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
163437995|NCT01380093|590307603|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
163437996|NCT01380093|590307604|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
163437997|NCT01380093|590307605|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
163437998|NCT01380093|590307606|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
163437999|NCT01380093|590307607|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
163438000|NCT01380093|590307608|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
163438001|NCT01380093|590307609|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
163438002|NCT01380093|590307610|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
163438003|NCT01380093|590307611|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
163438004|NCT01380093|590307603|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
163438005|NCT01380093|590307604|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
163438006|NCT01380093|590307605|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
163438007|NCT01380093|590307606|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
163438008|NCT01380093|590307607|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
163438009|NCT01380093|590307608|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
163438010|NCT01380093|590307609|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
163438011|NCT01380093|590307610|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
163438012|NCT01380093|590307611|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
163438013|NCT01380093|590307603|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
163438014|NCT01380093|590307604|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
163438015|NCT01380093|590307605|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
163438016|NCT01380093|590307606|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
163438017|NCT01380093|590307607|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
163438018|NCT01380093|590307608|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
163438019|NCT01380093|590307609|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
163438020|NCT01380093|590307610|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
163438021|NCT01380093|590307611|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
163438022|NCT01380093|590307603|FG000|Treatment Phase: Second Intervention|Other|0|||
163438023|NCT01380093|590307604|FG001|Treatment Phase: Second Intervention|Other|0|||
163438024|NCT01380093|590307605|FG002|Treatment Phase: Second Intervention|Other|0|||
163438025|NCT01380093|590307606|FG003|Treatment Phase: Second Intervention|Other|1|||
163438026|NCT01380093|590307607|FG004|Treatment Phase: Second Intervention|Other|0|||
163438027|NCT01380093|590307608|FG005|Treatment Phase: Second Intervention|Other|0|||
163438028|NCT01380093|590307609|FG006|Treatment Phase: Second Intervention|Other|0|||
163438029|NCT01380093|590307610|FG007|Treatment Phase: Second Intervention|Other|0|||
163438030|NCT01380093|590307611|FG008|Treatment Phase: Second Intervention|Other|0|||
163438031|NCT01380093|590307603|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
163438032|NCT01380093|590307604|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
163438033|NCT01380093|590307605|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
163438034|NCT01380093|590307606|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
163438035|NCT01380093|590307607|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
163438036|NCT01380093|590307608|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
163438037|NCT01380093|590307609|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
163438038|NCT01380093|590307610|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
163438039|NCT01380093|590307611|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
163438040|NCT01380093|590307603|FG000|Treatment Phase: Third Intervention|Other|0|||
163438041|NCT01380093|590307604|FG001|Treatment Phase: Third Intervention|Other|0|||
163438042|NCT01380093|590307605|FG002|Treatment Phase: Third Intervention|Other|0|||
163438043|NCT01380093|590307606|FG003|Treatment Phase: Third Intervention|Other|0|||
163438044|NCT01380093|590307607|FG004|Treatment Phase: Third Intervention|Other|0|||
163438045|NCT01380093|590307608|FG005|Treatment Phase: Third Intervention|Other|0|||
163438046|NCT01380093|590307609|FG006|Treatment Phase: Third Intervention|Other|0|||
163438047|NCT01380093|590307610|FG007|Treatment Phase: Third Intervention|Other|0|||
163438048|NCT01380093|590307611|FG008|Treatment Phase: Third Intervention|Other|1|||
163438049|NCT03952650|590307612|FG000|Overall Study|TRAVEL|0|||
163438050|NCT03952650|590307613|FG001|Overall Study|TRAVEL|4|||
163438051|NCT03952650|590307614|FG002|Overall Study|TRAVEL|0|||
163438052|NCT03952650|590307615|FG003|Overall Study|TRAVEL|4|||
163438053|NCT03952650|590307616|FG004|Overall Study|TRAVEL|0|||
163438054|NCT03952650|590307617|FG005|Overall Study|TRAVEL|3|||
163438055|NCT03952650|590307618|FG006|Overall Study|TRAVEL|2|||
163438056|NCT03952650|590307612|FG000|Overall Study|Withdrawal by Subject|0|||
163438057|NCT03952650|590307613|FG001|Overall Study|Withdrawal by Subject|2|||
163438058|NCT03952650|590307614|FG002|Overall Study|Withdrawal by Subject|0|||
163438059|NCT03952650|590307615|FG003|Overall Study|Withdrawal by Subject|3|||
163438060|NCT03952650|590307616|FG004|Overall Study|Withdrawal by Subject|0|||
163438061|NCT03952650|590307617|FG005|Overall Study|Withdrawal by Subject|1|||
163438062|NCT03952650|590307618|FG006|Overall Study|Withdrawal by Subject|1|||
163438063|NCT03952650|590307612|FG000|Overall Study|Lost to Follow-up|0|||
163438064|NCT03952650|590307613|FG001|Overall Study|Lost to Follow-up|1|||
163438065|NCT03952650|590307614|FG002|Overall Study|Lost to Follow-up|0|||
163438066|NCT03952650|590307615|FG003|Overall Study|Lost to Follow-up|0|||
163438067|NCT03952650|590307616|FG004|Overall Study|Lost to Follow-up|0|||
163438068|NCT03952650|590307617|FG005|Overall Study|Lost to Follow-up|1|||
163438069|NCT03952650|590307618|FG006|Overall Study|Lost to Follow-up|1|||
163438070|NCT03952650|590307612|FG000|Overall Study|Received wrong vaccine and travelled|0|||
163438071|NCT03952650|590307613|FG001|Overall Study|Received wrong vaccine and travelled|0|||
163438072|NCT03952650|590307614|FG002|Overall Study|Received wrong vaccine and travelled|0|||
163438073|NCT03952650|590307615|FG003|Overall Study|Received wrong vaccine and travelled|0|||
163438074|NCT03952650|590307616|FG004|Overall Study|Received wrong vaccine and travelled|0|||
163438075|NCT03952650|590307617|FG005|Overall Study|Received wrong vaccine and travelled|1|||
163438076|NCT03952650|590307618|FG006|Overall Study|Received wrong vaccine and travelled|0|||
163438077|NCT03952650|590307612|FG000|Overall Study|Unable to make study visit|0|||
163438078|NCT03952650|590307613|FG001|Overall Study|Unable to make study visit|0|||
163438079|NCT03952650|590307614|FG002|Overall Study|Unable to make study visit|0|||
163438080|NCT03952650|590307615|FG003|Overall Study|Unable to make study visit|0|||
163438081|NCT03952650|590307616|FG004|Overall Study|Unable to make study visit|0|||
163438082|NCT03952650|590307617|FG005|Overall Study|Unable to make study visit|1|||
163438083|NCT03952650|590307618|FG006|Overall Study|Unable to make study visit|0|||
163438084|NCT01342640|590307619|FG000|Overall Study|Adverse Event|3|||
163438085|NCT01342640|590307619|FG000|Overall Study|Protocol Violation|16|||
163438086|NCT01342640|590307619|FG000|Overall Study|Lost to Follow-up|21|||
163438087|NCT01342640|590307619|FG000|Overall Study|Other|1|||
163438088|NCT00670111|590307622|FG000|Enrollment to One Month|Testing Failure|0|||
163438089|NCT00670111|590307623|FG001|Enrollment to One Month|Testing Failure|0|||
163438090|NCT00670111|590307624|FG002|Enrollment to One Month|Testing Failure|13|||
163438091|NCT00670111|590307622|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
163438092|NCT00670111|590307623|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
163438093|NCT00670111|590307624|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
163438094|NCT00670111|590307622|FG000|Enrollment to One Month|Physician Decision|1|||
163438095|NCT00670111|590307623|FG001|Enrollment to One Month|Physician Decision|0|||
163438096|NCT00670111|590307624|FG002|Enrollment to One Month|Physician Decision|0|||
163438097|NCT02441803|590307625|FG000|Overall Study|Physician Decision|0|||
163438098|NCT02441803|590307626|FG001|Overall Study|Physician Decision|2|||
163438099|NCT02441803|590307627|FG002|Overall Study|Physician Decision|2|||
163438100|NCT02873221|590307628|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
163438101|NCT02873221|590307629|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
163438102|NCT02873221|590307630|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
163438103|NCT02873221|590307628|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
163438104|NCT02873221|590307629|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
163438105|NCT02873221|590307630|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
163438106|NCT02873221|590307628|FG000|Treatment Period|Protocol Violation|2|||
163438107|NCT02873221|590307629|FG001|Treatment Period|Protocol Violation|5|||
163438108|NCT02873221|590307630|FG002|Treatment Period|Protocol Violation|8|||
163438109|NCT02873221|590307628|FG000|Treatment Period|Pregnancy|4|||
163438110|NCT02873221|590307629|FG001|Treatment Period|Pregnancy|6|||
163438111|NCT02873221|590307630|FG002|Treatment Period|Pregnancy|3|||
163438112|NCT02873221|590307628|FG000|Treatment Period|Lack of Qualifying Event|0|||
163438113|NCT02873221|590307629|FG001|Treatment Period|Lack of Qualifying Event|3|||
163438114|NCT02873221|590307630|FG002|Treatment Period|Lack of Qualifying Event|1|||
163438115|NCT02873221|590307628|FG000|Treatment Period|Withdrawal of Consent|52|||
163438116|NCT02873221|590307629|FG001|Treatment Period|Withdrawal of Consent|51|||
163438117|NCT02873221|590307630|FG002|Treatment Period|Withdrawal of Consent|41|||
163438118|NCT02873221|590307628|FG000|Treatment Period|Lack of Efficacy|0|||
163438119|NCT02873221|590307629|FG001|Treatment Period|Lack of Efficacy|17|||
163438120|NCT02873221|590307630|FG002|Treatment Period|Lack of Efficacy|12|||
163438121|NCT02873221|590307628|FG000|Treatment Period|Adverse Event|4|||
163438122|NCT02873221|590307629|FG001|Treatment Period|Adverse Event|9|||
163438123|NCT02873221|590307630|FG002|Treatment Period|Adverse Event|11|||
163438124|NCT02873221|590307628|FG000|Treatment Period|Lost to Follow-up|26|||
163438125|NCT02873221|590307629|FG001|Treatment Period|Lost to Follow-up|30|||
163438126|NCT02873221|590307630|FG002|Treatment Period|Lost to Follow-up|26|||
163438127|NCT02873221|590307628|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
163438128|NCT02873221|590307629|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
163438129|NCT02873221|590307630|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
163438130|NCT02873221|590307628|FG000|Safety Follow-up Period|Protocol Violation|0|||
163438131|NCT02873221|590307629|FG001|Safety Follow-up Period|Protocol Violation|0|||
163438132|NCT02873221|590307630|FG002|Safety Follow-up Period|Protocol Violation|1|||
163438133|NCT02873221|590307628|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
163438134|NCT02873221|590307629|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
163438135|NCT02873221|590307630|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
163438136|NCT02873221|590307628|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
163438137|NCT02873221|590307629|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
163438138|NCT02873221|590307630|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
163438139|NCT01749735|590307631|FG000|Overall Study|Withdrawal by Subject|1|||
163438140|NCT01749735|590307632|FG001|Overall Study|Withdrawal by Subject|0|||
163438141|NCT02234583|590307637|FG000|Overall Study|Adverse Event|172|||
163438142|NCT02234583|590307638|FG001|Overall Study|Adverse Event|156|||
163438143|NCT02234583|590307637|FG000|Overall Study|Withdrawal by Subject|109|||
163438144|NCT02234583|590307638|FG001|Overall Study|Withdrawal by Subject|157|||
163438145|NCT02234583|590307637|FG000|Overall Study|Lost to Follow-up|0|||
163438146|NCT02234583|590307638|FG001|Overall Study|Lost to Follow-up|1|||
163438147|NCT02234583|590307637|FG000|Overall Study|Lack of Efficacy|58|||
163438148|NCT02234583|590307638|FG001|Overall Study|Lack of Efficacy|103|||
163438149|NCT02234583|590307637|FG000|Overall Study|Protocol Violation|35|||
163438150|NCT02234583|590307638|FG001|Overall Study|Protocol Violation|42|||
163438151|NCT02234583|590307637|FG000|Overall Study|Other|39|||
163438152|NCT02234583|590307638|FG001|Overall Study|Other|97|||
163438153|NCT01849250|590307639|FG000|Overall Study|Withdrawal by Subject|1|||
163438154|NCT01849250|590307640|FG001|Overall Study|Withdrawal by Subject|0|||
163438155|NCT01849250|590307639|FG000|Overall Study|Not Evaluable|5|||
163438156|NCT01849250|590307640|FG001|Overall Study|Not Evaluable|3|||
163438157|NCT01849250|590307639|FG000|Overall Study|Screen Failure|1|||
163438158|NCT01849250|590307640|FG001|Overall Study|Screen Failure|0|||
163438159|NCT00771030|590307643|FG000|Overall Study|Adverse Event|0|||
163438160|NCT00771030|590307644|FG001|Overall Study|Adverse Event|1|||
163438161|NCT00771030|590307645|FG002|Overall Study|Adverse Event|0|||
163438162|NCT00771030|590307646|FG003|Overall Study|Adverse Event|0|||
163438163|NCT00771030|590307647|FG004|Overall Study|Adverse Event|0|||
163438164|NCT00771030|590307648|FG005|Overall Study|Adverse Event|0|||
163438165|NCT00771030|590307649|FG006|Overall Study|Adverse Event|0|||
163438166|NCT01022853|590307656|FG000|Overall Study|Progressive disease|2|||
163438167|NCT01022853|590307657|FG001|Overall Study|Progressive disease|3|||
163438168|NCT01022853|590307658|FG002|Overall Study|Progressive disease|11|||
163438169|NCT01022853|590307659|FG003|Overall Study|Progressive disease|7|||
163438170|NCT01022853|590307660|FG004|Overall Study|Progressive disease|1|||
163438171|NCT01022853|590307656|FG000|Overall Study|Dose-limiting toxicity|0|||
163438172|NCT01022853|590307657|FG001|Overall Study|Dose-limiting toxicity|0|||
163438173|NCT01022853|590307658|FG002|Overall Study|Dose-limiting toxicity|0|||
163438174|NCT01022853|590307659|FG003|Overall Study|Dose-limiting toxicity|0|||
163438175|NCT01022853|590307660|FG004|Overall Study|Dose-limiting toxicity|1|||
163438176|NCT01022853|590307656|FG000|Overall Study|Withdrawal by Subject|0|||
163438177|NCT01022853|590307657|FG001|Overall Study|Withdrawal by Subject|1|||
163438178|NCT01022853|590307658|FG002|Overall Study|Withdrawal by Subject|1|||
163438179|NCT01022853|590307659|FG003|Overall Study|Withdrawal by Subject|1|||
163438180|NCT01022853|590307660|FG004|Overall Study|Withdrawal by Subject|0|||
163438181|NCT01022853|590307656|FG000|Overall Study|Other not stated above|1|||
163438182|NCT01022853|590307657|FG001|Overall Study|Other not stated above|0|||
163438183|NCT01022853|590307658|FG002|Overall Study|Other not stated above|1|||
163438184|NCT01022853|590307659|FG003|Overall Study|Other not stated above|0|||
163438185|NCT01022853|590307660|FG004|Overall Study|Other not stated above|0|||
163438186|NCT01651052|590307661|FG000|Overall Study|Death|21|||
163438187|NCT01651052|590307661|FG000|Overall Study|Explant|1|||
163438188|NCT01651052|590307661|FG000|Overall Study|Withdrawal by Subject|1|||
163438189|NCT01651052|590307661|FG000|Overall Study|Lost to Follow-up|3|||
163438190|NCT03503773|590307662|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
163438191|NCT03503773|590307663|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
163438192|NCT03503773|590307662|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
163438193|NCT03503773|590307663|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
163438194|NCT03503773|590307662|FG000|Overall Study|Not completing the primary ABPM|3|||
163438195|NCT03503773|590307663|FG001|Overall Study|Not completing the primary ABPM|1|||
163438196|NCT03503773|590307662|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
163438197|NCT03503773|590307663|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
163438198|NCT04156646|590307670|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
163438199|NCT04156646|590307671|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
163438200|NCT01208181|590307674|FG000|Part 1|Withdrawal by Subject|11|||
163438201|NCT01208181|590307675|FG001|Part 1|Withdrawal by Subject|10|||
163438202|NCT01208181|590307676|FG002|Part 1|Withdrawal by Subject|0|||
163438203|NCT01208181|590307677|FG003|Part 1|Withdrawal by Subject|0|||
163438204|NCT01208181|590307678|FG004|Part 1|Withdrawal by Subject|0|||
163438205|NCT01208181|590307674|FG000|Part 1|Technical problem|5|||
163438206|NCT01208181|590307675|FG001|Part 1|Technical problem|0|||
163438207|NCT01208181|590307676|FG002|Part 1|Technical problem|0|||
163438208|NCT01208181|590307677|FG003|Part 1|Technical problem|0|||
163438209|NCT01208181|590307678|FG004|Part 1|Technical problem|0|||
163438210|NCT01208181|590307674|FG000|Part 1|Protocol Violation|10|||
163438211|NCT01208181|590307675|FG001|Part 1|Protocol Violation|5|||
163438212|NCT01208181|590307676|FG002|Part 1|Protocol Violation|0|||
163438213|NCT01208181|590307677|FG003|Part 1|Protocol Violation|0|||
163438214|NCT01208181|590307678|FG004|Part 1|Protocol Violation|0|||
163438215|NCT01208181|590307674|FG000|Part 1|Physician Decision|4|||
163438216|NCT01208181|590307675|FG001|Part 1|Physician Decision|0|||
163438217|NCT01208181|590307676|FG002|Part 1|Physician Decision|0|||
163438218|NCT01208181|590307677|FG003|Part 1|Physician Decision|0|||
163438219|NCT01208181|590307678|FG004|Part 1|Physician Decision|0|||
163438220|NCT01208181|590307674|FG000|Part 1|Non-compliance with study drug|1|||
163438221|NCT01208181|590307675|FG001|Part 1|Non-compliance with study drug|1|||
163438222|NCT01208181|590307676|FG002|Part 1|Non-compliance with study drug|0|||
163438223|NCT01208181|590307677|FG003|Part 1|Non-compliance with study drug|0|||
163438224|NCT01208181|590307678|FG004|Part 1|Non-compliance with study drug|0|||
163438225|NCT01208181|590307674|FG000|Part 1|Lost to Follow-up|5|||
163438226|NCT01208181|590307675|FG001|Part 1|Lost to Follow-up|3|||
163438227|NCT01208181|590307676|FG002|Part 1|Lost to Follow-up|0|||
163438228|NCT01208181|590307677|FG003|Part 1|Lost to Follow-up|0|||
163438229|NCT01208181|590307678|FG004|Part 1|Lost to Follow-up|1|||
163438230|NCT01208181|590307674|FG000|Part 1|Lack of Efficacy|37|||
163438231|NCT01208181|590307675|FG001|Part 1|Lack of Efficacy|12|||
163438232|NCT01208181|590307676|FG002|Part 1|Lack of Efficacy|0|||
163438233|NCT01208181|590307677|FG003|Part 1|Lack of Efficacy|0|||
163438234|NCT01208181|590307678|FG004|Part 1|Lack of Efficacy|17|||
163438235|NCT01208181|590307674|FG000|Part 1|Adverse Event|26|||
163438236|NCT01208181|590307675|FG001|Part 1|Adverse Event|24|||
163438237|NCT01208181|590307676|FG002|Part 1|Adverse Event|0|||
163438238|NCT01208181|590307677|FG003|Part 1|Adverse Event|0|||
163438239|NCT01208181|590307678|FG004|Part 1|Adverse Event|4|||
163438240|NCT01208181|590307674|FG000|Part 2|Adverse Event|0|||
163438241|NCT01208181|590307675|FG001|Part 2|Adverse Event|0|||
163438242|NCT01208181|590307676|FG002|Part 2|Adverse Event|6|||
163438243|NCT01208181|590307677|FG003|Part 2|Adverse Event|7|||
163438244|NCT01208181|590307678|FG004|Part 2|Adverse Event|0|||
163438245|NCT01208181|590307674|FG000|Part 2|Withdrawal by Subject|0|||
163438246|NCT01208181|590307675|FG001|Part 2|Withdrawal by Subject|0|||
163438247|NCT01208181|590307676|FG002|Part 2|Withdrawal by Subject|1|||
163438248|NCT01208181|590307677|FG003|Part 2|Withdrawal by Subject|1|||
163438249|NCT01208181|590307678|FG004|Part 2|Withdrawal by Subject|0|||
163438250|NCT01208181|590307674|FG000|Part 2|Protocol Violation|0|||
163438251|NCT01208181|590307675|FG001|Part 2|Protocol Violation|0|||
163438252|NCT01208181|590307676|FG002|Part 2|Protocol Violation|1|||
163438253|NCT01208181|590307677|FG003|Part 2|Protocol Violation|0|||
163438254|NCT01208181|590307678|FG004|Part 2|Protocol Violation|0|||
163438255|NCT01208181|590307674|FG000|Part 2|Physician Decision|0|||
163438256|NCT01208181|590307675|FG001|Part 2|Physician Decision|0|||
163438257|NCT01208181|590307676|FG002|Part 2|Physician Decision|1|||
163438258|NCT01208181|590307677|FG003|Part 2|Physician Decision|2|||
163438259|NCT01208181|590307678|FG004|Part 2|Physician Decision|0|||
163438260|NCT01208181|590307674|FG000|Part 2|Non-compliance with study drug|0|||
163438261|NCT01208181|590307675|FG001|Part 2|Non-compliance with study drug|0|||
163438262|NCT01208181|590307676|FG002|Part 2|Non-compliance with study drug|1|||
163438263|NCT01208181|590307677|FG003|Part 2|Non-compliance with study drug|1|||
163438264|NCT01208181|590307678|FG004|Part 2|Non-compliance with study drug|0|||
163438265|NCT01208181|590307674|FG000|Part 2|Lost to Follow-up|0|||
163438266|NCT01208181|590307675|FG001|Part 2|Lost to Follow-up|0|||
163438267|NCT01208181|590307676|FG002|Part 2|Lost to Follow-up|1|||
163438268|NCT01208181|590307677|FG003|Part 2|Lost to Follow-up|2|||
163438269|NCT01208181|590307678|FG004|Part 2|Lost to Follow-up|0|||
163438270|NCT01208181|590307674|FG000|Part 2|Lack of Efficacy|0|||
163438271|NCT01208181|590307675|FG001|Part 2|Lack of Efficacy|0|||
163438272|NCT01208181|590307676|FG002|Part 2|Lack of Efficacy|5|||
163438273|NCT01208181|590307677|FG003|Part 2|Lack of Efficacy|7|||
163438274|NCT01208181|590307678|FG004|Part 2|Lack of Efficacy|0|||
163438275|NCT01478347|590307684|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
163438276|NCT01478347|590307684|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
163438277|NCT01478347|590307684|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
163438278|NCT01645930|590307685|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
163438279|NCT01645930|590307685|FG000|Overall Study|Progressive Disease|12|||
163438280|NCT01645930|590307685|FG000|Overall Study|Adverse Event|4|||
163438281|NCT01645930|590307685|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
163438282|NCT01645930|590307685|FG000|Overall Study|Withdrawal by Participant|2|||
163438283|NCT01645930|590307685|FG000|Overall Study|Reason not Defined|1|||
163438284|NCT03245814|590307686|FG000|Overall Study|Lost to Follow-up|5|||
163438285|NCT03245814|590307687|FG001|Overall Study|Lost to Follow-up|8|||
163438286|NCT03245814|590307686|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
163438287|NCT03245814|590307687|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
163438288|NCT01096667|590307691|FG000|Overall Study|Lost to Follow-up|1|||
163438289|NCT01096667|590307692|FG001|Overall Study|Lost to Follow-up|1|||
163438290|NCT01096667|590307693|FG002|Overall Study|Lost to Follow-up|1|||
163438291|NCT01096667|590307694|FG003|Overall Study|Lost to Follow-up|0|||
163438292|NCT01096667|590307695|FG004|Overall Study|Lost to Follow-up|0|||
163438293|NCT01096667|590307691|FG000|Overall Study|Withdrawal by Subject|1|||
163438294|NCT01096667|590307692|FG001|Overall Study|Withdrawal by Subject|0|||
163438295|NCT01096667|590307693|FG002|Overall Study|Withdrawal by Subject|0|||
163438296|NCT01096667|590307694|FG003|Overall Study|Withdrawal by Subject|1|||
163438297|NCT01096667|590307695|FG004|Overall Study|Withdrawal by Subject|0|||
163438298|NCT01096667|590307691|FG000|Overall Study|Reason not available|0|||
163438299|NCT01096667|590307692|FG001|Overall Study|Reason not available|1|||
163438300|NCT01096667|590307693|FG002|Overall Study|Reason not available|1|||
163438301|NCT01096667|590307694|FG003|Overall Study|Reason not available|1|||
163438302|NCT01096667|590307695|FG004|Overall Study|Reason not available|0|||
163438303|NCT01096667|590307691|FG000|Overall Study|Protocol Violation|0|||
163438304|NCT01096667|590307692|FG001|Overall Study|Protocol Violation|0|||
163438305|NCT01096667|590307693|FG002|Overall Study|Protocol Violation|0|||
163438306|NCT01096667|590307694|FG003|Overall Study|Protocol Violation|1|||
163438307|NCT01096667|590307695|FG004|Overall Study|Protocol Violation|0|||
163438308|NCT01096667|590307691|FG000|Overall Study|Not treated|1|||
163438309|NCT01096667|590307692|FG001|Overall Study|Not treated|0|||
163438310|NCT01096667|590307693|FG002|Overall Study|Not treated|0|||
163438311|NCT01096667|590307694|FG003|Overall Study|Not treated|0|||
163438312|NCT01096667|590307695|FG004|Overall Study|Not treated|0|||
163438313|NCT02263365|590307696|FG000|Overall Study|Physician Decision|22|||
163438314|NCT02263365|590307697|FG001|Overall Study|Physician Decision|18|||
163438315|NCT00206518|590307698|FG000|Overall Study|Lack of Efficacy|6|||
163438316|NCT00206518|590307699|FG001|Overall Study|Lack of Efficacy|4|||
163438317|NCT00206518|590307698|FG000|Overall Study|Adverse Event|2|||
163438318|NCT00206518|590307699|FG001|Overall Study|Adverse Event|1|||
163438319|NCT00206518|590307698|FG000|Overall Study|Physician Decision|1|||
163438320|NCT00206518|590307699|FG001|Overall Study|Physician Decision|0|||
163438321|NCT00206518|590307698|FG000|Overall Study|Protocol Violation|1|||
163438322|NCT00206518|590307699|FG001|Overall Study|Protocol Violation|1|||
163438323|NCT02335450|590307700|FG000|Overall Study|Pregnancy|1|||
163438324|NCT01845077|590307701|FG000|Washout Period|Lost to Follow-up|0|||
163438325|NCT01845077|590307702|FG001|Washout Period|Lost to Follow-up|1|||
163438326|NCT01845077|590307703|FG002|Washout Period|Lost to Follow-up|0|||
163438327|NCT01845077|590307704|FG003|Washout Period|Lost to Follow-up|1|||
163438328|NCT01845077|590307705|FG004|Washout Period|Lost to Follow-up|0|||
163438329|NCT01845077|590307706|FG005|Washout Period|Lost to Follow-up|1|||
163438330|NCT01845077|590307701|FG000|Washout Period|Adverse Event|1|||
163438331|NCT01845077|590307702|FG001|Washout Period|Adverse Event|0|||
163438332|NCT01845077|590307703|FG002|Washout Period|Adverse Event|0|||
163438333|NCT01845077|590307704|FG003|Washout Period|Adverse Event|0|||
163438334|NCT01845077|590307705|FG004|Washout Period|Adverse Event|0|||
163438335|NCT01845077|590307706|FG005|Washout Period|Adverse Event|0|||
163438336|NCT01845077|590307701|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
163438337|NCT01845077|590307702|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
163438338|NCT01845077|590307703|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
163438339|NCT01845077|590307704|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
163438340|NCT01845077|590307705|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
163438341|NCT01845077|590307706|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
163438342|NCT01845077|590307701|FG000|Washout Period|Protocol Violation|0|||
163438343|NCT01845077|590307702|FG001|Washout Period|Protocol Violation|0|||
163438344|NCT01845077|590307703|FG002|Washout Period|Protocol Violation|0|||
163438345|NCT01845077|590307704|FG003|Washout Period|Protocol Violation|1|||
163438346|NCT01845077|590307705|FG004|Washout Period|Protocol Violation|1|||
163438347|NCT01845077|590307706|FG005|Washout Period|Protocol Violation|0|||
163438348|NCT02613572|590307709|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
163438349|NCT02613572|590307710|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
163438350|NCT02613572|590307711|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
163438351|NCT02613572|590307709|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
163438352|NCT02613572|590307710|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
163438353|NCT02613572|590307711|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
163438354|NCT00312377|590307716|FG000|Overall Study|Death|403|||
163438355|NCT00312377|590307717|FG001|Overall Study|Death|418|||
163438356|NCT00312377|590307716|FG000|Overall Study|Withdrawal by Subject|23|||
163438357|NCT00312377|590307717|FG001|Overall Study|Withdrawal by Subject|30|||
163438358|NCT00312377|590307716|FG000|Overall Study|Lost to Follow-up|9|||
163438359|NCT00312377|590307717|FG001|Overall Study|Lost to Follow-up|12|||
163438360|NCT00312377|590307716|FG000|Overall Study|Non-compliance|0|||
163438361|NCT00312377|590307717|FG001|Overall Study|Non-compliance|2|||
163438362|NCT00312377|590307716|FG000|Overall Study|Randomised but never received treatment|6|||
163438363|NCT00312377|590307717|FG001|Overall Study|Randomised but never received treatment|6|||
163438364|NCT00312377|590307716|FG000|Overall Study|Discontinue treatment survival follow up|202|||
163438365|NCT00312377|590307717|FG001|Overall Study|Discontinue treatment survival follow up|200|||
163438366|NCT00312377|590307716|FG000|Overall Study|Site ended participation in study|1|||
163438367|NCT00312377|590307717|FG001|Overall Study|Site ended participation in study|0|||
163438368|NCT05258058|590307718|FG000|Overall Study|Withdrawal by Subject|2|||
163438369|NCT00393458|590307719|FG000|Overall Study|Adverse Event|35|||
163438370|NCT00393458|590307720|FG001|Overall Study|Adverse Event|24|||
163438371|NCT00393458|590307721|FG002|Overall Study|Adverse Event|40|||
163438372|NCT00393458|590307722|FG003|Overall Study|Adverse Event|35|||
163438373|NCT00393458|590307719|FG000|Overall Study|Subject withdrew consent|27|||
163438374|NCT00393458|590307720|FG001|Overall Study|Subject withdrew consent|40|||
163438375|NCT00393458|590307721|FG002|Overall Study|Subject withdrew consent|33|||
163438376|NCT00393458|590307722|FG003|Overall Study|Subject withdrew consent|50|||
163438377|NCT00393458|590307719|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
163438378|NCT00393458|590307720|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
163438379|NCT00393458|590307721|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
163438380|NCT00393458|590307722|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
163438381|NCT00393458|590307719|FG000|Overall Study|Protocol deviation|11|||
163438382|NCT00393458|590307720|FG001|Overall Study|Protocol deviation|11|||
163438383|NCT00393458|590307721|FG002|Overall Study|Protocol deviation|11|||
163438384|NCT00393458|590307722|FG003|Overall Study|Protocol deviation|10|||
163438385|NCT00393458|590307719|FG000|Overall Study|Administrative problems|7|||
163438386|NCT00393458|590307720|FG001|Overall Study|Administrative problems|8|||
163438387|NCT00393458|590307721|FG002|Overall Study|Administrative problems|5|||
163438388|NCT00393458|590307722|FG003|Overall Study|Administrative problems|2|||
163438389|NCT00393458|590307719|FG000|Overall Study|Lost to Follow-up|5|||
163438390|NCT00393458|590307720|FG001|Overall Study|Lost to Follow-up|6|||
163438391|NCT00393458|590307721|FG002|Overall Study|Lost to Follow-up|5|||
163438392|NCT00393458|590307722|FG003|Overall Study|Lost to Follow-up|3|||
163438393|NCT00393458|590307719|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163438394|NCT00393458|590307720|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163438395|NCT00393458|590307721|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163438396|NCT00393458|590307722|FG003|Overall Study|Abnormal laboratory value(s)|0|||
163438397|NCT00393458|590307719|FG000|Overall Study|Death|1|||
163438398|NCT00393458|590307720|FG001|Overall Study|Death|1|||
163438399|NCT00393458|590307721|FG002|Overall Study|Death|5|||
163438400|NCT00393458|590307722|FG003|Overall Study|Death|5|||
163438401|NCT00393458|590307719|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163438402|NCT00393458|590307720|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163438403|NCT00393458|590307721|FG002|Overall Study|Abnormal test procedure result(s)|1|||
163438404|NCT00393458|590307722|FG003|Overall Study|Abnormal test procedure result(s)|2|||
163438405|NCT00393458|590307719|FG000|Overall Study|Subject no longer requires study drug|0|||
163438406|NCT00393458|590307720|FG001|Overall Study|Subject no longer requires study drug|1|||
163438407|NCT00393458|590307721|FG002|Overall Study|Subject no longer requires study drug|0|||
163438408|NCT00393458|590307722|FG003|Overall Study|Subject no longer requires study drug|0|||
163438409|NCT01524289|590307729|FG000|Overall Study|Lost to Follow-up|0|||
163438410|NCT01524289|590307730|FG001|Overall Study|Lost to Follow-up|1|||
163438411|NCT01524289|590307729|FG000|Overall Study|Physician Decision|1|||
163438412|NCT01524289|590307730|FG001|Overall Study|Physician Decision|0|||
163438413|NCT01524289|590307729|FG000|Overall Study|Protocol Violation|5|||
163438414|NCT01524289|590307730|FG001|Overall Study|Protocol Violation|1|||
163438415|NCT01524289|590307729|FG000|Overall Study|Withdrawal by Subject|11|||
163438416|NCT01524289|590307730|FG001|Overall Study|Withdrawal by Subject|7|||
163438417|NCT01524289|590307729|FG000|Overall Study|Adverse Event|12|||
163438418|NCT01524289|590307730|FG001|Overall Study|Adverse Event|5|||
163438419|NCT01524289|590307729|FG000|Overall Study|Did not take study medication|1|||
163438420|NCT01524289|590307730|FG001|Overall Study|Did not take study medication|0|||
163438421|NCT01056523|590307731|FG000|Overall Study|Death|1|||
163438422|NCT01056523|590307732|FG001|Overall Study|Death|0|||
163438423|NCT01056523|590307733|FG002|Overall Study|Death|2|||
163438424|NCT01056523|590307734|FG003|Overall Study|Death|3|||
163438425|NCT01056523|590307735|FG004|Overall Study|Death|0|||
163438426|NCT01056523|590307736|FG005|Overall Study|Death|0|||
163438427|NCT01056523|590307737|FG006|Overall Study|Death|1|||
163438428|NCT00815308|590307738|FG000|Overall Study|Adverse Event|4|||
163438429|NCT00815308|590307738|FG000|Overall Study|Withdrawal by Subject|0|||
163438430|NCT00815308|590307738|FG000|Overall Study|Protocol Violation|6|||
163438431|NCT03429556|590307741|FG000|Overall Study|Lost to Follow-up|0|||
163438432|NCT03429556|590307742|FG001|Overall Study|Lost to Follow-up|1|||
163438433|NCT03429556|590307743|FG002|Overall Study|Lost to Follow-up|0|||
163438434|NCT03429556|590307744|FG003|Overall Study|Lost to Follow-up|0|||
163438435|NCT02209597|590307747|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
163438436|NCT02209597|590307747|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
163438437|NCT02209597|590307747|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
163438438|NCT02209597|590307747|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
163438439|NCT04799782|590307752|FG000|Washout|Physician Decision|2|||
163438440|NCT04799782|590307753|FG001|Washout|Physician Decision|0|||
163438441|NCT04799782|590307752|FG000|Washout|Withdrawal by Subject|0|||
163438442|NCT04799782|590307753|FG001|Washout|Withdrawal by Subject|2|||
163438443|NCT04799782|590307752|FG000|Washout|Lost to Follow-up|0|||
163438444|NCT04799782|590307753|FG001|Washout|Lost to Follow-up|1|||
163438445|NCT02050048|590307754|FG000|Overall Study|Lost to Follow-up|0|||
163438446|NCT02050048|590307755|FG001|Overall Study|Lost to Follow-up|1|||
163438447|NCT02050048|590307754|FG000|Overall Study|Death|1|||
163438448|NCT02050048|590307755|FG001|Overall Study|Death|0|||
163438449|NCT02050048|590307754|FG000|Overall Study|Ineligible after ERCP|4|||
163438450|NCT02050048|590307755|FG001|Overall Study|Ineligible after ERCP|1|||
163438451|NCT01589094|590307760|FG000|Overall Study|Did not receive treatment|2|||
163438452|NCT00907738|590307761|FG000|Overall Study|Adverse Event|2|||
163438453|NCT00907738|590307762|FG001|Overall Study|Adverse Event|0|||
163438454|NCT00907738|590307763|FG002|Overall Study|Adverse Event|1|||
163438455|NCT00907738|590307764|FG003|Overall Study|Adverse Event|0|||
163438456|NCT00907738|590307765|FG004|Overall Study|Adverse Event|0|||
163438457|NCT00907738|590307761|FG000|Overall Study|not specified or withdrew consent|3|||
163438458|NCT00907738|590307762|FG001|Overall Study|not specified or withdrew consent|0|||
163438459|NCT00907738|590307763|FG002|Overall Study|not specified or withdrew consent|0|||
163438460|NCT00907738|590307764|FG003|Overall Study|not specified or withdrew consent|0|||
163438461|NCT00907738|590307765|FG004|Overall Study|not specified or withdrew consent|0|||
163438462|NCT00907738|590307761|FG000|Overall Study|Disease progression|8|||
163438463|NCT00907738|590307762|FG001|Overall Study|Disease progression|1|||
163438464|NCT00907738|590307763|FG002|Overall Study|Disease progression|6|||
163438465|NCT00907738|590307764|FG003|Overall Study|Disease progression|4|||
163438466|NCT00907738|590307765|FG004|Overall Study|Disease progression|2|||
163438467|NCT05363293|590307766|FG000|Overall Study|Withdrawal by Subject|1|||
163438468|NCT05363293|590307767|FG001|Overall Study|Withdrawal by Subject|0|||
163438469|NCT05363293|590307768|FG002|Overall Study|Withdrawal by Subject|0|||
163438470|NCT05363293|590307769|FG003|Overall Study|Withdrawal by Subject|0|||
163438471|NCT05363293|590307770|FG004|Overall Study|Withdrawal by Subject|0|||
163438472|NCT05363293|590307771|FG005|Overall Study|Withdrawal by Subject|0|||
163438473|NCT05363293|590307772|FG006|Overall Study|Withdrawal by Subject|0|||
163438474|NCT05363293|590307773|FG007|Overall Study|Withdrawal by Subject|0|||
163438475|NCT05363293|590307774|FG008|Overall Study|Withdrawal by Subject|0|||
163438476|NCT05363293|590307775|FG009|Overall Study|Withdrawal by Subject|0|||
163438477|NCT04773041|590307776|FG000|Overall Study|Unable to data match|1|||
163438478|NCT04773041|590307777|FG001|Overall Study|Unable to data match|0|||
163438479|NCT04773041|590307778|FG002|Overall Study|Unable to data match|0|||
163438480|NCT01988012|590309463|FG000|Overall Study|Adverse Event|5|||
163438481|NCT01988012|590309463|FG000|Overall Study|Insufficient Therapeutic Response|3|||
163438482|NCT01988012|590309463|FG000|Overall Study|Patient Withdrawal of Consent|4|||
163438483|NCT01988012|590309463|FG000|Overall Study|Lost to Follow-up|1|||
163438484|NCT01988012|590309463|FG000|Overall Study|Physician Decision|1|||
163438485|NCT01988012|590309463|FG000|Overall Study|Protocol Violation|1|||
163438486|NCT01058369|590309464|FG000|Overall Study|Adverse Event|1|||
163438487|NCT01058369|590309464|FG000|Overall Study|Early termination study|1|||
163438488|NCT01666444|590309467|FG000|Overall Study|Did not initiate treatment|2|||
163438489|NCT01666444|590309468|FG001|Overall Study|Did not initiate treatment|1|||
163438490|NCT00592358|590309469|FG000|Overall Study|Withdrawal by Subject|2|||
163438491|NCT00592358|590309469|FG000|Overall Study|Adverse Event|1|||
163438492|NCT00592358|590309469|FG000|Overall Study|Lack of Efficacy|2|||
163438493|NCT00592358|590309469|FG000|Overall Study|Inability to swallow pills|1|||
163438494|NCT00084682|590309470|FG000|Overall Study|Withdrawal by Subject|1|||
163438495|NCT00634543|590309473|FG000|Overall Study|Other|1|||
163438496|NCT00634543|590309474|FG001|Overall Study|Other|2|||
163438497|NCT00634543|590309473|FG000|Overall Study|Protocol Violation|3|||
163438498|NCT00634543|590309474|FG001|Overall Study|Protocol Violation|3|||
163438499|NCT00634543|590309473|FG000|Overall Study|Adverse Event|11|||
163438500|NCT00634543|590309474|FG001|Overall Study|Adverse Event|11|||
163438501|NCT00634543|590309473|FG000|Overall Study|Withdrawal by Subject|4|||
163438502|NCT00634543|590309474|FG001|Overall Study|Withdrawal by Subject|4|||
163438503|NCT00634543|590309473|FG000|Overall Study|Lost to Follow-up|0|||
163438504|NCT00634543|590309474|FG001|Overall Study|Lost to Follow-up|1|||
163438505|NCT01650779|590309476|FG000|Overall Study|Withdrawal by Subject|1|||
163438506|NCT03567291|590309478|FG000|Period I|Adverse Event|14|||
163438507|NCT03567291|590309479|FG001|Period I|Adverse Event|0|||
163438508|NCT03567291|590309480|FG002|Period I|Adverse Event|0|||
163438509|NCT03567291|590309481|FG003|Period I|Adverse Event|0|||
163438510|NCT03567291|590309478|FG000|Period I|Protocol Violation|1|||
163438511|NCT03567291|590309479|FG001|Period I|Protocol Violation|0|||
163438512|NCT03567291|590309480|FG002|Period I|Protocol Violation|0|||
163438513|NCT03567291|590309481|FG003|Period I|Protocol Violation|0|||
163438514|NCT03567291|590309478|FG000|Period I|Withdrawal by Subject|23|||
163438515|NCT03567291|590309479|FG001|Period I|Withdrawal by Subject|0|||
163438516|NCT03567291|590309480|FG002|Period I|Withdrawal by Subject|0|||
163438517|NCT03567291|590309481|FG003|Period I|Withdrawal by Subject|0|||
163438518|NCT03567291|590309478|FG000|Period I|Lost to Follow-up|2|||
163438519|NCT03567291|590309479|FG001|Period I|Lost to Follow-up|0|||
163438520|NCT03567291|590309480|FG002|Period I|Lost to Follow-up|0|||
163438521|NCT03567291|590309481|FG003|Period I|Lost to Follow-up|0|||
163438522|NCT03567291|590309478|FG000|Period I|Terminated by sponsor|44|||
163438523|NCT03567291|590309479|FG001|Period I|Terminated by sponsor|0|||
163438524|NCT03567291|590309480|FG002|Period I|Terminated by sponsor|0|||
163438525|NCT03567291|590309481|FG003|Period I|Terminated by sponsor|0|||
163438526|NCT03567291|590309478|FG000|Period I|Missing or unknown|7|||
163438527|NCT03567291|590309479|FG001|Period I|Missing or unknown|0|||
163438528|NCT03567291|590309480|FG002|Period I|Missing or unknown|0|||
163438529|NCT03567291|590309481|FG003|Period I|Missing or unknown|0|||
163438530|NCT03567291|590309478|FG000|Period II|Adverse Event|0|||
163438531|NCT03567291|590309479|FG001|Period II|Adverse Event|1|||
163438532|NCT03567291|590309480|FG002|Period II|Adverse Event|0|||
163438533|NCT03567291|590309481|FG003|Period II|Adverse Event|0|||
163438534|NCT03567291|590309478|FG000|Period II|Missing or unknown|0|||
163438535|NCT03567291|590309479|FG001|Period II|Missing or unknown|2|||
163438536|NCT03567291|590309480|FG002|Period II|Missing or unknown|1|||
163438537|NCT03567291|590309481|FG003|Period II|Missing or unknown|0|||
163438538|NCT03567291|590309478|FG000|Period III|Adverse Event|0|||
163438539|NCT03567291|590309479|FG001|Period III|Adverse Event|0|||
163438540|NCT03567291|590309480|FG002|Period III|Adverse Event|0|||
163438541|NCT03567291|590309481|FG003|Period III|Adverse Event|4|||
163438542|NCT03567291|590309478|FG000|Period III|Withdrawal by Subject|0|||
163438543|NCT03567291|590309479|FG001|Period III|Withdrawal by Subject|0|||
163438544|NCT03567291|590309480|FG002|Period III|Withdrawal by Subject|0|||
163438545|NCT03567291|590309481|FG003|Period III|Withdrawal by Subject|4|||
163438546|NCT03567291|590309478|FG000|Period III|Lost to Follow-up|0|||
163438547|NCT03567291|590309479|FG001|Period III|Lost to Follow-up|0|||
163438548|NCT03567291|590309480|FG002|Period III|Lost to Follow-up|0|||
163438549|NCT03567291|590309481|FG003|Period III|Lost to Follow-up|1|||
163438550|NCT03567291|590309478|FG000|Period III|Terminated by sponsor|0|||
163438551|NCT03567291|590309479|FG001|Period III|Terminated by sponsor|0|||
163438552|NCT03567291|590309480|FG002|Period III|Terminated by sponsor|0|||
163438553|NCT03567291|590309481|FG003|Period III|Terminated by sponsor|68|||
163438554|NCT03567291|590309478|FG000|Period III|Missing or unknown|0|||
163438555|NCT03567291|590309479|FG001|Period III|Missing or unknown|0|||
163438556|NCT03567291|590309480|FG002|Period III|Missing or unknown|0|||
163438557|NCT03567291|590309481|FG003|Period III|Missing or unknown|8|||
163438558|NCT01103349|590309482|FG000|Overall Study|Adverse Event|8|||
163438559|NCT01103349|590309483|FG001|Overall Study|Adverse Event|5|||
163438560|NCT01103349|590309484|FG002|Overall Study|Adverse Event|3|||
163438561|NCT01103349|590309482|FG000|Overall Study|Consent withdrawn|1|||
163438562|NCT01103349|590309483|FG001|Overall Study|Consent withdrawn|0|||
163438563|NCT01103349|590309484|FG002|Overall Study|Consent withdrawn|0|||
163438564|NCT01103349|590309482|FG000|Overall Study|Incorrectly included in the trial|1|||
163438565|NCT01103349|590309483|FG001|Overall Study|Incorrectly included in the trial|0|||
163438566|NCT01103349|590309484|FG002|Overall Study|Incorrectly included in the trial|0|||
163438567|NCT01103349|590309482|FG000|Overall Study|Withdrawal by Subject|1|||
163438568|NCT01103349|590309483|FG001|Overall Study|Withdrawal by Subject|1|||
163438569|NCT01103349|590309484|FG002|Overall Study|Withdrawal by Subject|0|||
163438570|NCT01103349|590309482|FG000|Overall Study|did not want to take trial medication|0|||
163438571|NCT01103349|590309483|FG001|Overall Study|did not want to take trial medication|1|||
163438572|NCT01103349|590309484|FG002|Overall Study|did not want to take trial medication|0|||
163438573|NCT01103349|590309482|FG000|Overall Study|forgot to take medication|0|||
163438574|NCT01103349|590309483|FG001|Overall Study|forgot to take medication|0|||
163438575|NCT01103349|590309484|FG002|Overall Study|forgot to take medication|1|||
163438576|NCT01736683|590309490|FG000|Overall Study|Disease Relapse|0|||
163438577|NCT01736683|590309491|FG001|Overall Study|Disease Relapse|0|||
163438578|NCT01736683|590309492|FG002|Overall Study|Disease Relapse|2|||
163438579|NCT01736683|590309493|FG003|Overall Study|Disease Relapse|1|||
163438580|NCT01736683|590309494|FG004|Overall Study|Disease Relapse|0|||
163438581|NCT01736683|590309490|FG000|Overall Study|Adverse Event|0|||
163438582|NCT01736683|590309491|FG001|Overall Study|Adverse Event|2|||
163438583|NCT01736683|590309492|FG002|Overall Study|Adverse Event|2|||
163438584|NCT01736683|590309493|FG003|Overall Study|Adverse Event|3|||
163438585|NCT01736683|590309494|FG004|Overall Study|Adverse Event|2|||
163438586|NCT01736683|590309490|FG000|Overall Study|Withdrawal by Subject|0|||
163438587|NCT01736683|590309491|FG001|Overall Study|Withdrawal by Subject|0|||
163438588|NCT01736683|590309492|FG002|Overall Study|Withdrawal by Subject|3|||
162925349|NCT03901339|588428938|FG000|Overall Study|Death|220|||
163438589|NCT01736683|590309493|FG003|Overall Study|Withdrawal by Subject|1|||
163438590|NCT01736683|590309494|FG004|Overall Study|Withdrawal by Subject|1|||
163438591|NCT01736683|590309490|FG000|Overall Study|Lack of Therapeutic Effect|7|||
163438592|NCT01736683|590309491|FG001|Overall Study|Lack of Therapeutic Effect|4|||
163438593|NCT01736683|590309492|FG002|Overall Study|Lack of Therapeutic Effect|13|||
163438594|NCT01736683|590309493|FG003|Overall Study|Lack of Therapeutic Effect|20|||
163438595|NCT01736683|590309494|FG004|Overall Study|Lack of Therapeutic Effect|1|||
163438596|NCT01736683|590309490|FG000|Overall Study|Progressive Disease|0|||
163438597|NCT01736683|590309491|FG001|Overall Study|Progressive Disease|0|||
163438598|NCT01736683|590309492|FG002|Overall Study|Progressive Disease|0|||
163438599|NCT01736683|590309493|FG003|Overall Study|Progressive Disease|1|||
163438600|NCT01736683|590309494|FG004|Overall Study|Progressive Disease|0|||
163438601|NCT01736683|590309490|FG000|Overall Study|Other|0|||
163438602|NCT01736683|590309491|FG001|Overall Study|Other|0|||
163438603|NCT01736683|590309492|FG002|Overall Study|Other|1|||
163438604|NCT01736683|590309493|FG003|Overall Study|Other|9|||
163438605|NCT01736683|590309494|FG004|Overall Study|Other|1|||
163438606|NCT00283712|590309500|FG000|Overall Study|Death|0|||
163438607|NCT00283712|590309501|FG001|Overall Study|Death|1|||
163438608|NCT00090285|590309503|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
163438609|NCT00090285|590309504|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
163438610|NCT00090285|590309505|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
163438611|NCT00090285|590309506|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
163438612|NCT00090285|590309507|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
163438613|NCT00090285|590309508|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
163438614|NCT00090285|590309503|FG000|Base Study Vaccination Period|Adverse Event|2|||
163438615|NCT00090285|590309504|FG001|Base Study Vaccination Period|Adverse Event|4|||
163438616|NCT00090285|590309505|FG002|Base Study Vaccination Period|Adverse Event|0|||
163438617|NCT00090285|590309506|FG003|Base Study Vaccination Period|Adverse Event|0|||
163438618|NCT00090285|590309507|FG004|Base Study Vaccination Period|Adverse Event|0|||
163438619|NCT00090285|590309508|FG005|Base Study Vaccination Period|Adverse Event|0|||
163438620|NCT00090285|590309503|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
163438621|NCT00090285|590309504|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
163438622|NCT00090285|590309505|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
163438623|NCT00090285|590309506|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
163438624|NCT00090285|590309507|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
163438625|NCT00090285|590309508|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
163438626|NCT00090285|590309503|FG000|Base Study Vaccination Period|Protocol Violation|2|||
163438627|NCT00090285|590309504|FG001|Base Study Vaccination Period|Protocol Violation|3|||
163438628|NCT00090285|590309505|FG002|Base Study Vaccination Period|Protocol Violation|0|||
163438629|NCT00090285|590309506|FG003|Base Study Vaccination Period|Protocol Violation|0|||
163438630|NCT00090285|590309507|FG004|Base Study Vaccination Period|Protocol Violation|0|||
163438631|NCT00090285|590309508|FG005|Base Study Vaccination Period|Protocol Violation|0|||
163438632|NCT00090285|590309503|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
163438633|NCT00090285|590309504|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
163438634|NCT00090285|590309505|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
163438635|NCT00090285|590309506|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
163438636|NCT00090285|590309507|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
163438637|NCT00090285|590309508|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
163438638|NCT00090285|590309503|FG000|Base Study Vaccination Period|Uncooperative|2|||
163438639|NCT00090285|590309504|FG001|Base Study Vaccination Period|Uncooperative|2|||
163438640|NCT00090285|590309505|FG002|Base Study Vaccination Period|Uncooperative|0|||
163438641|NCT00090285|590309506|FG003|Base Study Vaccination Period|Uncooperative|0|||
163438642|NCT00090285|590309507|FG004|Base Study Vaccination Period|Uncooperative|0|||
163438643|NCT00090285|590309508|FG005|Base Study Vaccination Period|Uncooperative|0|||
163438644|NCT00090285|590309503|FG000|Base Study Vaccination Period|Moved|20|||
163438645|NCT00090285|590309504|FG001|Base Study Vaccination Period|Moved|21|||
163438646|NCT00090285|590309505|FG002|Base Study Vaccination Period|Moved|0|||
163438647|NCT00090285|590309506|FG003|Base Study Vaccination Period|Moved|0|||
163438648|NCT00090285|590309507|FG004|Base Study Vaccination Period|Moved|0|||
163438649|NCT00090285|590309508|FG005|Base Study Vaccination Period|Moved|0|||
163438650|NCT00090285|590309503|FG000|Base Study Vaccination Period|Site Terminated|1|||
163438651|NCT00090285|590309504|FG001|Base Study Vaccination Period|Site Terminated|0|||
163438652|NCT00090285|590309505|FG002|Base Study Vaccination Period|Site Terminated|0|||
163438653|NCT00090285|590309506|FG003|Base Study Vaccination Period|Site Terminated|0|||
163438654|NCT00090285|590309507|FG004|Base Study Vaccination Period|Site Terminated|0|||
163438655|NCT00090285|590309508|FG005|Base Study Vaccination Period|Site Terminated|0|||
163438656|NCT00090285|590309503|FG000|Base Study Vaccination Period|Other|2|||
163438657|NCT00090285|590309504|FG001|Base Study Vaccination Period|Other|2|||
163438658|NCT00090285|590309505|FG002|Base Study Vaccination Period|Other|0|||
163438659|NCT00090285|590309506|FG003|Base Study Vaccination Period|Other|0|||
163438660|NCT00090285|590309507|FG004|Base Study Vaccination Period|Other|0|||
163438661|NCT00090285|590309508|FG005|Base Study Vaccination Period|Other|0|||
163438662|NCT00090285|590309503|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
163438663|NCT00090285|590309504|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
163438664|NCT00090285|590309505|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
163438665|NCT00090285|590309506|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
163438666|NCT00090285|590309507|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
163438667|NCT00090285|590309508|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
163438668|NCT00090285|590309503|FG000|Base Study Vaccination Period|HIV positive|1|||
163438669|NCT00090285|590309504|FG001|Base Study Vaccination Period|HIV positive|1|||
163438670|NCT00090285|590309505|FG002|Base Study Vaccination Period|HIV positive|0|||
163438671|NCT00090285|590309506|FG003|Base Study Vaccination Period|HIV positive|0|||
163438672|NCT00090285|590309507|FG004|Base Study Vaccination Period|HIV positive|0|||
163438673|NCT00090285|590309508|FG005|Base Study Vaccination Period|HIV positive|0|||
163438674|NCT00090285|590309503|FG000|Base Study Follow-up Period|Adverse Event|3|||
163438675|NCT00090285|590309504|FG001|Base Study Follow-up Period|Adverse Event|10|||
163438676|NCT00090285|590309505|FG002|Base Study Follow-up Period|Adverse Event|0|||
163438677|NCT00090285|590309506|FG003|Base Study Follow-up Period|Adverse Event|0|||
163438678|NCT00090285|590309507|FG004|Base Study Follow-up Period|Adverse Event|0|||
163438679|NCT00090285|590309508|FG005|Base Study Follow-up Period|Adverse Event|0|||
163438680|NCT00090285|590309503|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
163438681|NCT00090285|590309504|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
163438682|NCT00090285|590309505|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
163438683|NCT00090285|590309506|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
163438684|NCT00090285|590309507|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
163438685|NCT00090285|590309508|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
163438686|NCT00090285|590309503|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
163438687|NCT00090285|590309504|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
163438688|NCT00090285|590309505|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
163438689|NCT00090285|590309506|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
163438690|NCT00090285|590309507|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
163438691|NCT00090285|590309508|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
163438692|NCT00090285|590309503|FG000|Base Study Follow-up Period|Moved|41|||
163438693|NCT00090285|590309504|FG001|Base Study Follow-up Period|Moved|36|||
163438694|NCT00090285|590309505|FG002|Base Study Follow-up Period|Moved|0|||
163438695|NCT00090285|590309506|FG003|Base Study Follow-up Period|Moved|0|||
163438696|NCT00090285|590309507|FG004|Base Study Follow-up Period|Moved|0|||
163438697|NCT00090285|590309508|FG005|Base Study Follow-up Period|Moved|0|||
163438698|NCT00090285|590309503|FG000|Base Study Follow-up Period|Other|2|||
163438699|NCT00090285|590309504|FG001|Base Study Follow-up Period|Other|0|||
163438700|NCT00090285|590309505|FG002|Base Study Follow-up Period|Other|0|||
163438701|NCT00090285|590309506|FG003|Base Study Follow-up Period|Other|0|||
163438702|NCT00090285|590309507|FG004|Base Study Follow-up Period|Other|0|||
163438703|NCT00090285|590309508|FG005|Base Study Follow-up Period|Other|0|||
163438704|NCT00090285|590309503|FG000|Base Study Follow-up Period|Protocol Violation|1|||
163438705|NCT00090285|590309504|FG001|Base Study Follow-up Period|Protocol Violation|0|||
163438706|NCT00090285|590309505|FG002|Base Study Follow-up Period|Protocol Violation|0|||
163438707|NCT00090285|590309506|FG003|Base Study Follow-up Period|Protocol Violation|0|||
163438708|NCT00090285|590309507|FG004|Base Study Follow-up Period|Protocol Violation|0|||
163438709|NCT00090285|590309508|FG005|Base Study Follow-up Period|Protocol Violation|0|||
163438710|NCT00090285|590309503|FG000|Base Study Follow-up Period|Uncooperative|3|||
163438711|NCT00090285|590309504|FG001|Base Study Follow-up Period|Uncooperative|4|||
163438712|NCT00090285|590309505|FG002|Base Study Follow-up Period|Uncooperative|0|||
163438713|NCT00090285|590309506|FG003|Base Study Follow-up Period|Uncooperative|0|||
163438714|NCT00090285|590309507|FG004|Base Study Follow-up Period|Uncooperative|0|||
163438715|NCT00090285|590309508|FG005|Base Study Follow-up Period|Uncooperative|0|||
163438716|NCT00090285|590309503|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
163438717|NCT00090285|590309504|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
163438718|NCT00090285|590309505|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
163438719|NCT00090285|590309506|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
163438720|NCT00090285|590309507|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
163438721|NCT00090285|590309508|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
163438722|NCT00090285|590309503|FG000|Extension 1|Adverse Event|0|||
163438723|NCT00090285|590309504|FG001|Extension 1|Adverse Event|0|||
163438724|NCT00090285|590309505|FG002|Extension 1|Adverse Event|2|||
163438725|NCT00090285|590309506|FG003|Extension 1|Adverse Event|0|||
163438726|NCT00090285|590309507|FG004|Extension 1|Adverse Event|0|||
163438727|NCT00090285|590309508|FG005|Extension 1|Adverse Event|0|||
163438728|NCT00090285|590309503|FG000|Extension 1|Lost to Follow-up|0|||
163438729|NCT00090285|590309504|FG001|Extension 1|Lost to Follow-up|0|||
163438730|NCT00090285|590309505|FG002|Extension 1|Lost to Follow-up|35|||
163438731|NCT00090285|590309506|FG003|Extension 1|Lost to Follow-up|0|||
163438732|NCT00090285|590309507|FG004|Extension 1|Lost to Follow-up|0|||
163438733|NCT00090285|590309508|FG005|Extension 1|Lost to Follow-up|0|||
163438734|NCT00090285|590309503|FG000|Extension 1|Withdrawal by Subject|0|||
163438735|NCT00090285|590309504|FG001|Extension 1|Withdrawal by Subject|0|||
163438736|NCT00090285|590309505|FG002|Extension 1|Withdrawal by Subject|13|||
163438737|NCT00090285|590309506|FG003|Extension 1|Withdrawal by Subject|1|||
163438738|NCT00090285|590309507|FG004|Extension 1|Withdrawal by Subject|0|||
163438739|NCT00090285|590309508|FG005|Extension 1|Withdrawal by Subject|0|||
163438740|NCT00090285|590309503|FG000|Extension 1|Other|0|||
163438741|NCT00090285|590309504|FG001|Extension 1|Other|0|||
163438742|NCT00090285|590309505|FG002|Extension 1|Other|4|||
163438743|NCT00090285|590309506|FG003|Extension 1|Other|0|||
163438744|NCT00090285|590309507|FG004|Extension 1|Other|0|||
163438745|NCT00090285|590309508|FG005|Extension 1|Other|0|||
163438746|NCT00090285|590309503|FG000|Extension 1|Moved|0|||
163438747|NCT00090285|590309504|FG001|Extension 1|Moved|0|||
163438748|NCT00090285|590309505|FG002|Extension 1|Moved|3|||
163438749|NCT00090285|590309506|FG003|Extension 1|Moved|0|||
163438750|NCT00090285|590309507|FG004|Extension 1|Moved|0|||
163438751|NCT00090285|590309508|FG005|Extension 1|Moved|0|||
163438752|NCT00090285|590309503|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
163438753|NCT00090285|590309504|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
163438754|NCT00090285|590309505|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
163438755|NCT00090285|590309506|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
163438756|NCT00090285|590309507|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
163438757|NCT00090285|590309508|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
163438758|NCT00090285|590309503|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
163438759|NCT00090285|590309504|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
163438760|NCT00090285|590309505|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
163438761|NCT00090285|590309506|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
163438762|NCT00090285|590309507|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
163438763|NCT00090285|590309508|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
163438764|NCT00090285|590309503|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
163438765|NCT00090285|590309504|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
163438766|NCT00090285|590309505|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
163438767|NCT00090285|590309506|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
163438768|NCT00090285|590309507|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
163438769|NCT00090285|590309508|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
163438770|NCT00090285|590309503|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
163438771|NCT00090285|590309504|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
163438772|NCT00090285|590309505|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
163438773|NCT00090285|590309506|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
163438774|NCT00090285|590309507|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
163438775|NCT00090285|590309508|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
163438776|NCT00907478|590309511|FG000|Overall Study|Ineligibility determined|0|||
163438777|NCT00907478|590309512|FG001|Overall Study|Ineligibility determined|0|||
163438778|NCT00907478|590309513|FG002|Overall Study|Ineligibility determined|1|||
163438779|NCT00907478|590309511|FG000|Overall Study|Noncompliance|0|||
163438780|NCT00907478|590309512|FG001|Overall Study|Noncompliance|0|||
163438781|NCT00907478|590309513|FG002|Overall Study|Noncompliance|1|||
163438782|NCT00907478|590309511|FG000|Overall Study|Adverse Event|3|||
163438783|NCT00907478|590309512|FG001|Overall Study|Adverse Event|1|||
163438784|NCT00907478|590309513|FG002|Overall Study|Adverse Event|2|||
163438785|NCT00907478|590309511|FG000|Overall Study|Withdrawal by Subject|8|||
163438786|NCT00907478|590309512|FG001|Overall Study|Withdrawal by Subject|9|||
163438787|NCT00907478|590309513|FG002|Overall Study|Withdrawal by Subject|6|||
163438788|NCT00907478|590309511|FG000|Overall Study|Requirement for alternative therapy|1|||
163438789|NCT00907478|590309512|FG001|Overall Study|Requirement for alternative therapy|2|||
163438790|NCT00907478|590309513|FG002|Overall Study|Requirement for alternative therapy|3|||
163438791|NCT00907478|590309511|FG000|Overall Study|Physician Decision|2|||
163438792|NCT00907478|590309512|FG001|Overall Study|Physician Decision|0|||
163438793|NCT00907478|590309513|FG002|Overall Study|Physician Decision|3|||
163438794|NCT00907478|590309511|FG000|Overall Study|Death|4|||
163438795|NCT00907478|590309512|FG001|Overall Study|Death|2|||
163438796|NCT00907478|590309513|FG002|Overall Study|Death|1|||
163438797|NCT00907478|590309511|FG000|Overall Study|Protocol-specified criteria|5|||
163438798|NCT00907478|590309512|FG001|Overall Study|Protocol-specified criteria|2|||
163438799|NCT00907478|590309513|FG002|Overall Study|Protocol-specified criteria|3|||
163438800|NCT00907478|590309511|FG000|Overall Study|Pregnancy|0|||
163438801|NCT00907478|590309512|FG001|Overall Study|Pregnancy|1|||
163438802|NCT00907478|590309513|FG002|Overall Study|Pregnancy|1|||
163438803|NCT00907478|590309511|FG000|Overall Study|Lost to Follow-up|1|||
163438804|NCT00907478|590309512|FG001|Overall Study|Lost to Follow-up|0|||
163438805|NCT00907478|590309513|FG002|Overall Study|Lost to Follow-up|0|||
163438806|NCT00907478|590309511|FG000|Overall Study|Other|3|||
163438807|NCT00907478|590309512|FG001|Overall Study|Other|0|||
163438808|NCT00907478|590309513|FG002|Overall Study|Other|1|||
163438809|NCT02747043|590309514|FG000|Overall Study|Other|1|||
163438810|NCT02747043|590309515|FG001|Overall Study|Other|1|||
163438811|NCT02747043|590309514|FG000|Overall Study|Adverse Event|3|||
163438812|NCT02747043|590309515|FG001|Overall Study|Adverse Event|1|||
163438813|NCT02747043|590309514|FG000|Overall Study|Withdrawal by Subject|1|||
163438814|NCT02747043|590309515|FG001|Overall Study|Withdrawal by Subject|1|||
163438815|NCT02747043|590309514|FG000|Overall Study|Physician Decision|1|||
163438816|NCT02747043|590309515|FG001|Overall Study|Physician Decision|1|||
163438817|NCT02747043|590309514|FG000|Overall Study|Protocol Violation|0|||
163438818|NCT02747043|590309515|FG001|Overall Study|Protocol Violation|1|||
163438819|NCT02747043|590309514|FG000|Overall Study|Disease progression|4|||
163438820|NCT02747043|590309515|FG001|Overall Study|Disease progression|0|||
163438821|NCT02046564|590309516|FG000|Overall Study|Adverse Event|6|||
163438822|NCT02046564|590309517|FG001|Overall Study|Adverse Event|3|||
163438823|NCT02046564|590309516|FG000|Overall Study|Physician Decision|0|||
163438824|NCT02046564|590309517|FG001|Overall Study|Physician Decision|1|||
163438825|NCT02046564|590309516|FG000|Overall Study|Protocol Violation|3|||
163438826|NCT02046564|590309517|FG001|Overall Study|Protocol Violation|1|||
163438827|NCT02046564|590309516|FG000|Overall Study|Withdrawal by Subject|4|||
163438828|NCT02046564|590309517|FG001|Overall Study|Withdrawal by Subject|10|||
163438829|NCT02046564|590309516|FG000|Overall Study|Subject met withdrawal criteria|2|||
163438830|NCT02046564|590309517|FG001|Overall Study|Subject met withdrawal criteria|5|||
163438831|NCT01936649|590309522|FG000|Overall Study|Withdrawal by Subject|4|||
163438832|NCT01936649|590309522|FG000|Overall Study|Physician Decision|2|||
163438833|NCT01936649|590309522|FG000|Overall Study|Protocol Violation|2|||
163438834|NCT01936649|590309522|FG000|Overall Study|Other than specified above|5|||
163438835|NCT03554005|590309529|FG000|Overall Study|Not in participant's best interest|0|||
163438836|NCT03554005|590309530|FG001|Overall Study|Not in participant's best interest|0|||
163438837|NCT03554005|590309531|FG002|Overall Study|Not in participant's best interest|0|||
163438838|NCT03554005|590309532|FG003|Overall Study|Not in participant's best interest|0|||
163438839|NCT03554005|590309533|FG004|Overall Study|Not in participant's best interest|0|||
163438840|NCT03554005|590309534|FG005|Overall Study|Not in participant's best interest|1|||
163438841|NCT03554005|590309529|FG000|Overall Study|Disease Progression|1|||
163438842|NCT03554005|590309530|FG001|Overall Study|Disease Progression|1|||
163438843|NCT03554005|590309531|FG002|Overall Study|Disease Progression|1|||
163438844|NCT03554005|590309532|FG003|Overall Study|Disease Progression|1|||
163438845|NCT03554005|590309533|FG004|Overall Study|Disease Progression|5|||
163438846|NCT03554005|590309534|FG005|Overall Study|Disease Progression|6|||
163438847|NCT03554005|590309529|FG000|Overall Study|Adverse Event|0|||
163438848|NCT03554005|590309530|FG001|Overall Study|Adverse Event|0|||
163438849|NCT03554005|590309531|FG002|Overall Study|Adverse Event|0|||
163438850|NCT03554005|590309532|FG003|Overall Study|Adverse Event|0|||
163438851|NCT03554005|590309533|FG004|Overall Study|Adverse Event|0|||
163438852|NCT03554005|590309534|FG005|Overall Study|Adverse Event|3|||
163438853|NCT03554005|590309529|FG000|Overall Study|Physician Decision|0|||
163438854|NCT03554005|590309530|FG001|Overall Study|Physician Decision|0|||
163438855|NCT03554005|590309531|FG002|Overall Study|Physician Decision|0|||
163438856|NCT03554005|590309532|FG003|Overall Study|Physician Decision|0|||
163438857|NCT03554005|590309533|FG004|Overall Study|Physician Decision|1|||
163438858|NCT03554005|590309534|FG005|Overall Study|Physician Decision|0|||
163438859|NCT03554005|590309529|FG000|Overall Study|Other|0|||
163438860|NCT03554005|590309530|FG001|Overall Study|Other|0|||
163438861|NCT03554005|590309531|FG002|Overall Study|Other|0|||
163438862|NCT03554005|590309532|FG003|Overall Study|Other|0|||
163438863|NCT03554005|590309533|FG004|Overall Study|Other|0|||
163438864|NCT03554005|590309534|FG005|Overall Study|Other|1|||
163438865|NCT00631488|590309535|FG000|Overall Study|Adverse Event|1|||
163438866|NCT00631488|590309536|FG001|Overall Study|Adverse Event|0|||
163438867|NCT00631488|590309537|FG002|Overall Study|Adverse Event|0|||
163438868|NCT00631488|590309535|FG000|Overall Study|Lost to Follow-up|2|||
163438869|NCT00631488|590309536|FG001|Overall Study|Lost to Follow-up|2|||
163438870|NCT00631488|590309537|FG002|Overall Study|Lost to Follow-up|0|||
163438871|NCT00631488|590309535|FG000|Overall Study|Physician Decision|1|||
163438872|NCT00631488|590309536|FG001|Overall Study|Physician Decision|0|||
163438873|NCT00631488|590309537|FG002|Overall Study|Physician Decision|1|||
163438874|NCT00631488|590309535|FG000|Overall Study|Protocol Violation|0|||
163438875|NCT00631488|590309536|FG001|Overall Study|Protocol Violation|0|||
163438876|NCT00631488|590309537|FG002|Overall Study|Protocol Violation|1|||
163438877|NCT02855411|590309543|FG000|Overall Study|Study terminated by sponsor|21|||
163438878|NCT02855411|590309543|FG000|Overall Study|Does not meet entrance criteria|14|||
163438879|NCT03988751|590309546|FG000|Overall Study|Withdrawal by Subject|1|||
163438880|NCT03988751|590309547|FG001|Overall Study|Withdrawal by Subject|0|||
163438881|NCT03988751|590309546|FG000|Overall Study|Protocol Violation|0|||
163438882|NCT03988751|590309547|FG001|Overall Study|Protocol Violation|1|||
163438883|NCT00844883|590309548|FG000|Overall Study|Bridged to liver transplant|3|||
163438884|NCT00844883|590309548|FG000|Overall Study|Bridged to resection|1|||
163438885|NCT01325493|590309553|FG000|Overall Study|Protocol Violation|0|||
163438886|NCT01325493|590309554|FG001|Overall Study|Protocol Violation|1|||
163438887|NCT01325493|590309553|FG000|Overall Study|loss of neuromonitoring signals|0|||
163438888|NCT01325493|590309554|FG001|Overall Study|loss of neuromonitoring signals|2|||
163438889|NCT01325493|590309553|FG000|Overall Study|Allergy|1|||
163438890|NCT01325493|590309554|FG001|Overall Study|Allergy|0|||
163438891|NCT02927171|590309555|FG000|Overall Study|Lost to Follow-up|0|||
163438892|NCT02927171|590309556|FG001|Overall Study|Lost to Follow-up|1|||
163438893|NCT02240628|590309559|FG000|Overall Study|Physician Decision|6|||
163438894|NCT02240628|590309560|FG001|Overall Study|Physician Decision|5|||
163438895|NCT04530825|590309561|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
163438896|NCT04530825|590309562|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
163438897|NCT04530825|590309563|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
163438898|NCT04530825|590309564|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
163438899|NCT04530825|590309561|FG000|Overall Study|Did not complete follow-up|3|||
163438900|NCT04530825|590309562|FG001|Overall Study|Did not complete follow-up|0|||
163438901|NCT04530825|590309563|FG002|Overall Study|Did not complete follow-up|0|||
163438902|NCT04530825|590309564|FG003|Overall Study|Did not complete follow-up|0|||
163438903|NCT00850499|590309566|FG000|Overall Study|Adverse Event|3|||
163438904|NCT00850499|590309567|FG001|Overall Study|Adverse Event|1|||
163438905|NCT00850499|590309566|FG000|Overall Study|Lack of Efficacy|0|||
163438906|NCT00850499|590309567|FG001|Overall Study|Lack of Efficacy|1|||
163438907|NCT00552305|590309568|FG000|Overall Study|Adverse Event|43|||
163438908|NCT00552305|590309568|FG000|Overall Study|Lack of Efficacy|120|||
163438909|NCT00552305|590309568|FG000|Overall Study|Lost to Follow-up|4|||
163438910|NCT00552305|590309568|FG000|Overall Study|Protocol Violation|3|||
163438911|NCT00552305|590309568|FG000|Overall Study|Withdrawal by Subject|44|||
163438912|NCT00552305|590309568|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
163438913|NCT00552305|590309568|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
163438914|NCT00552305|590309568|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
163438915|NCT00552305|590309568|FG000|Overall Study|Unsatisfactory compliance|11|||
163438916|NCT00552305|590309568|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
163438917|NCT00552305|590309568|FG000|Overall Study|AE/Other: prohibited drug required|1|||
163438918|NCT00552305|590309568|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
163438919|NCT00552305|590309568|FG000|Overall Study|Other: Site closed|4|||
163438920|NCT00552305|590309568|FG000|Overall Study|Other: Personal problems|1|||
163438921|NCT00552305|590309568|FG000|Overall Study|Other: Unable to attend visits|1|||
163438922|NCT00552305|590309568|FG000|Overall Study|Other: Subject underwent surgery|4|||
163438923|NCT00552305|590309568|FG000|Overall Study|Other: Subject became pregnant|1|||
163438924|NCT00552305|590309568|FG000|Overall Study|Other: Health problems, not drug related|1|||
163438925|NCT00552305|590309568|FG000|Overall Study|Other: Subject moved from area|2|||
163438926|NCT00552305|590309568|FG000|Overall Study|Other: Subject incarcerated|1|||
163438927|NCT00552305|590309568|FG000|Overall Study|Other: Subject went to rehab|1|||
163438928|NCT00718861|590309571|FG000|Overall Study|Withdrawal by Subject|15|||
163438929|NCT00718861|590309572|FG001|Overall Study|Withdrawal by Subject|10|||
163438930|NCT00718861|590309571|FG000|Overall Study|Adverse Event|2|||
163438931|NCT00718861|590309572|FG001|Overall Study|Adverse Event|1|||
163438932|NCT00718861|590309571|FG000|Overall Study|Lost to Follow-up|2|||
163438933|NCT00718861|590309572|FG001|Overall Study|Lost to Follow-up|1|||
163438934|NCT00718861|590309571|FG000|Overall Study|Administrative Problems|1|||
163438935|NCT00718861|590309572|FG001|Overall Study|Administrative Problems|1|||
163438936|NCT00718861|590309571|FG000|Overall Study|Death|1|||
163438937|NCT00718861|590309572|FG001|Overall Study|Death|5|||
163438938|NCT01703819|590309573|FG000|Overall Study|Adverse Event|0|||
163438939|NCT01703819|590309574|FG001|Overall Study|Adverse Event|1|||
163438940|NCT01703819|590309573|FG000|Overall Study|Withdrawal by Subject|0|||
163438941|NCT01703819|590309574|FG001|Overall Study|Withdrawal by Subject|1|||
163438942|NCT04230486|590309581|FG000|Overall Study|Screen Failure|1|||
163438943|NCT01302041|590309582|FG000|Overall Study|Death|5|||
163438944|NCT01302041|590309582|FG000|Overall Study|Withdrawal by Subject|4|||
163438945|NCT01302041|590309582|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
163438946|NCT01302041|590309582|FG000|Overall Study|Other-Miscellaneous Reason|2|||
163438947|NCT04504032|590309583|FG000|Overall Study|Adverse Event|1|||
163438948|NCT04504032|590309584|FG001|Overall Study|Adverse Event|2|||
163438949|NCT04504032|590309583|FG000|Overall Study|Lost to Follow-up|6|||
163438950|NCT04504032|590309584|FG001|Overall Study|Lost to Follow-up|9|||
163438951|NCT04504032|590309583|FG000|Overall Study|Protocol Violation|2|||
163438952|NCT04504032|590309584|FG001|Overall Study|Protocol Violation|0|||
163438953|NCT04504032|590309583|FG000|Overall Study|Study terminated by sponsor|1|||
163438954|NCT04504032|590309584|FG001|Overall Study|Study terminated by sponsor|2|||
163438955|NCT04504032|590309583|FG000|Overall Study|Withdrawal by Subject|9|||
163438956|NCT04504032|590309584|FG001|Overall Study|Withdrawal by Subject|11|||
163438957|NCT04504032|590309583|FG000|Overall Study|Disease progression prior to dosing|15|||
163438958|NCT04504032|590309584|FG001|Overall Study|Disease progression prior to dosing|3|||
163438959|NCT04504032|590309583|FG000|Overall Study|Drug supply issues|1|||
163438960|NCT04504032|590309584|FG001|Overall Study|Drug supply issues|1|||
163438961|NCT04504032|590309583|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
163438962|NCT04504032|590309584|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
163438963|NCT01839188|590309585|FG000|Overall Study|Withdrawal by Subject|1|||
163438964|NCT04983901|590309586|FG000|Overall Study|Death|1|||
163438965|NCT04983901|590309587|FG001|Overall Study|Death|4|||
163438966|NCT04983901|590309586|FG000|Overall Study|Lost to Follow-up|3|||
163438967|NCT04983901|590309587|FG001|Overall Study|Lost to Follow-up|0|||
163438968|NCT04983901|590309586|FG000|Overall Study|Protocol Violation|1|||
163438969|NCT04983901|590309587|FG001|Overall Study|Protocol Violation|0|||
163438970|NCT04983901|590309586|FG000|Overall Study|Withdrawal by Subject|1|||
163438971|NCT04983901|590309587|FG001|Overall Study|Withdrawal by Subject|2|||
163438972|NCT01671488|590309588|FG000|Overall Study|Withdrawal by Subject|1|||
163438973|NCT02416908|590309589|FG000|Dose Escalation Phase|Adverse Event|0|||
163438974|NCT02416908|590309590|FG001|Dose Escalation Phase|Adverse Event|0|||
163438975|NCT02416908|590309591|FG002|Dose Escalation Phase|Adverse Event|3|||
163438976|NCT02416908|590309592|FG003|Dose Escalation Phase|Adverse Event|0|||
163438977|NCT02416908|590309589|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
163438978|NCT02416908|590309590|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
163438979|NCT02416908|590309591|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
163438980|NCT02416908|590309592|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
163438981|NCT02285010|590309593|FG000|Overall Study|not abdominal hysterectomy|2|||
163438982|NCT02285010|590309594|FG001|Overall Study|not abdominal hysterectomy|0|||
163438983|NCT02285010|590309593|FG000|Overall Study|Not spinal anesthesia|3|||
163438984|NCT02285010|590309594|FG001|Overall Study|Not spinal anesthesia|1|||
163438985|NCT01164501|590309598|FG000|Overall Study|Not treated|2|||
163438986|NCT01164501|590309599|FG001|Overall Study|Not treated|0|||
163438987|NCT01164501|590309600|FG002|Overall Study|Not treated|1|||
163438988|NCT01164501|590309598|FG000|Overall Study|Adverse Event|18|||
163438989|NCT01164501|590309599|FG001|Overall Study|Adverse Event|4|||
163438990|NCT01164501|590309600|FG002|Overall Study|Adverse Event|21|||
163438991|NCT01164501|590309598|FG000|Overall Study|Lack of Efficacy|0|||
163438992|NCT01164501|590309599|FG001|Overall Study|Lack of Efficacy|0|||
163438993|NCT01164501|590309600|FG002|Overall Study|Lack of Efficacy|1|||
163438994|NCT01164501|590309598|FG000|Overall Study|Non compliant with protocol|1|||
163438995|NCT01164501|590309599|FG001|Overall Study|Non compliant with protocol|1|||
163438996|NCT01164501|590309600|FG002|Overall Study|Non compliant with protocol|4|||
163438997|NCT01164501|590309598|FG000|Overall Study|Lost to Follow-up|3|||
163438998|NCT01164501|590309599|FG001|Overall Study|Lost to Follow-up|0|||
163438999|NCT01164501|590309600|FG002|Overall Study|Lost to Follow-up|3|||
163439000|NCT01164501|590309598|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
163439001|NCT01164501|590309599|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
163439002|NCT01164501|590309600|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
163439003|NCT01164501|590309598|FG000|Overall Study|Other reason not defined above|9|||
163439004|NCT01164501|590309599|FG001|Overall Study|Other reason not defined above|1|||
163439005|NCT01164501|590309600|FG002|Overall Study|Other reason not defined above|4|||
163439006|NCT00231478|590309601|FG000|Overall Study|Protocol Violation|3|||
163439007|NCT00231478|590309602|FG001|Overall Study|Protocol Violation|2|||
163439008|NCT00231478|590309601|FG000|Overall Study|Refused Treatment|1|||
163439009|NCT00231478|590309602|FG001|Overall Study|Refused Treatment|1|||
163439010|NCT00231478|590309601|FG000|Overall Study|Withdrawal by Subject|1|||
163439011|NCT00231478|590309602|FG001|Overall Study|Withdrawal by Subject|0|||
163439012|NCT00231478|590309601|FG000|Overall Study|Adverse Event|0|||
163439013|NCT00231478|590309602|FG001|Overall Study|Adverse Event|1|||
163439014|NCT00231478|590309601|FG000|Overall Study|Administrative|3|||
163439015|NCT00231478|590309602|FG001|Overall Study|Administrative|2|||
163439016|NCT01001494|590309605|FG000|Overall Study|Adverse Event|8|||
163439017|NCT01001494|590309606|FG001|Overall Study|Adverse Event|4|||
163439018|NCT01001494|590309607|FG002|Overall Study|Adverse Event|6|||
163439019|NCT01001494|590309605|FG000|Overall Study|Protocol Violation|0|||
163439020|NCT01001494|590309606|FG001|Overall Study|Protocol Violation|1|||
163439021|NCT01001494|590309607|FG002|Overall Study|Protocol Violation|1|||
163439022|NCT01001494|590309605|FG000|Overall Study|Lost to Follow-up|2|||
163439023|NCT01001494|590309606|FG001|Overall Study|Lost to Follow-up|0|||
163439024|NCT01001494|590309607|FG002|Overall Study|Lost to Follow-up|1|||
163439025|NCT01001494|590309605|FG000|Overall Study|Withdrawal by Subject|9|||
163439026|NCT01001494|590309606|FG001|Overall Study|Withdrawal by Subject|7|||
163439027|NCT01001494|590309607|FG002|Overall Study|Withdrawal by Subject|17|||
163439028|NCT01001494|590309605|FG000|Overall Study|COPD exacerbation|3|||
163439029|NCT01001494|590309606|FG001|Overall Study|COPD exacerbation|4|||
163439030|NCT01001494|590309607|FG002|Overall Study|COPD exacerbation|5|||
163439031|NCT01001494|590309605|FG000|Overall Study|Lack of Efficacy|2|||
163439032|NCT01001494|590309606|FG001|Overall Study|Lack of Efficacy|0|||
163439033|NCT01001494|590309607|FG002|Overall Study|Lack of Efficacy|8|||
163439034|NCT01001494|590309605|FG000|Overall Study|Other|0|||
163439035|NCT01001494|590309606|FG001|Overall Study|Other|1|||
163439036|NCT01001494|590309607|FG002|Overall Study|Other|3|||
163439037|NCT02179398|590309608|FG000|Overall Study|Lack of obligatory data|3|||
163439038|NCT02179398|590309609|FG001|Overall Study|Lack of obligatory data|3|||
163439039|NCT02179398|590309608|FG000|Overall Study|Lost to Follow-up|0|||
163439040|NCT02179398|590309609|FG001|Overall Study|Lost to Follow-up|1|||
163439041|NCT00408681|590309613|FG000|Overall Study|Lack of Efficacy|2|||
163439042|NCT00408681|590309613|FG000|Overall Study|Adverse Event|7|||
163439043|NCT01787591|590309618|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
163439044|NCT01787591|590309619|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
163439045|NCT01787591|590309620|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
163439046|NCT01787591|590309621|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
163439047|NCT02489630|590309624|FG000|Overall Study|Oversedation|1|||
163439048|NCT02489630|590309625|FG001|Overall Study|Oversedation|1|||
163439049|NCT02489630|590309624|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
163439050|NCT02489630|590309625|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
163439051|NCT00377299|590309626|FG000|Overall Study|Lost to Follow-up|14|||
163439052|NCT00377299|590309627|FG001|Overall Study|Lost to Follow-up|19|||
163439053|NCT00377299|590309626|FG000|Overall Study|Adverse Event|0|||
163439054|NCT00377299|590309627|FG001|Overall Study|Adverse Event|1|||
163439055|NCT00377299|590309626|FG000|Overall Study|Withdrawal by Subject|5|||
163439056|NCT00377299|590309627|FG001|Overall Study|Withdrawal by Subject|4|||
163439057|NCT05270694|590311428|FG000|Overall Study|Death|1|||
163439058|NCT05270694|590311428|FG000|Overall Study|Medical issues impacted ability to participate|2|||
163439059|NCT05270694|590311428|FG000|Overall Study|Lost to Follow-up|3|||
163439060|NCT05270694|590311428|FG000|Overall Study|Withdrawal by Subject|3|||
163439061|NCT04267562|590311431|FG000|Assessed for Eligibility|Screen Failure|64|||
163439062|NCT04267562|590311431|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
163439063|NCT04267562|590311431|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
163439064|NCT04267562|590311431|FG000|Assessed for Eligibility|Site closure|6|||
163439065|NCT04267562|590311431|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
163439066|NCT04267562|590311431|FG000|Assessed for Eligibility|Physician Decision|1|||
163439067|NCT04267562|590311431|FG000|Month 24|Elective hysterectomy|1|||
163439068|NCT04267562|590311431|FG000|Month 24|Lost to Follow-up|1|||
163439069|NCT04267562|590311431|FG000|Month 36|Elective hysterectomy|2|||
163439070|NCT04267562|590311431|FG000|Month 36|Lost to Follow-up|3|||
163439071|NCT03270085|590311437|FG000|Overall Study|Withdrawal by Subject|1|||
163439072|NCT03270085|590311438|FG001|Overall Study|Withdrawal by Subject|0|||
163439073|NCT03825042|590311439|FG000|Overall Study|Adverse Event|1|||
163439074|NCT03825042|590311440|FG001|Overall Study|Adverse Event|0|||
163439075|NCT03825042|590311439|FG000|Overall Study|Withdrawal by Subject|1|||
163439076|NCT03825042|590311440|FG001|Overall Study|Withdrawal by Subject|0|||
163439077|NCT00521339|590311443|FG000|Treatment Phase|Adverse Event|2|||
163439078|NCT00521339|590311444|FG001|Treatment Phase|Adverse Event|0|||
163439079|NCT00521339|590311445|FG002|Treatment Phase|Adverse Event|0|||
163439080|NCT00521339|590311443|FG000|Treatment Phase|Intolerability to study drug|2|||
163439081|NCT00521339|590311444|FG001|Treatment Phase|Intolerability to study drug|0|||
163439082|NCT00521339|590311445|FG002|Treatment Phase|Intolerability to study drug|0|||
163439083|NCT00521339|590311443|FG000|Treatment Phase|Lack of Efficacy|3|||
163439084|NCT00521339|590311444|FG001|Treatment Phase|Lack of Efficacy|0|||
163439085|NCT00521339|590311445|FG002|Treatment Phase|Lack of Efficacy|0|||
163439086|NCT00521339|590311443|FG000|Treatment Phase|Withdrawal by Subject|3|||
163439087|NCT00521339|590311444|FG001|Treatment Phase|Withdrawal by Subject|0|||
163439088|NCT00521339|590311445|FG002|Treatment Phase|Withdrawal by Subject|0|||
163439089|NCT00521339|590311443|FG000|Treatment Phase|Lost to Follow-up|1|||
163439090|NCT00521339|590311444|FG001|Treatment Phase|Lost to Follow-up|0|||
163439091|NCT00521339|590311445|FG002|Treatment Phase|Lost to Follow-up|0|||
163439092|NCT00521339|590311443|FG000|Treatment Phase|Protocol Violation|1|||
163439093|NCT00521339|590311444|FG001|Treatment Phase|Protocol Violation|0|||
163439094|NCT00521339|590311445|FG002|Treatment Phase|Protocol Violation|0|||
163439095|NCT00521339|590311443|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
163439096|NCT00521339|590311444|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
163439097|NCT00521339|590311445|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
163439098|NCT00521339|590311443|FG000|Treatment Extension Phase|Death|0|||
163439099|NCT00521339|590311444|FG001|Treatment Extension Phase|Death|0|||
163439100|NCT00521339|590311445|FG002|Treatment Extension Phase|Death|1|||
163439101|NCT03314519|590311446|FG000|Overall Study|Protocol Violation|3|||
163439102|NCT03314519|590311447|FG001|Overall Study|Protocol Violation|2|||
163439103|NCT04003155|590311450|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
163439104|NCT04003155|590311451|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
163439105|NCT04003155|590311452|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
163439106|NCT04003155|590311453|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
163439107|NCT04003155|590311454|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
163439108|NCT04003155|590311450|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
163439109|NCT04003155|590311451|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
163439110|NCT04003155|590311452|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
163439111|NCT04003155|590311453|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
163439112|NCT04003155|590311454|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
163439113|NCT04003155|590311450|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
163439114|NCT04003155|590311451|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
163439115|NCT04003155|590311452|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
163439116|NCT04003155|590311453|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
163439117|NCT04003155|590311454|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
163439118|NCT04003155|590311450|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
163439119|NCT04003155|590311451|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
163439120|NCT04003155|590311452|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
163439121|NCT04003155|590311453|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
163439122|NCT04003155|590311454|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
163439123|NCT04003155|590311450|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
163439124|NCT04003155|590311451|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
163439125|NCT04003155|590311452|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
163439126|NCT04003155|590311453|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
163439127|NCT04003155|590311454|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
163439128|NCT04003155|590311450|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
163439129|NCT04003155|590311451|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
163439130|NCT04003155|590311452|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
163439131|NCT04003155|590311453|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
163439132|NCT04003155|590311454|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
163439133|NCT04003155|590311450|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
163439134|NCT04003155|590311451|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
163439135|NCT04003155|590311452|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
163439136|NCT04003155|590311453|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
163439137|NCT04003155|590311454|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
163439138|NCT04003155|590311450|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
163439139|NCT04003155|590311451|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
163439140|NCT04003155|590311452|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
163439141|NCT04003155|590311453|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
163439142|NCT04003155|590311454|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
163439143|NCT04003155|590311450|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
163439144|NCT04003155|590311451|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
163439145|NCT04003155|590311452|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
163439146|NCT04003155|590311453|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
163439147|NCT04003155|590311454|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
163439148|NCT01912872|590311455|FG000|Overall Study|Lost to Follow-up|2|||
163439149|NCT01912872|590311456|FG001|Overall Study|Lost to Follow-up|3|||
163439150|NCT01912872|590311457|FG002|Overall Study|Lost to Follow-up|5|||
163439151|NCT01912872|590311458|FG003|Overall Study|Lost to Follow-up|5|||
163439152|NCT01912872|590311455|FG000|Overall Study|Other unspecified|3|||
163439153|NCT01912872|590311456|FG001|Overall Study|Other unspecified|1|||
163439154|NCT01912872|590311457|FG002|Overall Study|Other unspecified|3|||
163439155|NCT01912872|590311458|FG003|Overall Study|Other unspecified|0|||
163439156|NCT01912872|590311455|FG000|Overall Study|Informed consent withdrawn|0|||
163439157|NCT01912872|590311456|FG001|Overall Study|Informed consent withdrawn|0|||
163439158|NCT01912872|590311457|FG002|Overall Study|Informed consent withdrawn|1|||
163439159|NCT01912872|590311458|FG003|Overall Study|Informed consent withdrawn|1|||
163439160|NCT01912872|590311455|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
163439161|NCT01912872|590311456|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
163439162|NCT01912872|590311457|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
163439163|NCT01912872|590311458|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
163439164|NCT01912872|590311455|FG000|Overall Study|Protocol Violation|0|||
163439165|NCT01912872|590311456|FG001|Overall Study|Protocol Violation|0|||
163439166|NCT01912872|590311457|FG002|Overall Study|Protocol Violation|1|||
163439167|NCT01912872|590311458|FG003|Overall Study|Protocol Violation|0|||
163439168|NCT01912872|590311455|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163439169|NCT01912872|590311456|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163439170|NCT01912872|590311457|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
163439171|NCT01912872|590311458|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
163439172|NCT01912872|590311455|FG000|Overall Study|Withdrawal of study medication|0|||
163439173|NCT01912872|590311456|FG001|Overall Study|Withdrawal of study medication|0|||
163439174|NCT01912872|590311457|FG002|Overall Study|Withdrawal of study medication|0|||
163439175|NCT01912872|590311458|FG003|Overall Study|Withdrawal of study medication|2|||
163439176|NCT01912872|590311455|FG000|Overall Study|Missing|0|||
163439177|NCT01912872|590311456|FG001|Overall Study|Missing|0|||
163439178|NCT01912872|590311457|FG002|Overall Study|Missing|0|||
163439179|NCT01912872|590311458|FG003|Overall Study|Missing|1|||
163439180|NCT01277289|590311460|FG000|Overall Study|fragile vein|1|||
163439181|NCT01277289|590311461|FG001|Overall Study|fragile vein|0|||
163439182|NCT01277289|590311460|FG000|Overall Study|Physician Decision|1|||
163439183|NCT01277289|590311461|FG001|Overall Study|Physician Decision|0|||
163439184|NCT01277289|590311460|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
163439185|NCT01277289|590311461|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
163439186|NCT01277289|590311460|FG000|Overall Study|Protocol Violation|1|||
163439187|NCT01277289|590311461|FG001|Overall Study|Protocol Violation|1|||
163439188|NCT01277289|590311460|FG000|Overall Study|Adverse Event|2|||
163439189|NCT01277289|590311461|FG001|Overall Study|Adverse Event|1|||
163439190|NCT01277289|590311460|FG000|Overall Study|consent withdrawn|1|||
163439191|NCT01277289|590311461|FG001|Overall Study|consent withdrawn|1|||
163439192|NCT01277289|590311460|FG000|Overall Study|premature closure of the study|4|||
163439193|NCT01277289|590311461|FG001|Overall Study|premature closure of the study|2|||
163439194|NCT04760314|590311464|FG000|Induction Period|Withdrawal by Subject|0|||
163439195|NCT04760314|590311465|FG001|Induction Period|Withdrawal by Subject|1|||
163439196|NCT04760314|590311466|FG002|Induction Period|Withdrawal by Subject|1|||
163439197|NCT04760314|590311467|FG003|Induction Period|Withdrawal by Subject|0|||
163439198|NCT04760314|590311468|FG004|Induction Period|Withdrawal by Subject|0|||
163439199|NCT04760314|590311469|FG005|Induction Period|Withdrawal by Subject|0|||
163439200|NCT04760314|590311470|FG006|Induction Period|Withdrawal by Subject|0|||
163439201|NCT04760314|590311471|FG007|Induction Period|Withdrawal by Subject|0|||
163439202|NCT04760314|590311472|FG008|Induction Period|Withdrawal by Subject|0|||
163439203|NCT04760314|590311473|FG009|Induction Period|Withdrawal by Subject|0|||
163439204|NCT04760314|590311474|FG010|Induction Period|Withdrawal by Subject|0|||
163439205|NCT04760314|590311464|FG000|Induction Period|Adverse Event|0|||
163439206|NCT04760314|590311465|FG001|Induction Period|Adverse Event|0|||
163439207|NCT04760314|590311466|FG002|Induction Period|Adverse Event|2|||
163439208|NCT04760314|590311467|FG003|Induction Period|Adverse Event|0|||
163439209|NCT04760314|590311468|FG004|Induction Period|Adverse Event|0|||
163439210|NCT04760314|590311469|FG005|Induction Period|Adverse Event|0|||
163439211|NCT04760314|590311470|FG006|Induction Period|Adverse Event|0|||
163439212|NCT04760314|590311471|FG007|Induction Period|Adverse Event|0|||
163439213|NCT04760314|590311472|FG008|Induction Period|Adverse Event|0|||
163439214|NCT04760314|590311473|FG009|Induction Period|Adverse Event|0|||
163439215|NCT04760314|590311474|FG010|Induction Period|Adverse Event|0|||
163439216|NCT04760314|590311464|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
163439217|NCT04760314|590311465|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
163439218|NCT04760314|590311466|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
163439219|NCT04760314|590311467|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
163439220|NCT04760314|590311468|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
163439221|NCT04760314|590311469|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
163439222|NCT04760314|590311470|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
163439223|NCT04760314|590311471|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
163439224|NCT04760314|590311472|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
163439225|NCT04760314|590311473|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
163439226|NCT04760314|590311474|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
163439227|NCT04760314|590311464|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
163439228|NCT04760314|590311465|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
163439229|NCT04760314|590311466|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
163439230|NCT04760314|590311467|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
163439231|NCT04760314|590311468|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
163439232|NCT04760314|590311469|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
163439233|NCT04760314|590311470|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
163439234|NCT04760314|590311471|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
163439235|NCT04760314|590311472|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
163439236|NCT04760314|590311473|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
163439237|NCT04760314|590311474|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
163439238|NCT04760314|590311464|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
163439239|NCT04760314|590311465|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
163439240|NCT04760314|590311466|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
163439241|NCT04760314|590311467|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
163439242|NCT04760314|590311468|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
163439243|NCT04760314|590311469|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
163439244|NCT04760314|590311470|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
163439245|NCT04760314|590311471|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
163439246|NCT04760314|590311472|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
163439247|NCT04760314|590311473|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
163439248|NCT04760314|590311474|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
163439249|NCT04760314|590311464|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
163439250|NCT04760314|590311465|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
163439251|NCT04760314|590311466|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
163439252|NCT04760314|590311467|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
163439253|NCT04760314|590311468|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
163439254|NCT04760314|590311469|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
163439255|NCT04760314|590311470|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
163439256|NCT04760314|590311471|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
163439257|NCT04760314|590311472|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
163439258|NCT04760314|590311473|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
163439259|NCT04760314|590311474|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
163439260|NCT04760314|590311464|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163439261|NCT04760314|590311465|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163439262|NCT04760314|590311466|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163439263|NCT04760314|590311467|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163439264|NCT04760314|590311468|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163439265|NCT04760314|590311469|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163439266|NCT04760314|590311470|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163439267|NCT04760314|590311471|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
163439268|NCT04760314|590311472|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163439269|NCT04760314|590311473|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
163439270|NCT04760314|590311474|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
163439271|NCT04760314|590311464|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163439272|NCT04760314|590311465|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163439273|NCT04760314|590311466|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163439274|NCT04760314|590311467|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163439275|NCT04760314|590311468|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163439276|NCT04760314|590311469|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163439277|NCT04760314|590311470|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163439278|NCT04760314|590311471|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
163439279|NCT04760314|590311472|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
163439280|NCT04760314|590311473|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
163439281|NCT04760314|590311474|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163439282|NCT04760314|590311464|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163439283|NCT04760314|590311465|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163439284|NCT04760314|590311466|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163439285|NCT04760314|590311467|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163439286|NCT04760314|590311468|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163439287|NCT04760314|590311469|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163439288|NCT04760314|590311470|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163439289|NCT04760314|590311471|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
163439290|NCT04760314|590311472|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163439291|NCT04760314|590311473|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163439292|NCT04760314|590311474|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163439293|NCT04760314|590311464|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
163439294|NCT04760314|590311465|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
163439295|NCT04760314|590311466|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
163439296|NCT04760314|590311467|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
163439297|NCT04760314|590311468|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
163439298|NCT04760314|590311469|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
163439299|NCT04760314|590311470|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
163439300|NCT04760314|590311471|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
163439301|NCT04760314|590311472|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
163439302|NCT04760314|590311473|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
163439303|NCT04760314|590311474|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
163439304|NCT01013883|590311477|FG000|Overall Study|Lost to Follow-up|2|||
163439305|NCT01013883|590311478|FG001|Overall Study|Lost to Follow-up|2|||
163439306|NCT01371838|590311479|FG000|Overall Study|Withdrawal by Subject|27|||
163439307|NCT01371838|590311480|FG001|Overall Study|Withdrawal by Subject|33|||
163439308|NCT01371838|590311479|FG000|Overall Study|Lost to Follow-up|10|||
163439309|NCT01371838|590311480|FG001|Overall Study|Lost to Follow-up|20|||
163439310|NCT01371838|590311479|FG000|Overall Study|Death|3|||
163439311|NCT01371838|590311480|FG001|Overall Study|Death|4|||
163439312|NCT01371838|590311479|FG000|Overall Study|Protocol Violation|3|||
163439313|NCT01371838|590311480|FG001|Overall Study|Protocol Violation|0|||
163439314|NCT01371838|590311479|FG000|Overall Study|Investigator Decision|3|||
163439315|NCT01371838|590311480|FG001|Overall Study|Investigator Decision|8|||
163439316|NCT01371838|590311479|FG000|Overall Study|Last follow-up visit not conducted|2|||
163439317|NCT01371838|590311480|FG001|Overall Study|Last follow-up visit not conducted|0|||
163439318|NCT01371838|590311479|FG000|Overall Study|Lack of therapeutic response|0|||
163439319|NCT01371838|590311480|FG001|Overall Study|Lack of therapeutic response|1|||
163439320|NCT01371838|590311479|FG000|Overall Study|Surgery|1|||
163439321|NCT01371838|590311480|FG001|Overall Study|Surgery|0|||
163439322|NCT02241512|590311483|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
163439323|NCT02241512|590311484|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
163439324|NCT00641043|590311487|FG000|Overall Study|Adverse Event|6|||
163439325|NCT00641043|590311488|FG001|Overall Study|Adverse Event|4|||
163439326|NCT00641043|590311487|FG000|Overall Study|Protocol Violation|2|||
163439327|NCT00641043|590311488|FG001|Overall Study|Protocol Violation|3|||
163439328|NCT00641043|590311487|FG000|Overall Study|Lost to Follow-up|3|||
163439329|NCT00641043|590311488|FG001|Overall Study|Lost to Follow-up|2|||
163439330|NCT00641043|590311487|FG000|Overall Study|Withdrawal by Subject|4|||
163439331|NCT00641043|590311488|FG001|Overall Study|Withdrawal by Subject|4|||
163439332|NCT00641043|590311487|FG000|Overall Study|Other incl. lack of efficacy|4|||
163439333|NCT00641043|590311488|FG001|Overall Study|Other incl. lack of efficacy|2|||
163439334|NCT04275310|590311489|FG000|Overall Study|Non-randomized due to running out of funding|4|||
163439335|NCT04275310|590311490|FG001|Overall Study|Non-randomized due to running out of funding|0|||
163439336|NCT00972244|590311491|FG000|Overall Study|Incorrect Enrolment|1|||
163439337|NCT00972244|590311492|FG001|Overall Study|Incorrect Enrolment|0|||
163439338|NCT00972244|590311493|FG002|Overall Study|Incorrect Enrolment|0|||
163439339|NCT00972244|590311494|FG003|Overall Study|Incorrect Enrolment|0|||
163439340|NCT00972244|590311495|FG004|Overall Study|Incorrect Enrolment|0|||
163439341|NCT00972244|590311491|FG000|Overall Study|Adverse Event|0|||
163439342|NCT00972244|590311492|FG001|Overall Study|Adverse Event|1|||
163439343|NCT00972244|590311493|FG002|Overall Study|Adverse Event|1|||
163439344|NCT00972244|590311494|FG003|Overall Study|Adverse Event|0|||
163439345|NCT00972244|590311495|FG004|Overall Study|Adverse Event|0|||
163439346|NCT00972244|590311491|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
163439347|NCT00972244|590311492|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
163439348|NCT00972244|590311493|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
163439349|NCT00972244|590311494|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
163439350|NCT00972244|590311495|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
163439351|NCT00972244|590311491|FG000|Overall Study|Withdrawal by Subject|1|||
163439352|NCT00972244|590311492|FG001|Overall Study|Withdrawal by Subject|2|||
163439353|NCT00972244|590311493|FG002|Overall Study|Withdrawal by Subject|1|||
163439354|NCT00972244|590311494|FG003|Overall Study|Withdrawal by Subject|0|||
163439355|NCT00972244|590311495|FG004|Overall Study|Withdrawal by Subject|1|||
163439356|NCT00972244|590311491|FG000|Overall Study|Safety|0|||
163439357|NCT00972244|590311492|FG001|Overall Study|Safety|0|||
163439358|NCT00972244|590311493|FG002|Overall Study|Safety|0|||
163439359|NCT00972244|590311494|FG003|Overall Study|Safety|0|||
163439360|NCT00972244|590311495|FG004|Overall Study|Safety|1|||
163439361|NCT00972244|590311491|FG000|Overall Study|Death|1|||
163439362|NCT00972244|590311492|FG001|Overall Study|Death|0|||
163439363|NCT00972244|590311493|FG002|Overall Study|Death|0|||
163439364|NCT00972244|590311494|FG003|Overall Study|Death|0|||
163439365|NCT00972244|590311495|FG004|Overall Study|Death|0|||
163439366|NCT00972244|590311491|FG000|Overall Study|Various|0|||
163439367|NCT00972244|590311492|FG001|Overall Study|Various|0|||
163439368|NCT00972244|590311493|FG002|Overall Study|Various|0|||
163439369|NCT00972244|590311494|FG003|Overall Study|Various|0|||
163439370|NCT00972244|590311495|FG004|Overall Study|Various|2|||
163439371|NCT03648476|590311496|FG000|Overall Study|Withdrawal by Subject|2|||
163439372|NCT03648476|590311497|FG001|Overall Study|Withdrawal by Subject|1|||
163439373|NCT00907881|590311498|FG000|Overall Study|Lost to Follow-up|59|||
163439374|NCT00907881|590311498|FG000|Overall Study|Noncompliance|5|||
163439375|NCT00907881|590311498|FG000|Overall Study|Withdrawal by Subject|5|||
163439376|NCT00907881|590311498|FG000|Overall Study|Protocol Violation|1|||
163439377|NCT00907881|590311498|FG000|Overall Study|Missing discontinuation information|15|||
163439378|NCT01097616|590311499|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
163439379|NCT01097616|590311500|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
163439380|NCT01097616|590311501|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
163439381|NCT01097616|590311502|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
163439382|NCT01097616|590311503|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
163439383|NCT01097616|590311504|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
163439384|NCT01097616|590311505|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
163439385|NCT01097616|590311506|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
163439386|NCT01097616|590311499|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
163439387|NCT01097616|590311500|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
163439388|NCT01097616|590311501|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
163439389|NCT01097616|590311502|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
163439390|NCT01097616|590311503|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
163439391|NCT01097616|590311504|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
163439392|NCT01097616|590311505|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
163439393|NCT01097616|590311506|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
163439394|NCT01097616|590311499|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
163439395|NCT01097616|590311500|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
163439396|NCT01097616|590311501|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
163439397|NCT01097616|590311502|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
163439398|NCT01097616|590311503|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
163439399|NCT01097616|590311504|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
163439400|NCT01097616|590311505|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
163439401|NCT01097616|590311506|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
163439402|NCT01097616|590311499|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
163439403|NCT01097616|590311500|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
163439404|NCT01097616|590311501|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163439405|NCT01097616|590311502|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163439406|NCT01097616|590311503|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163439407|NCT01097616|590311504|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163439408|NCT01097616|590311505|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163439409|NCT01097616|590311506|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163439410|NCT01097616|590311499|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
163439411|NCT01097616|590311500|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
163439412|NCT01097616|590311501|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
163439413|NCT01097616|590311502|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
163439414|NCT01097616|590311503|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
163439415|NCT01097616|590311504|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
163439416|NCT01097616|590311505|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
163439417|NCT01097616|590311506|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
163439418|NCT01097616|590311499|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
163439419|NCT01097616|590311500|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
163439420|NCT01097616|590311501|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
163439421|NCT01097616|590311502|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
163439422|NCT01097616|590311503|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
163439423|NCT01097616|590311504|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
163439424|NCT01097616|590311505|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
163439425|NCT01097616|590311506|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
163439426|NCT01097616|590311499|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
163439427|NCT01097616|590311500|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
163439428|NCT01097616|590311501|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163439429|NCT01097616|590311502|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163439430|NCT01097616|590311503|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163439431|NCT01097616|590311504|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163439432|NCT01097616|590311505|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163439433|NCT01097616|590311506|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163439434|NCT01097616|590311499|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163439435|NCT01097616|590311500|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163439436|NCT01097616|590311501|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
163439437|NCT01097616|590311502|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163439438|NCT01097616|590311503|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163439439|NCT01097616|590311504|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163439440|NCT01097616|590311505|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163439441|NCT01097616|590311506|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163439442|NCT01097616|590311499|FG000|Optional DB EXT Phase|Adverse Event|0|||
163439443|NCT01097616|590311500|FG001|Optional DB EXT Phase|Adverse Event|7|||
163439444|NCT01097616|590311501|FG002|Optional DB EXT Phase|Adverse Event|2|||
163439445|NCT01097616|590311502|FG003|Optional DB EXT Phase|Adverse Event|0|||
163439446|NCT01097616|590311503|FG004|Optional DB EXT Phase|Adverse Event|0|||
163439447|NCT01097616|590311504|FG005|Optional DB EXT Phase|Adverse Event|0|||
163439448|NCT01097616|590311505|FG006|Optional DB EXT Phase|Adverse Event|0|||
163439449|NCT01097616|590311506|FG007|Optional DB EXT Phase|Adverse Event|0|||
163439450|NCT01097616|590311499|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
163439451|NCT01097616|590311500|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
163439452|NCT01097616|590311501|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
163439453|NCT01097616|590311502|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
163439454|NCT01097616|590311503|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
163439455|NCT01097616|590311504|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
163439456|NCT01097616|590311505|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
163439457|NCT01097616|590311506|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
163439458|NCT01097616|590311499|FG000|Optional DB EXT Phase|Protocol Violation|0|||
163439459|NCT01097616|590311500|FG001|Optional DB EXT Phase|Protocol Violation|2|||
163439460|NCT01097616|590311501|FG002|Optional DB EXT Phase|Protocol Violation|3|||
163439461|NCT01097616|590311502|FG003|Optional DB EXT Phase|Protocol Violation|0|||
163439462|NCT01097616|590311503|FG004|Optional DB EXT Phase|Protocol Violation|0|||
163439463|NCT01097616|590311504|FG005|Optional DB EXT Phase|Protocol Violation|0|||
163439464|NCT01097616|590311505|FG006|Optional DB EXT Phase|Protocol Violation|0|||
163439465|NCT01097616|590311506|FG007|Optional DB EXT Phase|Protocol Violation|0|||
163439466|NCT01097616|590311499|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
163439467|NCT01097616|590311500|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
163439468|NCT01097616|590311501|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
163439469|NCT01097616|590311502|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
163439470|NCT01097616|590311503|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
163439471|NCT01097616|590311504|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
163439472|NCT01097616|590311505|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
163439473|NCT01097616|590311506|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
163439474|NCT01097616|590311499|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
163439475|NCT01097616|590311500|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
163439476|NCT01097616|590311501|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
163439477|NCT01097616|590311502|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
163439478|NCT01097616|590311503|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
163439479|NCT01097616|590311504|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
163439480|NCT01097616|590311505|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
163439481|NCT01097616|590311506|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
163439482|NCT01097616|590311499|FG000|Optional DB EXT Phase|Physician Decision|1|||
163439483|NCT01097616|590311500|FG001|Optional DB EXT Phase|Physician Decision|0|||
163439484|NCT01097616|590311501|FG002|Optional DB EXT Phase|Physician Decision|0|||
163439485|NCT01097616|590311502|FG003|Optional DB EXT Phase|Physician Decision|0|||
163439486|NCT01097616|590311503|FG004|Optional DB EXT Phase|Physician Decision|0|||
163439487|NCT01097616|590311504|FG005|Optional DB EXT Phase|Physician Decision|0|||
163439488|NCT01097616|590311505|FG006|Optional DB EXT Phase|Physician Decision|0|||
163439489|NCT01097616|590311506|FG007|Optional DB EXT Phase|Physician Decision|0|||
163439490|NCT01097616|590311499|FG000|DB RO Phase|Adverse Event|0|||
163439491|NCT01097616|590311500|FG001|DB RO Phase|Adverse Event|0|||
163439492|NCT01097616|590311501|FG002|DB RO Phase|Adverse Event|0|||
163439493|NCT01097616|590311502|FG003|DB RO Phase|Adverse Event|0|||
163439494|NCT01097616|590311503|FG004|DB RO Phase|Adverse Event|0|||
163439495|NCT01097616|590311504|FG005|DB RO Phase|Adverse Event|0|||
163439496|NCT01097616|590311505|FG006|DB RO Phase|Adverse Event|1|||
163439497|NCT01097616|590311506|FG007|DB RO Phase|Adverse Event|0|||
163439498|NCT01097616|590311499|FG000|DB RO Phase|Withdrawal by Subject|0|||
163439499|NCT01097616|590311500|FG001|DB RO Phase|Withdrawal by Subject|0|||
163439500|NCT01097616|590311501|FG002|DB RO Phase|Withdrawal by Subject|0|||
163439501|NCT01097616|590311502|FG003|DB RO Phase|Withdrawal by Subject|0|||
163439502|NCT01097616|590311503|FG004|DB RO Phase|Withdrawal by Subject|0|||
163439503|NCT01097616|590311504|FG005|DB RO Phase|Withdrawal by Subject|1|||
163439504|NCT01097616|590311505|FG006|DB RO Phase|Withdrawal by Subject|0|||
163439505|NCT01097616|590311506|FG007|DB RO Phase|Withdrawal by Subject|0|||
163439506|NCT01097616|590311499|FG000|DB RO Phase|Lost to Follow-up|0|||
163439507|NCT01097616|590311500|FG001|DB RO Phase|Lost to Follow-up|0|||
163439508|NCT01097616|590311501|FG002|DB RO Phase|Lost to Follow-up|0|||
163439509|NCT01097616|590311502|FG003|DB RO Phase|Lost to Follow-up|1|||
163439510|NCT01097616|590311503|FG004|DB RO Phase|Lost to Follow-up|1|||
163439511|NCT01097616|590311504|FG005|DB RO Phase|Lost to Follow-up|0|||
163439512|NCT01097616|590311505|FG006|DB RO Phase|Lost to Follow-up|0|||
163439513|NCT01097616|590311506|FG007|DB RO Phase|Lost to Follow-up|1|||
163439514|NCT01097616|590311499|FG000|DB RO Phase|Not Treated in RO|0|||
163439515|NCT01097616|590311500|FG001|DB RO Phase|Not Treated in RO|0|||
163439516|NCT01097616|590311501|FG002|DB RO Phase|Not Treated in RO|0|||
163439517|NCT01097616|590311502|FG003|DB RO Phase|Not Treated in RO|0|||
163439518|NCT01097616|590311503|FG004|DB RO Phase|Not Treated in RO|0|||
163439519|NCT01097616|590311504|FG005|DB RO Phase|Not Treated in RO|1|||
163439520|NCT01097616|590311505|FG006|DB RO Phase|Not Treated in RO|0|||
163439521|NCT01097616|590311506|FG007|DB RO Phase|Not Treated in RO|0|||
163439522|NCT04101422|590311509|FG000|Overall Study|Ineligible|1|||
163439523|NCT04101422|590311510|FG001|Overall Study|Ineligible|0|||
163439524|NCT04101422|590311511|FG002|Overall Study|Ineligible|9|||
163439525|NCT04101422|590311512|FG003|Overall Study|Ineligible|0|||
163439526|NCT04101422|590311509|FG000|Overall Study|Withdrawal by Subject|0|||
163439527|NCT04101422|590311510|FG001|Overall Study|Withdrawal by Subject|0|||
163439528|NCT04101422|590311511|FG002|Overall Study|Withdrawal by Subject|1|||
163439529|NCT04101422|590311512|FG003|Overall Study|Withdrawal by Subject|0|||
163439530|NCT04101422|590311509|FG000|Overall Study|Not attending to the stimuli|0|||
163439531|NCT04101422|590311510|FG001|Overall Study|Not attending to the stimuli|0|||
163439532|NCT04101422|590311511|FG002|Overall Study|Not attending to the stimuli|4|||
163439533|NCT04101422|590311512|FG003|Overall Study|Not attending to the stimuli|0|||
163439534|NCT04101422|590311509|FG000|Overall Study|Did not download app|0|||
163439535|NCT04101422|590311510|FG001|Overall Study|Did not download app|0|||
163439536|NCT04101422|590311511|FG002|Overall Study|Did not download app|0|||
163439537|NCT04101422|590311512|FG003|Overall Study|Did not download app|17|||
163439538|NCT04101422|590311509|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
163439539|NCT04101422|590311510|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
163439540|NCT04101422|590311511|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
163439541|NCT04101422|590311512|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
163439542|NCT01174784|590311513|FG000|Overall Study|Screen fails|4|||
163439543|NCT01214434|590311518|FG000|Overall Study|Withdrawal by Subject|1|||
163439544|NCT01214434|590311519|FG001|Overall Study|Withdrawal by Subject|0|||
163439545|NCT01214434|590311518|FG000|Overall Study|Lost to Follow-up|2|||
163439546|NCT01214434|590311519|FG001|Overall Study|Lost to Follow-up|2|||
163439547|NCT01214434|590311518|FG000|Overall Study|Site error|1|||
163439548|NCT01214434|590311519|FG001|Overall Study|Site error|0|||
163439549|NCT02075255|590311521|FG000|Overall Study|Study specific withdrawal criteria|0|||
163439550|NCT02075255|590311522|FG001|Overall Study|Study specific withdrawal criteria|1|||
163439551|NCT02075255|590311523|FG002|Overall Study|Study specific withdrawal criteria|1|||
163439552|NCT02075255|590311521|FG000|Overall Study|Withdrawal by Subject|4|||
163439553|NCT02075255|590311522|FG001|Overall Study|Withdrawal by Subject|1|||
163439554|NCT02075255|590311523|FG002|Overall Study|Withdrawal by Subject|0|||
163439555|NCT02075255|590311521|FG000|Overall Study|Lost to Follow-up|0|||
163439556|NCT02075255|590311522|FG001|Overall Study|Lost to Follow-up|0|||
163439557|NCT02075255|590311523|FG002|Overall Study|Lost to Follow-up|1|||
163439558|NCT02075255|590311521|FG000|Overall Study|Adverse Event|0|||
163439559|NCT02075255|590311522|FG001|Overall Study|Adverse Event|0|||
163439560|NCT02075255|590311523|FG002|Overall Study|Adverse Event|1|||
163439561|NCT02075255|590311521|FG000|Overall Study|Death|0|||
163439562|NCT02075255|590311522|FG001|Overall Study|Death|2|||
163439563|NCT02075255|590311523|FG002|Overall Study|Death|0|||
163439564|NCT03792750|590311524|FG000|Overall Study|Death|3|||
163439565|NCT01879618|590311529|FG000|Overall Study|Does not meet entrance criteria|1|||
163439566|NCT01879618|590311529|FG000|Overall Study|Withdrawal by Subject|1|||
163439567|NCT01879618|590311529|FG000|Overall Study|Surgery;changed schedule; not available|8|||
163439568|NCT01879618|590311529|FG000|Overall Study|Protocol Violation|6|||
163439569|NCT01879618|590311529|FG000|Overall Study|Adverse Event|5|||
163439570|NCT00394914|590311530|FG000|Treatment Period|Adverse Event|0|||
163439571|NCT00394914|590311531|FG001|Treatment Period|Adverse Event|3|||
163439572|NCT00394914|590311532|FG002|Treatment Period|Adverse Event|1|||
163439573|NCT00394914|590311530|FG000|Treatment Period|Lost to Follow-up|0|||
163439574|NCT00394914|590311531|FG001|Treatment Period|Lost to Follow-up|1|||
163439575|NCT00394914|590311532|FG002|Treatment Period|Lost to Follow-up|0|||
163439576|NCT00394914|590311530|FG000|Treatment Period|Withdrawal by Subject|0|||
163439577|NCT00394914|590311531|FG001|Treatment Period|Withdrawal by Subject|2|||
163439578|NCT00394914|590311532|FG002|Treatment Period|Withdrawal by Subject|2|||
163439579|NCT00394914|590311530|FG000|Treatment Period|Noncompliance with protocol|0|||
163439580|NCT00394914|590311531|FG001|Treatment Period|Noncompliance with protocol|3|||
163439581|NCT00394914|590311532|FG002|Treatment Period|Noncompliance with protocol|2|||
163439582|NCT00394914|590311530|FG000|Treatment Period|Did not meet protocol eligibility|0|||
163439583|NCT00394914|590311531|FG001|Treatment Period|Did not meet protocol eligibility|1|||
163439584|NCT00394914|590311532|FG002|Treatment Period|Did not meet protocol eligibility|1|||
163439585|NCT00465738|590311543|FG000|Overall Study|Lost to Follow-up|2|||
163439586|NCT00465738|590311544|FG001|Overall Study|Lost to Follow-up|0|||
163439587|NCT00465738|590311543|FG000|Overall Study|Adverse Event|0|||
163439588|NCT00465738|590311544|FG001|Overall Study|Adverse Event|1|||
163439589|NCT00465738|590311543|FG000|Overall Study|Withdrawal by Subject|2|||
163439590|NCT00465738|590311544|FG001|Overall Study|Withdrawal by Subject|0|||
163439591|NCT00465738|590311543|FG000|Overall Study|Other|2|||
163439592|NCT00465738|590311544|FG001|Overall Study|Other|5|||
163439593|NCT00734929|590311545|FG000|Overall Study|Lost to Follow-up|1|||
163439594|NCT00734929|590311546|FG001|Overall Study|Lost to Follow-up|2|||
163439595|NCT00734929|590311545|FG000|Overall Study|No intervention/ screen fail|5|||
163439596|NCT00734929|590311546|FG001|Overall Study|No intervention/ screen fail|3|||
163439597|NCT01863758|590311547|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
163439598|NCT01863758|590311547|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
163439599|NCT02961764|590311548|FG000|Overall Study|Protocol Violation|0|||
163439600|NCT02961764|590311549|FG001|Overall Study|Protocol Violation|1|||
163439601|NCT02961764|590311548|FG000|Overall Study|Death|2|||
163439602|NCT02961764|590311549|FG001|Overall Study|Death|0|||
163439603|NCT02961764|590311548|FG000|Overall Study|Lost to Follow-up|35|||
163439604|NCT02961764|590311549|FG001|Overall Study|Lost to Follow-up|24|||
163439605|NCT02961764|590311548|FG000|Overall Study|Withdrawal by Subject|2|||
163439606|NCT02961764|590311549|FG001|Overall Study|Withdrawal by Subject|0|||
163439607|NCT02369510|590311550|FG000|Overall Study|Spilled Medication|1|||
163439608|NCT02369510|590311551|FG001|Overall Study|Spilled Medication|2|||
163439609|NCT02369510|590311552|FG002|Overall Study|Spilled Medication|1|||
163439610|NCT02369510|590311550|FG000|Overall Study|Epidural Activation|1|||
163439611|NCT02369510|590311551|FG001|Overall Study|Epidural Activation|1|||
163439612|NCT02369510|590311552|FG002|Overall Study|Epidural Activation|5|||
163439613|NCT03067311|590311554|FG000|Overall Study|Lost to Follow-up|1|||
163439614|NCT03067311|590311555|FG001|Overall Study|Lost to Follow-up|1|||
163439615|NCT03067311|590311554|FG000|Overall Study|Moved away|1|||
163439616|NCT03067311|590311555|FG001|Overall Study|Moved away|1|||
163439617|NCT02160977|590311556|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
163439618|NCT02160977|590311557|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
163439619|NCT02160977|590311556|FG000|Three Months After Surgery|Lost to Follow-up|0|||
163439620|NCT02160977|590311557|FG001|Three Months After Surgery|Lost to Follow-up|2|||
163439621|NCT02160977|590311556|FG000|Six Months After Surgery|Lost to Follow-up|2|||
163439622|NCT02160977|590311557|FG001|Six Months After Surgery|Lost to Follow-up|1|||
163439623|NCT02975349|590311558|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163439624|NCT02975349|590311559|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163439625|NCT02975349|590311560|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163439626|NCT02975349|590311561|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
163439627|NCT02975349|590311562|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
163439628|NCT02975349|590311563|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163439629|NCT02975349|590311564|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163439630|NCT02975349|590311558|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
163439631|NCT02975349|590311559|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163439632|NCT02975349|590311560|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163439633|NCT02975349|590311561|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163439634|NCT02975349|590311562|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163439635|NCT02975349|590311563|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163439636|NCT02975349|590311564|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163439637|NCT02975349|590311558|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
163439638|NCT02975349|590311559|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
163439639|NCT02975349|590311560|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
163439640|NCT02975349|590311561|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
163439641|NCT02975349|590311562|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
163439642|NCT02975349|590311563|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
163439643|NCT02975349|590311564|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
163439644|NCT02975349|590311558|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
163439645|NCT02975349|590311559|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
163439646|NCT02975349|590311560|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
163439647|NCT02975349|590311561|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
163439648|NCT02975349|590311562|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
163439649|NCT02975349|590311563|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
163439650|NCT02975349|590311564|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
163439651|NCT02975349|590311558|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
163439652|NCT02975349|590311559|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
163439653|NCT02975349|590311560|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
163439654|NCT02975349|590311561|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
163439655|NCT02975349|590311562|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
163439656|NCT02975349|590311563|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
163439657|NCT02975349|590311564|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
163439658|NCT02975349|590311558|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
163439659|NCT02975349|590311559|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
163439660|NCT02975349|590311560|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
163439661|NCT02975349|590311561|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
163439662|NCT02975349|590311562|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
163439663|NCT02975349|590311563|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
163439664|NCT02975349|590311564|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
163439665|NCT02975349|590311558|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
163439666|NCT02975349|590311559|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
163439667|NCT02975349|590311560|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
163439668|NCT02975349|590311561|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
163439669|NCT02975349|590311562|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
163439670|NCT02975349|590311563|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
163439671|NCT02975349|590311564|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
163439672|NCT02975349|590311558|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
163439673|NCT02975349|590311559|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
163439674|NCT02975349|590311560|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
163439675|NCT02975349|590311561|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
163439676|NCT02975349|590311562|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
163439677|NCT02975349|590311563|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
163439678|NCT02975349|590311564|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
163439679|NCT02975349|590311558|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
163439680|NCT02975349|590311559|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
163439681|NCT02975349|590311560|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
163439682|NCT02975349|590311561|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
163439683|NCT02975349|590311562|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
163439684|NCT02975349|590311563|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
163439685|NCT02975349|590311564|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
163439686|NCT02975349|590311558|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
163439687|NCT02975349|590311559|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
163439688|NCT02975349|590311560|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
163439689|NCT02975349|590311561|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
163439690|NCT02975349|590311562|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
163439691|NCT02975349|590311563|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
163439692|NCT02975349|590311564|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
163439693|NCT02975349|590311558|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
163439694|NCT02975349|590311559|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
163439695|NCT02975349|590311560|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
163439696|NCT02975349|590311561|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
163439697|NCT02975349|590311562|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
163439698|NCT02975349|590311563|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
163439699|NCT02975349|590311564|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
163439700|NCT02975349|590311558|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
163439701|NCT02975349|590311559|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
163439702|NCT02975349|590311560|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
163439703|NCT02975349|590311561|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
163439704|NCT02975349|590311562|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
163439705|NCT02975349|590311563|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
163439706|NCT02975349|590311564|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
163439707|NCT02975349|590311558|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
163439708|NCT02975349|590311559|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
163439709|NCT02975349|590311560|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
163439710|NCT02975349|590311561|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
163439711|NCT02975349|590311562|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
163439712|NCT02975349|590311563|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
163439713|NCT02975349|590311564|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
163439714|NCT02975349|590311558|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
163439715|NCT02975349|590311559|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
163439716|NCT02975349|590311560|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
163439717|NCT02975349|590311561|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
163439718|NCT02975349|590311562|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
163439719|NCT02975349|590311563|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
163439720|NCT02975349|590311564|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
163439721|NCT02975349|590311558|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
163439722|NCT02975349|590311559|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
163439723|NCT02975349|590311560|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
163439724|NCT02975349|590311561|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
163439725|NCT02975349|590311562|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
163439726|NCT02975349|590311563|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
163439727|NCT02975349|590311564|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
163439728|NCT01663740|590311565|FG000|Overall Study|Lost to Follow-up|1|||
163439729|NCT01663740|590311566|FG001|Overall Study|Lost to Follow-up|4|||
163439730|NCT01663740|590311565|FG000|Overall Study|Other|9|||
163439731|NCT01663740|590311566|FG001|Overall Study|Other|2|||
163439732|NCT01663740|590311565|FG000|Overall Study|Inclusion/Exclusion not met|1|||
163439733|NCT01663740|590311566|FG001|Overall Study|Inclusion/Exclusion not met|0|||
163439734|NCT01663740|590311565|FG000|Overall Study|Death|0|||
163439735|NCT01663740|590311566|FG001|Overall Study|Death|1|||
163439736|NCT01663740|590311565|FG000|Overall Study|Withdrawal by Subject|2|||
163439737|NCT01663740|590311566|FG001|Overall Study|Withdrawal by Subject|1|||
163439738|NCT01663740|590311565|FG000|Overall Study|No end of study status|3|||
163439739|NCT01663740|590311566|FG001|Overall Study|No end of study status|0|||
163439740|NCT02658656|590311576|FG000|Screening|Failed eligibility criteria|0|||
163439741|NCT02658656|590311577|FG001|Screening|Failed eligibility criteria|0|||
163439742|NCT02658656|590311578|FG002|Screening|Failed eligibility criteria|263|||
163439743|NCT02658656|590311576|FG000|Randomization|Withdrawal by Subject|8|||
163439744|NCT02658656|590311577|FG001|Randomization|Withdrawal by Subject|7|||
163439745|NCT02658656|590311578|FG002|Randomization|Withdrawal by Subject|0|||
163439746|NCT02658656|590311576|FG000|Randomization|Lost to Follow-up|1|||
163439747|NCT02658656|590311577|FG001|Randomization|Lost to Follow-up|3|||
163439748|NCT02658656|590311578|FG002|Randomization|Lost to Follow-up|0|||
163439749|NCT02658656|590311576|FG000|Randomization|Adverse Event|4|||
163439750|NCT02658656|590311577|FG001|Randomization|Adverse Event|0|||
163439751|NCT02658656|590311578|FG002|Randomization|Adverse Event|0|||
163439752|NCT02658656|590311576|FG000|Randomization|Administrative Termination|3|||
163439753|NCT02658656|590311577|FG001|Randomization|Administrative Termination|1|||
163439754|NCT02658656|590311578|FG002|Randomization|Administrative Termination|0|||
163439755|NCT02658656|590311576|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
163439756|NCT02658656|590311577|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
163439757|NCT02658656|590311578|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
163439758|NCT02658656|590311576|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
163439759|NCT02658656|590311577|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
163439760|NCT02658656|590311578|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
163439761|NCT02658656|590311576|FG000|Randomization|Not eligible for Randomization|1|||
163439762|NCT02658656|590311577|FG001|Randomization|Not eligible for Randomization|0|||
163439763|NCT02658656|590311578|FG002|Randomization|Not eligible for Randomization|0|||
163439764|NCT02658656|590311576|FG000|Randomization|Protocol Violation|1|||
163439765|NCT02658656|590311577|FG001|Randomization|Protocol Violation|0|||
163439766|NCT02658656|590311578|FG002|Randomization|Protocol Violation|0|||
163439767|NCT02112448|590311579|FG000|Overall Study|lab values precluding use of ketorolac|2|||
163439768|NCT02112448|590311580|FG001|Overall Study|lab values precluding use of ketorolac|2|||
163439769|NCT02112448|590311579|FG000|Overall Study|Protocol Violation|1|||
163439770|NCT02112448|590311580|FG001|Overall Study|Protocol Violation|2|||
163439771|NCT02112448|590311579|FG000|Overall Study|Physician Decision|4|||
163439772|NCT02112448|590311580|FG001|Overall Study|Physician Decision|6|||
163439773|NCT02112448|590311579|FG000|Overall Study|required heparin so could not use ketoro|1|||
163439774|NCT02112448|590311580|FG001|Overall Study|required heparin so could not use ketoro|0|||
163439775|NCT00128206|590313168|FG000|Overall Study|Lost to Follow-up|137|||
163439776|NCT00128206|590313169|FG001|Overall Study|Lost to Follow-up|118|||
163439777|NCT00128206|590313168|FG000|Overall Study|Adverse Event|0|||
163439778|NCT00128206|590313169|FG001|Overall Study|Adverse Event|2|||
163439779|NCT03032068|590313178|FG000|Overall Study|Adverse Event|1|||
163439780|NCT01597622|590313179|FG000|Overall Study|Adverse Event|7|||
163439781|NCT01597622|590313179|FG000|Overall Study|Lack of Efficacy|3|||
163439782|NCT01597622|590313179|FG000|Overall Study|Protocol Violation|1|||
163439783|NCT01597622|590313179|FG000|Overall Study|Lost to Follow-up|1|||
163439784|NCT01597622|590313179|FG000|Overall Study|Investigator Discretion|5|||
163439785|NCT01597622|590313179|FG000|Overall Study|Withdrawal by Subject|20|||
163439786|NCT01597622|590313179|FG000|Overall Study|Death|1|||
163439787|NCT00408421|590313182|FG000|Treatment Initial Randomization|Adverse Event|5|||
163439788|NCT00408421|590313183|FG001|Treatment Initial Randomization|Adverse Event|9|||
163439789|NCT00408421|590313184|FG002|Treatment Initial Randomization|Adverse Event|0|||
163439790|NCT00408421|590313182|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
163439791|NCT00408421|590313183|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
163439792|NCT00408421|590313184|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
163439793|NCT00408421|590313182|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
163439794|NCT00408421|590313183|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
163439795|NCT00408421|590313184|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
163439796|NCT00408421|590313182|FG000|Treatment Initial Randomization|Physician Decision|1|||
163439797|NCT00408421|590313183|FG001|Treatment Initial Randomization|Physician Decision|0|||
163439798|NCT00408421|590313184|FG002|Treatment Initial Randomization|Physician Decision|0|||
163439799|NCT00408421|590313182|FG000|Treatment Initial Randomization|Protocol Violation|0|||
163439800|NCT00408421|590313183|FG001|Treatment Initial Randomization|Protocol Violation|1|||
163439801|NCT00408421|590313184|FG002|Treatment Initial Randomization|Protocol Violation|0|||
163439802|NCT00408421|590313182|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
163439803|NCT00408421|590313183|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
163439804|NCT00408421|590313184|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
163439805|NCT00408421|590313182|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
163439806|NCT00408421|590313183|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
163439807|NCT00408421|590313184|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
163439808|NCT00408421|590313182|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
163439809|NCT00408421|590313183|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
163439810|NCT00408421|590313184|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
163439811|NCT00408421|590313182|FG000|Treatment Re-Randomization|Adverse Event|2|||
163439812|NCT00408421|590313183|FG001|Treatment Re-Randomization|Adverse Event|2|||
163439813|NCT00408421|590313184|FG002|Treatment Re-Randomization|Adverse Event|4|||
163439814|NCT00408421|590313182|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
163439815|NCT00408421|590313183|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
163439816|NCT00408421|590313184|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
163439817|NCT00408421|590313182|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
163439818|NCT00408421|590313183|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
163439819|NCT00408421|590313184|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
163439820|NCT00408421|590313182|FG000|Treatment Re-Randomization|Physician Decision|1|||
163439821|NCT00408421|590313183|FG001|Treatment Re-Randomization|Physician Decision|3|||
163439822|NCT00408421|590313184|FG002|Treatment Re-Randomization|Physician Decision|0|||
163439823|NCT00408421|590313182|FG000|Treatment Re-Randomization|Protocol Violation|1|||
163439824|NCT00408421|590313183|FG001|Treatment Re-Randomization|Protocol Violation|1|||
163439825|NCT00408421|590313184|FG002|Treatment Re-Randomization|Protocol Violation|0|||
163439826|NCT00408421|590313182|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
163439827|NCT00408421|590313183|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
163439828|NCT00408421|590313184|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
163439829|NCT00710034|590313187|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
163439830|NCT00710034|590313188|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
163439831|NCT00710034|590313187|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
163439832|NCT00710034|590313188|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
163439833|NCT00710034|590313187|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
163439834|NCT00710034|590313188|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
163439835|NCT00710034|590313187|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
163439836|NCT00710034|590313188|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
163439837|NCT00710034|590313187|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
163439838|NCT00710034|590313188|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
163439839|NCT00710034|590313187|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
163439840|NCT00710034|590313188|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
163439841|NCT00710034|590313187|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
163439842|NCT00710034|590313188|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
163439843|NCT00710034|590313187|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
163439844|NCT00710034|590313188|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
163439845|NCT00710034|590313187|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
163439846|NCT00710034|590313188|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
163439847|NCT00710034|590313187|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
163439848|NCT00710034|590313188|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
163439849|NCT00710034|590313187|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
163439850|NCT00710034|590313188|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
163439851|NCT00494871|590313189|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
163439852|NCT00494871|590313190|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
163439853|NCT00494871|590313189|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
163439854|NCT00494871|590313190|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
163439855|NCT00494871|590313189|FG000|Double-blind (DB) Treatment Period|Death|8|||
163439856|NCT00494871|590313190|FG001|Double-blind (DB) Treatment Period|Death|3|||
163439857|NCT00494871|590313189|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
163439858|NCT00494871|590313190|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
163439859|NCT00494871|590313189|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
163439860|NCT00494871|590313190|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
163439861|NCT00494871|590313189|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
163439862|NCT00494871|590313190|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
163439863|NCT00494871|590313189|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
163439864|NCT00494871|590313190|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
163439865|NCT00494871|590313189|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
163439866|NCT00494871|590313190|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
163439867|NCT00494871|590313189|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
163439868|NCT00494871|590313190|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
163439869|NCT00494871|590313189|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
163439870|NCT00494871|590313190|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
163439871|NCT00494871|590313189|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
163439872|NCT00494871|590313190|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
163439873|NCT00494871|590313189|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
163439874|NCT00494871|590313190|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
163439875|NCT00494871|590313189|FG000|Follow-up (FU) Period|Adverse Event|1|||
163439876|NCT00494871|590313190|FG001|Follow-up (FU) Period|Adverse Event|1|||
163439877|NCT00494871|590313189|FG000|Follow-up (FU) Period|Death|13|||
163439878|NCT00494871|590313190|FG001|Follow-up (FU) Period|Death|12|||
163439879|NCT00494871|590313189|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
163439880|NCT00494871|590313190|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
163439881|NCT00494871|590313189|FG000|Follow-up (FU) Period|Physician Decision|0|||
163439882|NCT00494871|590313190|FG001|Follow-up (FU) Period|Physician Decision|1|||
163439883|NCT00494871|590313189|FG000|Follow-up (FU) Period|Protocol Violation|1|||
163439884|NCT00494871|590313190|FG001|Follow-up (FU) Period|Protocol Violation|0|||
163439885|NCT00494871|590313189|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
163439886|NCT00494871|590313190|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
163439887|NCT00494871|590313189|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
163439888|NCT00494871|590313190|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
163439889|NCT03515538|590313203|FG000|Overall Study|Lack of Efficacy|2|||
163439890|NCT03515538|590313204|FG001|Overall Study|Lack of Efficacy|0|||
163439891|NCT03515538|590313205|FG002|Overall Study|Lack of Efficacy|2|||
163439892|NCT03515538|590313206|FG003|Overall Study|Lack of Efficacy|0|||
163439893|NCT03515538|590313203|FG000|Overall Study|Death|0|||
163439894|NCT03515538|590313204|FG001|Overall Study|Death|0|||
163439895|NCT03515538|590313205|FG002|Overall Study|Death|1|||
163439896|NCT03515538|590313206|FG003|Overall Study|Death|0|||
163439897|NCT03515538|590313203|FG000|Overall Study|Protocol Violation|0|||
163439898|NCT03515538|590313204|FG001|Overall Study|Protocol Violation|0|||
163439899|NCT03515538|590313205|FG002|Overall Study|Protocol Violation|0|||
163439900|NCT03515538|590313206|FG003|Overall Study|Protocol Violation|1|||
163439901|NCT03515538|590313203|FG000|Overall Study|Screen failure (baseline dropout)|0|||
163439902|NCT03515538|590313204|FG001|Overall Study|Screen failure (baseline dropout)|1|||
163439903|NCT03515538|590313205|FG002|Overall Study|Screen failure (baseline dropout)|0|||
163439904|NCT03515538|590313206|FG003|Overall Study|Screen failure (baseline dropout)|0|||
163439905|NCT03515538|590313203|FG000|Overall Study|Withdrawal by Subject|2|||
163439906|NCT03515538|590313204|FG001|Overall Study|Withdrawal by Subject|2|||
163439907|NCT03515538|590313205|FG002|Overall Study|Withdrawal by Subject|1|||
163439908|NCT03515538|590313206|FG003|Overall Study|Withdrawal by Subject|3|||
163439909|NCT03515538|590313203|FG000|Overall Study|Physician Decision|1|||
163439910|NCT03515538|590313204|FG001|Overall Study|Physician Decision|0|||
163439911|NCT03515538|590313205|FG002|Overall Study|Physician Decision|0|||
163439912|NCT03515538|590313206|FG003|Overall Study|Physician Decision|1|||
163439913|NCT03088605|590313209|FG000|Overall Study|Withdrawal by Subject|1|||
163439914|NCT03088605|590313210|FG001|Overall Study|Withdrawal by Subject|0|||
163439915|NCT02345161|590313211|FG000|Overall Study|Withdrawal by Subject|25|||
163439916|NCT02345161|590313212|FG001|Overall Study|Withdrawal by Subject|33|||
163439917|NCT02345161|590313211|FG000|Overall Study|Adverse Event|16|||
163439918|NCT02345161|590313212|FG001|Overall Study|Adverse Event|19|||
163439919|NCT02345161|590313211|FG000|Overall Study|Physician Decision|4|||
163439920|NCT02345161|590313212|FG001|Overall Study|Physician Decision|4|||
163439921|NCT02345161|590313211|FG000|Overall Study|Lost to Follow-up|0|||
163439922|NCT02345161|590313212|FG001|Overall Study|Lost to Follow-up|1|||
163439923|NCT02225223|590313214|FG000|Overall Study|Death|10|||
163439924|NCT02225223|590313215|FG001|Overall Study|Death|1|||
163439925|NCT02225223|590313214|FG000|Overall Study|Lost to Follow-up|5|||
163439926|NCT02225223|590313215|FG001|Overall Study|Lost to Follow-up|0|||
163439927|NCT02225223|590313214|FG000|Overall Study|Other|1|||
163439928|NCT02225223|590313215|FG001|Overall Study|Other|2|||
163439929|NCT02225223|590313214|FG000|Overall Study|Physician Decision|1|||
163439930|NCT02225223|590313215|FG001|Overall Study|Physician Decision|0|||
163439931|NCT02225223|590313214|FG000|Overall Study|Withdrawal by Subject|2|||
163439932|NCT02225223|590313215|FG001|Overall Study|Withdrawal by Subject|2|||
163439933|NCT03666143|590313216|FG000|Overall Study|Death|158|||
163439934|NCT03666143|590313216|FG000|Overall Study|Sponsor Decision|31|||
163439935|NCT03666143|590313216|FG000|Overall Study|Withdrawal by Subject|11|||
163439936|NCT03666143|590313216|FG000|Overall Study|Lost to Follow-up|5|||
163439937|NCT03666143|590313216|FG000|Overall Study|Physician Decision|1|||
163439938|NCT03666143|590313216|FG000|Overall Study|Rolled into extension study|9|||
163439939|NCT03666143|590313216|FG000|Overall Study|Progressive Disease|1|||
163439940|NCT02639182|590313222|FG000|Overall Study|Disease Progression|50|||
163439941|NCT02639182|590313223|FG001|Overall Study|Disease Progression|49|||
163439942|NCT02639182|590313222|FG000|Overall Study|Adverse Event|7|||
163439943|NCT02639182|590313223|FG001|Overall Study|Adverse Event|5|||
163439944|NCT02639182|590313222|FG000|Overall Study|Physician Decision|3|||
163439945|NCT02639182|590313223|FG001|Overall Study|Physician Decision|3|||
163439946|NCT02639182|590313222|FG000|Overall Study|Withdrew Consent|5|||
163439947|NCT02639182|590313223|FG001|Overall Study|Withdrew Consent|4|||
163439948|NCT02639182|590313222|FG000|Overall Study|Lost to Follow-up|0|||
163439949|NCT02639182|590313223|FG001|Overall Study|Lost to Follow-up|1|||
163439950|NCT02639182|590313222|FG000|Overall Study|Study Closure|1|||
163439951|NCT02639182|590313223|FG001|Overall Study|Study Closure|2|||
163439952|NCT02639182|590313222|FG000|Overall Study|Sponsor Ended Study|0|||
163439953|NCT02639182|590313223|FG001|Overall Study|Sponsor Ended Study|1|||
163439954|NCT02639182|590313222|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
163439955|NCT02639182|590313223|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
163439956|NCT02546856|590313224|FG000|4 Months Evaluation|Death|2|||
163439957|NCT02546856|590313225|FG001|4 Months Evaluation|Death|3|||
163439958|NCT02546856|590313224|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
163439959|NCT02546856|590313225|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
163439960|NCT02546856|590313224|FG000|4 Months Evaluation|Lost to Follow-up|3|||
163439961|NCT02546856|590313225|FG001|4 Months Evaluation|Lost to Follow-up|3|||
163439962|NCT02546856|590313224|FG000|4 Months Evaluation|Physician Decision|3|||
163439963|NCT02546856|590313225|FG001|4 Months Evaluation|Physician Decision|0|||
163439964|NCT02546856|590313224|FG000|4 Months Evaluation|Working or living abroad|5|||
163439965|NCT02546856|590313225|FG001|4 Months Evaluation|Working or living abroad|1|||
163439966|NCT02546856|590313224|FG000|4 Months Evaluation|reasons not due to titration|4|||
163439967|NCT02546856|590313225|FG001|4 Months Evaluation|reasons not due to titration|1|||
163439968|NCT02546856|590313224|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
163439969|NCT02546856|590313225|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
163439970|NCT02546856|590313224|FG000|6 Months Evaluation|Death|1|||
163439971|NCT02546856|590313225|FG001|6 Months Evaluation|Death|1|||
163439972|NCT02546856|590313224|FG000|6 Months Evaluation|Lost to Follow-up|1|||
163439973|NCT02546856|590313225|FG001|6 Months Evaluation|Lost to Follow-up|1|||
163439974|NCT02546856|590313224|FG000|6 Months Evaluation|Working or living abroad|6|||
163439975|NCT02546856|590313225|FG001|6 Months Evaluation|Working or living abroad|4|||
163439976|NCT02546856|590313224|FG000|6 Months Evaluation|reasons not due to titration|0|||
163439977|NCT02546856|590313225|FG001|6 Months Evaluation|reasons not due to titration|1|||
163439978|NCT04655586|590313230|FG000|Overall Study|Physician Decision|1|||
163439979|NCT04655586|590313231|FG001|Overall Study|Physician Decision|3|||
163439980|NCT04655586|590313232|FG002|Overall Study|Physician Decision|4|||
163439981|NCT04655586|590313230|FG000|Overall Study|Withdrawal by Subject|1|||
163439982|NCT04655586|590313231|FG001|Overall Study|Withdrawal by Subject|3|||
163439983|NCT04655586|590313232|FG002|Overall Study|Withdrawal by Subject|1|||
163439984|NCT01372878|590313234|FG000|Overall Study|Withdrawal by Subject|63|||
163439985|NCT01372878|590313234|FG000|Overall Study|Protocol Violation|17|||
163439986|NCT01372878|590313234|FG000|Overall Study|incomplete study procedure|104|||
163439987|NCT02616029|590313237|FG000|Overall Study|Adverse Event|1|||
163439988|NCT02616029|590313238|FG001|Overall Study|Adverse Event|0|||
163439989|NCT02616029|590313237|FG000|Overall Study|Death|0|||
163439990|NCT02616029|590313238|FG001|Overall Study|Death|1|||
163439991|NCT02616029|590313237|FG000|Overall Study|Protocol Violation|1|||
163439992|NCT02616029|590313238|FG001|Overall Study|Protocol Violation|0|||
163439993|NCT02616029|590313237|FG000|Overall Study|Withdrew Consent|1|||
163439994|NCT02616029|590313238|FG001|Overall Study|Withdrew Consent|0|||
163439995|NCT02616029|590313237|FG000|Overall Study|Enrolled and Never Treated|1|||
163439996|NCT02616029|590313238|FG001|Overall Study|Enrolled and Never Treated|1|||
163439997|NCT00479466|590313239|FG000|Overall Study|Adverse Event|5|||
163439998|NCT00479466|590313240|FG001|Overall Study|Adverse Event|1|||
163439999|NCT00479466|590313241|FG002|Overall Study|Adverse Event|0|||
163440000|NCT00479466|590313242|FG003|Overall Study|Adverse Event|1|||
163440001|NCT00479466|590313243|FG004|Overall Study|Adverse Event|2|||
163440002|NCT00479466|590313244|FG005|Overall Study|Adverse Event|0|||
163440003|NCT00479466|590313239|FG000|Overall Study|Hyperglycemia|0|||
163440004|NCT00479466|590313240|FG001|Overall Study|Hyperglycemia|0|||
163440005|NCT00479466|590313241|FG002|Overall Study|Hyperglycemia|0|||
163440006|NCT00479466|590313242|FG003|Overall Study|Hyperglycemia|0|||
163440007|NCT00479466|590313243|FG004|Overall Study|Hyperglycemia|0|||
163440008|NCT00479466|590313244|FG005|Overall Study|Hyperglycemia|1|||
163440009|NCT00479466|590313239|FG000|Overall Study|Lack of Efficacy|2|||
163440010|NCT00479466|590313240|FG001|Overall Study|Lack of Efficacy|0|||
163440011|NCT00479466|590313241|FG002|Overall Study|Lack of Efficacy|1|||
163440012|NCT00479466|590313242|FG003|Overall Study|Lack of Efficacy|0|||
163440013|NCT00479466|590313243|FG004|Overall Study|Lack of Efficacy|0|||
163440014|NCT00479466|590313244|FG005|Overall Study|Lack of Efficacy|0|||
163440015|NCT00479466|590313239|FG000|Overall Study|Lost to Follow-up|0|||
163440016|NCT00479466|590313240|FG001|Overall Study|Lost to Follow-up|1|||
163440017|NCT00479466|590313241|FG002|Overall Study|Lost to Follow-up|1|||
163440018|NCT00479466|590313242|FG003|Overall Study|Lost to Follow-up|0|||
163440019|NCT00479466|590313243|FG004|Overall Study|Lost to Follow-up|2|||
163440020|NCT00479466|590313244|FG005|Overall Study|Lost to Follow-up|2|||
163440021|NCT00479466|590313239|FG000|Overall Study|Physician Decision|2|||
163440022|NCT00479466|590313240|FG001|Overall Study|Physician Decision|1|||
163440023|NCT00479466|590313241|FG002|Overall Study|Physician Decision|1|||
163440024|NCT00479466|590313242|FG003|Overall Study|Physician Decision|0|||
163440025|NCT00479466|590313243|FG004|Overall Study|Physician Decision|0|||
163440026|NCT00479466|590313244|FG005|Overall Study|Physician Decision|0|||
163440027|NCT00479466|590313239|FG000|Overall Study|Pregnancy|0|||
163440028|NCT00479466|590313240|FG001|Overall Study|Pregnancy|0|||
163440029|NCT00479466|590313241|FG002|Overall Study|Pregnancy|0|||
163440030|NCT00479466|590313242|FG003|Overall Study|Pregnancy|0|||
163440031|NCT00479466|590313243|FG004|Overall Study|Pregnancy|1|||
163440032|NCT00479466|590313244|FG005|Overall Study|Pregnancy|0|||
163440033|NCT00479466|590313239|FG000|Overall Study|Protocol Violation|1|||
163440034|NCT00479466|590313240|FG001|Overall Study|Protocol Violation|0|||
163440035|NCT00479466|590313241|FG002|Overall Study|Protocol Violation|0|||
163440036|NCT00479466|590313242|FG003|Overall Study|Protocol Violation|0|||
163440037|NCT00479466|590313243|FG004|Overall Study|Protocol Violation|0|||
163440038|NCT00479466|590313244|FG005|Overall Study|Protocol Violation|0|||
163440039|NCT00479466|590313239|FG000|Overall Study|Withdrawal by Subject|3|||
163440040|NCT00479466|590313240|FG001|Overall Study|Withdrawal by Subject|5|||
163440041|NCT00479466|590313241|FG002|Overall Study|Withdrawal by Subject|0|||
163440042|NCT00479466|590313242|FG003|Overall Study|Withdrawal by Subject|2|||
163440043|NCT00479466|590313243|FG004|Overall Study|Withdrawal by Subject|3|||
163440044|NCT00479466|590313244|FG005|Overall Study|Withdrawal by Subject|1|||
163440045|NCT00532883|590313255|FG000|Overall Study|Adverse Event|1|||
163440046|NCT00532883|590313256|FG001|Overall Study|Adverse Event|0|||
163440047|NCT00532883|590313257|FG002|Overall Study|Adverse Event|0|||
163440048|NCT00532883|590313258|FG003|Overall Study|Adverse Event|1|||
163440049|NCT00532883|590313255|FG000|Overall Study|Lost to Follow-up|1|||
163440050|NCT00532883|590313256|FG001|Overall Study|Lost to Follow-up|1|||
163440051|NCT00532883|590313257|FG002|Overall Study|Lost to Follow-up|1|||
163440052|NCT00532883|590313258|FG003|Overall Study|Lost to Follow-up|0|||
163440053|NCT00532883|590313255|FG000|Overall Study|Withdrawal by Subject|0|||
163440054|NCT00532883|590313256|FG001|Overall Study|Withdrawal by Subject|1|||
163440055|NCT00532883|590313257|FG002|Overall Study|Withdrawal by Subject|1|||
163440056|NCT00532883|590313258|FG003|Overall Study|Withdrawal by Subject|0|||
163440057|NCT00532883|590313255|FG000|Overall Study|Subject was Nonadherent|0|||
163440058|NCT00532883|590313256|FG001|Overall Study|Subject was Nonadherent|1|||
163440059|NCT00532883|590313257|FG002|Overall Study|Subject was Nonadherent|1|||
163440060|NCT00532883|590313258|FG003|Overall Study|Subject was Nonadherent|0|||
163440061|NCT00532883|590313255|FG000|Overall Study|Early Study Termination|4|||
163440062|NCT00532883|590313256|FG001|Overall Study|Early Study Termination|4|||
163440063|NCT00532883|590313257|FG002|Overall Study|Early Study Termination|1|||
163440064|NCT00532883|590313258|FG003|Overall Study|Early Study Termination|4|||
163440065|NCT01469013|590313259|FG000|Part A (Treatment Period)|Adverse Event|1|||
163440066|NCT01469013|590313260|FG001|Part A (Treatment Period)|Adverse Event|0|||
163440067|NCT01469013|590313261|FG002|Part A (Treatment Period)|Adverse Event|0|||
163440068|NCT01469013|590313262|FG003|Part A (Treatment Period)|Adverse Event|0|||
163440069|NCT01469013|590313263|FG004|Part A (Treatment Period)|Adverse Event|1|||
163440070|NCT01469013|590313264|FG005|Part A (Treatment Period)|Adverse Event|0|||
163440071|NCT01469013|590313265|FG006|Part A (Treatment Period)|Adverse Event|0|||
163440072|NCT01469013|590313266|FG007|Part A (Treatment Period)|Adverse Event|0|||
163440073|NCT01469013|590313267|FG008|Part A (Treatment Period)|Adverse Event|0|||
163440074|NCT01469013|590313268|FG009|Part A (Treatment Period)|Adverse Event|0|||
163440075|NCT01469013|590313269|FG010|Part A (Treatment Period)|Adverse Event|0|||
163440076|NCT01469013|590313270|FG011|Part A (Treatment Period)|Adverse Event|0|||
163440077|NCT01469013|590313271|FG012|Part A (Treatment Period)|Adverse Event|0|||
163440078|NCT01469013|590313259|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
163440079|NCT01469013|590313260|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
163440080|NCT01469013|590313261|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
163440081|NCT01469013|590313262|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
163440082|NCT01469013|590313263|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
163440083|NCT01469013|590313264|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
163440084|NCT01469013|590313265|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
163440085|NCT01469013|590313266|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
163440086|NCT01469013|590313267|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
163440087|NCT01469013|590313268|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
163440088|NCT01469013|590313269|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
163440089|NCT01469013|590313270|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
163440090|NCT01469013|590313271|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
163440091|NCT01469013|590313259|FG000|Part B (Extension Period)|Adverse Event|0|||
163440092|NCT01469013|590313260|FG001|Part B (Extension Period)|Adverse Event|0|||
163440093|NCT01469013|590313261|FG002|Part B (Extension Period)|Adverse Event|0|||
163440094|NCT01469013|590313262|FG003|Part B (Extension Period)|Adverse Event|0|||
163440095|NCT01469013|590313263|FG004|Part B (Extension Period)|Adverse Event|0|||
163440096|NCT01469013|590313264|FG005|Part B (Extension Period)|Adverse Event|2|||
163440097|NCT01469013|590313265|FG006|Part B (Extension Period)|Adverse Event|5|||
163440098|NCT01469013|590313266|FG007|Part B (Extension Period)|Adverse Event|5|||
163440099|NCT01469013|590313267|FG008|Part B (Extension Period)|Adverse Event|3|||
163440100|NCT01469013|590313268|FG009|Part B (Extension Period)|Adverse Event|3|||
163440101|NCT01469013|590313269|FG010|Part B (Extension Period)|Adverse Event|1|||
163440102|NCT01469013|590313270|FG011|Part B (Extension Period)|Adverse Event|6|||
163440103|NCT01469013|590313271|FG012|Part B (Extension Period)|Adverse Event|3|||
163440104|NCT01469013|590313259|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
163440105|NCT01469013|590313260|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
163440106|NCT01469013|590313261|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
163440107|NCT01469013|590313262|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
163440108|NCT01469013|590313263|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
163440109|NCT01469013|590313264|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
163440110|NCT01469013|590313265|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
163440111|NCT01469013|590313266|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
163440112|NCT01469013|590313267|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
163440113|NCT01469013|590313268|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
163440114|NCT01469013|590313269|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
163440115|NCT01469013|590313270|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
163440116|NCT01469013|590313271|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
163440117|NCT05232097|590313272|FG000|Overall Study|Physician Decision|1|||
163440118|NCT00425438|590313275|FG000|Overall Study|Termination by Sponsor|25|||
163440119|NCT00425438|590313276|FG001|Overall Study|Termination by Sponsor|27|||
163440120|NCT01172288|590313277|FG000|Overall Study|Adverse Event|1|||
163440121|NCT01172288|590313278|FG001|Overall Study|Adverse Event|0|||
163440122|NCT01172288|590313277|FG000|Overall Study|Protocol Violation|0|||
163440123|NCT01172288|590313278|FG001|Overall Study|Protocol Violation|1|||
163440124|NCT01327339|590313279|FG000|Overall Study|Protocol Violation|8|||
163440125|NCT02902809|590313282|FG000|Overall Study|Discontinuation of asthma program|28|||
163440126|NCT00532259|590313283|FG000|Overall Study|Withdrawal by Subject|2|||
163440127|NCT00532259|590313283|FG000|Overall Study|Adverse Event|1|||
163440128|NCT00532259|590313283|FG000|Overall Study|Death|1|||
163440129|NCT00532259|590313283|FG000|Overall Study|Lack of Efficacy|21|||
163440130|NCT00532259|590313283|FG000|Overall Study|Lost to Follow-up|3|||
163440131|NCT00532259|590313283|FG000|Overall Study|Physician Decision|3|||
163440132|NCT00532259|590313283|FG000|Overall Study|Protocol Violation|1|||
163440133|NCT00871858|590313284|FG000|Overall Study|Protocol Violation|3|||
163440134|NCT00871858|590313285|FG001|Overall Study|Protocol Violation|4|||
163440135|NCT00871858|590313284|FG000|Overall Study|Adverse Event|1|||
163440136|NCT00871858|590313285|FG001|Overall Study|Adverse Event|1|||
163440137|NCT00871858|590313284|FG000|Overall Study|Withdrawal by Subject|1|||
163440138|NCT00871858|590313285|FG001|Overall Study|Withdrawal by Subject|1|||
163440139|NCT00871858|590313284|FG000|Overall Study|Lost to Follow-up|0|||
163440140|NCT00871858|590313285|FG001|Overall Study|Lost to Follow-up|1|||
163440141|NCT02795767|590313290|FG000|Overall Study|Received Commercial Emicizumab|1|||
163440142|NCT02795767|590313291|FG001|Overall Study|Received Commercial Emicizumab|0|||
163440143|NCT02795767|590313292|FG002|Overall Study|Received Commercial Emicizumab|0|||
163440144|NCT04983940|590313293|FG000|Overall Study|Lost to Follow-up|14|||
163440145|NCT04983940|590313293|FG000|Overall Study|Lack of Efficacy|2|||
163440146|NCT01748760|590313294|FG000|Overall Study|Withdrawal by Subject|1|||
163440147|NCT01748760|590313295|FG001|Overall Study|Withdrawal by Subject|1|||
163440148|NCT01748760|590313294|FG000|Overall Study|Lost to Follow-up|5|||
163440149|NCT01748760|590313295|FG001|Overall Study|Lost to Follow-up|1|||
163440150|NCT01004146|590313297|FG000|Overall Study|Withdrawal by Subject|4|||
163440151|NCT01004146|590313298|FG001|Overall Study|Withdrawal by Subject|5|||
163440152|NCT01855789|590313307|FG000|1) Baseline up to Week 24|Adverse Event|37|||
163440153|NCT01855789|590313308|FG001|1) Baseline up to Week 24|Adverse Event|0|||
163440154|NCT01855789|590313309|FG002|1) Baseline up to Week 24|Adverse Event|0|||
163440155|NCT01855789|590313310|FG003|1) Baseline up to Week 24|Adverse Event|0|||
163440156|NCT01855789|590313307|FG000|1) Baseline up to Week 24|Death|2|||
163440157|NCT01855789|590313308|FG001|1) Baseline up to Week 24|Death|0|||
163440158|NCT01855789|590313309|FG002|1) Baseline up to Week 24|Death|0|||
163440159|NCT01855789|590313310|FG003|1) Baseline up to Week 24|Death|0|||
163440160|NCT01855789|590313307|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
163440161|NCT01855789|590313308|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
163440162|NCT01855789|590313309|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
163440163|NCT01855789|590313310|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
163440164|NCT01855789|590313307|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
163440165|NCT01855789|590313308|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
163440166|NCT01855789|590313309|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
163440167|NCT01855789|590313310|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
163440168|NCT01855789|590313307|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
163440169|NCT01855789|590313308|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
163440170|NCT01855789|590313309|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
163440171|NCT01855789|590313310|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
163440172|NCT01855789|590313307|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
163440173|NCT01855789|590313308|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
163440174|NCT01855789|590313309|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
163440175|NCT01855789|590313310|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
163440176|NCT01855789|590313307|FG000|1) Baseline up to Week 24|Physician Decision|4|||
163440177|NCT01855789|590313308|FG001|1) Baseline up to Week 24|Physician Decision|0|||
163440178|NCT01855789|590313309|FG002|1) Baseline up to Week 24|Physician Decision|0|||
163440179|NCT01855789|590313310|FG003|1) Baseline up to Week 24|Physician Decision|0|||
163440180|NCT01855789|590313307|FG000|1) Baseline up to Week 24|Pregnancy|1|||
163440181|NCT01855789|590313308|FG001|1) Baseline up to Week 24|Pregnancy|0|||
163440182|NCT01855789|590313309|FG002|1) Baseline up to Week 24|Pregnancy|0|||
163440183|NCT01855789|590313310|FG003|1) Baseline up to Week 24|Pregnancy|0|||
163440184|NCT01855789|590313307|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
163440185|NCT01855789|590313308|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
163440186|NCT01855789|590313309|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
163440187|NCT01855789|590313310|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
163440188|NCT01855789|590313307|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
163440189|NCT01855789|590313308|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
163440190|NCT01855789|590313309|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
163440191|NCT01855789|590313310|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
163440192|NCT01855789|590313307|FG000|1) Baseline up to Week 24|Other|4|||
163440193|NCT01855789|590313308|FG001|1) Baseline up to Week 24|Other|0|||
163440194|NCT01855789|590313309|FG002|1) Baseline up to Week 24|Other|0|||
163440195|NCT01855789|590313310|FG003|1) Baseline up to Week 24|Other|0|||
163440196|NCT01855789|590313307|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
163440197|NCT01855789|590313308|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
163440198|NCT01855789|590313309|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
163440199|NCT01855789|590313310|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
163440200|NCT01855789|590313307|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
163440201|NCT01855789|590313308|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
163440202|NCT01855789|590313309|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
163440203|NCT01855789|590313310|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
163440204|NCT01855789|590313307|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
163440205|NCT01855789|590313308|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
163440206|NCT01855789|590313309|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
163440207|NCT01855789|590313310|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
163440208|NCT01855789|590313307|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
163440209|NCT01855789|590313308|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
163440210|NCT01855789|590313309|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
163440211|NCT01855789|590313310|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
163440212|NCT01855789|590313307|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
163440213|NCT01855789|590313308|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
163440214|NCT01855789|590313309|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
163440215|NCT01855789|590313310|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
163440216|NCT01855789|590313307|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
163440217|NCT01855789|590313308|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
163440218|NCT01855789|590313309|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
163440219|NCT01855789|590313310|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
163440220|NCT01855789|590313307|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
163440221|NCT01855789|590313308|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
163440222|NCT01855789|590313309|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
163440223|NCT01855789|590313310|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
163440224|NCT01855789|590313307|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
163440225|NCT01855789|590313308|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
163440226|NCT01855789|590313309|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
163440227|NCT01855789|590313310|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
163440228|NCT01855789|590313307|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
163440229|NCT01855789|590313308|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
163440230|NCT01855789|590313309|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
163440231|NCT01855789|590313310|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
163440232|NCT01855789|590313307|FG000|2) Week 24 up to End of Study|Other|0|||
163440233|NCT01855789|590313308|FG001|2) Week 24 up to End of Study|Other|0|||
163440234|NCT01855789|590313309|FG002|2) Week 24 up to End of Study|Other|0|||
163440235|NCT01855789|590313310|FG003|2) Week 24 up to End of Study|Other|1|||
163440236|NCT03625986|590314918|FG000|Randomization Period|Lost to Follow-up|7|||
163440237|NCT03625986|590314919|FG001|Randomization Period|Lost to Follow-up|12|||
163440238|NCT03625986|590314918|FG000|Randomization Period|Withdrawal by Subject|10|||
163440239|NCT03625986|590314919|FG001|Randomization Period|Withdrawal by Subject|6|||
163440240|NCT01850563|590314920|FG000|Overall Study|Not eligible|3|||
163440241|NCT01850563|590314921|FG001|Overall Study|Not eligible|0|||
163440242|NCT04359823|590314922|FG000|Overall Study|Lost to Follow-up|0|||
163440243|NCT04359823|590314923|FG001|Overall Study|Lost to Follow-up|1|||
163440244|NCT04359823|590314922|FG000|Overall Study|Withdrawal by Subject|0|||
163440245|NCT04359823|590314923|FG001|Overall Study|Withdrawal by Subject|1|||
163440246|NCT03132805|590314924|FG000|Overall Study|Lost to Follow-up|142|||
163440247|NCT03132805|590314925|FG001|Overall Study|Lost to Follow-up|141|||
163440248|NCT03132805|590314926|FG002|Overall Study|Lost to Follow-up|113|||
163440249|NCT03009539|590314927|FG000|Overall Study|Lost to Follow-up|132|||
163440250|NCT03009539|590314928|FG001|Overall Study|Lost to Follow-up|113|||
163440251|NCT03009539|590314929|FG002|Overall Study|Lost to Follow-up|132|||
163440252|NCT03009539|590314930|FG003|Overall Study|Lost to Follow-up|113|||
163440253|NCT03151148|590314931|FG000|Overall Study|Lost to Follow-up|1|||
163440254|NCT03151148|590314932|FG001|Overall Study|Lost to Follow-up|0|||
163440255|NCT03151148|590314931|FG000|Overall Study|Withdrawal by Subject|1|||
163440256|NCT03151148|590314932|FG001|Overall Study|Withdrawal by Subject|0|||
163440257|NCT04543955|590314933|FG000|Overall Study|Company cancelled study|1|||
163440258|NCT04543955|590314934|FG001|Overall Study|Company cancelled study|0|||
163440259|NCT03918642|590314935|FG000|Overall Study|Lost to Follow-up|12|||
163440260|NCT03918642|590314936|FG001|Overall Study|Lost to Follow-up|10|||
163440261|NCT01228071|590314941|FG000|Overall Study|Protocol Violation|1|||
163440262|NCT01228071|590314941|FG000|Overall Study|Withdrawal by Subject|1|||
163440263|NCT04439838|590314942|FG000|Overall Study|Withdrawal by Subject|0|||
163440264|NCT04439838|590314943|FG001|Overall Study|Withdrawal by Subject|0|||
163440265|NCT04439838|590314944|FG002|Overall Study|Withdrawal by Subject|0|||
163440266|NCT04439838|590314945|FG003|Overall Study|Withdrawal by Subject|0|||
163440267|NCT04439838|590314946|FG004|Overall Study|Withdrawal by Subject|0|||
163440268|NCT04439838|590314947|FG005|Overall Study|Withdrawal by Subject|0|||
163440269|NCT04439838|590314948|FG006|Overall Study|Withdrawal by Subject|0|||
163440270|NCT04439838|590314949|FG007|Overall Study|Withdrawal by Subject|0|||
163440271|NCT04439838|590314950|FG008|Overall Study|Withdrawal by Subject|1|||
163440272|NCT00130208|590314955|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
163440273|NCT00130208|590314956|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
163440274|NCT00130208|590314955|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
163440275|NCT00130208|590314956|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
163440276|NCT00130208|590314955|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
163440277|NCT00130208|590314956|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
163440278|NCT00130208|590314955|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
163440279|NCT00130208|590314956|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
163440280|NCT00130208|590314955|FG000|Maintenance Period (26 Weeks)|Other|1|||
163440281|NCT00130208|590314956|FG001|Maintenance Period (26 Weeks)|Other|1|||
163440282|NCT00130208|590314955|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
163440283|NCT00130208|590314956|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
163440284|NCT00130208|590314955|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
163440285|NCT00130208|590314956|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
163440286|NCT00130208|590314955|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
163440287|NCT00130208|590314956|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
163440288|NCT00130208|590314955|FG000|Washout Period (8 Weeks)|Other|1|||
163440289|NCT00130208|590314956|FG001|Washout Period (8 Weeks)|Other|1|||
163440290|NCT03268746|590314959|FG000|Overall Study|Withdrawal by Subject|1|||
163440291|NCT00986258|590314960|FG000|Observation Period|Not eligible to be dosed|11|||
163440292|NCT00986258|590314960|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
163440293|NCT00986258|590314960|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
163440294|NCT00986258|590314960|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
163440295|NCT00986258|590314960|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
163440296|NCT00986258|590314960|FG000|Titration and Optimal Dose Period|Other|1|||
163440297|NCT00986258|590314960|FG000|Maintenance Period|Adverse Event|5|||
163440298|NCT00986258|590314960|FG000|Maintenance Period|Lack of Efficacy|2|||
163440299|NCT00986258|590314960|FG000|Maintenance Period|Withdrawal by Subject|2|||
163440300|NCT03332667|590314961|FG000|Overall Study|Adverse Event|0|||
163440301|NCT03332667|590314962|FG001|Overall Study|Adverse Event|0|||
163440302|NCT03332667|590314963|FG002|Overall Study|Adverse Event|2|||
163440303|NCT03332667|590314964|FG003|Overall Study|Adverse Event|1|||
163440304|NCT03332667|590314961|FG000|Overall Study|Withdrawal by Subject|2|||
163440305|NCT03332667|590314962|FG001|Overall Study|Withdrawal by Subject|1|||
163440306|NCT03332667|590314963|FG002|Overall Study|Withdrawal by Subject|5|||
163440307|NCT03332667|590314964|FG003|Overall Study|Withdrawal by Subject|1|||
163440308|NCT03332667|590314961|FG000|Overall Study|Disease Progression or Relapse|2|||
163440309|NCT03332667|590314962|FG001|Overall Study|Disease Progression or Relapse|1|||
163440310|NCT03332667|590314963|FG002|Overall Study|Disease Progression or Relapse|3|||
163440311|NCT03332667|590314964|FG003|Overall Study|Disease Progression or Relapse|0|||
163440312|NCT03332667|590314961|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
163440313|NCT03332667|590314962|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
163440314|NCT03332667|590314963|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
163440315|NCT03332667|590314964|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
163440316|NCT03332667|590314961|FG000|Overall Study|No Treatment Received|0|||
163440317|NCT03332667|590314962|FG001|Overall Study|No Treatment Received|0|||
163440318|NCT03332667|590314963|FG002|Overall Study|No Treatment Received|1|||
163440319|NCT03332667|590314964|FG003|Overall Study|No Treatment Received|0|||
163440320|NCT00546351|590314965|FG000|Overall Study|Adverse Event|76|||
163440321|NCT00546351|590314965|FG000|Overall Study|Lack of Efficacy|15|||
163440322|NCT00546351|590314965|FG000|Overall Study|Withdrawal by Subject|109|||
163440323|NCT00546351|590314965|FG000|Overall Study|Lost to Follow-up|9|||
163440324|NCT00546351|590314965|FG000|Overall Study|Protocol Deviation|1|||
163440325|NCT00546351|590314965|FG000|Overall Study|Unsatisfactory compliance|9|||
163440326|NCT00546351|590314965|FG000|Overall Study|Other reasons for premature termination|17|||
163440327|NCT04734873|590314966|FG000|Overall Study|Lost to Follow-up|1|||
163440328|NCT04734873|590314967|FG001|Overall Study|Lost to Follow-up|3|||
163440329|NCT04734873|590314968|FG002|Overall Study|Lost to Follow-up|2|||
163440330|NCT04734873|590314966|FG000|Overall Study|Randomized but not dosed|1|||
163440331|NCT04734873|590314967|FG001|Overall Study|Randomized but not dosed|0|||
163440332|NCT04734873|590314968|FG002|Overall Study|Randomized but not dosed|1|||
163440333|NCT00609609|590314971|FG000|Overall Study|Withdrawal by Subject|2|||
163440334|NCT00609609|590314972|FG001|Overall Study|Withdrawal by Subject|0|||
163440335|NCT00609609|590314971|FG000|Overall Study|Progression|4|||
163440336|NCT00609609|590314972|FG001|Overall Study|Progression|2|||
163440337|NCT03065530|590314973|FG000|Overall Study|Lack of Efficacy|1|||
163440338|NCT03065530|590314974|FG001|Overall Study|Lack of Efficacy|1|||
163440339|NCT03065530|590314975|FG002|Overall Study|Lack of Efficacy|0|||
163440340|NCT03065530|590314976|FG003|Overall Study|Lack of Efficacy|1|||
163440341|NCT03065530|590314973|FG000|Overall Study|Protocol Violation|1|||
163440342|NCT03065530|590314974|FG001|Overall Study|Protocol Violation|0|||
163440343|NCT03065530|590314975|FG002|Overall Study|Protocol Violation|1|||
163440344|NCT03065530|590314976|FG003|Overall Study|Protocol Violation|1|||
163440345|NCT01035606|590314979|FG000|Overall Study|change in health, job demands,family|3|||
163440346|NCT01035606|590314980|FG001|Overall Study|change in health, job demands,family|3|||
163440347|NCT01035606|590314981|FG002|Overall Study|change in health, job demands,family|4|||
163440348|NCT01070303|590314982|FG000|Overall Study|Adverse Event|39|||
163440349|NCT01070303|590314982|FG000|Overall Study|Withdrawal by Subject|20|||
163440350|NCT01070303|590314982|FG000|Overall Study|Lost to Follow-up|9|||
163440351|NCT01070303|590314982|FG000|Overall Study|Protocol Violation|0|||
163440352|NCT01070303|590314982|FG000|Overall Study|Lack of Efficacy|2|||
163440353|NCT01070303|590314982|FG000|Overall Study|Administrative Reason|1|||
163440354|NCT01070303|590314982|FG000|Overall Study|Other|18|||
163440355|NCT01809262|590314983|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
163440356|NCT01809262|590314984|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
163440357|NCT01809262|590314985|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
163440358|NCT01809262|590314986|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
163440359|NCT01809262|590314987|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
163440360|NCT01809262|590314988|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
163440361|NCT01809262|590314989|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
163440362|NCT01809262|590314990|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
163440363|NCT01809262|590314991|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
163440364|NCT01809262|590314992|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
163440365|NCT01809262|590314983|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
163440366|NCT01809262|590314984|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
163440367|NCT01809262|590314985|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
163440368|NCT01809262|590314986|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
163440369|NCT01809262|590314987|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
163440370|NCT01809262|590314988|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
163440371|NCT01809262|590314989|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
163440372|NCT01809262|590314990|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
163440373|NCT01809262|590314991|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
163440374|NCT01809262|590314992|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
163440375|NCT00859898|590314994|FG000|Overall Study|Lack of Efficacy|0|||
163440376|NCT00859898|590314995|FG001|Overall Study|Lack of Efficacy|1|||
163440377|NCT00859898|590314996|FG002|Overall Study|Lack of Efficacy|1|||
163440378|NCT00859898|590314994|FG000|Overall Study|Adverse Event|4|||
163440379|NCT00859898|590314995|FG001|Overall Study|Adverse Event|9|||
163440380|NCT00859898|590314996|FG002|Overall Study|Adverse Event|8|||
163440381|NCT00859898|590314994|FG000|Overall Study|Withdrawal by Subject|11|||
163440382|NCT00859898|590314995|FG001|Overall Study|Withdrawal by Subject|8|||
163440383|NCT00859898|590314996|FG002|Overall Study|Withdrawal by Subject|11|||
163440384|NCT00859898|590314994|FG000|Overall Study|Death|0|||
163440385|NCT00859898|590314995|FG001|Overall Study|Death|0|||
163440386|NCT00859898|590314996|FG002|Overall Study|Death|1|||
163440387|NCT00859898|590314994|FG000|Overall Study|Lost to Follow-up|10|||
163440388|NCT00859898|590314995|FG001|Overall Study|Lost to Follow-up|11|||
163440389|NCT00859898|590314996|FG002|Overall Study|Lost to Follow-up|5|||
163440390|NCT00859898|590314994|FG000|Overall Study|poor/non-compliance|2|||
163440391|NCT00859898|590314995|FG001|Overall Study|poor/non-compliance|0|||
163440392|NCT00859898|590314996|FG002|Overall Study|poor/non-compliance|0|||
163440393|NCT00859898|590314994|FG000|Overall Study|No longer meets criteria|0|||
163440394|NCT00859898|590314995|FG001|Overall Study|No longer meets criteria|1|||
163440395|NCT00859898|590314996|FG002|Overall Study|No longer meets criteria|0|||
163440396|NCT00859898|590314994|FG000|Overall Study|non-specified|1|||
163440397|NCT00859898|590314995|FG001|Overall Study|non-specified|1|||
163440398|NCT00859898|590314996|FG002|Overall Study|non-specified|1|||
163440399|NCT03215264|590314998|FG000|Dose Level 2|Adverse Event|0|||
163440400|NCT03215264|590314999|FG001|Dose Level 2|Adverse Event|1|||
163440401|NCT03215264|590315000|FG002|Dose Level 2|Adverse Event|0|||
163440402|NCT03215264|590314998|FG000|Dose Level 3|Withdrawal by Subject|0|||
163440403|NCT03215264|590314999|FG001|Dose Level 3|Withdrawal by Subject|0|||
163440404|NCT03215264|590315000|FG002|Dose Level 3|Withdrawal by Subject|1|||
163440405|NCT02145156|590315001|FG000|Overall Study|No match to vaccination records|60|||
163440406|NCT02145156|590315002|FG001|Overall Study|No match to vaccination records|52|||
163440407|NCT02145156|590315003|FG002|Overall Study|No match to vaccination records|41|||
163440408|NCT02064439|590315005|FG000|Overall Study|Adverse Event|51|||
163440409|NCT02064439|590315006|FG001|Overall Study|Adverse Event|47|||
163440410|NCT02064439|590315007|FG002|Overall Study|Adverse Event|46|||
163440411|NCT02064439|590315005|FG000|Overall Study|Death|0|||
163440412|NCT02064439|590315006|FG001|Overall Study|Death|2|||
163440413|NCT02064439|590315007|FG002|Overall Study|Death|3|||
163440414|NCT02064439|590315005|FG000|Overall Study|Withdrawal by Subject|29|||
163440415|NCT02064439|590315006|FG001|Overall Study|Withdrawal by Subject|18|||
163440416|NCT02064439|590315007|FG002|Overall Study|Withdrawal by Subject|26|||
163440417|NCT02064439|590315005|FG000|Overall Study|Protocol Violation|3|||
163440418|NCT02064439|590315006|FG001|Overall Study|Protocol Violation|5|||
163440419|NCT02064439|590315007|FG002|Overall Study|Protocol Violation|3|||
163440420|NCT02064439|590315005|FG000|Overall Study|Lost to Follow-up|1|||
163440421|NCT02064439|590315006|FG001|Overall Study|Lost to Follow-up|3|||
163440422|NCT02064439|590315007|FG002|Overall Study|Lost to Follow-up|4|||
163440423|NCT02064439|590315005|FG000|Overall Study|Non-compliance with study medication|21|||
163440424|NCT02064439|590315006|FG001|Overall Study|Non-compliance with study medication|19|||
163440425|NCT02064439|590315007|FG002|Overall Study|Non-compliance with study medication|23|||
163440426|NCT02064439|590315005|FG000|Overall Study|Physician Decision|0|||
163440427|NCT02064439|590315006|FG001|Overall Study|Physician Decision|1|||
163440428|NCT02064439|590315007|FG002|Overall Study|Physician Decision|1|||
163440429|NCT02064439|590315005|FG000|Overall Study|Logistical difficulties|6|||
163440430|NCT02064439|590315006|FG001|Overall Study|Logistical difficulties|5|||
163440431|NCT02064439|590315007|FG002|Overall Study|Logistical difficulties|2|||
163440432|NCT02064439|590315005|FG000|Overall Study|Efficacy outcome reached|18|||
163440433|NCT02064439|590315006|FG001|Overall Study|Efficacy outcome reached|16|||
163440434|NCT02064439|590315007|FG002|Overall Study|Efficacy outcome reached|57|||
163440435|NCT02064439|590315005|FG000|Overall Study|Safety outcome reached|12|||
163440436|NCT02064439|590315006|FG001|Overall Study|Safety outcome reached|20|||
163440437|NCT02064439|590315007|FG002|Overall Study|Safety outcome reached|10|||
163440438|NCT02064439|590315005|FG000|Overall Study|Other|2|||
163440439|NCT02064439|590315006|FG001|Overall Study|Other|2|||
163440440|NCT02064439|590315007|FG002|Overall Study|Other|7|||
163440441|NCT02433288|590315008|FG000|Overall Study|Severe non-compliance to protocol|13|||
163440442|NCT02433288|590315009|FG001|Overall Study|Severe non-compliance to protocol|7|||
163440443|NCT02433288|590315008|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
163440444|NCT02433288|590315009|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
163440445|NCT02433288|590315008|FG000|Overall Study|Withdrawal by Subject|101|||
163440446|NCT02433288|590315009|FG001|Overall Study|Withdrawal by Subject|99|||
163440447|NCT02433288|590315008|FG000|Overall Study|Lost to Follow-up|2|||
163440448|NCT02433288|590315009|FG001|Overall Study|Lost to Follow-up|14|||
163440449|NCT02433288|590315008|FG000|Overall Study|Death|0|||
163440450|NCT02433288|590315009|FG001|Overall Study|Death|3|||
163440451|NCT00858702|590315012|FG000|Overall Study|Lack of Efficacy|1|||
163440452|NCT00858702|590315013|FG001|Overall Study|Lack of Efficacy|0|||
163440453|NCT00858702|590315012|FG000|Overall Study|Protocol Violation|1|||
163440454|NCT00858702|590315013|FG001|Overall Study|Protocol Violation|1|||
163440455|NCT00858702|590315012|FG000|Overall Study|Other|2|||
163440456|NCT00858702|590315013|FG001|Overall Study|Other|1|||
163440457|NCT00858702|590315012|FG000|Overall Study|Withdrawal by Subject|1|||
163440458|NCT00858702|590315013|FG001|Overall Study|Withdrawal by Subject|0|||
163440459|NCT01740440|590315016|FG000|Overall Study|Lost to Follow-up|3|||
163440460|NCT00367640|590315017|FG000|Overall Study|Adverse Event|3|||
163440461|NCT00367640|590315018|FG001|Overall Study|Adverse Event|6|||
163440462|NCT00367640|590315019|FG002|Overall Study|Adverse Event|8|||
163440463|NCT00367640|590315020|FG003|Overall Study|Adverse Event|0|||
163440464|NCT00367640|590315017|FG000|Overall Study|Withdrawal by Subject|8|||
163440465|NCT00367640|590315018|FG001|Overall Study|Withdrawal by Subject|11|||
163440466|NCT00367640|590315019|FG002|Overall Study|Withdrawal by Subject|8|||
163440467|NCT00367640|590315020|FG003|Overall Study|Withdrawal by Subject|6|||
163440468|NCT00367640|590315017|FG000|Overall Study|Any other reason not above-mentioned|7|||
163440469|NCT00367640|590315018|FG001|Overall Study|Any other reason not above-mentioned|5|||
163440470|NCT00367640|590315019|FG002|Overall Study|Any other reason not above-mentioned|3|||
163440471|NCT00367640|590315020|FG003|Overall Study|Any other reason not above-mentioned|4|||
163440472|NCT02417233|590315021|FG000|Overall Study|Death|4|||
163440473|NCT02417233|590315022|FG001|Overall Study|Death|10|||
163440474|NCT02417233|590315023|FG002|Overall Study|Death|14|||
163440475|NCT02417233|590315021|FG000|Overall Study|Lost to Follow-up|27|||
163440476|NCT02417233|590315022|FG001|Overall Study|Lost to Follow-up|39|||
163440477|NCT02417233|590315023|FG002|Overall Study|Lost to Follow-up|34|||
163440478|NCT02417233|590315021|FG000|Overall Study|Protocol Violation|2|||
163440479|NCT02417233|590315022|FG001|Overall Study|Protocol Violation|0|||
163440480|NCT02417233|590315023|FG002|Overall Study|Protocol Violation|2|||
163440481|NCT02417233|590315021|FG000|Overall Study|Withdrawal by Subject|2|||
163440482|NCT02417233|590315022|FG001|Overall Study|Withdrawal by Subject|1|||
163440483|NCT02417233|590315023|FG002|Overall Study|Withdrawal by Subject|8|||
163440484|NCT02417233|590315021|FG000|Overall Study|Relocation out of study area|1|||
163440485|NCT02417233|590315022|FG001|Overall Study|Relocation out of study area|0|||
163440486|NCT02417233|590315023|FG002|Overall Study|Relocation out of study area|1|||
163440487|NCT02417233|590315021|FG000|Overall Study|Mentally unstable|0|||
163440488|NCT02417233|590315022|FG001|Overall Study|Mentally unstable|1|||
163440489|NCT02417233|590315023|FG002|Overall Study|Mentally unstable|0|||
163440490|NCT01063751|590315024|FG000|Overall Study|Censored from analyses|42|||
163440491|NCT01063751|590315024|FG000|Overall Study|Withdrawal by Subject|34|||
163440492|NCT01063751|590315024|FG000|Overall Study|Lost to Follow-up|30|||
163440493|NCT01063751|590315024|FG000|Overall Study|Death|13|||
163440494|NCT01063751|590315024|FG000|Overall Study|Sponsored Terminated Study|60|||
163440495|NCT01063751|590315024|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
163440496|NCT01063751|590315024|FG000|Overall Study|Investigator site closed|10|||
163440497|NCT01063751|590315024|FG000|Overall Study|Revision|6|||
163440498|NCT01063751|590315024|FG000|Overall Study|Physician Decision|4|||
163440499|NCT02805907|590315025|FG000|Overall Study|Lost to Follow-up|3|||
163440500|NCT02805907|590315026|FG001|Overall Study|Lost to Follow-up|3|||
163440501|NCT03408873|590315031|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
163440502|NCT03408873|590315031|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
163440503|NCT03408873|590315031|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
163440504|NCT03408873|590315031|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
163440505|NCT03408873|590315031|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
163440506|NCT03408873|590315031|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
163440507|NCT01264965|590315037|FG000|Overall Study|Withdrawal by Subject|10|||
163440508|NCT03799718|590315039|FG000|Overall Study|Adverse Event|2|||
163440509|NCT00700752|590315040|FG000|First Intervention|Withdrawal by Subject|0|||
163440510|NCT00700752|590315041|FG001|First Intervention|Withdrawal by Subject|2|||
163440511|NCT03662334|590315042|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
162925350|NCT03901339|588428939|FG001|Overall Study|Death|192|||
163440512|NCT03662334|590315043|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
163440513|NCT01097330|590315044|FG000|Overall Study|Study terminated early|7|||
163440514|NCT01097330|590315045|FG001|Overall Study|Study terminated early|5|||
163440515|NCT03303339|590315051|FG000|Overall Study|Death|2|||
163440516|NCT03303339|590315052|FG001|Overall Study|Death|2|||
163440517|NCT03303339|590315053|FG002|Overall Study|Death|2|||
163440518|NCT03303339|590315054|FG003|Overall Study|Death|1|||
163440519|NCT03303339|590315055|FG004|Overall Study|Death|4|||
163440520|NCT03303339|590315056|FG005|Overall Study|Death|2|||
163440521|NCT03303339|590315057|FG006|Overall Study|Death|2|||
163440522|NCT03303339|590315058|FG007|Overall Study|Death|2|||
163440523|NCT03303339|590315059|FG008|Overall Study|Death|3|||
163440524|NCT03303339|590315060|FG009|Overall Study|Death|3|||
163440525|NCT03303339|590315061|FG010|Overall Study|Death|4|||
163440526|NCT03303339|590315062|FG011|Overall Study|Death|24|||
163440527|NCT03303339|590315051|FG000|Overall Study|Study Terminated by Sponsor|0|||
163440528|NCT03303339|590315052|FG001|Overall Study|Study Terminated by Sponsor|0|||
163440529|NCT03303339|590315053|FG002|Overall Study|Study Terminated by Sponsor|0|||
163440530|NCT03303339|590315054|FG003|Overall Study|Study Terminated by Sponsor|0|||
163440531|NCT03303339|590315055|FG004|Overall Study|Study Terminated by Sponsor|0|||
163440532|NCT03303339|590315056|FG005|Overall Study|Study Terminated by Sponsor|0|||
163440533|NCT03303339|590315057|FG006|Overall Study|Study Terminated by Sponsor|0|||
163440534|NCT03303339|590315058|FG007|Overall Study|Study Terminated by Sponsor|0|||
163440535|NCT03303339|590315059|FG008|Overall Study|Study Terminated by Sponsor|1|||
163440536|NCT03303339|590315060|FG009|Overall Study|Study Terminated by Sponsor|0|||
163440537|NCT03303339|590315061|FG010|Overall Study|Study Terminated by Sponsor|1|||
163440538|NCT03303339|590315062|FG011|Overall Study|Study Terminated by Sponsor|1|||
163440539|NCT03303339|590315051|FG000|Overall Study|Withdrawal by Subject|1|||
163440540|NCT03303339|590315052|FG001|Overall Study|Withdrawal by Subject|0|||
163440541|NCT03303339|590315053|FG002|Overall Study|Withdrawal by Subject|0|||
163440542|NCT03303339|590315054|FG003|Overall Study|Withdrawal by Subject|0|||
163440543|NCT03303339|590315055|FG004|Overall Study|Withdrawal by Subject|0|||
163440544|NCT03303339|590315056|FG005|Overall Study|Withdrawal by Subject|1|||
163440545|NCT03303339|590315057|FG006|Overall Study|Withdrawal by Subject|1|||
163440546|NCT03303339|590315058|FG007|Overall Study|Withdrawal by Subject|0|||
163440547|NCT03303339|590315059|FG008|Overall Study|Withdrawal by Subject|0|||
163440548|NCT03303339|590315060|FG009|Overall Study|Withdrawal by Subject|0|||
163440549|NCT03303339|590315061|FG010|Overall Study|Withdrawal by Subject|0|||
163440550|NCT03303339|590315062|FG011|Overall Study|Withdrawal by Subject|2|||
163440551|NCT03303339|590315051|FG000|Overall Study|Physician Decision|0|||
163440552|NCT03303339|590315052|FG001|Overall Study|Physician Decision|0|||
163440553|NCT03303339|590315053|FG002|Overall Study|Physician Decision|0|||
163440554|NCT03303339|590315054|FG003|Overall Study|Physician Decision|0|||
163440555|NCT03303339|590315055|FG004|Overall Study|Physician Decision|1|||
163440556|NCT03303339|590315056|FG005|Overall Study|Physician Decision|0|||
163440557|NCT03303339|590315057|FG006|Overall Study|Physician Decision|0|||
163440558|NCT03303339|590315058|FG007|Overall Study|Physician Decision|0|||
163440559|NCT03303339|590315059|FG008|Overall Study|Physician Decision|0|||
163440560|NCT03303339|590315060|FG009|Overall Study|Physician Decision|0|||
163440561|NCT03303339|590315061|FG010|Overall Study|Physician Decision|0|||
163440562|NCT03303339|590315062|FG011|Overall Study|Physician Decision|0|||
163440563|NCT03303339|590315051|FG000|Overall Study|Safety/Non-compliance|0|||
163440564|NCT03303339|590315052|FG001|Overall Study|Safety/Non-compliance|0|||
163440565|NCT03303339|590315053|FG002|Overall Study|Safety/Non-compliance|0|||
163440566|NCT03303339|590315054|FG003|Overall Study|Safety/Non-compliance|0|||
163440567|NCT03303339|590315055|FG004|Overall Study|Safety/Non-compliance|0|||
163440568|NCT03303339|590315056|FG005|Overall Study|Safety/Non-compliance|0|||
163440569|NCT03303339|590315057|FG006|Overall Study|Safety/Non-compliance|0|||
163440570|NCT03303339|590315058|FG007|Overall Study|Safety/Non-compliance|0|||
163440571|NCT03303339|590315059|FG008|Overall Study|Safety/Non-compliance|0|||
163440572|NCT03303339|590315060|FG009|Overall Study|Safety/Non-compliance|0|||
163440573|NCT03303339|590315061|FG010|Overall Study|Safety/Non-compliance|0|||
163440574|NCT03303339|590315062|FG011|Overall Study|Safety/Non-compliance|1|||
163440575|NCT00510692|590315064|FG000|Overall Study|Adverse Event|1|||
163440576|NCT00510692|590315065|FG001|Overall Study|Adverse Event|3|||
163440577|NCT00510692|590315064|FG000|Overall Study|Withdrawal by Subject|1|||
163440578|NCT00510692|590315065|FG001|Overall Study|Withdrawal by Subject|0|||
163440579|NCT02116972|590315066|FG000|Overall Study|Adverse Event|4|||
163440580|NCT02116972|590315067|FG001|Overall Study|Adverse Event|4|||
163440581|NCT02116972|590315068|FG002|Overall Study|Adverse Event|1|||
163440582|NCT02116972|590315066|FG000|Overall Study|Withdrawal by Subject|1|||
163440583|NCT02116972|590315067|FG001|Overall Study|Withdrawal by Subject|1|||
163440584|NCT02116972|590315068|FG002|Overall Study|Withdrawal by Subject|5|||
163440585|NCT02116972|590315066|FG000|Overall Study|Protocol Violation|1|||
163440586|NCT02116972|590315067|FG001|Overall Study|Protocol Violation|0|||
163440587|NCT02116972|590315068|FG002|Overall Study|Protocol Violation|1|||
163440588|NCT02116972|590315066|FG000|Overall Study|Lost to Follow-up|4|||
163440589|NCT02116972|590315067|FG001|Overall Study|Lost to Follow-up|3|||
163440590|NCT02116972|590315068|FG002|Overall Study|Lost to Follow-up|1|||
163440591|NCT02116972|590315066|FG000|Overall Study|Lack of Efficacy|6|||
163440592|NCT02116972|590315067|FG001|Overall Study|Lack of Efficacy|6|||
163440593|NCT02116972|590315068|FG002|Overall Study|Lack of Efficacy|5|||
163440594|NCT02116972|590315066|FG000|Overall Study|scheduling conflicts and relocation|3|||
163440595|NCT02116972|590315067|FG001|Overall Study|scheduling conflicts and relocation|3|||
163440596|NCT02116972|590315068|FG002|Overall Study|scheduling conflicts and relocation|6|||
163440597|NCT00784784|590315069|FG000|Overall Study|Withdrawal by Subject|2|||
163440598|NCT00784784|590315070|FG001|Overall Study|Withdrawal by Subject|2|||
163440599|NCT00872898|590315071|FG000|Part Two - Double Blind|Adverse Event|4|||
163440600|NCT00872898|590315072|FG001|Part Two - Double Blind|Adverse Event|3|||
163440601|NCT00872898|590315071|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
163440602|NCT00872898|590315072|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
163440603|NCT00872898|590315071|FG000|Part Two - Double Blind|Protocol Violation|1|||
163440604|NCT00872898|590315072|FG001|Part Two - Double Blind|Protocol Violation|0|||
163440605|NCT00872898|590315071|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
163440606|NCT00872898|590315072|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
163440607|NCT00872898|590315071|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
163440608|NCT00872898|590315072|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
163440609|NCT00872898|590315071|FG000|Part Two - Double Blind|Other reasons|2|||
163440610|NCT00872898|590315072|FG001|Part Two - Double Blind|Other reasons|0|||
163440611|NCT03176966|590315075|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
163440612|NCT03176966|590315076|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
163440613|NCT03176966|590315075|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
163440614|NCT03176966|590315076|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
163440615|NCT03176966|590315075|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
163440616|NCT03176966|590315076|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
163440617|NCT03176966|590315075|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
163440618|NCT03176966|590315076|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
163440619|NCT03176966|590315075|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
163440620|NCT03176966|590315076|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
163440621|NCT03176966|590315075|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
163440622|NCT03176966|590315076|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
163440623|NCT03176966|590315075|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
163440624|NCT03176966|590315076|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
163440625|NCT01903434|590315081|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
163440626|NCT01903434|590315082|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
163440627|NCT01903434|590315081|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
163440628|NCT01903434|590315082|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
163440629|NCT00404768|590315083|FG000|Part A and B|Withdrawn due to labor progression|1|||
163440630|NCT00404768|590315084|FG001|Part A and B|Withdrawn due to labor progression|0|||
163440631|NCT00404768|590315085|FG002|Part A and B|Withdrawn due to labor progression|0|||
163440632|NCT00404768|590315086|FG003|Part A and B|Withdrawn due to labor progression|0|||
163440633|NCT00404768|590315083|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
163440634|NCT00404768|590315084|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
163440635|NCT00404768|590315085|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
163440636|NCT00404768|590315086|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
163440637|NCT00404768|590315083|FG000|Part C|Adverse Event|0|||
163440638|NCT00404768|590315084|FG001|Part C|Adverse Event|0|||
163440639|NCT00404768|590315085|FG002|Part C|Adverse Event|0|||
163440640|NCT00404768|590315086|FG003|Part C|Adverse Event|3|||
163440641|NCT00404768|590315083|FG000|Part C|Lost to Follow-up|0|||
163440642|NCT00404768|590315084|FG001|Part C|Lost to Follow-up|0|||
163440643|NCT00404768|590315085|FG002|Part C|Lost to Follow-up|3|||
163440644|NCT00404768|590315086|FG003|Part C|Lost to Follow-up|1|||
163440645|NCT00404768|590315083|FG000|Part C|Withdrawal by Subject|0|||
163440646|NCT00404768|590315084|FG001|Part C|Withdrawal by Subject|0|||
163440647|NCT00404768|590315085|FG002|Part C|Withdrawal by Subject|2|||
163440648|NCT00404768|590315086|FG003|Part C|Withdrawal by Subject|1|||
163440649|NCT00404768|590315083|FG000|Part C|Early withdrawal from study medication|0|||
163440650|NCT00404768|590315084|FG001|Part C|Early withdrawal from study medication|0|||
163440651|NCT00404768|590315085|FG002|Part C|Early withdrawal from study medication|1|||
163440652|NCT00404768|590315086|FG003|Part C|Early withdrawal from study medication|0|||
163440653|NCT00404768|590315083|FG000|Part C|Participant did not respond to therapy|0|||
163440654|NCT00404768|590315084|FG001|Part C|Participant did not respond to therapy|0|||
163440655|NCT00404768|590315085|FG002|Part C|Participant did not respond to therapy|1|||
163440656|NCT00404768|590315086|FG003|Part C|Participant did not respond to therapy|1|||
163440657|NCT00404768|590315083|FG000|Part C|Physician withdrew the study medication|0|||
163440658|NCT00404768|590315084|FG001|Part C|Physician withdrew the study medication|0|||
163440659|NCT00404768|590315085|FG002|Part C|Physician withdrew the study medication|1|||
163440660|NCT00404768|590315086|FG003|Part C|Physician withdrew the study medication|0|||
163440661|NCT00404768|590315083|FG000|Part C|Participant delivered baby|0|||
163440662|NCT00404768|590315084|FG001|Part C|Participant delivered baby|0|||
163440663|NCT00404768|590315085|FG002|Part C|Participant delivered baby|0|||
163440664|NCT00404768|590315086|FG003|Part C|Participant delivered baby|1|||
163440665|NCT00404768|590315083|FG000|Part C|Unsatisfactory uterine response to IP|0|||
163440666|NCT00404768|590315084|FG001|Part C|Unsatisfactory uterine response to IP|0|||
163440667|NCT00404768|590315085|FG002|Part C|Unsatisfactory uterine response to IP|0|||
163440668|NCT00404768|590315086|FG003|Part C|Unsatisfactory uterine response to IP|1|||
163440669|NCT00404768|590315083|FG000|Part C|Active labor|0|||
163440670|NCT00404768|590315084|FG001|Part C|Active labor|0|||
163440671|NCT00404768|590315085|FG002|Part C|Active labor|0|||
163440672|NCT00404768|590315086|FG003|Part C|Active labor|1|||
163440673|NCT00404768|590315083|FG000|Part C|Lack of Efficacy|0|||
163440674|NCT00404768|590315084|FG001|Part C|Lack of Efficacy|0|||
163440675|NCT00404768|590315085|FG002|Part C|Lack of Efficacy|0|||
163440676|NCT00404768|590315086|FG003|Part C|Lack of Efficacy|2|||
163440677|NCT00404768|590315083|FG000|Part C|Treatment failure|0|||
163440678|NCT00404768|590315084|FG001|Part C|Treatment failure|0|||
163440679|NCT00404768|590315085|FG002|Part C|Treatment failure|0|||
163440680|NCT00404768|590315086|FG003|Part C|Treatment failure|1|||
163440681|NCT00404768|590315083|FG000|Part C|Investigator discretion|0|||
163440682|NCT00404768|590315084|FG001|Part C|Investigator discretion|0|||
163440683|NCT00404768|590315085|FG002|Part C|Investigator discretion|0|||
163440684|NCT00404768|590315086|FG003|Part C|Investigator discretion|1|||
163440685|NCT00404768|590315083|FG000|Part C|Researcher suspended study medication|0|||
163440686|NCT00404768|590315084|FG001|Part C|Researcher suspended study medication|0|||
163440687|NCT00404768|590315085|FG002|Part C|Researcher suspended study medication|0|||
163440688|NCT00404768|590315086|FG003|Part C|Researcher suspended study medication|1|||
163440689|NCT01118143|590315087|FG000|Overall Study|Withdrawal by Subject|2|||
163440690|NCT01118143|590315088|FG001|Overall Study|Withdrawal by Subject|5|||
163440691|NCT01158534|590317049|FG000|Overall Study|Withdrawal by Subject|1|||
163440692|NCT01158534|590317049|FG000|Overall Study|Death|1|||
163440693|NCT01158534|590317049|FG000|Overall Study|Other|1|||
163440694|NCT01115569|590317050|FG000|Conversion/Titration Phase|Adverse Event|59|||
163440695|NCT01115569|590317051|FG001|Conversion/Titration Phase|Adverse Event|0|||
163440696|NCT01115569|590317050|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
163440697|NCT01115569|590317051|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
163440698|NCT01115569|590317050|FG000|Conversion/Titration Phase|Physician Decision|5|||
163440699|NCT01115569|590317051|FG001|Conversion/Titration Phase|Physician Decision|0|||
163440700|NCT01115569|590317050|FG000|Conversion/Titration Phase|Protocol Violation|68|||
163440701|NCT01115569|590317051|FG001|Conversion/Titration Phase|Protocol Violation|0|||
163440702|NCT01115569|590317050|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
163440703|NCT01115569|590317051|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
163440704|NCT01115569|590317050|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
163440705|NCT01115569|590317051|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
163440706|NCT01115569|590317050|FG000|Maintenance Phase|Adverse Event|0|||
163440707|NCT01115569|590317051|FG001|Maintenance Phase|Adverse Event|43|||
163440708|NCT01115569|590317050|FG000|Maintenance Phase|Lost to Follow-up|0|||
163440709|NCT01115569|590317051|FG001|Maintenance Phase|Lost to Follow-up|8|||
163440710|NCT01115569|590317050|FG000|Maintenance Phase|Physician Decision|0|||
163440711|NCT01115569|590317051|FG001|Maintenance Phase|Physician Decision|3|||
163440712|NCT01115569|590317050|FG000|Maintenance Phase|Protocol Violation|0|||
163440713|NCT01115569|590317051|FG001|Maintenance Phase|Protocol Violation|9|||
163440714|NCT01115569|590317050|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163440715|NCT01115569|590317051|FG001|Maintenance Phase|Withdrawal by Subject|27|||
163440716|NCT01115569|590317050|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
163440717|NCT01115569|590317051|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
163440718|NCT01115569|590317050|FG000|Maintenance Phase|Administrative|0|||
163440719|NCT01115569|590317051|FG001|Maintenance Phase|Administrative|1|||
163440720|NCT01614769|590317052|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
163440721|NCT01614769|590317053|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
163440722|NCT01614769|590317054|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
163440723|NCT01614769|590317055|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
163440724|NCT01614769|590317056|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
163440725|NCT01614769|590317057|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
163440726|NCT01614769|590317052|FG000|Period 1|Protocol Violation|0|||
163440727|NCT01614769|590317053|FG001|Period 1|Protocol Violation|0|||
163440728|NCT01614769|590317054|FG002|Period 1|Protocol Violation|0|||
163440729|NCT01614769|590317055|FG003|Period 1|Protocol Violation|1|||
163440730|NCT01614769|590317056|FG004|Period 1|Protocol Violation|0|||
163440731|NCT01614769|590317057|FG005|Period 1|Protocol Violation|0|||
163440732|NCT01614769|590317052|FG000|Period 1|Withdrawal by Subject|1|||
163440733|NCT01614769|590317053|FG001|Period 1|Withdrawal by Subject|0|||
163440734|NCT01614769|590317054|FG002|Period 1|Withdrawal by Subject|0|||
163440735|NCT01614769|590317055|FG003|Period 1|Withdrawal by Subject|0|||
163440736|NCT01614769|590317056|FG004|Period 1|Withdrawal by Subject|0|||
163440737|NCT01614769|590317057|FG005|Period 1|Withdrawal by Subject|0|||
163440738|NCT01614769|590317052|FG000|Period 3|Withdrawal by Subject|0|||
163440739|NCT01614769|590317053|FG001|Period 3|Withdrawal by Subject|0|||
163440740|NCT01614769|590317054|FG002|Period 3|Withdrawal by Subject|1|||
163440741|NCT01614769|590317055|FG003|Period 3|Withdrawal by Subject|0|||
163440742|NCT01614769|590317056|FG004|Period 3|Withdrawal by Subject|0|||
163440743|NCT01614769|590317057|FG005|Period 3|Withdrawal by Subject|0|||
163440744|NCT00960440|590317060|FG000|Overall Study|Death|0|||
163440745|NCT00960440|590317061|FG001|Overall Study|Death|0|||
163440746|NCT00960440|590317062|FG002|Overall Study|Death|0|||
163440747|NCT00960440|590317063|FG003|Overall Study|Death|1|||
163440748|NCT00960440|590317060|FG000|Overall Study|Adverse Event|12|||
163440749|NCT00960440|590317061|FG001|Overall Study|Adverse Event|12|||
163440750|NCT00960440|590317062|FG002|Overall Study|Adverse Event|4|||
163440751|NCT00960440|590317063|FG003|Overall Study|Adverse Event|4|||
163440752|NCT00960440|590317060|FG000|Overall Study|Lack of Efficacy|2|||
163440753|NCT00960440|590317061|FG001|Overall Study|Lack of Efficacy|5|||
163440754|NCT00960440|590317062|FG002|Overall Study|Lack of Efficacy|3|||
163440755|NCT00960440|590317063|FG003|Overall Study|Lack of Efficacy|8|||
163440756|NCT00960440|590317060|FG000|Overall Study|Protocol Violation|2|||
163440757|NCT00960440|590317061|FG001|Overall Study|Protocol Violation|8|||
163440758|NCT00960440|590317062|FG002|Overall Study|Protocol Violation|3|||
163440759|NCT00960440|590317063|FG003|Overall Study|Protocol Violation|4|||
163440760|NCT00960440|590317060|FG000|Overall Study|Withdrawal by Subject|9|||
163440761|NCT00960440|590317061|FG001|Overall Study|Withdrawal by Subject|5|||
163440762|NCT00960440|590317062|FG002|Overall Study|Withdrawal by Subject|2|||
163440763|NCT00960440|590317063|FG003|Overall Study|Withdrawal by Subject|1|||
163440764|NCT00960440|590317060|FG000|Overall Study|Other|1|||
163440765|NCT00960440|590317061|FG001|Overall Study|Other|1|||
163440766|NCT00960440|590317062|FG002|Overall Study|Other|1|||
163440767|NCT00960440|590317063|FG003|Overall Study|Other|0|||
163440768|NCT03504774|590317064|FG000|Overall Study|Adverse Event|2|||
163440769|NCT03504774|590317065|FG001|Overall Study|Adverse Event|0|||
163440770|NCT03504774|590317064|FG000|Overall Study|Lost to Follow-up|0|||
163440771|NCT03504774|590317065|FG001|Overall Study|Lost to Follow-up|1|||
163440772|NCT03504774|590317064|FG000|Overall Study|Protocol Violation|11|||
163440773|NCT03504774|590317065|FG001|Overall Study|Protocol Violation|3|||
163440774|NCT03504774|590317064|FG000|Overall Study|failed wk 52 DBPCFC|1|||
163440775|NCT03504774|590317065|FG001|Overall Study|failed wk 52 DBPCFC|0|||
163440776|NCT01781429|590317068|FG000|Overall Study|Death|0|||
163440777|NCT01781429|590317069|FG001|Overall Study|Death|0|||
163440778|NCT01781429|590317070|FG002|Overall Study|Death|0|||
163440779|NCT01781429|590317071|FG003|Overall Study|Death|0|||
163440780|NCT01781429|590317072|FG004|Overall Study|Death|0|||
163440781|NCT01781429|590317073|FG005|Overall Study|Death|0|||
163440782|NCT01781429|590317074|FG006|Overall Study|Death|0|||
163440783|NCT01781429|590317075|FG007|Overall Study|Death|0|||
163440784|NCT01781429|590317076|FG008|Overall Study|Death|0|||
163440785|NCT01781429|590317077|FG009|Overall Study|Death|1|||
163440786|NCT01781429|590317078|FG010|Overall Study|Death|0|||
163440787|NCT01781429|590317079|FG011|Overall Study|Death|0|||
163440788|NCT01781429|590317080|FG012|Overall Study|Death|1|||
163440789|NCT01781429|590317081|FG013|Overall Study|Death|0|||
163440790|NCT01781429|590317082|FG014|Overall Study|Death|1|||
163440791|NCT01781429|590317083|FG015|Overall Study|Death|0|||
163440792|NCT01781429|590317068|FG000|Overall Study|Withdrawal by Subject|0|||
163440793|NCT01781429|590317069|FG001|Overall Study|Withdrawal by Subject|0|||
163440794|NCT01781429|590317070|FG002|Overall Study|Withdrawal by Subject|0|||
163440795|NCT01781429|590317071|FG003|Overall Study|Withdrawal by Subject|0|||
163440796|NCT01781429|590317072|FG004|Overall Study|Withdrawal by Subject|0|||
163440797|NCT01781429|590317073|FG005|Overall Study|Withdrawal by Subject|0|||
163440798|NCT01781429|590317074|FG006|Overall Study|Withdrawal by Subject|0|||
163440799|NCT01781429|590317075|FG007|Overall Study|Withdrawal by Subject|0|||
163440800|NCT01781429|590317076|FG008|Overall Study|Withdrawal by Subject|1|||
163440801|NCT01781429|590317077|FG009|Overall Study|Withdrawal by Subject|3|||
163440802|NCT01781429|590317078|FG010|Overall Study|Withdrawal by Subject|1|||
163440803|NCT01781429|590317079|FG011|Overall Study|Withdrawal by Subject|1|||
163440804|NCT01781429|590317080|FG012|Overall Study|Withdrawal by Subject|5|||
163440805|NCT01781429|590317081|FG013|Overall Study|Withdrawal by Subject|2|||
163440806|NCT01781429|590317082|FG014|Overall Study|Withdrawal by Subject|3|||
163440807|NCT01781429|590317083|FG015|Overall Study|Withdrawal by Subject|0|||
163440808|NCT01781429|590317068|FG000|Overall Study|Disease Progression|1|||
163440809|NCT01781429|590317069|FG001|Overall Study|Disease Progression|0|||
163440810|NCT01781429|590317070|FG002|Overall Study|Disease Progression|1|||
163440811|NCT01781429|590317071|FG003|Overall Study|Disease Progression|1|||
163440812|NCT01781429|590317072|FG004|Overall Study|Disease Progression|1|||
163440813|NCT01781429|590317073|FG005|Overall Study|Disease Progression|4|||
163440814|NCT01781429|590317074|FG006|Overall Study|Disease Progression|7|||
163440815|NCT01781429|590317075|FG007|Overall Study|Disease Progression|4|||
163440816|NCT01781429|590317076|FG008|Overall Study|Disease Progression|6|||
163440817|NCT01781429|590317077|FG009|Overall Study|Disease Progression|15|||
163440818|NCT01781429|590317078|FG010|Overall Study|Disease Progression|15|||
163440819|NCT01781429|590317079|FG011|Overall Study|Disease Progression|15|||
163440820|NCT01781429|590317080|FG012|Overall Study|Disease Progression|15|||
163440821|NCT01781429|590317081|FG013|Overall Study|Disease Progression|4|||
163440822|NCT01781429|590317082|FG014|Overall Study|Disease Progression|11|||
163440823|NCT01781429|590317083|FG015|Overall Study|Disease Progression|0|||
163440824|NCT01781429|590317068|FG000|Overall Study|Unacceptable Toxicity|0|||
163440825|NCT01781429|590317069|FG001|Overall Study|Unacceptable Toxicity|0|||
163440826|NCT01781429|590317070|FG002|Overall Study|Unacceptable Toxicity|0|||
163440827|NCT01781429|590317071|FG003|Overall Study|Unacceptable Toxicity|0|||
163440828|NCT01781429|590317072|FG004|Overall Study|Unacceptable Toxicity|0|||
163440829|NCT01781429|590317073|FG005|Overall Study|Unacceptable Toxicity|0|||
163440830|NCT01781429|590317074|FG006|Overall Study|Unacceptable Toxicity|0|||
163440831|NCT01781429|590317075|FG007|Overall Study|Unacceptable Toxicity|0|||
163440832|NCT01781429|590317076|FG008|Overall Study|Unacceptable Toxicity|0|||
163440833|NCT01781429|590317077|FG009|Overall Study|Unacceptable Toxicity|0|||
163440834|NCT01781429|590317078|FG010|Overall Study|Unacceptable Toxicity|0|||
163440835|NCT01781429|590317079|FG011|Overall Study|Unacceptable Toxicity|2|||
163440836|NCT01781429|590317080|FG012|Overall Study|Unacceptable Toxicity|0|||
163440837|NCT01781429|590317081|FG013|Overall Study|Unacceptable Toxicity|0|||
163440838|NCT01781429|590317082|FG014|Overall Study|Unacceptable Toxicity|0|||
163440839|NCT01781429|590317083|FG015|Overall Study|Unacceptable Toxicity|0|||
163440840|NCT01781429|590317068|FG000|Overall Study|Patient Condition Changed|0|||
163440841|NCT01781429|590317069|FG001|Overall Study|Patient Condition Changed|0|||
163440842|NCT01781429|590317070|FG002|Overall Study|Patient Condition Changed|0|||
163440843|NCT01781429|590317071|FG003|Overall Study|Patient Condition Changed|0|||
163440844|NCT01781429|590317072|FG004|Overall Study|Patient Condition Changed|0|||
163440845|NCT01781429|590317073|FG005|Overall Study|Patient Condition Changed|0|||
163440846|NCT01781429|590317074|FG006|Overall Study|Patient Condition Changed|0|||
163440847|NCT01781429|590317075|FG007|Overall Study|Patient Condition Changed|0|||
163440848|NCT01781429|590317076|FG008|Overall Study|Patient Condition Changed|0|||
163440849|NCT01781429|590317077|FG009|Overall Study|Patient Condition Changed|4|||
163440850|NCT01781429|590317078|FG010|Overall Study|Patient Condition Changed|0|||
163440851|NCT01781429|590317079|FG011|Overall Study|Patient Condition Changed|1|||
163440852|NCT01781429|590317080|FG012|Overall Study|Patient Condition Changed|0|||
163440853|NCT01781429|590317081|FG013|Overall Study|Patient Condition Changed|1|||
163440854|NCT01781429|590317082|FG014|Overall Study|Patient Condition Changed|0|||
163440855|NCT01781429|590317083|FG015|Overall Study|Patient Condition Changed|0|||
163440856|NCT01781429|590317068|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
163440857|NCT01781429|590317069|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
163440858|NCT01781429|590317070|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
163440859|NCT01781429|590317071|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
163440860|NCT01781429|590317072|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
163440861|NCT01781429|590317073|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
163440862|NCT01781429|590317074|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
163440863|NCT01781429|590317075|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
163440864|NCT01781429|590317076|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
163440865|NCT01781429|590317077|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
163440866|NCT01781429|590317078|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
163440867|NCT01781429|590317079|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
163440868|NCT01781429|590317080|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
163440869|NCT01781429|590317081|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
163440870|NCT01781429|590317082|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
163440871|NCT01781429|590317083|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
163440872|NCT01781429|590317068|FG000|Overall Study|Enrolled, but not treated|0|||
163440873|NCT01781429|590317069|FG001|Overall Study|Enrolled, but not treated|0|||
163440874|NCT01781429|590317070|FG002|Overall Study|Enrolled, but not treated|0|||
163440875|NCT01781429|590317071|FG003|Overall Study|Enrolled, but not treated|0|||
163440876|NCT01781429|590317072|FG004|Overall Study|Enrolled, but not treated|0|||
163440877|NCT01781429|590317073|FG005|Overall Study|Enrolled, but not treated|0|||
163440878|NCT01781429|590317074|FG006|Overall Study|Enrolled, but not treated|0|||
163440879|NCT01781429|590317075|FG007|Overall Study|Enrolled, but not treated|0|||
163440880|NCT01781429|590317076|FG008|Overall Study|Enrolled, but not treated|0|||
163440881|NCT01781429|590317077|FG009|Overall Study|Enrolled, but not treated|0|||
163440882|NCT01781429|590317078|FG010|Overall Study|Enrolled, but not treated|1|||
163440883|NCT01781429|590317079|FG011|Overall Study|Enrolled, but not treated|0|||
163440884|NCT01781429|590317080|FG012|Overall Study|Enrolled, but not treated|0|||
163440885|NCT01781429|590317081|FG013|Overall Study|Enrolled, but not treated|0|||
163440886|NCT01781429|590317082|FG014|Overall Study|Enrolled, but not treated|0|||
163440887|NCT01781429|590317083|FG015|Overall Study|Enrolled, but not treated|0|||
163440888|NCT03238248|590317084|FG000|Overall Study|Death|5|||
163440889|NCT03238248|590317084|FG000|Overall Study|Withdrawal by Subject|7|||
163440890|NCT03238248|590317084|FG000|Overall Study|Participant proceeding to transplant|10|||
163440891|NCT03238248|590317084|FG000|Overall Study|Lack of Efficacy|4|||
163440892|NCT03238248|590317084|FG000|Overall Study|Physician Decision|3|||
163440893|NCT03238248|590317084|FG000|Overall Study|Transitioning to another study|1|||
163440894|NCT03238248|590317084|FG000|Overall Study|No longer benefiting|1|||
163440895|NCT03238248|590317084|FG000|Overall Study|Other complicating disease|1|||
163440896|NCT03238248|590317084|FG000|Overall Study|Adverse Event|5|||
163440897|NCT03238248|590317084|FG000|Overall Study|Disease progression|26|||
163440898|NCT03238248|590317084|FG000|Overall Study|N/A participant is still on treatment|1|||
163440899|NCT03238248|590317084|FG000|Overall Study|Decline in condition|1|||
163440900|NCT03238248|590317084|FG000|Overall Study|Alternative therapy|2|||
163440901|NCT02385123|590317087|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
163440902|NCT04498910|590317088|FG000|Overall Study|Lost to Follow-up|0|||
163440903|NCT04498910|590317089|FG001|Overall Study|Lost to Follow-up|1|||
163440904|NCT04498910|590317088|FG000|Overall Study|Withdrawal by Subject|2|||
163440905|NCT04498910|590317089|FG001|Overall Study|Withdrawal by Subject|1|||
163440906|NCT04498910|590317088|FG000|Overall Study|Adverse Event|1|||
163440907|NCT04498910|590317089|FG001|Overall Study|Adverse Event|0|||
163440908|NCT02345434|590317091|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
163440909|NCT02345434|590317092|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
163440910|NCT01188798|590317101|FG000|Overall Study|Death|0|||
163440911|NCT01188798|590317102|FG001|Overall Study|Death|1|||
163440912|NCT01188798|590317101|FG000|Overall Study|Required additional transplant|1|||
163440913|NCT01188798|590317102|FG001|Overall Study|Required additional transplant|1|||
163440914|NCT01188798|590317101|FG000|Overall Study|Protocol closure|1|||
163440915|NCT01188798|590317102|FG001|Overall Study|Protocol closure|1|||
163440916|NCT03964415|590317108|FG000|Overall Study|Sponsor's decision|1563|||
163440917|NCT03964415|590317109|FG001|Overall Study|Sponsor's decision|1528|||
163440918|NCT03964415|590317108|FG000|Overall Study|Lost to Follow-up|139|||
163440919|NCT03964415|590317109|FG001|Overall Study|Lost to Follow-up|146|||
163440920|NCT03964415|590317108|FG000|Overall Study|Withdrawal by Subject|68|||
163440921|NCT03964415|590317109|FG001|Overall Study|Withdrawal by Subject|72|||
163440922|NCT03964415|590317108|FG000|Overall Study|Physician Decision|34|||
163440923|NCT03964415|590317109|FG001|Overall Study|Physician Decision|48|||
163440924|NCT03964415|590317108|FG000|Overall Study|Adverse Event|3|||
163440925|NCT03964415|590317109|FG001|Overall Study|Adverse Event|0|||
163440926|NCT03964415|590317108|FG000|Overall Study|Death|4|||
163440927|NCT03964415|590317109|FG001|Overall Study|Death|6|||
163440928|NCT03964415|590317108|FG000|Overall Study|Protocol Violation|1|||
163440929|NCT03964415|590317109|FG001|Overall Study|Protocol Violation|4|||
163440930|NCT03964415|590317108|FG000|Overall Study|Other|35|||
163440931|NCT03964415|590317109|FG001|Overall Study|Other|38|||
163440932|NCT03964415|590317108|FG000|Overall Study|Randomized but not treated|6|||
163440933|NCT03964415|590317109|FG001|Overall Study|Randomized but not treated|7|||
163440934|NCT01302769|590317110|FG000|Overall Study|Lost to Follow-up|1|||
163440935|NCT01302769|590317111|FG001|Overall Study|Lost to Follow-up|1|||
163440936|NCT01734993|590317119|FG000|Overall Study|Adverse Event|1|||
163440937|NCT01734993|590317119|FG000|Overall Study|Lack of Efficacy|1|||
163440938|NCT01024465|590317120|FG000|Overall Study|Adverse Event|2|||
163440939|NCT01024465|590317120|FG000|Overall Study|Physician Decision|1|||
163440940|NCT03078608|590317122|FG000|Overall Study|Death|1|||
163440941|NCT03078608|590317123|FG001|Overall Study|Death|2|||
163440942|NCT03078608|590317124|FG002|Overall Study|Death|0|||
163440943|NCT03078608|590317125|FG003|Overall Study|Death|0|||
163440944|NCT03078608|590317122|FG000|Overall Study|Withdrawal by Subject|8|||
163440945|NCT03078608|590317123|FG001|Overall Study|Withdrawal by Subject|1|||
163440946|NCT03078608|590317124|FG002|Overall Study|Withdrawal by Subject|0|||
163440947|NCT03078608|590317125|FG003|Overall Study|Withdrawal by Subject|0|||
163440948|NCT03078608|590317122|FG000|Overall Study|Lost to Follow-up|5|||
163440949|NCT03078608|590317123|FG001|Overall Study|Lost to Follow-up|8|||
163440950|NCT03078608|590317124|FG002|Overall Study|Lost to Follow-up|4|||
163440951|NCT03078608|590317125|FG003|Overall Study|Lost to Follow-up|1|||
163440952|NCT00723840|590317126|FG000|Overall Study|Lost to Follow-up|2|||
163440953|NCT00723840|590317126|FG000|Overall Study|Failure to return|18|||
163440954|NCT00723840|590317126|FG000|Overall Study|Withdrawal by Subject|55|||
163440955|NCT00723840|590317126|FG000|Overall Study|Serious Adverse Events|3|||
163440956|NCT00723840|590317126|FG000|Overall Study|Other Medical Event|2|||
163440957|NCT00723840|590317126|FG000|Overall Study|Unspecified reason|2|||
163440958|NCT02760407|590317133|FG000|Overall Study|Death|2|||
163440959|NCT02760407|590317134|FG001|Overall Study|Death|3|||
163440960|NCT02760407|590317135|FG002|Overall Study|Death|1|||
163440961|NCT02760407|590317136|FG003|Overall Study|Death|1|||
163440962|NCT02760407|590317133|FG000|Overall Study|Lost to Follow-up|1|||
163440963|NCT02760407|590317134|FG001|Overall Study|Lost to Follow-up|7|||
163440964|NCT02760407|590317135|FG002|Overall Study|Lost to Follow-up|4|||
163440965|NCT02760407|590317136|FG003|Overall Study|Lost to Follow-up|6|||
163440966|NCT02760407|590317133|FG000|Overall Study|Withdrawal by Subject|25|||
163440967|NCT02760407|590317134|FG001|Overall Study|Withdrawal by Subject|31|||
163440968|NCT02760407|590317135|FG002|Overall Study|Withdrawal by Subject|37|||
163440969|NCT02760407|590317136|FG003|Overall Study|Withdrawal by Subject|25|||
163440970|NCT02760407|590317133|FG000|Overall Study|Violation of Eligibility criteria|0|||
163440971|NCT02760407|590317134|FG001|Overall Study|Violation of Eligibility criteria|0|||
163440972|NCT02760407|590317135|FG002|Overall Study|Violation of Eligibility criteria|1|||
163440973|NCT02760407|590317136|FG003|Overall Study|Violation of Eligibility criteria|1|||
163440974|NCT02760407|590317133|FG000|Overall Study|Personal reasons|0|||
163440975|NCT02760407|590317134|FG001|Overall Study|Personal reasons|0|||
163440976|NCT02760407|590317135|FG002|Overall Study|Personal reasons|0|||
163440977|NCT02760407|590317136|FG003|Overall Study|Personal reasons|1|||
163440978|NCT02760407|590317133|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
163440979|NCT02760407|590317134|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
163440980|NCT02760407|590317135|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
163440981|NCT02760407|590317136|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
163440982|NCT02760407|590317133|FG000|Overall Study|Use of prohibited Medication|0|||
163440983|NCT02760407|590317134|FG001|Overall Study|Use of prohibited Medication|0|||
163440984|NCT02760407|590317135|FG002|Overall Study|Use of prohibited Medication|1|||
163440985|NCT02760407|590317136|FG003|Overall Study|Use of prohibited Medication|0|||
163440986|NCT02760407|590317133|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
163440987|NCT02760407|590317134|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
163440988|NCT02760407|590317135|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
163440989|NCT02760407|590317136|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
163440990|NCT02760407|590317133|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
163440991|NCT02760407|590317134|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
163440992|NCT02760407|590317135|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
163440993|NCT02760407|590317136|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
163440994|NCT02760407|590317133|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
163440995|NCT02760407|590317134|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
163440996|NCT02760407|590317135|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
163440997|NCT02760407|590317136|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
163440998|NCT02760407|590317133|FG000|Overall Study|Inadequately Enrolled|0|||
163440999|NCT02760407|590317134|FG001|Overall Study|Inadequately Enrolled|0|||
163441000|NCT02760407|590317135|FG002|Overall Study|Inadequately Enrolled|0|||
163441001|NCT02760407|590317136|FG003|Overall Study|Inadequately Enrolled|1|||
163441002|NCT02760407|590317133|FG000|Overall Study|Withdrawal By PI's Decision|0|||
163441003|NCT02760407|590317134|FG001|Overall Study|Withdrawal By PI's Decision|1|||
163441004|NCT02760407|590317135|FG002|Overall Study|Withdrawal By PI's Decision|0|||
163441005|NCT02760407|590317136|FG003|Overall Study|Withdrawal By PI's Decision|0|||
163441006|NCT02760407|590317133|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
163441007|NCT02760407|590317134|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
163441008|NCT02760407|590317135|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
163441009|NCT02760407|590317136|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
163441010|NCT02760407|590317133|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
163441011|NCT02760407|590317134|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
163441012|NCT02760407|590317135|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
163441013|NCT02760407|590317136|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
163441014|NCT02760407|590317133|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
163441015|NCT02760407|590317134|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
163441016|NCT02760407|590317135|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
163441017|NCT02760407|590317136|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
163441018|NCT02760407|590317133|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
163441019|NCT02760407|590317134|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
163441020|NCT02760407|590317135|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
163441021|NCT02760407|590317136|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
163441022|NCT02760407|590317133|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
163441023|NCT02760407|590317134|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
163441024|NCT02760407|590317135|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
163441025|NCT02760407|590317136|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
163441026|NCT02760407|590317133|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
163441027|NCT02760407|590317134|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
163441028|NCT02760407|590317135|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
163441029|NCT02760407|590317136|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
163441030|NCT02760407|590317133|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
163441031|NCT02760407|590317134|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
163441032|NCT02760407|590317135|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
163441033|NCT02760407|590317136|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
163441034|NCT02760407|590317133|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
163441035|NCT02760407|590317134|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
163441036|NCT02760407|590317135|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
163441037|NCT02760407|590317136|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
163441038|NCT02760407|590317133|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
163441039|NCT02760407|590317134|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
163441040|NCT02760407|590317135|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
163441041|NCT02760407|590317136|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
163441042|NCT02522377|590317137|FG000|Overall Study|Withdrawal by Subject|1|||
163441043|NCT02522377|590317138|FG001|Overall Study|Withdrawal by Subject|0|||
163441044|NCT02522377|590317137|FG000|Overall Study|Remission Achieved|3|||
163441045|NCT02522377|590317138|FG001|Overall Study|Remission Achieved|0|||
163441046|NCT01158950|590317139|FG000|1st Intervention (1 Day)|Physician Decision|1|||
163441047|NCT01158950|590317140|FG001|1st Intervention (1 Day)|Physician Decision|2|||
163441048|NCT00945191|590317141|FG000|Overall Study|Did not achieve a complete response|18|||
163441049|NCT00945191|590317141|FG000|Overall Study|Participant relocated to another state|1|||
163441050|NCT00945191|590317141|FG000|Overall Study|Disease progression|3|||
163441051|NCT00945191|590317141|FG000|Overall Study|Serious adverse event or adverse event|1|||
163441052|NCT00945191|590317141|FG000|Overall Study|Investigator's discretion|1|||
163441053|NCT01921270|590317148|FG000|Overall Study|Withdrawal by Subject|1|||
163441054|NCT02137772|590317151|FG000|Overall Study|Adverse Event|6|||
163441055|NCT02137772|590317152|FG001|Overall Study|Adverse Event|3|||
163441056|NCT02137772|590317151|FG000|Overall Study|Death|71|||
163441057|NCT02137772|590317152|FG001|Overall Study|Death|44|||
163441058|NCT02137772|590317151|FG000|Overall Study|Lost to Follow-up|8|||
163441059|NCT02137772|590317152|FG001|Overall Study|Lost to Follow-up|4|||
163441060|NCT02137772|590317151|FG000|Overall Study|Physician Decision|15|||
163441061|NCT02137772|590317152|FG001|Overall Study|Physician Decision|5|||
163441062|NCT02137772|590317151|FG000|Overall Study|Withdrawal by Subject|28|||
163441063|NCT02137772|590317152|FG001|Overall Study|Withdrawal by Subject|17|||
163441064|NCT02137772|590317151|FG000|Overall Study|Non-compliance with study drug|1|||
163441065|NCT02137772|590317152|FG001|Overall Study|Non-compliance with study drug|0|||
163441066|NCT02137772|590317151|FG000|Overall Study|Not treated|3|||
163441067|NCT02137772|590317152|FG001|Overall Study|Not treated|2|||
163441068|NCT01844700|590317153|FG000|Overall Study|Lack of Efficacy|1|||
163441069|NCT01844700|590317154|FG001|Overall Study|Lack of Efficacy|0|||
163441070|NCT01844700|590317153|FG000|Overall Study|refused medication switch|1|||
163441071|NCT01844700|590317154|FG001|Overall Study|refused medication switch|0|||
163441072|NCT01844700|590317153|FG000|Overall Study|Withdrawal by Subject|1|||
163441073|NCT01844700|590317154|FG001|Overall Study|Withdrawal by Subject|0|||
163441074|NCT01844700|590317153|FG000|Overall Study|stopped taking meds|0|||
163441075|NCT01844700|590317154|FG001|Overall Study|stopped taking meds|1|||
163441076|NCT00863928|590317155|FG000|Overall Study|Protocol Violation|26|||
162925351|NCT03901339|588428938|FG000|Overall Study|Informed consent withdrawn|13|||
162925352|NCT03901339|588428939|FG001|Overall Study|Informed consent withdrawn|40|||
162925353|NCT03901339|588428938|FG000|Overall Study|Sponsor request|30|||
162925354|NCT03901339|588428939|FG001|Overall Study|Sponsor request|23|||
162925355|NCT03901339|588428938|FG000|Overall Study|Reason not specified|5|||
162925356|NCT03901339|588428939|FG001|Overall Study|Reason not specified|7|||
162925357|NCT03901339|588428938|FG000|Overall Study|Lost to Follow-up|4|||
162925358|NCT03901339|588428939|FG001|Overall Study|Lost to Follow-up|7|||
162925359|NCT03901339|588428938|FG000|Overall Study|Covid19|0|||
162925360|NCT03901339|588428939|FG001|Overall Study|Covid19|2|||
162925361|NCT01988337|588428942|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
162925362|NCT00457418|588428943|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
162925363|NCT00457418|588428943|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
162925364|NCT00457418|588428943|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
162925365|NCT00457418|588428943|FG000|Post PK Maintenance|Adverse Event|10|||
162925366|NCT00457418|588428943|FG000|Post PK Maintenance|Progression of Disease|6|||
162925367|NCT00457418|588428943|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
162925368|NCT00457418|588428943|FG000|Post PK Maintenance|Lost to Follow-up|1|||
162925369|NCT03387735|588428946|FG000|Overall Study|Lost to Follow-up|4|||
162925370|NCT03387735|588428947|FG001|Overall Study|Lost to Follow-up|8|||
162925371|NCT03387735|588428946|FG000|Overall Study|Death|4|||
162925372|NCT03387735|588428947|FG001|Overall Study|Death|8|||
162925373|NCT03099161|588428948|FG000|Overall Study|Adverse Event|0|||
162925374|NCT03099161|588428949|FG001|Overall Study|Adverse Event|0|||
162925375|NCT03099161|588428950|FG002|Overall Study|Adverse Event|2|||
162925376|NCT03099161|588428948|FG000|Overall Study|Physician Decision|2|||
162925377|NCT03099161|588428949|FG001|Overall Study|Physician Decision|0|||
162925378|NCT03099161|588428950|FG002|Overall Study|Physician Decision|0|||
162925379|NCT03099161|588428948|FG000|Overall Study|Progressive Disease|1|||
162925380|NCT03099161|588428949|FG001|Overall Study|Progressive Disease|4|||
162925381|NCT03099161|588428950|FG002|Overall Study|Progressive Disease|1|||
162925382|NCT00110084|588428953|FG000|Overall Study|Adverse Event|9|||
162925383|NCT00110084|588428953|FG000|Overall Study|Death|1|||
163441077|NCT00863928|590317156|FG001|Overall Study|Protocol Violation|0|||
163441078|NCT00863928|590317155|FG000|Overall Study|Withdrawal by Subject|3|||
163441079|NCT00863928|590317156|FG001|Overall Study|Withdrawal by Subject|0|||
163441080|NCT00863928|590317155|FG000|Overall Study|surgery cancellation|4|||
163441081|NCT00863928|590317156|FG001|Overall Study|surgery cancellation|0|||
163441082|NCT00863928|590317155|FG000|Overall Study|medication allergy|3|||
163441083|NCT00863928|590317156|FG001|Overall Study|medication allergy|0|||
163441084|NCT03290300|590317157|FG000|Overall Study|Lost to Follow-up|3|||
163441085|NCT00864227|590317158|FG000|Overall Study|Withdrawal by Subject|1|||
163441086|NCT00864227|590317158|FG000|Overall Study|Disease Relapse/Progression|3|||
163441087|NCT02124798|590317159|FG000|Overall Study|Adverse Event|3|||
163441088|NCT02124798|590317159|FG000|Overall Study|Lost to Follow-up|1|||
163441089|NCT01797432|590317160|FG000|Overall Study|Lost to Follow-up|1|||
163441090|NCT01797432|590317160|FG000|Overall Study|Adverse Event|1|||
163441091|NCT01797432|590317160|FG000|Overall Study|Withdrawal by Subject|1|||
163441092|NCT01797432|590317160|FG000|Overall Study|lived too far from study site|1|||
163441093|NCT02792777|590317161|FG000|Overall Study|Withdrawal by Subject|2|||
163441094|NCT02792777|590317162|FG001|Overall Study|Withdrawal by Subject|0|||
163441095|NCT02792777|590317161|FG000|Overall Study|Recording malfunction|2|||
163441096|NCT02792777|590317162|FG001|Overall Study|Recording malfunction|0|||
163441097|NCT02792777|590317161|FG000|Overall Study|Later determined to be ineligible|2|||
163441098|NCT02792777|590317162|FG001|Overall Study|Later determined to be ineligible|0|||
163441099|NCT02792777|590317161|FG000|Overall Study|Participant interviewed twice|1|||
163441100|NCT02792777|590317162|FG001|Overall Study|Participant interviewed twice|0|||
163441101|NCT02795156|590317163|FG000|Overall Study|Progressive Disease|22|||
163441102|NCT02795156|590317164|FG001|Overall Study|Progressive Disease|7|||
163441103|NCT02795156|590317165|FG002|Overall Study|Progressive Disease|34|||
163441104|NCT02795156|590317166|FG003|Overall Study|Progressive Disease|7|||
163441105|NCT02795156|590317163|FG000|Overall Study|Adverse Event|13|||
163441106|NCT02795156|590317164|FG001|Overall Study|Adverse Event|2|||
163441107|NCT02795156|590317165|FG002|Overall Study|Adverse Event|3|||
163441108|NCT02795156|590317166|FG003|Overall Study|Adverse Event|2|||
163441109|NCT02795156|590317163|FG000|Overall Study|Death|1|||
163441110|NCT02795156|590317164|FG001|Overall Study|Death|1|||
163441111|NCT02795156|590317165|FG002|Overall Study|Death|1|||
163441112|NCT02795156|590317166|FG003|Overall Study|Death|0|||
163441113|NCT02795156|590317163|FG000|Overall Study|Physician Decision|1|||
163441114|NCT02795156|590317164|FG001|Overall Study|Physician Decision|0|||
163441115|NCT02795156|590317165|FG002|Overall Study|Physician Decision|1|||
163441116|NCT02795156|590317166|FG003|Overall Study|Physician Decision|0|||
163441117|NCT02795156|590317163|FG000|Overall Study|Withdrawal by Subject|2|||
163441118|NCT02795156|590317164|FG001|Overall Study|Withdrawal by Subject|0|||
163441119|NCT02795156|590317165|FG002|Overall Study|Withdrawal by Subject|3|||
163441120|NCT02795156|590317166|FG003|Overall Study|Withdrawal by Subject|0|||
163441121|NCT01137435|590317170|FG000|Overall Study|Lost to Follow-up|24|||
163441122|NCT01137435|590317170|FG000|Overall Study|Off label usage|4|||
163441123|NCT02746679|590317178|FG000|Overall Study|Lost to Follow-up|4|||
163441124|NCT02746679|590317179|FG001|Overall Study|Lost to Follow-up|6|||
163441125|NCT00487279|590317180|FG000|Overall Study|Death|1|||
163441126|NCT00487279|590317181|FG001|Overall Study|Death|0|||
163441127|NCT00487279|590317180|FG000|Overall Study|Withdrawal by Subject|0|||
163441128|NCT00487279|590317181|FG001|Overall Study|Withdrawal by Subject|2|||
163441129|NCT00501852|590317182|FG000|Overall Study|Adverse Event|3|||
163441130|NCT00501852|590317182|FG000|Overall Study|Withdrawal by Subject|2|||
163441131|NCT01416610|590317183|FG000|Overall Study|Adverse Event|4|||
163441132|NCT01416610|590317183|FG000|Overall Study|Adverse Event -Patient decision|3|||
163441133|NCT01416610|590317183|FG000|Overall Study|Lack of Efficacy|4|||
163441134|NCT01416610|590317183|FG000|Overall Study|No reason given|5|||
163441135|NCT01416610|590317183|FG000|Overall Study|Withdrawal by Subject|13|||
163441136|NCT01416610|590317183|FG000|Overall Study|Lost to Follow-up|7|||
163441137|NCT01416610|590317183|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
163441138|NCT01171521|590317185|FG000|Overall Study|Lost to Follow-up|5|||
163441139|NCT01171521|590317185|FG000|Overall Study|screen failure|1|||
163441140|NCT00399802|590317186|FG000|Overall Study|Adverse Event|0|||
163441141|NCT00399802|590317187|FG001|Overall Study|Adverse Event|2|||
163441142|NCT00399802|590317186|FG000|Overall Study|Participant discontinued by mistake|0|||
163441143|NCT00399802|590317187|FG001|Overall Study|Participant discontinued by mistake|1|||
163441144|NCT00492921|590317188|FG000|Overall Study|Death|1|||
163441145|NCT00492921|590317189|FG001|Overall Study|Death|0|||
163441146|NCT00492921|590317190|FG002|Overall Study|Death|1|||
163441147|NCT00652093|590317191|FG000|Overall Study|Withdrawal by Subject|0|||
163441148|NCT00652093|590317192|FG001|Overall Study|Withdrawal by Subject|0|||
163441149|NCT00652093|590317193|FG002|Overall Study|Withdrawal by Subject|1|||
163441150|NCT00652093|590317194|FG003|Overall Study|Withdrawal by Subject|0|||
163441151|NCT00652093|590317195|FG004|Overall Study|Withdrawal by Subject|1|||
163441152|NCT00652093|590317196|FG005|Overall Study|Withdrawal by Subject|0|||
163441153|NCT00652093|590317191|FG000|Overall Study|Physician Decision|0|||
163441154|NCT00652093|590317192|FG001|Overall Study|Physician Decision|0|||
163441155|NCT00652093|590317193|FG002|Overall Study|Physician Decision|0|||
163441156|NCT00652093|590317194|FG003|Overall Study|Physician Decision|0|||
163441157|NCT00652093|590317195|FG004|Overall Study|Physician Decision|1|||
163441158|NCT00652093|590317196|FG005|Overall Study|Physician Decision|0|||
163441159|NCT01520922|590317199|FG000|Treatment Phase|Physician Decision|2|||
163441160|NCT01520922|590317200|FG001|Treatment Phase|Physician Decision|1|||
163441161|NCT01520922|590317199|FG000|Treatment Phase|Progression|0|||
163441162|NCT01520922|590317200|FG001|Treatment Phase|Progression|2|||
163441163|NCT01520922|590317199|FG000|Treatment Phase|Adverse Event|3|||
163441164|NCT01520922|590317200|FG001|Treatment Phase|Adverse Event|5|||
163441165|NCT01520922|590317199|FG000|Follow up|Lost to Follow-up|0|||
163441166|NCT01520922|590317200|FG001|Follow up|Lost to Follow-up|1|||
163441167|NCT01520922|590317199|FG000|Survival Follow-up|Withdrawal by Subject|1|||
163441168|NCT01520922|590317200|FG001|Survival Follow-up|Withdrawal by Subject|0|||
163441169|NCT01422304|590317203|FG000|Overall Study|Adverse Event|0|||
163441170|NCT01422304|590317204|FG001|Overall Study|Adverse Event|1|||
163441171|NCT01422304|590317203|FG000|Overall Study|Lost to Follow-up|14|||
163441172|NCT01422304|590317204|FG001|Overall Study|Lost to Follow-up|20|||
163441173|NCT01422304|590317203|FG000|Overall Study|Never Entered Follow-up|2|||
163441174|NCT01422304|590317204|FG001|Overall Study|Never Entered Follow-up|1|||
163441175|NCT01422304|590317203|FG000|Overall Study|Protocol Violation|1|||
163441176|NCT01422304|590317204|FG001|Overall Study|Protocol Violation|0|||
163441177|NCT01422304|590317203|FG000|Overall Study|Withdrawal by Subject|4|||
163441178|NCT01422304|590317204|FG001|Overall Study|Withdrawal by Subject|2|||
163441179|NCT01422304|590317203|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
163441180|NCT01422304|590317204|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
163441181|NCT01422304|590317203|FG000|Overall Study|Not Treated|3|||
163441182|NCT01422304|590317204|FG001|Overall Study|Not Treated|11|||
163441183|NCT00469014|590317207|FG000|Initial Phase Randomization|Disease Progression|0|||
163441184|NCT00469014|590317208|FG001|Initial Phase Randomization|Disease Progression|1|||
163441185|NCT00469014|590317209|FG002|Initial Phase Randomization|Disease Progression|1|||
163441186|NCT00469014|590317210|FG003|Initial Phase Randomization|Disease Progression|0|||
163441187|NCT00469014|590317207|FG000|Initial Phase Randomization|No Response|1|||
163441188|NCT00469014|590317208|FG001|Initial Phase Randomization|No Response|0|||
163441189|NCT00469014|590317209|FG002|Initial Phase Randomization|No Response|0|||
163441190|NCT00469014|590317210|FG003|Initial Phase Randomization|No Response|1|||
163441191|NCT00469014|590317207|FG000|Adaptive Randomization|Not Evaluable|1|||
163441192|NCT00469014|590317208|FG001|Adaptive Randomization|Not Evaluable|0|||
163441193|NCT00469014|590317209|FG002|Adaptive Randomization|Not Evaluable|0|||
163441194|NCT00469014|590317210|FG003|Adaptive Randomization|Not Evaluable|1|||
163441195|NCT00469014|590317207|FG000|Adaptive Randomization|No Response|0|||
163441196|NCT00469014|590317208|FG001|Adaptive Randomization|No Response|1|||
163441197|NCT00469014|590317209|FG002|Adaptive Randomization|No Response|0|||
163441198|NCT00469014|590317210|FG003|Adaptive Randomization|No Response|0|||
163441199|NCT00469014|590317207|FG000|Adaptive Randomization|Death|0|||
163441200|NCT00469014|590317208|FG001|Adaptive Randomization|Death|0|||
163441201|NCT00469014|590317209|FG002|Adaptive Randomization|Death|1|||
163441202|NCT00469014|590317210|FG003|Adaptive Randomization|Death|0|||
163441203|NCT03461289|590317214|FG000|Overall Study|Death|1|||
163441204|NCT03241173|590317217|FG000|Overall Study|Death|3|||
163441205|NCT03241173|590317218|FG001|Overall Study|Death|2|||
163441206|NCT03241173|590317219|FG002|Overall Study|Death|4|||
163441207|NCT03241173|590317220|FG003|Overall Study|Death|4|||
163441208|NCT03241173|590317221|FG004|Overall Study|Death|2|||
163441209|NCT03241173|590317222|FG005|Overall Study|Death|2|||
163441210|NCT03241173|590317223|FG006|Overall Study|Death|3|||
163441211|NCT03241173|590317224|FG007|Overall Study|Death|1|||
163441212|NCT03241173|590317225|FG008|Overall Study|Death|0|||
163441213|NCT03241173|590317226|FG009|Overall Study|Death|5|||
163441214|NCT03241173|590317227|FG010|Overall Study|Death|4|||
163441215|NCT03241173|590317228|FG011|Overall Study|Death|3|||
163441216|NCT03241173|590317229|FG012|Overall Study|Death|0|||
163441217|NCT03241173|590317230|FG013|Overall Study|Death|0|||
163441218|NCT03241173|590317231|FG014|Overall Study|Death|0|||
163441219|NCT03241173|590317217|FG000|Overall Study|Withdrawal by Subject|0|||
163441220|NCT03241173|590317218|FG001|Overall Study|Withdrawal by Subject|0|||
163441221|NCT03241173|590317219|FG002|Overall Study|Withdrawal by Subject|1|||
163441222|NCT03241173|590317220|FG003|Overall Study|Withdrawal by Subject|0|||
163441223|NCT03241173|590317221|FG004|Overall Study|Withdrawal by Subject|0|||
163441224|NCT03241173|590317222|FG005|Overall Study|Withdrawal by Subject|1|||
162925384|NCT00110084|588428953|FG000|Overall Study|Patient Refusal|10|||
163441225|NCT03241173|590317223|FG006|Overall Study|Withdrawal by Subject|0|||
163441226|NCT03241173|590317224|FG007|Overall Study|Withdrawal by Subject|0|||
163441227|NCT03241173|590317225|FG008|Overall Study|Withdrawal by Subject|0|||
163441228|NCT03241173|590317226|FG009|Overall Study|Withdrawal by Subject|0|||
163441229|NCT03241173|590317227|FG010|Overall Study|Withdrawal by Subject|0|||
163441230|NCT03241173|590317228|FG011|Overall Study|Withdrawal by Subject|0|||
163441231|NCT03241173|590317229|FG012|Overall Study|Withdrawal by Subject|0|||
163441232|NCT03241173|590317230|FG013|Overall Study|Withdrawal by Subject|0|||
163441233|NCT03241173|590317231|FG014|Overall Study|Withdrawal by Subject|0|||
163441234|NCT03241173|590317217|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
163441235|NCT03241173|590317218|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
163441236|NCT03241173|590317219|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
163441237|NCT03241173|590317220|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
163441238|NCT03241173|590317221|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
163441239|NCT03241173|590317222|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
163441240|NCT03241173|590317223|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
163441241|NCT03241173|590317224|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
163441242|NCT03241173|590317225|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
163441243|NCT03241173|590317226|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
163441244|NCT03241173|590317227|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
163441245|NCT03241173|590317228|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
163441246|NCT03241173|590317229|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
163441247|NCT03241173|590317230|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
163441248|NCT03241173|590317231|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
163441249|NCT03241173|590317217|FG000|Overall Study|Lost to Follow-up|0|||
163441250|NCT03241173|590317218|FG001|Overall Study|Lost to Follow-up|0|||
163441251|NCT03241173|590317219|FG002|Overall Study|Lost to Follow-up|0|||
163441252|NCT03241173|590317220|FG003|Overall Study|Lost to Follow-up|0|||
163441253|NCT03241173|590317221|FG004|Overall Study|Lost to Follow-up|1|||
163441254|NCT03241173|590317222|FG005|Overall Study|Lost to Follow-up|0|||
163441255|NCT03241173|590317223|FG006|Overall Study|Lost to Follow-up|0|||
163441256|NCT03241173|590317224|FG007|Overall Study|Lost to Follow-up|0|||
163441257|NCT03241173|590317225|FG008|Overall Study|Lost to Follow-up|0|||
163441258|NCT03241173|590317226|FG009|Overall Study|Lost to Follow-up|1|||
163441259|NCT03241173|590317227|FG010|Overall Study|Lost to Follow-up|0|||
163441260|NCT03241173|590317228|FG011|Overall Study|Lost to Follow-up|0|||
163441261|NCT03241173|590317229|FG012|Overall Study|Lost to Follow-up|0|||
163441262|NCT03241173|590317230|FG013|Overall Study|Lost to Follow-up|0|||
163441263|NCT03241173|590317231|FG014|Overall Study|Lost to Follow-up|0|||
163441264|NCT00564629|590317232|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
163441265|NCT00564629|590317233|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
163441266|NCT00515463|590317234|FG000|Overall Study|Physician Decision|4|||
163441267|NCT00515463|590317235|FG001|Overall Study|Physician Decision|2|||
163441268|NCT00515463|590317234|FG000|Overall Study|Adverse Event|1|||
163441269|NCT00515463|590317235|FG001|Overall Study|Adverse Event|2|||
163441270|NCT00515463|590317234|FG000|Overall Study|Withdrawal by Subject|3|||
163441271|NCT00515463|590317235|FG001|Overall Study|Withdrawal by Subject|4|||
163441272|NCT00515463|590317234|FG000|Overall Study|Lost to Follow-up|6|||
163441273|NCT00515463|590317235|FG001|Overall Study|Lost to Follow-up|5|||
163441274|NCT00515463|590317234|FG000|Overall Study|Other|0|||
163441275|NCT00515463|590317235|FG001|Overall Study|Other|1|||
163441276|NCT01519427|590317236|FG000|Overall Study|disease progression|2|||
163441277|NCT02269319|590317242|FG000|Overall Study|Lost to Follow-up|4|||
163441278|NCT02269319|590317243|FG001|Overall Study|Lost to Follow-up|3|||
163441279|NCT02269319|590317242|FG000|Overall Study|Adverse Event|0|||
163441280|NCT02269319|590317243|FG001|Overall Study|Adverse Event|1|||
163441281|NCT02269319|590317242|FG000|Overall Study|Instructions not followed|1|||
163441282|NCT02269319|590317243|FG001|Overall Study|Instructions not followed|0|||
163441283|NCT02115815|590318763|FG000|Overall Study|Withdrawal by Subject|2|||
163441284|NCT02115815|590318764|FG001|Overall Study|Withdrawal by Subject|0|||
163441285|NCT02115815|590318765|FG002|Overall Study|Withdrawal by Subject|0|||
163441286|NCT02115815|590318766|FG003|Overall Study|Withdrawal by Subject|0|||
163441287|NCT02115815|590318767|FG004|Overall Study|Withdrawal by Subject|0|||
163441288|NCT02115815|590318768|FG005|Overall Study|Withdrawal by Subject|0|||
163441289|NCT02115815|590318769|FG006|Overall Study|Withdrawal by Subject|0|||
163441290|NCT02115815|590318763|FG000|Overall Study|Not enough drug to dose participant|0|||
163441291|NCT02115815|590318764|FG001|Overall Study|Not enough drug to dose participant|0|||
163441292|NCT02115815|590318765|FG002|Overall Study|Not enough drug to dose participant|0|||
163441293|NCT02115815|590318766|FG003|Overall Study|Not enough drug to dose participant|0|||
163441294|NCT02115815|590318767|FG004|Overall Study|Not enough drug to dose participant|0|||
163441295|NCT02115815|590318768|FG005|Overall Study|Not enough drug to dose participant|1|||
163441296|NCT02115815|590318769|FG006|Overall Study|Not enough drug to dose participant|0|||
163441297|NCT02115815|590318763|FG000|Overall Study|Missed appointment, randomized in error|0|||
163441298|NCT02115815|590318764|FG001|Overall Study|Missed appointment, randomized in error|0|||
163441299|NCT02115815|590318765|FG002|Overall Study|Missed appointment, randomized in error|0|||
163441300|NCT02115815|590318766|FG003|Overall Study|Missed appointment, randomized in error|0|||
163441301|NCT02115815|590318767|FG004|Overall Study|Missed appointment, randomized in error|0|||
163441302|NCT02115815|590318768|FG005|Overall Study|Missed appointment, randomized in error|1|||
163441303|NCT02115815|590318769|FG006|Overall Study|Missed appointment, randomized in error|0|||
163441304|NCT01989546|590318770|FG000|Overall Study|Clinical Progression|1|||
163441305|NCT01989546|590318770|FG000|Overall Study|Disease progression on study|8|||
163441306|NCT02819310|590318771|FG000|Overall Study|Withdrawal by Subject|37|||
163441307|NCT02819310|590318771|FG000|Overall Study|Lost to Follow-up|16|||
163441308|NCT02819310|590318771|FG000|Overall Study|Adverse Event|13|||
163441309|NCT02819310|590318771|FG000|Overall Study|Lack of Efficacy|5|||
163441310|NCT02819310|590318771|FG000|Overall Study|Physician Decision|8|||
163441311|NCT02819310|590318771|FG000|Overall Study|Protocol Violation|30|||
163441312|NCT00059215|590318775|FG000|Overall Study|Adverse Event|5|||
163441313|NCT00059215|590318776|FG001|Overall Study|Adverse Event|5|||
163441314|NCT00059215|590318777|FG002|Overall Study|Adverse Event|9|||
163441315|NCT00059215|590318778|FG003|Overall Study|Adverse Event|9|||
163441316|NCT00059215|590318775|FG000|Overall Study|Death|0|||
163441317|NCT00059215|590318776|FG001|Overall Study|Death|0|||
163441318|NCT00059215|590318777|FG002|Overall Study|Death|3|||
163441319|NCT00059215|590318778|FG003|Overall Study|Death|0|||
163441320|NCT00059215|590318775|FG000|Overall Study|Lost to Follow-up|1|||
163441321|NCT00059215|590318776|FG001|Overall Study|Lost to Follow-up|2|||
163441322|NCT00059215|590318777|FG002|Overall Study|Lost to Follow-up|0|||
163441323|NCT00059215|590318778|FG003|Overall Study|Lost to Follow-up|0|||
163441324|NCT00059215|590318775|FG000|Overall Study|Withdrawal by Subject|4|||
163441325|NCT00059215|590318776|FG001|Overall Study|Withdrawal by Subject|4|||
163441326|NCT00059215|590318777|FG002|Overall Study|Withdrawal by Subject|1|||
163441327|NCT00059215|590318778|FG003|Overall Study|Withdrawal by Subject|3|||
163441328|NCT00059215|590318775|FG000|Overall Study|Protocol Violation|1|||
163441329|NCT00059215|590318776|FG001|Overall Study|Protocol Violation|0|||
163441330|NCT00059215|590318777|FG002|Overall Study|Protocol Violation|1|||
163441331|NCT00059215|590318778|FG003|Overall Study|Protocol Violation|0|||
163441332|NCT00059215|590318775|FG000|Overall Study|Protocol entry criteria not met|1|||
163441333|NCT00059215|590318776|FG001|Overall Study|Protocol entry criteria not met|1|||
163441334|NCT00059215|590318777|FG002|Overall Study|Protocol entry criteria not met|0|||
163441335|NCT00059215|590318778|FG003|Overall Study|Protocol entry criteria not met|2|||
163441336|NCT00059215|590318775|FG000|Overall Study|Physician Decision|1|||
163441337|NCT00059215|590318776|FG001|Overall Study|Physician Decision|2|||
163441338|NCT00059215|590318777|FG002|Overall Study|Physician Decision|1|||
163441339|NCT00059215|590318778|FG003|Overall Study|Physician Decision|1|||
163441340|NCT04494633|590318779|FG000|Overall Study|Lost to Follow-up|5|||
163441341|NCT04494633|590318780|FG001|Overall Study|Lost to Follow-up|3|||
163441342|NCT04494633|590318779|FG000|Overall Study|Protocol Violation|1|||
163441343|NCT04494633|590318780|FG001|Overall Study|Protocol Violation|1|||
163441344|NCT01254604|590318783|FG000|Overall Study|Lost to Follow-up|1|||
163441345|NCT01254604|590318784|FG001|Overall Study|Lost to Follow-up|1|||
163441346|NCT01254604|590318783|FG000|Overall Study|Protocol Violation|2|||
163441347|NCT01254604|590318784|FG001|Overall Study|Protocol Violation|2|||
163441348|NCT01254604|590318783|FG000|Overall Study|Withdrawal by Subject|2|||
163441349|NCT01254604|590318784|FG001|Overall Study|Withdrawal by Subject|4|||
163441350|NCT01254604|590318783|FG000|Overall Study|Adverse Event|3|||
163441351|NCT01254604|590318784|FG001|Overall Study|Adverse Event|2|||
163441352|NCT03074162|590318785|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
163441353|NCT03074162|590318786|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
163441354|NCT03074162|590318787|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
163441355|NCT03074162|590318788|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
163441356|NCT03074162|590318789|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
163441357|NCT03074162|590318790|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
163441358|NCT03074162|590318785|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
163441359|NCT03074162|590318786|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
163441360|NCT03074162|590318787|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
163441361|NCT03074162|590318788|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
163441362|NCT03074162|590318789|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
163441363|NCT03074162|590318790|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
163441364|NCT03074162|590318785|FG000|Period 3|Withdrawal by Subject|1|||
163441365|NCT03074162|590318786|FG001|Period 3|Withdrawal by Subject|0|||
163441366|NCT03074162|590318787|FG002|Period 3|Withdrawal by Subject|0|||
163441367|NCT03074162|590318788|FG003|Period 3|Withdrawal by Subject|0|||
163441368|NCT03074162|590318789|FG004|Period 3|Withdrawal by Subject|1|||
163441369|NCT03074162|590318790|FG005|Period 3|Withdrawal by Subject|0|||
163441370|NCT01958671|590318791|FG000|Overall Study|Adverse Event|1|||
163441371|NCT01958671|590318792|FG001|Overall Study|Adverse Event|1|||
163441372|NCT01958671|590318793|FG002|Overall Study|Adverse Event|5|||
163441373|NCT01958671|590318791|FG000|Overall Study|Death|1|||
163441374|NCT01958671|590318792|FG001|Overall Study|Death|0|||
163441375|NCT01958671|590318793|FG002|Overall Study|Death|0|||
163441376|NCT01958671|590318791|FG000|Overall Study|Excluded medication|0|||
163441377|NCT01958671|590318792|FG001|Overall Study|Excluded medication|0|||
163441378|NCT01958671|590318793|FG002|Overall Study|Excluded medication|1|||
163441379|NCT01958671|590318791|FG000|Overall Study|Hyperglycemia|0|||
163441380|NCT01958671|590318792|FG001|Overall Study|Hyperglycemia|0|||
163441381|NCT01958671|590318793|FG002|Overall Study|Hyperglycemia|2|||
163441382|NCT01958671|590318791|FG000|Overall Study|Lost to Follow-up|7|||
163441383|NCT01958671|590318792|FG001|Overall Study|Lost to Follow-up|11|||
163441384|NCT01958671|590318793|FG002|Overall Study|Lost to Follow-up|7|||
163441385|NCT01958671|590318791|FG000|Overall Study|Non-compliance with study drug|1|||
163441386|NCT01958671|590318792|FG001|Overall Study|Non-compliance with study drug|1|||
163441387|NCT01958671|590318793|FG002|Overall Study|Non-compliance with study drug|1|||
163441388|NCT01958671|590318791|FG000|Overall Study|Pregnancy|0|||
163441389|NCT01958671|590318792|FG001|Overall Study|Pregnancy|0|||
163441390|NCT01958671|590318793|FG002|Overall Study|Pregnancy|1|||
163441391|NCT01958671|590318791|FG000|Overall Study|Protocol Violation|0|||
163441392|NCT01958671|590318792|FG001|Overall Study|Protocol Violation|1|||
163441393|NCT01958671|590318793|FG002|Overall Study|Protocol Violation|0|||
163441394|NCT01958671|590318791|FG000|Overall Study|Study site terminated by sponsor|1|||
163441395|NCT01958671|590318792|FG001|Overall Study|Study site terminated by sponsor|0|||
163441396|NCT01958671|590318793|FG002|Overall Study|Study site terminated by sponsor|1|||
163441397|NCT01958671|590318791|FG000|Overall Study|Participant moved|0|||
163441398|NCT01958671|590318792|FG001|Overall Study|Participant moved|0|||
163441399|NCT01958671|590318793|FG002|Overall Study|Participant moved|1|||
163441400|NCT01958671|590318791|FG000|Overall Study|Withdrawal by Subject|8|||
163441401|NCT01958671|590318792|FG001|Overall Study|Withdrawal by Subject|10|||
163441402|NCT01958671|590318793|FG002|Overall Study|Withdrawal by Subject|13|||
163441403|NCT02778867|590318794|FG000|Phase 1|Withdrawal by Subject|2|||
163441404|NCT02778867|590318795|FG001|Phase 1|Withdrawal by Subject|3|||
163441405|NCT02778867|590318796|FG002|Phase 1|Withdrawal by Subject|0|||
163441406|NCT02778867|590318797|FG003|Phase 1|Withdrawal by Subject|0|||
163441407|NCT02778867|590318794|FG000|Phase 2|Withdrawal by Subject|0|||
163441408|NCT02778867|590318795|FG001|Phase 2|Withdrawal by Subject|0|||
163441409|NCT02778867|590318796|FG002|Phase 2|Withdrawal by Subject|1|||
163441410|NCT02778867|590318797|FG003|Phase 2|Withdrawal by Subject|0|||
163441411|NCT02778867|590318794|FG000|Phase 2|Physician Decision|0|||
163441412|NCT02778867|590318795|FG001|Phase 2|Physician Decision|0|||
163441413|NCT02778867|590318796|FG002|Phase 2|Physician Decision|0|||
163441414|NCT02778867|590318797|FG003|Phase 2|Physician Decision|1|||
163441415|NCT02778867|590318794|FG000|Phase 2|Adverse Event|0|||
163441416|NCT02778867|590318795|FG001|Phase 2|Adverse Event|0|||
163441417|NCT02778867|590318796|FG002|Phase 2|Adverse Event|0|||
163441418|NCT02778867|590318797|FG003|Phase 2|Adverse Event|1|||
163441419|NCT02948777|590318798|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
163441420|NCT02311478|590318800|FG000|Overall Study|Withdrawal by Subject|1|||
163441421|NCT02311478|590318800|FG000|Overall Study|Lost to Follow-up|5|||
163441422|NCT02311478|590318800|FG000|Overall Study|Failed IUD Insertion|1|||
163441423|NCT03242928|590318801|FG000|Overall Study|Adverse Event|2|||
163441424|NCT03242928|590318802|FG001|Overall Study|Adverse Event|1|||
163441425|NCT03242928|590318801|FG000|Overall Study|Lost to Follow-up|2|||
163441426|NCT03242928|590318802|FG001|Overall Study|Lost to Follow-up|0|||
163441427|NCT03242928|590318801|FG000|Overall Study|Physician Decision|0|||
163441428|NCT03242928|590318802|FG001|Overall Study|Physician Decision|1|||
163441429|NCT03242928|590318801|FG000|Overall Study|Withdrawal by Subject|5|||
163441430|NCT03242928|590318802|FG001|Overall Study|Withdrawal by Subject|3|||
163441431|NCT03276936|590318803|FG000|Overall Study|Adverse Event|4|||
163441432|NCT03276936|590318804|FG001|Overall Study|Adverse Event|2|||
163441433|NCT03276936|590318803|FG000|Overall Study|Lost to Follow-up|16|||
163441434|NCT03276936|590318804|FG001|Overall Study|Lost to Follow-up|13|||
163441435|NCT03276936|590318803|FG000|Overall Study|Withdrawal by Subject|30|||
163441436|NCT03276936|590318804|FG001|Overall Study|Withdrawal by Subject|20|||
163441437|NCT03276936|590318803|FG000|Overall Study|Not mentioned|6|||
163441438|NCT03276936|590318804|FG001|Overall Study|Not mentioned|3|||
163441439|NCT00943319|590318805|FG000|Overall Study|Death|1|||
163441440|NCT02043301|590318806|FG000|Overall Study|Discontinued|0|||
163441441|NCT02043301|590318807|FG001|Overall Study|Discontinued|1|||
163441442|NCT02043301|590318808|FG002|Overall Study|Discontinued|0|||
163441443|NCT03703375|590318812|FG000|Randomization Period|Withdrawal by Subject|0|||
163441444|NCT03703375|590318813|FG001|Randomization Period|Withdrawal by Subject|0|||
163441445|NCT03703375|590318814|FG002|Randomization Period|Withdrawal by Subject|0|||
163441446|NCT03703375|590318815|FG003|Randomization Period|Withdrawal by Subject|1|||
163441447|NCT03703375|590318812|FG000|Randomization Period|Completed safety run-in treatment|7|||
163441448|NCT03703375|590318813|FG001|Randomization Period|Completed safety run-in treatment|0|||
163441449|NCT03703375|590318814|FG002|Randomization Period|Completed safety run-in treatment|0|||
163441450|NCT03703375|590318815|FG003|Randomization Period|Completed safety run-in treatment|0|||
163441451|NCT03703375|590318812|FG000|Treatment Period|Other Reasons|0|||
163441452|NCT03703375|590318813|FG001|Treatment Period|Other Reasons|1|||
163441453|NCT03703375|590318814|FG002|Treatment Period|Other Reasons|0|||
163441454|NCT03703375|590318815|FG003|Treatment Period|Other Reasons|3|||
163441455|NCT03703375|590318812|FG000|Treatment Period|Consent Withdrawal|0|||
163441456|NCT03703375|590318813|FG001|Treatment Period|Consent Withdrawal|0|||
163441457|NCT03703375|590318814|FG002|Treatment Period|Consent Withdrawal|0|||
163441458|NCT03703375|590318815|FG003|Treatment Period|Consent Withdrawal|1|||
163441459|NCT03703375|590318812|FG000|Treatment Period|Death|1|||
163441460|NCT03703375|590318813|FG001|Treatment Period|Death|0|||
163441461|NCT03703375|590318814|FG002|Treatment Period|Death|1|||
163441462|NCT03703375|590318815|FG003|Treatment Period|Death|2|||
163441463|NCT03703375|590318812|FG000|Treatment Period|Toxicity of Study Treatment|2|||
163441464|NCT03703375|590318813|FG001|Treatment Period|Toxicity of Study Treatment|0|||
163441465|NCT03703375|590318814|FG002|Treatment Period|Toxicity of Study Treatment|4|||
163441466|NCT03703375|590318815|FG003|Treatment Period|Toxicity of Study Treatment|1|||
163441467|NCT03703375|590318812|FG000|Treatment Period|Progression|32|||
163441468|NCT03703375|590318813|FG001|Treatment Period|Progression|1|||
163441469|NCT03703375|590318814|FG002|Treatment Period|Progression|7|||
163441470|NCT03703375|590318815|FG003|Treatment Period|Progression|11|||
163441471|NCT03703375|590318812|FG000|Treatment Period|Completed treatment|7|||
163441472|NCT03703375|590318813|FG001|Treatment Period|Completed treatment|2|||
163441473|NCT03703375|590318814|FG002|Treatment Period|Completed treatment|0|||
163441474|NCT03703375|590318815|FG003|Treatment Period|Completed treatment|0|||
163441475|NCT00625365|590318816|FG000|Overall Study|Withdrawal by Subject|1|||
163441476|NCT00625365|590318816|FG000|Overall Study|No IV access|5|||
163441477|NCT00625365|590318816|FG000|Overall Study|VSD|1|||
163441478|NCT01703286|590318818|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
163441479|NCT01703286|590318819|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
163441480|NCT01703286|590318820|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
163441481|NCT01703286|590318821|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
163441482|NCT01703286|590318822|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
163441483|NCT01703286|590318823|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
163441484|NCT01703286|590318818|FG000|Period 2 Including Washout|Adverse Event|0|||
163441485|NCT01703286|590318819|FG001|Period 2 Including Washout|Adverse Event|0|||
163441486|NCT01703286|590318820|FG002|Period 2 Including Washout|Adverse Event|0|||
163441487|NCT01703286|590318821|FG003|Period 2 Including Washout|Adverse Event|1|||
163441488|NCT01703286|590318822|FG004|Period 2 Including Washout|Adverse Event|0|||
163441489|NCT01703286|590318823|FG005|Period 2 Including Washout|Adverse Event|0|||
163441490|NCT00931892|590318824|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
163441491|NCT00931892|590318825|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
163441492|NCT02207530|590318828|FG000|Overall Study|Worsening condition under investigation|78|||
163441493|NCT02207530|590318828|FG000|Overall Study|Patient decision to stop study treatment|5|||
163441494|NCT02207530|590318828|FG000|Overall Study|Adverse Event|8|||
163441495|NCT03952468|590318837|FG000|Overall Study|Death|0|||
163441496|NCT03952468|590318838|FG001|Overall Study|Death|1|||
163441497|NCT03952468|590318837|FG000|Overall Study|Adverse Event|0|||
163441498|NCT03952468|590318838|FG001|Overall Study|Adverse Event|1|||
163441499|NCT03952468|590318837|FG000|Overall Study|Physician Decision|1|||
163441500|NCT03952468|590318838|FG001|Overall Study|Physician Decision|0|||
163441501|NCT03952468|590318837|FG000|Overall Study|Lost to Follow-up|3|||
163441502|NCT03952468|590318838|FG001|Overall Study|Lost to Follow-up|4|||
163441503|NCT03952468|590318837|FG000|Overall Study|Withdrawal by Subject|2|||
163441504|NCT03952468|590318838|FG001|Overall Study|Withdrawal by Subject|1|||
163441505|NCT06094296|590318839|FG000|Overall Study|Progressive Disease|1|||
163441506|NCT06094296|590318840|FG001|Overall Study|Progressive Disease|0|||
163441507|NCT06094296|590318841|FG002|Overall Study|Progressive Disease|0|||
163441508|NCT06094296|590318842|FG003|Overall Study|Progressive Disease|0|||
163441509|NCT04964063|590318843|FG000|Overall Study|Adverse Event|4|||
163441510|NCT04964063|590318843|FG000|Overall Study|Lost to Follow-up|47|||
163441511|NCT04964063|590318843|FG000|Overall Study|Withdrawal by Subject|5|||
163441512|NCT04964063|590318843|FG000|Overall Study|Baseline Tasks Expired|41|||
163441513|NCT04964063|590318843|FG000|Overall Study|Participant withdrawn in error|1|||
163441514|NCT03350750|590318845|FG000|Overall Study|Death|1|||
163441515|NCT03350750|590318846|FG001|Overall Study|Death|1|||
163441516|NCT00406315|590318848|FG000|Overall Study|Death|1|||
163441517|NCT00406315|590318848|FG000|Overall Study|Adverse Event|39|||
163441518|NCT00406315|590318848|FG000|Overall Study|Laboratory Abnormality|4|||
163441519|NCT00406315|590318848|FG000|Overall Study|Lack of Efficacy|13|||
163441520|NCT00406315|590318848|FG000|Overall Study|Other|33|||
163441521|NCT00406315|590318848|FG000|Overall Study|Lost to Follow-up|21|||
163441522|NCT00406315|590318848|FG000|Overall Study|Withdrawal by Subject|30|||
163441523|NCT02202031|590318849|FG000|Overall Study|Lost to Follow-up|1|||
163441524|NCT02202031|590318850|FG001|Overall Study|Lost to Follow-up|0|||
163441525|NCT02202031|590318849|FG000|Overall Study|Too Busy|1|||
163441526|NCT02202031|590318850|FG001|Overall Study|Too Busy|3|||
163441527|NCT02202031|590318849|FG000|Overall Study|Illness/Medical Reason|0|||
163441528|NCT02202031|590318850|FG001|Overall Study|Illness/Medical Reason|2|||
163441529|NCT02202031|590318849|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
163441530|NCT02202031|590318850|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
163441531|NCT00321984|590318852|FG000|Overall Study|Adverse Event|9|||
163441532|NCT00321984|590318853|FG001|Overall Study|Adverse Event|6|||
163441533|NCT00321984|590318854|FG002|Overall Study|Adverse Event|8|||
163441534|NCT00321984|590318852|FG000|Overall Study|Protocol Violation|0|||
163441535|NCT00321984|590318853|FG001|Overall Study|Protocol Violation|1|||
163441536|NCT00321984|590318854|FG002|Overall Study|Protocol Violation|1|||
163441537|NCT00321984|590318852|FG000|Overall Study|Lost to Follow-up|2|||
163441538|NCT00321984|590318853|FG001|Overall Study|Lost to Follow-up|4|||
163441539|NCT00321984|590318854|FG002|Overall Study|Lost to Follow-up|2|||
163441540|NCT00321984|590318852|FG000|Overall Study|Withdrawal by Subject|8|||
163441541|NCT00321984|590318853|FG001|Overall Study|Withdrawal by Subject|6|||
163441542|NCT00321984|590318854|FG002|Overall Study|Withdrawal by Subject|5|||
163441543|NCT00321984|590318852|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
163441544|NCT00321984|590318853|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
163441545|NCT00321984|590318854|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
163441546|NCT00321984|590318852|FG000|Overall Study|Lack of Efficacy|3|||
163441547|NCT00321984|590318853|FG001|Overall Study|Lack of Efficacy|1|||
163441548|NCT00321984|590318854|FG002|Overall Study|Lack of Efficacy|3|||
163441549|NCT00321984|590318852|FG000|Overall Study|Noncompliant|0|||
163441550|NCT00321984|590318853|FG001|Overall Study|Noncompliant|0|||
163441551|NCT00321984|590318854|FG002|Overall Study|Noncompliant|2|||
163441552|NCT00321984|590318852|FG000|Overall Study|Pregnancy|0|||
163441553|NCT00321984|590318853|FG001|Overall Study|Pregnancy|1|||
163441554|NCT00321984|590318854|FG002|Overall Study|Pregnancy|0|||
163441555|NCT00321984|590318852|FG000|Overall Study|Per Subject Request|1|||
163441556|NCT00321984|590318853|FG001|Overall Study|Per Subject Request|0|||
163441557|NCT00321984|590318854|FG002|Overall Study|Per Subject Request|0|||
163441558|NCT00321984|590318852|FG000|Overall Study|Per Investigator Request|1|||
163441559|NCT00321984|590318853|FG001|Overall Study|Per Investigator Request|0|||
163441560|NCT00321984|590318854|FG002|Overall Study|Per Investigator Request|0|||
163441561|NCT00321984|590318852|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
163441562|NCT00321984|590318853|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
163441563|NCT00321984|590318854|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
163441564|NCT02214186|590318855|FG000|Overall Study|Lost to Follow-up|1|||
163441565|NCT02214186|590318856|FG001|Overall Study|Lost to Follow-up|1|||
163441566|NCT02214186|590318855|FG000|Overall Study|Protocol Violation|1|||
163441567|NCT02214186|590318856|FG001|Overall Study|Protocol Violation|1|||
163441568|NCT00525148|590318862|FG000|Overall Study|Other Adverse Event|3|||
163441569|NCT00525148|590318863|FG001|Overall Study|Other Adverse Event|5|||
163441570|NCT00525148|590318864|FG002|Overall Study|Other Adverse Event|1|||
163441571|NCT00525148|590318865|FG003|Overall Study|Other Adverse Event|8|||
163441572|NCT00525148|590318862|FG000|Overall Study|Progressive disease|18|||
163441573|NCT00525148|590318863|FG001|Overall Study|Progressive disease|30|||
163441574|NCT00525148|590318864|FG002|Overall Study|Progressive disease|6|||
163441575|NCT00525148|590318865|FG003|Overall Study|Progressive disease|49|||
163441576|NCT00525148|590318862|FG000|Overall Study|Refused continuation of study medication|0|||
163441577|NCT00525148|590318863|FG001|Overall Study|Refused continuation of study medication|2|||
163441578|NCT00525148|590318864|FG002|Overall Study|Refused continuation of study medication|0|||
163441579|NCT00525148|590318865|FG003|Overall Study|Refused continuation of study medication|1|||
163441580|NCT00525148|590318862|FG000|Overall Study|Other than stated|2|||
163441581|NCT00525148|590318863|FG001|Overall Study|Other than stated|1|||
163441582|NCT00525148|590318864|FG002|Overall Study|Other than stated|0|||
163441583|NCT00525148|590318865|FG003|Overall Study|Other than stated|3|||
163441584|NCT05100199|590318866|FG000|Overall Study|Lost to Follow-up|5|||
163441585|NCT05100199|590318867|FG001|Overall Study|Lost to Follow-up|8|||
163441586|NCT05100199|590318868|FG002|Overall Study|Lost to Follow-up|3|||
163441587|NCT05100199|590318869|FG003|Overall Study|Lost to Follow-up|6|||
163441588|NCT05100199|590318866|FG000|Overall Study|Withdrawal by Subject|3|||
163441589|NCT05100199|590318867|FG001|Overall Study|Withdrawal by Subject|3|||
163441590|NCT05100199|590318868|FG002|Overall Study|Withdrawal by Subject|9|||
163441591|NCT05100199|590318869|FG003|Overall Study|Withdrawal by Subject|7|||
163441592|NCT05100199|590318866|FG000|Overall Study|Other|0|||
163441593|NCT05100199|590318867|FG001|Overall Study|Other|0|||
163441594|NCT05100199|590318868|FG002|Overall Study|Other|1|||
163441595|NCT05100199|590318869|FG003|Overall Study|Other|1|||
163441596|NCT01426386|590318870|FG000|Overall Study|Adverse Event|0|||
163441597|NCT01426386|590318871|FG001|Overall Study|Adverse Event|1|||
163441598|NCT01426386|590318872|FG002|Overall Study|Adverse Event|0|||
163441599|NCT01426386|590318873|FG003|Overall Study|Adverse Event|0|||
163441600|NCT01426386|590318874|FG004|Overall Study|Adverse Event|0|||
163441601|NCT01426386|590318875|FG005|Overall Study|Adverse Event|0|||
163441602|NCT01426386|590318870|FG000|Overall Study|Did not attend scheduled visit|1|||
163441603|NCT01426386|590318871|FG001|Overall Study|Did not attend scheduled visit|4|||
163441604|NCT01426386|590318872|FG002|Overall Study|Did not attend scheduled visit|0|||
163441605|NCT01426386|590318873|FG003|Overall Study|Did not attend scheduled visit|0|||
163441606|NCT01426386|590318874|FG004|Overall Study|Did not attend scheduled visit|2|||
163441607|NCT01426386|590318875|FG005|Overall Study|Did not attend scheduled visit|1|||
163441608|NCT01426386|590318870|FG000|Overall Study|Poor response|2|||
163441609|NCT01426386|590318871|FG001|Overall Study|Poor response|1|||
163441610|NCT01426386|590318872|FG002|Overall Study|Poor response|2|||
163441611|NCT01426386|590318873|FG003|Overall Study|Poor response|0|||
163441612|NCT01426386|590318874|FG004|Overall Study|Poor response|1|||
163441613|NCT01426386|590318875|FG005|Overall Study|Poor response|0|||
163441614|NCT01426386|590318870|FG000|Overall Study|Personal reasons|0|||
163441615|NCT01426386|590318871|FG001|Overall Study|Personal reasons|0|||
163441616|NCT01426386|590318872|FG002|Overall Study|Personal reasons|0|||
163441617|NCT01426386|590318873|FG003|Overall Study|Personal reasons|0|||
163441618|NCT01426386|590318874|FG004|Overall Study|Personal reasons|1|||
163441619|NCT01426386|590318875|FG005|Overall Study|Personal reasons|0|||
163441620|NCT03694522|590318878|FG000|Overall Study|Withdrawal by Subject|8|||
163441621|NCT03694522|590318879|FG001|Overall Study|Withdrawal by Subject|10|||
163441622|NCT03694522|590318878|FG000|Overall Study|Physician Decision|53|||
163441623|NCT03694522|590318879|FG001|Overall Study|Physician Decision|54|||
163441624|NCT03694522|590318878|FG000|Overall Study|Other|1|||
163441625|NCT03694522|590318879|FG001|Overall Study|Other|1|||
163441626|NCT03694522|590318878|FG000|Overall Study|Lost to Follow-up|0|||
163441627|NCT03694522|590318879|FG001|Overall Study|Lost to Follow-up|1|||
163441628|NCT00257192|590318881|FG000|Overall Study|Adverse Event|21|||
163441629|NCT00257192|590318882|FG001|Overall Study|Adverse Event|10|||
163441630|NCT00257192|590318881|FG000|Overall Study|Laboratory abnormality|1|||
163441631|NCT00257192|590318882|FG001|Overall Study|Laboratory abnormality|1|||
163441632|NCT00257192|590318881|FG000|Overall Study|Lost to Follow-up|3|||
163441633|NCT00257192|590318882|FG001|Overall Study|Lost to Follow-up|3|||
163441634|NCT00257192|590318881|FG000|Overall Study|Insufficient clinical response|18|||
163441635|NCT00257192|590318882|FG001|Overall Study|Insufficient clinical response|18|||
163441636|NCT00257192|590318881|FG000|Overall Study|Withdrawal by Subject|14|||
163441637|NCT00257192|590318882|FG001|Overall Study|Withdrawal by Subject|2|||
163441638|NCT00257192|590318881|FG000|Overall Study|Randomized but not treated|0|||
163441639|NCT00257192|590318882|FG001|Overall Study|Randomized but not treated|1|||
163441640|NCT00257192|590318881|FG000|Overall Study|Study terminated by sponsor|1|||
163441641|NCT00257192|590318882|FG001|Overall Study|Study terminated by sponsor|0|||
163441642|NCT00257192|590318881|FG000|Overall Study|Miscellaneous|0|||
163441643|NCT00257192|590318882|FG001|Overall Study|Miscellaneous|4|||
163441644|NCT02062151|590318885|FG000|Overall Study|screen failure|1|||
163441645|NCT01905397|590318886|FG000|Overall Study|Death|0|||
163441646|NCT01905397|590318887|FG001|Overall Study|Death|1|||
163441647|NCT01905397|590318886|FG000|Overall Study|Withdrawal by Subject|2|||
163441648|NCT01905397|590318887|FG001|Overall Study|Withdrawal by Subject|0|||
163441649|NCT01905397|590318886|FG000|Overall Study|Surgery canceled/aborted|9|||
163441650|NCT01905397|590318887|FG001|Overall Study|Surgery canceled/aborted|5|||
163441651|NCT01905397|590318886|FG000|Overall Study|Incision < 7 cm|2|||
163441652|NCT01905397|590318887|FG001|Overall Study|Incision < 7 cm|0|||
163441653|NCT01905397|590318886|FG000|Overall Study|Wrong treatment|1|||
163441654|NCT01905397|590318887|FG001|Overall Study|Wrong treatment|1|||
163441655|NCT01905397|590318886|FG000|Overall Study|Device not applied|3|||
163441656|NCT01905397|590318887|FG001|Overall Study|Device not applied|0|||
163441657|NCT01905397|590318886|FG000|Overall Study|Dressing not applied in operating room|1|||
163441658|NCT01905397|590318887|FG001|Overall Study|Dressing not applied in operating room|0|||
163441659|NCT01905397|590318886|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
163441660|NCT01905397|590318887|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
163441661|NCT00638846|590318888|FG000|Overall Study|Adverse Event|0|||
163441662|NCT00638846|590318889|FG001|Overall Study|Adverse Event|1|||
163441663|NCT00638846|590318888|FG000|Overall Study|Lost to Follow-up|3|||
163441664|NCT00638846|590318889|FG001|Overall Study|Lost to Follow-up|2|||
163441665|NCT00638846|590318888|FG000|Overall Study|lens issue|1|||
163441666|NCT00638846|590318889|FG001|Overall Study|lens issue|3|||
163441667|NCT04172831|590318892|FG000|Overall Study|Adverse Event|21|||
163441668|NCT04172831|590318893|FG001|Overall Study|Adverse Event|9|||
163441669|NCT04172831|590318892|FG000|Overall Study|Lack of Efficacy|2|||
163441670|NCT04172831|590318893|FG001|Overall Study|Lack of Efficacy|8|||
163441671|NCT04172831|590318892|FG000|Overall Study|Physician Decision|0|||
163441672|NCT04172831|590318893|FG001|Overall Study|Physician Decision|1|||
163441673|NCT04172831|590318892|FG000|Overall Study|Withdrawal by Subject|12|||
163441674|NCT04172831|590318893|FG001|Overall Study|Withdrawal by Subject|11|||
163441675|NCT04172831|590318892|FG000|Overall Study|Lost to Follow-up|4|||
163441676|NCT04172831|590318893|FG001|Overall Study|Lost to Follow-up|9|||
163441677|NCT04172831|590318892|FG000|Overall Study|COVID-19 related crisis|3|||
163441678|NCT04172831|590318893|FG001|Overall Study|COVID-19 related crisis|3|||
163441679|NCT04172831|590318892|FG000|Overall Study|Subject non-compliance|1|||
163441680|NCT04172831|590318893|FG001|Overall Study|Subject non-compliance|1|||
163441681|NCT04172831|590318892|FG000|Overall Study|Family emergency|1|||
163441682|NCT04172831|590318893|FG001|Overall Study|Family emergency|0|||
163441683|NCT01696877|590318899|FG000|Overall Study|Adverse Event|0|||
163441684|NCT01696877|590318900|FG001|Overall Study|Adverse Event|1|||
163441685|NCT02119104|590318901|FG000|Overall Study|Protocol Violation|16|||
163441686|NCT00916721|590318904|FG000|Overall Study|Lost to Follow-up|0|||
163441687|NCT00916721|590318905|FG001|Overall Study|Lost to Follow-up|1|||
163441688|NCT00916721|590318904|FG000|Overall Study|Adverse Event|6|||
163441689|NCT00916721|590318905|FG001|Overall Study|Adverse Event|3|||
163441690|NCT00916721|590318904|FG000|Overall Study|Withdrawal by Subject|2|||
163441691|NCT00916721|590318905|FG001|Overall Study|Withdrawal by Subject|2|||
163441692|NCT00916721|590318904|FG000|Overall Study|Protocol Violation|2|||
163441693|NCT00916721|590318905|FG001|Overall Study|Protocol Violation|4|||
163441694|NCT00798967|590318910|FG000|Overall Study|Adverse Event|2|||
163441695|NCT00798967|590318911|FG001|Overall Study|Adverse Event|3|||
163441696|NCT00798967|590318910|FG000|Overall Study|Withdrawal by Subject|0|||
163441697|NCT00798967|590318911|FG001|Overall Study|Withdrawal by Subject|1|||
163441698|NCT00798967|590318910|FG000|Overall Study|Physician Decision|1|||
163441699|NCT00798967|590318911|FG001|Overall Study|Physician Decision|0|||
163441700|NCT00798967|590318910|FG000|Overall Study|Randomized in error by site|1|||
163441701|NCT00798967|590318911|FG001|Overall Study|Randomized in error by site|0|||
163441702|NCT00633139|590318914|FG000|Overall Study|Non compliance|0|||
163441703|NCT00633139|590318915|FG001|Overall Study|Non compliance|0|||
163441704|NCT00633139|590318916|FG002|Overall Study|Non compliance|1|||
163441705|NCT00633139|590318914|FG000|Overall Study|Withdrawal by Subject|0|||
163441706|NCT00633139|590318915|FG001|Overall Study|Withdrawal by Subject|1|||
163441707|NCT00633139|590318916|FG002|Overall Study|Withdrawal by Subject|0|||
163441708|NCT01507246|590318918|FG000|Overall Study|Required different surgical procedures|2|||
163441709|NCT01507246|590318919|FG001|Overall Study|Required different surgical procedures|1|||
163441710|NCT04083222|590318920|FG000|Overall Study|Voluntary Withdrawal|0|||
163441711|NCT04083222|590318921|FG001|Overall Study|Voluntary Withdrawal|1|||
163441712|NCT04083222|590318920|FG000|Overall Study|Reason not Specified|0|||
163441713|NCT04083222|590318921|FG001|Overall Study|Reason not Specified|1|||
163441714|NCT03575468|590318924|FG000|Overall Study|Withdrawal by Subject|3|||
163441715|NCT03575468|590318925|FG001|Overall Study|Withdrawal by Subject|0|||
163441716|NCT03575468|590318924|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
163441717|NCT03575468|590318925|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
163441718|NCT03575468|590318924|FG000|Overall Study|Lost to Follow-up|13|||
163441719|NCT03575468|590318925|FG001|Overall Study|Lost to Follow-up|17|||
163441720|NCT01522651|590318926|FG000|Overall Study|Adverse Event|3|||
163441721|NCT01522651|590318927|FG001|Overall Study|Adverse Event|4|||
163441722|NCT01522651|590318928|FG002|Overall Study|Adverse Event|4|||
163441723|NCT01522651|590318929|FG003|Overall Study|Adverse Event|5|||
163441724|NCT01522651|590318930|FG004|Overall Study|Adverse Event|4|||
163441725|NCT01522651|590318926|FG000|Overall Study|Cardioversion|1|||
163441726|NCT01522651|590318927|FG001|Overall Study|Cardioversion|0|||
163441727|NCT01522651|590318928|FG002|Overall Study|Cardioversion|0|||
163441728|NCT01522651|590318929|FG003|Overall Study|Cardioversion|0|||
163441729|NCT01522651|590318930|FG004|Overall Study|Cardioversion|0|||
163441730|NCT01522651|590318926|FG000|Overall Study|Device Malfunction|0|||
163441731|NCT01522651|590318927|FG001|Overall Study|Device Malfunction|1|||
163441732|NCT01522651|590318928|FG002|Overall Study|Device Malfunction|0|||
163441733|NCT01522651|590318929|FG003|Overall Study|Device Malfunction|0|||
163441734|NCT01522651|590318930|FG004|Overall Study|Device Malfunction|0|||
163441735|NCT01522651|590318926|FG000|Overall Study|Investigator's Discretion|0|||
163441736|NCT01522651|590318927|FG001|Overall Study|Investigator's Discretion|1|||
163441737|NCT01522651|590318928|FG002|Overall Study|Investigator's Discretion|0|||
163441738|NCT01522651|590318929|FG003|Overall Study|Investigator's Discretion|0|||
163441739|NCT01522651|590318930|FG004|Overall Study|Investigator's Discretion|0|||
163441740|NCT01522651|590318926|FG000|Overall Study|Protocol Violation|3|||
163441741|NCT01522651|590318927|FG001|Overall Study|Protocol Violation|0|||
163441742|NCT01522651|590318928|FG002|Overall Study|Protocol Violation|0|||
163441743|NCT01522651|590318929|FG003|Overall Study|Protocol Violation|0|||
163441744|NCT01522651|590318930|FG004|Overall Study|Protocol Violation|0|||
163441745|NCT01522651|590318926|FG000|Overall Study|Reason Not Specified|0|||
163441746|NCT01522651|590318927|FG001|Overall Study|Reason Not Specified|0|||
163441747|NCT01522651|590318928|FG002|Overall Study|Reason Not Specified|0|||
163441748|NCT01522651|590318929|FG003|Overall Study|Reason Not Specified|1|||
163441749|NCT01522651|590318930|FG004|Overall Study|Reason Not Specified|0|||
163441750|NCT01522651|590318926|FG000|Overall Study|Participant Non-Compliance|1|||
163441751|NCT01522651|590318927|FG001|Overall Study|Participant Non-Compliance|0|||
163441752|NCT01522651|590318928|FG002|Overall Study|Participant Non-Compliance|0|||
163441753|NCT01522651|590318929|FG003|Overall Study|Participant Non-Compliance|0|||
163441754|NCT01522651|590318930|FG004|Overall Study|Participant Non-Compliance|0|||
163441755|NCT01522651|590318926|FG000|Overall Study|Withdrew Consent|1|||
163441756|NCT01522651|590318927|FG001|Overall Study|Withdrew Consent|1|||
163441757|NCT01522651|590318928|FG002|Overall Study|Withdrew Consent|0|||
163441758|NCT01522651|590318929|FG003|Overall Study|Withdrew Consent|1|||
163441759|NCT01522651|590318930|FG004|Overall Study|Withdrew Consent|1|||
163441760|NCT01522651|590318926|FG000|Overall Study|Randomized but Never Treated|0|||
163441761|NCT01522651|590318927|FG001|Overall Study|Randomized but Never Treated|1|||
163441762|NCT01522651|590318928|FG002|Overall Study|Randomized but Never Treated|0|||
163441763|NCT01522651|590318929|FG003|Overall Study|Randomized but Never Treated|1|||
163441764|NCT01522651|590318930|FG004|Overall Study|Randomized but Never Treated|1|||
163441765|NCT04400318|590320708|FG000|Overall Study|Adverse Event|1|||
163441766|NCT04400318|590320709|FG001|Overall Study|Adverse Event|0|||
163441767|NCT04400318|590320708|FG000|Overall Study|Withdrawal by Subject|1|||
163441768|NCT04400318|590320709|FG001|Overall Study|Withdrawal by Subject|1|||
163441769|NCT04400318|590320708|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
163441770|NCT04400318|590320709|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
163441771|NCT02078713|590320710|FG000|Overall Study|Lost to Follow-up|49|||
163441772|NCT02078713|590320711|FG001|Overall Study|Lost to Follow-up|55|||
163441773|NCT02078713|590320712|FG002|Overall Study|Lost to Follow-up|0|||
163441774|NCT02078713|590320713|FG003|Overall Study|Lost to Follow-up|0|||
163441775|NCT02078713|590320710|FG000|Overall Study|Pregnant at baseline|3|||
163441776|NCT02078713|590320711|FG001|Overall Study|Pregnant at baseline|5|||
163441777|NCT02078713|590320712|FG002|Overall Study|Pregnant at baseline|0|||
163441778|NCT02078713|590320713|FG003|Overall Study|Pregnant at baseline|0|||
163441779|NCT02078713|590320710|FG000|Overall Study|Enrolled twice|0|||
163441780|NCT02078713|590320711|FG001|Overall Study|Enrolled twice|1|||
163441781|NCT02078713|590320712|FG002|Overall Study|Enrolled twice|0|||
163441782|NCT02078713|590320713|FG003|Overall Study|Enrolled twice|0|||
163441783|NCT01793051|590320724|FG000|Overall Study|Withdrawal by Subject|6|||
163441784|NCT01793051|590320725|FG001|Overall Study|Withdrawal by Subject|4|||
163441785|NCT01793051|590320724|FG000|Overall Study|Adverse Event|0|||
163441786|NCT01793051|590320725|FG001|Overall Study|Adverse Event|2|||
163441787|NCT01793051|590320724|FG000|Overall Study|Too ill to continue|1|||
163441788|NCT01793051|590320725|FG001|Overall Study|Too ill to continue|0|||
163441789|NCT01793051|590320724|FG000|Overall Study|Switched chemo|1|||
163441790|NCT01793051|590320725|FG001|Overall Study|Switched chemo|1|||
163441791|NCT01793051|590320724|FG000|Overall Study|Lack of compliance|1|||
163441792|NCT01793051|590320725|FG001|Overall Study|Lack of compliance|0|||
163441793|NCT01793051|590320724|FG000|Overall Study|Requested to be removed from the study|1|||
163441794|NCT01793051|590320725|FG001|Overall Study|Requested to be removed from the study|1|||
163441795|NCT02421120|590320728|FG000|Overall Study|Adverse Event|1|||
163441796|NCT00372190|590320729|FG000|Overall Study|Lost to Follow-up|3|||
163441797|NCT00372190|590320730|FG001|Overall Study|Lost to Follow-up|1|||
163441798|NCT00623467|590320731|FG000|Overall Study|Lost to Follow-up|1|||
163441799|NCT00623467|590320731|FG000|Overall Study|Protocol Violation|4|||
163441800|NCT00623467|590320731|FG000|Overall Study|Withdrawal by Subject|2|||
163441801|NCT00273858|590320745|FG000|Overall Study|Not completed 24 month observation time|334|||
163441802|NCT00273858|590320745|FG000|Overall Study|Lost to Follow-up|101|||
163441803|NCT00273858|590320745|FG000|Overall Study|Withdrawal by Subject|21|||
163441804|NCT00273858|590320745|FG000|Overall Study|Adverse Event|81|||
163441805|NCT02232516|590320746|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
163441806|NCT02232516|590320746|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
163441807|NCT02232516|590320746|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
163441808|NCT02232516|590320746|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
163441809|NCT02232516|590320746|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
163441810|NCT02232516|590320746|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
163441811|NCT02232516|590320746|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
163441812|NCT02232516|590320746|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
163441813|NCT02232516|590320746|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
163441814|NCT02232516|590320746|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
163441815|NCT02232516|590320746|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
163441816|NCT02232516|590320746|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
163441817|NCT02232516|590320746|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
163441818|NCT02232516|590320746|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
163441819|NCT02232516|590320746|FG000|Survival Follow-up|Death|15|||
163441820|NCT02232516|590320746|FG000|Survival Follow-up|Withdrawal by Subject|3|||
163441821|NCT02232516|590320746|FG000|Survival Follow-up|Lost to Follow-up|1|||
163441822|NCT02232516|590320746|FG000|Survival Follow-up|Still in follow-up|5|||
163441823|NCT01585961|590320747|FG000|Overall Study|Death|6|||
163441824|NCT01585961|590320747|FG000|Overall Study|Physician Decision|1|||
163441825|NCT01585961|590320747|FG000|Overall Study|Decision to use non-study catheter|1|||
163441826|NCT01585961|590320747|FG000|Overall Study|Withdrawal by Subject|1|||
163441827|NCT01585961|590320747|FG000|Overall Study|Lost to Follow-up|23|||
163441828|NCT01585961|590320747|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
163441829|NCT01258348|590320748|FG000|Overall Study|Adverse Event|1|||
163441830|NCT01258348|590320749|FG001|Overall Study|Adverse Event|1|||
163441831|NCT01258348|590320750|FG002|Overall Study|Adverse Event|3|||
163441832|NCT01258348|590320751|FG003|Overall Study|Adverse Event|2|||
163441833|NCT01258348|590320752|FG004|Overall Study|Adverse Event|4|||
163441834|NCT01258348|590320748|FG000|Overall Study|Progressive Disease|0|||
163441835|NCT01258348|590320749|FG001|Overall Study|Progressive Disease|3|||
163441836|NCT01258348|590320750|FG002|Overall Study|Progressive Disease|0|||
163441837|NCT01258348|590320751|FG003|Overall Study|Progressive Disease|2|||
163441838|NCT01258348|590320752|FG004|Overall Study|Progressive Disease|2|||
163441839|NCT01258348|590320748|FG000|Overall Study|Physician Decision|0|||
163441840|NCT01258348|590320749|FG001|Overall Study|Physician Decision|0|||
163441841|NCT01258348|590320750|FG002|Overall Study|Physician Decision|0|||
163441842|NCT01258348|590320751|FG003|Overall Study|Physician Decision|2|||
163441843|NCT01258348|590320752|FG004|Overall Study|Physician Decision|0|||
163441844|NCT01258348|590320748|FG000|Overall Study|Withdrawal by Subject|0|||
163441845|NCT01258348|590320749|FG001|Overall Study|Withdrawal by Subject|1|||
163441846|NCT01258348|590320750|FG002|Overall Study|Withdrawal by Subject|0|||
163441847|NCT01258348|590320751|FG003|Overall Study|Withdrawal by Subject|0|||
163441848|NCT01258348|590320752|FG004|Overall Study|Withdrawal by Subject|0|||
163441849|NCT01849848|590320755|FG000|Overall Study|Physician Decision|1|||
163441850|NCT01849848|590320755|FG000|Overall Study|Progression of the primary disease|3|||
163441851|NCT01505491|590320756|FG000|Overall Study|Other reason not listed|1|||
163441852|NCT01505491|590320757|FG001|Overall Study|Other reason not listed|0|||
163441853|NCT01505491|590320758|FG002|Overall Study|Other reason not listed|0|||
163441854|NCT01505491|590320756|FG000|Overall Study|Withdrawal by Subject|1|||
163441855|NCT01505491|590320757|FG001|Overall Study|Withdrawal by Subject|1|||
163441856|NCT01505491|590320758|FG002|Overall Study|Withdrawal by Subject|4|||
163441857|NCT01505491|590320756|FG000|Overall Study|Lost to Follow-up|0|||
163441858|NCT01505491|590320757|FG001|Overall Study|Lost to Follow-up|0|||
163441859|NCT01505491|590320758|FG002|Overall Study|Lost to Follow-up|1|||
163441860|NCT01120093|590320767|FG000|Treatment Period 1|Adverse Event|0|||
163441861|NCT01120093|590320768|FG001|Treatment Period 1|Adverse Event|0|||
163441862|NCT01120093|590320769|FG002|Treatment Period 1|Adverse Event|1|||
163441863|NCT01120093|590320770|FG003|Treatment Period 1|Adverse Event|0|||
163441864|NCT01120093|590320771|FG004|Treatment Period 1|Adverse Event|1|||
163441865|NCT01120093|590320767|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163441866|NCT01120093|590320768|FG001|Treatment Period 1|Withdrawal by Subject|1|||
163441867|NCT01120093|590320769|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163441868|NCT01120093|590320770|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163441869|NCT01120093|590320771|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163441870|NCT01120093|590320767|FG000|Treatment Period 2|Adverse Event|0|||
163441871|NCT01120093|590320768|FG001|Treatment Period 2|Adverse Event|0|||
163441872|NCT01120093|590320769|FG002|Treatment Period 2|Adverse Event|0|||
163441873|NCT01120093|590320770|FG003|Treatment Period 2|Adverse Event|1|||
163441874|NCT01120093|590320771|FG004|Treatment Period 2|Adverse Event|0|||
163441875|NCT01120093|590320767|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163441876|NCT01120093|590320768|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163441877|NCT01120093|590320769|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163441878|NCT01120093|590320770|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163441879|NCT01120093|590320771|FG004|Treatment Period 2|Withdrawal by Subject|1|||
163441880|NCT01120093|590320767|FG000|Treatment Period 3|Lack of Efficacy|0|||
163441881|NCT01120093|590320768|FG001|Treatment Period 3|Lack of Efficacy|0|||
163441882|NCT01120093|590320769|FG002|Treatment Period 3|Lack of Efficacy|0|||
163441883|NCT01120093|590320770|FG003|Treatment Period 3|Lack of Efficacy|1|||
163441884|NCT01120093|590320771|FG004|Treatment Period 3|Lack of Efficacy|0|||
163441885|NCT01120093|590320767|FG000|Treatment Period 3|Adverse Event|0|||
163441886|NCT01120093|590320768|FG001|Treatment Period 3|Adverse Event|0|||
163441887|NCT01120093|590320769|FG002|Treatment Period 3|Adverse Event|0|||
163441888|NCT01120093|590320770|FG003|Treatment Period 3|Adverse Event|0|||
163441889|NCT01120093|590320771|FG004|Treatment Period 3|Adverse Event|1|||
163441890|NCT01120093|590320767|FG000|Treatment Period 3|Withdrawal by Subject|0|||
163441891|NCT01120093|590320768|FG001|Treatment Period 3|Withdrawal by Subject|0|||
163441892|NCT01120093|590320769|FG002|Treatment Period 3|Withdrawal by Subject|1|||
163441893|NCT01120093|590320770|FG003|Treatment Period 3|Withdrawal by Subject|0|||
163441894|NCT01120093|590320771|FG004|Treatment Period 3|Withdrawal by Subject|0|||
163441895|NCT01120093|590320767|FG000|Treatment Period 4|Adverse Event|1|||
163441896|NCT01120093|590320768|FG001|Treatment Period 4|Adverse Event|0|||
163441897|NCT01120093|590320769|FG002|Treatment Period 4|Adverse Event|0|||
163441898|NCT01120093|590320770|FG003|Treatment Period 4|Adverse Event|0|||
163441899|NCT01120093|590320771|FG004|Treatment Period 4|Adverse Event|0|||
163441900|NCT01120093|590320767|FG000|Treatment Period 5|Adverse Event|0|||
163441901|NCT01120093|590320768|FG001|Treatment Period 5|Adverse Event|1|||
163441902|NCT01120093|590320769|FG002|Treatment Period 5|Adverse Event|0|||
163441903|NCT01120093|590320770|FG003|Treatment Period 5|Adverse Event|1|||
163441904|NCT01120093|590320771|FG004|Treatment Period 5|Adverse Event|0|||
163441905|NCT03649321|590320776|FG000|Overall Study|Withdrawal by Subject|1|||
163441906|NCT03649321|590320777|FG001|Overall Study|Withdrawal by Subject|0|||
163441907|NCT03649321|590320776|FG000|Overall Study|Death|1|||
163441908|NCT03649321|590320777|FG001|Overall Study|Death|0|||
163441909|NCT01702363|590320778|FG000|Overall Study|Adverse Event|14|||
163441910|NCT01702363|590320778|FG000|Overall Study|Lack of Efficacy|4|||
163441911|NCT01702363|590320778|FG000|Overall Study|Withdrawal by Subject|2|||
163441912|NCT01312428|590320779|FG000|Overall Study|Study Termination|3|||
163441913|NCT01312428|590320780|FG001|Overall Study|Study Termination|4|||
163441914|NCT01797783|590320783|FG000|Overall Study|Adverse Event|1|||
163441915|NCT01797783|590320784|FG001|Overall Study|Adverse Event|1|||
163441916|NCT01797783|590320783|FG000|Overall Study|Withdrawal by Subject|1|||
163441917|NCT01797783|590320784|FG001|Overall Study|Withdrawal by Subject|0|||
163441918|NCT02184143|590320786|FG000|Overall Study|Withdrawal by Subject|4|||
163441919|NCT02184143|590320787|FG001|Overall Study|Withdrawal by Subject|4|||
163441920|NCT02184143|590320786|FG000|Overall Study|Lost to Follow-up|5|||
163441921|NCT02184143|590320787|FG001|Overall Study|Lost to Follow-up|3|||
163441922|NCT02184143|590320786|FG000|Overall Study|Death|1|||
163441923|NCT02184143|590320787|FG001|Overall Study|Death|0|||
163441924|NCT01525849|590320792|FG000|Overall Study|Lost to Follow-up|3|||
163441925|NCT01525849|590320793|FG001|Overall Study|Lost to Follow-up|2|||
163441926|NCT01525849|590320792|FG000|Overall Study|Withdrawal by Subject|1|||
163441927|NCT01525849|590320793|FG001|Overall Study|Withdrawal by Subject|9|||
163441928|NCT01525849|590320792|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
163441929|NCT01525849|590320793|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
163441930|NCT01525849|590320792|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
163441931|NCT01525849|590320793|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
163441932|NCT00431847|590320796|FG000|Overall Study|completion of less than two study visits|6|||
163441933|NCT00431847|590320797|FG001|Overall Study|completion of less than two study visits|3|||
163441934|NCT00431847|590320798|FG002|Overall Study|completion of less than two study visits|4|||
163441935|NCT00431847|590320799|FG003|Overall Study|completion of less than two study visits|14|||
163441936|NCT00431847|590320800|FG004|Overall Study|completion of less than two study visits|0|||
163441937|NCT00431847|590320796|FG000|Overall Study|Protocol Violation|0|||
163441938|NCT00431847|590320797|FG001|Overall Study|Protocol Violation|0|||
163441939|NCT00431847|590320798|FG002|Overall Study|Protocol Violation|0|||
163441940|NCT00431847|590320799|FG003|Overall Study|Protocol Violation|0|||
163441941|NCT00431847|590320800|FG004|Overall Study|Protocol Violation|1|||
163441942|NCT00339183|590320801|FG000|Overall Study|Adverse Event|5|||
163441943|NCT00339183|590320802|FG001|Overall Study|Adverse Event|3|||
163441944|NCT00339183|590320801|FG000|Overall Study|Withdrawal by Subject|16|||
163441945|NCT00339183|590320802|FG001|Overall Study|Withdrawal by Subject|19|||
163441946|NCT00339183|590320801|FG000|Overall Study|Physician Decision|2|||
163441947|NCT00339183|590320802|FG001|Overall Study|Physician Decision|4|||
163441948|NCT00339183|590320801|FG000|Overall Study|Lost to Follow-up|17|||
163441949|NCT00339183|590320802|FG001|Overall Study|Lost to Follow-up|17|||
163441950|NCT00339183|590320801|FG000|Overall Study|Protocol-specified criteria|12|||
163441951|NCT00339183|590320802|FG001|Overall Study|Protocol-specified criteria|8|||
163441952|NCT00339183|590320801|FG000|Overall Study|Missing reason|3|||
163441953|NCT00339183|590320802|FG001|Overall Study|Missing reason|1|||
163441954|NCT00339183|590320801|FG000|Overall Study|Other|46|||
163441955|NCT00339183|590320802|FG001|Overall Study|Other|40|||
163441956|NCT00339183|590320801|FG000|Overall Study|Ongoing|20|||
163441957|NCT00339183|590320802|FG001|Overall Study|Ongoing|13|||
163441958|NCT00793819|590320803|FG000|Overall Study|Adverse Event|8|||
163441959|NCT00793819|590320804|FG001|Overall Study|Adverse Event|4|||
163441960|NCT00793819|590320803|FG000|Overall Study|Lack of Efficacy|1|||
163441961|NCT00793819|590320804|FG001|Overall Study|Lack of Efficacy|1|||
163441962|NCT00793819|590320803|FG000|Overall Study|Withdrawal by Subject|4|||
163441963|NCT00793819|590320804|FG001|Overall Study|Withdrawal by Subject|3|||
163441964|NCT00793819|590320803|FG000|Overall Study|Lost to Follow-up|1|||
163441965|NCT00793819|590320804|FG001|Overall Study|Lost to Follow-up|1|||
163441966|NCT00002663|590320805|FG000|Overall Study|Death|4|||
163441967|NCT00002663|590320806|FG001|Overall Study|Death|1|||
163441968|NCT00002663|590320807|FG002|Overall Study|Death|1|||
163441969|NCT00002663|590320808|FG003|Overall Study|Death|0|||
163441970|NCT00002663|590320809|FG004|Overall Study|Death|0|||
163441971|NCT00002663|590320810|FG005|Overall Study|Death|13|||
163441972|NCT00002663|590320811|FG006|Overall Study|Death|0|||
163441973|NCT00002663|590320812|FG007|Overall Study|Death|1|||
163441974|NCT00002663|590320813|FG008|Overall Study|Death|1|||
163441975|NCT00002663|590320814|FG009|Overall Study|Death|1|||
163441976|NCT00002663|590320805|FG000|Overall Study|Lost to Follow-up|3|||
163441977|NCT00002663|590320806|FG001|Overall Study|Lost to Follow-up|0|||
163441978|NCT00002663|590320807|FG002|Overall Study|Lost to Follow-up|0|||
163441979|NCT00002663|590320808|FG003|Overall Study|Lost to Follow-up|1|||
163441980|NCT00002663|590320809|FG004|Overall Study|Lost to Follow-up|0|||
163441981|NCT00002663|590320810|FG005|Overall Study|Lost to Follow-up|1|||
163441982|NCT00002663|590320811|FG006|Overall Study|Lost to Follow-up|0|||
163441983|NCT00002663|590320812|FG007|Overall Study|Lost to Follow-up|0|||
163441984|NCT00002663|590320813|FG008|Overall Study|Lost to Follow-up|0|||
163441985|NCT00002663|590320814|FG009|Overall Study|Lost to Follow-up|0|||
163441986|NCT00002663|590320805|FG000|Overall Study|Other|0|||
163441987|NCT00002663|590320806|FG001|Overall Study|Other|1|||
163441988|NCT00002663|590320807|FG002|Overall Study|Other|0|||
163441989|NCT00002663|590320808|FG003|Overall Study|Other|0|||
163441990|NCT00002663|590320809|FG004|Overall Study|Other|0|||
163441991|NCT00002663|590320810|FG005|Overall Study|Other|1|||
163441992|NCT00002663|590320811|FG006|Overall Study|Other|1|||
163441993|NCT00002663|590320812|FG007|Overall Study|Other|0|||
163441994|NCT00002663|590320813|FG008|Overall Study|Other|0|||
163441995|NCT00002663|590320814|FG009|Overall Study|Other|0|||
163441996|NCT00002663|590320805|FG000|Overall Study|Physician Decision|0|||
163441997|NCT00002663|590320806|FG001|Overall Study|Physician Decision|0|||
163441998|NCT00002663|590320807|FG002|Overall Study|Physician Decision|0|||
163441999|NCT00002663|590320808|FG003|Overall Study|Physician Decision|0|||
163442000|NCT00002663|590320809|FG004|Overall Study|Physician Decision|1|||
163442001|NCT00002663|590320810|FG005|Overall Study|Physician Decision|0|||
163442002|NCT00002663|590320811|FG006|Overall Study|Physician Decision|0|||
163442003|NCT00002663|590320812|FG007|Overall Study|Physician Decision|0|||
163442004|NCT00002663|590320813|FG008|Overall Study|Physician Decision|1|||
163442005|NCT00002663|590320814|FG009|Overall Study|Physician Decision|1|||
163442006|NCT00002663|590320805|FG000|Overall Study|Adverse Event|0|||
163442007|NCT00002663|590320806|FG001|Overall Study|Adverse Event|0|||
163442008|NCT00002663|590320807|FG002|Overall Study|Adverse Event|0|||
163442009|NCT00002663|590320808|FG003|Overall Study|Adverse Event|1|||
163442010|NCT00002663|590320809|FG004|Overall Study|Adverse Event|0|||
163442011|NCT00002663|590320810|FG005|Overall Study|Adverse Event|0|||
163442012|NCT00002663|590320811|FG006|Overall Study|Adverse Event|0|||
163442013|NCT00002663|590320812|FG007|Overall Study|Adverse Event|1|||
163442014|NCT00002663|590320813|FG008|Overall Study|Adverse Event|0|||
163442015|NCT00002663|590320814|FG009|Overall Study|Adverse Event|0|||
163442016|NCT00446446|590320818|FG000|Overall Study|Death|10|||
163442017|NCT00446446|590320818|FG000|Overall Study|Withdrawal by Subject|6|||
163442018|NCT00446446|590320818|FG000|Overall Study|Other|4|||
163442019|NCT00446446|590320818|FG000|Overall Study|Disease Progession|2|||
163442020|NCT00446446|590320818|FG000|Overall Study|Adverse Event|1|||
163442021|NCT00446446|590320818|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
163442022|NCT02142894|590320819|FG000|Overall Study|Protocol Violation|8|||
163442023|NCT00611130|590320825|FG000|Overall Study|Lost to Follow-up|25|||
163442024|NCT00611130|590320826|FG001|Overall Study|Lost to Follow-up|29|||
163442025|NCT00611130|590320825|FG000|Overall Study|Protocol noncompliance|7|||
163442026|NCT00611130|590320826|FG001|Overall Study|Protocol noncompliance|6|||
163442027|NCT00611130|590320825|FG000|Overall Study|Withdrawal by Subject|6|||
163442028|NCT00611130|590320826|FG001|Overall Study|Withdrawal by Subject|5|||
163442029|NCT00611130|590320825|FG000|Overall Study|Other|5|||
163442030|NCT00611130|590320826|FG001|Overall Study|Other|4|||
163442031|NCT00611130|590320825|FG000|Overall Study|Incarceration|3|||
163442032|NCT00611130|590320826|FG001|Overall Study|Incarceration|2|||
163442033|NCT00611130|590320825|FG000|Overall Study|Administrative|1|||
163442034|NCT00611130|590320826|FG001|Overall Study|Administrative|1|||
163442035|NCT00611130|590320825|FG000|Overall Study|Adverse Event|1|||
163442036|NCT00611130|590320826|FG001|Overall Study|Adverse Event|0|||
163442037|NCT00611130|590320825|FG000|Overall Study|Death|1|||
163442038|NCT00611130|590320826|FG001|Overall Study|Death|0|||
163442039|NCT01455428|590320832|FG000|Overall Study|Protocol Violation|2|||
163442040|NCT01455428|590320833|FG001|Overall Study|Protocol Violation|1|||
163442041|NCT01455428|590320832|FG000|Overall Study|Adverse Event|6|||
163442042|NCT01455428|590320833|FG001|Overall Study|Adverse Event|2|||
163442043|NCT01455428|590320832|FG000|Overall Study|Lost to Follow-up|1|||
163442044|NCT01455428|590320833|FG001|Overall Study|Lost to Follow-up|1|||
163442045|NCT01455428|590320832|FG000|Overall Study|Withdrawal by Subject|2|||
163442046|NCT01455428|590320833|FG001|Overall Study|Withdrawal by Subject|5|||
163442047|NCT01455428|590320832|FG000|Overall Study|Did not meet entrance criteria|0|||
163442048|NCT01455428|590320833|FG001|Overall Study|Did not meet entrance criteria|2|||
163442049|NCT01455428|590320832|FG000|Overall Study|Insufficient clinical response|0|||
163442050|NCT01455428|590320833|FG001|Overall Study|Insufficient clinical response|2|||
163442051|NCT01455428|590320832|FG000|Overall Study|Did not receive treatment|1|||
163442052|NCT01455428|590320833|FG001|Overall Study|Did not receive treatment|1|||
163442053|NCT01455428|590320832|FG000|Overall Study|Other|2|||
163442054|NCT01455428|590320833|FG001|Overall Study|Other|4|||
163442055|NCT01927562|590320836|FG000|Overall Study|Lost to Follow-up|30|||
163442056|NCT01927562|590320836|FG000|Overall Study|Withdrawal by Subject|3|||
163442057|NCT01927562|590320836|FG000|Overall Study|Physician Decision|5|||
163442058|NCT00642616|590320837|FG000|Overall Study|Adverse Event|2|||
163442059|NCT00642616|590320838|FG001|Overall Study|Adverse Event|0|||
163442060|NCT00642616|590320839|FG002|Overall Study|Adverse Event|1|||
163442061|NCT00642616|590320840|FG003|Overall Study|Adverse Event|0|||
163442062|NCT00642616|590320837|FG000|Overall Study|Study Terminated by Sponsor|7|||
163442063|NCT00642616|590320838|FG001|Overall Study|Study Terminated by Sponsor|6|||
163442064|NCT00642616|590320839|FG002|Overall Study|Study Terminated by Sponsor|4|||
163442065|NCT00642616|590320840|FG003|Overall Study|Study Terminated by Sponsor|5|||
163442066|NCT00642616|590320837|FG000|Overall Study|Withdrawal by Subject|0|||
163442067|NCT00642616|590320838|FG001|Overall Study|Withdrawal by Subject|1|||
163442068|NCT00642616|590320839|FG002|Overall Study|Withdrawal by Subject|1|||
163442069|NCT00642616|590320840|FG003|Overall Study|Withdrawal by Subject|1|||
163442070|NCT00642616|590320837|FG000|Overall Study|Protocol Violation|0|||
163442071|NCT00642616|590320838|FG001|Overall Study|Protocol Violation|0|||
163442072|NCT00642616|590320839|FG002|Overall Study|Protocol Violation|2|||
163442073|NCT00642616|590320840|FG003|Overall Study|Protocol Violation|0|||
163442074|NCT00642616|590320837|FG000|Overall Study|Physician Decision|0|||
163442075|NCT00642616|590320838|FG001|Overall Study|Physician Decision|0|||
163442076|NCT00642616|590320839|FG002|Overall Study|Physician Decision|1|||
163442077|NCT00642616|590320840|FG003|Overall Study|Physician Decision|1|||
163442078|NCT02955186|590320841|FG000|Overall Study|Withdrawal by Subject|6|||
163442079|NCT02955186|590320842|FG001|Overall Study|Withdrawal by Subject|2|||
163442080|NCT02955186|590320841|FG000|Overall Study|Protocol Violation|1|||
163442081|NCT02955186|590320842|FG001|Overall Study|Protocol Violation|0|||
163442082|NCT01618656|590320844|FG000|Overall Study|Withdrawal by Subject|7|||
163442083|NCT01618656|590320845|FG001|Overall Study|Withdrawal by Subject|3|||
163442084|NCT01618656|590320844|FG000|Overall Study|Physician Decision|1|||
163442085|NCT01618656|590320845|FG001|Overall Study|Physician Decision|1|||
163442086|NCT01276847|590320846|FG000|Overall Study|Withdrawal by Subject|1|||
163442087|NCT01276847|590320847|FG001|Overall Study|Withdrawal by Subject|0|||
163442088|NCT01276847|590320848|FG002|Overall Study|Withdrawal by Subject|0|||
163442089|NCT01899144|590320849|FG000|Treatment Period 2|Other|1|||
163442090|NCT01899144|590320849|FG000|Treatment Period 3|Other|2|||
163442091|NCT01899144|590320849|FG000|Treatment Period 5|Other|1|||
163442092|NCT00751881|590320850|FG000|Core Treatment Period|Not treated|1|||
163442093|NCT00751881|590320851|FG001|Core Treatment Period|Not treated|1|||
163442094|NCT00751881|590320852|FG002|Core Treatment Period|Not treated|2|||
163442095|NCT00751881|590320850|FG000|Core Treatment Period|Adverse Event|26|||
163442096|NCT00751881|590320851|FG001|Core Treatment Period|Adverse Event|54|||
163442097|NCT00751881|590320852|FG002|Core Treatment Period|Adverse Event|58|||
163442098|NCT00751881|590320850|FG000|Core Treatment Period|Lack of Efficacy|37|||
163442099|NCT00751881|590320851|FG001|Core Treatment Period|Lack of Efficacy|30|||
163442100|NCT00751881|590320852|FG002|Core Treatment Period|Lack of Efficacy|20|||
163442101|NCT00751881|590320850|FG000|Core Treatment Period|Poor compliance to protocol|15|||
163442102|NCT00751881|590320851|FG001|Core Treatment Period|Poor compliance to protocol|3|||
163442103|NCT00751881|590320852|FG002|Core Treatment Period|Poor compliance to protocol|4|||
163442104|NCT00751881|590320850|FG000|Core Treatment Period|Lost to Follow-up|6|||
163442105|NCT00751881|590320851|FG001|Core Treatment Period|Lost to Follow-up|4|||
163442106|NCT00751881|590320852|FG002|Core Treatment Period|Lost to Follow-up|3|||
163442107|NCT00751881|590320850|FG000|Core Treatment Period|Other: protocol deviation|3|||
163442108|NCT00751881|590320851|FG001|Core Treatment Period|Other: protocol deviation|3|||
163442109|NCT00751881|590320852|FG002|Core Treatment Period|Other: protocol deviation|7|||
163442110|NCT00751881|590320850|FG000|Core Treatment Period|Other: wish to parent|5|||
163442111|NCT00751881|590320851|FG001|Core Treatment Period|Other: wish to parent|7|||
163442112|NCT00751881|590320852|FG002|Core Treatment Period|Other: wish to parent|4|||
163442113|NCT00751881|590320850|FG000|Core Treatment Period|Other: personal/family constraints|6|||
163442114|NCT00751881|590320851|FG001|Core Treatment Period|Other: personal/family constraints|7|||
163442115|NCT00751881|590320852|FG002|Core Treatment Period|Other: personal/family constraints|10|||
163442116|NCT00751881|590320850|FG000|Core Treatment Period|Other: MS treatment change|6|||
163442117|NCT00751881|590320851|FG001|Core Treatment Period|Other: MS treatment change|4|||
163442118|NCT00751881|590320852|FG002|Core Treatment Period|Other: MS treatment change|4|||
163442119|NCT00751881|590320850|FG000|Core Treatment Period|Other: tolerability complaints|2|||
163442120|NCT00751881|590320851|FG001|Core Treatment Period|Other: tolerability complaints|0|||
163442121|NCT00751881|590320852|FG002|Core Treatment Period|Other: tolerability complaints|0|||
163442122|NCT00751881|590320850|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
163442123|NCT00751881|590320851|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
163442124|NCT00751881|590320852|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
163442125|NCT00751881|590320850|FG000|Extension Study Period|Adverse Event|18|||
163442126|NCT00751881|590320851|FG001|Extension Study Period|Adverse Event|20|||
163442127|NCT00751881|590320852|FG002|Extension Study Period|Adverse Event|21|||
163442128|NCT00751881|590320850|FG000|Extension Study Period|Lack of Efficacy|14|||
163442129|NCT00751881|590320851|FG001|Extension Study Period|Lack of Efficacy|10|||
163442130|NCT00751881|590320852|FG002|Extension Study Period|Lack of Efficacy|20|||
163442131|NCT00751881|590320850|FG000|Extension Study Period|Lost to Follow-up|4|||
163442132|NCT00751881|590320851|FG001|Extension Study Period|Lost to Follow-up|9|||
163442133|NCT00751881|590320852|FG002|Extension Study Period|Lost to Follow-up|6|||
163442134|NCT00751881|590320850|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
163442135|NCT00751881|590320851|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
163442136|NCT00751881|590320852|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
163442137|NCT00751881|590320850|FG000|Extension Study Period|Other than specified above|26|||
163442138|NCT00751881|590320851|FG001|Extension Study Period|Other than specified above|30|||
163442139|NCT00751881|590320852|FG002|Extension Study Period|Other than specified above|18|||
163442140|NCT04770155|590320853|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
163442141|NCT04770155|590320854|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
163442142|NCT04770155|590320855|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
163442143|NCT04770155|590320856|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
163442144|NCT04770155|590320857|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
163442145|NCT04770155|590320858|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
163442146|NCT04770155|590320859|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
163442147|NCT04770155|590320860|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
163442148|NCT02021812|590320861|FG000|Overall Study|Death|8|||
163442149|NCT02021812|590320861|FG000|Overall Study|Withdrawal by Subject|3|||
163442150|NCT02021812|590320861|FG000|Overall Study|Lost to Follow-up|2|||
163442151|NCT02021812|590320861|FG000|Overall Study|Refuse to return, COVD 19|2|||
163442152|NCT00081289|590320862|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
163442153|NCT00081289|590320863|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
163442154|NCT00081289|590320862|FG000|Overall Study|Ineligible / no protocol treatment|3|||
163442155|NCT00081289|590320863|FG001|Overall Study|Ineligible / no protocol treatment|4|||
163442156|NCT02239094|590320866|FG000|Overall Study|Withdrawal by Subject|1|||
163442157|NCT02239094|590320866|FG000|Overall Study|Remitted before started|1|||
163442158|NCT01469052|590320869|FG000|Overall Study|Adverse Event|2|||
163442159|NCT01469052|590320870|FG001|Overall Study|Adverse Event|3|||
163442160|NCT01469052|590320871|FG002|Overall Study|Adverse Event|0|||
163442161|NCT01469052|590320872|FG003|Overall Study|Adverse Event|2|||
163442162|NCT01469052|590320873|FG004|Overall Study|Adverse Event|0|||
163442163|NCT01469052|590320874|FG005|Overall Study|Adverse Event|1|||
163442164|NCT01469052|590320869|FG000|Overall Study|Progressive disease|3|||
163442165|NCT01469052|590320870|FG001|Overall Study|Progressive disease|0|||
163442166|NCT01469052|590320871|FG002|Overall Study|Progressive disease|5|||
163442167|NCT01469052|590320872|FG003|Overall Study|Progressive disease|3|||
163442168|NCT01469052|590320873|FG004|Overall Study|Progressive disease|7|||
163442169|NCT01469052|590320874|FG005|Overall Study|Progressive disease|2|||
163442170|NCT01469052|590320869|FG000|Overall Study|Lack of Efficacy|0|||
163442171|NCT01469052|590320870|FG001|Overall Study|Lack of Efficacy|0|||
163442172|NCT01469052|590320871|FG002|Overall Study|Lack of Efficacy|0|||
163442173|NCT01469052|590320872|FG003|Overall Study|Lack of Efficacy|0|||
163442174|NCT01469052|590320873|FG004|Overall Study|Lack of Efficacy|0|||
163442175|NCT01469052|590320874|FG005|Overall Study|Lack of Efficacy|2|||
163442176|NCT01469052|590320869|FG000|Overall Study|Moved to rollover protocol|1|||
163442177|NCT01469052|590320870|FG001|Overall Study|Moved to rollover protocol|0|||
163442178|NCT01469052|590320871|FG002|Overall Study|Moved to rollover protocol|1|||
163442179|NCT01469052|590320872|FG003|Overall Study|Moved to rollover protocol|0|||
163442180|NCT01469052|590320873|FG004|Overall Study|Moved to rollover protocol|0|||
163442181|NCT01469052|590320874|FG005|Overall Study|Moved to rollover protocol|1|||
163442182|NCT01469052|590320869|FG000|Overall Study|Other|0|||
163442183|NCT01469052|590320870|FG001|Overall Study|Other|1|||
163442184|NCT01469052|590320871|FG002|Overall Study|Other|0|||
163442185|NCT01469052|590320872|FG003|Overall Study|Other|0|||
163442186|NCT01469052|590320873|FG004|Overall Study|Other|1|||
163442187|NCT01469052|590320874|FG005|Overall Study|Other|0|||
163442188|NCT02508701|590320875|FG000|Overall Study|Lost to Follow-up|9|||
163442189|NCT02508701|590320876|FG001|Overall Study|Lost to Follow-up|5|||
163442190|NCT02508701|590320877|FG002|Overall Study|Lost to Follow-up|5|||
163442191|NCT02508701|590320878|FG003|Overall Study|Lost to Follow-up|3|||
163442192|NCT03648996|590320879|FG000|Overall Study|Withdrawal by Subject|0|||
163442193|NCT03648996|590320880|FG001|Overall Study|Withdrawal by Subject|2|||
163442194|NCT03648996|590320881|FG002|Overall Study|Withdrawal by Subject|2|||
163442195|NCT03648996|590320879|FG000|Overall Study|Physician Decision|2|||
163442196|NCT03648996|590320880|FG001|Overall Study|Physician Decision|0|||
163442197|NCT03648996|590320881|FG002|Overall Study|Physician Decision|0|||
163442198|NCT03894904|590320886|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
163442199|NCT03894904|590320887|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
163442200|NCT03894904|590320886|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
163442201|NCT03894904|590320887|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
163442202|NCT00504166|590320890|FG000|Overall Study|Adverse Event|1|||
163442203|NCT00504166|590320891|FG001|Overall Study|Adverse Event|4|||
163442204|NCT00504166|590320890|FG000|Overall Study|Withdrawal by Subject|3|||
163442205|NCT00504166|590320891|FG001|Overall Study|Withdrawal by Subject|6|||
163442206|NCT00504166|590320890|FG000|Overall Study|Physician Decision|1|||
163442207|NCT00504166|590320891|FG001|Overall Study|Physician Decision|1|||
163442208|NCT00504166|590320890|FG000|Overall Study|Lost to Follow-up|1|||
163442209|NCT00504166|590320891|FG001|Overall Study|Lost to Follow-up|3|||
163442210|NCT00365976|590320894|FG000|Overall Study|Withdrawal by Subject|1|||
163442211|NCT00365976|590320895|FG001|Overall Study|Withdrawal by Subject|5|||
163442212|NCT01415440|590320896|FG000|Overall Study|Lost to Follow-up|0|||
163442213|NCT01415440|590320897|FG001|Overall Study|Lost to Follow-up|1|||
163442214|NCT01415440|590320898|FG002|Overall Study|Lost to Follow-up|2|||
163442215|NCT01415440|590320896|FG000|Overall Study|Physician Decision|3|||
162925385|NCT00110084|588428953|FG000|Overall Study|Alternate Therapy|5|||
163442216|NCT01415440|590320897|FG001|Overall Study|Physician Decision|0|||
163442217|NCT01415440|590320898|FG002|Overall Study|Physician Decision|0|||
163442218|NCT01415440|590320896|FG000|Overall Study|Withdrawal by Subject|1|||
163442219|NCT01415440|590320897|FG001|Overall Study|Withdrawal by Subject|0|||
163442220|NCT01415440|590320898|FG002|Overall Study|Withdrawal by Subject|0|||
163442221|NCT03090737|590320899|FG000|Overall Study|Other reasons|1|||
163442222|NCT03090737|590320899|FG000|Overall Study|Completed treatment as per protocol|17|||
163442223|NCT03090737|590320899|FG000|Overall Study|Maximum clinical benefit|2|||
163442224|NCT03090737|590320899|FG000|Overall Study|Adverse event unrelated to study drug|7|||
163442225|NCT03090737|590320899|FG000|Overall Study|Study drug toxicity|4|||
163442226|NCT03090737|590320899|FG000|Overall Study|Disease progression|98|||
163442227|NCT03596177|590320901|FG000|Single Blind Period|Withdrawal by Subject|1|||
163442228|NCT03596177|590320902|FG001|Single Blind Period|Withdrawal by Subject|1|||
163442229|NCT03596177|590320901|FG000|Single Blind Period|Other|1|||
163442230|NCT03596177|590320902|FG001|Single Blind Period|Other|0|||
163442231|NCT03596177|590320901|FG000|Double Blind Period|Withdrawal by Subject|0|||
163442232|NCT03596177|590320902|FG001|Double Blind Period|Withdrawal by Subject|1|||
163442233|NCT03596177|590320901|FG000|Double Blind Period|Other|0|||
163442234|NCT03596177|590320902|FG001|Double Blind Period|Other|4|||
163442235|NCT03596177|590320901|FG000|Double Blind Period|Death during safety follow-up|0|||
163442236|NCT03596177|590320902|FG001|Double Blind Period|Death during safety follow-up|1|||
163442237|NCT03103750|590320905|FG000|Overall Study|Adverse Event|1|||
163442238|NCT03103750|590320906|FG001|Overall Study|Adverse Event|0|||
163442239|NCT03103750|590320905|FG000|Overall Study|Lost to Follow-up|1|||
163442240|NCT03103750|590320906|FG001|Overall Study|Lost to Follow-up|0|||
163442241|NCT03103750|590320905|FG000|Overall Study|PET Equipment Related|2|||
163442242|NCT03103750|590320906|FG001|Overall Study|PET Equipment Related|2|||
163442243|NCT03123939|590320908|FG000|Overall Study|Lack of Efficacy|6|||
163442244|NCT03123939|590320908|FG000|Overall Study|Death|5|||
163442245|NCT03123939|590320908|FG000|Overall Study|Physician Decision|2|||
163442246|NCT03123939|590320908|FG000|Overall Study|Subject/guardian decision|2|||
163442247|NCT03123939|590320908|FG000|Overall Study|Lost to Follow-up|1|||
163442248|NCT03123939|590320908|FG000|Overall Study|New therapy for study indication|1|||
163442249|NCT03123939|590320908|FG000|Overall Study|Protocol deviation|1|||
163442250|NCT03123939|590320908|FG000|Overall Study|Progressive disease|18|||
163442251|NCT03123939|590320908|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
163442252|NCT03123939|590320908|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
163442253|NCT04191967|590322434|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
163442254|NCT04191967|590322434|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
163442255|NCT00953043|590322438|FG000|Overall Study|Withdrawal by Subject|4|||
163442256|NCT00953043|590322439|FG001|Overall Study|Withdrawal by Subject|0|||
163442257|NCT00953043|590322438|FG000|Overall Study|Physician Decision|0|||
163442258|NCT00953043|590322439|FG001|Overall Study|Physician Decision|2|||
163442259|NCT03509207|590322441|FG000|Overall Study|Death|2|||
163442260|NCT02125331|590322442|FG000|Overall Study|Protocol Violation|1|||
163442261|NCT02125331|590322443|FG001|Overall Study|Protocol Violation|0|||
163442262|NCT02125331|590322442|FG000|Overall Study|technical problem|2|||
163442263|NCT02125331|590322443|FG001|Overall Study|technical problem|0|||
163442264|NCT02125331|590322442|FG000|Overall Study|screen failure|2|||
163442265|NCT02125331|590322443|FG001|Overall Study|screen failure|0|||
163442266|NCT01675531|590322444|FG000|Overall Study|Adverse Event|9|||
163442267|NCT01675531|590322444|FG000|Overall Study|Withdrawal by Subject|7|||
163442268|NCT01675531|590322444|FG000|Overall Study|Lack of Efficacy|1|||
163442269|NCT01675531|590322444|FG000|Overall Study|Protocol Violation|8|||
163442270|NCT01070550|590322445|FG000|Overall Study|Adverse Event|43|||
163442271|NCT01070550|590322446|FG001|Overall Study|Adverse Event|1|||
163442272|NCT01070550|590322447|FG002|Overall Study|Adverse Event|3|||
163442273|NCT01070550|590322448|FG003|Overall Study|Adverse Event|0|||
163442274|NCT01070550|590322449|FG004|Overall Study|Adverse Event|0|||
163442275|NCT01070550|590322450|FG005|Overall Study|Adverse Event|0|||
163442276|NCT01070550|590322445|FG000|Overall Study|Death|20|||
163442277|NCT01070550|590322446|FG001|Overall Study|Death|4|||
163442278|NCT01070550|590322447|FG002|Overall Study|Death|3|||
163442279|NCT01070550|590322448|FG003|Overall Study|Death|0|||
163442280|NCT01070550|590322449|FG004|Overall Study|Death|0|||
163442281|NCT01070550|590322450|FG005|Overall Study|Death|0|||
163442282|NCT01070550|590322445|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
163442283|NCT01070550|590322446|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
163442284|NCT01070550|590322447|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
163442285|NCT01070550|590322448|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
163442286|NCT01070550|590322449|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
163442287|NCT01070550|590322450|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
163442288|NCT01070550|590322445|FG000|Overall Study|Early termination|3|||
163442289|NCT01070550|590322446|FG001|Overall Study|Early termination|0|||
163442290|NCT01070550|590322447|FG002|Overall Study|Early termination|0|||
163442291|NCT01070550|590322448|FG003|Overall Study|Early termination|0|||
163442292|NCT01070550|590322449|FG004|Overall Study|Early termination|0|||
163442293|NCT01070550|590322450|FG005|Overall Study|Early termination|0|||
163442294|NCT01070550|590322445|FG000|Overall Study|Failed to return|450|||
163442295|NCT01070550|590322446|FG001|Overall Study|Failed to return|33|||
163442296|NCT01070550|590322447|FG002|Overall Study|Failed to return|144|||
163442297|NCT01070550|590322448|FG003|Overall Study|Failed to return|40|||
163442298|NCT01070550|590322449|FG004|Overall Study|Failed to return|1|||
163442299|NCT01070550|590322450|FG005|Overall Study|Failed to return|2|||
163442300|NCT01070550|590322445|FG000|Overall Study|Incomplete treatment|2|||
163442301|NCT01070550|590322446|FG001|Overall Study|Incomplete treatment|0|||
163442302|NCT01070550|590322447|FG002|Overall Study|Incomplete treatment|0|||
163442303|NCT01070550|590322448|FG003|Overall Study|Incomplete treatment|0|||
163442304|NCT01070550|590322449|FG004|Overall Study|Incomplete treatment|0|||
163442305|NCT01070550|590322450|FG005|Overall Study|Incomplete treatment|0|||
163442306|NCT01070550|590322445|FG000|Overall Study|Lab test not done|22|||
163442307|NCT01070550|590322446|FG001|Overall Study|Lab test not done|3|||
163442308|NCT01070550|590322447|FG002|Overall Study|Lab test not done|4|||
163442309|NCT01070550|590322448|FG003|Overall Study|Lab test not done|1|||
163442310|NCT01070550|590322449|FG004|Overall Study|Lab test not done|0|||
163442311|NCT01070550|590322450|FG005|Overall Study|Lab test not done|1|||
163442312|NCT01070550|590322445|FG000|Overall Study|Lack of Efficacy|65|||
163442313|NCT01070550|590322446|FG001|Overall Study|Lack of Efficacy|1|||
163442314|NCT01070550|590322447|FG002|Overall Study|Lack of Efficacy|5|||
163442315|NCT01070550|590322448|FG003|Overall Study|Lack of Efficacy|5|||
163442316|NCT01070550|590322449|FG004|Overall Study|Lack of Efficacy|0|||
163442317|NCT01070550|590322450|FG005|Overall Study|Lack of Efficacy|1|||
163442318|NCT01070550|590322445|FG000|Overall Study|Miscellaneous|12|||
163442319|NCT01070550|590322446|FG001|Overall Study|Miscellaneous|2|||
163442320|NCT01070550|590322447|FG002|Overall Study|Miscellaneous|3|||
163442321|NCT01070550|590322448|FG003|Overall Study|Miscellaneous|1|||
163442322|NCT01070550|590322449|FG004|Overall Study|Miscellaneous|0|||
163442323|NCT01070550|590322450|FG005|Overall Study|Miscellaneous|0|||
163442324|NCT01070550|590322445|FG000|Overall Study|New treatment started|3|||
163442325|NCT01070550|590322446|FG001|Overall Study|New treatment started|1|||
163442326|NCT01070550|590322447|FG002|Overall Study|New treatment started|0|||
163442327|NCT01070550|590322448|FG003|Overall Study|New treatment started|2|||
163442328|NCT01070550|590322449|FG004|Overall Study|New treatment started|0|||
163442329|NCT01070550|590322450|FG005|Overall Study|New treatment started|0|||
163442330|NCT01070550|590322445|FG000|Overall Study|Non-responders|493|||
163442331|NCT01070550|590322446|FG001|Overall Study|Non-responders|4|||
163442332|NCT01070550|590322447|FG002|Overall Study|Non-responders|21|||
163442333|NCT01070550|590322448|FG003|Overall Study|Non-responders|20|||
163442334|NCT01070550|590322449|FG004|Overall Study|Non-responders|0|||
163442335|NCT01070550|590322450|FG005|Overall Study|Non-responders|2|||
163442336|NCT01070550|590322445|FG000|Overall Study|Not categorized|33|||
163442337|NCT01070550|590322446|FG001|Overall Study|Not categorized|2|||
163442338|NCT01070550|590322447|FG002|Overall Study|Not categorized|6|||
163442339|NCT01070550|590322448|FG003|Overall Study|Not categorized|1|||
163442340|NCT01070550|590322449|FG004|Overall Study|Not categorized|0|||
163442341|NCT01070550|590322450|FG005|Overall Study|Not categorized|1|||
163442342|NCT01070550|590322445|FG000|Overall Study|Protocol Violation|15|||
163442343|NCT01070550|590322446|FG001|Overall Study|Protocol Violation|1|||
163442344|NCT01070550|590322447|FG002|Overall Study|Protocol Violation|1|||
163442345|NCT01070550|590322448|FG003|Overall Study|Protocol Violation|1|||
163442346|NCT01070550|590322449|FG004|Overall Study|Protocol Violation|0|||
163442347|NCT01070550|590322450|FG005|Overall Study|Protocol Violation|0|||
163442348|NCT01070550|590322445|FG000|Overall Study|Relapse|44|||
163442349|NCT01070550|590322446|FG001|Overall Study|Relapse|5|||
163442350|NCT01070550|590322447|FG002|Overall Study|Relapse|14|||
163442351|NCT01070550|590322448|FG003|Overall Study|Relapse|4|||
163442352|NCT01070550|590322449|FG004|Overall Study|Relapse|0|||
163442353|NCT01070550|590322450|FG005|Overall Study|Relapse|0|||
163442354|NCT01070550|590322445|FG000|Overall Study|Result not available|3|||
163442355|NCT01070550|590322446|FG001|Overall Study|Result not available|1|||
163442356|NCT01070550|590322447|FG002|Overall Study|Result not available|3|||
163442357|NCT01070550|590322448|FG003|Overall Study|Result not available|0|||
163442358|NCT01070550|590322449|FG004|Overall Study|Result not available|0|||
163442359|NCT01070550|590322450|FG005|Overall Study|Result not available|0|||
163442360|NCT01070550|590322445|FG000|Overall Study|Screen failure|1|||
163442361|NCT01070550|590322446|FG001|Overall Study|Screen failure|0|||
163442362|NCT01070550|590322447|FG002|Overall Study|Screen failure|0|||
163442363|NCT01070550|590322448|FG003|Overall Study|Screen failure|0|||
163442364|NCT01070550|590322449|FG004|Overall Study|Screen failure|0|||
163442365|NCT01070550|590322450|FG005|Overall Study|Screen failure|0|||
163442366|NCT01070550|590322445|FG000|Overall Study|Sponsor decision|1|||
163442367|NCT01070550|590322446|FG001|Overall Study|Sponsor decision|0|||
163442368|NCT01070550|590322447|FG002|Overall Study|Sponsor decision|0|||
163442369|NCT01070550|590322448|FG003|Overall Study|Sponsor decision|0|||
163442370|NCT01070550|590322449|FG004|Overall Study|Sponsor decision|0|||
163442371|NCT01070550|590322450|FG005|Overall Study|Sponsor decision|0|||
163442372|NCT01070550|590322445|FG000|Overall Study|Treatment duration shortened|1|||
163442373|NCT01070550|590322446|FG001|Overall Study|Treatment duration shortened|0|||
163442374|NCT01070550|590322447|FG002|Overall Study|Treatment duration shortened|0|||
163442375|NCT01070550|590322448|FG003|Overall Study|Treatment duration shortened|0|||
163442376|NCT01070550|590322449|FG004|Overall Study|Treatment duration shortened|0|||
163442377|NCT01070550|590322450|FG005|Overall Study|Treatment duration shortened|0|||
163442378|NCT01070550|590322445|FG000|Overall Study|Treatment interrupted|7|||
163442379|NCT01070550|590322446|FG001|Overall Study|Treatment interrupted|0|||
163442380|NCT01070550|590322447|FG002|Overall Study|Treatment interrupted|1|||
163442381|NCT01070550|590322448|FG003|Overall Study|Treatment interrupted|1|||
163442382|NCT01070550|590322449|FG004|Overall Study|Treatment interrupted|0|||
163442383|NCT01070550|590322450|FG005|Overall Study|Treatment interrupted|0|||
163442384|NCT01070550|590322445|FG000|Overall Study|Treatment not started|14|||
163442385|NCT01070550|590322446|FG001|Overall Study|Treatment not started|2|||
163442386|NCT01070550|590322447|FG002|Overall Study|Treatment not started|4|||
163442387|NCT01070550|590322448|FG003|Overall Study|Treatment not started|0|||
163442388|NCT01070550|590322449|FG004|Overall Study|Treatment not started|0|||
163442389|NCT01070550|590322450|FG005|Overall Study|Treatment not started|0|||
163442390|NCT01070550|590322445|FG000|Overall Study|Treatment restarted|0|||
163442391|NCT01070550|590322446|FG001|Overall Study|Treatment restarted|1|||
163442392|NCT01070550|590322447|FG002|Overall Study|Treatment restarted|0|||
163442393|NCT01070550|590322448|FG003|Overall Study|Treatment restarted|0|||
163442394|NCT01070550|590322449|FG004|Overall Study|Treatment restarted|0|||
163442395|NCT01070550|590322450|FG005|Overall Study|Treatment restarted|0|||
163442396|NCT01070550|590322445|FG000|Overall Study|Treatment stopped|3|||
163442397|NCT01070550|590322446|FG001|Overall Study|Treatment stopped|0|||
163442398|NCT01070550|590322447|FG002|Overall Study|Treatment stopped|0|||
163442399|NCT01070550|590322448|FG003|Overall Study|Treatment stopped|0|||
163442400|NCT01070550|590322449|FG004|Overall Study|Treatment stopped|0|||
163442401|NCT01070550|590322450|FG005|Overall Study|Treatment stopped|0|||
163442402|NCT01070550|590322445|FG000|Overall Study|Treatment unavailable|1|||
163442403|NCT01070550|590322446|FG001|Overall Study|Treatment unavailable|0|||
163442404|NCT01070550|590322447|FG002|Overall Study|Treatment unavailable|0|||
163442405|NCT01070550|590322448|FG003|Overall Study|Treatment unavailable|0|||
163442406|NCT01070550|590322449|FG004|Overall Study|Treatment unavailable|0|||
163442407|NCT01070550|590322450|FG005|Overall Study|Treatment unavailable|0|||
163442408|NCT01070550|590322445|FG000|Overall Study|Treatment was stopped early|7|||
163442409|NCT01070550|590322446|FG001|Overall Study|Treatment was stopped early|0|||
163442410|NCT01070550|590322447|FG002|Overall Study|Treatment was stopped early|0|||
163442411|NCT01070550|590322448|FG003|Overall Study|Treatment was stopped early|0|||
163442412|NCT01070550|590322449|FG004|Overall Study|Treatment was stopped early|0|||
163442413|NCT01070550|590322450|FG005|Overall Study|Treatment was stopped early|0|||
163442414|NCT01070550|590322445|FG000|Overall Study|Other|5|||
163442415|NCT01070550|590322446|FG001|Overall Study|Other|0|||
163442416|NCT01070550|590322447|FG002|Overall Study|Other|0|||
163442417|NCT01070550|590322448|FG003|Overall Study|Other|1|||
163442418|NCT01070550|590322449|FG004|Overall Study|Other|0|||
163442419|NCT01070550|590322450|FG005|Overall Study|Other|0|||
163442420|NCT01070550|590322445|FG000|Overall Study|Withdrawal by Subject|35|||
163442421|NCT01070550|590322446|FG001|Overall Study|Withdrawal by Subject|0|||
163442422|NCT01070550|590322447|FG002|Overall Study|Withdrawal by Subject|3|||
163442423|NCT01070550|590322448|FG003|Overall Study|Withdrawal by Subject|0|||
163442424|NCT01070550|590322449|FG004|Overall Study|Withdrawal by Subject|0|||
163442425|NCT01070550|590322450|FG005|Overall Study|Withdrawal by Subject|0|||
163442426|NCT00365716|590322452|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
163442427|NCT00365716|590322453|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
163442428|NCT00365716|590322454|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
163442429|NCT00365716|590322455|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
163442430|NCT00365716|590322456|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
163442431|NCT00365716|590322457|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
163442432|NCT00365716|590322458|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
163442433|NCT00365716|590322452|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
163442434|NCT00365716|590322453|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
163442435|NCT00365716|590322454|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
163442436|NCT00365716|590322455|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
163442437|NCT00365716|590322456|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
163442438|NCT00365716|590322457|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
163442439|NCT00365716|590322458|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
163442440|NCT00365716|590322452|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
163442441|NCT00365716|590322453|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
163442442|NCT00365716|590322454|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
163442443|NCT00365716|590322455|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
163442444|NCT00365716|590322456|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
163442445|NCT00365716|590322457|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
163442446|NCT00365716|590322458|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
163442447|NCT00365716|590322452|FG000|Base Study (Day 1 to Month 7)|Other|0|||
163442448|NCT00365716|590322453|FG001|Base Study (Day 1 to Month 7)|Other|1|||
163442449|NCT00365716|590322454|FG002|Base Study (Day 1 to Month 7)|Other|0|||
163442450|NCT00365716|590322455|FG003|Base Study (Day 1 to Month 7)|Other|0|||
163442451|NCT00365716|590322456|FG004|Base Study (Day 1 to Month 7)|Other|0|||
163442452|NCT00365716|590322457|FG005|Base Study (Day 1 to Month 7)|Other|0|||
163442453|NCT00365716|590322458|FG006|Base Study (Day 1 to Month 7)|Other|0|||
163442454|NCT00365716|590322452|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
163442455|NCT00365716|590322453|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
163442456|NCT00365716|590322454|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
163442457|NCT00365716|590322455|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
163442458|NCT00365716|590322456|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
163442459|NCT00365716|590322457|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
163442460|NCT00365716|590322458|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
163442461|NCT00365716|590322452|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
163442462|NCT00365716|590322453|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
163442463|NCT00365716|590322454|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
163442464|NCT00365716|590322455|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
163442465|NCT00365716|590322456|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
163442466|NCT00365716|590322457|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
163442467|NCT00365716|590322458|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
163442468|NCT00365716|590322452|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
163442469|NCT00365716|590322453|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
163442470|NCT00365716|590322454|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
163442471|NCT00365716|590322455|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
163442472|NCT00365716|590322456|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
163442473|NCT00365716|590322457|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
163442474|NCT00365716|590322458|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
163442475|NCT00365716|590322452|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
163442476|NCT00365716|590322453|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
163442477|NCT00365716|590322454|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
163442478|NCT00365716|590322455|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
163442479|NCT00365716|590322456|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
163442480|NCT00365716|590322457|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
163442481|NCT00365716|590322458|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
163442482|NCT00365716|590322452|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
163442483|NCT00365716|590322453|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
163442484|NCT00365716|590322454|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
163442485|NCT00365716|590322455|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
163442486|NCT00365716|590322456|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
163442487|NCT00365716|590322457|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
163442488|NCT00365716|590322458|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
163442489|NCT00365716|590322452|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
163442490|NCT00365716|590322453|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
163442491|NCT00365716|590322454|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
163442492|NCT00365716|590322455|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
163442493|NCT00365716|590322456|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
163442494|NCT00365716|590322457|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
163442495|NCT00365716|590322458|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
163442496|NCT00365716|590322452|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
163442497|NCT00365716|590322453|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
163442498|NCT00365716|590322454|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
163442499|NCT00365716|590322455|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
163442500|NCT00365716|590322456|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
163442501|NCT00365716|590322457|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
163442502|NCT00365716|590322458|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
163442503|NCT00365716|590322452|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
163442504|NCT00365716|590322453|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
163442505|NCT00365716|590322454|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
163442506|NCT00365716|590322455|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
163442507|NCT00365716|590322456|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
163442508|NCT00365716|590322457|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
163442509|NCT00365716|590322458|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
163442510|NCT00365716|590322452|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
163442511|NCT00365716|590322453|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
163442512|NCT00365716|590322454|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
163442513|NCT00365716|590322455|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
163442514|NCT00365716|590322456|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
163442515|NCT00365716|590322457|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
163442516|NCT00365716|590322458|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
163442517|NCT00365716|590322452|FG000|Extension 1|Lost to Follow-up|0|||
163442518|NCT00365716|590322453|FG001|Extension 1|Lost to Follow-up|0|||
163442519|NCT00365716|590322454|FG002|Extension 1|Lost to Follow-up|0|||
163442520|NCT00365716|590322455|FG003|Extension 1|Lost to Follow-up|0|||
163442521|NCT00365716|590322456|FG004|Extension 1|Lost to Follow-up|0|||
163442522|NCT00365716|590322457|FG005|Extension 1|Lost to Follow-up|1|||
163442523|NCT00365716|590322458|FG006|Extension 1|Lost to Follow-up|0|||
163442524|NCT00365716|590322452|FG000|Extension 1|Other|0|||
163442525|NCT00365716|590322453|FG001|Extension 1|Other|0|||
163442526|NCT00365716|590322454|FG002|Extension 1|Other|0|||
163442527|NCT00365716|590322455|FG003|Extension 1|Other|0|||
163442528|NCT00365716|590322456|FG004|Extension 1|Other|0|||
163442529|NCT00365716|590322457|FG005|Extension 1|Other|9|||
163442530|NCT00365716|590322458|FG006|Extension 1|Other|0|||
163442531|NCT00365716|590322452|FG000|Extension 1|Moved|0|||
163442532|NCT00365716|590322453|FG001|Extension 1|Moved|0|||
163442533|NCT00365716|590322454|FG002|Extension 1|Moved|0|||
163442534|NCT00365716|590322455|FG003|Extension 1|Moved|0|||
163442535|NCT00365716|590322456|FG004|Extension 1|Moved|0|||
163442536|NCT00365716|590322457|FG005|Extension 1|Moved|4|||
163442537|NCT00365716|590322458|FG006|Extension 1|Moved|0|||
163442538|NCT00365716|590322452|FG000|Extension 1|Withdrawal by Subject|0|||
163442539|NCT00365716|590322453|FG001|Extension 1|Withdrawal by Subject|0|||
163442540|NCT00365716|590322454|FG002|Extension 1|Withdrawal by Subject|0|||
163442541|NCT00365716|590322455|FG003|Extension 1|Withdrawal by Subject|0|||
163442542|NCT00365716|590322456|FG004|Extension 1|Withdrawal by Subject|0|||
163442543|NCT00365716|590322457|FG005|Extension 1|Withdrawal by Subject|3|||
163442544|NCT00365716|590322458|FG006|Extension 1|Withdrawal by Subject|0|||
163442545|NCT00365716|590322452|FG000|Extension 1|Pregnancy|0|||
163384940|NCT00427895|590119251|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
163384941|NCT00427895|590119252|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
163384942|NCT00427895|590119253|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
163384943|NCT00427895|590119254|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
163384944|NCT00427895|590119255|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
163384945|NCT00427895|590119256|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
163384946|NCT00427895|590119257|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
163384947|NCT02796560|590119265|FG000|Overall Study|Adverse Event|2|||
163384948|NCT02796560|590119266|FG001|Overall Study|Adverse Event|0|||
163384949|NCT02796560|590119265|FG000|Overall Study|Withdrawal by Subject|2|||
163384950|NCT02796560|590119266|FG001|Overall Study|Withdrawal by Subject|2|||
163384951|NCT03816332|590119268|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
163384952|NCT03816332|590119268|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
163442546|NCT00365716|590322453|FG001|Extension 1|Pregnancy|0|||
163442547|NCT00365716|590322454|FG002|Extension 1|Pregnancy|0|||
163442548|NCT00365716|590322455|FG003|Extension 1|Pregnancy|0|||
163442549|NCT00365716|590322456|FG004|Extension 1|Pregnancy|0|||
163442550|NCT00365716|590322457|FG005|Extension 1|Pregnancy|4|||
163442551|NCT00365716|590322458|FG006|Extension 1|Pregnancy|0|||
163442552|NCT00365716|590322452|FG000|Extension 1|Protocol Violation|0|||
163442553|NCT00365716|590322453|FG001|Extension 1|Protocol Violation|0|||
163442554|NCT00365716|590322454|FG002|Extension 1|Protocol Violation|0|||
163442555|NCT00365716|590322455|FG003|Extension 1|Protocol Violation|0|||
163442556|NCT00365716|590322456|FG004|Extension 1|Protocol Violation|0|||
163442557|NCT00365716|590322457|FG005|Extension 1|Protocol Violation|1|||
163442558|NCT00365716|590322458|FG006|Extension 1|Protocol Violation|0|||
163442559|NCT00365716|590322452|FG000|Extension 2|Lost to Follow-up|0|||
163442560|NCT00365716|590322453|FG001|Extension 2|Lost to Follow-up|0|||
163442561|NCT00365716|590322454|FG002|Extension 2|Lost to Follow-up|0|||
163442562|NCT00365716|590322455|FG003|Extension 2|Lost to Follow-up|0|||
163442563|NCT00365716|590322456|FG004|Extension 2|Lost to Follow-up|0|||
163442564|NCT00365716|590322457|FG005|Extension 2|Lost to Follow-up|0|||
163442565|NCT00365716|590322458|FG006|Extension 2|Lost to Follow-up|2|||
163442566|NCT00365716|590322452|FG000|Extension 2|Other|0|||
163442567|NCT00365716|590322453|FG001|Extension 2|Other|0|||
163442568|NCT00365716|590322454|FG002|Extension 2|Other|0|||
163442569|NCT00365716|590322455|FG003|Extension 2|Other|0|||
163442570|NCT00365716|590322456|FG004|Extension 2|Other|0|||
163442571|NCT00365716|590322457|FG005|Extension 2|Other|0|||
163442572|NCT00365716|590322458|FG006|Extension 2|Other|3|||
163442573|NCT00365716|590322452|FG000|Extension 2|Withdrawal by Subject|0|||
163442574|NCT00365716|590322453|FG001|Extension 2|Withdrawal by Subject|0|||
163442575|NCT00365716|590322454|FG002|Extension 2|Withdrawal by Subject|0|||
163442576|NCT00365716|590322455|FG003|Extension 2|Withdrawal by Subject|0|||
163442577|NCT00365716|590322456|FG004|Extension 2|Withdrawal by Subject|0|||
163442578|NCT00365716|590322457|FG005|Extension 2|Withdrawal by Subject|0|||
163442579|NCT00365716|590322458|FG006|Extension 2|Withdrawal by Subject|5|||
163442580|NCT00751101|590322460|FG000|Overall Study|Withdrawal by Subject|1|||
163442581|NCT00751101|590322461|FG001|Overall Study|Withdrawal by Subject|0|||
163442582|NCT00751101|590322460|FG000|Overall Study|No HFS / Never Started Patch/|0|||
163442583|NCT00751101|590322461|FG001|Overall Study|No HFS / Never Started Patch/|4|||
163442584|NCT00751101|590322460|FG000|Overall Study|Never began capecitabine|1|||
163442585|NCT00751101|590322461|FG001|Overall Study|Never began capecitabine|0|||
163442586|NCT00751101|590322460|FG000|Overall Study|Physician Decision|0|||
163442587|NCT00751101|590322461|FG001|Overall Study|Physician Decision|1|||
163442588|NCT00789477|590322465|FG000|Overall Study|Withdrawal by Subject|2|||
163442589|NCT00789477|590322466|FG001|Overall Study|Withdrawal by Subject|1|||
163442590|NCT00789477|590322467|FG002|Overall Study|Withdrawal by Subject|3|||
163442591|NCT00789477|590322468|FG003|Overall Study|Withdrawal by Subject|2|||
163442592|NCT00789477|590322469|FG004|Overall Study|Withdrawal by Subject|3|||
163442593|NCT00789477|590322465|FG000|Overall Study|Protocol Violation|1|||
163442594|NCT00789477|590322466|FG001|Overall Study|Protocol Violation|0|||
163442595|NCT00789477|590322467|FG002|Overall Study|Protocol Violation|0|||
163442596|NCT00789477|590322468|FG003|Overall Study|Protocol Violation|1|||
163442597|NCT00789477|590322469|FG004|Overall Study|Protocol Violation|0|||
163442598|NCT00789477|590322465|FG000|Overall Study|Adverse Event|3|||
163442599|NCT00789477|590322466|FG001|Overall Study|Adverse Event|3|||
163442600|NCT00789477|590322467|FG002|Overall Study|Adverse Event|1|||
163442601|NCT00789477|590322468|FG003|Overall Study|Adverse Event|0|||
163442602|NCT00789477|590322469|FG004|Overall Study|Adverse Event|0|||
163442603|NCT00789477|590322465|FG000|Overall Study|Death|1|||
163442604|NCT00789477|590322466|FG001|Overall Study|Death|1|||
163442605|NCT00789477|590322467|FG002|Overall Study|Death|2|||
163442606|NCT00789477|590322468|FG003|Overall Study|Death|2|||
163442607|NCT00789477|590322469|FG004|Overall Study|Death|0|||
163442608|NCT00789477|590322465|FG000|Overall Study|Lost to Follow-up|0|||
163442609|NCT00789477|590322466|FG001|Overall Study|Lost to Follow-up|1|||
163442610|NCT00789477|590322467|FG002|Overall Study|Lost to Follow-up|4|||
163442611|NCT00789477|590322468|FG003|Overall Study|Lost to Follow-up|2|||
163442612|NCT00789477|590322469|FG004|Overall Study|Lost to Follow-up|4|||
163442613|NCT00789477|590322465|FG000|Overall Study|Lack of Efficacy|2|||
163442614|NCT00789477|590322466|FG001|Overall Study|Lack of Efficacy|0|||
163442615|NCT00789477|590322467|FG002|Overall Study|Lack of Efficacy|0|||
163442616|NCT00789477|590322468|FG003|Overall Study|Lack of Efficacy|0|||
163442617|NCT00789477|590322469|FG004|Overall Study|Lack of Efficacy|0|||
163442618|NCT00789477|590322465|FG000|Overall Study|Other|2|||
163442619|NCT00789477|590322466|FG001|Overall Study|Other|0|||
163442620|NCT00789477|590322467|FG002|Overall Study|Other|1|||
163442621|NCT00789477|590322468|FG003|Overall Study|Other|3|||
163442622|NCT00789477|590322469|FG004|Overall Study|Other|0|||
163442623|NCT00455858|590322470|FG000|Overall Study|Lost to Follow-up|2|||
163442624|NCT00455858|590322470|FG000|Overall Study|Protocol Violation|1|||
163442625|NCT00455858|590322470|FG000|Overall Study|Lack of Efficacy|1|||
163442626|NCT00455858|590322470|FG000|Overall Study|Well controlled FPG without insulin|1|||
163442627|NCT00455858|590322470|FG000|Overall Study|Withdrawal|1|||
163442628|NCT02092389|590322471|FG000|Overall Study|Adverse Event|1|||
163442629|NCT02092389|590322471|FG000|Overall Study|Other|5|||
163442630|NCT01242020|590322472|FG000|Overall Study|Withdrawal by Subject|2|||
163442631|NCT01242020|590322473|FG001|Overall Study|Withdrawal by Subject|0|||
163442632|NCT01242020|590322472|FG000|Overall Study|Failed screening|1|||
163442633|NCT01242020|590322473|FG001|Overall Study|Failed screening|0|||
163442634|NCT02680847|590322474|FG000|Overall Study|Other|2|||
163442635|NCT02680847|590322475|FG001|Overall Study|Other|0|||
163442636|NCT02680847|590322476|FG002|Overall Study|Other|0|||
163442637|NCT02680847|590322474|FG000|Overall Study|No longer met eligibility criteria|2|||
163442638|NCT02680847|590322475|FG001|Overall Study|No longer met eligibility criteria|2|||
163442639|NCT02680847|590322476|FG002|Overall Study|No longer met eligibility criteria|0|||
163442640|NCT02680847|590322474|FG000|Overall Study|Unwilling to participate in study|1|||
163442641|NCT02680847|590322475|FG001|Overall Study|Unwilling to participate in study|1|||
163442642|NCT02680847|590322476|FG002|Overall Study|Unwilling to participate in study|0|||
163442643|NCT02680847|590322474|FG000|Overall Study|Lack of Efficacy|0|||
163442644|NCT02680847|590322475|FG001|Overall Study|Lack of Efficacy|0|||
163442645|NCT02680847|590322476|FG002|Overall Study|Lack of Efficacy|2|||
163442646|NCT02680847|590322474|FG000|Overall Study|Adverse Event|0|||
163442647|NCT02680847|590322475|FG001|Overall Study|Adverse Event|0|||
163442648|NCT02680847|590322476|FG002|Overall Study|Adverse Event|1|||
163442649|NCT00866294|590322480|FG000|Overall Study|Adverse Event|12|||
163442650|NCT00866294|590322481|FG001|Overall Study|Adverse Event|13|||
163442651|NCT00866294|590322482|FG002|Overall Study|Adverse Event|9|||
163442652|NCT00866294|590322480|FG000|Overall Study|Lack of Efficacy|7|||
163442653|NCT00866294|590322481|FG001|Overall Study|Lack of Efficacy|1|||
163442654|NCT00866294|590322482|FG002|Overall Study|Lack of Efficacy|0|||
163442655|NCT00866294|590322480|FG000|Overall Study|Protocol Violation|2|||
163442656|NCT00866294|590322481|FG001|Overall Study|Protocol Violation|0|||
163442657|NCT00866294|590322482|FG002|Overall Study|Protocol Violation|0|||
163442658|NCT00866294|590322480|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
163442659|NCT00866294|590322481|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
163442660|NCT00866294|590322482|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
163442661|NCT00866294|590322480|FG000|Overall Study|Lost to Follow-up|1|||
163442662|NCT00866294|590322481|FG001|Overall Study|Lost to Follow-up|3|||
163442663|NCT00866294|590322482|FG002|Overall Study|Lost to Follow-up|0|||
163442664|NCT00866294|590322480|FG000|Overall Study|Physician Decision|6|||
163442665|NCT00866294|590322481|FG001|Overall Study|Physician Decision|2|||
163442666|NCT00866294|590322482|FG002|Overall Study|Physician Decision|1|||
163442667|NCT01651260|590322486|FG000|Overall Study|unable to apply product|3|||
163442668|NCT01952015|590322487|FG000|Induction|Protocol Violation|1|||
163442669|NCT01952015|590322487|FG000|Maintenance|Adverse Event|2|||
163442670|NCT01952015|590322487|FG000|Treatment Period 3|Physician Decision|9|||
163442671|NCT00530712|590322495|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
163442672|NCT00530712|590322495|FG000|30 Day Follow-up Visit|Missed Visit|5|||
163442673|NCT00530712|590322495|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
163442674|NCT00530712|590322495|FG000|6 Month Follow-up Visit|Missed Visit|3|||
163442675|NCT00530712|590322495|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
163442676|NCT00530712|590322495|FG000|6 Month Follow-up Visit|Death|2|||
163442677|NCT00530712|590322495|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
163442678|NCT00530712|590322495|FG000|12 Month Follow-up Visit|Missed Visit|3|||
163442679|NCT00530712|590322495|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
163442680|NCT00530712|590322495|FG000|12 Month Follow-up Visit|Death|9|||
163442681|NCT02749370|590322496|FG000|Overall Study|Withdrawal by Subject|11|||
163442682|NCT02749370|590322496|FG000|Overall Study|Lost to Follow-up|3|||
163442683|NCT03242759|590322498|FG000|Overall Study|Adverse Event|5|||
163442684|NCT03242759|590322499|FG001|Overall Study|Adverse Event|1|||
163442685|NCT03242759|590322498|FG000|Overall Study|Withdrawal by Subject|4|||
163442686|NCT03242759|590322499|FG001|Overall Study|Withdrawal by Subject|3|||
163442687|NCT03242759|590322498|FG000|Overall Study|Lost to Follow-up|3|||
163442688|NCT03242759|590322499|FG001|Overall Study|Lost to Follow-up|1|||
163442689|NCT03242759|590322498|FG000|Overall Study|Administrative problems|1|||
163442690|NCT03242759|590322499|FG001|Overall Study|Administrative problems|1|||
163442691|NCT03242759|590322498|FG000|Overall Study|Death|22|||
163442692|NCT03242759|590322499|FG001|Overall Study|Death|0|||
163442693|NCT03242759|590322498|FG000|Overall Study|Change visit schedule|0|||
163442694|NCT03242759|590322499|FG001|Overall Study|Change visit schedule|1|||
163442695|NCT01096550|590322502|FG000|Overall Study|discontinued site|10|||
163442696|NCT01096550|590322503|FG001|Overall Study|discontinued site|11|||
163442697|NCT01096550|590322502|FG000|Overall Study|non-regular treatment track at clinic|1|||
163442698|NCT01096550|590322503|FG001|Overall Study|non-regular treatment track at clinic|1|||
163442699|NCT01096550|590322502|FG000|Overall Study|clinic readmission|1|||
163442700|NCT01096550|590322503|FG001|Overall Study|clinic readmission|1|||
163442701|NCT01096550|590322502|FG000|Overall Study|Withdrawal by Subject|0|||
163442702|NCT01096550|590322503|FG001|Overall Study|Withdrawal by Subject|1|||
163442703|NCT01096550|590322502|FG000|Overall Study|non-African American participant|13|||
163442704|NCT01096550|590322503|FG001|Overall Study|non-African American participant|6|||
163442705|NCT01096550|590322502|FG000|Overall Study|Lost to Follow-up|12|||
163442706|NCT01096550|590322503|FG001|Overall Study|Lost to Follow-up|9|||
163442707|NCT03117049|590322504|FG000|Overall Study|Continued the follow-up period|109|||
163442708|NCT03117049|590322505|FG001|Overall Study|Continued the follow-up period|129|||
163442709|NCT03117049|590322504|FG000|Overall Study|Died|82|||
163442710|NCT03117049|590322505|FG001|Overall Study|Died|93|||
163442711|NCT03117049|590322504|FG000|Overall Study|Consent withdrawal|7|||
163442712|NCT03117049|590322505|FG001|Overall Study|Consent withdrawal|6|||
163442713|NCT03117049|590322504|FG000|Overall Study|Missing contact|3|||
163442714|NCT03117049|590322505|FG001|Overall Study|Missing contact|3|||
163442715|NCT00651118|590322506|FG000|Overall Study|Adverse Event|4|||
163442716|NCT00651118|590322507|FG001|Overall Study|Adverse Event|0|||
163442717|NCT00651118|590322508|FG002|Overall Study|Adverse Event|1|||
163442718|NCT00651118|590322509|FG003|Overall Study|Adverse Event|1|||
163442719|NCT00651118|590322506|FG000|Overall Study|Protocol Violation|2|||
163442720|NCT00651118|590322507|FG001|Overall Study|Protocol Violation|2|||
163442721|NCT00651118|590322508|FG002|Overall Study|Protocol Violation|6|||
163442722|NCT00651118|590322509|FG003|Overall Study|Protocol Violation|2|||
163442723|NCT00651118|590322506|FG000|Overall Study|Lost to Follow-up|2|||
163442724|NCT00651118|590322507|FG001|Overall Study|Lost to Follow-up|0|||
163442725|NCT00651118|590322508|FG002|Overall Study|Lost to Follow-up|1|||
163442726|NCT00651118|590322509|FG003|Overall Study|Lost to Follow-up|2|||
163442727|NCT00651118|590322506|FG000|Overall Study|administrative|1|||
163442728|NCT00651118|590322507|FG001|Overall Study|administrative|4|||
163442729|NCT00651118|590322508|FG002|Overall Study|administrative|2|||
163442730|NCT00651118|590322509|FG003|Overall Study|administrative|1|||
163442731|NCT00651118|590322506|FG000|Overall Study|Withdrawal by Subject|0|||
163442732|NCT00651118|590322507|FG001|Overall Study|Withdrawal by Subject|1|||
163442733|NCT00651118|590322508|FG002|Overall Study|Withdrawal by Subject|1|||
163442734|NCT00651118|590322509|FG003|Overall Study|Withdrawal by Subject|1|||
163442735|NCT00839098|590322512|FG000|Overall Study|Withdrawal by Subject|2|||
163442736|NCT00839098|590322513|FG001|Overall Study|Withdrawal by Subject|1|||
163442737|NCT00839098|590322514|FG002|Overall Study|Withdrawal by Subject|7|||
163442738|NCT01345786|590322515|FG000|Overall Study|Adverse Event|0|||
163442739|NCT01345786|590322516|FG001|Overall Study|Adverse Event|1|||
163442740|NCT01345786|590322517|FG002|Overall Study|Adverse Event|3|||
163442741|NCT01345786|590322518|FG003|Overall Study|Adverse Event|1|||
163442742|NCT01345786|590322515|FG000|Overall Study|Subject withdrew consent|2|||
163442743|NCT01345786|590322516|FG001|Overall Study|Subject withdrew consent|2|||
163442744|NCT01345786|590322517|FG002|Overall Study|Subject withdrew consent|1|||
163442745|NCT01345786|590322518|FG003|Overall Study|Subject withdrew consent|0|||
163442746|NCT01345786|590322515|FG000|Overall Study|Noncompliance with protocol|1|||
163442747|NCT01345786|590322516|FG001|Overall Study|Noncompliance with protocol|0|||
163442748|NCT01345786|590322517|FG002|Overall Study|Noncompliance with protocol|1|||
163442749|NCT01345786|590322518|FG003|Overall Study|Noncompliance with protocol|0|||
163442750|NCT01345786|590322515|FG000|Overall Study|Administrative|3|||
163442751|NCT01345786|590322516|FG001|Overall Study|Administrative|5|||
163442752|NCT01345786|590322517|FG002|Overall Study|Administrative|0|||
163442753|NCT01345786|590322518|FG003|Overall Study|Administrative|0|||
163442754|NCT01345786|590322515|FG000|Overall Study|Lost to Follow-up|0|||
163442755|NCT01345786|590322516|FG001|Overall Study|Lost to Follow-up|0|||
163442756|NCT01345786|590322517|FG002|Overall Study|Lost to Follow-up|0|||
163442757|NCT01345786|590322518|FG003|Overall Study|Lost to Follow-up|2|||
163442758|NCT02190435|590322519|FG000|Overall Study|First 12 patients were lead-ins|12|||
163442759|NCT02190435|590322520|FG001|Overall Study|First 12 patients were lead-ins|0|||
163442760|NCT02190435|590322519|FG000|Overall Study|3 consented screen fails|3|||
163442761|NCT02190435|590322520|FG001|Overall Study|3 consented screen fails|0|||
163442762|NCT02399475|590322529|FG000|Overall Study|Physician Decision|1|||
163442763|NCT02399475|590322530|FG001|Overall Study|Physician Decision|0|||
163442764|NCT02260193|590322531|FG000|Overall Study|Lack of Efficacy|0|||
163442765|NCT02260193|590322532|FG001|Overall Study|Lack of Efficacy|1|||
163442766|NCT02260193|590322533|FG002|Overall Study|Lack of Efficacy|6|||
163442767|NCT02260193|590322531|FG000|Overall Study|Adverse Event|3|||
163442768|NCT02260193|590322532|FG001|Overall Study|Adverse Event|4|||
163442769|NCT02260193|590322533|FG002|Overall Study|Adverse Event|1|||
163442770|NCT02260193|590322531|FG000|Overall Study|Protocol Violation|0|||
163442771|NCT02260193|590322532|FG001|Overall Study|Protocol Violation|4|||
163442772|NCT02260193|590322533|FG002|Overall Study|Protocol Violation|0|||
163442773|NCT02260193|590322531|FG000|Overall Study|Withdrawal by Subject|3|||
163442774|NCT02260193|590322532|FG001|Overall Study|Withdrawal by Subject|0|||
163442775|NCT02260193|590322533|FG002|Overall Study|Withdrawal by Subject|2|||
163442776|NCT02260193|590322531|FG000|Overall Study|Kidney Transplantation|0|||
163442777|NCT02260193|590322532|FG001|Overall Study|Kidney Transplantation|0|||
163442778|NCT02260193|590322533|FG002|Overall Study|Kidney Transplantation|1|||
163442779|NCT01963117|590322534|FG000|Overall Study|Death|1|||
163442780|NCT01070784|590322535|FG000|Overall Study|Withdrawal by Subject|6|||
163442781|NCT01070784|590322536|FG001|Overall Study|Withdrawal by Subject|9|||
163442782|NCT01070784|590322535|FG000|Overall Study|Adverse Event|14|||
163442783|NCT01070784|590322536|FG001|Overall Study|Adverse Event|9|||
163442784|NCT01780389|590322537|FG000|Overall Study|Adverse Event|1|||
163442785|NCT00935220|590322538|FG000|Overall Study|Adverse Event|1|||
163442786|NCT00935220|590322538|FG000|Overall Study|Other reason (not specified)|1|||
163442787|NCT01095250|590322539|FG000|Overall Study|administrative reasons|8|||
163442788|NCT01095250|590322540|FG001|Overall Study|administrative reasons|10|||
163442789|NCT01095250|590322541|FG002|Overall Study|administrative reasons|7|||
163442790|NCT01095250|590322542|FG003|Overall Study|administrative reasons|5|||
163442791|NCT01095250|590322539|FG000|Overall Study|Withdrawal by Subject|0|||
163442792|NCT01095250|590322540|FG001|Overall Study|Withdrawal by Subject|0|||
163442793|NCT01095250|590322541|FG002|Overall Study|Withdrawal by Subject|1|||
163442794|NCT01095250|590322542|FG003|Overall Study|Withdrawal by Subject|0|||
163442795|NCT01000064|590322543|FG000|Overall Study|Withdrawal by Subject|1|||
163442796|NCT01000064|590322544|FG001|Overall Study|Withdrawal by Subject|1|||
163442797|NCT02518620|590322545|FG000|Overall Study|Adverse Event|23|||
163442798|NCT02518620|590322546|FG001|Overall Study|Adverse Event|11|||
163442799|NCT02518620|590322545|FG000|Overall Study|Lack of Efficacy|2|||
163442800|NCT02518620|590322546|FG001|Overall Study|Lack of Efficacy|0|||
163442801|NCT02518620|590322545|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163442802|NCT02518620|590322546|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163442803|NCT02518620|590322545|FG000|Overall Study|Physician Decision|1|||
163442804|NCT02518620|590322546|FG001|Overall Study|Physician Decision|1|||
163442805|NCT02518620|590322545|FG000|Overall Study|Sponsor's Decision|0|||
163442806|NCT02518620|590322546|FG001|Overall Study|Sponsor's Decision|3|||
163442807|NCT02518620|590322545|FG000|Overall Study|Lost to Follow-up|1|||
163442808|NCT02518620|590322546|FG001|Overall Study|Lost to Follow-up|1|||
163442809|NCT02518620|590322545|FG000|Overall Study|Withdrawal by Subject|17|||
163442810|NCT02518620|590322546|FG001|Overall Study|Withdrawal by Subject|9|||
163442811|NCT02518620|590322545|FG000|Overall Study|Death|1|||
163442812|NCT02518620|590322546|FG001|Overall Study|Death|0|||
163442813|NCT02518620|590322545|FG000|Overall Study|Pregnancy Wish|3|||
163442814|NCT02518620|590322546|FG001|Overall Study|Pregnancy Wish|0|||
163442815|NCT02518620|590322545|FG000|Overall Study|Pregnancy|1|||
163442816|NCT02518620|590322546|FG001|Overall Study|Pregnancy|0|||
163442817|NCT02518620|590322545|FG000|Overall Study|Relocation|2|||
163442818|NCT02518620|590322546|FG001|Overall Study|Relocation|1|||
163442819|NCT03844633|590322550|FG000|1 Week FU|Lost to Follow-up|0|||
163442820|NCT03844633|590322551|FG001|1 Week FU|Lost to Follow-up|1|||
163442821|NCT03844633|590322552|FG002|1 Week FU|Lost to Follow-up|4|||
163442822|NCT03844633|590322550|FG000|12-month Follow-up|Lost to Follow-up|7|||
163442823|NCT03844633|590322551|FG001|12-month Follow-up|Lost to Follow-up|5|||
163442824|NCT03844633|590322552|FG002|12-month Follow-up|Lost to Follow-up|8|||
163442825|NCT02588248|590322555|FG000|Overall Study|Physician Decision|4|||
163442826|NCT02588248|590322556|FG001|Overall Study|Physician Decision|3|||
163442827|NCT01355068|590322559|FG000|First Intervention Period|Adverse Event|0|||
163442828|NCT01355068|590322560|FG001|First Intervention Period|Adverse Event|1|||
163442829|NCT01355068|590322559|FG000|First Intervention Period|Withdrawal by Subject|0|||
163442830|NCT01355068|590322560|FG001|First Intervention Period|Withdrawal by Subject|1|||
163442831|NCT00336492|590322561|FG000|Overall Study|Adverse Event|4|||
163442832|NCT00336492|590322562|FG001|Overall Study|Adverse Event|3|||
163442833|NCT00336492|590322563|FG002|Overall Study|Adverse Event|6|||
163442834|NCT00336492|590322561|FG000|Overall Study|Lack of Efficacy|6|||
163442835|NCT00336492|590322562|FG001|Overall Study|Lack of Efficacy|1|||
163442836|NCT00336492|590322563|FG002|Overall Study|Lack of Efficacy|4|||
163442837|NCT00336492|590322561|FG000|Overall Study|Other|5|||
163442838|NCT00336492|590322562|FG001|Overall Study|Other|0|||
163442839|NCT00336492|590322563|FG002|Overall Study|Other|1|||
163442840|NCT04229446|590322566|FG000|Overall Study|Death|12|||
163442841|NCT04229446|590322567|FG001|Overall Study|Death|10|||
163442842|NCT04229446|590322566|FG000|Overall Study|Lost to Follow-up|5|||
163442843|NCT04229446|590322567|FG001|Overall Study|Lost to Follow-up|8|||
163442844|NCT01781026|590322568|FG000|Overall Study|Lack of Efficacy|2|||
163442845|NCT03141307|590322569|FG000|In-Hospital|Withdrawal by Subject|0|||
163442846|NCT03141307|590322570|FG001|In-Hospital|Withdrawal by Subject|2|||
163442847|NCT03141307|590322569|FG000|In-Hospital|Protocol Violation|4|||
163442848|NCT03141307|590322570|FG001|In-Hospital|Protocol Violation|0|||
163442849|NCT03141307|590322569|FG000|Follow-Up|Lost to Follow-up|97|||
163442850|NCT03141307|590322570|FG001|Follow-Up|Lost to Follow-up|54|||
163442851|NCT00227877|590322571|FG000|Pre-visit Assessment|Technical difficulties|7|||
163442852|NCT00227877|590322572|FG001|Pre-visit Assessment|Technical difficulties|3|||
163442853|NCT00227877|590322573|FG002|Pre-visit Assessment|Technical difficulties|0|||
163442854|NCT00227877|590322574|FG003|Pre-visit Assessment|Technical difficulties|0|||
163442855|NCT00227877|590322571|FG000|Post-visit Checklist|Lost to Follow-up|24|||
163442856|NCT00227877|590322572|FG001|Post-visit Checklist|Lost to Follow-up|13|||
163442857|NCT00227877|590322573|FG002|Post-visit Checklist|Lost to Follow-up|1|||
163442858|NCT00227877|590322574|FG003|Post-visit Checklist|Lost to Follow-up|0|||
163442859|NCT00227877|590322571|FG000|3-months Follow-up|Completed late|135|||
163442860|NCT00227877|590322572|FG001|3-months Follow-up|Completed late|128|||
163442861|NCT00227877|590322573|FG002|3-months Follow-up|Completed late|34|||
163442862|NCT00227877|590322574|FG003|3-months Follow-up|Completed late|8|||
163442863|NCT00227877|590322571|FG000|3-months Follow-up|Lost to Follow-up|178|||
163442864|NCT00227877|590322572|FG001|3-months Follow-up|Lost to Follow-up|139|||
163442865|NCT00227877|590322573|FG002|3-months Follow-up|Lost to Follow-up|18|||
163442866|NCT00227877|590322574|FG003|3-months Follow-up|Lost to Follow-up|13|||
163442867|NCT00227877|590322571|FG000|12-months Follow-up|Completed late|78|||
163442868|NCT00227877|590322572|FG001|12-months Follow-up|Completed late|74|||
163442869|NCT00227877|590322573|FG002|12-months Follow-up|Completed late|1|||
163442870|NCT00227877|590322574|FG003|12-months Follow-up|Completed late|0|||
163442871|NCT00227877|590322571|FG000|12-months Follow-up|Lost to Follow-up|232|||
163442872|NCT00227877|590322572|FG001|12-months Follow-up|Lost to Follow-up|189|||
163442873|NCT00227877|590322573|FG002|12-months Follow-up|Lost to Follow-up|30|||
163442874|NCT00227877|590322574|FG003|12-months Follow-up|Lost to Follow-up|26|||
163442875|NCT02522481|590322578|FG000|Overall Study|discontinued|1|||
163442876|NCT02522481|590322578|FG000|Overall Study|Not dosed|2|||
163442877|NCT01937130|590324655|FG000|Overall Study|Withdrawal by Subject|0|||
163442878|NCT01937130|590324656|FG001|Overall Study|Withdrawal by Subject|0|||
163442879|NCT01937130|590324657|FG002|Overall Study|Withdrawal by Subject|0|||
163442880|NCT01937130|590324658|FG003|Overall Study|Withdrawal by Subject|1|||
163442881|NCT01937130|590324655|FG000|Overall Study|Adverse Event|0|||
163442882|NCT01937130|590324656|FG001|Overall Study|Adverse Event|1|||
163442883|NCT01937130|590324657|FG002|Overall Study|Adverse Event|0|||
163442884|NCT01937130|590324658|FG003|Overall Study|Adverse Event|1|||
163442885|NCT01937130|590324655|FG000|Overall Study|Death|1|||
163442886|NCT01937130|590324656|FG001|Overall Study|Death|1|||
163442887|NCT01937130|590324657|FG002|Overall Study|Death|1|||
163442888|NCT01937130|590324658|FG003|Overall Study|Death|0|||
163442889|NCT01937130|590324655|FG000|Overall Study|Lost to Follow-up|2|||
163442890|NCT01937130|590324656|FG001|Overall Study|Lost to Follow-up|0|||
163442891|NCT01937130|590324657|FG002|Overall Study|Lost to Follow-up|2|||
163442892|NCT01937130|590324658|FG003|Overall Study|Lost to Follow-up|0|||
163442893|NCT01937130|590324655|FG000|Overall Study|Physician Decision|0|||
163442894|NCT01937130|590324656|FG001|Overall Study|Physician Decision|1|||
163442895|NCT01937130|590324657|FG002|Overall Study|Physician Decision|0|||
163442896|NCT01937130|590324658|FG003|Overall Study|Physician Decision|0|||
163442897|NCT01937130|590324655|FG000|Overall Study|Patients unable to swallow|0|||
163442898|NCT01937130|590324656|FG001|Overall Study|Patients unable to swallow|1|||
163442899|NCT01937130|590324657|FG002|Overall Study|Patients unable to swallow|0|||
163442900|NCT01937130|590324658|FG003|Overall Study|Patients unable to swallow|0|||
163442901|NCT01937130|590324655|FG000|Overall Study|Patient lost to FU due to death|2|||
163442902|NCT01937130|590324656|FG001|Overall Study|Patient lost to FU due to death|0|||
163442903|NCT01937130|590324657|FG002|Overall Study|Patient lost to FU due to death|0|||
163442904|NCT01937130|590324658|FG003|Overall Study|Patient lost to FU due to death|0|||
163442905|NCT01431144|590324659|FG000|Overall Study|Implant mobility and removal|2|||
163442906|NCT01431144|590324660|FG001|Overall Study|Implant mobility and removal|0|||
163442907|NCT02322892|590324666|FG000|Overall Study|Surgery cancelled|1|||
163442908|NCT02322892|590324667|FG001|Overall Study|Surgery cancelled|2|||
163442909|NCT02322892|590324666|FG000|Overall Study|Met exclusion criteria|0|||
163442910|NCT02322892|590324667|FG001|Overall Study|Met exclusion criteria|1|||
163442911|NCT02322892|590324666|FG000|Overall Study|Protocol Violation|1|||
163442912|NCT02322892|590324667|FG001|Overall Study|Protocol Violation|0|||
163442913|NCT00747617|590324668|FG000|Overall Study|Lost to Follow-up|3|||
163442914|NCT00747617|590324669|FG001|Overall Study|Lost to Follow-up|1|||
163442915|NCT01746732|590324670|FG000|Lead-In Period|Withdrawal by Subject|1|||
163442916|NCT01746732|590324671|FG001|Lead-In Period|Withdrawal by Subject|0|||
163442917|NCT01746732|590324672|FG002|Lead-In Period|Withdrawal by Subject|0|||
163442918|NCT01746732|590324670|FG000|Period 1|Physician Decision|0|||
163442919|NCT01746732|590324671|FG001|Period 1|Physician Decision|1|||
163442920|NCT01746732|590324672|FG002|Period 1|Physician Decision|0|||
163442921|NCT01746732|590324670|FG000|Period 2|Withdrawal by Subject|0|||
163442922|NCT01746732|590324671|FG001|Period 2|Withdrawal by Subject|0|||
163442923|NCT01746732|590324672|FG002|Period 2|Withdrawal by Subject|2|||
163442924|NCT01746732|590324670|FG000|Period 2|Adverse Event|0|||
163442925|NCT01746732|590324671|FG001|Period 2|Adverse Event|0|||
163442926|NCT01746732|590324672|FG002|Period 2|Adverse Event|1|||
163442927|NCT01746732|590324670|FG000|Period 2|Lost to Follow-up|0|||
163442928|NCT01746732|590324671|FG001|Period 2|Lost to Follow-up|0|||
163442929|NCT01746732|590324672|FG002|Period 2|Lost to Follow-up|1|||
163442930|NCT02817555|590324673|FG000|Overall Study|Death|1|||
163442931|NCT02817555|590324674|FG001|Overall Study|Death|3|||
163442932|NCT02817555|590324673|FG000|Overall Study|moved away|1|||
163442933|NCT02817555|590324674|FG001|Overall Study|moved away|0|||
163442934|NCT02817555|590324673|FG000|Overall Study|transplant|1|||
163442935|NCT02817555|590324674|FG001|Overall Study|transplant|1|||
163442936|NCT02817555|590324673|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
163442937|NCT02817555|590324674|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
163442938|NCT00137436|590324675|FG000|Overall Study|Adverse Event|13|||
163442939|NCT00137436|590324675|FG000|Overall Study|Death|2|||
163442940|NCT00137436|590324675|FG000|Overall Study|Lack of Efficacy|17|||
163442941|NCT00137436|590324675|FG000|Overall Study|Withdrawal by Subject|6|||
163442942|NCT00137436|590324675|FG000|Overall Study|Other|5|||
163442943|NCT01432262|590324676|FG000|Overall Study|Withdrawal by Subject|2|||
163442944|NCT01432262|590324677|FG001|Overall Study|Withdrawal by Subject|1|||
163442945|NCT00165646|590324678|FG000|Overall Study|Adverse Event|1|||
163442946|NCT00165646|590324679|FG001|Overall Study|Adverse Event|1|||
163442947|NCT00165646|590324680|FG002|Overall Study|Adverse Event|1|||
163442948|NCT00165646|590324678|FG000|Overall Study|Lack of Efficacy|1|||
163442949|NCT00165646|590324679|FG001|Overall Study|Lack of Efficacy|2|||
163442950|NCT00165646|590324680|FG002|Overall Study|Lack of Efficacy|0|||
163442951|NCT00165646|590324678|FG000|Overall Study|Withdrawal by Subject|0|||
163442952|NCT00165646|590324679|FG001|Overall Study|Withdrawal by Subject|2|||
163442953|NCT00165646|590324680|FG002|Overall Study|Withdrawal by Subject|1|||
163442954|NCT00165646|590324678|FG000|Overall Study|Physician Decision|2|||
163442955|NCT00165646|590324679|FG001|Overall Study|Physician Decision|0|||
163442956|NCT00165646|590324680|FG002|Overall Study|Physician Decision|2|||
163442957|NCT00165646|590324678|FG000|Overall Study|Protocol Violation|1|||
163442958|NCT00165646|590324679|FG001|Overall Study|Protocol Violation|0|||
163442959|NCT00165646|590324680|FG002|Overall Study|Protocol Violation|0|||
163442960|NCT04657016|590324681|FG000|Overall Study|Adverse Event|2|||
163442961|NCT04657016|590324682|FG001|Overall Study|Adverse Event|4|||
163442962|NCT04657016|590324681|FG000|Overall Study|Death|1|||
163442963|NCT04657016|590324682|FG001|Overall Study|Death|1|||
163442964|NCT04657016|590324681|FG000|Overall Study|Lost to Follow-up|24|||
163442965|NCT04657016|590324682|FG001|Overall Study|Lost to Follow-up|12|||
163442966|NCT04657016|590324681|FG000|Overall Study|Physician Decision|1|||
163442967|NCT04657016|590324682|FG001|Overall Study|Physician Decision|2|||
163442968|NCT04657016|590324681|FG000|Overall Study|Pregnancy|2|||
163442969|NCT04657016|590324682|FG001|Overall Study|Pregnancy|2|||
163442970|NCT04657016|590324681|FG000|Overall Study|Protocol Deviation|1|||
163442971|NCT04657016|590324682|FG001|Overall Study|Protocol Deviation|0|||
163442972|NCT04657016|590324681|FG000|Overall Study|Withdrawal by Subject|28|||
163442973|NCT04657016|590324682|FG001|Overall Study|Withdrawal by Subject|14|||
163442974|NCT04657016|590324681|FG000|Overall Study|Other - as reported by the investigator|6|||
163442975|NCT04657016|590324682|FG001|Overall Study|Other - as reported by the investigator|0|||
163442976|NCT00701727|590324683|FG000|First Treatment Period|Adverse Event|0|||
163442977|NCT00701727|590324684|FG001|First Treatment Period|Adverse Event|0|||
163442978|NCT00701727|590324683|FG000|First Treatment Period|Withdrawal by Subject|1|||
163442979|NCT00701727|590324684|FG001|First Treatment Period|Withdrawal by Subject|0|||
163442980|NCT00701727|590324683|FG000|First Treatment Period|sponsor decision|0|||
163442981|NCT00701727|590324684|FG001|First Treatment Period|sponsor decision|1|||
163442982|NCT00701727|590324683|FG000|First Treatment Period|Lost to Follow-up|0|||
163442983|NCT00701727|590324684|FG001|First Treatment Period|Lost to Follow-up|1|||
163442984|NCT00701727|590324683|FG000|Second Treatment Period|Withdrawal by Subject|2|||
163442985|NCT00701727|590324684|FG001|Second Treatment Period|Withdrawal by Subject|0|||
163442986|NCT01104558|590324687|FG000|Overall Study|Protocol Violation|6|||
163442987|NCT01104558|590324687|FG000|Overall Study|Missing of primary efficacy assessment|10|||
163442988|NCT01104558|590324687|FG000|Overall Study|Missing of genetic analysis results|1|||
163442989|NCT00696657|590324688|FG000|Overall Study|Protocol Violation|0|||
163442990|NCT00696657|590324689|FG001|Overall Study|Protocol Violation|0|||
163442991|NCT00696657|590324690|FG002|Overall Study|Protocol Violation|0|||
163442992|NCT00696657|590324691|FG003|Overall Study|Protocol Violation|0|||
163442993|NCT00696657|590324692|FG004|Overall Study|Protocol Violation|0|||
163442994|NCT00696657|590324693|FG005|Overall Study|Protocol Violation|1|||
163442995|NCT00696657|590324694|FG006|Overall Study|Protocol Violation|0|||
163442996|NCT00696657|590324695|FG007|Overall Study|Protocol Violation|0|||
163442997|NCT00696657|590324696|FG008|Overall Study|Protocol Violation|1|||
163442998|NCT00696657|590324688|FG000|Overall Study|Lack of Efficacy|0|||
163442999|NCT00696657|590324689|FG001|Overall Study|Lack of Efficacy|1|||
163443000|NCT00696657|590324690|FG002|Overall Study|Lack of Efficacy|0|||
163443001|NCT00696657|590324691|FG003|Overall Study|Lack of Efficacy|0|||
163443002|NCT00696657|590324692|FG004|Overall Study|Lack of Efficacy|0|||
163443003|NCT00696657|590324693|FG005|Overall Study|Lack of Efficacy|0|||
163443004|NCT00696657|590324694|FG006|Overall Study|Lack of Efficacy|0|||
163443005|NCT00696657|590324695|FG007|Overall Study|Lack of Efficacy|0|||
163443006|NCT00696657|590324696|FG008|Overall Study|Lack of Efficacy|0|||
163443007|NCT00696657|590324688|FG000|Overall Study|Withdrawal criteria|1|||
163443008|NCT00696657|590324689|FG001|Overall Study|Withdrawal criteria|3|||
163443009|NCT00696657|590324690|FG002|Overall Study|Withdrawal criteria|2|||
163443010|NCT00696657|590324691|FG003|Overall Study|Withdrawal criteria|2|||
163443011|NCT00696657|590324692|FG004|Overall Study|Withdrawal criteria|0|||
163443012|NCT00696657|590324693|FG005|Overall Study|Withdrawal criteria|0|||
163443013|NCT00696657|590324694|FG006|Overall Study|Withdrawal criteria|1|||
163443014|NCT00696657|590324695|FG007|Overall Study|Withdrawal criteria|1|||
163443015|NCT00696657|590324696|FG008|Overall Study|Withdrawal criteria|2|||
163443016|NCT00696657|590324688|FG000|Overall Study|Unclassified|0|||
163443017|NCT00696657|590324689|FG001|Overall Study|Unclassified|1|||
163443018|NCT00696657|590324690|FG002|Overall Study|Unclassified|3|||
163443019|NCT00696657|590324691|FG003|Overall Study|Unclassified|2|||
163443020|NCT00696657|590324692|FG004|Overall Study|Unclassified|4|||
163443021|NCT00696657|590324693|FG005|Overall Study|Unclassified|2|||
163443022|NCT00696657|590324694|FG006|Overall Study|Unclassified|0|||
163443023|NCT00696657|590324695|FG007|Overall Study|Unclassified|0|||
163443024|NCT00696657|590324696|FG008|Overall Study|Unclassified|1|||
163443025|NCT00696657|590324688|FG000|Overall Study|Adverse Event|0|||
163443026|NCT00696657|590324689|FG001|Overall Study|Adverse Event|0|||
163443027|NCT00696657|590324690|FG002|Overall Study|Adverse Event|3|||
163443028|NCT00696657|590324691|FG003|Overall Study|Adverse Event|7|||
163443029|NCT00696657|590324692|FG004|Overall Study|Adverse Event|6|||
163443030|NCT00696657|590324693|FG005|Overall Study|Adverse Event|9|||
163443031|NCT00696657|590324694|FG006|Overall Study|Adverse Event|14|||
163443032|NCT00696657|590324695|FG007|Overall Study|Adverse Event|2|||
163443033|NCT00696657|590324696|FG008|Overall Study|Adverse Event|5|||
163443034|NCT00523341|590324700|FG000|Overall Study|Withdrawal by Subject|399|||
163443035|NCT00523341|590324701|FG001|Overall Study|Withdrawal by Subject|427|||
163443036|NCT00523341|590324700|FG000|Overall Study|Other|181|||
163443037|NCT00523341|590324701|FG001|Overall Study|Other|198|||
163443038|NCT00523341|590324700|FG000|Overall Study|Adverse Event|122|||
163443039|NCT00523341|590324701|FG001|Overall Study|Adverse Event|155|||
163443040|NCT00523341|590324700|FG000|Overall Study|Death|101|||
163443041|NCT00523341|590324701|FG001|Overall Study|Death|110|||
163443042|NCT00523341|590324700|FG000|Overall Study|Lost to Follow-up|73|||
163443043|NCT00523341|590324701|FG001|Overall Study|Lost to Follow-up|61|||
163443044|NCT00523341|590324700|FG000|Overall Study|Non-compliance|20|||
163443045|NCT00523341|590324701|FG001|Overall Study|Non-compliance|13|||
163443046|NCT00523341|590324700|FG000|Overall Study|Physician Decision|14|||
163443047|NCT00523341|590324701|FG001|Overall Study|Physician Decision|13|||
163443048|NCT00523341|590324700|FG000|Overall Study|Requirement for Alternative Therapy|4|||
163443049|NCT00523341|590324701|FG001|Overall Study|Requirement for Alternative Therapy|14|||
163443050|NCT00523341|590324700|FG000|Overall Study|Protocol Deviation|6|||
163443051|NCT00523341|590324701|FG001|Overall Study|Protocol Deviation|5|||
163443052|NCT00523341|590324700|FG000|Overall Study|Ineligibility Determined|3|||
163443053|NCT00523341|590324701|FG001|Overall Study|Ineligibility Determined|4|||
163443054|NCT00523341|590324700|FG000|Overall Study|Disease Progression|1|||
163443055|NCT00523341|590324701|FG001|Overall Study|Disease Progression|0|||
163443056|NCT02601001|590324704|FG000|Dosing Period 2|Adverse Event|0|||
163443057|NCT02601001|590324705|FG001|Dosing Period 2|Adverse Event|0|||
163443058|NCT02601001|590324706|FG002|Dosing Period 2|Adverse Event|0|||
163443059|NCT02601001|590324707|FG003|Dosing Period 2|Adverse Event|0|||
163443060|NCT02601001|590324708|FG004|Dosing Period 2|Adverse Event|0|||
163443061|NCT02601001|590324709|FG005|Dosing Period 2|Adverse Event|0|||
163443062|NCT02601001|590324710|FG006|Dosing Period 2|Adverse Event|1|||
163443063|NCT00912015|590324711|FG000|Overall Study|Lack of Efficacy|1|||
163443064|NCT00912015|590324712|FG001|Overall Study|Lack of Efficacy|0|||
163443065|NCT00912015|590324713|FG002|Overall Study|Lack of Efficacy|0|||
163443066|NCT00912015|590324714|FG003|Overall Study|Lack of Efficacy|0|||
163443067|NCT00912015|590324711|FG000|Overall Study|Withdrawal by Subject|8|||
163443068|NCT00912015|590324712|FG001|Overall Study|Withdrawal by Subject|8|||
163443069|NCT00912015|590324713|FG002|Overall Study|Withdrawal by Subject|3|||
163443070|NCT00912015|590324714|FG003|Overall Study|Withdrawal by Subject|0|||
163443071|NCT00912015|590324711|FG000|Overall Study|Protocol Violation|1|||
163443072|NCT00912015|590324712|FG001|Overall Study|Protocol Violation|0|||
163443073|NCT00912015|590324713|FG002|Overall Study|Protocol Violation|0|||
163443074|NCT00912015|590324714|FG003|Overall Study|Protocol Violation|1|||
163443075|NCT00912015|590324711|FG000|Overall Study|Adverse Event|6|||
163443076|NCT00912015|590324712|FG001|Overall Study|Adverse Event|0|||
163443077|NCT00912015|590324713|FG002|Overall Study|Adverse Event|0|||
163443078|NCT00912015|590324714|FG003|Overall Study|Adverse Event|1|||
163443079|NCT01790438|590324715|FG000|Overall Study|Adverse Event|3|||
163443080|NCT01790438|590324716|FG001|Overall Study|Adverse Event|2|||
163443081|NCT01790438|590324715|FG000|Overall Study|Death|4|||
163443082|NCT01790438|590324716|FG001|Overall Study|Death|0|||
163443083|NCT01790438|590324715|FG000|Overall Study|Lost to Follow-up|5|||
163443084|NCT01790438|590324716|FG001|Overall Study|Lost to Follow-up|2|||
163443085|NCT01790438|590324715|FG000|Overall Study|Withdrawal by Subject|13|||
163443086|NCT01790438|590324716|FG001|Overall Study|Withdrawal by Subject|2|||
163443087|NCT01790438|590324715|FG000|Overall Study|Physician Decision|3|||
163443088|NCT01790438|590324716|FG001|Overall Study|Physician Decision|1|||
163443089|NCT01790438|590324715|FG000|Overall Study|Sponsor Decision|0|||
163443090|NCT01790438|590324716|FG001|Overall Study|Sponsor Decision|3|||
163443091|NCT01790438|590324715|FG000|Overall Study|Protocol Required Discontinuation|7|||
163443092|NCT01790438|590324716|FG001|Overall Study|Protocol Required Discontinuation|1|||
163443093|NCT01356602|590324719|FG000|Overall Study|Protocol Deviation|0|||
163443094|NCT01356602|590324720|FG001|Overall Study|Protocol Deviation|1|||
163443095|NCT01356602|590324721|FG002|Overall Study|Protocol Deviation|1|||
163443096|NCT01356602|590324719|FG000|Overall Study|Administrative Problems|1|||
163443097|NCT01356602|590324720|FG001|Overall Study|Administrative Problems|4|||
163443098|NCT01356602|590324721|FG002|Overall Study|Administrative Problems|5|||
163443099|NCT01356602|590324719|FG000|Overall Study|Lost to Follow-up|4|||
163443100|NCT01356602|590324720|FG001|Overall Study|Lost to Follow-up|5|||
163443101|NCT01356602|590324721|FG002|Overall Study|Lost to Follow-up|6|||
163443102|NCT01356602|590324719|FG000|Overall Study|Withdrawal by Subject|4|||
163443103|NCT01356602|590324720|FG001|Overall Study|Withdrawal by Subject|3|||
163443104|NCT01356602|590324721|FG002|Overall Study|Withdrawal by Subject|7|||
163443105|NCT01356602|590324719|FG000|Overall Study|Lack of Efficacy|0|||
163443106|NCT01356602|590324720|FG001|Overall Study|Lack of Efficacy|1|||
163443107|NCT01356602|590324721|FG002|Overall Study|Lack of Efficacy|4|||
163443108|NCT01356602|590324719|FG000|Overall Study|Adverse Event|0|||
163443109|NCT01356602|590324720|FG001|Overall Study|Adverse Event|1|||
163443110|NCT01356602|590324721|FG002|Overall Study|Adverse Event|1|||
163443111|NCT01931462|590324722|FG000|Overall Study|Withdrawal by Subject|1|||
163443112|NCT01701583|590324723|FG000|Overall Study|Withdrawal by Subject|2|||
163443113|NCT01701583|590324724|FG001|Overall Study|Withdrawal by Subject|0|||
163443114|NCT05070429|590324725|FG000|Overall Study|Death|0|||
163443115|NCT05070429|590324726|FG001|Overall Study|Death|4|||
163443116|NCT05070429|590324725|FG000|Overall Study|Withdrawal by Subject|2|||
163443117|NCT05070429|590324726|FG001|Overall Study|Withdrawal by Subject|1|||
163443118|NCT05070429|590324725|FG000|Overall Study|Other|15|||
163443119|NCT05070429|590324726|FG001|Overall Study|Other|5|||
163443120|NCT01345123|590324727|FG000|Overall Study|participants no longer with health plan|79|||
163443121|NCT01345123|590324728|FG001|Overall Study|participants no longer with health plan|85|||
163443122|NCT01345123|590324729|FG002|Overall Study|participants no longer with health plan|88|||
163443123|NCT02653976|590324730|FG000|Overall Study|Withdrawal by Subject|5|||
163443124|NCT02653976|590324730|FG000|Overall Study|Death|4|||
163443125|NCT02436577|590324731|FG000|Overall Study|Protocol Deviation|0|||
163443126|NCT02436577|590324732|FG001|Overall Study|Protocol Deviation|1|||
163443127|NCT02436577|590324733|FG002|Overall Study|Protocol Deviation|0|||
163443128|NCT02436577|590324734|FG003|Overall Study|Protocol Deviation|0|||
163443129|NCT02436577|590324735|FG004|Overall Study|Protocol Deviation|0|||
163443130|NCT02436577|590324736|FG005|Overall Study|Protocol Deviation|0|||
163443131|NCT00615290|590324737|FG000|Overall Study|Adverse Event|2|||
163443132|NCT00615290|590324737|FG000|Overall Study|Lost to Follow-up|3|||
163443133|NCT00615290|590324737|FG000|Overall Study|Withdrawal by Subject|1|||
163443134|NCT00615290|590324737|FG000|Overall Study|Other|2|||
163443135|NCT00366548|590324738|FG000|Infant Series|Adverse Event|1|||
163443136|NCT00366548|590324739|FG001|Infant Series|Adverse Event|3|||
163443137|NCT00366548|590324738|FG000|Infant Series|Protocol Violation|0|||
163443138|NCT00366548|590324739|FG001|Infant Series|Protocol Violation|1|||
163443139|NCT00366548|590324738|FG000|Infant Series|Withdrawal by Subject|3|||
163443140|NCT00366548|590324739|FG001|Infant Series|Withdrawal by Subject|1|||
163443141|NCT00366548|590324738|FG000|After Infant Series|Withdrawal by Subject|3|||
163443142|NCT00366548|590324739|FG001|After Infant Series|Withdrawal by Subject|1|||
163443143|NCT00366548|590324738|FG000|After Infant Series|Adverse Event|2|||
163443144|NCT00366548|590324739|FG001|After Infant Series|Adverse Event|0|||
163443145|NCT00366548|590324738|FG000|After Infant Series|Lost to Follow-up|1|||
163443146|NCT00366548|590324739|FG001|After Infant Series|Lost to Follow-up|0|||
163443147|NCT02849990|590324740|FG000|Overall Study|Adverse Event|1|||
163443148|NCT02849990|590324740|FG000|Overall Study|Withdrawal by Subject|1|||
163443149|NCT01252134|590324741|FG000|Period 1, 8 Hours|Personal Reasons|0|||
163443150|NCT01252134|590324742|FG001|Period 1, 8 Hours|Personal Reasons|1|||
163443151|NCT01252134|590324743|FG002|Period 1, 8 Hours|Personal Reasons|1|||
163443152|NCT01252134|590324744|FG003|Period 1, 8 Hours|Personal Reasons|0|||
163443153|NCT01252134|590324745|FG004|Period 1, 8 Hours|Personal Reasons|0|||
163443154|NCT01252134|590324746|FG005|Period 1, 8 Hours|Personal Reasons|0|||
163443155|NCT03650452|590324747|FG000|Overall Study|Physician Decision|1|||
163443156|NCT03650452|590324748|FG001|Overall Study|Physician Decision|0|||
163443157|NCT03650452|590324747|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
163443158|NCT03650452|590324748|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163443159|NCT03650452|590324747|FG000|Overall Study|Adverse Event|3|||
163443160|NCT03650452|590324748|FG001|Overall Study|Adverse Event|4|||
163443161|NCT03650452|590324747|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
163443162|NCT03650452|590324748|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
163443163|NCT02678741|590324750|FG000|Overall Study|Death|4|||
163443164|NCT02678741|590324750|FG000|Overall Study|Withdrawal by Subject|1|||
163443165|NCT02678741|590324750|FG000|Overall Study|ineligible|3|||
163443166|NCT02678741|590324750|FG000|Overall Study|Not RECIST Measurable|2|||
163443167|NCT02678741|590324750|FG000|Overall Study|Lack of Efficacy|10|||
163443168|NCT01795898|590324751|FG000|Overall Study|Adverse Event|27|||
163443169|NCT01795898|590324751|FG000|Overall Study|Lost to Follow-up|20|||
163443170|NCT01795898|590324751|FG000|Overall Study|Withdrawal of consent|6|||
163443171|NCT01795898|590324751|FG000|Overall Study|Diagnosed with metastasis|1|||
163443172|NCT01795898|590324751|FG000|Overall Study|No pain|1|||
163443173|NCT01795898|590324751|FG000|Overall Study|Death|1|||
163443174|NCT01795898|590324751|FG000|Overall Study|Withdrew consent & had adverse events|3|||
163443175|NCT01795898|590324751|FG000|Overall Study|Physician Decision|1|||
163443176|NCT02531373|590324760|FG000|Overall Study|Lack of Efficacy|0|||
163443177|NCT02531373|590324761|FG001|Overall Study|Lack of Efficacy|0|||
163443178|NCT02531373|590324762|FG002|Overall Study|Lack of Efficacy|0|||
163443179|NCT02531373|590324763|FG003|Overall Study|Lack of Efficacy|0|||
163443180|NCT02531373|590324764|FG004|Overall Study|Lack of Efficacy|3|||
163443181|NCT02531373|590324765|FG005|Overall Study|Lack of Efficacy|2|||
163443182|NCT02531373|590324766|FG006|Overall Study|Lack of Efficacy|4|||
163443183|NCT02531373|590324767|FG007|Overall Study|Lack of Efficacy|8|||
163443184|NCT02531373|590324768|FG008|Overall Study|Lack of Efficacy|5|||
163443185|NCT02531373|590324760|FG000|Overall Study|Lost to Follow-up|0|||
163443186|NCT02531373|590324761|FG001|Overall Study|Lost to Follow-up|0|||
163443187|NCT02531373|590324762|FG002|Overall Study|Lost to Follow-up|0|||
163443188|NCT02531373|590324763|FG003|Overall Study|Lost to Follow-up|0|||
163443189|NCT02531373|590324764|FG004|Overall Study|Lost to Follow-up|0|||
163443190|NCT02531373|590324765|FG005|Overall Study|Lost to Follow-up|2|||
163443191|NCT02531373|590324766|FG006|Overall Study|Lost to Follow-up|2|||
163443192|NCT02531373|590324767|FG007|Overall Study|Lost to Follow-up|0|||
163443193|NCT02531373|590324768|FG008|Overall Study|Lost to Follow-up|0|||
163443194|NCT02531373|590324760|FG000|Overall Study|Physician Decision|0|||
163443195|NCT02531373|590324761|FG001|Overall Study|Physician Decision|0|||
163443196|NCT02531373|590324762|FG002|Overall Study|Physician Decision|0|||
163443197|NCT02531373|590324763|FG003|Overall Study|Physician Decision|0|||
163443198|NCT02531373|590324764|FG004|Overall Study|Physician Decision|2|||
163443199|NCT02531373|590324765|FG005|Overall Study|Physician Decision|1|||
163443200|NCT02531373|590324766|FG006|Overall Study|Physician Decision|0|||
163443201|NCT02531373|590324767|FG007|Overall Study|Physician Decision|0|||
163443202|NCT02531373|590324768|FG008|Overall Study|Physician Decision|0|||
163443203|NCT02531373|590324760|FG000|Overall Study|Protocol Violation|0|||
163443204|NCT02531373|590324761|FG001|Overall Study|Protocol Violation|0|||
163443205|NCT02531373|590324762|FG002|Overall Study|Protocol Violation|0|||
163443206|NCT02531373|590324763|FG003|Overall Study|Protocol Violation|0|||
163443207|NCT02531373|590324764|FG004|Overall Study|Protocol Violation|0|||
163443208|NCT02531373|590324765|FG005|Overall Study|Protocol Violation|1|||
163443209|NCT02531373|590324766|FG006|Overall Study|Protocol Violation|1|||
163443210|NCT02531373|590324767|FG007|Overall Study|Protocol Violation|0|||
163443211|NCT02531373|590324768|FG008|Overall Study|Protocol Violation|1|||
163443212|NCT02531373|590324760|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163443213|NCT02531373|590324761|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163443214|NCT02531373|590324762|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163443215|NCT02531373|590324763|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163443216|NCT02531373|590324764|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
163443217|NCT02531373|590324765|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
163443218|NCT02531373|590324766|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
163443219|NCT02531373|590324767|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
163443220|NCT02531373|590324768|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
163443221|NCT02531373|590324760|FG000|Overall Study|Withdrawal by Subject|0|||
163443222|NCT02531373|590324761|FG001|Overall Study|Withdrawal by Subject|0|||
163443223|NCT02531373|590324762|FG002|Overall Study|Withdrawal by Subject|0|||
163443224|NCT02531373|590324763|FG003|Overall Study|Withdrawal by Subject|0|||
163443225|NCT02531373|590324764|FG004|Overall Study|Withdrawal by Subject|3|||
163443226|NCT02531373|590324765|FG005|Overall Study|Withdrawal by Subject|0|||
163443227|NCT02531373|590324766|FG006|Overall Study|Withdrawal by Subject|0|||
163443228|NCT02531373|590324767|FG007|Overall Study|Withdrawal by Subject|0|||
163443229|NCT02531373|590324768|FG008|Overall Study|Withdrawal by Subject|0|||
163443230|NCT01623531|590324769|FG000|Overall Study|Death|1|||
163443231|NCT01623531|590324770|FG001|Overall Study|Death|0|||
163443232|NCT01623531|590324769|FG000|Overall Study|Protocol Violation|2|||
163443233|NCT01623531|590324770|FG001|Overall Study|Protocol Violation|1|||
163443234|NCT01623531|590324769|FG000|Overall Study|Missing data at primary outcome time poi|1|||
163443235|NCT01623531|590324770|FG001|Overall Study|Missing data at primary outcome time poi|1|||
163443236|NCT02834403|590324771|FG000|Overall Study|Physician Decision|2|||
163443237|NCT02834403|590324772|FG001|Overall Study|Physician Decision|1|||
163443238|NCT02834403|590324773|FG002|Overall Study|Physician Decision|2|||
163443239|NCT02834403|590324774|FG003|Overall Study|Physician Decision|1|||
163443240|NCT02834403|590324775|FG004|Overall Study|Physician Decision|1|||
163443241|NCT02834403|590324776|FG005|Overall Study|Physician Decision|2|||
163443242|NCT02834403|590324777|FG006|Overall Study|Physician Decision|12|||
163443243|NCT02834403|590324771|FG000|Overall Study|Adverse Event|0|||
163443244|NCT02834403|590324772|FG001|Overall Study|Adverse Event|0|||
163443245|NCT02834403|590324773|FG002|Overall Study|Adverse Event|0|||
163443246|NCT02834403|590324774|FG003|Overall Study|Adverse Event|0|||
163443247|NCT02834403|590324775|FG004|Overall Study|Adverse Event|1|||
163443248|NCT02834403|590324776|FG005|Overall Study|Adverse Event|1|||
163443249|NCT02834403|590324777|FG006|Overall Study|Adverse Event|3|||
163443250|NCT02834403|590324771|FG000|Overall Study|Withdrawal by Subject|0|||
163443251|NCT02834403|590324772|FG001|Overall Study|Withdrawal by Subject|1|||
163443252|NCT02834403|590324773|FG002|Overall Study|Withdrawal by Subject|0|||
163443253|NCT02834403|590324774|FG003|Overall Study|Withdrawal by Subject|0|||
163443254|NCT02834403|590324775|FG004|Overall Study|Withdrawal by Subject|1|||
163443255|NCT02834403|590324776|FG005|Overall Study|Withdrawal by Subject|0|||
163443256|NCT02834403|590324777|FG006|Overall Study|Withdrawal by Subject|0|||
163443257|NCT02834403|590324771|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
163443258|NCT02834403|590324772|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
163443259|NCT02834403|590324773|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
163443260|NCT02834403|590324774|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
163443261|NCT02834403|590324775|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
163443262|NCT02834403|590324776|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
163443263|NCT02834403|590324777|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
163443264|NCT04705597|590324778|FG000|Overall Study|Death|16|||
163443265|NCT04705597|590324779|FG001|Overall Study|Death|9|||
163443266|NCT04705597|590324778|FG000|Overall Study|Lost to Follow-up|1|||
163443267|NCT04705597|590324779|FG001|Overall Study|Lost to Follow-up|0|||
163443268|NCT04705597|590324778|FG000|Overall Study|Withdrawal by Subject|1|||
163443269|NCT04705597|590324779|FG001|Overall Study|Withdrawal by Subject|2|||
163443270|NCT00390780|590324780|FG000|Overall Study|Not completed|10|||
163443271|NCT00390780|590324781|FG001|Overall Study|Not completed|4|||
163443272|NCT00390780|590324780|FG000|Overall Study|Protocol Violation|6|||
163443273|NCT00390780|590324781|FG001|Overall Study|Protocol Violation|4|||
163443274|NCT00390780|590324780|FG000|Overall Study|Lost to Follow-up|3|||
163443275|NCT00390780|590324781|FG001|Overall Study|Lost to Follow-up|6|||
163443276|NCT00390780|590324780|FG000|Overall Study|Adverse Event|2|||
163443277|NCT00390780|590324781|FG001|Overall Study|Adverse Event|3|||
163443278|NCT00390780|590324780|FG000|Overall Study|Death|1|||
163443279|NCT00390780|590324781|FG001|Overall Study|Death|3|||
163443280|NCT00390780|590324780|FG000|Overall Study|Withdrawal by Subject|1|||
163443281|NCT00390780|590324781|FG001|Overall Study|Withdrawal by Subject|2|||
163443282|NCT00390780|590324780|FG000|Overall Study|Inclusion criteria not satisfied|0|||
163443283|NCT00390780|590324781|FG001|Overall Study|Inclusion criteria not satisfied|2|||
163443284|NCT00390780|590324780|FG000|Overall Study|Lost to follow up and other reasons|0|||
163443285|NCT00390780|590324781|FG001|Overall Study|Lost to follow up and other reasons|1|||
163443286|NCT00390780|590324780|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
163443287|NCT00390780|590324781|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
163443288|NCT00390780|590324780|FG000|Overall Study|SAE, death|0|||
163443289|NCT00390780|590324781|FG001|Overall Study|SAE, death|1|||
163443290|NCT00305006|590324782|FG000|Overall Study|Withdrawal by Subject|1|||
163443291|NCT00305006|590324783|FG001|Overall Study|Withdrawal by Subject|0|||
163443292|NCT00305006|590324782|FG000|Overall Study|Failure to complete pretest|0|||
163443293|NCT00305006|590324783|FG001|Overall Study|Failure to complete pretest|1|||
163443294|NCT02606045|590324784|FG000|Overall Study|Study closed before treament could begin|1|||
163443295|NCT02606045|590324785|FG001|Overall Study|Study closed before treament could begin|2|||
163443296|NCT01996319|590324786|FG000|Overall Study|Protocol Violation|1|||
163443297|NCT01996319|590324787|FG001|Overall Study|Protocol Violation|0|||
163443298|NCT01996319|590324786|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
163443299|NCT01996319|590324787|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
163443300|NCT01996319|590324786|FG000|Overall Study|Adverse Event|2|||
163443301|NCT01996319|590324787|FG001|Overall Study|Adverse Event|2|||
163443302|NCT01671085|590324789|FG000|Overall Study|Withdrawal by Subject|1|||
163443303|NCT01671085|590324790|FG001|Overall Study|Withdrawal by Subject|0|||
163443304|NCT00637273|590324791|FG000|Overall Study|Adverse Event|11|||
163443305|NCT00637273|590324792|FG001|Overall Study|Adverse Event|5|||
163443306|NCT00637273|590324793|FG002|Overall Study|Adverse Event|7|||
163443307|NCT00637273|590324791|FG000|Overall Study|Lost to Follow-up|8|||
163443308|NCT00637273|590324792|FG001|Overall Study|Lost to Follow-up|9|||
163443309|NCT00637273|590324793|FG002|Overall Study|Lost to Follow-up|13|||
163443310|NCT00637273|590324791|FG000|Overall Study|Protocol Violation|2|||
163443311|NCT00637273|590324792|FG001|Overall Study|Protocol Violation|4|||
163443312|NCT00637273|590324793|FG002|Overall Study|Protocol Violation|1|||
163443313|NCT00637273|590324791|FG000|Overall Study|Withdrawal of Consent|18|||
163443314|NCT00637273|590324792|FG001|Overall Study|Withdrawal of Consent|6|||
163443315|NCT00637273|590324793|FG002|Overall Study|Withdrawal of Consent|18|||
163443316|NCT00637273|590324791|FG000|Overall Study|Investigator Decision|1|||
163443317|NCT00637273|590324792|FG001|Overall Study|Investigator Decision|3|||
163443318|NCT00637273|590324793|FG002|Overall Study|Investigator Decision|1|||
163443319|NCT00637273|590324791|FG000|Overall Study|Administrative|2|||
163443320|NCT00637273|590324792|FG001|Overall Study|Administrative|0|||
163443321|NCT00637273|590324793|FG002|Overall Study|Administrative|0|||
163443322|NCT00637273|590324791|FG000|Overall Study|Loss of Glucose Control|1|||
163443323|NCT00637273|590324792|FG001|Overall Study|Loss of Glucose Control|1|||
163443324|NCT00637273|590324793|FG002|Overall Study|Loss of Glucose Control|1|||
163443325|NCT02853331|590324794|FG000|Overall Study|Death|59|||
163443326|NCT02853331|590324795|FG001|Overall Study|Death|95|||
163443327|NCT02853331|590324794|FG000|Overall Study|Withdrawal by Subject|5|||
163443328|NCT02853331|590324795|FG001|Overall Study|Withdrawal by Subject|9|||
163443329|NCT02853331|590324794|FG000|Overall Study|Ongoing in study|368|||
163443330|NCT02853331|590324795|FG001|Overall Study|Ongoing in study|325|||
163443331|NCT00844428|590324796|FG000|Screening Period|Screen Failure|3|||
163443332|NCT00844428|590324796|FG000|Extension Treatment Period|Death|1|||
163443333|NCT00844428|590324796|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
163443334|NCT02375698|590324797|FG000|Overall Study|Withdrawal by Subject|0|||
163443335|NCT02375698|590324798|FG001|Overall Study|Withdrawal by Subject|2|||
163443336|NCT02375698|590324797|FG000|Overall Study|Physician Decision|2|||
163443337|NCT02375698|590324798|FG001|Overall Study|Physician Decision|0|||
163443338|NCT01595646|590324799|FG000|Overall Study|Withdrawal by Subject|1|||
163443339|NCT01595646|590324800|FG001|Overall Study|Withdrawal by Subject|0|||
163443340|NCT01595646|590324801|FG002|Overall Study|Withdrawal by Subject|0|||
163443341|NCT01161524|590324803|FG000|Core Study (23 Weeks)|Adverse Event|3|||
163443342|NCT01161524|590324804|FG001|Core Study (23 Weeks)|Adverse Event|0|||
163443343|NCT01161524|590324805|FG002|Core Study (23 Weeks)|Adverse Event|0|||
163443344|NCT01161524|590324803|FG000|Core Study (23 Weeks)|Other|1|||
163443345|NCT01161524|590324804|FG001|Core Study (23 Weeks)|Other|0|||
163443346|NCT01161524|590324805|FG002|Core Study (23 Weeks)|Other|0|||
163443347|NCT01161524|590324803|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
163443348|NCT01161524|590324804|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
163443349|NCT01161524|590324805|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
163443350|NCT01161524|590324803|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
163443351|NCT01161524|590324804|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
163443352|NCT01161524|590324805|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
163443353|NCT01161524|590324803|FG000|Core Study (23 Weeks)|Subject Choice|3|||
163443354|NCT01161524|590324804|FG001|Core Study (23 Weeks)|Subject Choice|2|||
163443355|NCT01161524|590324805|FG002|Core Study (23 Weeks)|Subject Choice|0|||
163443356|NCT01161524|590324803|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
163443357|NCT01161524|590324804|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
163443358|NCT01161524|590324805|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
163443359|NCT01161524|590324803|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
163443360|NCT01161524|590324804|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
163443361|NCT01161524|590324805|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
163443362|NCT01161524|590324803|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
163443363|NCT01161524|590324804|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
163443364|NCT01161524|590324805|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
163443365|NCT01161524|590324803|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
163443366|NCT01161524|590324804|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
163443367|NCT01161524|590324805|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
163443368|NCT01161524|590324803|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
163443369|NCT01161524|590324804|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
163443370|NCT01161524|590324805|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
163443371|NCT01632878|590324810|FG000|Screening|Physician Decision|268|||
163443372|NCT01632878|590324810|FG000|Treatment|Lost to Follow-up|41|||
163443373|NCT01632878|590324810|FG000|Treatment|Withdrawal by Subject|36|||
163443374|NCT01632878|590324810|FG000|Treatment|Physician Decision|34|||
163443375|NCT01632878|590324810|FG000|Treatment|missing information|4|||
163443376|NCT01632878|590324810|FG000|Treatment|no information on study completion|43|||
163443377|NCT02698423|590324811|FG000|Overall Study|Lost to Follow-up|19|||
163443378|NCT02698423|590324812|FG001|Overall Study|Lost to Follow-up|24|||
163443379|NCT01765764|590324813|FG000|Treatment Period|Adverse Event|1|||
163443380|NCT01765764|590324814|FG001|Treatment Period|Adverse Event|2|||
163443381|NCT01765764|590324815|FG002|Treatment Period|Adverse Event|1|||
163443382|NCT01765764|590324813|FG000|Treatment Period|Lost to Follow-up|0|||
163443383|NCT01765764|590324814|FG001|Treatment Period|Lost to Follow-up|3|||
163443384|NCT01765764|590324815|FG002|Treatment Period|Lost to Follow-up|2|||
163443385|NCT01765764|590324813|FG000|Treatment Period|Personal Reasons|1|||
163443386|NCT01765764|590324814|FG001|Treatment Period|Personal Reasons|2|||
163443387|NCT01765764|590324815|FG002|Treatment Period|Personal Reasons|1|||
163443388|NCT01765764|590324813|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
163443389|NCT01765764|590324814|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
163443390|NCT01765764|590324815|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
163443391|NCT00064662|590324820|FG000|Overall Study|Death|1|||
163443392|NCT00064662|590324821|FG001|Overall Study|Death|1|||
163443393|NCT00064662|590324820|FG000|Overall Study|Lost to Follow-up|57|||
163443394|NCT00064662|590324821|FG001|Overall Study|Lost to Follow-up|44|||
163443395|NCT00064662|590324820|FG000|Overall Study|Withdrawal by Subject|14|||
163443396|NCT00064662|590324821|FG001|Overall Study|Withdrawal by Subject|14|||
163443397|NCT00064662|590324820|FG000|Overall Study|Administratively withdrawn|2|||
163443398|NCT00064662|590324821|FG001|Overall Study|Administratively withdrawn|2|||
163443399|NCT01555463|590324824|FG000|Treatment|Adverse Event|6|||
163443400|NCT01555463|590324825|FG001|Treatment|Adverse Event|12|||
163443401|NCT01555463|590324824|FG000|Treatment|Withdrawal by Subject|24|||
163443402|NCT01555463|590324825|FG001|Treatment|Withdrawal by Subject|36|||
163443403|NCT01555463|590324824|FG000|Treatment|Lost to Follow-up|28|||
163443404|NCT01555463|590324825|FG001|Treatment|Lost to Follow-up|23|||
163443405|NCT01555463|590324824|FG000|Treatment|Protocol Violation|4|||
163443406|NCT01555463|590324825|FG001|Treatment|Protocol Violation|5|||
163443407|NCT01555463|590324824|FG000|Treatment|Other reason|2|||
163443408|NCT01555463|590324825|FG001|Treatment|Other reason|3|||
163443409|NCT01555463|590324824|FG000|Follow up|Adverse Event|2|||
163443410|NCT01555463|590324825|FG001|Follow up|Adverse Event|5|||
163443411|NCT01555463|590324824|FG000|Follow up|Death|0|||
163443412|NCT01555463|590324825|FG001|Follow up|Death|1|||
163443413|NCT01555463|590324824|FG000|Follow up|Withdrawal by Subject|22|||
163443414|NCT01555463|590324825|FG001|Follow up|Withdrawal by Subject|22|||
163443415|NCT01555463|590324824|FG000|Follow up|Lost to Follow-up|9|||
163443416|NCT01555463|590324825|FG001|Follow up|Lost to Follow-up|10|||
163443417|NCT01555463|590324824|FG000|Follow up|Protocol Violation|2|||
163443418|NCT01555463|590324825|FG001|Follow up|Protocol Violation|4|||
163443419|NCT01555463|590324824|FG000|Follow up|Other reason|3|||
163443420|NCT01555463|590324825|FG001|Follow up|Other reason|3|||
163443421|NCT01165203|590324828|FG000|Active Phase|Serious Adverse Event|1|||
163443422|NCT01165203|590324829|FG001|Active Phase|Serious Adverse Event|0|||
163443423|NCT01165203|590324828|FG000|Active Phase|Withdrawal by Subject|2|||
163443424|NCT01165203|590324829|FG001|Active Phase|Withdrawal by Subject|1|||
163443425|NCT01165203|590324828|FG000|Active Phase|Migrated/moved from study area|0|||
163443426|NCT01165203|590324829|FG001|Active Phase|Migrated/moved from study area|1|||
163443427|NCT01165203|590324828|FG000|Active Phase|Lost to Follow-up|2|||
163443428|NCT01165203|590324829|FG001|Active Phase|Lost to Follow-up|0|||
163443429|NCT01165203|590324828|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
163443430|NCT01165203|590324829|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
163443431|NCT01165203|590324828|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
163443432|NCT01165203|590324829|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
163443433|NCT01165203|590324828|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
163443434|NCT01165203|590324829|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
163443435|NCT01165203|590324828|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
163443436|NCT01165203|590324829|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
163443437|NCT01165203|590324828|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
163443438|NCT01165203|590324829|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
163443439|NCT02090114|590326347|FG000|Overall Study|Withdrawal by Subject|3|||
163443440|NCT02090114|590326348|FG001|Overall Study|Withdrawal by Subject|6|||
163443441|NCT02090114|590326349|FG002|Overall Study|Withdrawal by Subject|2|||
163443442|NCT02090114|590326350|FG003|Overall Study|Withdrawal by Subject|1|||
163443443|NCT02090114|590326347|FG000|Overall Study|Physician Decision|5|||
163443444|NCT02090114|590326348|FG001|Overall Study|Physician Decision|0|||
163443445|NCT02090114|590326349|FG002|Overall Study|Physician Decision|1|||
163443446|NCT02090114|590326350|FG003|Overall Study|Physician Decision|1|||
163443447|NCT02090114|590326347|FG000|Overall Study|Adverse Event|1|||
163443448|NCT02090114|590326348|FG001|Overall Study|Adverse Event|2|||
163443449|NCT02090114|590326349|FG002|Overall Study|Adverse Event|2|||
163443450|NCT02090114|590326350|FG003|Overall Study|Adverse Event|0|||
163443451|NCT02090114|590326347|FG000|Overall Study|Progressive Disease|20|||
163443452|NCT02090114|590326348|FG001|Overall Study|Progressive Disease|21|||
163443453|NCT02090114|590326349|FG002|Overall Study|Progressive Disease|23|||
163443454|NCT02090114|590326350|FG003|Overall Study|Progressive Disease|6|||
163443455|NCT02090114|590326347|FG000|Overall Study|Death|1|||
163443456|NCT02090114|590326348|FG001|Overall Study|Death|0|||
163443457|NCT02090114|590326349|FG002|Overall Study|Death|1|||
163443458|NCT02090114|590326350|FG003|Overall Study|Death|0|||
163443459|NCT01605071|590326351|FG000|Overall Study|Withdrawal by Subject|3|||
163443460|NCT01605071|590326352|FG001|Overall Study|Withdrawal by Subject|2|||
163443461|NCT03123354|590326353|FG000|Overall Study|Physician Decision|6|||
163443462|NCT04907539|590326356|FG000|Overall Study|Consent withdrawn|1|||
163443463|NCT04907539|590326357|FG001|Overall Study|Consent withdrawn|0|||
163443464|NCT04907539|590326356|FG000|Overall Study|Death|14|||
163443465|NCT04907539|590326357|FG001|Overall Study|Death|3|||
163443466|NCT00051558|590326358|FG000|Overall Study|Adverse Event|30|||
163443467|NCT00051558|590326359|FG001|Overall Study|Adverse Event|18|||
163443468|NCT00051558|590326358|FG000|Overall Study|Withdrawal by Subject|29|||
163443469|NCT00051558|590326359|FG001|Overall Study|Withdrawal by Subject|42|||
163443470|NCT00051558|590326358|FG000|Overall Study|Death|9|||
163443471|NCT00051558|590326359|FG001|Overall Study|Death|15|||
163443472|NCT00051558|590326358|FG000|Overall Study|Lost to Follow-up|4|||
163443473|NCT00051558|590326359|FG001|Overall Study|Lost to Follow-up|13|||
163443474|NCT00051558|590326358|FG000|Overall Study|Protocol Violation|3|||
163443475|NCT00051558|590326359|FG001|Overall Study|Protocol Violation|4|||
163443476|NCT00051558|590326358|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
163443477|NCT00051558|590326359|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
163443478|NCT00051558|590326358|FG000|Overall Study|Sponsor Decision|6|||
163443479|NCT00051558|590326359|FG001|Overall Study|Sponsor Decision|1|||
163443480|NCT00051558|590326358|FG000|Overall Study|Other|2|||
163443481|NCT00051558|590326359|FG001|Overall Study|Other|1|||
163443482|NCT00051558|590326358|FG000|Overall Study|Significant Lab Value|2|||
163443483|NCT00051558|590326359|FG001|Overall Study|Significant Lab Value|0|||
163443484|NCT00051558|590326358|FG000|Overall Study|Physician Decision|5|||
163443485|NCT00051558|590326359|FG001|Overall Study|Physician Decision|0|||
163443486|NCT02163993|590326361|FG000|Treatment Period|Adverse Event|0|||
163443487|NCT02163993|590326362|FG001|Treatment Period|Adverse Event|1|||
163443488|NCT02163993|590326363|FG002|Treatment Period|Adverse Event|0|||
163443489|NCT02163993|590326364|FG003|Treatment Period|Adverse Event|0|||
163443490|NCT02163993|590326365|FG004|Treatment Period|Adverse Event|1|||
163443491|NCT02163993|590326361|FG000|Treatment Period|Lost to Follow-up|2|||
163443492|NCT02163993|590326362|FG001|Treatment Period|Lost to Follow-up|3|||
163443493|NCT02163993|590326363|FG002|Treatment Period|Lost to Follow-up|1|||
163443494|NCT02163993|590326364|FG003|Treatment Period|Lost to Follow-up|3|||
163443495|NCT02163993|590326365|FG004|Treatment Period|Lost to Follow-up|1|||
163443496|NCT02163993|590326361|FG000|Treatment Period|Physician Decision|1|||
163443497|NCT02163993|590326362|FG001|Treatment Period|Physician Decision|0|||
163443498|NCT02163993|590326363|FG002|Treatment Period|Physician Decision|0|||
163443499|NCT02163993|590326364|FG003|Treatment Period|Physician Decision|0|||
163443500|NCT02163993|590326365|FG004|Treatment Period|Physician Decision|0|||
163443501|NCT02163993|590326361|FG000|Treatment Period|Protocol Violation|2|||
163443502|NCT02163993|590326362|FG001|Treatment Period|Protocol Violation|1|||
163443503|NCT02163993|590326363|FG002|Treatment Period|Protocol Violation|0|||
163443504|NCT02163993|590326364|FG003|Treatment Period|Protocol Violation|1|||
163443505|NCT02163993|590326365|FG004|Treatment Period|Protocol Violation|2|||
163443506|NCT02163993|590326361|FG000|Treatment Period|Withdrawal by Subject|6|||
163443507|NCT02163993|590326362|FG001|Treatment Period|Withdrawal by Subject|4|||
163443508|NCT02163993|590326363|FG002|Treatment Period|Withdrawal by Subject|1|||
163443509|NCT02163993|590326364|FG003|Treatment Period|Withdrawal by Subject|4|||
163443510|NCT02163993|590326365|FG004|Treatment Period|Withdrawal by Subject|1|||
163443511|NCT02163993|590326361|FG000|Treatment Period|Not treated|1|||
163443512|NCT02163993|590326362|FG001|Treatment Period|Not treated|0|||
163443513|NCT02163993|590326363|FG002|Treatment Period|Not treated|0|||
163443514|NCT02163993|590326364|FG003|Treatment Period|Not treated|1|||
163443515|NCT02163993|590326365|FG004|Treatment Period|Not treated|2|||
163443516|NCT02163993|590326361|FG000|Post-treatment Period|Adverse Event|0|||
163443517|NCT02163993|590326362|FG001|Post-treatment Period|Adverse Event|0|||
163443518|NCT02163993|590326363|FG002|Post-treatment Period|Adverse Event|1|||
163443519|NCT02163993|590326364|FG003|Post-treatment Period|Adverse Event|0|||
163443520|NCT02163993|590326365|FG004|Post-treatment Period|Adverse Event|0|||
163443521|NCT02163993|590326361|FG000|Post-treatment Period|Lost to Follow-up|2|||
163443522|NCT02163993|590326362|FG001|Post-treatment Period|Lost to Follow-up|2|||
163443523|NCT02163993|590326363|FG002|Post-treatment Period|Lost to Follow-up|3|||
163443524|NCT02163993|590326364|FG003|Post-treatment Period|Lost to Follow-up|1|||
163443525|NCT02163993|590326365|FG004|Post-treatment Period|Lost to Follow-up|0|||
163443526|NCT02163993|590326361|FG000|Post-treatment Period|Protocol Violation|0|||
163443527|NCT02163993|590326362|FG001|Post-treatment Period|Protocol Violation|0|||
163443528|NCT02163993|590326363|FG002|Post-treatment Period|Protocol Violation|0|||
163443529|NCT02163993|590326364|FG003|Post-treatment Period|Protocol Violation|0|||
163443530|NCT02163993|590326365|FG004|Post-treatment Period|Protocol Violation|1|||
163443531|NCT02163993|590326361|FG000|Post-treatment Period|Withdrawal by Subject|2|||
163443532|NCT02163993|590326362|FG001|Post-treatment Period|Withdrawal by Subject|4|||
163443533|NCT02163993|590326363|FG002|Post-treatment Period|Withdrawal by Subject|0|||
163443534|NCT02163993|590326364|FG003|Post-treatment Period|Withdrawal by Subject|1|||
163443535|NCT02163993|590326365|FG004|Post-treatment Period|Withdrawal by Subject|2|||
163443536|NCT01808118|590326366|FG000|Period 1|Adverse Event|15|||
163443537|NCT01808118|590326367|FG001|Period 1|Adverse Event|0|||
163443538|NCT01808118|590326368|FG002|Period 1|Adverse Event|0|||
163443539|NCT01808118|590326366|FG000|Period 1|Withdrew consent|24|||
163443540|NCT01808118|590326367|FG001|Period 1|Withdrew consent|0|||
163443541|NCT01808118|590326368|FG002|Period 1|Withdrew consent|0|||
163443542|NCT01808118|590326366|FG000|Period 1|Lost to Follow-up|9|||
163443543|NCT01808118|590326367|FG001|Period 1|Lost to Follow-up|0|||
163443544|NCT01808118|590326368|FG002|Period 1|Lost to Follow-up|0|||
163443545|NCT01808118|590326366|FG000|Period 1|Did not meet criteria for remission|303|||
163443546|NCT01808118|590326367|FG001|Period 1|Did not meet criteria for remission|0|||
163443547|NCT01808118|590326368|FG002|Period 1|Did not meet criteria for remission|0|||
163443548|NCT01808118|590326366|FG000|Period 1|Enrolled in error|7|||
163443549|NCT01808118|590326367|FG001|Period 1|Enrolled in error|0|||
163443550|NCT01808118|590326368|FG002|Period 1|Enrolled in error|0|||
163443551|NCT01808118|590326366|FG000|Period 1|Did not meet inclusion criteria|3|||
163443552|NCT01808118|590326367|FG001|Period 1|Did not meet inclusion criteria|0|||
163443553|NCT01808118|590326368|FG002|Period 1|Did not meet inclusion criteria|0|||
163443554|NCT01808118|590326366|FG000|Period 1|Non-conformance with inclusion criteria|3|||
163443555|NCT01808118|590326367|FG001|Period 1|Non-conformance with inclusion criteria|0|||
163443556|NCT01808118|590326368|FG002|Period 1|Non-conformance with inclusion criteria|0|||
163443557|NCT01808118|590326366|FG000|Period 1|Investigator decision: site closure|2|||
163443558|NCT01808118|590326367|FG001|Period 1|Investigator decision: site closure|0|||
163443559|NCT01808118|590326368|FG002|Period 1|Investigator decision: site closure|0|||
163443560|NCT01808118|590326366|FG000|Period 1|Non-compliance per sponsor|1|||
163443561|NCT01808118|590326367|FG001|Period 1|Non-compliance per sponsor|0|||
163443562|NCT01808118|590326368|FG002|Period 1|Non-compliance per sponsor|0|||
163443563|NCT01808118|590326366|FG000|Period 1|Lack of Efficacy|1|||
163443564|NCT01808118|590326367|FG001|Period 1|Lack of Efficacy|0|||
163443565|NCT01808118|590326368|FG002|Period 1|Lack of Efficacy|0|||
163443566|NCT01808118|590326366|FG000|Period 2|Adverse Event|0|||
163443567|NCT01808118|590326367|FG001|Period 2|Adverse Event|4|||
163443568|NCT01808118|590326368|FG002|Period 2|Adverse Event|0|||
163443569|NCT01808118|590326366|FG000|Period 2|Withdrew consent|0|||
163443570|NCT01808118|590326367|FG001|Period 2|Withdrew consent|7|||
163443571|NCT01808118|590326368|FG002|Period 2|Withdrew consent|6|||
163443572|NCT01808118|590326366|FG000|Period 2|Lost to Follow-up|0|||
163443573|NCT01808118|590326367|FG001|Period 2|Lost to Follow-up|0|||
163443574|NCT01808118|590326368|FG002|Period 2|Lost to Follow-up|2|||
163443575|NCT01808118|590326366|FG000|Period 2|Investigator no longer conducting trials|0|||
163443576|NCT01808118|590326367|FG001|Period 2|Investigator no longer conducting trials|1|||
163443577|NCT01808118|590326368|FG002|Period 2|Investigator no longer conducting trials|0|||
163443578|NCT01808118|590326366|FG000|Period 2|Switched to other therapy|0|||
163443579|NCT01808118|590326367|FG001|Period 2|Switched to other therapy|1|||
163443580|NCT01808118|590326368|FG002|Period 2|Switched to other therapy|0|||
163443581|NCT03041116|590326379|FG000|Double-blind|Death|0|||
163443582|NCT03041116|590326380|FG001|Double-blind|Death|2|||
163443583|NCT03041116|590326379|FG000|Double-blind|Withdrawal by Subject|0|||
163443584|NCT03041116|590326380|FG001|Double-blind|Withdrawal by Subject|4|||
163443585|NCT03041116|590326379|FG000|Open-label|Death|1|||
163443586|NCT03041116|590326380|FG001|Open-label|Death|0|||
163443587|NCT03041116|590326379|FG000|Open-label|Termination of the study by Sponsor|39|||
163443588|NCT03041116|590326380|FG001|Open-label|Termination of the study by Sponsor|37|||
163443589|NCT03041116|590326379|FG000|Open-label|Withdrawal by Subject|1|||
163443590|NCT03041116|590326380|FG001|Open-label|Withdrawal by Subject|0|||
163443591|NCT03097328|590326381|FG000|Overall Study|Still on Therapy|2|||
163443592|NCT03097328|590326381|FG000|Overall Study|Progressive Disease|29|||
163443593|NCT03097328|590326381|FG000|Overall Study|Adverse Event|4|||
163443594|NCT03097328|590326381|FG000|Overall Study|Withdrawal by Subject|1|||
163443595|NCT03097328|590326381|FG000|Overall Study|Physician Decision|1|||
163443596|NCT03097328|590326381|FG000|Overall Study|Patient Decision|1|||
163443597|NCT03097328|590326381|FG000|Overall Study|Ineligible for Study Drug|1|||
163443598|NCT01798134|590326382|FG000|Overall Study|Lost to Follow-up|1|||
163443599|NCT01798134|590326382|FG000|Overall Study|Withdrawal by Subject|3|||
163443600|NCT01798134|590326382|FG000|Overall Study|Death|2|||
163443601|NCT01798134|590326382|FG000|Overall Study|Adverse Event|3|||
163443602|NCT01798134|590326382|FG000|Overall Study|Physician Decision|3|||
163443603|NCT01798134|590326382|FG000|Overall Study|Liver transplant/surgery|4|||
163443604|NCT02023164|590326383|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
163443605|NCT02023164|590326384|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
163443606|NCT01675011|590326385|FG000|Overall Study|Trial terminated by Sponsor|3|||
163443607|NCT01675011|590326386|FG001|Overall Study|Trial terminated by Sponsor|1|||
163443608|NCT01984346|590326391|FG000|Overall Study|Physician Decision|4|||
163443609|NCT01984346|590326392|FG001|Overall Study|Physician Decision|2|||
163443610|NCT01984346|590326391|FG000|Overall Study|Withdrawal by Subject|2|||
163443611|NCT01984346|590326392|FG001|Overall Study|Withdrawal by Subject|2|||
163443612|NCT01984346|590326391|FG000|Overall Study|Enrollment Closed|8|||
163443613|NCT01984346|590326392|FG001|Overall Study|Enrollment Closed|1|||
163443614|NCT01984346|590326391|FG000|Overall Study|Insurance Coverage|1|||
163443615|NCT01984346|590326392|FG001|Overall Study|Insurance Coverage|0|||
163443616|NCT01984346|590326391|FG000|Overall Study|Intra-operative Exclusion|2|||
163443617|NCT01984346|590326392|FG001|Overall Study|Intra-operative Exclusion|0|||
163443618|NCT02042404|590326393|FG000|Overall Study|Death|1|||
163443619|NCT02042404|590326394|FG001|Overall Study|Death|0|||
163443620|NCT02042404|590326393|FG000|Overall Study|Unrelated Adverse Event|3|||
163443621|NCT02042404|590326394|FG001|Overall Study|Unrelated Adverse Event|0|||
163443622|NCT02042404|590326393|FG000|Overall Study|Inability to meet time requirements|1|||
163443623|NCT02042404|590326394|FG001|Overall Study|Inability to meet time requirements|0|||
163443624|NCT03100942|590326395|FG000|Randomized Treatment Period|Withdrew Consent|4|||
163443625|NCT03100942|590326396|FG001|Randomized Treatment Period|Withdrew Consent|5|||
163443626|NCT03100942|590326397|FG002|Randomized Treatment Period|Withdrew Consent|3|||
163443627|NCT03100942|590326398|FG003|Randomized Treatment Period|Withdrew Consent|3|||
163443628|NCT03100942|590326399|FG004|Randomized Treatment Period|Withdrew Consent|0|||
163443629|NCT03100942|590326400|FG005|Randomized Treatment Period|Withdrew Consent|0|||
163443630|NCT03100942|590326401|FG006|Randomized Treatment Period|Withdrew Consent|0|||
163443631|NCT03100942|590326395|FG000|Randomized Treatment Period|Adverse Event|5|||
163443632|NCT03100942|590326396|FG001|Randomized Treatment Period|Adverse Event|2|||
163443633|NCT03100942|590326397|FG002|Randomized Treatment Period|Adverse Event|1|||
163443634|NCT03100942|590326398|FG003|Randomized Treatment Period|Adverse Event|0|||
163443635|NCT03100942|590326399|FG004|Randomized Treatment Period|Adverse Event|0|||
163443636|NCT03100942|590326400|FG005|Randomized Treatment Period|Adverse Event|0|||
163443637|NCT03100942|590326401|FG006|Randomized Treatment Period|Adverse Event|0|||
163443638|NCT03100942|590326395|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
163443639|NCT03100942|590326396|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
163443640|NCT03100942|590326397|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
163443641|NCT03100942|590326398|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
163443642|NCT03100942|590326399|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
163443643|NCT03100942|590326400|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
163443644|NCT03100942|590326401|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
163443645|NCT03100942|590326395|FG000|Randomized Treatment Period|Protocol Violation|0|||
163443646|NCT03100942|590326396|FG001|Randomized Treatment Period|Protocol Violation|1|||
163443647|NCT03100942|590326397|FG002|Randomized Treatment Period|Protocol Violation|1|||
163443648|NCT03100942|590326398|FG003|Randomized Treatment Period|Protocol Violation|1|||
163443649|NCT03100942|590326399|FG004|Randomized Treatment Period|Protocol Violation|0|||
163443650|NCT03100942|590326400|FG005|Randomized Treatment Period|Protocol Violation|0|||
163443651|NCT03100942|590326401|FG006|Randomized Treatment Period|Protocol Violation|0|||
163443652|NCT03100942|590326395|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
163443653|NCT03100942|590326396|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
163443654|NCT03100942|590326397|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
163443655|NCT03100942|590326398|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
163443656|NCT03100942|590326399|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
163443657|NCT03100942|590326400|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
163443658|NCT03100942|590326401|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
163443659|NCT03100942|590326395|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
163443660|NCT03100942|590326396|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
163443661|NCT03100942|590326397|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
163443662|NCT03100942|590326398|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
163443663|NCT03100942|590326399|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
163443664|NCT03100942|590326400|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
163443665|NCT03100942|590326401|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
163443666|NCT03100942|590326395|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
163443667|NCT03100942|590326396|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
163443668|NCT03100942|590326397|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
163443669|NCT03100942|590326398|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
163443670|NCT03100942|590326399|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
163443671|NCT03100942|590326400|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
163443672|NCT03100942|590326401|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
163443673|NCT01876732|590326406|FG000|Overall Study|MMA was not over 800mg/dL|75|||
163443674|NCT00536731|590326407|FG000|Overall Study|Adverse Event|3|||
163443675|NCT00536731|590326408|FG001|Overall Study|Adverse Event|2|||
163443676|NCT00536731|590326409|FG002|Overall Study|Adverse Event|3|||
163443677|NCT00536731|590326407|FG000|Overall Study|Withdrawal by Subject|0|||
163443678|NCT00536731|590326408|FG001|Overall Study|Withdrawal by Subject|2|||
163443679|NCT00536731|590326409|FG002|Overall Study|Withdrawal by Subject|0|||
163443680|NCT00536731|590326407|FG000|Overall Study|Intake of prohibited conc. medication|0|||
163443681|NCT00536731|590326408|FG001|Overall Study|Intake of prohibited conc. medication|0|||
163443682|NCT00536731|590326409|FG002|Overall Study|Intake of prohibited conc. medication|1|||
163443683|NCT00536731|590326407|FG000|Overall Study|Safety reasons|0|||
163443684|NCT00536731|590326408|FG001|Overall Study|Safety reasons|0|||
163443685|NCT00536731|590326409|FG002|Overall Study|Safety reasons|1|||
163443686|NCT00536731|590326407|FG000|Overall Study|Other|1|||
163443687|NCT00536731|590326408|FG001|Overall Study|Other|1|||
163443688|NCT00536731|590326409|FG002|Overall Study|Other|0|||
163443689|NCT00718419|590326410|FG000|Overall Study|Adverse Event|2|||
163443690|NCT00718419|590326411|FG001|Overall Study|Adverse Event|1|||
163443691|NCT00718419|590326410|FG000|Overall Study|Physician Decision|1|||
163443692|NCT00718419|590326411|FG001|Overall Study|Physician Decision|6|||
163443693|NCT00718419|590326410|FG000|Overall Study|Sponsor decision|0|||
163443694|NCT00718419|590326411|FG001|Overall Study|Sponsor decision|1|||
163443695|NCT00718419|590326410|FG000|Overall Study|Withdrawal by Subject|0|||
163443696|NCT00718419|590326411|FG001|Overall Study|Withdrawal by Subject|5|||
163443697|NCT00718419|590326410|FG000|Overall Study|Progressive Disease|7|||
163443698|NCT00718419|590326411|FG001|Overall Study|Progressive Disease|25|||
163443699|NCT00718419|590326410|FG000|Overall Study|Death Due to Progressive Disease|2|||
163443700|NCT00718419|590326411|FG001|Overall Study|Death Due to Progressive Disease|0|||
163443701|NCT00718419|590326410|FG000|Overall Study|Death Due to Study Drug Related|0|||
163443702|NCT00718419|590326411|FG001|Overall Study|Death Due to Study Drug Related|1|||
163443703|NCT00718419|590326410|FG000|Overall Study|Death Due to Adverse Events|1|||
163443704|NCT00718419|590326411|FG001|Overall Study|Death Due to Adverse Events|0|||
163443705|NCT04184622|590326414|FG000|Primary Treatment Period|Adverse Event|6|||
163443706|NCT04184622|590326415|FG001|Primary Treatment Period|Adverse Event|4|||
163443707|NCT04184622|590326416|FG002|Primary Treatment Period|Adverse Event|8|||
163443708|NCT04184622|590326417|FG003|Primary Treatment Period|Adverse Event|6|||
163443709|NCT04184622|590326414|FG000|Primary Treatment Period|Death|4|||
163443710|NCT04184622|590326415|FG001|Primary Treatment Period|Death|4|||
163443711|NCT04184622|590326416|FG002|Primary Treatment Period|Death|2|||
163443712|NCT04184622|590326417|FG003|Primary Treatment Period|Death|1|||
163443713|NCT04184622|590326414|FG000|Primary Treatment Period|Lost to Follow-up|41|||
163443714|NCT04184622|590326415|FG001|Primary Treatment Period|Lost to Follow-up|17|||
163443715|NCT04184622|590326416|FG002|Primary Treatment Period|Lost to Follow-up|15|||
163443716|NCT04184622|590326417|FG003|Primary Treatment Period|Lost to Follow-up|13|||
163443717|NCT04184622|590326414|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
163443718|NCT04184622|590326415|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
163443719|NCT04184622|590326416|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
163443720|NCT04184622|590326417|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
163443721|NCT04184622|590326414|FG000|Primary Treatment Period|Physician Decision|0|||
163443722|NCT04184622|590326415|FG001|Primary Treatment Period|Physician Decision|0|||
163443723|NCT04184622|590326416|FG002|Primary Treatment Period|Physician Decision|3|||
163443724|NCT04184622|590326417|FG003|Primary Treatment Period|Physician Decision|1|||
163443725|NCT04184622|590326414|FG000|Primary Treatment Period|Pregnancy|4|||
163443726|NCT04184622|590326415|FG001|Primary Treatment Period|Pregnancy|3|||
163443727|NCT04184622|590326416|FG002|Primary Treatment Period|Pregnancy|4|||
163443728|NCT04184622|590326417|FG003|Primary Treatment Period|Pregnancy|1|||
163443729|NCT04184622|590326414|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
163443730|NCT04184622|590326415|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
163443731|NCT04184622|590326416|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
163443732|NCT04184622|590326417|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
163443733|NCT04184622|590326414|FG000|Additional Treatment Period|Adverse Event|1|||
163443734|NCT04184622|590326415|FG001|Additional Treatment Period|Adverse Event|2|||
163443735|NCT04184622|590326416|FG002|Additional Treatment Period|Adverse Event|1|||
163443736|NCT04184622|590326417|FG003|Additional Treatment Period|Adverse Event|0|||
163443737|NCT04184622|590326414|FG000|Additional Treatment Period|Death|0|||
163443738|NCT04184622|590326415|FG001|Additional Treatment Period|Death|0|||
163443739|NCT04184622|590326416|FG002|Additional Treatment Period|Death|1|||
163443740|NCT04184622|590326417|FG003|Additional Treatment Period|Death|1|||
163443741|NCT04184622|590326414|FG000|Additional Treatment Period|Lost to Follow-up|6|||
163443742|NCT04184622|590326415|FG001|Additional Treatment Period|Lost to Follow-up|4|||
163443743|NCT04184622|590326416|FG002|Additional Treatment Period|Lost to Follow-up|8|||
163443744|NCT04184622|590326417|FG003|Additional Treatment Period|Lost to Follow-up|6|||
163443745|NCT04184622|590326414|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
163443746|NCT04184622|590326415|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
163443747|NCT04184622|590326416|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
163443748|NCT04184622|590326417|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
163443749|NCT04184622|590326414|FG000|Additional Treatment Period|Physician Decision|0|||
163443750|NCT04184622|590326415|FG001|Additional Treatment Period|Physician Decision|0|||
163443751|NCT04184622|590326416|FG002|Additional Treatment Period|Physician Decision|1|||
163443752|NCT04184622|590326417|FG003|Additional Treatment Period|Physician Decision|0|||
163443753|NCT04184622|590326414|FG000|Additional Treatment Period|Pregnancy|0|||
163443754|NCT04184622|590326415|FG001|Additional Treatment Period|Pregnancy|0|||
163443755|NCT04184622|590326416|FG002|Additional Treatment Period|Pregnancy|0|||
163443756|NCT04184622|590326417|FG003|Additional Treatment Period|Pregnancy|1|||
163443757|NCT04184622|590326414|FG000|Additional Treatment Period|Protocol deviation|0|||
163443758|NCT04184622|590326415|FG001|Additional Treatment Period|Protocol deviation|0|||
163443759|NCT04184622|590326416|FG002|Additional Treatment Period|Protocol deviation|1|||
163443760|NCT04184622|590326417|FG003|Additional Treatment Period|Protocol deviation|0|||
163443761|NCT04184622|590326414|FG000|Additional Treatment Period|Site closed|1|||
163443762|NCT04184622|590326415|FG001|Additional Treatment Period|Site closed|0|||
163443763|NCT04184622|590326416|FG002|Additional Treatment Period|Site closed|1|||
163443764|NCT04184622|590326417|FG003|Additional Treatment Period|Site closed|0|||
163443765|NCT04184622|590326414|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
163443766|NCT04184622|590326415|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
163443767|NCT04184622|590326416|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
163443768|NCT04184622|590326417|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
163443769|NCT04184622|590326414|FG000|Safety Follow-up Period|Adverse Event|6|||
163443770|NCT04184622|590326415|FG001|Safety Follow-up Period|Adverse Event|8|||
163443771|NCT04184622|590326416|FG002|Safety Follow-up Period|Adverse Event|9|||
163443772|NCT04184622|590326417|FG003|Safety Follow-up Period|Adverse Event|16|||
163443773|NCT04184622|590326414|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
163443774|NCT04184622|590326415|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
163443775|NCT04184622|590326416|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
163443776|NCT04184622|590326417|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
163443777|NCT04184622|590326414|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
163443778|NCT04184622|590326415|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
163443779|NCT04184622|590326416|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
163443780|NCT04184622|590326417|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
163443781|NCT04184622|590326414|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
163443782|NCT04184622|590326415|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
163443783|NCT04184622|590326416|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
163443784|NCT04184622|590326417|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
163443785|NCT04184622|590326414|FG000|Safety Follow-up Period|Physician Decision|1|||
163443786|NCT04184622|590326415|FG001|Safety Follow-up Period|Physician Decision|0|||
163443787|NCT04184622|590326416|FG002|Safety Follow-up Period|Physician Decision|0|||
163443788|NCT04184622|590326417|FG003|Safety Follow-up Period|Physician Decision|1|||
163443789|NCT04184622|590326414|FG000|Safety Follow-up Period|Pregnancy|1|||
163443790|NCT04184622|590326415|FG001|Safety Follow-up Period|Pregnancy|3|||
163443791|NCT04184622|590326416|FG002|Safety Follow-up Period|Pregnancy|0|||
163443792|NCT04184622|590326417|FG003|Safety Follow-up Period|Pregnancy|6|||
163443793|NCT04184622|590326414|FG000|Safety Follow-up Period|Protocol deviation|1|||
163443794|NCT04184622|590326415|FG001|Safety Follow-up Period|Protocol deviation|0|||
163443795|NCT04184622|590326416|FG002|Safety Follow-up Period|Protocol deviation|0|||
163443796|NCT04184622|590326417|FG003|Safety Follow-up Period|Protocol deviation|0|||
163443797|NCT04184622|590326414|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
163443798|NCT04184622|590326415|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
163443799|NCT04184622|590326416|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
163443800|NCT04184622|590326417|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
163443801|NCT02795988|590326422|FG000|Phase 1b|Withdrawal by Subject|0|||
163443802|NCT02795988|590326423|FG001|Phase 1b|Withdrawal by Subject|1|||
163443803|NCT02795988|590326424|FG002|Phase 1b|Withdrawal by Subject|0|||
163443804|NCT02795988|590326425|FG003|Phase 1b|Withdrawal by Subject|0|||
163443805|NCT02795988|590326426|FG004|Phase 1b|Withdrawal by Subject|0|||
163443806|NCT02795988|590326427|FG005|Phase 1b|Withdrawal by Subject|0|||
163443807|NCT02795988|590326428|FG006|Phase 1b|Withdrawal by Subject|0|||
163443808|NCT02795988|590326422|FG000|Phase 1b|Death|1|||
163443809|NCT02795988|590326423|FG001|Phase 1b|Death|2|||
163443810|NCT02795988|590326424|FG002|Phase 1b|Death|1|||
163443811|NCT02795988|590326425|FG003|Phase 1b|Death|0|||
163443812|NCT02795988|590326426|FG004|Phase 1b|Death|0|||
163443813|NCT02795988|590326427|FG005|Phase 1b|Death|0|||
163443814|NCT02795988|590326428|FG006|Phase 1b|Death|0|||
163443815|NCT02795988|590326422|FG000|Phase 1b|Physician Decision|0|||
163443816|NCT02795988|590326423|FG001|Phase 1b|Physician Decision|0|||
163443817|NCT02795988|590326424|FG002|Phase 1b|Physician Decision|1|||
163443818|NCT02795988|590326425|FG003|Phase 1b|Physician Decision|0|||
163443819|NCT02795988|590326426|FG004|Phase 1b|Physician Decision|0|||
163443820|NCT02795988|590326427|FG005|Phase 1b|Physician Decision|0|||
163443821|NCT02795988|590326428|FG006|Phase 1b|Physician Decision|0|||
163443822|NCT02795988|590326422|FG000|Phase 1b|Progressive Disease|2|||
163443823|NCT02795988|590326423|FG001|Phase 1b|Progressive Disease|2|||
163443824|NCT02795988|590326424|FG002|Phase 1b|Progressive Disease|0|||
163443825|NCT02795988|590326425|FG003|Phase 1b|Progressive Disease|0|||
163443826|NCT02795988|590326426|FG004|Phase 1b|Progressive Disease|0|||
163443827|NCT02795988|590326427|FG005|Phase 1b|Progressive Disease|0|||
163443828|NCT02795988|590326428|FG006|Phase 1b|Progressive Disease|0|||
163443829|NCT02795988|590326422|FG000|Phase 2|Withdrawal by Subject|0|||
163443830|NCT02795988|590326423|FG001|Phase 2|Withdrawal by Subject|0|||
163443831|NCT02795988|590326424|FG002|Phase 2|Withdrawal by Subject|0|||
163443832|NCT02795988|590326425|FG003|Phase 2|Withdrawal by Subject|1|||
163443833|NCT02795988|590326426|FG004|Phase 2|Withdrawal by Subject|0|||
163443834|NCT02795988|590326427|FG005|Phase 2|Withdrawal by Subject|0|||
163443835|NCT02795988|590326428|FG006|Phase 2|Withdrawal by Subject|0|||
163443836|NCT02795988|590326422|FG000|Phase 2|Death|0|||
163443837|NCT02795988|590326423|FG001|Phase 2|Death|0|||
163443838|NCT02795988|590326424|FG002|Phase 2|Death|0|||
163443839|NCT02795988|590326425|FG003|Phase 2|Death|17|||
163443840|NCT02795988|590326426|FG004|Phase 2|Death|17|||
163443841|NCT02795988|590326427|FG005|Phase 2|Death|0|||
163443842|NCT02795988|590326428|FG006|Phase 2|Death|0|||
163443843|NCT02795988|590326422|FG000|Phase 2|Other|0|||
163443844|NCT02795988|590326423|FG001|Phase 2|Other|0|||
163443845|NCT02795988|590326424|FG002|Phase 2|Other|0|||
163443846|NCT02795988|590326425|FG003|Phase 2|Other|1|||
163443847|NCT02795988|590326426|FG004|Phase 2|Other|0|||
163443848|NCT02795988|590326427|FG005|Phase 2|Other|0|||
163443849|NCT02795988|590326428|FG006|Phase 2|Other|0|||
163443850|NCT02795988|590326422|FG000|Phase 2 Extension|Death|0|||
163443851|NCT02795988|590326423|FG001|Phase 2 Extension|Death|0|||
163443852|NCT02795988|590326424|FG002|Phase 2 Extension|Death|0|||
163443853|NCT02795988|590326425|FG003|Phase 2 Extension|Death|0|||
163443854|NCT02795988|590326426|FG004|Phase 2 Extension|Death|0|||
163443855|NCT02795988|590326427|FG005|Phase 2 Extension|Death|5|||
163443856|NCT02795988|590326428|FG006|Phase 2 Extension|Death|6|||
163443857|NCT02795988|590326422|FG000|Phase 2 Extension|Other reasons|0|||
163443858|NCT02795988|590326423|FG001|Phase 2 Extension|Other reasons|0|||
163443859|NCT02795988|590326424|FG002|Phase 2 Extension|Other reasons|0|||
163443860|NCT02795988|590326425|FG003|Phase 2 Extension|Other reasons|0|||
163443861|NCT02795988|590326426|FG004|Phase 2 Extension|Other reasons|0|||
163443862|NCT02795988|590326427|FG005|Phase 2 Extension|Other reasons|2|||
163443863|NCT02795988|590326428|FG006|Phase 2 Extension|Other reasons|1|||
163443864|NCT02341014|590326429|FG000|Overall Study|Adverse Event|0|||
163443865|NCT02341014|590326430|FG001|Overall Study|Adverse Event|1|||
163443866|NCT02341014|590326431|FG002|Overall Study|Adverse Event|0|||
163443867|NCT02341014|590326432|FG003|Overall Study|Adverse Event|0|||
163443868|NCT02341014|590326433|FG004|Overall Study|Adverse Event|2|||
163443869|NCT00726323|590326434|FG000|Overall Study|Withdrawal by Subject|3|||
163443870|NCT00726323|590326435|FG001|Overall Study|Withdrawal by Subject|1|||
163443871|NCT00726323|590326434|FG000|Overall Study|Physician Decision|1|||
163443872|NCT00726323|590326435|FG001|Overall Study|Physician Decision|0|||
163443873|NCT00726323|590326434|FG000|Overall Study|Progressive disease|23|||
163443874|NCT00726323|590326435|FG001|Overall Study|Progressive disease|16|||
163443875|NCT00726323|590326434|FG000|Overall Study|Clinical progression|0|||
163443876|NCT00726323|590326435|FG001|Overall Study|Clinical progression|3|||
163443877|NCT00726323|590326434|FG000|Overall Study|Adverse Event|9|||
163443878|NCT00726323|590326435|FG001|Overall Study|Adverse Event|9|||
163443879|NCT00726323|590326434|FG000|Overall Study|Death|1|||
163443880|NCT00726323|590326435|FG001|Overall Study|Death|0|||
163443881|NCT00726323|590326434|FG000|Overall Study|Participant wished to discontinue|0|||
163443882|NCT00726323|590326435|FG001|Overall Study|Participant wished to discontinue|1|||
163443883|NCT00726323|590326434|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
163443884|NCT00726323|590326435|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
163443885|NCT05058664|590326436|FG000|Overall Study|No follow-up data provided|4|||
163443886|NCT05058664|590326437|FG001|Overall Study|No follow-up data provided|0|||
163443887|NCT05058664|590326438|FG002|Overall Study|No follow-up data provided|2|||
163443888|NCT05058664|590326436|FG000|Overall Study|Withdrawal by Subject|0|||
163443889|NCT05058664|590326437|FG001|Overall Study|Withdrawal by Subject|0|||
163443890|NCT05058664|590326438|FG002|Overall Study|Withdrawal by Subject|1|||
163443891|NCT01617681|590326440|FG000|Period 1 Double Blind|Adverse Event|2|||
163443892|NCT01617681|590326441|FG001|Period 1 Double Blind|Adverse Event|0|||
163443893|NCT01617681|590326442|FG002|Period 1 Double Blind|Adverse Event|0|||
163443894|NCT01617681|590326443|FG003|Period 1 Double Blind|Adverse Event|2|||
163443895|NCT01617681|590326444|FG004|Period 1 Double Blind|Adverse Event|0|||
163443896|NCT01617681|590326440|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
163443897|NCT01617681|590326441|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
163443898|NCT01617681|590326442|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
163443899|NCT01617681|590326443|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
163443900|NCT01617681|590326444|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
163443901|NCT01617681|590326440|FG000|Period 2 Open Label|Adverse Event|0|||
163443902|NCT01617681|590326441|FG001|Period 2 Open Label|Adverse Event|0|||
163443903|NCT01617681|590326442|FG002|Period 2 Open Label|Adverse Event|0|||
163443904|NCT01617681|590326443|FG003|Period 2 Open Label|Adverse Event|0|||
163443905|NCT01617681|590326444|FG004|Period 2 Open Label|Adverse Event|3|||
163443906|NCT01617681|590326440|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
163443907|NCT01617681|590326441|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
163443908|NCT01617681|590326442|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
163443909|NCT01617681|590326443|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
163443910|NCT01617681|590326444|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
163443911|NCT00109733|590326454|FG000|Overall Study|Protocol Violation|0|||
163443912|NCT00109733|590326455|FG001|Overall Study|Protocol Violation|1|||
163443913|NCT00109733|590326454|FG000|Overall Study|Stopped taking study drug|1|||
163443914|NCT00109733|590326455|FG001|Overall Study|Stopped taking study drug|1|||
163443915|NCT00109733|590326454|FG000|Overall Study|Non-compliant|0|||
163443916|NCT00109733|590326455|FG001|Overall Study|Non-compliant|1|||
163443917|NCT00109733|590326454|FG000|Overall Study|Could not commit time for study|1|||
163443918|NCT00109733|590326455|FG001|Overall Study|Could not commit time for study|1|||
163443919|NCT05628181|590326461|FG000|Overall Study|Death|2|||
163443920|NCT05628181|590326462|FG001|Overall Study|Death|4|||
163443921|NCT05628181|590326463|FG002|Overall Study|Death|0|||
163443922|NCT01234402|590326464|FG000|Overall Study|Lost to Follow-up|0|||
163443923|NCT01234402|590326465|FG001|Overall Study|Lost to Follow-up|1|||
163443924|NCT01234402|590326466|FG002|Overall Study|Lost to Follow-up|3|||
163443925|NCT01234402|590326464|FG000|Overall Study|Withdrawal by Subject|1|||
163443926|NCT01234402|590326465|FG001|Overall Study|Withdrawal by Subject|3|||
163443927|NCT01234402|590326466|FG002|Overall Study|Withdrawal by Subject|4|||
163443928|NCT01234402|590326464|FG000|Overall Study|Never treated: Death|0|||
163443929|NCT01234402|590326465|FG001|Overall Study|Never treated: Death|0|||
163443930|NCT01234402|590326466|FG002|Overall Study|Never treated: Death|1|||
163443931|NCT01234402|590326464|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
163443932|NCT01234402|590326465|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
163443933|NCT01234402|590326466|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
163443934|NCT01234402|590326464|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
163443935|NCT01234402|590326465|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
163443936|NCT01234402|590326466|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
163443937|NCT02280291|590326468|FG000|Overall Study|Lost to Follow-up|2|||
163443938|NCT02280291|590326469|FG001|Overall Study|Lost to Follow-up|1|||
163443939|NCT02280291|590326470|FG002|Overall Study|Lost to Follow-up|3|||
163443940|NCT02280291|590326471|FG003|Overall Study|Lost to Follow-up|8|||
163443941|NCT02280291|590326468|FG000|Overall Study|Protocol Violation|1|||
163443942|NCT02280291|590326469|FG001|Overall Study|Protocol Violation|0|||
163443943|NCT02280291|590326470|FG002|Overall Study|Protocol Violation|0|||
163443944|NCT02280291|590326471|FG003|Overall Study|Protocol Violation|0|||
163443945|NCT02280291|590326468|FG000|Overall Study|Other|1|||
163443946|NCT02280291|590326469|FG001|Overall Study|Other|1|||
163443947|NCT02280291|590326470|FG002|Overall Study|Other|0|||
163443948|NCT02280291|590326471|FG003|Overall Study|Other|0|||
163443949|NCT03508622|590326472|FG000|Overall Study|Protocol Violation|1|||
163443950|NCT03508622|590326473|FG001|Overall Study|Protocol Violation|0|||
163443951|NCT03508622|590326472|FG000|Overall Study|Withdrawal by Subject|1|||
163443952|NCT03508622|590326473|FG001|Overall Study|Withdrawal by Subject|0|||
163443953|NCT03508622|590326472|FG000|Overall Study|Lost to Follow-up|16|||
163443954|NCT03508622|590326473|FG001|Overall Study|Lost to Follow-up|0|||
163443955|NCT03508622|590326472|FG000|Overall Study|Incomplete data|0|||
163443956|NCT03508622|590326473|FG001|Overall Study|Incomplete data|24|||
163443957|NCT00506077|590326475|FG000|Treatment Period 1|Adverse Event|2|||
163443958|NCT00506077|590326476|FG001|Treatment Period 1|Adverse Event|1|||
163443959|NCT00506077|590326475|FG000|Treatment Period 1|Lost to Follow-up|0|||
163443960|NCT00506077|590326476|FG001|Treatment Period 1|Lost to Follow-up|2|||
163443961|NCT00506077|590326475|FG000|Treatment Period 1|Withdrawal by Subject|2|||
163443962|NCT00506077|590326476|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163443963|NCT00506077|590326475|FG000|Treatment Period 2|Adverse Event|0|||
163443964|NCT00506077|590326476|FG001|Treatment Period 2|Adverse Event|1|||
163443965|NCT00506077|590326475|FG000|Treatment Period 2|Withdrawal by Subject|1|||
163443966|NCT00506077|590326476|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163443967|NCT00316303|590326477|FG000|Overall Study|Lost to Follow-up|11|||
163443968|NCT00316303|590326478|FG001|Overall Study|Lost to Follow-up|16|||
163443969|NCT01106534|590326481|FG000|Overall Study|Withdrawal by Subject|18|||
163443970|NCT01106534|590326481|FG000|Overall Study|Lost to Follow-up|2|||
163443971|NCT01106534|590326481|FG000|Overall Study|Death|16|||
163443972|NCT01106534|590326481|FG000|Overall Study|Physician Decision|1|||
163443973|NCT00570739|590326486|FG000|Overall Study|Adverse Event|8|||
163443974|NCT00570739|590326487|FG001|Overall Study|Adverse Event|6|||
163443975|NCT00570739|590326488|FG002|Overall Study|Adverse Event|2|||
163443976|NCT00570739|590326489|FG003|Overall Study|Adverse Event|2|||
163443977|NCT00570739|590326486|FG000|Overall Study|Lost to Follow-up|4|||
163443978|NCT00570739|590326487|FG001|Overall Study|Lost to Follow-up|5|||
163443979|NCT00570739|590326488|FG002|Overall Study|Lost to Follow-up|4|||
163443980|NCT00570739|590326489|FG003|Overall Study|Lost to Follow-up|1|||
163443981|NCT00570739|590326486|FG000|Overall Study|Physician Decision|1|||
163443982|NCT00570739|590326487|FG001|Overall Study|Physician Decision|1|||
163443983|NCT00570739|590326488|FG002|Overall Study|Physician Decision|0|||
163443984|NCT00570739|590326489|FG003|Overall Study|Physician Decision|0|||
163443985|NCT00570739|590326486|FG000|Overall Study|Withdrawal by Subject|7|||
163443986|NCT00570739|590326487|FG001|Overall Study|Withdrawal by Subject|7|||
163443987|NCT00570739|590326488|FG002|Overall Study|Withdrawal by Subject|3|||
163443988|NCT00570739|590326489|FG003|Overall Study|Withdrawal by Subject|5|||
163443989|NCT00570739|590326486|FG000|Overall Study|Required restricted medication|0|||
163443990|NCT00570739|590326487|FG001|Overall Study|Required restricted medication|0|||
163443991|NCT00570739|590326488|FG002|Overall Study|Required restricted medication|1|||
163443992|NCT00570739|590326489|FG003|Overall Study|Required restricted medication|0|||
163443993|NCT00570739|590326486|FG000|Overall Study|Met discontinuation criteria|1|||
163443994|NCT00570739|590326487|FG001|Overall Study|Met discontinuation criteria|0|||
163443995|NCT00570739|590326488|FG002|Overall Study|Met discontinuation criteria|1|||
163443996|NCT00570739|590326489|FG003|Overall Study|Met discontinuation criteria|1|||
163443997|NCT00570739|590326486|FG000|Overall Study|Other|0|||
163443998|NCT00570739|590326487|FG001|Overall Study|Other|2|||
163443999|NCT00570739|590326488|FG002|Overall Study|Other|5|||
163444000|NCT00570739|590326489|FG003|Overall Study|Other|3|||
163444001|NCT00739297|590326491|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
163444002|NCT00739297|590326492|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
163444003|NCT00739297|590326493|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
163444004|NCT00739297|590326494|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
163444005|NCT00739297|590326495|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
163444006|NCT00739297|590326496|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
163444007|NCT00739297|590326497|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
163444008|NCT00739297|590326491|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
163444009|NCT00739297|590326492|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
163444010|NCT00739297|590326493|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
163444011|NCT00739297|590326494|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
163444012|NCT00739297|590326495|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
163444013|NCT00739297|590326496|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
163444014|NCT00739297|590326497|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
163444015|NCT01400971|590326498|FG000|Overall Study|Death|82|||
163444016|NCT01400971|590326498|FG000|Overall Study|Lost to Follow-up|196|||
163444017|NCT01400971|590326498|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
163444018|NCT01400971|590326498|FG000|Overall Study|Physician Decision|57|||
163444019|NCT01400971|590326498|FG000|Overall Study|Withdrawal by Subject|158|||
163444020|NCT01400971|590326498|FG000|Overall Study|Other|422|||
163444021|NCT01041573|590326501|FG000|Overall Study|Withdrawal by Subject|2|||
163444022|NCT01041573|590326502|FG001|Overall Study|Withdrawal by Subject|5|||
163444023|NCT01041573|590326503|FG002|Overall Study|Withdrawal by Subject|2|||
163444024|NCT01041573|590326504|FG003|Overall Study|Withdrawal by Subject|0|||
163444025|NCT01041573|590326501|FG000|Overall Study|Death|1|||
163444026|NCT01041573|590326502|FG001|Overall Study|Death|0|||
163444027|NCT01041573|590326503|FG002|Overall Study|Death|0|||
163444028|NCT01041573|590326504|FG003|Overall Study|Death|0|||
163444029|NCT01041573|590326501|FG000|Overall Study|Lost to Follow-up|0|||
163444030|NCT01041573|590326502|FG001|Overall Study|Lost to Follow-up|1|||
163444031|NCT01041573|590326503|FG002|Overall Study|Lost to Follow-up|2|||
163444032|NCT01041573|590326504|FG003|Overall Study|Lost to Follow-up|1|||
163444033|NCT01041573|590326501|FG000|Overall Study|Adverse Event|0|||
163444034|NCT01041573|590326502|FG001|Overall Study|Adverse Event|2|||
163444035|NCT01041573|590326503|FG002|Overall Study|Adverse Event|0|||
163444036|NCT01041573|590326504|FG003|Overall Study|Adverse Event|0|||
163444037|NCT01041573|590326501|FG000|Overall Study|relocation|1|||
163444038|NCT01041573|590326502|FG001|Overall Study|relocation|4|||
163444039|NCT01041573|590326503|FG002|Overall Study|relocation|3|||
163444040|NCT01041573|590326504|FG003|Overall Study|relocation|1|||
163444041|NCT01041573|590326501|FG000|Overall Study|further blood extraction|0|||
163444042|NCT01041573|590326502|FG001|Overall Study|further blood extraction|1|||
163444043|NCT01041573|590326503|FG002|Overall Study|further blood extraction|0|||
163444044|NCT01041573|590326504|FG003|Overall Study|further blood extraction|0|||
163444045|NCT01041573|590326501|FG000|Overall Study|positive to anti-HCV|1|||
163444046|NCT01041573|590326502|FG001|Overall Study|positive to anti-HCV|0|||
163444047|NCT01041573|590326503|FG002|Overall Study|positive to anti-HCV|0|||
163444048|NCT01041573|590326504|FG003|Overall Study|positive to anti-HCV|0|||
163444049|NCT03634072|590326505|FG000|Overall Study|Early termination of overall study|1|||
163444050|NCT03634072|590326506|FG001|Overall Study|Early termination of overall study|0|||
163444051|NCT01323673|590326509|FG000|Overall Study|Adverse Event|0|||
163444052|NCT01323673|590326510|FG001|Overall Study|Adverse Event|1|||
163444053|NCT01323673|590326509|FG000|Overall Study|Lost to Follow-up|0|||
163444054|NCT01323673|590326510|FG001|Overall Study|Lost to Follow-up|1|||
163444055|NCT01323673|590326509|FG000|Overall Study|Protocol Violation|1|||
163444056|NCT01323673|590326510|FG001|Overall Study|Protocol Violation|0|||
163444057|NCT01323673|590326509|FG000|Overall Study|Withdrawal by Subject|2|||
163444058|NCT01323673|590326510|FG001|Overall Study|Withdrawal by Subject|3|||
163444059|NCT00620321|590328013|FG000|Overall Study|Adverse Event|1|||
163444060|NCT00620321|590328014|FG001|Overall Study|Adverse Event|1|||
163444061|NCT00620321|590328013|FG000|Overall Study|Death|1|||
163444062|NCT00620321|590328014|FG001|Overall Study|Death|1|||
163444063|NCT00620321|590328013|FG000|Overall Study|Physician Decision|0|||
163444064|NCT00620321|590328014|FG001|Overall Study|Physician Decision|7|||
163444065|NCT00620321|590328013|FG000|Overall Study|Progressive Disease|5|||
163444066|NCT00620321|590328014|FG001|Overall Study|Progressive Disease|5|||
163444067|NCT00620321|590328013|FG000|Overall Study|Sponsor Decision|0|||
163444068|NCT00620321|590328014|FG001|Overall Study|Sponsor Decision|1|||
163444069|NCT00620321|590328013|FG000|Overall Study|Withdrawal by Subject|1|||
163444070|NCT00620321|590328014|FG001|Overall Study|Withdrawal by Subject|1|||
163444071|NCT05137041|590328015|FG000|Overall Study|Lost to Follow-up|1|||
163444072|NCT05137041|590328016|FG001|Overall Study|Lost to Follow-up|1|||
163444073|NCT05137041|590328015|FG000|Overall Study|Withdrawal by Subject|0|||
163444074|NCT05137041|590328016|FG001|Overall Study|Withdrawal by Subject|2|||
163444075|NCT05137041|590328015|FG000|Overall Study|Reason not Specified|0|||
163444076|NCT05137041|590328016|FG001|Overall Study|Reason not Specified|1|||
163444077|NCT02433210|590328017|FG000|Overall Study|Physician Decision|1|||
163444078|NCT02433210|590328018|FG001|Overall Study|Physician Decision|0|||
163444079|NCT02433210|590328019|FG002|Overall Study|Physician Decision|0|||
163444080|NCT00883558|590328020|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
163444081|NCT00883558|590328021|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
163444082|NCT00883558|590328022|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
163444083|NCT00883558|590328020|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
163444084|NCT00883558|590328021|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
163444085|NCT00883558|590328022|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
163444086|NCT00883558|590328020|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
163444087|NCT00883558|590328021|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
163444088|NCT00883558|590328022|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
163444089|NCT00883558|590328020|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
163444090|NCT00883558|590328021|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
163444091|NCT00883558|590328022|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
163444092|NCT00883558|590328020|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
163444093|NCT00883558|590328021|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
163444094|NCT00883558|590328022|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
163444095|NCT00643487|590328026|FG000|Overall Study|Technical difficulty|3|||
162925386|NCT00110084|588428953|FG000|Overall Study|Intercurrent Illness|1|||
163444096|NCT00879814|590328033|FG000|Overall Study|Adverse Event|0|||
163444097|NCT00879814|590328034|FG001|Overall Study|Adverse Event|1|||
163444098|NCT00879814|590328035|FG002|Overall Study|Adverse Event|0|||
163444099|NCT00879814|590328036|FG003|Overall Study|Adverse Event|0|||
163444100|NCT00879814|590328033|FG000|Overall Study|Lost to Follow-up|1|||
163444101|NCT00879814|590328034|FG001|Overall Study|Lost to Follow-up|0|||
163444102|NCT00879814|590328035|FG002|Overall Study|Lost to Follow-up|0|||
163444103|NCT00879814|590328036|FG003|Overall Study|Lost to Follow-up|2|||
163444104|NCT00879814|590328033|FG000|Overall Study|Participant Failed to Return|0|||
163444105|NCT00879814|590328034|FG001|Overall Study|Participant Failed to Return|0|||
163444106|NCT00879814|590328035|FG002|Overall Study|Participant Failed to Return|0|||
163444107|NCT00879814|590328036|FG003|Overall Study|Participant Failed to Return|1|||
163444108|NCT00879814|590328033|FG000|Overall Study|Withdrawal by Subject|3|||
163444109|NCT00879814|590328034|FG001|Overall Study|Withdrawal by Subject|1|||
163444110|NCT00879814|590328035|FG002|Overall Study|Withdrawal by Subject|1|||
163444111|NCT00879814|590328036|FG003|Overall Study|Withdrawal by Subject|2|||
163444112|NCT00879814|590328033|FG000|Overall Study|Physician Decision|0|||
163444113|NCT00879814|590328034|FG001|Overall Study|Physician Decision|0|||
163444114|NCT00879814|590328035|FG002|Overall Study|Physician Decision|1|||
163444115|NCT00879814|590328036|FG003|Overall Study|Physician Decision|0|||
163444116|NCT00879814|590328033|FG000|Overall Study|Other|0|||
163444117|NCT00879814|590328034|FG001|Overall Study|Other|0|||
163444118|NCT00879814|590328035|FG002|Overall Study|Other|1|||
163444119|NCT00879814|590328036|FG003|Overall Study|Other|0|||
163444120|NCT01005719|590328037|FG000|Period 1|Adverse Event|0|||
163444121|NCT01005719|590328038|FG001|Period 1|Adverse Event|0|||
163444122|NCT01005719|590328039|FG002|Period 1|Adverse Event|0|||
163444123|NCT01005719|590328040|FG003|Period 1|Adverse Event|1|||
163444124|NCT01005719|590328041|FG004|Period 1|Adverse Event|0|||
163444125|NCT01005719|590328042|FG005|Period 1|Adverse Event|0|||
163444126|NCT01005719|590328037|FG000|Period 1|Delay in completing study procedures|0|||
163444127|NCT01005719|590328038|FG001|Period 1|Delay in completing study procedures|0|||
163444128|NCT01005719|590328039|FG002|Period 1|Delay in completing study procedures|0|||
163444129|NCT01005719|590328040|FG003|Period 1|Delay in completing study procedures|0|||
163444130|NCT01005719|590328041|FG004|Period 1|Delay in completing study procedures|0|||
163444131|NCT01005719|590328042|FG005|Period 1|Delay in completing study procedures|1|||
163444132|NCT01005719|590328037|FG000|Period 2|Adverse Event|0|||
163444133|NCT01005719|590328038|FG001|Period 2|Adverse Event|0|||
163444134|NCT01005719|590328039|FG002|Period 2|Adverse Event|0|||
163444135|NCT01005719|590328040|FG003|Period 2|Adverse Event|0|||
163444136|NCT01005719|590328041|FG004|Period 2|Adverse Event|1|||
163444137|NCT01005719|590328042|FG005|Period 2|Adverse Event|1|||
163444138|NCT01753076|590328043|FG000|Overall Study|Adverse Event|17|||
163444139|NCT01753076|590328044|FG001|Overall Study|Adverse Event|18|||
163444140|NCT01753076|590328043|FG000|Overall Study|Lack of Efficacy|3|||
163444141|NCT01753076|590328044|FG001|Overall Study|Lack of Efficacy|1|||
163444142|NCT01753076|590328043|FG000|Overall Study|Lost to Follow-up|2|||
163444143|NCT01753076|590328044|FG001|Overall Study|Lost to Follow-up|1|||
163444144|NCT01753076|590328043|FG000|Overall Study|Physician Decision|4|||
163444145|NCT01753076|590328044|FG001|Overall Study|Physician Decision|2|||
163444146|NCT01753076|590328043|FG000|Overall Study|Withdrawal by Subject|14|||
163444147|NCT01753076|590328044|FG001|Overall Study|Withdrawal by Subject|24|||
163444148|NCT01753076|590328043|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
163444149|NCT01753076|590328044|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
163444150|NCT02985450|590328050|FG000|Overall Study|Lost to Follow-up|7|||
163444151|NCT00069576|590328051|FG000|Original Trial|Lost to Follow-up|25|||
163444152|NCT00069576|590328052|FG001|Original Trial|Lost to Follow-up|33|||
163444153|NCT00069576|590328051|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
163444154|NCT00069576|590328052|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
163444155|NCT00905307|590328053|FG000|Overall Study|Switched to Open Label Rescue|7|||
163444156|NCT00905307|590328054|FG001|Overall Study|Switched to Open Label Rescue|17|||
163444157|NCT00905307|590328055|FG002|Overall Study|Switched to Open Label Rescue|11|||
163444158|NCT00905307|590328056|FG003|Overall Study|Switched to Open Label Rescue|11|||
163444159|NCT00905307|590328057|FG004|Overall Study|Switched to Open Label Rescue|4|||
163444160|NCT00905307|590328058|FG005|Overall Study|Switched to Open Label Rescue|15|||
163444161|NCT00905307|590328053|FG000|Overall Study|Lost to Follow-up|0|||
163444162|NCT00905307|590328054|FG001|Overall Study|Lost to Follow-up|0|||
163444163|NCT00905307|590328055|FG002|Overall Study|Lost to Follow-up|0|||
163444164|NCT00905307|590328056|FG003|Overall Study|Lost to Follow-up|0|||
163444165|NCT00905307|590328057|FG004|Overall Study|Lost to Follow-up|1|||
163444166|NCT00905307|590328058|FG005|Overall Study|Lost to Follow-up|1|||
163444167|NCT00905307|590328053|FG000|Overall Study|Adverse Event|3|||
163444168|NCT00905307|590328054|FG001|Overall Study|Adverse Event|4|||
163444169|NCT00905307|590328055|FG002|Overall Study|Adverse Event|5|||
163444170|NCT00905307|590328056|FG003|Overall Study|Adverse Event|11|||
163444171|NCT00905307|590328057|FG004|Overall Study|Adverse Event|3|||
163444172|NCT00905307|590328058|FG005|Overall Study|Adverse Event|5|||
163444173|NCT00905307|590328053|FG000|Overall Study|Withdrawal by Subject|5|||
163444174|NCT00905307|590328054|FG001|Overall Study|Withdrawal by Subject|13|||
163444175|NCT00905307|590328055|FG002|Overall Study|Withdrawal by Subject|15|||
163444176|NCT00905307|590328056|FG003|Overall Study|Withdrawal by Subject|11|||
163444177|NCT00905307|590328057|FG004|Overall Study|Withdrawal by Subject|4|||
163444178|NCT00905307|590328058|FG005|Overall Study|Withdrawal by Subject|13|||
163444179|NCT00905307|590328053|FG000|Overall Study|Protocol Violation|1|||
163444180|NCT00905307|590328054|FG001|Overall Study|Protocol Violation|0|||
163444181|NCT00905307|590328055|FG002|Overall Study|Protocol Violation|1|||
163444182|NCT00905307|590328056|FG003|Overall Study|Protocol Violation|0|||
163444183|NCT00905307|590328057|FG004|Overall Study|Protocol Violation|0|||
163444184|NCT00905307|590328058|FG005|Overall Study|Protocol Violation|0|||
163444185|NCT00905307|590328053|FG000|Overall Study|Lack of Efficacy|6|||
163444186|NCT00905307|590328054|FG001|Overall Study|Lack of Efficacy|3|||
163444187|NCT00905307|590328055|FG002|Overall Study|Lack of Efficacy|5|||
163444188|NCT00905307|590328056|FG003|Overall Study|Lack of Efficacy|4|||
163444189|NCT00905307|590328057|FG004|Overall Study|Lack of Efficacy|4|||
163444190|NCT00905307|590328058|FG005|Overall Study|Lack of Efficacy|8|||
163444191|NCT05590793|590328059|FG000|Overall Study|Withdrawal by Subject|6|||
163444192|NCT05590793|590328059|FG000|Overall Study|Physician Decision|1|||
163444193|NCT04060667|590328060|FG000|Overall Study|Lost to Follow-up|75|||
163444194|NCT04060667|590328061|FG001|Overall Study|Lost to Follow-up|10|||
163444195|NCT03015610|590328062|FG000|Overall Study|Lost to Follow-up|1|||
163444196|NCT03015610|590328063|FG001|Overall Study|Lost to Follow-up|5|||
163444197|NCT01603641|590328064|FG000|Overall Study|Did not Receive Treatment|3|||
163444198|NCT01603641|590328064|FG000|Overall Study|Adverse Event|1|||
163444199|NCT01603641|590328064|FG000|Overall Study|Lack of Efficacy|1|||
163444200|NCT01603641|590328064|FG000|Overall Study|Lost to Follow-up|6|||
163444201|NCT01603641|590328064|FG000|Overall Study|Personal Reasons|18|||
163444202|NCT01603641|590328064|FG000|Overall Study|Other Miscellaneous Reasons|6|||
163444203|NCT00114972|590328065|FG000|Overall Study|Withdrawal by Subject|40|||
163444204|NCT00114972|590328066|FG001|Overall Study|Withdrawal by Subject|7|||
163444205|NCT00114972|590328065|FG000|Overall Study|Lost to Follow-up|8|||
163444206|NCT00114972|590328066|FG001|Overall Study|Lost to Follow-up|5|||
163444207|NCT00358917|590328067|FG000|Overall Study|Adverse Event|14|||
163444208|NCT00358917|590328068|FG001|Overall Study|Adverse Event|21|||
163444209|NCT00358917|590328067|FG000|Overall Study|Withdrawal by Subject|5|||
163444210|NCT00358917|590328068|FG001|Overall Study|Withdrawal by Subject|7|||
163444211|NCT00358917|590328067|FG000|Overall Study|Lost to Follow-up|20|||
163444212|NCT00358917|590328068|FG001|Overall Study|Lost to Follow-up|17|||
163444213|NCT00358917|590328067|FG000|Overall Study|Noncompliance|12|||
163444214|NCT00358917|590328068|FG001|Overall Study|Noncompliance|11|||
163444215|NCT00358917|590328067|FG000|Overall Study|Death|2|||
163444216|NCT00358917|590328068|FG001|Overall Study|Death|3|||
163444217|NCT00358917|590328067|FG000|Overall Study|Virologic failure|11|||
163444218|NCT00358917|590328068|FG001|Overall Study|Virologic failure|8|||
163444219|NCT00358917|590328067|FG000|Overall Study|Unable to Continue Participation|2|||
163444220|NCT00358917|590328068|FG001|Overall Study|Unable to Continue Participation|2|||
163444221|NCT02086565|590328078|FG000|Overall Study|Lost to Follow-up|9|||
163444222|NCT02086565|590328079|FG001|Overall Study|Lost to Follow-up|7|||
163444223|NCT02086565|590328078|FG000|Overall Study|Withdrawal by Subject|2|||
163444224|NCT02086565|590328079|FG001|Overall Study|Withdrawal by Subject|1|||
163444225|NCT02086565|590328078|FG000|Overall Study|Death|3|||
163444226|NCT02086565|590328079|FG001|Overall Study|Death|2|||
163444227|NCT02086565|590328078|FG000|Overall Study|withdrawn by research team|2|||
163444228|NCT02086565|590328079|FG001|Overall Study|withdrawn by research team|2|||
163444229|NCT01757704|590328080|FG000|Overall Study|Protocol Violation|1|||
163444230|NCT01757704|590328081|FG001|Overall Study|Protocol Violation|3|||
163444231|NCT02890329|590328084|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
163444232|NCT02890329|590328085|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
163444233|NCT02890329|590328086|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
163444234|NCT02890329|590328087|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
163444235|NCT02890329|590328088|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
163444236|NCT02890329|590328089|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
163444237|NCT02890329|590328084|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
163444238|NCT02890329|590328085|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
163444239|NCT02890329|590328086|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
163444240|NCT02890329|590328087|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
163444241|NCT02890329|590328088|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
163444242|NCT02890329|590328089|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
163444243|NCT02890329|590328084|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
163444244|NCT02890329|590328085|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
163444245|NCT02890329|590328086|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
162925387|NCT00110084|588428953|FG000|Overall Study|Other|2|||
163444246|NCT02890329|590328087|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
163444247|NCT02890329|590328088|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
163444248|NCT02890329|590328089|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
163444249|NCT02890329|590328084|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
163444250|NCT02890329|590328085|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
163444251|NCT02890329|590328086|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
163444252|NCT02890329|590328087|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
162925388|NCT04854707|588428955|FG000|Overall Study|Lack of Efficacy|78|||
163444253|NCT02890329|590328088|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
163444254|NCT02890329|590328089|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
163444255|NCT01035255|590328090|FG000|Overall Study|Death|724|||
163444256|NCT01035255|590328091|FG001|Overall Study|Death|844|||
163444257|NCT01035255|590328090|FG000|Overall Study|Lost to Follow-up|2|||
163444258|NCT01035255|590328091|FG001|Overall Study|Lost to Follow-up|5|||
163444259|NCT01035255|590328090|FG000|Overall Study|patient's request|15|||
163444260|NCT01035255|590328091|FG001|Overall Study|patient's request|13|||
163444261|NCT01379534|590328094|FG000|Treatment Phase|Withdrawal by Subject|2|||
163444262|NCT01379534|590328095|FG001|Treatment Phase|Withdrawal by Subject|2|||
163444263|NCT01379534|590328094|FG000|Treatment Phase|Progressive disease|13|||
163444264|NCT01379534|590328095|FG001|Treatment Phase|Progressive disease|22|||
163444265|NCT01379534|590328094|FG000|Treatment Phase|Adverse Event|7|||
163444266|NCT01379534|590328095|FG001|Treatment Phase|Adverse Event|7|||
163444267|NCT01379534|590328094|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
163444268|NCT01379534|590328095|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
163444269|NCT01379534|590328094|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
163444270|NCT01379534|590328095|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
163444271|NCT01379534|590328094|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
163444272|NCT01379534|590328095|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
163444273|NCT01379534|590328094|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
163444274|NCT01379534|590328095|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
163444275|NCT00616239|590328101|FG000|Overall Study|Withdrawal by Subject|2|||
163444276|NCT01558089|590328104|FG000|Overall Study|Adverse Event|1|||
163444277|NCT01558089|590328104|FG000|Overall Study|Lack of Efficacy|1|||
163444278|NCT01558089|590328104|FG000|Overall Study|Lost to Follow-up|5|||
163444279|NCT01558089|590328104|FG000|Overall Study|Withdrawal by Subject|6|||
163444280|NCT01597193|590328105|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
163444281|NCT01597193|590328106|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
163444282|NCT01597193|590328107|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
163444283|NCT01597193|590328108|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
163444284|NCT01597193|590328109|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
163444285|NCT01597193|590328110|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
163444286|NCT01597193|590328111|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
163444287|NCT01597193|590328105|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
163444288|NCT01597193|590328106|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
163444289|NCT01597193|590328107|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
163444290|NCT01597193|590328108|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
163444291|NCT01597193|590328109|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
163444292|NCT01597193|590328110|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
163444293|NCT01597193|590328111|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
163444294|NCT01597193|590328105|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
163444295|NCT01597193|590328106|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
163444296|NCT01597193|590328107|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
163444297|NCT01597193|590328108|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
163444298|NCT01597193|590328109|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
163444299|NCT01597193|590328110|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
163444300|NCT01597193|590328111|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
163444301|NCT01597193|590328105|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
163444302|NCT01597193|590328106|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
163444303|NCT01597193|590328107|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
163444304|NCT01597193|590328108|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
163444305|NCT01597193|590328109|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
163444306|NCT01597193|590328110|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
163444307|NCT01597193|590328111|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
163444308|NCT01597193|590328105|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
163444309|NCT01597193|590328106|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
163444310|NCT01597193|590328107|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
163444311|NCT01597193|590328108|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
163444312|NCT01597193|590328109|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
163444313|NCT01597193|590328110|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
163444314|NCT01597193|590328111|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
163444315|NCT03184701|590328113|FG000|Overall Study|Death|3|||
163444316|NCT03184701|590328113|FG000|Overall Study|Physician Decision|3|||
163444317|NCT03184701|590328113|FG000|Overall Study|Withdrawal by Subject|6|||
163444318|NCT03184701|590328113|FG000|Overall Study|Lost to Follow-up|5|||
163444319|NCT00590681|590328116|FG000|Overall Study|Withdrawal by Subject|7|||
163444320|NCT00590681|590328116|FG000|Overall Study|Adverse Event|8|||
163444321|NCT00590681|590328116|FG000|Overall Study|Death|3|||
163444322|NCT00590681|590328116|FG000|Overall Study|Lost to Follow-up|1|||
163444323|NCT00590681|590328116|FG000|Overall Study|disease progression|1|||
163444324|NCT01259297|590328117|FG000|Double Blind Randomized Period|Death|1|||
163444325|NCT01259297|590328118|FG001|Double Blind Randomized Period|Death|1|||
163444326|NCT01259297|590328119|FG002|Double Blind Randomized Period|Death|1|||
163444327|NCT01259297|590328120|FG003|Double Blind Randomized Period|Death|2|||
163444328|NCT01259297|590328121|FG004|Double Blind Randomized Period|Death|1|||
163444329|NCT01259297|590328122|FG005|Double Blind Randomized Period|Death|5|||
163444330|NCT01259297|590328123|FG006|Double Blind Randomized Period|Death|2|||
163444331|NCT01259297|590328124|FG007|Double Blind Randomized Period|Death|1|||
163444332|NCT01259297|590328117|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
163444333|NCT01259297|590328118|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
163444334|NCT01259297|590328119|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
163444335|NCT01259297|590328120|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
163444336|NCT01259297|590328121|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
163444337|NCT01259297|590328122|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
163444338|NCT01259297|590328123|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
163444339|NCT01259297|590328124|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
163444340|NCT01259297|590328117|FG000|Double Blind Randomized Period|Other reasons|0|||
163444341|NCT01259297|590328118|FG001|Double Blind Randomized Period|Other reasons|1|||
163444342|NCT01259297|590328119|FG002|Double Blind Randomized Period|Other reasons|0|||
163444343|NCT01259297|590328120|FG003|Double Blind Randomized Period|Other reasons|0|||
163444344|NCT01259297|590328121|FG004|Double Blind Randomized Period|Other reasons|1|||
163444345|NCT01259297|590328122|FG005|Double Blind Randomized Period|Other reasons|2|||
163444346|NCT01259297|590328123|FG006|Double Blind Randomized Period|Other reasons|3|||
163444347|NCT01259297|590328124|FG007|Double Blind Randomized Period|Other reasons|1|||
163444348|NCT00933335|590328125|FG000|Overall Study|Lost to Follow-up|1|||
163444349|NCT00933335|590328126|FG001|Overall Study|Lost to Follow-up|3|||
163444350|NCT00933335|590328125|FG000|Overall Study|Withdrawal by Subject|0|||
163444351|NCT00933335|590328126|FG001|Overall Study|Withdrawal by Subject|1|||
163444352|NCT00933335|590328125|FG000|Overall Study|Progressive Disease|0|||
163444353|NCT00933335|590328126|FG001|Overall Study|Progressive Disease|11|||
163444354|NCT00933335|590328125|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
163444355|NCT00933335|590328126|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
163444356|NCT00933335|590328125|FG000|Overall Study|Co-morbid Illness|1|||
163444357|NCT00933335|590328126|FG001|Overall Study|Co-morbid Illness|0|||
163444358|NCT02229864|590328127|FG000|Overall Study|Death|2|||
163444359|NCT02229864|590328127|FG000|Overall Study|Lost to Follow-up|1|||
163444360|NCT02650284|590328130|FG000|Overall Study|Lost to Follow-up|3|||
163444361|NCT02650284|590328131|FG001|Overall Study|Lost to Follow-up|3|||
163444362|NCT02650284|590328130|FG000|Overall Study|Consent incorrectly taken|0|||
163444363|NCT02650284|590328131|FG001|Overall Study|Consent incorrectly taken|1|||
163444364|NCT00374907|590328136|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
163444365|NCT00374907|590328137|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
163444366|NCT00374907|590328136|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
163444367|NCT00374907|590328137|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
163444368|NCT00374907|590328136|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
163444369|NCT00374907|590328137|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
163444370|NCT00374907|590328136|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
163444371|NCT00374907|590328137|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
163444372|NCT00374907|590328136|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
163444373|NCT00374907|590328137|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
163444374|NCT04598165|590328142|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
163444375|NCT04598165|590328143|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
163444376|NCT04598165|590328142|FG000|Completed 6-week Follow-up|Death|2|||
163444377|NCT04598165|590328143|FG001|Completed 6-week Follow-up|Death|1|||
163444378|NCT04598165|590328142|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
163444379|NCT04598165|590328143|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
163444380|NCT04598165|590328142|FG000|Completed 6-week Follow-up|Ineligible|4|||
163444381|NCT04598165|590328143|FG001|Completed 6-week Follow-up|Ineligible|3|||
163444382|NCT04598165|590328142|FG000|Completed 6-week Follow-up|Partner refusal|0|||
163444383|NCT04598165|590328143|FG001|Completed 6-week Follow-up|Partner refusal|1|||
163444384|NCT04598165|590328142|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
163444385|NCT04598165|590328143|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
163444386|NCT00426751|590328144|FG000|Overall Study|Adverse Event|8|||
163444387|NCT00426751|590328145|FG001|Overall Study|Adverse Event|1|||
163444388|NCT00426751|590328144|FG000|Overall Study|Lost to Follow-up|7|||
163444389|NCT00426751|590328145|FG001|Overall Study|Lost to Follow-up|6|||
163444390|NCT00426751|590328144|FG000|Overall Study|Consent Withdrawn|0|||
163444391|NCT00426751|590328145|FG001|Overall Study|Consent Withdrawn|1|||
163444392|NCT00426751|590328144|FG000|Overall Study|Other Reasons|7|||
163444393|NCT00426751|590328145|FG001|Overall Study|Other Reasons|12|||
163444394|NCT01721408|590328146|FG000|Overall Study|Adverse Event|6|||
163444395|NCT01721408|590328147|FG001|Overall Study|Adverse Event|1|||
163444396|NCT01721408|590328146|FG000|Overall Study|Death|1|||
163444397|NCT01721408|590328147|FG001|Overall Study|Death|0|||
163444398|NCT01721408|590328146|FG000|Overall Study|Insufficient clinical response|15|||
163444399|NCT01721408|590328147|FG001|Overall Study|Insufficient clinical response|6|||
163444400|NCT01721408|590328146|FG000|Overall Study|No longer willing to participate study|9|||
163444401|NCT01721408|590328147|FG001|Overall Study|No longer willing to participate study|10|||
163444402|NCT01721408|590328146|FG000|Overall Study|Protocol Violation|0|||
163444403|NCT01721408|590328147|FG001|Overall Study|Protocol Violation|2|||
163444404|NCT01721408|590328146|FG000|Overall Study|Other|3|||
163444405|NCT01721408|590328147|FG001|Overall Study|Other|3|||
163444406|NCT01721408|590328146|FG000|Overall Study|Lost to Follow-up|1|||
163444407|NCT01721408|590328147|FG001|Overall Study|Lost to Follow-up|2|||
163444408|NCT01721408|590328146|FG000|Overall Study|Does not meet entrance criteria|1|||
163444409|NCT01721408|590328147|FG001|Overall Study|Does not meet entrance criteria|0|||
163444410|NCT04160468|590328148|FG000|Overall Study|Lost to Follow-up|19|||
163444411|NCT04160468|590328149|FG001|Overall Study|Lost to Follow-up|4|||
163444412|NCT04160468|590328148|FG000|Overall Study|Randomized but not dosed|6|||
163444413|NCT04160468|590328149|FG001|Overall Study|Randomized but not dosed|0|||
163444414|NCT04160468|590328148|FG000|Overall Study|Withdrawal by Subject|4|||
163444415|NCT04160468|590328149|FG001|Overall Study|Withdrawal by Subject|1|||
163444416|NCT04160468|590328148|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
163444417|NCT04160468|590328149|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
163444418|NCT04160468|590328148|FG000|Overall Study|Participant incarcerated|1|||
163444419|NCT04160468|590328149|FG001|Overall Study|Participant incarcerated|0|||
163444420|NCT03987620|590328150|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
163444421|NCT03987620|590328151|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
163444422|NCT03987620|590328150|FG000|Overall Study|Adverse Event|3|||
163444423|NCT03987620|590328151|FG001|Overall Study|Adverse Event|0|||
163444424|NCT03987620|590328150|FG000|Overall Study|Lost to Follow-up|1|||
163444425|NCT03987620|590328151|FG001|Overall Study|Lost to Follow-up|2|||
163444426|NCT03987620|590328150|FG000|Overall Study|Physician Decision|0|||
163444427|NCT03987620|590328151|FG001|Overall Study|Physician Decision|1|||
163444428|NCT03987620|590328150|FG000|Overall Study|Pregnancy|1|||
163444429|NCT03987620|590328151|FG001|Overall Study|Pregnancy|0|||
163444430|NCT03987620|590328150|FG000|Overall Study|Withdrawal by Subject|7|||
163444431|NCT03987620|590328151|FG001|Overall Study|Withdrawal by Subject|1|||
163444432|NCT03987620|590328150|FG000|Overall Study|Other|2|||
163444433|NCT03987620|590328151|FG001|Overall Study|Other|5|||
163444434|NCT01770353|590328152|FG000|Overall Study|Progressive disease|2|||
163444435|NCT01770353|590328153|FG001|Overall Study|Progressive disease|1|||
163444436|NCT01770353|590328152|FG000|Overall Study|Adverse Event|0|||
163444437|NCT01770353|590328153|FG001|Overall Study|Adverse Event|1|||
163444438|NCT01770353|590328152|FG000|Overall Study|Protocol Violation|1|||
163444439|NCT01770353|590328153|FG001|Overall Study|Protocol Violation|0|||
163444440|NCT01770353|590328152|FG000|Overall Study|Physician Decision|0|||
163444441|NCT01770353|590328153|FG001|Overall Study|Physician Decision|3|||
163444442|NCT01770353|590328152|FG000|Overall Study|Clinical deterioration|3|||
163444443|NCT01770353|590328153|FG001|Overall Study|Clinical deterioration|6|||
163444444|NCT01770353|590328152|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
163444445|NCT01770353|590328153|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
163444446|NCT05128162|590328154|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
163444447|NCT05128162|590328154|FG000|Overall Study|Physician Decision|1|||
163444448|NCT00370149|590328155|FG000|Overall Study|Physician Decision|16|||
163444449|NCT00370149|590328156|FG001|Overall Study|Physician Decision|16|||
163444450|NCT00370149|590328155|FG000|Overall Study|Protocol Violation|1|||
163444451|NCT00370149|590328156|FG001|Overall Study|Protocol Violation|0|||
163444452|NCT00370149|590328155|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
163444453|NCT00370149|590328156|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
163444454|NCT00370149|590328155|FG000|Overall Study|Pre-existing infection|0|||
163444455|NCT00370149|590328156|FG001|Overall Study|Pre-existing infection|1|||
163444456|NCT00370149|590328155|FG000|Overall Study|Antibiotic coated dressing placed|0|||
162925389|NCT04854707|588428956|FG001|Overall Study|Lack of Efficacy|59|||
162925390|NCT04854707|588428957|FG002|Overall Study|Lack of Efficacy|30|||
163444457|NCT00370149|590328156|FG001|Overall Study|Antibiotic coated dressing placed|1|||
163444458|NCT04920084|590329487|FG000|Overall Study|Adverse Event|1|||
163444459|NCT04920084|590329487|FG000|Overall Study|Lost to Follow-up|2|||
163444460|NCT04920084|590329487|FG000|Overall Study|Withdrawal by Subject|2|||
163444461|NCT01096446|590329488|FG000|Overall Study|Death|1|||
163444462|NCT01096446|590329489|FG001|Overall Study|Death|0|||
163444463|NCT01096446|590329488|FG000|Overall Study|Protocol Violation|2|||
163444464|NCT01096446|590329489|FG001|Overall Study|Protocol Violation|0|||
163444465|NCT02279524|590329491|FG000|Overall Study|Withdrawal by Subject|3|||
163444466|NCT02279524|590329492|FG001|Overall Study|Withdrawal by Subject|6|||
163444467|NCT02279524|590329493|FG002|Overall Study|Withdrawal by Subject|3|||
163444468|NCT02279524|590329491|FG000|Overall Study|Adverse Event|4|||
163444469|NCT02279524|590329492|FG001|Overall Study|Adverse Event|3|||
163444470|NCT02279524|590329493|FG002|Overall Study|Adverse Event|2|||
163444471|NCT02279524|590329491|FG000|Overall Study|Lost to Follow-up|1|||
163444472|NCT02279524|590329492|FG001|Overall Study|Lost to Follow-up|1|||
163444473|NCT02279524|590329493|FG002|Overall Study|Lost to Follow-up|0|||
163444474|NCT02279524|590329491|FG000|Overall Study|Disallowed medication|1|||
163444475|NCT02279524|590329492|FG001|Overall Study|Disallowed medication|1|||
163444476|NCT02279524|590329493|FG002|Overall Study|Disallowed medication|2|||
163444477|NCT02279524|590329491|FG000|Overall Study|Bariatric surgery|1|||
163444478|NCT02279524|590329492|FG001|Overall Study|Bariatric surgery|0|||
163444479|NCT02279524|590329493|FG002|Overall Study|Bariatric surgery|0|||
163444480|NCT01043185|590329494|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
163444481|NCT01043185|590329495|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
163444482|NCT01043185|590329496|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
163444483|NCT01043185|590329497|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
163444484|NCT01043185|590329498|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
163444485|NCT01043185|590329499|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
163444486|NCT01043185|590329500|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
163444487|NCT01043185|590329501|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
163444488|NCT01043185|590329502|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
163444489|NCT01043185|590329503|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
163444490|NCT00392171|590329508|FG000|Overall Study|Did not meet inclusion criteria|4|||
163444491|NCT00392171|590329508|FG000|Overall Study|Disease progression|101|||
163444492|NCT03488472|590329509|FG000|Overall Study|disease progression additional mets|1|||
163444493|NCT00028002|590329510|FG000|Overall Study|Withdrawal by Subject|3|||
163444494|NCT00028002|590329510|FG000|Overall Study|Ineligible|8|||
163444495|NCT00414310|590329516|FG000|Overall Study|Not treated|1|||
163444496|NCT00414310|590329517|FG001|Overall Study|Not treated|0|||
163444497|NCT01441440|590329521|FG000|Overall Study|Death|1|||
163444498|NCT01441440|590329522|FG001|Overall Study|Death|0|||
163444499|NCT01441440|590329523|FG002|Overall Study|Death|1|||
163444500|NCT01441440|590329521|FG000|Overall Study|Adverse Event|2|||
163444501|NCT01441440|590329522|FG001|Overall Study|Adverse Event|9|||
163444502|NCT01441440|590329523|FG002|Overall Study|Adverse Event|9|||
163444503|NCT01441440|590329521|FG000|Overall Study|Lost to Follow-up|0|||
163444504|NCT01441440|590329522|FG001|Overall Study|Lost to Follow-up|2|||
163444505|NCT01441440|590329523|FG002|Overall Study|Lost to Follow-up|1|||
163444506|NCT01441440|590329521|FG000|Overall Study|Withdrawal by Subject|11|||
163444507|NCT01441440|590329522|FG001|Overall Study|Withdrawal by Subject|9|||
163444508|NCT01441440|590329523|FG002|Overall Study|Withdrawal by Subject|9|||
163444509|NCT01441440|590329521|FG000|Overall Study|Pregnancy|1|||
163444510|NCT01441440|590329522|FG001|Overall Study|Pregnancy|0|||
163444511|NCT01441440|590329523|FG002|Overall Study|Pregnancy|0|||
163444512|NCT01441440|590329521|FG000|Overall Study|Lack of Efficacy|1|||
163444513|NCT01441440|590329522|FG001|Overall Study|Lack of Efficacy|0|||
163444514|NCT01441440|590329523|FG002|Overall Study|Lack of Efficacy|1|||
163444515|NCT01441440|590329521|FG000|Overall Study|Moving|0|||
163444516|NCT01441440|590329522|FG001|Overall Study|Moving|1|||
163444517|NCT01441440|590329523|FG002|Overall Study|Moving|1|||
163444518|NCT01441440|590329521|FG000|Overall Study|Work-related matter|0|||
163444519|NCT01441440|590329522|FG001|Overall Study|Work-related matter|1|||
163444520|NCT01441440|590329523|FG002|Overall Study|Work-related matter|0|||
163444521|NCT01441440|590329521|FG000|Overall Study|Difficllty in keeping the schedule|1|||
163444522|NCT01441440|590329522|FG001|Overall Study|Difficllty in keeping the schedule|1|||
163444523|NCT01441440|590329523|FG002|Overall Study|Difficllty in keeping the schedule|0|||
163444524|NCT01993329|590329524|FG000|Period 2|Adverse Event|0|||
163444525|NCT01993329|590329525|FG001|Period 2|Adverse Event|0|||
163444526|NCT01993329|590329526|FG002|Period 2|Adverse Event|0|||
163444527|NCT01993329|590329527|FG003|Period 2|Adverse Event|0|||
163444528|NCT01993329|590329528|FG004|Period 2|Adverse Event|0|||
163444529|NCT01993329|590329529|FG005|Period 2|Adverse Event|1|||
163444530|NCT01993329|590329524|FG000|Wash-out|Personal reasons|0|||
163444531|NCT01993329|590329525|FG001|Wash-out|Personal reasons|1|||
163444532|NCT01993329|590329526|FG002|Wash-out|Personal reasons|0|||
163444533|NCT01993329|590329527|FG003|Wash-out|Personal reasons|0|||
163444534|NCT01993329|590329528|FG004|Wash-out|Personal reasons|0|||
163444535|NCT01993329|590329529|FG005|Wash-out|Personal reasons|0|||
163444536|NCT03539458|590329530|FG000|Overall Study|Death|1|||
163444537|NCT02750800|590329533|FG000|Overall Study|Adverse Event|18|||
163444538|NCT02750800|590329533|FG000|Overall Study|Lost to Follow-up|12|||
163444539|NCT02750800|590329533|FG000|Overall Study|Investigator decision|53|||
163444540|NCT02750800|590329533|FG000|Overall Study|Patient request|12|||
163444541|NCT02750800|590329533|FG000|Overall Study|Other, not specified|3|||
163444542|NCT00972478|590329534|FG000|Overall Study|Adverse Event|3|||
163444543|NCT00972478|590329535|FG001|Overall Study|Adverse Event|16|||
163444544|NCT00972478|590329534|FG000|Overall Study|Withdrawal by Subject|1|||
163444545|NCT00972478|590329535|FG001|Overall Study|Withdrawal by Subject|8|||
163444546|NCT00972478|590329534|FG000|Overall Study|Progression/Relapse|0|||
163444547|NCT00972478|590329535|FG001|Overall Study|Progression/Relapse|2|||
163444548|NCT00972478|590329534|FG000|Overall Study|Death|0|||
163444549|NCT00972478|590329535|FG001|Overall Study|Death|2|||
163444550|NCT00972478|590329534|FG000|Overall Study|Not protocol specified|1|||
163444551|NCT00972478|590329535|FG001|Overall Study|Not protocol specified|1|||
163444552|NCT00972478|590329534|FG000|Overall Study|Ineligible|1|||
163444553|NCT00972478|590329535|FG001|Overall Study|Ineligible|7|||
163444554|NCT00972478|590329534|FG000|Overall Study|Not start protocol treatment|1|||
163444555|NCT00972478|590329535|FG001|Overall Study|Not start protocol treatment|2|||
163444556|NCT04742907|590329542|FG000|Overall Study|Adverse Event|1|||
163444557|NCT04742907|590329543|FG001|Overall Study|Adverse Event|0|||
163444558|NCT04742907|590329544|FG002|Overall Study|Adverse Event|1|||
163444559|NCT04742907|590329542|FG000|Overall Study|Lost to Follow-up|3|||
163444560|NCT04742907|590329543|FG001|Overall Study|Lost to Follow-up|3|||
163444561|NCT04742907|590329544|FG002|Overall Study|Lost to Follow-up|2|||
163444562|NCT04742907|590329542|FG000|Overall Study|Physician Decision|0|||
163444563|NCT04742907|590329543|FG001|Overall Study|Physician Decision|1|||
163444564|NCT04742907|590329544|FG002|Overall Study|Physician Decision|0|||
163444565|NCT04742907|590329542|FG000|Overall Study|Protocol Violation|1|||
163444566|NCT04742907|590329543|FG001|Overall Study|Protocol Violation|1|||
163444567|NCT04742907|590329544|FG002|Overall Study|Protocol Violation|1|||
163444568|NCT04742907|590329542|FG000|Overall Study|Withdrawal by Subject|5|||
163444569|NCT04742907|590329543|FG001|Overall Study|Withdrawal by Subject|6|||
163444570|NCT04742907|590329544|FG002|Overall Study|Withdrawal by Subject|4|||
163444571|NCT04742907|590329542|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
163444572|NCT04742907|590329543|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
163444573|NCT04742907|590329544|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
163444574|NCT04742907|590329542|FG000|Overall Study|Did Not Receive the Study Drug|2|||
163444575|NCT04742907|590329543|FG001|Overall Study|Did Not Receive the Study Drug|4|||
163444576|NCT04742907|590329544|FG002|Overall Study|Did Not Receive the Study Drug|4|||
163444577|NCT01428063|590329545|FG000|Overall Study|Lack of Efficacy|8|||
163444578|NCT01428063|590329546|FG001|Overall Study|Lack of Efficacy|4|||
163444579|NCT01428063|590329547|FG002|Overall Study|Lack of Efficacy|1|||
163444580|NCT01428063|590329545|FG000|Overall Study|Adverse Event|2|||
163444581|NCT01428063|590329546|FG001|Overall Study|Adverse Event|3|||
163444582|NCT01428063|590329547|FG002|Overall Study|Adverse Event|0|||
163444583|NCT01428063|590329545|FG000|Overall Study|Lost to Follow-up|0|||
163444584|NCT01428063|590329546|FG001|Overall Study|Lost to Follow-up|2|||
163444585|NCT01428063|590329547|FG002|Overall Study|Lost to Follow-up|0|||
163444586|NCT01428063|590329545|FG000|Overall Study|No longer meets study criteria|0|||
163444587|NCT01428063|590329546|FG001|Overall Study|No longer meets study criteria|1|||
163444588|NCT01428063|590329547|FG002|Overall Study|No longer meets study criteria|0|||
163444589|NCT01259856|590329548|FG000|Overall Study|Adverse Event|12|||
163444590|NCT01259856|590329549|FG001|Overall Study|Adverse Event|9|||
163444591|NCT01259856|590329548|FG000|Overall Study|Death|0|||
163444592|NCT01259856|590329549|FG001|Overall Study|Death|1|||
163444593|NCT01259856|590329548|FG000|Overall Study|Lack of Efficacy|3|||
163444594|NCT01259856|590329549|FG001|Overall Study|Lack of Efficacy|1|||
163444595|NCT01259856|590329548|FG000|Overall Study|Lost to Follow-up|1|||
163444596|NCT01259856|590329549|FG001|Overall Study|Lost to Follow-up|1|||
163444597|NCT01259856|590329548|FG000|Overall Study|Physician Decision|2|||
163444598|NCT01259856|590329549|FG001|Overall Study|Physician Decision|1|||
163444599|NCT01259856|590329548|FG000|Overall Study|Withdrawal by Subject|9|||
163444600|NCT01259856|590329549|FG001|Overall Study|Withdrawal by Subject|10|||
163444601|NCT01259856|590329548|FG000|Overall Study|Treatment never started|0|||
163444602|NCT01259856|590329549|FG001|Overall Study|Treatment never started|6|||
163444603|NCT01259856|590329548|FG000|Overall Study|Study closure by sponsor|40|||
163444604|NCT01259856|590329549|FG001|Overall Study|Study closure by sponsor|41|||
163444605|NCT01259856|590329548|FG000|Overall Study|Patient developed other disease|0|||
163444606|NCT01259856|590329549|FG001|Overall Study|Patient developed other disease|1|||
163444607|NCT01259856|590329548|FG000|Overall Study|Transfer to another study|0|||
163444608|NCT01259856|590329549|FG001|Overall Study|Transfer to another study|1|||
163444609|NCT01259856|590329548|FG000|Overall Study|Unknown/missing|2|||
163444610|NCT01259856|590329549|FG001|Overall Study|Unknown/missing|2|||
163444611|NCT00788775|590329550|FG000|Overall Study|Progressive Disease|8|||
163444612|NCT00788775|590329551|FG001|Overall Study|Progressive Disease|6|||
163444613|NCT00788775|590329550|FG000|Overall Study|Withdrawal by Subject|0|||
163444614|NCT00788775|590329551|FG001|Overall Study|Withdrawal by Subject|2|||
163444615|NCT00788775|590329550|FG000|Overall Study|Patient Non-Compliance|1|||
163444616|NCT00788775|590329551|FG001|Overall Study|Patient Non-Compliance|0|||
163444617|NCT00788775|590329550|FG000|Overall Study|Patient's measurable disease resected.|1|||
163444618|NCT00788775|590329551|FG001|Overall Study|Patient's measurable disease resected.|0|||
163444619|NCT04488822|590329554|FG000|Overall Study|Adverse Event|8|||
163444620|NCT04488822|590329554|FG000|Overall Study|Withdrawal by Subject|1|||
163444621|NCT03838367|590329555|FG000|Overall Study|Early termination of study|3|||
163444622|NCT03838367|590329556|FG001|Overall Study|Early termination of study|4|||
163444623|NCT03838367|590329557|FG002|Overall Study|Early termination of study|3|||
163444624|NCT03838367|590329558|FG003|Overall Study|Early termination of study|0|||
163444625|NCT03406104|590329559|FG000|Overall Study|Lost to Follow-up|2|||
163444626|NCT03406104|590329559|FG000|Overall Study|Withdrawal by Subject|2|||
163444627|NCT03406104|590329559|FG000|Overall Study|due to Covid patient did not want to travel|1|||
163444628|NCT03406104|590329559|FG000|Overall Study|Death|2|||
163444629|NCT00772967|590329568|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
163444630|NCT00772967|590329569|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
163444631|NCT00772967|590329570|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
163444632|NCT00772967|590329571|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
163444633|NCT00772967|590329572|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
163444634|NCT00772967|590329573|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
163444635|NCT00772967|590329568|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
163444636|NCT00772967|590329569|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
163444637|NCT00772967|590329570|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
163444638|NCT00772967|590329571|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
163444639|NCT00772967|590329572|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
163444640|NCT00772967|590329573|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
163444641|NCT00772967|590329568|FG000|Crossover Treatment 3|Adverse Event|0|||
163444642|NCT00772967|590329569|FG001|Crossover Treatment 3|Adverse Event|0|||
163444643|NCT00772967|590329570|FG002|Crossover Treatment 3|Adverse Event|0|||
163444644|NCT00772967|590329571|FG003|Crossover Treatment 3|Adverse Event|0|||
163444645|NCT00772967|590329572|FG004|Crossover Treatment 3|Adverse Event|1|||
163444646|NCT00772967|590329573|FG005|Crossover Treatment 3|Adverse Event|0|||
163444647|NCT00231062|590329576|FG000|Overall Study|Physician Decision|6|||
163444648|NCT00803244|590329577|FG000|Overall Study|Adverse Event|1|||
163444649|NCT00803244|590329578|FG001|Overall Study|Adverse Event|2|||
163444650|NCT00803244|590329577|FG000|Overall Study|Withdrawal by Subject|2|||
163444651|NCT00803244|590329578|FG001|Overall Study|Withdrawal by Subject|3|||
163444652|NCT00803244|590329577|FG000|Overall Study|Any other reason not above-mentioned|4|||
163444653|NCT00803244|590329578|FG001|Overall Study|Any other reason not above-mentioned|10|||
163444654|NCT03321929|590329579|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
163444655|NCT00443430|590329582|FG000|Overall Study|Lack of Efficacy|3|||
163444656|NCT00443430|590329583|FG001|Overall Study|Lack of Efficacy|3|||
163444657|NCT00443430|590329582|FG000|Overall Study|Adverse Event|1|||
163444658|NCT00443430|590329583|FG001|Overall Study|Adverse Event|1|||
163444659|NCT00053846|590329584|FG000|Overall Study|Changed mind|8|||
163444660|NCT00053846|590329585|FG001|Overall Study|Changed mind|13|||
163444661|NCT00053846|590329584|FG000|Overall Study|Became too ill|8|||
163444662|NCT00053846|590329585|FG001|Overall Study|Became too ill|7|||
163444663|NCT00053846|590329584|FG000|Overall Study|Expired|5|||
163444664|NCT00053846|590329585|FG001|Overall Study|Expired|0|||
163444665|NCT00053846|590329584|FG000|Overall Study|Became ineligible|3|||
163444666|NCT00053846|590329585|FG001|Overall Study|Became ineligible|1|||
163444667|NCT00053846|590329584|FG000|Overall Study|Did not return data|1|||
163444668|NCT00053846|590329585|FG001|Overall Study|Did not return data|2|||
163444669|NCT00053846|590329584|FG000|Overall Study|Quit due to side effects|1|||
163444670|NCT00053846|590329585|FG001|Overall Study|Quit due to side effects|3|||
163444671|NCT00053846|590329584|FG000|Overall Study|Pills too large|0|||
163444672|NCT00053846|590329585|FG001|Overall Study|Pills too large|1|||
163444673|NCT03880227|590329586|FG000|First Visit|Withdrawal by Subject|1|||
163444674|NCT03880227|590329587|FG001|First Visit|Withdrawal by Subject|0|||
163444675|NCT03880227|590329588|FG002|First Visit|Withdrawal by Subject|0|||
163444676|NCT03880227|590329589|FG003|First Visit|Withdrawal by Subject|0|||
163444677|NCT03880227|590329586|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
163444678|NCT03880227|590329587|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
163444679|NCT03880227|590329588|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
163444680|NCT03880227|590329589|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
163444681|NCT03880227|590329586|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
163444682|NCT03880227|590329587|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
163444683|NCT03880227|590329588|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
163444684|NCT03880227|590329589|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
163444685|NCT03880227|590329586|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
163444686|NCT03880227|590329587|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
163444687|NCT03880227|590329588|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
163444688|NCT03880227|590329589|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
163444689|NCT02815397|590329590|FG000|Overall Study|Physician Decision|2|||
163444690|NCT00085540|590329593|FG000|Overall Study|Withdrawal by Subject|0|||
163444691|NCT00085540|590329594|FG001|Overall Study|Withdrawal by Subject|1|||
163444692|NCT00085540|590329593|FG000|Overall Study|Protocol Violation|0|||
163444693|NCT00085540|590329594|FG001|Overall Study|Protocol Violation|1|||
163444694|NCT01605396|590329595|FG000|Overall Study|Adverse Event|5|||
163444695|NCT01605396|590329596|FG001|Overall Study|Adverse Event|3|||
163444696|NCT01605396|590329595|FG000|Overall Study|Lost to Follow-up|1|||
163444697|NCT01605396|590329596|FG001|Overall Study|Lost to Follow-up|0|||
163444698|NCT01605396|590329595|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163444699|NCT01605396|590329596|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163444700|NCT01605396|590329595|FG000|Overall Study|Physician Decision|2|||
163444701|NCT01605396|590329596|FG001|Overall Study|Physician Decision|2|||
163444702|NCT01605396|590329595|FG000|Overall Study|Progressive Disease|23|||
163444703|NCT01605396|590329596|FG001|Overall Study|Progressive Disease|27|||
163444704|NCT01605396|590329595|FG000|Overall Study|Withdrawal by Subject|4|||
163444705|NCT01605396|590329596|FG001|Overall Study|Withdrawal by Subject|2|||
163444706|NCT01605396|590329595|FG000|Overall Study|Transfer Off Study|4|||
163444707|NCT01605396|590329596|FG001|Overall Study|Transfer Off Study|5|||
163444708|NCT00878072|590329597|FG000|Overall Study|Withdrew consent|2|||
163444709|NCT01200511|590329612|FG000|Overall Study|Lost to Follow-up|3|||
163444710|NCT01200511|590329612|FG000|Overall Study|Withdrawal by Subject|1|||
163444711|NCT01200511|590329612|FG000|Overall Study|Adverse Event|1|||
163444712|NCT03288779|590329613|FG000|Overall Study|Withdrawal by Subject|3|||
163444713|NCT03382899|590329614|FG000|Overall Study|Ineligibility Determined|0|||
163444714|NCT03382899|590329615|FG001|Overall Study|Ineligibility Determined|1|||
163444715|NCT03382899|590329614|FG000|Overall Study|Lost to Follow-up|0|||
163444716|NCT03382899|590329615|FG001|Overall Study|Lost to Follow-up|1|||
163444717|NCT03382899|590329614|FG000|Overall Study|Sponsor's decision|31|||
163444718|NCT03382899|590329615|FG001|Overall Study|Sponsor's decision|28|||
163444719|NCT03382899|590329614|FG000|Overall Study|Withdrawal by Subject|0|||
163444720|NCT03382899|590329615|FG001|Overall Study|Withdrawal by Subject|5|||
163444721|NCT02504892|590329617|FG000|Overall Study|Adverse event-pneumonitis|2|||
163444722|NCT00524745|590329618|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
163444723|NCT00524745|590329619|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
163444724|NCT00524745|590329620|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
163444725|NCT00524745|590329621|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
163444726|NCT01413178|590329622|FG000|Overall Study|Toxicity|1|||
163444727|NCT01413178|590329623|FG001|Overall Study|Toxicity|0|||
163444728|NCT01413178|590329622|FG000|Overall Study|Ineligible|0|||
163444729|NCT01413178|590329623|FG001|Overall Study|Ineligible|2|||
163444730|NCT00576693|590329624|FG000|Overall Study|Lost to Follow-up|7|||
163444731|NCT00576693|590329625|FG001|Overall Study|Lost to Follow-up|11|||
163444732|NCT00576693|590329624|FG000|Overall Study|Withdrawal by Subject|3|||
163444733|NCT00576693|590329625|FG001|Overall Study|Withdrawal by Subject|13|||
163444734|NCT00540449|590329626|FG000|Overall Study|Adverse Event|12|||
163444735|NCT00540449|590329627|FG001|Overall Study|Adverse Event|32|||
163444736|NCT00540449|590329626|FG000|Overall Study|Sponsor's Decision|1|||
163444737|NCT00540449|590329627|FG001|Overall Study|Sponsor's Decision|1|||
163444738|NCT00540449|590329626|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
163444739|NCT00540449|590329627|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
163444740|NCT00540449|590329626|FG000|Overall Study|Lost to Follow-up|19|||
163444741|NCT00540449|590329627|FG001|Overall Study|Lost to Follow-up|17|||
163444742|NCT00540449|590329626|FG000|Overall Study|Subject Non-Compliant|7|||
163444743|NCT00540449|590329627|FG001|Overall Study|Subject Non-Compliant|5|||
163444744|NCT00540449|590329626|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
163444745|NCT00540449|590329627|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
163444746|NCT00540449|590329626|FG000|Overall Study|Withdrawal by Subject|10|||
163444747|NCT00540449|590329627|FG001|Overall Study|Withdrawal by Subject|10|||
163444748|NCT00540449|590329626|FG000|Overall Study|Other|1|||
163444749|NCT00540449|590329627|FG001|Overall Study|Other|4|||
163444750|NCT00705224|590329628|FG000|Overall Study|Adverse Event|1|||
163444751|NCT00705224|590329628|FG000|Overall Study|Lack of Efficacy|2|||
163444752|NCT00705224|590329628|FG000|Overall Study|Withdrawal by Subject|3|||
163444753|NCT00705224|590329628|FG000|Overall Study|Lost to Follow-up|5|||
163444754|NCT03283163|590329629|FG000|Overall Study|Lost to Follow-up|1|||
163444755|NCT03283163|590329629|FG000|Overall Study|other life commitments|6|||
163444756|NCT03283163|590329629|FG000|Overall Study|COVID-19 institution wide halting|1|||
163444757|NCT03283163|590329629|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
163444758|NCT03283163|590329629|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
163444759|NCT00237796|590329630|FG000|Overall Study|Baseline and one other ILSS required|10|||
163444760|NCT00237796|590329631|FG001|Overall Study|Baseline and one other ILSS required|5|||
163444761|NCT04238663|590329632|FG000|Overall Study|Lost to Follow-up|0|||
163444762|NCT04238663|590329633|FG001|Overall Study|Lost to Follow-up|1|||
163444763|NCT04238663|590329634|FG002|Overall Study|Lost to Follow-up|0|||
163444764|NCT02566525|590329635|FG000|Overall Study|Protocol Violation|3|||
163444765|NCT02566525|590329636|FG001|Overall Study|Protocol Violation|5|||
163444766|NCT02149836|590329637|FG000|Overall Study|Withdrawal by Subject|1|||
163444767|NCT04430582|590329639|FG000|Overall Study|Found to meet exclusionary criteria|1|||
163444768|NCT04430582|590329640|FG001|Overall Study|Found to meet exclusionary criteria|0|||
163444769|NCT04430582|590329639|FG000|Overall Study|Withdrawal by Subject|0|||
163444770|NCT04430582|590329640|FG001|Overall Study|Withdrawal by Subject|1|||
163444771|NCT00376688|590329641|FG000|Overall Study|Adverse Event|3|||
163444772|NCT00376688|590329641|FG000|Overall Study|Death|1|||
163444773|NCT02410902|590330800|FG000|Overall Study|Adverse Event|2|||
163444774|NCT02410902|590330801|FG001|Overall Study|Adverse Event|3|||
163444775|NCT02410902|590330800|FG000|Overall Study|Lost to Follow-up|4|||
163444776|NCT02410902|590330801|FG001|Overall Study|Lost to Follow-up|1|||
163444777|NCT02410902|590330800|FG000|Overall Study|Protocol Violation|1|||
163444778|NCT02410902|590330801|FG001|Overall Study|Protocol Violation|4|||
163444779|NCT02410902|590330800|FG000|Overall Study|Withdrawal by Subject|6|||
163444780|NCT02410902|590330801|FG001|Overall Study|Withdrawal by Subject|8|||
163444781|NCT02410902|590330800|FG000|Overall Study|Non-Compliance|8|||
163444782|NCT02410902|590330801|FG001|Overall Study|Non-Compliance|2|||
163444783|NCT00074412|590330802|FG000|Overall Study|Death|30|||
163444784|NCT00074412|590330803|FG001|Overall Study|Death|26|||
163444785|NCT00074412|590330802|FG000|Overall Study|Lost to Follow-up|52|||
163444786|NCT00074412|590330803|FG001|Overall Study|Lost to Follow-up|58|||
163444787|NCT01881620|590330804|FG000|Overall Study|Protocol Violation|4|||
163444788|NCT02561000|590330806|FG000|Overall Study|Withdrawal by Subject|2|||
163444789|NCT02561000|590330807|FG001|Overall Study|Withdrawal by Subject|3|||
163444790|NCT02561000|590330808|FG002|Overall Study|Withdrawal by Subject|0|||
163444791|NCT02561000|590330806|FG000|Overall Study|Adverse Event|0|||
163444792|NCT02561000|590330807|FG001|Overall Study|Adverse Event|1|||
163444793|NCT02561000|590330808|FG002|Overall Study|Adverse Event|0|||
163444794|NCT03430245|590330811|FG000|Overall Study|Withdrawal by Subject|6|||
163444795|NCT03430245|590330811|FG000|Overall Study|Lost to Follow-up|1|||
163444796|NCT03656926|590330812|FG000|Overall Study|Adverse Event|5|||
163444797|NCT03656926|590330813|FG001|Overall Study|Adverse Event|4|||
163444798|NCT03656926|590330812|FG000|Overall Study|Withdrawal by Subject|7|||
163444799|NCT03656926|590330813|FG001|Overall Study|Withdrawal by Subject|2|||
163444800|NCT03656926|590330812|FG000|Overall Study|Screen fail after randomization|1|||
163444801|NCT03656926|590330813|FG001|Overall Study|Screen fail after randomization|0|||
163444802|NCT03656926|590330812|FG000|Overall Study|PI decision due to patient condition|1|||
163444803|NCT03656926|590330813|FG001|Overall Study|PI decision due to patient condition|0|||
163444804|NCT03656926|590330812|FG000|Overall Study|Patient unresponsiveness|1|||
163444805|NCT03656926|590330813|FG001|Overall Study|Patient unresponsiveness|0|||
163444806|NCT00850759|590330818|FG000|Overall Study|Lost to Follow-up|7|||
163444807|NCT00850759|590330819|FG001|Overall Study|Lost to Follow-up|5|||
163444808|NCT00850759|590330820|FG002|Overall Study|Lost to Follow-up|5|||
163444809|NCT00850759|590330821|FG003|Overall Study|Lost to Follow-up|3|||
163444810|NCT03196505|590330822|FG000|Overall Study|Physician Decision|26|||
163444811|NCT03196505|590330823|FG001|Overall Study|Physician Decision|26|||
163444812|NCT02575079|590330825|FG000|Overall Study|Death|3|||
163444813|NCT02575079|590330826|FG001|Overall Study|Death|0|||
163444814|NCT02575079|590330825|FG000|Overall Study|Withdrawal by Subject|3|||
163444815|NCT02575079|590330826|FG001|Overall Study|Withdrawal by Subject|0|||
163444816|NCT02918266|590330827|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
163444817|NCT02918266|590330828|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
163444818|NCT02918266|590330829|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
163444819|NCT02918266|590330830|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
163444820|NCT02918266|590330831|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
163444821|NCT02918266|590330832|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
163444822|NCT02918266|590330833|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
163444823|NCT02918266|590330834|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
163444824|NCT02918266|590330835|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
163444825|NCT02918266|590330836|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
163444826|NCT02918266|590330837|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
163444827|NCT00578864|590330840|FG000|Overall Study|Death|1|||
163444828|NCT00578864|590330841|FG001|Overall Study|Death|0|||
163444829|NCT01293032|590330845|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
163444830|NCT01293032|590330846|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
163444831|NCT01293032|590330847|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
163444832|NCT01293032|590330848|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
163444833|NCT01293032|590330845|FG000|Treatment|Adverse Event|0|||
163444834|NCT01293032|590330846|FG001|Treatment|Adverse Event|0|||
163444835|NCT01293032|590330847|FG002|Treatment|Adverse Event|1|||
163444836|NCT01293032|590330848|FG003|Treatment|Adverse Event|1|||
163444837|NCT01293032|590330845|FG000|Treatment|Withdrawal by Subject|2|||
163444838|NCT01293032|590330846|FG001|Treatment|Withdrawal by Subject|4|||
163444839|NCT01293032|590330847|FG002|Treatment|Withdrawal by Subject|0|||
163444840|NCT01293032|590330848|FG003|Treatment|Withdrawal by Subject|0|||
163444841|NCT01293032|590330845|FG000|Treatment|Disease Progression, relapse|0|||
163444842|NCT01293032|590330846|FG001|Treatment|Disease Progression, relapse|1|||
163444843|NCT01293032|590330847|FG002|Treatment|Disease Progression, relapse|0|||
163444844|NCT01293032|590330848|FG003|Treatment|Disease Progression, relapse|0|||
163444845|NCT01253044|590330849|FG000|Overall Study|Lost to Follow-up|38|||
163444846|NCT01253044|590330850|FG001|Overall Study|Lost to Follow-up|29|||
163444847|NCT01087528|590330853|FG000|Overall Study|Withdrawal by Subject|1|||
163444848|NCT01087528|590330853|FG000|Overall Study|Incomplete CE procedure|6|||
163444849|NCT03116399|590330854|FG000|Overall Study|Death|8|||
163444850|NCT03116399|590330855|FG001|Overall Study|Death|3|||
163444851|NCT03116399|590330854|FG000|Overall Study|Lost to Follow-up|7|||
163444852|NCT03116399|590330855|FG001|Overall Study|Lost to Follow-up|11|||
163444853|NCT03116399|590330854|FG000|Overall Study|Investigator Decision|1|||
163444854|NCT03116399|590330855|FG001|Overall Study|Investigator Decision|1|||
163444855|NCT03116399|590330854|FG000|Overall Study|Withdrawal by Subject|24|||
163444856|NCT03116399|590330855|FG001|Overall Study|Withdrawal by Subject|9|||
163444857|NCT00987623|590330857|FG000|Overall Study|Lost to Follow-up|2|||
163444858|NCT00987623|590330858|FG001|Overall Study|Lost to Follow-up|1|||
163444859|NCT00987623|590330857|FG000|Overall Study|Time/job conflict|2|||
163444860|NCT00987623|590330858|FG001|Overall Study|Time/job conflict|0|||
163444861|NCT00987623|590330857|FG000|Overall Study|Discomfort|1|||
163444862|NCT00987623|590330858|FG001|Overall Study|Discomfort|0|||
163444863|NCT00987623|590330857|FG000|Overall Study|Biomicroscopy|0|||
163444864|NCT00987623|590330858|FG001|Overall Study|Biomicroscopy|1|||
163444865|NCT00987623|590330857|FG000|Overall Study|Influenza|0|||
163444866|NCT00987623|590330858|FG001|Overall Study|Influenza|1|||
163444867|NCT00195260|590330864|FG000|Part 1: Dose Escalation|Adverse Event|0|||
163444868|NCT00195260|590330865|FG001|Part 1: Dose Escalation|Adverse Event|1|||
163444869|NCT00195260|590330866|FG002|Part 1: Dose Escalation|Adverse Event|0|||
163444870|NCT00195260|590330867|FG003|Part 1: Dose Escalation|Adverse Event|1|||
163444871|NCT00195260|590330868|FG004|Part 1: Dose Escalation|Adverse Event|1|||
163444872|NCT00195260|590330869|FG005|Part 1: Dose Escalation|Adverse Event|0|||
163444873|NCT00195260|590330870|FG006|Part 1: Dose Escalation|Adverse Event|3|||
163444874|NCT00195260|590330871|FG007|Part 1: Dose Escalation|Adverse Event|0|||
163444875|NCT00195260|590330872|FG008|Part 1: Dose Escalation|Adverse Event|0|||
163444876|NCT00195260|590330873|FG009|Part 1: Dose Escalation|Adverse Event|0|||
163444877|NCT00195260|590330874|FG010|Part 1: Dose Escalation|Adverse Event|0|||
163444878|NCT00195260|590330864|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163444879|NCT00195260|590330865|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163444880|NCT00195260|590330866|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163444881|NCT00195260|590330867|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163444882|NCT00195260|590330868|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
163444883|NCT00195260|590330869|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163444884|NCT00195260|590330870|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163444885|NCT00195260|590330871|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
163444886|NCT00195260|590330872|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163444887|NCT00195260|590330873|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163444888|NCT00195260|590330874|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163444889|NCT00195260|590330864|FG000|Part 1: Dose Escalation|Death|0|||
163444890|NCT00195260|590330865|FG001|Part 1: Dose Escalation|Death|0|||
163444891|NCT00195260|590330866|FG002|Part 1: Dose Escalation|Death|0|||
163444892|NCT00195260|590330867|FG003|Part 1: Dose Escalation|Death|0|||
163444893|NCT00195260|590330868|FG004|Part 1: Dose Escalation|Death|0|||
163444894|NCT00195260|590330869|FG005|Part 1: Dose Escalation|Death|0|||
163444895|NCT00195260|590330870|FG006|Part 1: Dose Escalation|Death|0|||
163444896|NCT00195260|590330871|FG007|Part 1: Dose Escalation|Death|1|||
163444897|NCT00195260|590330872|FG008|Part 1: Dose Escalation|Death|0|||
163444898|NCT00195260|590330873|FG009|Part 1: Dose Escalation|Death|0|||
163444899|NCT00195260|590330874|FG010|Part 1: Dose Escalation|Death|0|||
163444900|NCT00195260|590330864|FG000|Part 1: Dose Escalation|Disease Progression|3|||
163444901|NCT00195260|590330865|FG001|Part 1: Dose Escalation|Disease Progression|2|||
163444902|NCT00195260|590330866|FG002|Part 1: Dose Escalation|Disease Progression|5|||
163444903|NCT00195260|590330867|FG003|Part 1: Dose Escalation|Disease Progression|6|||
163444904|NCT00195260|590330868|FG004|Part 1: Dose Escalation|Disease Progression|4|||
163444905|NCT00195260|590330869|FG005|Part 1: Dose Escalation|Disease Progression|6|||
163444906|NCT00195260|590330870|FG006|Part 1: Dose Escalation|Disease Progression|7|||
163444907|NCT00195260|590330871|FG007|Part 1: Dose Escalation|Disease Progression|4|||
163444908|NCT00195260|590330872|FG008|Part 1: Dose Escalation|Disease Progression|0|||
163444909|NCT00195260|590330873|FG009|Part 1: Dose Escalation|Disease Progression|0|||
163444910|NCT00195260|590330874|FG010|Part 1: Dose Escalation|Disease Progression|0|||
163444911|NCT00195260|590330864|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
163444912|NCT00195260|590330865|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
163444913|NCT00195260|590330866|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
163444914|NCT00195260|590330867|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
163444915|NCT00195260|590330868|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
163444916|NCT00195260|590330869|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
163444917|NCT00195260|590330870|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
163444918|NCT00195260|590330871|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
163444919|NCT00195260|590330872|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
163444920|NCT00195260|590330873|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
163444921|NCT00195260|590330874|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
163444922|NCT00195260|590330864|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
163444923|NCT00195260|590330865|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
163444924|NCT00195260|590330866|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
163444925|NCT00195260|590330867|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
163444926|NCT00195260|590330868|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
163444927|NCT00195260|590330869|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
163444928|NCT00195260|590330870|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
163444929|NCT00195260|590330871|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
163444930|NCT00195260|590330872|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
163444931|NCT00195260|590330873|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
163444932|NCT00195260|590330874|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
163444933|NCT00195260|590330864|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
163444934|NCT00195260|590330865|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
163444935|NCT00195260|590330866|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
163444936|NCT00195260|590330867|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
163444937|NCT00195260|590330868|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
163444938|NCT00195260|590330869|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
163444939|NCT00195260|590330870|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
163444940|NCT00195260|590330871|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
163444941|NCT00195260|590330872|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
163444942|NCT00195260|590330873|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
163444943|NCT00195260|590330874|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
163444944|NCT00195260|590330864|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
163444945|NCT00195260|590330865|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
163444946|NCT00195260|590330866|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
163444947|NCT00195260|590330867|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
163444948|NCT00195260|590330868|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
163444949|NCT00195260|590330869|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
163444950|NCT00195260|590330870|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
163444951|NCT00195260|590330871|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
163444952|NCT00195260|590330872|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
163444953|NCT00195260|590330873|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
163444954|NCT00195260|590330874|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
163444955|NCT00195260|590330864|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
163444956|NCT00195260|590330865|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
163444957|NCT00195260|590330866|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
163444958|NCT00195260|590330867|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
163444959|NCT00195260|590330868|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
163444960|NCT00195260|590330869|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
163444961|NCT00195260|590330870|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
163444962|NCT00195260|590330871|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
163444963|NCT00195260|590330872|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
163444964|NCT00195260|590330873|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
163444965|NCT00195260|590330874|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
163444966|NCT02749721|590330875|FG000|Screening|Withdrawal by Subject|1|||
163444967|NCT02749721|590330875|FG000|Screening|Lost to Follow-up|2|||
163444968|NCT02749721|590330875|FG000|Screening|Protocol Violation|3|||
163444969|NCT02749721|590330875|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
163444970|NCT02749721|590330875|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
163444971|NCT02691247|590330876|FG000|Overall Study|Withdrawal by Subject|1|||
163444972|NCT02691247|590330877|FG001|Overall Study|Withdrawal by Subject|2|||
163444973|NCT02691247|590330878|FG002|Overall Study|Withdrawal by Subject|2|||
163444974|NCT02691247|590330876|FG000|Overall Study|Lost to Follow-up|2|||
163444975|NCT02691247|590330877|FG001|Overall Study|Lost to Follow-up|0|||
163444976|NCT02691247|590330878|FG002|Overall Study|Lost to Follow-up|1|||
163444977|NCT01519245|590330879|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
163444978|NCT01519245|590330880|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
163444979|NCT02873715|590330881|FG000|Overall Study|Lost to Follow-up|84|||
163444980|NCT02873715|590330882|FG001|Overall Study|Lost to Follow-up|94|||
163444981|NCT02873715|590330881|FG000|Overall Study|Withdrawal by Subject|7|||
163444982|NCT02873715|590330882|FG001|Overall Study|Withdrawal by Subject|26|||
163444983|NCT02144220|590330886|FG000|Overall Study|technology incompatibility|9|||
163444984|NCT02144220|590330886|FG000|Overall Study|Lack of Efficacy|4|||
163444985|NCT02144220|590330886|FG000|Overall Study|Physician Decision|3|||
163444986|NCT02144220|590330886|FG000|Overall Study|Withdrawal by Subject|2|||
163444987|NCT02144220|590330886|FG000|Overall Study|Protocol Violation|1|||
163444988|NCT00592501|590330889|FG000|Overall Study|Withdrawal by Subject|1|||
163444989|NCT00592501|590330889|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
163444990|NCT04590937|590330890|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
163444991|NCT01635933|590330891|FG000|Overall Study|Adverse Event|1|||
163444992|NCT01635933|590330892|FG001|Overall Study|Adverse Event|0|||
163444993|NCT01635933|590330891|FG000|Overall Study|Lost to Follow-up|0|||
163444994|NCT01635933|590330892|FG001|Overall Study|Lost to Follow-up|5|||
163444995|NCT01635933|590330891|FG000|Overall Study|Subject decision|1|||
163444996|NCT01635933|590330892|FG001|Overall Study|Subject decision|1|||
163444997|NCT01635933|590330891|FG000|Overall Study|Noncompliance|0|||
163444998|NCT01635933|590330892|FG001|Overall Study|Noncompliance|1|||
163444999|NCT01635933|590330891|FG000|Overall Study|No longer had transportation|0|||
163445000|NCT01635933|590330892|FG001|Overall Study|No longer had transportation|1|||
163445001|NCT01544595|590330893|FG000|Status at Week 68|Adverse Event|3|||
163445002|NCT01544595|590330894|FG001|Status at Week 68|Adverse Event|2|||
163445003|NCT01544595|590330895|FG002|Status at Week 68|Adverse Event|1|||
163445004|NCT01544595|590330896|FG003|Status at Week 68|Adverse Event|0|||
163445005|NCT01544595|590330897|FG004|Status at Week 68|Adverse Event|0|||
163445006|NCT01544595|590330898|FG005|Status at Week 68|Adverse Event|0|||
163445007|NCT01544595|590330893|FG000|Status at Week 68|Lack of Efficacy|1|||
163445008|NCT01544595|590330894|FG001|Status at Week 68|Lack of Efficacy|0|||
163445009|NCT01544595|590330895|FG002|Status at Week 68|Lack of Efficacy|0|||
163445010|NCT01544595|590330896|FG003|Status at Week 68|Lack of Efficacy|0|||
163445011|NCT01544595|590330897|FG004|Status at Week 68|Lack of Efficacy|0|||
163445012|NCT01544595|590330898|FG005|Status at Week 68|Lack of Efficacy|0|||
163445013|NCT01544595|590330893|FG000|Status at Week 68|Lost to Follow-up|1|||
163445014|NCT01544595|590330894|FG001|Status at Week 68|Lost to Follow-up|1|||
163445015|NCT01544595|590330895|FG002|Status at Week 68|Lost to Follow-up|0|||
163445016|NCT01544595|590330896|FG003|Status at Week 68|Lost to Follow-up|0|||
163445017|NCT01544595|590330897|FG004|Status at Week 68|Lost to Follow-up|0|||
163445018|NCT01544595|590330898|FG005|Status at Week 68|Lost to Follow-up|0|||
163445019|NCT01544595|590330893|FG000|Status at Week 68|Non-compliance with study treatment|1|||
163445020|NCT01544595|590330894|FG001|Status at Week 68|Non-compliance with study treatment|0|||
163445021|NCT01544595|590330895|FG002|Status at Week 68|Non-compliance with study treatment|0|||
163445022|NCT01544595|590330896|FG003|Status at Week 68|Non-compliance with study treatment|1|||
163445023|NCT01544595|590330897|FG004|Status at Week 68|Non-compliance with study treatment|0|||
163445024|NCT01544595|590330898|FG005|Status at Week 68|Non-compliance with study treatment|0|||
163445025|NCT01544595|590330893|FG000|Status at Week 68|Protocol Violation|2|||
163445026|NCT01544595|590330894|FG001|Status at Week 68|Protocol Violation|0|||
163445027|NCT01544595|590330895|FG002|Status at Week 68|Protocol Violation|1|||
163445028|NCT01544595|590330896|FG003|Status at Week 68|Protocol Violation|1|||
163445029|NCT01544595|590330897|FG004|Status at Week 68|Protocol Violation|0|||
163445030|NCT01544595|590330898|FG005|Status at Week 68|Protocol Violation|0|||
163445031|NCT01544595|590330893|FG000|Status at Week 68|Technical problems|1|||
163445032|NCT01544595|590330894|FG001|Status at Week 68|Technical problems|0|||
163445033|NCT01544595|590330895|FG002|Status at Week 68|Technical problems|0|||
163445034|NCT01544595|590330896|FG003|Status at Week 68|Technical problems|1|||
163445035|NCT01544595|590330897|FG004|Status at Week 68|Technical problems|0|||
163445036|NCT01544595|590330898|FG005|Status at Week 68|Technical problems|0|||
163445037|NCT01544595|590330893|FG000|Status at Week 68|Withdrawal by Subject|0|||
163445038|NCT01544595|590330894|FG001|Status at Week 68|Withdrawal by Subject|1|||
163445039|NCT01544595|590330895|FG002|Status at Week 68|Withdrawal by Subject|1|||
163445040|NCT01544595|590330896|FG003|Status at Week 68|Withdrawal by Subject|2|||
163445041|NCT01544595|590330897|FG004|Status at Week 68|Withdrawal by Subject|0|||
163445042|NCT01544595|590330898|FG005|Status at Week 68|Withdrawal by Subject|0|||
163445043|NCT01544595|590330893|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
163445044|NCT01544595|590330894|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
163445045|NCT01544595|590330895|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
163445046|NCT01544595|590330896|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
163445047|NCT01544595|590330897|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
163445048|NCT01544595|590330898|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
163445049|NCT01544595|590330893|FG000|Status at Week 156|Withdrawal by Subject|9|||
163445050|NCT01544595|590330894|FG001|Status at Week 156|Withdrawal by Subject|10|||
163445051|NCT01544595|590330895|FG002|Status at Week 156|Withdrawal by Subject|4|||
163445052|NCT01544595|590330896|FG003|Status at Week 156|Withdrawal by Subject|9|||
163445053|NCT01544595|590330897|FG004|Status at Week 156|Withdrawal by Subject|20|||
163445054|NCT01544595|590330898|FG005|Status at Week 156|Withdrawal by Subject|6|||
163445055|NCT01544595|590330893|FG000|Status at Week 156|Adverse Event|9|||
163445056|NCT01544595|590330894|FG001|Status at Week 156|Adverse Event|11|||
163445057|NCT01544595|590330895|FG002|Status at Week 156|Adverse Event|1|||
163445058|NCT01544595|590330896|FG003|Status at Week 156|Adverse Event|3|||
163445059|NCT01544595|590330897|FG004|Status at Week 156|Adverse Event|4|||
163445060|NCT01544595|590330898|FG005|Status at Week 156|Adverse Event|2|||
163445061|NCT01544595|590330893|FG000|Status at Week 156|Lost to Follow-up|4|||
163445062|NCT01544595|590330894|FG001|Status at Week 156|Lost to Follow-up|4|||
163445063|NCT01544595|590330895|FG002|Status at Week 156|Lost to Follow-up|0|||
163445064|NCT01544595|590330896|FG003|Status at Week 156|Lost to Follow-up|1|||
163445065|NCT01544595|590330897|FG004|Status at Week 156|Lost to Follow-up|4|||
163445066|NCT01544595|590330898|FG005|Status at Week 156|Lost to Follow-up|1|||
163445067|NCT01544595|590330893|FG000|Status at Week 156|Non-compliance with study treatement|0|||
163445068|NCT01544595|590330894|FG001|Status at Week 156|Non-compliance with study treatement|1|||
163445069|NCT01544595|590330895|FG002|Status at Week 156|Non-compliance with study treatement|0|||
163445070|NCT01544595|590330896|FG003|Status at Week 156|Non-compliance with study treatement|1|||
163445071|NCT01544595|590330897|FG004|Status at Week 156|Non-compliance with study treatement|0|||
163445072|NCT01544595|590330898|FG005|Status at Week 156|Non-compliance with study treatement|1|||
163445073|NCT01544595|590330893|FG000|Status at Week 156|Physician Decision|0|||
163445074|NCT01544595|590330894|FG001|Status at Week 156|Physician Decision|3|||
163445075|NCT01544595|590330895|FG002|Status at Week 156|Physician Decision|1|||
163445076|NCT01544595|590330896|FG003|Status at Week 156|Physician Decision|0|||
163445077|NCT01544595|590330897|FG004|Status at Week 156|Physician Decision|0|||
163445078|NCT01544595|590330898|FG005|Status at Week 156|Physician Decision|0|||
163445079|NCT01544595|590330893|FG000|Status at Week 156|Pregnancy|2|||
163445080|NCT01544595|590330894|FG001|Status at Week 156|Pregnancy|3|||
163445081|NCT01544595|590330895|FG002|Status at Week 156|Pregnancy|0|||
163445082|NCT01544595|590330896|FG003|Status at Week 156|Pregnancy|0|||
163445083|NCT01544595|590330897|FG004|Status at Week 156|Pregnancy|0|||
163445084|NCT01544595|590330898|FG005|Status at Week 156|Pregnancy|0|||
163445085|NCT01544595|590330893|FG000|Status at Week 156|Protocol Violation|3|||
163445086|NCT01544595|590330894|FG001|Status at Week 156|Protocol Violation|1|||
163445087|NCT01544595|590330895|FG002|Status at Week 156|Protocol Violation|2|||
163445088|NCT01544595|590330896|FG003|Status at Week 156|Protocol Violation|2|||
163445089|NCT01544595|590330897|FG004|Status at Week 156|Protocol Violation|0|||
163445090|NCT01544595|590330898|FG005|Status at Week 156|Protocol Violation|0|||
163445091|NCT01544595|590330893|FG000|Status at Week 156|Technical problems|3|||
163445092|NCT01544595|590330894|FG001|Status at Week 156|Technical problems|1|||
163445093|NCT01544595|590330895|FG002|Status at Week 156|Technical problems|0|||
163445094|NCT01544595|590330896|FG003|Status at Week 156|Technical problems|1|||
163445095|NCT01544595|590330897|FG004|Status at Week 156|Technical problems|0|||
163445096|NCT01544595|590330898|FG005|Status at Week 156|Technical problems|0|||
163445097|NCT01544595|590330893|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
163445098|NCT01544595|590330894|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
163445099|NCT01544595|590330895|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
163445100|NCT01544595|590330896|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
163445101|NCT01544595|590330897|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
163445102|NCT01544595|590330898|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
163445103|NCT01544595|590330893|FG000|Status at Week 156|Lack of Efficacy|1|||
163445104|NCT01544595|590330894|FG001|Status at Week 156|Lack of Efficacy|0|||
163445105|NCT01544595|590330895|FG002|Status at Week 156|Lack of Efficacy|1|||
163445106|NCT01544595|590330896|FG003|Status at Week 156|Lack of Efficacy|4|||
163445107|NCT01544595|590330897|FG004|Status at Week 156|Lack of Efficacy|10|||
163445108|NCT01544595|590330898|FG005|Status at Week 156|Lack of Efficacy|5|||
163445109|NCT01929044|590330899|FG000|Overall Study|Adverse Event|1|||
163445110|NCT01929044|590330900|FG001|Overall Study|Adverse Event|0|||
163445111|NCT01929044|590330899|FG000|Overall Study|Protocol Violation|9|||
163445112|NCT01929044|590330900|FG001|Overall Study|Protocol Violation|14|||
163445113|NCT01929044|590330899|FG000|Overall Study|Not Treated|1|||
163445114|NCT01929044|590330900|FG001|Overall Study|Not Treated|3|||
163445115|NCT02275026|590330907|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
163445116|NCT02275026|590330907|FG000|Overall Study|Withdrawal by Subject|4|||
163445117|NCT02275026|590330907|FG000|Overall Study|Ineligible due to medical history|13|||
163445118|NCT02275026|590330907|FG000|Overall Study|MRI malfunction precluded testing|1|||
163445119|NCT02275026|590330907|FG000|Overall Study|Ineligible after MRI findings|1|||
163445120|NCT02275026|590330907|FG000|Overall Study|Lost to Follow-up|2|||
163445121|NCT02275026|590330907|FG000|Overall Study|Scanner failure|1|||
163445122|NCT02379923|590330908|FG000|Overall Study|Death|5|||
163445123|NCT03643432|590330909|FG000|Overall Study|Lost to Follow-up|1|||
163445124|NCT03643432|590330910|FG001|Overall Study|Lost to Follow-up|0|||
163445125|NCT00337467|590330911|FG000|Overall Study|Adverse Event|3|||
163445126|NCT00337467|590330911|FG000|Overall Study|Subject Withdrew Consent|2|||
163445127|NCT00337467|590330911|FG000|Overall Study|Pregnancy|1|||
163445128|NCT00337467|590330911|FG000|Overall Study|Lost to Follow-up|2|||
163445129|NCT00337467|590330911|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
163445130|NCT01187901|590330914|FG000|Overall Study|Protocol Violation|1|||
163445131|NCT01187901|590330915|FG001|Overall Study|Protocol Violation|0|||
163445132|NCT01187901|590330914|FG000|Overall Study|Lost to Follow-up|1|||
163445133|NCT01187901|590330915|FG001|Overall Study|Lost to Follow-up|2|||
163445134|NCT01187901|590330914|FG000|Overall Study|Unrelated Health Reasons|1|||
163445135|NCT01187901|590330915|FG001|Overall Study|Unrelated Health Reasons|2|||
163445136|NCT01187901|590330914|FG000|Overall Study|Suspected Allergic Reaction|1|||
163445137|NCT01187901|590330915|FG001|Overall Study|Suspected Allergic Reaction|1|||
163445138|NCT01187901|590330914|FG000|Overall Study|Adverse Event|3|||
163445139|NCT01187901|590330915|FG001|Overall Study|Adverse Event|0|||
163445140|NCT01187901|590330914|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
163445141|NCT01187901|590330915|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
163445142|NCT01187901|590330914|FG000|Overall Study|Pregnancy|0|||
163445143|NCT01187901|590330915|FG001|Overall Study|Pregnancy|2|||
163445144|NCT03141086|590330916|FG000|Overall Study|Study Terminated By Sponsor|1|||
163445145|NCT03141086|590330917|FG001|Overall Study|Study Terminated By Sponsor|1|||
163445146|NCT03141086|590330916|FG000|Overall Study|Withdrawal by Subject|0|||
163445147|NCT03141086|590330917|FG001|Overall Study|Withdrawal by Subject|1|||
163445148|NCT03141086|590330916|FG000|Overall Study|Protocol Violation|0|||
163445149|NCT03141086|590330917|FG001|Overall Study|Protocol Violation|1|||
163445150|NCT03141086|590330916|FG000|Overall Study|Adverse Event|0|||
163445151|NCT03141086|590330917|FG001|Overall Study|Adverse Event|2|||
163445152|NCT02488759|590330920|FG000|Overall Study|Disease progression|73|||
163445153|NCT02488759|590330921|FG001|Overall Study|Disease progression|111|||
163445154|NCT02488759|590330922|FG002|Overall Study|Disease progression|62|||
163445155|NCT02488759|590330923|FG003|Overall Study|Disease progression|7|||
163445156|NCT02488759|590330924|FG004|Overall Study|Disease progression|4|||
163445157|NCT02488759|590330925|FG005|Overall Study|Disease progression|2|||
163445158|NCT02488759|590330920|FG000|Overall Study|Study drug toxicity|11|||
163445159|NCT02488759|590330921|FG001|Overall Study|Study drug toxicity|33|||
163445160|NCT02488759|590330922|FG002|Overall Study|Study drug toxicity|31|||
163445161|NCT02488759|590330923|FG003|Overall Study|Study drug toxicity|0|||
163445162|NCT02488759|590330924|FG004|Overall Study|Study drug toxicity|0|||
163445163|NCT02488759|590330925|FG005|Overall Study|Study drug toxicity|2|||
163445164|NCT02488759|590330920|FG000|Overall Study|Adverse event unrelated to study drug|9|||
163445165|NCT02488759|590330921|FG001|Overall Study|Adverse event unrelated to study drug|11|||
163445166|NCT02488759|590330922|FG002|Overall Study|Adverse event unrelated to study drug|7|||
163445167|NCT02488759|590330923|FG003|Overall Study|Adverse event unrelated to study drug|0|||
163445168|NCT02488759|590330924|FG004|Overall Study|Adverse event unrelated to study drug|1|||
163445169|NCT02488759|590330925|FG005|Overall Study|Adverse event unrelated to study drug|0|||
163445170|NCT02488759|590330920|FG000|Overall Study|Participant request to discontinue study treatment|6|||
163445171|NCT02488759|590330921|FG001|Overall Study|Participant request to discontinue study treatment|8|||
163445172|NCT02488759|590330922|FG002|Overall Study|Participant request to discontinue study treatment|4|||
163445173|NCT02488759|590330923|FG003|Overall Study|Participant request to discontinue study treatment|0|||
163445174|NCT02488759|590330924|FG004|Overall Study|Participant request to discontinue study treatment|0|||
163445175|NCT02488759|590330925|FG005|Overall Study|Participant request to discontinue study treatment|0|||
163445176|NCT02488759|590330920|FG000|Overall Study|Withdrawal by Subject|4|||
163445177|NCT02488759|590330921|FG001|Overall Study|Withdrawal by Subject|0|||
163445178|NCT02488759|590330922|FG002|Overall Study|Withdrawal by Subject|3|||
163445179|NCT02488759|590330923|FG003|Overall Study|Withdrawal by Subject|0|||
163445180|NCT02488759|590330924|FG004|Overall Study|Withdrawal by Subject|0|||
163445181|NCT02488759|590330925|FG005|Overall Study|Withdrawal by Subject|2|||
163445182|NCT02488759|590330920|FG000|Overall Study|Lost to Follow-up|0|||
163445183|NCT02488759|590330921|FG001|Overall Study|Lost to Follow-up|0|||
163445184|NCT02488759|590330922|FG002|Overall Study|Lost to Follow-up|2|||
163445185|NCT02488759|590330923|FG003|Overall Study|Lost to Follow-up|0|||
163445186|NCT02488759|590330924|FG004|Overall Study|Lost to Follow-up|0|||
163445187|NCT02488759|590330925|FG005|Overall Study|Lost to Follow-up|0|||
163445188|NCT02488759|590330920|FG000|Overall Study|Maximum clinical benefit|3|||
163445189|NCT02488759|590330921|FG001|Overall Study|Maximum clinical benefit|0|||
163445190|NCT02488759|590330922|FG002|Overall Study|Maximum clinical benefit|1|||
163445191|NCT02488759|590330923|FG003|Overall Study|Maximum clinical benefit|0|||
163445192|NCT02488759|590330924|FG004|Overall Study|Maximum clinical benefit|0|||
163445193|NCT02488759|590330925|FG005|Overall Study|Maximum clinical benefit|0|||
163445194|NCT02488759|590330920|FG000|Overall Study|Other reasons|7|||
163445195|NCT02488759|590330921|FG001|Overall Study|Other reasons|32|||
163445196|NCT02488759|590330922|FG002|Overall Study|Other reasons|23|||
163445197|NCT02488759|590330923|FG003|Overall Study|Other reasons|1|||
163445198|NCT02488759|590330924|FG004|Overall Study|Other reasons|1|||
163445199|NCT02488759|590330925|FG005|Overall Study|Other reasons|1|||
163445200|NCT03607682|590330931|FG000|Overall Study|Withdrawal by Subject|1|||
163445201|NCT03607682|590330931|FG000|Overall Study|Disease progression|1|||
163445202|NCT02574312|590330932|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
163445203|NCT02574312|590330933|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
163445204|NCT02326467|590332359|FG000|Overall Study|Withdrawal by Subject|1|||
163445205|NCT04467164|590332361|FG000|Washout (1 Week)|Lost to Follow-up|2|||
163445206|NCT04467164|590332362|FG001|Washout (1 Week)|Lost to Follow-up|0|||
163445207|NCT01998581|590332363|FG000|Overall Study|Refused repeat treatment|20|||
163445208|NCT01998581|590332364|FG001|Overall Study|Refused repeat treatment|4|||
163445209|NCT01998581|590332363|FG000|Overall Study|Protocol Violation|1|||
163445210|NCT01998581|590332364|FG001|Overall Study|Protocol Violation|0|||
163445211|NCT01998581|590332363|FG000|Overall Study|Withdrawal by Subject|8|||
163445212|NCT01998581|590332364|FG001|Overall Study|Withdrawal by Subject|1|||
163445213|NCT01998581|590332363|FG000|Overall Study|Lost to Follow-up|12|||
163445214|NCT01998581|590332364|FG001|Overall Study|Lost to Follow-up|4|||
163445215|NCT01998581|590332363|FG000|Overall Study|Adverse Event|1|||
163445216|NCT01998581|590332364|FG001|Overall Study|Adverse Event|1|||
163445217|NCT01998581|590332363|FG000|Overall Study|Other reasons|3|||
163445218|NCT01998581|590332364|FG001|Overall Study|Other reasons|2|||
163445219|NCT01998581|590332363|FG000|Overall Study|Randomized but withdrew before treatment|1|||
163445220|NCT01998581|590332364|FG001|Overall Study|Randomized but withdrew before treatment|0|||
163445221|NCT02273050|590332367|FG000|Overall Study|Adverse Event|4|||
163445222|NCT02273050|590332368|FG001|Overall Study|Adverse Event|3|||
163445223|NCT02273050|590332369|FG002|Overall Study|Adverse Event|3|||
163445224|NCT02273050|590332367|FG000|Overall Study|Death|0|||
163445225|NCT02273050|590332368|FG001|Overall Study|Death|0|||
163445226|NCT02273050|590332369|FG002|Overall Study|Death|1|||
163445227|NCT02273050|590332367|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
163445228|NCT02273050|590332368|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
163445229|NCT02273050|590332369|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
163445230|NCT02273050|590332367|FG000|Overall Study|Lack of Efficacy|0|||
163445231|NCT02273050|590332368|FG001|Overall Study|Lack of Efficacy|1|||
163445232|NCT02273050|590332369|FG002|Overall Study|Lack of Efficacy|1|||
163445233|NCT02273050|590332367|FG000|Overall Study|Withdrawal by Subject|17|||
163445234|NCT02273050|590332368|FG001|Overall Study|Withdrawal by Subject|14|||
163445235|NCT02273050|590332369|FG002|Overall Study|Withdrawal by Subject|16|||
163445236|NCT02273050|590332367|FG000|Overall Study|Lost to Follow-up|0|||
163445237|NCT02273050|590332368|FG001|Overall Study|Lost to Follow-up|2|||
163445238|NCT02273050|590332369|FG002|Overall Study|Lost to Follow-up|3|||
163445239|NCT02273050|590332367|FG000|Overall Study|Protocol Violation|3|||
163445240|NCT02273050|590332368|FG001|Overall Study|Protocol Violation|1|||
163445241|NCT02273050|590332369|FG002|Overall Study|Protocol Violation|4|||
163445242|NCT02273752|590332370|FG000|Overall Study|Trial was terminated early|2|||
163445243|NCT00903032|590332371|FG000|Overall Study|Withdrawal by Subject|5|||
163445244|NCT00903032|590332372|FG001|Overall Study|Withdrawal by Subject|3|||
163445245|NCT00903032|590332371|FG000|Overall Study|Lost to Follow-up|2|||
163445246|NCT00903032|590332372|FG001|Overall Study|Lost to Follow-up|2|||
163445247|NCT05619172|590332373|FG000|Safety Cohort 1|Death|7|||
163445248|NCT05619172|590332374|FG001|Safety Cohort 1|Death|0|||
163445249|NCT05619172|590332373|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
163445250|NCT05619172|590332374|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
163445251|NCT05619172|590332373|FG000|Safety Cohort 2|Death|0|||
163445252|NCT05619172|590332374|FG001|Safety Cohort 2|Death|1|||
163445253|NCT05619172|590332373|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
163445254|NCT05619172|590332374|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
163445255|NCT01429792|590332375|FG000|Overall Study|Other Reasons|67|||
163445256|NCT01429792|590332375|FG000|Overall Study|Unknown Disposition|94|||
163445257|NCT01429792|590332375|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
163445258|NCT01429792|590332375|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
163445259|NCT01429792|590332375|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
163445260|NCT01429792|590332375|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
163445261|NCT01429792|590332375|FG000|Overall Study|Withdrawal by Subject|70|||
163445262|NCT01429792|590332375|FG000|Overall Study|Lost to Follow-up|88|||
163445263|NCT01763905|590332378|FG000|Overall Study|Withdrawal by Subject|1|||
163445264|NCT01763905|590332379|FG001|Overall Study|Withdrawal by Subject|1|||
163445265|NCT01763905|590332380|FG002|Overall Study|Withdrawal by Subject|0|||
163445266|NCT01763905|590332381|FG003|Overall Study|Withdrawal by Subject|1|||
163445267|NCT01763905|590332378|FG000|Overall Study|Decision by sponsor|5|||
163445268|NCT01763905|590332379|FG001|Overall Study|Decision by sponsor|0|||
163445269|NCT01763905|590332380|FG002|Overall Study|Decision by sponsor|8|||
163445270|NCT01763905|590332381|FG003|Overall Study|Decision by sponsor|0|||
163445271|NCT01763905|590332378|FG000|Overall Study|Lost to Follow-up|0|||
163445272|NCT01763905|590332379|FG001|Overall Study|Lost to Follow-up|0|||
163445273|NCT01763905|590332380|FG002|Overall Study|Lost to Follow-up|1|||
163445274|NCT01763905|590332381|FG003|Overall Study|Lost to Follow-up|0|||
163445275|NCT04346628|590332382|FG000|Overall Study|Lost to Follow-up|4|||
163445276|NCT04346628|590332383|FG001|Overall Study|Lost to Follow-up|4|||
163445277|NCT04346628|590332382|FG000|Overall Study|Withdrew (had personal reasons)|2|||
163445278|NCT04346628|590332383|FG001|Overall Study|Withdrew (had personal reasons)|5|||
163445279|NCT04346628|590332382|FG000|Overall Study|Withdrew (medication intolerant)|0|||
163445280|NCT04346628|590332383|FG001|Overall Study|Withdrew (medication intolerant)|3|||
163445281|NCT04346628|590332382|FG000|Overall Study|Withdrew (declined intervention)|0|||
163445282|NCT04346628|590332383|FG001|Overall Study|Withdrew (declined intervention)|1|||
163445283|NCT03165721|590332390|FG000|Overall Study|Refused further treatment|3|||
163445284|NCT03165721|590332391|FG001|Overall Study|Refused further treatment|0|||
163445285|NCT03165721|590332392|FG002|Overall Study|Refused further treatment|0|||
163445286|NCT03165721|590332390|FG000|Overall Study|Physician Decision|1|||
163445287|NCT03165721|590332391|FG001|Overall Study|Physician Decision|0|||
163445288|NCT03165721|590332392|FG002|Overall Study|Physician Decision|0|||
163445289|NCT01457118|590332394|FG000|Overall Study|Adverse Event|1|||
163445290|NCT01457118|590332395|FG001|Overall Study|Adverse Event|0|||
163445291|NCT01457118|590332396|FG002|Overall Study|Adverse Event|0|||
163445292|NCT01457118|590332397|FG003|Overall Study|Adverse Event|1|||
163445293|NCT01457118|590332394|FG000|Overall Study|Clinical Progression|0|||
163445294|NCT01457118|590332395|FG001|Overall Study|Clinical Progression|1|||
163445295|NCT01457118|590332396|FG002|Overall Study|Clinical Progression|0|||
163445296|NCT01457118|590332397|FG003|Overall Study|Clinical Progression|1|||
163445297|NCT01457118|590332394|FG000|Overall Study|Physician Decision|2|||
163445298|NCT01457118|590332395|FG001|Overall Study|Physician Decision|0|||
163445299|NCT01457118|590332396|FG002|Overall Study|Physician Decision|0|||
163445300|NCT01457118|590332397|FG003|Overall Study|Physician Decision|0|||
163445301|NCT01457118|590332394|FG000|Overall Study|Progressive Disease by RECIST|12|||
163445302|NCT01457118|590332395|FG001|Overall Study|Progressive Disease by RECIST|3|||
163445303|NCT01457118|590332396|FG002|Overall Study|Progressive Disease by RECIST|1|||
163445304|NCT01457118|590332397|FG003|Overall Study|Progressive Disease by RECIST|0|||
163445305|NCT01457118|590332394|FG000|Overall Study|Withdrawal by Subject|5|||
163445306|NCT01457118|590332395|FG001|Overall Study|Withdrawal by Subject|0|||
163445307|NCT01457118|590332396|FG002|Overall Study|Withdrawal by Subject|0|||
163445308|NCT01457118|590332397|FG003|Overall Study|Withdrawal by Subject|0|||
163445309|NCT02324842|590332398|FG000|Overall Study|Lost to Follow-up|1|||
163445310|NCT02324842|590332399|FG001|Overall Study|Lost to Follow-up|1|||
163445311|NCT02324842|590332400|FG002|Overall Study|Lost to Follow-up|2|||
163445312|NCT01263691|590332401|FG000|Overall Study|Lost to Follow-up|1|||
163445313|NCT01263691|590332402|FG001|Overall Study|Lost to Follow-up|0|||
163445314|NCT01263691|590332403|FG002|Overall Study|Lost to Follow-up|1|||
163445315|NCT01263691|590332404|FG003|Overall Study|Lost to Follow-up|1|||
163445316|NCT01263691|590332405|FG004|Overall Study|Lost to Follow-up|0|||
163445317|NCT01263691|590332406|FG005|Overall Study|Lost to Follow-up|0|||
163445318|NCT01263691|590332401|FG000|Overall Study|Withdrawal by Subject|1|||
163445319|NCT01263691|590332402|FG001|Overall Study|Withdrawal by Subject|0|||
163445320|NCT01263691|590332403|FG002|Overall Study|Withdrawal by Subject|0|||
163445321|NCT01263691|590332404|FG003|Overall Study|Withdrawal by Subject|0|||
163445322|NCT01263691|590332405|FG004|Overall Study|Withdrawal by Subject|0|||
163445323|NCT01263691|590332406|FG005|Overall Study|Withdrawal by Subject|0|||
163445324|NCT01263691|590332401|FG000|Overall Study|Adverse Event|1|||
163445325|NCT01263691|590332402|FG001|Overall Study|Adverse Event|0|||
163445326|NCT01263691|590332403|FG002|Overall Study|Adverse Event|0|||
163445327|NCT01263691|590332404|FG003|Overall Study|Adverse Event|0|||
163445328|NCT01263691|590332405|FG004|Overall Study|Adverse Event|0|||
163445329|NCT01263691|590332406|FG005|Overall Study|Adverse Event|0|||
163445330|NCT00630812|590332407|FG000|Randomisation to First Dose|Adverse Event|1|||
163445331|NCT00630812|590332408|FG001|Randomisation to First Dose|Adverse Event|1|||
163445332|NCT00630812|590332407|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
163445333|NCT00630812|590332408|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
163445334|NCT00630812|590332407|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
163445335|NCT00630812|590332408|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
163445336|NCT00630812|590332407|FG000|Randomisation to First Dose|Protocol Violation|4|||
163445337|NCT00630812|590332408|FG001|Randomisation to First Dose|Protocol Violation|1|||
163445338|NCT00630812|590332407|FG000|Double Blind Treatment Period|Adverse Event|13|||
163445339|NCT00630812|590332408|FG001|Double Blind Treatment Period|Adverse Event|5|||
163445340|NCT00630812|590332407|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
163445341|NCT00630812|590332408|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
163445342|NCT00630812|590332407|FG000|Double Blind Treatment Period|Physician Decision|2|||
163445343|NCT00630812|590332408|FG001|Double Blind Treatment Period|Physician Decision|1|||
163445344|NCT00630812|590332407|FG000|Double Blind Treatment Period|Protocol Violation|1|||
163445345|NCT00630812|590332408|FG001|Double Blind Treatment Period|Protocol Violation|0|||
163445346|NCT00630812|590332407|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
163445347|NCT00630812|590332408|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
163445348|NCT00630812|590332407|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
163445349|NCT00630812|590332408|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
163445350|NCT00630812|590332407|FG000|Double Blind Treatment Period|Non-compliance|0|||
163445351|NCT00630812|590332408|FG001|Double Blind Treatment Period|Non-compliance|1|||
163445352|NCT01554956|590332409|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
163445353|NCT01554956|590332410|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
163445354|NCT01554956|590332411|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
163445355|NCT01554956|590332409|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
163445356|NCT01554956|590332410|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
163445357|NCT01554956|590332411|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
163445358|NCT01554956|590332409|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
163445359|NCT01554956|590332410|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
163445360|NCT01554956|590332411|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
163445361|NCT00069095|590332412|FG000|Primary Treatment Phase|Ongoing|0|||
163445362|NCT00069095|590332413|FG001|Primary Treatment Phase|Ongoing|0|||
163445363|NCT00069095|590332414|FG002|Primary Treatment Phase|Ongoing|5|||
163445364|NCT00069095|590332415|FG003|Primary Treatment Phase|Ongoing|7|||
163445365|NCT00069095|590332416|FG004|Primary Treatment Phase|Ongoing|7|||
163445366|NCT00069095|590332417|FG005|Primary Treatment Phase|Ongoing|4|||
163445367|NCT00069095|590332412|FG000|Primary Treatment Phase|Admin/Other|29|||
163445368|NCT00069095|590332413|FG001|Primary Treatment Phase|Admin/Other|38|||
163445369|NCT00069095|590332414|FG002|Primary Treatment Phase|Admin/Other|31|||
163445370|NCT00069095|590332415|FG003|Primary Treatment Phase|Admin/Other|45|||
163445371|NCT00069095|590332416|FG004|Primary Treatment Phase|Admin/Other|48|||
163445372|NCT00069095|590332417|FG005|Primary Treatment Phase|Admin/Other|42|||
163445373|NCT00069095|590332412|FG000|Primary Treatment Phase|Adverse Event|99|||
163445374|NCT00069095|590332413|FG001|Primary Treatment Phase|Adverse Event|92|||
163445375|NCT00069095|590332414|FG002|Primary Treatment Phase|Adverse Event|71|||
163445376|NCT00069095|590332415|FG003|Primary Treatment Phase|Adverse Event|72|||
163445377|NCT00069095|590332416|FG004|Primary Treatment Phase|Adverse Event|109|||
163445378|NCT00069095|590332417|FG005|Primary Treatment Phase|Adverse Event|101|||
163445379|NCT00069095|590332412|FG000|Primary Treatment Phase|Death|14|||
163445380|NCT00069095|590332413|FG001|Primary Treatment Phase|Death|8|||
163445381|NCT00069095|590332414|FG002|Primary Treatment Phase|Death|2|||
163445382|NCT00069095|590332415|FG003|Primary Treatment Phase|Death|5|||
163445383|NCT00069095|590332416|FG004|Primary Treatment Phase|Death|8|||
163445384|NCT00069095|590332417|FG005|Primary Treatment Phase|Death|8|||
163445385|NCT00069095|590332412|FG000|Primary Treatment Phase|Failure to return|5|||
163445386|NCT00069095|590332413|FG001|Primary Treatment Phase|Failure to return|5|||
163445387|NCT00069095|590332414|FG002|Primary Treatment Phase|Failure to return|0|||
163445388|NCT00069095|590332415|FG003|Primary Treatment Phase|Failure to return|0|||
163445389|NCT00069095|590332416|FG004|Primary Treatment Phase|Failure to return|0|||
163445390|NCT00069095|590332417|FG005|Primary Treatment Phase|Failure to return|2|||
163445391|NCT00069095|590332412|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
163445392|NCT00069095|590332413|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
163445393|NCT00069095|590332414|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
163445394|NCT00069095|590332415|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
163445395|NCT00069095|590332416|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
163445396|NCT00069095|590332417|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
163445397|NCT00069095|590332412|FG000|Primary Treatment Phase|Refused treatment|15|||
163445398|NCT00069095|590332413|FG001|Primary Treatment Phase|Refused treatment|26|||
163445399|NCT00069095|590332414|FG002|Primary Treatment Phase|Refused treatment|17|||
163445400|NCT00069095|590332415|FG003|Primary Treatment Phase|Refused treatment|31|||
163445401|NCT00069095|590332416|FG004|Primary Treatment Phase|Refused treatment|24|||
163445402|NCT00069095|590332417|FG005|Primary Treatment Phase|Refused treatment|27|||
163445403|NCT00069095|590332412|FG000|Primary Treatment Phase|Withdrew|2|||
163445404|NCT00069095|590332413|FG001|Primary Treatment Phase|Withdrew|3|||
163445405|NCT00069095|590332414|FG002|Primary Treatment Phase|Withdrew|8|||
163445406|NCT00069095|590332415|FG003|Primary Treatment Phase|Withdrew|2|||
163445407|NCT00069095|590332416|FG004|Primary Treatment Phase|Withdrew|4|||
163445408|NCT00069095|590332417|FG005|Primary Treatment Phase|Withdrew|9|||
163445409|NCT00069095|590332412|FG000|Primary Treatment Phase|Other Violation|0|||
163445410|NCT00069095|590332413|FG001|Primary Treatment Phase|Other Violation|1|||
163445411|NCT00069095|590332414|FG002|Primary Treatment Phase|Other Violation|1|||
163445412|NCT00069095|590332415|FG003|Primary Treatment Phase|Other Violation|1|||
163445413|NCT00069095|590332416|FG004|Primary Treatment Phase|Other Violation|0|||
163445414|NCT00069095|590332417|FG005|Primary Treatment Phase|Other Violation|1|||
163445415|NCT00069095|590332412|FG000|Primary Treatment Phase|Violation criteria|0|||
163445416|NCT00069095|590332413|FG001|Primary Treatment Phase|Violation criteria|2|||
163445417|NCT00069095|590332414|FG002|Primary Treatment Phase|Violation criteria|4|||
163445418|NCT00069095|590332415|FG003|Primary Treatment Phase|Violation criteria|3|||
163445419|NCT00069095|590332416|FG004|Primary Treatment Phase|Violation criteria|1|||
163445420|NCT00069095|590332417|FG005|Primary Treatment Phase|Violation criteria|5|||
163445421|NCT00069095|590332412|FG000|Post-study Treatment Phase|Missing reason|1|||
163445422|NCT00069095|590332413|FG001|Post-study Treatment Phase|Missing reason|3|||
163445423|NCT00069095|590332414|FG002|Post-study Treatment Phase|Missing reason|12|||
163445424|NCT00069095|590332415|FG003|Post-study Treatment Phase|Missing reason|8|||
163445425|NCT00069095|590332416|FG004|Post-study Treatment Phase|Missing reason|18|||
163445426|NCT00069095|590332417|FG005|Post-study Treatment Phase|Missing reason|17|||
163445427|NCT00069095|590332412|FG000|Post-study Treatment Phase|Adverse Event|2|||
163445428|NCT00069095|590332413|FG001|Post-study Treatment Phase|Adverse Event|3|||
163445429|NCT00069095|590332414|FG002|Post-study Treatment Phase|Adverse Event|1|||
163445430|NCT00069095|590332415|FG003|Post-study Treatment Phase|Adverse Event|0|||
163445431|NCT00069095|590332416|FG004|Post-study Treatment Phase|Adverse Event|5|||
163445432|NCT00069095|590332417|FG005|Post-study Treatment Phase|Adverse Event|1|||
163445433|NCT00069095|590332412|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
163445434|NCT00069095|590332413|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
163445435|NCT00069095|590332414|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
163445436|NCT00069095|590332415|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
163445437|NCT00069095|590332416|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
163445438|NCT00069095|590332417|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
163445439|NCT00069095|590332412|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
163445440|NCT00069095|590332413|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
163445441|NCT00069095|590332414|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
163445442|NCT00069095|590332415|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
163445443|NCT00069095|590332416|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
163445444|NCT00069095|590332417|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
163445445|NCT00069095|590332412|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
163445446|NCT00069095|590332413|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
163445447|NCT00069095|590332414|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
163445448|NCT00069095|590332415|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
163445449|NCT00069095|590332416|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
163445450|NCT00069095|590332417|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
163445451|NCT00069095|590332412|FG000|Post-study Treatment Phase|Participant had complete response|1|||
163445452|NCT00069095|590332413|FG001|Post-study Treatment Phase|Participant had complete response|1|||
163445453|NCT00069095|590332414|FG002|Post-study Treatment Phase|Participant had complete response|0|||
163445454|NCT00069095|590332415|FG003|Post-study Treatment Phase|Participant had complete response|0|||
163445455|NCT00069095|590332416|FG004|Post-study Treatment Phase|Participant had complete response|0|||
163445456|NCT00069095|590332417|FG005|Post-study Treatment Phase|Participant had complete response|0|||
163445457|NCT00069095|590332412|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
163445458|NCT00069095|590332413|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
163445459|NCT00069095|590332414|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
163445460|NCT00069095|590332415|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
163445461|NCT00069095|590332416|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
163445462|NCT00069095|590332417|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
163445463|NCT00069095|590332412|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
163445464|NCT00069095|590332413|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
163445465|NCT00069095|590332414|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
163445466|NCT00069095|590332415|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
163445467|NCT00069095|590332416|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
163445468|NCT00069095|590332417|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
163445469|NCT00069095|590332412|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
163445470|NCT00069095|590332413|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
163445471|NCT00069095|590332414|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
163445472|NCT00069095|590332415|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
163445473|NCT00069095|590332416|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
163445474|NCT00069095|590332417|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
163445475|NCT00069095|590332412|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
163445476|NCT00069095|590332413|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
163445477|NCT00069095|590332414|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
163445478|NCT00069095|590332415|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
163445479|NCT00069095|590332416|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
163445480|NCT00069095|590332417|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
163445481|NCT00069095|590332412|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
163445482|NCT00069095|590332413|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
163445483|NCT00069095|590332414|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
163445484|NCT00069095|590332415|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
163445485|NCT00069095|590332416|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
163445486|NCT00069095|590332417|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
163445487|NCT00069095|590332412|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
163445488|NCT00069095|590332413|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
163445489|NCT00069095|590332414|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
163445490|NCT00069095|590332415|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
163445491|NCT00069095|590332416|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
163445492|NCT00069095|590332417|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
163445493|NCT00069095|590332412|FG000|Post-study Treatment Phase|Surgery|0|||
163445494|NCT00069095|590332413|FG001|Post-study Treatment Phase|Surgery|0|||
163445495|NCT00069095|590332414|FG002|Post-study Treatment Phase|Surgery|0|||
163445496|NCT00069095|590332415|FG003|Post-study Treatment Phase|Surgery|1|||
163445497|NCT00069095|590332416|FG004|Post-study Treatment Phase|Surgery|1|||
163445498|NCT00069095|590332417|FG005|Post-study Treatment Phase|Surgery|0|||
163445499|NCT00069095|590332412|FG000|Post-study Treatment Phase|Death|0|||
163445500|NCT00069095|590332413|FG001|Post-study Treatment Phase|Death|0|||
163445501|NCT00069095|590332414|FG002|Post-study Treatment Phase|Death|0|||
163445502|NCT00069095|590332415|FG003|Post-study Treatment Phase|Death|0|||
163445503|NCT00069095|590332416|FG004|Post-study Treatment Phase|Death|1|||
163445504|NCT00069095|590332417|FG005|Post-study Treatment Phase|Death|0|||
163445505|NCT00069095|590332412|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
163445506|NCT00069095|590332413|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
163445507|NCT00069095|590332414|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
163445508|NCT00069095|590332415|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
163445509|NCT00069095|590332416|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
163445510|NCT00069095|590332417|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
163445511|NCT00069095|590332412|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
163445512|NCT00069095|590332413|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
163445513|NCT00069095|590332414|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
163445514|NCT00069095|590332415|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
163445515|NCT00069095|590332416|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
163445516|NCT00069095|590332417|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
163445517|NCT00069095|590332412|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
163445518|NCT00069095|590332413|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
163445519|NCT00069095|590332414|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
163445520|NCT00069095|590332415|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
163445521|NCT00069095|590332416|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
163445522|NCT00069095|590332417|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
163445523|NCT00069095|590332412|FG000|Post-study Treatment Phase|Investigator decision|0|||
163445524|NCT00069095|590332413|FG001|Post-study Treatment Phase|Investigator decision|0|||
163445525|NCT00069095|590332414|FG002|Post-study Treatment Phase|Investigator decision|0|||
163445526|NCT00069095|590332415|FG003|Post-study Treatment Phase|Investigator decision|0|||
163445527|NCT00069095|590332416|FG004|Post-study Treatment Phase|Investigator decision|0|||
163445528|NCT00069095|590332417|FG005|Post-study Treatment Phase|Investigator decision|1|||
163445529|NCT00069095|590332412|FG000|Follow-up Phase|Death|174|||
163445530|NCT00069095|590332413|FG001|Follow-up Phase|Death|206|||
163445531|NCT00069095|590332414|FG002|Follow-up Phase|Death|120|||
163445532|NCT00069095|590332415|FG003|Follow-up Phase|Death|112|||
163445533|NCT00069095|590332416|FG004|Follow-up Phase|Death|92|||
163445534|NCT00069095|590332417|FG005|Follow-up Phase|Death|101|||
163445535|NCT05761444|590332418|FG000|Overall Study|Protocol Violation|2|||
163445536|NCT05761444|590332419|FG001|Overall Study|Protocol Violation|1|||
163445537|NCT05761444|590332418|FG000|Overall Study|Adverse Event|2|||
163445538|NCT05761444|590332419|FG001|Overall Study|Adverse Event|2|||
163445539|NCT05761444|590332418|FG000|Overall Study|Withdrawal by Subject|3|||
163445540|NCT05761444|590332419|FG001|Overall Study|Withdrawal by Subject|2|||
163445541|NCT05761444|590332418|FG000|Overall Study|Other|1|||
163445542|NCT05761444|590332419|FG001|Overall Study|Other|0|||
163445543|NCT05610176|590332420|FG000|Overall Study|Death|6|||
163445544|NCT01842308|590332423|FG000|Overall Study|Withdrawal by Subject|0|||
163445545|NCT01842308|590332424|FG001|Overall Study|Withdrawal by Subject|0|||
163445546|NCT01842308|590332425|FG002|Overall Study|Withdrawal by Subject|0|||
163445547|NCT01842308|590332426|FG003|Overall Study|Withdrawal by Subject|0|||
163445548|NCT01842308|590332427|FG004|Overall Study|Withdrawal by Subject|1|||
163445549|NCT02868216|590332428|FG000|Overall Study|Death|0|||
163445550|NCT02868216|590332429|FG001|Overall Study|Death|1|||
163445551|NCT02868216|590332428|FG000|Overall Study|coronary artery bypass|1|||
163445552|NCT02868216|590332429|FG001|Overall Study|coronary artery bypass|0|||
163445553|NCT02868216|590332428|FG000|Overall Study|Withdrawal by Subject|7|||
163445554|NCT02868216|590332429|FG001|Overall Study|Withdrawal by Subject|5|||
163445555|NCT03161678|590332430|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
163445556|NCT03161678|590332431|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
163445557|NCT03161678|590332432|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
163445558|NCT03161678|590332433|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
163445559|NCT03161678|590332434|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
163445560|NCT03161678|590332435|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
163445561|NCT03161678|590332430|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
163445562|NCT03161678|590332431|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
163445563|NCT03161678|590332432|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
163445564|NCT03161678|590332433|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
163445565|NCT03161678|590332434|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
163445566|NCT03161678|590332435|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
163445567|NCT03161678|590332430|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
163445568|NCT03161678|590332431|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
163445569|NCT03161678|590332432|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
163445570|NCT03161678|590332433|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
163445571|NCT03161678|590332434|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
163445572|NCT03161678|590332435|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
163445573|NCT03161678|590332430|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
163445574|NCT03161678|590332431|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
163445575|NCT03161678|590332432|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
163445576|NCT03161678|590332433|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
163445577|NCT03161678|590332434|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
163445578|NCT03161678|590332435|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
163445579|NCT00752609|590332436|FG000|Overall Study|Adverse Event|2|||
163445580|NCT00752609|590332437|FG001|Overall Study|Adverse Event|2|||
163445581|NCT00752609|590332436|FG000|Overall Study|Withdrawal by Subject|3|||
163445582|NCT00752609|590332437|FG001|Overall Study|Withdrawal by Subject|0|||
163445583|NCT00752609|590332436|FG000|Overall Study|Physician Decision|1|||
163445584|NCT00752609|590332437|FG001|Overall Study|Physician Decision|0|||
163445585|NCT00752609|590332436|FG000|Overall Study|Death|1|||
163445586|NCT00752609|590332437|FG001|Overall Study|Death|0|||
163445587|NCT00752609|590332436|FG000|Overall Study|Met exclusion criteria|1|||
163445588|NCT00752609|590332437|FG001|Overall Study|Met exclusion criteria|0|||
163445589|NCT00752609|590332436|FG000|Overall Study|Received Aranesp in error|1|||
163445590|NCT00752609|590332437|FG001|Overall Study|Received Aranesp in error|0|||
163445591|NCT00938327|590332438|FG000|Overall Study|Adverse Event|2|||
163445592|NCT00938327|590332438|FG000|Overall Study|Protocol Violation|1|||
163445593|NCT00938327|590332438|FG000|Overall Study|Withdrawal by Subject|4|||
163445594|NCT00938327|590332438|FG000|Overall Study|Lost to Follow-up|37|||
163445595|NCT00938327|590332438|FG000|Overall Study|2nd dose received outside of the study|7|||
163445596|NCT00938327|590332438|FG000|Overall Study|Vaccine not received as out of stock|9|||
163445597|NCT01425190|590332439|FG000|Overall Study|Full dose not consumed.|1|||
163445598|NCT01425190|590332440|FG001|Overall Study|Full dose not consumed.|0|||
163445599|NCT01425190|590332441|FG002|Overall Study|Full dose not consumed.|0|||
163445600|NCT02552355|590332443|FG000|Overall Study|Adverse Event|0|||
163445601|NCT02552355|590332444|FG001|Overall Study|Adverse Event|2|||
163445602|NCT02552355|590332445|FG002|Overall Study|Adverse Event|2|||
163445603|NCT02552355|590332446|FG003|Overall Study|Adverse Event|0|||
163445604|NCT02552355|590332443|FG000|Overall Study|Withdrawal by Subject|0|||
163445605|NCT02552355|590332444|FG001|Overall Study|Withdrawal by Subject|0|||
163445606|NCT02552355|590332445|FG002|Overall Study|Withdrawal by Subject|0|||
163445607|NCT02552355|590332446|FG003|Overall Study|Withdrawal by Subject|1|||
163445608|NCT00850460|590332449|FG000|Overall Study|Lost to Follow-up|4|||
163445609|NCT00850460|590332450|FG001|Overall Study|Lost to Follow-up|4|||
163445610|NCT02084134|590332455|FG000|Overall Study|Protocol Violation|4|||
163445611|NCT02084134|590332456|FG001|Overall Study|Protocol Violation|2|||
163445612|NCT02084134|590332455|FG000|Overall Study|Death|0|||
163445613|NCT02084134|590332456|FG001|Overall Study|Death|1|||
163445614|NCT02026271|590332457|FG000|Overall Study|Adverse Event|2|||
163445615|NCT02026271|590332458|FG001|Overall Study|Adverse Event|3|||
163445616|NCT02026271|590332459|FG002|Overall Study|Adverse Event|2|||
163445617|NCT02026271|590332460|FG003|Overall Study|Adverse Event|3|||
163445618|NCT02026271|590332461|FG004|Overall Study|Adverse Event|0|||
163445619|NCT02026271|590332457|FG000|Overall Study|Withdrawal by Subject|0|||
163445620|NCT02026271|590332458|FG001|Overall Study|Withdrawal by Subject|0|||
163445621|NCT02026271|590332459|FG002|Overall Study|Withdrawal by Subject|0|||
163445622|NCT02026271|590332460|FG003|Overall Study|Withdrawal by Subject|0|||
163445623|NCT02026271|590332461|FG004|Overall Study|Withdrawal by Subject|1|||
163445624|NCT04333433|590332462|FG000|Overall Study|Withdrawal by Subject|6|||
163445625|NCT04333433|590332463|FG001|Overall Study|Withdrawal by Subject|3|||
163445626|NCT04333433|590332462|FG000|Overall Study|Death|3|||
163445627|NCT04333433|590332463|FG001|Overall Study|Death|0|||
163445628|NCT04333433|590332462|FG000|Overall Study|Lost to Follow-up|6|||
163445629|NCT04333433|590332463|FG001|Overall Study|Lost to Follow-up|1|||
163445630|NCT04333433|590332462|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
163445631|NCT04333433|590332463|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
163445632|NCT02807454|590332464|FG000|Overall Study|Adverse Event|1|||
163445633|NCT02807454|590332465|FG001|Overall Study|Adverse Event|0|||
163445634|NCT02807454|590332464|FG000|Overall Study|Withdrawal by Subject|0|||
163445635|NCT02807454|590332465|FG001|Overall Study|Withdrawal by Subject|1|||
163445636|NCT02807454|590332464|FG000|Overall Study|Progressive Disease|30|||
163445637|NCT02807454|590332465|FG001|Overall Study|Progressive Disease|3|||
163445638|NCT02807454|590332464|FG000|Overall Study|Other Reasons|1|||
163445639|NCT02807454|590332465|FG001|Overall Study|Other Reasons|1|||
163445640|NCT05468086|590332468|FG000|Overall Study|Withdrawal by Subject|3|||
163445641|NCT05468086|590332468|FG000|Overall Study|Subject was found ineligible after consent|1|||
163445642|NCT01108809|590332469|FG000|Overall Study|Adverse Event|3|||
163445643|NCT01108809|590332469|FG000|Overall Study|Lost to Follow-up|1|||
163445644|NCT00001262|590332475|FG000|Overall Study|Death|10|||
163445645|NCT00001262|590332476|FG001|Overall Study|Death|11|||
163445646|NCT00001262|590332477|FG002|Overall Study|Death|0|||
163445647|NCT00001262|590332475|FG000|Overall Study|Withdrawal by Subject|0|||
163445648|NCT00001262|590332476|FG001|Overall Study|Withdrawal by Subject|3|||
163445649|NCT00001262|590332477|FG002|Overall Study|Withdrawal by Subject|0|||
163445650|NCT00783705|590332479|FG000|Overall Study|Adverse Event|2|||
163445651|NCT00783705|590332480|FG001|Overall Study|Adverse Event|0|||
163445652|NCT00783705|590332479|FG000|Overall Study|Withdrawal by Subject|3|||
163445653|NCT00783705|590332480|FG001|Overall Study|Withdrawal by Subject|2|||
163445654|NCT00783705|590332479|FG000|Overall Study|Lost to Follow-up|1|||
163445655|NCT00783705|590332480|FG001|Overall Study|Lost to Follow-up|3|||
163445656|NCT00748540|590332481|FG000|Overall Study|Physician Decision|1|||
163445657|NCT04743635|590332482|FG000|Overall Study|Lost to Follow-up|2|||
163445658|NCT04743635|590332483|FG001|Overall Study|Lost to Follow-up|0|||
163445659|NCT00804193|590332484|FG000|Overall Study|Lack of baseline fungus|32|||
163445660|NCT00804193|590332485|FG001|Overall Study|Lack of baseline fungus|31|||
163445661|NCT00804193|590332486|FG002|Overall Study|Lack of baseline fungus|19|||
163445662|NCT00804193|590332484|FG000|Overall Study|Adverse Event|0|||
163445663|NCT00804193|590332485|FG001|Overall Study|Adverse Event|0|||
163445664|NCT00804193|590332486|FG002|Overall Study|Adverse Event|2|||
163445665|NCT00804193|590332484|FG000|Overall Study|Lack of Efficacy|1|||
163445666|NCT00804193|590332485|FG001|Overall Study|Lack of Efficacy|1|||
163445667|NCT00804193|590332486|FG002|Overall Study|Lack of Efficacy|3|||
163445668|NCT00804193|590332484|FG000|Overall Study|Protocol Violation|0|||
163445669|NCT00804193|590332485|FG001|Overall Study|Protocol Violation|8|||
163445670|NCT00804193|590332486|FG002|Overall Study|Protocol Violation|2|||
163445671|NCT00804193|590332484|FG000|Overall Study|Lost to Follow-up|3|||
163445672|NCT00804193|590332485|FG001|Overall Study|Lost to Follow-up|3|||
163445673|NCT00804193|590332486|FG002|Overall Study|Lost to Follow-up|4|||
163445674|NCT00804193|590332484|FG000|Overall Study|Withdrawal by Subject|3|||
163445675|NCT00804193|590332485|FG001|Overall Study|Withdrawal by Subject|1|||
163445676|NCT00804193|590332486|FG002|Overall Study|Withdrawal by Subject|2|||
163445677|NCT01193348|590332487|FG000|Screening Period|Screen Failure|5|||
163445678|NCT01193348|590332487|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
163445679|NCT01193348|590332487|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
163445680|NCT01193348|590332487|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
163445681|NCT01193348|590332487|FG000|Extension Treatment Period|Physician Decision|1|||
163445682|NCT01193348|590332487|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
163445683|NCT00968253|590332488|FG000|Overall Study|Death|0|||
163445684|NCT00968253|590332489|FG001|Overall Study|Death|0|||
163445685|NCT00968253|590332490|FG002|Overall Study|Death|2|||
163445686|NCT00968253|590332488|FG000|Overall Study|Withdrawal by Subject|0|||
163445687|NCT00968253|590332489|FG001|Overall Study|Withdrawal by Subject|0|||
163445688|NCT00968253|590332490|FG002|Overall Study|Withdrawal by Subject|1|||
163445689|NCT00968253|590332488|FG000|Overall Study|Disease Progression|0|||
163445690|NCT00968253|590332489|FG001|Overall Study|Disease Progression|3|||
163445691|NCT00968253|590332490|FG002|Overall Study|Disease Progression|3|||
163445692|NCT00968253|590332488|FG000|Overall Study|Adverse Event|0|||
163445693|NCT00968253|590332489|FG001|Overall Study|Adverse Event|0|||
163445694|NCT00968253|590332490|FG002|Overall Study|Adverse Event|1|||
163445695|NCT03860844|590332492|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
163445696|NCT03860844|590332493|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
163445697|NCT03860844|590332494|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
163445698|NCT03860844|590332492|FG000|Overall Study|Progressive disease|5|||
163445699|NCT03860844|590332493|FG001|Overall Study|Progressive disease|3|||
163445700|NCT03860844|590332494|FG002|Overall Study|Progressive disease|4|||
163445701|NCT03860844|590332492|FG000|Overall Study|Other, Not related to COVID-19|0|||
163445702|NCT03860844|590332493|FG001|Overall Study|Other, Not related to COVID-19|1|||
163445703|NCT03860844|590332494|FG002|Overall Study|Other, Not related to COVID-19|0|||
163445704|NCT01678807|590332497|FG000|Overall Study|Adverse Event|4|||
163445705|NCT01678807|590332498|FG001|Overall Study|Adverse Event|4|||
163445706|NCT01678807|590332499|FG002|Overall Study|Adverse Event|0|||
163445707|NCT01678807|590332497|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
163445708|NCT01678807|590332498|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
163445709|NCT01678807|590332499|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
163445710|NCT05281523|590332500|FG000|Overall Study|Adverse Event|1|||
163445711|NCT05281523|590332501|FG001|Overall Study|Adverse Event|1|||
163445712|NCT05281523|590332500|FG000|Overall Study|Physician Decision|1|||
163445713|NCT05281523|590332501|FG001|Overall Study|Physician Decision|1|||
163445714|NCT05281523|590332500|FG000|Overall Study|Withdrawal by Subject|5|||
163445715|NCT05281523|590332501|FG001|Overall Study|Withdrawal by Subject|15|||
163445716|NCT05281523|590332500|FG000|Overall Study|GCP violations|3|||
163445717|NCT05281523|590332501|FG001|Overall Study|GCP violations|4|||
163445718|NCT04038255|590334318|FG000|Overall Study|Lost to Follow-up|0|||
163445719|NCT04038255|590334319|FG001|Overall Study|Lost to Follow-up|9|||
163445720|NCT04038255|590334320|FG002|Overall Study|Lost to Follow-up|5|||
163445721|NCT04038255|590334318|FG000|Overall Study|Withdrawal by Subject|0|||
163445722|NCT04038255|590334319|FG001|Overall Study|Withdrawal by Subject|0|||
162925391|NCT05302414|588428961|FG000|Pretest to Posttest|Lost to Follow-up|12|||
163445723|NCT04038255|590334320|FG002|Overall Study|Withdrawal by Subject|1|||
163445724|NCT05183867|590334321|FG000|Overall Study|Withdrawal by Subject|3|||
163445725|NCT05183867|590334322|FG001|Overall Study|Withdrawal by Subject|2|||
163445726|NCT05183867|590334323|FG002|Overall Study|Withdrawal by Subject|0|||
163445727|NCT05306873|590334326|FG000|Stage 2|Study stopped|1|||
163445728|NCT05306873|590334327|FG001|Stage 2|Study stopped|1|||
163445729|NCT05306873|590334328|FG002|Stage 2|Study stopped|0|||
163445730|NCT05306873|590334329|FG003|Stage 2|Study stopped|0|||
163445731|NCT05306873|590334326|FG000|Stage 2|Stage 2 Treatment Failure|2|||
163445732|NCT05306873|590334327|FG001|Stage 2|Stage 2 Treatment Failure|3|||
163445733|NCT05306873|590334328|FG002|Stage 2|Stage 2 Treatment Failure|0|||
163445734|NCT05306873|590334329|FG003|Stage 2|Stage 2 Treatment Failure|0|||
163445735|NCT05306873|590334326|FG000|Stage 2|Logistical issues due to participant moving|1|||
163445736|NCT05306873|590334327|FG001|Stage 2|Logistical issues due to participant moving|0|||
163445737|NCT05306873|590334328|FG002|Stage 2|Logistical issues due to participant moving|0|||
163445738|NCT05306873|590334329|FG003|Stage 2|Logistical issues due to participant moving|0|||
163445739|NCT05306873|590334326|FG000|Stage 3|Stage 3 Treatment Failure|0|||
163445740|NCT05306873|590334327|FG001|Stage 3|Stage 3 Treatment Failure|0|||
163445741|NCT05306873|590334328|FG002|Stage 3|Stage 3 Treatment Failure|0|||
163445742|NCT05306873|590334329|FG003|Stage 3|Stage 3 Treatment Failure|1|||
163445743|NCT05306873|590334326|FG000|Stage 3|Study Stopped|0|||
163445744|NCT05306873|590334327|FG001|Stage 3|Study Stopped|0|||
163445745|NCT05306873|590334328|FG002|Stage 3|Study Stopped|1|||
163445746|NCT05306873|590334329|FG003|Stage 3|Study Stopped|0|||
163445747|NCT01953328|590334330|FG000|Overall Study|Withdrawal by Subject|0|||
163445748|NCT01953328|590334331|FG001|Overall Study|Withdrawal by Subject|0|||
163445749|NCT01953328|590334332|FG002|Overall Study|Withdrawal by Subject|0|||
163445750|NCT01953328|590334333|FG003|Overall Study|Withdrawal by Subject|0|||
163445751|NCT01953328|590334334|FG004|Overall Study|Withdrawal by Subject|1|||
163445752|NCT01953328|590334335|FG005|Overall Study|Withdrawal by Subject|0|||
163445753|NCT01953328|590334336|FG006|Overall Study|Withdrawal by Subject|0|||
163445754|NCT01953328|590334337|FG007|Overall Study|Withdrawal by Subject|0|||
163445755|NCT01953328|590334330|FG000|Overall Study|Lost to Follow-up|0|||
163445756|NCT01953328|590334331|FG001|Overall Study|Lost to Follow-up|0|||
163445757|NCT01953328|590334332|FG002|Overall Study|Lost to Follow-up|0|||
163445758|NCT01953328|590334333|FG003|Overall Study|Lost to Follow-up|0|||
163445759|NCT01953328|590334334|FG004|Overall Study|Lost to Follow-up|1|||
163445760|NCT01953328|590334335|FG005|Overall Study|Lost to Follow-up|0|||
163445761|NCT01953328|590334336|FG006|Overall Study|Lost to Follow-up|0|||
163445762|NCT01953328|590334337|FG007|Overall Study|Lost to Follow-up|0|||
163445763|NCT01755195|590334340|FG000|Overall Study|Participant noncompliance|2|||
163445764|NCT01755195|590334340|FG000|Overall Study|Switched to alternative treatment|4|||
163445765|NCT01755195|590334340|FG000|Overall Study|Withdrawal by Subject|1|||
163445766|NCT01755195|590334340|FG000|Overall Study|Participant refused to start treatment|1|||
163445767|NCT01755195|590334340|FG000|Overall Study|Participant has been consented for another trial|1|||
163445768|NCT01755195|590334340|FG000|Overall Study|Refused further treatment|3|||
163445769|NCT01755195|590334340|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
163445770|NCT05113953|590334341|FG000|Overall Study|Adverse Event|5|||
163445771|NCT05113953|590334342|FG001|Overall Study|Adverse Event|0|||
163445772|NCT05113953|590334343|FG002|Overall Study|Adverse Event|3|||
163445773|NCT05113953|590334341|FG000|Overall Study|Lost to Follow-up|3|||
163445774|NCT05113953|590334342|FG001|Overall Study|Lost to Follow-up|4|||
163445775|NCT05113953|590334343|FG002|Overall Study|Lost to Follow-up|2|||
163445776|NCT05113953|590334341|FG000|Overall Study|Non-compliance with Study Drug|1|||
163445777|NCT05113953|590334342|FG001|Overall Study|Non-compliance with Study Drug|0|||
163445778|NCT05113953|590334343|FG002|Overall Study|Non-compliance with Study Drug|0|||
163445779|NCT05113953|590334341|FG000|Overall Study|Withdrawal by Subject|2|||
163445780|NCT05113953|590334342|FG001|Overall Study|Withdrawal by Subject|6|||
163445781|NCT05113953|590334343|FG002|Overall Study|Withdrawal by Subject|4|||
163445782|NCT05113953|590334341|FG000|Overall Study|Reason not Specified|2|||
163445783|NCT05113953|590334342|FG001|Overall Study|Reason not Specified|0|||
163445784|NCT05113953|590334343|FG002|Overall Study|Reason not Specified|0|||
163445785|NCT02340819|590334346|FG000|Overall Study|Adverse Event|1|||
163445786|NCT02340819|590334346|FG000|Overall Study|Withdrawal by Subject|2|||
163445787|NCT02340819|590334346|FG000|Overall Study|Discontinued with other reason|1|||
163445788|NCT01328249|590334347|FG000|Overall Study|Adverse Event|3|||
163445789|NCT01328249|590334348|FG001|Overall Study|Adverse Event|0|||
163445790|NCT01328249|590334347|FG000|Overall Study|Disease progression|1|||
163445791|NCT01328249|590334348|FG001|Overall Study|Disease progression|0|||
163445792|NCT01328249|590334347|FG000|Overall Study|Withdrawal by Subject|1|||
163445793|NCT01328249|590334348|FG001|Overall Study|Withdrawal by Subject|1|||
163445794|NCT01328249|590334347|FG000|Overall Study|Moved before end of treatment visit|1|||
163445795|NCT01328249|590334348|FG001|Overall Study|Moved before end of treatment visit|0|||
163445796|NCT01328249|590334347|FG000|Overall Study|Subject choice|1|||
163445797|NCT01328249|590334348|FG001|Overall Study|Subject choice|1|||
163445798|NCT01328249|590334347|FG000|Overall Study|Protocol Violation|0|||
163445799|NCT01328249|590334348|FG001|Overall Study|Protocol Violation|1|||
163445800|NCT02330549|590334349|FG000|Overall Study|Adverse Event|1|||
163445801|NCT02330549|590334350|FG001|Overall Study|Adverse Event|0|||
163445802|NCT02330549|590334349|FG000|Overall Study|Subject withdrew consent|2|||
163445803|NCT02330549|590334350|FG001|Overall Study|Subject withdrew consent|1|||
163445804|NCT02330549|590334349|FG000|Overall Study|Failure to meet randomization criteria|1|||
163445805|NCT02330549|590334350|FG001|Overall Study|Failure to meet randomization criteria|0|||
163445806|NCT00423085|590334351|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
163445807|NCT00423085|590334352|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
163445808|NCT00423085|590334353|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
163445809|NCT00423085|590334354|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
163445810|NCT00423085|590334351|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
163445811|NCT00423085|590334352|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
163445812|NCT00423085|590334353|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
163445813|NCT00423085|590334354|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
163445814|NCT00423085|590334351|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
163445815|NCT00423085|590334352|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
163445816|NCT00423085|590334353|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
163445817|NCT00423085|590334354|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
163445818|NCT00423085|590334351|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
163445819|NCT00423085|590334352|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
163445820|NCT00423085|590334353|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
163445821|NCT00423085|590334354|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
163445822|NCT00423085|590334351|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
163445823|NCT00423085|590334352|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
163445824|NCT00423085|590334353|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
163445825|NCT00423085|590334354|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
163445826|NCT00423085|590334351|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
163445827|NCT00423085|590334352|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
163445828|NCT00423085|590334353|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
163445829|NCT00423085|590334354|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
163445830|NCT00423085|590334351|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
163445831|NCT00423085|590334352|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
163445832|NCT00423085|590334353|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
163445833|NCT00423085|590334354|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
163445834|NCT00423085|590334351|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
163445835|NCT00423085|590334352|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
163445836|NCT00423085|590334353|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
163445837|NCT00423085|590334354|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
163445838|NCT00423085|590334351|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
163445839|NCT00423085|590334352|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
163445840|NCT00423085|590334353|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
163445841|NCT00423085|590334354|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
163445842|NCT00423085|590334351|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
163445843|NCT00423085|590334352|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
163445844|NCT00423085|590334353|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
163445845|NCT00423085|590334354|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
163445846|NCT00423085|590334351|FG000|52-Week Open-Label Extension Phase|Death|0|||
163445847|NCT00423085|590334352|FG001|52-Week Open-Label Extension Phase|Death|0|||
163445848|NCT00423085|590334353|FG002|52-Week Open-Label Extension Phase|Death|0|||
163445849|NCT00423085|590334354|FG003|52-Week Open-Label Extension Phase|Death|2|||
163445850|NCT03331666|590334355|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
163445851|NCT03331666|590334356|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
163445852|NCT00434512|590334357|FG000|Overall Study|Migrated/moved from study area|0|||
163445853|NCT00434512|590334358|FG001|Overall Study|Migrated/moved from study area|0|||
163445854|NCT00434512|590334359|FG002|Overall Study|Migrated/moved from study area|0|||
163445855|NCT00434512|590334360|FG003|Overall Study|Migrated/moved from study area|1|||
163445856|NCT00434512|590334361|FG004|Overall Study|Migrated/moved from study area|1|||
163445857|NCT00434512|590334362|FG005|Overall Study|Migrated/moved from study area|1|||
163445858|NCT00434512|590334357|FG000|Overall Study|Other|0|||
163445859|NCT00434512|590334358|FG001|Overall Study|Other|1|||
163445860|NCT00434512|590334359|FG002|Overall Study|Other|0|||
163445861|NCT00434512|590334360|FG003|Overall Study|Other|0|||
163445862|NCT00434512|590334361|FG004|Overall Study|Other|0|||
163445863|NCT00434512|590334362|FG005|Overall Study|Other|0|||
163445864|NCT02750813|590334365|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
163445865|NCT02750813|590334366|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
163445866|NCT02750813|590334365|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
163445867|NCT02750813|590334366|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
163445868|NCT02245568|590334367|FG000|Overall Study|Study terminated by Sponsor|346|||
163445869|NCT02245568|590334367|FG000|Overall Study|Adverse Event|144|||
163445870|NCT02245568|590334367|FG000|Overall Study|Lack of Efficacy|98|||
163445871|NCT02245568|590334367|FG000|Overall Study|Withdrawal by Caregiver|85|||
163445872|NCT02245568|590334367|FG000|Overall Study|Withdrawal by Subject|77|||
163445873|NCT02245568|590334367|FG000|Overall Study|Withdrawal by Legal Representative|31|||
163445874|NCT02245568|590334367|FG000|Overall Study|Missing (Site closure)|16|||
163445875|NCT02245568|590334367|FG000|Overall Study|Physician Decision|14|||
163445876|NCT02245568|590334367|FG000|Overall Study|Non-compliance with study drug|11|||
163445877|NCT02245568|590334367|FG000|Overall Study|Death|9|||
163445878|NCT02245568|590334367|FG000|Overall Study|Blue staining|6|||
163445879|NCT02245568|590334367|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
163445880|NCT02245568|590334367|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
163445881|NCT02245568|590334367|FG000|Overall Study|Lost to Follow-up|5|||
163445882|NCT00441441|590334368|FG000|Overall Study|Adverse Event|2|||
163445883|NCT00441441|590334369|FG001|Overall Study|Adverse Event|1|||
163445884|NCT00441441|590334368|FG000|Overall Study|Protocol Violation|4|||
163445885|NCT00441441|590334369|FG001|Overall Study|Protocol Violation|6|||
163445886|NCT00441441|590334368|FG000|Overall Study|Exacerbation of asthma|1|||
163445887|NCT00441441|590334369|FG001|Overall Study|Exacerbation of asthma|2|||
163445888|NCT00441441|590334368|FG000|Overall Study|Withdrawal by Subject|1|||
163445889|NCT00441441|590334369|FG001|Overall Study|Withdrawal by Subject|2|||
163445890|NCT00441441|590334368|FG000|Overall Study|Other|3|||
163445891|NCT00441441|590334369|FG001|Overall Study|Other|3|||
163445892|NCT00769704|590334376|FG000|Overall Study|Lost to Follow-up|3|||
163445893|NCT00769704|590334377|FG001|Overall Study|Lost to Follow-up|2|||
163445894|NCT00769704|590334376|FG000|Overall Study|Death|95|||
163445895|NCT00769704|590334377|FG001|Overall Study|Death|190|||
163445896|NCT00769704|590334376|FG000|Overall Study|Withdrawal by Subject|12|||
163445897|NCT00769704|590334377|FG001|Overall Study|Withdrawal by Subject|5|||
163445898|NCT00769704|590334376|FG000|Overall Study|Other|1|||
163445899|NCT00769704|590334377|FG001|Overall Study|Other|2|||
163445900|NCT00520676|590334378|FG000|Overall Study|Death|84|||
163445901|NCT00520676|590334379|FG001|Overall Study|Death|81|||
163445902|NCT00520676|590334378|FG000|Overall Study|Lost to Follow-up|6|||
163445903|NCT00520676|590334379|FG001|Overall Study|Lost to Follow-up|10|||
163445904|NCT00520676|590334378|FG000|Overall Study|Physician Decision|4|||
163445905|NCT00520676|590334379|FG001|Overall Study|Physician Decision|1|||
163445906|NCT00520676|590334378|FG000|Overall Study|Withdrawal by Subject|7|||
163445907|NCT00520676|590334379|FG001|Overall Study|Withdrawal by Subject|11|||
163445908|NCT03298412|590334383|FG000|Run-in Period|Other, Not Specified|1|||
163445909|NCT03298412|590334383|FG000|Run-in Period|Disease Progression|1|||
163445910|NCT03298412|590334383|FG000|Run-in Period|Ineligibility Determined|1|||
163445911|NCT03298412|590334383|FG000|Run-in Period|Decision by Sponsor|6|||
163445912|NCT03456713|590334386|FG000|Overall Study|Lost to Follow-up|1|||
163445913|NCT03456713|590334387|FG001|Overall Study|Lost to Follow-up|0|||
163445914|NCT03456713|590334388|FG002|Overall Study|Lost to Follow-up|0|||
163445915|NCT03456713|590334389|FG003|Overall Study|Lost to Follow-up|0|||
163445916|NCT01202227|590334390|FG000|Overall Study|Adverse Event|16|||
163445917|NCT01202227|590334390|FG000|Overall Study|Withdrawal by Subject|2|||
163445918|NCT01202227|590334390|FG000|Overall Study|Lack of Efficacy|1|||
163445919|NCT01894477|590334391|FG000|Overall Study|Protocol Violation|0|||
163445920|NCT01894477|590334392|FG001|Overall Study|Protocol Violation|1|||
163445921|NCT01894477|590334391|FG000|Overall Study|protocol changed due SC changed to cord|0|||
163445922|NCT01894477|590334392|FG001|Overall Study|protocol changed due SC changed to cord|1|||
163445923|NCT01533935|590334394|FG000|Overall Study|Adverse Event|5|||
163445924|NCT01533935|590334395|FG001|Overall Study|Adverse Event|7|||
163445925|NCT01533935|590334396|FG002|Overall Study|Adverse Event|1|||
163445926|NCT01533935|590334397|FG003|Overall Study|Adverse Event|5|||
163445927|NCT01533935|590334398|FG004|Overall Study|Adverse Event|3|||
163445928|NCT01533935|590334394|FG000|Overall Study|Protocol Violation|0|||
163445929|NCT01533935|590334395|FG001|Overall Study|Protocol Violation|2|||
163445930|NCT01533935|590334396|FG002|Overall Study|Protocol Violation|0|||
163445931|NCT01533935|590334397|FG003|Overall Study|Protocol Violation|0|||
163445932|NCT01533935|590334398|FG004|Overall Study|Protocol Violation|0|||
163445933|NCT01533935|590334394|FG000|Overall Study|Lost to Follow-up|0|||
163445934|NCT01533935|590334395|FG001|Overall Study|Lost to Follow-up|0|||
163445935|NCT01533935|590334396|FG002|Overall Study|Lost to Follow-up|1|||
163445936|NCT01533935|590334397|FG003|Overall Study|Lost to Follow-up|0|||
163445937|NCT01533935|590334398|FG004|Overall Study|Lost to Follow-up|0|||
163445938|NCT01533935|590334394|FG000|Overall Study|Withdrawal by Subject|0|||
163445939|NCT01533935|590334395|FG001|Overall Study|Withdrawal by Subject|4|||
163445940|NCT01533935|590334396|FG002|Overall Study|Withdrawal by Subject|5|||
163445941|NCT01533935|590334397|FG003|Overall Study|Withdrawal by Subject|2|||
163445942|NCT01533935|590334398|FG004|Overall Study|Withdrawal by Subject|4|||
163445943|NCT01533935|590334394|FG000|Overall Study|Other reason not defined above|1|||
163445944|NCT01533935|590334395|FG001|Overall Study|Other reason not defined above|0|||
163445945|NCT01533935|590334396|FG002|Overall Study|Other reason not defined above|1|||
163445946|NCT01533935|590334397|FG003|Overall Study|Other reason not defined above|0|||
163445947|NCT01533935|590334398|FG004|Overall Study|Other reason not defined above|1|||
163445948|NCT01727713|590334414|FG000|Overall Study|Lost to Follow-up|5|||
163445949|NCT01727713|590334414|FG000|Overall Study|Adverse Event|10|||
163445950|NCT01727713|590334414|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
163445951|NCT01727713|590334414|FG000|Overall Study|Withdrawal by Subject|13|||
163445952|NCT01727713|590334414|FG000|Overall Study|Protocol Deviation|2|||
163445953|NCT02389816|590334415|FG000|Overall Study|Randomized but Not Treated|1|||
163445954|NCT02389816|590334416|FG001|Overall Study|Randomized but Not Treated|0|||
163445955|NCT02389816|590334417|FG002|Overall Study|Randomized but Not Treated|0|||
163445956|NCT02389816|590334415|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
163445957|NCT02389816|590334416|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
163445958|NCT02389816|590334417|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
163445959|NCT02389816|590334415|FG000|Overall Study|Major Protocol Deviation|1|||
163445960|NCT02389816|590334416|FG001|Overall Study|Major Protocol Deviation|0|||
163445961|NCT02389816|590334417|FG002|Overall Study|Major Protocol Deviation|0|||
163445962|NCT02389816|590334415|FG000|Overall Study|Lost to Follow-up|1|||
163445963|NCT02389816|590334416|FG001|Overall Study|Lost to Follow-up|0|||
163445964|NCT02389816|590334417|FG002|Overall Study|Lost to Follow-up|0|||
163445965|NCT02389816|590334415|FG000|Overall Study|Withdrawal of Consent|6|||
163445966|NCT02389816|590334416|FG001|Overall Study|Withdrawal of Consent|4|||
163445967|NCT02389816|590334417|FG002|Overall Study|Withdrawal of Consent|4|||
163445968|NCT02389816|590334415|FG000|Overall Study|Lack of Efficacy|1|||
163445969|NCT02389816|590334416|FG001|Overall Study|Lack of Efficacy|0|||
163445970|NCT02389816|590334417|FG002|Overall Study|Lack of Efficacy|0|||
163445971|NCT02389816|590334415|FG000|Overall Study|Non Compliance with Study Drug|1|||
163445972|NCT02389816|590334416|FG001|Overall Study|Non Compliance with Study Drug|1|||
163445973|NCT02389816|590334417|FG002|Overall Study|Non Compliance with Study Drug|1|||
163445974|NCT02389816|590334415|FG000|Overall Study|Reason not Specified|0|||
163445975|NCT02389816|590334416|FG001|Overall Study|Reason not Specified|2|||
163445976|NCT02389816|590334417|FG002|Overall Study|Reason not Specified|0|||
163445977|NCT01217190|590334424|FG000|Second Dosing|Withdrawal by Subject|0|||
163445978|NCT01217190|590334425|FG001|Second Dosing|Withdrawal by Subject|2|||
163445979|NCT01594476|590334426|FG000|Overall Study|Protocol Violation|1|||
163445980|NCT01594476|590334427|FG001|Overall Study|Protocol Violation|3|||
163445981|NCT05114590|590334428|FG000|Overall Study|Adverse Event|1|||
163445982|NCT05114590|590334428|FG000|Overall Study|Investigator decision|1|||
163445983|NCT05114590|590334428|FG000|Overall Study|Lost to Follow-up|5|||
163445984|NCT05114590|590334428|FG000|Overall Study|Withdrawal by Subject|5|||
163445985|NCT05114590|590334428|FG000|Overall Study|Other|2|||
163445986|NCT03007953|590334429|FG000|Overall Study|Withdrawal by Subject|5|||
163445987|NCT03007953|590334430|FG001|Overall Study|Withdrawal by Subject|2|||
163445988|NCT03007953|590334429|FG000|Overall Study|Death|5|||
163445989|NCT03007953|590334430|FG001|Overall Study|Death|7|||
163445990|NCT03007953|590334429|FG000|Overall Study|Lost to Follow-up|3|||
163445991|NCT03007953|590334430|FG001|Overall Study|Lost to Follow-up|2|||
163445992|NCT03007953|590334429|FG000|Overall Study|Enrolled in Hospice|3|||
163445993|NCT03007953|590334430|FG001|Overall Study|Enrolled in Hospice|2|||
163445994|NCT02224846|590334431|FG000|Period 1 (Month 3)|Adverse Event|2|||
163445995|NCT02224846|590334432|FG001|Period 1 (Month 3)|Adverse Event|1|||
163445996|NCT02224846|590334431|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
163445997|NCT02224846|590334432|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
163445998|NCT02224846|590334431|FG000|Period 1 (Month 3)|Protocol Violation|4|||
163445999|NCT02224846|590334432|FG001|Period 1 (Month 3)|Protocol Violation|8|||
163446000|NCT02224846|590334431|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
163446001|NCT02224846|590334432|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
163446002|NCT02224846|590334431|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
163446003|NCT02224846|590334432|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
163446004|NCT02224846|590334431|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
163446005|NCT02224846|590334432|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
163446006|NCT02224846|590334431|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
163446007|NCT02224846|590334432|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
163446008|NCT02224846|590334431|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
163446009|NCT02224846|590334432|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
163446010|NCT02224846|590334431|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
163446011|NCT02224846|590334432|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
163446012|NCT02224846|590334431|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
163446013|NCT02224846|590334432|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
163446014|NCT02224846|590334431|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
163446015|NCT02224846|590334432|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
163446016|NCT02224846|590334431|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
163446017|NCT02224846|590334432|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
163446018|NCT02224846|590334431|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
163446019|NCT02224846|590334432|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
163446020|NCT02224846|590334431|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
163446021|NCT02224846|590334432|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
163446022|NCT02224846|590334431|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
163446023|NCT02224846|590334432|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
163446024|NCT02224846|590334431|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
163446025|NCT02224846|590334432|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
163446026|NCT02224846|590334431|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
163446027|NCT02224846|590334432|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
163446028|NCT03196297|590334433|FG000|Main Period|Withdrawal by Subject|4|||
163446029|NCT03196297|590334433|FG000|Extension Period|Withdrawal by Subject|1|||
163446030|NCT03196297|590334433|FG000|Extension Period|Lack of Efficacy|2|||
163446031|NCT00872170|590334437|FG000|Overall Study|Adverse Event|1|||
163446032|NCT00872170|590334438|FG001|Overall Study|Adverse Event|0|||
163446033|NCT01402284|590334441|FG000|Overall Study|Withdrawal consent|2|||
163446034|NCT01402284|590334441|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
163446035|NCT01402284|590334441|FG000|Overall Study|Physician Decision|1|||
163446036|NCT01402284|590334441|FG000|Overall Study|Disease progression on study|10|||
163446037|NCT01745393|590334443|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
163446038|NCT01745393|590334444|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
163446039|NCT01745393|590334443|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
163446040|NCT01745393|590334444|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
163446041|NCT01745393|590334443|FG000|12-month Follow-up|Lost to Follow-up|6|||
163446042|NCT01745393|590334444|FG001|12-month Follow-up|Lost to Follow-up|5|||
163446043|NCT00905021|590334449|FG000|Overall Study|Adverse Event|2|||
163446044|NCT00786838|590334450|FG000|Overall Study|Physician Decision|4|||
163446045|NCT00786838|590334450|FG000|Overall Study|Death|4|||
163446046|NCT00786838|590334450|FG000|Overall Study|Adverse Event|6|||
163446047|NCT00786838|590334450|FG000|Overall Study|Progressive disease|31|||
163446048|NCT00786838|590334450|FG000|Overall Study|Withdrawal by Subject|4|||
163446049|NCT04937816|590334451|FG000|Overall Study|Study drug stopped, reason missing|5|||
163446050|NCT04937816|590334452|FG001|Overall Study|Study drug stopped, reason missing|3|||
163446051|NCT04937816|590334453|FG002|Overall Study|Study drug stopped, reason missing|4|||
163446052|NCT04937816|590334454|FG003|Overall Study|Study drug stopped, reason missing|6|||
163446053|NCT04937816|590334455|FG004|Overall Study|Study drug stopped, reason missing|1|||
163446054|NCT04937816|590334456|FG005|Overall Study|Study drug stopped, reason missing|0|||
163446055|NCT04937816|590334457|FG006|Overall Study|Study drug stopped, reason missing|0|||
163446056|NCT04937816|590334451|FG000|Overall Study|Other than stated below|173|||
163446057|NCT04937816|590334452|FG001|Overall Study|Other than stated below|143|||
163446058|NCT04937816|590334453|FG002|Overall Study|Other than stated below|125|||
163446059|NCT04937816|590334454|FG003|Overall Study|Other than stated below|44|||
163446060|NCT04937816|590334455|FG004|Overall Study|Other than stated below|45|||
163446061|NCT04937816|590334456|FG005|Overall Study|Other than stated below|28|||
163446062|NCT04937816|590334457|FG006|Overall Study|Other than stated below|31|||
163446063|NCT04937816|590334451|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
163446064|NCT04937816|590334452|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
163446065|NCT04937816|590334453|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
163446066|NCT04937816|590334454|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
163446067|NCT04937816|590334455|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
163446068|NCT04937816|590334456|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
163446069|NCT04937816|590334457|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
163446070|NCT04937816|590334451|FG000|Overall Study|Lost to Follow-up|15|||
163446071|NCT04937816|590334452|FG001|Overall Study|Lost to Follow-up|9|||
163446072|NCT04937816|590334453|FG002|Overall Study|Lost to Follow-up|6|||
163446073|NCT04937816|590334454|FG003|Overall Study|Lost to Follow-up|6|||
163446074|NCT04937816|590334455|FG004|Overall Study|Lost to Follow-up|16|||
163446075|NCT04937816|590334456|FG005|Overall Study|Lost to Follow-up|11|||
163446076|NCT04937816|590334457|FG006|Overall Study|Lost to Follow-up|17|||
163446077|NCT04937816|590334451|FG000|Overall Study|Protocol Violation|15|||
163446078|NCT04937816|590334452|FG001|Overall Study|Protocol Violation|15|||
163446079|NCT04937816|590334453|FG002|Overall Study|Protocol Violation|12|||
163446080|NCT04937816|590334454|FG003|Overall Study|Protocol Violation|30|||
163446081|NCT04937816|590334455|FG004|Overall Study|Protocol Violation|24|||
163446082|NCT04937816|590334456|FG005|Overall Study|Protocol Violation|5|||
163446083|NCT04937816|590334457|FG006|Overall Study|Protocol Violation|5|||
163446084|NCT04937816|590334451|FG000|Overall Study|Adverse Event|303|||
163446085|NCT04937816|590334452|FG001|Overall Study|Adverse Event|267|||
163446086|NCT04937816|590334453|FG002|Overall Study|Adverse Event|273|||
163446087|NCT04937816|590334454|FG003|Overall Study|Adverse Event|553|||
163446088|NCT04937816|590334455|FG004|Overall Study|Adverse Event|575|||
163446089|NCT04937816|590334456|FG005|Overall Study|Adverse Event|343|||
163446090|NCT04937816|590334457|FG006|Overall Study|Adverse Event|337|||
163446091|NCT04937816|590334451|FG000|Overall Study|Not treated|4|||
163446092|NCT04937816|590334452|FG001|Overall Study|Not treated|2|||
163446093|NCT04937816|590334453|FG002|Overall Study|Not treated|2|||
163446094|NCT04937816|590334454|FG003|Overall Study|Not treated|2|||
163446095|NCT04937816|590334455|FG004|Overall Study|Not treated|1|||
163446096|NCT04937816|590334456|FG005|Overall Study|Not treated|4|||
163446097|NCT04937816|590334457|FG006|Overall Study|Not treated|0|||
163446098|NCT00436215|590334458|FG000|Overall Study|Refused further treatment|3|||
163446099|NCT00436215|590334458|FG000|Overall Study|Small bowel obstruction|1|||
163446100|NCT05513053|590334459|FG000|Overall Study|Lost to Follow-up|9|||
163446101|NCT05513053|590334460|FG001|Overall Study|Lost to Follow-up|11|||
163446102|NCT05513053|590334459|FG000|Overall Study|Withdrawal by parent/guardian|2|||
163446103|NCT05513053|590334460|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163446104|NCT05513053|590334459|FG000|Overall Study|Withdrawal by Subject|2|||
163446105|NCT05513053|590334460|FG001|Overall Study|Withdrawal by Subject|9|||
163446106|NCT05513053|590334459|FG000|Overall Study|Protocol Violation|6|||
163446107|NCT05513053|590334460|FG001|Overall Study|Protocol Violation|3|||
163446108|NCT05513053|590334459|FG000|Overall Study|Adverse Event|0|||
163446109|NCT05513053|590334460|FG001|Overall Study|Adverse Event|2|||
163446110|NCT04491877|590335994|FG000|Overall Study|Protocol Deviation|1|||
163446111|NCT04491877|590335995|FG001|Overall Study|Protocol Deviation|0|||
163446112|NCT04491877|590335996|FG002|Overall Study|Protocol Deviation|2|||
163446113|NCT04491877|590335997|FG003|Overall Study|Protocol Deviation|0|||
163446114|NCT04491877|590335998|FG004|Overall Study|Protocol Deviation|0|||
163446115|NCT04491877|590335999|FG005|Overall Study|Protocol Deviation|0|||
163446116|NCT04491877|590336000|FG006|Overall Study|Protocol Deviation|1|||
163446117|NCT04491877|590336001|FG007|Overall Study|Protocol Deviation|1|||
163446118|NCT04491877|590336002|FG008|Overall Study|Protocol Deviation|0|||
163446119|NCT04491877|590335994|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163446120|NCT04491877|590335995|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163446121|NCT04491877|590335996|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163446122|NCT04491877|590335997|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
163446123|NCT04491877|590335998|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
163446124|NCT04491877|590335999|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
163446125|NCT04491877|590336000|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
163446126|NCT04491877|590336001|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
163446127|NCT04491877|590336002|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
163446128|NCT04491877|590335994|FG000|Overall Study|Lost to Follow-up|0|||
163446129|NCT04491877|590335995|FG001|Overall Study|Lost to Follow-up|2|||
163446130|NCT04491877|590335996|FG002|Overall Study|Lost to Follow-up|0|||
163446131|NCT04491877|590335997|FG003|Overall Study|Lost to Follow-up|0|||
163446132|NCT04491877|590335998|FG004|Overall Study|Lost to Follow-up|0|||
163446133|NCT04491877|590335999|FG005|Overall Study|Lost to Follow-up|0|||
163446134|NCT04491877|590336000|FG006|Overall Study|Lost to Follow-up|2|||
163446135|NCT04491877|590336001|FG007|Overall Study|Lost to Follow-up|1|||
163446136|NCT04491877|590336002|FG008|Overall Study|Lost to Follow-up|1|||
163446137|NCT02614287|590336003|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
163446138|NCT02614287|590336004|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
163446139|NCT02614287|590336003|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
163446140|NCT02614287|590336004|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
163446141|NCT02614287|590336003|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
163446142|NCT02614287|590336004|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
163446143|NCT02614287|590336003|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
163446144|NCT02614287|590336004|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
163446145|NCT02614287|590336003|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
163446146|NCT02614287|590336004|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
163446147|NCT02614287|590336003|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
163446148|NCT02614287|590336004|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
163446149|NCT02614287|590336003|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
163446150|NCT02614287|590336004|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
163446151|NCT02614287|590336003|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
163446152|NCT02614287|590336004|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
163446153|NCT00418834|590336005|FG000|Overall Study|Adverse Event|16|||
163446154|NCT00418834|590336006|FG001|Overall Study|Adverse Event|9|||
163446155|NCT00418834|590336005|FG000|Overall Study|Lost to Follow-up|0|||
163446156|NCT00418834|590336006|FG001|Overall Study|Lost to Follow-up|1|||
163446157|NCT00418834|590336005|FG000|Overall Study|Protocol Violation|4|||
163446158|NCT00418834|590336006|FG001|Overall Study|Protocol Violation|3|||
163446159|NCT00418834|590336005|FG000|Overall Study|Withdrawal by Subject|3|||
163446160|NCT00418834|590336006|FG001|Overall Study|Withdrawal by Subject|7|||
163446161|NCT02429258|590336007|FG000|Overall Study|Withdrawal by Subject|2|||
163446162|NCT02429258|590336008|FG001|Overall Study|Withdrawal by Subject|0|||
163446163|NCT02429258|590336007|FG000|Overall Study|Protocol Violation|0|||
163446164|NCT02429258|590336008|FG001|Overall Study|Protocol Violation|1|||
163446165|NCT00492856|590336009|FG000|Induction|Adverse Event|2|||
163446166|NCT00492856|590336010|FG001|Induction|Adverse Event|0|||
163446167|NCT00492856|590336011|FG002|Induction|Adverse Event|0|||
163446168|NCT00492856|590336012|FG003|Induction|Adverse Event|0|||
163446169|NCT00492856|590336009|FG000|Induction|Withdrawal by Subject|1|||
163446170|NCT00492856|590336010|FG001|Induction|Withdrawal by Subject|0|||
163446171|NCT00492856|590336011|FG002|Induction|Withdrawal by Subject|0|||
163446172|NCT00492856|590336012|FG003|Induction|Withdrawal by Subject|0|||
163446173|NCT00492856|590336009|FG000|Induction|Death|3|||
163446174|NCT00492856|590336010|FG001|Induction|Death|0|||
163446175|NCT00492856|590336011|FG002|Induction|Death|0|||
163446176|NCT00492856|590336012|FG003|Induction|Death|0|||
163446177|NCT00492856|590336009|FG000|Consolidation|Adverse Event|6|||
163446178|NCT00492856|590336010|FG001|Consolidation|Adverse Event|0|||
163446179|NCT00492856|590336011|FG002|Consolidation|Adverse Event|0|||
163446180|NCT00492856|590336012|FG003|Consolidation|Adverse Event|0|||
163446181|NCT00492856|590336009|FG000|Consolidation|Not protocol specified|2|||
163446182|NCT00492856|590336010|FG001|Consolidation|Not protocol specified|0|||
163446183|NCT00492856|590336011|FG002|Consolidation|Not protocol specified|0|||
163446184|NCT00492856|590336012|FG003|Consolidation|Not protocol specified|0|||
163446185|NCT00492856|590336009|FG000|Consolidation|Lost to Follow-up|1|||
163446186|NCT00492856|590336010|FG001|Consolidation|Lost to Follow-up|0|||
163446187|NCT00492856|590336011|FG002|Consolidation|Lost to Follow-up|0|||
163446188|NCT00492856|590336012|FG003|Consolidation|Lost to Follow-up|0|||
163446189|NCT00492856|590336009|FG000|Post-consolidation|Adverse Event|0|||
163446190|NCT00492856|590336010|FG001|Post-consolidation|Adverse Event|4|||
163446191|NCT00492856|590336011|FG002|Post-consolidation|Adverse Event|0|||
163446192|NCT00492856|590336012|FG003|Post-consolidation|Adverse Event|1|||
163446193|NCT00492856|590336009|FG000|Post-consolidation|Withdrawal by Subject|0|||
163446194|NCT00492856|590336010|FG001|Post-consolidation|Withdrawal by Subject|4|||
163446195|NCT00492856|590336011|FG002|Post-consolidation|Withdrawal by Subject|0|||
163446196|NCT00492856|590336012|FG003|Post-consolidation|Withdrawal by Subject|0|||
163446197|NCT00492856|590336009|FG000|Post-consolidation|Death|0|||
163446198|NCT00492856|590336010|FG001|Post-consolidation|Death|1|||
163446199|NCT00492856|590336011|FG002|Post-consolidation|Death|0|||
163446200|NCT00492856|590336012|FG003|Post-consolidation|Death|0|||
163446201|NCT00492856|590336009|FG000|Post-consolidation|Not protocol specified|0|||
163446202|NCT00492856|590336010|FG001|Post-consolidation|Not protocol specified|1|||
163446203|NCT00492856|590336011|FG002|Post-consolidation|Not protocol specified|0|||
163446204|NCT00492856|590336012|FG003|Post-consolidation|Not protocol specified|0|||
163446205|NCT00492856|590336009|FG000|Post-consolidation|Lost to Follow-up|0|||
163446206|NCT00492856|590336010|FG001|Post-consolidation|Lost to Follow-up|2|||
163446207|NCT00492856|590336011|FG002|Post-consolidation|Lost to Follow-up|0|||
163446208|NCT00492856|590336012|FG003|Post-consolidation|Lost to Follow-up|0|||
163446209|NCT00492856|590336009|FG000|Post-consolidation|Observation Arm|0|||
163446210|NCT00492856|590336010|FG001|Post-consolidation|Observation Arm|0|||
163446211|NCT00492856|590336011|FG002|Post-consolidation|Observation Arm|27|||
163446212|NCT00492856|590336012|FG003|Post-consolidation|Observation Arm|0|||
163446213|NCT03987919|590336013|FG000|Overall Study|Adverse Event|1|||
163446214|NCT03987919|590336014|FG001|Overall Study|Adverse Event|4|||
163446215|NCT03987919|590336015|FG002|Overall Study|Adverse Event|1|||
163446216|NCT03987919|590336016|FG003|Overall Study|Adverse Event|3|||
163446217|NCT03987919|590336013|FG000|Overall Study|Death|4|||
163446218|NCT03987919|590336014|FG001|Overall Study|Death|4|||
163446219|NCT03987919|590336015|FG002|Overall Study|Death|4|||
163446220|NCT03987919|590336016|FG003|Overall Study|Death|1|||
163446221|NCT03987919|590336013|FG000|Overall Study|Lost to Follow-up|5|||
163446222|NCT03987919|590336014|FG001|Overall Study|Lost to Follow-up|6|||
163446223|NCT03987919|590336015|FG002|Overall Study|Lost to Follow-up|8|||
163446224|NCT03987919|590336016|FG003|Overall Study|Lost to Follow-up|12|||
163446225|NCT03987919|590336013|FG000|Overall Study|Physician Decision|0|||
163446226|NCT03987919|590336014|FG001|Overall Study|Physician Decision|2|||
163446227|NCT03987919|590336015|FG002|Overall Study|Physician Decision|0|||
163446228|NCT03987919|590336016|FG003|Overall Study|Physician Decision|4|||
163446229|NCT03987919|590336013|FG000|Overall Study|Pregnancy|1|||
163446230|NCT03987919|590336014|FG001|Overall Study|Pregnancy|0|||
163446231|NCT03987919|590336015|FG002|Overall Study|Pregnancy|1|||
163446232|NCT03987919|590336016|FG003|Overall Study|Pregnancy|1|||
163446233|NCT03987919|590336013|FG000|Overall Study|Protocol Violation|0|||
163446234|NCT03987919|590336014|FG001|Overall Study|Protocol Violation|1|||
163446235|NCT03987919|590336015|FG002|Overall Study|Protocol Violation|0|||
163446236|NCT03987919|590336016|FG003|Overall Study|Protocol Violation|0|||
163446237|NCT03987919|590336013|FG000|Overall Study|Site terminated by Sponsor|0|||
163446238|NCT03987919|590336014|FG001|Overall Study|Site terminated by Sponsor|0|||
163446239|NCT03987919|590336015|FG002|Overall Study|Site terminated by Sponsor|0|||
163446240|NCT03987919|590336016|FG003|Overall Study|Site terminated by Sponsor|1|||
163446241|NCT03987919|590336013|FG000|Overall Study|Withdrawal by Subject|7|||
163446242|NCT03987919|590336014|FG001|Overall Study|Withdrawal by Subject|7|||
163446243|NCT03987919|590336015|FG002|Overall Study|Withdrawal by Subject|8|||
163446244|NCT03987919|590336016|FG003|Overall Study|Withdrawal by Subject|4|||
163446245|NCT03987919|590336013|FG000|Overall Study|Other - as reported by the investigator|1|||
163446246|NCT03987919|590336014|FG001|Overall Study|Other - as reported by the investigator|3|||
163446247|NCT03987919|590336015|FG002|Overall Study|Other - as reported by the investigator|2|||
163446248|NCT03987919|590336016|FG003|Overall Study|Other - as reported by the investigator|0|||
163446249|NCT01520324|590336021|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
163446250|NCT03470922|590336022|FG000|Overall Study|Death|107|||
163446251|NCT03470922|590336023|FG001|Overall Study|Death|118|||
163446252|NCT03470922|590336022|FG000|Overall Study|Lost to Follow-up|5|||
163446253|NCT03470922|590336023|FG001|Overall Study|Lost to Follow-up|5|||
163446254|NCT03470922|590336022|FG000|Overall Study|Participant Withdrew Consent|4|||
163446255|NCT03470922|590336023|FG001|Overall Study|Participant Withdrew Consent|9|||
163446256|NCT03470922|590336022|FG000|Overall Study|Other reasons|1|||
163446257|NCT03470922|590336023|FG001|Overall Study|Other reasons|0|||
163446258|NCT03470922|590336022|FG000|Overall Study|Not reported|1|||
163446259|NCT03470922|590336023|FG001|Overall Study|Not reported|0|||
163446260|NCT02626819|590336024|FG000|Overall Study|Lost to Follow-up|3|||
163446261|NCT02626819|590336025|FG001|Overall Study|Lost to Follow-up|2|||
163446262|NCT02626819|590336024|FG000|Overall Study|Withdrawal by Subject|1|||
163446263|NCT02626819|590336025|FG001|Overall Study|Withdrawal by Subject|0|||
163446264|NCT02626819|590336024|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
163446265|NCT02626819|590336025|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
163446266|NCT02361762|590336026|FG000|Overall Study|Withdrawal by Subject|0|||
163446267|NCT02361762|590336027|FG001|Overall Study|Withdrawal by Subject|1|||
163446268|NCT02361762|590336026|FG000|Overall Study|Lost to Follow-up|0|||
163446269|NCT02361762|590336027|FG001|Overall Study|Lost to Follow-up|1|||
163446270|NCT00502307|590336030|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
163446271|NCT00502307|590336031|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
163446272|NCT00502307|590336032|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
163446273|NCT00502307|590336030|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
163446274|NCT00502307|590336031|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
163446275|NCT00502307|590336032|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
163446276|NCT00502307|590336030|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
163446277|NCT00502307|590336031|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
163446278|NCT00502307|590336032|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
163446279|NCT00502307|590336030|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
163446280|NCT00502307|590336031|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
163446281|NCT00502307|590336032|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
163446282|NCT00502307|590336030|FG000|Maintenance Period|Progressive disease|80|||
163446283|NCT00502307|590336031|FG001|Maintenance Period|Progressive disease|0|||
163446284|NCT00502307|590336032|FG002|Maintenance Period|Progressive disease|0|||
163446285|NCT00502307|590336030|FG000|Maintenance Period|Discontinued due to other reasons|68|||
163446286|NCT00502307|590336031|FG001|Maintenance Period|Discontinued due to other reasons|0|||
163446287|NCT00502307|590336032|FG002|Maintenance Period|Discontinued due to other reasons|0|||
163446288|NCT00748553|590336033|FG000|Overall Study|Adverse Event|0|||
163446289|NCT00748553|590336034|FG001|Overall Study|Adverse Event|1|||
163446290|NCT00748553|590336033|FG000|Overall Study|disease progression|2|||
163446291|NCT00748553|590336034|FG001|Overall Study|disease progression|0|||
163446292|NCT00748553|590336033|FG000|Overall Study|noncompliance|1|||
163446293|NCT00748553|590336034|FG001|Overall Study|noncompliance|0|||
163446294|NCT00495495|590336037|FG000|Overall Study|Protocol Violation|99|||
163446295|NCT00745368|590336038|FG000|Overall Study|Unable to provide sample|3|||
163446296|NCT04009096|590336039|FG000|Overall Study|Withdrawal by Subject|0|||
163446297|NCT04009096|590336040|FG001|Overall Study|Withdrawal by Subject|7|||
163446298|NCT04009096|590336041|FG002|Overall Study|Withdrawal by Subject|0|||
163446299|NCT04009096|590336039|FG000|Overall Study|Physician Decision|0|||
163446300|NCT04009096|590336040|FG001|Overall Study|Physician Decision|1|||
163446301|NCT04009096|590336041|FG002|Overall Study|Physician Decision|0|||
163446302|NCT00450372|590336042|FG000|Overall Study|Physician Decision|1|||
163446303|NCT03010423|590336043|FG000|Overall Study|Study termination|8|||
163446304|NCT03439748|590336044|FG000|Overall Study|Withdrawal by Subject|11|||
163446305|NCT03439748|590336045|FG001|Overall Study|Withdrawal by Subject|17|||
163446306|NCT05131451|590336046|FG000|Overall Study|Protocol Violation|1|||
163446307|NCT05131451|590336047|FG001|Overall Study|Protocol Violation|0|||
163446308|NCT01856595|590336054|FG000|Overall Study|Withdrawal by Subject|0|||
163446309|NCT01856595|590336055|FG001|Overall Study|Withdrawal by Subject|1|||
163446310|NCT01856595|590336056|FG002|Overall Study|Withdrawal by Subject|0|||
163446311|NCT01856595|590336057|FG003|Overall Study|Withdrawal by Subject|0|||
163446312|NCT01856595|590336058|FG004|Overall Study|Withdrawal by Subject|0|||
163446313|NCT01856595|590336059|FG005|Overall Study|Withdrawal by Subject|0|||
163446314|NCT01856595|590336060|FG006|Overall Study|Withdrawal by Subject|1|||
163446315|NCT01856595|590336061|FG007|Overall Study|Withdrawal by Subject|0|||
163446316|NCT01856595|590336062|FG008|Overall Study|Withdrawal by Subject|0|||
163446317|NCT04426825|590336064|FG000|Overall Study|Death|17|||
163446318|NCT04426825|590336064|FG000|Overall Study|Lost to Follow-up|1|||
163446319|NCT04426825|590336064|FG000|Overall Study|Study terminated by sponsor|5|||
163446320|NCT01912729|590336073|FG000|Overall Study|Withdrawal by Subject|0|||
163446321|NCT01912729|590336074|FG001|Overall Study|Withdrawal by Subject|1|||
163446322|NCT00988559|590336076|FG000|Overall Study|Withdrawal by Subject|1|||
163446323|NCT00988559|590336077|FG001|Overall Study|Withdrawal by Subject|1|||
163446324|NCT00988559|590336078|FG002|Overall Study|Withdrawal by Subject|0|||
163446325|NCT00988559|590336079|FG003|Overall Study|Withdrawal by Subject|1|||
163446326|NCT00988559|590336076|FG000|Overall Study|Pregnancy|0|||
163446327|NCT00988559|590336077|FG001|Overall Study|Pregnancy|1|||
163446328|NCT00988559|590336078|FG002|Overall Study|Pregnancy|1|||
163446329|NCT00988559|590336079|FG003|Overall Study|Pregnancy|0|||
163446330|NCT00988559|590336076|FG000|Overall Study|Lost to Follow-up|0|||
163446331|NCT00988559|590336077|FG001|Overall Study|Lost to Follow-up|0|||
163446332|NCT00988559|590336078|FG002|Overall Study|Lost to Follow-up|1|||
163446333|NCT00988559|590336079|FG003|Overall Study|Lost to Follow-up|0|||
163446334|NCT00829166|590336080|FG000|Overall Study|Death|305|||
163446335|NCT00829166|590336081|FG001|Overall Study|Death|333|||
163446336|NCT00829166|590336080|FG000|Overall Study|Lost to Follow-up|5|||
163446337|NCT00829166|590336081|FG001|Overall Study|Lost to Follow-up|4|||
163446338|NCT00829166|590336080|FG000|Overall Study|Physician's Decision|4|||
163446339|NCT00829166|590336081|FG001|Overall Study|Physician's Decision|3|||
163446340|NCT00829166|590336080|FG000|Overall Study|Subject's Decision|41|||
163446341|NCT00829166|590336081|FG001|Overall Study|Subject's Decision|55|||
163446342|NCT00829166|590336080|FG000|Overall Study|Sponsor's Decision|137|||
163446343|NCT00829166|590336081|FG001|Overall Study|Sponsor's Decision|98|||
163446344|NCT00829166|590336080|FG000|Overall Study|Reason Not Specified|3|||
163446345|NCT00829166|590336081|FG001|Overall Study|Reason Not Specified|3|||
163446346|NCT02538666|590336082|FG000|Pre-Treatment|Disease progression|1|||
163446347|NCT02538666|590336083|FG001|Pre-Treatment|Disease progression|0|||
163446348|NCT02538666|590336084|FG002|Pre-Treatment|Disease progression|0|||
163446349|NCT02538666|590336082|FG000|Pre-Treatment|no longer meets study criteria|1|||
163446350|NCT02538666|590336083|FG001|Pre-Treatment|no longer meets study criteria|0|||
163446351|NCT02538666|590336084|FG002|Pre-Treatment|no longer meets study criteria|0|||
163446352|NCT02538666|590336082|FG000|Pre-Treatment|Withdrew Consent|0|||
163446353|NCT02538666|590336083|FG001|Pre-Treatment|Withdrew Consent|1|||
163446354|NCT02538666|590336084|FG002|Pre-Treatment|Withdrew Consent|1|||
163446355|NCT02538666|590336082|FG000|Treatment|Disease progression|270|||
163446356|NCT02538666|590336083|FG001|Treatment|Disease progression|227|||
163446357|NCT02538666|590336084|FG002|Treatment|Disease progression|165|||
163446358|NCT02538666|590336082|FG000|Treatment|Study drug toxicity|1|||
163446359|NCT02538666|590336083|FG001|Treatment|Study drug toxicity|29|||
163446360|NCT02538666|590336084|FG002|Treatment|Study drug toxicity|92|||
163446361|NCT02538666|590336082|FG000|Treatment|Death|0|||
163446362|NCT02538666|590336083|FG001|Treatment|Death|2|||
163446363|NCT02538666|590336084|FG002|Treatment|Death|3|||
163446364|NCT02538666|590336082|FG000|Treatment|Adverse event unrelated to study drug|8|||
163446365|NCT02538666|590336083|FG001|Treatment|Adverse event unrelated to study drug|10|||
163446366|NCT02538666|590336084|FG002|Treatment|Adverse event unrelated to study drug|15|||
163446367|NCT02538666|590336082|FG000|Treatment|Participant request to discontinue study treatment|3|||
163446368|NCT02538666|590336083|FG001|Treatment|Participant request to discontinue study treatment|6|||
163446369|NCT02538666|590336084|FG002|Treatment|Participant request to discontinue study treatment|11|||
163446370|NCT02538666|590336082|FG000|Treatment|Participant withdrew consent|2|||
163446371|NCT02538666|590336083|FG001|Treatment|Participant withdrew consent|5|||
163446372|NCT02538666|590336084|FG002|Treatment|Participant withdrew consent|3|||
163446373|NCT02538666|590336082|FG000|Treatment|Lost to Follow-up|0|||
163446374|NCT02538666|590336083|FG001|Treatment|Lost to Follow-up|1|||
163446375|NCT02538666|590336084|FG002|Treatment|Lost to Follow-up|1|||
163446376|NCT02538666|590336082|FG000|Treatment|Maximum clinical benefit|4|||
163446377|NCT02538666|590336083|FG001|Treatment|Maximum clinical benefit|3|||
163446378|NCT02538666|590336084|FG002|Treatment|Maximum clinical benefit|4|||
163446379|NCT02538666|590336082|FG000|Treatment|Poor/non-compliance|0|||
163446380|NCT02538666|590336083|FG001|Treatment|Poor/non-compliance|1|||
163446381|NCT02538666|590336084|FG002|Treatment|Poor/non-compliance|0|||
163446382|NCT02538666|590336082|FG000|Treatment|Participant no longer meets study criteria|0|||
163446383|NCT02538666|590336083|FG001|Treatment|Participant no longer meets study criteria|2|||
163446384|NCT02538666|590336084|FG002|Treatment|Participant no longer meets study criteria|0|||
163446385|NCT02538666|590336082|FG000|Treatment|Administrative reason by sponsor|0|||
163446386|NCT02538666|590336083|FG001|Treatment|Administrative reason by sponsor|0|||
163446387|NCT02538666|590336084|FG002|Treatment|Administrative reason by sponsor|1|||
163446388|NCT02538666|590336082|FG000|Treatment|Other reasons|8|||
163446389|NCT02538666|590336083|FG001|Treatment|Other reasons|15|||
163446390|NCT02538666|590336084|FG002|Treatment|Other reasons|5|||
163446391|NCT02538666|590336082|FG000|Treatment|Not reported|2|||
163446392|NCT02538666|590336083|FG001|Treatment|Not reported|2|||
163446393|NCT02538666|590336084|FG002|Treatment|Not reported|2|||
163446394|NCT00320385|590336085|FG000|Overall Study|Lost to Follow-up|7|||
163446395|NCT00320385|590336086|FG001|Overall Study|Lost to Follow-up|10|||
163446396|NCT00320385|590336085|FG000|Overall Study|Withdrawal by Subject|6|||
163446397|NCT00320385|590336086|FG001|Overall Study|Withdrawal by Subject|7|||
163446398|NCT00320385|590336085|FG000|Overall Study|Sponsor Terminated Study|2|||
163446399|NCT00320385|590336086|FG001|Overall Study|Sponsor Terminated Study|1|||
163446400|NCT00320385|590336085|FG000|Overall Study|Investigator Decision|0|||
163446401|NCT00320385|590336086|FG001|Overall Study|Investigator Decision|1|||
163446402|NCT00320385|590336085|FG000|Overall Study|Death|1|||
163446403|NCT00320385|590336086|FG001|Overall Study|Death|2|||
163446404|NCT00320385|590336085|FG000|Overall Study|Serious Adverse Event|1|||
163446405|NCT00320385|590336086|FG001|Overall Study|Serious Adverse Event|0|||
163446406|NCT00320385|590336085|FG000|Overall Study|Withdrew Consent|1|||
163446407|NCT00320385|590336086|FG001|Overall Study|Withdrew Consent|0|||
163446408|NCT00320385|590336085|FG000|Overall Study|Adverse Event|0|||
163446409|NCT00320385|590336086|FG001|Overall Study|Adverse Event|1|||
163446410|NCT02582749|590336093|FG000|Overall Study|Study terminated by funder|5|||
163446411|NCT02582749|590336094|FG001|Overall Study|Study terminated by funder|10|||
163446412|NCT02582749|590336093|FG000|Overall Study|Withdrawal by Subject|0|||
163446413|NCT02582749|590336094|FG001|Overall Study|Withdrawal by Subject|1|||
163446414|NCT02213198|590336095|FG000|Baseline|No show for intake|7|||
163446415|NCT02213198|590336096|FG001|Baseline|No show for intake|9|||
163446416|NCT02213198|590336095|FG000|Baseline|Withdrawal by Subject|34|||
163446417|NCT02213198|590336096|FG001|Baseline|Withdrawal by Subject|11|||
163446418|NCT02213198|590336095|FG000|Baseline|transferred out of clinic|7|||
163446419|NCT02213198|590336096|FG001|Baseline|transferred out of clinic|9|||
163446420|NCT02213198|590336095|FG000|Baseline|Lost to Follow-up|40|||
163446421|NCT02213198|590336096|FG001|Baseline|Lost to Follow-up|21|||
163446422|NCT02213198|590336095|FG000|Baseline|incarcerated,violent|0|||
163446423|NCT02213198|590336096|FG001|Baseline|incarcerated,violent|1|||
163446424|NCT02213198|590336095|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
163446425|NCT02213198|590336096|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
163446426|NCT02213198|590336095|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
163446427|NCT02213198|590336096|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
163446428|NCT02213198|590336095|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
163446429|NCT02213198|590336096|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
163446430|NCT02213198|590336095|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
163446431|NCT02213198|590336096|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
163446432|NCT02213198|590336095|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
163446433|NCT02213198|590336096|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
163446434|NCT02213198|590336095|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
163446435|NCT02213198|590336096|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
163446436|NCT01518192|590336097|FG000|Overall Study|Lost to Follow-up|29|||
163446437|NCT01518192|590336098|FG001|Overall Study|Lost to Follow-up|26|||
163446438|NCT01518192|590336099|FG002|Overall Study|Lost to Follow-up|35|||
163446439|NCT01954121|590336101|FG000|Overall Study|Lack of Efficacy|94|||
163446440|NCT01954121|590336102|FG001|Overall Study|Lack of Efficacy|41|||
163446441|NCT01954121|590336101|FG000|Overall Study|Protocol Violation|0|||
163446442|NCT01954121|590336102|FG001|Overall Study|Protocol Violation|2|||
163446443|NCT01954121|590336101|FG000|Overall Study|Lost to Follow-up|5|||
163446444|NCT01954121|590336102|FG001|Overall Study|Lost to Follow-up|6|||
163446445|NCT01954121|590336101|FG000|Overall Study|Withdrawal by Subject|18|||
163446446|NCT01954121|590336102|FG001|Overall Study|Withdrawal by Subject|12|||
163446447|NCT01954121|590336101|FG000|Overall Study|Pregnancy|1|||
163446448|NCT01954121|590336102|FG001|Overall Study|Pregnancy|1|||
163446449|NCT01954121|590336101|FG000|Overall Study|AE, serious fatal|1|||
163446450|NCT01954121|590336102|FG001|Overall Study|AE, serious fatal|0|||
163446451|NCT01954121|590336101|FG000|Overall Study|AE, non-serious non-fatal|5|||
163446452|NCT01954121|590336102|FG001|Overall Study|AE, non-serious non-fatal|22|||
163446453|NCT01954121|590336101|FG000|Overall Study|SAE, non-fatal|1|||
163446454|NCT01954121|590336102|FG001|Overall Study|SAE, non-fatal|4|||
163446455|NCT01954121|590336101|FG000|Overall Study|Non-compliant with study procedures|1|||
163446456|NCT01954121|590336102|FG001|Overall Study|Non-compliant with study procedures|0|||
163446457|NCT01954121|590336101|FG000|Overall Study|Non-compliant patient|1|||
163446458|NCT01954121|590336102|FG001|Overall Study|Non-compliant patient|1|||
163446459|NCT01954121|590336101|FG000|Overall Study|Subject did not follow instructions|0|||
163446460|NCT01954121|590336102|FG001|Overall Study|Subject did not follow instructions|2|||
163446461|NCT00601523|590336103|FG000|Overall Study|Adverse Event|42|||
163446462|NCT00601523|590336104|FG001|Overall Study|Adverse Event|14|||
163446463|NCT00601523|590336103|FG000|Overall Study|Lack of Efficacy|3|||
163446464|NCT00601523|590336104|FG001|Overall Study|Lack of Efficacy|0|||
163446465|NCT00601523|590336103|FG000|Overall Study|Protocol Violation|5|||
163446466|NCT00601523|590336104|FG001|Overall Study|Protocol Violation|1|||
163446467|NCT00601523|590336103|FG000|Overall Study|Lost to Follow-up|0|||
163446468|NCT00601523|590336104|FG001|Overall Study|Lost to Follow-up|1|||
163446469|NCT00601523|590336103|FG000|Overall Study|Withdrawal by Subject|18|||
163446470|NCT00601523|590336104|FG001|Overall Study|Withdrawal by Subject|9|||
163446471|NCT00601523|590336103|FG000|Overall Study|Other|9|||
163446472|NCT00601523|590336104|FG001|Overall Study|Other|1|||
163446473|NCT01987986|590336105|FG000|Overall Study|Lost to Follow-up|1|||
163446474|NCT01987986|590336106|FG001|Overall Study|Lost to Follow-up|0|||
163446475|NCT01987986|590336107|FG002|Overall Study|Lost to Follow-up|0|||
163446476|NCT01987986|590336108|FG003|Overall Study|Lost to Follow-up|0|||
163446477|NCT01987986|590336105|FG000|Overall Study|Adverse Event|1|||
163446478|NCT01987986|590336106|FG001|Overall Study|Adverse Event|0|||
163446479|NCT01987986|590336107|FG002|Overall Study|Adverse Event|2|||
163446480|NCT01987986|590336108|FG003|Overall Study|Adverse Event|0|||
163446481|NCT03342469|590336109|FG000|Overall Study|Withdrawal by Subject|0|||
163446482|NCT03342469|590336110|FG001|Overall Study|Withdrawal by Subject|1|||
163446483|NCT03342469|590336111|FG002|Overall Study|Withdrawal by Subject|0|||
163446484|NCT03342469|590336112|FG003|Overall Study|Withdrawal by Subject|0|||
163446485|NCT05515601|590336116|FG000|Overall Study|Withdrawal by Subject|1|||
163446486|NCT05515601|590336117|FG001|Overall Study|Withdrawal by Subject|3|||
163446487|NCT05515601|590336118|FG002|Overall Study|Withdrawal by Subject|2|||
163446488|NCT05515601|590336119|FG003|Overall Study|Withdrawal by Subject|1|||
163446489|NCT05515601|590336120|FG004|Overall Study|Withdrawal by Subject|1|||
163446490|NCT05515601|590336121|FG005|Overall Study|Withdrawal by Subject|1|||
163446491|NCT05515601|590336116|FG000|Overall Study|Lost to Follow-up|0|||
163446492|NCT05515601|590336117|FG001|Overall Study|Lost to Follow-up|0|||
163446493|NCT05515601|590336118|FG002|Overall Study|Lost to Follow-up|0|||
163446494|NCT05515601|590336119|FG003|Overall Study|Lost to Follow-up|0|||
163446495|NCT05515601|590336120|FG004|Overall Study|Lost to Follow-up|1|||
163446496|NCT05515601|590336121|FG005|Overall Study|Lost to Follow-up|0|||
163446497|NCT00540436|590336122|FG000|First 12-Week Treatment Period|Adverse Event|1|||
163446498|NCT00540436|590336122|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
163446499|NCT00540436|590336122|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
163446500|NCT00540436|590336122|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
163446501|NCT02928406|590336123|FG000|Overall Study|Death|780|||
163446502|NCT02928406|590336123|FG000|Overall Study|Progressive disease|3|||
163446503|NCT02928406|590336123|FG000|Overall Study|Lost to Follow-up|49|||
163446504|NCT02928406|590336123|FG000|Overall Study|Non-compliance|2|||
163446505|NCT02928406|590336123|FG000|Overall Study|Withdrawal by Subject|40|||
163446506|NCT02928406|590336123|FG000|Overall Study|Study terminated by sponsor|57|||
163446507|NCT02928406|590336123|FG000|Overall Study|Physician Decision|1|||
163446508|NCT02928406|590336123|FG000|Overall Study|Various reasons|72|||
163446509|NCT01515306|590336124|FG000|Overall Study|Adverse Event|3|||
163446510|NCT01515306|590336125|FG001|Overall Study|Adverse Event|2|||
163446511|NCT01515306|590336124|FG000|Overall Study|Progressive Disease|19|||
163446512|NCT01515306|590336125|FG001|Overall Study|Progressive Disease|9|||
163446513|NCT01515306|590336124|FG000|Overall Study|Withdrawal by Subject|1|||
163446514|NCT01515306|590336125|FG001|Overall Study|Withdrawal by Subject|2|||
163446515|NCT01515306|590336124|FG000|Overall Study|Physician Decision|1|||
163446516|NCT01515306|590336125|FG001|Overall Study|Physician Decision|1|||
163446517|NCT02678780|590336127|FG000|Overall Study|Adverse Event|11|||
163446518|NCT02678780|590336128|FG001|Overall Study|Adverse Event|14|||
163446519|NCT02678780|590336127|FG000|Overall Study|Withdrawal by Subject|2|||
163446520|NCT02678780|590336128|FG001|Overall Study|Withdrawal by Subject|1|||
163446521|NCT02678780|590336127|FG000|Overall Study|Sponsor discontinuation|7|||
163446522|NCT02678780|590336128|FG001|Overall Study|Sponsor discontinuation|4|||
163446523|NCT02678780|590336127|FG000|Overall Study|Death|1|||
163446524|NCT02678780|590336128|FG001|Overall Study|Death|1|||
163446525|NCT02678780|590336127|FG000|Overall Study|Other|6|||
163446526|NCT02678780|590336128|FG001|Overall Study|Other|8|||
163446527|NCT01064648|590336141|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
163446528|NCT01064648|590336142|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
163446529|NCT01064648|590336143|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
163446530|NCT01064648|590336144|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
163446531|NCT01064648|590336141|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
163446532|NCT01064648|590336142|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
163446533|NCT01064648|590336143|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
163446534|NCT01064648|590336144|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
163446535|NCT01064648|590336141|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
163446536|NCT01064648|590336142|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
163446537|NCT01064648|590336143|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
163446538|NCT01064648|590336144|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
163446539|NCT01064648|590336141|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
163446540|NCT01064648|590336142|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
163446541|NCT01064648|590336143|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
163446542|NCT01064648|590336144|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
163446543|NCT01064648|590336141|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
163446544|NCT01064648|590336142|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
163446545|NCT01064648|590336143|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
163446546|NCT01064648|590336144|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
163446547|NCT01064648|590336141|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
163446548|NCT01064648|590336142|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
163446549|NCT01064648|590336143|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
163446550|NCT01064648|590336144|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
163446551|NCT01064648|590336141|FG000|Phase II|Adverse Event|0|||
163446552|NCT01064648|590336142|FG001|Phase II|Adverse Event|0|||
163446553|NCT01064648|590336143|FG002|Phase II|Adverse Event|15|||
163446554|NCT01064648|590336144|FG003|Phase II|Adverse Event|8|||
163446555|NCT01064648|590336141|FG000|Phase II|Death|0|||
163446556|NCT01064648|590336142|FG001|Phase II|Death|0|||
163446557|NCT01064648|590336143|FG002|Phase II|Death|4|||
163446558|NCT01064648|590336144|FG003|Phase II|Death|5|||
163446559|NCT01064648|590336141|FG000|Phase II|Withdrawal by Subject|0|||
163446560|NCT01064648|590336142|FG001|Phase II|Withdrawal by Subject|0|||
163446561|NCT01064648|590336143|FG002|Phase II|Withdrawal by Subject|2|||
163446562|NCT01064648|590336144|FG003|Phase II|Withdrawal by Subject|5|||
163446563|NCT01064648|590336141|FG000|Phase II|Progression|0|||
163446564|NCT01064648|590336142|FG001|Phase II|Progression|0|||
163446565|NCT01064648|590336143|FG002|Phase II|Progression|21|||
163446566|NCT01064648|590336144|FG003|Phase II|Progression|27|||
163446567|NCT01064648|590336141|FG000|Phase II|Non-protocol specified|0|||
163446568|NCT01064648|590336142|FG001|Phase II|Non-protocol specified|0|||
163446569|NCT01064648|590336143|FG002|Phase II|Non-protocol specified|5|||
163446570|NCT01064648|590336144|FG003|Phase II|Non-protocol specified|3|||
163446571|NCT01064648|590336141|FG000|Phase II|Under Review|0|||
163446572|NCT01064648|590336142|FG001|Phase II|Under Review|0|||
163446573|NCT01064648|590336143|FG002|Phase II|Under Review|2|||
163446574|NCT01064648|590336144|FG003|Phase II|Under Review|0|||
163446575|NCT05513391|590336145|FG000|Overall Study|Adverse Event|1|||
163446576|NCT05513391|590336146|FG001|Overall Study|Adverse Event|0|||
163446577|NCT05513391|590336145|FG000|Overall Study|Protocol Deviation|0|||
163446578|NCT05513391|590336146|FG001|Overall Study|Protocol Deviation|1|||
163446579|NCT05513391|590336145|FG000|Overall Study|Withdrawal by Subject|3|||
163446580|NCT05513391|590336146|FG001|Overall Study|Withdrawal by Subject|1|||
163446581|NCT05513391|590336145|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
163446582|NCT05513391|590336146|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
163446583|NCT05513391|590336145|FG000|Overall Study|Lost to Follow-up|0|||
163446584|NCT05513391|590336146|FG001|Overall Study|Lost to Follow-up|2|||
163446585|NCT02429427|590336147|FG000|Overall Study|Adverse Event|220|||
163446586|NCT02429427|590336148|FG001|Overall Study|Adverse Event|92|||
163446587|NCT02429427|590336147|FG000|Overall Study|Protocol Violation|10|||
163446588|NCT02429427|590336148|FG001|Overall Study|Protocol Violation|6|||
163446589|NCT02429427|590336147|FG000|Overall Study|Lost to Follow-up|15|||
163446590|NCT02429427|590336148|FG001|Overall Study|Lost to Follow-up|6|||
163446591|NCT02429427|590336147|FG000|Overall Study|Withdrawal by Subject|64|||
163446592|NCT02429427|590336148|FG001|Overall Study|Withdrawal by Subject|34|||
163446593|NCT02429427|590336147|FG000|Overall Study|Other|62|||
163446594|NCT02429427|590336148|FG001|Overall Study|Other|41|||
163446595|NCT00719732|590336149|FG000|Overall Study|Lost to Follow-up|20|||
163446596|NCT00719732|590336149|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
163446597|NCT00719732|590336149|FG000|Overall Study|Illness not associated with device|1|||
163446598|NCT00309777|590336154|FG000|Overall Study|Adverse Event|13|||
163446599|NCT00309777|590336155|FG001|Overall Study|Adverse Event|2|||
163446600|NCT00309777|590336156|FG002|Overall Study|Adverse Event|8|||
163446601|NCT00309777|590336157|FG003|Overall Study|Adverse Event|1|||
163446602|NCT00309777|590336154|FG000|Overall Study|Protocol Violation|4|||
163446603|NCT00309777|590336155|FG001|Overall Study|Protocol Violation|1|||
163446604|NCT00309777|590336156|FG002|Overall Study|Protocol Violation|3|||
163446605|NCT00309777|590336157|FG003|Overall Study|Protocol Violation|1|||
163446606|NCT00309777|590336154|FG000|Overall Study|Withdrawal by Subject|6|||
163446607|NCT00309777|590336155|FG001|Overall Study|Withdrawal by Subject|5|||
163446608|NCT00309777|590336156|FG002|Overall Study|Withdrawal by Subject|7|||
163446609|NCT00309777|590336157|FG003|Overall Study|Withdrawal by Subject|2|||
163446610|NCT00309777|590336154|FG000|Overall Study|Lost to Follow-up|0|||
163446611|NCT00309777|590336155|FG001|Overall Study|Lost to Follow-up|0|||
163446612|NCT00309777|590336156|FG002|Overall Study|Lost to Follow-up|1|||
163446613|NCT00309777|590336157|FG003|Overall Study|Lost to Follow-up|0|||
163446614|NCT00309777|590336154|FG000|Overall Study|Death|0|||
163446615|NCT00309777|590336155|FG001|Overall Study|Death|1|||
163446616|NCT00309777|590336156|FG002|Overall Study|Death|0|||
163446617|NCT00309777|590336157|FG003|Overall Study|Death|0|||
163446618|NCT00683475|590338365|FG000|Overall Study|Withdrawal by Subject|1|||
163446619|NCT00683475|590338366|FG001|Overall Study|Withdrawal by Subject|0|||
163446620|NCT00683475|590338365|FG000|Overall Study|Never Treated: Adverse Event|2|||
163446621|NCT00683475|590338366|FG001|Overall Study|Never Treated: Adverse Event|3|||
163446622|NCT00683475|590338365|FG000|Overall Study|Never Treated: Progressive Disease|1|||
163446623|NCT00683475|590338366|FG001|Overall Study|Never Treated: Progressive Disease|0|||
163446624|NCT03364335|590338373|FG000|Overall Study|Adverse Event|3|||
163446625|NCT03364335|590338374|FG001|Overall Study|Adverse Event|4|||
163446626|NCT03364335|590338375|FG002|Overall Study|Adverse Event|1|||
163446627|NCT03364335|590338376|FG003|Overall Study|Adverse Event|2|||
163446628|NCT03364335|590338377|FG004|Overall Study|Adverse Event|0|||
163446629|NCT03364335|590338373|FG000|Overall Study|Lost to Follow-up|7|||
163446630|NCT03364335|590338374|FG001|Overall Study|Lost to Follow-up|7|||
163446631|NCT03364335|590338375|FG002|Overall Study|Lost to Follow-up|10|||
163446632|NCT03364335|590338376|FG003|Overall Study|Lost to Follow-up|11|||
163446633|NCT03364335|590338377|FG004|Overall Study|Lost to Follow-up|11|||
163446634|NCT03725202|590338380|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
163446635|NCT03725202|590338381|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
163446636|NCT03725202|590338382|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
163446637|NCT03725202|590338383|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
163446638|NCT03725202|590338384|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
163446639|NCT03725202|590338385|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
163446640|NCT03725202|590338386|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
163446641|NCT03725202|590338387|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
163446642|NCT03725202|590338380|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
163446643|NCT03725202|590338381|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
163446644|NCT03725202|590338382|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
163446645|NCT03725202|590338383|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
163446646|NCT03725202|590338384|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
163446647|NCT03725202|590338385|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
163446648|NCT03725202|590338386|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
163446649|NCT03725202|590338387|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
163446650|NCT03725202|590338380|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
163446651|NCT03725202|590338381|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
163446652|NCT03725202|590338382|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
163446653|NCT03725202|590338383|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
163446654|NCT03725202|590338384|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
163446655|NCT03725202|590338385|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
163446656|NCT03725202|590338386|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
163446657|NCT03725202|590338387|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
163446658|NCT03725202|590338380|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
163446659|NCT03725202|590338381|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
163446660|NCT03725202|590338382|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
163446661|NCT03725202|590338383|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
163446662|NCT03725202|590338384|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
163446663|NCT03725202|590338385|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
163446664|NCT03725202|590338386|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
163446665|NCT03725202|590338387|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
163446666|NCT03725202|590338380|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
163446667|NCT03725202|590338381|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
163446668|NCT03725202|590338382|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
163446669|NCT03725202|590338383|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
163446670|NCT03725202|590338384|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
163446671|NCT03725202|590338385|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
163446672|NCT03725202|590338386|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
163446673|NCT03725202|590338387|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
163446674|NCT03725202|590338380|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
163446675|NCT03725202|590338381|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
163446676|NCT03725202|590338382|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
163446677|NCT03725202|590338383|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
163446678|NCT03725202|590338384|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
163446679|NCT03725202|590338385|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
163446680|NCT03725202|590338386|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
163446681|NCT03725202|590338387|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
163446682|NCT03725202|590338380|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
163446683|NCT03725202|590338381|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
163446684|NCT03725202|590338382|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
163446685|NCT03725202|590338383|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
163446686|NCT03725202|590338384|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
163446687|NCT03725202|590338385|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
163446688|NCT03725202|590338386|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
163446689|NCT03725202|590338387|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
163446690|NCT03725202|590338380|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
163446691|NCT03725202|590338381|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
163446692|NCT03725202|590338382|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
163446693|NCT03725202|590338383|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
163446694|NCT03725202|590338384|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
163446695|NCT03725202|590338385|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
163446696|NCT03725202|590338386|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
163446697|NCT03725202|590338387|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
163446698|NCT03725202|590338380|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
163446699|NCT03725202|590338381|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
163446700|NCT03725202|590338382|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
163446701|NCT03725202|590338383|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
163446702|NCT03725202|590338384|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
163446703|NCT03725202|590338385|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
163446704|NCT03725202|590338386|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
163446705|NCT03725202|590338387|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
163446706|NCT03725202|590338380|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
163446707|NCT03725202|590338381|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
163446708|NCT03725202|590338382|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
163446709|NCT03725202|590338383|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
163446710|NCT03725202|590338384|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
163446711|NCT03725202|590338385|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
163446712|NCT03725202|590338386|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
163446713|NCT03725202|590338387|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
163446714|NCT03725202|590338380|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
163446715|NCT03725202|590338381|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
163446716|NCT03725202|590338382|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
163446717|NCT03725202|590338383|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
163446718|NCT03725202|590338384|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
163446719|NCT03725202|590338385|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
163446720|NCT03725202|590338386|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
163446721|NCT03725202|590338387|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
163446722|NCT03725202|590338380|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
163446723|NCT03725202|590338381|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
163446724|NCT03725202|590338382|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
163446725|NCT03725202|590338383|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
163446726|NCT03725202|590338384|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
163446727|NCT03725202|590338385|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
163446728|NCT03725202|590338386|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
163446729|NCT03725202|590338387|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
163446730|NCT00948818|590338388|FG000|Overall Study|Adverse Event|10|||
163446731|NCT00948818|590338389|FG001|Overall Study|Adverse Event|32|||
163446732|NCT00948818|590338388|FG000|Overall Study|Protocol Violation|9|||
163446733|NCT00948818|590338389|FG001|Overall Study|Protocol Violation|10|||
163446734|NCT00948818|590338388|FG000|Overall Study|Withdrawal by Subject|25|||
163446735|NCT00948818|590338389|FG001|Overall Study|Withdrawal by Subject|25|||
163446736|NCT00948818|590338388|FG000|Overall Study|Lost to Follow-up|10|||
163446737|NCT00948818|590338389|FG001|Overall Study|Lost to Follow-up|17|||
163446738|NCT00948818|590338388|FG000|Overall Study|Lack of Efficacy|4|||
163446739|NCT00948818|590338389|FG001|Overall Study|Lack of Efficacy|5|||
163446740|NCT00948818|590338388|FG000|Overall Study|Other Reason|4|||
163446741|NCT00948818|590338389|FG001|Overall Study|Other Reason|5|||
163446742|NCT02364947|590338392|FG000|Overall Study|Withdrawal by Subject|10|||
163446743|NCT02364947|590338393|FG001|Overall Study|Withdrawal by Subject|8|||
163446744|NCT02364947|590338394|FG002|Overall Study|Withdrawal by Subject|9|||
163446745|NCT02364947|590338392|FG000|Overall Study|Adverse Event|45|||
163446746|NCT02364947|590338393|FG001|Overall Study|Adverse Event|33|||
163446747|NCT02364947|590338394|FG002|Overall Study|Adverse Event|11|||
163446748|NCT02364947|590338392|FG000|Overall Study|Protocol Violation|1|||
163446749|NCT02364947|590338393|FG001|Overall Study|Protocol Violation|1|||
163446750|NCT02364947|590338394|FG002|Overall Study|Protocol Violation|1|||
163446751|NCT02364947|590338392|FG000|Overall Study|Physician Decision|3|||
163446752|NCT02364947|590338393|FG001|Overall Study|Physician Decision|2|||
163446753|NCT02364947|590338394|FG002|Overall Study|Physician Decision|5|||
163446754|NCT02364947|590338392|FG000|Overall Study|Death|0|||
163446755|NCT02364947|590338393|FG001|Overall Study|Death|1|||
163446756|NCT02364947|590338394|FG002|Overall Study|Death|0|||
163446757|NCT02702518|590338398|FG000|Overall Study|Lost to Follow-up|3|||
163446758|NCT02702518|590338399|FG001|Overall Study|Lost to Follow-up|4|||
163446759|NCT00853489|590338400|FG000|Overall Study|Lost to Follow-up|5|||
163446760|NCT00853489|590338401|FG001|Overall Study|Lost to Follow-up|2|||
163446761|NCT01251276|590338403|FG000|Overall Study|Protocol Violation|1|||
163446762|NCT01251276|590338404|FG001|Overall Study|Protocol Violation|0|||
163446763|NCT01251276|590338403|FG000|Overall Study|Lost to Follow-up|0|||
163446764|NCT01251276|590338404|FG001|Overall Study|Lost to Follow-up|1|||
163446765|NCT01051986|590338410|FG000|Overall Study|Death|1|||
163446766|NCT01051986|590338411|FG001|Overall Study|Death|0|||
163446767|NCT01051986|590338410|FG000|Overall Study|Withdrawal by Subject|2|||
163446768|NCT01051986|590338411|FG001|Overall Study|Withdrawal by Subject|1|||
163446769|NCT01051986|590338410|FG000|Overall Study|Protocol Violation|2|||
163446770|NCT01051986|590338411|FG001|Overall Study|Protocol Violation|3|||
163446771|NCT01725152|590338413|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
163446772|NCT01725152|590338414|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
163446773|NCT01725152|590338413|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
163446774|NCT01725152|590338414|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
163446775|NCT01725152|590338413|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
163446776|NCT01725152|590338414|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
163446777|NCT01725152|590338413|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
163446778|NCT01725152|590338414|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
163446779|NCT01111539|590338417|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
163446780|NCT01111539|590338418|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
163446781|NCT01111539|590338419|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
163446782|NCT01111539|590338420|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
163446783|NCT01111539|590338421|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
163446784|NCT01111539|590338417|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
163446785|NCT01111539|590338418|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
163446786|NCT01111539|590338419|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
163446787|NCT01111539|590338420|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
163446788|NCT01111539|590338421|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
163446789|NCT01111539|590338417|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
163446790|NCT01111539|590338418|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
163446791|NCT01111539|590338419|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
163446792|NCT01111539|590338420|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
163446793|NCT01111539|590338421|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
163446794|NCT01111539|590338417|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
163446795|NCT01111539|590338418|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
163446796|NCT01111539|590338419|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
163446797|NCT01111539|590338420|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
163446798|NCT01111539|590338421|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
163446799|NCT01111539|590338417|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
163446800|NCT01111539|590338418|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
163446801|NCT01111539|590338419|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
163446802|NCT01111539|590338420|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
163446803|NCT01111539|590338421|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
163446804|NCT01111539|590338417|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
163446805|NCT01111539|590338418|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
163446806|NCT01111539|590338419|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
163446807|NCT01111539|590338420|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
163446808|NCT01111539|590338421|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
163446809|NCT01111539|590338417|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
163446810|NCT01111539|590338418|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
163446811|NCT01111539|590338419|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
163446812|NCT01111539|590338420|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
163446813|NCT01111539|590338421|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
163446814|NCT01111539|590338417|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
163446815|NCT01111539|590338418|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
163446816|NCT01111539|590338419|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
163446817|NCT01111539|590338420|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
163446818|NCT01111539|590338421|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
163446819|NCT01111539|590338417|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163446820|NCT01111539|590338418|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163446821|NCT01111539|590338419|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
163446822|NCT01111539|590338420|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163446823|NCT01111539|590338421|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
163446824|NCT01111539|590338417|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
163446825|NCT01111539|590338418|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
163446826|NCT01111539|590338419|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
163446827|NCT01111539|590338420|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
163446828|NCT01111539|590338421|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
163446829|NCT01111539|590338417|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
163446830|NCT01111539|590338418|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
163446831|NCT01111539|590338419|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
163446832|NCT01111539|590338420|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
163446833|NCT01111539|590338421|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
163446834|NCT01111539|590338417|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
163446835|NCT01111539|590338418|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
163446836|NCT01111539|590338419|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
163446837|NCT01111539|590338420|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
163446838|NCT01111539|590338421|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
163446839|NCT01111539|590338417|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
163446840|NCT01111539|590338418|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
163446841|NCT01111539|590338419|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
163446842|NCT01111539|590338420|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
163446843|NCT01111539|590338421|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
163446844|NCT01111539|590338417|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
163446845|NCT01111539|590338418|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
163446846|NCT01111539|590338419|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
163446847|NCT01111539|590338420|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
163446848|NCT01111539|590338421|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
163446849|NCT03580382|590338424|FG000|Overall Study|Early Termination of Study|0|||
163446850|NCT03580382|590338425|FG001|Overall Study|Early Termination of Study|3|||
163446851|NCT02808312|590338426|FG000|Overall Study|Enrolled but Never Treated|0|||
163446852|NCT02808312|590338427|FG001|Overall Study|Enrolled but Never Treated|0|||
163446853|NCT02808312|590338428|FG002|Overall Study|Enrolled but Never Treated|1|||
163446854|NCT02808312|590338429|FG003|Overall Study|Enrolled but Never Treated|0|||
163446855|NCT02808312|590338430|FG004|Overall Study|Enrolled but Never Treated|0|||
163446856|NCT03628417|590338431|FG000|Overall Study|Death|1|||
163446857|NCT03628417|590338432|FG001|Overall Study|Death|1|||
163446858|NCT02420223|590338433|FG000|Overall Study|Adverse Event|1|||
163446859|NCT02420223|590338434|FG001|Overall Study|Adverse Event|0|||
163446860|NCT02420223|590338433|FG000|Overall Study|Physician Decision|0|||
163446861|NCT02420223|590338434|FG001|Overall Study|Physician Decision|2|||
163446862|NCT01361009|590338435|FG000|Overall Study|Protocol Violation|116|||
163446863|NCT01826422|590338436|FG000|Overall Study|Withdrawal by Subject|1|||
163446864|NCT01826422|590338437|FG001|Overall Study|Withdrawal by Subject|3|||
163446865|NCT04263142|590338438|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
163446866|NCT04263142|590338439|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
163446867|NCT04263142|590338440|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
163446868|NCT04263142|590338441|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
163446869|NCT04263142|590338442|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
163446870|NCT04263142|590338438|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
163446871|NCT04263142|590338439|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
163446872|NCT04263142|590338440|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
163446873|NCT04263142|590338441|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
163446874|NCT04263142|590338442|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
163446875|NCT03484923|590338448|FG000|Overall Study|Adverse Event|3|||
163446876|NCT03484923|590338449|FG001|Overall Study|Adverse Event|3|||
163446877|NCT03484923|590338450|FG002|Overall Study|Adverse Event|5|||
163446878|NCT03484923|590338451|FG003|Overall Study|Adverse Event|11|||
163446879|NCT03484923|590338452|FG004|Overall Study|Adverse Event|1|||
163446880|NCT03484923|590338448|FG000|Overall Study|Death|2|||
163446881|NCT03484923|590338449|FG001|Overall Study|Death|2|||
163446882|NCT03484923|590338450|FG002|Overall Study|Death|3|||
163446883|NCT03484923|590338451|FG003|Overall Study|Death|0|||
163446884|NCT03484923|590338452|FG004|Overall Study|Death|1|||
163446885|NCT03484923|590338448|FG000|Overall Study|Physician Decision|6|||
163446886|NCT03484923|590338449|FG001|Overall Study|Physician Decision|7|||
163446887|NCT03484923|590338450|FG002|Overall Study|Physician Decision|6|||
163446888|NCT03484923|590338451|FG003|Overall Study|Physician Decision|3|||
163446889|NCT03484923|590338452|FG004|Overall Study|Physician Decision|2|||
163446890|NCT03484923|590338448|FG000|Overall Study|Progressive disease|33|||
163446891|NCT03484923|590338449|FG001|Overall Study|Progressive disease|28|||
163446892|NCT03484923|590338450|FG002|Overall Study|Progressive disease|26|||
163446893|NCT03484923|590338451|FG003|Overall Study|Progressive disease|30|||
163446894|NCT03484923|590338452|FG004|Overall Study|Progressive disease|16|||
163446895|NCT03484923|590338448|FG000|Overall Study|Subject Decision|1|||
163446896|NCT03484923|590338449|FG001|Overall Study|Subject Decision|3|||
163446897|NCT03484923|590338450|FG002|Overall Study|Subject Decision|3|||
163446898|NCT03484923|590338451|FG003|Overall Study|Subject Decision|0|||
163446899|NCT03484923|590338452|FG004|Overall Study|Subject Decision|1|||
163446900|NCT01863849|590338453|FG000|Overall Study|Lost to Follow-up|1|||
163446901|NCT01863849|590338454|FG001|Overall Study|Lost to Follow-up|0|||
163446902|NCT04402008|590338457|FG000|Overall Study|Adverse Event|0|||
163446903|NCT04402008|590338458|FG001|Overall Study|Adverse Event|0|||
163446904|NCT04402008|590338459|FG002|Overall Study|Adverse Event|0|||
163446905|NCT04402008|590338460|FG003|Overall Study|Adverse Event|1|||
163446906|NCT04402008|590338461|FG004|Overall Study|Adverse Event|0|||
163446907|NCT04402008|590338462|FG005|Overall Study|Adverse Event|0|||
163446908|NCT04402008|590338463|FG006|Overall Study|Adverse Event|0|||
163446909|NCT04402008|590338457|FG000|Overall Study|Disease Progression|3|||
163446910|NCT04402008|590338458|FG001|Overall Study|Disease Progression|2|||
163446911|NCT04402008|590338459|FG002|Overall Study|Disease Progression|3|||
163446912|NCT04402008|590338460|FG003|Overall Study|Disease Progression|3|||
163446913|NCT04402008|590338461|FG004|Overall Study|Disease Progression|4|||
163446914|NCT04402008|590338462|FG005|Overall Study|Disease Progression|3|||
163446915|NCT04402008|590338463|FG006|Overall Study|Disease Progression|10|||
163446916|NCT04402008|590338457|FG000|Overall Study|Withdrawal by Subject|0|||
163446917|NCT04402008|590338458|FG001|Overall Study|Withdrawal by Subject|1|||
163446918|NCT04402008|590338459|FG002|Overall Study|Withdrawal by Subject|0|||
163446919|NCT04402008|590338460|FG003|Overall Study|Withdrawal by Subject|0|||
163446920|NCT04402008|590338461|FG004|Overall Study|Withdrawal by Subject|1|||
163446921|NCT04402008|590338462|FG005|Overall Study|Withdrawal by Subject|0|||
163446922|NCT04402008|590338463|FG006|Overall Study|Withdrawal by Subject|0|||
163446923|NCT04402008|590338457|FG000|Overall Study|Sponsor Decision|0|||
163446924|NCT04402008|590338458|FG001|Overall Study|Sponsor Decision|0|||
163446925|NCT04402008|590338459|FG002|Overall Study|Sponsor Decision|0|||
163446926|NCT04402008|590338460|FG003|Overall Study|Sponsor Decision|0|||
163446927|NCT04402008|590338461|FG004|Overall Study|Sponsor Decision|0|||
163446928|NCT04402008|590338462|FG005|Overall Study|Sponsor Decision|0|||
163446929|NCT04402008|590338463|FG006|Overall Study|Sponsor Decision|3|||
163446930|NCT04402008|590338457|FG000|Overall Study|Death|0|||
163446931|NCT04402008|590338458|FG001|Overall Study|Death|0|||
163446932|NCT04402008|590338459|FG002|Overall Study|Death|0|||
163446933|NCT04402008|590338460|FG003|Overall Study|Death|0|||
163446934|NCT04402008|590338461|FG004|Overall Study|Death|1|||
163446935|NCT04402008|590338462|FG005|Overall Study|Death|0|||
163446936|NCT04402008|590338463|FG006|Overall Study|Death|2|||
163446937|NCT04402008|590338457|FG000|Overall Study|Other|0|||
163446938|NCT04402008|590338458|FG001|Overall Study|Other|0|||
163446939|NCT04402008|590338459|FG002|Overall Study|Other|0|||
163446940|NCT04402008|590338460|FG003|Overall Study|Other|0|||
163446941|NCT04402008|590338461|FG004|Overall Study|Other|0|||
163446942|NCT04402008|590338462|FG005|Overall Study|Other|0|||
163446943|NCT04402008|590338463|FG006|Overall Study|Other|5|||
163446944|NCT00913978|590338464|FG000|Overall Study|Surgeon choice|1|||
163446945|NCT00913978|590338465|FG001|Overall Study|Surgeon choice|3|||
163446946|NCT04716933|590338466|FG000|Overall Study|Sponsor Decision|36|||
163446947|NCT04716933|590338467|FG001|Overall Study|Sponsor Decision|33|||
163446948|NCT04716933|590338466|FG000|Overall Study|Death|65|||
163446949|NCT04716933|590338467|FG001|Overall Study|Death|67|||
163446950|NCT01327651|590338468|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
163446951|NCT01327651|590338469|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
163446952|NCT01327651|590338470|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
163446953|NCT01327651|590338471|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
163446954|NCT01327651|590338472|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
163446955|NCT01327651|590338473|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
163446956|NCT01327651|590338474|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
163446957|NCT01327651|590338475|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
163446958|NCT01327651|590338476|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
163446959|NCT01327651|590338468|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
163446960|NCT01327651|590338469|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
163446961|NCT01327651|590338470|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
163446962|NCT01327651|590338471|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
163446963|NCT01327651|590338472|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
163446964|NCT01327651|590338473|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
163446965|NCT01327651|590338474|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
163446966|NCT01327651|590338475|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
163446967|NCT01327651|590338476|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
163446968|NCT01327651|590338468|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
163446969|NCT01327651|590338469|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
163446970|NCT01327651|590338470|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
163446971|NCT01327651|590338471|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
163446972|NCT01327651|590338472|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
163446973|NCT01327651|590338473|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
163446974|NCT01327651|590338474|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
163446975|NCT01327651|590338475|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
163446976|NCT01327651|590338476|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
163446977|NCT01327651|590338468|FG000|Post Study Follow-up|Lost to Follow-up|0|||
163446978|NCT01327651|590338469|FG001|Post Study Follow-up|Lost to Follow-up|1|||
163446979|NCT01327651|590338470|FG002|Post Study Follow-up|Lost to Follow-up|1|||
163446980|NCT01327651|590338471|FG003|Post Study Follow-up|Lost to Follow-up|0|||
163446981|NCT01327651|590338472|FG004|Post Study Follow-up|Lost to Follow-up|0|||
163446982|NCT01327651|590338473|FG005|Post Study Follow-up|Lost to Follow-up|0|||
163446983|NCT01327651|590338474|FG006|Post Study Follow-up|Lost to Follow-up|4|||
163446984|NCT01327651|590338475|FG007|Post Study Follow-up|Lost to Follow-up|1|||
163446985|NCT01327651|590338476|FG008|Post Study Follow-up|Lost to Follow-up|2|||
163446986|NCT03249792|590338477|FG000|Arms 1, 2, and 4|Death|1|||
163446987|NCT03249792|590338478|FG001|Arms 1, 2, and 4|Death|1|||
163446988|NCT03249792|590338479|FG002|Arms 1, 2, and 4|Death|0|||
163446989|NCT03249792|590338480|FG003|Arms 1, 2, and 4|Death|2|||
163446990|NCT03249792|590338481|FG004|Arms 1, 2, and 4|Death|3|||
163446991|NCT03249792|590338482|FG005|Arms 1, 2, and 4|Death|2|||
163446992|NCT03249792|590338483|FG006|Arms 1, 2, and 4|Death|2|||
163446993|NCT03249792|590338484|FG007|Arms 1, 2, and 4|Death|4|||
163446994|NCT03249792|590338485|FG008|Arms 1, 2, and 4|Death|2|||
163446995|NCT03249792|590338486|FG009|Arms 1, 2, and 4|Death|1|||
163446996|NCT03249792|590338487|FG010|Arms 1, 2, and 4|Death|7|||
163446997|NCT03249792|590338488|FG011|Arms 1, 2, and 4|Death|7|||
163446998|NCT03249792|590338489|FG012|Arms 1, 2, and 4|Death|12|||
163446999|NCT03249792|590338490|FG013|Arms 1, 2, and 4|Death|7|||
163447000|NCT03249792|590338491|FG014|Arms 1, 2, and 4|Death|0|||
163447001|NCT03249792|590338492|FG015|Arms 1, 2, and 4|Death|4|||
163447002|NCT03249792|590338493|FG016|Arms 1, 2, and 4|Death|4|||
163447003|NCT03249792|590338494|FG017|Arms 1, 2, and 4|Death|12|||
163447004|NCT03249792|590338495|FG018|Arms 1, 2, and 4|Death|6|||
163447005|NCT03249792|590338496|FG019|Arms 1, 2, and 4|Death|4|||
163447006|NCT03249792|590338497|FG020|Arms 1, 2, and 4|Death|2|||
163447007|NCT03249792|590338498|FG021|Arms 1, 2, and 4|Death|3|||
163447008|NCT03249792|590338499|FG022|Arms 1, 2, and 4|Death|1|||
163447009|NCT03249792|590338500|FG023|Arms 1, 2, and 4|Death|1|||
163447010|NCT03249792|590338501|FG024|Arms 1, 2, and 4|Death|4|||
163447011|NCT03249792|590338502|FG025|Arms 1, 2, and 4|Death|0|||
163447012|NCT03249792|590338503|FG026|Arms 1, 2, and 4|Death|0|||
163447013|NCT03249792|590338504|FG027|Arms 1, 2, and 4|Death|0|||
163447014|NCT03249792|590338505|FG028|Arms 1, 2, and 4|Death|0|||
163447015|NCT03249792|590338506|FG029|Arms 1, 2, and 4|Death|0|||
163447016|NCT03249792|590338507|FG030|Arms 1, 2, and 4|Death|0|||
163447017|NCT03249792|590338508|FG031|Arms 1, 2, and 4|Death|0|||
163447018|NCT03249792|590338509|FG032|Arms 1, 2, and 4|Death|0|||
163447019|NCT03249792|590338477|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447020|NCT03249792|590338478|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447021|NCT03249792|590338479|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
163447022|NCT03249792|590338480|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447023|NCT03249792|590338481|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447024|NCT03249792|590338482|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
163447025|NCT03249792|590338483|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
163447026|NCT03249792|590338484|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447027|NCT03249792|590338485|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
163447028|NCT03249792|590338486|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
163447029|NCT03249792|590338487|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
163447030|NCT03249792|590338488|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
163447031|NCT03249792|590338489|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
163447032|NCT03249792|590338490|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
163447033|NCT03249792|590338491|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447034|NCT03249792|590338492|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447035|NCT03249792|590338493|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
163447036|NCT03249792|590338494|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447037|NCT03249792|590338495|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
163447038|NCT03249792|590338496|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447039|NCT03249792|590338497|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447040|NCT03249792|590338498|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447041|NCT03249792|590338499|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
163447042|NCT03249792|590338500|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
163447043|NCT03249792|590338501|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447044|NCT03249792|590338502|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447045|NCT03249792|590338503|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447046|NCT03249792|590338504|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447047|NCT03249792|590338505|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447048|NCT03249792|590338506|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447049|NCT03249792|590338507|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447050|NCT03249792|590338508|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447051|NCT03249792|590338509|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163447052|NCT03249792|590338477|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
163447053|NCT03249792|590338478|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
163447054|NCT03249792|590338479|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
163447055|NCT03249792|590338480|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
163447056|NCT03249792|590338481|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
163447057|NCT03249792|590338482|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
163447058|NCT03249792|590338483|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
163447059|NCT03249792|590338484|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
163447060|NCT03249792|590338485|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
163447061|NCT03249792|590338486|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
163447062|NCT03249792|590338487|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
163447063|NCT03249792|590338488|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
163447064|NCT03249792|590338489|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
163447065|NCT03249792|590338490|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
163447066|NCT03249792|590338491|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
163447067|NCT03249792|590338492|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
163447068|NCT03249792|590338493|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
163447069|NCT03249792|590338494|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
163447070|NCT03249792|590338495|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
163447071|NCT03249792|590338496|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
163447072|NCT03249792|590338497|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
163447073|NCT03249792|590338498|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
163447074|NCT03249792|590338499|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
163447075|NCT03249792|590338500|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
163447076|NCT03249792|590338501|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
163447077|NCT03249792|590338502|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
163447078|NCT03249792|590338503|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
163447079|NCT03249792|590338504|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
163447080|NCT03249792|590338505|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
163447081|NCT03249792|590338506|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
163447082|NCT03249792|590338507|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
163447083|NCT03249792|590338508|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
163447084|NCT03249792|590338509|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
163447085|NCT03249792|590338477|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447086|NCT03249792|590338478|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447087|NCT03249792|590338479|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447088|NCT03249792|590338480|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447089|NCT03249792|590338481|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447090|NCT03249792|590338482|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447091|NCT03249792|590338483|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447092|NCT03249792|590338484|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447093|NCT03249792|590338485|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
163447094|NCT03249792|590338486|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447095|NCT03249792|590338487|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447096|NCT03249792|590338488|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447097|NCT03249792|590338489|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447098|NCT03249792|590338490|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447099|NCT03249792|590338491|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447100|NCT03249792|590338492|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447101|NCT03249792|590338493|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
163447102|NCT03249792|590338494|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
163447103|NCT03249792|590338495|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447104|NCT03249792|590338496|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
163447105|NCT03249792|590338497|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447106|NCT03249792|590338498|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447107|NCT03249792|590338499|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447108|NCT03249792|590338500|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447109|NCT03249792|590338501|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447110|NCT03249792|590338502|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447111|NCT03249792|590338503|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447112|NCT03249792|590338504|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447113|NCT03249792|590338505|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447114|NCT03249792|590338506|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447115|NCT03249792|590338507|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447116|NCT03249792|590338508|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447117|NCT03249792|590338509|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
163447118|NCT03249792|590338477|FG000|Switch Over Period|Withdrawal by Subject|0|||
163447119|NCT03249792|590338478|FG001|Switch Over Period|Withdrawal by Subject|0|||
163447120|NCT03249792|590338479|FG002|Switch Over Period|Withdrawal by Subject|0|||
163447121|NCT03249792|590338480|FG003|Switch Over Period|Withdrawal by Subject|0|||
163447122|NCT03249792|590338481|FG004|Switch Over Period|Withdrawal by Subject|0|||
163447123|NCT03249792|590338482|FG005|Switch Over Period|Withdrawal by Subject|0|||
163447124|NCT03249792|590338483|FG006|Switch Over Period|Withdrawal by Subject|0|||
163447125|NCT03249792|590338484|FG007|Switch Over Period|Withdrawal by Subject|0|||
163447126|NCT03249792|590338485|FG008|Switch Over Period|Withdrawal by Subject|0|||
163447127|NCT03249792|590338486|FG009|Switch Over Period|Withdrawal by Subject|0|||
163447128|NCT03249792|590338487|FG010|Switch Over Period|Withdrawal by Subject|0|||
163447129|NCT03249792|590338488|FG011|Switch Over Period|Withdrawal by Subject|0|||
163447130|NCT03249792|590338489|FG012|Switch Over Period|Withdrawal by Subject|0|||
163447131|NCT03249792|590338490|FG013|Switch Over Period|Withdrawal by Subject|0|||
163447132|NCT03249792|590338491|FG014|Switch Over Period|Withdrawal by Subject|0|||
163447133|NCT03249792|590338492|FG015|Switch Over Period|Withdrawal by Subject|0|||
163447134|NCT03249792|590338493|FG016|Switch Over Period|Withdrawal by Subject|0|||
163447135|NCT03249792|590338494|FG017|Switch Over Period|Withdrawal by Subject|0|||
163447136|NCT03249792|590338495|FG018|Switch Over Period|Withdrawal by Subject|0|||
163447137|NCT03249792|590338496|FG019|Switch Over Period|Withdrawal by Subject|0|||
163447138|NCT03249792|590338497|FG020|Switch Over Period|Withdrawal by Subject|0|||
163447139|NCT03249792|590338498|FG021|Switch Over Period|Withdrawal by Subject|0|||
163447140|NCT03249792|590338499|FG022|Switch Over Period|Withdrawal by Subject|0|||
163447141|NCT03249792|590338500|FG023|Switch Over Period|Withdrawal by Subject|0|||
163447142|NCT03249792|590338501|FG024|Switch Over Period|Withdrawal by Subject|0|||
163447143|NCT03249792|590338502|FG025|Switch Over Period|Withdrawal by Subject|0|||
163447144|NCT03249792|590338503|FG026|Switch Over Period|Withdrawal by Subject|0|||
163447145|NCT03249792|590338504|FG027|Switch Over Period|Withdrawal by Subject|0|||
163447146|NCT03249792|590338505|FG028|Switch Over Period|Withdrawal by Subject|0|||
163447147|NCT03249792|590338506|FG029|Switch Over Period|Withdrawal by Subject|0|||
163447148|NCT03249792|590338507|FG030|Switch Over Period|Withdrawal by Subject|0|||
163447149|NCT03249792|590338508|FG031|Switch Over Period|Withdrawal by Subject|1|||
163447150|NCT03249792|590338509|FG032|Switch Over Period|Withdrawal by Subject|0|||
163447151|NCT03249792|590338477|FG000|Switch Over Period|Progressive Disease|0|||
163447152|NCT03249792|590338478|FG001|Switch Over Period|Progressive Disease|0|||
163447153|NCT03249792|590338479|FG002|Switch Over Period|Progressive Disease|0|||
163447154|NCT03249792|590338480|FG003|Switch Over Period|Progressive Disease|0|||
163447155|NCT03249792|590338481|FG004|Switch Over Period|Progressive Disease|0|||
163447156|NCT03249792|590338482|FG005|Switch Over Period|Progressive Disease|0|||
163447157|NCT03249792|590338483|FG006|Switch Over Period|Progressive Disease|0|||
163447158|NCT03249792|590338484|FG007|Switch Over Period|Progressive Disease|0|||
163447159|NCT03249792|590338485|FG008|Switch Over Period|Progressive Disease|0|||
163447160|NCT03249792|590338486|FG009|Switch Over Period|Progressive Disease|0|||
163447161|NCT03249792|590338487|FG010|Switch Over Period|Progressive Disease|0|||
163447162|NCT03249792|590338488|FG011|Switch Over Period|Progressive Disease|0|||
163447163|NCT03249792|590338489|FG012|Switch Over Period|Progressive Disease|0|||
163447164|NCT03249792|590338490|FG013|Switch Over Period|Progressive Disease|0|||
163447165|NCT03249792|590338491|FG014|Switch Over Period|Progressive Disease|0|||
163447166|NCT03249792|590338492|FG015|Switch Over Period|Progressive Disease|0|||
163447167|NCT03249792|590338493|FG016|Switch Over Period|Progressive Disease|0|||
163447168|NCT03249792|590338494|FG017|Switch Over Period|Progressive Disease|0|||
163447169|NCT03249792|590338495|FG018|Switch Over Period|Progressive Disease|0|||
163447170|NCT03249792|590338496|FG019|Switch Over Period|Progressive Disease|0|||
163447171|NCT03249792|590338497|FG020|Switch Over Period|Progressive Disease|0|||
163447172|NCT03249792|590338498|FG021|Switch Over Period|Progressive Disease|0|||
163447173|NCT03249792|590338499|FG022|Switch Over Period|Progressive Disease|0|||
163447174|NCT03249792|590338500|FG023|Switch Over Period|Progressive Disease|0|||
163447175|NCT03249792|590338501|FG024|Switch Over Period|Progressive Disease|0|||
163447176|NCT03249792|590338502|FG025|Switch Over Period|Progressive Disease|0|||
163447177|NCT03249792|590338503|FG026|Switch Over Period|Progressive Disease|1|||
163447178|NCT03249792|590338504|FG027|Switch Over Period|Progressive Disease|0|||
163447179|NCT03249792|590338505|FG028|Switch Over Period|Progressive Disease|1|||
163447180|NCT03249792|590338506|FG029|Switch Over Period|Progressive Disease|2|||
163447181|NCT03249792|590338507|FG030|Switch Over Period|Progressive Disease|1|||
163447182|NCT03249792|590338508|FG031|Switch Over Period|Progressive Disease|0|||
163447183|NCT03249792|590338509|FG032|Switch Over Period|Progressive Disease|1|||
163447184|NCT03249792|590338477|FG000|Switch Over Period|Adverse Event|0|||
163447185|NCT03249792|590338478|FG001|Switch Over Period|Adverse Event|0|||
163447186|NCT03249792|590338479|FG002|Switch Over Period|Adverse Event|0|||
163447187|NCT03249792|590338480|FG003|Switch Over Period|Adverse Event|0|||
163447188|NCT03249792|590338481|FG004|Switch Over Period|Adverse Event|0|||
163447189|NCT03249792|590338482|FG005|Switch Over Period|Adverse Event|0|||
163447190|NCT03249792|590338483|FG006|Switch Over Period|Adverse Event|0|||
163447191|NCT03249792|590338484|FG007|Switch Over Period|Adverse Event|0|||
163447192|NCT03249792|590338485|FG008|Switch Over Period|Adverse Event|0|||
163447193|NCT03249792|590338486|FG009|Switch Over Period|Adverse Event|0|||
163447194|NCT03249792|590338487|FG010|Switch Over Period|Adverse Event|0|||
163447195|NCT03249792|590338488|FG011|Switch Over Period|Adverse Event|0|||
163447196|NCT03249792|590338489|FG012|Switch Over Period|Adverse Event|0|||
163447197|NCT03249792|590338490|FG013|Switch Over Period|Adverse Event|0|||
163447198|NCT03249792|590338491|FG014|Switch Over Period|Adverse Event|0|||
163447199|NCT03249792|590338492|FG015|Switch Over Period|Adverse Event|0|||
163447200|NCT03249792|590338493|FG016|Switch Over Period|Adverse Event|0|||
163447201|NCT03249792|590338494|FG017|Switch Over Period|Adverse Event|0|||
163447202|NCT03249792|590338495|FG018|Switch Over Period|Adverse Event|0|||
163447203|NCT03249792|590338496|FG019|Switch Over Period|Adverse Event|0|||
163447204|NCT03249792|590338497|FG020|Switch Over Period|Adverse Event|0|||
163447205|NCT03249792|590338498|FG021|Switch Over Period|Adverse Event|0|||
163447206|NCT03249792|590338499|FG022|Switch Over Period|Adverse Event|0|||
163447207|NCT03249792|590338500|FG023|Switch Over Period|Adverse Event|0|||
163447208|NCT03249792|590338501|FG024|Switch Over Period|Adverse Event|0|||
163447209|NCT03249792|590338502|FG025|Switch Over Period|Adverse Event|1|||
163447210|NCT03249792|590338503|FG026|Switch Over Period|Adverse Event|0|||
163447211|NCT03249792|590338504|FG027|Switch Over Period|Adverse Event|1|||
163447212|NCT03249792|590338505|FG028|Switch Over Period|Adverse Event|0|||
163447213|NCT03249792|590338506|FG029|Switch Over Period|Adverse Event|0|||
163447214|NCT03249792|590338507|FG030|Switch Over Period|Adverse Event|0|||
163447215|NCT03249792|590338508|FG031|Switch Over Period|Adverse Event|0|||
163447216|NCT03249792|590338509|FG032|Switch Over Period|Adverse Event|0|||
163447217|NCT01409031|590338513|FG000|Overall Study|transferred to other hosp|1|||
163447218|NCT01409031|590338514|FG001|Overall Study|transferred to other hosp|0|||
163447219|NCT00532948|590338515|FG000|Overall Study|Protocol Violation|1|||
163447220|NCT00532948|590338516|FG001|Overall Study|Protocol Violation|0|||
163447221|NCT00532948|590338517|FG002|Overall Study|Protocol Violation|0|||
163447222|NCT00532948|590338515|FG000|Overall Study|Death|3|||
163447223|NCT00532948|590338516|FG001|Overall Study|Death|3|||
163447224|NCT00532948|590338517|FG002|Overall Study|Death|4|||
163447225|NCT00532948|590338515|FG000|Overall Study|Violation of selection criteria at entry|0|||
163447226|NCT00532948|590338516|FG001|Overall Study|Violation of selection criteria at entry|1|||
163447227|NCT00532948|590338517|FG002|Overall Study|Violation of selection criteria at entry|0|||
163447228|NCT00532948|590338515|FG000|Overall Study|Failure to return|0|||
163447229|NCT00532948|590338516|FG001|Overall Study|Failure to return|1|||
163447230|NCT00532948|590338517|FG002|Overall Study|Failure to return|0|||
163447231|NCT00995345|590338518|FG000|Overall Study|Withdrawal by Subject|4|||
163447232|NCT00995345|590338519|FG001|Overall Study|Withdrawal by Subject|2|||
163447233|NCT00995345|590338520|FG002|Overall Study|Withdrawal by Subject|1|||
163447234|NCT00995345|590338521|FG003|Overall Study|Withdrawal by Subject|3|||
163447235|NCT00995345|590338522|FG004|Overall Study|Withdrawal by Subject|1|||
163447236|NCT00995345|590338518|FG000|Overall Study|Adverse Event|3|||
163447237|NCT00995345|590338519|FG001|Overall Study|Adverse Event|1|||
163447238|NCT00995345|590338520|FG002|Overall Study|Adverse Event|2|||
163447239|NCT00995345|590338521|FG003|Overall Study|Adverse Event|0|||
163447240|NCT00995345|590338522|FG004|Overall Study|Adverse Event|1|||
163447241|NCT00995345|590338518|FG000|Overall Study|Lost to Follow-up|2|||
163447242|NCT00995345|590338519|FG001|Overall Study|Lost to Follow-up|2|||
163447243|NCT00995345|590338520|FG002|Overall Study|Lost to Follow-up|2|||
163447244|NCT00995345|590338521|FG003|Overall Study|Lost to Follow-up|1|||
163447245|NCT00995345|590338522|FG004|Overall Study|Lost to Follow-up|0|||
163447246|NCT00995345|590338518|FG000|Overall Study|all other reasons combined|2|||
163447247|NCT00995345|590338519|FG001|Overall Study|all other reasons combined|2|||
163447248|NCT00995345|590338520|FG002|Overall Study|all other reasons combined|2|||
163447249|NCT00995345|590338521|FG003|Overall Study|all other reasons combined|1|||
163447250|NCT00995345|590338522|FG004|Overall Study|all other reasons combined|3|||
163447251|NCT01201798|590338531|FG000|Overall Study|Adverse Event|2|||
163447252|NCT01201798|590338532|FG001|Overall Study|Adverse Event|0|||
163447253|NCT01201798|590338531|FG000|Overall Study|Lost to Follow-up|3|||
163447254|NCT01201798|590338532|FG001|Overall Study|Lost to Follow-up|5|||
163447255|NCT01201798|590338531|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
163447256|NCT01201798|590338532|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
163447257|NCT01201798|590338531|FG000|Overall Study|Noncompliance|1|||
163447258|NCT01201798|590338532|FG001|Overall Study|Noncompliance|0|||
163447259|NCT01201798|590338531|FG000|Overall Study|Protocol Violation|1|||
163447260|NCT01201798|590338532|FG001|Overall Study|Protocol Violation|1|||
163447261|NCT01201798|590338531|FG000|Overall Study|Treatment Failure|1|||
163447262|NCT01201798|590338532|FG001|Overall Study|Treatment Failure|8|||
163447263|NCT02509598|590338533|FG000|Overall Study|Withdrawal by Subject|1|||
163447264|NCT03521687|590338534|FG000|Overall Study|Adverse Event|4|||
163447265|NCT03521687|590338534|FG000|Overall Study|Physician Decision|1|||
163447266|NCT04891770|590338538|FG000|Overall Study|Withdrew consent|1|||
163447267|NCT04891770|590338539|FG001|Overall Study|Withdrew consent|3|||
163447268|NCT04891770|590338540|FG002|Overall Study|Withdrew consent|0|||
163447269|NCT04891770|590338538|FG000|Overall Study|Enrolled but never treated|0|||
163447270|NCT04891770|590338539|FG001|Overall Study|Enrolled but never treated|0|||
163447271|NCT04891770|590338540|FG002|Overall Study|Enrolled but never treated|1|||
163447272|NCT04891770|590338538|FG000|Overall Study|Investigator's discretion|0|||
163447273|NCT04891770|590338539|FG001|Overall Study|Investigator's discretion|1|||
163447274|NCT04891770|590338540|FG002|Overall Study|Investigator's discretion|0|||
163447275|NCT05692154|590338542|FG000|Overall Study|Adverse Event|0|||
163447276|NCT05692154|590338543|FG001|Overall Study|Adverse Event|1|||
163447277|NCT03609359|590338544|FG000|Overall Study|Progression of primary disease (PD)|25|||
163447278|NCT03609359|590338544|FG000|Overall Study|Patient's refusal|1|||
163447279|NCT03609359|590338544|FG000|Overall Study|Physician Decision|1|||
163447280|NCT03609359|590338544|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
163447281|NCT01952834|590338551|FG000|Overall Study|Adverse Event|1|||
163447282|NCT01975272|590338554|FG000|Overall Study|Excluded after protocol amendment|1|||
163447283|NCT01975272|590338555|FG001|Overall Study|Excluded after protocol amendment|1|||
163447284|NCT01975272|590338556|FG002|Overall Study|Excluded after protocol amendment|2|||
163447285|NCT00740779|590338562|FG000|Overall Study|Adverse Event|4|||
163447286|NCT00740779|590338563|FG001|Overall Study|Adverse Event|6|||
163447287|NCT00740779|590338564|FG002|Overall Study|Adverse Event|3|||
163447288|NCT00740779|590338562|FG000|Overall Study|Protocol Violation|1|||
163447289|NCT00740779|590338563|FG001|Overall Study|Protocol Violation|1|||
163447290|NCT00740779|590338564|FG002|Overall Study|Protocol Violation|1|||
163447291|NCT00740779|590338562|FG000|Overall Study|Lack of Efficacy|0|||
163447292|NCT00740779|590338563|FG001|Overall Study|Lack of Efficacy|0|||
163447293|NCT00740779|590338564|FG002|Overall Study|Lack of Efficacy|2|||
163447294|NCT00740779|590338562|FG000|Overall Study|Withdrawal by Subject|2|||
163447295|NCT00740779|590338563|FG001|Overall Study|Withdrawal by Subject|4|||
163447296|NCT00740779|590338564|FG002|Overall Study|Withdrawal by Subject|2|||
163447297|NCT00740779|590338562|FG000|Overall Study|Lost to Follow-up|2|||
163447298|NCT00740779|590338563|FG001|Overall Study|Lost to Follow-up|3|||
163447299|NCT00740779|590338564|FG002|Overall Study|Lost to Follow-up|5|||
163447300|NCT01052012|590338568|FG000|Overall Study|Not treated|2|||
163447301|NCT01052012|590338569|FG001|Overall Study|Not treated|5|||
163447302|NCT01052012|590338570|FG002|Overall Study|Not treated|0|||
163447303|NCT01052012|590338571|FG003|Overall Study|Not treated|0|||
163447304|NCT01052012|590338572|FG004|Overall Study|Not treated|11|||
163447305|NCT01052012|590338573|FG005|Overall Study|Not treated|8|||
163447306|NCT01052012|590338568|FG000|Overall Study|Adverse Event|1|||
163447307|NCT01052012|590338569|FG001|Overall Study|Adverse Event|0|||
163447308|NCT01052012|590338570|FG002|Overall Study|Adverse Event|0|||
163447309|NCT01052012|590338571|FG003|Overall Study|Adverse Event|1|||
163447310|NCT01052012|590338572|FG004|Overall Study|Adverse Event|0|||
163447311|NCT01052012|590338573|FG005|Overall Study|Adverse Event|0|||
163447312|NCT01052012|590338568|FG000|Overall Study|Lost to Follow-up|0|||
163447313|NCT01052012|590338569|FG001|Overall Study|Lost to Follow-up|0|||
163447314|NCT01052012|590338570|FG002|Overall Study|Lost to Follow-up|0|||
163447315|NCT01052012|590338571|FG003|Overall Study|Lost to Follow-up|0|||
163447316|NCT01052012|590338572|FG004|Overall Study|Lost to Follow-up|1|||
163447317|NCT01052012|590338573|FG005|Overall Study|Lost to Follow-up|0|||
163447318|NCT01052012|590338568|FG000|Overall Study|Withdrawal by Subject|1|||
163447319|NCT01052012|590338569|FG001|Overall Study|Withdrawal by Subject|1|||
163447320|NCT01052012|590338570|FG002|Overall Study|Withdrawal by Subject|0|||
163447321|NCT01052012|590338571|FG003|Overall Study|Withdrawal by Subject|0|||
163447322|NCT01052012|590338572|FG004|Overall Study|Withdrawal by Subject|3|||
163447323|NCT01052012|590338573|FG005|Overall Study|Withdrawal by Subject|1|||
163447324|NCT01052012|590338568|FG000|Overall Study|Physician Decision|0|||
163447325|NCT01052012|590338569|FG001|Overall Study|Physician Decision|0|||
163447326|NCT01052012|590338570|FG002|Overall Study|Physician Decision|0|||
163447327|NCT01052012|590338571|FG003|Overall Study|Physician Decision|0|||
163447328|NCT01052012|590338572|FG004|Overall Study|Physician Decision|0|||
163447329|NCT01052012|590338573|FG005|Overall Study|Physician Decision|1|||
163447330|NCT01052012|590338568|FG000|Overall Study|Other|0|||
163447331|NCT01052012|590338569|FG001|Overall Study|Other|0|||
163447332|NCT01052012|590338570|FG002|Overall Study|Other|0|||
163447333|NCT01052012|590338571|FG003|Overall Study|Other|0|||
163447334|NCT01052012|590338572|FG004|Overall Study|Other|1|||
163447335|NCT01052012|590338573|FG005|Overall Study|Other|0|||
163447336|NCT04370028|590338580|FG000|Overall Study|Withdrawal by Subject|695|||
163447337|NCT04370028|590338580|FG000|Overall Study|Protocol Violation|9|||
163447338|NCT04370028|590338580|FG000|Overall Study|Adverse Event|3|||
163447339|NCT02993224|590338582|FG000|Core Phase - Period 1|Adverse Event|4|||
163447340|NCT02993224|590338582|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
163447341|NCT02993224|590338582|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
163447342|NCT02993224|590338582|FG000|Core Phase- Period 2|Adverse Event|1|||
163447343|NCT02993224|590338582|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
163447344|NCT02993224|590338582|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
163447345|NCT02993224|590338582|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
163447346|NCT02993224|590338582|FG000|Extension Phase|Adverse Event|3|||
163447347|NCT02993224|590338582|FG000|Extension Phase|Withdrawal by Subject|3|||
163447348|NCT02993224|590338582|FG000|Extension Phase|Lost to Follow-up|2|||
163447349|NCT02993224|590338582|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
163447350|NCT02426658|590338588|FG000|Overall Study|Withdrawal by Subject|1|||
163447351|NCT02426658|590338588|FG000|Overall Study|Patient expired before treatment|2|||
163447352|NCT03050359|590340528|FG000|Overall Study|Randomized But Not Treated|2|||
163447353|NCT03050359|590340529|FG001|Overall Study|Randomized But Not Treated|0|||
163447354|NCT03050359|590340528|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
163447355|NCT03050359|590340529|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
163447356|NCT03050359|590340528|FG000|Overall Study|Significant Protocol Deviation|2|||
163447357|NCT03050359|590340529|FG001|Overall Study|Significant Protocol Deviation|3|||
163447358|NCT03050359|590340528|FG000|Overall Study|Lost to Follow-up|2|||
163447359|NCT03050359|590340529|FG001|Overall Study|Lost to Follow-up|1|||
163447360|NCT03050359|590340528|FG000|Overall Study|Voluntary Withdrawal|4|||
163447361|NCT03050359|590340529|FG001|Overall Study|Voluntary Withdrawal|6|||
163447362|NCT03050359|590340528|FG000|Overall Study|Pregnancy|1|||
163447363|NCT03050359|590340529|FG001|Overall Study|Pregnancy|0|||
163447364|NCT03050359|590340528|FG000|Overall Study|Reason Not Specified|1|||
163447365|NCT03050359|590340529|FG001|Overall Study|Reason Not Specified|0|||
163447366|NCT02020031|590340530|FG000|Overall Study|Physician Decision|1|||
163447367|NCT02020031|590340531|FG001|Overall Study|Physician Decision|1|||
163447368|NCT00755846|590340534|FG000|Overall Study|Adverse Event|0|||
163447369|NCT00755846|590340535|FG001|Overall Study|Adverse Event|0|||
163447370|NCT00755846|590340536|FG002|Overall Study|Adverse Event|0|||
163447371|NCT00755846|590340537|FG003|Overall Study|Adverse Event|1|||
163447372|NCT00755846|590340538|FG004|Overall Study|Adverse Event|3|||
163447373|NCT00755846|590340539|FG005|Overall Study|Adverse Event|2|||
163447374|NCT00755846|590340534|FG000|Overall Study|Protocol Violation|1|||
163447375|NCT00755846|590340535|FG001|Overall Study|Protocol Violation|1|||
163447376|NCT00755846|590340536|FG002|Overall Study|Protocol Violation|1|||
163447377|NCT00755846|590340537|FG003|Overall Study|Protocol Violation|1|||
163447378|NCT00755846|590340538|FG004|Overall Study|Protocol Violation|1|||
163447379|NCT00755846|590340539|FG005|Overall Study|Protocol Violation|1|||
163447380|NCT00755846|590340534|FG000|Overall Study|Lost to Follow-up|0|||
163447381|NCT00755846|590340535|FG001|Overall Study|Lost to Follow-up|2|||
163447382|NCT00755846|590340536|FG002|Overall Study|Lost to Follow-up|1|||
163447383|NCT00755846|590340537|FG003|Overall Study|Lost to Follow-up|0|||
163447384|NCT00755846|590340538|FG004|Overall Study|Lost to Follow-up|4|||
163447385|NCT00755846|590340539|FG005|Overall Study|Lost to Follow-up|2|||
163447386|NCT00755846|590340534|FG000|Overall Study|Withdrawal by Subject|2|||
163447387|NCT00755846|590340535|FG001|Overall Study|Withdrawal by Subject|3|||
163447388|NCT00755846|590340536|FG002|Overall Study|Withdrawal by Subject|5|||
163447389|NCT00755846|590340537|FG003|Overall Study|Withdrawal by Subject|2|||
163447390|NCT00755846|590340538|FG004|Overall Study|Withdrawal by Subject|0|||
163447391|NCT00755846|590340539|FG005|Overall Study|Withdrawal by Subject|1|||
163447392|NCT00755846|590340534|FG000|Overall Study|Hyperglycemic Rescue|21|||
163447393|NCT00755846|590340535|FG001|Overall Study|Hyperglycemic Rescue|7|||
163447394|NCT00755846|590340536|FG002|Overall Study|Hyperglycemic Rescue|5|||
163447395|NCT00755846|590340537|FG003|Overall Study|Hyperglycemic Rescue|8|||
163447396|NCT00755846|590340538|FG004|Overall Study|Hyperglycemic Rescue|8|||
163447397|NCT00755846|590340539|FG005|Overall Study|Hyperglycemic Rescue|7|||
163447398|NCT00755846|590340534|FG000|Overall Study|Physician Decision|1|||
163447399|NCT00755846|590340535|FG001|Overall Study|Physician Decision|3|||
163447400|NCT00755846|590340536|FG002|Overall Study|Physician Decision|0|||
163447401|NCT00755846|590340537|FG003|Overall Study|Physician Decision|1|||
163447402|NCT00755846|590340538|FG004|Overall Study|Physician Decision|0|||
163447403|NCT00755846|590340539|FG005|Overall Study|Physician Decision|1|||
163447404|NCT00755846|590340534|FG000|Overall Study|Administrative Error|0|||
163447405|NCT00755846|590340535|FG001|Overall Study|Administrative Error|1|||
163447406|NCT00755846|590340536|FG002|Overall Study|Administrative Error|0|||
163447407|NCT00755846|590340537|FG003|Overall Study|Administrative Error|0|||
163447408|NCT00755846|590340538|FG004|Overall Study|Administrative Error|0|||
163447409|NCT00755846|590340539|FG005|Overall Study|Administrative Error|0|||
163447410|NCT00755846|590340534|FG000|Overall Study|Participant Non-compliance|0|||
163447411|NCT00755846|590340535|FG001|Overall Study|Participant Non-compliance|0|||
163447412|NCT00755846|590340536|FG002|Overall Study|Participant Non-compliance|0|||
163447413|NCT00755846|590340537|FG003|Overall Study|Participant Non-compliance|0|||
163447414|NCT00755846|590340538|FG004|Overall Study|Participant Non-compliance|1|||
163447415|NCT00755846|590340539|FG005|Overall Study|Participant Non-compliance|0|||
163447416|NCT00262080|590340550|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
163447417|NCT00262080|590340551|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
163447418|NCT00262080|590340552|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
163447419|NCT00262080|590340550|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
163447420|NCT00262080|590340551|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
163447421|NCT00262080|590340552|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
163447422|NCT00262080|590340550|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
163447423|NCT00262080|590340551|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
163447424|NCT00262080|590340552|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
163447425|NCT00262080|590340550|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
163447426|NCT00262080|590340551|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
163447427|NCT00262080|590340552|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
163447428|NCT00262080|590340550|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
163447429|NCT00262080|590340551|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
163447430|NCT00262080|590340552|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
163447431|NCT00262080|590340550|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
163447432|NCT00262080|590340551|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
163447433|NCT00262080|590340552|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
163447434|NCT02044159|590340553|FG000|Overall Study|Consent declined (deferred consent)|2|||
163447435|NCT02044159|590340554|FG001|Overall Study|Consent declined (deferred consent)|4|||
163447436|NCT02044159|590340553|FG000|Overall Study|No longer eligible, drug not given|1|||
163447437|NCT02044159|590340554|FG001|Overall Study|No longer eligible, drug not given|0|||
163447438|NCT02044159|590340553|FG000|Overall Study|Nurse declined to give study drug|1|||
163447439|NCT02044159|590340554|FG001|Overall Study|Nurse declined to give study drug|0|||
163447440|NCT01597557|590340560|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
163447441|NCT01597557|590340561|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
163447442|NCT02935634|590340565|FG000|Randomization|Participant withdrew consent|0|||
163447443|NCT02935634|590340566|FG001|Randomization|Participant withdrew consent|1|||
163447444|NCT02935634|590340567|FG002|Randomization|Participant withdrew consent|0|||
163447445|NCT02935634|590340568|FG003|Randomization|Participant withdrew consent|0|||
163447446|NCT02935634|590340569|FG004|Randomization|Participant withdrew consent|0|||
163447447|NCT02935634|590340570|FG005|Randomization|Participant withdrew consent|0|||
163447448|NCT02935634|590340565|FG000|Randomization|Death|2|||
163447449|NCT02935634|590340566|FG001|Randomization|Death|1|||
163447450|NCT02935634|590340567|FG002|Randomization|Death|1|||
163447451|NCT02935634|590340568|FG003|Randomization|Death|0|||
163447452|NCT02935634|590340569|FG004|Randomization|Death|0|||
163447453|NCT02935634|590340570|FG005|Randomization|Death|0|||
163447454|NCT02935634|590340565|FG000|Randomization|Other reasons|0|||
163447455|NCT02935634|590340566|FG001|Randomization|Other reasons|2|||
163447456|NCT02935634|590340567|FG002|Randomization|Other reasons|2|||
163447457|NCT02935634|590340568|FG003|Randomization|Other reasons|0|||
163447458|NCT02935634|590340569|FG004|Randomization|Other reasons|0|||
163447459|NCT02935634|590340570|FG005|Randomization|Other reasons|0|||
163447460|NCT02935634|590340565|FG000|Treatment: Track 1|Disease progression|15|||
163447461|NCT02935634|590340566|FG001|Treatment: Track 1|Disease progression|17|||
163447462|NCT02935634|590340567|FG002|Treatment: Track 1|Disease progression|28|||
163447463|NCT02935634|590340568|FG003|Treatment: Track 1|Disease progression|4|||
163447464|NCT02935634|590340569|FG004|Treatment: Track 1|Disease progression|6|||
163447465|NCT02935634|590340570|FG005|Treatment: Track 1|Disease progression|2|||
163447466|NCT02935634|590340565|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
163447467|NCT02935634|590340566|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
163447468|NCT02935634|590340567|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
163447469|NCT02935634|590340568|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
163447470|NCT02935634|590340569|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
163447471|NCT02935634|590340570|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
163447472|NCT02935634|590340565|FG000|Treatment: Track 1|Lost to Follow-up|1|||
163447473|NCT02935634|590340566|FG001|Treatment: Track 1|Lost to Follow-up|0|||
163447474|NCT02935634|590340567|FG002|Treatment: Track 1|Lost to Follow-up|0|||
163447475|NCT02935634|590340568|FG003|Treatment: Track 1|Lost to Follow-up|0|||
163447476|NCT02935634|590340569|FG004|Treatment: Track 1|Lost to Follow-up|0|||
163447477|NCT02935634|590340570|FG005|Treatment: Track 1|Lost to Follow-up|0|||
163447478|NCT02935634|590340565|FG000|Treatment: Track 1|Study drug toxicity|2|||
163447479|NCT02935634|590340566|FG001|Treatment: Track 1|Study drug toxicity|1|||
163447480|NCT02935634|590340567|FG002|Treatment: Track 1|Study drug toxicity|3|||
163447481|NCT02935634|590340568|FG003|Treatment: Track 1|Study drug toxicity|0|||
163447482|NCT02935634|590340569|FG004|Treatment: Track 1|Study drug toxicity|0|||
163447483|NCT02935634|590340570|FG005|Treatment: Track 1|Study drug toxicity|1|||
163447484|NCT02935634|590340565|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
163447485|NCT02935634|590340566|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
163447486|NCT02935634|590340567|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
163447487|NCT02935634|590340568|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
163447488|NCT02935634|590340569|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
163447489|NCT02935634|590340570|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
163447490|NCT02935634|590340565|FG000|Treatment: Track 1|Participant withdrew consent|2|||
163447491|NCT02935634|590340566|FG001|Treatment: Track 1|Participant withdrew consent|0|||
163447492|NCT02935634|590340567|FG002|Treatment: Track 1|Participant withdrew consent|1|||
163447493|NCT02935634|590340568|FG003|Treatment: Track 1|Participant withdrew consent|0|||
163447494|NCT02935634|590340569|FG004|Treatment: Track 1|Participant withdrew consent|1|||
163447495|NCT02935634|590340570|FG005|Treatment: Track 1|Participant withdrew consent|0|||
163447496|NCT02935634|590340565|FG000|Treatment: Track 1|Other reasons|0|||
163447497|NCT02935634|590340566|FG001|Treatment: Track 1|Other reasons|0|||
163447498|NCT02935634|590340567|FG002|Treatment: Track 1|Other reasons|2|||
163447499|NCT02935634|590340568|FG003|Treatment: Track 1|Other reasons|0|||
163447500|NCT02935634|590340569|FG004|Treatment: Track 1|Other reasons|0|||
163447501|NCT02935634|590340570|FG005|Treatment: Track 1|Other reasons|0|||
163447502|NCT02935634|590340565|FG000|Treatment: Track 2|Disease progression|13|||
163447503|NCT02935634|590340566|FG001|Treatment: Track 2|Disease progression|26|||
163447504|NCT02935634|590340567|FG002|Treatment: Track 2|Disease progression|20|||
163447505|NCT02935634|590340568|FG003|Treatment: Track 2|Disease progression|5|||
163447506|NCT02935634|590340569|FG004|Treatment: Track 2|Disease progression|1|||
163447507|NCT02935634|590340570|FG005|Treatment: Track 2|Disease progression|4|||
163447508|NCT02935634|590340565|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
163447509|NCT02935634|590340566|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
163447510|NCT02935634|590340567|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
163447511|NCT02935634|590340568|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
163447512|NCT02935634|590340569|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
163447513|NCT02935634|590340570|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
163447514|NCT02935634|590340565|FG000|Treatment: Track 2|Study drug toxicity|7|||
163447515|NCT02935634|590340566|FG001|Treatment: Track 2|Study drug toxicity|3|||
163447516|NCT02935634|590340567|FG002|Treatment: Track 2|Study drug toxicity|0|||
163447517|NCT02935634|590340568|FG003|Treatment: Track 2|Study drug toxicity|0|||
163447518|NCT02935634|590340569|FG004|Treatment: Track 2|Study drug toxicity|0|||
163447519|NCT02935634|590340570|FG005|Treatment: Track 2|Study drug toxicity|0|||
163447520|NCT02935634|590340565|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
163447521|NCT02935634|590340566|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
163447522|NCT02935634|590340567|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
163447523|NCT02935634|590340568|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
163447524|NCT02935634|590340569|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
163447525|NCT02935634|590340570|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
163447526|NCT02935634|590340565|FG000|Treatment: Track 2|Participant withdrew consent|0|||
163447527|NCT02935634|590340566|FG001|Treatment: Track 2|Participant withdrew consent|1|||
163447528|NCT02935634|590340567|FG002|Treatment: Track 2|Participant withdrew consent|1|||
163447529|NCT02935634|590340568|FG003|Treatment: Track 2|Participant withdrew consent|0|||
163447530|NCT02935634|590340569|FG004|Treatment: Track 2|Participant withdrew consent|1|||
163447531|NCT02935634|590340570|FG005|Treatment: Track 2|Participant withdrew consent|0|||
163447532|NCT06150573|590340573|FG000|Overall Study|Did not meet study criteria|1|||
163447533|NCT06150573|590340574|FG001|Overall Study|Did not meet study criteria|0|||
163447534|NCT06150573|590340573|FG000|Overall Study|Adverse Event|1|||
163447535|NCT06150573|590340574|FG001|Overall Study|Adverse Event|0|||
163447536|NCT06150573|590340573|FG000|Overall Study|Lost to Follow-up|0|||
163447537|NCT06150573|590340574|FG001|Overall Study|Lost to Follow-up|1|||
163447538|NCT06150573|590340573|FG000|Overall Study|Protocol Violation|0|||
163447539|NCT06150573|590340574|FG001|Overall Study|Protocol Violation|1|||
163447540|NCT06150573|590340573|FG000|Overall Study|Withdrawal by Subject|2|||
163447541|NCT06150573|590340574|FG001|Overall Study|Withdrawal by Subject|0|||
163447542|NCT00210158|590340575|FG000|Overall Study|Protocol Violation|0|||
163447543|NCT00210158|590340576|FG001|Overall Study|Protocol Violation|2|||
163447544|NCT02284906|590340581|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
163447545|NCT02284906|590340582|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
163447546|NCT02284906|590340583|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
163447547|NCT02284906|590340581|FG000|Overall Study|Major Protocol Deviation|0|||
163447548|NCT02284906|590340582|FG001|Overall Study|Major Protocol Deviation|1|||
163447549|NCT02284906|590340583|FG002|Overall Study|Major Protocol Deviation|0|||
163447550|NCT02284906|590340581|FG000|Overall Study|Voluntary Withdrawal|2|||
163447551|NCT02284906|590340582|FG001|Overall Study|Voluntary Withdrawal|4|||
163447552|NCT02284906|590340583|FG002|Overall Study|Voluntary Withdrawal|5|||
163447553|NCT02284906|590340581|FG000|Overall Study|Study Termination|0|||
163447554|NCT02284906|590340582|FG001|Overall Study|Study Termination|11|||
163447555|NCT02284906|590340583|FG002|Overall Study|Study Termination|14|||
163447556|NCT02284906|590340581|FG000|Overall Study|Reason not Specified|1|||
163447557|NCT02284906|590340582|FG001|Overall Study|Reason not Specified|1|||
163447558|NCT02284906|590340583|FG002|Overall Study|Reason not Specified|0|||
163447559|NCT01094730|590340584|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
163447560|NCT01094730|590340585|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
163447561|NCT01094730|590340584|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
163447562|NCT01094730|590340585|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
163447563|NCT01094730|590340584|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
163447564|NCT01094730|590340585|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
163447565|NCT01094730|590340584|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
163447566|NCT01094730|590340585|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
163447567|NCT01094730|590340584|FG000|Period 2 (14 Days)|Protocol Violation|2|||
163447568|NCT01094730|590340585|FG001|Period 2 (14 Days)|Protocol Violation|0|||
163447569|NCT01094730|590340584|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
163447570|NCT01094730|590340585|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
163447571|NCT01094730|590340584|FG000|Period 2 (14 Days)|Adverse Event|0|||
163447572|NCT01094730|590340585|FG001|Period 2 (14 Days)|Adverse Event|1|||
163447573|NCT01094730|590340584|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
163447574|NCT01094730|590340585|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
163447575|NCT03885726|590340587|FG000|Overall Study|Staffing issues/lost interest|1|||
163447576|NCT03885726|590340587|FG000|Overall Study|Early discharge from hospital|3|||
163447577|NCT04096326|590340588|FG000|Overall Study|Withdrawal by Subject|0|||
163447578|NCT04096326|590340589|FG001|Overall Study|Withdrawal by Subject|0|||
163447579|NCT04096326|590340590|FG002|Overall Study|Withdrawal by Subject|0|||
163447580|NCT04096326|590340591|FG003|Overall Study|Withdrawal by Subject|0|||
163447581|NCT04096326|590340592|FG004|Overall Study|Withdrawal by Subject|0|||
163447582|NCT04096326|590340593|FG005|Overall Study|Withdrawal by Subject|0|||
163447583|NCT04096326|590340594|FG006|Overall Study|Withdrawal by Subject|1|||
163447584|NCT04096326|590340595|FG007|Overall Study|Withdrawal by Subject|0|||
163447585|NCT04096326|590340596|FG008|Overall Study|Withdrawal by Subject|0|||
163447586|NCT04096326|590340597|FG009|Overall Study|Withdrawal by Subject|0|||
163447587|NCT04096326|590340588|FG000|Overall Study|Lost to Follow-up|0|||
163447588|NCT04096326|590340589|FG001|Overall Study|Lost to Follow-up|1|||
163447589|NCT04096326|590340590|FG002|Overall Study|Lost to Follow-up|0|||
163447590|NCT04096326|590340591|FG003|Overall Study|Lost to Follow-up|0|||
163447591|NCT04096326|590340592|FG004|Overall Study|Lost to Follow-up|0|||
163447592|NCT04096326|590340593|FG005|Overall Study|Lost to Follow-up|0|||
163447593|NCT04096326|590340594|FG006|Overall Study|Lost to Follow-up|0|||
163447594|NCT04096326|590340595|FG007|Overall Study|Lost to Follow-up|0|||
163447595|NCT04096326|590340596|FG008|Overall Study|Lost to Follow-up|0|||
163447596|NCT04096326|590340597|FG009|Overall Study|Lost to Follow-up|0|||
163447597|NCT04096326|590340588|FG000|Overall Study|COVID-19-related reasons|0|||
163447598|NCT04096326|590340589|FG001|Overall Study|COVID-19-related reasons|0|||
163447599|NCT04096326|590340590|FG002|Overall Study|COVID-19-related reasons|0|||
163447600|NCT04096326|590340591|FG003|Overall Study|COVID-19-related reasons|0|||
163447601|NCT04096326|590340592|FG004|Overall Study|COVID-19-related reasons|1|||
163447602|NCT04096326|590340593|FG005|Overall Study|COVID-19-related reasons|5|||
163447603|NCT04096326|590340594|FG006|Overall Study|COVID-19-related reasons|0|||
163447604|NCT04096326|590340595|FG007|Overall Study|COVID-19-related reasons|0|||
163447605|NCT04096326|590340596|FG008|Overall Study|COVID-19-related reasons|0|||
163447606|NCT04096326|590340597|FG009|Overall Study|COVID-19-related reasons|0|||
163447607|NCT04804033|590340598|FG000|Period 1: DBT Phase|Adverse Event|1|||
163447608|NCT04804033|590340599|FG001|Period 1: DBT Phase|Adverse Event|5|||
163447609|NCT04804033|590340600|FG002|Period 1: DBT Phase|Adverse Event|3|||
163447610|NCT04804033|590340601|FG003|Period 1: DBT Phase|Adverse Event|4|||
163447611|NCT04804033|590340598|FG000|Period 1: DBT Phase|Death|1|||
163447612|NCT04804033|590340599|FG001|Period 1: DBT Phase|Death|0|||
163447613|NCT04804033|590340600|FG002|Period 1: DBT Phase|Death|0|||
163447614|NCT04804033|590340601|FG003|Period 1: DBT Phase|Death|0|||
163447615|NCT04804033|590340598|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
163447616|NCT04804033|590340599|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
163447617|NCT04804033|590340600|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
163447618|NCT04804033|590340601|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
163447619|NCT04804033|590340598|FG000|Period 1: DBT Phase|Non-compliance|1|||
163447620|NCT04804033|590340599|FG001|Period 1: DBT Phase|Non-compliance|0|||
163447621|NCT04804033|590340600|FG002|Period 1: DBT Phase|Non-compliance|1|||
163447622|NCT04804033|590340601|FG003|Period 1: DBT Phase|Non-compliance|2|||
163447623|NCT04804033|590340598|FG000|Period 1: DBT Phase|Other|0|||
163447624|NCT04804033|590340599|FG001|Period 1: DBT Phase|Other|1|||
163447625|NCT04804033|590340600|FG002|Period 1: DBT Phase|Other|0|||
163447626|NCT04804033|590340601|FG003|Period 1: DBT Phase|Other|0|||
163447627|NCT04804033|590340598|FG000|Period 1: DBT Phase|Pregnancy|2|||
163447628|NCT04804033|590340599|FG001|Period 1: DBT Phase|Pregnancy|0|||
163447629|NCT04804033|590340600|FG002|Period 1: DBT Phase|Pregnancy|0|||
163447630|NCT04804033|590340601|FG003|Period 1: DBT Phase|Pregnancy|0|||
163447631|NCT04804033|590340598|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
163447632|NCT04804033|590340599|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
163447633|NCT04804033|590340600|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
163447634|NCT04804033|590340601|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
163447635|NCT04804033|590340598|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
163447636|NCT04804033|590340599|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
163447637|NCT04804033|590340600|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
163447638|NCT04804033|590340601|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
163447639|NCT04804033|590340598|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
163447640|NCT04804033|590340599|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
163447641|NCT04804033|590340600|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
163447642|NCT04804033|590340601|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
163447643|NCT04804033|590340598|FG000|Period 2: OLE Phase|Adverse Event|3|||
163447644|NCT04804033|590340599|FG001|Period 2: OLE Phase|Adverse Event|4|||
163447645|NCT04804033|590340600|FG002|Period 2: OLE Phase|Adverse Event|2|||
163447646|NCT04804033|590340601|FG003|Period 2: OLE Phase|Adverse Event|0|||
163447647|NCT04804033|590340598|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
163447648|NCT04804033|590340599|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
163447649|NCT04804033|590340600|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
163447650|NCT04804033|590340601|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
163447651|NCT04804033|590340598|FG000|Period 2: OLE Phase|Non-compliance|2|||
163447652|NCT04804033|590340599|FG001|Period 2: OLE Phase|Non-compliance|2|||
163447653|NCT04804033|590340600|FG002|Period 2: OLE Phase|Non-compliance|0|||
163447654|NCT04804033|590340601|FG003|Period 2: OLE Phase|Non-compliance|1|||
163447655|NCT04804033|590340598|FG000|Period 2: OLE Phase|Other|0|||
163447656|NCT04804033|590340599|FG001|Period 2: OLE Phase|Other|2|||
163447657|NCT04804033|590340600|FG002|Period 2: OLE Phase|Other|0|||
163447658|NCT04804033|590340601|FG003|Period 2: OLE Phase|Other|0|||
163447659|NCT04804033|590340598|FG000|Period 2: OLE Phase|Physician Decision|1|||
163447660|NCT04804033|590340599|FG001|Period 2: OLE Phase|Physician Decision|1|||
163447661|NCT04804033|590340600|FG002|Period 2: OLE Phase|Physician Decision|0|||
163447662|NCT04804033|590340601|FG003|Period 2: OLE Phase|Physician Decision|0|||
163447663|NCT04804033|590340598|FG000|Period 2: OLE Phase|Pregnancy|0|||
163447664|NCT04804033|590340599|FG001|Period 2: OLE Phase|Pregnancy|0|||
163447665|NCT04804033|590340600|FG002|Period 2: OLE Phase|Pregnancy|2|||
163447666|NCT04804033|590340601|FG003|Period 2: OLE Phase|Pregnancy|0|||
163447667|NCT04804033|590340598|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
163447668|NCT04804033|590340599|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
163447669|NCT04804033|590340600|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
163447670|NCT04804033|590340601|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
163447671|NCT04804033|590340598|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
163447672|NCT04804033|590340599|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
163447673|NCT04804033|590340600|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
163447674|NCT04804033|590340601|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
163447675|NCT04804033|590340598|FG000|Period 2: OLE Phase|Not reported|0|||
163447676|NCT04804033|590340599|FG001|Period 2: OLE Phase|Not reported|2|||
163447677|NCT04804033|590340600|FG002|Period 2: OLE Phase|Not reported|0|||
163447678|NCT04804033|590340601|FG003|Period 2: OLE Phase|Not reported|0|||
163447679|NCT04804033|590340598|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
163447680|NCT04804033|590340599|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
163447681|NCT04804033|590340600|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
163447682|NCT04804033|590340601|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
163447683|NCT04804033|590340598|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
163447684|NCT04804033|590340599|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
163447685|NCT04804033|590340600|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
163447686|NCT04804033|590340601|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
163447687|NCT04804033|590340598|FG000|Period 3: Follow-up Phase|Other|0|||
163447688|NCT04804033|590340599|FG001|Period 3: Follow-up Phase|Other|1|||
163447689|NCT04804033|590340600|FG002|Period 3: Follow-up Phase|Other|2|||
163447690|NCT04804033|590340601|FG003|Period 3: Follow-up Phase|Other|1|||
163447691|NCT04804033|590340598|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
163447692|NCT04804033|590340599|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
163447693|NCT04804033|590340600|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
163447694|NCT04804033|590340601|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
163447695|NCT04804033|590340598|FG000|Period 3: Follow-up Phase|Not reported|18|||
163447696|NCT04804033|590340599|FG001|Period 3: Follow-up Phase|Not reported|15|||
163447697|NCT04804033|590340600|FG002|Period 3: Follow-up Phase|Not reported|1|||
163447698|NCT04804033|590340601|FG003|Period 3: Follow-up Phase|Not reported|4|||
163447699|NCT02496585|590340604|FG000|Overall Study|Death|3|||
163447700|NCT02496585|590340605|FG001|Overall Study|Death|0|||
163447701|NCT02496585|590340604|FG000|Overall Study|Lost to Follow-up|2|||
163447702|NCT02496585|590340605|FG001|Overall Study|Lost to Follow-up|0|||
163447703|NCT02496585|590340604|FG000|Overall Study|Withdrawal by Subject|1|||
163447704|NCT02496585|590340605|FG001|Overall Study|Withdrawal by Subject|2|||
163447705|NCT02496585|590340604|FG000|Overall Study|Progression of Malignancy|4|||
163447706|NCT02496585|590340605|FG001|Overall Study|Progression of Malignancy|1|||
163447707|NCT01276457|590340609|FG000|Core Study|Adverse Event|6|||
163447708|NCT01276457|590340610|FG001|Core Study|Adverse Event|3|||
163447709|NCT01276457|590340609|FG000|Core Study|Lost to Follow-up|1|||
163447710|NCT01276457|590340610|FG001|Core Study|Lost to Follow-up|2|||
163447711|NCT01276457|590340609|FG000|Core Study|Administrative problems|1|||
163447712|NCT01276457|590340610|FG001|Core Study|Administrative problems|1|||
163447713|NCT01276457|590340609|FG000|Core Study|Death|2|||
163447714|NCT01276457|590340610|FG001|Core Study|Death|2|||
163447715|NCT01276457|590340609|FG000|Core Study|Lack of Efficacy|3|||
163447716|NCT01276457|590340610|FG001|Core Study|Lack of Efficacy|12|||
163447717|NCT01276457|590340609|FG000|Extension Study|Lost to Follow-up|3|||
163447718|NCT01276457|590340610|FG001|Extension Study|Lost to Follow-up|0|||
163447719|NCT01276457|590340609|FG000|Extension Study|Death|0|||
163447720|NCT01276457|590340610|FG001|Extension Study|Death|1|||
163447721|NCT01276457|590340609|FG000|Extension Study|Lack of Efficacy|3|||
163447722|NCT01276457|590340610|FG001|Extension Study|Lack of Efficacy|1|||
163447723|NCT05122650|590340612|FG000|Overall Study|Adverse Event|4|||
163447724|NCT05122650|590340613|FG001|Overall Study|Adverse Event|16|||
163447725|NCT05122650|590340614|FG002|Overall Study|Adverse Event|11|||
163447726|NCT05122650|590340615|FG003|Overall Study|Adverse Event|12|||
163447727|NCT05122650|590340612|FG000|Overall Study|Lack of Efficacy|0|||
163447728|NCT05122650|590340613|FG001|Overall Study|Lack of Efficacy|1|||
163447729|NCT05122650|590340614|FG002|Overall Study|Lack of Efficacy|1|||
163447730|NCT05122650|590340615|FG003|Overall Study|Lack of Efficacy|2|||
163447731|NCT05122650|590340612|FG000|Overall Study|Lost to Follow-up|1|||
163447732|NCT05122650|590340613|FG001|Overall Study|Lost to Follow-up|1|||
163447733|NCT05122650|590340614|FG002|Overall Study|Lost to Follow-up|3|||
163447734|NCT05122650|590340615|FG003|Overall Study|Lost to Follow-up|0|||
163447735|NCT05122650|590340612|FG000|Overall Study|Non-compliance with study intervention|0|||
163447736|NCT05122650|590340613|FG001|Overall Study|Non-compliance with study intervention|0|||
163447737|NCT05122650|590340614|FG002|Overall Study|Non-compliance with study intervention|0|||
163447738|NCT05122650|590340615|FG003|Overall Study|Non-compliance with study intervention|2|||
163447739|NCT05122650|590340612|FG000|Overall Study|Protocol Violation|0|||
163447740|NCT05122650|590340613|FG001|Overall Study|Protocol Violation|1|||
163447741|NCT05122650|590340614|FG002|Overall Study|Protocol Violation|0|||
163447742|NCT05122650|590340615|FG003|Overall Study|Protocol Violation|1|||
163447743|NCT05122650|590340612|FG000|Overall Study|Randomized by mistake|0|||
163447744|NCT05122650|590340613|FG001|Overall Study|Randomized by mistake|0|||
163447745|NCT05122650|590340614|FG002|Overall Study|Randomized by mistake|3|||
163447746|NCT05122650|590340615|FG003|Overall Study|Randomized by mistake|2|||
163447747|NCT05122650|590340612|FG000|Overall Study|Sponsor request|0|||
163447748|NCT05122650|590340613|FG001|Overall Study|Sponsor request|1|||
163447749|NCT05122650|590340614|FG002|Overall Study|Sponsor request|1|||
163447750|NCT05122650|590340615|FG003|Overall Study|Sponsor request|2|||
163447751|NCT05122650|590340612|FG000|Overall Study|Withdrawal by Subject|3|||
163447752|NCT05122650|590340613|FG001|Overall Study|Withdrawal by Subject|7|||
163447753|NCT05122650|590340614|FG002|Overall Study|Withdrawal by Subject|4|||
163447754|NCT05122650|590340615|FG003|Overall Study|Withdrawal by Subject|8|||
163447755|NCT05122650|590340612|FG000|Overall Study|Other|5|||
163447756|NCT05122650|590340613|FG001|Overall Study|Other|0|||
163447757|NCT05122650|590340614|FG002|Overall Study|Other|0|||
163447758|NCT05122650|590340615|FG003|Overall Study|Other|0|||
163447759|NCT03280550|590340620|FG000|Overall Study|Withdrawal by Subject|2|||
163447760|NCT03280550|590340621|FG001|Overall Study|Withdrawal by Subject|2|||
163447761|NCT03280550|590340620|FG000|Overall Study|Physician Decision|0|||
163447762|NCT03280550|590340621|FG001|Overall Study|Physician Decision|1|||
163447763|NCT05896761|590340622|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
163447764|NCT05896761|590340623|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
163447765|NCT05896761|590340622|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
163447766|NCT05896761|590340623|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
163447767|NCT01318083|590340624|FG000|Overall Study|Adverse Event|4|||
163447768|NCT01318083|590340625|FG001|Overall Study|Adverse Event|1|||
163447769|NCT01318083|590340626|FG002|Overall Study|Adverse Event|2|||
163447770|NCT01318083|590340624|FG000|Overall Study|Withdrawal by Subject|1|||
163447771|NCT01318083|590340625|FG001|Overall Study|Withdrawal by Subject|0|||
163447772|NCT01318083|590340626|FG002|Overall Study|Withdrawal by Subject|2|||
163447773|NCT01318083|590340624|FG000|Overall Study|Lack of Efficacy|0|||
163447774|NCT01318083|590340625|FG001|Overall Study|Lack of Efficacy|0|||
163447775|NCT01318083|590340626|FG002|Overall Study|Lack of Efficacy|1|||
163447776|NCT01318083|590340624|FG000|Overall Study|Treatment Complications|1|||
163447777|NCT01318083|590340625|FG001|Overall Study|Treatment Complications|0|||
163447778|NCT01318083|590340626|FG002|Overall Study|Treatment Complications|0|||
163447779|NCT01318083|590340624|FG000|Overall Study|Lack of Study Medication Compliance|0|||
163447780|NCT01318083|590340625|FG001|Overall Study|Lack of Study Medication Compliance|1|||
163447781|NCT01318083|590340626|FG002|Overall Study|Lack of Study Medication Compliance|0|||
163447782|NCT02028338|590340629|FG000|Overall Study|Withdrawal by Subject|3|||
163447783|NCT02028338|590340630|FG001|Overall Study|Withdrawal by Subject|1|||
163447784|NCT02028338|590340629|FG000|Overall Study|Unable to contact participant|1|||
163447785|NCT02028338|590340630|FG001|Overall Study|Unable to contact participant|0|||
163447786|NCT03552549|590340632|FG000|Overall Study|Disease progression|25|||
163447787|NCT03552549|590340633|FG001|Overall Study|Disease progression|17|||
163447788|NCT03552549|590340632|FG000|Overall Study|Adverse event in first 12 months|12|||
163447789|NCT03552549|590340633|FG001|Overall Study|Adverse event in first 12 months|8|||
163447790|NCT03552549|590340632|FG000|Overall Study|Withdrawal by Subject|7|||
163447791|NCT03552549|590340633|FG001|Overall Study|Withdrawal by Subject|7|||
163447792|NCT03552549|590340632|FG000|Overall Study|Unknown (no reason provided)|4|||
163447793|NCT03552549|590340633|FG001|Overall Study|Unknown (no reason provided)|2|||
163447794|NCT03552549|590340632|FG000|Overall Study|Not in participant's best interest|2|||
163447795|NCT03552549|590340633|FG001|Overall Study|Not in participant's best interest|1|||
163447796|NCT03552549|590340632|FG000|Overall Study|Did not complete study treatment|2|||
163447797|NCT03552549|590340633|FG001|Overall Study|Did not complete study treatment|3|||
163447798|NCT03552549|590340632|FG000|Overall Study|Did not meet eligibility criteria|1|||
163447799|NCT03552549|590340633|FG001|Overall Study|Did not meet eligibility criteria|0|||
163447800|NCT03552549|590340632|FG000|Overall Study|Administrative|0|||
163447801|NCT03552549|590340633|FG001|Overall Study|Administrative|14|||
163447802|NCT02761993|590340642|FG000|Overall Study|Adverse Event|0|||
163447803|NCT02761993|590340643|FG001|Overall Study|Adverse Event|2|||
163447804|NCT02761993|590340644|FG002|Overall Study|Adverse Event|0|||
163447805|NCT02761993|590340642|FG000|Overall Study|Lost to Follow-up|1|||
163447806|NCT02761993|590340643|FG001|Overall Study|Lost to Follow-up|3|||
163447807|NCT02761993|590340644|FG002|Overall Study|Lost to Follow-up|2|||
163447808|NCT02761993|590340642|FG000|Overall Study|Withdrawal by Subject|1|||
163447809|NCT02761993|590340643|FG001|Overall Study|Withdrawal by Subject|1|||
163447810|NCT02761993|590340644|FG002|Overall Study|Withdrawal by Subject|2|||
163447811|NCT00256867|590340645|FG000|Overall Study|Adverse Event|0|||
163447812|NCT00256867|590340646|FG001|Overall Study|Adverse Event|1|||
163447813|NCT00256867|590340647|FG002|Overall Study|Adverse Event|1|||
163447814|NCT00256867|590340648|FG003|Overall Study|Adverse Event|1|||
163447815|NCT00256867|590340649|FG004|Overall Study|Adverse Event|2|||
163447816|NCT00256867|590340650|FG005|Overall Study|Adverse Event|2|||
163447817|NCT00256867|590340651|FG006|Overall Study|Adverse Event|1|||
163447818|NCT00256867|590340652|FG007|Overall Study|Adverse Event|4|||
163447819|NCT00256867|590340645|FG000|Overall Study|Lost to Follow-up|2|||
163447820|NCT00256867|590340646|FG001|Overall Study|Lost to Follow-up|2|||
163447821|NCT00256867|590340647|FG002|Overall Study|Lost to Follow-up|2|||
163447822|NCT00256867|590340648|FG003|Overall Study|Lost to Follow-up|3|||
163447823|NCT00256867|590340649|FG004|Overall Study|Lost to Follow-up|2|||
163447824|NCT00256867|590340650|FG005|Overall Study|Lost to Follow-up|0|||
163447825|NCT00256867|590340651|FG006|Overall Study|Lost to Follow-up|1|||
163447826|NCT00256867|590340652|FG007|Overall Study|Lost to Follow-up|2|||
163447827|NCT00256867|590340645|FG000|Overall Study|Protocol Violation|0|||
163447828|NCT00256867|590340646|FG001|Overall Study|Protocol Violation|0|||
163447829|NCT00256867|590340647|FG002|Overall Study|Protocol Violation|0|||
163447830|NCT00256867|590340648|FG003|Overall Study|Protocol Violation|1|||
163447831|NCT00256867|590340649|FG004|Overall Study|Protocol Violation|0|||
163447832|NCT00256867|590340650|FG005|Overall Study|Protocol Violation|1|||
163447833|NCT00256867|590340651|FG006|Overall Study|Protocol Violation|0|||
163447834|NCT00256867|590340652|FG007|Overall Study|Protocol Violation|1|||
163447835|NCT00256867|590340645|FG000|Overall Study|Withdrawal by Subject|0|||
163447836|NCT00256867|590340646|FG001|Overall Study|Withdrawal by Subject|0|||
163447837|NCT00256867|590340647|FG002|Overall Study|Withdrawal by Subject|1|||
163447838|NCT00256867|590340648|FG003|Overall Study|Withdrawal by Subject|1|||
163447839|NCT00256867|590340649|FG004|Overall Study|Withdrawal by Subject|2|||
163447840|NCT00256867|590340650|FG005|Overall Study|Withdrawal by Subject|2|||
163447841|NCT00256867|590340651|FG006|Overall Study|Withdrawal by Subject|3|||
163447842|NCT00256867|590340652|FG007|Overall Study|Withdrawal by Subject|2|||
163447843|NCT00256867|590340645|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
163447844|NCT00256867|590340646|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
163447845|NCT00256867|590340647|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
163447846|NCT00256867|590340648|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
163447847|NCT00256867|590340649|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
163447848|NCT00256867|590340650|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
163447849|NCT00256867|590340651|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
163447850|NCT00256867|590340652|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
163447851|NCT00256867|590340645|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
163447852|NCT00256867|590340646|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
163447853|NCT00256867|590340647|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
163447854|NCT00256867|590340648|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
163447855|NCT00256867|590340649|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
163447856|NCT00256867|590340650|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
163447857|NCT00256867|590340651|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
163447858|NCT00256867|590340652|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
163447859|NCT00256867|590340645|FG000|Overall Study|Investigator's Decision|0|||
163447860|NCT00256867|590340646|FG001|Overall Study|Investigator's Decision|0|||
163447861|NCT00256867|590340647|FG002|Overall Study|Investigator's Decision|0|||
163447862|NCT00256867|590340648|FG003|Overall Study|Investigator's Decision|0|||
163447863|NCT00256867|590340649|FG004|Overall Study|Investigator's Decision|1|||
163447864|NCT00256867|590340650|FG005|Overall Study|Investigator's Decision|0|||
163447865|NCT00256867|590340651|FG006|Overall Study|Investigator's Decision|0|||
163447866|NCT00256867|590340652|FG007|Overall Study|Investigator's Decision|0|||
163447867|NCT00256867|590340645|FG000|Overall Study|Non-compliance with study medication|0|||
163447868|NCT00256867|590340646|FG001|Overall Study|Non-compliance with study medication|0|||
163447869|NCT00256867|590340647|FG002|Overall Study|Non-compliance with study medication|0|||
163447870|NCT00256867|590340648|FG003|Overall Study|Non-compliance with study medication|0|||
163447871|NCT00256867|590340649|FG004|Overall Study|Non-compliance with study medication|0|||
163447872|NCT00256867|590340650|FG005|Overall Study|Non-compliance with study medication|0|||
163447873|NCT00256867|590340651|FG006|Overall Study|Non-compliance with study medication|0|||
163447874|NCT00256867|590340652|FG007|Overall Study|Non-compliance with study medication|1|||
163447875|NCT00256867|590340645|FG000|Overall Study|Participant travelled Overseas|0|||
163447876|NCT00256867|590340646|FG001|Overall Study|Participant travelled Overseas|1|||
163447877|NCT00256867|590340647|FG002|Overall Study|Participant travelled Overseas|0|||
163447878|NCT00256867|590340648|FG003|Overall Study|Participant travelled Overseas|0|||
163447879|NCT00256867|590340649|FG004|Overall Study|Participant travelled Overseas|0|||
163447880|NCT00256867|590340650|FG005|Overall Study|Participant travelled Overseas|0|||
163447881|NCT00256867|590340651|FG006|Overall Study|Participant travelled Overseas|0|||
163447882|NCT00256867|590340652|FG007|Overall Study|Participant travelled Overseas|0|||
163447883|NCT00256867|590340645|FG000|Overall Study|Participant out of assessment window|0|||
163447884|NCT00256867|590340646|FG001|Overall Study|Participant out of assessment window|0|||
163447885|NCT00256867|590340647|FG002|Overall Study|Participant out of assessment window|1|||
163447886|NCT00256867|590340648|FG003|Overall Study|Participant out of assessment window|0|||
163447887|NCT00256867|590340649|FG004|Overall Study|Participant out of assessment window|0|||
163447888|NCT00256867|590340650|FG005|Overall Study|Participant out of assessment window|0|||
163447889|NCT00256867|590340651|FG006|Overall Study|Participant out of assessment window|0|||
163447890|NCT00256867|590340652|FG007|Overall Study|Participant out of assessment window|0|||
163447891|NCT00256867|590340645|FG000|Overall Study|Withdrawal by participant|0|||
163447892|NCT00256867|590340646|FG001|Overall Study|Withdrawal by participant|0|||
163447893|NCT00256867|590340647|FG002|Overall Study|Withdrawal by participant|0|||
163447894|NCT00256867|590340648|FG003|Overall Study|Withdrawal by participant|0|||
163447895|NCT00256867|590340649|FG004|Overall Study|Withdrawal by participant|0|||
163447896|NCT00256867|590340650|FG005|Overall Study|Withdrawal by participant|1|||
163447897|NCT00256867|590340651|FG006|Overall Study|Withdrawal by participant|0|||
163447898|NCT00256867|590340652|FG007|Overall Study|Withdrawal by participant|0|||
163447899|NCT01465178|590340655|FG000|Overall Study|Withdrawal by Subject|1|||
163447900|NCT01465178|590340656|FG001|Overall Study|Withdrawal by Subject|0|||
163447901|NCT00527111|590340657|FG000|Overall Study|Adverse Event|14|||
163447902|NCT00527111|590340658|FG001|Overall Study|Adverse Event|13|||
163447903|NCT00527111|590340657|FG000|Overall Study|Death|0|||
163447904|NCT00527111|590340658|FG001|Overall Study|Death|1|||
163447905|NCT00527111|590340657|FG000|Overall Study|Investigator Request|2|||
163447906|NCT00527111|590340658|FG001|Overall Study|Investigator Request|1|||
163447907|NCT00527111|590340657|FG000|Overall Study|Patient Request|2|||
163447908|NCT00527111|590340658|FG001|Overall Study|Patient Request|5|||
163447909|NCT00527111|590340657|FG000|Overall Study|Other|2|||
163447910|NCT00527111|590340658|FG001|Overall Study|Other|2|||
163447911|NCT04072146|590340661|FG000|Overall Study|Adverse Event|0|||
163447912|NCT04072146|590340662|FG001|Overall Study|Adverse Event|1|||
163447913|NCT01617434|590340663|FG000|Overall Study|Adverse Event|12|||
163447914|NCT01617434|590340664|FG001|Overall Study|Adverse Event|3|||
163447915|NCT01617434|590340663|FG000|Overall Study|Protocol Violation|8|||
163447916|NCT01617434|590340664|FG001|Overall Study|Protocol Violation|7|||
163447917|NCT01617434|590340663|FG000|Overall Study|Withdrawal Criteria|12|||
163447918|NCT01617434|590340664|FG001|Overall Study|Withdrawal Criteria|37|||
163447919|NCT01617434|590340663|FG000|Overall Study|Unclassified|3|||
163447920|NCT01617434|590340664|FG001|Overall Study|Unclassified|4|||
163447921|NCT01930799|590340668|FG000|Overall Study|Withdrawal by Subject|3|||
163447922|NCT01930799|590340668|FG000|Overall Study|Lost to Follow-up|5|||
163447923|NCT00875017|590340674|FG000|First Intervention|Withdrawal by Subject|1|||
163447924|NCT00875017|590340675|FG001|First Intervention|Withdrawal by Subject|0|||
163447925|NCT00875017|590340676|FG002|First Intervention|Withdrawal by Subject|1|||
163447926|NCT00875017|590340677|FG003|First Intervention|Withdrawal by Subject|0|||
163447927|NCT00875017|590340678|FG004|First Intervention|Withdrawal by Subject|0|||
163447928|NCT00875017|590340679|FG005|First Intervention|Withdrawal by Subject|0|||
163447929|NCT00875017|590340674|FG000|First Intervention|Adverse Event|0|||
163447930|NCT00875017|590340675|FG001|First Intervention|Adverse Event|0|||
163447931|NCT00875017|590340676|FG002|First Intervention|Adverse Event|0|||
163447932|NCT00875017|590340677|FG003|First Intervention|Adverse Event|1|||
163447933|NCT00875017|590340678|FG004|First Intervention|Adverse Event|0|||
163447934|NCT00875017|590340679|FG005|First Intervention|Adverse Event|0|||
163447935|NCT00875017|590340674|FG000|First Intervention|Problems collecting rectal effluent|1|||
163447936|NCT00875017|590340675|FG001|First Intervention|Problems collecting rectal effluent|0|||
163447937|NCT00875017|590340676|FG002|First Intervention|Problems collecting rectal effluent|0|||
163447938|NCT00875017|590340677|FG003|First Intervention|Problems collecting rectal effluent|0|||
163447939|NCT00875017|590340678|FG004|First Intervention|Problems collecting rectal effluent|0|||
163447940|NCT00875017|590340679|FG005|First Intervention|Problems collecting rectal effluent|0|||
163447941|NCT00875017|590340674|FG000|First Intervention|Intolerance to nasogastric tube|0|||
163447942|NCT00875017|590340675|FG001|First Intervention|Intolerance to nasogastric tube|0|||
163447943|NCT00875017|590340676|FG002|First Intervention|Intolerance to nasogastric tube|0|||
163447944|NCT00875017|590340677|FG003|First Intervention|Intolerance to nasogastric tube|0|||
163447945|NCT00875017|590340678|FG004|First Intervention|Intolerance to nasogastric tube|1|||
163447946|NCT00875017|590340679|FG005|First Intervention|Intolerance to nasogastric tube|0|||
163447947|NCT00875017|590340674|FG000|Washout|Problem collecting rectal effluent|0|||
163447948|NCT00875017|590340675|FG001|Washout|Problem collecting rectal effluent|0|||
163447949|NCT00875017|590340676|FG002|Washout|Problem collecting rectal effluent|1|||
163447950|NCT00875017|590340677|FG003|Washout|Problem collecting rectal effluent|0|||
163447951|NCT00875017|590340678|FG004|Washout|Problem collecting rectal effluent|0|||
163447952|NCT00875017|590340679|FG005|Washout|Problem collecting rectal effluent|0|||
163447953|NCT00875017|590340674|FG000|Second Intervention|Adverse Event|0|||
163447954|NCT00875017|590340675|FG001|Second Intervention|Adverse Event|0|||
163447955|NCT00875017|590340676|FG002|Second Intervention|Adverse Event|0|||
163447956|NCT00875017|590340677|FG003|Second Intervention|Adverse Event|1|||
163447957|NCT00875017|590340678|FG004|Second Intervention|Adverse Event|0|||
163447958|NCT00875017|590340679|FG005|Second Intervention|Adverse Event|0|||
163447959|NCT00875017|590340674|FG000|Washout|Problems collecting rectal effluent|0|||
163447960|NCT00875017|590340675|FG001|Washout|Problems collecting rectal effluent|1|||
163447961|NCT00875017|590340676|FG002|Washout|Problems collecting rectal effluent|0|||
163447962|NCT00875017|590340677|FG003|Washout|Problems collecting rectal effluent|0|||
163447963|NCT00875017|590340678|FG004|Washout|Problems collecting rectal effluent|0|||
163447964|NCT00875017|590340679|FG005|Washout|Problems collecting rectal effluent|0|||
163447965|NCT00875017|590340674|FG000|Third Intervention|Adverse Event|0|||
163447966|NCT00875017|590340675|FG001|Third Intervention|Adverse Event|1|||
163447967|NCT00875017|590340676|FG002|Third Intervention|Adverse Event|1|||
163447968|NCT00875017|590340677|FG003|Third Intervention|Adverse Event|0|||
163447969|NCT00875017|590340678|FG004|Third Intervention|Adverse Event|0|||
163447970|NCT00875017|590340679|FG005|Third Intervention|Adverse Event|0|||
163447971|NCT00875017|590340674|FG000|Washout|Withdrawal by Subject|0|||
163447972|NCT00875017|590340675|FG001|Washout|Withdrawal by Subject|0|||
163447973|NCT00875017|590340676|FG002|Washout|Withdrawal by Subject|0|||
163447974|NCT00875017|590340677|FG003|Washout|Withdrawal by Subject|0|||
163447975|NCT00875017|590340678|FG004|Washout|Withdrawal by Subject|1|||
163447976|NCT00875017|590340679|FG005|Washout|Withdrawal by Subject|0|||
163447977|NCT00875017|590340674|FG000|Fourth Intervention|Inability to comply with fasting|0|||
163447978|NCT00875017|590340675|FG001|Fourth Intervention|Inability to comply with fasting|0|||
163447979|NCT00875017|590340676|FG002|Fourth Intervention|Inability to comply with fasting|0|||
163447980|NCT00875017|590340677|FG003|Fourth Intervention|Inability to comply with fasting|0|||
163447981|NCT00875017|590340678|FG004|Fourth Intervention|Inability to comply with fasting|0|||
163447982|NCT00875017|590340679|FG005|Fourth Intervention|Inability to comply with fasting|1|||
163447983|NCT02689219|590340680|FG000|Overall Study|Death|1|||
163447984|NCT02689219|590340681|FG001|Overall Study|Death|1|||
163447985|NCT02689219|590340680|FG000|Overall Study|Disease Progression|10|||
163447986|NCT02689219|590340681|FG001|Overall Study|Disease Progression|6|||
163447987|NCT01477892|590340682|FG000|Overall Study|Withdrawal by Subject|0|||
163447988|NCT01477892|590340683|FG001|Overall Study|Withdrawal by Subject|2|||
163447989|NCT01921257|590340688|FG000|Overall Study|Adverse Event|1|||
163447990|NCT01921257|590340688|FG000|Overall Study|Protocol Violation|1|||
163447991|NCT01921257|590340688|FG000|Overall Study|Withdrawal by Subject|1|||
163447992|NCT00364845|590340689|FG000|Overall Study|Adverse Event|1|||
163447993|NCT00364845|590340690|FG001|Overall Study|Adverse Event|0|||
163447994|NCT00364845|590340689|FG000|Overall Study|Withdrawal by Subject|2|||
163447995|NCT00364845|590340690|FG001|Overall Study|Withdrawal by Subject|1|||
163447996|NCT00364845|590340689|FG000|Overall Study|Physician Decision|8|||
163447997|NCT00364845|590340690|FG001|Overall Study|Physician Decision|8|||
163447998|NCT00364845|590340689|FG000|Overall Study|Lost to Follow-up|0|||
163447999|NCT00364845|590340690|FG001|Overall Study|Lost to Follow-up|1|||
163448000|NCT00364845|590340689|FG000|Overall Study|Death|0|||
163448001|NCT00364845|590340690|FG001|Overall Study|Death|1|||
163448002|NCT01423617|590340691|FG000|Overall Study|Lost to Follow-up|0|||
163448003|NCT01423617|590340692|FG001|Overall Study|Lost to Follow-up|1|||
163448004|NCT03255291|590340693|FG000|Overall Study|Determined to be ineligible|10|||
163448005|NCT03255291|590340694|FG001|Overall Study|Determined to be ineligible|12|||
163448006|NCT03255291|590340695|FG002|Overall Study|Determined to be ineligible|6|||
163448007|NCT03255291|590340696|FG003|Overall Study|Determined to be ineligible|6|||
163448008|NCT03255291|590340697|FG004|Overall Study|Determined to be ineligible|5|||
163448009|NCT03255291|590340698|FG005|Overall Study|Determined to be ineligible|10|||
163448010|NCT03255291|590340693|FG000|Overall Study|Baseline data collection issues|3|||
163448011|NCT03255291|590340694|FG001|Overall Study|Baseline data collection issues|0|||
163448012|NCT03255291|590340695|FG002|Overall Study|Baseline data collection issues|0|||
163448013|NCT03255291|590340696|FG003|Overall Study|Baseline data collection issues|0|||
163448014|NCT03255291|590340697|FG004|Overall Study|Baseline data collection issues|2|||
163448015|NCT03255291|590340698|FG005|Overall Study|Baseline data collection issues|0|||
163448016|NCT00634244|590340699|FG000|Overall Study|Never started treatment|0|||
163448017|NCT00634244|590340700|FG001|Overall Study|Never started treatment|1|||
163448018|NCT00634244|590340701|FG002|Overall Study|Never started treatment|0|||
163448019|NCT00634244|590340699|FG000|Overall Study|Death|1|||
163448020|NCT00634244|590340700|FG001|Overall Study|Death|6|||
163448021|NCT00634244|590340701|FG002|Overall Study|Death|0|||
163448022|NCT00634244|590340699|FG000|Overall Study|Adverse Event|0|||
163448023|NCT00634244|590340700|FG001|Overall Study|Adverse Event|2|||
163448024|NCT00634244|590340701|FG002|Overall Study|Adverse Event|0|||
163448025|NCT00634244|590340699|FG000|Overall Study|Withdrawal by Subject|0|||
163448026|NCT00634244|590340700|FG001|Overall Study|Withdrawal by Subject|1|||
163448027|NCT00634244|590340701|FG002|Overall Study|Withdrawal by Subject|0|||
163448028|NCT00634244|590340699|FG000|Overall Study|Physician Decision|0|||
163448029|NCT00634244|590340700|FG001|Overall Study|Physician Decision|1|||
163448030|NCT00634244|590340701|FG002|Overall Study|Physician Decision|0|||
163448031|NCT00634244|590340699|FG000|Overall Study|Disease progression/relapse|0|||
163448032|NCT00634244|590340700|FG001|Overall Study|Disease progression/relapse|1|||
163448033|NCT00634244|590340701|FG002|Overall Study|Disease progression/relapse|0|||
163448034|NCT00634244|590340699|FG000|Overall Study|Other complicating disease|0|||
163448035|NCT00634244|590340700|FG001|Overall Study|Other complicating disease|1|||
163448036|NCT00634244|590340701|FG002|Overall Study|Other complicating disease|0|||
163448037|NCT01204658|590340703|FG000|Primary Phase|Adverse Event|0|||
163448038|NCT01204658|590340704|FG001|Primary Phase|Adverse Event|0|||
163448039|NCT01204658|590340705|FG002|Primary Phase|Adverse Event|1|||
163448040|NCT01204658|590340706|FG003|Primary Phase|Adverse Event|0|||
163448041|NCT02723604|590342201|FG000|Overall Study|ineligible|1|||
163448042|NCT02723604|590342201|FG000|Overall Study|never received treatment|1|||
163448043|NCT00111475|590342202|FG000|Overall Study|Lost to Follow-up|0|||
163448044|NCT00111475|590342203|FG001|Overall Study|Lost to Follow-up|0|||
163448045|NCT00111475|590342204|FG002|Overall Study|Lost to Follow-up|0|||
163448046|NCT00111475|590342205|FG003|Overall Study|Lost to Follow-up|0|||
163448047|NCT00111475|590342206|FG004|Overall Study|Lost to Follow-up|0|||
163448048|NCT00111475|590342207|FG005|Overall Study|Lost to Follow-up|1|||
163448049|NCT00111475|590342208|FG006|Overall Study|Lost to Follow-up|0|||
163448050|NCT00111475|590342209|FG007|Overall Study|Lost to Follow-up|0|||
163448051|NCT00111475|590342210|FG008|Overall Study|Lost to Follow-up|0|||
163448052|NCT00111475|590342211|FG009|Overall Study|Lost to Follow-up|0|||
163448053|NCT00833248|590342214|FG000|Overall Study|Adverse Event|3|||
163448054|NCT00833248|590342215|FG001|Overall Study|Adverse Event|0|||
163448055|NCT00833248|590342214|FG000|Overall Study|Protocol Violation|1|||
163448056|NCT00833248|590342215|FG001|Overall Study|Protocol Violation|2|||
163448057|NCT00833248|590342214|FG000|Overall Study|Withdrawal by Subject|0|||
163448058|NCT00833248|590342215|FG001|Overall Study|Withdrawal by Subject|1|||
163448059|NCT01369849|590342218|FG000|Overall Study|Ineligible prior to treatment|0|||
163448060|NCT01369849|590342219|FG001|Overall Study|Ineligible prior to treatment|0|||
163448061|NCT01369849|590342220|FG002|Overall Study|Ineligible prior to treatment|1|||
163448062|NCT01369849|590342218|FG000|Overall Study|Ineligible after receiving treatment|0|||
163448063|NCT01369849|590342219|FG001|Overall Study|Ineligible after receiving treatment|1|||
163448064|NCT01369849|590342220|FG002|Overall Study|Ineligible after receiving treatment|0|||
163448065|NCT00288860|590342223|FG000|Overall Study|Did not complete intake|4|||
163448066|NCT00288860|590342224|FG001|Overall Study|Did not complete intake|8|||
163448067|NCT00288860|590342223|FG000|Overall Study|Death|4|||
163448068|NCT00288860|590342224|FG001|Overall Study|Death|3|||
163448069|NCT00288860|590342223|FG000|Overall Study|Withdrawal by Subject|20|||
163448070|NCT00288860|590342224|FG001|Overall Study|Withdrawal by Subject|15|||
163448071|NCT00288860|590342223|FG000|Overall Study|Lost to Follow-up|74|||
163448072|NCT00288860|590342224|FG001|Overall Study|Lost to Follow-up|71|||
163448073|NCT00115349|590342231|FG000|Overall Study|Study closed due to low enrollment.|11|||
163448074|NCT00115349|590342232|FG001|Overall Study|Study closed due to low enrollment.|9|||
163448075|NCT01028651|590342237|FG000|Overall Study|Death|2|||
163448076|NCT01028651|590342237|FG000|Overall Study|Adverse Event|1|||
163448077|NCT00390416|590342239|FG000|Overall Study|Withdrawal by Subject|1|||
163448078|NCT00390416|590342239|FG000|Overall Study|Not treated|3|||
163448079|NCT01592409|590342240|FG000|Overall Study|Withdrawal by Subject|0|||
163448080|NCT01592409|590342241|FG001|Overall Study|Withdrawal by Subject|1|||
163448081|NCT01728584|590342242|FG000|Overall Study|Adverse Event|1|||
163448082|NCT01728584|590342243|FG001|Overall Study|Adverse Event|0|||
163448083|NCT01728584|590342244|FG002|Overall Study|Adverse Event|0|||
163448084|NCT01728584|590342245|FG003|Overall Study|Adverse Event|0|||
163448085|NCT01728584|590342242|FG000|Overall Study|Physician Decision|4|||
163448086|NCT01728584|590342243|FG001|Overall Study|Physician Decision|0|||
163448087|NCT01728584|590342244|FG002|Overall Study|Physician Decision|1|||
163448088|NCT01728584|590342245|FG003|Overall Study|Physician Decision|0|||
163448089|NCT01728584|590342242|FG000|Overall Study|Withdrawal by Subject|1|||
163448090|NCT01728584|590342243|FG001|Overall Study|Withdrawal by Subject|0|||
163448091|NCT01728584|590342244|FG002|Overall Study|Withdrawal by Subject|0|||
163448092|NCT01728584|590342245|FG003|Overall Study|Withdrawal by Subject|0|||
163448093|NCT01728584|590342242|FG000|Overall Study|Screen failure|1|||
163448094|NCT01728584|590342243|FG001|Overall Study|Screen failure|0|||
163448095|NCT01728584|590342244|FG002|Overall Study|Screen failure|0|||
163448096|NCT01728584|590342245|FG003|Overall Study|Screen failure|0|||
163448097|NCT01728584|590342242|FG000|Overall Study|Other reason (not specified)|1|||
163448098|NCT01728584|590342243|FG001|Overall Study|Other reason (not specified)|0|||
163448099|NCT01728584|590342244|FG002|Overall Study|Other reason (not specified)|0|||
163448100|NCT01728584|590342245|FG003|Overall Study|Other reason (not specified)|1|||
163448101|NCT05132569|590342247|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
163448102|NCT05132569|590342248|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
163448103|NCT05132569|590342247|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
163448104|NCT05132569|590342248|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
163448105|NCT05132569|590342247|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
163448106|NCT05132569|590342248|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
163448107|NCT02345252|590342263|FG000|Double-Blind Phase|Adverse Event|2|||
163448108|NCT02345252|590342264|FG001|Double-Blind Phase|Adverse Event|3|||
163448109|NCT02345252|590342263|FG000|Double-Blind Phase|Death|1|||
163448110|NCT02345252|590342264|FG001|Double-Blind Phase|Death|2|||
163448111|NCT02345252|590342263|FG000|Double-Blind Phase|Lack of Efficacy|1|||
163448112|NCT02345252|590342264|FG001|Double-Blind Phase|Lack of Efficacy|0|||
163448113|NCT02345252|590342263|FG000|Double-Blind Phase|Investigator's Discretion|4|||
163448114|NCT02345252|590342264|FG001|Double-Blind Phase|Investigator's Discretion|6|||
163448115|NCT02345252|590342263|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
163448116|NCT02345252|590342264|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
163448117|NCT02345252|590342263|FG000|Double-Blind Phase|Protocol Violation|2|||
163448118|NCT02345252|590342264|FG001|Double-Blind Phase|Protocol Violation|1|||
163448119|NCT02345252|590342263|FG000|Double-Blind Phase|Withdrew Consent|21|||
163448120|NCT02345252|590342264|FG001|Double-Blind Phase|Withdrew Consent|23|||
163448121|NCT02345252|590342263|FG000|Double-Blind Phase|Lost to Follow-up|8|||
163448122|NCT02345252|590342264|FG001|Double-Blind Phase|Lost to Follow-up|10|||
163448123|NCT02345252|590342263|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
163448124|NCT02345252|590342264|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
163448125|NCT00471536|590342275|FG000|Overall Study|Withdrawal by Subject|1|||
163448126|NCT01188564|590342278|FG000|Double-blind Phase|randomized not treated|1|||
163448127|NCT01188564|590342279|FG001|Double-blind Phase|randomized not treated|0|||
163448128|NCT04171037|590342282|FG000|Overall Study|Lost to Follow-up|1|||
163448129|NCT04171037|590342283|FG001|Overall Study|Lost to Follow-up|0|||
163448130|NCT04171037|590342282|FG000|Overall Study|Physician Decision|3|||
163448131|NCT04171037|590342283|FG001|Overall Study|Physician Decision|3|||
163448132|NCT01934894|590342284|FG000|Overall Study|Adverse Event|1|||
163448133|NCT01934894|590342285|FG001|Overall Study|Adverse Event|2|||
163448134|NCT01934894|590342284|FG000|Overall Study|Death|2|||
163448135|NCT01934894|590342285|FG001|Overall Study|Death|0|||
163448136|NCT01934894|590342284|FG000|Overall Study|Withdrawal by Subject|0|||
163448137|NCT01934894|590342285|FG001|Overall Study|Withdrawal by Subject|1|||
163448138|NCT01934894|590342284|FG000|Overall Study|Progressive Disease|3|||
163448139|NCT01934894|590342285|FG001|Overall Study|Progressive Disease|2|||
163448140|NCT01954251|590342286|FG000|Overall Study|Adverse Event|5|||
163448141|NCT01954251|590342287|FG001|Overall Study|Adverse Event|7|||
163448142|NCT01954251|590342286|FG000|Overall Study|Lost to Follow-up|6|||
163448143|NCT01954251|590342287|FG001|Overall Study|Lost to Follow-up|6|||
163448144|NCT01954251|590342286|FG000|Overall Study|Withdrawal by Subject|2|||
163448145|NCT01954251|590342287|FG001|Overall Study|Withdrawal by Subject|6|||
163448146|NCT02864940|590342288|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
163448147|NCT02864940|590342289|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
163448148|NCT01864018|590342290|FG000|Overall Study|Ineligible|3|||
163448149|NCT01864018|590342291|FG001|Overall Study|Ineligible|1|||
163448150|NCT02702193|590342292|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
163448151|NCT02702193|590342293|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
163448152|NCT02702193|590342292|FG000|4 Month Follow up|Withdrawal by Subject|1|||
163448153|NCT02702193|590342293|FG001|4 Month Follow up|Withdrawal by Subject|0|||
163448154|NCT02702193|590342292|FG000|4 Month Follow up|Lost to Follow-up|17|||
163448155|NCT02702193|590342293|FG001|4 Month Follow up|Lost to Follow-up|18|||
163448156|NCT02702193|590342292|FG000|8 Month Follow up|Withdrawal by Subject|1|||
163448157|NCT02702193|590342293|FG001|8 Month Follow up|Withdrawal by Subject|0|||
163448158|NCT02702193|590342292|FG000|8 Month Follow up|Lost to Follow-up|14|||
163448159|NCT02702193|590342293|FG001|8 Month Follow up|Lost to Follow-up|18|||
163448160|NCT02702193|590342292|FG000|12 Month Follow up|Withdrawal by Subject|1|||
163448161|NCT02702193|590342293|FG001|12 Month Follow up|Withdrawal by Subject|0|||
163448162|NCT02702193|590342292|FG000|12 Month Follow up|Lost to Follow-up|16|||
163448163|NCT02702193|590342293|FG001|12 Month Follow up|Lost to Follow-up|18|||
163448164|NCT03510663|590342299|FG000|Overall Study|Withdrawal by Subject|0|||
163448165|NCT03510663|590342300|FG001|Overall Study|Withdrawal by Subject|1|||
163448166|NCT03510663|590342301|FG002|Overall Study|Withdrawal by Subject|0|||
163448167|NCT03510663|590342302|FG003|Overall Study|Withdrawal by Subject|0|||
163448168|NCT03510663|590342303|FG004|Overall Study|Withdrawal by Subject|0|||
163448169|NCT03510663|590342304|FG005|Overall Study|Withdrawal by Subject|0|||
163448170|NCT03510663|590342305|FG006|Overall Study|Withdrawal by Subject|0|||
163448171|NCT03510663|590342306|FG007|Overall Study|Withdrawal by Subject|0|||
163448172|NCT00222729|590342309|FG000|Overall Study|Adverse Event|3|||
163448173|NCT01915849|590342312|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
163448174|NCT01915849|590342313|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
163448175|NCT01915849|590342314|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
163448176|NCT01915849|590342315|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
163448177|NCT01915849|590342312|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
163448178|NCT01915849|590342313|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
163448179|NCT01915849|590342314|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
163448180|NCT01915849|590342315|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
163448181|NCT01798706|590342316|FG000|Overall Study|Adverse Event|15|||
163448182|NCT01798706|590342317|FG001|Overall Study|Adverse Event|10|||
163448183|NCT01798706|590342316|FG000|Overall Study|Lack of Efficacy|0|||
163448184|NCT01798706|590342317|FG001|Overall Study|Lack of Efficacy|2|||
163448185|NCT01798706|590342316|FG000|Overall Study|Poor compliance to protocol|1|||
163448186|NCT01798706|590342317|FG001|Overall Study|Poor compliance to protocol|0|||
163448187|NCT01798706|590342316|FG000|Overall Study|Other than specified above|5|||
163448188|NCT01798706|590342317|FG001|Overall Study|Other than specified above|9|||
163448189|NCT02775864|590342318|FG000|Overall Study|Data ended end of 2010|1764|||
163448190|NCT02775864|590342319|FG001|Overall Study|Data ended end of 2010|2880|||
163448191|NCT02775864|590342320|FG002|Overall Study|Data ended end of 2010|1140|||
163448192|NCT02775864|590342321|FG003|Overall Study|Data ended end of 2010|1194|||
163448193|NCT02775864|590342318|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
163448194|NCT02775864|590342319|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
163448195|NCT02775864|590342320|FG002|Overall Study|Medicaid eligibility discontinued|720|||
163448196|NCT02775864|590342321|FG003|Overall Study|Medicaid eligibility discontinued|890|||
163448197|NCT01689207|590342322|FG000|Overall Study|Adverse Event|0|||
163448198|NCT01689207|590342323|FG001|Overall Study|Adverse Event|1|||
163448199|NCT01689207|590342324|FG002|Overall Study|Adverse Event|0|||
163448200|NCT01689207|590342325|FG003|Overall Study|Adverse Event|0|||
163448201|NCT01689207|590342326|FG004|Overall Study|Adverse Event|2|||
163448202|NCT01689207|590342327|FG005|Overall Study|Adverse Event|1|||
163448203|NCT01689207|590342328|FG006|Overall Study|Adverse Event|0|||
163448204|NCT01689207|590342329|FG007|Overall Study|Adverse Event|0|||
163448205|NCT01689207|590342330|FG008|Overall Study|Adverse Event|1|||
163448206|NCT01689207|590342331|FG009|Overall Study|Adverse Event|0|||
163448207|NCT01689207|590342332|FG010|Overall Study|Adverse Event|0|||
163448208|NCT01912768|590342333|FG000|Overall Study|Adverse Event|2|||
163448209|NCT01912768|590342334|FG001|Overall Study|Adverse Event|0|||
163448210|NCT01912768|590342333|FG000|Overall Study|Lost to Follow-up|2|||
163448211|NCT01912768|590342334|FG001|Overall Study|Lost to Follow-up|1|||
163448212|NCT01912768|590342333|FG000|Overall Study|Withdrawal by Subject|5|||
163448213|NCT01912768|590342334|FG001|Overall Study|Withdrawal by Subject|3|||
163448214|NCT01912768|590342333|FG000|Overall Study|Randomized in error|1|||
163448215|NCT01912768|590342334|FG001|Overall Study|Randomized in error|0|||
163448216|NCT04369430|590342342|FG000|Overall Study|Adverse Event|2|||
163448217|NCT04369430|590342343|FG001|Overall Study|Adverse Event|3|||
163448218|NCT04369430|590342342|FG000|Overall Study|Death|1|||
163448219|NCT04369430|590342343|FG001|Overall Study|Death|0|||
163448220|NCT04369430|590342342|FG000|Overall Study|Withdrawal by Subject|4|||
163448221|NCT04369430|590342343|FG001|Overall Study|Withdrawal by Subject|3|||
163448222|NCT04369430|590342342|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
163448223|NCT04369430|590342343|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
163448224|NCT04369430|590342342|FG000|Overall Study|Lost to Follow-up|0|||
163448225|NCT04369430|590342343|FG001|Overall Study|Lost to Follow-up|1|||
163448226|NCT04737031|590342344|FG000|Overall Study|Patients who did not have a treatment visit|0|||
163448227|NCT04737031|590342345|FG001|Overall Study|Patients who did not have a treatment visit|31|||
163448228|NCT04737031|590342346|FG002|Overall Study|Patients who did not have a treatment visit|93|||
163448229|NCT04737031|590342347|FG003|Overall Study|Patients who did not have a treatment visit|227|||
163448230|NCT03453151|590342350|FG000|Overall Study|Withdrawal by Subject|1|||
163448231|NCT03453151|590342350|FG000|Overall Study|Physician Decision|3|||
163448232|NCT00142519|590342351|FG000|Overall Study|Not Treated|7|||
163448233|NCT00142519|590342352|FG001|Overall Study|Not Treated|9|||
163448234|NCT00142519|590342351|FG000|Overall Study|Protocol Violation|1|||
163448235|NCT00142519|590342352|FG001|Overall Study|Protocol Violation|0|||
163448236|NCT00142519|590342351|FG000|Overall Study|Withdrawal by Subject|10|||
163448237|NCT00142519|590342352|FG001|Overall Study|Withdrawal by Subject|7|||
163448238|NCT01468909|590342353|FG000|Overall Study|Never Treated|2|||
163448239|NCT01468909|590342354|FG001|Overall Study|Never Treated|2|||
163448240|NCT04594239|590342362|FG000|Overall Study|Withdrawal by Subject|3|||
163448241|NCT04594239|590342363|FG001|Overall Study|Withdrawal by Subject|4|||
163448242|NCT04594239|590342364|FG002|Overall Study|Withdrawal by Subject|2|||
163448243|NCT04594239|590342365|FG003|Overall Study|Withdrawal by Subject|4|||
163448244|NCT04594239|590342362|FG000|Overall Study|Lost to Follow-up|8|||
163448245|NCT04594239|590342363|FG001|Overall Study|Lost to Follow-up|5|||
163448246|NCT04594239|590342364|FG002|Overall Study|Lost to Follow-up|4|||
163448247|NCT04594239|590342365|FG003|Overall Study|Lost to Follow-up|6|||
163448248|NCT04594239|590342362|FG000|Overall Study|Subject relocated|0|||
163448249|NCT04594239|590342363|FG001|Overall Study|Subject relocated|0|||
163448250|NCT04594239|590342364|FG002|Overall Study|Subject relocated|0|||
163448251|NCT04594239|590342365|FG003|Overall Study|Subject relocated|1|||
163448252|NCT03229759|590342366|FG000|Overall Study|Screen Failure|30|||
163448253|NCT00762372|590344404|FG000|Overall Study|Adverse Event|1|||
163448254|NCT00762372|590344405|FG001|Overall Study|Adverse Event|0|||
163448255|NCT00762372|590344406|FG002|Overall Study|Adverse Event|0|||
163448256|NCT01194804|590344407|FG000|Overall Study|Withdrawal by Subject|1|||
163448257|NCT02670915|590344408|FG000|Overall Study|Withdrawal by Subject|0|||
163448258|NCT02670915|590344409|FG001|Overall Study|Withdrawal by Subject|1|||
163448259|NCT02670915|590344410|FG002|Overall Study|Withdrawal by Subject|4|||
163448260|NCT02670915|590344408|FG000|Overall Study|Withdrawal by parent/guardian|4|||
163448261|NCT02670915|590344409|FG001|Overall Study|Withdrawal by parent/guardian|4|||
163448262|NCT02670915|590344410|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163448263|NCT02670915|590344408|FG000|Overall Study|Unclassified|0|||
163448264|NCT02670915|590344409|FG001|Overall Study|Unclassified|3|||
163448265|NCT02670915|590344410|FG002|Overall Study|Unclassified|0|||
163448266|NCT00818207|590344411|FG000|Overall Study|Adverse Event|6|||
163448267|NCT00818207|590344412|FG001|Overall Study|Adverse Event|0|||
163448268|NCT00818207|590344411|FG000|Overall Study|Lost to Follow-up|160|||
163448269|NCT00818207|590344412|FG001|Overall Study|Lost to Follow-up|146|||
163448270|NCT00818207|590344411|FG000|Overall Study|Multiple reasons|11|||
163448271|NCT00818207|590344412|FG001|Overall Study|Multiple reasons|12|||
163448272|NCT00818207|590344411|FG000|Overall Study|Withdrawal by Subject|42|||
163448273|NCT00818207|590344412|FG001|Overall Study|Withdrawal by Subject|104|||
163448274|NCT00818207|590344411|FG000|Overall Study|Death|3|||
163448275|NCT00818207|590344412|FG001|Overall Study|Death|5|||
163448276|NCT02616185|590344413|FG000|Overall Study|Death|0|||
163448277|NCT02616185|590344414|FG001|Overall Study|Death|0|||
163448278|NCT02616185|590344415|FG002|Overall Study|Death|0|||
163448279|NCT02616185|590344416|FG003|Overall Study|Death|1|||
163448280|NCT02616185|590344417|FG004|Overall Study|Death|2|||
163448281|NCT02616185|590344418|FG005|Overall Study|Death|0|||
163448282|NCT02616185|590344419|FG006|Overall Study|Death|0|||
163448283|NCT02616185|590344420|FG007|Overall Study|Death|2|||
163448284|NCT02616185|590344421|FG008|Overall Study|Death|1|||
163448285|NCT02616185|590344413|FG000|Overall Study|Study terminated by sponsor|0|||
163448286|NCT02616185|590344414|FG001|Overall Study|Study terminated by sponsor|0|||
163448287|NCT02616185|590344415|FG002|Overall Study|Study terminated by sponsor|1|||
163448288|NCT02616185|590344416|FG003|Overall Study|Study terminated by sponsor|0|||
163448289|NCT02616185|590344417|FG004|Overall Study|Study terminated by sponsor|0|||
163448290|NCT02616185|590344418|FG005|Overall Study|Study terminated by sponsor|0|||
163448291|NCT02616185|590344419|FG006|Overall Study|Study terminated by sponsor|5|||
163448292|NCT02616185|590344420|FG007|Overall Study|Study terminated by sponsor|2|||
163448293|NCT02616185|590344421|FG008|Overall Study|Study terminated by sponsor|0|||
163448294|NCT02616185|590344413|FG000|Overall Study|Participant refused further follow-up|1|||
163448295|NCT02616185|590344414|FG001|Overall Study|Participant refused further follow-up|1|||
163448296|NCT02616185|590344415|FG002|Overall Study|Participant refused further follow-up|2|||
163448297|NCT02616185|590344416|FG003|Overall Study|Participant refused further follow-up|3|||
163448298|NCT02616185|590344417|FG004|Overall Study|Participant refused further follow-up|4|||
163448299|NCT02616185|590344418|FG005|Overall Study|Participant refused further follow-up|0|||
163448300|NCT02616185|590344419|FG006|Overall Study|Participant refused further follow-up|3|||
163448301|NCT02616185|590344420|FG007|Overall Study|Participant refused further follow-up|4|||
163448302|NCT02616185|590344421|FG008|Overall Study|Participant refused further follow-up|3|||
163448303|NCT02616185|590344413|FG000|Overall Study|Not reported|0|||
163448304|NCT02616185|590344414|FG001|Overall Study|Not reported|0|||
163448305|NCT02616185|590344415|FG002|Overall Study|Not reported|0|||
163448306|NCT02616185|590344416|FG003|Overall Study|Not reported|1|||
163448307|NCT02616185|590344417|FG004|Overall Study|Not reported|3|||
163448308|NCT02616185|590344418|FG005|Overall Study|Not reported|1|||
163448309|NCT02616185|590344419|FG006|Overall Study|Not reported|0|||
163448310|NCT02616185|590344420|FG007|Overall Study|Not reported|5|||
163448311|NCT02616185|590344421|FG008|Overall Study|Not reported|2|||
163448312|NCT01303380|590344422|FG000|Overall Study|Lack of compliance to study procedures|1|||
163448313|NCT00967226|590344423|FG000|Overall Study|Adverse Event|0|||
163448314|NCT00967226|590344424|FG001|Overall Study|Adverse Event|5|||
163448315|NCT00967226|590344423|FG000|Overall Study|Protocol Violation|2|||
163448316|NCT00967226|590344424|FG001|Overall Study|Protocol Violation|0|||
163448317|NCT00967226|590344423|FG000|Overall Study|Physician Decision|0|||
163448318|NCT00967226|590344424|FG001|Overall Study|Physician Decision|1|||
163448319|NCT01670656|590344425|FG000|Overall Study|Non-compliance with study drug|0|||
163448320|NCT01670656|590344426|FG001|Overall Study|Non-compliance with study drug|0|||
163448321|NCT01670656|590344427|FG002|Overall Study|Non-compliance with study drug|3|||
163448322|NCT01670656|590344428|FG003|Overall Study|Non-compliance with study drug|0|||
163448323|NCT01670656|590344429|FG004|Overall Study|Non-compliance with study drug|1|||
163448324|NCT01670656|590344425|FG000|Overall Study|Pregnancy|0|||
163448325|NCT01670656|590344426|FG001|Overall Study|Pregnancy|0|||
163448326|NCT01670656|590344427|FG002|Overall Study|Pregnancy|0|||
163448327|NCT01670656|590344428|FG003|Overall Study|Pregnancy|0|||
163448328|NCT01670656|590344429|FG004|Overall Study|Pregnancy|1|||
163448329|NCT01670656|590344425|FG000|Overall Study|Withdrawal by Subject|1|||
163448330|NCT01670656|590344426|FG001|Overall Study|Withdrawal by Subject|1|||
163448331|NCT01670656|590344427|FG002|Overall Study|Withdrawal by Subject|0|||
163448332|NCT01670656|590344428|FG003|Overall Study|Withdrawal by Subject|0|||
163448333|NCT01670656|590344429|FG004|Overall Study|Withdrawal by Subject|0|||
163448334|NCT01670656|590344425|FG000|Overall Study|Non-compliance with protocol|0|||
163448335|NCT01670656|590344426|FG001|Overall Study|Non-compliance with protocol|3|||
163448336|NCT01670656|590344427|FG002|Overall Study|Non-compliance with protocol|1|||
163448337|NCT01670656|590344428|FG003|Overall Study|Non-compliance with protocol|1|||
163448338|NCT01670656|590344429|FG004|Overall Study|Non-compliance with protocol|2|||
163448339|NCT01670656|590344425|FG000|Overall Study|Adverse Event|2|||
163448340|NCT01670656|590344426|FG001|Overall Study|Adverse Event|2|||
163448341|NCT01670656|590344427|FG002|Overall Study|Adverse Event|2|||
163448342|NCT01670656|590344428|FG003|Overall Study|Adverse Event|3|||
163448343|NCT01670656|590344429|FG004|Overall Study|Adverse Event|3|||
163448344|NCT01670656|590344425|FG000|Overall Study|Subject withdrew consent|0|||
163448345|NCT01670656|590344426|FG001|Overall Study|Subject withdrew consent|1|||
163448346|NCT01670656|590344427|FG002|Overall Study|Subject withdrew consent|2|||
163448347|NCT01670656|590344428|FG003|Overall Study|Subject withdrew consent|1|||
163448348|NCT01670656|590344429|FG004|Overall Study|Subject withdrew consent|1|||
163448349|NCT01670656|590344425|FG000|Overall Study|Lost to Follow-up|0|||
163448350|NCT01670656|590344426|FG001|Overall Study|Lost to Follow-up|0|||
163448351|NCT01670656|590344427|FG002|Overall Study|Lost to Follow-up|0|||
163448352|NCT01670656|590344428|FG003|Overall Study|Lost to Follow-up|0|||
163448353|NCT01670656|590344429|FG004|Overall Study|Lost to Follow-up|3|||
163448354|NCT01670656|590344425|FG000|Overall Study|Subject moved|0|||
163448355|NCT01670656|590344426|FG001|Overall Study|Subject moved|0|||
163448356|NCT01670656|590344427|FG002|Overall Study|Subject moved|0|||
163448357|NCT01670656|590344428|FG003|Overall Study|Subject moved|1|||
163448358|NCT01670656|590344429|FG004|Overall Study|Subject moved|0|||
163448359|NCT00165841|590344430|FG000|Overall Study|Adverse Event|2|||
163448360|NCT00165841|590344431|FG001|Overall Study|Adverse Event|3|||
163448361|NCT00165841|590344430|FG000|Overall Study|Lack of Efficacy|6|||
163448362|NCT00165841|590344431|FG001|Overall Study|Lack of Efficacy|33|||
163448363|NCT00165841|590344430|FG000|Overall Study|Lost to Follow-up|4|||
163448364|NCT00165841|590344431|FG001|Overall Study|Lost to Follow-up|4|||
163448365|NCT00165841|590344430|FG000|Overall Study|Withdrawal by Subject|7|||
163448366|NCT00165841|590344431|FG001|Overall Study|Withdrawal by Subject|8|||
163448367|NCT00165841|590344430|FG000|Overall Study|Physician Decision|1|||
163448368|NCT00165841|590344431|FG001|Overall Study|Physician Decision|0|||
163448369|NCT00165841|590344430|FG000|Overall Study|Protocol Violation|6|||
163448370|NCT00165841|590344431|FG001|Overall Study|Protocol Violation|8|||
163448371|NCT00165841|590344430|FG000|Overall Study|Other|3|||
163448372|NCT00165841|590344431|FG001|Overall Study|Other|5|||
163448373|NCT00165841|590344430|FG000|Overall Study|Medication Noncompliance|1|||
163448374|NCT00165841|590344431|FG001|Overall Study|Medication Noncompliance|1|||
163448375|NCT00789958|590344432|FG000|Overall Study|Adverse Event|3|||
163448376|NCT00789958|590344432|FG000|Overall Study|Withdrawal by Subject|4|||
163448377|NCT00789958|590344432|FG000|Overall Study|Progression|3|||
163448378|NCT00789958|590344432|FG000|Overall Study|not protocol specified|1|||
163448379|NCT00789958|590344432|FG000|Overall Study|Not eligible/not analyzable|26|||
163448380|NCT00487084|590344433|FG000|Overall Study|Did not receive intervention|4|||
163448381|NCT00487084|590344434|FG001|Overall Study|Did not receive intervention|3|||
163448382|NCT00487084|590344435|FG002|Overall Study|Did not receive intervention|5|||
163448383|NCT03303092|590344438|FG000|Overall Study|Adverse Event|1|||
163448384|NCT03303092|590344439|FG001|Overall Study|Adverse Event|0|||
163448385|NCT03303092|590344440|FG002|Overall Study|Adverse Event|1|||
163448386|NCT03303092|590344438|FG000|Overall Study|Protocol Violation|1|||
163448387|NCT03303092|590344439|FG001|Overall Study|Protocol Violation|5|||
163448388|NCT03303092|590344440|FG002|Overall Study|Protocol Violation|1|||
163448389|NCT03303092|590344438|FG000|Overall Study|Withdrawal by Subject|1|||
163448390|NCT03303092|590344439|FG001|Overall Study|Withdrawal by Subject|1|||
163448391|NCT03303092|590344440|FG002|Overall Study|Withdrawal by Subject|3|||
163448392|NCT01995136|590344443|FG000|Overall Study|Change in residence|1|||
163448393|NCT01697267|590344444|FG000|Overall Study|Death|3|||
163448394|NCT01697267|590344445|FG001|Overall Study|Death|1|||
163448395|NCT01697267|590344444|FG000|Overall Study|Withdrawal by Subject|5|||
163448396|NCT01697267|590344445|FG001|Overall Study|Withdrawal by Subject|5|||
163448397|NCT01697267|590344444|FG000|Overall Study|Adverse Event|2|||
163448398|NCT01697267|590344445|FG001|Overall Study|Adverse Event|1|||
163448399|NCT01697267|590344444|FG000|Overall Study|Lost to Follow-up|2|||
163448400|NCT01697267|590344445|FG001|Overall Study|Lost to Follow-up|4|||
163448401|NCT01697267|590344444|FG000|Overall Study|Physician Decision|2|||
163448402|NCT01697267|590344445|FG001|Overall Study|Physician Decision|4|||
163448403|NCT01830543|590344448|FG000|Overall Study|Subject Decision|19|||
163448404|NCT01830543|590344449|FG001|Overall Study|Subject Decision|21|||
163448405|NCT01830543|590344450|FG002|Overall Study|Subject Decision|57|||
163448406|NCT01830543|590344448|FG000|Overall Study|Adverse Event|91|||
163448407|NCT01830543|590344449|FG001|Overall Study|Adverse Event|77|||
163448408|NCT01830543|590344450|FG002|Overall Study|Adverse Event|76|||
163448409|NCT01830543|590344448|FG000|Overall Study|Death|20|||
163448410|NCT01830543|590344449|FG001|Overall Study|Death|22|||
163448411|NCT01830543|590344450|FG002|Overall Study|Death|22|||
163448412|NCT01830543|590344448|FG000|Overall Study|Protocol Violation|3|||
163448413|NCT01830543|590344449|FG001|Overall Study|Protocol Violation|7|||
163448414|NCT01830543|590344450|FG002|Overall Study|Protocol Violation|7|||
163448415|NCT01830543|590344448|FG000|Overall Study|Physician Decision|11|||
163448416|NCT01830543|590344449|FG001|Overall Study|Physician Decision|5|||
163448417|NCT01830543|590344450|FG002|Overall Study|Physician Decision|12|||
163448418|NCT01830543|590344448|FG000|Overall Study|Withdrawal by consent|3|||
163448419|NCT01830543|590344449|FG001|Overall Study|Withdrawal by consent|3|||
163448420|NCT01830543|590344450|FG002|Overall Study|Withdrawal by consent|3|||
163448421|NCT01830543|590344448|FG000|Overall Study|Other|12|||
163448422|NCT01830543|590344449|FG001|Overall Study|Other|17|||
163448423|NCT01830543|590344450|FG002|Overall Study|Other|37|||
163448424|NCT02681055|590344455|FG000|Weeks 5-12|Adverse Event|1|||
163448425|NCT00377611|590344458|FG000|Overall Study|Adverse Event|2|||
163448426|NCT00377611|590344459|FG001|Overall Study|Adverse Event|9|||
163448427|NCT00377611|590344458|FG000|Overall Study|Protocol Violation|2|||
163448428|NCT00377611|590344459|FG001|Overall Study|Protocol Violation|0|||
163448429|NCT00377611|590344458|FG000|Overall Study|Withdrawal by Subject|0|||
163448430|NCT00377611|590344459|FG001|Overall Study|Withdrawal by Subject|5|||
163448431|NCT00377611|590344458|FG000|Overall Study|Lost to Follow-up|18|||
163448432|NCT00377611|590344459|FG001|Overall Study|Lost to Follow-up|16|||
163448433|NCT00377611|590344458|FG000|Overall Study|Other|0|||
163448434|NCT00377611|590344459|FG001|Overall Study|Other|3|||
163448435|NCT01030458|590344460|FG000|Overall Study|Lost to Follow-up|9|||
163448436|NCT01030458|590344461|FG001|Overall Study|Lost to Follow-up|10|||
163448437|NCT01030458|590344460|FG000|Overall Study|Withdrawal by Subject|2|||
163448438|NCT01030458|590344461|FG001|Overall Study|Withdrawal by Subject|3|||
163448439|NCT01030458|590344460|FG000|Overall Study|Logistical reasons|9|||
163448440|NCT01030458|590344461|FG001|Overall Study|Logistical reasons|5|||
163448441|NCT01030458|590344460|FG000|Overall Study|Moved or changed job|6|||
163448442|NCT01030458|590344461|FG001|Overall Study|Moved or changed job|13|||
163448443|NCT01030458|590344460|FG000|Overall Study|Side effect of medication|1|||
163448444|NCT01030458|590344461|FG001|Overall Study|Side effect of medication|1|||
163448445|NCT00839423|590344464|FG000|Overall Study|Adverse Event|4|||
163448446|NCT00839423|590344465|FG001|Overall Study|Adverse Event|3|||
163448447|NCT00839423|590344466|FG002|Overall Study|Adverse Event|7|||
163448448|NCT00839423|590344467|FG003|Overall Study|Adverse Event|16|||
163448449|NCT00839423|590344464|FG000|Overall Study|Lack of Efficacy|6|||
163448450|NCT00839423|590344465|FG001|Overall Study|Lack of Efficacy|6|||
163448451|NCT00839423|590344466|FG002|Overall Study|Lack of Efficacy|3|||
163448452|NCT00839423|590344467|FG003|Overall Study|Lack of Efficacy|2|||
163448453|NCT00839423|590344464|FG000|Overall Study|Non-compliance|0|||
163448454|NCT00839423|590344465|FG001|Overall Study|Non-compliance|0|||
163448455|NCT00839423|590344466|FG002|Overall Study|Non-compliance|0|||
163448456|NCT00839423|590344467|FG003|Overall Study|Non-compliance|1|||
163448457|NCT00839423|590344464|FG000|Overall Study|Protocol Violation|0|||
163448458|NCT00839423|590344465|FG001|Overall Study|Protocol Violation|1|||
163448459|NCT00839423|590344466|FG002|Overall Study|Protocol Violation|2|||
163448460|NCT00839423|590344467|FG003|Overall Study|Protocol Violation|0|||
163448461|NCT00839423|590344464|FG000|Overall Study|Withdrawal of consent|4|||
163448462|NCT00839423|590344465|FG001|Overall Study|Withdrawal of consent|0|||
163448463|NCT00839423|590344466|FG002|Overall Study|Withdrawal of consent|4|||
163448464|NCT00839423|590344467|FG003|Overall Study|Withdrawal of consent|1|||
163448465|NCT00839423|590344464|FG000|Overall Study|Lost to Follow-up|1|||
163448466|NCT00839423|590344465|FG001|Overall Study|Lost to Follow-up|0|||
163448467|NCT00839423|590344466|FG002|Overall Study|Lost to Follow-up|1|||
163448468|NCT00839423|590344467|FG003|Overall Study|Lost to Follow-up|0|||
163448469|NCT00839423|590344464|FG000|Overall Study|Administrative or other reasons|3|||
163448470|NCT00839423|590344465|FG001|Overall Study|Administrative or other reasons|0|||
163448471|NCT00839423|590344466|FG002|Overall Study|Administrative or other reasons|1|||
163448472|NCT00839423|590344467|FG003|Overall Study|Administrative or other reasons|0|||
163448473|NCT01071096|590344468|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
163448474|NCT01071096|590344469|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
163448475|NCT02585999|590344470|FG000|Overall Study|Lost to Follow-up|1|||
163448476|NCT02585999|590344470|FG000|Overall Study|Protocol Violation|1|||
163448477|NCT00756886|590344471|FG000|Overall Study|Lost to Follow-up|1|||
163448478|NCT00756886|590344472|FG001|Overall Study|Lost to Follow-up|0|||
163448479|NCT00756886|590344471|FG000|Overall Study|Adverse Event|0|||
163448480|NCT00756886|590344472|FG001|Overall Study|Adverse Event|3|||
163448481|NCT00756886|590344471|FG000|Overall Study|Lack of Efficacy|1|||
163448482|NCT00756886|590344472|FG001|Overall Study|Lack of Efficacy|0|||
163448483|NCT00756886|590344471|FG000|Overall Study|Ineligible|9|||
163448484|NCT00756886|590344472|FG001|Overall Study|Ineligible|4|||
163448485|NCT00871377|590344477|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
163448486|NCT00871377|590344478|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
163448487|NCT00871377|590344479|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
163448488|NCT00871377|590344480|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
163448489|NCT00871377|590344481|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
163448490|NCT00871377|590344482|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
163448491|NCT00871377|590344477|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
163448492|NCT00871377|590344478|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
163448493|NCT00871377|590344479|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
163448494|NCT00871377|590344480|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
163448495|NCT00871377|590344481|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
163448496|NCT00871377|590344482|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
163448497|NCT00871377|590344477|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
163448498|NCT00871377|590344478|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
163448499|NCT00871377|590344479|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
163448500|NCT00871377|590344480|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
163448501|NCT00871377|590344481|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
163448502|NCT00871377|590344482|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
163448503|NCT00871377|590344477|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
163448504|NCT00871377|590344478|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
163448505|NCT00871377|590344479|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
163448506|NCT00871377|590344480|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
163448507|NCT00871377|590344481|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
163448508|NCT00871377|590344482|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
163448509|NCT00871377|590344477|FG000|Third Intervention (10 Weeks)|Death|0|||
163448510|NCT00871377|590344478|FG001|Third Intervention (10 Weeks)|Death|0|||
163448511|NCT00871377|590344479|FG002|Third Intervention (10 Weeks)|Death|0|||
163448512|NCT00871377|590344480|FG003|Third Intervention (10 Weeks)|Death|1|||
163448513|NCT00871377|590344481|FG004|Third Intervention (10 Weeks)|Death|0|||
163448514|NCT00871377|590344482|FG005|Third Intervention (10 Weeks)|Death|0|||
163448515|NCT04348656|590344483|FG000|Overall Study|Withdrawal by Subject|2|||
163448516|NCT04348656|590344484|FG001|Overall Study|Withdrawal by Subject|0|||
163448517|NCT04348656|590344483|FG000|Overall Study|Lost to Follow-up|11|||
163448518|NCT04348656|590344484|FG001|Overall Study|Lost to Follow-up|6|||
163448519|NCT05142332|590344487|FG000|Overall Study|Withdrawal by Subject|0|||
163448520|NCT05142332|590344488|FG001|Overall Study|Withdrawal by Subject|1|||
163448521|NCT05142332|590344489|FG002|Overall Study|Withdrawal by Subject|2|||
163448522|NCT05142332|590344490|FG003|Overall Study|Withdrawal by Subject|0|||
163448523|NCT05142332|590344491|FG004|Overall Study|Withdrawal by Subject|0|||
163448524|NCT05142332|590344492|FG005|Overall Study|Withdrawal by Subject|2|||
163448525|NCT05142332|590344493|FG006|Overall Study|Withdrawal by Subject|6|||
163448526|NCT05142332|590344487|FG000|Overall Study|Left ED|3|||
163448527|NCT05142332|590344488|FG001|Overall Study|Left ED|0|||
163448528|NCT05142332|590344489|FG002|Overall Study|Left ED|4|||
163448529|NCT05142332|590344490|FG003|Overall Study|Left ED|6|||
163448530|NCT05142332|590344491|FG004|Overall Study|Left ED|1|||
163448531|NCT05142332|590344492|FG005|Overall Study|Left ED|2|||
163448532|NCT05142332|590344493|FG006|Overall Study|Left ED|6|||
163448533|NCT05142332|590344487|FG000|Overall Study|Physician Decision|0|||
163448534|NCT05142332|590344488|FG001|Overall Study|Physician Decision|0|||
163448535|NCT05142332|590344489|FG002|Overall Study|Physician Decision|2|||
163448536|NCT05142332|590344490|FG003|Overall Study|Physician Decision|1|||
163448537|NCT05142332|590344491|FG004|Overall Study|Physician Decision|0|||
163448538|NCT05142332|590344492|FG005|Overall Study|Physician Decision|0|||
163448539|NCT05142332|590344493|FG006|Overall Study|Physician Decision|3|||
163448540|NCT05142332|590344487|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
163448541|NCT05142332|590344488|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
163448542|NCT05142332|590344489|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
163448543|NCT05142332|590344490|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
163448544|NCT05142332|590344491|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
163448545|NCT05142332|590344492|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
163448546|NCT05142332|590344493|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
163448547|NCT02116660|590344494|FG000|Overall Study|Deteriorating renal function|0|||
163448548|NCT02116660|590344495|FG001|Overall Study|Deteriorating renal function|1|||
163448549|NCT02116660|590344494|FG000|Overall Study|Adverse Event|1|||
163448550|NCT02116660|590344495|FG001|Overall Study|Adverse Event|1|||
163448551|NCT02116660|590344494|FG000|Overall Study|Withdrawal by Subject|0|||
163448552|NCT02116660|590344495|FG001|Overall Study|Withdrawal by Subject|2|||
163448553|NCT02116660|590344494|FG000|Overall Study|Organization reason|1|||
163448554|NCT02116660|590344495|FG001|Overall Study|Organization reason|0|||
163448555|NCT00411788|590344499|FG000|Overall Study|Protocol Violation|1|||
163448556|NCT00411788|590344499|FG000|Overall Study|Adverse Event|1|||
163448557|NCT00848549|590344500|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
163448558|NCT00848549|590344501|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
163448559|NCT00848549|590344500|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
163448560|NCT00848549|590344501|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
163448561|NCT00848549|590344500|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
163448562|NCT00848549|590344501|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
163448563|NCT00848549|590344500|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
163448564|NCT00848549|590344501|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
163448565|NCT00848549|590344500|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
163448566|NCT00848549|590344501|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
163448567|NCT00848549|590344500|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
163448568|NCT00848549|590344501|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
163448569|NCT00848549|590344500|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
163448570|NCT00848549|590344501|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
163448571|NCT00848549|590344500|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
163448572|NCT00848549|590344501|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
163448573|NCT00848549|590344500|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
163448574|NCT00848549|590344501|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
163448575|NCT00848549|590344500|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
163448576|NCT00848549|590344501|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
163448577|NCT00848549|590344500|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
163448578|NCT00848549|590344501|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
163448579|NCT00848549|590344500|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
163448580|NCT00848549|590344501|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
163448581|NCT00848549|590344500|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
163448582|NCT00848549|590344501|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
163448583|NCT00848549|590344500|FG000|E2090-E044-314 (Extension Study)|Other|5|||
163448584|NCT00848549|590344501|FG001|E2090-E044-314 (Extension Study)|Other|6|||
163448585|NCT02561299|590344502|FG000|Overall Study|Death|2|||
163448586|NCT02561299|590344503|FG001|Overall Study|Death|4|||
163448587|NCT02561299|590344502|FG000|Overall Study|Lost to Follow-up|1|||
163448588|NCT02561299|590344503|FG001|Overall Study|Lost to Follow-up|0|||
163448589|NCT02561299|590344502|FG000|Overall Study|Withdrawal by Subject|2|||
163448590|NCT02561299|590344503|FG001|Overall Study|Withdrawal by Subject|2|||
163448591|NCT05631548|590344504|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
163448592|NCT05631548|590344505|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
163448593|NCT02232087|590344506|FG000|Overall Study|Withdrawal by Subject|2|||
163448594|NCT02232087|590344507|FG001|Overall Study|Withdrawal by Subject|0|||
163448595|NCT02232087|590344508|FG002|Overall Study|Withdrawal by Subject|0|||
163448596|NCT02232087|590344509|FG003|Overall Study|Withdrawal by Subject|0|||
163448597|NCT02232087|590344510|FG004|Overall Study|Withdrawal by Subject|0|||
163448598|NCT02232087|590344511|FG005|Overall Study|Withdrawal by Subject|1|||
163448599|NCT02232087|590344506|FG000|Overall Study|poor inhalation technique|0|||
163448600|NCT02232087|590344507|FG001|Overall Study|poor inhalation technique|1|||
163448601|NCT02232087|590344508|FG002|Overall Study|poor inhalation technique|0|||
163448602|NCT02232087|590344509|FG003|Overall Study|poor inhalation technique|0|||
163448603|NCT02232087|590344510|FG004|Overall Study|poor inhalation technique|0|||
163448604|NCT02232087|590344511|FG005|Overall Study|poor inhalation technique|2|||
163448605|NCT02232087|590344506|FG000|Overall Study|protocol stop criteria|0|||
163448606|NCT02232087|590344507|FG001|Overall Study|protocol stop criteria|1|||
163448607|NCT02232087|590344508|FG002|Overall Study|protocol stop criteria|0|||
163448608|NCT02232087|590344509|FG003|Overall Study|protocol stop criteria|1|||
163448609|NCT02232087|590344510|FG004|Overall Study|protocol stop criteria|0|||
163448610|NCT02232087|590344511|FG005|Overall Study|protocol stop criteria|0|||
163448611|NCT02232087|590344506|FG000|Overall Study|Adverse Event|0|||
163448612|NCT02232087|590344507|FG001|Overall Study|Adverse Event|0|||
163448613|NCT02232087|590344508|FG002|Overall Study|Adverse Event|0|||
163448614|NCT02232087|590344509|FG003|Overall Study|Adverse Event|0|||
163448615|NCT02232087|590344510|FG004|Overall Study|Adverse Event|1|||
163448616|NCT02232087|590344511|FG005|Overall Study|Adverse Event|0|||
163448617|NCT02208024|590344512|FG000|Overall Study|Withdrawal by Subject|1|||
163448618|NCT01958125|590344513|FG000|Overall Study|Missing diary data|2|||
163448619|NCT01958125|590344514|FG001|Overall Study|Missing diary data|6|||
163448620|NCT01958125|590344513|FG000|Overall Study|No headache attacks|0|||
163448621|NCT01958125|590344514|FG001|Overall Study|No headache attacks|2|||
163448622|NCT01106625|590344515|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
163448623|NCT01106625|590344516|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
163448624|NCT01106625|590344517|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
163448625|NCT01106625|590344515|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
163448626|NCT01106625|590344516|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
163448627|NCT01106625|590344517|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
163448628|NCT01106625|590344515|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
163448629|NCT01106625|590344516|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
163448630|NCT01106625|590344517|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
163448631|NCT01106625|590344515|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
163448632|NCT01106625|590344516|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
163448633|NCT01106625|590344517|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
163448634|NCT01106625|590344515|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
163448635|NCT01106625|590344516|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
163448636|NCT01106625|590344517|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
163448637|NCT01106625|590344515|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
163448638|NCT01106625|590344516|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
163448639|NCT01106625|590344517|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
163448640|NCT01106625|590344515|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
163448641|NCT01106625|590344516|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
163448642|NCT01106625|590344517|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
163448643|NCT01106625|590344515|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
163448644|NCT01106625|590344516|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
163448645|NCT01106625|590344517|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
163448646|NCT01106625|590344515|FG000|Core Period: Baseline to Week 26|Other|8|||
163448647|NCT01106625|590344516|FG001|Core Period: Baseline to Week 26|Other|7|||
163448648|NCT01106625|590344517|FG002|Core Period: Baseline to Week 26|Other|4|||
163448649|NCT01106625|590344515|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
163448650|NCT01106625|590344516|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
163448651|NCT01106625|590344517|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
163448652|NCT01106625|590344515|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
163448653|NCT01106625|590344516|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
163448654|NCT01106625|590344517|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
163448655|NCT01106625|590344515|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
163448656|NCT01106625|590344516|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
163448657|NCT01106625|590344517|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
163448658|NCT01106625|590344515|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
163448659|NCT01106625|590344516|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
163448660|NCT01106625|590344517|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
163448661|NCT01106625|590344515|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
163448662|NCT01106625|590344516|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
163448663|NCT01106625|590344517|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
163448664|NCT01106625|590344515|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
163448665|NCT01106625|590344516|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
163448666|NCT01106625|590344517|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
163448667|NCT01106625|590344515|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
163448668|NCT01106625|590344516|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
163448669|NCT01106625|590344517|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
163448670|NCT01106625|590344515|FG000|Extension Period: Week 26 to Week 52|Other|5|||
163448671|NCT01106625|590344516|FG001|Extension Period: Week 26 to Week 52|Other|5|||
163448672|NCT01106625|590344517|FG002|Extension Period: Week 26 to Week 52|Other|4|||
163448673|NCT04056455|590344519|FG000|Overall Study|Adverse Event|1|||
163448674|NCT04056455|590344520|FG001|Overall Study|Adverse Event|0|||
163448675|NCT02512068|590344521|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
163448676|NCT02512068|590344522|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
163448677|NCT02512068|590344521|FG000|Overall Study|Major Protocol Deviation|1|||
163448678|NCT02512068|590344522|FG001|Overall Study|Major Protocol Deviation|0|||
163448679|NCT02512068|590344521|FG000|Overall Study|Voluntary Withdrawal|0|||
163448680|NCT02512068|590344522|FG001|Overall Study|Voluntary Withdrawal|1|||
163448681|NCT02512068|590344521|FG000|Overall Study|Lack of Efficacy|0|||
163448682|NCT02512068|590344522|FG001|Overall Study|Lack of Efficacy|1|||
163448683|NCT02512068|590344521|FG000|Overall Study|Reason Not Specified|3|||
163448684|NCT02512068|590344522|FG001|Overall Study|Reason Not Specified|5|||
163448685|NCT00830037|590344529|FG000|Overall Study|Withdrawal by Subject|2|||
163448686|NCT00830037|590344530|FG001|Overall Study|Withdrawal by Subject|3|||
163448687|NCT00830037|590344529|FG000|Overall Study|Lost to Follow-up|1|||
163448688|NCT00830037|590344530|FG001|Overall Study|Lost to Follow-up|2|||
163448689|NCT00830037|590344529|FG000|Overall Study|Active when terminated by DSMB|15|||
163448690|NCT00830037|590344530|FG001|Overall Study|Active when terminated by DSMB|14|||
163448691|NCT04285346|590344534|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
163448692|NCT04285346|590344535|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
163448693|NCT04285346|590344534|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
163448694|NCT04285346|590344535|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163448695|NCT04285346|590344534|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
163448696|NCT04285346|590344535|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
163448697|NCT00610935|590344536|FG000|Overall Study|Lost to Follow-up|0|||
163448698|NCT00610935|590344537|FG001|Overall Study|Lost to Follow-up|1|||
163448699|NCT00610935|590344536|FG000|Overall Study|Withdrawal by Subject|0|||
163448700|NCT00610935|590344537|FG001|Overall Study|Withdrawal by Subject|2|||
163448701|NCT00610935|590344536|FG000|Overall Study|Sponsor Discontinuation|1|||
163448702|NCT00610935|590344537|FG001|Overall Study|Sponsor Discontinuation|0|||
163448703|NCT04360187|590344538|FG000|Double-Blind Treatment|Adverse Event|9|||
163448704|NCT04360187|590344539|FG001|Double-Blind Treatment|Adverse Event|11|||
163448705|NCT04360187|590344538|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
163448706|NCT04360187|590344539|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
163448707|NCT04360187|590344538|FG000|Double-Blind Treatment|Physician Decision|1|||
163448708|NCT04360187|590344539|FG001|Double-Blind Treatment|Physician Decision|0|||
163448709|NCT04360187|590344538|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
163448710|NCT04360187|590344539|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
163448711|NCT04360187|590344538|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
163448712|NCT04360187|590344539|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
163448713|NCT04360187|590344538|FG000|Follow-Up|Lost to Follow-up|1|||
163448714|NCT04360187|590344539|FG001|Follow-Up|Lost to Follow-up|0|||
163448715|NCT02399813|590344540|FG000|Overall Study|Progressive Disease-Radiographic|2|||
163448716|NCT02399813|590344540|FG000|Overall Study|Death|20|||
163448717|NCT02399813|590344540|FG000|Overall Study|Withdrawal by Subject|3|||
163448718|NCT02399813|590344540|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
163448719|NCT02399813|590344540|FG000|Overall Study|Lost to Follow-up|2|||
163448720|NCT02399813|590344540|FG000|Overall Study|Other than specified|5|||
163448721|NCT05372575|590344541|FG000|Overall Study|Protocol Violation|7|||
163448722|NCT05372575|590344542|FG001|Overall Study|Protocol Violation|16|||
163448723|NCT02203838|590344545|FG000|Overall Study|Lack of Efficacy|7|||
163448724|NCT02203838|590344546|FG001|Overall Study|Lack of Efficacy|0|||
163448725|NCT02203838|590344547|FG002|Overall Study|Lack of Efficacy|1|||
163448726|NCT02203838|590344548|FG003|Overall Study|Lack of Efficacy|1|||
163448727|NCT02203838|590344545|FG000|Overall Study|Adverse Event|46|||
163448728|NCT02203838|590344546|FG001|Overall Study|Adverse Event|6|||
163448729|NCT02203838|590344547|FG002|Overall Study|Adverse Event|3|||
163448730|NCT02203838|590344548|FG003|Overall Study|Adverse Event|2|||
163448731|NCT02203838|590344545|FG000|Overall Study|Lost to Follow-up|39|||
163448732|NCT02203838|590344546|FG001|Overall Study|Lost to Follow-up|3|||
163448733|NCT02203838|590344547|FG002|Overall Study|Lost to Follow-up|2|||
163448734|NCT02203838|590344548|FG003|Overall Study|Lost to Follow-up|1|||
163448735|NCT02203838|590344545|FG000|Overall Study|Protocol Violation|7|||
163448736|NCT02203838|590344546|FG001|Overall Study|Protocol Violation|3|||
163448737|NCT02203838|590344547|FG002|Overall Study|Protocol Violation|0|||
163448738|NCT02203838|590344548|FG003|Overall Study|Protocol Violation|0|||
163448739|NCT02203838|590344545|FG000|Overall Study|Withdrawal by Subject|83|||
163448740|NCT02203838|590344546|FG001|Overall Study|Withdrawal by Subject|10|||
163448741|NCT02203838|590344547|FG002|Overall Study|Withdrawal by Subject|8|||
163448742|NCT02203838|590344548|FG003|Overall Study|Withdrawal by Subject|11|||
163448743|NCT02203838|590344545|FG000|Overall Study|Physician Decision|27|||
163448744|NCT02203838|590344546|FG001|Overall Study|Physician Decision|0|||
163448745|NCT02203838|590344547|FG002|Overall Study|Physician Decision|2|||
163448746|NCT02203838|590344548|FG003|Overall Study|Physician Decision|3|||
163448747|NCT02203838|590344545|FG000|Overall Study|Other|1|||
163448748|NCT02203838|590344546|FG001|Overall Study|Other|0|||
163448749|NCT02203838|590344547|FG002|Overall Study|Other|0|||
163448750|NCT02203838|590344548|FG003|Overall Study|Other|0|||
163448751|NCT03345836|590344549|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
163448752|NCT03345836|590344550|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
163448753|NCT03345836|590344551|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
163448754|NCT03345836|590344552|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
163448755|NCT03345836|590344553|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
163448756|NCT03345836|590344554|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
163448757|NCT03345836|590344549|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
163448758|NCT03345836|590344550|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
163448759|NCT03345836|590344551|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
163448760|NCT03345836|590344552|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
163448761|NCT03345836|590344553|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
163448762|NCT03345836|590344554|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
163448763|NCT03345836|590344549|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
163448764|NCT03345836|590344550|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
163448765|NCT03345836|590344551|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
163448766|NCT03345836|590344552|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
163448767|NCT03345836|590344553|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
163448768|NCT03345836|590344554|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
163448769|NCT03345836|590344549|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
163448770|NCT03345836|590344550|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
163448771|NCT03345836|590344551|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
163448772|NCT03345836|590344552|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
163448773|NCT03345836|590344553|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
163448774|NCT03345836|590344554|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
163448775|NCT03345836|590344549|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
163448776|NCT03345836|590344550|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
163448777|NCT03345836|590344551|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
163448778|NCT03345836|590344552|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
163448779|NCT03345836|590344553|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
163448780|NCT03345836|590344554|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
163448781|NCT03345836|590344549|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
163448782|NCT03345836|590344550|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
163448783|NCT03345836|590344551|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
163448784|NCT03345836|590344552|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
163448785|NCT03345836|590344553|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
163448786|NCT03345836|590344554|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
163448787|NCT03345836|590344549|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
163448788|NCT03345836|590344550|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
163448789|NCT03345836|590344551|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
163448790|NCT03345836|590344552|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
163448791|NCT03345836|590344553|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
163448792|NCT03345836|590344554|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
163448793|NCT03345836|590344549|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
163448794|NCT03345836|590344550|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
163448795|NCT03345836|590344551|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
163448796|NCT03345836|590344552|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
163448797|NCT03345836|590344553|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
163448798|NCT03345836|590344554|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
163448799|NCT03345836|590344549|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
163448800|NCT03345836|590344550|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
163448801|NCT03345836|590344551|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
163448802|NCT03345836|590344552|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
163448803|NCT03345836|590344553|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
163448804|NCT03345836|590344554|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
163448805|NCT03345836|590344549|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
163448806|NCT03345836|590344550|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
163448807|NCT03345836|590344551|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
163448808|NCT03345836|590344552|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
163448809|NCT03345836|590344553|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
163448810|NCT03345836|590344554|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
163448811|NCT03345836|590344549|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
163448812|NCT03345836|590344550|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
163448813|NCT03345836|590344551|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
163448814|NCT03345836|590344552|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
163448815|NCT03345836|590344553|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
163448816|NCT03345836|590344554|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
163448817|NCT05091060|590344557|FG000|Overall Study|Lost to Follow-up|1|||
163448818|NCT02739594|590344558|FG000|Overall Study|Undesired Event|3|||
163448819|NCT02739594|590344559|FG001|Overall Study|Undesired Event|4|||
163448820|NCT02739594|590344558|FG000|Overall Study|Violation of Eligibility Criteria|1|||
163448821|NCT02739594|590344559|FG001|Overall Study|Violation of Eligibility Criteria|2|||
163448822|NCT02739594|590344558|FG000|Overall Study|Protocol Violation|5|||
163448823|NCT02739594|590344559|FG001|Overall Study|Protocol Violation|6|||
163448824|NCT02739594|590344558|FG000|Overall Study|Death|4|||
163448825|NCT02739594|590344559|FG001|Overall Study|Death|2|||
163448826|NCT02739594|590344558|FG000|Overall Study|Renal Insufficiency|4|||
163448827|NCT02739594|590344559|FG001|Overall Study|Renal Insufficiency|6|||
163448828|NCT02739594|590344558|FG000|Overall Study|Administrative Reasons|1|||
163448829|NCT02739594|590344559|FG001|Overall Study|Administrative Reasons|3|||
163448830|NCT02739594|590344558|FG000|Overall Study|Withdrawal by Subject|1|||
163448831|NCT02739594|590344559|FG001|Overall Study|Withdrawal by Subject|1|||
163448832|NCT02739594|590344558|FG000|Overall Study|Lost to Follow-up|0|||
163448833|NCT02739594|590344559|FG001|Overall Study|Lost to Follow-up|1|||
163448834|NCT02739594|590344558|FG000|Overall Study|Elevated Serum Creatinine|0|||
163448835|NCT02739594|590344559|FG001|Overall Study|Elevated Serum Creatinine|1|||
163448836|NCT02739594|590344558|FG000|Overall Study|Other|6|||
163448837|NCT02739594|590344559|FG001|Overall Study|Other|2|||
163448838|NCT00952289|590344562|FG000|All Participants|Death|9|||
163448839|NCT00952289|590344563|FG001|All Participants|Death|9|||
163448840|NCT00952289|590344562|FG000|All Participants|Adverse Event|8|||
163448841|NCT00952289|590344563|FG001|All Participants|Adverse Event|8|||
163448842|NCT00952289|590344562|FG000|All Participants|Disease progression|3|||
163448843|NCT00952289|590344563|FG001|All Participants|Disease progression|12|||
163448844|NCT00952289|590344562|FG000|All Participants|Withdrawal by Subject|1|||
163448845|NCT00952289|590344563|FG001|All Participants|Withdrawal by Subject|10|||
163448846|NCT00952289|590344562|FG000|All Participants|Data lost during site relocation|0|||
163448847|NCT00952289|590344563|FG001|All Participants|Data lost during site relocation|1|||
163448848|NCT00952289|590344562|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
163448849|NCT00952289|590344563|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
163448850|NCT00952289|590344562|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
163448851|NCT00952289|590344563|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
163448852|NCT00952289|590344562|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
163448853|NCT00952289|590344563|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
163448854|NCT00952289|590344562|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
163448855|NCT00952289|590344563|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
163448856|NCT00952289|590344562|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
163448857|NCT00952289|590344563|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
163448858|NCT03259334|590344564|FG000|Overall Study|Adverse Event|3|||
163448859|NCT03259334|590344565|FG001|Overall Study|Adverse Event|8|||
163448860|NCT03259334|590344566|FG002|Overall Study|Adverse Event|5|||
163448861|NCT03259334|590344564|FG000|Overall Study|Withdrawal by Subject|4|||
163448862|NCT03259334|590344565|FG001|Overall Study|Withdrawal by Subject|2|||
163448863|NCT03259334|590344566|FG002|Overall Study|Withdrawal by Subject|4|||
163448864|NCT03259334|590344564|FG000|Overall Study|Physician Decision|1|||
163448865|NCT03259334|590344565|FG001|Overall Study|Physician Decision|0|||
163448866|NCT03259334|590344566|FG002|Overall Study|Physician Decision|0|||
163448867|NCT03259334|590344564|FG000|Overall Study|Lost to Follow-up|0|||
163448868|NCT03259334|590344565|FG001|Overall Study|Lost to Follow-up|2|||
163448869|NCT03259334|590344566|FG002|Overall Study|Lost to Follow-up|1|||
163448870|NCT03259334|590344564|FG000|Overall Study|Protocol Deviation|0|||
163448871|NCT03259334|590344565|FG001|Overall Study|Protocol Deviation|3|||
163448872|NCT03259334|590344566|FG002|Overall Study|Protocol Deviation|2|||
163448873|NCT03259334|590344564|FG000|Overall Study|Lack of Efficacy|2|||
163448874|NCT03259334|590344565|FG001|Overall Study|Lack of Efficacy|0|||
163448875|NCT03259334|590344566|FG002|Overall Study|Lack of Efficacy|1|||
163448876|NCT03259334|590344564|FG000|Overall Study|Randomized but never treated|0|||
163448877|NCT03259334|590344565|FG001|Overall Study|Randomized but never treated|2|||
163448878|NCT03259334|590344566|FG002|Overall Study|Randomized but never treated|0|||
163448879|NCT03375112|590344567|FG000|Overall Study|Withdrawal by Subject|3|||
163448880|NCT03375112|590344568|FG001|Overall Study|Withdrawal by Subject|0|||
163448881|NCT03599141|590344569|FG000|Overall Study|Lost to Follow-up|3|||
163448882|NCT03599141|590344570|FG001|Overall Study|Lost to Follow-up|1|||
163448883|NCT00777491|590344571|FG000|Overall Study|Protocol Violation|0|||
163448884|NCT00777491|590344572|FG001|Overall Study|Protocol Violation|2|||
163448885|NCT00777491|590344571|FG000|Overall Study|Did not receive any protocol treatment|2|||
163448886|NCT00777491|590344572|FG001|Overall Study|Did not receive any protocol treatment|0|||
163448887|NCT03591146|590344573|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
163448888|NCT03591146|590344574|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
163448889|NCT03591146|590344575|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
163448890|NCT03591146|590344576|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
163448891|NCT03591146|590344577|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
163448892|NCT03591146|590344573|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
163448893|NCT03591146|590344574|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
163448894|NCT03591146|590344575|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
163448895|NCT03591146|590344576|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
163448896|NCT03591146|590344577|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
163448897|NCT03591146|590344573|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
163448898|NCT03591146|590344574|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
163448899|NCT03591146|590344575|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
163448900|NCT03591146|590344576|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
163448901|NCT03591146|590344577|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
163448902|NCT03591146|590344573|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
163448903|NCT03591146|590344574|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
163448904|NCT03591146|590344575|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
163448905|NCT03591146|590344576|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
163448906|NCT03591146|590344577|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
163448907|NCT01511419|590344580|FG000|Dose 2|Physician Decision|1|||
163448908|NCT01511419|590344581|FG001|Dose 2|Physician Decision|0|||
163448909|NCT00937768|590344582|FG000|Overall Study|Refused Further Treatment|3|||
163448910|NCT00937768|590344583|FG001|Overall Study|Refused Further Treatment|2|||
163448911|NCT00937768|590344582|FG000|Overall Study|Disease Progression|1|||
163448912|NCT00937768|590344583|FG001|Overall Study|Disease Progression|1|||
163448913|NCT00937768|590344582|FG000|Overall Study|Alternate Treatment|0|||
163448914|NCT00937768|590344583|FG001|Overall Study|Alternate Treatment|1|||
163448915|NCT00937768|590344582|FG000|Overall Study|No Further Funding|4|||
163448916|NCT00937768|590344583|FG001|Overall Study|No Further Funding|4|||
163448917|NCT00311181|590346131|FG000|Overall Study|Final DFTs were not obtained|96|||
163448918|NCT02669862|590346132|FG000|Overall Study|Lost to Follow-up|0|||
163448919|NCT02669862|590346133|FG001|Overall Study|Lost to Follow-up|2|||
163448920|NCT02669862|590346134|FG002|Overall Study|Lost to Follow-up|1|||
163448921|NCT02669862|590346132|FG000|Overall Study|Withdrawal by Subject|2|||
163448922|NCT02669862|590346133|FG001|Overall Study|Withdrawal by Subject|2|||
163448923|NCT02669862|590346134|FG002|Overall Study|Withdrawal by Subject|3|||
163448924|NCT02669862|590346132|FG000|Overall Study|moved|0|||
163448925|NCT02669862|590346133|FG001|Overall Study|moved|1|||
163448926|NCT02669862|590346134|FG002|Overall Study|moved|0|||
163448927|NCT02669862|590346132|FG000|Overall Study|Protocol Violation|0|||
163448928|NCT02669862|590346133|FG001|Overall Study|Protocol Violation|0|||
163448929|NCT02669862|590346134|FG002|Overall Study|Protocol Violation|1|||
163448930|NCT02294318|590346135|FG000|Overall Study|Worsening of drinking|3|||
163448931|NCT02294318|590346136|FG001|Overall Study|Worsening of drinking|0|||
163448932|NCT02294318|590346135|FG000|Overall Study|Not exposed to intervention|0|||
163448933|NCT02294318|590346136|FG001|Overall Study|Not exposed to intervention|2|||
163448934|NCT01694420|590346140|FG000|Overall Study|Lost to Follow-up|3|||
163448935|NCT00506948|590346141|FG000|Overall Study|Death|4|||
163448936|NCT00506948|590346141|FG000|Overall Study|Adverse Event|5|||
163448937|NCT00506948|590346141|FG000|Overall Study|Physician Decision|1|||
163448938|NCT02395653|590346142|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
163448939|NCT02395653|590346142|FG000|Overall Study|Consent Withdrawn at Screening|1|||
163448940|NCT02395653|590346142|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
163448941|NCT02395653|590346142|FG000|Overall Study|Investigator Decision at Screening|1|||
163448942|NCT02395653|590346142|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
163448943|NCT02395653|590346142|FG000|Overall Study|Withdrawal by Subject|1|||
163448944|NCT02395653|590346142|FG000|Overall Study|Lost to Follow-up|1|||
163448945|NCT02494778|590346143|FG000|Overall Study|Death|3|||
163448946|NCT02494778|590346143|FG000|Overall Study|Other|173|||
163448947|NCT02494778|590346143|FG000|Overall Study|Lack of Efficacy|4|||
163448948|NCT02494778|590346143|FG000|Overall Study|Adverse Event|18|||
163448949|NCT02494778|590346143|FG000|Overall Study|Withdrawal by Subject|20|||
163448950|NCT02494778|590346143|FG000|Overall Study|Lost to Follow-up|2|||
163448951|NCT02494778|590346143|FG000|Overall Study|Noncompliant with study drug admin.|1|||
163448952|NCT03621943|590346144|FG000|First Randomized Intervention|Lost to Follow-up|51|||
163448953|NCT03621943|590346145|FG001|First Randomized Intervention|Lost to Follow-up|54|||
163448954|NCT03621943|590346144|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
163448955|NCT03621943|590346145|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
163448956|NCT03621943|590346144|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
163448957|NCT03621943|590346145|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
163448958|NCT03621943|590346144|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
163448959|NCT03621943|590346145|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
163448960|NCT02174861|590346146|FG000|Overall Study|Decision by sponsor|8|||
163448961|NCT02174861|590346146|FG000|Overall Study|Withdrawal by Subject|124|||
163448962|NCT02174861|590346146|FG000|Overall Study|Lost to Follow-up|26|||
163448963|NCT00315705|590346147|FG000|Phase 1|Refused further treatment|1|||
163448964|NCT00315705|590346147|FG000|Phase 1|Failure to achieve response|8|||
163448965|NCT00315705|590346147|FG000|Phase 1|Disease relapse|4|||
163448966|NCT00315705|590346147|FG000|Phase 1|Scheduled for transplant|9|||
163448967|NCT00315705|590346147|FG000|Phase 1|Death|3|||
163448968|NCT00315705|590346147|FG000|Phase 2|Physician Decision|4|||
163448969|NCT00315705|590346147|FG000|Phase 2|Adverse Event|1|||
163448970|NCT00315705|590346147|FG000|Phase 2|Failure to achieve response|3|||
163448971|NCT00315705|590346147|FG000|Phase 2|Disease relapse|1|||
163448972|NCT00315705|590346147|FG000|Phase 2|Scheduled for transplant|8|||
163448973|NCT00315705|590346147|FG000|Phase 2|Other|1|||
163448974|NCT00315705|590346147|FG000|Phase 2|Death|7|||
163448975|NCT01346371|590346148|FG000|Overall Study|Lost to Follow-up|2|||
163448976|NCT01346371|590346149|FG001|Overall Study|Lost to Follow-up|0|||
163448977|NCT01716533|590346150|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
163448978|NCT01716533|590346151|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
163448979|NCT01716533|590346152|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
163448980|NCT01716533|590346153|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
163448981|NCT01716533|590346150|FG000|Overall Study|Withdrawal by Subject|0|||
163448982|NCT01716533|590346151|FG001|Overall Study|Withdrawal by Subject|0|||
163448983|NCT01716533|590346152|FG002|Overall Study|Withdrawal by Subject|0|||
163448984|NCT01716533|590346153|FG003|Overall Study|Withdrawal by Subject|5|||
163448985|NCT01716533|590346150|FG000|Overall Study|Death|0|||
163448986|NCT01716533|590346151|FG001|Overall Study|Death|0|||
163448987|NCT01716533|590346152|FG002|Overall Study|Death|0|||
163448988|NCT01716533|590346153|FG003|Overall Study|Death|2|||
163448989|NCT01716533|590346150|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
163448990|NCT01716533|590346151|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
163448991|NCT01716533|590346152|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
163448992|NCT01716533|590346153|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
163448993|NCT01575197|590346154|FG000|Overall Study|Migration out of study area|1|||
163448994|NCT01575197|590346155|FG001|Overall Study|Migration out of study area|5|||
163448995|NCT01575197|590346156|FG002|Overall Study|Migration out of study area|4|||
163448996|NCT01575197|590346154|FG000|Overall Study|SAE|0|||
163448997|NCT01575197|590346155|FG001|Overall Study|SAE|1|||
163448998|NCT01575197|590346156|FG002|Overall Study|SAE|0|||
163448999|NCT01575197|590346154|FG000|Overall Study|Lost to Follow-up|0|||
163449000|NCT01575197|590346155|FG001|Overall Study|Lost to Follow-up|1|||
163449001|NCT01575197|590346156|FG002|Overall Study|Lost to Follow-up|0|||
163449002|NCT01575197|590346154|FG000|Overall Study|Withdrawal by Subject|0|||
163449003|NCT01575197|590346155|FG001|Overall Study|Withdrawal by Subject|1|||
163449004|NCT01575197|590346156|FG002|Overall Study|Withdrawal by Subject|1|||
163449005|NCT01575197|590346154|FG000|Overall Study|Protocol Violation|2|||
163449006|NCT01575197|590346155|FG001|Overall Study|Protocol Violation|1|||
163449007|NCT01575197|590346156|FG002|Overall Study|Protocol Violation|1|||
163449008|NCT01000727|590346157|FG000|Overall Study|Lost to Follow-up|41|||
163449009|NCT01000727|590346158|FG001|Overall Study|Lost to Follow-up|43|||
163449010|NCT01000727|590346157|FG000|Overall Study|Withdrawal by Subject|111|||
163449011|NCT01000727|590346158|FG001|Overall Study|Withdrawal by Subject|109|||
163449012|NCT01000727|590346157|FG000|Overall Study|Study closed/terminated|23|||
163449013|NCT01000727|590346158|FG001|Overall Study|Study closed/terminated|24|||
163449014|NCT03196193|590346159|FG000|Overall Study|Adverse Event|1|||
163449015|NCT03196193|590346160|FG001|Overall Study|Adverse Event|0|||
163449016|NCT03196193|590346159|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
163449017|NCT03196193|590346160|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
163449018|NCT02709083|590346161|FG000|Overall Study|Original PI left institution|7|||
163449019|NCT01026389|590346162|FG000|Overall Study|Withdrawal by Subject|1|||
163449020|NCT01026389|590346163|FG001|Overall Study|Withdrawal by Subject|3|||
163449021|NCT01026389|590346162|FG000|Overall Study|change of treatment, patient moved|4|||
163449022|NCT01026389|590346163|FG001|Overall Study|change of treatment, patient moved|2|||
163449023|NCT01626352|590346167|FG000|Overall Study|Disease Progression|3|||
163449024|NCT01626352|590346167|FG000|Overall Study|Intercurrent Illness|2|||
163449025|NCT01626352|590346167|FG000|Overall Study|Death|2|||
163449026|NCT01626352|590346167|FG000|Overall Study|Withdrawal by Subject|1|||
163449027|NCT01626352|590346167|FG000|Overall Study|Non-Compliance|1|||
163449028|NCT01626352|590346167|FG000|Overall Study|Never Treated|1|||
163449029|NCT02338492|590346170|FG000|Overall Study|Death|32|||
163449030|NCT02338492|590346170|FG000|Overall Study|Adverse Event|3|||
163449031|NCT02338492|590346170|FG000|Overall Study|Lost to Follow-up|4|||
163449032|NCT02338492|590346170|FG000|Overall Study|Reason not captured above|6|||
163449033|NCT04281030|590346173|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
163449034|NCT04281030|590346174|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
163449035|NCT04281030|590346173|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
163449036|NCT04281030|590346174|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
163449037|NCT01395368|590346175|FG000|Overall Study|Physician Decision|14|||
163449038|NCT01395368|590346175|FG000|Overall Study|Withdrawal by Subject|2|||
163449039|NCT00310388|590346176|FG000|Primary Reporting Phase|Adverse Event|101|||
163449040|NCT00310388|590346177|FG001|Primary Reporting Phase|Adverse Event|0|||
163449041|NCT00310388|590346176|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
163449042|NCT00310388|590346177|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
163449043|NCT00310388|590346176|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
163449044|NCT00310388|590346177|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
163449045|NCT00310388|590346176|FG000|Primary Reporting Phase|Protocol Violation|10|||
163449046|NCT00310388|590346177|FG001|Primary Reporting Phase|Protocol Violation|0|||
163449047|NCT00310388|590346176|FG000|Primary Reporting Phase|Pregnancy|3|||
163449048|NCT00310388|590346177|FG001|Primary Reporting Phase|Pregnancy|0|||
163449049|NCT00310388|590346176|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
163449050|NCT00310388|590346177|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
163449051|NCT00310388|590346176|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
163449052|NCT00310388|590346177|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
163449053|NCT00310388|590346176|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
163449054|NCT00310388|590346177|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
163449055|NCT00310388|590346176|FG000|Primary Reporting Phase|Physician Decision|2|||
163449056|NCT00310388|590346177|FG001|Primary Reporting Phase|Physician Decision|0|||
163449057|NCT00310388|590346176|FG000|Primary Reporting Phase|Request of the sponsor|19|||
163449058|NCT00310388|590346177|FG001|Primary Reporting Phase|Request of the sponsor|0|||
163449059|NCT00310388|590346176|FG000|Primary Reporting Phase|Failed to return|8|||
163449060|NCT00310388|590346177|FG001|Primary Reporting Phase|Failed to return|0|||
163449061|NCT00310388|590346176|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
163449062|NCT00310388|590346177|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
163449063|NCT00310388|590346176|FG000|Primary Reporting Phase|Participant request|2|||
163449064|NCT00310388|590346177|FG001|Primary Reporting Phase|Participant request|0|||
163449065|NCT00310388|590346176|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
163449066|NCT00310388|590346177|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
163449067|NCT00310388|590346176|FG000|Primary Reporting Phase|Discontinuation of study|1|||
163449068|NCT00310388|590346177|FG001|Primary Reporting Phase|Discontinuation of study|0|||
163449069|NCT00310388|590346176|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
163449070|NCT00310388|590346177|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
163449071|NCT00310388|590346176|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
163449072|NCT00310388|590346177|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
163449073|NCT00310388|590346176|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
163449074|NCT00310388|590346177|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
163449075|NCT00310388|590346176|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
163449076|NCT00310388|590346177|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
163449077|NCT00310388|590346176|FG000|Primary Reporting Phase|Participant passed away|1|||
163449078|NCT00310388|590346177|FG001|Primary Reporting Phase|Participant passed away|0|||
163449079|NCT00310388|590346176|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
163449080|NCT00310388|590346177|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
163449081|NCT00310388|590346176|FG000|Primary Reporting Phase|Missing|1|||
163449082|NCT00310388|590346177|FG001|Primary Reporting Phase|Missing|0|||
163449083|NCT00310388|590346176|FG000|Primary Reporting Phase|Other|1|||
163449084|NCT00310388|590346177|FG001|Primary Reporting Phase|Other|0|||
163449085|NCT00310388|590346176|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
163449086|NCT00310388|590346177|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
163449087|NCT00310388|590346176|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
163449088|NCT00310388|590346177|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
163449089|NCT00310388|590346176|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
163449090|NCT00310388|590346177|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
163449091|NCT00310388|590346176|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
163449092|NCT00310388|590346177|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
163449093|NCT00882999|590346182|FG000|Overall Study|Adverse Event|0|||
163449094|NCT00882999|590346183|FG001|Overall Study|Adverse Event|0|||
163449095|NCT00882999|590346184|FG002|Overall Study|Adverse Event|0|||
163449096|NCT00882999|590346185|FG003|Overall Study|Adverse Event|0|||
163449097|NCT00882999|590346186|FG004|Overall Study|Adverse Event|1|||
163449098|NCT00882999|590346187|FG005|Overall Study|Adverse Event|0|||
163449099|NCT00882999|590346188|FG006|Overall Study|Adverse Event|0|||
163449100|NCT00882999|590346182|FG000|Overall Study|Death|0|||
163449101|NCT00882999|590346183|FG001|Overall Study|Death|1|||
163449102|NCT00882999|590346184|FG002|Overall Study|Death|0|||
163449103|NCT00882999|590346185|FG003|Overall Study|Death|0|||
163449104|NCT00882999|590346186|FG004|Overall Study|Death|0|||
163449105|NCT00882999|590346187|FG005|Overall Study|Death|0|||
163449106|NCT00882999|590346188|FG006|Overall Study|Death|0|||
163449107|NCT00882999|590346182|FG000|Overall Study|Withdrawal by Subject|7|||
163449108|NCT00882999|590346183|FG001|Overall Study|Withdrawal by Subject|6|||
163449109|NCT00882999|590346184|FG002|Overall Study|Withdrawal by Subject|3|||
163449110|NCT00882999|590346185|FG003|Overall Study|Withdrawal by Subject|3|||
163449111|NCT00882999|590346186|FG004|Overall Study|Withdrawal by Subject|6|||
163449112|NCT00882999|590346187|FG005|Overall Study|Withdrawal by Subject|5|||
163449113|NCT00882999|590346188|FG006|Overall Study|Withdrawal by Subject|5|||
163449114|NCT00882999|590346182|FG000|Overall Study|Lost to Follow-up|0|||
163449115|NCT00882999|590346183|FG001|Overall Study|Lost to Follow-up|1|||
163449116|NCT00882999|590346184|FG002|Overall Study|Lost to Follow-up|1|||
163449117|NCT00882999|590346185|FG003|Overall Study|Lost to Follow-up|2|||
163449118|NCT00882999|590346186|FG004|Overall Study|Lost to Follow-up|1|||
163449119|NCT00882999|590346187|FG005|Overall Study|Lost to Follow-up|1|||
163449120|NCT00882999|590346188|FG006|Overall Study|Lost to Follow-up|2|||
163449121|NCT00882999|590346182|FG000|Overall Study|Physician Decision|1|||
163449122|NCT00882999|590346183|FG001|Overall Study|Physician Decision|0|||
163449123|NCT00882999|590346184|FG002|Overall Study|Physician Decision|0|||
163449124|NCT00882999|590346185|FG003|Overall Study|Physician Decision|0|||
163449125|NCT00882999|590346186|FG004|Overall Study|Physician Decision|0|||
163449126|NCT00882999|590346187|FG005|Overall Study|Physician Decision|1|||
163449127|NCT00882999|590346188|FG006|Overall Study|Physician Decision|1|||
163449128|NCT01757405|590346191|FG000|Overall Study|Lost to Follow-up|1|||
163449129|NCT01757405|590346192|FG001|Overall Study|Lost to Follow-up|1|||
163449130|NCT01757405|590346191|FG000|Overall Study|Withdrawal by Subject|0|||
163449131|NCT01757405|590346192|FG001|Overall Study|Withdrawal by Subject|1|||
163449132|NCT00082758|590346193|FG000|Overall Study|Adverse Event|0|||
163449133|NCT00082758|590346194|FG001|Overall Study|Adverse Event|2|||
163449134|NCT00082758|590346195|FG002|Overall Study|Adverse Event|0|||
163449135|NCT00082758|590346193|FG000|Overall Study|Lack of Efficacy|12|||
163449136|NCT00082758|590346194|FG001|Overall Study|Lack of Efficacy|13|||
163449137|NCT00082758|590346195|FG002|Overall Study|Lack of Efficacy|0|||
163449138|NCT00082758|590346193|FG000|Overall Study|Physician Decision|0|||
163449139|NCT00082758|590346194|FG001|Overall Study|Physician Decision|1|||
163449140|NCT00082758|590346195|FG002|Overall Study|Physician Decision|0|||
163449141|NCT00082758|590346193|FG000|Overall Study|Withdrawal by Subject|3|||
163449142|NCT00082758|590346194|FG001|Overall Study|Withdrawal by Subject|0|||
163449143|NCT00082758|590346195|FG002|Overall Study|Withdrawal by Subject|0|||
163449144|NCT00082758|590346193|FG000|Overall Study|Protocol Violation|0|||
163449145|NCT00082758|590346194|FG001|Overall Study|Protocol Violation|1|||
163449146|NCT00082758|590346195|FG002|Overall Study|Protocol Violation|0|||
163449147|NCT00937560|590346196|FG000|Initial Treatment|Death|6|||
163449148|NCT00937560|590346196|FG000|Initial Treatment|Withdraw consent|3|||
163449149|NCT00937560|590346196|FG000|Initial Treatment|Adverse Event|1|||
163449150|NCT00937560|590346196|FG000|Initial Treatment|Lost to Follow-up|1|||
163449151|NCT00937560|590346196|FG000|Initial Treatment|No end of study page|10|||
163449152|NCT00937560|590346196|FG000|Maintenance Treatment|Death|12|||
163449153|NCT00937560|590346196|FG000|Maintenance Treatment|Withdraw consent|5|||
163449154|NCT00937560|590346196|FG000|Maintenance Treatment|According to protocol|1|||
163449155|NCT01219959|590346197|FG000|Overall Study|Adverse Event|6|||
163449156|NCT01219959|590346198|FG001|Overall Study|Adverse Event|14|||
163449157|NCT01219959|590346197|FG000|Overall Study|Physician Decision|0|||
163449158|NCT01219959|590346198|FG001|Overall Study|Physician Decision|4|||
163449159|NCT01219959|590346197|FG000|Overall Study|Withdrawal by Subject|0|||
163449160|NCT01219959|590346198|FG001|Overall Study|Withdrawal by Subject|2|||
163449161|NCT01219959|590346197|FG000|Overall Study|Renal Transplantation|0|||
163449162|NCT01219959|590346198|FG001|Overall Study|Renal Transplantation|3|||
163449163|NCT01219959|590346197|FG000|Overall Study|Other|1|||
163449164|NCT01219959|590346198|FG001|Overall Study|Other|0|||
163449165|NCT05906732|590346199|FG000|Overall Study|Withdrawal by Subject|1|||
163449166|NCT05906732|590346200|FG001|Overall Study|Withdrawal by Subject|0|||
163449167|NCT05906732|590346201|FG002|Overall Study|Withdrawal by Subject|0|||
163449168|NCT05906732|590346202|FG003|Overall Study|Withdrawal by Subject|0|||
163449169|NCT05906732|590346199|FG000|Overall Study|Physician Decision|2|||
163449170|NCT05906732|590346200|FG001|Overall Study|Physician Decision|4|||
163449171|NCT05906732|590346201|FG002|Overall Study|Physician Decision|0|||
163449172|NCT05906732|590346202|FG003|Overall Study|Physician Decision|0|||
163449173|NCT01248130|590346203|FG000|Overall Study|Protocol Violation|1|||
163449174|NCT01248130|590346204|FG001|Overall Study|Protocol Violation|0|||
163449175|NCT01248130|590346203|FG000|Overall Study|Ineligible|1|||
163449176|NCT01248130|590346204|FG001|Overall Study|Ineligible|0|||
163449177|NCT02052778|590346205|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
163449178|NCT02052778|590346206|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
163449179|NCT02052778|590346207|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
163449180|NCT02052778|590346208|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
163449181|NCT02052778|590346209|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
163449182|NCT02052778|590346210|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
163449183|NCT02052778|590346211|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
163449184|NCT02052778|590346212|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
163449185|NCT02052778|590346213|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
163449186|NCT02052778|590346214|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
163449187|NCT02052778|590346215|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
163449188|NCT02052778|590346216|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
163449189|NCT02052778|590346217|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
163449190|NCT02052778|590346218|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
163449191|NCT02052778|590346219|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
163449192|NCT02052778|590346220|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
163449193|NCT02052778|590346221|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
163449194|NCT02052778|590346222|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
163449195|NCT02052778|590346223|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
163449196|NCT02052778|590346224|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
163449197|NCT02052778|590346225|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
163449198|NCT02052778|590346226|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
163449199|NCT02052778|590346227|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
163449200|NCT02052778|590346205|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
163449201|NCT02052778|590346206|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
163449202|NCT02052778|590346207|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
163449203|NCT02052778|590346208|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
163449204|NCT02052778|590346209|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
163449205|NCT02052778|590346210|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
163449206|NCT02052778|590346211|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
163449207|NCT02052778|590346212|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
163449208|NCT02052778|590346213|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
163449209|NCT02052778|590346214|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
163449210|NCT02052778|590346215|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
163449211|NCT02052778|590346216|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
163449212|NCT02052778|590346217|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
163449213|NCT02052778|590346218|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
163449214|NCT02052778|590346219|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
163449215|NCT02052778|590346220|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
163449216|NCT02052778|590346221|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
163449217|NCT02052778|590346222|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
163449218|NCT02052778|590346223|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
163449219|NCT02052778|590346224|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
163449220|NCT02052778|590346225|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
163449221|NCT02052778|590346226|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
163449222|NCT02052778|590346227|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
163449223|NCT02052778|590346205|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449224|NCT02052778|590346206|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449225|NCT02052778|590346207|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449226|NCT02052778|590346208|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449227|NCT02052778|590346209|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449228|NCT02052778|590346210|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449229|NCT02052778|590346211|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449230|NCT02052778|590346212|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449231|NCT02052778|590346213|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449232|NCT02052778|590346214|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449233|NCT02052778|590346215|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449234|NCT02052778|590346216|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449235|NCT02052778|590346217|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449236|NCT02052778|590346218|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
163449237|NCT02052778|590346219|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449238|NCT02052778|590346220|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449239|NCT02052778|590346221|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449240|NCT02052778|590346222|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449241|NCT02052778|590346223|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449242|NCT02052778|590346224|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449243|NCT02052778|590346225|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449244|NCT02052778|590346226|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449245|NCT02052778|590346227|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163449246|NCT02052778|590346205|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
163449247|NCT02052778|590346206|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
163449248|NCT02052778|590346207|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
163449249|NCT02052778|590346208|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
163449250|NCT02052778|590346209|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
163449251|NCT02052778|590346210|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
163449252|NCT02052778|590346211|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
163449253|NCT02052778|590346212|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
163449254|NCT02052778|590346213|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
163449255|NCT02052778|590346214|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
163449256|NCT02052778|590346215|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
163449257|NCT02052778|590346216|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
163449258|NCT02052778|590346217|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
163449259|NCT02052778|590346218|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
163449260|NCT02052778|590346219|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
163449261|NCT02052778|590346220|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
163449262|NCT02052778|590346221|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
163449263|NCT02052778|590346222|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
163449264|NCT02052778|590346223|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
163449265|NCT02052778|590346224|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
163449266|NCT02052778|590346225|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
163449267|NCT02052778|590346226|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
163449268|NCT02052778|590346227|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
163449269|NCT02052778|590346205|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449270|NCT02052778|590346206|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449271|NCT02052778|590346207|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449272|NCT02052778|590346208|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449273|NCT02052778|590346209|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449274|NCT02052778|590346210|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449275|NCT02052778|590346211|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449276|NCT02052778|590346212|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449277|NCT02052778|590346213|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
163449278|NCT02052778|590346214|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449279|NCT02052778|590346215|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449280|NCT02052778|590346216|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449281|NCT02052778|590346217|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449282|NCT02052778|590346218|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
163449283|NCT02052778|590346219|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449284|NCT02052778|590346220|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449285|NCT02052778|590346221|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449286|NCT02052778|590346222|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449287|NCT02052778|590346223|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449288|NCT02052778|590346224|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449289|NCT02052778|590346225|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449290|NCT02052778|590346226|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449291|NCT02052778|590346227|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
163449292|NCT02052778|590346205|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449293|NCT02052778|590346206|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449294|NCT02052778|590346207|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449295|NCT02052778|590346208|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449296|NCT02052778|590346209|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449297|NCT02052778|590346210|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
163449298|NCT02052778|590346211|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449299|NCT02052778|590346212|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449300|NCT02052778|590346213|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449301|NCT02052778|590346214|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449302|NCT02052778|590346215|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449303|NCT02052778|590346216|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449304|NCT02052778|590346217|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
163449305|NCT02052778|590346218|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449306|NCT02052778|590346219|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449307|NCT02052778|590346220|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449308|NCT02052778|590346221|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449309|NCT02052778|590346222|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449310|NCT02052778|590346223|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449311|NCT02052778|590346224|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449312|NCT02052778|590346225|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449313|NCT02052778|590346226|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449314|NCT02052778|590346227|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
163449315|NCT02052778|590346205|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
163449316|NCT02052778|590346206|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
163449317|NCT02052778|590346207|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
163449318|NCT02052778|590346208|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
163449319|NCT02052778|590346209|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
163449320|NCT02052778|590346210|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
163449321|NCT02052778|590346211|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
163449322|NCT02052778|590346212|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
163449323|NCT02052778|590346213|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
163449324|NCT02052778|590346214|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
163449325|NCT02052778|590346215|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
163449326|NCT02052778|590346216|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
163449327|NCT02052778|590346217|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
163449328|NCT02052778|590346218|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
163449329|NCT02052778|590346219|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
163449330|NCT02052778|590346220|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
163449331|NCT02052778|590346221|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
163449332|NCT02052778|590346222|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
163449333|NCT02052778|590346223|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
163449334|NCT02052778|590346224|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
163449335|NCT02052778|590346225|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
163449336|NCT02052778|590346226|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
163449337|NCT02052778|590346227|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
163449338|NCT02052778|590346205|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449339|NCT02052778|590346206|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449340|NCT02052778|590346207|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449341|NCT02052778|590346208|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449342|NCT02052778|590346209|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449343|NCT02052778|590346210|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449344|NCT02052778|590346211|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449345|NCT02052778|590346212|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449346|NCT02052778|590346213|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449347|NCT02052778|590346214|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449348|NCT02052778|590346215|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449349|NCT02052778|590346216|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449350|NCT02052778|590346217|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449351|NCT02052778|590346218|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449352|NCT02052778|590346219|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
163449353|NCT02052778|590346220|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
163449354|NCT02052778|590346221|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449355|NCT02052778|590346222|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
163449356|NCT02052778|590346223|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
163449357|NCT02052778|590346224|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
163449358|NCT02052778|590346225|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
163449359|NCT02052778|590346226|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
163449360|NCT02052778|590346227|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
163449361|NCT02052778|590346205|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449362|NCT02052778|590346206|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449363|NCT02052778|590346207|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449364|NCT02052778|590346208|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449365|NCT02052778|590346209|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449366|NCT02052778|590346210|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449367|NCT02052778|590346211|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449368|NCT02052778|590346212|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449369|NCT02052778|590346213|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449370|NCT02052778|590346214|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449371|NCT02052778|590346215|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449372|NCT02052778|590346216|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449373|NCT02052778|590346217|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449374|NCT02052778|590346218|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449375|NCT02052778|590346219|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
163449376|NCT02052778|590346220|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
163449377|NCT02052778|590346221|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
163449378|NCT02052778|590346222|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449379|NCT02052778|590346223|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
163449380|NCT02052778|590346224|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
163449381|NCT02052778|590346225|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449382|NCT02052778|590346226|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449383|NCT02052778|590346227|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
163449384|NCT02052778|590346205|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449385|NCT02052778|590346206|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449386|NCT02052778|590346207|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449387|NCT02052778|590346208|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449388|NCT02052778|590346209|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449389|NCT02052778|590346210|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449390|NCT02052778|590346211|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449391|NCT02052778|590346212|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449392|NCT02052778|590346213|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449393|NCT02052778|590346214|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449394|NCT02052778|590346215|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449395|NCT02052778|590346216|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449396|NCT02052778|590346217|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449397|NCT02052778|590346218|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449398|NCT02052778|590346219|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
163449399|NCT02052778|590346220|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
163449400|NCT02052778|590346221|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449401|NCT02052778|590346222|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449402|NCT02052778|590346223|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449403|NCT02052778|590346224|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449404|NCT02052778|590346225|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449405|NCT02052778|590346226|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449406|NCT02052778|590346227|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
163449407|NCT02052778|590346205|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449408|NCT02052778|590346206|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449409|NCT02052778|590346207|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449410|NCT02052778|590346208|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449411|NCT02052778|590346209|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449412|NCT02052778|590346210|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449413|NCT02052778|590346211|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449414|NCT02052778|590346212|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449415|NCT02052778|590346213|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449416|NCT02052778|590346214|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449417|NCT02052778|590346215|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449418|NCT02052778|590346216|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449419|NCT02052778|590346217|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449420|NCT02052778|590346218|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449421|NCT02052778|590346219|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
163449422|NCT02052778|590346220|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
163449423|NCT02052778|590346221|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449424|NCT02052778|590346222|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449425|NCT02052778|590346223|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449426|NCT02052778|590346224|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
163449427|NCT02052778|590346225|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449428|NCT02052778|590346226|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449429|NCT02052778|590346227|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163449430|NCT02052778|590346205|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
163449431|NCT02052778|590346206|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
163449432|NCT02052778|590346207|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
163449433|NCT02052778|590346208|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
163449434|NCT02052778|590346209|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
163449435|NCT02052778|590346210|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
163449436|NCT02052778|590346211|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
163449437|NCT02052778|590346212|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
163449438|NCT02052778|590346213|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
163449439|NCT02052778|590346214|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
163449440|NCT02052778|590346215|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
163449441|NCT02052778|590346216|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
163449442|NCT02052778|590346217|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
163449443|NCT02052778|590346218|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
163449444|NCT02052778|590346219|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
163449445|NCT02052778|590346220|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
163449446|NCT02052778|590346221|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
163449447|NCT02052778|590346222|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
163449448|NCT02052778|590346223|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
163449449|NCT02052778|590346224|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
163449450|NCT02052778|590346225|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
163449451|NCT02052778|590346226|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
163449452|NCT02052778|590346227|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
163449453|NCT02052778|590346205|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449454|NCT02052778|590346206|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449455|NCT02052778|590346207|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449456|NCT02052778|590346208|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449457|NCT02052778|590346209|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449458|NCT02052778|590346210|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449459|NCT02052778|590346211|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449460|NCT02052778|590346212|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449461|NCT02052778|590346213|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449462|NCT02052778|590346214|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449463|NCT02052778|590346215|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449464|NCT02052778|590346216|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449465|NCT02052778|590346217|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449466|NCT02052778|590346218|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449467|NCT02052778|590346219|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
163449468|NCT02052778|590346220|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
163449469|NCT02052778|590346221|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
163449470|NCT02052778|590346222|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449471|NCT02052778|590346223|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
163449472|NCT02052778|590346224|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449473|NCT02052778|590346225|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449474|NCT02052778|590346226|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449475|NCT02052778|590346227|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163449476|NCT02052778|590346205|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449477|NCT02052778|590346206|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449478|NCT02052778|590346207|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449479|NCT02052778|590346208|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449480|NCT02052778|590346209|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449481|NCT02052778|590346210|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449482|NCT02052778|590346211|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449483|NCT02052778|590346212|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449484|NCT02052778|590346213|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449485|NCT02052778|590346214|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449486|NCT02052778|590346215|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449487|NCT02052778|590346216|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449488|NCT02052778|590346217|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449489|NCT02052778|590346218|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449490|NCT02052778|590346219|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449491|NCT02052778|590346220|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449492|NCT02052778|590346221|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449493|NCT02052778|590346222|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449494|NCT02052778|590346223|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449495|NCT02052778|590346224|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449496|NCT02052778|590346225|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449497|NCT02052778|590346226|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
163449498|NCT02052778|590346227|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
163449499|NCT02052778|590346205|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449500|NCT02052778|590346206|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449501|NCT02052778|590346207|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449502|NCT02052778|590346208|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449503|NCT02052778|590346209|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449504|NCT02052778|590346210|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449505|NCT02052778|590346211|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449506|NCT02052778|590346212|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449507|NCT02052778|590346213|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449508|NCT02052778|590346214|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449509|NCT02052778|590346215|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449510|NCT02052778|590346216|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449511|NCT02052778|590346217|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449512|NCT02052778|590346218|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449513|NCT02052778|590346219|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449514|NCT02052778|590346220|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449515|NCT02052778|590346221|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449516|NCT02052778|590346222|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449517|NCT02052778|590346223|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449518|NCT02052778|590346224|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449519|NCT02052778|590346225|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449520|NCT02052778|590346226|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
163449521|NCT02052778|590346227|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
163449522|NCT02052778|590346205|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449523|NCT02052778|590346206|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449524|NCT02052778|590346207|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449525|NCT02052778|590346208|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449526|NCT02052778|590346209|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449527|NCT02052778|590346210|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449528|NCT02052778|590346211|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449529|NCT02052778|590346212|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449530|NCT02052778|590346213|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449531|NCT02052778|590346214|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449532|NCT02052778|590346215|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449533|NCT02052778|590346216|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449534|NCT02052778|590346217|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449535|NCT02052778|590346218|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449536|NCT02052778|590346219|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449537|NCT02052778|590346220|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449538|NCT02052778|590346221|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449539|NCT02052778|590346222|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449540|NCT02052778|590346223|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449541|NCT02052778|590346224|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449542|NCT02052778|590346225|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449543|NCT02052778|590346226|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
163449544|NCT02052778|590346227|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
163449545|NCT02052778|590346205|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449546|NCT02052778|590346206|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449547|NCT02052778|590346207|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449548|NCT02052778|590346208|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449549|NCT02052778|590346209|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449550|NCT02052778|590346210|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449551|NCT02052778|590346211|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449552|NCT02052778|590346212|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449553|NCT02052778|590346213|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449554|NCT02052778|590346214|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449555|NCT02052778|590346215|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449556|NCT02052778|590346216|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449557|NCT02052778|590346217|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449558|NCT02052778|590346218|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449559|NCT02052778|590346219|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449560|NCT02052778|590346220|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449561|NCT02052778|590346221|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449562|NCT02052778|590346222|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449563|NCT02052778|590346223|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449564|NCT02052778|590346224|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449565|NCT02052778|590346225|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449566|NCT02052778|590346226|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
163449567|NCT02052778|590346227|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
163449568|NCT02052778|590346205|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449569|NCT02052778|590346206|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449570|NCT02052778|590346207|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449571|NCT02052778|590346208|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449572|NCT02052778|590346209|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449573|NCT02052778|590346210|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449574|NCT02052778|590346211|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449575|NCT02052778|590346212|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449576|NCT02052778|590346213|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449577|NCT02052778|590346214|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449578|NCT02052778|590346215|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449579|NCT02052778|590346216|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449580|NCT02052778|590346217|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449581|NCT02052778|590346218|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449582|NCT02052778|590346219|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449583|NCT02052778|590346220|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449584|NCT02052778|590346221|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449585|NCT02052778|590346222|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449586|NCT02052778|590346223|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449587|NCT02052778|590346224|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449588|NCT02052778|590346225|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449589|NCT02052778|590346226|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
163449590|NCT02052778|590346227|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
163449591|NCT02052778|590346205|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
163449592|NCT02052778|590346206|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
163449593|NCT02052778|590346207|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
163449594|NCT02052778|590346208|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
163449595|NCT02052778|590346209|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
163449596|NCT02052778|590346210|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
163449597|NCT02052778|590346211|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
163449598|NCT02052778|590346212|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
163449599|NCT02052778|590346213|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
163449600|NCT02052778|590346214|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
163449601|NCT02052778|590346215|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
163449602|NCT02052778|590346216|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
163449603|NCT02052778|590346217|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
163449604|NCT02052778|590346218|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
163449605|NCT02052778|590346219|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
163449606|NCT02052778|590346220|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
163449607|NCT02052778|590346221|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
163449608|NCT02052778|590346222|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
163449609|NCT02052778|590346223|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
163449610|NCT02052778|590346224|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
163449611|NCT02052778|590346225|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
163449612|NCT02052778|590346226|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
163449613|NCT02052778|590346227|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
163449614|NCT02052778|590346205|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449615|NCT02052778|590346206|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449616|NCT02052778|590346207|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449617|NCT02052778|590346208|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449618|NCT02052778|590346209|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449619|NCT02052778|590346210|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449620|NCT02052778|590346211|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449621|NCT02052778|590346212|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449622|NCT02052778|590346213|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449623|NCT02052778|590346214|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449624|NCT02052778|590346215|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449625|NCT02052778|590346216|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449626|NCT02052778|590346217|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449627|NCT02052778|590346218|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449628|NCT02052778|590346219|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449629|NCT02052778|590346220|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449630|NCT02052778|590346221|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449631|NCT02052778|590346222|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449632|NCT02052778|590346223|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449633|NCT02052778|590346224|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449634|NCT02052778|590346225|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449635|NCT02052778|590346226|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
163449636|NCT02052778|590346227|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
163449637|NCT01994226|590346234|FG000|Overall Study|Protocol Violation|13|||
163449638|NCT01994226|590346235|FG001|Overall Study|Protocol Violation|10|||
163449639|NCT01994226|590346234|FG000|Overall Study|Early Cessation of treatment|6|||
163449640|NCT01994226|590346235|FG001|Overall Study|Early Cessation of treatment|11|||
163449641|NCT02488551|590346236|FG000|Overall Study|Lost to Follow-up|4|||
163449642|NCT02488551|590346237|FG001|Overall Study|Lost to Follow-up|7|||
163449643|NCT02488551|590346238|FG002|Overall Study|Lost to Follow-up|0|||
163449644|NCT02488551|590346239|FG003|Overall Study|Lost to Follow-up|0|||
163449645|NCT02488551|590346236|FG000|Overall Study|Military Deployment|1|||
163449646|NCT02488551|590346237|FG001|Overall Study|Military Deployment|1|||
163449647|NCT02488551|590346238|FG002|Overall Study|Military Deployment|0|||
163449648|NCT02488551|590346239|FG003|Overall Study|Military Deployment|0|||
163449649|NCT00436566|590346240|FG000|Overall Study|Withdrawal by Subject|2|||
163449650|NCT00436566|590346240|FG000|Overall Study|Protocol Violation|1|||
163449651|NCT02651194|590346241|FG000|Overall Study|Lost to Follow-up|3|||
163449652|NCT02651194|590346241|FG000|Overall Study|Other|2|||
163449653|NCT01980706|590346242|FG000|Overall Study|Withdrawal by Subject|9|||
163449654|NCT01980706|590346243|FG001|Overall Study|Withdrawal by Subject|6|||
163449655|NCT01980706|590346244|FG002|Overall Study|Withdrawal by Subject|2|||
163449656|NCT01980706|590346242|FG000|Overall Study|Adverse Event|1|||
163449657|NCT01980706|590346243|FG001|Overall Study|Adverse Event|2|||
163449658|NCT01980706|590346244|FG002|Overall Study|Adverse Event|5|||
163449659|NCT01980706|590346242|FG000|Overall Study|Lost to Follow-up|3|||
163449660|NCT01980706|590346243|FG001|Overall Study|Lost to Follow-up|4|||
163449661|NCT01980706|590346244|FG002|Overall Study|Lost to Follow-up|3|||
163449662|NCT01980706|590346242|FG000|Overall Study|miscellaneous|4|||
163449663|NCT01980706|590346243|FG001|Overall Study|miscellaneous|5|||
163449664|NCT01980706|590346244|FG002|Overall Study|miscellaneous|3|||
163449665|NCT02546674|590346245|FG000|Overall Study|Adverse Event|19|||
163449666|NCT02546674|590346245|FG000|Overall Study|Death|1|||
163449667|NCT02546674|590346245|FG000|Overall Study|Lost to Follow-up|1|||
163449668|NCT02546674|590346245|FG000|Overall Study|Physician Decision|13|||
163449669|NCT02546674|590346245|FG000|Overall Study|Pregnancy|1|||
163449670|NCT02546674|590346245|FG000|Overall Study|Progressive Disease|2|||
163449671|NCT02546674|590346245|FG000|Overall Study|Protocol Deviation|2|||
163449672|NCT02546674|590346245|FG000|Overall Study|Subject/Guardian Decision|6|||
163449673|NCT02546674|590346245|FG000|Overall Study|Withdrawal of Informed Consent|3|||
163449674|NCT01401010|590346255|FG000|Overall Study|Could not interpret assay results|1|||
163449675|NCT01401010|590346256|FG001|Overall Study|Could not interpret assay results|0|||
163449676|NCT02841787|590346257|FG000|Overall Study|Lost to Follow-up|1|||
163449677|NCT02841787|590346258|FG001|Overall Study|Lost to Follow-up|0|||
163449678|NCT02841787|590346259|FG002|Overall Study|Lost to Follow-up|0|||
163449679|NCT02841787|590346257|FG000|Overall Study|Symptoms dropped below threshold|1|||
163449680|NCT02841787|590346258|FG001|Overall Study|Symptoms dropped below threshold|0|||
163449681|NCT02841787|590346259|FG002|Overall Study|Symptoms dropped below threshold|0|||
163449682|NCT02841787|590346257|FG000|Overall Study|Withdrawal by Subject|1|||
163449683|NCT02841787|590346258|FG001|Overall Study|Withdrawal by Subject|4|||
163449684|NCT02841787|590346259|FG002|Overall Study|Withdrawal by Subject|0|||
163449685|NCT01474746|590346260|FG000|Overall Study|Lost to Follow-up|1|||
163449686|NCT01474746|590346261|FG001|Overall Study|Lost to Follow-up|1|||
163449687|NCT01474746|590346260|FG000|Overall Study|Withdrawal by Subject|2|||
163449688|NCT01474746|590346261|FG001|Overall Study|Withdrawal by Subject|1|||
163449689|NCT00524316|590346264|FG000|Overall Study|Withdrawal by Subject|2|||
163449690|NCT00524316|590346264|FG000|Overall Study|Adverse Event|7|||
163449691|NCT00524316|590346264|FG000|Overall Study|Disease Progression|7|||
163449692|NCT01199263|590346265|FG000|Overall Study|Ineligible|0|||
163449693|NCT01199263|590346266|FG001|Overall Study|Ineligible|2|||
163449694|NCT01199263|590346265|FG000|Overall Study|Never Treated|6|||
163449695|NCT01199263|590346266|FG001|Overall Study|Never Treated|0|||
163449696|NCT01687413|590346271|FG000|Overall Study|Withdrawal by Subject|0|||
163449697|NCT01687413|590346272|FG001|Overall Study|Withdrawal by Subject|2|||
163449698|NCT01687413|590346271|FG000|Overall Study|Not eligible|0|||
163449699|NCT01687413|590346272|FG001|Overall Study|Not eligible|2|||
163449700|NCT01687413|590346271|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
163449701|NCT01687413|590346272|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
163449702|NCT00091390|590346274|FG000|Overall Study|Protocol Violation|1|||
163449703|NCT00091390|590346274|FG000|Overall Study|No protocol treatment|3|||
163449704|NCT02349789|590348022|FG000|Overall Study|Withdrawal by Subject|2|||
163449705|NCT01116687|590348023|FG000|Overall Study|Withdrawal by Subject|4|||
163449706|NCT03497429|590348025|FG000|Overall Study|Progressive disease|3|||
163449707|NCT03497429|590348026|FG001|Overall Study|Progressive disease|4|||
163449708|NCT03497429|590348025|FG000|Overall Study|Adverse Event|0|||
163449709|NCT03497429|590348026|FG001|Overall Study|Adverse Event|2|||
163449710|NCT01215734|590348027|FG000|Overall Study|Death|0|||
163449711|NCT01215734|590348028|FG001|Overall Study|Death|1|||
163449712|NCT02622724|590348038|FG000|Overall Study|Death|51|||
163449713|NCT02622724|590348039|FG001|Overall Study|Death|53|||
163449714|NCT02622724|590348038|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
163449715|NCT02622724|590348039|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
163449716|NCT02622724|590348038|FG000|Overall Study|Early termination of study|38|||
163449717|NCT02622724|590348039|FG001|Overall Study|Early termination of study|43|||
163449718|NCT00254293|590348040|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
163449719|NCT00254293|590348041|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
163449720|NCT00254293|590348042|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
163449721|NCT00254293|590348043|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
163449722|NCT00254293|590348044|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
163449723|NCT00254293|590348045|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
163449724|NCT00254293|590348046|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
163449725|NCT00254293|590348040|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
163449726|NCT00254293|590348041|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
163449727|NCT00254293|590348042|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
163449728|NCT00254293|590348043|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
163449729|NCT00254293|590348044|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
163449730|NCT00254293|590348045|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
163449731|NCT00254293|590348046|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
163449732|NCT00254293|590348040|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
163449733|NCT00254293|590348041|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
163449734|NCT00254293|590348042|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
163449735|NCT00254293|590348043|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
163449736|NCT00254293|590348044|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
163449737|NCT00254293|590348045|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
163449738|NCT00254293|590348046|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
163449739|NCT00254293|590348040|FG000|LTE Open Label Variable SC Dosing|Death|0|||
163449740|NCT00254293|590348041|FG001|LTE Open Label Variable SC Dosing|Death|0|||
163449741|NCT00254293|590348042|FG002|LTE Open Label Variable SC Dosing|Death|1|||
163449742|NCT00254293|590348043|FG003|LTE Open Label Variable SC Dosing|Death|0|||
163449743|NCT00254293|590348044|FG004|LTE Open Label Variable SC Dosing|Death|0|||
163449744|NCT00254293|590348045|FG005|LTE Open Label Variable SC Dosing|Death|0|||
163449745|NCT00254293|590348046|FG006|LTE Open Label Variable SC Dosing|Death|0|||
163449746|NCT00254293|590348040|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
163449747|NCT00254293|590348041|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
163449748|NCT00254293|590348042|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
163449749|NCT00254293|590348043|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
163449750|NCT00254293|590348044|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
163449751|NCT00254293|590348045|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
163449752|NCT00254293|590348046|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
163449753|NCT00254293|590348040|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
163449754|NCT00254293|590348041|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
163449755|NCT00254293|590348042|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
163449756|NCT00254293|590348043|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
163449757|NCT00254293|590348044|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
163449758|NCT00254293|590348045|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
163449759|NCT00254293|590348046|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
163449760|NCT00254293|590348040|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
163449761|NCT00254293|590348041|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
163449762|NCT00254293|590348042|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
163449763|NCT00254293|590348043|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
163449764|NCT00254293|590348044|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
163449765|NCT00254293|590348045|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
163449766|NCT00254293|590348046|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
163449767|NCT00254293|590348040|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
163449768|NCT00254293|590348041|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
163449769|NCT00254293|590348042|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
163449770|NCT00254293|590348043|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
163449771|NCT00254293|590348044|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
163449772|NCT00254293|590348045|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
163449773|NCT00254293|590348046|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
163449774|NCT00254293|590348040|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
163449775|NCT00254293|590348041|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
163449776|NCT00254293|590348042|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
163449777|NCT00254293|590348043|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
163449778|NCT00254293|590348044|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
163449779|NCT00254293|590348045|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
163449780|NCT00254293|590348046|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
163449781|NCT00254293|590348040|FG000|LTE Open Label Variable SC Dosing|Other|0|||
163449782|NCT00254293|590348041|FG001|LTE Open Label Variable SC Dosing|Other|0|||
163449783|NCT00254293|590348042|FG002|LTE Open Label Variable SC Dosing|Other|2|||
163449784|NCT00254293|590348043|FG003|LTE Open Label Variable SC Dosing|Other|0|||
163449785|NCT00254293|590348044|FG004|LTE Open Label Variable SC Dosing|Other|0|||
163449786|NCT00254293|590348045|FG005|LTE Open Label Variable SC Dosing|Other|0|||
163449787|NCT00254293|590348046|FG006|LTE Open Label Variable SC Dosing|Other|0|||
163449788|NCT00254293|590348040|FG000|LTE Open Label Fixed Dosing|Death|0|||
163449789|NCT00254293|590348041|FG001|LTE Open Label Fixed Dosing|Death|0|||
163449790|NCT00254293|590348042|FG002|LTE Open Label Fixed Dosing|Death|0|||
163449791|NCT00254293|590348043|FG003|LTE Open Label Fixed Dosing|Death|0|||
163449792|NCT00254293|590348044|FG004|LTE Open Label Fixed Dosing|Death|0|||
163449793|NCT00254293|590348045|FG005|LTE Open Label Fixed Dosing|Death|0|||
163449794|NCT00254293|590348046|FG006|LTE Open Label Fixed Dosing|Death|3|||
163449795|NCT00254293|590348040|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
163449796|NCT00254293|590348041|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
163449797|NCT00254293|590348042|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
163449798|NCT00254293|590348043|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
163449799|NCT00254293|590348044|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
163449800|NCT00254293|590348045|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
163449801|NCT00254293|590348046|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
163449802|NCT00254293|590348040|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
163449803|NCT00254293|590348041|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
163449804|NCT00254293|590348042|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
163449805|NCT00254293|590348043|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
163449806|NCT00254293|590348044|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
163449807|NCT00254293|590348045|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
163449808|NCT00254293|590348046|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
163449809|NCT00254293|590348040|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
163449810|NCT00254293|590348041|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
163449811|NCT00254293|590348042|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
163449812|NCT00254293|590348043|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
163449813|NCT00254293|590348044|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
163449814|NCT00254293|590348045|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
163449815|NCT00254293|590348046|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
163449816|NCT00254293|590348040|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
163449817|NCT00254293|590348041|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
163449818|NCT00254293|590348042|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
163449819|NCT00254293|590348043|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
163449820|NCT00254293|590348044|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
163449821|NCT00254293|590348045|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
163449822|NCT00254293|590348046|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
163449823|NCT00254293|590348040|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
163449824|NCT00254293|590348041|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
163449825|NCT00254293|590348042|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
163449826|NCT00254293|590348043|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
163449827|NCT00254293|590348044|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
163449828|NCT00254293|590348045|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
163449829|NCT00254293|590348046|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
163449830|NCT00254293|590348040|FG000|LTE Open Label Fixed Dosing|Other|0|||
163449831|NCT00254293|590348041|FG001|LTE Open Label Fixed Dosing|Other|0|||
163449832|NCT00254293|590348042|FG002|LTE Open Label Fixed Dosing|Other|0|||
163449833|NCT00254293|590348043|FG003|LTE Open Label Fixed Dosing|Other|0|||
163449834|NCT00254293|590348044|FG004|LTE Open Label Fixed Dosing|Other|0|||
163449835|NCT00254293|590348045|FG005|LTE Open Label Fixed Dosing|Other|0|||
163449836|NCT00254293|590348046|FG006|LTE Open Label Fixed Dosing|Other|1|||
163449837|NCT03544268|590348050|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
163449838|NCT03544268|590348051|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
163449839|NCT03583372|590348052|FG000|Overall Study|Withdrawal by Subject|6|||
163449840|NCT03583372|590348053|FG001|Overall Study|Withdrawal by Subject|11|||
163449841|NCT03583372|590348054|FG002|Overall Study|Withdrawal by Subject|7|||
163449842|NCT03583372|590348055|FG003|Overall Study|Withdrawal by Subject|8|||
163449843|NCT03583372|590348052|FG000|Overall Study|Lost to Follow-up|4|||
163449844|NCT03583372|590348053|FG001|Overall Study|Lost to Follow-up|6|||
163449845|NCT03583372|590348054|FG002|Overall Study|Lost to Follow-up|3|||
163449846|NCT03583372|590348055|FG003|Overall Study|Lost to Follow-up|2|||
163449847|NCT03583372|590348052|FG000|Overall Study|Adverse Event|1|||
163449848|NCT03583372|590348053|FG001|Overall Study|Adverse Event|3|||
163449849|NCT03583372|590348054|FG002|Overall Study|Adverse Event|4|||
163449850|NCT03583372|590348055|FG003|Overall Study|Adverse Event|4|||
163449851|NCT03583372|590348052|FG000|Overall Study|Physician Decision|0|||
163449852|NCT03583372|590348053|FG001|Overall Study|Physician Decision|1|||
163449853|NCT03583372|590348054|FG002|Overall Study|Physician Decision|1|||
163449854|NCT03583372|590348055|FG003|Overall Study|Physician Decision|1|||
163449855|NCT03583372|590348052|FG000|Overall Study|Lack of Efficacy|0|||
163449856|NCT03583372|590348053|FG001|Overall Study|Lack of Efficacy|1|||
163449857|NCT03583372|590348054|FG002|Overall Study|Lack of Efficacy|0|||
163449858|NCT03583372|590348055|FG003|Overall Study|Lack of Efficacy|1|||
163449859|NCT03583372|590348052|FG000|Overall Study|Death|1|||
163449860|NCT03583372|590348053|FG001|Overall Study|Death|0|||
163449861|NCT03583372|590348054|FG002|Overall Study|Death|0|||
163449862|NCT03583372|590348055|FG003|Overall Study|Death|0|||
163449863|NCT03583372|590348052|FG000|Overall Study|Protocol Violation|0|||
163449864|NCT03583372|590348053|FG001|Overall Study|Protocol Violation|1|||
163449865|NCT03583372|590348054|FG002|Overall Study|Protocol Violation|0|||
163449866|NCT03583372|590348055|FG003|Overall Study|Protocol Violation|0|||
163449867|NCT03583372|590348052|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
163449868|NCT03583372|590348053|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
163449869|NCT03583372|590348054|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
163449870|NCT03583372|590348055|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
163449871|NCT03583372|590348052|FG000|Overall Study|Did Not Receive Study Drug|0|||
163449872|NCT03583372|590348053|FG001|Overall Study|Did Not Receive Study Drug|1|||
163449873|NCT03583372|590348054|FG002|Overall Study|Did Not Receive Study Drug|0|||
163449874|NCT03583372|590348055|FG003|Overall Study|Did Not Receive Study Drug|0|||
163449875|NCT03583372|590348052|FG000|Overall Study|Captured as Other in the Database|1|||
163449876|NCT03583372|590348053|FG001|Overall Study|Captured as Other in the Database|2|||
163449877|NCT03583372|590348054|FG002|Overall Study|Captured as Other in the Database|4|||
163449878|NCT03583372|590348055|FG003|Overall Study|Captured as Other in the Database|1|||
163449879|NCT02796391|590348056|FG000|Overall Study|Lost to Follow-up|2|||
163449880|NCT02796391|590348057|FG001|Overall Study|Lost to Follow-up|2|||
163449881|NCT02796391|590348058|FG002|Overall Study|Lost to Follow-up|13|||
163449882|NCT02796391|590348059|FG003|Overall Study|Lost to Follow-up|8|||
163449883|NCT02796391|590348060|FG004|Overall Study|Lost to Follow-up|14|||
163449884|NCT02796391|590348061|FG005|Overall Study|Lost to Follow-up|13|||
163449885|NCT02796391|590348056|FG000|Overall Study|COVID|0|||
163449886|NCT02796391|590348057|FG001|Overall Study|COVID|0|||
163449887|NCT02796391|590348058|FG002|Overall Study|COVID|5|||
163449888|NCT02796391|590348059|FG003|Overall Study|COVID|5|||
163449889|NCT02796391|590348060|FG004|Overall Study|COVID|2|||
163449890|NCT02796391|590348061|FG005|Overall Study|COVID|4|||
163449891|NCT02796391|590348056|FG000|Overall Study|Participant did not like study cigarettes|0|||
163449892|NCT02796391|590348057|FG001|Overall Study|Participant did not like study cigarettes|0|||
163449893|NCT02796391|590348058|FG002|Overall Study|Participant did not like study cigarettes|3|||
163449894|NCT02796391|590348059|FG003|Overall Study|Participant did not like study cigarettes|0|||
163449895|NCT02796391|590348060|FG004|Overall Study|Participant did not like study cigarettes|0|||
163449896|NCT02796391|590348061|FG005|Overall Study|Participant did not like study cigarettes|0|||
163449897|NCT02796391|590348056|FG000|Overall Study|Withdrawal by Subject|1|||
163449898|NCT02796391|590348057|FG001|Overall Study|Withdrawal by Subject|1|||
163449899|NCT02796391|590348058|FG002|Overall Study|Withdrawal by Subject|4|||
163449900|NCT02796391|590348059|FG003|Overall Study|Withdrawal by Subject|3|||
163449901|NCT02796391|590348060|FG004|Overall Study|Withdrawal by Subject|4|||
163449902|NCT02796391|590348061|FG005|Overall Study|Withdrawal by Subject|3|||
163449903|NCT02796391|590348056|FG000|Overall Study|Adverse Event|0|||
163449904|NCT02796391|590348057|FG001|Overall Study|Adverse Event|0|||
163449905|NCT02796391|590348058|FG002|Overall Study|Adverse Event|0|||
163449906|NCT02796391|590348059|FG003|Overall Study|Adverse Event|1|||
163449907|NCT02796391|590348060|FG004|Overall Study|Adverse Event|0|||
163449908|NCT02796391|590348061|FG005|Overall Study|Adverse Event|0|||
163449909|NCT02796391|590348056|FG000|Overall Study|Protocol Violation|0|||
163449910|NCT02796391|590348057|FG001|Overall Study|Protocol Violation|0|||
163449911|NCT02796391|590348058|FG002|Overall Study|Protocol Violation|0|||
163449912|NCT02796391|590348059|FG003|Overall Study|Protocol Violation|1|||
163449913|NCT02796391|590348060|FG004|Overall Study|Protocol Violation|0|||
163449914|NCT02796391|590348061|FG005|Overall Study|Protocol Violation|0|||
163449915|NCT02695524|590348062|FG000|Overall Study|Lost to Follow-up|3|||
163449916|NCT02695524|590348063|FG001|Overall Study|Lost to Follow-up|2|||
163449917|NCT02695524|590348062|FG000|Overall Study|Death|0|||
163449918|NCT02695524|590348063|FG001|Overall Study|Death|1|||
163449919|NCT03446651|590348071|FG000|Overall Study|Lost to Follow-up|4|||
163449920|NCT03446651|590348072|FG001|Overall Study|Lost to Follow-up|0|||
163449921|NCT03446651|590348071|FG000|Overall Study|Open Label Participants|5|||
163449922|NCT03446651|590348072|FG001|Overall Study|Open Label Participants|0|||
163449923|NCT00798655|590348073|FG000|Overall Study|Did not receive at least one dose of pan|2|||
163449924|NCT00343291|590348074|FG000|Overall Study|Adverse Event|13|||
163449925|NCT00343291|590348075|FG001|Overall Study|Adverse Event|13|||
163449926|NCT00343291|590348074|FG000|Overall Study|Death|3|||
163449927|NCT00343291|590348075|FG001|Overall Study|Death|2|||
163449928|NCT00343291|590348074|FG000|Overall Study|Progressive disease|33|||
163449929|NCT00343291|590348075|FG001|Overall Study|Progressive disease|34|||
163449930|NCT00343291|590348074|FG000|Overall Study|Withdrawal by Subject|0|||
163449931|NCT00343291|590348075|FG001|Overall Study|Withdrawal by Subject|2|||
163449932|NCT00343291|590348074|FG000|Overall Study|Other|8|||
163449933|NCT00343291|590348075|FG001|Overall Study|Other|5|||
163449934|NCT04831515|590348076|FG000|First Intervention|Adverse Event|0|||
163449935|NCT04831515|590348077|FG001|First Intervention|Adverse Event|1|||
163449936|NCT03712345|590348078|FG000|Overall Study|Failure to meet randomization criteria|0|||
163449937|NCT03712345|590348079|FG001|Overall Study|Failure to meet randomization criteria|0|||
163449938|NCT03712345|590348080|FG002|Overall Study|Failure to meet randomization criteria|1|||
163449939|NCT00960934|590348083|FG000|Overall Study|Adverse Event|2|||
163449940|NCT00960934|590348084|FG001|Overall Study|Adverse Event|3|||
163449941|NCT00960934|590348085|FG002|Overall Study|Adverse Event|3|||
163449942|NCT00960934|590348086|FG003|Overall Study|Adverse Event|2|||
163449943|NCT00960934|590348087|FG004|Overall Study|Adverse Event|4|||
163449944|NCT00960934|590348088|FG005|Overall Study|Adverse Event|3|||
163449945|NCT00960934|590348083|FG000|Overall Study|Lack of Efficacy|1|||
163449946|NCT00960934|590348084|FG001|Overall Study|Lack of Efficacy|0|||
163449947|NCT00960934|590348085|FG002|Overall Study|Lack of Efficacy|0|||
163449948|NCT00960934|590348086|FG003|Overall Study|Lack of Efficacy|0|||
163449949|NCT00960934|590348087|FG004|Overall Study|Lack of Efficacy|0|||
163449950|NCT00960934|590348088|FG005|Overall Study|Lack of Efficacy|0|||
163449951|NCT00960934|590348083|FG000|Overall Study|Lost to Follow-up|0|||
163449952|NCT00960934|590348084|FG001|Overall Study|Lost to Follow-up|1|||
163449953|NCT00960934|590348085|FG002|Overall Study|Lost to Follow-up|0|||
163449954|NCT00960934|590348086|FG003|Overall Study|Lost to Follow-up|0|||
163449955|NCT00960934|590348087|FG004|Overall Study|Lost to Follow-up|0|||
163449956|NCT00960934|590348088|FG005|Overall Study|Lost to Follow-up|0|||
163449957|NCT00960934|590348083|FG000|Overall Study|Other|2|||
163449958|NCT00960934|590348084|FG001|Overall Study|Other|1|||
163449959|NCT00960934|590348085|FG002|Overall Study|Other|5|||
163449960|NCT00960934|590348086|FG003|Overall Study|Other|4|||
163449961|NCT00960934|590348087|FG004|Overall Study|Other|2|||
163449962|NCT00960934|590348088|FG005|Overall Study|Other|2|||
163449963|NCT00960934|590348083|FG000|Overall Study|Physician Decision|0|||
163449964|NCT00960934|590348084|FG001|Overall Study|Physician Decision|1|||
163449965|NCT00960934|590348085|FG002|Overall Study|Physician Decision|0|||
163449966|NCT00960934|590348086|FG003|Overall Study|Physician Decision|0|||
163449967|NCT00960934|590348087|FG004|Overall Study|Physician Decision|0|||
163449968|NCT00960934|590348088|FG005|Overall Study|Physician Decision|0|||
163449969|NCT00960934|590348083|FG000|Overall Study|Progressive Disease|1|||
163449970|NCT00960934|590348084|FG001|Overall Study|Progressive Disease|1|||
163449971|NCT00960934|590348085|FG002|Overall Study|Progressive Disease|0|||
163449972|NCT00960934|590348086|FG003|Overall Study|Progressive Disease|0|||
163449973|NCT00960934|590348087|FG004|Overall Study|Progressive Disease|1|||
163449974|NCT00960934|590348088|FG005|Overall Study|Progressive Disease|1|||
163449975|NCT00960934|590348083|FG000|Overall Study|Protocol Violation|3|||
163449976|NCT00960934|590348084|FG001|Overall Study|Protocol Violation|4|||
163449977|NCT00960934|590348085|FG002|Overall Study|Protocol Violation|0|||
163449978|NCT00960934|590348086|FG003|Overall Study|Protocol Violation|3|||
163449979|NCT00960934|590348087|FG004|Overall Study|Protocol Violation|3|||
163449980|NCT00960934|590348088|FG005|Overall Study|Protocol Violation|2|||
163449981|NCT00960934|590348083|FG000|Overall Study|Withdrawal by Subject|5|||
163449982|NCT00960934|590348084|FG001|Overall Study|Withdrawal by Subject|6|||
163449983|NCT00960934|590348085|FG002|Overall Study|Withdrawal by Subject|4|||
163449984|NCT00960934|590348086|FG003|Overall Study|Withdrawal by Subject|5|||
163449985|NCT00960934|590348087|FG004|Overall Study|Withdrawal by Subject|5|||
163449986|NCT00960934|590348088|FG005|Overall Study|Withdrawal by Subject|7|||
163449987|NCT00960934|590348083|FG000|Overall Study|Study Terminated by Sponsor|50|||
163449988|NCT00960934|590348084|FG001|Overall Study|Study Terminated by Sponsor|46|||
163449989|NCT00960934|590348085|FG002|Overall Study|Study Terminated by Sponsor|52|||
163449990|NCT00960934|590348086|FG003|Overall Study|Study Terminated by Sponsor|50|||
163449991|NCT00960934|590348087|FG004|Overall Study|Study Terminated by Sponsor|49|||
163449992|NCT00960934|590348088|FG005|Overall Study|Study Terminated by Sponsor|49|||
163449993|NCT01332019|590348096|FG000|Overall Study|Was Not Dosed|1|||
163449994|NCT01332019|590348097|FG001|Overall Study|Was Not Dosed|0|||
163449995|NCT01332019|590348096|FG000|Overall Study|Other|16|||
163449996|NCT01332019|590348097|FG001|Overall Study|Other|18|||
163449997|NCT01332019|590348096|FG000|Overall Study|Death|2|||
163449998|NCT01332019|590348097|FG001|Overall Study|Death|1|||
163449999|NCT01332019|590348096|FG000|Overall Study|Physician Decision|4|||
163450000|NCT01332019|590348097|FG001|Overall Study|Physician Decision|3|||
163450001|NCT01332019|590348096|FG000|Overall Study|Withdrawal by Subject|73|||
163450002|NCT01332019|590348097|FG001|Overall Study|Withdrawal by Subject|71|||
163450003|NCT01332019|590348096|FG000|Overall Study|Lost to Follow-up|4|||
163450004|NCT01332019|590348097|FG001|Overall Study|Lost to Follow-up|7|||
163450005|NCT01332019|590348096|FG000|Overall Study|Adverse Event|13|||
163450006|NCT01332019|590348097|FG001|Overall Study|Adverse Event|22|||
163450007|NCT00174785|590348098|FG000|Overall Study|Adverse Event|293|||
163450008|NCT00174785|590348099|FG001|Overall Study|Adverse Event|191|||
163450009|NCT00174785|590348098|FG000|Overall Study|Protocol Violation|14|||
163450010|NCT00174785|590348099|FG001|Overall Study|Protocol Violation|14|||
163450011|NCT00174785|590348098|FG000|Overall Study|Withdrawal by Subject|173|||
163450012|NCT00174785|590348099|FG001|Overall Study|Withdrawal by Subject|175|||
163450013|NCT00174785|590348098|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
163450014|NCT00174785|590348099|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
163450015|NCT00174785|590348098|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
163450016|NCT00174785|590348099|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
163450017|NCT00174785|590348098|FG000|Overall Study|Other prohibited medication|5|||
163450018|NCT00174785|590348099|FG001|Overall Study|Other prohibited medication|3|||
163450019|NCT00174785|590348098|FG000|Overall Study|Family request|6|||
163450020|NCT00174785|590348099|FG001|Overall Study|Family request|8|||
163450021|NCT00174785|590348098|FG000|Overall Study|Not pre-specified/Not coded|56|||
163450022|NCT00174785|590348099|FG001|Overall Study|Not pre-specified/Not coded|70|||
163450023|NCT00120289|590348100|FG000|Overall Study|Death|96|||
163450024|NCT00120289|590348101|FG001|Overall Study|Death|82|||
163450025|NCT00120289|590348100|FG000|Overall Study|Lost to Follow-up|11|||
163450026|NCT00120289|590348101|FG001|Overall Study|Lost to Follow-up|14|||
163450027|NCT00120289|590348100|FG000|Overall Study|Withdrawal by Subject|14|||
163450028|NCT00120289|590348101|FG001|Overall Study|Withdrawal by Subject|13|||
163450029|NCT00782418|590348105|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
163450030|NCT00782418|590348106|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
163450031|NCT00782418|590348107|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
163450032|NCT00782418|590348108|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
163450033|NCT00782418|590348109|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
163450034|NCT00782418|590348110|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
163450035|NCT00782418|590348111|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
163450036|NCT00782418|590348105|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
163450037|NCT00782418|590348106|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
163450038|NCT00782418|590348107|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
163450039|NCT00782418|590348108|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
163450040|NCT00782418|590348109|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
163450041|NCT00782418|590348110|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
163450042|NCT00782418|590348111|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
163450043|NCT01718509|590348112|FG000|Overall Study|Lost to Follow-up|18|||
163450044|NCT01718509|590348113|FG001|Overall Study|Lost to Follow-up|15|||
163450045|NCT01718509|590348112|FG000|Overall Study|Withdrawal by Subject|7|||
163450046|NCT01718509|590348113|FG001|Overall Study|Withdrawal by Subject|13|||
163450047|NCT01718509|590348112|FG000|Overall Study|Adverse Event|5|||
163450048|NCT01718509|590348113|FG001|Overall Study|Adverse Event|7|||
163450049|NCT01718509|590348112|FG000|Overall Study|Other|13|||
163450050|NCT01718509|590348113|FG001|Overall Study|Other|11|||
163450051|NCT01718509|590348112|FG000|Overall Study|Protocol Violation|4|||
163450052|NCT01718509|590348113|FG001|Overall Study|Protocol Violation|2|||
163450053|NCT01718509|590348112|FG000|Overall Study|Lack of Efficacy|1|||
163450054|NCT01718509|590348113|FG001|Overall Study|Lack of Efficacy|0|||
163450055|NCT00238303|590348114|FG000|Overall Study|Withdrawal by Subject|11|||
163450056|NCT00238303|590348115|FG001|Overall Study|Withdrawal by Subject|1|||
163450057|NCT00238303|590348116|FG002|Overall Study|Withdrawal by Subject|2|||
163450058|NCT00238303|590348114|FG000|Overall Study|Death|1|||
163450059|NCT00238303|590348115|FG001|Overall Study|Death|0|||
163450060|NCT00238303|590348116|FG002|Overall Study|Death|1|||
163450061|NCT00238303|590348114|FG000|Overall Study|Other Medical Problems|2|||
163450062|NCT00238303|590348115|FG001|Overall Study|Other Medical Problems|0|||
163450063|NCT00238303|590348116|FG002|Overall Study|Other Medical Problems|2|||
163450064|NCT00238303|590348114|FG000|Overall Study|Poor tolerance of study treatment|1|||
163450065|NCT00238303|590348115|FG001|Overall Study|Poor tolerance of study treatment|0|||
163450066|NCT00238303|590348116|FG002|Overall Study|Poor tolerance of study treatment|1|||
163450067|NCT00238303|590348114|FG000|Overall Study|Adverse Event|0|||
163450068|NCT00238303|590348115|FG001|Overall Study|Adverse Event|1|||
163450069|NCT00238303|590348116|FG002|Overall Study|Adverse Event|3|||
163450070|NCT01860534|590348118|FG000|ROP #1|Needed treatment for ROP|0|||
163450071|NCT01860534|590348119|FG001|ROP #1|Needed treatment for ROP|1|||
163450072|NCT01860534|590348118|FG000|ROP #2|discharged prior to ROP #2|1|||
163450073|NCT01860534|590348119|FG001|ROP #2|discharged prior to ROP #2|0|||
163450074|NCT03364673|590348125|FG000|Overall Study|Withdrawal by Subject|2|||
163450075|NCT03364673|590348125|FG000|Overall Study|Injury unrelated to study|3|||
163450076|NCT00779324|590348126|FG000|Overall Study|Lost to Follow-up|2|||
163450077|NCT00779324|590348127|FG001|Overall Study|Lost to Follow-up|1|||
163450078|NCT00779324|590348126|FG000|Overall Study|Withdrawal by Subject|4|||
163450079|NCT00779324|590348127|FG001|Overall Study|Withdrawal by Subject|2|||
163450080|NCT00779324|590348126|FG000|Overall Study|Missed visit|1|||
163450081|NCT00779324|590348127|FG001|Overall Study|Missed visit|1|||
163450082|NCT02207556|590348128|FG000|Overall Study|Physician Decision|1|||
163450083|NCT02207556|590348129|FG001|Overall Study|Physician Decision|0|||
163450084|NCT02207556|590348128|FG000|Overall Study|Withdrawal by Subject|1|||
163450085|NCT02207556|590348129|FG001|Overall Study|Withdrawal by Subject|0|||
163450086|NCT02207556|590348128|FG000|Overall Study|Death|0|||
163450087|NCT02207556|590348129|FG001|Overall Study|Death|5|||
163450088|NCT03558555|590348130|FG000|Overall Study|Lost to Follow-up|2|||
163450089|NCT03558555|590348131|FG001|Overall Study|Lost to Follow-up|1|||
163450090|NCT00194025|590348132|FG000|Overall Study|Adverse Event|1|||
163450091|NCT00194025|590348132|FG000|Overall Study|non-adherence with study medication|4|||
163450092|NCT01199055|590348141|FG000|Overall Study|Death|0|||
163450093|NCT01199055|590348142|FG001|Overall Study|Death|1|||
163450094|NCT01199055|590348143|FG002|Overall Study|Death|0|||
163450095|NCT01199055|590348141|FG000|Overall Study|Physician Decision|0|||
163450096|NCT01199055|590348142|FG001|Overall Study|Physician Decision|1|||
163450097|NCT01199055|590348143|FG002|Overall Study|Physician Decision|1|||
163450098|NCT01199055|590348141|FG000|Overall Study|Progressive disease|2|||
163450099|NCT01199055|590348142|FG001|Overall Study|Progressive disease|1|||
163450100|NCT01199055|590348143|FG002|Overall Study|Progressive disease|2|||
163450101|NCT01199055|590348141|FG000|Overall Study|Withdrawal by Subject|0|||
163450102|NCT01199055|590348142|FG001|Overall Study|Withdrawal by Subject|0|||
163450103|NCT01199055|590348143|FG002|Overall Study|Withdrawal by Subject|1|||
163450104|NCT00511342|590348144|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
163450105|NCT00511342|590348145|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
163450106|NCT00511342|590348144|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
163450107|NCT00511342|590348145|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
163450108|NCT00511342|590348144|FG000|Overall Study|Pregnancy|0|||
163450109|NCT00511342|590348145|FG001|Overall Study|Pregnancy|1|||
163450110|NCT00511342|590348144|FG000|Overall Study|Pregnancy wish|0|||
163450111|NCT00511342|590348145|FG001|Overall Study|Pregnancy wish|1|||
163450112|NCT00511342|590348144|FG000|Overall Study|Lost to Follow-up|1|||
163450113|NCT00511342|590348145|FG001|Overall Study|Lost to Follow-up|5|||
163450114|NCT00511342|590348144|FG000|Overall Study|Other Reason|2|||
163450115|NCT00511342|590348145|FG001|Overall Study|Other Reason|2|||
163450116|NCT02432040|590348146|FG000|Overall Study|Lack of Efficacy|3|||
163450117|NCT02432040|590348147|FG001|Overall Study|Lack of Efficacy|0|||
163450118|NCT02432040|590348146|FG000|Overall Study|Lost to Follow-up|4|||
163450119|NCT02432040|590348147|FG001|Overall Study|Lost to Follow-up|5|||
163450120|NCT02432040|590348146|FG000|Overall Study|Physician Decision|1|||
163450121|NCT02432040|590348147|FG001|Overall Study|Physician Decision|1|||
163450122|NCT00718666|590348148|FG000|Booster Phase Year 5|No active participation request|0|||
163450123|NCT00718666|590348149|FG001|Booster Phase Year 5|No active participation request|0|||
163450124|NCT00718666|590348150|FG002|Booster Phase Year 5|No active participation request|1|||
163450125|NCT00718666|590348148|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
163450126|NCT00718666|590348149|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
163450127|NCT00718666|590348150|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
163450128|NCT00718666|590348148|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
163450129|NCT00718666|590348149|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
163450130|NCT00718666|590348150|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
163450131|NCT00718666|590348148|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
163450132|NCT00718666|590348149|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
163450133|NCT00718666|590348150|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
163450134|NCT02196038|590348151|FG000|Overall Study|Death|16|||
163450135|NCT02196038|590348152|FG001|Overall Study|Death|21|||
163450136|NCT02196038|590348151|FG000|Overall Study|Withdrawal by Subject|0|||
163450137|NCT02196038|590348152|FG001|Overall Study|Withdrawal by Subject|1|||
163450138|NCT02196038|590348151|FG000|Overall Study|Lost to Follow-up|1|||
163450139|NCT02196038|590348152|FG001|Overall Study|Lost to Follow-up|0|||
163450140|NCT01766336|590348162|FG000|Overall Study|Adverse Event|11|||
163450141|NCT01766336|590348163|FG001|Overall Study|Adverse Event|8|||
163450142|NCT01766336|590348162|FG000|Overall Study|Death|4|||
163450143|NCT01766336|590348163|FG001|Overall Study|Death|3|||
163450144|NCT01766336|590348162|FG000|Overall Study|Lost to Follow-up|1|||
163450145|NCT01766336|590348163|FG001|Overall Study|Lost to Follow-up|3|||
163450146|NCT01766336|590348162|FG000|Overall Study|Physician Decision|4|||
163450147|NCT01766336|590348163|FG001|Overall Study|Physician Decision|2|||
163450148|NCT01766336|590348162|FG000|Overall Study|Protocol Violation|0|||
163450149|NCT01766336|590348163|FG001|Overall Study|Protocol Violation|1|||
163450150|NCT01766336|590348162|FG000|Overall Study|Sponsor Decision|52|||
163450151|NCT01766336|590348163|FG001|Overall Study|Sponsor Decision|43|||
163450152|NCT01766336|590348162|FG000|Overall Study|Withdrawal by Subject|18|||
163450153|NCT01766336|590348163|FG001|Overall Study|Withdrawal by Subject|15|||
163450154|NCT03029650|590348164|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
163450155|NCT03029650|590348165|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
163450156|NCT03029650|590348164|FG000|Washout (1 Week)|Physician Decision|0|||
163450157|NCT03029650|590348165|FG001|Washout (1 Week)|Physician Decision|1|||
163450158|NCT01814800|590348168|FG000|Overall Study|Adverse Event|2|||
163450159|NCT01814800|590348168|FG000|Overall Study|Pregnancy|1|||
163450160|NCT01814800|590348168|FG000|Overall Study|Sponsor decision|1|||
163450161|NCT01814800|590348168|FG000|Overall Study|Subject relocation|1|||
163450162|NCT02402218|590348169|FG000|Overall Study|Did not pickup study medication|12|||
163450163|NCT02402218|590348170|FG001|Overall Study|Did not pickup study medication|9|||
163450164|NCT02402218|590348171|FG002|Overall Study|Did not pickup study medication|13|||
163450165|NCT02402218|590348169|FG000|Overall Study|Lack of Efficacy|0|||
163450166|NCT02402218|590348170|FG001|Overall Study|Lack of Efficacy|1|||
163450167|NCT02402218|590348171|FG002|Overall Study|Lack of Efficacy|1|||
163450168|NCT02402218|590348169|FG000|Overall Study|Death|1|||
163450169|NCT02402218|590348170|FG001|Overall Study|Death|0|||
163450170|NCT02402218|590348171|FG002|Overall Study|Death|0|||
163450171|NCT02402218|590348169|FG000|Overall Study|Reinfection|0|||
163450172|NCT02402218|590348170|FG001|Overall Study|Reinfection|0|||
163450173|NCT02402218|590348171|FG002|Overall Study|Reinfection|1|||
163450174|NCT02402218|590348169|FG000|Overall Study|Adverse Event|0|||
163450175|NCT02402218|590348170|FG001|Overall Study|Adverse Event|2|||
163450176|NCT02402218|590348171|FG002|Overall Study|Adverse Event|1|||
163450177|NCT02402218|590348169|FG000|Overall Study|Withdrawal by Subject|1|||
163450178|NCT02402218|590348170|FG001|Overall Study|Withdrawal by Subject|1|||
163450179|NCT02402218|590348171|FG002|Overall Study|Withdrawal by Subject|1|||
163450180|NCT03827473|590348172|FG000|Overall Study|Withdrawal by Subject|1|||
163450181|NCT03827473|590348173|FG001|Overall Study|Withdrawal by Subject|0|||
163450182|NCT04436822|590348174|FG000|Overall Study|Physician Decision|2|||
163450183|NCT04436822|590348175|FG001|Overall Study|Physician Decision|0|||
163450184|NCT04436822|590348174|FG000|Overall Study|Sponsor request|1|||
163450185|NCT04436822|590348175|FG001|Overall Study|Sponsor request|0|||
163450186|NCT04436822|590348174|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163450187|NCT04436822|590348175|FG001|Overall Study|Withdrawal by parent/guardian|3|||
163450188|NCT04436822|590348174|FG000|Overall Study|Unsuccessful procedure|0|||
163450189|NCT04436822|590348175|FG001|Overall Study|Unsuccessful procedure|1|||
163450190|NCT04436822|590348174|FG000|Overall Study|Withdrawal due to Covid-19|8|||
163450191|NCT04436822|590348175|FG001|Overall Study|Withdrawal due to Covid-19|1|||
163450192|NCT04436822|590348174|FG000|Overall Study|Withdrawal by Subject|1|||
163450193|NCT04436822|590348175|FG001|Overall Study|Withdrawal by Subject|0|||
163450194|NCT04436822|590348174|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
163450195|NCT04436822|590348175|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
163450196|NCT03807739|590348176|FG000|Overall Study|Adverse Event|1|||
163450197|NCT03807739|590348177|FG001|Overall Study|Adverse Event|0|||
163450198|NCT03807739|590348178|FG002|Overall Study|Adverse Event|0|||
163450199|NCT03807739|590348179|FG003|Overall Study|Adverse Event|0|||
163450200|NCT03807739|590348176|FG000|Overall Study|Withdrawal by Subject|1|||
163450201|NCT03807739|590348177|FG001|Overall Study|Withdrawal by Subject|0|||
163450202|NCT03807739|590348178|FG002|Overall Study|Withdrawal by Subject|0|||
163450203|NCT03807739|590348179|FG003|Overall Study|Withdrawal by Subject|0|||
163450204|NCT00488033|590348189|FG000|Overall Study|Withdrawal by Subject|1|||
163450205|NCT00488033|590348190|FG001|Overall Study|Withdrawal by Subject|0|||
163450206|NCT00369668|590348191|FG000|Overall Study|Lack of Efficacy|4|||
163450207|NCT00369668|590348192|FG001|Overall Study|Lack of Efficacy|5|||
163450208|NCT00369668|590348193|FG002|Overall Study|Lack of Efficacy|7|||
163450209|NCT00303108|590348196|FG000|Overall Study|Adverse Event|5|||
163450210|NCT00303108|590348197|FG001|Overall Study|Adverse Event|6|||
163450211|NCT00303108|590348198|FG002|Overall Study|Adverse Event|7|||
163450212|NCT00303108|590348196|FG000|Overall Study|Patient Request|4|||
163450213|NCT00303108|590348197|FG001|Overall Study|Patient Request|2|||
163450214|NCT00303108|590348198|FG002|Overall Study|Patient Request|8|||
163450215|NCT00303108|590348196|FG000|Overall Study|Failed Entry|1|||
163450216|NCT00303108|590348197|FG001|Overall Study|Failed Entry|0|||
163450217|NCT00303108|590348198|FG002|Overall Study|Failed Entry|1|||
163450218|NCT00303108|590348196|FG000|Overall Study|ineligible|2|||
163450219|NCT00303108|590348197|FG001|Overall Study|ineligible|1|||
163450220|NCT00303108|590348198|FG002|Overall Study|ineligible|0|||
163450221|NCT03855137|590348199|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
163450222|NCT03855137|590348200|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
163450223|NCT03855137|590348201|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
163450224|NCT03855137|590348199|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
163450225|NCT03855137|590348200|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
163450226|NCT03855137|590348201|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
163450227|NCT03855137|590348199|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
163450228|NCT03855137|590348200|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
163450229|NCT03855137|590348201|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
163450230|NCT03855137|590348199|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
163450231|NCT03855137|590348200|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
163450232|NCT03855137|590348201|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
163450233|NCT03855137|590348199|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
163450234|NCT03855137|590348200|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
163450235|NCT03855137|590348201|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
163450236|NCT03855137|590348199|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
163450237|NCT03855137|590348200|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
163450238|NCT03855137|590348201|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
163450239|NCT03855137|590348199|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
163450240|NCT03855137|590348200|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
163450241|NCT03855137|590348201|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
163450242|NCT03855137|590348199|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
163450243|NCT03855137|590348200|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
163450244|NCT03855137|590348201|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
163450245|NCT03855137|590348199|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
163450246|NCT03855137|590348200|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
163450247|NCT03855137|590348201|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
163450248|NCT03855137|590348199|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
163450249|NCT03855137|590348200|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
163450250|NCT03855137|590348201|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
163450251|NCT02427477|590348202|FG000|Period 1|Adverse Event|1|||
163450252|NCT02427477|590348203|FG001|Period 1|Adverse Event|0|||
163450253|NCT02435277|590348204|FG000|Overall Study|Adverse Event|1|||
163450254|NCT02435277|590348205|FG001|Overall Study|Adverse Event|1|||
163450255|NCT02435277|590348206|FG002|Overall Study|Adverse Event|0|||
163450256|NCT02435277|590348207|FG003|Overall Study|Adverse Event|0|||
163450257|NCT02435277|590348204|FG000|Overall Study|Withdrawal by Subject|1|||
163450258|NCT02435277|590348205|FG001|Overall Study|Withdrawal by Subject|0|||
163450259|NCT02435277|590348206|FG002|Overall Study|Withdrawal by Subject|0|||
163450260|NCT02435277|590348207|FG003|Overall Study|Withdrawal by Subject|0|||
163450261|NCT00444626|590348210|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
163450262|NCT00444626|590348210|FG000|Initial Treatment Period|Adverse Event|1|||
163450263|NCT00444626|590348210|FG000|Initial Treatment Period|Lost to Follow-up|9|||
163450264|NCT00008138|590348211|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
163450265|NCT00008138|590348211|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
163450266|NCT00008138|590348211|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
163450267|NCT00008138|590348211|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
163450268|NCT00008138|590348211|FG000|Interval Debulking|Withdrawal by Subject|2|||
163450269|NCT00008138|590348211|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
163450270|NCT00008138|590348211|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
163450271|NCT00008138|590348211|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
163450272|NCT03213626|590348212|FG000|Overall Study|Adverse Event|1|||
163450273|NCT03213626|590348212|FG000|Overall Study|Progressive Disease|6|||
163450274|NCT01005732|590348213|FG000|Overall Study|Lost to Follow-up|10|||
163450275|NCT01005732|590348213|FG000|Overall Study|Death|1|||
163450276|NCT00406640|590348224|FG000|Acute Phase|Adverse Event|18|||
163450277|NCT00406640|590348225|FG001|Acute Phase|Adverse Event|13|||
163450278|NCT00406640|590348224|FG000|Acute Phase|Failed to Return|5|||
163450279|NCT00406640|590348225|FG001|Acute Phase|Failed to Return|1|||
163450280|NCT00406640|590348224|FG000|Acute Phase|Physician Decision|0|||
163450281|NCT00406640|590348225|FG001|Acute Phase|Physician Decision|1|||
163450282|NCT00406640|590348224|FG000|Acute Phase|Lost to Follow-up|7|||
163450283|NCT00406640|590348225|FG001|Acute Phase|Lost to Follow-up|4|||
163450284|NCT00406640|590348224|FG000|Acute Phase|Protocol deviation|4|||
163450285|NCT00406640|590348225|FG001|Acute Phase|Protocol deviation|10|||
163450286|NCT00406640|590348224|FG000|Acute Phase|Protocol Violation|3|||
163450287|NCT00406640|590348225|FG001|Acute Phase|Protocol Violation|2|||
163450288|NCT00406640|590348224|FG000|Acute Phase|Withdrawal by Subject|11|||
163450289|NCT00406640|590348225|FG001|Acute Phase|Withdrawal by Subject|9|||
163450290|NCT00406640|590348224|FG000|Acute Phase|Lack of Efficacy|3|||
163450291|NCT00406640|590348225|FG001|Acute Phase|Lack of Efficacy|3|||
163450292|NCT00406640|590348224|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
163450293|NCT00406640|590348225|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
163450294|NCT00406640|590348224|FG000|DB Continuation Phase for Responders|Death|1|||
163450295|NCT00406640|590348225|FG001|DB Continuation Phase for Responders|Death|0|||
163450296|NCT00406640|590348224|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
163450297|NCT00406640|590348225|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
163450298|NCT00406640|590348224|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
163450299|NCT00406640|590348225|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
163450300|NCT00406640|590348224|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
163450301|NCT00406640|590348225|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
163450302|NCT00406640|590348224|FG000|DB Continuation Phase for Responders|non-compliance|7|||
163450303|NCT00406640|590348225|FG001|DB Continuation Phase for Responders|non-compliance|5|||
163450304|NCT00406640|590348224|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
163450305|NCT00406640|590348225|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
163450306|NCT00406640|590348224|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
163450307|NCT00406640|590348225|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
163450308|NCT00406640|590348224|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
163450309|NCT00406640|590348225|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
163450310|NCT00406640|590348224|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
163450311|NCT00406640|590348225|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
163450312|NCT00406640|590348224|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
163450313|NCT00406640|590348225|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
163450314|NCT00406640|590348224|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
163450315|NCT00406640|590348225|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
163450316|NCT00406640|590348224|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
163450317|NCT00406640|590348225|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
163450318|NCT00406640|590348224|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
163450319|NCT00406640|590348225|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
163450320|NCT00406640|590348224|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
163450321|NCT00406640|590348225|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
163450322|NCT00406640|590348224|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
163450323|NCT00406640|590348225|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
163450324|NCT02198651|590350145|FG000|Lead-in Period|Withdrew consent|13|||
163450325|NCT02198651|590350146|FG001|Lead-in Period|Withdrew consent|0|||
163450326|NCT02198651|590350147|FG002|Lead-in Period|Withdrew consent|0|||
163450327|NCT02198651|590350148|FG003|Lead-in Period|Withdrew consent|0|||
163450328|NCT02198651|590350149|FG004|Lead-in Period|Withdrew consent|0|||
163450329|NCT02198651|590350145|FG000|Lead-in Period|Adverse Event|2|||
163450330|NCT02198651|590350146|FG001|Lead-in Period|Adverse Event|0|||
163450331|NCT02198651|590350147|FG002|Lead-in Period|Adverse Event|0|||
163450332|NCT02198651|590350148|FG003|Lead-in Period|Adverse Event|0|||
163450333|NCT02198651|590350149|FG004|Lead-in Period|Adverse Event|0|||
163450334|NCT02198651|590350145|FG000|Lead-in Period|Other, not specified|22|||
163450335|NCT02198651|590350146|FG001|Lead-in Period|Other, not specified|0|||
163450336|NCT02198651|590350147|FG002|Lead-in Period|Other, not specified|0|||
163450337|NCT02198651|590350148|FG003|Lead-in Period|Other, not specified|0|||
163450338|NCT02198651|590350149|FG004|Lead-in Period|Other, not specified|0|||
163450339|NCT02198651|590350145|FG000|Double-blind Period|Withdrew consent|0|||
163450340|NCT02198651|590350146|FG001|Double-blind Period|Withdrew consent|4|||
163450341|NCT02198651|590350147|FG002|Double-blind Period|Withdrew consent|0|||
163450342|NCT02198651|590350148|FG003|Double-blind Period|Withdrew consent|0|||
163450343|NCT02198651|590350149|FG004|Double-blind Period|Withdrew consent|0|||
163450344|NCT02198651|590350145|FG000|Double-blind Period|Adverse Event|0|||
163450345|NCT02198651|590350146|FG001|Double-blind Period|Adverse Event|1|||
163450346|NCT02198651|590350147|FG002|Double-blind Period|Adverse Event|0|||
163450347|NCT02198651|590350148|FG003|Double-blind Period|Adverse Event|0|||
163450348|NCT02198651|590350149|FG004|Double-blind Period|Adverse Event|0|||
163450349|NCT02198651|590350145|FG000|Double-blind Period|Other, not specified|0|||
163450350|NCT02198651|590350146|FG001|Double-blind Period|Other, not specified|4|||
163450351|NCT02198651|590350147|FG002|Double-blind Period|Other, not specified|1|||
163450352|NCT02198651|590350148|FG003|Double-blind Period|Other, not specified|0|||
163450353|NCT02198651|590350149|FG004|Double-blind Period|Other, not specified|0|||
163450354|NCT02198651|590350145|FG000|Open-label Rescue Period|Withdrew consent|0|||
163450355|NCT02198651|590350146|FG001|Open-label Rescue Period|Withdrew consent|0|||
163450356|NCT02198651|590350147|FG002|Open-label Rescue Period|Withdrew consent|0|||
163450357|NCT02198651|590350148|FG003|Open-label Rescue Period|Withdrew consent|2|||
163450358|NCT02198651|590350149|FG004|Open-label Rescue Period|Withdrew consent|0|||
163450359|NCT02198651|590350145|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
163450360|NCT02198651|590350146|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
163450361|NCT02198651|590350147|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
163450362|NCT02198651|590350148|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
163450363|NCT02198651|590350149|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
163450364|NCT00786032|590350154|FG000|Overall Study|Death|4|||
163450365|NCT00786032|590350154|FG000|Overall Study|Withdrawal by Subject|14|||
163450366|NCT00786032|590350154|FG000|Overall Study|Did not complete in the timeframe|6|||
163450367|NCT02922634|590350155|FG000|Overall Study|Withdrawal by Subject|5|||
163450368|NCT02922634|590350155|FG000|Overall Study|Did not have their surgery|5|||
163450369|NCT02625324|590350156|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
163450370|NCT02625324|590350156|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
163450371|NCT02625324|590350156|FG000|6-Month Follow-up Subject Accountability|Death|5|||
163450372|NCT02625324|590350156|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
163450373|NCT02625324|590350156|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
163450374|NCT02625324|590350156|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
163450375|NCT02625324|590350156|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
163450376|NCT02625324|590350156|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
163450377|NCT02625324|590350156|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
163450378|NCT02625324|590350156|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
163450379|NCT02625324|590350156|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
163450380|NCT02625324|590350156|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
163450381|NCT02625324|590350156|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
163450382|NCT02625324|590350156|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
163450383|NCT02625324|590350156|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
163450384|NCT02625324|590350156|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
163450385|NCT02625324|590350156|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
163450386|NCT02457182|590350157|FG000|Overall Study|Lost to Follow-up|1|||
163450387|NCT02457182|590350158|FG001|Overall Study|Lost to Follow-up|0|||
163450388|NCT00352755|590350161|FG000|Overall Study|Physician Decision|1|||
163450389|NCT00352755|590350161|FG000|Overall Study|Adverse Event|1|||
163450390|NCT02397694|590350164|FG000|Double-Blinded Phase|Adverse Event|1|||
163450391|NCT02397694|590350165|FG001|Double-Blinded Phase|Adverse Event|0|||
163450392|NCT02397694|590350164|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
163450393|NCT02397694|590350165|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
163450394|NCT02397694|590350164|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
163450395|NCT02397694|590350165|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
163450396|NCT02397694|590350164|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
163450397|NCT02397694|590350165|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
163450398|NCT02397694|590350164|FG000|Open Label Extension Phase|Protocol Violation|1|||
163450399|NCT02397694|590350165|FG001|Open Label Extension Phase|Protocol Violation|0|||
163450400|NCT02397694|590350164|FG000|Open Label Extension Phase|Withdrew Consent|3|||
163450401|NCT02397694|590350165|FG001|Open Label Extension Phase|Withdrew Consent|1|||
163450402|NCT02397694|590350164|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
163450403|NCT02397694|590350165|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
163450404|NCT00424528|590350166|FG000|Overall Study|Adverse Event|2|||
163450405|NCT00424528|590350167|FG001|Overall Study|Adverse Event|1|||
163450406|NCT00424528|590350168|FG002|Overall Study|Adverse Event|2|||
163450407|NCT00424528|590350166|FG000|Overall Study|Protocol Violation|1|||
163450408|NCT00424528|590350167|FG001|Overall Study|Protocol Violation|1|||
163450409|NCT00424528|590350168|FG002|Overall Study|Protocol Violation|0|||
163450410|NCT00424528|590350166|FG000|Overall Study|Lost to Follow-up|0|||
163450411|NCT00424528|590350167|FG001|Overall Study|Lost to Follow-up|1|||
163450412|NCT00424528|590350168|FG002|Overall Study|Lost to Follow-up|0|||
163450413|NCT00424528|590350166|FG000|Overall Study|noncompliance with study requirements|2|||
163450414|NCT00424528|590350167|FG001|Overall Study|noncompliance with study requirements|1|||
163450415|NCT00424528|590350168|FG002|Overall Study|noncompliance with study requirements|2|||
163450416|NCT02115113|590350169|FG000|Participants in Run-in Period|Death|0|||
163450417|NCT02115113|590350170|FG001|Participants in Run-in Period|Death|0|||
163450418|NCT02115113|590350171|FG002|Participants in Run-in Period|Death|1|||
163450419|NCT02115113|590350169|FG000|Participants in Run-in Period|Administrative problems|0|||
163450420|NCT02115113|590350170|FG001|Participants in Run-in Period|Administrative problems|0|||
163450421|NCT02115113|590350171|FG002|Participants in Run-in Period|Administrative problems|1|||
163450422|NCT02115113|590350169|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
163450423|NCT02115113|590350170|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
163450424|NCT02115113|590350171|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
163450425|NCT02115113|590350169|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
163450426|NCT02115113|590350170|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
163450427|NCT02115113|590350171|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
163450428|NCT02115113|590350169|FG000|Participants Randomized|Lost to Follow-up|1|||
163450429|NCT02115113|590350170|FG001|Participants Randomized|Lost to Follow-up|0|||
163450430|NCT02115113|590350171|FG002|Participants Randomized|Lost to Follow-up|0|||
163450431|NCT02115113|590350169|FG000|Participants Randomized|Death|1|||
163450432|NCT02115113|590350170|FG001|Participants Randomized|Death|0|||
163450433|NCT02115113|590350171|FG002|Participants Randomized|Death|0|||
163450434|NCT00789191|590350175|FG000|Overall Study|Adverse Event|2|||
163450435|NCT00789191|590350176|FG001|Overall Study|Adverse Event|4|||
163450436|NCT00789191|590350175|FG000|Overall Study|Lack of Efficacy|0|||
163450437|NCT00789191|590350176|FG001|Overall Study|Lack of Efficacy|5|||
163450438|NCT00789191|590350175|FG000|Overall Study|Protocol Violation|5|||
163450439|NCT00789191|590350176|FG001|Overall Study|Protocol Violation|3|||
163450440|NCT00789191|590350175|FG000|Overall Study|Withdrawal Criteria|2|||
163450441|NCT00789191|590350176|FG001|Overall Study|Withdrawal Criteria|4|||
163450442|NCT00789191|590350175|FG000|Overall Study|Unclassified|5|||
163450443|NCT00789191|590350176|FG001|Overall Study|Unclassified|3|||
163450444|NCT01009983|590350177|FG000|Overall Study|necessary scans not completed|1|||
163450445|NCT03137121|590350185|FG000|Overall Study|Withdrawal by Subject|0|||
163450446|NCT03137121|590350186|FG001|Overall Study|Withdrawal by Subject|1|||
163450447|NCT04410198|590350187|FG000|Overall Study|Death|10|||
163450448|NCT04410198|590350187|FG000|Overall Study|Withdrawal by Subject|7|||
163450449|NCT04410198|590350187|FG000|Overall Study|Transferred/Relocation|4|||
163450450|NCT04410198|590350187|FG000|Overall Study|Kidney Transplant|9|||
163450451|NCT04410198|590350187|FG000|Overall Study|Adverse Event|4|||
163450452|NCT04410198|590350187|FG000|Overall Study|Physician Decision|2|||
163450453|NCT04410198|590350187|FG000|Overall Study|Other than specified|1|||
163450454|NCT02871401|590350188|FG000|Overall Study|Adverse Event|1|||
163450455|NCT02871401|590350189|FG001|Overall Study|Adverse Event|0|||
163450456|NCT02282982|590350190|FG000|Overall Study|Lost to Follow-up|15|||
163450457|NCT02282982|590350190|FG000|Overall Study|Withdrew consent|2|||
163450458|NCT02282982|590350190|FG000|Overall Study|Death|4|||
163450459|NCT02282982|590350190|FG000|Overall Study|Lack of product|156|||
163450460|NCT02282982|590350190|FG000|Overall Study|Palivizumab is ended|11|||
163450461|NCT02282982|590350190|FG000|Overall Study|Other, not specified|18|||
163450462|NCT02006667|590350191|FG000|Overall Study|Adverse Event|3|||
163450463|NCT02006667|590350191|FG000|Overall Study|Death|2|||
163450464|NCT02006667|590350191|FG000|Overall Study|Withdrawal by Subject|1|||
163450465|NCT02939937|590350192|FG000|Overall Study|Adverse Event|5|||
163450466|NCT02939937|590350193|FG001|Overall Study|Adverse Event|0|||
163450467|NCT02939937|590350192|FG000|Overall Study|Lost to Follow-up|1|||
163450468|NCT02939937|590350193|FG001|Overall Study|Lost to Follow-up|3|||
163450469|NCT00568958|590350195|FG000|Allocation|Withdrawal by Subject|7|||
163450470|NCT00568958|590350196|FG001|Allocation|Withdrawal by Subject|3|||
163450471|NCT00568958|590350195|FG000|Allocation|Physician Decision|2|||
163450472|NCT00568958|590350196|FG001|Allocation|Physician Decision|0|||
163450473|NCT00568958|590350195|FG000|Follow-Up|Withdrawal by Subject|6|||
163450474|NCT00568958|590350196|FG001|Follow-Up|Withdrawal by Subject|6|||
163450475|NCT00568958|590350195|FG000|Follow-Up|Physician Decision|1|||
163450476|NCT00568958|590350196|FG001|Follow-Up|Physician Decision|1|||
163450477|NCT00568958|590350195|FG000|Follow-Up|Family Emergency|1|||
163450478|NCT00568958|590350196|FG001|Follow-Up|Family Emergency|0|||
163450479|NCT00568958|590350195|FG000|Follow-Up|Adverse Event|1|||
163450480|NCT00568958|590350196|FG001|Follow-Up|Adverse Event|0|||
163450481|NCT02179515|590350210|FG000|Overall Study|switched to alternative treatment|0|||
163450482|NCT02179515|590350211|FG001|Overall Study|switched to alternative treatment|1|||
163450483|NCT02179515|590350212|FG002|Overall Study|switched to alternative treatment|1|||
163450484|NCT02179515|590350210|FG000|Overall Study|Death|0|||
163450485|NCT02179515|590350211|FG001|Overall Study|Death|1|||
163450486|NCT02179515|590350212|FG002|Overall Study|Death|1|||
163450487|NCT02179515|590350210|FG000|Overall Study|refused further treatment|0|||
163450488|NCT02179515|590350211|FG001|Overall Study|refused further treatment|3|||
163450489|NCT02179515|590350212|FG002|Overall Study|refused further treatment|4|||
163450490|NCT02179515|590350210|FG000|Overall Study|Disease progression on study|2|||
163450491|NCT02179515|590350211|FG001|Overall Study|Disease progression on study|11|||
163450492|NCT02179515|590350212|FG002|Overall Study|Disease progression on study|8|||
163450493|NCT01911845|590350214|FG000|Overall Study|Adverse Event|2|||
163450494|NCT01911845|590350214|FG000|Overall Study|Lost to Follow-up|1|||
163450495|NCT01911845|590350214|FG000|Overall Study|Other (not specified)|3|||
163450496|NCT01774344|590350215|FG000|Overall Study|Withdrawal by Subject|3|||
163450497|NCT01774344|590350216|FG001|Overall Study|Withdrawal by Subject|10|||
163450498|NCT01774344|590350215|FG000|Overall Study|Protocol Violation|0|||
163450499|NCT01774344|590350216|FG001|Overall Study|Protocol Violation|1|||
163450500|NCT01774344|590350215|FG000|Overall Study|Lost to Follow-up|4|||
163450501|NCT01774344|590350216|FG001|Overall Study|Lost to Follow-up|10|||
163450502|NCT01774344|590350215|FG000|Overall Study|End of survival follow-up not available|2|||
163450503|NCT01774344|590350216|FG001|Overall Study|End of survival follow-up not available|2|||
163450504|NCT01774344|590350215|FG000|Overall Study|Data collection finished|4|||
163450505|NCT01774344|590350216|FG001|Overall Study|Data collection finished|14|||
163450506|NCT01774344|590350215|FG000|Overall Study|Other|0|||
163450507|NCT01774344|590350216|FG001|Overall Study|Other|1|||
163450508|NCT01774344|590350215|FG000|Overall Study|Did not enter Survival Follow up|49|||
163450509|NCT01774344|590350216|FG001|Overall Study|Did not enter Survival Follow up|83|||
163450510|NCT04507867|590350222|FG000|Overall Study|Death|7|||
163450511|NCT04507867|590350223|FG001|Overall Study|Death|1|||
163450512|NCT00502320|590350226|FG000|Overall Study|Lost to Follow-up|1|||
163450513|NCT00502320|590350227|FG001|Overall Study|Lost to Follow-up|1|||
163450514|NCT00502320|590350226|FG000|Overall Study|Withdrew Consent|1|||
163450515|NCT00502320|590350227|FG001|Overall Study|Withdrew Consent|0|||
163450516|NCT00502320|590350226|FG000|Overall Study|No longer met criteria|1|||
163450517|NCT00502320|590350227|FG001|Overall Study|No longer met criteria|0|||
163450518|NCT00502320|590350226|FG000|Overall Study|Screen Failure|0|||
163450519|NCT00502320|590350227|FG001|Overall Study|Screen Failure|1|||
163450520|NCT00502320|590350226|FG000|Overall Study|Adverse Event|3|||
163450521|NCT00502320|590350227|FG001|Overall Study|Adverse Event|5|||
163450522|NCT00543569|590350231|FG000|Overall Study|Death|2|||
163450523|NCT00543569|590350232|FG001|Overall Study|Death|2|||
163450524|NCT00543569|590350233|FG002|Overall Study|Death|3|||
163450525|NCT00543569|590350234|FG003|Overall Study|Death|1|||
163450526|NCT00543569|590350231|FG000|Overall Study|Lost to Follow-up|0|||
163450527|NCT00543569|590350232|FG001|Overall Study|Lost to Follow-up|0|||
163450528|NCT00543569|590350233|FG002|Overall Study|Lost to Follow-up|1|||
163450529|NCT00543569|590350234|FG003|Overall Study|Lost to Follow-up|1|||
163450530|NCT00543569|590350231|FG000|Overall Study|Miscellaneous Reasons|7|||
163450531|NCT00543569|590350232|FG001|Overall Study|Miscellaneous Reasons|3|||
163450532|NCT00543569|590350233|FG002|Overall Study|Miscellaneous Reasons|11|||
163450533|NCT00543569|590350234|FG003|Overall Study|Miscellaneous Reasons|4|||
163450534|NCT00543569|590350231|FG000|Overall Study|Randomized but never received study drug|3|||
163450535|NCT00543569|590350232|FG001|Overall Study|Randomized but never received study drug|3|||
163450536|NCT00543569|590350233|FG002|Overall Study|Randomized but never received study drug|5|||
163450537|NCT00543569|590350234|FG003|Overall Study|Randomized but never received study drug|3|||
163450538|NCT00862849|590350236|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
163450539|NCT00862849|590350237|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
163450540|NCT00862849|590350238|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
163450541|NCT00862849|590350239|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
163450542|NCT00862849|590350240|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
163450543|NCT00862849|590350241|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
163450544|NCT00862849|590350236|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
163450545|NCT00862849|590350237|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
163450546|NCT00862849|590350238|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
163450547|NCT00862849|590350239|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
163450548|NCT00862849|590350240|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
163450549|NCT00862849|590350241|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
163450550|NCT00617409|590350242|FG000|Overall Study|Withdrawal by Subject|4|||
163450551|NCT00617409|590350243|FG001|Overall Study|Withdrawal by Subject|1|||
163450552|NCT00617409|590350244|FG002|Overall Study|Withdrawal by Subject|2|||
163450553|NCT00617409|590350242|FG000|Overall Study|Adverse Event|0|||
163450554|NCT00617409|590350243|FG001|Overall Study|Adverse Event|2|||
163450555|NCT00617409|590350244|FG002|Overall Study|Adverse Event|3|||
163450556|NCT00617409|590350242|FG000|Overall Study|Disease Progression|8|||
163450557|NCT00617409|590350243|FG001|Overall Study|Disease Progression|8|||
163450558|NCT00617409|590350244|FG002|Overall Study|Disease Progression|18|||
163450559|NCT00617409|590350242|FG000|Overall Study|Death|3|||
163450560|NCT00617409|590350243|FG001|Overall Study|Death|5|||
163450561|NCT00617409|590350244|FG002|Overall Study|Death|4|||
163450562|NCT00617409|590350242|FG000|Overall Study|Alternative Therapy|1|||
163450563|NCT00617409|590350243|FG001|Overall Study|Alternative Therapy|2|||
163450564|NCT00617409|590350244|FG002|Overall Study|Alternative Therapy|0|||
163450565|NCT02124707|590350253|FG000|Overall Study|Adverse Event|5|||
163450566|NCT02124707|590350253|FG000|Overall Study|Physician Decision|1|||
163450567|NCT02124707|590350253|FG000|Overall Study|Death|1|||
163450568|NCT01363713|590350256|FG000|Overall Study|Adverse Event|1|||
163450569|NCT01363713|590350256|FG000|Overall Study|Protocol Violation|3|||
163450570|NCT01363713|590350256|FG000|Overall Study|Withdrawal by Subject|2|||
163450571|NCT04544709|590350260|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
163450572|NCT03135028|590350261|FG000|Overall Study|Death|6|||
163450573|NCT03135028|590350261|FG000|Overall Study|Study Terminated by Sponsor|2|||
163450574|NCT03135028|590350261|FG000|Overall Study|Withdrew Consent|1|||
163450575|NCT00496873|590350262|FG000|Overall Study|Ineligible|2|||
163450576|NCT00496873|590350262|FG000|Overall Study|Death|2|||
163450577|NCT00496873|590350262|FG000|Overall Study|Withdrawal by Subject|3|||
163450578|NCT02065869|590350263|FG000|Overall Study|Death|7|||
163450579|NCT02065869|590350263|FG000|Overall Study|Disease relapse|16|||
163450580|NCT02065869|590350263|FG000|Overall Study|Lost to Follow-up|4|||
163450581|NCT02065869|590350263|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
163450582|NCT02065869|590350263|FG000|Overall Study|Withdrawal by Subject|1|||
163450583|NCT01842620|590350264|FG000|Period 1|Withdrawal by Subject|1|||
163450584|NCT01842620|590350265|FG001|Period 1|Withdrawal by Subject|0|||
163450585|NCT02371759|590350266|FG000|Overall Study|Protocol Violation|3|||
163450586|NCT02371759|590350267|FG001|Overall Study|Protocol Violation|1|||
163450587|NCT02371759|590350268|FG002|Overall Study|Protocol Violation|1|||
163450588|NCT02371759|590350269|FG003|Overall Study|Protocol Violation|0|||
163450589|NCT02371759|590350270|FG004|Overall Study|Protocol Violation|3|||
163450590|NCT02371759|590350271|FG005|Overall Study|Protocol Violation|1|||
163450591|NCT02371759|590350272|FG006|Overall Study|Protocol Violation|0|||
163450592|NCT02371759|590350273|FG007|Overall Study|Protocol Violation|3|||
163450593|NCT02371759|590350266|FG000|Overall Study|Withdrawal by Subject|0|||
163450594|NCT02371759|590350267|FG001|Overall Study|Withdrawal by Subject|0|||
163450595|NCT02371759|590350268|FG002|Overall Study|Withdrawal by Subject|0|||
163450596|NCT02371759|590350269|FG003|Overall Study|Withdrawal by Subject|0|||
163450597|NCT02371759|590350270|FG004|Overall Study|Withdrawal by Subject|0|||
163450598|NCT02371759|590350271|FG005|Overall Study|Withdrawal by Subject|0|||
163450599|NCT02371759|590350272|FG006|Overall Study|Withdrawal by Subject|0|||
163450600|NCT02371759|590350273|FG007|Overall Study|Withdrawal by Subject|1|||
163450601|NCT03136185|590350277|FG000|Overall Study|Adverse Event|0|||
163450602|NCT03136185|590350278|FG001|Overall Study|Adverse Event|1|||
163450603|NCT03136185|590350279|FG002|Overall Study|Adverse Event|3|||
163450604|NCT03136185|590350280|FG003|Overall Study|Adverse Event|1|||
163450605|NCT03136185|590350281|FG004|Overall Study|Adverse Event|2|||
163450606|NCT03136185|590350282|FG005|Overall Study|Adverse Event|2|||
163450607|NCT03136185|590350283|FG006|Overall Study|Adverse Event|5|||
163450608|NCT03136185|590350284|FG007|Overall Study|Adverse Event|1|||
163450609|NCT03136185|590350285|FG008|Overall Study|Adverse Event|1|||
163450610|NCT03136185|590350277|FG000|Overall Study|Death|0|||
163450611|NCT03136185|590350278|FG001|Overall Study|Death|0|||
163450612|NCT03136185|590350279|FG002|Overall Study|Death|0|||
163450613|NCT03136185|590350280|FG003|Overall Study|Death|1|||
163450614|NCT03136185|590350281|FG004|Overall Study|Death|1|||
163450615|NCT03136185|590350282|FG005|Overall Study|Death|0|||
163450616|NCT03136185|590350283|FG006|Overall Study|Death|1|||
163450617|NCT03136185|590350284|FG007|Overall Study|Death|0|||
163450618|NCT03136185|590350285|FG008|Overall Study|Death|0|||
163450619|NCT03136185|590350277|FG000|Overall Study|Physician Decision|3|||
163450620|NCT03136185|590350278|FG001|Overall Study|Physician Decision|1|||
163450621|NCT03136185|590350279|FG002|Overall Study|Physician Decision|1|||
163450622|NCT03136185|590350280|FG003|Overall Study|Physician Decision|2|||
163450623|NCT03136185|590350281|FG004|Overall Study|Physician Decision|1|||
163450624|NCT03136185|590350282|FG005|Overall Study|Physician Decision|2|||
163450625|NCT03136185|590350283|FG006|Overall Study|Physician Decision|1|||
163450626|NCT03136185|590350284|FG007|Overall Study|Physician Decision|0|||
163450627|NCT03136185|590350285|FG008|Overall Study|Physician Decision|1|||
163450628|NCT03136185|590350277|FG000|Overall Study|Protocol Defined Disease Progression|0|||
163450629|NCT03136185|590350278|FG001|Overall Study|Protocol Defined Disease Progression|0|||
163450630|NCT03136185|590350279|FG002|Overall Study|Protocol Defined Disease Progression|1|||
163450631|NCT03136185|590350280|FG003|Overall Study|Protocol Defined Disease Progression|0|||
163450632|NCT03136185|590350281|FG004|Overall Study|Protocol Defined Disease Progression|0|||
163450633|NCT03136185|590350282|FG005|Overall Study|Protocol Defined Disease Progression|1|||
163450634|NCT03136185|590350283|FG006|Overall Study|Protocol Defined Disease Progression|0|||
163450635|NCT03136185|590350284|FG007|Overall Study|Protocol Defined Disease Progression|1|||
163450636|NCT03136185|590350285|FG008|Overall Study|Protocol Defined Disease Progression|1|||
163450637|NCT03136185|590350277|FG000|Overall Study|Withdrawal by Subject|1|||
163450638|NCT03136185|590350278|FG001|Overall Study|Withdrawal by Subject|0|||
163450639|NCT03136185|590350279|FG002|Overall Study|Withdrawal by Subject|1|||
163450640|NCT03136185|590350280|FG003|Overall Study|Withdrawal by Subject|1|||
163450641|NCT03136185|590350281|FG004|Overall Study|Withdrawal by Subject|1|||
163450642|NCT03136185|590350282|FG005|Overall Study|Withdrawal by Subject|1|||
163450643|NCT03136185|590350283|FG006|Overall Study|Withdrawal by Subject|2|||
163450644|NCT03136185|590350284|FG007|Overall Study|Withdrawal by Subject|3|||
163450645|NCT03136185|590350285|FG008|Overall Study|Withdrawal by Subject|3|||
163450646|NCT03136185|590350277|FG000|Overall Study|Not Reported|4|||
163450647|NCT03136185|590350278|FG001|Overall Study|Not Reported|1|||
163450648|NCT03136185|590350279|FG002|Overall Study|Not Reported|0|||
163450649|NCT03136185|590350280|FG003|Overall Study|Not Reported|1|||
163450650|NCT03136185|590350281|FG004|Overall Study|Not Reported|0|||
163450651|NCT03136185|590350282|FG005|Overall Study|Not Reported|2|||
163450652|NCT03136185|590350283|FG006|Overall Study|Not Reported|1|||
163450653|NCT03136185|590350284|FG007|Overall Study|Not Reported|1|||
163450654|NCT03136185|590350285|FG008|Overall Study|Not Reported|0|||
163450655|NCT05118386|590350289|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
163450656|NCT05118386|590350290|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
163450657|NCT05118386|590350291|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
163450658|NCT05118386|590350292|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
163450659|NCT05118386|590350293|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
163450660|NCT05118386|590350294|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
163450661|NCT05118386|590350289|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
163450662|NCT05118386|590350290|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
163450663|NCT05118386|590350291|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
163450664|NCT05118386|590350292|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
163450665|NCT05118386|590350293|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
163450666|NCT05118386|590350294|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
163450667|NCT00894413|590350295|FG000|Overall Study|Physician Decision|0|||
163450668|NCT00894413|590350296|FG001|Overall Study|Physician Decision|2|||
163450669|NCT00894413|590350295|FG000|Overall Study|Adverse Event|0|||
163450670|NCT00894413|590350296|FG001|Overall Study|Adverse Event|2|||
163450671|NCT00894413|590350295|FG000|Overall Study|Withdrawal by Subject|0|||
163450672|NCT00894413|590350296|FG001|Overall Study|Withdrawal by Subject|4|||
163450673|NCT01067508|590350303|FG000|Overall Study|Physician Decision|0|||
163450674|NCT01067508|590350304|FG001|Overall Study|Physician Decision|1|||
163450675|NCT01067508|590350303|FG000|Overall Study|Withdrawal by Subject|0|||
163450676|NCT01067508|590350304|FG001|Overall Study|Withdrawal by Subject|1|||
163450677|NCT02635737|590350308|FG000|Overall Study|Protocol Violation|1|||
163450678|NCT01552928|590350309|FG000|Period 3|Adverse Event|0|||
163450679|NCT01552928|590350310|FG001|Period 3|Adverse Event|0|||
163450680|NCT01552928|590350311|FG002|Period 3|Adverse Event|1|||
163450681|NCT01552928|590350312|FG003|Period 3|Adverse Event|0|||
163450682|NCT00632463|590350314|FG000|Overall Study|Adverse Event|0|||
163450683|NCT00632463|590350315|FG001|Overall Study|Adverse Event|1|||
163450684|NCT00632463|590350316|FG002|Overall Study|Adverse Event|0|||
163450685|NCT02065622|590350317|FG000|Induction Study|Adverse Event|13|||
163450686|NCT02065622|590350318|FG001|Induction Study|Adverse Event|19|||
163450687|NCT02065622|590350319|FG002|Induction Study|Adverse Event|0|||
163450688|NCT02065622|590350320|FG003|Induction Study|Adverse Event|0|||
163450689|NCT02065622|590350321|FG004|Induction Study|Adverse Event|0|||
163450690|NCT02065622|590350317|FG000|Induction Study|Withdrawal by Subject|3|||
163450691|NCT02065622|590350318|FG001|Induction Study|Withdrawal by Subject|5|||
163450692|NCT02065622|590350319|FG002|Induction Study|Withdrawal by Subject|0|||
163450693|NCT02065622|590350320|FG003|Induction Study|Withdrawal by Subject|0|||
163450694|NCT02065622|590350321|FG004|Induction Study|Withdrawal by Subject|0|||
163450695|NCT02065622|590350317|FG000|Induction Study|Lost to Follow-up|1|||
163450696|NCT02065622|590350318|FG001|Induction Study|Lost to Follow-up|0|||
163450697|NCT02065622|590350319|FG002|Induction Study|Lost to Follow-up|0|||
163450698|NCT02065622|590350320|FG003|Induction Study|Lost to Follow-up|0|||
163450699|NCT02065622|590350321|FG004|Induction Study|Lost to Follow-up|0|||
163450700|NCT02065622|590350317|FG000|Induction Study|Lack of Efficacy|22|||
163450701|NCT02065622|590350318|FG001|Induction Study|Lack of Efficacy|27|||
163450702|NCT02065622|590350319|FG002|Induction Study|Lack of Efficacy|0|||
163450703|NCT02065622|590350320|FG003|Induction Study|Lack of Efficacy|0|||
163450704|NCT02065622|590350321|FG004|Induction Study|Lack of Efficacy|0|||
163450705|NCT02065622|590350317|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
163450706|NCT02065622|590350318|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
163450707|NCT02065622|590350319|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
163450708|NCT02065622|590350320|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
163450709|NCT02065622|590350321|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
163450710|NCT02065622|590350317|FG000|Induction Study|Subject Noncompliance|1|||
163450711|NCT02065622|590350318|FG001|Induction Study|Subject Noncompliance|1|||
163450712|NCT02065622|590350319|FG002|Induction Study|Subject Noncompliance|0|||
163450713|NCT02065622|590350320|FG003|Induction Study|Subject Noncompliance|0|||
163450714|NCT02065622|590350321|FG004|Induction Study|Subject Noncompliance|0|||
163450715|NCT02065622|590350317|FG000|Induction Study|Other, Not Specified|3|||
163450716|NCT02065622|590350318|FG001|Induction Study|Other, Not Specified|2|||
163450717|NCT02065622|590350319|FG002|Induction Study|Other, Not Specified|0|||
163450718|NCT02065622|590350320|FG003|Induction Study|Other, Not Specified|0|||
163450719|NCT02065622|590350321|FG004|Induction Study|Other, Not Specified|0|||
163450720|NCT02065622|590350317|FG000|Maintenance Study|Adverse Event|0|||
163450721|NCT02065622|590350318|FG001|Maintenance Study|Adverse Event|0|||
163450722|NCT02065622|590350319|FG002|Maintenance Study|Adverse Event|25|||
163450723|NCT02065622|590350320|FG003|Maintenance Study|Adverse Event|22|||
163450724|NCT02065622|590350321|FG004|Maintenance Study|Adverse Event|11|||
163450725|NCT02065622|590350317|FG000|Maintenance Study|Withdrawal by Subject|0|||
163450726|NCT02065622|590350318|FG001|Maintenance Study|Withdrawal by Subject|0|||
163450727|NCT02065622|590350319|FG002|Maintenance Study|Withdrawal by Subject|11|||
163450728|NCT02065622|590350320|FG003|Maintenance Study|Withdrawal by Subject|5|||
163450729|NCT02065622|590350321|FG004|Maintenance Study|Withdrawal by Subject|7|||
163450730|NCT02065622|590350317|FG000|Maintenance Study|Lost to Follow-up|0|||
163450731|NCT02065622|590350318|FG001|Maintenance Study|Lost to Follow-up|0|||
163450732|NCT02065622|590350319|FG002|Maintenance Study|Lost to Follow-up|4|||
163450733|NCT02065622|590350320|FG003|Maintenance Study|Lost to Follow-up|1|||
163450734|NCT02065622|590350321|FG004|Maintenance Study|Lost to Follow-up|1|||
163450735|NCT02065622|590350317|FG000|Maintenance Study|Lack of Efficacy|0|||
163450736|NCT02065622|590350318|FG001|Maintenance Study|Lack of Efficacy|0|||
163450737|NCT02065622|590350319|FG002|Maintenance Study|Lack of Efficacy|70|||
163450738|NCT02065622|590350320|FG003|Maintenance Study|Lack of Efficacy|55|||
163450739|NCT02065622|590350321|FG004|Maintenance Study|Lack of Efficacy|19|||
163450740|NCT02065622|590350317|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
163450741|NCT02065622|590350318|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
163450742|NCT02065622|590350319|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
163450743|NCT02065622|590350320|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
163450744|NCT02065622|590350321|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
163450745|NCT02065622|590350317|FG000|Maintenance Study|Subject Non-Compliance|0|||
163450746|NCT02065622|590350318|FG001|Maintenance Study|Subject Non-Compliance|0|||
163450747|NCT02065622|590350319|FG002|Maintenance Study|Subject Non-Compliance|1|||
163450748|NCT02065622|590350320|FG003|Maintenance Study|Subject Non-Compliance|3|||
163450749|NCT02065622|590350321|FG004|Maintenance Study|Subject Non-Compliance|2|||
163450750|NCT02065622|590350317|FG000|Maintenance Study|Other, Not Specified|0|||
163450751|NCT02065622|590350318|FG001|Maintenance Study|Other, Not Specified|0|||
163450752|NCT02065622|590350319|FG002|Maintenance Study|Other, Not Specified|6|||
163450753|NCT02065622|590350320|FG003|Maintenance Study|Other, Not Specified|14|||
163450754|NCT02065622|590350321|FG004|Maintenance Study|Other, Not Specified|2|||
163450755|NCT02065622|590350317|FG000|Maintenance Study|Unknown Reason|0|||
163450756|NCT02065622|590350318|FG001|Maintenance Study|Unknown Reason|0|||
163450757|NCT02065622|590350319|FG002|Maintenance Study|Unknown Reason|0|||
163450758|NCT02065622|590350320|FG003|Maintenance Study|Unknown Reason|1|||
163450759|NCT02065622|590350321|FG004|Maintenance Study|Unknown Reason|0|||
163450760|NCT04973228|590350330|FG000|Overall Study|Adverse Event|2|||
163450761|NCT04973228|590350331|FG001|Overall Study|Adverse Event|3|||
163450762|NCT04973228|590350330|FG000|Overall Study|Lack of Efficacy|1|||
163450763|NCT04973228|590350331|FG001|Overall Study|Lack of Efficacy|3|||
163450764|NCT04973228|590350330|FG000|Overall Study|Lost to Follow-up|12|||
163450765|NCT04973228|590350331|FG001|Overall Study|Lost to Follow-up|4|||
163450766|NCT04973228|590350330|FG000|Overall Study|Withdrawal by Subject|11|||
163450767|NCT04973228|590350331|FG001|Overall Study|Withdrawal by Subject|4|||
163450768|NCT04973228|590350330|FG000|Overall Study|Did not tolerate application|1|||
163450769|NCT04973228|590350331|FG001|Overall Study|Did not tolerate application|0|||
163450770|NCT04973228|590350330|FG000|Overall Study|Wanted to early terminate and use own product|0|||
163450771|NCT04973228|590350331|FG001|Overall Study|Wanted to early terminate and use own product|1|||
163450772|NCT04973228|590350330|FG000|Overall Study|Missed visits due to new work schedule|1|||
163450773|NCT04973228|590350331|FG001|Overall Study|Missed visits due to new work schedule|0|||
163450774|NCT00488618|590350332|FG000|Overall Study|Adverse Event|13|||
163450775|NCT00488618|590350333|FG001|Overall Study|Adverse Event|17|||
163450776|NCT00488618|590350332|FG000|Overall Study|Insufficient Therapeutic Response|18|||
163450777|NCT00488618|590350333|FG001|Overall Study|Insufficient Therapeutic Response|11|||
163450778|NCT00488618|590350332|FG000|Overall Study|Protocol Violation|0|||
163450779|NCT00488618|590350333|FG001|Overall Study|Protocol Violation|2|||
163450780|NCT00488618|590350332|FG000|Overall Study|Withdrawal of Consent|15|||
163450781|NCT00488618|590350333|FG001|Overall Study|Withdrawal of Consent|13|||
163450782|NCT00488618|590350332|FG000|Overall Study|Lost to Follow-up|1|||
163450783|NCT00488618|590350333|FG001|Overall Study|Lost to Follow-up|0|||
163450784|NCT00296725|590352408|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
163450785|NCT00296725|590352408|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
163450786|NCT00296725|590352408|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
163450787|NCT00356863|590352411|FG000|Overall Study|Death|16|||
163450788|NCT00356863|590352412|FG001|Overall Study|Death|32|||
163450789|NCT00356863|590352411|FG000|Overall Study|Lost to Follow-up|76|||
163450790|NCT00356863|590352412|FG001|Overall Study|Lost to Follow-up|43|||
163450791|NCT00836277|590352422|FG000|Overall Study|Not evaluable for response|6|||
163450792|NCT00333619|590352423|FG000|Overall Study|Death|12|||
163450793|NCT00333619|590352424|FG001|Overall Study|Death|6|||
163450794|NCT00333619|590352423|FG000|Overall Study|Withdrawal by Subject|6|||
163450795|NCT00333619|590352424|FG001|Overall Study|Withdrawal by Subject|1|||
163450796|NCT00333619|590352423|FG000|Overall Study|Lost to Follow-up|3|||
163450797|NCT00333619|590352424|FG001|Overall Study|Lost to Follow-up|3|||
163450798|NCT00280150|590352425|FG000|Overall Study|Adverse Event|0|||
163450799|NCT00280150|590352426|FG001|Overall Study|Adverse Event|1|||
163450800|NCT00280150|590352427|FG002|Overall Study|Adverse Event|2|||
163450801|NCT00280150|590352428|FG003|Overall Study|Adverse Event|3|||
163450802|NCT00280150|590352425|FG000|Overall Study|Lack of Efficacy|0|||
163450803|NCT00280150|590352426|FG001|Overall Study|Lack of Efficacy|0|||
163450804|NCT00280150|590352427|FG002|Overall Study|Lack of Efficacy|0|||
163450805|NCT00280150|590352428|FG003|Overall Study|Lack of Efficacy|3|||
163450806|NCT00280150|590352425|FG000|Overall Study|Physician Decision|0|||
163450807|NCT00280150|590352426|FG001|Overall Study|Physician Decision|0|||
163450808|NCT00280150|590352427|FG002|Overall Study|Physician Decision|0|||
163450809|NCT00280150|590352428|FG003|Overall Study|Physician Decision|1|||
163450810|NCT00280150|590352425|FG000|Overall Study|Protocol Violation|0|||
163450811|NCT00280150|590352426|FG001|Overall Study|Protocol Violation|0|||
163450812|NCT00280150|590352427|FG002|Overall Study|Protocol Violation|0|||
163450813|NCT00280150|590352428|FG003|Overall Study|Protocol Violation|1|||
163450814|NCT00280150|590352425|FG000|Overall Study|Withdrawal by Subject|0|||
163450815|NCT00280150|590352426|FG001|Overall Study|Withdrawal by Subject|0|||
163450816|NCT00280150|590352427|FG002|Overall Study|Withdrawal by Subject|0|||
163450817|NCT00280150|590352428|FG003|Overall Study|Withdrawal by Subject|1|||
163450818|NCT00280150|590352425|FG000|Overall Study|Did not get consolidation therapy|3|||
163450819|NCT00280150|590352426|FG001|Overall Study|Did not get consolidation therapy|0|||
163450820|NCT00280150|590352427|FG002|Overall Study|Did not get consolidation therapy|3|||
163450821|NCT00280150|590352428|FG003|Overall Study|Did not get consolidation therapy|0|||
163450822|NCT00280150|590352425|FG000|Overall Study|Declining Performance Status|0|||
163450823|NCT00280150|590352426|FG001|Overall Study|Declining Performance Status|0|||
163450824|NCT00280150|590352427|FG002|Overall Study|Declining Performance Status|0|||
163450825|NCT00280150|590352428|FG003|Overall Study|Declining Performance Status|1|||
163450826|NCT05254613|590352434|FG000|Overall Study|Lost to Follow-up|0|||
163450827|NCT05254613|590352435|FG001|Overall Study|Lost to Follow-up|0|||
163450828|NCT05254613|590352436|FG002|Overall Study|Lost to Follow-up|1|||
163450829|NCT01944969|590352438|FG000|Overall Study|Adverse Event|1|||
163450830|NCT01944969|590352438|FG000|Overall Study|Lack of Efficacy|1|||
163450831|NCT01944969|590352438|FG000|Overall Study|Non-compliance with IMP|1|||
163450832|NCT01944969|590352438|FG000|Overall Study|Administrative or other reasons|23|||
163450833|NCT01104584|590352439|FG000|Overall Study|Study drug never administered|21|||
163450834|NCT01104584|590352439|FG000|Overall Study|Study prematurely discontinued|2|||
163450835|NCT02370498|590352440|FG000|Overall Study|Adverse Event|10|||
163450836|NCT02370498|590352441|FG001|Overall Study|Adverse Event|8|||
163450837|NCT02370498|590352440|FG000|Overall Study|Death|263|||
163450838|NCT02370498|590352441|FG001|Overall Study|Death|265|||
163450839|NCT02370498|590352440|FG000|Overall Study|Protocol Violation|1|||
163450840|NCT02370498|590352441|FG001|Overall Study|Protocol Violation|2|||
163450841|NCT02370498|590352440|FG000|Overall Study|Withdrawal by Subject|7|||
163450842|NCT02370498|590352441|FG001|Overall Study|Withdrawal by Subject|12|||
163450843|NCT02370498|590352440|FG000|Overall Study|Sponsor's decision|15|||
163450844|NCT02370498|590352441|FG001|Overall Study|Sponsor's decision|9|||
163450845|NCT02387372|590352445|FG000|Overall Study|Not Treated|1|||
163450846|NCT02387372|590352446|FG001|Overall Study|Not Treated|0|||
163450847|NCT01576016|590352447|FG000|Lead Safety|Death|132|||
163450848|NCT01576016|590352448|FG001|Lead Safety|Death|0|||
163450849|NCT01576016|590352447|FG000|Lead Safety|Withdrawal by Subject|81|||
163450850|NCT01576016|590352448|FG001|Lead Safety|Withdrawal by Subject|0|||
163450851|NCT01576016|590352447|FG000|Lead Safety|System Explanted without Replacement|24|||
163450852|NCT01576016|590352448|FG001|Lead Safety|System Explanted without Replacement|0|||
163450853|NCT01576016|590352447|FG000|Lead Safety|Physician Decision|14|||
163450854|NCT01576016|590352448|FG001|Lead Safety|Physician Decision|0|||
163450855|NCT01576016|590352447|FG000|Lead Safety|Lost to Follow-up|13|||
163450856|NCT01576016|590352448|FG001|Lead Safety|Lost to Follow-up|0|||
163450857|NCT01576016|590352447|FG000|Lead Safety|Unsuccessful implant|2|||
163450858|NCT01576016|590352448|FG001|Lead Safety|Unsuccessful implant|0|||
163450859|NCT01576016|590352447|FG000|Lead Safety|Sponsor request|1|||
163450860|NCT01576016|590352448|FG001|Lead Safety|Sponsor request|0|||
163450861|NCT01576016|590352447|FG000|Lead Safety|Device replaced with CRT-D|1|||
163450862|NCT01576016|590352448|FG001|Lead Safety|Device replaced with CRT-D|0|||
163450863|NCT01576016|590352447|FG000|Lead Safety|Patient on Palliative Care|1|||
163450864|NCT01576016|590352448|FG001|Lead Safety|Patient on Palliative Care|0|||
163450865|NCT01576016|590352447|FG000|Lead Safety|Patient noncompliance|1|||
163450866|NCT01576016|590352448|FG001|Lead Safety|Patient noncompliance|0|||
163450867|NCT01576016|590352447|FG000|Lead Safety|Too far from study site|1|||
163450868|NCT01576016|590352448|FG001|Lead Safety|Too far from study site|0|||
163450869|NCT01576016|590352447|FG000|Lead Safety|System deactivated|1|||
163450870|NCT01576016|590352448|FG001|Lead Safety|System deactivated|0|||
163450871|NCT01576016|590352447|FG000|Lead Safety|Patient no longer followed by study PI|1|||
163450872|NCT01576016|590352448|FG001|Lead Safety|Patient no longer followed by study PI|0|||
163450873|NCT01576016|590352447|FG000|MRI Safety|Withdrawal by Subject|0|||
163450874|NCT01576016|590352448|FG001|MRI Safety|Withdrawal by Subject|10|||
163450875|NCT01576016|590352447|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
163450876|NCT01576016|590352448|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
163450877|NCT01576016|590352447|FG000|MRI Safety|Has not yet completed MRI scan|0|||
163450878|NCT01576016|590352448|FG001|MRI Safety|Has not yet completed MRI scan|56|||
163450879|NCT01576016|590352447|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
163450880|NCT01576016|590352448|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
163450881|NCT02175771|590352457|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
163450882|NCT02175771|590352458|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163450883|NCT02175771|590352459|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163450884|NCT02175771|590352460|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163450885|NCT02175771|590352461|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163450886|NCT02175771|590352462|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163450887|NCT02175771|590352463|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163450888|NCT02175771|590352464|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163450889|NCT02175771|590352465|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163450890|NCT02175771|590352457|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
163450891|NCT02175771|590352458|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163450892|NCT02175771|590352459|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163450893|NCT02175771|590352460|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163450894|NCT02175771|590352461|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163450895|NCT02175771|590352462|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163450896|NCT02175771|590352463|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163450897|NCT02175771|590352464|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163450898|NCT02175771|590352465|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163450899|NCT02175771|590352457|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
163450900|NCT02175771|590352458|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163450901|NCT02175771|590352459|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163450902|NCT02175771|590352460|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163450903|NCT02175771|590352461|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163450904|NCT02175771|590352462|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163450905|NCT02175771|590352463|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163450906|NCT02175771|590352464|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163450907|NCT02175771|590352465|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163450908|NCT02175771|590352457|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
163450909|NCT02175771|590352458|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
163450910|NCT02175771|590352459|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
163450911|NCT02175771|590352460|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
163450912|NCT02175771|590352461|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
163450913|NCT02175771|590352462|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
163450914|NCT02175771|590352463|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
163450915|NCT02175771|590352464|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
163450916|NCT02175771|590352465|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
163450917|NCT02175771|590352457|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
163450918|NCT02175771|590352458|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163450919|NCT02175771|590352459|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163450920|NCT02175771|590352460|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163450921|NCT02175771|590352461|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163450922|NCT02175771|590352462|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163450923|NCT02175771|590352463|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163450924|NCT02175771|590352464|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163450925|NCT02175771|590352465|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163450926|NCT02175771|590352457|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
163450927|NCT02175771|590352458|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163450928|NCT02175771|590352459|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163450929|NCT02175771|590352460|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163450930|NCT02175771|590352461|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163450931|NCT02175771|590352462|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163450932|NCT02175771|590352463|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163450933|NCT02175771|590352464|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163450934|NCT02175771|590352465|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163450935|NCT02175771|590352457|FG000|Run-In Period (Pre-assignment)|Other|8|||
163450936|NCT02175771|590352458|FG001|Run-In Period (Pre-assignment)|Other|0|||
163450937|NCT02175771|590352459|FG002|Run-In Period (Pre-assignment)|Other|0|||
163450938|NCT02175771|590352460|FG003|Run-In Period (Pre-assignment)|Other|0|||
163450939|NCT02175771|590352461|FG004|Run-In Period (Pre-assignment)|Other|0|||
163450940|NCT02175771|590352462|FG005|Run-In Period (Pre-assignment)|Other|0|||
163450941|NCT02175771|590352463|FG006|Run-In Period (Pre-assignment)|Other|0|||
163450942|NCT02175771|590352464|FG007|Run-In Period (Pre-assignment)|Other|0|||
163450943|NCT02175771|590352465|FG008|Run-In Period (Pre-assignment)|Other|0|||
163450944|NCT02175771|590352457|FG000|Treatment Period|Adverse Event|0|||
163450945|NCT02175771|590352458|FG001|Treatment Period|Adverse Event|2|||
163450946|NCT02175771|590352459|FG002|Treatment Period|Adverse Event|1|||
163450947|NCT02175771|590352460|FG003|Treatment Period|Adverse Event|1|||
163450948|NCT02175771|590352461|FG004|Treatment Period|Adverse Event|1|||
163450949|NCT02175771|590352462|FG005|Treatment Period|Adverse Event|3|||
163450950|NCT02175771|590352463|FG006|Treatment Period|Adverse Event|2|||
163450951|NCT02175771|590352464|FG007|Treatment Period|Adverse Event|0|||
163450952|NCT02175771|590352465|FG008|Treatment Period|Adverse Event|1|||
163450953|NCT02175771|590352457|FG000|Treatment Period|Withdrawal by Subject|0|||
163450954|NCT02175771|590352458|FG001|Treatment Period|Withdrawal by Subject|9|||
163450955|NCT02175771|590352459|FG002|Treatment Period|Withdrawal by Subject|3|||
163450956|NCT02175771|590352460|FG003|Treatment Period|Withdrawal by Subject|6|||
163450957|NCT02175771|590352461|FG004|Treatment Period|Withdrawal by Subject|2|||
163450958|NCT02175771|590352462|FG005|Treatment Period|Withdrawal by Subject|4|||
163450959|NCT02175771|590352463|FG006|Treatment Period|Withdrawal by Subject|2|||
163450960|NCT02175771|590352464|FG007|Treatment Period|Withdrawal by Subject|9|||
163450961|NCT02175771|590352465|FG008|Treatment Period|Withdrawal by Subject|2|||
163450962|NCT02175771|590352457|FG000|Treatment Period|Noncompliance|0|||
163450963|NCT02175771|590352458|FG001|Treatment Period|Noncompliance|1|||
163450964|NCT02175771|590352459|FG002|Treatment Period|Noncompliance|2|||
163450965|NCT02175771|590352460|FG003|Treatment Period|Noncompliance|0|||
163450966|NCT02175771|590352461|FG004|Treatment Period|Noncompliance|0|||
163450967|NCT02175771|590352462|FG005|Treatment Period|Noncompliance|0|||
163450968|NCT02175771|590352463|FG006|Treatment Period|Noncompliance|0|||
163450969|NCT02175771|590352464|FG007|Treatment Period|Noncompliance|0|||
163450970|NCT02175771|590352465|FG008|Treatment Period|Noncompliance|1|||
163450971|NCT02175771|590352457|FG000|Treatment Period|Protocol Violation|0|||
163450972|NCT02175771|590352458|FG001|Treatment Period|Protocol Violation|0|||
163450973|NCT02175771|590352459|FG002|Treatment Period|Protocol Violation|0|||
163450974|NCT02175771|590352460|FG003|Treatment Period|Protocol Violation|0|||
163450975|NCT02175771|590352461|FG004|Treatment Period|Protocol Violation|0|||
163450976|NCT02175771|590352462|FG005|Treatment Period|Protocol Violation|0|||
163450977|NCT02175771|590352463|FG006|Treatment Period|Protocol Violation|0|||
163450978|NCT02175771|590352464|FG007|Treatment Period|Protocol Violation|1|||
163450979|NCT02175771|590352465|FG008|Treatment Period|Protocol Violation|0|||
163450980|NCT02175771|590352457|FG000|Treatment Period|Disease progression|0|||
163450981|NCT02175771|590352458|FG001|Treatment Period|Disease progression|0|||
163450982|NCT02175771|590352459|FG002|Treatment Period|Disease progression|0|||
163450983|NCT02175771|590352460|FG003|Treatment Period|Disease progression|0|||
163450984|NCT02175771|590352461|FG004|Treatment Period|Disease progression|0|||
163450985|NCT02175771|590352462|FG005|Treatment Period|Disease progression|0|||
163450986|NCT02175771|590352463|FG006|Treatment Period|Disease progression|0|||
163450987|NCT02175771|590352464|FG007|Treatment Period|Disease progression|2|||
163450988|NCT02175771|590352465|FG008|Treatment Period|Disease progression|0|||
163450989|NCT02175771|590352457|FG000|Treatment Period|Lost to Follow-up|0|||
163450990|NCT02175771|590352458|FG001|Treatment Period|Lost to Follow-up|3|||
163450991|NCT02175771|590352459|FG002|Treatment Period|Lost to Follow-up|1|||
163450992|NCT02175771|590352460|FG003|Treatment Period|Lost to Follow-up|3|||
163450993|NCT02175771|590352461|FG004|Treatment Period|Lost to Follow-up|1|||
163450994|NCT02175771|590352462|FG005|Treatment Period|Lost to Follow-up|2|||
163450995|NCT02175771|590352463|FG006|Treatment Period|Lost to Follow-up|1|||
163450996|NCT02175771|590352464|FG007|Treatment Period|Lost to Follow-up|2|||
163450997|NCT02175771|590352465|FG008|Treatment Period|Lost to Follow-up|2|||
163450998|NCT02175771|590352457|FG000|Treatment Period|Lack of Efficacy|0|||
163450999|NCT02175771|590352458|FG001|Treatment Period|Lack of Efficacy|0|||
163451000|NCT02175771|590352459|FG002|Treatment Period|Lack of Efficacy|0|||
163451001|NCT02175771|590352460|FG003|Treatment Period|Lack of Efficacy|0|||
163451002|NCT02175771|590352461|FG004|Treatment Period|Lack of Efficacy|0|||
163451003|NCT02175771|590352462|FG005|Treatment Period|Lack of Efficacy|1|||
163451004|NCT02175771|590352463|FG006|Treatment Period|Lack of Efficacy|0|||
163451005|NCT02175771|590352464|FG007|Treatment Period|Lack of Efficacy|1|||
163451006|NCT02175771|590352465|FG008|Treatment Period|Lack of Efficacy|0|||
163451007|NCT02175771|590352457|FG000|Treatment Period|Other|0|||
163451008|NCT02175771|590352458|FG001|Treatment Period|Other|1|||
163451009|NCT02175771|590352459|FG002|Treatment Period|Other|0|||
163451010|NCT02175771|590352460|FG003|Treatment Period|Other|3|||
163451011|NCT02175771|590352461|FG004|Treatment Period|Other|1|||
163451012|NCT02175771|590352462|FG005|Treatment Period|Other|0|||
163451013|NCT02175771|590352463|FG006|Treatment Period|Other|0|||
163451014|NCT02175771|590352464|FG007|Treatment Period|Other|2|||
163451015|NCT02175771|590352465|FG008|Treatment Period|Other|0|||
163451016|NCT02504268|590352466|FG000|Overall Study|Adverse Event|18|||
163451017|NCT02504268|590352467|FG001|Overall Study|Adverse Event|8|||
163451018|NCT02504268|590352468|FG002|Overall Study|Adverse Event|14|||
163451019|NCT02504268|590352469|FG003|Overall Study|Adverse Event|0|||
163451020|NCT02504268|590352470|FG004|Overall Study|Adverse Event|0|||
163451021|NCT02504268|590352471|FG005|Overall Study|Adverse Event|0|||
163451022|NCT02504268|590352472|FG006|Overall Study|Adverse Event|0|||
163451023|NCT02504268|590352473|FG007|Overall Study|Adverse Event|0|||
163451024|NCT02504268|590352474|FG008|Overall Study|Adverse Event|0|||
163451025|NCT02504268|590352466|FG000|Overall Study|Withdrawal of Consent|11|||
163451026|NCT02504268|590352467|FG001|Overall Study|Withdrawal of Consent|10|||
163451027|NCT02504268|590352468|FG002|Overall Study|Withdrawal of Consent|3|||
163451028|NCT02504268|590352469|FG003|Overall Study|Withdrawal of Consent|0|||
163451029|NCT02504268|590352470|FG004|Overall Study|Withdrawal of Consent|0|||
163451030|NCT02504268|590352471|FG005|Overall Study|Withdrawal of Consent|0|||
163451031|NCT02504268|590352472|FG006|Overall Study|Withdrawal of Consent|0|||
163451032|NCT02504268|590352473|FG007|Overall Study|Withdrawal of Consent|0|||
163451033|NCT02504268|590352474|FG008|Overall Study|Withdrawal of Consent|0|||
163451034|NCT02504268|590352466|FG000|Overall Study|Pregnancy|2|||
163451035|NCT02504268|590352467|FG001|Overall Study|Pregnancy|0|||
163451036|NCT02504268|590352468|FG002|Overall Study|Pregnancy|0|||
163451037|NCT02504268|590352469|FG003|Overall Study|Pregnancy|0|||
163451038|NCT02504268|590352470|FG004|Overall Study|Pregnancy|0|||
163451039|NCT02504268|590352471|FG005|Overall Study|Pregnancy|0|||
163451040|NCT02504268|590352472|FG006|Overall Study|Pregnancy|0|||
163451041|NCT02504268|590352473|FG007|Overall Study|Pregnancy|0|||
163451042|NCT02504268|590352474|FG008|Overall Study|Pregnancy|0|||
163451043|NCT02504268|590352466|FG000|Overall Study|Lost to Follow-up|3|||
163451044|NCT02504268|590352467|FG001|Overall Study|Lost to Follow-up|6|||
163451045|NCT02504268|590352468|FG002|Overall Study|Lost to Follow-up|4|||
163451046|NCT02504268|590352469|FG003|Overall Study|Lost to Follow-up|0|||
163451047|NCT02504268|590352470|FG004|Overall Study|Lost to Follow-up|0|||
163451048|NCT02504268|590352471|FG005|Overall Study|Lost to Follow-up|0|||
163451049|NCT02504268|590352472|FG006|Overall Study|Lost to Follow-up|0|||
163451050|NCT02504268|590352473|FG007|Overall Study|Lost to Follow-up|0|||
163451051|NCT02504268|590352474|FG008|Overall Study|Lost to Follow-up|0|||
163451052|NCT02504268|590352466|FG000|Overall Study|Death|1|||
163451053|NCT02504268|590352467|FG001|Overall Study|Death|1|||
163451054|NCT02504268|590352468|FG002|Overall Study|Death|0|||
163451055|NCT02504268|590352469|FG003|Overall Study|Death|0|||
163451056|NCT02504268|590352470|FG004|Overall Study|Death|0|||
163451057|NCT02504268|590352471|FG005|Overall Study|Death|0|||
163451058|NCT02504268|590352472|FG006|Overall Study|Death|0|||
163451059|NCT02504268|590352473|FG007|Overall Study|Death|0|||
163451060|NCT02504268|590352474|FG008|Overall Study|Death|0|||
163451061|NCT02504268|590352466|FG000|Overall Study|Subject Request to Discontinue|11|||
163451062|NCT02504268|590352467|FG001|Overall Study|Subject Request to Discontinue|3|||
163451063|NCT02504268|590352468|FG002|Overall Study|Subject Request to Discontinue|6|||
163451064|NCT02504268|590352469|FG003|Overall Study|Subject Request to Discontinue|0|||
163451065|NCT02504268|590352470|FG004|Overall Study|Subject Request to Discontinue|0|||
163451066|NCT02504268|590352471|FG005|Overall Study|Subject Request to Discontinue|0|||
163451067|NCT02504268|590352472|FG006|Overall Study|Subject Request to Discontinue|0|||
163451068|NCT02504268|590352473|FG007|Overall Study|Subject Request to Discontinue|0|||
163451069|NCT02504268|590352474|FG008|Overall Study|Subject Request to Discontinue|0|||
163451070|NCT02504268|590352466|FG000|Overall Study|No Longer Meets Study Criteria|2|||
163451071|NCT02504268|590352467|FG001|Overall Study|No Longer Meets Study Criteria|3|||
163451072|NCT02504268|590352468|FG002|Overall Study|No Longer Meets Study Criteria|0|||
163451073|NCT02504268|590352469|FG003|Overall Study|No Longer Meets Study Criteria|0|||
163451074|NCT02504268|590352470|FG004|Overall Study|No Longer Meets Study Criteria|0|||
163451075|NCT02504268|590352471|FG005|Overall Study|No Longer Meets Study Criteria|0|||
163451076|NCT02504268|590352472|FG006|Overall Study|No Longer Meets Study Criteria|0|||
163451077|NCT02504268|590352473|FG007|Overall Study|No Longer Meets Study Criteria|0|||
163451078|NCT02504268|590352474|FG008|Overall Study|No Longer Meets Study Criteria|0|||
163451079|NCT02504268|590352466|FG000|Overall Study|Lack of Efficacy|11|||
163451080|NCT02504268|590352467|FG001|Overall Study|Lack of Efficacy|35|||
163451081|NCT02504268|590352468|FG002|Overall Study|Lack of Efficacy|9|||
163451082|NCT02504268|590352469|FG003|Overall Study|Lack of Efficacy|0|||
163451083|NCT02504268|590352470|FG004|Overall Study|Lack of Efficacy|0|||
163451084|NCT02504268|590352471|FG005|Overall Study|Lack of Efficacy|0|||
163451085|NCT02504268|590352472|FG006|Overall Study|Lack of Efficacy|0|||
163451086|NCT02504268|590352473|FG007|Overall Study|Lack of Efficacy|0|||
163451087|NCT02504268|590352474|FG008|Overall Study|Lack of Efficacy|0|||
163451088|NCT02504268|590352466|FG000|Overall Study|Poor/Non-Compliance|3|||
163451089|NCT02504268|590352467|FG001|Overall Study|Poor/Non-Compliance|2|||
163451090|NCT02504268|590352468|FG002|Overall Study|Poor/Non-Compliance|3|||
163451091|NCT02504268|590352469|FG003|Overall Study|Poor/Non-Compliance|0|||
163451092|NCT02504268|590352470|FG004|Overall Study|Poor/Non-Compliance|0|||
163451093|NCT02504268|590352471|FG005|Overall Study|Poor/Non-Compliance|0|||
163451094|NCT02504268|590352472|FG006|Overall Study|Poor/Non-Compliance|0|||
163451095|NCT02504268|590352473|FG007|Overall Study|Poor/Non-Compliance|0|||
163451096|NCT02504268|590352474|FG008|Overall Study|Poor/Non-Compliance|0|||
163451097|NCT02504268|590352466|FG000|Overall Study|Not Disclosed|1|||
163451098|NCT02504268|590352467|FG001|Overall Study|Not Disclosed|0|||
163451099|NCT02504268|590352468|FG002|Overall Study|Not Disclosed|2|||
163451100|NCT02504268|590352469|FG003|Overall Study|Not Disclosed|0|||
163451101|NCT02504268|590352470|FG004|Overall Study|Not Disclosed|0|||
163451102|NCT02504268|590352471|FG005|Overall Study|Not Disclosed|0|||
163451103|NCT02504268|590352472|FG006|Overall Study|Not Disclosed|0|||
163451104|NCT02504268|590352473|FG007|Overall Study|Not Disclosed|0|||
163451105|NCT02504268|590352474|FG008|Overall Study|Not Disclosed|0|||
163451106|NCT03198754|590352484|FG000|Overall Study|Withdrawal by Subject|5|||
163451107|NCT03198754|590352485|FG001|Overall Study|Withdrawal by Subject|4|||
163451108|NCT03198754|590352484|FG000|Overall Study|Lost to Follow-up|4|||
163451109|NCT03198754|590352485|FG001|Overall Study|Lost to Follow-up|3|||
163451110|NCT03198754|590352484|FG000|Overall Study|Ineligible|2|||
163451111|NCT03198754|590352485|FG001|Overall Study|Ineligible|1|||
163451112|NCT03247413|590352486|FG000|Overall Study|Lost to Follow-up|28|||
163451113|NCT00668200|590352487|FG000|Overall Study|Withdrawal by Subject|2|||
163451114|NCT00668200|590352487|FG000|Overall Study|Lost to Follow-up|1|||
163451115|NCT00642746|590352488|FG000|Overall Study|Patient unevaluable|1|||
163451116|NCT00642746|590352489|FG001|Overall Study|Patient unevaluable|0|||
163451117|NCT00424294|590352493|FG000|Overall Study|Adverse Event|4|||
163451118|NCT00424294|590352494|FG001|Overall Study|Adverse Event|10|||
163451119|NCT00424294|590352493|FG000|Overall Study|Lack of Efficacy|2|||
163451120|NCT00424294|590352494|FG001|Overall Study|Lack of Efficacy|1|||
163451121|NCT00424294|590352493|FG000|Overall Study|Withdrawal by Subject|1|||
163451122|NCT00424294|590352494|FG001|Overall Study|Withdrawal by Subject|2|||
163451123|NCT00424294|590352493|FG000|Overall Study|Other|0|||
163451124|NCT00424294|590352494|FG001|Overall Study|Other|2|||
163451125|NCT00424294|590352493|FG000|Overall Study|Randomized but not Treated|1|||
163451126|NCT00424294|590352494|FG001|Overall Study|Randomized but not Treated|0|||
163451127|NCT01100307|590352495|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
163451128|NCT01100307|590352496|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
163451129|NCT01100307|590352495|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
163451130|NCT01100307|590352496|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
163451131|NCT01100307|590352495|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
163451132|NCT01100307|590352496|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
163451133|NCT01100307|590352495|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
163451134|NCT01100307|590352496|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
163451135|NCT01100307|590352495|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
163451136|NCT01100307|590352496|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
163451137|NCT01100307|590352495|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
163451138|NCT01100307|590352496|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
163451139|NCT01496430|590352497|FG000|Overall Study|Adverse Event|0|||
163451140|NCT01496430|590352498|FG001|Overall Study|Adverse Event|0|||
163451141|NCT01496430|590352499|FG002|Overall Study|Adverse Event|1|||
163451142|NCT01496430|590352497|FG000|Overall Study|Major Protocol Deviation|0|||
163451143|NCT01496430|590352498|FG001|Overall Study|Major Protocol Deviation|0|||
163451144|NCT01496430|590352499|FG002|Overall Study|Major Protocol Deviation|1|||
163451145|NCT01496430|590352497|FG000|Overall Study|Lost to Follow-up|2|||
163451146|NCT01496430|590352498|FG001|Overall Study|Lost to Follow-up|3|||
163451147|NCT01496430|590352499|FG002|Overall Study|Lost to Follow-up|1|||
163451148|NCT01496430|590352497|FG000|Overall Study|Voluntary Withdrawal|2|||
163451149|NCT01496430|590352498|FG001|Overall Study|Voluntary Withdrawal|1|||
163451150|NCT01496430|590352499|FG002|Overall Study|Voluntary Withdrawal|6|||
163451151|NCT01496430|590352497|FG000|Overall Study|Principal Investigator Discretion|0|||
163451152|NCT01496430|590352498|FG001|Overall Study|Principal Investigator Discretion|1|||
163451153|NCT01496430|590352499|FG002|Overall Study|Principal Investigator Discretion|1|||
163451154|NCT01496430|590352497|FG000|Overall Study|Other|2|||
163451155|NCT01496430|590352498|FG001|Overall Study|Other|0|||
163451156|NCT01496430|590352499|FG002|Overall Study|Other|0|||
163451157|NCT02108951|590352500|FG000|Overall Study|Lost to Follow-up|1|||
163451158|NCT02108951|590352500|FG000|Overall Study|Patient's/guardian's decision|1|||
163451159|NCT02108951|590352500|FG000|Overall Study|Study Terminated by Sponsor|14|||
163451160|NCT00997321|590352501|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
163451161|NCT00997321|590352502|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
163451162|NCT01151579|590352511|FG000|Overall Study|Physician Decision|3|||
163451163|NCT01151579|590352512|FG001|Overall Study|Physician Decision|1|||
163451164|NCT01151579|590352511|FG000|Overall Study|Withdrawal by Subject|3|||
163451165|NCT01151579|590352512|FG001|Overall Study|Withdrawal by Subject|2|||
163451166|NCT01151579|590352511|FG000|Overall Study|Not meet inclusion criteria|6|||
163451167|NCT01151579|590352512|FG001|Overall Study|Not meet inclusion criteria|4|||
163451168|NCT00608530|590352513|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
163451169|NCT00608530|590352514|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
163451170|NCT00608530|590352515|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
163451171|NCT00608530|590352516|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
163451172|NCT00608530|590352513|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
163451173|NCT00608530|590352514|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
163451174|NCT00608530|590352515|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
163451175|NCT00608530|590352516|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
163451176|NCT00608530|590352513|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
163451177|NCT00608530|590352514|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
163451178|NCT00608530|590352515|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
163451179|NCT00608530|590352516|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
163451180|NCT00608530|590352513|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
163451181|NCT00608530|590352514|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
163451182|NCT00608530|590352515|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
163451183|NCT00608530|590352516|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
163451184|NCT00608530|590352513|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
163451185|NCT00608530|590352514|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
163451186|NCT00608530|590352515|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
163451187|NCT00608530|590352516|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
163451188|NCT00608530|590352513|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
163451189|NCT00608530|590352514|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
163451190|NCT00608530|590352515|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
163451191|NCT00608530|590352516|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
163451192|NCT00077610|590352517|FG000|Overall Study|Adverse Event|9|||
163451193|NCT00077610|590352518|FG001|Overall Study|Adverse Event|7|||
163451194|NCT00077610|590352519|FG002|Overall Study|Adverse Event|1|||
163451195|NCT00077610|590352517|FG000|Overall Study|Lost to Follow-up|0|||
163451196|NCT00077610|590352518|FG001|Overall Study|Lost to Follow-up|1|||
163451197|NCT00077610|590352519|FG002|Overall Study|Lost to Follow-up|2|||
163451198|NCT00077610|590352517|FG000|Overall Study|Withdrawal by Subject|4|||
163451199|NCT00077610|590352518|FG001|Overall Study|Withdrawal by Subject|10|||
163451200|NCT00077610|590352519|FG002|Overall Study|Withdrawal by Subject|6|||
163451201|NCT00077610|590352517|FG000|Overall Study|Death|17|||
163451202|NCT00077610|590352518|FG001|Overall Study|Death|13|||
163451203|NCT00077610|590352519|FG002|Overall Study|Death|13|||
163451204|NCT00077610|590352517|FG000|Overall Study|Renal transplant|12|||
163451205|NCT00077610|590352518|FG001|Overall Study|Renal transplant|15|||
163451206|NCT00077610|590352519|FG002|Overall Study|Renal transplant|11|||
163451207|NCT00077610|590352517|FG000|Overall Study|Withdrew from dialysis care|5|||
163451208|NCT00077610|590352518|FG001|Overall Study|Withdrew from dialysis care|0|||
163451209|NCT00077610|590352519|FG002|Overall Study|Withdrew from dialysis care|3|||
163451210|NCT00077610|590352517|FG000|Overall Study|Insufficient Therapeutic Response|1|||
163451211|NCT00077610|590352518|FG001|Overall Study|Insufficient Therapeutic Response|0|||
163451212|NCT00077610|590352519|FG002|Overall Study|Insufficient Therapeutic Response|0|||
163451213|NCT00077610|590352517|FG000|Overall Study|Multiple blood transfusions|0|||
163451214|NCT00077610|590352518|FG001|Overall Study|Multiple blood transfusions|0|||
163451215|NCT00077610|590352519|FG002|Overall Study|Multiple blood transfusions|1|||
163451216|NCT00077610|590352517|FG000|Overall Study|Principal Investigator's decision|1|||
163451217|NCT00077610|590352518|FG001|Overall Study|Principal Investigator's decision|0|||
163451218|NCT00077610|590352519|FG002|Overall Study|Principal Investigator's decision|1|||
163451219|NCT00077610|590352517|FG000|Overall Study|Worsening of health condition|1|||
163451220|NCT00077610|590352518|FG001|Overall Study|Worsening of health condition|1|||
163451221|NCT00077610|590352519|FG002|Overall Study|Worsening of health condition|0|||
163451222|NCT00077610|590352517|FG000|Overall Study|Given Epogen in hospital|1|||
163451223|NCT00077610|590352518|FG001|Overall Study|Given Epogen in hospital|0|||
163451224|NCT00077610|590352519|FG002|Overall Study|Given Epogen in hospital|0|||
163451225|NCT00077610|590352517|FG000|Overall Study|Transferred to other unit|0|||
163451226|NCT00077610|590352518|FG001|Overall Study|Transferred to other unit|0|||
163451227|NCT00077610|590352519|FG002|Overall Study|Transferred to other unit|1|||
163451228|NCT00077610|590352517|FG000|Overall Study|Transferred to nursing home|0|||
163451229|NCT00077610|590352518|FG001|Overall Study|Transferred to nursing home|0|||
163451230|NCT00077610|590352519|FG002|Overall Study|Transferred to nursing home|1|||
163451231|NCT00077610|590352517|FG000|Overall Study|Transfer to satellite unit|1|||
163451232|NCT00077610|590352518|FG001|Overall Study|Transfer to satellite unit|0|||
163451233|NCT00077610|590352519|FG002|Overall Study|Transfer to satellite unit|0|||
163451234|NCT00077610|590352517|FG000|Overall Study|Transfer to other center for surgery|1|||
163451235|NCT00077610|590352518|FG001|Overall Study|Transfer to other center for surgery|0|||
163451236|NCT00077610|590352519|FG002|Overall Study|Transfer to other center for surgery|0|||
163451237|NCT00077610|590352517|FG000|Overall Study|Change in dialysis modality|1|||
163451238|NCT00077610|590352518|FG001|Overall Study|Change in dialysis modality|0|||
163451239|NCT00077610|590352519|FG002|Overall Study|Change in dialysis modality|0|||
163451240|NCT00077610|590352517|FG000|Overall Study|Relocation|0|||
163451241|NCT00077610|590352518|FG001|Overall Study|Relocation|8|||
163451242|NCT00077610|590352519|FG002|Overall Study|Relocation|5|||
163451243|NCT00077610|590352517|FG000|Overall Study|Financial issues|0|||
163451244|NCT00077610|590352518|FG001|Overall Study|Financial issues|1|||
163451245|NCT00077610|590352519|FG002|Overall Study|Financial issues|0|||
163451246|NCT00077610|590352517|FG000|Overall Study|Sponsors decision to withdraw|0|||
163451247|NCT00077610|590352518|FG001|Overall Study|Sponsors decision to withdraw|0|||
163451248|NCT00077610|590352519|FG002|Overall Study|Sponsors decision to withdraw|1|||
163451249|NCT01357915|590352525|FG000|Overall Study|Lost to Follow-up|3|||
163451250|NCT01357915|590352526|FG001|Overall Study|Lost to Follow-up|0|||
163451251|NCT00305253|590352527|FG000|Overall Study|Withdrawal by Subject|0|||
163451252|NCT00305253|590352528|FG001|Overall Study|Withdrawal by Subject|1|||
163451253|NCT01098461|590352529|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
163451254|NCT01098461|590352530|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
163451255|NCT01098461|590352531|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
163451256|NCT01098461|590352532|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
163451257|NCT01098461|590352529|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
163451258|NCT01098461|590352530|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
163451259|NCT01098461|590352531|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
163451260|NCT01098461|590352532|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
163451261|NCT01098461|590352529|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
163451262|NCT01098461|590352530|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
163451263|NCT01098461|590352531|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
163451264|NCT01098461|590352532|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
163451265|NCT01098461|590352529|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
163451266|NCT01098461|590352530|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
163451267|NCT01098461|590352531|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
163451268|NCT01098461|590352532|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
163451269|NCT01098461|590352529|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
163451270|NCT01098461|590352530|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
163451271|NCT01098461|590352531|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
163451272|NCT01098461|590352532|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
163451273|NCT01098461|590352529|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
163451274|NCT01098461|590352530|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
163451275|NCT01098461|590352531|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
163451276|NCT01098461|590352532|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
163451277|NCT01098461|590352529|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
163451278|NCT01098461|590352530|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
163451279|NCT01098461|590352531|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
163451280|NCT01098461|590352532|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
163451281|NCT02662985|590352533|FG000|Treatment Period 1|Adverse Event|0|||
163451282|NCT02662985|590352534|FG001|Treatment Period 1|Adverse Event|2|||
163451283|NCT02662985|590352533|FG000|Treatment Period 1|Protocol Violation|0|||
163451284|NCT02662985|590352534|FG001|Treatment Period 1|Protocol Violation|1|||
163451285|NCT02662985|590352533|FG000|Treatment Period 1|Physician Decision|1|||
163451286|NCT02662985|590352534|FG001|Treatment Period 1|Physician Decision|0|||
163451287|NCT02662985|590352533|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163451288|NCT02662985|590352534|FG001|Treatment Period 1|Withdrawal by Subject|1|||
163451289|NCT02662985|590352533|FG000|Treatment Period 2|Lack of Efficacy|0|||
163451290|NCT02662985|590352534|FG001|Treatment Period 2|Lack of Efficacy|1|||
163451291|NCT02662985|590352533|FG000|Treatment Period 2|Lost to Follow-up|1|||
163451292|NCT02662985|590352534|FG001|Treatment Period 2|Lost to Follow-up|0|||
163451293|NCT02662985|590352533|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
163451294|NCT02662985|590352534|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
163451295|NCT02662985|590352533|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
163451296|NCT02662985|590352534|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
163451297|NCT02662985|590352533|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
163451298|NCT02662985|590352534|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
163451299|NCT02662985|590352533|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
163451300|NCT02662985|590352534|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
163451301|NCT02662985|590352533|FG000|Treatment Period 3 (Extension Period)|Death|0|||
163451302|NCT02662985|590352534|FG001|Treatment Period 3 (Extension Period)|Death|1|||
163451303|NCT01153763|590352535|FG000|Overall Study|Study Closed|16|||
163451304|NCT01153763|590352535|FG000|Overall Study|Lost to Follow-up|1|||
163451305|NCT01153763|590352535|FG000|Overall Study|Physician Decision|2|||
163451306|NCT01153763|590352535|FG000|Overall Study|Withdrawal by Subject|2|||
163451307|NCT01486784|590352536|FG000|Overall Study|Withdrawal by Subject|0|||
163451308|NCT01486784|590352537|FG001|Overall Study|Withdrawal by Subject|0|||
163451309|NCT01486784|590352538|FG002|Overall Study|Withdrawal by Subject|1|||
163451310|NCT01486784|590352539|FG003|Overall Study|Withdrawal by Subject|0|||
163451311|NCT01486784|590352540|FG004|Overall Study|Withdrawal by Subject|1|||
163451312|NCT01486784|590352541|FG005|Overall Study|Withdrawal by Subject|2|||
163451313|NCT01486784|590352536|FG000|Overall Study|Subject did not meet entry criteria|0|||
163451314|NCT01486784|590352537|FG001|Overall Study|Subject did not meet entry criteria|0|||
163451315|NCT01486784|590352538|FG002|Overall Study|Subject did not meet entry criteria|0|||
163451316|NCT01486784|590352539|FG003|Overall Study|Subject did not meet entry criteria|0|||
163451317|NCT01486784|590352540|FG004|Overall Study|Subject did not meet entry criteria|1|||
163451318|NCT01486784|590352541|FG005|Overall Study|Subject did not meet entry criteria|0|||
163451319|NCT01486784|590352536|FG000|Overall Study|Death|0|||
163451320|NCT01486784|590352537|FG001|Overall Study|Death|0|||
163451321|NCT01486784|590352538|FG002|Overall Study|Death|0|||
163451322|NCT01486784|590352539|FG003|Overall Study|Death|0|||
163451323|NCT01486784|590352540|FG004|Overall Study|Death|0|||
163451324|NCT01486784|590352541|FG005|Overall Study|Death|1|||
163451325|NCT03491553|590352542|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
163451326|NCT03491553|590352543|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
163451327|NCT03491553|590352544|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
163451328|NCT03491553|590352545|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
163451329|NCT03491553|590352546|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
163451330|NCT03491553|590352547|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
163451331|NCT03491553|590352542|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
163451332|NCT03491553|590352543|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
163451333|NCT03491553|590352544|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
163451334|NCT03491553|590352545|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
163451335|NCT03491553|590352546|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
163451336|NCT03491553|590352547|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
163451337|NCT03633227|590352548|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
163451338|NCT03633227|590352549|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
163451339|NCT03633227|590352548|FG000|Double Blind (DB), up to Week 48|Death|2|||
163451340|NCT03633227|590352549|FG001|Double Blind (DB), up to Week 48|Death|1|||
163451341|NCT03633227|590352548|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
163451342|NCT03633227|590352549|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
163451343|NCT03633227|590352548|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
163451344|NCT03633227|590352549|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
163451345|NCT03633227|590352548|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
163451346|NCT03633227|590352549|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
163451347|NCT03633227|590352548|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
163451348|NCT03633227|590352549|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
163451349|NCT03633227|590352548|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
163451350|NCT03633227|590352549|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
163451351|NCT03633227|590352548|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
163451352|NCT03633227|590352549|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
163451353|NCT03633227|590352548|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
163451354|NCT03633227|590352549|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
163451355|NCT03633227|590352548|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
163451356|NCT03633227|590352549|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
163451357|NCT03633227|590352548|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
163451358|NCT03633227|590352549|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
163451359|NCT03633227|590352548|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
163451360|NCT03633227|590352549|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
163451361|NCT01479374|590352557|FG000|Overall Study|Adverse Event|2|||
163451362|NCT01479374|590352558|FG001|Overall Study|Adverse Event|1|||
163451363|NCT01479374|590352559|FG002|Overall Study|Adverse Event|0|||
163451364|NCT01479374|590352557|FG000|Overall Study|Lost to Follow-up|1|||
163451365|NCT01479374|590352558|FG001|Overall Study|Lost to Follow-up|2|||
163451366|NCT01479374|590352559|FG002|Overall Study|Lost to Follow-up|0|||
163451367|NCT01479374|590352557|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
163451368|NCT01479374|590352558|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
163451369|NCT01479374|590352559|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
163451370|NCT01479374|590352557|FG000|Overall Study|Other|0|||
163451371|NCT01479374|590352558|FG001|Overall Study|Other|4|||
163451372|NCT01479374|590352559|FG002|Overall Study|Other|5|||
163451373|NCT01606761|590352560|FG000|Prior to Week 24|Lost to Follow-up|0|||
163451374|NCT01606761|590352561|FG001|Prior to Week 24|Lost to Follow-up|3|||
163451375|NCT01606761|590352562|FG002|Prior to Week 24|Lost to Follow-up|2|||
163451376|NCT01606761|590352563|FG003|Prior to Week 24|Lost to Follow-up|0|||
163451377|NCT01606761|590352564|FG004|Prior to Week 24|Lost to Follow-up|0|||
163451378|NCT01606761|590352560|FG000|Prior to Week 24|Withdrawal by Subject|12|||
163451379|NCT01606761|590352561|FG001|Prior to Week 24|Withdrawal by Subject|10|||
163451380|NCT01606761|590352562|FG002|Prior to Week 24|Withdrawal by Subject|9|||
163451381|NCT01606761|590352563|FG003|Prior to Week 24|Withdrawal by Subject|0|||
163451382|NCT01606761|590352564|FG004|Prior to Week 24|Withdrawal by Subject|0|||
163451383|NCT01606761|590352560|FG000|Prior to Week 24|Adverse Event|11|||
163451384|NCT01606761|590352561|FG001|Prior to Week 24|Adverse Event|18|||
163451385|NCT01606761|590352562|FG002|Prior to Week 24|Adverse Event|22|||
163451386|NCT01606761|590352563|FG003|Prior to Week 24|Adverse Event|0|||
163451387|NCT01606761|590352564|FG004|Prior to Week 24|Adverse Event|0|||
163451388|NCT01606761|590352560|FG000|Prior to Week 24|Lack of Efficacy|15|||
163451389|NCT01606761|590352561|FG001|Prior to Week 24|Lack of Efficacy|14|||
163451390|NCT01606761|590352562|FG002|Prior to Week 24|Lack of Efficacy|8|||
163451391|NCT01606761|590352563|FG003|Prior to Week 24|Lack of Efficacy|0|||
163451392|NCT01606761|590352564|FG004|Prior to Week 24|Lack of Efficacy|0|||
163451393|NCT01606761|590352560|FG000|Prior to Week 24|Physician Decision|0|||
163451394|NCT01606761|590352561|FG001|Prior to Week 24|Physician Decision|3|||
163451395|NCT01606761|590352562|FG002|Prior to Week 24|Physician Decision|1|||
163451396|NCT01606761|590352563|FG003|Prior to Week 24|Physician Decision|0|||
163451397|NCT01606761|590352564|FG004|Prior to Week 24|Physician Decision|0|||
163451398|NCT01606761|590352560|FG000|Prior to Week 24|Other|4|||
163451399|NCT01606761|590352561|FG001|Prior to Week 24|Other|7|||
163451400|NCT01606761|590352562|FG002|Prior to Week 24|Other|5|||
163451401|NCT01606761|590352563|FG003|Prior to Week 24|Other|0|||
163451402|NCT01606761|590352564|FG004|Prior to Week 24|Other|0|||
163451403|NCT01606761|590352560|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
163451404|NCT01606761|590352561|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
163451405|NCT01606761|590352562|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
163451406|NCT01606761|590352563|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
163451407|NCT01606761|590352564|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
163451408|NCT01606761|590352560|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
163451409|NCT01606761|590352561|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
163451410|NCT01606761|590352562|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
163451411|NCT01606761|590352563|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
163451412|NCT01606761|590352564|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
163451413|NCT01606761|590352560|FG000|Week 24 to Week 52|Adverse Event|0|||
163451414|NCT01606761|590352561|FG001|Week 24 to Week 52|Adverse Event|11|||
163451415|NCT01606761|590352562|FG002|Week 24 to Week 52|Adverse Event|14|||
163451416|NCT01606761|590352563|FG003|Week 24 to Week 52|Adverse Event|3|||
163451417|NCT01606761|590352564|FG004|Week 24 to Week 52|Adverse Event|15|||
163451418|NCT01606761|590352560|FG000|Week 24 to Week 52|Death|0|||
163451419|NCT01606761|590352561|FG001|Week 24 to Week 52|Death|0|||
163451420|NCT01606761|590352562|FG002|Week 24 to Week 52|Death|2|||
163451421|NCT01606761|590352563|FG003|Week 24 to Week 52|Death|1|||
163451422|NCT01606761|590352564|FG004|Week 24 to Week 52|Death|0|||
163451423|NCT01606761|590352560|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
163451424|NCT01606761|590352561|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
163451425|NCT01606761|590352562|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
163451426|NCT01606761|590352563|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
163451427|NCT01606761|590352564|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
163451428|NCT01606761|590352560|FG000|Week 24 to Week 52|Physician Decision|0|||
163451429|NCT01606761|590352561|FG001|Week 24 to Week 52|Physician Decision|1|||
163451430|NCT01606761|590352562|FG002|Week 24 to Week 52|Physician Decision|1|||
163451431|NCT01606761|590352563|FG003|Week 24 to Week 52|Physician Decision|0|||
163451432|NCT01606761|590352564|FG004|Week 24 to Week 52|Physician Decision|0|||
163451433|NCT01606761|590352560|FG000|Week 24 to Week 52|Other|0|||
163451434|NCT01606761|590352561|FG001|Week 24 to Week 52|Other|1|||
163451435|NCT01606761|590352562|FG002|Week 24 to Week 52|Other|5|||
163451436|NCT01606761|590352563|FG003|Week 24 to Week 52|Other|2|||
163451437|NCT01606761|590352564|FG004|Week 24 to Week 52|Other|2|||
163451438|NCT01606761|590352560|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
163451439|NCT01606761|590352561|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
163451440|NCT01606761|590352562|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
163451441|NCT01606761|590352563|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
163451442|NCT01606761|590352564|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
163451443|NCT01606761|590352560|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
163451444|NCT01606761|590352561|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
163451445|NCT01606761|590352562|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
163451446|NCT01606761|590352563|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
163451447|NCT01606761|590352564|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
163451448|NCT01606761|590352560|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
163451449|NCT01606761|590352561|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
163451450|NCT01606761|590352562|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
163451451|NCT01606761|590352563|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
163451452|NCT01606761|590352564|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
163451453|NCT01606761|590352560|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
163451454|NCT01606761|590352561|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
163451455|NCT01606761|590352562|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
163451456|NCT01606761|590352563|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
163451457|NCT01606761|590352564|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
163451458|NCT03073213|590354015|FG000|Multiple Dose Period|Protocol Violation|0|||
163451459|NCT03073213|590354016|FG001|Multiple Dose Period|Protocol Violation|0|||
163451460|NCT03073213|590354017|FG002|Multiple Dose Period|Protocol Violation|1|||
163451461|NCT01120379|590354036|FG000|One Year Timepoint|Withdrawal by Subject|41|||
163451462|NCT01120379|590354036|FG000|One Year Timepoint|Lost to Follow-up|115|||
163451463|NCT01120379|590354036|FG000|One Year Timepoint|Death|108|||
163451464|NCT01120379|590354036|FG000|One Year Timepoint|Physician Decision|9|||
163451465|NCT01120379|590354036|FG000|One Year Timepoint|Any other reason for early termination|5|||
163451466|NCT01120379|590354036|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
163451467|NCT01120379|590354036|FG000|Two Year Timepoint|Lost to Follow-up|87|||
163451468|NCT01120379|590354036|FG000|Two Year Timepoint|Death|123|||
163451469|NCT01120379|590354036|FG000|Two Year Timepoint|Physician Decision|12|||
163451470|NCT01120379|590354036|FG000|Two Year Timepoint|Any other reason for early termination|4|||
163451471|NCT01120379|590354036|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
163451472|NCT01120379|590354036|FG000|Three Year Timepoint|Lost to Follow-up|43|||
163451473|NCT01120379|590354036|FG000|Three Year Timepoint|Death|120|||
163451474|NCT01120379|590354036|FG000|Three Year Timepoint|Physician Decision|9|||
163451475|NCT01120379|590354036|FG000|Three Year Timepoint|Any other reason for early termination|17|||
163451476|NCT01120379|590354036|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
163451477|NCT01120379|590354036|FG000|Four Year Timepoint|Lost to Follow-up|10|||
163451478|NCT01120379|590354036|FG000|Four Year Timepoint|Death|131|||
163451479|NCT01120379|590354036|FG000|Four Year Timepoint|Physician Decision|5|||
163451480|NCT01120379|590354036|FG000|Four Year Timepoint|Any other reason for early termination|217|||
163451481|NCT03162055|590354037|FG000|Overall Study|Adverse Event|6|||
163451482|NCT03162055|590354038|FG001|Overall Study|Adverse Event|5|||
163451483|NCT03162055|590354037|FG000|Overall Study|Death|3|||
163451484|NCT03162055|590354038|FG001|Overall Study|Death|3|||
163451485|NCT03162055|590354037|FG000|Overall Study|Lost to Follow-up|0|||
163451486|NCT03162055|590354038|FG001|Overall Study|Lost to Follow-up|1|||
163451487|NCT03162055|590354037|FG000|Overall Study|Study-specific withdrawal criteria|22|||
163451488|NCT03162055|590354038|FG001|Overall Study|Study-specific withdrawal criteria|14|||
163451489|NCT03162055|590354037|FG000|Overall Study|Withdrawal by Subject|17|||
163451490|NCT03162055|590354038|FG001|Overall Study|Withdrawal by Subject|2|||
163451491|NCT03162055|590354037|FG000|Overall Study|Did not receive treatment|2|||
163451492|NCT03162055|590354038|FG001|Overall Study|Did not receive treatment|0|||
163451493|NCT03162055|590354037|FG000|Overall Study|Incorrect randomization|4|||
163451494|NCT03162055|590354038|FG001|Overall Study|Incorrect randomization|3|||
163451495|NCT03162055|590354037|FG000|Overall Study|Other|8|||
163451496|NCT03162055|590354038|FG001|Overall Study|Other|15|||
163451497|NCT04031404|590354039|FG000|Baseline|Lost to Follow-up|0|||
163451498|NCT04031404|590354040|FG001|Baseline|Lost to Follow-up|1|||
163451499|NCT04031404|590354039|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
163451500|NCT04031404|590354040|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
163451501|NCT04031404|590354039|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
163451502|NCT04031404|590354040|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
163451503|NCT04031404|590354039|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
163451504|NCT04031404|590354040|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
163451505|NCT04031404|590354039|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
163451506|NCT04031404|590354040|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
163451507|NCT01993615|590354044|FG000|Overall Study|Death|1|||
163451508|NCT01993615|590354045|FG001|Overall Study|Death|0|||
163451509|NCT02064205|590354048|FG000|Overall Study|Withdrawal by Subject|1|||
163451510|NCT01354353|590354052|FG000|Overall Study|Adverse Event|1|||
163451511|NCT01354353|590354053|FG001|Overall Study|Adverse Event|0|||
163451512|NCT01354353|590354054|FG002|Overall Study|Adverse Event|0|||
163451513|NCT01354353|590354055|FG003|Overall Study|Adverse Event|4|||
163451514|NCT01354353|590354056|FG004|Overall Study|Adverse Event|0|||
163451515|NCT01354353|590354057|FG005|Overall Study|Adverse Event|5|||
163451516|NCT01354353|590354052|FG000|Overall Study|Entry Criteria Not Met|0|||
163451517|NCT01354353|590354053|FG001|Overall Study|Entry Criteria Not Met|0|||
163451518|NCT01354353|590354054|FG002|Overall Study|Entry Criteria Not Met|0|||
163451519|NCT01354353|590354055|FG003|Overall Study|Entry Criteria Not Met|1|||
163451520|NCT01354353|590354056|FG004|Overall Study|Entry Criteria Not Met|1|||
163451521|NCT01354353|590354057|FG005|Overall Study|Entry Criteria Not Met|0|||
163451522|NCT01354353|590354052|FG000|Overall Study|Physician Decision|0|||
163451523|NCT01354353|590354053|FG001|Overall Study|Physician Decision|1|||
163451524|NCT01354353|590354054|FG002|Overall Study|Physician Decision|1|||
163451525|NCT01354353|590354055|FG003|Overall Study|Physician Decision|0|||
163451526|NCT01354353|590354056|FG004|Overall Study|Physician Decision|0|||
163451527|NCT01354353|590354057|FG005|Overall Study|Physician Decision|0|||
163451528|NCT01354353|590354052|FG000|Overall Study|Withdrawal by Subject|2|||
163451529|NCT01354353|590354053|FG001|Overall Study|Withdrawal by Subject|0|||
163451530|NCT01354353|590354054|FG002|Overall Study|Withdrawal by Subject|1|||
163451531|NCT01354353|590354055|FG003|Overall Study|Withdrawal by Subject|0|||
163451532|NCT01354353|590354056|FG004|Overall Study|Withdrawal by Subject|0|||
163451533|NCT01354353|590354057|FG005|Overall Study|Withdrawal by Subject|1|||
163451534|NCT05674344|590354058|FG000|Overall Study|Screen Fail|21|||
163451535|NCT05674344|590354058|FG000|Overall Study|Incomplete study procedures|3|||
163451536|NCT00111917|590354059|FG000|Overall Study|Withdrawal by Subject|1|||
163451537|NCT00111917|590354060|FG001|Overall Study|Withdrawal by Subject|1|||
163451538|NCT01640925|590354061|FG000|Overall Study|Withdrawal by Subject|1|||
163451539|NCT01640925|590354062|FG001|Overall Study|Withdrawal by Subject|0|||
163451540|NCT01640925|590354061|FG000|Overall Study|Previously enrolled in this trial|13|||
163451541|NCT01640925|590354062|FG001|Overall Study|Previously enrolled in this trial|11|||
163451542|NCT02156492|590354063|FG000|Period 1|No Reason Given|0|||
163451543|NCT02156492|590354064|FG001|Period 1|No Reason Given|1|||
163451544|NCT02156492|590354065|FG002|Period 1|No Reason Given|0|||
163451545|NCT02156492|590354063|FG000|Period 3|Adverse Event|0|||
163451546|NCT02156492|590354064|FG001|Period 3|Adverse Event|1|||
163451547|NCT02156492|590354065|FG002|Period 3|Adverse Event|0|||
163451548|NCT03225716|590354070|FG000|Overall Study|Withdrawal by Subject|2|||
163451549|NCT03225716|590354071|FG001|Overall Study|Withdrawal by Subject|2|||
163451550|NCT03225716|590354072|FG002|Overall Study|Withdrawal by Subject|0|||
163451551|NCT03225716|590354070|FG000|Overall Study|Lack of Efficacy|1|||
163451552|NCT03225716|590354071|FG001|Overall Study|Lack of Efficacy|0|||
163451553|NCT03225716|590354072|FG002|Overall Study|Lack of Efficacy|0|||
163451554|NCT03225716|590354070|FG000|Overall Study|Adverse Event|2|||
163451555|NCT03225716|590354071|FG001|Overall Study|Adverse Event|0|||
163451556|NCT03225716|590354072|FG002|Overall Study|Adverse Event|1|||
163451557|NCT03225716|590354070|FG000|Overall Study|Study early termination by Sponsor|0|||
163451558|NCT03225716|590354071|FG001|Overall Study|Study early termination by Sponsor|0|||
163451559|NCT03225716|590354072|FG002|Overall Study|Study early termination by Sponsor|2|||
163451560|NCT00848250|590354073|FG000|Overall Study|surgery was completed without cardiopulm|0|||
163451561|NCT00848250|590354074|FG001|Overall Study|surgery was completed without cardiopulm|1|||
163451562|NCT02883049|590354075|FG000|Induction|Adverse Event|52|||
163451563|NCT02883049|590354076|FG001|Induction|Adverse Event|2|||
163451564|NCT02883049|590354077|FG002|Induction|Adverse Event|0|||
163451565|NCT02883049|590354078|FG003|Induction|Adverse Event|0|||
163451566|NCT02883049|590354079|FG004|Induction|Adverse Event|0|||
163451567|NCT02883049|590354080|FG005|Induction|Adverse Event|0|||
163451568|NCT02883049|590354081|FG006|Induction|Adverse Event|0|||
163451569|NCT02883049|590354082|FG007|Induction|Adverse Event|0|||
163451570|NCT02883049|590354083|FG008|Induction|Adverse Event|0|||
163451571|NCT02883049|590354084|FG009|Induction|Adverse Event|0|||
163451572|NCT02883049|590354085|FG010|Induction|Adverse Event|0|||
163451573|NCT02883049|590354086|FG011|Induction|Adverse Event|0|||
163451574|NCT02883049|590354087|FG012|Induction|Adverse Event|0|||
163451575|NCT02883049|590354088|FG013|Induction|Adverse Event|0|||
163451576|NCT02883049|590354089|FG014|Induction|Adverse Event|0|||
163451577|NCT02883049|590354090|FG015|Induction|Adverse Event|0|||
163451578|NCT02883049|590354075|FG000|Induction|Death|76|||
163451579|NCT02883049|590354076|FG001|Induction|Death|8|||
163451580|NCT02883049|590354077|FG002|Induction|Death|0|||
163451581|NCT02883049|590354078|FG003|Induction|Death|0|||
163451582|NCT02883049|590354079|FG004|Induction|Death|0|||
163451583|NCT02883049|590354080|FG005|Induction|Death|0|||
163451584|NCT02883049|590354081|FG006|Induction|Death|0|||
163451585|NCT02883049|590354082|FG007|Induction|Death|0|||
163451586|NCT02883049|590354083|FG008|Induction|Death|0|||
163451587|NCT02883049|590354084|FG009|Induction|Death|0|||
163451588|NCT02883049|590354085|FG010|Induction|Death|0|||
163451589|NCT02883049|590354086|FG011|Induction|Death|0|||
163451590|NCT02883049|590354087|FG012|Induction|Death|0|||
163451591|NCT02883049|590354088|FG013|Induction|Death|0|||
163451592|NCT02883049|590354089|FG014|Induction|Death|0|||
163451593|NCT02883049|590354090|FG015|Induction|Death|0|||
163451594|NCT02883049|590354075|FG000|Induction|Lost to Follow-up|2|||
163451595|NCT02883049|590354076|FG001|Induction|Lost to Follow-up|0|||
163451596|NCT02883049|590354077|FG002|Induction|Lost to Follow-up|0|||
163451597|NCT02883049|590354078|FG003|Induction|Lost to Follow-up|0|||
163451598|NCT02883049|590354079|FG004|Induction|Lost to Follow-up|0|||
163451599|NCT02883049|590354080|FG005|Induction|Lost to Follow-up|0|||
163451600|NCT02883049|590354081|FG006|Induction|Lost to Follow-up|0|||
163451601|NCT02883049|590354082|FG007|Induction|Lost to Follow-up|0|||
163451602|NCT02883049|590354083|FG008|Induction|Lost to Follow-up|0|||
163451603|NCT02883049|590354084|FG009|Induction|Lost to Follow-up|0|||
163451604|NCT02883049|590354085|FG010|Induction|Lost to Follow-up|0|||
163451605|NCT02883049|590354086|FG011|Induction|Lost to Follow-up|0|||
163451606|NCT02883049|590354087|FG012|Induction|Lost to Follow-up|0|||
163451607|NCT02883049|590354088|FG013|Induction|Lost to Follow-up|0|||
163451608|NCT02883049|590354089|FG014|Induction|Lost to Follow-up|0|||
163451609|NCT02883049|590354090|FG015|Induction|Lost to Follow-up|0|||
163451610|NCT02883049|590354075|FG000|Induction|Physician Decision|1407|||
163451611|NCT02883049|590354076|FG001|Induction|Physician Decision|8|||
163451612|NCT02883049|590354077|FG002|Induction|Physician Decision|0|||
163451613|NCT02883049|590354078|FG003|Induction|Physician Decision|0|||
163451614|NCT02883049|590354079|FG004|Induction|Physician Decision|0|||
163451615|NCT02883049|590354080|FG005|Induction|Physician Decision|0|||
163451616|NCT02883049|590354081|FG006|Induction|Physician Decision|0|||
163451617|NCT02883049|590354082|FG007|Induction|Physician Decision|0|||
163451618|NCT02883049|590354083|FG008|Induction|Physician Decision|0|||
163451619|NCT02883049|590354084|FG009|Induction|Physician Decision|0|||
163451620|NCT02883049|590354085|FG010|Induction|Physician Decision|0|||
163451621|NCT02883049|590354086|FG011|Induction|Physician Decision|0|||
163451622|NCT02883049|590354087|FG012|Induction|Physician Decision|0|||
163451623|NCT02883049|590354088|FG013|Induction|Physician Decision|0|||
163451624|NCT02883049|590354089|FG014|Induction|Physician Decision|0|||
163451625|NCT02883049|590354090|FG015|Induction|Physician Decision|0|||
163451626|NCT02883049|590354075|FG000|Induction|Protocol Violation|6|||
163451627|NCT02883049|590354076|FG001|Induction|Protocol Violation|0|||
163451628|NCT02883049|590354077|FG002|Induction|Protocol Violation|0|||
163451629|NCT02883049|590354078|FG003|Induction|Protocol Violation|0|||
163451630|NCT02883049|590354079|FG004|Induction|Protocol Violation|0|||
163451631|NCT02883049|590354080|FG005|Induction|Protocol Violation|0|||
163451632|NCT02883049|590354081|FG006|Induction|Protocol Violation|0|||
163451633|NCT02883049|590354082|FG007|Induction|Protocol Violation|0|||
163451634|NCT02883049|590354083|FG008|Induction|Protocol Violation|0|||
163451635|NCT02883049|590354084|FG009|Induction|Protocol Violation|0|||
163451636|NCT02883049|590354085|FG010|Induction|Protocol Violation|0|||
163451637|NCT02883049|590354086|FG011|Induction|Protocol Violation|0|||
163451638|NCT02883049|590354087|FG012|Induction|Protocol Violation|0|||
163451639|NCT02883049|590354088|FG013|Induction|Protocol Violation|0|||
163451640|NCT02883049|590354089|FG014|Induction|Protocol Violation|0|||
163451641|NCT02883049|590354090|FG015|Induction|Protocol Violation|0|||
163451642|NCT02883049|590354075|FG000|Induction|Withdrawal by Subject|6|||
163451643|NCT02883049|590354076|FG001|Induction|Withdrawal by Subject|0|||
163451644|NCT02883049|590354077|FG002|Induction|Withdrawal by Subject|0|||
163451645|NCT02883049|590354078|FG003|Induction|Withdrawal by Subject|0|||
163451646|NCT02883049|590354079|FG004|Induction|Withdrawal by Subject|0|||
163451647|NCT02883049|590354080|FG005|Induction|Withdrawal by Subject|0|||
163451648|NCT02883049|590354081|FG006|Induction|Withdrawal by Subject|0|||
163451649|NCT02883049|590354082|FG007|Induction|Withdrawal by Subject|0|||
163451650|NCT02883049|590354083|FG008|Induction|Withdrawal by Subject|0|||
163451651|NCT02883049|590354084|FG009|Induction|Withdrawal by Subject|0|||
163451652|NCT02883049|590354085|FG010|Induction|Withdrawal by Subject|0|||
163451653|NCT02883049|590354086|FG011|Induction|Withdrawal by Subject|0|||
163451654|NCT02883049|590354087|FG012|Induction|Withdrawal by Subject|0|||
163451655|NCT02883049|590354088|FG013|Induction|Withdrawal by Subject|0|||
163451656|NCT02883049|590354089|FG014|Induction|Withdrawal by Subject|0|||
163451657|NCT02883049|590354090|FG015|Induction|Withdrawal by Subject|0|||
163451658|NCT02883049|590354075|FG000|Induction|Ineligible|35|||
163451659|NCT02883049|590354076|FG001|Induction|Ineligible|1|||
163451660|NCT02883049|590354077|FG002|Induction|Ineligible|0|||
163451661|NCT02883049|590354078|FG003|Induction|Ineligible|0|||
163451662|NCT02883049|590354079|FG004|Induction|Ineligible|0|||
163451663|NCT02883049|590354080|FG005|Induction|Ineligible|0|||
163451664|NCT02883049|590354081|FG006|Induction|Ineligible|0|||
163451665|NCT02883049|590354082|FG007|Induction|Ineligible|0|||
163451666|NCT02883049|590354083|FG008|Induction|Ineligible|0|||
163451667|NCT02883049|590354084|FG009|Induction|Ineligible|0|||
163451668|NCT02883049|590354085|FG010|Induction|Ineligible|0|||
163451669|NCT02883049|590354086|FG011|Induction|Ineligible|0|||
163451670|NCT02883049|590354087|FG012|Induction|Ineligible|0|||
163451671|NCT02883049|590354088|FG013|Induction|Ineligible|0|||
163451672|NCT02883049|590354089|FG014|Induction|Ineligible|0|||
163451673|NCT02883049|590354090|FG015|Induction|Ineligible|0|||
163451674|NCT02883049|590354075|FG000|Induction|Refusal of further protocol therapy|466|||
163451675|NCT02883049|590354076|FG001|Induction|Refusal of further protocol therapy|2|||
163451676|NCT02883049|590354077|FG002|Induction|Refusal of further protocol therapy|0|||
163451677|NCT02883049|590354078|FG003|Induction|Refusal of further protocol therapy|0|||
163451678|NCT02883049|590354079|FG004|Induction|Refusal of further protocol therapy|0|||
163451679|NCT02883049|590354080|FG005|Induction|Refusal of further protocol therapy|0|||
163451680|NCT02883049|590354081|FG006|Induction|Refusal of further protocol therapy|0|||
163451681|NCT02883049|590354082|FG007|Induction|Refusal of further protocol therapy|0|||
163451682|NCT02883049|590354083|FG008|Induction|Refusal of further protocol therapy|0|||
163451683|NCT02883049|590354084|FG009|Induction|Refusal of further protocol therapy|0|||
163451684|NCT02883049|590354085|FG010|Induction|Refusal of further protocol therapy|0|||
163451685|NCT02883049|590354086|FG011|Induction|Refusal of further protocol therapy|0|||
163451686|NCT02883049|590354087|FG012|Induction|Refusal of further protocol therapy|0|||
163451687|NCT02883049|590354088|FG013|Induction|Refusal of further protocol therapy|0|||
163451688|NCT02883049|590354089|FG014|Induction|Refusal of further protocol therapy|0|||
163451689|NCT02883049|590354090|FG015|Induction|Refusal of further protocol therapy|0|||
163451690|NCT02883049|590354075|FG000|Induction|Identified as Ph+ patients|279|||
163451691|NCT02883049|590354076|FG001|Induction|Identified as Ph+ patients|1|||
163451692|NCT02883049|590354077|FG002|Induction|Identified as Ph+ patients|0|||
163451693|NCT02883049|590354078|FG003|Induction|Identified as Ph+ patients|0|||
163451694|NCT02883049|590354079|FG004|Induction|Identified as Ph+ patients|0|||
163451695|NCT02883049|590354080|FG005|Induction|Identified as Ph+ patients|0|||
163451696|NCT02883049|590354081|FG006|Induction|Identified as Ph+ patients|0|||
163451697|NCT02883049|590354082|FG007|Induction|Identified as Ph+ patients|0|||
163451698|NCT02883049|590354083|FG008|Induction|Identified as Ph+ patients|0|||
163451699|NCT02883049|590354084|FG009|Induction|Identified as Ph+ patients|0|||
163451700|NCT02883049|590354085|FG010|Induction|Identified as Ph+ patients|0|||
163451701|NCT02883049|590354086|FG011|Induction|Identified as Ph+ patients|0|||
163451702|NCT02883049|590354087|FG012|Induction|Identified as Ph+ patients|0|||
163451703|NCT02883049|590354088|FG013|Induction|Identified as Ph+ patients|0|||
163451704|NCT02883049|590354089|FG014|Induction|Identified as Ph+ patients|0|||
163451705|NCT02883049|590354090|FG015|Induction|Identified as Ph+ patients|0|||
163451706|NCT02883049|590354075|FG000|Induction|M3 Marrow at Day29|8|||
163451707|NCT02883049|590354076|FG001|Induction|M3 Marrow at Day29|1|||
163451708|NCT02883049|590354077|FG002|Induction|M3 Marrow at Day29|0|||
163451709|NCT02883049|590354078|FG003|Induction|M3 Marrow at Day29|0|||
163451710|NCT02883049|590354079|FG004|Induction|M3 Marrow at Day29|0|||
163451711|NCT02883049|590354080|FG005|Induction|M3 Marrow at Day29|0|||
163451712|NCT02883049|590354081|FG006|Induction|M3 Marrow at Day29|0|||
163451713|NCT02883049|590354082|FG007|Induction|M3 Marrow at Day29|0|||
163451714|NCT02883049|590354083|FG008|Induction|M3 Marrow at Day29|0|||
163451715|NCT02883049|590354084|FG009|Induction|M3 Marrow at Day29|0|||
163451716|NCT02883049|590354085|FG010|Induction|M3 Marrow at Day29|0|||
163451717|NCT02883049|590354086|FG011|Induction|M3 Marrow at Day29|0|||
163451718|NCT02883049|590354087|FG012|Induction|M3 Marrow at Day29|0|||
163451719|NCT02883049|590354088|FG013|Induction|M3 Marrow at Day29|0|||
163451720|NCT02883049|590354089|FG014|Induction|M3 Marrow at Day29|0|||
163451721|NCT02883049|590354090|FG015|Induction|M3 Marrow at Day29|0|||
163451722|NCT02883049|590354075|FG000|Induction|Inevaluable|33|||
163451723|NCT02883049|590354076|FG001|Induction|Inevaluable|1|||
163451724|NCT02883049|590354077|FG002|Induction|Inevaluable|0|||
163451725|NCT02883049|590354078|FG003|Induction|Inevaluable|0|||
163451726|NCT02883049|590354079|FG004|Induction|Inevaluable|0|||
163451727|NCT02883049|590354080|FG005|Induction|Inevaluable|0|||
163451728|NCT02883049|590354081|FG006|Induction|Inevaluable|0|||
163451729|NCT02883049|590354082|FG007|Induction|Inevaluable|0|||
163451730|NCT02883049|590354083|FG008|Induction|Inevaluable|0|||
163451731|NCT02883049|590354084|FG009|Induction|Inevaluable|0|||
163451732|NCT02883049|590354085|FG010|Induction|Inevaluable|0|||
163451733|NCT02883049|590354086|FG011|Induction|Inevaluable|0|||
163451734|NCT02883049|590354087|FG012|Induction|Inevaluable|0|||
163451735|NCT02883049|590354088|FG013|Induction|Inevaluable|0|||
163451736|NCT02883049|590354089|FG014|Induction|Inevaluable|0|||
163451737|NCT02883049|590354090|FG015|Induction|Inevaluable|0|||
163451738|NCT02883049|590354075|FG000|Induction|Identified as VHR at end of Induction|244|||
163451739|NCT02883049|590354076|FG001|Induction|Identified as VHR at end of Induction|0|||
163451740|NCT02883049|590354077|FG002|Induction|Identified as VHR at end of Induction|0|||
163451741|NCT02883049|590354078|FG003|Induction|Identified as VHR at end of Induction|0|||
163451742|NCT02883049|590354079|FG004|Induction|Identified as VHR at end of Induction|0|||
163451743|NCT02883049|590354080|FG005|Induction|Identified as VHR at end of Induction|0|||
163451744|NCT02883049|590354081|FG006|Induction|Identified as VHR at end of Induction|0|||
163451745|NCT02883049|590354082|FG007|Induction|Identified as VHR at end of Induction|0|||
163451746|NCT02883049|590354083|FG008|Induction|Identified as VHR at end of Induction|0|||
163451747|NCT02883049|590354084|FG009|Induction|Identified as VHR at end of Induction|0|||
163451748|NCT02883049|590354085|FG010|Induction|Identified as VHR at end of Induction|0|||
163451749|NCT02883049|590354086|FG011|Induction|Identified as VHR at end of Induction|0|||
163451750|NCT02883049|590354087|FG012|Induction|Identified as VHR at end of Induction|0|||
163451751|NCT02883049|590354088|FG013|Induction|Identified as VHR at end of Induction|0|||
163451752|NCT02883049|590354089|FG014|Induction|Identified as VHR at end of Induction|0|||
163451753|NCT02883049|590354090|FG015|Induction|Identified as VHR at end of Induction|0|||
163451754|NCT02883049|590354075|FG000|Induction|Moved to another non-COG institution|3|||
163451755|NCT02883049|590354076|FG001|Induction|Moved to another non-COG institution|0|||
163451756|NCT02883049|590354077|FG002|Induction|Moved to another non-COG institution|0|||
163451757|NCT02883049|590354078|FG003|Induction|Moved to another non-COG institution|0|||
163451758|NCT02883049|590354079|FG004|Induction|Moved to another non-COG institution|0|||
163451759|NCT02883049|590354080|FG005|Induction|Moved to another non-COG institution|0|||
163451760|NCT02883049|590354081|FG006|Induction|Moved to another non-COG institution|0|||
163451761|NCT02883049|590354082|FG007|Induction|Moved to another non-COG institution|0|||
163451762|NCT02883049|590354083|FG008|Induction|Moved to another non-COG institution|0|||
163451763|NCT02883049|590354084|FG009|Induction|Moved to another non-COG institution|0|||
163451764|NCT02883049|590354085|FG010|Induction|Moved to another non-COG institution|0|||
163451765|NCT02883049|590354086|FG011|Induction|Moved to another non-COG institution|0|||
163451766|NCT02883049|590354087|FG012|Induction|Moved to another non-COG institution|0|||
163451767|NCT02883049|590354088|FG013|Induction|Moved to another non-COG institution|0|||
163451768|NCT02883049|590354089|FG014|Induction|Moved to another non-COG institution|0|||
163451769|NCT02883049|590354090|FG015|Induction|Moved to another non-COG institution|0|||
163451770|NCT02883049|590354075|FG000|Induction|Randomization closed|41|||
163451771|NCT02883049|590354076|FG001|Induction|Randomization closed|0|||
163451772|NCT02883049|590354077|FG002|Induction|Randomization closed|0|||
163451773|NCT02883049|590354078|FG003|Induction|Randomization closed|0|||
163451774|NCT02883049|590354079|FG004|Induction|Randomization closed|0|||
163451775|NCT02883049|590354080|FG005|Induction|Randomization closed|0|||
163451776|NCT02883049|590354081|FG006|Induction|Randomization closed|0|||
163451777|NCT02883049|590354082|FG007|Induction|Randomization closed|0|||
163451778|NCT02883049|590354083|FG008|Induction|Randomization closed|0|||
163451779|NCT02883049|590354084|FG009|Induction|Randomization closed|0|||
163451780|NCT02883049|590354085|FG010|Induction|Randomization closed|0|||
163451781|NCT02883049|590354086|FG011|Induction|Randomization closed|0|||
163451782|NCT02883049|590354087|FG012|Induction|Randomization closed|0|||
163451783|NCT02883049|590354088|FG013|Induction|Randomization closed|0|||
163451784|NCT02883049|590354089|FG014|Induction|Randomization closed|0|||
163451785|NCT02883049|590354090|FG015|Induction|Randomization closed|0|||
163451786|NCT02883049|590354075|FG000|Induction|MRD negative|36|||
163451787|NCT02883049|590354076|FG001|Induction|MRD negative|0|||
163451788|NCT02883049|590354077|FG002|Induction|MRD negative|0|||
163451789|NCT02883049|590354078|FG003|Induction|MRD negative|0|||
163451790|NCT02883049|590354079|FG004|Induction|MRD negative|0|||
163451791|NCT02883049|590354080|FG005|Induction|MRD negative|0|||
163451792|NCT02883049|590354081|FG006|Induction|MRD negative|0|||
163451793|NCT02883049|590354082|FG007|Induction|MRD negative|0|||
163451794|NCT02883049|590354083|FG008|Induction|MRD negative|0|||
163451795|NCT02883049|590354084|FG009|Induction|MRD negative|0|||
163451796|NCT02883049|590354085|FG010|Induction|MRD negative|0|||
163451797|NCT02883049|590354086|FG011|Induction|MRD negative|0|||
163451798|NCT02883049|590354087|FG012|Induction|MRD negative|0|||
163451799|NCT02883049|590354088|FG013|Induction|MRD negative|0|||
163451800|NCT02883049|590354089|FG014|Induction|MRD negative|0|||
163451801|NCT02883049|590354090|FG015|Induction|MRD negative|0|||
163451802|NCT02883049|590354075|FG000|Induction|Identified as HR patients|165|||
163451803|NCT02883049|590354076|FG001|Induction|Identified as HR patients|0|||
163451804|NCT02883049|590354077|FG002|Induction|Identified as HR patients|0|||
163451805|NCT02883049|590354078|FG003|Induction|Identified as HR patients|0|||
163451806|NCT02883049|590354079|FG004|Induction|Identified as HR patients|0|||
163451807|NCT02883049|590354080|FG005|Induction|Identified as HR patients|0|||
163451808|NCT02883049|590354081|FG006|Induction|Identified as HR patients|0|||
163451809|NCT02883049|590354082|FG007|Induction|Identified as HR patients|0|||
163451810|NCT02883049|590354083|FG008|Induction|Identified as HR patients|0|||
163451811|NCT02883049|590354084|FG009|Induction|Identified as HR patients|0|||
163451812|NCT02883049|590354085|FG010|Induction|Identified as HR patients|0|||
163451813|NCT02883049|590354086|FG011|Induction|Identified as HR patients|0|||
163451814|NCT02883049|590354087|FG012|Induction|Identified as HR patients|0|||
163451815|NCT02883049|590354088|FG013|Induction|Identified as HR patients|0|||
163451816|NCT02883049|590354089|FG014|Induction|Identified as HR patients|0|||
163451817|NCT02883049|590354090|FG015|Induction|Identified as HR patients|0|||
163451818|NCT02883049|590354075|FG000|Induction|Developed SMN|0|||
163451819|NCT02883049|590354076|FG001|Induction|Developed SMN|1|||
163451820|NCT02883049|590354077|FG002|Induction|Developed SMN|0|||
163451821|NCT02883049|590354078|FG003|Induction|Developed SMN|0|||
163451822|NCT02883049|590354079|FG004|Induction|Developed SMN|0|||
163451823|NCT02883049|590354080|FG005|Induction|Developed SMN|0|||
163451824|NCT02883049|590354081|FG006|Induction|Developed SMN|0|||
163451825|NCT02883049|590354082|FG007|Induction|Developed SMN|0|||
163451826|NCT02883049|590354083|FG008|Induction|Developed SMN|0|||
163451827|NCT02883049|590354084|FG009|Induction|Developed SMN|0|||
163451828|NCT02883049|590354085|FG010|Induction|Developed SMN|0|||
163451829|NCT02883049|590354086|FG011|Induction|Developed SMN|0|||
163451830|NCT02883049|590354087|FG012|Induction|Developed SMN|0|||
163451831|NCT02883049|590354088|FG013|Induction|Developed SMN|0|||
163451832|NCT02883049|590354089|FG014|Induction|Developed SMN|0|||
163451833|NCT02883049|590354090|FG015|Induction|Developed SMN|0|||
163451834|NCT02883049|590354075|FG000|Induction|Enrolled onto another COG study|72|||
163451835|NCT02883049|590354076|FG001|Induction|Enrolled onto another COG study|0|||
163451836|NCT02883049|590354077|FG002|Induction|Enrolled onto another COG study|0|||
163451837|NCT02883049|590354078|FG003|Induction|Enrolled onto another COG study|0|||
163451838|NCT02883049|590354079|FG004|Induction|Enrolled onto another COG study|0|||
163451839|NCT02883049|590354080|FG005|Induction|Enrolled onto another COG study|0|||
163451840|NCT02883049|590354081|FG006|Induction|Enrolled onto another COG study|0|||
163451841|NCT02883049|590354082|FG007|Induction|Enrolled onto another COG study|0|||
163451842|NCT02883049|590354083|FG008|Induction|Enrolled onto another COG study|0|||
163451843|NCT02883049|590354084|FG009|Induction|Enrolled onto another COG study|0|||
163451844|NCT02883049|590354085|FG010|Induction|Enrolled onto another COG study|0|||
163451845|NCT02883049|590354086|FG011|Induction|Enrolled onto another COG study|0|||
163451846|NCT02883049|590354087|FG012|Induction|Enrolled onto another COG study|0|||
163451847|NCT02883049|590354088|FG013|Induction|Enrolled onto another COG study|0|||
163451848|NCT02883049|590354089|FG014|Induction|Enrolled onto another COG study|0|||
163451849|NCT02883049|590354090|FG015|Induction|Enrolled onto another COG study|0|||
163451850|NCT02883049|590354075|FG000|Induction|Incomplete induction data|17|||
163451851|NCT02883049|590354076|FG001|Induction|Incomplete induction data|0|||
163451852|NCT02883049|590354077|FG002|Induction|Incomplete induction data|0|||
163451853|NCT02883049|590354078|FG003|Induction|Incomplete induction data|0|||
163451854|NCT02883049|590354079|FG004|Induction|Incomplete induction data|0|||
163451855|NCT02883049|590354080|FG005|Induction|Incomplete induction data|0|||
163451856|NCT02883049|590354081|FG006|Induction|Incomplete induction data|0|||
163451857|NCT02883049|590354082|FG007|Induction|Incomplete induction data|0|||
163451858|NCT02883049|590354083|FG008|Induction|Incomplete induction data|0|||
163451859|NCT02883049|590354084|FG009|Induction|Incomplete induction data|0|||
163451860|NCT02883049|590354085|FG010|Induction|Incomplete induction data|0|||
163451861|NCT02883049|590354086|FG011|Induction|Incomplete induction data|0|||
163451862|NCT02883049|590354087|FG012|Induction|Incomplete induction data|0|||
163451863|NCT02883049|590354088|FG013|Induction|Incomplete induction data|0|||
163451864|NCT02883049|590354089|FG014|Induction|Incomplete induction data|0|||
163451865|NCT02883049|590354090|FG015|Induction|Incomplete induction data|0|||
163451866|NCT02883049|590354075|FG000|Post Induction|Adverse Event|0|||
163451867|NCT02883049|590354076|FG001|Post Induction|Adverse Event|0|||
163451868|NCT02883049|590354077|FG002|Post Induction|Adverse Event|0|||
163451869|NCT02883049|590354078|FG003|Post Induction|Adverse Event|7|||
163451870|NCT02883049|590354079|FG004|Post Induction|Adverse Event|8|||
163451871|NCT02883049|590354080|FG005|Post Induction|Adverse Event|3|||
163451872|NCT02883049|590354081|FG006|Post Induction|Adverse Event|4|||
163451873|NCT02883049|590354082|FG007|Post Induction|Adverse Event|5|||
163451874|NCT02883049|590354083|FG008|Post Induction|Adverse Event|6|||
163451875|NCT02883049|590354084|FG009|Post Induction|Adverse Event|7|||
163451876|NCT02883049|590354085|FG010|Post Induction|Adverse Event|2|||
163451877|NCT02883049|590354086|FG011|Post Induction|Adverse Event|2|||
163451878|NCT02883049|590354087|FG012|Post Induction|Adverse Event|0|||
163451879|NCT02883049|590354088|FG013|Post Induction|Adverse Event|0|||
163451880|NCT02883049|590354089|FG014|Post Induction|Adverse Event|5|||
163451881|NCT02883049|590354090|FG015|Post Induction|Adverse Event|2|||
163451882|NCT02883049|590354075|FG000|Post Induction|Death|0|||
163451883|NCT02883049|590354076|FG001|Post Induction|Death|0|||
163451884|NCT02883049|590354077|FG002|Post Induction|Death|0|||
163451885|NCT02883049|590354078|FG003|Post Induction|Death|9|||
163451886|NCT02883049|590354079|FG004|Post Induction|Death|9|||
163451887|NCT02883049|590354080|FG005|Post Induction|Death|0|||
163451888|NCT02883049|590354081|FG006|Post Induction|Death|1|||
163451889|NCT02883049|590354082|FG007|Post Induction|Death|6|||
163451890|NCT02883049|590354083|FG008|Post Induction|Death|5|||
163451891|NCT02883049|590354084|FG009|Post Induction|Death|3|||
163451892|NCT02883049|590354085|FG010|Post Induction|Death|1|||
163451893|NCT02883049|590354086|FG011|Post Induction|Death|0|||
163451894|NCT02883049|590354087|FG012|Post Induction|Death|1|||
163451895|NCT02883049|590354088|FG013|Post Induction|Death|1|||
163451896|NCT02883049|590354089|FG014|Post Induction|Death|10|||
163451897|NCT02883049|590354090|FG015|Post Induction|Death|2|||
163451898|NCT02883049|590354075|FG000|Post Induction|Lost to Follow-up|0|||
163451899|NCT02883049|590354076|FG001|Post Induction|Lost to Follow-up|0|||
163451900|NCT02883049|590354077|FG002|Post Induction|Lost to Follow-up|0|||
163451901|NCT02883049|590354078|FG003|Post Induction|Lost to Follow-up|0|||
163451902|NCT02883049|590354079|FG004|Post Induction|Lost to Follow-up|1|||
163451903|NCT02883049|590354080|FG005|Post Induction|Lost to Follow-up|1|||
163451904|NCT02883049|590354081|FG006|Post Induction|Lost to Follow-up|0|||
163451905|NCT02883049|590354082|FG007|Post Induction|Lost to Follow-up|0|||
163451906|NCT02883049|590354083|FG008|Post Induction|Lost to Follow-up|3|||
163451907|NCT02883049|590354084|FG009|Post Induction|Lost to Follow-up|0|||
163451908|NCT02883049|590354085|FG010|Post Induction|Lost to Follow-up|1|||
163451909|NCT02883049|590354086|FG011|Post Induction|Lost to Follow-up|0|||
163451910|NCT02883049|590354087|FG012|Post Induction|Lost to Follow-up|0|||
163451911|NCT02883049|590354088|FG013|Post Induction|Lost to Follow-up|0|||
163451912|NCT02883049|590354089|FG014|Post Induction|Lost to Follow-up|0|||
163451913|NCT02883049|590354090|FG015|Post Induction|Lost to Follow-up|0|||
163451914|NCT02883049|590354075|FG000|Post Induction|Physician Decision|0|||
163451915|NCT02883049|590354076|FG001|Post Induction|Physician Decision|0|||
163451916|NCT02883049|590354077|FG002|Post Induction|Physician Decision|0|||
163451917|NCT02883049|590354078|FG003|Post Induction|Physician Decision|27|||
163451918|NCT02883049|590354079|FG004|Post Induction|Physician Decision|27|||
163451919|NCT02883049|590354080|FG005|Post Induction|Physician Decision|23|||
163451920|NCT02883049|590354081|FG006|Post Induction|Physician Decision|30|||
163451921|NCT02883049|590354082|FG007|Post Induction|Physician Decision|56|||
163451922|NCT02883049|590354083|FG008|Post Induction|Physician Decision|85|||
163451923|NCT02883049|590354084|FG009|Post Induction|Physician Decision|12|||
163451924|NCT02883049|590354085|FG010|Post Induction|Physician Decision|5|||
163451925|NCT02883049|590354086|FG011|Post Induction|Physician Decision|14|||
163451926|NCT02883049|590354087|FG012|Post Induction|Physician Decision|1|||
163451927|NCT02883049|590354088|FG013|Post Induction|Physician Decision|11|||
163451928|NCT02883049|590354089|FG014|Post Induction|Physician Decision|19|||
163451929|NCT02883049|590354090|FG015|Post Induction|Physician Decision|5|||
163451930|NCT02883049|590354075|FG000|Post Induction|Protocol Violation|0|||
163451931|NCT02883049|590354076|FG001|Post Induction|Protocol Violation|0|||
163451932|NCT02883049|590354077|FG002|Post Induction|Protocol Violation|0|||
163451933|NCT02883049|590354078|FG003|Post Induction|Protocol Violation|0|||
163451934|NCT02883049|590354079|FG004|Post Induction|Protocol Violation|0|||
163451935|NCT02883049|590354080|FG005|Post Induction|Protocol Violation|0|||
163451936|NCT02883049|590354081|FG006|Post Induction|Protocol Violation|0|||
163451937|NCT02883049|590354082|FG007|Post Induction|Protocol Violation|1|||
163451938|NCT02883049|590354083|FG008|Post Induction|Protocol Violation|0|||
163451939|NCT02883049|590354084|FG009|Post Induction|Protocol Violation|0|||
163451940|NCT02883049|590354085|FG010|Post Induction|Protocol Violation|0|||
163451941|NCT02883049|590354086|FG011|Post Induction|Protocol Violation|0|||
163451942|NCT02883049|590354087|FG012|Post Induction|Protocol Violation|0|||
163451943|NCT02883049|590354088|FG013|Post Induction|Protocol Violation|0|||
163451944|NCT02883049|590354089|FG014|Post Induction|Protocol Violation|0|||
163451945|NCT02883049|590354090|FG015|Post Induction|Protocol Violation|0|||
163451946|NCT02883049|590354075|FG000|Post Induction|Withdrawal by Subject|0|||
163451947|NCT02883049|590354076|FG001|Post Induction|Withdrawal by Subject|0|||
163451948|NCT02883049|590354077|FG002|Post Induction|Withdrawal by Subject|0|||
163451949|NCT02883049|590354078|FG003|Post Induction|Withdrawal by Subject|5|||
163451950|NCT02883049|590354079|FG004|Post Induction|Withdrawal by Subject|2|||
163451951|NCT02883049|590354080|FG005|Post Induction|Withdrawal by Subject|1|||
163451952|NCT02883049|590354081|FG006|Post Induction|Withdrawal by Subject|0|||
163451953|NCT02883049|590354082|FG007|Post Induction|Withdrawal by Subject|0|||
163451954|NCT02883049|590354083|FG008|Post Induction|Withdrawal by Subject|2|||
163451955|NCT02883049|590354084|FG009|Post Induction|Withdrawal by Subject|0|||
163451956|NCT02883049|590354085|FG010|Post Induction|Withdrawal by Subject|1|||
163451957|NCT02883049|590354086|FG011|Post Induction|Withdrawal by Subject|1|||
163451958|NCT02883049|590354087|FG012|Post Induction|Withdrawal by Subject|0|||
163451959|NCT02883049|590354088|FG013|Post Induction|Withdrawal by Subject|0|||
163451960|NCT02883049|590354089|FG014|Post Induction|Withdrawal by Subject|1|||
163451961|NCT02883049|590354090|FG015|Post Induction|Withdrawal by Subject|0|||
163451962|NCT02883049|590354075|FG000|Post Induction|Ineligible|0|||
163451963|NCT02883049|590354076|FG001|Post Induction|Ineligible|0|||
163451964|NCT02883049|590354077|FG002|Post Induction|Ineligible|2|||
163451965|NCT02883049|590354078|FG003|Post Induction|Ineligible|0|||
163451966|NCT02883049|590354079|FG004|Post Induction|Ineligible|0|||
163451967|NCT02883049|590354080|FG005|Post Induction|Ineligible|0|||
163451968|NCT02883049|590354081|FG006|Post Induction|Ineligible|1|||
163451969|NCT02883049|590354082|FG007|Post Induction|Ineligible|0|||
163451970|NCT02883049|590354083|FG008|Post Induction|Ineligible|0|||
163451971|NCT02883049|590354084|FG009|Post Induction|Ineligible|0|||
163451972|NCT02883049|590354085|FG010|Post Induction|Ineligible|1|||
163451973|NCT02883049|590354086|FG011|Post Induction|Ineligible|0|||
163451974|NCT02883049|590354087|FG012|Post Induction|Ineligible|0|||
163451975|NCT02883049|590354088|FG013|Post Induction|Ineligible|0|||
163451976|NCT02883049|590354089|FG014|Post Induction|Ineligible|0|||
163451977|NCT02883049|590354090|FG015|Post Induction|Ineligible|1|||
163451978|NCT02883049|590354075|FG000|Post Induction|Refusal of further protocol therapy|0|||
163451979|NCT02883049|590354076|FG001|Post Induction|Refusal of further protocol therapy|0|||
163451980|NCT02883049|590354077|FG002|Post Induction|Refusal of further protocol therapy|0|||
163451981|NCT02883049|590354078|FG003|Post Induction|Refusal of further protocol therapy|11|||
163451982|NCT02883049|590354079|FG004|Post Induction|Refusal of further protocol therapy|15|||
163451983|NCT02883049|590354080|FG005|Post Induction|Refusal of further protocol therapy|9|||
163451984|NCT02883049|590354081|FG006|Post Induction|Refusal of further protocol therapy|13|||
163451985|NCT02883049|590354082|FG007|Post Induction|Refusal of further protocol therapy|5|||
163451986|NCT02883049|590354083|FG008|Post Induction|Refusal of further protocol therapy|21|||
163451987|NCT02883049|590354084|FG009|Post Induction|Refusal of further protocol therapy|7|||
163451988|NCT02883049|590354085|FG010|Post Induction|Refusal of further protocol therapy|0|||
163451989|NCT02883049|590354086|FG011|Post Induction|Refusal of further protocol therapy|7|||
163451990|NCT02883049|590354087|FG012|Post Induction|Refusal of further protocol therapy|3|||
163451991|NCT02883049|590354088|FG013|Post Induction|Refusal of further protocol therapy|0|||
163451992|NCT02883049|590354089|FG014|Post Induction|Refusal of further protocol therapy|4|||
163451993|NCT02883049|590354090|FG015|Post Induction|Refusal of further protocol therapy|1|||
163451994|NCT02883049|590354075|FG000|Post Induction|Inevaluable|0|||
163451995|NCT02883049|590354076|FG001|Post Induction|Inevaluable|0|||
163451996|NCT02883049|590354077|FG002|Post Induction|Inevaluable|0|||
163451997|NCT02883049|590354078|FG003|Post Induction|Inevaluable|1|||
163451998|NCT02883049|590354079|FG004|Post Induction|Inevaluable|1|||
163451999|NCT02883049|590354080|FG005|Post Induction|Inevaluable|2|||
163452000|NCT02883049|590354081|FG006|Post Induction|Inevaluable|7|||
163452001|NCT02883049|590354082|FG007|Post Induction|Inevaluable|6|||
163452002|NCT02883049|590354083|FG008|Post Induction|Inevaluable|4|||
163452003|NCT02883049|590354084|FG009|Post Induction|Inevaluable|4|||
163452004|NCT02883049|590354085|FG010|Post Induction|Inevaluable|1|||
163452005|NCT02883049|590354086|FG011|Post Induction|Inevaluable|1|||
163452006|NCT02883049|590354087|FG012|Post Induction|Inevaluable|2|||
163452007|NCT02883049|590354088|FG013|Post Induction|Inevaluable|0|||
163452008|NCT02883049|590354089|FG014|Post Induction|Inevaluable|0|||
163452009|NCT02883049|590354090|FG015|Post Induction|Inevaluable|1|||
163452010|NCT02883049|590354075|FG000|Post Induction|Moved to another non-COG institution|0|||
163452011|NCT02883049|590354076|FG001|Post Induction|Moved to another non-COG institution|0|||
163452012|NCT02883049|590354077|FG002|Post Induction|Moved to another non-COG institution|0|||
163452013|NCT02883049|590354078|FG003|Post Induction|Moved to another non-COG institution|0|||
163452014|NCT02883049|590354079|FG004|Post Induction|Moved to another non-COG institution|0|||
163452015|NCT02883049|590354080|FG005|Post Induction|Moved to another non-COG institution|0|||
163452016|NCT02883049|590354081|FG006|Post Induction|Moved to another non-COG institution|0|||
163452017|NCT02883049|590354082|FG007|Post Induction|Moved to another non-COG institution|2|||
163452018|NCT02883049|590354083|FG008|Post Induction|Moved to another non-COG institution|2|||
163452019|NCT02883049|590354084|FG009|Post Induction|Moved to another non-COG institution|0|||
163452020|NCT02883049|590354085|FG010|Post Induction|Moved to another non-COG institution|0|||
163452021|NCT02883049|590354086|FG011|Post Induction|Moved to another non-COG institution|1|||
163452022|NCT02883049|590354087|FG012|Post Induction|Moved to another non-COG institution|0|||
163452023|NCT02883049|590354088|FG013|Post Induction|Moved to another non-COG institution|0|||
163452024|NCT02883049|590354089|FG014|Post Induction|Moved to another non-COG institution|0|||
163452025|NCT02883049|590354090|FG015|Post Induction|Moved to another non-COG institution|0|||
163452026|NCT02883049|590354075|FG000|Post Induction|Randomization closed|0|||
163452027|NCT02883049|590354076|FG001|Post Induction|Randomization closed|0|||
163452028|NCT02883049|590354077|FG002|Post Induction|Randomization closed|0|||
163452029|NCT02883049|590354078|FG003|Post Induction|Randomization closed|0|||
163452030|NCT02883049|590354079|FG004|Post Induction|Randomization closed|0|||
163452031|NCT02883049|590354080|FG005|Post Induction|Randomization closed|0|||
163452032|NCT02883049|590354081|FG006|Post Induction|Randomization closed|0|||
163452033|NCT02883049|590354082|FG007|Post Induction|Randomization closed|20|||
163452034|NCT02883049|590354083|FG008|Post Induction|Randomization closed|0|||
163452035|NCT02883049|590354084|FG009|Post Induction|Randomization closed|0|||
163452036|NCT02883049|590354085|FG010|Post Induction|Randomization closed|0|||
163452037|NCT02883049|590354086|FG011|Post Induction|Randomization closed|0|||
163452038|NCT02883049|590354087|FG012|Post Induction|Randomization closed|0|||
163452039|NCT02883049|590354088|FG013|Post Induction|Randomization closed|0|||
163452040|NCT02883049|590354089|FG014|Post Induction|Randomization closed|0|||
163452041|NCT02883049|590354090|FG015|Post Induction|Randomization closed|0|||
163452042|NCT02883049|590354075|FG000|Post Induction|MRD negative|0|||
163452043|NCT02883049|590354076|FG001|Post Induction|MRD negative|0|||
163452044|NCT02883049|590354077|FG002|Post Induction|MRD negative|0|||
163452045|NCT02883049|590354078|FG003|Post Induction|MRD negative|0|||
163452046|NCT02883049|590354079|FG004|Post Induction|MRD negative|0|||
163452047|NCT02883049|590354080|FG005|Post Induction|MRD negative|0|||
163452048|NCT02883049|590354081|FG006|Post Induction|MRD negative|0|||
163452049|NCT02883049|590354082|FG007|Post Induction|MRD negative|11|||
163452050|NCT02883049|590354083|FG008|Post Induction|MRD negative|0|||
163452051|NCT02883049|590354084|FG009|Post Induction|MRD negative|0|||
163452052|NCT02883049|590354085|FG010|Post Induction|MRD negative|0|||
163452053|NCT02883049|590354086|FG011|Post Induction|MRD negative|0|||
163452054|NCT02883049|590354087|FG012|Post Induction|MRD negative|0|||
163452055|NCT02883049|590354088|FG013|Post Induction|MRD negative|0|||
163452056|NCT02883049|590354089|FG014|Post Induction|MRD negative|0|||
163452057|NCT02883049|590354090|FG015|Post Induction|MRD negative|0|||
163452058|NCT02883049|590354075|FG000|Post Induction|Developed SMN|0|||
163452059|NCT02883049|590354076|FG001|Post Induction|Developed SMN|0|||
163452060|NCT02883049|590354077|FG002|Post Induction|Developed SMN|0|||
163452061|NCT02883049|590354078|FG003|Post Induction|Developed SMN|0|||
163452062|NCT02883049|590354079|FG004|Post Induction|Developed SMN|1|||
163452063|NCT02883049|590354080|FG005|Post Induction|Developed SMN|0|||
163452064|NCT02883049|590354081|FG006|Post Induction|Developed SMN|1|||
163452065|NCT02883049|590354082|FG007|Post Induction|Developed SMN|0|||
163452066|NCT02883049|590354083|FG008|Post Induction|Developed SMN|0|||
163452067|NCT02883049|590354084|FG009|Post Induction|Developed SMN|0|||
163452068|NCT02883049|590354085|FG010|Post Induction|Developed SMN|1|||
163452069|NCT02883049|590354086|FG011|Post Induction|Developed SMN|1|||
163452070|NCT02883049|590354087|FG012|Post Induction|Developed SMN|0|||
163452071|NCT02883049|590354088|FG013|Post Induction|Developed SMN|0|||
163452072|NCT02883049|590354089|FG014|Post Induction|Developed SMN|1|||
163452073|NCT02883049|590354090|FG015|Post Induction|Developed SMN|0|||
163452074|NCT02883049|590354075|FG000|Post Induction|Enrolled onto another COG study|0|||
163452075|NCT02883049|590354076|FG001|Post Induction|Enrolled onto another COG study|0|||
163452076|NCT02883049|590354077|FG002|Post Induction|Enrolled onto another COG study|0|||
163452077|NCT02883049|590354078|FG003|Post Induction|Enrolled onto another COG study|1|||
163452078|NCT02883049|590354079|FG004|Post Induction|Enrolled onto another COG study|1|||
163452079|NCT02883049|590354080|FG005|Post Induction|Enrolled onto another COG study|0|||
163452080|NCT02883049|590354081|FG006|Post Induction|Enrolled onto another COG study|0|||
163452081|NCT02883049|590354082|FG007|Post Induction|Enrolled onto another COG study|4|||
163452082|NCT02883049|590354083|FG008|Post Induction|Enrolled onto another COG study|0|||
163452083|NCT02883049|590354084|FG009|Post Induction|Enrolled onto another COG study|0|||
163452084|NCT02883049|590354085|FG010|Post Induction|Enrolled onto another COG study|0|||
163452085|NCT02883049|590354086|FG011|Post Induction|Enrolled onto another COG study|2|||
163452086|NCT02883049|590354087|FG012|Post Induction|Enrolled onto another COG study|0|||
163452087|NCT02883049|590354088|FG013|Post Induction|Enrolled onto another COG study|1|||
163452088|NCT02883049|590354089|FG014|Post Induction|Enrolled onto another COG study|0|||
163452089|NCT02883049|590354090|FG015|Post Induction|Enrolled onto another COG study|0|||
163452090|NCT02883049|590354075|FG000|Post Induction|Recurrent leukemia|0|||
163452091|NCT02883049|590354076|FG001|Post Induction|Recurrent leukemia|0|||
163452092|NCT02883049|590354077|FG002|Post Induction|Recurrent leukemia|0|||
163452093|NCT02883049|590354078|FG003|Post Induction|Recurrent leukemia|17|||
163452094|NCT02883049|590354079|FG004|Post Induction|Recurrent leukemia|12|||
163452095|NCT02883049|590354080|FG005|Post Induction|Recurrent leukemia|4|||
163452096|NCT02883049|590354081|FG006|Post Induction|Recurrent leukemia|1|||
163452097|NCT02883049|590354082|FG007|Post Induction|Recurrent leukemia|13|||
163452098|NCT02883049|590354083|FG008|Post Induction|Recurrent leukemia|27|||
163452099|NCT02883049|590354084|FG009|Post Induction|Recurrent leukemia|5|||
163452100|NCT02883049|590354085|FG010|Post Induction|Recurrent leukemia|3|||
163452101|NCT02883049|590354086|FG011|Post Induction|Recurrent leukemia|12|||
163452102|NCT02883049|590354087|FG012|Post Induction|Recurrent leukemia|1|||
163452103|NCT02883049|590354088|FG013|Post Induction|Recurrent leukemia|1|||
163452104|NCT02883049|590354089|FG014|Post Induction|Recurrent leukemia|9|||
163452105|NCT02883049|590354090|FG015|Post Induction|Recurrent leukemia|3|||
163452106|NCT02883049|590354075|FG000|Post Induction|Induction Failure|0|||
163452107|NCT02883049|590354076|FG001|Post Induction|Induction Failure|0|||
163452108|NCT02883049|590354077|FG002|Post Induction|Induction Failure|0|||
163452109|NCT02883049|590354078|FG003|Post Induction|Induction Failure|0|||
163452110|NCT02883049|590354079|FG004|Post Induction|Induction Failure|0|||
163452111|NCT02883049|590354080|FG005|Post Induction|Induction Failure|0|||
163452112|NCT02883049|590354081|FG006|Post Induction|Induction Failure|0|||
163452113|NCT02883049|590354082|FG007|Post Induction|Induction Failure|2|||
163452114|NCT02883049|590354083|FG008|Post Induction|Induction Failure|2|||
163452115|NCT02883049|590354084|FG009|Post Induction|Induction Failure|0|||
163452116|NCT02883049|590354085|FG010|Post Induction|Induction Failure|0|||
163452117|NCT02883049|590354086|FG011|Post Induction|Induction Failure|0|||
163452118|NCT02883049|590354087|FG012|Post Induction|Induction Failure|0|||
163452119|NCT02883049|590354088|FG013|Post Induction|Induction Failure|2|||
163452120|NCT02883049|590354089|FG014|Post Induction|Induction Failure|0|||
163452121|NCT02883049|590354090|FG015|Post Induction|Induction Failure|0|||
163452122|NCT03421964|590354091|FG000|Overall Study|Lost to Follow-up|11|||
163452123|NCT03421964|590354092|FG001|Overall Study|Lost to Follow-up|21|||
163452124|NCT03421964|590354091|FG000|Overall Study|Withdrawal by Subject|9|||
163452125|NCT03421964|590354092|FG001|Overall Study|Withdrawal by Subject|3|||
163452126|NCT03421964|590354091|FG000|Overall Study|Incarcerated|1|||
163452127|NCT03421964|590354092|FG001|Overall Study|Incarcerated|0|||
163452128|NCT03421964|590354091|FG000|Overall Study|Inpt Treatment Facility|1|||
163452129|NCT03421964|590354092|FG001|Overall Study|Inpt Treatment Facility|1|||
163452130|NCT03421964|590354091|FG000|Overall Study|Virtual Platform Issues|1|||
163452131|NCT03421964|590354092|FG001|Overall Study|Virtual Platform Issues|1|||
163452132|NCT03654755|590354095|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
163452133|NCT03654755|590354096|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
163452134|NCT03654755|590354097|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
163452135|NCT03654755|590354095|FG000|Overall Study|Withdrawal by Subject|2|||
163452136|NCT03654755|590354096|FG001|Overall Study|Withdrawal by Subject|4|||
163452137|NCT03654755|590354097|FG002|Overall Study|Withdrawal by Subject|8|||
163452138|NCT03654755|590354095|FG000|Overall Study|Lost to Follow-up|1|||
163452139|NCT03654755|590354096|FG001|Overall Study|Lost to Follow-up|3|||
163452140|NCT03654755|590354097|FG002|Overall Study|Lost to Follow-up|7|||
163452141|NCT03654755|590354095|FG000|Overall Study|Physician Decision|0|||
163452142|NCT03654755|590354096|FG001|Overall Study|Physician Decision|1|||
163452143|NCT03654755|590354097|FG002|Overall Study|Physician Decision|0|||
163452144|NCT03654755|590354095|FG000|Overall Study|Adverse Event|0|||
163452145|NCT03654755|590354096|FG001|Overall Study|Adverse Event|0|||
163452146|NCT03654755|590354097|FG002|Overall Study|Adverse Event|4|||
163452147|NCT03654755|590354095|FG000|Overall Study|Lack of Efficacy|0|||
163452148|NCT03654755|590354096|FG001|Overall Study|Lack of Efficacy|0|||
163452149|NCT03654755|590354097|FG002|Overall Study|Lack of Efficacy|1|||
163452150|NCT05373706|590354102|FG000|Overall Study|Lost to Follow-up|2|||
163452151|NCT05373706|590354103|FG001|Overall Study|Lost to Follow-up|2|||
163452152|NCT05086289|590354104|FG000|Overall Study|Adverse Event|4|||
163452153|NCT05086289|590354105|FG001|Overall Study|Adverse Event|2|||
163452154|NCT05086289|590354104|FG000|Overall Study|Lost to Follow-up|2|||
163452155|NCT05086289|590354105|FG001|Overall Study|Lost to Follow-up|0|||
163452156|NCT05086289|590354104|FG000|Overall Study|Non-compliance with study drug|2|||
163452157|NCT05086289|590354105|FG001|Overall Study|Non-compliance with study drug|1|||
163452158|NCT05086289|590354104|FG000|Overall Study|Physician Decision|2|||
163452159|NCT05086289|590354105|FG001|Overall Study|Physician Decision|0|||
163452160|NCT05086289|590354104|FG000|Overall Study|Withdrawal by Subject|5|||
163452161|NCT05086289|590354105|FG001|Overall Study|Withdrawal by Subject|2|||
163452162|NCT03628508|590354111|FG000|Overall Study|Lost to Follow-up|1|||
163452163|NCT01996748|590354112|FG000|Overall Study|Personal reason|1|||
163452164|NCT01996748|590354113|FG001|Overall Study|Personal reason|0|||
163452165|NCT01996748|590354112|FG000|Overall Study|Physician Decision|2|||
163452166|NCT01996748|590354113|FG001|Overall Study|Physician Decision|0|||
163452167|NCT01996748|590354112|FG000|Overall Study|Adverse Event|1|||
163452168|NCT01996748|590354113|FG001|Overall Study|Adverse Event|4|||
163452169|NCT01996748|590354112|FG000|Overall Study|Withdrawal by Subject|0|||
163452170|NCT01996748|590354113|FG001|Overall Study|Withdrawal by Subject|1|||
163452171|NCT01996748|590354112|FG000|Overall Study|Lost to Follow-up|4|||
163452172|NCT01996748|590354113|FG001|Overall Study|Lost to Follow-up|1|||
163452173|NCT03238235|590354114|FG000|Overall Study|Adverse Event|2|||
163452174|NCT03238235|590354115|FG001|Overall Study|Adverse Event|0|||
163452175|NCT03238235|590354114|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
163452176|NCT03238235|590354115|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
163452177|NCT00243230|590354120|FG000|Double-Blind Period|Adverse Event|0|||
163452178|NCT00243230|590354121|FG001|Double-Blind Period|Adverse Event|2|||
163452179|NCT00243230|590354122|FG002|Double-Blind Period|Adverse Event|2|||
163452180|NCT00243230|590354123|FG003|Double-Blind Period|Adverse Event|0|||
163452181|NCT00243230|590354120|FG000|Double-Blind Period|Withdrawal by Subject|1|||
163452182|NCT00243230|590354121|FG001|Double-Blind Period|Withdrawal by Subject|0|||
163452183|NCT00243230|590354122|FG002|Double-Blind Period|Withdrawal by Subject|0|||
163452184|NCT00243230|590354123|FG003|Double-Blind Period|Withdrawal by Subject|0|||
163452185|NCT00243230|590354120|FG000|Double-Blind Period|Protocol Violation|0|||
163452186|NCT00243230|590354121|FG001|Double-Blind Period|Protocol Violation|0|||
163452187|NCT00243230|590354122|FG002|Double-Blind Period|Protocol Violation|1|||
163452188|NCT00243230|590354123|FG003|Double-Blind Period|Protocol Violation|0|||
163452189|NCT00243230|590354120|FG000|Double-Blind Period|Randomized but Not Treated|0|||
163452190|NCT00243230|590354121|FG001|Double-Blind Period|Randomized but Not Treated|0|||
163452191|NCT00243230|590354122|FG002|Double-Blind Period|Randomized but Not Treated|2|||
163452192|NCT00243230|590354123|FG003|Double-Blind Period|Randomized but Not Treated|0|||
163452193|NCT00243230|590354120|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
163452194|NCT00243230|590354121|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
163452195|NCT00243230|590354122|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
163452196|NCT00243230|590354123|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
163452197|NCT00243230|590354120|FG000|Open Label Period|Adverse Event|0|||
163452198|NCT00243230|590354121|FG001|Open Label Period|Adverse Event|0|||
163452199|NCT00243230|590354122|FG002|Open Label Period|Adverse Event|0|||
163452200|NCT00243230|590354123|FG003|Open Label Period|Adverse Event|2|||
163452201|NCT00243230|590354120|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
163452202|NCT00243230|590354121|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
163452203|NCT00243230|590354122|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
163452204|NCT00243230|590354123|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
163452205|NCT00243230|590354120|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
163452206|NCT00243230|590354121|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
163452207|NCT00243230|590354122|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
163452208|NCT00243230|590354123|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
163452209|NCT00243230|590354120|FG000|Open Label Period|Lost to Follow-up|0|||
163452210|NCT00243230|590354121|FG001|Open Label Period|Lost to Follow-up|0|||
163452211|NCT00243230|590354122|FG002|Open Label Period|Lost to Follow-up|0|||
163452212|NCT00243230|590354123|FG003|Open Label Period|Lost to Follow-up|2|||
163452213|NCT00243230|590354120|FG000|Open Label Period|Withdrawal by Subject|0|||
163452214|NCT00243230|590354121|FG001|Open Label Period|Withdrawal by Subject|0|||
163452215|NCT00243230|590354122|FG002|Open Label Period|Withdrawal by Subject|0|||
163452216|NCT00243230|590354123|FG003|Open Label Period|Withdrawal by Subject|2|||
163452217|NCT00243230|590354120|FG000|Open Label Period|Protocol Violation|0|||
163452218|NCT00243230|590354121|FG001|Open Label Period|Protocol Violation|0|||
163452219|NCT00243230|590354122|FG002|Open Label Period|Protocol Violation|0|||
163452220|NCT00243230|590354123|FG003|Open Label Period|Protocol Violation|2|||
163452221|NCT00243230|590354120|FG000|Open Label Period|Administrative Reason|0|||
163452222|NCT00243230|590354121|FG001|Open Label Period|Administrative Reason|0|||
163452223|NCT00243230|590354122|FG002|Open Label Period|Administrative Reason|0|||
163452224|NCT00243230|590354123|FG003|Open Label Period|Administrative Reason|63|||
163452225|NCT03011840|590354125|FG000|Overall Study|Not received PIL in post PIL phase|0|||
163452226|NCT03011840|590354126|FG001|Overall Study|Not received PIL in post PIL phase|21|||
163452227|NCT03201198|590354132|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
163452228|NCT03201198|590354133|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
163452229|NCT03201198|590354132|FG000|Overall Study|Withdrawal by Subject|2|||
163452230|NCT03201198|590354133|FG001|Overall Study|Withdrawal by Subject|3|||
163452231|NCT00471445|590354134|FG000|Overall Study|Withdrawal by Subject|1|||
163452232|NCT00471445|590354135|FG001|Overall Study|Withdrawal by Subject|1|||
163452233|NCT00471445|590354134|FG000|Overall Study|Ineligible|1|||
163452234|NCT00471445|590354135|FG001|Overall Study|Ineligible|0|||
163452235|NCT00471445|590354134|FG000|Overall Study|Protocol Violation|0|||
163452236|NCT00471445|590354135|FG001|Overall Study|Protocol Violation|1|||
163452237|NCT04715230|590354136|FG000|Overall Study|Withdrawal by Subject|1|||
163452238|NCT04715230|590354137|FG001|Overall Study|Withdrawal by Subject|0|||
163452239|NCT04715230|590354138|FG002|Overall Study|Withdrawal by Subject|0|||
163452240|NCT04715230|590354136|FG000|Overall Study|Lost to Follow-up|0|||
163452241|NCT04715230|590354137|FG001|Overall Study|Lost to Follow-up|5|||
163452242|NCT04715230|590354138|FG002|Overall Study|Lost to Follow-up|1|||
163452243|NCT02596711|590354145|FG000|Overall Study|Lost to Follow-up|1|||
163452244|NCT02596711|590354146|FG001|Overall Study|Lost to Follow-up|2|||
163452245|NCT02596711|590354147|FG002|Overall Study|Lost to Follow-up|3|||
163452246|NCT00586924|590354148|FG000|Overall Study|Adverse event/serious adverse event|0|||
163452247|NCT00586924|590354149|FG001|Overall Study|Adverse event/serious adverse event|0|||
163452248|NCT00586924|590354150|FG002|Overall Study|Adverse event/serious adverse event|0|||
163452249|NCT00586924|590354151|FG003|Overall Study|Adverse event/serious adverse event|1|||
163452250|NCT00586924|590354152|FG004|Overall Study|Adverse event/serious adverse event|0|||
163452251|NCT00586924|590354153|FG005|Overall Study|Adverse event/serious adverse event|2|||
163452252|NCT00586924|590354148|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
163452253|NCT00586924|590354149|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
163452254|NCT00586924|590354150|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
163452255|NCT00586924|590354151|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
163452256|NCT00586924|590354152|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
163452257|NCT00586924|590354153|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
163452258|NCT00586924|590354148|FG000|Overall Study|Disease progression|0|||
163452259|NCT00586924|590354149|FG001|Overall Study|Disease progression|0|||
163452260|NCT00586924|590354150|FG002|Overall Study|Disease progression|0|||
163452261|NCT00586924|590354151|FG003|Overall Study|Disease progression|1|||
163452262|NCT00586924|590354152|FG004|Overall Study|Disease progression|1|||
163452263|NCT00586924|590354153|FG005|Overall Study|Disease progression|0|||
163452264|NCT00586924|590354148|FG000|Overall Study|Development of neutralizing antibodies|2|||
163452265|NCT00586924|590354149|FG001|Overall Study|Development of neutralizing antibodies|2|||
163452266|NCT00586924|590354150|FG002|Overall Study|Development of neutralizing antibodies|2|||
163452267|NCT00586924|590354151|FG003|Overall Study|Development of neutralizing antibodies|0|||
163452268|NCT00586924|590354152|FG004|Overall Study|Development of neutralizing antibodies|0|||
163452269|NCT00586924|590354153|FG005|Overall Study|Development of neutralizing antibodies|22|||
163452270|NCT00586924|590354148|FG000|Overall Study|Complete response|0|||
163452271|NCT00586924|590354149|FG001|Overall Study|Complete response|1|||
163452272|NCT00586924|590354150|FG002|Overall Study|Complete response|0|||
163452273|NCT00586924|590354151|FG003|Overall Study|Complete response|0|||
163452274|NCT00586924|590354152|FG004|Overall Study|Complete response|2|||
163452275|NCT00586924|590354153|FG005|Overall Study|Complete response|2|||
163452276|NCT00586924|590354148|FG000|Overall Study|Other|1|||
163452277|NCT00586924|590354149|FG001|Overall Study|Other|0|||
163452278|NCT00586924|590354150|FG002|Overall Study|Other|1|||
163452279|NCT00586924|590354151|FG003|Overall Study|Other|1|||
163452280|NCT00586924|590354152|FG004|Overall Study|Other|1|||
163452281|NCT00586924|590354153|FG005|Overall Study|Other|6|||
163452282|NCT01767194|590354156|FG000|Overall Study|Adverse Event|1|||
163452283|NCT01767194|590354157|FG001|Overall Study|Adverse Event|1|||
163452284|NCT01767194|590354156|FG000|Overall Study|Death|0|||
163452285|NCT01767194|590354157|FG001|Overall Study|Death|1|||
163452286|NCT01767194|590354156|FG000|Overall Study|Lack of Efficacy|12|||
163452287|NCT01767194|590354157|FG001|Overall Study|Lack of Efficacy|11|||
163452288|NCT01767194|590354156|FG000|Overall Study|Physician Decision|2|||
163452289|NCT01767194|590354157|FG001|Overall Study|Physician Decision|23|||
163452290|NCT01767194|590354156|FG000|Overall Study|Withdrawal by Subject|0|||
163452291|NCT01767194|590354157|FG001|Overall Study|Withdrawal by Subject|1|||
163452292|NCT01767194|590354156|FG000|Overall Study|Ineligible|1|||
163452293|NCT01767194|590354157|FG001|Overall Study|Ineligible|1|||
163452294|NCT01767194|590354156|FG000|Overall Study|Refusal by patient/parent|2|||
163452295|NCT01767194|590354157|FG001|Overall Study|Refusal by patient/parent|4|||
163452296|NCT01767194|590354156|FG000|Overall Study|Criteria not met on time for next cycle|0|||
163452297|NCT01767194|590354157|FG001|Overall Study|Criteria not met on time for next cycle|1|||
163452298|NCT04191577|590354161|FG000|Overall Study|Withdrawal by Subject|2|||
163452299|NCT04191577|590354162|FG001|Overall Study|Withdrawal by Subject|2|||
163452300|NCT04191577|590354163|FG002|Overall Study|Withdrawal by Subject|1|||
163452301|NCT04191577|590354161|FG000|Overall Study|Physician Decision|1|||
163452302|NCT04191577|590354162|FG001|Overall Study|Physician Decision|1|||
163452303|NCT04191577|590354163|FG002|Overall Study|Physician Decision|0|||
163452304|NCT04191577|590354161|FG000|Overall Study|Adverse Event|0|||
163452305|NCT04191577|590354162|FG001|Overall Study|Adverse Event|0|||
163452306|NCT04191577|590354163|FG002|Overall Study|Adverse Event|1|||
163452307|NCT04191577|590354161|FG000|Overall Study|Death|0|||
163452308|NCT04191577|590354162|FG001|Overall Study|Death|0|||
163452309|NCT04191577|590354163|FG002|Overall Study|Death|1|||
163452310|NCT00992446|590354167|FG000|Overall Study|Disease Progression|1|||
163452311|NCT00992446|590354167|FG000|Overall Study|Withdrawal by Subject|2|||
163452312|NCT00992446|590354167|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
163452313|NCT01927744|590355813|FG000|Overall Study|Death|2|||
163452314|NCT01927744|590355814|FG001|Overall Study|Death|9|||
163452315|NCT00369967|590355815|FG000|Overall Study|Lost to Follow-up|23|||
163452316|NCT00369967|590355816|FG001|Overall Study|Lost to Follow-up|12|||
163452317|NCT00605722|590355821|FG000|Overall Study|Adverse Event|6|||
163452318|NCT00605722|590355821|FG000|Overall Study|Insufficient therapeutic response|44|||
163452319|NCT00605722|590355821|FG000|Overall Study|Failure to return|1|||
163452320|NCT00485589|590355828|FG000|Overall Study|Death|2|||
163452321|NCT00485589|590355829|FG001|Overall Study|Death|2|||
163452322|NCT00485589|590355830|FG002|Overall Study|Death|0|||
163452323|NCT00485589|590355828|FG000|Overall Study|Failure to return|6|||
163452324|NCT00485589|590355829|FG001|Overall Study|Failure to return|5|||
163452325|NCT00485589|590355830|FG002|Overall Study|Failure to return|1|||
163452326|NCT00485589|590355828|FG000|Overall Study|Protocol Violation|1|||
163452327|NCT00485589|590355829|FG001|Overall Study|Protocol Violation|0|||
163452328|NCT00485589|590355830|FG002|Overall Study|Protocol Violation|0|||
163452329|NCT00485589|590355828|FG000|Overall Study|Violation of selection criteria at entry|0|||
163452330|NCT00485589|590355829|FG001|Overall Study|Violation of selection criteria at entry|3|||
163452331|NCT00485589|590355830|FG002|Overall Study|Violation of selection criteria at entry|1|||
163452332|NCT00485589|590355828|FG000|Overall Study|Administrative/Other|1|||
163452333|NCT00485589|590355829|FG001|Overall Study|Administrative/Other|2|||
163452334|NCT00485589|590355830|FG002|Overall Study|Administrative/Other|1|||
163452335|NCT00485589|590355828|FG000|Overall Study|Insufficient therapeutic response|10|||
163452336|NCT00485589|590355829|FG001|Overall Study|Insufficient therapeutic response|3|||
163452337|NCT00485589|590355830|FG002|Overall Study|Insufficient therapeutic response|1|||
163452338|NCT00485589|590355828|FG000|Overall Study|Refused treatment/did not cooperate|1|||
163452339|NCT00485589|590355829|FG001|Overall Study|Refused treatment/did not cooperate|0|||
163452340|NCT00485589|590355830|FG002|Overall Study|Refused treatment/did not cooperate|2|||
163452341|NCT00485589|590355828|FG000|Overall Study|Withdrawal by Subject|3|||
163452342|NCT00485589|590355829|FG001|Overall Study|Withdrawal by Subject|2|||
163452343|NCT00485589|590355830|FG002|Overall Study|Withdrawal by Subject|2|||
163452344|NCT00485589|590355828|FG000|Overall Study|Adverse Event|3|||
163452345|NCT00485589|590355829|FG001|Overall Study|Adverse Event|3|||
163452346|NCT00485589|590355830|FG002|Overall Study|Adverse Event|10|||
163452347|NCT04017442|590355835|FG000|Overall Study|Withdrawal by Subject|0|||
163452348|NCT04017442|590355836|FG001|Overall Study|Withdrawal by Subject|3|||
163452349|NCT04017442|590355835|FG000|Overall Study|Lost to Follow-up|21|||
163452350|NCT04017442|590355836|FG001|Overall Study|Lost to Follow-up|19|||
163452351|NCT01205451|590355844|FG000|Overall Study|Lost to Follow-up|1|||
163452352|NCT01205451|590355845|FG001|Overall Study|Lost to Follow-up|1|||
163452353|NCT01205451|590355844|FG000|Overall Study|Withdrawal by Subject|5|||
163452354|NCT01205451|590355845|FG001|Overall Study|Withdrawal by Subject|9|||
163452355|NCT02226146|590355849|FG000|Overall Study|Received rescue therapy|1|||
163452356|NCT02226146|590355849|FG000|Overall Study|Withdrawal by Subject|2|||
163452357|NCT05464836|590355850|FG000|Overall Study|Progression of Disease|1|||
163452358|NCT05464836|590355850|FG000|Overall Study|Physician Decision|1|||
163452359|NCT01522976|590355851|FG000|Overall Study|Ineligible|4|||
163452360|NCT01522976|590355852|FG001|Overall Study|Ineligible|0|||
163452361|NCT01522976|590355853|FG002|Overall Study|Ineligible|1|||
163452362|NCT01522976|590355851|FG000|Overall Study|Death|7|||
163452363|NCT01522976|590355852|FG001|Overall Study|Death|6|||
163452364|NCT01522976|590355853|FG002|Overall Study|Death|2|||
163452365|NCT01522976|590355851|FG000|Overall Study|Still on treatment|9|||
163452366|NCT01522976|590355852|FG001|Overall Study|Still on treatment|9|||
163452367|NCT01522976|590355853|FG002|Overall Study|Still on treatment|6|||
163452368|NCT01522976|590355851|FG000|Overall Study|Disease progression|28|||
163452369|NCT01522976|590355852|FG001|Overall Study|Disease progression|30|||
163452370|NCT01522976|590355853|FG002|Overall Study|Disease progression|25|||
163452371|NCT01522976|590355851|FG000|Overall Study|Adverse Event|17|||
163452372|NCT01522976|590355852|FG001|Overall Study|Adverse Event|7|||
163452373|NCT01522976|590355853|FG002|Overall Study|Adverse Event|18|||
163452374|NCT01522976|590355851|FG000|Overall Study|Refusal unrelated to adverse event|10|||
163452375|NCT01522976|590355852|FG001|Overall Study|Refusal unrelated to adverse event|13|||
163452376|NCT01522976|590355853|FG002|Overall Study|Refusal unrelated to adverse event|14|||
163452377|NCT01522976|590355851|FG000|Overall Study|Not protocol specified|22|||
163452378|NCT01522976|590355852|FG001|Overall Study|Not protocol specified|27|||
163452379|NCT01522976|590355853|FG002|Overall Study|Not protocol specified|27|||
163452380|NCT02938585|590355856|FG000|Overall Study|Withdrawal by parent or guardian|0|||
163452381|NCT02938585|590355857|FG001|Overall Study|Withdrawal by parent or guardian|1|||
163452382|NCT02938585|590355858|FG002|Overall Study|Withdrawal by parent or guardian|0|||
163452383|NCT02938585|590355859|FG003|Overall Study|Withdrawal by parent or guardian|0|||
163452384|NCT02938585|590355856|FG000|Overall Study|Withdrawal by Subject|0|||
163452385|NCT02938585|590355857|FG001|Overall Study|Withdrawal by Subject|0|||
163452386|NCT02938585|590355858|FG002|Overall Study|Withdrawal by Subject|0|||
163452387|NCT02938585|590355859|FG003|Overall Study|Withdrawal by Subject|5|||
163452388|NCT02106455|590355867|FG000|Overall Study|Case Report Form Uncollected|6|||
163452389|NCT02106455|590355867|FG000|Overall Study|Protocol Deviation|2|||
163452390|NCT00213980|590355868|FG000|Overall Study|Withdrawal by Subject|3|||
163452391|NCT00213980|590355869|FG001|Overall Study|Withdrawal by Subject|1|||
163452392|NCT00213980|590355868|FG000|Overall Study|Adverse Event|1|||
163452393|NCT00213980|590355869|FG001|Overall Study|Adverse Event|1|||
163452394|NCT00213980|590355868|FG000|Overall Study|Disease progression|0|||
163452395|NCT00213980|590355869|FG001|Overall Study|Disease progression|2|||
163452396|NCT00213980|590355868|FG000|Overall Study|Developed ovarian cancer|1|||
163452397|NCT00213980|590355869|FG001|Overall Study|Developed ovarian cancer|0|||
163452398|NCT00213980|590355868|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
163452399|NCT00213980|590355869|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
163452400|NCT03607838|590355870|FG000|Overall Study|Lack of Efficacy|14|||
163452401|NCT03607838|590355871|FG001|Overall Study|Lack of Efficacy|20|||
163452402|NCT03607838|590355870|FG000|Overall Study|Withdrawal by Subject|13|||
163452403|NCT03607838|590355871|FG001|Overall Study|Withdrawal by Subject|8|||
163452404|NCT03607838|590355870|FG000|Overall Study|Lost to Follow-up|6|||
163452405|NCT03607838|590355871|FG001|Overall Study|Lost to Follow-up|11|||
163452406|NCT03607838|590355870|FG000|Overall Study|Adverse Event|2|||
163452407|NCT03607838|590355871|FG001|Overall Study|Adverse Event|2|||
163452408|NCT03607838|590355870|FG000|Overall Study|Physician Decision|2|||
163452409|NCT03607838|590355871|FG001|Overall Study|Physician Decision|0|||
163452410|NCT03607838|590355870|FG000|Overall Study|Failure to meet randomization criteria|1|||
163452411|NCT03607838|590355871|FG001|Overall Study|Failure to meet randomization criteria|2|||
163452412|NCT03607838|590355870|FG000|Overall Study|Pregnancy|1|||
163452413|NCT03607838|590355871|FG001|Overall Study|Pregnancy|0|||
163452414|NCT03607838|590355870|FG000|Overall Study|Protocol Violation|1|||
163452415|NCT03607838|590355871|FG001|Overall Study|Protocol Violation|0|||
163452416|NCT03607838|590355870|FG000|Overall Study|Due to work|1|||
163452417|NCT03607838|590355871|FG001|Overall Study|Due to work|0|||
163452418|NCT03607838|590355870|FG000|Overall Study|Litigation|0|||
163452419|NCT03607838|590355871|FG001|Overall Study|Litigation|1|||
163452420|NCT03607838|590355870|FG000|Overall Study|Temperature excursion for study drug|0|||
163452421|NCT03607838|590355871|FG001|Overall Study|Temperature excursion for study drug|1|||
163452422|NCT03607838|590355870|FG000|Overall Study|Change of mind|0|||
163452423|NCT03607838|590355871|FG001|Overall Study|Change of mind|1|||
163452424|NCT02411201|590355872|FG000|Overall Study|Adverse Event|2|||
163452425|NCT02411201|590355872|FG000|Overall Study|Withdrawal by Subject|2|||
163452426|NCT02411201|590355872|FG000|Overall Study|Age group completed|2|||
163452427|NCT01260467|590355873|FG000|Overall Study|Withdrawal by Subject|2|||
163452428|NCT00798694|590355874|FG000|Overall Study|Lost to Follow-up|1|||
163452429|NCT00798694|590355875|FG001|Overall Study|Lost to Follow-up|1|||
163452430|NCT00798694|590355874|FG000|Overall Study|Physician Decision|1|||
163452431|NCT00798694|590355875|FG001|Overall Study|Physician Decision|0|||
163452432|NCT03364608|590355879|FG000|Overall Study|Withdrawal by Subject|4|||
163452433|NCT03364608|590355879|FG000|Overall Study|Protocol Violation|2|||
163452434|NCT03364608|590355879|FG000|Overall Study|Lost to Follow-up|2|||
163452435|NCT01163253|590355882|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
163452436|NCT01163253|590355883|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
163452437|NCT01163253|590355882|FG000|Overall Study|Study Terminated by Sponsor|978|||
163452438|NCT01163253|590355883|FG001|Overall Study|Study Terminated by Sponsor|349|||
163452439|NCT01163253|590355882|FG000|Overall Study|Protocol Violation|43|||
163452440|NCT01163253|590355883|FG001|Overall Study|Protocol Violation|12|||
163452441|NCT01163253|590355882|FG000|Overall Study|Withdrawal by Subject|199|||
163452442|NCT01163253|590355883|FG001|Overall Study|Withdrawal by Subject|50|||
163452443|NCT01163253|590355882|FG000|Overall Study|Medication Error|1|||
163452444|NCT01163253|590355883|FG001|Overall Study|Medication Error|0|||
163452445|NCT01163253|590355882|FG000|Overall Study|Lost to Follow-up|125|||
163452446|NCT01163253|590355883|FG001|Overall Study|Lost to Follow-up|23|||
163452447|NCT01163253|590355882|FG000|Overall Study|Insufficient Clinical Response|423|||
163452448|NCT01163253|590355883|FG001|Overall Study|Insufficient Clinical Response|29|||
163452449|NCT01163253|590355882|FG000|Overall Study|Adverse Event|300|||
163452450|NCT01163253|590355883|FG001|Overall Study|Adverse Event|78|||
163452451|NCT01163253|590355882|FG000|Overall Study|Death|17|||
163452452|NCT01163253|590355883|FG001|Overall Study|Death|5|||
163452453|NCT01163253|590355882|FG000|Overall Study|Ongoing|13|||
163452454|NCT01163253|590355883|FG001|Overall Study|Ongoing|4|||
163452455|NCT01163253|590355882|FG000|Overall Study|Other Unspecified|170|||
163452456|NCT01163253|590355883|FG001|Overall Study|Other Unspecified|34|||
163452457|NCT03888391|590355886|FG000|Overall Study|Lost to Follow-up|15|||
163452458|NCT03025217|590355890|FG000|Overall Study|Pregnancy|1|||
163452459|NCT03025217|590355890|FG000|Overall Study|Lost to Follow-up|1|||
163452460|NCT03025217|590355890|FG000|Overall Study|Not eligible, poor English|2|||
163452461|NCT00992784|590355896|FG000|Overall Study|Adverse Event|2|||
163452462|NCT00992784|590355897|FG001|Overall Study|Adverse Event|1|||
163452463|NCT00992784|590355898|FG002|Overall Study|Adverse Event|0|||
163452464|NCT00992784|590355896|FG000|Overall Study|Withdrawal by Subject|1|||
163452465|NCT00992784|590355897|FG001|Overall Study|Withdrawal by Subject|1|||
163452466|NCT00992784|590355898|FG002|Overall Study|Withdrawal by Subject|1|||
163452467|NCT00781599|590355899|FG000|Overall Study|Lost to Follow-up|7|||
163452468|NCT00781599|590355900|FG001|Overall Study|Lost to Follow-up|4|||
163452469|NCT01088438|590355901|FG000|Overall Study|Withdrawal by Subject|11|||
163452470|NCT01088438|590355902|FG001|Overall Study|Withdrawal by Subject|6|||
163452471|NCT01088438|590355901|FG000|Overall Study|Lost to Follow-up|18|||
163452472|NCT01088438|590355902|FG001|Overall Study|Lost to Follow-up|30|||
163452473|NCT01952730|590355907|FG000|Overall Study|FDA shut down core lab used by study|1|||
163452474|NCT01514188|590355916|FG000|Overall Study|Adverse Event|3|||
163452475|NCT01514188|590355917|FG001|Overall Study|Adverse Event|5|||
163452476|NCT01514188|590355916|FG000|Overall Study|Withdrawal by Subject|2|||
163452477|NCT01514188|590355917|FG001|Overall Study|Withdrawal by Subject|4|||
163452478|NCT01514188|590355916|FG000|Overall Study|Protocol Violation|2|||
163452479|NCT01514188|590355917|FG001|Overall Study|Protocol Violation|4|||
163452480|NCT01514188|590355916|FG000|Overall Study|Physician Decision|0|||
163452481|NCT01514188|590355917|FG001|Overall Study|Physician Decision|2|||
163452482|NCT01514188|590355916|FG000|Overall Study|Disease Progression|13|||
163452483|NCT01514188|590355917|FG001|Overall Study|Disease Progression|14|||
163452484|NCT01514188|590355916|FG000|Overall Study|Death|1|||
163452485|NCT01514188|590355917|FG001|Overall Study|Death|3|||
163452486|NCT01514188|590355916|FG000|Overall Study|Other|2|||
163452487|NCT01514188|590355917|FG001|Overall Study|Other|1|||
163452488|NCT03442829|590355918|FG000|Overall Study|Scheduling clash|3|||
163452489|NCT03442829|590355919|FG001|Overall Study|Scheduling clash|1|||
163452490|NCT03442829|590355918|FG000|Overall Study|Illness unrelated to study|1|||
163452491|NCT03442829|590355919|FG001|Overall Study|Illness unrelated to study|1|||
163452492|NCT02605447|590355922|FG000|Overall Study|Death|66|||
163452493|NCT02605447|590355922|FG000|Overall Study|Physician Decision|1|||
163452494|NCT02605447|590355922|FG000|Overall Study|Lost to Follow-up|24|||
163452495|NCT02605447|590355922|FG000|Overall Study|Withdrawal by Subject|10|||
163452496|NCT02605447|590355922|FG000|Overall Study|Not disclosed|1|||
163452497|NCT02237157|590355923|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
163452498|NCT02237157|590355924|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
163452499|NCT02237157|590355925|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
163452500|NCT02237157|590355926|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
163452501|NCT02237157|590355923|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
163452502|NCT02237157|590355924|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
163452503|NCT02237157|590355925|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
163452504|NCT02237157|590355926|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
163452505|NCT04533815|590355928|FG000|Overall Study|Adverse Event|2|||
163452506|NCT04533815|590355928|FG000|Overall Study|Site withdrew|5|||
163452507|NCT02045212|590355929|FG000|Overall Study|Adverse Event|0|||
163452508|NCT02045212|590355930|FG001|Overall Study|Adverse Event|1|||
163452509|NCT02045212|590355929|FG000|Overall Study|Withdrawal by Subject|1|||
163452510|NCT02045212|590355930|FG001|Overall Study|Withdrawal by Subject|0|||
163452511|NCT02045212|590355929|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
163452512|NCT02045212|590355930|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
163452513|NCT00488592|590355931|FG000|Overall Study|Withdrawal by Subject|1|||
163452514|NCT00488592|590355931|FG000|Overall Study|Disease progression|1|||
163452515|NCT00488592|590355931|FG000|Overall Study|Enrolled but not treated|1|||
163452516|NCT00441103|590355932|FG000|Overall Study|Adverse Event|2|||
163452517|NCT00441103|590355933|FG001|Overall Study|Adverse Event|1|||
163452518|NCT00441103|590355932|FG000|Overall Study|Death|1|||
163452519|NCT00441103|590355933|FG001|Overall Study|Death|0|||
163452520|NCT00441103|590355932|FG000|Overall Study|Disease Progression|2|||
163452521|NCT00441103|590355933|FG001|Overall Study|Disease Progression|0|||
163452522|NCT00441103|590355932|FG000|Overall Study|Lost to Follow-up|1|||
163452523|NCT00441103|590355933|FG001|Overall Study|Lost to Follow-up|0|||
163452524|NCT00441103|590355932|FG000|Overall Study|Protocol Violation|1|||
163452525|NCT00441103|590355933|FG001|Overall Study|Protocol Violation|0|||
163452526|NCT00441103|590355932|FG000|Overall Study|Participant unable to use Rebiject II|1|||
163452527|NCT00441103|590355933|FG001|Overall Study|Participant unable to use Rebiject II|0|||
163452528|NCT00441103|590355932|FG000|Overall Study|Participant refused MRI|1|||
163452529|NCT00441103|590355933|FG001|Overall Study|Participant refused MRI|0|||
163452530|NCT00441103|590355932|FG000|Overall Study|Inclusion criteria absent|1|||
163452531|NCT00441103|590355933|FG001|Overall Study|Inclusion criteria absent|0|||
163452532|NCT00441103|590355932|FG000|Overall Study|Non-compliant|0|||
163452533|NCT00441103|590355933|FG001|Overall Study|Non-compliant|1|||
163452534|NCT00441103|590355932|FG000|Overall Study|Participant decided to withdraw|1|||
163452535|NCT00441103|590355933|FG001|Overall Study|Participant decided to withdraw|0|||
163452536|NCT00441103|590355932|FG000|Overall Study|Participant's reason|0|||
163452537|NCT00441103|590355933|FG001|Overall Study|Participant's reason|1|||
163452538|NCT00441103|590355932|FG000|Overall Study|Participant decided to stop|0|||
163452539|NCT00441103|590355933|FG001|Overall Study|Participant decided to stop|1|||
163452540|NCT05836818|590355934|FG000|Overall Study|Physician Decision|1|||
163452541|NCT05836818|590355935|FG001|Overall Study|Physician Decision|1|||
163452542|NCT05836818|590355936|FG002|Overall Study|Physician Decision|0|||
163452543|NCT05836818|590355934|FG000|Overall Study|Withdrawal by Subject|0|||
163452544|NCT05836818|590355935|FG001|Overall Study|Withdrawal by Subject|0|||
163452545|NCT05836818|590355936|FG002|Overall Study|Withdrawal by Subject|1|||
163452546|NCT05836818|590355934|FG000|Overall Study|Later found to be previously vaccinated|0|||
163452547|NCT05836818|590355935|FG001|Overall Study|Later found to be previously vaccinated|1|||
163452548|NCT05836818|590355936|FG002|Overall Study|Later found to be previously vaccinated|3|||
163452549|NCT05836818|590355934|FG000|Overall Study|Pregnancy|0|||
163452550|NCT05836818|590355935|FG001|Overall Study|Pregnancy|1|||
163452551|NCT05836818|590355936|FG002|Overall Study|Pregnancy|0|||
163452552|NCT05836818|590355934|FG000|Overall Study|Allergic to vaccines|0|||
163452553|NCT05836818|590355935|FG001|Overall Study|Allergic to vaccines|1|||
163452554|NCT05836818|590355936|FG002|Overall Study|Allergic to vaccines|0|||
163452555|NCT03738566|590355937|FG000|Initial Study Phase|Withdrawal by Subject|1|||
163452556|NCT03738566|590355938|FG001|Initial Study Phase|Withdrawal by Subject|1|||
163452557|NCT03738566|590355939|FG002|Initial Study Phase|Withdrawal by Subject|2|||
163452558|NCT03738566|590355940|FG003|Initial Study Phase|Withdrawal by Subject|0|||
163452559|NCT03738566|590355937|FG000|Initial Study Phase|Death|0|||
163452560|NCT03738566|590355938|FG001|Initial Study Phase|Death|1|||
163452561|NCT03738566|590355939|FG002|Initial Study Phase|Death|0|||
163452562|NCT03738566|590355940|FG003|Initial Study Phase|Death|0|||
163452563|NCT03738566|590355937|FG000|Initial Study Phase|Treatment failure|5|||
163452564|NCT03738566|590355938|FG001|Initial Study Phase|Treatment failure|0|||
163452565|NCT03738566|590355939|FG002|Initial Study Phase|Treatment failure|0|||
163452566|NCT03738566|590355940|FG003|Initial Study Phase|Treatment failure|0|||
163452567|NCT03738566|590355937|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
163452568|NCT03738566|590355938|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
163452569|NCT03738566|590355939|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
163452570|NCT03738566|590355940|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
163452571|NCT03126539|590355949|FG000|Overall Study|Lost to Follow-up|1|||
163452572|NCT03126539|590355950|FG001|Overall Study|Lost to Follow-up|1|||
163452573|NCT03126539|590355951|FG002|Overall Study|Lost to Follow-up|1|||
163452574|NCT03126539|590355952|FG003|Overall Study|Lost to Follow-up|0|||
163452575|NCT03126539|590355953|FG004|Overall Study|Lost to Follow-up|0|||
163452576|NCT01627067|590355954|FG000|Overall Study|Screen Failure|1|||
163452577|NCT00926796|590355955|FG000|Overall Study|Did not receive randomized treatment|4|||
163452578|NCT00926796|590355956|FG001|Overall Study|Did not receive randomized treatment|7|||
163452579|NCT00926796|590355955|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
163452580|NCT00926796|590355956|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
163452581|NCT00926796|590355955|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
163452582|NCT00926796|590355956|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
163452583|NCT00926796|590355955|FG000|Overall Study|Adverse Event|7|||
163452584|NCT00926796|590355956|FG001|Overall Study|Adverse Event|14|||
163452585|NCT00926796|590355955|FG000|Overall Study|Lost to Follow-up|22|||
163452586|NCT00926796|590355956|FG001|Overall Study|Lost to Follow-up|13|||
163452587|NCT00926796|590355955|FG000|Overall Study|Protocol Violation|15|||
163452588|NCT00926796|590355956|FG001|Overall Study|Protocol Violation|11|||
163452589|NCT00926796|590355955|FG000|Overall Study|Withdrawal by Subject|1|||
163452590|NCT00926796|590355956|FG001|Overall Study|Withdrawal by Subject|0|||
163452591|NCT01331239|590355958|FG000|Part II: Core Study|Adverse Event|0|||
163452592|NCT01331239|590355959|FG001|Part II: Core Study|Adverse Event|3|||
163452593|NCT01331239|590355960|FG002|Part II: Core Study|Adverse Event|0|||
163452594|NCT01331239|590355958|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
163452595|NCT01331239|590355959|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
163452596|NCT01331239|590355960|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
163452597|NCT01331239|590355958|FG000|Part II: Core Study|Withdrawal by Subject|0|||
163452598|NCT01331239|590355959|FG001|Part II: Core Study|Withdrawal by Subject|2|||
163452599|NCT01331239|590355960|FG002|Part II: Core Study|Withdrawal by Subject|0|||
163452600|NCT01331239|590355958|FG000|Part II: Core Study|Administrative problems|0|||
163452601|NCT01331239|590355959|FG001|Part II: Core Study|Administrative problems|1|||
163452602|NCT01331239|590355960|FG002|Part II: Core Study|Administrative problems|0|||
163452603|NCT00621855|590355962|FG000|Overall Study|Adverse Event|32|||
163452604|NCT00621855|590355963|FG001|Overall Study|Adverse Event|31|||
163452605|NCT00621855|590355964|FG002|Overall Study|Adverse Event|48|||
163452606|NCT00621855|590355965|FG003|Overall Study|Adverse Event|34|||
163452607|NCT00621855|590355966|FG004|Overall Study|Adverse Event|31|||
163452608|NCT00621855|590355962|FG000|Overall Study|Lost to Follow-up|0|||
163452609|NCT00621855|590355963|FG001|Overall Study|Lost to Follow-up|1|||
163452610|NCT00621855|590355964|FG002|Overall Study|Lost to Follow-up|3|||
163452611|NCT00621855|590355965|FG003|Overall Study|Lost to Follow-up|4|||
163452612|NCT00621855|590355966|FG004|Overall Study|Lost to Follow-up|1|||
163452613|NCT00621855|590355962|FG000|Overall Study|Protocol Violation|16|||
163452614|NCT00621855|590355963|FG001|Overall Study|Protocol Violation|8|||
163452615|NCT00621855|590355964|FG002|Overall Study|Protocol Violation|6|||
163452616|NCT00621855|590355965|FG003|Overall Study|Protocol Violation|7|||
163452617|NCT00621855|590355966|FG004|Overall Study|Protocol Violation|8|||
163452618|NCT00621855|590355962|FG000|Overall Study|Withdrawal by Subject|16|||
163452619|NCT00621855|590355963|FG001|Overall Study|Withdrawal by Subject|11|||
163452620|NCT00621855|590355964|FG002|Overall Study|Withdrawal by Subject|13|||
163452621|NCT00621855|590355965|FG003|Overall Study|Withdrawal by Subject|13|||
163452622|NCT00621855|590355966|FG004|Overall Study|Withdrawal by Subject|9|||
163452623|NCT00621855|590355962|FG000|Overall Study|Other|9|||
163452624|NCT00621855|590355963|FG001|Overall Study|Other|7|||
163452625|NCT00621855|590355964|FG002|Overall Study|Other|6|||
163452626|NCT00621855|590355965|FG003|Overall Study|Other|5|||
163452627|NCT00621855|590355966|FG004|Overall Study|Other|4|||
163452628|NCT00621855|590355962|FG000|Overall Study|Patients did not receive study drug|3|||
163452629|NCT00621855|590355963|FG001|Overall Study|Patients did not receive study drug|3|||
163452630|NCT00621855|590355964|FG002|Overall Study|Patients did not receive study drug|5|||
163452631|NCT00621855|590355965|FG003|Overall Study|Patients did not receive study drug|4|||
163452632|NCT00621855|590355966|FG004|Overall Study|Patients did not receive study drug|2|||
163452633|NCT02112994|590355967|FG000|Overall Study|Progressive Disease|0|||
163452634|NCT02112994|590355968|FG001|Overall Study|Progressive Disease|0|||
163452635|NCT02112994|590355969|FG002|Overall Study|Progressive Disease|1|||
163452636|NCT02112994|590355967|FG000|Overall Study|Pregnancy|0|||
163452637|NCT02112994|590355968|FG001|Overall Study|Pregnancy|1|||
163452638|NCT02112994|590355969|FG002|Overall Study|Pregnancy|1|||
163452639|NCT02112994|590355967|FG000|Overall Study|Liver Transplant|0|||
163452640|NCT02112994|590355968|FG001|Overall Study|Liver Transplant|1|||
163452641|NCT02112994|590355969|FG002|Overall Study|Liver Transplant|0|||
163452642|NCT02112994|590355967|FG000|Overall Study|Withdrawal by Subject|0|||
163452643|NCT02112994|590355968|FG001|Overall Study|Withdrawal by Subject|0|||
163452644|NCT02112994|590355969|FG002|Overall Study|Withdrawal by Subject|1|||
163452645|NCT01274338|590357382|FG000|Overall Study|Lack of Efficacy|72|||
163452646|NCT01274338|590357383|FG001|Overall Study|Lack of Efficacy|108|||
163452647|NCT01274338|590357384|FG002|Overall Study|Lack of Efficacy|116|||
163452648|NCT01274338|590357385|FG003|Overall Study|Lack of Efficacy|0|||
163452649|NCT01274338|590357386|FG004|Overall Study|Lack of Efficacy|0|||
163452650|NCT01274338|590357387|FG005|Overall Study|Lack of Efficacy|0|||
163452651|NCT01274338|590357382|FG000|Overall Study|Adverse Event|272|||
163452652|NCT01274338|590357383|FG001|Overall Study|Adverse Event|105|||
163452653|NCT01274338|590357384|FG002|Overall Study|Adverse Event|180|||
163452654|NCT01274338|590357385|FG003|Overall Study|Adverse Event|1|||
163452655|NCT01274338|590357386|FG004|Overall Study|Adverse Event|0|||
163452656|NCT01274338|590357387|FG005|Overall Study|Adverse Event|0|||
163452657|NCT01274338|590357382|FG000|Overall Study|Death|8|||
163452658|NCT01274338|590357383|FG001|Overall Study|Death|1|||
163452659|NCT01274338|590357384|FG002|Overall Study|Death|0|||
163452660|NCT01274338|590357385|FG003|Overall Study|Death|0|||
163452661|NCT01274338|590357386|FG004|Overall Study|Death|0|||
163452662|NCT01274338|590357387|FG005|Overall Study|Death|0|||
163452663|NCT01274338|590357382|FG000|Overall Study|Withdrawal by Subject|27|||
163452664|NCT01274338|590357383|FG001|Overall Study|Withdrawal by Subject|99|||
163452665|NCT01274338|590357384|FG002|Overall Study|Withdrawal by Subject|17|||
163452666|NCT01274338|590357385|FG003|Overall Study|Withdrawal by Subject|0|||
163452667|NCT01274338|590357386|FG004|Overall Study|Withdrawal by Subject|0|||
163452668|NCT01274338|590357387|FG005|Overall Study|Withdrawal by Subject|0|||
163452669|NCT01274338|590357382|FG000|Overall Study|Did not start treatment|8|||
163452670|NCT01274338|590357383|FG001|Overall Study|Did not start treatment|116|||
163452671|NCT01274338|590357384|FG002|Overall Study|Did not start treatment|7|||
163452672|NCT01274338|590357385|FG003|Overall Study|Did not start treatment|0|||
163452673|NCT01274338|590357386|FG004|Overall Study|Did not start treatment|0|||
163452674|NCT01274338|590357387|FG005|Overall Study|Did not start treatment|0|||
163452675|NCT01274338|590357382|FG000|Overall Study|Alternative therapy|0|||
163452676|NCT01274338|590357383|FG001|Overall Study|Alternative therapy|1|||
163452677|NCT01274338|590357384|FG002|Overall Study|Alternative therapy|0|||
163452678|NCT01274338|590357385|FG003|Overall Study|Alternative therapy|0|||
163452679|NCT01274338|590357386|FG004|Overall Study|Alternative therapy|0|||
163452680|NCT01274338|590357387|FG005|Overall Study|Alternative therapy|0|||
163452681|NCT01274338|590357382|FG000|Overall Study|Other complicating diseases|0|||
163452682|NCT01274338|590357383|FG001|Overall Study|Other complicating diseases|3|||
163452683|NCT01274338|590357384|FG002|Overall Study|Other complicating diseases|1|||
163452684|NCT01274338|590357385|FG003|Overall Study|Other complicating diseases|0|||
163452685|NCT01274338|590357386|FG004|Overall Study|Other complicating diseases|0|||
163452686|NCT01274338|590357387|FG005|Overall Study|Other complicating diseases|0|||
163452687|NCT01274338|590357382|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
163452688|NCT01274338|590357383|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
163452689|NCT01274338|590357384|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
163452690|NCT01274338|590357385|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
163452691|NCT01274338|590357386|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
163452692|NCT01274338|590357387|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
163452693|NCT01274338|590357382|FG000|Overall Study|Pregnancy|0|||
163452694|NCT01274338|590357383|FG001|Overall Study|Pregnancy|0|||
163452695|NCT01274338|590357384|FG002|Overall Study|Pregnancy|1|||
163452696|NCT01274338|590357385|FG003|Overall Study|Pregnancy|0|||
163452697|NCT01274338|590357386|FG004|Overall Study|Pregnancy|0|||
163452698|NCT01274338|590357387|FG005|Overall Study|Pregnancy|0|||
163452699|NCT01274338|590357382|FG000|Overall Study|Reason not reported|12|||
163452700|NCT01274338|590357383|FG001|Overall Study|Reason not reported|21|||
163452701|NCT01274338|590357384|FG002|Overall Study|Reason not reported|3|||
163452702|NCT01274338|590357385|FG003|Overall Study|Reason not reported|0|||
163452703|NCT01274338|590357386|FG004|Overall Study|Reason not reported|1|||
163452704|NCT01274338|590357387|FG005|Overall Study|Reason not reported|0|||
163452705|NCT00831441|590357388|FG000|Randomized|Death|82|||
163452706|NCT00831441|590357389|FG001|Randomized|Death|81|||
163452707|NCT00831441|590357388|FG000|Randomized|Adverse Event|248|||
163452708|NCT00831441|590357389|FG001|Randomized|Adverse Event|321|||
163452709|NCT00831441|590357388|FG000|Randomized|Emergency procedure|2|||
163452710|NCT00831441|590357389|FG001|Randomized|Emergency procedure|2|||
163452711|NCT00831441|590357388|FG000|Randomized|Elective procedure|26|||
163452712|NCT00831441|590357389|FG001|Randomized|Elective procedure|25|||
163452713|NCT00831441|590357388|FG000|Randomized|Physician Decision|26|||
163452714|NCT00831441|590357389|FG001|Randomized|Physician Decision|35|||
163452715|NCT00831441|590357388|FG000|Randomized|No longer met criteria|13|||
163452716|NCT00831441|590357389|FG001|Randomized|No longer met criteria|19|||
163452717|NCT00831441|590357388|FG000|Randomized|Withdrawal by Subject|178|||
163452718|NCT00831441|590357389|FG001|Randomized|Withdrawal by Subject|212|||
163452719|NCT00831441|590357388|FG000|Randomized|Lost to Follow-up|26|||
163452720|NCT00831441|590357389|FG001|Randomized|Lost to Follow-up|35|||
163452721|NCT00831441|590357388|FG000|Randomized|Administrative reason by sponsor|2780|||
163452722|NCT00831441|590357389|FG001|Randomized|Administrative reason by sponsor|2671|||
163452723|NCT00831441|590357388|FG000|Randomized|poor/non-compliance|30|||
163452724|NCT00831441|590357389|FG001|Randomized|poor/non-compliance|38|||
163452725|NCT00831441|590357388|FG000|Randomized|non-specified|276|||
163452726|NCT00831441|590357389|FG001|Randomized|non-specified|266|||
163452727|NCT00831441|590357388|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
163452728|NCT00831441|590357389|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
163452729|NCT00831441|590357388|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
163452730|NCT00831441|590357389|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
163452731|NCT00831441|590357388|FG000|Follow Up (30 Days)|Death|63|||
163452732|NCT00831441|590357389|FG001|Follow Up (30 Days)|Death|86|||
163452733|NCT00831441|590357388|FG000|Follow Up (30 Days)|non-specified|16|||
163452734|NCT00831441|590357389|FG001|Follow Up (30 Days)|non-specified|26|||
163452735|NCT00831441|590357388|FG000|Follow Up (30 Days)|missing end of study status|0|||
163452736|NCT00831441|590357389|FG001|Follow Up (30 Days)|missing end of study status|1|||
163452737|NCT02924688|590357393|FG000|Overall Study|Adverse Event|9|||
163452738|NCT02924688|590357394|FG001|Overall Study|Adverse Event|3|||
163452739|NCT02924688|590357395|FG002|Overall Study|Adverse Event|2|||
163452740|NCT02924688|590357396|FG003|Overall Study|Adverse Event|2|||
163452741|NCT02924688|590357397|FG004|Overall Study|Adverse Event|3|||
163452742|NCT02924688|590357398|FG005|Overall Study|Adverse Event|2|||
163452743|NCT02924688|590357393|FG000|Overall Study|Lack of Efficacy|2|||
163452744|NCT02924688|590357394|FG001|Overall Study|Lack of Efficacy|3|||
163452745|NCT02924688|590357395|FG002|Overall Study|Lack of Efficacy|4|||
163452746|NCT02924688|590357396|FG003|Overall Study|Lack of Efficacy|2|||
163452747|NCT02924688|590357397|FG004|Overall Study|Lack of Efficacy|1|||
163452748|NCT02924688|590357398|FG005|Overall Study|Lack of Efficacy|1|||
163452749|NCT02924688|590357393|FG000|Overall Study|Protocol Violation|3|||
163452750|NCT02924688|590357394|FG001|Overall Study|Protocol Violation|7|||
163452751|NCT02924688|590357395|FG002|Overall Study|Protocol Violation|5|||
163452752|NCT02924688|590357396|FG003|Overall Study|Protocol Violation|6|||
163452753|NCT02924688|590357397|FG004|Overall Study|Protocol Violation|2|||
163452754|NCT02924688|590357398|FG005|Overall Study|Protocol Violation|2|||
163452755|NCT02924688|590357393|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
163452756|NCT02924688|590357394|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
163452757|NCT02924688|590357395|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
163452758|NCT02924688|590357396|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
163452759|NCT02924688|590357397|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
163452760|NCT02924688|590357398|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
163452761|NCT02924688|590357393|FG000|Overall Study|Lost to Follow-up|2|||
163452762|NCT02924688|590357394|FG001|Overall Study|Lost to Follow-up|4|||
163452763|NCT02924688|590357395|FG002|Overall Study|Lost to Follow-up|2|||
163452764|NCT02924688|590357396|FG003|Overall Study|Lost to Follow-up|4|||
163452765|NCT02924688|590357397|FG004|Overall Study|Lost to Follow-up|2|||
163452766|NCT02924688|590357398|FG005|Overall Study|Lost to Follow-up|4|||
163452767|NCT02924688|590357393|FG000|Overall Study|Physician Decision|2|||
163452768|NCT02924688|590357394|FG001|Overall Study|Physician Decision|1|||
163452769|NCT02924688|590357395|FG002|Overall Study|Physician Decision|0|||
163452770|NCT02924688|590357396|FG003|Overall Study|Physician Decision|1|||
163452771|NCT02924688|590357397|FG004|Overall Study|Physician Decision|1|||
163452772|NCT02924688|590357398|FG005|Overall Study|Physician Decision|1|||
163452773|NCT02924688|590357393|FG000|Overall Study|Withdrawal by Subject|14|||
163452774|NCT02924688|590357394|FG001|Overall Study|Withdrawal by Subject|13|||
163452775|NCT02924688|590357395|FG002|Overall Study|Withdrawal by Subject|9|||
163452776|NCT02924688|590357396|FG003|Overall Study|Withdrawal by Subject|12|||
163452777|NCT02924688|590357397|FG004|Overall Study|Withdrawal by Subject|13|||
163452778|NCT02924688|590357398|FG005|Overall Study|Withdrawal by Subject|14|||
163452779|NCT03072719|590357399|FG000|Overall Study|Adverse Event|1|||
163452780|NCT03072719|590357400|FG001|Overall Study|Adverse Event|1|||
163452781|NCT00229203|590357401|FG000|Overall Study|Progressive disease|18|||
163452782|NCT00229203|590357402|FG001|Overall Study|Progressive disease|9|||
163452783|NCT00229203|590357401|FG000|Overall Study|Toxicity|6|||
163452784|NCT00229203|590357402|FG001|Overall Study|Toxicity|1|||
163452785|NCT00229203|590357401|FG000|Overall Study|Death|4|||
163452786|NCT00229203|590357402|FG001|Overall Study|Death|2|||
163452787|NCT00229203|590357401|FG000|Overall Study|Other|3|||
163452788|NCT00229203|590357402|FG001|Overall Study|Other|3|||
163452789|NCT00229203|590357401|FG000|Overall Study|Withdrawal by Subject|1|||
163452790|NCT00229203|590357402|FG001|Overall Study|Withdrawal by Subject|4|||
163452791|NCT03457103|590357403|FG000|Overall Study|illness/hospitalization|4|||
163452792|NCT03457103|590357404|FG001|Overall Study|illness/hospitalization|2|||
163452793|NCT03457103|590357403|FG000|Overall Study|Lost to Follow-up|2|||
163452794|NCT03457103|590357404|FG001|Overall Study|Lost to Follow-up|1|||
163452795|NCT03457103|590357403|FG000|Overall Study|Withdrawal by Subject|1|||
163452796|NCT03457103|590357404|FG001|Overall Study|Withdrawal by Subject|2|||
163452797|NCT03457103|590357403|FG000|Overall Study|financial/ insurance issues|1|||
163452798|NCT03457103|590357404|FG001|Overall Study|financial/ insurance issues|1|||
163452799|NCT03004469|590357405|FG000|Overall Study|Adverse Event|6|||
163452800|NCT03004469|590357406|FG001|Overall Study|Adverse Event|4|||
163452801|NCT03004469|590357407|FG002|Overall Study|Adverse Event|6|||
163452802|NCT03004469|590357405|FG000|Overall Study|Lack of Efficacy|1|||
163452803|NCT03004469|590357406|FG001|Overall Study|Lack of Efficacy|0|||
163452804|NCT03004469|590357407|FG002|Overall Study|Lack of Efficacy|1|||
163452805|NCT03004469|590357405|FG000|Overall Study|Lost to Follow-up|23|||
163452806|NCT03004469|590357406|FG001|Overall Study|Lost to Follow-up|14|||
163452807|NCT03004469|590357407|FG002|Overall Study|Lost to Follow-up|6|||
163452808|NCT03004469|590357405|FG000|Overall Study|Non-Compliance with Study Drug|2|||
163452809|NCT03004469|590357406|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163452810|NCT03004469|590357407|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163452811|NCT03004469|590357405|FG000|Overall Study|Protocol Violation|0|||
163452812|NCT03004469|590357406|FG001|Overall Study|Protocol Violation|0|||
163452813|NCT03004469|590357407|FG002|Overall Study|Protocol Violation|1|||
163452814|NCT03004469|590357405|FG000|Overall Study|Withdrawal by Subject|29|||
163452815|NCT03004469|590357406|FG001|Overall Study|Withdrawal by Subject|27|||
163452816|NCT03004469|590357407|FG002|Overall Study|Withdrawal by Subject|10|||
163452817|NCT03004469|590357405|FG000|Overall Study|Other unspecified reason|0|||
163452818|NCT03004469|590357406|FG001|Overall Study|Other unspecified reason|4|||
163452819|NCT03004469|590357407|FG002|Overall Study|Other unspecified reason|1|||
163452820|NCT00423735|590357408|FG000|Overall Study|Ineligible / No protocol treatment|8|||
163452821|NCT00423735|590357409|FG001|Overall Study|Ineligible / No protocol treatment|6|||
163452822|NCT00423735|590357410|FG002|Overall Study|Ineligible / No protocol treatment|0|||
163452823|NCT00579501|590357413|FG000|Overall Study|Death|1|||
163452824|NCT00579501|590357413|FG000|Overall Study|End of neoadjuvant therapy|25|||
163452825|NCT00579501|590357413|FG000|Overall Study|toxicity|1|||
163452826|NCT00579501|590357413|FG000|Overall Study|Secondary lesion|1|||
163452827|NCT00579501|590357413|FG000|Overall Study|Radiation therapy before surgery|1|||
163452828|NCT00190983|590357414|FG000|Overall Study|Inevaluable (never treated)|2|||
163452829|NCT02130427|590357418|FG000|Overall Study|Imaging results not interpretable|30|||
163452830|NCT03150095|590357419|FG000|Overall Study|Death|0|||
163452831|NCT03150095|590357420|FG001|Overall Study|Death|1|||
163452832|NCT03150095|590357419|FG000|Overall Study|Lost to Follow-up|1|||
163452833|NCT03150095|590357420|FG001|Overall Study|Lost to Follow-up|1|||
163452834|NCT03150095|590357419|FG000|Overall Study|Withdrawal by Subject|4|||
163452835|NCT03150095|590357420|FG001|Overall Study|Withdrawal by Subject|0|||
163452836|NCT03150095|590357419|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
163452837|NCT03150095|590357420|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
163452838|NCT04032171|590357422|FG000|Overall Study|Study Termination|1|||
163452839|NCT04032171|590357423|FG001|Overall Study|Study Termination|0|||
163452840|NCT00089479|590357433|FG000|Overall Study|Death|108|||
163452841|NCT00089479|590357434|FG001|Overall Study|Death|75|||
163452842|NCT00089479|590357433|FG000|Overall Study|Withdrawal by Subject|86|||
163452843|NCT00089479|590357434|FG001|Overall Study|Withdrawal by Subject|107|||
163452844|NCT00089479|590357433|FG000|Overall Study|Lost to Follow-up|137|||
163452845|NCT00089479|590357434|FG001|Overall Study|Lost to Follow-up|107|||
163452846|NCT00289185|590357437|FG000|Overall Study|Withdrawal by Subject|4|||
163452847|NCT00289185|590357438|FG001|Overall Study|Withdrawal by Subject|8|||
163452848|NCT00289185|590357437|FG000|Overall Study|Lost to Follow-up|23|||
163452849|NCT00289185|590357438|FG001|Overall Study|Lost to Follow-up|17|||
163452850|NCT00289185|590357437|FG000|Overall Study|Death|1|||
163452851|NCT00289185|590357438|FG001|Overall Study|Death|1|||
163452852|NCT03337152|590357440|FG000|Overall Study|Physician Decision|1|||
163452853|NCT03337152|590357441|FG001|Overall Study|Physician Decision|0|||
163452854|NCT03337152|590357440|FG000|Overall Study|Lost to Follow-up|1|||
163452855|NCT03337152|590357441|FG001|Overall Study|Lost to Follow-up|3|||
163452856|NCT03337152|590357440|FG000|Overall Study|Adverse Event|3|||
163452857|NCT03337152|590357441|FG001|Overall Study|Adverse Event|1|||
163452858|NCT03337152|590357440|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
163452859|NCT03337152|590357441|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
163452860|NCT00421343|590357442|FG000|Overall Study|Death|1|||
163452861|NCT00421343|590357442|FG000|Overall Study|Withdrawal by Subject|2|||
163452862|NCT00421343|590357442|FG000|Overall Study|Lost to Follow-up|3|||
163452863|NCT00678587|590357443|FG000|Overall Study|Adverse Event|3|||
163452864|NCT00678587|590357444|FG001|Overall Study|Adverse Event|3|||
163452865|NCT00678587|590357443|FG000|Overall Study|Lack of Efficacy|1|||
163452866|NCT00678587|590357444|FG001|Overall Study|Lack of Efficacy|0|||
163452867|NCT00678587|590357443|FG000|Overall Study|Protocol Violation|2|||
163452868|NCT00678587|590357444|FG001|Overall Study|Protocol Violation|1|||
163452869|NCT00678587|590357443|FG000|Overall Study|Study Closed/Terminated|1|||
163452870|NCT00678587|590357444|FG001|Overall Study|Study Closed/Terminated|0|||
163452871|NCT00678587|590357443|FG000|Overall Study|Lost to Follow-up|3|||
163452872|NCT00678587|590357444|FG001|Overall Study|Lost to Follow-up|5|||
163452873|NCT00678587|590357443|FG000|Overall Study|Investigator Discretion|2|||
163452874|NCT00678587|590357444|FG001|Overall Study|Investigator Discretion|6|||
163452875|NCT00678587|590357443|FG000|Overall Study|Withdrew Consent|8|||
163452876|NCT00678587|590357444|FG001|Overall Study|Withdrew Consent|3|||
163452877|NCT00976950|590357445|FG000|Overall Study|Adverse Event|3|||
163452878|NCT00976950|590357445|FG000|Overall Study|Events with no relationship to Aptivus|3|||
163452879|NCT01019486|590357446|FG000|Overall Study|Withdrawal by Subject|1|||
163452880|NCT01019486|590357447|FG001|Overall Study|Withdrawal by Subject|1|||
163452881|NCT01019486|590357448|FG002|Overall Study|Withdrawal by Subject|1|||
163452882|NCT02932332|590357449|FG000|Overall Study|Withdrawal by Subject|1|||
163452883|NCT02932332|590357450|FG001|Overall Study|Withdrawal by Subject|1|||
163452884|NCT02932332|590357451|FG002|Overall Study|Withdrawal by Subject|0|||
163452885|NCT02932332|590357452|FG003|Overall Study|Withdrawal by Subject|1|||
163452886|NCT02932332|590357449|FG000|Overall Study|Chest pain|0|||
163452887|NCT02932332|590357450|FG001|Overall Study|Chest pain|0|||
163452888|NCT02932332|590357451|FG002|Overall Study|Chest pain|0|||
163452889|NCT02932332|590357452|FG003|Overall Study|Chest pain|1|||
163452890|NCT02932332|590357449|FG000|Overall Study|Not Dyspneic cough|1|||
163452891|NCT02932332|590357450|FG001|Overall Study|Not Dyspneic cough|2|||
163452892|NCT02932332|590357451|FG002|Overall Study|Not Dyspneic cough|1|||
163452893|NCT02932332|590357452|FG003|Overall Study|Not Dyspneic cough|0|||
163452894|NCT01069523|590357454|FG000|Overall Study|Withdrawal by Subject|4|||
163452895|NCT01069523|590357455|FG001|Overall Study|Withdrawal by Subject|7|||
163452896|NCT01875367|590357456|FG000|Overall Study|Not complete at least 2 questionaries|4|||
163452897|NCT01875367|590357457|FG001|Overall Study|Not complete at least 2 questionaries|2|||
163452898|NCT01875367|590357456|FG000|Overall Study|Not receive study treatment|1|||
163452899|NCT01875367|590357457|FG001|Overall Study|Not receive study treatment|0|||
163452900|NCT00515008|590357463|FG000|Overall Study|Lost to Follow-up|1|||
163452901|NCT00515008|590357464|FG001|Overall Study|Lost to Follow-up|0|||
163452902|NCT00515008|590357463|FG000|Overall Study|Declined|0|||
163452903|NCT00515008|590357464|FG001|Overall Study|Declined|3|||
163452904|NCT00515008|590357463|FG000|Overall Study|Left the Boston Area|1|||
163452905|NCT00515008|590357464|FG001|Overall Study|Left the Boston Area|1|||
163452906|NCT00515008|590357463|FG000|Overall Study|Scheduling conflict|1|||
163452907|NCT00515008|590357464|FG001|Overall Study|Scheduling conflict|0|||
163452908|NCT02951988|590357465|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
163452909|NCT02951988|590357466|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
163452910|NCT02951988|590357467|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
163452911|NCT02951988|590357468|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
163452912|NCT02951988|590357465|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
163452913|NCT02951988|590357466|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
163452914|NCT02951988|590357467|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
163452915|NCT02951988|590357468|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
163452916|NCT02951988|590357465|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
163452917|NCT02951988|590357466|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
163452918|NCT02951988|590357467|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
163452919|NCT02951988|590357468|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
163452920|NCT02951988|590357465|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
163452921|NCT02951988|590357466|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
163452922|NCT02951988|590357467|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
163452923|NCT02951988|590357468|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
163452924|NCT02951988|590357465|FG000|Open-Label Treatment Period|Protocol Violation|22|||
163452925|NCT02951988|590357466|FG001|Open-Label Treatment Period|Protocol Violation|0|||
163452926|NCT02951988|590357467|FG002|Open-Label Treatment Period|Protocol Violation|0|||
163452927|NCT02951988|590357468|FG003|Open-Label Treatment Period|Protocol Violation|0|||
163452928|NCT02951988|590357465|FG000|Open-Label Treatment Period|Pregnancy|2|||
163452929|NCT02951988|590357466|FG001|Open-Label Treatment Period|Pregnancy|0|||
163452930|NCT02951988|590357467|FG002|Open-Label Treatment Period|Pregnancy|0|||
163452931|NCT02951988|590357468|FG003|Open-Label Treatment Period|Pregnancy|0|||
163452932|NCT02951988|590357465|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
163452933|NCT02951988|590357466|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
163452934|NCT02951988|590357467|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
163452935|NCT02951988|590357468|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
163452936|NCT02951988|590357465|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
163452937|NCT02951988|590357466|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
163452938|NCT02951988|590357467|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
163452939|NCT02951988|590357468|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
163452940|NCT02951988|590357465|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
163452941|NCT02951988|590357466|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
163452942|NCT02951988|590357467|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
163452943|NCT02951988|590357468|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
163452944|NCT02951988|590357465|FG000|Open-Label Treatment Period|Adverse Event|45|||
163452945|NCT02951988|590357466|FG001|Open-Label Treatment Period|Adverse Event|0|||
163452946|NCT02951988|590357467|FG002|Open-Label Treatment Period|Adverse Event|0|||
163452947|NCT02951988|590357468|FG003|Open-Label Treatment Period|Adverse Event|0|||
163452948|NCT02951988|590357465|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
163452949|NCT02951988|590357466|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
163452950|NCT02951988|590357467|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
163452951|NCT02951988|590357468|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
163452952|NCT02951988|590357465|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
163452953|NCT02951988|590357466|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
163452954|NCT02951988|590357467|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
163452955|NCT02951988|590357468|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
163452956|NCT02951988|590357465|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
163452957|NCT02951988|590357466|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
163452958|NCT02951988|590357467|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
163452959|NCT02951988|590357468|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
163452960|NCT02951988|590357465|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
163452961|NCT02951988|590357466|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
163452962|NCT02951988|590357467|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
163452963|NCT02951988|590357468|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
163452964|NCT02951988|590357465|FG000|Double-Blind Treatment Period|Pregnancy|0|||
163452965|NCT02951988|590357466|FG001|Double-Blind Treatment Period|Pregnancy|1|||
163452966|NCT02951988|590357467|FG002|Double-Blind Treatment Period|Pregnancy|1|||
163452967|NCT02951988|590357468|FG003|Double-Blind Treatment Period|Pregnancy|0|||
163452968|NCT02951988|590357465|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163452969|NCT02951988|590357466|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
163452970|NCT02951988|590357467|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
163452971|NCT02951988|590357468|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
163452972|NCT02951988|590357465|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163452973|NCT02951988|590357466|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
163452974|NCT02951988|590357467|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
163452975|NCT02951988|590357468|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
163452976|NCT02951988|590357465|FG000|Double-Blind Treatment Period|Adverse Event|0|||
163452977|NCT02951988|590357466|FG001|Double-Blind Treatment Period|Adverse Event|8|||
163452978|NCT02951988|590357467|FG002|Double-Blind Treatment Period|Adverse Event|3|||
163452979|NCT02951988|590357468|FG003|Double-Blind Treatment Period|Adverse Event|6|||
163452980|NCT02951988|590357465|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
163452981|NCT02951988|590357466|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
163452982|NCT02951988|590357467|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
163452983|NCT02951988|590357468|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
163452984|NCT00516269|590357469|FG000|Overall Study|Adverse Event|2|||
163452985|NCT00516269|590357470|FG001|Overall Study|Adverse Event|1|||
163452986|NCT00516269|590357469|FG000|Overall Study|Lost to Follow-up|0|||
163452987|NCT00516269|590357470|FG001|Overall Study|Lost to Follow-up|1|||
163452988|NCT00516269|590357469|FG000|Overall Study|Protocol Violation|0|||
163452989|NCT00516269|590357470|FG001|Overall Study|Protocol Violation|1|||
163452990|NCT04570657|590357473|FG000|Overall Study|Adverse Event|0|||
163452991|NCT04570657|590357474|FG001|Overall Study|Adverse Event|0|||
163452992|NCT04570657|590357475|FG002|Overall Study|Adverse Event|1|||
163452993|NCT04570657|590357473|FG000|Overall Study|Lost to Follow-up|0|||
163452994|NCT04570657|590357474|FG001|Overall Study|Lost to Follow-up|0|||
163452995|NCT04570657|590357475|FG002|Overall Study|Lost to Follow-up|1|||
163452996|NCT04570657|590357473|FG000|Overall Study|Physician Decision|0|||
163452997|NCT04570657|590357474|FG001|Overall Study|Physician Decision|1|||
163452998|NCT04570657|590357475|FG002|Overall Study|Physician Decision|0|||
163452999|NCT04570657|590357473|FG000|Overall Study|Withdrawal by Subject|1|||
163453000|NCT04570657|590357474|FG001|Overall Study|Withdrawal by Subject|2|||
163453001|NCT04570657|590357475|FG002|Overall Study|Withdrawal by Subject|2|||
163453002|NCT01079962|590357476|FG000|Overall Study|Adverse Event|2|||
163453003|NCT01079962|590357477|FG001|Overall Study|Adverse Event|2|||
163453004|NCT01079962|590357476|FG000|Overall Study|Withdrawal by Subject|5|||
163453005|NCT01079962|590357477|FG001|Overall Study|Withdrawal by Subject|7|||
163453006|NCT01079962|590357476|FG000|Overall Study|Protocol Violation|2|||
163453007|NCT01079962|590357477|FG001|Overall Study|Protocol Violation|2|||
163453008|NCT01079962|590357476|FG000|Overall Study|No blood pressure (BP) control|3|||
163453009|NCT01079962|590357477|FG001|Overall Study|No blood pressure (BP) control|0|||
163453010|NCT01079962|590357476|FG000|Overall Study|Inclusion/exclusion criteria|1|||
163453011|NCT01079962|590357477|FG001|Overall Study|Inclusion/exclusion criteria|3|||
163453012|NCT01079962|590357476|FG000|Overall Study|Participant not returning for next visit|1|||
163453013|NCT01079962|590357477|FG001|Overall Study|Participant not returning for next visit|0|||
163453014|NCT01079962|590357476|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
163453015|NCT01079962|590357477|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
163453016|NCT01072539|590357478|FG000|Overall Study|Treated prior to the Site Initiation|1|||
163453017|NCT01072539|590357478|FG000|Overall Study|Protocol Violation|2|||
163453018|NCT00946530|590357479|FG000|Overall Study|Withdrawal by Subject|0|||
163453019|NCT00946530|590357480|FG001|Overall Study|Withdrawal by Subject|3|||
163453020|NCT00946530|590357481|FG002|Overall Study|Withdrawal by Subject|0|||
163453021|NCT00946530|590357482|FG003|Overall Study|Withdrawal by Subject|3|||
163453022|NCT00946530|590357479|FG000|Overall Study|Physician Decision|1|||
163453023|NCT00946530|590357480|FG001|Overall Study|Physician Decision|1|||
163453024|NCT00946530|590357481|FG002|Overall Study|Physician Decision|1|||
163453025|NCT00946530|590357482|FG003|Overall Study|Physician Decision|1|||
163453026|NCT04167306|590357483|FG000|Overall Study|Lost to Follow-up|2|||
163453027|NCT04167306|590357484|FG001|Overall Study|Lost to Follow-up|2|||
163453028|NCT04167306|590357485|FG002|Overall Study|Lost to Follow-up|5|||
163453029|NCT04167306|590357486|FG003|Overall Study|Lost to Follow-up|5|||
163453030|NCT04167306|590357483|FG000|Overall Study|Adverse Event|13|||
163453031|NCT04167306|590357484|FG001|Overall Study|Adverse Event|14|||
163453032|NCT04167306|590357485|FG002|Overall Study|Adverse Event|5|||
163453033|NCT04167306|590357486|FG003|Overall Study|Adverse Event|4|||
163453034|NCT04167306|590357483|FG000|Overall Study|Withdrawal by Subject|4|||
163453035|NCT04167306|590357484|FG001|Overall Study|Withdrawal by Subject|6|||
163453036|NCT04167306|590357485|FG002|Overall Study|Withdrawal by Subject|8|||
163453037|NCT04167306|590357486|FG003|Overall Study|Withdrawal by Subject|3|||
163453038|NCT04167306|590357483|FG000|Overall Study|covid|1|||
163453039|NCT04167306|590357484|FG001|Overall Study|covid|1|||
163453040|NCT04167306|590357485|FG002|Overall Study|covid|2|||
163453041|NCT04167306|590357486|FG003|Overall Study|covid|1|||
163453042|NCT04167306|590357483|FG000|Overall Study|concomitant medication|0|||
163453043|NCT04167306|590357484|FG001|Overall Study|concomitant medication|0|||
163453044|NCT04167306|590357485|FG002|Overall Study|concomitant medication|0|||
163453045|NCT04167306|590357486|FG003|Overall Study|concomitant medication|1|||
163453046|NCT04167306|590357483|FG000|Overall Study|Alcohol treatment|0|||
163453047|NCT04167306|590357484|FG001|Overall Study|Alcohol treatment|4|||
163453048|NCT04167306|590357485|FG002|Overall Study|Alcohol treatment|3|||
163453049|NCT04167306|590357486|FG003|Overall Study|Alcohol treatment|2|||
163453050|NCT04167306|590357483|FG000|Overall Study|non-compliance|0|||
163453051|NCT04167306|590357484|FG001|Overall Study|non-compliance|0|||
163453052|NCT04167306|590357485|FG002|Overall Study|non-compliance|1|||
163453053|NCT04167306|590357486|FG003|Overall Study|non-compliance|0|||
163453054|NCT04167306|590357483|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
163453055|NCT04167306|590357484|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
163453056|NCT04167306|590357485|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
163453057|NCT04167306|590357486|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
163453058|NCT03731364|590357487|FG000|Overall Study|Adverse Event|0|||
163453059|NCT03731364|590357488|FG001|Overall Study|Adverse Event|0|||
163453060|NCT03731364|590357489|FG002|Overall Study|Adverse Event|1|||
163453061|NCT03731364|590357490|FG003|Overall Study|Adverse Event|2|||
163453062|NCT03731364|590357491|FG004|Overall Study|Adverse Event|1|||
163453063|NCT04387136|590357492|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
163453064|NCT04387136|590357493|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
163453065|NCT00417976|590357494|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
163453066|NCT00417976|590357494|FG000|Overall Study|Treatment -related toxicity|2|||
163453067|NCT02358369|590357495|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
163453068|NCT02358369|590357496|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
163453069|NCT02358369|590357497|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
163453070|NCT02358369|590357498|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
163453071|NCT02358369|590357499|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
163453072|NCT02358369|590357495|FG000|Treatment Period A/B|Adverse Event|0|||
163453073|NCT02358369|590357496|FG001|Treatment Period A/B|Adverse Event|0|||
163453074|NCT02358369|590357497|FG002|Treatment Period A/B|Adverse Event|1|||
163453075|NCT02358369|590357498|FG003|Treatment Period A/B|Adverse Event|2|||
163453076|NCT02358369|590357499|FG004|Treatment Period A/B|Adverse Event|0|||
163453077|NCT02358369|590357495|FG000|Treatment Period A/B|Death|0|||
163453078|NCT02358369|590357496|FG001|Treatment Period A/B|Death|0|||
163453079|NCT02358369|590357497|FG002|Treatment Period A/B|Death|1|||
163453080|NCT02358369|590357498|FG003|Treatment Period A/B|Death|0|||
163453081|NCT02358369|590357499|FG004|Treatment Period A/B|Death|0|||
163453082|NCT02358369|590357495|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
163453083|NCT02358369|590357496|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
163453084|NCT02358369|590357497|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
163453085|NCT02358369|590357498|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
163453086|NCT02358369|590357499|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
163453087|NCT02358369|590357495|FG000|Treatment Period C|Adverse Event|0|||
163453088|NCT02358369|590357496|FG001|Treatment Period C|Adverse Event|0|||
163453089|NCT02358369|590357497|FG002|Treatment Period C|Adverse Event|0|||
163453090|NCT02358369|590357498|FG003|Treatment Period C|Adverse Event|0|||
163453091|NCT02358369|590357499|FG004|Treatment Period C|Adverse Event|7|||
163453092|NCT03655717|590357500|FG000|Overall Study|Withdrawal by Subject|4|||
163453093|NCT03655717|590357501|FG001|Overall Study|Withdrawal by Subject|8|||
163453094|NCT03655717|590357502|FG002|Overall Study|Withdrawal by Subject|1|||
163453095|NCT03655717|590357503|FG003|Overall Study|Withdrawal by Subject|0|||
163453096|NCT03655717|590357504|FG004|Overall Study|Withdrawal by Subject|0|||
163453097|NCT03655717|590357505|FG005|Overall Study|Withdrawal by Subject|1|||
163453098|NCT03655717|590357506|FG006|Overall Study|Withdrawal by Subject|3|||
163453099|NCT03655717|590357507|FG007|Overall Study|Withdrawal by Subject|1|||
163453100|NCT03655717|590357508|FG008|Overall Study|Withdrawal by Subject|2|||
163453101|NCT03655717|590357509|FG009|Overall Study|Withdrawal by Subject|0|||
163453102|NCT03655717|590357510|FG010|Overall Study|Withdrawal by Subject|0|||
163453103|NCT03655717|590357511|FG011|Overall Study|Withdrawal by Subject|1|||
163453104|NCT03655717|590357512|FG012|Overall Study|Withdrawal by Subject|0|||
163453105|NCT03655717|590357513|FG013|Overall Study|Withdrawal by Subject|3|||
163453106|NCT03655717|590357514|FG014|Overall Study|Withdrawal by Subject|0|||
163453107|NCT03655717|590357515|FG015|Overall Study|Withdrawal by Subject|1|||
163453108|NCT03655717|590357516|FG016|Overall Study|Withdrawal by Subject|0|||
163453109|NCT03655717|590357517|FG017|Overall Study|Withdrawal by Subject|0|||
163453110|NCT03655717|590357518|FG018|Overall Study|Withdrawal by Subject|1|||
163453111|NCT03655717|590357519|FG019|Overall Study|Withdrawal by Subject|0|||
163453112|NCT03655717|590357520|FG020|Overall Study|Withdrawal by Subject|0|||
163453113|NCT03655717|590357521|FG021|Overall Study|Withdrawal by Subject|1|||
163453114|NCT03655717|590357522|FG022|Overall Study|Withdrawal by Subject|2|||
163453115|NCT03655717|590357523|FG023|Overall Study|Withdrawal by Subject|1|||
163453116|NCT03655717|590357524|FG024|Overall Study|Withdrawal by Subject|1|||
163453117|NCT03655717|590357525|FG025|Overall Study|Withdrawal by Subject|0|||
163453118|NCT03655717|590357500|FG000|Overall Study|Physician Decision|3|||
163453119|NCT03655717|590357501|FG001|Overall Study|Physician Decision|3|||
163453120|NCT03655717|590357502|FG002|Overall Study|Physician Decision|0|||
163453121|NCT03655717|590357503|FG003|Overall Study|Physician Decision|0|||
163453122|NCT03655717|590357504|FG004|Overall Study|Physician Decision|0|||
163453123|NCT03655717|590357505|FG005|Overall Study|Physician Decision|0|||
163453124|NCT03655717|590357506|FG006|Overall Study|Physician Decision|0|||
163453125|NCT03655717|590357507|FG007|Overall Study|Physician Decision|0|||
163453126|NCT03655717|590357508|FG008|Overall Study|Physician Decision|0|||
163453127|NCT03655717|590357509|FG009|Overall Study|Physician Decision|1|||
163453128|NCT03655717|590357510|FG010|Overall Study|Physician Decision|0|||
163453129|NCT03655717|590357511|FG011|Overall Study|Physician Decision|0|||
163453130|NCT03655717|590357512|FG012|Overall Study|Physician Decision|0|||
163453131|NCT03655717|590357513|FG013|Overall Study|Physician Decision|0|||
163453132|NCT03655717|590357514|FG014|Overall Study|Physician Decision|0|||
163453133|NCT03655717|590357515|FG015|Overall Study|Physician Decision|0|||
163453134|NCT03655717|590357516|FG016|Overall Study|Physician Decision|0|||
163453135|NCT03655717|590357517|FG017|Overall Study|Physician Decision|0|||
163453136|NCT03655717|590357518|FG018|Overall Study|Physician Decision|0|||
163453137|NCT03655717|590357519|FG019|Overall Study|Physician Decision|1|||
163453138|NCT03655717|590357520|FG020|Overall Study|Physician Decision|0|||
163453139|NCT03655717|590357521|FG021|Overall Study|Physician Decision|0|||
163453140|NCT03655717|590357522|FG022|Overall Study|Physician Decision|0|||
163453141|NCT03655717|590357523|FG023|Overall Study|Physician Decision|1|||
163453142|NCT03655717|590357524|FG024|Overall Study|Physician Decision|0|||
163453143|NCT03655717|590357525|FG025|Overall Study|Physician Decision|0|||
163453144|NCT03655717|590357500|FG000|Overall Study|Lost to Follow-up|3|||
163453145|NCT03655717|590357501|FG001|Overall Study|Lost to Follow-up|1|||
163453146|NCT03655717|590357502|FG002|Overall Study|Lost to Follow-up|0|||
163453147|NCT03655717|590357503|FG003|Overall Study|Lost to Follow-up|1|||
163453148|NCT03655717|590357504|FG004|Overall Study|Lost to Follow-up|0|||
163453149|NCT03655717|590357505|FG005|Overall Study|Lost to Follow-up|1|||
163453150|NCT03655717|590357506|FG006|Overall Study|Lost to Follow-up|0|||
163453151|NCT03655717|590357507|FG007|Overall Study|Lost to Follow-up|0|||
163453152|NCT03655717|590357508|FG008|Overall Study|Lost to Follow-up|0|||
163453153|NCT03655717|590357509|FG009|Overall Study|Lost to Follow-up|0|||
163453154|NCT03655717|590357510|FG010|Overall Study|Lost to Follow-up|0|||
163453155|NCT03655717|590357511|FG011|Overall Study|Lost to Follow-up|1|||
163453156|NCT03655717|590357512|FG012|Overall Study|Lost to Follow-up|0|||
163453157|NCT03655717|590357513|FG013|Overall Study|Lost to Follow-up|0|||
163453158|NCT03655717|590357514|FG014|Overall Study|Lost to Follow-up|0|||
163453159|NCT03655717|590357515|FG015|Overall Study|Lost to Follow-up|0|||
163453160|NCT03655717|590357516|FG016|Overall Study|Lost to Follow-up|0|||
163453161|NCT03655717|590357517|FG017|Overall Study|Lost to Follow-up|0|||
163453162|NCT03655717|590357518|FG018|Overall Study|Lost to Follow-up|0|||
163453163|NCT03655717|590357519|FG019|Overall Study|Lost to Follow-up|0|||
163453164|NCT03655717|590357520|FG020|Overall Study|Lost to Follow-up|0|||
163453165|NCT03655717|590357521|FG021|Overall Study|Lost to Follow-up|0|||
163453166|NCT03655717|590357522|FG022|Overall Study|Lost to Follow-up|0|||
163453167|NCT03655717|590357523|FG023|Overall Study|Lost to Follow-up|0|||
163453168|NCT03655717|590357524|FG024|Overall Study|Lost to Follow-up|0|||
163453169|NCT03655717|590357525|FG025|Overall Study|Lost to Follow-up|0|||
163453170|NCT01185249|590357526|FG000|Overall Study|Patients discharged or change in status|42|||
163453171|NCT01973452|590357527|FG000|Overall Study|Lack of Efficacy|0|||
163453172|NCT01973452|590357528|FG001|Overall Study|Lack of Efficacy|1|||
163453173|NCT01973452|590357527|FG000|Overall Study|Lost to Follow-up|1|||
163453174|NCT01973452|590357528|FG001|Overall Study|Lost to Follow-up|0|||
163453175|NCT01973452|590357527|FG000|Overall Study|Withdrawal by Subject|10|||
163453176|NCT01973452|590357528|FG001|Overall Study|Withdrawal by Subject|9|||
163453177|NCT01973452|590357527|FG000|Overall Study|Ineligible|1|||
163453178|NCT01973452|590357528|FG001|Overall Study|Ineligible|1|||
163453179|NCT01973452|590357527|FG000|Overall Study|Surgery canceled by participant|5|||
163453180|NCT01973452|590357528|FG001|Overall Study|Surgery canceled by participant|3|||
163453181|NCT00064350|590357530|FG000|Induction Treatment|Disease Progression|5|||
163453182|NCT00064350|590357531|FG001|Induction Treatment|Disease Progression|1|||
163453183|NCT00064350|590357532|FG002|Induction Treatment|Disease Progression|110|||
163453184|NCT00064350|590357530|FG000|Induction Treatment|Adverse Event|0|||
163453185|NCT00064350|590357531|FG001|Induction Treatment|Adverse Event|2|||
163453186|NCT00064350|590357532|FG002|Induction Treatment|Adverse Event|49|||
163453187|NCT00064350|590357530|FG000|Induction Treatment|Death|0|||
163453188|NCT00064350|590357531|FG001|Induction Treatment|Death|0|||
163453189|NCT00064350|590357532|FG002|Induction Treatment|Death|9|||
163453190|NCT00064350|590357530|FG000|Induction Treatment|Withdrawal by Subject|0|||
163453191|NCT00064350|590357531|FG001|Induction Treatment|Withdrawal by Subject|0|||
163453192|NCT00064350|590357532|FG002|Induction Treatment|Withdrawal by Subject|21|||
163453193|NCT00064350|590357530|FG000|Induction Treatment|Ineligible or never started treatment|3|||
163453194|NCT00064350|590357531|FG001|Induction Treatment|Ineligible or never started treatment|6|||
163453195|NCT00064350|590357532|FG002|Induction Treatment|Ineligible or never started treatment|34|||
163453196|NCT00064350|590357530|FG000|Induction Treatment|Other|0|||
163453197|NCT00064350|590357531|FG001|Induction Treatment|Other|0|||
163453198|NCT00064350|590357532|FG002|Induction Treatment|Other|13|||
163453199|NCT00064350|590357530|FG000|Randomization|Adverse Event|8|||
163453200|NCT00064350|590357531|FG001|Randomization|Adverse Event|3|||
163453201|NCT00064350|590357532|FG002|Randomization|Adverse Event|0|||
163453202|NCT00064350|590357530|FG000|Randomization|Death|3|||
163453203|NCT00064350|590357531|FG001|Randomization|Death|0|||
163453204|NCT00064350|590357532|FG002|Randomization|Death|0|||
163453205|NCT00064350|590357530|FG000|Randomization|Withdrawal by Subject|1|||
163453206|NCT00064350|590357531|FG001|Randomization|Withdrawal by Subject|0|||
163453207|NCT00064350|590357532|FG002|Randomization|Withdrawal by Subject|0|||
163453208|NCT00064350|590357530|FG000|Randomization|Ineligible or never started treatment|9|||
163453209|NCT00064350|590357531|FG001|Randomization|Ineligible or never started treatment|15|||
163453210|NCT00064350|590357532|FG002|Randomization|Ineligible or never started treatment|0|||
163453211|NCT00064350|590357530|FG000|Randomization|Other|5|||
163453212|NCT00064350|590357531|FG001|Randomization|Other|0|||
163453213|NCT00064350|590357532|FG002|Randomization|Other|0|||
163453214|NCT00064350|590357530|FG000|Cross-Over|Adverse Event|0|||
163453215|NCT00064350|590357531|FG001|Cross-Over|Adverse Event|1|||
163453216|NCT00064350|590357532|FG002|Cross-Over|Adverse Event|0|||
163453217|NCT00064350|590357530|FG000|Cross-Over|Death|1|||
163453218|NCT00064350|590357531|FG001|Cross-Over|Death|3|||
163453219|NCT00064350|590357532|FG002|Cross-Over|Death|0|||
163453220|NCT00064350|590357530|FG000|Cross-Over|Withdrawal by Subject|2|||
163453221|NCT00064350|590357531|FG001|Cross-Over|Withdrawal by Subject|2|||
163453222|NCT00064350|590357532|FG002|Cross-Over|Withdrawal by Subject|0|||
163453223|NCT00064350|590357530|FG000|Cross-Over|Ineligible or never started treatment|3|||
163453224|NCT00064350|590357531|FG001|Cross-Over|Ineligible or never started treatment|6|||
163453225|NCT00064350|590357532|FG002|Cross-Over|Ineligible or never started treatment|0|||
163453226|NCT00064350|590357530|FG000|Cross-Over|Other|0|||
163453227|NCT00064350|590357531|FG001|Cross-Over|Other|2|||
163453228|NCT00064350|590357532|FG002|Cross-Over|Other|0|||
163453229|NCT00115765|590357533|FG000|Overall Study|Withdrawal by Subject|22|||
163453230|NCT00115765|590357534|FG001|Overall Study|Withdrawal by Subject|53|||
163453231|NCT00115765|590357535|FG002|Overall Study|Withdrawal by Subject|76|||
163453232|NCT00115765|590357536|FG003|Overall Study|Withdrawal by Subject|15|||
163453233|NCT00115765|590357533|FG000|Overall Study|Physician Decision|4|||
163453234|NCT00115765|590357534|FG001|Overall Study|Physician Decision|15|||
163453235|NCT00115765|590357535|FG002|Overall Study|Physician Decision|18|||
163453236|NCT00115765|590357536|FG003|Overall Study|Physician Decision|13|||
163453237|NCT00115765|590357533|FG000|Overall Study|Lost to Follow-up|3|||
163453238|NCT00115765|590357534|FG001|Overall Study|Lost to Follow-up|20|||
163453239|NCT00115765|590357535|FG002|Overall Study|Lost to Follow-up|18|||
163453240|NCT00115765|590357536|FG003|Overall Study|Lost to Follow-up|1|||
163453241|NCT00115765|590357533|FG000|Overall Study|Other|6|||
163453242|NCT00115765|590357534|FG001|Overall Study|Other|12|||
163453243|NCT00115765|590357535|FG002|Overall Study|Other|9|||
163453244|NCT00115765|590357536|FG003|Overall Study|Other|2|||
163453245|NCT01683071|590357539|FG000|Part 1|Lack of Efficacy|1|||
163453246|NCT01683071|590357540|FG001|Part 1|Lack of Efficacy|0|||
163453247|NCT01683071|590357541|FG002|Part 1|Lack of Efficacy|0|||
163453248|NCT01683071|590357542|FG003|Part 1|Lack of Efficacy|3|||
163453249|NCT01683071|590357543|FG004|Part 1|Lack of Efficacy|0|||
163453250|NCT01683071|590357544|FG005|Part 1|Lack of Efficacy|0|||
163453251|NCT01683071|590357539|FG000|Part 1|Withdrawal by Subject|1|||
163453252|NCT01683071|590357540|FG001|Part 1|Withdrawal by Subject|2|||
163453253|NCT01683071|590357541|FG002|Part 1|Withdrawal by Subject|2|||
163453254|NCT01683071|590357542|FG003|Part 1|Withdrawal by Subject|1|||
163453255|NCT01683071|590357543|FG004|Part 1|Withdrawal by Subject|0|||
163453256|NCT01683071|590357544|FG005|Part 1|Withdrawal by Subject|0|||
163453257|NCT01683071|590357539|FG000|Part 1|Surgery Cancelled|1|||
163453258|NCT01683071|590357540|FG001|Part 1|Surgery Cancelled|0|||
163453259|NCT01683071|590357541|FG002|Part 1|Surgery Cancelled|0|||
163453260|NCT01683071|590357542|FG003|Part 1|Surgery Cancelled|0|||
163453261|NCT01683071|590357543|FG004|Part 1|Surgery Cancelled|0|||
163453262|NCT01683071|590357544|FG005|Part 1|Surgery Cancelled|0|||
163453263|NCT01683071|590357539|FG000|Part 1|Did not receive study drug|1|||
163453264|NCT01683071|590357540|FG001|Part 1|Did not receive study drug|0|||
163453265|NCT01683071|590357541|FG002|Part 1|Did not receive study drug|0|||
163453266|NCT01683071|590357542|FG003|Part 1|Did not receive study drug|1|||
163453267|NCT01683071|590357543|FG004|Part 1|Did not receive study drug|0|||
163453268|NCT01683071|590357544|FG005|Part 1|Did not receive study drug|0|||
163453269|NCT01683071|590357539|FG000|Part 1|Early termination; met exclusion criteria|0|||
163453270|NCT01683071|590357540|FG001|Part 1|Early termination; met exclusion criteria|2|||
163453271|NCT01683071|590357541|FG002|Part 1|Early termination; met exclusion criteria|1|||
163453272|NCT01683071|590357542|FG003|Part 1|Early termination; met exclusion criteria|0|||
163453273|NCT01683071|590357543|FG004|Part 1|Early termination; met exclusion criteria|0|||
163453274|NCT01683071|590357544|FG005|Part 1|Early termination; met exclusion criteria|0|||
163453275|NCT01683071|590357539|FG000|Part 2|Lack of Efficacy|0|||
163453276|NCT01683071|590357540|FG001|Part 2|Lack of Efficacy|0|||
163453277|NCT01683071|590357541|FG002|Part 2|Lack of Efficacy|0|||
163453278|NCT01683071|590357542|FG003|Part 2|Lack of Efficacy|0|||
163453279|NCT01683071|590357543|FG004|Part 2|Lack of Efficacy|3|||
163453280|NCT01683071|590357544|FG005|Part 2|Lack of Efficacy|4|||
163453281|NCT01683071|590357539|FG000|Part 2|Lost to Follow-up|0|||
163453282|NCT01683071|590357540|FG001|Part 2|Lost to Follow-up|0|||
163453283|NCT01683071|590357541|FG002|Part 2|Lost to Follow-up|0|||
163453284|NCT01683071|590357542|FG003|Part 2|Lost to Follow-up|0|||
163453285|NCT01683071|590357543|FG004|Part 2|Lost to Follow-up|2|||
163453286|NCT01683071|590357544|FG005|Part 2|Lost to Follow-up|0|||
163453287|NCT01683071|590357539|FG000|Part 2|Withdrawal by Subject|0|||
163453288|NCT01683071|590357540|FG001|Part 2|Withdrawal by Subject|0|||
163453289|NCT01683071|590357541|FG002|Part 2|Withdrawal by Subject|0|||
163453290|NCT01683071|590357542|FG003|Part 2|Withdrawal by Subject|0|||
163453291|NCT01683071|590357543|FG004|Part 2|Withdrawal by Subject|3|||
163453292|NCT01683071|590357544|FG005|Part 2|Withdrawal by Subject|3|||
163453293|NCT01683071|590357539|FG000|Part 2|Surgery cancelled|0|||
163453294|NCT01683071|590357540|FG001|Part 2|Surgery cancelled|0|||
163453295|NCT01683071|590357541|FG002|Part 2|Surgery cancelled|0|||
163453296|NCT01683071|590357542|FG003|Part 2|Surgery cancelled|0|||
163453297|NCT01683071|590357543|FG004|Part 2|Surgery cancelled|4|||
163453298|NCT01683071|590357544|FG005|Part 2|Surgery cancelled|2|||
163453299|NCT01683071|590357539|FG000|Part 2|Did not receive study drug|0|||
163453300|NCT01683071|590357540|FG001|Part 2|Did not receive study drug|0|||
163453301|NCT01683071|590357541|FG002|Part 2|Did not receive study drug|0|||
163453302|NCT01683071|590357542|FG003|Part 2|Did not receive study drug|0|||
163453303|NCT01683071|590357543|FG004|Part 2|Did not receive study drug|2|||
163453304|NCT01683071|590357544|FG005|Part 2|Did not receive study drug|1|||
163453305|NCT01683071|590357539|FG000|Part 2|Met exclusion criterion|0|||
163453306|NCT01683071|590357540|FG001|Part 2|Met exclusion criterion|0|||
163453307|NCT01683071|590357541|FG002|Part 2|Met exclusion criterion|0|||
163453308|NCT01683071|590357542|FG003|Part 2|Met exclusion criterion|0|||
163453309|NCT01683071|590357543|FG004|Part 2|Met exclusion criterion|1|||
163453310|NCT01683071|590357544|FG005|Part 2|Met exclusion criterion|1|||
163453311|NCT01683071|590357539|FG000|Part 2|Protocol deviation|0|||
163453312|NCT01683071|590357540|FG001|Part 2|Protocol deviation|0|||
163453313|NCT01683071|590357541|FG002|Part 2|Protocol deviation|0|||
163453314|NCT01683071|590357542|FG003|Part 2|Protocol deviation|0|||
163453315|NCT01683071|590357543|FG004|Part 2|Protocol deviation|1|||
163453316|NCT01683071|590357544|FG005|Part 2|Protocol deviation|2|||
163453317|NCT01683071|590357539|FG000|Part 2|Withdrawal by investigator decision|0|||
163453318|NCT01683071|590357540|FG001|Part 2|Withdrawal by investigator decision|0|||
163453319|NCT01683071|590357541|FG002|Part 2|Withdrawal by investigator decision|0|||
163453320|NCT01683071|590357542|FG003|Part 2|Withdrawal by investigator decision|0|||
163453321|NCT01683071|590357543|FG004|Part 2|Withdrawal by investigator decision|1|||
163453322|NCT01683071|590357544|FG005|Part 2|Withdrawal by investigator decision|2|||
163453323|NCT03707158|590357545|FG000|Midtreatment|Lost to Follow-up|16|||
163453324|NCT03707158|590357546|FG001|Midtreatment|Lost to Follow-up|7|||
163453325|NCT03707158|590357545|FG000|Midtreatment|Withdrawal by Subject|28|||
163453326|NCT03707158|590357546|FG001|Midtreatment|Withdrawal by Subject|19|||
163453327|NCT03707158|590357545|FG000|Posttreatment|Lost to Follow-up|0|||
163453328|NCT03707158|590357546|FG001|Posttreatment|Lost to Follow-up|5|||
163453329|NCT03707158|590357545|FG000|Follow-up|Lost to Follow-up|19|||
163453330|NCT03707158|590357546|FG001|Follow-up|Lost to Follow-up|18|||
163453331|NCT03707158|590357545|FG000|Follow-up|Withdrawal by Subject|13|||
163453332|NCT03707158|590357546|FG001|Follow-up|Withdrawal by Subject|6|||
163453333|NCT01454401|590357549|FG000|Overall Study|Death|1|||
163453334|NCT01454401|590357549|FG000|Overall Study|hospitalised|1|||
163453335|NCT01454401|590357549|FG000|Overall Study|osteomyelitis|2|||
163453336|NCT01454401|590357549|FG000|Overall Study|non-adherence|1|||
163453337|NCT01968187|590357550|FG000|Overall Study|Adverse Event|0|||
163453338|NCT01968187|590357551|FG001|Overall Study|Adverse Event|1|||
163453339|NCT01968187|590357550|FG000|Overall Study|Randomized but not treated|1|||
163453340|NCT01968187|590357551|FG001|Overall Study|Randomized but not treated|0|||
163453341|NCT00430521|590357552|FG000|Overall Study|Adverse Event|0|||
163453342|NCT00430521|590357553|FG001|Overall Study|Adverse Event|0|||
163453343|NCT00430521|590357554|FG002|Overall Study|Adverse Event|0|||
163453344|NCT00430521|590357555|FG003|Overall Study|Adverse Event|0|||
163453345|NCT00430521|590357556|FG004|Overall Study|Adverse Event|0|||
163453346|NCT00430521|590357557|FG005|Overall Study|Adverse Event|2|||
163453347|NCT00430521|590357558|FG006|Overall Study|Adverse Event|1|||
163453348|NCT00430521|590357559|FG007|Overall Study|Adverse Event|0|||
163453349|NCT00430521|590357552|FG000|Overall Study|Lost to Follow-up|7|||
163453350|NCT00430521|590357553|FG001|Overall Study|Lost to Follow-up|8|||
163453351|NCT00430521|590357554|FG002|Overall Study|Lost to Follow-up|3|||
163453352|NCT00430521|590357555|FG003|Overall Study|Lost to Follow-up|5|||
163453353|NCT00430521|590357556|FG004|Overall Study|Lost to Follow-up|5|||
163453354|NCT00430521|590357557|FG005|Overall Study|Lost to Follow-up|2|||
163453355|NCT00430521|590357558|FG006|Overall Study|Lost to Follow-up|8|||
163453356|NCT00430521|590357559|FG007|Overall Study|Lost to Follow-up|10|||
163453357|NCT00430521|590357552|FG000|Overall Study|Pregnancy|0|||
163453358|NCT00430521|590357553|FG001|Overall Study|Pregnancy|0|||
163453359|NCT00430521|590357554|FG002|Overall Study|Pregnancy|0|||
163453360|NCT00430521|590357555|FG003|Overall Study|Pregnancy|0|||
163453361|NCT00430521|590357556|FG004|Overall Study|Pregnancy|0|||
163453362|NCT00430521|590357557|FG005|Overall Study|Pregnancy|0|||
163453363|NCT00430521|590357558|FG006|Overall Study|Pregnancy|1|||
163453364|NCT00430521|590357559|FG007|Overall Study|Pregnancy|0|||
163453365|NCT00430521|590357552|FG000|Overall Study|Vaccine Expired|0|||
163453366|NCT00430521|590357553|FG001|Overall Study|Vaccine Expired|0|||
163453367|NCT00430521|590357554|FG002|Overall Study|Vaccine Expired|0|||
163453368|NCT00430521|590357555|FG003|Overall Study|Vaccine Expired|0|||
163453369|NCT00430521|590357556|FG004|Overall Study|Vaccine Expired|0|||
163453370|NCT00430521|590357557|FG005|Overall Study|Vaccine Expired|1|||
163453371|NCT00430521|590357558|FG006|Overall Study|Vaccine Expired|0|||
163453372|NCT00430521|590357559|FG007|Overall Study|Vaccine Expired|0|||
163453373|NCT00430521|590357552|FG000|Overall Study|Protocol Violation|1|||
163453374|NCT00430521|590357553|FG001|Overall Study|Protocol Violation|0|||
163453375|NCT00430521|590357554|FG002|Overall Study|Protocol Violation|0|||
163453376|NCT00430521|590357555|FG003|Overall Study|Protocol Violation|0|||
163453377|NCT00430521|590357556|FG004|Overall Study|Protocol Violation|0|||
163453378|NCT00430521|590357557|FG005|Overall Study|Protocol Violation|0|||
163453379|NCT00430521|590357558|FG006|Overall Study|Protocol Violation|0|||
163453380|NCT00430521|590357559|FG007|Overall Study|Protocol Violation|0|||
163453381|NCT00430521|590357552|FG000|Overall Study|Withdrawal by Subject|3|||
163453382|NCT00430521|590357553|FG001|Overall Study|Withdrawal by Subject|1|||
163453383|NCT00430521|590357554|FG002|Overall Study|Withdrawal by Subject|0|||
163453384|NCT00430521|590357555|FG003|Overall Study|Withdrawal by Subject|3|||
163453385|NCT00430521|590357556|FG004|Overall Study|Withdrawal by Subject|0|||
163453386|NCT00430521|590357557|FG005|Overall Study|Withdrawal by Subject|0|||
163453387|NCT00430521|590357558|FG006|Overall Study|Withdrawal by Subject|0|||
163453388|NCT00430521|590357559|FG007|Overall Study|Withdrawal by Subject|2|||
163453389|NCT02586233|590359688|FG000|Overall Study|Randomized but did not receive treatment|0|||
163453390|NCT02586233|590359689|FG001|Overall Study|Randomized but did not receive treatment|1|||
163453391|NCT02586233|590359690|FG002|Overall Study|Randomized but did not receive treatment|0|||
163453392|NCT02586233|590359691|FG003|Overall Study|Randomized but did not receive treatment|0|||
163453393|NCT02586233|590359692|FG004|Overall Study|Randomized but did not receive treatment|0|||
163453394|NCT02586233|590359693|FG005|Overall Study|Randomized but did not receive treatment|2|||
163453395|NCT02586233|590359694|FG006|Overall Study|Randomized but did not receive treatment|2|||
163453396|NCT02586233|590359688|FG000|Overall Study|Death|0|||
163453397|NCT02586233|590359689|FG001|Overall Study|Death|1|||
163453398|NCT02586233|590359690|FG002|Overall Study|Death|0|||
163453399|NCT02586233|590359691|FG003|Overall Study|Death|0|||
163453400|NCT02586233|590359692|FG004|Overall Study|Death|2|||
163453401|NCT02586233|590359693|FG005|Overall Study|Death|0|||
163453402|NCT02586233|590359694|FG006|Overall Study|Death|0|||
163453403|NCT01708941|590359697|FG000|Overall Study|Adverse Event|4|||
163453404|NCT01708941|590359698|FG001|Overall Study|Adverse Event|6|||
163453405|NCT01708941|590359699|FG002|Overall Study|Adverse Event|1|||
163453406|NCT01708941|590359700|FG003|Overall Study|Adverse Event|0|||
163453407|NCT01708941|590359697|FG000|Overall Study|Death|1|||
163453408|NCT01708941|590359698|FG001|Overall Study|Death|1|||
163453409|NCT01708941|590359699|FG002|Overall Study|Death|2|||
163453410|NCT01708941|590359700|FG003|Overall Study|Death|14|||
163453411|NCT01708941|590359697|FG000|Overall Study|Withdrawal by Subject|1|||
163453412|NCT01708941|590359698|FG001|Overall Study|Withdrawal by Subject|0|||
163453413|NCT01708941|590359699|FG002|Overall Study|Withdrawal by Subject|3|||
163453414|NCT01708941|590359700|FG003|Overall Study|Withdrawal by Subject|4|||
163453415|NCT01708941|590359697|FG000|Overall Study|Disease progression|9|||
163453416|NCT01708941|590359698|FG001|Overall Study|Disease progression|10|||
163453417|NCT01708941|590359699|FG002|Overall Study|Disease progression|8|||
163453418|NCT01708941|590359700|FG003|Overall Study|Disease progression|0|||
163453419|NCT01708941|590359697|FG000|Overall Study|Alternative therapy|0|||
163453420|NCT01708941|590359698|FG001|Overall Study|Alternative therapy|0|||
163453421|NCT01708941|590359699|FG002|Overall Study|Alternative therapy|2|||
163453422|NCT01708941|590359700|FG003|Overall Study|Alternative therapy|0|||
163453423|NCT01708941|590359697|FG000|Overall Study|Ineligible and never started treatment|1|||
163453424|NCT01708941|590359698|FG001|Overall Study|Ineligible and never started treatment|0|||
163453425|NCT01708941|590359699|FG002|Overall Study|Ineligible and never started treatment|1|||
163453426|NCT01708941|590359700|FG003|Overall Study|Ineligible and never started treatment|0|||
163453427|NCT01708941|590359697|FG000|Overall Study|Never started treatment|2|||
163453428|NCT01708941|590359698|FG001|Overall Study|Never started treatment|1|||
163453429|NCT01708941|590359699|FG002|Overall Study|Never started treatment|0|||
163453430|NCT01708941|590359700|FG003|Overall Study|Never started treatment|0|||
163453431|NCT01708941|590359697|FG000|Overall Study|Ineligible|0|||
163453432|NCT01708941|590359698|FG001|Overall Study|Ineligible|0|||
163453433|NCT01708941|590359699|FG002|Overall Study|Ineligible|2|||
163453434|NCT01708941|590359700|FG003|Overall Study|Ineligible|0|||
163453435|NCT01397552|590359701|FG000|Overall Study|Adverse Event|1|||
163453436|NCT01397552|590359702|FG001|Overall Study|Adverse Event|0|||
163453437|NCT01397552|590359701|FG000|Overall Study|Withdrawal by Subject|2|||
163453438|NCT01397552|590359702|FG001|Overall Study|Withdrawal by Subject|1|||
163453439|NCT02287402|590359703|FG000|Treatment Period|Adverse Event|17|||
163453440|NCT02287402|590359703|FG000|Treatment Period|Voluntary Withdrawal|10|||
163453441|NCT02287402|590359703|FG000|Follow-up|Lost to Follow-up|1|||
163453442|NCT02287402|590359703|FG000|Follow-up|Voluntary Withdrawal|2|||
163453443|NCT04247815|590359704|FG000|Overall Study|Adverse Event|1|||
163453444|NCT04247815|590359705|FG001|Overall Study|Adverse Event|0|||
163453445|NCT04247815|590359704|FG000|Overall Study|Withdrawal by Subject|1|||
163453446|NCT04247815|590359705|FG001|Overall Study|Withdrawal by Subject|0|||
163453447|NCT04247815|590359704|FG000|Overall Study|Protocol Violation|0|||
163453448|NCT04247815|590359705|FG001|Overall Study|Protocol Violation|1|||
163453449|NCT02394808|590359706|FG000|Period 1|Unsatisfactory lens fitting|0|||
163453450|NCT02394808|590359707|FG001|Period 1|Unsatisfactory lens fitting|1|||
163453451|NCT02394808|590359706|FG000|Period 2|Lost to Follow-up|1|||
163453452|NCT02394808|590359707|FG001|Period 2|Lost to Follow-up|0|||
163453453|NCT02108600|590359708|FG000|Overall Study|Withdrawal by Subject|2|||
163453454|NCT02108600|590359709|FG001|Overall Study|Withdrawal by Subject|0|||
163453455|NCT02108600|590359708|FG000|Overall Study|Lost to Follow-up|1|||
163453456|NCT02108600|590359709|FG001|Overall Study|Lost to Follow-up|1|||
163453457|NCT01295580|590359712|FG000|Overall Study|Protocol Violation|4|||
163453458|NCT01295580|590359713|FG001|Overall Study|Protocol Violation|2|||
163453459|NCT01295580|590359712|FG000|Overall Study|Withdrawal by Subject|1|||
163453460|NCT01295580|590359713|FG001|Overall Study|Withdrawal by Subject|4|||
163453461|NCT01295580|590359712|FG000|Overall Study|Adverse Event|2|||
163453462|NCT01295580|590359713|FG001|Overall Study|Adverse Event|1|||
163453463|NCT01295580|590359712|FG000|Overall Study|Lost to Follow-up|1|||
163453464|NCT01295580|590359713|FG001|Overall Study|Lost to Follow-up|0|||
163453465|NCT01295580|590359712|FG000|Overall Study|Lack of Efficacy|1|||
163453466|NCT01295580|590359713|FG001|Overall Study|Lack of Efficacy|0|||
163453467|NCT01295580|590359712|FG000|Overall Study|Other: inconvenience|1|||
163453468|NCT01295580|590359713|FG001|Overall Study|Other: inconvenience|0|||
163453469|NCT01295580|590359712|FG000|Overall Study|Other: family objection|0|||
163453470|NCT01295580|590359713|FG001|Overall Study|Other: family objection|1|||
163453471|NCT03943953|590359714|FG000|Trial of ITG 1|Lost to Follow-up|19|||
163453472|NCT03943953|590359715|FG001|Trial of ITG 1|Lost to Follow-up|1|||
163453473|NCT03943953|590359714|FG000|Trial of ITG 2|Lost to Follow-up|8|||
163453474|NCT03943953|590359715|FG001|Trial of ITG 2|Lost to Follow-up|0|||
163453475|NCT03943953|590359714|FG000|Trial of ITG 3|Lost to Follow-up|2|||
163453476|NCT03943953|590359715|FG001|Trial of ITG 3|Lost to Follow-up|0|||
163453477|NCT03943953|590359714|FG000|Trial of ITG 4|Lost to Follow-up|2|||
163453478|NCT03943953|590359715|FG001|Trial of ITG 4|Lost to Follow-up|0|||
163453479|NCT01742078|590359716|FG000|Overall Study|Withdrawal by Subject|0|||
163453480|NCT01742078|590359717|FG001|Overall Study|Withdrawal by Subject|0|||
163453481|NCT01742078|590359718|FG002|Overall Study|Withdrawal by Subject|0|||
163453482|NCT01742078|590359719|FG003|Overall Study|Withdrawal by Subject|1|||
163453483|NCT01742078|590359720|FG004|Overall Study|Withdrawal by Subject|0|||
163453484|NCT01742078|590359721|FG005|Overall Study|Withdrawal by Subject|0|||
163453485|NCT01742078|590359722|FG006|Overall Study|Withdrawal by Subject|0|||
163453486|NCT01742078|590359723|FG007|Overall Study|Withdrawal by Subject|0|||
163453487|NCT01742078|590359724|FG008|Overall Study|Withdrawal by Subject|0|||
163453488|NCT01124448|590359725|FG000|Overall Study|Lost to Follow-up|0|||
163453489|NCT01124448|590359726|FG001|Overall Study|Lost to Follow-up|3|||
163453490|NCT01124448|590359725|FG000|Overall Study|Protocol Violation|2|||
163453491|NCT01124448|590359726|FG001|Overall Study|Protocol Violation|0|||
163453492|NCT05025787|590359732|FG000|Overall Study|Lack of Efficacy|0|||
163453493|NCT05025787|590359733|FG001|Overall Study|Lack of Efficacy|1|||
163453494|NCT05025787|590359732|FG000|Overall Study|Adverse Event|2|||
163453495|NCT05025787|590359733|FG001|Overall Study|Adverse Event|4|||
163453496|NCT05025787|590359732|FG000|Overall Study|Non compliance|0|||
163453497|NCT05025787|590359733|FG001|Overall Study|Non compliance|1|||
163453498|NCT05025787|590359732|FG000|Overall Study|Protocol Violation|3|||
163453499|NCT05025787|590359733|FG001|Overall Study|Protocol Violation|1|||
163453500|NCT05025787|590359732|FG000|Overall Study|Stopping criteria met|1|||
163453501|NCT05025787|590359733|FG001|Overall Study|Stopping criteria met|1|||
163453502|NCT05025787|590359732|FG000|Overall Study|Withdrawal by Subject|3|||
163453503|NCT05025787|590359733|FG001|Overall Study|Withdrawal by Subject|1|||
163453504|NCT03471767|590359734|FG000|Overall Study|Withdrawal by Subject|3|||
163453505|NCT03471767|590359735|FG001|Overall Study|Withdrawal by Subject|1|||
163453506|NCT03471767|590359734|FG000|Overall Study|Adverse Event|1|||
163453507|NCT03471767|590359735|FG001|Overall Study|Adverse Event|0|||
163453508|NCT03471767|590359734|FG000|Overall Study|Lost to Follow-up|1|||
163453509|NCT03471767|590359735|FG001|Overall Study|Lost to Follow-up|0|||
163453510|NCT03471767|590359734|FG000|Overall Study|PI Withdrawal|1|||
163453511|NCT03471767|590359735|FG001|Overall Study|PI Withdrawal|3|||
163453512|NCT05600309|590359736|FG000|Overall Study|Death|41|||
163453513|NCT05600309|590359737|FG001|Overall Study|Death|38|||
163453514|NCT05600309|590359736|FG000|Overall Study|Sponsor Decision|9|||
163453515|NCT05600309|590359737|FG001|Overall Study|Sponsor Decision|6|||
163453516|NCT00807846|590359738|FG000|Overall Study|Adverse Event|5|||
163453517|NCT00807846|590359739|FG001|Overall Study|Adverse Event|0|||
163453518|NCT00807846|590359738|FG000|Overall Study|Lack of Efficacy|2|||
163453519|NCT00807846|590359739|FG001|Overall Study|Lack of Efficacy|0|||
163453520|NCT00807846|590359738|FG000|Overall Study|Protocol Violation|2|||
163453521|NCT00807846|590359739|FG001|Overall Study|Protocol Violation|1|||
163453522|NCT00807846|590359738|FG000|Overall Study|Withdrawal by Subject|2|||
163453523|NCT00807846|590359739|FG001|Overall Study|Withdrawal by Subject|1|||
163453524|NCT00807846|590359738|FG000|Overall Study|Other|1|||
163453525|NCT00807846|590359739|FG001|Overall Study|Other|2|||
163453526|NCT01081873|590359740|FG000|Overall Study|Death|86|||
163453527|NCT01081873|590359740|FG000|Overall Study|Withdrawal by Subject|10|||
163453528|NCT01081873|590359740|FG000|Overall Study|Lost to Follow-up|142|||
163453529|NCT01081873|590359740|FG000|Overall Study|Progression of prostate cancer|13|||
163453530|NCT01081873|590359740|FG000|Overall Study|Other|47|||
163453531|NCT02491073|590359741|FG000|Overall Study|screen failure|1|||
163453532|NCT02491073|590359742|FG001|Overall Study|screen failure|0|||
163453533|NCT03977727|590359743|FG000|Second Treatment|Lost to Follow-up|0|||
163453534|NCT03977727|590359744|FG001|Second Treatment|Lost to Follow-up|3|||
163453535|NCT01419665|590359745|FG000|Combination Treatment|Adverse Event|7|||
163453536|NCT01419665|590359746|FG001|Combination Treatment|Adverse Event|10|||
163453537|NCT01419665|590359745|FG000|Combination Treatment|Physician Decision|5|||
163453538|NCT01419665|590359746|FG001|Combination Treatment|Physician Decision|8|||
163453539|NCT01419665|590359745|FG000|Combination Treatment|Protocol Violation|6|||
163453540|NCT01419665|590359746|FG001|Combination Treatment|Protocol Violation|2|||
163453541|NCT01419665|590359745|FG000|Combination Treatment|disease progression|10|||
163453542|NCT01419665|590359746|FG001|Combination Treatment|disease progression|9|||
163453543|NCT01419665|590359745|FG000|Combination Treatment|Death|5|||
163453544|NCT01419665|590359746|FG001|Combination Treatment|Death|7|||
163453545|NCT01419665|590359745|FG000|Combination Treatment|administrative problems|0|||
163453546|NCT01419665|590359746|FG001|Combination Treatment|administrative problems|1|||
163453547|NCT01419665|590359745|FG000|Combination Treatment|Withdrawal by Subject|5|||
163453548|NCT01419665|590359746|FG001|Combination Treatment|Withdrawal by Subject|4|||
163453549|NCT01419665|590359745|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
163453550|NCT01419665|590359746|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
163453551|NCT01419665|590359745|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
163453552|NCT01419665|590359746|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
163453553|NCT01419665|590359745|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
163453554|NCT01419665|590359746|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
163453555|NCT01419665|590359745|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
163453556|NCT01419665|590359746|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
163453557|NCT01419665|590359745|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
163453558|NCT01419665|590359746|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
163453559|NCT01419665|590359745|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
163453560|NCT01419665|590359746|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
163453561|NCT01419665|590359745|FG000|Maintenance Treatment and/or Follow up|Death|1|||
163453562|NCT01419665|590359746|FG001|Maintenance Treatment and/or Follow up|Death|2|||
163453563|NCT01419665|590359745|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
163453564|NCT01419665|590359746|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
163453565|NCT01419665|590359745|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
163453566|NCT01419665|590359746|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
163453567|NCT01419665|590359745|FG000|Open Label Phase|Death|1|||
163453568|NCT01419665|590359746|FG001|Open Label Phase|Death|0|||
163453569|NCT01419665|590359745|FG000|Open Label Phase|disease progression|0|||
163453570|NCT01419665|590359746|FG001|Open Label Phase|disease progression|1|||
163453571|NCT01655823|590359747|FG000|Overall Study|Lost to Follow-up|0|||
163453572|NCT01655823|590359748|FG001|Overall Study|Lost to Follow-up|1|||
163453573|NCT01655823|590359749|FG002|Overall Study|Lost to Follow-up|0|||
163453574|NCT01655823|590359750|FG003|Overall Study|Lost to Follow-up|0|||
163453575|NCT01655823|590359751|FG004|Overall Study|Lost to Follow-up|1|||
163453576|NCT01655823|590359747|FG000|Overall Study|Withdrawal by Subject|0|||
163453577|NCT01655823|590359748|FG001|Overall Study|Withdrawal by Subject|1|||
163453578|NCT01655823|590359749|FG002|Overall Study|Withdrawal by Subject|0|||
163453579|NCT01655823|590359750|FG003|Overall Study|Withdrawal by Subject|1|||
163453580|NCT01655823|590359751|FG004|Overall Study|Withdrawal by Subject|0|||
163453581|NCT03352414|590359759|FG000|Overall Study|Ineligible by operative criteria|12|||
163453582|NCT03352414|590359760|FG001|Overall Study|Ineligible by operative criteria|10|||
163453583|NCT02632110|590359761|FG000|Overall Study|Withdrawal by Subject|1|||
163453584|NCT02632110|590359762|FG001|Overall Study|Withdrawal by Subject|1|||
163453585|NCT02632110|590359763|FG002|Overall Study|Withdrawal by Subject|0|||
163453586|NCT02632110|590359764|FG003|Overall Study|Withdrawal by Subject|0|||
163453587|NCT02632110|590359765|FG004|Overall Study|Withdrawal by Subject|1|||
163453588|NCT02632110|590359766|FG005|Overall Study|Withdrawal by Subject|1|||
163453589|NCT02632110|590359767|FG006|Overall Study|Withdrawal by Subject|3|||
163453590|NCT02632110|590359768|FG007|Overall Study|Withdrawal by Subject|3|||
163453591|NCT02632110|590359769|FG008|Overall Study|Withdrawal by Subject|1|||
163453592|NCT02632110|590359770|FG009|Overall Study|Withdrawal by Subject|1|||
163453593|NCT00403559|590359777|FG000|Overall Study|Adverse Event|0|||
163453594|NCT00403559|590359778|FG001|Overall Study|Adverse Event|1|||
163453595|NCT00403559|590359777|FG000|Overall Study|Lost to Follow-up|3|||
163453596|NCT00403559|590359778|FG001|Overall Study|Lost to Follow-up|3|||
163453597|NCT00403559|590359777|FG000|Overall Study|Withdrawal by Subject|1|||
163453598|NCT00403559|590359778|FG001|Overall Study|Withdrawal by Subject|0|||
163453599|NCT02768194|590359779|FG000|Period 1|Adverse Event|0|||
163453600|NCT02768194|590359780|FG001|Period 1|Adverse Event|0|||
163453601|NCT02768194|590359781|FG002|Period 1|Adverse Event|0|||
163453602|NCT02768194|590359782|FG003|Period 1|Adverse Event|1|||
163453603|NCT02768194|590359783|FG004|Period 1|Adverse Event|0|||
163453604|NCT02768194|590359784|FG005|Period 1|Adverse Event|0|||
163453605|NCT02768194|590359779|FG000|Period 2|Other (Reason not specified)|1|||
163453606|NCT02768194|590359780|FG001|Period 2|Other (Reason not specified)|0|||
163453607|NCT02768194|590359781|FG002|Period 2|Other (Reason not specified)|0|||
163453608|NCT02768194|590359782|FG003|Period 2|Other (Reason not specified)|0|||
163453609|NCT02768194|590359783|FG004|Period 2|Other (Reason not specified)|0|||
163453610|NCT02768194|590359784|FG005|Period 2|Other (Reason not specified)|0|||
163453611|NCT02768194|590359779|FG000|Period 3|Other (Reason not specified)|0|||
163453612|NCT02768194|590359780|FG001|Period 3|Other (Reason not specified)|1|||
163453613|NCT02768194|590359781|FG002|Period 3|Other (Reason not specified)|0|||
163453614|NCT02768194|590359782|FG003|Period 3|Other (Reason not specified)|0|||
163453615|NCT02768194|590359783|FG004|Period 3|Other (Reason not specified)|0|||
163453616|NCT02768194|590359784|FG005|Period 3|Other (Reason not specified)|0|||
163453617|NCT01982773|590359788|FG000|Overall Study|Withdrawal by Subject|1|||
163453618|NCT01982773|590359789|FG001|Overall Study|Withdrawal by Subject|3|||
163453619|NCT01982773|590359788|FG000|Overall Study|Lost to Follow-up|7|||
163453620|NCT01982773|590359789|FG001|Overall Study|Lost to Follow-up|1|||
163453621|NCT01029886|590359790|FG000|Overall Study|Adverse Event|12|||
163453622|NCT01029886|590359791|FG001|Overall Study|Adverse Event|25|||
163453623|NCT01029886|590359790|FG000|Overall Study|Lost to Follow-up|1|||
163453624|NCT01029886|590359791|FG001|Overall Study|Lost to Follow-up|0|||
163453625|NCT01029886|590359790|FG000|Overall Study|Physician Decision|2|||
163453626|NCT01029886|590359791|FG001|Overall Study|Physician Decision|6|||
163453627|NCT01029886|590359790|FG000|Overall Study|Protocol Violation|17|||
163453628|NCT01029886|590359791|FG001|Overall Study|Protocol Violation|5|||
163453629|NCT01029886|590359790|FG000|Overall Study|Withdrawal by Subject|8|||
163453630|NCT01029886|590359791|FG001|Overall Study|Withdrawal by Subject|18|||
163453631|NCT01029886|590359790|FG000|Overall Study|Entry Criteria Not Met|13|||
163453632|NCT01029886|590359791|FG001|Overall Study|Entry Criteria Not Met|5|||
163453633|NCT01029886|590359790|FG000|Overall Study|Sponsor Decision|1|||
163453634|NCT01029886|590359791|FG001|Overall Study|Sponsor Decision|0|||
163453635|NCT01029886|590359790|FG000|Overall Study|Loss Glucose Control|7|||
163453636|NCT01029886|590359791|FG001|Overall Study|Loss Glucose Control|1|||
163453637|NCT01553916|590359792|FG000|Overall Study|Withdrawal by Subject|2|||
163453638|NCT01553916|590359792|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
163453639|NCT03294681|590359793|FG000|Overall Study|Withdrawal by Subject|1|||
163453640|NCT03089216|590359796|FG000|Overall Study|Adverse Event|0|||
163453641|NCT03089216|590359797|FG001|Overall Study|Adverse Event|0|||
163453642|NCT03089216|590359798|FG002|Overall Study|Adverse Event|0|||
163453643|NCT03089216|590359799|FG003|Overall Study|Adverse Event|1|||
163453644|NCT02720016|590359800|FG000|Overall Study|Separation of couple|6|||
163453645|NCT02720016|590359801|FG001|Overall Study|Separation of couple|8|||
163453646|NCT02720016|590359802|FG002|Overall Study|Separation of couple|2|||
163453647|NCT02720016|590359800|FG000|Overall Study|Withdrawal by Subject|6|||
163453648|NCT02720016|590359801|FG001|Overall Study|Withdrawal by Subject|6|||
163453649|NCT02720016|590359802|FG002|Overall Study|Withdrawal by Subject|4|||
163453650|NCT02720016|590359800|FG000|Overall Study|Scheduling issues|2|||
163453651|NCT02720016|590359801|FG001|Overall Study|Scheduling issues|4|||
163453652|NCT02720016|590359802|FG002|Overall Study|Scheduling issues|7|||
163453653|NCT02720016|590359800|FG000|Overall Study|Childcare|2|||
163453654|NCT02720016|590359801|FG001|Overall Study|Childcare|0|||
163453655|NCT02720016|590359802|FG002|Overall Study|Childcare|2|||
163453656|NCT02720016|590359800|FG000|Overall Study|Withdrawal by PI|2|||
163453657|NCT02720016|590359801|FG001|Overall Study|Withdrawal by PI|2|||
163453658|NCT02720016|590359802|FG002|Overall Study|Withdrawal by PI|0|||
163453659|NCT02720016|590359800|FG000|Overall Study|Moved away|2|||
163453660|NCT02720016|590359801|FG001|Overall Study|Moved away|0|||
163453661|NCT02720016|590359802|FG002|Overall Study|Moved away|0|||
163453662|NCT02720016|590359800|FG000|Overall Study|Not Primary Health Concern|0|||
163453663|NCT02720016|590359801|FG001|Overall Study|Not Primary Health Concern|0|||
163453664|NCT02720016|590359802|FG002|Overall Study|Not Primary Health Concern|2|||
163453665|NCT02720016|590359800|FG000|Overall Study|Transportation issues|0|||
163453666|NCT02720016|590359801|FG001|Overall Study|Transportation issues|0|||
163453667|NCT02720016|590359802|FG002|Overall Study|Transportation issues|1|||
163453668|NCT02720016|590359800|FG000|Overall Study|Other|0|||
163453669|NCT02720016|590359801|FG001|Overall Study|Other|0|||
163453670|NCT02720016|590359802|FG002|Overall Study|Other|2|||
163453671|NCT04501679|590359803|FG000|Overall Study|Pregnancy|0|||
163453672|NCT04501679|590359804|FG001|Overall Study|Pregnancy|1|||
163453673|NCT04501679|590359803|FG000|Overall Study|Adverse Event|4|||
163453674|NCT04501679|590359804|FG001|Overall Study|Adverse Event|2|||
163453675|NCT04501679|590359803|FG000|Overall Study|Withdrawal by Subject|2|||
163453676|NCT04501679|590359804|FG001|Overall Study|Withdrawal by Subject|0|||
163453677|NCT04501679|590359803|FG000|Overall Study|Physician Decision|1|||
163453678|NCT04501679|590359804|FG001|Overall Study|Physician Decision|0|||
163453679|NCT04501679|590359803|FG000|Overall Study|Lost to Follow-up|2|||
163453680|NCT04501679|590359804|FG001|Overall Study|Lost to Follow-up|0|||
163453681|NCT02121756|590359808|FG000|Overall Study|Adverse Event|3|||
163453682|NCT02121756|590359809|FG001|Overall Study|Adverse Event|0|||
163453683|NCT02121756|590359808|FG000|Overall Study|Protocol Violation|1|||
163453684|NCT02121756|590359809|FG001|Overall Study|Protocol Violation|1|||
163453685|NCT02121756|590359808|FG000|Overall Study|Physician Decision|2|||
163453686|NCT02121756|590359809|FG001|Overall Study|Physician Decision|1|||
163453687|NCT00751114|590359810|FG000|Overall Study|Adverse Event|2|||
163453688|NCT00751114|590359811|FG001|Overall Study|Adverse Event|4|||
163453689|NCT00751114|590359810|FG000|Overall Study|Protocol Violation|8|||
163453690|NCT00751114|590359811|FG001|Overall Study|Protocol Violation|9|||
163453691|NCT00751114|590359810|FG000|Overall Study|Withdrawal by Subject|9|||
163453692|NCT00751114|590359811|FG001|Overall Study|Withdrawal by Subject|4|||
163453693|NCT00751114|590359810|FG000|Overall Study|Lost to Follow-up|4|||
163453694|NCT00751114|590359811|FG001|Overall Study|Lost to Follow-up|7|||
163453695|NCT00751114|590359810|FG000|Overall Study|Lack of Efficacy|0|||
163453696|NCT00751114|590359811|FG001|Overall Study|Lack of Efficacy|7|||
163453697|NCT00751114|590359810|FG000|Overall Study|Not Treated|13|||
163453698|NCT00751114|590359811|FG001|Overall Study|Not Treated|1|||
163453699|NCT00751114|590359810|FG000|Overall Study|Out of country for 2 months|1|||
163453700|NCT00751114|590359811|FG001|Overall Study|Out of country for 2 months|0|||
163453701|NCT00751114|590359810|FG000|Overall Study|Move to another city|1|||
163453702|NCT00751114|590359811|FG001|Overall Study|Move to another city|0|||
163453703|NCT05319080|590359812|FG000|Overall Study|Withdrawal by Subject|2|||
163453704|NCT05319080|590359812|FG000|Overall Study|Physician Decision|4|||
163453705|NCT03095521|590359813|FG000|Overall Study|Withdrawal by Subject|0|||
163453706|NCT03095521|590359814|FG001|Overall Study|Withdrawal by Subject|1|||
163453707|NCT03095521|590359813|FG000|Overall Study|Lost to Follow-up|0|||
163453708|NCT03095521|590359814|FG001|Overall Study|Lost to Follow-up|1|||
163453709|NCT03259490|590359815|FG000|Period 1|Withdrawal by Subject|0|||
163453710|NCT03259490|590359816|FG001|Period 1|Withdrawal by Subject|1|||
163453711|NCT03259490|590359815|FG000|Period 2|Protocol Violation|1|||
163453712|NCT03259490|590359816|FG001|Period 2|Protocol Violation|0|||
163453713|NCT01536119|590359821|FG000|Overall Study|Lost to Follow-up|17|||
163453714|NCT01536119|590359822|FG001|Overall Study|Lost to Follow-up|14|||
163453715|NCT00448916|590359823|FG000|Overall Study|Adverse Event|2|||
163453716|NCT00448916|590359824|FG001|Overall Study|Adverse Event|2|||
163453717|NCT00448916|590359825|FG002|Overall Study|Adverse Event|3|||
163453718|NCT00448916|590359826|FG003|Overall Study|Adverse Event|2|||
163453719|NCT00448916|590359823|FG000|Overall Study|Lack of Efficacy|1|||
163453720|NCT00448916|590359824|FG001|Overall Study|Lack of Efficacy|0|||
163453721|NCT00448916|590359825|FG002|Overall Study|Lack of Efficacy|2|||
163453722|NCT00448916|590359826|FG003|Overall Study|Lack of Efficacy|1|||
163453723|NCT00448916|590359823|FG000|Overall Study|Withdrawal by Subject|3|||
163453724|NCT00448916|590359824|FG001|Overall Study|Withdrawal by Subject|3|||
163453725|NCT00448916|590359825|FG002|Overall Study|Withdrawal by Subject|1|||
163453726|NCT00448916|590359826|FG003|Overall Study|Withdrawal by Subject|1|||
163453727|NCT00448916|590359823|FG000|Overall Study|Other|1|||
163453728|NCT00448916|590359824|FG001|Overall Study|Other|0|||
163453729|NCT00448916|590359825|FG002|Overall Study|Other|0|||
163453730|NCT00448916|590359826|FG003|Overall Study|Other|0|||
163453731|NCT00448916|590359823|FG000|Overall Study|Lost to Follow-up|0|||
163453732|NCT00448916|590359824|FG001|Overall Study|Lost to Follow-up|1|||
163453733|NCT00448916|590359825|FG002|Overall Study|Lost to Follow-up|0|||
163453734|NCT00448916|590359826|FG003|Overall Study|Lost to Follow-up|1|||
163453735|NCT00448916|590359823|FG000|Overall Study|Protocol Violation|0|||
163453736|NCT00448916|590359824|FG001|Overall Study|Protocol Violation|0|||
163453737|NCT00448916|590359825|FG002|Overall Study|Protocol Violation|0|||
163453738|NCT00448916|590359826|FG003|Overall Study|Protocol Violation|1|||
163453739|NCT02365584|590359827|FG000|Overall Study|Adverse Event|2|||
163453740|NCT02365584|590359828|FG001|Overall Study|Adverse Event|2|||
163453741|NCT02365584|590359827|FG000|Overall Study|Withdrawal by Subject|1|||
163453742|NCT02365584|590359828|FG001|Overall Study|Withdrawal by Subject|0|||
163453743|NCT02365584|590359827|FG000|Overall Study|Disease Progression|9|||
163453744|NCT02365584|590359828|FG001|Overall Study|Disease Progression|12|||
163453745|NCT03521193|590359829|FG000|Overall Study|Withdrawal by Subject|8|||
163453746|NCT03521193|590359830|FG001|Overall Study|Withdrawal by Subject|0|||
163453747|NCT03521193|590359829|FG000|Overall Study|non compliant to ASA treatment|8|||
163453748|NCT03521193|590359830|FG001|Overall Study|non compliant to ASA treatment|0|||
163453749|NCT00838916|590359831|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
163453750|NCT00838916|590359832|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
163453751|NCT00838916|590359831|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
163453752|NCT00838916|590359832|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
163453753|NCT00838916|590359831|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
163453754|NCT00838916|590359832|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
163453755|NCT00838916|590359831|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
163453756|NCT00838916|590359832|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
163453757|NCT00838916|590359831|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
163453758|NCT00838916|590359832|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
163453759|NCT00838916|590359831|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
163453760|NCT00838916|590359832|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
163453761|NCT00838916|590359831|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
163453762|NCT00838916|590359832|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
163453763|NCT00838916|590359831|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
163453764|NCT00838916|590359832|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
163453765|NCT00838916|590359831|FG000|Treatment Period (156 Weeks)|Missing|3|||
163453766|NCT00838916|590359832|FG001|Treatment Period (156 Weeks)|Missing|1|||
163453767|NCT00838916|590359831|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
163453768|NCT00838916|590359832|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
163453769|NCT00838916|590359831|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
163453770|NCT00838916|590359832|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
163453771|NCT00838916|590359831|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
163453772|NCT00838916|590359832|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
163453773|NCT00838916|590359831|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
163453774|NCT00838916|590359832|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
163453775|NCT00838916|590359831|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
163453776|NCT00838916|590359832|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
163453777|NCT00838916|590359831|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
163453778|NCT00838916|590359832|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
163453779|NCT00838916|590359831|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
163453780|NCT00838916|590359832|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
163453781|NCT00838916|590359831|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
163453782|NCT00838916|590359832|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
163453783|NCT00838916|590359831|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
163453784|NCT00838916|590359832|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
163453785|NCT00838916|590359831|FG000|Follow-up Period (8 Weeks)|Missing|3|||
163453786|NCT00838916|590359832|FG001|Follow-up Period (8 Weeks)|Missing|0|||
163453787|NCT01927419|590359833|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
163453788|NCT01927419|590359834|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
163453789|NCT01927419|590359833|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
163453790|NCT01927419|590359834|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
163453791|NCT01927419|590359833|FG000|Treatment Period|Disease progression|17|||
163453792|NCT01927419|590359834|FG001|Treatment Period|Disease progression|20|||
163453793|NCT01927419|590359833|FG000|Treatment Period|Study drug toxicity|48|||
163453794|NCT01927419|590359834|FG001|Treatment Period|Study drug toxicity|10|||
163453795|NCT01927419|590359833|FG000|Treatment Period|Death|0|||
163453796|NCT01927419|590359834|FG001|Treatment Period|Death|1|||
163453797|NCT01927419|590359833|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
163453798|NCT01927419|590359834|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
163453799|NCT01927419|590359833|FG000|Treatment Period|Participant request to discontinue|12|||
163453800|NCT01927419|590359834|FG001|Treatment Period|Participant request to discontinue|4|||
163453801|NCT01927419|590359833|FG000|Treatment Period|Withdrawal by Subject|1|||
163453802|NCT01927419|590359834|FG001|Treatment Period|Withdrawal by Subject|1|||
163453803|NCT01927419|590359833|FG000|Treatment Period|Maximum Clinical Benefit|6|||
163453804|NCT01927419|590359834|FG001|Treatment Period|Maximum Clinical Benefit|2|||
163453805|NCT01927419|590359833|FG000|Treatment Period|Other reasons|3|||
163453806|NCT01927419|590359834|FG001|Treatment Period|Other reasons|4|||
163453807|NCT01927419|590359833|FG000|Treatment Period|Not Reported|1|||
163453808|NCT01927419|590359834|FG001|Treatment Period|Not Reported|1|||
163453809|NCT01935336|590359837|FG000|Overall Study|Adverse Event|1|||
163453810|NCT01935336|590359838|FG001|Overall Study|Adverse Event|0|||
163453811|NCT01935336|590359839|FG002|Overall Study|Adverse Event|0|||
163453812|NCT01935336|590359840|FG003|Overall Study|Adverse Event|0|||
163453813|NCT01935336|590359837|FG000|Overall Study|Progressive disease|5|||
163453814|NCT01935336|590359838|FG001|Overall Study|Progressive disease|3|||
163453815|NCT01935336|590359839|FG002|Overall Study|Progressive disease|47|||
163453816|NCT01935336|590359840|FG003|Overall Study|Progressive disease|66|||
163453817|NCT02773238|590359842|FG000|Overall Study|Lack of Efficacy|4|||
163453818|NCT03260205|590359843|FG000|Overall Study|Adverse Event|2|||
163453819|NCT03260205|590359844|FG001|Overall Study|Adverse Event|0|||
163453820|NCT03260205|590359845|FG002|Overall Study|Adverse Event|2|||
163453821|NCT03260205|590359846|FG003|Overall Study|Adverse Event|2|||
163453822|NCT03260205|590359847|FG004|Overall Study|Adverse Event|4|||
163453823|NCT03260205|590359843|FG000|Overall Study|Lost to Follow-up|2|||
163453824|NCT03260205|590359844|FG001|Overall Study|Lost to Follow-up|2|||
163453825|NCT03260205|590359845|FG002|Overall Study|Lost to Follow-up|1|||
163453826|NCT03260205|590359846|FG003|Overall Study|Lost to Follow-up|1|||
163453827|NCT03260205|590359847|FG004|Overall Study|Lost to Follow-up|5|||
163453828|NCT03260205|590359843|FG000|Overall Study|Protocol Violation|0|||
163453829|NCT03260205|590359844|FG001|Overall Study|Protocol Violation|0|||
163453830|NCT03260205|590359845|FG002|Overall Study|Protocol Violation|2|||
163453831|NCT03260205|590359846|FG003|Overall Study|Protocol Violation|0|||
163453832|NCT03260205|590359847|FG004|Overall Study|Protocol Violation|1|||
163453833|NCT03260205|590359843|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
163453834|NCT03260205|590359844|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
163453835|NCT03260205|590359845|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
163453836|NCT03260205|590359846|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
163453837|NCT03260205|590359847|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
163453838|NCT03260205|590359843|FG000|Overall Study|Other: Unspecified|0|||
163453839|NCT03260205|590359844|FG001|Overall Study|Other: Unspecified|0|||
163453840|NCT03260205|590359845|FG002|Overall Study|Other: Unspecified|3|||
163453841|NCT03260205|590359846|FG003|Overall Study|Other: Unspecified|1|||
163453842|NCT03260205|590359847|FG004|Overall Study|Other: Unspecified|1|||
163453843|NCT03260205|590359843|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
163453844|NCT03260205|590359844|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
163453845|NCT03260205|590359845|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
163453846|NCT03260205|590359846|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
163453847|NCT03260205|590359847|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
163453848|NCT03675737|590359850|FG000|Overall Study|Death|593|||
163453849|NCT03675737|590359851|FG001|Overall Study|Death|660|||
163453850|NCT03675737|590359850|FG000|Overall Study|Lost to Follow-up|1|||
163453851|NCT03675737|590359851|FG001|Overall Study|Lost to Follow-up|5|||
163453852|NCT03675737|590359850|FG000|Overall Study|Physician Decision|1|||
163453853|NCT03675737|590359851|FG001|Overall Study|Physician Decision|0|||
163453854|NCT03675737|590359850|FG000|Overall Study|Withdrawal by Subject|14|||
163453855|NCT03675737|590359851|FG001|Overall Study|Withdrawal by Subject|12|||
163453856|NCT03675737|590359850|FG000|Overall Study|Ongoing in Study|181|||
163453857|NCT03675737|590359851|FG001|Overall Study|Ongoing in Study|112|||
163453858|NCT03422133|590359856|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
163453859|NCT03422133|590359857|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
163453860|NCT02180724|590361480|FG000|Overall Study|Death|26|||
163453861|NCT02180724|590361481|FG001|Overall Study|Death|1|||
163453862|NCT02180724|590361480|FG000|Overall Study|Lost to Follow-up|3|||
163453863|NCT02180724|590361481|FG001|Overall Study|Lost to Follow-up|1|||
163453864|NCT02180724|590361480|FG000|Overall Study|Withdrawal by Subject|4|||
163453865|NCT02180724|590361481|FG001|Overall Study|Withdrawal by Subject|2|||
163453866|NCT02180724|590361480|FG000|Overall Study|PI Decision|5|||
163453867|NCT02180724|590361481|FG001|Overall Study|PI Decision|2|||
163453868|NCT02180724|590361480|FG000|Overall Study|Study terminated by sponsor|54|||
163453869|NCT02180724|590361481|FG001|Overall Study|Study terminated by sponsor|8|||
163453870|NCT05195359|590361482|FG000|Overall Study|Lost to Follow-up|124|||
163453871|NCT05195359|590361483|FG001|Overall Study|Lost to Follow-up|34|||
163453872|NCT01146951|590361484|FG000|Overall Study|Adverse Event|4|||
163453873|NCT01146951|590361485|FG001|Overall Study|Adverse Event|1|||
163453874|NCT01747811|590361489|FG000|Overall Study|Lack of Efficacy|2|||
163453875|NCT01747811|590361490|FG001|Overall Study|Lack of Efficacy|4|||
163453876|NCT01517412|590361491|FG000|Overall Study|Adverse Event|10|||
163453877|NCT01517412|590361492|FG001|Overall Study|Adverse Event|11|||
163453878|NCT01517412|590361491|FG000|Overall Study|Lack of Efficacy|10|||
163453879|NCT01517412|590361492|FG001|Overall Study|Lack of Efficacy|5|||
163453880|NCT01517412|590361491|FG000|Overall Study|Poor compliance to protocol|8|||
163453881|NCT01517412|590361492|FG001|Overall Study|Poor compliance to protocol|3|||
163453882|NCT01517412|590361491|FG000|Overall Study|Other than specified above|8|||
163453883|NCT01517412|590361492|FG001|Overall Study|Other than specified above|5|||
163453884|NCT01253187|590361493|FG000|Period 2|Withdrawal by Subject|0|||
163453885|NCT01253187|590361494|FG001|Period 2|Withdrawal by Subject|0|||
163453886|NCT01253187|590361495|FG002|Period 2|Withdrawal by Subject|0|||
163453887|NCT01253187|590361496|FG003|Period 2|Withdrawal by Subject|0|||
163453888|NCT01253187|590361497|FG004|Period 2|Withdrawal by Subject|1|||
163453889|NCT01253187|590361498|FG005|Period 2|Withdrawal by Subject|0|||
163453890|NCT01253187|590361493|FG000|Period 3|Pregnancy|1|||
163453891|NCT01253187|590361494|FG001|Period 3|Pregnancy|0|||
163453892|NCT01253187|590361495|FG002|Period 3|Pregnancy|0|||
163453893|NCT01253187|590361496|FG003|Period 3|Pregnancy|0|||
163453894|NCT01253187|590361497|FG004|Period 3|Pregnancy|0|||
163453895|NCT01253187|590361498|FG005|Period 3|Pregnancy|0|||
163453896|NCT01253187|590361493|FG000|Period 3|difficulty with blood sampling|0|||
163453897|NCT01253187|590361494|FG001|Period 3|difficulty with blood sampling|1|||
163453898|NCT01253187|590361495|FG002|Period 3|difficulty with blood sampling|0|||
163453899|NCT01253187|590361496|FG003|Period 3|difficulty with blood sampling|0|||
163453900|NCT01253187|590361497|FG004|Period 3|difficulty with blood sampling|0|||
163453901|NCT01253187|590361498|FG005|Period 3|difficulty with blood sampling|0|||
163453902|NCT01253187|590361493|FG000|Period 3|non-compliance|0|||
163453903|NCT01253187|590361494|FG001|Period 3|non-compliance|0|||
163453904|NCT01253187|590361495|FG002|Period 3|non-compliance|0|||
163453905|NCT01253187|590361496|FG003|Period 3|non-compliance|0|||
163453906|NCT01253187|590361497|FG004|Period 3|non-compliance|1|||
163453907|NCT01253187|590361498|FG005|Period 3|non-compliance|0|||
163453908|NCT03569449|590361499|FG000|Overall Study|Lost to Follow-up|0|||
163453909|NCT03569449|590361500|FG001|Overall Study|Lost to Follow-up|1|||
163453910|NCT03569449|590361501|FG002|Overall Study|Lost to Follow-up|0|||
163453911|NCT03569449|590361502|FG003|Overall Study|Lost to Follow-up|2|||
163453912|NCT03569449|590361503|FG004|Overall Study|Lost to Follow-up|0|||
163453913|NCT03569449|590361504|FG005|Overall Study|Lost to Follow-up|0|||
163453914|NCT03569449|590361505|FG006|Overall Study|Lost to Follow-up|0|||
163453915|NCT03569449|590361506|FG007|Overall Study|Lost to Follow-up|0|||
163453916|NCT03569449|590361507|FG008|Overall Study|Lost to Follow-up|0|||
163453917|NCT03569449|590361508|FG009|Overall Study|Lost to Follow-up|0|||
163453918|NCT03569449|590361509|FG010|Overall Study|Lost to Follow-up|0|||
163453919|NCT03569449|590361510|FG011|Overall Study|Lost to Follow-up|0|||
163453920|NCT03569449|590361511|FG012|Overall Study|Lost to Follow-up|0|||
163453921|NCT03569449|590361512|FG013|Overall Study|Lost to Follow-up|0|||
163453922|NCT03569449|590361513|FG014|Overall Study|Lost to Follow-up|1|||
163453923|NCT03569449|590361514|FG015|Overall Study|Lost to Follow-up|0|||
163453924|NCT03569449|590361499|FG000|Overall Study|Withdrawal by Subject|0|||
163453925|NCT03569449|590361500|FG001|Overall Study|Withdrawal by Subject|1|||
163453926|NCT03569449|590361501|FG002|Overall Study|Withdrawal by Subject|0|||
163453927|NCT03569449|590361502|FG003|Overall Study|Withdrawal by Subject|0|||
163453928|NCT03569449|590361503|FG004|Overall Study|Withdrawal by Subject|1|||
163453929|NCT03569449|590361504|FG005|Overall Study|Withdrawal by Subject|0|||
163453930|NCT03569449|590361505|FG006|Overall Study|Withdrawal by Subject|0|||
163453931|NCT03569449|590361506|FG007|Overall Study|Withdrawal by Subject|0|||
163453932|NCT03569449|590361507|FG008|Overall Study|Withdrawal by Subject|0|||
163453933|NCT03569449|590361508|FG009|Overall Study|Withdrawal by Subject|0|||
163453934|NCT03569449|590361509|FG010|Overall Study|Withdrawal by Subject|0|||
163453935|NCT03569449|590361510|FG011|Overall Study|Withdrawal by Subject|0|||
163453936|NCT03569449|590361511|FG012|Overall Study|Withdrawal by Subject|0|||
163453937|NCT03569449|590361512|FG013|Overall Study|Withdrawal by Subject|0|||
163453938|NCT03569449|590361513|FG014|Overall Study|Withdrawal by Subject|0|||
163453939|NCT03569449|590361514|FG015|Overall Study|Withdrawal by Subject|0|||
163453940|NCT04124692|590361515|FG000|Overall Study|Medical reason|0|||
163453941|NCT04124692|590361516|FG001|Overall Study|Medical reason|1|||
163453942|NCT04124692|590361515|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
163453943|NCT04124692|590361516|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
163453944|NCT04124692|590361515|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
163453945|NCT04124692|590361516|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
163453946|NCT04124692|590361515|FG000|Overall Study|Lost to Follow-up|2|||
163453947|NCT04124692|590361516|FG001|Overall Study|Lost to Follow-up|4|||
163453948|NCT04124692|590361515|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
163453949|NCT04124692|590361516|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
163453950|NCT05136170|590361522|FG000|Overall Study|Withdrawal by Subject|2|||
163453951|NCT05136170|590361523|FG001|Overall Study|Withdrawal by Subject|2|||
163453952|NCT05136170|590361522|FG000|Overall Study|Can no longer make office visits|1|||
163453953|NCT05136170|590361523|FG001|Overall Study|Can no longer make office visits|0|||
163453954|NCT04393038|590361524|FG000|Overall Study|Adverse Event|11|||
163453955|NCT04393038|590361525|FG001|Overall Study|Adverse Event|2|||
163453956|NCT04393038|590361524|FG000|Overall Study|Protocol Violation|1|||
163453957|NCT04393038|590361525|FG001|Overall Study|Protocol Violation|0|||
163453958|NCT04393038|590361524|FG000|Overall Study|Death|6|||
163453959|NCT04393038|590361525|FG001|Overall Study|Death|4|||
163453960|NCT04393038|590361524|FG000|Overall Study|Withdrawal by Subject|24|||
163453961|NCT04393038|590361525|FG001|Overall Study|Withdrawal by Subject|8|||
163453962|NCT04393038|590361524|FG000|Overall Study|Lost to Follow-up|5|||
163453963|NCT04393038|590361525|FG001|Overall Study|Lost to Follow-up|4|||
163453964|NCT04393038|590361524|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
163453965|NCT04393038|590361525|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
163453966|NCT04393038|590361524|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
163453967|NCT04393038|590361525|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
163453968|NCT05168813|590361526|FG000|Part A (Open-label)|Lost to Follow-up|21|||
163453969|NCT05168813|590361527|FG001|Part A (Open-label)|Lost to Follow-up|39|||
163453970|NCT05168813|590361528|FG002|Part A (Open-label)|Lost to Follow-up|8|||
163453971|NCT05168813|590361529|FG003|Part A (Open-label)|Lost to Follow-up|26|||
163453972|NCT05168813|590361530|FG004|Part A (Open-label)|Lost to Follow-up|0|||
163453973|NCT05168813|590361531|FG005|Part A (Open-label)|Lost to Follow-up|0|||
163453974|NCT05168813|590361526|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
163453975|NCT05168813|590361527|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
163453976|NCT05168813|590361528|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
163453977|NCT05168813|590361529|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
163453978|NCT05168813|590361530|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
163453979|NCT05168813|590361531|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
163453980|NCT05168813|590361526|FG000|Part A (Open-label)|Death|23|||
163453981|NCT05168813|590361527|FG001|Part A (Open-label)|Death|28|||
163453982|NCT05168813|590361528|FG002|Part A (Open-label)|Death|1|||
163453983|NCT05168813|590361529|FG003|Part A (Open-label)|Death|9|||
163453984|NCT05168813|590361530|FG004|Part A (Open-label)|Death|0|||
163453985|NCT05168813|590361531|FG005|Part A (Open-label)|Death|0|||
163453986|NCT05168813|590361526|FG000|Part A (Open-label)|Physician Decision|0|||
163453987|NCT05168813|590361527|FG001|Part A (Open-label)|Physician Decision|1|||
163453988|NCT05168813|590361528|FG002|Part A (Open-label)|Physician Decision|0|||
163453989|NCT05168813|590361529|FG003|Part A (Open-label)|Physician Decision|2|||
163453990|NCT05168813|590361530|FG004|Part A (Open-label)|Physician Decision|0|||
163453991|NCT05168813|590361531|FG005|Part A (Open-label)|Physician Decision|0|||
163453992|NCT05168813|590361526|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
163453993|NCT05168813|590361527|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
163453994|NCT05168813|590361528|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
163453995|NCT05168813|590361529|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
163453996|NCT05168813|590361530|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
163453997|NCT05168813|590361531|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
163453998|NCT05168813|590361526|FG000|Part A (Open-label)|Protocol Violation|0|||
163453999|NCT05168813|590361527|FG001|Part A (Open-label)|Protocol Violation|1|||
163454000|NCT05168813|590361528|FG002|Part A (Open-label)|Protocol Violation|0|||
163454001|NCT05168813|590361529|FG003|Part A (Open-label)|Protocol Violation|0|||
163454002|NCT05168813|590361530|FG004|Part A (Open-label)|Protocol Violation|0|||
163454003|NCT05168813|590361531|FG005|Part A (Open-label)|Protocol Violation|0|||
163454004|NCT05168813|590361526|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
163454005|NCT05168813|590361527|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
163454006|NCT05168813|590361528|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
163454007|NCT05168813|590361529|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
163454008|NCT05168813|590361530|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
163454009|NCT05168813|590361531|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
163454010|NCT05168813|590361526|FG000|Part A (Open-label)|Other|0|||
163454011|NCT05168813|590361527|FG001|Part A (Open-label)|Other|1|||
163454012|NCT05168813|590361528|FG002|Part A (Open-label)|Other|0|||
163454013|NCT05168813|590361529|FG003|Part A (Open-label)|Other|0|||
163454014|NCT05168813|590361530|FG004|Part A (Open-label)|Other|0|||
163454015|NCT05168813|590361531|FG005|Part A (Open-label)|Other|0|||
163454016|NCT05168813|590361526|FG000|Part B (Blinded)|Lost to Follow-up|0|||
163454017|NCT05168813|590361527|FG001|Part B (Blinded)|Lost to Follow-up|0|||
163454018|NCT05168813|590361528|FG002|Part B (Blinded)|Lost to Follow-up|0|||
163454019|NCT05168813|590361529|FG003|Part B (Blinded)|Lost to Follow-up|0|||
163454020|NCT05168813|590361530|FG004|Part B (Blinded)|Lost to Follow-up|219|||
163454021|NCT05168813|590361531|FG005|Part B (Blinded)|Lost to Follow-up|88|||
163454022|NCT05168813|590361526|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
163454023|NCT05168813|590361527|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
163454024|NCT05168813|590361528|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
163454025|NCT05168813|590361529|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
163454026|NCT05168813|590361530|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
163454027|NCT05168813|590361531|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
163454028|NCT05168813|590361526|FG000|Part B (Blinded)|Death|0|||
163454029|NCT05168813|590361527|FG001|Part B (Blinded)|Death|0|||
163454030|NCT05168813|590361528|FG002|Part B (Blinded)|Death|0|||
163454031|NCT05168813|590361529|FG003|Part B (Blinded)|Death|0|||
163454032|NCT05168813|590361530|FG004|Part B (Blinded)|Death|63|||
163454033|NCT05168813|590361531|FG005|Part B (Blinded)|Death|19|||
163454034|NCT05168813|590361526|FG000|Part B (Blinded)|Physician Decision|0|||
163454035|NCT05168813|590361527|FG001|Part B (Blinded)|Physician Decision|0|||
163454036|NCT05168813|590361528|FG002|Part B (Blinded)|Physician Decision|0|||
163454037|NCT05168813|590361529|FG003|Part B (Blinded)|Physician Decision|0|||
163454038|NCT05168813|590361530|FG004|Part B (Blinded)|Physician Decision|6|||
163454039|NCT05168813|590361531|FG005|Part B (Blinded)|Physician Decision|1|||
163454040|NCT05168813|590361526|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
163454041|NCT05168813|590361527|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
163454042|NCT05168813|590361528|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
163454043|NCT05168813|590361529|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
163454044|NCT05168813|590361530|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
163454045|NCT05168813|590361531|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
163454046|NCT05168813|590361526|FG000|Part B (Blinded)|Pregnancy|0|||
163454047|NCT05168813|590361527|FG001|Part B (Blinded)|Pregnancy|0|||
163454048|NCT05168813|590361528|FG002|Part B (Blinded)|Pregnancy|0|||
163454049|NCT05168813|590361529|FG003|Part B (Blinded)|Pregnancy|0|||
163454050|NCT05168813|590361530|FG004|Part B (Blinded)|Pregnancy|1|||
163454051|NCT05168813|590361531|FG005|Part B (Blinded)|Pregnancy|0|||
163454052|NCT05168813|590361526|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
163454053|NCT05168813|590361527|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
163454054|NCT05168813|590361528|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
163454055|NCT05168813|590361529|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
163454056|NCT05168813|590361530|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
163454057|NCT05168813|590361531|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
163454058|NCT05168813|590361526|FG000|Part B (Blinded)|Other|0|||
163454059|NCT05168813|590361527|FG001|Part B (Blinded)|Other|0|||
163454060|NCT05168813|590361528|FG002|Part B (Blinded)|Other|0|||
163454061|NCT05168813|590361529|FG003|Part B (Blinded)|Other|0|||
163454062|NCT05168813|590361530|FG004|Part B (Blinded)|Other|41|||
163454063|NCT05168813|590361531|FG005|Part B (Blinded)|Other|27|||
163454064|NCT02492997|590361533|FG000|Overall Study|Withdrawal by Subject|1|||
163454065|NCT02492997|590361534|FG001|Overall Study|Withdrawal by Subject|0|||
163454066|NCT02492997|590361533|FG000|Overall Study|Gained Weight|1|||
163454067|NCT02492997|590361534|FG001|Overall Study|Gained Weight|0|||
163454068|NCT02492997|590361533|FG000|Overall Study|Lost to Follow-up|0|||
163454069|NCT02492997|590361534|FG001|Overall Study|Lost to Follow-up|1|||
163454070|NCT01089582|590361535|FG000|Overall Study|Death|2|||
163454071|NCT01089582|590361535|FG000|Overall Study|Adverse Event|15|||
163454072|NCT01089582|590361535|FG000|Overall Study|Lost to Follow-up|8|||
163454073|NCT01089582|590361535|FG000|Overall Study|Other|4|||
163454074|NCT01089582|590361535|FG000|Overall Study|Withdrawal by Subject|1|||
163454075|NCT04069156|590361536|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
163454076|NCT04069156|590361537|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
163454077|NCT04069156|590361536|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
163454078|NCT04069156|590361537|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
163454079|NCT04069156|590361536|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
163454080|NCT04069156|590361537|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
163454081|NCT04069156|590361536|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
163454082|NCT04069156|590361537|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
163454083|NCT03806179|590361542|FG000|Overall Study|Progressive disease|0|||
163454084|NCT03806179|590361543|FG001|Overall Study|Progressive disease|2|||
163454085|NCT05822830|590361544|FG000|Overall Study|Adverse Event|6|||
163454086|NCT05822830|590361545|FG001|Overall Study|Adverse Event|6|||
163454087|NCT05822830|590361544|FG000|Overall Study|Assigned Treatment by Mistake|5|||
163454088|NCT05822830|590361545|FG001|Overall Study|Assigned Treatment by Mistake|3|||
163454089|NCT05822830|590361544|FG000|Overall Study|Lost to Follow-up|16|||
163454090|NCT05822830|590361545|FG001|Overall Study|Lost to Follow-up|18|||
163454091|NCT05822830|590361544|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163454092|NCT05822830|590361545|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163454093|NCT05822830|590361544|FG000|Overall Study|Participant was Out of the Country|0|||
163454094|NCT05822830|590361545|FG001|Overall Study|Participant was Out of the Country|1|||
163454095|NCT05822830|590361544|FG000|Overall Study|Pregnancy|1|||
163454096|NCT05822830|590361545|FG001|Overall Study|Pregnancy|2|||
163454097|NCT05822830|590361544|FG000|Overall Study|Withdrawal by Subject|27|||
163454098|NCT05822830|590361545|FG001|Overall Study|Withdrawal by Subject|26|||
163454099|NCT03368664|590361546|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
163454100|NCT03368664|590361546|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
163454101|NCT03368664|590361546|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
163454102|NCT03368664|590361546|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
163454103|NCT01021852|590361547|FG000|Treatment Period 1|Adverse Event|3|||
163454104|NCT01021852|590361548|FG001|Treatment Period 1|Adverse Event|1|||
163454105|NCT01021852|590361549|FG002|Treatment Period 1|Adverse Event|1|||
163454106|NCT01021852|590361550|FG003|Treatment Period 1|Adverse Event|0|||
163454107|NCT01021852|590361551|FG004|Treatment Period 1|Adverse Event|2|||
163454108|NCT01021852|590361552|FG005|Treatment Period 1|Adverse Event|2|||
163454109|NCT01021852|590361553|FG006|Treatment Period 1|Adverse Event|0|||
163454110|NCT01021852|590361554|FG007|Treatment Period 1|Adverse Event|0|||
163454111|NCT01021852|590361547|FG000|Treatment Period 1|Pregnancy|0|||
163454112|NCT01021852|590361548|FG001|Treatment Period 1|Pregnancy|0|||
163454113|NCT01021852|590361549|FG002|Treatment Period 1|Pregnancy|1|||
163454114|NCT01021852|590361550|FG003|Treatment Period 1|Pregnancy|0|||
163454115|NCT01021852|590361551|FG004|Treatment Period 1|Pregnancy|0|||
163454116|NCT01021852|590361552|FG005|Treatment Period 1|Pregnancy|0|||
163454117|NCT01021852|590361553|FG006|Treatment Period 1|Pregnancy|0|||
163454118|NCT01021852|590361554|FG007|Treatment Period 1|Pregnancy|0|||
163454119|NCT01021852|590361547|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163454120|NCT01021852|590361548|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163454121|NCT01021852|590361549|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163454122|NCT01021852|590361550|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163454123|NCT01021852|590361551|FG004|Treatment Period 1|Withdrawal by Subject|1|||
163454124|NCT01021852|590361552|FG005|Treatment Period 1|Withdrawal by Subject|0|||
163454125|NCT01021852|590361553|FG006|Treatment Period 1|Withdrawal by Subject|0|||
163454126|NCT01021852|590361554|FG007|Treatment Period 1|Withdrawal by Subject|1|||
163454127|NCT01021852|590361547|FG000|Treatment Period 1|Not Treated|0|||
163454128|NCT01021852|590361548|FG001|Treatment Period 1|Not Treated|0|||
163454129|NCT01021852|590361549|FG002|Treatment Period 1|Not Treated|0|||
163454130|NCT01021852|590361550|FG003|Treatment Period 1|Not Treated|2|||
163454131|NCT01021852|590361551|FG004|Treatment Period 1|Not Treated|0|||
163454132|NCT01021852|590361552|FG005|Treatment Period 1|Not Treated|0|||
163454133|NCT01021852|590361553|FG006|Treatment Period 1|Not Treated|0|||
163454134|NCT01021852|590361554|FG007|Treatment Period 1|Not Treated|0|||
163454135|NCT01021852|590361547|FG000|Washout Period-Placebo|Adverse Event|0|||
163454136|NCT01021852|590361548|FG001|Washout Period-Placebo|Adverse Event|0|||
163454137|NCT01021852|590361549|FG002|Washout Period-Placebo|Adverse Event|0|||
163454138|NCT01021852|590361550|FG003|Washout Period-Placebo|Adverse Event|1|||
163454139|NCT01021852|590361551|FG004|Washout Period-Placebo|Adverse Event|0|||
163454140|NCT01021852|590361552|FG005|Washout Period-Placebo|Adverse Event|1|||
163454141|NCT01021852|590361553|FG006|Washout Period-Placebo|Adverse Event|0|||
163454142|NCT01021852|590361554|FG007|Washout Period-Placebo|Adverse Event|0|||
163454143|NCT01021852|590361547|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
163454144|NCT01021852|590361548|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
163454145|NCT01021852|590361549|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
163454146|NCT01021852|590361550|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
163454147|NCT01021852|590361551|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
163454148|NCT01021852|590361552|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
163454149|NCT01021852|590361553|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
163454150|NCT01021852|590361554|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
163454151|NCT01021852|590361547|FG000|Washout Period-Placebo|Protocol Violation|0|||
163454152|NCT01021852|590361548|FG001|Washout Period-Placebo|Protocol Violation|0|||
163454153|NCT01021852|590361549|FG002|Washout Period-Placebo|Protocol Violation|0|||
163454154|NCT01021852|590361550|FG003|Washout Period-Placebo|Protocol Violation|0|||
163454155|NCT01021852|590361551|FG004|Washout Period-Placebo|Protocol Violation|0|||
163454156|NCT01021852|590361552|FG005|Washout Period-Placebo|Protocol Violation|0|||
163454157|NCT01021852|590361553|FG006|Washout Period-Placebo|Protocol Violation|1|||
163454158|NCT01021852|590361554|FG007|Washout Period-Placebo|Protocol Violation|0|||
163454159|NCT01021852|590361547|FG000|Washout Period-No Drug|Adverse Event|1|||
163454160|NCT01021852|590361548|FG001|Washout Period-No Drug|Adverse Event|0|||
163454161|NCT01021852|590361549|FG002|Washout Period-No Drug|Adverse Event|0|||
163454162|NCT01021852|590361550|FG003|Washout Period-No Drug|Adverse Event|0|||
163454163|NCT01021852|590361551|FG004|Washout Period-No Drug|Adverse Event|0|||
163454164|NCT01021852|590361552|FG005|Washout Period-No Drug|Adverse Event|1|||
163454165|NCT01021852|590361553|FG006|Washout Period-No Drug|Adverse Event|0|||
163454166|NCT01021852|590361554|FG007|Washout Period-No Drug|Adverse Event|0|||
163454167|NCT01021852|590361547|FG000|Treatment Period 2|Adverse Event|0|||
163454168|NCT01021852|590361548|FG001|Treatment Period 2|Adverse Event|1|||
163454169|NCT01021852|590361549|FG002|Treatment Period 2|Adverse Event|0|||
163454170|NCT01021852|590361550|FG003|Treatment Period 2|Adverse Event|0|||
163454171|NCT01021852|590361551|FG004|Treatment Period 2|Adverse Event|1|||
163454172|NCT01021852|590361552|FG005|Treatment Period 2|Adverse Event|0|||
163454173|NCT01021852|590361553|FG006|Treatment Period 2|Adverse Event|1|||
163454174|NCT01021852|590361554|FG007|Treatment Period 2|Adverse Event|0|||
163454175|NCT01021852|590361547|FG000|Treatment Period 2|Lack of Efficacy|0|||
163454176|NCT01021852|590361548|FG001|Treatment Period 2|Lack of Efficacy|0|||
163454177|NCT01021852|590361549|FG002|Treatment Period 2|Lack of Efficacy|0|||
163454178|NCT01021852|590361550|FG003|Treatment Period 2|Lack of Efficacy|0|||
163454179|NCT01021852|590361551|FG004|Treatment Period 2|Lack of Efficacy|0|||
163454180|NCT01021852|590361552|FG005|Treatment Period 2|Lack of Efficacy|1|||
163454181|NCT01021852|590361553|FG006|Treatment Period 2|Lack of Efficacy|0|||
163454182|NCT01021852|590361554|FG007|Treatment Period 2|Lack of Efficacy|0|||
163454183|NCT01021852|590361547|FG000|Treatment Period 2|Physician Decision|0|||
163454184|NCT01021852|590361548|FG001|Treatment Period 2|Physician Decision|0|||
163454185|NCT01021852|590361549|FG002|Treatment Period 2|Physician Decision|1|||
163454186|NCT01021852|590361550|FG003|Treatment Period 2|Physician Decision|0|||
163454187|NCT01021852|590361551|FG004|Treatment Period 2|Physician Decision|0|||
163454188|NCT01021852|590361552|FG005|Treatment Period 2|Physician Decision|0|||
163454189|NCT01021852|590361553|FG006|Treatment Period 2|Physician Decision|0|||
163454190|NCT01021852|590361554|FG007|Treatment Period 2|Physician Decision|0|||
163454191|NCT01021852|590361547|FG000|Treatment Period 2|Protocol Violation|0|||
163454192|NCT01021852|590361548|FG001|Treatment Period 2|Protocol Violation|0|||
163454193|NCT01021852|590361549|FG002|Treatment Period 2|Protocol Violation|0|||
163454194|NCT01021852|590361550|FG003|Treatment Period 2|Protocol Violation|0|||
163454195|NCT01021852|590361551|FG004|Treatment Period 2|Protocol Violation|1|||
163454196|NCT01021852|590361552|FG005|Treatment Period 2|Protocol Violation|0|||
163454197|NCT01021852|590361553|FG006|Treatment Period 2|Protocol Violation|1|||
163454198|NCT01021852|590361554|FG007|Treatment Period 2|Protocol Violation|0|||
163454199|NCT01021852|590361547|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163454200|NCT01021852|590361548|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163454201|NCT01021852|590361549|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163454202|NCT01021852|590361550|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163454203|NCT01021852|590361551|FG004|Treatment Period 2|Withdrawal by Subject|0|||
163454204|NCT01021852|590361552|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163454205|NCT01021852|590361553|FG006|Treatment Period 2|Withdrawal by Subject|1|||
163454206|NCT01021852|590361554|FG007|Treatment Period 2|Withdrawal by Subject|2|||
163454207|NCT01025817|590361555|FG000|Completed Study Medication|Adverse Event|66|||
163454208|NCT01025817|590361556|FG001|Completed Study Medication|Adverse Event|39|||
163454209|NCT01025817|590361555|FG000|Completed Study Medication|Protocol Deviation|9|||
163454210|NCT01025817|590361556|FG001|Completed Study Medication|Protocol Deviation|8|||
163454211|NCT01025817|590361555|FG000|Completed Study Medication|Withdrawal by Subject|8|||
163454212|NCT01025817|590361556|FG001|Completed Study Medication|Withdrawal by Subject|9|||
163454213|NCT01025817|590361555|FG000|Completed Study Medication|Administrative problems|7|||
163454214|NCT01025817|590361556|FG001|Completed Study Medication|Administrative problems|5|||
163454215|NCT01025817|590361555|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
163454216|NCT01025817|590361556|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
163454217|NCT01025817|590361555|FG000|Completed Study Medication|Abnormal test procedure|4|||
163454218|NCT01025817|590361556|FG001|Completed Study Medication|Abnormal test procedure|0|||
163454219|NCT01025817|590361555|FG000|Completed Study Medication|Graft loss|2|||
163454220|NCT01025817|590361556|FG001|Completed Study Medication|Graft loss|5|||
163454221|NCT01025817|590361555|FG000|Completed Study Medication|Death|2|||
163454222|NCT01025817|590361556|FG001|Completed Study Medication|Death|2|||
163454223|NCT01025817|590361555|FG000|Completed Study Medication|Abnormal lab values|0|||
163454224|NCT01025817|590361556|FG001|Completed Study Medication|Abnormal lab values|2|||
163454225|NCT01025817|590361555|FG000|Completed Study Medication|Subject no longer required study drug|0|||
163454226|NCT01025817|590361556|FG001|Completed Study Medication|Subject no longer required study drug|1|||
163454227|NCT01025817|590361555|FG000|Completed Study Medication|Lost to Follow-up|0|||
163454228|NCT01025817|590361556|FG001|Completed Study Medication|Lost to Follow-up|1|||
163454229|NCT01025817|590361555|FG000|Completed Study|Withdrawal by Subject|8|||
163454230|NCT01025817|590361556|FG001|Completed Study|Withdrawal by Subject|16|||
163454231|NCT01025817|590361555|FG000|Completed Study|Death|6|||
163454232|NCT01025817|590361556|FG001|Completed Study|Death|5|||
163454233|NCT01025817|590361555|FG000|Completed Study|Missing|2|||
163454234|NCT01025817|590361556|FG001|Completed Study|Missing|0|||
163454235|NCT01025817|590361555|FG000|Completed Study|Lost to Follow-up|0|||
163454236|NCT01025817|590361556|FG001|Completed Study|Lost to Follow-up|1|||
163454237|NCT01165021|590361560|FG000|Overall Study|Death|1|||
163454238|NCT04799405|590361562|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
163454239|NCT01029002|590361563|FG000|Overall Study|Lost to Follow-up|2|||
163454240|NCT01029002|590361564|FG001|Overall Study|Lost to Follow-up|4|||
163454241|NCT02683525|590361565|FG000|Overall Study|Lost to Follow-up|1|||
163454242|NCT02683525|590361565|FG000|Overall Study|Physician Decision|1|||
163454243|NCT02683525|590361565|FG000|Overall Study|Disease Progression|6|||
163454244|NCT01008995|590361566|FG000|Controlled Period|Adverse Event|1|||
163454245|NCT01008995|590361567|FG001|Controlled Period|Adverse Event|2|||
163454246|NCT01008995|590361568|FG002|Controlled Period|Adverse Event|0|||
163454247|NCT01008995|590361569|FG003|Controlled Period|Adverse Event|0|||
163454248|NCT01008995|590361566|FG000|Controlled Period|Other|2|||
163454249|NCT01008995|590361567|FG001|Controlled Period|Other|1|||
163454250|NCT01008995|590361568|FG002|Controlled Period|Other|0|||
163454251|NCT01008995|590361569|FG003|Controlled Period|Other|0|||
163454252|NCT01008995|590361566|FG000|After Controlled Period|Adverse Event|0|||
163454253|NCT01008995|590361567|FG001|After Controlled Period|Adverse Event|0|||
163454254|NCT01008995|590361568|FG002|After Controlled Period|Adverse Event|1|||
163454255|NCT01008995|590361569|FG003|After Controlled Period|Adverse Event|1|||
163454256|NCT01008995|590361566|FG000|After Controlled Period|Other|0|||
163454257|NCT01008995|590361567|FG001|After Controlled Period|Other|0|||
163454258|NCT01008995|590361568|FG002|After Controlled Period|Other|1|||
163454259|NCT01008995|590361569|FG003|After Controlled Period|Other|0|||
163454260|NCT00115804|590361574|FG000|Overall Study|Adverse Event|2|||
163454261|NCT01737840|590361575|FG000|Overall Study|Diagnosed with an other pathology|2|||
163454262|NCT01737840|590361576|FG001|Overall Study|Diagnosed with an other pathology|2|||
163454263|NCT00547378|590361579|FG000|Randomized Cohort|Withdrawal by Subject|7|||
163454264|NCT00547378|590361580|FG001|Randomized Cohort|Withdrawal by Subject|5|||
163454265|NCT00547378|590361581|FG002|Randomized Cohort|Withdrawal by Subject|0|||
163454266|NCT00547378|590361579|FG000|Randomized Cohort|Death|0|||
163454267|NCT00547378|590361580|FG001|Randomized Cohort|Death|1|||
163454268|NCT00547378|590361581|FG002|Randomized Cohort|Death|0|||
163454269|NCT00547378|590361579|FG000|Randomized Cohort|Lost to Follow-up|1|||
163454270|NCT00547378|590361580|FG001|Randomized Cohort|Lost to Follow-up|0|||
163454271|NCT00547378|590361581|FG002|Randomized Cohort|Lost to Follow-up|0|||
163454272|NCT00547378|590361579|FG000|Randomized Cohort|Adverse Event|1|||
163454273|NCT00547378|590361580|FG001|Randomized Cohort|Adverse Event|0|||
163454274|NCT00547378|590361581|FG002|Randomized Cohort|Adverse Event|0|||
163454275|NCT00547378|590361579|FG000|Randomized Cohort|Other reasons|2|||
163454276|NCT00547378|590361580|FG001|Randomized Cohort|Other reasons|0|||
163454277|NCT00547378|590361581|FG002|Randomized Cohort|Other reasons|0|||
163454278|NCT00547378|590361579|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
163454279|NCT00547378|590361580|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
163454280|NCT00547378|590361581|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
163454281|NCT00547378|590361579|FG000|All Implanted Cohort|Adverse Event|4|||
163454282|NCT00547378|590361580|FG001|All Implanted Cohort|Adverse Event|10|||
163454283|NCT00547378|590361581|FG002|All Implanted Cohort|Adverse Event|17|||
163454284|NCT00547378|590361579|FG000|All Implanted Cohort|Lost to Follow-up|0|||
163454285|NCT00547378|590361580|FG001|All Implanted Cohort|Lost to Follow-up|1|||
163454286|NCT00547378|590361581|FG002|All Implanted Cohort|Lost to Follow-up|14|||
163454287|NCT00547378|590361579|FG000|All Implanted Cohort|Death|3|||
163454288|NCT00547378|590361580|FG001|All Implanted Cohort|Death|1|||
163454289|NCT00547378|590361581|FG002|All Implanted Cohort|Death|4|||
163454290|NCT00547378|590361579|FG000|All Implanted Cohort|Physician Decision|0|||
163454291|NCT00547378|590361580|FG001|All Implanted Cohort|Physician Decision|2|||
163454292|NCT00547378|590361581|FG002|All Implanted Cohort|Physician Decision|6|||
163454293|NCT00547378|590361579|FG000|All Implanted Cohort|Site closure|2|||
163454294|NCT00547378|590361580|FG001|All Implanted Cohort|Site closure|0|||
163454295|NCT00547378|590361581|FG002|All Implanted Cohort|Site closure|1|||
163454296|NCT00547378|590361579|FG000|All Implanted Cohort|Other reasons|1|||
163454297|NCT00547378|590361580|FG001|All Implanted Cohort|Other reasons|0|||
163454298|NCT00547378|590361581|FG002|All Implanted Cohort|Other reasons|1|||
163454299|NCT01449682|590361582|FG000|Overall Study|Death|0|||
163454300|NCT01449682|590361583|FG001|Overall Study|Death|1|||
163454301|NCT01449682|590361582|FG000|Overall Study|Adverse Event|1|||
163454302|NCT01449682|590361583|FG001|Overall Study|Adverse Event|0|||
163454303|NCT04863014|590361584|FG000|Overall Study|Lost to Follow-up|3|||
163454304|NCT04863014|590361585|FG001|Overall Study|Lost to Follow-up|2|||
163454305|NCT04863014|590361584|FG000|Overall Study|Subject Decision|0|||
163454306|NCT04863014|590361585|FG001|Overall Study|Subject Decision|4|||
163454307|NCT04633473|590361586|FG000|Overall Study|Withdrawal by Subject|6|||
163454308|NCT01822691|590361591|FG000|Overall Study|Withdrawal by Subject|2|||
163454309|NCT00819585|590361592|FG000|Core Study|Adverse Event|2|||
163454310|NCT00819585|590361593|FG001|Core Study|Adverse Event|1|||
163454311|NCT00819585|590361594|FG002|Core Study|Adverse Event|1|||
163454312|NCT00819585|590361595|FG003|Core Study|Adverse Event|4|||
163454313|NCT00819585|590361596|FG004|Core Study|Adverse Event|1|||
163454314|NCT00819585|590361597|FG005|Core Study|Adverse Event|0|||
163454315|NCT00819585|590361598|FG006|Core Study|Adverse Event|2|||
163454316|NCT00819585|590361599|FG007|Core Study|Adverse Event|0|||
163454317|NCT00819585|590361600|FG008|Core Study|Adverse Event|0|||
163454318|NCT00819585|590361601|FG009|Core Study|Adverse Event|0|||
163454319|NCT00819585|590361602|FG010|Core Study|Adverse Event|0|||
163454320|NCT00819585|590361592|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
163454321|NCT00819585|590361593|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
163454322|NCT00819585|590361594|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
163454323|NCT00819585|590361595|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
163454324|NCT00819585|590361596|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
163454325|NCT00819585|590361597|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
163454326|NCT00819585|590361598|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
163454327|NCT00819585|590361599|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
163454328|NCT00819585|590361600|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
163454329|NCT00819585|590361601|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
163454330|NCT00819585|590361602|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
163454331|NCT00819585|590361592|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
163454332|NCT00819585|590361593|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
163454333|NCT00819585|590361594|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
163454334|NCT00819585|590361595|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
163454335|NCT00819585|590361596|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
163454336|NCT00819585|590361597|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
163454337|NCT00819585|590361598|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
163454338|NCT00819585|590361599|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
163454339|NCT00819585|590361600|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
163454340|NCT00819585|590361601|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
163454341|NCT00819585|590361602|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
163454342|NCT00819585|590361592|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
163454343|NCT00819585|590361593|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
163454344|NCT00819585|590361594|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
163454345|NCT00819585|590361595|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
163454346|NCT00819585|590361596|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
163454347|NCT00819585|590361597|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
163454348|NCT00819585|590361598|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
163454349|NCT00819585|590361599|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
163454350|NCT00819585|590361600|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
163454351|NCT00819585|590361601|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
163454352|NCT00819585|590361602|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
163454353|NCT00819585|590361592|FG000|Core Study|Subject Withdrew Consent|0|||
163454354|NCT00819585|590361593|FG001|Core Study|Subject Withdrew Consent|3|||
163454355|NCT00819585|590361594|FG002|Core Study|Subject Withdrew Consent|2|||
163454356|NCT00819585|590361595|FG003|Core Study|Subject Withdrew Consent|1|||
163454357|NCT00819585|590361596|FG004|Core Study|Subject Withdrew Consent|0|||
163454358|NCT00819585|590361597|FG005|Core Study|Subject Withdrew Consent|0|||
163454359|NCT00819585|590361598|FG006|Core Study|Subject Withdrew Consent|3|||
163454360|NCT00819585|590361599|FG007|Core Study|Subject Withdrew Consent|0|||
163454361|NCT00819585|590361600|FG008|Core Study|Subject Withdrew Consent|0|||
163454362|NCT00819585|590361601|FG009|Core Study|Subject Withdrew Consent|0|||
163454363|NCT00819585|590361602|FG010|Core Study|Subject Withdrew Consent|0|||
163454364|NCT00819585|590361592|FG000|Core Study|Lost to Follow-up|2|||
163454365|NCT00819585|590361593|FG001|Core Study|Lost to Follow-up|1|||
163454366|NCT00819585|590361594|FG002|Core Study|Lost to Follow-up|2|||
163454367|NCT00819585|590361595|FG003|Core Study|Lost to Follow-up|0|||
163454368|NCT00819585|590361596|FG004|Core Study|Lost to Follow-up|1|||
163454369|NCT00819585|590361597|FG005|Core Study|Lost to Follow-up|1|||
163454370|NCT00819585|590361598|FG006|Core Study|Lost to Follow-up|1|||
163454371|NCT00819585|590361599|FG007|Core Study|Lost to Follow-up|0|||
163454372|NCT00819585|590361600|FG008|Core Study|Lost to Follow-up|0|||
163454373|NCT00819585|590361601|FG009|Core Study|Lost to Follow-up|0|||
163454374|NCT00819585|590361602|FG010|Core Study|Lost to Follow-up|0|||
163454375|NCT00819585|590361592|FG000|Core Study|Administrative Problems|0|||
163454376|NCT00819585|590361593|FG001|Core Study|Administrative Problems|0|||
163454377|NCT00819585|590361594|FG002|Core Study|Administrative Problems|0|||
163454378|NCT00819585|590361595|FG003|Core Study|Administrative Problems|0|||
163454379|NCT00819585|590361596|FG004|Core Study|Administrative Problems|0|||
163454380|NCT00819585|590361597|FG005|Core Study|Administrative Problems|0|||
163454381|NCT00819585|590361598|FG006|Core Study|Administrative Problems|2|||
163454382|NCT00819585|590361599|FG007|Core Study|Administrative Problems|0|||
163454383|NCT00819585|590361600|FG008|Core Study|Administrative Problems|0|||
163454384|NCT00819585|590361601|FG009|Core Study|Administrative Problems|0|||
163454385|NCT00819585|590361602|FG010|Core Study|Administrative Problems|0|||
163454386|NCT00819585|590361592|FG000|Core Study|Death|0|||
163454387|NCT00819585|590361593|FG001|Core Study|Death|0|||
163454388|NCT00819585|590361594|FG002|Core Study|Death|0|||
163454389|NCT00819585|590361595|FG003|Core Study|Death|0|||
163454390|NCT00819585|590361596|FG004|Core Study|Death|0|||
163454391|NCT00819585|590361597|FG005|Core Study|Death|0|||
163454392|NCT00819585|590361598|FG006|Core Study|Death|1|||
163454393|NCT00819585|590361599|FG007|Core Study|Death|0|||
163454394|NCT00819585|590361600|FG008|Core Study|Death|0|||
163454395|NCT00819585|590361601|FG009|Core Study|Death|0|||
163454396|NCT00819585|590361602|FG010|Core Study|Death|0|||
163454397|NCT00819585|590361592|FG000|Core Study|Protocol Violation|0|||
163454398|NCT00819585|590361593|FG001|Core Study|Protocol Violation|0|||
163454399|NCT00819585|590361594|FG002|Core Study|Protocol Violation|1|||
163454400|NCT00819585|590361595|FG003|Core Study|Protocol Violation|0|||
163454401|NCT00819585|590361596|FG004|Core Study|Protocol Violation|0|||
163454402|NCT00819585|590361597|FG005|Core Study|Protocol Violation|1|||
163454403|NCT00819585|590361598|FG006|Core Study|Protocol Violation|3|||
163454404|NCT00819585|590361599|FG007|Core Study|Protocol Violation|0|||
163454405|NCT00819585|590361600|FG008|Core Study|Protocol Violation|0|||
163454406|NCT00819585|590361601|FG009|Core Study|Protocol Violation|0|||
163454407|NCT00819585|590361602|FG010|Core Study|Protocol Violation|0|||
163454408|NCT00819585|590361592|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
163454409|NCT00819585|590361593|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
163454410|NCT00819585|590361594|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
163454411|NCT00819585|590361595|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
163454412|NCT00819585|590361596|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
163454413|NCT00819585|590361597|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
163454414|NCT00819585|590361598|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
163454415|NCT00819585|590361599|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
163454416|NCT00819585|590361600|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
163454417|NCT00819585|590361601|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
163454418|NCT00819585|590361602|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
163454419|NCT00819585|590361592|FG000|Extension Study|Subject Withdrew Consent|0|||
163454420|NCT00819585|590361593|FG001|Extension Study|Subject Withdrew Consent|0|||
163454421|NCT00819585|590361594|FG002|Extension Study|Subject Withdrew Consent|0|||
163454422|NCT00819585|590361595|FG003|Extension Study|Subject Withdrew Consent|0|||
163454423|NCT00819585|590361596|FG004|Extension Study|Subject Withdrew Consent|0|||
163454424|NCT00819585|590361597|FG005|Extension Study|Subject Withdrew Consent|0|||
163454425|NCT00819585|590361598|FG006|Extension Study|Subject Withdrew Consent|0|||
163454426|NCT00819585|590361599|FG007|Extension Study|Subject Withdrew Consent|0|||
163454427|NCT00819585|590361600|FG008|Extension Study|Subject Withdrew Consent|3|||
163454428|NCT00819585|590361601|FG009|Extension Study|Subject Withdrew Consent|0|||
163454429|NCT00819585|590361602|FG010|Extension Study|Subject Withdrew Consent|1|||
163454430|NCT00819585|590361592|FG000|Extension Study|Lost to Follow-up|0|||
163454431|NCT00819585|590361593|FG001|Extension Study|Lost to Follow-up|0|||
163454432|NCT00819585|590361594|FG002|Extension Study|Lost to Follow-up|0|||
163454433|NCT00819585|590361595|FG003|Extension Study|Lost to Follow-up|0|||
163454434|NCT00819585|590361596|FG004|Extension Study|Lost to Follow-up|0|||
163454435|NCT00819585|590361597|FG005|Extension Study|Lost to Follow-up|0|||
163454436|NCT00819585|590361598|FG006|Extension Study|Lost to Follow-up|0|||
163454437|NCT00819585|590361599|FG007|Extension Study|Lost to Follow-up|0|||
163454438|NCT00819585|590361600|FG008|Extension Study|Lost to Follow-up|2|||
163454439|NCT00819585|590361601|FG009|Extension Study|Lost to Follow-up|1|||
163454440|NCT00819585|590361602|FG010|Extension Study|Lost to Follow-up|1|||
163454441|NCT00819585|590361592|FG000|Extension Study|Death|0|||
163454442|NCT00819585|590361593|FG001|Extension Study|Death|0|||
163454443|NCT00819585|590361594|FG002|Extension Study|Death|0|||
163454444|NCT00819585|590361595|FG003|Extension Study|Death|0|||
163454445|NCT00819585|590361596|FG004|Extension Study|Death|0|||
163454446|NCT00819585|590361597|FG005|Extension Study|Death|0|||
163454447|NCT00819585|590361598|FG006|Extension Study|Death|0|||
163454448|NCT00819585|590361599|FG007|Extension Study|Death|0|||
163454449|NCT00819585|590361600|FG008|Extension Study|Death|2|||
163454450|NCT00819585|590361601|FG009|Extension Study|Death|0|||
163454451|NCT00819585|590361602|FG010|Extension Study|Death|0|||
163454452|NCT01877382|590361603|FG000|Dose Escalation|Progressive disease|2|||
163454453|NCT01877382|590361604|FG001|Dose Escalation|Progressive disease|0|||
163454454|NCT01877382|590361605|FG002|Dose Escalation|Progressive disease|1|||
163454455|NCT01877382|590361606|FG003|Dose Escalation|Progressive disease|6|||
163454456|NCT01877382|590361607|FG004|Dose Escalation|Progressive disease|1|||
163454457|NCT01877382|590361608|FG005|Dose Escalation|Progressive disease|0|||
163454458|NCT01877382|590361609|FG006|Dose Escalation|Progressive disease|3|||
163454459|NCT01877382|590361610|FG007|Dose Escalation|Progressive disease|10|||
163454460|NCT01877382|590361611|FG008|Dose Escalation|Progressive disease|4|||
163454461|NCT01877382|590361612|FG009|Dose Escalation|Progressive disease|2|||
163454462|NCT01877382|590361613|FG010|Dose Escalation|Progressive disease|3|||
163454463|NCT01877382|590361614|FG011|Dose Escalation|Progressive disease|3|||
163454464|NCT01877382|590361615|FG012|Dose Escalation|Progressive disease|13|||
163454465|NCT01877382|590361616|FG013|Dose Escalation|Progressive disease|1|||
163454466|NCT01877382|590361617|FG014|Dose Escalation|Progressive disease|0|||
163454467|NCT01877382|590361603|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
163454468|NCT01877382|590361604|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454469|NCT01877382|590361605|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454470|NCT01877382|590361606|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
163454471|NCT01877382|590361607|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454472|NCT01877382|590361608|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454473|NCT01877382|590361609|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
163454474|NCT01877382|590361610|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454475|NCT01877382|590361611|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454476|NCT01877382|590361612|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454477|NCT01877382|590361613|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454478|NCT01877382|590361614|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454479|NCT01877382|590361615|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454480|NCT01877382|590361616|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454481|NCT01877382|590361617|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454482|NCT01877382|590361603|FG000|Dose Escalation|Clinical progression|0|||
163454483|NCT01877382|590361604|FG001|Dose Escalation|Clinical progression|1|||
163454484|NCT01877382|590361605|FG002|Dose Escalation|Clinical progression|0|||
163454485|NCT01877382|590361606|FG003|Dose Escalation|Clinical progression|2|||
163454486|NCT01877382|590361607|FG004|Dose Escalation|Clinical progression|0|||
163454487|NCT01877382|590361608|FG005|Dose Escalation|Clinical progression|0|||
163454488|NCT01877382|590361609|FG006|Dose Escalation|Clinical progression|1|||
163454489|NCT01877382|590361610|FG007|Dose Escalation|Clinical progression|0|||
163454490|NCT01877382|590361611|FG008|Dose Escalation|Clinical progression|0|||
163454491|NCT01877382|590361612|FG009|Dose Escalation|Clinical progression|1|||
163454492|NCT01877382|590361613|FG010|Dose Escalation|Clinical progression|0|||
163454493|NCT01877382|590361614|FG011|Dose Escalation|Clinical progression|0|||
163454494|NCT01877382|590361615|FG012|Dose Escalation|Clinical progression|2|||
163454495|NCT01877382|590361616|FG013|Dose Escalation|Clinical progression|1|||
163454496|NCT01877382|590361617|FG014|Dose Escalation|Clinical progression|0|||
163454497|NCT01877382|590361603|FG000|Dose Escalation|Adverse Event|0|||
163454498|NCT01877382|590361604|FG001|Dose Escalation|Adverse Event|0|||
163454499|NCT01877382|590361605|FG002|Dose Escalation|Adverse Event|0|||
163454500|NCT01877382|590361606|FG003|Dose Escalation|Adverse Event|4|||
163454501|NCT01877382|590361607|FG004|Dose Escalation|Adverse Event|1|||
163454502|NCT01877382|590361608|FG005|Dose Escalation|Adverse Event|2|||
163454503|NCT01877382|590361609|FG006|Dose Escalation|Adverse Event|1|||
163454504|NCT01877382|590361610|FG007|Dose Escalation|Adverse Event|2|||
163454505|NCT01877382|590361611|FG008|Dose Escalation|Adverse Event|0|||
163454506|NCT01877382|590361612|FG009|Dose Escalation|Adverse Event|0|||
163454507|NCT01877382|590361613|FG010|Dose Escalation|Adverse Event|0|||
163454508|NCT01877382|590361614|FG011|Dose Escalation|Adverse Event|0|||
163454509|NCT01877382|590361615|FG012|Dose Escalation|Adverse Event|1|||
163454510|NCT01877382|590361616|FG013|Dose Escalation|Adverse Event|0|||
163454511|NCT01877382|590361617|FG014|Dose Escalation|Adverse Event|0|||
163454512|NCT01877382|590361603|FG000|Dose Escalation|Withdrawal by Subject|0|||
163454513|NCT01877382|590361604|FG001|Dose Escalation|Withdrawal by Subject|0|||
163454514|NCT01877382|590361605|FG002|Dose Escalation|Withdrawal by Subject|0|||
163454515|NCT01877382|590361606|FG003|Dose Escalation|Withdrawal by Subject|0|||
163454516|NCT01877382|590361607|FG004|Dose Escalation|Withdrawal by Subject|0|||
163454517|NCT01877382|590361608|FG005|Dose Escalation|Withdrawal by Subject|3|||
163454518|NCT01877382|590361609|FG006|Dose Escalation|Withdrawal by Subject|2|||
163454519|NCT01877382|590361610|FG007|Dose Escalation|Withdrawal by Subject|1|||
163454520|NCT01877382|590361611|FG008|Dose Escalation|Withdrawal by Subject|1|||
163454521|NCT01877382|590361612|FG009|Dose Escalation|Withdrawal by Subject|0|||
163454522|NCT01877382|590361613|FG010|Dose Escalation|Withdrawal by Subject|0|||
163454523|NCT01877382|590361614|FG011|Dose Escalation|Withdrawal by Subject|0|||
163454524|NCT01877382|590361615|FG012|Dose Escalation|Withdrawal by Subject|0|||
163454525|NCT01877382|590361616|FG013|Dose Escalation|Withdrawal by Subject|0|||
163454526|NCT01877382|590361617|FG014|Dose Escalation|Withdrawal by Subject|0|||
163454527|NCT01877382|590361603|FG000|Dose Escalation|Protocol Violation|0|||
163454528|NCT01877382|590361604|FG001|Dose Escalation|Protocol Violation|0|||
163454529|NCT01877382|590361605|FG002|Dose Escalation|Protocol Violation|0|||
163454530|NCT01877382|590361606|FG003|Dose Escalation|Protocol Violation|0|||
163454531|NCT01877382|590361607|FG004|Dose Escalation|Protocol Violation|0|||
163454532|NCT01877382|590361608|FG005|Dose Escalation|Protocol Violation|0|||
163454533|NCT01877382|590361609|FG006|Dose Escalation|Protocol Violation|1|||
163454534|NCT01877382|590361610|FG007|Dose Escalation|Protocol Violation|0|||
163454535|NCT01877382|590361611|FG008|Dose Escalation|Protocol Violation|0|||
163454536|NCT01877382|590361612|FG009|Dose Escalation|Protocol Violation|0|||
163454537|NCT01877382|590361613|FG010|Dose Escalation|Protocol Violation|0|||
163454538|NCT01877382|590361614|FG011|Dose Escalation|Protocol Violation|0|||
163454539|NCT01877382|590361615|FG012|Dose Escalation|Protocol Violation|0|||
163454540|NCT01877382|590361616|FG013|Dose Escalation|Protocol Violation|0|||
163454541|NCT01877382|590361617|FG014|Dose Escalation|Protocol Violation|0|||
163454542|NCT01877382|590361603|FG000|Dose Escalation|Study terminated by sponsor|0|||
163454543|NCT01877382|590361604|FG001|Dose Escalation|Study terminated by sponsor|0|||
163454544|NCT01877382|590361605|FG002|Dose Escalation|Study terminated by sponsor|0|||
163454545|NCT01877382|590361606|FG003|Dose Escalation|Study terminated by sponsor|0|||
163454546|NCT01877382|590361607|FG004|Dose Escalation|Study terminated by sponsor|0|||
163454547|NCT01877382|590361608|FG005|Dose Escalation|Study terminated by sponsor|0|||
163454548|NCT01877382|590361609|FG006|Dose Escalation|Study terminated by sponsor|0|||
163454549|NCT01877382|590361610|FG007|Dose Escalation|Study terminated by sponsor|1|||
163454550|NCT01877382|590361611|FG008|Dose Escalation|Study terminated by sponsor|1|||
163454551|NCT01877382|590361612|FG009|Dose Escalation|Study terminated by sponsor|0|||
163454552|NCT01877382|590361613|FG010|Dose Escalation|Study terminated by sponsor|0|||
163454553|NCT01877382|590361614|FG011|Dose Escalation|Study terminated by sponsor|0|||
163454554|NCT01877382|590361615|FG012|Dose Escalation|Study terminated by sponsor|3|||
163454555|NCT01877382|590361616|FG013|Dose Escalation|Study terminated by sponsor|0|||
163454556|NCT01877382|590361617|FG014|Dose Escalation|Study terminated by sponsor|0|||
163454557|NCT01877382|590361603|FG000|Dose Escalation|Death|0|||
163454558|NCT01877382|590361604|FG001|Dose Escalation|Death|0|||
163454559|NCT01877382|590361605|FG002|Dose Escalation|Death|0|||
163454560|NCT01877382|590361606|FG003|Dose Escalation|Death|0|||
163454561|NCT01877382|590361607|FG004|Dose Escalation|Death|0|||
163454562|NCT01877382|590361608|FG005|Dose Escalation|Death|0|||
163454563|NCT01877382|590361609|FG006|Dose Escalation|Death|0|||
163454564|NCT01877382|590361610|FG007|Dose Escalation|Death|1|||
163454565|NCT01877382|590361611|FG008|Dose Escalation|Death|0|||
163454566|NCT01877382|590361612|FG009|Dose Escalation|Death|0|||
163454567|NCT01877382|590361613|FG010|Dose Escalation|Death|0|||
163454568|NCT01877382|590361614|FG011|Dose Escalation|Death|0|||
163454569|NCT01877382|590361615|FG012|Dose Escalation|Death|1|||
163454570|NCT01877382|590361616|FG013|Dose Escalation|Death|1|||
163454571|NCT01877382|590361617|FG014|Dose Escalation|Death|0|||
163454572|NCT01877382|590361603|FG000|Dose Expansion|Progressive disease|0|||
163454573|NCT01877382|590361604|FG001|Dose Expansion|Progressive disease|0|||
163454574|NCT01877382|590361605|FG002|Dose Expansion|Progressive disease|0|||
163454575|NCT01877382|590361606|FG003|Dose Expansion|Progressive disease|0|||
163454576|NCT01877382|590361607|FG004|Dose Expansion|Progressive disease|0|||
163454577|NCT01877382|590361608|FG005|Dose Expansion|Progressive disease|0|||
163454578|NCT01877382|590361609|FG006|Dose Expansion|Progressive disease|0|||
163454579|NCT01877382|590361610|FG007|Dose Expansion|Progressive disease|0|||
163454580|NCT01877382|590361611|FG008|Dose Expansion|Progressive disease|0|||
163454581|NCT01877382|590361612|FG009|Dose Expansion|Progressive disease|0|||
163454582|NCT01877382|590361613|FG010|Dose Expansion|Progressive disease|0|||
163454583|NCT01877382|590361614|FG011|Dose Expansion|Progressive disease|0|||
163454584|NCT01877382|590361615|FG012|Dose Expansion|Progressive disease|0|||
163454585|NCT01877382|590361616|FG013|Dose Expansion|Progressive disease|0|||
163454586|NCT01877382|590361617|FG014|Dose Expansion|Progressive disease|11|||
163454587|NCT01877382|590361603|FG000|Dose Expansion|Clinical progression|0|||
163454588|NCT01877382|590361604|FG001|Dose Expansion|Clinical progression|0|||
163454589|NCT01877382|590361605|FG002|Dose Expansion|Clinical progression|0|||
163454590|NCT01877382|590361606|FG003|Dose Expansion|Clinical progression|0|||
163454591|NCT01877382|590361607|FG004|Dose Expansion|Clinical progression|0|||
163454592|NCT01877382|590361608|FG005|Dose Expansion|Clinical progression|0|||
163454593|NCT01877382|590361609|FG006|Dose Expansion|Clinical progression|0|||
163454594|NCT01877382|590361610|FG007|Dose Expansion|Clinical progression|0|||
163454595|NCT01877382|590361611|FG008|Dose Expansion|Clinical progression|0|||
163454596|NCT01877382|590361612|FG009|Dose Expansion|Clinical progression|0|||
163454597|NCT01877382|590361613|FG010|Dose Expansion|Clinical progression|0|||
163454598|NCT01877382|590361614|FG011|Dose Expansion|Clinical progression|0|||
163454599|NCT01877382|590361615|FG012|Dose Expansion|Clinical progression|0|||
163454600|NCT01877382|590361616|FG013|Dose Expansion|Clinical progression|0|||
163454601|NCT01877382|590361617|FG014|Dose Expansion|Clinical progression|6|||
163454602|NCT01877382|590361603|FG000|Dose Expansion|Adverse Event|0|||
163454603|NCT01877382|590361604|FG001|Dose Expansion|Adverse Event|0|||
163454604|NCT01877382|590361605|FG002|Dose Expansion|Adverse Event|0|||
163454605|NCT01877382|590361606|FG003|Dose Expansion|Adverse Event|0|||
163454606|NCT01877382|590361607|FG004|Dose Expansion|Adverse Event|0|||
163454607|NCT01877382|590361608|FG005|Dose Expansion|Adverse Event|0|||
163454608|NCT01877382|590361609|FG006|Dose Expansion|Adverse Event|0|||
163454609|NCT01877382|590361610|FG007|Dose Expansion|Adverse Event|0|||
163454610|NCT01877382|590361611|FG008|Dose Expansion|Adverse Event|0|||
163454611|NCT01877382|590361612|FG009|Dose Expansion|Adverse Event|0|||
163454612|NCT01877382|590361613|FG010|Dose Expansion|Adverse Event|0|||
163454613|NCT01877382|590361614|FG011|Dose Expansion|Adverse Event|0|||
163454614|NCT01877382|590361615|FG012|Dose Expansion|Adverse Event|0|||
163454615|NCT01877382|590361616|FG013|Dose Expansion|Adverse Event|0|||
163454616|NCT01877382|590361617|FG014|Dose Expansion|Adverse Event|1|||
163454617|NCT01877382|590361603|FG000|Dose Expansion|Death|0|||
163454618|NCT01877382|590361604|FG001|Dose Expansion|Death|0|||
163454619|NCT01877382|590361605|FG002|Dose Expansion|Death|0|||
163454620|NCT01877382|590361606|FG003|Dose Expansion|Death|0|||
163454621|NCT01877382|590361607|FG004|Dose Expansion|Death|0|||
163454622|NCT01877382|590361608|FG005|Dose Expansion|Death|0|||
163454623|NCT01877382|590361609|FG006|Dose Expansion|Death|0|||
163454624|NCT01877382|590361610|FG007|Dose Expansion|Death|0|||
163454625|NCT01877382|590361611|FG008|Dose Expansion|Death|0|||
163454626|NCT01877382|590361612|FG009|Dose Expansion|Death|0|||
163454627|NCT01877382|590361613|FG010|Dose Expansion|Death|0|||
163454628|NCT01877382|590361614|FG011|Dose Expansion|Death|0|||
163454629|NCT01877382|590361615|FG012|Dose Expansion|Death|0|||
163454630|NCT01877382|590361616|FG013|Dose Expansion|Death|0|||
163454631|NCT01877382|590361617|FG014|Dose Expansion|Death|1|||
163454632|NCT01877382|590361603|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454633|NCT01877382|590361604|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454634|NCT01877382|590361605|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454635|NCT01877382|590361606|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454636|NCT01877382|590361607|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454637|NCT01877382|590361608|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454638|NCT01877382|590361609|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454639|NCT01877382|590361610|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454640|NCT01877382|590361611|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454641|NCT01877382|590361612|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454642|NCT01877382|590361613|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454643|NCT01877382|590361614|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454644|NCT01877382|590361615|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454645|NCT01877382|590361616|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163454646|NCT01877382|590361617|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
163454647|NCT03423979|590361618|FG000|Overall Study|Death|5|||
163454648|NCT03423979|590361618|FG000|Overall Study|Adverse Event|4|||
163454649|NCT03423979|590361618|FG000|Overall Study|Withdrawal by Subject|3|||
163454650|NCT03423979|590361618|FG000|Overall Study|Lost to Follow-up|16|||
163454651|NCT00808249|590361621|FG000|Overall Study|Adverse Event|4|||
163454652|NCT00808249|590361622|FG001|Overall Study|Adverse Event|7|||
163454653|NCT00808249|590361623|FG002|Overall Study|Adverse Event|10|||
163454654|NCT00808249|590361624|FG003|Overall Study|Adverse Event|6|||
163454655|NCT00808249|590361621|FG000|Overall Study|Lost to Follow-up|2|||
163454656|NCT00808249|590361622|FG001|Overall Study|Lost to Follow-up|3|||
163454657|NCT00808249|590361623|FG002|Overall Study|Lost to Follow-up|3|||
163454658|NCT00808249|590361624|FG003|Overall Study|Lost to Follow-up|5|||
163454659|NCT00808249|590361621|FG000|Overall Study|Withdrawal by Subject|4|||
163454660|NCT00808249|590361622|FG001|Overall Study|Withdrawal by Subject|0|||
163454661|NCT00808249|590361623|FG002|Overall Study|Withdrawal by Subject|2|||
163454662|NCT00808249|590361624|FG003|Overall Study|Withdrawal by Subject|4|||
163454663|NCT00808249|590361621|FG000|Overall Study|Protocol Violation|3|||
163454664|NCT00808249|590361622|FG001|Overall Study|Protocol Violation|3|||
163454665|NCT00808249|590361623|FG002|Overall Study|Protocol Violation|3|||
163454666|NCT00808249|590361624|FG003|Overall Study|Protocol Violation|0|||
163454667|NCT00808249|590361621|FG000|Overall Study|Lack of Efficacy|1|||
163454668|NCT00808249|590361622|FG001|Overall Study|Lack of Efficacy|1|||
163454669|NCT00808249|590361623|FG002|Overall Study|Lack of Efficacy|0|||
163454670|NCT00808249|590361624|FG003|Overall Study|Lack of Efficacy|0|||
163454671|NCT00808249|590361621|FG000|Overall Study|study specific discontinuation criteria|1|||
163454672|NCT00808249|590361622|FG001|Overall Study|study specific discontinuation criteria|0|||
163454673|NCT00808249|590361623|FG002|Overall Study|study specific discontinuation criteria|1|||
163454674|NCT00808249|590361624|FG003|Overall Study|study specific discontinuation criteria|0|||
163454675|NCT00808249|590361621|FG000|Overall Study|All other reasons|2|||
163454676|NCT00808249|590361622|FG001|Overall Study|All other reasons|1|||
163454677|NCT00808249|590361623|FG002|Overall Study|All other reasons|3|||
163454678|NCT00808249|590361624|FG003|Overall Study|All other reasons|1|||
163454679|NCT05108805|590361628|FG000|Overall Study|T-cell expansion was not successful.|5|||
163454680|NCT04095286|590361629|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
163454681|NCT04095286|590361630|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
163454682|NCT04095286|590361631|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
163454683|NCT04095286|590361632|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
163454684|NCT04095286|590361633|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
163454685|NCT04095286|590361634|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
163454686|NCT04095286|590361629|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
163454687|NCT04095286|590361630|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
163454688|NCT04095286|590361631|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
163454689|NCT04095286|590361632|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
163454690|NCT04095286|590361633|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
163454691|NCT04095286|590361634|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
163454692|NCT04095286|590361629|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
163454693|NCT04095286|590361630|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
163454694|NCT04095286|590361631|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
163454695|NCT04095286|590361632|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
163454696|NCT04095286|590361633|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
163454697|NCT04095286|590361634|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
163454698|NCT04095286|590361629|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
163454699|NCT04095286|590361630|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
163454700|NCT04095286|590361631|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
163454701|NCT04095286|590361632|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
163454702|NCT04095286|590361633|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
163454703|NCT04095286|590361634|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
163454704|NCT04095286|590361629|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
163454705|NCT04095286|590361630|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
163454706|NCT04095286|590361631|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
163454707|NCT04095286|590361632|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
163454708|NCT04095286|590361633|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
163454709|NCT04095286|590361634|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
163454710|NCT00479557|590361635|FG000|Overall Study|Death|0|||
163454711|NCT00479557|590361636|FG001|Overall Study|Death|0|||
163454712|NCT00479557|590361637|FG002|Overall Study|Death|0|||
163454713|NCT00479557|590361638|FG003|Overall Study|Death|0|||
163454714|NCT00479557|590361639|FG004|Overall Study|Death|0|||
163454715|NCT00479557|590361640|FG005|Overall Study|Death|1|||
163454716|NCT00479557|590361641|FG006|Overall Study|Death|0|||
163454717|NCT00479557|590361635|FG000|Overall Study|Lack of Efficacy|1|||
163454718|NCT00479557|590361636|FG001|Overall Study|Lack of Efficacy|0|||
163454719|NCT00479557|590361637|FG002|Overall Study|Lack of Efficacy|0|||
163454720|NCT00479557|590361638|FG003|Overall Study|Lack of Efficacy|0|||
163454721|NCT00479557|590361639|FG004|Overall Study|Lack of Efficacy|0|||
163454722|NCT00479557|590361640|FG005|Overall Study|Lack of Efficacy|0|||
163454723|NCT00479557|590361641|FG006|Overall Study|Lack of Efficacy|0|||
163454724|NCT00479557|590361635|FG000|Overall Study|Lost to Follow-up|0|||
163454725|NCT00479557|590361636|FG001|Overall Study|Lost to Follow-up|2|||
163454726|NCT00479557|590361637|FG002|Overall Study|Lost to Follow-up|0|||
163454727|NCT00479557|590361638|FG003|Overall Study|Lost to Follow-up|2|||
163454728|NCT00479557|590361639|FG004|Overall Study|Lost to Follow-up|0|||
163454729|NCT00479557|590361640|FG005|Overall Study|Lost to Follow-up|0|||
163454730|NCT00479557|590361641|FG006|Overall Study|Lost to Follow-up|0|||
163454731|NCT00479557|590361635|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
163454732|NCT00479557|590361636|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
163454733|NCT00479557|590361637|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
163454734|NCT00479557|590361638|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
163454735|NCT00479557|590361639|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
163454736|NCT00479557|590361640|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
163454737|NCT00479557|590361641|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
163454738|NCT00479557|590361635|FG000|Overall Study|AE not related to Study Drug|1|||
163454739|NCT00479557|590361636|FG001|Overall Study|AE not related to Study Drug|3|||
163454740|NCT00479557|590361637|FG002|Overall Study|AE not related to Study Drug|0|||
163454741|NCT00479557|590361638|FG003|Overall Study|AE not related to Study Drug|0|||
163454742|NCT00479557|590361639|FG004|Overall Study|AE not related to Study Drug|2|||
163454743|NCT00479557|590361640|FG005|Overall Study|AE not related to Study Drug|2|||
163454744|NCT00479557|590361641|FG006|Overall Study|AE not related to Study Drug|1|||
163454745|NCT00479557|590361635|FG000|Overall Study|Caregiver Request|2|||
163454746|NCT00479557|590361636|FG001|Overall Study|Caregiver Request|2|||
163454747|NCT00479557|590361637|FG002|Overall Study|Caregiver Request|2|||
163454748|NCT00479557|590361638|FG003|Overall Study|Caregiver Request|0|||
163454749|NCT00479557|590361639|FG004|Overall Study|Caregiver Request|1|||
163454750|NCT00479557|590361640|FG005|Overall Study|Caregiver Request|2|||
163454751|NCT00479557|590361641|FG006|Overall Study|Caregiver Request|0|||
163454752|NCT00479557|590361635|FG000|Overall Study|Investigator Request|0|||
163454753|NCT00479557|590361636|FG001|Overall Study|Investigator Request|0|||
163454754|NCT00479557|590361637|FG002|Overall Study|Investigator Request|1|||
163454755|NCT00479557|590361638|FG003|Overall Study|Investigator Request|0|||
163454756|NCT00479557|590361639|FG004|Overall Study|Investigator Request|0|||
163454757|NCT00479557|590361640|FG005|Overall Study|Investigator Request|0|||
163454758|NCT00479557|590361641|FG006|Overall Study|Investigator Request|0|||
163454759|NCT00479557|590361635|FG000|Overall Study|Subject Request|3|||
163454760|NCT00479557|590361636|FG001|Overall Study|Subject Request|0|||
163454761|NCT00479557|590361637|FG002|Overall Study|Subject Request|1|||
163454762|NCT00479557|590361638|FG003|Overall Study|Subject Request|1|||
163454763|NCT00479557|590361639|FG004|Overall Study|Subject Request|1|||
163454764|NCT00479557|590361640|FG005|Overall Study|Subject Request|4|||
163454765|NCT00479557|590361641|FG006|Overall Study|Subject Request|1|||
163454766|NCT00479557|590361635|FG000|Overall Study|Other|2|||
163454767|NCT00479557|590361636|FG001|Overall Study|Other|3|||
163454768|NCT00479557|590361637|FG002|Overall Study|Other|1|||
163454769|NCT00479557|590361638|FG003|Overall Study|Other|0|||
163454770|NCT00479557|590361639|FG004|Overall Study|Other|0|||
163454771|NCT00479557|590361640|FG005|Overall Study|Other|3|||
163454772|NCT00479557|590361641|FG006|Overall Study|Other|0|||
163454773|NCT02509494|590361644|FG000|Overall Study|Lost to Follow-up|8|||
163454774|NCT02509494|590361645|FG001|Overall Study|Lost to Follow-up|47|||
163454775|NCT02509494|590361646|FG002|Overall Study|Lost to Follow-up|19|||
163454776|NCT02509494|590361647|FG003|Overall Study|Lost to Follow-up|6|||
163454777|NCT02509494|590361648|FG004|Overall Study|Lost to Follow-up|3|||
163454778|NCT02509494|590361649|FG005|Overall Study|Lost to Follow-up|3|||
163454779|NCT02509494|590361650|FG006|Overall Study|Lost to Follow-up|1|||
163454780|NCT02509494|590361651|FG007|Overall Study|Lost to Follow-up|3|||
163454781|NCT02509494|590361652|FG008|Overall Study|Lost to Follow-up|1|||
163454782|NCT02509494|590361644|FG000|Overall Study|Physician Decision|2|||
163454783|NCT02509494|590361645|FG001|Overall Study|Physician Decision|1|||
163454784|NCT02509494|590361646|FG002|Overall Study|Physician Decision|0|||
163454785|NCT02509494|590361647|FG003|Overall Study|Physician Decision|0|||
163454786|NCT02509494|590361648|FG004|Overall Study|Physician Decision|0|||
163454787|NCT02509494|590361649|FG005|Overall Study|Physician Decision|0|||
163454788|NCT02509494|590361650|FG006|Overall Study|Physician Decision|0|||
163454789|NCT02509494|590361651|FG007|Overall Study|Physician Decision|0|||
163454790|NCT02509494|590361652|FG008|Overall Study|Physician Decision|0|||
163454791|NCT02509494|590361644|FG000|Overall Study|Withdrawal by Subject|4|||
163454792|NCT02509494|590361645|FG001|Overall Study|Withdrawal by Subject|17|||
163454793|NCT02509494|590361646|FG002|Overall Study|Withdrawal by Subject|7|||
163454794|NCT02509494|590361647|FG003|Overall Study|Withdrawal by Subject|5|||
163454795|NCT02509494|590361648|FG004|Overall Study|Withdrawal by Subject|0|||
163454796|NCT02509494|590361649|FG005|Overall Study|Withdrawal by Subject|6|||
163454797|NCT02509494|590361650|FG006|Overall Study|Withdrawal by Subject|1|||
163454798|NCT02509494|590361651|FG007|Overall Study|Withdrawal by Subject|2|||
163454799|NCT02509494|590361652|FG008|Overall Study|Withdrawal by Subject|1|||
163454800|NCT02509494|590361644|FG000|Overall Study|Death|0|||
163454801|NCT02509494|590361645|FG001|Overall Study|Death|1|||
163454802|NCT02509494|590361646|FG002|Overall Study|Death|0|||
163454803|NCT02509494|590361647|FG003|Overall Study|Death|0|||
163454804|NCT02509494|590361648|FG004|Overall Study|Death|1|||
163454805|NCT02509494|590361649|FG005|Overall Study|Death|0|||
163454806|NCT02509494|590361650|FG006|Overall Study|Death|0|||
163454807|NCT02509494|590361651|FG007|Overall Study|Death|1|||
163454808|NCT02509494|590361652|FG008|Overall Study|Death|0|||
163454809|NCT02509494|590361644|FG000|Overall Study|Other|0|||
163454810|NCT02509494|590361645|FG001|Overall Study|Other|4|||
163454811|NCT02509494|590361646|FG002|Overall Study|Other|5|||
163454812|NCT02509494|590361647|FG003|Overall Study|Other|0|||
163454813|NCT02509494|590361648|FG004|Overall Study|Other|0|||
163454814|NCT02509494|590361649|FG005|Overall Study|Other|0|||
163454815|NCT02509494|590361650|FG006|Overall Study|Other|0|||
163454816|NCT02509494|590361651|FG007|Overall Study|Other|0|||
163454817|NCT02509494|590361652|FG008|Overall Study|Other|0|||
163454818|NCT02509494|590361644|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163454819|NCT02509494|590361645|FG001|Overall Study|Non-Compliance With Study Drug|11|||
163454820|NCT02509494|590361646|FG002|Overall Study|Non-Compliance With Study Drug|7|||
163454821|NCT02509494|590361647|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163454822|NCT02509494|590361648|FG004|Overall Study|Non-Compliance With Study Drug|1|||
163454823|NCT02509494|590361649|FG005|Overall Study|Non-Compliance With Study Drug|2|||
163454824|NCT02509494|590361650|FG006|Overall Study|Non-Compliance With Study Drug|1|||
163454825|NCT02509494|590361651|FG007|Overall Study|Non-Compliance With Study Drug|1|||
163454826|NCT02509494|590361652|FG008|Overall Study|Non-Compliance With Study Drug|0|||
163454827|NCT01511107|590361653|FG000|Overall Study|Ineligible|3|||
163454828|NCT01511107|590361654|FG001|Overall Study|Ineligible|2|||
163454829|NCT01511107|590361653|FG000|Overall Study|Lost to Follow-up|10|||
163454830|NCT01511107|590361654|FG001|Overall Study|Lost to Follow-up|19|||
163454831|NCT01511107|590361653|FG000|Overall Study|Withdrawal by Subject|9|||
163454832|NCT01511107|590361654|FG001|Overall Study|Withdrawal by Subject|20|||
163454833|NCT05371912|590361655|FG000|Overall Study|Lost to Follow-up|3|||
163454834|NCT05371912|590361656|FG001|Overall Study|Lost to Follow-up|2|||
163454835|NCT04752189|590361657|FG000|Overall Study|Withdrawal by Subject|0|||
163454836|NCT04752189|590361658|FG001|Overall Study|Withdrawal by Subject|150|||
163454837|NCT04752189|590361657|FG000|Overall Study|Lost to Follow-up|261|||
163454838|NCT04752189|590361658|FG001|Overall Study|Lost to Follow-up|126|||
163454839|NCT00975195|590361659|FG000|Overall Study|Adverse Event|108|||
163454840|NCT00975195|590361660|FG001|Overall Study|Adverse Event|101|||
163454841|NCT00975195|590361659|FG000|Overall Study|Lack of Efficacy|6|||
163454842|NCT00975195|590361660|FG001|Overall Study|Lack of Efficacy|6|||
163454843|NCT00975195|590361659|FG000|Overall Study|Protocol Violation|27|||
163454844|NCT00975195|590361660|FG001|Overall Study|Protocol Violation|23|||
163454845|NCT00975195|590361659|FG000|Overall Study|Lost to Follow-up|9|||
163454846|NCT00975195|590361660|FG001|Overall Study|Lost to Follow-up|7|||
163454847|NCT00975195|590361659|FG000|Overall Study|Withdrawal by Subject|48|||
163454848|NCT00975195|590361660|FG001|Overall Study|Withdrawal by Subject|61|||
163454849|NCT00975195|590361659|FG000|Overall Study|Other reason not defined above|29|||
163454850|NCT00975195|590361660|FG001|Overall Study|Other reason not defined above|33|||
163454851|NCT00975195|590361659|FG000|Overall Study|Not treated|1|||
163454852|NCT00975195|590361660|FG001|Overall Study|Not treated|2|||
163454853|NCT03003403|590361661|FG000|Overall Study|Ineligible|8|||
163454854|NCT03003403|590361662|FG001|Overall Study|Ineligible|7|||
163454855|NCT03003403|590361661|FG000|Overall Study|Withdrawal by Subject|3|||
163454856|NCT03003403|590361662|FG001|Overall Study|Withdrawal by Subject|1|||
163454857|NCT05084053|590363424|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
163454858|NCT05084053|590363425|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
163454859|NCT05084053|590363426|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
163454860|NCT05084053|590363427|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
163454861|NCT05084053|590363424|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
163454862|NCT05084053|590363425|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
163454863|NCT05084053|590363426|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
163454864|NCT05084053|590363427|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
162925392|NCT05302414|588428962|FG001|Pretest to Posttest|Lost to Follow-up|8|||
162925393|NCT05302414|588428963|FG002|Pretest to Posttest|Lost to Follow-up|8|||
163454865|NCT05084053|590363424|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
163454866|NCT05084053|590363425|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
163454867|NCT05084053|590363426|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
163454868|NCT05084053|590363427|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
163454869|NCT01255306|590363431|FG000|Overall Study|Physician Decision|1|||
163454870|NCT01255306|590363432|FG001|Overall Study|Physician Decision|1|||
163454871|NCT01179347|590363437|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
163454872|NCT01179347|590363438|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
163454873|NCT01179347|590363437|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
163454874|NCT01179347|590363438|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
163454875|NCT01179347|590363437|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
163454876|NCT01179347|590363438|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
163454877|NCT01179347|590363437|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
163454878|NCT01179347|590363438|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
163454879|NCT01179347|590363437|FG000|Double-blind Period (12 Weeks)|Other|2|||
163454880|NCT01179347|590363438|FG001|Double-blind Period (12 Weeks)|Other|4|||
163454881|NCT01179347|590363437|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
163454882|NCT01179347|590363438|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
163454883|NCT01179347|590363437|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
163454884|NCT01179347|590363438|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
163454885|NCT01179347|590363437|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
163454886|NCT01179347|590363438|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
163454887|NCT01179347|590363437|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
163454888|NCT01179347|590363438|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
163454889|NCT01179347|590363437|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
163454890|NCT01179347|590363438|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
163454891|NCT01179347|590363437|FG000|Open-label Period (12 Weeks)|Other|7|||
163454892|NCT01179347|590363438|FG001|Open-label Period (12 Weeks)|Other|4|||
163454893|NCT01677624|590363440|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
163454894|NCT01617655|590363444|FG000|Overall Study|Adverse Event|2|||
163454895|NCT01617655|590363445|FG001|Overall Study|Adverse Event|3|||
163454896|NCT01617655|590363444|FG000|Overall Study|Poor compliance to protocol|1|||
163454897|NCT01617655|590363445|FG001|Overall Study|Poor compliance to protocol|4|||
163454898|NCT01617655|590363444|FG000|Overall Study|Participants moved|0|||
163454899|NCT01617655|590363445|FG001|Overall Study|Participants moved|4|||
163454900|NCT01617655|590363444|FG000|Overall Study|Consent withdrawn by participant|1|||
163454901|NCT01617655|590363445|FG001|Overall Study|Consent withdrawn by participant|1|||
163454902|NCT01617655|590363444|FG000|Overall Study|Last visit outside protocol visit window|1|||
163454903|NCT01617655|590363445|FG001|Overall Study|Last visit outside protocol visit window|10|||
163454904|NCT01617655|590363444|FG000|Overall Study|Site closure|3|||
163454905|NCT01617655|590363445|FG001|Overall Study|Site closure|5|||
163454906|NCT01617655|590363444|FG000|Overall Study|Other than specified above|1|||
163454907|NCT01617655|590363445|FG001|Overall Study|Other than specified above|2|||
163454908|NCT01175213|590363446|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
163454909|NCT01175213|590363447|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
163454910|NCT01175213|590363446|FG000|IGSC, 10%/rHuPH20|Death|1|||
163454911|NCT01175213|590363447|FG001|IGSC, 10%/rHuPH20|Death|0|||
163454912|NCT01175213|590363446|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
163454913|NCT01175213|590363447|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
163454914|NCT01175213|590363446|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
163454915|NCT01175213|590363447|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
163454916|NCT01175213|590363446|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
163454917|NCT01175213|590363447|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
163454918|NCT01175213|590363446|FG000|Safety Follow-up|Adverse Event|1|||
163454919|NCT01175213|590363447|FG001|Safety Follow-up|Adverse Event|0|||
163454920|NCT05279898|590363459|FG000|Overall Study|Withdrawal by Subject|1|||
163454921|NCT05279898|590363460|FG001|Overall Study|Withdrawal by Subject|0|||
163454922|NCT05279898|590363459|FG000|Overall Study|Physician Decision|1|||
163454923|NCT05279898|590363460|FG001|Overall Study|Physician Decision|1|||
163454924|NCT04580394|590363465|FG000|First Intervention|Incorrectly Randomized|1|||
163454925|NCT04580394|590363465|FG000|First Intervention|Physician Decision|1|||
163454926|NCT04580394|590363465|FG000|First Intervention|Lost to Follow-up|1|||
163454927|NCT04580394|590363465|FG000|Washout (One Week)|Withdrawal by Subject|1|||
163454928|NCT04580394|590363465|FG000|Washout (One Week)|Adverse Event|1|||
163454929|NCT04580394|590363465|FG000|Washout (One Week)|Withdrawal by Subject|2|||
163454930|NCT04580394|590363465|FG000|Third Intervention|Adverse Event|1|||
163454931|NCT04580394|590363465|FG000|Third Intervention|Withdrawal by Subject|1|||
163454932|NCT04580394|590363465|FG000|Washout (One Week)|Withdrawal by Subject|2|||
163454933|NCT03201965|590363474|FG000|Overall Study|Death|5|||
163454934|NCT03201965|590363475|FG001|Overall Study|Death|65|||
163454935|NCT03201965|590363476|FG002|Overall Study|Death|47|||
163454936|NCT03201965|590363474|FG000|Overall Study|Lost to Follow-up|0|||
163454937|NCT03201965|590363475|FG001|Overall Study|Lost to Follow-up|6|||
163454938|NCT03201965|590363476|FG002|Overall Study|Lost to Follow-up|0|||
163454939|NCT03201965|590363474|FG000|Overall Study|Withdrawal by Subject|3|||
163454940|NCT03201965|590363475|FG001|Overall Study|Withdrawal by Subject|23|||
163454941|NCT03201965|590363476|FG002|Overall Study|Withdrawal by Subject|8|||
163454942|NCT03201965|590363474|FG000|Overall Study|Sponsor's Decision|20|||
163454943|NCT03201965|590363475|FG001|Overall Study|Sponsor's Decision|99|||
163454944|NCT03201965|590363476|FG002|Overall Study|Sponsor's Decision|140|||
163454945|NCT05441592|590363477|FG000|Overall Study|Lost to Follow-up|1|||
163454946|NCT05441592|590363478|FG001|Overall Study|Lost to Follow-up|5|||
163454947|NCT01371981|590363479|FG000|Overall Study|Adverse Event|12|||
163454948|NCT01371981|590363480|FG001|Overall Study|Adverse Event|17|||
163454949|NCT01371981|590363481|FG002|Overall Study|Adverse Event|0|||
163454950|NCT01371981|590363482|FG003|Overall Study|Adverse Event|4|||
163454951|NCT01371981|590363483|FG004|Overall Study|Adverse Event|1|||
163454952|NCT01371981|590363484|FG005|Overall Study|Adverse Event|0|||
163454953|NCT01371981|590363479|FG000|Overall Study|Death|22|||
163454954|NCT01371981|590363480|FG001|Overall Study|Death|16|||
163454955|NCT01371981|590363481|FG002|Overall Study|Death|0|||
163454956|NCT01371981|590363482|FG003|Overall Study|Death|0|||
163454957|NCT01371981|590363483|FG004|Overall Study|Death|2|||
163454958|NCT01371981|590363484|FG005|Overall Study|Death|2|||
163454959|NCT01371981|590363479|FG000|Overall Study|Lack of Efficacy|69|||
163454960|NCT01371981|590363480|FG001|Overall Study|Lack of Efficacy|61|||
163454961|NCT01371981|590363481|FG002|Overall Study|Lack of Efficacy|4|||
163454962|NCT01371981|590363482|FG003|Overall Study|Lack of Efficacy|8|||
163454963|NCT01371981|590363483|FG004|Overall Study|Lack of Efficacy|5|||
163454964|NCT01371981|590363484|FG005|Overall Study|Lack of Efficacy|0|||
163454965|NCT01371981|590363479|FG000|Overall Study|Physician Decision|48|||
163454966|NCT01371981|590363480|FG001|Overall Study|Physician Decision|63|||
163454967|NCT01371981|590363481|FG002|Overall Study|Physician Decision|1|||
163454968|NCT01371981|590363482|FG003|Overall Study|Physician Decision|7|||
163454969|NCT01371981|590363483|FG004|Overall Study|Physician Decision|14|||
163454970|NCT01371981|590363484|FG005|Overall Study|Physician Decision|3|||
163454971|NCT01371981|590363479|FG000|Overall Study|Withdrawal by Subject|12|||
163454972|NCT01371981|590363480|FG001|Overall Study|Withdrawal by Subject|19|||
163454973|NCT01371981|590363481|FG002|Overall Study|Withdrawal by Subject|1|||
163454974|NCT01371981|590363482|FG003|Overall Study|Withdrawal by Subject|2|||
163454975|NCT01371981|590363483|FG004|Overall Study|Withdrawal by Subject|10|||
163454976|NCT01371981|590363484|FG005|Overall Study|Withdrawal by Subject|3|||
163454977|NCT01371981|590363479|FG000|Overall Study|Ineligible|19|||
163454978|NCT01371981|590363480|FG001|Overall Study|Ineligible|13|||
163454979|NCT01371981|590363481|FG002|Overall Study|Ineligible|0|||
163454980|NCT01371981|590363482|FG003|Overall Study|Ineligible|0|||
163454981|NCT01371981|590363483|FG004|Overall Study|Ineligible|0|||
163454982|NCT01371981|590363484|FG005|Overall Study|Ineligible|4|||
163454983|NCT01371981|590363479|FG000|Overall Study|Did not start treatment|2|||
163454984|NCT01371981|590363480|FG001|Overall Study|Did not start treatment|3|||
163454985|NCT01371981|590363481|FG002|Overall Study|Did not start treatment|0|||
163454986|NCT01371981|590363482|FG003|Overall Study|Did not start treatment|0|||
163454987|NCT01371981|590363483|FG004|Overall Study|Did not start treatment|0|||
163454988|NCT01371981|590363484|FG005|Overall Study|Did not start treatment|2|||
163454989|NCT02493426|590363485|FG000|Overall Study|Withdrawal by Subject|0|||
163454990|NCT02493426|590363486|FG001|Overall Study|Withdrawal by Subject|1|||
163454991|NCT01153893|590363488|FG000|Overall Study|Adverse Event|1|||
163454992|NCT01153893|590363489|FG001|Overall Study|Adverse Event|0|||
163454993|NCT00603980|590363490|FG000|Study Qualification|Protocol Violation|3|||
163454994|NCT00603980|590363490|FG000|Study Qualification|Inconsistent data reporting|13|||
163454995|NCT00603980|590363490|FG000|Main Study|14th subject completed trial|1|||
163454996|NCT01577160|590363491|FG000|Overall Study|Adverse Event|9|||
163454997|NCT01577160|590363491|FG000|Overall Study|Lack of Efficacy|15|||
163454998|NCT01577160|590363491|FG000|Overall Study|Lost to Follow-up|40|||
163454999|NCT01577160|590363491|FG000|Overall Study|Withdrawal by Subject|18|||
163455000|NCT01577160|590363491|FG000|Overall Study|Subject Uncooperative|7|||
163455001|NCT01577160|590363491|FG000|Overall Study|Other|9|||
163455002|NCT01341652|590363492|FG000|Overall Study|Incorrect Random Assignment|0|||
163455003|NCT01341652|590363493|FG001|Overall Study|Incorrect Random Assignment|1|||
163455004|NCT01341652|590363492|FG000|Overall Study|ineligible; presence metastatic disease|0|||
163455005|NCT01341652|590363493|FG001|Overall Study|ineligible; presence metastatic disease|1|||
163455006|NCT02618928|590363494|FG000|Overall Study|Failure to Return|28|||
163455007|NCT02618928|590363494|FG000|Overall Study|Insufficient Virological Response|1|||
163455008|NCT02618928|590363494|FG000|Overall Study|Withdrawal by Subject|2|||
163455009|NCT02618928|590363494|FG000|Overall Study|Death|3|||
163455010|NCT02618928|590363494|FG000|Overall Study|Other|11|||
163455011|NCT02618928|590363494|FG000|Overall Study|Missing|6|||
163455012|NCT02618928|590363494|FG000|Overall Study|Treatment Never Started|7|||
163455013|NCT01096849|590363499|FG000|Overall Study|Consent Withdrawn|1|||
163455014|NCT01096849|590363500|FG001|Overall Study|Consent Withdrawn|4|||
163455015|NCT01096849|590363501|FG002|Overall Study|Consent Withdrawn|2|||
163455016|NCT01096849|590363499|FG000|Overall Study|Lack of Efficacy|0|||
163455017|NCT01096849|590363500|FG001|Overall Study|Lack of Efficacy|2|||
163455018|NCT01096849|590363501|FG002|Overall Study|Lack of Efficacy|0|||
163455019|NCT01096849|590363499|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
163455020|NCT01096849|590363500|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
163455021|NCT01096849|590363501|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
163455022|NCT01096849|590363499|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
163455023|NCT01096849|590363500|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
163455024|NCT01096849|590363501|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
163455025|NCT01096849|590363499|FG000|Overall Study|Administrative Reasons|0|||
163455026|NCT01096849|590363500|FG001|Overall Study|Administrative Reasons|1|||
163455027|NCT01096849|590363501|FG002|Overall Study|Administrative Reasons|2|||
163455028|NCT01096849|590363499|FG000|Overall Study|Lost to Follow-up|1|||
163455029|NCT01096849|590363500|FG001|Overall Study|Lost to Follow-up|3|||
163455030|NCT01096849|590363501|FG002|Overall Study|Lost to Follow-up|1|||
163455031|NCT00118482|590363502|FG000|Overall Study|Lost to Follow-up|7|||
163455032|NCT00118482|590363503|FG001|Overall Study|Lost to Follow-up|7|||
163455033|NCT00118482|590363502|FG000|Overall Study|Withdrawal by Subject|23|||
163455034|NCT00118482|590363503|FG001|Overall Study|Withdrawal by Subject|22|||
163455035|NCT04146467|590363504|FG000|Overall Study|Adverse Event|0|||
163455036|NCT04146467|590363505|FG001|Overall Study|Adverse Event|1|||
163455037|NCT04146467|590363504|FG000|Overall Study|Lost to Follow-up|0|||
163455038|NCT04146467|590363505|FG001|Overall Study|Lost to Follow-up|2|||
163455039|NCT02953782|590363508|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
163455040|NCT02953782|590363509|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
163455041|NCT02953782|590363510|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
163455042|NCT02953782|590363511|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
163455043|NCT02953782|590363512|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
163455044|NCT02953782|590363513|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
163455045|NCT02953782|590363514|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
163455046|NCT02953782|590363515|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
163455047|NCT02953782|590363508|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
163455048|NCT02953782|590363509|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
163455049|NCT02953782|590363510|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
163455050|NCT02953782|590363511|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
163455051|NCT02953782|590363512|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
163455052|NCT02953782|590363513|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
163455053|NCT02953782|590363514|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
163455054|NCT02953782|590363515|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
163455055|NCT02953782|590363508|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
163455056|NCT02953782|590363509|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
163455057|NCT02953782|590363510|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
163455058|NCT02953782|590363511|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
163455059|NCT02953782|590363512|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
163455060|NCT02953782|590363513|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
163455061|NCT02953782|590363514|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
163455062|NCT02953782|590363515|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
163455063|NCT02953782|590363508|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
163455064|NCT02953782|590363509|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
163455065|NCT02953782|590363510|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
163455066|NCT02953782|590363511|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
163455067|NCT02953782|590363512|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
163455068|NCT02953782|590363513|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
163455069|NCT02953782|590363514|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
163455070|NCT02953782|590363515|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
163455071|NCT02953782|590363508|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
163455072|NCT02953782|590363509|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
163455073|NCT02953782|590363510|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
163455074|NCT02953782|590363511|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
163455075|NCT02953782|590363512|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
163455076|NCT02953782|590363513|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
163455077|NCT02953782|590363514|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
163455078|NCT02953782|590363515|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
163455079|NCT02953782|590363508|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
163455080|NCT02953782|590363509|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
163455081|NCT02953782|590363510|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
163455082|NCT02953782|590363511|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
163455083|NCT02953782|590363512|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
163455084|NCT02953782|590363513|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
163455085|NCT02953782|590363514|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
163455086|NCT02953782|590363515|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
163455087|NCT02953782|590363508|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
163455088|NCT02953782|590363509|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
163455089|NCT02953782|590363510|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
163455090|NCT02953782|590363511|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
163455091|NCT02953782|590363512|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
163455092|NCT02953782|590363513|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
163455093|NCT02953782|590363514|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
163455094|NCT02953782|590363515|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
163455095|NCT02953782|590363508|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
163455096|NCT02953782|590363509|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
163455097|NCT02953782|590363510|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
163455098|NCT02953782|590363511|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
163455099|NCT02953782|590363512|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
163455100|NCT02953782|590363513|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
163455101|NCT02953782|590363514|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
163455102|NCT02953782|590363515|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
163455103|NCT02128763|590363516|FG000|Overall Study|Death|1|||
163455104|NCT02128763|590363517|FG001|Overall Study|Death|0|||
163455105|NCT02128763|590363516|FG000|Overall Study|Lost to Follow-up|19|||
163455106|NCT02128763|590363517|FG001|Overall Study|Lost to Follow-up|16|||
163455107|NCT01934192|590363520|FG000|Overall Study|Protocol Violation|0|||
163455108|NCT01934192|590363521|FG001|Overall Study|Protocol Violation|0|||
163455109|NCT01934192|590363522|FG002|Overall Study|Protocol Violation|0|||
163455110|NCT01934192|590363523|FG003|Overall Study|Protocol Violation|1|||
163455111|NCT01934192|590363520|FG000|Overall Study|Other: reached stopping criteria|6|||
163455112|NCT01934192|590363521|FG001|Overall Study|Other: reached stopping criteria|5|||
163455113|NCT01934192|590363522|FG002|Overall Study|Other: reached stopping criteria|1|||
163455114|NCT01934192|590363523|FG003|Overall Study|Other: reached stopping criteria|0|||
163455115|NCT01934192|590363520|FG000|Overall Study|Physician Decision|3|||
163455116|NCT01934192|590363521|FG001|Overall Study|Physician Decision|2|||
163455117|NCT01934192|590363522|FG002|Overall Study|Physician Decision|0|||
163455118|NCT01934192|590363523|FG003|Overall Study|Physician Decision|0|||
163455119|NCT01189435|590363524|FG000|Overall Study|Withdrawal by Subject|1|||
163455120|NCT01189435|590363524|FG000|Overall Study|Physician Decision|1|||
163455121|NCT02357849|590363525|FG000|Overall Study|Withdrawal by Subject|2|||
163455122|NCT02357849|590363526|FG001|Overall Study|Withdrawal by Subject|3|||
163455123|NCT03105700|590363529|FG000|Overall Study|screen fail|3|||
163455124|NCT03105700|590363529|FG000|Overall Study|Lost to Follow-up|4|||
163455125|NCT01253421|590363530|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
163455126|NCT01253421|590363531|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
163455127|NCT01253421|590363532|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
163455128|NCT01253421|590363533|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
163455129|NCT01253421|590363534|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
163455130|NCT01253421|590363530|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
163455131|NCT01253421|590363531|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
163455132|NCT01253421|590363532|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
163455133|NCT01253421|590363533|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
163455134|NCT01253421|590363534|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
163455135|NCT01253421|590363530|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
163455136|NCT01253421|590363531|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
163455137|NCT01253421|590363532|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
163455138|NCT01253421|590363533|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
163455139|NCT01253421|590363534|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
163455140|NCT01253421|590363530|FG000|Assessment and Scheduling|Physician Decision|1|||
163455141|NCT01253421|590363531|FG001|Assessment and Scheduling|Physician Decision|0|||
163455142|NCT01253421|590363532|FG002|Assessment and Scheduling|Physician Decision|0|||
163455143|NCT01253421|590363533|FG003|Assessment and Scheduling|Physician Decision|0|||
163455144|NCT01253421|590363534|FG004|Assessment and Scheduling|Physician Decision|0|||
163455145|NCT01253421|590363530|FG000|Drug+Scanning Visit|Physician Decision|0|||
163455146|NCT01253421|590363531|FG001|Drug+Scanning Visit|Physician Decision|0|||
163455147|NCT01253421|590363532|FG002|Drug+Scanning Visit|Physician Decision|0|||
163455148|NCT01253421|590363533|FG003|Drug+Scanning Visit|Physician Decision|0|||
163455149|NCT01253421|590363534|FG004|Drug+Scanning Visit|Physician Decision|1|||
163455150|NCT04105244|590363535|FG000|Overall Study|Withdrawal by Subject|10|||
163455151|NCT04105244|590363536|FG001|Overall Study|Withdrawal by Subject|12|||
163455152|NCT04105244|590363535|FG000|Overall Study|Lost to Follow-up|20|||
163455153|NCT04105244|590363536|FG001|Overall Study|Lost to Follow-up|15|||
163455154|NCT04105244|590363535|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
163455155|NCT04105244|590363536|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
163455156|NCT04105244|590363535|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
163455157|NCT04105244|590363536|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
163455158|NCT01608724|590363538|FG000|Overall Study|Withdrawal by Subject|131|||
163455159|NCT01608724|590363538|FG000|Overall Study|Lost to Follow-up|41|||
163455160|NCT01608724|590363538|FG000|Overall Study|Study-specific discontinuation criteria|32|||
163455161|NCT01608724|590363538|FG000|Overall Study|Adverse Event|29|||
163455162|NCT01608724|590363538|FG000|Overall Study|Protocol Violation|6|||
163455163|NCT01608724|590363538|FG000|Overall Study|bood sugar too high, etc.|3|||
163455164|NCT01608724|590363538|FG000|Overall Study|Safety reasons|1|||
163455165|NCT00099359|590363539|FG000|Overall Study|Death|11|||
163455166|NCT00099359|590363540|FG001|Overall Study|Death|15|||
163455167|NCT00099359|590363541|FG002|Overall Study|Death|17|||
163455168|NCT00099359|590363539|FG000|Overall Study|Withdrawal by Subject|19|||
163455169|NCT00099359|590363540|FG001|Overall Study|Withdrawal by Subject|19|||
163455170|NCT00099359|590363541|FG002|Overall Study|Withdrawal by Subject|23|||
163455171|NCT00099359|590363539|FG000|Overall Study|Lost to Follow-up|15|||
163455172|NCT00099359|590363540|FG001|Overall Study|Lost to Follow-up|24|||
163455173|NCT00099359|590363541|FG002|Overall Study|Lost to Follow-up|24|||
163455174|NCT00099359|590363539|FG000|Overall Study|moved out of area|9|||
163455175|NCT00099359|590363540|FG001|Overall Study|moved out of area|7|||
163455176|NCT00099359|590363541|FG002|Overall Study|moved out of area|4|||
163455177|NCT00717366|590363542|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
163455178|NCT00717366|590363543|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
163455179|NCT00717366|590363542|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
163455180|NCT00717366|590363543|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
163455181|NCT00717366|590363542|FG000|Core Study Period (20 Weeks)|Death|0|||
163455182|NCT00717366|590363543|FG001|Core Study Period (20 Weeks)|Death|1|||
163455183|NCT00717366|590363542|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
163455184|NCT00717366|590363543|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
163455185|NCT00717366|590363542|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
163455186|NCT00717366|590363543|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
163455187|NCT00717366|590363542|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
163455188|NCT00717366|590363543|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
163455189|NCT00717366|590363542|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
163455190|NCT00717366|590363543|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
163455191|NCT02104804|590363546|FG000|Overall Study|Did not take study medication|0|||
163455192|NCT02104804|590363547|FG001|Overall Study|Did not take study medication|1|||
163455193|NCT02104804|590363546|FG000|Overall Study|Study specific discontinuation criteria|6|||
163455194|NCT02104804|590363547|FG001|Overall Study|Study specific discontinuation criteria|1|||
163455195|NCT02104804|590363546|FG000|Overall Study|Other listed|2|||
163455196|NCT02104804|590363547|FG001|Overall Study|Other listed|1|||
163455197|NCT02104804|590363546|FG000|Overall Study|Protocol Violation|0|||
163455198|NCT02104804|590363547|FG001|Overall Study|Protocol Violation|1|||
163455199|NCT02104804|590363546|FG000|Overall Study|Adverse Event|4|||
163455200|NCT02104804|590363547|FG001|Overall Study|Adverse Event|3|||
163455201|NCT02104804|590363546|FG000|Overall Study|Withdrawal by Subject|4|||
163455202|NCT02104804|590363547|FG001|Overall Study|Withdrawal by Subject|12|||
163455203|NCT00645567|590363548|FG000|Overall Study|Adverse Event|1|||
163455204|NCT01364233|590363549|FG000|Overall Study|Lost to Follow-up|1|||
163455205|NCT00406783|590363550|FG000|Overall Study|Adverse Event|4|||
163455206|NCT00406783|590363551|FG001|Overall Study|Adverse Event|4|||
163455207|NCT00406783|590363550|FG000|Overall Study|Treatment Failure|2|||
163455208|NCT00406783|590363551|FG001|Overall Study|Treatment Failure|3|||
163455209|NCT00406783|590363550|FG000|Overall Study|Lost to Follow-up|3|||
163455210|NCT00406783|590363551|FG001|Overall Study|Lost to Follow-up|0|||
163455211|NCT00406783|590363550|FG000|Overall Study|Withdrawal by Subject|1|||
163455212|NCT00406783|590363551|FG001|Overall Study|Withdrawal by Subject|4|||
163455213|NCT00406783|590363550|FG000|Overall Study|Protocol Violation|4|||
163455214|NCT00406783|590363551|FG001|Overall Study|Protocol Violation|4|||
163455215|NCT02034474|590363552|FG000|Overall Study|Adverse Event|3|||
163455216|NCT02034474|590363553|FG001|Overall Study|Adverse Event|2|||
163455217|NCT02034474|590363552|FG000|Overall Study|Withdrawal by Subject|1|||
163455218|NCT02034474|590363553|FG001|Overall Study|Withdrawal by Subject|2|||
163455219|NCT01391819|590363554|FG000|Overall Study|Withdrawal by Subject|56|||
163455220|NCT01391819|590363554|FG000|Overall Study|Migrated/moved from study area|82|||
163455221|NCT01391819|590363554|FG000|Overall Study|Lost to Follow-up|252|||
163455222|NCT01391819|590363554|FG000|Overall Study|Death|3|||
163455223|NCT01391819|590363554|FG000|Overall Study|Other|9|||
163455224|NCT00995670|590363556|FG000|Overall Study|Failed arterial cannulation|1|||
163455225|NCT00995670|590363557|FG001|Overall Study|Failed arterial cannulation|0|||
163455226|NCT00995670|590363558|FG002|Overall Study|Failed arterial cannulation|3|||
163455227|NCT00675103|590363559|FG000|Overall Study|Lack of Efficacy|2|||
163455228|NCT00675103|590363559|FG000|Overall Study|Adverse Event|1|||
163455229|NCT01810042|590363562|FG000|Overall Study|Lost to Follow-up|10|||
163455230|NCT01208038|590363565|FG000|Overall Study|Withdrawal by Subject|1|||
163455231|NCT04092816|590365617|FG000|Overall Study|Lost to Follow-up|1|||
163455232|NCT04092816|590365618|FG001|Overall Study|Lost to Follow-up|2|||
163455233|NCT01337167|590365619|FG000|Infant Series|Adverse Event|1|||
163455234|NCT01337167|590365620|FG001|Infant Series|Adverse Event|1|||
163455235|NCT01337167|590365619|FG000|Infant Series|Death|1|||
163455236|NCT01337167|590365620|FG001|Infant Series|Death|1|||
163455237|NCT01337167|590365619|FG000|Infant Series|Lost to Follow-up|13|||
163455238|NCT01337167|590365620|FG001|Infant Series|Lost to Follow-up|7|||
163455239|NCT01337167|590365619|FG000|Infant Series|Non-compliance with study drug|2|||
163455240|NCT01337167|590365620|FG001|Infant Series|Non-compliance with study drug|1|||
163455241|NCT01337167|590365619|FG000|Infant Series|Physician Decision|3|||
163455242|NCT01337167|590365620|FG001|Infant Series|Physician Decision|1|||
163455243|NCT01337167|590365619|FG000|Infant Series|Protocol Violation|22|||
163455244|NCT01337167|590365620|FG001|Infant Series|Protocol Violation|9|||
163455245|NCT01337167|590365619|FG000|Infant Series|Withdrawal by Subject|15|||
163455246|NCT01337167|590365620|FG001|Infant Series|Withdrawal by Subject|4|||
163455247|NCT01337167|590365619|FG000|Infant Series|Randomized but not vaccinated|5|||
163455248|NCT01337167|590365620|FG001|Infant Series|Randomized but not vaccinated|3|||
163455249|NCT01337167|590365619|FG000|Interim Period|Lost to Follow-up|51|||
163455250|NCT01337167|590365620|FG001|Interim Period|Lost to Follow-up|23|||
163455251|NCT01337167|590365619|FG000|Interim Period|Non-compliance with study drug|1|||
163455252|NCT01337167|590365620|FG001|Interim Period|Non-compliance with study drug|0|||
163455253|NCT01337167|590365619|FG000|Interim Period|Physician Decision|6|||
163455254|NCT01337167|590365620|FG001|Interim Period|Physician Decision|3|||
163455255|NCT01337167|590365619|FG000|Interim Period|Protocol Violation|5|||
163455256|NCT01337167|590365620|FG001|Interim Period|Protocol Violation|3|||
163455257|NCT01337167|590365619|FG000|Interim Period|Withdrawal by Subject|18|||
163455258|NCT01337167|590365620|FG001|Interim Period|Withdrawal by Subject|10|||
163455259|NCT01337167|590365619|FG000|Interim Period|Other protocol criterion not met|0|||
163455260|NCT01337167|590365620|FG001|Interim Period|Other protocol criterion not met|1|||
163455261|NCT01337167|590365619|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
163455262|NCT01337167|590365620|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
163455263|NCT01337167|590365619|FG000|Toddler Vaccinations|Protocol Violation|0|||
163455264|NCT01337167|590365620|FG001|Toddler Vaccinations|Protocol Violation|1|||
163455265|NCT01337167|590365619|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
163455266|NCT01337167|590365620|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
163455267|NCT03833817|590365621|FG000|Overall Study|Withdrawal by Subject|3|||
163455268|NCT03833817|590365622|FG001|Overall Study|Withdrawal by Subject|3|||
163455269|NCT03833817|590365621|FG000|Overall Study|Lost to Follow-up|3|||
163455270|NCT03833817|590365622|FG001|Overall Study|Lost to Follow-up|3|||
163455271|NCT02126670|590365627|FG000|Overall Study|Withdrawal by Subject|1|||
163455272|NCT02126670|590365628|FG001|Overall Study|Withdrawal by Subject|0|||
163455273|NCT02126670|590365629|FG002|Overall Study|Withdrawal by Subject|0|||
163455274|NCT02126670|590365630|FG003|Overall Study|Withdrawal by Subject|1|||
163455275|NCT03363919|590365633|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
163455276|NCT03363919|590365634|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
163455277|NCT03363919|590365633|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
163455278|NCT03363919|590365634|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
163455279|NCT01975246|590365635|FG000|Overall Study|Adverse Event|2|||
163455280|NCT01975246|590365636|FG001|Overall Study|Adverse Event|1|||
163455281|NCT01975246|590365635|FG000|Overall Study|Lack of Efficacy|1|||
163455282|NCT01975246|590365636|FG001|Overall Study|Lack of Efficacy|0|||
163455283|NCT01975246|590365635|FG000|Overall Study|Protocol Violation|1|||
163455284|NCT01975246|590365636|FG001|Overall Study|Protocol Violation|0|||
163455285|NCT01975246|590365635|FG000|Overall Study|Other than stated|0|||
163455286|NCT01975246|590365636|FG001|Overall Study|Other than stated|1|||
163455287|NCT01646398|590365637|FG000|Overall Study|Withdrawal by Subject|1|||
163455288|NCT01646398|590365638|FG001|Overall Study|Withdrawal by Subject|0|||
163455289|NCT01827319|590365639|FG000|Overall Study|Lost to Follow-up|3|||
163455290|NCT00574119|590365640|FG000|Overall Study|Adverse Event|1|||
163455291|NCT00574119|590365640|FG000|Overall Study|Protocol Violation|1|||
163455292|NCT00574119|590365640|FG000|Overall Study|Withdrawal by Subject|1|||
163455293|NCT00574119|590365640|FG000|Overall Study|Physician Decision|1|||
163455294|NCT03287245|590365641|FG000|Overall Study|Study terminated by sponsor|3|||
163455295|NCT03287245|590365642|FG001|Overall Study|Study terminated by sponsor|0|||
163455296|NCT03287245|590365643|FG002|Overall Study|Study terminated by sponsor|3|||
163455297|NCT03287245|590365644|FG003|Overall Study|Study terminated by sponsor|1|||
163455298|NCT03287245|590365641|FG000|Overall Study|Adverse Event|1|||
163455299|NCT03287245|590365642|FG001|Overall Study|Adverse Event|0|||
163455300|NCT03287245|590365643|FG002|Overall Study|Adverse Event|0|||
163455301|NCT03287245|590365644|FG003|Overall Study|Adverse Event|0|||
163455302|NCT03287245|590365641|FG000|Overall Study|Withdrawal by Subject|8|||
163455303|NCT03287245|590365642|FG001|Overall Study|Withdrawal by Subject|3|||
163455304|NCT03287245|590365643|FG002|Overall Study|Withdrawal by Subject|3|||
163455305|NCT03287245|590365644|FG003|Overall Study|Withdrawal by Subject|0|||
163455306|NCT03287245|590365641|FG000|Overall Study|Physician Decision|3|||
163455307|NCT03287245|590365642|FG001|Overall Study|Physician Decision|2|||
163455308|NCT03287245|590365643|FG002|Overall Study|Physician Decision|0|||
163455309|NCT03287245|590365644|FG003|Overall Study|Physician Decision|0|||
163455310|NCT02862548|590365645|FG000|Randomized Phase (Up to Week 48)|Death|0|||
163455311|NCT02862548|590365646|FG001|Randomized Phase (Up to Week 48)|Death|1|||
163455312|NCT02862548|590365645|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
163455313|NCT02862548|590365646|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
163455314|NCT02862548|590365645|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
163455315|NCT02862548|590365646|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
163455316|NCT02862548|590365645|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
163455317|NCT02862548|590365646|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
163455318|NCT00880763|590365647|FG000|Extension Period (Part 2)|Adverse Event|0|||
163455319|NCT00880763|590365648|FG001|Extension Period (Part 2)|Adverse Event|0|||
163455320|NCT00880763|590365649|FG002|Extension Period (Part 2)|Adverse Event|1|||
163455321|NCT00880763|590365650|FG003|Extension Period (Part 2)|Adverse Event|1|||
163455322|NCT00880763|590365647|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
163455323|NCT00880763|590365648|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
163455324|NCT00880763|590365649|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
163455325|NCT00880763|590365650|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
163455326|NCT00880763|590365647|FG000|Extension Period (Part 2)|Physician Decision|0|||
163455327|NCT00880763|590365648|FG001|Extension Period (Part 2)|Physician Decision|1|||
163455328|NCT00880763|590365649|FG002|Extension Period (Part 2)|Physician Decision|1|||
163455329|NCT00880763|590365650|FG003|Extension Period (Part 2)|Physician Decision|0|||
163455330|NCT00880763|590365647|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
163455331|NCT00880763|590365648|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
163455332|NCT00880763|590365649|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
163455333|NCT00880763|590365650|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
163455334|NCT03057951|590365657|FG000|Overall Study|Adverse Event|553|||
163455335|NCT03057951|590365658|FG001|Overall Study|Adverse Event|575|||
163455336|NCT03057951|590365657|FG000|Overall Study|Protocol Violation|30|||
163455337|NCT03057951|590365658|FG001|Overall Study|Protocol Violation|24|||
163455338|NCT03057951|590365657|FG000|Overall Study|Lost to Follow-up|6|||
163455339|NCT03057951|590365658|FG001|Overall Study|Lost to Follow-up|16|||
163455340|NCT03057951|590365657|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
163455341|NCT03057951|590365658|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
163455342|NCT03057951|590365657|FG000|Overall Study|Study drug stopped, reason missing|6|||
163455343|NCT03057951|590365658|FG001|Overall Study|Study drug stopped, reason missing|1|||
163455344|NCT03057951|590365657|FG000|Overall Study|Medical advice|6|||
163455345|NCT03057951|590365658|FG001|Overall Study|Medical advice|2|||
163455346|NCT03057951|590365657|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
163455347|NCT03057951|590365658|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
163455348|NCT03057951|590365657|FG000|Overall Study|Investigator decision|2|||
163455349|NCT03057951|590365658|FG001|Overall Study|Investigator decision|0|||
163455350|NCT03057951|590365657|FG000|Overall Study|Patient decision|5|||
163455351|NCT03057951|590365658|FG001|Overall Study|Patient decision|2|||
163455352|NCT03057951|590365657|FG000|Overall Study|Not attending study visits|3|||
163455353|NCT03057951|590365658|FG001|Overall Study|Not attending study visits|0|||
163455354|NCT03057951|590365657|FG000|Overall Study|Patient moved away|3|||
163455355|NCT03057951|590365658|FG001|Overall Study|Patient moved away|4|||
163455356|NCT03057951|590365657|FG000|Overall Study|Other reason than stated above|23|||
163455357|NCT03057951|590365658|FG001|Overall Study|Other reason than stated above|29|||
163455358|NCT03057951|590365657|FG000|Overall Study|Not treated|2|||
163455359|NCT03057951|590365658|FG001|Overall Study|Not treated|1|||
163455360|NCT00696436|590365659|FG000|Overall Study|Adverse Event|7|||
163455361|NCT00696436|590365660|FG001|Overall Study|Adverse Event|9|||
163455362|NCT00696436|590365661|FG002|Overall Study|Adverse Event|8|||
163455363|NCT00696436|590365662|FG003|Overall Study|Adverse Event|6|||
163455364|NCT00696436|590365663|FG004|Overall Study|Adverse Event|4|||
163455365|NCT00696436|590365659|FG000|Overall Study|Protocol Violation|3|||
163455366|NCT00696436|590365660|FG001|Overall Study|Protocol Violation|2|||
163455367|NCT00696436|590365661|FG002|Overall Study|Protocol Violation|2|||
163455368|NCT00696436|590365662|FG003|Overall Study|Protocol Violation|0|||
163455369|NCT00696436|590365663|FG004|Overall Study|Protocol Violation|1|||
163455370|NCT00696436|590365659|FG000|Overall Study|Lost to Follow-up|1|||
163455371|NCT00696436|590365660|FG001|Overall Study|Lost to Follow-up|6|||
163455372|NCT00696436|590365661|FG002|Overall Study|Lost to Follow-up|2|||
163455373|NCT00696436|590365662|FG003|Overall Study|Lost to Follow-up|4|||
163455374|NCT00696436|590365663|FG004|Overall Study|Lost to Follow-up|3|||
163455375|NCT00696436|590365659|FG000|Overall Study|Withdrawal by Subject|4|||
163455376|NCT00696436|590365660|FG001|Overall Study|Withdrawal by Subject|11|||
163455377|NCT00696436|590365661|FG002|Overall Study|Withdrawal by Subject|5|||
163455378|NCT00696436|590365662|FG003|Overall Study|Withdrawal by Subject|7|||
163455379|NCT00696436|590365663|FG004|Overall Study|Withdrawal by Subject|1|||
163455380|NCT00696436|590365659|FG000|Overall Study|Lack of Efficacy|3|||
163455381|NCT00696436|590365660|FG001|Overall Study|Lack of Efficacy|1|||
163455382|NCT00696436|590365661|FG002|Overall Study|Lack of Efficacy|5|||
163455383|NCT00696436|590365662|FG003|Overall Study|Lack of Efficacy|2|||
163455384|NCT00696436|590365663|FG004|Overall Study|Lack of Efficacy|4|||
163455385|NCT00696436|590365659|FG000|Overall Study|Participant Unavailability|2|||
163455386|NCT00696436|590365660|FG001|Overall Study|Participant Unavailability|0|||
163455387|NCT00696436|590365661|FG002|Overall Study|Participant Unavailability|2|||
163455388|NCT00696436|590365662|FG003|Overall Study|Participant Unavailability|1|||
163455389|NCT00696436|590365663|FG004|Overall Study|Participant Unavailability|0|||
163455390|NCT00696436|590365659|FG000|Overall Study|Administrative Error|2|||
163455391|NCT00696436|590365660|FG001|Overall Study|Administrative Error|0|||
163455392|NCT00696436|590365661|FG002|Overall Study|Administrative Error|2|||
163455393|NCT00696436|590365662|FG003|Overall Study|Administrative Error|0|||
163455394|NCT00696436|590365663|FG004|Overall Study|Administrative Error|0|||
163455395|NCT00696436|590365659|FG000|Overall Study|Participant Non-compliance|0|||
163455396|NCT00696436|590365660|FG001|Overall Study|Participant Non-compliance|0|||
163455397|NCT00696436|590365661|FG002|Overall Study|Participant Non-compliance|1|||
163455398|NCT00696436|590365662|FG003|Overall Study|Participant Non-compliance|2|||
163455399|NCT00696436|590365663|FG004|Overall Study|Participant Non-compliance|0|||
163455400|NCT00696436|590365659|FG000|Overall Study|Administrative Decision|1|||
163455401|NCT00696436|590365660|FG001|Overall Study|Administrative Decision|0|||
163455402|NCT00696436|590365661|FG002|Overall Study|Administrative Decision|0|||
163455403|NCT00696436|590365662|FG003|Overall Study|Administrative Decision|0|||
163455404|NCT00696436|590365663|FG004|Overall Study|Administrative Decision|0|||
163455405|NCT00696436|590365659|FG000|Overall Study|Missing|0|||
163455406|NCT00696436|590365660|FG001|Overall Study|Missing|1|||
163455407|NCT00696436|590365661|FG002|Overall Study|Missing|1|||
163455408|NCT00696436|590365662|FG003|Overall Study|Missing|0|||
163455409|NCT00696436|590365663|FG004|Overall Study|Missing|0|||
163455410|NCT01293006|590365668|FG000|Period 2|Lost to Follow-up|1|||
163455411|NCT01293006|590365669|FG001|Period 2|Lost to Follow-up|0|||
163455412|NCT01293006|590365670|FG002|Period 2|Lost to Follow-up|0|||
163455413|NCT01293006|590365671|FG003|Period 2|Lost to Follow-up|0|||
163455414|NCT00600028|590365679|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
163455415|NCT00600028|590365680|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
163455416|NCT00600028|590365679|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
163455417|NCT00600028|590365680|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
163455418|NCT00600028|590365679|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
163455419|NCT00600028|590365680|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
163455420|NCT01830816|590365681|FG000|Overall Study|Progressive Disease|12|||
163455421|NCT01830816|590365682|FG001|Overall Study|Progressive Disease|7|||
163455422|NCT01830816|590365683|FG002|Overall Study|Progressive Disease|7|||
163455423|NCT01830816|590365681|FG000|Overall Study|Adverse Event|3|||
163455424|NCT01830816|590365682|FG001|Overall Study|Adverse Event|4|||
163455425|NCT01830816|590365683|FG002|Overall Study|Adverse Event|0|||
163455426|NCT01830816|590365681|FG000|Overall Study|Study Terminated by Sponsor|1|||
163455427|NCT01830816|590365682|FG001|Overall Study|Study Terminated by Sponsor|1|||
163455428|NCT01830816|590365683|FG002|Overall Study|Study Terminated by Sponsor|0|||
163455429|NCT01830816|590365681|FG000|Overall Study|Withdrawal by Subject|1|||
163455430|NCT01830816|590365682|FG001|Overall Study|Withdrawal by Subject|1|||
163455431|NCT01830816|590365683|FG002|Overall Study|Withdrawal by Subject|0|||
163455432|NCT01830816|590365681|FG000|Overall Study|Lost to Follow-up|0|||
163455433|NCT01830816|590365682|FG001|Overall Study|Lost to Follow-up|1|||
163455434|NCT01830816|590365683|FG002|Overall Study|Lost to Follow-up|0|||
163455435|NCT01830816|590365681|FG000|Overall Study|Symptomatic Deterioration|1|||
163455436|NCT01830816|590365682|FG001|Overall Study|Symptomatic Deterioration|0|||
163455437|NCT01830816|590365683|FG002|Overall Study|Symptomatic Deterioration|0|||
163455438|NCT01830816|590365681|FG000|Overall Study|Reason not Specified|2|||
163455439|NCT01830816|590365682|FG001|Overall Study|Reason not Specified|0|||
163455440|NCT01830816|590365683|FG002|Overall Study|Reason not Specified|0|||
163455441|NCT01754922|590365689|FG000|Overall Study|Adverse Event|0|||
163455442|NCT01754922|590365690|FG001|Overall Study|Adverse Event|1|||
163455443|NCT01885078|590365693|FG000|Treatment Period|Adverse Event|52|||
163455444|NCT01885078|590365694|FG001|Treatment Period|Adverse Event|136|||
163455445|NCT01885078|590365695|FG002|Treatment Period|Adverse Event|30|||
163455446|NCT01885078|590365696|FG003|Treatment Period|Adverse Event|73|||
163455447|NCT01885078|590365697|FG004|Treatment Period|Adverse Event|17|||
163455448|NCT01885078|590365698|FG005|Treatment Period|Adverse Event|72|||
163455449|NCT01885078|590365699|FG006|Treatment Period|Adverse Event|24|||
163455450|NCT01885078|590365700|FG007|Treatment Period|Adverse Event|5|||
163455451|NCT01885078|590365701|FG008|Treatment Period|Adverse Event|0|||
163455452|NCT01885078|590365702|FG009|Treatment Period|Adverse Event|0|||
163455453|NCT01885078|590365693|FG000|Treatment Period|Death|13|||
163455454|NCT01885078|590365694|FG001|Treatment Period|Death|33|||
163455455|NCT01885078|590365695|FG002|Treatment Period|Death|5|||
163455456|NCT01885078|590365696|FG003|Treatment Period|Death|9|||
163455457|NCT01885078|590365697|FG004|Treatment Period|Death|2|||
163455458|NCT01885078|590365698|FG005|Treatment Period|Death|10|||
163455459|NCT01885078|590365699|FG006|Treatment Period|Death|3|||
163455460|NCT01885078|590365700|FG007|Treatment Period|Death|2|||
163455461|NCT01885078|590365701|FG008|Treatment Period|Death|0|||
163455462|NCT01885078|590365702|FG009|Treatment Period|Death|0|||
163455463|NCT01885078|590365693|FG000|Treatment Period|Lack of Efficacy|12|||
163455464|NCT01885078|590365694|FG001|Treatment Period|Lack of Efficacy|33|||
163455465|NCT01885078|590365695|FG002|Treatment Period|Lack of Efficacy|10|||
163455466|NCT01885078|590365696|FG003|Treatment Period|Lack of Efficacy|23|||
163455467|NCT01885078|590365697|FG004|Treatment Period|Lack of Efficacy|24|||
163455468|NCT01885078|590365698|FG005|Treatment Period|Lack of Efficacy|58|||
163455469|NCT01885078|590365699|FG006|Treatment Period|Lack of Efficacy|9|||
163455470|NCT01885078|590365700|FG007|Treatment Period|Lack of Efficacy|5|||
163455471|NCT01885078|590365701|FG008|Treatment Period|Lack of Efficacy|0|||
163455472|NCT01885078|590365702|FG009|Treatment Period|Lack of Efficacy|0|||
163455473|NCT01885078|590365693|FG000|Treatment Period|Lost to Follow-up|16|||
163455474|NCT01885078|590365694|FG001|Treatment Period|Lost to Follow-up|19|||
163455475|NCT01885078|590365695|FG002|Treatment Period|Lost to Follow-up|7|||
163455476|NCT01885078|590365696|FG003|Treatment Period|Lost to Follow-up|9|||
163455477|NCT01885078|590365697|FG004|Treatment Period|Lost to Follow-up|2|||
163455478|NCT01885078|590365698|FG005|Treatment Period|Lost to Follow-up|8|||
163455479|NCT01885078|590365699|FG006|Treatment Period|Lost to Follow-up|2|||
163455480|NCT01885078|590365700|FG007|Treatment Period|Lost to Follow-up|0|||
163455481|NCT01885078|590365701|FG008|Treatment Period|Lost to Follow-up|0|||
163455482|NCT01885078|590365702|FG009|Treatment Period|Lost to Follow-up|0|||
163455483|NCT01885078|590365693|FG000|Treatment Period|Physician Decision|19|||
163455484|NCT01885078|590365694|FG001|Treatment Period|Physician Decision|21|||
163455485|NCT01885078|590365695|FG002|Treatment Period|Physician Decision|5|||
163455486|NCT01885078|590365696|FG003|Treatment Period|Physician Decision|12|||
163455487|NCT01885078|590365697|FG004|Treatment Period|Physician Decision|9|||
163455488|NCT01885078|590365698|FG005|Treatment Period|Physician Decision|24|||
163455489|NCT01885078|590365699|FG006|Treatment Period|Physician Decision|4|||
163455490|NCT01885078|590365700|FG007|Treatment Period|Physician Decision|3|||
163455491|NCT01885078|590365701|FG008|Treatment Period|Physician Decision|0|||
163455492|NCT01885078|590365702|FG009|Treatment Period|Physician Decision|0|||
163455493|NCT01885078|590365693|FG000|Treatment Period|Protocol Violation|3|||
163455494|NCT01885078|590365694|FG001|Treatment Period|Protocol Violation|5|||
163455495|NCT01885078|590365695|FG002|Treatment Period|Protocol Violation|0|||
163455496|NCT01885078|590365696|FG003|Treatment Period|Protocol Violation|3|||
163455497|NCT01885078|590365697|FG004|Treatment Period|Protocol Violation|1|||
163455498|NCT01885078|590365698|FG005|Treatment Period|Protocol Violation|6|||
163455499|NCT01885078|590365699|FG006|Treatment Period|Protocol Violation|0|||
163455500|NCT01885078|590365700|FG007|Treatment Period|Protocol Violation|0|||
163455501|NCT01885078|590365701|FG008|Treatment Period|Protocol Violation|0|||
163455502|NCT01885078|590365702|FG009|Treatment Period|Protocol Violation|0|||
163455503|NCT01885078|590365693|FG000|Treatment Period|Sponsor Decision|245|||
163455504|NCT01885078|590365694|FG001|Treatment Period|Sponsor Decision|648|||
163455505|NCT01885078|590365695|FG002|Treatment Period|Sponsor Decision|49|||
163455506|NCT01885078|590365696|FG003|Treatment Period|Sponsor Decision|90|||
163455507|NCT01885078|590365697|FG004|Treatment Period|Sponsor Decision|20|||
163455508|NCT01885078|590365698|FG005|Treatment Period|Sponsor Decision|38|||
163455509|NCT01885078|590365699|FG006|Treatment Period|Sponsor Decision|162|||
163455510|NCT01885078|590365700|FG007|Treatment Period|Sponsor Decision|3|||
163455511|NCT01885078|590365701|FG008|Treatment Period|Sponsor Decision|0|||
163455512|NCT01885078|590365702|FG009|Treatment Period|Sponsor Decision|0|||
163455513|NCT01885078|590365693|FG000|Treatment Period|Withdrawal by Subject|72|||
163455514|NCT01885078|590365694|FG001|Treatment Period|Withdrawal by Subject|132|||
163455515|NCT01885078|590365695|FG002|Treatment Period|Withdrawal by Subject|25|||
163455516|NCT01885078|590365696|FG003|Treatment Period|Withdrawal by Subject|63|||
163455517|NCT01885078|590365697|FG004|Treatment Period|Withdrawal by Subject|15|||
163455518|NCT01885078|590365698|FG005|Treatment Period|Withdrawal by Subject|34|||
163455519|NCT01885078|590365699|FG006|Treatment Period|Withdrawal by Subject|17|||
163455520|NCT01885078|590365700|FG007|Treatment Period|Withdrawal by Subject|10|||
163455521|NCT01885078|590365701|FG008|Treatment Period|Withdrawal by Subject|0|||
163455522|NCT01885078|590365702|FG009|Treatment Period|Withdrawal by Subject|0|||
163455523|NCT01885078|590365693|FG000|Treatment Period|Other|0|||
163455524|NCT01885078|590365694|FG001|Treatment Period|Other|0|||
163455525|NCT01885078|590365695|FG002|Treatment Period|Other|0|||
163455526|NCT01885078|590365696|FG003|Treatment Period|Other|1|||
163455527|NCT01885078|590365697|FG004|Treatment Period|Other|0|||
163455528|NCT01885078|590365698|FG005|Treatment Period|Other|0|||
163455529|NCT01885078|590365699|FG006|Treatment Period|Other|0|||
163455530|NCT01885078|590365700|FG007|Treatment Period|Other|0|||
163455531|NCT01885078|590365701|FG008|Treatment Period|Other|0|||
163455532|NCT01885078|590365702|FG009|Treatment Period|Other|0|||
163455533|NCT01885078|590365693|FG000|Step-down Period|Sponsor Decision|0|||
163455534|NCT01885078|590365694|FG001|Step-down Period|Sponsor Decision|0|||
163455535|NCT01885078|590365695|FG002|Step-down Period|Sponsor Decision|0|||
163455536|NCT01885078|590365696|FG003|Step-down Period|Sponsor Decision|0|||
163455537|NCT01885078|590365697|FG004|Step-down Period|Sponsor Decision|0|||
163455538|NCT01885078|590365698|FG005|Step-down Period|Sponsor Decision|0|||
163455539|NCT01885078|590365699|FG006|Step-down Period|Sponsor Decision|0|||
163455540|NCT01885078|590365700|FG007|Step-down Period|Sponsor Decision|0|||
163455541|NCT01885078|590365701|FG008|Step-down Period|Sponsor Decision|1|||
163455542|NCT01885078|590365702|FG009|Step-down Period|Sponsor Decision|1|||
163455543|NCT01885078|590365693|FG000|Step-down Period|Adverse Event|0|||
163455544|NCT01885078|590365694|FG001|Step-down Period|Adverse Event|0|||
163455545|NCT01885078|590365695|FG002|Step-down Period|Adverse Event|0|||
163455546|NCT01885078|590365696|FG003|Step-down Period|Adverse Event|0|||
163455547|NCT01885078|590365697|FG004|Step-down Period|Adverse Event|0|||
163455548|NCT01885078|590365698|FG005|Step-down Period|Adverse Event|0|||
163455549|NCT01885078|590365699|FG006|Step-down Period|Adverse Event|0|||
163455550|NCT01885078|590365700|FG007|Step-down Period|Adverse Event|0|||
163455551|NCT01885078|590365701|FG008|Step-down Period|Adverse Event|29|||
163455552|NCT01885078|590365702|FG009|Step-down Period|Adverse Event|38|||
163455553|NCT01885078|590365693|FG000|Step-down Period|Withdrawal by Subject|0|||
163455554|NCT01885078|590365694|FG001|Step-down Period|Withdrawal by Subject|0|||
163455555|NCT01885078|590365695|FG002|Step-down Period|Withdrawal by Subject|0|||
163455556|NCT01885078|590365696|FG003|Step-down Period|Withdrawal by Subject|0|||
163455557|NCT01885078|590365697|FG004|Step-down Period|Withdrawal by Subject|0|||
163455558|NCT01885078|590365698|FG005|Step-down Period|Withdrawal by Subject|0|||
163455559|NCT01885078|590365699|FG006|Step-down Period|Withdrawal by Subject|0|||
163455560|NCT01885078|590365700|FG007|Step-down Period|Withdrawal by Subject|0|||
163455561|NCT01885078|590365701|FG008|Step-down Period|Withdrawal by Subject|25|||
163455562|NCT01885078|590365702|FG009|Step-down Period|Withdrawal by Subject|15|||
163455563|NCT01885078|590365693|FG000|Step-down Period|Physician Decision|0|||
163455564|NCT01885078|590365694|FG001|Step-down Period|Physician Decision|0|||
163455565|NCT01885078|590365695|FG002|Step-down Period|Physician Decision|0|||
163455566|NCT01885078|590365696|FG003|Step-down Period|Physician Decision|0|||
163455567|NCT01885078|590365697|FG004|Step-down Period|Physician Decision|0|||
163455568|NCT01885078|590365698|FG005|Step-down Period|Physician Decision|0|||
163455569|NCT01885078|590365699|FG006|Step-down Period|Physician Decision|0|||
163455570|NCT01885078|590365700|FG007|Step-down Period|Physician Decision|0|||
163455571|NCT01885078|590365701|FG008|Step-down Period|Physician Decision|7|||
163455572|NCT01885078|590365702|FG009|Step-down Period|Physician Decision|2|||
163455573|NCT01885078|590365693|FG000|Step-down Period|Death|0|||
163455574|NCT01885078|590365694|FG001|Step-down Period|Death|0|||
163455575|NCT01885078|590365695|FG002|Step-down Period|Death|0|||
163455576|NCT01885078|590365696|FG003|Step-down Period|Death|0|||
163455577|NCT01885078|590365697|FG004|Step-down Period|Death|0|||
163455578|NCT01885078|590365698|FG005|Step-down Period|Death|0|||
163455579|NCT01885078|590365699|FG006|Step-down Period|Death|0|||
163455580|NCT01885078|590365700|FG007|Step-down Period|Death|0|||
163455581|NCT01885078|590365701|FG008|Step-down Period|Death|4|||
163455582|NCT01885078|590365702|FG009|Step-down Period|Death|3|||
163455583|NCT01885078|590365693|FG000|Step-down Period|Lost to Follow-up|0|||
163455584|NCT01885078|590365694|FG001|Step-down Period|Lost to Follow-up|0|||
163455585|NCT01885078|590365695|FG002|Step-down Period|Lost to Follow-up|0|||
163455586|NCT01885078|590365696|FG003|Step-down Period|Lost to Follow-up|0|||
163455587|NCT01885078|590365697|FG004|Step-down Period|Lost to Follow-up|0|||
163455588|NCT01885078|590365698|FG005|Step-down Period|Lost to Follow-up|0|||
163455589|NCT01885078|590365699|FG006|Step-down Period|Lost to Follow-up|0|||
163455590|NCT01885078|590365700|FG007|Step-down Period|Lost to Follow-up|0|||
163455591|NCT01885078|590365701|FG008|Step-down Period|Lost to Follow-up|1|||
163455592|NCT01885078|590365702|FG009|Step-down Period|Lost to Follow-up|1|||
163455593|NCT01885078|590365693|FG000|Step-down Period|Lack of Efficacy|0|||
163455594|NCT01885078|590365694|FG001|Step-down Period|Lack of Efficacy|0|||
163455595|NCT01885078|590365695|FG002|Step-down Period|Lack of Efficacy|0|||
163455596|NCT01885078|590365696|FG003|Step-down Period|Lack of Efficacy|0|||
163455597|NCT01885078|590365697|FG004|Step-down Period|Lack of Efficacy|0|||
163455598|NCT01885078|590365698|FG005|Step-down Period|Lack of Efficacy|0|||
163455599|NCT01885078|590365699|FG006|Step-down Period|Lack of Efficacy|0|||
163455600|NCT01885078|590365700|FG007|Step-down Period|Lack of Efficacy|0|||
163455601|NCT01885078|590365701|FG008|Step-down Period|Lack of Efficacy|1|||
163455602|NCT01885078|590365702|FG009|Step-down Period|Lack of Efficacy|0|||
163455603|NCT01885078|590365693|FG000|Step-down Period|Protocol Violation|0|||
163455604|NCT01885078|590365694|FG001|Step-down Period|Protocol Violation|0|||
163455605|NCT01885078|590365695|FG002|Step-down Period|Protocol Violation|0|||
163455606|NCT01885078|590365696|FG003|Step-down Period|Protocol Violation|0|||
163455607|NCT01885078|590365697|FG004|Step-down Period|Protocol Violation|0|||
163455608|NCT01885078|590365698|FG005|Step-down Period|Protocol Violation|0|||
163455609|NCT01885078|590365699|FG006|Step-down Period|Protocol Violation|0|||
163455610|NCT01885078|590365700|FG007|Step-down Period|Protocol Violation|0|||
163455611|NCT01885078|590365701|FG008|Step-down Period|Protocol Violation|1|||
163455612|NCT01885078|590365702|FG009|Step-down Period|Protocol Violation|1|||
163455613|NCT02680587|590365703|FG000|Overall Study|Withdrawal by Subject|1|||
163455614|NCT02680587|590365704|FG001|Overall Study|Withdrawal by Subject|0|||
163455615|NCT00571688|590365708|FG000|Overall Study|Lost to Follow-up|3|||
163455616|NCT00571688|590365709|FG001|Overall Study|Lost to Follow-up|6|||
163455617|NCT00571688|590365708|FG000|Overall Study|subject did not tolerate Consta|1|||
163455618|NCT00571688|590365709|FG001|Overall Study|subject did not tolerate Consta|0|||
163455619|NCT00571688|590365708|FG000|Overall Study|subject moved out of the area|1|||
163455620|NCT00571688|590365709|FG001|Overall Study|subject moved out of the area|0|||
163455621|NCT01194869|590365710|FG000|Overall Study|Disease Progression|2|||
163455622|NCT01194869|590365710|FG000|Overall Study|Toxicity|2|||
163455623|NCT00259740|590365714|FG000|Overall Study|Physician Decision|1|||
163455624|NCT00259740|590365715|FG001|Overall Study|Physician Decision|1|||
163455625|NCT00259740|590365714|FG000|Overall Study|Adverse Event|0|||
163455626|NCT00259740|590365715|FG001|Overall Study|Adverse Event|2|||
163455627|NCT00259740|590365714|FG000|Overall Study|Withdrawal by Subject|2|||
163455628|NCT00259740|590365715|FG001|Overall Study|Withdrawal by Subject|6|||
163455629|NCT00259740|590365714|FG000|Overall Study|Death|1|||
163455630|NCT00259740|590365715|FG001|Overall Study|Death|1|||
163455631|NCT00259740|590365714|FG000|Overall Study|Disease progression|19|||
163455632|NCT00259740|590365715|FG001|Overall Study|Disease progression|36|||
163455633|NCT00259740|590365714|FG000|Overall Study|Ongoing|17|||
163455634|NCT00259740|590365715|FG001|Overall Study|Ongoing|3|||
163455635|NCT00259740|590365714|FG000|Overall Study|Other|3|||
163455636|NCT00259740|590365715|FG001|Overall Study|Other|0|||
163455637|NCT00259740|590365714|FG000|Overall Study|Requirement for alternative therapy|0|||
163455638|NCT00259740|590365715|FG001|Overall Study|Requirement for alternative therapy|4|||
163455639|NCT01844830|590365720|FG000|Overall Study|Withdrawal by Subject|1|||
163455640|NCT01844830|590365721|FG001|Overall Study|Withdrawal by Subject|0|||
163455641|NCT04735393|590365725|FG000|Overall Study|Lost to Follow-up|46|||
163455642|NCT04735393|590365726|FG001|Overall Study|Lost to Follow-up|24|||
163455643|NCT04735393|590365725|FG000|Overall Study|Physician Decision|2|||
163455644|NCT04735393|590365726|FG001|Overall Study|Physician Decision|1|||
163455645|NCT04735393|590365725|FG000|Overall Study|Not Detailed|1|||
163455646|NCT04735393|590365726|FG001|Overall Study|Not Detailed|2|||
163455647|NCT04735393|590365725|FG000|Overall Study|Withdrawal by Subject|71|||
163455648|NCT04735393|590365726|FG001|Overall Study|Withdrawal by Subject|28|||
163455649|NCT04735393|590365725|FG000|Overall Study|Adverse Event|56|||
163455650|NCT04735393|590365726|FG001|Overall Study|Adverse Event|7|||
163455651|NCT04735393|590365725|FG000|Overall Study|Protocol Violation|6|||
163455652|NCT04735393|590365726|FG001|Overall Study|Protocol Violation|1|||
163455653|NCT04735393|590365725|FG000|Overall Study|Trial terminated by Sponsor|49|||
163455654|NCT04735393|590365726|FG001|Overall Study|Trial terminated by Sponsor|29|||
163455655|NCT00209170|590365727|FG000|Overall Study|Adverse Event|0|||
163455656|NCT00209170|590365728|FG001|Overall Study|Adverse Event|1|||
163455657|NCT00209170|590365727|FG000|Overall Study|Withdrawal by Subject|2|||
163455658|NCT00209170|590365728|FG001|Overall Study|Withdrawal by Subject|1|||
163455659|NCT00209170|590365727|FG000|Overall Study|Lack of Efficacy|0|||
163455660|NCT00209170|590365728|FG001|Overall Study|Lack of Efficacy|1|||
163455661|NCT03224104|590365732|FG000|Overall Study|Lack of Efficacy|2|||
163455662|NCT03224104|590365733|FG001|Overall Study|Lack of Efficacy|6|||
163455663|NCT03224104|590365734|FG002|Overall Study|Lack of Efficacy|3|||
163455664|NCT03224104|590365735|FG003|Overall Study|Lack of Efficacy|4|||
163455665|NCT03224104|590365736|FG004|Overall Study|Lack of Efficacy|42|||
163455666|NCT03224104|590365732|FG000|Overall Study|Withdrawal by Subject|0|||
163455667|NCT03224104|590365733|FG001|Overall Study|Withdrawal by Subject|2|||
163455668|NCT03224104|590365734|FG002|Overall Study|Withdrawal by Subject|0|||
163455669|NCT03224104|590365735|FG003|Overall Study|Withdrawal by Subject|1|||
163455670|NCT03224104|590365736|FG004|Overall Study|Withdrawal by Subject|3|||
163455671|NCT03224104|590365732|FG000|Overall Study|Death|0|||
163455672|NCT03224104|590365733|FG001|Overall Study|Death|1|||
163455673|NCT03224104|590365734|FG002|Overall Study|Death|0|||
163455674|NCT03224104|590365735|FG003|Overall Study|Death|0|||
163455675|NCT03224104|590365736|FG004|Overall Study|Death|0|||
163455676|NCT03224104|590365732|FG000|Overall Study|Adverse Event|1|||
163455677|NCT03224104|590365733|FG001|Overall Study|Adverse Event|0|||
163455678|NCT03224104|590365734|FG002|Overall Study|Adverse Event|0|||
163455679|NCT03224104|590365735|FG003|Overall Study|Adverse Event|1|||
163455680|NCT03224104|590365736|FG004|Overall Study|Adverse Event|3|||
163455681|NCT03224104|590365732|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
163455682|NCT03224104|590365733|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
163455683|NCT03224104|590365734|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
163455684|NCT03224104|590365735|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
163455685|NCT03224104|590365736|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
163455686|NCT03224104|590365732|FG000|Overall Study|Treatment ongoing|0|||
163455687|NCT03224104|590365733|FG001|Overall Study|Treatment ongoing|0|||
163455688|NCT03224104|590365734|FG002|Overall Study|Treatment ongoing|0|||
163455689|NCT03224104|590365735|FG003|Overall Study|Treatment ongoing|0|||
163455690|NCT03224104|590365736|FG004|Overall Study|Treatment ongoing|1|||
163455691|NCT04397718|590365737|FG000|Overall Study|Death|7|||
163455692|NCT04397718|590365738|FG001|Overall Study|Death|11|||
163455693|NCT04397718|590365737|FG000|Overall Study|Lost to Follow-up|0|||
163455694|NCT04397718|590365738|FG001|Overall Study|Lost to Follow-up|4|||
163455695|NCT06087328|590365739|FG000|28-Day Treatment|Lost to Follow-up|7|||
163455696|NCT06087328|590365740|FG001|28-Day Treatment|Lost to Follow-up|3|||
163455697|NCT06087328|590365741|FG002|28-Day Treatment|Lost to Follow-up|4|||
163455698|NCT06087328|590365739|FG000|1-month Follow-up|Lost to Follow-up|0|||
163455699|NCT06087328|590365740|FG001|1-month Follow-up|Lost to Follow-up|1|||
163455700|NCT06087328|590365741|FG002|1-month Follow-up|Lost to Follow-up|1|||
163455701|NCT03589326|590365742|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
163455702|NCT03589326|590365743|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
163455703|NCT03589326|590365742|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
163455704|NCT03589326|590365743|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
163455705|NCT03589326|590365742|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
163455706|NCT03589326|590365743|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
163455707|NCT03589326|590365742|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
163455708|NCT03589326|590365743|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
163455709|NCT03589326|590365742|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
163455710|NCT03589326|590365743|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
163455711|NCT02998554|590365748|FG000|Overall Study|Adverse Event|8|||
163455712|NCT02998554|590365749|FG001|Overall Study|Adverse Event|3|||
163455713|NCT02998554|590365748|FG000|Overall Study|Protocol deviation|1|||
163455714|NCT02998554|590365749|FG001|Overall Study|Protocol deviation|0|||
163455715|NCT02998554|590365748|FG000|Overall Study|Withdrawal by Subject|2|||
163455716|NCT02998554|590365749|FG001|Overall Study|Withdrawal by Subject|6|||
163455717|NCT02998554|590365748|FG000|Overall Study|Lost to Follow-up|0|||
163455718|NCT02998554|590365749|FG001|Overall Study|Lost to Follow-up|1|||
163455719|NCT02998554|590365748|FG000|Overall Study|Lack of Efficacy|0|||
163455720|NCT02998554|590365749|FG001|Overall Study|Lack of Efficacy|1|||
163455721|NCT01778127|590365750|FG000|Overall Study|Lost to Follow-up|5|||
163455722|NCT01778127|590365751|FG001|Overall Study|Lost to Follow-up|1|||
163455723|NCT01778127|590365752|FG002|Overall Study|Lost to Follow-up|2|||
163455724|NCT01778127|590365750|FG000|Overall Study|Withdrawal by Subject|3|||
163455725|NCT01778127|590365751|FG001|Overall Study|Withdrawal by Subject|1|||
163455726|NCT01778127|590365752|FG002|Overall Study|Withdrawal by Subject|4|||
163455727|NCT01348425|590365755|FG000|Overall Study|Imaging was not taken.|1|||
163455728|NCT01348425|590365756|FG001|Overall Study|Imaging was not taken.|1|||
163455729|NCT01968954|590365766|FG000|Overall Study|Adverse Event|6|||
163455730|NCT01968954|590365767|FG001|Overall Study|Adverse Event|3|||
163455731|NCT01968954|590365766|FG000|Overall Study|Death|1|||
163455732|NCT01968954|590365767|FG001|Overall Study|Death|2|||
163455733|NCT01968954|590365766|FG000|Overall Study|Lost to Follow-up|6|||
163455734|NCT01968954|590365767|FG001|Overall Study|Lost to Follow-up|4|||
163455735|NCT01968954|590365766|FG000|Overall Study|Withdrawal by Subject|20|||
163455736|NCT01968954|590365767|FG001|Overall Study|Withdrawal by Subject|23|||
163455737|NCT01968954|590365766|FG000|Overall Study|Other|7|||
163455738|NCT01968954|590365767|FG001|Overall Study|Other|8|||
163455739|NCT01968954|590365766|FG000|Overall Study|Protocol Violation|0|||
163455740|NCT01968954|590365767|FG001|Overall Study|Protocol Violation|1|||
163455741|NCT01968954|590365766|FG000|Overall Study|Did not met inclusion criteria|0|||
163455742|NCT01968954|590365767|FG001|Overall Study|Did not met inclusion criteria|2|||
163455743|NCT00255086|590365772|FG000|Overall Study|Adverse Event|1|||
163455744|NCT00255086|590365773|FG001|Overall Study|Adverse Event|1|||
163455745|NCT00255086|590365772|FG000|Overall Study|Protocol Violation|1|||
163455746|NCT00255086|590365773|FG001|Overall Study|Protocol Violation|1|||
163455747|NCT00434122|590365774|FG000|Overall Study|Non-compliance with protocol|0|||
163455748|NCT00434122|590365775|FG001|Overall Study|Non-compliance with protocol|1|||
163455749|NCT00434122|590365774|FG000|Overall Study|loss of subject contact|1|||
163455750|NCT00434122|590365775|FG001|Overall Study|loss of subject contact|1|||
163455751|NCT00434122|590365774|FG000|Overall Study|Personal reasons|1|||
163455752|NCT00434122|590365775|FG001|Overall Study|Personal reasons|1|||
163455753|NCT00434122|590365774|FG000|Overall Study|Large follicle size|2|||
163455754|NCT00434122|590365775|FG001|Overall Study|Large follicle size|2|||
163455755|NCT00434122|590365774|FG000|Overall Study|Low follicular response.|1|||
163455756|NCT00434122|590365775|FG001|Overall Study|Low follicular response.|2|||
163455757|NCT00434122|590365774|FG000|Overall Study|Travelling of subject.|1|||
163455758|NCT00434122|590365775|FG001|Overall Study|Travelling of subject.|0|||
163455759|NCT01963208|590365777|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
163455760|NCT01963208|590365778|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
163455761|NCT01963208|590365779|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
163455762|NCT01963208|590365780|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
163455763|NCT01963208|590365781|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
163455764|NCT01963208|590365782|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
163455765|NCT01963208|590365777|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
163455766|NCT01963208|590365778|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
163455767|NCT01963208|590365779|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
163455768|NCT01963208|590365780|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
163455769|NCT01963208|590365781|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
163455770|NCT01963208|590365782|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
163455771|NCT01963208|590365777|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
163455772|NCT01963208|590365778|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
163455773|NCT01963208|590365779|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
163455774|NCT01963208|590365780|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
163455775|NCT01963208|590365781|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
163455776|NCT01963208|590365782|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
163455777|NCT01963208|590365777|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
163455778|NCT01963208|590365778|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
163455779|NCT01963208|590365779|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
163455780|NCT01963208|590365780|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
163455781|NCT01963208|590365781|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
163455782|NCT01963208|590365782|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
163455783|NCT01963208|590365777|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
163455784|NCT01963208|590365778|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
163455785|NCT01963208|590365779|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
163455786|NCT01963208|590365780|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
163455787|NCT01963208|590365781|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
163455788|NCT01963208|590365782|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
163455789|NCT01963208|590365777|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
163455790|NCT01963208|590365778|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
163455791|NCT01963208|590365779|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
163455792|NCT01963208|590365780|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
163455793|NCT01963208|590365781|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
163455794|NCT01963208|590365782|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
163455795|NCT01963208|590365777|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
163455796|NCT01963208|590365778|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
163455797|NCT01963208|590365779|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
163455798|NCT01963208|590365780|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
163455799|NCT01963208|590365781|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
163455800|NCT01963208|590365782|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
163455801|NCT01963208|590365777|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
163455802|NCT01963208|590365778|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
163455803|NCT01963208|590365779|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
163455804|NCT01963208|590365780|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
163455805|NCT01963208|590365781|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
163455806|NCT01963208|590365782|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
163455807|NCT01963208|590365777|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
163455808|NCT01963208|590365778|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
163455809|NCT01963208|590365779|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
163455810|NCT01963208|590365780|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
163455811|NCT01963208|590365781|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
163455812|NCT01963208|590365782|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
163455813|NCT01963208|590365777|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
163455814|NCT01963208|590365778|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
163455815|NCT01963208|590365779|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
163455816|NCT01963208|590365780|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
163455817|NCT01963208|590365781|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
163455818|NCT01963208|590365782|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
163455819|NCT01963208|590365777|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
163455820|NCT01963208|590365778|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
163455821|NCT01963208|590365779|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
163455822|NCT01963208|590365780|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
163455823|NCT01963208|590365781|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
163455824|NCT01963208|590365782|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
163455825|NCT01963208|590365777|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
163455826|NCT01963208|590365778|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
163455827|NCT01963208|590365779|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
163455828|NCT01963208|590365780|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
163455829|NCT01963208|590365781|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
163455830|NCT01963208|590365782|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
163455831|NCT01963208|590365777|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
163455832|NCT01963208|590365778|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
163455833|NCT01963208|590365779|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
163455834|NCT01963208|590365780|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
163455835|NCT01963208|590365781|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
163455836|NCT01963208|590365782|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
163455837|NCT01963208|590365777|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
163455838|NCT01963208|590365778|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
163455839|NCT01963208|590365779|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
163455840|NCT01963208|590365780|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
163455841|NCT01963208|590365781|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
163455842|NCT01963208|590365782|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
163455843|NCT00438399|590365783|FG000|Overall Study|Lost to Follow-up|2|||
163455844|NCT00438399|590365784|FG001|Overall Study|Lost to Follow-up|2|||
163455845|NCT00438399|590365785|FG002|Overall Study|Lost to Follow-up|1|||
163455846|NCT00438399|590365786|FG003|Overall Study|Lost to Follow-up|1|||
163455847|NCT00438399|590365787|FG004|Overall Study|Lost to Follow-up|1|||
163455848|NCT00438399|590365788|FG005|Overall Study|Lost to Follow-up|1|||
163455849|NCT00438399|590365783|FG000|Overall Study|Adverse Event|0|||
163455850|NCT00438399|590365784|FG001|Overall Study|Adverse Event|0|||
163455851|NCT00438399|590365785|FG002|Overall Study|Adverse Event|1|||
163455852|NCT00438399|590365786|FG003|Overall Study|Adverse Event|1|||
163455853|NCT00438399|590365787|FG004|Overall Study|Adverse Event|0|||
163455854|NCT00438399|590365788|FG005|Overall Study|Adverse Event|1|||
163455855|NCT00438399|590365783|FG000|Overall Study|Withdrawal by Subject|5|||
163455856|NCT00438399|590365784|FG001|Overall Study|Withdrawal by Subject|6|||
163455857|NCT00438399|590365785|FG002|Overall Study|Withdrawal by Subject|3|||
163455858|NCT00438399|590365786|FG003|Overall Study|Withdrawal by Subject|2|||
163455859|NCT00438399|590365787|FG004|Overall Study|Withdrawal by Subject|2|||
163455860|NCT00438399|590365788|FG005|Overall Study|Withdrawal by Subject|2|||
163455861|NCT00438399|590365783|FG000|Overall Study|Protocol Violation|0|||
163455862|NCT00438399|590365784|FG001|Overall Study|Protocol Violation|0|||
163455863|NCT00438399|590365785|FG002|Overall Study|Protocol Violation|1|||
163455864|NCT00438399|590365786|FG003|Overall Study|Protocol Violation|0|||
163455865|NCT00438399|590365787|FG004|Overall Study|Protocol Violation|0|||
163455866|NCT00438399|590365788|FG005|Overall Study|Protocol Violation|1|||
163455867|NCT00438399|590365783|FG000|Overall Study|Subje stopped study|0|||
163455868|NCT00438399|590365784|FG001|Overall Study|Subje stopped study|0|||
163455869|NCT00438399|590365785|FG002|Overall Study|Subje stopped study|1|||
163455870|NCT00438399|590365786|FG003|Overall Study|Subje stopped study|0|||
163455871|NCT00438399|590365787|FG004|Overall Study|Subje stopped study|0|||
163455872|NCT00438399|590365788|FG005|Overall Study|Subje stopped study|0|||
163455873|NCT00438399|590365783|FG000|Overall Study|Pregnancy|0|||
163455874|NCT00438399|590365784|FG001|Overall Study|Pregnancy|0|||
163455875|NCT00438399|590365785|FG002|Overall Study|Pregnancy|0|||
163455876|NCT00438399|590365786|FG003|Overall Study|Pregnancy|0|||
163455877|NCT00438399|590365787|FG004|Overall Study|Pregnancy|0|||
163455878|NCT00438399|590365788|FG005|Overall Study|Pregnancy|1|||
163455879|NCT00438399|590365783|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
163455880|NCT00438399|590365784|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
163455881|NCT00438399|590365785|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
163455882|NCT00438399|590365786|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
163455883|NCT00438399|590365787|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
163455884|NCT00438399|590365788|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
163455885|NCT01283997|590367884|FG000|Overall Study|Physician Decision|8|||
163455886|NCT01283997|590367885|FG001|Overall Study|Physician Decision|10|||
163455887|NCT01283997|590367884|FG000|Overall Study|Withdrawal by Subject|3|||
163455888|NCT01283997|590367885|FG001|Overall Study|Withdrawal by Subject|2|||
163455889|NCT01283997|590367884|FG000|Overall Study|Physically unable to continue|0|||
163455890|NCT01283997|590367885|FG001|Overall Study|Physically unable to continue|1|||
163455891|NCT01283997|590367884|FG000|Overall Study|Progressive disease|1|||
163455892|NCT01283997|590367885|FG001|Overall Study|Progressive disease|0|||
163455893|NCT01283997|590367884|FG000|Overall Study|Other|4|||
163455894|NCT01283997|590367885|FG001|Overall Study|Other|4|||
163455895|NCT02109744|590367886|FG000|Overall Study|Death|1|||
163455896|NCT02109744|590367887|FG001|Overall Study|Death|1|||
163455897|NCT02109744|590367886|FG000|Overall Study|no marrow exam|1|||
163455898|NCT02109744|590367887|FG001|Overall Study|no marrow exam|0|||
163455899|NCT04095442|590367891|FG000|Overall Study|Lost to Follow-up|0|||
163455900|NCT04095442|590367892|FG001|Overall Study|Lost to Follow-up|1|||
163455901|NCT04095442|590367891|FG000|Overall Study|Screen failure|1|||
163455902|NCT04095442|590367892|FG001|Overall Study|Screen failure|0|||
163455903|NCT00884221|590367897|FG000|Overall Study|Withdrawal by Subject|0|||
163455904|NCT00884221|590367898|FG001|Overall Study|Withdrawal by Subject|3|||
163455905|NCT00884221|590367897|FG000|Overall Study|Adverse Event|6|||
163455906|NCT00884221|590367898|FG001|Overall Study|Adverse Event|3|||
163455907|NCT00884221|590367897|FG000|Overall Study|Protocol Violation|16|||
163455908|NCT00884221|590367898|FG001|Overall Study|Protocol Violation|13|||
163455909|NCT00884221|590367897|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
163455910|NCT00884221|590367898|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
163455911|NCT00255034|590367899|FG000|Overall Study|Withdrawal by Subject|15|||
163455912|NCT00255034|590367900|FG001|Overall Study|Withdrawal by Subject|38|||
163455913|NCT01263093|590367901|FG000|Washout|Physician Decision|1|||
163455914|NCT01263093|590367902|FG001|Washout|Physician Decision|0|||
163455915|NCT01263093|590367901|FG000|Period 2|Adverse Event|1|||
163455916|NCT01263093|590367902|FG001|Period 2|Adverse Event|0|||
163455917|NCT00424346|590367903|FG000|Core Study|Adverse Event|5|||
163455918|NCT00424346|590367904|FG001|Core Study|Adverse Event|3|||
163455919|NCT00424346|590367905|FG002|Core Study|Adverse Event|1|||
163455920|NCT00424346|590367906|FG003|Core Study|Adverse Event|1|||
163455921|NCT00424346|590367903|FG000|Core Study|Abnormal Laboratory Values|0|||
163455922|NCT00424346|590367904|FG001|Core Study|Abnormal Laboratory Values|1|||
163455923|NCT00424346|590367905|FG002|Core Study|Abnormal Laboratory Values|0|||
163455924|NCT00424346|590367906|FG003|Core Study|Abnormal Laboratory Values|0|||
163455925|NCT00424346|590367903|FG000|Core Study|Lack of Efficacy|1|||
163455926|NCT00424346|590367904|FG001|Core Study|Lack of Efficacy|3|||
163455927|NCT00424346|590367905|FG002|Core Study|Lack of Efficacy|0|||
163455928|NCT00424346|590367906|FG003|Core Study|Lack of Efficacy|4|||
163455929|NCT00424346|590367903|FG000|Core Study|Withdrawal by Subject|1|||
163455930|NCT00424346|590367904|FG001|Core Study|Withdrawal by Subject|0|||
163455931|NCT00424346|590367905|FG002|Core Study|Withdrawal by Subject|0|||
163455932|NCT00424346|590367906|FG003|Core Study|Withdrawal by Subject|2|||
163455933|NCT00424346|590367903|FG000|Core Study|Lost to Follow-up|1|||
163455934|NCT00424346|590367904|FG001|Core Study|Lost to Follow-up|1|||
163455935|NCT00424346|590367905|FG002|Core Study|Lost to Follow-up|0|||
163455936|NCT00424346|590367906|FG003|Core Study|Lost to Follow-up|0|||
163455937|NCT00424346|590367903|FG000|Core Study|Administrative Problems|1|||
163455938|NCT00424346|590367904|FG001|Core Study|Administrative Problems|0|||
163455939|NCT00424346|590367905|FG002|Core Study|Administrative Problems|1|||
163455940|NCT00424346|590367906|FG003|Core Study|Administrative Problems|0|||
163455941|NCT00424346|590367903|FG000|Core Study|Protocol Violation|0|||
163455942|NCT00424346|590367904|FG001|Core Study|Protocol Violation|0|||
163455943|NCT00424346|590367905|FG002|Core Study|Protocol Violation|2|||
163455944|NCT00424346|590367906|FG003|Core Study|Protocol Violation|0|||
163455945|NCT00424346|590367903|FG000|Extension Phase|Adverse Event|0|||
163455946|NCT00424346|590367904|FG001|Extension Phase|Adverse Event|9|||
163455947|NCT00424346|590367905|FG002|Extension Phase|Adverse Event|5|||
163455948|NCT00424346|590367906|FG003|Extension Phase|Adverse Event|4|||
163455949|NCT00424346|590367903|FG000|Extension Phase|Lack of Efficacy|0|||
163455950|NCT00424346|590367904|FG001|Extension Phase|Lack of Efficacy|16|||
163455951|NCT00424346|590367905|FG002|Extension Phase|Lack of Efficacy|14|||
163455952|NCT00424346|590367906|FG003|Extension Phase|Lack of Efficacy|11|||
163455953|NCT00424346|590367903|FG000|Extension Phase|Withdrawal by Subject|0|||
163455954|NCT00424346|590367904|FG001|Extension Phase|Withdrawal by Subject|5|||
163455955|NCT00424346|590367905|FG002|Extension Phase|Withdrawal by Subject|3|||
163455956|NCT00424346|590367906|FG003|Extension Phase|Withdrawal by Subject|4|||
163455957|NCT00424346|590367903|FG000|Extension Phase|Lost to Follow-up|0|||
163455958|NCT00424346|590367904|FG001|Extension Phase|Lost to Follow-up|2|||
163455959|NCT00424346|590367905|FG002|Extension Phase|Lost to Follow-up|0|||
163455960|NCT00424346|590367906|FG003|Extension Phase|Lost to Follow-up|0|||
163455961|NCT00424346|590367903|FG000|Extension Phase|Administrative Problems|0|||
163455962|NCT00424346|590367904|FG001|Extension Phase|Administrative Problems|69|||
163455963|NCT00424346|590367905|FG002|Extension Phase|Administrative Problems|32|||
163455964|NCT00424346|590367906|FG003|Extension Phase|Administrative Problems|35|||
163455965|NCT00424346|590367903|FG000|Extension Phase|Death|0|||
163455966|NCT00424346|590367904|FG001|Extension Phase|Death|0|||
163455967|NCT00424346|590367905|FG002|Extension Phase|Death|0|||
163455968|NCT00424346|590367906|FG003|Extension Phase|Death|1|||
163455969|NCT00424346|590367903|FG000|Extension Phase|Protocol Violation|0|||
163455970|NCT00424346|590367904|FG001|Extension Phase|Protocol Violation|1|||
163455971|NCT00424346|590367905|FG002|Extension Phase|Protocol Violation|1|||
163455972|NCT00424346|590367906|FG003|Extension Phase|Protocol Violation|0|||
163455973|NCT00571519|590367907|FG000|Overall Study|Subject withdrew consent|0|||
163455974|NCT00571519|590367908|FG001|Overall Study|Subject withdrew consent|1|||
163455975|NCT00571519|590367909|FG002|Overall Study|Subject withdrew consent|0|||
163455976|NCT00571519|590367910|FG003|Overall Study|Subject withdrew consent|2|||
163455977|NCT00571519|590367911|FG004|Overall Study|Subject withdrew consent|1|||
163455978|NCT00571519|590367912|FG005|Overall Study|Subject withdrew consent|1|||
163455979|NCT00571519|590367913|FG006|Overall Study|Subject withdrew consent|2|||
163455980|NCT00571519|590367907|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
163455981|NCT00571519|590367908|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
163455982|NCT00571519|590367909|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
163455983|NCT00571519|590367910|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
163455984|NCT00571519|590367911|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
163455985|NCT00571519|590367912|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
163455986|NCT00571519|590367913|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
163455987|NCT00571519|590367907|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
163455988|NCT00571519|590367908|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
163455989|NCT00571519|590367909|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
163455990|NCT00571519|590367910|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
163455991|NCT00571519|590367911|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
163455992|NCT00571519|590367912|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
163455993|NCT00571519|590367913|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
163455994|NCT00571519|590367907|FG000|Overall Study|Termination of study by Sponsor|2|||
163455995|NCT00571519|590367908|FG001|Overall Study|Termination of study by Sponsor|7|||
163455996|NCT00571519|590367909|FG002|Overall Study|Termination of study by Sponsor|10|||
163455997|NCT00571519|590367910|FG003|Overall Study|Termination of study by Sponsor|24|||
163455998|NCT00571519|590367911|FG004|Overall Study|Termination of study by Sponsor|8|||
163455999|NCT00571519|590367912|FG005|Overall Study|Termination of study by Sponsor|9|||
163456000|NCT00571519|590367913|FG006|Overall Study|Termination of study by Sponsor|22|||
163456001|NCT00571519|590367907|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
163456002|NCT00571519|590367908|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
163456003|NCT00571519|590367909|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
163456004|NCT00571519|590367910|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
163456005|NCT00571519|590367911|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
163456006|NCT00571519|590367912|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
163456007|NCT00571519|590367913|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
163456008|NCT03947255|590367915|FG000|Overall Study|Study Closure by Sponsor|2|||
163456009|NCT03947255|590367916|FG001|Overall Study|Study Closure by Sponsor|2|||
163456010|NCT03947255|590367915|FG000|Overall Study|Withdrawal by Subject|2|||
163456011|NCT03947255|590367916|FG001|Overall Study|Withdrawal by Subject|2|||
163456012|NCT03947255|590367915|FG000|Overall Study|Lost to Follow-up|2|||
163456013|NCT03947255|590367916|FG001|Overall Study|Lost to Follow-up|0|||
163456014|NCT03947255|590367915|FG000|Overall Study|Death|0|||
163456015|NCT03947255|590367916|FG001|Overall Study|Death|2|||
163456016|NCT02499575|590367917|FG000|Overall Study|Protocol Violation|0|||
163456017|NCT02499575|590367918|FG001|Overall Study|Protocol Violation|1|||
163456018|NCT03434418|590367921|FG000|Overall Study|Disease Progression|11|||
163456019|NCT03434418|590367921|FG000|Overall Study|Adverse Event|2|||
163456020|NCT03434418|590367921|FG000|Overall Study|Physician Decision|1|||
163456021|NCT03434418|590367921|FG000|Overall Study|Decline in Performance Status (PS)|1|||
163456022|NCT03039738|590367923|FG000|Overall Study|Incomplete data sets|54|||
163456023|NCT03039738|590367924|FG001|Overall Study|Incomplete data sets|0|||
163456024|NCT01494987|590367925|FG000|Overall Study|Adverse Event|6|||
163456025|NCT01494987|590367926|FG001|Overall Study|Adverse Event|5|||
163456026|NCT01494987|590367925|FG000|Overall Study|Hyperglycemia|6|||
163456027|NCT01494987|590367926|FG001|Overall Study|Hyperglycemia|4|||
163456028|NCT01494987|590367925|FG000|Overall Study|Investigator's Discretion|1|||
163456029|NCT01494987|590367926|FG001|Overall Study|Investigator's Discretion|2|||
163456030|NCT01494987|590367925|FG000|Overall Study|Lost to Follow-up|1|||
163456031|NCT01494987|590367926|FG001|Overall Study|Lost to Follow-up|1|||
163456032|NCT01494987|590367925|FG000|Overall Study|Protocol Violation|3|||
163456033|NCT01494987|590367926|FG001|Overall Study|Protocol Violation|3|||
163456034|NCT01494987|590367925|FG000|Overall Study|Subject Non-Compliance|9|||
163456035|NCT01494987|590367926|FG001|Overall Study|Subject Non-Compliance|10|||
163456036|NCT01494987|590367925|FG000|Overall Study|Subject Withdrew Consent|2|||
163456037|NCT01494987|590367926|FG001|Overall Study|Subject Withdrew Consent|3|||
163456038|NCT02716194|590367927|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
163456039|NCT02716194|590367928|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
163456040|NCT02716194|590367929|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
163456041|NCT00363051|590367930|FG000|Overall Study|Adminstrative problems|1|||
163456042|NCT00363051|590367931|FG001|Overall Study|Adminstrative problems|1|||
163456043|NCT00363051|590367930|FG000|Overall Study|Adverse Event|21|||
163456044|NCT00363051|590367931|FG001|Overall Study|Adverse Event|12|||
163456045|NCT00363051|590367930|FG000|Overall Study|New Cancer Therapy|2|||
163456046|NCT00363051|590367931|FG001|Overall Study|New Cancer Therapy|1|||
163456047|NCT00363051|590367930|FG000|Overall Study|Withdrawal by Subject|11|||
163456048|NCT00363051|590367931|FG001|Overall Study|Withdrawal by Subject|3|||
163456049|NCT00363051|590367930|FG000|Overall Study|Lost to Follow-up|0|||
163456050|NCT00363051|590367931|FG001|Overall Study|Lost to Follow-up|1|||
163456051|NCT00363051|590367930|FG000|Overall Study|Protocol Violation|0|||
163456052|NCT00363051|590367931|FG001|Overall Study|Protocol Violation|2|||
163456053|NCT00363051|590367930|FG000|Overall Study|Death|3|||
163456054|NCT00363051|590367931|FG001|Overall Study|Death|2|||
163456055|NCT02293993|590367932|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
163456056|NCT02293993|590367933|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
163456057|NCT02293993|590367934|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
163456058|NCT02293993|590367935|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
163456059|NCT02293993|590367932|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
163456060|NCT02293993|590367933|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
163456061|NCT02293993|590367934|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
163456062|NCT02293993|590367935|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
163456063|NCT02293993|590367932|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
163456064|NCT02293993|590367933|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
163456065|NCT02293993|590367934|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
163456066|NCT02293993|590367935|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
163456067|NCT02293993|590367932|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
163456068|NCT02293993|590367933|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
163456069|NCT02293993|590367934|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
163456070|NCT02293993|590367935|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
163456071|NCT02293993|590367932|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
163456072|NCT02293993|590367933|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
163456073|NCT02293993|590367934|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
163456074|NCT02293993|590367935|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
163456075|NCT00205699|590367936|FG000|Overall Study|Lost to Follow-up|1|||
163456076|NCT00205699|590367937|FG001|Overall Study|Lost to Follow-up|3|||
163456077|NCT00205699|590367938|FG002|Overall Study|Lost to Follow-up|5|||
163456078|NCT00205699|590367936|FG000|Overall Study|Adverse Event|1|||
163456079|NCT00205699|590367937|FG001|Overall Study|Adverse Event|0|||
163456080|NCT00205699|590367938|FG002|Overall Study|Adverse Event|0|||
163456081|NCT00205699|590367936|FG000|Overall Study|Withdrawal by Subject|1|||
163456082|NCT00205699|590367937|FG001|Overall Study|Withdrawal by Subject|2|||
163456083|NCT00205699|590367938|FG002|Overall Study|Withdrawal by Subject|1|||
163456084|NCT00205699|590367936|FG000|Overall Study|Lack of Efficacy|0|||
163456085|NCT00205699|590367937|FG001|Overall Study|Lack of Efficacy|1|||
163456086|NCT00205699|590367938|FG002|Overall Study|Lack of Efficacy|0|||
163456087|NCT03587584|590367939|FG000|Overall Study|SOC deviations|4|||
163456088|NCT03587584|590367940|FG001|Overall Study|SOC deviations|6|||
163456089|NCT03587584|590367939|FG000|Overall Study|Incomplete data|0|||
163456090|NCT03587584|590367940|FG001|Overall Study|Incomplete data|3|||
163456091|NCT00830115|590367941|FG000|Overall Study|Adverse Event|2|||
163456092|NCT00830115|590367941|FG000|Overall Study|Improvement/recovery|1|||
163456093|NCT01207388|590367948|FG000|Overall Study|Death|67|||
163456094|NCT01207388|590367948|FG000|Overall Study|Withdrawal by Subject|1|||
163456095|NCT01677507|590367949|FG000|Initial Assignment|Adverse Event|0|||
163456096|NCT01677507|590367950|FG001|Initial Assignment|Adverse Event|1|||
163456097|NCT01677507|590367949|FG000|Initial Assignment|Protocol Violation|0|||
163456098|NCT01677507|590367950|FG001|Initial Assignment|Protocol Violation|1|||
163456099|NCT01677507|590367949|FG000|Second Assigment|Withdrawal by Subject|2|||
163456100|NCT01677507|590367950|FG001|Second Assigment|Withdrawal by Subject|2|||
163456101|NCT01677507|590367949|FG000|Second Assigment|Adverse Event|1|||
163456102|NCT01677507|590367950|FG001|Second Assigment|Adverse Event|3|||
163456103|NCT00469209|590367951|FG000|Overall Study|Adverse Event|1|||
163456104|NCT00469209|590367952|FG001|Overall Study|Adverse Event|0|||
163456105|NCT00469209|590367953|FG002|Overall Study|Adverse Event|1|||
163456106|NCT01586156|590367956|FG000|Overall Study|Pregnancy|0|||
163456107|NCT01586156|590367957|FG001|Overall Study|Pregnancy|1|||
163456108|NCT01586156|590367958|FG002|Overall Study|Pregnancy|0|||
163456109|NCT04465396|590367959|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
163456110|NCT04465396|590367960|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
163456111|NCT04465396|590367961|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
163456112|NCT04465396|590367962|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
163456113|NCT00349752|590367964|FG000|Overall Study|Adverse Event|8|||
163456114|NCT00349752|590367965|FG001|Overall Study|Adverse Event|12|||
163456115|NCT00349752|590367964|FG000|Overall Study|Lack of Efficacy|37|||
163456116|NCT00349752|590367965|FG001|Overall Study|Lack of Efficacy|42|||
163456117|NCT00349752|590367964|FG000|Overall Study|Lost to Follow-up|4|||
163456118|NCT00349752|590367965|FG001|Overall Study|Lost to Follow-up|2|||
163456119|NCT00349752|590367964|FG000|Overall Study|Personal reasons|6|||
163456120|NCT00349752|590367965|FG001|Overall Study|Personal reasons|5|||
163456121|NCT00349752|590367964|FG000|Overall Study|Other: Required exclusionary medication|0|||
163456122|NCT00349752|590367965|FG001|Overall Study|Other: Required exclusionary medication|1|||
163456123|NCT00349752|590367964|FG000|Overall Study|Other: Non compliance|0|||
163456124|NCT00349752|590367965|FG001|Overall Study|Other: Non compliance|1|||
163456125|NCT00349752|590367964|FG000|Overall Study|Other: Patient stopped steroids|0|||
163456126|NCT00349752|590367965|FG001|Overall Study|Other: Patient stopped steroids|1|||
163456127|NCT00349752|590367964|FG000|Overall Study|Other: Patient's steroid use|1|||
163456128|NCT00349752|590367965|FG001|Overall Study|Other: Patient's steroid use|0|||
163456129|NCT00349752|590367964|FG000|Overall Study|Other: Ineligible|1|||
163456130|NCT00349752|590367965|FG001|Overall Study|Other: Ineligible|0|||
163456131|NCT00349752|590367964|FG000|Overall Study|Other: Inadvertently unblinded|1|||
163456132|NCT00349752|590367965|FG001|Overall Study|Other: Inadvertently unblinded|0|||
163456133|NCT00349752|590367964|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
163456134|NCT00349752|590367965|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
163456135|NCT05294211|590367966|FG000|Overall Study|Withdrawal by Subject|3|||
163456136|NCT05294211|590367966|FG000|Overall Study|Physician Decision|2|||
163456137|NCT05294211|590367966|FG000|Overall Study|Progressed to active labor|1|||
163456138|NCT05294211|590367966|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
163456139|NCT05294211|590367966|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
163456140|NCT03334396|590367967|FG000|Overall Study|Adverse Event|1|||
163456141|NCT03334396|590367968|FG001|Overall Study|Adverse Event|0|||
163456142|NCT03334396|590367969|FG002|Overall Study|Adverse Event|1|||
163456143|NCT03334396|590367970|FG003|Overall Study|Adverse Event|0|||
163456144|NCT03334396|590367971|FG004|Overall Study|Adverse Event|0|||
163456145|NCT03334396|590367972|FG005|Overall Study|Adverse Event|0|||
163456146|NCT03334396|590367973|FG006|Overall Study|Adverse Event|0|||
163456147|NCT03334396|590367974|FG007|Overall Study|Adverse Event|0|||
163456148|NCT03334396|590367967|FG000|Overall Study|Lack of Efficacy|10|||
163456149|NCT03334396|590367968|FG001|Overall Study|Lack of Efficacy|4|||
163456150|NCT03334396|590367969|FG002|Overall Study|Lack of Efficacy|1|||
163456151|NCT03334396|590367970|FG003|Overall Study|Lack of Efficacy|3|||
163456152|NCT03334396|590367971|FG004|Overall Study|Lack of Efficacy|1|||
163456153|NCT03334396|590367972|FG005|Overall Study|Lack of Efficacy|0|||
163456154|NCT03334396|590367973|FG006|Overall Study|Lack of Efficacy|0|||
163456155|NCT03334396|590367974|FG007|Overall Study|Lack of Efficacy|1|||
163456156|NCT03334396|590367967|FG000|Overall Study|Lost to Follow-up|0|||
163456157|NCT03334396|590367968|FG001|Overall Study|Lost to Follow-up|0|||
163456158|NCT03334396|590367969|FG002|Overall Study|Lost to Follow-up|1|||
163456159|NCT03334396|590367970|FG003|Overall Study|Lost to Follow-up|0|||
163456160|NCT03334396|590367971|FG004|Overall Study|Lost to Follow-up|0|||
163456161|NCT03334396|590367972|FG005|Overall Study|Lost to Follow-up|0|||
163456162|NCT03334396|590367973|FG006|Overall Study|Lost to Follow-up|1|||
163456163|NCT03334396|590367974|FG007|Overall Study|Lost to Follow-up|0|||
163456164|NCT03334396|590367967|FG000|Overall Study|Physician Decision|1|||
163456165|NCT03334396|590367968|FG001|Overall Study|Physician Decision|0|||
163456166|NCT03334396|590367969|FG002|Overall Study|Physician Decision|0|||
163456167|NCT03334396|590367970|FG003|Overall Study|Physician Decision|0|||
163456168|NCT03334396|590367971|FG004|Overall Study|Physician Decision|0|||
163456169|NCT03334396|590367972|FG005|Overall Study|Physician Decision|0|||
163456170|NCT03334396|590367973|FG006|Overall Study|Physician Decision|0|||
163456171|NCT03334396|590367974|FG007|Overall Study|Physician Decision|0|||
163456172|NCT03334396|590367967|FG000|Overall Study|Withdrawal by Subject|10|||
163456173|NCT03334396|590367968|FG001|Overall Study|Withdrawal by Subject|5|||
163456174|NCT03334396|590367969|FG002|Overall Study|Withdrawal by Subject|7|||
163456175|NCT03334396|590367970|FG003|Overall Study|Withdrawal by Subject|2|||
163456176|NCT03334396|590367971|FG004|Overall Study|Withdrawal by Subject|2|||
163456177|NCT03334396|590367972|FG005|Overall Study|Withdrawal by Subject|1|||
163456178|NCT03334396|590367973|FG006|Overall Study|Withdrawal by Subject|2|||
163456179|NCT03334396|590367974|FG007|Overall Study|Withdrawal by Subject|0|||
163456180|NCT03334396|590367967|FG000|Overall Study|Pregnancy|0|||
163456181|NCT03334396|590367968|FG001|Overall Study|Pregnancy|1|||
163456182|NCT03334396|590367969|FG002|Overall Study|Pregnancy|0|||
163456183|NCT03334396|590367970|FG003|Overall Study|Pregnancy|0|||
163456184|NCT03334396|590367971|FG004|Overall Study|Pregnancy|0|||
163456185|NCT03334396|590367972|FG005|Overall Study|Pregnancy|0|||
163456186|NCT03334396|590367973|FG006|Overall Study|Pregnancy|0|||
163456187|NCT03334396|590367974|FG007|Overall Study|Pregnancy|0|||
163456188|NCT03334396|590367967|FG000|Overall Study|Ineligible|0|||
163456189|NCT03334396|590367968|FG001|Overall Study|Ineligible|1|||
163456190|NCT03334396|590367969|FG002|Overall Study|Ineligible|0|||
163456191|NCT03334396|590367970|FG003|Overall Study|Ineligible|0|||
163456192|NCT03334396|590367971|FG004|Overall Study|Ineligible|0|||
163456193|NCT03334396|590367972|FG005|Overall Study|Ineligible|0|||
163456194|NCT03334396|590367973|FG006|Overall Study|Ineligible|0|||
163456195|NCT03334396|590367974|FG007|Overall Study|Ineligible|0|||
163456196|NCT03334396|590367967|FG000|Overall Study|Started New Job|1|||
163456197|NCT03334396|590367968|FG001|Overall Study|Started New Job|0|||
163456198|NCT03334396|590367969|FG002|Overall Study|Started New Job|0|||
163456199|NCT03334396|590367970|FG003|Overall Study|Started New Job|0|||
163456200|NCT03334396|590367971|FG004|Overall Study|Started New Job|0|||
163456201|NCT03334396|590367972|FG005|Overall Study|Started New Job|0|||
163456202|NCT03334396|590367973|FG006|Overall Study|Started New Job|0|||
163456203|NCT03334396|590367974|FG007|Overall Study|Started New Job|0|||
163456204|NCT01842607|590367976|FG000|Overall Study|Adverse Event|11|||
163456205|NCT01842607|590367976|FG000|Overall Study|Lack of Efficacy|19|||
163456206|NCT01842607|590367976|FG000|Overall Study|Protocol Violation|8|||
163456207|NCT01842607|590367976|FG000|Overall Study|Protocol defined stopping criteria|2|||
163456208|NCT01842607|590367976|FG000|Overall Study|Lost to Follow-up|3|||
163456209|NCT01842607|590367976|FG000|Overall Study|Physician Decision|9|||
163456210|NCT01842607|590367976|FG000|Overall Study|Withdrawal by Subject|14|||
163456211|NCT00012012|590367977|FG000|Overall Study|Protocol Violation|1|||
163456212|NCT00012012|590367978|FG001|Overall Study|Protocol Violation|1|||
163456213|NCT00012012|590367977|FG000|Overall Study|Withdrawal by Subject|0|||
163456214|NCT00012012|590367978|FG001|Overall Study|Withdrawal by Subject|2|||
163456215|NCT02159469|590367979|FG000|Overall Study|Missing Completion status|1|||
163456216|NCT02159469|590367979|FG000|Overall Study|Adverse Event|5|||
163456217|NCT02159469|590367979|FG000|Overall Study|Non-compliance|2|||
163456218|NCT02159469|590367979|FG000|Overall Study|Withdrawal by Subject|9|||
163456219|NCT02159469|590367979|FG000|Overall Study|Lost to Follow-up|1|||
163456220|NCT02159469|590367979|FG000|Overall Study|Sponsor's request|2|||
163456221|NCT02159469|590367979|FG000|Overall Study|Met Stopping Criteria|3|||
163456222|NCT02159469|590367979|FG000|Overall Study|Other|1|||
163456223|NCT02159469|590367979|FG000|Overall Study|Multiple|29|||
163456224|NCT03629041|590367980|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
163456225|NCT03629041|590367981|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
163456226|NCT03629041|590367982|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
163456227|NCT03629041|590367983|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
163456228|NCT03488251|590367989|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
163456229|NCT03488251|590367990|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
163456230|NCT03488251|590367991|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
163456231|NCT03488251|590367992|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
163456232|NCT03488251|590367989|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
163456233|NCT03488251|590367990|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
163456234|NCT03488251|590367991|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
163456235|NCT03488251|590367992|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
163456236|NCT03488251|590367989|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
163456237|NCT03488251|590367990|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
163456238|NCT03488251|590367991|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
163456239|NCT03488251|590367992|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
163456240|NCT03488251|590367989|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
163456241|NCT03488251|590367990|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
163456242|NCT03488251|590367991|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
163456243|NCT03488251|590367992|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
163456244|NCT03488251|590367989|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
163456245|NCT03488251|590367990|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
163456246|NCT03488251|590367991|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
163456247|NCT03488251|590367992|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
163456248|NCT03730194|590367993|FG000|First Stage Treatment|Withdrawal by Subject|1|||
163456249|NCT03730194|590367994|FG001|First Stage Treatment|Withdrawal by Subject|1|||
163456250|NCT03730194|590367995|FG002|First Stage Treatment|Withdrawal by Subject|0|||
163456251|NCT03730194|590367996|FG003|First Stage Treatment|Withdrawal by Subject|0|||
163456252|NCT03730194|590367997|FG004|First Stage Treatment|Withdrawal by Subject|0|||
163456253|NCT03730194|590367998|FG005|First Stage Treatment|Withdrawal by Subject|0|||
163456254|NCT03730194|590367993|FG000|First Stage Treatment|Protocol Violation|3|||
163456255|NCT03730194|590367994|FG001|First Stage Treatment|Protocol Violation|3|||
163456256|NCT03730194|590367995|FG002|First Stage Treatment|Protocol Violation|0|||
163456257|NCT03730194|590367996|FG003|First Stage Treatment|Protocol Violation|0|||
163456258|NCT03730194|590367997|FG004|First Stage Treatment|Protocol Violation|0|||
163456259|NCT03730194|590367998|FG005|First Stage Treatment|Protocol Violation|0|||
163456260|NCT01766817|590368001|FG000|Overall Study|Drug-related adverse event|1|||
163456261|NCT01766817|590368002|FG001|Overall Study|Drug-related adverse event|2|||
163456262|NCT01766817|590368003|FG002|Overall Study|Drug-related adverse event|1|||
163456263|NCT01766817|590368001|FG000|Overall Study|Drug-unrelated adverse event|3|||
163456264|NCT01766817|590368002|FG001|Overall Study|Drug-unrelated adverse event|3|||
163456265|NCT01766817|590368003|FG002|Overall Study|Drug-unrelated adverse event|3|||
163456266|NCT01766817|590368001|FG000|Overall Study|Death|1|||
163456267|NCT01766817|590368002|FG001|Overall Study|Death|1|||
163456268|NCT01766817|590368003|FG002|Overall Study|Death|0|||
163456269|NCT01766817|590368001|FG000|Overall Study|Unable to take study drug|0|||
163456270|NCT01766817|590368002|FG001|Overall Study|Unable to take study drug|1|||
163456271|NCT01766817|590368003|FG002|Overall Study|Unable to take study drug|0|||
163456272|NCT01766817|590368001|FG000|Overall Study|Withdrawal by Subject|2|||
163456273|NCT01766817|590368002|FG001|Overall Study|Withdrawal by Subject|0|||
163456274|NCT01766817|590368003|FG002|Overall Study|Withdrawal by Subject|3|||
163456275|NCT01766817|590368001|FG000|Overall Study|Subject non-compliance|0|||
163456276|NCT01766817|590368002|FG001|Overall Study|Subject non-compliance|1|||
163456277|NCT01766817|590368003|FG002|Overall Study|Subject non-compliance|2|||
163456278|NCT01766817|590368001|FG000|Overall Study|Physician Decision|3|||
163456279|NCT01766817|590368002|FG001|Overall Study|Physician Decision|3|||
163456280|NCT01766817|590368003|FG002|Overall Study|Physician Decision|4|||
163456281|NCT01766817|590368001|FG000|Overall Study|Other|1|||
163456282|NCT01766817|590368002|FG001|Overall Study|Other|0|||
163456283|NCT01766817|590368003|FG002|Overall Study|Other|0|||
163456284|NCT03600714|590368004|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
163456285|NCT03814590|590368005|FG000|Overall Study|Adverse Event|0|||
163456286|NCT03814590|590368006|FG001|Overall Study|Adverse Event|0|||
163456287|NCT03814590|590368007|FG002|Overall Study|Adverse Event|0|||
163456288|NCT03814590|590368008|FG003|Overall Study|Adverse Event|0|||
163456289|NCT03814590|590368009|FG004|Overall Study|Adverse Event|0|||
163456290|NCT03814590|590368010|FG005|Overall Study|Adverse Event|1|||
163456291|NCT03814590|590368011|FG006|Overall Study|Adverse Event|1|||
163456292|NCT03814590|590368012|FG007|Overall Study|Adverse Event|1|||
163456293|NCT03814590|590368013|FG008|Overall Study|Adverse Event|0|||
163456294|NCT03814590|590368014|FG009|Overall Study|Adverse Event|0|||
163456295|NCT03814590|590368015|FG010|Overall Study|Adverse Event|1|||
163456296|NCT03814590|590368016|FG011|Overall Study|Adverse Event|0|||
163456297|NCT03814590|590368017|FG012|Overall Study|Adverse Event|3|||
163456298|NCT03814590|590368018|FG013|Overall Study|Adverse Event|0|||
163456299|NCT03814590|590368005|FG000|Overall Study|Lost to Follow-up|0|||
163456300|NCT03814590|590368006|FG001|Overall Study|Lost to Follow-up|2|||
163456301|NCT03814590|590368007|FG002|Overall Study|Lost to Follow-up|1|||
163456302|NCT03814590|590368008|FG003|Overall Study|Lost to Follow-up|0|||
163456303|NCT03814590|590368009|FG004|Overall Study|Lost to Follow-up|1|||
163456304|NCT03814590|590368010|FG005|Overall Study|Lost to Follow-up|1|||
163456305|NCT03814590|590368011|FG006|Overall Study|Lost to Follow-up|1|||
163456306|NCT03814590|590368012|FG007|Overall Study|Lost to Follow-up|1|||
163456307|NCT03814590|590368013|FG008|Overall Study|Lost to Follow-up|0|||
163456308|NCT03814590|590368014|FG009|Overall Study|Lost to Follow-up|0|||
163456309|NCT03814590|590368015|FG010|Overall Study|Lost to Follow-up|1|||
163456310|NCT03814590|590368016|FG011|Overall Study|Lost to Follow-up|0|||
163456311|NCT03814590|590368017|FG012|Overall Study|Lost to Follow-up|0|||
163456312|NCT03814590|590368018|FG013|Overall Study|Lost to Follow-up|1|||
163456313|NCT03814590|590368005|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
163456314|NCT03814590|590368006|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
163456315|NCT03814590|590368007|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
163456316|NCT03814590|590368008|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
163456317|NCT03814590|590368009|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
163456318|NCT03814590|590368010|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
163456319|NCT03814590|590368011|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
163456320|NCT03814590|590368012|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
163456321|NCT03814590|590368013|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
163456322|NCT03814590|590368014|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
163456323|NCT03814590|590368015|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
163456324|NCT03814590|590368016|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
163456325|NCT03814590|590368017|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
163456326|NCT03814590|590368018|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
163456327|NCT03814590|590368005|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
163456328|NCT03814590|590368006|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
163456329|NCT03814590|590368007|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
163456330|NCT03814590|590368008|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
163456331|NCT03814590|590368009|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
163456332|NCT03814590|590368010|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
163456333|NCT03814590|590368011|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
163456334|NCT03814590|590368012|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
163456335|NCT03814590|590368013|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
163456336|NCT03814590|590368014|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
163456337|NCT03814590|590368015|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
163456338|NCT03814590|590368016|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
163456339|NCT03814590|590368017|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
163456340|NCT03814590|590368018|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
163456341|NCT03814590|590368005|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163456342|NCT03814590|590368006|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163456343|NCT03814590|590368007|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163456344|NCT03814590|590368008|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163456345|NCT03814590|590368009|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163456346|NCT03814590|590368010|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163456347|NCT03814590|590368011|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163456348|NCT03814590|590368012|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163456349|NCT03814590|590368013|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163456350|NCT03814590|590368014|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163456351|NCT03814590|590368015|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163456352|NCT03814590|590368016|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163456353|NCT03814590|590368017|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163456354|NCT03814590|590368018|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163456355|NCT03814590|590368005|FG000|Overall Study|UNKNOWN REASON|0|||
163456356|NCT03814590|590368006|FG001|Overall Study|UNKNOWN REASON|0|||
163456357|NCT03814590|590368007|FG002|Overall Study|UNKNOWN REASON|0|||
163456358|NCT03814590|590368008|FG003|Overall Study|UNKNOWN REASON|0|||
163456359|NCT03814590|590368009|FG004|Overall Study|UNKNOWN REASON|0|||
163456360|NCT03814590|590368010|FG005|Overall Study|UNKNOWN REASON|0|||
163456361|NCT03814590|590368011|FG006|Overall Study|UNKNOWN REASON|0|||
163456362|NCT03814590|590368012|FG007|Overall Study|UNKNOWN REASON|1|||
163456363|NCT03814590|590368013|FG008|Overall Study|UNKNOWN REASON|0|||
163456364|NCT03814590|590368014|FG009|Overall Study|UNKNOWN REASON|0|||
163456365|NCT03814590|590368015|FG010|Overall Study|UNKNOWN REASON|0|||
163456366|NCT03814590|590368016|FG011|Overall Study|UNKNOWN REASON|0|||
163456367|NCT03814590|590368017|FG012|Overall Study|UNKNOWN REASON|0|||
163456368|NCT03814590|590368018|FG013|Overall Study|UNKNOWN REASON|0|||
163456369|NCT03519516|590368022|FG000|Overall Study|Adverse Event|0|||
163456370|NCT03519516|590368023|FG001|Overall Study|Adverse Event|1|||
163456371|NCT00592553|590368024|FG000|Overall Study|Protocol Noncompliance|1|||
163456372|NCT00592553|590368025|FG001|Overall Study|Protocol Noncompliance|0|||
163456373|NCT00592553|590368026|FG002|Overall Study|Protocol Noncompliance|0|||
163456374|NCT01244191|590368029|FG000|Overall Study|Progressive disease|295|||
163456375|NCT01244191|590368030|FG001|Overall Study|Progressive disease|350|||
163456376|NCT01244191|590368029|FG000|Overall Study|Clinical disease progression|54|||
163456377|NCT01244191|590368030|FG001|Overall Study|Clinical disease progression|36|||
163456378|NCT01244191|590368029|FG000|Overall Study|Adverse Event|65|||
163456379|NCT01244191|590368030|FG001|Overall Study|Adverse Event|48|||
163456380|NCT01244191|590368029|FG000|Overall Study|Death|22|||
163456381|NCT01244191|590368030|FG001|Overall Study|Death|29|||
163456382|NCT01244191|590368029|FG000|Overall Study|Lost to Follow-up|0|||
163456383|NCT01244191|590368030|FG001|Overall Study|Lost to Follow-up|2|||
163456384|NCT01244191|590368029|FG000|Overall Study|Protocol Violation|1|||
163456385|NCT01244191|590368030|FG001|Overall Study|Protocol Violation|2|||
163456386|NCT01244191|590368029|FG000|Overall Study|Withdrawal by Subject|31|||
163456387|NCT01244191|590368030|FG001|Overall Study|Withdrawal by Subject|23|||
163456388|NCT01244191|590368029|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
163456389|NCT01244191|590368030|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
163456390|NCT01752842|590368031|FG000|Overall Study|Adverse Event|3|||
163456391|NCT01752842|590368032|FG001|Overall Study|Adverse Event|0|||
163456392|NCT01752842|590368031|FG000|Overall Study|Withdrawal by Subject|0|||
163456393|NCT01752842|590368032|FG001|Overall Study|Withdrawal by Subject|2|||
163456394|NCT02164513|590368033|FG000|Overall Study|Adverse Event|162|||
163456395|NCT02164513|590368034|FG001|Overall Study|Adverse Event|180|||
163456396|NCT02164513|590368035|FG002|Overall Study|Adverse Event|111|||
163456397|NCT02164513|590368033|FG000|Overall Study|Other: Study Closed or terminated|5|||
163456398|NCT02164513|590368034|FG001|Overall Study|Other: Study Closed or terminated|2|||
163456399|NCT02164513|590368035|FG002|Overall Study|Other: Study Closed or terminated|4|||
163456400|NCT02164513|590368033|FG000|Overall Study|Lost to Follow-up|30|||
163456401|NCT02164513|590368034|FG001|Overall Study|Lost to Follow-up|36|||
163456402|NCT02164513|590368035|FG002|Overall Study|Lost to Follow-up|22|||
163456403|NCT02164513|590368033|FG000|Overall Study|Physician Decision|47|||
163456404|NCT02164513|590368034|FG001|Overall Study|Physician Decision|57|||
163456405|NCT02164513|590368035|FG002|Overall Study|Physician Decision|28|||
163456406|NCT02164513|590368033|FG000|Overall Study|Withdrawal by Subject|192|||
163456407|NCT02164513|590368034|FG001|Overall Study|Withdrawal by Subject|261|||
163456408|NCT02164513|590368035|FG002|Overall Study|Withdrawal by Subject|130|||
163456409|NCT02164513|590368033|FG000|Overall Study|Other: Reason not provided by site|1|||
163456410|NCT02164513|590368034|FG001|Overall Study|Other: Reason not provided by site|0|||
163456411|NCT02164513|590368035|FG002|Overall Study|Other: Reason not provided by site|0|||
163456412|NCT05301322|590368036|FG000|Overall Study|Adverse Event|7|||
163456413|NCT05301322|590368037|FG001|Overall Study|Adverse Event|3|||
163456414|NCT05301322|590368036|FG000|Overall Study|Death|0|||
163456415|NCT05301322|590368037|FG001|Overall Study|Death|1|||
163456416|NCT05301322|590368036|FG000|Overall Study|Lost to Follow-up|2|||
163456417|NCT05301322|590368037|FG001|Overall Study|Lost to Follow-up|1|||
163456418|NCT05301322|590368036|FG000|Overall Study|Protocol Violation|3|||
163456419|NCT05301322|590368037|FG001|Overall Study|Protocol Violation|1|||
163456420|NCT05301322|590368036|FG000|Overall Study|Withdrawal by Subject|3|||
163456421|NCT05301322|590368037|FG001|Overall Study|Withdrawal by Subject|0|||
163456422|NCT05301322|590368036|FG000|Overall Study|Other|4|||
163456423|NCT05301322|590368037|FG001|Overall Study|Other|0|||
163456424|NCT04971785|590368038|FG000|Overall Study|Withdrew Consent|5|||
163456425|NCT04971785|590368039|FG001|Overall Study|Withdrew Consent|5|||
163456426|NCT04971785|590368040|FG002|Overall Study|Withdrew Consent|17|||
163456427|NCT04971785|590368041|FG003|Overall Study|Withdrew Consent|7|||
163456428|NCT04971785|590368038|FG000|Overall Study|Adverse Event|7|||
163456429|NCT04971785|590368039|FG001|Overall Study|Adverse Event|8|||
163456430|NCT04971785|590368040|FG002|Overall Study|Adverse Event|6|||
163456431|NCT04971785|590368041|FG003|Overall Study|Adverse Event|3|||
163456432|NCT04971785|590368038|FG000|Overall Study|Lost to Follow-up|2|||
163456433|NCT04971785|590368039|FG001|Overall Study|Lost to Follow-up|1|||
163456434|NCT04971785|590368040|FG002|Overall Study|Lost to Follow-up|6|||
163456435|NCT04971785|590368041|FG003|Overall Study|Lost to Follow-up|7|||
163456436|NCT04971785|590368038|FG000|Overall Study|Protocol Violation|3|||
163456437|NCT04971785|590368039|FG001|Overall Study|Protocol Violation|1|||
163456438|NCT04971785|590368040|FG002|Overall Study|Protocol Violation|1|||
163456439|NCT04971785|590368041|FG003|Overall Study|Protocol Violation|2|||
163456440|NCT04971785|590368038|FG000|Overall Study|Investigator's Discretion|3|||
163456441|NCT04971785|590368039|FG001|Overall Study|Investigator's Discretion|1|||
163456442|NCT04971785|590368040|FG002|Overall Study|Investigator's Discretion|1|||
163456443|NCT04971785|590368041|FG003|Overall Study|Investigator's Discretion|0|||
163456444|NCT04971785|590368038|FG000|Overall Study|Randomized but Never Treated|1|||
163456445|NCT04971785|590368039|FG001|Overall Study|Randomized but Never Treated|2|||
163456446|NCT04971785|590368040|FG002|Overall Study|Randomized but Never Treated|0|||
163456447|NCT04971785|590368041|FG003|Overall Study|Randomized but Never Treated|1|||
163456448|NCT04971785|590368038|FG000|Overall Study|Death|0|||
163456449|NCT04971785|590368039|FG001|Overall Study|Death|1|||
163456450|NCT04971785|590368040|FG002|Overall Study|Death|1|||
163456451|NCT04971785|590368041|FG003|Overall Study|Death|0|||
163456452|NCT04971785|590368038|FG000|Overall Study|Site Terminated by Sponsor|1|||
163456453|NCT04971785|590368039|FG001|Overall Study|Site Terminated by Sponsor|1|||
163456454|NCT04971785|590368040|FG002|Overall Study|Site Terminated by Sponsor|0|||
163456455|NCT04971785|590368041|FG003|Overall Study|Site Terminated by Sponsor|0|||
163456456|NCT03829332|590368042|FG000|Overall Study|Death|225|||
163456457|NCT03829332|590368043|FG001|Overall Study|Death|230|||
163456458|NCT03829332|590368042|FG000|Overall Study|Lost to Follow-up|1|||
163456459|NCT03829332|590368043|FG001|Overall Study|Lost to Follow-up|3|||
163456460|NCT03829332|590368042|FG000|Overall Study|Physician Decision|1|||
163456461|NCT03829332|590368043|FG001|Overall Study|Physician Decision|0|||
163456462|NCT03829332|590368042|FG000|Overall Study|Sponsor Decision|71|||
163456463|NCT03829332|590368043|FG001|Overall Study|Sponsor Decision|72|||
163456464|NCT03829332|590368042|FG000|Overall Study|Withdrawal by Subject|11|||
163456465|NCT03829332|590368043|FG001|Overall Study|Withdrawal by Subject|9|||
163456466|NCT00646113|590369339|FG000|Overall Study|Lost to Follow-up|5|||
163456467|NCT00646113|590369339|FG000|Overall Study|Adverse Event|3|||
163456468|NCT05458011|590369340|FG000|DB Period (12 Weeks)|Adverse Event|2|||
163456469|NCT05458011|590369341|FG001|DB Period (12 Weeks)|Adverse Event|1|||
163456470|NCT05458011|590369342|FG002|DB Period (12 Weeks)|Adverse Event|1|||
163456471|NCT05458011|590369340|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
163456472|NCT05458011|590369341|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
163456473|NCT05458011|590369342|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
163456474|NCT05458011|590369340|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
163456475|NCT05458011|590369341|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
163456476|NCT05458011|590369342|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
163456477|NCT05458011|590369340|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
163456478|NCT05458011|590369341|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
163456479|NCT05458011|590369342|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
163456480|NCT05458011|590369340|FG000|OL Period (12 Weeks)|Adverse Event|1|||
163456481|NCT05458011|590369341|FG001|OL Period (12 Weeks)|Adverse Event|2|||
163456482|NCT05458011|590369342|FG002|OL Period (12 Weeks)|Adverse Event|1|||
163456483|NCT05458011|590369340|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
163456484|NCT05458011|590369341|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
163456485|NCT05458011|590369342|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
163456486|NCT02690207|590369350|FG000|Overall Study|Lost to Follow-up|48|||
163456487|NCT02690207|590369350|FG000|Overall Study|Withdrawal by Subject|46|||
163456488|NCT02690207|590369350|FG000|Overall Study|Protocol Violation|2|||
163456489|NCT02690207|590369350|FG000|Overall Study|Serious adverse event|110|||
163456490|NCT02690207|590369350|FG000|Overall Study|Non-serious Adverse Event|18|||
163456491|NCT02690207|590369350|FG000|Overall Study|Migrated/moved from study area|5|||
163456492|NCT02690207|590369350|FG000|Overall Study|Suspected HZ Episode|1|||
163456493|NCT02690207|590369350|FG000|Overall Study|Other reasons for withdrawal|23|||
163456494|NCT04656418|590369353|FG000|Overall Study|Withdrawal by Subject|1|||
163456495|NCT04656418|590369354|FG001|Overall Study|Withdrawal by Subject|3|||
163456496|NCT02586077|590369355|FG000|Overall Study|Withdrawal by Subject|1|||
163456497|NCT02586077|590369355|FG000|Overall Study|Physician Decision|4|||
163456498|NCT02586077|590369355|FG000|Overall Study|Lost to Follow-up|3|||
163456499|NCT02701192|590369356|FG000|Overall Study|Protocol Violation|2|||
163456500|NCT02701192|590369356|FG000|Overall Study|Lost to Follow-up|4|||
163456501|NCT01245764|590369358|FG000|Study Phase A|Other|3|||
163456502|NCT01245764|590369359|FG001|Study Phase A|Other|2|||
163456503|NCT01245764|590369360|FG002|Study Phase A|Other|3|||
163456504|NCT01245764|590369361|FG003|Study Phase A|Other|1|||
163456505|NCT01245764|590369358|FG000|Study Phase A|Protocol Violation|6|||
163456506|NCT01245764|590369359|FG001|Study Phase A|Protocol Violation|3|||
163456507|NCT01245764|590369360|FG002|Study Phase A|Protocol Violation|2|||
163456508|NCT01245764|590369361|FG003|Study Phase A|Protocol Violation|2|||
163456509|NCT01245764|590369358|FG000|Study Phase A|Lost to Follow-up|0|||
163456510|NCT01245764|590369359|FG001|Study Phase A|Lost to Follow-up|0|||
163456511|NCT01245764|590369360|FG002|Study Phase A|Lost to Follow-up|5|||
163456512|NCT01245764|590369361|FG003|Study Phase A|Lost to Follow-up|0|||
163456513|NCT00003476|590369362|FG000|Overall Study|Not evaluable|1|||
163456514|NCT02667457|590369363|FG000|Overall Study|Withdrawal by Subject|1|||
163456515|NCT02667457|590369364|FG001|Overall Study|Withdrawal by Subject|0|||
163456516|NCT02667457|590369363|FG000|Overall Study|Other Reason|0|||
163456517|NCT02667457|590369364|FG001|Overall Study|Other Reason|2|||
163456518|NCT02475850|590369365|FG000|Overall Study|Death|155|||
163456519|NCT02475850|590369366|FG001|Overall Study|Death|141|||
163456520|NCT02475850|590369365|FG000|Overall Study|Lost to Follow-up|217|||
163456521|NCT02475850|590369366|FG001|Overall Study|Lost to Follow-up|188|||
163456522|NCT02475850|590369365|FG000|Overall Study|Withdrawal by Subject|221|||
163456523|NCT02475850|590369366|FG001|Overall Study|Withdrawal by Subject|155|||
163456524|NCT03097614|590369368|FG000|Overall Study|Adverse Event|3|||
163456525|NCT00603733|590369369|FG000|Active Phase ITT|Adverse Event|8|||
163456526|NCT00603733|590369370|FG001|Active Phase ITT|Adverse Event|7|||
163456527|NCT00603733|590369369|FG000|Active Phase ITT|Withdrawal by Subject|0|||
163456528|NCT00603733|590369370|FG001|Active Phase ITT|Withdrawal by Subject|3|||
163456529|NCT00603733|590369369|FG000|Active Phase ITT|Lost to Follow-up|0|||
163456530|NCT00603733|590369370|FG001|Active Phase ITT|Lost to Follow-up|1|||
163456531|NCT00603733|590369369|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
163456532|NCT00603733|590369370|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
163456533|NCT00603733|590369369|FG000|Active Phase ITT|Lack of Efficacy|1|||
163456534|NCT00603733|590369370|FG001|Active Phase ITT|Lack of Efficacy|2|||
163456535|NCT00603733|590369369|FG000|Active Phase ITT|Subject moved, site closed|1|||
163456536|NCT00603733|590369370|FG001|Active Phase ITT|Subject moved, site closed|1|||
163456537|NCT00603733|590369369|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
163456538|NCT00603733|590369370|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
163456539|NCT00603733|590369369|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
163456540|NCT00603733|590369370|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
163456541|NCT00603733|590369369|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
163456542|NCT00603733|590369370|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
163456543|NCT00603733|590369369|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
163456544|NCT00603733|590369370|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
163456545|NCT00603733|590369369|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
163456546|NCT00603733|590369370|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
163456547|NCT00603733|590369369|FG000|Maintenance Phase ITT|Adverse Event|3|||
163456548|NCT00603733|590369370|FG001|Maintenance Phase ITT|Adverse Event|6|||
163456549|NCT00603733|590369369|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
163456550|NCT00603733|590369370|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
163456551|NCT00603733|590369369|FG000|Maintenance Phase ITT|Protocol Violation|1|||
163456552|NCT00603733|590369370|FG001|Maintenance Phase ITT|Protocol Violation|1|||
163456553|NCT00603733|590369369|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
163456554|NCT00603733|590369370|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
163456555|NCT00603733|590369369|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
163456556|NCT00603733|590369370|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
163456557|NCT00603733|590369369|FG000|Maintenance Phase ITT|Physician Decision|0|||
163456558|NCT00603733|590369370|FG001|Maintenance Phase ITT|Physician Decision|1|||
163456559|NCT00603733|590369369|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
163456560|NCT00603733|590369370|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
163456561|NCT00912340|590369374|FG000|Overall Study|Adverse Event|2|||
163456562|NCT00912340|590369375|FG001|Overall Study|Adverse Event|4|||
163456563|NCT00912340|590369376|FG002|Overall Study|Adverse Event|0|||
163456564|NCT00912340|590369374|FG000|Overall Study|Protocol revised to remove arm|0|||
163456565|NCT00912340|590369375|FG001|Overall Study|Protocol revised to remove arm|0|||
163456566|NCT00912340|590369376|FG002|Overall Study|Protocol revised to remove arm|4|||
163456567|NCT00436982|590369381|FG000|Overall Study|Withdrawal by Subject|3|||
163456568|NCT00436982|590369382|FG001|Overall Study|Withdrawal by Subject|1|||
163456569|NCT00436982|590369381|FG000|Overall Study|Did not receive allocated intervention|0|||
163456570|NCT00436982|590369382|FG001|Overall Study|Did not receive allocated intervention|1|||
163456571|NCT00436982|590369381|FG000|Overall Study|no RSA data|1|||
163456572|NCT00436982|590369382|FG001|Overall Study|no RSA data|2|||
163456573|NCT00953225|590369383|FG000|Overall Study|Withdrawal by Subject|2|||
163456574|NCT00953225|590369384|FG001|Overall Study|Withdrawal by Subject|0|||
163456575|NCT02254551|590369388|FG000|Dose Escalation|Physician Decision|1|||
163456576|NCT02254551|590369388|FG000|Dose Escalation|Dose-limiting toxicity|2|||
163456577|NCT04058158|590369389|FG000|Period 1|Death|1|||
163456578|NCT04058158|590369390|FG001|Period 1|Death|0|||
163456579|NCT04058158|590369389|FG000|Period 1|Adverse Event|1|||
163456580|NCT04058158|590369390|FG001|Period 1|Adverse Event|1|||
163456581|NCT04058158|590369389|FG000|Period 1|Pregnancy|0|||
163456582|NCT04058158|590369390|FG001|Period 1|Pregnancy|1|||
163456583|NCT02215616|590369391|FG000|Overall Study|Sponsor requested to stop study drug|0|||
163456584|NCT02215616|590369392|FG001|Overall Study|Sponsor requested to stop study drug|0|||
163456585|NCT02215616|590369393|FG002|Overall Study|Sponsor requested to stop study drug|1|||
163456586|NCT02215616|590369394|FG003|Overall Study|Sponsor requested to stop study drug|4|||
163456587|NCT02215616|590369391|FG000|Overall Study|Death|1|||
163456588|NCT02215616|590369392|FG001|Overall Study|Death|0|||
163456589|NCT02215616|590369393|FG002|Overall Study|Death|0|||
163456590|NCT02215616|590369394|FG003|Overall Study|Death|0|||
163456591|NCT02215616|590369391|FG000|Overall Study|Adverse Event|7|||
163456592|NCT02215616|590369392|FG001|Overall Study|Adverse Event|4|||
163456593|NCT02215616|590369393|FG002|Overall Study|Adverse Event|9|||
163456594|NCT02215616|590369394|FG003|Overall Study|Adverse Event|2|||
163456595|NCT02215616|590369391|FG000|Overall Study|Withdrawal by Subject|1|||
163456596|NCT02215616|590369392|FG001|Overall Study|Withdrawal by Subject|8|||
163456597|NCT02215616|590369393|FG002|Overall Study|Withdrawal by Subject|2|||
163456598|NCT02215616|590369394|FG003|Overall Study|Withdrawal by Subject|5|||
163456599|NCT02215616|590369391|FG000|Overall Study|Non-compliance|0|||
163456600|NCT02215616|590369392|FG001|Overall Study|Non-compliance|2|||
163456601|NCT02215616|590369393|FG002|Overall Study|Non-compliance|1|||
163456602|NCT02215616|590369394|FG003|Overall Study|Non-compliance|0|||
163456603|NCT02215616|590369391|FG000|Overall Study|Protocol Violation|0|||
163456604|NCT02215616|590369392|FG001|Overall Study|Protocol Violation|2|||
163456605|NCT02215616|590369393|FG002|Overall Study|Protocol Violation|0|||
163456606|NCT02215616|590369394|FG003|Overall Study|Protocol Violation|0|||
163456607|NCT02215616|590369391|FG000|Overall Study|Lost to Follow-up|1|||
163456608|NCT02215616|590369392|FG001|Overall Study|Lost to Follow-up|1|||
163456609|NCT02215616|590369393|FG002|Overall Study|Lost to Follow-up|0|||
163456610|NCT02215616|590369394|FG003|Overall Study|Lost to Follow-up|1|||
163456611|NCT02215616|590369391|FG000|Overall Study|Other than specified|1|||
163456612|NCT02215616|590369392|FG001|Overall Study|Other than specified|0|||
163456613|NCT02215616|590369393|FG002|Overall Study|Other than specified|1|||
163456614|NCT02215616|590369394|FG003|Overall Study|Other than specified|1|||
163456615|NCT01634113|590369395|FG000|Overall Study|Not treated|0|||
163456616|NCT01634113|590369396|FG001|Overall Study|Not treated|0|||
163456617|NCT01634113|590369397|FG002|Overall Study|Not treated|1|||
163456618|NCT00520299|590369400|FG000|Overall Study|Withdrawal by Subject|0|||
163456619|NCT00520299|590369401|FG001|Overall Study|Withdrawal by Subject|0|||
163456620|NCT00520299|590369402|FG002|Overall Study|Withdrawal by Subject|2|||
163456621|NCT00520299|590369400|FG000|Overall Study|Progressive disease|0|||
163456622|NCT00520299|590369401|FG001|Overall Study|Progressive disease|3|||
163456623|NCT00520299|590369402|FG002|Overall Study|Progressive disease|4|||
163456624|NCT01352845|590369403|FG000|Overall Study|Lost to Follow-up|313|||
163456625|NCT01352845|590369404|FG001|Overall Study|Lost to Follow-up|92|||
163456626|NCT01352845|590369403|FG000|Overall Study|No Longer Willing to Participate|205|||
163456627|NCT01352845|590369404|FG001|Overall Study|No Longer Willing to Participate|58|||
163456628|NCT01352845|590369403|FG000|Overall Study|Withdrawal by Subject|48|||
163456629|NCT01352845|590369404|FG001|Overall Study|Withdrawal by Subject|16|||
163456630|NCT01352845|590369403|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
163456631|NCT01352845|590369404|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
163456632|NCT01352845|590369403|FG000|Overall Study|Pregnancy|27|||
163456633|NCT01352845|590369404|FG001|Overall Study|Pregnancy|7|||
163456634|NCT01352845|590369403|FG000|Overall Study|Adverse Event|22|||
163456635|NCT01352845|590369404|FG001|Overall Study|Adverse Event|6|||
163456636|NCT01352845|590369403|FG000|Overall Study|Other|17|||
163456637|NCT01352845|590369404|FG001|Overall Study|Other|7|||
163456638|NCT01352845|590369403|FG000|Overall Study|Protocol Violation|12|||
163456639|NCT01352845|590369404|FG001|Overall Study|Protocol Violation|6|||
163456640|NCT01352845|590369403|FG000|Overall Study|Death|3|||
163456641|NCT01352845|590369404|FG001|Overall Study|Death|0|||
163456642|NCT02062463|590369405|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
163456643|NCT02062463|590369406|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
163456644|NCT02062463|590369407|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
163456645|NCT02062463|590369408|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
163456646|NCT02062463|590369405|FG000|Stage 2|Adverse Event|0|||
163456647|NCT02062463|590369406|FG001|Stage 2|Adverse Event|0|||
163456648|NCT02062463|590369407|FG002|Stage 2|Adverse Event|12|||
163456649|NCT02062463|590369408|FG003|Stage 2|Adverse Event|20|||
163456650|NCT02062463|590369405|FG000|Stage 2|Lack of Efficacy|0|||
163456651|NCT02062463|590369406|FG001|Stage 2|Lack of Efficacy|0|||
163456652|NCT02062463|590369407|FG002|Stage 2|Lack of Efficacy|3|||
163456653|NCT02062463|590369408|FG003|Stage 2|Lack of Efficacy|4|||
163456654|NCT02062463|590369405|FG000|Stage 2|Lost to Follow-up|0|||
163456655|NCT02062463|590369406|FG001|Stage 2|Lost to Follow-up|0|||
163456656|NCT02062463|590369407|FG002|Stage 2|Lost to Follow-up|20|||
163456657|NCT02062463|590369408|FG003|Stage 2|Lost to Follow-up|20|||
163456658|NCT02062463|590369405|FG000|Stage 2|Non-Compliance|0|||
163456659|NCT02062463|590369406|FG001|Stage 2|Non-Compliance|0|||
163456660|NCT02062463|590369407|FG002|Stage 2|Non-Compliance|0|||
163456661|NCT02062463|590369408|FG003|Stage 2|Non-Compliance|1|||
163456662|NCT02062463|590369405|FG000|Stage 2|Other than specified|0|||
163456663|NCT02062463|590369406|FG001|Stage 2|Other than specified|0|||
163456664|NCT02062463|590369407|FG002|Stage 2|Other than specified|3|||
163456665|NCT02062463|590369408|FG003|Stage 2|Other than specified|1|||
163456666|NCT02062463|590369405|FG000|Stage 2|Withdrawal by Subject|0|||
163456667|NCT02062463|590369406|FG001|Stage 2|Withdrawal by Subject|0|||
163456668|NCT02062463|590369407|FG002|Stage 2|Withdrawal by Subject|15|||
163456669|NCT02062463|590369408|FG003|Stage 2|Withdrawal by Subject|10|||
163456670|NCT01956240|590369417|FG000|Overall Study|Lost to Follow-up|6|||
163456671|NCT01956240|590369418|FG001|Overall Study|Lost to Follow-up|20|||
163456672|NCT01956240|590369417|FG000|Overall Study|Adverse Event|17|||
163456673|NCT01956240|590369418|FG001|Overall Study|Adverse Event|4|||
163456674|NCT03172481|590369422|FG000|Double-blind|Withdrawal by Subject|1|||
163456675|NCT03172481|590369423|FG001|Double-blind|Withdrawal by Subject|0|||
163456676|NCT02759562|590369427|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
163456677|NCT02759562|590369428|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
163456678|NCT02759562|590369427|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
163456679|NCT02759562|590369428|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
163456680|NCT01957709|590369429|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
163456681|NCT01061736|590369431|FG000|Overall Study|Dose regimen not selected|0|||
163456682|NCT01061736|590369432|FG001|Overall Study|Dose regimen not selected|0|||
163456683|NCT01061736|590369433|FG002|Overall Study|Dose regimen not selected|0|||
163456684|NCT01061736|590369434|FG003|Overall Study|Dose regimen not selected|0|||
163456685|NCT01061736|590369435|FG004|Overall Study|Dose regimen not selected|0|||
163456686|NCT01061736|590369436|FG005|Overall Study|Dose regimen not selected|0|||
163456687|NCT01061736|590369437|FG006|Overall Study|Dose regimen not selected|79|||
163456688|NCT01061736|590369438|FG007|Overall Study|Dose regimen not selected|0|||
163456689|NCT01061736|590369439|FG008|Overall Study|Dose regimen not selected|0|||
163456690|NCT01061736|590369440|FG009|Overall Study|Dose regimen not selected|0|||
163456691|NCT01061736|590369431|FG000|Overall Study|Adverse Event|13|||
163456692|NCT01061736|590369432|FG001|Overall Study|Adverse Event|1|||
163456693|NCT01061736|590369433|FG002|Overall Study|Adverse Event|3|||
163456694|NCT01061736|590369434|FG003|Overall Study|Adverse Event|2|||
163456695|NCT01061736|590369435|FG004|Overall Study|Adverse Event|4|||
163456696|NCT01061736|590369436|FG005|Overall Study|Adverse Event|1|||
163456697|NCT01061736|590369437|FG006|Overall Study|Adverse Event|4|||
163456698|NCT01061736|590369438|FG007|Overall Study|Adverse Event|63|||
163456699|NCT01061736|590369439|FG008|Overall Study|Adverse Event|67|||
163456700|NCT01061736|590369440|FG009|Overall Study|Adverse Event|34|||
163456701|NCT01061736|590369431|FG000|Overall Study|Lack of Efficacy|0|||
163456702|NCT01061736|590369432|FG001|Overall Study|Lack of Efficacy|2|||
163456703|NCT01061736|590369433|FG002|Overall Study|Lack of Efficacy|1|||
163456704|NCT01061736|590369434|FG003|Overall Study|Lack of Efficacy|1|||
163456705|NCT01061736|590369435|FG004|Overall Study|Lack of Efficacy|1|||
163456706|NCT01061736|590369436|FG005|Overall Study|Lack of Efficacy|2|||
163456707|NCT01061736|590369437|FG006|Overall Study|Lack of Efficacy|1|||
163456708|NCT01061736|590369438|FG007|Overall Study|Lack of Efficacy|9|||
163456709|NCT01061736|590369439|FG008|Overall Study|Lack of Efficacy|9|||
163456710|NCT01061736|590369440|FG009|Overall Study|Lack of Efficacy|10|||
163456711|NCT01061736|590369431|FG000|Overall Study|Poor compliance to protocol|0|||
163456712|NCT01061736|590369432|FG001|Overall Study|Poor compliance to protocol|0|||
163456713|NCT01061736|590369433|FG002|Overall Study|Poor compliance to protocol|0|||
163456714|NCT01061736|590369434|FG003|Overall Study|Poor compliance to protocol|0|||
163456715|NCT01061736|590369435|FG004|Overall Study|Poor compliance to protocol|0|||
163456716|NCT01061736|590369436|FG005|Overall Study|Poor compliance to protocol|0|||
163456717|NCT01061736|590369437|FG006|Overall Study|Poor compliance to protocol|0|||
163456718|NCT01061736|590369438|FG007|Overall Study|Poor compliance to protocol|2|||
163456719|NCT01061736|590369439|FG008|Overall Study|Poor compliance to protocol|5|||
163456720|NCT01061736|590369440|FG009|Overall Study|Poor compliance to protocol|9|||
163456721|NCT01061736|590369431|FG000|Overall Study|Not treated|0|||
163456722|NCT01061736|590369432|FG001|Overall Study|Not treated|0|||
163456723|NCT01061736|590369433|FG002|Overall Study|Not treated|0|||
163456724|NCT01061736|590369434|FG003|Overall Study|Not treated|0|||
163456725|NCT01061736|590369435|FG004|Overall Study|Not treated|1|||
163456726|NCT01061736|590369436|FG005|Overall Study|Not treated|0|||
163456727|NCT01061736|590369437|FG006|Overall Study|Not treated|0|||
163456728|NCT01061736|590369438|FG007|Overall Study|Not treated|2|||
163456729|NCT01061736|590369439|FG008|Overall Study|Not treated|1|||
163456730|NCT01061736|590369440|FG009|Overall Study|Not treated|0|||
163456731|NCT01061736|590369431|FG000|Overall Study|Other than specified above|0|||
163456732|NCT01061736|590369432|FG001|Overall Study|Other than specified above|1|||
163456733|NCT01061736|590369433|FG002|Overall Study|Other than specified above|2|||
163456734|NCT01061736|590369434|FG003|Overall Study|Other than specified above|0|||
163456735|NCT01061736|590369435|FG004|Overall Study|Other than specified above|1|||
163456736|NCT01061736|590369436|FG005|Overall Study|Other than specified above|0|||
163456737|NCT01061736|590369437|FG006|Overall Study|Other than specified above|0|||
163456738|NCT01061736|590369438|FG007|Overall Study|Other than specified above|18|||
163456739|NCT01061736|590369439|FG008|Overall Study|Other than specified above|15|||
163456740|NCT01061736|590369440|FG009|Overall Study|Other than specified above|21|||
163456741|NCT01925612|590369441|FG000|Overall Study|Progressive Disease|1|||
163456742|NCT01925612|590369442|FG001|Overall Study|Progressive Disease|1|||
163456743|NCT01925612|590369443|FG002|Overall Study|Progressive Disease|1|||
163456744|NCT01925612|590369444|FG003|Overall Study|Progressive Disease|0|||
163456745|NCT01925612|590369445|FG004|Overall Study|Progressive Disease|0|||
163456746|NCT01925612|590369441|FG000|Overall Study|Adverse Event|3|||
163456747|NCT01925612|590369442|FG001|Overall Study|Adverse Event|3|||
163456748|NCT01925612|590369443|FG002|Overall Study|Adverse Event|0|||
163456749|NCT01925612|590369444|FG003|Overall Study|Adverse Event|1|||
163456750|NCT01925612|590369445|FG004|Overall Study|Adverse Event|2|||
163456751|NCT01093755|590369447|FG000|Overall Study|Withdrawal by Subject|3|||
163456752|NCT01093755|590369448|FG001|Overall Study|Withdrawal by Subject|4|||
163456753|NCT03115112|590369449|FG000|Overall Study|Adverse Event|5|||
163456754|NCT03115112|590369450|FG001|Overall Study|Adverse Event|1|||
163456755|NCT03115112|590369449|FG000|Overall Study|Withdrawal by Subject|4|||
163456756|NCT03115112|590369450|FG001|Overall Study|Withdrawal by Subject|2|||
163456757|NCT03115112|590369449|FG000|Overall Study|Lost to Follow-up|0|||
163456758|NCT03115112|590369450|FG001|Overall Study|Lost to Follow-up|1|||
163456759|NCT03115112|590369449|FG000|Overall Study|Death|1|||
163456760|NCT03115112|590369450|FG001|Overall Study|Death|0|||
163456761|NCT03115112|590369449|FG000|Overall Study|Pregnancy|1|||
163456762|NCT03115112|590369450|FG001|Overall Study|Pregnancy|0|||
163456763|NCT03115112|590369449|FG000|Overall Study|Site closure|1|||
163456764|NCT03115112|590369450|FG001|Overall Study|Site closure|1|||
163456765|NCT01610076|590369451|FG000|Overall Study|Technical issue with video|0|||
163456766|NCT01610076|590369452|FG001|Overall Study|Technical issue with video|1|||
163456767|NCT01610076|590369451|FG000|Overall Study|Lost to Follow-up|3|||
163456768|NCT01610076|590369452|FG001|Overall Study|Lost to Follow-up|4|||
163456769|NCT02168803|590369456|FG000|Overall Study|Lost to Follow-up|1|||
163456770|NCT02168803|590369457|FG001|Overall Study|Lost to Follow-up|0|||
163456771|NCT02168803|590369458|FG002|Overall Study|Lost to Follow-up|1|||
163456772|NCT02168803|590369456|FG000|Overall Study|Withdrawal by Subject|1|||
163456773|NCT02168803|590369457|FG001|Overall Study|Withdrawal by Subject|1|||
163456774|NCT02168803|590369458|FG002|Overall Study|Withdrawal by Subject|2|||
163456775|NCT02168803|590369456|FG000|Overall Study|Physician Decision|0|||
163456776|NCT02168803|590369457|FG001|Overall Study|Physician Decision|1|||
163456777|NCT02168803|590369458|FG002|Overall Study|Physician Decision|0|||
163456778|NCT02168803|590369456|FG000|Overall Study|Adverse Event|0|||
163456779|NCT02168803|590369457|FG001|Overall Study|Adverse Event|1|||
163456780|NCT02168803|590369458|FG002|Overall Study|Adverse Event|1|||
163456781|NCT02168803|590369456|FG000|Overall Study|Death|0|||
163456782|NCT02168803|590369457|FG001|Overall Study|Death|0|||
163456783|NCT02168803|590369458|FG002|Overall Study|Death|1|||
163456784|NCT02168803|590369456|FG000|Overall Study|Sponsor Decision|0|||
163456785|NCT02168803|590369457|FG001|Overall Study|Sponsor Decision|0|||
163456786|NCT02168803|590369458|FG002|Overall Study|Sponsor Decision|1|||
163456787|NCT01107405|590369459|FG000|Overall Study|Adverse Event|1|||
163456788|NCT01107405|590369460|FG001|Overall Study|Adverse Event|1|||
163456789|NCT01107405|590369461|FG002|Overall Study|Adverse Event|0|||
163456790|NCT01107405|590369462|FG003|Overall Study|Adverse Event|0|||
163456791|NCT01107405|590369463|FG004|Overall Study|Adverse Event|2|||
163456792|NCT01107405|590369459|FG000|Overall Study|Withdrawal by Subject|1|||
163456793|NCT01107405|590369460|FG001|Overall Study|Withdrawal by Subject|0|||
163456794|NCT01107405|590369461|FG002|Overall Study|Withdrawal by Subject|1|||
163456795|NCT01107405|590369462|FG003|Overall Study|Withdrawal by Subject|2|||
163456796|NCT01107405|590369463|FG004|Overall Study|Withdrawal by Subject|1|||
163456797|NCT01107405|590369459|FG000|Overall Study|Protocol Violation|0|||
163456798|NCT01107405|590369460|FG001|Overall Study|Protocol Violation|0|||
163456799|NCT01107405|590369461|FG002|Overall Study|Protocol Violation|1|||
163456800|NCT01107405|590369462|FG003|Overall Study|Protocol Violation|1|||
163456801|NCT01107405|590369463|FG004|Overall Study|Protocol Violation|0|||
163456802|NCT01895452|590369470|FG000|Overall Study|Adverse Event|1|||
163456803|NCT01895452|590369471|FG001|Overall Study|Adverse Event|4|||
163456804|NCT01895452|590369470|FG000|Overall Study|Lost to Follow-up|1|||
163456805|NCT01895452|590369471|FG001|Overall Study|Lost to Follow-up|5|||
163456806|NCT01895452|590369470|FG000|Overall Study|Pregnancy|0|||
163456807|NCT01895452|590369471|FG001|Overall Study|Pregnancy|1|||
163456808|NCT01895452|590369470|FG000|Overall Study|Withdrawal by Subject|2|||
163456809|NCT01895452|590369471|FG001|Overall Study|Withdrawal by Subject|14|||
163456810|NCT01895452|590369470|FG000|Overall Study|Underlying disease|0|||
163456811|NCT01895452|590369471|FG001|Overall Study|Underlying disease|3|||
163456812|NCT01895452|590369470|FG000|Overall Study|Noncompliance with study drug|0|||
163456813|NCT01895452|590369471|FG001|Overall Study|Noncompliance with study drug|1|||
163456814|NCT00980343|590369472|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
163456815|NCT00980343|590369473|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
163456816|NCT01188538|590369478|FG000|Overall Study|Lost to Follow-up|0|||
163456817|NCT01188538|590369479|FG001|Overall Study|Lost to Follow-up|1|||
163456818|NCT01170702|590369482|FG000|Overall Study|Exclusion criteria met after consent|1|||
163456819|NCT01170702|590369483|FG001|Overall Study|Exclusion criteria met after consent|2|||
163456820|NCT01170702|590369484|FG002|Overall Study|Exclusion criteria met after consent|0|||
163456821|NCT01170702|590369485|FG003|Overall Study|Exclusion criteria met after consent|2|||
163456822|NCT04999969|590369486|FG000|Overall Study|Death|76|||
163456823|NCT04999969|590369486|FG000|Overall Study|Progressive Disease|1|||
163456824|NCT04999969|590369486|FG000|Overall Study|Withdrawal by Subject|8|||
163456825|NCT06964165|590369487|FG000|Overall Study|Death|4|||
163456826|NCT06964165|590369488|FG001|Overall Study|Death|4|||
163456827|NCT06964165|590369487|FG000|Overall Study|Physician Decision|1|||
163456828|NCT06964165|590369488|FG001|Overall Study|Physician Decision|1|||
163456829|NCT06964165|590369487|FG000|Overall Study|Withdrawal by Subject|0|||
163456830|NCT06964165|590369488|FG001|Overall Study|Withdrawal by Subject|2|||
163456831|NCT06964165|590369487|FG000|Overall Study|Study terminated by sponsor|12|||
163456832|NCT06964165|590369488|FG001|Overall Study|Study terminated by sponsor|10|||
163456833|NCT06964165|590369487|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
163456834|NCT06964165|590369488|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
163456835|NCT06964165|590369487|FG000|Overall Study|Participant removed due to non-compliance|0|||
163456836|NCT06964165|590369488|FG001|Overall Study|Participant removed due to non-compliance|1|||
163456837|NCT01551758|590369489|FG000|Overall Study|Adverse Event|29|||
163456838|NCT01551758|590369490|FG001|Overall Study|Adverse Event|43|||
163456839|NCT01551758|590369489|FG000|Overall Study|Lack of Efficacy|0|||
163456840|NCT01551758|590369490|FG001|Overall Study|Lack of Efficacy|1|||
163456841|NCT01551758|590369489|FG000|Overall Study|Protocol Violation|5|||
163456842|NCT01551758|590369490|FG001|Overall Study|Protocol Violation|6|||
163456843|NCT01551758|590369489|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
163456844|NCT01551758|590369490|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
163456845|NCT01551758|590369489|FG000|Overall Study|Lost to Follow-up|29|||
163456846|NCT01551758|590369490|FG001|Overall Study|Lost to Follow-up|25|||
163456847|NCT01551758|590369489|FG000|Overall Study|Physician Decision|9|||
163456848|NCT01551758|590369490|FG001|Overall Study|Physician Decision|3|||
163456849|NCT01551758|590369489|FG000|Overall Study|Withdrawal by Subject|14|||
163456850|NCT01551758|590369490|FG001|Overall Study|Withdrawal by Subject|17|||
163456851|NCT05584202|590369495|FG000|Overall Study|Withdrawal of Consent|3|||
163456852|NCT05584202|590369496|FG001|Overall Study|Withdrawal of Consent|2|||
163456853|NCT05584202|590369495|FG000|Overall Study|Lost to Follow-up|2|||
163456854|NCT05584202|590369496|FG001|Overall Study|Lost to Follow-up|1|||
163456855|NCT05584202|590369495|FG000|Overall Study|Death|0|||
163456856|NCT05584202|590369496|FG001|Overall Study|Death|1|||
163456857|NCT03297216|590371122|FG000|Overall Study|Death|0|||
163456858|NCT03297216|590371123|FG001|Overall Study|Death|1|||
163456859|NCT03297216|590371122|FG000|Overall Study|Miscarriage|0|||
163456860|NCT03297216|590371123|FG001|Overall Study|Miscarriage|2|||
163456861|NCT03297216|590371122|FG000|Overall Study|Lost to Follow-up|3|||
163456862|NCT03297216|590371123|FG001|Overall Study|Lost to Follow-up|2|||
163456863|NCT00781963|590371124|FG000|Overall Study|Death|3|||
163456864|NCT00781963|590371125|FG001|Overall Study|Death|0|||
163456865|NCT00781963|590371124|FG000|Overall Study|Lost to Follow-up|2|||
163456866|NCT00781963|590371125|FG001|Overall Study|Lost to Follow-up|1|||
163456867|NCT00781963|590371124|FG000|Overall Study|Withdrawal by Subject|3|||
163456868|NCT00781963|590371125|FG001|Overall Study|Withdrawal by Subject|1|||
163456869|NCT00781963|590371124|FG000|Overall Study|Refused follow-up|9|||
163456870|NCT00781963|590371125|FG001|Overall Study|Refused follow-up|0|||
163456871|NCT02700919|590371126|FG000|Overall Study|Physician Decision|1|||
163456872|NCT02700919|590371127|FG001|Overall Study|Physician Decision|0|||
163456873|NCT02700919|590371128|FG002|Overall Study|Physician Decision|0|||
163456874|NCT02700919|590371126|FG000|Overall Study|Protocol Violation|1|||
163456875|NCT02700919|590371127|FG001|Overall Study|Protocol Violation|0|||
163456876|NCT02700919|590371128|FG002|Overall Study|Protocol Violation|0|||
163456877|NCT02700919|590371126|FG000|Overall Study|Adverse Event|1|||
163456878|NCT02700919|590371127|FG001|Overall Study|Adverse Event|3|||
163456879|NCT02700919|590371128|FG002|Overall Study|Adverse Event|1|||
163456880|NCT02700919|590371126|FG000|Overall Study|Withdrawal by Subject|5|||
163456881|NCT02700919|590371127|FG001|Overall Study|Withdrawal by Subject|8|||
163456882|NCT02700919|590371128|FG002|Overall Study|Withdrawal by Subject|2|||
163456883|NCT02700919|590371126|FG000|Overall Study|Lost to Follow-up|2|||
163456884|NCT02700919|590371127|FG001|Overall Study|Lost to Follow-up|0|||
163456885|NCT02700919|590371128|FG002|Overall Study|Lost to Follow-up|0|||
163456886|NCT02700919|590371126|FG000|Overall Study|Other|2|||
163456887|NCT02700919|590371127|FG001|Overall Study|Other|1|||
163456888|NCT02700919|590371128|FG002|Overall Study|Other|1|||
163456889|NCT02310906|590371144|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
163456890|NCT02310906|590371145|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
163456891|NCT02310906|590371146|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
163456892|NCT02310906|590371147|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
163456893|NCT02310906|590371144|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
163456894|NCT02310906|590371145|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
163456895|NCT02310906|590371146|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
163456896|NCT02310906|590371147|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
163456897|NCT02310906|590371144|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
163456898|NCT02310906|590371145|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
163456899|NCT02310906|590371146|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
163456900|NCT02310906|590371147|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
163456901|NCT02310906|590371144|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
163456902|NCT02310906|590371145|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
163456903|NCT02310906|590371146|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
163456904|NCT02310906|590371147|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
163456905|NCT00433446|590371148|FG000|Overall Study|Adverse Event|4|||
163456906|NCT00433446|590371148|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
163456907|NCT00433446|590371148|FG000|Overall Study|Progression|44|||
163456908|NCT00433446|590371148|FG000|Overall Study|Other - Not Protocol specified|3|||
163456909|NCT00433446|590371148|FG000|Overall Study|Ineligible|9|||
163456910|NCT02899377|590371149|FG000|Overall Study|Adverse Event|1|||
163456911|NCT02899377|590371150|FG001|Overall Study|Adverse Event|0|||
163456912|NCT01231607|590371151|FG000|Overall Study|Adverse Event|0|||
163456913|NCT01231607|590371152|FG001|Overall Study|Adverse Event|8|||
163456914|NCT01231607|590371153|FG002|Overall Study|Adverse Event|4|||
163456915|NCT01231607|590371154|FG003|Overall Study|Adverse Event|4|||
163456916|NCT01231607|590371155|FG004|Overall Study|Adverse Event|5|||
163456917|NCT01231607|590371151|FG000|Overall Study|Lost to Follow-up|13|||
163456918|NCT01231607|590371152|FG001|Overall Study|Lost to Follow-up|11|||
163456919|NCT01231607|590371153|FG002|Overall Study|Lost to Follow-up|10|||
163456920|NCT01231607|590371154|FG003|Overall Study|Lost to Follow-up|10|||
163456921|NCT01231607|590371155|FG004|Overall Study|Lost to Follow-up|4|||
163456922|NCT01231607|590371151|FG000|Overall Study|Physician Decision|4|||
163456923|NCT01231607|590371152|FG001|Overall Study|Physician Decision|4|||
163456924|NCT01231607|590371153|FG002|Overall Study|Physician Decision|3|||
163456925|NCT01231607|590371154|FG003|Overall Study|Physician Decision|5|||
163456926|NCT01231607|590371155|FG004|Overall Study|Physician Decision|4|||
163456927|NCT01231607|590371151|FG000|Overall Study|Protocol Violation|3|||
163456928|NCT01231607|590371152|FG001|Overall Study|Protocol Violation|2|||
163456929|NCT01231607|590371153|FG002|Overall Study|Protocol Violation|0|||
163456930|NCT01231607|590371154|FG003|Overall Study|Protocol Violation|2|||
163456931|NCT01231607|590371155|FG004|Overall Study|Protocol Violation|2|||
163456932|NCT01231607|590371151|FG000|Overall Study|Withdrawal by Subject|9|||
163456933|NCT01231607|590371152|FG001|Overall Study|Withdrawal by Subject|9|||
163456934|NCT01231607|590371153|FG002|Overall Study|Withdrawal by Subject|14|||
163456935|NCT01231607|590371154|FG003|Overall Study|Withdrawal by Subject|17|||
163456936|NCT01231607|590371155|FG004|Overall Study|Withdrawal by Subject|9|||
163456937|NCT03779334|590371160|FG000|Overall Study|Withdrawal by Subject|3|||
163456938|NCT03779334|590371161|FG001|Overall Study|Withdrawal by Subject|0|||
163456939|NCT03779334|590371162|FG002|Overall Study|Withdrawal by Subject|0|||
163456940|NCT03779334|590371160|FG000|Overall Study|Ongoing in Study|5|||
163456941|NCT03779334|590371161|FG001|Overall Study|Ongoing in Study|13|||
163456942|NCT03779334|590371162|FG002|Overall Study|Ongoing in Study|5|||
163456943|NCT04321252|590371169|FG000|Overall Study|Withdrawal by Subject|0|||
163456944|NCT04321252|590371170|FG001|Overall Study|Withdrawal by Subject|0|||
163456945|NCT04321252|590371171|FG002|Overall Study|Withdrawal by Subject|0|||
163456946|NCT04321252|590371172|FG003|Overall Study|Withdrawal by Subject|0|||
163456947|NCT04321252|590371173|FG004|Overall Study|Withdrawal by Subject|0|||
163456948|NCT04321252|590371174|FG005|Overall Study|Withdrawal by Subject|1|||
163456949|NCT04321252|590371175|FG006|Overall Study|Withdrawal by Subject|0|||
163456950|NCT04321252|590371176|FG007|Overall Study|Withdrawal by Subject|0|||
163456951|NCT04321252|590371177|FG008|Overall Study|Withdrawal by Subject|0|||
163456952|NCT06245044|590371178|FG000|No MI help|Technical issues|18|||
163456953|NCT01082367|590371181|FG000|Double-blind Period|Administrative problems|0|||
163456954|NCT01082367|590371182|FG001|Double-blind Period|Administrative problems|1|||
163456955|NCT01082367|590371181|FG000|Double-blind Period|Lack of Efficacy|5|||
163456956|NCT01082367|590371182|FG001|Double-blind Period|Lack of Efficacy|11|||
163456957|NCT01082367|590371181|FG000|Double-blind Period|Adverse Event|0|||
163456958|NCT01082367|590371182|FG001|Double-blind Period|Adverse Event|1|||
163456959|NCT01082367|590371181|FG000|Follow-up (F-U) Period|Administrative problems|1|||
163456960|NCT01082367|590371182|FG001|Follow-up (F-U) Period|Administrative problems|0|||
163456961|NCT01082367|590371181|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
163456962|NCT01082367|590371182|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
163456963|NCT01082367|590371181|FG000|Follow-up (F-U) Period|Adverse Event|0|||
163456964|NCT01082367|590371182|FG001|Follow-up (F-U) Period|Adverse Event|1|||
163456965|NCT00098020|590371185|FG000|Overall Study|Adverse Event|2|||
163456966|NCT00098020|590371185|FG000|Overall Study|Lost to Follow-up|1|||
163456967|NCT00098020|590371185|FG000|Overall Study|elevated liver enzymes|1|||
163456968|NCT00098020|590371185|FG000|Overall Study|Low urine PCR|1|||
163456969|NCT00098020|590371185|FG000|Overall Study|Low epidermal growth factor receptor|1|||
163456970|NCT00085917|590371192|FG000|Overall Study|Adverse Event|4|||
163456971|NCT00085917|590371193|FG001|Overall Study|Adverse Event|3|||
163456972|NCT00865189|590371194|FG000|Overall Study|Other|1|||
163456973|NCT00865189|590371195|FG001|Overall Study|Other|2|||
163456974|NCT00865189|590371194|FG000|Overall Study|Death|4|||
163456975|NCT00865189|590371195|FG001|Overall Study|Death|11|||
163456976|NCT00865189|590371194|FG000|Overall Study|Lost to Follow-up|6|||
163456977|NCT00865189|590371195|FG001|Overall Study|Lost to Follow-up|6|||
163456978|NCT00865189|590371194|FG000|Overall Study|Withdrawal by Subject|1|||
163456979|NCT00865189|590371195|FG001|Overall Study|Withdrawal by Subject|0|||
163456980|NCT01658579|590371197|FG000|Treatment Period A|Other|0|||
163456981|NCT01658579|590371198|FG001|Treatment Period A|Other|0|||
163456982|NCT01658579|590371199|FG002|Treatment Period A|Other|1|||
163456983|NCT01658579|590371200|FG003|Treatment Period A|Other|1|||
163456984|NCT01658579|590371197|FG000|Treatment Period A|Adverse Event|1|||
163456985|NCT01658579|590371198|FG001|Treatment Period A|Adverse Event|0|||
163456986|NCT01658579|590371199|FG002|Treatment Period A|Adverse Event|0|||
163456987|NCT01658579|590371200|FG003|Treatment Period A|Adverse Event|0|||
163456988|NCT01658579|590371197|FG000|Treatment Period B|Other|0|||
163456989|NCT01658579|590371198|FG001|Treatment Period B|Other|0|||
163456990|NCT01658579|590371199|FG002|Treatment Period B|Other|0|||
163456991|NCT01658579|590371200|FG003|Treatment Period B|Other|1|||
163456992|NCT02767856|590371211|FG000|Overall Study|Lost to Follow-up|9|||
163456993|NCT02767856|590371212|FG001|Overall Study|Lost to Follow-up|1|||
163456994|NCT02767856|590371211|FG000|Overall Study|Withdrawal by Subject|2|||
163456995|NCT02767856|590371212|FG001|Overall Study|Withdrawal by Subject|1|||
163456996|NCT01464788|590371215|FG000|Overall Study|Lost to Follow-up|0|||
163456997|NCT01464788|590371216|FG001|Overall Study|Lost to Follow-up|1|||
163456998|NCT01464788|590371217|FG002|Overall Study|Lost to Follow-up|0|||
163456999|NCT01464788|590371215|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
163457000|NCT01464788|590371216|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
163457001|NCT01464788|590371217|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
163457002|NCT00418379|590371220|FG000|Year 1|Adverse Event|9|||
163457003|NCT00418379|590371221|FG001|Year 1|Adverse Event|15|||
163457004|NCT00418379|590371222|FG002|Year 1|Adverse Event|3|||
163457005|NCT00418379|590371220|FG000|Year 1|Withdrawal by Subject|7|||
163457006|NCT00418379|590371221|FG001|Year 1|Withdrawal by Subject|8|||
163457007|NCT00418379|590371222|FG002|Year 1|Withdrawal by Subject|5|||
163457008|NCT00418379|590371220|FG000|Year 1|Any other reason not above-mentioned|2|||
163457009|NCT00418379|590371221|FG001|Year 1|Any other reason not above-mentioned|5|||
163457010|NCT00418379|590371222|FG002|Year 1|Any other reason not above-mentioned|7|||
163457011|NCT00418379|590371220|FG000|Year 2|Adverse Event|5|||
163457012|NCT00418379|590371221|FG001|Year 2|Adverse Event|2|||
163457013|NCT00418379|590371222|FG002|Year 2|Adverse Event|1|||
163457014|NCT00418379|590371220|FG000|Year 2|Withdrawal by Subject|1|||
163457015|NCT00418379|590371221|FG001|Year 2|Withdrawal by Subject|1|||
163457016|NCT00418379|590371222|FG002|Year 2|Withdrawal by Subject|3|||
163457017|NCT00418379|590371220|FG000|Year 2|Any other reason not above-mentioned|2|||
163457018|NCT00418379|590371221|FG001|Year 2|Any other reason not above-mentioned|1|||
163457019|NCT00418379|590371222|FG002|Year 2|Any other reason not above-mentioned|6|||
163457020|NCT00418379|590371220|FG000|Year 3|Withdrawal by Subject|1|||
163457021|NCT00418379|590371221|FG001|Year 3|Withdrawal by Subject|1|||
163457022|NCT00418379|590371222|FG002|Year 3|Withdrawal by Subject|2|||
163457023|NCT00418379|590371220|FG000|Year 3|Any other reason not above-mentioned|2|||
163457024|NCT00418379|590371221|FG001|Year 3|Any other reason not above-mentioned|1|||
163457025|NCT00418379|590371222|FG002|Year 3|Any other reason not above-mentioned|1|||
163457026|NCT00418379|590371220|FG000|Year 4|Adverse Event|0|||
163457027|NCT00418379|590371221|FG001|Year 4|Adverse Event|1|||
163457028|NCT00418379|590371222|FG002|Year 4|Adverse Event|0|||
163457029|NCT00418379|590371220|FG000|Year 4|Withdrawal by Subject|2|||
163457030|NCT00418379|590371221|FG001|Year 4|Withdrawal by Subject|3|||
163457031|NCT00418379|590371222|FG002|Year 4|Withdrawal by Subject|2|||
163457032|NCT00418379|590371220|FG000|Year 4|Any other reason not above-mentioned|1|||
163457033|NCT00418379|590371221|FG001|Year 4|Any other reason not above-mentioned|1|||
163457034|NCT00418379|590371222|FG002|Year 4|Any other reason not above-mentioned|0|||
163457035|NCT00418379|590371220|FG000|Year 5|Adverse Event|0|||
163457036|NCT00418379|590371221|FG001|Year 5|Adverse Event|1|||
163457037|NCT00418379|590371222|FG002|Year 5|Adverse Event|0|||
163457038|NCT00418379|590371220|FG000|Year 5|Any other reason not above-mentioned|2|||
163457039|NCT00418379|590371221|FG001|Year 5|Any other reason not above-mentioned|4|||
163457040|NCT00418379|590371222|FG002|Year 5|Any other reason not above-mentioned|3|||
163457041|NCT00843843|590371223|FG000|Overall Study|Physician Decision|1|||
163457042|NCT00843843|590371224|FG001|Overall Study|Physician Decision|1|||
163457043|NCT00843843|590371223|FG000|Overall Study|Protocol Violation|1|||
163457044|NCT00843843|590371224|FG001|Overall Study|Protocol Violation|1|||
163457045|NCT00565058|590371225|FG000|Overall Study|Adverse Event|1|||
163457046|NCT00565058|590371226|FG001|Overall Study|Adverse Event|0|||
163457047|NCT00400712|590371245|FG000|Overall Study|Death|1|||
163457048|NCT00400712|590371246|FG001|Overall Study|Death|0|||
163457049|NCT00400712|590371245|FG000|Overall Study|Withdrawal by Subject|11|||
163457050|NCT00400712|590371246|FG001|Overall Study|Withdrawal by Subject|12|||
163457051|NCT00400712|590371245|FG000|Overall Study|Physician Decision|5|||
163457052|NCT00400712|590371246|FG001|Overall Study|Physician Decision|4|||
163457053|NCT02670330|590371247|FG000|Overall Study|Protocol Deviation|1|||
163457054|NCT02670330|590371248|FG001|Overall Study|Protocol Deviation|0|||
163457055|NCT02670330|590371247|FG000|Overall Study|Study Terminated By Sponsor|36|||
163457056|NCT02670330|590371248|FG001|Overall Study|Study Terminated By Sponsor|43|||
163457057|NCT02670330|590371247|FG000|Overall Study|Adverse Event|1|||
163457058|NCT02670330|590371248|FG001|Overall Study|Adverse Event|3|||
163457059|NCT02670330|590371247|FG000|Overall Study|Withdrawal by Subject|34|||
163457060|NCT02670330|590371248|FG001|Overall Study|Withdrawal by Subject|29|||
163457061|NCT02670330|590371247|FG000|Overall Study|Lost to Follow-up|3|||
163457062|NCT02670330|590371248|FG001|Overall Study|Lost to Follow-up|2|||
163457063|NCT00634114|590371249|FG000|Overall Study|Adverse Event|6|||
163457064|NCT00634114|590371250|FG001|Overall Study|Adverse Event|8|||
163457065|NCT00634114|590371251|FG002|Overall Study|Adverse Event|3|||
163457066|NCT00634114|590371249|FG000|Overall Study|Withdrawal by Subject|9|||
163457067|NCT00634114|590371250|FG001|Overall Study|Withdrawal by Subject|6|||
163457068|NCT00634114|590371251|FG002|Overall Study|Withdrawal by Subject|11|||
163457069|NCT00634114|590371249|FG000|Overall Study|Lost to Follow-up|0|||
163457070|NCT00634114|590371250|FG001|Overall Study|Lost to Follow-up|0|||
163457071|NCT00634114|590371251|FG002|Overall Study|Lost to Follow-up|1|||
163457072|NCT00634114|590371249|FG000|Overall Study|Protocol Violation|3|||
163457073|NCT00634114|590371250|FG001|Overall Study|Protocol Violation|3|||
163457074|NCT00634114|590371251|FG002|Overall Study|Protocol Violation|1|||
163457075|NCT00634114|590371249|FG000|Overall Study|Pregnancy|1|||
163457076|NCT00634114|590371250|FG001|Overall Study|Pregnancy|0|||
163457077|NCT00634114|590371251|FG002|Overall Study|Pregnancy|0|||
163457078|NCT00634114|590371249|FG000|Overall Study|Incorrect enrolment|0|||
163457079|NCT00634114|590371250|FG001|Overall Study|Incorrect enrolment|1|||
163457080|NCT00634114|590371251|FG002|Overall Study|Incorrect enrolment|0|||
163457081|NCT00634114|590371249|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
163457082|NCT00634114|590371250|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
163457083|NCT00634114|590371251|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
163457084|NCT00634114|590371249|FG000|Overall Study|Difficult to continue|3|||
163457085|NCT00634114|590371250|FG001|Overall Study|Difficult to continue|1|||
163457086|NCT00634114|590371251|FG002|Overall Study|Difficult to continue|1|||
163457087|NCT00634114|590371249|FG000|Overall Study|Other reason|1|||
163457088|NCT00634114|590371250|FG001|Overall Study|Other reason|1|||
163457089|NCT00634114|590371251|FG002|Overall Study|Other reason|1|||
163457090|NCT03670641|590371256|FG000|Overall Study|Lost to Follow-up|3|||
163457091|NCT00125190|590371262|FG000|Overall Study|Subject/Parent Decision|7|||
163457092|NCT00125190|590371262|FG000|Overall Study|Non-compliance|2|||
163457093|NCT00125190|590371262|FG000|Overall Study|Adverse Event|1|||
163457094|NCT00125190|590371262|FG000|Overall Study|Other|1|||
163457095|NCT00125190|590371262|FG000|Overall Study|Lost to Follow-up|4|||
163457096|NCT00916370|590371263|FG000|Overall Study|Death|3|||
163457097|NCT00916370|590371264|FG001|Overall Study|Death|1|||
163457098|NCT00916370|590371263|FG000|Overall Study|Withdrawal by Subject|2|||
163457099|NCT00916370|590371264|FG001|Overall Study|Withdrawal by Subject|0|||
163457100|NCT00916370|590371263|FG000|Overall Study|Physician Decision|0|||
163457101|NCT00916370|590371264|FG001|Overall Study|Physician Decision|1|||
163457102|NCT00414960|590371266|FG000|Overall Study|Adverse Event|4|||
163457103|NCT00414960|590371267|FG001|Overall Study|Adverse Event|0|||
163457104|NCT00414960|590371266|FG000|Overall Study|Withdrawal by Subject|3|||
163457105|NCT00414960|590371267|FG001|Overall Study|Withdrawal by Subject|0|||
163457106|NCT00414960|590371266|FG000|Overall Study|Physician Decision|0|||
163457107|NCT00414960|590371267|FG001|Overall Study|Physician Decision|1|||
163457108|NCT01318512|590371268|FG000|Maintenance Period (6 Months)|Death|2|||
163457109|NCT01318512|590371268|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
163457110|NCT00363246|590371269|FG000|Overall Study|Death|40|||
163457111|NCT00363246|590371269|FG000|Overall Study|Withdrawal by Subject|19|||
163457112|NCT00363246|590371269|FG000|Overall Study|Lost to Follow-up|14|||
163457113|NCT00363246|590371269|FG000|Overall Study|Bad health|6|||
163457114|NCT00363246|590371269|FG000|Overall Study|Stopped using wheelchair|11|||
163457115|NCT00363246|590371269|FG000|Overall Study|Subject expressed security concerns|2|||
163457116|NCT00363246|590371269|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
163457117|NCT00264849|590371272|FG000|Overall Study|Adverse Event|7|||
163457118|NCT00264849|590371273|FG001|Overall Study|Adverse Event|2|||
163457119|NCT00264849|590371272|FG000|Overall Study|Withdrawal by Subject|7|||
163457120|NCT00264849|590371273|FG001|Overall Study|Withdrawal by Subject|11|||
163457121|NCT00264849|590371272|FG000|Overall Study|Protocol Violation|5|||
163457122|NCT00264849|590371273|FG001|Overall Study|Protocol Violation|3|||
163457123|NCT00264849|590371272|FG000|Overall Study|Lack of Efficacy|1|||
163457124|NCT00264849|590371273|FG001|Overall Study|Lack of Efficacy|6|||
163457125|NCT00264849|590371272|FG000|Overall Study|Lost to Follow-up|0|||
163457126|NCT00264849|590371273|FG001|Overall Study|Lost to Follow-up|2|||
163457127|NCT00264849|590371272|FG000|Overall Study|Death|0|||
163457128|NCT00264849|590371273|FG001|Overall Study|Death|1|||
163457129|NCT00264849|590371272|FG000|Overall Study|Administrative Problems|2|||
163457130|NCT00264849|590371273|FG001|Overall Study|Administrative Problems|0|||
163457131|NCT02756650|590371276|FG000|Overall Study|Physician Decision|1|||
163457132|NCT02756650|590371276|FG000|Overall Study|Adverse Event|1|||
163457133|NCT00383721|590371277|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
163457134|NCT00383721|590371278|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
163457135|NCT00383721|590371279|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
163457136|NCT00383721|590371280|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
163457137|NCT00383721|590371281|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
163457138|NCT00383721|590371277|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
163457139|NCT00383721|590371278|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
163457140|NCT00383721|590371279|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
163457141|NCT00383721|590371280|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
163457142|NCT00383721|590371281|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
163457143|NCT00383721|590371277|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
163457144|NCT00383721|590371278|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
163457145|NCT00383721|590371279|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
163457146|NCT00383721|590371280|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
163457147|NCT00383721|590371281|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
163457148|NCT00383721|590371277|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
163457149|NCT00383721|590371278|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
163457150|NCT00383721|590371279|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
163457151|NCT00383721|590371280|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
163457152|NCT00383721|590371281|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
163457153|NCT00383721|590371277|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
163457154|NCT00383721|590371278|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
163457155|NCT00383721|590371279|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
163457156|NCT00383721|590371280|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
163457157|NCT00383721|590371281|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
163457158|NCT00383721|590371277|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
163457159|NCT00383721|590371278|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
163457160|NCT00383721|590371279|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
163457161|NCT00383721|590371280|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
163457162|NCT00383721|590371281|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
163457163|NCT00383721|590371277|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
163457164|NCT00383721|590371278|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
163457165|NCT00383721|590371279|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
163457166|NCT00383721|590371280|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
163457167|NCT00383721|590371281|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
163457168|NCT00383721|590371277|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
163457169|NCT00383721|590371278|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
163457170|NCT00383721|590371279|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
163457171|NCT00383721|590371280|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
163457172|NCT00383721|590371281|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
163457173|NCT00383721|590371277|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
163457174|NCT00383721|590371278|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
163457175|NCT00383721|590371279|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
163457176|NCT00383721|590371280|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
163457177|NCT00383721|590371281|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
163457178|NCT00383721|590371277|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
163457179|NCT00383721|590371278|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
163457180|NCT00383721|590371279|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
163457181|NCT00383721|590371280|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
163457182|NCT00383721|590371281|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
163457183|NCT00383721|590371277|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
163457184|NCT00383721|590371278|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
163457185|NCT00383721|590371279|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
163457186|NCT00383721|590371280|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
163457187|NCT00383721|590371281|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
163457188|NCT00383721|590371277|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
163457189|NCT00383721|590371278|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
163457190|NCT00383721|590371279|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
163457191|NCT00383721|590371280|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
163457192|NCT00383721|590371281|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
163457193|NCT00383721|590371277|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
163457194|NCT00383721|590371278|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
163457195|NCT00383721|590371279|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
163457196|NCT00383721|590371280|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
163457197|NCT00383721|590371281|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
163457198|NCT00383721|590371277|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
163457199|NCT00383721|590371278|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
163457200|NCT00383721|590371279|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
163457201|NCT00383721|590371280|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
163457202|NCT00383721|590371281|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
163457203|NCT00383721|590371277|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
163457204|NCT00383721|590371278|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
163457205|NCT00383721|590371279|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
163457206|NCT00383721|590371280|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
163457207|NCT00383721|590371281|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
163457208|NCT00383721|590371277|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
163457209|NCT00383721|590371278|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
163457210|NCT00383721|590371279|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
163457211|NCT00383721|590371280|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
163457212|NCT00383721|590371281|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
163457213|NCT00383721|590371277|FG000|26-Week Treatment Safety Extension|Administrative|1|||
163457214|NCT00383721|590371278|FG001|26-Week Treatment Safety Extension|Administrative|2|||
163457215|NCT00383721|590371279|FG002|26-Week Treatment Safety Extension|Administrative|3|||
163457216|NCT00383721|590371280|FG003|26-Week Treatment Safety Extension|Administrative|1|||
163457217|NCT00383721|590371281|FG004|26-Week Treatment Safety Extension|Administrative|0|||
163457218|NCT00132314|590373034|FG000|Overall Study|Lost to Follow-up|70|||
163457219|NCT00132314|590373035|FG001|Overall Study|Lost to Follow-up|62|||
163457220|NCT00132314|590373034|FG000|Overall Study|Lacked SSN|1|||
163457221|NCT00132314|590373035|FG001|Overall Study|Lacked SSN|3|||
163457222|NCT00132314|590373034|FG000|Overall Study|Refused intervention at baseline|2|||
163457223|NCT00132314|590373035|FG001|Overall Study|Refused intervention at baseline|7|||
163457224|NCT01653158|590373049|FG000|Overall Study|Death|0|||
163457225|NCT01653158|590373050|FG001|Overall Study|Death|0|||
163457226|NCT01653158|590373051|FG002|Overall Study|Death|0|||
163457227|NCT01653158|590373052|FG003|Overall Study|Death|1|||
163457228|NCT01653158|590373053|FG004|Overall Study|Death|0|||
163457229|NCT01653158|590373054|FG005|Overall Study|Death|0|||
163457230|NCT01653158|590373055|FG006|Overall Study|Death|0|||
163457231|NCT01653158|590373056|FG007|Overall Study|Death|2|||
163457232|NCT01653158|590373049|FG000|Overall Study|Adverse Event|0|||
163457233|NCT01653158|590373050|FG001|Overall Study|Adverse Event|0|||
163457234|NCT01653158|590373051|FG002|Overall Study|Adverse Event|0|||
163457235|NCT01653158|590373052|FG003|Overall Study|Adverse Event|1|||
163457236|NCT01653158|590373053|FG004|Overall Study|Adverse Event|0|||
163457237|NCT01653158|590373054|FG005|Overall Study|Adverse Event|0|||
163457238|NCT01653158|590373055|FG006|Overall Study|Adverse Event|0|||
163457239|NCT01653158|590373056|FG007|Overall Study|Adverse Event|3|||
163457240|NCT01653158|590373049|FG000|Overall Study|Other|0|||
163457241|NCT01653158|590373050|FG001|Overall Study|Other|0|||
163457242|NCT01653158|590373051|FG002|Overall Study|Other|0|||
163457243|NCT01653158|590373052|FG003|Overall Study|Other|0|||
163457244|NCT01653158|590373053|FG004|Overall Study|Other|0|||
163457245|NCT01653158|590373054|FG005|Overall Study|Other|0|||
163457246|NCT01653158|590373055|FG006|Overall Study|Other|0|||
163457247|NCT01653158|590373056|FG007|Overall Study|Other|1|||
163457248|NCT01653158|590373049|FG000|Overall Study|Progressive disease|0|||
163457249|NCT01653158|590373050|FG001|Overall Study|Progressive disease|0|||
163457250|NCT01653158|590373051|FG002|Overall Study|Progressive disease|0|||
163457251|NCT01653158|590373052|FG003|Overall Study|Progressive disease|0|||
163457252|NCT01653158|590373053|FG004|Overall Study|Progressive disease|1|||
163457253|NCT01653158|590373054|FG005|Overall Study|Progressive disease|1|||
163457254|NCT01653158|590373055|FG006|Overall Study|Progressive disease|2|||
163457255|NCT01653158|590373056|FG007|Overall Study|Progressive disease|9|||
163457256|NCT01653158|590373049|FG000|Overall Study|Withdrawal by Subject|1|||
163457257|NCT01653158|590373050|FG001|Overall Study|Withdrawal by Subject|0|||
163457258|NCT01653158|590373051|FG002|Overall Study|Withdrawal by Subject|0|||
163457259|NCT01653158|590373052|FG003|Overall Study|Withdrawal by Subject|0|||
163457260|NCT01653158|590373053|FG004|Overall Study|Withdrawal by Subject|0|||
163457261|NCT01653158|590373054|FG005|Overall Study|Withdrawal by Subject|0|||
163457262|NCT01653158|590373055|FG006|Overall Study|Withdrawal by Subject|0|||
163457263|NCT01653158|590373056|FG007|Overall Study|Withdrawal by Subject|0|||
163457264|NCT03819218|590373059|FG000|Overall Study|Protocol Violation|1|||
163457265|NCT04116073|590373063|FG000|Overall Study|Withdrawal by Subject|2|||
163457266|NCT04116073|590373063|FG000|Overall Study|failed to maintained eligibility|1|||
163457267|NCT01453998|590373067|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
163457268|NCT01453998|590373068|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
163457269|NCT01453998|590373069|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
163457270|NCT01840228|590373076|FG000|Overall Study|Lost to Follow-up|1|||
163457271|NCT01840228|590373077|FG001|Overall Study|Lost to Follow-up|1|||
163457272|NCT00712933|590373078|FG000|Overall Study|Adverse Event|69|||
163457273|NCT00712933|590373078|FG000|Overall Study|Lack of Efficacy|6|||
163457274|NCT00712933|590373078|FG000|Overall Study|Lost to Follow-up|22|||
163457275|NCT00712933|590373078|FG000|Overall Study|Non-compliance with study drug|13|||
163457276|NCT00712933|590373078|FG000|Overall Study|Other Pregnancy|37|||
163457277|NCT00712933|590373078|FG000|Overall Study|Sponsor decision|14|||
163457278|NCT00712933|590373078|FG000|Overall Study|Withdrew consent|4|||
163457279|NCT00712933|590373078|FG000|Overall Study|Hip replacement surgery|1|||
163457280|NCT00712933|590373078|FG000|Overall Study|Involved in Clinical research|3|||
163457281|NCT00712933|590373078|FG000|Overall Study|Participant hospitalized|1|||
163457282|NCT00712933|590373078|FG000|Overall Study|Participant travelled overseas|2|||
163457283|NCT00712933|590373078|FG000|Overall Study|Death of patient|1|||
163457284|NCT00712933|590373078|FG000|Overall Study|Other Physician decision|1|||
163457285|NCT00712933|590373078|FG000|Overall Study|Not committed to contraception|1|||
163457286|NCT00712933|590373078|FG000|Overall Study|Participant received medication|1|||
163457287|NCT00712933|590373078|FG000|Overall Study|Physician Decision|36|||
163457288|NCT00712933|590373078|FG000|Overall Study|Protocol Violation|4|||
163457289|NCT00712933|590373078|FG000|Overall Study|Withdrawal by Subject|151|||
163457290|NCT02022033|590373084|FG000|Overall Study|Physician Decision|1|||
163457291|NCT01429077|590373085|FG000|Overall Study|Lost to Follow-up|0|||
163457292|NCT01429077|590373086|FG001|Overall Study|Lost to Follow-up|3|||
163457293|NCT01413542|590373088|FG000|Overall Study|Physician Decision|1|||
163457294|NCT01413542|590373089|FG001|Overall Study|Physician Decision|0|||
163457295|NCT01413542|590373090|FG002|Overall Study|Physician Decision|3|||
163457296|NCT01413542|590373091|FG003|Overall Study|Physician Decision|0|||
163457297|NCT01413542|590373088|FG000|Overall Study|Adverse Event|0|||
163457298|NCT01413542|590373089|FG001|Overall Study|Adverse Event|0|||
163457299|NCT01413542|590373090|FG002|Overall Study|Adverse Event|0|||
163457300|NCT01413542|590373091|FG003|Overall Study|Adverse Event|1|||
163457301|NCT01879319|590373096|FG000|Overall Study|Withdrawal by Subject|1|||
163457302|NCT01879319|590373097|FG001|Overall Study|Withdrawal by Subject|0|||
163457303|NCT01879319|590373096|FG000|Overall Study|Lost to Follow-up|1|||
163457304|NCT01879319|590373097|FG001|Overall Study|Lost to Follow-up|5|||
163457305|NCT05590767|590373098|FG000|Overall Study|Protocol Violation|1|||
163457306|NCT05590767|590373098|FG000|Overall Study|surgery canceled|1|||
163457307|NCT05590767|590373098|FG000|Overall Study|interscalene brachial block not performed|1|||
163457308|NCT00084929|590373099|FG000|Overall Study|ineligible - medical contraindication|1|||
163457309|NCT00084929|590373099|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
163457310|NCT00084929|590373099|FG000|Overall Study|Ineligible - Medical history|6|||
163457311|NCT00084929|590373099|FG000|Overall Study|Withdrawal by Subject|10|||
163457312|NCT00084929|590373099|FG000|Overall Study|Missing/incomplete CTC exam|9|||
163457313|NCT00084929|590373099|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
163457314|NCT00664209|590373101|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
163457315|NCT00664209|590373101|FG000|Study Treatment Period|Physician Decision|4|||
163457316|NCT00664209|590373101|FG000|Study Treatment Period|Withdrawal by Subject|2|||
163457317|NCT00091026|590373102|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
163457318|NCT00091026|590373103|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
163457319|NCT00091026|590373102|FG000|Overall Study|Patient withdrew and never received trea|0|||
163457320|NCT00091026|590373103|FG001|Overall Study|Patient withdrew and never received trea|2|||
163457321|NCT00091026|590373102|FG000|Overall Study|Unknown-never received treatment|0|||
163457322|NCT00091026|590373103|FG001|Overall Study|Unknown-never received treatment|1|||
163457323|NCT00065442|590373104|FG000|Overall Study|Lost to Follow-up|1|||
163457324|NCT00065442|590373105|FG001|Overall Study|Lost to Follow-up|1|||
163457325|NCT00065442|590373104|FG000|Overall Study|Death|121|||
163457326|NCT00065442|590373105|FG001|Overall Study|Death|210|||
163457327|NCT00065442|590373104|FG000|Overall Study|Withdrawal by Subject|3|||
163457328|NCT00065442|590373105|FG001|Overall Study|Withdrawal by Subject|9|||
163457329|NCT01797965|590373106|FG000|Overall Study|Adverse Event|104|||
163457330|NCT01797965|590373107|FG001|Overall Study|Adverse Event|129|||
163457331|NCT01797965|590373108|FG002|Overall Study|Adverse Event|4|||
163457332|NCT01797965|590373109|FG003|Overall Study|Adverse Event|21|||
163457333|NCT01797965|590373106|FG000|Overall Study|Lost to Follow-up|9|||
163457334|NCT01797965|590373107|FG001|Overall Study|Lost to Follow-up|8|||
163457335|NCT01797965|590373108|FG002|Overall Study|Lost to Follow-up|1|||
163457336|NCT01797965|590373109|FG003|Overall Study|Lost to Follow-up|2|||
163457337|NCT01797965|590373106|FG000|Overall Study|Consent withdrawn|130|||
163457338|NCT01797965|590373107|FG001|Overall Study|Consent withdrawn|117|||
163457339|NCT01797965|590373108|FG002|Overall Study|Consent withdrawn|3|||
163457340|NCT01797965|590373109|FG003|Overall Study|Consent withdrawn|35|||
163457341|NCT01797965|590373106|FG000|Overall Study|Investigator decision|21|||
163457342|NCT01797965|590373107|FG001|Overall Study|Investigator decision|15|||
163457343|NCT01797965|590373108|FG002|Overall Study|Investigator decision|0|||
163457344|NCT01797965|590373109|FG003|Overall Study|Investigator decision|0|||
163457345|NCT01797965|590373106|FG000|Overall Study|Death|2|||
163457346|NCT01797965|590373107|FG001|Overall Study|Death|4|||
163457347|NCT01797965|590373108|FG002|Overall Study|Death|0|||
163457348|NCT01797965|590373109|FG003|Overall Study|Death|0|||
163457349|NCT01797965|590373106|FG000|Overall Study|Disease progression, defined by protocol|3|||
163457350|NCT01797965|590373107|FG001|Overall Study|Disease progression, defined by protocol|1|||
163457351|NCT01797965|590373108|FG002|Overall Study|Disease progression, defined by protocol|0|||
163457352|NCT01797965|590373109|FG003|Overall Study|Disease progression, defined by protocol|0|||
163457353|NCT01797965|590373106|FG000|Overall Study|Reason Not Specified|280|||
163457354|NCT01797965|590373107|FG001|Overall Study|Reason Not Specified|295|||
163457355|NCT01797965|590373108|FG002|Overall Study|Reason Not Specified|0|||
163457356|NCT01797965|590373109|FG003|Overall Study|Reason Not Specified|15|||
163457357|NCT01764256|590373110|FG000|Received All Vaccinations|Adverse Event|1|||
163457358|NCT01764256|590373111|FG001|Received All Vaccinations|Adverse Event|1|||
163457359|NCT01764256|590373112|FG002|Received All Vaccinations|Adverse Event|0|||
163457360|NCT01764256|590373113|FG003|Received All Vaccinations|Adverse Event|0|||
163457361|NCT01764256|590373110|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
163457362|NCT01764256|590373111|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
163457363|NCT01764256|590373112|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
163457364|NCT01764256|590373113|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
163457365|NCT01764256|590373110|FG000|Received All Vaccinations|Lost to Follow-up|1|||
163457366|NCT01764256|590373111|FG001|Received All Vaccinations|Lost to Follow-up|0|||
163457367|NCT01764256|590373112|FG002|Received All Vaccinations|Lost to Follow-up|0|||
163457368|NCT01764256|590373113|FG003|Received All Vaccinations|Lost to Follow-up|0|||
163457369|NCT01764256|590373110|FG000|Completed Study|Lost to Follow-up|0|||
163457370|NCT01764256|590373111|FG001|Completed Study|Lost to Follow-up|0|||
163457371|NCT01764256|590373112|FG002|Completed Study|Lost to Follow-up|0|||
163457372|NCT01764256|590373113|FG003|Completed Study|Lost to Follow-up|1|||
163457373|NCT00304915|590373114|FG000|Overall Study|Lost to Follow-up|11|||
163457374|NCT00304915|590373115|FG001|Overall Study|Lost to Follow-up|11|||
163457375|NCT00304915|590373114|FG000|Overall Study|Death|4|||
163457376|NCT00304915|590373115|FG001|Overall Study|Death|5|||
163457377|NCT00304915|590373114|FG000|Overall Study|Withdrawal by Subject|3|||
163457378|NCT00304915|590373115|FG001|Overall Study|Withdrawal by Subject|0|||
163457379|NCT02029638|590373116|FG000|Overall Study|Death|0|||
163457380|NCT02029638|590373117|FG001|Overall Study|Death|0|||
163457381|NCT02029638|590373118|FG002|Overall Study|Death|1|||
163457382|NCT02029638|590373116|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
163457383|NCT02029638|590373117|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
163457384|NCT02029638|590373118|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
163457385|NCT05489081|590373121|FG000|Overall Study|student left classroom|0|||
163457386|NCT05489081|590373122|FG001|Overall Study|student left classroom|1|||
163457387|NCT05489081|590373121|FG000|Overall Study|teacher left school|0|||
163457388|NCT05489081|590373122|FG001|Overall Study|teacher left school|2|||
163457389|NCT00973921|590373125|FG000|Overall Study|IVUS results were not available|9|||
163457390|NCT04348591|590373129|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
163457391|NCT04348591|590373130|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
163457392|NCT04348591|590373129|FG000|Imaging Session (120 Min)|Physician Decision|0|||
163457393|NCT04348591|590373130|FG001|Imaging Session (120 Min)|Physician Decision|1|||
163457394|NCT04348591|590373129|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
163457395|NCT04348591|590373130|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
163457396|NCT00622869|590373131|FG000|Overall Study|Subject Withdrew Consent|13|||
163457397|NCT00622869|590373132|FG001|Overall Study|Subject Withdrew Consent|17|||
163457398|NCT00622869|590373133|FG002|Overall Study|Subject Withdrew Consent|11|||
163457399|NCT00622869|590373131|FG000|Overall Study|Administrative Problems|11|||
163457400|NCT00622869|590373132|FG001|Overall Study|Administrative Problems|17|||
163457401|NCT00622869|590373133|FG002|Overall Study|Administrative Problems|13|||
163457402|NCT00622869|590373131|FG000|Overall Study|Death|12|||
163457403|NCT00622869|590373132|FG001|Overall Study|Death|15|||
163457404|NCT00622869|590373133|FG002|Overall Study|Death|10|||
163457405|NCT00622869|590373131|FG000|Overall Study|Lost to Follow-up|2|||
163457406|NCT00622869|590373132|FG001|Overall Study|Lost to Follow-up|4|||
163457407|NCT00622869|590373133|FG002|Overall Study|Lost to Follow-up|2|||
163457408|NCT00622869|590373131|FG000|Overall Study|Graft Loss|5|||
163457409|NCT00622869|590373132|FG001|Overall Study|Graft Loss|3|||
163457410|NCT00622869|590373133|FG002|Overall Study|Graft Loss|2|||
163457411|NCT00622869|590373131|FG000|Overall Study|Missing|0|||
163457412|NCT00622869|590373132|FG001|Overall Study|Missing|1|||
163457413|NCT00622869|590373133|FG002|Overall Study|Missing|1|||
163457414|NCT03722784|590373134|FG000|Overall Study|Withdrawal by Subject|1|||
163457415|NCT03722784|590373135|FG001|Overall Study|Withdrawal by Subject|0|||
163457416|NCT03722784|590373134|FG000|Overall Study|Physician Decision|1|||
163457417|NCT03722784|590373135|FG001|Overall Study|Physician Decision|1|||
163457418|NCT03722784|590373134|FG000|Overall Study|Protocol Violation|0|||
163457419|NCT03722784|590373135|FG001|Overall Study|Protocol Violation|1|||
163457420|NCT01317615|590373138|FG000|Overall Study|Disease progression|25|||
163457421|NCT01317615|590373138|FG000|Overall Study|New cancer therapy|5|||
163457422|NCT01317615|590373138|FG000|Overall Study|Death|6|||
163457423|NCT01317615|590373138|FG000|Overall Study|Withdrawal by Subject|5|||
163457424|NCT01317615|590373138|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163457425|NCT01317615|590373138|FG000|Overall Study|Adverse Event|7|||
163457426|NCT02648724|590373141|FG000|Overall Study|Withdrawal by Subject|0|||
163457427|NCT02648724|590373142|FG001|Overall Study|Withdrawal by Subject|1|||
163457428|NCT02648724|590373143|FG002|Overall Study|Withdrawal by Subject|1|||
163457429|NCT02648724|590373144|FG003|Overall Study|Withdrawal by Subject|0|||
163457430|NCT02648724|590373145|FG004|Overall Study|Withdrawal by Subject|1|||
163457431|NCT02648724|590373146|FG005|Overall Study|Withdrawal by Subject|0|||
163457432|NCT02648724|590373147|FG006|Overall Study|Withdrawal by Subject|0|||
163457433|NCT02648724|590373141|FG000|Overall Study|Progressive disease|2|||
163457434|NCT02648724|590373142|FG001|Overall Study|Progressive disease|2|||
163457435|NCT02648724|590373143|FG002|Overall Study|Progressive disease|2|||
163457436|NCT02648724|590373144|FG003|Overall Study|Progressive disease|3|||
163457437|NCT02648724|590373145|FG004|Overall Study|Progressive disease|22|||
163457438|NCT02648724|590373146|FG005|Overall Study|Progressive disease|7|||
163457439|NCT02648724|590373147|FG006|Overall Study|Progressive disease|8|||
163457440|NCT02648724|590373141|FG000|Overall Study|Other reason (unknown)|1|||
163457441|NCT02648724|590373142|FG001|Overall Study|Other reason (unknown)|0|||
163457442|NCT02648724|590373143|FG002|Overall Study|Other reason (unknown)|0|||
163457443|NCT02648724|590373144|FG003|Overall Study|Other reason (unknown)|0|||
163457444|NCT02648724|590373145|FG004|Overall Study|Other reason (unknown)|0|||
163457445|NCT02648724|590373146|FG005|Overall Study|Other reason (unknown)|0|||
163457446|NCT02648724|590373147|FG006|Overall Study|Other reason (unknown)|0|||
163457447|NCT02648724|590373141|FG000|Overall Study|Protocol Violation|0|||
163457448|NCT02648724|590373142|FG001|Overall Study|Protocol Violation|0|||
163457449|NCT02648724|590373143|FG002|Overall Study|Protocol Violation|0|||
163457450|NCT02648724|590373144|FG003|Overall Study|Protocol Violation|0|||
163457451|NCT02648724|590373145|FG004|Overall Study|Protocol Violation|1|||
163457452|NCT02648724|590373146|FG005|Overall Study|Protocol Violation|0|||
163457453|NCT02648724|590373147|FG006|Overall Study|Protocol Violation|0|||
163457454|NCT02648724|590373141|FG000|Overall Study|Death|0|||
163457455|NCT02648724|590373142|FG001|Overall Study|Death|0|||
163457456|NCT02648724|590373143|FG002|Overall Study|Death|0|||
163457457|NCT02648724|590373144|FG003|Overall Study|Death|0|||
163457458|NCT02648724|590373145|FG004|Overall Study|Death|0|||
163457459|NCT02648724|590373146|FG005|Overall Study|Death|0|||
163457460|NCT02648724|590373147|FG006|Overall Study|Death|3|||
163457461|NCT02648724|590373141|FG000|Overall Study|Physician Decision|0|||
163457462|NCT02648724|590373142|FG001|Overall Study|Physician Decision|0|||
163457463|NCT02648724|590373143|FG002|Overall Study|Physician Decision|0|||
163457464|NCT02648724|590373144|FG003|Overall Study|Physician Decision|0|||
163457465|NCT02648724|590373145|FG004|Overall Study|Physician Decision|1|||
163457466|NCT02648724|590373146|FG005|Overall Study|Physician Decision|0|||
163457467|NCT02648724|590373147|FG006|Overall Study|Physician Decision|1|||
163457468|NCT02648724|590373141|FG000|Overall Study|Transferred to named patient program|0|||
163457469|NCT02648724|590373142|FG001|Overall Study|Transferred to named patient program|0|||
163457470|NCT02648724|590373143|FG002|Overall Study|Transferred to named patient program|0|||
163457471|NCT02648724|590373144|FG003|Overall Study|Transferred to named patient program|0|||
163457472|NCT02648724|590373145|FG004|Overall Study|Transferred to named patient program|0|||
163457473|NCT02648724|590373146|FG005|Overall Study|Transferred to named patient program|1|||
163457474|NCT02648724|590373147|FG006|Overall Study|Transferred to named patient program|0|||
163457475|NCT00302718|590373149|FG000|Overall Study|Participant left the hospital|1|||
163457476|NCT00302718|590373150|FG001|Overall Study|Participant left the hospital|0|||
163457477|NCT00302718|590373151|FG002|Overall Study|Participant left the hospital|0|||
163457478|NCT00302718|590373152|FG003|Overall Study|Participant left the hospital|1|||
163457479|NCT00302718|590373149|FG000|Overall Study|Withdrawal by Subject|0|||
163457480|NCT00302718|590373150|FG001|Overall Study|Withdrawal by Subject|1|||
163457481|NCT00302718|590373151|FG002|Overall Study|Withdrawal by Subject|0|||
163457482|NCT00302718|590373152|FG003|Overall Study|Withdrawal by Subject|0|||
163457483|NCT00302718|590373149|FG000|Overall Study|Participant left primary care setting|0|||
163457484|NCT00302718|590373150|FG001|Overall Study|Participant left primary care setting|0|||
163457485|NCT00302718|590373151|FG002|Overall Study|Participant left primary care setting|2|||
163457486|NCT00302718|590373152|FG003|Overall Study|Participant left primary care setting|1|||
163457487|NCT00738374|590373153|FG000|Induction Treatment Phase|Adverse Event|14|||
163457488|NCT00738374|590373154|FG001|Induction Treatment Phase|Adverse Event|0|||
163457489|NCT00738374|590373155|FG002|Induction Treatment Phase|Adverse Event|0|||
163457490|NCT00738374|590373156|FG003|Induction Treatment Phase|Adverse Event|0|||
163457491|NCT00738374|590373153|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
163457492|NCT00738374|590373154|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
163457493|NCT00738374|590373155|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
163457494|NCT00738374|590373156|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
163457495|NCT00738374|590373153|FG000|Induction Treatment Phase|Physician Decision|2|||
163457496|NCT00738374|590373154|FG001|Induction Treatment Phase|Physician Decision|0|||
163457497|NCT00738374|590373155|FG002|Induction Treatment Phase|Physician Decision|0|||
163457498|NCT00738374|590373156|FG003|Induction Treatment Phase|Physician Decision|0|||
163457499|NCT00738374|590373153|FG000|Induction Treatment Phase|Protocol Violation|2|||
163457500|NCT00738374|590373154|FG001|Induction Treatment Phase|Protocol Violation|0|||
163457501|NCT00738374|590373155|FG002|Induction Treatment Phase|Protocol Violation|0|||
163457502|NCT00738374|590373156|FG003|Induction Treatment Phase|Protocol Violation|0|||
163457503|NCT00738374|590373153|FG000|Induction Treatment Phase|Non-compliance|1|||
163457504|NCT00738374|590373154|FG001|Induction Treatment Phase|Non-compliance|0|||
163457505|NCT00738374|590373155|FG002|Induction Treatment Phase|Non-compliance|0|||
163457506|NCT00738374|590373156|FG003|Induction Treatment Phase|Non-compliance|0|||
163457507|NCT00738374|590373153|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
163457508|NCT00738374|590373154|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
163457509|NCT00738374|590373155|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
163457510|NCT00738374|590373156|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
163457511|NCT00738374|590373153|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
163457512|NCT00738374|590373154|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
163457513|NCT00738374|590373155|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
163457514|NCT00738374|590373156|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
163457515|NCT00738374|590373153|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
163457516|NCT00738374|590373154|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
163457517|NCT00738374|590373155|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
163457518|NCT00738374|590373156|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
163457519|NCT00738374|590373153|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
163457520|NCT00738374|590373154|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
163457521|NCT00738374|590373155|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
163457522|NCT00738374|590373156|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
163457523|NCT00738374|590373153|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
163457524|NCT00738374|590373154|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
163457525|NCT00738374|590373155|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
163457526|NCT00738374|590373156|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
163457527|NCT00738374|590373153|FG000|Maintenance Treatment/Observation Phase|Other|0|||
163457528|NCT00738374|590373154|FG001|Maintenance Treatment/Observation Phase|Other|1|||
163457529|NCT00738374|590373155|FG002|Maintenance Treatment/Observation Phase|Other|0|||
163457530|NCT00738374|590373156|FG003|Maintenance Treatment/Observation Phase|Other|0|||
163457531|NCT00632541|590373157|FG000|Overall Study|Adverse Event|7|||
163457532|NCT02927873|590373159|FG000|Overall Study|Lost to Follow-up|0|||
163457533|NCT02927873|590373160|FG001|Overall Study|Lost to Follow-up|1|||
163457534|NCT02927873|590373161|FG002|Overall Study|Lost to Follow-up|0|||
163457535|NCT02927873|590373162|FG003|Overall Study|Lost to Follow-up|0|||
163457536|NCT02927873|590373163|FG004|Overall Study|Lost to Follow-up|0|||
163457537|NCT02927873|590373164|FG005|Overall Study|Lost to Follow-up|0|||
163457538|NCT02927873|590373159|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
163457539|NCT02927873|590373160|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
163457540|NCT02927873|590373161|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
163457541|NCT02927873|590373162|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
163457542|NCT02927873|590373163|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
163457543|NCT02927873|590373164|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
163457544|NCT02927873|590373159|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163457545|NCT02927873|590373160|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163457546|NCT02927873|590373161|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163457547|NCT02927873|590373162|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163457548|NCT02927873|590373163|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163457549|NCT02927873|590373164|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163457550|NCT02927873|590373159|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
163457551|NCT02927873|590373160|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
163457552|NCT02927873|590373161|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
163457553|NCT02927873|590373162|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
163457554|NCT02927873|590373163|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
163457555|NCT02927873|590373164|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
163457556|NCT02927873|590373159|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
163457557|NCT02927873|590373160|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
163457558|NCT02927873|590373161|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
163457559|NCT02927873|590373162|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
163457560|NCT02927873|590373163|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
163457561|NCT02927873|590373164|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
163457562|NCT02927873|590373159|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
163457563|NCT02927873|590373160|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
163457564|NCT02927873|590373161|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
163457565|NCT02927873|590373162|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
163457566|NCT02927873|590373163|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
163457567|NCT02927873|590373164|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
163457568|NCT00393913|590373165|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
163457569|NCT00393913|590373165|FG000|Initial Assessment|Withdrawal by Subject|16|||
163457570|NCT00393913|590373165|FG000|CPAP|Withdrawal by Subject|3|||
163457571|NCT00393913|590373165|FG000|CPAP|Physician Decision|1|||
163457572|NCT00393913|590373165|FG000|CPAP|TEchnical problem with CPAP|3|||
163457573|NCT01518244|590373166|FG000|Overall Study|Adverse Event|3|||
163457574|NCT04900038|590373168|FG000|Overall Study|Adverse Event|1|||
163457575|NCT04900038|590373169|FG001|Overall Study|Adverse Event|0|||
163457576|NCT04900038|590373170|FG002|Overall Study|Adverse Event|1|||
163457577|NCT04900038|590373171|FG003|Overall Study|Adverse Event|1|||
163457578|NCT04900038|590373168|FG000|Overall Study|Withdrawal by Subject|0|||
163457579|NCT04900038|590373169|FG001|Overall Study|Withdrawal by Subject|1|||
163457580|NCT04900038|590373170|FG002|Overall Study|Withdrawal by Subject|0|||
163457581|NCT04900038|590373171|FG003|Overall Study|Withdrawal by Subject|0|||
163457582|NCT04900038|590373168|FG000|Overall Study|Study terminated by sponsor|18|||
163457583|NCT04900038|590373169|FG001|Overall Study|Study terminated by sponsor|15|||
163457584|NCT04900038|590373170|FG002|Overall Study|Study terminated by sponsor|17|||
163457585|NCT04900038|590373171|FG003|Overall Study|Study terminated by sponsor|14|||
163457586|NCT04900038|590373168|FG000|Overall Study|Protocol Deviation|1|||
163457587|NCT04900038|590373169|FG001|Overall Study|Protocol Deviation|1|||
163457588|NCT04900038|590373170|FG002|Overall Study|Protocol Deviation|0|||
163457589|NCT04900038|590373171|FG003|Overall Study|Protocol Deviation|0|||
163457590|NCT04900038|590373168|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
163457591|NCT04900038|590373169|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
163457592|NCT04900038|590373170|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
163457593|NCT04900038|590373171|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
163457594|NCT04900038|590373168|FG000|Overall Study|Lost to Follow-up|0|||
163457595|NCT04900038|590373169|FG001|Overall Study|Lost to Follow-up|0|||
163457596|NCT04900038|590373170|FG002|Overall Study|Lost to Follow-up|0|||
163457597|NCT04900038|590373171|FG003|Overall Study|Lost to Follow-up|1|||
163457598|NCT00077376|590373176|FG000|Overall Study|Adverse Event|8|||
163457599|NCT00077376|590373176|FG000|Overall Study|Withdrawal by Subject|2|||
163457600|NCT00077376|590373176|FG000|Overall Study|Death|1|||
163457601|NCT00077376|590373176|FG000|Overall Study|Physician Decision|1|||
163457602|NCT00077376|590373176|FG000|Overall Study|Alternative therapy|5|||
163457603|NCT00077376|590373176|FG000|Overall Study|Complicating disease|1|||
163457604|NCT00077376|590373176|FG000|Overall Study|Still on treatment|1|||
163457605|NCT00077376|590373176|FG000|Overall Study|Symptomatic deterioration|1|||
163457606|NCT00077376|590373176|FG000|Overall Study|Surgery|1|||
163457607|NCT00077376|590373176|FG000|Overall Study|Insurance ran out|1|||
163457608|NCT05757427|590373177|FG000|Overall Study|Adverse Event|1|||
163457609|NCT05757427|590373177|FG000|Overall Study|Device deficiency|1|||
163457610|NCT05757427|590373177|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
163457611|NCT05757427|590373177|FG000|Overall Study|MWBI scan of only 1 breast|3|||
163457612|NCT05757427|590373177|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
163457613|NCT02017899|590375228|FG000|Overall Study|Withdrawal by Subject|0|||
163457614|NCT02017899|590375229|FG001|Overall Study|Withdrawal by Subject|0|||
163457615|NCT02017899|590375230|FG002|Overall Study|Withdrawal by Subject|0|||
163457616|NCT02017899|590375231|FG003|Overall Study|Withdrawal by Subject|1|||
163457617|NCT02017899|590375232|FG004|Overall Study|Withdrawal by Subject|1|||
163457618|NCT02017899|590375233|FG005|Overall Study|Withdrawal by Subject|0|||
163457619|NCT02843178|590375235|FG000|Overall Study|Lost to Follow-up|8|||
163457620|NCT02843178|590375236|FG001|Overall Study|Lost to Follow-up|8|||
163457621|NCT02843178|590375237|FG002|Overall Study|Lost to Follow-up|6|||
163457622|NCT02843178|590375238|FG003|Overall Study|Lost to Follow-up|3|||
163457623|NCT02843178|590375235|FG000|Overall Study|Withdrawal by Subject|0|||
163457624|NCT02843178|590375236|FG001|Overall Study|Withdrawal by Subject|0|||
163457625|NCT02843178|590375237|FG002|Overall Study|Withdrawal by Subject|1|||
163457626|NCT02843178|590375238|FG003|Overall Study|Withdrawal by Subject|1|||
163457627|NCT02420795|590375245|FG000|Overall Study|Withdrawal by Subject|1|||
163457628|NCT02420795|590375246|FG001|Overall Study|Withdrawal by Subject|0|||
163457629|NCT02420795|590375247|FG002|Overall Study|Withdrawal by Subject|0|||
163457630|NCT02420795|590375245|FG000|Overall Study|Adverse Event|1|||
163457631|NCT02420795|590375246|FG001|Overall Study|Adverse Event|0|||
163457632|NCT02420795|590375247|FG002|Overall Study|Adverse Event|0|||
163457633|NCT02420795|590375245|FG000|Overall Study|Progressive disease|2|||
163457634|NCT02420795|590375246|FG001|Overall Study|Progressive disease|2|||
163457635|NCT02420795|590375247|FG002|Overall Study|Progressive disease|4|||
163457636|NCT02420795|590375245|FG000|Overall Study|Death|0|||
163457637|NCT02420795|590375246|FG001|Overall Study|Death|0|||
163457638|NCT02420795|590375247|FG002|Overall Study|Death|1|||
163457639|NCT00949910|590375250|FG000|Overall Study|Progressive Disease|3750|||
163457640|NCT00949910|590375250|FG000|Overall Study|Symptomatic Deterioration|1088|||
163457641|NCT00949910|590375250|FG000|Overall Study|Lost to Follow-up|100|||
163457642|NCT00949910|590375250|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
163457643|NCT00949910|590375250|FG000|Overall Study|Participant Refusal|390|||
163457644|NCT00949910|590375250|FG000|Overall Study|Death Due to Malignant Disease|456|||
163457645|NCT00949910|590375250|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
163457646|NCT00949910|590375250|FG000|Overall Study|Death Due to Adverse Event|115|||
163457647|NCT00949910|590375250|FG000|Overall Study|Death Due to Toxicity|3|||
163457648|NCT00949910|590375250|FG000|Overall Study|Death from Unknown Cause|5|||
163457649|NCT00949910|590375250|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
163457650|NCT00949910|590375250|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
163457651|NCT00949910|590375250|FG000|Overall Study|Switched to Commercial Treatment|4|||
163457652|NCT00949910|590375250|FG000|Overall Study|Violation of Eligibility|23|||
163457653|NCT00949910|590375250|FG000|Overall Study|Logistical Reasons|13|||
163457654|NCT00949910|590375250|FG000|Overall Study|Non-Compliance|10|||
163457655|NCT00949910|590375250|FG000|Overall Study|Prolonged Dosing Interruption|4|||
163457656|NCT00949910|590375250|FG000|Overall Study|Adverse Event|83|||
163457657|NCT00949910|590375250|FG000|Overall Study|Serious Adverse Event|6|||
163457658|NCT00949910|590375250|FG000|Overall Study|Physician/Participant Decision|7|||
163457659|NCT00949910|590375250|FG000|Overall Study|Other|4|||
163457660|NCT00949910|590375250|FG000|Overall Study|No Data|9|||
163457661|NCT00971425|590375251|FG000|Overall Study|Adverse Event|1|||
163457662|NCT00971425|590375252|FG001|Overall Study|Adverse Event|1|||
163457663|NCT00971425|590375251|FG000|Overall Study|Withdrawal by Subject|0|||
163457664|NCT00971425|590375252|FG001|Overall Study|Withdrawal by Subject|1|||
163457665|NCT02528253|590375255|FG000|Overall Study|Adverse Event|3|||
163457666|NCT02528253|590375256|FG001|Overall Study|Adverse Event|4|||
163457667|NCT02528253|590375257|FG002|Overall Study|Adverse Event|4|||
163457668|NCT02528253|590375258|FG003|Overall Study|Adverse Event|8|||
163457669|NCT02528253|590375259|FG004|Overall Study|Adverse Event|18|||
163457670|NCT02528253|590375255|FG000|Overall Study|Death|2|||
163457671|NCT02528253|590375256|FG001|Overall Study|Death|2|||
163457672|NCT02528253|590375257|FG002|Overall Study|Death|1|||
163457673|NCT02528253|590375258|FG003|Overall Study|Death|0|||
163457674|NCT02528253|590375259|FG004|Overall Study|Death|1|||
163457675|NCT02528253|590375255|FG000|Overall Study|Insufficient clinical response|7|||
163457676|NCT02528253|590375256|FG001|Overall Study|Insufficient clinical response|10|||
163457677|NCT02528253|590375257|FG002|Overall Study|Insufficient clinical response|13|||
163457678|NCT02528253|590375258|FG003|Overall Study|Insufficient clinical response|12|||
163457679|NCT02528253|590375259|FG004|Overall Study|Insufficient clinical response|16|||
163457680|NCT02528253|590375255|FG000|Overall Study|Lost to Follow-up|16|||
163457681|NCT02528253|590375256|FG001|Overall Study|Lost to Follow-up|9|||
163457682|NCT02528253|590375257|FG002|Overall Study|Lost to Follow-up|31|||
163457683|NCT02528253|590375258|FG003|Overall Study|Lost to Follow-up|16|||
163457684|NCT02528253|590375259|FG004|Overall Study|Lost to Follow-up|34|||
163457685|NCT02528253|590375255|FG000|Overall Study|Other|21|||
163457686|NCT02528253|590375256|FG001|Overall Study|Other|22|||
163457687|NCT02528253|590375257|FG002|Overall Study|Other|58|||
163457688|NCT02528253|590375258|FG003|Overall Study|Other|52|||
163457689|NCT02528253|590375259|FG004|Overall Study|Other|76|||
163457690|NCT02528253|590375255|FG000|Overall Study|Withdrawal by Subject|25|||
163457691|NCT02528253|590375256|FG001|Overall Study|Withdrawal by Subject|20|||
163457692|NCT02528253|590375257|FG002|Overall Study|Withdrawal by Subject|29|||
163457693|NCT02528253|590375258|FG003|Overall Study|Withdrawal by Subject|48|||
163457694|NCT02528253|590375259|FG004|Overall Study|Withdrawal by Subject|73|||
163457695|NCT02528253|590375255|FG000|Overall Study|Protocol Violation|1|||
163457696|NCT02528253|590375256|FG001|Overall Study|Protocol Violation|2|||
163457697|NCT02528253|590375257|FG002|Overall Study|Protocol Violation|4|||
163457698|NCT02528253|590375258|FG003|Overall Study|Protocol Violation|0|||
163457699|NCT02528253|590375259|FG004|Overall Study|Protocol Violation|4|||
163457700|NCT02528253|590375255|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
163457701|NCT02528253|590375256|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
163457702|NCT02528253|590375257|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
163457703|NCT02528253|590375258|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
163457704|NCT02528253|590375259|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
163457705|NCT00505752|590375260|FG000|Overall Study|Adverse Event|1|||
163457706|NCT00505752|590375261|FG001|Overall Study|Adverse Event|0|||
163457707|NCT00505752|590375262|FG002|Overall Study|Adverse Event|1|||
163457708|NCT00505752|590375263|FG003|Overall Study|Adverse Event|0|||
163457709|NCT00505752|590375260|FG000|Overall Study|Lost to Follow-up|1|||
163457710|NCT00505752|590375261|FG001|Overall Study|Lost to Follow-up|0|||
163457711|NCT00505752|590375262|FG002|Overall Study|Lost to Follow-up|0|||
163457712|NCT00505752|590375263|FG003|Overall Study|Lost to Follow-up|0|||
163457713|NCT00505752|590375260|FG000|Overall Study|Lack of ovarian response|1|||
163457714|NCT00505752|590375261|FG001|Overall Study|Lack of ovarian response|3|||
163457715|NCT00505752|590375262|FG002|Overall Study|Lack of ovarian response|0|||
163457716|NCT00505752|590375263|FG003|Overall Study|Lack of ovarian response|0|||
163457717|NCT00505752|590375260|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
163457718|NCT00505752|590375261|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
163457719|NCT00505752|590375262|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
163457720|NCT00505752|590375263|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
163457721|NCT00505752|590375260|FG000|Overall Study|No oocytes retrieved|0|||
163457722|NCT00505752|590375261|FG001|Overall Study|No oocytes retrieved|2|||
163457723|NCT00505752|590375262|FG002|Overall Study|No oocytes retrieved|0|||
163457724|NCT00505752|590375263|FG003|Overall Study|No oocytes retrieved|1|||
163457725|NCT00505752|590375260|FG000|Overall Study|No Fertilization|1|||
163457726|NCT00505752|590375261|FG001|Overall Study|No Fertilization|1|||
163457727|NCT00505752|590375262|FG002|Overall Study|No Fertilization|2|||
163457728|NCT00505752|590375263|FG003|Overall Study|No Fertilization|1|||
163457729|NCT00505752|590375260|FG000|Overall Study|All embryos/blastocysts discarded|0|||
163457730|NCT00505752|590375261|FG001|Overall Study|All embryos/blastocysts discarded|0|||
163457731|NCT00505752|590375262|FG002|Overall Study|All embryos/blastocysts discarded|1|||
163457732|NCT00505752|590375263|FG003|Overall Study|All embryos/blastocysts discarded|1|||
163457733|NCT00505752|590375260|FG000|Overall Study|Other|1|||
163457734|NCT00505752|590375261|FG001|Overall Study|Other|2|||
163457735|NCT00505752|590375262|FG002|Overall Study|Other|1|||
163457736|NCT00505752|590375263|FG003|Overall Study|Other|2|||
163457737|NCT01624506|590375264|FG000|Overall Study|Lost to Follow-up|29|||
163457738|NCT01624506|590375265|FG001|Overall Study|Lost to Follow-up|15|||
163457739|NCT01624506|590375264|FG000|Overall Study|Withdrawal by Subject|9|||
163457740|NCT01624506|590375265|FG001|Overall Study|Withdrawal by Subject|2|||
163457741|NCT01624506|590375264|FG000|Overall Study|Death|1|||
163457742|NCT01624506|590375265|FG001|Overall Study|Death|0|||
163457743|NCT01624506|590375264|FG000|Overall Study|LINX explants|23|||
163457744|NCT01624506|590375265|FG001|Overall Study|LINX explants|0|||
163457745|NCT01624506|590375264|FG000|Overall Study|Adverse Event|3|||
163457746|NCT01624506|590375265|FG001|Overall Study|Adverse Event|0|||
163457747|NCT00225147|590375267|FG000|Open-label Phase|Lost to Follow-up|0|||
163457748|NCT00225147|590375268|FG001|Open-label Phase|Lost to Follow-up|0|||
163457749|NCT00225147|590375269|FG002|Open-label Phase|Lost to Follow-up|0|||
163457750|NCT00225147|590375270|FG003|Open-label Phase|Lost to Follow-up|4|||
163457751|NCT00225147|590375267|FG000|Open-label Phase|Withdrawal by Subject|0|||
163457752|NCT00225147|590375268|FG001|Open-label Phase|Withdrawal by Subject|0|||
163457753|NCT00225147|590375269|FG002|Open-label Phase|Withdrawal by Subject|0|||
163457754|NCT00225147|590375270|FG003|Open-label Phase|Withdrawal by Subject|6|||
163457755|NCT04019795|590375271|FG000|Overall Study|Withdrawal by Subject|1|||
163457756|NCT04019795|590375272|FG001|Overall Study|Withdrawal by Subject|2|||
163457757|NCT04019795|590375273|FG002|Overall Study|Withdrawal by Subject|2|||
163457758|NCT04019795|590375274|FG003|Overall Study|Withdrawal by Subject|1|||
163457759|NCT04019795|590375271|FG000|Overall Study|Lost to Follow-up|0|||
163457760|NCT04019795|590375272|FG001|Overall Study|Lost to Follow-up|1|||
163457761|NCT04019795|590375273|FG002|Overall Study|Lost to Follow-up|1|||
163457762|NCT04019795|590375274|FG003|Overall Study|Lost to Follow-up|2|||
163457763|NCT04019795|590375271|FG000|Overall Study|Treatment non-compliance|3|||
163457764|NCT04019795|590375272|FG001|Overall Study|Treatment non-compliance|1|||
163457765|NCT04019795|590375273|FG002|Overall Study|Treatment non-compliance|2|||
163457766|NCT04019795|590375274|FG003|Overall Study|Treatment non-compliance|0|||
163457767|NCT04019795|590375271|FG000|Overall Study|Physician Decision|0|||
163457768|NCT04019795|590375272|FG001|Overall Study|Physician Decision|0|||
163457769|NCT04019795|590375273|FG002|Overall Study|Physician Decision|1|||
163457770|NCT04019795|590375274|FG003|Overall Study|Physician Decision|0|||
163457771|NCT04019795|590375271|FG000|Overall Study|Adverse Event|1|||
163457772|NCT04019795|590375272|FG001|Overall Study|Adverse Event|0|||
163457773|NCT04019795|590375273|FG002|Overall Study|Adverse Event|0|||
163457774|NCT04019795|590375274|FG003|Overall Study|Adverse Event|0|||
163457775|NCT03625141|590375275|FG000|Overall Study|Adverse Event|0|||
163457776|NCT03625141|590375276|FG001|Overall Study|Adverse Event|2|||
163457777|NCT03625141|590375275|FG000|Overall Study|Study Terminated By Sponsor|1|||
163457778|NCT03625141|590375276|FG001|Overall Study|Study Terminated By Sponsor|13|||
163457779|NCT03625141|590375275|FG000|Overall Study|Withdrawal by Subject|3|||
163457780|NCT03625141|590375276|FG001|Overall Study|Withdrawal by Subject|0|||
163457781|NCT03625141|590375275|FG000|Overall Study|Withdrawal Of Consent|0|||
163457782|NCT03625141|590375276|FG001|Overall Study|Withdrawal Of Consent|1|||
163457783|NCT03625141|590375275|FG000|Overall Study|Death|11|||
163457784|NCT03625141|590375276|FG001|Overall Study|Death|47|||
163457785|NCT03625141|590375275|FG000|Overall Study|Progressive Disease|0|||
163457786|NCT03625141|590375276|FG001|Overall Study|Progressive Disease|2|||
163457787|NCT03250377|590375277|FG000|Overall Study|Adverse Event|2|||
163457788|NCT03250377|590375278|FG001|Overall Study|Adverse Event|4|||
163457789|NCT03250377|590375279|FG002|Overall Study|Adverse Event|0|||
163457790|NCT03250377|590375280|FG003|Overall Study|Adverse Event|4|||
163457791|NCT03250377|590375277|FG000|Overall Study|Lack of Efficacy|5|||
163457792|NCT03250377|590375278|FG001|Overall Study|Lack of Efficacy|14|||
163457793|NCT03250377|590375279|FG002|Overall Study|Lack of Efficacy|1|||
163457794|NCT03250377|590375280|FG003|Overall Study|Lack of Efficacy|3|||
163457795|NCT03250377|590375277|FG000|Overall Study|Protocol Violation|0|||
163457796|NCT03250377|590375278|FG001|Overall Study|Protocol Violation|2|||
163457797|NCT03250377|590375279|FG002|Overall Study|Protocol Violation|0|||
163457798|NCT03250377|590375280|FG003|Overall Study|Protocol Violation|1|||
163457799|NCT03250377|590375277|FG000|Overall Study|Lost to Follow-up|0|||
163457800|NCT03250377|590375278|FG001|Overall Study|Lost to Follow-up|1|||
163457801|NCT03250377|590375279|FG002|Overall Study|Lost to Follow-up|0|||
163457802|NCT03250377|590375280|FG003|Overall Study|Lost to Follow-up|0|||
163457803|NCT03250377|590375277|FG000|Overall Study|Withdrawal by Subject|7|||
163457804|NCT03250377|590375278|FG001|Overall Study|Withdrawal by Subject|7|||
163457805|NCT03250377|590375279|FG002|Overall Study|Withdrawal by Subject|0|||
163457806|NCT03250377|590375280|FG003|Overall Study|Withdrawal by Subject|4|||
163457807|NCT03250377|590375277|FG000|Overall Study|Investigator's Judgment|1|||
163457808|NCT03250377|590375278|FG001|Overall Study|Investigator's Judgment|0|||
163457809|NCT03250377|590375279|FG002|Overall Study|Investigator's Judgment|0|||
163457810|NCT03250377|590375280|FG003|Overall Study|Investigator's Judgment|0|||
163457811|NCT03250377|590375277|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
163457812|NCT03250377|590375278|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
163457813|NCT03250377|590375279|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
163457814|NCT03250377|590375280|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
163457815|NCT03250377|590375277|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
163457816|NCT03250377|590375278|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
163457817|NCT03250377|590375279|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
163457818|NCT03250377|590375280|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
163457819|NCT03250377|590375277|FG000|Overall Study|Epilepsy Surgery|0|||
163457820|NCT03250377|590375278|FG001|Overall Study|Epilepsy Surgery|1|||
163457821|NCT03250377|590375279|FG002|Overall Study|Epilepsy Surgery|2|||
163457822|NCT03250377|590375280|FG003|Overall Study|Epilepsy Surgery|0|||
163457823|NCT03250377|590375277|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
163457824|NCT03250377|590375278|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
163457825|NCT03250377|590375279|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
163457826|NCT03250377|590375280|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
163457827|NCT03250377|590375277|FG000|Overall Study|Request From The Sponsor|0|||
163457828|NCT03250377|590375278|FG001|Overall Study|Request From The Sponsor|1|||
163457829|NCT03250377|590375279|FG002|Overall Study|Request From The Sponsor|0|||
163457830|NCT03250377|590375280|FG003|Overall Study|Request From The Sponsor|0|||
163457831|NCT03250377|590375277|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
163457832|NCT03250377|590375278|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
163457833|NCT03250377|590375279|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
163457834|NCT03250377|590375280|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
163457835|NCT03250377|590375277|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
163457836|NCT03250377|590375278|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
163457837|NCT03250377|590375279|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
163457838|NCT03250377|590375280|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
163457839|NCT03250377|590375277|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
163457840|NCT03250377|590375278|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
163457841|NCT03250377|590375279|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
163457842|NCT03250377|590375280|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
163457843|NCT03250377|590375277|FG000|Overall Study|Pregnancy Event|0|||
163457844|NCT03250377|590375278|FG001|Overall Study|Pregnancy Event|1|||
163457845|NCT03250377|590375279|FG002|Overall Study|Pregnancy Event|0|||
163457846|NCT03250377|590375280|FG003|Overall Study|Pregnancy Event|0|||
163457847|NCT03250377|590375277|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
163457848|NCT03250377|590375278|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
163457849|NCT03250377|590375279|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
163457850|NCT03250377|590375280|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
163457851|NCT03250377|590375277|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
163457852|NCT03250377|590375278|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
163457853|NCT03250377|590375279|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
163457854|NCT03250377|590375280|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
163457855|NCT03250377|590375277|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
163457856|NCT03250377|590375278|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
163457857|NCT03250377|590375279|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
163457858|NCT03250377|590375280|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
163457859|NCT03250377|590375277|FG000|Overall Study|Patient requested to change hospital|0|||
163457860|NCT03250377|590375278|FG001|Overall Study|Patient requested to change hospital|0|||
163457861|NCT03250377|590375279|FG002|Overall Study|Patient requested to change hospital|0|||
163457862|NCT03250377|590375280|FG003|Overall Study|Patient requested to change hospital|1|||
163457863|NCT03250377|590375277|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
163457864|NCT03250377|590375278|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
163457865|NCT03250377|590375279|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
163457866|NCT03250377|590375280|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
163457867|NCT01114373|590375281|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
163457868|NCT01114373|590375282|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
163457869|NCT01114373|590375281|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
163457870|NCT01114373|590375282|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
163457871|NCT01114373|590375281|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
163457872|NCT01114373|590375282|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
163457873|NCT01114373|590375281|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
163457874|NCT01114373|590375282|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
163457875|NCT03444870|590375283|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
163457876|NCT03444870|590375284|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
163457877|NCT03444870|590375285|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
163457878|NCT03444870|590375286|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
163457879|NCT03444870|590375287|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
163457880|NCT03444870|590375288|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
163457881|NCT03444870|590375283|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
163457882|NCT03444870|590375284|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
163457883|NCT03444870|590375285|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
163457884|NCT03444870|590375286|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
163457885|NCT03444870|590375287|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
163457886|NCT03444870|590375288|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
163457887|NCT03444870|590375283|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
163457888|NCT03444870|590375284|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
163457889|NCT03444870|590375285|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
163457890|NCT03444870|590375286|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
163457891|NCT03444870|590375287|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
163457892|NCT03444870|590375288|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
163457893|NCT03444870|590375283|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
163457894|NCT03444870|590375284|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
163457895|NCT03444870|590375285|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
163457896|NCT03444870|590375286|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
163457897|NCT03444870|590375287|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
163457898|NCT03444870|590375288|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
163457899|NCT03444870|590375283|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
163457900|NCT03444870|590375284|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
163457901|NCT03444870|590375285|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
163457902|NCT03444870|590375286|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
163457903|NCT03444870|590375287|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
163457904|NCT03444870|590375288|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
163457905|NCT03444870|590375283|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
163457906|NCT03444870|590375284|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
163457907|NCT03444870|590375285|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
163457908|NCT03444870|590375286|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
163457909|NCT03444870|590375287|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
163457910|NCT03444870|590375288|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
163457911|NCT03444870|590375283|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
163457912|NCT03444870|590375284|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
163457913|NCT03444870|590375285|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
163457914|NCT03444870|590375286|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
163457915|NCT03444870|590375287|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
163457916|NCT03444870|590375288|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
163457917|NCT03444870|590375283|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
163457918|NCT03444870|590375284|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
163457919|NCT03444870|590375285|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
163457920|NCT03444870|590375286|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
163457921|NCT03444870|590375287|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
163457922|NCT03444870|590375288|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
163457923|NCT03444870|590375283|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
163457924|NCT03444870|590375284|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
163457925|NCT03444870|590375285|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
163457926|NCT03444870|590375286|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
163457927|NCT03444870|590375287|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
163457928|NCT03444870|590375288|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
163457929|NCT03444870|590375283|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163457930|NCT03444870|590375284|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163457931|NCT03444870|590375285|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163457932|NCT03444870|590375286|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163457933|NCT03444870|590375287|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
163457934|NCT03444870|590375288|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
163457935|NCT03444870|590375283|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
163457936|NCT03444870|590375284|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
163457937|NCT03444870|590375285|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
163457938|NCT03444870|590375286|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
163457939|NCT03444870|590375287|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
163457940|NCT03444870|590375288|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
163457941|NCT03444870|590375283|FG000|Open-Label Extension (OLE) Period|Death|0|||
163457942|NCT03444870|590375284|FG001|Open-Label Extension (OLE) Period|Death|0|||
163457943|NCT03444870|590375285|FG002|Open-Label Extension (OLE) Period|Death|0|||
163457944|NCT03444870|590375286|FG003|Open-Label Extension (OLE) Period|Death|0|||
163457945|NCT03444870|590375287|FG004|Open-Label Extension (OLE) Period|Death|1|||
163457946|NCT03444870|590375288|FG005|Open-Label Extension (OLE) Period|Death|0|||
163457947|NCT02034552|590375289|FG000|Overall Study|Never treated|3|||
163457948|NCT02034552|590375290|FG001|Overall Study|Never treated|2|||
163457949|NCT02034552|590375291|FG002|Overall Study|Never treated|0|||
163457950|NCT02034552|590375289|FG000|Overall Study|Radiological progression|3|||
163457951|NCT02034552|590375290|FG001|Overall Study|Radiological progression|5|||
163457952|NCT02034552|590375291|FG002|Overall Study|Radiological progression|4|||
163457953|NCT02034552|590375289|FG000|Overall Study|AE not assoc. with disease progression|1|||
163457954|NCT02034552|590375290|FG001|Overall Study|AE not assoc. with disease progression|4|||
163457955|NCT02034552|590375291|FG002|Overall Study|AE not assoc. with disease progression|2|||
163457956|NCT02034552|590375289|FG000|Overall Study|AE associated with disease progression|0|||
163457957|NCT02034552|590375290|FG001|Overall Study|AE associated with disease progression|1|||
163457958|NCT02034552|590375291|FG002|Overall Study|AE associated with disease progression|0|||
163457959|NCT02034552|590375289|FG000|Overall Study|Withdrawal by Subject|2|||
163457960|NCT02034552|590375290|FG001|Overall Study|Withdrawal by Subject|1|||
163457961|NCT02034552|590375291|FG002|Overall Study|Withdrawal by Subject|1|||
163457962|NCT02034552|590375289|FG000|Overall Study|Non-compliance with study drug|0|||
163457963|NCT02034552|590375290|FG001|Overall Study|Non-compliance with study drug|0|||
163457964|NCT02034552|590375291|FG002|Overall Study|Non-compliance with study drug|1|||
163457965|NCT02034552|590375289|FG000|Overall Study|Clinical progression|5|||
163457966|NCT02034552|590375290|FG001|Overall Study|Clinical progression|7|||
163457967|NCT02034552|590375291|FG002|Overall Study|Clinical progression|9|||
163457968|NCT02501902|590375294|FG000|Overall Study|Subject Refused Further Follow-up|0|||
163457969|NCT02501902|590375295|FG001|Overall Study|Subject Refused Further Follow-up|0|||
163457970|NCT02501902|590375296|FG002|Overall Study|Subject Refused Further Follow-up|0|||
163457971|NCT02501902|590375297|FG003|Overall Study|Subject Refused Further Follow-up|0|||
163457972|NCT02501902|590375298|FG004|Overall Study|Subject Refused Further Follow-up|0|||
163457973|NCT02501902|590375299|FG005|Overall Study|Subject Refused Further Follow-up|0|||
163457974|NCT02501902|590375300|FG006|Overall Study|Subject Refused Further Follow-up|0|||
163457975|NCT02501902|590375301|FG007|Overall Study|Subject Refused Further Follow-up|1|||
163457976|NCT02501902|590375294|FG000|Overall Study|Study Terminated by Sponsor|0|||
163457977|NCT02501902|590375295|FG001|Overall Study|Study Terminated by Sponsor|3|||
163457978|NCT02501902|590375296|FG002|Overall Study|Study Terminated by Sponsor|0|||
163457979|NCT02501902|590375297|FG003|Overall Study|Study Terminated by Sponsor|1|||
163457980|NCT02501902|590375298|FG004|Overall Study|Study Terminated by Sponsor|1|||
163457981|NCT02501902|590375299|FG005|Overall Study|Study Terminated by Sponsor|0|||
163457982|NCT02501902|590375300|FG006|Overall Study|Study Terminated by Sponsor|2|||
163457983|NCT02501902|590375301|FG007|Overall Study|Study Terminated by Sponsor|4|||
163457984|NCT02501902|590375294|FG000|Overall Study|Death|3|||
163457985|NCT02501902|590375295|FG001|Overall Study|Death|4|||
163457986|NCT02501902|590375296|FG002|Overall Study|Death|4|||
163457987|NCT02501902|590375297|FG003|Overall Study|Death|10|||
163457988|NCT02501902|590375298|FG004|Overall Study|Death|10|||
163457989|NCT02501902|590375299|FG005|Overall Study|Death|11|||
163457990|NCT02501902|590375300|FG006|Overall Study|Death|7|||
163457991|NCT02501902|590375301|FG007|Overall Study|Death|15|||
163457992|NCT02267278|590375302|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
163457993|NCT02267278|590375302|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
163457994|NCT02267278|590375302|FG000|Overall Study|Developed new cancer diagnoses|2|||
163457995|NCT02267278|590375302|FG000|Overall Study|prescribed prohibited medication|1|||
163457996|NCT02513771|590375303|FG000|Overall Study|Lost to Follow-up|1|||
163457997|NCT02513771|590375304|FG001|Overall Study|Lost to Follow-up|1|||
163457998|NCT02513771|590375303|FG000|Overall Study|Not being able to get to clinic|1|||
163457999|NCT02513771|590375304|FG001|Overall Study|Not being able to get to clinic|0|||
163458000|NCT00650091|590375305|FG000|Amended Study Design|Withdrawal by Subject|12|||
163458001|NCT00650091|590375306|FG001|Amended Study Design|Withdrawal by Subject|11|||
163458002|NCT00650091|590375307|FG002|Amended Study Design|Withdrawal by Subject|0|||
163458003|NCT00650091|590375305|FG000|Amended Study Design|Physician Decision|5|||
163458004|NCT00650091|590375306|FG001|Amended Study Design|Physician Decision|0|||
163458005|NCT00650091|590375307|FG002|Amended Study Design|Physician Decision|0|||
163458006|NCT00650091|590375305|FG000|Amended Study Design|Adverse Event|1|||
163458007|NCT00650091|590375306|FG001|Amended Study Design|Adverse Event|4|||
163458008|NCT00650091|590375307|FG002|Amended Study Design|Adverse Event|0|||
163458009|NCT00650091|590375305|FG000|Amended Study Design|Lung transplantation|4|||
163458010|NCT00650091|590375306|FG001|Amended Study Design|Lung transplantation|2|||
163458011|NCT00650091|590375307|FG002|Amended Study Design|Lung transplantation|0|||
163458012|NCT00650091|590375305|FG000|Amended Study Design|Other|1|||
163458013|NCT00650091|590375306|FG001|Amended Study Design|Other|3|||
163458014|NCT00650091|590375307|FG002|Amended Study Design|Other|0|||
163458015|NCT01280266|590375314|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
163458016|NCT01280266|590375315|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
163458017|NCT01280266|590375314|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
163458018|NCT01280266|590375315|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
163458019|NCT04295356|590375316|FG000|Overall Study|Physician Decision|1|||
163458020|NCT04295356|590375317|FG001|Overall Study|Physician Decision|0|||
163458021|NCT04295356|590375316|FG000|Overall Study|Lost to Follow-up|0|||
163458022|NCT04295356|590375317|FG001|Overall Study|Lost to Follow-up|3|||
163458023|NCT04295356|590375316|FG000|Overall Study|Protocol Violation|0|||
163458024|NCT04295356|590375317|FG001|Overall Study|Protocol Violation|1|||
163458025|NCT04268004|590375331|FG000|Overall Study|Excluded from analyses|0|||
163458026|NCT04268004|590375332|FG001|Overall Study|Excluded from analyses|1|||
163458027|NCT03495453|590375333|FG000|Overall Study|Withdrawal by Subject|0|||
163458028|NCT03495453|590375334|FG001|Overall Study|Withdrawal by Subject|1|||
163458029|NCT01360762|590375337|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
163458030|NCT01360762|590375337|FG000|Main Study Period (12-month Treatment)|Death|5|||
163458031|NCT01360762|590375337|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
163458032|NCT01360762|590375337|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
163458033|NCT01360762|590375337|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
163458034|NCT01360762|590375337|FG000|Whole Study Period|Lost to Follow-up|10|||
163458035|NCT01360762|590375337|FG000|Whole Study Period|Death|7|||
163458036|NCT01360762|590375337|FG000|Whole Study Period|Patient relapsed|18|||
163458037|NCT01360762|590375337|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
163458038|NCT04724733|590375338|FG000|Overall Study|Lost to Follow-up|1|||
163458039|NCT04724733|590375339|FG001|Overall Study|Lost to Follow-up|1|||
163458040|NCT04724733|590375340|FG002|Overall Study|Lost to Follow-up|1|||
163458041|NCT03067129|590375341|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
163458042|NCT03067129|590375342|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
163458043|NCT03067129|590375343|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
163458044|NCT03067129|590375344|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
163458045|NCT03067129|590375341|FG000|Overall Study|Withdrawal by Subject|0|||
163458046|NCT03067129|590375342|FG001|Overall Study|Withdrawal by Subject|0|||
163458047|NCT03067129|590375343|FG002|Overall Study|Withdrawal by Subject|1|||
163458048|NCT03067129|590375344|FG003|Overall Study|Withdrawal by Subject|2|||
163458049|NCT03067129|590375341|FG000|Overall Study|Lost to Follow-up|5|||
163458050|NCT03067129|590375342|FG001|Overall Study|Lost to Follow-up|5|||
163458051|NCT03067129|590375343|FG002|Overall Study|Lost to Follow-up|4|||
163458052|NCT03067129|590375344|FG003|Overall Study|Lost to Follow-up|3|||
163458053|NCT03372603|590375345|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
163458054|NCT03372603|590375346|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
163458055|NCT03372603|590375345|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
163458056|NCT03372603|590375346|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
163458057|NCT03341923|590375347|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
163458058|NCT03341923|590375348|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
163458059|NCT03986190|590375349|FG000|Overall Study|Withdrawal by Subject|12|||
163458060|NCT03986190|590375350|FG001|Overall Study|Withdrawal by Subject|0|||
163458061|NCT02806947|590375351|FG000|Overall Study|Withdrawal by Subject|5|||
163458062|NCT02806947|590375352|FG001|Overall Study|Withdrawal by Subject|1|||
163458063|NCT04511819|590375353|FG000|Overall Study|Non-compliance with study drug|5|||
163458064|NCT04511819|590375354|FG001|Overall Study|Non-compliance with study drug|1|||
163458065|NCT04511819|590375353|FG000|Overall Study|Withdrawal by Subject|0|||
163458066|NCT04511819|590375354|FG001|Overall Study|Withdrawal by Subject|3|||
163458067|NCT04511819|590375353|FG000|Overall Study|Adverse Event|0|||
163458068|NCT04511819|590375354|FG001|Overall Study|Adverse Event|1|||
163458069|NCT04511819|590375353|FG000|Overall Study|Protocol deviation|1|||
163458070|NCT04511819|590375354|FG001|Overall Study|Protocol deviation|0|||
163458071|NCT04929613|590375355|FG000|Overall Study|Withdrawal by Subject|12|||
163458072|NCT00844649|590375361|FG000|Overall Study|Progressive Disease|196|||
163458073|NCT00844649|590375362|FG001|Overall Study|Progressive Disease|245|||
163458074|NCT00844649|590375361|FG000|Overall Study|Adverse Event|128|||
163458075|NCT00844649|590375362|FG001|Overall Study|Adverse Event|73|||
163458076|NCT00844649|590375361|FG000|Overall Study|Physician Decision|25|||
163458077|NCT00844649|590375362|FG001|Overall Study|Physician Decision|18|||
163458078|NCT00844649|590375361|FG000|Overall Study|Protocol Violation|10|||
163458079|NCT00844649|590375362|FG001|Overall Study|Protocol Violation|6|||
163458080|NCT00844649|590375361|FG000|Overall Study|Withdrawal by Subject|28|||
163458081|NCT00844649|590375362|FG001|Overall Study|Withdrawal by Subject|39|||
163458082|NCT00844649|590375361|FG000|Overall Study|Other|7|||
163458083|NCT00844649|590375362|FG001|Overall Study|Other|10|||
163458084|NCT00844649|590375361|FG000|Overall Study|Withdrew prior to starting treatment|11|||
163458085|NCT00844649|590375362|FG001|Overall Study|Withdrew prior to starting treatment|27|||
163458086|NCT01153841|590375363|FG000|Overall Study|Adverse Event|1|||
163458087|NCT01153841|590375364|FG001|Overall Study|Adverse Event|0|||
163458088|NCT01153841|590375363|FG000|Overall Study|Withdrawal by Subject|1|||
163458089|NCT01153841|590375364|FG001|Overall Study|Withdrawal by Subject|0|||
163458090|NCT01153841|590375363|FG000|Overall Study|Protocol Violation|2|||
163458091|NCT01153841|590375364|FG001|Overall Study|Protocol Violation|0|||
163458092|NCT01153841|590375363|FG000|Overall Study|Lost to Follow-up|2|||
163458093|NCT01153841|590375364|FG001|Overall Study|Lost to Follow-up|0|||
163458094|NCT00712322|590375371|FG000|Overall Study|Protocol deviation|0|||
163458095|NCT00712322|590375372|FG001|Overall Study|Protocol deviation|1|||
163458096|NCT00712322|590375373|FG002|Overall Study|Protocol deviation|0|||
163458097|NCT04404010|590375374|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
163458098|NCT04404010|590375375|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
163458099|NCT01599754|590375379|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
163458100|NCT01599754|590375380|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
163458101|NCT01599754|590375379|FG000|Overall Study|Participant noncompliance|4|||
163458102|NCT01599754|590375380|FG001|Overall Study|Participant noncompliance|4|||
163458103|NCT01599754|590375379|FG000|Overall Study|Lost to Follow-up|13|||
163458104|NCT01599754|590375380|FG001|Overall Study|Lost to Follow-up|6|||
163458105|NCT01599754|590375379|FG000|Overall Study|Death|31|||
163458106|NCT01599754|590375380|FG001|Overall Study|Death|33|||
163458107|NCT01599754|590375379|FG000|Overall Study|Adverse Event|3|||
163458108|NCT01599754|590375380|FG001|Overall Study|Adverse Event|2|||
163458109|NCT01599754|590375379|FG000|Overall Study|Investigator decision|1|||
163458110|NCT01599754|590375380|FG001|Overall Study|Investigator decision|3|||
163458111|NCT01599754|590375379|FG000|Overall Study|Withdrawal by Subject|24|||
163458112|NCT01599754|590375380|FG001|Overall Study|Withdrawal by Subject|25|||
163458113|NCT01599754|590375379|FG000|Overall Study|Study terminated by sponsor|282|||
163458114|NCT01599754|590375380|FG001|Overall Study|Study terminated by sponsor|285|||
163458115|NCT00242580|590375381|FG000|Overall Study|Adverse Event|3|||
163458116|NCT00242580|590375382|FG001|Overall Study|Adverse Event|0|||
163458117|NCT00242580|590375383|FG002|Overall Study|Adverse Event|2|||
163458118|NCT00242580|590375381|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
163458119|NCT00242580|590375382|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
163458120|NCT00242580|590375383|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
163458121|NCT00242580|590375381|FG000|Overall Study|Protocol Violation|0|||
163458122|NCT00242580|590375382|FG001|Overall Study|Protocol Violation|0|||
163458123|NCT00242580|590375383|FG002|Overall Study|Protocol Violation|1|||
163458124|NCT00242580|590375381|FG000|Overall Study|Subject withdrew consent|2|||
163458125|NCT00242580|590375382|FG001|Overall Study|Subject withdrew consent|2|||
163458126|NCT00242580|590375383|FG002|Overall Study|Subject withdrew consent|5|||
163458127|NCT00242580|590375381|FG000|Overall Study|Lost to Follow-up|0|||
163458128|NCT00242580|590375382|FG001|Overall Study|Lost to Follow-up|3|||
163458129|NCT00242580|590375383|FG002|Overall Study|Lost to Follow-up|0|||
163458130|NCT00242580|590375381|FG000|Overall Study|Death|1|||
163458131|NCT00242580|590375382|FG001|Overall Study|Death|2|||
163458132|NCT00242580|590375383|FG002|Overall Study|Death|1|||
163458133|NCT03666858|590375386|FG000|Cohort 1|Adverse Event|1|||
163458134|NCT03666858|590375387|FG001|Cohort 1|Adverse Event|0|||
163458135|NCT03666858|590375386|FG000|Cohort 2|Adverse Event|0|||
163458136|NCT03666858|590375387|FG001|Cohort 2|Adverse Event|1|||
163458137|NCT03282357|590375388|FG000|Overall Study|Lost to Follow-up|3|||
163458138|NCT03282357|590375388|FG000|Overall Study|Withdrawal by Subject|4|||
163458139|NCT03282357|590375388|FG000|Overall Study|Adverse Event|1|||
163458140|NCT03282357|590375388|FG000|Overall Study|Other|9|||
163458141|NCT03550131|590375389|FG000|Overall Study|Lost to Follow-up|16|||
163458142|NCT03550131|590375390|FG001|Overall Study|Lost to Follow-up|24|||
163458143|NCT03550131|590375389|FG000|Overall Study|Withdrawal by Subject|36|||
163458144|NCT03550131|590375390|FG001|Overall Study|Withdrawal by Subject|28|||
163458145|NCT03550131|590375389|FG000|Overall Study|Illness of dyad member|10|||
163458146|NCT03550131|590375390|FG001|Overall Study|Illness of dyad member|2|||
163458147|NCT03550131|590375389|FG000|Overall Study|Death of person with dementia|4|||
163458148|NCT03550131|590375390|FG001|Overall Study|Death of person with dementia|8|||
163458149|NCT00910429|590375395|FG000|Overall Study|Death|18|||
163458150|NCT00910429|590375396|FG001|Overall Study|Death|12|||
163458151|NCT00910429|590375395|FG000|Overall Study|Withdrawal by Subject|3|||
163458152|NCT00910429|590375396|FG001|Overall Study|Withdrawal by Subject|2|||
163458153|NCT00910429|590375395|FG000|Overall Study|Protocol Violation|1|||
163458154|NCT00910429|590375396|FG001|Overall Study|Protocol Violation|0|||
163458155|NCT00910429|590375395|FG000|Overall Study|Lost to Follow-up|2|||
163458156|NCT00910429|590375396|FG001|Overall Study|Lost to Follow-up|1|||
163458157|NCT00910429|590375395|FG000|Overall Study|Adverse Event|10|||
163458158|NCT00910429|590375396|FG001|Overall Study|Adverse Event|5|||
163458159|NCT00910429|590375395|FG000|Overall Study|Drug non-compliance|1|||
163458160|NCT00910429|590375396|FG001|Overall Study|Drug non-compliance|0|||
163458161|NCT00910429|590375395|FG000|Overall Study|Lack of Efficacy|4|||
163458162|NCT00910429|590375396|FG001|Overall Study|Lack of Efficacy|1|||
163458163|NCT00594204|590375397|FG000|Overall Study|Adverse Event|15|||
163458164|NCT00594204|590375398|FG001|Overall Study|Adverse Event|3|||
163458165|NCT00594204|590375397|FG000|Overall Study|Lost to Follow-up|9|||
163458166|NCT00594204|590375398|FG001|Overall Study|Lost to Follow-up|5|||
163458167|NCT00594204|590375397|FG000|Overall Study|Withdrawal by Subject|23|||
163458168|NCT00594204|590375398|FG001|Overall Study|Withdrawal by Subject|29|||
163458169|NCT00594204|590375397|FG000|Overall Study|Other|4|||
163458170|NCT00594204|590375398|FG001|Overall Study|Other|3|||
163458171|NCT00594204|590375397|FG000|Overall Study|Lack of Efficacy|3|||
163458172|NCT00594204|590375398|FG001|Overall Study|Lack of Efficacy|4|||
163458173|NCT00594204|590375397|FG000|Overall Study|Randomized but not treated|4|||
163458174|NCT00594204|590375398|FG001|Overall Study|Randomized but not treated|1|||
163458175|NCT01740388|590375399|FG000|Overall Study|Withdrawal by Subject|1|||
163458176|NCT01740388|590375400|FG001|Overall Study|Withdrawal by Subject|2|||
163458177|NCT01740388|590375399|FG000|Overall Study|Lost to Follow-up|2|||
163458178|NCT01740388|590375400|FG001|Overall Study|Lost to Follow-up|0|||
163458179|NCT01740388|590375399|FG000|Overall Study|Physician Decision|2|||
163458180|NCT01740388|590375400|FG001|Overall Study|Physician Decision|6|||
163458181|NCT01740388|590375399|FG000|Overall Study|Subjects missing data, completed|41|||
163458182|NCT01740388|590375400|FG001|Overall Study|Subjects missing data, completed|36|||
163458183|NCT03927911|590376993|FG000|Overall Study|problems with eDiary|0|||
163458184|NCT03927911|590376994|FG001|Overall Study|problems with eDiary|1|||
163458185|NCT03927911|590376995|FG002|Overall Study|problems with eDiary|0|||
163458186|NCT03927911|590376996|FG003|Overall Study|problems with eDiary|1|||
163458187|NCT03927911|590376997|FG004|Overall Study|problems with eDiary|0|||
163458188|NCT03927911|590376998|FG005|Overall Study|problems with eDiary|4|||
163458189|NCT03927911|590376993|FG000|Overall Study|Adverse Event|0|||
163458190|NCT03927911|590376994|FG001|Overall Study|Adverse Event|0|||
163458191|NCT03927911|590376995|FG002|Overall Study|Adverse Event|0|||
163458192|NCT03927911|590376996|FG003|Overall Study|Adverse Event|0|||
163458193|NCT03927911|590376997|FG004|Overall Study|Adverse Event|0|||
163458194|NCT03927911|590376998|FG005|Overall Study|Adverse Event|1|||
163458195|NCT03927911|590376993|FG000|Overall Study|not treated -study terminated by sponsor|0|||
163458196|NCT03927911|590376994|FG001|Overall Study|not treated -study terminated by sponsor|1|||
163458197|NCT03927911|590376995|FG002|Overall Study|not treated -study terminated by sponsor|0|||
163458198|NCT03927911|590376996|FG003|Overall Study|not treated -study terminated by sponsor|0|||
163458199|NCT03927911|590376997|FG004|Overall Study|not treated -study terminated by sponsor|0|||
163458200|NCT03927911|590376998|FG005|Overall Study|not treated -study terminated by sponsor|0|||
163458201|NCT03927911|590376993|FG000|Overall Study|Surgery cancelled|0|||
163458202|NCT03927911|590376994|FG001|Overall Study|Surgery cancelled|0|||
163458203|NCT03927911|590376995|FG002|Overall Study|Surgery cancelled|0|||
163458204|NCT03927911|590376996|FG003|Overall Study|Surgery cancelled|1|||
163458205|NCT03927911|590376997|FG004|Overall Study|Surgery cancelled|0|||
163458206|NCT03927911|590376998|FG005|Overall Study|Surgery cancelled|1|||
163458207|NCT03927911|590376993|FG000|Overall Study|Protocol Violation|0|||
163458208|NCT03927911|590376994|FG001|Overall Study|Protocol Violation|0|||
163458209|NCT03927911|590376995|FG002|Overall Study|Protocol Violation|0|||
163458210|NCT03927911|590376996|FG003|Overall Study|Protocol Violation|0|||
163458211|NCT03927911|590376997|FG004|Overall Study|Protocol Violation|0|||
163458212|NCT03927911|590376998|FG005|Overall Study|Protocol Violation|1|||
163458213|NCT02658968|590376999|FG000|Received Rituximab|Adverse Event|0|||
163458214|NCT02658968|590377000|FG001|Received Rituximab|Adverse Event|0|||
163458215|NCT02658968|590377001|FG002|Received Rituximab|Adverse Event|0|||
163458216|NCT02658968|590377002|FG003|Received Rituximab|Adverse Event|0|||
163458217|NCT02658968|590377003|FG004|Received Rituximab|Adverse Event|1|||
163458218|NCT02658968|590376999|FG000|Received Rituximab|Progressive disease|0|||
163458219|NCT02658968|590377000|FG001|Received Rituximab|Progressive disease|0|||
163458220|NCT02658968|590377001|FG002|Received Rituximab|Progressive disease|0|||
163458221|NCT02658968|590377002|FG003|Received Rituximab|Progressive disease|0|||
163458222|NCT02658968|590377003|FG004|Received Rituximab|Progressive disease|1|||
163458223|NCT02658968|590376999|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
163458224|NCT02658968|590377000|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
163458225|NCT02658968|590377001|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
163458226|NCT02658968|590377002|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
163458227|NCT02658968|590377003|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
163458228|NCT02658968|590376999|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
163458229|NCT02658968|590377000|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
163458230|NCT02658968|590377001|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
163458231|NCT02658968|590377002|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
163458232|NCT02658968|590377003|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
163458233|NCT02658968|590376999|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
163458234|NCT02658968|590377000|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
163458235|NCT02658968|590377001|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
163458236|NCT02658968|590377002|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
163458237|NCT02658968|590377003|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
163458238|NCT02658968|590376999|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
163458239|NCT02658968|590377000|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
163458240|NCT02658968|590377001|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
163458241|NCT02658968|590377002|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
163458242|NCT02658968|590377003|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
163458243|NCT02658968|590376999|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
163458244|NCT02658968|590377000|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
163458245|NCT02658968|590377001|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
163458246|NCT02658968|590377002|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
163458247|NCT02658968|590377003|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
163458248|NCT01149343|590377004|FG000|Overall Study|Withdrawal by Subject|1|||
163458249|NCT01149343|590377005|FG001|Overall Study|Withdrawal by Subject|1|||
163458250|NCT01149343|590377006|FG002|Overall Study|Withdrawal by Subject|1|||
163458251|NCT01149343|590377007|FG003|Overall Study|Withdrawal by Subject|5|||
163458252|NCT01149343|590377004|FG000|Overall Study|Death|10|||
163458253|NCT01149343|590377005|FG001|Overall Study|Death|13|||
163458254|NCT01149343|590377006|FG002|Overall Study|Death|18|||
163458255|NCT01149343|590377007|FG003|Overall Study|Death|18|||
163458256|NCT01149343|590377004|FG000|Overall Study|Lost to Follow-up|1|||
163458257|NCT01149343|590377005|FG001|Overall Study|Lost to Follow-up|0|||
163458258|NCT01149343|590377006|FG002|Overall Study|Lost to Follow-up|0|||
163458259|NCT01149343|590377007|FG003|Overall Study|Lost to Follow-up|1|||
163458260|NCT01149343|590377004|FG000|Overall Study|Other|8|||
163458261|NCT01149343|590377005|FG001|Overall Study|Other|10|||
163458262|NCT01149343|590377006|FG002|Overall Study|Other|2|||
163458263|NCT01149343|590377007|FG003|Overall Study|Other|14|||
163458264|NCT01149343|590377004|FG000|Overall Study|Sponsor study termination|0|||
163458265|NCT01149343|590377005|FG001|Overall Study|Sponsor study termination|0|||
163458266|NCT01149343|590377006|FG002|Overall Study|Sponsor study termination|0|||
163458267|NCT01149343|590377007|FG003|Overall Study|Sponsor study termination|2|||
163458268|NCT01149343|590377004|FG000|Overall Study|Recurrence / Progressive disease|0|||
163458269|NCT01149343|590377005|FG001|Overall Study|Recurrence / Progressive disease|0|||
163458270|NCT01149343|590377006|FG002|Overall Study|Recurrence / Progressive disease|1|||
163458271|NCT01149343|590377007|FG003|Overall Study|Recurrence / Progressive disease|0|||
163458272|NCT03472040|590377021|FG000|Overall Study|Physician Decision|0|||
163458273|NCT03472040|590377022|FG001|Overall Study|Physician Decision|3|||
163458274|NCT03472040|590377021|FG000|Overall Study|Withdrawal by Subject|10|||
163458275|NCT03472040|590377022|FG001|Overall Study|Withdrawal by Subject|23|||
163458276|NCT03472040|590377021|FG000|Overall Study|Perceived Lack of Efficacy|29|||
163458277|NCT03472040|590377022|FG001|Overall Study|Perceived Lack of Efficacy|30|||
163458278|NCT03472040|590377021|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
163458279|NCT03472040|590377022|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
163458280|NCT03472040|590377021|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
163458281|NCT03472040|590377022|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
163458282|NCT03472040|590377021|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
163458283|NCT03472040|590377022|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
163458284|NCT03472040|590377021|FG000|Overall Study|Subject Non-compliance|2|||
163458285|NCT03472040|590377022|FG001|Overall Study|Subject Non-compliance|5|||
163458286|NCT03472040|590377021|FG000|Overall Study|Discontinuation due to Rash|0|||
163458287|NCT03472040|590377022|FG001|Overall Study|Discontinuation due to Rash|1|||
163458288|NCT03472040|590377021|FG000|Overall Study|Subsequent Ineligibility|0|||
163458289|NCT03472040|590377022|FG001|Overall Study|Subsequent Ineligibility|2|||
163458290|NCT03472040|590377021|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
163458291|NCT03472040|590377022|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
163458292|NCT02769832|590377023|FG000|Overall Study|Death|30|||
163458293|NCT02197897|590377024|FG000|Overall Study|not eligible|1|||
163458294|NCT01103778|590377026|FG000|Overall Study|Lost to Follow-up|1|||
163458295|NCT01103778|590377026|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
163458296|NCT01103778|590377026|FG000|Overall Study|Screen failure|1|||
163458297|NCT03084718|590377027|FG000|Overall Study|Withdrawal by Subject|4|||
163458298|NCT03084718|590377028|FG001|Overall Study|Withdrawal by Subject|3|||
163458299|NCT03084718|590377029|FG002|Overall Study|Withdrawal by Subject|4|||
163458300|NCT03084718|590377030|FG003|Overall Study|Withdrawal by Subject|0|||
163458301|NCT03084718|590377031|FG004|Overall Study|Withdrawal by Subject|0|||
163458302|NCT03084718|590377027|FG000|Overall Study|Physician Decision|1|||
163458303|NCT03084718|590377028|FG001|Overall Study|Physician Decision|0|||
163458304|NCT03084718|590377029|FG002|Overall Study|Physician Decision|0|||
163458305|NCT03084718|590377030|FG003|Overall Study|Physician Decision|0|||
163458306|NCT03084718|590377031|FG004|Overall Study|Physician Decision|0|||
163458307|NCT03084718|590377027|FG000|Overall Study|Adverse Event|3|||
163458308|NCT03084718|590377028|FG001|Overall Study|Adverse Event|5|||
163458309|NCT03084718|590377029|FG002|Overall Study|Adverse Event|5|||
163458310|NCT03084718|590377030|FG003|Overall Study|Adverse Event|8|||
163458311|NCT03084718|590377031|FG004|Overall Study|Adverse Event|2|||
163458312|NCT03084718|590377027|FG000|Overall Study|Lack of Efficacy|2|||
163458313|NCT03084718|590377028|FG001|Overall Study|Lack of Efficacy|0|||
163458314|NCT03084718|590377029|FG002|Overall Study|Lack of Efficacy|1|||
163458315|NCT03084718|590377030|FG003|Overall Study|Lack of Efficacy|4|||
163458316|NCT03084718|590377031|FG004|Overall Study|Lack of Efficacy|0|||
163458317|NCT03084718|590377027|FG000|Overall Study|Lost to Follow-up|0|||
163458318|NCT03084718|590377028|FG001|Overall Study|Lost to Follow-up|1|||
163458319|NCT03084718|590377029|FG002|Overall Study|Lost to Follow-up|0|||
163458320|NCT03084718|590377030|FG003|Overall Study|Lost to Follow-up|0|||
163458321|NCT03084718|590377031|FG004|Overall Study|Lost to Follow-up|2|||
163458322|NCT03084718|590377027|FG000|Overall Study|Protocol Violation|0|||
163458323|NCT03084718|590377028|FG001|Overall Study|Protocol Violation|0|||
163458324|NCT03084718|590377029|FG002|Overall Study|Protocol Violation|1|||
163458325|NCT03084718|590377030|FG003|Overall Study|Protocol Violation|0|||
163458326|NCT03084718|590377031|FG004|Overall Study|Protocol Violation|0|||
163458327|NCT03084718|590377027|FG000|Overall Study|Death|0|||
163458328|NCT03084718|590377028|FG001|Overall Study|Death|1|||
163458329|NCT03084718|590377029|FG002|Overall Study|Death|0|||
163458330|NCT03084718|590377030|FG003|Overall Study|Death|0|||
163458331|NCT03084718|590377031|FG004|Overall Study|Death|0|||
163458332|NCT03084718|590377027|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
163458333|NCT03084718|590377028|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
163458334|NCT03084718|590377029|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
163458335|NCT03084718|590377030|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
163458336|NCT03084718|590377031|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
163458337|NCT01594333|590377036|FG000|Overall Study|Death|96|||
163458338|NCT01594333|590377037|FG001|Overall Study|Death|83|||
163458339|NCT01594333|590377036|FG000|Overall Study|Lost to Follow-up|5|||
163458340|NCT01594333|590377037|FG001|Overall Study|Lost to Follow-up|5|||
163458341|NCT01594333|590377036|FG000|Overall Study|Withdrawal by Subject|60|||
163458342|NCT01594333|590377037|FG001|Overall Study|Withdrawal by Subject|63|||
163458343|NCT00589979|590377038|FG000|Run-In Period|Adverse Event|5|||
163458344|NCT00589979|590377039|FG001|Run-In Period|Adverse Event|0|||
163458345|NCT00589979|590377040|FG002|Run-In Period|Adverse Event|0|||
163458346|NCT00589979|590377038|FG000|Run-In Period|Protocol Violation|3|||
163458347|NCT00589979|590377039|FG001|Run-In Period|Protocol Violation|0|||
163458348|NCT00589979|590377040|FG002|Run-In Period|Protocol Violation|0|||
163458349|NCT00589979|590377038|FG000|Run-In Period|Did not qualify for randomization|54|||
163458350|NCT00589979|590377039|FG001|Run-In Period|Did not qualify for randomization|0|||
163458351|NCT00589979|590377040|FG002|Run-In Period|Did not qualify for randomization|0|||
163458352|NCT00589979|590377038|FG000|Run-In Period|Withdrawal by Subject|10|||
163458353|NCT00589979|590377039|FG001|Run-In Period|Withdrawal by Subject|0|||
163458354|NCT00589979|590377040|FG002|Run-In Period|Withdrawal by Subject|0|||
163458355|NCT00589979|590377038|FG000|Run-In Period|Informed Consent Withdrawn|4|||
163458356|NCT00589979|590377039|FG001|Run-In Period|Informed Consent Withdrawn|0|||
163458357|NCT00589979|590377040|FG002|Run-In Period|Informed Consent Withdrawn|0|||
163458358|NCT00589979|590377038|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
163458359|NCT00589979|590377039|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
163458360|NCT00589979|590377040|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
163458361|NCT00589979|590377038|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
163458362|NCT00589979|590377039|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
163458363|NCT00589979|590377040|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
163458364|NCT00589979|590377038|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
163458365|NCT00589979|590377039|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
163458366|NCT00589979|590377040|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
163458367|NCT00589979|590377038|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
163458368|NCT00589979|590377039|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
163458369|NCT00589979|590377040|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
163458370|NCT00589979|590377038|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
163458371|NCT00589979|590377039|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
163458372|NCT00589979|590377040|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
163458373|NCT00589979|590377038|FG000|Double-Blind Treatment Period 2|Other|0|||
163458374|NCT00589979|590377039|FG001|Double-Blind Treatment Period 2|Other|0|||
163458375|NCT00589979|590377040|FG002|Double-Blind Treatment Period 2|Other|1|||
163458376|NCT00589979|590377038|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
163458377|NCT00589979|590377039|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
163458378|NCT00589979|590377040|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
163458379|NCT00589979|590377038|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
163458380|NCT00589979|590377039|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
163458381|NCT00589979|590377040|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
163458382|NCT03428997|590377046|FG000|Overall Study|Sponsor decision.|1|||
163458383|NCT03428997|590377046|FG000|Overall Study|Withdrawal by Subject|3|||
163458384|NCT03428997|590377046|FG000|Overall Study|Lost to Follow-up|4|||
163458385|NCT00510068|590377050|FG000|Double-blind Period|Disease progression|98|||
163458386|NCT00510068|590377051|FG001|Double-blind Period|Disease progression|169|||
163458387|NCT00510068|590377050|FG000|Double-blind Period|Final primary analysis|52|||
163458388|NCT00510068|590377051|FG001|Double-blind Period|Final primary analysis|18|||
163458389|NCT00510068|590377050|FG000|Double-blind Period|Adverse Event|37|||
163458390|NCT00510068|590377051|FG001|Double-blind Period|Adverse Event|7|||
163458391|NCT00510068|590377050|FG000|Double-blind Period|Withdrawal by Subject|8|||
163458392|NCT00510068|590377051|FG001|Double-blind Period|Withdrawal by Subject|6|||
163458393|NCT00510068|590377050|FG000|Double-blind Period|Death|4|||
163458394|NCT00510068|590377051|FG001|Double-blind Period|Death|3|||
163458395|NCT00510068|590377050|FG000|Double-blind Period|Abnormal test result (s)|1|||
163458396|NCT00510068|590377051|FG001|Double-blind Period|Abnormal test result (s)|0|||
163458397|NCT00510068|590377050|FG000|Double-blind Period|Lost to Follow-up|1|||
163458398|NCT00510068|590377051|FG001|Double-blind Period|Lost to Follow-up|0|||
163458399|NCT00510068|590377050|FG000|Double-blind Period|Protocol Violation|6|||
163458400|NCT00510068|590377051|FG001|Double-blind Period|Protocol Violation|0|||
163458401|NCT00510068|590377050|FG000|Open-label Period|Disease Progression|124|||
163458402|NCT00510068|590377051|FG001|Open-label Period|Disease Progression|0|||
163458403|NCT00510068|590377050|FG000|Open-label Period|Adverse Event|46|||
163458404|NCT00510068|590377051|FG001|Open-label Period|Adverse Event|0|||
163458405|NCT00510068|590377050|FG000|Open-label Period|Withdrawal by Subject|21|||
163458406|NCT00510068|590377051|FG001|Open-label Period|Withdrawal by Subject|0|||
163458407|NCT00510068|590377050|FG000|Open-label Period|Administrative problems|17|||
163458408|NCT00510068|590377051|FG001|Open-label Period|Administrative problems|0|||
163458409|NCT00510068|590377050|FG000|Open-label Period|Death|7|||
163458410|NCT00510068|590377051|FG001|Open-label Period|Death|0|||
163458411|NCT00510068|590377050|FG000|Open-label Period|New cancer therapy|7|||
163458412|NCT00510068|590377051|FG001|Open-label Period|New cancer therapy|0|||
163458413|NCT00510068|590377050|FG000|Open-label Period|Protocol Violation|2|||
163458414|NCT00510068|590377051|FG001|Open-label Period|Protocol Violation|0|||
163458415|NCT00510068|590377050|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
163458416|NCT00510068|590377051|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
163458417|NCT02120157|590377052|FG000|Overall Study|Death|8|||
163458418|NCT02553317|590377053|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
163458419|NCT02553317|590377054|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
163458420|NCT02553317|590377053|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
163458421|NCT02553317|590377054|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
163458422|NCT02553317|590377053|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
163458423|NCT02553317|590377054|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
163458424|NCT02553317|590377053|FG000|Overall Treatment Period + Follow-up|Death|1|||
163458425|NCT02553317|590377054|FG001|Overall Treatment Period + Follow-up|Death|3|||
163458426|NCT02553317|590377053|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
163458427|NCT02553317|590377054|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
163458428|NCT02553317|590377053|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
163458429|NCT02553317|590377054|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
163458430|NCT02553317|590377053|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
163458431|NCT02553317|590377054|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
163458432|NCT02553317|590377053|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
163458433|NCT02553317|590377054|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
163458434|NCT02553317|590377053|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
163458435|NCT02553317|590377054|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
163458436|NCT02553317|590377053|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
163458437|NCT02553317|590377054|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
163458438|NCT01354431|590377056|FG000|Pre-Treatment Period|Not reported|1|||
163458439|NCT01354431|590377057|FG001|Pre-Treatment Period|Not reported|0|||
163458440|NCT01354431|590377058|FG002|Pre-Treatment Period|Not reported|0|||
163458441|NCT01354431|590377056|FG000|Treatment Period|Disease Progression|50|||
163458442|NCT01354431|590377057|FG001|Treatment Period|Disease Progression|40|||
163458443|NCT01354431|590377058|FG002|Treatment Period|Disease Progression|44|||
163458444|NCT01354431|590377056|FG000|Treatment Period|Study Drug Toxicity|5|||
163458445|NCT01354431|590377057|FG001|Treatment Period|Study Drug Toxicity|8|||
163458446|NCT01354431|590377058|FG002|Treatment Period|Study Drug Toxicity|4|||
163458447|NCT01354431|590377056|FG000|Treatment Period|Death|0|||
163458448|NCT01354431|590377057|FG001|Treatment Period|Death|1|||
163458449|NCT01354431|590377058|FG002|Treatment Period|Death|0|||
163458450|NCT01354431|590377056|FG000|Treatment Period|AE unrelated to study drug|1|||
163458451|NCT01354431|590377057|FG001|Treatment Period|AE unrelated to study drug|2|||
163458452|NCT01354431|590377058|FG002|Treatment Period|AE unrelated to study drug|5|||
163458453|NCT01354431|590377056|FG000|Treatment Period|Participant request to discontinue|2|||
163458454|NCT01354431|590377057|FG001|Treatment Period|Participant request to discontinue|2|||
163458455|NCT01354431|590377058|FG002|Treatment Period|Participant request to discontinue|1|||
163458456|NCT01354431|590377056|FG000|Treatment Period|Participant withdrew consent|0|||
163458457|NCT01354431|590377057|FG001|Treatment Period|Participant withdrew consent|1|||
163458458|NCT01354431|590377058|FG002|Treatment Period|Participant withdrew consent|0|||
163458459|NCT01354431|590377056|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
163458460|NCT01354431|590377057|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
163458461|NCT01354431|590377058|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
163458462|NCT03176277|590377059|FG000|Part A Dose Escalation Study|Adverse Event|1|||
163458463|NCT03176277|590377060|FG001|Part A Dose Escalation Study|Adverse Event|0|||
163458464|NCT03176277|590377061|FG002|Part A Dose Escalation Study|Adverse Event|1|||
163458465|NCT03176277|590377062|FG003|Part A Dose Escalation Study|Adverse Event|0|||
163458466|NCT03176277|590377059|FG000|Part A Dose Escalation Study|Physician Decision|1|||
163458467|NCT03176277|590377060|FG001|Part A Dose Escalation Study|Physician Decision|1|||
163458468|NCT03176277|590377061|FG002|Part A Dose Escalation Study|Physician Decision|2|||
163458469|NCT03176277|590377062|FG003|Part A Dose Escalation Study|Physician Decision|0|||
163458470|NCT03176277|590377059|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
163458471|NCT03176277|590377060|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
163458472|NCT03176277|590377061|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
163458473|NCT03176277|590377062|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
163458474|NCT03176277|590377059|FG000|Part A Dose Escalation Study|Progressive disease|3|||
163458475|NCT03176277|590377060|FG001|Part A Dose Escalation Study|Progressive disease|1|||
163458476|NCT03176277|590377061|FG002|Part A Dose Escalation Study|Progressive disease|3|||
163458477|NCT03176277|590377062|FG003|Part A Dose Escalation Study|Progressive disease|0|||
163458478|NCT02802878|590377063|FG000|Overall Study|Withdrawal by Subject|3|||
163458479|NCT02802878|590377064|FG001|Overall Study|Withdrawal by Subject|3|||
163458480|NCT02802878|590377063|FG000|Overall Study|Protocol Violation|1|||
163458481|NCT02802878|590377064|FG001|Overall Study|Protocol Violation|0|||
163458482|NCT00702052|590377065|FG000|Overall Study|Adverse Event|23|||
163458483|NCT00702052|590377065|FG000|Overall Study|Disease Progression|30|||
163458484|NCT00702052|590377065|FG000|Overall Study|Withdrawal by Subject|5|||
163458485|NCT00101192|590377066|FG000|Overall Study|Ineligible|6|||
163458486|NCT00101192|590377066|FG000|Overall Study|Inevaluable|1|||
163458487|NCT03691610|590377067|FG000|Overall Study|Adverse Event|0|||
163458488|NCT03691610|590377068|FG001|Overall Study|Adverse Event|1|||
163458489|NCT03691610|590377069|FG002|Overall Study|Adverse Event|0|||
163458490|NCT03691610|590377070|FG003|Overall Study|Adverse Event|0|||
163458491|NCT03691610|590377067|FG000|Overall Study|Protocol Deviation|15|||
163458492|NCT03691610|590377068|FG001|Overall Study|Protocol Deviation|8|||
163458493|NCT03691610|590377069|FG002|Overall Study|Protocol Deviation|1|||
163458494|NCT03691610|590377070|FG003|Overall Study|Protocol Deviation|2|||
163458495|NCT03691610|590377067|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
163458496|NCT03691610|590377068|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
163458497|NCT03691610|590377069|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
163458498|NCT03691610|590377070|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
163458499|NCT03691610|590377067|FG000|Overall Study|Lost to Follow-up|20|||
163458500|NCT03691610|590377068|FG001|Overall Study|Lost to Follow-up|11|||
163458501|NCT03691610|590377069|FG002|Overall Study|Lost to Follow-up|5|||
163458502|NCT03691610|590377070|FG003|Overall Study|Lost to Follow-up|2|||
163458503|NCT00536978|590377071|FG000|Overall Study|Not eligible for Adback Infusion|22|||
163458504|NCT03970395|590377072|FG000|Overall Study|Withdrawal by Subject|3|||
163458505|NCT03970395|590377073|FG001|Overall Study|Withdrawal by Subject|4|||
163458506|NCT03970395|590377072|FG000|Overall Study|Lost to Follow-up|4|||
163458507|NCT03970395|590377073|FG001|Overall Study|Lost to Follow-up|8|||
163458508|NCT02921919|590377074|FG000|Overall Study|Other|5|||
163458509|NCT02921919|590377075|FG001|Overall Study|Other|6|||
163458510|NCT02921919|590377074|FG000|Overall Study|Lost to Follow-up|0|||
163458511|NCT02921919|590377075|FG001|Overall Study|Lost to Follow-up|1|||
163458512|NCT02921919|590377074|FG000|Overall Study|Withdrawal by Subject|5|||
163458513|NCT02921919|590377075|FG001|Overall Study|Withdrawal by Subject|1|||
163458514|NCT02921919|590377074|FG000|Overall Study|Disease Progression|47|||
163458515|NCT02921919|590377075|FG001|Overall Study|Disease Progression|38|||
163458516|NCT02921919|590377074|FG000|Overall Study|Physician Decision|3|||
163458517|NCT02921919|590377075|FG001|Overall Study|Physician Decision|2|||
163458518|NCT02921919|590377074|FG000|Overall Study|Adverse Event|6|||
163458519|NCT02921919|590377075|FG001|Overall Study|Adverse Event|4|||
163458520|NCT04664855|590377076|FG000|Overall Study|Withdrawal by Subject|0|||
163458521|NCT04664855|590377077|FG001|Overall Study|Withdrawal by Subject|2|||
163458522|NCT01086150|590377085|FG000|Overall Study|Withdrawal by Subject|0|||
163458523|NCT01086150|590377086|FG001|Overall Study|Withdrawal by Subject|4|||
163458524|NCT01086150|590377087|FG002|Overall Study|Withdrawal by Subject|1|||
163458525|NCT01086150|590377085|FG000|Overall Study|Lost to Follow-up|0|||
163458526|NCT01086150|590377086|FG001|Overall Study|Lost to Follow-up|1|||
163458527|NCT01086150|590377087|FG002|Overall Study|Lost to Follow-up|0|||
163458528|NCT01086150|590377085|FG000|Overall Study|Screen Failure|0|||
163458529|NCT01086150|590377086|FG001|Overall Study|Screen Failure|1|||
163458530|NCT01086150|590377087|FG002|Overall Study|Screen Failure|0|||
163458531|NCT00870818|590377089|FG000|Overall Study|Lost to Follow-up|3|||
163458532|NCT00870818|590377090|FG001|Overall Study|Lost to Follow-up|2|||
163458533|NCT00870818|590377091|FG002|Overall Study|Lost to Follow-up|1|||
163458534|NCT00870818|590377092|FG003|Overall Study|Lost to Follow-up|0|||
163458535|NCT00870818|590377093|FG004|Overall Study|Lost to Follow-up|0|||
163458536|NCT00870818|590377089|FG000|Overall Study|Withdrawal by Subject|0|||
163458537|NCT00870818|590377090|FG001|Overall Study|Withdrawal by Subject|0|||
163458538|NCT00870818|590377091|FG002|Overall Study|Withdrawal by Subject|1|||
163458539|NCT00870818|590377092|FG003|Overall Study|Withdrawal by Subject|2|||
163458540|NCT00870818|590377093|FG004|Overall Study|Withdrawal by Subject|0|||
163458541|NCT00870818|590377089|FG000|Overall Study|Terminated by sponsor|29|||
163458542|NCT00870818|590377090|FG001|Overall Study|Terminated by sponsor|70|||
163458543|NCT00870818|590377091|FG002|Overall Study|Terminated by sponsor|36|||
163458544|NCT00870818|590377092|FG003|Overall Study|Terminated by sponsor|36|||
163458545|NCT00870818|590377093|FG004|Overall Study|Terminated by sponsor|38|||
163458546|NCT00870818|590377089|FG000|Overall Study|Other|0|||
163458547|NCT00870818|590377090|FG001|Overall Study|Other|1|||
163458548|NCT00870818|590377091|FG002|Overall Study|Other|0|||
163458549|NCT00870818|590377092|FG003|Overall Study|Other|0|||
163458550|NCT00870818|590377093|FG004|Overall Study|Other|0|||
163458551|NCT00178464|590377094|FG000|Overall Study|Withdrawal by Subject|1|||
163458552|NCT00178464|590377094|FG000|Overall Study|Physician Decision|1|||
163458553|NCT01529385|590377095|FG000|Overall Study|Lost to Follow-up|2|||
163458554|NCT01529385|590377096|FG001|Overall Study|Lost to Follow-up|1|||
163458555|NCT01401465|590377097|FG000|Treatment Period 1|Adverse Event|4|||
163458556|NCT01401465|590377098|FG001|Treatment Period 1|Adverse Event|1|||
163458557|NCT01401465|590377097|FG000|Treatment Period 1|Pregnancy|0|||
163458558|NCT01401465|590377098|FG001|Treatment Period 1|Pregnancy|1|||
163458559|NCT01401465|590377097|FG000|Treatment Period 1|Protocol Violation|5|||
163458560|NCT01401465|590377098|FG001|Treatment Period 1|Protocol Violation|0|||
163458561|NCT01401465|590377097|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163458562|NCT01401465|590377098|FG001|Treatment Period 1|Withdrawal by Subject|4|||
163458563|NCT01401465|590377097|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
163458564|NCT01401465|590377098|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
163458565|NCT01401465|590377097|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
163458566|NCT01401465|590377098|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
163458567|NCT01401465|590377097|FG000|Treatment Period 1|Scheduling Difficulties|1|||
163458568|NCT01401465|590377098|FG001|Treatment Period 1|Scheduling Difficulties|1|||
163458569|NCT01401465|590377097|FG000|Treatment Period 2|Lost to Follow-up|0|||
163458570|NCT01401465|590377098|FG001|Treatment Period 2|Lost to Follow-up|1|||
163458571|NCT01401465|590377097|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163458572|NCT01401465|590377098|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163458573|NCT01115738|590377099|FG000|Overall Study|Death|1|||
163458574|NCT01115738|590377100|FG001|Overall Study|Death|0|||
163458575|NCT01115738|590377101|FG002|Overall Study|Death|0|||
163458576|NCT01115738|590377099|FG000|Overall Study|Lost to Follow-up|0|||
163458577|NCT01115738|590377100|FG001|Overall Study|Lost to Follow-up|0|||
163458578|NCT01115738|590377101|FG002|Overall Study|Lost to Follow-up|1|||
163458579|NCT01115738|590377099|FG000|Overall Study|Physician Decision|18|||
163458580|NCT01115738|590377100|FG001|Overall Study|Physician Decision|15|||
163458581|NCT01115738|590377101|FG002|Overall Study|Physician Decision|17|||
163458582|NCT01115738|590377099|FG000|Overall Study|Withdrawal by Subject|6|||
163458583|NCT01115738|590377100|FG001|Overall Study|Withdrawal by Subject|6|||
163458584|NCT01115738|590377101|FG002|Overall Study|Withdrawal by Subject|9|||
163458585|NCT02921763|590377106|FG000|Overall Study|Adverse Event|4|||
163458586|NCT02921763|590377106|FG000|Overall Study|Lost to Follow-up|4|||
163458587|NCT02921763|590377106|FG000|Overall Study|Lack of Efficacy|3|||
163458588|NCT02921763|590377106|FG000|Overall Study|Protocol Violation|2|||
163458589|NCT02921763|590377106|FG000|Overall Study|Withdrawal by Subject|2|||
163458590|NCT02921763|590377106|FG000|Overall Study|Physician Decision|1|||
163458591|NCT02921763|590377106|FG000|Overall Study|No data obtained|2|||
163458592|NCT04142216|590377107|FG000|Overall Study|Hospitalization|0|||
163458593|NCT04142216|590377108|FG001|Overall Study|Hospitalization|2|||
163458594|NCT04142216|590377107|FG000|Overall Study|Death|3|||
163458595|NCT04142216|590377108|FG001|Overall Study|Death|1|||
163458596|NCT04142216|590377107|FG000|Overall Study|Referral to another hemodialysis unit|3|||
163458597|NCT04142216|590377108|FG001|Overall Study|Referral to another hemodialysis unit|2|||
163458598|NCT04142216|590377107|FG000|Overall Study|Use of clove|0|||
163458599|NCT04142216|590377108|FG001|Overall Study|Use of clove|1|||
163458600|NCT01582971|590377111|FG000|Overall Study|Death|2|||
163458601|NCT01582971|590377112|FG001|Overall Study|Death|1|||
163458602|NCT01582971|590377111|FG000|Overall Study|Lost to Follow-up|18|||
163458603|NCT01582971|590377112|FG001|Overall Study|Lost to Follow-up|21|||
163458604|NCT01582971|590377111|FG000|Overall Study|Withdrawal by Subject|4|||
163458605|NCT01582971|590377112|FG001|Overall Study|Withdrawal by Subject|2|||
163458606|NCT01582971|590377111|FG000|Overall Study|Other|15|||
163458607|NCT01582971|590377112|FG001|Overall Study|Other|13|||
163458608|NCT01054976|590377117|FG000|Overall Study|Adverse Event|16|||
163458609|NCT01054976|590377117|FG000|Overall Study|Uncooperative participations to study|7|||
163458610|NCT01054976|590377117|FG000|Overall Study|Withdrawal by Subject|4|||
163458611|NCT01054976|590377117|FG000|Overall Study|Other|8|||
163458612|NCT01641991|590377118|FG000|Overall Study|Physician Decision|0|||
163458613|NCT01641991|590377119|FG001|Overall Study|Physician Decision|1|||
163458614|NCT01641991|590377120|FG002|Overall Study|Physician Decision|7|||
163458615|NCT01641991|590377121|FG003|Overall Study|Physician Decision|5|||
163458616|NCT01641991|590377118|FG000|Overall Study|Withdrawal by Subject|4|||
163458617|NCT01641991|590377119|FG001|Overall Study|Withdrawal by Subject|2|||
163458618|NCT01641991|590377120|FG002|Overall Study|Withdrawal by Subject|1|||
163458619|NCT01641991|590377121|FG003|Overall Study|Withdrawal by Subject|5|||
163458620|NCT01641991|590377118|FG000|Overall Study|Adverse Event|2|||
163458621|NCT01641991|590377119|FG001|Overall Study|Adverse Event|1|||
163458622|NCT01641991|590377120|FG002|Overall Study|Adverse Event|2|||
163458623|NCT01641991|590377121|FG003|Overall Study|Adverse Event|1|||
163458624|NCT01641991|590377118|FG000|Overall Study|Lost to Follow-up|0|||
163458625|NCT01641991|590377119|FG001|Overall Study|Lost to Follow-up|2|||
163458626|NCT01641991|590377120|FG002|Overall Study|Lost to Follow-up|3|||
163458627|NCT01641991|590377121|FG003|Overall Study|Lost to Follow-up|1|||
163458628|NCT01641991|590377118|FG000|Overall Study|Protocol Violation|1|||
163458629|NCT01641991|590377119|FG001|Overall Study|Protocol Violation|1|||
163458630|NCT01641991|590377120|FG002|Overall Study|Protocol Violation|3|||
163458631|NCT01641991|590377121|FG003|Overall Study|Protocol Violation|0|||
163458632|NCT01641991|590377118|FG000|Overall Study|Pregnancy|0|||
163458633|NCT01641991|590377119|FG001|Overall Study|Pregnancy|0|||
163458634|NCT01641991|590377120|FG002|Overall Study|Pregnancy|1|||
163458635|NCT01641991|590377121|FG003|Overall Study|Pregnancy|0|||
163458636|NCT01641991|590377118|FG000|Overall Study|no longer eligible|2|||
163458637|NCT01641991|590377119|FG001|Overall Study|no longer eligible|1|||
163458638|NCT01641991|590377120|FG002|Overall Study|no longer eligible|0|||
163458639|NCT01641991|590377121|FG003|Overall Study|no longer eligible|4|||
163458640|NCT00475540|590377125|FG000|36 Months|Lost to Follow-up|4|||
163458641|NCT00475540|590377126|FG001|36 Months|Lost to Follow-up|4|||
163458642|NCT00475540|590377125|FG000|36 Months|Death|1|||
163458643|NCT00475540|590377126|FG001|36 Months|Death|2|||
163458644|NCT00475540|590377125|FG000|36 Months|Censored due to reoperation|3|||
163458645|NCT00475540|590377126|FG001|36 Months|Censored due to reoperation|0|||
163458646|NCT02394795|590377129|FG000|Overall Study|Adverse Event|92|||
163458647|NCT02394795|590377130|FG001|Overall Study|Adverse Event|70|||
163458648|NCT02394795|590377129|FG000|Overall Study|Lost to Follow-up|0|||
163458649|NCT02394795|590377130|FG001|Overall Study|Lost to Follow-up|1|||
163458650|NCT02394795|590377129|FG000|Overall Study|Withdrawal by Subject|17|||
163458651|NCT02394795|590377130|FG001|Overall Study|Withdrawal by Subject|26|||
163458652|NCT02394795|590377129|FG000|Overall Study|Lack of Efficacy|181|||
163458653|NCT02394795|590377130|FG001|Overall Study|Lack of Efficacy|211|||
163458654|NCT02394795|590377129|FG000|Overall Study|Death|4|||
163458655|NCT02394795|590377130|FG001|Overall Study|Death|5|||
163458656|NCT02394795|590377129|FG000|Overall Study|Physician Decision|109|||
163458657|NCT02394795|590377130|FG001|Overall Study|Physician Decision|93|||
163458658|NCT03245723|590377137|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
163458659|NCT03245723|590377138|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
163458660|NCT03245723|590377137|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
163458661|NCT03245723|590377138|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
163458662|NCT03245723|590377137|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
163458663|NCT03245723|590377138|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
163458664|NCT03245723|590377137|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
163458665|NCT03245723|590377138|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
163458666|NCT03784027|590377141|FG000|Period 1|Withdrawal by Subject|0|||
163458667|NCT03784027|590377142|FG001|Period 1|Withdrawal by Subject|1|||
163458668|NCT01512108|590378322|FG000|Overall Study|Adverse Event|9|||
163458669|NCT01512108|590378323|FG001|Overall Study|Adverse Event|4|||
163458670|NCT01512108|590378322|FG000|Overall Study|Protocol Violation|1|||
163458671|NCT01512108|590378323|FG001|Overall Study|Protocol Violation|2|||
163458672|NCT01512108|590378322|FG000|Overall Study|Withdrawal Criteria|1|||
163458673|NCT01512108|590378323|FG001|Overall Study|Withdrawal Criteria|0|||
163458674|NCT01512108|590378322|FG000|Overall Study|Unclassified|11|||
163458675|NCT01512108|590378323|FG001|Overall Study|Unclassified|3|||
163458676|NCT03287869|590378328|FG000|Overall Study|Adverse Event|14|||
163458677|NCT03287869|590378329|FG001|Overall Study|Adverse Event|12|||
163458678|NCT03287869|590378328|FG000|Overall Study|Lack of Efficacy|1|||
163458679|NCT03287869|590378329|FG001|Overall Study|Lack of Efficacy|0|||
163458680|NCT03287869|590378328|FG000|Overall Study|Lost to Follow-up|13|||
163458681|NCT03287869|590378329|FG001|Overall Study|Lost to Follow-up|19|||
163458682|NCT03287869|590378328|FG000|Overall Study|Non-Compliance With Study Drug|5|||
163458683|NCT03287869|590378329|FG001|Overall Study|Non-Compliance With Study Drug|9|||
163458684|NCT03287869|590378328|FG000|Overall Study|Progressive Disease|1|||
163458685|NCT03287869|590378329|FG001|Overall Study|Progressive Disease|0|||
163458686|NCT03287869|590378328|FG000|Overall Study|Protocol Deviation|2|||
163458687|NCT03287869|590378329|FG001|Overall Study|Protocol Deviation|1|||
163458688|NCT03287869|590378328|FG000|Overall Study|Withdrawal by Subject|36|||
163458689|NCT03287869|590378329|FG001|Overall Study|Withdrawal by Subject|43|||
163458690|NCT03287869|590378328|FG000|Overall Study|Early Closure of the Site|0|||
163458691|NCT03287869|590378329|FG001|Overall Study|Early Closure of the Site|1|||
163458692|NCT03287869|590378328|FG000|Overall Study|Physician Decision|5|||
163458693|NCT03287869|590378329|FG001|Overall Study|Physician Decision|5|||
163458694|NCT03287869|590378328|FG000|Overall Study|Reason not Specified|6|||
163458695|NCT03287869|590378329|FG001|Overall Study|Reason not Specified|3|||
163458696|NCT04847141|590378330|FG000|Overall Study|Adverse Event|1|||
163458697|NCT04847141|590378331|FG001|Overall Study|Adverse Event|0|||
163458698|NCT04847141|590378332|FG002|Overall Study|Adverse Event|1|||
163458699|NCT04847141|590378330|FG000|Overall Study|Withdrawal by Subject|2|||
163458700|NCT04847141|590378331|FG001|Overall Study|Withdrawal by Subject|4|||
163458701|NCT04847141|590378332|FG002|Overall Study|Withdrawal by Subject|3|||
163458702|NCT04847141|590378330|FG000|Overall Study|Lost to Follow-up|7|||
163458703|NCT04847141|590378331|FG001|Overall Study|Lost to Follow-up|5|||
163458704|NCT04847141|590378332|FG002|Overall Study|Lost to Follow-up|7|||
163458705|NCT04847141|590378330|FG000|Overall Study|Reason not Specified|0|||
163458706|NCT04847141|590378331|FG001|Overall Study|Reason not Specified|1|||
163458707|NCT04847141|590378332|FG002|Overall Study|Reason not Specified|0|||
163458708|NCT00324740|590378333|FG000|Overall Study|Withdrawal by Subject|1|||
163458709|NCT00324740|590378334|FG001|Overall Study|Withdrawal by Subject|0|||
163458710|NCT00324740|590378335|FG002|Overall Study|Withdrawal by Subject|1|||
163458711|NCT01357980|590378340|FG000|Overall Study|Lack of Efficacy|0|||
163458712|NCT01357980|590378341|FG001|Overall Study|Lack of Efficacy|1|||
163458713|NCT01357980|590378342|FG002|Overall Study|Lack of Efficacy|0|||
163458714|NCT01357980|590378343|FG003|Overall Study|Lack of Efficacy|0|||
163458715|NCT01357980|590378340|FG000|Overall Study|Consent withdrawn|0|||
163458716|NCT01357980|590378341|FG001|Overall Study|Consent withdrawn|0|||
163458717|NCT01357980|590378342|FG002|Overall Study|Consent withdrawn|1|||
163458718|NCT01357980|590378343|FG003|Overall Study|Consent withdrawn|0|||
163458719|NCT04507776|590378344|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
163458720|NCT00094835|590378348|FG000|Overall Study|Physician Decision|1|||
163458721|NCT00094835|590378349|FG001|Overall Study|Physician Decision|0|||
163458722|NCT00094835|590378350|FG002|Overall Study|Physician Decision|0|||
163458723|NCT00094835|590378351|FG003|Overall Study|Physician Decision|0|||
163458724|NCT00094835|590378352|FG004|Overall Study|Physician Decision|0|||
163458725|NCT00094835|590378353|FG005|Overall Study|Physician Decision|1|||
163458726|NCT00094835|590378354|FG006|Overall Study|Physician Decision|0|||
163458727|NCT00094835|590378348|FG000|Overall Study|Withdrawal by Subject|0|||
163458728|NCT00094835|590378349|FG001|Overall Study|Withdrawal by Subject|0|||
163458729|NCT00094835|590378350|FG002|Overall Study|Withdrawal by Subject|0|||
163458730|NCT00094835|590378351|FG003|Overall Study|Withdrawal by Subject|0|||
163458731|NCT00094835|590378352|FG004|Overall Study|Withdrawal by Subject|0|||
163458732|NCT00094835|590378353|FG005|Overall Study|Withdrawal by Subject|0|||
163458733|NCT00094835|590378354|FG006|Overall Study|Withdrawal by Subject|1|||
163458734|NCT00094835|590378348|FG000|Overall Study|Lost to Follow-up|0|||
163458735|NCT00094835|590378349|FG001|Overall Study|Lost to Follow-up|0|||
163458736|NCT00094835|590378350|FG002|Overall Study|Lost to Follow-up|0|||
163458737|NCT00094835|590378351|FG003|Overall Study|Lost to Follow-up|0|||
163458738|NCT00094835|590378352|FG004|Overall Study|Lost to Follow-up|1|||
163458739|NCT00094835|590378353|FG005|Overall Study|Lost to Follow-up|0|||
163458740|NCT00094835|590378354|FG006|Overall Study|Lost to Follow-up|0|||
163458741|NCT00094835|590378348|FG000|Overall Study|Death|1|||
163458742|NCT00094835|590378349|FG001|Overall Study|Death|0|||
163458743|NCT00094835|590378350|FG002|Overall Study|Death|0|||
163458744|NCT00094835|590378351|FG003|Overall Study|Death|0|||
163458745|NCT00094835|590378352|FG004|Overall Study|Death|1|||
163458746|NCT00094835|590378353|FG005|Overall Study|Death|0|||
163458747|NCT00094835|590378354|FG006|Overall Study|Death|0|||
163458748|NCT00094835|590378348|FG000|Overall Study|Non-compliance|1|||
163458749|NCT00094835|590378349|FG001|Overall Study|Non-compliance|2|||
163458750|NCT00094835|590378350|FG002|Overall Study|Non-compliance|2|||
163458751|NCT00094835|590378351|FG003|Overall Study|Non-compliance|0|||
163458752|NCT00094835|590378352|FG004|Overall Study|Non-compliance|2|||
163458753|NCT00094835|590378353|FG005|Overall Study|Non-compliance|2|||
163458754|NCT00094835|590378354|FG006|Overall Study|Non-compliance|1|||
163458755|NCT00094835|590378348|FG000|Overall Study|Other|1|||
163458756|NCT00094835|590378349|FG001|Overall Study|Other|1|||
163458757|NCT00094835|590378350|FG002|Overall Study|Other|1|||
163458758|NCT00094835|590378351|FG003|Overall Study|Other|1|||
163458759|NCT00094835|590378352|FG004|Overall Study|Other|0|||
163458760|NCT00094835|590378353|FG005|Overall Study|Other|0|||
163458761|NCT00094835|590378354|FG006|Overall Study|Other|0|||
163458762|NCT00387348|590378355|FG000|Overall Study|Death|1|||
163458763|NCT00387348|590378356|FG001|Overall Study|Death|1|||
163458764|NCT00387348|590378357|FG002|Overall Study|Death|0|||
163458765|NCT00387348|590378355|FG000|Overall Study|Physician Decision|1|||
163458766|NCT00387348|590378356|FG001|Overall Study|Physician Decision|0|||
163458767|NCT00387348|590378357|FG002|Overall Study|Physician Decision|1|||
163458768|NCT00387348|590378355|FG000|Overall Study|Withdrawal by Subject|0|||
163458769|NCT00387348|590378356|FG001|Overall Study|Withdrawal by Subject|2|||
163458770|NCT00387348|590378357|FG002|Overall Study|Withdrawal by Subject|2|||
163458771|NCT00387348|590378355|FG000|Overall Study|Adverse Event|1|||
163458772|NCT00387348|590378356|FG001|Overall Study|Adverse Event|0|||
163458773|NCT00387348|590378357|FG002|Overall Study|Adverse Event|1|||
163458774|NCT03628599|590378358|FG000|Overall Study|Adverse Event|0|||
163458775|NCT03628599|590378359|FG001|Overall Study|Adverse Event|1|||
163458776|NCT05905601|590378367|FG000|Overall Study|Lost to Follow-up|1|||
163458777|NCT05905601|590378368|FG001|Overall Study|Lost to Follow-up|3|||
163458778|NCT03024255|590378369|FG000|Overall Study|Adverse Event|1|||
163458779|NCT03024255|590378370|FG001|Overall Study|Adverse Event|4|||
163458780|NCT03024255|590378371|FG002|Overall Study|Adverse Event|8|||
163458781|NCT03024255|590378372|FG003|Overall Study|Adverse Event|0|||
163458782|NCT03024255|590378369|FG000|Overall Study|Withdrawal by Subject|3|||
163458783|NCT03024255|590378370|FG001|Overall Study|Withdrawal by Subject|1|||
163458784|NCT03024255|590378371|FG002|Overall Study|Withdrawal by Subject|0|||
163458785|NCT03024255|590378372|FG003|Overall Study|Withdrawal by Subject|3|||
163458786|NCT03024255|590378369|FG000|Overall Study|Protocol Violation|0|||
163458787|NCT03024255|590378370|FG001|Overall Study|Protocol Violation|0|||
163458788|NCT03024255|590378371|FG002|Overall Study|Protocol Violation|2|||
163458789|NCT03024255|590378372|FG003|Overall Study|Protocol Violation|0|||
163458790|NCT03024255|590378369|FG000|Overall Study|Lost to Follow-up|1|||
163458791|NCT03024255|590378370|FG001|Overall Study|Lost to Follow-up|2|||
163458792|NCT03024255|590378371|FG002|Overall Study|Lost to Follow-up|1|||
163458793|NCT03024255|590378372|FG003|Overall Study|Lost to Follow-up|1|||
163458794|NCT03024255|590378369|FG000|Overall Study|Lack of Efficacy|1|||
163458795|NCT03024255|590378370|FG001|Overall Study|Lack of Efficacy|0|||
163458796|NCT03024255|590378371|FG002|Overall Study|Lack of Efficacy|0|||
163458797|NCT03024255|590378372|FG003|Overall Study|Lack of Efficacy|0|||
163458798|NCT03024255|590378369|FG000|Overall Study|Protocol Noncompliance|1|||
163458799|NCT03024255|590378370|FG001|Overall Study|Protocol Noncompliance|1|||
163458800|NCT03024255|590378371|FG002|Overall Study|Protocol Noncompliance|0|||
163458801|NCT03024255|590378372|FG003|Overall Study|Protocol Noncompliance|1|||
163458802|NCT00868166|590378376|FG000|Overall Study|Death|58|||
163458803|NCT00868166|590378377|FG001|Overall Study|Death|65|||
163458804|NCT00868166|590378376|FG000|Overall Study|Withdrawal by Subject|33|||
163458805|NCT00868166|590378377|FG001|Overall Study|Withdrawal by Subject|25|||
163458806|NCT00868166|590378376|FG000|Overall Study|Protocol Violation|1|||
163458807|NCT00868166|590378377|FG001|Overall Study|Protocol Violation|0|||
163458808|NCT00868166|590378376|FG000|Overall Study|Lost to Follow-up|1|||
163458809|NCT00868166|590378377|FG001|Overall Study|Lost to Follow-up|3|||
163458810|NCT00868166|590378376|FG000|Overall Study|Adverse Event|9|||
163458811|NCT00868166|590378377|FG001|Overall Study|Adverse Event|10|||
163458812|NCT00868166|590378376|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
163458813|NCT00868166|590378377|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
163458814|NCT00868166|590378376|FG000|Overall Study|Non-compliance with IMP|1|||
163458815|NCT00868166|590378377|FG001|Overall Study|Non-compliance with IMP|1|||
163458816|NCT01797445|590378383|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
163458817|NCT01797445|590378384|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
163458818|NCT01797445|590378383|FG000|Double-Blind Phase|Adverse Event|3|||
163458819|NCT01797445|590378384|FG001|Double-Blind Phase|Adverse Event|0|||
163458820|NCT01797445|590378383|FG000|Double-Blind Phase|Death|5|||
163458821|NCT01797445|590378384|FG001|Double-Blind Phase|Death|4|||
163458822|NCT01797445|590378383|FG000|Double-Blind Phase|Pregnancy|0|||
163458823|NCT01797445|590378384|FG001|Double-Blind Phase|Pregnancy|1|||
163458824|NCT01797445|590378383|FG000|Double-Blind Phase|Lack of Efficacy|1|||
163458825|NCT01797445|590378384|FG001|Double-Blind Phase|Lack of Efficacy|2|||
163458826|NCT01797445|590378383|FG000|Double-Blind Phase|Investigator's Discretion|15|||
163458827|NCT01797445|590378384|FG001|Double-Blind Phase|Investigator's Discretion|17|||
163458828|NCT01797445|590378383|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
163458829|NCT01797445|590378384|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
163458830|NCT01797445|590378383|FG000|Double-Blind Phase|Protocol Violation|0|||
163458831|NCT01797445|590378384|FG001|Double-Blind Phase|Protocol Violation|1|||
163458832|NCT01797445|590378383|FG000|Double-Blind Phase|Withdrew Consent|20|||
163458833|NCT01797445|590378384|FG001|Double-Blind Phase|Withdrew Consent|35|||
163458834|NCT01797445|590378383|FG000|Double-Blind Phase|Lost to Follow-up|34|||
163458835|NCT01797445|590378384|FG001|Double-Blind Phase|Lost to Follow-up|26|||
163458836|NCT01797445|590378383|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
163458837|NCT01797445|590378384|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
163458838|NCT01204697|590378385|FG000|Overall Study|Death|26|||
163458839|NCT01204697|590378386|FG001|Overall Study|Death|27|||
163458840|NCT01204697|590378385|FG000|Overall Study|Lost to Follow-up|3|||
163458841|NCT01204697|590378386|FG001|Overall Study|Lost to Follow-up|4|||
163458842|NCT01204697|590378385|FG000|Overall Study|Withdrawal by Subject|2|||
163458843|NCT01204697|590378386|FG001|Overall Study|Withdrawal by Subject|4|||
163458844|NCT01204697|590378385|FG000|Overall Study|Randomized, but not treated|0|||
163458845|NCT01204697|590378386|FG001|Overall Study|Randomized, but not treated|1|||
163458846|NCT03939637|590378387|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
163458847|NCT03939637|590378388|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
163458848|NCT03939637|590378387|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
163458849|NCT03939637|590378388|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
163458850|NCT04190186|590378389|FG000|Overall Study|ILR is no longer functioning|0|||
163458851|NCT04190186|590378390|FG001|Overall Study|ILR is no longer functioning|1|||
163458852|NCT04190186|590378389|FG000|Overall Study|Lost to Follow-up|0|||
163458853|NCT04190186|590378390|FG001|Overall Study|Lost to Follow-up|1|||
163458854|NCT04190186|590378389|FG000|Overall Study|Withdrawal by Subject|2|||
163458855|NCT04190186|590378390|FG001|Overall Study|Withdrawal by Subject|0|||
163458856|NCT04190186|590378389|FG000|Overall Study|Subject choice to explant|1|||
163458857|NCT04190186|590378390|FG001|Overall Study|Subject choice to explant|0|||
163458858|NCT04190186|590378389|FG000|Overall Study|Physician Decision|0|||
163458859|NCT04190186|590378390|FG001|Overall Study|Physician Decision|1|||
163458860|NCT04190186|590378389|FG000|Overall Study|Study was stopped|4|||
163458861|NCT04190186|590378390|FG001|Overall Study|Study was stopped|5|||
163458862|NCT00168064|590378391|FG000|Overall Study|Adverse Event|26|||
163458863|NCT00168064|590378392|FG001|Overall Study|Adverse Event|22|||
163458864|NCT00168064|590378391|FG000|Overall Study|Withdrawal by Subject|3|||
163458865|NCT00168064|590378392|FG001|Overall Study|Withdrawal by Subject|4|||
163458866|NCT00168064|590378391|FG000|Overall Study|Lack of Efficacy|4|||
163458867|NCT00168064|590378392|FG001|Overall Study|Lack of Efficacy|4|||
163458868|NCT00168064|590378391|FG000|Overall Study|Lost to Follow-up|4|||
163458869|NCT00168064|590378392|FG001|Overall Study|Lost to Follow-up|3|||
163458870|NCT00168064|590378391|FG000|Overall Study|Non-compliance|2|||
163458871|NCT00168064|590378392|FG001|Overall Study|Non-compliance|3|||
163458872|NCT00168064|590378391|FG000|Overall Study|Concurrent Illness|4|||
163458873|NCT00168064|590378392|FG001|Overall Study|Concurrent Illness|3|||
163458874|NCT00168064|590378391|FG000|Overall Study|Subject's Best interest|2|||
163458875|NCT00168064|590378392|FG001|Overall Study|Subject's Best interest|2|||
163458876|NCT00168064|590378391|FG000|Overall Study|Various|4|||
163458877|NCT00168064|590378392|FG001|Overall Study|Various|3|||
163458878|NCT00830804|590378393|FG000|Overall Study|Lost to Follow-up|4|||
163458879|NCT00830804|590378393|FG000|Overall Study|Death|1|||
163458880|NCT00830804|590378393|FG000|Overall Study|Unable to get to clinic|7|||
163458881|NCT00830804|590378393|FG000|Overall Study|Consent withdrawn|2|||
163458882|NCT00830804|590378393|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
163458883|NCT01397448|590378395|FG000|Overall Study|Adverse Event|4|||
163458884|NCT01397448|590378396|FG001|Overall Study|Adverse Event|4|||
163458885|NCT01397448|590378397|FG002|Overall Study|Adverse Event|6|||
163458886|NCT01397448|590378395|FG000|Overall Study|Withdrawal by Subject|4|||
163458887|NCT01397448|590378396|FG001|Overall Study|Withdrawal by Subject|4|||
163458888|NCT01397448|590378397|FG002|Overall Study|Withdrawal by Subject|3|||
163458889|NCT01397448|590378395|FG000|Overall Study|Lack of Efficacy|2|||
163458890|NCT01397448|590378396|FG001|Overall Study|Lack of Efficacy|0|||
163458891|NCT01397448|590378397|FG002|Overall Study|Lack of Efficacy|5|||
163458892|NCT01397448|590378395|FG000|Overall Study|Other|8|||
163458893|NCT01397448|590378396|FG001|Overall Study|Other|7|||
163458894|NCT01397448|590378397|FG002|Overall Study|Other|4|||
163458895|NCT00776555|590378401|FG000|Overall Study|Study terminated|3|||
163458896|NCT00776555|590378402|FG001|Overall Study|Study terminated|0|||
163458897|NCT03483116|590378406|FG000|Overall Study|Adverse Event|0|||
163458898|NCT03483116|590378407|FG001|Overall Study|Adverse Event|1|||
163458899|NCT03483116|590378408|FG002|Overall Study|Adverse Event|0|||
163458900|NCT03483116|590378409|FG003|Overall Study|Adverse Event|1|||
163458901|NCT03483116|590378406|FG000|Overall Study|Protocol Violation|1|||
163458902|NCT03483116|590378407|FG001|Overall Study|Protocol Violation|0|||
163458903|NCT03483116|590378408|FG002|Overall Study|Protocol Violation|0|||
163458904|NCT03483116|590378409|FG003|Overall Study|Protocol Violation|7|||
163458905|NCT03483116|590378406|FG000|Overall Study|Lost to Follow-up|9|||
163458906|NCT03483116|590378407|FG001|Overall Study|Lost to Follow-up|4|||
163458907|NCT03483116|590378408|FG002|Overall Study|Lost to Follow-up|9|||
163458908|NCT03483116|590378409|FG003|Overall Study|Lost to Follow-up|5|||
163458909|NCT03483116|590378406|FG000|Overall Study|Death|1|||
163458910|NCT03483116|590378407|FG001|Overall Study|Death|0|||
163458911|NCT03483116|590378408|FG002|Overall Study|Death|2|||
163458912|NCT03483116|590378409|FG003|Overall Study|Death|1|||
163458913|NCT03483116|590378406|FG000|Overall Study|Withdrawal by Subject|14|||
163458914|NCT03483116|590378407|FG001|Overall Study|Withdrawal by Subject|16|||
163458915|NCT03483116|590378408|FG002|Overall Study|Withdrawal by Subject|14|||
163458916|NCT03483116|590378409|FG003|Overall Study|Withdrawal by Subject|16|||
163458917|NCT03483116|590378406|FG000|Overall Study|Unknown other reason|3|||
163458918|NCT03483116|590378407|FG001|Overall Study|Unknown other reason|2|||
163458919|NCT03483116|590378408|FG002|Overall Study|Unknown other reason|1|||
163458920|NCT03483116|590378409|FG003|Overall Study|Unknown other reason|1|||
163458921|NCT01181102|590378410|FG000|Overall Study|Adverse Event|28|||
163458922|NCT01181102|590378411|FG001|Overall Study|Adverse Event|26|||
163458923|NCT01181102|590378410|FG000|Overall Study|Lack of Efficacy|3|||
163458924|NCT01181102|590378411|FG001|Overall Study|Lack of Efficacy|1|||
163458925|NCT01181102|590378410|FG000|Overall Study|Lost to Follow-up|2|||
163458926|NCT01181102|590378411|FG001|Overall Study|Lost to Follow-up|0|||
163458927|NCT01181102|590378410|FG000|Overall Study|Physician Decision|3|||
163458928|NCT01181102|590378411|FG001|Overall Study|Physician Decision|1|||
163458929|NCT01181102|590378410|FG000|Overall Study|Protocol Violation|5|||
163458930|NCT01181102|590378411|FG001|Overall Study|Protocol Violation|6|||
163458931|NCT01181102|590378410|FG000|Overall Study|Withdrawal by Subject|10|||
163458932|NCT01181102|590378411|FG001|Overall Study|Withdrawal by Subject|12|||
163458933|NCT00239837|590378416|FG000|Overall Study|Lost to Follow-up|3|||
163458934|NCT00239837|590378417|FG001|Overall Study|Lost to Follow-up|7|||
163458935|NCT01838590|590378418|FG000|Overall Study|Lack of Efficacy|12|||
163458936|NCT01838590|590378419|FG001|Overall Study|Lack of Efficacy|4|||
163458937|NCT01838590|590378418|FG000|Overall Study|Lost to Follow-up|0|||
163458938|NCT01838590|590378419|FG001|Overall Study|Lost to Follow-up|1|||
163458939|NCT04685499|590378420|FG000|Overall Study|Study Terminated Early|1|||
163458940|NCT01232894|590378421|FG000|Overall Study|Lost to Follow-up|0|||
163458941|NCT01232894|590378422|FG001|Overall Study|Lost to Follow-up|1|||
163458942|NCT01232894|590378421|FG000|Overall Study|Death|1|||
163458943|NCT01232894|590378422|FG001|Overall Study|Death|0|||
163458944|NCT01232894|590378421|FG000|Overall Study|Protocol Violation|1|||
163458945|NCT01232894|590378422|FG001|Overall Study|Protocol Violation|1|||
163458946|NCT01232894|590378421|FG000|Overall Study|Withdrawal by Subject|8|||
163458947|NCT01232894|590378422|FG001|Overall Study|Withdrawal by Subject|5|||
163458948|NCT01232894|590378421|FG000|Overall Study|Physician Decision|2|||
163458949|NCT01232894|590378422|FG001|Overall Study|Physician Decision|1|||
163458950|NCT01996904|590378425|FG000|Overall Study|Lost to Follow-up|38|||
163458951|NCT01996904|590378426|FG001|Overall Study|Lost to Follow-up|27|||
163458952|NCT00929734|590378428|FG000|Overall Study|Lost to Follow-up|2|||
163458953|NCT00929734|590378429|FG001|Overall Study|Lost to Follow-up|1|||
163458954|NCT00929734|590378428|FG000|Overall Study|Withdrawal by Subject|0|||
163458955|NCT00929734|590378429|FG001|Overall Study|Withdrawal by Subject|2|||
163458956|NCT00980980|590378430|FG000|Overall Study|Withdrawal by Hospital|0|||
163458957|NCT00980980|590378431|FG001|Overall Study|Withdrawal by Hospital|1|||
163458958|NCT00980980|590378432|FG002|Overall Study|Withdrawal by Hospital|0|||
163458959|NCT00121992|590378433|FG000|Overall Study|Treatment not received|2|||
163458960|NCT00121992|590378434|FG001|Overall Study|Treatment not received|11|||
163458961|NCT03076190|590378435|FG000|Overall Study|Lost to Follow-up|9|||
163458962|NCT03076190|590378436|FG001|Overall Study|Lost to Follow-up|34|||
163458963|NCT03076190|590378435|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
163458964|NCT03076190|590378436|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
163458965|NCT01441115|590378437|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
163458966|NCT02260648|590378440|FG000|Overall Study|Adverse Event|3|||
163458967|NCT02260648|590378441|FG001|Overall Study|Adverse Event|0|||
163458968|NCT02260648|590378442|FG002|Overall Study|Adverse Event|1|||
163458969|NCT02260648|590378440|FG000|Overall Study|Withdrawal by Subject|1|||
163458970|NCT02260648|590378441|FG001|Overall Study|Withdrawal by Subject|1|||
163458971|NCT02260648|590378442|FG002|Overall Study|Withdrawal by Subject|0|||
163458972|NCT02260648|590378440|FG000|Overall Study|Protocol Violation|1|||
163458973|NCT02260648|590378441|FG001|Overall Study|Protocol Violation|0|||
163458974|NCT02260648|590378442|FG002|Overall Study|Protocol Violation|0|||
163458975|NCT02260648|590378440|FG000|Overall Study|Discontinue Due to Study Termination|13|||
163458976|NCT02260648|590378441|FG001|Overall Study|Discontinue Due to Study Termination|12|||
163458977|NCT02260648|590378442|FG002|Overall Study|Discontinue Due to Study Termination|7|||
163458978|NCT04093258|590378443|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
163458979|NCT04093258|590378444|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
163458980|NCT01890512|590378445|FG000|Overall Study|Physician Decision|1|||
163458981|NCT01890512|590378445|FG000|Overall Study|Withdrawal by Subject|1|||
163458982|NCT01890512|590378445|FG000|Overall Study|Protocol Violation|1|||
163458983|NCT00805545|590378446|FG000|Overall Study|Protocol Violation|3|||
163458984|NCT00805545|590378447|FG001|Overall Study|Protocol Violation|2|||
163458985|NCT00805545|590378446|FG000|Overall Study|Protocol Violation|3|||
163458986|NCT00805545|590378447|FG001|Overall Study|Protocol Violation|1|||
163458987|NCT03543358|590378448|FG000|Overall Study|Death|1|||
163458988|NCT03543358|590378449|FG001|Overall Study|Death|0|||
163458989|NCT03543358|590378448|FG000|Overall Study|Disease Progression|1|||
163458990|NCT03543358|590378449|FG001|Overall Study|Disease Progression|0|||
163458991|NCT03543358|590378448|FG000|Overall Study|Parent Study Closure|1|||
163458992|NCT03543358|590378449|FG001|Overall Study|Parent Study Closure|0|||
163458993|NCT00986427|590378450|FG000|Overall Study|Lost to Follow-up|2|||
163458994|NCT00986427|590378451|FG001|Overall Study|Lost to Follow-up|0|||
163458995|NCT00986427|590378450|FG000|Overall Study|Lack of Efficacy|1|||
163458996|NCT00986427|590378451|FG001|Overall Study|Lack of Efficacy|0|||
163458997|NCT00986427|590378450|FG000|Overall Study|Withdrawal by Subject|1|||
163458998|NCT00986427|590378451|FG001|Overall Study|Withdrawal by Subject|0|||
163458999|NCT02379390|590378452|FG000|Overall Study|Adverse Event|1|||
163459000|NCT02379390|590378453|FG001|Overall Study|Adverse Event|1|||
163459001|NCT02379390|590378452|FG000|Overall Study|Investigator's decision|1|||
163459002|NCT02379390|590378453|FG001|Overall Study|Investigator's decision|0|||
163459003|NCT02379390|590378452|FG000|Overall Study|Study Termination|0|||
163459004|NCT02379390|590378453|FG001|Overall Study|Study Termination|1|||
163459005|NCT00575094|590378454|FG000|Overall Study|Adverse Event|2|||
163459006|NCT00575094|590378454|FG000|Overall Study|Withdrawal by Subject|1|||
163459007|NCT00643604|590378458|FG000|Overall Study|Death|1|||
163459008|NCT02702011|590378459|FG000|Overall Study|Withdrawal by Subject|0|||
163459009|NCT02702011|590378460|FG001|Overall Study|Withdrawal by Subject|1|||
163459010|NCT02702011|590378461|FG002|Overall Study|Withdrawal by Subject|0|||
163459011|NCT02702011|590378462|FG003|Overall Study|Withdrawal by Subject|0|||
163459012|NCT02721251|590378464|FG000|Overall Study|Withdrawal by Subject|8|||
163459013|NCT02721251|590378465|FG001|Overall Study|Withdrawal by Subject|7|||
163459014|NCT02721251|590378466|FG002|Overall Study|Withdrawal by Subject|9|||
163459015|NCT02721251|590378464|FG000|Overall Study|poor adherence|2|||
163459016|NCT02721251|590378465|FG001|Overall Study|poor adherence|2|||
163459017|NCT02721251|590378466|FG002|Overall Study|poor adherence|2|||
163459018|NCT02007954|590378471|FG000|Overall Study|Received liver transplant|3|||
163459019|NCT02007954|590378471|FG000|Overall Study|Switch in treatment modality|2|||
163459020|NCT02007954|590378471|FG000|Overall Study|Disease progression and unrelated AE|1|||
163459021|NCT02007954|590378471|FG000|Overall Study|Death|1|||
163459022|NCT01164865|590378472|FG000|Overall Study|Lost to Follow-up|2|||
163459023|NCT01164865|590378473|FG001|Overall Study|Lost to Follow-up|1|||
163459024|NCT06025396|590379925|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
163459025|NCT06025396|590379926|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
163459026|NCT06025396|590379927|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
163459027|NCT06025396|590379928|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
163459028|NCT06025396|590379929|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
163459029|NCT06025396|590379925|FG000|Overall Study|Withdrawal by Subject|0|||
163459030|NCT06025396|590379926|FG001|Overall Study|Withdrawal by Subject|1|||
163459031|NCT06025396|590379927|FG002|Overall Study|Withdrawal by Subject|1|||
163459032|NCT06025396|590379928|FG003|Overall Study|Withdrawal by Subject|0|||
163459033|NCT06025396|590379929|FG004|Overall Study|Withdrawal by Subject|0|||
163459034|NCT06422377|590379930|FG000|Overall Study|Study Terminated by Sponsor|1|||
163459035|NCT00453180|590379931|FG000|Overall Study|Lost to Follow-up|2|||
163459036|NCT00453180|590379932|FG001|Overall Study|Lost to Follow-up|1|||
163459037|NCT00453180|590379931|FG000|Overall Study|Adverse Event|1|||
163459038|NCT00453180|590379932|FG001|Overall Study|Adverse Event|2|||
163459039|NCT03326869|590379934|FG000|Overall Study|Study data has been lost to natural disa|1|||
163459040|NCT03326869|590379935|FG001|Overall Study|Study data has been lost to natural disa|1|||
163459041|NCT01002742|590379938|FG000|Overall Study|Determined to be ineligible|0|||
163459042|NCT01002742|590379939|FG001|Overall Study|Determined to be ineligible|1|||
163459043|NCT00562640|590379940|FG000|Overall Study|Death|0|||
163459044|NCT00562640|590379941|FG001|Overall Study|Death|1|||
163459045|NCT00562640|590379942|FG002|Overall Study|Death|1|||
163459046|NCT00562640|590379943|FG003|Overall Study|Death|0|||
163459047|NCT05263921|590379944|FG000|Overall Study|Other: family emergency.|0|||
163459048|NCT05263921|590379945|FG001|Overall Study|Other: family emergency.|0|||
163459049|NCT05263921|590379946|FG002|Overall Study|Other: family emergency.|1|||
163459050|NCT05263921|590379947|FG003|Overall Study|Other: family emergency.|0|||
163459051|NCT01297309|590379950|FG000|Overall Study|Eligibility failure|2|||
163459052|NCT01297309|590379950|FG000|Overall Study|Screen failure|2|||
163459053|NCT01297309|590379950|FG000|Overall Study|Withdrawal by Subject|5|||
163459054|NCT01297309|590379950|FG000|Overall Study|Adverse Event|1|||
163459055|NCT01297309|590379950|FG000|Overall Study|Investigator Decision|2|||
163459056|NCT01297309|590379950|FG000|Overall Study|Death|1|||
163459057|NCT01297309|590379950|FG000|Overall Study|Participant not entering extensionperiod|1|||
163459058|NCT02591238|590379951|FG000|Overall Study|Pregnancy|1|||
163459059|NCT02591238|590379952|FG001|Overall Study|Pregnancy|0|||
163459060|NCT02591238|590379953|FG002|Overall Study|Pregnancy|0|||
163459061|NCT02591238|590379954|FG003|Overall Study|Pregnancy|0|||
163459062|NCT02591238|590379951|FG000|Overall Study|Withdrawal by Subject|0|||
163459063|NCT02591238|590379952|FG001|Overall Study|Withdrawal by Subject|0|||
163459064|NCT02591238|590379953|FG002|Overall Study|Withdrawal by Subject|0|||
163459065|NCT02591238|590379954|FG003|Overall Study|Withdrawal by Subject|1|||
163459066|NCT02591238|590379951|FG000|Overall Study|influenza|0|||
163459067|NCT02591238|590379952|FG001|Overall Study|influenza|0|||
163459068|NCT02591238|590379953|FG002|Overall Study|influenza|0|||
163459069|NCT02591238|590379954|FG003|Overall Study|influenza|1|||
163459070|NCT02591238|590379951|FG000|Overall Study|personal circumstances|0|||
163459071|NCT02591238|590379952|FG001|Overall Study|personal circumstances|0|||
163459072|NCT02591238|590379953|FG002|Overall Study|personal circumstances|0|||
163459073|NCT02591238|590379954|FG003|Overall Study|personal circumstances|1|||
163459074|NCT02591238|590379951|FG000|Overall Study|personal circumstances|0|||
163459075|NCT02591238|590379952|FG001|Overall Study|personal circumstances|1|||
163459076|NCT02591238|590379953|FG002|Overall Study|personal circumstances|0|||
163459077|NCT02591238|590379954|FG003|Overall Study|personal circumstances|0|||
163459078|NCT00640146|590379958|FG000|Overall Study|Adverse Event|2|||
163459079|NCT00640146|590379959|FG001|Overall Study|Adverse Event|0|||
163459080|NCT00640146|590379958|FG000|Overall Study|Lost to Follow-up|0|||
163459081|NCT00640146|590379959|FG001|Overall Study|Lost to Follow-up|1|||
163459082|NCT00640146|590379958|FG000|Overall Study|Lack of Efficacy|0|||
163459083|NCT00640146|590379959|FG001|Overall Study|Lack of Efficacy|1|||
163459084|NCT00640146|590379958|FG000|Overall Study|Withdrawal by Subject|1|||
163459085|NCT00640146|590379959|FG001|Overall Study|Withdrawal by Subject|1|||
163459086|NCT00640146|590379958|FG000|Overall Study|Randomized but not treated|1|||
163459087|NCT00640146|590379959|FG001|Overall Study|Randomized but not treated|3|||
163459088|NCT00525785|590379960|FG000|Overall Study|Withdrawal by Subject|1|||
163459089|NCT00525785|590379960|FG000|Overall Study|Lack of Efficacy|1|||
163459090|NCT00525785|590379960|FG000|Overall Study|Physician Decision|1|||
163459091|NCT04624672|590379962|FG000|Overall Study|Early Study Closure|2|||
163459092|NCT04624672|590379963|FG001|Overall Study|Early Study Closure|1|||
163459093|NCT01415908|590379968|FG000|Overall Study|Withdrawal by Subject|1|||
163459094|NCT01415908|590379969|FG001|Overall Study|Withdrawal by Subject|0|||
163459095|NCT01779648|590379976|FG000|Overall Study|Protocol Violation|1|||
163459096|NCT01779648|590379977|FG001|Overall Study|Protocol Violation|0|||
163459097|NCT02119026|590379981|FG000|1st-line Treatment|Adverse Event|9|||
163459098|NCT02119026|590379982|FG001|1st-line Treatment|Adverse Event|14|||
163459099|NCT02119026|590379981|FG000|1st-line Treatment|Physician Decision|3|||
163459100|NCT02119026|590379982|FG001|1st-line Treatment|Physician Decision|8|||
163459101|NCT02119026|590379981|FG000|1st-line Treatment|Withdrawal by Subject|4|||
163459102|NCT02119026|590379982|FG001|1st-line Treatment|Withdrawal by Subject|10|||
163459103|NCT02119026|590379981|FG000|1st-line Treatment|Patient condition or compliance|6|||
163459104|NCT02119026|590379982|FG001|1st-line Treatment|Patient condition or compliance|4|||
163459105|NCT02119026|590379981|FG000|1st-line Treatment|Surgery of metastases|2|||
163459106|NCT02119026|590379982|FG001|1st-line Treatment|Surgery of metastases|1|||
163459107|NCT02119026|590379981|FG000|1st-line Treatment|Death|2|||
163459108|NCT02119026|590379982|FG001|1st-line Treatment|Death|1|||
163459109|NCT02119026|590379981|FG000|2nd-line Treatment|Lost to Follow-up|2|||
163459110|NCT02119026|590379982|FG001|2nd-line Treatment|Lost to Follow-up|0|||
163459111|NCT02119026|590379981|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
163459112|NCT02119026|590379982|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
163459113|NCT02119026|590379981|FG000|2nd-line Treatment|Adverse Event|4|||
163459114|NCT02119026|590379982|FG001|2nd-line Treatment|Adverse Event|1|||
163459115|NCT01373918|590379983|FG000|Overall Study|Physician Decision|0|||
163459116|NCT01373918|590379984|FG001|Overall Study|Physician Decision|1|||
163459117|NCT01143714|590379987|FG000|Overall Study|Adverse Event|4|||
163459118|NCT01143714|590379988|FG001|Overall Study|Adverse Event|2|||
163459119|NCT01143714|590379987|FG000|Overall Study|Withdrawal by Subject|1|||
163459120|NCT01143714|590379988|FG001|Overall Study|Withdrawal by Subject|0|||
163459121|NCT01143714|590379987|FG000|Overall Study|Subject non-compliance|0|||
163459122|NCT01143714|590379988|FG001|Overall Study|Subject non-compliance|1|||
163459123|NCT01143714|590379987|FG000|Overall Study|wound closed = deemed healed|1|||
163459124|NCT01143714|590379988|FG001|Overall Study|wound closed = deemed healed|0|||
163459125|NCT01143714|590379987|FG000|Overall Study|wound size increased|1|||
163459126|NCT01143714|590379988|FG001|Overall Study|wound size increased|0|||
163459127|NCT03783442|590379992|FG000|Overall Study|Death|252|||
163459128|NCT03783442|590379993|FG001|Overall Study|Death|268|||
163459129|NCT03783442|590379992|FG000|Overall Study|Withdrawal by Subject|19|||
163459130|NCT03783442|590379993|FG001|Overall Study|Withdrawal by Subject|21|||
163459131|NCT03783442|590379992|FG000|Overall Study|Lost to Follow-up|7|||
163459132|NCT03783442|590379993|FG001|Overall Study|Lost to Follow-up|6|||
163459133|NCT03783442|590379992|FG000|Overall Study|Sponsor Ended Study|48|||
163459134|NCT03783442|590379993|FG001|Overall Study|Sponsor Ended Study|28|||
163459135|NCT02016898|590379994|FG000|Overall Study|Death|1|||
163459136|NCT02016898|590379995|FG001|Overall Study|Death|1|||
163459137|NCT02016898|590379994|FG000|Overall Study|Lost to Follow-up|4|||
163459138|NCT02016898|590379995|FG001|Overall Study|Lost to Follow-up|4|||
163459139|NCT01381718|590379996|FG000|Overall Study|Withdrawal by Subject|2|||
163459140|NCT01381718|590379997|FG001|Overall Study|Withdrawal by Subject|5|||
163459141|NCT01381718|590379996|FG000|Overall Study|Lost to Follow-up|3|||
163459142|NCT01381718|590379997|FG001|Overall Study|Lost to Follow-up|5|||
163459143|NCT01381718|590379996|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
163459144|NCT01381718|590379997|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
163459145|NCT03017846|590380000|FG000|Overall Study|Lost to Follow-up|3|||
163459146|NCT03017846|590380000|FG000|Overall Study|Adverse Event|2|||
163459147|NCT02505542|590380001|FG000|Part A: Open-Label Period|Adverse Event|31|||
163459148|NCT02505542|590380002|FG001|Part A: Open-Label Period|Adverse Event|0|||
163459149|NCT02505542|590380003|FG002|Part A: Open-Label Period|Adverse Event|0|||
163459150|NCT02505542|590380004|FG003|Part A: Open-Label Period|Adverse Event|0|||
163459151|NCT02505542|590380001|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
163459152|NCT02505542|590380002|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
163459153|NCT02505542|590380003|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
163459154|NCT02505542|590380004|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
163459155|NCT02505542|590380001|FG000|Part A: Open-Label Period|Protocol Violation|1|||
163459156|NCT02505542|590380002|FG001|Part A: Open-Label Period|Protocol Violation|0|||
163459157|NCT02505542|590380003|FG002|Part A: Open-Label Period|Protocol Violation|0|||
163459158|NCT02505542|590380004|FG003|Part A: Open-Label Period|Protocol Violation|0|||
163459159|NCT02505542|590380001|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
163459160|NCT02505542|590380002|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
163459161|NCT02505542|590380003|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
163459162|NCT02505542|590380004|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
163459163|NCT02505542|590380001|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
163459164|NCT02505542|590380002|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
163459165|NCT02505542|590380003|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
163459166|NCT02505542|590380004|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
163459167|NCT02505542|590380001|FG000|Part A: Open-Label Period|New medical history available|1|||
163459168|NCT02505542|590380002|FG001|Part A: Open-Label Period|New medical history available|0|||
163459169|NCT02505542|590380003|FG002|Part A: Open-Label Period|New medical history available|0|||
163459170|NCT02505542|590380004|FG003|Part A: Open-Label Period|New medical history available|0|||
163459171|NCT02505542|590380001|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
163459172|NCT02505542|590380002|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
163459173|NCT02505542|590380003|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
163459174|NCT02505542|590380004|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
163459175|NCT02505542|590380001|FG000|Part A: Open-Label Period|Pregnancy|2|||
163459176|NCT02505542|590380002|FG001|Part A: Open-Label Period|Pregnancy|0|||
163459177|NCT02505542|590380003|FG002|Part A: Open-Label Period|Pregnancy|0|||
163459178|NCT02505542|590380004|FG003|Part A: Open-Label Period|Pregnancy|0|||
163459179|NCT02505542|590380001|FG000|Part A: Open-Label Period|Sponsor directive|1|||
163459180|NCT02505542|590380002|FG001|Part A: Open-Label Period|Sponsor directive|0|||
163459181|NCT02505542|590380003|FG002|Part A: Open-Label Period|Sponsor directive|0|||
163459182|NCT02505542|590380004|FG003|Part A: Open-Label Period|Sponsor directive|0|||
163459183|NCT02505542|590380001|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
163459184|NCT02505542|590380002|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
163459185|NCT02505542|590380003|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
163459186|NCT02505542|590380004|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
163459187|NCT02505542|590380001|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
163459188|NCT02505542|590380002|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
163459189|NCT02505542|590380003|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
163459190|NCT02505542|590380004|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
163459191|NCT02505542|590380001|FG000|Part A: Open-Label Period|Non-compliance|1|||
163459192|NCT02505542|590380002|FG001|Part A: Open-Label Period|Non-compliance|0|||
163459193|NCT02505542|590380003|FG002|Part A: Open-Label Period|Non-compliance|0|||
163459194|NCT02505542|590380004|FG003|Part A: Open-Label Period|Non-compliance|0|||
163459195|NCT02505542|590380001|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
163459196|NCT02505542|590380002|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
163459197|NCT02505542|590380003|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
163459198|NCT02505542|590380004|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
163459199|NCT02505542|590380001|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
163459200|NCT02505542|590380002|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
163459201|NCT02505542|590380003|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
163459202|NCT02505542|590380004|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
163459203|NCT02505542|590380001|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
163459204|NCT02505542|590380002|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
163459205|NCT02505542|590380003|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
163459206|NCT02505542|590380004|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
163459207|NCT02505542|590380001|FG000|Part B: Double-Blind Period|Adverse Event|0|||
163459208|NCT02505542|590380002|FG001|Part B: Double-Blind Period|Adverse Event|0|||
163459209|NCT02505542|590380003|FG002|Part B: Double-Blind Period|Adverse Event|1|||
163459210|NCT02505542|590380004|FG003|Part B: Double-Blind Period|Adverse Event|3|||
163459211|NCT02505542|590380001|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
163459212|NCT02505542|590380002|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
163459213|NCT02505542|590380003|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
163459214|NCT02505542|590380004|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
163459215|NCT02505542|590380001|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
163459216|NCT02505542|590380002|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
163459217|NCT02505542|590380003|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
163459218|NCT02505542|590380004|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
163459219|NCT02505542|590380001|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
163459220|NCT02505542|590380002|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
163459221|NCT02505542|590380003|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
163459222|NCT02505542|590380004|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
163459223|NCT02505542|590380001|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
163459224|NCT02505542|590380002|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
163459225|NCT02505542|590380003|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
163459226|NCT02505542|590380004|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
163459227|NCT02505542|590380001|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
163459228|NCT02505542|590380002|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
163459229|NCT02505542|590380003|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
163459230|NCT02505542|590380004|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
163459231|NCT02505542|590380001|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
163459232|NCT02505542|590380002|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
163459233|NCT02505542|590380003|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
163459234|NCT02505542|590380004|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
163459235|NCT02505542|590380001|FG000|Part B: Double-Blind Period|Miscalculation|0|||
163459236|NCT02505542|590380002|FG001|Part B: Double-Blind Period|Miscalculation|1|||
163459237|NCT02505542|590380003|FG002|Part B: Double-Blind Period|Miscalculation|0|||
163459238|NCT02505542|590380004|FG003|Part B: Double-Blind Period|Miscalculation|0|||
163459239|NCT02505542|590380001|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
163459240|NCT02505542|590380002|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
163459241|NCT02505542|590380003|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
163459242|NCT02505542|590380004|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
163459243|NCT00992186|590380007|FG000|Overall Study|Withdrawal by Subject|2|||
163459244|NCT00992186|590380007|FG000|Overall Study|Protocol Violation|1|||
163459245|NCT00992186|590380007|FG000|Overall Study|Physician Decision|1|||
163459246|NCT00992186|590380007|FG000|Overall Study|Adverse Event|9|||
163459247|NCT00992186|590380007|FG000|Overall Study|Progressive Disease|30|||
163459248|NCT00992186|590380007|FG000|Overall Study|Refusal To Receive Study Agent|3|||
163459249|NCT01438307|590380013|FG000|Overall Study|Death|1|||
163459250|NCT01438307|590380014|FG001|Overall Study|Death|1|||
163459251|NCT00171314|590380015|FG000|Overall Study|Adverse Event|44|||
163459252|NCT00171314|590380016|FG001|Overall Study|Adverse Event|41|||
163459253|NCT00171314|590380015|FG000|Overall Study|Lack of Efficacy|19|||
163459254|NCT00171314|590380016|FG001|Overall Study|Lack of Efficacy|14|||
163459255|NCT00171314|590380015|FG000|Overall Study|Withdrawal by Subject|9|||
163459256|NCT00171314|590380016|FG001|Overall Study|Withdrawal by Subject|6|||
163459257|NCT00171314|590380015|FG000|Overall Study|Abnormal Test Procedure Results|9|||
163459258|NCT00171314|590380016|FG001|Overall Study|Abnormal Test Procedure Results|3|||
163459259|NCT00171314|590380015|FG000|Overall Study|Protocol Violation|3|||
163459260|NCT00171314|590380016|FG001|Overall Study|Protocol Violation|7|||
163459261|NCT00171314|590380015|FG000|Overall Study|Administrative Problems|4|||
163459262|NCT00171314|590380016|FG001|Overall Study|Administrative Problems|3|||
163459263|NCT00171314|590380015|FG000|Overall Study|Lost to Follow-up|1|||
163459264|NCT00171314|590380016|FG001|Overall Study|Lost to Follow-up|3|||
163459265|NCT00171314|590380015|FG000|Overall Study|Death|2|||
163459266|NCT00171314|590380016|FG001|Overall Study|Death|1|||
163459267|NCT02378883|590380017|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
163459268|NCT02378883|590380017|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
163459269|NCT02378883|590380017|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
163459270|NCT02378883|590380017|FG000|30 Day Follow-Up|Physician Decision|2|||
163459271|NCT02378883|590380017|FG000|30 Day Follow-Up|Missed Visit|2|||
163459272|NCT02378883|590380017|FG000|30 Day Follow-Up|Death|1|||
163459273|NCT02378883|590380017|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
163459274|NCT02378883|590380017|FG000|12 Months Follow-Up|Death|2|||
163459275|NCT00318565|590380018|FG000|Overall Study|Excluded per protocol|24|||
163459276|NCT01588353|590380019|FG000|Step2|Withdrawal by Subject|0|||
163459277|NCT01588353|590380020|FG001|Step2|Withdrawal by Subject|1|||
163459278|NCT01588353|590380021|FG002|Step2|Withdrawal by Subject|0|||
163459279|NCT01588353|590380019|FG000|Step3|Adverse Event|0|||
163459280|NCT01588353|590380020|FG001|Step3|Adverse Event|0|||
163459281|NCT01588353|590380021|FG002|Step3|Adverse Event|2|||
163459282|NCT00493467|590380022|FG000|Overall Study|Death|1|||
163459283|NCT01409993|590380027|FG000|Overall Study|Adverse Event|4|||
163459284|NCT01409993|590380028|FG001|Overall Study|Adverse Event|4|||
163459285|NCT01409993|590380029|FG002|Overall Study|Adverse Event|3|||
163459286|NCT01409993|590380030|FG003|Overall Study|Adverse Event|1|||
163459287|NCT01409993|590380027|FG000|Overall Study|Withdrawal by Subject|0|||
163459288|NCT01409993|590380028|FG001|Overall Study|Withdrawal by Subject|0|||
163459289|NCT01409993|590380029|FG002|Overall Study|Withdrawal by Subject|0|||
163459290|NCT01409993|590380030|FG003|Overall Study|Withdrawal by Subject|4|||
163459291|NCT01409993|590380027|FG000|Overall Study|Lost to Follow-up|0|||
163459292|NCT01409993|590380028|FG001|Overall Study|Lost to Follow-up|1|||
163459293|NCT01409993|590380029|FG002|Overall Study|Lost to Follow-up|0|||
163459294|NCT01409993|590380030|FG003|Overall Study|Lost to Follow-up|0|||
163459295|NCT03074149|590380034|FG000|Overall Study|Reason unknown|22|||
163459296|NCT03074149|590380035|FG001|Overall Study|Reason unknown|35|||
163459297|NCT03074149|590380034|FG000|Overall Study|Death|10|||
163459298|NCT03074149|590380035|FG001|Overall Study|Death|45|||
163459299|NCT00830960|590380036|FG000|Overall Study|Death|5|||
163459300|NCT00830960|590380037|FG001|Overall Study|Death|4|||
163459301|NCT00830960|590380038|FG002|Overall Study|Death|3|||
163459302|NCT00830960|590380039|FG003|Overall Study|Death|2|||
163459303|NCT00830960|590380040|FG004|Overall Study|Death|6|||
163459304|NCT00830960|590380041|FG005|Overall Study|Death|1|||
163459305|NCT00830960|590380036|FG000|Overall Study|Lost to Follow-up|1|||
163459306|NCT00830960|590380037|FG001|Overall Study|Lost to Follow-up|1|||
163459307|NCT00830960|590380038|FG002|Overall Study|Lost to Follow-up|1|||
163459308|NCT00830960|590380039|FG003|Overall Study|Lost to Follow-up|0|||
163459309|NCT00830960|590380040|FG004|Overall Study|Lost to Follow-up|0|||
163459310|NCT00830960|590380041|FG005|Overall Study|Lost to Follow-up|1|||
163459311|NCT00830960|590380036|FG000|Overall Study|Withdrawal by Subject|19|||
163459312|NCT00830960|590380037|FG001|Overall Study|Withdrawal by Subject|19|||
163459313|NCT00830960|590380038|FG002|Overall Study|Withdrawal by Subject|18|||
163459314|NCT00830960|590380039|FG003|Overall Study|Withdrawal by Subject|23|||
163459315|NCT00830960|590380040|FG004|Overall Study|Withdrawal by Subject|16|||
163459316|NCT00830960|590380041|FG005|Overall Study|Withdrawal by Subject|21|||
163459317|NCT00830960|590380036|FG000|Overall Study|Sponsor Decision|1|||
163459318|NCT00830960|590380037|FG001|Overall Study|Sponsor Decision|2|||
163459319|NCT00830960|590380038|FG002|Overall Study|Sponsor Decision|3|||
163459320|NCT00830960|590380039|FG003|Overall Study|Sponsor Decision|4|||
163459321|NCT00830960|590380040|FG004|Overall Study|Sponsor Decision|5|||
163459322|NCT00830960|590380041|FG005|Overall Study|Sponsor Decision|7|||
163459323|NCT00830960|590380036|FG000|Overall Study|No study drug received|7|||
163459324|NCT00830960|590380037|FG001|Overall Study|No study drug received|2|||
163459325|NCT00830960|590380038|FG002|Overall Study|No study drug received|4|||
163459326|NCT00830960|590380039|FG003|Overall Study|No study drug received|3|||
163459327|NCT00830960|590380040|FG004|Overall Study|No study drug received|5|||
163459328|NCT00830960|590380041|FG005|Overall Study|No study drug received|7|||
163459329|NCT02180217|590380044|FG000|Overall Study|Adverse Event|3|||
163459330|NCT02180217|590380045|FG001|Overall Study|Adverse Event|2|||
163459331|NCT02180217|590380046|FG002|Overall Study|Adverse Event|22|||
163459332|NCT02180217|590380044|FG000|Overall Study|Death|1|||
163459333|NCT02180217|590380045|FG001|Overall Study|Death|1|||
163459334|NCT02180217|590380046|FG002|Overall Study|Death|0|||
163459335|NCT02180217|590380044|FG000|Overall Study|Withdrawal by Subject|1|||
163459336|NCT02180217|590380045|FG001|Overall Study|Withdrawal by Subject|1|||
163459337|NCT02180217|590380046|FG002|Overall Study|Withdrawal by Subject|4|||
163459338|NCT02180217|590380044|FG000|Overall Study|Subject/Guardian decision|5|||
163459339|NCT02180217|590380045|FG001|Overall Study|Subject/Guardian decision|3|||
163459340|NCT02180217|590380046|FG002|Overall Study|Subject/Guardian decision|6|||
163459341|NCT02180217|590380044|FG000|Overall Study|Physician Decision|1|||
163459342|NCT02180217|590380045|FG001|Overall Study|Physician Decision|1|||
163459343|NCT02180217|590380046|FG002|Overall Study|Physician Decision|6|||
163459344|NCT02180217|590380044|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163459345|NCT02180217|590380045|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163459346|NCT02180217|590380046|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
163459347|NCT01504971|590380048|FG000|Overall Study|Physician Decision|13|||
163459348|NCT01309841|590380053|FG000|Overall Study|Other|0|||
163459349|NCT01309841|590380054|FG001|Overall Study|Other|1|||
163459350|NCT01309841|590380055|FG002|Overall Study|Other|1|||
163459351|NCT01309841|590380053|FG000|Overall Study|Lost to Follow-up|7|||
163459352|NCT01309841|590380054|FG001|Overall Study|Lost to Follow-up|6|||
163459353|NCT01309841|590380055|FG002|Overall Study|Lost to Follow-up|4|||
163459354|NCT01309841|590380053|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
163459355|NCT01309841|590380054|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
163459356|NCT01309841|590380055|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
163459357|NCT01309841|590380053|FG000|Overall Study|Lack of Efficacy|0|||
163459358|NCT01309841|590380054|FG001|Overall Study|Lack of Efficacy|0|||
163459359|NCT01309841|590380055|FG002|Overall Study|Lack of Efficacy|2|||
163459360|NCT01309841|590380053|FG000|Overall Study|Adverse Event|9|||
163459361|NCT01309841|590380054|FG001|Overall Study|Adverse Event|22|||
163459362|NCT01309841|590380055|FG002|Overall Study|Adverse Event|11|||
163459363|NCT01309841|590380053|FG000|Overall Study|Death|1|||
163459364|NCT01309841|590380054|FG001|Overall Study|Death|0|||
163459365|NCT01309841|590380055|FG002|Overall Study|Death|0|||
163459366|NCT01309841|590380053|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
163459367|NCT01309841|590380054|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
163459368|NCT01309841|590380055|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
163459369|NCT01309841|590380053|FG000|Overall Study|Withdrawal by Subject|17|||
163459370|NCT01309841|590380054|FG001|Overall Study|Withdrawal by Subject|6|||
163459371|NCT01309841|590380055|FG002|Overall Study|Withdrawal by Subject|13|||
163459372|NCT01309841|590380053|FG000|Overall Study|Did Not Receive Treatment|2|||
163459373|NCT01309841|590380054|FG001|Overall Study|Did Not Receive Treatment|0|||
163459374|NCT01309841|590380055|FG002|Overall Study|Did Not Receive Treatment|1|||
163459375|NCT01309841|590380053|FG000|Overall Study|Severe non-compliance with protocol|0|||
163459376|NCT01309841|590380054|FG001|Overall Study|Severe non-compliance with protocol|5|||
163459377|NCT01309841|590380055|FG002|Overall Study|Severe non-compliance with protocol|2|||
163459378|NCT02475395|590380056|FG000|Overall Study|Protocol Violation|30|||
163459379|NCT02475395|590380057|FG001|Overall Study|Protocol Violation|3|||
163459380|NCT01681576|590380058|FG000|Period 1|Adverse Event|1|||
163459381|NCT01681576|590380059|FG001|Period 1|Adverse Event|0|||
163459382|NCT01681576|590380058|FG000|Period 1|Protocol Deviation|1|||
163459383|NCT01681576|590380059|FG001|Period 1|Protocol Deviation|0|||
163459384|NCT01681576|590380058|FG000|Period 2|subject/guardian decision|3|||
163459385|NCT01681576|590380059|FG001|Period 2|subject/guardian decision|1|||
163459386|NCT01681576|590380058|FG000|Period 2|Non-compliance with study treatment|1|||
163459387|NCT01681576|590380059|FG001|Period 2|Non-compliance with study treatment|0|||
163459388|NCT03448224|590380063|FG000|Overall Study|Provided same answer to every question|1|||
163459389|NCT03448224|590380064|FG001|Overall Study|Provided same answer to every question|0|||
163459390|NCT03103906|590380065|FG000|Overall Study|Adverse Event|2|||
163459391|NCT03103906|590380066|FG001|Overall Study|Adverse Event|3|||
163459392|NCT03103906|590380065|FG000|Overall Study|Other|2|||
163459393|NCT03103906|590380066|FG001|Overall Study|Other|0|||
163459394|NCT00764478|590380067|FG000|Overall Study|Adverse Event|1|||
163459395|NCT00764478|590380068|FG001|Overall Study|Adverse Event|1|||
163459396|NCT00764478|590380069|FG002|Overall Study|Adverse Event|1|||
163459397|NCT00764478|590380067|FG000|Overall Study|Withdrawal by Subject|7|||
163459398|NCT00764478|590380068|FG001|Overall Study|Withdrawal by Subject|12|||
163459399|NCT00764478|590380069|FG002|Overall Study|Withdrawal by Subject|1|||
163459400|NCT00764478|590380067|FG000|Overall Study|Lost to Follow-up|7|||
163459401|NCT00764478|590380068|FG001|Overall Study|Lost to Follow-up|8|||
163459402|NCT00764478|590380069|FG002|Overall Study|Lost to Follow-up|5|||
163459403|NCT00764478|590380067|FG000|Overall Study|Protocol Violation|0|||
163459404|NCT00764478|590380068|FG001|Overall Study|Protocol Violation|1|||
163459405|NCT00764478|590380069|FG002|Overall Study|Protocol Violation|1|||
163459406|NCT00862121|590380070|FG000|Overall Study|Adverse Event|1|||
163459407|NCT00862121|590380071|FG001|Overall Study|Adverse Event|2|||
163459408|NCT00862121|590380070|FG000|Overall Study|Lack of Efficacy|0|||
163459409|NCT00862121|590380071|FG001|Overall Study|Lack of Efficacy|3|||
163459410|NCT00862121|590380070|FG000|Overall Study|Protocol Violation|0|||
163459411|NCT00862121|590380071|FG001|Overall Study|Protocol Violation|1|||
163459412|NCT00862121|590380070|FG000|Overall Study|Exclusion criterion violation|0|||
163459413|NCT00862121|590380071|FG001|Overall Study|Exclusion criterion violation|1|||
163459414|NCT00862121|590380070|FG000|Overall Study|Incorrect randomisation|0|||
163459415|NCT00862121|590380071|FG001|Overall Study|Incorrect randomisation|1|||
163459416|NCT01195363|590380073|FG000|Overall Study|Lost to Follow-up|7|||
163459417|NCT01195363|590380074|FG001|Overall Study|Lost to Follow-up|4|||
163459418|NCT01195363|590380073|FG000|Overall Study|Adverse Event|3|||
163459419|NCT01195363|590380074|FG001|Overall Study|Adverse Event|1|||
163459420|NCT01195363|590380073|FG000|Overall Study|Lack of Efficacy|0|||
163459421|NCT01195363|590380074|FG001|Overall Study|Lack of Efficacy|4|||
163459422|NCT01195363|590380073|FG000|Overall Study|incarceration|1|||
163459423|NCT01195363|590380074|FG001|Overall Study|incarceration|0|||
163459424|NCT00377429|590380077|FG000|Overall Study|Withdrawal by Subject|5|||
163459425|NCT00377429|590380077|FG000|Overall Study|Adverse Event|8|||
163459426|NCT00377429|590380077|FG000|Overall Study|Physician Decision|1|||
163459427|NCT00377429|590380077|FG000|Overall Study|Patient non-compliance|1|||
163459428|NCT05691829|590382409|FG000|Overall Study|Physician Decision|2|||
163459429|NCT05691829|590382409|FG000|Overall Study|Eligibility criteria not met|3|||
163459430|NCT00804843|590382410|FG000|Overall Study|Protocol Violation|1|||
163459431|NCT00804843|590382411|FG001|Overall Study|Protocol Violation|0|||
163459432|NCT00804843|590382410|FG000|Overall Study|Adverse Event|8|||
163459433|NCT00804843|590382411|FG001|Overall Study|Adverse Event|5|||
163459434|NCT00804843|590382410|FG000|Overall Study|Withdrawal by Subject|1|||
163459435|NCT00804843|590382411|FG001|Overall Study|Withdrawal by Subject|2|||
163459436|NCT02670928|590382418|FG000|Overall Study|Adverse Event|3|||
163459437|NCT02670928|590382419|FG001|Overall Study|Adverse Event|1|||
163459438|NCT02670928|590382418|FG000|Overall Study|Withdrawal by Subject|4|||
163459439|NCT02670928|590382419|FG001|Overall Study|Withdrawal by Subject|0|||
163459440|NCT02670928|590382418|FG000|Overall Study|Lost to Follow-up|1|||
163459441|NCT02670928|590382419|FG001|Overall Study|Lost to Follow-up|0|||
163459442|NCT02670928|590382418|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
163459443|NCT02670928|590382419|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
163459444|NCT02678312|590382420|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
163459445|NCT02678312|590382421|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
163459446|NCT02678312|590382422|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
163459447|NCT02678312|590382423|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
163459448|NCT02678312|590382424|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
163459449|NCT02678312|590382420|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
163459450|NCT02678312|590382421|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
163459451|NCT02678312|590382422|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
163459452|NCT02678312|590382423|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
163459453|NCT02678312|590382424|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
163459454|NCT02678312|590382420|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
163459455|NCT02678312|590382421|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
163459456|NCT02678312|590382422|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
163459457|NCT02678312|590382423|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
163459458|NCT02678312|590382424|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
163459459|NCT02678312|590382420|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
163459460|NCT02678312|590382421|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
163459461|NCT02678312|590382422|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
163459462|NCT02678312|590382423|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
163459463|NCT02678312|590382424|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
163459464|NCT02678312|590382420|FG000|Part 2 Double Blind Epoch|Death|0|||
163459465|NCT02678312|590382421|FG001|Part 2 Double Blind Epoch|Death|0|||
163459466|NCT02678312|590382422|FG002|Part 2 Double Blind Epoch|Death|0|||
163459467|NCT02678312|590382423|FG003|Part 2 Double Blind Epoch|Death|8|||
163459468|NCT02678312|590382424|FG004|Part 2 Double Blind Epoch|Death|12|||
163459469|NCT02678312|590382420|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
163459470|NCT02678312|590382421|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
163459471|NCT02678312|590382422|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
163459472|NCT02678312|590382423|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
163459473|NCT02678312|590382424|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
163459474|NCT02678312|590382420|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
163459475|NCT02678312|590382421|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
163459476|NCT02678312|590382422|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
163459477|NCT02678312|590382423|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
163459478|NCT02678312|590382424|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
163459479|NCT02678312|590382420|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
163459480|NCT02678312|590382421|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
163459481|NCT02678312|590382422|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
163459482|NCT02678312|590382423|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
163459483|NCT02678312|590382424|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
163459484|NCT00656084|590382425|FG000|Overall Study|Adverse Event|4|||
163459485|NCT00656084|590382425|FG000|Overall Study|Withdrawal by Subject|1|||
163459486|NCT00656084|590382425|FG000|Overall Study|Patient Request|1|||
163459487|NCT00656084|590382425|FG000|Overall Study|Investigator Request|1|||
163459488|NCT02455388|590382429|FG000|Overall Study|Protocol Violation|1|||
163459489|NCT02455388|590382430|FG001|Overall Study|Protocol Violation|0|||
163459490|NCT02455388|590382431|FG002|Overall Study|Protocol Violation|4|||
163459491|NCT02455388|590382429|FG000|Overall Study|Withdrawal by Subject|0|||
163459492|NCT02455388|590382430|FG001|Overall Study|Withdrawal by Subject|0|||
163459493|NCT02455388|590382431|FG002|Overall Study|Withdrawal by Subject|7|||
163459494|NCT01136746|590382432|FG000|Overall Study|Lost to Follow-up|0|||
163459495|NCT01136746|590382433|FG001|Overall Study|Lost to Follow-up|2|||
163459496|NCT01136746|590382432|FG000|Overall Study|Protocol Violation|2|||
163459497|NCT01136746|590382433|FG001|Overall Study|Protocol Violation|1|||
163459498|NCT01136746|590382432|FG000|Overall Study|Death|1|||
163459499|NCT01136746|590382433|FG001|Overall Study|Death|0|||
163459500|NCT00092677|590382439|FG000|Overall Study|Lost to Follow-up|0|||
163459501|NCT00092677|590382440|FG001|Overall Study|Lost to Follow-up|2|||
163459502|NCT00092677|590382439|FG000|Overall Study|Adminstrative|5|||
163459503|NCT00092677|590382440|FG001|Overall Study|Adminstrative|9|||
163459504|NCT00010803|590382445|FG000|Overall Study|Withdrawal by Subject|97|||
163459505|NCT00010803|590382446|FG001|Overall Study|Withdrawal by Subject|98|||
163459506|NCT02685995|590382447|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
163459507|NCT02685995|590382448|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
163459508|NCT01188096|590382449|FG000|Overall Study|progression of disease|4|||
163459509|NCT01188096|590382449|FG000|Overall Study|Withdrawal by Subject|2|||
163459510|NCT02384395|590382450|FG000|Overall Study|Physician Decision|4|||
163459511|NCT02384395|590382450|FG000|Overall Study|Withdrawal by Subject|3|||
163459512|NCT02384395|590382450|FG000|Overall Study|Lost to Follow-up|3|||
163459513|NCT03485222|590382451|FG000|Overall Study|Death|0|||
163459514|NCT03485222|590382452|FG001|Overall Study|Death|1|||
163459515|NCT03485222|590382451|FG000|Overall Study|Lost to Follow-up|2|||
163459516|NCT03485222|590382452|FG001|Overall Study|Lost to Follow-up|1|||
163459517|NCT00688545|590382453|FG000|Overall Study|Lost to Follow-up|1|||
163459518|NCT00688545|590382454|FG001|Overall Study|Lost to Follow-up|4|||
163459519|NCT00688545|590382453|FG000|Overall Study|Insurance/cost of drug|0|||
163459520|NCT00688545|590382454|FG001|Overall Study|Insurance/cost of drug|1|||
163459521|NCT00688545|590382453|FG000|Overall Study|Withdrawal by Subject|2|||
163459522|NCT00688545|590382454|FG001|Overall Study|Withdrawal by Subject|3|||
163459523|NCT00688545|590382453|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
163459524|NCT00688545|590382454|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
163459525|NCT01878097|590382455|FG000|Baseline|Surveys not fully completed|2497|||
163459526|NCT01878097|590382456|FG001|Baseline|Surveys not fully completed|1800|||
163459527|NCT01878097|590382455|FG000|Implementation Year 1|Surveys not fully completed|3202|||
163459528|NCT01878097|590382456|FG001|Implementation Year 1|Surveys not fully completed|2549|||
163459529|NCT01878097|590382455|FG000|Implementation Year 2|Surveys not fully completed|3281|||
163459530|NCT01878097|590382456|FG001|Implementation Year 2|Surveys not fully completed|2841|||
163459531|NCT01878097|590382455|FG000|Implementation Year 3|Surveys not fully completed|3494|||
163459532|NCT01878097|590382456|FG001|Implementation Year 3|Surveys not fully completed|2980|||
163459533|NCT01878097|590382455|FG000|Implementation Year 4|Surveys not fully completed|3604|||
163459534|NCT01878097|590382456|FG001|Implementation Year 4|Surveys not fully completed|3007|||
163459535|NCT01595438|590382457|FG000|Overall Study|Lost to Follow-up|20|||
163459536|NCT01595438|590382458|FG001|Overall Study|Lost to Follow-up|20|||
163459537|NCT01595438|590382457|FG000|Overall Study|Withdrawal by Subject|12|||
163459538|NCT01595438|590382458|FG001|Overall Study|Withdrawal by Subject|12|||
163459539|NCT01595438|590382457|FG000|Overall Study|Other Eligibility criteria|11|||
163459540|NCT01595438|590382458|FG001|Overall Study|Other Eligibility criteria|9|||
163459541|NCT00985738|590382459|FG000|Overall Study|Study closed prematurely|8|||
163459542|NCT00985738|590382460|FG001|Overall Study|Study closed prematurely|8|||
163459543|NCT00340834|590382464|FG000|Core Phase of Study|Adverse Event|26|||
163459544|NCT00340834|590382465|FG001|Core Phase of Study|Adverse Event|9|||
163459545|NCT00340834|590382466|FG002|Core Phase of Study|Adverse Event|9|||
163459546|NCT00340834|590382467|FG003|Core Phase of Study|Adverse Event|0|||
163459547|NCT00340834|590382468|FG004|Core Phase of Study|Adverse Event|0|||
163459548|NCT00340834|590382464|FG000|Core Phase of Study|Withdrawal by Subject|11|||
163459549|NCT00340834|590382465|FG001|Core Phase of Study|Withdrawal by Subject|9|||
163459550|NCT00340834|590382466|FG002|Core Phase of Study|Withdrawal by Subject|16|||
163459551|NCT00340834|590382467|FG003|Core Phase of Study|Withdrawal by Subject|0|||
163459552|NCT00340834|590382468|FG004|Core Phase of Study|Withdrawal by Subject|0|||
163459553|NCT00340834|590382464|FG000|Core Phase of Study|Administrative Problems|6|||
163459554|NCT00340834|590382465|FG001|Core Phase of Study|Administrative Problems|2|||
163459555|NCT00340834|590382466|FG002|Core Phase of Study|Administrative Problems|7|||
163459556|NCT00340834|590382467|FG003|Core Phase of Study|Administrative Problems|0|||
163459557|NCT00340834|590382468|FG004|Core Phase of Study|Administrative Problems|0|||
163459558|NCT00340834|590382464|FG000|Core Phase of Study|Lack of Efficacy|3|||
163459559|NCT00340834|590382465|FG001|Core Phase of Study|Lack of Efficacy|3|||
163459560|NCT00340834|590382466|FG002|Core Phase of Study|Lack of Efficacy|7|||
163459561|NCT00340834|590382467|FG003|Core Phase of Study|Lack of Efficacy|0|||
163459562|NCT00340834|590382468|FG004|Core Phase of Study|Lack of Efficacy|0|||
163459563|NCT00340834|590382464|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
163459564|NCT00340834|590382465|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
163459565|NCT00340834|590382466|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
163459566|NCT00340834|590382467|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
163459567|NCT00340834|590382468|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
163459568|NCT00340834|590382464|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
163459569|NCT00340834|590382465|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
163459570|NCT00340834|590382466|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
163459571|NCT00340834|590382467|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
163459572|NCT00340834|590382468|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
163459573|NCT00340834|590382464|FG000|Core Phase of Study|Lost to Follow-up|1|||
163459574|NCT00340834|590382465|FG001|Core Phase of Study|Lost to Follow-up|1|||
163459575|NCT00340834|590382466|FG002|Core Phase of Study|Lost to Follow-up|4|||
163459576|NCT00340834|590382467|FG003|Core Phase of Study|Lost to Follow-up|0|||
163459577|NCT00340834|590382468|FG004|Core Phase of Study|Lost to Follow-up|0|||
163459578|NCT00340834|590382464|FG000|Core Phase of Study|Death|2|||
163459579|NCT00340834|590382465|FG001|Core Phase of Study|Death|0|||
163459580|NCT00340834|590382466|FG002|Core Phase of Study|Death|0|||
163459581|NCT00340834|590382467|FG003|Core Phase of Study|Death|0|||
163459582|NCT00340834|590382468|FG004|Core Phase of Study|Death|0|||
163459583|NCT00340834|590382464|FG000|Core Phase of Study|Protocol Violation|0|||
163459584|NCT00340834|590382465|FG001|Core Phase of Study|Protocol Violation|0|||
163459585|NCT00340834|590382466|FG002|Core Phase of Study|Protocol Violation|2|||
163459586|NCT00340834|590382467|FG003|Core Phase of Study|Protocol Violation|0|||
163459587|NCT00340834|590382468|FG004|Core Phase of Study|Protocol Violation|0|||
163459588|NCT00340834|590382464|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
163459589|NCT00340834|590382465|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
163459590|NCT00340834|590382466|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
163459591|NCT00340834|590382467|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
163459592|NCT00340834|590382468|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
163459593|NCT00340834|590382464|FG000|Extension Phase of Study|Subject withdrew consent|26|||
163459594|NCT00340834|590382465|FG001|Extension Phase of Study|Subject withdrew consent|31|||
163459595|NCT00340834|590382466|FG002|Extension Phase of Study|Subject withdrew consent|0|||
163459596|NCT00340834|590382467|FG003|Extension Phase of Study|Subject withdrew consent|12|||
163459597|NCT00340834|590382468|FG004|Extension Phase of Study|Subject withdrew consent|15|||
163459598|NCT00340834|590382464|FG000|Extension Phase of Study|Adverse Event|21|||
163459599|NCT00340834|590382465|FG001|Extension Phase of Study|Adverse Event|22|||
163459600|NCT00340834|590382466|FG002|Extension Phase of Study|Adverse Event|0|||
163459601|NCT00340834|590382467|FG003|Extension Phase of Study|Adverse Event|19|||
163459602|NCT00340834|590382468|FG004|Extension Phase of Study|Adverse Event|7|||
163459603|NCT00340834|590382464|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
163459604|NCT00340834|590382465|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
163459605|NCT00340834|590382466|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
163459606|NCT00340834|590382467|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
163459607|NCT00340834|590382468|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
163459608|NCT00340834|590382464|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
163459609|NCT00340834|590382465|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
163459610|NCT00340834|590382466|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
163459611|NCT00340834|590382467|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
163459612|NCT00340834|590382468|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
163459613|NCT00340834|590382464|FG000|Extension Phase of Study|Lost to Follow-up|1|||
163459614|NCT00340834|590382465|FG001|Extension Phase of Study|Lost to Follow-up|1|||
163459615|NCT00340834|590382466|FG002|Extension Phase of Study|Lost to Follow-up|0|||
163459616|NCT00340834|590382467|FG003|Extension Phase of Study|Lost to Follow-up|2|||
163459617|NCT00340834|590382468|FG004|Extension Phase of Study|Lost to Follow-up|3|||
163459618|NCT00340834|590382464|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
163459619|NCT00340834|590382465|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
163459620|NCT00340834|590382466|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
163459621|NCT00340834|590382467|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
163459622|NCT00340834|590382468|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
163459623|NCT00340834|590382464|FG000|Extension Phase of Study|Administrative problems|3|||
163459624|NCT00340834|590382465|FG001|Extension Phase of Study|Administrative problems|0|||
163459625|NCT00340834|590382466|FG002|Extension Phase of Study|Administrative problems|0|||
163459626|NCT00340834|590382467|FG003|Extension Phase of Study|Administrative problems|1|||
163459627|NCT00340834|590382468|FG004|Extension Phase of Study|Administrative problems|1|||
163459628|NCT00340834|590382464|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
163459629|NCT00340834|590382465|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
163459630|NCT00340834|590382466|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
163459631|NCT00340834|590382467|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
163459632|NCT00340834|590382468|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
163459633|NCT00340834|590382464|FG000|Extension Phase of Study|Protocol Violation|3|||
163459634|NCT00340834|590382465|FG001|Extension Phase of Study|Protocol Violation|0|||
163459635|NCT00340834|590382466|FG002|Extension Phase of Study|Protocol Violation|0|||
163459636|NCT00340834|590382467|FG003|Extension Phase of Study|Protocol Violation|0|||
163459637|NCT00340834|590382468|FG004|Extension Phase of Study|Protocol Violation|0|||
163459638|NCT00340834|590382464|FG000|Extension Phase of Study|Death|0|||
163459639|NCT00340834|590382465|FG001|Extension Phase of Study|Death|0|||
163459640|NCT00340834|590382466|FG002|Extension Phase of Study|Death|0|||
163459641|NCT00340834|590382467|FG003|Extension Phase of Study|Death|0|||
163459642|NCT00340834|590382468|FG004|Extension Phase of Study|Death|1|||
163459643|NCT02786836|590382469|FG000|Overall Study|Death|1|||
163459644|NCT02786836|590382469|FG000|Overall Study|Lack of Efficacy|2|||
163459645|NCT02786836|590382469|FG000|Overall Study|Protocol Violation|3|||
163459646|NCT02786836|590382469|FG000|Overall Study|Withdrawal by Subject|3|||
163459647|NCT02786836|590382469|FG000|Overall Study|Liver Transplantation|2|||
163459648|NCT02786836|590382469|FG000|Overall Study|Device or Pharmacy Issues|3|||
163459649|NCT02855450|590382477|FG000|Overall Study|Adverse Event|1|||
163459650|NCT02855450|590382478|FG001|Overall Study|Adverse Event|0|||
163459651|NCT02855450|590382477|FG000|Overall Study|Lost to Follow-up|4|||
163459652|NCT02855450|590382478|FG001|Overall Study|Lost to Follow-up|0|||
163459653|NCT01803711|590382479|FG000|Overall Study|Adverse Event|1|||
163459654|NCT01803711|590382480|FG001|Overall Study|Adverse Event|1|||
163459655|NCT01376245|590382483|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
163459656|NCT01376245|590382484|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
163459657|NCT01376245|590382485|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
163459658|NCT01376245|590382486|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
163459659|NCT01376245|590382487|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
163459660|NCT01376245|590382483|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
163459661|NCT01376245|590382484|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
163459662|NCT01376245|590382485|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
163459663|NCT01376245|590382486|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
163459664|NCT01376245|590382487|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
163459665|NCT01376245|590382483|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
163459666|NCT01376245|590382484|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
163459667|NCT01376245|590382485|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
163459668|NCT01376245|590382486|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
163459669|NCT01376245|590382487|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
163459670|NCT01376245|590382483|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
163459671|NCT01376245|590382484|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
163459672|NCT01376245|590382485|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
163459673|NCT01376245|590382486|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
163459674|NCT01376245|590382487|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
163459675|NCT01376245|590382483|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
163459676|NCT01376245|590382484|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
163459677|NCT01376245|590382485|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
163459678|NCT01376245|590382486|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
163459679|NCT01376245|590382487|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
163459680|NCT01376245|590382483|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
163459681|NCT01376245|590382484|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
163459682|NCT01376245|590382485|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
163459683|NCT01376245|590382486|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
163459684|NCT01376245|590382487|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
163459685|NCT01376245|590382483|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
163459686|NCT01376245|590382484|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
163459687|NCT01376245|590382485|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
163459688|NCT01376245|590382486|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
163459689|NCT01376245|590382487|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
163459690|NCT01376245|590382483|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
163459691|NCT01376245|590382484|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
163459692|NCT01376245|590382485|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
163459693|NCT01376245|590382486|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
163459694|NCT01376245|590382487|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
163459695|NCT01376245|590382483|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
163459696|NCT01376245|590382484|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
163459697|NCT01376245|590382485|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
163459698|NCT01376245|590382486|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
163459699|NCT01376245|590382487|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
163459700|NCT01376245|590382483|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163459701|NCT01376245|590382484|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
163459702|NCT01376245|590382485|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163459703|NCT01376245|590382486|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
163459704|NCT01376245|590382487|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
163459705|NCT01376245|590382483|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
163459706|NCT01376245|590382484|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
163459707|NCT01376245|590382485|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
163459708|NCT01376245|590382486|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
163459709|NCT01376245|590382487|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
163459710|NCT01376245|590382483|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
163459711|NCT01376245|590382484|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
163459712|NCT01376245|590382485|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
163459713|NCT01376245|590382486|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
163459714|NCT01376245|590382487|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
163459715|NCT05159362|590382488|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
163459716|NCT05159362|590382489|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
163459717|NCT05159362|590382490|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
163459718|NCT01357889|590382491|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
163459719|NCT01357889|590382492|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
163459720|NCT01357889|590382491|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
163459721|NCT01357889|590382492|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
163459722|NCT01357889|590382491|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
163459723|NCT01357889|590382492|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
163459724|NCT01357889|590382491|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
163459725|NCT01357889|590382492|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
163459726|NCT01357889|590382491|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
163459727|NCT01357889|590382492|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
163459728|NCT01357889|590382491|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
163459729|NCT01357889|590382492|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
163459730|NCT01357889|590382491|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
163459731|NCT01357889|590382492|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
163459732|NCT01357889|590382491|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
163459733|NCT01357889|590382492|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
163459734|NCT01357889|590382491|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
163459735|NCT01357889|590382492|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
163459736|NCT01357889|590382491|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
163459737|NCT01357889|590382492|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
163459738|NCT01357889|590382491|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
163459739|NCT01357889|590382492|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
163459740|NCT01357889|590382491|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
163459741|NCT01357889|590382492|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
163459742|NCT01357889|590382491|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
163459743|NCT01357889|590382492|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
163459744|NCT01335698|590382493|FG000|Treatment Stage 1|Lack of Efficacy|3|||
163459745|NCT01335698|590382494|FG001|Treatment Stage 1|Lack of Efficacy|1|||
163459746|NCT01335698|590382495|FG002|Treatment Stage 1|Lack of Efficacy|3|||
163459747|NCT01335698|590382496|FG003|Treatment Stage 1|Lack of Efficacy|3|||
163459748|NCT01335698|590382497|FG004|Treatment Stage 1|Lack of Efficacy|1|||
163459749|NCT01335698|590382493|FG000|Treatment Stage 1|Adverse Event|1|||
163459750|NCT01335698|590382494|FG001|Treatment Stage 1|Adverse Event|2|||
163459751|NCT01335698|590382495|FG002|Treatment Stage 1|Adverse Event|2|||
163459752|NCT01335698|590382496|FG003|Treatment Stage 1|Adverse Event|1|||
163459753|NCT01335698|590382497|FG004|Treatment Stage 1|Adverse Event|1|||
163459754|NCT01335698|590382493|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
163459755|NCT01335698|590382494|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
163459756|NCT01335698|590382495|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
163459757|NCT01335698|590382496|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
163459758|NCT01335698|590382497|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
163459759|NCT01335698|590382493|FG000|Treatment Stage 1|Lost to Follow-up|1|||
163459760|NCT01335698|590382494|FG001|Treatment Stage 1|Lost to Follow-up|1|||
163459761|NCT01335698|590382495|FG002|Treatment Stage 1|Lost to Follow-up|0|||
163459762|NCT01335698|590382496|FG003|Treatment Stage 1|Lost to Follow-up|0|||
163459763|NCT01335698|590382497|FG004|Treatment Stage 1|Lost to Follow-up|0|||
163459764|NCT01335698|590382493|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
163459765|NCT01335698|590382494|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
163459766|NCT01335698|590382495|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
163459767|NCT01335698|590382496|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
163459768|NCT01335698|590382497|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
163459769|NCT01335698|590382493|FG000|Treatment Stage 1|No longer meets study criteria|1|||
163459770|NCT01335698|590382494|FG001|Treatment Stage 1|No longer meets study criteria|1|||
163459771|NCT01335698|590382495|FG002|Treatment Stage 1|No longer meets study criteria|0|||
163459772|NCT01335698|590382496|FG003|Treatment Stage 1|No longer meets study criteria|1|||
163459773|NCT01335698|590382497|FG004|Treatment Stage 1|No longer meets study criteria|0|||
163459774|NCT01335698|590382493|FG000|Treatment Stage 1|Other|1|||
163459775|NCT01335698|590382494|FG001|Treatment Stage 1|Other|0|||
163459776|NCT01335698|590382495|FG002|Treatment Stage 1|Other|0|||
163459777|NCT01335698|590382496|FG003|Treatment Stage 1|Other|1|||
163459778|NCT01335698|590382497|FG004|Treatment Stage 1|Other|0|||
163459779|NCT01335698|590382493|FG000|Treatment Stage 2|Lack of Efficacy|2|||
163459780|NCT01335698|590382494|FG001|Treatment Stage 2|Lack of Efficacy|1|||
163459781|NCT01335698|590382495|FG002|Treatment Stage 2|Lack of Efficacy|3|||
163459782|NCT01335698|590382496|FG003|Treatment Stage 2|Lack of Efficacy|1|||
163459783|NCT01335698|590382497|FG004|Treatment Stage 2|Lack of Efficacy|0|||
163459784|NCT01335698|590382493|FG000|Treatment Stage 2|Adverse Event|2|||
163459785|NCT01335698|590382494|FG001|Treatment Stage 2|Adverse Event|0|||
163459786|NCT01335698|590382495|FG002|Treatment Stage 2|Adverse Event|0|||
163459787|NCT01335698|590382496|FG003|Treatment Stage 2|Adverse Event|3|||
163459788|NCT01335698|590382497|FG004|Treatment Stage 2|Adverse Event|0|||
163459789|NCT01335698|590382493|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
163459790|NCT01335698|590382494|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
163459791|NCT01335698|590382495|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
163459792|NCT01335698|590382496|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
163459793|NCT01335698|590382497|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
163459794|NCT01335698|590382493|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
163459795|NCT01335698|590382494|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
163459796|NCT01335698|590382495|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
163459797|NCT01335698|590382496|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
163459798|NCT01335698|590382497|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
163459799|NCT01335698|590382493|FG000|Treatment Stage 2|Lost to Follow-up|1|||
163459800|NCT01335698|590382494|FG001|Treatment Stage 2|Lost to Follow-up|0|||
163459801|NCT01335698|590382495|FG002|Treatment Stage 2|Lost to Follow-up|0|||
163459802|NCT01335698|590382496|FG003|Treatment Stage 2|Lost to Follow-up|0|||
163459803|NCT01335698|590382497|FG004|Treatment Stage 2|Lost to Follow-up|0|||
163459804|NCT01335698|590382493|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
163459805|NCT01335698|590382494|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
163459806|NCT01335698|590382495|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
163459807|NCT01335698|590382496|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
163459808|NCT01335698|590382497|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
163459809|NCT01335698|590382493|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
163459810|NCT01335698|590382494|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
163459811|NCT01335698|590382495|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
163459812|NCT01335698|590382496|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
163459813|NCT01335698|590382497|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
163459814|NCT01335698|590382493|FG000|Treatment Stage 2|Switched to another formulation|1|||
163459815|NCT01335698|590382494|FG001|Treatment Stage 2|Switched to another formulation|1|||
163459816|NCT01335698|590382495|FG002|Treatment Stage 2|Switched to another formulation|0|||
163459817|NCT01335698|590382496|FG003|Treatment Stage 2|Switched to another formulation|0|||
163459818|NCT01335698|590382497|FG004|Treatment Stage 2|Switched to another formulation|0|||
163459819|NCT01170221|590382498|FG000|Overall Study|Lost to Follow-up|22|||
163459820|NCT01170221|590382499|FG001|Overall Study|Lost to Follow-up|21|||
163459821|NCT01170221|590382498|FG000|Overall Study|Withdrawal by Subject|9|||
163459822|NCT01170221|590382499|FG001|Overall Study|Withdrawal by Subject|7|||
163459823|NCT01170221|590382498|FG000|Overall Study|Subject completed only screening and LFU|1|||
163459824|NCT01170221|590382499|FG001|Overall Study|Subject completed only screening and LFU|0|||
163459825|NCT01170221|590382498|FG000|Overall Study|Randomized but not treated|1|||
163459826|NCT01170221|590382499|FG001|Overall Study|Randomized but not treated|0|||
163459827|NCT02693691|590382500|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
163459828|NCT02693691|590382500|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
163459829|NCT02693691|590382500|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
163459830|NCT02693691|590382500|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
163459831|NCT02693691|590382500|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
163459832|NCT02693691|590382500|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
163459833|NCT02693691|590382500|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
163459834|NCT02727660|590382501|FG000|Overall Study|Lack of Efficacy|40|||
163459835|NCT02727660|590382502|FG001|Overall Study|Lack of Efficacy|40|||
163459836|NCT02727660|590382503|FG002|Overall Study|Lack of Efficacy|70|||
163459837|NCT02727660|590382501|FG000|Overall Study|Adverse Event|28|||
163459838|NCT02727660|590382502|FG001|Overall Study|Adverse Event|21|||
163459839|NCT02727660|590382503|FG002|Overall Study|Adverse Event|32|||
163459840|NCT02727660|590382501|FG000|Overall Study|Withdrawal by Subject|26|||
163459841|NCT02727660|590382502|FG001|Overall Study|Withdrawal by Subject|25|||
163459842|NCT02727660|590382503|FG002|Overall Study|Withdrawal by Subject|30|||
163459843|NCT02727660|590382501|FG000|Overall Study|Physician Decision|3|||
163459844|NCT02727660|590382502|FG001|Overall Study|Physician Decision|8|||
163459845|NCT02727660|590382503|FG002|Overall Study|Physician Decision|14|||
163459846|NCT02727660|590382501|FG000|Overall Study|Lost to Follow-up|5|||
163459847|NCT02727660|590382502|FG001|Overall Study|Lost to Follow-up|9|||
163459848|NCT02727660|590382503|FG002|Overall Study|Lost to Follow-up|8|||
163459849|NCT02727660|590382501|FG000|Overall Study|Protocol Violation|7|||
163459850|NCT02727660|590382502|FG001|Overall Study|Protocol Violation|5|||
163459851|NCT02727660|590382503|FG002|Overall Study|Protocol Violation|5|||
163459852|NCT02727660|590382501|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
163459853|NCT02727660|590382502|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
163459854|NCT02727660|590382503|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
163459855|NCT02727660|590382501|FG000|Overall Study|Administrative Reasons|2|||
163459856|NCT02727660|590382502|FG001|Overall Study|Administrative Reasons|3|||
163459857|NCT02727660|590382503|FG002|Overall Study|Administrative Reasons|4|||
163459858|NCT00050960|590382504|FG000|Overall Study|Progressive Disease|137|||
163459859|NCT00050960|590382505|FG001|Overall Study|Progressive Disease|93|||
163459860|NCT00050960|590382504|FG000|Overall Study|Stable Disease|19|||
163459861|NCT00050960|590382505|FG001|Overall Study|Stable Disease|48|||
163459862|NCT00050960|590382504|FG000|Overall Study|Partial Response|14|||
163459863|NCT00050960|590382505|FG001|Overall Study|Partial Response|19|||
163459864|NCT00050960|590382504|FG000|Overall Study|Complete Response|0|||
163459865|NCT00050960|590382505|FG001|Overall Study|Complete Response|2|||
163459866|NCT00050960|590382504|FG000|Overall Study|Adverse Event|62|||
163459867|NCT00050960|590382505|FG001|Overall Study|Adverse Event|61|||
163459868|NCT00050960|590382504|FG000|Overall Study|Lost to Follow-up|0|||
163459869|NCT00050960|590382505|FG001|Overall Study|Lost to Follow-up|1|||
163459870|NCT00050960|590382504|FG000|Overall Study|Withdrawal by Subject|23|||
163459871|NCT00050960|590382505|FG001|Overall Study|Withdrawal by Subject|18|||
163459872|NCT00050960|590382504|FG000|Overall Study|Administrative|31|||
163459873|NCT00050960|590382505|FG001|Overall Study|Administrative|46|||
163459874|NCT00050960|590382504|FG000|Overall Study|Non-compliance|3|||
163459875|NCT00050960|590382505|FG001|Overall Study|Non-compliance|1|||
163459876|NCT00050960|590382504|FG000|Overall Study|Death|13|||
163459877|NCT00050960|590382505|FG001|Overall Study|Death|15|||
163459878|NCT00764946|590382510|FG000|Overall Study|Lack of Efficacy|1|||
163459879|NCT00764946|590382511|FG001|Overall Study|Lack of Efficacy|0|||
163459880|NCT00764946|590382512|FG002|Overall Study|Lack of Efficacy|0|||
163459881|NCT00764946|590382510|FG000|Overall Study|Lost to Follow-up|3|||
163459882|NCT00764946|590382511|FG001|Overall Study|Lost to Follow-up|4|||
163459883|NCT00764946|590382512|FG002|Overall Study|Lost to Follow-up|0|||
163459884|NCT00764946|590382510|FG000|Overall Study|Physician Decision|2|||
163459885|NCT00764946|590382511|FG001|Overall Study|Physician Decision|4|||
163459886|NCT00764946|590382512|FG002|Overall Study|Physician Decision|0|||
163459887|NCT00764946|590382510|FG000|Overall Study|Adverse Event|3|||
163459888|NCT00764946|590382511|FG001|Overall Study|Adverse Event|2|||
163459889|NCT00764946|590382512|FG002|Overall Study|Adverse Event|1|||
163459890|NCT00764946|590382510|FG000|Overall Study|Withdrawal by Subject|3|||
163459891|NCT00764946|590382511|FG001|Overall Study|Withdrawal by Subject|6|||
163459892|NCT00764946|590382512|FG002|Overall Study|Withdrawal by Subject|2|||
163459893|NCT00764946|590382510|FG000|Overall Study|Never Treated|1|||
163459894|NCT00764946|590382511|FG001|Overall Study|Never Treated|1|||
163459895|NCT00764946|590382512|FG002|Overall Study|Never Treated|1|||
163459896|NCT01162304|590382513|FG000|Overall Study|Beck scale to high|11|||
163459897|NCT01315847|590382514|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
163459898|NCT01315847|590382515|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
163459899|NCT01315847|590382514|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
163459900|NCT01315847|590382515|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
163459901|NCT02940626|590382516|FG000|Overall Study|Death|40|||
163459902|NCT02940626|590382517|FG001|Overall Study|Death|32|||
163459903|NCT02940626|590382516|FG000|Overall Study|Lost to Follow-up|5|||
163459904|NCT02940626|590382517|FG001|Overall Study|Lost to Follow-up|2|||
163459905|NCT02940626|590382516|FG000|Overall Study|Withdrawal by Subject|1|||
163459906|NCT02940626|590382517|FG001|Overall Study|Withdrawal by Subject|0|||
163459907|NCT02940626|590382516|FG000|Overall Study|Transfer to Hospice Care|1|||
163459908|NCT02940626|590382517|FG001|Overall Study|Transfer to Hospice Care|0|||
163459909|NCT02940626|590382516|FG000|Overall Study|Prohibited Concomitant Medication|0|||
163459910|NCT02940626|590382517|FG001|Overall Study|Prohibited Concomitant Medication|1|||
163459911|NCT00585923|590382519|FG000|Overall Study|Physician decided not to continue|31|||
163459912|NCT00585923|590382520|FG001|Overall Study|Physician decided not to continue|33|||
163459913|NCT01324622|590382521|FG000|Overall Study|Lost to Follow-up|7|||
163459914|NCT01324622|590382522|FG001|Overall Study|Lost to Follow-up|7|||
163459915|NCT01324622|590382521|FG000|Overall Study|Death|1|||
163459916|NCT01324622|590382522|FG001|Overall Study|Death|0|||
163459917|NCT01324622|590382521|FG000|Overall Study|Lack of Efficacy|1|||
163459918|NCT01324622|590382522|FG001|Overall Study|Lack of Efficacy|0|||
163459919|NCT00878215|590382523|FG000|Overall Study|Determined to be ineligible|0|||
163459920|NCT00878215|590382524|FG001|Overall Study|Determined to be ineligible|10|||
163459921|NCT00878215|590382525|FG002|Overall Study|Determined to be ineligible|0|||
163459922|NCT00878215|590382526|FG003|Overall Study|Determined to be ineligible|0|||
163459923|NCT00138424|590382527|FG000|Overall Study|Physician Decision|0|||
163459924|NCT00138424|590382528|FG001|Overall Study|Physician Decision|1|||
163459925|NCT00138424|590382529|FG002|Overall Study|Physician Decision|0|||
163459926|NCT00138424|590382530|FG003|Overall Study|Physician Decision|0|||
163459927|NCT00413062|590382537|FG000|Overall Study|Adverse event/serious adverse event|289|||
163459928|NCT00413062|590382538|FG001|Overall Study|Adverse event/serious adverse event|56|||
163459929|NCT00413062|590382537|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
163459930|NCT00413062|590382538|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
163459931|NCT00413062|590382537|FG000|Overall Study|Withdrawal of informed consent|111|||
163459932|NCT00413062|590382538|FG001|Overall Study|Withdrawal of informed consent|36|||
163459933|NCT00413062|590382537|FG000|Overall Study|Pregnancy|15|||
163459934|NCT00413062|590382538|FG001|Overall Study|Pregnancy|5|||
163459935|NCT00413062|590382537|FG000|Overall Study|Pregnancy wish|17|||
163459936|NCT00413062|590382538|FG001|Overall Study|Pregnancy wish|6|||
163459937|NCT00413062|590382537|FG000|Overall Study|Lost to Follow-up|175|||
163459938|NCT00413062|590382538|FG001|Overall Study|Lost to Follow-up|73|||
163459939|NCT00413062|590382537|FG000|Overall Study|Other reason|70|||
163459940|NCT00413062|590382538|FG001|Overall Study|Other reason|34|||
163459941|NCT02176291|590382539|FG000|Overall Study|Death|1|||
163459942|NCT02176291|590382540|FG001|Overall Study|Death|0|||
163459943|NCT02176291|590382539|FG000|Overall Study|non compliance with protocol|2|||
163459944|NCT02176291|590382540|FG001|Overall Study|non compliance with protocol|0|||
163459945|NCT02176291|590382539|FG000|Overall Study|Withdrawal by Subject|2|||
163459946|NCT02176291|590382540|FG001|Overall Study|Withdrawal by Subject|0|||
163459947|NCT02815293|590382541|FG000|Overall Study|Study termination by sponsor|10|||
163459948|NCT02815293|590382542|FG001|Overall Study|Study termination by sponsor|7|||
163459949|NCT02815293|590382543|FG002|Overall Study|Study termination by sponsor|0|||
163459950|NCT02815293|590382541|FG000|Overall Study|Participants not randomized|0|||
163459951|NCT02815293|590382542|FG001|Overall Study|Participants not randomized|0|||
163459952|NCT02815293|590382543|FG002|Overall Study|Participants not randomized|18|||
163459953|NCT02815293|590382541|FG000|Overall Study|Adverse Event|0|||
163459954|NCT02815293|590382542|FG001|Overall Study|Adverse Event|1|||
163459955|NCT02815293|590382543|FG002|Overall Study|Adverse Event|0|||
163459956|NCT02431468|590382544|FG000|Overall Study|Adverse Event|2|||
163459957|NCT02431468|590382545|FG001|Overall Study|Adverse Event|4|||
163459958|NCT02431468|590382546|FG002|Overall Study|Adverse Event|5|||
163459959|NCT02431468|590382544|FG000|Overall Study|Withdrawal by Subject|4|||
163459960|NCT02431468|590382545|FG001|Overall Study|Withdrawal by Subject|12|||
163459961|NCT02431468|590382546|FG002|Overall Study|Withdrawal by Subject|2|||
163459962|NCT02431468|590382544|FG000|Overall Study|noncompliance, investigator termination,|2|||
163459963|NCT02431468|590382545|FG001|Overall Study|noncompliance, investigator termination,|2|||
163459964|NCT02431468|590382546|FG002|Overall Study|noncompliance, investigator termination,|2|||
163459965|NCT00006604|590382547|FG000|Overall Study|Met study objective - no further FU|1|||
163459966|NCT00006604|590382548|FG001|Overall Study|Met study objective - no further FU|0|||
163459967|NCT00006604|590382549|FG002|Overall Study|Met study objective - no further FU|0|||
163459968|NCT00006604|590382550|FG003|Overall Study|Met study objective - no further FU|0|||
163459969|NCT00006604|590382551|FG004|Overall Study|Met study objective - no further FU|0|||
163459970|NCT00006604|590382552|FG005|Overall Study|Met study objective - no further FU|0|||
163459971|NCT00006604|590382553|FG006|Overall Study|Met study objective - no further FU|0|||
163459972|NCT00006604|590382554|FG007|Overall Study|Met study objective - no further FU|0|||
163459973|NCT00006604|590382555|FG008|Overall Study|Met study objective - no further FU|0|||
163459974|NCT00006604|590382556|FG009|Overall Study|Met study objective - no further FU|0|||
163459975|NCT00006604|590382557|FG010|Overall Study|Met study objective - no further FU|0|||
163459976|NCT00006604|590382558|FG011|Overall Study|Met study objective - no further FU|0|||
163459977|NCT00006604|590382559|FG012|Overall Study|Met study objective - no further FU|0|||
163459978|NCT00006604|590382560|FG013|Overall Study|Met study objective - no further FU|0|||
163459979|NCT00006604|590382561|FG014|Overall Study|Met study objective - no further FU|1|||
163459980|NCT00006604|590382562|FG015|Overall Study|Met study objective - no further FU|1|||
163459981|NCT00006604|590382563|FG016|Overall Study|Met study objective - no further FU|0|||
163459982|NCT00006604|590382547|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
163459983|NCT00006604|590382548|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
163459984|NCT00006604|590382549|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
163459985|NCT00006604|590382550|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
163459986|NCT00006604|590382551|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
163459987|NCT00006604|590382552|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
163459988|NCT00006604|590382553|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
163459989|NCT00006604|590382554|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
163459990|NCT00006604|590382555|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
163459991|NCT00006604|590382556|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
163459992|NCT00006604|590382557|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
163459993|NCT00006604|590382558|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
163459994|NCT00006604|590382559|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
163459995|NCT00006604|590382560|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
163459996|NCT00006604|590382561|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
163459997|NCT00006604|590382562|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
163459998|NCT00006604|590382563|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
163459999|NCT00006604|590382547|FG000|Overall Study|Death|0|||
163460000|NCT00006604|590382548|FG001|Overall Study|Death|0|||
163460001|NCT00006604|590382549|FG002|Overall Study|Death|0|||
163460002|NCT00006604|590382550|FG003|Overall Study|Death|0|||
163460003|NCT00006604|590382551|FG004|Overall Study|Death|0|||
163460004|NCT00006604|590382552|FG005|Overall Study|Death|0|||
163460005|NCT00006604|590382553|FG006|Overall Study|Death|0|||
163460006|NCT00006604|590382554|FG007|Overall Study|Death|0|||
163460007|NCT00006604|590382555|FG008|Overall Study|Death|0|||
163460008|NCT00006604|590382556|FG009|Overall Study|Death|1|||
163460009|NCT00006604|590382557|FG010|Overall Study|Death|1|||
163460010|NCT00006604|590382558|FG011|Overall Study|Death|1|||
163460011|NCT00006604|590382559|FG012|Overall Study|Death|0|||
163460012|NCT00006604|590382560|FG013|Overall Study|Death|0|||
163460013|NCT00006604|590382561|FG014|Overall Study|Death|0|||
163460014|NCT00006604|590382562|FG015|Overall Study|Death|0|||
163460015|NCT00006604|590382563|FG016|Overall Study|Death|0|||
163460016|NCT00006604|590382547|FG000|Overall Study|Severe debilitation, unable to continue|0|||
163460017|NCT00006604|590382548|FG001|Overall Study|Severe debilitation, unable to continue|0|||
163460018|NCT00006604|590382549|FG002|Overall Study|Severe debilitation, unable to continue|0|||
163460019|NCT00006604|590382550|FG003|Overall Study|Severe debilitation, unable to continue|0|||
163460020|NCT00006604|590382551|FG004|Overall Study|Severe debilitation, unable to continue|0|||
163460021|NCT00006604|590382552|FG005|Overall Study|Severe debilitation, unable to continue|0|||
163460022|NCT00006604|590382553|FG006|Overall Study|Severe debilitation, unable to continue|3|||
163460023|NCT00006604|590382554|FG007|Overall Study|Severe debilitation, unable to continue|0|||
163460024|NCT00006604|590382555|FG008|Overall Study|Severe debilitation, unable to continue|0|||
163460025|NCT00006604|590382556|FG009|Overall Study|Severe debilitation, unable to continue|5|||
163460026|NCT00006604|590382557|FG010|Overall Study|Severe debilitation, unable to continue|0|||
163460027|NCT00006604|590382558|FG011|Overall Study|Severe debilitation, unable to continue|2|||
163460028|NCT00006604|590382559|FG012|Overall Study|Severe debilitation, unable to continue|1|||
163460029|NCT00006604|590382560|FG013|Overall Study|Severe debilitation, unable to continue|0|||
163460030|NCT00006604|590382561|FG014|Overall Study|Severe debilitation, unable to continue|2|||
163460031|NCT00006604|590382562|FG015|Overall Study|Severe debilitation, unable to continue|0|||
163460032|NCT00006604|590382563|FG016|Overall Study|Severe debilitation, unable to continue|0|||
163460033|NCT00006604|590382547|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
163460034|NCT00006604|590382548|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
163460035|NCT00006604|590382549|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
163460036|NCT00006604|590382550|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
163460037|NCT00006604|590382551|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
163460038|NCT00006604|590382552|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
163460039|NCT00006604|590382553|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
163460040|NCT00006604|590382554|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
163460041|NCT00006604|590382555|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
163460042|NCT00006604|590382556|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
163460043|NCT00006604|590382557|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
163460044|NCT00006604|590382558|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
163460045|NCT00006604|590382559|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
163460046|NCT00006604|590382560|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
163460047|NCT00006604|590382561|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
163460048|NCT00006604|590382562|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
163460049|NCT00006604|590382563|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
163460050|NCT00006604|590382547|FG000|Overall Study|Site closing|0|||
163460051|NCT00006604|590382548|FG001|Overall Study|Site closing|0|||
163460052|NCT00006604|590382549|FG002|Overall Study|Site closing|1|||
163460053|NCT00006604|590382550|FG003|Overall Study|Site closing|1|||
163460054|NCT00006604|590382551|FG004|Overall Study|Site closing|0|||
163460055|NCT00006604|590382552|FG005|Overall Study|Site closing|0|||
163460056|NCT00006604|590382553|FG006|Overall Study|Site closing|0|||
163460057|NCT00006604|590382554|FG007|Overall Study|Site closing|1|||
163460058|NCT00006604|590382555|FG008|Overall Study|Site closing|0|||
163460059|NCT00006604|590382556|FG009|Overall Study|Site closing|0|||
163460060|NCT00006604|590382557|FG010|Overall Study|Site closing|0|||
163460061|NCT00006604|590382558|FG011|Overall Study|Site closing|1|||
163460062|NCT00006604|590382559|FG012|Overall Study|Site closing|1|||
163460063|NCT00006604|590382560|FG013|Overall Study|Site closing|1|||
163460064|NCT00006604|590382561|FG014|Overall Study|Site closing|0|||
163460065|NCT00006604|590382562|FG015|Overall Study|Site closing|0|||
163460066|NCT00006604|590382563|FG016|Overall Study|Site closing|1|||
163460067|NCT00006604|590382547|FG000|Overall Study|Withdrawal by Subject|1|||
163460068|NCT00006604|590382548|FG001|Overall Study|Withdrawal by Subject|0|||
163460069|NCT00006604|590382549|FG002|Overall Study|Withdrawal by Subject|2|||
163460070|NCT00006604|590382550|FG003|Overall Study|Withdrawal by Subject|0|||
163460071|NCT00006604|590382551|FG004|Overall Study|Withdrawal by Subject|1|||
163460072|NCT00006604|590382552|FG005|Overall Study|Withdrawal by Subject|2|||
163460073|NCT00006604|590382553|FG006|Overall Study|Withdrawal by Subject|2|||
163460074|NCT00006604|590382554|FG007|Overall Study|Withdrawal by Subject|0|||
163460075|NCT00006604|590382555|FG008|Overall Study|Withdrawal by Subject|1|||
163460076|NCT00006604|590382556|FG009|Overall Study|Withdrawal by Subject|3|||
163460077|NCT00006604|590382557|FG010|Overall Study|Withdrawal by Subject|2|||
163460078|NCT00006604|590382558|FG011|Overall Study|Withdrawal by Subject|0|||
163460079|NCT00006604|590382559|FG012|Overall Study|Withdrawal by Subject|1|||
163460080|NCT00006604|590382560|FG013|Overall Study|Withdrawal by Subject|2|||
163460081|NCT00006604|590382561|FG014|Overall Study|Withdrawal by Subject|1|||
163460082|NCT00006604|590382562|FG015|Overall Study|Withdrawal by Subject|0|||
163460083|NCT00006604|590382563|FG016|Overall Study|Withdrawal by Subject|1|||
163460084|NCT00006604|590382547|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
163460085|NCT00006604|590382548|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
163460086|NCT00006604|590382549|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
163460087|NCT00006604|590382550|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
163460088|NCT00006604|590382551|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
163460089|NCT00006604|590382552|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
163460090|NCT00006604|590382553|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
163460091|NCT00006604|590382554|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
163460092|NCT00006604|590382555|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
163460093|NCT00006604|590382556|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
163460094|NCT00006604|590382557|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
163460095|NCT00006604|590382558|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
163460096|NCT00006604|590382559|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
163460097|NCT00006604|590382560|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
163460098|NCT00006604|590382561|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
163460099|NCT00006604|590382562|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
163460100|NCT00006604|590382563|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
163460101|NCT00006604|590382547|FG000|Overall Study|Lost to Follow-up|0|||
163460102|NCT00006604|590382548|FG001|Overall Study|Lost to Follow-up|0|||
163460103|NCT00006604|590382549|FG002|Overall Study|Lost to Follow-up|0|||
163460104|NCT00006604|590382550|FG003|Overall Study|Lost to Follow-up|0|||
163460105|NCT00006604|590382551|FG004|Overall Study|Lost to Follow-up|0|||
163460106|NCT00006604|590382552|FG005|Overall Study|Lost to Follow-up|0|||
163460107|NCT00006604|590382553|FG006|Overall Study|Lost to Follow-up|0|||
163460108|NCT00006604|590382554|FG007|Overall Study|Lost to Follow-up|1|||
163460109|NCT00006604|590382555|FG008|Overall Study|Lost to Follow-up|0|||
163460110|NCT00006604|590382556|FG009|Overall Study|Lost to Follow-up|2|||
163460111|NCT00006604|590382557|FG010|Overall Study|Lost to Follow-up|0|||
163460112|NCT00006604|590382558|FG011|Overall Study|Lost to Follow-up|0|||
163460113|NCT00006604|590382559|FG012|Overall Study|Lost to Follow-up|0|||
163460114|NCT00006604|590382560|FG013|Overall Study|Lost to Follow-up|0|||
163460115|NCT00006604|590382561|FG014|Overall Study|Lost to Follow-up|0|||
163460116|NCT00006604|590382562|FG015|Overall Study|Lost to Follow-up|1|||
163460117|NCT00006604|590382563|FG016|Overall Study|Lost to Follow-up|3|||
163460118|NCT00006604|590382547|FG000|Overall Study|Other Reason|0|||
163460119|NCT00006604|590382548|FG001|Overall Study|Other Reason|0|||
163460120|NCT00006604|590382549|FG002|Overall Study|Other Reason|0|||
163460121|NCT00006604|590382550|FG003|Overall Study|Other Reason|0|||
163460122|NCT00006604|590382551|FG004|Overall Study|Other Reason|0|||
163460123|NCT00006604|590382552|FG005|Overall Study|Other Reason|1|||
163460124|NCT00006604|590382553|FG006|Overall Study|Other Reason|0|||
163460125|NCT00006604|590382554|FG007|Overall Study|Other Reason|0|||
163460126|NCT00006604|590382555|FG008|Overall Study|Other Reason|0|||
163460127|NCT00006604|590382556|FG009|Overall Study|Other Reason|1|||
163460128|NCT00006604|590382557|FG010|Overall Study|Other Reason|0|||
163460129|NCT00006604|590382558|FG011|Overall Study|Other Reason|0|||
163460130|NCT00006604|590382559|FG012|Overall Study|Other Reason|0|||
163460131|NCT00006604|590382560|FG013|Overall Study|Other Reason|0|||
163460132|NCT00006604|590382561|FG014|Overall Study|Other Reason|0|||
163460133|NCT00006604|590382562|FG015|Overall Study|Other Reason|0|||
163460134|NCT00006604|590382563|FG016|Overall Study|Other Reason|0|||
163460135|NCT01056341|590382564|FG000|Overall Study|Treatment Intolerance|0|||
163460136|NCT01056341|590382565|FG001|Overall Study|Treatment Intolerance|2|||
163460137|NCT01056341|590382566|FG002|Overall Study|Treatment Intolerance|0|||
163460138|NCT01056341|590382567|FG003|Overall Study|Treatment Intolerance|2|||
163460139|NCT01056341|590382568|FG004|Overall Study|Treatment Intolerance|0|||
163460140|NCT01056341|590382564|FG000|Overall Study|Lack of Efficacy|32|||
163460141|NCT01056341|590382565|FG001|Overall Study|Lack of Efficacy|30|||
163460142|NCT01056341|590382566|FG002|Overall Study|Lack of Efficacy|7|||
163460143|NCT01056341|590382567|FG003|Overall Study|Lack of Efficacy|25|||
163460144|NCT01056341|590382568|FG004|Overall Study|Lack of Efficacy|9|||
163460145|NCT01056341|590382564|FG000|Overall Study|Other reasons|4|||
163460146|NCT01056341|590382565|FG001|Overall Study|Other reasons|4|||
163460147|NCT01056341|590382566|FG002|Overall Study|Other reasons|8|||
163460148|NCT01056341|590382567|FG003|Overall Study|Other reasons|9|||
163460149|NCT01056341|590382568|FG004|Overall Study|Other reasons|5|||
163460150|NCT01361919|590382569|FG000|Overall Study|technical issues|10|||
163460151|NCT01361919|590382570|FG001|Overall Study|technical issues|12|||
163460152|NCT01361919|590382571|FG002|Overall Study|technical issues|10|||
163460153|NCT03454412|590382572|FG000|Baseline Assesment|Physician Decision|12|||
163460154|NCT01167582|590382575|FG000|Overall Study|Lost to Follow-up|0|||
163460155|NCT01167582|590382576|FG001|Overall Study|Lost to Follow-up|1|||
163460156|NCT03956225|590382577|FG000|Overall Study|Lack of Efficacy|1|||
163460157|NCT03956225|590382578|FG001|Overall Study|Lack of Efficacy|1|||
163460158|NCT03956225|590382577|FG000|Overall Study|Lost to Follow-up|0|||
163460159|NCT03956225|590382578|FG001|Overall Study|Lost to Follow-up|1|||
163460160|NCT03956225|590382577|FG000|Overall Study|Withdrawal by Subject|2|||
163460161|NCT03956225|590382578|FG001|Overall Study|Withdrawal by Subject|1|||
163460162|NCT03956225|590382577|FG000|Overall Study|Other Reasons|2|||
163460163|NCT03956225|590382578|FG001|Overall Study|Other Reasons|1|||
163460164|NCT00567541|590382579|FG000|Overall Study|Adverse Event|0|||
163460165|NCT00567541|590382580|FG001|Overall Study|Adverse Event|1|||
163460166|NCT01182337|590382583|FG000|Overall Study|Withdrawal by Subject|3|||
163460167|NCT01182337|590382584|FG001|Overall Study|Withdrawal by Subject|1|||
163460168|NCT01182337|590382583|FG000|Overall Study|Lost to Follow-up|0|||
163460169|NCT01182337|590382584|FG001|Overall Study|Lost to Follow-up|1|||
163460170|NCT02157506|590382585|FG000|Overall Study|Adverse Event|0|||
163460171|NCT02157506|590382586|FG001|Overall Study|Adverse Event|1|||
163460172|NCT02157506|590382587|FG002|Overall Study|Adverse Event|0|||
163460173|NCT02157506|590382588|FG003|Overall Study|Adverse Event|0|||
163460174|NCT02157506|590382589|FG004|Overall Study|Adverse Event|0|||
163460175|NCT02157506|590382585|FG000|Overall Study|Lost to Follow-up|0|||
163460176|NCT02157506|590382586|FG001|Overall Study|Lost to Follow-up|0|||
163460177|NCT02157506|590382587|FG002|Overall Study|Lost to Follow-up|1|||
163460178|NCT02157506|590382588|FG003|Overall Study|Lost to Follow-up|0|||
163460179|NCT02157506|590382589|FG004|Overall Study|Lost to Follow-up|0|||
163460180|NCT03498287|590382595|FG000|Overall Study|Withdrawal by Subject|3|||
163460181|NCT03498287|590382596|FG001|Overall Study|Withdrawal by Subject|0|||
163460182|NCT03498287|590382595|FG000|Overall Study|Protocol Violation|0|||
163460183|NCT03498287|590382596|FG001|Overall Study|Protocol Violation|4|||
163460184|NCT03498287|590382595|FG000|Overall Study|Adverse Event|0|||
163460185|NCT03498287|590382596|FG001|Overall Study|Adverse Event|1|||
163460186|NCT04169061|590382599|FG000|Overall Study|Adverse Event|2|||
163460187|NCT04169061|590382599|FG000|Overall Study|Death|1|||
163460188|NCT04169061|590382599|FG000|Overall Study|Withdrawal by Subject|1|||
163460189|NCT04169061|590382599|FG000|Overall Study|Protocol Violation|1|||
163460190|NCT01763866|590382600|FG000|Overall Study|Withdrawal by Subject|2|||
163460191|NCT01763866|590382601|FG001|Overall Study|Withdrawal by Subject|1|||
163460192|NCT01763866|590382602|FG002|Overall Study|Withdrawal by Subject|4|||
163460193|NCT01763866|590382603|FG003|Overall Study|Withdrawal by Subject|0|||
163460194|NCT01763866|590382604|FG004|Overall Study|Withdrawal by Subject|0|||
163460195|NCT01763866|590382605|FG005|Overall Study|Withdrawal by Subject|3|||
163460196|NCT01763866|590382606|FG006|Overall Study|Withdrawal by Subject|4|||
163460197|NCT01763866|590382607|FG007|Overall Study|Withdrawal by Subject|0|||
163460198|NCT01763866|590382608|FG008|Overall Study|Withdrawal by Subject|1|||
163460199|NCT01763866|590382609|FG009|Overall Study|Withdrawal by Subject|1|||
163460200|NCT01763866|590382610|FG010|Overall Study|Withdrawal by Subject|2|||
163460201|NCT01763866|590382611|FG011|Overall Study|Withdrawal by Subject|2|||
163460202|NCT01763866|590382612|FG012|Overall Study|Withdrawal by Subject|2|||
163460203|NCT01763866|590382613|FG013|Overall Study|Withdrawal by Subject|0|||
163460204|NCT01763866|590382614|FG014|Overall Study|Withdrawal by Subject|6|||
163460205|NCT01763866|590382615|FG015|Overall Study|Withdrawal by Subject|3|||
163460206|NCT01763866|590382616|FG016|Overall Study|Withdrawal by Subject|0|||
163460207|NCT01763866|590382617|FG017|Overall Study|Withdrawal by Subject|1|||
163460208|NCT01763866|590382618|FG018|Overall Study|Withdrawal by Subject|1|||
163460209|NCT01763866|590382619|FG019|Overall Study|Withdrawal by Subject|1|||
163460210|NCT01763866|590382620|FG020|Overall Study|Withdrawal by Subject|2|||
163460211|NCT01763866|590382621|FG021|Overall Study|Withdrawal by Subject|1|||
163460212|NCT01763866|590382622|FG022|Overall Study|Withdrawal by Subject|2|||
163460213|NCT01763866|590382623|FG023|Overall Study|Withdrawal by Subject|1|||
163460214|NCT01763866|590382600|FG000|Overall Study|Decision by sponsor|0|||
163460215|NCT01763866|590382601|FG001|Overall Study|Decision by sponsor|0|||
163460216|NCT01763866|590382602|FG002|Overall Study|Decision by sponsor|1|||
163460217|NCT01763866|590382603|FG003|Overall Study|Decision by sponsor|0|||
163460218|NCT01763866|590382604|FG004|Overall Study|Decision by sponsor|2|||
163460219|NCT01763866|590382605|FG005|Overall Study|Decision by sponsor|0|||
163460220|NCT01763866|590382606|FG006|Overall Study|Decision by sponsor|2|||
163460221|NCT01763866|590382607|FG007|Overall Study|Decision by sponsor|0|||
163460222|NCT01763866|590382608|FG008|Overall Study|Decision by sponsor|2|||
163460223|NCT01763866|590382609|FG009|Overall Study|Decision by sponsor|0|||
163460224|NCT01763866|590382610|FG010|Overall Study|Decision by sponsor|6|||
163460225|NCT01763866|590382611|FG011|Overall Study|Decision by sponsor|0|||
163460226|NCT01763866|590382612|FG012|Overall Study|Decision by sponsor|1|||
163460227|NCT01763866|590382613|FG013|Overall Study|Decision by sponsor|0|||
163460228|NCT01763866|590382614|FG014|Overall Study|Decision by sponsor|5|||
163460229|NCT01763866|590382615|FG015|Overall Study|Decision by sponsor|0|||
163460230|NCT01763866|590382616|FG016|Overall Study|Decision by sponsor|0|||
163460231|NCT01763866|590382617|FG017|Overall Study|Decision by sponsor|0|||
163460232|NCT01763866|590382618|FG018|Overall Study|Decision by sponsor|4|||
163460233|NCT01763866|590382619|FG019|Overall Study|Decision by sponsor|0|||
163460234|NCT01763866|590382620|FG020|Overall Study|Decision by sponsor|2|||
163460235|NCT01763866|590382621|FG021|Overall Study|Decision by sponsor|0|||
163460236|NCT01763866|590382622|FG022|Overall Study|Decision by sponsor|1|||
163460237|NCT01763866|590382623|FG023|Overall Study|Decision by sponsor|0|||
163460238|NCT01763866|590382600|FG000|Overall Study|Lost to Follow-up|0|||
163460239|NCT01763866|590382601|FG001|Overall Study|Lost to Follow-up|0|||
163460240|NCT01763866|590382602|FG002|Overall Study|Lost to Follow-up|0|||
163460241|NCT01763866|590382603|FG003|Overall Study|Lost to Follow-up|0|||
163460242|NCT01763866|590382604|FG004|Overall Study|Lost to Follow-up|0|||
163460243|NCT01763866|590382605|FG005|Overall Study|Lost to Follow-up|0|||
163460244|NCT01763866|590382606|FG006|Overall Study|Lost to Follow-up|1|||
163460245|NCT01763866|590382607|FG007|Overall Study|Lost to Follow-up|0|||
163460246|NCT01763866|590382608|FG008|Overall Study|Lost to Follow-up|0|||
163460247|NCT01763866|590382609|FG009|Overall Study|Lost to Follow-up|0|||
163460248|NCT01763866|590382610|FG010|Overall Study|Lost to Follow-up|0|||
163460249|NCT01763866|590382611|FG011|Overall Study|Lost to Follow-up|0|||
163460250|NCT01763866|590382612|FG012|Overall Study|Lost to Follow-up|1|||
163460251|NCT01763866|590382613|FG013|Overall Study|Lost to Follow-up|0|||
163460252|NCT01763866|590382614|FG014|Overall Study|Lost to Follow-up|1|||
163460253|NCT01763866|590382615|FG015|Overall Study|Lost to Follow-up|0|||
163460254|NCT01763866|590382616|FG016|Overall Study|Lost to Follow-up|0|||
163460255|NCT01763866|590382617|FG017|Overall Study|Lost to Follow-up|0|||
163460256|NCT01763866|590382618|FG018|Overall Study|Lost to Follow-up|1|||
163460257|NCT01763866|590382619|FG019|Overall Study|Lost to Follow-up|1|||
163460258|NCT01763866|590382620|FG020|Overall Study|Lost to Follow-up|0|||
163460259|NCT01763866|590382621|FG021|Overall Study|Lost to Follow-up|0|||
163460260|NCT01763866|590382622|FG022|Overall Study|Lost to Follow-up|0|||
163460261|NCT01763866|590382623|FG023|Overall Study|Lost to Follow-up|1|||
163460262|NCT01763866|590382600|FG000|Overall Study|Death|0|||
163460263|NCT01763866|590382601|FG001|Overall Study|Death|0|||
163460264|NCT01763866|590382602|FG002|Overall Study|Death|0|||
163460265|NCT01763866|590382603|FG003|Overall Study|Death|0|||
163460266|NCT01763866|590382604|FG004|Overall Study|Death|0|||
163460267|NCT01763866|590382605|FG005|Overall Study|Death|0|||
163460268|NCT01763866|590382606|FG006|Overall Study|Death|0|||
163460269|NCT01763866|590382607|FG007|Overall Study|Death|0|||
163460270|NCT01763866|590382608|FG008|Overall Study|Death|0|||
163460271|NCT01763866|590382609|FG009|Overall Study|Death|0|||
163460272|NCT01763866|590382610|FG010|Overall Study|Death|0|||
163460273|NCT01763866|590382611|FG011|Overall Study|Death|0|||
163460274|NCT01763866|590382612|FG012|Overall Study|Death|0|||
163460275|NCT01763866|590382613|FG013|Overall Study|Death|0|||
163460276|NCT01763866|590382614|FG014|Overall Study|Death|0|||
163460277|NCT01763866|590382615|FG015|Overall Study|Death|0|||
163460278|NCT01763866|590382616|FG016|Overall Study|Death|1|||
163460279|NCT01763866|590382617|FG017|Overall Study|Death|0|||
163460280|NCT01763866|590382618|FG018|Overall Study|Death|0|||
163460281|NCT01763866|590382619|FG019|Overall Study|Death|0|||
163460282|NCT01763866|590382620|FG020|Overall Study|Death|0|||
163460283|NCT01763866|590382621|FG021|Overall Study|Death|0|||
163460284|NCT01763866|590382622|FG022|Overall Study|Death|0|||
163460285|NCT01763866|590382623|FG023|Overall Study|Death|0|||
163460286|NCT02939599|590382628|FG000|Overall Study|Adverse Event|1|||
163460287|NCT02939599|590382629|FG001|Overall Study|Adverse Event|0|||
163460288|NCT02939599|590382628|FG000|Overall Study|Study Terminated By Sponsor|2|||
163460289|NCT02939599|590382629|FG001|Overall Study|Study Terminated By Sponsor|2|||
163460290|NCT01669811|590382630|FG000|Overall Study|Investigator decision|0|||
163460291|NCT01669811|590382631|FG001|Overall Study|Investigator decision|1|||
163460292|NCT01669811|590382630|FG000|Overall Study|Withdrawal by Subject|1|||
163460293|NCT01669811|590382631|FG001|Overall Study|Withdrawal by Subject|2|||
163460294|NCT01669811|590382630|FG000|Overall Study|Adverse Event|2|||
163460295|NCT01669811|590382631|FG001|Overall Study|Adverse Event|6|||
163460296|NCT01669811|590382630|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
163460297|NCT01669811|590382631|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
163460298|NCT03288493|590382636|FG000|Overall Study|Withdrawal by Subject|4|||
163460299|NCT03288493|590382637|FG001|Overall Study|Withdrawal by Subject|0|||
163460300|NCT03288493|590382638|FG002|Overall Study|Withdrawal by Subject|0|||
163460301|NCT03288493|590382639|FG003|Overall Study|Withdrawal by Subject|0|||
163460302|NCT03288493|590382640|FG004|Overall Study|Withdrawal by Subject|0|||
163460303|NCT03288493|590382641|FG005|Overall Study|Withdrawal by Subject|2|||
163460304|NCT03288493|590382642|FG006|Overall Study|Withdrawal by Subject|0|||
163460305|NCT03288493|590382636|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
163460306|NCT03288493|590382637|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
163460307|NCT03288493|590382638|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
163460308|NCT03288493|590382639|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
163460309|NCT03288493|590382640|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
163460310|NCT03288493|590382641|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
163460311|NCT03288493|590382642|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
163460312|NCT03288493|590382636|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
163460313|NCT03288493|590382637|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
163460314|NCT03288493|590382638|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
163460315|NCT03288493|590382639|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
163460316|NCT03288493|590382640|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
163460317|NCT03288493|590382641|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
163460318|NCT03288493|590382642|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
163460319|NCT03288493|590382636|FG000|Overall Study|Death|2|||
163460320|NCT03288493|590382637|FG001|Overall Study|Death|0|||
163460321|NCT03288493|590382638|FG002|Overall Study|Death|0|||
163460322|NCT03288493|590382639|FG003|Overall Study|Death|0|||
163460323|NCT03288493|590382640|FG004|Overall Study|Death|0|||
163460324|NCT03288493|590382641|FG005|Overall Study|Death|0|||
163460325|NCT03288493|590382642|FG006|Overall Study|Death|0|||
163460326|NCT03288493|590382636|FG000|Overall Study|other reason not listed above|2|||
163460327|NCT03288493|590382637|FG001|Overall Study|other reason not listed above|0|||
163460328|NCT03288493|590382638|FG002|Overall Study|other reason not listed above|0|||
163460329|NCT03288493|590382639|FG003|Overall Study|other reason not listed above|0|||
163460330|NCT03288493|590382640|FG004|Overall Study|other reason not listed above|0|||
163460331|NCT03288493|590382641|FG005|Overall Study|other reason not listed above|0|||
163460332|NCT03288493|590382642|FG006|Overall Study|other reason not listed above|0|||
163460333|NCT00093470|590384434|FG000|Overall Study|Disease progression|39|||
163460334|NCT00093470|590384435|FG001|Overall Study|Disease progression|0|||
163460335|NCT00093470|590384434|FG000|Overall Study|Adverse Event|15|||
163460336|NCT00093470|590384435|FG001|Overall Study|Adverse Event|0|||
163460337|NCT00093470|590384434|FG000|Overall Study|Death|2|||
163460338|NCT00093470|590384435|FG001|Overall Study|Death|0|||
163460339|NCT00093470|590384434|FG000|Overall Study|Withdrawal by Subject|8|||
163460340|NCT00093470|590384435|FG001|Overall Study|Withdrawal by Subject|0|||
163460341|NCT00093470|590384434|FG000|Overall Study|Alternative therapy|2|||
163460342|NCT00093470|590384435|FG001|Overall Study|Alternative therapy|0|||
163460343|NCT00093470|590384434|FG000|Overall Study|Other complicating disease|3|||
163460344|NCT00093470|590384435|FG001|Overall Study|Other complicating disease|0|||
163460345|NCT00093470|590384434|FG000|Overall Study|Physician Decision|2|||
163460346|NCT00093470|590384435|FG001|Overall Study|Physician Decision|0|||
163460347|NCT00093470|590384434|FG000|Overall Study|Never started treatment|1|||
163460348|NCT00093470|590384435|FG001|Overall Study|Never started treatment|0|||
163460349|NCT00093470|590384434|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
163460350|NCT00093470|590384435|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
163460351|NCT01019252|590384436|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
163460352|NCT01019252|590384437|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
163460353|NCT01019252|590384436|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
163460354|NCT01019252|590384437|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
163460355|NCT01019252|590384436|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
163460356|NCT01019252|590384437|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
163460357|NCT01019252|590384436|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
163460358|NCT01019252|590384437|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
163460359|NCT02514772|590384438|FG000|Overall Study|Adverse Event|1|||
163460360|NCT02514772|590384439|FG001|Overall Study|Adverse Event|0|||
163460361|NCT02514772|590384438|FG000|Overall Study|Death|0|||
163460362|NCT02514772|590384439|FG001|Overall Study|Death|1|||
163460363|NCT02514772|590384438|FG000|Overall Study|Withdrawal by Subject|2|||
163460364|NCT02514772|590384439|FG001|Overall Study|Withdrawal by Subject|1|||
163460365|NCT00877006|590384440|FG000|Treatment Period|Death|2|||
163460366|NCT00877006|590384441|FG001|Treatment Period|Death|1|||
163460367|NCT00877006|590384440|FG000|Treatment Period|Adverse Event|10|||
163460368|NCT00877006|590384441|FG001|Treatment Period|Adverse Event|3|||
163460369|NCT00877006|590384440|FG000|Treatment Period|Withdrawal by Subject|2|||
163460370|NCT00877006|590384441|FG001|Treatment Period|Withdrawal by Subject|3|||
163460371|NCT00877006|590384440|FG000|Treatment Period|Protocol Violation|1|||
163460372|NCT00877006|590384441|FG001|Treatment Period|Protocol Violation|0|||
163460373|NCT00877006|590384440|FG000|Treatment Period|Lost to Follow-up|0|||
163460374|NCT00877006|590384441|FG001|Treatment Period|Lost to Follow-up|1|||
163460375|NCT00877006|590384440|FG000|Treatment Period|Disease Progression|1|||
163460376|NCT00877006|590384441|FG001|Treatment Period|Disease Progression|2|||
163460377|NCT00877006|590384440|FG000|Treatment Period|Started New Treatment Regimen|2|||
163460378|NCT00877006|590384441|FG001|Treatment Period|Started New Treatment Regimen|5|||
163460379|NCT00877006|590384440|FG000|Treatment Period|Other|4|||
163460380|NCT00877006|590384441|FG001|Treatment Period|Other|4|||
163460381|NCT00877006|590384440|FG000|Treatment Period|Randomized but Not Treated|3|||
163460382|NCT00877006|590384441|FG001|Treatment Period|Randomized but Not Treated|8|||
163460383|NCT00877006|590384440|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
163460384|NCT00877006|590384441|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
163460385|NCT00877006|590384440|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
163460386|NCT00877006|590384441|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
163460387|NCT00877006|590384440|FG000|Long-Term Follow-up Period|Death|26|||
163460388|NCT00877006|590384441|FG001|Long-Term Follow-up Period|Death|18|||
163460389|NCT00877006|590384440|FG000|Long-Term Follow-up Period|Other|7|||
163460390|NCT00877006|590384441|FG001|Long-Term Follow-up Period|Other|9|||
163460391|NCT04671342|590384442|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
163460392|NCT04671342|590384442|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
163460393|NCT04671342|590384442|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
163460394|NCT04671342|590384442|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
163460395|NCT04671342|590384442|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
163460396|NCT04671342|590384442|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
163460397|NCT03583606|590384443|FG000|Overall Study|Lost to Follow-up|0|||
163460398|NCT03583606|590384444|FG001|Overall Study|Lost to Follow-up|1|||
163460399|NCT03583606|590384445|FG002|Overall Study|Lost to Follow-up|0|||
163460400|NCT03583606|590384443|FG000|Overall Study|Ineligible at baseline|1|||
163460401|NCT03583606|590384444|FG001|Overall Study|Ineligible at baseline|0|||
163460402|NCT03583606|590384445|FG002|Overall Study|Ineligible at baseline|0|||
163460403|NCT00817206|590384446|FG000|Overall Study|Adverse Event|10|||
163460404|NCT00817206|590384447|FG001|Overall Study|Adverse Event|3|||
163460405|NCT00817206|590384446|FG000|Overall Study|Protocol Violation|0|||
163460406|NCT00817206|590384447|FG001|Overall Study|Protocol Violation|2|||
163460407|NCT00817206|590384446|FG000|Overall Study|Lost to Follow-up|0|||
163460408|NCT00817206|590384447|FG001|Overall Study|Lost to Follow-up|1|||
163460409|NCT00817206|590384446|FG000|Overall Study|Death|2|||
163460410|NCT00817206|590384447|FG001|Overall Study|Death|0|||
163460411|NCT00817206|590384446|FG000|Overall Study|Withdrawal by Subject|7|||
163460412|NCT00817206|590384447|FG001|Overall Study|Withdrawal by Subject|3|||
163460413|NCT00817206|590384446|FG000|Overall Study|Physician Decision|2|||
163460414|NCT00817206|590384447|FG001|Overall Study|Physician Decision|0|||
163460415|NCT00126581|590384448|FG000|Overall Study|Adverse Event|3|||
163460416|NCT00126581|590384449|FG001|Overall Study|Adverse Event|7|||
163460417|NCT00126581|590384448|FG000|Overall Study|Death|3|||
163460418|NCT00126581|590384449|FG001|Overall Study|Death|2|||
163460419|NCT00126581|590384448|FG000|Overall Study|Withdrawal by Subject|1|||
163460420|NCT00126581|590384449|FG001|Overall Study|Withdrawal by Subject|4|||
163460421|NCT00126581|590384448|FG000|Overall Study|Alternative therapy|3|||
163460422|NCT00126581|590384449|FG001|Overall Study|Alternative therapy|3|||
163460423|NCT00126581|590384448|FG000|Overall Study|Other illness/MD discretion|3|||
163460424|NCT00126581|590384449|FG001|Overall Study|Other illness/MD discretion|4|||
163460425|NCT00793182|590384450|FG000|Overall Study|Adverse Event|0|||
163460426|NCT00793182|590384451|FG001|Overall Study|Adverse Event|1|||
163460427|NCT03728140|590384452|FG000|Overall Study|Abnormal embryo transfer operation|10|||
163460428|NCT03728140|590384453|FG001|Overall Study|Abnormal embryo transfer operation|7|||
163460429|NCT02273037|590384455|FG000|Overall Study|Lost to Follow-up|1|||
163460430|NCT02273037|590384456|FG001|Overall Study|Lost to Follow-up|0|||
163460431|NCT02273037|590384455|FG000|Overall Study|Delivered before monitoring initiated|1|||
163460432|NCT02273037|590384456|FG001|Overall Study|Delivered before monitoring initiated|3|||
163460433|NCT02273037|590384455|FG000|Overall Study|Breech delivery|2|||
163460434|NCT02273037|590384456|FG001|Overall Study|Breech delivery|3|||
163460435|NCT02273037|590384455|FG000|Overall Study|Multiple delivery|2|||
163460436|NCT02273037|590384456|FG001|Overall Study|Multiple delivery|2|||
163460437|NCT02273037|590384455|FG000|Overall Study|Other complication|2|||
163460438|NCT02273037|590384456|FG001|Overall Study|Other complication|0|||
163460439|NCT00851253|590384457|FG000|Overall Study|Disease Progression|1|||
163460440|NCT00851253|590384458|FG001|Overall Study|Disease Progression|0|||
163460441|NCT03657810|590384463|FG000|Overall Study|Adverse Event|0|||
163460442|NCT03657810|590384464|FG001|Overall Study|Adverse Event|1|||
163460443|NCT03657810|590384465|FG002|Overall Study|Adverse Event|0|||
163460444|NCT03657810|590384463|FG000|Overall Study|Lack of Efficacy|4|||
163460445|NCT03657810|590384464|FG001|Overall Study|Lack of Efficacy|1|||
163460446|NCT03657810|590384465|FG002|Overall Study|Lack of Efficacy|3|||
163460447|NCT03657810|590384463|FG000|Overall Study|Protocol Violation|1|||
163460448|NCT03657810|590384464|FG001|Overall Study|Protocol Violation|0|||
163460449|NCT03657810|590384465|FG002|Overall Study|Protocol Violation|0|||
163460450|NCT03657810|590384463|FG000|Overall Study|Lost to Follow-up|0|||
163460451|NCT03657810|590384464|FG001|Overall Study|Lost to Follow-up|1|||
163460452|NCT03657810|590384465|FG002|Overall Study|Lost to Follow-up|0|||
163460453|NCT03657810|590384463|FG000|Overall Study|Not provided|0|||
163460454|NCT03657810|590384464|FG001|Overall Study|Not provided|1|||
163460455|NCT03657810|590384465|FG002|Overall Study|Not provided|0|||
163460456|NCT00291499|590384471|FG000|Overall Study|Adverse Event|3|||
163460457|NCT00291499|590384472|FG001|Overall Study|Adverse Event|8|||
163460458|NCT00291499|590384471|FG000|Overall Study|Change to other therapy|2|||
163460459|NCT00291499|590384472|FG001|Overall Study|Change to other therapy|1|||
163460460|NCT00291499|590384471|FG000|Overall Study|Intercurrent illness|1|||
163460461|NCT00291499|590384472|FG001|Overall Study|Intercurrent illness|0|||
163460462|NCT00291499|590384471|FG000|Overall Study|Protocol Violation|2|||
163460463|NCT00291499|590384472|FG001|Overall Study|Protocol Violation|2|||
163460464|NCT00291499|590384471|FG000|Overall Study|Other reasons|1|||
163460465|NCT00291499|590384472|FG001|Overall Study|Other reasons|4|||
163460466|NCT01457924|590384473|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
163460467|NCT01457924|590384474|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
163460468|NCT01457924|590384475|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
163460469|NCT01457924|590384476|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
163460470|NCT01457924|590384477|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
163460471|NCT01457924|590384473|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
163460472|NCT01457924|590384474|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
163460473|NCT01457924|590384475|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
163460474|NCT01457924|590384476|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
163460475|NCT01457924|590384477|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
163460476|NCT01457924|590384473|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
163460477|NCT01457924|590384474|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
163460478|NCT01457924|590384475|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
163460479|NCT01457924|590384476|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
163460480|NCT01457924|590384477|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
163460481|NCT01457924|590384473|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
163460482|NCT01457924|590384474|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
163460483|NCT01457924|590384475|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
163460484|NCT01457924|590384476|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
163460485|NCT01457924|590384477|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
163460486|NCT01457924|590384473|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
163460487|NCT01457924|590384474|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
163460488|NCT01457924|590384475|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
163460489|NCT01457924|590384476|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
163460490|NCT01457924|590384477|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
163460491|NCT01457924|590384473|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
163460492|NCT01457924|590384474|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
163460493|NCT01457924|590384475|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
163460494|NCT01457924|590384476|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
163460495|NCT01457924|590384477|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
163460496|NCT01457924|590384473|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
163460497|NCT01457924|590384474|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
163460498|NCT01457924|590384475|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
163460499|NCT01457924|590384476|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
163460500|NCT01457924|590384477|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
163460501|NCT01457924|590384473|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
163460502|NCT01457924|590384474|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
163460503|NCT01457924|590384475|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
163460504|NCT01457924|590384476|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
163460505|NCT01457924|590384477|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
163460506|NCT01457924|590384473|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
163460507|NCT01457924|590384474|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
163460508|NCT01457924|590384475|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
163460509|NCT01457924|590384476|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
163460510|NCT01457924|590384477|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
163460511|NCT01457924|590384473|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
163460512|NCT01457924|590384474|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
163460513|NCT01457924|590384475|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
163460514|NCT01457924|590384476|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
163460515|NCT01457924|590384477|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
163460516|NCT01457924|590384473|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
163460517|NCT01457924|590384474|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
163460518|NCT01457924|590384475|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
163460519|NCT01457924|590384476|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
163460520|NCT01457924|590384477|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
163460521|NCT01457924|590384473|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
163460522|NCT01457924|590384474|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
163460523|NCT01457924|590384475|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
163460524|NCT01457924|590384476|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
163460525|NCT01457924|590384477|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
163460526|NCT01457924|590384473|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
163460527|NCT01457924|590384474|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
163460528|NCT01457924|590384475|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
163460529|NCT01457924|590384476|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
163460530|NCT01457924|590384477|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
163460531|NCT00936117|590384479|FG000|Overall Study|Adverse Event|7|||
163460532|NCT00936117|590384479|FG000|Overall Study|Unable to continue oral medication|3|||
163460533|NCT04581863|590384480|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
163460534|NCT04581863|590384481|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
163460535|NCT00225212|590384490|FG000|Overall Study|Disease progression|2|||
163460536|NCT00225212|590384490|FG000|Overall Study|Death|1|||
163460537|NCT00225212|590384490|FG000|Overall Study|Adverse Event|2|||
163460538|NCT00225212|590384490|FG000|Overall Study|Intercurrent illness|1|||
163460539|NCT00416312|590384491|FG000|Overall Study|tumors not visible on imaging|2|||
163460540|NCT00574496|590384494|FG000|Overall Study|Withdrawal by Subject|1|||
163460541|NCT01969799|590384495|FG000|Overall Study|Adverse Event|0|||
163460542|NCT01969799|590384496|FG001|Overall Study|Adverse Event|1|||
163460543|NCT01969799|590384495|FG000|Overall Study|Death|16|||
163460544|NCT01969799|590384496|FG001|Overall Study|Death|11|||
163460545|NCT01969799|590384495|FG000|Overall Study|Lost to Follow-up|0|||
163460546|NCT01969799|590384496|FG001|Overall Study|Lost to Follow-up|2|||
163460547|NCT01969799|590384495|FG000|Overall Study|Physician Decision|1|||
163460548|NCT01969799|590384496|FG001|Overall Study|Physician Decision|0|||
163460549|NCT02227108|590384499|FG000|Overall Study|Did not receive treatment|2|||
163460550|NCT02227108|590384499|FG000|Overall Study|Other|3|||
163460551|NCT02227108|590384499|FG000|Overall Study|Progressive disease|17|||
163460552|NCT02227108|590384499|FG000|Overall Study|Initiation of alternative therapy|2|||
163460553|NCT02227108|590384499|FG000|Overall Study|Investigator discretion|1|||
163460554|NCT02227108|590384499|FG000|Overall Study|Adverse Event|6|||
163460555|NCT02486952|590384500|FG000|Overall Study|Not Started Induction Therapy|3|||
163460556|NCT02486952|590384500|FG000|Overall Study|Adverse Event|1|||
163460557|NCT02486952|590384500|FG000|Overall Study|Death|15|||
163460558|NCT02486952|590384500|FG000|Overall Study|Lack of Efficacy|3|||
163460559|NCT02486952|590384500|FG000|Overall Study|Lost to Follow-up|26|||
163460560|NCT02486952|590384500|FG000|Overall Study|Other|2|||
163460561|NCT01928485|590384501|FG000|Overall Study|Physician Decision|0|||
163460562|NCT01928485|590384502|FG001|Overall Study|Physician Decision|1|||
163460563|NCT03589885|590384503|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
163460564|NCT03589885|590384504|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
163460565|NCT03589885|590384505|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
163460566|NCT03589885|590384506|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
163460567|NCT03589885|590384507|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
163460568|NCT03589885|590384503|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
163460569|NCT03589885|590384504|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
163460570|NCT03589885|590384505|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
163460571|NCT03589885|590384506|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
163460572|NCT03589885|590384507|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
163460573|NCT03589885|590384503|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
163460574|NCT03589885|590384504|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
163460575|NCT03589885|590384505|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
163460576|NCT03589885|590384506|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
163460577|NCT03589885|590384507|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
163460578|NCT03589885|590384503|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
163460579|NCT03589885|590384504|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
163460580|NCT03589885|590384505|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
163460581|NCT03589885|590384506|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
163460582|NCT03589885|590384507|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
163460583|NCT03589885|590384503|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
163460584|NCT03589885|590384504|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
163460585|NCT03589885|590384505|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
163460586|NCT03589885|590384506|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
163460587|NCT03589885|590384507|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
163460588|NCT03589885|590384503|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
163460589|NCT03589885|590384504|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
163460590|NCT03589885|590384505|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
163460591|NCT03589885|590384506|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
163460592|NCT03589885|590384507|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
163460593|NCT03589885|590384503|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
163460594|NCT03589885|590384504|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
163460595|NCT03589885|590384505|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
163460596|NCT03589885|590384506|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
163460597|NCT03589885|590384507|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
163460598|NCT03589885|590384503|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
163460599|NCT03589885|590384504|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
163460600|NCT03589885|590384505|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
163460601|NCT03589885|590384506|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
163460602|NCT03589885|590384507|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
163460603|NCT04111107|590384508|FG000|Overall Study|Withdrawal by Subject|6|||
163460604|NCT04111107|590384508|FG000|Overall Study|Declining Health|5|||
163460605|NCT00039741|590384511|FG000|Overall Study|Death|0|||
163460606|NCT00039741|590384512|FG001|Overall Study|Death|1|||
163460607|NCT00039741|590384513|FG002|Overall Study|Death|0|||
163460608|NCT00039741|590384514|FG003|Overall Study|Death|0|||
163460609|NCT00039741|590384511|FG000|Overall Study|Lost to Follow-up|3|||
163460610|NCT00039741|590384512|FG001|Overall Study|Lost to Follow-up|1|||
163460611|NCT00039741|590384513|FG002|Overall Study|Lost to Follow-up|5|||
163460612|NCT00039741|590384514|FG003|Overall Study|Lost to Follow-up|2|||
163460613|NCT00039741|590384511|FG000|Overall Study|Confounding medical condition|1|||
163460614|NCT00039741|590384512|FG001|Overall Study|Confounding medical condition|0|||
163460615|NCT00039741|590384513|FG002|Overall Study|Confounding medical condition|0|||
163460616|NCT00039741|590384514|FG003|Overall Study|Confounding medical condition|0|||
163460617|NCT00039741|590384511|FG000|Overall Study|Not able to get to clinic|5|||
163460618|NCT00039741|590384512|FG001|Overall Study|Not able to get to clinic|2|||
163460619|NCT00039741|590384513|FG002|Overall Study|Not able to get to clinic|0|||
163460620|NCT00039741|590384514|FG003|Overall Study|Not able to get to clinic|3|||
163460621|NCT00039741|590384511|FG000|Overall Study|Moved|3|||
163460622|NCT00039741|590384512|FG001|Overall Study|Moved|2|||
163460623|NCT00039741|590384513|FG002|Overall Study|Moved|3|||
163460624|NCT00039741|590384514|FG003|Overall Study|Moved|6|||
163460625|NCT00039741|590384511|FG000|Overall Study|Non-compliance with protocol|1|||
163460626|NCT00039741|590384512|FG001|Overall Study|Non-compliance with protocol|0|||
163460627|NCT00039741|590384513|FG002|Overall Study|Non-compliance with protocol|1|||
163460628|NCT00039741|590384514|FG003|Overall Study|Non-compliance with protocol|0|||
163460629|NCT00039741|590384511|FG000|Overall Study|Withdrew consent|0|||
163460630|NCT00039741|590384512|FG001|Overall Study|Withdrew consent|5|||
163460631|NCT00039741|590384513|FG002|Overall Study|Withdrew consent|0|||
163460632|NCT00039741|590384514|FG003|Overall Study|Withdrew consent|1|||
163460633|NCT00039741|590384511|FG000|Overall Study|Missed final visit|2|||
163460634|NCT00039741|590384512|FG001|Overall Study|Missed final visit|1|||
163460635|NCT00039741|590384513|FG002|Overall Study|Missed final visit|2|||
163460636|NCT00039741|590384514|FG003|Overall Study|Missed final visit|2|||
163460637|NCT00946881|590384515|FG000|First Treatment|Withdrawal by Subject|1|||
163460638|NCT00946881|590384515|FG000|First Treatment|Patient relocated to another state|1|||
163460639|NCT00946881|590384515|FG000|Retreatment|Withdrawal by Subject|1|||
163460640|NCT00293423|590384516|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
163460641|NCT00293423|590384517|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
163460642|NCT00293423|590384516|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
163460643|NCT00293423|590384517|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
163460644|NCT00293423|590384516|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
163460645|NCT00293423|590384517|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
163460646|NCT00293423|590384516|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
163460647|NCT00293423|590384517|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
163460648|NCT00293423|590384516|FG000|Surgical Resection|processing error during surgical resection|1|||
163460649|NCT00293423|590384517|FG001|Surgical Resection|processing error during surgical resection|0|||
163460650|NCT00293423|590384516|FG000|Surgical Resection|Withdrawal by Subject|4|||
163460651|NCT00293423|590384517|FG001|Surgical Resection|Withdrawal by Subject|0|||
163460652|NCT00293423|590384516|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
163460653|NCT00293423|590384517|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
163460654|NCT03571256|590384522|FG000|Overall Study|Adverse Event|3|||
163460655|NCT03571256|590384523|FG001|Overall Study|Adverse Event|0|||
163460656|NCT03571256|590384524|FG002|Overall Study|Adverse Event|1|||
163460657|NCT03571256|590384522|FG000|Overall Study|Withdrawal by Subject|3|||
163460658|NCT03571256|590384523|FG001|Overall Study|Withdrawal by Subject|1|||
163460659|NCT03571256|590384524|FG002|Overall Study|Withdrawal by Subject|1|||
163460660|NCT03571256|590384522|FG000|Overall Study|Other than specified|0|||
163460661|NCT03571256|590384523|FG001|Overall Study|Other than specified|1|||
163460662|NCT03571256|590384524|FG002|Overall Study|Other than specified|1|||
163460663|NCT03571256|590384522|FG000|Overall Study|Protocol Violation|0|||
163460664|NCT03571256|590384523|FG001|Overall Study|Protocol Violation|1|||
163460665|NCT03571256|590384524|FG002|Overall Study|Protocol Violation|1|||
163460666|NCT02270684|590384525|FG000|Overall Study|Lost to Follow-up|0|||
163460667|NCT02270684|590384526|FG001|Overall Study|Lost to Follow-up|3|||
163460668|NCT02270684|590384525|FG000|Overall Study|Study terminated|1|||
163460669|NCT02270684|590384526|FG001|Overall Study|Study terminated|0|||
163460670|NCT02247401|590384527|FG000|Overall Study|Adverse Event|1|||
163460671|NCT02247401|590384528|FG001|Overall Study|Adverse Event|0|||
163460672|NCT02247401|590384529|FG002|Overall Study|Adverse Event|0|||
163460673|NCT02247401|590384527|FG000|Overall Study|Withdrawal by Subject|4|||
163460674|NCT02247401|590384528|FG001|Overall Study|Withdrawal by Subject|1|||
163460675|NCT02247401|590384529|FG002|Overall Study|Withdrawal by Subject|1|||
163460676|NCT02247401|590384527|FG000|Overall Study|Lost to Follow-up|1|||
163460677|NCT02247401|590384528|FG001|Overall Study|Lost to Follow-up|1|||
163460678|NCT02247401|590384529|FG002|Overall Study|Lost to Follow-up|1|||
163460679|NCT02807363|590384530|FG000|Dosing Period|Adverse Event|0|||
163460680|NCT02807363|590384531|FG001|Dosing Period|Adverse Event|1|||
163460681|NCT02807363|590384532|FG002|Dosing Period|Adverse Event|0|||
163460682|NCT02807363|590384533|FG003|Dosing Period|Adverse Event|0|||
163460683|NCT02188719|590384535|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
163460684|NCT02188719|590384536|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
163460685|NCT02188719|590384537|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
163460686|NCT02188719|590384538|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
163460687|NCT00192036|590384539|FG000|Overall Study|Protocol Violation|3|||
163460688|NCT00192036|590384539|FG000|Overall Study|Adverse Event|6|||
163460689|NCT00192036|590384539|FG000|Overall Study|Patient/Physician Perception|1|||
163460690|NCT00192036|590384539|FG000|Overall Study|Objective Tumor Progression|4|||
163460691|NCT00192036|590384539|FG000|Overall Study|Clinical Disease Progression|1|||
163460692|NCT00192036|590384539|FG000|Overall Study|Death|1|||
163460693|NCT00192036|590384539|FG000|Overall Study|Unknown or Not Specified|5|||
163460694|NCT03371732|590384540|FG000|Overall Study|Withdrawal by Subject|9|||
163460695|NCT03371732|590384541|FG001|Overall Study|Withdrawal by Subject|3|||
163460696|NCT03371732|590384540|FG000|Overall Study|Refusal to continue|3|||
163460697|NCT03371732|590384541|FG001|Overall Study|Refusal to continue|4|||
163460698|NCT00599027|590384544|FG000|Overall Study|Withdrawal by Subject|1|||
163460699|NCT00599027|590384545|FG001|Overall Study|Withdrawal by Subject|1|||
163460700|NCT00599027|590384544|FG000|Overall Study|Adverse Event|0|||
163460701|NCT00599027|590384545|FG001|Overall Study|Adverse Event|1|||
163460702|NCT00599027|590384544|FG000|Overall Study|Treatment Failure|0|||
163460703|NCT00599027|590384545|FG001|Overall Study|Treatment Failure|1|||
163460704|NCT00476996|590384549|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
163460705|NCT00476996|590384550|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
163460706|NCT00476996|590384551|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
163460707|NCT00476996|590384552|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
163460708|NCT00476996|590384549|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
163460709|NCT00476996|590384550|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
163460710|NCT00476996|590384551|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
163460711|NCT00476996|590384552|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
163460712|NCT00476996|590384549|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
163460713|NCT00476996|590384550|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
163460714|NCT00476996|590384551|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
163460715|NCT00476996|590384552|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
163460716|NCT00476996|590384549|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
163460717|NCT00476996|590384550|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
163460718|NCT00476996|590384551|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
163460719|NCT00476996|590384552|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
163460720|NCT00476996|590384549|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
163460721|NCT00476996|590384550|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
163460722|NCT00476996|590384551|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
163460723|NCT00476996|590384552|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
163460724|NCT00476996|590384549|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
163460725|NCT00476996|590384550|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
163460726|NCT00476996|590384551|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
163460727|NCT00476996|590384552|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
163460728|NCT00476996|590384549|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
163460729|NCT00476996|590384550|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
163460730|NCT00476996|590384551|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
163460731|NCT00476996|590384552|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
163460732|NCT00476996|590384549|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
163460733|NCT00476996|590384550|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
163460734|NCT00476996|590384551|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
163460735|NCT00476996|590384552|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
163460736|NCT00476996|590384549|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
163460737|NCT00476996|590384550|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
163460738|NCT00476996|590384551|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
163460739|NCT00476996|590384552|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
163460740|NCT00476996|590384549|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
163460741|NCT00476996|590384550|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
163460742|NCT00476996|590384551|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
163460743|NCT00476996|590384552|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
163460744|NCT00476996|590384549|FG000|OLE Phase (From Week 48)|Death|0|||
163460745|NCT00476996|590384550|FG001|OLE Phase (From Week 48)|Death|0|||
163460746|NCT00476996|590384551|FG002|OLE Phase (From Week 48)|Death|0|||
163460747|NCT00476996|590384552|FG003|OLE Phase (From Week 48)|Death|7|||
163460748|NCT00476996|590384549|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
163460749|NCT00476996|590384550|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
163460750|NCT00476996|590384551|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
163460751|NCT00476996|590384552|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
163460752|NCT00476996|590384549|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
163460753|NCT00476996|590384550|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
163460754|NCT00476996|590384551|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
163460755|NCT00476996|590384552|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
163460756|NCT00476996|590384549|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
163460757|NCT00476996|590384550|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
163460758|NCT00476996|590384551|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
163460759|NCT00476996|590384552|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
163460760|NCT00476996|590384549|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
163460761|NCT00476996|590384550|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
163460762|NCT00476996|590384551|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
163460763|NCT00476996|590384552|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
163460764|NCT02133742|590384565|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
163460765|NCT02133742|590384565|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
163460766|NCT02133742|590384565|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
163460767|NCT02133742|590384565|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
163460768|NCT02133742|590384565|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
163460769|NCT03479216|590384566|FG000|Overall Study|Withdrawal by Subject|3|||
163460770|NCT03479216|590384567|FG001|Overall Study|Withdrawal by Subject|2|||
163460771|NCT03479216|590384566|FG000|Overall Study|Physician Decision|2|||
163460772|NCT03479216|590384567|FG001|Overall Study|Physician Decision|3|||
163460773|NCT02031432|590384568|FG000|Overall Study|Protocol Violation|1|||
163460774|NCT02031432|590384568|FG000|Overall Study|Lack of Efficacy|5|||
163460775|NCT02031432|590384568|FG000|Overall Study|Cancer Progression|2|||
163460776|NCT02031432|590384568|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
163460777|NCT02031432|590384568|FG000|Overall Study|Adverse Event|8|||
163460778|NCT02031432|590384568|FG000|Overall Study|Withdrawal by Subject|5|||
163460779|NCT02031432|590384568|FG000|Overall Study|Lost to Follow-up|1|||
163460780|NCT02031432|590384568|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
163460781|NCT02031432|590384568|FG000|Overall Study|Death|10|||
163460782|NCT02148211|590384569|FG000|Overall Study|Lost to Follow-up|352|||
163460783|NCT01617187|590384571|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
163460784|NCT01617187|590384572|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
163460785|NCT01617187|590384573|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
163460786|NCT01617187|590384574|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
163460787|NCT01617187|590384571|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
163460788|NCT01617187|590384572|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
163460789|NCT01617187|590384573|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
163460790|NCT01617187|590384574|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
163460791|NCT01617187|590384571|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
163460792|NCT01617187|590384572|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
163460793|NCT01617187|590384573|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
163460794|NCT01617187|590384574|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
163460795|NCT01617187|590384571|FG000|Treatment Through Study Completion|Adverse Event|1|||
163460796|NCT01617187|590384572|FG001|Treatment Through Study Completion|Adverse Event|1|||
163460797|NCT01617187|590384573|FG002|Treatment Through Study Completion|Adverse Event|0|||
163460798|NCT01617187|590384574|FG003|Treatment Through Study Completion|Adverse Event|1|||
163460799|NCT01617187|590384571|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
163460800|NCT01617187|590384572|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
163460801|NCT01617187|590384573|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
163460802|NCT01617187|590384574|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
163460803|NCT01617187|590384571|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
163460804|NCT01617187|590384572|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
163460805|NCT01617187|590384573|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
163460806|NCT01617187|590384574|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
163460807|NCT01617187|590384571|FG000|Treatment Through Study Completion|Protocol Violation|1|||
163460808|NCT01617187|590384572|FG001|Treatment Through Study Completion|Protocol Violation|0|||
163460809|NCT01617187|590384573|FG002|Treatment Through Study Completion|Protocol Violation|0|||
163460810|NCT01617187|590384574|FG003|Treatment Through Study Completion|Protocol Violation|1|||
163460811|NCT01265420|590384576|FG000|Overall Study|Lost to Follow-up|1|||
163460812|NCT03337139|590384579|FG000|Phase I|Withdrawal by Subject|10|||
163460813|NCT03337139|590384580|FG001|Phase I|Withdrawal by Subject|0|||
163460814|NCT02554253|590384581|FG000|Overall Study|ineligible after enrollment|1|||
163460815|NCT02554253|590384582|FG001|Overall Study|ineligible after enrollment|0|||
163460816|NCT02554253|590384581|FG000|Overall Study|converted to transcatheter procedure|0|||
163460817|NCT02554253|590384582|FG001|Overall Study|converted to transcatheter procedure|1|||
163460818|NCT02554253|590384581|FG000|Overall Study|received both drugs|0|||
163460819|NCT02554253|590384582|FG001|Overall Study|received both drugs|1|||
163460820|NCT02559206|590384589|FG000|Overall Study|Adverse Event|0|||
163460821|NCT02559206|590384590|FG001|Overall Study|Adverse Event|4|||
163460822|NCT02559206|590384591|FG002|Overall Study|Adverse Event|1|||
163460823|NCT02559206|590384592|FG003|Overall Study|Adverse Event|5|||
163460824|NCT02559206|590384593|FG004|Overall Study|Adverse Event|3|||
163460825|NCT02559206|590384594|FG005|Overall Study|Adverse Event|0|||
163460826|NCT02559206|590384595|FG006|Overall Study|Adverse Event|1|||
163460827|NCT02559206|590384596|FG007|Overall Study|Adverse Event|0|||
163460828|NCT02559206|590384589|FG000|Overall Study|Protocol Violation|1|||
163460829|NCT02559206|590384590|FG001|Overall Study|Protocol Violation|0|||
163460830|NCT02559206|590384591|FG002|Overall Study|Protocol Violation|1|||
163460831|NCT02559206|590384592|FG003|Overall Study|Protocol Violation|0|||
163460832|NCT02559206|590384593|FG004|Overall Study|Protocol Violation|0|||
163460833|NCT02559206|590384594|FG005|Overall Study|Protocol Violation|2|||
163460834|NCT02559206|590384595|FG006|Overall Study|Protocol Violation|0|||
163460835|NCT02559206|590384596|FG007|Overall Study|Protocol Violation|0|||
163460836|NCT02559206|590384589|FG000|Overall Study|Withdrawal by Subject|3|||
163460837|NCT02559206|590384590|FG001|Overall Study|Withdrawal by Subject|3|||
163460838|NCT02559206|590384591|FG002|Overall Study|Withdrawal by Subject|1|||
163460839|NCT02559206|590384592|FG003|Overall Study|Withdrawal by Subject|3|||
163460840|NCT02559206|590384593|FG004|Overall Study|Withdrawal by Subject|5|||
163460841|NCT02559206|590384594|FG005|Overall Study|Withdrawal by Subject|4|||
163460842|NCT02559206|590384595|FG006|Overall Study|Withdrawal by Subject|1|||
163460843|NCT02559206|590384596|FG007|Overall Study|Withdrawal by Subject|2|||
163460844|NCT02559206|590384589|FG000|Overall Study|Lost to Follow-up|3|||
163460845|NCT02559206|590384590|FG001|Overall Study|Lost to Follow-up|5|||
163460846|NCT02559206|590384591|FG002|Overall Study|Lost to Follow-up|3|||
163460847|NCT02559206|590384592|FG003|Overall Study|Lost to Follow-up|3|||
163460848|NCT02559206|590384593|FG004|Overall Study|Lost to Follow-up|2|||
163460849|NCT02559206|590384594|FG005|Overall Study|Lost to Follow-up|5|||
163460850|NCT02559206|590384595|FG006|Overall Study|Lost to Follow-up|1|||
163460851|NCT02559206|590384596|FG007|Overall Study|Lost to Follow-up|4|||
163460852|NCT02559206|590384589|FG000|Overall Study|Lack of Efficacy|1|||
163460853|NCT02559206|590384590|FG001|Overall Study|Lack of Efficacy|0|||
163460854|NCT02559206|590384591|FG002|Overall Study|Lack of Efficacy|3|||
163460855|NCT02559206|590384592|FG003|Overall Study|Lack of Efficacy|2|||
163460856|NCT02559206|590384593|FG004|Overall Study|Lack of Efficacy|2|||
163460857|NCT02559206|590384594|FG005|Overall Study|Lack of Efficacy|3|||
163460858|NCT02559206|590384595|FG006|Overall Study|Lack of Efficacy|3|||
163460859|NCT02559206|590384596|FG007|Overall Study|Lack of Efficacy|3|||
163460860|NCT02559206|590384589|FG000|Overall Study|Other Not Specified|0|||
163460861|NCT02559206|590384590|FG001|Overall Study|Other Not Specified|0|||
163460862|NCT02559206|590384591|FG002|Overall Study|Other Not Specified|0|||
163460863|NCT02559206|590384592|FG003|Overall Study|Other Not Specified|1|||
163460864|NCT02559206|590384593|FG004|Overall Study|Other Not Specified|0|||
163460865|NCT02559206|590384594|FG005|Overall Study|Other Not Specified|0|||
163460866|NCT02559206|590384595|FG006|Overall Study|Other Not Specified|0|||
163460867|NCT02559206|590384596|FG007|Overall Study|Other Not Specified|0|||
163460868|NCT01561560|590384597|FG000|First Two Weeks of Wear|Time/job conflict|0|||
163460869|NCT01561560|590384598|FG001|First Two Weeks of Wear|Time/job conflict|1|||
163460870|NCT01561560|590384597|FG000|First Two Weeks of Wear|Adverse Event|0|||
163460871|NCT01561560|590384598|FG001|First Two Weeks of Wear|Adverse Event|1|||
163460872|NCT01561560|590384597|FG000|Second Two Weeks of Wear|Adverse Event|0|||
163460873|NCT01561560|590384598|FG001|Second Two Weeks of Wear|Adverse Event|1|||
163460874|NCT03862131|590384599|FG000|Overall Study|Lost to Follow-up|1|||
163460875|NCT03862131|590384600|FG001|Overall Study|Lost to Follow-up|0|||
163460876|NCT03862131|590384601|FG002|Overall Study|Lost to Follow-up|1|||
163460877|NCT03862131|590384599|FG000|Overall Study|Determined to be ineligible|0|||
163460878|NCT03862131|590384600|FG001|Overall Study|Determined to be ineligible|0|||
163460879|NCT03862131|590384601|FG002|Overall Study|Determined to be ineligible|5|||
163460880|NCT03862131|590384599|FG000|Overall Study|Death|4|||
163460881|NCT03862131|590384600|FG001|Overall Study|Death|4|||
163460882|NCT03862131|590384601|FG002|Overall Study|Death|0|||
163460883|NCT03862131|590384599|FG000|Overall Study|Withdrawal by Subject|5|||
163460884|NCT03862131|590384600|FG001|Overall Study|Withdrawal by Subject|3|||
163460885|NCT03862131|590384601|FG002|Overall Study|Withdrawal by Subject|0|||
163460886|NCT03862131|590384599|FG000|Overall Study|Physician Decision|0|||
163460887|NCT03862131|590384600|FG001|Overall Study|Physician Decision|1|||
163460888|NCT03862131|590384601|FG002|Overall Study|Physician Decision|0|||
163460889|NCT01871896|590384604|FG000|Overall Study|Lost to Follow-up|1|||
163460890|NCT01412151|590386446|FG000|Week 0 - 306 - Treatment Period|Death|1|||
163460891|NCT01412151|590386446|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
163460892|NCT01412151|590386446|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
163460893|NCT01412151|590386446|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
163460894|NCT03127852|590386447|FG000|Overall Study|Withdrawal by Subject|4|||
163460895|NCT03127852|590386448|FG001|Overall Study|Withdrawal by Subject|1|||
163460896|NCT03127852|590386447|FG000|Overall Study|Death|1|||
163460897|NCT03127852|590386448|FG001|Overall Study|Death|1|||
163460898|NCT03621189|590386449|FG000|Overall Study|Withdrawal by Subject|0|||
163460899|NCT03621189|590386450|FG001|Overall Study|Withdrawal by Subject|3|||
163460900|NCT03621189|590386449|FG000|Overall Study|Physician Decision|0|||
163460901|NCT03621189|590386450|FG001|Overall Study|Physician Decision|2|||
163460902|NCT03382262|590386451|FG000|Overall Study|Physician Decision|0|||
163460903|NCT03382262|590386452|FG001|Overall Study|Physician Decision|0|||
163460904|NCT03382262|590386453|FG002|Overall Study|Physician Decision|1|||
163460905|NCT03382262|590386454|FG003|Overall Study|Physician Decision|0|||
163460906|NCT03382262|590386451|FG000|Overall Study|Withdrawal by Subject|0|||
163460907|NCT03382262|590386452|FG001|Overall Study|Withdrawal by Subject|0|||
163460908|NCT03382262|590386453|FG002|Overall Study|Withdrawal by Subject|0|||
163460909|NCT03382262|590386454|FG003|Overall Study|Withdrawal by Subject|1|||
163460910|NCT03518034|590386455|FG000|Overall Study|Not Treated|5|||
163460911|NCT03518034|590386456|FG001|Overall Study|Not Treated|1|||
163460912|NCT03518034|590386455|FG000|Overall Study|Withdrawal by Subject|309|||
163460913|NCT03518034|590386456|FG001|Overall Study|Withdrawal by Subject|351|||
163460914|NCT03518034|590386455|FG000|Overall Study|Lost to Follow-up|446|||
163460915|NCT03518034|590386456|FG001|Overall Study|Lost to Follow-up|458|||
163460916|NCT03518034|590386455|FG000|Overall Study|Adverse Event|138|||
163460917|NCT03518034|590386456|FG001|Overall Study|Adverse Event|130|||
163460918|NCT03518034|590386455|FG000|Overall Study|Lack of Efficacy|11|||
163460919|NCT03518034|590386456|FG001|Overall Study|Lack of Efficacy|23|||
163460920|NCT03518034|590386455|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
163460921|NCT03518034|590386456|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
163460922|NCT03518034|590386455|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
163460923|NCT03518034|590386456|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
163460924|NCT03518034|590386455|FG000|Overall Study|Other, Not Specified|84|||
163460925|NCT03518034|590386456|FG001|Overall Study|Other, Not Specified|53|||
163460926|NCT03518034|590386455|FG000|Overall Study|Reason Missing|2|||
163460927|NCT03518034|590386456|FG001|Overall Study|Reason Missing|3|||
163460928|NCT02007252|590386457|FG000|Overall Study|Administrative problems|3|||
163460929|NCT02007252|590386458|FG001|Overall Study|Administrative problems|7|||
163460930|NCT02007252|590386457|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163460931|NCT02007252|590386458|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163460932|NCT02007252|590386457|FG000|Overall Study|Adverse Event|7|||
163460933|NCT02007252|590386458|FG001|Overall Study|Adverse Event|4|||
163460934|NCT03325556|590386459|FG000|Open-label Period|Lack of Response in OL period|70|||
163460935|NCT03325556|590386460|FG001|Open-label Period|Lack of Response in OL period|0|||
163460936|NCT03325556|590386461|FG002|Open-label Period|Lack of Response in OL period|0|||
163460937|NCT03325556|590386459|FG000|Open-label Period|Adverse Event|27|||
163460938|NCT03325556|590386460|FG001|Open-label Period|Adverse Event|0|||
163460939|NCT03325556|590386461|FG002|Open-label Period|Adverse Event|0|||
163460940|NCT03325556|590386459|FG000|Open-label Period|Death|1|||
163460941|NCT03325556|590386460|FG001|Open-label Period|Death|0|||
163460942|NCT03325556|590386461|FG002|Open-label Period|Death|0|||
163460943|NCT03325556|590386459|FG000|Open-label Period|Lost to Follow-up|1|||
163460944|NCT03325556|590386460|FG001|Open-label Period|Lost to Follow-up|0|||
163460945|NCT03325556|590386461|FG002|Open-label Period|Lost to Follow-up|0|||
163460946|NCT03325556|590386459|FG000|Open-label Period|Non-compliance with study drug|5|||
163460947|NCT03325556|590386460|FG001|Open-label Period|Non-compliance with study drug|0|||
163460948|NCT03325556|590386461|FG002|Open-label Period|Non-compliance with study drug|0|||
163460949|NCT03325556|590386459|FG000|Open-label Period|Use of prohibited medication|1|||
163460950|NCT03325556|590386460|FG001|Open-label Period|Use of prohibited medication|0|||
163460951|NCT03325556|590386461|FG002|Open-label Period|Use of prohibited medication|0|||
163460952|NCT03325556|590386459|FG000|Open-label Period|Protocol Violation|4|||
163460953|NCT03325556|590386460|FG001|Open-label Period|Protocol Violation|0|||
163460954|NCT03325556|590386461|FG002|Open-label Period|Protocol Violation|0|||
163460955|NCT03325556|590386459|FG000|Open-label Period|Withdrawal by Subject|17|||
163460956|NCT03325556|590386460|FG001|Open-label Period|Withdrawal by Subject|0|||
163460957|NCT03325556|590386461|FG002|Open-label Period|Withdrawal by Subject|0|||
163460958|NCT03325556|590386459|FG000|Open-label Period|Not otherwise specified|8|||
163460959|NCT03325556|590386460|FG001|Open-label Period|Not otherwise specified|0|||
163460960|NCT03325556|590386461|FG002|Open-label Period|Not otherwise specified|0|||
163460961|NCT03325556|590386459|FG000|Open-label Period|Administrative discont. at study termination|41|||
163460962|NCT03325556|590386460|FG001|Open-label Period|Administrative discont. at study termination|0|||
163460963|NCT03325556|590386461|FG002|Open-label Period|Administrative discont. at study termination|0|||
163460964|NCT03325556|590386459|FG000|Double-blind Period|Relapse|0|||
163460965|NCT03325556|590386460|FG001|Double-blind Period|Relapse|15|||
163460966|NCT03325556|590386461|FG002|Double-blind Period|Relapse|34|||
163460967|NCT03325556|590386459|FG000|Double-blind Period|Adverse Event|0|||
163460968|NCT03325556|590386460|FG001|Double-blind Period|Adverse Event|3|||
163460969|NCT03325556|590386461|FG002|Double-blind Period|Adverse Event|1|||
163460970|NCT03325556|590386459|FG000|Double-blind Period|Noncompliance with study drug|0|||
163460971|NCT03325556|590386460|FG001|Double-blind Period|Noncompliance with study drug|0|||
163460972|NCT03325556|590386461|FG002|Double-blind Period|Noncompliance with study drug|1|||
163460973|NCT03325556|590386459|FG000|Double-blind Period|Use of prohibited medication|0|||
163460974|NCT03325556|590386460|FG001|Double-blind Period|Use of prohibited medication|1|||
163460975|NCT03325556|590386461|FG002|Double-blind Period|Use of prohibited medication|0|||
163460976|NCT03325556|590386459|FG000|Double-blind Period|Physician Decision|0|||
163460977|NCT03325556|590386460|FG001|Double-blind Period|Physician Decision|0|||
163460978|NCT03325556|590386461|FG002|Double-blind Period|Physician Decision|1|||
163460979|NCT03325556|590386459|FG000|Double-blind Period|Withdrawal by Subject|0|||
163460980|NCT03325556|590386460|FG001|Double-blind Period|Withdrawal by Subject|6|||
163460981|NCT03325556|590386461|FG002|Double-blind Period|Withdrawal by Subject|4|||
163460982|NCT03325556|590386459|FG000|Double-blind Period|Not otherwise specified|0|||
163460983|NCT03325556|590386460|FG001|Double-blind Period|Not otherwise specified|1|||
163460984|NCT03325556|590386461|FG002|Double-blind Period|Not otherwise specified|5|||
163460985|NCT03325556|590386459|FG000|Double-blind Period|Administrative discont. at study termination|0|||
163460986|NCT03325556|590386460|FG001|Double-blind Period|Administrative discont. at study termination|35|||
163460987|NCT03325556|590386461|FG002|Double-blind Period|Administrative discont. at study termination|31|||
163460988|NCT01705587|590386462|FG000|Overall Study|Withdrawal by Subject|0|||
163460989|NCT01705587|590386463|FG001|Overall Study|Withdrawal by Subject|1|||
163460990|NCT00762268|590386464|FG000|Overall Study|Withdrawal by Subject|3|||
163460991|NCT00762268|590386465|FG001|Overall Study|Withdrawal by Subject|3|||
163460992|NCT03892707|590386474|FG000|Overall Study|Screen failure|6|||
163460993|NCT03892707|590386475|FG001|Overall Study|Screen failure|0|||
163460994|NCT03892707|590386474|FG000|Overall Study|Pain resolution|0|||
163460995|NCT03892707|590386475|FG001|Overall Study|Pain resolution|4|||
163460996|NCT03892707|590386474|FG000|Overall Study|Withdrawal by Subject|0|||
163460997|NCT03892707|590386475|FG001|Overall Study|Withdrawal by Subject|1|||
163460998|NCT03892707|590386474|FG000|Overall Study|Other (long business trip)|0|||
163460999|NCT03892707|590386475|FG001|Overall Study|Other (long business trip)|1|||
163461000|NCT05224076|590386478|FG000|Overall Study|Lost to Follow-up|24|||
163461001|NCT01807949|590386480|FG000|Overall Study|Adverse Event|1|||
163461002|NCT01807949|590386481|FG001|Overall Study|Adverse Event|2|||
163461003|NCT01807949|590386482|FG002|Overall Study|Adverse Event|2|||
163461004|NCT01807949|590386480|FG000|Overall Study|Withdrawal by Subject|1|||
163461005|NCT01807949|590386481|FG001|Overall Study|Withdrawal by Subject|2|||
163461006|NCT01807949|590386482|FG002|Overall Study|Withdrawal by Subject|2|||
163461007|NCT01807949|590386480|FG000|Overall Study|Non-Compliance|0|||
163461008|NCT01807949|590386481|FG001|Overall Study|Non-Compliance|0|||
163461009|NCT01807949|590386482|FG002|Overall Study|Non-Compliance|1|||
163461010|NCT01807949|590386480|FG000|Overall Study|Undefined|0|||
163461011|NCT01807949|590386481|FG001|Overall Study|Undefined|1|||
163461012|NCT01807949|590386482|FG002|Overall Study|Undefined|2|||
163461013|NCT01807949|590386480|FG000|Overall Study|Randomized But Not Treated|0|||
163461014|NCT01807949|590386481|FG001|Overall Study|Randomized But Not Treated|2|||
163461015|NCT01807949|590386482|FG002|Overall Study|Randomized But Not Treated|2|||
163461016|NCT04325906|590386485|FG000|Overall Study|Withdrawal by Subject|2|||
163461017|NCT04325906|590386486|FG001|Overall Study|Withdrawal by Subject|0|||
163461018|NCT00881361|590386487|FG000|Overall Study|Terminated prior to surgery|27|||
163461019|NCT00881361|590386488|FG001|Overall Study|Terminated prior to surgery|7|||
163461020|NCT00881361|590386489|FG002|Overall Study|Terminated prior to surgery|0|||
163461021|NCT00881361|590386487|FG000|Overall Study|Ineligible|17|||
163461022|NCT00881361|590386488|FG001|Overall Study|Ineligible|2|||
163461023|NCT00881361|590386489|FG002|Overall Study|Ineligible|2|||
163461024|NCT02141217|590386490|FG000|Overall Study|Adverse Event|1|||
163461025|NCT02141217|590386491|FG001|Overall Study|Adverse Event|2|||
163461026|NCT02141217|590386490|FG000|Overall Study|Protocol Violation|1|||
163461027|NCT02141217|590386491|FG001|Overall Study|Protocol Violation|4|||
163461028|NCT02141217|590386490|FG000|Overall Study|Withdrawal by Subject|6|||
163461029|NCT02141217|590386491|FG001|Overall Study|Withdrawal by Subject|0|||
163461030|NCT02141217|590386490|FG000|Overall Study|Lost to Follow-up|1|||
163461031|NCT02141217|590386491|FG001|Overall Study|Lost to Follow-up|1|||
163461032|NCT02141217|590386490|FG000|Overall Study|Physician Decision|1|||
163461033|NCT02141217|590386491|FG001|Overall Study|Physician Decision|0|||
163461034|NCT02141217|590386490|FG000|Overall Study|Surgical Intervention|1|||
163461035|NCT02141217|590386491|FG001|Overall Study|Surgical Intervention|1|||
163461036|NCT01628393|590386496|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
163461037|NCT01628393|590386497|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
163461038|NCT01628393|590386498|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
163461039|NCT01628393|590386499|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
163461040|NCT01628393|590386500|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
163461041|NCT01628393|590386496|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
163461042|NCT01628393|590386497|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
163461043|NCT01628393|590386498|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
163461044|NCT01628393|590386499|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
163461045|NCT01628393|590386500|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
163461046|NCT01628393|590386496|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
163461047|NCT01628393|590386497|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
163461048|NCT01628393|590386498|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
163461049|NCT01628393|590386499|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
163461050|NCT01628393|590386500|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
163461051|NCT01628393|590386496|FG000|Blinded Active Extension Period|Adverse Event|0|||
163461052|NCT01628393|590386497|FG001|Blinded Active Extension Period|Adverse Event|1|||
163461053|NCT01628393|590386498|FG002|Blinded Active Extension Period|Adverse Event|0|||
163461054|NCT01628393|590386499|FG003|Blinded Active Extension Period|Adverse Event|2|||
163461055|NCT01628393|590386500|FG004|Blinded Active Extension Period|Adverse Event|2|||
163461056|NCT01628393|590386496|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
163461057|NCT01628393|590386497|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
163461058|NCT01628393|590386498|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
163461059|NCT01628393|590386499|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
163461060|NCT01628393|590386500|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
163461061|NCT01628393|590386496|FG000|Blinded Active Extension Period|Physician Decision|0|||
163461062|NCT01628393|590386497|FG001|Blinded Active Extension Period|Physician Decision|3|||
163461063|NCT01628393|590386498|FG002|Blinded Active Extension Period|Physician Decision|0|||
163461064|NCT01628393|590386499|FG003|Blinded Active Extension Period|Physician Decision|1|||
163461065|NCT01628393|590386500|FG004|Blinded Active Extension Period|Physician Decision|0|||
163461066|NCT01628393|590386496|FG000|Blinded Active Extension Period|Protocol Violation|0|||
163461067|NCT01628393|590386497|FG001|Blinded Active Extension Period|Protocol Violation|0|||
163461068|NCT01628393|590386498|FG002|Blinded Active Extension Period|Protocol Violation|2|||
163461069|NCT01628393|590386499|FG003|Blinded Active Extension Period|Protocol Violation|1|||
163461070|NCT01628393|590386500|FG004|Blinded Active Extension Period|Protocol Violation|0|||
163461071|NCT01628393|590386496|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
163461072|NCT01628393|590386497|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
163461073|NCT01628393|590386498|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
163461074|NCT01628393|590386499|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
163461075|NCT01628393|590386500|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
163461076|NCT04603391|590386505|FG000|First Intervention (4 Days)|Adverse Event|1|||
163461077|NCT04603391|590386506|FG001|First Intervention (4 Days)|Adverse Event|0|||
163461078|NCT04603391|590386505|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
163461079|NCT04603391|590386506|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
163461080|NCT02759861|590386509|FG000|Overall Study|Death|1|||
163461081|NCT02151682|590386510|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
163461082|NCT02151682|590386511|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
163461083|NCT02151682|590386512|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
163461084|NCT02151682|590386513|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
163461085|NCT02151682|590386514|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
163461086|NCT02151682|590386515|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
163461087|NCT02151682|590386510|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
163461088|NCT02151682|590386511|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
163461089|NCT02151682|590386512|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
163461090|NCT02151682|590386513|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
163461091|NCT02151682|590386514|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
163461092|NCT02151682|590386515|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
163461093|NCT02151682|590386510|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
163461094|NCT02151682|590386511|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
163461095|NCT02151682|590386512|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
163461096|NCT02151682|590386513|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
163461097|NCT02151682|590386514|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
163461098|NCT02151682|590386515|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
163461099|NCT02151682|590386510|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
163461100|NCT02151682|590386511|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
163461101|NCT02151682|590386512|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
163461102|NCT02151682|590386513|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
163461103|NCT02151682|590386514|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
163461104|NCT02151682|590386515|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
163461105|NCT02151682|590386510|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
163461106|NCT02151682|590386511|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
163461107|NCT02151682|590386512|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
163461108|NCT02151682|590386513|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
163461109|NCT02151682|590386514|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
163461110|NCT02151682|590386515|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
163461111|NCT02151682|590386510|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
163461112|NCT02151682|590386511|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
163461113|NCT02151682|590386512|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
163461114|NCT02151682|590386513|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
163461115|NCT02151682|590386514|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
163461116|NCT02151682|590386515|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
163461117|NCT02151682|590386510|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
163461118|NCT02151682|590386511|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
163461119|NCT02151682|590386512|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
163461120|NCT02151682|590386513|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
163461121|NCT02151682|590386514|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
163461122|NCT02151682|590386515|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
163461123|NCT02151682|590386510|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
163461124|NCT02151682|590386511|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
163461125|NCT02151682|590386512|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
163461126|NCT02151682|590386513|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
163461127|NCT02151682|590386514|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
163461128|NCT02151682|590386515|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
163461129|NCT02151682|590386510|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
163461130|NCT02151682|590386511|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
163461131|NCT02151682|590386512|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
163461132|NCT02151682|590386513|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
163461133|NCT02151682|590386514|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
163461134|NCT02151682|590386515|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
163461135|NCT02151682|590386510|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
163461136|NCT02151682|590386511|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
163461137|NCT02151682|590386512|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
163461138|NCT02151682|590386513|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
163461139|NCT02151682|590386514|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
163461140|NCT02151682|590386515|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
163461141|NCT02151682|590386510|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
163461142|NCT02151682|590386511|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
163461143|NCT02151682|590386512|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
163461144|NCT02151682|590386513|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
163461145|NCT02151682|590386514|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
163461146|NCT02151682|590386515|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
163461147|NCT02151682|590386510|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
163461148|NCT02151682|590386511|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
163461149|NCT02151682|590386512|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
163461150|NCT02151682|590386513|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
163461151|NCT02151682|590386514|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
163461152|NCT02151682|590386515|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
163461153|NCT02151682|590386510|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
163461154|NCT02151682|590386511|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
163461155|NCT02151682|590386512|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
163461156|NCT02151682|590386513|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
163461157|NCT02151682|590386514|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
163461158|NCT02151682|590386515|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
163461159|NCT02151682|590386510|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
163461160|NCT02151682|590386511|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
163461161|NCT02151682|590386512|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
163461162|NCT02151682|590386513|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
163461163|NCT02151682|590386514|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
163461164|NCT02151682|590386515|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
163461165|NCT02151682|590386510|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
163461166|NCT02151682|590386511|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
163461167|NCT02151682|590386512|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
163461168|NCT02151682|590386513|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
163461169|NCT02151682|590386514|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
163461170|NCT02151682|590386515|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
163461171|NCT02151682|590386510|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
163461172|NCT02151682|590386511|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
163461173|NCT02151682|590386512|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
163461174|NCT02151682|590386513|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
163461175|NCT02151682|590386514|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
163461176|NCT02151682|590386515|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
163461177|NCT02151682|590386510|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
163461178|NCT02151682|590386511|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
163461179|NCT02151682|590386512|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
163461180|NCT02151682|590386513|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
163461181|NCT02151682|590386514|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
163461182|NCT02151682|590386515|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
163461183|NCT02151682|590386510|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
163461184|NCT02151682|590386511|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
163461185|NCT02151682|590386512|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
163461186|NCT02151682|590386513|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
163461187|NCT02151682|590386514|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
163461188|NCT02151682|590386515|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
163461189|NCT01306032|590386516|FG000|First Intervention|Adverse Event|1|||
163461190|NCT01306032|590386517|FG001|First Intervention|Adverse Event|0|||
163461191|NCT01306032|590386518|FG002|First Intervention|Adverse Event|1|||
163461192|NCT01306032|590386519|FG003|First Intervention|Adverse Event|0|||
163461193|NCT01306032|590386520|FG004|First Intervention|Adverse Event|0|||
163461194|NCT01306032|590386521|FG005|First Intervention|Adverse Event|1|||
163461195|NCT01306032|590386516|FG000|First Intervention|Withdrawal by Subject|0|||
163461196|NCT01306032|590386517|FG001|First Intervention|Withdrawal by Subject|2|||
163461197|NCT01306032|590386518|FG002|First Intervention|Withdrawal by Subject|0|||
163461198|NCT01306032|590386519|FG003|First Intervention|Withdrawal by Subject|1|||
163461199|NCT01306032|590386520|FG004|First Intervention|Withdrawal by Subject|0|||
163461200|NCT01306032|590386521|FG005|First Intervention|Withdrawal by Subject|0|||
163461201|NCT01306032|590386516|FG000|First Intervention|Death|0|||
163461202|NCT01306032|590386517|FG001|First Intervention|Death|0|||
163461203|NCT01306032|590386518|FG002|First Intervention|Death|1|||
163461204|NCT01306032|590386519|FG003|First Intervention|Death|0|||
163461205|NCT01306032|590386520|FG004|First Intervention|Death|0|||
163461206|NCT01306032|590386521|FG005|First Intervention|Death|0|||
163461207|NCT01306032|590386516|FG000|First Intervention|Ineligible|0|||
163461208|NCT01306032|590386517|FG001|First Intervention|Ineligible|0|||
163461209|NCT01306032|590386518|FG002|First Intervention|Ineligible|0|||
163461210|NCT01306032|590386519|FG003|First Intervention|Ineligible|0|||
163461211|NCT01306032|590386520|FG004|First Intervention|Ineligible|0|||
163461212|NCT01306032|590386521|FG005|First Intervention|Ineligible|1|||
163461213|NCT01306032|590386516|FG000|First Intervention|Progressive disease|0|||
163461214|NCT01306032|590386517|FG001|First Intervention|Progressive disease|0|||
163461215|NCT01306032|590386518|FG002|First Intervention|Progressive disease|0|||
163461216|NCT01306032|590386519|FG003|First Intervention|Progressive disease|0|||
163461217|NCT01306032|590386520|FG004|First Intervention|Progressive disease|2|||
163461218|NCT01306032|590386521|FG005|First Intervention|Progressive disease|0|||
163461219|NCT01306032|590386516|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
163461220|NCT01306032|590386517|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
163461221|NCT01306032|590386518|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
163461222|NCT01306032|590386519|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
163461223|NCT01306032|590386520|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
163461224|NCT01306032|590386521|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
163461225|NCT01306032|590386516|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
163461226|NCT01306032|590386517|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
163461227|NCT01306032|590386518|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
163461228|NCT01306032|590386519|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
163461229|NCT01306032|590386520|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
163461230|NCT01306032|590386521|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
163461231|NCT02988219|590386522|FG000|Overall Study|Lack of Efficacy|1|||
163461232|NCT02988219|590386523|FG001|Overall Study|Lack of Efficacy|1|||
163461233|NCT02988219|590386522|FG000|Overall Study|Withdrawal by Subject|0|||
163461234|NCT02988219|590386523|FG001|Overall Study|Withdrawal by Subject|2|||
163461235|NCT01213264|590386524|FG000|Overall Study|Adverse Event|1|||
163461236|NCT01213264|590386525|FG001|Overall Study|Adverse Event|0|||
163461237|NCT01213264|590386526|FG002|Overall Study|Adverse Event|0|||
163461238|NCT01213264|590386524|FG000|Overall Study|Lost to Follow-up|1|||
163461239|NCT01213264|590386525|FG001|Overall Study|Lost to Follow-up|2|||
163461240|NCT01213264|590386526|FG002|Overall Study|Lost to Follow-up|6|||
163461241|NCT01522443|590386529|FG000|Overall Study|No longer receiving clinical benefit|36|||
163461242|NCT01522443|590386530|FG001|Overall Study|No longer receiving clinical benefit|28|||
163461243|NCT01522443|590386529|FG000|Overall Study|Adverse Event|10|||
163461244|NCT01522443|590386530|FG001|Overall Study|Adverse Event|15|||
163461245|NCT01522443|590386529|FG000|Overall Study|Withdrawal by Subject|5|||
163461246|NCT01522443|590386530|FG001|Overall Study|Withdrawal by Subject|8|||
163461247|NCT01522443|590386529|FG000|Overall Study|No study treatment given|1|||
163461248|NCT01522443|590386530|FG001|Overall Study|No study treatment given|1|||
163461249|NCT01522443|590386529|FG000|Overall Study|Other|1|||
163461250|NCT01522443|590386530|FG001|Overall Study|Other|3|||
163461251|NCT03260894|590386531|FG000|Overall Study|Death|6|||
163461252|NCT03260894|590386532|FG001|Overall Study|Death|8|||
163461253|NCT03260894|590386531|FG000|Overall Study|Withdrawal by Subject|4|||
163461254|NCT03260894|590386532|FG001|Overall Study|Withdrawal by Subject|11|||
163461255|NCT03260894|590386531|FG000|Overall Study|On-going at clinical cut off date|36|||
163461256|NCT03260894|590386532|FG001|Overall Study|On-going at clinical cut off date|31|||
163461257|NCT00973622|590386533|FG000|Overall Study|did not attend MRI|14|||
163461258|NCT00973622|590386534|FG001|Overall Study|did not attend MRI|3|||
163461259|NCT00973622|590386533|FG000|Overall Study|did not pass MRI screen|6|||
163461260|NCT00973622|590386534|FG001|Overall Study|did not pass MRI screen|0|||
163461261|NCT00973622|590386533|FG000|Overall Study|did not complete rTMS sessions|11|||
163461262|NCT00973622|590386534|FG001|Overall Study|did not complete rTMS sessions|2|||
163461263|NCT00555568|590386535|FG000|Overall Study|Lost to Follow-up|26|||
163461264|NCT00555568|590386536|FG001|Overall Study|Lost to Follow-up|16|||
163461265|NCT00555568|590386537|FG002|Overall Study|Lost to Follow-up|16|||
163461266|NCT06000501|590386538|FG000|Overall Study|Screen failure|3|||
163461267|NCT06000501|590386538|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
163461268|NCT06000501|590386538|FG000|Overall Study|Physician Decision|4|||
163461269|NCT06000501|590386538|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
163461270|NCT06000501|590386538|FG000|Overall Study|Scheduling issues|2|||
163461271|NCT01700985|590386539|FG000|Overall Study|Incarcerated|0|||
163461272|NCT01700985|590386540|FG001|Overall Study|Incarcerated|1|||
163461273|NCT02677220|590386541|FG000|Overall Study|Adverse Event|1|||
163461274|NCT00067470|590386542|FG000|Overall Study|Withdrawal by Subject|0|||
163461275|NCT00067470|590386543|FG001|Overall Study|Withdrawal by Subject|1|||
163461276|NCT01148693|590386544|FG000|Overall Study|Attempts for cannulation were failed|13|||
163461277|NCT01148693|590386545|FG001|Overall Study|Attempts for cannulation were failed|10|||
163461278|NCT01074658|590386546|FG000|Overall Study|No implant attempted|19|||
163461279|NCT00050622|590386547|FG000|Overall Study|Adverse Event|1|||
163461280|NCT01342952|590386548|FG000|Overall Study|Adverse Event|0|||
163461281|NCT01342952|590386549|FG001|Overall Study|Adverse Event|5|||
163461282|NCT01342952|590386550|FG002|Overall Study|Adverse Event|1|||
163461283|NCT01342952|590386551|FG003|Overall Study|Adverse Event|0|||
163461284|NCT01342952|590386548|FG000|Overall Study|Lost to Follow-up|0|||
163461285|NCT01342952|590386549|FG001|Overall Study|Lost to Follow-up|2|||
163461286|NCT01342952|590386550|FG002|Overall Study|Lost to Follow-up|0|||
163461287|NCT01342952|590386551|FG003|Overall Study|Lost to Follow-up|0|||
163461288|NCT01342952|590386548|FG000|Overall Study|Withdrawal by Subject|1|||
163461289|NCT01342952|590386549|FG001|Overall Study|Withdrawal by Subject|1|||
163461290|NCT01342952|590386550|FG002|Overall Study|Withdrawal by Subject|0|||
163461291|NCT01342952|590386551|FG003|Overall Study|Withdrawal by Subject|0|||
163461292|NCT01342952|590386548|FG000|Overall Study|Physician Decision|3|||
163461293|NCT01342952|590386549|FG001|Overall Study|Physician Decision|3|||
163461294|NCT01342952|590386550|FG002|Overall Study|Physician Decision|1|||
163461295|NCT01342952|590386551|FG003|Overall Study|Physician Decision|0|||
163461296|NCT00426556|590386552|FG000|Phase I - Core Phase|Disease Progression|0|||
163461297|NCT00426556|590386553|FG001|Phase I - Core Phase|Disease Progression|6|||
163461298|NCT00426556|590386554|FG002|Phase I - Core Phase|Disease Progression|2|||
163461299|NCT00426556|590386555|FG003|Phase I - Core Phase|Disease Progression|0|||
163461300|NCT00426556|590386552|FG000|Phase I - Core Phase|Adverse Event|1|||
163461301|NCT00426556|590386553|FG001|Phase I - Core Phase|Adverse Event|3|||
163461302|NCT00426556|590386554|FG002|Phase I - Core Phase|Adverse Event|1|||
163461303|NCT00426556|590386555|FG003|Phase I - Core Phase|Adverse Event|0|||
163461304|NCT00426556|590386552|FG000|Phase I - Core Phase|Death|0|||
163461305|NCT00426556|590386553|FG001|Phase I - Core Phase|Death|1|||
163461306|NCT00426556|590386554|FG002|Phase I - Core Phase|Death|0|||
163461307|NCT00426556|590386555|FG003|Phase I - Core Phase|Death|0|||
163461308|NCT00426556|590386552|FG000|Phase I - Extension Phase|Adverse Event|0|||
163461309|NCT00426556|590386553|FG001|Phase I - Extension Phase|Adverse Event|1|||
163461310|NCT00426556|590386554|FG002|Phase I - Extension Phase|Adverse Event|1|||
163461311|NCT00426556|590386555|FG003|Phase I - Extension Phase|Adverse Event|0|||
163461312|NCT00426556|590386552|FG000|Phase I - Extension Phase|Disease Progression|5|||
163461313|NCT00426556|590386553|FG001|Phase I - Extension Phase|Disease Progression|5|||
163461314|NCT00426556|590386554|FG002|Phase I - Extension Phase|Disease Progression|6|||
163461315|NCT00426556|590386555|FG003|Phase I - Extension Phase|Disease Progression|0|||
163461316|NCT00426556|590386552|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
163461317|NCT00426556|590386553|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
163461318|NCT00426556|590386554|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
163461319|NCT00426556|590386555|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
163461320|NCT00426556|590386552|FG000|Phase II - Core Phase|Disease Progression|0|||
163461321|NCT00426556|590386553|FG001|Phase II - Core Phase|Disease Progression|0|||
163461322|NCT00426556|590386554|FG002|Phase II - Core Phase|Disease Progression|0|||
163461323|NCT00426556|590386555|FG003|Phase II - Core Phase|Disease Progression|16|||
163461324|NCT00426556|590386552|FG000|Phase II - Core Phase|Adverse Event|0|||
163461325|NCT00426556|590386553|FG001|Phase II - Core Phase|Adverse Event|0|||
163461326|NCT00426556|590386554|FG002|Phase II - Core Phase|Adverse Event|0|||
163461327|NCT00426556|590386555|FG003|Phase II - Core Phase|Adverse Event|8|||
163461328|NCT00426556|590386552|FG000|Phase II - Extension Phase|Disease Progression|0|||
163461329|NCT00426556|590386553|FG001|Phase II - Extension Phase|Disease Progression|0|||
163461330|NCT00426556|590386554|FG002|Phase II - Extension Phase|Disease Progression|0|||
163461331|NCT00426556|590386555|FG003|Phase II - Extension Phase|Disease Progression|21|||
163461332|NCT00426556|590386552|FG000|Phase II - Extension Phase|Adverse Event|0|||
163461333|NCT00426556|590386553|FG001|Phase II - Extension Phase|Adverse Event|0|||
163461334|NCT00426556|590386554|FG002|Phase II - Extension Phase|Adverse Event|0|||
163461335|NCT00426556|590386555|FG003|Phase II - Extension Phase|Adverse Event|2|||
163461336|NCT03970824|590386559|FG000|Overall Study|Withdrawal by Subject|1|||
163461337|NCT03970824|590386560|FG001|Overall Study|Withdrawal by Subject|1|||
163461338|NCT03970824|590386561|FG002|Overall Study|Withdrawal by Subject|3|||
163461339|NCT03970824|590386559|FG000|Overall Study|Lost to Follow-up|0|||
163461340|NCT03970824|590386560|FG001|Overall Study|Lost to Follow-up|2|||
163461341|NCT03970824|590386561|FG002|Overall Study|Lost to Follow-up|1|||
163461342|NCT03970824|590386559|FG000|Overall Study|Adverse Event|1|||
163461343|NCT03970824|590386560|FG001|Overall Study|Adverse Event|0|||
163461344|NCT03970824|590386561|FG002|Overall Study|Adverse Event|0|||
163461345|NCT01192204|590386564|FG000|Overall Study|could not keep recall appointments|1|||
163461346|NCT01192204|590386565|FG001|Overall Study|could not keep recall appointments|0|||
163461347|NCT02146248|590386566|FG000|Overall Study|Withdrawal by Subject|2|||
163461348|NCT00425100|590386567|FG000|Overall Study|Adverse Event|36|||
163461349|NCT00425100|590386567|FG000|Overall Study|Lack of Efficacy|4|||
163461350|NCT00425100|590386567|FG000|Overall Study|Lost to Follow-up|2|||
163461351|NCT00425100|590386567|FG000|Overall Study|Protocol Violation|4|||
163461352|NCT00425100|590386567|FG000|Overall Study|Withdrawal by Subject|7|||
163461353|NCT03699631|590386571|FG000|Overall Study|Adverse Event|3|||
163461354|NCT00618449|590386572|FG000|Overall Study|Lost to Follow-up|98|||
163461355|NCT00618449|590386573|FG001|Overall Study|Lost to Follow-up|110|||
163461356|NCT02219087|590386574|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
163461357|NCT02219087|590386575|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
163461358|NCT05127421|590386576|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
163461359|NCT05127421|590386577|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
163461360|NCT05127421|590386578|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
163461361|NCT05127421|590386579|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
163461362|NCT05127421|590386576|FG000|4-Week Double-Blind Period|Physician Decision|1|||
163461363|NCT05127421|590386577|FG001|4-Week Double-Blind Period|Physician Decision|0|||
163461364|NCT05127421|590386578|FG002|4-Week Double-Blind Period|Physician Decision|0|||
163461365|NCT05127421|590386579|FG003|4-Week Double-Blind Period|Physician Decision|0|||
163461366|NCT05127421|590386576|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
163461367|NCT05127421|590386577|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
163461368|NCT05127421|590386578|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
163461369|NCT05127421|590386579|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
163461370|NCT05127421|590386576|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
163461371|NCT05127421|590386577|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
163461372|NCT05127421|590386578|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
163461373|NCT05127421|590386579|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
163461374|NCT05127421|590386576|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
163461375|NCT05127421|590386577|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
163461376|NCT05127421|590386578|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
163461377|NCT05127421|590386579|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
163461378|NCT05127421|590386576|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
163461379|NCT05127421|590386577|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
163461380|NCT05127421|590386578|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
163461381|NCT05127421|590386579|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
163461382|NCT05127421|590386576|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
163461383|NCT05127421|590386577|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
163461384|NCT05127421|590386578|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
163461385|NCT05127421|590386579|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
163461386|NCT05127421|590386576|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
163461387|NCT05127421|590386577|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
163461388|NCT05127421|590386578|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
163461389|NCT05127421|590386579|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
163461390|NCT01714817|590386580|FG000|Year 1 Period|Lack of Efficacy|11|||
163461391|NCT01714817|590386581|FG001|Year 1 Period|Lack of Efficacy|9|||
163461392|NCT01714817|590386580|FG000|Year 1 Period|Adverse Event|20|||
163461393|NCT01714817|590386581|FG001|Year 1 Period|Adverse Event|17|||
163461394|NCT01714817|590386580|FG000|Year 1 Period|Withdrawal by Subject|6|||
163461395|NCT01714817|590386581|FG001|Year 1 Period|Withdrawal by Subject|7|||
163461396|NCT01714817|590386580|FG000|Year 1 Period|Death|1|||
163461397|NCT01714817|590386581|FG001|Year 1 Period|Death|1|||
163461398|NCT01714817|590386580|FG000|Year 1 Period|Lost to Follow-up|0|||
163461399|NCT01714817|590386581|FG001|Year 1 Period|Lost to Follow-up|2|||
163461400|NCT01714817|590386580|FG000|Year 1 Period|Poor / non-compliance|0|||
163461401|NCT01714817|590386581|FG001|Year 1 Period|Poor / non-compliance|1|||
163461402|NCT01714817|590386580|FG000|Year 1 Period|Pregnancy|2|||
163461403|NCT01714817|590386581|FG001|Year 1 Period|Pregnancy|0|||
163461404|NCT01714817|590386580|FG000|Year 1 Period|Participant no longer meets criteria|6|||
163461405|NCT01714817|590386581|FG001|Year 1 Period|Participant no longer meets criteria|2|||
163461406|NCT01714817|590386580|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
163461407|NCT01714817|590386581|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
163461408|NCT01714817|590386580|FG000|Year 1 Period|Change in Concomitant Medication|0|||
163461409|NCT01714817|590386581|FG001|Year 1 Period|Change in Concomitant Medication|1|||
163461410|NCT01714817|590386580|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
163461411|NCT01714817|590386581|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
163461412|NCT01714817|590386580|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
163461413|NCT01714817|590386581|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
163461414|NCT01714817|590386580|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
163461415|NCT01714817|590386581|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
163461416|NCT01714817|590386580|FG000|Year 2 Period|Lack of Efficacy|4|||
163461417|NCT01714817|590386581|FG001|Year 2 Period|Lack of Efficacy|12|||
163461418|NCT01714817|590386580|FG000|Year 2 Period|Adverse Event|7|||
163461419|NCT01714817|590386581|FG001|Year 2 Period|Adverse Event|6|||
163461420|NCT01714817|590386580|FG000|Year 2 Period|Participant request to stop treatment|4|||
163461421|NCT01714817|590386581|FG001|Year 2 Period|Participant request to stop treatment|4|||
163461422|NCT01714817|590386580|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
163461423|NCT01714817|590386581|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
163461424|NCT01714817|590386580|FG000|Year 2 Period|Participant withdrew consent|1|||
163461425|NCT01714817|590386581|FG001|Year 2 Period|Participant withdrew consent|5|||
163461426|NCT01714817|590386580|FG000|Year 2 Period|Participant no longer meets criteria|1|||
163461427|NCT01714817|590386581|FG001|Year 2 Period|Participant no longer meets criteria|4|||
163461428|NCT01714817|590386580|FG000|Year 2 Period|Lost to Follow-up|2|||
163461429|NCT01714817|590386581|FG001|Year 2 Period|Lost to Follow-up|0|||
163461430|NCT01714817|590386580|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
163461431|NCT01714817|590386581|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
163461432|NCT01714817|590386580|FG000|Year 2 Period|Pregnancy|1|||
163461433|NCT01714817|590386581|FG001|Year 2 Period|Pregnancy|1|||
163461434|NCT01714817|590386580|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
163461435|NCT01714817|590386581|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
163461436|NCT01714817|590386580|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
163461437|NCT01714817|590386581|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
163461438|NCT01714817|590386580|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
163461439|NCT01714817|590386581|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
163461440|NCT01714817|590386580|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
163461441|NCT01714817|590386581|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
163461442|NCT01714817|590386580|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
163461443|NCT01714817|590386581|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
163461444|NCT01714817|590386580|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
163461445|NCT01714817|590386581|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
163461446|NCT01714817|590386580|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
163461447|NCT01714817|590386581|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
163461448|NCT01714817|590386580|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
163461449|NCT01714817|590386581|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
163461450|NCT01714817|590386580|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
163461451|NCT01714817|590386581|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
163461452|NCT01714817|590386580|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
163461453|NCT01714817|590386581|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
163461454|NCT01714817|590386580|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
163461455|NCT01714817|590386581|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
163461456|NCT01714817|590386580|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
163461457|NCT01714817|590386581|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
163461458|NCT01714817|590386580|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
163461459|NCT01714817|590386581|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
163461460|NCT01714817|590386580|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
163461461|NCT01714817|590386581|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
163461462|NCT01714817|590386580|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
163461463|NCT01714817|590386581|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
163461464|NCT01714817|590386580|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
163461465|NCT01714817|590386581|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
163461466|NCT01374217|590386582|FG000|Overall Study|Lack of Efficacy|13|||
163461467|NCT02555657|590386583|FG000|Overall Study|Death|274|||
163461468|NCT02555657|590386584|FG001|Overall Study|Death|262|||
163461469|NCT02555657|590386583|FG000|Overall Study|Physician Decision|0|||
163461470|NCT02555657|590386584|FG001|Overall Study|Physician Decision|1|||
163461471|NCT02555657|590386583|FG000|Overall Study|Sponsor Decision|27|||
163461472|NCT02555657|590386584|FG001|Overall Study|Sponsor Decision|15|||
163461473|NCT02555657|590386583|FG000|Overall Study|Withdrawal by Subject|11|||
163461474|NCT02555657|590386584|FG001|Overall Study|Withdrawal by Subject|32|||
163461475|NCT00405821|590386587|FG000|Overall Study|Death|5|||
163461476|NCT00405821|590386588|FG001|Overall Study|Death|7|||
163461477|NCT00405821|590386587|FG000|Overall Study|Lost to Follow-up|7|||
163461478|NCT00405821|590386588|FG001|Overall Study|Lost to Follow-up|7|||
163461479|NCT00405821|590386587|FG000|Overall Study|Protocol Violation|1|||
163461480|NCT00405821|590386588|FG001|Overall Study|Protocol Violation|0|||
163461481|NCT00405821|590386587|FG000|Overall Study|initiated ART|9|||
163461482|NCT00405821|590386588|FG001|Overall Study|initiated ART|8|||
163461483|NCT01770145|590388663|FG000|Baseline|Adverse Event|20|||
163461484|NCT01770145|590388663|FG000|Baseline|Withdrawal by Subject|1|||
163461485|NCT01770145|590388663|FG000|Baseline|Lost to Follow-up|1|||
163461486|NCT01770145|590388663|FG000|Baseline|Unable to define optimal dose|4|||
163461487|NCT01770145|590388663|FG000|Treatment|Adverse Event|3|||
163461488|NCT01770145|590388663|FG000|Treatment|Withdrawal by Subject|1|||
163461489|NCT01102140|590388664|FG000|Overall Study|Lost to Follow-up|1|||
163461490|NCT01102140|590388665|FG001|Overall Study|Lost to Follow-up|0|||
163461491|NCT01102140|590388664|FG000|Overall Study|Investigator terminated study|2|||
163461492|NCT01102140|590388665|FG001|Overall Study|Investigator terminated study|2|||
163461493|NCT05406440|590388666|FG000|Overall Study|Lost to Follow-up|0|||
163461494|NCT05406440|590388667|FG001|Overall Study|Lost to Follow-up|0|||
163461495|NCT05406440|590388668|FG002|Overall Study|Lost to Follow-up|0|||
163461496|NCT05406440|590388669|FG003|Overall Study|Lost to Follow-up|0|||
163461497|NCT05406440|590388670|FG004|Overall Study|Lost to Follow-up|2|||
163461498|NCT05406440|590388671|FG005|Overall Study|Lost to Follow-up|0|||
163461499|NCT05406440|590388672|FG006|Overall Study|Lost to Follow-up|0|||
163461500|NCT05406440|590388666|FG000|Overall Study|Physician Decision|0|||
163461501|NCT05406440|590388667|FG001|Overall Study|Physician Decision|0|||
163461502|NCT05406440|590388668|FG002|Overall Study|Physician Decision|0|||
163461503|NCT05406440|590388669|FG003|Overall Study|Physician Decision|0|||
163461504|NCT05406440|590388670|FG004|Overall Study|Physician Decision|1|||
163461505|NCT05406440|590388671|FG005|Overall Study|Physician Decision|0|||
163461506|NCT05406440|590388672|FG006|Overall Study|Physician Decision|0|||
163461507|NCT05406440|590388666|FG000|Overall Study|Withdrawal by Subject|0|||
163461508|NCT05406440|590388667|FG001|Overall Study|Withdrawal by Subject|0|||
163461509|NCT05406440|590388668|FG002|Overall Study|Withdrawal by Subject|0|||
163461510|NCT05406440|590388669|FG003|Overall Study|Withdrawal by Subject|0|||
163461511|NCT05406440|590388670|FG004|Overall Study|Withdrawal by Subject|0|||
163461512|NCT05406440|590388671|FG005|Overall Study|Withdrawal by Subject|2|||
163461513|NCT05406440|590388672|FG006|Overall Study|Withdrawal by Subject|0|||
163461514|NCT01824693|590388678|FG000|Overall Study|Death|0|||
163461515|NCT01824693|590388679|FG001|Overall Study|Death|1|||
163461516|NCT01824693|590388680|FG002|Overall Study|Death|0|||
163461517|NCT01824693|590388678|FG000|Overall Study|Physician Decision|1|||
163461518|NCT01824693|590388679|FG001|Overall Study|Physician Decision|1|||
163461519|NCT01824693|590388680|FG002|Overall Study|Physician Decision|1|||
163461520|NCT01824693|590388678|FG000|Overall Study|Withdrawal by Subject|0|||
163461521|NCT01824693|590388679|FG001|Overall Study|Withdrawal by Subject|0|||
163461522|NCT01824693|590388680|FG002|Overall Study|Withdrawal by Subject|1|||
163461523|NCT01824693|590388678|FG000|Overall Study|Progressive Disease|0|||
163461524|NCT01824693|590388679|FG001|Overall Study|Progressive Disease|5|||
163461525|NCT01824693|590388680|FG002|Overall Study|Progressive Disease|0|||
163461526|NCT01824693|590388678|FG000|Overall Study|Ineligible|0|||
163461527|NCT01824693|590388679|FG001|Overall Study|Ineligible|0|||
163461528|NCT01824693|590388680|FG002|Overall Study|Ineligible|3|||
163461529|NCT01824693|590388678|FG000|Overall Study|No Transplant Planned|0|||
163461530|NCT01824693|590388679|FG001|Overall Study|No Transplant Planned|0|||
163461531|NCT01824693|590388680|FG002|Overall Study|No Transplant Planned|10|||
163461532|NCT02150213|590388681|FG000|Overall Study|Lost to Follow-up|1|||
163461533|NCT02150213|590388681|FG000|Overall Study|Withdrawal by Subject|1|||
163461534|NCT03488238|590388682|FG000|Overall Study|Equipment malfunction|1|||
163461535|NCT03488238|590388682|FG000|Overall Study|Adverse Event|1|||
163461536|NCT01432457|590388683|FG000|Overall Study|Adverse Event|7|||
163461537|NCT01432457|590388684|FG001|Overall Study|Adverse Event|10|||
163461538|NCT01432457|590388685|FG002|Overall Study|Adverse Event|16|||
163461539|NCT01432457|590388683|FG000|Overall Study|Lack of Efficacy|2|||
163461540|NCT01432457|590388684|FG001|Overall Study|Lack of Efficacy|1|||
163461541|NCT01432457|590388685|FG002|Overall Study|Lack of Efficacy|1|||
163461542|NCT01432457|590388683|FG000|Overall Study|Lost to Follow-up|11|||
163461543|NCT01432457|590388684|FG001|Overall Study|Lost to Follow-up|15|||
163461544|NCT01432457|590388685|FG002|Overall Study|Lost to Follow-up|20|||
163461545|NCT01432457|590388683|FG000|Overall Study|Protocol Violation|3|||
163461546|NCT01432457|590388684|FG001|Overall Study|Protocol Violation|2|||
163461547|NCT01432457|590388685|FG002|Overall Study|Protocol Violation|6|||
163461548|NCT01432457|590388683|FG000|Overall Study|Withdrawal by Subject|6|||
163461549|NCT01432457|590388684|FG001|Overall Study|Withdrawal by Subject|11|||
163461550|NCT01432457|590388685|FG002|Overall Study|Withdrawal by Subject|9|||
163461551|NCT01432457|590388683|FG000|Overall Study|Reasons not defined|2|||
163461552|NCT01432457|590388684|FG001|Overall Study|Reasons not defined|3|||
163461553|NCT01432457|590388685|FG002|Overall Study|Reasons not defined|4|||
163461554|NCT01432457|590388683|FG000|Overall Study|Did not take study drug|6|||
163461555|NCT01432457|590388684|FG001|Overall Study|Did not take study drug|6|||
163461556|NCT01432457|590388685|FG002|Overall Study|Did not take study drug|3|||
163461557|NCT04134728|590388686|FG000|Overall Study|Adverse Event|3|||
163461558|NCT04134728|590388687|FG001|Overall Study|Adverse Event|2|||
163461559|NCT04134728|590388688|FG002|Overall Study|Adverse Event|9|||
163461560|NCT04134728|590388689|FG003|Overall Study|Adverse Event|0|||
163461561|NCT04134728|590388690|FG004|Overall Study|Adverse Event|0|||
163461562|NCT04134728|590388691|FG005|Overall Study|Adverse Event|0|||
163461563|NCT04134728|590388686|FG000|Overall Study|Lack of Efficacy|3|||
163461564|NCT04134728|590388687|FG001|Overall Study|Lack of Efficacy|3|||
163461565|NCT04134728|590388688|FG002|Overall Study|Lack of Efficacy|1|||
163461566|NCT04134728|590388689|FG003|Overall Study|Lack of Efficacy|2|||
163461567|NCT04134728|590388690|FG004|Overall Study|Lack of Efficacy|0|||
163461568|NCT04134728|590388691|FG005|Overall Study|Lack of Efficacy|0|||
163461569|NCT04134728|590388686|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
163461570|NCT04134728|590388687|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163461571|NCT04134728|590388688|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
163461572|NCT04134728|590388689|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163461573|NCT04134728|590388690|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163461574|NCT04134728|590388691|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163461575|NCT04134728|590388686|FG000|Overall Study|Protocol Deviation|0|||
163461576|NCT04134728|590388687|FG001|Overall Study|Protocol Deviation|0|||
163461577|NCT04134728|590388688|FG002|Overall Study|Protocol Deviation|1|||
163461578|NCT04134728|590388689|FG003|Overall Study|Protocol Deviation|0|||
163461579|NCT04134728|590388690|FG004|Overall Study|Protocol Deviation|0|||
163461580|NCT04134728|590388691|FG005|Overall Study|Protocol Deviation|0|||
163461581|NCT04134728|590388686|FG000|Overall Study|Informed Consent Withdrawn|3|||
163461582|NCT04134728|590388687|FG001|Overall Study|Informed Consent Withdrawn|6|||
163461583|NCT04134728|590388688|FG002|Overall Study|Informed Consent Withdrawn|8|||
163461584|NCT04134728|590388689|FG003|Overall Study|Informed Consent Withdrawn|1|||
163461585|NCT04134728|590388690|FG004|Overall Study|Informed Consent Withdrawn|1|||
163461586|NCT04134728|590388691|FG005|Overall Study|Informed Consent Withdrawn|0|||
163461587|NCT04134728|590388686|FG000|Overall Study|Physician Decision|2|||
163461588|NCT04134728|590388687|FG001|Overall Study|Physician Decision|0|||
163461589|NCT04134728|590388688|FG002|Overall Study|Physician Decision|0|||
163461590|NCT04134728|590388689|FG003|Overall Study|Physician Decision|0|||
163461591|NCT04134728|590388690|FG004|Overall Study|Physician Decision|0|||
163461592|NCT04134728|590388691|FG005|Overall Study|Physician Decision|0|||
163461593|NCT04134728|590388686|FG000|Overall Study|Lost to Follow-up|1|||
163461594|NCT04134728|590388687|FG001|Overall Study|Lost to Follow-up|2|||
163461595|NCT04134728|590388688|FG002|Overall Study|Lost to Follow-up|1|||
163461596|NCT04134728|590388689|FG003|Overall Study|Lost to Follow-up|0|||
163461597|NCT04134728|590388690|FG004|Overall Study|Lost to Follow-up|0|||
163461598|NCT04134728|590388691|FG005|Overall Study|Lost to Follow-up|1|||
163461599|NCT04134728|590388686|FG000|Overall Study|Investigator Site Closed|0|||
163461600|NCT04134728|590388687|FG001|Overall Study|Investigator Site Closed|1|||
163461601|NCT04134728|590388688|FG002|Overall Study|Investigator Site Closed|1|||
163461602|NCT04134728|590388689|FG003|Overall Study|Investigator Site Closed|0|||
163461603|NCT04134728|590388690|FG004|Overall Study|Investigator Site Closed|0|||
163461604|NCT04134728|590388691|FG005|Overall Study|Investigator Site Closed|0|||
163461605|NCT00801892|590388692|FG000|Main Study Period|Withdrawal by Subject|0|||
163461606|NCT00801892|590388693|FG001|Main Study Period|Withdrawal by Subject|1|||
163461607|NCT00801892|590388692|FG000|Sham Crossover Period|Lost to Follow-up|0|||
163461608|NCT00801892|590388693|FG001|Sham Crossover Period|Lost to Follow-up|2|||
163461609|NCT01175590|590388695|FG000|Overall Study|Lost to Follow-up|1|||
163461610|NCT01175590|590388696|FG001|Overall Study|Lost to Follow-up|0|||
163461611|NCT01175590|590388695|FG000|Overall Study|Withdrawal by Subject|0|||
163461612|NCT01175590|590388696|FG001|Overall Study|Withdrawal by Subject|2|||
163461613|NCT01175590|590388695|FG000|Overall Study|Adverse Event|4|||
163461614|NCT01175590|590388696|FG001|Overall Study|Adverse Event|0|||
163461615|NCT01175590|590388695|FG000|Overall Study|Physician Decision|1|||
163461616|NCT01175590|590388696|FG001|Overall Study|Physician Decision|4|||
163461617|NCT01175590|590388695|FG000|Overall Study|Lack of Efficacy|1|||
163461618|NCT01175590|590388696|FG001|Overall Study|Lack of Efficacy|1|||
163461619|NCT01175590|590388695|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
163461620|NCT01175590|590388696|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
163461621|NCT01175590|590388695|FG000|Overall Study|Treated not as randomized|3|||
163461622|NCT01175590|590388696|FG001|Overall Study|Treated not as randomized|2|||
163461623|NCT01175590|590388695|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
163461624|NCT01175590|590388696|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
163461625|NCT01175590|590388695|FG000|Overall Study|Protocol Violation|0|||
163461626|NCT01175590|590388696|FG001|Overall Study|Protocol Violation|1|||
163461627|NCT02966353|590388697|FG000|Overall Study|Withdrawal by Subject|7|||
163461628|NCT02966353|590388697|FG000|Overall Study|Adverse Event|4|||
163461629|NCT02966353|590388697|FG000|Overall Study|Death|4|||
163461630|NCT02966353|590388697|FG000|Overall Study|Physician Decision|3|||
163461631|NCT02966353|590388697|FG000|Overall Study|Progressive disease|2|||
163461632|NCT02966353|590388697|FG000|Overall Study|Protocol deviation|2|||
163461633|NCT01090102|590388698|FG000|First 12 Weeks|Withdrawal by Subject|1|||
163461634|NCT01090102|590388699|FG001|First 12 Weeks|Withdrawal by Subject|1|||
163461635|NCT01090102|590388698|FG000|First 12 Weeks|Adverse Event|2|||
163461636|NCT01090102|590388699|FG001|First 12 Weeks|Adverse Event|0|||
163461637|NCT01090102|590388698|FG000|First 12 Weeks|Death|1|||
163461638|NCT01090102|590388699|FG001|First 12 Weeks|Death|1|||
163461639|NCT01090102|590388698|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
163461640|NCT01090102|590388699|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
163461641|NCT02062398|590388702|FG000|Overall Study|Implant removal|1|||
163461642|NCT01527110|590388703|FG000|Overall Study|Adverse Event|1|||
163461643|NCT00367341|590388704|FG000|Overall Study|Physician Decision|1|||
163461644|NCT00367341|590388705|FG001|Overall Study|Physician Decision|0|||
163461645|NCT00367341|590388704|FG000|Overall Study|Protocol Violation|1|||
163461646|NCT00367341|590388705|FG001|Overall Study|Protocol Violation|0|||
163461647|NCT01387074|590388706|FG000|Overall Study|Lost to Follow-up|7|||
163461648|NCT01387074|590388706|FG000|Overall Study|Lack of Efficacy|1|||
163461649|NCT00150345|590388707|FG000|Overall Study|Death|5|||
163461650|NCT00150345|590388708|FG001|Overall Study|Death|2|||
163461651|NCT00150345|590388707|FG000|Overall Study|Adverse Event|8|||
163461652|NCT00150345|590388708|FG001|Overall Study|Adverse Event|6|||
163461653|NCT00150345|590388707|FG000|Overall Study|Lack of Efficacy|5|||
163461654|NCT00150345|590388708|FG001|Overall Study|Lack of Efficacy|4|||
163461655|NCT00150345|590388707|FG000|Overall Study|Withdrawal by Subject|3|||
163461656|NCT00150345|590388708|FG001|Overall Study|Withdrawal by Subject|4|||
163461657|NCT00150345|590388707|FG000|Overall Study|Laboratory abnormality|1|||
163461658|NCT00150345|590388708|FG001|Overall Study|Laboratory abnormality|2|||
163461659|NCT00150345|590388707|FG000|Overall Study|Other|12|||
163461660|NCT00150345|590388708|FG001|Overall Study|Other|14|||
163461661|NCT01392742|590388709|FG000|Overall Study|Premature study termination|42|||
163461662|NCT01392742|590388709|FG000|Overall Study|Failure to return|35|||
163461663|NCT01392742|590388709|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
163461664|NCT01392742|590388709|FG000|Overall Study|Lost to Follow-up|34|||
163461665|NCT01392742|590388709|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
163461666|NCT01392742|590388709|FG000|Overall Study|ITR and Protocol deviation|1|||
163461667|NCT01392742|590388709|FG000|Overall Study|Adverse event/intercurrent illness|17|||
163461668|NCT01392742|590388709|FG000|Overall Study|Protocol Violation|14|||
163461669|NCT01392742|590388709|FG000|Overall Study|Other|3|||
163461670|NCT01392742|590388709|FG000|Overall Study|Missing information|13|||
163461671|NCT01998958|590388710|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461672|NCT01998958|590388711|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
163461673|NCT01998958|590388712|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461674|NCT01998958|590388713|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461675|NCT01998958|590388714|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461676|NCT01998958|590388715|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461677|NCT01998958|590388716|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461678|NCT01998958|590388717|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461679|NCT01998958|590388718|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461680|NCT01998958|590388719|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461681|NCT01998958|590388720|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461682|NCT01998958|590388721|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461683|NCT01998958|590388722|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461684|NCT01998958|590388723|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461685|NCT01998958|590388724|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461686|NCT01998958|590388725|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461687|NCT01998958|590388726|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461688|NCT01998958|590388727|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461689|NCT01998958|590388728|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461690|NCT01998958|590388729|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461691|NCT01998958|590388730|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461692|NCT01998958|590388731|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461693|NCT01998958|590388732|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461694|NCT01998958|590388733|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461695|NCT01998958|590388734|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461696|NCT01998958|590388735|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461697|NCT01998958|590388736|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461698|NCT01998958|590388737|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461699|NCT01998958|590388738|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461700|NCT01998958|590388739|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461701|NCT01998958|590388740|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461702|NCT01998958|590388741|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163461703|NCT01998958|590388710|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461704|NCT01998958|590388711|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
163461705|NCT01998958|590388712|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461706|NCT01998958|590388713|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461707|NCT01998958|590388714|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461708|NCT01998958|590388715|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461709|NCT01998958|590388716|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461710|NCT01998958|590388717|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461711|NCT01998958|590388718|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461712|NCT01998958|590388719|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461713|NCT01998958|590388720|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461714|NCT01998958|590388721|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461715|NCT01998958|590388722|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461716|NCT01998958|590388723|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461717|NCT01998958|590388724|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461718|NCT01998958|590388725|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461719|NCT01998958|590388726|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461720|NCT01998958|590388727|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461721|NCT01998958|590388728|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461722|NCT01998958|590388729|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461723|NCT01998958|590388730|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461724|NCT01998958|590388731|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461725|NCT01998958|590388732|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461726|NCT01998958|590388733|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461727|NCT01998958|590388734|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461728|NCT01998958|590388735|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461729|NCT01998958|590388736|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461730|NCT01998958|590388737|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461731|NCT01998958|590388738|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461732|NCT01998958|590388739|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461733|NCT01998958|590388740|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461734|NCT01998958|590388741|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163461735|NCT01998958|590388710|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
163461736|NCT01998958|590388711|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
163461737|NCT01998958|590388712|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
163461738|NCT01998958|590388713|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
163461739|NCT01998958|590388714|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
163461740|NCT01998958|590388715|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
163461741|NCT01998958|590388716|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
163461742|NCT01998958|590388717|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
163461743|NCT01998958|590388718|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
163461744|NCT01998958|590388719|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
163461745|NCT01998958|590388720|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
163461746|NCT01998958|590388721|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
163461747|NCT01998958|590388722|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
163461748|NCT01998958|590388723|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
163461749|NCT01998958|590388724|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
163461750|NCT01998958|590388725|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
163461751|NCT01998958|590388726|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
163461752|NCT01998958|590388727|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
163461753|NCT01998958|590388728|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
163461754|NCT01998958|590388729|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
163461755|NCT01998958|590388730|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
163461756|NCT01998958|590388731|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
163461757|NCT01998958|590388732|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
163461758|NCT01998958|590388733|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
163461759|NCT01998958|590388734|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
163461760|NCT01998958|590388735|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
163461761|NCT01998958|590388736|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
163461762|NCT01998958|590388737|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
163461763|NCT01998958|590388738|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
163461764|NCT01998958|590388739|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
163461765|NCT01998958|590388740|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
163461766|NCT01998958|590388741|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
163461767|NCT01998958|590388710|FG000|Period 1 (Panel A and B)|Other|1|||
163461768|NCT01998958|590388711|FG001|Period 1 (Panel A and B)|Other|0|||
163461769|NCT01998958|590388712|FG002|Period 1 (Panel A and B)|Other|0|||
163461770|NCT01998958|590388713|FG003|Period 1 (Panel A and B)|Other|0|||
163461771|NCT01998958|590388714|FG004|Period 1 (Panel A and B)|Other|0|||
163461772|NCT01998958|590388715|FG005|Period 1 (Panel A and B)|Other|0|||
163461773|NCT01998958|590388716|FG006|Period 1 (Panel A and B)|Other|0|||
163461774|NCT01998958|590388717|FG007|Period 1 (Panel A and B)|Other|0|||
163461775|NCT01998958|590388718|FG008|Period 1 (Panel A and B)|Other|0|||
163461776|NCT01998958|590388719|FG009|Period 1 (Panel A and B)|Other|0|||
163461777|NCT01998958|590388720|FG010|Period 1 (Panel A and B)|Other|0|||
163461778|NCT01998958|590388721|FG011|Period 1 (Panel A and B)|Other|0|||
163461779|NCT01998958|590388722|FG012|Period 1 (Panel A and B)|Other|0|||
163461780|NCT01998958|590388723|FG013|Period 1 (Panel A and B)|Other|0|||
163461781|NCT01998958|590388724|FG014|Period 1 (Panel A and B)|Other|0|||
163461782|NCT01998958|590388725|FG015|Period 1 (Panel A and B)|Other|0|||
163461783|NCT01998958|590388726|FG016|Period 1 (Panel A and B)|Other|0|||
163461784|NCT01998958|590388727|FG017|Period 1 (Panel A and B)|Other|0|||
163461785|NCT01998958|590388728|FG018|Period 1 (Panel A and B)|Other|0|||
163461786|NCT01998958|590388729|FG019|Period 1 (Panel A and B)|Other|0|||
163461787|NCT01998958|590388730|FG020|Period 1 (Panel A and B)|Other|0|||
163461788|NCT01998958|590388731|FG021|Period 1 (Panel A and B)|Other|0|||
163461789|NCT01998958|590388732|FG022|Period 1 (Panel A and B)|Other|0|||
163461790|NCT01998958|590388733|FG023|Period 1 (Panel A and B)|Other|0|||
163461791|NCT01998958|590388734|FG024|Period 1 (Panel A and B)|Other|0|||
163461792|NCT01998958|590388735|FG025|Period 1 (Panel A and B)|Other|0|||
163461793|NCT01998958|590388736|FG026|Period 1 (Panel A and B)|Other|0|||
163461794|NCT01998958|590388737|FG027|Period 1 (Panel A and B)|Other|0|||
163461795|NCT01998958|590388738|FG028|Period 1 (Panel A and B)|Other|0|||
163461796|NCT01998958|590388739|FG029|Period 1 (Panel A and B)|Other|0|||
163461797|NCT01998958|590388740|FG030|Period 1 (Panel A and B)|Other|0|||
163461798|NCT01998958|590388741|FG031|Period 1 (Panel A and B)|Other|0|||
163461799|NCT01998958|590388710|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
163461800|NCT01998958|590388711|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
163461801|NCT01998958|590388712|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
163461802|NCT01998958|590388713|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
163461803|NCT01998958|590388714|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
163461804|NCT01998958|590388715|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
163461805|NCT01998958|590388716|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
163461806|NCT01998958|590388717|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
163461807|NCT01998958|590388718|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
163461808|NCT01998958|590388719|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
163461809|NCT01998958|590388720|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
163461810|NCT01998958|590388721|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
163461811|NCT01998958|590388722|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
163461812|NCT01998958|590388723|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
163461813|NCT01998958|590388724|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
163461814|NCT01998958|590388725|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
163461815|NCT01998958|590388726|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
163461816|NCT01998958|590388727|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
163461817|NCT01998958|590388728|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
163461818|NCT01998958|590388729|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
163461819|NCT01998958|590388730|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
163461820|NCT01998958|590388731|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
163461821|NCT01998958|590388732|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
163461822|NCT01998958|590388733|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
163461823|NCT01998958|590388734|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
163461824|NCT01998958|590388735|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
163461825|NCT01998958|590388736|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
163461826|NCT01998958|590388737|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
163461827|NCT01998958|590388738|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
163461828|NCT01998958|590388739|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
163461829|NCT01998958|590388740|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
163461830|NCT01998958|590388741|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
163461831|NCT01998958|590388710|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461832|NCT01998958|590388711|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461833|NCT01998958|590388712|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461834|NCT01998958|590388713|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461835|NCT01998958|590388714|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461836|NCT01998958|590388715|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461837|NCT01998958|590388716|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461838|NCT01998958|590388717|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461839|NCT01998958|590388718|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461840|NCT01998958|590388719|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461841|NCT01998958|590388720|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461842|NCT01998958|590388721|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461843|NCT01998958|590388722|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461844|NCT01998958|590388723|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461845|NCT01998958|590388724|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
163461846|NCT01998958|590388725|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461847|NCT01998958|590388726|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461848|NCT01998958|590388727|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461849|NCT01998958|590388728|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
163461850|NCT01998958|590388729|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461851|NCT01998958|590388730|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461852|NCT01998958|590388731|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461853|NCT01998958|590388732|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461854|NCT01998958|590388733|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461855|NCT01998958|590388734|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461856|NCT01998958|590388735|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461857|NCT01998958|590388736|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461858|NCT01998958|590388737|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461859|NCT01998958|590388738|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461860|NCT01998958|590388739|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461861|NCT01998958|590388740|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461862|NCT01998958|590388741|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
163461863|NCT01998958|590388710|FG000|Open Label Phase (Optional)|Adverse Event|0|||
163461864|NCT01998958|590388711|FG001|Open Label Phase (Optional)|Adverse Event|0|||
163461865|NCT01998958|590388712|FG002|Open Label Phase (Optional)|Adverse Event|0|||
163461866|NCT01998958|590388713|FG003|Open Label Phase (Optional)|Adverse Event|0|||
163461867|NCT01998958|590388714|FG004|Open Label Phase (Optional)|Adverse Event|0|||
163461868|NCT01998958|590388715|FG005|Open Label Phase (Optional)|Adverse Event|0|||
163461869|NCT01998958|590388716|FG006|Open Label Phase (Optional)|Adverse Event|0|||
163461870|NCT01998958|590388717|FG007|Open Label Phase (Optional)|Adverse Event|0|||
163461871|NCT01998958|590388718|FG008|Open Label Phase (Optional)|Adverse Event|0|||
163461872|NCT01998958|590388719|FG009|Open Label Phase (Optional)|Adverse Event|0|||
163461873|NCT01998958|590388720|FG010|Open Label Phase (Optional)|Adverse Event|0|||
163461874|NCT01998958|590388721|FG011|Open Label Phase (Optional)|Adverse Event|0|||
163461875|NCT01998958|590388722|FG012|Open Label Phase (Optional)|Adverse Event|0|||
163461876|NCT01998958|590388723|FG013|Open Label Phase (Optional)|Adverse Event|0|||
163461877|NCT01998958|590388724|FG014|Open Label Phase (Optional)|Adverse Event|0|||
163461878|NCT01998958|590388725|FG015|Open Label Phase (Optional)|Adverse Event|0|||
163461879|NCT01998958|590388726|FG016|Open Label Phase (Optional)|Adverse Event|0|||
163461880|NCT01998958|590388727|FG017|Open Label Phase (Optional)|Adverse Event|0|||
163461881|NCT01998958|590388728|FG018|Open Label Phase (Optional)|Adverse Event|0|||
163461882|NCT01998958|590388729|FG019|Open Label Phase (Optional)|Adverse Event|0|||
163461883|NCT01998958|590388730|FG020|Open Label Phase (Optional)|Adverse Event|0|||
163461884|NCT01998958|590388731|FG021|Open Label Phase (Optional)|Adverse Event|0|||
163461885|NCT01998958|590388732|FG022|Open Label Phase (Optional)|Adverse Event|0|||
163461886|NCT01998958|590388733|FG023|Open Label Phase (Optional)|Adverse Event|1|||
163461887|NCT01998958|590388734|FG024|Open Label Phase (Optional)|Adverse Event|0|||
163461888|NCT01998958|590388735|FG025|Open Label Phase (Optional)|Adverse Event|0|||
163461889|NCT01998958|590388736|FG026|Open Label Phase (Optional)|Adverse Event|0|||
163461890|NCT01998958|590388737|FG027|Open Label Phase (Optional)|Adverse Event|0|||
163461891|NCT01998958|590388738|FG028|Open Label Phase (Optional)|Adverse Event|0|||
163461892|NCT01998958|590388739|FG029|Open Label Phase (Optional)|Adverse Event|0|||
163461893|NCT01998958|590388740|FG030|Open Label Phase (Optional)|Adverse Event|0|||
163461894|NCT01998958|590388741|FG031|Open Label Phase (Optional)|Adverse Event|0|||
163461895|NCT01998958|590388710|FG000|Open Label Phase (Optional)|Other|0|||
163461896|NCT01998958|590388711|FG001|Open Label Phase (Optional)|Other|0|||
163461897|NCT01998958|590388712|FG002|Open Label Phase (Optional)|Other|0|||
163461898|NCT01998958|590388713|FG003|Open Label Phase (Optional)|Other|0|||
163461899|NCT01998958|590388714|FG004|Open Label Phase (Optional)|Other|0|||
163461900|NCT01998958|590388715|FG005|Open Label Phase (Optional)|Other|0|||
163461901|NCT01998958|590388716|FG006|Open Label Phase (Optional)|Other|0|||
163461902|NCT01998958|590388717|FG007|Open Label Phase (Optional)|Other|0|||
163461903|NCT01998958|590388718|FG008|Open Label Phase (Optional)|Other|0|||
163461904|NCT01998958|590388719|FG009|Open Label Phase (Optional)|Other|0|||
163461905|NCT01998958|590388720|FG010|Open Label Phase (Optional)|Other|0|||
163461906|NCT01998958|590388721|FG011|Open Label Phase (Optional)|Other|0|||
163461907|NCT01998958|590388722|FG012|Open Label Phase (Optional)|Other|0|||
163461908|NCT01998958|590388723|FG013|Open Label Phase (Optional)|Other|0|||
163461909|NCT01998958|590388724|FG014|Open Label Phase (Optional)|Other|0|||
163461910|NCT01998958|590388725|FG015|Open Label Phase (Optional)|Other|0|||
163461911|NCT01998958|590388726|FG016|Open Label Phase (Optional)|Other|0|||
163461912|NCT01998958|590388727|FG017|Open Label Phase (Optional)|Other|0|||
163461913|NCT01998958|590388728|FG018|Open Label Phase (Optional)|Other|0|||
163461914|NCT01998958|590388729|FG019|Open Label Phase (Optional)|Other|0|||
163461915|NCT01998958|590388730|FG020|Open Label Phase (Optional)|Other|0|||
163461916|NCT01998958|590388731|FG021|Open Label Phase (Optional)|Other|0|||
163461917|NCT01998958|590388732|FG022|Open Label Phase (Optional)|Other|5|||
163461918|NCT01998958|590388733|FG023|Open Label Phase (Optional)|Other|1|||
163461919|NCT01998958|590388734|FG024|Open Label Phase (Optional)|Other|0|||
163461920|NCT01998958|590388735|FG025|Open Label Phase (Optional)|Other|0|||
163461921|NCT01998958|590388736|FG026|Open Label Phase (Optional)|Other|0|||
163461922|NCT01998958|590388737|FG027|Open Label Phase (Optional)|Other|0|||
163461923|NCT01998958|590388738|FG028|Open Label Phase (Optional)|Other|0|||
163461924|NCT01998958|590388739|FG029|Open Label Phase (Optional)|Other|0|||
163461925|NCT01998958|590388740|FG030|Open Label Phase (Optional)|Other|0|||
163461926|NCT01998958|590388741|FG031|Open Label Phase (Optional)|Other|0|||
163461927|NCT01998958|590388710|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461928|NCT01998958|590388711|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461929|NCT01998958|590388712|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461930|NCT01998958|590388713|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461931|NCT01998958|590388714|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461932|NCT01998958|590388715|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461933|NCT01998958|590388716|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461934|NCT01998958|590388717|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461935|NCT01998958|590388718|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461936|NCT01998958|590388719|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461937|NCT01998958|590388720|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461938|NCT01998958|590388721|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461939|NCT01998958|590388722|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461940|NCT01998958|590388723|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461941|NCT01998958|590388724|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461942|NCT01998958|590388725|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461943|NCT01998958|590388726|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461944|NCT01998958|590388727|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461945|NCT01998958|590388728|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461946|NCT01998958|590388729|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461947|NCT01998958|590388730|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461948|NCT01998958|590388731|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461949|NCT01998958|590388732|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
163461950|NCT01998958|590388733|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461951|NCT01998958|590388734|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461952|NCT01998958|590388735|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461953|NCT01998958|590388736|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461954|NCT01998958|590388737|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461955|NCT01998958|590388738|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461956|NCT01998958|590388739|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461957|NCT01998958|590388740|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461958|NCT01998958|590388741|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
163461959|NCT01998958|590388710|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461960|NCT01998958|590388711|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461961|NCT01998958|590388712|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461962|NCT01998958|590388713|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461963|NCT01998958|590388714|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461964|NCT01998958|590388715|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461965|NCT01998958|590388716|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461966|NCT01998958|590388717|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461967|NCT01998958|590388718|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461968|NCT01998958|590388719|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461969|NCT01998958|590388720|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461970|NCT01998958|590388721|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461971|NCT01998958|590388722|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461972|NCT01998958|590388723|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461973|NCT01998958|590388724|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461974|NCT01998958|590388725|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461975|NCT01998958|590388726|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461976|NCT01998958|590388727|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461977|NCT01998958|590388728|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461978|NCT01998958|590388729|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461979|NCT01998958|590388730|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461980|NCT01998958|590388731|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
163461981|NCT01998958|590388732|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
163461982|NCT01998958|590388733|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461983|NCT01998958|590388734|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461984|NCT01998958|590388735|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461985|NCT01998958|590388736|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461986|NCT01998958|590388737|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461987|NCT01998958|590388738|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461988|NCT01998958|590388739|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461989|NCT01998958|590388740|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461990|NCT01998958|590388741|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
163461991|NCT01998958|590388710|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163461992|NCT01998958|590388711|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163461993|NCT01998958|590388712|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163461994|NCT01998958|590388713|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163461995|NCT01998958|590388714|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163461996|NCT01998958|590388715|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163461997|NCT01998958|590388716|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163461998|NCT01998958|590388717|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163461999|NCT01998958|590388718|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462000|NCT01998958|590388719|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462001|NCT01998958|590388720|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462002|NCT01998958|590388721|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462003|NCT01998958|590388722|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462004|NCT01998958|590388723|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462005|NCT01998958|590388724|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462006|NCT01998958|590388725|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462007|NCT01998958|590388726|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462008|NCT01998958|590388727|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462009|NCT01998958|590388728|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462010|NCT01998958|590388729|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462011|NCT01998958|590388730|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462012|NCT01998958|590388731|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
163462013|NCT01998958|590388732|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
163462014|NCT01998958|590388733|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
163462015|NCT01998958|590388734|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462016|NCT01998958|590388735|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462017|NCT01998958|590388736|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462018|NCT01998958|590388737|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462019|NCT01998958|590388738|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462020|NCT01998958|590388739|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462021|NCT01998958|590388740|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462022|NCT01998958|590388741|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163462023|NCT02432703|590388742|FG000|Overall Study|Adverse Event|1|||
163462024|NCT02432703|590388743|FG001|Overall Study|Adverse Event|4|||
163462025|NCT02432703|590388742|FG000|Overall Study|Lack of Efficacy|1|||
163462026|NCT02432703|590388743|FG001|Overall Study|Lack of Efficacy|0|||
163462027|NCT02432703|590388742|FG000|Overall Study|Lost to Follow-up|5|||
163462028|NCT02432703|590388743|FG001|Overall Study|Lost to Follow-up|3|||
163462029|NCT02432703|590388742|FG000|Overall Study|Withdrawal by Subject|9|||
163462030|NCT02432703|590388743|FG001|Overall Study|Withdrawal by Subject|6|||
163462031|NCT02432703|590388742|FG000|Overall Study|Other|6|||
163462032|NCT02432703|590388743|FG001|Overall Study|Other|5|||
163462033|NCT02137837|590388747|FG000|Overall Study|Adverse Event|0|||
163462034|NCT02137837|590388748|FG001|Overall Study|Adverse Event|2|||
163462035|NCT02137837|590388749|FG002|Overall Study|Adverse Event|1|||
163462036|NCT02137837|590388747|FG000|Overall Study|Refusal unrelated to adverse event|2|||
163462037|NCT02137837|590388748|FG001|Overall Study|Refusal unrelated to adverse event|2|||
163462038|NCT02137837|590388749|FG002|Overall Study|Refusal unrelated to adverse event|1|||
163462039|NCT02137837|590388747|FG000|Overall Study|Progression/relapse|9|||
163462040|NCT02137837|590388748|FG001|Overall Study|Progression/relapse|7|||
163462041|NCT02137837|590388749|FG002|Overall Study|Progression/relapse|7|||
163462042|NCT02137837|590388747|FG000|Overall Study|Not protocol specified|2|||
163462043|NCT02137837|590388748|FG001|Overall Study|Not protocol specified|1|||
163462044|NCT02137837|590388749|FG002|Overall Study|Not protocol specified|3|||
163462045|NCT01329341|590388750|FG000|Overall Study|Withdrawal by Subject|44|||
163462046|NCT00448760|590388751|FG000|Overall Study|Death|3|||
163462047|NCT00561340|590388752|FG000|Overall Study|refused to drink pediasure|6|||
163462048|NCT00561340|590388753|FG001|Overall Study|refused to drink pediasure|0|||
163462049|NCT00618995|590388755|FG000|Period 1|Adverse Event|0|||
163462050|NCT00618995|590388756|FG001|Period 1|Adverse Event|0|||
163462051|NCT00618995|590388757|FG002|Period 1|Adverse Event|1|||
163462052|NCT00618995|590388758|FG003|Period 1|Adverse Event|0|||
163462053|NCT00618995|590388755|FG000|Period 1|Protocol Violation|0|||
163462054|NCT00618995|590388756|FG001|Period 1|Protocol Violation|1|||
163462055|NCT00618995|590388757|FG002|Period 1|Protocol Violation|1|||
163462056|NCT00618995|590388758|FG003|Period 1|Protocol Violation|0|||
163462057|NCT00618995|590388755|FG000|Period 2|Protocol Violation|0|||
163462058|NCT00618995|590388756|FG001|Period 2|Protocol Violation|0|||
163462059|NCT00618995|590388757|FG002|Period 2|Protocol Violation|1|||
163462060|NCT00618995|590388758|FG003|Period 2|Protocol Violation|0|||
163462061|NCT00618995|590388755|FG000|Period 4|Adverse Event|1|||
163462062|NCT00618995|590388756|FG001|Period 4|Adverse Event|0|||
163462063|NCT00618995|590388757|FG002|Period 4|Adverse Event|0|||
163462064|NCT00618995|590388758|FG003|Period 4|Adverse Event|0|||
163462065|NCT00290589|590388760|FG000|Overall Study|Lost to Follow-up|2|||
163462066|NCT00290589|590388761|FG001|Overall Study|Lost to Follow-up|2|||
163462067|NCT03814005|590388763|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
163462068|NCT03814005|590388764|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
163462069|NCT03814005|590388765|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
163462070|NCT03814005|590388763|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
163462071|NCT03814005|590388764|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
163462072|NCT03814005|590388765|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
163462073|NCT03814005|590388763|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
163462074|NCT03814005|590388764|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
163462075|NCT03814005|590388765|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
163462076|NCT03814005|590388763|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
163462077|NCT03814005|590388764|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
163462078|NCT03814005|590388765|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
163462079|NCT03814005|590388763|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
163462080|NCT03814005|590388764|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
163462081|NCT03814005|590388765|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
163462082|NCT03814005|590388763|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
163462083|NCT03814005|590388764|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
163462084|NCT03814005|590388765|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
163462085|NCT00965146|590388766|FG000|Overall Study|Death|7|||
163462086|NCT00965146|590388766|FG000|Overall Study|Lost to Follow-up|22|||
163462087|NCT00965146|590388766|FG000|Overall Study|Withdrawal by Subject|17|||
163462088|NCT00965146|590388766|FG000|Overall Study|Unable to return|1|||
163462089|NCT00965146|590388766|FG000|Overall Study|Unwilling to return|11|||
163462090|NCT00965146|590388766|FG000|Overall Study|Intercurrent illness|1|||
163462091|NCT00965146|590388766|FG000|Overall Study|Revision / Removal of Study Implant|6|||
163462092|NCT00965146|590388766|FG000|Overall Study|Overall Study Termination|145|||
163462093|NCT05067452|590388767|FG000|Overall Study|Lost to Follow-up|0|||
163462094|NCT05067452|590388768|FG001|Overall Study|Lost to Follow-up|4|||
163462095|NCT01135017|590388769|FG000|Overall Study|Adverse Event|3|||
163462096|NCT01135017|590388770|FG001|Overall Study|Adverse Event|8|||
163462097|NCT01135017|590388769|FG000|Overall Study|Other than above|3|||
163462098|NCT01135017|590388770|FG001|Overall Study|Other than above|4|||
163462099|NCT00432562|590388771|FG000|Overall Study|Death|3|||
163462100|NCT00432562|590388772|FG001|Overall Study|Death|0|||
163462101|NCT04311177|590388775|FG000|Overall Study|Adverse Event|3|||
163462102|NCT04311177|590388776|FG001|Overall Study|Adverse Event|1|||
163462103|NCT04311177|590388775|FG000|Overall Study|Physician Decision|4|||
163462104|NCT04311177|590388776|FG001|Overall Study|Physician Decision|3|||
163462105|NCT04311177|590388775|FG000|Overall Study|Withdrawal by Subject|1|||
163462106|NCT04311177|590388776|FG001|Overall Study|Withdrawal by Subject|0|||
163462107|NCT00964158|590388777|FG000|Overall Study|Lost to Follow-up|0|||
163462108|NCT00964158|590388778|FG001|Overall Study|Lost to Follow-up|1|||
163462109|NCT00964158|590388779|FG002|Overall Study|Lost to Follow-up|2|||
163462110|NCT00964158|590388777|FG000|Overall Study|Withdrawal by Subject|0|||
163462111|NCT00964158|590388778|FG001|Overall Study|Withdrawal by Subject|0|||
163462112|NCT00964158|590388779|FG002|Overall Study|Withdrawal by Subject|6|||
163462113|NCT00507416|590388780|FG000|Overall Study|Adverse Event|58|||
163462114|NCT00507416|590388781|FG001|Overall Study|Adverse Event|67|||
163462115|NCT00507416|590388782|FG002|Overall Study|Adverse Event|65|||
163462116|NCT00507416|590388780|FG000|Overall Study|Protocol Violation|1|||
163462117|NCT00507416|590388781|FG001|Overall Study|Protocol Violation|2|||
163462118|NCT00507416|590388782|FG002|Overall Study|Protocol Violation|0|||
163462119|NCT00507416|590388780|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
163462120|NCT00507416|590388781|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
163462121|NCT00507416|590388782|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
163462122|NCT00507416|590388780|FG000|Overall Study|Progressive Disease|20|||
163462123|NCT00507416|590388781|FG001|Overall Study|Progressive Disease|10|||
163462124|NCT00507416|590388782|FG002|Overall Study|Progressive Disease|13|||
163462125|NCT00507416|590388780|FG000|Overall Study|Patient declined further treatment|18|||
163462126|NCT00507416|590388781|FG001|Overall Study|Patient declined further treatment|14|||
163462127|NCT00507416|590388782|FG002|Overall Study|Patient declined further treatment|11|||
163462128|NCT00507416|590388780|FG000|Overall Study|Other|11|||
163462129|NCT00507416|590388781|FG001|Overall Study|Other|16|||
163462130|NCT00507416|590388782|FG002|Overall Study|Other|13|||
163462131|NCT00507416|590388780|FG000|Overall Study|Did not Receive Study Treatment|3|||
163462132|NCT00507416|590388781|FG001|Overall Study|Did not Receive Study Treatment|9|||
163462133|NCT00507416|590388782|FG002|Overall Study|Did not Receive Study Treatment|4|||
163462134|NCT03101514|590388783|FG000|Overall Study|Withdrawal by Subject|4|||
163462135|NCT03101514|590388783|FG000|Overall Study|Protocol Violation|2|||
163462136|NCT03101514|590388783|FG000|Overall Study|patient's information was incomplete|1|||
163462137|NCT03695393|590388792|FG000|Overall Study|Death|3|||
163462138|NCT03695393|590388793|FG001|Overall Study|Death|1|||
163462139|NCT03695393|590388792|FG000|Overall Study|Lost to Follow-up|0|||
163462140|NCT03695393|590388793|FG001|Overall Study|Lost to Follow-up|1|||
163462141|NCT04585451|590388794|FG000|Overall Study|Withdrawal by Subject|26|||
163462142|NCT04585451|590388795|FG001|Overall Study|Withdrawal by Subject|0|||
163462143|NCT01578785|590388796|FG000|Overall Study|Withdrawal by Subject|0|||
163462144|NCT01578785|590388797|FG001|Overall Study|Withdrawal by Subject|1|||
163462145|NCT01578785|590388796|FG000|Overall Study|Study terminated by sponsor|59|||
163462146|NCT01578785|590388797|FG001|Overall Study|Study terminated by sponsor|118|||
163462147|NCT00966693|590388798|FG000|Overall Study|Adverse Event|0|||
163462148|NCT00966693|590388799|FG001|Overall Study|Adverse Event|0|||
163462149|NCT00966693|590388800|FG002|Overall Study|Adverse Event|1|||
163462150|NCT00966693|590388801|FG003|Overall Study|Adverse Event|2|||
163462151|NCT00966693|590388798|FG000|Overall Study|Death|0|||
163462152|NCT00966693|590388799|FG001|Overall Study|Death|0|||
163462153|NCT00966693|590388800|FG002|Overall Study|Death|1|||
163462154|NCT00966693|590388801|FG003|Overall Study|Death|0|||
163462155|NCT00966693|590388798|FG000|Overall Study|Withdrawal by Subject|1|||
163462156|NCT00966693|590388799|FG001|Overall Study|Withdrawal by Subject|0|||
163462157|NCT00966693|590388800|FG002|Overall Study|Withdrawal by Subject|0|||
163462158|NCT00966693|590388801|FG003|Overall Study|Withdrawal by Subject|5|||
163462159|NCT00966693|590388798|FG000|Overall Study|Disease Progression|0|||
163462160|NCT00966693|590388799|FG001|Overall Study|Disease Progression|0|||
163462161|NCT00966693|590388800|FG002|Overall Study|Disease Progression|1|||
163462162|NCT00966693|590388801|FG003|Overall Study|Disease Progression|16|||
163462163|NCT02581982|590388802|FG000|Overall Study|Lack of Efficacy|12|||
163462164|NCT02581982|590388802|FG000|Overall Study|Adverse Event|3|||
163462165|NCT02581982|590388802|FG000|Overall Study|Physician Decision|1|||
163462166|NCT01769469|590388803|FG000|Overall Study|Consent Withdrawn|5|||
163462167|NCT01769469|590388803|FG000|Overall Study|Moved Out Of Area|3|||
163462168|NCT01769469|590388803|FG000|Overall Study|Lost to Follow-up|17|||
163462169|NCT01769469|590388803|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
163462170|NCT01769469|590388803|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
163462171|NCT02713789|590388815|FG000|Overall Study|Lost to Follow-up|0|||
163462172|NCT02713789|590388816|FG001|Overall Study|Lost to Follow-up|1|||
163462173|NCT02713789|590388817|FG002|Overall Study|Lost to Follow-up|1|||
163462174|NCT00141037|590388825|FG000|Overall Study|Physician Decision|1|||
163462175|NCT00141037|590388826|FG001|Overall Study|Physician Decision|2|||
163462176|NCT00141037|590388825|FG000|Overall Study|Lost to Follow-up|3|||
163462177|NCT00141037|590388826|FG001|Overall Study|Lost to Follow-up|1|||
163462178|NCT00141037|590388825|FG000|Overall Study|Protocol Violation|0|||
163462179|NCT00141037|590388826|FG001|Overall Study|Protocol Violation|2|||
163462180|NCT00141037|590388825|FG000|Overall Study|Withdrawal by Subject|2|||
163462181|NCT00141037|590388826|FG001|Overall Study|Withdrawal by Subject|1|||
163462182|NCT00141037|590388825|FG000|Overall Study|Other|0|||
163462183|NCT00141037|590388826|FG001|Overall Study|Other|1|||
163462184|NCT00141037|590388825|FG000|Overall Study|Moved from area|1|||
163462185|NCT00141037|590388826|FG001|Overall Study|Moved from area|7|||
163462186|NCT00141037|590388825|FG000|Overall Study|Graft Failure|3|||
163462187|NCT00141037|590388826|FG001|Overall Study|Graft Failure|4|||
163462188|NCT00888615|590388827|FG000|Overall Study|No treatment|2|||
163462189|NCT00861380|590388828|FG000|Overall Study|Withdrawal Information not recorded|8427|||
163462190|NCT00861380|590388829|FG001|Overall Study|Withdrawal Information not recorded|9112|||
163462191|NCT00861380|590388830|FG002|Overall Study|Withdrawal Information not recorded|8872|||
163462192|NCT00861380|590388831|FG003|Overall Study|Withdrawal Information not recorded|3689|||
163462193|NCT00861380|590388832|FG004|Overall Study|Withdrawal Information not recorded|1812|||
163462194|NCT00861380|590388833|FG005|Overall Study|Withdrawal Information not recorded|6249|||
163462195|NCT00861380|590388834|FG006|Overall Study|Withdrawal Information not recorded|3020|||
163462196|NCT00637377|590388835|FG000|Overall Study|Adverse Event|2|||
163462197|NCT00637377|590388836|FG001|Overall Study|Adverse Event|6|||
163462198|NCT00637377|590388837|FG002|Overall Study|Adverse Event|8|||
163462199|NCT00637377|590388838|FG003|Overall Study|Adverse Event|9|||
163462200|NCT00637377|590388835|FG000|Overall Study|Death|1|||
163462201|NCT00637377|590388836|FG001|Overall Study|Death|3|||
163462202|NCT00637377|590388837|FG002|Overall Study|Death|2|||
163462203|NCT00637377|590388838|FG003|Overall Study|Death|1|||
163462204|NCT00637377|590388835|FG000|Overall Study|Lack of Efficacy|0|||
163462205|NCT00637377|590388836|FG001|Overall Study|Lack of Efficacy|0|||
163462206|NCT00637377|590388837|FG002|Overall Study|Lack of Efficacy|1|||
163462207|NCT00637377|590388838|FG003|Overall Study|Lack of Efficacy|1|||
163462208|NCT00637377|590388835|FG000|Overall Study|Lost to Follow-up|4|||
163462209|NCT00637377|590388836|FG001|Overall Study|Lost to Follow-up|1|||
163462210|NCT00637377|590388837|FG002|Overall Study|Lost to Follow-up|2|||
163462211|NCT00637377|590388838|FG003|Overall Study|Lost to Follow-up|2|||
163462212|NCT00637377|590388835|FG000|Overall Study|Protocol Violation|2|||
163462213|NCT00637377|590388836|FG001|Overall Study|Protocol Violation|1|||
163462214|NCT00637377|590388837|FG002|Overall Study|Protocol Violation|1|||
163462215|NCT00637377|590388838|FG003|Overall Study|Protocol Violation|0|||
163462216|NCT00637377|590388835|FG000|Overall Study|Withdrawal by Subject|11|||
163462217|NCT00637377|590388836|FG001|Overall Study|Withdrawal by Subject|15|||
163462218|NCT00637377|590388837|FG002|Overall Study|Withdrawal by Subject|13|||
163462219|NCT00637377|590388838|FG003|Overall Study|Withdrawal by Subject|11|||
163462220|NCT00637377|590388835|FG000|Overall Study|Other (no further information available)|7|||
163462221|NCT00637377|590388836|FG001|Overall Study|Other (no further information available)|6|||
163462222|NCT00637377|590388837|FG002|Overall Study|Other (no further information available)|10|||
163462223|NCT00637377|590388838|FG003|Overall Study|Other (no further information available)|5|||
163462224|NCT01293084|590388840|FG000|Overall Study|Physician Decision|3|||
163462225|NCT01293084|590388840|FG000|Overall Study|Withdrawal by Subject|2|||
163462226|NCT04186663|590388841|FG000|Overall Study|Lost to Follow-up|1|||
163462227|NCT04186663|590388841|FG000|Overall Study|Unable to complete blood draw|3|||
163462228|NCT01375647|590390294|FG000|Overall Study|Lost to Follow-up|3|||
163462229|NCT01375647|590390295|FG001|Overall Study|Lost to Follow-up|3|||
163462230|NCT01375647|590390296|FG002|Overall Study|Lost to Follow-up|7|||
163462231|NCT01375647|590390297|FG003|Overall Study|Lost to Follow-up|10|||
163462232|NCT01375647|590390294|FG000|Overall Study|Death|1|||
163462233|NCT01375647|590390295|FG001|Overall Study|Death|2|||
163462234|NCT01375647|590390296|FG002|Overall Study|Death|1|||
163462235|NCT01375647|590390297|FG003|Overall Study|Death|0|||
163462236|NCT01375647|590390294|FG000|Overall Study|Withdrawal by Subject|17|||
163462237|NCT01375647|590390295|FG001|Overall Study|Withdrawal by Subject|20|||
163462238|NCT01375647|590390296|FG002|Overall Study|Withdrawal by Subject|26|||
163462239|NCT01375647|590390297|FG003|Overall Study|Withdrawal by Subject|14|||
163462240|NCT01375647|590390294|FG000|Overall Study|Physician Decision|1|||
163462241|NCT01375647|590390295|FG001|Overall Study|Physician Decision|0|||
163462242|NCT01375647|590390296|FG002|Overall Study|Physician Decision|0|||
163462243|NCT01375647|590390297|FG003|Overall Study|Physician Decision|0|||
163462244|NCT03788967|590390300|FG000|Overall Study|Lost to Follow-up|14|||
163462245|NCT03788967|590390301|FG001|Overall Study|Lost to Follow-up|10|||
163462246|NCT03788967|590390300|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
163462247|NCT03788967|590390301|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
163462248|NCT03788967|590390300|FG000|Overall Study|Participant Withdrawal of Consent|13|||
163462249|NCT03788967|590390301|FG001|Overall Study|Participant Withdrawal of Consent|5|||
163462250|NCT03788967|590390300|FG000|Overall Study|Adverse Event|1|||
163462251|NCT03788967|590390301|FG001|Overall Study|Adverse Event|1|||
163462252|NCT03788967|590390300|FG000|Overall Study|COVID-19|1|||
163462253|NCT03788967|590390301|FG001|Overall Study|COVID-19|2|||
163462254|NCT01316939|590390304|FG000|Overall Study|Study closed/terminated|26|||
163462255|NCT01316939|590390305|FG001|Overall Study|Study closed/terminated|25|||
163462256|NCT01316939|590390306|FG002|Overall Study|Study closed/terminated|23|||
163462257|NCT01316939|590390304|FG000|Overall Study|Lack of Efficacy|24|||
163462258|NCT01316939|590390305|FG001|Overall Study|Lack of Efficacy|25|||
163462259|NCT01316939|590390306|FG002|Overall Study|Lack of Efficacy|25|||
163462260|NCT01316939|590390304|FG000|Overall Study|Adverse Event|9|||
163462261|NCT01316939|590390305|FG001|Overall Study|Adverse Event|12|||
163462262|NCT01316939|590390306|FG002|Overall Study|Adverse Event|11|||
163462263|NCT01316939|590390304|FG000|Overall Study|Withdrawal by Subject|1|||
163462264|NCT01316939|590390305|FG001|Overall Study|Withdrawal by Subject|3|||
163462265|NCT01316939|590390306|FG002|Overall Study|Withdrawal by Subject|6|||
163462266|NCT01316939|590390304|FG000|Overall Study|Physician Decision|2|||
163462267|NCT01316939|590390305|FG001|Overall Study|Physician Decision|2|||
163462268|NCT01316939|590390306|FG002|Overall Study|Physician Decision|1|||
163462269|NCT01316939|590390304|FG000|Overall Study|Lost to Follow-up|0|||
163462270|NCT01316939|590390305|FG001|Overall Study|Lost to Follow-up|0|||
163462271|NCT01316939|590390306|FG002|Overall Study|Lost to Follow-up|2|||
163462272|NCT01316939|590390304|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
163462273|NCT01316939|590390305|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
163462274|NCT01316939|590390306|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
163462275|NCT01316939|590390304|FG000|Overall Study|Protocol Violation|0|||
163462276|NCT01316939|590390305|FG001|Overall Study|Protocol Violation|1|||
163462277|NCT01316939|590390306|FG002|Overall Study|Protocol Violation|0|||
163462278|NCT02715804|590390307|FG000|Overall Study|Death|222|||
163462279|NCT02715804|590390308|FG001|Overall Study|Death|106|||
163462280|NCT02715804|590390307|FG000|Overall Study|Withdrawal by Subject|5|||
163462281|NCT02715804|590390308|FG001|Overall Study|Withdrawal by Subject|4|||
163462282|NCT02715804|590390307|FG000|Overall Study|Other than specified|2|||
163462283|NCT02715804|590390308|FG001|Overall Study|Other than specified|3|||
163462284|NCT01281189|590390319|FG000|Overall Study|Adverse Event|7|||
163462285|NCT01281189|590390320|FG001|Overall Study|Adverse Event|9|||
163462286|NCT01281189|590390319|FG000|Overall Study|Lost to Follow-up|6|||
163462287|NCT01281189|590390320|FG001|Overall Study|Lost to Follow-up|4|||
163462288|NCT01281189|590390319|FG000|Overall Study|Withdrawal by Subject|21|||
163462289|NCT01281189|590390320|FG001|Overall Study|Withdrawal by Subject|24|||
163462290|NCT01281189|590390319|FG000|Overall Study|Physician Decision|2|||
163462291|NCT01281189|590390320|FG001|Overall Study|Physician Decision|3|||
163462292|NCT01281189|590390319|FG000|Overall Study|Death|103|||
163462293|NCT01281189|590390320|FG001|Overall Study|Death|91|||
163462294|NCT01281189|590390319|FG000|Overall Study|Other|8|||
163462295|NCT01281189|590390320|FG001|Overall Study|Other|12|||
163462296|NCT03351478|590390321|FG000|Overall Study|At the subject's own request|11|||
163462297|NCT03351478|590390322|FG001|Overall Study|At the subject's own request|12|||
163462298|NCT03351478|590390323|FG002|Overall Study|At the subject's own request|5|||
163462299|NCT03351478|590390321|FG000|Overall Study|Adverse Event|1|||
163462300|NCT03351478|590390322|FG001|Overall Study|Adverse Event|2|||
163462301|NCT03351478|590390323|FG002|Overall Study|Adverse Event|1|||
163462302|NCT03351478|590390321|FG000|Overall Study|Poor compliance to protocol|1|||
163462303|NCT03351478|590390322|FG001|Overall Study|Poor compliance to protocol|0|||
163462304|NCT03351478|590390323|FG002|Overall Study|Poor compliance to protocol|0|||
163462305|NCT03351478|590390321|FG000|Overall Study|Reason not Specified|1|||
163462306|NCT03351478|590390322|FG001|Overall Study|Reason not Specified|3|||
163462307|NCT03351478|590390323|FG002|Overall Study|Reason not Specified|0|||
163462308|NCT03351478|590390321|FG000|Overall Study|Lost to Follow-up|0|||
163462309|NCT03351478|590390322|FG001|Overall Study|Lost to Follow-up|0|||
163462310|NCT03351478|590390323|FG002|Overall Study|Lost to Follow-up|1|||
163462311|NCT03911869|590390326|FG000|Safety Lead-in Phase|Death|7|||
163462312|NCT03911869|590390327|FG001|Safety Lead-in Phase|Death|0|||
163462313|NCT03911869|590390328|FG002|Safety Lead-in Phase|Death|0|||
163462314|NCT03911869|590390326|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
163462315|NCT03911869|590390327|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
163462316|NCT03911869|590390328|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
163462317|NCT03911869|590390326|FG000|Safety Lead-in Phase|Other|1|||
163462318|NCT03911869|590390327|FG001|Safety Lead-in Phase|Other|0|||
163462319|NCT03911869|590390328|FG002|Safety Lead-in Phase|Other|0|||
163462320|NCT03911869|590390326|FG000|Phase 2|Death|0|||
163462321|NCT03911869|590390327|FG001|Phase 2|Death|3|||
163462322|NCT03911869|590390328|FG002|Phase 2|Death|0|||
163462323|NCT00527072|590390329|FG000|Overall Study|Adverse Event|13|||
163462324|NCT00527072|590390329|FG000|Overall Study|Lack of Efficacy|11|||
163462325|NCT00527072|590390329|FG000|Overall Study|Lost to Follow-up|3|||
163462326|NCT00527072|590390329|FG000|Overall Study|Protocol Violation|2|||
163462327|NCT00527072|590390329|FG000|Overall Study|Withdrawal by Subject|7|||
163462328|NCT02657434|590390330|FG000|Overall Study|Study Terminated By Sponsor|64|||
163462329|NCT02657434|590390331|FG001|Overall Study|Study Terminated By Sponsor|82|||
163462330|NCT02657434|590390330|FG000|Overall Study|Death|189|||
163462331|NCT02657434|590390331|FG001|Overall Study|Death|190|||
163462332|NCT02657434|590390330|FG000|Overall Study|Lost to Follow-up|2|||
163462333|NCT02657434|590390331|FG001|Overall Study|Lost to Follow-up|2|||
163462334|NCT02657434|590390330|FG000|Overall Study|Randomization by Error|2|||
163462335|NCT02657434|590390331|FG001|Overall Study|Randomization by Error|0|||
163462336|NCT02657434|590390330|FG000|Overall Study|Withdrawal by Subject|28|||
163462337|NCT02657434|590390331|FG001|Overall Study|Withdrawal by Subject|17|||
163462338|NCT02657434|590390330|FG000|Overall Study|Protocol Violation|1|||
163462339|NCT02657434|590390331|FG001|Overall Study|Protocol Violation|0|||
163462340|NCT02657434|590390330|FG000|Overall Study|Physician Decision|0|||
163462341|NCT02657434|590390331|FG001|Overall Study|Physician Decision|1|||
163462342|NCT00608881|590390332|FG000|Overall Study|Death|22|||
163462343|NCT00608881|590390333|FG001|Overall Study|Death|13|||
163462344|NCT00608881|590390332|FG000|Overall Study|Adverse Event|5|||
163462345|NCT00608881|590390333|FG001|Overall Study|Adverse Event|3|||
163462346|NCT00608881|590390332|FG000|Overall Study|Lost to Follow-up|28|||
163462347|NCT00608881|590390333|FG001|Overall Study|Lost to Follow-up|14|||
163462348|NCT00608881|590390332|FG000|Overall Study|Withdrawal by Subject|18|||
163462349|NCT00608881|590390333|FG001|Overall Study|Withdrawal by Subject|29|||
163462350|NCT00608881|590390332|FG000|Overall Study|Physician Decision|5|||
163462351|NCT00608881|590390333|FG001|Overall Study|Physician Decision|5|||
163462352|NCT00608881|590390332|FG000|Overall Study|Institutionalized|1|||
163462353|NCT00608881|590390333|FG001|Overall Study|Institutionalized|2|||
163462354|NCT00510484|590390335|FG000|Wash-out Period|Adverse Event|0|||
163462355|NCT00510484|590390336|FG001|Wash-out Period|Adverse Event|1|||
163462356|NCT01590212|590390337|FG000|Overall Study|Withdrawal by Subject|2|||
163462357|NCT01590212|590390338|FG001|Overall Study|Withdrawal by Subject|2|||
163462358|NCT01590212|590390339|FG002|Overall Study|Withdrawal by Subject|2|||
163462359|NCT01590212|590390337|FG000|Overall Study|Lost to Follow-up|1|||
163462360|NCT01590212|590390338|FG001|Overall Study|Lost to Follow-up|2|||
163462361|NCT01590212|590390339|FG002|Overall Study|Lost to Follow-up|3|||
163462362|NCT02533401|590390340|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
163462363|NCT02533401|590390340|FG000|Overall Study|Death|5|||
163462364|NCT02533401|590390340|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
163462365|NCT02533401|590390340|FG000|Overall Study|Lost to Follow-up|1|||
163462366|NCT02533401|590390340|FG000|Overall Study|Violation of Selection Criteria|1|||
163462367|NCT01106391|590390343|FG000|Overall Study|Death|12|||
163462368|NCT01106391|590390343|FG000|Overall Study|Withdrawal by Subject|7|||
163462369|NCT04897594|590390346|FG000|Overall Study|Lost to Follow-up|0|||
163462370|NCT04897594|590390347|FG001|Overall Study|Lost to Follow-up|1|||
163462371|NCT04897594|590390348|FG002|Overall Study|Lost to Follow-up|1|||
163462372|NCT04897594|590390346|FG000|Overall Study|Sponsor Decision|0|||
163462373|NCT04897594|590390347|FG001|Overall Study|Sponsor Decision|0|||
163462374|NCT04897594|590390348|FG002|Overall Study|Sponsor Decision|1|||
163462375|NCT04897594|590390346|FG000|Overall Study|Withdrawal by Subject|1|||
163462376|NCT04897594|590390347|FG001|Overall Study|Withdrawal by Subject|0|||
163462377|NCT04897594|590390348|FG002|Overall Study|Withdrawal by Subject|1|||
163462378|NCT02147691|590390351|FG000|Overall Study|Withdrawal by Subject|2|||
163462379|NCT02147691|590390352|FG001|Overall Study|Withdrawal by Subject|0|||
163462380|NCT02147691|590390351|FG000|Overall Study|Adverse Event|2|||
163462381|NCT02147691|590390352|FG001|Overall Study|Adverse Event|0|||
163462382|NCT02147691|590390351|FG000|Overall Study|Lost to Follow-up|0|||
163462383|NCT02147691|590390352|FG001|Overall Study|Lost to Follow-up|1|||
163462384|NCT01181141|590390355|FG000|Overall Study|Adverse Event|2|||
163462385|NCT01181141|590390356|FG001|Overall Study|Adverse Event|1|||
163462386|NCT01181141|590390355|FG000|Overall Study|Lack of Efficacy|1|||
163462387|NCT01181141|590390356|FG001|Overall Study|Lack of Efficacy|0|||
163462388|NCT01181141|590390355|FG000|Overall Study|Lost to Follow-up|1|||
163462389|NCT01181141|590390356|FG001|Overall Study|Lost to Follow-up|1|||
163462390|NCT01181141|590390355|FG000|Overall Study|Physician Decision|2|||
163462391|NCT01181141|590390356|FG001|Overall Study|Physician Decision|0|||
163462392|NCT01181141|590390355|FG000|Overall Study|Protocol Violation|3|||
163462393|NCT01181141|590390356|FG001|Overall Study|Protocol Violation|1|||
163462394|NCT01181141|590390355|FG000|Overall Study|Withdrawal by Subject|3|||
163462395|NCT01181141|590390356|FG001|Overall Study|Withdrawal by Subject|1|||
163462396|NCT00118911|590390357|FG000|Overall Study|Withdrawal by Subject|2|||
163462397|NCT00118911|590390358|FG001|Overall Study|Withdrawal by Subject|5|||
163462398|NCT05014542|590390359|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
163462399|NCT05014542|590390360|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
163462400|NCT05014542|590390359|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
163462401|NCT05014542|590390360|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
163462402|NCT05014542|590390359|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
163462403|NCT05014542|590390360|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
163462404|NCT05014542|590390359|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
163462405|NCT05014542|590390360|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
163462406|NCT03496662|590390361|FG000|Overall Study|Adverse Event|0|||
163462407|NCT03496662|590390362|FG001|Overall Study|Adverse Event|0|||
163462408|NCT03496662|590390363|FG002|Overall Study|Adverse Event|4|||
163462409|NCT03496662|590390361|FG000|Overall Study|Withdrawal by Subject|1|||
163462410|NCT03496662|590390362|FG001|Overall Study|Withdrawal by Subject|0|||
163462411|NCT03496662|590390363|FG002|Overall Study|Withdrawal by Subject|2|||
163462412|NCT03496662|590390361|FG000|Overall Study|Death|0|||
163462413|NCT03496662|590390362|FG001|Overall Study|Death|0|||
163462414|NCT03496662|590390363|FG002|Overall Study|Death|2|||
163462415|NCT03496662|590390361|FG000|Overall Study|Noncompliance|0|||
163462416|NCT03496662|590390362|FG001|Overall Study|Noncompliance|0|||
163462417|NCT03496662|590390363|FG002|Overall Study|Noncompliance|1|||
163462418|NCT01467661|590390364|FG000|Overall Study|Adverse Event|16|||
163462419|NCT01467661|590390364|FG000|Overall Study|Withdrawal by Subject|1|||
163462420|NCT01467661|590390364|FG000|Overall Study|Lack of Efficacy|3|||
163462421|NCT01467661|590390364|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
163462422|NCT00691093|590390366|FG000|Overall Study|Adverse Event|1|||
163462423|NCT00691093|590390366|FG000|Overall Study|Lost to Follow-up|1|||
163462424|NCT00691093|590390366|FG000|Overall Study|Lack of Efficacy|1|||
163462425|NCT00691093|590390366|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
163462426|NCT03395223|590390368|FG000|Overall Study|Lost to Follow-up|3|||
163462427|NCT03395223|590390368|FG000|Overall Study|Other|1|||
163462428|NCT00810810|590390369|FG000|Overall Study|Withdrawal by Subject|0|||
163462429|NCT00810810|590390370|FG001|Overall Study|Withdrawal by Subject|8|||
163462430|NCT00810810|590390371|FG002|Overall Study|Withdrawal by Subject|10|||
163462431|NCT00810810|590390372|FG003|Overall Study|Withdrawal by Subject|8|||
163462432|NCT00810810|590390369|FG000|Overall Study|Physician Decision|0|||
163462433|NCT00810810|590390370|FG001|Overall Study|Physician Decision|3|||
163462434|NCT00810810|590390371|FG002|Overall Study|Physician Decision|1|||
163462435|NCT00810810|590390372|FG003|Overall Study|Physician Decision|5|||
163462436|NCT01896856|590390373|FG000|Overall Study|Transportation issues / Non-compliance|0|||
163462437|NCT01896856|590390374|FG001|Overall Study|Transportation issues / Non-compliance|0|||
163462438|NCT01896856|590390375|FG002|Overall Study|Transportation issues / Non-compliance|1|||
163462439|NCT01896856|590390376|FG003|Overall Study|Transportation issues / Non-compliance|0|||
163462440|NCT01896856|590390377|FG004|Overall Study|Transportation issues / Non-compliance|0|||
163462441|NCT01896856|590390378|FG005|Overall Study|Transportation issues / Non-compliance|0|||
163462442|NCT01156532|590390379|FG000|Overall Study|Family Reasons|1|||
163462443|NCT01156532|590390379|FG000|Overall Study|Lost to Follow-up|1|||
163462444|NCT02563925|590390382|FG000|Overall Study|Withdrawal by Subject|2|||
163462445|NCT00282867|590390386|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
163462446|NCT00282867|590390387|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
163462447|NCT00282867|590390388|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
163462448|NCT00673894|590390399|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
163462449|NCT00673894|590390400|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
163462450|NCT00673894|590390399|FG000|First Intervention 4 Weeks|Adverse Event|1|||
163462451|NCT00673894|590390400|FG001|First Intervention 4 Weeks|Adverse Event|0|||
163462452|NCT02726113|590390411|FG000|Total Enrollment|Physician Decision|0|||
163462453|NCT02726113|590390412|FG001|Total Enrollment|Physician Decision|1|||
163462454|NCT02726113|590390411|FG000|Total Enrollment|Protocol Violation|1|||
163462455|NCT02726113|590390412|FG001|Total Enrollment|Protocol Violation|0|||
163462456|NCT02726113|590390411|FG000|Total Enrollment|Withdrawal by Subject|2|||
163462457|NCT02726113|590390412|FG001|Total Enrollment|Withdrawal by Subject|1|||
163462458|NCT02726113|590390411|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
163462459|NCT02726113|590390412|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
163462460|NCT02726113|590390411|FG000|Genomic Analysis|Protocol Violation|1|||
163462461|NCT02726113|590390412|FG001|Genomic Analysis|Protocol Violation|0|||
163462462|NCT02726113|590390411|FG000|Genomic Analysis|Withdrawal by Subject|2|||
163462463|NCT02726113|590390412|FG001|Genomic Analysis|Withdrawal by Subject|1|||
163462464|NCT02726113|590390411|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
163462465|NCT02726113|590390412|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
163462466|NCT03549117|590390413|FG000|Overall Study|Withdrawal by Subject|1|||
163462467|NCT03549117|590390414|FG001|Overall Study|Withdrawal by Subject|0|||
163462468|NCT03820726|590390415|FG000|Overall Study|Other than listed|23|||
163462469|NCT03820726|590390415|FG000|Overall Study|Withdrawal by Subject|37|||
163462470|NCT03820726|590390415|FG000|Overall Study|Lost to Follow-up|3|||
163462471|NCT03820726|590390415|FG000|Overall Study|Protocol deviation|1|||
163462472|NCT03820726|590390415|FG000|Overall Study|Adverse Event|146|||
163462473|NCT03820726|590390415|FG000|Overall Study|Not treated|1|||
163462474|NCT00719862|590390423|FG000|Overall Study|Adverse Event|1|||
163462475|NCT00719862|590390424|FG001|Overall Study|Adverse Event|2|||
163462476|NCT00719862|590390423|FG000|Overall Study|Lack of Efficacy|3|||
163462477|NCT00719862|590390424|FG001|Overall Study|Lack of Efficacy|0|||
163462478|NCT00719862|590390423|FG000|Overall Study|Non-Compliance|1|||
163462479|NCT00719862|590390424|FG001|Overall Study|Non-Compliance|0|||
163462480|NCT00719862|590390423|FG000|Overall Study|Withdrawal by Subject|1|||
163462481|NCT00719862|590390424|FG001|Overall Study|Withdrawal by Subject|0|||
163462482|NCT00719862|590390423|FG000|Overall Study|Lost to Follow-up|0|||
163462483|NCT00719862|590390424|FG001|Overall Study|Lost to Follow-up|1|||
163462484|NCT00719862|590390423|FG000|Overall Study|Other|2|||
163462485|NCT00719862|590390424|FG001|Overall Study|Other|3|||
163462486|NCT01736254|590390425|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
163462487|NCT01736254|590390425|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
163462488|NCT00107172|590392349|FG000|Overall Study|Withdrawal by Subject|1|||
163462489|NCT00107172|590392350|FG001|Overall Study|Withdrawal by Subject|0|||
163462490|NCT00107172|590392349|FG000|Overall Study|Death|0|||
163462491|NCT00107172|590392350|FG001|Overall Study|Death|2|||
163462492|NCT00107172|590392349|FG000|Overall Study|Other Reason|4|||
163462493|NCT00107172|590392350|FG001|Overall Study|Other Reason|3|||
163462494|NCT04268303|590392351|FG000|Overall Study|Lost to Follow-up|1|||
163462495|NCT04268303|590392352|FG001|Overall Study|Lost to Follow-up|1|||
163462496|NCT04268303|590392353|FG002|Overall Study|Lost to Follow-up|2|||
163462497|NCT04268303|590392351|FG000|Overall Study|Withdrawal by Subject|0|||
163462498|NCT04268303|590392352|FG001|Overall Study|Withdrawal by Subject|1|||
163462499|NCT04268303|590392353|FG002|Overall Study|Withdrawal by Subject|1|||
163462500|NCT04268303|590392351|FG000|Overall Study|Adverse Event|2|||
163462501|NCT04268303|590392352|FG001|Overall Study|Adverse Event|0|||
163462502|NCT04268303|590392353|FG002|Overall Study|Adverse Event|0|||
163462503|NCT00355134|590392354|FG000|Core Phase|Withdrawal by Subject|35|||
163462504|NCT00355134|590392355|FG001|Core Phase|Withdrawal by Subject|24|||
163462505|NCT00355134|590392356|FG002|Core Phase|Withdrawal by Subject|35|||
163462506|NCT00355134|590392357|FG003|Core Phase|Withdrawal by Subject|0|||
163462507|NCT00355134|590392358|FG004|Core Phase|Withdrawal by Subject|0|||
163462508|NCT00355134|590392354|FG000|Core Phase|Adverse Event|28|||
163462509|NCT00355134|590392355|FG001|Core Phase|Adverse Event|22|||
163462510|NCT00355134|590392356|FG002|Core Phase|Adverse Event|16|||
163462511|NCT00355134|590392357|FG003|Core Phase|Adverse Event|0|||
163462512|NCT00355134|590392358|FG004|Core Phase|Adverse Event|0|||
163462513|NCT00355134|590392354|FG000|Core Phase|Lost to Follow-up|17|||
163462514|NCT00355134|590392355|FG001|Core Phase|Lost to Follow-up|13|||
163462515|NCT00355134|590392356|FG002|Core Phase|Lost to Follow-up|21|||
163462516|NCT00355134|590392357|FG003|Core Phase|Lost to Follow-up|0|||
163462517|NCT00355134|590392358|FG004|Core Phase|Lost to Follow-up|0|||
163462518|NCT00355134|590392354|FG000|Core Phase|Abnormal laboratory value(s)|19|||
163462519|NCT00355134|590392355|FG001|Core Phase|Abnormal laboratory value(s)|14|||
163462520|NCT00355134|590392356|FG002|Core Phase|Abnormal laboratory value(s)|2|||
163462521|NCT00355134|590392357|FG003|Core Phase|Abnormal laboratory value(s)|0|||
163462522|NCT00355134|590392358|FG004|Core Phase|Abnormal laboratory value(s)|0|||
163462523|NCT00355134|590392354|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
163462524|NCT00355134|590392355|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
163462525|NCT00355134|590392356|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
163462526|NCT00355134|590392357|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
163462527|NCT00355134|590392358|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
163462528|NCT00355134|590392354|FG000|Core Phase|Administrative problems|5|||
163462529|NCT00355134|590392355|FG001|Core Phase|Administrative problems|3|||
163462530|NCT00355134|590392356|FG002|Core Phase|Administrative problems|5|||
163462531|NCT00355134|590392357|FG003|Core Phase|Administrative problems|0|||
163462532|NCT00355134|590392358|FG004|Core Phase|Administrative problems|0|||
163462533|NCT00355134|590392354|FG000|Core Phase|Protocol Violation|3|||
163462534|NCT00355134|590392355|FG001|Core Phase|Protocol Violation|2|||
163462535|NCT00355134|590392356|FG002|Core Phase|Protocol Violation|2|||
163462536|NCT00355134|590392357|FG003|Core Phase|Protocol Violation|0|||
163462537|NCT00355134|590392358|FG004|Core Phase|Protocol Violation|0|||
163462538|NCT00355134|590392354|FG000|Core Phase|Abnormal test procedure result(s)|1|||
163462539|NCT00355134|590392355|FG001|Core Phase|Abnormal test procedure result(s)|2|||
163462540|NCT00355134|590392356|FG002|Core Phase|Abnormal test procedure result(s)|1|||
163462541|NCT00355134|590392357|FG003|Core Phase|Abnormal test procedure result(s)|0|||
163462542|NCT00355134|590392358|FG004|Core Phase|Abnormal test procedure result(s)|0|||
163462543|NCT00355134|590392354|FG000|Core Phase|Condition no longer requires study drug|1|||
163462544|NCT00355134|590392355|FG001|Core Phase|Condition no longer requires study drug|0|||
163462545|NCT00355134|590392356|FG002|Core Phase|Condition no longer requires study drug|1|||
163462546|NCT00355134|590392357|FG003|Core Phase|Condition no longer requires study drug|0|||
163462547|NCT00355134|590392358|FG004|Core Phase|Condition no longer requires study drug|0|||
163462548|NCT00355134|590392354|FG000|Extension Phase|Withdrawal by Subject|7|||
163462549|NCT00355134|590392355|FG001|Extension Phase|Withdrawal by Subject|11|||
163462550|NCT00355134|590392356|FG002|Extension Phase|Withdrawal by Subject|0|||
163462551|NCT00355134|590392357|FG003|Extension Phase|Withdrawal by Subject|7|||
163462552|NCT00355134|590392358|FG004|Extension Phase|Withdrawal by Subject|5|||
163462553|NCT00355134|590392354|FG000|Extension Phase|Adverse Event|13|||
163462554|NCT00355134|590392355|FG001|Extension Phase|Adverse Event|9|||
163462555|NCT00355134|590392356|FG002|Extension Phase|Adverse Event|0|||
163462556|NCT00355134|590392357|FG003|Extension Phase|Adverse Event|3|||
163462557|NCT00355134|590392358|FG004|Extension Phase|Adverse Event|5|||
163462558|NCT00355134|590392354|FG000|Extension Phase|Lost to Follow-up|2|||
163462559|NCT00355134|590392355|FG001|Extension Phase|Lost to Follow-up|6|||
163462560|NCT00355134|590392356|FG002|Extension Phase|Lost to Follow-up|0|||
163462561|NCT00355134|590392357|FG003|Extension Phase|Lost to Follow-up|2|||
163462562|NCT00355134|590392358|FG004|Extension Phase|Lost to Follow-up|4|||
163462563|NCT00355134|590392354|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
163462564|NCT00355134|590392355|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
163462565|NCT00355134|590392356|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
163462566|NCT00355134|590392357|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
163462567|NCT00355134|590392358|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
163462568|NCT00355134|590392354|FG000|Extension Phase|Administrative problems|2|||
163462569|NCT00355134|590392355|FG001|Extension Phase|Administrative problems|4|||
163462570|NCT00355134|590392356|FG002|Extension Phase|Administrative problems|0|||
163462571|NCT00355134|590392357|FG003|Extension Phase|Administrative problems|1|||
163462572|NCT00355134|590392358|FG004|Extension Phase|Administrative problems|1|||
163462573|NCT00355134|590392354|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
163462574|NCT00355134|590392355|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
163462575|NCT00355134|590392356|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
163462576|NCT00355134|590392357|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
163462577|NCT00355134|590392358|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
163462578|NCT00355134|590392354|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
163462579|NCT00355134|590392355|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
163462580|NCT00355134|590392356|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
163462581|NCT00355134|590392357|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
163462582|NCT00355134|590392358|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
163462583|NCT00355134|590392354|FG000|Extension Phase|Protocol Violation|0|||
163462584|NCT00355134|590392355|FG001|Extension Phase|Protocol Violation|0|||
163462585|NCT00355134|590392356|FG002|Extension Phase|Protocol Violation|0|||
163462586|NCT00355134|590392357|FG003|Extension Phase|Protocol Violation|1|||
163462587|NCT00355134|590392358|FG004|Extension Phase|Protocol Violation|0|||
163462588|NCT04432376|590392359|FG000|Double-blind Treatment Period|Adverse Event|2|||
163462589|NCT04432376|590392360|FG001|Double-blind Treatment Period|Adverse Event|6|||
163462590|NCT04432376|590392361|FG002|Double-blind Treatment Period|Adverse Event|0|||
163462591|NCT04432376|590392359|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
163462592|NCT04432376|590392360|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
163462593|NCT04432376|590392361|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
163462594|NCT04432376|590392359|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
163462595|NCT04432376|590392360|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
163462596|NCT04432376|590392361|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
163462597|NCT04432376|590392359|FG000|Double-blind Treatment Period|Protocol Violation|0|||
163462598|NCT04432376|590392360|FG001|Double-blind Treatment Period|Protocol Violation|1|||
163462599|NCT04432376|590392361|FG002|Double-blind Treatment Period|Protocol Violation|0|||
163462600|NCT04432376|590392359|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
163462601|NCT04432376|590392360|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
163462602|NCT04432376|590392361|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
163462603|NCT03706040|590392362|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
163462604|NCT03706040|590392363|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
163462605|NCT03706040|590392364|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
163462606|NCT03706040|590392365|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
163462607|NCT03706040|590392366|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
163462608|NCT03706040|590392367|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
163462609|NCT03706040|590392368|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
163462610|NCT03706040|590392362|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
163462611|NCT03706040|590392363|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
163462612|NCT03706040|590392364|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
163462613|NCT03706040|590392365|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
163462614|NCT03706040|590392366|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
163462615|NCT03706040|590392367|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
163462616|NCT03706040|590392368|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
163462617|NCT03706040|590392362|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
163462618|NCT03706040|590392363|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
163462619|NCT03706040|590392364|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
163462620|NCT03706040|590392365|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
163462621|NCT03706040|590392366|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
163462622|NCT03706040|590392367|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
163462623|NCT03706040|590392368|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
163462624|NCT03706040|590392362|FG000|Period A (Week 0 to Week 16)|Other|2|||
163462625|NCT03706040|590392363|FG001|Period A (Week 0 to Week 16)|Other|0|||
163462626|NCT03706040|590392364|FG002|Period A (Week 0 to Week 16)|Other|2|||
163462627|NCT03706040|590392365|FG003|Period A (Week 0 to Week 16)|Other|0|||
163462628|NCT03706040|590392366|FG004|Period A (Week 0 to Week 16)|Other|0|||
163462629|NCT03706040|590392367|FG005|Period A (Week 0 to Week 16)|Other|0|||
163462630|NCT03706040|590392368|FG006|Period A (Week 0 to Week 16)|Other|0|||
163462631|NCT03706040|590392362|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
163462632|NCT03706040|590392363|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
163462633|NCT03706040|590392364|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
163462634|NCT03706040|590392365|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
163462635|NCT03706040|590392366|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
163462636|NCT03706040|590392367|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
163462637|NCT03706040|590392368|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
163462638|NCT03706040|590392362|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
163462639|NCT03706040|590392363|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
163462640|NCT03706040|590392364|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
163462641|NCT03706040|590392365|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
163462642|NCT03706040|590392366|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
163462643|NCT03706040|590392367|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
163462644|NCT03706040|590392368|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
163462645|NCT03706040|590392362|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
163462646|NCT03706040|590392363|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
163462647|NCT03706040|590392364|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
163462648|NCT03706040|590392365|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
163462649|NCT03706040|590392366|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
163462650|NCT03706040|590392367|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
163462651|NCT03706040|590392368|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
163462652|NCT03706040|590392362|FG000|Period B (Week 16 to Week 52)|Other|0|||
163462653|NCT03706040|590392363|FG001|Period B (Week 16 to Week 52)|Other|0|||
163462654|NCT03706040|590392364|FG002|Period B (Week 16 to Week 52)|Other|0|||
163462655|NCT03706040|590392365|FG003|Period B (Week 16 to Week 52)|Other|4|||
163462656|NCT03706040|590392366|FG004|Period B (Week 16 to Week 52)|Other|5|||
163462657|NCT03706040|590392367|FG005|Period B (Week 16 to Week 52)|Other|23|||
163462658|NCT03706040|590392368|FG006|Period B (Week 16 to Week 52)|Other|17|||
163462659|NCT00927758|590392369|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
163462660|NCT00927758|590392370|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
163462661|NCT00927758|590392371|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
163462662|NCT00927758|590392372|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
163462663|NCT00927758|590392373|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
163462664|NCT00927758|590392374|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
163462665|NCT00927758|590392369|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
163462666|NCT00927758|590392370|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
163462667|NCT00927758|590392371|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
163462668|NCT00927758|590392372|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
163462669|NCT00927758|590392373|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
163462670|NCT00927758|590392374|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
163462671|NCT00439725|590392375|FG000|Treatment Period|Withdrawal by Subject|22|||
163462672|NCT00439725|590392376|FG001|Treatment Period|Withdrawal by Subject|19|||
163462673|NCT00439725|590392375|FG000|Treatment Period|Study terminated by sponsor|156|||
163462674|NCT00439725|590392376|FG001|Treatment Period|Study terminated by sponsor|148|||
163462675|NCT00439725|590392375|FG000|Treatment Period|Site closed by investigator|1|||
163462676|NCT00439725|590392376|FG001|Treatment Period|Site closed by investigator|2|||
163462677|NCT00439725|590392375|FG000|Treatment Period|Adverse Event|39|||
163462678|NCT00439725|590392376|FG001|Treatment Period|Adverse Event|18|||
163462679|NCT00439725|590392375|FG000|Treatment Period|Physician Decision|1|||
163462680|NCT00439725|590392376|FG001|Treatment Period|Physician Decision|1|||
163462681|NCT00439725|590392375|FG000|Treatment Period|Protocol Violation|2|||
163462682|NCT00439725|590392376|FG001|Treatment Period|Protocol Violation|1|||
163462683|NCT00439725|590392375|FG000|Treatment Period|Clinical endpoint reached|6|||
163462684|NCT00439725|590392376|FG001|Treatment Period|Clinical endpoint reached|50|||
163462685|NCT00439725|590392375|FG000|Treatment Period|Technical problems|1|||
163462686|NCT00439725|590392376|FG001|Treatment Period|Technical problems|0|||
163462687|NCT00439725|590392375|FG000|Treatment Period|Lost to Follow-up|1|||
163462688|NCT00439725|590392376|FG001|Treatment Period|Lost to Follow-up|1|||
163462689|NCT00439725|590392375|FG000|Treatment Period|Participant convenience|1|||
163462690|NCT00439725|590392376|FG001|Treatment Period|Participant convenience|0|||
163462691|NCT00439725|590392375|FG000|Treatment Period|Protocol driven decision point|1|||
163462692|NCT00439725|590392376|FG001|Treatment Period|Protocol driven decision point|1|||
163462693|NCT00439725|590392375|FG000|Treatment Period|Death|1|||
163462694|NCT00439725|590392376|FG001|Treatment Period|Death|1|||
163462695|NCT00439725|590392375|FG000|Treatment Period|Participant did not receive treatment|4|||
163462696|NCT00439725|590392376|FG001|Treatment Period|Participant did not receive treatment|4|||
163462697|NCT00439725|590392375|FG000|Observational Period|Withdrawal by Subject|2|||
163462698|NCT00439725|590392376|FG001|Observational Period|Withdrawal by Subject|2|||
163462699|NCT00439725|590392375|FG000|Observational Period|Lost to Follow-up|0|||
163462700|NCT00439725|590392376|FG001|Observational Period|Lost to Follow-up|1|||
163462701|NCT00439725|590392375|FG000|Observational Period|Death|0|||
163462702|NCT00439725|590392376|FG001|Observational Period|Death|2|||
163462703|NCT00439725|590392375|FG000|Observational Period|Study termination by sponsor|1|||
163462704|NCT00439725|590392376|FG001|Observational Period|Study termination by sponsor|1|||
163462705|NCT00439725|590392375|FG000|Observational Period|Clinical endpoint reached|3|||
163462706|NCT00439725|590392376|FG001|Observational Period|Clinical endpoint reached|1|||
163462707|NCT00439725|590392375|FG000|Observational Period|Technical problems|1|||
163462708|NCT00439725|590392376|FG001|Observational Period|Technical problems|0|||
163462709|NCT00439725|590392375|FG000|Observational Period|Participant convenience|1|||
163462710|NCT00439725|590392376|FG001|Observational Period|Participant convenience|0|||
163462711|NCT03510910|590392377|FG000|Overall Study|Incomplete Survey|2|||
163462712|NCT03510910|590392378|FG001|Overall Study|Incomplete Survey|3|||
163462713|NCT01673490|590392379|FG000|Overall Study|Lost to Follow-up|1|||
163462714|NCT01673490|590392379|FG000|Overall Study|Adverse Event|3|||
163462715|NCT01673490|590392379|FG000|Overall Study|Withdrawal by Subject|3|||
163462716|NCT00379236|590392380|FG000|Double-blind|Adverse Event|11|||
163462717|NCT00379236|590392381|FG001|Double-blind|Adverse Event|6|||
163462718|NCT00379236|590392382|FG002|Double-blind|Adverse Event|0|||
163462719|NCT00379236|590392380|FG000|Double-blind|Protocol Violation|3|||
163462720|NCT00379236|590392381|FG001|Double-blind|Protocol Violation|3|||
163462721|NCT00379236|590392382|FG002|Double-blind|Protocol Violation|0|||
163462722|NCT00379236|590392380|FG000|Double-blind|Withdrawal by Subject|12|||
163462723|NCT00379236|590392381|FG001|Double-blind|Withdrawal by Subject|13|||
163462724|NCT00379236|590392382|FG002|Double-blind|Withdrawal by Subject|0|||
163462725|NCT00379236|590392380|FG000|Double-blind|Lost to Follow-up|4|||
163462726|NCT00379236|590392381|FG001|Double-blind|Lost to Follow-up|3|||
163462727|NCT00379236|590392382|FG002|Double-blind|Lost to Follow-up|0|||
163462728|NCT00379236|590392380|FG000|Double-blind|Use of exclusionary medication|1|||
163462729|NCT00379236|590392381|FG001|Double-blind|Use of exclusionary medication|2|||
163462730|NCT00379236|590392382|FG002|Double-blind|Use of exclusionary medication|0|||
163462731|NCT00379236|590392380|FG000|Double-blind|Other|3|||
163462732|NCT00379236|590392381|FG001|Double-blind|Other|7|||
163462733|NCT00379236|590392382|FG002|Double-blind|Other|0|||
163462734|NCT00379236|590392380|FG000|Double-blind|Data could not be retrieved|2|||
163462735|NCT00379236|590392381|FG001|Double-blind|Data could not be retrieved|2|||
163462736|NCT00379236|590392382|FG002|Double-blind|Data could not be retrieved|0|||
163462737|NCT00379236|590392380|FG000|Open-label Extension|Adverse Event|0|||
163462738|NCT00379236|590392381|FG001|Open-label Extension|Adverse Event|0|||
163462739|NCT00379236|590392382|FG002|Open-label Extension|Adverse Event|13|||
163462740|NCT00379236|590392380|FG000|Open-label Extension|Protocol Violation|0|||
163462741|NCT00379236|590392381|FG001|Open-label Extension|Protocol Violation|0|||
163462742|NCT00379236|590392382|FG002|Open-label Extension|Protocol Violation|7|||
163462743|NCT00379236|590392380|FG000|Open-label Extension|Withdrawal by Subject|0|||
163462744|NCT00379236|590392381|FG001|Open-label Extension|Withdrawal by Subject|0|||
163462745|NCT00379236|590392382|FG002|Open-label Extension|Withdrawal by Subject|13|||
163462746|NCT00379236|590392380|FG000|Open-label Extension|Lost to Follow-up|0|||
163462747|NCT00379236|590392381|FG001|Open-label Extension|Lost to Follow-up|0|||
163462748|NCT00379236|590392382|FG002|Open-label Extension|Lost to Follow-up|12|||
163462749|NCT00379236|590392380|FG000|Open-label Extension|Use of exclusionary medication|0|||
163462750|NCT00379236|590392381|FG001|Open-label Extension|Use of exclusionary medication|0|||
163462751|NCT00379236|590392382|FG002|Open-label Extension|Use of exclusionary medication|3|||
163462752|NCT00379236|590392380|FG000|Open-label Extension|Other|0|||
163462753|NCT00379236|590392381|FG001|Open-label Extension|Other|0|||
163462754|NCT00379236|590392382|FG002|Open-label Extension|Other|7|||
163462755|NCT02940860|590392388|FG000|Overall Study|Non-serious AE|1|||
163462756|NCT02940860|590392389|FG001|Overall Study|Non-serious AE|2|||
163462757|NCT02940860|590392388|FG000|Overall Study|Serious AE|7|||
163462758|NCT02940860|590392389|FG001|Overall Study|Serious AE|3|||
163462759|NCT02940860|590392388|FG000|Overall Study|Withdrawal by Subject|19|||
163462760|NCT02940860|590392389|FG001|Overall Study|Withdrawal by Subject|9|||
163462761|NCT02940860|590392388|FG000|Overall Study|Lost to Follow-up|13|||
163462762|NCT02940860|590392389|FG001|Overall Study|Lost to Follow-up|7|||
163462763|NCT02940860|590392388|FG000|Overall Study|Physician Decision|5|||
163462764|NCT02940860|590392389|FG001|Overall Study|Physician Decision|3|||
163462765|NCT02940860|590392388|FG000|Overall Study|Sponsor Decision|0|||
163462766|NCT02940860|590392389|FG001|Overall Study|Sponsor Decision|1|||
163462767|NCT02940860|590392388|FG000|Overall Study|Protocol Violation|0|||
163462768|NCT02940860|590392389|FG001|Overall Study|Protocol Violation|2|||
163462769|NCT02940860|590392388|FG000|Overall Study|Death|3|||
163462770|NCT02940860|590392389|FG001|Overall Study|Death|2|||
163462771|NCT02940860|590392388|FG000|Overall Study|Moved, poor venous access, transport|6|||
163462772|NCT02940860|590392389|FG001|Overall Study|Moved, poor venous access, transport|4|||
163462773|NCT02940860|590392388|FG000|Overall Study|Not treated|2|||
163462774|NCT02940860|590392389|FG001|Overall Study|Not treated|2|||
163462775|NCT04914819|590392390|FG000|Overall Study|Pregnancy|3|||
163462776|NCT04914819|590392391|FG001|Overall Study|Pregnancy|1|||
163462777|NCT04914819|590392390|FG000|Overall Study|Discontinued study|4|||
163462778|NCT04914819|590392391|FG001|Overall Study|Discontinued study|1|||
163462779|NCT04914819|590392390|FG000|Overall Study|Lost to Follow-up|7|||
163462780|NCT04914819|590392391|FG001|Overall Study|Lost to Follow-up|0|||
163462781|NCT01625611|590392395|FG000|Overall Study|No adlib drinks Lab 1|3|||
163462782|NCT01625611|590392396|FG001|Overall Study|No adlib drinks Lab 1|0|||
163462783|NCT01625611|590392395|FG000|Overall Study|Technical issues with PET|1|||
163462784|NCT01625611|590392396|FG001|Overall Study|Technical issues with PET|0|||
163462785|NCT01625611|590392395|FG000|Overall Study|Unable to complete study procedures|1|||
163462786|NCT01625611|590392396|FG001|Overall Study|Unable to complete study procedures|0|||
163462787|NCT01625611|590392395|FG000|Overall Study|Withdrawal by Subject|3|||
163462788|NCT01625611|590392396|FG001|Overall Study|Withdrawal by Subject|0|||
163462789|NCT00948194|590392397|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
163462790|NCT00948194|590392398|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
163462791|NCT02431793|590392399|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
163462792|NCT02431793|590392400|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
163462793|NCT02431793|590392401|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
163462794|NCT02431793|590392399|FG000|Overall Study|Withdrawal by Subject|7|||
163462795|NCT02431793|590392400|FG001|Overall Study|Withdrawal by Subject|5|||
163462796|NCT02431793|590392401|FG002|Overall Study|Withdrawal by Subject|5|||
163462797|NCT02431793|590392399|FG000|Overall Study|Lost to Follow-up|101|||
163462798|NCT02431793|590392400|FG001|Overall Study|Lost to Follow-up|122|||
163462799|NCT02431793|590392401|FG002|Overall Study|Lost to Follow-up|104|||
163462800|NCT00233324|590392402|FG000|Main Study|Death|68|||
163462801|NCT00233324|590392403|FG001|Main Study|Death|60|||
163462802|NCT00233324|590392404|FG002|Main Study|Death|62|||
163462803|NCT00233324|590392405|FG003|Main Study|Death|47|||
163462804|NCT00233324|590392402|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
163462805|NCT00233324|590392403|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
163462806|NCT00233324|590392404|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
163462807|NCT00233324|590392405|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
163462808|NCT00233324|590392402|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
163462809|NCT00233324|590392403|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
163462810|NCT00233324|590392404|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
163462811|NCT00233324|590392405|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
163462812|NCT01711541|590392412|FG000|Overall Study|Cancel prior to treatment|0|||
163462813|NCT01711541|590392413|FG001|Overall Study|Cancel prior to treatment|0|||
163462814|NCT01711541|590392414|FG002|Overall Study|Cancel prior to treatment|0|||
163462815|NCT01711541|590392415|FG003|Overall Study|Cancel prior to treatment|1|||
163462816|NCT01711541|590392416|FG004|Overall Study|Cancel prior to treatment|0|||
163462817|NCT01711541|590392412|FG000|Overall Study|Ineligible|0|||
163462818|NCT01711541|590392413|FG001|Overall Study|Ineligible|1|||
163462819|NCT01711541|590392414|FG002|Overall Study|Ineligible|0|||
163462820|NCT01711541|590392415|FG003|Overall Study|Ineligible|0|||
163462821|NCT01711541|590392416|FG004|Overall Study|Ineligible|0|||
163462822|NCT00728936|590392417|FG000|Overall Study|Withdrawal by Subject|0|||
163462823|NCT00728936|590392418|FG001|Overall Study|Withdrawal by Subject|0|||
163462824|NCT00728936|590392419|FG002|Overall Study|Withdrawal by Subject|0|||
163462825|NCT00728936|590392420|FG003|Overall Study|Withdrawal by Subject|0|||
163462826|NCT00728936|590392421|FG004|Overall Study|Withdrawal by Subject|0|||
163462827|NCT00728936|590392422|FG005|Overall Study|Withdrawal by Subject|1|||
163462828|NCT00728936|590392423|FG006|Overall Study|Withdrawal by Subject|0|||
163462829|NCT00438464|590392424|FG000|Overall Study|Terminated Early|14|||
163462830|NCT00438464|590392425|FG001|Overall Study|Terminated Early|5|||
163462831|NCT00438464|590392424|FG000|Overall Study|Incomplete data submission|0|||
163462832|NCT00438464|590392425|FG001|Overall Study|Incomplete data submission|2|||
163462833|NCT03943446|590392426|FG000|Overall Study|Lost to Follow-up|0|||
163462834|NCT03943446|590392427|FG001|Overall Study|Lost to Follow-up|0|||
163462835|NCT03943446|590392428|FG002|Overall Study|Lost to Follow-up|1|||
163462836|NCT03943446|590392426|FG000|Overall Study|Withdrawal by Subject|1|||
163462837|NCT03943446|590392427|FG001|Overall Study|Withdrawal by Subject|1|||
163462838|NCT03943446|590392428|FG002|Overall Study|Withdrawal by Subject|2|||
163462839|NCT03943446|590392426|FG000|Overall Study|Study Terminated by Sponsor|1|||
163462840|NCT03943446|590392427|FG001|Overall Study|Study Terminated by Sponsor|2|||
163462841|NCT03943446|590392428|FG002|Overall Study|Study Terminated by Sponsor|1|||
163462842|NCT03943446|590392426|FG000|Overall Study|Reason not Specified|5|||
163462843|NCT03943446|590392427|FG001|Overall Study|Reason not Specified|1|||
163462844|NCT03943446|590392428|FG002|Overall Study|Reason not Specified|3|||
163462845|NCT02707601|590392431|FG000|Overall Study|Death|0|||
163462846|NCT02707601|590392432|FG001|Overall Study|Death|1|||
163462847|NCT02707601|590392431|FG000|Overall Study|Lack of Efficacy|0|||
163462848|NCT02707601|590392432|FG001|Overall Study|Lack of Efficacy|1|||
163462849|NCT02707601|590392431|FG000|Overall Study|Investigator's Discretion|1|||
163462850|NCT02707601|590392432|FG001|Overall Study|Investigator's Discretion|0|||
163462851|NCT02707601|590392431|FG000|Overall Study|Withdrew Consent|0|||
163462852|NCT02707601|590392432|FG001|Overall Study|Withdrew Consent|1|||
163462853|NCT02707601|590392431|FG000|Overall Study|Lost to Follow-up|1|||
163462854|NCT02707601|590392432|FG001|Overall Study|Lost to Follow-up|1|||
163462855|NCT02707601|590392431|FG000|Overall Study|Participants Randomized but Not Treated|2|||
163462856|NCT02707601|590392432|FG001|Overall Study|Participants Randomized but Not Treated|0|||
163462857|NCT03004976|590392438|FG000|Overall Study|Lost to Follow-up|7|||
163462858|NCT03004976|590392439|FG001|Overall Study|Lost to Follow-up|5|||
163462859|NCT03004976|590392438|FG000|Overall Study|Physician Decision|1|||
163462860|NCT03004976|590392439|FG001|Overall Study|Physician Decision|0|||
163462861|NCT03004976|590392438|FG000|Overall Study|Withdrawal by Subject|1|||
163462862|NCT03004976|590392439|FG001|Overall Study|Withdrawal by Subject|0|||
163462863|NCT03004976|590392438|FG000|Overall Study|Death|4|||
163462864|NCT03004976|590392439|FG001|Overall Study|Death|1|||
163462865|NCT01665768|590392440|FG000|Overall Study|Adverse Event|3|||
163462866|NCT01665768|590392440|FG000|Overall Study|Lack of Efficacy|19|||
163462867|NCT01665768|590392440|FG000|Overall Study|Withdrawal by Subject|1|||
163462868|NCT01117012|590392443|FG000|Overall Study|Adverse Event|0|||
163462869|NCT01117012|590392444|FG001|Overall Study|Adverse Event|1|||
163462870|NCT01117012|590392443|FG000|Overall Study|Death|1|||
163462871|NCT01117012|590392444|FG001|Overall Study|Death|1|||
163462872|NCT01117012|590392443|FG000|Overall Study|Withdrawal by Subject|3|||
163462873|NCT01117012|590392444|FG001|Overall Study|Withdrawal by Subject|0|||
163462874|NCT01117012|590392443|FG000|Overall Study|Undefined|4|||
163462875|NCT01117012|590392444|FG001|Overall Study|Undefined|3|||
163462876|NCT00493974|590392448|FG000|Overall Study|Death|1|||
163462877|NCT00493974|590392449|FG001|Overall Study|Death|2|||
163462878|NCT00493974|590392448|FG000|Overall Study|Withdrawal by Subject|8|||
163462879|NCT00493974|590392449|FG001|Overall Study|Withdrawal by Subject|6|||
163462880|NCT00493974|590392448|FG000|Overall Study|Lost to Follow-up|4|||
163462881|NCT00493974|590392449|FG001|Overall Study|Lost to Follow-up|6|||
163462882|NCT00326417|590392450|FG000|Overall Study|Withdrawal by Subject|0|||
163462883|NCT00326417|590392451|FG001|Overall Study|Withdrawal by Subject|0|||
163462884|NCT00326417|590392452|FG002|Overall Study|Withdrawal by Subject|1|||
163462885|NCT00326417|590392453|FG003|Overall Study|Withdrawal by Subject|0|||
163462886|NCT00326417|590392450|FG000|Overall Study|Arm Closed|7|||
163462887|NCT00326417|590392451|FG001|Overall Study|Arm Closed|0|||
163462888|NCT00326417|590392452|FG002|Overall Study|Arm Closed|0|||
163462889|NCT00326417|590392453|FG003|Overall Study|Arm Closed|3|||
163462890|NCT00326417|590392450|FG000|Overall Study|Death|7|||
163462891|NCT00326417|590392451|FG001|Overall Study|Death|0|||
163462892|NCT00326417|590392452|FG002|Overall Study|Death|0|||
163462893|NCT00326417|590392453|FG003|Overall Study|Death|0|||
163462894|NCT00844285|590392454|FG000|Overall Study|Other|0|||
163462895|NCT00844285|590392455|FG001|Overall Study|Other|1|||
163462896|NCT00844285|590392456|FG002|Overall Study|Other|0|||
163462897|NCT00844285|590392454|FG000|Overall Study|Other than specified|95|||
163462898|NCT00844285|590392455|FG001|Overall Study|Other than specified|129|||
163462899|NCT00844285|590392456|FG002|Overall Study|Other than specified|12|||
163462900|NCT00844285|590392454|FG000|Overall Study|Site closure|256|||
163462901|NCT00844285|590392455|FG001|Overall Study|Site closure|450|||
163462902|NCT00844285|590392456|FG002|Overall Study|Site closure|50|||
163462903|NCT00844285|590392454|FG000|Overall Study|Follow-up < 8 years|16|||
163462904|NCT00844285|590392455|FG001|Overall Study|Follow-up < 8 years|23|||
163462905|NCT00844285|590392456|FG002|Overall Study|Follow-up < 8 years|4|||
163462906|NCT00844285|590392454|FG000|Overall Study|Protocol Violation|26|||
163462907|NCT00844285|590392455|FG001|Overall Study|Protocol Violation|28|||
163462908|NCT00844285|590392456|FG002|Overall Study|Protocol Violation|54|||
163462909|NCT00844285|590392454|FG000|Overall Study|Death|22|||
163462910|NCT00844285|590392455|FG001|Overall Study|Death|21|||
163462911|NCT00844285|590392456|FG002|Overall Study|Death|8|||
163462912|NCT00844285|590392454|FG000|Overall Study|Withdrew Consent|344|||
163462913|NCT00844285|590392455|FG001|Overall Study|Withdrew Consent|466|||
163462914|NCT00844285|590392456|FG002|Overall Study|Withdrew Consent|70|||
163462915|NCT00844285|590392454|FG000|Overall Study|Lost to Follow-up|330|||
163462916|NCT00844285|590392455|FG001|Overall Study|Lost to Follow-up|486|||
163462917|NCT00844285|590392456|FG002|Overall Study|Lost to Follow-up|74|||
163462918|NCT04682353|590392461|FG000|Overall Study|Lost to Follow-up|0|||
163462919|NCT04682353|590392462|FG001|Overall Study|Lost to Follow-up|1|||
163462920|NCT04682353|590392463|FG002|Overall Study|Lost to Follow-up|0|||
163462921|NCT04682353|590392464|FG003|Overall Study|Lost to Follow-up|1|||
163462922|NCT04682353|590392461|FG000|Overall Study|Personal reasons|0|||
163462923|NCT04682353|590392462|FG001|Overall Study|Personal reasons|1|||
163462924|NCT04682353|590392463|FG002|Overall Study|Personal reasons|0|||
163462925|NCT04682353|590392464|FG003|Overall Study|Personal reasons|0|||
163462926|NCT00555906|590392465|FG000|Phase 1|Objective Progression or Relapse|3|||
163462927|NCT00555906|590392466|FG001|Phase 1|Objective Progression or Relapse|5|||
163462928|NCT00555906|590392467|FG002|Phase 1|Objective Progression or Relapse|3|||
163462929|NCT00555906|590392468|FG003|Phase 1|Objective Progression or Relapse|1|||
163462930|NCT00555906|590392469|FG004|Phase 1|Objective Progression or Relapse|0|||
163462931|NCT00555906|590392465|FG000|Phase 1|Global Deterioration of Health Status|0|||
163462932|NCT00555906|590392466|FG001|Phase 1|Global Deterioration of Health Status|1|||
163462933|NCT00555906|590392467|FG002|Phase 1|Global Deterioration of Health Status|1|||
163462934|NCT00555906|590392468|FG003|Phase 1|Global Deterioration of Health Status|1|||
163462935|NCT00555906|590392469|FG004|Phase 1|Global Deterioration of Health Status|0|||
163462936|NCT00555906|590392465|FG000|Phase 1|Adverse Event|0|||
163462937|NCT00555906|590392466|FG001|Phase 1|Adverse Event|0|||
163462938|NCT00555906|590392467|FG002|Phase 1|Adverse Event|3|||
163462939|NCT00555906|590392468|FG003|Phase 1|Adverse Event|2|||
163462940|NCT00555906|590392469|FG004|Phase 1|Adverse Event|0|||
163462941|NCT00555906|590392465|FG000|Phase 1|Withdrawal by Subject|0|||
163462942|NCT00555906|590392466|FG001|Phase 1|Withdrawal by Subject|0|||
163462943|NCT00555906|590392467|FG002|Phase 1|Withdrawal by Subject|0|||
163462944|NCT00555906|590392468|FG003|Phase 1|Withdrawal by Subject|1|||
163462945|NCT00555906|590392469|FG004|Phase 1|Withdrawal by Subject|0|||
163462946|NCT00555906|590392465|FG000|Phase 2|Adverse Event|0|||
163462947|NCT00555906|590392466|FG001|Phase 2|Adverse Event|0|||
163462948|NCT00555906|590392467|FG002|Phase 2|Adverse Event|0|||
163462949|NCT00555906|590392468|FG003|Phase 2|Adverse Event|0|||
163462950|NCT00555906|590392469|FG004|Phase 2|Adverse Event|4|||
163462951|NCT00555906|590392465|FG000|Phase 2|Global Deterioration of Health Status|0|||
163462952|NCT00555906|590392466|FG001|Phase 2|Global Deterioration of Health Status|0|||
163462953|NCT00555906|590392467|FG002|Phase 2|Global Deterioration of Health Status|0|||
163462954|NCT00555906|590392468|FG003|Phase 2|Global Deterioration of Health Status|0|||
163462955|NCT00555906|590392469|FG004|Phase 2|Global Deterioration of Health Status|2|||
163462956|NCT00555906|590392465|FG000|Phase 2|Objective Progression or Relapse|0|||
163462957|NCT00555906|590392466|FG001|Phase 2|Objective Progression or Relapse|0|||
163462958|NCT00555906|590392467|FG002|Phase 2|Objective Progression or Relapse|0|||
163462959|NCT00555906|590392468|FG003|Phase 2|Objective Progression or Relapse|0|||
163462960|NCT00555906|590392469|FG004|Phase 2|Objective Progression or Relapse|16|||
163462961|NCT00555906|590392465|FG000|Phase 2|Withdrawal by Subject|0|||
163462962|NCT00555906|590392466|FG001|Phase 2|Withdrawal by Subject|0|||
163462963|NCT00555906|590392467|FG002|Phase 2|Withdrawal by Subject|0|||
163462964|NCT00555906|590392468|FG003|Phase 2|Withdrawal by Subject|0|||
163462965|NCT00555906|590392469|FG004|Phase 2|Withdrawal by Subject|2|||
163462966|NCT00555906|590392465|FG000|Phase 2|Other|0|||
163462967|NCT00555906|590392466|FG001|Phase 2|Other|0|||
163462968|NCT00555906|590392467|FG002|Phase 2|Other|0|||
163462969|NCT00555906|590392468|FG003|Phase 2|Other|0|||
163462970|NCT00555906|590392469|FG004|Phase 2|Other|6|||
163462971|NCT00555906|590392465|FG000|Phase 2|Randomized but not Treated|0|||
163462972|NCT00555906|590392466|FG001|Phase 2|Randomized but not Treated|0|||
163462973|NCT00555906|590392467|FG002|Phase 2|Randomized but not Treated|0|||
163462974|NCT00555906|590392468|FG003|Phase 2|Randomized but not Treated|0|||
163462975|NCT00555906|590392469|FG004|Phase 2|Randomized but not Treated|2|||
163462976|NCT01586806|590392470|FG000|Overall Study|Protocol Violation|0|||
163462977|NCT01586806|590392471|FG001|Overall Study|Protocol Violation|1|||
163462978|NCT01586806|590392472|FG002|Overall Study|Protocol Violation|0|||
163462979|NCT01586806|590392470|FG000|Overall Study|Withdrawal by Subject|1|||
163462980|NCT01586806|590392471|FG001|Overall Study|Withdrawal by Subject|0|||
163462981|NCT01586806|590392472|FG002|Overall Study|Withdrawal by Subject|0|||
163462982|NCT01586806|590392470|FG000|Overall Study|Lost to Follow-up|2|||
163462983|NCT01586806|590392471|FG001|Overall Study|Lost to Follow-up|3|||
163462984|NCT01586806|590392472|FG002|Overall Study|Lost to Follow-up|2|||
163462985|NCT02193828|590392473|FG000|Overall Study|Withdrawal by Subject|0|||
163462986|NCT02193828|590392474|FG001|Overall Study|Withdrawal by Subject|0|||
163462987|NCT02193828|590392475|FG002|Overall Study|Withdrawal by Subject|1|||
163462988|NCT02193828|590392476|FG003|Overall Study|Withdrawal by Subject|1|||
163462989|NCT00862654|590392477|FG000|Overall Study|Lack of Efficacy|1|||
163462990|NCT00862654|590392478|FG001|Overall Study|Lack of Efficacy|0|||
163462991|NCT00862654|590392479|FG002|Overall Study|Lack of Efficacy|1|||
163462992|NCT00862654|590392480|FG003|Overall Study|Lack of Efficacy|0|||
163462993|NCT00862654|590392477|FG000|Overall Study|Lost to Follow-up|1|||
163462994|NCT00862654|590392478|FG001|Overall Study|Lost to Follow-up|2|||
163462995|NCT00862654|590392479|FG002|Overall Study|Lost to Follow-up|1|||
163462996|NCT00862654|590392480|FG003|Overall Study|Lost to Follow-up|3|||
163462997|NCT00862654|590392477|FG000|Overall Study|Adverse Event|0|||
163462998|NCT00862654|590392478|FG001|Overall Study|Adverse Event|1|||
163462999|NCT00862654|590392479|FG002|Overall Study|Adverse Event|1|||
163463000|NCT00862654|590392480|FG003|Overall Study|Adverse Event|0|||
163463001|NCT00862654|590392477|FG000|Overall Study|Pregnancy|1|||
163463002|NCT00862654|590392478|FG001|Overall Study|Pregnancy|1|||
163463003|NCT00862654|590392479|FG002|Overall Study|Pregnancy|0|||
163463004|NCT00862654|590392480|FG003|Overall Study|Pregnancy|0|||
163463005|NCT00862654|590392477|FG000|Overall Study|Withdrawal by Subject|2|||
163463006|NCT00862654|590392478|FG001|Overall Study|Withdrawal by Subject|2|||
163463007|NCT00862654|590392479|FG002|Overall Study|Withdrawal by Subject|2|||
163463008|NCT00862654|590392480|FG003|Overall Study|Withdrawal by Subject|3|||
163463009|NCT00862654|590392477|FG000|Overall Study|Subject mistake|0|||
163463010|NCT00862654|590392478|FG001|Overall Study|Subject mistake|1|||
163463011|NCT00862654|590392479|FG002|Overall Study|Subject mistake|0|||
163463012|NCT00862654|590392480|FG003|Overall Study|Subject mistake|0|||
163463013|NCT00862654|590392477|FG000|Overall Study|Familly constraint|0|||
163463014|NCT00862654|590392478|FG001|Overall Study|Familly constraint|1|||
163463015|NCT00862654|590392479|FG002|Overall Study|Familly constraint|0|||
163463016|NCT00862654|590392480|FG003|Overall Study|Familly constraint|0|||
163463017|NCT00862654|590392477|FG000|Overall Study|Never used study drugs|1|||
163463018|NCT00862654|590392478|FG001|Overall Study|Never used study drugs|0|||
163463019|NCT00862654|590392479|FG002|Overall Study|Never used study drugs|0|||
163463020|NCT00862654|590392480|FG003|Overall Study|Never used study drugs|0|||
163463021|NCT00862654|590392477|FG000|Overall Study|Included after end of inclusions|0|||
163463022|NCT00862654|590392478|FG001|Overall Study|Included after end of inclusions|0|||
163463023|NCT00862654|590392479|FG002|Overall Study|Included after end of inclusions|1|||
163463024|NCT00862654|590392480|FG003|Overall Study|Included after end of inclusions|0|||
163463025|NCT03219567|590392481|FG000|Overall Study|Withdrawal by Subject|0|||
163463026|NCT03219567|590392482|FG001|Overall Study|Withdrawal by Subject|1|||
163463027|NCT01313208|590392483|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
163463028|NCT01313208|590392484|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
163463029|NCT01313208|590392483|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
163463030|NCT01313208|590392484|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
163463031|NCT01313208|590392483|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
163463032|NCT01313208|590392484|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
163463033|NCT01313208|590392483|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
163463034|NCT01313208|590392484|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
163463035|NCT01313208|590392483|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
163463036|NCT01313208|590392484|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
163463037|NCT01313208|590392483|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
163463038|NCT01313208|590392484|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
163463039|NCT01313208|590392483|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
163463040|NCT01313208|590392484|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
163463041|NCT01313208|590392483|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
163463042|NCT01313208|590392484|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
163463043|NCT01313208|590392483|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
163463044|NCT01313208|590392484|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
163463045|NCT01151540|590392486|FG000|Overall Study|Other|2|||
163463046|NCT01151540|590392486|FG000|Overall Study|Adverse event, non-fatal|4|||
163463047|NCT01151540|590392486|FG000|Overall Study|Withdrawal by Subject|7|||
163463048|NCT01412060|590392487|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
163463049|NCT01412060|590392488|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
163463050|NCT01412060|590392489|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
163463051|NCT01412060|590392487|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
163463052|NCT01412060|590392488|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
163463053|NCT01412060|590392489|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
163463054|NCT01412060|590392487|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
163463055|NCT01412060|590392488|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
163463056|NCT01412060|590392489|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
163463057|NCT01412060|590392487|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
163463058|NCT01412060|590392488|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
163463059|NCT01412060|590392489|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
163463060|NCT01412060|590392487|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
163463061|NCT01412060|590392488|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
163463062|NCT01412060|590392489|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
163463063|NCT01412060|590392487|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
163463064|NCT01412060|590392488|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
163463065|NCT01412060|590392489|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
163463066|NCT01412060|590392487|FG000|Period Between RIP and SP|Adverse Event|4|||
163463067|NCT01412060|590392488|FG001|Period Between RIP and SP|Adverse Event|0|||
163463068|NCT01412060|590392489|FG002|Period Between RIP and SP|Adverse Event|0|||
163463069|NCT01412060|590392487|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
163463070|NCT01412060|590392488|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
163463071|NCT01412060|590392489|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
163463072|NCT01412060|590392487|FG000|Period Between RIP and SP|Protocol Violation|2|||
163463073|NCT01412060|590392488|FG001|Period Between RIP and SP|Protocol Violation|0|||
163463074|NCT01412060|590392489|FG002|Period Between RIP and SP|Protocol Violation|0|||
163463075|NCT01412060|590392487|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
163463076|NCT01412060|590392488|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
163463077|NCT01412060|590392489|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
163463078|NCT01412060|590392487|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
163463079|NCT01412060|590392488|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
163463080|NCT01412060|590392489|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
163463081|NCT01412060|590392487|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
163463082|NCT01412060|590392488|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
163463083|NCT01412060|590392489|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
163463084|NCT01412060|590392487|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
163463085|NCT01412060|590392488|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
163463086|NCT01412060|590392489|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
163463087|NCT01412060|590392487|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
163463088|NCT01412060|590392488|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
163463089|NCT01412060|590392489|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
163463090|NCT01412060|590392487|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
163463091|NCT01412060|590392488|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
163463092|NCT01412060|590392489|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
163463093|NCT01412060|590392487|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
163463094|NCT01412060|590392488|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
163463095|NCT01412060|590392489|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
163463096|NCT01412060|590392487|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
163463097|NCT01412060|590392488|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
163463098|NCT01412060|590392489|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
163463099|NCT01412060|590392487|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
163463100|NCT01412060|590392488|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
163463101|NCT01412060|590392489|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
163463102|NCT01412060|590392487|FG000|Period Between SP and DBP|Protocol Violation|2|||
163463103|NCT01412060|590392488|FG001|Period Between SP and DBP|Protocol Violation|0|||
163463104|NCT01412060|590392489|FG002|Period Between SP and DBP|Protocol Violation|0|||
163463105|NCT01412060|590392487|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
163463106|NCT01412060|590392488|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
163463107|NCT01412060|590392489|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
163463108|NCT01412060|590392487|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
163463109|NCT01412060|590392488|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
163463110|NCT01412060|590392489|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
163463111|NCT01412060|590392487|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
163463112|NCT01412060|590392488|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
163463113|NCT01412060|590392489|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
163463114|NCT01412060|590392487|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
163463115|NCT01412060|590392488|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
163463116|NCT01412060|590392489|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
163463117|NCT01412060|590392487|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
163463118|NCT01412060|590392488|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
163463119|NCT01412060|590392489|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
163463120|NCT01412060|590392487|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
163463121|NCT01412060|590392488|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
163463122|NCT01412060|590392489|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
163463123|NCT01412060|590392487|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
163463124|NCT01412060|590392488|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
163463125|NCT01412060|590392489|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
163463126|NCT01412060|590392487|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
163463127|NCT01412060|590392488|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
163463128|NCT01412060|590392489|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
163463129|NCT01412060|590392487|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
163463130|NCT01412060|590392488|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
163463131|NCT01412060|590392489|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
163463132|NCT01412060|590392487|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
163463133|NCT01412060|590392488|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
163463134|NCT01412060|590392489|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
163463135|NCT00004732|590392490|FG000|Overall Study|Withdrawal by Subject|36|||
163463136|NCT00004732|590392491|FG001|Overall Study|Withdrawal by Subject|64|||
163463137|NCT00004732|590392490|FG000|Overall Study|Lost to Follow-up|33|||
163463138|NCT00004732|590392491|FG001|Overall Study|Lost to Follow-up|47|||
163463139|NCT01688635|590392492|FG000|Washout 1|Withdrawal by Subject|1|||
163463140|NCT01688635|590392493|FG001|Washout 1|Withdrawal by Subject|0|||
163463141|NCT01688635|590392492|FG000|Washout 1|Adverse Event|0|||
163463142|NCT01688635|590392493|FG001|Washout 1|Adverse Event|1|||
163463143|NCT01688635|590392492|FG000|Washout 1|Physician Decision|0|||
163463144|NCT01688635|590392493|FG001|Washout 1|Physician Decision|1|||
162925394|NCT05302414|588428961|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
163463145|NCT01688635|590392492|FG000|Washout 2|Physician Decision|1|||
163463146|NCT01688635|590392493|FG001|Washout 2|Physician Decision|0|||
163463147|NCT01688635|590392492|FG000|Washout 2|Withdrawal by Subject|1|||
163463148|NCT01688635|590392493|FG001|Washout 2|Withdrawal by Subject|0|||
163463149|NCT01688635|590392492|FG000|Washout 2|Sponsor Decision|1|||
163463150|NCT01688635|590392493|FG001|Washout 2|Sponsor Decision|2|||
163463151|NCT01688635|590392492|FG000|Washout 3|Withdrawal by Subject|1|||
163463152|NCT01688635|590392493|FG001|Washout 3|Withdrawal by Subject|0|||
163463153|NCT02674685|590392494|FG000|Overall Study|Withdrawal by Subject|4|||
163463154|NCT01181778|590392495|FG000|Overall Study|Physician Decision|48|||
163463155|NCT02661464|590392498|FG000|Overall Study|Lost to Follow-up|28|||
163463156|NCT02661464|590392499|FG001|Overall Study|Lost to Follow-up|0|||
163463157|NCT02661464|590392500|FG002|Overall Study|Lost to Follow-up|0|||
163463158|NCT02661464|590392501|FG003|Overall Study|Lost to Follow-up|0|||
163463159|NCT02661464|590392498|FG000|Overall Study|Withdrawal by Subject|3|||
163463160|NCT02661464|590392499|FG001|Overall Study|Withdrawal by Subject|1|||
163463161|NCT02661464|590392500|FG002|Overall Study|Withdrawal by Subject|0|||
163463162|NCT02661464|590392501|FG003|Overall Study|Withdrawal by Subject|0|||
163463163|NCT02661464|590392498|FG000|Overall Study|Participants terminated prematurely|288|||
163463164|NCT02661464|590392499|FG001|Overall Study|Participants terminated prematurely|52|||
163463165|NCT02661464|590392500|FG002|Overall Study|Participants terminated prematurely|1|||
163463166|NCT02661464|590392501|FG003|Overall Study|Participants terminated prematurely|1|||
163463167|NCT02661464|590392498|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
163463168|NCT02661464|590392499|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
163463169|NCT02661464|590392500|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
163463170|NCT02661464|590392501|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
163463171|NCT05567393|590392503|FG000|Overall Study|Voluntary Withdrawal|0|||
163463172|NCT05567393|590392504|FG001|Overall Study|Voluntary Withdrawal|0|||
163463173|NCT05567393|590392505|FG002|Overall Study|Voluntary Withdrawal|0|||
163463174|NCT05567393|590392506|FG003|Overall Study|Voluntary Withdrawal|0|||
163463175|NCT05567393|590392507|FG004|Overall Study|Voluntary Withdrawal|0|||
163463176|NCT05567393|590392508|FG005|Overall Study|Voluntary Withdrawal|0|||
163463177|NCT05567393|590392509|FG006|Overall Study|Voluntary Withdrawal|0|||
163463178|NCT05567393|590392510|FG007|Overall Study|Voluntary Withdrawal|0|||
163463179|NCT05567393|590392511|FG008|Overall Study|Voluntary Withdrawal|0|||
163463180|NCT05567393|590392512|FG009|Overall Study|Voluntary Withdrawal|0|||
163463181|NCT05567393|590392513|FG010|Overall Study|Voluntary Withdrawal|0|||
163463182|NCT05567393|590392514|FG011|Overall Study|Voluntary Withdrawal|0|||
163463183|NCT05567393|590392515|FG012|Overall Study|Voluntary Withdrawal|0|||
163463184|NCT05567393|590392516|FG013|Overall Study|Voluntary Withdrawal|1|||
163463185|NCT05567393|590392517|FG014|Overall Study|Voluntary Withdrawal|0|||
163463186|NCT05567393|590392518|FG015|Overall Study|Voluntary Withdrawal|0|||
163463187|NCT05567393|590392519|FG016|Overall Study|Voluntary Withdrawal|0|||
163463188|NCT05567393|590392520|FG017|Overall Study|Voluntary Withdrawal|0|||
163463189|NCT03148756|590392521|FG000|Overall Study|Study Terminated|0|||
163463190|NCT03148756|590392522|FG001|Overall Study|Study Terminated|1|||
163463191|NCT01924299|590392526|FG000|Period 2|Withdrawal by Subject|1|||
163463192|NCT01924299|590392527|FG001|Period 2|Withdrawal by Subject|0|||
163463193|NCT01924299|590392526|FG000|Period 2|Adverse Event|0|||
163463194|NCT01924299|590392527|FG001|Period 2|Adverse Event|1|||
163463195|NCT02177175|590392528|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
163463196|NCT02177175|590392529|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
163463197|NCT04199793|590392530|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
163463198|NCT04199793|590392531|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
163463199|NCT04199793|590392530|FG000|Overall Study|Withdrawal by Subject|1|||
163463200|NCT04199793|590392531|FG001|Overall Study|Withdrawal by Subject|1|||
163463201|NCT00628758|590392532|FG000|Overall Study|Adverse Event|2|||
163463202|NCT00628758|590392533|FG001|Overall Study|Adverse Event|3|||
163463203|NCT00628758|590392532|FG000|Overall Study|Withdrawal by Subject|6|||
163463204|NCT00628758|590392533|FG001|Overall Study|Withdrawal by Subject|3|||
163463205|NCT00628758|590392532|FG000|Overall Study|Death|1|||
163463206|NCT00628758|590392533|FG001|Overall Study|Death|0|||
163463207|NCT00628758|590392532|FG000|Overall Study|Protocol Violation|5|||
163463208|NCT00628758|590392533|FG001|Overall Study|Protocol Violation|1|||
163463209|NCT00628758|590392532|FG000|Overall Study|Lost to Follow-up|25|||
163463210|NCT00628758|590392533|FG001|Overall Study|Lost to Follow-up|31|||
163463211|NCT00628758|590392532|FG000|Overall Study|Pregnancy|2|||
163463212|NCT00628758|590392533|FG001|Overall Study|Pregnancy|2|||
163463213|NCT00628758|590392532|FG000|Overall Study|Investigator Moved|3|||
163463214|NCT00628758|590392533|FG001|Overall Study|Investigator Moved|0|||
163463215|NCT00628758|590392532|FG000|Overall Study|Treatment Failure|0|||
163463216|NCT00628758|590392533|FG001|Overall Study|Treatment Failure|2|||
163463217|NCT02983799|590392538|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
163463218|NCT02983799|590392539|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
163463219|NCT02983799|590392540|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
163463220|NCT02983799|590392541|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
163463221|NCT02983799|590392542|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
163463222|NCT02983799|590392538|FG000|Overall Study|Death|20|||
163463223|NCT02983799|590392539|FG001|Overall Study|Death|5|||
163463224|NCT02983799|590392540|FG002|Overall Study|Death|23|||
163463225|NCT02983799|590392541|FG003|Overall Study|Death|47|||
163463226|NCT02983799|590392542|FG004|Overall Study|Death|7|||
163463227|NCT02983799|590392538|FG000|Overall Study|Withdrawal by Subject|1|||
163463228|NCT02983799|590392539|FG001|Overall Study|Withdrawal by Subject|0|||
163463229|NCT02983799|590392540|FG002|Overall Study|Withdrawal by Subject|3|||
163463230|NCT02983799|590392541|FG003|Overall Study|Withdrawal by Subject|4|||
163463231|NCT02983799|590392542|FG004|Overall Study|Withdrawal by Subject|1|||
163463232|NCT02983799|590392538|FG000|Overall Study|Protocol Violation|0|||
163463233|NCT02983799|590392539|FG001|Overall Study|Protocol Violation|1|||
163463234|NCT02983799|590392540|FG002|Overall Study|Protocol Violation|0|||
163463235|NCT02983799|590392541|FG003|Overall Study|Protocol Violation|0|||
163463236|NCT02983799|590392542|FG004|Overall Study|Protocol Violation|1|||
163463237|NCT02983799|590392538|FG000|Overall Study|Lost to Follow-up|1|||
163463238|NCT02983799|590392539|FG001|Overall Study|Lost to Follow-up|0|||
163463239|NCT02983799|590392540|FG002|Overall Study|Lost to Follow-up|1|||
163463240|NCT02983799|590392541|FG003|Overall Study|Lost to Follow-up|0|||
163463241|NCT02983799|590392542|FG004|Overall Study|Lost to Follow-up|0|||
163463242|NCT01184846|590392548|FG000|Overall Study|Adverse Event|2|||
163463243|NCT01184846|590392548|FG000|Overall Study|Insufficient response|1|||
163463244|NCT02293902|590392558|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
163463245|NCT02293902|590392559|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
163463246|NCT02293902|590392560|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
163463247|NCT02293902|590392561|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
163463248|NCT02293902|590392562|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
163463249|NCT02293902|590392558|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
163463250|NCT02293902|590392559|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
163463251|NCT02293902|590392560|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
163463252|NCT02293902|590392561|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
163463253|NCT02293902|590392562|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
163463254|NCT02293902|590392558|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
163463255|NCT02293902|590392559|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
163463256|NCT02293902|590392560|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
163463257|NCT02293902|590392561|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
163463258|NCT02293902|590392562|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
163463259|NCT02293902|590392558|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
163463260|NCT02293902|590392559|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
163463261|NCT02293902|590392560|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
163463262|NCT02293902|590392561|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
163463263|NCT02293902|590392562|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
163463264|NCT02293902|590392558|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
163463265|NCT02293902|590392559|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
163463266|NCT02293902|590392560|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
163463267|NCT02293902|590392561|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
163463268|NCT02293902|590392562|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
163463269|NCT04021706|590394447|FG000|Overall Study|Adverse Event|2|||
163463270|NCT04021706|590394448|FG001|Overall Study|Adverse Event|0|||
163463271|NCT04021706|590394447|FG000|Overall Study|Withdrawal by Subject|1|||
163463272|NCT04021706|590394448|FG001|Overall Study|Withdrawal by Subject|2|||
163463273|NCT04021706|590394447|FG000|Overall Study|Physician Decision|1|||
163463274|NCT04021706|590394448|FG001|Overall Study|Physician Decision|0|||
163463275|NCT00859573|590394449|FG000|Overall Study|Withdrawal by Subject|4|||
163463276|NCT00859573|590394450|FG001|Overall Study|Withdrawal by Subject|1|||
163463277|NCT00859573|590394449|FG000|Overall Study|Physician Decision|1|||
163463278|NCT00859573|590394450|FG001|Overall Study|Physician Decision|1|||
163463279|NCT01135394|590394462|FG000|Screening|Lost to Follow-up|2|||
163463280|NCT01135394|590394462|FG000|Screening|Withdrawal by Subject|10|||
163463281|NCT01135394|590394462|FG000|Screening|Screening failure|16|||
163463282|NCT01135394|590394462|FG000|Screening|Physician Decision|5|||
163463283|NCT01135394|590394462|FG000|Baseline Assessment|Withdrawal by Subject|9|||
163463284|NCT01135394|590394462|FG000|Baseline Assessment|Physician Decision|3|||
163463285|NCT01135394|590394462|FG000|Baseline Assessment|Lost to Follow-up|2|||
163463286|NCT01135394|590394462|FG000|Baseline Assessment|Adverse Event|1|||
163463287|NCT01135394|590394462|FG000|Study Treatment|Withdrawal by Subject|1|||
163463288|NCT01135394|590394462|FG000|Study Treatment|Physician Decision|1|||
163463289|NCT01135394|590394462|FG000|Study Treatment|Adverse Event|2|||
163463290|NCT00462488|590394463|FG000|Overall Study|Protocol Violation|1|||
163463291|NCT00462488|590394464|FG001|Overall Study|Protocol Violation|0|||
163463292|NCT00462488|590394463|FG000|Overall Study|Lack of Efficacy|19|||
163463293|NCT00462488|590394464|FG001|Overall Study|Lack of Efficacy|17|||
163463294|NCT02088541|590394467|FG000|Overall Study|Adverse Event|3|||
163463295|NCT02088541|590394468|FG001|Overall Study|Adverse Event|0|||
163463296|NCT02088541|590394469|FG002|Overall Study|Adverse Event|3|||
163463297|NCT02088541|590394470|FG003|Overall Study|Adverse Event|3|||
163463298|NCT02088541|590394471|FG004|Overall Study|Adverse Event|0|||
163463299|NCT02088541|590394467|FG000|Overall Study|Death|51|||
163463300|NCT02088541|590394468|FG001|Overall Study|Death|21|||
163463301|NCT02088541|590394469|FG002|Overall Study|Death|85|||
163463302|NCT02088541|590394470|FG003|Overall Study|Death|28|||
163463303|NCT02088541|590394471|FG004|Overall Study|Death|38|||
163463304|NCT02088541|590394467|FG000|Overall Study|Lost to Follow-up|2|||
163463305|NCT02088541|590394468|FG001|Overall Study|Lost to Follow-up|0|||
163463306|NCT02088541|590394469|FG002|Overall Study|Lost to Follow-up|1|||
163463307|NCT02088541|590394470|FG003|Overall Study|Lost to Follow-up|0|||
163463308|NCT02088541|590394471|FG004|Overall Study|Lost to Follow-up|0|||
163463309|NCT02088541|590394467|FG000|Overall Study|Physician Decision|2|||
163463310|NCT02088541|590394468|FG001|Overall Study|Physician Decision|1|||
163463311|NCT02088541|590394469|FG002|Overall Study|Physician Decision|2|||
163463312|NCT02088541|590394470|FG003|Overall Study|Physician Decision|0|||
163463313|NCT02088541|590394471|FG004|Overall Study|Physician Decision|2|||
163463314|NCT02088541|590394467|FG000|Overall Study|Disease progression|7|||
163463315|NCT02088541|590394468|FG001|Overall Study|Disease progression|1|||
163463316|NCT02088541|590394469|FG002|Overall Study|Disease progression|2|||
163463317|NCT02088541|590394470|FG003|Overall Study|Disease progression|3|||
163463318|NCT02088541|590394471|FG004|Overall Study|Disease progression|1|||
163463319|NCT02088541|590394467|FG000|Overall Study|Study terminated by sponsor|1|||
163463320|NCT02088541|590394468|FG001|Overall Study|Study terminated by sponsor|1|||
163463321|NCT02088541|590394469|FG002|Overall Study|Study terminated by sponsor|12|||
163463322|NCT02088541|590394470|FG003|Overall Study|Study terminated by sponsor|2|||
163463323|NCT02088541|590394471|FG004|Overall Study|Study terminated by sponsor|6|||
163463324|NCT02088541|590394467|FG000|Overall Study|Withdrawal by Subject|3|||
163463325|NCT02088541|590394468|FG001|Overall Study|Withdrawal by Subject|2|||
163463326|NCT02088541|590394469|FG002|Overall Study|Withdrawal by Subject|9|||
163463327|NCT02088541|590394470|FG003|Overall Study|Withdrawal by Subject|7|||
163463328|NCT02088541|590394471|FG004|Overall Study|Withdrawal by Subject|10|||
163463329|NCT02088541|590394467|FG000|Overall Study|Other|2|||
163463330|NCT02088541|590394468|FG001|Overall Study|Other|1|||
163463331|NCT02088541|590394469|FG002|Overall Study|Other|3|||
163463332|NCT02088541|590394470|FG003|Overall Study|Other|1|||
163463333|NCT02088541|590394471|FG004|Overall Study|Other|1|||
163463334|NCT02848313|590394473|FG000|Overall Study|Adverse Event|1|||
163463335|NCT02848313|590394474|FG001|Overall Study|Adverse Event|2|||
163463336|NCT02848313|590394473|FG000|Overall Study|Lack of Efficacy|0|||
163463337|NCT02848313|590394474|FG001|Overall Study|Lack of Efficacy|1|||
163463338|NCT02848313|590394473|FG000|Overall Study|Withdrawal by Subject|1|||
163463339|NCT02848313|590394474|FG001|Overall Study|Withdrawal by Subject|1|||
163463340|NCT02848313|590394473|FG000|Overall Study|Lost to follow up|1|||
163463341|NCT02848313|590394474|FG001|Overall Study|Lost to follow up|0|||
163463342|NCT03984812|590394475|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
163463343|NCT03984812|590394476|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
163463344|NCT03984812|590394477|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
163463345|NCT03984812|590394478|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
163463346|NCT03984812|590394479|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
163463347|NCT03984812|590394480|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
163463348|NCT03984812|590394481|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
163463349|NCT03984812|590394482|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
163463350|NCT03984812|590394483|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
163463351|NCT03984812|590394484|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
163463352|NCT03984812|590394485|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
163463353|NCT02905825|590394493|FG000|Overall Study|Protocol Violation|11|||
163463354|NCT02905825|590394493|FG000|Overall Study|Device Malfunction|1|||
163463355|NCT01563107|590394494|FG000|Overall Study|Physician Decision|0|||
163463356|NCT01563107|590394495|FG001|Overall Study|Physician Decision|1|||
163463357|NCT01563107|590394496|FG002|Overall Study|Physician Decision|1|||
163463358|NCT01563107|590394497|FG003|Overall Study|Physician Decision|3|||
163463359|NCT01563107|590394494|FG000|Overall Study|Withdrawal by Subject|1|||
163463360|NCT01563107|590394495|FG001|Overall Study|Withdrawal by Subject|2|||
163463361|NCT01563107|590394496|FG002|Overall Study|Withdrawal by Subject|1|||
163463362|NCT01563107|590394497|FG003|Overall Study|Withdrawal by Subject|2|||
163463363|NCT05355818|590394498|FG000|Overall Study|Adverse Event|1|||
163463364|NCT05355818|590394499|FG001|Overall Study|Adverse Event|1|||
163463365|NCT05355818|590394498|FG000|Overall Study|Lack of Efficacy|2|||
163463366|NCT05355818|590394499|FG001|Overall Study|Lack of Efficacy|1|||
163463367|NCT05355818|590394498|FG000|Overall Study|Lost to Follow-up|0|||
163463368|NCT05355818|590394499|FG001|Overall Study|Lost to Follow-up|1|||
163463369|NCT00063986|590394502|FG000|Overall Study|Withdrawal by Subject|1|||
163463370|NCT00063986|590394502|FG000|Overall Study|Ineligible|1|||
163463371|NCT00063986|590394502|FG000|Overall Study|Intra-operatively ineligible|4|||
163463372|NCT01601704|590394503|FG000|Overall Study|Randomized but not dispensed study med|1|||
163463373|NCT01601704|590394504|FG001|Overall Study|Randomized but not dispensed study med|4|||
163463374|NCT00247273|590394507|FG000|Overall Study|Adverse Event|85|||
163463375|NCT00247273|590394508|FG001|Overall Study|Adverse Event|80|||
163463376|NCT00247273|590394507|FG000|Overall Study|Physician Decision|6|||
163463377|NCT00247273|590394508|FG001|Overall Study|Physician Decision|3|||
163463378|NCT00247273|590394507|FG000|Overall Study|Lost to Follow-up|7|||
163463379|NCT00247273|590394508|FG001|Overall Study|Lost to Follow-up|7|||
163463380|NCT00247273|590394507|FG000|Overall Study|Withdrawal by Subject|46|||
163463381|NCT00247273|590394508|FG001|Overall Study|Withdrawal by Subject|47|||
163463382|NCT00247273|590394507|FG000|Overall Study|Did not take any study drug|2|||
163463383|NCT00247273|590394508|FG001|Overall Study|Did not take any study drug|0|||
163463384|NCT03276572|590394509|FG000|Overall Study|In follow-up|0|||
163463385|NCT03276572|590394510|FG001|Overall Study|In follow-up|0|||
163463386|NCT03276572|590394511|FG002|Overall Study|In follow-up|0|||
163463387|NCT03276572|590394512|FG003|Overall Study|In follow-up|0|||
163463388|NCT03276572|590394513|FG004|Overall Study|In follow-up|0|||
163463389|NCT03276572|590394514|FG005|Overall Study|In follow-up|1|||
163463390|NCT03276572|590394515|FG006|Overall Study|In follow-up|1|||
163463391|NCT03276572|590394509|FG000|Overall Study|Lost to Follow-up|0|||
163463392|NCT03276572|590394510|FG001|Overall Study|Lost to Follow-up|0|||
163463393|NCT03276572|590394511|FG002|Overall Study|Lost to Follow-up|0|||
163463394|NCT03276572|590394512|FG003|Overall Study|Lost to Follow-up|0|||
163463395|NCT03276572|590394513|FG004|Overall Study|Lost to Follow-up|0|||
163463396|NCT03276572|590394514|FG005|Overall Study|Lost to Follow-up|0|||
163463397|NCT03276572|590394515|FG006|Overall Study|Lost to Follow-up|1|||
163463398|NCT02580240|590394516|FG000|Overall Study|Physician Decision|2|||
163463399|NCT02580240|590394517|FG001|Overall Study|Physician Decision|0|||
163463400|NCT01709708|590394530|FG000|Overall Study|Protocol Violation|1|||
163463401|NCT01709708|590394531|FG001|Overall Study|Protocol Violation|2|||
163463402|NCT00511108|590394534|FG000|Overall Study|Adverse Event|2|||
163463403|NCT00511108|590394535|FG001|Overall Study|Adverse Event|0|||
163463404|NCT00511108|590394536|FG002|Overall Study|Adverse Event|1|||
163463405|NCT00511108|590394537|FG003|Overall Study|Adverse Event|2|||
163463406|NCT00511108|590394534|FG000|Overall Study|Lost to Follow-up|0|||
163463407|NCT00511108|590394535|FG001|Overall Study|Lost to Follow-up|2|||
163463408|NCT00511108|590394536|FG002|Overall Study|Lost to Follow-up|1|||
163463409|NCT00511108|590394537|FG003|Overall Study|Lost to Follow-up|0|||
163463410|NCT00511108|590394534|FG000|Overall Study|Physician Decision|0|||
163463411|NCT00511108|590394535|FG001|Overall Study|Physician Decision|0|||
163463412|NCT00511108|590394536|FG002|Overall Study|Physician Decision|0|||
163463413|NCT00511108|590394537|FG003|Overall Study|Physician Decision|1|||
163463414|NCT00511108|590394534|FG000|Overall Study|Withdrawal by Subject|4|||
163463415|NCT00511108|590394535|FG001|Overall Study|Withdrawal by Subject|0|||
163463416|NCT00511108|590394536|FG002|Overall Study|Withdrawal by Subject|3|||
163463417|NCT00511108|590394537|FG003|Overall Study|Withdrawal by Subject|2|||
163463418|NCT02954952|590394538|FG000|Overall Study|Withdrawal by Subject|1|||
163463419|NCT02954952|590394539|FG001|Overall Study|Withdrawal by Subject|0|||
163463420|NCT02954952|590394540|FG002|Overall Study|Withdrawal by Subject|0|||
163463421|NCT02954952|590394538|FG000|Overall Study|No data collected|0|||
163463422|NCT02954952|590394539|FG001|Overall Study|No data collected|1|||
163463423|NCT02954952|590394540|FG002|Overall Study|No data collected|0|||
163463424|NCT02911519|590394541|FG000|Overall Study|Lost to Follow-up|2|||
163463425|NCT02911519|590394542|FG001|Overall Study|Lost to Follow-up|2|||
163463426|NCT02911519|590394541|FG000|Overall Study|Death|0|||
163463427|NCT02911519|590394542|FG001|Overall Study|Death|2|||
163463428|NCT00810043|590394543|FG000|Overall Study|Withdrawal by Subject|1|||
163463429|NCT00810043|590394544|FG001|Overall Study|Withdrawal by Subject|0|||
163463430|NCT00810043|590394545|FG002|Overall Study|Withdrawal by Subject|2|||
163463431|NCT00810043|590394543|FG000|Overall Study|Lost to Follow-up|1|||
163463432|NCT00810043|590394544|FG001|Overall Study|Lost to Follow-up|0|||
163463433|NCT00810043|590394545|FG002|Overall Study|Lost to Follow-up|0|||
163463434|NCT00810043|590394543|FG000|Overall Study|Physician Decision|0|||
163463435|NCT00810043|590394544|FG001|Overall Study|Physician Decision|0|||
163463436|NCT00810043|590394545|FG002|Overall Study|Physician Decision|2|||
163463437|NCT00810043|590394543|FG000|Overall Study|Death|2|||
163463438|NCT00810043|590394544|FG001|Overall Study|Death|0|||
163463439|NCT00810043|590394545|FG002|Overall Study|Death|0|||
163463440|NCT00810043|590394543|FG000|Overall Study|Unrelated medical problem|0|||
163463441|NCT00810043|590394544|FG001|Overall Study|Unrelated medical problem|1|||
163463442|NCT00810043|590394545|FG002|Overall Study|Unrelated medical problem|0|||
163463443|NCT00810043|590394543|FG000|Overall Study|Non-medical problem|0|||
163463444|NCT00810043|590394544|FG001|Overall Study|Non-medical problem|0|||
163463445|NCT00810043|590394545|FG002|Overall Study|Non-medical problem|1|||
163463446|NCT00810043|590394543|FG000|Overall Study|No longer met enrollment criteria|0|||
163463447|NCT00810043|590394544|FG001|Overall Study|No longer met enrollment criteria|0|||
163463448|NCT00810043|590394545|FG002|Overall Study|No longer met enrollment criteria|3|||
163463449|NCT02001688|590394546|FG000|Overall Study|Withdrawal by Subject|0|||
163463450|NCT02001688|590394547|FG001|Overall Study|Withdrawal by Subject|0|||
163463451|NCT02001688|590394548|FG002|Overall Study|Withdrawal by Subject|1|||
163463452|NCT02001688|590394546|FG000|Overall Study|Adverse Event|0|||
163463453|NCT02001688|590394547|FG001|Overall Study|Adverse Event|1|||
163463454|NCT02001688|590394548|FG002|Overall Study|Adverse Event|0|||
163463455|NCT01675141|590394552|FG000|Overall Study|Lenalidomide outside NIH|3|||
163463456|NCT01675141|590394552|FG000|Overall Study|Withdrawal by Subject|3|||
163463457|NCT01675141|590394552|FG000|Overall Study|Physician Decision|4|||
163463458|NCT01675141|590394552|FG000|Overall Study|No treatment, per protocol|1|||
163463459|NCT00105183|590394556|FG000|Overall Study|Death|19|||
163463460|NCT00105183|590394557|FG001|Overall Study|Death|13|||
163463461|NCT00105183|590394558|FG002|Overall Study|Death|15|||
163463462|NCT00105183|590394556|FG000|Overall Study|Withdrawal by Subject|1|||
163463463|NCT00105183|590394557|FG001|Overall Study|Withdrawal by Subject|1|||
163463464|NCT00105183|590394558|FG002|Overall Study|Withdrawal by Subject|4|||
163463465|NCT00105183|590394556|FG000|Overall Study|Physician Decision|1|||
163463466|NCT00105183|590394557|FG001|Overall Study|Physician Decision|2|||
163463467|NCT00105183|590394558|FG002|Overall Study|Physician Decision|3|||
163463468|NCT00105183|590394556|FG000|Overall Study|Lost to Follow-up|0|||
163463469|NCT00105183|590394557|FG001|Overall Study|Lost to Follow-up|1|||
163463470|NCT00105183|590394558|FG002|Overall Study|Lost to Follow-up|1|||
163463471|NCT00105183|590394556|FG000|Overall Study|Other reason|1|||
163463472|NCT00105183|590394557|FG001|Overall Study|Other reason|2|||
163463473|NCT00105183|590394558|FG002|Overall Study|Other reason|0|||
163463474|NCT00270998|590394562|FG000|3 Month Follow-up|Adverse Event|1|||
163463475|NCT00270998|590394563|FG001|3 Month Follow-up|Adverse Event|0|||
163463476|NCT00270998|590394564|FG002|3 Month Follow-up|Adverse Event|0|||
163463477|NCT00270998|590394562|FG000|3 Month Follow-up|Lack of Efficacy|1|||
163463478|NCT00270998|590394563|FG001|3 Month Follow-up|Lack of Efficacy|2|||
163463479|NCT00270998|590394564|FG002|3 Month Follow-up|Lack of Efficacy|1|||
163463480|NCT00270998|590394562|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
163463481|NCT00270998|590394563|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
163463482|NCT00270998|590394564|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
163463483|NCT00270998|590394562|FG000|3 Month Follow-up|Pessary did not fit|12|||
163463484|NCT00270998|590394563|FG001|3 Month Follow-up|Pessary did not fit|0|||
163463485|NCT00270998|590394564|FG002|3 Month Follow-up|Pessary did not fit|0|||
163463486|NCT00270998|590394562|FG000|3 Month Follow-up|Personal/family health|1|||
163463487|NCT00270998|590394563|FG001|3 Month Follow-up|Personal/family health|1|||
163463488|NCT00270998|590394564|FG002|3 Month Follow-up|Personal/family health|0|||
163463489|NCT00270998|590394562|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
163463490|NCT00270998|590394563|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
163463491|NCT00270998|590394564|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
163463492|NCT00270998|590394562|FG000|12 Month Follow-up|Lack of Efficacy|5|||
163463493|NCT00270998|590394563|FG001|12 Month Follow-up|Lack of Efficacy|4|||
163463494|NCT00270998|590394564|FG002|12 Month Follow-up|Lack of Efficacy|3|||
163463495|NCT00270998|590394562|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
163463496|NCT00270998|590394563|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
163463497|NCT00270998|590394564|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
163463498|NCT00270998|590394562|FG000|12 Month Follow-up|Pessary did not fit|1|||
163463499|NCT00270998|590394563|FG001|12 Month Follow-up|Pessary did not fit|0|||
163463500|NCT00270998|590394564|FG002|12 Month Follow-up|Pessary did not fit|0|||
163463501|NCT00270998|590394562|FG000|12 Month Follow-up|Personal/family health|0|||
163463502|NCT00270998|590394563|FG001|12 Month Follow-up|Personal/family health|5|||
163463503|NCT00270998|590394564|FG002|12 Month Follow-up|Personal/family health|1|||
163463504|NCT00270998|590394562|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
163463505|NCT00270998|590394563|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
163463506|NCT00270998|590394564|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
163463507|NCT02443805|590394573|FG000|Overall Study|Adverse Event|100|||
163463508|NCT02443805|590394574|FG001|Overall Study|Adverse Event|18|||
163463509|NCT02443805|590394573|FG000|Overall Study|Withdrawal by Subject|73|||
163463510|NCT02443805|590394574|FG001|Overall Study|Withdrawal by Subject|74|||
163463511|NCT02443805|590394573|FG000|Overall Study|Lost to Follow-up|19|||
163463512|NCT02443805|590394574|FG001|Overall Study|Lost to Follow-up|14|||
163463513|NCT02443805|590394573|FG000|Overall Study|Pregnancy|6|||
163463514|NCT02443805|590394574|FG001|Overall Study|Pregnancy|5|||
163463515|NCT02443805|590394573|FG000|Overall Study|Protocol Violation|2|||
163463516|NCT02443805|590394574|FG001|Overall Study|Protocol Violation|4|||
163463517|NCT02443805|590394573|FG000|Overall Study|Lack of Efficacy|1|||
163463518|NCT02443805|590394574|FG001|Overall Study|Lack of Efficacy|1|||
163463519|NCT02443805|590394573|FG000|Overall Study|Non-compliance with study drug|6|||
163463520|NCT02443805|590394574|FG001|Overall Study|Non-compliance with study drug|4|||
163463521|NCT02443805|590394573|FG000|Overall Study|Withdrawal by parent/guardian|3|||
163463522|NCT02443805|590394574|FG001|Overall Study|Withdrawal by parent/guardian|5|||
163463523|NCT02443805|590394573|FG000|Overall Study|Any other reason not above-mentioned|3|||
163463524|NCT02443805|590394574|FG001|Overall Study|Any other reason not above-mentioned|2|||
163463525|NCT00961116|590394575|FG000|Washout Period of 7 Days|Adverse Event|1|||
163463526|NCT00961116|590394576|FG001|Washout Period of 7 Days|Adverse Event|1|||
163463527|NCT00961116|590394575|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
163463528|NCT00961116|590394576|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
163463529|NCT00961116|590394575|FG000|Washout Period of 7 Days|Protocol Violation|0|||
163463530|NCT00961116|590394576|FG001|Washout Period of 7 Days|Protocol Violation|1|||
163463531|NCT00968708|590394577|FG000|Overall Study|Adverse Event|169|||
163463532|NCT00968708|590394578|FG001|Overall Study|Adverse Event|150|||
163463533|NCT00968708|590394577|FG000|Overall Study|Major Protocol Deviation|0|||
163463534|NCT00968708|590394578|FG001|Overall Study|Major Protocol Deviation|1|||
163463535|NCT00968708|590394577|FG000|Overall Study|Lost to Follow-up|19|||
163463536|NCT00968708|590394578|FG001|Overall Study|Lost to Follow-up|11|||
163463537|NCT00968708|590394577|FG000|Overall Study|Voluntary Withdrawal|104|||
163463538|NCT00968708|590394578|FG001|Overall Study|Voluntary Withdrawal|101|||
163463539|NCT00968708|590394577|FG000|Overall Study|Investigator Discretion|0|||
163463540|NCT00968708|590394578|FG001|Overall Study|Investigator Discretion|1|||
163463541|NCT00968708|590394577|FG000|Overall Study|Other|26|||
163463542|NCT00968708|590394578|FG001|Overall Study|Other|34|||
163463543|NCT02708966|590394579|FG000|Overall Study|Lost to Follow-up|2|||
163463544|NCT02708966|590394580|FG001|Overall Study|Lost to Follow-up|2|||
163463545|NCT00389441|590394581|FG000|Overall Study|Adverse Event|7|||
163463546|NCT00389441|590394581|FG000|Overall Study|Death|4|||
163463547|NCT00389441|590394581|FG000|Overall Study|Lost to Follow-up|2|||
163463548|NCT00389441|590394581|FG000|Overall Study|Withdrawal by Subject|4|||
163463549|NCT00389441|590394581|FG000|Overall Study|Physician Decision|1|||
163463550|NCT00389441|590394581|FG000|Overall Study|Protocol Violation|1|||
163463551|NCT00389441|590394581|FG000|Overall Study|Global deterioration of health status|4|||
163463552|NCT00389441|590394581|FG000|Overall Study|Objective progression or relapse|26|||
163463553|NCT00389441|590394581|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
163463554|NCT00389441|590394581|FG000|Overall Study|Clinical progression|1|||
163463555|NCT01981109|590394582|FG000|Overall Study|Death|36|||
163463556|NCT01981109|590394582|FG000|Overall Study|Withdrawal by Subject|40|||
163463557|NCT01981109|590394582|FG000|Overall Study|Lost to Follow-up|9|||
163463558|NCT01981109|590394582|FG000|Overall Study|No Discontinuation Documentation|37|||
163463559|NCT01981109|590394582|FG000|Overall Study|Study Termination|100|||
163463560|NCT01981109|590394582|FG000|Overall Study|No data available|2|||
163463561|NCT03407170|590394583|FG000|Overall Study|Adverse Event|1|||
163463562|NCT00305604|590394585|FG000|Overall Study|Adverse Event|6|||
163463563|NCT00305604|590394586|FG001|Overall Study|Adverse Event|3|||
163463564|NCT00305604|590394585|FG000|Overall Study|Lack of Efficacy|11|||
163463565|NCT00305604|590394586|FG001|Overall Study|Lack of Efficacy|18|||
163463566|NCT00305604|590394585|FG000|Overall Study|Lost to Follow-up|0|||
163463567|NCT00305604|590394586|FG001|Overall Study|Lost to Follow-up|4|||
163463568|NCT00305604|590394585|FG000|Overall Study|Protocol Violation|2|||
163463569|NCT00305604|590394586|FG001|Overall Study|Protocol Violation|1|||
163463570|NCT00305604|590394585|FG000|Overall Study|Withdrawal by Subject|12|||
163463571|NCT00305604|590394586|FG001|Overall Study|Withdrawal by Subject|21|||
163463572|NCT00305604|590394585|FG000|Overall Study|Patient moved|1|||
163463573|NCT00305604|590394586|FG001|Overall Study|Patient moved|0|||
163463574|NCT00105560|590394587|FG000|Overall Study|Lost to Follow-up|1|||
163463575|NCT00636441|590394588|FG000|Overall Study|Adverse Event|0|||
163463576|NCT00636441|590394589|FG001|Overall Study|Adverse Event|1|||
163463577|NCT00636441|590394590|FG002|Overall Study|Adverse Event|1|||
163463578|NCT00636441|590394591|FG003|Overall Study|Adverse Event|0|||
163463579|NCT00636441|590394592|FG004|Overall Study|Adverse Event|0|||
163463580|NCT00636441|590394593|FG005|Overall Study|Adverse Event|1|||
163463581|NCT00636441|590394594|FG006|Overall Study|Adverse Event|0|||
163463582|NCT00636441|590394588|FG000|Overall Study|Late, ineligible|0|||
163463583|NCT00636441|590394589|FG001|Overall Study|Late, ineligible|0|||
163463584|NCT00636441|590394590|FG002|Overall Study|Late, ineligible|0|||
163463585|NCT00636441|590394591|FG003|Overall Study|Late, ineligible|0|||
163463586|NCT00636441|590394592|FG004|Overall Study|Late, ineligible|0|||
163463587|NCT00636441|590394593|FG005|Overall Study|Late, ineligible|0|||
163463588|NCT00636441|590394594|FG006|Overall Study|Late, ineligible|1|||
163463589|NCT00636441|590394588|FG000|Overall Study|Screen Failure|0|||
163463590|NCT00636441|590394589|FG001|Overall Study|Screen Failure|0|||
163463591|NCT00636441|590394590|FG002|Overall Study|Screen Failure|0|||
163463592|NCT00636441|590394591|FG003|Overall Study|Screen Failure|0|||
163463593|NCT00636441|590394592|FG004|Overall Study|Screen Failure|0|||
163463594|NCT00636441|590394593|FG005|Overall Study|Screen Failure|0|||
163463595|NCT00636441|590394594|FG006|Overall Study|Screen Failure|17|||
163463596|NCT02559713|590394599|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
163463597|NCT01021813|590394601|FG000|DB Treatment Phase|Adverse Event|60|||
163463598|NCT01021813|590394602|FG001|DB Treatment Phase|Adverse Event|22|||
163463599|NCT01021813|590394603|FG002|DB Treatment Phase|Adverse Event|0|||
163463600|NCT01021813|590394604|FG003|DB Treatment Phase|Adverse Event|0|||
163463601|NCT01021813|590394605|FG004|DB Treatment Phase|Adverse Event|0|||
163463602|NCT01021813|590394601|FG000|DB Treatment Phase|Lack of Efficacy|44|||
163463603|NCT01021813|590394602|FG001|DB Treatment Phase|Lack of Efficacy|28|||
163463604|NCT01021813|590394603|FG002|DB Treatment Phase|Lack of Efficacy|0|||
163463605|NCT01021813|590394604|FG003|DB Treatment Phase|Lack of Efficacy|0|||
163463606|NCT01021813|590394605|FG004|DB Treatment Phase|Lack of Efficacy|0|||
163463607|NCT01021813|590394601|FG000|DB Treatment Phase|Lost to Follow-up|14|||
163463608|NCT01021813|590394602|FG001|DB Treatment Phase|Lost to Follow-up|12|||
163463609|NCT01021813|590394603|FG002|DB Treatment Phase|Lost to Follow-up|0|||
163463610|NCT01021813|590394604|FG003|DB Treatment Phase|Lost to Follow-up|0|||
163463611|NCT01021813|590394605|FG004|DB Treatment Phase|Lost to Follow-up|0|||
163463612|NCT01021813|590394601|FG000|DB Treatment Phase|Physician Decision|17|||
163463613|NCT01021813|590394602|FG001|DB Treatment Phase|Physician Decision|8|||
163463614|NCT01021813|590394603|FG002|DB Treatment Phase|Physician Decision|0|||
163463615|NCT01021813|590394604|FG003|DB Treatment Phase|Physician Decision|0|||
163463616|NCT01021813|590394605|FG004|DB Treatment Phase|Physician Decision|0|||
163463617|NCT01021813|590394601|FG000|DB Treatment Phase|Pregnancy|1|||
163463618|NCT01021813|590394602|FG001|DB Treatment Phase|Pregnancy|0|||
163463619|NCT01021813|590394603|FG002|DB Treatment Phase|Pregnancy|0|||
163463620|NCT01021813|590394604|FG003|DB Treatment Phase|Pregnancy|0|||
163463621|NCT01021813|590394605|FG004|DB Treatment Phase|Pregnancy|0|||
163463622|NCT01021813|590394601|FG000|DB Treatment Phase|Protocol Violation|4|||
163463623|NCT01021813|590394602|FG001|DB Treatment Phase|Protocol Violation|3|||
163463624|NCT01021813|590394603|FG002|DB Treatment Phase|Protocol Violation|0|||
163463625|NCT01021813|590394604|FG003|DB Treatment Phase|Protocol Violation|0|||
163463626|NCT01021813|590394605|FG004|DB Treatment Phase|Protocol Violation|0|||
163463627|NCT01021813|590394601|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
163463628|NCT01021813|590394602|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
163463629|NCT01021813|590394603|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
163463630|NCT01021813|590394604|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
163463631|NCT01021813|590394605|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
163463632|NCT01021813|590394601|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
163463633|NCT01021813|590394602|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
163463634|NCT01021813|590394603|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
163463635|NCT01021813|590394604|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
163463636|NCT01021813|590394605|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
163463637|NCT01021813|590394601|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
163463638|NCT01021813|590394602|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
163463639|NCT01021813|590394603|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
163463640|NCT01021813|590394604|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
163463641|NCT01021813|590394605|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
163463642|NCT01021813|590394601|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
163463643|NCT01021813|590394602|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
163463644|NCT01021813|590394603|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
163463645|NCT01021813|590394604|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
163463646|NCT01021813|590394605|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
163463647|NCT01021813|590394601|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
163463648|NCT01021813|590394602|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
163463649|NCT01021813|590394603|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
163463650|NCT01021813|590394604|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
163463651|NCT01021813|590394605|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
163463652|NCT01021813|590394601|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
163463653|NCT01021813|590394602|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
163463654|NCT01021813|590394603|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
163463655|NCT01021813|590394604|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
163463656|NCT01021813|590394605|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
163463657|NCT02261883|590394609|FG000|Overall Study|Death|3|||
163463658|NCT02261883|590394610|FG001|Overall Study|Death|2|||
163463659|NCT02261883|590394609|FG000|Overall Study|Physician Decision|1|||
163463660|NCT02261883|590394610|FG001|Overall Study|Physician Decision|0|||
163463661|NCT02261883|590394609|FG000|Overall Study|Protocol Violation|1|||
163463662|NCT02261883|590394610|FG001|Overall Study|Protocol Violation|0|||
163463663|NCT02261883|590394609|FG000|Overall Study|Withdrawal by Subject|0|||
163463664|NCT02261883|590394610|FG001|Overall Study|Withdrawal by Subject|1|||
163463665|NCT02261883|590394609|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
163463666|NCT02261883|590394610|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
163463667|NCT01626989|590394616|FG000|Screening Period|Screen Failure|15|||
163463668|NCT01626989|590394617|FG001|Screening Period|Screen Failure|0|||
163463669|NCT01626989|590394618|FG002|Screening Period|Screen Failure|0|||
163463670|NCT01626989|590394616|FG000|Screening Period|Withdrawal by Subject|2|||
163463671|NCT01626989|590394617|FG001|Screening Period|Withdrawal by Subject|0|||
163463672|NCT01626989|590394618|FG002|Screening Period|Withdrawal by Subject|0|||
163463673|NCT03366844|590396835|FG000|Overall Study|Physician Decision|1|||
163463674|NCT03366844|590396835|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
163463675|NCT02332798|590396838|FG000|Overall Study|Unwilling to Participate in Study|0|||
163463676|NCT02332798|590396839|FG001|Overall Study|Unwilling to Participate in Study|1|||
163463677|NCT02332798|590396840|FG002|Overall Study|Unwilling to Participate in Study|1|||
163463678|NCT02332798|590396838|FG000|Overall Study|Positive Urine Drug Test|0|||
163463679|NCT02332798|590396839|FG001|Overall Study|Positive Urine Drug Test|1|||
163463680|NCT02332798|590396840|FG002|Overall Study|Positive Urine Drug Test|0|||
163463681|NCT02332798|590396838|FG000|Overall Study|Abnormal Laboratory Findings|1|||
163463682|NCT02332798|590396839|FG001|Overall Study|Abnormal Laboratory Findings|0|||
163463683|NCT02332798|590396840|FG002|Overall Study|Abnormal Laboratory Findings|0|||
163463684|NCT02688153|590396841|FG000|Overall Study|Death|7|||
163463685|NCT02688153|590396842|FG001|Overall Study|Death|5|||
163463686|NCT02688153|590396841|FG000|Overall Study|Withdrawal by Subject|4|||
163463687|NCT02688153|590396842|FG001|Overall Study|Withdrawal by Subject|2|||
163463688|NCT02688153|590396841|FG000|Overall Study|Valve Explant|1|||
163463689|NCT02688153|590396842|FG001|Overall Study|Valve Explant|0|||
163463690|NCT02688153|590396841|FG000|Overall Study|Conversion to Commercial Valve|3|||
163463691|NCT02688153|590396842|FG001|Overall Study|Conversion to Commercial Valve|0|||
163463692|NCT00595868|590396843|FG000|Overall Study|Lost to Follow-up|45|||
163463693|NCT00595868|590396844|FG001|Overall Study|Lost to Follow-up|50|||
163463694|NCT02687711|590396845|FG000|Overall Study|Adverse Event|89|||
163463695|NCT02687711|590396845|FG000|Overall Study|Lack of Efficacy|70|||
163463696|NCT02687711|590396845|FG000|Overall Study|Lost to Follow-up|20|||
163463697|NCT02687711|590396845|FG000|Overall Study|Consent withdrawn|15|||
163463698|NCT02687711|590396845|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
163463699|NCT02687711|590396845|FG000|Overall Study|Too expensive|4|||
163463700|NCT02687711|590396845|FG000|Overall Study|Participant moved abroad|1|||
163463701|NCT02687711|590396845|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
163463702|NCT02687711|590396845|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
163463703|NCT02687711|590396845|FG000|Overall Study|Disliked taste|1|||
163463704|NCT02687711|590396845|FG000|Overall Study|Low mood|1|||
163463705|NCT02687711|590396845|FG000|Overall Study|Side effects|1|||
163463706|NCT02687711|590396845|FG000|Overall Study|Change of Hospital|1|||
163463707|NCT02687711|590396845|FG000|Overall Study|Liver Encephalopathy|1|||
163463708|NCT02687711|590396845|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
163463709|NCT02687711|590396845|FG000|Overall Study|Withdrawn due to intake interruption|1|||
163463710|NCT02687711|590396845|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
163463711|NCT02687711|590396845|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
163463712|NCT02687711|590396845|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
163463713|NCT01742091|590396848|FG000|Overall Study|Adverse Event|0|||
163463714|NCT01742091|590396849|FG001|Overall Study|Adverse Event|0|||
163463715|NCT01742091|590396850|FG002|Overall Study|Adverse Event|0|||
163463716|NCT01742091|590396851|FG003|Overall Study|Adverse Event|0|||
163463717|NCT01742091|590396852|FG004|Overall Study|Adverse Event|1|||
163463718|NCT01742091|590396853|FG005|Overall Study|Adverse Event|0|||
163463719|NCT01742091|590396848|FG000|Overall Study|Physician Decision|0|||
163463720|NCT01742091|590396849|FG001|Overall Study|Physician Decision|0|||
163463721|NCT01742091|590396850|FG002|Overall Study|Physician Decision|0|||
163463722|NCT01742091|590396851|FG003|Overall Study|Physician Decision|0|||
163463723|NCT01742091|590396852|FG004|Overall Study|Physician Decision|0|||
163463724|NCT01742091|590396853|FG005|Overall Study|Physician Decision|1|||
163463725|NCT01742091|590396848|FG000|Overall Study|Withdrawal by Subject|0|||
163463726|NCT01742091|590396849|FG001|Overall Study|Withdrawal by Subject|0|||
163463727|NCT01742091|590396850|FG002|Overall Study|Withdrawal by Subject|0|||
163463728|NCT01742091|590396851|FG003|Overall Study|Withdrawal by Subject|1|||
163463729|NCT01742091|590396852|FG004|Overall Study|Withdrawal by Subject|0|||
163463730|NCT01742091|590396853|FG005|Overall Study|Withdrawal by Subject|0|||
163463731|NCT01742091|590396848|FG000|Overall Study|Lost to Follow-up|0|||
163463732|NCT01742091|590396849|FG001|Overall Study|Lost to Follow-up|0|||
163463733|NCT01742091|590396850|FG002|Overall Study|Lost to Follow-up|0|||
163463734|NCT01742091|590396851|FG003|Overall Study|Lost to Follow-up|0|||
163463735|NCT01742091|590396852|FG004|Overall Study|Lost to Follow-up|0|||
163463736|NCT01742091|590396853|FG005|Overall Study|Lost to Follow-up|1|||
163463737|NCT05742841|590396854|FG000|Overall Study|Withdrawal by Subject|1|||
163463738|NCT05742841|590396854|FG000|Overall Study|Lost to Follow-up|1|||
163463739|NCT03750240|590396855|FG000|Overall Study|Technical Difficulties|2|||
163463740|NCT02971007|590396857|FG000|Overall Study|Adverse Event|1|||
163463741|NCT02971007|590396858|FG001|Overall Study|Adverse Event|0|||
163463742|NCT02971007|590396859|FG002|Overall Study|Adverse Event|0|||
163463743|NCT02971007|590396857|FG000|Overall Study|Lost to Follow-up|0|||
163463744|NCT02971007|590396858|FG001|Overall Study|Lost to Follow-up|1|||
163463745|NCT02971007|590396859|FG002|Overall Study|Lost to Follow-up|1|||
163463746|NCT02971007|590396857|FG000|Overall Study|Withdrawal by Subject|0|||
163463747|NCT02971007|590396858|FG001|Overall Study|Withdrawal by Subject|1|||
163463748|NCT02971007|590396859|FG002|Overall Study|Withdrawal by Subject|0|||
163463749|NCT02971007|590396857|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
163463750|NCT02971007|590396858|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
163463751|NCT02971007|590396859|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
163463752|NCT02971007|590396857|FG000|Overall Study|Patient discontinued study drug|0|||
163463753|NCT02971007|590396858|FG001|Overall Study|Patient discontinued study drug|1|||
163463754|NCT02971007|590396859|FG002|Overall Study|Patient discontinued study drug|0|||
163463755|NCT02471586|590396860|FG000|Overall Study|Lost to Follow-up|3|||
163463756|NCT02471586|590396861|FG001|Overall Study|Lost to Follow-up|8|||
163463757|NCT02471586|590396862|FG002|Overall Study|Lost to Follow-up|4|||
163463758|NCT02471586|590396860|FG000|Overall Study|Death|2|||
163463759|NCT02471586|590396861|FG001|Overall Study|Death|2|||
163463760|NCT02471586|590396862|FG002|Overall Study|Death|0|||
163463761|NCT00607919|590396863|FG000|Acute Phase|Adverse Event|9|||
163463762|NCT00607919|590396864|FG001|Acute Phase|Adverse Event|2|||
163463763|NCT00607919|590396863|FG000|Acute Phase|Entry Criteria Not Met|1|||
163463764|NCT00607919|590396864|FG001|Acute Phase|Entry Criteria Not Met|1|||
163463765|NCT00607919|590396863|FG000|Acute Phase|Lack of Efficacy|1|||
163463766|NCT00607919|590396864|FG001|Acute Phase|Lack of Efficacy|2|||
163463767|NCT00607919|590396863|FG000|Acute Phase|Lost to Follow-up|9|||
163463768|NCT00607919|590396864|FG001|Acute Phase|Lost to Follow-up|3|||
163463769|NCT00607919|590396863|FG000|Acute Phase|Parent/Caregiver Decision|6|||
163463770|NCT00607919|590396864|FG001|Acute Phase|Parent/Caregiver Decision|4|||
163463771|NCT00607919|590396863|FG000|Acute Phase|Protocol Violation|5|||
163463772|NCT00607919|590396864|FG001|Acute Phase|Protocol Violation|1|||
163463773|NCT00607919|590396863|FG000|Acute Phase|Withdrawal by Subject|3|||
163463774|NCT00607919|590396864|FG001|Acute Phase|Withdrawal by Subject|3|||
163463775|NCT00607919|590396863|FG000|Open-Label Phase|Adverse Event|1|||
163463776|NCT00607919|590396864|FG001|Open-Label Phase|Adverse Event|5|||
163463777|NCT00607919|590396863|FG000|Open-Label Phase|Lost to Follow-up|4|||
163463778|NCT00607919|590396864|FG001|Open-Label Phase|Lost to Follow-up|1|||
163463779|NCT00607919|590396863|FG000|Open-Label Phase|Protocol Violation|2|||
163463780|NCT00607919|590396864|FG001|Open-Label Phase|Protocol Violation|2|||
163463781|NCT00607919|590396863|FG000|Open-Label Phase|Withdrawal by Subject|2|||
163463782|NCT00607919|590396864|FG001|Open-Label Phase|Withdrawal by Subject|2|||
163463783|NCT00607919|590396863|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
163463784|NCT00607919|590396864|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
163463785|NCT00239356|590396870|FG000|Overall Study|Lack of Efficacy|1|||
163463786|NCT00239356|590396871|FG001|Overall Study|Lack of Efficacy|0|||
163463787|NCT00239356|590396870|FG000|Overall Study|Adverse Event|6|||
163463788|NCT00239356|590396871|FG001|Overall Study|Adverse Event|0|||
163463789|NCT00239356|590396870|FG000|Overall Study|Withdrawal by Subject|15|||
163463790|NCT00239356|590396871|FG001|Overall Study|Withdrawal by Subject|6|||
163463791|NCT00239356|590396870|FG000|Overall Study|Lost to Follow-up|3|||
163463792|NCT00239356|590396871|FG001|Overall Study|Lost to Follow-up|0|||
163463793|NCT00239356|590396870|FG000|Overall Study|poor/non-compliance|2|||
163463794|NCT00239356|590396871|FG001|Overall Study|poor/non-compliance|0|||
163463795|NCT00239356|590396870|FG000|Overall Study|Pregnancy|1|||
163463796|NCT00239356|590396871|FG001|Overall Study|Pregnancy|0|||
163463797|NCT00239356|590396870|FG000|Overall Study|Administrative reason|0|||
163463798|NCT00239356|590396871|FG001|Overall Study|Administrative reason|1|||
163463799|NCT00239356|590396870|FG000|Overall Study|Drug available on market|11|||
163463800|NCT00239356|590396871|FG001|Overall Study|Drug available on market|2|||
163463801|NCT01001572|590396872|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
163463802|NCT01001572|590396873|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
163463803|NCT01001572|590396874|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
163463804|NCT01001572|590396872|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
163463805|NCT01001572|590396873|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
163463806|NCT01001572|590396874|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
163463807|NCT01001572|590396872|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
163463808|NCT01001572|590396873|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
163463809|NCT01001572|590396874|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
163463810|NCT01001572|590396872|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
163463811|NCT01001572|590396873|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
163463812|NCT01001572|590396874|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
163463813|NCT01001572|590396872|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
163463814|NCT01001572|590396873|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
163463815|NCT01001572|590396874|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
163463816|NCT01001572|590396872|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
163463817|NCT01001572|590396873|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
163463818|NCT01001572|590396874|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
163463819|NCT01001572|590396872|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
163463820|NCT01001572|590396873|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
163463821|NCT01001572|590396874|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
163463822|NCT01001572|590396872|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
163463823|NCT01001572|590396873|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
163463824|NCT01001572|590396874|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
163463825|NCT01001572|590396872|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
163463826|NCT01001572|590396873|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
163463827|NCT01001572|590396874|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
163463828|NCT01001572|590396872|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
163463829|NCT01001572|590396873|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
163463830|NCT01001572|590396874|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
163463831|NCT01001572|590396872|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
163463832|NCT01001572|590396873|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
163463833|NCT01001572|590396874|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
163463834|NCT01001572|590396872|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
163463835|NCT01001572|590396873|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
163463836|NCT01001572|590396874|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
163463837|NCT01001572|590396872|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
163463838|NCT01001572|590396873|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
163463839|NCT01001572|590396874|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
163463840|NCT01001572|590396872|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
163463841|NCT01001572|590396873|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
163463842|NCT01001572|590396874|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
163463843|NCT01237223|590396877|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
163463844|NCT01237223|590396878|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
163463845|NCT01237223|590396879|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
163463846|NCT01237223|590396880|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
163463847|NCT01237223|590396881|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
163463848|NCT01237223|590396882|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
163463849|NCT01237223|590396877|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
163463850|NCT01237223|590396878|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
163463851|NCT01237223|590396879|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
163463852|NCT01237223|590396880|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
163463853|NCT01237223|590396881|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
163463854|NCT01237223|590396882|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
163463855|NCT01237223|590396877|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
163463856|NCT01237223|590396878|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
163463857|NCT01237223|590396879|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
163463858|NCT01237223|590396880|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
163463859|NCT01237223|590396881|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
163463860|NCT01237223|590396882|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
163463861|NCT01237223|590396877|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
163463862|NCT01237223|590396878|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
163463863|NCT01237223|590396879|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
163463864|NCT01237223|590396880|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
163463865|NCT01237223|590396881|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
163463866|NCT01237223|590396882|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
163463867|NCT01237223|590396877|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
163463868|NCT01237223|590396878|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
163463869|NCT01237223|590396879|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
163463870|NCT01237223|590396880|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
163463871|NCT01237223|590396881|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
163463872|NCT01237223|590396882|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
163463873|NCT01237223|590396877|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
163463874|NCT01237223|590396878|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
163463875|NCT01237223|590396879|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
163463876|NCT01237223|590396880|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
163463877|NCT01237223|590396881|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
163463878|NCT01237223|590396882|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
163463879|NCT01237223|590396877|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
163463880|NCT01237223|590396878|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
163463881|NCT01237223|590396879|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
163463882|NCT01237223|590396880|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
163463883|NCT01237223|590396881|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
163463884|NCT01237223|590396882|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
163463885|NCT01237223|590396877|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
163463886|NCT01237223|590396878|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
163463887|NCT01237223|590396879|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
163463888|NCT01237223|590396880|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
163463889|NCT01237223|590396881|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
163463890|NCT01237223|590396882|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
163463891|NCT01237223|590396877|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
163463892|NCT01237223|590396878|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
163463893|NCT01237223|590396879|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
163463894|NCT01237223|590396880|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
163463895|NCT01237223|590396881|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
163463896|NCT01237223|590396882|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
163463897|NCT01237223|590396877|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
163463898|NCT01237223|590396878|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
163463899|NCT01237223|590396879|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
163463900|NCT01237223|590396880|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
163463901|NCT01237223|590396881|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
163463902|NCT01237223|590396882|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
163463903|NCT00724815|590396885|FG000|Overall Study|Randomized, not treated|31|||
163463904|NCT00724815|590396886|FG001|Overall Study|Randomized, not treated|30|||
163463905|NCT00724815|590396885|FG000|Overall Study|Adverse Event|5|||
163463906|NCT00724815|590396886|FG001|Overall Study|Adverse Event|3|||
163463907|NCT00724815|590396885|FG000|Overall Study|Lost to Follow-up|4|||
163463908|NCT00724815|590396886|FG001|Overall Study|Lost to Follow-up|1|||
163463909|NCT00724815|590396885|FG000|Overall Study|Other Various|3|||
163463910|NCT00724815|590396886|FG001|Overall Study|Other Various|5|||
163463911|NCT00443846|590396887|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
163463912|NCT00443846|590396888|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
163463913|NCT00443846|590396887|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
163463914|NCT00443846|590396888|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
163463915|NCT00443846|590396887|FG000|Overall Study|Adverse Event|0|||
163463916|NCT00443846|590396888|FG001|Overall Study|Adverse Event|1|||
163463917|NCT00443846|590396887|FG000|Overall Study|Personal reason|8|||
163463918|NCT00443846|590396888|FG001|Overall Study|Personal reason|3|||
163463919|NCT00443846|590396887|FG000|Overall Study|Lost to Follow-up|1|||
163463920|NCT00443846|590396888|FG001|Overall Study|Lost to Follow-up|2|||
163463921|NCT00445341|590396892|FG000|Overall Study|refused further treatment|1|||
163463922|NCT00445341|590396892|FG000|Overall Study|taken off treatment too early|1|||
163463923|NCT00641706|590396893|FG000|Overall Study|Adverse Event|2|||
163463924|NCT00641706|590396894|FG001|Overall Study|Adverse Event|1|||
163463925|NCT00641706|590396893|FG000|Overall Study|Withdrawal by Subject|6|||
163463926|NCT00641706|590396894|FG001|Overall Study|Withdrawal by Subject|1|||
163463927|NCT00641706|590396893|FG000|Overall Study|Clinical Decline|1|||
163463928|NCT00641706|590396894|FG001|Overall Study|Clinical Decline|0|||
163463929|NCT00641706|590396893|FG000|Overall Study|Lead Investigator Decision|0|||
163463930|NCT00641706|590396894|FG001|Overall Study|Lead Investigator Decision|1|||
163463931|NCT00109772|590396895|FG000|Double-blind Treatment|Adverse Event|14|||
163463932|NCT00109772|590396896|FG001|Double-blind Treatment|Adverse Event|5|||
163463933|NCT00109772|590396895|FG000|Double-blind Treatment|Lack of Efficacy|1|||
163463934|NCT00109772|590396896|FG001|Double-blind Treatment|Lack of Efficacy|0|||
163463935|NCT00109772|590396895|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
163463936|NCT00109772|590396896|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
163463937|NCT00109772|590396895|FG000|Double-blind Treatment|Lost to Follow-up|2|||
163463938|NCT00109772|590396896|FG001|Double-blind Treatment|Lost to Follow-up|3|||
163463939|NCT00109772|590396895|FG000|Double-blind Treatment|Protocol Violation|0|||
163463940|NCT00109772|590396896|FG001|Double-blind Treatment|Protocol Violation|1|||
163463941|NCT00109772|590396895|FG000|Double-blind Treatment|Other|0|||
163463942|NCT00109772|590396896|FG001|Double-blind Treatment|Other|4|||
163463943|NCT00109772|590396895|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
163463944|NCT00109772|590396896|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
163463945|NCT00109772|590396895|FG000|Open-label Extension|Adverse Event|10|||
163463946|NCT00109772|590396896|FG001|Open-label Extension|Adverse Event|19|||
163463947|NCT00109772|590396895|FG000|Open-label Extension|Lack of Efficacy|19|||
163463948|NCT00109772|590396896|FG001|Open-label Extension|Lack of Efficacy|11|||
163463949|NCT00109772|590396895|FG000|Open-label Extension|Withdrawal by Subject|9|||
163463950|NCT00109772|590396896|FG001|Open-label Extension|Withdrawal by Subject|6|||
163463951|NCT00109772|590396895|FG000|Open-label Extension|Lost to Follow-up|1|||
163463952|NCT00109772|590396896|FG001|Open-label Extension|Lost to Follow-up|0|||
163463953|NCT00109772|590396895|FG000|Open-label Extension|Death|0|||
163463954|NCT00109772|590396896|FG001|Open-label Extension|Death|1|||
163463955|NCT00109772|590396895|FG000|Open-label Extension|Protocol Violation|2|||
163463956|NCT00109772|590396896|FG001|Open-label Extension|Protocol Violation|2|||
163463957|NCT00109772|590396895|FG000|Open-label Extension|Other|4|||
163463958|NCT00109772|590396896|FG001|Open-label Extension|Other|10|||
163463959|NCT00813917|590396901|FG000|Overall Study|Adverse Event|0|||
163463960|NCT00813917|590396902|FG001|Overall Study|Adverse Event|1|||
163463961|NCT00813917|590396901|FG000|Overall Study|Withdrawal by Subject|3|||
163463962|NCT00813917|590396902|FG001|Overall Study|Withdrawal by Subject|4|||
163463963|NCT00813917|590396901|FG000|Overall Study|Lost to Follow-up|3|||
163463964|NCT00813917|590396902|FG001|Overall Study|Lost to Follow-up|1|||
163463965|NCT05441540|590396903|FG000|Overall Study|Withdrawal by Subject|2|||
163463966|NCT01359046|590396904|FG000|Overall Study|Did not receive allocated intervention|6|||
163463967|NCT01359046|590396905|FG001|Overall Study|Did not receive allocated intervention|6|||
163463968|NCT01359046|590396904|FG000|Overall Study|Physician Decision|1|||
163463969|NCT01359046|590396905|FG001|Overall Study|Physician Decision|11|||
163463970|NCT03862495|590396908|FG000|Overall Study|Lost to Follow-up|37|||
163463971|NCT03862495|590396909|FG001|Overall Study|Lost to Follow-up|35|||
163463972|NCT00064077|590396910|FG000|Overall Study|Improper prior treatment|1|||
163463973|NCT00064077|590396911|FG001|Overall Study|Improper prior treatment|0|||
163463974|NCT00064077|590396912|FG002|Overall Study|Improper prior treatment|0|||
163463975|NCT00064077|590396913|FG003|Overall Study|Improper prior treatment|0|||
163463976|NCT00064077|590396910|FG000|Overall Study|Poor risk|2|||
163463977|NCT00064077|590396911|FG001|Overall Study|Poor risk|0|||
163463978|NCT00064077|590396912|FG002|Overall Study|Poor risk|1|||
163463979|NCT00064077|590396913|FG003|Overall Study|Poor risk|1|||
163463980|NCT00064077|590396910|FG000|Overall Study|Pathology|10|||
163463981|NCT00064077|590396911|FG001|Overall Study|Pathology|7|||
163463982|NCT00064077|590396912|FG002|Overall Study|Pathology|3|||
163463983|NCT00064077|590396913|FG003|Overall Study|Pathology|4|||
163463984|NCT00064077|590396910|FG000|Overall Study|No surgery|0|||
163463985|NCT00064077|590396911|FG001|Overall Study|No surgery|0|||
163463986|NCT00064077|590396912|FG002|Overall Study|No surgery|1|||
163463987|NCT00064077|590396913|FG003|Overall Study|No surgery|0|||
163463988|NCT00064077|590396910|FG000|Overall Study|No tumor|0|||
163463989|NCT00064077|590396911|FG001|Overall Study|No tumor|0|||
163463990|NCT00064077|590396912|FG002|Overall Study|No tumor|1|||
163463991|NCT00064077|590396913|FG003|Overall Study|No tumor|0|||
163463992|NCT00064077|590396910|FG000|Overall Study|Other reasons|2|||
163463993|NCT00064077|590396911|FG001|Overall Study|Other reasons|2|||
163463994|NCT00064077|590396912|FG002|Overall Study|Other reasons|1|||
163463995|NCT00064077|590396913|FG003|Overall Study|Other reasons|2|||
163463996|NCT00615914|590396914|FG000|Overall Study|Adverse Event|274|||
163463997|NCT00615914|590396914|FG000|Overall Study|Death|20|||
163463998|NCT00615914|590396914|FG000|Overall Study|Lack of Efficacy|59|||
163463999|NCT00615914|590396914|FG000|Overall Study|Lost to Follow-up|187|||
163464000|NCT00615914|590396914|FG000|Overall Study|Withdrawal by Subject|16|||
163464001|NCT00615914|590396914|FG000|Overall Study|Physician Decision|4|||
163464002|NCT00615914|590396914|FG000|Overall Study|No data was collected.|65|||
163464003|NCT00615914|590396914|FG000|Overall Study|No treatment|2|||
163464004|NCT00615914|590396914|FG000|Overall Study|Irregularly enrolled patients|10|||
163464005|NCT04397796|590396915|FG000|Overall Study|Death|3|||
163464006|NCT04397796|590396916|FG001|Overall Study|Death|1|||
163464007|NCT03037307|590396917|FG000|Period 1|Did Not Meet Study Criteria|0|||
163464008|NCT03037307|590396918|FG001|Period 1|Did Not Meet Study Criteria|0|||
163464009|NCT03037307|590396919|FG002|Period 1|Did Not Meet Study Criteria|0|||
163464010|NCT03037307|590396920|FG003|Period 1|Did Not Meet Study Criteria|1|||
163464011|NCT03037307|590396921|FG004|Period 1|Did Not Meet Study Criteria|0|||
163464012|NCT03037307|590396922|FG005|Period 1|Did Not Meet Study Criteria|0|||
163464013|NCT04075396|590396925|FG000|Overall Study|Death|11|||
163464014|NCT04075396|590396926|FG001|Overall Study|Death|9|||
163464015|NCT04075396|590396925|FG000|Overall Study|Withdrawal by Subject|1|||
163464016|NCT04075396|590396926|FG001|Overall Study|Withdrawal by Subject|2|||
163464017|NCT04075396|590396925|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
163464018|NCT04075396|590396926|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
163464019|NCT04075396|590396925|FG000|Overall Study|Enrolled but not-treated|0|||
163464020|NCT04075396|590396926|FG001|Overall Study|Enrolled but not-treated|1|||
163464021|NCT04737759|590396927|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
163464022|NCT04737759|590396928|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
163464023|NCT04737759|590396927|FG000|Overall Study|Death|2|||
163464024|NCT04737759|590396928|FG001|Overall Study|Death|0|||
163464025|NCT04737759|590396927|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
163464026|NCT04737759|590396928|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
163464027|NCT04737759|590396927|FG000|Overall Study|Lost to Follow-up|4|||
163464028|NCT04737759|590396928|FG001|Overall Study|Lost to Follow-up|12|||
163464029|NCT00294684|590396929|FG000|Overall Study|Lost to Follow-up|5|||
163464030|NCT00294684|590396930|FG001|Overall Study|Lost to Follow-up|8|||
163464031|NCT01248364|590396933|FG000|Overall Study|Adverse Event|0|||
163464032|NCT01248364|590396934|FG001|Overall Study|Adverse Event|1|||
163464033|NCT01248364|590396935|FG002|Overall Study|Adverse Event|0|||
163464034|NCT01248364|590396936|FG003|Overall Study|Adverse Event|0|||
163464035|NCT01767519|590396937|FG000|Overall Study|Other Reasons|4|||
163464036|NCT01767519|590396938|FG001|Overall Study|Other Reasons|4|||
163464037|NCT01767519|590396939|FG002|Overall Study|Other Reasons|2|||
163464038|NCT01767519|590396937|FG000|Overall Study|Protocol Violation|0|||
163464039|NCT01767519|590396938|FG001|Overall Study|Protocol Violation|3|||
163464040|NCT01767519|590396939|FG002|Overall Study|Protocol Violation|0|||
163464041|NCT01767519|590396937|FG000|Overall Study|Personal Reasons|1|||
163464042|NCT01767519|590396938|FG001|Overall Study|Personal Reasons|0|||
163464043|NCT01767519|590396939|FG002|Overall Study|Personal Reasons|0|||
163464044|NCT01767519|590396937|FG000|Overall Study|Lost to Follow-up|3|||
163464045|NCT01767519|590396938|FG001|Overall Study|Lost to Follow-up|1|||
163464046|NCT01767519|590396939|FG002|Overall Study|Lost to Follow-up|2|||
163464047|NCT01767519|590396937|FG000|Overall Study|Lack of Efficacy|1|||
163464048|NCT01767519|590396938|FG001|Overall Study|Lack of Efficacy|0|||
163464049|NCT01767519|590396939|FG002|Overall Study|Lack of Efficacy|0|||
163464050|NCT01767519|590396937|FG000|Overall Study|Adverse Event|5|||
163464051|NCT01767519|590396938|FG001|Overall Study|Adverse Event|5|||
163464052|NCT01767519|590396939|FG002|Overall Study|Adverse Event|1|||
163464053|NCT00996593|590396942|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
163464054|NCT00996593|590396942|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
163464055|NCT00996593|590396942|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
163464056|NCT00996593|590396942|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
163464057|NCT00996593|590396942|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
163464058|NCT00996593|590396942|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
163464059|NCT00996593|590396942|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
163464060|NCT00996593|590396942|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
163464061|NCT00996593|590396942|FG000|Long-Term Follow-Up|Site Closed|1|||
163464062|NCT01033487|590396943|FG000|Fourth Intervention Period|Adverse Event|0|||
163464063|NCT01033487|590396944|FG001|Fourth Intervention Period|Adverse Event|0|||
163464064|NCT01033487|590396945|FG002|Fourth Intervention Period|Adverse Event|0|||
163464065|NCT01033487|590396946|FG003|Fourth Intervention Period|Adverse Event|0|||
163464066|NCT01033487|590396947|FG004|Fourth Intervention Period|Adverse Event|0|||
163464067|NCT01033487|590396948|FG005|Fourth Intervention Period|Adverse Event|0|||
163464068|NCT01033487|590396949|FG006|Fourth Intervention Period|Adverse Event|0|||
163464069|NCT01033487|590396950|FG007|Fourth Intervention Period|Adverse Event|0|||
163464070|NCT01033487|590396951|FG008|Fourth Intervention Period|Adverse Event|1|||
163464071|NCT01033487|590396952|FG009|Fourth Intervention Period|Adverse Event|0|||
163464072|NCT02849626|590396953|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
163464073|NCT02849626|590396954|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
163464074|NCT02849626|590396955|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
163464075|NCT02849626|590396956|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
163464076|NCT02849626|590396953|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
163464077|NCT02849626|590396954|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
163464078|NCT02849626|590396955|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
163464079|NCT02849626|590396956|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
163464080|NCT02849626|590396953|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
163464081|NCT02849626|590396954|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
163464082|NCT02849626|590396955|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
163464083|NCT02849626|590396956|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
163464084|NCT02849626|590396953|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
163464085|NCT02849626|590396954|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
163464086|NCT02849626|590396955|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
163464087|NCT02849626|590396956|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
163464088|NCT02849626|590396953|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
163464089|NCT02849626|590396954|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
163464090|NCT02849626|590396955|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
163464091|NCT02849626|590396956|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
163464092|NCT02849626|590396953|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
163464093|NCT02849626|590396954|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
163464094|NCT02849626|590396955|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
163464095|NCT02849626|590396956|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
163464096|NCT02849626|590396953|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
163464097|NCT02849626|590396954|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
163464098|NCT02849626|590396955|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
163464099|NCT02849626|590396956|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
163464100|NCT02849626|590396953|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
163464101|NCT02849626|590396954|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
163464102|NCT02849626|590396955|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
163464103|NCT02849626|590396956|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
163464104|NCT02849626|590396953|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
163464105|NCT02849626|590396954|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
163464106|NCT02849626|590396955|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
163464107|NCT02849626|590396956|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
163464108|NCT02849626|590396953|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
163464109|NCT02849626|590396954|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
163464110|NCT02849626|590396955|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
163464111|NCT02849626|590396956|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
163464112|NCT02849626|590396953|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
163464113|NCT02849626|590396954|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
163464114|NCT02849626|590396955|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
163464115|NCT02849626|590396956|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
163464116|NCT04046341|590396961|FG000|Overall Study|Lost to Follow-up|2|||
163464117|NCT04046341|590396961|FG000|Overall Study|Withdrawal by Subject|1|||
163464118|NCT04377672|590396962|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
163464119|NCT02447458|590396963|FG000|Overall Study|Other|0|||
163464120|NCT02447458|590396964|FG001|Overall Study|Other|0|||
163464121|NCT02447458|590396965|FG002|Overall Study|Other|1|||
163464122|NCT02447458|590396966|FG003|Overall Study|Other|0|||
163464123|NCT02447458|590396967|FG004|Overall Study|Other|0|||
163464124|NCT02447458|590396968|FG005|Overall Study|Other|0|||
163464125|NCT00405652|590396969|FG000|Overall Study|Adverse Event|4|||
163464126|NCT00435994|590396971|FG000|Overall Study|Lost to Follow-up|7|||
163464127|NCT00435994|590396972|FG001|Overall Study|Lost to Follow-up|0|||
163464128|NCT00435994|590396973|FG002|Overall Study|Lost to Follow-up|0|||
163464129|NCT03505749|590396974|FG000|Overall Study|Lost to Follow-up|7|||
163464130|NCT03505749|590396975|FG001|Overall Study|Lost to Follow-up|11|||
163464131|NCT03505749|590396974|FG000|Overall Study|Withdrawal by Subject|6|||
163464132|NCT03505749|590396975|FG001|Overall Study|Withdrawal by Subject|0|||
163464133|NCT03505749|590396974|FG000|Overall Study|Discharged from treatment|3|||
163464134|NCT03505749|590396975|FG001|Overall Study|Discharged from treatment|6|||
163464135|NCT03846219|590396978|FG000|Overall Study|Withdrawal by Subject|3|||
163464136|NCT03846219|590396979|FG001|Overall Study|Withdrawal by Subject|2|||
163464137|NCT03846219|590396980|FG002|Overall Study|Withdrawal by Subject|2|||
163464138|NCT03846219|590396978|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
163464139|NCT03846219|590396979|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
163464140|NCT03846219|590396980|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
163464141|NCT03846219|590396978|FG000|Overall Study|Physician Decision|0|||
163464142|NCT03846219|590396979|FG001|Overall Study|Physician Decision|0|||
163464143|NCT03846219|590396980|FG002|Overall Study|Physician Decision|2|||
163464144|NCT05109702|590396981|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
163464145|NCT05109702|590396982|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
163464146|NCT05109702|590396983|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
163464147|NCT05109702|590396981|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
163464148|NCT05109702|590396982|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
163464149|NCT05109702|590396983|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
163464150|NCT05109702|590396981|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
163464151|NCT05109702|590396982|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
163464152|NCT05109702|590396983|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
163464153|NCT05109702|590396981|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
163464154|NCT05109702|590396982|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
163464155|NCT05109702|590396983|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
163464156|NCT05109702|590396981|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
163464157|NCT05109702|590396982|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
163464158|NCT05109702|590396983|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
163464159|NCT03094832|590396988|FG000|Overall Study|Lost to Follow-up|0|||
163464160|NCT03094832|590396989|FG001|Overall Study|Lost to Follow-up|0|||
163464161|NCT03094832|590396990|FG002|Overall Study|Lost to Follow-up|0|||
163464162|NCT03094832|590396991|FG003|Overall Study|Lost to Follow-up|1|||
163464163|NCT03094832|590396992|FG004|Overall Study|Lost to Follow-up|1|||
163464164|NCT03094832|590396988|FG000|Overall Study|Death|1|||
163464165|NCT03094832|590396989|FG001|Overall Study|Death|0|||
163464166|NCT03094832|590396990|FG002|Overall Study|Death|0|||
163464167|NCT03094832|590396991|FG003|Overall Study|Death|0|||
163464168|NCT03094832|590396992|FG004|Overall Study|Death|0|||
163464169|NCT03094832|590396988|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163464170|NCT03094832|590396989|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163464171|NCT03094832|590396990|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163464172|NCT03094832|590396991|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163464173|NCT03094832|590396992|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
163464174|NCT03094832|590396988|FG000|Overall Study|Other|13|||
163464175|NCT03094832|590396989|FG001|Overall Study|Other|20|||
163464176|NCT03094832|590396990|FG002|Overall Study|Other|1|||
163464177|NCT03094832|590396991|FG003|Overall Study|Other|7|||
163464178|NCT03094832|590396992|FG004|Overall Study|Other|1|||
163464179|NCT01392378|590396993|FG000|Infant Series|Adverse Event|0|||
163464180|NCT01392378|590396994|FG001|Infant Series|Adverse Event|0|||
163464181|NCT01392378|590396995|FG002|Infant Series|Adverse Event|0|||
163464182|NCT01392378|590396996|FG003|Infant Series|Adverse Event|1|||
163464183|NCT01392378|590396997|FG004|Infant Series|Adverse Event|0|||
163464184|NCT01392378|590396993|FG000|Infant Series|Lost to Follow-up|0|||
163464185|NCT01392378|590396994|FG001|Infant Series|Lost to Follow-up|0|||
163464186|NCT01392378|590396995|FG002|Infant Series|Lost to Follow-up|0|||
163464187|NCT01392378|590396996|FG003|Infant Series|Lost to Follow-up|1|||
163464188|NCT01392378|590396997|FG004|Infant Series|Lost to Follow-up|0|||
163464189|NCT01392378|590396993|FG000|Infant Series|Protocol Violation|0|||
163464190|NCT01392378|590396994|FG001|Infant Series|Protocol Violation|1|||
163464191|NCT01392378|590396995|FG002|Infant Series|Protocol Violation|0|||
163464192|NCT01392378|590396996|FG003|Infant Series|Protocol Violation|0|||
163464193|NCT01392378|590396997|FG004|Infant Series|Protocol Violation|0|||
163464194|NCT01392378|590396993|FG000|Infant Series|Withdrawal by Parent|4|||
163464195|NCT01392378|590396994|FG001|Infant Series|Withdrawal by Parent|1|||
163464196|NCT01392378|590396995|FG002|Infant Series|Withdrawal by Parent|0|||
163464197|NCT01392378|590396996|FG003|Infant Series|Withdrawal by Parent|0|||
163464198|NCT01392378|590396997|FG004|Infant Series|Withdrawal by Parent|0|||
163464199|NCT01392378|590396993|FG000|After Infant Series|Lost to Follow-up|0|||
163464200|NCT01392378|590396994|FG001|After Infant Series|Lost to Follow-up|0|||
163464201|NCT01392378|590396995|FG002|After Infant Series|Lost to Follow-up|1|||
163464202|NCT01392378|590396996|FG003|After Infant Series|Lost to Follow-up|0|||
163464203|NCT01392378|590396997|FG004|After Infant Series|Lost to Follow-up|0|||
163464204|NCT01392378|590396993|FG000|After Infant Series|Withdrawal by Parent|0|||
163464205|NCT01392378|590396994|FG001|After Infant Series|Withdrawal by Parent|1|||
163464206|NCT01392378|590396995|FG002|After Infant Series|Withdrawal by Parent|1|||
163464207|NCT01392378|590396996|FG003|After Infant Series|Withdrawal by Parent|0|||
163464208|NCT01392378|590396997|FG004|After Infant Series|Withdrawal by Parent|1|||
163464209|NCT01392378|590396993|FG000|Toddler Dose|Lost to Follow-up|0|||
163464210|NCT01392378|590396994|FG001|Toddler Dose|Lost to Follow-up|0|||
163464211|NCT01392378|590396995|FG002|Toddler Dose|Lost to Follow-up|0|||
163464212|NCT01392378|590396996|FG003|Toddler Dose|Lost to Follow-up|1|||
163464213|NCT01392378|590396997|FG004|Toddler Dose|Lost to Follow-up|0|||
163464214|NCT01392378|590396993|FG000|Toddler Dose|Withdrawal by Parent|0|||
163464215|NCT01392378|590396994|FG001|Toddler Dose|Withdrawal by Parent|1|||
163464216|NCT01392378|590396995|FG002|Toddler Dose|Withdrawal by Parent|0|||
163464217|NCT01392378|590396996|FG003|Toddler Dose|Withdrawal by Parent|1|||
163464218|NCT01392378|590396997|FG004|Toddler Dose|Withdrawal by Parent|1|||
163464219|NCT02322411|590397002|FG000|Overall Study|Lost to Follow-up|4|||
163464220|NCT02322411|590397003|FG001|Overall Study|Lost to Follow-up|7|||
163464221|NCT02322411|590397002|FG000|Overall Study|Withdrawal by Subject|1|||
163464222|NCT02322411|590397003|FG001|Overall Study|Withdrawal by Subject|0|||
163464223|NCT00788697|590397004|FG000|Overall Study|No study drug administered|12|||
163464224|NCT00788697|590397004|FG000|Overall Study|Training Patients|74|||
163464225|NCT00788697|590397004|FG000|Overall Study|no truth standard procedure available|5|||
163464226|NCT00788697|590397004|FG000|Overall Study|Technically inadequate truth standard|1|||
163464227|NCT00788697|590397004|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
163464228|NCT01998880|590397006|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
163464229|NCT01998880|590397007|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
163464230|NCT01998880|590397006|FG000|Overall Study|Disease Progression|1|||
163464231|NCT01998880|590397007|FG001|Overall Study|Disease Progression|8|||
163464232|NCT01998880|590397006|FG000|Overall Study|Withdrew Consent|2|||
163464233|NCT01998880|590397007|FG001|Overall Study|Withdrew Consent|1|||
163464234|NCT01998880|590397006|FG000|Overall Study|Death|3|||
163464235|NCT01998880|590397007|FG001|Overall Study|Death|6|||
163464236|NCT01998880|590397006|FG000|Overall Study|Insufficient Therapeutic Response|1|||
163464237|NCT01998880|590397007|FG001|Overall Study|Insufficient Therapeutic Response|5|||
163464238|NCT01998880|590397006|FG000|Overall Study|Administrative/Other|1|||
163464239|NCT01998880|590397007|FG001|Overall Study|Administrative/Other|1|||
163464240|NCT01998880|590397006|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
163464241|NCT01998880|590397007|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
163464242|NCT01998880|590397006|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
163464243|NCT01998880|590397007|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
163464244|NCT01998880|590397006|FG000|Overall Study|Did Not Receive Treatment|3|||
163464245|NCT01998880|590397007|FG001|Overall Study|Did Not Receive Treatment|2|||
163464246|NCT02248857|590397008|FG000|3 Month|Withdrawal by Subject|9|||
163464247|NCT02248857|590397009|FG001|3 Month|Withdrawal by Subject|3|||
163464248|NCT02248857|590397010|FG002|3 Month|Withdrawal by Subject|4|||
163464249|NCT02248857|590397008|FG000|3 Month|Unable to reach for 3 month|35|||
163464250|NCT02248857|590397009|FG001|3 Month|Unable to reach for 3 month|29|||
163464251|NCT02248857|590397010|FG002|3 Month|Unable to reach for 3 month|26|||
163464252|NCT02248857|590397008|FG000|3 Month|Partially completed, unable to finish|2|||
163464253|NCT02248857|590397009|FG001|3 Month|Partially completed, unable to finish|2|||
163464254|NCT02248857|590397010|FG002|3 Month|Partially completed, unable to finish|1|||
163464255|NCT02248857|590397008|FG000|6 Month|Lost to Follow-up|27|||
163464256|NCT02248857|590397009|FG001|6 Month|Lost to Follow-up|26|||
163464257|NCT02248857|590397010|FG002|6 Month|Lost to Follow-up|15|||
163464258|NCT02248857|590397008|FG000|6 Month|Partially completed, unable to finish|0|||
163464259|NCT02248857|590397009|FG001|6 Month|Partially completed, unable to finish|1|||
163464260|NCT02248857|590397010|FG002|6 Month|Partially completed, unable to finish|0|||
163464261|NCT02248857|590397008|FG000|6 Month|Withdrawal by Subject|0|||
163464262|NCT02248857|590397009|FG001|6 Month|Withdrawal by Subject|2|||
163464263|NCT02248857|590397010|FG002|6 Month|Withdrawal by Subject|2|||
163464264|NCT02248857|590397008|FG000|6 Month|Death|1|||
163464265|NCT02248857|590397009|FG001|6 Month|Death|0|||
163464266|NCT02248857|590397010|FG002|6 Month|Death|0|||
163464267|NCT02671461|590397011|FG000|Treatment|Adverse Event|0|||
163464268|NCT02671461|590397012|FG001|Treatment|Adverse Event|0|||
163464269|NCT02671461|590397013|FG002|Treatment|Adverse Event|1|||
163464270|NCT02671461|590397011|FG000|Treatment|Administrative Reason by Sponsor|1|||
163464271|NCT02671461|590397012|FG001|Treatment|Administrative Reason by Sponsor|3|||
163464272|NCT02671461|590397013|FG002|Treatment|Administrative Reason by Sponsor|4|||
163464273|NCT02671461|590397011|FG000|Treatment|Randomized, not treated|1|||
163464274|NCT02671461|590397012|FG001|Treatment|Randomized, not treated|0|||
163464275|NCT02671461|590397013|FG002|Treatment|Randomized, not treated|0|||
163464276|NCT02671461|590397011|FG000|Follow-up|Withdrawal by Subject|1|||
163464277|NCT02671461|590397012|FG001|Follow-up|Withdrawal by Subject|0|||
163464278|NCT02671461|590397013|FG002|Follow-up|Withdrawal by Subject|0|||
163464279|NCT02671461|590397011|FG000|Follow-up|Lost to Follow-up|0|||
163464280|NCT02671461|590397012|FG001|Follow-up|Lost to Follow-up|0|||
163464281|NCT02671461|590397013|FG002|Follow-up|Lost to Follow-up|1|||
163464282|NCT02671461|590397011|FG000|Follow-up|Administrative Reason by Sponsor|0|||
163464283|NCT02671461|590397012|FG001|Follow-up|Administrative Reason by Sponsor|1|||
163464284|NCT02671461|590397013|FG002|Follow-up|Administrative Reason by Sponsor|0|||
163464285|NCT00367432|590397015|FG000|First Period (16 Weeks)|Adverse Event|6|||
163464286|NCT00367432|590397016|FG001|First Period (16 Weeks)|Adverse Event|0|||
163464287|NCT00367432|590397015|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
163464288|NCT00367432|590397016|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
163464289|NCT00367432|590397015|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
163464290|NCT00367432|590397016|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
163464291|NCT00367432|590397015|FG000|First Period (16 Weeks)|Other Reason|2|||
163464292|NCT00367432|590397016|FG001|First Period (16 Weeks)|Other Reason|0|||
163464293|NCT00367432|590397015|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
163464294|NCT00367432|590397016|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
163464295|NCT00367432|590397015|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
163464296|NCT00367432|590397016|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
163464297|NCT00367432|590397015|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
163464298|NCT00367432|590397016|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
163464299|NCT00367432|590397015|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
163464300|NCT00367432|590397016|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
163464301|NCT00367432|590397015|FG000|Second Period (up to 54 Months)|Other Reason|6|||
163464302|NCT00367432|590397016|FG001|Second Period (up to 54 Months)|Other Reason|2|||
163464303|NCT00903370|590397017|FG000|Overall Study|Death|13|||
163464304|NCT00903370|590397018|FG001|Overall Study|Death|10|||
163464305|NCT00903370|590397017|FG000|Overall Study|Withdrawal by Subject|9|||
163464306|NCT00903370|590397018|FG001|Overall Study|Withdrawal by Subject|6|||
163464307|NCT00903370|590397017|FG000|Overall Study|Lost to Follow-up|6|||
163464308|NCT00903370|590397018|FG001|Overall Study|Lost to Follow-up|8|||
163464309|NCT00014911|590397019|FG000|Overall Study|Adverse Event|1|||
163464310|NCT00014911|590397019|FG000|Overall Study|Lost to Follow-up|1|||
163464311|NCT00014911|590397019|FG000|Overall Study|Withdrawal by Subject|6|||
163464312|NCT00014911|590397019|FG000|Overall Study|Unknown Reasons|2|||
163464313|NCT00014911|590397019|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
163464314|NCT04209530|590399069|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
163464315|NCT04209530|590399070|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
163464316|NCT04209530|590399069|FG000|Overall Study|Withdrawal by Subject|0|||
163464317|NCT04209530|590399070|FG001|Overall Study|Withdrawal by Subject|1|||
163464318|NCT04839393|590399071|FG000|Overall Study|Adverse Event|0|||
163464319|NCT04839393|590399072|FG001|Overall Study|Adverse Event|0|||
163464320|NCT04839393|590399073|FG002|Overall Study|Adverse Event|2|||
163464321|NCT04839393|590399071|FG000|Overall Study|Withdrawal by participant|0|||
163464322|NCT04839393|590399072|FG001|Overall Study|Withdrawal by participant|0|||
163464323|NCT04839393|590399073|FG002|Overall Study|Withdrawal by participant|1|||
163464324|NCT05091918|590399076|FG000|Overall Study|Adverse Event|1|||
163464325|NCT05091918|590399076|FG000|Overall Study|Withdrawal by Subject|81|||
163464326|NCT01100658|590399078|FG000|Overall Study|Withdrawal by Subject|1|||
163464327|NCT01094808|590399081|FG000|Overall Study|Withdrawal by Subject|1|||
163464328|NCT01094808|590399082|FG001|Overall Study|Withdrawal by Subject|1|||
163464329|NCT01094808|590399083|FG002|Overall Study|Withdrawal by Subject|0|||
163464330|NCT00369278|590399084|FG000|Overall Study|Adverse Event|14|||
163464331|NCT00369278|590399085|FG001|Overall Study|Adverse Event|11|||
163464332|NCT00369278|590399084|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
163464333|NCT00369278|590399085|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
163464334|NCT00369278|590399084|FG000|Overall Study|Protocol Violation|2|||
163464335|NCT00369278|590399085|FG001|Overall Study|Protocol Violation|1|||
163464336|NCT00369278|590399084|FG000|Overall Study|Withdrawal by Subject|2|||
163464337|NCT00369278|590399085|FG001|Overall Study|Withdrawal by Subject|2|||
163464338|NCT00369278|590399084|FG000|Overall Study|Lost to Follow-up|1|||
163464339|NCT00369278|590399085|FG001|Overall Study|Lost to Follow-up|0|||
163464340|NCT00369278|590399084|FG000|Overall Study|Graft loss|1|||
163464341|NCT00369278|590399085|FG001|Overall Study|Graft loss|2|||
163464342|NCT02044822|590399086|FG000|Overall Study|Study Terminated by Sponsor|77|||
163464343|NCT02044822|590399086|FG000|Overall Study|Investigator's Discretion|10|||
163464344|NCT02044822|590399086|FG000|Overall Study|Withdrew Consent|3|||
163464345|NCT02044822|590399086|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
163464346|NCT02044822|590399086|FG000|Overall Study|Lost to Follow-up|1|||
163464347|NCT02025530|590399089|FG000|Overall Study|No longer met elligibility criteria|5|||
163464348|NCT02025530|590399090|FG001|Overall Study|No longer met elligibility criteria|1|||
163464349|NCT03551626|590399095|FG000|Overall Study|Adverse Event|88|||
163464350|NCT03551626|590399095|FG000|Overall Study|Disease relapse|18|||
163464351|NCT03551626|590399095|FG000|Overall Study|Withdrawal of informed consent|6|||
163464352|NCT03551626|590399095|FG000|Overall Study|Patient decision|5|||
163464353|NCT03551626|590399095|FG000|Overall Study|Physician Decision|4|||
163464354|NCT03551626|590399095|FG000|Overall Study|Lost to Follow-up|3|||
163464355|NCT03551626|590399095|FG000|Overall Study|Pregnancy|1|||
163464356|NCT03551626|590399095|FG000|Overall Study|Protocol deviation|1|||
163464357|NCT03551626|590399095|FG000|Overall Study|Technical problems|1|||
163464358|NCT00653328|590399096|FG000|Overall Study|Withdrawal by Subject|1|||
163464359|NCT00653328|590399096|FG000|Overall Study|Adverse Event|2|||
163464360|NCT00653328|590399096|FG000|Overall Study|Disease progression|10|||
163464361|NCT00653328|590399096|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
163464362|NCT03051217|590399107|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
163464363|NCT03051217|590399108|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163464364|NCT03051217|590399109|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
163464365|NCT03051217|590399110|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163464366|NCT03051217|590399111|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163464367|NCT03051217|590399112|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163464368|NCT03051217|590399113|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163464369|NCT03051217|590399107|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
163464370|NCT03051217|590399108|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
163464371|NCT03051217|590399109|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
163464372|NCT03051217|590399110|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
163464373|NCT03051217|590399111|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
163464374|NCT03051217|590399112|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
163464375|NCT03051217|590399113|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
163464376|NCT03051217|590399107|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
163464377|NCT03051217|590399108|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
163464378|NCT03051217|590399109|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
163464379|NCT03051217|590399110|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163464380|NCT03051217|590399111|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163464381|NCT03051217|590399112|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163464382|NCT03051217|590399113|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163464383|NCT03051217|590399107|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
163464384|NCT03051217|590399108|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
163464385|NCT03051217|590399109|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
163464386|NCT03051217|590399110|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
163464387|NCT03051217|590399111|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
163464388|NCT03051217|590399112|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
163464389|NCT03051217|590399113|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
163464390|NCT03051217|590399107|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
163464391|NCT03051217|590399108|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
163464392|NCT03051217|590399109|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
163464393|NCT03051217|590399110|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
163464394|NCT03051217|590399111|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
163464395|NCT03051217|590399112|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
163464396|NCT03051217|590399113|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
163464397|NCT03051217|590399107|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
163464398|NCT03051217|590399108|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
163464399|NCT03051217|590399109|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
163464400|NCT03051217|590399110|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
163464401|NCT03051217|590399111|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
163464402|NCT03051217|590399112|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
163464403|NCT03051217|590399113|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
163464404|NCT03051217|590399107|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
163464405|NCT03051217|590399108|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
163464406|NCT03051217|590399109|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
163464407|NCT03051217|590399110|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
163464408|NCT03051217|590399111|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
163464409|NCT03051217|590399112|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
163464410|NCT03051217|590399113|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
163464411|NCT03051217|590399107|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
163464412|NCT03051217|590399108|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
163464413|NCT03051217|590399109|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
163464414|NCT03051217|590399110|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
163464415|NCT03051217|590399111|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
163464416|NCT03051217|590399112|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
163464417|NCT03051217|590399113|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
163464418|NCT01989754|590399114|FG000|Overall Study|Withdrawal by Subject|10|||
163464419|NCT01989754|590399115|FG001|Overall Study|Withdrawal by Subject|14|||
163464420|NCT01989754|590399114|FG000|Overall Study|Lost to Follow-up|28|||
163464421|NCT01989754|590399115|FG001|Overall Study|Lost to Follow-up|20|||
163464422|NCT01989754|590399114|FG000|Overall Study|Closed Site|1|||
163464423|NCT01989754|590399115|FG001|Overall Study|Closed Site|1|||
163464424|NCT00391807|590399117|FG000|Overall Study|Did not receive study medication|23|||
163464425|NCT00391807|590399117|FG000|Overall Study|Adverse Event|177|||
163464426|NCT00391807|590399117|FG000|Overall Study|Pregnancy|25|||
163464427|NCT00391807|590399117|FG000|Overall Study|Lost to Follow-up|227|||
163464428|NCT00391807|590399117|FG000|Overall Study|Withdrawal by Subject|147|||
163464429|NCT00391807|590399117|FG000|Overall Study|Protocol Violation|20|||
163464430|NCT00391807|590399117|FG000|Overall Study|Various|96|||
163464431|NCT01369225|590399120|FG000|Overall Study|Withdrawal by Subject|1|||
163464432|NCT01369225|590399121|FG001|Overall Study|Withdrawal by Subject|0|||
163464433|NCT01369225|590399122|FG002|Overall Study|Withdrawal by Subject|2|||
163464434|NCT01369225|590399123|FG003|Overall Study|Withdrawal by Subject|1|||
163464435|NCT01369225|590399124|FG004|Overall Study|Withdrawal by Subject|0|||
163464436|NCT01369225|590399125|FG005|Overall Study|Withdrawal by Subject|0|||
163464437|NCT01369225|590399120|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
163464438|NCT01369225|590399121|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
163464439|NCT01369225|590399122|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
163464440|NCT01369225|590399123|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
163464441|NCT01369225|590399124|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
163464442|NCT01369225|590399125|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
163464443|NCT01369225|590399120|FG000|Overall Study|Other|1|||
163464444|NCT01369225|590399121|FG001|Overall Study|Other|0|||
163464445|NCT01369225|590399122|FG002|Overall Study|Other|0|||
163464446|NCT01369225|590399123|FG003|Overall Study|Other|0|||
163464447|NCT01369225|590399124|FG004|Overall Study|Other|1|||
163464448|NCT01369225|590399125|FG005|Overall Study|Other|0|||
163464449|NCT01369225|590399120|FG000|Overall Study|Adverse Event|0|||
163464450|NCT01369225|590399121|FG001|Overall Study|Adverse Event|0|||
163464451|NCT01369225|590399122|FG002|Overall Study|Adverse Event|0|||
163464452|NCT01369225|590399123|FG003|Overall Study|Adverse Event|1|||
163464453|NCT01369225|590399124|FG004|Overall Study|Adverse Event|1|||
163464454|NCT01369225|590399125|FG005|Overall Study|Adverse Event|0|||
163464455|NCT04539262|590399129|FG000|Overall Study|Adverse Event|0|||
163464456|NCT04539262|590399130|FG001|Overall Study|Adverse Event|0|||
163464457|NCT04539262|590399131|FG002|Overall Study|Adverse Event|1|||
163464458|NCT04539262|590399132|FG003|Overall Study|Adverse Event|0|||
163464459|NCT04539262|590399133|FG004|Overall Study|Adverse Event|0|||
163464460|NCT04539262|590399134|FG005|Overall Study|Adverse Event|0|||
163464461|NCT04539262|590399135|FG006|Overall Study|Adverse Event|0|||
163464462|NCT04539262|590399136|FG007|Overall Study|Adverse Event|0|||
163464463|NCT04539262|590399129|FG000|Overall Study|Withdrew Consent|0|||
163464464|NCT04539262|590399130|FG001|Overall Study|Withdrew Consent|0|||
163464465|NCT04539262|590399131|FG002|Overall Study|Withdrew Consent|0|||
163464466|NCT04539262|590399132|FG003|Overall Study|Withdrew Consent|1|||
163464467|NCT04539262|590399133|FG004|Overall Study|Withdrew Consent|0|||
163464468|NCT04539262|590399134|FG005|Overall Study|Withdrew Consent|0|||
163464469|NCT04539262|590399135|FG006|Overall Study|Withdrew Consent|0|||
163464470|NCT04539262|590399136|FG007|Overall Study|Withdrew Consent|0|||
163464471|NCT04539262|590399129|FG000|Overall Study|Randomized, Not treated|0|||
163464472|NCT04539262|590399130|FG001|Overall Study|Randomized, Not treated|1|||
163464473|NCT04539262|590399131|FG002|Overall Study|Randomized, Not treated|0|||
163464474|NCT04539262|590399132|FG003|Overall Study|Randomized, Not treated|0|||
163464475|NCT04539262|590399133|FG004|Overall Study|Randomized, Not treated|0|||
163464476|NCT04539262|590399134|FG005|Overall Study|Randomized, Not treated|0|||
163464477|NCT04539262|590399135|FG006|Overall Study|Randomized, Not treated|1|||
163464478|NCT04539262|590399136|FG007|Overall Study|Randomized, Not treated|0|||
163464479|NCT02980692|590399139|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
163464480|NCT02980692|590399140|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
163464481|NCT02980692|590399141|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
163464482|NCT02980692|590399142|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
163464483|NCT02980692|590399143|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
163464484|NCT02980692|590399139|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
163464485|NCT02980692|590399140|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
163464486|NCT02980692|590399141|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
163464487|NCT02980692|590399142|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
163464488|NCT02980692|590399143|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
163464489|NCT02980692|590399139|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
163464490|NCT02980692|590399140|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
163464491|NCT02980692|590399141|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
163464492|NCT02980692|590399142|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
163464493|NCT02980692|590399143|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
163464494|NCT02980692|590399139|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
163464495|NCT02980692|590399140|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
163464496|NCT02980692|590399141|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
163464497|NCT02980692|590399142|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
163464498|NCT02980692|590399143|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
163464499|NCT02980692|590399139|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
163464500|NCT02980692|590399140|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
163464501|NCT02980692|590399141|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
163464502|NCT02980692|590399142|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
163464503|NCT02980692|590399143|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
163464504|NCT02980692|590399139|FG000|Double Blind Placebo Controlled Period|Other|1|||
163464505|NCT02980692|590399140|FG001|Double Blind Placebo Controlled Period|Other|0|||
163464506|NCT02980692|590399141|FG002|Double Blind Placebo Controlled Period|Other|0|||
163464507|NCT02980692|590399142|FG003|Double Blind Placebo Controlled Period|Other|0|||
163464508|NCT02980692|590399143|FG004|Double Blind Placebo Controlled Period|Other|1|||
163464509|NCT02980692|590399139|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
163464510|NCT02980692|590399140|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
163464511|NCT02980692|590399141|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
163464512|NCT02980692|590399142|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
163464513|NCT02980692|590399143|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
163464514|NCT02980692|590399139|FG000|Double-blind Follow-up Period|Adverse Event|0|||
163464515|NCT02980692|590399140|FG001|Double-blind Follow-up Period|Adverse Event|0|||
163464516|NCT02980692|590399141|FG002|Double-blind Follow-up Period|Adverse Event|0|||
163464517|NCT02980692|590399142|FG003|Double-blind Follow-up Period|Adverse Event|1|||
163464518|NCT02980692|590399143|FG004|Double-blind Follow-up Period|Adverse Event|1|||
163464519|NCT02980692|590399139|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
163464520|NCT02980692|590399140|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
163464521|NCT02980692|590399141|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
163464522|NCT02980692|590399142|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
163464523|NCT02980692|590399143|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
163464524|NCT02980692|590399139|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
163464525|NCT02980692|590399140|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
163464526|NCT02980692|590399141|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
163464527|NCT02980692|590399142|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
163464528|NCT02980692|590399143|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
163464529|NCT02980692|590399139|FG000|Double-blind Follow-up Period|Pregnancy|0|||
163464530|NCT02980692|590399140|FG001|Double-blind Follow-up Period|Pregnancy|0|||
163464531|NCT02980692|590399141|FG002|Double-blind Follow-up Period|Pregnancy|1|||
163464532|NCT02980692|590399142|FG003|Double-blind Follow-up Period|Pregnancy|1|||
163464533|NCT02980692|590399143|FG004|Double-blind Follow-up Period|Pregnancy|0|||
163464534|NCT02980692|590399139|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
163464535|NCT02980692|590399140|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
163464536|NCT02980692|590399141|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
163464537|NCT02980692|590399142|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
163464538|NCT02980692|590399143|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
163464539|NCT02980692|590399139|FG000|Double-blind Follow-up Period|Other|0|||
163464540|NCT02980692|590399140|FG001|Double-blind Follow-up Period|Other|0|||
163464541|NCT02980692|590399141|FG002|Double-blind Follow-up Period|Other|1|||
163464542|NCT02980692|590399142|FG003|Double-blind Follow-up Period|Other|1|||
163464543|NCT02980692|590399143|FG004|Double-blind Follow-up Period|Other|3|||
163464544|NCT00792701|590399144|FG000|Overall Study|Adverse Event|0|||
163464545|NCT00792701|590399145|FG001|Overall Study|Adverse Event|22|||
163464546|NCT00792701|590399144|FG000|Overall Study|Ineligible|1|||
163464547|NCT00792701|590399145|FG001|Overall Study|Ineligible|3|||
163464548|NCT00792701|590399144|FG000|Overall Study|Withdrawal by Subject|1|||
163464549|NCT00792701|590399145|FG001|Overall Study|Withdrawal by Subject|19|||
163464550|NCT00792701|590399144|FG000|Overall Study|Not protocol specified|17|||
163464551|NCT00792701|590399145|FG001|Overall Study|Not protocol specified|0|||
163464552|NCT05507580|590399148|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163464553|NCT05507580|590399149|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
163464554|NCT05507580|590399150|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
163464555|NCT05507580|590399151|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
163464556|NCT05507580|590399152|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
163464557|NCT05507580|590399153|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
163464558|NCT05507580|590399148|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
163464559|NCT05507580|590399149|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
163464560|NCT05507580|590399150|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163464561|NCT05507580|590399151|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163464562|NCT05507580|590399152|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163464563|NCT05507580|590399153|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163464564|NCT05507580|590399148|FG000|Double-Blind Treatment Period|Other, not specified|5|||
163464565|NCT05507580|590399149|FG001|Double-Blind Treatment Period|Other, not specified|4|||
163464566|NCT05507580|590399150|FG002|Double-Blind Treatment Period|Other, not specified|0|||
163464567|NCT05507580|590399151|FG003|Double-Blind Treatment Period|Other, not specified|0|||
163464568|NCT05507580|590399152|FG004|Double-Blind Treatment Period|Other, not specified|0|||
163464569|NCT05507580|590399153|FG005|Double-Blind Treatment Period|Other, not specified|0|||
163464570|NCT05507580|590399148|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
163464571|NCT05507580|590399149|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
163464572|NCT05507580|590399150|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
163464573|NCT05507580|590399151|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
163464574|NCT05507580|590399152|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
163464575|NCT05507580|590399153|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
163464576|NCT05507580|590399148|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
163464577|NCT05507580|590399149|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
163464578|NCT05507580|590399150|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
163464579|NCT05507580|590399151|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
163464580|NCT05507580|590399152|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
163464581|NCT05507580|590399153|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
163464582|NCT05507580|590399148|FG000|Single-Blind Treatment Period|Other, not specified|0|||
163464583|NCT05507580|590399149|FG001|Single-Blind Treatment Period|Other, not specified|0|||
163464584|NCT05507580|590399150|FG002|Single-Blind Treatment Period|Other, not specified|2|||
163464585|NCT05507580|590399151|FG003|Single-Blind Treatment Period|Other, not specified|7|||
163464586|NCT05507580|590399152|FG004|Single-Blind Treatment Period|Other, not specified|3|||
163464587|NCT05507580|590399153|FG005|Single-Blind Treatment Period|Other, not specified|5|||
163464588|NCT04702984|590399154|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
163464589|NCT00802867|590399157|FG000|Overall Study|Lost to Follow-up|6|||
163464590|NCT00802867|590399157|FG000|Overall Study|Protocol Violation|6|||
163464591|NCT00802867|590399157|FG000|Overall Study|Withdrawal by Subject|1|||
163464592|NCT03363165|590399158|FG000|3-month Follow-up|Death|0|||
163464593|NCT03363165|590399159|FG001|3-month Follow-up|Death|1|||
163464594|NCT03363165|590399158|FG000|6-month Follow-up|Death|0|||
163464595|NCT03363165|590399159|FG001|6-month Follow-up|Death|1|||
163464596|NCT03363165|590399158|FG000|6-month Follow-up|Withdrawal by Subject|1|||
163464597|NCT03363165|590399159|FG001|6-month Follow-up|Withdrawal by Subject|1|||
163464598|NCT03363165|590399158|FG000|12-month Follow-up|Death|1|||
163464599|NCT03363165|590399159|FG001|12-month Follow-up|Death|1|||
163464600|NCT03363165|590399158|FG000|12-month Follow-up|Withdrawal by Subject|1|||
163464601|NCT03363165|590399159|FG001|12-month Follow-up|Withdrawal by Subject|1|||
163464602|NCT01809197|590399160|FG000|Overall Study|Lost to Follow-up|4|||
163464603|NCT01809197|590399161|FG001|Overall Study|Lost to Follow-up|2|||
163464604|NCT01809197|590399160|FG000|Overall Study|Adverse Event|2|||
163464605|NCT01809197|590399161|FG001|Overall Study|Adverse Event|3|||
163464606|NCT01809197|590399160|FG000|Overall Study|Failed slit lamp exam|1|||
163464607|NCT01809197|590399161|FG001|Overall Study|Failed slit lamp exam|0|||
163464608|NCT01809197|590399160|FG000|Overall Study|Non-Compliance|1|||
163464609|NCT01809197|590399161|FG001|Overall Study|Non-Compliance|1|||
163464610|NCT01809197|590399160|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
163464611|NCT01809197|590399161|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
163464612|NCT01809197|590399160|FG000|Overall Study|Withdrawal by Subject|1|||
163464613|NCT01809197|590399161|FG001|Overall Study|Withdrawal by Subject|1|||
163464614|NCT01809197|590399160|FG000|Overall Study|Product not available|0|||
163464615|NCT01809197|590399161|FG001|Overall Study|Product not available|1|||
163464616|NCT01855945|590399162|FG000|Overall Study|Adverse Event|0|||
163464617|NCT01855945|590399163|FG001|Overall Study|Adverse Event|0|||
163464618|NCT01855945|590399164|FG002|Overall Study|Adverse Event|0|||
163464619|NCT01855945|590399165|FG003|Overall Study|Adverse Event|0|||
163464620|NCT01855945|590399166|FG004|Overall Study|Adverse Event|0|||
163464621|NCT01855945|590399167|FG005|Overall Study|Adverse Event|0|||
163464622|NCT01855945|590399168|FG006|Overall Study|Adverse Event|1|||
163464623|NCT01855945|590399169|FG007|Overall Study|Adverse Event|0|||
163464624|NCT01855945|590399170|FG008|Overall Study|Adverse Event|0|||
163464625|NCT01855945|590399171|FG009|Overall Study|Adverse Event|0|||
163464626|NCT01855945|590399172|FG010|Overall Study|Adverse Event|0|||
163464627|NCT01855945|590399173|FG011|Overall Study|Adverse Event|0|||
163464628|NCT01855945|590399162|FG000|Overall Study|Death|0|||
163464629|NCT01855945|590399163|FG001|Overall Study|Death|0|||
163464630|NCT01855945|590399164|FG002|Overall Study|Death|0|||
163464631|NCT01855945|590399165|FG003|Overall Study|Death|0|||
163464632|NCT01855945|590399166|FG004|Overall Study|Death|0|||
163464633|NCT01855945|590399167|FG005|Overall Study|Death|0|||
163464634|NCT01855945|590399168|FG006|Overall Study|Death|2|||
163464635|NCT01855945|590399169|FG007|Overall Study|Death|0|||
163464636|NCT01855945|590399170|FG008|Overall Study|Death|0|||
163464637|NCT01855945|590399171|FG009|Overall Study|Death|0|||
163464638|NCT01855945|590399172|FG010|Overall Study|Death|0|||
163464639|NCT01855945|590399173|FG011|Overall Study|Death|0|||
163464640|NCT01855945|590399162|FG000|Overall Study|Lost to Follow-up|11|||
163464641|NCT01855945|590399163|FG001|Overall Study|Lost to Follow-up|10|||
163464642|NCT01855945|590399164|FG002|Overall Study|Lost to Follow-up|7|||
163464643|NCT01855945|590399165|FG003|Overall Study|Lost to Follow-up|3|||
163464644|NCT01855945|590399166|FG004|Overall Study|Lost to Follow-up|0|||
163464645|NCT01855945|590399167|FG005|Overall Study|Lost to Follow-up|3|||
163464646|NCT01855945|590399168|FG006|Overall Study|Lost to Follow-up|4|||
163464647|NCT01855945|590399169|FG007|Overall Study|Lost to Follow-up|7|||
163464648|NCT01855945|590399170|FG008|Overall Study|Lost to Follow-up|2|||
163464649|NCT01855945|590399171|FG009|Overall Study|Lost to Follow-up|0|||
163464650|NCT01855945|590399172|FG010|Overall Study|Lost to Follow-up|0|||
163464651|NCT01855945|590399173|FG011|Overall Study|Lost to Follow-up|2|||
163464652|NCT01855945|590399162|FG000|Overall Study|Other - Unclassified|1|||
163464653|NCT01855945|590399163|FG001|Overall Study|Other - Unclassified|1|||
163464654|NCT01855945|590399164|FG002|Overall Study|Other - Unclassified|1|||
163464655|NCT01855945|590399165|FG003|Overall Study|Other - Unclassified|0|||
163464656|NCT01855945|590399166|FG004|Overall Study|Other - Unclassified|0|||
163464657|NCT01855945|590399167|FG005|Overall Study|Other - Unclassified|0|||
163464658|NCT01855945|590399168|FG006|Overall Study|Other - Unclassified|2|||
163464659|NCT01855945|590399169|FG007|Overall Study|Other - Unclassified|1|||
163464660|NCT01855945|590399170|FG008|Overall Study|Other - Unclassified|0|||
163464661|NCT01855945|590399171|FG009|Overall Study|Other - Unclassified|0|||
163464662|NCT01855945|590399172|FG010|Overall Study|Other - Unclassified|1|||
163464663|NCT01855945|590399173|FG011|Overall Study|Other - Unclassified|0|||
163464664|NCT01855945|590399162|FG000|Overall Study|Withdrawal by Subject|4|||
163464665|NCT01855945|590399163|FG001|Overall Study|Withdrawal by Subject|0|||
163464666|NCT01855945|590399164|FG002|Overall Study|Withdrawal by Subject|4|||
163464667|NCT01855945|590399165|FG003|Overall Study|Withdrawal by Subject|1|||
163464668|NCT01855945|590399166|FG004|Overall Study|Withdrawal by Subject|1|||
163464669|NCT01855945|590399167|FG005|Overall Study|Withdrawal by Subject|0|||
163464670|NCT01855945|590399168|FG006|Overall Study|Withdrawal by Subject|1|||
163464671|NCT01855945|590399169|FG007|Overall Study|Withdrawal by Subject|0|||
163464672|NCT01855945|590399170|FG008|Overall Study|Withdrawal by Subject|0|||
163464673|NCT01855945|590399171|FG009|Overall Study|Withdrawal by Subject|2|||
163464674|NCT01855945|590399172|FG010|Overall Study|Withdrawal by Subject|4|||
163464675|NCT01855945|590399173|FG011|Overall Study|Withdrawal by Subject|1|||
163464676|NCT02156804|590399178|FG000|Overall Study|Withdrawal by Subject|1|||
163464677|NCT03000686|590399179|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
163464678|NCT03000686|590399180|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
163464679|NCT03000686|590399181|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
163464680|NCT03000686|590399182|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
163464681|NCT00770224|590399186|FG000|Step 1: Induction|Adverse Event|3|||
163464682|NCT00770224|590399187|FG001|Step 1: Induction|Adverse Event|0|||
163464683|NCT00770224|590399186|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
163464684|NCT00770224|590399187|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
163464685|NCT00770224|590399186|FG000|Step 1: Induction|Other reason not protocol specified|2|||
163464686|NCT00770224|590399187|FG001|Step 1: Induction|Other reason not protocol specified|0|||
163464687|NCT00770224|590399186|FG000|Step 1: Induction|Ineligible|2|||
163464688|NCT00770224|590399187|FG001|Step 1: Induction|Ineligible|0|||
163464689|NCT00770224|590399186|FG000|Step 1: Induction|No protocol treatment given|1|||
163464690|NCT00770224|590399187|FG001|Step 1: Induction|No protocol treatment given|0|||
163464691|NCT00770224|590399186|FG000|Step 2: Maintenance|Adverse Event|0|||
163464692|NCT00770224|590399187|FG001|Step 2: Maintenance|Adverse Event|10|||
163464693|NCT00770224|590399186|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
163464694|NCT00770224|590399187|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
163464695|NCT00770224|590399186|FG000|Step 2: Maintenance|Progression/relapse|0|||
163464696|NCT00770224|590399187|FG001|Step 2: Maintenance|Progression/relapse|1|||
163464697|NCT00770224|590399186|FG000|Step 2: Maintenance|Death|0|||
163464698|NCT00770224|590399187|FG001|Step 2: Maintenance|Death|2|||
163464699|NCT00770224|590399186|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
163464700|NCT00770224|590399187|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
163464701|NCT00770224|590399186|FG000|Step 2: Maintenance|Ineligible|0|||
163464702|NCT00770224|590399187|FG001|Step 2: Maintenance|Ineligible|2|||
163464703|NCT01484561|590399188|FG000|Overall Study|Lack of Efficacy|3|||
163464704|NCT01484561|590399189|FG001|Overall Study|Lack of Efficacy|1|||
163464705|NCT01484561|590399188|FG000|Overall Study|Lost to Follow-up|1|||
163464706|NCT01484561|590399189|FG001|Overall Study|Lost to Follow-up|0|||
163464707|NCT01484561|590399188|FG000|Overall Study|Withdrawal by Subject|3|||
163464708|NCT01484561|590399189|FG001|Overall Study|Withdrawal by Subject|0|||
163464709|NCT01484561|590399188|FG000|Overall Study|Other|1|||
163464710|NCT01484561|590399189|FG001|Overall Study|Other|1|||
163464711|NCT01484561|590399188|FG000|Overall Study|Adverse Event|1|||
163464712|NCT01484561|590399189|FG001|Overall Study|Adverse Event|4|||
163464713|NCT01112982|590399190|FG000|Overall Study|Withdrawal by Subject|1|||
163464714|NCT01112982|590399190|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
163464715|NCT03371251|590399191|FG000|Overall Study|Withdrawal by Subject|1|||
163464716|NCT03371251|590399192|FG001|Overall Study|Withdrawal by Subject|0|||
163464717|NCT03371251|590399193|FG002|Overall Study|Withdrawal by Subject|1|||
163464718|NCT03371251|590399194|FG003|Overall Study|Withdrawal by Subject|0|||
163464719|NCT03371251|590399195|FG004|Overall Study|Withdrawal by Subject|2|||
163464720|NCT03371251|590399196|FG005|Overall Study|Withdrawal by Subject|2|||
163464721|NCT03371251|590399191|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
163464722|NCT03371251|590399192|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
163464723|NCT03371251|590399193|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
163464724|NCT03371251|590399194|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
163464725|NCT03371251|590399195|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
163464726|NCT03371251|590399196|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
163464727|NCT03371251|590399191|FG000|Overall Study|Adverse Event|0|||
163464728|NCT03371251|590399192|FG001|Overall Study|Adverse Event|0|||
163464729|NCT03371251|590399193|FG002|Overall Study|Adverse Event|0|||
163464730|NCT03371251|590399194|FG003|Overall Study|Adverse Event|0|||
163464731|NCT03371251|590399195|FG004|Overall Study|Adverse Event|1|||
163464732|NCT03371251|590399196|FG005|Overall Study|Adverse Event|0|||
163464733|NCT03371251|590399191|FG000|Overall Study|Decision by Sponsor|0|||
163464734|NCT03371251|590399192|FG001|Overall Study|Decision by Sponsor|0|||
163464735|NCT03371251|590399193|FG002|Overall Study|Decision by Sponsor|0|||
163464736|NCT03371251|590399194|FG003|Overall Study|Decision by Sponsor|0|||
163464737|NCT03371251|590399195|FG004|Overall Study|Decision by Sponsor|2|||
163464738|NCT03371251|590399196|FG005|Overall Study|Decision by Sponsor|0|||
163464739|NCT02260388|590399199|FG000|Overall Study|Lost to Follow-up|2|||
163464740|NCT02260388|590399200|FG001|Overall Study|Lost to Follow-up|8|||
163464741|NCT02260388|590399201|FG002|Overall Study|Lost to Follow-up|3|||
163464742|NCT02260388|590399202|FG003|Overall Study|Lost to Follow-up|4|||
163464743|NCT01851863|590399203|FG000|Overall Study|Did not receive study medication|2|||
163464744|NCT01851863|590399204|FG001|Overall Study|Did not receive study medication|5|||
163464745|NCT01851863|590399205|FG002|Overall Study|Did not receive study medication|3|||
163464746|NCT01851863|590399206|FG003|Overall Study|Did not receive study medication|0|||
163464747|NCT01851863|590399203|FG000|Overall Study|Lost to Follow-up|3|||
163464748|NCT01851863|590399204|FG001|Overall Study|Lost to Follow-up|4|||
163464749|NCT01851863|590399205|FG002|Overall Study|Lost to Follow-up|2|||
163464750|NCT01851863|590399206|FG003|Overall Study|Lost to Follow-up|3|||
163464751|NCT00753623|590399207|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
163464752|NCT00753623|590399208|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
163464753|NCT00753623|590399207|FG000|Phase I (14 Days)|Physician Decision|1|||
163464754|NCT00753623|590399208|FG001|Phase I (14 Days)|Physician Decision|2|||
163464755|NCT00753623|590399207|FG000|Phase I (14 Days)|Adverse Event|0|||
163464756|NCT00753623|590399208|FG001|Phase I (14 Days)|Adverse Event|1|||
163464757|NCT00753623|590399207|FG000|Washout (7 Days)|Physician Decision|1|||
163464758|NCT00753623|590399208|FG001|Washout (7 Days)|Physician Decision|0|||
163464759|NCT00753623|590399207|FG000|Phase II (14 Days)|Physician Decision|0|||
163464760|NCT00753623|590399208|FG001|Phase II (14 Days)|Physician Decision|1|||
163464761|NCT03332303|590399209|FG000|Overall Study|Participant did not dose|1|||
163464762|NCT03332303|590399210|FG001|Overall Study|Participant did not dose|2|||
163464763|NCT03332303|590399211|FG002|Overall Study|Participant did not dose|0|||
163464764|NCT03332303|590399209|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
163464765|NCT03332303|590399210|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
163464766|NCT03332303|590399211|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
163464767|NCT03332303|590399209|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
163464768|NCT03332303|590399210|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
163464769|NCT03332303|590399211|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
163464770|NCT03332303|590399209|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
163464771|NCT03332303|590399210|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
163464772|NCT03332303|590399211|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
163464773|NCT03332303|590399209|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
163464774|NCT03332303|590399210|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
163464775|NCT03332303|590399211|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
163464776|NCT03332303|590399209|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
163464777|NCT03332303|590399210|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
163464778|NCT03332303|590399211|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
163464779|NCT03332303|590399209|FG000|Overall Study|Participant had a significant protocol deviation|0|||
163464780|NCT03332303|590399210|FG001|Overall Study|Participant had a significant protocol deviation|1|||
163464781|NCT03332303|590399211|FG002|Overall Study|Participant had a significant protocol deviation|0|||
163464782|NCT05425719|590399212|FG000|Overall Study|Lost to Follow-up|4|||
163464783|NCT05425719|590399213|FG001|Overall Study|Lost to Follow-up|0|||
163464784|NCT05425719|590399212|FG000|Overall Study|Withdrew consent|1|||
163464785|NCT05425719|590399213|FG001|Overall Study|Withdrew consent|1|||
163464786|NCT00889681|590399214|FG000|Overall Study|Not meeting qualification Criteria|2|||
163464787|NCT00889681|590399214|FG000|Overall Study|Insurance disapproval|1|||
163464788|NCT01185704|590399215|FG000|Overall Study|Randomized but not treated|3|||
163464789|NCT01185704|590399216|FG001|Overall Study|Randomized but not treated|3|||
163464790|NCT01185704|590399215|FG000|Overall Study|Lack of ovarian response|5|||
163464791|NCT01185704|590399216|FG001|Overall Study|Lack of ovarian response|1|||
163464792|NCT01185704|590399215|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
163464793|NCT01185704|590399216|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
163464794|NCT01185704|590399215|FG000|Overall Study|Ectopic pregnancy|0|||
163464795|NCT01185704|590399216|FG001|Overall Study|Ectopic pregnancy|1|||
163464796|NCT00871572|590399217|FG000|Overall Study|Adverse Event|0|||
163464797|NCT00871572|590399218|FG001|Overall Study|Adverse Event|2|||
163464798|NCT00871572|590399219|FG002|Overall Study|Adverse Event|0|||
163464799|NCT00871572|590399220|FG003|Overall Study|Adverse Event|3|||
163464800|NCT00871572|590399217|FG000|Overall Study|Investigator Decision|0|||
163464801|NCT00871572|590399218|FG001|Overall Study|Investigator Decision|1|||
163464802|NCT00871572|590399219|FG002|Overall Study|Investigator Decision|0|||
163464803|NCT00871572|590399220|FG003|Overall Study|Investigator Decision|1|||
163464804|NCT00871572|590399217|FG000|Overall Study|Lost to Follow-up|0|||
163464805|NCT00871572|590399218|FG001|Overall Study|Lost to Follow-up|1|||
163464806|NCT00871572|590399219|FG002|Overall Study|Lost to Follow-up|0|||
163464807|NCT00871572|590399220|FG003|Overall Study|Lost to Follow-up|1|||
163464808|NCT00871572|590399217|FG000|Overall Study|Protocol Violation|0|||
163464809|NCT00871572|590399218|FG001|Overall Study|Protocol Violation|0|||
163464810|NCT00871572|590399219|FG002|Overall Study|Protocol Violation|1|||
163464811|NCT00871572|590399220|FG003|Overall Study|Protocol Violation|1|||
163464812|NCT00871572|590399217|FG000|Overall Study|Sponsor Decision|1|||
163464813|NCT00871572|590399218|FG001|Overall Study|Sponsor Decision|0|||
163464814|NCT00871572|590399219|FG002|Overall Study|Sponsor Decision|0|||
163464815|NCT00871572|590399220|FG003|Overall Study|Sponsor Decision|0|||
163464816|NCT00871572|590399217|FG000|Overall Study|Withdrawal by Subject|1|||
163464817|NCT00871572|590399218|FG001|Overall Study|Withdrawal by Subject|2|||
163464818|NCT00871572|590399219|FG002|Overall Study|Withdrawal by Subject|3|||
163464819|NCT00871572|590399220|FG003|Overall Study|Withdrawal by Subject|1|||
163464820|NCT04176445|590399221|FG000|Overall Study|Adverse Event|0|||
163464821|NCT04176445|590399222|FG001|Overall Study|Adverse Event|1|||
163464822|NCT04176445|590399221|FG000|Overall Study|change plans weaning after first intervention|0|||
163464823|NCT04176445|590399222|FG001|Overall Study|change plans weaning after first intervention|1|||
163464824|NCT00187889|590399223|FG000|Overall Study|Withdrawal by Subject|6|||
163464825|NCT00187889|590399224|FG001|Overall Study|Withdrawal by Subject|4|||
163464826|NCT03954444|590399225|FG000|Overall Study|Withdrawal by Subject|5|||
163464827|NCT03954444|590399226|FG001|Overall Study|Withdrawal by Subject|5|||
163464828|NCT03954444|590399227|FG002|Overall Study|Withdrawal by Subject|5|||
163464829|NCT03954444|590399225|FG000|Overall Study|Adverse Event|1|||
163464830|NCT03954444|590399226|FG001|Overall Study|Adverse Event|3|||
163464831|NCT03954444|590399227|FG002|Overall Study|Adverse Event|2|||
163464832|NCT03954444|590399225|FG000|Overall Study|Protocol Violation|0|||
163464833|NCT03954444|590399226|FG001|Overall Study|Protocol Violation|3|||
163464834|NCT03954444|590399227|FG002|Overall Study|Protocol Violation|5|||
163464835|NCT03954444|590399225|FG000|Overall Study|Use of prohibited therapy|1|||
163464836|NCT03954444|590399226|FG001|Overall Study|Use of prohibited therapy|1|||
163464837|NCT03954444|590399227|FG002|Overall Study|Use of prohibited therapy|2|||
163464838|NCT03954444|590399225|FG000|Overall Study|Lost to Follow-up|1|||
163464839|NCT03954444|590399226|FG001|Overall Study|Lost to Follow-up|0|||
163464840|NCT03954444|590399227|FG002|Overall Study|Lost to Follow-up|1|||
163464841|NCT03954444|590399225|FG000|Overall Study|Non-compliant with study drug application|2|||
163464842|NCT03954444|590399226|FG001|Overall Study|Non-compliant with study drug application|2|||
163464843|NCT03954444|590399227|FG002|Overall Study|Non-compliant with study drug application|0|||
163464844|NCT03954444|590399225|FG000|Overall Study|Administrative reasons|0|||
163464845|NCT03954444|590399226|FG001|Overall Study|Administrative reasons|0|||
163464846|NCT03954444|590399227|FG002|Overall Study|Administrative reasons|1|||
163464847|NCT03954444|590399225|FG000|Overall Study|Miscellaneous|3|||
163464848|NCT03954444|590399226|FG001|Overall Study|Miscellaneous|2|||
163464849|NCT03954444|590399227|FG002|Overall Study|Miscellaneous|1|||
163464850|NCT00345540|590399228|FG000|Overall Study|Withdrawal by Subject|1|||
163464851|NCT04179786|590399229|FG000|Overall Study|Withdrawal by Subject|8|||
163464852|NCT01938001|590399230|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
163464853|NCT01938001|590399231|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
163464854|NCT01938001|590399230|FG000|Pre-Treatment|Death|1|||
163464855|NCT01938001|590399231|FG001|Pre-Treatment|Death|0|||
163464856|NCT01938001|590399230|FG000|Treatment|Death|2|||
163464857|NCT01938001|590399231|FG001|Treatment|Death|0|||
163464858|NCT01938001|590399230|FG000|Treatment|Adverse Event|14|||
163464859|NCT01938001|590399231|FG001|Treatment|Adverse Event|8|||
163464860|NCT01938001|590399230|FG000|Treatment|Progressive Disease|21|||
163464861|NCT01938001|590399231|FG001|Treatment|Progressive Disease|54|||
163464862|NCT01938001|590399230|FG000|Treatment|Withdrawal by Subject|13|||
163464863|NCT01938001|590399231|FG001|Treatment|Withdrawal by Subject|7|||
163464864|NCT01938001|590399230|FG000|Treatment|Other reasons|2|||
163464865|NCT01938001|590399231|FG001|Treatment|Other reasons|1|||
163464866|NCT03310580|590399232|FG000|Overall Study|Adverse Event|0|||
163464867|NCT03310580|590399233|FG001|Overall Study|Adverse Event|1|||
163464868|NCT03310580|590399234|FG002|Overall Study|Adverse Event|0|||
163464869|NCT03205982|590399235|FG000|Overall Study|Lost to Follow-up|20|||
163464870|NCT03205982|590399236|FG001|Overall Study|Lost to Follow-up|19|||
163464871|NCT03205982|590399235|FG000|Overall Study|Withdrawal by Subject|4|||
163464872|NCT03205982|590399236|FG001|Overall Study|Withdrawal by Subject|3|||
163464873|NCT03205982|590399235|FG000|Overall Study|Withdrawal by PI|0|||
163464874|NCT03205982|590399236|FG001|Overall Study|Withdrawal by PI|1|||
163464875|NCT01468701|590399239|FG000|Overall Study|Not eligible|91|||
163464876|NCT01468701|590399240|FG001|Overall Study|Not eligible|140|||
163464877|NCT01468701|590399241|FG002|Overall Study|Not eligible|29|||
163464878|NCT01468701|590399242|FG003|Overall Study|Not eligible|12|||
163464879|NCT01468701|590399243|FG004|Overall Study|Not eligible|22|||
163464880|NCT01468701|590399244|FG005|Overall Study|Not eligible|2|||
163464881|NCT01468701|590399245|FG006|Overall Study|Not eligible|39|||
163464882|NCT01468701|590399246|FG007|Overall Study|Not eligible|1|||
163464883|NCT01468701|590399247|FG008|Overall Study|Not eligible|40|||
163464884|NCT01468701|590399248|FG009|Overall Study|Not eligible|126|||
163464885|NCT01468701|590399249|FG010|Overall Study|Not eligible|39|||
163464886|NCT01468701|590399250|FG011|Overall Study|Not eligible|33|||
163464887|NCT01468701|590399251|FG012|Overall Study|Not eligible|1|||
163464888|NCT01468701|590399252|FG013|Overall Study|Not eligible|19|||
163464889|NCT01468701|590399253|FG014|Overall Study|Not eligible|1|||
163464890|NCT01468701|590399254|FG015|Overall Study|Not eligible|32|||
163464891|NCT01468701|590399255|FG016|Overall Study|Not eligible|0|||
163464892|NCT01468701|590399239|FG000|Overall Study|Lost to Follow-up|306|||
163464893|NCT01468701|590399240|FG001|Overall Study|Lost to Follow-up|0|||
163464894|NCT01468701|590399241|FG002|Overall Study|Lost to Follow-up|0|||
163464895|NCT01468701|590399242|FG003|Overall Study|Lost to Follow-up|0|||
163464896|NCT01468701|590399243|FG004|Overall Study|Lost to Follow-up|0|||
163464897|NCT01468701|590399244|FG005|Overall Study|Lost to Follow-up|0|||
163464898|NCT01468701|590399245|FG006|Overall Study|Lost to Follow-up|0|||
163464899|NCT01468701|590399246|FG007|Overall Study|Lost to Follow-up|0|||
163464900|NCT01468701|590399247|FG008|Overall Study|Lost to Follow-up|215|||
163464901|NCT01468701|590399248|FG009|Overall Study|Lost to Follow-up|309|||
163464902|NCT01468701|590399249|FG010|Overall Study|Lost to Follow-up|224|||
163464903|NCT01468701|590399250|FG011|Overall Study|Lost to Follow-up|212|||
163464904|NCT01468701|590399251|FG012|Overall Study|Lost to Follow-up|11|||
163464905|NCT01468701|590399252|FG013|Overall Study|Lost to Follow-up|164|||
163464906|NCT01468701|590399253|FG014|Overall Study|Lost to Follow-up|17|||
163464907|NCT01468701|590399254|FG015|Overall Study|Lost to Follow-up|127|||
163464908|NCT01468701|590399255|FG016|Overall Study|Lost to Follow-up|1|||
163464909|NCT01468701|590399239|FG000|Overall Study|Withdrawal by Subject|165|||
163464910|NCT01468701|590399240|FG001|Overall Study|Withdrawal by Subject|0|||
163464911|NCT01468701|590399241|FG002|Overall Study|Withdrawal by Subject|0|||
163464912|NCT01468701|590399242|FG003|Overall Study|Withdrawal by Subject|0|||
163464913|NCT01468701|590399243|FG004|Overall Study|Withdrawal by Subject|0|||
163464914|NCT01468701|590399244|FG005|Overall Study|Withdrawal by Subject|0|||
163464915|NCT01468701|590399245|FG006|Overall Study|Withdrawal by Subject|0|||
163464916|NCT01468701|590399246|FG007|Overall Study|Withdrawal by Subject|0|||
163464917|NCT01468701|590399247|FG008|Overall Study|Withdrawal by Subject|83|||
163464918|NCT01468701|590399248|FG009|Overall Study|Withdrawal by Subject|88|||
163464919|NCT01468701|590399249|FG010|Overall Study|Withdrawal by Subject|100|||
163464920|NCT01468701|590399250|FG011|Overall Study|Withdrawal by Subject|114|||
163464921|NCT01468701|590399251|FG012|Overall Study|Withdrawal by Subject|9|||
163464922|NCT01468701|590399252|FG013|Overall Study|Withdrawal by Subject|47|||
163464923|NCT01468701|590399253|FG014|Overall Study|Withdrawal by Subject|6|||
163464924|NCT01468701|590399254|FG015|Overall Study|Withdrawal by Subject|31|||
163464925|NCT01468701|590399255|FG016|Overall Study|Withdrawal by Subject|0|||
163464926|NCT01468701|590399239|FG000|Overall Study|Other reasons than listed|437|||
163464927|NCT01468701|590399240|FG001|Overall Study|Other reasons than listed|0|||
163464928|NCT01468701|590399241|FG002|Overall Study|Other reasons than listed|0|||
163464929|NCT01468701|590399242|FG003|Overall Study|Other reasons than listed|0|||
163464930|NCT01468701|590399243|FG004|Overall Study|Other reasons than listed|0|||
163464931|NCT01468701|590399244|FG005|Overall Study|Other reasons than listed|0|||
163464932|NCT01468701|590399245|FG006|Overall Study|Other reasons than listed|0|||
163464933|NCT01468701|590399246|FG007|Overall Study|Other reasons than listed|0|||
163464934|NCT01468701|590399247|FG008|Overall Study|Other reasons than listed|318|||
163464935|NCT01468701|590399248|FG009|Overall Study|Other reasons than listed|658|||
163464936|NCT01468701|590399249|FG010|Overall Study|Other reasons than listed|433|||
163464937|NCT01468701|590399250|FG011|Overall Study|Other reasons than listed|504|||
163464938|NCT01468701|590399251|FG012|Overall Study|Other reasons than listed|28|||
163464939|NCT01468701|590399252|FG013|Overall Study|Other reasons than listed|239|||
163464940|NCT01468701|590399253|FG014|Overall Study|Other reasons than listed|39|||
163464941|NCT01468701|590399254|FG015|Overall Study|Other reasons than listed|172|||
163464942|NCT01468701|590399255|FG016|Overall Study|Other reasons than listed|0|||
163464943|NCT01468701|590399239|FG000|Overall Study|No end of study case report form|0|||
163464944|NCT01468701|590399240|FG001|Overall Study|No end of study case report form|0|||
163464945|NCT01468701|590399241|FG002|Overall Study|No end of study case report form|0|||
163464946|NCT01468701|590399242|FG003|Overall Study|No end of study case report form|0|||
163464947|NCT01468701|590399243|FG004|Overall Study|No end of study case report form|0|||
163464948|NCT01468701|590399244|FG005|Overall Study|No end of study case report form|0|||
163464949|NCT01468701|590399245|FG006|Overall Study|No end of study case report form|0|||
163464950|NCT01468701|590399246|FG007|Overall Study|No end of study case report form|0|||
163464951|NCT01468701|590399247|FG008|Overall Study|No end of study case report form|4|||
163464952|NCT01468701|590399248|FG009|Overall Study|No end of study case report form|1|||
163464953|NCT01468701|590399249|FG010|Overall Study|No end of study case report form|2|||
163464954|NCT01468701|590399250|FG011|Overall Study|No end of study case report form|3|||
163464955|NCT01468701|590399251|FG012|Overall Study|No end of study case report form|0|||
163464956|NCT01468701|590399252|FG013|Overall Study|No end of study case report form|1|||
163464957|NCT01468701|590399253|FG014|Overall Study|No end of study case report form|0|||
163464958|NCT01468701|590399254|FG015|Overall Study|No end of study case report form|0|||
163464959|NCT01468701|590399255|FG016|Overall Study|No end of study case report form|0|||
163464960|NCT01468701|590399239|FG000|Overall Study|Not being followed up|0|||
163464961|NCT01468701|590399240|FG001|Overall Study|Not being followed up|4963|||
163464962|NCT01468701|590399241|FG002|Overall Study|Not being followed up|1755|||
163464963|NCT01468701|590399242|FG003|Overall Study|Not being followed up|703|||
163464964|NCT01468701|590399243|FG004|Overall Study|Not being followed up|1714|||
163464965|NCT01468701|590399244|FG005|Overall Study|Not being followed up|126|||
163464966|NCT01468701|590399245|FG006|Overall Study|Not being followed up|1170|||
163464967|NCT01468701|590399246|FG007|Overall Study|Not being followed up|4|||
163464968|NCT01468701|590399247|FG008|Overall Study|Not being followed up|0|||
163464969|NCT01468701|590399248|FG009|Overall Study|Not being followed up|0|||
163464970|NCT01468701|590399249|FG010|Overall Study|Not being followed up|0|||
163464971|NCT01468701|590399250|FG011|Overall Study|Not being followed up|0|||
163464972|NCT01468701|590399251|FG012|Overall Study|Not being followed up|0|||
163464973|NCT01468701|590399252|FG013|Overall Study|Not being followed up|0|||
163464974|NCT01468701|590399253|FG014|Overall Study|Not being followed up|0|||
163464975|NCT01468701|590399254|FG015|Overall Study|Not being followed up|0|||
163464976|NCT01468701|590399255|FG016|Overall Study|Not being followed up|0|||
163464977|NCT01079195|590399263|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
163464978|NCT01079195|590399263|FG000|Overall Study|No Documentation Available|437|||
163464979|NCT01079195|590399263|FG000|Overall Study|Adverse Event|157|||
163464980|NCT01079195|590399263|FG000|Overall Study|Reason Unknown|39|||
163464981|NCT01079195|590399263|FG000|Overall Study|Withdrawal by Subject|18|||
163464982|NCT01079195|590399263|FG000|Overall Study|Financial Reasons|15|||
163464983|NCT01079195|590399263|FG000|Overall Study|Lack of Effectiveness|12|||
163464984|NCT01079195|590399263|FG000|Overall Study|Physician Decision|4|||
163464985|NCT01079195|590399263|FG000|Overall Study|Improved Status of Participant|4|||
163464986|NCT01079195|590399263|FG000|Overall Study|No Follow-up Documentation Available|4|||
163464987|NCT01079195|590399263|FG000|Overall Study|Non-compliance|2|||
163464988|NCT01999946|590399264|FG000|Overall Study|Participant not released from jail|2|||
163464989|NCT01999946|590399265|FG001|Overall Study|Participant not released from jail|2|||
163464990|NCT01999946|590399266|FG002|Overall Study|Participant not released from jail|0|||
163464991|NCT01999946|590399264|FG000|Overall Study|Not included in primary outcome analysis|0|||
163464992|NCT01999946|590399265|FG001|Overall Study|Not included in primary outcome analysis|0|||
163464993|NCT01999946|590399266|FG002|Overall Study|Not included in primary outcome analysis|79|||
163464994|NCT03170258|590400560|FG000|Overall Study|Physician Decision|4|||
163464995|NCT03170258|590400561|FG001|Overall Study|Physician Decision|0|||
163464996|NCT03170258|590400560|FG000|Overall Study|Equipment issues|1|||
163464997|NCT03170258|590400561|FG001|Overall Study|Equipment issues|0|||
163464998|NCT03170258|590400560|FG000|Overall Study|Medication|1|||
163464999|NCT03170258|590400561|FG001|Overall Study|Medication|0|||
163465000|NCT03170258|590400560|FG000|Overall Study|Sleep issues|1|||
163465001|NCT03170258|590400561|FG001|Overall Study|Sleep issues|0|||
163465002|NCT00666536|590400562|FG000|Overall Study|Adverse Event|9|||
163465003|NCT00666536|590400563|FG001|Overall Study|Adverse Event|19|||
163465004|NCT00666536|590400562|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163465005|NCT00666536|590400563|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163465006|NCT00666536|590400562|FG000|Overall Study|Protocol deviation(s)|8|||
163465007|NCT00666536|590400563|FG001|Overall Study|Protocol deviation(s)|6|||
163465008|NCT00666536|590400562|FG000|Overall Study|Withdrawal by Subject|10|||
163465009|NCT00666536|590400563|FG001|Overall Study|Withdrawal by Subject|9|||
163465010|NCT00666536|590400562|FG000|Overall Study|Lost to Follow-up|4|||
163465011|NCT00666536|590400563|FG001|Overall Study|Lost to Follow-up|3|||
163465012|NCT02853123|590400567|FG000|Treatment Period 1|Adverse Event|0|||
163465013|NCT02853123|590400568|FG001|Treatment Period 1|Adverse Event|3|||
163465014|NCT02853123|590400567|FG000|Washout Period|Worsening of COPD|0|||
163465015|NCT02853123|590400568|FG001|Washout Period|Worsening of COPD|3|||
163465016|NCT02853123|590400567|FG000|Washout Period|Adverse Event|1|||
163465017|NCT02853123|590400568|FG001|Washout Period|Adverse Event|0|||
163465018|NCT01510028|590400581|FG000|Overall Study|Lack of Efficacy|1|||
163465019|NCT01510028|590400582|FG001|Overall Study|Lack of Efficacy|0|||
163465020|NCT01510028|590400583|FG002|Overall Study|Lack of Efficacy|0|||
163465021|NCT01510028|590400584|FG003|Overall Study|Lack of Efficacy|0|||
163465022|NCT00633893|590400585|FG000|Overall Study|Death|1|||
163465023|NCT00633893|590400586|FG001|Overall Study|Death|3|||
163465024|NCT00633893|590400587|FG002|Overall Study|Death|9|||
163465025|NCT00633893|590400585|FG000|Overall Study|Adverse Event|65|||
163465026|NCT00633893|590400586|FG001|Overall Study|Adverse Event|58|||
163465027|NCT00633893|590400587|FG002|Overall Study|Adverse Event|126|||
163465028|NCT00633893|590400585|FG000|Overall Study|Withdrawal by Subject|7|||
163465029|NCT00633893|590400586|FG001|Overall Study|Withdrawal by Subject|12|||
163465030|NCT00633893|590400587|FG002|Overall Study|Withdrawal by Subject|6|||
163465031|NCT00633893|590400585|FG000|Overall Study|Lost to Follow-up|2|||
163465032|NCT00633893|590400586|FG001|Overall Study|Lost to Follow-up|4|||
163465033|NCT00633893|590400587|FG002|Overall Study|Lost to Follow-up|8|||
163465034|NCT00633893|590400585|FG000|Overall Study|Poor/non-compliance|5|||
163465035|NCT00633893|590400586|FG001|Overall Study|Poor/non-compliance|12|||
163465036|NCT00633893|590400587|FG002|Overall Study|Poor/non-compliance|3|||
163465037|NCT00633893|590400585|FG000|Overall Study|Pregnancy|2|||
163465038|NCT00633893|590400586|FG001|Overall Study|Pregnancy|1|||
163465039|NCT00633893|590400587|FG002|Overall Study|Pregnancy|1|||
163465040|NCT00633893|590400585|FG000|Overall Study|Not meet/no longer meets criteria|4|||
163465041|NCT00633893|590400586|FG001|Overall Study|Not meet/no longer meets criteria|6|||
163465042|NCT00633893|590400587|FG002|Overall Study|Not meet/no longer meets criteria|4|||
163465043|NCT00633893|590400585|FG000|Overall Study|Other|28|||
163465044|NCT00633893|590400586|FG001|Overall Study|Other|33|||
163465045|NCT00633893|590400587|FG002|Overall Study|Other|31|||
163465046|NCT02741310|590400588|FG000|Overall Study|Sponsor Decision|2|||
163465047|NCT02741310|590400589|FG001|Overall Study|Sponsor Decision|2|||
163465048|NCT01784211|590400590|FG000|Part A (Days 1-15)|Adverse Event|1|||
163465049|NCT01784211|590400591|FG001|Part A (Days 1-15)|Adverse Event|1|||
163465050|NCT01784211|590400592|FG002|Part A (Days 1-15)|Adverse Event|0|||
163465051|NCT01784211|590400593|FG003|Part A (Days 1-15)|Adverse Event|0|||
163465052|NCT01784211|590400594|FG004|Part A (Days 1-15)|Adverse Event|0|||
163465053|NCT01784211|590400595|FG005|Part A (Days 1-15)|Adverse Event|0|||
163465054|NCT01784211|590400590|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
163465055|NCT01784211|590400591|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
163465056|NCT01784211|590400592|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
163465057|NCT01784211|590400593|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
163465058|NCT01784211|590400594|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
163465059|NCT01784211|590400595|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
163465060|NCT01017549|590400596|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
163465061|NCT01017549|590400596|FG000|One-year Follow-up|Lost to Follow-up|2|||
163465062|NCT01017549|590400596|FG000|One-year Follow-up|Withdrawal by Subject|5|||
163465063|NCT01017549|590400596|FG000|5 Year Follow-up|Lost to Follow-up|9|||
163465064|NCT01017549|590400596|FG000|5 Year Follow-up|Mastectomy|3|||
163465065|NCT03725293|590400610|FG000|Overall Study|Physician Decision|9|||
163465066|NCT03725293|590400611|FG001|Overall Study|Physician Decision|6|||
163465067|NCT03725293|590400610|FG000|Overall Study|alternative vascular access needs|1|||
163465068|NCT03725293|590400611|FG001|Overall Study|alternative vascular access needs|2|||
163465069|NCT03725293|590400610|FG000|Overall Study|venous anatomy screen failures|2|||
163465070|NCT03725293|590400611|FG001|Overall Study|venous anatomy screen failures|1|||
163465071|NCT02143141|590400612|FG000|Overall Study|pain scores at 24 hours not collected|1|||
163465072|NCT02143141|590400613|FG001|Overall Study|pain scores at 24 hours not collected|0|||
163465073|NCT03673956|590400614|FG000|Overall Study|Lost to Follow-up|1|||
163465074|NCT03673956|590400615|FG001|Overall Study|Lost to Follow-up|0|||
163465075|NCT03673956|590400616|FG002|Overall Study|Lost to Follow-up|0|||
163465076|NCT03673956|590400617|FG003|Overall Study|Lost to Follow-up|0|||
163465077|NCT03673956|590400614|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
163465078|NCT03673956|590400615|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
163465079|NCT03673956|590400616|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
163465080|NCT03673956|590400617|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
163465081|NCT01057862|590400618|FG000|Overall Study|Withdrawal by Subject|1|||
163465082|NCT01057862|590400619|FG001|Overall Study|Withdrawal by Subject|2|||
163465083|NCT02255760|590400620|FG000|Overall Study|Lost to Follow-up|0|||
163465084|NCT02255760|590400621|FG001|Overall Study|Lost to Follow-up|1|||
163465085|NCT02255760|590400622|FG002|Overall Study|Lost to Follow-up|0|||
163465086|NCT02255760|590400623|FG003|Overall Study|Lost to Follow-up|0|||
163465087|NCT02255760|590400624|FG004|Overall Study|Lost to Follow-up|0|||
163465088|NCT00618813|590400625|FG000|Overall Study|Lack of Efficacy|1|||
163465089|NCT00618813|590400625|FG000|Overall Study|Physician Decision|2|||
163465090|NCT00618813|590400625|FG000|Overall Study|Withdrawal by Subject|1|||
163465091|NCT00003838|590400626|FG000|Overall Study|Death|0|||
163465092|NCT00003838|590400627|FG001|Overall Study|Death|12|||
163465093|NCT00003838|590400628|FG002|Overall Study|Death|7|||
163465094|NCT00003838|590400626|FG000|Overall Study|Lost to Follow-up|0|||
163465095|NCT00003838|590400627|FG001|Overall Study|Lost to Follow-up|1|||
163465096|NCT00003838|590400628|FG002|Overall Study|Lost to Follow-up|1|||
163465097|NCT00003838|590400626|FG000|Overall Study|Disease Progression|0|||
163465098|NCT00003838|590400627|FG001|Overall Study|Disease Progression|12|||
163465099|NCT00003838|590400628|FG002|Overall Study|Disease Progression|0|||
163465100|NCT03228394|590400629|FG000|Overall Study|Lost to Follow-up|0|||
163465101|NCT03228394|590400630|FG001|Overall Study|Lost to Follow-up|0|||
163465102|NCT03228394|590400631|FG002|Overall Study|Lost to Follow-up|1|||
163465103|NCT03228394|590400632|FG003|Overall Study|Lost to Follow-up|1|||
163465104|NCT03228394|590400633|FG004|Overall Study|Lost to Follow-up|0|||
163465105|NCT03228394|590400634|FG005|Overall Study|Lost to Follow-up|0|||
163465106|NCT03228394|590400635|FG006|Overall Study|Lost to Follow-up|2|||
163465107|NCT03228394|590400636|FG007|Overall Study|Lost to Follow-up|0|||
163465108|NCT03228394|590400629|FG000|Overall Study|Withdrawal by Subject|0|||
163465109|NCT03228394|590400630|FG001|Overall Study|Withdrawal by Subject|0|||
163465110|NCT03228394|590400631|FG002|Overall Study|Withdrawal by Subject|1|||
163465111|NCT03228394|590400632|FG003|Overall Study|Withdrawal by Subject|0|||
163465112|NCT03228394|590400633|FG004|Overall Study|Withdrawal by Subject|0|||
163465113|NCT03228394|590400634|FG005|Overall Study|Withdrawal by Subject|0|||
163465114|NCT03228394|590400635|FG006|Overall Study|Withdrawal by Subject|1|||
163465115|NCT03228394|590400636|FG007|Overall Study|Withdrawal by Subject|3|||
163465116|NCT03228394|590400629|FG000|Overall Study|Protocol Violation|0|||
163465117|NCT03228394|590400630|FG001|Overall Study|Protocol Violation|0|||
163465118|NCT03228394|590400631|FG002|Overall Study|Protocol Violation|0|||
163465119|NCT03228394|590400632|FG003|Overall Study|Protocol Violation|1|||
163465120|NCT03228394|590400633|FG004|Overall Study|Protocol Violation|0|||
163465121|NCT03228394|590400634|FG005|Overall Study|Protocol Violation|0|||
163465122|NCT03228394|590400635|FG006|Overall Study|Protocol Violation|0|||
163465123|NCT03228394|590400636|FG007|Overall Study|Protocol Violation|0|||
163465124|NCT03228394|590400629|FG000|Overall Study|Physician Decision|0|||
163465125|NCT03228394|590400630|FG001|Overall Study|Physician Decision|0|||
163465126|NCT03228394|590400631|FG002|Overall Study|Physician Decision|0|||
163465127|NCT03228394|590400632|FG003|Overall Study|Physician Decision|0|||
163465128|NCT03228394|590400633|FG004|Overall Study|Physician Decision|0|||
163465129|NCT03228394|590400634|FG005|Overall Study|Physician Decision|0|||
163465130|NCT03228394|590400635|FG006|Overall Study|Physician Decision|1|||
163465131|NCT03228394|590400636|FG007|Overall Study|Physician Decision|0|||
163465132|NCT03228394|590400629|FG000|Overall Study|Noncompliance|0|||
163465133|NCT03228394|590400630|FG001|Overall Study|Noncompliance|0|||
163465134|NCT03228394|590400631|FG002|Overall Study|Noncompliance|0|||
163465135|NCT03228394|590400632|FG003|Overall Study|Noncompliance|0|||
163465136|NCT03228394|590400633|FG004|Overall Study|Noncompliance|0|||
163465137|NCT03228394|590400634|FG005|Overall Study|Noncompliance|0|||
163465138|NCT03228394|590400635|FG006|Overall Study|Noncompliance|1|||
163465139|NCT03228394|590400636|FG007|Overall Study|Noncompliance|0|||
163465140|NCT00291187|590400640|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
163465141|NCT00291187|590400641|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
163465142|NCT00291187|590400642|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
163465143|NCT00291187|590400643|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
163465144|NCT02023268|590400644|FG000|Overall Study|Lack of Efficacy|0|||
163465145|NCT02023268|590400645|FG001|Overall Study|Lack of Efficacy|1|||
163465146|NCT02023268|590400644|FG000|Overall Study|Adverse Event|0|||
163465147|NCT02023268|590400645|FG001|Overall Study|Adverse Event|2|||
163465148|NCT02023268|590400644|FG000|Overall Study|Withdrawal by Subject|0|||
163465149|NCT02023268|590400645|FG001|Overall Study|Withdrawal by Subject|1|||
163465150|NCT00126672|590400647|FG000|Overall Study|Adverse Event|4|||
163465151|NCT00126672|590400647|FG000|Overall Study|Lost to Follow-up|4|||
163465152|NCT01296698|590400652|FG000|Overall Study|Adverse Event|1|||
163465153|NCT01296698|590400653|FG001|Overall Study|Adverse Event|0|||
163465154|NCT01296698|590400652|FG000|Overall Study|Death|1|||
163465155|NCT01296698|590400653|FG001|Overall Study|Death|0|||
163465156|NCT01296698|590400652|FG000|Overall Study|Lost to Follow-up|19|||
163465157|NCT01296698|590400653|FG001|Overall Study|Lost to Follow-up|1|||
163465158|NCT01296698|590400652|FG000|Overall Study|Withdrawal by Subject|12|||
163465159|NCT01296698|590400653|FG001|Overall Study|Withdrawal by Subject|0|||
163465160|NCT01296698|590400652|FG000|Overall Study|Difficulty Contacting Subject|2|||
163465161|NCT01296698|590400653|FG001|Overall Study|Difficulty Contacting Subject|0|||
163465162|NCT01296698|590400652|FG000|Overall Study|Study Terminated by Sponsor|209|||
163465163|NCT01296698|590400653|FG001|Overall Study|Study Terminated by Sponsor|12|||
163465164|NCT03495817|590400657|FG000|26 Week Open Label|Adverse Event|3|||
163465165|NCT03495817|590400657|FG000|26 Week Open Label|Withdrawal by Subject|4|||
163465166|NCT03495817|590400657|FG000|26 Week Open Label|Lost to Follow-up|1|||
163465167|NCT03495817|590400657|FG000|26 Week Extension|Lost to Follow-up|2|||
163465168|NCT01957787|590400658|FG000|Overall Study|Death|18|||
163465169|NCT01957787|590400658|FG000|Overall Study|Lost to Follow-up|3|||
163465170|NCT01957787|590400658|FG000|Overall Study|Withdrawal by Subject|3|||
163465171|NCT01957787|590400658|FG000|Overall Study|Entered Hospice or Similar Program|2|||
163465172|NCT01957787|590400658|FG000|Overall Study|Index Tumor(s) Resected|2|||
163465173|NCT01957787|590400658|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
163465174|NCT01957787|590400658|FG000|Overall Study|Local therapy, not cryoablation|6|||
163465175|NCT04294095|590400665|FG000|Overall Study|Adverse Event|1|||
163465176|NCT04294095|590400666|FG001|Overall Study|Adverse Event|0|||
163465177|NCT02224638|590400669|FG000|Overall Study|Adverse Event|1|||
163465178|NCT02224638|590400670|FG001|Overall Study|Adverse Event|1|||
163465179|NCT00659126|590400675|FG000|Overall Study|Adverse Event|2|||
163465180|NCT00659126|590400676|FG001|Overall Study|Adverse Event|2|||
163465181|NCT00659126|590400675|FG000|Overall Study|Screen failure|1|||
163465182|NCT00659126|590400676|FG001|Overall Study|Screen failure|1|||
163465183|NCT00659126|590400675|FG000|Overall Study|Technical problems with MRI|0|||
163465184|NCT00659126|590400676|FG001|Overall Study|Technical problems with MRI|1|||
163465185|NCT00260429|590400677|FG000|Overall Study|failure to follow appointments|1|||
163465186|NCT00260429|590400678|FG001|Overall Study|failure to follow appointments|0|||
163465187|NCT00260429|590400677|FG000|Overall Study|scheduled hand surgery|1|||
163465188|NCT00260429|590400678|FG001|Overall Study|scheduled hand surgery|0|||
163465189|NCT02762708|590400684|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
163465190|NCT02762708|590400685|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
163465191|NCT02762708|590400686|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
163465192|NCT02762708|590400687|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
163465193|NCT00631540|590400688|FG000|Overall Study|Withdrawal by Subject|5|||
163465194|NCT00631540|590400688|FG000|Overall Study|Death|4|||
163465195|NCT00631540|590400688|FG000|Overall Study|Lost to Follow-up|2|||
163465196|NCT00631540|590400688|FG000|Overall Study|Core Lab Data Unavailable|3|||
163465197|NCT00795509|590400689|FG000|Overall Study|Protocol Violation|31|||
163465198|NCT00970268|590400690|FG000|Overall Study|Withdrawal by Subject|12|||
163465199|NCT00970268|590400691|FG001|Overall Study|Withdrawal by Subject|19|||
163465200|NCT00970268|590400690|FG000|Overall Study|Adverse Event|15|||
163465201|NCT00970268|590400691|FG001|Overall Study|Adverse Event|12|||
163465202|NCT00970268|590400690|FG000|Overall Study|Lack of Efficacy|3|||
163465203|NCT00970268|590400691|FG001|Overall Study|Lack of Efficacy|6|||
163465204|NCT00970268|590400690|FG000|Overall Study|Protocol Violation|4|||
163465205|NCT00970268|590400691|FG001|Overall Study|Protocol Violation|7|||
163465206|NCT00970268|590400690|FG000|Overall Study|Other Reason|3|||
163465207|NCT00970268|590400691|FG001|Overall Study|Other Reason|1|||
163465208|NCT00970268|590400690|FG000|Overall Study|COPD Exacerbation|4|||
163465209|NCT00970268|590400691|FG001|Overall Study|COPD Exacerbation|2|||
163465210|NCT00970268|590400690|FG000|Overall Study|Lost to Follow-up|1|||
163465211|NCT00970268|590400691|FG001|Overall Study|Lost to Follow-up|2|||
163465212|NCT00970268|590400690|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
163465213|NCT00970268|590400691|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
163465214|NCT00719953|590400692|FG000|Overall Study|Adverse Event|4|||
163465215|NCT03726333|590400698|FG000|Overall Study|Progressive Disease|0|||
163465216|NCT03726333|590400699|FG001|Overall Study|Progressive Disease|0|||
163465217|NCT03726333|590400700|FG002|Overall Study|Progressive Disease|1|||
163465218|NCT03726333|590400701|FG003|Overall Study|Progressive Disease|0|||
163465219|NCT03726333|590400702|FG004|Overall Study|Progressive Disease|0|||
163465220|NCT02947022|590400703|FG000|Overall Study|Study Stopped|1|||
163465221|NCT01230749|590400704|FG000|Overall Study|Adverse Event|0|||
163465222|NCT01230749|590400705|FG001|Overall Study|Adverse Event|0|||
163465223|NCT01230749|590400706|FG002|Overall Study|Adverse Event|0|||
163465224|NCT01230749|590400707|FG003|Overall Study|Adverse Event|1|||
163465225|NCT01230749|590400704|FG000|Overall Study|Physician Decision|0|||
163465226|NCT01230749|590400705|FG001|Overall Study|Physician Decision|0|||
163465227|NCT01230749|590400706|FG002|Overall Study|Physician Decision|1|||
163465228|NCT01230749|590400707|FG003|Overall Study|Physician Decision|0|||
163465229|NCT01230749|590400704|FG000|Overall Study|Withdrawal by Subject|0|||
163465230|NCT01230749|590400705|FG001|Overall Study|Withdrawal by Subject|1|||
163465231|NCT01230749|590400706|FG002|Overall Study|Withdrawal by Subject|0|||
163465232|NCT01230749|590400707|FG003|Overall Study|Withdrawal by Subject|0|||
163465233|NCT01230749|590400704|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
163465234|NCT01230749|590400705|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
163465235|NCT01230749|590400706|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
163465236|NCT01230749|590400707|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
163465237|NCT03906136|590403207|FG000|Overall Study|Adverse Event|1|||
163465238|NCT03906136|590403208|FG001|Overall Study|Adverse Event|0|||
163465239|NCT03906136|590403207|FG000|Overall Study|Lost to Follow-up|7|||
163465240|NCT03906136|590403208|FG001|Overall Study|Lost to Follow-up|4|||
163465241|NCT03906136|590403207|FG000|Overall Study|Physician Decision|1|||
163465242|NCT03906136|590403208|FG001|Overall Study|Physician Decision|0|||
163465243|NCT03906136|590403207|FG000|Overall Study|Withdrawal by Subject|3|||
163465244|NCT03906136|590403208|FG001|Overall Study|Withdrawal by Subject|7|||
163465245|NCT01696396|590403213|FG000|Overall Study|Withdrawal by Subject|19|||
163465246|NCT01696396|590403214|FG001|Overall Study|Withdrawal by Subject|5|||
163465247|NCT01696396|590403215|FG002|Overall Study|Withdrawal by Subject|19|||
163465248|NCT01696396|590403216|FG003|Overall Study|Withdrawal by Subject|11|||
163465249|NCT01696396|590403213|FG000|Overall Study|Decision by Sponsor|3|||
163465250|NCT01696396|590403214|FG001|Overall Study|Decision by Sponsor|1|||
163465251|NCT01696396|590403215|FG002|Overall Study|Decision by Sponsor|2|||
163465252|NCT01696396|590403216|FG003|Overall Study|Decision by Sponsor|2|||
163465253|NCT01696396|590403213|FG000|Overall Study|Lost to Follow-up|9|||
163465254|NCT01696396|590403214|FG001|Overall Study|Lost to Follow-up|1|||
163465255|NCT01696396|590403215|FG002|Overall Study|Lost to Follow-up|4|||
163465256|NCT01696396|590403216|FG003|Overall Study|Lost to Follow-up|1|||
163465257|NCT01696396|590403213|FG000|Overall Study|Death|0|||
163465258|NCT01696396|590403214|FG001|Overall Study|Death|0|||
163465259|NCT01696396|590403215|FG002|Overall Study|Death|1|||
163465260|NCT01696396|590403216|FG003|Overall Study|Death|0|||
163465261|NCT02371980|590403222|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
163465262|NCT02371980|590403223|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
163465263|NCT02371980|590403224|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
163465264|NCT02371980|590403225|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
163465265|NCT02371980|590403226|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
163465266|NCT02371980|590403222|FG000|Open-label Period|Significant Protocol Deviation|19|||
163465267|NCT02371980|590403223|FG001|Open-label Period|Significant Protocol Deviation|0|||
163465268|NCT02371980|590403224|FG002|Open-label Period|Significant Protocol Deviation|0|||
163465269|NCT02371980|590403225|FG003|Open-label Period|Significant Protocol Deviation|0|||
163465270|NCT02371980|590403226|FG004|Open-label Period|Significant Protocol Deviation|0|||
163465271|NCT02371980|590403222|FG000|Open-label Period|Noncompliance with Study Drug|10|||
163465272|NCT02371980|590403223|FG001|Open-label Period|Noncompliance with Study Drug|0|||
163465273|NCT02371980|590403224|FG002|Open-label Period|Noncompliance with Study Drug|0|||
163465274|NCT02371980|590403225|FG003|Open-label Period|Noncompliance with Study Drug|0|||
163465275|NCT02371980|590403226|FG004|Open-label Period|Noncompliance with Study Drug|0|||
163465276|NCT02371980|590403222|FG000|Open-label Period|Lost to Follow-up|55|||
163465277|NCT02371980|590403223|FG001|Open-label Period|Lost to Follow-up|0|||
163465278|NCT02371980|590403224|FG002|Open-label Period|Lost to Follow-up|0|||
163465279|NCT02371980|590403225|FG003|Open-label Period|Lost to Follow-up|0|||
163465280|NCT02371980|590403226|FG004|Open-label Period|Lost to Follow-up|0|||
163465281|NCT02371980|590403222|FG000|Open-label Period|Voluntary Withdrawal|91|||
163465282|NCT02371980|590403223|FG001|Open-label Period|Voluntary Withdrawal|0|||
163465283|NCT02371980|590403224|FG002|Open-label Period|Voluntary Withdrawal|0|||
163465284|NCT02371980|590403225|FG003|Open-label Period|Voluntary Withdrawal|0|||
163465285|NCT02371980|590403226|FG004|Open-label Period|Voluntary Withdrawal|0|||
163465286|NCT02371980|590403222|FG000|Open-label Period|Pregnancy|1|||
163465287|NCT02371980|590403223|FG001|Open-label Period|Pregnancy|0|||
163465288|NCT02371980|590403224|FG002|Open-label Period|Pregnancy|0|||
163465289|NCT02371980|590403225|FG003|Open-label Period|Pregnancy|0|||
163465290|NCT02371980|590403226|FG004|Open-label Period|Pregnancy|0|||
163465291|NCT02371980|590403222|FG000|Open-label Period|Lack of Efficacy|116|||
163465292|NCT02371980|590403223|FG001|Open-label Period|Lack of Efficacy|0|||
163465293|NCT02371980|590403224|FG002|Open-label Period|Lack of Efficacy|0|||
163465294|NCT02371980|590403225|FG003|Open-label Period|Lack of Efficacy|0|||
163465295|NCT02371980|590403226|FG004|Open-label Period|Lack of Efficacy|0|||
163465296|NCT02371980|590403222|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
163465297|NCT02371980|590403223|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
163465298|NCT02371980|590403224|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
163465299|NCT02371980|590403225|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
163465300|NCT02371980|590403226|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
163465301|NCT02371980|590403222|FG000|Open-label Period|Reason not Specified|9|||
163465302|NCT02371980|590403223|FG001|Open-label Period|Reason not Specified|0|||
163465303|NCT02371980|590403224|FG002|Open-label Period|Reason not Specified|0|||
163465304|NCT02371980|590403225|FG003|Open-label Period|Reason not Specified|0|||
163465305|NCT02371980|590403226|FG004|Open-label Period|Reason not Specified|0|||
163465306|NCT02371980|590403222|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
163465307|NCT02371980|590403223|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
163465308|NCT02371980|590403224|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
163465309|NCT02371980|590403225|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
163465310|NCT02371980|590403226|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
163465311|NCT02371980|590403222|FG000|Double-blind Period|Significant Protocol Deviation|0|||
163465312|NCT02371980|590403223|FG001|Double-blind Period|Significant Protocol Deviation|2|||
163465313|NCT02371980|590403224|FG002|Double-blind Period|Significant Protocol Deviation|7|||
163465314|NCT02371980|590403225|FG003|Double-blind Period|Significant Protocol Deviation|3|||
163465315|NCT02371980|590403226|FG004|Double-blind Period|Significant Protocol Deviation|3|||
163465316|NCT02371980|590403222|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
163465317|NCT02371980|590403223|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
163465318|NCT02371980|590403224|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
163465319|NCT02371980|590403225|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
163465320|NCT02371980|590403226|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
163465321|NCT02371980|590403222|FG000|Double-blind Period|Lost to Follow-up|0|||
163465322|NCT02371980|590403223|FG001|Double-blind Period|Lost to Follow-up|8|||
163465323|NCT02371980|590403224|FG002|Double-blind Period|Lost to Follow-up|8|||
163465324|NCT02371980|590403225|FG003|Double-blind Period|Lost to Follow-up|6|||
163465325|NCT02371980|590403226|FG004|Double-blind Period|Lost to Follow-up|5|||
163465326|NCT02371980|590403222|FG000|Double-blind Period|Voluntary Withdrawal|0|||
163465327|NCT02371980|590403223|FG001|Double-blind Period|Voluntary Withdrawal|12|||
163465328|NCT02371980|590403224|FG002|Double-blind Period|Voluntary Withdrawal|8|||
163465329|NCT02371980|590403225|FG003|Double-blind Period|Voluntary Withdrawal|9|||
163465330|NCT02371980|590403226|FG004|Double-blind Period|Voluntary Withdrawal|11|||
163465331|NCT02371980|590403222|FG000|Double-blind Period|Relapse|0|||
163465332|NCT02371980|590403223|FG001|Double-blind Period|Relapse|50|||
163465333|NCT02371980|590403224|FG002|Double-blind Period|Relapse|25|||
163465334|NCT02371980|590403225|FG003|Double-blind Period|Relapse|25|||
163465335|NCT02371980|590403226|FG004|Double-blind Period|Relapse|26|||
163465336|NCT02371980|590403222|FG000|Double-blind Period|Reason not Specified|0|||
163465337|NCT02371980|590403223|FG001|Double-blind Period|Reason not Specified|3|||
163465338|NCT02371980|590403224|FG002|Double-blind Period|Reason not Specified|3|||
163465339|NCT02371980|590403225|FG003|Double-blind Period|Reason not Specified|2|||
163465340|NCT02371980|590403226|FG004|Double-blind Period|Reason not Specified|1|||
163465341|NCT02371980|590403222|FG000|Double-blind Period|Missing|0|||
163465342|NCT02371980|590403223|FG001|Double-blind Period|Missing|1|||
163465343|NCT02371980|590403224|FG002|Double-blind Period|Missing|0|||
163465344|NCT02371980|590403225|FG003|Double-blind Period|Missing|0|||
163465345|NCT02371980|590403226|FG004|Double-blind Period|Missing|0|||
163465346|NCT01280812|590403228|FG000|Overall Study|Withdrawal by Subject|2|||
163465347|NCT01280812|590403229|FG001|Overall Study|Withdrawal by Subject|1|||
163465348|NCT01280812|590403230|FG002|Overall Study|Withdrawal by Subject|0|||
163465349|NCT01280812|590403228|FG000|Overall Study|Lost to Follow-up|1|||
163465350|NCT01280812|590403229|FG001|Overall Study|Lost to Follow-up|1|||
163465351|NCT01280812|590403230|FG002|Overall Study|Lost to Follow-up|1|||
163465352|NCT01594749|590403236|FG000|Overall Study|Adverse Event|2|||
163465353|NCT01594749|590403237|FG001|Overall Study|Adverse Event|1|||
163465354|NCT01594749|590403236|FG000|Overall Study|Withdrawal by Subject|2|||
163465355|NCT01594749|590403237|FG001|Overall Study|Withdrawal by Subject|2|||
163465356|NCT01594749|590403236|FG000|Overall Study|Protocol Violation|2|||
163465357|NCT01594749|590403237|FG001|Overall Study|Protocol Violation|0|||
163465358|NCT01594749|590403236|FG000|Overall Study|Physician Decision|1|||
163465359|NCT01594749|590403237|FG001|Overall Study|Physician Decision|1|||
163465360|NCT01594749|590403236|FG000|Overall Study|Non-compliance with Protocol|0|||
163465361|NCT01594749|590403237|FG001|Overall Study|Non-compliance with Protocol|1|||
163465362|NCT01594749|590403236|FG000|Overall Study|Lost to Follow-up|1|||
163465363|NCT01594749|590403237|FG001|Overall Study|Lost to Follow-up|0|||
163465364|NCT01594749|590403236|FG000|Overall Study|Death|9|||
163465365|NCT01594749|590403237|FG001|Overall Study|Death|3|||
163465366|NCT01594749|590403236|FG000|Overall Study|Not Treated|4|||
163465367|NCT01594749|590403237|FG001|Overall Study|Not Treated|10|||
163465368|NCT01594749|590403236|FG000|Overall Study|Lost Source Documentation|1|||
163465369|NCT01594749|590403237|FG001|Overall Study|Lost Source Documentation|0|||
163465370|NCT00959894|590403238|FG000|Overall Study|Lost to Follow-up|10|||
163465371|NCT00959894|590403238|FG000|Overall Study|Adverse Event|3|||
163465372|NCT00959894|590403238|FG000|Overall Study|Withdrawal by Subject|1|||
163465373|NCT00959894|590403238|FG000|Overall Study|Need for contraindicated medication|1|||
163465374|NCT00959894|590403238|FG000|Overall Study|Subject moved out of town|1|||
163465375|NCT00922974|590403239|FG000|Phase II Component|Protocol Violation|2|||
163465376|NCT00922974|590403240|FG001|Phase II Component|Protocol Violation|0|||
163465377|NCT00922974|590403239|FG000|Phase II Component|Not evaluable for treatment review|5|||
163465378|NCT00922974|590403240|FG001|Phase II Component|Not evaluable for treatment review|0|||
163465379|NCT00922974|590403239|FG000|Phase III Component|Protocol Violation|8|||
163465380|NCT00922974|590403240|FG001|Phase III Component|Protocol Violation|6|||
163465381|NCT03682055|590403241|FG000|Overall Study|Lack of Efficacy|1|||
163465382|NCT03682055|590403242|FG001|Overall Study|Lack of Efficacy|2|||
163465383|NCT03682055|590403243|FG002|Overall Study|Lack of Efficacy|1|||
163465384|NCT03682055|590403244|FG003|Overall Study|Lack of Efficacy|2|||
163465385|NCT03682055|590403245|FG004|Overall Study|Lack of Efficacy|1|||
163465386|NCT03682055|590403246|FG005|Overall Study|Lack of Efficacy|3|||
163465387|NCT03682055|590403241|FG000|Overall Study|Withdrawal by Subject|0|||
163465388|NCT03682055|590403242|FG001|Overall Study|Withdrawal by Subject|0|||
163465389|NCT03682055|590403243|FG002|Overall Study|Withdrawal by Subject|0|||
163465390|NCT03682055|590403244|FG003|Overall Study|Withdrawal by Subject|0|||
163465391|NCT03682055|590403245|FG004|Overall Study|Withdrawal by Subject|0|||
163465392|NCT03682055|590403246|FG005|Overall Study|Withdrawal by Subject|1|||
163465393|NCT03682055|590403241|FG000|Overall Study|Termination of Study by Sponsor|0|||
163465394|NCT03682055|590403242|FG001|Overall Study|Termination of Study by Sponsor|0|||
163465395|NCT03682055|590403243|FG002|Overall Study|Termination of Study by Sponsor|0|||
163465396|NCT03682055|590403244|FG003|Overall Study|Termination of Study by Sponsor|0|||
163465397|NCT03682055|590403245|FG004|Overall Study|Termination of Study by Sponsor|0|||
163465398|NCT03682055|590403246|FG005|Overall Study|Termination of Study by Sponsor|3|||
163465399|NCT00191386|590403247|FG000|Overall Study|Adverse Event|16|||
163465400|NCT00191386|590403247|FG000|Overall Study|Lost to Follow-up|1|||
163465401|NCT00191386|590403247|FG000|Overall Study|Entry Criteria Exclusion|3|||
163465402|NCT00191386|590403247|FG000|Overall Study|Protocol Violation|18|||
163465403|NCT00191386|590403247|FG000|Overall Study|Withdrawal by Subject|96|||
163465404|NCT00191386|590403247|FG000|Overall Study|Physician Decision|11|||
163465405|NCT00191386|590403247|FG000|Overall Study|Lack of Efficacy|15|||
163465406|NCT03077243|590403249|FG000|Overall Study|Death|1|||
163465407|NCT03077243|590403250|FG001|Overall Study|Death|2|||
163465408|NCT03077243|590403251|FG002|Overall Study|Death|0|||
163465409|NCT03077243|590403252|FG003|Overall Study|Death|0|||
163465410|NCT03077243|590403249|FG000|Overall Study|Withdrawal by Subject|1|||
163465411|NCT03077243|590403250|FG001|Overall Study|Withdrawal by Subject|3|||
163465412|NCT03077243|590403251|FG002|Overall Study|Withdrawal by Subject|0|||
163465413|NCT03077243|590403252|FG003|Overall Study|Withdrawal by Subject|0|||
163465414|NCT03077243|590403249|FG000|Overall Study|Physician Decision|1|||
163465415|NCT03077243|590403250|FG001|Overall Study|Physician Decision|0|||
163465416|NCT03077243|590403251|FG002|Overall Study|Physician Decision|0|||
163465417|NCT03077243|590403252|FG003|Overall Study|Physician Decision|0|||
163465418|NCT03077243|590403249|FG000|Overall Study|Research at two study sites terminated early|0|||
163465419|NCT03077243|590403250|FG001|Overall Study|Research at two study sites terminated early|0|||
163465420|NCT03077243|590403251|FG002|Overall Study|Research at two study sites terminated early|0|||
163465421|NCT03077243|590403252|FG003|Overall Study|Research at two study sites terminated early|69|||
163465422|NCT02574481|590403253|FG000|Overall Study|Withdrawal by Subject|29|||
163465423|NCT02574481|590403254|FG001|Overall Study|Withdrawal by Subject|15|||
163465424|NCT02574481|590403255|FG002|Overall Study|Withdrawal by Subject|4|||
163465425|NCT02574481|590403256|FG003|Overall Study|Withdrawal by Subject|1|||
163465426|NCT02574481|590403253|FG000|Overall Study|Adverse Event|5|||
163465427|NCT02574481|590403254|FG001|Overall Study|Adverse Event|1|||
163465428|NCT02574481|590403255|FG002|Overall Study|Adverse Event|1|||
163465429|NCT02574481|590403256|FG003|Overall Study|Adverse Event|0|||
163465430|NCT02574481|590403253|FG000|Overall Study|Visit Missed|15|||
163465431|NCT02574481|590403254|FG001|Overall Study|Visit Missed|7|||
163465432|NCT02574481|590403255|FG002|Overall Study|Visit Missed|5|||
163465433|NCT02574481|590403256|FG003|Overall Study|Visit Missed|0|||
163465434|NCT02574481|590403253|FG000|Overall Study|Other|7|||
163465435|NCT02574481|590403254|FG001|Overall Study|Other|2|||
163465436|NCT02574481|590403255|FG002|Overall Study|Other|0|||
163465437|NCT02574481|590403256|FG003|Overall Study|Other|0|||
163465438|NCT02574481|590403253|FG000|Overall Study|Death|48|||
163465439|NCT02574481|590403254|FG001|Overall Study|Death|26|||
163465440|NCT02574481|590403255|FG002|Overall Study|Death|12|||
163465441|NCT02574481|590403256|FG003|Overall Study|Death|4|||
163465442|NCT02574481|590403253|FG000|Overall Study|Physician Decision|5|||
163465443|NCT02574481|590403254|FG001|Overall Study|Physician Decision|2|||
163465444|NCT02574481|590403255|FG002|Overall Study|Physician Decision|0|||
163465445|NCT02574481|590403256|FG003|Overall Study|Physician Decision|0|||
163465446|NCT02574481|590403253|FG000|Overall Study|Lost to Follow-up|5|||
163465447|NCT02574481|590403254|FG001|Overall Study|Lost to Follow-up|1|||
163465448|NCT02574481|590403255|FG002|Overall Study|Lost to Follow-up|3|||
163465449|NCT02574481|590403256|FG003|Overall Study|Lost to Follow-up|0|||
163465450|NCT01105936|590403257|FG000|Period 1|Adverse Event|0|||
163465451|NCT01105936|590403258|FG001|Period 1|Adverse Event|0|||
163465452|NCT01105936|590403259|FG002|Period 1|Adverse Event|0|||
163465453|NCT01105936|590403260|FG003|Period 1|Adverse Event|1|||
163465454|NCT01105936|590403257|FG000|Period 2|Adverse Event|1|||
163465455|NCT01105936|590403258|FG001|Period 2|Adverse Event|0|||
163465456|NCT01105936|590403259|FG002|Period 2|Adverse Event|0|||
163465457|NCT01105936|590403260|FG003|Period 2|Adverse Event|0|||
163465458|NCT01105936|590403257|FG000|Period 3|Protocol Violation|0|||
163465459|NCT01105936|590403258|FG001|Period 3|Protocol Violation|2|||
163465460|NCT01105936|590403259|FG002|Period 3|Protocol Violation|0|||
163465461|NCT01105936|590403260|FG003|Period 3|Protocol Violation|0|||
163465462|NCT01826448|590403262|FG000|Overall Study|Adverse Event|1|||
163465463|NCT01826448|590403263|FG001|Overall Study|Adverse Event|3|||
163465464|NCT01826448|590403262|FG000|Overall Study|Disease progression|2|||
163465465|NCT01826448|590403263|FG001|Overall Study|Disease progression|4|||
163465466|NCT01826448|590403262|FG000|Overall Study|Withdrawal by Subject|1|||
163465467|NCT01826448|590403263|FG001|Overall Study|Withdrawal by Subject|0|||
163465468|NCT01826448|590403262|FG000|Overall Study|Physician Decision|0|||
163465469|NCT01826448|590403263|FG001|Overall Study|Physician Decision|1|||
163465470|NCT01826448|590403262|FG000|Overall Study|2 active cancers|0|||
163465471|NCT01826448|590403263|FG001|Overall Study|2 active cancers|1|||
163465472|NCT02578992|590403265|FG000|Overall Study|equipment not available or malfunction|3|||
163465473|NCT02578992|590403266|FG001|Overall Study|equipment not available or malfunction|3|||
163465474|NCT00880100|590403268|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
163465475|NCT00880100|590403268|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
163465476|NCT00880100|590403268|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
163465477|NCT02038790|590403271|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
163465478|NCT02038790|590403272|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
163465479|NCT02431702|590403274|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
163465480|NCT02431702|590403275|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
163465481|NCT02431702|590403276|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
163465482|NCT02431702|590403277|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
163465483|NCT02431702|590403278|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
163465484|NCT02431702|590403279|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
163465485|NCT02431702|590403280|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
163465486|NCT02431702|590403274|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
163465487|NCT02431702|590403275|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
163465488|NCT02431702|590403276|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
163465489|NCT02431702|590403277|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
163465490|NCT02431702|590403278|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
163465491|NCT02431702|590403279|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
163465492|NCT02431702|590403280|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
163465493|NCT02431702|590403274|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
163465494|NCT02431702|590403275|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
163465495|NCT02431702|590403276|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
163465496|NCT02431702|590403277|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
163465497|NCT02431702|590403278|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
163465498|NCT02431702|590403279|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
163465499|NCT02431702|590403280|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
163465500|NCT02431702|590403274|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
163465501|NCT02431702|590403275|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
163465502|NCT02431702|590403276|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
163465503|NCT02431702|590403277|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
163465504|NCT02431702|590403278|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
163465505|NCT02431702|590403279|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
163465506|NCT02431702|590403280|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
163465507|NCT02431702|590403274|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
163465508|NCT02431702|590403275|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
163465509|NCT02431702|590403276|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
163465510|NCT02431702|590403277|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
163465511|NCT02431702|590403278|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
163465512|NCT02431702|590403279|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
163465513|NCT02431702|590403280|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
163465514|NCT02431702|590403274|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
163465515|NCT02431702|590403275|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
163465516|NCT02431702|590403276|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
163465517|NCT02431702|590403277|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
163465518|NCT02431702|590403278|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
163465519|NCT02431702|590403279|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
163465520|NCT02431702|590403280|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
163465521|NCT02431702|590403274|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
163465522|NCT02431702|590403275|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
163465523|NCT02431702|590403276|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
163465524|NCT02431702|590403277|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
163465525|NCT02431702|590403278|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
163465526|NCT02431702|590403279|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
163465527|NCT02431702|590403280|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
163465528|NCT02431702|590403274|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
163465529|NCT02431702|590403275|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
163465530|NCT02431702|590403276|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
163465531|NCT02431702|590403277|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
163465532|NCT02431702|590403278|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
163465533|NCT02431702|590403279|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
163465534|NCT02431702|590403280|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
163465535|NCT02431702|590403274|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
163465536|NCT02431702|590403275|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
163465537|NCT02431702|590403276|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
163465538|NCT02431702|590403277|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
163465539|NCT02431702|590403278|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
163465540|NCT02431702|590403279|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
163465541|NCT02431702|590403280|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
163465542|NCT02431702|590403274|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
163465543|NCT02431702|590403275|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
163465544|NCT02431702|590403276|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
163465545|NCT02431702|590403277|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
163465546|NCT02431702|590403278|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
163465547|NCT02431702|590403279|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
163465548|NCT02431702|590403280|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
163465549|NCT02431702|590403274|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
163465550|NCT02431702|590403275|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
163465551|NCT02431702|590403276|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
163465552|NCT02431702|590403277|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
163465553|NCT02431702|590403278|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
163465554|NCT02431702|590403279|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
163465555|NCT02431702|590403280|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
163465556|NCT02431702|590403274|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
163465557|NCT02431702|590403275|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
163465558|NCT02431702|590403276|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
163465559|NCT02431702|590403277|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
163465560|NCT02431702|590403278|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
163465561|NCT02431702|590403279|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
163465562|NCT02431702|590403280|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
163465563|NCT02431702|590403274|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
163465564|NCT02431702|590403275|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
163465565|NCT02431702|590403276|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
163465566|NCT02431702|590403277|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
163465567|NCT02431702|590403278|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
163465568|NCT02431702|590403279|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
163465569|NCT02431702|590403280|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
163465570|NCT02431702|590403274|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
163465571|NCT02431702|590403275|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
163465572|NCT02431702|590403276|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
163465573|NCT02431702|590403277|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
163465574|NCT02431702|590403278|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
163465575|NCT02431702|590403279|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
163465576|NCT02431702|590403280|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
163465577|NCT02431702|590403274|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
163465578|NCT02431702|590403275|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
163465579|NCT02431702|590403276|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
163465580|NCT02431702|590403277|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
163465581|NCT02431702|590403278|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
163465582|NCT02431702|590403279|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
163465583|NCT02431702|590403280|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
163465584|NCT01376388|590403290|FG000|Overall Study|Adverse Event|13|||
163465585|NCT01376388|590403290|FG000|Overall Study|Lack of Efficacy|2|||
163465586|NCT01376388|590403290|FG000|Overall Study|Withdrawal by Subject|3|||
163465587|NCT02009930|590403291|FG000|Overall Study|withdrawn|5|||
163465588|NCT03907969|590403295|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
163465589|NCT03907969|590403296|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
163465590|NCT03907969|590403297|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
163465591|NCT03907969|590403298|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
163465592|NCT03907969|590403299|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
163465593|NCT03907969|590403300|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
163465594|NCT03907969|590403301|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
163465595|NCT03907969|590403302|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
163465596|NCT03907969|590403303|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
163465597|NCT03907969|590403304|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
163465598|NCT03907969|590403305|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
163465599|NCT03907969|590403295|FG000|Monotherapy Part A|Progressive Disease|0|||
163465600|NCT03907969|590403296|FG001|Monotherapy Part A|Progressive Disease|1|||
163465601|NCT03907969|590403297|FG002|Monotherapy Part A|Progressive Disease|0|||
163465602|NCT03907969|590403298|FG003|Monotherapy Part A|Progressive Disease|0|||
163465603|NCT03907969|590403299|FG004|Monotherapy Part A|Progressive Disease|0|||
163465604|NCT03907969|590403300|FG005|Monotherapy Part A|Progressive Disease|1|||
163465605|NCT03907969|590403301|FG006|Monotherapy Part A|Progressive Disease|2|||
163465606|NCT03907969|590403302|FG007|Monotherapy Part A|Progressive Disease|0|||
163465607|NCT03907969|590403303|FG008|Monotherapy Part A|Progressive Disease|0|||
163465608|NCT03907969|590403304|FG009|Monotherapy Part A|Progressive Disease|0|||
163465609|NCT03907969|590403305|FG010|Monotherapy Part A|Progressive Disease|0|||
163465610|NCT03907969|590403295|FG000|Monotherapy Part A|Death|0|||
163465611|NCT03907969|590403296|FG001|Monotherapy Part A|Death|0|||
163465612|NCT03907969|590403297|FG002|Monotherapy Part A|Death|1|||
163465613|NCT03907969|590403298|FG003|Monotherapy Part A|Death|1|||
163465614|NCT03907969|590403299|FG004|Monotherapy Part A|Death|0|||
163465615|NCT03907969|590403300|FG005|Monotherapy Part A|Death|1|||
163465616|NCT03907969|590403301|FG006|Monotherapy Part A|Death|0|||
163465617|NCT03907969|590403302|FG007|Monotherapy Part A|Death|0|||
163465618|NCT03907969|590403303|FG008|Monotherapy Part A|Death|0|||
163465619|NCT03907969|590403304|FG009|Monotherapy Part A|Death|0|||
163465620|NCT03907969|590403305|FG010|Monotherapy Part A|Death|0|||
163465621|NCT03907969|590403295|FG000|Combination Therapy Part A|Adverse Event|0|||
163465622|NCT03907969|590403296|FG001|Combination Therapy Part A|Adverse Event|0|||
163465623|NCT03907969|590403297|FG002|Combination Therapy Part A|Adverse Event|0|||
163465624|NCT03907969|590403298|FG003|Combination Therapy Part A|Adverse Event|0|||
163465625|NCT03907969|590403299|FG004|Combination Therapy Part A|Adverse Event|0|||
163465626|NCT03907969|590403300|FG005|Combination Therapy Part A|Adverse Event|0|||
163465627|NCT03907969|590403301|FG006|Combination Therapy Part A|Adverse Event|0|||
163465628|NCT03907969|590403302|FG007|Combination Therapy Part A|Adverse Event|0|||
163465629|NCT03907969|590403303|FG008|Combination Therapy Part A|Adverse Event|0|||
163465630|NCT03907969|590403304|FG009|Combination Therapy Part A|Adverse Event|1|||
163465631|NCT03907969|590403305|FG010|Combination Therapy Part A|Adverse Event|1|||
163465632|NCT03907969|590403295|FG000|Combination Therapy Part A|Progressive disease|0|||
163465633|NCT03907969|590403296|FG001|Combination Therapy Part A|Progressive disease|0|||
163465634|NCT03907969|590403297|FG002|Combination Therapy Part A|Progressive disease|0|||
163465635|NCT03907969|590403298|FG003|Combination Therapy Part A|Progressive disease|0|||
163465636|NCT03907969|590403299|FG004|Combination Therapy Part A|Progressive disease|0|||
163465637|NCT03907969|590403300|FG005|Combination Therapy Part A|Progressive disease|0|||
163465638|NCT03907969|590403301|FG006|Combination Therapy Part A|Progressive disease|0|||
163465639|NCT03907969|590403302|FG007|Combination Therapy Part A|Progressive disease|1|||
163465640|NCT03907969|590403303|FG008|Combination Therapy Part A|Progressive disease|0|||
163465641|NCT03907969|590403304|FG009|Combination Therapy Part A|Progressive disease|2|||
163465642|NCT03907969|590403305|FG010|Combination Therapy Part A|Progressive disease|3|||
163465643|NCT03907969|590403295|FG000|Combination Therapy Part A|Death|0|||
163465644|NCT03907969|590403296|FG001|Combination Therapy Part A|Death|0|||
163465645|NCT03907969|590403297|FG002|Combination Therapy Part A|Death|0|||
163465646|NCT03907969|590403298|FG003|Combination Therapy Part A|Death|0|||
163465647|NCT03907969|590403299|FG004|Combination Therapy Part A|Death|0|||
163465648|NCT03907969|590403300|FG005|Combination Therapy Part A|Death|0|||
163465649|NCT03907969|590403301|FG006|Combination Therapy Part A|Death|0|||
163465650|NCT03907969|590403302|FG007|Combination Therapy Part A|Death|0|||
163465651|NCT03907969|590403303|FG008|Combination Therapy Part A|Death|1|||
163465652|NCT03907969|590403304|FG009|Combination Therapy Part A|Death|0|||
163465653|NCT03907969|590403305|FG010|Combination Therapy Part A|Death|1|||
163465654|NCT03907969|590403295|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
163465655|NCT03907969|590403296|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
163465656|NCT03907969|590403297|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
163465657|NCT03907969|590403298|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
163465658|NCT03907969|590403299|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
163465659|NCT03907969|590403300|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
163465660|NCT03907969|590403301|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
163465661|NCT03907969|590403302|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
163465662|NCT03907969|590403303|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
163465663|NCT03907969|590403304|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
163465664|NCT03907969|590403305|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
163465665|NCT03907969|590403295|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
163465666|NCT03907969|590403296|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
163465667|NCT03907969|590403297|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
163465668|NCT03907969|590403298|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
163465669|NCT03907969|590403299|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
163465670|NCT03907969|590403300|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
163465671|NCT03907969|590403301|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
163465672|NCT03907969|590403302|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
163465673|NCT03907969|590403303|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
163465674|NCT03907969|590403304|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
163465675|NCT03907969|590403305|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
163465676|NCT03907969|590403295|FG000|Combination Therapy Part A|Physician Decision|0|||
163465677|NCT03907969|590403296|FG001|Combination Therapy Part A|Physician Decision|0|||
163465678|NCT03907969|590403297|FG002|Combination Therapy Part A|Physician Decision|0|||
163465679|NCT03907969|590403298|FG003|Combination Therapy Part A|Physician Decision|0|||
163465680|NCT03907969|590403299|FG004|Combination Therapy Part A|Physician Decision|0|||
163465681|NCT03907969|590403300|FG005|Combination Therapy Part A|Physician Decision|0|||
163465682|NCT03907969|590403301|FG006|Combination Therapy Part A|Physician Decision|0|||
163465683|NCT03907969|590403302|FG007|Combination Therapy Part A|Physician Decision|1|||
163465684|NCT03907969|590403303|FG008|Combination Therapy Part A|Physician Decision|0|||
163465685|NCT03907969|590403304|FG009|Combination Therapy Part A|Physician Decision|0|||
163465686|NCT03907969|590403305|FG010|Combination Therapy Part A|Physician Decision|1|||
163465687|NCT01419015|590403306|FG000|Overall Study|Death|2|||
163465688|NCT00425113|590403311|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
163465689|NCT00425113|590403312|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
163465690|NCT00425113|590403311|FG000|Overall Study|diagnosis of abdominal TB|0|||
163465691|NCT00425113|590403312|FG001|Overall Study|diagnosis of abdominal TB|1|||
163465692|NCT00425113|590403311|FG000|Overall Study|missing study drug more than 14 days|0|||
163465693|NCT00425113|590403312|FG001|Overall Study|missing study drug more than 14 days|1|||
163465694|NCT00425113|590403311|FG000|Overall Study|Withdrawal by Subject|1|||
163465695|NCT00425113|590403312|FG001|Overall Study|Withdrawal by Subject|0|||
163465696|NCT00879437|590403313|FG000|Overall Study|Protocol Violation|0|||
163465697|NCT00879437|590403314|FG001|Overall Study|Protocol Violation|1|||
163465698|NCT00879437|590403313|FG000|Overall Study|Death|1|||
163465699|NCT00879437|590403314|FG001|Overall Study|Death|0|||
163465700|NCT02920450|590403315|FG000|Overall Study|Death|1|||
163465701|NCT02920450|590403316|FG001|Overall Study|Death|0|||
163465702|NCT02920450|590403317|FG002|Overall Study|Death|0|||
163465703|NCT02920450|590403318|FG003|Overall Study|Death|0|||
163465704|NCT02920450|590403315|FG000|Overall Study|Withdrawal by Subject|1|||
163465705|NCT02920450|590403316|FG001|Overall Study|Withdrawal by Subject|0|||
163465706|NCT02920450|590403317|FG002|Overall Study|Withdrawal by Subject|0|||
163465707|NCT02920450|590403318|FG003|Overall Study|Withdrawal by Subject|0|||
163465708|NCT01001234|590403319|FG000|Overall Study|Withdrawal by Subject|2|||
163465709|NCT01001234|590403320|FG001|Overall Study|Withdrawal by Subject|0|||
163465710|NCT01001234|590403321|FG002|Overall Study|Withdrawal by Subject|3|||
163465711|NCT01001234|590403322|FG003|Overall Study|Withdrawal by Subject|0|||
163465712|NCT01001234|590403323|FG004|Overall Study|Withdrawal by Subject|0|||
163465713|NCT01001234|590403319|FG000|Overall Study|Protocol Violation|34|||
163465714|NCT01001234|590403320|FG001|Overall Study|Protocol Violation|3|||
163465715|NCT01001234|590403321|FG002|Overall Study|Protocol Violation|19|||
163465716|NCT01001234|590403322|FG003|Overall Study|Protocol Violation|18|||
163465717|NCT01001234|590403323|FG004|Overall Study|Protocol Violation|0|||
163465718|NCT01001234|590403319|FG000|Overall Study|Lost to Follow-up|0|||
163465719|NCT01001234|590403320|FG001|Overall Study|Lost to Follow-up|0|||
163465720|NCT01001234|590403321|FG002|Overall Study|Lost to Follow-up|1|||
163465721|NCT01001234|590403322|FG003|Overall Study|Lost to Follow-up|2|||
163465722|NCT01001234|590403323|FG004|Overall Study|Lost to Follow-up|0|||
163465723|NCT01001234|590403319|FG000|Overall Study|Physician Decision|1|||
163465724|NCT01001234|590403320|FG001|Overall Study|Physician Decision|0|||
163465725|NCT01001234|590403321|FG002|Overall Study|Physician Decision|0|||
163465726|NCT01001234|590403322|FG003|Overall Study|Physician Decision|0|||
163465727|NCT01001234|590403323|FG004|Overall Study|Physician Decision|0|||
163465728|NCT01001234|590403319|FG000|Overall Study|Not Treated: Adverse Event|1|||
163465729|NCT01001234|590403320|FG001|Overall Study|Not Treated: Adverse Event|0|||
163465730|NCT01001234|590403321|FG002|Overall Study|Not Treated: Adverse Event|0|||
163465731|NCT01001234|590403322|FG003|Overall Study|Not Treated: Adverse Event|0|||
163465732|NCT01001234|590403323|FG004|Overall Study|Not Treated: Adverse Event|0|||
163465733|NCT01001234|590403319|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
163465734|NCT01001234|590403320|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
163465735|NCT01001234|590403321|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
163465736|NCT01001234|590403322|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
163465737|NCT01001234|590403323|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
163465738|NCT01001234|590403319|FG000|Overall Study|Not Treated: Protocol Violation|3|||
163465739|NCT01001234|590403320|FG001|Overall Study|Not Treated: Protocol Violation|0|||
163465740|NCT01001234|590403321|FG002|Overall Study|Not Treated: Protocol Violation|0|||
163465741|NCT01001234|590403322|FG003|Overall Study|Not Treated: Protocol Violation|0|||
163465742|NCT01001234|590403323|FG004|Overall Study|Not Treated: Protocol Violation|0|||
163465743|NCT01001234|590403319|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
163465744|NCT01001234|590403320|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
163465745|NCT01001234|590403321|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
163465746|NCT01001234|590403322|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
163465747|NCT01001234|590403323|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
163465748|NCT01001234|590403319|FG000|Overall Study|Not Treated: Pregnancy|3|||
163465749|NCT01001234|590403320|FG001|Overall Study|Not Treated: Pregnancy|0|||
163465750|NCT01001234|590403321|FG002|Overall Study|Not Treated: Pregnancy|0|||
163465751|NCT01001234|590403322|FG003|Overall Study|Not Treated: Pregnancy|0|||
163465752|NCT01001234|590403323|FG004|Overall Study|Not Treated: Pregnancy|0|||
163465753|NCT01001234|590403319|FG000|Overall Study|Not Treated: Physician Decision|37|||
163465754|NCT01001234|590403320|FG001|Overall Study|Not Treated: Physician Decision|4|||
163465755|NCT01001234|590403321|FG002|Overall Study|Not Treated: Physician Decision|0|||
163465756|NCT01001234|590403322|FG003|Overall Study|Not Treated: Physician Decision|0|||
163465757|NCT01001234|590403323|FG004|Overall Study|Not Treated: Physician Decision|0|||
163465758|NCT01001234|590403319|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
163465759|NCT01001234|590403320|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
163465760|NCT01001234|590403321|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
163465761|NCT01001234|590403322|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
163465762|NCT01001234|590403323|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
163465763|NCT03379376|590403326|FG000|Overall Study|Lost to Follow-up|2|||
163465764|NCT03379376|590403326|FG000|Overall Study|Did not wish to complete follow up|1|||
163465765|NCT03379376|590403326|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
163465766|NCT03379376|590403326|FG000|Overall Study|Death|1|||
163465767|NCT02475629|590403327|FG000|Overall Study|Adverse Event|1|||
163465768|NCT02475629|590403327|FG000|Overall Study|Death|4|||
163465769|NCT02475629|590403327|FG000|Overall Study|Physician Decision|1|||
163465770|NCT02475629|590403327|FG000|Overall Study|Withdrawal by Subject|1|||
163465771|NCT02475629|590403327|FG000|Overall Study|Lost to Follow-up|1|||
163465772|NCT02475629|590403327|FG000|Overall Study|Subject non-compliance|1|||
163465773|NCT01611298|590403328|FG000|Overall Study|Relapsed|2|||
163465774|NCT03238352|590403329|FG000|Overall Study|Lost to Follow-up|0|||
163465775|NCT03238352|590403330|FG001|Overall Study|Lost to Follow-up|2|||
163465776|NCT03238352|590403331|FG002|Overall Study|Lost to Follow-up|1|||
163465777|NCT03238352|590403329|FG000|Overall Study|Withdrawal by Subject|0|||
163465778|NCT03238352|590403330|FG001|Overall Study|Withdrawal by Subject|1|||
163465779|NCT03238352|590403331|FG002|Overall Study|Withdrawal by Subject|0|||
163465780|NCT00928512|590403332|FG000|Overall Study|Adverse Event|4|||
163465781|NCT00928512|590403333|FG001|Overall Study|Adverse Event|3|||
163465782|NCT00928512|590403334|FG002|Overall Study|Adverse Event|2|||
163465783|NCT00928512|590403335|FG003|Overall Study|Adverse Event|8|||
163465784|NCT00928512|590403336|FG004|Overall Study|Adverse Event|6|||
163465785|NCT00928512|590403332|FG000|Overall Study|Lack of Efficacy|2|||
163465786|NCT00928512|590403333|FG001|Overall Study|Lack of Efficacy|0|||
163465787|NCT00928512|590403334|FG002|Overall Study|Lack of Efficacy|4|||
163465788|NCT00928512|590403335|FG003|Overall Study|Lack of Efficacy|7|||
163465789|NCT00928512|590403336|FG004|Overall Study|Lack of Efficacy|3|||
163465790|NCT00928512|590403332|FG000|Overall Study|Protocol Violation|0|||
163465791|NCT00928512|590403333|FG001|Overall Study|Protocol Violation|1|||
163465792|NCT00928512|590403334|FG002|Overall Study|Protocol Violation|0|||
163465793|NCT00928512|590403335|FG003|Overall Study|Protocol Violation|1|||
163465794|NCT00928512|590403336|FG004|Overall Study|Protocol Violation|3|||
163465795|NCT00928512|590403332|FG000|Overall Study|Withdrawal by Subject|3|||
163465796|NCT00928512|590403333|FG001|Overall Study|Withdrawal by Subject|0|||
163465797|NCT00928512|590403334|FG002|Overall Study|Withdrawal by Subject|3|||
163465798|NCT00928512|590403335|FG003|Overall Study|Withdrawal by Subject|4|||
163465799|NCT00928512|590403336|FG004|Overall Study|Withdrawal by Subject|0|||
163465800|NCT00928512|590403332|FG000|Overall Study|Lost to Follow-up|1|||
163465801|NCT00928512|590403333|FG001|Overall Study|Lost to Follow-up|1|||
163465802|NCT00928512|590403334|FG002|Overall Study|Lost to Follow-up|2|||
163465803|NCT00928512|590403335|FG003|Overall Study|Lost to Follow-up|1|||
163465804|NCT00928512|590403336|FG004|Overall Study|Lost to Follow-up|3|||
163465805|NCT00928512|590403332|FG000|Overall Study|Administrative Problems|0|||
163465806|NCT00928512|590403333|FG001|Overall Study|Administrative Problems|1|||
163465807|NCT00928512|590403334|FG002|Overall Study|Administrative Problems|0|||
163465808|NCT00928512|590403335|FG003|Overall Study|Administrative Problems|0|||
163465809|NCT00928512|590403336|FG004|Overall Study|Administrative Problems|0|||
163465810|NCT04153929|590403337|FG000|Overall Study|Other than listed|2|||
163465811|NCT04153929|590403338|FG001|Overall Study|Other than listed|2|||
163465812|NCT04153929|590403339|FG002|Overall Study|Other than listed|0|||
163465813|NCT04153929|590403340|FG003|Overall Study|Other than listed|1|||
163465814|NCT04153929|590403341|FG004|Overall Study|Other than listed|0|||
163465815|NCT04153929|590403342|FG005|Overall Study|Other than listed|2|||
163465816|NCT04153929|590403343|FG006|Overall Study|Other than listed|2|||
163465817|NCT04153929|590403344|FG007|Overall Study|Other than listed|1|||
163465818|NCT04153929|590403337|FG000|Overall Study|Lost to Follow-up|2|||
163465819|NCT04153929|590403338|FG001|Overall Study|Lost to Follow-up|1|||
163465820|NCT04153929|590403339|FG002|Overall Study|Lost to Follow-up|0|||
163465821|NCT04153929|590403340|FG003|Overall Study|Lost to Follow-up|1|||
163465822|NCT04153929|590403341|FG004|Overall Study|Lost to Follow-up|1|||
163465823|NCT04153929|590403342|FG005|Overall Study|Lost to Follow-up|0|||
163465824|NCT04153929|590403343|FG006|Overall Study|Lost to Follow-up|0|||
163465825|NCT04153929|590403344|FG007|Overall Study|Lost to Follow-up|0|||
163465826|NCT04153929|590403337|FG000|Overall Study|Withdrawal by Subject|3|||
163465827|NCT04153929|590403338|FG001|Overall Study|Withdrawal by Subject|1|||
163465828|NCT04153929|590403339|FG002|Overall Study|Withdrawal by Subject|0|||
163465829|NCT04153929|590403340|FG003|Overall Study|Withdrawal by Subject|3|||
163465830|NCT04153929|590403341|FG004|Overall Study|Withdrawal by Subject|1|||
163465831|NCT04153929|590403342|FG005|Overall Study|Withdrawal by Subject|0|||
163465832|NCT04153929|590403343|FG006|Overall Study|Withdrawal by Subject|1|||
163465833|NCT04153929|590403344|FG007|Overall Study|Withdrawal by Subject|0|||
163465834|NCT04153929|590403337|FG000|Overall Study|Protocol Violation|0|||
163465835|NCT04153929|590403338|FG001|Overall Study|Protocol Violation|0|||
163465836|NCT04153929|590403339|FG002|Overall Study|Protocol Violation|0|||
163465837|NCT04153929|590403340|FG003|Overall Study|Protocol Violation|0|||
163465838|NCT04153929|590403341|FG004|Overall Study|Protocol Violation|0|||
163465839|NCT04153929|590403342|FG005|Overall Study|Protocol Violation|0|||
163465840|NCT04153929|590403343|FG006|Overall Study|Protocol Violation|1|||
163465841|NCT04153929|590403344|FG007|Overall Study|Protocol Violation|2|||
163465842|NCT04153929|590403337|FG000|Overall Study|Adverse Event|3|||
163465843|NCT04153929|590403338|FG001|Overall Study|Adverse Event|5|||
163465844|NCT04153929|590403339|FG002|Overall Study|Adverse Event|5|||
163465845|NCT04153929|590403340|FG003|Overall Study|Adverse Event|11|||
163465846|NCT04153929|590403341|FG004|Overall Study|Adverse Event|15|||
163465847|NCT04153929|590403342|FG005|Overall Study|Adverse Event|4|||
163465848|NCT04153929|590403343|FG006|Overall Study|Adverse Event|8|||
163465849|NCT04153929|590403344|FG007|Overall Study|Adverse Event|2|||
163465850|NCT04153929|590403337|FG000|Overall Study|Not treated|1|||
163465851|NCT04153929|590403338|FG001|Overall Study|Not treated|0|||
163465852|NCT04153929|590403339|FG002|Overall Study|Not treated|0|||
163465853|NCT04153929|590403340|FG003|Overall Study|Not treated|0|||
163465854|NCT04153929|590403341|FG004|Overall Study|Not treated|0|||
163465855|NCT04153929|590403342|FG005|Overall Study|Not treated|0|||
163465856|NCT04153929|590403343|FG006|Overall Study|Not treated|1|||
163465857|NCT04153929|590403344|FG007|Overall Study|Not treated|0|||
163465858|NCT03383614|590403345|FG000|Overall Study|Withdrawal by Subject|0|||
163465859|NCT03383614|590403346|FG001|Overall Study|Withdrawal by Subject|1|||
163465860|NCT03383614|590403347|FG002|Overall Study|Withdrawal by Subject|0|||
163465861|NCT03383614|590403348|FG003|Overall Study|Withdrawal by Subject|0|||
163465862|NCT01686958|590403349|FG000|Overall Study|Withdrawal by Subject|1|||
163465863|NCT03199638|590403354|FG000|Overall Study|inability to drink glutamine during regularly|0|||
163465864|NCT03199638|590403355|FG001|Overall Study|inability to drink glutamine during regularly|2|||
163465865|NCT02807844|590403356|FG000|Overall Study|Physician Decision|0|||
163465866|NCT02807844|590403357|FG001|Overall Study|Physician Decision|0|||
163465867|NCT02807844|590403358|FG002|Overall Study|Physician Decision|0|||
163465868|NCT02807844|590403359|FG003|Overall Study|Physician Decision|0|||
163465869|NCT02807844|590403360|FG004|Overall Study|Physician Decision|0|||
163465870|NCT02807844|590403361|FG005|Overall Study|Physician Decision|0|||
163465871|NCT02807844|590403362|FG006|Overall Study|Physician Decision|3|||
163465872|NCT02807844|590403363|FG007|Overall Study|Physician Decision|0|||
163465873|NCT02807844|590403364|FG008|Overall Study|Physician Decision|1|||
163465874|NCT02807844|590403365|FG009|Overall Study|Physician Decision|2|||
163465875|NCT02807844|590403356|FG000|Overall Study|Death|0|||
163465876|NCT02807844|590403357|FG001|Overall Study|Death|0|||
163465877|NCT02807844|590403358|FG002|Overall Study|Death|2|||
163465878|NCT02807844|590403359|FG003|Overall Study|Death|4|||
163465879|NCT02807844|590403360|FG004|Overall Study|Death|1|||
163465880|NCT02807844|590403361|FG005|Overall Study|Death|2|||
163465881|NCT02807844|590403362|FG006|Overall Study|Death|1|||
163465882|NCT02807844|590403363|FG007|Overall Study|Death|2|||
163465883|NCT02807844|590403364|FG008|Overall Study|Death|0|||
163465884|NCT02807844|590403365|FG009|Overall Study|Death|1|||
163465885|NCT02807844|590403356|FG000|Overall Study|Withdrawal by Subject|0|||
163465886|NCT02807844|590403357|FG001|Overall Study|Withdrawal by Subject|0|||
163465887|NCT02807844|590403358|FG002|Overall Study|Withdrawal by Subject|2|||
163465888|NCT02807844|590403359|FG003|Overall Study|Withdrawal by Subject|1|||
163465889|NCT02807844|590403360|FG004|Overall Study|Withdrawal by Subject|1|||
163465890|NCT02807844|590403361|FG005|Overall Study|Withdrawal by Subject|0|||
163465891|NCT02807844|590403362|FG006|Overall Study|Withdrawal by Subject|1|||
163465892|NCT02807844|590403363|FG007|Overall Study|Withdrawal by Subject|0|||
163465893|NCT02807844|590403364|FG008|Overall Study|Withdrawal by Subject|0|||
163465894|NCT02807844|590403365|FG009|Overall Study|Withdrawal by Subject|0|||
163465895|NCT02807844|590403356|FG000|Overall Study|Progressive disease|5|||
163465896|NCT02807844|590403357|FG001|Overall Study|Progressive disease|12|||
163465897|NCT02807844|590403358|FG002|Overall Study|Progressive disease|8|||
163465898|NCT02807844|590403359|FG003|Overall Study|Progressive disease|8|||
163465899|NCT02807844|590403360|FG004|Overall Study|Progressive disease|3|||
163465900|NCT02807844|590403361|FG005|Overall Study|Progressive disease|8|||
163465901|NCT02807844|590403362|FG006|Overall Study|Progressive disease|14|||
163465902|NCT02807844|590403363|FG007|Overall Study|Progressive disease|17|||
163465903|NCT02807844|590403364|FG008|Overall Study|Progressive disease|19|||
163465904|NCT02807844|590403365|FG009|Overall Study|Progressive disease|15|||
163465905|NCT02807844|590403356|FG000|Overall Study|Adverse Event|1|||
163465906|NCT02807844|590403357|FG001|Overall Study|Adverse Event|0|||
163465907|NCT02807844|590403358|FG002|Overall Study|Adverse Event|0|||
163465908|NCT02807844|590403359|FG003|Overall Study|Adverse Event|0|||
163465909|NCT02807844|590403360|FG004|Overall Study|Adverse Event|1|||
163465910|NCT02807844|590403361|FG005|Overall Study|Adverse Event|1|||
163465911|NCT02807844|590403362|FG006|Overall Study|Adverse Event|1|||
163465912|NCT02807844|590403363|FG007|Overall Study|Adverse Event|1|||
163465913|NCT02807844|590403364|FG008|Overall Study|Adverse Event|1|||
163465914|NCT02807844|590403365|FG009|Overall Study|Adverse Event|2|||
163465915|NCT00108953|590403372|FG000|Follow-up|Death|18|||
163465916|NCT00108953|590403373|FG001|Follow-up|Death|26|||
163465917|NCT00108953|590403372|FG000|Follow-up|Lost to Follow-up|1|||
163465918|NCT00108953|590403373|FG001|Follow-up|Lost to Follow-up|1|||
163465919|NCT00108953|590403372|FG000|Follow-up|Study terminated by sponsor|10|||
163465920|NCT00108953|590403373|FG001|Follow-up|Study terminated by sponsor|6|||
163465921|NCT00293241|590403375|FG000|Overall Study|Lost to Follow-up|9|||
163465922|NCT00293241|590403376|FG001|Overall Study|Lost to Follow-up|16|||
163465923|NCT00293241|590403375|FG000|Overall Study|Physician Decision|23|||
163465924|NCT00293241|590403376|FG001|Overall Study|Physician Decision|17|||
163465925|NCT00293241|590403375|FG000|Overall Study|Withdrawal by Subject|4|||
163465926|NCT00293241|590403376|FG001|Overall Study|Withdrawal by Subject|8|||
163465927|NCT03803202|590403377|FG000|Overall Study|Other|0|||
163465928|NCT03803202|590403378|FG001|Overall Study|Other|1|||
163465929|NCT03803202|590403379|FG002|Overall Study|Other|0|||
163465930|NCT03803202|590403380|FG003|Overall Study|Other|0|||
163465931|NCT03803202|590403381|FG004|Overall Study|Other|0|||
163465932|NCT03803202|590403382|FG005|Overall Study|Other|0|||
163465933|NCT03803202|590403383|FG006|Overall Study|Other|0|||
163465934|NCT03803202|590403384|FG007|Overall Study|Other|0|||
163465935|NCT03803202|590403385|FG008|Overall Study|Other|0|||
163465936|NCT03803202|590403377|FG000|Overall Study|Death|0|||
163465937|NCT03803202|590403378|FG001|Overall Study|Death|0|||
163465938|NCT03803202|590403379|FG002|Overall Study|Death|0|||
163465939|NCT03803202|590403380|FG003|Overall Study|Death|0|||
163465940|NCT03803202|590403381|FG004|Overall Study|Death|0|||
163465941|NCT03803202|590403382|FG005|Overall Study|Death|1|||
163465942|NCT03803202|590403383|FG006|Overall Study|Death|0|||
163465943|NCT03803202|590403384|FG007|Overall Study|Death|0|||
163465944|NCT03803202|590403385|FG008|Overall Study|Death|0|||
163465945|NCT03803202|590403377|FG000|Overall Study|Withdrawal by Subject|0|||
163465946|NCT03803202|590403378|FG001|Overall Study|Withdrawal by Subject|0|||
163465947|NCT03803202|590403379|FG002|Overall Study|Withdrawal by Subject|1|||
163465948|NCT03803202|590403380|FG003|Overall Study|Withdrawal by Subject|0|||
163465949|NCT03803202|590403381|FG004|Overall Study|Withdrawal by Subject|0|||
163465950|NCT03803202|590403382|FG005|Overall Study|Withdrawal by Subject|0|||
163465951|NCT03803202|590403383|FG006|Overall Study|Withdrawal by Subject|0|||
163465952|NCT03803202|590403384|FG007|Overall Study|Withdrawal by Subject|1|||
163465953|NCT03803202|590403385|FG008|Overall Study|Withdrawal by Subject|0|||
163465954|NCT03803202|590403377|FG000|Overall Study|Lost to Follow-up|0|||
163465955|NCT03803202|590403378|FG001|Overall Study|Lost to Follow-up|0|||
163465956|NCT03803202|590403379|FG002|Overall Study|Lost to Follow-up|0|||
163465957|NCT03803202|590403380|FG003|Overall Study|Lost to Follow-up|1|||
163465958|NCT03803202|590403381|FG004|Overall Study|Lost to Follow-up|1|||
163465959|NCT03803202|590403382|FG005|Overall Study|Lost to Follow-up|0|||
163465960|NCT03803202|590403383|FG006|Overall Study|Lost to Follow-up|1|||
163465961|NCT03803202|590403384|FG007|Overall Study|Lost to Follow-up|0|||
163465962|NCT03803202|590403385|FG008|Overall Study|Lost to Follow-up|0|||
163465963|NCT03595384|590403386|FG000|Overall Study|Other time commitments|8|||
163465964|NCT03595384|590403386|FG000|Overall Study|Changes to session time|7|||
163465965|NCT03595384|590403386|FG000|Overall Study|Relocation out of country|1|||
163465966|NCT01125293|590403387|FG000|Overall Study|Disease Progression|1|||
163465967|NCT01125293|590403388|FG001|Overall Study|Disease Progression|3|||
163465968|NCT01125293|590403389|FG002|Overall Study|Disease Progression|4|||
163465969|NCT01125293|590403390|FG003|Overall Study|Disease Progression|3|||
163465970|NCT01125293|590403391|FG004|Overall Study|Disease Progression|5|||
163465971|NCT01125293|590403392|FG005|Overall Study|Disease Progression|12|||
163465972|NCT01125293|590403387|FG000|Overall Study|Adverse Event|1|||
163465973|NCT01125293|590403388|FG001|Overall Study|Adverse Event|0|||
163465974|NCT01125293|590403389|FG002|Overall Study|Adverse Event|0|||
163465975|NCT01125293|590403390|FG003|Overall Study|Adverse Event|0|||
163465976|NCT01125293|590403391|FG004|Overall Study|Adverse Event|2|||
163465977|NCT01125293|590403392|FG005|Overall Study|Adverse Event|8|||
163465978|NCT01125293|590403387|FG000|Overall Study|Symptomatic Deterioration|1|||
163465979|NCT01125293|590403388|FG001|Overall Study|Symptomatic Deterioration|0|||
163465980|NCT01125293|590403389|FG002|Overall Study|Symptomatic Deterioration|0|||
163465981|NCT01125293|590403390|FG003|Overall Study|Symptomatic Deterioration|0|||
163465982|NCT01125293|590403391|FG004|Overall Study|Symptomatic Deterioration|0|||
163465983|NCT01125293|590403392|FG005|Overall Study|Symptomatic Deterioration|0|||
163465984|NCT01125293|590403387|FG000|Overall Study|Death|0|||
163465985|NCT01125293|590403388|FG001|Overall Study|Death|0|||
163465986|NCT01125293|590403389|FG002|Overall Study|Death|0|||
163465987|NCT01125293|590403390|FG003|Overall Study|Death|0|||
163465988|NCT01125293|590403391|FG004|Overall Study|Death|1|||
163465989|NCT01125293|590403392|FG005|Overall Study|Death|0|||
163465990|NCT01125293|590403387|FG000|Overall Study|Withdrawal by Subject|0|||
163465991|NCT01125293|590403388|FG001|Overall Study|Withdrawal by Subject|0|||
163465992|NCT01125293|590403389|FG002|Overall Study|Withdrawal by Subject|0|||
163465993|NCT01125293|590403390|FG003|Overall Study|Withdrawal by Subject|0|||
163465994|NCT01125293|590403391|FG004|Overall Study|Withdrawal by Subject|2|||
163465995|NCT01125293|590403392|FG005|Overall Study|Withdrawal by Subject|1|||
163465996|NCT01125293|590403387|FG000|Overall Study|Physician Decision|0|||
163465997|NCT01125293|590403388|FG001|Overall Study|Physician Decision|0|||
163465998|NCT01125293|590403389|FG002|Overall Study|Physician Decision|0|||
163465999|NCT01125293|590403390|FG003|Overall Study|Physician Decision|0|||
163466000|NCT01125293|590403391|FG004|Overall Study|Physician Decision|0|||
163466001|NCT01125293|590403392|FG005|Overall Study|Physician Decision|2|||
163466002|NCT01270958|590403393|FG000|Overall Study|Lost to Follow-up|2|||
163466003|NCT01270958|590403393|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
163466004|NCT01406652|590403394|FG000|Overall Study|Lost-to-follow-up|3|||
163466005|NCT01406652|590403395|FG001|Overall Study|Lost-to-follow-up|4|||
163466006|NCT01406652|590403394|FG000|Overall Study|Withdrawal by Subject|2|||
163466007|NCT01406652|590403395|FG001|Overall Study|Withdrawal by Subject|2|||
163466008|NCT01406652|590403394|FG000|Overall Study|Insufficient follow-up|5|||
163466009|NCT01406652|590403395|FG001|Overall Study|Insufficient follow-up|4|||
163466010|NCT01406652|590403394|FG000|Overall Study|Infection not sure|10|||
163466011|NCT01406652|590403395|FG001|Overall Study|Infection not sure|10|||
163466012|NCT02228564|590403396|FG000|Overall Study|Withdrawal by Subject|10|||
163466013|NCT02228564|590403396|FG000|Overall Study|Death|11|||
163466014|NCT02228564|590403396|FG000|Overall Study|Physician Decision|5|||
163466015|NCT02228564|590403396|FG000|Overall Study|Lost to Follow-up|17|||
163466016|NCT02228564|590403396|FG000|Overall Study|Other|6|||
163466017|NCT02633046|590403398|FG000|Overall Study|Adverse Event|8|||
163466018|NCT02633046|590403398|FG000|Overall Study|Physician Decision|7|||
163466019|NCT02633046|590403398|FG000|Overall Study|Withdrawal by Subject|8|||
163466020|NCT02633046|590403398|FG000|Overall Study|Increased proteinuria|2|||
163466021|NCT02633046|590403398|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
163466022|NCT02633046|590403398|FG000|Overall Study|Mutual decision patient and physician|1|||
163466023|NCT02925312|590403399|FG000|Overall Study|Lost to Follow-up|25|||
163466024|NCT02925312|590403400|FG001|Overall Study|Lost to Follow-up|0|||
163466025|NCT02925312|590403399|FG000|Overall Study|Adverse Event|2|||
163466026|NCT02925312|590403400|FG001|Overall Study|Adverse Event|0|||
163466027|NCT02142504|590403401|FG000|Overall Study|Protocol Violation|2|||
163466028|NCT02142504|590403402|FG001|Overall Study|Protocol Violation|1|||
163466029|NCT02142504|590403403|FG002|Overall Study|Protocol Violation|2|||
163466030|NCT02142504|590403401|FG000|Overall Study|Adverse Event|2|||
163466031|NCT02142504|590403402|FG001|Overall Study|Adverse Event|3|||
163466032|NCT02142504|590403403|FG002|Overall Study|Adverse Event|4|||
163466033|NCT02142504|590403401|FG000|Overall Study|Lost to Follow-up|12|||
163466034|NCT02142504|590403402|FG001|Overall Study|Lost to Follow-up|19|||
163466035|NCT02142504|590403403|FG002|Overall Study|Lost to Follow-up|17|||
163466036|NCT02142504|590403401|FG000|Overall Study|Withdrawal by Subject|7|||
163466037|NCT02142504|590403402|FG001|Overall Study|Withdrawal by Subject|9|||
163466038|NCT02142504|590403403|FG002|Overall Study|Withdrawal by Subject|11|||
163466039|NCT02142504|590403401|FG000|Overall Study|Pregnancy|4|||
163466040|NCT02142504|590403402|FG001|Overall Study|Pregnancy|4|||
163466041|NCT02142504|590403403|FG002|Overall Study|Pregnancy|2|||
163466042|NCT02142504|590403401|FG000|Overall Study|Physician Decision|0|||
163466043|NCT02142504|590403402|FG001|Overall Study|Physician Decision|1|||
163466044|NCT02142504|590403403|FG002|Overall Study|Physician Decision|3|||
163466045|NCT02142504|590403401|FG000|Overall Study|Reason Not Specified|4|||
163466046|NCT02142504|590403402|FG001|Overall Study|Reason Not Specified|5|||
163466047|NCT02142504|590403403|FG002|Overall Study|Reason Not Specified|4|||
163466048|NCT04114539|590403411|FG000|Overall Study|Adverse Event|14|||
163466049|NCT04114539|590403411|FG000|Overall Study|Lost to Follow-up|2|||
163466050|NCT04114539|590403411|FG000|Overall Study|Non-compliance with Protocol|2|||
163466051|NCT04114539|590403411|FG000|Overall Study|Non-compliance with Study Drug|1|||
163466052|NCT04114539|590403411|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
163466053|NCT04114539|590403411|FG000|Overall Study|Withdrew consent|10|||
163466054|NCT04114539|590403411|FG000|Overall Study|Others not specified|5|||
163466055|NCT04114539|590403411|FG000|Overall Study|Investigator Decision|2|||
163466056|NCT00418717|590403420|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
163466057|NCT00418717|590403420|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
163466058|NCT01400139|590403421|FG000|HYD Core Study|Adverse Event|210|||
163466059|NCT01400139|590403421|FG000|HYD Core Study|Lack of Efficacy|59|||
163466060|NCT01400139|590403421|FG000|HYD Core Study|Withdrawal by Subject|114|||
163466061|NCT01400139|590403421|FG000|HYD Core Study|Lost to Follow-up|39|||
163466062|NCT01400139|590403421|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
163466063|NCT01400139|590403421|FG000|HYD Core Study|Administrative|56|||
163466064|NCT01400139|590403421|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
163466065|NCT01400139|590403421|FG000|HYD Extension Period|Adverse Event|8|||
163466066|NCT01400139|590403421|FG000|HYD Extension Period|Withdrawal by Subject|5|||
163466067|NCT01400139|590403421|FG000|HYD Extension Period|Administrative|10|||
163466068|NCT03136367|590403428|FG000|T1 Consultation|discontinued mistakenly included|2|||
163466069|NCT03136367|590403429|FG001|T1 Consultation|discontinued mistakenly included|6|||
163466070|NCT03136367|590403430|FG002|T1 Consultation|discontinued mistakenly included|1|||
163466071|NCT03136367|590403428|FG000|T1 Consultation|Discontinued other|0|||
163466072|NCT03136367|590403429|FG001|T1 Consultation|Discontinued other|1|||
163466073|NCT03136367|590403430|FG002|T1 Consultation|Discontinued other|0|||
163466074|NCT03136367|590403428|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
163466075|NCT03136367|590403429|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
163466076|NCT03136367|590403430|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
163466077|NCT03136367|590403428|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
163466078|NCT03136367|590403429|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
163466079|NCT03136367|590403430|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
163466080|NCT03136367|590403428|FG000|T2 Post-consultation|Discontinued other|0|||
163466081|NCT03136367|590403429|FG001|T2 Post-consultation|Discontinued other|2|||
163466082|NCT03136367|590403430|FG002|T2 Post-consultation|Discontinued other|6|||
163466083|NCT03136367|590403428|FG000|T2 Post-consultation|Discontinued transferred care|0|||
163466084|NCT03136367|590403429|FG001|T2 Post-consultation|Discontinued transferred care|0|||
163466085|NCT03136367|590403430|FG002|T2 Post-consultation|Discontinued transferred care|3|||
163466086|NCT03136367|590403428|FG000|T2 Post-consultation|Discontinued lost contact|0|||
163466087|NCT03136367|590403429|FG001|T2 Post-consultation|Discontinued lost contact|1|||
163466088|NCT03136367|590403430|FG002|T2 Post-consultation|Discontinued lost contact|0|||
163466089|NCT03136367|590403428|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
163466090|NCT03136367|590403429|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
163466091|NCT03136367|590403430|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
163466092|NCT03136367|590403428|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
163466093|NCT03136367|590403429|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
163466094|NCT03136367|590403430|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
163466095|NCT03136367|590403428|FG000|T3 1 Week After Surgery|other discontinued|2|||
163466096|NCT03136367|590403429|FG001|T3 1 Week After Surgery|other discontinued|4|||
163466097|NCT03136367|590403430|FG002|T3 1 Week After Surgery|other discontinued|3|||
163466098|NCT03136367|590403428|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
163466099|NCT03136367|590403429|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
163466100|NCT03136367|590403430|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
163466101|NCT03136367|590403428|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
163466102|NCT03136367|590403429|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
163466103|NCT03136367|590403430|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
163466104|NCT03136367|590403428|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
163466105|NCT03136367|590403429|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
163466106|NCT03136367|590403430|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
163466107|NCT03136367|590403428|FG000|T4 12 Weeks After Surgery|Death|0|||
163466108|NCT03136367|590403429|FG001|T4 12 Weeks After Surgery|Death|1|||
163466109|NCT03136367|590403430|FG002|T4 12 Weeks After Surgery|Death|3|||
163466110|NCT03136367|590403428|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
163466111|NCT03136367|590403429|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
163466112|NCT03136367|590403430|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
163466113|NCT03136367|590403428|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
163466114|NCT03136367|590403429|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
163466115|NCT03136367|590403430|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
163466116|NCT03136367|590403428|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
163466117|NCT03136367|590403429|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
163466118|NCT03136367|590403430|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
163466119|NCT03136367|590403428|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
163466120|NCT03136367|590403429|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
163466121|NCT03136367|590403430|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
163466122|NCT03136367|590403428|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
163466123|NCT03136367|590403429|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
163466124|NCT03136367|590403430|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
163466125|NCT03136367|590403428|FG000|T5 1 Year After Surgery|Death|0|||
163466126|NCT03136367|590403429|FG001|T5 1 Year After Surgery|Death|0|||
163466127|NCT03136367|590403430|FG002|T5 1 Year After Surgery|Death|1|||
163466128|NCT03136367|590403428|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
163466129|NCT03136367|590403429|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
163466130|NCT03136367|590403430|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
163466131|NCT03136367|590403428|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
163466132|NCT03136367|590403429|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
163466133|NCT03136367|590403430|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
163466134|NCT03136367|590403428|FG000|T5 1 Year After Surgery|study ended before due|31|||
163466135|NCT03136367|590403429|FG001|T5 1 Year After Surgery|study ended before due|103|||
163466136|NCT03136367|590403430|FG002|T5 1 Year After Surgery|study ended before due|110|||
163466137|NCT03136367|590403428|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
163466138|NCT03136367|590403429|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
163466139|NCT03136367|590403430|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
163466140|NCT01544478|590405660|FG000|Overall Study|Adverse Event|1|||
163466141|NCT01544478|590405660|FG000|Overall Study|Death|1|||
163466142|NCT01544478|590405660|FG000|Overall Study|Lost to Follow-up|48|||
163466143|NCT01544478|590405660|FG000|Overall Study|Physician Decision|15|||
163466144|NCT01544478|590405660|FG000|Overall Study|Pregnancy|1|||
163466145|NCT01544478|590405660|FG000|Overall Study|Withdrawal by Subject|52|||
163466146|NCT00212758|590405661|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
163466147|NCT00212758|590405662|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
163466148|NCT00212758|590405661|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
163466149|NCT00212758|590405662|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
163466150|NCT00446641|590405666|FG000|Overall Study|Withdrawal by Subject|8|||
163466151|NCT00446641|590405667|FG001|Overall Study|Withdrawal by Subject|3|||
163466152|NCT00446641|590405666|FG000|Overall Study|poor compliance|8|||
163466153|NCT00446641|590405667|FG001|Overall Study|poor compliance|6|||
163466154|NCT00446641|590405666|FG000|Overall Study|Lost to Follow-up|1|||
163466155|NCT00446641|590405667|FG001|Overall Study|Lost to Follow-up|1|||
163466156|NCT00086385|590405670|FG000|Overall Study|Death|2|||
163466157|NCT00086385|590405671|FG001|Overall Study|Death|2|||
163466158|NCT00086385|590405672|FG002|Overall Study|Death|1|||
163466159|NCT00086385|590405673|FG003|Overall Study|Death|1|||
163466160|NCT04038385|590405674|FG000|Overall Study|Completed baseline assessment only|7|||
163466161|NCT04038385|590405675|FG001|Overall Study|Completed baseline assessment only|4|||
163466162|NCT04038385|590405674|FG000|Overall Study|Moved out of area|4|||
163466163|NCT04038385|590405675|FG001|Overall Study|Moved out of area|2|||
163466164|NCT04038385|590405674|FG000|Overall Study|Discontinued study involvement|6|||
163466165|NCT04038385|590405675|FG001|Overall Study|Discontinued study involvement|1|||
163466166|NCT00402285|590405682|FG000|Overall Study|insufficient RNA quality|7|||
163466167|NCT00402285|590405683|FG001|Overall Study|insufficient RNA quality|6|||
163466168|NCT00402285|590405684|FG002|Overall Study|insufficient RNA quality|2|||
163466169|NCT00405275|590405687|FG000|Overall Study|Death|1|||
163466170|NCT00405275|590405688|FG001|Overall Study|Death|0|||
163466171|NCT00405275|590405687|FG000|Overall Study|Lost to Follow-up|5|||
163466172|NCT00405275|590405688|FG001|Overall Study|Lost to Follow-up|1|||
163466173|NCT00405275|590405687|FG000|Overall Study|Withdrawal by Subject|7|||
163466174|NCT00405275|590405688|FG001|Overall Study|Withdrawal by Subject|9|||
163466175|NCT00405275|590405687|FG000|Overall Study|Unwilling to continue|10|||
163466176|NCT00405275|590405688|FG001|Overall Study|Unwilling to continue|9|||
163466177|NCT00784459|590405689|FG000|Overall Study|Adverse Event|0|||
163466178|NCT00784459|590405690|FG001|Overall Study|Adverse Event|2|||
163466179|NCT00088595|590405691|FG000|Overall Study|Adverse Event|11|||
163466180|NCT00088595|590405691|FG000|Overall Study|Withdrawal by Subject|8|||
163466181|NCT00088595|590405691|FG000|Overall Study|Ongoing (After Core)|7|||
163466182|NCT00088595|590405691|FG000|Overall Study|New Cancer Therapy|2|||
163466183|NCT02959970|590405706|FG000|Overall Study|Adverse Event|1|||
163466184|NCT02959970|590405707|FG001|Overall Study|Adverse Event|0|||
163466185|NCT02959970|590405706|FG000|Overall Study|Withdrawal by Subject|0|||
163466186|NCT02959970|590405707|FG001|Overall Study|Withdrawal by Subject|2|||
163466187|NCT02959970|590405706|FG000|Overall Study|Lost to Follow-up|1|||
163466188|NCT02959970|590405707|FG001|Overall Study|Lost to Follow-up|5|||
163466189|NCT01473355|590405712|FG000|Overall Study|Protocol Violation|2|||
163466190|NCT01473355|590405712|FG000|Overall Study|Adverse Event|2|||
163466191|NCT01473355|590405712|FG000|Overall Study|Lost to Follow-up|2|||
163466192|NCT02603172|590405721|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
163466193|NCT02603172|590405722|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
163466194|NCT02603172|590405723|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
163466195|NCT02603172|590405724|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
163466196|NCT02603172|590405725|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
163466197|NCT02603172|590405726|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
163466198|NCT02603172|590405727|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
163466199|NCT02603172|590405728|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
163466200|NCT00863317|590405729|FG000|Overall Study|Lost to Follow-up|8|||
163466201|NCT00863317|590405730|FG001|Overall Study|Lost to Follow-up|9|||
163466202|NCT00441727|590405731|FG000|Overall Study|Protocol Violation|19|||
163466203|NCT00441727|590405732|FG001|Overall Study|Protocol Violation|28|||
163466204|NCT00441727|590405733|FG002|Overall Study|Protocol Violation|32|||
163466205|NCT00441727|590405731|FG000|Overall Study|Adverse Event|26|||
163466206|NCT00441727|590405732|FG001|Overall Study|Adverse Event|33|||
163466207|NCT00441727|590405733|FG002|Overall Study|Adverse Event|28|||
163466208|NCT00441727|590405731|FG000|Overall Study|Lack of Efficacy|7|||
163466209|NCT00441727|590405732|FG001|Overall Study|Lack of Efficacy|8|||
163466210|NCT00441727|590405733|FG002|Overall Study|Lack of Efficacy|48|||
163466211|NCT00441727|590405731|FG000|Overall Study|Withdrawal by Subject|40|||
163466212|NCT00441727|590405732|FG001|Overall Study|Withdrawal by Subject|34|||
163466213|NCT00441727|590405733|FG002|Overall Study|Withdrawal by Subject|47|||
163466214|NCT00441727|590405731|FG000|Overall Study|Lost to Follow-up|5|||
163466215|NCT00441727|590405732|FG001|Overall Study|Lost to Follow-up|6|||
163466216|NCT00441727|590405733|FG002|Overall Study|Lost to Follow-up|5|||
163466217|NCT00441727|590405731|FG000|Overall Study|Safety Reasons|3|||
163466218|NCT00441727|590405732|FG001|Overall Study|Safety Reasons|1|||
163466219|NCT00441727|590405733|FG002|Overall Study|Safety Reasons|3|||
163466220|NCT00441727|590405731|FG000|Overall Study|Various reason specified|6|||
163466221|NCT00441727|590405732|FG001|Overall Study|Various reason specified|8|||
163466222|NCT00441727|590405733|FG002|Overall Study|Various reason specified|5|||
163466223|NCT03417505|590405736|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
163466224|NCT03417505|590405737|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
163466225|NCT02133001|590405738|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
163466226|NCT02133001|590405739|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
163466227|NCT02133001|590405738|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
163466228|NCT02133001|590405739|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
163466229|NCT02133001|590405738|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
163466230|NCT02133001|590405739|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
163466231|NCT02133001|590405738|FG000|Double Blind (Day 1-25)|Other|2|||
163466232|NCT02133001|590405739|FG001|Double Blind (Day 1-25)|Other|2|||
163466233|NCT02133001|590405738|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
163466234|NCT02133001|590405739|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
163466235|NCT02133001|590405738|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
163466236|NCT02133001|590405739|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
163466237|NCT02133001|590405738|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
163466238|NCT02133001|590405739|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
163466239|NCT02133001|590405738|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
163466240|NCT02133001|590405739|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
163466241|NCT04211961|590405740|FG000|Overall Study|Death|0|||
163466242|NCT04211961|590405741|FG001|Overall Study|Death|1|||
163466243|NCT04211961|590405740|FG000|Overall Study|Lost to Follow-up|0|||
163466244|NCT04211961|590405741|FG001|Overall Study|Lost to Follow-up|1|||
163466245|NCT04211961|590405740|FG000|Overall Study|Withdrawal by Subject|0|||
163466246|NCT04211961|590405741|FG001|Overall Study|Withdrawal by Subject|1|||
163466247|NCT03235726|590405742|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
163466248|NCT03235726|590405743|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
163466249|NCT03235726|590405744|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
163466250|NCT03235726|590405745|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
163466251|NCT03235726|590405746|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
163466252|NCT03235726|590405747|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
163466253|NCT03235726|590405748|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
163466254|NCT03235726|590405749|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
163466255|NCT03235726|590405750|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
163466256|NCT03235726|590405751|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
163466257|NCT03235726|590405742|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
163466258|NCT03235726|590405743|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
163466259|NCT03235726|590405744|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
163466260|NCT03235726|590405745|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
163466261|NCT03235726|590405746|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
163466262|NCT03235726|590405747|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
163466263|NCT03235726|590405748|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
163466264|NCT03235726|590405749|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
163466265|NCT03235726|590405750|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
163466266|NCT03235726|590405751|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
163466267|NCT00268463|590405752|FG000|Overall Study|study terminated due to low accrual|10|||
163466268|NCT00268463|590405753|FG001|Overall Study|study terminated due to low accrual|12|||
163466269|NCT04685538|590405754|FG000|Overall Study|Adverse Event|0|||
163466270|NCT04685538|590405755|FG001|Overall Study|Adverse Event|1|||
163466271|NCT04685538|590405754|FG000|Overall Study|Lost to Follow-up|0|||
163466272|NCT04685538|590405755|FG001|Overall Study|Lost to Follow-up|2|||
163466273|NCT01040845|590405756|FG000|Overall Study|Withdrawal by Subject|1|||
163466274|NCT01040845|590405757|FG001|Overall Study|Withdrawal by Subject|1|||
163466275|NCT01040845|590405756|FG000|Overall Study|Physician Decision|1|||
163466276|NCT01040845|590405757|FG001|Overall Study|Physician Decision|0|||
163466277|NCT04362813|590405758|FG000|Overall Study|Death|12|||
163466278|NCT04362813|590405759|FG001|Overall Study|Death|16|||
163466279|NCT04362813|590405758|FG000|Overall Study|Withdrawal by Subject|3|||
163466280|NCT04362813|590405759|FG001|Overall Study|Withdrawal by Subject|1|||
163466281|NCT04362813|590405758|FG000|Overall Study|Protocol Violation|0|||
163466282|NCT04362813|590405759|FG001|Overall Study|Protocol Violation|3|||
163466283|NCT04362813|590405758|FG000|Overall Study|Lost to Follow-up|1|||
163466284|NCT04362813|590405759|FG001|Overall Study|Lost to Follow-up|1|||
163466285|NCT04362813|590405758|FG000|Overall Study|Enrolled but did not receive treatment|2|||
163466286|NCT04362813|590405759|FG001|Overall Study|Enrolled but did not receive treatment|4|||
163466287|NCT01732107|590405763|FG000|Overall Study|Adverse Event|2|||
163466288|NCT01732107|590405763|FG000|Overall Study|Disease Progression|8|||
163466289|NCT01732107|590405763|FG000|Overall Study|Physician Decision|1|||
163466290|NCT01732107|590405763|FG000|Overall Study|Withdrawal by Subject|2|||
163466291|NCT04445688|590405765|FG000|Washout (One Week)|Adverse Event|2|||
163466292|NCT04445688|590405765|FG000|Washout (One Week)|Withdrawal by Subject|1|||
163466293|NCT00918346|590405767|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
163466294|NCT00918346|590405768|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
163466295|NCT04083794|590405769|FG000|Overall Study|Lost to Follow-up|9|||
163466296|NCT00224003|590405776|FG000|Overall Study|Adverse Event|1|||
163466297|NCT00224003|590405776|FG000|Overall Study|Protocol Violation|2|||
163466298|NCT00224003|590405776|FG000|Overall Study|Withdrawal by Subject|1|||
163466299|NCT00224003|590405776|FG000|Overall Study|unk|3|||
163466300|NCT03549429|590405777|FG000|Overall Study|Protocol Violation|5|||
163466301|NCT03549429|590405778|FG001|Overall Study|Protocol Violation|3|||
163466302|NCT00729326|590405786|FG000|Overall Study|Lost to Follow-up|2|||
163466303|NCT00729326|590405787|FG001|Overall Study|Lost to Follow-up|0|||
163466304|NCT00729326|590405786|FG000|Overall Study|Physician Decision|0|||
163466305|NCT00729326|590405787|FG001|Overall Study|Physician Decision|1|||
163466306|NCT00729326|590405786|FG000|Overall Study|Protocol Violation|3|||
163466307|NCT00729326|590405787|FG001|Overall Study|Protocol Violation|2|||
163466308|NCT00729326|590405786|FG000|Overall Study|Subject Decision|4|||
163466309|NCT00729326|590405787|FG001|Overall Study|Subject Decision|4|||
163466310|NCT00729326|590405786|FG000|Overall Study|Sponsor Decision|1|||
163466311|NCT00729326|590405787|FG001|Overall Study|Sponsor Decision|2|||
163466312|NCT01235728|590405790|FG000|Overall Study|Protocol Violation|0|||
163466313|NCT01235728|590405791|FG001|Overall Study|Protocol Violation|0|||
163466314|NCT01235728|590405792|FG002|Overall Study|Protocol Violation|0|||
163466315|NCT01235728|590405793|FG003|Overall Study|Protocol Violation|1|||
163466316|NCT01235728|590405794|FG004|Overall Study|Protocol Violation|0|||
163466317|NCT01235728|590405795|FG005|Overall Study|Protocol Violation|0|||
163466318|NCT01235728|590405796|FG006|Overall Study|Protocol Violation|0|||
163466319|NCT01235728|590405797|FG007|Overall Study|Protocol Violation|0|||
163466320|NCT01000025|590405798|FG000|Overall Study|Adverse Event|43|||
163466321|NCT01000025|590405799|FG001|Overall Study|Adverse Event|2|||
163466322|NCT01000025|590405798|FG000|Overall Study|Withdrawal by Subject|13|||
163466323|NCT01000025|590405799|FG001|Overall Study|Withdrawal by Subject|8|||
163466324|NCT01000025|590405798|FG000|Overall Study|Death|23|||
163466325|NCT01000025|590405799|FG001|Overall Study|Death|13|||
163466326|NCT01000025|590405798|FG000|Overall Study|Lack of Efficacy|363|||
163466327|NCT01000025|590405799|FG001|Overall Study|Lack of Efficacy|208|||
163466328|NCT01000025|590405798|FG000|Overall Study|Intercurrent Illness|26|||
163466329|NCT01000025|590405799|FG001|Overall Study|Intercurrent Illness|7|||
163466330|NCT04423757|590405800|FG000|Overall Study|Adverse Event|2|||
163466331|NCT04423757|590405801|FG001|Overall Study|Adverse Event|0|||
163466332|NCT04423757|590405800|FG000|Overall Study|Not treated|1|||
163466333|NCT04423757|590405801|FG001|Overall Study|Not treated|1|||
163466334|NCT01202760|590405802|FG000|Overall Study|Entry Criteria Not Met|0|||
163466335|NCT01202760|590405803|FG001|Overall Study|Entry Criteria Not Met|3|||
163466336|NCT01202760|590405804|FG002|Overall Study|Entry Criteria Not Met|1|||
163466337|NCT01202760|590405802|FG000|Overall Study|Adverse Event|11|||
163466338|NCT01202760|590405803|FG001|Overall Study|Adverse Event|9|||
163466339|NCT01202760|590405804|FG002|Overall Study|Adverse Event|10|||
163466340|NCT01202760|590405802|FG000|Overall Study|Death|2|||
163466341|NCT01202760|590405803|FG001|Overall Study|Death|1|||
163466342|NCT01202760|590405804|FG002|Overall Study|Death|0|||
163466343|NCT01202760|590405802|FG000|Overall Study|Lack of Efficacy|6|||
163466344|NCT01202760|590405803|FG001|Overall Study|Lack of Efficacy|8|||
163466345|NCT01202760|590405804|FG002|Overall Study|Lack of Efficacy|7|||
163466346|NCT01202760|590405802|FG000|Overall Study|Lost to Follow-up|0|||
163466347|NCT01202760|590405803|FG001|Overall Study|Lost to Follow-up|2|||
163466348|NCT01202760|590405804|FG002|Overall Study|Lost to Follow-up|1|||
163466349|NCT01202760|590405802|FG000|Overall Study|Parent / Caregiver Decision|0|||
163466350|NCT01202760|590405803|FG001|Overall Study|Parent / Caregiver Decision|1|||
163466351|NCT01202760|590405804|FG002|Overall Study|Parent / Caregiver Decision|0|||
163466352|NCT01202760|590405802|FG000|Overall Study|Withdrawal by Subject|17|||
163466353|NCT01202760|590405803|FG001|Overall Study|Withdrawal by Subject|18|||
163466354|NCT01202760|590405804|FG002|Overall Study|Withdrawal by Subject|14|||
163466355|NCT01202760|590405802|FG000|Overall Study|Physician Decision|0|||
163466356|NCT01202760|590405803|FG001|Overall Study|Physician Decision|1|||
163466357|NCT01202760|590405804|FG002|Overall Study|Physician Decision|0|||
163466358|NCT01202760|590405802|FG000|Overall Study|Protocol Violation|7|||
163466359|NCT01202760|590405803|FG001|Overall Study|Protocol Violation|5|||
163466360|NCT01202760|590405804|FG002|Overall Study|Protocol Violation|2|||
163466361|NCT01202760|590405802|FG000|Overall Study|Sponsor Decision|4|||
163466362|NCT01202760|590405803|FG001|Overall Study|Sponsor Decision|4|||
163466363|NCT01202760|590405804|FG002|Overall Study|Sponsor Decision|0|||
163466364|NCT01654523|590405805|FG000|Overall Study|Withdrawal by Subject|1|||
163466365|NCT02810951|590405806|FG000|Overall Study|Adverse Event|1|||
163466366|NCT01575899|590405807|FG000|Overall Study|Lost to Follow-up|3|||
163466367|NCT01575899|590405808|FG001|Overall Study|Lost to Follow-up|4|||
163466368|NCT01575899|590405809|FG002|Overall Study|Lost to Follow-up|2|||
163466369|NCT01575899|590405807|FG000|Overall Study|Protocol Violation|2|||
163466370|NCT01575899|590405808|FG001|Overall Study|Protocol Violation|1|||
163466371|NCT01575899|590405809|FG002|Overall Study|Protocol Violation|0|||
163466372|NCT03097029|590405810|FG000|Overall Study|Withdrawal by Subject|1|||
163466373|NCT00709124|590405811|FG000|Overall Study|Death|3|||
163466374|NCT00709124|590405812|FG001|Overall Study|Death|1|||
163466375|NCT00709124|590405811|FG000|Overall Study|encephalopathy; can't do assessment|1|||
163466376|NCT00709124|590405812|FG001|Overall Study|encephalopathy; can't do assessment|0|||
163466377|NCT00373490|590405813|FG000|Overall Study|Adverse Event|0|||
163466378|NCT00373490|590405814|FG001|Overall Study|Adverse Event|1|||
163466379|NCT00373490|590405813|FG000|Overall Study|Lack of Efficacy|9|||
163466380|NCT00373490|590405814|FG001|Overall Study|Lack of Efficacy|4|||
163466381|NCT00373490|590405813|FG000|Overall Study|Withdrawal by Subject|0|||
163466382|NCT00373490|590405814|FG001|Overall Study|Withdrawal by Subject|1|||
163466383|NCT01250756|590405815|FG000|Infant Series|Withdrawal by Subject|4|||
163466384|NCT01250756|590405816|FG001|Infant Series|Withdrawal by Subject|5|||
163466385|NCT01250756|590405815|FG000|Infant Series|Randomized, Not Vaccinated|2|||
163466386|NCT01250756|590405816|FG001|Infant Series|Randomized, Not Vaccinated|2|||
163466387|NCT01250756|590405815|FG000|Infant Series|Other|22|||
163466388|NCT01250756|590405816|FG001|Infant Series|Other|0|||
163466389|NCT01250756|590405815|FG000|After Infant Series|Adverse Event|5|||
163466390|NCT01250756|590405816|FG001|After Infant Series|Adverse Event|2|||
163466391|NCT01250756|590405815|FG000|After Infant Series|Withdrawal by Subject|4|||
163466392|NCT01250756|590405816|FG001|After Infant Series|Withdrawal by Subject|1|||
163466393|NCT01250756|590405815|FG000|After Infant Series|Other|2|||
163466394|NCT01250756|590405816|FG001|After Infant Series|Other|1|||
163466395|NCT01250756|590405815|FG000|Toddler Dose|Adverse Event|0|||
163466396|NCT01250756|590405816|FG001|Toddler Dose|Adverse Event|1|||
163466397|NCT01250756|590405815|FG000|After Toddler Dose|Adverse Event|0|||
163466398|NCT01250756|590405816|FG001|After Toddler Dose|Adverse Event|1|||
163466399|NCT00753688|590405817|FG000|Overall Study|Death|102|||
163466400|NCT00753688|590405818|FG001|Overall Study|Death|203|||
163466401|NCT00753688|590405817|FG000|Overall Study|Missing|4|||
163466402|NCT00753688|590405818|FG001|Overall Study|Missing|9|||
163466403|NCT00753688|590405817|FG000|Overall Study|Participant Withdrew Consent|2|||
163466404|NCT00753688|590405818|FG001|Overall Study|Participant Withdrew Consent|2|||
163466405|NCT00753688|590405817|FG000|Overall Study|Ongoing - in Follow-up|15|||
163466406|NCT00753688|590405818|FG001|Overall Study|Ongoing - in Follow-up|31|||
163466407|NCT00753688|590405817|FG000|Overall Study|Adverse Event|0|||
163466408|NCT00753688|590405818|FG001|Overall Study|Adverse Event|1|||
163466409|NCT02999100|590405821|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
163466410|NCT02999100|590405822|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
163466411|NCT02999100|590405823|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
163466412|NCT02999100|590405824|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
163466413|NCT02999100|590405825|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
163466414|NCT02999100|590405826|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
163466415|NCT02999100|590405821|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
163466416|NCT02999100|590405822|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
163466417|NCT02999100|590405823|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
163466418|NCT02999100|590405824|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
163466419|NCT02999100|590405825|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
163466420|NCT02999100|590405826|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
163466421|NCT02999100|590405821|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
163466422|NCT02999100|590405822|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
163466423|NCT02999100|590405823|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
163466424|NCT02999100|590405824|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
163466425|NCT02999100|590405825|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
163466426|NCT02999100|590405826|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
163466427|NCT01455415|590405829|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
163466428|NCT01455415|590405830|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
163466429|NCT01455415|590405829|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
163466430|NCT01455415|590405830|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
163466431|NCT01455415|590405829|FG000|Period 1|Drug Error not Associated to AE|0|||
163466432|NCT01455415|590405830|FG001|Period 1|Drug Error not Associated to AE|1|||
163466433|NCT01455415|590405829|FG000|Period 1|AE Not Related to Study Drug|2|||
163466434|NCT01455415|590405830|FG001|Period 1|AE Not Related to Study Drug|6|||
163466435|NCT01455415|590405829|FG000|Period 1|Withdrawal by Subject|4|||
163466436|NCT01455415|590405830|FG001|Period 1|Withdrawal by Subject|5|||
163466437|NCT01455415|590405829|FG000|Period 1|Unspecified Reason|1|||
163466438|NCT01455415|590405830|FG001|Period 1|Unspecified Reason|1|||
163466439|NCT01455415|590405829|FG000|Period 1|Protocol Violation|0|||
163466440|NCT01455415|590405830|FG001|Period 1|Protocol Violation|2|||
163466441|NCT01455415|590405829|FG000|Washout|AE Related to Study Drug|2|||
163466442|NCT01455415|590405830|FG001|Washout|AE Related to Study Drug|0|||
163466443|NCT01455415|590405829|FG000|Washout|Lost to Follow-up|1|||
163466444|NCT01455415|590405830|FG001|Washout|Lost to Follow-up|0|||
163466445|NCT01455415|590405829|FG000|Washout|Drug Error not Associated to AE|2|||
163466446|NCT01455415|590405830|FG001|Washout|Drug Error not Associated to AE|1|||
163466447|NCT01455415|590405829|FG000|Washout|AE Not Related to Study Drug|2|||
163466448|NCT01455415|590405830|FG001|Washout|AE Not Related to Study Drug|3|||
163466449|NCT01455415|590405829|FG000|Washout|Unspecified Reason|1|||
163466450|NCT01455415|590405830|FG001|Washout|Unspecified Reason|2|||
163466451|NCT01455415|590405829|FG000|Washout|Protocol Violation|0|||
163466452|NCT01455415|590405830|FG001|Washout|Protocol Violation|1|||
163466453|NCT01455415|590405829|FG000|Period 2|AE Related to Study Drug|1|||
163466454|NCT01455415|590405830|FG001|Period 2|AE Related to Study Drug|2|||
163466455|NCT01455415|590405829|FG000|Period 2|Lost to Follow-up|2|||
163466456|NCT01455415|590405830|FG001|Period 2|Lost to Follow-up|1|||
163466457|NCT01455415|590405829|FG000|Period 2|AE Not Related to Study Drug|2|||
163466458|NCT01455415|590405830|FG001|Period 2|AE Not Related to Study Drug|1|||
163466459|NCT01455415|590405829|FG000|Period 2|Lack of Efficacy|2|||
163466460|NCT01455415|590405830|FG001|Period 2|Lack of Efficacy|0|||
163466461|NCT01455415|590405829|FG000|Period 2|Withdrawal by Subject|2|||
163466462|NCT01455415|590405830|FG001|Period 2|Withdrawal by Subject|3|||
163466463|NCT01455415|590405829|FG000|Period 2|Unspecified Reason|2|||
163466464|NCT01455415|590405830|FG001|Period 2|Unspecified Reason|3|||
163466465|NCT01455415|590405829|FG000|Period 2|Protocol Violation|2|||
163466466|NCT01455415|590405830|FG001|Period 2|Protocol Violation|0|||
163466467|NCT01455415|590405829|FG000|Follow-up|AE Related to Study Drug|0|||
163466468|NCT01455415|590405830|FG001|Follow-up|AE Related to Study Drug|1|||
163466469|NCT01455415|590405829|FG000|Follow-up|Lack of Efficacy|0|||
163466470|NCT01455415|590405830|FG001|Follow-up|Lack of Efficacy|1|||
163466471|NCT01455415|590405829|FG000|Follow-up|Withdrawal by Subject|2|||
163466472|NCT01455415|590405830|FG001|Follow-up|Withdrawal by Subject|0|||
163466473|NCT01455415|590405829|FG000|Follow-up|Unspecified Reason|1|||
163466474|NCT01455415|590405830|FG001|Follow-up|Unspecified Reason|0|||
163466475|NCT00587301|590405831|FG000|Overall Study|Screen Failure|9|||
163466476|NCT00587301|590405831|FG000|Overall Study|Lost to Follow-up|22|||
163466477|NCT00587301|590405831|FG000|Overall Study|Withdrawal by Subject|7|||
163466478|NCT00587301|590405831|FG000|Overall Study|Protocol Violation|7|||
163466479|NCT00719537|590405833|FG000|Overall Study|Withdrawal by Subject|1|||
163466480|NCT00719537|590405834|FG001|Overall Study|Withdrawal by Subject|0|||
163466481|NCT00719537|590405833|FG000|Overall Study|Lost to Follow-up|0|||
163466482|NCT00719537|590405834|FG001|Overall Study|Lost to Follow-up|1|||
163466483|NCT02460978|590405835|FG000|Overall Study|Adverse Event|17|||
163466484|NCT02460978|590405836|FG001|Overall Study|Adverse Event|11|||
163466485|NCT02460978|590405837|FG002|Overall Study|Adverse Event|11|||
163466486|NCT02460978|590405835|FG000|Overall Study|Withdrawal by Subject|5|||
163466487|NCT02460978|590405836|FG001|Overall Study|Withdrawal by Subject|5|||
163466488|NCT02460978|590405837|FG002|Overall Study|Withdrawal by Subject|14|||
163466489|NCT02460978|590405835|FG000|Overall Study|Lost to Follow-up|2|||
163466490|NCT02460978|590405836|FG001|Overall Study|Lost to Follow-up|3|||
163466491|NCT02460978|590405837|FG002|Overall Study|Lost to Follow-up|1|||
163466492|NCT02460978|590405835|FG000|Overall Study|Protocol Violation|1|||
163466493|NCT02460978|590405836|FG001|Overall Study|Protocol Violation|1|||
163466494|NCT02460978|590405837|FG002|Overall Study|Protocol Violation|1|||
163466495|NCT02460978|590405835|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
163466496|NCT02460978|590405836|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
163466497|NCT02460978|590405837|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
163466498|NCT02460978|590405835|FG000|Overall Study|Pregnancy|0|||
163466499|NCT02460978|590405836|FG001|Overall Study|Pregnancy|0|||
163466500|NCT02460978|590405837|FG002|Overall Study|Pregnancy|2|||
163466501|NCT00994162|590405838|FG000|Overall Study|Withdrawal by Subject|1|||
163466502|NCT00994162|590405838|FG000|Overall Study|Lost to Follow-up|2|||
163466503|NCT00994162|590405838|FG000|Overall Study|Product Complaint|1|||
163466504|NCT00994162|590405838|FG000|Overall Study|Poor Compliance|5|||
163466505|NCT00994162|590405838|FG000|Overall Study|Lack of Response|3|||
163466506|NCT00994162|590405838|FG000|Overall Study|Discharged from Hospital|4|||
163466507|NCT00994162|590405838|FG000|Overall Study|Death|2|||
163466508|NCT00994162|590405838|FG000|Overall Study|Care Transferred to Another Physician|2|||
163466509|NCT00994162|590405838|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
163466510|NCT00994162|590405838|FG000|Overall Study|Physician Decision|2|||
163466511|NCT00994162|590405838|FG000|Overall Study|Surrounding Wound Erythematous|1|||
163466512|NCT00994162|590405838|FG000|Overall Study|Machine Losing Vaccum|1|||
163466513|NCT00994162|590405838|FG000|Overall Study|Patient Lived Too Far Away|1|||
163466514|NCT00994162|590405838|FG000|Overall Study|Above Knee Amputation|1|||
163466515|NCT00994162|590405838|FG000|Overall Study|Reason Not Reported By Site|1|||
163466516|NCT01142193|590405839|FG000|Overall Study|Adverse Event|12|||
163466517|NCT01142193|590405840|FG001|Overall Study|Adverse Event|4|||
163466518|NCT01142193|590405839|FG000|Overall Study|Lack of Efficacy|2|||
163466519|NCT01142193|590405840|FG001|Overall Study|Lack of Efficacy|1|||
163466520|NCT01142193|590405839|FG000|Overall Study|Physician Decision|1|||
163466521|NCT01142193|590405840|FG001|Overall Study|Physician Decision|1|||
163466522|NCT01142193|590405839|FG000|Overall Study|Withdrawal by Subject|4|||
163466523|NCT01142193|590405840|FG001|Overall Study|Withdrawal by Subject|3|||
163466524|NCT01142193|590405839|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
163466525|NCT01142193|590405840|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
163466526|NCT01142193|590405839|FG000|Overall Study|Other|1|||
163466527|NCT01142193|590405840|FG001|Overall Study|Other|2|||
163466528|NCT00910728|590405843|FG000|Overall Study|Lack of Efficacy|2|||
163466529|NCT00910728|590405844|FG001|Overall Study|Lack of Efficacy|3|||
163466530|NCT00910728|590405845|FG002|Overall Study|Lack of Efficacy|1|||
163466531|NCT00910728|590405846|FG003|Overall Study|Lack of Efficacy|2|||
163466532|NCT00910728|590405847|FG004|Overall Study|Lack of Efficacy|1|||
163466533|NCT00910728|590405848|FG005|Overall Study|Lack of Efficacy|0|||
163466534|NCT00910728|590405849|FG006|Overall Study|Lack of Efficacy|2|||
163466535|NCT00910728|590405850|FG007|Overall Study|Lack of Efficacy|2|||
163466536|NCT00910728|590405851|FG008|Overall Study|Lack of Efficacy|2|||
163466537|NCT00910728|590405843|FG000|Overall Study|Withdrawal by Subject|0|||
163466538|NCT00910728|590405844|FG001|Overall Study|Withdrawal by Subject|0|||
163466539|NCT00910728|590405845|FG002|Overall Study|Withdrawal by Subject|0|||
163466540|NCT00910728|590405846|FG003|Overall Study|Withdrawal by Subject|0|||
163466541|NCT00910728|590405847|FG004|Overall Study|Withdrawal by Subject|3|||
163466542|NCT00910728|590405848|FG005|Overall Study|Withdrawal by Subject|1|||
163466543|NCT00910728|590405849|FG006|Overall Study|Withdrawal by Subject|2|||
163466544|NCT00910728|590405850|FG007|Overall Study|Withdrawal by Subject|0|||
163466545|NCT00910728|590405851|FG008|Overall Study|Withdrawal by Subject|0|||
163466546|NCT00910728|590405843|FG000|Overall Study|(not specified)|2|||
163466547|NCT00910728|590405844|FG001|Overall Study|(not specified)|0|||
163466548|NCT00910728|590405845|FG002|Overall Study|(not specified)|1|||
163466549|NCT00910728|590405846|FG003|Overall Study|(not specified)|0|||
163466550|NCT00910728|590405847|FG004|Overall Study|(not specified)|1|||
163466551|NCT00910728|590405848|FG005|Overall Study|(not specified)|0|||
163466552|NCT00910728|590405849|FG006|Overall Study|(not specified)|0|||
163466553|NCT00910728|590405850|FG007|Overall Study|(not specified)|0|||
163466554|NCT00910728|590405851|FG008|Overall Study|(not specified)|0|||
163466555|NCT00910728|590405843|FG000|Overall Study|Adverse Event|2|||
163466556|NCT00910728|590405844|FG001|Overall Study|Adverse Event|0|||
163466557|NCT00910728|590405845|FG002|Overall Study|Adverse Event|1|||
163466558|NCT00910728|590405846|FG003|Overall Study|Adverse Event|1|||
163466559|NCT00910728|590405847|FG004|Overall Study|Adverse Event|0|||
163466560|NCT00910728|590405848|FG005|Overall Study|Adverse Event|0|||
163466561|NCT00910728|590405849|FG006|Overall Study|Adverse Event|2|||
163466562|NCT00910728|590405850|FG007|Overall Study|Adverse Event|1|||
163466563|NCT00910728|590405851|FG008|Overall Study|Adverse Event|1|||
163466564|NCT01225172|590405853|FG000|Overall Study|Subject decision to stop|1|||
163466565|NCT01225172|590405854|FG001|Overall Study|Subject decision to stop|0|||
163466566|NCT01225172|590405853|FG000|Overall Study|Subject request to discontinue treatment|3|||
163466567|NCT01225172|590405854|FG001|Overall Study|Subject request to discontinue treatment|1|||
163466568|NCT01225172|590405853|FG000|Overall Study|Subject no longer meets study criteria|1|||
163466569|NCT01225172|590405854|FG001|Overall Study|Subject no longer meets study criteria|0|||
163466570|NCT01225172|590405853|FG000|Overall Study|Withdrawal by Subject|1|||
163466571|NCT01225172|590405854|FG001|Overall Study|Withdrawal by Subject|0|||
163466572|NCT03175562|590405860|FG000|Overall Study|Adverse Event|1|||
163466573|NCT03175562|590405860|FG000|Overall Study|Lost to Follow-up|3|||
163466574|NCT03175562|590405860|FG000|Overall Study|Withdrawal by Subject|7|||
163466575|NCT03175562|590405860|FG000|Overall Study|Other (Not Specified)|5|||
163466576|NCT01946412|590405861|FG000|Overall Study|Adverse Event|1|||
163466577|NCT01946412|590405861|FG000|Overall Study|Non-Compliance|1|||
163466578|NCT01946412|590405861|FG000|Overall Study|Continued with commercial Kalydeco|2|||
163466579|NCT01946412|590405861|FG000|Overall Study|Difficulty in swallowing|1|||
163466580|NCT01731990|590407262|FG000|Overall Study|Adverse Event|1|||
163466581|NCT01731990|590407263|FG001|Overall Study|Adverse Event|5|||
163466582|NCT01731990|590407262|FG000|Overall Study|Withdrawal by Subject|1|||
163466583|NCT01731990|590407263|FG001|Overall Study|Withdrawal by Subject|1|||
163466584|NCT01731990|590407262|FG000|Overall Study|Protocol deviation|1|||
163466585|NCT01731990|590407263|FG001|Overall Study|Protocol deviation|2|||
163466586|NCT01731990|590407262|FG000|Overall Study|Death|1|||
163466587|NCT01731990|590407263|FG001|Overall Study|Death|0|||
163466588|NCT01183104|590407264|FG000|Overall Study|Adverse Event|8|||
163466589|NCT01183104|590407265|FG001|Overall Study|Adverse Event|6|||
163466590|NCT01183104|590407264|FG000|Overall Study|Death|0|||
163466591|NCT01183104|590407265|FG001|Overall Study|Death|1|||
163466592|NCT01183104|590407264|FG000|Overall Study|Lost to Follow-up|14|||
163466593|NCT01183104|590407265|FG001|Overall Study|Lost to Follow-up|7|||
163466594|NCT01183104|590407264|FG000|Overall Study|Physician Decision|5|||
163466595|NCT01183104|590407265|FG001|Overall Study|Physician Decision|8|||
163466596|NCT01183104|590407264|FG000|Overall Study|Withdrawal by Subject|6|||
163466597|NCT01183104|590407265|FG001|Overall Study|Withdrawal by Subject|11|||
163466598|NCT01183104|590407264|FG000|Overall Study|Nonparticipation in Extension Study|39|||
163466599|NCT01183104|590407265|FG001|Overall Study|Nonparticipation in Extension Study|50|||
163466600|NCT01183104|590407264|FG000|Overall Study|Did not receive study drug|5|||
163466601|NCT01183104|590407265|FG001|Overall Study|Did not receive study drug|9|||
163466602|NCT00323310|590407266|FG000|Overall Study|Withdrawal by Subject|1|||
163466603|NCT00323310|590407266|FG000|Overall Study|a parent refused blood draw|1|||
163466604|NCT00323310|590407266|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
163466605|NCT02944513|590407267|FG000|Overall Study|Withdrawal by Subject|4|||
163466606|NCT02944513|590407268|FG001|Overall Study|Withdrawal by Subject|1|||
163466607|NCT00937326|590407269|FG000|Overall Study|Adverse Event|0|||
163466608|NCT00937326|590407270|FG001|Overall Study|Adverse Event|3|||
163466609|NCT00937326|590407271|FG002|Overall Study|Adverse Event|1|||
163466610|NCT00937326|590407272|FG003|Overall Study|Adverse Event|1|||
163466611|NCT00937326|590407273|FG004|Overall Study|Adverse Event|2|||
163466612|NCT00937326|590407269|FG000|Overall Study|Death|0|||
163466613|NCT00937326|590407270|FG001|Overall Study|Death|0|||
163466614|NCT00937326|590407271|FG002|Overall Study|Death|1|||
163466615|NCT00937326|590407272|FG003|Overall Study|Death|0|||
163466616|NCT00937326|590407273|FG004|Overall Study|Death|0|||
163466617|NCT00937326|590407269|FG000|Overall Study|Withdrawal by Subject|3|||
163466618|NCT00937326|590407270|FG001|Overall Study|Withdrawal by Subject|4|||
163466619|NCT00937326|590407271|FG002|Overall Study|Withdrawal by Subject|1|||
163466620|NCT00937326|590407272|FG003|Overall Study|Withdrawal by Subject|4|||
163466621|NCT00937326|590407273|FG004|Overall Study|Withdrawal by Subject|3|||
163466622|NCT00937326|590407269|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
163466623|NCT00937326|590407270|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
163466624|NCT00937326|590407271|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
163466625|NCT00937326|590407272|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
163466626|NCT00937326|590407273|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
163466627|NCT00790218|590407274|FG000|Overall Study|Death|1|||
163466628|NCT00790218|590407275|FG001|Overall Study|Death|0|||
163466629|NCT00790218|590407276|FG002|Overall Study|Death|0|||
163466630|NCT03424044|590407282|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
163466631|NCT03424044|590407283|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
163466632|NCT03424044|590407284|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
163466633|NCT03424044|590407285|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
163466634|NCT03424044|590407286|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
163466635|NCT03424044|590407287|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
163466636|NCT03424044|590407288|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
163466637|NCT03424044|590407289|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
163466638|NCT03424044|590407290|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
163466639|NCT03424044|590407282|FG000|First Intervention (76 Hours)|Adverse Event|0|||
163466640|NCT03424044|590407283|FG001|First Intervention (76 Hours)|Adverse Event|0|||
163466641|NCT03424044|590407284|FG002|First Intervention (76 Hours)|Adverse Event|0|||
163466642|NCT03424044|590407285|FG003|First Intervention (76 Hours)|Adverse Event|0|||
163466643|NCT03424044|590407286|FG004|First Intervention (76 Hours)|Adverse Event|1|||
163466644|NCT03424044|590407287|FG005|First Intervention (76 Hours)|Adverse Event|0|||
163466645|NCT03424044|590407288|FG006|First Intervention (76 Hours)|Adverse Event|0|||
163466646|NCT03424044|590407289|FG007|First Intervention (76 Hours)|Adverse Event|0|||
163466647|NCT03424044|590407290|FG008|First Intervention (76 Hours)|Adverse Event|0|||
163466648|NCT03424044|590407282|FG000|First Intervention (76 Hours)|device issues|0|||
163466649|NCT03424044|590407283|FG001|First Intervention (76 Hours)|device issues|0|||
163466650|NCT03424044|590407284|FG002|First Intervention (76 Hours)|device issues|0|||
163466651|NCT03424044|590407285|FG003|First Intervention (76 Hours)|device issues|0|||
163466652|NCT03424044|590407286|FG004|First Intervention (76 Hours)|device issues|0|||
163466653|NCT03424044|590407287|FG005|First Intervention (76 Hours)|device issues|0|||
163466654|NCT03424044|590407288|FG006|First Intervention (76 Hours)|device issues|1|||
163466655|NCT03424044|590407289|FG007|First Intervention (76 Hours)|device issues|1|||
163466656|NCT03424044|590407290|FG008|First Intervention (76 Hours)|device issues|1|||
163466657|NCT03424044|590407282|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
163466658|NCT03424044|590407283|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
163466659|NCT03424044|590407284|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
163466660|NCT03424044|590407285|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
163466661|NCT03424044|590407286|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
163466662|NCT03424044|590407287|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
163466663|NCT03424044|590407288|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
163466664|NCT03424044|590407289|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
163466665|NCT03424044|590407290|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
163466666|NCT03424044|590407282|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
163466667|NCT03424044|590407283|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
163466668|NCT03424044|590407284|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
163466669|NCT03424044|590407285|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
163466670|NCT03424044|590407286|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
163466671|NCT03424044|590407287|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
163466672|NCT03424044|590407288|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
163466673|NCT03424044|590407289|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
163466674|NCT03424044|590407290|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
163466675|NCT04402385|590407292|FG000|Overall Study|Withdrawal by Subject|4|||
163466676|NCT04402385|590407293|FG001|Overall Study|Withdrawal by Subject|4|||
163466677|NCT04402385|590407292|FG000|Overall Study|Lost to Follow-up|1|||
163466678|NCT04402385|590407293|FG001|Overall Study|Lost to Follow-up|1|||
163466679|NCT04402385|590407292|FG000|Overall Study|Physician Decision|0|||
163466680|NCT04402385|590407293|FG001|Overall Study|Physician Decision|1|||
163466681|NCT00731666|590407294|FG000|Overall Study|Adverse Event|2|||
163466682|NCT00731666|590407294|FG000|Overall Study|Lost to Follow-up|8|||
163466683|NCT00731666|590407294|FG000|Overall Study|Withdrawal by Subject|2|||
163466684|NCT01308853|590407295|FG000|Overall Study|Adverse Event|1|||
163466685|NCT01308853|590407295|FG000|Overall Study|Lost to Follow-up|2|||
163466686|NCT01308853|590407295|FG000|Overall Study|Insertion of permanent implants|1|||
163466687|NCT03250624|590407299|FG000|Overall Study|Lack of Efficacy|1|||
163466688|NCT03250624|590407300|FG001|Overall Study|Lack of Efficacy|4|||
163466689|NCT03250624|590407299|FG000|Overall Study|Adverse Event|0|||
163466690|NCT03250624|590407300|FG001|Overall Study|Adverse Event|1|||
163466691|NCT03250624|590407299|FG000|Overall Study|Other|1|||
163466692|NCT03250624|590407300|FG001|Overall Study|Other|2|||
163466693|NCT00106249|590407301|FG000|Overall Study|Lost to Follow-up|3|||
163466694|NCT00106249|590407302|FG001|Overall Study|Lost to Follow-up|2|||
163466695|NCT01843205|590407303|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
163466696|NCT01843205|590407304|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
163466697|NCT00606177|590407305|FG000|Overall Study|Adverse Event|9|||
163466698|NCT00606177|590407306|FG001|Overall Study|Adverse Event|5|||
163466699|NCT00606177|590407305|FG000|Overall Study|Lack of Efficacy|3|||
163466700|NCT00606177|590407306|FG001|Overall Study|Lack of Efficacy|7|||
163466701|NCT00606177|590407305|FG000|Overall Study|Physician Decision|1|||
163466702|NCT00606177|590407306|FG001|Overall Study|Physician Decision|0|||
163466703|NCT00606177|590407305|FG000|Overall Study|Protocol Violation|1|||
163466704|NCT00606177|590407306|FG001|Overall Study|Protocol Violation|4|||
163466705|NCT00606177|590407305|FG000|Overall Study|Withdrawal by Subject|5|||
163466706|NCT00606177|590407306|FG001|Overall Study|Withdrawal by Subject|6|||
163466707|NCT00606177|590407305|FG000|Overall Study|Progression to depressive phase|6|||
163466708|NCT00606177|590407306|FG001|Overall Study|Progression to depressive phase|1|||
163466709|NCT00606177|590407305|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
163466710|NCT00606177|590407306|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
163466711|NCT00606177|590407305|FG000|Overall Study|Change of residence or other commitments|1|||
163466712|NCT00606177|590407306|FG001|Overall Study|Change of residence or other commitments|1|||
163466713|NCT00136357|590407307|FG000|Overall Study|Withdrawal by Subject|3|||
163466714|NCT00136357|590407308|FG001|Overall Study|Withdrawal by Subject|2|||
163466715|NCT01518309|590407309|FG000|Overall Study|Adverse Event|6|||
163466716|NCT01518309|590407309|FG000|Overall Study|Death|6|||
163466717|NCT01518309|590407309|FG000|Overall Study|Lack of Efficacy|7|||
163466718|NCT01518309|590407309|FG000|Overall Study|Withdrawal by Subject|6|||
163466719|NCT01518309|590407309|FG000|Overall Study|Physician Decision|3|||
163466720|NCT01518309|590407309|FG000|Overall Study|Sponsor Decision|2|||
163466721|NCT01518309|590407309|FG000|Overall Study|Not in Predefined Categories|9|||
163466722|NCT01819506|590407316|FG000|Overall Study|Physician Decision|5|||
163466723|NCT01819506|590407317|FG001|Overall Study|Physician Decision|2|||
163466724|NCT01819506|590407316|FG000|Overall Study|Withdrawal by Subject|3|||
163466725|NCT01819506|590407317|FG001|Overall Study|Withdrawal by Subject|3|||
163466726|NCT01505114|590407320|FG000|Overall Study|Withdrawal by Subject|5|||
163466727|NCT01505114|590407321|FG001|Overall Study|Withdrawal by Subject|4|||
163466728|NCT01505114|590407322|FG002|Overall Study|Withdrawal by Subject|4|||
163466729|NCT01505114|590407323|FG003|Overall Study|Withdrawal by Subject|7|||
163466730|NCT01505114|590407320|FG000|Overall Study|Death|1|||
163466731|NCT01505114|590407321|FG001|Overall Study|Death|0|||
163466732|NCT01505114|590407322|FG002|Overall Study|Death|0|||
163466733|NCT01505114|590407323|FG003|Overall Study|Death|1|||
163466734|NCT01505114|590407320|FG000|Overall Study|unable to adhere to visit schedule|3|||
163466735|NCT01505114|590407321|FG001|Overall Study|unable to adhere to visit schedule|2|||
163466736|NCT01505114|590407322|FG002|Overall Study|unable to adhere to visit schedule|3|||
163466737|NCT01505114|590407323|FG003|Overall Study|unable to adhere to visit schedule|3|||
163466738|NCT01505114|590407320|FG000|Overall Study|Lost to Follow-up|11|||
163466739|NCT01505114|590407321|FG001|Overall Study|Lost to Follow-up|5|||
163466740|NCT01505114|590407322|FG002|Overall Study|Lost to Follow-up|8|||
163466741|NCT01505114|590407323|FG003|Overall Study|Lost to Follow-up|7|||
163466742|NCT01505114|590407320|FG000|Overall Study|relocated|4|||
163466743|NCT01505114|590407321|FG001|Overall Study|relocated|2|||
163466744|NCT01505114|590407322|FG002|Overall Study|relocated|2|||
163466745|NCT01505114|590407323|FG003|Overall Study|relocated|3|||
163466746|NCT01505114|590407320|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
163466747|NCT01505114|590407321|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
163466748|NCT01505114|590407322|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
163466749|NCT01505114|590407323|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
163466750|NCT01505114|590407320|FG000|Overall Study|staff safety concerns|0|||
163466751|NCT01505114|590407321|FG001|Overall Study|staff safety concerns|0|||
163466752|NCT01505114|590407322|FG002|Overall Study|staff safety concerns|0|||
163466753|NCT01505114|590407323|FG003|Overall Study|staff safety concerns|1|||
163466754|NCT01505114|590407320|FG000|Overall Study|investigator decision|1|||
163466755|NCT01505114|590407321|FG001|Overall Study|investigator decision|0|||
163466756|NCT01505114|590407322|FG002|Overall Study|investigator decision|1|||
163466757|NCT01505114|590407323|FG003|Overall Study|investigator decision|0|||
163466758|NCT02017704|590407330|FG000|Overall Study|Withdrawal by Subject|2|||
163466759|NCT02017704|590407331|FG001|Overall Study|Withdrawal by Subject|0|||
163466760|NCT02076334|590407332|FG000|Overall Study|Protocol Violation|1|||
163466761|NCT02076334|590407333|FG001|Overall Study|Protocol Violation|0|||
163466762|NCT02076334|590407334|FG002|Overall Study|Protocol Violation|0|||
163466763|NCT02076334|590407335|FG003|Overall Study|Protocol Violation|0|||
163466764|NCT02076334|590407332|FG000|Overall Study|Lost to Follow-up|0|||
163466765|NCT02076334|590407333|FG001|Overall Study|Lost to Follow-up|1|||
163466766|NCT02076334|590407334|FG002|Overall Study|Lost to Follow-up|1|||
163466767|NCT02076334|590407335|FG003|Overall Study|Lost to Follow-up|0|||
163466768|NCT02076334|590407332|FG000|Overall Study|muscle soreness|0|||
163466769|NCT02076334|590407333|FG001|Overall Study|muscle soreness|0|||
163466770|NCT02076334|590407334|FG002|Overall Study|muscle soreness|0|||
163466771|NCT02076334|590407335|FG003|Overall Study|muscle soreness|1|||
163466772|NCT01963780|590407336|FG000|Overall Study|Death|7|||
163466773|NCT01749800|590407337|FG000|Overall Study|not meeting inclusion criteria|3|||
163466774|NCT01749800|590407338|FG001|Overall Study|not meeting inclusion criteria|0|||
163466775|NCT01749800|590407339|FG002|Overall Study|not meeting inclusion criteria|0|||
163466776|NCT01749800|590407337|FG000|Overall Study|Withdrawal by Subject|0|||
163466777|NCT01749800|590407338|FG001|Overall Study|Withdrawal by Subject|1|||
163466778|NCT01749800|590407339|FG002|Overall Study|Withdrawal by Subject|0|||
163466779|NCT01975675|590407340|FG000|Overall Study|Death|0|||
163466780|NCT01975675|590407341|FG001|Overall Study|Death|1|||
163466781|NCT01975675|590407342|FG002|Overall Study|Death|0|||
163466782|NCT01975675|590407343|FG003|Overall Study|Death|0|||
163466783|NCT03639987|590407344|FG000|Overall Study|Study terminated by sponsor|26|||
163466784|NCT03639987|590407345|FG001|Overall Study|Study terminated by sponsor|25|||
163466785|NCT03639987|590407344|FG000|Overall Study|Lost to Follow-up|0|||
163466786|NCT03639987|590407345|FG001|Overall Study|Lost to Follow-up|1|||
163466787|NCT04354155|590407346|FG000|Overall Study|Withdrawal by Subject|1|||
163466788|NCT04354155|590407346|FG000|Overall Study|Did not meet criteria for study intervention|1|||
163466789|NCT01015820|590407349|FG000|Overall Study|Suboptimal measurements|1|||
163466790|NCT01015820|590407350|FG001|Overall Study|Suboptimal measurements|0|||
163466791|NCT01998399|590407351|FG000|Overall Study|Lost to Follow-up|1|||
163466792|NCT01998399|590407352|FG001|Overall Study|Lost to Follow-up|3|||
163466793|NCT01998399|590407351|FG000|Overall Study|Death|4|||
163466794|NCT01998399|590407352|FG001|Overall Study|Death|2|||
163466795|NCT01998399|590407351|FG000|Overall Study|Study stopped before dosing completed|3|||
163466796|NCT01998399|590407352|FG001|Overall Study|Study stopped before dosing completed|3|||
163466797|NCT01998399|590407351|FG000|Overall Study|Withdrawal by Subject|0|||
163466798|NCT01998399|590407352|FG001|Overall Study|Withdrawal by Subject|1|||
163466799|NCT00376246|590407353|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
163466800|NCT00376246|590407354|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
163466801|NCT00376246|590407353|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
163466802|NCT00376246|590407354|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
163466803|NCT00376246|590407353|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
163466804|NCT00376246|590407354|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
163466805|NCT00351819|590407358|FG000|Overall Study|Lost to Follow-up|4|||
163466806|NCT00351819|590407359|FG001|Overall Study|Lost to Follow-up|4|||
163466807|NCT00351819|590407358|FG000|Overall Study|Withdrawal by Subject|0|||
163466808|NCT00351819|590407359|FG001|Overall Study|Withdrawal by Subject|4|||
163466809|NCT00351819|590407358|FG000|Overall Study|Elevated PSA|1|||
163466810|NCT00351819|590407359|FG001|Overall Study|Elevated PSA|1|||
163466811|NCT00351819|590407358|FG000|Overall Study|Traumatic ankle fracture|1|||
163466812|NCT00351819|590407359|FG001|Overall Study|Traumatic ankle fracture|0|||
163466813|NCT00351819|590407358|FG000|Overall Study|Unprofessional behavior|1|||
163466814|NCT00351819|590407359|FG001|Overall Study|Unprofessional behavior|0|||
163466815|NCT00351819|590407358|FG000|Overall Study|Non-compliance|0|||
163466816|NCT00351819|590407359|FG001|Overall Study|Non-compliance|1|||
163466817|NCT00351819|590407358|FG000|Overall Study|Incarcerated|0|||
163466818|NCT00351819|590407359|FG001|Overall Study|Incarcerated|1|||
163466819|NCT00351819|590407358|FG000|Overall Study|Enrolled in another trial|0|||
163466820|NCT00351819|590407359|FG001|Overall Study|Enrolled in another trial|1|||
163466821|NCT01459068|590407362|FG000|Overall Study|Withdrawal by Subject|8|||
163466822|NCT01459068|590407363|FG001|Overall Study|Withdrawal by Subject|18|||
163466823|NCT01459068|590407362|FG000|Overall Study|Lost to Follow-up|31|||
163466824|NCT01459068|590407363|FG001|Overall Study|Lost to Follow-up|15|||
163466825|NCT01459068|590407362|FG000|Overall Study|Death|0|||
163466826|NCT01459068|590407363|FG001|Overall Study|Death|1|||
163466827|NCT02023112|590407364|FG000|Overall Study|Withdrawal by Subject|2|||
163466828|NCT02023112|590407365|FG001|Overall Study|Withdrawal by Subject|1|||
163466829|NCT02910219|590407366|FG000|Overall Study|Withdrawal by Subject|1|||
163466830|NCT02910219|590407367|FG001|Overall Study|Withdrawal by Subject|1|||
163466831|NCT01313078|590407372|FG000|Overall Study|Death|1|||
163466832|NCT01313078|590407372|FG000|Overall Study|Discontinued study drug|1|||
163466833|NCT01313078|590407372|FG000|Overall Study|Withdrawal by Subject|1|||
163466834|NCT01068717|590407376|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
163466835|NCT01068717|590407377|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
163466836|NCT01068717|590407378|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
163466837|NCT01068717|590407379|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
163466838|NCT01822223|590407380|FG000|Overall Study|Death|0|||
163466839|NCT01822223|590407381|FG001|Overall Study|Death|1|||
163466840|NCT01449955|590407387|FG000|Overall Study|Withdrawal by Subject|1|||
163466841|NCT01449955|590407388|FG001|Overall Study|Withdrawal by Subject|2|||
163466842|NCT03404518|590407394|FG000|Overall Study|Lost to Follow-up|28|||
163466843|NCT03404518|590407395|FG001|Overall Study|Lost to Follow-up|30|||
163466844|NCT03404518|590407394|FG000|Overall Study|Protocol Violation|13|||
163466845|NCT03404518|590407395|FG001|Overall Study|Protocol Violation|6|||
163466846|NCT03693404|590407398|FG000|Overall Study|Withdrawal by Subject|1|||
163466847|NCT03693404|590407399|FG001|Overall Study|Withdrawal by Subject|0|||
163466848|NCT03693404|590407398|FG000|Overall Study|Lost to Follow-up|0|||
163466849|NCT03693404|590407399|FG001|Overall Study|Lost to Follow-up|5|||
163466850|NCT03693404|590407398|FG000|Overall Study|Excluded from Analysis|0|||
163466851|NCT03693404|590407399|FG001|Overall Study|Excluded from Analysis|1|||
163466852|NCT01176240|590407400|FG000|Study 306A|Lack of Efficacy|2|||
163466853|NCT01176240|590407401|FG001|Study 306A|Lack of Efficacy|1|||
163466854|NCT01176240|590407400|FG000|Study 306A|Protocol Violation|0|||
163466855|NCT01176240|590407401|FG001|Study 306A|Protocol Violation|1|||
163466856|NCT01176240|590407400|FG000|Study 306A|Withdrawal by Subject|0|||
163466857|NCT01176240|590407401|FG001|Study 306A|Withdrawal by Subject|1|||
163466858|NCT01176240|590407400|FG000|Study 306A|Stop due to diverse problems|1|||
163466859|NCT01176240|590407401|FG001|Study 306A|Stop due to diverse problems|0|||
163466860|NCT01176240|590407400|FG000|Study 306B|Lack of Efficacy|5|||
163466861|NCT01176240|590407401|FG001|Study 306B|Lack of Efficacy|3|||
163466862|NCT01176240|590407400|FG000|Study 306B|Adverse Event|10|||
163466863|NCT01176240|590407401|FG001|Study 306B|Adverse Event|5|||
163466864|NCT01176240|590407400|FG000|Study 306B|Protocol Violation|2|||
163466865|NCT01176240|590407401|FG001|Study 306B|Protocol Violation|3|||
163466866|NCT01176240|590407400|FG000|Study 306B|Withdrawal by Subject|4|||
163466867|NCT01176240|590407401|FG001|Study 306B|Withdrawal by Subject|1|||
163466868|NCT01176240|590407400|FG000|Study 306B|Physician Decision|2|||
163466869|NCT01176240|590407401|FG001|Study 306B|Physician Decision|1|||
163466870|NCT01176240|590407400|FG000|Study 306B|Supine Hypertension|1|||
163466871|NCT01176240|590407401|FG001|Study 306B|Supine Hypertension|2|||
163466872|NCT01176240|590407400|FG000|Study 306B|Lost to Follow-up|0|||
163466873|NCT01176240|590407401|FG001|Study 306B|Lost to Follow-up|1|||
163466874|NCT01176240|590407400|FG000|Study 306B|withdrew prior to dosing|2|||
163466875|NCT01176240|590407401|FG001|Study 306B|withdrew prior to dosing|1|||
163466876|NCT00807014|590407404|FG000|Overall Study|Participant Considered Disease Cured|13|||
163466877|NCT00807014|590407405|FG001|Overall Study|Participant Considered Disease Cured|2|||
163466878|NCT00807014|590407404|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
163466879|NCT00807014|590407405|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
163466880|NCT00807014|590407404|FG000|Overall Study|Protocol Violation|2|||
163466881|NCT00807014|590407405|FG001|Overall Study|Protocol Violation|8|||
163466882|NCT00807014|590407404|FG000|Overall Study|Adverse Event|0|||
163466883|NCT00807014|590407405|FG001|Overall Study|Adverse Event|2|||
163466884|NCT00807014|590407404|FG000|Overall Study|Lost to Follow-up|9|||
163466885|NCT00807014|590407405|FG001|Overall Study|Lost to Follow-up|7|||
163466886|NCT00807014|590407404|FG000|Overall Study|Recovery|1|||
163466887|NCT00807014|590407405|FG001|Overall Study|Recovery|0|||
163466888|NCT00807014|590407404|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
163466889|NCT00807014|590407405|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
163466890|NCT00651313|590407406|FG000|Overall Study|Adverse Event|0|||
163466891|NCT00651313|590407407|FG001|Overall Study|Adverse Event|1|||
163466892|NCT00651313|590407406|FG000|Overall Study|Withdrawal by Subject|3|||
163466893|NCT00651313|590407407|FG001|Overall Study|Withdrawal by Subject|1|||
163466894|NCT00651313|590407406|FG000|Overall Study|Lost to Follow-up|1|||
163466895|NCT00651313|590407407|FG001|Overall Study|Lost to Follow-up|1|||
163466896|NCT00651313|590407406|FG000|Overall Study|Adminstrative Discontinuation|2|||
163466897|NCT00651313|590407407|FG001|Overall Study|Adminstrative Discontinuation|3|||
163466898|NCT02146833|590407408|FG000|Overall Study|Death|10|||
163466899|NCT02146833|590407408|FG000|Overall Study|No longer consented to study treatment|1|||
163466900|NCT03565991|590409228|FG000|Overall Study|Other|11|||
163466901|NCT03565991|590409229|FG001|Overall Study|Other|0|||
163466902|NCT03565991|590409228|FG000|Overall Study|Global deterioration of health status|14|||
163466903|NCT03565991|590409229|FG001|Overall Study|Global deterioration of health status|4|||
163466904|NCT03565991|590409228|FG000|Overall Study|Withdrawal by Subject|2|||
163466905|NCT03565991|590409229|FG001|Overall Study|Withdrawal by Subject|6|||
163466906|NCT03565991|590409228|FG000|Overall Study|Progressive disease|121|||
163466907|NCT03565991|590409229|FG001|Overall Study|Progressive disease|29|||
163466908|NCT03565991|590409228|FG000|Overall Study|Death|3|||
163466909|NCT03565991|590409229|FG001|Overall Study|Death|0|||
163466910|NCT03565991|590409228|FG000|Overall Study|Adverse Event|7|||
163466911|NCT03565991|590409229|FG001|Overall Study|Adverse Event|2|||
163466912|NCT00948428|590409230|FG000|Overall Study|Withdrawal by Subject|6|||
163466913|NCT00948428|590409231|FG001|Overall Study|Withdrawal by Subject|12|||
163466914|NCT00948428|590409232|FG002|Overall Study|Withdrawal by Subject|7|||
163466915|NCT00948428|590409230|FG000|Overall Study|Adverse Event|6|||
163466916|NCT00948428|590409231|FG001|Overall Study|Adverse Event|3|||
163466917|NCT00948428|590409232|FG002|Overall Study|Adverse Event|0|||
163466918|NCT00948428|590409230|FG000|Overall Study|Lost to Follow-up|2|||
163466919|NCT00948428|590409231|FG001|Overall Study|Lost to Follow-up|1|||
163466920|NCT00948428|590409232|FG002|Overall Study|Lost to Follow-up|1|||
163466921|NCT00948428|590409230|FG000|Overall Study|Death|2|||
163466922|NCT00948428|590409231|FG001|Overall Study|Death|0|||
163466923|NCT00948428|590409232|FG002|Overall Study|Death|0|||
163466924|NCT00948428|590409230|FG000|Overall Study|Intercurrent Illness|1|||
163466925|NCT00948428|590409231|FG001|Overall Study|Intercurrent Illness|0|||
163466926|NCT00948428|590409232|FG002|Overall Study|Intercurrent Illness|0|||
163466927|NCT00948428|590409230|FG000|Overall Study|Non-compliance|1|||
163466928|NCT00948428|590409231|FG001|Overall Study|Non-compliance|2|||
163466929|NCT00948428|590409232|FG002|Overall Study|Non-compliance|0|||
163466930|NCT01495689|590409236|FG000|Overall Study|Death|0|||
163466931|NCT01495689|590409237|FG001|Overall Study|Death|1|||
163466932|NCT01495689|590409236|FG000|Overall Study|Withdrawal by Subject|3|||
163466933|NCT01495689|590409237|FG001|Overall Study|Withdrawal by Subject|0|||
163466934|NCT01495689|590409236|FG000|Overall Study|Lost to Follow-up|7|||
163466935|NCT01495689|590409237|FG001|Overall Study|Lost to Follow-up|6|||
163466936|NCT05516134|590409244|FG000|Overall Study|Lost to Follow-up|1|||
163466937|NCT05516134|590409245|FG001|Overall Study|Lost to Follow-up|0|||
163466938|NCT05516134|590409246|FG002|Overall Study|Lost to Follow-up|0|||
163466939|NCT01119963|590409253|FG000|Overall Study|Lost to Follow-up|1|||
163466940|NCT01119963|590409254|FG001|Overall Study|Lost to Follow-up|1|||
163466941|NCT01355497|590409259|FG000|Overall Study|Death|19|||
163466942|NCT01355497|590409260|FG001|Overall Study|Death|18|||
163466943|NCT01355497|590409259|FG000|Overall Study|Lost to Follow-up|3|||
163466944|NCT01355497|590409260|FG001|Overall Study|Lost to Follow-up|0|||
163466945|NCT01355497|590409259|FG000|Overall Study|Protocol Violation|0|||
163466946|NCT01355497|590409260|FG001|Overall Study|Protocol Violation|1|||
163466947|NCT01355497|590409259|FG000|Overall Study|other-not provided|9|||
163466948|NCT01355497|590409260|FG001|Overall Study|other-not provided|4|||
163466949|NCT01355497|590409259|FG000|Overall Study|Withdrawal by Subject|12|||
163466950|NCT01355497|590409260|FG001|Overall Study|Withdrawal by Subject|20|||
163466951|NCT01355497|590409259|FG000|Overall Study|noncompliance|1|||
163466952|NCT01355497|590409260|FG001|Overall Study|noncompliance|2|||
163466953|NCT01355497|590409259|FG000|Overall Study|progressive disease|11|||
163466954|NCT01355497|590409260|FG001|Overall Study|progressive disease|8|||
163466955|NCT01355497|590409259|FG000|Overall Study|Adverse Event|11|||
163466956|NCT01355497|590409260|FG001|Overall Study|Adverse Event|10|||
163466957|NCT00038142|590409261|FG000|Overall Study|Ineligible|1|||
163466958|NCT00038142|590409262|FG001|Overall Study|Ineligible|0|||
163466959|NCT00038142|590409261|FG000|Overall Study|Progressive Disease|11|||
163466960|NCT00038142|590409262|FG001|Overall Study|Progressive Disease|7|||
163466961|NCT00038142|590409261|FG000|Overall Study|Death|1|||
163466962|NCT00038142|590409262|FG001|Overall Study|Death|0|||
163466963|NCT00038142|590409261|FG000|Overall Study|Adverse Event|1|||
163466964|NCT00038142|590409262|FG001|Overall Study|Adverse Event|0|||
163466965|NCT00038142|590409261|FG000|Overall Study|Unknown Reason|8|||
163466966|NCT00038142|590409262|FG001|Overall Study|Unknown Reason|0|||
163466967|NCT00420342|590409265|FG000|Overall Study|Lost to Follow-up|1|||
163466968|NCT00420342|590409266|FG001|Overall Study|Lost to Follow-up|0|||
163466969|NCT00420342|590409267|FG002|Overall Study|Lost to Follow-up|1|||
163466970|NCT00420342|590409265|FG000|Overall Study|Withdrawal by Subject|0|||
163466971|NCT00420342|590409266|FG001|Overall Study|Withdrawal by Subject|2|||
163466972|NCT00420342|590409267|FG002|Overall Study|Withdrawal by Subject|0|||
163466973|NCT00839436|590409270|FG000|Overall Study|Developed exclusionary condition|1|||
163466974|NCT00839436|590409271|FG001|Overall Study|Developed exclusionary condition|0|||
163466975|NCT00839436|590409272|FG002|Overall Study|Developed exclusionary condition|0|||
163466976|NCT00839436|590409270|FG000|Overall Study|Withdrawal by Subject|0|||
163466977|NCT00839436|590409271|FG001|Overall Study|Withdrawal by Subject|1|||
163466978|NCT00839436|590409272|FG002|Overall Study|Withdrawal by Subject|0|||
163466979|NCT00839436|590409270|FG000|Overall Study|Study drug no longer available|0|||
163466980|NCT00839436|590409271|FG001|Overall Study|Study drug no longer available|0|||
163466981|NCT00839436|590409272|FG002|Overall Study|Study drug no longer available|1|||
163466982|NCT01440972|590409273|FG000|Overall Study|Withdrawal by Subject|3|||
163466983|NCT01440972|590409274|FG001|Overall Study|Withdrawal by Subject|2|||
163466984|NCT03933215|590409275|FG000|Overall Study|Other|6|||
163466985|NCT03933215|590409275|FG000|Overall Study|Sponsor decision|5|||
163466986|NCT03933215|590409275|FG000|Overall Study|Protocol Violation|5|||
163466987|NCT03933215|590409275|FG000|Overall Study|Withdrawal by Subject|6|||
163466988|NCT03933215|590409275|FG000|Overall Study|Lost to Follow-up|6|||
163466989|NCT03933215|590409275|FG000|Overall Study|Enrolled but not treated|38|||
163466990|NCT04072575|590409278|FG000|Overall Study|Physician Decision|1|||
163466991|NCT04072575|590409278|FG000|Overall Study|Adverse Event|7|||
163466992|NCT04072575|590409278|FG000|Overall Study|Withdrawal by Subject|14|||
163466993|NCT04072575|590409278|FG000|Overall Study|Other|2|||
163466994|NCT05784129|590409279|FG000|Overall Study|Study terminated by sponsor|2|||
163466995|NCT05784129|590409280|FG001|Overall Study|Study terminated by sponsor|2|||
163466996|NCT00407550|590409281|FG000|Overall Study|Adverse Event|0|||
163466997|NCT00407550|590409282|FG001|Overall Study|Adverse Event|1|||
163466998|NCT00407550|590409281|FG000|Overall Study|Withdrawal by Subject|0|||
163466999|NCT00407550|590409282|FG001|Overall Study|Withdrawal by Subject|2|||
163467000|NCT00407550|590409281|FG000|Overall Study|Death|1|||
163467001|NCT00407550|590409282|FG001|Overall Study|Death|0|||
163467002|NCT00407550|590409281|FG000|Overall Study|Insurance or Other medical condition|2|||
163467003|NCT00407550|590409282|FG001|Overall Study|Insurance or Other medical condition|1|||
163467004|NCT01444898|590409283|FG000|Overall Study|Withdrawal by Subject|1|||
163467005|NCT01599806|590409285|FG000|Overall Study|Lost to Follow-up|20|||
163467006|NCT01599806|590409286|FG001|Overall Study|Lost to Follow-up|20|||
163467007|NCT01599806|590409285|FG000|Overall Study|Withdrawal by Subject|12|||
163467008|NCT01599806|590409286|FG001|Overall Study|Withdrawal by Subject|12|||
163467009|NCT01599806|590409285|FG000|Overall Study|Other Eligibility criteria|11|||
163467010|NCT01599806|590409286|FG001|Overall Study|Other Eligibility criteria|9|||
163467011|NCT02873208|590409287|FG000|Overall Study|Withdrawal by Subject|36|||
163467012|NCT02873208|590409287|FG000|Overall Study|Lost to Follow-up|22|||
163467013|NCT02873208|590409287|FG000|Overall Study|Adverse Event|15|||
163467014|NCT02873208|590409287|FG000|Overall Study|Non-compliance with study drug|12|||
163467015|NCT02873208|590409287|FG000|Overall Study|Protocol Violation|8|||
163467016|NCT02873208|590409287|FG000|Overall Study|Pregnancy|2|||
163467017|NCT02873208|590409287|FG000|Overall Study|Incarceration|1|||
163467018|NCT02873208|590409287|FG000|Overall Study|Lack of Efficacy|1|||
163467019|NCT02873208|590409287|FG000|Overall Study|Physician Decision|1|||
163467020|NCT00415584|590409288|FG000|Overall Study|Withdrawal by Subject|1|||
163467021|NCT01061567|590409289|FG000|Overall Study|Adverse Event|32|||
163467022|NCT01061567|590409289|FG000|Overall Study|Death|2|||
163467023|NCT01061567|590409289|FG000|Overall Study|Lack of Efficacy|3|||
163467024|NCT01061567|590409289|FG000|Overall Study|Lost to Follow-up|24|||
163467025|NCT01061567|590409289|FG000|Overall Study|Protocol Violation|1|||
163467026|NCT01061567|590409289|FG000|Overall Study|Withdrawal by Subject|11|||
163467027|NCT01061567|590409289|FG000|Overall Study|Other reason than stated above|3|||
163467028|NCT00563368|590409290|FG000|Overall Study|Lost to Follow-up|14|||
163467029|NCT00563368|590409291|FG001|Overall Study|Lost to Follow-up|14|||
163467030|NCT00563368|590409292|FG002|Overall Study|Lost to Follow-up|12|||
163467031|NCT00563368|590409293|FG003|Overall Study|Lost to Follow-up|6|||
163467032|NCT00563368|590409294|FG004|Overall Study|Lost to Follow-up|9|||
163467033|NCT00563368|590409295|FG005|Overall Study|Lost to Follow-up|8|||
163467034|NCT00563368|590409296|FG006|Overall Study|Lost to Follow-up|9|||
163467035|NCT00563368|590409290|FG000|Overall Study|Adverse Event|3|||
163467036|NCT00563368|590409291|FG001|Overall Study|Adverse Event|4|||
163467037|NCT00563368|590409292|FG002|Overall Study|Adverse Event|5|||
163467038|NCT00563368|590409293|FG003|Overall Study|Adverse Event|9|||
163467039|NCT00563368|590409294|FG004|Overall Study|Adverse Event|6|||
163467040|NCT00563368|590409295|FG005|Overall Study|Adverse Event|10|||
163467041|NCT00563368|590409296|FG006|Overall Study|Adverse Event|17|||
163467042|NCT00563368|590409290|FG000|Overall Study|Withdrawal by Subject|11|||
163467043|NCT00563368|590409291|FG001|Overall Study|Withdrawal by Subject|6|||
163467044|NCT00563368|590409292|FG002|Overall Study|Withdrawal by Subject|5|||
163467045|NCT00563368|590409293|FG003|Overall Study|Withdrawal by Subject|7|||
163467046|NCT00563368|590409294|FG004|Overall Study|Withdrawal by Subject|8|||
163467047|NCT00563368|590409295|FG005|Overall Study|Withdrawal by Subject|5|||
163467048|NCT00563368|590409296|FG006|Overall Study|Withdrawal by Subject|4|||
163467049|NCT00563368|590409290|FG000|Overall Study|protocol non-compliance|1|||
163467050|NCT00563368|590409291|FG001|Overall Study|protocol non-compliance|1|||
163467051|NCT00563368|590409292|FG002|Overall Study|protocol non-compliance|2|||
163467052|NCT00563368|590409293|FG003|Overall Study|protocol non-compliance|1|||
163467053|NCT00563368|590409294|FG004|Overall Study|protocol non-compliance|0|||
163467054|NCT00563368|590409295|FG005|Overall Study|protocol non-compliance|1|||
163467055|NCT00563368|590409296|FG006|Overall Study|protocol non-compliance|3|||
163467056|NCT00563368|590409290|FG000|Overall Study|Pregnancy|1|||
163467057|NCT00563368|590409291|FG001|Overall Study|Pregnancy|0|||
163467058|NCT00563368|590409292|FG002|Overall Study|Pregnancy|1|||
163467059|NCT00563368|590409293|FG003|Overall Study|Pregnancy|2|||
163467060|NCT00563368|590409294|FG004|Overall Study|Pregnancy|1|||
163467061|NCT00563368|590409295|FG005|Overall Study|Pregnancy|2|||
163467062|NCT00563368|590409296|FG006|Overall Study|Pregnancy|0|||
163467063|NCT00563368|590409290|FG000|Overall Study|requirement for restricted medication|0|||
163467064|NCT00563368|590409291|FG001|Overall Study|requirement for restricted medication|0|||
163467065|NCT00563368|590409292|FG002|Overall Study|requirement for restricted medication|2|||
163467066|NCT00563368|590409293|FG003|Overall Study|requirement for restricted medication|0|||
163467067|NCT00563368|590409294|FG004|Overall Study|requirement for restricted medication|0|||
163467068|NCT00563368|590409295|FG005|Overall Study|requirement for restricted medication|0|||
163467069|NCT00563368|590409296|FG006|Overall Study|requirement for restricted medication|0|||
163467070|NCT00563368|590409290|FG000|Overall Study|Other|5|||
163467071|NCT00563368|590409291|FG001|Overall Study|Other|5|||
163467072|NCT00563368|590409292|FG002|Overall Study|Other|3|||
163467073|NCT00563368|590409293|FG003|Overall Study|Other|4|||
163467074|NCT00563368|590409294|FG004|Overall Study|Other|4|||
163467075|NCT00563368|590409295|FG005|Overall Study|Other|4|||
163467076|NCT00563368|590409296|FG006|Overall Study|Other|0|||
163467077|NCT01831804|590409297|FG000|Overall Study|Adverse Event|0|||
163467078|NCT01831804|590409298|FG001|Overall Study|Adverse Event|0|||
163467079|NCT01831804|590409299|FG002|Overall Study|Adverse Event|0|||
163467080|NCT01831804|590409300|FG003|Overall Study|Adverse Event|0|||
163467081|NCT01831804|590409301|FG004|Overall Study|Adverse Event|0|||
163467082|NCT01831804|590409302|FG005|Overall Study|Adverse Event|0|||
163467083|NCT01831804|590409303|FG006|Overall Study|Adverse Event|1|||
163467084|NCT01831804|590409304|FG007|Overall Study|Adverse Event|0|||
163467085|NCT01831804|590409305|FG008|Overall Study|Adverse Event|1|||
163467086|NCT01831804|590409297|FG000|Overall Study|Protocol Violation|0|||
163467087|NCT01831804|590409298|FG001|Overall Study|Protocol Violation|0|||
163467088|NCT01831804|590409299|FG002|Overall Study|Protocol Violation|2|||
163467089|NCT01831804|590409300|FG003|Overall Study|Protocol Violation|0|||
163467090|NCT01831804|590409301|FG004|Overall Study|Protocol Violation|0|||
163467091|NCT01831804|590409302|FG005|Overall Study|Protocol Violation|0|||
163467092|NCT01831804|590409303|FG006|Overall Study|Protocol Violation|0|||
163467093|NCT01831804|590409304|FG007|Overall Study|Protocol Violation|0|||
163467094|NCT01831804|590409305|FG008|Overall Study|Protocol Violation|0|||
163467095|NCT01831804|590409297|FG000|Overall Study|Protocol defined stopping criteria|1|||
163467096|NCT01831804|590409298|FG001|Overall Study|Protocol defined stopping criteria|1|||
163467097|NCT01831804|590409299|FG002|Overall Study|Protocol defined stopping criteria|3|||
163467098|NCT01831804|590409300|FG003|Overall Study|Protocol defined stopping criteria|0|||
163467099|NCT01831804|590409301|FG004|Overall Study|Protocol defined stopping criteria|1|||
163467100|NCT01831804|590409302|FG005|Overall Study|Protocol defined stopping criteria|0|||
163467101|NCT01831804|590409303|FG006|Overall Study|Protocol defined stopping criteria|0|||
163467102|NCT01831804|590409304|FG007|Overall Study|Protocol defined stopping criteria|0|||
163467103|NCT01831804|590409305|FG008|Overall Study|Protocol defined stopping criteria|0|||
163467104|NCT01831804|590409297|FG000|Overall Study|Lost to Follow-up|0|||
163467105|NCT01831804|590409298|FG001|Overall Study|Lost to Follow-up|0|||
163467106|NCT01831804|590409299|FG002|Overall Study|Lost to Follow-up|1|||
163467107|NCT01831804|590409300|FG003|Overall Study|Lost to Follow-up|0|||
163467108|NCT01831804|590409301|FG004|Overall Study|Lost to Follow-up|0|||
163467109|NCT01831804|590409302|FG005|Overall Study|Lost to Follow-up|0|||
163467110|NCT01831804|590409303|FG006|Overall Study|Lost to Follow-up|0|||
163467111|NCT01831804|590409304|FG007|Overall Study|Lost to Follow-up|0|||
163467112|NCT01831804|590409305|FG008|Overall Study|Lost to Follow-up|1|||
163467113|NCT01831804|590409297|FG000|Overall Study|Investigator discretion|0|||
163467114|NCT01831804|590409298|FG001|Overall Study|Investigator discretion|0|||
163467115|NCT01831804|590409299|FG002|Overall Study|Investigator discretion|0|||
163467116|NCT01831804|590409300|FG003|Overall Study|Investigator discretion|0|||
163467117|NCT01831804|590409301|FG004|Overall Study|Investigator discretion|1|||
163467118|NCT01831804|590409302|FG005|Overall Study|Investigator discretion|0|||
163467119|NCT01831804|590409303|FG006|Overall Study|Investigator discretion|0|||
163467120|NCT01831804|590409304|FG007|Overall Study|Investigator discretion|1|||
163467121|NCT01831804|590409305|FG008|Overall Study|Investigator discretion|0|||
163467122|NCT01831804|590409297|FG000|Overall Study|Withdrew Consent|0|||
163467123|NCT01831804|590409298|FG001|Overall Study|Withdrew Consent|1|||
163467124|NCT01831804|590409299|FG002|Overall Study|Withdrew Consent|0|||
163467125|NCT01831804|590409300|FG003|Overall Study|Withdrew Consent|0|||
163467126|NCT01831804|590409301|FG004|Overall Study|Withdrew Consent|0|||
163467127|NCT01831804|590409302|FG005|Overall Study|Withdrew Consent|0|||
163467128|NCT01831804|590409303|FG006|Overall Study|Withdrew Consent|0|||
163467129|NCT01831804|590409304|FG007|Overall Study|Withdrew Consent|2|||
163467130|NCT01831804|590409305|FG008|Overall Study|Withdrew Consent|0|||
163467131|NCT00114218|590409317|FG000|Overall Study|Wrong Cell Type|2|||
163467132|NCT00114218|590409317|FG000|Overall Study|Wrong Primary|1|||
163467133|NCT00114218|590409317|FG000|Overall Study|Never Treated|1|||
163467134|NCT03168555|590409318|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
163467135|NCT03168555|590409318|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
163467136|NCT03168555|590409318|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
163467137|NCT03168555|590409318|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
163467138|NCT02959190|590409320|FG000|Open Label|Adverse Event|5|||
163467139|NCT02959190|590409321|FG001|Open Label|Adverse Event|7|||
163467140|NCT02959190|590409322|FG002|Open Label|Adverse Event|3|||
163467141|NCT02959190|590409323|FG003|Open Label|Adverse Event|4|||
163467142|NCT02959190|590409320|FG000|Open Label|Pregnancy|0|||
163467143|NCT02959190|590409321|FG001|Open Label|Pregnancy|1|||
163467144|NCT02959190|590409322|FG002|Open Label|Pregnancy|0|||
163467145|NCT02959190|590409323|FG003|Open Label|Pregnancy|0|||
163467146|NCT02959190|590409320|FG000|Open Label|Withdrawal by Subject|2|||
163467147|NCT02959190|590409321|FG001|Open Label|Withdrawal by Subject|8|||
163467148|NCT02959190|590409322|FG002|Open Label|Withdrawal by Subject|0|||
163467149|NCT02959190|590409323|FG003|Open Label|Withdrawal by Subject|0|||
163467150|NCT02959190|590409320|FG000|Open Label|Physician Decision|0|||
163467151|NCT02959190|590409321|FG001|Open Label|Physician Decision|0|||
163467152|NCT02959190|590409322|FG002|Open Label|Physician Decision|1|||
163467153|NCT02959190|590409323|FG003|Open Label|Physician Decision|0|||
163467154|NCT02959190|590409320|FG000|Open Label|Protocol Violation|0|||
163467155|NCT02959190|590409321|FG001|Open Label|Protocol Violation|0|||
163467156|NCT02959190|590409322|FG002|Open Label|Protocol Violation|0|||
163467157|NCT02959190|590409323|FG003|Open Label|Protocol Violation|2|||
163467158|NCT02959190|590409320|FG000|Post Treatment Follow Up|Adverse Event|1|||
163467159|NCT02959190|590409321|FG001|Post Treatment Follow Up|Adverse Event|1|||
163467160|NCT02959190|590409322|FG002|Post Treatment Follow Up|Adverse Event|0|||
163467161|NCT02959190|590409323|FG003|Post Treatment Follow Up|Adverse Event|0|||
163467162|NCT02959190|590409320|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
163467163|NCT02959190|590409321|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
163467164|NCT02959190|590409322|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
163467165|NCT02959190|590409323|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
163467166|NCT00615459|590409324|FG000|Period I|Adverse Event|2|||
163467167|NCT00615459|590409325|FG001|Period I|Adverse Event|0|||
163467168|NCT00615459|590409326|FG002|Period I|Adverse Event|1|||
163467169|NCT00615459|590409327|FG003|Period I|Adverse Event|0|||
163467170|NCT00615459|590409324|FG000|Period I|Subject withdrew consent|1|||
163467171|NCT00615459|590409325|FG001|Period I|Subject withdrew consent|0|||
163467172|NCT00615459|590409326|FG002|Period I|Subject withdrew consent|0|||
163467173|NCT00615459|590409327|FG003|Period I|Subject withdrew consent|1|||
163467174|NCT00615459|590409324|FG000|Period I|Abnormal test procedure results|1|||
163467175|NCT00615459|590409325|FG001|Period I|Abnormal test procedure results|1|||
163467176|NCT00615459|590409326|FG002|Period I|Abnormal test procedure results|1|||
163467177|NCT00615459|590409327|FG003|Period I|Abnormal test procedure results|0|||
163467178|NCT00615459|590409324|FG000|Period II|Adverse Event|1|||
163467179|NCT00615459|590409325|FG001|Period II|Adverse Event|0|||
163467180|NCT00615459|590409326|FG002|Period II|Adverse Event|0|||
163467181|NCT00615459|590409327|FG003|Period II|Adverse Event|0|||
163467182|NCT00615459|590409324|FG000|Period II|Lost to Follow-up|0|||
163467183|NCT00615459|590409325|FG001|Period II|Lost to Follow-up|0|||
163467184|NCT00615459|590409326|FG002|Period II|Lost to Follow-up|0|||
163467185|NCT00615459|590409327|FG003|Period II|Lost to Follow-up|1|||
163467186|NCT00615459|590409324|FG000|Period III|Adverse Event|0|||
163467187|NCT00615459|590409325|FG001|Period III|Adverse Event|1|||
163467188|NCT00615459|590409326|FG002|Period III|Adverse Event|0|||
163467189|NCT00615459|590409327|FG003|Period III|Adverse Event|0|||
163467190|NCT00615459|590409324|FG000|Period III|Administrative problems|0|||
163467191|NCT00615459|590409325|FG001|Period III|Administrative problems|1|||
163467192|NCT00615459|590409326|FG002|Period III|Administrative problems|1|||
163467193|NCT00615459|590409327|FG003|Period III|Administrative problems|0|||
163467194|NCT00615459|590409324|FG000|Period III|Unsatisfactory therapeutic effect|0|||
163467195|NCT00615459|590409325|FG001|Period III|Unsatisfactory therapeutic effect|1|||
163467196|NCT00615459|590409326|FG002|Period III|Unsatisfactory therapeutic effect|0|||
163467197|NCT00615459|590409327|FG003|Period III|Unsatisfactory therapeutic effect|0|||
163467198|NCT01235507|590409329|FG000|Overall Study|Adverse Event|1|||
163467199|NCT01235507|590409329|FG000|Overall Study|Withdrawal by Subject|1|||
163467200|NCT02738580|590409332|FG000|Overall Study|Adverse Event|1|||
163467201|NCT02738580|590409333|FG001|Overall Study|Adverse Event|0|||
163467202|NCT02738580|590409332|FG000|Overall Study|Lack of Efficacy|3|||
163467203|NCT02738580|590409333|FG001|Overall Study|Lack of Efficacy|2|||
163467204|NCT02738580|590409332|FG000|Overall Study|Withdrawal by Subject|0|||
163467205|NCT02738580|590409333|FG001|Overall Study|Withdrawal by Subject|1|||
163467206|NCT02738580|590409332|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
163467207|NCT02738580|590409333|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
163467208|NCT00617591|590409337|FG000|Overall Study|Withdrew consent during Induction|4|||
163467209|NCT00617591|590409337|FG000|Overall Study|Withdrew consent during Maintenance|6|||
163467210|NCT00588523|590409340|FG000|Overall Study|Not treated|3|||
163467211|NCT01425749|590409341|FG000|Overall Study|progression of melanoma|0|||
163467212|NCT01425749|590409342|FG001|Overall Study|progression of melanoma|1|||
163467213|NCT02096042|590409343|FG000|Overall Study|Disease Progression|1|||
163467214|NCT02096042|590409344|FG001|Overall Study|Disease Progression|0|||
163467215|NCT02096042|590409345|FG002|Overall Study|Disease Progression|0|||
163467216|NCT00701441|590409347|FG000|Overall Study|failure in cpap compliance|0|||
163467217|NCT00701441|590409348|FG001|Overall Study|failure in cpap compliance|4|||
163467218|NCT03034057|590409349|FG000|Overall Study|Withdrawal by Subject|10|||
163467219|NCT03034057|590409349|FG000|Overall Study|Protocol Violation|1|||
163467220|NCT03034057|590409349|FG000|Overall Study|Not defined|2|||
163467221|NCT03034057|590409349|FG000|Overall Study|Lost to Follow-up|19|||
163467222|NCT03034057|590409349|FG000|Overall Study|Adverse Event|22|||
163467223|NCT03034057|590409349|FG000|Overall Study|Medication error without associated AE|1|||
163467224|NCT03339401|590409350|FG000|Overall Study|Death|2|||
163467225|NCT03339401|590409351|FG001|Overall Study|Death|1|||
163467226|NCT03339401|590409350|FG000|Overall Study|Withdrawal by Subject|2|||
163467227|NCT03339401|590409351|FG001|Overall Study|Withdrawal by Subject|0|||
163467228|NCT03339401|590409350|FG000|Overall Study|Study terminated|4|||
163467229|NCT03339401|590409351|FG001|Overall Study|Study terminated|3|||
163467230|NCT03339401|590409350|FG000|Overall Study|Investigator Decision|1|||
163467231|NCT03339401|590409351|FG001|Overall Study|Investigator Decision|0|||
163467232|NCT00718523|590409353|FG000|Overall Study|Withdrawal by Subject|5|||
163467233|NCT00718523|590409354|FG001|Overall Study|Withdrawal by Subject|7|||
163467234|NCT00718523|590409353|FG000|Overall Study|Death|13|||
163467235|NCT00718523|590409354|FG001|Overall Study|Death|17|||
163467236|NCT02679781|590409355|FG000|Overall Study|Lost to Follow-up|1|||
163467237|NCT02679781|590409356|FG001|Overall Study|Lost to Follow-up|2|||
163467238|NCT02679781|590409355|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
163467239|NCT02679781|590409356|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
163467240|NCT04209400|590409359|FG000|Overall Study|Withdrawal by Subject|0|||
163467241|NCT04209400|590409360|FG001|Overall Study|Withdrawal by Subject|1|||
163467242|NCT01496274|590409361|FG000|Overall Study|Protocol Violation|0|||
163467243|NCT01496274|590409362|FG001|Overall Study|Protocol Violation|1|||
163467244|NCT01496274|590409361|FG000|Overall Study|Adverse Event|1|||
163467245|NCT01496274|590409362|FG001|Overall Study|Adverse Event|1|||
163467246|NCT01496274|590409361|FG000|Overall Study|Withdrawal by Subject|2|||
163467247|NCT01496274|590409362|FG001|Overall Study|Withdrawal by Subject|0|||
163467248|NCT01496274|590409361|FG000|Overall Study|Lost to Follow-up|0|||
163467249|NCT01496274|590409362|FG001|Overall Study|Lost to Follow-up|3|||
163467250|NCT05041062|590409364|FG000|Overall Study|Adverse Event|2|||
163467251|NCT04968353|590409368|FG000|Overall Study|Non-compliance|1|||
163467252|NCT04968353|590409369|FG001|Overall Study|Non-compliance|0|||
163467253|NCT04968353|590409370|FG002|Overall Study|Non-compliance|2|||
163467254|NCT04968353|590409371|FG003|Overall Study|Non-compliance|0|||
163467255|NCT00318370|590409372|FG000|Period 1|Lack of Efficacy|5|||
163467256|NCT00318370|590409373|FG001|Period 1|Lack of Efficacy|0|||
163467257|NCT00318370|590409374|FG002|Period 1|Lack of Efficacy|0|||
163467258|NCT00318370|590409372|FG000|Period 1|Physician Decision|1|||
163467259|NCT00318370|590409373|FG001|Period 1|Physician Decision|0|||
163467260|NCT00318370|590409374|FG002|Period 1|Physician Decision|0|||
163467261|NCT00318370|590409372|FG000|Period 1|Withdrawal by Subject|1|||
163467262|NCT00318370|590409373|FG001|Period 1|Withdrawal by Subject|0|||
163467263|NCT00318370|590409374|FG002|Period 1|Withdrawal by Subject|0|||
163467264|NCT00318370|590409372|FG000|Period 2|Adverse Event|0|||
163467265|NCT00318370|590409373|FG001|Period 2|Adverse Event|3|||
163467266|NCT00318370|590409374|FG002|Period 2|Adverse Event|0|||
163467267|NCT00318370|590409372|FG000|Period 2|Lack of Efficacy|0|||
163467268|NCT00318370|590409373|FG001|Period 2|Lack of Efficacy|5|||
163467269|NCT00318370|590409374|FG002|Period 2|Lack of Efficacy|0|||
163467270|NCT00318370|590409372|FG000|Period 2|Physician Decision|0|||
163467271|NCT00318370|590409373|FG001|Period 2|Physician Decision|1|||
163467272|NCT00318370|590409374|FG002|Period 2|Physician Decision|0|||
163467273|NCT00318370|590409372|FG000|Period 2|Withdrawal by Subject|0|||
163467274|NCT00318370|590409373|FG001|Period 2|Withdrawal by Subject|1|||
163467275|NCT00318370|590409374|FG002|Period 2|Withdrawal by Subject|0|||
163467276|NCT00318370|590409372|FG000|Period 2|Other|0|||
163467277|NCT00318370|590409373|FG001|Period 2|Other|1|||
163467278|NCT00318370|590409374|FG002|Period 2|Other|0|||
163467279|NCT00318370|590409372|FG000|Period 3|Adverse Event|0|||
163467280|NCT00318370|590409373|FG001|Period 3|Adverse Event|0|||
163467281|NCT00318370|590409374|FG002|Period 3|Adverse Event|1|||
163467282|NCT00318370|590409372|FG000|Period 3|Lack of Efficacy|0|||
163467283|NCT00318370|590409373|FG001|Period 3|Lack of Efficacy|0|||
163467284|NCT00318370|590409374|FG002|Period 3|Lack of Efficacy|24|||
163467285|NCT00318370|590409372|FG000|Period 3|Death|0|||
163467286|NCT00318370|590409373|FG001|Period 3|Death|0|||
163467287|NCT00318370|590409374|FG002|Period 3|Death|1|||
163467288|NCT00318370|590409372|FG000|Period 3|Physician Decision|0|||
163467289|NCT00318370|590409373|FG001|Period 3|Physician Decision|0|||
163467290|NCT00318370|590409374|FG002|Period 3|Physician Decision|1|||
163467291|NCT00318370|590409372|FG000|Period 3|Withdrawal by Subject|0|||
163467292|NCT00318370|590409373|FG001|Period 3|Withdrawal by Subject|0|||
163467293|NCT00318370|590409374|FG002|Period 3|Withdrawal by Subject|3|||
163467294|NCT00318370|590409372|FG000|Period 3|Other|0|||
163467295|NCT00318370|590409373|FG001|Period 3|Other|0|||
163467296|NCT00318370|590409374|FG002|Period 3|Other|3|||
163467297|NCT05200455|590409375|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
163467298|NCT03307629|590409381|FG000|Overall Study|Withdrawal by Subject|0|||
163467299|NCT03307629|590409382|FG001|Overall Study|Withdrawal by Subject|0|||
163467300|NCT03307629|590409383|FG002|Overall Study|Withdrawal by Subject|0|||
163467301|NCT03307629|590409384|FG003|Overall Study|Withdrawal by Subject|2|||
163467302|NCT03307629|590409381|FG000|Overall Study|Disease Progression|0|||
163467303|NCT03307629|590409382|FG001|Overall Study|Disease Progression|0|||
163467304|NCT03307629|590409383|FG002|Overall Study|Disease Progression|0|||
163467305|NCT03307629|590409384|FG003|Overall Study|Disease Progression|3|||
163467306|NCT03307629|590409381|FG000|Overall Study|Death|0|||
163467307|NCT03307629|590409382|FG001|Overall Study|Death|3|||
163467308|NCT03307629|590409383|FG002|Overall Study|Death|0|||
163467309|NCT03307629|590409384|FG003|Overall Study|Death|1|||
163467310|NCT02853032|590409389|FG000|Overall Study|Adverse Event|4|||
163467311|NCT02853032|590409390|FG001|Overall Study|Adverse Event|0|||
163467312|NCT02853032|590409389|FG000|Overall Study|Withdrawal by Subject|3|||
163467313|NCT02853032|590409390|FG001|Overall Study|Withdrawal by Subject|1|||
163467314|NCT02853032|590409389|FG000|Overall Study|Requested to withdraw from all treatment|2|||
163467315|NCT02853032|590409390|FG001|Overall Study|Requested to withdraw from all treatment|2|||
163467316|NCT00676208|590409393|FG000|Overall Study|Lost to Follow-up|0|||
163467317|NCT00676208|590409394|FG001|Overall Study|Lost to Follow-up|2|||
163467318|NCT00676208|590409393|FG000|Overall Study|Incomplete data|2|||
163467319|NCT00676208|590409394|FG001|Overall Study|Incomplete data|4|||
163467320|NCT03700736|590409397|FG000|Overall Study|Pregnancy|1|||
163467321|NCT03700736|590409398|FG001|Overall Study|Pregnancy|1|||
163467322|NCT03700736|590409397|FG000|Overall Study|Withdrawal by Subject|2|||
163467323|NCT03700736|590409398|FG001|Overall Study|Withdrawal by Subject|6|||
163467324|NCT00642018|590409399|FG000|Overall Study|Adverse Event|11|||
163467325|NCT00642018|590409400|FG001|Overall Study|Adverse Event|36|||
163467326|NCT00642018|590409399|FG000|Overall Study|Withdrawal by Subject|4|||
163467327|NCT00642018|590409400|FG001|Overall Study|Withdrawal by Subject|10|||
163467328|NCT00642018|590409399|FG000|Overall Study|Progressive Disease|13|||
163467329|NCT00642018|590409400|FG001|Overall Study|Progressive Disease|18|||
163467330|NCT00642018|590409399|FG000|Overall Study|Physician Decision|0|||
163467331|NCT00642018|590409400|FG001|Overall Study|Physician Decision|10|||
163467332|NCT00642018|590409399|FG000|Overall Study|Protocol Violation|0|||
163467333|NCT00642018|590409400|FG001|Overall Study|Protocol Violation|1|||
163467334|NCT00642018|590409399|FG000|Overall Study|Death|0|||
163467335|NCT00642018|590409400|FG001|Overall Study|Death|3|||
163467336|NCT00642018|590409399|FG000|Overall Study|Entry Criteria Not Met|0|||
163467337|NCT00642018|590409400|FG001|Overall Study|Entry Criteria Not Met|1|||
163467338|NCT01410799|590409401|FG000|Overall Study|PI decision|13|||
163467339|NCT00617656|590409402|FG000|Overall Study|Inclusion error|4|||
163467340|NCT00617656|590409403|FG001|Overall Study|Inclusion error|4|||
163467341|NCT00617656|590409404|FG002|Overall Study|Inclusion error|0|||
163467342|NCT00617656|590409405|FG003|Overall Study|Inclusion error|0|||
163467343|NCT00617656|590409402|FG000|Overall Study|Missing data|44|||
163467344|NCT00617656|590409403|FG001|Overall Study|Missing data|30|||
163467345|NCT00617656|590409404|FG002|Overall Study|Missing data|13|||
163467346|NCT00617656|590409405|FG003|Overall Study|Missing data|6|||
163467347|NCT00617656|590409402|FG000|Overall Study|Withdrawal by Subject|0|||
163467348|NCT00617656|590409403|FG001|Overall Study|Withdrawal by Subject|2|||
163467349|NCT00617656|590409404|FG002|Overall Study|Withdrawal by Subject|0|||
163467350|NCT00617656|590409405|FG003|Overall Study|Withdrawal by Subject|0|||
163467351|NCT00254163|590411129|FG000|Overall Study|Adverse Event|29|||
163467352|NCT00254163|590411130|FG001|Overall Study|Adverse Event|26|||
163467353|NCT00254163|590411129|FG000|Overall Study|Patient request/withdrew consent|6|||
163467354|NCT00254163|590411130|FG001|Overall Study|Patient request/withdrew consent|4|||
163467355|NCT00254163|590411129|FG000|Overall Study|Investigator request|1|||
163467356|NCT00254163|590411130|FG001|Overall Study|Investigator request|3|||
163467357|NCT00254163|590411129|FG000|Overall Study|Failed entry|1|||
163467358|NCT00254163|590411130|FG001|Overall Study|Failed entry|3|||
163467359|NCT00254163|590411129|FG000|Overall Study|Progressive disease|0|||
163467360|NCT00254163|590411130|FG001|Overall Study|Progressive disease|1|||
163467361|NCT00254163|590411129|FG000|Overall Study|Death|0|||
163467362|NCT00254163|590411130|FG001|Overall Study|Death|1|||
163467363|NCT00254163|590411129|FG000|Overall Study|Other|8|||
163467364|NCT00254163|590411130|FG001|Overall Study|Other|8|||
163467365|NCT02579863|590411132|FG000|Overall Study|Final Disposition Unknown|2|||
163467366|NCT02579863|590411133|FG001|Overall Study|Final Disposition Unknown|1|||
163467367|NCT02579863|590411132|FG000|Overall Study|Adverse Event|18|||
163467368|NCT02579863|590411133|FG001|Overall Study|Adverse Event|11|||
163467369|NCT02579863|590411132|FG000|Overall Study|Death|31|||
163467370|NCT02579863|590411133|FG001|Overall Study|Death|29|||
163467371|NCT02579863|590411132|FG000|Overall Study|Lost to Follow-up|2|||
163467372|NCT02579863|590411133|FG001|Overall Study|Lost to Follow-up|1|||
163467373|NCT02579863|590411132|FG000|Overall Study|Physician Decision|1|||
163467374|NCT02579863|590411133|FG001|Overall Study|Physician Decision|2|||
163467375|NCT02579863|590411132|FG000|Overall Study|Screen Failure|0|||
163467376|NCT02579863|590411133|FG001|Overall Study|Screen Failure|2|||
163467377|NCT02579863|590411132|FG000|Overall Study|Study Terminated at Selected Sites|82|||
163467378|NCT02579863|590411133|FG001|Overall Study|Study Terminated at Selected Sites|88|||
163467379|NCT02579863|590411132|FG000|Overall Study|Withdrawal by Subject|20|||
163467380|NCT02579863|590411133|FG001|Overall Study|Withdrawal by Subject|20|||
163467381|NCT00809614|590411138|FG000|Overall Study|Lack of Efficacy|2|||
163467382|NCT00809614|590411139|FG001|Overall Study|Lack of Efficacy|3|||
163467383|NCT00809614|590411138|FG000|Overall Study|Withdrawal by Subject|1|||
163467384|NCT00809614|590411139|FG001|Overall Study|Withdrawal by Subject|1|||
163467385|NCT01224106|590411140|FG000|Double-Blind Treatment Phase|Death|3|||
163467386|NCT01224106|590411141|FG001|Double-Blind Treatment Phase|Death|0|||
163467387|NCT01224106|590411142|FG002|Double-Blind Treatment Phase|Death|0|||
163467388|NCT01224106|590411143|FG003|Double-Blind Treatment Phase|Death|0|||
163467389|NCT01224106|590411144|FG004|Double-Blind Treatment Phase|Death|0|||
163467390|NCT01224106|590411140|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
163467391|NCT01224106|590411141|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
163467392|NCT01224106|590411142|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
163467393|NCT01224106|590411143|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
163467394|NCT01224106|590411144|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
163467395|NCT01224106|590411140|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
163467396|NCT01224106|590411141|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
163467397|NCT01224106|590411142|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
163467398|NCT01224106|590411143|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
163467399|NCT01224106|590411144|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
163467400|NCT01224106|590411140|FG000|Double-Blind Treatment Phase|Other|0|||
163467401|NCT01224106|590411141|FG001|Double-Blind Treatment Phase|Other|0|||
163467402|NCT01224106|590411142|FG002|Double-Blind Treatment Phase|Other|1|||
163467403|NCT01224106|590411143|FG003|Double-Blind Treatment Phase|Other|0|||
163467404|NCT01224106|590411144|FG004|Double-Blind Treatment Phase|Other|0|||
163467405|NCT01224106|590411140|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
163467406|NCT01224106|590411141|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
163467407|NCT01224106|590411142|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
163467408|NCT01224106|590411143|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
163467409|NCT01224106|590411144|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
163467410|NCT01224106|590411140|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
163467411|NCT01224106|590411141|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
163467412|NCT01224106|590411142|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
163467413|NCT01224106|590411143|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
163467414|NCT01224106|590411144|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
163467415|NCT01224106|590411140|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
163467416|NCT01224106|590411141|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
163467417|NCT01224106|590411142|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
163467418|NCT01224106|590411143|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
163467419|NCT01224106|590411144|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
163467420|NCT01224106|590411140|FG000|Open-Label Extension (OLE) Phase|Death|0|||
163467421|NCT01224106|590411141|FG001|Open-Label Extension (OLE) Phase|Death|0|||
163467422|NCT01224106|590411142|FG002|Open-Label Extension (OLE) Phase|Death|0|||
163467423|NCT01224106|590411143|FG003|Open-Label Extension (OLE) Phase|Death|1|||
163467424|NCT01224106|590411144|FG004|Open-Label Extension (OLE) Phase|Death|3|||
163467425|NCT01224106|590411140|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
163467426|NCT01224106|590411141|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
163467427|NCT01224106|590411142|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
163467428|NCT01224106|590411143|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
163467429|NCT01224106|590411144|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
163467430|NCT01224106|590411140|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
163467431|NCT01224106|590411141|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
163467432|NCT01224106|590411142|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
163467433|NCT01224106|590411143|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
163467434|NCT01224106|590411144|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
163467435|NCT01224106|590411140|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
163467436|NCT01224106|590411141|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
163467437|NCT01224106|590411142|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
163467438|NCT01224106|590411143|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
163467439|NCT01224106|590411144|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
163467440|NCT01224106|590411140|FG000|Open-Label Extension (OLE) Phase|Other|0|||
163467441|NCT01224106|590411141|FG001|Open-Label Extension (OLE) Phase|Other|0|||
163467442|NCT01224106|590411142|FG002|Open-Label Extension (OLE) Phase|Other|0|||
163467443|NCT01224106|590411143|FG003|Open-Label Extension (OLE) Phase|Other|5|||
163467444|NCT01224106|590411144|FG004|Open-Label Extension (OLE) Phase|Other|3|||
163467445|NCT00446797|590411145|FG000|Overall Study|Lack of Efficacy|0|||
163467446|NCT00446797|590411146|FG001|Overall Study|Lack of Efficacy|2|||
163467447|NCT00446797|590411145|FG000|Overall Study|Lost to Follow-up|5|||
163467448|NCT00446797|590411146|FG001|Overall Study|Lost to Follow-up|3|||
163467449|NCT00446797|590411145|FG000|Overall Study|Withdrawal by Subject|2|||
163467450|NCT00446797|590411146|FG001|Overall Study|Withdrawal by Subject|2|||
163467451|NCT00446797|590411145|FG000|Overall Study|Protocol Violation|1|||
163467452|NCT00446797|590411146|FG001|Overall Study|Protocol Violation|3|||
163467453|NCT00446797|590411145|FG000|Overall Study|subject entered at another site|0|||
163467454|NCT00446797|590411146|FG001|Overall Study|subject entered at another site|1|||
163467455|NCT00446797|590411145|FG000|Overall Study|did not meet entrance criteria|0|||
163467456|NCT00446797|590411146|FG001|Overall Study|did not meet entrance criteria|1|||
163467457|NCT03210220|590411147|FG000|Overall Study|Physician Decision|1|||
163467458|NCT03210220|590411148|FG001|Overall Study|Physician Decision|0|||
163467459|NCT02580591|590411149|FG000|Overall Study|Adverse Event|0|||
163467460|NCT02580591|590411150|FG001|Overall Study|Adverse Event|1|||
163467461|NCT02580591|590411151|FG002|Overall Study|Adverse Event|2|||
163467462|NCT02580591|590411152|FG003|Overall Study|Adverse Event|5|||
163467463|NCT02580591|590411149|FG000|Overall Study|Protocol Violation|3|||
163467464|NCT02580591|590411150|FG001|Overall Study|Protocol Violation|2|||
163467465|NCT02580591|590411151|FG002|Overall Study|Protocol Violation|1|||
163467466|NCT02580591|590411152|FG003|Overall Study|Protocol Violation|1|||
163467467|NCT02580591|590411149|FG000|Overall Study|Lost to Follow-up|5|||
163467468|NCT02580591|590411150|FG001|Overall Study|Lost to Follow-up|3|||
163467469|NCT02580591|590411151|FG002|Overall Study|Lost to Follow-up|3|||
163467470|NCT02580591|590411152|FG003|Overall Study|Lost to Follow-up|1|||
163467471|NCT02580591|590411149|FG000|Overall Study|Withdrawal by Subject|6|||
163467472|NCT02580591|590411150|FG001|Overall Study|Withdrawal by Subject|1|||
163467473|NCT02580591|590411151|FG002|Overall Study|Withdrawal by Subject|2|||
163467474|NCT02580591|590411152|FG003|Overall Study|Withdrawal by Subject|3|||
163467475|NCT02580591|590411149|FG000|Overall Study|Not treated|1|||
163467476|NCT02580591|590411150|FG001|Overall Study|Not treated|1|||
163467477|NCT02580591|590411151|FG002|Overall Study|Not treated|0|||
163467478|NCT02580591|590411152|FG003|Overall Study|Not treated|0|||
163467479|NCT02580591|590411149|FG000|Overall Study|Other than specified|3|||
163467480|NCT02580591|590411150|FG001|Overall Study|Other than specified|2|||
163467481|NCT02580591|590411151|FG002|Overall Study|Other than specified|5|||
163467482|NCT02580591|590411152|FG003|Overall Study|Other than specified|2|||
163467483|NCT01366534|590411157|FG000|Overall Study|Lost to Follow-up|1|||
163467484|NCT01366534|590411158|FG001|Overall Study|Lost to Follow-up|0|||
163467485|NCT01366534|590411159|FG002|Overall Study|Lost to Follow-up|0|||
163467486|NCT01366534|590411157|FG000|Overall Study|Migrated|1|||
163467487|NCT01366534|590411158|FG001|Overall Study|Migrated|1|||
163467488|NCT01366534|590411159|FG002|Overall Study|Migrated|0|||
163467489|NCT01366534|590411157|FG000|Overall Study|Declined challenged|0|||
163467490|NCT01366534|590411158|FG001|Overall Study|Declined challenged|1|||
163467491|NCT01366534|590411159|FG002|Overall Study|Declined challenged|0|||
163467492|NCT03006926|590411160|FG000|Overall Study|Adverse Event|0|||
163467493|NCT03006926|590411161|FG001|Overall Study|Adverse Event|27|||
163467494|NCT03006926|590411160|FG000|Overall Study|Withdrawal by Subject|0|||
163467495|NCT03006926|590411161|FG001|Overall Study|Withdrawal by Subject|1|||
163467496|NCT03006926|590411160|FG000|Overall Study|Radiological Disease Progression|0|||
163467497|NCT03006926|590411161|FG001|Overall Study|Radiological Disease Progression|52|||
163467498|NCT03006926|590411160|FG000|Overall Study|Clinical Disease Progression|0|||
163467499|NCT03006926|590411161|FG001|Overall Study|Clinical Disease Progression|10|||
163467500|NCT03006926|590411160|FG000|Overall Study|Other|0|||
163467501|NCT03006926|590411161|FG001|Overall Study|Other|8|||
163467502|NCT01838213|590411162|FG000|Overall Study|Ineligible|166|||
163467503|NCT01838213|590411163|FG001|Overall Study|Ineligible|191|||
163467504|NCT04882072|590411168|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
163467505|NCT04882072|590411169|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
163467506|NCT04882072|590411168|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
163467507|NCT04882072|590411169|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
163467508|NCT04882072|590411168|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
163467509|NCT04882072|590411169|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
163467510|NCT02918318|590411170|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
163467511|NCT02918318|590411171|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
163467512|NCT02918318|590411172|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
163467513|NCT02918318|590411173|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
163467514|NCT02918318|590411174|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
163467515|NCT02918318|590411170|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
163467516|NCT02918318|590411171|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
163467517|NCT02918318|590411172|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
163467518|NCT02918318|590411173|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
163467519|NCT02918318|590411174|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
163467520|NCT02918318|590411170|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
163467521|NCT02918318|590411171|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
163467522|NCT02918318|590411172|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
163467523|NCT02918318|590411173|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
163467524|NCT02918318|590411174|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
163467525|NCT02918318|590411170|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
163467526|NCT02918318|590411171|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
163467527|NCT02918318|590411172|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
163467528|NCT02918318|590411173|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
163467529|NCT02918318|590411174|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
163467530|NCT02918318|590411170|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
163467531|NCT02918318|590411171|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
163467532|NCT02918318|590411172|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
163467533|NCT02918318|590411173|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
163467534|NCT02918318|590411174|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
163467535|NCT02918318|590411170|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
163467536|NCT02918318|590411171|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
163467537|NCT02918318|590411172|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
163467538|NCT02918318|590411173|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
163467539|NCT02918318|590411174|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
163467540|NCT02918318|590411170|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
163467541|NCT02918318|590411171|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
163467542|NCT02918318|590411172|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
163467543|NCT02918318|590411173|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
163467544|NCT02918318|590411174|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
163467545|NCT02918318|590411170|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
163467546|NCT02918318|590411171|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
163467547|NCT02918318|590411172|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
163467548|NCT02918318|590411173|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
163467549|NCT02918318|590411174|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
163467550|NCT02918318|590411170|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
163467551|NCT02918318|590411171|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
163467552|NCT02918318|590411172|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
163467553|NCT02918318|590411173|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
163467554|NCT02918318|590411174|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
163467555|NCT02918318|590411170|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
163467556|NCT02918318|590411171|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
163467557|NCT02918318|590411172|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
163467558|NCT02918318|590411173|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
163467559|NCT02918318|590411174|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
163467560|NCT02918318|590411170|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
163467561|NCT02918318|590411171|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
163467562|NCT02918318|590411172|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
163467563|NCT02918318|590411173|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
163467564|NCT02918318|590411174|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
163467565|NCT02918318|590411170|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
163467566|NCT02918318|590411171|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
163467567|NCT02918318|590411172|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
163467568|NCT02918318|590411173|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
163467569|NCT02918318|590411174|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
163467570|NCT00990249|590411175|FG000|Overall Study|Disease Progression|8|||
163467571|NCT00990249|590411175|FG000|Overall Study|Non-Compliance|1|||
163467572|NCT00990249|590411175|FG000|Overall Study|Death|2|||
163467573|NCT00990249|590411175|FG000|Overall Study|Not treated|2|||
163467574|NCT01548417|590411176|FG000|Overall Study|Withdrawal by Subject|0|||
163467575|NCT01548417|590411177|FG001|Overall Study|Withdrawal by Subject|2|||
163467576|NCT04583969|590411180|FG000|Overall Study|Death|31|||
163467577|NCT04583969|590411181|FG001|Overall Study|Death|38|||
163467578|NCT04583969|590411180|FG000|Overall Study|Lost to Follow-up|16|||
163467579|NCT04583969|590411181|FG001|Overall Study|Lost to Follow-up|13|||
163467580|NCT04583969|590411180|FG000|Overall Study|Protocol Violation|1|||
163467581|NCT04583969|590411181|FG001|Overall Study|Protocol Violation|0|||
163467582|NCT04583969|590411180|FG000|Overall Study|Withdrawal by Subject|3|||
163467583|NCT04583969|590411181|FG001|Overall Study|Withdrawal by Subject|3|||
163467584|NCT04583969|590411180|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
163467585|NCT04583969|590411181|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
163467586|NCT04583969|590411180|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
163467587|NCT04583969|590411181|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
163467588|NCT04583969|590411180|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
163467589|NCT04583969|590411181|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
163467590|NCT04583969|590411180|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
163467591|NCT04583969|590411181|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
163467592|NCT04583969|590411180|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
163467593|NCT04583969|590411181|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
163467594|NCT04080752|590411182|FG000|Overall Study|Adverse Event|2|||
163467595|NCT04080752|590411183|FG001|Overall Study|Adverse Event|3|||
163467596|NCT04080752|590411182|FG000|Overall Study|Lack of Efficacy|1|||
163467597|NCT04080752|590411183|FG001|Overall Study|Lack of Efficacy|0|||
163467598|NCT04080752|590411182|FG000|Overall Study|Lost to Follow-up|1|||
163467599|NCT04080752|590411183|FG001|Overall Study|Lost to Follow-up|0|||
163467600|NCT04080752|590411182|FG000|Overall Study|Pregnancy|0|||
163467601|NCT04080752|590411183|FG001|Overall Study|Pregnancy|1|||
163467602|NCT04080752|590411182|FG000|Overall Study|Withdrawal by Subject|7|||
163467603|NCT04080752|590411183|FG001|Overall Study|Withdrawal by Subject|0|||
163467604|NCT04080752|590411182|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163467605|NCT04080752|590411183|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163467606|NCT04080752|590411182|FG000|Overall Study|Other|2|||
163467607|NCT04080752|590411183|FG001|Overall Study|Other|1|||
163467608|NCT01194414|590411186|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
163467609|NCT01194414|590411187|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
163467610|NCT01194414|590411188|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
163467611|NCT01194414|590411189|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
163467612|NCT01194414|590411186|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
163467613|NCT01194414|590411187|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
163467614|NCT01194414|590411188|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
163467615|NCT01194414|590411189|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
163467616|NCT01194414|590411186|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
163467617|NCT01194414|590411187|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
163467618|NCT01194414|590411188|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
163467619|NCT01194414|590411189|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
163467620|NCT01194414|590411186|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
163467621|NCT01194414|590411187|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
163467622|NCT01194414|590411188|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
163467623|NCT01194414|590411189|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
163467624|NCT01194414|590411186|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
163467625|NCT01194414|590411187|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
163467626|NCT01194414|590411188|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
163467627|NCT01194414|590411189|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
163467628|NCT01194414|590411186|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
163467629|NCT01194414|590411187|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
163467630|NCT01194414|590411188|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
163467631|NCT01194414|590411189|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
163467632|NCT01194414|590411186|FG000|24 Weeks Double Blind Period|Other|0|||
163467633|NCT01194414|590411187|FG001|24 Weeks Double Blind Period|Other|1|||
163467634|NCT01194414|590411188|FG002|24 Weeks Double Blind Period|Other|0|||
163467635|NCT01194414|590411189|FG003|24 Weeks Double Blind Period|Other|0|||
163467636|NCT01194414|590411186|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
163467637|NCT01194414|590411187|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
163467638|NCT01194414|590411188|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
163467639|NCT01194414|590411189|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
163467640|NCT01194414|590411186|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
163467641|NCT01194414|590411187|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
163467642|NCT01194414|590411188|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
163467643|NCT01194414|590411189|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
163467644|NCT01194414|590411186|FG000|24 Weeks Double Blind Period|Death|0|||
163467645|NCT01194414|590411187|FG001|24 Weeks Double Blind Period|Death|1|||
163467646|NCT01194414|590411188|FG002|24 Weeks Double Blind Period|Death|0|||
163467647|NCT01194414|590411189|FG003|24 Weeks Double Blind Period|Death|0|||
163467648|NCT01194414|590411186|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
163467649|NCT01194414|590411187|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
163467650|NCT01194414|590411188|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
163467651|NCT01194414|590411189|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
163467652|NCT01194414|590411186|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
163467653|NCT01194414|590411187|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
163467654|NCT01194414|590411188|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
163467655|NCT01194414|590411189|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
163467656|NCT01194414|590411186|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
163467657|NCT01194414|590411187|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
163467658|NCT01194414|590411188|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
163467659|NCT01194414|590411189|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
163467660|NCT01194414|590411186|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
163467661|NCT01194414|590411187|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
163467662|NCT01194414|590411188|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
163467663|NCT01194414|590411189|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
163467664|NCT01194414|590411186|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
163467665|NCT01194414|590411187|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
163467666|NCT01194414|590411188|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
163467667|NCT01194414|590411189|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
163467668|NCT01194414|590411186|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
163467669|NCT01194414|590411187|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
163467670|NCT01194414|590411188|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
163467671|NCT01194414|590411189|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
163467672|NCT01194414|590411186|FG000|72 Weeks Open Label Extension|Other|2|||
163467673|NCT01194414|590411187|FG001|72 Weeks Open Label Extension|Other|1|||
163467674|NCT01194414|590411188|FG002|72 Weeks Open Label Extension|Other|0|||
163467675|NCT01194414|590411189|FG003|72 Weeks Open Label Extension|Other|0|||
163467676|NCT01194414|590411186|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
163467677|NCT01194414|590411187|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
163467678|NCT01194414|590411188|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
163467679|NCT01194414|590411189|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
163467680|NCT01194414|590411186|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
163467681|NCT01194414|590411187|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
163467682|NCT01194414|590411188|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
163467683|NCT01194414|590411189|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
163467684|NCT01194414|590411186|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
163467685|NCT01194414|590411187|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
163467686|NCT01194414|590411188|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
163467687|NCT01194414|590411189|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
163467688|NCT01194414|590411186|FG000|72 Weeks Open Label Extension|Death|1|||
163467689|NCT01194414|590411187|FG001|72 Weeks Open Label Extension|Death|2|||
163467690|NCT01194414|590411188|FG002|72 Weeks Open Label Extension|Death|0|||
163467691|NCT01194414|590411189|FG003|72 Weeks Open Label Extension|Death|2|||
163467692|NCT01098032|590411191|FG000|Overall Study|Withdrawal by Subject|1|||
163467693|NCT01098032|590411192|FG001|Overall Study|Withdrawal by Subject|1|||
163467694|NCT01641081|590411193|FG000|Period 1|Sponsor request (potential unblinding)|0|||
163467695|NCT01641081|590411194|FG001|Period 1|Sponsor request (potential unblinding)|0|||
163467696|NCT01641081|590411195|FG002|Period 1|Sponsor request (potential unblinding)|0|||
163467697|NCT01641081|590411196|FG003|Period 1|Sponsor request (potential unblinding)|0|||
163467698|NCT01641081|590411197|FG004|Period 1|Sponsor request (potential unblinding)|0|||
163467699|NCT01641081|590411198|FG005|Period 1|Sponsor request (potential unblinding)|0|||
163467700|NCT01641081|590411199|FG006|Period 1|Sponsor request (potential unblinding)|1|||
163467701|NCT01641081|590411200|FG007|Period 1|Sponsor request (potential unblinding)|0|||
163467702|NCT01641081|590411201|FG008|Period 1|Sponsor request (potential unblinding)|0|||
163467703|NCT01641081|590411202|FG009|Period 1|Sponsor request (potential unblinding)|0|||
163467704|NCT01641081|590411193|FG000|Period 1|Protocol Violation|0|||
163467705|NCT01641081|590411194|FG001|Period 1|Protocol Violation|0|||
163467706|NCT01641081|590411195|FG002|Period 1|Protocol Violation|0|||
163467707|NCT01641081|590411196|FG003|Period 1|Protocol Violation|0|||
163467708|NCT01641081|590411197|FG004|Period 1|Protocol Violation|1|||
163467709|NCT01641081|590411198|FG005|Period 1|Protocol Violation|0|||
163467710|NCT01641081|590411199|FG006|Period 1|Protocol Violation|0|||
163467711|NCT01641081|590411200|FG007|Period 1|Protocol Violation|1|||
163467712|NCT01641081|590411201|FG008|Period 1|Protocol Violation|0|||
163467713|NCT01641081|590411202|FG009|Period 1|Protocol Violation|0|||
163467714|NCT01641081|590411193|FG000|Period 1|Adverse Event|1|||
163467715|NCT01641081|590411194|FG001|Period 1|Adverse Event|0|||
163467716|NCT01641081|590411195|FG002|Period 1|Adverse Event|0|||
163467717|NCT01641081|590411196|FG003|Period 1|Adverse Event|0|||
163467718|NCT01641081|590411197|FG004|Period 1|Adverse Event|0|||
163467719|NCT01641081|590411198|FG005|Period 1|Adverse Event|0|||
163467720|NCT01641081|590411199|FG006|Period 1|Adverse Event|0|||
163467721|NCT01641081|590411200|FG007|Period 1|Adverse Event|2|||
163467722|NCT01641081|590411201|FG008|Period 1|Adverse Event|0|||
163467723|NCT01641081|590411202|FG009|Period 1|Adverse Event|0|||
163467724|NCT01641081|590411193|FG000|Period 2|Adverse Event|0|||
163467725|NCT01641081|590411194|FG001|Period 2|Adverse Event|0|||
163467726|NCT01641081|590411195|FG002|Period 2|Adverse Event|0|||
163467727|NCT01641081|590411196|FG003|Period 2|Adverse Event|0|||
163467728|NCT01641081|590411197|FG004|Period 2|Adverse Event|0|||
163467729|NCT01641081|590411198|FG005|Period 2|Adverse Event|1|||
163467730|NCT01641081|590411199|FG006|Period 2|Adverse Event|0|||
163467731|NCT01641081|590411200|FG007|Period 2|Adverse Event|0|||
163467732|NCT01641081|590411201|FG008|Period 2|Adverse Event|0|||
163467733|NCT01641081|590411202|FG009|Period 2|Adverse Event|0|||
163467734|NCT01641081|590411193|FG000|Period 2|Withdrawal by Subject|0|||
163467735|NCT01641081|590411194|FG001|Period 2|Withdrawal by Subject|0|||
163467736|NCT01641081|590411195|FG002|Period 2|Withdrawal by Subject|0|||
163467737|NCT01641081|590411196|FG003|Period 2|Withdrawal by Subject|1|||
163467738|NCT01641081|590411197|FG004|Period 2|Withdrawal by Subject|0|||
163467739|NCT01641081|590411198|FG005|Period 2|Withdrawal by Subject|0|||
163467740|NCT01641081|590411199|FG006|Period 2|Withdrawal by Subject|2|||
163467741|NCT01641081|590411200|FG007|Period 2|Withdrawal by Subject|0|||
163467742|NCT01641081|590411201|FG008|Period 2|Withdrawal by Subject|0|||
163467743|NCT01641081|590411202|FG009|Period 2|Withdrawal by Subject|0|||
163467744|NCT01641081|590411193|FG000|Period 2|Protocol Violation|1|||
163467745|NCT01641081|590411194|FG001|Period 2|Protocol Violation|0|||
163467746|NCT01641081|590411195|FG002|Period 2|Protocol Violation|0|||
163467747|NCT01641081|590411196|FG003|Period 2|Protocol Violation|0|||
163467748|NCT01641081|590411197|FG004|Period 2|Protocol Violation|0|||
163467749|NCT01641081|590411198|FG005|Period 2|Protocol Violation|0|||
163467750|NCT01641081|590411199|FG006|Period 2|Protocol Violation|0|||
163467751|NCT01641081|590411200|FG007|Period 2|Protocol Violation|0|||
163467752|NCT01641081|590411201|FG008|Period 2|Protocol Violation|0|||
163467753|NCT01641081|590411202|FG009|Period 2|Protocol Violation|0|||
163467754|NCT01641081|590411193|FG000|Period 3|Adverse Event|0|||
163467755|NCT01641081|590411194|FG001|Period 3|Adverse Event|0|||
163467756|NCT01641081|590411195|FG002|Period 3|Adverse Event|1|||
163467757|NCT01641081|590411196|FG003|Period 3|Adverse Event|0|||
163467758|NCT01641081|590411197|FG004|Period 3|Adverse Event|0|||
163467759|NCT01641081|590411198|FG005|Period 3|Adverse Event|0|||
163467760|NCT01641081|590411199|FG006|Period 3|Adverse Event|0|||
163467761|NCT01641081|590411200|FG007|Period 3|Adverse Event|0|||
163467762|NCT01641081|590411201|FG008|Period 3|Adverse Event|0|||
163467763|NCT01641081|590411202|FG009|Period 3|Adverse Event|0|||
163467764|NCT01641081|590411193|FG000|Period 3|Withdrawal by Subject|0|||
163467765|NCT01641081|590411194|FG001|Period 3|Withdrawal by Subject|0|||
163467766|NCT01641081|590411195|FG002|Period 3|Withdrawal by Subject|0|||
163467767|NCT01641081|590411196|FG003|Period 3|Withdrawal by Subject|0|||
163467768|NCT01641081|590411197|FG004|Period 3|Withdrawal by Subject|0|||
163467769|NCT01641081|590411198|FG005|Period 3|Withdrawal by Subject|0|||
163467770|NCT01641081|590411199|FG006|Period 3|Withdrawal by Subject|0|||
163467771|NCT01641081|590411200|FG007|Period 3|Withdrawal by Subject|0|||
163467772|NCT01641081|590411201|FG008|Period 3|Withdrawal by Subject|1|||
163467773|NCT01641081|590411202|FG009|Period 3|Withdrawal by Subject|0|||
163467774|NCT01641081|590411193|FG000|Period 4|Adverse Event|0|||
163467775|NCT01641081|590411194|FG001|Period 4|Adverse Event|1|||
163467776|NCT01641081|590411195|FG002|Period 4|Adverse Event|0|||
163467777|NCT01641081|590411196|FG003|Period 4|Adverse Event|1|||
163467778|NCT01641081|590411197|FG004|Period 4|Adverse Event|0|||
163467779|NCT01641081|590411198|FG005|Period 4|Adverse Event|0|||
163467780|NCT01641081|590411199|FG006|Period 4|Adverse Event|0|||
163467781|NCT01641081|590411200|FG007|Period 4|Adverse Event|0|||
163467782|NCT01641081|590411201|FG008|Period 4|Adverse Event|0|||
163467783|NCT01641081|590411202|FG009|Period 4|Adverse Event|0|||
163467784|NCT01641081|590411193|FG000|Period 5|Adverse Event|0|||
163467785|NCT01641081|590411194|FG001|Period 5|Adverse Event|0|||
163467786|NCT01641081|590411195|FG002|Period 5|Adverse Event|2|||
163467787|NCT01641081|590411196|FG003|Period 5|Adverse Event|0|||
163467788|NCT01641081|590411197|FG004|Period 5|Adverse Event|0|||
163467789|NCT01641081|590411198|FG005|Period 5|Adverse Event|0|||
163467790|NCT01641081|590411199|FG006|Period 5|Adverse Event|0|||
163467791|NCT01641081|590411200|FG007|Period 5|Adverse Event|0|||
163467792|NCT01641081|590411201|FG008|Period 5|Adverse Event|0|||
163467793|NCT01641081|590411202|FG009|Period 5|Adverse Event|0|||
163467794|NCT01095666|590411203|FG000|Overall Study|Lack of Efficacy|0|||
163467795|NCT01095666|590411204|FG001|Overall Study|Lack of Efficacy|0|||
163467796|NCT01095666|590411205|FG002|Overall Study|Lack of Efficacy|1|||
163467797|NCT01095666|590411203|FG000|Overall Study|Adverse Event|2|||
163467798|NCT01095666|590411204|FG001|Overall Study|Adverse Event|1|||
163467799|NCT01095666|590411205|FG002|Overall Study|Adverse Event|3|||
163467800|NCT01095666|590411203|FG000|Overall Study|Lost to Follow-up|2|||
163467801|NCT01095666|590411204|FG001|Overall Study|Lost to Follow-up|2|||
163467802|NCT01095666|590411205|FG002|Overall Study|Lost to Follow-up|0|||
163467803|NCT01095666|590411203|FG000|Overall Study|Withdrawal by Subject|6|||
163467804|NCT01095666|590411204|FG001|Overall Study|Withdrawal by Subject|6|||
163467805|NCT01095666|590411205|FG002|Overall Study|Withdrawal by Subject|1|||
163467806|NCT01095666|590411203|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
163467807|NCT01095666|590411204|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
163467808|NCT01095666|590411205|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
163467809|NCT04285853|590411208|FG000|Overall Study|Withdrawal by Subject|1|||
163467810|NCT04285853|590411209|FG001|Overall Study|Withdrawal by Subject|0|||
163467811|NCT04285853|590411208|FG000|Overall Study|Lost to Follow-up|9|||
163467812|NCT04285853|590411209|FG001|Overall Study|Lost to Follow-up|5|||
163467813|NCT02758613|590411212|FG000|Treatment|Physician and Sponsor Decision|1|||
163467814|NCT02758613|590411213|FG001|Treatment|Physician and Sponsor Decision|0|||
163467815|NCT02758613|590411214|FG002|Treatment|Physician and Sponsor Decision|0|||
163467816|NCT02758613|590411215|FG003|Treatment|Physician and Sponsor Decision|0|||
163467817|NCT02758613|590411212|FG000|Treatment|Withdrawal by Subject|1|||
163467818|NCT02758613|590411213|FG001|Treatment|Withdrawal by Subject|0|||
163467819|NCT02758613|590411214|FG002|Treatment|Withdrawal by Subject|1|||
163467820|NCT02758613|590411215|FG003|Treatment|Withdrawal by Subject|0|||
163467821|NCT00196196|590411221|FG000|Overall Study|Withdrawal by Subject|2|||
163467822|NCT00196196|590411221|FG000|Overall Study|Did not have required condition (hydroce|5|||
163467823|NCT02343952|590411222|FG000|Study Treatment|Disease Progression|23|||
163467824|NCT02343952|590411222|FG000|Study Treatment|Death|3|||
163467825|NCT02343952|590411222|FG000|Study Treatment|Adverse Event|19|||
163467826|NCT02343952|590411222|FG000|Study Treatment|Withdrawal by Subject|7|||
163467827|NCT02343952|590411222|FG000|Study Treatment|other complicating Diseases|1|||
163467828|NCT02343952|590411222|FG000|Follow up|Withdrawal by Subject|3|||
163467829|NCT02343952|590411222|FG000|Follow up|Death|33|||
163467830|NCT02343952|590411222|FG000|Follow up|Patient does not meet eligibility for study.|1|||
163467831|NCT02343952|590411222|FG000|Follow up|Research department closed by the practice.|5|||
163467832|NCT02343952|590411222|FG000|Follow up|Patient went home to Russia|1|||
163467833|NCT02343952|590411222|FG000|Follow up|Disease Progression|1|||
163467834|NCT02343952|590411222|FG000|Follow up|study terminated|1|||
163467835|NCT04018612|590411223|FG000|Overall Study|Withdrawal by Subject|1|||
163467836|NCT04018612|590411224|FG001|Overall Study|Withdrawal by Subject|0|||
163467837|NCT04018612|590411225|FG002|Overall Study|Withdrawal by Subject|1|||
163467838|NCT00361218|590411226|FG000|Overall Study|Lost to Follow-up|11|||
163467839|NCT00361218|590411226|FG000|Overall Study|Personal Reasons|7|||
163467840|NCT00361218|590411226|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
163467841|NCT02671760|590411227|FG000|Overall Study|Lost to Follow-up|0|||
163467842|NCT02671760|590411228|FG001|Overall Study|Lost to Follow-up|1|||
163467843|NCT02671760|590411229|FG002|Overall Study|Lost to Follow-up|0|||
163467844|NCT01041404|590411236|FG000|Overall Study|Adverse Event|45|||
163467845|NCT01041404|590411237|FG001|Overall Study|Adverse Event|35|||
163467846|NCT01041404|590411236|FG000|Overall Study|Lack of Efficacy|200|||
163467847|NCT01041404|590411237|FG001|Overall Study|Lack of Efficacy|210|||
163467848|NCT01041404|590411236|FG000|Overall Study|Violation of Selection Criteria|0|||
163467849|NCT01041404|590411237|FG001|Overall Study|Violation of Selection Criteria|1|||
163467850|NCT01041404|590411236|FG000|Overall Study|Protocol Violation|4|||
163467851|NCT01041404|590411237|FG001|Overall Study|Protocol Violation|0|||
163467852|NCT01041404|590411236|FG000|Overall Study|Withdrawal by Subject|29|||
163467853|NCT01041404|590411237|FG001|Overall Study|Withdrawal by Subject|23|||
163467854|NCT01041404|590411236|FG000|Overall Study|Failure to Return|1|||
163467855|NCT01041404|590411237|FG001|Overall Study|Failure to Return|2|||
163467856|NCT01041404|590411236|FG000|Overall Study|Other|11|||
163467857|NCT01041404|590411237|FG001|Overall Study|Other|23|||
163467858|NCT01750840|590411240|FG000|Overall Study|Lost to Follow-up|4|||
163467859|NCT00892957|590411244|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
163467860|NCT00892957|590411245|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
163467861|NCT00892957|590411244|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
163467862|NCT00892957|590411245|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
163467863|NCT02091921|590411246|FG000|Overall Study|Adverse Event|3|||
163467864|NCT02483078|590411247|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
163467865|NCT02483078|590411248|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
163467866|NCT02483078|590411247|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
163467867|NCT02483078|590411248|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
163467868|NCT02483078|590411247|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
163467869|NCT02483078|590411248|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
163467870|NCT02483078|590411247|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
163467871|NCT02483078|590411248|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
163467872|NCT02483078|590411247|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
163467873|NCT02483078|590411248|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
163467874|NCT02483078|590411247|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
163467875|NCT02483078|590411248|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
163467876|NCT04876599|590411249|FG000|Overall Study|Missed|2|||
163467877|NCT04876599|590411250|FG001|Overall Study|Missed|0|||
163467878|NCT04876599|590411249|FG000|Overall Study|Declined|2|||
163467879|NCT04876599|590411250|FG001|Overall Study|Declined|3|||
163467880|NCT00669032|590411255|FG000|Overall Study|Lost to Follow-up|6|||
163467881|NCT00669032|590411256|FG001|Overall Study|Lost to Follow-up|5|||
163467882|NCT00669032|590411255|FG000|Overall Study|Lack of Efficacy|8|||
163467883|NCT00669032|590411256|FG001|Overall Study|Lack of Efficacy|19|||
163467884|NCT00669032|590411255|FG000|Overall Study|Withdrawal by Subject|12|||
163467885|NCT00669032|590411256|FG001|Overall Study|Withdrawal by Subject|13|||
163467886|NCT00669032|590411255|FG000|Overall Study|Adverse Event|12|||
163467887|NCT00669032|590411256|FG001|Overall Study|Adverse Event|16|||
163467888|NCT00669032|590411255|FG000|Overall Study|Physician Decision|1|||
163467889|NCT00669032|590411256|FG001|Overall Study|Physician Decision|1|||
163467890|NCT00669032|590411255|FG000|Overall Study|No fulfilment of the selection criteria|5|||
163467891|NCT00669032|590411256|FG001|Overall Study|No fulfilment of the selection criteria|5|||
163467892|NCT01607073|590411257|FG000|Overall Study|Adverse Event|1|||
163467893|NCT04126031|590411259|FG000|Part A|Withdrawal by Subject|0|||
163467894|NCT04126031|590411260|FG001|Part A|Withdrawal by Subject|0|||
163467895|NCT04126031|590411261|FG002|Part A|Withdrawal by Subject|1|||
163467896|NCT04126031|590411262|FG003|Part A|Withdrawal by Subject|0|||
163467897|NCT04126031|590411263|FG004|Part A|Withdrawal by Subject|0|||
163467898|NCT04126031|590411264|FG005|Part A|Withdrawal by Subject|0|||
163467899|NCT04126031|590411259|FG000|Part A|Other|1|||
163467900|NCT04126031|590411260|FG001|Part A|Other|0|||
163467901|NCT04126031|590411261|FG002|Part A|Other|0|||
163467902|NCT04126031|590411262|FG003|Part A|Other|0|||
163467903|NCT04126031|590411263|FG004|Part A|Other|0|||
163467904|NCT04126031|590411264|FG005|Part A|Other|0|||
163467905|NCT04126031|590411259|FG000|Part B|Adverse Event|0|||
163467906|NCT04126031|590411260|FG001|Part B|Adverse Event|0|||
163467907|NCT04126031|590411261|FG002|Part B|Adverse Event|0|||
163467908|NCT04126031|590411262|FG003|Part B|Adverse Event|0|||
163467909|NCT04126031|590411263|FG004|Part B|Adverse Event|0|||
163467910|NCT04126031|590411264|FG005|Part B|Adverse Event|2|||
163467911|NCT04126031|590411259|FG000|Part B|Pre-existing hypertransaminasemia|0|||
163467912|NCT04126031|590411260|FG001|Part B|Pre-existing hypertransaminasemia|0|||
163467913|NCT04126031|590411261|FG002|Part B|Pre-existing hypertransaminasemia|0|||
163467914|NCT04126031|590411262|FG003|Part B|Pre-existing hypertransaminasemia|0|||
163467915|NCT04126031|590411263|FG004|Part B|Pre-existing hypertransaminasemia|1|||
163467916|NCT04126031|590411264|FG005|Part B|Pre-existing hypertransaminasemia|0|||
163467917|NCT00131664|590411265|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
163467918|NCT00131664|590411266|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
163467919|NCT00131664|590411267|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
163467920|NCT00131664|590411268|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
163467921|NCT00131664|590411269|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
163467922|NCT00131664|590411270|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
163467923|NCT00131664|590411265|FG000|First Period (First 6 Months)|Death|0|||
163467924|NCT00131664|590411266|FG001|First Period (First 6 Months)|Death|1|||
163467925|NCT00131664|590411267|FG002|First Period (First 6 Months)|Death|0|||
163467926|NCT00131664|590411268|FG003|First Period (First 6 Months)|Death|0|||
163467927|NCT00131664|590411269|FG004|First Period (First 6 Months)|Death|0|||
163467928|NCT00131664|590411270|FG005|First Period (First 6 Months)|Death|0|||
163467929|NCT00131664|590411265|FG000|First Period (First 6 Months)|Protocol Violation|2|||
163467930|NCT00131664|590411266|FG001|First Period (First 6 Months)|Protocol Violation|2|||
163467931|NCT00131664|590411267|FG002|First Period (First 6 Months)|Protocol Violation|1|||
163467932|NCT00131664|590411268|FG003|First Period (First 6 Months)|Protocol Violation|0|||
163467933|NCT00131664|590411269|FG004|First Period (First 6 Months)|Protocol Violation|0|||
163467934|NCT00131664|590411270|FG005|First Period (First 6 Months)|Protocol Violation|0|||
163467935|NCT00131664|590411265|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
163467936|NCT00131664|590411266|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
163467937|NCT00131664|590411267|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
163467938|NCT00131664|590411268|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
163467939|NCT00131664|590411269|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
163467940|NCT00131664|590411270|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
163467941|NCT00131664|590411265|FG000|First Period (First 6 Months)|Adverse Event|9|||
163467942|NCT00131664|590411266|FG001|First Period (First 6 Months)|Adverse Event|4|||
163467943|NCT00131664|590411267|FG002|First Period (First 6 Months)|Adverse Event|5|||
163467944|NCT00131664|590411268|FG003|First Period (First 6 Months)|Adverse Event|0|||
163467945|NCT00131664|590411269|FG004|First Period (First 6 Months)|Adverse Event|0|||
163467946|NCT00131664|590411270|FG005|First Period (First 6 Months)|Adverse Event|0|||
163467947|NCT00131664|590411265|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
163467948|NCT00131664|590411266|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
163467949|NCT00131664|590411267|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
163467950|NCT00131664|590411268|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
163467951|NCT00131664|590411269|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
163467952|NCT00131664|590411270|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
163467953|NCT00131664|590411265|FG000|First Period (First 6 Months)|Administrative reasons|2|||
163467954|NCT00131664|590411266|FG001|First Period (First 6 Months)|Administrative reasons|0|||
163467955|NCT00131664|590411267|FG002|First Period (First 6 Months)|Administrative reasons|5|||
163467956|NCT00131664|590411268|FG003|First Period (First 6 Months)|Administrative reasons|0|||
163467957|NCT00131664|590411269|FG004|First Period (First 6 Months)|Administrative reasons|0|||
163467958|NCT00131664|590411270|FG005|First Period (First 6 Months)|Administrative reasons|0|||
163467959|NCT00131664|590411265|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
163467960|NCT00131664|590411266|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
163467961|NCT00131664|590411267|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
163467962|NCT00131664|590411268|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
163467963|NCT00131664|590411269|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
163467964|NCT00131664|590411270|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
163467965|NCT00131664|590411265|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
163467966|NCT00131664|590411266|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
163467967|NCT00131664|590411267|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
163467968|NCT00131664|590411268|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
163467969|NCT00131664|590411269|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
163467970|NCT00131664|590411270|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
163467971|NCT00131664|590411265|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
163467972|NCT00131664|590411266|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
163467973|NCT00131664|590411267|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
163467974|NCT00131664|590411268|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
163467975|NCT00131664|590411269|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
163467976|NCT00131664|590411270|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
163467977|NCT00131664|590411265|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
163467978|NCT00131664|590411266|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
163467979|NCT00131664|590411267|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
163467980|NCT00131664|590411268|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
163467981|NCT00131664|590411269|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
163467982|NCT00131664|590411270|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
163467983|NCT00131664|590411265|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
163467984|NCT00131664|590411266|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
163467985|NCT00131664|590411267|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
163467986|NCT00131664|590411268|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
163467987|NCT00131664|590411269|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
163467988|NCT00131664|590411270|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
163467989|NCT00131664|590411265|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
163467990|NCT00131664|590411266|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
163467991|NCT00131664|590411267|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
163467992|NCT00131664|590411268|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
163467993|NCT00131664|590411269|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
163467994|NCT00131664|590411270|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
163467995|NCT01432756|590413029|FG000|Overall Study|Lost to Follow-up|1|||
163467996|NCT01432756|590413030|FG001|Overall Study|Lost to Follow-up|0|||
163467997|NCT01432756|590413031|FG002|Overall Study|Lost to Follow-up|2|||
163467998|NCT01432756|590413032|FG003|Overall Study|Lost to Follow-up|1|||
163467999|NCT02712008|590413033|FG000|Baseline (Day 1) up to Week 12|Death|3|||
163468000|NCT02712008|590413034|FG001|Baseline (Day 1) up to Week 12|Death|0|||
163468001|NCT02712008|590413035|FG002|Baseline (Day 1) up to Week 12|Death|0|||
163468002|NCT02712008|590413036|FG003|Baseline (Day 1) up to Week 12|Death|0|||
163468003|NCT02712008|590413037|FG004|Baseline (Day 1) up to Week 12|Death|0|||
163468004|NCT02712008|590413038|FG005|Baseline (Day 1) up to Week 12|Death|0|||
163468005|NCT02712008|590413039|FG006|Baseline (Day 1) up to Week 12|Death|0|||
163468006|NCT02712008|590413040|FG007|Baseline (Day 1) up to Week 12|Death|0|||
163468007|NCT02712008|590413033|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
163468008|NCT02712008|590413034|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
163468009|NCT02712008|590413035|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
163468010|NCT02712008|590413036|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
163468011|NCT02712008|590413037|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
163468012|NCT02712008|590413038|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
163468013|NCT02712008|590413039|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
163468014|NCT02712008|590413040|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
163468015|NCT02712008|590413033|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
163468016|NCT02712008|590413034|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
163468017|NCT02712008|590413035|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
163468018|NCT02712008|590413036|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
163468019|NCT02712008|590413037|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
163468020|NCT02712008|590413038|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
163468021|NCT02712008|590413039|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
163468022|NCT02712008|590413040|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
163468023|NCT02712008|590413033|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
163468024|NCT02712008|590413034|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
163468025|NCT02712008|590413035|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
163468026|NCT02712008|590413036|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
163468027|NCT02712008|590413037|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
163468028|NCT02712008|590413038|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
163468029|NCT02712008|590413039|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
163468030|NCT02712008|590413040|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
163468031|NCT02712008|590413033|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
163468032|NCT02712008|590413034|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
163468033|NCT02712008|590413035|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
163468034|NCT02712008|590413036|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
163468035|NCT02712008|590413037|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
163468036|NCT02712008|590413038|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
163468037|NCT02712008|590413039|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
163468038|NCT02712008|590413040|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
163468039|NCT02712008|590413033|FG000|From Week 12 up to Week 36|Adverse Event|0|||
163468040|NCT02712008|590413034|FG001|From Week 12 up to Week 36|Adverse Event|0|||
163468041|NCT02712008|590413035|FG002|From Week 12 up to Week 36|Adverse Event|0|||
163468042|NCT02712008|590413036|FG003|From Week 12 up to Week 36|Adverse Event|0|||
163468043|NCT02712008|590413037|FG004|From Week 12 up to Week 36|Adverse Event|1|||
163468044|NCT02712008|590413038|FG005|From Week 12 up to Week 36|Adverse Event|0|||
163468045|NCT02712008|590413039|FG006|From Week 12 up to Week 36|Adverse Event|0|||
163468046|NCT02712008|590413040|FG007|From Week 12 up to Week 36|Adverse Event|2|||
163468047|NCT02712008|590413033|FG000|From Week 12 up to Week 36|Death|1|||
163468048|NCT02712008|590413034|FG001|From Week 12 up to Week 36|Death|0|||
163468049|NCT02712008|590413035|FG002|From Week 12 up to Week 36|Death|0|||
163468050|NCT02712008|590413036|FG003|From Week 12 up to Week 36|Death|0|||
163468051|NCT02712008|590413037|FG004|From Week 12 up to Week 36|Death|0|||
163468052|NCT02712008|590413038|FG005|From Week 12 up to Week 36|Death|0|||
163468053|NCT02712008|590413039|FG006|From Week 12 up to Week 36|Death|1|||
163468054|NCT02712008|590413040|FG007|From Week 12 up to Week 36|Death|0|||
163468055|NCT02712008|590413033|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
163468056|NCT02712008|590413034|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
163468057|NCT02712008|590413035|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
163468058|NCT02712008|590413036|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
163468059|NCT02712008|590413037|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
163468060|NCT02712008|590413038|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
163468061|NCT02712008|590413039|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
163468062|NCT02712008|590413040|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
163468063|NCT02712008|590413033|FG000|From Week 12 up to Week 36|Physician Decision|0|||
163468064|NCT02712008|590413034|FG001|From Week 12 up to Week 36|Physician Decision|0|||
163468065|NCT02712008|590413035|FG002|From Week 12 up to Week 36|Physician Decision|0|||
163468066|NCT02712008|590413036|FG003|From Week 12 up to Week 36|Physician Decision|1|||
163468067|NCT02712008|590413037|FG004|From Week 12 up to Week 36|Physician Decision|1|||
163468068|NCT02712008|590413038|FG005|From Week 12 up to Week 36|Physician Decision|0|||
163468069|NCT02712008|590413039|FG006|From Week 12 up to Week 36|Physician Decision|0|||
163468070|NCT02712008|590413040|FG007|From Week 12 up to Week 36|Physician Decision|0|||
163468071|NCT02712008|590413033|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
163468072|NCT02712008|590413034|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
163468073|NCT02712008|590413035|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
163468074|NCT02712008|590413036|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
163468075|NCT02712008|590413037|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
163468076|NCT02712008|590413038|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
163468077|NCT02712008|590413039|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
163468078|NCT02712008|590413040|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
163468079|NCT00364351|590413041|FG000|Overall Study|Adverse Event|90|||
163468080|NCT00364351|590413042|FG001|Overall Study|Adverse Event|44|||
163468081|NCT00364351|590413041|FG000|Overall Study|Condition under investigation worsened|469|||
163468082|NCT00364351|590413042|FG001|Overall Study|Condition under investigation worsened|497|||
163468083|NCT00364351|590413041|FG000|Overall Study|Prohibited concomitant medication|0|||
163468084|NCT00364351|590413042|FG001|Overall Study|Prohibited concomitant medication|2|||
163468085|NCT00364351|590413041|FG000|Overall Study|Lost to Follow-up|1|||
163468086|NCT00364351|590413042|FG001|Overall Study|Lost to Follow-up|1|||
163468087|NCT00364351|590413041|FG000|Overall Study|Withdrawal by Subject|30|||
163468088|NCT00364351|590413042|FG001|Overall Study|Withdrawal by Subject|29|||
163468089|NCT00364351|590413041|FG000|Overall Study|Incorrect enrollment|1|||
163468090|NCT00364351|590413042|FG001|Overall Study|Incorrect enrollment|1|||
163468091|NCT00364351|590413041|FG000|Overall Study|Sponsor decision|1|||
163468092|NCT00364351|590413042|FG001|Overall Study|Sponsor decision|0|||
163468093|NCT00364351|590413041|FG000|Overall Study|Poor treatment compliance|0|||
163468094|NCT00364351|590413042|FG001|Overall Study|Poor treatment compliance|3|||
163468095|NCT00364351|590413041|FG000|Overall Study|Investigator error|0|||
163468096|NCT00364351|590413042|FG001|Overall Study|Investigator error|2|||
163468097|NCT00364351|590413041|FG000|Overall Study|Patient could not travel to site|0|||
163468098|NCT00364351|590413042|FG001|Overall Study|Patient could not travel to site|1|||
163468099|NCT00364351|590413041|FG000|Overall Study|Randomised treatment not started|0|||
163468100|NCT00364351|590413042|FG001|Overall Study|Randomised treatment not started|3|||
163468101|NCT00509028|590413046|FG000|Overall Study|Adverse Event|2|||
163468102|NCT00509028|590413047|FG001|Overall Study|Adverse Event|0|||
163468103|NCT00509028|590413046|FG000|Overall Study|Withdrawal by Subject|4|||
163468104|NCT00509028|590413047|FG001|Overall Study|Withdrawal by Subject|3|||
163468105|NCT00509028|590413046|FG000|Overall Study|Lost to Follow-up|0|||
163468106|NCT00509028|590413047|FG001|Overall Study|Lost to Follow-up|1|||
163468107|NCT00509028|590413046|FG000|Overall Study|Protocol Violation|4|||
163468108|NCT00509028|590413047|FG001|Overall Study|Protocol Violation|2|||
163468109|NCT00509028|590413046|FG000|Overall Study|Non-compliance|2|||
163468110|NCT00509028|590413047|FG001|Overall Study|Non-compliance|1|||
163468111|NCT02996110|590413048|FG000|Pre-Treatment|Other Reasons|0|||
163468112|NCT02996110|590413049|FG001|Pre-Treatment|Other Reasons|1|||
163468113|NCT02996110|590413050|FG002|Pre-Treatment|Other Reasons|0|||
163468114|NCT02996110|590413051|FG003|Pre-Treatment|Other Reasons|0|||
163468115|NCT02996110|590413052|FG004|Pre-Treatment|Other Reasons|1|||
163468116|NCT02996110|590413048|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
163468117|NCT02996110|590413049|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
163468118|NCT02996110|590413050|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
163468119|NCT02996110|590413051|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
163468120|NCT02996110|590413052|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
163468121|NCT02996110|590413048|FG000|Track 1|Disease Progression|15|||
163468122|NCT02996110|590413049|FG001|Track 1|Disease Progression|17|||
163468123|NCT02996110|590413050|FG002|Track 1|Disease Progression|0|||
163468124|NCT02996110|590413051|FG003|Track 1|Disease Progression|0|||
163468125|NCT02996110|590413052|FG004|Track 1|Disease Progression|0|||
163468126|NCT02996110|590413048|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
163468127|NCT02996110|590413049|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
163468128|NCT02996110|590413050|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
163468129|NCT02996110|590413051|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
163468130|NCT02996110|590413052|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
163468131|NCT02996110|590413048|FG000|Track 1|Study Drug Toxicity|5|||
163468132|NCT02996110|590413049|FG001|Track 1|Study Drug Toxicity|3|||
163468133|NCT02996110|590413050|FG002|Track 1|Study Drug Toxicity|0|||
163468134|NCT02996110|590413051|FG003|Track 1|Study Drug Toxicity|0|||
163468135|NCT02996110|590413052|FG004|Track 1|Study Drug Toxicity|0|||
163468136|NCT02996110|590413048|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
163468137|NCT02996110|590413049|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
163468138|NCT02996110|590413050|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
163468139|NCT02996110|590413051|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
163468140|NCT02996110|590413052|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
163468141|NCT02996110|590413048|FG000|Track 1|Administrative Reason by Sponsor|0|||
163468142|NCT02996110|590413049|FG001|Track 1|Administrative Reason by Sponsor|1|||
163468143|NCT02996110|590413050|FG002|Track 1|Administrative Reason by Sponsor|0|||
163468144|NCT02996110|590413051|FG003|Track 1|Administrative Reason by Sponsor|0|||
163468145|NCT02996110|590413052|FG004|Track 1|Administrative Reason by Sponsor|0|||
163468146|NCT02996110|590413048|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
163468147|NCT02996110|590413049|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
163468148|NCT02996110|590413050|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
163468149|NCT02996110|590413051|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
163468150|NCT02996110|590413052|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
163468151|NCT02996110|590413048|FG000|Track 2|Disease Progression|33|||
163468152|NCT02996110|590413049|FG001|Track 2|Disease Progression|26|||
163468153|NCT02996110|590413050|FG002|Track 2|Disease Progression|19|||
163468154|NCT02996110|590413051|FG003|Track 2|Disease Progression|16|||
163468155|NCT02996110|590413052|FG004|Track 2|Disease Progression|15|||
163468156|NCT02996110|590413048|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
163468157|NCT02996110|590413049|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
163468158|NCT02996110|590413050|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
163468159|NCT02996110|590413051|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
163468160|NCT02996110|590413052|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
163468161|NCT02996110|590413048|FG000|Track 2|Death|0|||
163468162|NCT02996110|590413049|FG001|Track 2|Death|0|||
163468163|NCT02996110|590413050|FG002|Track 2|Death|1|||
163468164|NCT02996110|590413051|FG003|Track 2|Death|0|||
163468165|NCT02996110|590413052|FG004|Track 2|Death|1|||
163468166|NCT02996110|590413048|FG000|Track 2|Study Drug Toxicity|4|||
163468167|NCT02996110|590413049|FG001|Track 2|Study Drug Toxicity|1|||
163468168|NCT02996110|590413050|FG002|Track 2|Study Drug Toxicity|4|||
163468169|NCT02996110|590413051|FG003|Track 2|Study Drug Toxicity|1|||
163468170|NCT02996110|590413052|FG004|Track 2|Study Drug Toxicity|0|||
163468171|NCT02996110|590413048|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
163468172|NCT02996110|590413049|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
163468173|NCT02996110|590413050|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
163468174|NCT02996110|590413051|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
163468175|NCT02996110|590413052|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
163468176|NCT02996110|590413048|FG000|Track 2|Participant Withdrew Consent|1|||
163468177|NCT02996110|590413049|FG001|Track 2|Participant Withdrew Consent|2|||
163468178|NCT02996110|590413050|FG002|Track 2|Participant Withdrew Consent|3|||
163468179|NCT02996110|590413051|FG003|Track 2|Participant Withdrew Consent|1|||
163468180|NCT02996110|590413052|FG004|Track 2|Participant Withdrew Consent|1|||
163468181|NCT02996110|590413048|FG000|Track 2|Other Reasons|0|||
163468182|NCT02996110|590413049|FG001|Track 2|Other Reasons|0|||
163468183|NCT02996110|590413050|FG002|Track 2|Other Reasons|1|||
163468184|NCT02996110|590413051|FG003|Track 2|Other Reasons|0|||
163468185|NCT02996110|590413052|FG004|Track 2|Other Reasons|1|||
163468186|NCT02436915|590413053|FG000|Overall Study|Withdrawal by Subject|0|||
163468187|NCT02436915|590413054|FG001|Overall Study|Withdrawal by Subject|1|||
163468188|NCT03805971|590413055|FG000|Overall Study|Withdrawal by Subject|1|||
163468189|NCT03805971|590413055|FG000|Overall Study|Protocol Violation|2|||
163468190|NCT00364832|590413060|FG000|Core Period|Early Withdrawals|2|||
163468191|NCT00364832|590413061|FG001|Core Period|Early Withdrawals|2|||
163468192|NCT00364832|590413062|FG002|Core Period|Early Withdrawals|1|||
163468193|NCT00364832|590413063|FG003|Core Period|Early Withdrawals|1|||
163468194|NCT00364832|590413064|FG004|Core Period|Early Withdrawals|0|||
163468195|NCT00364832|590413065|FG005|Core Period|Early Withdrawals|0|||
163468196|NCT00364832|590413066|FG006|Core Period|Early Withdrawals|4|||
163468197|NCT00364832|590413067|FG007|Core Period|Early Withdrawals|1|||
163468198|NCT00364832|590413068|FG008|Core Period|Early Withdrawals|0|||
163468199|NCT00364832|590413069|FG009|Core Period|Early Withdrawals|0|||
163468200|NCT00364832|590413070|FG010|Core Period|Early Withdrawals|0|||
163468201|NCT00364832|590413071|FG011|Core Period|Early Withdrawals|0|||
163468202|NCT00364832|590413060|FG000|Extension Year 1|Early Withdrawals|0|||
163468203|NCT00364832|590413061|FG001|Extension Year 1|Early Withdrawals|0|||
163468204|NCT00364832|590413062|FG002|Extension Year 1|Early Withdrawals|0|||
163468205|NCT00364832|590413063|FG003|Extension Year 1|Early Withdrawals|0|||
163468206|NCT00364832|590413064|FG004|Extension Year 1|Early Withdrawals|0|||
163468207|NCT00364832|590413065|FG005|Extension Year 1|Early Withdrawals|0|||
163468208|NCT00364832|590413066|FG006|Extension Year 1|Early Withdrawals|0|||
163468209|NCT00364832|590413067|FG007|Extension Year 1|Early Withdrawals|0|||
163468210|NCT00364832|590413068|FG008|Extension Year 1|Early Withdrawals|0|||
163468211|NCT00364832|590413069|FG009|Extension Year 1|Early Withdrawals|4|||
163468212|NCT00364832|590413070|FG010|Extension Year 1|Early Withdrawals|2|||
163468213|NCT00364832|590413071|FG011|Extension Year 1|Early Withdrawals|10|||
163468214|NCT00364832|590413060|FG000|Extension Year 2|Early Withdrawals|0|||
163468215|NCT00364832|590413061|FG001|Extension Year 2|Early Withdrawals|0|||
163468216|NCT00364832|590413062|FG002|Extension Year 2|Early Withdrawals|0|||
163468217|NCT00364832|590413063|FG003|Extension Year 2|Early Withdrawals|0|||
163468218|NCT00364832|590413064|FG004|Extension Year 2|Early Withdrawals|0|||
163468219|NCT00364832|590413065|FG005|Extension Year 2|Early Withdrawals|0|||
163468220|NCT00364832|590413066|FG006|Extension Year 2|Early Withdrawals|0|||
163468221|NCT00364832|590413067|FG007|Extension Year 2|Early Withdrawals|0|||
163468222|NCT00364832|590413068|FG008|Extension Year 2|Early Withdrawals|0|||
163468223|NCT00364832|590413069|FG009|Extension Year 2|Early Withdrawals|5|||
163468224|NCT00364832|590413070|FG010|Extension Year 2|Early Withdrawals|5|||
163468225|NCT00364832|590413071|FG011|Extension Year 2|Early Withdrawals|3|||
163468226|NCT02939976|590413075|FG000|Overall Study|Lost to Follow-up|7|||
163468227|NCT02939976|590413076|FG001|Overall Study|Lost to Follow-up|1|||
163468228|NCT02939976|590413077|FG002|Overall Study|Lost to Follow-up|1|||
163468229|NCT02939976|590413078|FG003|Overall Study|Lost to Follow-up|2|||
163468230|NCT02939976|590413075|FG000|Overall Study|Withdrawal by Subject|4|||
163468231|NCT02939976|590413076|FG001|Overall Study|Withdrawal by Subject|0|||
163468232|NCT02939976|590413077|FG002|Overall Study|Withdrawal by Subject|2|||
163468233|NCT02939976|590413078|FG003|Overall Study|Withdrawal by Subject|4|||
163468234|NCT02939976|590413075|FG000|Overall Study|Due to early study closure|4|||
163468235|NCT02939976|590413076|FG001|Overall Study|Due to early study closure|3|||
163468236|NCT02939976|590413077|FG002|Overall Study|Due to early study closure|2|||
163468237|NCT02939976|590413078|FG003|Overall Study|Due to early study closure|3|||
163468238|NCT01585168|590413083|FG000|Overall Study|Lost to Follow-up|3|||
163468239|NCT01585168|590413084|FG001|Overall Study|Lost to Follow-up|1|||
163468240|NCT01585168|590413085|FG002|Overall Study|Lost to Follow-up|1|||
163468241|NCT01585168|590413086|FG003|Overall Study|Lost to Follow-up|1|||
163468242|NCT01192100|590413087|FG000|Overall Study|Withdrawal by Subject|0|||
163468243|NCT01192100|590413088|FG001|Overall Study|Withdrawal by Subject|0|||
163468244|NCT01192100|590413089|FG002|Overall Study|Withdrawal by Subject|0|||
163468245|NCT01192100|590413090|FG003|Overall Study|Withdrawal by Subject|0|||
163468246|NCT01192100|590413091|FG004|Overall Study|Withdrawal by Subject|1|||
163468247|NCT01192100|590413092|FG005|Overall Study|Withdrawal by Subject|0|||
163468248|NCT01192100|590413087|FG000|Overall Study|Protocol Violation|0|||
163468249|NCT01192100|590413088|FG001|Overall Study|Protocol Violation|0|||
163468250|NCT01192100|590413089|FG002|Overall Study|Protocol Violation|0|||
163468251|NCT01192100|590413090|FG003|Overall Study|Protocol Violation|1|||
163468252|NCT01192100|590413091|FG004|Overall Study|Protocol Violation|0|||
163468253|NCT01192100|590413092|FG005|Overall Study|Protocol Violation|0|||
163468254|NCT02057068|590413093|FG000|Overall Study|Withdrawal by Subject|2|||
163468255|NCT02057068|590413094|FG001|Overall Study|Withdrawal by Subject|2|||
163468256|NCT02057068|590413093|FG000|Overall Study|Caregiver (CG) Health|0|||
163468257|NCT02057068|590413094|FG001|Overall Study|Caregiver (CG) Health|2|||
163468258|NCT02057068|590413093|FG000|Overall Study|Carepartner (CP) Health|4|||
163468259|NCT02057068|590413094|FG001|Overall Study|Carepartner (CP) Health|2|||
163468260|NCT02057068|590413093|FG000|Overall Study|Lost to Follow-up|2|||
163468261|NCT02057068|590413094|FG001|Overall Study|Lost to Follow-up|2|||
163468262|NCT00329784|590413098|FG000|Overall Study|Lost to Follow-up|0|||
163468263|NCT00329784|590413099|FG001|Overall Study|Lost to Follow-up|1|||
163468264|NCT00329784|590413100|FG002|Overall Study|Lost to Follow-up|0|||
163468265|NCT00329784|590413101|FG003|Overall Study|Lost to Follow-up|0|||
163468266|NCT00329784|590413098|FG000|Overall Study|Withdrawal by Subject|4|||
163468267|NCT00329784|590413099|FG001|Overall Study|Withdrawal by Subject|2|||
163468268|NCT00329784|590413100|FG002|Overall Study|Withdrawal by Subject|0|||
163468269|NCT00329784|590413101|FG003|Overall Study|Withdrawal by Subject|0|||
163468270|NCT00329784|590413098|FG000|Overall Study|Other|1|||
163468271|NCT00329784|590413099|FG001|Overall Study|Other|2|||
163468272|NCT00329784|590413100|FG002|Overall Study|Other|0|||
163468273|NCT00329784|590413101|FG003|Overall Study|Other|0|||
163468274|NCT01421069|590413102|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
163468275|NCT01421069|590413102|FG000|Parent Study|Failed to return|3|||
163468276|NCT01421069|590413102|FG000|Parent Study|Withdrawal by Subject|1|||
163468277|NCT01421069|590413102|FG000|Parent Study|Lost to Follow-up|2|||
163468278|NCT01421069|590413102|FG000|Parent Study|Lack of Efficacy|1|||
163468279|NCT01421069|590413102|FG000|Overall Period for Extension Study|Other|2|||
163468280|NCT01421069|590413102|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
163468281|NCT01421069|590413102|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
163468282|NCT01421069|590413102|FG000|Overall Period for Extension Study|Pregnancy|1|||
163468283|NCT01421069|590413102|FG000|Overall Period for Extension Study|Adverse Event|1|||
163468284|NCT01421069|590413102|FG000|Overall Period for Extension Study|Protocol Violation|1|||
163468285|NCT01421069|590413102|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
163468286|NCT01421069|590413102|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
163468287|NCT01421069|590413102|FG000|Active Treatment Period|Other|1|||
163468288|NCT01421069|590413102|FG000|Active Treatment Period|No longer willing to participate in study|8|||
163468289|NCT01421069|590413102|FG000|Active Treatment Period|Insufficient clinical response|1|||
163468290|NCT01421069|590413102|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
163468291|NCT01421069|590413102|FG000|Active Treatment Period|Pregnancy|1|||
163468292|NCT01421069|590413102|FG000|Active Treatment Period|Adverse Event|1|||
163468293|NCT01421069|590413102|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
163468294|NCT01421069|590413102|FG000|Active Treatment Period|Enrolled in observational period|29|||
163468295|NCT01421069|590413102|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
163468296|NCT01421069|590413102|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
163468297|NCT01421069|590413102|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
163468298|NCT01421069|590413102|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
163468299|NCT01421069|590413102|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
163468300|NCT01421069|590413102|FG000|2b. Retreatment Period|Protocol Violation|1|||
163468301|NCT01421069|590413102|FG000|Observational Period|Other|1|||
163468302|NCT01421069|590413102|FG000|Observational Period|No longer willing to participate in study|4|||
163468303|NCT01421069|590413102|FG000|Observational Period|Lost to Follow-up|3|||
163468304|NCT00841672|590413110|FG000|Overall Study|Adverse Event|7|||
163468305|NCT00841672|590413111|FG001|Overall Study|Adverse Event|16|||
163468306|NCT00841672|590413110|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163468307|NCT00841672|590413111|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163468308|NCT00841672|590413110|FG000|Overall Study|Subject withdrew consent|2|||
163468309|NCT00841672|590413111|FG001|Overall Study|Subject withdrew consent|4|||
163468310|NCT00841672|590413110|FG000|Overall Study|Lost to Follow-up|1|||
163468311|NCT00841672|590413111|FG001|Overall Study|Lost to Follow-up|1|||
163468312|NCT00841672|590413110|FG000|Overall Study|Administrative problems|9|||
163468313|NCT00841672|590413111|FG001|Overall Study|Administrative problems|9|||
163468314|NCT00841672|590413110|FG000|Overall Study|Misrandomized|1|||
163468315|NCT00841672|590413111|FG001|Overall Study|Misrandomized|0|||
163468316|NCT00841672|590413110|FG000|Overall Study|Protocol Deviation|0|||
163468317|NCT00841672|590413111|FG001|Overall Study|Protocol Deviation|1|||
163468318|NCT01928082|590413113|FG000|Overall Study|Study terminated.|1|||
163468319|NCT05563714|590413114|FG000|Overall Study|Death|2|||
163468320|NCT05563714|590413115|FG001|Overall Study|Death|2|||
163468321|NCT05563714|590413116|FG002|Overall Study|Death|0|||
163468322|NCT05563714|590413117|FG003|Overall Study|Death|0|||
163468323|NCT05563714|590413114|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
163468324|NCT05563714|590413115|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
163468325|NCT05563714|590413116|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
163468326|NCT05563714|590413117|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
163468327|NCT05563714|590413114|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
163468328|NCT05563714|590413115|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
163468329|NCT05563714|590413116|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
163468330|NCT05563714|590413117|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
163468331|NCT05563714|590413114|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
163468332|NCT05563714|590413115|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
163468333|NCT05563714|590413116|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
163468334|NCT05563714|590413117|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
163468335|NCT05563714|590413114|FG000|Overall Study|Lost to Follow-up|22|||
163468336|NCT05563714|590413115|FG001|Overall Study|Lost to Follow-up|19|||
163468337|NCT05563714|590413116|FG002|Overall Study|Lost to Follow-up|0|||
163468338|NCT05563714|590413117|FG003|Overall Study|Lost to Follow-up|0|||
163468339|NCT02427100|590413120|FG000|Overall Study|Lost to Follow-up|0|||
163468340|NCT02427100|590413121|FG001|Overall Study|Lost to Follow-up|2|||
163468341|NCT02120352|590413122|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
163468342|NCT02120352|590413123|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
163468343|NCT02120352|590413124|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
163468344|NCT02120352|590413125|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
163468345|NCT02120352|590413126|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
163468346|NCT02120352|590413127|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
163468347|NCT02120352|590413128|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
163468348|NCT02120352|590413122|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
163468349|NCT02120352|590413123|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
163468350|NCT02120352|590413124|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
163468351|NCT02120352|590413125|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
163468352|NCT02120352|590413126|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
163468353|NCT02120352|590413127|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
163468354|NCT02120352|590413128|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
163468355|NCT02120352|590413122|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
163468356|NCT02120352|590413123|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
163468357|NCT02120352|590413124|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
163468358|NCT02120352|590413125|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
163468359|NCT02120352|590413126|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
163468360|NCT02120352|590413127|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
163468361|NCT02120352|590413128|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
163468362|NCT02120352|590413122|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
163468363|NCT02120352|590413123|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
163468364|NCT02120352|590413124|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
163468365|NCT02120352|590413125|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
163468366|NCT02120352|590413126|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
163468367|NCT02120352|590413127|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
163468368|NCT02120352|590413128|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
163468369|NCT02120352|590413122|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
163468370|NCT02120352|590413123|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
163468371|NCT02120352|590413124|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
163468372|NCT02120352|590413125|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
163468373|NCT02120352|590413126|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
163468374|NCT02120352|590413127|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
163468375|NCT02120352|590413128|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
163468376|NCT02120352|590413122|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
163468377|NCT02120352|590413123|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
163468378|NCT02120352|590413124|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
163468379|NCT02120352|590413125|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
163468380|NCT02120352|590413126|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
163468381|NCT02120352|590413127|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
163468382|NCT02120352|590413128|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
163468383|NCT02120352|590413122|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
163468384|NCT02120352|590413123|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
163468385|NCT02120352|590413124|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
163468386|NCT02120352|590413125|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
163468387|NCT02120352|590413126|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
163468388|NCT02120352|590413127|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
163468389|NCT02120352|590413128|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
163468390|NCT02120352|590413122|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
163468391|NCT02120352|590413123|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
163468392|NCT02120352|590413124|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
163468393|NCT02120352|590413125|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
163468394|NCT02120352|590413126|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
163468395|NCT02120352|590413127|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
163468396|NCT02120352|590413128|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
163468397|NCT02120352|590413122|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
163468398|NCT02120352|590413123|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
163468399|NCT02120352|590413124|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
163468400|NCT02120352|590413125|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
163468401|NCT02120352|590413126|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
163468402|NCT02120352|590413127|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
163468403|NCT02120352|590413128|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
163468404|NCT02120352|590413122|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
163468405|NCT02120352|590413123|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
163468406|NCT02120352|590413124|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
163468407|NCT02120352|590413125|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
163468408|NCT02120352|590413126|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
163468409|NCT02120352|590413127|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
163468410|NCT02120352|590413128|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
163468411|NCT02120352|590413122|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
163468412|NCT02120352|590413123|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
163468413|NCT02120352|590413124|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
163468414|NCT02120352|590413125|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
163468415|NCT02120352|590413126|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
163468416|NCT02120352|590413127|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
163468417|NCT02120352|590413128|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
163468418|NCT02120352|590413122|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
163468419|NCT02120352|590413123|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
163468420|NCT02120352|590413124|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
163468421|NCT02120352|590413125|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
163468422|NCT02120352|590413126|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
163468423|NCT02120352|590413127|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
163468424|NCT02120352|590413128|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
163468425|NCT02120352|590413122|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
163468426|NCT02120352|590413123|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
163468427|NCT02120352|590413124|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
163468428|NCT02120352|590413125|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
163468429|NCT02120352|590413126|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
163468430|NCT02120352|590413127|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
163468431|NCT02120352|590413128|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
163468432|NCT02120352|590413122|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
163468433|NCT02120352|590413123|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
163468434|NCT02120352|590413124|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
163468435|NCT02120352|590413125|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
163468436|NCT02120352|590413126|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
163468437|NCT02120352|590413127|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
163468438|NCT02120352|590413128|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
163468439|NCT02120352|590413122|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
163468440|NCT02120352|590413123|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
163468441|NCT02120352|590413124|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
163468442|NCT02120352|590413125|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
163468443|NCT02120352|590413126|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
163468444|NCT02120352|590413127|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
163468445|NCT02120352|590413128|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
163468446|NCT02120352|590413122|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
163468447|NCT02120352|590413123|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
163468448|NCT02120352|590413124|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
163468449|NCT02120352|590413125|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
163468450|NCT02120352|590413126|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
163468451|NCT02120352|590413127|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
163468452|NCT02120352|590413128|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
163468453|NCT02120352|590413122|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
163468454|NCT02120352|590413123|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
163468455|NCT02120352|590413124|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
163468456|NCT02120352|590413125|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
163468457|NCT02120352|590413126|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
163468458|NCT02120352|590413127|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
163468459|NCT02120352|590413128|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
163468460|NCT02120352|590413122|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
163468461|NCT02120352|590413123|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
163468462|NCT02120352|590413124|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
163468463|NCT02120352|590413125|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
163468464|NCT02120352|590413126|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
163468465|NCT02120352|590413127|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
163468466|NCT02120352|590413128|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
163468467|NCT02120352|590413122|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
163468468|NCT02120352|590413123|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
163468469|NCT02120352|590413124|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
163468470|NCT02120352|590413125|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
163468471|NCT02120352|590413126|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
163468472|NCT02120352|590413127|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
163468473|NCT02120352|590413128|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
163468474|NCT02120352|590413122|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
163468475|NCT02120352|590413123|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
163468476|NCT02120352|590413124|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
163468477|NCT02120352|590413125|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
163468478|NCT02120352|590413126|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
163468479|NCT02120352|590413127|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
163468480|NCT02120352|590413128|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
163468481|NCT02120352|590413122|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
163468482|NCT02120352|590413123|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
163468483|NCT02120352|590413124|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
163468484|NCT02120352|590413125|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
163468485|NCT02120352|590413126|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
163468486|NCT02120352|590413127|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
163468487|NCT02120352|590413128|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
163468488|NCT02120352|590413122|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
163468489|NCT02120352|590413123|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
163468490|NCT02120352|590413124|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
163468491|NCT02120352|590413125|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
163468492|NCT02120352|590413126|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
163468493|NCT02120352|590413127|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
163468494|NCT02120352|590413128|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
163468495|NCT00166517|590413130|FG000|Overall Study|Lost to Follow-up|1|||
163468496|NCT00166517|590413131|FG001|Overall Study|Lost to Follow-up|0|||
163468497|NCT00166517|590413130|FG000|Overall Study|Protocol Violation|4|||
163468498|NCT00166517|590413131|FG001|Overall Study|Protocol Violation|1|||
163468499|NCT00166517|590413130|FG000|Overall Study|Withdrawal by Subject|0|||
163468500|NCT00166517|590413131|FG001|Overall Study|Withdrawal by Subject|1|||
163468501|NCT00842361|590413135|FG000|Overall Study|Protocol Violation|1|||
163468502|NCT00842361|590413136|FG001|Overall Study|Protocol Violation|0|||
163468503|NCT00842361|590413135|FG000|Overall Study|Unclassified|0|||
163468504|NCT00842361|590413136|FG001|Overall Study|Unclassified|2|||
163468505|NCT02186561|590413137|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
163468506|NCT02186561|590413137|FG000|Enrollment|Enrollment Cap Reached|5|||
163468507|NCT02186561|590413137|FG000|Enrollment|Insurance Denial|2|||
163468508|NCT02186561|590413137|FG000|Enrollment|Withdrawal by Subject|2|||
163468509|NCT02186561|590413137|FG000|Enrollment|Investigator Withdrew Consent|1|||
163468510|NCT02186561|590413137|FG000|30-Day Post Index Procedure Visit|Death|1|||
163468511|NCT02186561|590413137|FG000|1- Year Post Index Procedure Visit|Death|1|||
163468512|NCT02186561|590413137|FG000|1- Year Post Index Procedure Visit|Missed|1|||
163468513|NCT03094611|590413138|FG000|Overall Study|Lack of Efficacy|1|||
163468514|NCT03094611|590413138|FG000|Overall Study|Stem Cell Transplant|1|||
163468515|NCT01072448|590413141|FG000|Overall Study|Adverse Event|9|||
163468516|NCT01072448|590413142|FG001|Overall Study|Adverse Event|10|||
163468517|NCT01072448|590413141|FG000|Overall Study|Subject withdrew consent|4|||
163468518|NCT01072448|590413142|FG001|Overall Study|Subject withdrew consent|9|||
163468519|NCT01072448|590413141|FG000|Overall Study|Protocol deviation|3|||
163468520|NCT01072448|590413142|FG001|Overall Study|Protocol deviation|4|||
163468521|NCT01072448|590413141|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163468522|NCT01072448|590413142|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163468523|NCT01072448|590413141|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163468524|NCT01072448|590413142|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
163468525|NCT01072448|590413141|FG000|Overall Study|Lost to Follow-up|1|||
163468526|NCT01072448|590413142|FG001|Overall Study|Lost to Follow-up|1|||
163468527|NCT01072448|590413141|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163468528|NCT01072448|590413142|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163468529|NCT01072448|590413141|FG000|Overall Study|Death|0|||
163468530|NCT01072448|590413142|FG001|Overall Study|Death|2|||
163468531|NCT00249795|590413143|FG000|Overall Study|Not treated|16|||
163468532|NCT00249795|590413144|FG001|Overall Study|Not treated|14|||
163468533|NCT00249795|590413143|FG000|Overall Study|Symptomatic hypotension|127|||
163468534|NCT00249795|590413144|FG001|Overall Study|Symptomatic hypotension|64|||
163468535|NCT00249795|590413143|FG000|Overall Study|Other Serious Adverse Event|84|||
163468536|NCT00249795|590413144|FG001|Overall Study|Other Serious Adverse Event|93|||
163468537|NCT00249795|590413143|FG000|Overall Study|Qualifying condition not present|26|||
163468538|NCT00249795|590413144|FG001|Overall Study|Qualifying condition not present|29|||
163468539|NCT00249795|590413143|FG000|Overall Study|Withdrawal by Subject|678|||
163468540|NCT00249795|590413144|FG001|Overall Study|Withdrawal by Subject|742|||
163468541|NCT00249795|590413143|FG000|Overall Study|Thromboembolic / outcome event|39|||
163468542|NCT00249795|590413144|FG001|Overall Study|Thromboembolic / outcome event|45|||
163468543|NCT00249795|590413143|FG000|Overall Study|Oral anticoagulant required|2|||
163468544|NCT00249795|590413144|FG001|Overall Study|Oral anticoagulant required|0|||
163468545|NCT00249795|590413143|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
163468546|NCT00249795|590413144|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
163468547|NCT00249795|590413143|FG000|Overall Study|Non-compliance|71|||
163468548|NCT00249795|590413144|FG001|Overall Study|Non-compliance|69|||
163468549|NCT00249795|590413143|FG000|Overall Study|Study drug intolerance|3|||
163468550|NCT00249795|590413144|FG001|Overall Study|Study drug intolerance|3|||
163468551|NCT00249795|590413143|FG000|Overall Study|Other adverse events (non-serious)|188|||
163468552|NCT00249795|590413144|FG001|Overall Study|Other adverse events (non-serious)|159|||
163468553|NCT00249795|590413143|FG000|Overall Study|Physician withdrew consent|71|||
163468554|NCT00249795|590413144|FG001|Overall Study|Physician withdrew consent|63|||
163468555|NCT00249795|590413143|FG000|Overall Study|Surgery / procedure|4|||
163468556|NCT00249795|590413144|FG001|Overall Study|Surgery / procedure|5|||
163468557|NCT00249795|590413143|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
163468558|NCT00249795|590413144|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
163468559|NCT00249795|590413143|FG000|Overall Study|Lightheadedness / dizziness|15|||
163468560|NCT00249795|590413144|FG001|Overall Study|Lightheadedness / dizziness|11|||
163468561|NCT00249795|590413143|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
163468562|NCT00249795|590413144|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
163468563|NCT00249795|590413143|FG000|Overall Study|Other contraindicated medication|1|||
163468564|NCT00249795|590413144|FG001|Overall Study|Other contraindicated medication|1|||
163468565|NCT00249795|590413143|FG000|Overall Study|Event related to cardiac condition|17|||
163468566|NCT00249795|590413144|FG001|Overall Study|Event related to cardiac condition|16|||
163468567|NCT00249795|590413143|FG000|Overall Study|Patient not wish to continue after May08|4|||
163468568|NCT00249795|590413144|FG001|Overall Study|Patient not wish to continue after May08|6|||
163468569|NCT00249795|590413143|FG000|Overall Study|Site not agree to continue after May08|1|||
163468570|NCT00249795|590413144|FG001|Overall Study|Site not agree to continue after May08|1|||
163468571|NCT00249795|590413143|FG000|Overall Study|Lost to Follow-up|0|||
163468572|NCT00249795|590413144|FG001|Overall Study|Lost to Follow-up|2|||
163468573|NCT00249795|590413143|FG000|Overall Study|Missing|0|||
163468574|NCT00249795|590413144|FG001|Overall Study|Missing|1|||
163468575|NCT01814826|590413149|FG000|Overall Study|Other|3|||
163468576|NCT01814826|590413150|FG001|Overall Study|Other|5|||
163468577|NCT01814826|590413151|FG002|Overall Study|Other|0|||
163468578|NCT01814826|590413149|FG000|Overall Study|Death|29|||
163468579|NCT01814826|590413150|FG001|Overall Study|Death|24|||
163468580|NCT01814826|590413151|FG002|Overall Study|Death|3|||
163468581|NCT02917629|590413152|FG000|Overall Study|Withdrawal by Subject|0|||
163468582|NCT02917629|590413153|FG001|Overall Study|Withdrawal by Subject|1|||
163468583|NCT03271307|590413154|FG000|Overall Study|Lost to Follow-up|0|||
163468584|NCT03271307|590413155|FG001|Overall Study|Lost to Follow-up|0|||
163468585|NCT03271307|590413156|FG002|Overall Study|Lost to Follow-up|0|||
163468586|NCT03271307|590413157|FG003|Overall Study|Lost to Follow-up|28|||
163468587|NCT03271307|590413158|FG004|Overall Study|Lost to Follow-up|91|||
163468588|NCT01042938|590413159|FG000|Overall Study|Withdrawal by Subject|1|||
163468589|NCT01042938|590413160|FG001|Overall Study|Withdrawal by Subject|1|||
163468590|NCT01042938|590413159|FG000|Overall Study|Protocol Violation|1|||
163468591|NCT01042938|590413160|FG001|Overall Study|Protocol Violation|1|||
163468592|NCT01042938|590413159|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
163468593|NCT01042938|590413160|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
163468594|NCT03136484|590413161|FG000|Overall Study|Withdrawal by Subject|19|||
163468595|NCT03136484|590413162|FG001|Overall Study|Withdrawal by Subject|14|||
163468596|NCT03136484|590413161|FG000|Overall Study|Lost to Follow-up|7|||
163468597|NCT03136484|590413162|FG001|Overall Study|Lost to Follow-up|8|||
163468598|NCT03136484|590413161|FG000|Overall Study|Death|1|||
163468599|NCT03136484|590413162|FG001|Overall Study|Death|0|||
163468600|NCT03032510|590413165|FG000|Overall Study|Adverse Event|5|||
163468601|NCT03032510|590413166|FG001|Overall Study|Adverse Event|2|||
163468602|NCT03032510|590413165|FG000|Overall Study|Lost to Follow-up|8|||
163468603|NCT03032510|590413166|FG001|Overall Study|Lost to Follow-up|7|||
163468604|NCT03032510|590413165|FG000|Overall Study|Withdrawal by Subject|8|||
163468605|NCT03032510|590413166|FG001|Overall Study|Withdrawal by Subject|7|||
163468606|NCT03032510|590413165|FG000|Overall Study|Subject noncompliance|4|||
163468607|NCT03032510|590413166|FG001|Overall Study|Subject noncompliance|2|||
163468608|NCT03032510|590413165|FG000|Overall Study|Physician Decision|2|||
163468609|NCT03032510|590413166|FG001|Overall Study|Physician Decision|0|||
163468610|NCT01601470|590413167|FG000|Period 2 - LCZ696|Physician Decision|1|||
163468611|NCT01203787|590413168|FG000|Overall Study|Death|12|||
163468612|NCT01203787|590413169|FG001|Overall Study|Death|10|||
163468613|NCT01203787|590413168|FG000|Overall Study|Withdrawal by Subject|6|||
163468614|NCT01203787|590413169|FG001|Overall Study|Withdrawal by Subject|2|||
163468615|NCT01203787|590413168|FG000|Overall Study|Lost to Follow-up|2|||
163468616|NCT01203787|590413169|FG001|Overall Study|Lost to Follow-up|0|||
163468617|NCT01203787|590413168|FG000|Overall Study|Adverse Event|11|||
163468618|NCT01203787|590413169|FG001|Overall Study|Adverse Event|15|||
163468619|NCT00431496|590413172|FG000|Overall Study|Adverse Event|3|||
163468620|NCT00431496|590413172|FG000|Overall Study|Lost to Follow-up|1|||
163468621|NCT00431496|590413172|FG000|Overall Study|Withdrawal by Subject|2|||
163468622|NCT00431496|590413172|FG000|Overall Study|Protocol-specified criteria|5|||
163468623|NCT01931150|590413175|FG000|Overall Study|Withdrawal by Subject|1|||
163468624|NCT01931150|590413176|FG001|Overall Study|Withdrawal by Subject|2|||
163468625|NCT00845845|590413177|FG000|Overall Study|Lost to Follow-up|0|||
163468626|NCT00845845|590413178|FG001|Overall Study|Lost to Follow-up|4|||
163468627|NCT01685203|590413179|FG000|Overall Study|Lost to Follow-up|3|||
163468628|NCT01685203|590413180|FG001|Overall Study|Lost to Follow-up|3|||
163468629|NCT01685203|590413181|FG002|Overall Study|Lost to Follow-up|0|||
163468630|NCT01685203|590413182|FG003|Overall Study|Lost to Follow-up|1|||
163468631|NCT01685203|590413183|FG004|Overall Study|Lost to Follow-up|0|||
163468632|NCT01685203|590413184|FG005|Overall Study|Lost to Follow-up|0|||
163468633|NCT01685203|590413185|FG006|Overall Study|Lost to Follow-up|0|||
163468634|NCT01685203|590413179|FG000|Overall Study|Adverse Event|0|||
163468635|NCT01685203|590413180|FG001|Overall Study|Adverse Event|0|||
163468636|NCT01685203|590413181|FG002|Overall Study|Adverse Event|0|||
163468637|NCT01685203|590413182|FG003|Overall Study|Adverse Event|0|||
163468638|NCT01685203|590413183|FG004|Overall Study|Adverse Event|0|||
163468639|NCT01685203|590413184|FG005|Overall Study|Adverse Event|2|||
163468640|NCT01685203|590413185|FG006|Overall Study|Adverse Event|0|||
163468641|NCT01685203|590413179|FG000|Overall Study|Adverse event and withdrew consent|1|||
163468642|NCT01685203|590413180|FG001|Overall Study|Adverse event and withdrew consent|0|||
163468643|NCT01685203|590413181|FG002|Overall Study|Adverse event and withdrew consent|0|||
163468644|NCT01685203|590413182|FG003|Overall Study|Adverse event and withdrew consent|0|||
163468645|NCT01685203|590413183|FG004|Overall Study|Adverse event and withdrew consent|0|||
163468646|NCT01685203|590413184|FG005|Overall Study|Adverse event and withdrew consent|0|||
163468647|NCT01685203|590413185|FG006|Overall Study|Adverse event and withdrew consent|0|||
163468648|NCT01685203|590413179|FG000|Overall Study|Patient's decision|0|||
163468649|NCT01685203|590413180|FG001|Overall Study|Patient's decision|0|||
163468650|NCT01685203|590413181|FG002|Overall Study|Patient's decision|0|||
163468651|NCT01685203|590413182|FG003|Overall Study|Patient's decision|0|||
163468652|NCT01685203|590413183|FG004|Overall Study|Patient's decision|0|||
163468653|NCT01685203|590413184|FG005|Overall Study|Patient's decision|1|||
163468654|NCT01685203|590413185|FG006|Overall Study|Patient's decision|0|||
163468655|NCT01570309|590413186|FG000|Overall Study|Withdrawal by Subject|3|||
163468656|NCT01570309|590413187|FG001|Overall Study|Withdrawal by Subject|3|||
163468657|NCT04095793|590413188|FG000|Overall Study|Adverse Event|3|||
163468658|NCT04095793|590413188|FG000|Overall Study|Study Terminated by Sponsor|103|||
163468659|NCT04095793|590413188|FG000|Overall Study|Withdrawal by Subject|4|||
163468660|NCT03619837|590413189|FG000|Screening|received organs from HCV-negative donors|47|||
163468661|NCT03619837|590413189|FG000|Screening|died on the wait-list|2|||
163468662|NCT03619837|590413189|FG000|Screening|remained on the wait list|40|||
163468663|NCT03619837|590413189|FG000|Screening|didn't meet eligibility criteria|3|||
163468664|NCT03619837|590413189|FG000|Screening|withdrew consent|2|||
163468665|NCT03619837|590413189|FG000|Screening|never listed for HCV-viremic donor|1|||
163468666|NCT03619837|590413189|FG000|Screening|developed exclusion criteria|2|||
163468667|NCT03619837|590413189|FG000|Screening|excluded by the investigator due to non-compliance|1|||
163468668|NCT01602549|590413190|FG000|Overall Study|Protocol Violation|0|||
163468669|NCT01602549|590413191|FG001|Overall Study|Protocol Violation|1|||
163468670|NCT01602549|590413190|FG000|Overall Study|Withdrawal by Subject|1|||
163468671|NCT01602549|590413191|FG001|Overall Study|Withdrawal by Subject|0|||
163468672|NCT03627494|590413194|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
163468673|NCT03627494|590413195|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
163468674|NCT03627494|590413196|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
163468675|NCT03627494|590413197|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
163468676|NCT03627494|590413198|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
163468677|NCT03627494|590413199|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
163468678|NCT03627494|590413200|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
163468679|NCT03627494|590413201|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
163468680|NCT03627494|590413202|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
163468681|NCT03627494|590413203|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
163468682|NCT03627494|590413204|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
163468683|NCT03627494|590413205|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
163468684|NCT03627494|590413194|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
163468685|NCT03627494|590413195|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
163468686|NCT03627494|590413196|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
163468687|NCT03627494|590413197|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
163468688|NCT03627494|590413198|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
163468689|NCT03627494|590413199|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
163468690|NCT03627494|590413200|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
163468691|NCT03627494|590413201|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
163468692|NCT03627494|590413202|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
163468693|NCT03627494|590413203|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
163468694|NCT03627494|590413204|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
163468695|NCT03627494|590413205|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
163468696|NCT03627494|590413194|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
163468697|NCT03627494|590413195|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
163468698|NCT03627494|590413196|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
163468699|NCT03627494|590413197|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
163468700|NCT03627494|590413198|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
163468701|NCT03627494|590413199|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
163468702|NCT03627494|590413200|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
163468703|NCT03627494|590413201|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
163468704|NCT03627494|590413202|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
163468705|NCT03627494|590413203|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
163468706|NCT03627494|590413204|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
163468707|NCT03627494|590413205|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
163468708|NCT04483544|590414752|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
163468709|NCT04483544|590414752|FG000|Post-Treatment|Admitted to hospice|2|||
163468710|NCT04483544|590414752|FG000|Post-Treatment|Study terminated|3|||
163468711|NCT01131078|590414753|FG000|Overall Study|Adverse Event|22|||
163468712|NCT01131078|590414754|FG001|Overall Study|Adverse Event|12|||
163468713|NCT01131078|590414755|FG002|Overall Study|Adverse Event|17|||
163468714|NCT01131078|590414753|FG000|Overall Study|Progressive Disease|58|||
163468715|NCT01131078|590414754|FG001|Overall Study|Progressive Disease|77|||
163468716|NCT01131078|590414755|FG002|Overall Study|Progressive Disease|71|||
163468717|NCT01131078|590414753|FG000|Overall Study|Protocol Violation|1|||
163468718|NCT01131078|590414754|FG001|Overall Study|Protocol Violation|0|||
163468719|NCT01131078|590414755|FG002|Overall Study|Protocol Violation|0|||
163468720|NCT01131078|590414753|FG000|Overall Study|Lost to Follow-up|1|||
163468721|NCT01131078|590414754|FG001|Overall Study|Lost to Follow-up|1|||
163468722|NCT01131078|590414755|FG002|Overall Study|Lost to Follow-up|1|||
163468723|NCT01131078|590414753|FG000|Overall Study|Withdrawal by Subject|2|||
163468724|NCT01131078|590414754|FG001|Overall Study|Withdrawal by Subject|4|||
163468725|NCT01131078|590414755|FG002|Overall Study|Withdrawal by Subject|3|||
163468726|NCT01131078|590414753|FG000|Overall Study|Non-compliance|3|||
163468727|NCT01131078|590414754|FG001|Overall Study|Non-compliance|0|||
163468728|NCT01131078|590414755|FG002|Overall Study|Non-compliance|0|||
163468729|NCT01131078|590414753|FG000|Overall Study|Physician Decision|10|||
163468730|NCT01131078|590414754|FG001|Overall Study|Physician Decision|6|||
163468731|NCT01131078|590414755|FG002|Overall Study|Physician Decision|8|||
163468732|NCT01131078|590414753|FG000|Overall Study|Death|4|||
163468733|NCT01131078|590414754|FG001|Overall Study|Death|0|||
163468734|NCT01131078|590414755|FG002|Overall Study|Death|2|||
163468735|NCT01131078|590414753|FG000|Overall Study|Other|0|||
163468736|NCT01131078|590414754|FG001|Overall Study|Other|1|||
163468737|NCT01131078|590414755|FG002|Overall Study|Other|0|||
163468738|NCT02177786|590414756|FG000|Overall Study|Withdrew Consent|2|||
163468739|NCT02177786|590414757|FG001|Overall Study|Withdrew Consent|6|||
163468740|NCT02177786|590414758|FG002|Overall Study|Withdrew Consent|9|||
163468741|NCT02177786|590414759|FG003|Overall Study|Withdrew Consent|5|||
163468742|NCT02177786|590414756|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
163468743|NCT02177786|590414757|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
163468744|NCT02177786|590414758|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
163468745|NCT02177786|590414759|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
163468746|NCT02177786|590414756|FG000|Overall Study|Adverse Event|1|||
163468747|NCT02177786|590414757|FG001|Overall Study|Adverse Event|1|||
163468748|NCT02177786|590414758|FG002|Overall Study|Adverse Event|2|||
163468749|NCT02177786|590414759|FG003|Overall Study|Adverse Event|3|||
163468750|NCT02177786|590414756|FG000|Overall Study|Death|1|||
163468751|NCT02177786|590414757|FG001|Overall Study|Death|1|||
163468752|NCT02177786|590414758|FG002|Overall Study|Death|1|||
163468753|NCT02177786|590414759|FG003|Overall Study|Death|1|||
163468754|NCT02177786|590414756|FG000|Overall Study|Lost to Follow-up|0|||
163468755|NCT02177786|590414757|FG001|Overall Study|Lost to Follow-up|0|||
163468756|NCT02177786|590414758|FG002|Overall Study|Lost to Follow-up|2|||
163468757|NCT02177786|590414759|FG003|Overall Study|Lost to Follow-up|2|||
163468758|NCT02177786|590414756|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163468759|NCT02177786|590414757|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163468760|NCT02177786|590414758|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163468761|NCT02177786|590414759|FG003|Overall Study|Non-Compliance with Study Drug|1|||
163468762|NCT02177786|590414756|FG000|Overall Study|Protocol Violation|0|||
163468763|NCT02177786|590414757|FG001|Overall Study|Protocol Violation|0|||
163468764|NCT02177786|590414758|FG002|Overall Study|Protocol Violation|2|||
163468765|NCT02177786|590414759|FG003|Overall Study|Protocol Violation|0|||
163468766|NCT02177786|590414756|FG000|Overall Study|Progressive Disease|0|||
163468767|NCT02177786|590414757|FG001|Overall Study|Progressive Disease|1|||
163468768|NCT02177786|590414758|FG002|Overall Study|Progressive Disease|0|||
163468769|NCT02177786|590414759|FG003|Overall Study|Progressive Disease|0|||
163468770|NCT02177786|590414756|FG000|Overall Study|Missing study completion status|0|||
163468771|NCT02177786|590414757|FG001|Overall Study|Missing study completion status|1|||
163468772|NCT02177786|590414758|FG002|Overall Study|Missing study completion status|0|||
163468773|NCT02177786|590414759|FG003|Overall Study|Missing study completion status|0|||
163468774|NCT01305941|590414760|FG000|Overall Study|Adverse Event|6|||
163468775|NCT01305941|590414760|FG000|Overall Study|Clinical decline|2|||
163468776|NCT01305941|590414760|FG000|Overall Study|Withdrawal by Subject|1|||
163468777|NCT01305941|590414760|FG000|Overall Study|Death|1|||
163468778|NCT00430027|590414762|FG000|Overall Study|Study terminated|8|||
163468779|NCT01957215|590414763|FG000|Overall Study|Adverse Event|2|||
163468780|NCT01957215|590414764|FG001|Overall Study|Adverse Event|2|||
163468781|NCT01957215|590414763|FG000|Overall Study|Lost to Follow-up|3|||
163468782|NCT01957215|590414764|FG001|Overall Study|Lost to Follow-up|3|||
163468783|NCT01957215|590414763|FG000|Overall Study|Protocol Violation|1|||
163468784|NCT01957215|590414764|FG001|Overall Study|Protocol Violation|2|||
163468785|NCT01957215|590414763|FG000|Overall Study|Withdrawal by Subject|7|||
163468786|NCT01957215|590414764|FG001|Overall Study|Withdrawal by Subject|5|||
163468787|NCT01977040|590414767|FG000|Overall Study|Vasa previa not confirmed|2|||
163468788|NCT03597503|590414771|FG000|Overall Study|Withdrawal by Subject|0|||
163468789|NCT03597503|590414772|FG001|Overall Study|Withdrawal by Subject|2|||
163468790|NCT03597503|590414771|FG000|Overall Study|Lost to Follow-up|1|||
163468791|NCT03597503|590414772|FG001|Overall Study|Lost to Follow-up|2|||
163468792|NCT03597503|590414771|FG000|Overall Study|Protocol Violation|1|||
163468793|NCT03597503|590414772|FG001|Overall Study|Protocol Violation|0|||
163468794|NCT02667236|590414775|FG000|Overall Study|Adverse Event|1|||
163468795|NCT02667236|590414776|FG001|Overall Study|Adverse Event|1|||
163468796|NCT02667236|590414775|FG000|Overall Study|Withdrawal by Subject|2|||
163468797|NCT02667236|590414776|FG001|Overall Study|Withdrawal by Subject|0|||
163468798|NCT00634751|590414777|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
163468799|NCT00634751|590414778|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
163468800|NCT00634751|590414779|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
163468801|NCT00634751|590414780|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
163468802|NCT00634751|590414777|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
163468803|NCT00634751|590414778|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
163468804|NCT00634751|590414779|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
163468805|NCT00634751|590414780|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
163468806|NCT00634751|590414777|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
163468807|NCT00634751|590414778|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
163468808|NCT00634751|590414779|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
163468809|NCT00634751|590414780|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
163468810|NCT00608894|590414781|FG000|Overall Study|Withdrawal by Subject|0|||
163468811|NCT00608894|590414782|FG001|Overall Study|Withdrawal by Subject|2|||
163468812|NCT03654560|590414783|FG000|Overall Study|Death|3|||
163468813|NCT03654560|590414784|FG001|Overall Study|Death|1|||
163468814|NCT03654560|590414783|FG000|Overall Study|Lost to Follow-up|1|||
163468815|NCT03654560|590414784|FG001|Overall Study|Lost to Follow-up|0|||
163468816|NCT01235338|590414786|FG000|Overall Study|Adverse Event|3|||
163468817|NCT01235338|590414787|FG001|Overall Study|Adverse Event|2|||
163468818|NCT01235338|590414786|FG000|Overall Study|Protocol Violation|1|||
163468819|NCT01235338|590414787|FG001|Overall Study|Protocol Violation|1|||
163468820|NCT01235338|590414786|FG000|Overall Study|Withdrawal by Subject|5|||
163468821|NCT01235338|590414787|FG001|Overall Study|Withdrawal by Subject|0|||
163468822|NCT01235338|590414786|FG000|Overall Study|Exclusion criteria violations|1|||
163468823|NCT01235338|590414787|FG001|Overall Study|Exclusion criteria violations|1|||
163468824|NCT01235338|590414786|FG000|Overall Study|Positive drug screen|0|||
163468825|NCT01235338|590414787|FG001|Overall Study|Positive drug screen|1|||
163468826|NCT01235338|590414786|FG000|Overall Study|Prohibited meds|1|||
163468827|NCT01235338|590414787|FG001|Overall Study|Prohibited meds|0|||
163468828|NCT05283499|590414789|FG000|Overall Study|Did not receive intervention|1|||
163468829|NCT05283499|590414790|FG001|Overall Study|Did not receive intervention|2|||
163468830|NCT02828644|590414791|FG000|Overall Study|Lost to Follow-up|23|||
163468831|NCT02828644|590414792|FG001|Overall Study|Lost to Follow-up|22|||
163468832|NCT02408484|590414793|FG000|Overall Study|Withdrawal by Subject|3|||
163468833|NCT02408484|590414793|FG000|Overall Study|Not treated during study period|1|||
163468834|NCT01117181|590414797|FG000|Overall Study|Lost to Follow-up|1|||
163468835|NCT01117181|590414798|FG001|Overall Study|Lost to Follow-up|0|||
163468836|NCT01117181|590414797|FG000|Overall Study|Withdrawal by Subject|0|||
163468837|NCT01117181|590414798|FG001|Overall Study|Withdrawal by Subject|2|||
163468838|NCT00524043|590414804|FG000|Overall Study|Lack of Efficacy|15|||
163468839|NCT00524043|590414805|FG001|Overall Study|Lack of Efficacy|13|||
163468840|NCT00524043|590414806|FG002|Overall Study|Lack of Efficacy|14|||
163468841|NCT00524043|590414804|FG000|Overall Study|Withdrawal by Subject|5|||
163468842|NCT00524043|590414805|FG001|Overall Study|Withdrawal by Subject|7|||
163468843|NCT00524043|590414806|FG002|Overall Study|Withdrawal by Subject|7|||
163468844|NCT00524043|590414804|FG000|Overall Study|Adverse Event|5|||
163468845|NCT00524043|590414805|FG001|Overall Study|Adverse Event|2|||
163468846|NCT00524043|590414806|FG002|Overall Study|Adverse Event|7|||
163468847|NCT00524043|590414804|FG000|Overall Study|Lost to Follow-up|3|||
163468848|NCT00524043|590414805|FG001|Overall Study|Lost to Follow-up|5|||
163468849|NCT00524043|590414806|FG002|Overall Study|Lost to Follow-up|3|||
163468850|NCT00524043|590414804|FG000|Overall Study|Various (eg, incarceration)|2|||
163468851|NCT00524043|590414805|FG001|Overall Study|Various (eg, incarceration)|1|||
163468852|NCT00524043|590414806|FG002|Overall Study|Various (eg, incarceration)|0|||
163468853|NCT00517413|590414808|FG000|Overall Study|Adverse Event|7|||
163468854|NCT00517413|590414808|FG000|Overall Study|Death|13|||
163468855|NCT00517413|590414808|FG000|Overall Study|Protocol Violation|15|||
163468856|NCT00517413|590414808|FG000|Overall Study|Withdrawal by Subject|2|||
163468857|NCT00517413|590414808|FG000|Overall Study|Failure to return|1|||
163468858|NCT00517413|590414808|FG000|Overall Study|Other-Reasons|23|||
163468859|NCT03938636|590414809|FG000|Overall Study|Protocol Violation|0|||
163468860|NCT03938636|590414810|FG001|Overall Study|Protocol Violation|1|||
163468861|NCT03938636|590414811|FG002|Overall Study|Protocol Violation|1|||
163468862|NCT03938636|590414809|FG000|Overall Study|Subject withdrew due to death in family|0|||
163468863|NCT03938636|590414810|FG001|Overall Study|Subject withdrew due to death in family|1|||
163468864|NCT03938636|590414811|FG002|Overall Study|Subject withdrew due to death in family|0|||
163468865|NCT03938636|590414809|FG000|Overall Study|Missed visit|0|||
163468866|NCT03938636|590414810|FG001|Overall Study|Missed visit|1|||
163468867|NCT03938636|590414811|FG002|Overall Study|Missed visit|0|||
163468868|NCT03938636|590414809|FG000|Overall Study|Adverse Event|0|||
163468869|NCT03938636|590414810|FG001|Overall Study|Adverse Event|0|||
163468870|NCT03938636|590414811|FG002|Overall Study|Adverse Event|1|||
163468871|NCT03938636|590414809|FG000|Overall Study|Lost to Follow-up|0|||
163468872|NCT03938636|590414810|FG001|Overall Study|Lost to Follow-up|0|||
163468873|NCT03938636|590414811|FG002|Overall Study|Lost to Follow-up|1|||
163468874|NCT00216086|590414812|FG000|Overall Study|Protocol Violation|1|||
163468875|NCT00216086|590414812|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
163468876|NCT00216086|590414812|FG000|Overall Study|Social Reasons|2|||
163468877|NCT01080625|590414819|FG000|Overall Study|Physician Decision|0|||
163468878|NCT01080625|590414820|FG001|Overall Study|Physician Decision|2|||
163468879|NCT01080625|590414821|FG002|Overall Study|Physician Decision|1|||
163468880|NCT00735072|590414826|FG000|Overall Study|interrupted study med during ARV change|1|||
163468881|NCT00735072|590414827|FG001|Overall Study|interrupted study med during ARV change|0|||
163468882|NCT00735072|590414826|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
163468883|NCT00735072|590414827|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
163468884|NCT00911144|590414828|FG000|Overall Study|Withdrawal by Subject|16|||
163468885|NCT00911144|590414829|FG001|Overall Study|Withdrawal by Subject|5|||
163468886|NCT01291511|590414830|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
163468887|NCT01291511|590414831|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
163468888|NCT01291511|590414830|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
163468889|NCT01291511|590414831|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
163468890|NCT01291511|590414830|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
163468891|NCT01291511|590414831|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
163468892|NCT01291511|590414830|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
163468893|NCT01291511|590414831|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
163468894|NCT01291511|590414830|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
163468895|NCT01291511|590414831|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
163468896|NCT01291511|590414830|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
163468897|NCT01291511|590414831|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
163468898|NCT01291511|590414830|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
163468899|NCT01291511|590414831|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
163468900|NCT01291511|590414830|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
163468901|NCT01291511|590414831|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
163468902|NCT01291511|590414830|FG000|Cross-Titration and Stabilization Phase|Death|1|||
163468903|NCT01291511|590414831|FG001|Cross-Titration and Stabilization Phase|Death|0|||
163468904|NCT01291511|590414830|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
163468905|NCT01291511|590414831|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
163468906|NCT01291511|590414830|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
163468907|NCT01291511|590414831|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
163468908|NCT01291511|590414830|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
163468909|NCT01291511|590414831|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
163468910|NCT01291511|590414830|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
163468911|NCT01291511|590414831|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
163468912|NCT01291511|590414830|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
163468913|NCT01291511|590414831|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
163468914|NCT01291511|590414830|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
163468915|NCT01291511|590414831|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
163468916|NCT01291511|590414830|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
163468917|NCT01291511|590414831|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
163468918|NCT01291511|590414830|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
163468919|NCT01291511|590414831|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
163468920|NCT01291511|590414830|FG000|Double-blind Relapse Prevention Phase|Death|1|||
163468921|NCT01291511|590414831|FG001|Double-blind Relapse Prevention Phase|Death|0|||
163468922|NCT02640755|590414842|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
163468923|NCT02640755|590414843|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
163468924|NCT02640755|590414842|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
163468925|NCT02640755|590414843|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
163468926|NCT02640755|590414842|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
163468927|NCT02640755|590414843|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
163468928|NCT00865046|590414844|FG000|Overall Study|Lost to Follow-up|1|||
163468929|NCT00865046|590414845|FG001|Overall Study|Lost to Follow-up|4|||
163468930|NCT00865046|590414846|FG002|Overall Study|Lost to Follow-up|0|||
163468931|NCT00865046|590414844|FG000|Overall Study|Death|0|||
163468932|NCT00865046|590414845|FG001|Overall Study|Death|1|||
163468933|NCT00865046|590414846|FG002|Overall Study|Death|1|||
163468934|NCT00865046|590414844|FG000|Overall Study|Withdrawal by Subject|5|||
163468935|NCT00865046|590414845|FG001|Overall Study|Withdrawal by Subject|0|||
163468936|NCT00865046|590414846|FG002|Overall Study|Withdrawal by Subject|0|||
163468937|NCT00654420|590414849|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
163468938|NCT00654420|590414850|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
163468939|NCT00654420|590414851|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
163468940|NCT00654420|590414852|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
163468941|NCT00654420|590414849|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
163468942|NCT00654420|590414850|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
163468943|NCT00654420|590414851|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
163468944|NCT00654420|590414852|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
163468945|NCT00654420|590414849|FG000|Phase II|Adverse Event|0|||
163468946|NCT00654420|590414850|FG001|Phase II|Adverse Event|0|||
163468947|NCT00654420|590414851|FG002|Phase II|Adverse Event|3|||
163468948|NCT00654420|590414852|FG003|Phase II|Adverse Event|3|||
163468949|NCT00654420|590414849|FG000|Phase II|Lost to Follow-up|0|||
163468950|NCT00654420|590414850|FG001|Phase II|Lost to Follow-up|0|||
163468951|NCT00654420|590414851|FG002|Phase II|Lost to Follow-up|0|||
163468952|NCT00654420|590414852|FG003|Phase II|Lost to Follow-up|1|||
163468953|NCT00654420|590414849|FG000|Phase II|Physician Decision|0|||
163468954|NCT00654420|590414850|FG001|Phase II|Physician Decision|0|||
163468955|NCT00654420|590414851|FG002|Phase II|Physician Decision|0|||
163468956|NCT00654420|590414852|FG003|Phase II|Physician Decision|4|||
163468957|NCT00654420|590414849|FG000|Phase II|Progressive Disease|0|||
163468958|NCT00654420|590414850|FG001|Phase II|Progressive Disease|0|||
163468959|NCT00654420|590414851|FG002|Phase II|Progressive Disease|29|||
163468960|NCT00654420|590414852|FG003|Phase II|Progressive Disease|29|||
163468961|NCT00654420|590414849|FG000|Phase II|Withdrawal by Subject|0|||
163468962|NCT00654420|590414850|FG001|Phase II|Withdrawal by Subject|0|||
163468963|NCT00654420|590414851|FG002|Phase II|Withdrawal by Subject|4|||
163468964|NCT00654420|590414852|FG003|Phase II|Withdrawal by Subject|1|||
163468965|NCT00654420|590414849|FG000|Phase II|Missing Disposition Record|0|||
163468966|NCT00654420|590414850|FG001|Phase II|Missing Disposition Record|0|||
163468967|NCT00654420|590414851|FG002|Phase II|Missing Disposition Record|1|||
163468968|NCT00654420|590414852|FG003|Phase II|Missing Disposition Record|0|||
163468969|NCT01587274|590414857|FG000|Overall Study|Lost to Follow-up|4|||
163468970|NCT01587274|590414858|FG001|Overall Study|Lost to Follow-up|5|||
163468971|NCT01587274|590414859|FG002|Overall Study|Lost to Follow-up|3|||
163468972|NCT03236506|590414867|FG000|Overall Study|Death|1|||
163468973|NCT03236506|590414868|FG001|Overall Study|Death|1|||
163468974|NCT03236506|590414869|FG002|Overall Study|Death|1|||
163468975|NCT03236506|590414867|FG000|Overall Study|Withdrawal by Subject|3|||
163468976|NCT03236506|590414868|FG001|Overall Study|Withdrawal by Subject|3|||
163468977|NCT03236506|590414869|FG002|Overall Study|Withdrawal by Subject|4|||
163468978|NCT03236506|590414867|FG000|Overall Study|Did not initiate treatment|2|||
163468979|NCT03236506|590414868|FG001|Overall Study|Did not initiate treatment|1|||
163468980|NCT03236506|590414869|FG002|Overall Study|Did not initiate treatment|2|||
163468981|NCT00422669|590414880|FG000|Overall Study|The study was terminated early.|98|||
163468982|NCT00422669|590414881|FG001|Overall Study|The study was terminated early.|100|||
163468983|NCT00422669|590414882|FG002|Overall Study|The study was terminated early.|7|||
163468984|NCT02709109|590414883|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
163468985|NCT02709109|590414884|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
163468986|NCT02709109|590414885|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
163468987|NCT02709109|590414886|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
163468988|NCT02709109|590414883|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
163468989|NCT02709109|590414884|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
163468990|NCT02709109|590414885|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
163468991|NCT02709109|590414886|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
163468992|NCT02709109|590414883|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
163468993|NCT02709109|590414884|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
163468994|NCT02709109|590414885|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
163468995|NCT02709109|590414886|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
163468996|NCT02709109|590414883|FG000|Washout Period (28 Days)|Other|2|||
163468997|NCT02709109|590414884|FG001|Washout Period (28 Days)|Other|2|||
163468998|NCT02709109|590414885|FG002|Washout Period (28 Days)|Other|3|||
163468999|NCT02709109|590414886|FG003|Washout Period (28 Days)|Other|0|||
163469000|NCT02709109|590414883|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
163469001|NCT02709109|590414884|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
163469002|NCT02709109|590414885|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
163469003|NCT02709109|590414886|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
163469004|NCT02709109|590414883|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
163469005|NCT02709109|590414884|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
163469006|NCT02709109|590414885|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
163469007|NCT02709109|590414886|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
163469008|NCT02709109|590414883|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
163469009|NCT02709109|590414884|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
163469010|NCT02709109|590414885|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
163469011|NCT02709109|590414886|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
163469012|NCT02709109|590414883|FG000|Treatment Period 2 (28 Days)|Other|0|||
163469013|NCT02709109|590414884|FG001|Treatment Period 2 (28 Days)|Other|0|||
163469014|NCT02709109|590414885|FG002|Treatment Period 2 (28 Days)|Other|1|||
163469015|NCT02709109|590414886|FG003|Treatment Period 2 (28 Days)|Other|0|||
163469016|NCT00741260|590414888|FG000|Overall Study|Disease Progression|3|||
163469017|NCT00741260|590414889|FG001|Overall Study|Disease Progression|5|||
163469018|NCT00741260|590414890|FG002|Overall Study|Disease Progression|3|||
163469019|NCT00741260|590414891|FG003|Overall Study|Disease Progression|3|||
163469020|NCT00741260|590414892|FG004|Overall Study|Disease Progression|5|||
163469021|NCT00741260|590414893|FG005|Overall Study|Disease Progression|37|||
163469022|NCT00741260|590414894|FG006|Overall Study|Disease Progression|4|||
163469023|NCT00741260|590414888|FG000|Overall Study|Death|0|||
163469024|NCT00741260|590414889|FG001|Overall Study|Death|1|||
163469025|NCT00741260|590414890|FG002|Overall Study|Death|0|||
163469026|NCT00741260|590414891|FG003|Overall Study|Death|1|||
163469027|NCT00741260|590414892|FG004|Overall Study|Death|2|||
163469028|NCT00741260|590414893|FG005|Overall Study|Death|2|||
163469029|NCT00741260|590414894|FG006|Overall Study|Death|1|||
163469030|NCT00741260|590414888|FG000|Overall Study|Withdrawal by Subject|0|||
163469031|NCT00741260|590414889|FG001|Overall Study|Withdrawal by Subject|0|||
163469032|NCT00741260|590414890|FG002|Overall Study|Withdrawal by Subject|0|||
163469033|NCT00741260|590414891|FG003|Overall Study|Withdrawal by Subject|0|||
163469034|NCT00741260|590414892|FG004|Overall Study|Withdrawal by Subject|1|||
163469035|NCT00741260|590414893|FG005|Overall Study|Withdrawal by Subject|3|||
163469036|NCT00741260|590414894|FG006|Overall Study|Withdrawal by Subject|1|||
163469037|NCT00741260|590414888|FG000|Overall Study|Physician Decision|1|||
163469038|NCT00741260|590414889|FG001|Overall Study|Physician Decision|1|||
163469039|NCT00741260|590414890|FG002|Overall Study|Physician Decision|0|||
163469040|NCT00741260|590414891|FG003|Overall Study|Physician Decision|0|||
163469041|NCT00741260|590414892|FG004|Overall Study|Physician Decision|0|||
163469042|NCT00741260|590414893|FG005|Overall Study|Physician Decision|0|||
163469043|NCT00741260|590414894|FG006|Overall Study|Physician Decision|0|||
163469044|NCT00741260|590414888|FG000|Overall Study|Other|2|||
163469045|NCT00741260|590414889|FG001|Overall Study|Other|1|||
163469046|NCT00741260|590414890|FG002|Overall Study|Other|1|||
163469047|NCT00741260|590414891|FG003|Overall Study|Other|2|||
163469048|NCT00741260|590414892|FG004|Overall Study|Other|1|||
163469049|NCT00741260|590414893|FG005|Overall Study|Other|3|||
163469050|NCT00741260|590414894|FG006|Overall Study|Other|1|||
163469051|NCT02565615|590414895|FG000|Overall Study|Death|0|||
163469052|NCT02565615|590414896|FG001|Overall Study|Death|1|||
163469053|NCT02565615|590414897|FG002|Overall Study|Death|0|||
163469054|NCT02565615|590414898|FG003|Overall Study|Death|0|||
163469055|NCT02565615|590414899|FG004|Overall Study|Death|4|||
163469056|NCT02565615|590414895|FG000|Overall Study|Not willing to participate in study|2|||
163469057|NCT02565615|590414896|FG001|Overall Study|Not willing to participate in study|21|||
163469058|NCT02565615|590414897|FG002|Overall Study|Not willing to participate in study|0|||
163469059|NCT02565615|590414898|FG003|Overall Study|Not willing to participate in study|1|||
163469060|NCT02565615|590414899|FG004|Overall Study|Not willing to participate in study|169|||
163469061|NCT02565615|590414895|FG000|Overall Study|Lost to Follow-up|0|||
163469062|NCT02565615|590414896|FG001|Overall Study|Lost to Follow-up|4|||
163469063|NCT02565615|590414897|FG002|Overall Study|Lost to Follow-up|0|||
163469064|NCT02565615|590414898|FG003|Overall Study|Lost to Follow-up|1|||
163469065|NCT02565615|590414899|FG004|Overall Study|Lost to Follow-up|765|||
163469066|NCT02565615|590414895|FG000|Overall Study|Not meeting eligibility criteria|0|||
163469067|NCT02565615|590414896|FG001|Overall Study|Not meeting eligibility criteria|7|||
163469068|NCT02565615|590414897|FG002|Overall Study|Not meeting eligibility criteria|0|||
163469069|NCT02565615|590414898|FG003|Overall Study|Not meeting eligibility criteria|0|||
163469070|NCT02565615|590414899|FG004|Overall Study|Not meeting eligibility criteria|25|||
163469071|NCT02565615|590414895|FG000|Overall Study|Reason not defined|0|||
163469072|NCT02565615|590414896|FG001|Overall Study|Reason not defined|2|||
163469073|NCT02565615|590414897|FG002|Overall Study|Reason not defined|0|||
163469074|NCT02565615|590414898|FG003|Overall Study|Reason not defined|1|||
163469075|NCT02565615|590414899|FG004|Overall Study|Reason not defined|62|||
163469076|NCT02565615|590414895|FG000|Overall Study|Adverse Event|1|||
163469077|NCT02565615|590414896|FG001|Overall Study|Adverse Event|1|||
163469078|NCT02565615|590414897|FG002|Overall Study|Adverse Event|0|||
163469079|NCT02565615|590414898|FG003|Overall Study|Adverse Event|0|||
163469080|NCT02565615|590414899|FG004|Overall Study|Adverse Event|9|||
163469081|NCT02565615|590414895|FG000|Overall Study|Untreated|0|||
163469082|NCT02565615|590414896|FG001|Overall Study|Untreated|0|||
163469083|NCT02565615|590414897|FG002|Overall Study|Untreated|0|||
163469084|NCT02565615|590414898|FG003|Overall Study|Untreated|0|||
163469085|NCT02565615|590414899|FG004|Overall Study|Untreated|567|||
163469086|NCT01815580|590414906|FG000|Overall Study|Lost to Follow-up|4|||
163469087|NCT01815580|590414907|FG001|Overall Study|Lost to Follow-up|7|||
163469088|NCT01815580|590414906|FG000|Overall Study|Withdrawal by Subject|3|||
163469089|NCT01815580|590414907|FG001|Overall Study|Withdrawal by Subject|4|||
163469090|NCT01815580|590414906|FG000|Overall Study|Excluded from analysis|5|||
163469091|NCT01815580|590414907|FG001|Overall Study|Excluded from analysis|4|||
163469092|NCT01610206|590414915|FG000|Overall Study|Adverse Event|10|||
163469093|NCT01610206|590414916|FG001|Overall Study|Adverse Event|30|||
163469094|NCT00023712|590414917|FG000|Overall Study|Not platinum sensitive|1|||
163469095|NCT00023712|590414918|FG001|Overall Study|Not platinum sensitive|0|||
163469096|NCT00023712|590414917|FG000|Overall Study|Never treated|1|||
163469097|NCT00023712|590414918|FG001|Overall Study|Never treated|1|||
163469098|NCT02999191|590414919|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
163469099|NCT02999191|590414920|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
163469100|NCT02999191|590414921|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
163469101|NCT02079519|590414925|FG000|Overall Study|Disease Progression|9|||
163469102|NCT02079519|590414925|FG000|Overall Study|Adverse Event|1|||
163469103|NCT01802515|590414926|FG000|Overall Study|Withdrawal by Subject|3|||
163469104|NCT01802515|590414927|FG001|Overall Study|Withdrawal by Subject|0|||
163469105|NCT01802515|590414928|FG002|Overall Study|Withdrawal by Subject|0|||
163469106|NCT02566109|590414929|FG000|Overall Study|Withdrawal by Subject|1|||
163469107|NCT01993667|590414932|FG000|Overall Study|Insufficient data to analyze|16|||
163469108|NCT01993667|590414933|FG001|Overall Study|Insufficient data to analyze|16|||
163469109|NCT01993667|590414932|FG000|Overall Study|Insufficient altitude reached|3|||
163469110|NCT01993667|590414933|FG001|Overall Study|Insufficient altitude reached|1|||
163469111|NCT01993667|590414932|FG000|Overall Study|Lost to Follow-up|2|||
163469112|NCT01993667|590414933|FG001|Overall Study|Lost to Follow-up|2|||
163469113|NCT03695471|590417392|FG000|Overall Study|Cancellation|1|||
163469114|NCT02859558|590417393|FG000|Step 1|Not Eligible|0|||
163469115|NCT02859558|590417394|FG001|Step 1|Not Eligible|0|||
163469116|NCT02859558|590417395|FG002|Step 1|Not Eligible|0|||
163469117|NCT02859558|590417396|FG003|Step 1|Not Eligible|0|||
163469118|NCT02859558|590417397|FG004|Step 1|Not Eligible|3|||
163469119|NCT02859558|590417393|FG000|Step 1|Lost to Follow-up|1|||
163469120|NCT02859558|590417394|FG001|Step 1|Lost to Follow-up|3|||
163469121|NCT02859558|590417395|FG002|Step 1|Lost to Follow-up|3|||
163469122|NCT02859558|590417396|FG003|Step 1|Lost to Follow-up|0|||
163469123|NCT02859558|590417397|FG004|Step 1|Lost to Follow-up|0|||
163469124|NCT02859558|590417393|FG000|Step 1|Did Not Return to Clinic|2|||
163469125|NCT02859558|590417394|FG001|Step 1|Did Not Return to Clinic|3|||
163469126|NCT02859558|590417395|FG002|Step 1|Did Not Return to Clinic|4|||
163469127|NCT02859558|590417396|FG003|Step 1|Did Not Return to Clinic|0|||
163469128|NCT02859558|590417397|FG004|Step 1|Did Not Return to Clinic|0|||
163469129|NCT02859558|590417393|FG000|Step 1|Moved|0|||
163469130|NCT02859558|590417394|FG001|Step 1|Moved|1|||
163469131|NCT02859558|590417395|FG002|Step 1|Moved|1|||
163469132|NCT02859558|590417396|FG003|Step 1|Moved|0|||
163469133|NCT02859558|590417397|FG004|Step 1|Moved|0|||
163469134|NCT02859558|590417393|FG000|Step 1|Withdrawal By Participant|1|||
163469135|NCT02859558|590417394|FG001|Step 1|Withdrawal By Participant|2|||
163469136|NCT02859558|590417395|FG002|Step 1|Withdrawal By Participant|1|||
163469137|NCT02859558|590417396|FG003|Step 1|Withdrawal By Participant|0|||
163469138|NCT02859558|590417397|FG004|Step 1|Withdrawal By Participant|0|||
163469139|NCT02859558|590417393|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
163469140|NCT02859558|590417394|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
163469141|NCT02859558|590417395|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
163469142|NCT02859558|590417396|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
163469143|NCT02859558|590417397|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
163469144|NCT02859558|590417393|FG000|Step 1|Incarceration|0|||
163469145|NCT02859558|590417394|FG001|Step 1|Incarceration|1|||
163469146|NCT02859558|590417395|FG002|Step 1|Incarceration|0|||
163469147|NCT02859558|590417396|FG003|Step 1|Incarceration|0|||
163469148|NCT02859558|590417397|FG004|Step 1|Incarceration|0|||
163469149|NCT02859558|590417393|FG000|Step 1|Non-Adherence to Study Drug|2|||
163469150|NCT02859558|590417394|FG001|Step 1|Non-Adherence to Study Drug|0|||
163469151|NCT02859558|590417395|FG002|Step 1|Non-Adherence to Study Drug|1|||
163469152|NCT02859558|590417396|FG003|Step 1|Non-Adherence to Study Drug|0|||
163469153|NCT02859558|590417397|FG004|Step 1|Non-Adherence to Study Drug|0|||
163469154|NCT02859558|590417393|FG000|Step 1|Non-Adherence to Study Requirements|3|||
163469155|NCT02859558|590417394|FG001|Step 1|Non-Adherence to Study Requirements|1|||
163469156|NCT02859558|590417395|FG002|Step 1|Non-Adherence to Study Requirements|0|||
163469157|NCT02859558|590417396|FG003|Step 1|Non-Adherence to Study Requirements|0|||
163469158|NCT02859558|590417397|FG004|Step 1|Non-Adherence to Study Requirements|0|||
163469159|NCT02859558|590417393|FG000|Step 1|Virologic Failure|2|||
163469160|NCT02859558|590417394|FG001|Step 1|Virologic Failure|1|||
163469161|NCT02859558|590417395|FG002|Step 1|Virologic Failure|1|||
163469162|NCT02859558|590417396|FG003|Step 1|Virologic Failure|0|||
163469163|NCT02859558|590417397|FG004|Step 1|Virologic Failure|0|||
163469164|NCT02859558|590417393|FG000|Step 2|Lost to Follow-up|3|||
163469165|NCT02859558|590417394|FG001|Step 2|Lost to Follow-up|3|||
163469166|NCT02859558|590417395|FG002|Step 2|Lost to Follow-up|1|||
163469167|NCT02859558|590417396|FG003|Step 2|Lost to Follow-up|0|||
163469168|NCT02859558|590417397|FG004|Step 2|Lost to Follow-up|0|||
163469169|NCT02859558|590417393|FG000|Step 2|Withdrawal by Subject|0|||
163469170|NCT02859558|590417394|FG001|Step 2|Withdrawal by Subject|1|||
163469171|NCT02859558|590417395|FG002|Step 2|Withdrawal by Subject|1|||
163469172|NCT02859558|590417396|FG003|Step 2|Withdrawal by Subject|0|||
163469173|NCT02859558|590417397|FG004|Step 2|Withdrawal by Subject|0|||
163469174|NCT02859558|590417393|FG000|Step 2|Unexpected Closure of Site|0|||
163469175|NCT02859558|590417394|FG001|Step 2|Unexpected Closure of Site|1|||
163469176|NCT02859558|590417395|FG002|Step 2|Unexpected Closure of Site|1|||
163469177|NCT02859558|590417396|FG003|Step 2|Unexpected Closure of Site|0|||
163469178|NCT02859558|590417397|FG004|Step 2|Unexpected Closure of Site|0|||
163469179|NCT02859558|590417393|FG000|Step 2|Death|1|||
163469180|NCT02859558|590417394|FG001|Step 2|Death|0|||
163469181|NCT02859558|590417395|FG002|Step 2|Death|0|||
163469182|NCT02859558|590417396|FG003|Step 2|Death|0|||
163469183|NCT02859558|590417397|FG004|Step 2|Death|0|||
163469184|NCT02859558|590417393|FG000|Step 2|Incarceration|0|||
163469185|NCT02859558|590417394|FG001|Step 2|Incarceration|0|||
163469186|NCT02859558|590417395|FG002|Step 2|Incarceration|1|||
163469187|NCT02859558|590417396|FG003|Step 2|Incarceration|0|||
163469188|NCT02859558|590417397|FG004|Step 2|Incarceration|0|||
163469189|NCT04507360|590417398|FG000|Week 1|Lost to Follow-up|0|||
163469190|NCT04507360|590417399|FG001|Week 1|Lost to Follow-up|0|||
163469191|NCT04507360|590417400|FG002|Week 1|Lost to Follow-up|0|||
163469192|NCT04507360|590417401|FG003|Week 1|Lost to Follow-up|0|||
163469193|NCT04507360|590417402|FG004|Week 1|Lost to Follow-up|0|||
163469194|NCT04507360|590417403|FG005|Week 1|Lost to Follow-up|0|||
163469195|NCT04507360|590417404|FG006|Week 1|Lost to Follow-up|0|||
163469196|NCT04507360|590417405|FG007|Week 1|Lost to Follow-up|0|||
163469197|NCT04507360|590417406|FG008|Week 1|Lost to Follow-up|72|||
163469198|NCT04507360|590417407|FG009|Week 1|Lost to Follow-up|22|||
163469199|NCT04507360|590417408|FG010|Week 1|Lost to Follow-up|10|||
163469200|NCT04507360|590417398|FG000|Week 2|Lost to Follow-up|0|||
163469201|NCT04507360|590417399|FG001|Week 2|Lost to Follow-up|0|||
163469202|NCT04507360|590417400|FG002|Week 2|Lost to Follow-up|0|||
163469203|NCT04507360|590417401|FG003|Week 2|Lost to Follow-up|0|||
163469204|NCT04507360|590417402|FG004|Week 2|Lost to Follow-up|0|||
163469205|NCT04507360|590417403|FG005|Week 2|Lost to Follow-up|0|||
163469206|NCT04507360|590417404|FG006|Week 2|Lost to Follow-up|0|||
163469207|NCT04507360|590417405|FG007|Week 2|Lost to Follow-up|0|||
163469208|NCT04507360|590417406|FG008|Week 2|Lost to Follow-up|121|||
163469209|NCT04507360|590417407|FG009|Week 2|Lost to Follow-up|85|||
163469210|NCT04507360|590417408|FG010|Week 2|Lost to Follow-up|82|||
163469211|NCT04507360|590417398|FG000|Week 3|Lost to Follow-up|0|||
163469212|NCT04507360|590417399|FG001|Week 3|Lost to Follow-up|0|||
163469213|NCT04507360|590417400|FG002|Week 3|Lost to Follow-up|0|||
163469214|NCT04507360|590417401|FG003|Week 3|Lost to Follow-up|0|||
163469215|NCT04507360|590417402|FG004|Week 3|Lost to Follow-up|0|||
163469216|NCT04507360|590417403|FG005|Week 3|Lost to Follow-up|0|||
163469217|NCT04507360|590417404|FG006|Week 3|Lost to Follow-up|0|||
163469218|NCT04507360|590417405|FG007|Week 3|Lost to Follow-up|0|||
163469219|NCT04507360|590417406|FG008|Week 3|Lost to Follow-up|123|||
163469220|NCT04507360|590417407|FG009|Week 3|Lost to Follow-up|92|||
163469221|NCT04507360|590417408|FG010|Week 3|Lost to Follow-up|84|||
163469222|NCT04507360|590417398|FG000|Week 4|Lost to Follow-up|0|||
163469223|NCT04507360|590417399|FG001|Week 4|Lost to Follow-up|0|||
163469224|NCT04507360|590417400|FG002|Week 4|Lost to Follow-up|0|||
163469225|NCT04507360|590417401|FG003|Week 4|Lost to Follow-up|0|||
163469226|NCT04507360|590417402|FG004|Week 4|Lost to Follow-up|0|||
163469227|NCT04507360|590417403|FG005|Week 4|Lost to Follow-up|0|||
163469228|NCT04507360|590417404|FG006|Week 4|Lost to Follow-up|0|||
163469229|NCT04507360|590417405|FG007|Week 4|Lost to Follow-up|0|||
163469230|NCT04507360|590417406|FG008|Week 4|Lost to Follow-up|131|||
163469231|NCT04507360|590417407|FG009|Week 4|Lost to Follow-up|115|||
163469232|NCT04507360|590417408|FG010|Week 4|Lost to Follow-up|102|||
163469233|NCT04507360|590417398|FG000|Week 5|Lost to Follow-up|0|||
163469234|NCT04507360|590417399|FG001|Week 5|Lost to Follow-up|0|||
163469235|NCT04507360|590417400|FG002|Week 5|Lost to Follow-up|0|||
163469236|NCT04507360|590417401|FG003|Week 5|Lost to Follow-up|0|||
163469237|NCT04507360|590417402|FG004|Week 5|Lost to Follow-up|0|||
163469238|NCT04507360|590417403|FG005|Week 5|Lost to Follow-up|0|||
163469239|NCT04507360|590417404|FG006|Week 5|Lost to Follow-up|0|||
163469240|NCT04507360|590417405|FG007|Week 5|Lost to Follow-up|0|||
163469241|NCT04507360|590417406|FG008|Week 5|Lost to Follow-up|103|||
163469242|NCT04507360|590417407|FG009|Week 5|Lost to Follow-up|135|||
163469243|NCT04507360|590417408|FG010|Week 5|Lost to Follow-up|143|||
163469244|NCT04507360|590417398|FG000|Week 8|Lost to Follow-up|0|||
163469245|NCT04507360|590417399|FG001|Week 8|Lost to Follow-up|0|||
163469246|NCT04507360|590417400|FG002|Week 8|Lost to Follow-up|0|||
163469247|NCT04507360|590417401|FG003|Week 8|Lost to Follow-up|0|||
163469248|NCT04507360|590417402|FG004|Week 8|Lost to Follow-up|0|||
163469249|NCT04507360|590417403|FG005|Week 8|Lost to Follow-up|0|||
163469250|NCT04507360|590417404|FG006|Week 8|Lost to Follow-up|0|||
163469251|NCT04507360|590417405|FG007|Week 8|Lost to Follow-up|0|||
163469252|NCT04507360|590417406|FG008|Week 8|Lost to Follow-up|139|||
163469253|NCT04507360|590417407|FG009|Week 8|Lost to Follow-up|145|||
163469254|NCT04507360|590417408|FG010|Week 8|Lost to Follow-up|152|||
163469255|NCT00400946|590417409|FG000|Overall Study|Ineligible|0|||
163469256|NCT00400946|590417410|FG001|Overall Study|Ineligible|0|||
163469257|NCT00400946|590417411|FG002|Overall Study|Ineligible|0|||
163469258|NCT00400946|590417412|FG003|Overall Study|Ineligible|5|||
163469259|NCT00400946|590417413|FG004|Overall Study|Ineligible|1|||
163469260|NCT00400946|590417409|FG000|Overall Study|Induction Failure|0|||
163469261|NCT00400946|590417410|FG001|Overall Study|Induction Failure|0|||
163469262|NCT00400946|590417411|FG002|Overall Study|Induction Failure|0|||
163469263|NCT00400946|590417412|FG003|Overall Study|Induction Failure|11|||
163469264|NCT00400946|590417413|FG004|Overall Study|Induction Failure|8|||
163469265|NCT00400946|590417409|FG000|Overall Study|Induction Death|0|||
163469266|NCT00400946|590417410|FG001|Overall Study|Induction Death|0|||
163469267|NCT00400946|590417411|FG002|Overall Study|Induction Death|0|||
163469268|NCT00400946|590417412|FG003|Overall Study|Induction Death|13|||
163469269|NCT00400946|590417413|FG004|Overall Study|Induction Death|3|||
163469270|NCT00400946|590417409|FG000|Overall Study|Lost to Follow-up|1|||
163469271|NCT00400946|590417410|FG001|Overall Study|Lost to Follow-up|1|||
163469272|NCT00400946|590417411|FG002|Overall Study|Lost to Follow-up|0|||
163469273|NCT00400946|590417412|FG003|Overall Study|Lost to Follow-up|0|||
163469274|NCT00400946|590417413|FG004|Overall Study|Lost to Follow-up|1|||
163469275|NCT00400946|590417409|FG000|Overall Study|Remission Death|1|||
163469276|NCT00400946|590417410|FG001|Overall Study|Remission Death|1|||
163469277|NCT00400946|590417411|FG002|Overall Study|Remission Death|0|||
163469278|NCT00400946|590417412|FG003|Overall Study|Remission Death|0|||
163469279|NCT00400946|590417413|FG004|Overall Study|Remission Death|1|||
163469280|NCT00400946|590417409|FG000|Overall Study|Relapse|9|||
163469281|NCT00400946|590417410|FG001|Overall Study|Relapse|2|||
163469282|NCT00400946|590417411|FG002|Overall Study|Relapse|1|||
163469283|NCT00400946|590417412|FG003|Overall Study|Relapse|1|||
163469284|NCT00400946|590417413|FG004|Overall Study|Relapse|5|||
163469285|NCT00400946|590417409|FG000|Overall Study|Transplant in CR1|0|||
163469286|NCT00400946|590417410|FG001|Overall Study|Transplant in CR1|0|||
163469287|NCT00400946|590417411|FG002|Overall Study|Transplant in CR1|0|||
163469288|NCT00400946|590417412|FG003|Overall Study|Transplant in CR1|10|||
163469289|NCT00400946|590417413|FG004|Overall Study|Transplant in CR1|1|||
163469290|NCT00400946|590417409|FG000|Overall Study|Withdrawal by Subject|2|||
163469291|NCT00400946|590417410|FG001|Overall Study|Withdrawal by Subject|5|||
163469292|NCT00400946|590417411|FG002|Overall Study|Withdrawal by Subject|1|||
163469293|NCT00400946|590417412|FG003|Overall Study|Withdrawal by Subject|5|||
163469294|NCT00400946|590417413|FG004|Overall Study|Withdrawal by Subject|8|||
163469295|NCT00400946|590417409|FG000|Overall Study|Clinical|1|||
163469296|NCT00400946|590417410|FG001|Overall Study|Clinical|2|||
163469297|NCT00400946|590417411|FG002|Overall Study|Clinical|0|||
163469298|NCT00400946|590417412|FG003|Overall Study|Clinical|2|||
163469299|NCT00400946|590417413|FG004|Overall Study|Clinical|9|||
163469300|NCT00400946|590417409|FG000|Overall Study|Other|0|||
163469301|NCT00400946|590417410|FG001|Overall Study|Other|0|||
163469302|NCT00400946|590417411|FG002|Overall Study|Other|0|||
163469303|NCT00400946|590417412|FG003|Overall Study|Other|0|||
163469304|NCT00400946|590417413|FG004|Overall Study|Other|1|||
163469305|NCT03950440|590417416|FG000|Overall Study|Death|8|||
163469306|NCT03950440|590417417|FG001|Overall Study|Death|2|||
163469307|NCT03950440|590417418|FG002|Overall Study|Death|1|||
163469308|NCT02892734|590417419|FG000|Treatment on Study|Progressive Disease|2|||
163469309|NCT02892734|590417419|FG000|Follow up for 2 Years|Death|2|||
163469310|NCT02892734|590417419|FG000|Follow up for 2 Years|Study closed early|1|||
163469311|NCT00439309|590417420|FG000|Follow-Up|Death|1|||
163469312|NCT00439309|590417421|FG001|Follow-Up|Death|0|||
163469313|NCT00439309|590417420|FG000|Follow-Up|Lost to Follow-up|2|||
163469314|NCT00439309|590417421|FG001|Follow-Up|Lost to Follow-up|0|||
163469315|NCT00439309|590417420|FG000|Follow-Up|Withdrawal by Subject|0|||
163469316|NCT00439309|590417421|FG001|Follow-Up|Withdrawal by Subject|1|||
163469317|NCT00439309|590417420|FG000|Follow-Up|Late response by subject|0|||
163469318|NCT00439309|590417421|FG001|Follow-Up|Late response by subject|1|||
163469319|NCT02043509|590417422|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
163469320|NCT02043509|590417423|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
163469321|NCT02043509|590417422|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
163469322|NCT02043509|590417423|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
163469323|NCT02043509|590417422|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
163469324|NCT02043509|590417423|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
163469325|NCT02043509|590417422|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
163469326|NCT02043509|590417423|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
163469327|NCT00608244|590417428|FG000|Overall Study|Adverse Event|1|||
163469328|NCT00608244|590417428|FG000|Overall Study|Low trough levels|1|||
163469329|NCT01685060|590417431|FG000|Overall Study|Rollover patients|16|||
163469330|NCT01685060|590417431|FG000|Overall Study|Adverse Event|12|||
163469331|NCT01685060|590417431|FG000|Overall Study|Progressive disease|69|||
163469332|NCT01685060|590417431|FG000|Overall Study|Physician Decision|14|||
163469333|NCT01685060|590417431|FG000|Overall Study|Subject/guardian decision|20|||
163469334|NCT01685060|590417431|FG000|Overall Study|Lost to Follow-up|1|||
163469335|NCT01685060|590417431|FG000|Overall Study|Death|8|||
163469336|NCT00688623|590417434|FG000|Overall Study|Adverse Event|22|||
163469337|NCT00688623|590417434|FG000|Overall Study|abnormal lab value|1|||
163469338|NCT00688623|590417434|FG000|Overall Study|Withdrawal by Subject|4|||
163469339|NCT00688623|590417434|FG000|Overall Study|Death|3|||
163469340|NCT00688623|590417434|FG000|Overall Study|disease progression|23|||
163469341|NCT00688623|590417434|FG000|Overall Study|Protocol Violation|2|||
163469342|NCT02443155|590417435|FG000|Overall Study|Adverse Event|3|||
163469343|NCT02443155|590417436|FG001|Overall Study|Adverse Event|4|||
163469344|NCT02443155|590417437|FG002|Overall Study|Adverse Event|1|||
163469345|NCT02443155|590417438|FG003|Overall Study|Adverse Event|2|||
163469346|NCT02443155|590417435|FG000|Overall Study|Unclassified|0|||
163469347|NCT02443155|590417436|FG001|Overall Study|Unclassified|0|||
163469348|NCT02443155|590417437|FG002|Overall Study|Unclassified|2|||
163469349|NCT02443155|590417438|FG003|Overall Study|Unclassified|1|||
163469350|NCT02443155|590417435|FG000|Overall Study|Withdrawal by Subject|4|||
163469351|NCT02443155|590417436|FG001|Overall Study|Withdrawal by Subject|7|||
163469352|NCT02443155|590417437|FG002|Overall Study|Withdrawal by Subject|3|||
163469353|NCT02443155|590417438|FG003|Overall Study|Withdrawal by Subject|9|||
163469354|NCT02443155|590417435|FG000|Overall Study|Pregnancy|3|||
163469355|NCT02443155|590417436|FG001|Overall Study|Pregnancy|1|||
163469356|NCT02443155|590417437|FG002|Overall Study|Pregnancy|1|||
163469357|NCT02443155|590417438|FG003|Overall Study|Pregnancy|2|||
163469358|NCT02443155|590417435|FG000|Overall Study|Lost to Follow-up|1|||
163469359|NCT02443155|590417436|FG001|Overall Study|Lost to Follow-up|2|||
163469360|NCT02443155|590417437|FG002|Overall Study|Lost to Follow-up|0|||
163469361|NCT02443155|590417438|FG003|Overall Study|Lost to Follow-up|1|||
163469362|NCT02443155|590417435|FG000|Overall Study|Protocol Violation|1|||
163469363|NCT02443155|590417436|FG001|Overall Study|Protocol Violation|0|||
163469364|NCT02443155|590417437|FG002|Overall Study|Protocol Violation|1|||
163469365|NCT02443155|590417438|FG003|Overall Study|Protocol Violation|1|||
163469366|NCT02443155|590417435|FG000|Overall Study|Death|0|||
163469367|NCT02443155|590417436|FG001|Overall Study|Death|0|||
163469368|NCT02443155|590417437|FG002|Overall Study|Death|1|||
163469369|NCT02443155|590417438|FG003|Overall Study|Death|0|||
163469370|NCT02000219|590417439|FG000|14-Week Study Period|Physician Decision|1|||
163469371|NCT02000219|590417439|FG000|14-Week Study Period|Adverse Event|1|||
163469372|NCT02000219|590417439|FG000|14-Week Study Period|Underwent transplantation|1|||
163469373|NCT02000219|590417439|FG000|Continuation Period|Withdrawal by Subject|1|||
163469374|NCT02000219|590417439|FG000|Continuation Period|Had liver transplant|2|||
163469375|NCT02000219|590417439|FG000|Continuation Period|Non-compliance with study drug|2|||
163469376|NCT00464620|590417440|FG000|Overall Study|Physician Decision|1|||
163469377|NCT00464620|590417441|FG001|Overall Study|Physician Decision|0|||
163469378|NCT00464620|590417442|FG002|Overall Study|Physician Decision|0|||
163469379|NCT00464620|590417440|FG000|Overall Study|Withdrawal by Subject|1|||
163469380|NCT00464620|590417441|FG001|Overall Study|Withdrawal by Subject|0|||
163469381|NCT00464620|590417442|FG002|Overall Study|Withdrawal by Subject|3|||
163469382|NCT00464620|590417440|FG000|Overall Study|Ineligible sarcoma subtype|0|||
163469383|NCT00464620|590417441|FG001|Overall Study|Ineligible sarcoma subtype|2|||
163469384|NCT00464620|590417442|FG002|Overall Study|Ineligible sarcoma subtype|2|||
163469385|NCT00464620|590417440|FG000|Overall Study|Use of prohibited concomitant medication|0|||
163469386|NCT00464620|590417441|FG001|Overall Study|Use of prohibited concomitant medication|0|||
163469387|NCT00464620|590417442|FG002|Overall Study|Use of prohibited concomitant medication|2|||
163469388|NCT01998906|590417443|FG000|Overall Study|Participants ongoing in follow-up|77|||
163469389|NCT01998906|590417444|FG001|Overall Study|Participants ongoing in follow-up|60|||
163469390|NCT01998906|590417445|FG002|Overall Study|Participants ongoing in follow-up|58|||
163469391|NCT01998906|590417443|FG000|Overall Study|Death|21|||
163469392|NCT01998906|590417444|FG001|Overall Study|Death|30|||
163469393|NCT01998906|590417445|FG002|Overall Study|Death|17|||
163469394|NCT01998906|590417443|FG000|Overall Study|Lack of Efficacy|10|||
163469395|NCT01998906|590417444|FG001|Overall Study|Lack of Efficacy|9|||
163469396|NCT01998906|590417445|FG002|Overall Study|Lack of Efficacy|8|||
163469397|NCT01998906|590417443|FG000|Overall Study|Failure to return|0|||
163469398|NCT01998906|590417444|FG001|Overall Study|Failure to return|2|||
163469399|NCT01998906|590417445|FG002|Overall Study|Failure to return|4|||
163469400|NCT01998906|590417443|FG000|Overall Study|Violation of Selection Criteria|0|||
163469401|NCT01998906|590417444|FG001|Overall Study|Violation of Selection Criteria|0|||
163469402|NCT01998906|590417445|FG002|Overall Study|Violation of Selection Criteria|1|||
163469403|NCT01998906|590417443|FG000|Overall Study|Withdrawal by Subject|1|||
163469404|NCT01998906|590417444|FG001|Overall Study|Withdrawal by Subject|4|||
163469405|NCT01998906|590417445|FG002|Overall Study|Withdrawal by Subject|3|||
163469406|NCT01998906|590417443|FG000|Overall Study|Administrative/Other|2|||
163469407|NCT01998906|590417444|FG001|Overall Study|Administrative/Other|1|||
163469408|NCT01998906|590417445|FG002|Overall Study|Administrative/Other|3|||
163469409|NCT01998906|590417443|FG000|Overall Study|Other|3|||
163469410|NCT01998906|590417444|FG001|Overall Study|Other|8|||
163469411|NCT01998906|590417445|FG002|Overall Study|Other|4|||
163469412|NCT01572844|590417446|FG000|Overall Study|Physician Decision|1|||
163469413|NCT01572844|590417447|FG001|Overall Study|Physician Decision|1|||
163469414|NCT00209092|590417456|FG000|Overall Study|Progression of disease|7|||
163469415|NCT00209092|590417457|FG001|Overall Study|Progression of disease|1|||
163469416|NCT00209092|590417456|FG000|Overall Study|Adverse Event|0|||
163469417|NCT00209092|590417457|FG001|Overall Study|Adverse Event|1|||
163469418|NCT00209092|590417456|FG000|Overall Study|Withdrawal by Subject|1|||
163469419|NCT00209092|590417457|FG001|Overall Study|Withdrawal by Subject|0|||
163469420|NCT00693420|590417458|FG000|Overall Study|Adverse Event|4|||
163469421|NCT00693420|590417459|FG001|Overall Study|Adverse Event|4|||
163469422|NCT00693420|590417458|FG000|Overall Study|Lost to Follow-up|0|||
163469423|NCT00693420|590417459|FG001|Overall Study|Lost to Follow-up|3|||
163469424|NCT00693420|590417458|FG000|Overall Study|Withdrawal by Subject|1|||
163469425|NCT00693420|590417459|FG001|Overall Study|Withdrawal by Subject|0|||
163469426|NCT00693420|590417458|FG000|Overall Study|Protocol Violation|0|||
163469427|NCT00693420|590417459|FG001|Overall Study|Protocol Violation|2|||
163469428|NCT00693420|590417458|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
163469429|NCT00693420|590417459|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
163469430|NCT00693420|590417458|FG000|Overall Study|Personal Reasons|1|||
163469431|NCT00693420|590417459|FG001|Overall Study|Personal Reasons|4|||
163469432|NCT02809118|590417460|FG000|Overall Study|Withdrawal by Subject|0|||
163469433|NCT02809118|590417461|FG001|Overall Study|Withdrawal by Subject|1|||
163469434|NCT02809118|590417462|FG002|Overall Study|Withdrawal by Subject|1|||
163469435|NCT06048809|590417471|FG000|Overall Study|Adverse Event|2|||
163469436|NCT06048809|590417472|FG001|Overall Study|Adverse Event|0|||
163469437|NCT06048809|590417471|FG000|Overall Study|Withdrawal by Subject|1|||
163469438|NCT06048809|590417472|FG001|Overall Study|Withdrawal by Subject|1|||
163469439|NCT02158728|590417473|FG000|Overall Study|no procedure according to CIP done|3|||
163469440|NCT02158728|590417473|FG000|Overall Study|no qualified dataset|24|||
163469441|NCT02658149|590417477|FG000|Overall Study|Physician Decision|1|||
163469442|NCT02658149|590417478|FG001|Overall Study|Physician Decision|0|||
163469443|NCT01680991|590417480|FG000|Overall Study|Adverse Event|1|||
163469444|NCT01680991|590417481|FG001|Overall Study|Adverse Event|0|||
163469445|NCT01680991|590417482|FG002|Overall Study|Adverse Event|0|||
163469446|NCT01680991|590417480|FG000|Overall Study|Death|1|||
163469447|NCT01680991|590417481|FG001|Overall Study|Death|0|||
163469448|NCT01680991|590417482|FG002|Overall Study|Death|1|||
163469449|NCT01680991|590417480|FG000|Overall Study|Protocol Violation|0|||
163469450|NCT01680991|590417481|FG001|Overall Study|Protocol Violation|1|||
163469451|NCT01680991|590417482|FG002|Overall Study|Protocol Violation|0|||
163469452|NCT01680991|590417480|FG000|Overall Study|Withdrawal by Subject|5|||
163469453|NCT01680991|590417481|FG001|Overall Study|Withdrawal by Subject|1|||
163469454|NCT01680991|590417482|FG002|Overall Study|Withdrawal by Subject|0|||
163469455|NCT01680991|590417480|FG000|Overall Study|Progressive disease (PD)|0|||
163469456|NCT01680991|590417481|FG001|Overall Study|Progressive disease (PD)|10|||
163469457|NCT01680991|590417482|FG002|Overall Study|Progressive disease (PD)|0|||
163469458|NCT01680991|590417480|FG000|Overall Study|Physician Decision|0|||
163469459|NCT01680991|590417481|FG001|Overall Study|Physician Decision|7|||
163469460|NCT01680991|590417482|FG002|Overall Study|Physician Decision|2|||
163469461|NCT01680991|590417480|FG000|Overall Study|Bad physical condition|0|||
163469462|NCT01680991|590417481|FG001|Overall Study|Bad physical condition|0|||
163469463|NCT01680991|590417482|FG002|Overall Study|Bad physical condition|1|||
163469464|NCT01680991|590417480|FG000|Overall Study|PD confirmed in other hospital|1|||
163469465|NCT01680991|590417481|FG001|Overall Study|PD confirmed in other hospital|0|||
163469466|NCT01680991|590417482|FG002|Overall Study|PD confirmed in other hospital|0|||
163469467|NCT01156363|590417483|FG000|Overall Study|Adverse Event|6|||
163469468|NCT01156363|590417483|FG000|Overall Study|Insufficient Therapeutic Response|5|||
163469469|NCT01156363|590417483|FG000|Overall Study|Failure to Return|1|||
163469470|NCT01156363|590417483|FG000|Overall Study|Refused Treatment|4|||
163469471|NCT01156363|590417483|FG000|Overall Study|Other|6|||
163469472|NCT03135262|590417484|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
163469473|NCT03135262|590417485|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
163469474|NCT03135262|590417486|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
163469475|NCT03135262|590417487|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
163469476|NCT03135262|590417488|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
163469477|NCT03135262|590417484|FG000|Overall Study|Progression of disease|0|||
163469478|NCT03135262|590417485|FG001|Overall Study|Progression of disease|0|||
163469479|NCT03135262|590417486|FG002|Overall Study|Progression of disease|0|||
163469480|NCT03135262|590417487|FG003|Overall Study|Progression of disease|1|||
163469481|NCT03135262|590417488|FG004|Overall Study|Progression of disease|0|||
163469482|NCT03135262|590417484|FG000|Overall Study|Death|6|||
163469483|NCT03135262|590417485|FG001|Overall Study|Death|2|||
163469484|NCT03135262|590417486|FG002|Overall Study|Death|2|||
163469485|NCT03135262|590417487|FG003|Overall Study|Death|2|||
163469486|NCT03135262|590417488|FG004|Overall Study|Death|0|||
163469487|NCT03135262|590417484|FG000|Overall Study|Withdrawal by Subject|0|||
163469488|NCT03135262|590417485|FG001|Overall Study|Withdrawal by Subject|0|||
163469489|NCT03135262|590417486|FG002|Overall Study|Withdrawal by Subject|1|||
163469490|NCT03135262|590417487|FG003|Overall Study|Withdrawal by Subject|0|||
163469491|NCT03135262|590417488|FG004|Overall Study|Withdrawal by Subject|1|||
163469492|NCT03135262|590417484|FG000|Overall Study|Study terminated by sponsor|2|||
163469493|NCT03135262|590417485|FG001|Overall Study|Study terminated by sponsor|4|||
163469494|NCT03135262|590417486|FG002|Overall Study|Study terminated by sponsor|4|||
163469495|NCT03135262|590417487|FG003|Overall Study|Study terminated by sponsor|3|||
163469496|NCT03135262|590417488|FG004|Overall Study|Study terminated by sponsor|0|||
163469497|NCT03745989|590417489|FG000|Overall Study|Death|3|||
163469498|NCT03745989|590417490|FG001|Overall Study|Death|7|||
163469499|NCT03745989|590417491|FG002|Overall Study|Death|4|||
163469500|NCT03745989|590417489|FG000|Overall Study|Lost to Follow-up|0|||
163469501|NCT03745989|590417490|FG001|Overall Study|Lost to Follow-up|2|||
163469502|NCT03745989|590417491|FG002|Overall Study|Lost to Follow-up|0|||
163469503|NCT03745989|590417489|FG000|Overall Study|Sponsor Decision|0|||
163469504|NCT03745989|590417490|FG001|Overall Study|Sponsor Decision|2|||
163469505|NCT03745989|590417491|FG002|Overall Study|Sponsor Decision|8|||
163469506|NCT03745989|590417489|FG000|Overall Study|Withdrawal by Subject|0|||
163469507|NCT03745989|590417490|FG001|Overall Study|Withdrawal by Subject|1|||
163469508|NCT03745989|590417491|FG002|Overall Study|Withdrawal by Subject|3|||
163469509|NCT00047008|590417493|FG000|Overall Study|Withdrawn consent|2|||
163469510|NCT00047008|590417494|FG001|Overall Study|Withdrawn consent|3|||
163469511|NCT00047008|590417493|FG000|Overall Study|Ineligible|9|||
163469512|NCT00047008|590417494|FG001|Overall Study|Ineligible|8|||
163469513|NCT00429572|590417495|FG000|Overall Study|Disease progression|1|||
163469514|NCT02773368|590417496|FG000|Overall Study|Lost to Follow-up|4|||
163469515|NCT02773368|590417497|FG001|Overall Study|Lost to Follow-up|1|||
163469516|NCT02773368|590417496|FG000|Overall Study|Withdrawal by Subject|5|||
163469517|NCT02773368|590417497|FG001|Overall Study|Withdrawal by Subject|1|||
163469518|NCT02773368|590417496|FG000|Overall Study|Unclassified|1|||
163469519|NCT02773368|590417497|FG001|Overall Study|Unclassified|1|||
163469520|NCT02773368|590417496|FG000|Overall Study|Missing|0|||
163469521|NCT02773368|590417497|FG001|Overall Study|Missing|1|||
163469522|NCT01929018|590417500|FG000|Overall Study|Lost to Follow-up|1|||
163469523|NCT01929018|590417501|FG001|Overall Study|Lost to Follow-up|0|||
163469524|NCT01929018|590417500|FG000|Overall Study|Hospitalization|0|||
163469525|NCT01929018|590417501|FG001|Overall Study|Hospitalization|1|||
163469526|NCT01047436|590417507|FG000|Overall Study|Protocol Violation|1|||
163469527|NCT01047436|590417508|FG001|Overall Study|Protocol Violation|0|||
163469528|NCT02635867|590417511|FG000|Overall Study|Lost to Follow-up|4|||
163469529|NCT02635867|590417512|FG001|Overall Study|Lost to Follow-up|3|||
163469530|NCT02635867|590417513|FG002|Overall Study|Lost to Follow-up|3|||
163469531|NCT02635867|590417514|FG003|Overall Study|Lost to Follow-up|4|||
163469532|NCT02635867|590417515|FG004|Overall Study|Lost to Follow-up|1|||
163469533|NCT02565576|590417518|FG000|Overall Study|abnormal lab value|2|||
163469534|NCT02565576|590417519|FG001|Overall Study|abnormal lab value|0|||
163469535|NCT02565576|590417518|FG000|Overall Study|subject / guardian decision|1|||
163469536|NCT02565576|590417519|FG001|Overall Study|subject / guardian decision|3|||
163469537|NCT02565576|590417518|FG000|Overall Study|Lost to Follow-up|1|||
163469538|NCT02565576|590417519|FG001|Overall Study|Lost to Follow-up|0|||
163469539|NCT02565576|590417518|FG000|Overall Study|Death|0|||
163469540|NCT02565576|590417519|FG001|Overall Study|Death|2|||
163469541|NCT02565576|590417518|FG000|Overall Study|Adverse Event|1|||
163469542|NCT02565576|590417519|FG001|Overall Study|Adverse Event|0|||
163469543|NCT00282568|590417520|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
163469544|NCT00282568|590417520|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
163469545|NCT00282568|590417520|FG000|Extended Treatment Period|Adverse Event|17|||
163469546|NCT00282568|590417520|FG000|Extended Treatment Period|Non-compliance|4|||
163469547|NCT00282568|590417520|FG000|Extended Treatment Period|Physician Decision|1|||
163469548|NCT00282568|590417520|FG000|Extended Treatment Period|Lost to Follow-up|2|||
163469549|NCT01266070|590417521|FG000|Overall Study|Adverse Event|3|||
163469550|NCT01266070|590417521|FG000|Overall Study|Protocol Violation|1|||
163469551|NCT00939341|590417522|FG000|Overall Study|Adverse Event|15|||
163469552|NCT00939341|590417522|FG000|Overall Study|Pregnancy|1|||
163469553|NCT00939341|590417522|FG000|Overall Study|Lost to Follow-up|23|||
163469554|NCT00939341|590417522|FG000|Overall Study|Withdrawal by Subject|13|||
163469555|NCT00939341|590417522|FG000|Overall Study|Protocol Violation|6|||
163469556|NCT00939341|590417522|FG000|Overall Study|Incorrect enrolment|8|||
163469557|NCT01408732|590417523|FG000|Overall Study|Withdrawal by Subject|2|||
163469558|NCT01408732|590417524|FG001|Overall Study|Withdrawal by Subject|2|||
163469559|NCT00764322|590417526|FG000|Overall Study|Withdrawal by Subject|11|||
163469560|NCT00764322|590417526|FG000|Overall Study|No CYP2D6 genotyping|9|||
163469561|NCT00796003|590417527|FG000|Overall Study|Disease Progression|2|||
163469562|NCT00796003|590417528|FG001|Overall Study|Disease Progression|13|||
163469563|NCT00796003|590417527|FG000|Overall Study|Adverse Event|1|||
163469564|NCT00796003|590417528|FG001|Overall Study|Adverse Event|7|||
163469565|NCT00796003|590417527|FG000|Overall Study|Specified organ function not met|0|||
163469566|NCT00796003|590417528|FG001|Overall Study|Specified organ function not met|1|||
163469567|NCT00796003|590417527|FG000|Overall Study|Physician Decision|0|||
163469568|NCT00796003|590417528|FG001|Overall Study|Physician Decision|4|||
163469569|NCT00796003|590417527|FG000|Overall Study|Withdrawal by Subject|0|||
163469570|NCT00796003|590417528|FG001|Overall Study|Withdrawal by Subject|1|||
163469571|NCT00796003|590417527|FG000|Overall Study|Other|0|||
163469572|NCT00796003|590417528|FG001|Overall Study|Other|1|||
163469573|NCT00796003|590417527|FG000|Overall Study|Participants Not treated|0|||
163469574|NCT00796003|590417528|FG001|Overall Study|Participants Not treated|2|||
163469575|NCT03185819|590417533|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
163469576|NCT03185819|590417534|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
163469577|NCT03185819|590417535|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
163469578|NCT03185819|590417536|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
163469579|NCT03185819|590417533|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
163469580|NCT03185819|590417534|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
163469581|NCT03185819|590417535|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
163469582|NCT03185819|590417536|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
163469583|NCT03185819|590417533|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
163469584|NCT03185819|590417534|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
163469585|NCT03185819|590417535|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
163469586|NCT03185819|590417536|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
163469587|NCT03185819|590417533|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
163469588|NCT03185819|590417534|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
163469589|NCT03185819|590417535|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
163469590|NCT03185819|590417536|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
163469591|NCT03185819|590417533|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
163469592|NCT03185819|590417534|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
163469593|NCT03185819|590417535|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
163469594|NCT03185819|590417536|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
163469595|NCT03185819|590417533|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
163469596|NCT03185819|590417534|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
163469597|NCT03185819|590417535|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
163469598|NCT03185819|590417536|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
163469599|NCT03185819|590417533|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
163469600|NCT03185819|590417534|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
163469601|NCT03185819|590417535|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
163469602|NCT03185819|590417536|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
163469603|NCT03185819|590417533|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
163469604|NCT03185819|590417534|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
163469605|NCT03185819|590417535|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
163469606|NCT03185819|590417536|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
163469607|NCT03185819|590417533|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
163469608|NCT03185819|590417534|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
163469609|NCT03185819|590417535|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
163469610|NCT03185819|590417536|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
163469611|NCT03185819|590417533|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
163469612|NCT03185819|590417534|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
163469613|NCT03185819|590417535|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
163469614|NCT03185819|590417536|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
163469615|NCT03185819|590417533|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
163469616|NCT03185819|590417534|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
163469617|NCT03185819|590417535|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
163469618|NCT03185819|590417536|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
163469619|NCT03185819|590417533|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
163469620|NCT03185819|590417534|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
163469621|NCT03185819|590417535|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
163469622|NCT03185819|590417536|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
163469623|NCT03185819|590417533|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
163469624|NCT03185819|590417534|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
163469625|NCT03185819|590417535|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
163469626|NCT03185819|590417536|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
163469627|NCT00732641|590417537|FG000|Overall Study|Relapse or Progressive Disease|65|||
163469628|NCT00732641|590417538|FG001|Overall Study|Relapse or Progressive Disease|101|||
163469629|NCT00732641|590417537|FG000|Overall Study|Serious Adverse Events|12|||
163469630|NCT00732641|590417538|FG001|Overall Study|Serious Adverse Events|3|||
163469631|NCT00732641|590417537|FG000|Overall Study|Physician Decision|6|||
163469632|NCT00732641|590417538|FG001|Overall Study|Physician Decision|0|||
163469633|NCT00732641|590417537|FG000|Overall Study|Withdrawal by Subject|4|||
163469634|NCT00732641|590417538|FG001|Overall Study|Withdrawal by Subject|2|||
163469635|NCT00732641|590417537|FG000|Overall Study|Unable to Complete|1|||
163469636|NCT00732641|590417538|FG001|Overall Study|Unable to Complete|1|||
163469637|NCT00732641|590417537|FG000|Overall Study|Other|18|||
163469638|NCT00732641|590417538|FG001|Overall Study|Other|5|||
163469639|NCT02910089|590417539|FG000|Overall Study|Lost insurance eligibility|22|||
163469640|NCT02910089|590417540|FG001|Overall Study|Lost insurance eligibility|16|||
163469641|NCT03434041|590417543|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
163469642|NCT03434041|590417544|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
163469643|NCT03434041|590417543|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
163469644|NCT03434041|590417544|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
163469645|NCT03434041|590417543|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
163469646|NCT03434041|590417544|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
163469647|NCT03434041|590417543|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
163469648|NCT03434041|590417544|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
163469649|NCT03434041|590417543|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
163469650|NCT03434041|590417544|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
163469651|NCT03434041|590417543|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
163469652|NCT03434041|590417544|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
163469653|NCT03434041|590417543|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
163469654|NCT03434041|590417544|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
163469655|NCT03434041|590417543|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
163469656|NCT03434041|590417544|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
163469657|NCT03434041|590417543|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
163469658|NCT03434041|590417544|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
163469659|NCT03434041|590417543|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
163469660|NCT03434041|590417544|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
163469661|NCT03434041|590417543|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
163469662|NCT03434041|590417544|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
163469663|NCT03447821|590417545|FG000|Overall Study|Withdrawal by Subject|1|||
163469664|NCT03447821|590417546|FG001|Overall Study|Withdrawal by Subject|1|||
163469665|NCT03447821|590417547|FG002|Overall Study|Withdrawal by Subject|0|||
163469666|NCT03447821|590417545|FG000|Overall Study|Lost to Follow-up|0|||
163469667|NCT03447821|590417546|FG001|Overall Study|Lost to Follow-up|0|||
163469668|NCT03447821|590417547|FG002|Overall Study|Lost to Follow-up|1|||
163469669|NCT02977507|590417548|FG000|Overall Study|Protocol Deviation|1|||
163469670|NCT02977507|590417549|FG001|Overall Study|Protocol Deviation|0|||
163469671|NCT02977507|590417548|FG000|Overall Study|Lost to Follow-up|1|||
163469672|NCT02977507|590417549|FG001|Overall Study|Lost to Follow-up|0|||
163469673|NCT00437203|590417550|FG000|Overall Study|Death|0|||
163469674|NCT00437203|590417551|FG001|Overall Study|Death|0|||
163469675|NCT00437203|590417552|FG002|Overall Study|Death|1|||
163469676|NCT00437203|590417553|FG003|Overall Study|Death|0|||
163469677|NCT00437203|590417554|FG004|Overall Study|Death|0|||
163469678|NCT00437203|590417555|FG005|Overall Study|Death|0|||
163469679|NCT00437203|590417556|FG006|Overall Study|Death|0|||
163469680|NCT00437203|590417557|FG007|Overall Study|Death|1|||
163469681|NCT00437203|590417558|FG008|Overall Study|Death|0|||
163469682|NCT00437203|590417559|FG009|Overall Study|Death|1|||
163469683|NCT00437203|590417550|FG000|Overall Study|Adverse Event|1|||
163469684|NCT00437203|590417551|FG001|Overall Study|Adverse Event|1|||
163469685|NCT00437203|590417552|FG002|Overall Study|Adverse Event|0|||
163469686|NCT00437203|590417553|FG003|Overall Study|Adverse Event|0|||
163469687|NCT00437203|590417554|FG004|Overall Study|Adverse Event|0|||
163469688|NCT00437203|590417555|FG005|Overall Study|Adverse Event|0|||
163469689|NCT00437203|590417556|FG006|Overall Study|Adverse Event|0|||
163469690|NCT00437203|590417557|FG007|Overall Study|Adverse Event|1|||
163469691|NCT00437203|590417558|FG008|Overall Study|Adverse Event|0|||
163469692|NCT00437203|590417559|FG009|Overall Study|Adverse Event|1|||
163469693|NCT00437203|590417550|FG000|Overall Study|Study terminated by sponsor|0|||
163469694|NCT00437203|590417551|FG001|Overall Study|Study terminated by sponsor|0|||
163469695|NCT00437203|590417552|FG002|Overall Study|Study terminated by sponsor|0|||
163469696|NCT00437203|590417553|FG003|Overall Study|Study terminated by sponsor|0|||
163469697|NCT00437203|590417554|FG004|Overall Study|Study terminated by sponsor|0|||
163469698|NCT00437203|590417555|FG005|Overall Study|Study terminated by sponsor|0|||
163469699|NCT00437203|590417556|FG006|Overall Study|Study terminated by sponsor|0|||
163469700|NCT00437203|590417557|FG007|Overall Study|Study terminated by sponsor|0|||
163469701|NCT00437203|590417558|FG008|Overall Study|Study terminated by sponsor|1|||
163469702|NCT00437203|590417559|FG009|Overall Study|Study terminated by sponsor|0|||
163469703|NCT00437203|590417550|FG000|Overall Study|Objective progression or relapse|5|||
163469704|NCT00437203|590417551|FG001|Overall Study|Objective progression or relapse|6|||
163469705|NCT00437203|590417552|FG002|Overall Study|Objective progression or relapse|2|||
163469706|NCT00437203|590417553|FG003|Overall Study|Objective progression or relapse|3|||
163469707|NCT00437203|590417554|FG004|Overall Study|Objective progression or relapse|3|||
163469708|NCT00437203|590417555|FG005|Overall Study|Objective progression or relapse|3|||
163469709|NCT00437203|590417556|FG006|Overall Study|Objective progression or relapse|6|||
163469710|NCT00437203|590417557|FG007|Overall Study|Objective progression or relapse|1|||
163469711|NCT00437203|590417558|FG008|Overall Study|Objective progression or relapse|2|||
163469712|NCT00437203|590417559|FG009|Overall Study|Objective progression or relapse|2|||
163469713|NCT00437203|590417550|FG000|Overall Study|Other|0|||
163469714|NCT00437203|590417551|FG001|Overall Study|Other|1|||
163469715|NCT00437203|590417552|FG002|Overall Study|Other|0|||
163469716|NCT00437203|590417553|FG003|Overall Study|Other|0|||
163469717|NCT00437203|590417554|FG004|Overall Study|Other|0|||
163469718|NCT00437203|590417555|FG005|Overall Study|Other|0|||
163469719|NCT00437203|590417556|FG006|Overall Study|Other|1|||
163469720|NCT00437203|590417557|FG007|Overall Study|Other|0|||
163469721|NCT00437203|590417558|FG008|Overall Study|Other|0|||
163469722|NCT00437203|590417559|FG009|Overall Study|Other|0|||
163469723|NCT03997760|590417560|FG000|Overall Study|Protocol Deviation|0|||
163469724|NCT03997760|590417561|FG001|Overall Study|Protocol Deviation|1|||
163469725|NCT03997760|590417562|FG002|Overall Study|Protocol Deviation|0|||
163469726|NCT03997760|590417563|FG003|Overall Study|Protocol Deviation|0|||
163469727|NCT01906476|590417565|FG000|Overall Study|Lost to Follow-up|17|||
163469728|NCT01906476|590417566|FG001|Overall Study|Lost to Follow-up|16|||
163469729|NCT00479167|590417569|FG000|Overall Study|Withdrawal by Subject|1|||
163469730|NCT01576406|590417571|FG000|Overall Study|Lost to Follow-up|1|||
163469731|NCT01576406|590417572|FG001|Overall Study|Lost to Follow-up|2|||
163469732|NCT01576406|590417573|FG002|Overall Study|Lost to Follow-up|0|||
163469733|NCT01576406|590417574|FG003|Overall Study|Lost to Follow-up|0|||
163469734|NCT01576406|590417575|FG004|Overall Study|Lost to Follow-up|0|||
163469735|NCT01576406|590417576|FG005|Overall Study|Lost to Follow-up|0|||
163469736|NCT01576406|590417571|FG000|Overall Study|Death|3|||
163469737|NCT01576406|590417572|FG001|Overall Study|Death|4|||
163469738|NCT01576406|590417573|FG002|Overall Study|Death|8|||
163469739|NCT01576406|590417574|FG003|Overall Study|Death|5|||
163469740|NCT01576406|590417575|FG004|Overall Study|Death|7|||
163469741|NCT01576406|590417576|FG005|Overall Study|Death|9|||
163469742|NCT01576406|590417571|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
163469743|NCT01576406|590417572|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
163469744|NCT01576406|590417573|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
163469745|NCT01576406|590417574|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
163469746|NCT01576406|590417575|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
163469747|NCT01576406|590417576|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
163469748|NCT01576406|590417571|FG000|Overall Study|Withdrawal the consent|2|||
163469749|NCT01576406|590417572|FG001|Overall Study|Withdrawal the consent|2|||
163469750|NCT01576406|590417573|FG002|Overall Study|Withdrawal the consent|5|||
163469751|NCT01576406|590417574|FG003|Overall Study|Withdrawal the consent|1|||
163469752|NCT01576406|590417575|FG004|Overall Study|Withdrawal the consent|1|||
163469753|NCT01576406|590417576|FG005|Overall Study|Withdrawal the consent|3|||
163469754|NCT01576406|590417571|FG000|Overall Study|Other|0|||
163469755|NCT01576406|590417572|FG001|Overall Study|Other|0|||
163469756|NCT01576406|590417573|FG002|Overall Study|Other|2|||
163469757|NCT01576406|590417574|FG003|Overall Study|Other|2|||
163469758|NCT01576406|590417575|FG004|Overall Study|Other|0|||
163469759|NCT01576406|590417576|FG005|Overall Study|Other|0|||
163469760|NCT01627782|590417577|FG000|Overall Study|Adverse Event|1|||
163469761|NCT01627782|590417578|FG001|Overall Study|Adverse Event|2|||
163469762|NCT01627782|590417579|FG002|Overall Study|Adverse Event|0|||
163469763|NCT01627782|590417580|FG003|Overall Study|Adverse Event|1|||
163469764|NCT01627782|590417577|FG000|Overall Study|Lack of Efficacy|11|||
163469765|NCT01627782|590417578|FG001|Overall Study|Lack of Efficacy|1|||
163469766|NCT01627782|590417579|FG002|Overall Study|Lack of Efficacy|15|||
163469767|NCT01627782|590417580|FG003|Overall Study|Lack of Efficacy|2|||
163469768|NCT01627782|590417577|FG000|Overall Study|Protocol Violation|1|||
163469769|NCT01627782|590417578|FG001|Overall Study|Protocol Violation|0|||
163469770|NCT01627782|590417579|FG002|Overall Study|Protocol Violation|0|||
163469771|NCT01627782|590417580|FG003|Overall Study|Protocol Violation|0|||
163469772|NCT01627782|590417577|FG000|Overall Study|Withdrawal by Subject|2|||
163469773|NCT01627782|590417578|FG001|Overall Study|Withdrawal by Subject|1|||
163469774|NCT01627782|590417579|FG002|Overall Study|Withdrawal by Subject|0|||
163469775|NCT01627782|590417580|FG003|Overall Study|Withdrawal by Subject|0|||
163469776|NCT01627782|590417577|FG000|Overall Study|Other|0|||
163469777|NCT01627782|590417578|FG001|Overall Study|Other|2|||
163469778|NCT01627782|590417579|FG002|Overall Study|Other|0|||
163469779|NCT01627782|590417580|FG003|Overall Study|Other|3|||
163469780|NCT01627782|590417577|FG000|Overall Study|Randomized But Not Treated|1|||
163469781|NCT01627782|590417578|FG001|Overall Study|Randomized But Not Treated|0|||
163469782|NCT01627782|590417579|FG002|Overall Study|Randomized But Not Treated|0|||
163469783|NCT01627782|590417580|FG003|Overall Study|Randomized But Not Treated|0|||
163469784|NCT01004159|590419968|FG000|Overall Study|Adverse Event|2|||
163469785|NCT01004159|590419968|FG000|Overall Study|Disease Progression|18|||
163469786|NCT01199198|590419974|FG000|Overall Study|Adverse Event|3|||
163469787|NCT01199198|590419975|FG001|Overall Study|Adverse Event|0|||
163469788|NCT01199198|590419974|FG000|Overall Study|Lost to Follow-up|1|||
163469789|NCT01199198|590419975|FG001|Overall Study|Lost to Follow-up|5|||
163469790|NCT01199198|590419974|FG000|Overall Study|Withdrawal by Subject|1|||
163469791|NCT01199198|590419975|FG001|Overall Study|Withdrawal by Subject|2|||
163469792|NCT01199198|590419974|FG000|Overall Study|ICU Transfer|1|||
163469793|NCT01199198|590419975|FG001|Overall Study|ICU Transfer|2|||
163469794|NCT01199198|590419974|FG000|Overall Study|Hospice-care transfer|1|||
163469795|NCT01199198|590419975|FG001|Overall Study|Hospice-care transfer|2|||
163469796|NCT04315298|590419976|FG000|Overall Study|Withdrawal by Subject|0|||
163469797|NCT04315298|590419977|FG001|Overall Study|Withdrawal by Subject|0|||
163469798|NCT04315298|590419978|FG002|Overall Study|Withdrawal by Subject|0|||
163469799|NCT04315298|590419979|FG003|Overall Study|Withdrawal by Subject|2|||
163469800|NCT04315298|590419980|FG004|Overall Study|Withdrawal by Subject|2|||
163469801|NCT04315298|590419981|FG005|Overall Study|Withdrawal by Subject|2|||
163469802|NCT04315298|590419982|FG006|Overall Study|Withdrawal by Subject|0|||
163469803|NCT04315298|590419983|FG007|Overall Study|Withdrawal by Subject|1|||
163469804|NCT04315298|590419984|FG008|Overall Study|Withdrawal by Subject|1|||
163469805|NCT04315298|590419985|FG009|Overall Study|Withdrawal by Subject|1|||
163469806|NCT04315298|590419986|FG010|Overall Study|Withdrawal by Subject|0|||
163469807|NCT04315298|590419987|FG011|Overall Study|Withdrawal by Subject|0|||
163469808|NCT04315298|590419988|FG012|Overall Study|Withdrawal by Subject|0|||
163469809|NCT04315298|590419989|FG013|Overall Study|Withdrawal by Subject|0|||
163469810|NCT04315298|590419990|FG014|Overall Study|Withdrawal by Subject|0|||
163469811|NCT04315298|590419991|FG015|Overall Study|Withdrawal by Subject|0|||
163469812|NCT04315298|590419992|FG016|Overall Study|Withdrawal by Subject|0|||
163469813|NCT04315298|590419993|FG017|Overall Study|Withdrawal by Subject|0|||
163469814|NCT04315298|590419994|FG018|Overall Study|Withdrawal by Subject|0|||
163469815|NCT04315298|590419976|FG000|Overall Study|Physician Decision|0|||
163469816|NCT04315298|590419977|FG001|Overall Study|Physician Decision|0|||
163469817|NCT04315298|590419978|FG002|Overall Study|Physician Decision|0|||
163469818|NCT04315298|590419979|FG003|Overall Study|Physician Decision|0|||
163469819|NCT04315298|590419980|FG004|Overall Study|Physician Decision|1|||
163469820|NCT04315298|590419981|FG005|Overall Study|Physician Decision|0|||
163469821|NCT04315298|590419982|FG006|Overall Study|Physician Decision|0|||
163469822|NCT04315298|590419983|FG007|Overall Study|Physician Decision|0|||
163469823|NCT04315298|590419984|FG008|Overall Study|Physician Decision|0|||
163469824|NCT04315298|590419985|FG009|Overall Study|Physician Decision|0|||
163469825|NCT04315298|590419986|FG010|Overall Study|Physician Decision|0|||
163469826|NCT04315298|590419987|FG011|Overall Study|Physician Decision|0|||
163469827|NCT04315298|590419988|FG012|Overall Study|Physician Decision|0|||
163469828|NCT04315298|590419989|FG013|Overall Study|Physician Decision|0|||
163469829|NCT04315298|590419990|FG014|Overall Study|Physician Decision|0|||
163469830|NCT04315298|590419991|FG015|Overall Study|Physician Decision|0|||
163469831|NCT04315298|590419992|FG016|Overall Study|Physician Decision|0|||
163469832|NCT04315298|590419993|FG017|Overall Study|Physician Decision|0|||
163469833|NCT04315298|590419994|FG018|Overall Study|Physician Decision|0|||
163469834|NCT04315298|590419976|FG000|Overall Study|Lost to Follow-up|5|||
163469835|NCT04315298|590419977|FG001|Overall Study|Lost to Follow-up|10|||
163469836|NCT04315298|590419978|FG002|Overall Study|Lost to Follow-up|6|||
163469837|NCT04315298|590419979|FG003|Overall Study|Lost to Follow-up|8|||
163469838|NCT04315298|590419980|FG004|Overall Study|Lost to Follow-up|12|||
163469839|NCT04315298|590419981|FG005|Overall Study|Lost to Follow-up|13|||
163469840|NCT04315298|590419982|FG006|Overall Study|Lost to Follow-up|9|||
163469841|NCT04315298|590419983|FG007|Overall Study|Lost to Follow-up|16|||
163469842|NCT04315298|590419984|FG008|Overall Study|Lost to Follow-up|14|||
163469843|NCT04315298|590419985|FG009|Overall Study|Lost to Follow-up|0|||
163469844|NCT04315298|590419986|FG010|Overall Study|Lost to Follow-up|2|||
163469845|NCT04315298|590419987|FG011|Overall Study|Lost to Follow-up|1|||
163469846|NCT04315298|590419988|FG012|Overall Study|Lost to Follow-up|0|||
163469847|NCT04315298|590419989|FG013|Overall Study|Lost to Follow-up|0|||
163469848|NCT04315298|590419990|FG014|Overall Study|Lost to Follow-up|0|||
163469849|NCT04315298|590419991|FG015|Overall Study|Lost to Follow-up|2|||
163469850|NCT04315298|590419992|FG016|Overall Study|Lost to Follow-up|0|||
163469851|NCT04315298|590419993|FG017|Overall Study|Lost to Follow-up|0|||
163469852|NCT04315298|590419994|FG018|Overall Study|Lost to Follow-up|0|||
163469853|NCT04315298|590419976|FG000|Overall Study|Death|24|||
163469854|NCT04315298|590419977|FG001|Overall Study|Death|60|||
163469855|NCT04315298|590419978|FG002|Overall Study|Death|49|||
163469856|NCT04315298|590419979|FG003|Overall Study|Death|59|||
163469857|NCT04315298|590419980|FG004|Overall Study|Death|70|||
163469858|NCT04315298|590419981|FG005|Overall Study|Death|114|||
163469859|NCT04315298|590419982|FG006|Overall Study|Death|9|||
163469860|NCT04315298|590419983|FG007|Overall Study|Death|12|||
163469861|NCT04315298|590419984|FG008|Overall Study|Death|21|||
163469862|NCT04315298|590419985|FG009|Overall Study|Death|16|||
163469863|NCT04315298|590419986|FG010|Overall Study|Death|40|||
163469864|NCT04315298|590419987|FG011|Overall Study|Death|40|||
163469865|NCT04315298|590419988|FG012|Overall Study|Death|3|||
163469866|NCT04315298|590419989|FG013|Overall Study|Death|4|||
163469867|NCT04315298|590419990|FG014|Overall Study|Death|6|||
163469868|NCT04315298|590419991|FG015|Overall Study|Death|4|||
163469869|NCT04315298|590419992|FG016|Overall Study|Death|3|||
163469870|NCT04315298|590419993|FG017|Overall Study|Death|1|||
163469871|NCT04315298|590419994|FG018|Overall Study|Death|0|||
163469872|NCT00736385|590419995|FG000|Overall Study|Withdrawal by Subject|2|||
163469873|NCT00736385|590419996|FG001|Overall Study|Withdrawal by Subject|2|||
163469874|NCT00736385|590419995|FG000|Overall Study|Adverse Event|0|||
163469875|NCT00736385|590419996|FG001|Overall Study|Adverse Event|1|||
163469876|NCT03267511|590419997|FG000|Overall Study|Lost to Follow-up|0|||
163469877|NCT03267511|590419998|FG001|Overall Study|Lost to Follow-up|0|||
163469878|NCT03267511|590419999|FG002|Overall Study|Lost to Follow-up|0|||
163469879|NCT03267511|590420000|FG003|Overall Study|Lost to Follow-up|1|||
163469880|NCT03050307|590420001|FG000|Overall Study|Adverse Event|4|||
163469881|NCT03050307|590420002|FG001|Overall Study|Adverse Event|2|||
163469882|NCT03050307|590420001|FG000|Overall Study|Significant Protocol Deviation|0|||
163469883|NCT03050307|590420002|FG001|Overall Study|Significant Protocol Deviation|1|||
163469884|NCT03050307|590420001|FG000|Overall Study|Lost to Follow-up|0|||
163469885|NCT03050307|590420002|FG001|Overall Study|Lost to Follow-up|1|||
163469886|NCT03050307|590420001|FG000|Overall Study|Voluntary Withdrawal|3|||
163469887|NCT03050307|590420002|FG001|Overall Study|Voluntary Withdrawal|4|||
163469888|NCT03050307|590420001|FG000|Overall Study|Reason not Specified|1|||
163469889|NCT03050307|590420002|FG001|Overall Study|Reason not Specified|1|||
163469890|NCT01536418|590420021|FG000|Overall Study|Protocol Violation|2|||
163469891|NCT01536418|590420022|FG001|Overall Study|Protocol Violation|3|||
163469892|NCT01536418|590420021|FG000|Overall Study|Physician Decision|1|||
163469893|NCT01536418|590420022|FG001|Overall Study|Physician Decision|3|||
163469894|NCT01536418|590420021|FG000|Overall Study|Study closed/terminated|41|||
163469895|NCT01536418|590420022|FG001|Overall Study|Study closed/terminated|37|||
163469896|NCT01536418|590420021|FG000|Overall Study|Lack of Efficacy|10|||
163469897|NCT01536418|590420022|FG001|Overall Study|Lack of Efficacy|16|||
163469898|NCT01536418|590420021|FG000|Overall Study|Adverse Event|9|||
163469899|NCT01536418|590420022|FG001|Overall Study|Adverse Event|4|||
163469900|NCT01536418|590420021|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
163469901|NCT01536418|590420022|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
163469902|NCT01536418|590420021|FG000|Overall Study|Withdrawal by Subject|5|||
163469903|NCT01536418|590420022|FG001|Overall Study|Withdrawal by Subject|3|||
163469904|NCT00711412|590420024|FG000|Induction Treatment|Death|2|||
163469905|NCT00711412|590420024|FG000|Induction Treatment|Adverse Event|1|||
163469906|NCT00711412|590420024|FG000|Induction Treatment|Other|1|||
163469907|NCT00711412|590420024|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
163469908|NCT00711412|590420024|FG000|Evaluated for Combination Treatment|Death|1|||
163469909|NCT00711412|590420024|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
163469910|NCT00711412|590420024|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
163469911|NCT00711412|590420024|FG000|Combination Treatment|Progressive Disease|1|||
163469912|NCT00711412|590420024|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
163469913|NCT00711412|590420024|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
163469914|NCT00711412|590420024|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
163469915|NCT00711412|590420024|FG000|Evaluation for Response and Surgery|Death|1|||
163469916|NCT00711412|590420024|FG000|Survival Follow up Until Death|Other|12|||
163469917|NCT04097028|590420029|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
163469918|NCT04097028|590420029|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
163469919|NCT04097028|590420029|FG000|Overall Study|Disease Progression prior to Surgery|2|||
163469920|NCT04097028|590420029|FG000|Overall Study|Adverse Event prior to Surgery|1|||
163469921|NCT02498392|590420030|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
163469922|NCT02498392|590420031|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
163469923|NCT02498392|590420030|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
163469924|NCT02498392|590420031|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
163469925|NCT02498392|590420030|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
163469926|NCT02498392|590420031|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
163469927|NCT02498392|590420030|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
163469928|NCT02498392|590420031|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
163469929|NCT02498392|590420030|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
163469930|NCT02498392|590420031|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
163469931|NCT02498392|590420030|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
163469932|NCT02498392|590420031|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
163469933|NCT02473289|590420032|FG000|Overall Study|Adverse Event|2|||
163469934|NCT02473289|590420033|FG001|Overall Study|Adverse Event|3|||
163469935|NCT02473289|590420032|FG000|Overall Study|Lost to Follow-up|1|||
163469936|NCT02473289|590420033|FG001|Overall Study|Lost to Follow-up|1|||
163469937|NCT02473289|590420032|FG000|Overall Study|Protocol Violation|0|||
163469938|NCT02473289|590420033|FG001|Overall Study|Protocol Violation|1|||
163469939|NCT02473289|590420032|FG000|Overall Study|Withdrawal of consent|6|||
163469940|NCT02473289|590420033|FG001|Overall Study|Withdrawal of consent|7|||
163469941|NCT02473289|590420032|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
163469942|NCT02473289|590420033|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
163469943|NCT02473289|590420032|FG000|Overall Study|Other|2|||
163469944|NCT02473289|590420033|FG001|Overall Study|Other|0|||
163469945|NCT06073054|590420034|FG000|Overall Study|Withdrawal by Subject|2|||
163469946|NCT02244619|590420035|FG000|Overall Study|Did not receive study intervention|8|||
163469947|NCT02244619|590420036|FG001|Overall Study|Did not receive study intervention|21|||
163469948|NCT03285490|590420038|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
163469949|NCT03285490|590420039|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
163469950|NCT03285490|590420038|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
163469951|NCT03285490|590420039|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
163469952|NCT00068822|590420040|FG000|First Randomized Intervention|Lost to Follow-up|1|||
163469953|NCT00068822|590420041|FG001|First Randomized Intervention|Lost to Follow-up|2|||
163469954|NCT02728206|590420042|FG000|Overall Study|Death|1|||
163469955|NCT00424099|590420046|FG000|Overall Study|Adverse Event|0|||
163469956|NCT00424099|590420047|FG001|Overall Study|Adverse Event|1|||
163469957|NCT00424099|590420048|FG002|Overall Study|Adverse Event|1|||
163469958|NCT00424099|590420049|FG003|Overall Study|Adverse Event|0|||
163469959|NCT00424099|590420046|FG000|Overall Study|Death|0|||
163469960|NCT00424099|590420047|FG001|Overall Study|Death|1|||
163469961|NCT00424099|590420048|FG002|Overall Study|Death|0|||
163469962|NCT00424099|590420049|FG003|Overall Study|Death|0|||
163469963|NCT00424099|590420046|FG000|Overall Study|Illness|2|||
163469964|NCT00424099|590420047|FG001|Overall Study|Illness|0|||
163469965|NCT00424099|590420048|FG002|Overall Study|Illness|1|||
163469966|NCT00424099|590420049|FG003|Overall Study|Illness|4|||
163469967|NCT00424099|590420046|FG000|Overall Study|Lost to Follow-up|0|||
163469968|NCT00424099|590420047|FG001|Overall Study|Lost to Follow-up|0|||
163469969|NCT00424099|590420048|FG002|Overall Study|Lost to Follow-up|3|||
163469970|NCT00424099|590420049|FG003|Overall Study|Lost to Follow-up|0|||
163469971|NCT00424099|590420046|FG000|Overall Study|Hospitalized|1|||
163469972|NCT00424099|590420047|FG001|Overall Study|Hospitalized|2|||
163469973|NCT00424099|590420048|FG002|Overall Study|Hospitalized|1|||
163469974|NCT00424099|590420049|FG003|Overall Study|Hospitalized|3|||
163469975|NCT00424099|590420046|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
163469976|NCT00424099|590420047|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
163469977|NCT00424099|590420048|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
163469978|NCT00424099|590420049|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
163469979|NCT00424099|590420046|FG000|Overall Study|Withdrawal by Subject|1|||
163469980|NCT00424099|590420047|FG001|Overall Study|Withdrawal by Subject|9|||
163469981|NCT00424099|590420048|FG002|Overall Study|Withdrawal by Subject|4|||
163469982|NCT00424099|590420049|FG003|Overall Study|Withdrawal by Subject|6|||
163469983|NCT00424099|590420046|FG000|Overall Study|Physician Decision|0|||
163469984|NCT00424099|590420047|FG001|Overall Study|Physician Decision|0|||
163469985|NCT00424099|590420048|FG002|Overall Study|Physician Decision|1|||
163469986|NCT00424099|590420049|FG003|Overall Study|Physician Decision|0|||
163469987|NCT00424099|590420046|FG000|Overall Study|Missing|0|||
163469988|NCT00424099|590420047|FG001|Overall Study|Missing|0|||
163469989|NCT00424099|590420048|FG002|Overall Study|Missing|1|||
163469990|NCT00424099|590420049|FG003|Overall Study|Missing|0|||
163469991|NCT03689972|590420050|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
163469992|NCT03689972|590420051|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
163469993|NCT03689972|590420052|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
163469994|NCT03689972|590420053|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
163469995|NCT03689972|590420054|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
163469996|NCT03689972|590420050|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
163469997|NCT03689972|590420051|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
163469998|NCT03689972|590420052|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
163469999|NCT03689972|590420053|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
163470000|NCT03689972|590420054|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
163470001|NCT03689972|590420050|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
163470002|NCT03689972|590420051|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
163470003|NCT03689972|590420052|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
163470004|NCT03689972|590420053|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
163470005|NCT03689972|590420054|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
163470006|NCT03689972|590420050|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
163470007|NCT03689972|590420051|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
163470008|NCT03689972|590420052|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
163470009|NCT03689972|590420053|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
163470010|NCT03689972|590420054|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
163470011|NCT03689972|590420050|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
163470012|NCT03689972|590420051|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
163470013|NCT03689972|590420052|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
163470014|NCT03689972|590420053|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
163470015|NCT03689972|590420054|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
163470016|NCT03689972|590420050|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
163470017|NCT03689972|590420051|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
163470018|NCT03689972|590420052|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
163470019|NCT03689972|590420053|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
163470020|NCT03689972|590420054|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
163470021|NCT03689972|590420050|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
163470022|NCT03689972|590420051|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
163470023|NCT03689972|590420052|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
163470024|NCT03689972|590420053|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
163470025|NCT03689972|590420054|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
163470026|NCT03689972|590420050|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
163470027|NCT03689972|590420051|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
163470028|NCT03689972|590420052|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
163470029|NCT03689972|590420053|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
163470030|NCT03689972|590420054|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
163470031|NCT03689972|590420050|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
163470032|NCT03689972|590420051|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
163470033|NCT03689972|590420052|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
163470034|NCT03689972|590420053|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
163470035|NCT03689972|590420054|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
163470036|NCT03689972|590420050|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
163470037|NCT03689972|590420051|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
163470038|NCT03689972|590420052|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
163470039|NCT03689972|590420053|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
163470040|NCT03689972|590420054|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
163470041|NCT03689972|590420050|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
163470042|NCT03689972|590420051|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
163470043|NCT03689972|590420052|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
163470044|NCT03689972|590420053|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
163470045|NCT03689972|590420054|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
163470046|NCT03689972|590420050|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
163470047|NCT03689972|590420051|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
163470048|NCT03689972|590420052|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
163470049|NCT03689972|590420053|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
163470050|NCT03689972|590420054|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
163470051|NCT03689972|590420050|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
163470052|NCT03689972|590420051|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
163470053|NCT03689972|590420052|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
163470054|NCT03689972|590420053|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
163470055|NCT03689972|590420054|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
163470056|NCT03689972|590420050|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
163470057|NCT03689972|590420051|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
163470058|NCT03689972|590420052|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
163470059|NCT03689972|590420053|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
163470060|NCT03689972|590420054|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
163470061|NCT03689972|590420050|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
163470062|NCT03689972|590420051|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
163470063|NCT03689972|590420052|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
163470064|NCT03689972|590420053|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
163470065|NCT03689972|590420054|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
163470066|NCT03689972|590420050|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
163470067|NCT03689972|590420051|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
163470068|NCT03689972|590420052|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
163470069|NCT03689972|590420053|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
163470070|NCT03689972|590420054|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
163470071|NCT03689972|590420050|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
163470072|NCT03689972|590420051|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
163470073|NCT03689972|590420052|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
163470074|NCT03689972|590420053|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
163470075|NCT03689972|590420054|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
163470076|NCT03689972|590420050|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
163470077|NCT03689972|590420051|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
163470078|NCT03689972|590420052|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
163470079|NCT03689972|590420053|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
163470080|NCT03689972|590420054|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
163470081|NCT03689972|590420050|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
163470082|NCT03689972|590420051|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
163470083|NCT03689972|590420052|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
163470084|NCT03689972|590420053|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
163470085|NCT03689972|590420054|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
163470086|NCT01131130|590420058|FG000|Period 1 - Baseline|Pregnancy|1|||
163470087|NCT01131130|590420058|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
163470088|NCT02417064|590420059|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
163470089|NCT02417064|590420060|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
163470090|NCT02417064|590420061|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
163470091|NCT02417064|590420059|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
163470092|NCT02417064|590420060|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
163470093|NCT02417064|590420061|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
163470094|NCT02417064|590420059|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
163470095|NCT02417064|590420060|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
163470096|NCT02417064|590420061|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
163470097|NCT02417064|590420059|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
163470098|NCT02417064|590420060|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
163470099|NCT02417064|590420061|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
163470100|NCT02417064|590420059|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
163470101|NCT02417064|590420060|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
163470102|NCT02417064|590420061|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
163470103|NCT02417064|590420059|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
163470104|NCT02417064|590420060|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
163470105|NCT02417064|590420061|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
163470106|NCT02417064|590420059|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
163470107|NCT02417064|590420060|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
163470108|NCT02417064|590420061|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
163470109|NCT02417064|590420059|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
163470110|NCT02417064|590420060|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
163470111|NCT02417064|590420061|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
163470112|NCT02417064|590420059|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
163470113|NCT02417064|590420060|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
163470114|NCT02417064|590420061|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
163470115|NCT02417064|590420059|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
163470116|NCT02417064|590420060|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
163470117|NCT02417064|590420061|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
163470118|NCT02417064|590420059|FG000|Follow-up Phase (24 Weeks)|Other|2|||
163470119|NCT02417064|590420060|FG001|Follow-up Phase (24 Weeks)|Other|2|||
163470120|NCT02417064|590420061|FG002|Follow-up Phase (24 Weeks)|Other|3|||
163470121|NCT02437162|590420062|FG000|Overall Study|Protocol Violation|0|||
163470122|NCT02437162|590420063|FG001|Overall Study|Protocol Violation|1|||
163470123|NCT02437162|590420064|FG002|Overall Study|Protocol Violation|0|||
163470124|NCT02437162|590420062|FG000|Overall Study|Randomized but not treated|0|||
163470125|NCT02437162|590420063|FG001|Overall Study|Randomized but not treated|0|||
163470126|NCT02437162|590420064|FG002|Overall Study|Randomized but not treated|1|||
163470127|NCT02437162|590420062|FG000|Overall Study|Study discontinued by Sponsor|93|||
163470128|NCT02437162|590420063|FG001|Overall Study|Study discontinued by Sponsor|98|||
163470129|NCT02437162|590420064|FG002|Overall Study|Study discontinued by Sponsor|97|||
163470130|NCT02437162|590420062|FG000|Overall Study|Withdrawal by Subject|13|||
163470131|NCT02437162|590420063|FG001|Overall Study|Withdrawal by Subject|7|||
163470132|NCT02437162|590420064|FG002|Overall Study|Withdrawal by Subject|9|||
163470133|NCT02437162|590420062|FG000|Overall Study|Adverse Event|0|||
163470134|NCT02437162|590420063|FG001|Overall Study|Adverse Event|1|||
163470135|NCT02437162|590420064|FG002|Overall Study|Adverse Event|0|||
163470136|NCT02437162|590420062|FG000|Overall Study|Lost to Follow-up|1|||
163470137|NCT02437162|590420063|FG001|Overall Study|Lost to Follow-up|0|||
163470138|NCT02437162|590420064|FG002|Overall Study|Lost to Follow-up|1|||
163470139|NCT02437162|590420062|FG000|Overall Study|Death|0|||
163470140|NCT02437162|590420063|FG001|Overall Study|Death|1|||
163470141|NCT02437162|590420064|FG002|Overall Study|Death|0|||
163470142|NCT02437162|590420062|FG000|Overall Study|Other|0|||
163470143|NCT02437162|590420063|FG001|Overall Study|Other|0|||
163470144|NCT02437162|590420064|FG002|Overall Study|Other|1|||
163470145|NCT03981744|590420065|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
163470146|NCT03981744|590420066|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
163470147|NCT03981744|590420067|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
163470148|NCT03981744|590420068|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
163470149|NCT03981744|590420065|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
163470150|NCT03981744|590420066|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
163470151|NCT03981744|590420067|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
163470152|NCT03981744|590420068|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
163470153|NCT03981744|590420065|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
163470154|NCT03981744|590420066|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
163470155|NCT03981744|590420067|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
163470156|NCT03981744|590420068|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
163470157|NCT02782104|590420069|FG000|Overall Study|Other|215|||
163470158|NCT02782104|590420069|FG000|Overall Study|Induction Day 28 Non Responder|9|||
163470159|NCT02782104|590420069|FG000|Overall Study|Non-Compliance with Study Drug|2|||
163470160|NCT02782104|590420069|FG000|Overall Study|Death|8|||
163470161|NCT02782104|590420069|FG000|Overall Study|Pregnancy|6|||
163470162|NCT02782104|590420069|FG000|Overall Study|Withdrawal by Subject|63|||
163470163|NCT02782104|590420069|FG000|Overall Study|Protocol Violation|7|||
163470164|NCT02782104|590420069|FG000|Overall Study|Lack of Efficacy|61|||
163470165|NCT02782104|590420069|FG000|Overall Study|Lost to Follow-up|23|||
163470166|NCT02782104|590420069|FG000|Overall Study|Adverse Event|74|||
163470167|NCT04338321|590420070|FG000|Overall Study|Adverse Event|4|||
163470168|NCT04338321|590420071|FG001|Overall Study|Adverse Event|10|||
163470169|NCT04338321|590420070|FG000|Overall Study|Death|1|||
163470170|NCT04338321|590420071|FG001|Overall Study|Death|1|||
163470171|NCT04338321|590420070|FG000|Overall Study|Lost to Follow-up|4|||
163470172|NCT04338321|590420071|FG001|Overall Study|Lost to Follow-up|9|||
163470173|NCT04338321|590420070|FG000|Overall Study|Withdrawal by Subject|45|||
163470174|NCT04338321|590420071|FG001|Overall Study|Withdrawal by Subject|69|||
163470175|NCT04338321|590420070|FG000|Overall Study|Physician Decision|5|||
163470176|NCT04338321|590420071|FG001|Overall Study|Physician Decision|9|||
163470177|NCT04338321|590420070|FG000|Overall Study|Other|3|||
163470178|NCT04338321|590420071|FG001|Overall Study|Other|10|||
163470179|NCT03321526|590420072|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
163470180|NCT03321526|590420073|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
163470181|NCT03321526|590420072|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
163470182|NCT03321526|590420073|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
163470183|NCT03321526|590420072|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
163470184|NCT03321526|590420073|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
163470185|NCT03321526|590420072|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
163470186|NCT03321526|590420073|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
163470187|NCT03321526|590420072|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
163470188|NCT03321526|590420073|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
163470189|NCT03321526|590420072|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
163470190|NCT03321526|590420073|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
163470191|NCT03321526|590420072|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
163470192|NCT03321526|590420073|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
163470193|NCT03321526|590420072|FG000|Follow-up Phase (2 Weeks)|Other|24|||
163470194|NCT03321526|590420073|FG001|Follow-up Phase (2 Weeks)|Other|24|||
163470195|NCT03097133|590420074|FG000|Overall Study|Lost to Follow-up|3|||
163470196|NCT03097133|590420075|FG001|Overall Study|Lost to Follow-up|2|||
163470197|NCT03097133|590420074|FG000|Overall Study|Withdrawal by Subject|2|||
163470198|NCT03097133|590420075|FG001|Overall Study|Withdrawal by Subject|5|||
163470199|NCT03097133|590420074|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
163470200|NCT03097133|590420075|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
163470201|NCT03097133|590420074|FG000|Overall Study|Other|3|||
163470202|NCT03097133|590420075|FG001|Overall Study|Other|2|||
163470203|NCT03097133|590420074|FG000|Overall Study|Adverse Event|1|||
163470204|NCT03097133|590420075|FG001|Overall Study|Adverse Event|0|||
163470205|NCT01989572|590420078|FG000|Overall Study|Lack of Efficacy|35|||
163470206|NCT01989572|590420079|FG001|Overall Study|Lack of Efficacy|48|||
163470207|NCT01989572|590420080|FG002|Overall Study|Lack of Efficacy|48|||
163470208|NCT01989572|590420081|FG003|Overall Study|Lack of Efficacy|43|||
163470209|NCT01989572|590420082|FG004|Overall Study|Lack of Efficacy|71|||
163470210|NCT01989572|590420083|FG005|Overall Study|Lack of Efficacy|79|||
163470211|NCT01989572|590420078|FG000|Overall Study|Adverse Event|2|||
163470212|NCT01989572|590420079|FG001|Overall Study|Adverse Event|1|||
163470213|NCT01989572|590420080|FG002|Overall Study|Adverse Event|3|||
163470214|NCT01989572|590420081|FG003|Overall Study|Adverse Event|0|||
163470215|NCT01989572|590420082|FG004|Overall Study|Adverse Event|3|||
163470216|NCT01989572|590420083|FG005|Overall Study|Adverse Event|0|||
163470217|NCT01989572|590420078|FG000|Overall Study|Death|0|||
163470218|NCT01989572|590420079|FG001|Overall Study|Death|0|||
163470219|NCT01989572|590420080|FG002|Overall Study|Death|0|||
163470220|NCT01989572|590420081|FG003|Overall Study|Death|0|||
163470221|NCT01989572|590420082|FG004|Overall Study|Death|1|||
163470222|NCT01989572|590420083|FG005|Overall Study|Death|0|||
162925395|NCT05302414|588428962|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
162925396|NCT05302414|588428963|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
162925397|NCT00742859|588428964|FG000|Overall Study|Adverse Event|5|||
162925398|NCT00742859|588428965|FG001|Overall Study|Adverse Event|6|||
162925399|NCT00742859|588428966|FG002|Overall Study|Adverse Event|3|||
162925400|NCT00742859|588428967|FG003|Overall Study|Adverse Event|1|||
162925401|NCT00742859|588428964|FG000|Overall Study|Death|1|||
162925402|NCT00742859|588428965|FG001|Overall Study|Death|0|||
162925403|NCT00742859|588428966|FG002|Overall Study|Death|0|||
162925404|NCT00742859|588428967|FG003|Overall Study|Death|1|||
162925405|NCT00742859|588428964|FG000|Overall Study|Physician Decision|1|||
162925406|NCT00742859|588428965|FG001|Overall Study|Physician Decision|2|||
162925407|NCT00742859|588428966|FG002|Overall Study|Physician Decision|0|||
162925408|NCT00742859|588428967|FG003|Overall Study|Physician Decision|0|||
162925409|NCT00742859|588428964|FG000|Overall Study|Withdrawal by Subject|4|||
162925410|NCT00742859|588428965|FG001|Overall Study|Withdrawal by Subject|2|||
162925411|NCT00742859|588428966|FG002|Overall Study|Withdrawal by Subject|4|||
162925412|NCT00742859|588428967|FG003|Overall Study|Withdrawal by Subject|1|||
162925413|NCT00742859|588428964|FG000|Overall Study|Endpoint|0|||
162925414|NCT00742859|588428965|FG001|Overall Study|Endpoint|1|||
162925415|NCT00742859|588428966|FG002|Overall Study|Endpoint|1|||
162925416|NCT00742859|588428967|FG003|Overall Study|Endpoint|2|||
162925417|NCT00742859|588428964|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
162925418|NCT00742859|588428965|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
162925419|NCT00742859|588428966|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
162925420|NCT00742859|588428967|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
162925421|NCT00742859|588428964|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
162925422|NCT00742859|588428965|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
162925423|NCT00742859|588428966|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
162925424|NCT00742859|588428967|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
162925425|NCT00742859|588428964|FG000|Overall Study|Sponsor request patient out of town|0|||
162925426|NCT00742859|588428965|FG001|Overall Study|Sponsor request patient out of town|0|||
162925427|NCT00742859|588428966|FG002|Overall Study|Sponsor request patient out of town|1|||
163470223|NCT01989572|590420078|FG000|Overall Study|Withdrawal by Subject|4|||
163470224|NCT01989572|590420079|FG001|Overall Study|Withdrawal by Subject|1|||
163470225|NCT01989572|590420080|FG002|Overall Study|Withdrawal by Subject|5|||
163470226|NCT01989572|590420081|FG003|Overall Study|Withdrawal by Subject|1|||
163470227|NCT01989572|590420082|FG004|Overall Study|Withdrawal by Subject|12|||
163470228|NCT01989572|590420083|FG005|Overall Study|Withdrawal by Subject|4|||
163470229|NCT01989572|590420078|FG000|Overall Study|complicating disease|1|||
163470230|NCT01989572|590420079|FG001|Overall Study|complicating disease|1|||
163470231|NCT01989572|590420080|FG002|Overall Study|complicating disease|2|||
163470232|NCT01989572|590420081|FG003|Overall Study|complicating disease|0|||
163470233|NCT01989572|590420082|FG004|Overall Study|complicating disease|1|||
163470234|NCT01989572|590420083|FG005|Overall Study|complicating disease|0|||
163470235|NCT01989572|590420078|FG000|Overall Study|error|2|||
163470236|NCT01989572|590420079|FG001|Overall Study|error|1|||
163470237|NCT01989572|590420080|FG002|Overall Study|error|1|||
163470238|NCT01989572|590420081|FG003|Overall Study|error|1|||
163470239|NCT01989572|590420082|FG004|Overall Study|error|1|||
163470240|NCT01989572|590420083|FG005|Overall Study|error|1|||
163470241|NCT01989572|590420078|FG000|Overall Study|maximum dose reached|0|||
163470242|NCT01989572|590420079|FG001|Overall Study|maximum dose reached|1|||
163470243|NCT01989572|590420080|FG002|Overall Study|maximum dose reached|0|||
163470244|NCT01989572|590420081|FG003|Overall Study|maximum dose reached|0|||
163470245|NCT01989572|590420082|FG004|Overall Study|maximum dose reached|1|||
163470246|NCT01989572|590420083|FG005|Overall Study|maximum dose reached|0|||
163470247|NCT01989572|590420078|FG000|Overall Study|unknown/not specify|3|||
163470248|NCT01989572|590420079|FG001|Overall Study|unknown/not specify|4|||
163470249|NCT01989572|590420080|FG002|Overall Study|unknown/not specify|1|||
163470250|NCT01989572|590420081|FG003|Overall Study|unknown/not specify|3|||
163470251|NCT01989572|590420082|FG004|Overall Study|unknown/not specify|3|||
163470252|NCT01989572|590420083|FG005|Overall Study|unknown/not specify|5|||
163470253|NCT01989572|590420078|FG000|Overall Study|not start protocol therapy|5|||
163470254|NCT01989572|590420079|FG001|Overall Study|not start protocol therapy|1|||
163470255|NCT01989572|590420080|FG002|Overall Study|not start protocol therapy|2|||
163470256|NCT01989572|590420081|FG003|Overall Study|not start protocol therapy|3|||
163470257|NCT01989572|590420082|FG004|Overall Study|not start protocol therapy|4|||
163470258|NCT01989572|590420083|FG005|Overall Study|not start protocol therapy|18|||
163470259|NCT01989572|590420078|FG000|Overall Study|alternative therapy|3|||
163470260|NCT01989572|590420079|FG001|Overall Study|alternative therapy|0|||
163470261|NCT01989572|590420080|FG002|Overall Study|alternative therapy|0|||
163470262|NCT01989572|590420081|FG003|Overall Study|alternative therapy|0|||
163470263|NCT01989572|590420082|FG004|Overall Study|alternative therapy|1|||
163470264|NCT01989572|590420083|FG005|Overall Study|alternative therapy|3|||
163470265|NCT00732238|590420088|FG000|Overall Study|Bacteremia|4|||
163470266|NCT00732238|590420089|FG001|Overall Study|Bacteremia|1|||
163470267|NCT00732238|590420088|FG000|Overall Study|Asymptomatic bacteriuria|1|||
163470268|NCT00732238|590420089|FG001|Overall Study|Asymptomatic bacteriuria|0|||
163470269|NCT04159701|590420090|FG000|Period 1: Treatment Period|Pregnancy|1|||
163470270|NCT04159701|590420091|FG001|Period 1: Treatment Period|Pregnancy|0|||
163470271|NCT04159701|590420090|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
163470272|NCT04159701|590420091|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
163470273|NCT04159701|590420090|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
163470274|NCT04159701|590420091|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
163470275|NCT04159701|590420090|FG000|Washout Period|site terminated by sponsor|0|||
163470276|NCT04159701|590420091|FG001|Washout Period|site terminated by sponsor|1|||
163470277|NCT04159701|590420090|FG000|Washout Period|study terminated by sponsor|10|||
163470278|NCT04159701|590420091|FG001|Washout Period|study terminated by sponsor|3|||
163470279|NCT04159701|590420090|FG000|Washout Period|Withdrawal by Subject|1|||
163470280|NCT04159701|590420091|FG001|Washout Period|Withdrawal by Subject|0|||
163470281|NCT04159701|590420090|FG000|Washout Period|Inadvertent Enrollment|1|||
163470282|NCT04159701|590420091|FG001|Washout Period|Inadvertent Enrollment|0|||
163470283|NCT04159701|590420090|FG000|Washout Period|Miscellaneous|1|||
163470284|NCT04159701|590420091|FG001|Washout Period|Miscellaneous|0|||
163470285|NCT04159701|590420090|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
163470286|NCT04159701|590420091|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
163470287|NCT04159701|590420090|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
163470288|NCT04159701|590420091|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
163470289|NCT04159701|590420090|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
163470290|NCT04159701|590420091|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
163470291|NCT04159701|590420090|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
163470292|NCT04159701|590420091|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
163470293|NCT04159701|590420090|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
163470294|NCT04159701|590420091|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
163470295|NCT03605836|590420092|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
163470296|NCT03605836|590420093|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
163470297|NCT03605836|590420094|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
163470298|NCT03605836|590420095|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
163470299|NCT03605836|590420092|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
163470300|NCT03605836|590420093|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
163470301|NCT03605836|590420094|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
163470302|NCT03605836|590420095|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
163470303|NCT03605836|590420092|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
163470304|NCT03605836|590420093|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
163470305|NCT03605836|590420094|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
163470306|NCT03605836|590420095|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
163470307|NCT03605836|590420092|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
163470308|NCT03605836|590420093|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
163470309|NCT03605836|590420094|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
163470310|NCT03605836|590420095|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
163470311|NCT03605836|590420092|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
163470312|NCT03605836|590420093|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
163470313|NCT03605836|590420094|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
163470314|NCT03605836|590420095|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
163470315|NCT03605836|590420092|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
163470316|NCT03605836|590420093|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
163470317|NCT03605836|590420094|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
163470318|NCT03605836|590420095|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
163470319|NCT03605836|590420092|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
163470320|NCT03605836|590420093|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
163470321|NCT03605836|590420094|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
163470322|NCT03605836|590420095|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
163470323|NCT03605836|590420092|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
163470324|NCT03605836|590420093|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
163470325|NCT03605836|590420094|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
163470326|NCT03605836|590420095|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
163470327|NCT03605836|590420092|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
163470328|NCT03605836|590420093|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
163470329|NCT03605836|590420094|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
163470330|NCT03605836|590420095|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
163470331|NCT03605836|590420092|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
163470332|NCT03605836|590420093|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
163470333|NCT03605836|590420094|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
163470334|NCT03605836|590420095|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
163470335|NCT03605836|590420092|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
163470336|NCT03605836|590420093|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
163470337|NCT03605836|590420094|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
163470338|NCT03605836|590420095|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
163470339|NCT03605836|590420092|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
163470340|NCT03605836|590420093|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
163470341|NCT03605836|590420094|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
163470342|NCT03605836|590420095|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
163470343|NCT03605836|590420092|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
163470344|NCT03605836|590420093|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
163470345|NCT03605836|590420094|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
163470346|NCT03605836|590420095|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
163470347|NCT03605836|590420092|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
163470348|NCT03605836|590420093|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
163470349|NCT03605836|590420094|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
163470350|NCT03605836|590420095|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
163470351|NCT03605836|590420092|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
163470352|NCT03605836|590420093|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
163470353|NCT03605836|590420094|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
163470354|NCT03605836|590420095|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
163470355|NCT03605836|590420092|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
163470356|NCT03605836|590420093|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
163470357|NCT03605836|590420094|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
163470358|NCT03605836|590420095|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
163470359|NCT03605836|590420092|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
163470360|NCT03605836|590420093|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
163470361|NCT03605836|590420094|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
163470362|NCT03605836|590420095|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
163470363|NCT03605836|590420092|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
163470364|NCT03605836|590420093|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
163470365|NCT03605836|590420094|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
163470366|NCT03605836|590420095|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
163470367|NCT03605836|590420092|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
163470368|NCT03605836|590420093|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
163470369|NCT03605836|590420094|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
163470370|NCT03605836|590420095|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
163470371|NCT03605836|590420092|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
163470372|NCT03605836|590420093|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
163470373|NCT03605836|590420094|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
163470374|NCT03605836|590420095|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
163470375|NCT03605836|590420092|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
163470376|NCT03605836|590420093|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
163470377|NCT03605836|590420094|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
163470378|NCT03605836|590420095|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
163470379|NCT03605836|590420092|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
163470380|NCT03605836|590420093|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
163470381|NCT03605836|590420094|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
163470382|NCT03605836|590420095|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
163470383|NCT01782885|590420101|FG000|Overall Study|Lost to Follow-up|4|||
163470384|NCT01782885|590420102|FG001|Overall Study|Lost to Follow-up|6|||
163470385|NCT00633360|590420103|FG000|Overall Study|Lost to Follow-up|1|||
163470386|NCT00633360|590420104|FG001|Overall Study|Lost to Follow-up|1|||
163470387|NCT00633360|590420103|FG000|Overall Study|Adverse Event|3|||
163470388|NCT00633360|590420104|FG001|Overall Study|Adverse Event|1|||
163470389|NCT00633360|590420103|FG000|Overall Study|Protocol Violation|0|||
163470390|NCT00633360|590420104|FG001|Overall Study|Protocol Violation|1|||
163470391|NCT00610207|590420105|FG000|Overall Study|Lost to Follow-up|3|||
163470392|NCT02348840|590420111|FG000|Overall Study|Withdrawal by Subject|2|||
163470393|NCT02348840|590420112|FG001|Overall Study|Withdrawal by Subject|1|||
163470394|NCT02348840|590420113|FG002|Overall Study|Withdrawal by Subject|0|||
163470395|NCT02348840|590420114|FG003|Overall Study|Withdrawal by Subject|0|||
163470396|NCT01025232|590420115|FG000|Overall Study|Study drug no longer available|3|||
163470397|NCT01025232|590420116|FG001|Overall Study|Study drug no longer available|6|||
163470398|NCT03748420|590420119|FG000|Overall Study|No 12 month medication adherence data available|0|||
163470399|NCT03748420|590420120|FG001|Overall Study|No 12 month medication adherence data available|1|||
163470400|NCT03748420|590420119|FG000|Overall Study|Death|24|||
163470401|NCT03748420|590420120|FG001|Overall Study|Death|28|||
163470402|NCT03748420|590420119|FG000|Overall Study|Lost to Follow-up|231|||
163470403|NCT03748420|590420120|FG001|Overall Study|Lost to Follow-up|230|||
163470404|NCT00373880|590420121|FG000|Overall Study|Physician Decision|3|||
163470405|NCT00373880|590420121|FG000|Overall Study|Arrested|1|||
163470406|NCT00373880|590420121|FG000|Overall Study|Protocol Violation|14|||
163470407|NCT01347073|590420122|FG000|Overall Study|Adverse Event|1|||
163470408|NCT01347073|590420122|FG000|Overall Study|Liver Transplant|1|||
163470409|NCT00621244|590420124|FG000|Overall Study|Withdrawal by Subject|7|||
163470410|NCT00621244|590420125|FG001|Overall Study|Withdrawal by Subject|3|||
163470411|NCT00621244|590420126|FG002|Overall Study|Withdrawal by Subject|3|||
163470412|NCT00621244|590420127|FG003|Overall Study|Withdrawal by Subject|3|||
163470413|NCT00621244|590420124|FG000|Overall Study|Disease progression|44|||
163470414|NCT00621244|590420125|FG001|Overall Study|Disease progression|20|||
163470415|NCT00621244|590420126|FG002|Overall Study|Disease progression|20|||
163470416|NCT00621244|590420127|FG003|Overall Study|Disease progression|15|||
163470417|NCT00621244|590420124|FG000|Overall Study|Death|3|||
163470418|NCT00621244|590420125|FG001|Overall Study|Death|3|||
163470419|NCT00621244|590420126|FG002|Overall Study|Death|1|||
163470420|NCT00621244|590420127|FG003|Overall Study|Death|1|||
163470421|NCT00621244|590420124|FG000|Overall Study|Adverse Event|27|||
163470422|NCT00621244|590420125|FG001|Overall Study|Adverse Event|7|||
163470423|NCT00621244|590420126|FG002|Overall Study|Adverse Event|9|||
163470424|NCT00621244|590420127|FG003|Overall Study|Adverse Event|2|||
163470425|NCT00621244|590420124|FG000|Overall Study|Administrative problems|5|||
163470426|NCT00621244|590420125|FG001|Overall Study|Administrative problems|1|||
163470427|NCT00621244|590420126|FG002|Overall Study|Administrative problems|0|||
163470428|NCT00621244|590420127|FG003|Overall Study|Administrative problems|2|||
163470429|NCT00312728|590420132|FG000|Overall Study|Progressive disease|53|||
163470430|NCT00312728|590420132|FG000|Overall Study|Adverse Event|32|||
163470431|NCT00312728|590420132|FG000|Overall Study|Withdrawal by Subject|10|||
163470432|NCT00312728|590420132|FG000|Overall Study|Required non-protocol cancer treatment|2|||
163470433|NCT00312728|590420132|FG000|Overall Study|Protocol Violation|2|||
163470434|NCT00312728|590420132|FG000|Overall Study|Other|10|||
163470435|NCT00312728|590420132|FG000|Overall Study|Other|1|||
163470436|NCT01634100|590420133|FG000|Overall Study|Withdrawal by Subject|1|||
163470437|NCT01634100|590420134|FG001|Overall Study|Withdrawal by Subject|0|||
163470438|NCT01634100|590420135|FG002|Overall Study|Withdrawal by Subject|1|||
163470439|NCT01634100|590420136|FG003|Overall Study|Withdrawal by Subject|0|||
163470440|NCT01634100|590420137|FG004|Overall Study|Withdrawal by Subject|0|||
163470441|NCT01634100|590420138|FG005|Overall Study|Withdrawal by Subject|0|||
163470442|NCT00338806|590420139|FG000|Acute Phase|Withdrawal by Subject|0|||
163470443|NCT00338806|590420140|FG001|Acute Phase|Withdrawal by Subject|1|||
163470444|NCT00338806|590420139|FG000|Follow-up|Lost to Follow-up|1|||
163470445|NCT00338806|590420140|FG001|Follow-up|Lost to Follow-up|3|||
163470446|NCT00744991|590420141|FG000|Overall Study|Progressive Disease|11|||
163470447|NCT00744991|590420141|FG000|Overall Study|Withdrawal by Subject|8|||
163470448|NCT00744991|590420141|FG000|Overall Study|Physician Decision|3|||
163470449|NCT00744991|590420141|FG000|Overall Study|Adverse Event|2|||
163470450|NCT00744991|590420141|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
163470451|NCT01662986|590420144|FG000|Overall Study|Adverse Event|5|||
163470452|NCT01662986|590420145|FG001|Overall Study|Adverse Event|4|||
163470453|NCT01662986|590420144|FG000|Overall Study|Protocol Violation|2|||
163470454|NCT01662986|590420145|FG001|Overall Study|Protocol Violation|3|||
163470455|NCT01662986|590420144|FG000|Overall Study|Lost to Follow-up|5|||
163470456|NCT01662986|590420145|FG001|Overall Study|Lost to Follow-up|4|||
163470457|NCT01662986|590420144|FG000|Overall Study|Withdrawal by Subject|2|||
163470458|NCT01662986|590420145|FG001|Overall Study|Withdrawal by Subject|2|||
163470459|NCT01662986|590420144|FG000|Overall Study|Not Treated|1|||
163470460|NCT01662986|590420145|FG001|Overall Study|Not Treated|0|||
163470461|NCT01662986|590420144|FG000|Overall Study|Other than stated above|3|||
163470462|NCT01662986|590420145|FG001|Overall Study|Other than stated above|0|||
163470463|NCT01594411|590420146|FG000|Overall Study|Lost to Follow-up|2|||
163470464|NCT00924729|590420147|FG000|Overall Study|insufficient volume for analysis|1|||
163470465|NCT00924729|590420148|FG001|Overall Study|insufficient volume for analysis|0|||
163470466|NCT00924729|590420147|FG000|Overall Study|Protocol Violation|1|||
163470467|NCT00924729|590420148|FG001|Overall Study|Protocol Violation|0|||
163470468|NCT01929707|590420149|FG000|Intervention Period 1|Lost to Follow-up|0|||
163470469|NCT01929707|590420150|FG001|Intervention Period 1|Lost to Follow-up|0|||
163470470|NCT01929707|590420151|FG002|Intervention Period 1|Lost to Follow-up|0|||
163470471|NCT01929707|590420152|FG003|Intervention Period 1|Lost to Follow-up|1|||
163470472|NCT01929707|590420153|FG004|Intervention Period 1|Lost to Follow-up|0|||
163470473|NCT01929707|590420154|FG005|Intervention Period 1|Lost to Follow-up|0|||
163470474|NCT01929707|590420155|FG006|Intervention Period 1|Lost to Follow-up|0|||
163470475|NCT01929707|590420156|FG007|Intervention Period 1|Lost to Follow-up|0|||
163470476|NCT01929707|590420149|FG000|Intervention Period 1|Withdrawal by Subject|0|||
163470477|NCT01929707|590420150|FG001|Intervention Period 1|Withdrawal by Subject|0|||
163470478|NCT01929707|590420151|FG002|Intervention Period 1|Withdrawal by Subject|0|||
163470479|NCT01929707|590420152|FG003|Intervention Period 1|Withdrawal by Subject|2|||
163470480|NCT01929707|590420153|FG004|Intervention Period 1|Withdrawal by Subject|0|||
163470481|NCT01929707|590420154|FG005|Intervention Period 1|Withdrawal by Subject|0|||
163470482|NCT01929707|590420155|FG006|Intervention Period 1|Withdrawal by Subject|0|||
163470483|NCT01929707|590420156|FG007|Intervention Period 1|Withdrawal by Subject|0|||
163470484|NCT01929707|590420149|FG000|Intervention Period 2|Withdrawal by Subject|0|||
163470485|NCT01929707|590420150|FG001|Intervention Period 2|Withdrawal by Subject|0|||
163470486|NCT01929707|590420151|FG002|Intervention Period 2|Withdrawal by Subject|0|||
163470487|NCT01929707|590420152|FG003|Intervention Period 2|Withdrawal by Subject|0|||
163470488|NCT01929707|590420153|FG004|Intervention Period 2|Withdrawal by Subject|0|||
163470489|NCT01929707|590420154|FG005|Intervention Period 2|Withdrawal by Subject|2|||
163470490|NCT01929707|590420155|FG006|Intervention Period 2|Withdrawal by Subject|0|||
163470491|NCT01929707|590420156|FG007|Intervention Period 2|Withdrawal by Subject|0|||
163470492|NCT00856986|590420163|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
163470493|NCT00856986|590420164|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
163470494|NCT00856986|590420165|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
163470495|NCT00856986|590420166|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
163470496|NCT00856986|590420167|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
163470497|NCT00856986|590420163|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
163470498|NCT00856986|590420164|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
163470499|NCT00856986|590420165|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
163470500|NCT00856986|590420166|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
163470501|NCT00856986|590420167|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
163470502|NCT00856986|590420163|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
163470503|NCT00856986|590420164|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
163470504|NCT00856986|590420165|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
163470505|NCT00856986|590420166|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
163470506|NCT00856986|590420167|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
163470507|NCT00856986|590420163|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
163470508|NCT00856986|590420164|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
163470509|NCT00856986|590420165|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
163470510|NCT00856986|590420166|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
163470511|NCT00856986|590420167|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
163470512|NCT00856986|590420163|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
163470513|NCT00856986|590420164|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
163470514|NCT00856986|590420165|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
163470515|NCT00856986|590420166|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
163470516|NCT00856986|590420167|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
163470517|NCT00856986|590420163|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
163470518|NCT00856986|590420164|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
163470519|NCT00856986|590420165|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
163470520|NCT00856986|590420166|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
163470521|NCT00856986|590420167|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
163470522|NCT00856986|590420163|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
163470523|NCT00856986|590420164|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
163470524|NCT00856986|590420165|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
163470525|NCT00856986|590420166|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
163470526|NCT00856986|590420167|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
163470527|NCT00856986|590420163|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
163470528|NCT00856986|590420164|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
163470529|NCT00856986|590420165|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
163470530|NCT00856986|590420166|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
163470531|NCT00856986|590420167|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
163470532|NCT00856986|590420163|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
163470533|NCT00856986|590420164|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
163470534|NCT00856986|590420165|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
163470535|NCT00856986|590420166|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
163470536|NCT00856986|590420167|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
163470537|NCT00856986|590420163|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
163470538|NCT00856986|590420164|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
163470539|NCT00856986|590420165|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
163470540|NCT00856986|590420166|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
163470541|NCT00856986|590420167|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
163470542|NCT00856986|590420163|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
163470543|NCT00856986|590420164|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
163470544|NCT00856986|590420165|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
163470545|NCT00856986|590420166|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
163470546|NCT00856986|590420167|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
163470547|NCT00856986|590420163|FG000|Main Period, Weeks 0-26|Unclassified|7|||
163470548|NCT00856986|590420164|FG001|Main Period, Weeks 0-26|Unclassified|6|||
163470549|NCT00856986|590420165|FG002|Main Period, Weeks 0-26|Unclassified|7|||
163470550|NCT00856986|590420166|FG003|Main Period, Weeks 0-26|Unclassified|0|||
163470551|NCT00856986|590420167|FG004|Main Period, Weeks 0-26|Unclassified|0|||
163470552|NCT00856986|590420163|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
163470553|NCT00856986|590420164|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
163470554|NCT00856986|590420165|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
163470555|NCT00856986|590420166|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
163470556|NCT00856986|590420167|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
163470557|NCT00856986|590420163|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
163470558|NCT00856986|590420164|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
163470559|NCT00856986|590420165|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
163470560|NCT00856986|590420166|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
163470561|NCT00856986|590420167|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
163470562|NCT00856986|590420163|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
163470563|NCT00856986|590420164|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
163470564|NCT00856986|590420165|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
163470565|NCT00856986|590420166|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
163470566|NCT00856986|590420167|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
163470567|NCT00856986|590420163|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
163470568|NCT00856986|590420164|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
163470569|NCT00856986|590420165|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
163470570|NCT00856986|590420166|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
163470571|NCT00856986|590420167|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
163470572|NCT00856986|590420163|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
163470573|NCT00856986|590420164|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
163470574|NCT00856986|590420165|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
163470575|NCT00856986|590420166|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
163470576|NCT00856986|590420167|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
163470577|NCT00856986|590420163|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
163470578|NCT00856986|590420164|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
163470579|NCT00856986|590420165|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
163470580|NCT00856986|590420166|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
163470581|NCT00856986|590420167|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
163470582|NCT02384993|590420171|FG000|Overall Study|Adverse Event|0|||
163470583|NCT02384993|590420172|FG001|Overall Study|Adverse Event|1|||
163470584|NCT03209362|590420173|FG000|Overall Study|Adverse Event|0|||
163470585|NCT03209362|590420174|FG001|Overall Study|Adverse Event|1|||
163470586|NCT03209362|590420173|FG000|Overall Study|Lost to Follow-up|0|||
163470587|NCT03209362|590420174|FG001|Overall Study|Lost to Follow-up|1|||
163470588|NCT03209362|590420173|FG000|Overall Study|Withdrawal by Subject|2|||
163470589|NCT03209362|590420174|FG001|Overall Study|Withdrawal by Subject|0|||
163470590|NCT03209362|590420173|FG000|Overall Study|Other|0|||
163470591|NCT03209362|590420174|FG001|Overall Study|Other|1|||
163470592|NCT00643448|590420179|FG000|Overall Study|Lack of Efficacy|2|||
163470593|NCT00643448|590420180|FG001|Overall Study|Lack of Efficacy|0|||
163470594|NCT00643448|590420181|FG002|Overall Study|Lack of Efficacy|4|||
163470595|NCT00643448|590420179|FG000|Overall Study|Adverse Event|2|||
163470596|NCT00643448|590420180|FG001|Overall Study|Adverse Event|2|||
163470597|NCT00643448|590420181|FG002|Overall Study|Adverse Event|2|||
163470598|NCT00643448|590420179|FG000|Overall Study|QTcF>550 ms|0|||
163470599|NCT00643448|590420180|FG001|Overall Study|QTcF>550 ms|3|||
163470600|NCT00643448|590420181|FG002|Overall Study|QTcF>550 ms|0|||
163470601|NCT00981682|590420182|FG000|Overall Study|Adverse Event|48|||
163470602|NCT00981682|590420182|FG000|Overall Study|Withdrawal by Subject|52|||
163470603|NCT00981682|590420182|FG000|Overall Study|Lost to Follow-up|14|||
163470604|NCT00981682|590420182|FG000|Overall Study|Lack of Efficacy|13|||
163470605|NCT00981682|590420182|FG000|Overall Study|Protocol Violation|6|||
163470606|NCT00981682|590420182|FG000|Overall Study|administrative|9|||
163470607|NCT02358863|590422122|FG000|Overall Study|Physician Decision|3|||
163470608|NCT00098865|590422123|FG000|Overall Study|Progressive Disease|6|||
163470609|NCT00098865|590422123|FG000|Overall Study|Adverse Event|2|||
163470610|NCT00098865|590422123|FG000|Overall Study|Alternative Therapy|1|||
163470611|NCT05426460|590422130|FG000|Overall Study|Protocol Violation|1|||
163470612|NCT05426460|590422131|FG001|Overall Study|Protocol Violation|1|||
163470613|NCT05426460|590422132|FG002|Overall Study|Protocol Violation|1|||
163470614|NCT05426460|590422133|FG003|Overall Study|Protocol Violation|0|||
163470615|NCT00653068|590422134|FG000|Overall Study|Death|9|||
163470616|NCT00653068|590422134|FG000|Overall Study|Lack of Efficacy|34|||
163470617|NCT00653068|590422134|FG000|Overall Study|Physician Decision|4|||
163470618|NCT00653068|590422134|FG000|Overall Study|Withdrawal by Subject|1|||
163470619|NCT00653068|590422134|FG000|Overall Study|Ineligible|2|||
163470620|NCT02204410|590422135|FG000|Overall Study|Lost to Follow-up|5|||
163470621|NCT02204410|590422135|FG000|Overall Study|Physician Decision|2|||
163470622|NCT02204410|590422135|FG000|Overall Study|Protocol Violation|1|||
163470623|NCT02204410|590422135|FG000|Overall Study|Withdrawal by Subject|3|||
163470624|NCT01405027|590422138|FG000|Overall Study|Withdrawn consent|3|||
163470625|NCT01405027|590422139|FG001|Overall Study|Withdrawn consent|0|||
163470626|NCT01405027|590422138|FG000|Overall Study|Lost to Follow-up|16|||
163470627|NCT01405027|590422139|FG001|Overall Study|Lost to Follow-up|24|||
163470628|NCT01405027|590422138|FG000|Overall Study|Investigator judgement|0|||
163470629|NCT01405027|590422139|FG001|Overall Study|Investigator judgement|2|||
163470630|NCT01405027|590422138|FG000|Overall Study|Death|1|||
163470631|NCT01405027|590422139|FG001|Overall Study|Death|0|||
163470632|NCT01405027|590422138|FG000|Overall Study|Other or Unknown|12|||
163470633|NCT01405027|590422139|FG001|Overall Study|Other or Unknown|25|||
163470634|NCT02234050|590422148|FG000|Overall Study|Lack of Efficacy|38|||
163470635|NCT02234050|590422149|FG001|Overall Study|Lack of Efficacy|22|||
163470636|NCT02234050|590422148|FG000|Overall Study|Adverse Event|13|||
163470637|NCT02234050|590422149|FG001|Overall Study|Adverse Event|1|||
163470638|NCT02234050|590422148|FG000|Overall Study|Withdrawal by Subject|4|||
163470639|NCT02234050|590422149|FG001|Overall Study|Withdrawal by Subject|2|||
163470640|NCT02234050|590422148|FG000|Overall Study|Sponsor's decision|6|||
163470641|NCT02234050|590422149|FG001|Overall Study|Sponsor's decision|0|||
163470642|NCT02438787|590422151|FG000|Overall Study|Adverse Event|1|||
163470643|NCT02438787|590422152|FG001|Overall Study|Adverse Event|0|||
163470644|NCT02438787|590422153|FG002|Overall Study|Adverse Event|2|||
163470645|NCT02438787|590422151|FG000|Overall Study|Lack of Efficacy|1|||
163470646|NCT02438787|590422152|FG001|Overall Study|Lack of Efficacy|2|||
163470647|NCT02438787|590422153|FG002|Overall Study|Lack of Efficacy|0|||
163470648|NCT02438787|590422151|FG000|Overall Study|Lost to Follow-up|0|||
163470649|NCT02438787|590422152|FG001|Overall Study|Lost to Follow-up|1|||
163470650|NCT02438787|590422153|FG002|Overall Study|Lost to Follow-up|0|||
163470651|NCT02438787|590422151|FG000|Overall Study|Protocol Violation|0|||
163470652|NCT02438787|590422152|FG001|Overall Study|Protocol Violation|0|||
163470653|NCT02438787|590422153|FG002|Overall Study|Protocol Violation|1|||
163470654|NCT02438787|590422151|FG000|Overall Study|Withdrawal by Subject|15|||
163470655|NCT02438787|590422152|FG001|Overall Study|Withdrawal by Subject|7|||
163470656|NCT02438787|590422153|FG002|Overall Study|Withdrawal by Subject|10|||
163470657|NCT02438787|590422151|FG000|Overall Study|Study discontinued by sponsor|64|||
163470658|NCT02438787|590422152|FG001|Overall Study|Study discontinued by sponsor|72|||
163470659|NCT02438787|590422153|FG002|Overall Study|Study discontinued by sponsor|69|||
163470660|NCT02438787|590422151|FG000|Overall Study|Other|0|||
163470661|NCT02438787|590422152|FG001|Overall Study|Other|1|||
163470662|NCT02438787|590422153|FG002|Overall Study|Other|0|||
163470663|NCT02438787|590422151|FG000|Overall Study|Site terminated by sponsor|0|||
163470664|NCT02438787|590422152|FG001|Overall Study|Site terminated by sponsor|0|||
163470665|NCT02438787|590422153|FG002|Overall Study|Site terminated by sponsor|1|||
163470666|NCT03412565|590422154|FG000|Overall Study|Lost to Follow-up|0|||
163470667|NCT03412565|590422155|FG001|Overall Study|Lost to Follow-up|0|||
163470668|NCT03412565|590422156|FG002|Overall Study|Lost to Follow-up|1|||
163470669|NCT03412565|590422157|FG003|Overall Study|Lost to Follow-up|0|||
163470670|NCT03412565|590422154|FG000|Overall Study|Physician Decision|0|||
163470671|NCT03412565|590422155|FG001|Overall Study|Physician Decision|0|||
163470672|NCT03412565|590422156|FG002|Overall Study|Physician Decision|0|||
163470673|NCT03412565|590422157|FG003|Overall Study|Physician Decision|1|||
163470674|NCT03412565|590422154|FG000|Overall Study|Withdrawal by Subject|0|||
163470675|NCT03412565|590422155|FG001|Overall Study|Withdrawal by Subject|4|||
163470676|NCT03412565|590422156|FG002|Overall Study|Withdrawal by Subject|5|||
163470677|NCT03412565|590422157|FG003|Overall Study|Withdrawal by Subject|5|||
163470678|NCT03412565|590422154|FG000|Overall Study|Death|1|||
163470679|NCT03412565|590422155|FG001|Overall Study|Death|3|||
163470680|NCT03412565|590422156|FG002|Overall Study|Death|4|||
163470681|NCT03412565|590422157|FG003|Overall Study|Death|5|||
163470682|NCT03412565|590422154|FG000|Overall Study|Data collection ended|0|||
163470683|NCT03412565|590422155|FG001|Overall Study|Data collection ended|41|||
163470684|NCT03412565|590422156|FG002|Overall Study|Data collection ended|41|||
163470685|NCT03412565|590422157|FG003|Overall Study|Data collection ended|40|||
163470686|NCT02280096|590422158|FG000|Overall Study|Pregnancy|1|||
163470687|NCT02280096|590422159|FG001|Overall Study|Pregnancy|0|||
163470688|NCT02280096|590422158|FG000|Overall Study|Functional neurological disorder|1|||
163470689|NCT02280096|590422159|FG001|Overall Study|Functional neurological disorder|0|||
163470690|NCT02280096|590422158|FG000|Overall Study|Lack of attachment|0|||
163470691|NCT02280096|590422159|FG001|Overall Study|Lack of attachment|1|||
163470692|NCT00246376|590422164|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
163470693|NCT00246376|590422165|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
163470694|NCT00246376|590422166|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
163470695|NCT00246376|590422167|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
163470696|NCT00246376|590422168|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
163470697|NCT00246376|590422164|FG000|Overall Study|Adverse Event|2|||
163470698|NCT00246376|590422165|FG001|Overall Study|Adverse Event|3|||
163470699|NCT00246376|590422166|FG002|Overall Study|Adverse Event|1|||
163470700|NCT00246376|590422167|FG003|Overall Study|Adverse Event|3|||
163470701|NCT00246376|590422168|FG004|Overall Study|Adverse Event|1|||
163470702|NCT00246376|590422164|FG000|Overall Study|Lost to Follow-up|2|||
163470703|NCT00246376|590422165|FG001|Overall Study|Lost to Follow-up|11|||
163470704|NCT00246376|590422166|FG002|Overall Study|Lost to Follow-up|11|||
163470705|NCT00246376|590422167|FG003|Overall Study|Lost to Follow-up|16|||
163470706|NCT00246376|590422168|FG004|Overall Study|Lost to Follow-up|13|||
163470707|NCT01872897|590422173|FG000|Overall Study|Withdrawal by Subject|1|||
163470708|NCT01872897|590422174|FG001|Overall Study|Withdrawal by Subject|0|||
163470709|NCT01849562|590422182|FG000|Overall Study|Lost to Follow-up|1|||
163470710|NCT01849562|590422183|FG001|Overall Study|Lost to Follow-up|0|||
163470711|NCT01849562|590422184|FG002|Overall Study|Lost to Follow-up|0|||
163470712|NCT01849562|590422182|FG000|Overall Study|Non-compliance with Study Drug|1|||
163470713|NCT01849562|590422183|FG001|Overall Study|Non-compliance with Study Drug|0|||
163470714|NCT01849562|590422184|FG002|Overall Study|Non-compliance with Study Drug|0|||
163470715|NCT00693693|590422188|FG000|Overall Study|Lost to Follow-up|1|||
163470716|NCT00693693|590422189|FG001|Overall Study|Lost to Follow-up|1|||
163470717|NCT00693693|590422190|FG002|Overall Study|Lost to Follow-up|2|||
163470718|NCT04599972|590422191|FG000|Overall Study|Withdrawal by Subject|6|||
163470719|NCT04599972|590422192|FG001|Overall Study|Withdrawal by Subject|1|||
163470720|NCT04599972|590422191|FG000|Overall Study|Adverse Event|1|||
163470721|NCT04599972|590422192|FG001|Overall Study|Adverse Event|1|||
163470722|NCT04599972|590422191|FG000|Overall Study|Lost to Follow-up|1|||
163470723|NCT04599972|590422192|FG001|Overall Study|Lost to Follow-up|6|||
163470724|NCT04599972|590422191|FG000|Overall Study|Protocol Violation|1|||
163470725|NCT04599972|590422192|FG001|Overall Study|Protocol Violation|0|||
163470726|NCT04599972|590422191|FG000|Overall Study|Other reason|1|||
163470727|NCT04599972|590422192|FG001|Overall Study|Other reason|0|||
163470728|NCT01690988|590422200|FG000|Overall Study|Withdrawal by Subject|2|||
163470729|NCT01690988|590422201|FG001|Overall Study|Withdrawal by Subject|2|||
163470730|NCT01690988|590422202|FG002|Overall Study|Withdrawal by Subject|3|||
163470731|NCT01690988|590422200|FG000|Overall Study|Physician Decision|0|||
163470732|NCT01690988|590422201|FG001|Overall Study|Physician Decision|0|||
163470733|NCT01690988|590422202|FG002|Overall Study|Physician Decision|1|||
163470734|NCT01690988|590422200|FG000|Overall Study|Operation Cancelled|1|||
163470735|NCT01690988|590422201|FG001|Overall Study|Operation Cancelled|1|||
163470736|NCT01690988|590422202|FG002|Overall Study|Operation Cancelled|0|||
163470737|NCT01690988|590422200|FG000|Overall Study|Determined ineligible|1|||
163470738|NCT01690988|590422201|FG001|Overall Study|Determined ineligible|0|||
163470739|NCT01690988|590422202|FG002|Overall Study|Determined ineligible|0|||
163470740|NCT01690988|590422200|FG000|Overall Study|Death|1|||
163470741|NCT01690988|590422201|FG001|Overall Study|Death|1|||
163470742|NCT01690988|590422202|FG002|Overall Study|Death|1|||
163470743|NCT01690988|590422200|FG000|Overall Study|Sedated|1|||
163470744|NCT01690988|590422201|FG001|Overall Study|Sedated|1|||
163470745|NCT01690988|590422202|FG002|Overall Study|Sedated|2|||
163470746|NCT03696576|590422203|FG000|Overall Study|Soreness of throat after therapy|1|||
163470747|NCT03696576|590422204|FG001|Overall Study|Soreness of throat after therapy|1|||
163470748|NCT03696576|590422203|FG000|Overall Study|Lost to Follow-up|2|||
163470749|NCT03696576|590422204|FG001|Overall Study|Lost to Follow-up|4|||
163470750|NCT01975376|590422207|FG000|Overall Study|Adverse Event|5|||
163470751|NCT01975376|590422208|FG001|Overall Study|Adverse Event|5|||
163470752|NCT01975376|590422207|FG000|Overall Study|Death|65|||
163470753|NCT01975376|590422208|FG001|Overall Study|Death|72|||
163470754|NCT01975376|590422207|FG000|Overall Study|Lost to Follow-up|70|||
163470755|NCT01975376|590422208|FG001|Overall Study|Lost to Follow-up|66|||
163470756|NCT01975376|590422207|FG000|Overall Study|Withdrew consent|68|||
163470757|NCT01975376|590422208|FG001|Overall Study|Withdrew consent|62|||
163470758|NCT01975376|590422207|FG000|Overall Study|Other|2|||
163470759|NCT01975376|590422208|FG001|Overall Study|Other|4|||
163470760|NCT01975376|590422207|FG000|Overall Study|Randomized, Not Treated|16|||
163470761|NCT01975376|590422208|FG001|Overall Study|Randomized, Not Treated|8|||
163470762|NCT01451398|590422212|FG000|Overall Study|Adverse Event|7|||
163470763|NCT01451398|590422213|FG001|Overall Study|Adverse Event|9|||
163470764|NCT01451398|590422212|FG000|Overall Study|Protocol Violation|1|||
163470765|NCT01451398|590422213|FG001|Overall Study|Protocol Violation|2|||
163470766|NCT01451398|590422212|FG000|Overall Study|Physician Decision|1|||
163470767|NCT01451398|590422213|FG001|Overall Study|Physician Decision|1|||
163470768|NCT01451398|590422212|FG000|Overall Study|Withdrawal by Subject|10|||
163470769|NCT01451398|590422213|FG001|Overall Study|Withdrawal by Subject|14|||
163470770|NCT01451398|590422212|FG000|Overall Study|Lost to Follow-up|6|||
163470771|NCT01451398|590422213|FG001|Overall Study|Lost to Follow-up|4|||
163470772|NCT01451398|590422212|FG000|Overall Study|Non-compliance with study drug|1|||
163470773|NCT01451398|590422213|FG001|Overall Study|Non-compliance with study drug|3|||
163470774|NCT01451398|590422212|FG000|Overall Study|Non-compliance with protocol|1|||
163470775|NCT01451398|590422213|FG001|Overall Study|Non-compliance with protocol|1|||
163470776|NCT01451398|590422212|FG000|Overall Study|Moved out of country|0|||
163470777|NCT01451398|590422213|FG001|Overall Study|Moved out of country|1|||
163470778|NCT01451398|590422212|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
163470779|NCT01451398|590422213|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
163470780|NCT01451398|590422212|FG000|Overall Study|Lack of Efficacy|0|||
163470781|NCT01451398|590422213|FG001|Overall Study|Lack of Efficacy|1|||
163470782|NCT04449276|590422214|FG000|Overall Study|Adverse Event|1|||
163470783|NCT04449276|590422215|FG001|Overall Study|Adverse Event|2|||
163470784|NCT04449276|590422216|FG002|Overall Study|Adverse Event|0|||
163470785|NCT04449276|590422217|FG003|Overall Study|Adverse Event|0|||
163470786|NCT04449276|590422218|FG004|Overall Study|Adverse Event|2|||
163470787|NCT04449276|590422219|FG005|Overall Study|Adverse Event|0|||
163470788|NCT04449276|590422220|FG006|Overall Study|Adverse Event|0|||
163470789|NCT04449276|590422221|FG007|Overall Study|Adverse Event|1|||
163470790|NCT04449276|590422214|FG000|Overall Study|Withdrawal by Subject|2|||
163470791|NCT04449276|590422215|FG001|Overall Study|Withdrawal by Subject|0|||
163470792|NCT04449276|590422216|FG002|Overall Study|Withdrawal by Subject|0|||
163470793|NCT04449276|590422217|FG003|Overall Study|Withdrawal by Subject|1|||
163470794|NCT04449276|590422218|FG004|Overall Study|Withdrawal by Subject|0|||
163470795|NCT04449276|590422219|FG005|Overall Study|Withdrawal by Subject|0|||
163470796|NCT04449276|590422220|FG006|Overall Study|Withdrawal by Subject|0|||
163470797|NCT04449276|590422221|FG007|Overall Study|Withdrawal by Subject|0|||
163470798|NCT04449276|590422214|FG000|Overall Study|Other|0|||
163470799|NCT04449276|590422215|FG001|Overall Study|Other|2|||
163470800|NCT04449276|590422216|FG002|Overall Study|Other|3|||
163470801|NCT04449276|590422217|FG003|Overall Study|Other|2|||
163470802|NCT04449276|590422218|FG004|Overall Study|Other|0|||
163470803|NCT04449276|590422219|FG005|Overall Study|Other|0|||
163470804|NCT04449276|590422220|FG006|Overall Study|Other|0|||
163470805|NCT04449276|590422221|FG007|Overall Study|Other|1|||
163470806|NCT01614795|590422222|FG000|Overall Study|Adverse Event|0|||
163470807|NCT01614795|590422223|FG001|Overall Study|Adverse Event|0|||
163470808|NCT01614795|590422224|FG002|Overall Study|Adverse Event|1|||
163470809|NCT01614795|590422225|FG003|Overall Study|Adverse Event|1|||
163470810|NCT01614795|590422222|FG000|Overall Study|Lack of Efficacy|10|||
163470811|NCT01614795|590422223|FG001|Overall Study|Lack of Efficacy|10|||
163470812|NCT01614795|590422224|FG002|Overall Study|Lack of Efficacy|9|||
163470813|NCT01614795|590422225|FG003|Overall Study|Lack of Efficacy|8|||
163470814|NCT01614795|590422222|FG000|Overall Study|Physician Decision|1|||
163470815|NCT01614795|590422223|FG001|Overall Study|Physician Decision|0|||
163470816|NCT01614795|590422224|FG002|Overall Study|Physician Decision|1|||
163470817|NCT01614795|590422225|FG003|Overall Study|Physician Decision|1|||
163470818|NCT01614795|590422222|FG000|Overall Study|Withdrawal by Subject|0|||
163470819|NCT01614795|590422223|FG001|Overall Study|Withdrawal by Subject|1|||
163470820|NCT01614795|590422224|FG002|Overall Study|Withdrawal by Subject|0|||
163470821|NCT01614795|590422225|FG003|Overall Study|Withdrawal by Subject|2|||
163470822|NCT01614795|590422222|FG000|Overall Study|Ineligible|0|||
163470823|NCT01614795|590422223|FG001|Overall Study|Ineligible|1|||
163470824|NCT01614795|590422224|FG002|Overall Study|Ineligible|0|||
163470825|NCT01614795|590422225|FG003|Overall Study|Ineligible|0|||
163470826|NCT00701103|590422226|FG000|Overall Study|Adverse Event|0|||
163470827|NCT00701103|590422227|FG001|Overall Study|Adverse Event|0|||
163470828|NCT00701103|590422228|FG002|Overall Study|Adverse Event|1|||
163470829|NCT00701103|590422229|FG003|Overall Study|Adverse Event|1|||
163470830|NCT00701103|590422230|FG004|Overall Study|Adverse Event|0|||
163470831|NCT00701103|590422231|FG005|Overall Study|Adverse Event|1|||
163470832|NCT00701103|590422232|FG006|Overall Study|Adverse Event|1|||
163470833|NCT00701103|590422233|FG007|Overall Study|Adverse Event|0|||
163470834|NCT00701103|590422234|FG008|Overall Study|Adverse Event|0|||
163470835|NCT00701103|590422235|FG009|Overall Study|Adverse Event|2|||
163470836|NCT00701103|590422236|FG010|Overall Study|Adverse Event|0|||
163470837|NCT00701103|590422226|FG000|Overall Study|Progressive Disease|5|||
163470838|NCT00701103|590422227|FG001|Overall Study|Progressive Disease|2|||
163470839|NCT00701103|590422228|FG002|Overall Study|Progressive Disease|6|||
163470840|NCT00701103|590422229|FG003|Overall Study|Progressive Disease|5|||
163470841|NCT00701103|590422230|FG004|Overall Study|Progressive Disease|6|||
163470842|NCT00701103|590422231|FG005|Overall Study|Progressive Disease|5|||
163470843|NCT00701103|590422232|FG006|Overall Study|Progressive Disease|7|||
163470844|NCT00701103|590422233|FG007|Overall Study|Progressive Disease|7|||
163470845|NCT00701103|590422234|FG008|Overall Study|Progressive Disease|8|||
163470846|NCT00701103|590422235|FG009|Overall Study|Progressive Disease|8|||
163470847|NCT00701103|590422236|FG010|Overall Study|Progressive Disease|11|||
163470848|NCT00701103|590422226|FG000|Overall Study|Withdrawal by Subject|0|||
163470849|NCT00701103|590422227|FG001|Overall Study|Withdrawal by Subject|1|||
163470850|NCT00701103|590422228|FG002|Overall Study|Withdrawal by Subject|1|||
163470851|NCT00701103|590422229|FG003|Overall Study|Withdrawal by Subject|0|||
163470852|NCT00701103|590422230|FG004|Overall Study|Withdrawal by Subject|0|||
163470853|NCT00701103|590422231|FG005|Overall Study|Withdrawal by Subject|0|||
163470854|NCT00701103|590422232|FG006|Overall Study|Withdrawal by Subject|0|||
163470855|NCT00701103|590422233|FG007|Overall Study|Withdrawal by Subject|0|||
163470856|NCT00701103|590422234|FG008|Overall Study|Withdrawal by Subject|0|||
163470857|NCT00701103|590422235|FG009|Overall Study|Withdrawal by Subject|0|||
163470858|NCT00701103|590422236|FG010|Overall Study|Withdrawal by Subject|0|||
163470859|NCT00701103|590422226|FG000|Overall Study|Other|0|||
163470860|NCT00701103|590422227|FG001|Overall Study|Other|0|||
163470861|NCT00701103|590422228|FG002|Overall Study|Other|0|||
163470862|NCT00701103|590422229|FG003|Overall Study|Other|0|||
163470863|NCT00701103|590422230|FG004|Overall Study|Other|0|||
163470864|NCT00701103|590422231|FG005|Overall Study|Other|0|||
163470865|NCT00701103|590422232|FG006|Overall Study|Other|0|||
163470866|NCT00701103|590422233|FG007|Overall Study|Other|0|||
163470867|NCT00701103|590422234|FG008|Overall Study|Other|1|||
163470868|NCT00701103|590422235|FG009|Overall Study|Other|1|||
163470869|NCT00701103|590422236|FG010|Overall Study|Other|0|||
163470870|NCT00179517|590422237|FG000|Overall Study|Withdrawal by Subject|2|||
163470871|NCT00179517|590422238|FG001|Overall Study|Withdrawal by Subject|1|||
163470872|NCT01915095|590422239|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
163470873|NCT01915095|590422240|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
163470874|NCT01915095|590422241|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
163470875|NCT01915095|590422242|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
163470876|NCT01915095|590422243|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
163470877|NCT02067533|590422244|FG000|Overall Study|Lost to Follow-up|4|||
163470878|NCT02067533|590422245|FG001|Overall Study|Lost to Follow-up|2|||
163470879|NCT00565812|590422246|FG000|Overall Study|Death|2|||
163470880|NCT00565812|590422247|FG001|Overall Study|Death|1|||
163470881|NCT00565812|590422248|FG002|Overall Study|Death|3|||
163470882|NCT00565812|590422246|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
163470883|NCT00565812|590422247|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
163470884|NCT00565812|590422248|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
163470885|NCT00565812|590422246|FG000|Overall Study|Lost to Follow-up|10|||
163470886|NCT00565812|590422247|FG001|Overall Study|Lost to Follow-up|8|||
163470887|NCT00565812|590422248|FG002|Overall Study|Lost to Follow-up|8|||
163470888|NCT00565812|590422246|FG000|Overall Study|Withdrawal by Subject|58|||
163470889|NCT00565812|590422247|FG001|Overall Study|Withdrawal by Subject|47|||
163470890|NCT00565812|590422248|FG002|Overall Study|Withdrawal by Subject|48|||
163470891|NCT00565812|590422246|FG000|Overall Study|Work Schedule|5|||
163470892|NCT00565812|590422247|FG001|Overall Study|Work Schedule|3|||
163470893|NCT00565812|590422248|FG002|Overall Study|Work Schedule|1|||
163470894|NCT00565812|590422246|FG000|Overall Study|Protocol Violation|2|||
163470895|NCT00565812|590422247|FG001|Overall Study|Protocol Violation|6|||
163470896|NCT00565812|590422248|FG002|Overall Study|Protocol Violation|4|||
163470897|NCT00565812|590422246|FG000|Overall Study|Adverse Event|41|||
163470898|NCT00565812|590422247|FG001|Overall Study|Adverse Event|54|||
163470899|NCT00565812|590422248|FG002|Overall Study|Adverse Event|40|||
163470900|NCT00565812|590422246|FG000|Overall Study|Jury Duty|1|||
163470901|NCT00565812|590422247|FG001|Overall Study|Jury Duty|0|||
163470902|NCT00565812|590422248|FG002|Overall Study|Jury Duty|0|||
163470903|NCT00565812|590422246|FG000|Overall Study|Relocated Out of Area|5|||
163470904|NCT00565812|590422247|FG001|Overall Study|Relocated Out of Area|8|||
163470905|NCT00565812|590422248|FG002|Overall Study|Relocated Out of Area|9|||
163470906|NCT00565812|590422246|FG000|Overall Study|Sponsor Decision|1|||
163470907|NCT00565812|590422247|FG001|Overall Study|Sponsor Decision|5|||
163470908|NCT00565812|590422248|FG002|Overall Study|Sponsor Decision|1|||
163470909|NCT00565812|590422246|FG000|Overall Study|Domestic Reasons|7|||
163470910|NCT00565812|590422247|FG001|Overall Study|Domestic Reasons|1|||
163470911|NCT00565812|590422248|FG002|Overall Study|Domestic Reasons|3|||
163470912|NCT00565812|590422246|FG000|Overall Study|Research Site Closure|6|||
163470913|NCT00565812|590422247|FG001|Overall Study|Research Site Closure|1|||
163470914|NCT00565812|590422248|FG002|Overall Study|Research Site Closure|8|||
163470915|NCT00565812|590422246|FG000|Overall Study|Surgical Intervention|0|||
163470916|NCT00565812|590422247|FG001|Overall Study|Surgical Intervention|1|||
163470917|NCT00565812|590422248|FG002|Overall Study|Surgical Intervention|2|||
163470918|NCT00565812|590422246|FG000|Overall Study|Low Compliance|1|||
163470919|NCT00565812|590422247|FG001|Overall Study|Low Compliance|0|||
163470920|NCT00565812|590422248|FG002|Overall Study|Low Compliance|1|||
163470921|NCT00565812|590422246|FG000|Overall Study|Follow-up Visit Not Completed|2|||
163470922|NCT00565812|590422247|FG001|Overall Study|Follow-up Visit Not Completed|0|||
163470923|NCT00565812|590422248|FG002|Overall Study|Follow-up Visit Not Completed|1|||
163470924|NCT00565812|590422246|FG000|Overall Study|Physician Decision|2|||
163470925|NCT00565812|590422247|FG001|Overall Study|Physician Decision|0|||
163470926|NCT00565812|590422248|FG002|Overall Study|Physician Decision|0|||
163470927|NCT02896192|590422256|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
163470928|NCT02896192|590422256|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
163470929|NCT02896192|590422256|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
163470930|NCT04857892|590422261|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
163470931|NCT04857892|590422262|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
163470932|NCT04857892|590422263|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
163470933|NCT04857892|590422264|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
163470934|NCT04857892|590422265|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
163470935|NCT04857892|590422261|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
163470936|NCT04857892|590422262|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
163470937|NCT04857892|590422263|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
163470938|NCT04857892|590422264|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
163470939|NCT04857892|590422265|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
163470940|NCT04857892|590422261|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
163470941|NCT04857892|590422262|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
163470942|NCT04857892|590422263|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
163470943|NCT04857892|590422264|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
163470944|NCT04857892|590422265|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
163470945|NCT00899678|590422266|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
163470946|NCT00899678|590422267|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
163470947|NCT00899678|590422268|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
163470948|NCT00899678|590422266|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
163470949|NCT00899678|590422267|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
163470950|NCT00899678|590422268|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
163470951|NCT00899678|590422266|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
163470952|NCT00899678|590422267|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
163470953|NCT00899678|590422268|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
163470954|NCT00899678|590422266|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
163470955|NCT00899678|590422267|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
163470956|NCT00899678|590422268|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
163470957|NCT00899678|590422266|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
163470958|NCT00899678|590422267|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
163470959|NCT00899678|590422268|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
163470960|NCT00899678|590422266|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
163470961|NCT00899678|590422267|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
163470962|NCT00899678|590422268|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
163470963|NCT00899678|590422266|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
163470964|NCT00899678|590422267|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
163470965|NCT00899678|590422268|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
163470966|NCT00899678|590422266|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
163470967|NCT00899678|590422267|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
163470968|NCT00899678|590422268|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
163470969|NCT00899678|590422266|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
163470970|NCT00899678|590422267|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
163470971|NCT00899678|590422268|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
163470972|NCT00368472|590422272|FG000|Overall Study|Adverse Event|22|||
163470973|NCT00368472|590422272|FG000|Overall Study|Medication non-compliance|4|||
163470974|NCT00368472|590422272|FG000|Overall Study|Protocol Violation|2|||
163470975|NCT00368472|590422272|FG000|Overall Study|Request of Investigator or Sponsor|3|||
163470976|NCT00368472|590422272|FG000|Overall Study|Withdrawal by Subject|40|||
163470977|NCT00368472|590422272|FG000|Overall Study|Diary non-compliance|1|||
163470978|NCT00368472|590422272|FG000|Overall Study|Other|32|||
163470979|NCT00368472|590422272|FG000|Overall Study|Missing Final Disposition Date|1|||
163470980|NCT02650895|590422274|FG000|Overall Study|Withdrawal by Subject|0|||
163470981|NCT02650895|590422275|FG001|Overall Study|Withdrawal by Subject|1|||
163470982|NCT02650895|590422276|FG002|Overall Study|Withdrawal by Subject|0|||
163470983|NCT02650895|590422277|FG003|Overall Study|Withdrawal by Subject|0|||
163470984|NCT02650895|590422278|FG004|Overall Study|Withdrawal by Subject|0|||
163470985|NCT02650895|590422279|FG005|Overall Study|Withdrawal by Subject|0|||
163470986|NCT02632344|590423770|FG000|Overall Study|Adverse Event|3|||
163470987|NCT02632344|590423770|FG000|Overall Study|Lack of Efficacy|3|||
163470988|NCT02632344|590423770|FG000|Overall Study|Withdrawal by Subject|2|||
163470989|NCT00777257|590423771|FG000|Overall Study|Adverse Event|3|||
163470990|NCT00777257|590423772|FG001|Overall Study|Adverse Event|1|||
163470991|NCT00777257|590423773|FG002|Overall Study|Adverse Event|0|||
163470992|NCT00777257|590423771|FG000|Overall Study|Lost to Follow-up|3|||
163470993|NCT00777257|590423772|FG001|Overall Study|Lost to Follow-up|3|||
163470994|NCT00777257|590423773|FG002|Overall Study|Lost to Follow-up|2|||
163470995|NCT00777257|590423771|FG000|Overall Study|Protocol Violation|2|||
163470996|NCT00777257|590423772|FG001|Overall Study|Protocol Violation|2|||
163470997|NCT00777257|590423773|FG002|Overall Study|Protocol Violation|2|||
163470998|NCT00777257|590423771|FG000|Overall Study|Withdrawal by Subject|3|||
163470999|NCT00777257|590423772|FG001|Overall Study|Withdrawal by Subject|6|||
163471000|NCT00777257|590423773|FG002|Overall Study|Withdrawal by Subject|5|||
163471001|NCT01370499|590423774|FG000|Overall Study|Adverse Event|38|||
163471002|NCT01370499|590423775|FG001|Overall Study|Adverse Event|12|||
163471003|NCT01370499|590423774|FG000|Overall Study|Lack of Efficacy|4|||
163471004|NCT01370499|590423775|FG001|Overall Study|Lack of Efficacy|2|||
163471005|NCT01370499|590423774|FG000|Overall Study|Lost to Follow-up|2|||
163471006|NCT01370499|590423775|FG001|Overall Study|Lost to Follow-up|1|||
163471007|NCT01370499|590423774|FG000|Overall Study|Physician Decision|3|||
163471008|NCT01370499|590423775|FG001|Overall Study|Physician Decision|3|||
163471009|NCT01370499|590423774|FG000|Overall Study|Protocol Violation|5|||
163471010|NCT01370499|590423775|FG001|Overall Study|Protocol Violation|4|||
163471011|NCT01370499|590423774|FG000|Overall Study|Withdrawal by Subject|18|||
163471012|NCT01370499|590423775|FG001|Overall Study|Withdrawal by Subject|7|||
163471013|NCT01370499|590423774|FG000|Overall Study|Sponsor Decision|41|||
163471014|NCT01370499|590423775|FG001|Overall Study|Sponsor Decision|15|||
163471015|NCT04984876|590423776|FG000|Overall Study|Subject decision|2|||
163471016|NCT04984876|590423777|FG001|Overall Study|Subject decision|10|||
163471017|NCT04984876|590423778|FG002|Overall Study|Subject decision|3|||
163471018|NCT04984876|590423779|FG003|Overall Study|Subject decision|3|||
163471019|NCT04984876|590423780|FG004|Overall Study|Subject decision|3|||
163471020|NCT04984876|590423781|FG005|Overall Study|Subject decision|0|||
163471021|NCT04984876|590423776|FG000|Overall Study|Guardian decision|0|||
163471022|NCT04984876|590423777|FG001|Overall Study|Guardian decision|1|||
163471023|NCT04984876|590423778|FG002|Overall Study|Guardian decision|0|||
163471024|NCT04984876|590423779|FG003|Overall Study|Guardian decision|2|||
163471025|NCT04984876|590423780|FG004|Overall Study|Guardian decision|0|||
163471026|NCT04984876|590423781|FG005|Overall Study|Guardian decision|1|||
163471027|NCT04984876|590423776|FG000|Overall Study|Lost to Follow-up|0|||
163471028|NCT04984876|590423777|FG001|Overall Study|Lost to Follow-up|0|||
163471029|NCT04984876|590423778|FG002|Overall Study|Lost to Follow-up|1|||
163471030|NCT04984876|590423779|FG003|Overall Study|Lost to Follow-up|1|||
163471031|NCT04984876|590423780|FG004|Overall Study|Lost to Follow-up|0|||
163471032|NCT04984876|590423781|FG005|Overall Study|Lost to Follow-up|0|||
163471033|NCT04984876|590423776|FG000|Overall Study|Physician Decision|1|||
163471034|NCT04984876|590423777|FG001|Overall Study|Physician Decision|0|||
163471035|NCT04984876|590423778|FG002|Overall Study|Physician Decision|0|||
163471036|NCT04984876|590423779|FG003|Overall Study|Physician Decision|1|||
163471037|NCT04984876|590423780|FG004|Overall Study|Physician Decision|0|||
163471038|NCT04984876|590423781|FG005|Overall Study|Physician Decision|0|||
163471039|NCT04984876|590423776|FG000|Overall Study|Adverse Event|0|||
163471040|NCT04984876|590423777|FG001|Overall Study|Adverse Event|0|||
163471041|NCT04984876|590423778|FG002|Overall Study|Adverse Event|1|||
163471042|NCT04984876|590423779|FG003|Overall Study|Adverse Event|0|||
163471043|NCT04984876|590423780|FG004|Overall Study|Adverse Event|0|||
163471044|NCT04984876|590423781|FG005|Overall Study|Adverse Event|0|||
163471045|NCT01077193|590423784|FG000|Overall Study|Lost to Follow-up|1|||
163471046|NCT01077193|590423784|FG000|Overall Study|Withdrawal by Subject|2|||
163471047|NCT01077193|590423784|FG000|Overall Study|Lack of Efficacy|1|||
163471048|NCT01077193|590423784|FG000|Overall Study|Study Terminated by Sponsor|40|||
163471049|NCT04960202|590423786|FG000|Overall Study|Other|5|||
163471050|NCT04960202|590423787|FG001|Overall Study|Other|0|||
163471051|NCT04960202|590423786|FG000|Overall Study|Withdrawal by Subject|37|||
163471052|NCT04960202|590423787|FG001|Overall Study|Withdrawal by Subject|43|||
163471053|NCT04960202|590423786|FG000|Overall Study|Lost to Follow-up|20|||
163471054|NCT04960202|590423787|FG001|Overall Study|Lost to Follow-up|16|||
163471055|NCT04960202|590423786|FG000|Overall Study|Death|0|||
163471056|NCT04960202|590423787|FG001|Overall Study|Death|15|||
163471057|NCT03687827|590423792|FG000|Treatment Period 1|Death|0|||
163471058|NCT03687827|590423793|FG001|Treatment Period 1|Death|1|||
163471059|NCT03687827|590423792|FG000|Treatment Period 1|Lost to Follow-up|2|||
163471060|NCT03687827|590423793|FG001|Treatment Period 1|Lost to Follow-up|2|||
163471061|NCT03687827|590423792|FG000|Treatment Period 1|Physician Decision|5|||
163471062|NCT03687827|590423793|FG001|Treatment Period 1|Physician Decision|2|||
163471063|NCT03687827|590423792|FG000|Treatment Period 1|Withdrawal by Subject|7|||
163471064|NCT03687827|590423793|FG001|Treatment Period 1|Withdrawal by Subject|3|||
163471065|NCT03687827|590423792|FG000|Treatment Period 2|Physician Decision|4|||
163471066|NCT03687827|590423793|FG001|Treatment Period 2|Physician Decision|1|||
163471067|NCT03687827|590423792|FG000|Treatment Period 2|Withdrawal by Subject|1|||
163471068|NCT03687827|590423793|FG001|Treatment Period 2|Withdrawal by Subject|2|||
163471069|NCT00981292|590423798|FG000|Day 1|Protocol Violation|1|||
163471070|NCT00981292|590423799|FG001|Day 1|Protocol Violation|0|||
163471071|NCT00981292|590423800|FG002|Day 1|Protocol Violation|0|||
163471072|NCT00981292|590423801|FG003|Day 1|Protocol Violation|0|||
163471073|NCT00981292|590423802|FG004|Day 1|Protocol Violation|0|||
163471074|NCT00981292|590423803|FG005|Day 1|Protocol Violation|2|||
163471075|NCT00981292|590423798|FG000|Day 2|Protocol Violation|2|||
163471076|NCT00981292|590423799|FG001|Day 2|Protocol Violation|0|||
163471077|NCT00981292|590423800|FG002|Day 2|Protocol Violation|0|||
163471078|NCT00981292|590423801|FG003|Day 2|Protocol Violation|0|||
163471079|NCT00981292|590423802|FG004|Day 2|Protocol Violation|0|||
163471080|NCT00981292|590423803|FG005|Day 2|Protocol Violation|0|||
163471081|NCT00981292|590423798|FG000|Day 3|Protocol Violation|0|||
163471082|NCT00981292|590423799|FG001|Day 3|Protocol Violation|0|||
163471083|NCT00981292|590423800|FG002|Day 3|Protocol Violation|0|||
163471084|NCT00981292|590423801|FG003|Day 3|Protocol Violation|0|||
163471085|NCT00981292|590423802|FG004|Day 3|Protocol Violation|0|||
163471086|NCT00981292|590423803|FG005|Day 3|Protocol Violation|1|||
163471087|NCT03377452|590423804|FG000|Overall Study|Refused assessment|0|||
163471088|NCT03377452|590423805|FG001|Overall Study|Refused assessment|2|||
163471089|NCT03377452|590423804|FG000|Overall Study|Lost to Follow-up|5|||
163471090|NCT03377452|590423805|FG001|Overall Study|Lost to Follow-up|4|||
163471091|NCT03464136|590423806|FG000|Overall Study|Lost to Follow-up|5|||
163471092|NCT03464136|590423807|FG001|Overall Study|Lost to Follow-up|8|||
163471093|NCT03464136|590423806|FG000|Overall Study|Withdrawal by Subject|16|||
163471094|NCT03464136|590423807|FG001|Overall Study|Withdrawal by Subject|13|||
163471095|NCT03464136|590423806|FG000|Overall Study|Death|1|||
163471096|NCT03464136|590423807|FG001|Overall Study|Death|0|||
163471097|NCT03464136|590423806|FG000|Overall Study|Other|8|||
163471098|NCT03464136|590423807|FG001|Overall Study|Other|4|||
163471099|NCT03146403|590423808|FG000|Overall Study|Withdrawal by Subject|0|||
163471100|NCT03146403|590423809|FG001|Overall Study|Withdrawal by Subject|3|||
163471101|NCT03146403|590423808|FG000|Overall Study|Lost to Follow-up|2|||
163471102|NCT03146403|590423809|FG001|Overall Study|Lost to Follow-up|0|||
163471103|NCT00481988|590423810|FG000|Overall Study|Withdrawal by Subject|1|||
163471104|NCT00481988|590423811|FG001|Overall Study|Withdrawal by Subject|1|||
163471105|NCT02182999|590423812|FG000|Overall Study|Adverse Event|4|||
163471106|NCT02182999|590423813|FG001|Overall Study|Adverse Event|3|||
163471107|NCT02182999|590423812|FG000|Overall Study|Physician Decision|1|||
163471108|NCT02182999|590423813|FG001|Overall Study|Physician Decision|0|||
163471109|NCT02252588|590423815|FG000|Overall Study|Withdrawal by Subject|4|||
163471110|NCT02252588|590423816|FG001|Overall Study|Withdrawal by Subject|0|||
163471111|NCT00638690|590423821|FG000|Overall Study|Death|655|||
163471112|NCT00638690|590423822|FG001|Overall Study|Death|335|||
163471113|NCT00638690|590423821|FG000|Overall Study|Withdrawal by Subject|22|||
163471114|NCT00638690|590423822|FG001|Overall Study|Withdrawal by Subject|5|||
163471115|NCT00638690|590423821|FG000|Overall Study|Lost to Follow-up|4|||
163471116|NCT00638690|590423822|FG001|Overall Study|Lost to Follow-up|2|||
163471117|NCT02203916|590423825|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
163471118|NCT02203916|590423826|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
163471119|NCT02203916|590423827|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
163471120|NCT02203916|590423825|FG000|Overall Study|Major Protocol Deviation|1|||
163471121|NCT02203916|590423826|FG001|Overall Study|Major Protocol Deviation|1|||
163471122|NCT02203916|590423827|FG002|Overall Study|Major Protocol Deviation|0|||
163471123|NCT02203916|590423825|FG000|Overall Study|Lost to Follow-up|0|||
163471124|NCT02203916|590423826|FG001|Overall Study|Lost to Follow-up|1|||
163471125|NCT02203916|590423827|FG002|Overall Study|Lost to Follow-up|0|||
163471126|NCT02203916|590423825|FG000|Overall Study|Voluntary Withdrawal|3|||
163471127|NCT02203916|590423826|FG001|Overall Study|Voluntary Withdrawal|3|||
163471128|NCT02203916|590423827|FG002|Overall Study|Voluntary Withdrawal|8|||
163471129|NCT02203916|590423825|FG000|Overall Study|Lack of Efficacy|3|||
163471130|NCT02203916|590423826|FG001|Overall Study|Lack of Efficacy|0|||
163471131|NCT02203916|590423827|FG002|Overall Study|Lack of Efficacy|0|||
163471132|NCT02203916|590423825|FG000|Overall Study|Reason Not Specified|0|||
163471133|NCT02203916|590423826|FG001|Overall Study|Reason Not Specified|2|||
163471134|NCT02203916|590423827|FG002|Overall Study|Reason Not Specified|1|||
163471135|NCT03152110|590423838|FG000|Overall Study|Withdrawal by Subject|3|||
163471136|NCT00552344|590423848|FG000|Overall Study|Lack of Efficacy|55|||
163471137|NCT00552344|590423848|FG000|Overall Study|Loss of efficacy|75|||
163471138|NCT00552344|590423848|FG000|Overall Study|Lost to Follow-up|8|||
163471139|NCT00552344|590423848|FG000|Overall Study|Withdrawal by Subject|48|||
163471140|NCT00552344|590423848|FG000|Overall Study|SAE, non-fatal|6|||
163471141|NCT00552344|590423848|FG000|Overall Study|AE, non-serious non-fatal|38|||
163471142|NCT00552344|590423848|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
163471143|NCT00552344|590423848|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
163471144|NCT00552344|590423848|FG000|Overall Study|Other Reason|22|||
163471145|NCT04247828|590423851|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
163471146|NCT00045630|590423854|FG000|Overall Study|Adverse Event|1|||
163471147|NCT00045630|590423854|FG000|Overall Study|Refusal unrelated to adverse event|1|||
163471148|NCT00045630|590423854|FG000|Overall Study|Progression/relapse|1|||
163471149|NCT00045630|590423854|FG000|Overall Study|Death|1|||
163471150|NCT00045630|590423854|FG000|Overall Study|Ineligible|2|||
163471151|NCT01448707|590423861|FG000|Overall Study|Adverse Event|3|||
163471152|NCT01448707|590423862|FG001|Overall Study|Adverse Event|1|||
163471153|NCT01448707|590423861|FG000|Overall Study|Lost to Follow-up|2|||
163471154|NCT01448707|590423862|FG001|Overall Study|Lost to Follow-up|6|||
163471155|NCT01448707|590423861|FG000|Overall Study|Withdrawal by Subject|6|||
163471156|NCT01448707|590423862|FG001|Overall Study|Withdrawal by Subject|7|||
163471157|NCT01448707|590423861|FG000|Overall Study|Other|7|||
163471158|NCT01448707|590423862|FG001|Overall Study|Other|4|||
163471159|NCT00383708|590423866|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
163471160|NCT00383708|590423866|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
163471161|NCT00383708|590423866|FG000|Run-in Period|Protocol Violation|4|||
163471162|NCT00383708|590423866|FG000|Run-in Period|Adverse Event|2|||
163471163|NCT00383708|590423866|FG000|Run-in Period|Claustrophobia|1|||
163471164|NCT00383708|590423866|FG000|Co-administration Period|Adverse Event|5|||
163471165|NCT02033850|590423867|FG000|Overall Study|Death|1|||
163471166|NCT02033850|590423868|FG001|Overall Study|Death|0|||
163471167|NCT02033850|590423867|FG000|Overall Study|unrelated medical reason|1|||
163471168|NCT02033850|590423868|FG001|Overall Study|unrelated medical reason|1|||
163471169|NCT02820038|590423869|FG000|Overall Study|Lost to Follow-up|7|||
163471170|NCT02820038|590423870|FG001|Overall Study|Lost to Follow-up|11|||
163471171|NCT02820038|590423871|FG002|Overall Study|Lost to Follow-up|2|||
163471172|NCT02820038|590423872|FG003|Overall Study|Lost to Follow-up|9|||
163471173|NCT02820038|590423869|FG000|Overall Study|Withdrawal by Subject|3|||
163471174|NCT02820038|590423870|FG001|Overall Study|Withdrawal by Subject|14|||
163471175|NCT02820038|590423871|FG002|Overall Study|Withdrawal by Subject|3|||
163471176|NCT02820038|590423872|FG003|Overall Study|Withdrawal by Subject|13|||
163471177|NCT03215667|590423873|FG000|Overall Study|Physician Decision|4|||
163471178|NCT01997281|590423874|FG000|Overall Study|Withdrawal by Subject|1|||
163471179|NCT01997281|590423875|FG001|Overall Study|Withdrawal by Subject|0|||
163471180|NCT03934203|590423876|FG000|Overall Study|Adverse Event|0|||
163471181|NCT03934203|590423877|FG001|Overall Study|Adverse Event|0|||
163471182|NCT03934203|590423878|FG002|Overall Study|Adverse Event|1|||
163471183|NCT03934203|590423879|FG003|Overall Study|Adverse Event|0|||
163471184|NCT03934203|590423880|FG004|Overall Study|Adverse Event|1|||
163471185|NCT03934203|590423881|FG005|Overall Study|Adverse Event|0|||
163471186|NCT03934203|590423882|FG006|Overall Study|Adverse Event|2|||
163471187|NCT03934203|590423883|FG007|Overall Study|Adverse Event|0|||
163471188|NCT03934203|590423884|FG008|Overall Study|Adverse Event|0|||
163471189|NCT03934203|590423885|FG009|Overall Study|Adverse Event|0|||
163471190|NCT03934203|590423886|FG010|Overall Study|Adverse Event|0|||
163471191|NCT03934203|590423887|FG011|Overall Study|Adverse Event|0|||
163471192|NCT03934203|590423888|FG012|Overall Study|Adverse Event|0|||
163471193|NCT03934203|590423889|FG013|Overall Study|Adverse Event|1|||
163471194|NCT03934203|590423890|FG014|Overall Study|Adverse Event|0|||
163471195|NCT00333970|590423892|FG000|Overall Study|Withdrawal by Subject|13|||
163471196|NCT00333970|590423893|FG001|Overall Study|Withdrawal by Subject|7|||
163471197|NCT00560794|590423894|FG000|Overall Study|Adverse Event|2|||
163471198|NCT00560794|590423894|FG000|Overall Study|Patient was not Compliant|1|||
163471199|NCT00560794|590423894|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
163471200|NCT00560794|590423894|FG000|Overall Study|Hematological Relapse|1|||
163471201|NCT00560794|590423894|FG000|Overall Study|Received Bone Marrow Transplant|6|||
163471202|NCT00614991|590423895|FG000|Overall Study|Adverse Event|3|||
163471203|NCT00614991|590423896|FG001|Overall Study|Adverse Event|3|||
163471204|NCT00614991|590423897|FG002|Overall Study|Adverse Event|0|||
163471205|NCT00614991|590423898|FG003|Overall Study|Adverse Event|0|||
163471206|NCT00614991|590423899|FG004|Overall Study|Adverse Event|1|||
163471207|NCT00614991|590423900|FG005|Overall Study|Adverse Event|0|||
163471208|NCT00441480|590423901|FG000|Overall Study|Protocol Violation|1|||
163471209|NCT00441480|590423902|FG001|Overall Study|Protocol Violation|1|||
163471210|NCT00441480|590423901|FG000|Overall Study|Withdrawal by Subject|2|||
163471211|NCT00441480|590423902|FG001|Overall Study|Withdrawal by Subject|3|||
163471212|NCT01922739|590423910|FG000|Titration/Adjustment Period|Adverse Event|3|||
163471213|NCT01922739|590423910|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
163471214|NCT01922739|590423910|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
163471215|NCT01922739|590423910|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
163471216|NCT01922739|590423910|FG000|Open-label Treatment Period|Adverse Event|6|||
163471217|NCT01922739|590423910|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
163471218|NCT01922739|590423910|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
163471219|NCT01922739|590423910|FG000|Open-label Treatment Period|Protocol Violation|5|||
163471220|NCT01922739|590423910|FG000|Open-label Treatment Period|Pregnancy|1|||
163471221|NCT01922739|590423910|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
163471222|NCT01922739|590423910|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
163471223|NCT01922739|590423910|FG000|Open-label Treatment Period|Physician Decision|1|||
163471224|NCT01922739|590423910|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
163471225|NCT00044213|590423911|FG000|Overall Study|Withdrawal by Subject|50|||
163471226|NCT00044213|590423912|FG001|Overall Study|Withdrawal by Subject|65|||
163471227|NCT00044213|590423913|FG002|Overall Study|Withdrawal by Subject|91|||
163471228|NCT00044213|590423914|FG003|Overall Study|Withdrawal by Subject|83|||
163471229|NCT00044213|590423911|FG000|Overall Study|Death|42|||
163471230|NCT00044213|590423912|FG001|Overall Study|Death|42|||
163471231|NCT00044213|590423913|FG002|Overall Study|Death|42|||
163471232|NCT00044213|590423914|FG003|Overall Study|Death|49|||
163471233|NCT00044213|590423911|FG000|Overall Study|Lost to Follow-up|8|||
163471234|NCT00044213|590423912|FG001|Overall Study|Lost to Follow-up|5|||
163471235|NCT00044213|590423913|FG002|Overall Study|Lost to Follow-up|5|||
163471236|NCT00044213|590423914|FG003|Overall Study|Lost to Follow-up|4|||
163471237|NCT00422240|590423915|FG000|Overall Study|Lack of Efficacy|1|||
163471238|NCT00422240|590423916|FG001|Overall Study|Lack of Efficacy|2|||
163471239|NCT00422240|590423917|FG002|Overall Study|Lack of Efficacy|0|||
163471240|NCT00422240|590423918|FG003|Overall Study|Lack of Efficacy|1|||
163471241|NCT00422240|590423915|FG000|Overall Study|Adverse Event|11|||
163471242|NCT00422240|590423916|FG001|Overall Study|Adverse Event|4|||
163471243|NCT00422240|590423917|FG002|Overall Study|Adverse Event|5|||
163471244|NCT00422240|590423918|FG003|Overall Study|Adverse Event|2|||
163471245|NCT00422240|590423915|FG000|Overall Study|Subject request|21|||
163471246|NCT00422240|590423916|FG001|Overall Study|Subject request|17|||
163471247|NCT00422240|590423917|FG002|Overall Study|Subject request|18|||
163471248|NCT00422240|590423918|FG003|Overall Study|Subject request|30|||
163471249|NCT00422240|590423915|FG000|Overall Study|Protocol Violation|0|||
163471250|NCT00422240|590423916|FG001|Overall Study|Protocol Violation|1|||
163471251|NCT00422240|590423917|FG002|Overall Study|Protocol Violation|0|||
163471252|NCT00422240|590423918|FG003|Overall Study|Protocol Violation|1|||
163471253|NCT00422240|590423915|FG000|Overall Study|Lost to Follow-up|31|||
163471254|NCT00422240|590423916|FG001|Overall Study|Lost to Follow-up|32|||
163471255|NCT00422240|590423917|FG002|Overall Study|Lost to Follow-up|19|||
163471256|NCT00422240|590423918|FG003|Overall Study|Lost to Follow-up|34|||
163471257|NCT00422240|590423915|FG000|Overall Study|Other|1|||
163471258|NCT00422240|590423916|FG001|Overall Study|Other|0|||
163471259|NCT00422240|590423917|FG002|Overall Study|Other|0|||
163471260|NCT00422240|590423918|FG003|Overall Study|Other|1|||
163471261|NCT00422240|590423915|FG000|Overall Study|Pregnancy|3|||
163471262|NCT00422240|590423916|FG001|Overall Study|Pregnancy|1|||
163471263|NCT00422240|590423917|FG002|Overall Study|Pregnancy|1|||
163471264|NCT00422240|590423918|FG003|Overall Study|Pregnancy|2|||
163471265|NCT00880607|590423919|FG000|Overall Study|Physician Decision|2|||
163471266|NCT00880607|590423920|FG001|Overall Study|Physician Decision|2|||
163471267|NCT00880607|590423919|FG000|Overall Study|Protocol Violation|2|||
163471268|NCT00880607|590423920|FG001|Overall Study|Protocol Violation|1|||
163471269|NCT00880607|590423919|FG000|Overall Study|surgery did not extend past L1 level|3|||
163471270|NCT00880607|590423920|FG001|Overall Study|surgery did not extend past L1 level|0|||
163471271|NCT05104749|590423921|FG000|Overall Study|Lost to Follow-up|2|||
163471272|NCT05104749|590423922|FG001|Overall Study|Lost to Follow-up|3|||
163471273|NCT00901394|590423923|FG000|Overall Study|Physician Decision|1|||
163471274|NCT00901394|590423924|FG001|Overall Study|Physician Decision|1|||
163471275|NCT00901394|590423925|FG002|Overall Study|Physician Decision|2|||
163471276|NCT01167153|590423929|FG000|Overall Study|Non-effective therapy|1|||
163471277|NCT01167153|590423930|FG001|Overall Study|Non-effective therapy|4|||
163471278|NCT01167153|590423929|FG000|Overall Study|AE including clinical laboratory AE|2|||
163471279|NCT01167153|590423930|FG001|Overall Study|AE including clinical laboratory AE|8|||
163471280|NCT01167153|590423929|FG000|Overall Study|Hypotension|1|||
163471281|NCT01167153|590423930|FG001|Overall Study|Hypotension|0|||
163471282|NCT01167153|590423929|FG000|Overall Study|Lost to Follow-up|7|||
163471283|NCT01167153|590423930|FG001|Overall Study|Lost to Follow-up|9|||
163471284|NCT01167153|590423929|FG000|Overall Study|Non-compliance to concomitant medication|0|||
163471285|NCT01167153|590423930|FG001|Overall Study|Non-compliance to concomitant medication|2|||
163471286|NCT01167153|590423929|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
163471287|NCT01167153|590423930|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
163471288|NCT01167153|590423929|FG000|Overall Study|Withdrawal consent|1|||
163471289|NCT01167153|590423930|FG001|Overall Study|Withdrawal consent|1|||
163471290|NCT01167153|590423929|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
163471291|NCT01167153|590423930|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
163471292|NCT04888507|590426174|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
163471293|NCT00636155|590426175|FG000|Overall Study|Adverse Event|8|||
163471294|NCT00636155|590426175|FG000|Overall Study|Lack of Efficacy|1|||
163471295|NCT00636155|590426175|FG000|Overall Study|Withdrawal by Subject|3|||
163471296|NCT00636155|590426175|FG000|Overall Study|Stem cell transplant|1|||
163471297|NCT00636155|590426175|FG000|Overall Study|Physician Decision|5|||
163471298|NCT00766142|590426176|FG000|Overall Study|Protocol Violation|4|||
163471299|NCT05643170|590426182|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
163471300|NCT05643170|590426182|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
163471301|NCT00444951|590426189|FG000|Overall Study|Lost to Follow-up|1|||
163471302|NCT00444951|590426190|FG001|Overall Study|Lost to Follow-up|1|||
163471303|NCT00444951|590426191|FG002|Overall Study|Lost to Follow-up|0|||
163471304|NCT00444951|590426189|FG000|Overall Study|Withdrawal by Subject|4|||
163471305|NCT00444951|590426190|FG001|Overall Study|Withdrawal by Subject|5|||
163471306|NCT00444951|590426191|FG002|Overall Study|Withdrawal by Subject|3|||
163471307|NCT02710422|590426192|FG000|Overall Study|Termination of study|9|||
163471308|NCT02710422|590426193|FG001|Overall Study|Termination of study|9|||
163471309|NCT00887822|590426194|FG000|Overall Study|Insufficient therapeutic response|53|||
163471310|NCT00887822|590426195|FG001|Overall Study|Insufficient therapeutic response|55|||
163471311|NCT00887822|590426194|FG000|Overall Study|Adverse Event|14|||
163471312|NCT00887822|590426195|FG001|Overall Study|Adverse Event|17|||
163471313|NCT00887822|590426194|FG000|Overall Study|Failure to return|11|||
163471314|NCT00887822|590426195|FG001|Overall Study|Failure to return|11|||
163471315|NCT00887822|590426194|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
163471316|NCT00887822|590426195|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
163471317|NCT00887822|590426194|FG000|Overall Study|Administrative/Other than specified|5|||
163471318|NCT00887822|590426195|FG001|Overall Study|Administrative/Other than specified|4|||
163471319|NCT00887822|590426194|FG000|Overall Study|Death|2|||
163471320|NCT00887822|590426195|FG001|Overall Study|Death|3|||
163471321|NCT00887822|590426194|FG000|Overall Study|Protocol Violation|0|||
163471322|NCT00887822|590426195|FG001|Overall Study|Protocol Violation|1|||
163471323|NCT00887822|590426194|FG000|Overall Study|Randomized but not treated|0|||
163471324|NCT00887822|590426195|FG001|Overall Study|Randomized but not treated|1|||
163471325|NCT02000622|590426196|FG000|Overall Study|Withdrawal by Subject|5|||
163471326|NCT02000622|590426197|FG001|Overall Study|Withdrawal by Subject|7|||
163471327|NCT02000622|590426196|FG000|Overall Study|Lost to Follow-up|4|||
163471328|NCT02000622|590426197|FG001|Overall Study|Lost to Follow-up|0|||
163471329|NCT02000622|590426196|FG000|Overall Study|Death|159|||
163471330|NCT02000622|590426197|FG001|Overall Study|Death|73|||
163471331|NCT02000622|590426196|FG000|Overall Study|Withdrawn due to site closure|1|||
163471332|NCT02000622|590426197|FG001|Overall Study|Withdrawn due to site closure|0|||
163471333|NCT01462045|590426198|FG000|Overall Study|Family matter|0|||
163471334|NCT01462045|590426199|FG001|Overall Study|Family matter|1|||
163471335|NCT01462045|590426200|FG002|Overall Study|Family matter|0|||
163471336|NCT02045979|590426201|FG000|Overall Study|Informed Consent Withdrawn|2|||
163471337|NCT02045979|590426202|FG001|Overall Study|Informed Consent Withdrawn|0|||
163471338|NCT02045979|590426203|FG002|Overall Study|Informed Consent Withdrawn|1|||
163471339|NCT02045979|590426201|FG000|Overall Study|not specified above|0|||
163471340|NCT02045979|590426202|FG001|Overall Study|not specified above|1|||
163471341|NCT02045979|590426203|FG002|Overall Study|not specified above|0|||
163471342|NCT01938391|590426206|FG000|6 Month Follow up|Withdrawal by Subject|1|||
163471343|NCT01938391|590426206|FG000|12 Month Follow up|Physician Decision|1|||
163471344|NCT01938391|590426206|FG000|12 Month Follow up|Withdrawal by Subject|1|||
163471345|NCT04924114|590426210|FG000|Overall Study|Withdrawal by Subject|0|||
163471346|NCT04924114|590426211|FG001|Overall Study|Withdrawal by Subject|2|||
163471347|NCT04924114|590426212|FG002|Overall Study|Withdrawal by Subject|2|||
163471348|NCT04924114|590426213|FG003|Overall Study|Withdrawal by Subject|0|||
163471349|NCT04924114|590426214|FG004|Overall Study|Withdrawal by Subject|2|||
163471350|NCT03558828|590426218|FG000|Overall Study|Lost to Follow-up|4|||
163471351|NCT03558828|590426219|FG001|Overall Study|Lost to Follow-up|3|||
163471352|NCT03558828|590426220|FG002|Overall Study|Lost to Follow-up|3|||
163471353|NCT03558828|590426221|FG003|Overall Study|Lost to Follow-up|5|||
163471354|NCT03558828|590426222|FG004|Overall Study|Lost to Follow-up|2|||
163471355|NCT03558828|590426223|FG005|Overall Study|Lost to Follow-up|3|||
163471356|NCT03558828|590426218|FG000|Overall Study|dropped before the intervention|1|||
163471357|NCT03558828|590426219|FG001|Overall Study|dropped before the intervention|1|||
163471358|NCT03558828|590426220|FG002|Overall Study|dropped before the intervention|0|||
163471359|NCT03558828|590426221|FG003|Overall Study|dropped before the intervention|0|||
163471360|NCT03558828|590426222|FG004|Overall Study|dropped before the intervention|0|||
163471361|NCT03558828|590426223|FG005|Overall Study|dropped before the intervention|0|||
163471362|NCT00378534|590426224|FG000|Overall Study|Participants did not receive transplant|3|||
163471363|NCT00378534|590426225|FG001|Overall Study|Participants did not receive transplant|0|||
163471364|NCT03671148|590426229|FG000|Overall Study|Adverse Event|3|||
163471365|NCT03671148|590426230|FG001|Overall Study|Adverse Event|2|||
163471366|NCT03671148|590426229|FG000|Overall Study|Withdrawal by Subject|8|||
163471367|NCT03671148|590426230|FG001|Overall Study|Withdrawal by Subject|2|||
163471368|NCT03671148|590426229|FG000|Overall Study|Lost to Follow-up|1|||
163471369|NCT03671148|590426230|FG001|Overall Study|Lost to Follow-up|2|||
163471370|NCT03671148|590426229|FG000|Overall Study|Lack of Efficacy|7|||
163471371|NCT03671148|590426230|FG001|Overall Study|Lack of Efficacy|2|||
163471372|NCT03671148|590426229|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
163471373|NCT03671148|590426230|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
163471374|NCT03671148|590426229|FG000|Overall Study|Other|1|||
163471375|NCT03671148|590426230|FG001|Overall Study|Other|0|||
163471376|NCT03671148|590426229|FG000|Overall Study|Incomplete Randomization Visit|1|||
163471377|NCT03671148|590426230|FG001|Overall Study|Incomplete Randomization Visit|0|||
163471378|NCT00425945|590426231|FG000|Overall Study|Concern about Supplement|2|||
163471379|NCT00425945|590426232|FG001|Overall Study|Concern about Supplement|0|||
163471380|NCT00425945|590426231|FG000|Overall Study|Inconvenience|0|||
163471381|NCT00425945|590426232|FG001|Overall Study|Inconvenience|2|||
163471382|NCT00425945|590426231|FG000|Overall Study|Lost to Follow-up|0|||
163471383|NCT00425945|590426232|FG001|Overall Study|Lost to Follow-up|2|||
163471384|NCT00425945|590426231|FG000|Overall Study|Began hypertension medication|1|||
163471385|NCT00425945|590426232|FG001|Overall Study|Began hypertension medication|0|||
163471386|NCT00425945|590426231|FG000|Overall Study|Began cancer treatments|1|||
163471387|NCT00425945|590426232|FG001|Overall Study|Began cancer treatments|0|||
163471388|NCT00425945|590426231|FG000|Overall Study|Moved from area|0|||
163471389|NCT00425945|590426232|FG001|Overall Study|Moved from area|1|||
163471390|NCT03878160|590426236|FG000|Overall Study|Lost to Follow-up|1|||
163471391|NCT03878160|590426237|FG001|Overall Study|Lost to Follow-up|1|||
163471392|NCT03878160|590426238|FG002|Overall Study|Lost to Follow-up|1|||
163471393|NCT03878160|590426236|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
163471394|NCT03878160|590426237|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
163471395|NCT03878160|590426238|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
163471396|NCT00673816|590426239|FG000|Overall Study|Adverse Event|1|||
163471397|NCT00673816|590426239|FG000|Overall Study|Withdrawal by Subject|1|||
163471398|NCT05618808|590426240|FG000|Overall Study|Withdrawal by Subject|3|||
163471399|NCT05618808|590426241|FG001|Overall Study|Withdrawal by Subject|1|||
163471400|NCT05618808|590426242|FG002|Overall Study|Withdrawal by Subject|3|||
163471401|NCT01804842|590426246|FG000|Overall Study|Adverse Event|1|||
163471402|NCT01804842|590426247|FG001|Overall Study|Adverse Event|1|||
163471403|NCT01804842|590426248|FG002|Overall Study|Adverse Event|0|||
163471404|NCT01804842|590426246|FG000|Overall Study|Lost to Follow-up|1|||
163471405|NCT01804842|590426247|FG001|Overall Study|Lost to Follow-up|0|||
163471406|NCT01804842|590426248|FG002|Overall Study|Lost to Follow-up|0|||
163471407|NCT01804842|590426246|FG000|Overall Study|Non-Compliance|1|||
163471408|NCT01804842|590426247|FG001|Overall Study|Non-Compliance|1|||
163471409|NCT01804842|590426248|FG002|Overall Study|Non-Compliance|0|||
163471410|NCT01804842|590426246|FG000|Overall Study|Personal Reason|0|||
163471411|NCT01804842|590426247|FG001|Overall Study|Personal Reason|0|||
163471412|NCT01804842|590426248|FG002|Overall Study|Personal Reason|1|||
163471413|NCT02365506|590426251|FG000|Overall Study|Investigator's Discretion|0|||
163471414|NCT02365506|590426252|FG001|Overall Study|Investigator's Discretion|0|||
163471415|NCT02365506|590426253|FG002|Overall Study|Investigator's Discretion|1|||
163471416|NCT03774875|590426254|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
163471417|NCT03774875|590426255|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
163471418|NCT03774875|590426254|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
163471419|NCT03774875|590426255|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
163471420|NCT03774875|590426254|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
163471421|NCT03774875|590426255|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
163471422|NCT03774875|590426254|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
163471423|NCT03774875|590426255|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
163471424|NCT03774875|590426254|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
163471425|NCT03774875|590426255|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
163471426|NCT03774875|590426254|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
163471427|NCT03774875|590426255|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
163471428|NCT03774875|590426254|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
163471429|NCT03774875|590426255|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
163471430|NCT03774875|590426254|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
163471431|NCT03774875|590426255|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
163471432|NCT03774875|590426254|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
163471433|NCT03774875|590426255|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
163471434|NCT03774875|590426254|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
163471435|NCT03774875|590426255|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
163471436|NCT03774875|590426254|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
163471437|NCT03774875|590426255|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
163471438|NCT03774875|590426254|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
163471439|NCT03774875|590426255|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
163471440|NCT03774875|590426254|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
163471441|NCT03774875|590426255|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
163471442|NCT02352090|590426256|FG000|Overall Study|general malaise|1|||
163471443|NCT02352090|590426257|FG001|Overall Study|general malaise|0|||
163471444|NCT02352090|590426258|FG002|Overall Study|general malaise|0|||
163471445|NCT02352090|590426256|FG000|Overall Study|non-specified mild side-effects|0|||
163471446|NCT02352090|590426257|FG001|Overall Study|non-specified mild side-effects|0|||
163471447|NCT02352090|590426258|FG002|Overall Study|non-specified mild side-effects|2|||
163471448|NCT06048367|590426261|FG000|Overall Study|Withdrawal by Subject|0|||
163471449|NCT06048367|590426262|FG001|Overall Study|Withdrawal by Subject|1|||
163471450|NCT06048367|590426263|FG002|Overall Study|Withdrawal by Subject|0|||
163471451|NCT06048367|590426264|FG003|Overall Study|Withdrawal by Subject|0|||
163471452|NCT06048367|590426265|FG004|Overall Study|Withdrawal by Subject|0|||
163471453|NCT06048367|590426261|FG000|Overall Study|Withdrawal by Subject|0|||
163471454|NCT06048367|590426262|FG001|Overall Study|Withdrawal by Subject|0|||
163471455|NCT06048367|590426263|FG002|Overall Study|Withdrawal by Subject|1|||
163471456|NCT06048367|590426264|FG003|Overall Study|Withdrawal by Subject|0|||
163471457|NCT06048367|590426265|FG004|Overall Study|Withdrawal by Subject|0|||
163471458|NCT06048367|590426261|FG000|Overall Study|Withdrawal by Subject|0|||
163471459|NCT06048367|590426262|FG001|Overall Study|Withdrawal by Subject|0|||
163471460|NCT06048367|590426263|FG002|Overall Study|Withdrawal by Subject|0|||
163471461|NCT06048367|590426264|FG003|Overall Study|Withdrawal by Subject|1|||
163471462|NCT06048367|590426265|FG004|Overall Study|Withdrawal by Subject|0|||
163471463|NCT06048367|590426261|FG000|Overall Study|Withdrawal by Subject|0|||
163471464|NCT06048367|590426262|FG001|Overall Study|Withdrawal by Subject|0|||
163471465|NCT06048367|590426263|FG002|Overall Study|Withdrawal by Subject|0|||
163471466|NCT06048367|590426264|FG003|Overall Study|Withdrawal by Subject|1|||
163471467|NCT06048367|590426265|FG004|Overall Study|Withdrawal by Subject|0|||
163471468|NCT00413777|590426267|FG000|Fixed-dose Period|Lost to Follow-up|1|||
163471469|NCT00413777|590426268|FG001|Fixed-dose Period|Lost to Follow-up|1|||
163471470|NCT00413777|590426267|FG000|Fixed-dose Period|Adverse Event|2|||
163471471|NCT00413777|590426268|FG001|Fixed-dose Period|Adverse Event|1|||
163471472|NCT00413777|590426267|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
163471473|NCT00413777|590426268|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
163471474|NCT00413777|590426267|FG000|Fixed-dose Period|Withdrew Consent|0|||
163471475|NCT00413777|590426268|FG001|Fixed-dose Period|Withdrew Consent|1|||
163471476|NCT01678313|590426269|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
163471477|NCT01678313|590426270|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
163471478|NCT01678313|590426269|FG000|Completed the 3-month Therapy|Physician Decision|3|||
163471479|NCT01678313|590426270|FG001|Completed the 3-month Therapy|Physician Decision|4|||
163471480|NCT01678313|590426269|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
163471481|NCT01678313|590426270|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
163471482|NCT01678313|590426269|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
163471483|NCT01678313|590426270|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
163471484|NCT05179057|590426271|FG000|Overall Study|Adverse Event|3|||
163471485|NCT05179057|590426272|FG001|Overall Study|Adverse Event|2|||
163471486|NCT05179057|590426271|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
163471487|NCT05179057|590426272|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
163471488|NCT05179057|590426271|FG000|Overall Study|Study terminated|13|||
163471489|NCT05179057|590426272|FG001|Overall Study|Study terminated|7|||
163471490|NCT05179057|590426271|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
163471491|NCT05179057|590426272|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
163471492|NCT05179057|590426271|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
163471493|NCT05179057|590426272|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
163471494|NCT03345342|590426273|FG000|Open-Label Phase|Adverse Event|30|||
163471495|NCT03345342|590426274|FG001|Open-Label Phase|Adverse Event|0|||
163471496|NCT03345342|590426275|FG002|Open-Label Phase|Adverse Event|0|||
163471497|NCT03345342|590426276|FG003|Open-Label Phase|Adverse Event|0|||
163471498|NCT03345342|590426277|FG004|Open-Label Phase|Adverse Event|0|||
163471499|NCT03345342|590426273|FG000|Open-Label Phase|Death|1|||
163471500|NCT03345342|590426274|FG001|Open-Label Phase|Death|0|||
163471501|NCT03345342|590426275|FG002|Open-Label Phase|Death|0|||
163471502|NCT03345342|590426276|FG003|Open-Label Phase|Death|0|||
163471503|NCT03345342|590426277|FG004|Open-Label Phase|Death|0|||
163471504|NCT03345342|590426273|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
163471505|NCT03345342|590426274|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
163471506|NCT03345342|590426275|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
163471507|NCT03345342|590426276|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
163471508|NCT03345342|590426277|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
163471509|NCT03345342|590426273|FG000|Open-Label Phase|Lack of Efficacy|6|||
163471510|NCT03345342|590426274|FG001|Open-Label Phase|Lack of Efficacy|0|||
163471511|NCT03345342|590426275|FG002|Open-Label Phase|Lack of Efficacy|0|||
163471512|NCT03345342|590426276|FG003|Open-Label Phase|Lack of Efficacy|0|||
163471513|NCT03345342|590426277|FG004|Open-Label Phase|Lack of Efficacy|0|||
163471514|NCT03345342|590426273|FG000|Open-Label Phase|Lost to Follow-up|9|||
163471515|NCT03345342|590426274|FG001|Open-Label Phase|Lost to Follow-up|0|||
163471516|NCT03345342|590426275|FG002|Open-Label Phase|Lost to Follow-up|0|||
163471517|NCT03345342|590426276|FG003|Open-Label Phase|Lost to Follow-up|0|||
163471518|NCT03345342|590426277|FG004|Open-Label Phase|Lost to Follow-up|0|||
163471519|NCT03345342|590426273|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
163471520|NCT03345342|590426274|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
163471521|NCT03345342|590426275|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
163471522|NCT03345342|590426276|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
163471523|NCT03345342|590426277|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
163471524|NCT03345342|590426273|FG000|Open-Label Phase|Physician Decision|4|||
163471525|NCT03345342|590426274|FG001|Open-Label Phase|Physician Decision|0|||
163471526|NCT03345342|590426275|FG002|Open-Label Phase|Physician Decision|0|||
163471527|NCT03345342|590426276|FG003|Open-Label Phase|Physician Decision|0|||
163471528|NCT03345342|590426277|FG004|Open-Label Phase|Physician Decision|0|||
163471529|NCT03345342|590426273|FG000|Open-Label Phase|Protocol Violation|8|||
163471530|NCT03345342|590426274|FG001|Open-Label Phase|Protocol Violation|0|||
163471531|NCT03345342|590426275|FG002|Open-Label Phase|Protocol Violation|0|||
163471532|NCT03345342|590426276|FG003|Open-Label Phase|Protocol Violation|0|||
163471533|NCT03345342|590426277|FG004|Open-Label Phase|Protocol Violation|0|||
163471534|NCT03345342|590426273|FG000|Open-Label Phase|Withdrawal by Subject|57|||
163471535|NCT03345342|590426274|FG001|Open-Label Phase|Withdrawal by Subject|0|||
163471536|NCT03345342|590426275|FG002|Open-Label Phase|Withdrawal by Subject|0|||
163471537|NCT03345342|590426276|FG003|Open-Label Phase|Withdrawal by Subject|0|||
163471538|NCT03345342|590426277|FG004|Open-Label Phase|Withdrawal by Subject|0|||
163471539|NCT03345342|590426273|FG000|Open-Label Phase|Other|15|||
163471540|NCT03345342|590426274|FG001|Open-Label Phase|Other|0|||
163471541|NCT03345342|590426275|FG002|Open-Label Phase|Other|0|||
163471542|NCT03345342|590426276|FG003|Open-Label Phase|Other|0|||
163471543|NCT03345342|590426277|FG004|Open-Label Phase|Other|0|||
163471544|NCT03345342|590426273|FG000|Double-Blind Phase|Adverse Event|0|||
163471545|NCT03345342|590426274|FG001|Double-Blind Phase|Adverse Event|1|||
163471546|NCT03345342|590426275|FG002|Double-Blind Phase|Adverse Event|6|||
163471547|NCT03345342|590426276|FG003|Double-Blind Phase|Adverse Event|0|||
163471548|NCT03345342|590426277|FG004|Double-Blind Phase|Adverse Event|0|||
163471549|NCT03345342|590426273|FG000|Double-Blind Phase|Death|0|||
163471550|NCT03345342|590426274|FG001|Double-Blind Phase|Death|2|||
163471551|NCT03345342|590426275|FG002|Double-Blind Phase|Death|1|||
163471552|NCT03345342|590426276|FG003|Double-Blind Phase|Death|0|||
163471553|NCT03345342|590426277|FG004|Double-Blind Phase|Death|0|||
163471554|NCT03345342|590426273|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
163471555|NCT03345342|590426274|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
163471556|NCT03345342|590426275|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
163471557|NCT03345342|590426276|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
163471558|NCT03345342|590426277|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
163471559|NCT03345342|590426273|FG000|Double-Blind Phase|Lost to Follow-up|0|||
163471560|NCT03345342|590426274|FG001|Double-Blind Phase|Lost to Follow-up|1|||
163471561|NCT03345342|590426275|FG002|Double-Blind Phase|Lost to Follow-up|7|||
163471562|NCT03345342|590426276|FG003|Double-Blind Phase|Lost to Follow-up|0|||
163471563|NCT03345342|590426277|FG004|Double-Blind Phase|Lost to Follow-up|0|||
163471564|NCT03345342|590426273|FG000|Double-Blind Phase|Physician Decision|0|||
163471565|NCT03345342|590426274|FG001|Double-Blind Phase|Physician Decision|1|||
163471566|NCT03345342|590426275|FG002|Double-Blind Phase|Physician Decision|4|||
163471567|NCT03345342|590426276|FG003|Double-Blind Phase|Physician Decision|0|||
163471568|NCT03345342|590426277|FG004|Double-Blind Phase|Physician Decision|0|||
163471569|NCT03345342|590426273|FG000|Double-Blind Phase|Protocol Violation|0|||
163471570|NCT03345342|590426274|FG001|Double-Blind Phase|Protocol Violation|0|||
163471571|NCT03345342|590426275|FG002|Double-Blind Phase|Protocol Violation|1|||
163471572|NCT03345342|590426276|FG003|Double-Blind Phase|Protocol Violation|0|||
163471573|NCT03345342|590426277|FG004|Double-Blind Phase|Protocol Violation|0|||
163471574|NCT03345342|590426273|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
163471575|NCT03345342|590426274|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
163471576|NCT03345342|590426275|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
163471577|NCT03345342|590426276|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
163471578|NCT03345342|590426277|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
163471579|NCT03345342|590426273|FG000|Double-Blind Phase|Other|0|||
163471580|NCT03345342|590426274|FG001|Double-Blind Phase|Other|1|||
163471581|NCT03345342|590426275|FG002|Double-Blind Phase|Other|3|||
163471582|NCT03345342|590426276|FG003|Double-Blind Phase|Other|0|||
163471583|NCT03345342|590426277|FG004|Double-Blind Phase|Other|0|||
163471584|NCT03345342|590426273|FG000|Follow-Up Phase|Adverse Event|0|||
163471585|NCT03345342|590426274|FG001|Follow-Up Phase|Adverse Event|0|||
163471586|NCT03345342|590426275|FG002|Follow-Up Phase|Adverse Event|0|||
163471587|NCT03345342|590426276|FG003|Follow-Up Phase|Adverse Event|0|||
163471588|NCT03345342|590426277|FG004|Follow-Up Phase|Adverse Event|4|||
163471589|NCT03345342|590426273|FG000|Follow-Up Phase|Lost to Follow-up|0|||
163471590|NCT03345342|590426274|FG001|Follow-Up Phase|Lost to Follow-up|0|||
163471591|NCT03345342|590426275|FG002|Follow-Up Phase|Lost to Follow-up|0|||
163471592|NCT03345342|590426276|FG003|Follow-Up Phase|Lost to Follow-up|0|||
163471593|NCT03345342|590426277|FG004|Follow-Up Phase|Lost to Follow-up|6|||
163471594|NCT03345342|590426273|FG000|Follow-Up Phase|Physician Decision|0|||
163471595|NCT03345342|590426274|FG001|Follow-Up Phase|Physician Decision|0|||
163471596|NCT03345342|590426275|FG002|Follow-Up Phase|Physician Decision|0|||
163471597|NCT03345342|590426276|FG003|Follow-Up Phase|Physician Decision|0|||
163471598|NCT03345342|590426277|FG004|Follow-Up Phase|Physician Decision|5|||
163471599|NCT03345342|590426273|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
163471600|NCT03345342|590426274|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
163471601|NCT03345342|590426275|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
163471602|NCT03345342|590426276|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
163471603|NCT03345342|590426277|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
163471604|NCT03345342|590426273|FG000|Follow-Up Phase|Other|0|||
163471605|NCT03345342|590426274|FG001|Follow-Up Phase|Other|0|||
163471606|NCT03345342|590426275|FG002|Follow-Up Phase|Other|0|||
163471607|NCT03345342|590426276|FG003|Follow-Up Phase|Other|3|||
163471608|NCT03345342|590426277|FG004|Follow-Up Phase|Other|1|||
163471609|NCT03375203|590426278|FG000|Overall Study|Protocol Violation|0|||
163471610|NCT03375203|590426279|FG001|Overall Study|Protocol Violation|0|||
163471611|NCT03375203|590426280|FG002|Overall Study|Protocol Violation|1|||
163471612|NCT03375203|590426281|FG003|Overall Study|Protocol Violation|0|||
163471613|NCT03375203|590426282|FG004|Overall Study|Protocol Violation|0|||
163471614|NCT03375203|590426278|FG000|Overall Study|Adverse Event|2|||
163471615|NCT03375203|590426279|FG001|Overall Study|Adverse Event|3|||
163471616|NCT03375203|590426280|FG002|Overall Study|Adverse Event|0|||
163471617|NCT03375203|590426281|FG003|Overall Study|Adverse Event|2|||
163471618|NCT03375203|590426282|FG004|Overall Study|Adverse Event|2|||
163471619|NCT03375203|590426278|FG000|Overall Study|Withdrawal by Subject|3|||
163471620|NCT03375203|590426279|FG001|Overall Study|Withdrawal by Subject|0|||
163471621|NCT03375203|590426280|FG002|Overall Study|Withdrawal by Subject|1|||
163471622|NCT03375203|590426281|FG003|Overall Study|Withdrawal by Subject|0|||
163471623|NCT03375203|590426282|FG004|Overall Study|Withdrawal by Subject|2|||
163471624|NCT03375203|590426278|FG000|Overall Study|Non-compliance with study drug|1|||
163471625|NCT03375203|590426279|FG001|Overall Study|Non-compliance with study drug|0|||
163471626|NCT03375203|590426280|FG002|Overall Study|Non-compliance with study drug|0|||
163471627|NCT03375203|590426281|FG003|Overall Study|Non-compliance with study drug|0|||
163471628|NCT03375203|590426282|FG004|Overall Study|Non-compliance with study drug|0|||
163471629|NCT03375203|590426278|FG000|Overall Study|Randomized, not treated.|0|||
163471630|NCT03375203|590426279|FG001|Overall Study|Randomized, not treated.|1|||
163471631|NCT03375203|590426280|FG002|Overall Study|Randomized, not treated.|0|||
163471632|NCT03375203|590426281|FG003|Overall Study|Randomized, not treated.|0|||
163471633|NCT03375203|590426282|FG004|Overall Study|Randomized, not treated.|0|||
163471634|NCT03107793|590426283|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
163471635|NCT03107793|590426284|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
163471636|NCT03107793|590426285|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
163471637|NCT03107793|590426286|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
163471638|NCT03107793|590426287|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
163471639|NCT03107793|590426283|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
163471640|NCT03107793|590426284|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
163471641|NCT03107793|590426285|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
163471642|NCT03107793|590426286|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
163471643|NCT03107793|590426287|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
163471644|NCT03107793|590426283|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
163471645|NCT03107793|590426284|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
163471646|NCT03107793|590426285|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
163471647|NCT03107793|590426286|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
163471648|NCT03107793|590426287|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
163471649|NCT03107793|590426283|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
163471650|NCT03107793|590426284|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163471651|NCT03107793|590426285|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163471652|NCT03107793|590426286|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163471653|NCT03107793|590426287|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163471654|NCT03107793|590426283|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
163471655|NCT03107793|590426284|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
163471656|NCT03107793|590426285|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
163471657|NCT03107793|590426286|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
163471658|NCT03107793|590426287|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
163471659|NCT03107793|590426283|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
163471660|NCT03107793|590426284|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
163471661|NCT03107793|590426285|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
163471662|NCT03107793|590426286|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
163471663|NCT03107793|590426287|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
163471664|NCT03107793|590426283|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
163471665|NCT03107793|590426284|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
163471666|NCT03107793|590426285|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
163471667|NCT03107793|590426286|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
163471668|NCT03107793|590426287|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
163471669|NCT03107793|590426283|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
163471670|NCT03107793|590426284|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
163471671|NCT03107793|590426285|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
163471672|NCT03107793|590426286|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
163471673|NCT03107793|590426287|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
163471674|NCT03107793|590426283|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
163471675|NCT03107793|590426284|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
163471676|NCT03107793|590426285|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
163471677|NCT03107793|590426286|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
163471678|NCT03107793|590426287|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
163471679|NCT03107793|590426283|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
163471680|NCT03107793|590426284|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
163471681|NCT03107793|590426285|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
163471682|NCT03107793|590426286|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
163471683|NCT03107793|590426287|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
163471684|NCT03107793|590426283|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163471685|NCT03107793|590426284|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
163471686|NCT03107793|590426285|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163471687|NCT03107793|590426286|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163471688|NCT03107793|590426287|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163471689|NCT03107793|590426283|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
163471690|NCT03107793|590426284|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
163471691|NCT03107793|590426285|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
163471692|NCT03107793|590426286|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
163471693|NCT03107793|590426287|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
163471694|NCT03107793|590426283|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
163471695|NCT03107793|590426284|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
163471696|NCT03107793|590426285|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
163471697|NCT03107793|590426286|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
163471698|NCT03107793|590426287|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
163471699|NCT03107793|590426283|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
163471700|NCT03107793|590426284|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
163471701|NCT03107793|590426285|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
163471702|NCT03107793|590426286|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
163471703|NCT03107793|590426287|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
163471704|NCT03107793|590426283|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
163471705|NCT03107793|590426284|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
163471706|NCT03107793|590426285|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
163471707|NCT03107793|590426286|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
163471708|NCT03107793|590426287|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
163471709|NCT03107793|590426283|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
163471710|NCT03107793|590426284|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
163471711|NCT03107793|590426285|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
163471712|NCT03107793|590426286|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
163471713|NCT03107793|590426287|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
163471714|NCT03107793|590426283|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
163471715|NCT03107793|590426284|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
163471716|NCT03107793|590426285|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
163471717|NCT03107793|590426286|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
163471718|NCT03107793|590426287|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
163471719|NCT03107793|590426283|FG000|Extension Period (Week 48- Week 104)|Death|0|||
163471720|NCT03107793|590426284|FG001|Extension Period (Week 48- Week 104)|Death|0|||
163471721|NCT03107793|590426285|FG002|Extension Period (Week 48- Week 104)|Death|0|||
163471722|NCT03107793|590426286|FG003|Extension Period (Week 48- Week 104)|Death|0|||
163471723|NCT03107793|590426287|FG004|Extension Period (Week 48- Week 104)|Death|1|||
163471724|NCT03107793|590426283|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
163471725|NCT03107793|590426284|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
163471726|NCT03107793|590426285|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
163471727|NCT03107793|590426286|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
163471728|NCT03107793|590426287|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
163471729|NCT03107793|590426283|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
163471730|NCT03107793|590426284|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
163471731|NCT03107793|590426285|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
163471732|NCT03107793|590426286|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
163471733|NCT03107793|590426287|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
163471734|NCT03107793|590426283|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
163471735|NCT03107793|590426284|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
163471736|NCT03107793|590426285|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
163471737|NCT03107793|590426286|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
163471738|NCT03107793|590426287|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
163471739|NCT03107793|590426283|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
163471740|NCT03107793|590426284|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
163471741|NCT03107793|590426285|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
163471742|NCT03107793|590426286|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
163471743|NCT03107793|590426287|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
163471744|NCT03107793|590426283|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
163471745|NCT03107793|590426284|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
163471746|NCT03107793|590426285|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
163471747|NCT03107793|590426286|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
163471748|NCT03107793|590426287|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
163471749|NCT03107793|590426283|FG000|Extension Period (Week 48- Week 104)|Other|0|||
163471750|NCT03107793|590426284|FG001|Extension Period (Week 48- Week 104)|Other|0|||
163471751|NCT03107793|590426285|FG002|Extension Period (Week 48- Week 104)|Other|0|||
163471752|NCT03107793|590426286|FG003|Extension Period (Week 48- Week 104)|Other|1|||
163471753|NCT03107793|590426287|FG004|Extension Period (Week 48- Week 104)|Other|3|||
163471754|NCT03107793|590426283|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
163471755|NCT03107793|590426284|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
163471756|NCT03107793|590426285|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
163471757|NCT03107793|590426286|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
163471758|NCT03107793|590426287|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
163471759|NCT03277105|590426288|FG000|Overall Study|Death|129|||
163471760|NCT03277105|590426289|FG001|Overall Study|Death|124|||
163471761|NCT03277105|590426288|FG000|Overall Study|Lost to Follow-up|2|||
163471762|NCT03277105|590426289|FG001|Overall Study|Lost to Follow-up|4|||
163471763|NCT03277105|590426288|FG000|Overall Study|Withdrawal by Subject|10|||
163471764|NCT03277105|590426289|FG001|Overall Study|Withdrawal by Subject|10|||
163471765|NCT03277105|590426288|FG000|Overall Study|Other|118|||
163471766|NCT03277105|590426289|FG001|Overall Study|Other|125|||
163471767|NCT05180721|590426293|FG000|Overall Study|Lost to Follow-up|4|||
163471768|NCT02040857|590426297|FG000|Overall Study|Adverse Event|14|||
163471769|NCT02040857|590426297|FG000|Overall Study|Physician Decision|5|||
163471770|NCT02040857|590426297|FG000|Overall Study|Withdrawal by Subject|31|||
163471771|NCT02040857|590426297|FG000|Overall Study|patient non-compliance|3|||
163471772|NCT02040857|590426297|FG000|Overall Study|Lost to Follow-up|2|||
163471773|NCT02040857|590426297|FG000|Overall Study|recurrence|4|||
163471774|NCT02040857|590426297|FG000|Overall Study|ineligible|1|||
163471775|NCT00976963|590426298|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
163471776|NCT00976963|590426299|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
163471777|NCT00976963|590426298|FG000|Overall Study|administrative error|1|||
163471778|NCT00976963|590426299|FG001|Overall Study|administrative error|0|||
163471779|NCT00976963|590426298|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
163471780|NCT00976963|590426299|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
163471781|NCT00608842|590426300|FG000|Overall Study|Participant's Request|0|||
163471782|NCT00608842|590426301|FG001|Overall Study|Participant's Request|1|||
163471783|NCT00608842|590426302|FG002|Overall Study|Participant's Request|2|||
163471784|NCT00608842|590426303|FG003|Overall Study|Participant's Request|1|||
163471785|NCT00608842|590426300|FG000|Overall Study|Lost to Follow-up|1|||
163471786|NCT00608842|590426301|FG001|Overall Study|Lost to Follow-up|0|||
163471787|NCT00608842|590426302|FG002|Overall Study|Lost to Follow-up|0|||
163471788|NCT00608842|590426303|FG003|Overall Study|Lost to Follow-up|0|||
163471789|NCT01024920|590426304|FG000|Overall Study|Progressive disease|47|||
163471790|NCT01024920|590426305|FG001|Overall Study|Progressive disease|25|||
163471791|NCT01024920|590426304|FG000|Overall Study|Adverse Event|8|||
163471792|NCT01024920|590426305|FG001|Overall Study|Adverse Event|4|||
163471793|NCT01024920|590426304|FG000|Overall Study|Lost to Follow-up|0|||
163471794|NCT01024920|590426305|FG001|Overall Study|Lost to Follow-up|1|||
163471795|NCT01024920|590426304|FG000|Overall Study|Patient refusal to continue|4|||
163471796|NCT01024920|590426305|FG001|Overall Study|Patient refusal to continue|0|||
163471797|NCT01024920|590426304|FG000|Overall Study|Other than listed|5|||
163471798|NCT01024920|590426305|FG001|Overall Study|Other than listed|1|||
163471799|NCT01024920|590426304|FG000|Overall Study|Not treated|3|||
163471800|NCT01024920|590426305|FG001|Overall Study|Not treated|0|||
163471801|NCT01024920|590426304|FG000|Overall Study|Protocol Violation|0|||
163471802|NCT01024920|590426305|FG001|Overall Study|Protocol Violation|1|||
163471803|NCT03039790|590426307|FG000|Overall Study|Lost to Follow-up|2|||
163471804|NCT03039790|590426308|FG001|Overall Study|Lost to Follow-up|0|||
163471805|NCT03039790|590426309|FG002|Overall Study|Lost to Follow-up|1|||
163471806|NCT03039790|590426310|FG003|Overall Study|Lost to Follow-up|1|||
163471807|NCT03039790|590426311|FG004|Overall Study|Lost to Follow-up|0|||
163471808|NCT03039790|590426312|FG005|Overall Study|Lost to Follow-up|1|||
163471809|NCT03039790|590426313|FG006|Overall Study|Lost to Follow-up|1|||
163471810|NCT03039790|590426314|FG007|Overall Study|Lost to Follow-up|1|||
163471811|NCT03039790|590426315|FG008|Overall Study|Lost to Follow-up|0|||
163471812|NCT03039790|590426316|FG009|Overall Study|Lost to Follow-up|1|||
163471813|NCT03039790|590426317|FG010|Overall Study|Lost to Follow-up|1|||
163471814|NCT03039790|590426318|FG011|Overall Study|Lost to Follow-up|0|||
163471815|NCT03039790|590426319|FG012|Overall Study|Lost to Follow-up|1|||
163471816|NCT03039790|590426320|FG013|Overall Study|Lost to Follow-up|0|||
163471817|NCT03039790|590426321|FG014|Overall Study|Lost to Follow-up|3|||
163471818|NCT03039790|590426322|FG015|Overall Study|Lost to Follow-up|1|||
163471819|NCT03039790|590426323|FG016|Overall Study|Lost to Follow-up|2|||
163471820|NCT03039790|590426324|FG017|Overall Study|Lost to Follow-up|2|||
163471821|NCT03039790|590426325|FG018|Overall Study|Lost to Follow-up|1|||
163471822|NCT03039790|590426326|FG019|Overall Study|Lost to Follow-up|3|||
163471823|NCT03039790|590426307|FG000|Overall Study|Withdrawal of Consent|1|||
163471824|NCT03039790|590426308|FG001|Overall Study|Withdrawal of Consent|0|||
163471825|NCT03039790|590426309|FG002|Overall Study|Withdrawal of Consent|0|||
163471826|NCT03039790|590426310|FG003|Overall Study|Withdrawal of Consent|1|||
163471827|NCT03039790|590426311|FG004|Overall Study|Withdrawal of Consent|0|||
163471828|NCT03039790|590426312|FG005|Overall Study|Withdrawal of Consent|0|||
163471829|NCT03039790|590426313|FG006|Overall Study|Withdrawal of Consent|0|||
163471830|NCT03039790|590426314|FG007|Overall Study|Withdrawal of Consent|0|||
163471831|NCT03039790|590426315|FG008|Overall Study|Withdrawal of Consent|0|||
163471832|NCT03039790|590426316|FG009|Overall Study|Withdrawal of Consent|1|||
163471833|NCT03039790|590426317|FG010|Overall Study|Withdrawal of Consent|0|||
163471834|NCT03039790|590426318|FG011|Overall Study|Withdrawal of Consent|0|||
163471835|NCT03039790|590426319|FG012|Overall Study|Withdrawal of Consent|2|||
163471836|NCT03039790|590426320|FG013|Overall Study|Withdrawal of Consent|0|||
163471837|NCT03039790|590426321|FG014|Overall Study|Withdrawal of Consent|1|||
163471838|NCT03039790|590426322|FG015|Overall Study|Withdrawal of Consent|5|||
163471839|NCT03039790|590426323|FG016|Overall Study|Withdrawal of Consent|3|||
163471840|NCT03039790|590426324|FG017|Overall Study|Withdrawal of Consent|0|||
163471841|NCT03039790|590426325|FG018|Overall Study|Withdrawal of Consent|2|||
163471842|NCT03039790|590426326|FG019|Overall Study|Withdrawal of Consent|5|||
163471843|NCT03039790|590426307|FG000|Overall Study|Death|0|||
163471844|NCT03039790|590426308|FG001|Overall Study|Death|0|||
163471845|NCT03039790|590426309|FG002|Overall Study|Death|0|||
163471846|NCT03039790|590426310|FG003|Overall Study|Death|0|||
163471847|NCT03039790|590426311|FG004|Overall Study|Death|0|||
163471848|NCT03039790|590426312|FG005|Overall Study|Death|0|||
163471849|NCT03039790|590426313|FG006|Overall Study|Death|0|||
163471850|NCT03039790|590426314|FG007|Overall Study|Death|0|||
163471851|NCT03039790|590426315|FG008|Overall Study|Death|0|||
163471852|NCT03039790|590426316|FG009|Overall Study|Death|0|||
163471853|NCT03039790|590426317|FG010|Overall Study|Death|0|||
163471854|NCT03039790|590426318|FG011|Overall Study|Death|0|||
163471855|NCT03039790|590426319|FG012|Overall Study|Death|0|||
163471856|NCT03039790|590426320|FG013|Overall Study|Death|0|||
163471857|NCT03039790|590426321|FG014|Overall Study|Death|0|||
163471858|NCT03039790|590426322|FG015|Overall Study|Death|1|||
163471859|NCT03039790|590426323|FG016|Overall Study|Death|3|||
163471860|NCT03039790|590426324|FG017|Overall Study|Death|0|||
163471861|NCT03039790|590426325|FG018|Overall Study|Death|2|||
163471862|NCT03039790|590426326|FG019|Overall Study|Death|0|||
163471863|NCT03039790|590426307|FG000|Overall Study|Reason, not Specified|1|||
163471864|NCT03039790|590426308|FG001|Overall Study|Reason, not Specified|0|||
163471865|NCT03039790|590426309|FG002|Overall Study|Reason, not Specified|0|||
163471866|NCT03039790|590426310|FG003|Overall Study|Reason, not Specified|0|||
163471867|NCT03039790|590426311|FG004|Overall Study|Reason, not Specified|0|||
163471868|NCT03039790|590426312|FG005|Overall Study|Reason, not Specified|0|||
163471869|NCT03039790|590426313|FG006|Overall Study|Reason, not Specified|0|||
163471870|NCT03039790|590426314|FG007|Overall Study|Reason, not Specified|0|||
163471871|NCT03039790|590426315|FG008|Overall Study|Reason, not Specified|0|||
163471872|NCT03039790|590426316|FG009|Overall Study|Reason, not Specified|0|||
163471873|NCT03039790|590426317|FG010|Overall Study|Reason, not Specified|0|||
163471874|NCT03039790|590426318|FG011|Overall Study|Reason, not Specified|0|||
163471875|NCT03039790|590426319|FG012|Overall Study|Reason, not Specified|0|||
163471876|NCT03039790|590426320|FG013|Overall Study|Reason, not Specified|0|||
163471877|NCT03039790|590426321|FG014|Overall Study|Reason, not Specified|0|||
163471878|NCT03039790|590426322|FG015|Overall Study|Reason, not Specified|0|||
163471879|NCT03039790|590426323|FG016|Overall Study|Reason, not Specified|2|||
163471880|NCT03039790|590426324|FG017|Overall Study|Reason, not Specified|0|||
163471881|NCT03039790|590426325|FG018|Overall Study|Reason, not Specified|1|||
163471882|NCT03039790|590426326|FG019|Overall Study|Reason, not Specified|0|||
163471883|NCT02736929|590426331|FG000|Main Study|Lost to Follow-up|7|||
163471884|NCT02736929|590426332|FG001|Main Study|Lost to Follow-up|1|||
163471885|NCT02736929|590426333|FG002|Main Study|Lost to Follow-up|0|||
163471886|NCT02736929|590426331|FG000|Main Study|Withdrawal by Subject|1|||
163471887|NCT02736929|590426332|FG001|Main Study|Withdrawal by Subject|1|||
163471888|NCT02736929|590426333|FG002|Main Study|Withdrawal by Subject|0|||
163471889|NCT02736929|590426331|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
163471890|NCT02736929|590426332|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
163471891|NCT02736929|590426333|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
163471892|NCT00285649|590426334|FG000|Overall Study|Lost to Follow-up|6|||
163471893|NCT00285649|590426335|FG001|Overall Study|Lost to Follow-up|4|||
163471894|NCT00285649|590426336|FG002|Overall Study|Lost to Follow-up|4|||
163471895|NCT00285649|590426334|FG000|Overall Study|Withdrawal by Subject|3|||
163471896|NCT00285649|590426335|FG001|Overall Study|Withdrawal by Subject|2|||
163471897|NCT00285649|590426336|FG002|Overall Study|Withdrawal by Subject|2|||
163471898|NCT02972593|590426337|FG000|Overall Study|Lost to Follow-up|19|||
163471899|NCT02972593|590426338|FG001|Overall Study|Lost to Follow-up|15|||
163471900|NCT02972593|590426337|FG000|Overall Study|Protocol Violation|1|||
163471901|NCT02972593|590426338|FG001|Overall Study|Protocol Violation|0|||
163471902|NCT03077711|590426341|FG000|Overall Study|Lost to Follow-up|2|||
163471903|NCT03077711|590426342|FG001|Overall Study|Lost to Follow-up|2|||
163471904|NCT03077711|590426341|FG000|Overall Study|noncompliant taking medication|2|||
163471905|NCT03077711|590426342|FG001|Overall Study|noncompliant taking medication|0|||
163471906|NCT01819194|590426343|FG000|Overall Study|Loss of study articles|2|||
163471907|NCT02963766|590426347|FG000|Double-Blind Period|Adverse Event|1|||
163471908|NCT02963766|590426348|FG001|Double-Blind Period|Adverse Event|0|||
163471909|NCT02963766|590426349|FG002|Double-Blind Period|Adverse Event|1|||
163471910|NCT02963766|590426347|FG000|Double-Blind Period|Physician Decision|1|||
163471911|NCT02963766|590426348|FG001|Double-Blind Period|Physician Decision|0|||
163471912|NCT02963766|590426349|FG002|Double-Blind Period|Physician Decision|0|||
163471913|NCT02963766|590426347|FG000|Double-Blind Period|Withdrawal by Subject|1|||
163471914|NCT02963766|590426348|FG001|Double-Blind Period|Withdrawal by Subject|1|||
163471915|NCT02963766|590426349|FG002|Double-Blind Period|Withdrawal by Subject|0|||
163471916|NCT02963766|590426347|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
163471917|NCT02963766|590426348|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
163471918|NCT02963766|590426349|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
163471919|NCT02963766|590426347|FG000|Double-Blind Period|Protocol Violation|1|||
163471920|NCT02963766|590426348|FG001|Double-Blind Period|Protocol Violation|0|||
163471921|NCT02963766|590426349|FG002|Double-Blind Period|Protocol Violation|0|||
163471922|NCT02963766|590426347|FG000|Double-Blind Period|Lost to Follow-up|0|||
163471923|NCT02963766|590426348|FG001|Double-Blind Period|Lost to Follow-up|1|||
163471924|NCT02963766|590426349|FG002|Double-Blind Period|Lost to Follow-up|0|||
163471925|NCT02963766|590426347|FG000|Open Label Extension (OLE)|Physician Decision|1|||
163471926|NCT02963766|590426348|FG001|Open Label Extension (OLE)|Physician Decision|2|||
163471927|NCT02963766|590426349|FG002|Open Label Extension (OLE)|Physician Decision|2|||
163471928|NCT02963766|590426347|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
163471929|NCT02963766|590426348|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
163471930|NCT02963766|590426349|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
163471931|NCT04964557|590426350|FG000|Overall Study|Withdrawal by Subject|3|||
163471932|NCT04964557|590426351|FG001|Overall Study|Withdrawal by Subject|2|||
163471933|NCT04964557|590426350|FG000|Overall Study|Lost to Follow-up|1|||
163471934|NCT04964557|590426351|FG001|Overall Study|Lost to Follow-up|2|||
163471935|NCT04964557|590426350|FG000|Overall Study|Physician Decision|2|||
163471936|NCT04964557|590426351|FG001|Overall Study|Physician Decision|0|||
163471937|NCT04964557|590426350|FG000|Overall Study|Death|3|||
163471938|NCT04964557|590426351|FG001|Overall Study|Death|0|||
163471939|NCT04964557|590426350|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
163471940|NCT04964557|590426351|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
163471941|NCT00251589|590426353|FG000|Overall Study|Adverse Event|5|||
163471942|NCT00251589|590426354|FG001|Overall Study|Adverse Event|1|||
163471943|NCT00251589|590426355|FG002|Overall Study|Adverse Event|2|||
163471944|NCT00251589|590426356|FG003|Overall Study|Adverse Event|1|||
163471945|NCT00251589|590426353|FG000|Overall Study|Withdrawal by Subject|1|||
163471946|NCT00251589|590426354|FG001|Overall Study|Withdrawal by Subject|1|||
163471947|NCT00251589|590426355|FG002|Overall Study|Withdrawal by Subject|0|||
163471948|NCT00251589|590426356|FG003|Overall Study|Withdrawal by Subject|0|||
163471949|NCT00251589|590426353|FG000|Overall Study|Discontinued due to progressive disease|9|||
163471950|NCT00251589|590426354|FG001|Overall Study|Discontinued due to progressive disease|1|||
163471951|NCT00251589|590426355|FG002|Overall Study|Discontinued due to progressive disease|0|||
163471952|NCT00251589|590426356|FG003|Overall Study|Discontinued due to progressive disease|1|||
163471953|NCT02493868|590426359|FG000|Induction Phase: DE Participants|Adverse Event|22|||
163471954|NCT02493868|590426360|FG001|Induction Phase: DE Participants|Adverse Event|0|||
163471955|NCT02493868|590426359|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
163471956|NCT02493868|590426360|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
163471957|NCT02493868|590426359|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
163471958|NCT02493868|590426360|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
163471959|NCT02493868|590426359|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
163471960|NCT02493868|590426360|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
163471961|NCT02493868|590426359|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
163471962|NCT02493868|590426360|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
163471963|NCT02493868|590426359|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
163471964|NCT02493868|590426360|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
163471965|NCT02493868|590426359|FG000|Induction Phase: DE Participants|Other|8|||
163471966|NCT02493868|590426360|FG001|Induction Phase: DE Participants|Other|0|||
163471967|NCT02493868|590426359|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
163471968|NCT02493868|590426360|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
163471969|NCT02493868|590426359|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
163471970|NCT02493868|590426360|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
163471971|NCT02493868|590426359|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
163471972|NCT02493868|590426360|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
163471973|NCT02493868|590426359|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
163471974|NCT02493868|590426360|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
163471975|NCT02493868|590426359|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
163471976|NCT02493868|590426360|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
163471977|NCT02493868|590426359|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
163471978|NCT02493868|590426360|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
163471979|NCT02493868|590426359|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
163471980|NCT02493868|590426360|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
163471981|NCT02493868|590426359|FG000|Optimization Phase: DE+TE Participants|Other|10|||
163471982|NCT02493868|590426360|FG001|Optimization Phase: DE+TE Participants|Other|2|||
163471983|NCT02493868|590426359|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
163471984|NCT02493868|590426360|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
163471985|NCT02493868|590426359|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
163471986|NCT02493868|590426360|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
163471987|NCT02493868|590426359|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
163471988|NCT02493868|590426360|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
163471989|NCT02493868|590426359|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
163471990|NCT02493868|590426360|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
163471991|NCT02493868|590426359|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
163471992|NCT02493868|590426360|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
163471993|NCT02493868|590426359|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
163471994|NCT02493868|590426360|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
163471995|NCT02493868|590426359|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
163471996|NCT02493868|590426360|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
163471997|NCT02493868|590426359|FG000|Follow-up Phase|Lost to Follow-up|1|||
163471998|NCT02493868|590426360|FG001|Follow-up Phase|Lost to Follow-up|0|||
163471999|NCT02493868|590426359|FG000|Follow-up Phase|Withdrawal by Subject|3|||
163472000|NCT02493868|590426360|FG001|Follow-up Phase|Withdrawal by Subject|0|||
163472001|NCT02493868|590426359|FG000|Follow-up Phase|Investigator Decision|5|||
163472002|NCT02493868|590426360|FG001|Follow-up Phase|Investigator Decision|1|||
163472003|NCT02493868|590426359|FG000|Follow-up Phase|Other|2|||
163472004|NCT02493868|590426360|FG001|Follow-up Phase|Other|1|||
163472005|NCT03039569|590426365|FG000|Overall Study|Lost to Follow-up|5|||
163472006|NCT03039569|590426366|FG001|Overall Study|Lost to Follow-up|4|||
163472007|NCT02973997|590428900|FG000|Overall Study|Withdrawal by Subject|4|||
163472008|NCT02973997|590428901|FG001|Overall Study|Withdrawal by Subject|0|||
163472009|NCT02973997|590428900|FG000|Overall Study|Adverse Event|4|||
163472010|NCT02973997|590428901|FG001|Overall Study|Adverse Event|1|||
163472011|NCT02973997|590428900|FG000|Overall Study|Disease Progression|11|||
163472012|NCT02973997|590428901|FG001|Overall Study|Disease Progression|20|||
163472013|NCT02973997|590428900|FG000|Overall Study|Alternative Therapy|3|||
163472014|NCT02973997|590428901|FG001|Overall Study|Alternative Therapy|0|||
163472015|NCT02973997|590428900|FG000|Overall Study|Other complicating disease|0|||
163472016|NCT02973997|590428901|FG001|Overall Study|Other complicating disease|1|||
163472017|NCT02973997|590428900|FG000|Overall Study|Death|0|||
163472018|NCT02973997|590428901|FG001|Overall Study|Death|1|||
163472019|NCT01431521|590428902|FG000|Overall Study|Withdrawal by Subject|0|||
163472020|NCT01431521|590428903|FG001|Overall Study|Withdrawal by Subject|0|||
163472021|NCT01431521|590428904|FG002|Overall Study|Withdrawal by Subject|1|||
163472022|NCT01431521|590428905|FG003|Overall Study|Withdrawal by Subject|0|||
163472023|NCT03287830|590428913|FG000|Overall Study|Withdrawal by Subject|1|||
163472024|NCT03287830|590428914|FG001|Overall Study|Withdrawal by Subject|1|||
163472025|NCT03287830|590428913|FG000|Overall Study|not meeting inclusion criteria|5|||
163472026|NCT03287830|590428914|FG001|Overall Study|not meeting inclusion criteria|12|||
163472027|NCT03598140|590428917|FG000|Overall Study|enrolled but didn't start|1|||
163472028|NCT03598140|590428918|FG001|Overall Study|enrolled but didn't start|0|||
163472029|NCT02155712|590428922|FG000|Overall Study|Death|12|||
163472030|NCT02155712|590428923|FG001|Overall Study|Death|0|||
163472031|NCT02155712|590428922|FG000|Overall Study|Lost to Follow-up|37|||
163472032|NCT02155712|590428923|FG001|Overall Study|Lost to Follow-up|22|||
163472033|NCT02155712|590428922|FG000|Overall Study|Revision of device|4|||
163472034|NCT02155712|590428923|FG001|Overall Study|Revision of device|3|||
163472035|NCT02155712|590428922|FG000|Overall Study|Withdrawal by Subject|39|||
163472036|NCT02155712|590428923|FG001|Overall Study|Withdrawal by Subject|21|||
163472037|NCT02155712|590428922|FG000|Overall Study|Site termination|77|||
163472038|NCT02155712|590428923|FG001|Overall Study|Site termination|19|||
163472039|NCT02155712|590428922|FG000|Overall Study|Sponsor terminated study early|150|||
163472040|NCT02155712|590428923|FG001|Overall Study|Sponsor terminated study early|0|||
163472041|NCT02155712|590428922|FG000|Overall Study|Missed final 5-year protocol visit|0|||
163472042|NCT02155712|590428923|FG001|Overall Study|Missed final 5-year protocol visit|32|||
163472043|NCT02155712|590428922|FG000|Overall Study|Censored because surgery cancelled|6|||
163472044|NCT02155712|590428923|FG001|Overall Study|Censored because surgery cancelled|10|||
163472045|NCT02155712|590428922|FG000|Overall Study|Censored because study device was not implanted|61|||
163472046|NCT02155712|590428923|FG001|Overall Study|Censored because study device was not implanted|66|||
163472047|NCT02155712|590428922|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
163472048|NCT02155712|590428923|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
163472049|NCT02060903|590428924|FG000|Overall Study|Lost to Follow-up|4|||
163472050|NCT02060903|590428925|FG001|Overall Study|Lost to Follow-up|0|||
163472051|NCT02060903|590428924|FG000|Overall Study|Withdrawal by Subject|0|||
163472052|NCT02060903|590428925|FG001|Overall Study|Withdrawal by Subject|7|||
163472053|NCT02418585|590428926|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
163472054|NCT02418585|590428927|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
163472055|NCT02418585|590428926|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
163472056|NCT02418585|590428927|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
163472057|NCT02418585|590428926|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
163472058|NCT02418585|590428927|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
163472059|NCT02418585|590428926|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
163472060|NCT02418585|590428927|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
163472061|NCT02418585|590428926|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
163472062|NCT02418585|590428927|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
163472063|NCT02418585|590428926|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
163472064|NCT02418585|590428927|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
163472065|NCT02418585|590428926|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
163472066|NCT02418585|590428927|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
163472067|NCT02418585|590428926|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
163472068|NCT02418585|590428927|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
163472069|NCT02418585|590428926|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
163472070|NCT02418585|590428927|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
163472071|NCT02418585|590428926|FG000|Follow-up Phase (24 Weeks)|Other|3|||
163472072|NCT02418585|590428927|FG001|Follow-up Phase (24 Weeks)|Other|2|||
163472073|NCT01688999|590428930|FG000|Overall Study|Withdrawal by Subject|5|||
163472074|NCT01688999|590428931|FG001|Overall Study|Withdrawal by Subject|1|||
163472075|NCT01688999|590428932|FG002|Overall Study|Withdrawal by Subject|1|||
163472076|NCT01688999|590428930|FG000|Overall Study|Adverse Event|2|||
163472077|NCT01688999|590428931|FG001|Overall Study|Adverse Event|0|||
163472078|NCT01688999|590428932|FG002|Overall Study|Adverse Event|2|||
163472079|NCT01688999|590428930|FG000|Overall Study|Ineligible/Not treated|1|||
163472080|NCT01688999|590428931|FG001|Overall Study|Ineligible/Not treated|0|||
163472081|NCT01688999|590428932|FG002|Overall Study|Ineligible/Not treated|0|||
163472082|NCT02768103|590428933|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
163472083|NCT00498368|590428961|FG000|Overall Study|Withdrawal by Subject|3|||
163472084|NCT00498368|590428962|FG001|Overall Study|Withdrawal by Subject|2|||
163472085|NCT01855425|590428970|FG000|Overall Study|Physician Decision|20|||
163472086|NCT02148952|590428977|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
163472087|NCT02148952|590428978|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
163472088|NCT02148952|590428977|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
163472089|NCT02148952|590428978|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
163472090|NCT02148952|590428977|FG000|Follow-Up|Lost to Follow-up|219|||
163472091|NCT02148952|590428978|FG001|Follow-Up|Lost to Follow-up|231|||
163472092|NCT02148952|590428977|FG000|Follow-Up|Withdrawal by Subject|46|||
163472093|NCT02148952|590428978|FG001|Follow-Up|Withdrawal by Subject|48|||
163472094|NCT01600105|590428979|FG000|Total Participants|Withdrawal by Subject|1|||
163472095|NCT01600105|590428980|FG001|Total Participants|Withdrawal by Subject|0|||
163472096|NCT01600105|590428979|FG000|Total Participants|No images in PACS|10|||
163472097|NCT01600105|590428980|FG001|Total Participants|No images in PACS|0|||
163472098|NCT01600105|590428979|FG000|Total Participants|Insufficient image quality|30|||
163472099|NCT01600105|590428980|FG001|Total Participants|Insufficient image quality|10|||
163472100|NCT01600105|590428979|FG000|Sub Study I|Insufficient image quality|0|||
163472101|NCT01600105|590428980|FG001|Sub Study I|Insufficient image quality|10|||
163472102|NCT01600105|590428979|FG000|Sub Study II|Withdrawal by Subject|1|||
163472103|NCT01600105|590428980|FG001|Sub Study II|Withdrawal by Subject|0|||
163472104|NCT01600105|590428979|FG000|Sub Study II|No images in PACS|1|||
163472105|NCT01600105|590428980|FG001|Sub Study II|No images in PACS|0|||
163472106|NCT01600105|590428979|FG000|Sub Study II|Insufficient image quality|3|||
163472107|NCT01600105|590428980|FG001|Sub Study II|Insufficient image quality|0|||
163472108|NCT01600105|590428979|FG000|Sub Study III|Insufficient image quality|5|||
163472109|NCT01600105|590428980|FG001|Sub Study III|Insufficient image quality|0|||
163472110|NCT01600105|590428979|FG000|Sub Study V|Poor Image Quality|2|||
163472111|NCT01600105|590428980|FG001|Sub Study V|Poor Image Quality|0|||
163472112|NCT01263444|590428981|FG000|Overall Study|Adverse Event|8|||
163472113|NCT01263444|590428981|FG000|Overall Study|Withdrawal by Subject|1|||
163472114|NCT01263444|590428981|FG000|Overall Study|Protocol Violation|1|||
163472115|NCT01764022|590428982|FG000|Overall Study|Death|3|||
163472116|NCT01764022|590428983|FG001|Overall Study|Death|5|||
163472117|NCT01764022|590428982|FG000|Overall Study|Withdrawal by Subject|2|||
163472118|NCT01764022|590428983|FG001|Overall Study|Withdrawal by Subject|6|||
163472119|NCT01764022|590428982|FG000|Overall Study|Lack of Efficacy|0|||
163472120|NCT01764022|590428983|FG001|Overall Study|Lack of Efficacy|1|||
163472121|NCT01764022|590428982|FG000|Overall Study|Physician Decision|0|||
163472122|NCT01764022|590428983|FG001|Overall Study|Physician Decision|2|||
163472123|NCT01764022|590428982|FG000|Overall Study|Lost to Follow-up|2|||
163472124|NCT01764022|590428983|FG001|Overall Study|Lost to Follow-up|0|||
163472125|NCT01764022|590428982|FG000|Overall Study|Protocol Violation|1|||
163472126|NCT01764022|590428983|FG001|Overall Study|Protocol Violation|0|||
163472127|NCT01899768|590428985|FG000|Part A|Adverse Event|2|||
163472128|NCT01899768|590428985|FG000|Part A|Withdrawal by Subject|1|||
163472129|NCT01899768|590428985|FG000|Part B|Adverse Event|1|||
163472130|NCT01899768|590428985|FG000|Part B|Withdrawal by Subject|1|||
163472131|NCT04043416|590428986|FG000|Washout|Change in health condition|0|||
163472132|NCT04043416|590428987|FG001|Washout|Change in health condition|1|||
163472133|NCT00414973|590428988|FG000|Overall Study|Withdrawal by Subject|14|||
163472134|NCT00414973|590428989|FG001|Overall Study|Withdrawal by Subject|4|||
163472135|NCT00414973|590428990|FG002|Overall Study|Withdrawal by Subject|1|||
163472136|NCT00414973|590428991|FG003|Overall Study|Withdrawal by Subject|0|||
163472137|NCT00414973|590428988|FG000|Overall Study|Adverse Event|10|||
163472138|NCT00414973|590428989|FG001|Overall Study|Adverse Event|0|||
163472139|NCT00414973|590428990|FG002|Overall Study|Adverse Event|1|||
163472140|NCT00414973|590428991|FG003|Overall Study|Adverse Event|0|||
163472141|NCT00414973|590428988|FG000|Overall Study|Protocol Violation|3|||
163472142|NCT00414973|590428989|FG001|Overall Study|Protocol Violation|4|||
163472143|NCT00414973|590428990|FG002|Overall Study|Protocol Violation|0|||
163472144|NCT00414973|590428991|FG003|Overall Study|Protocol Violation|0|||
163472145|NCT00414973|590428988|FG000|Overall Study|Lost to Follow-up|0|||
163472146|NCT00414973|590428989|FG001|Overall Study|Lost to Follow-up|2|||
163472147|NCT00414973|590428990|FG002|Overall Study|Lost to Follow-up|0|||
163472148|NCT00414973|590428991|FG003|Overall Study|Lost to Follow-up|0|||
163472149|NCT00414973|590428988|FG000|Overall Study|Sponsor Decision|1|||
163472150|NCT00414973|590428989|FG001|Overall Study|Sponsor Decision|0|||
163472151|NCT00414973|590428990|FG002|Overall Study|Sponsor Decision|0|||
163472152|NCT00414973|590428991|FG003|Overall Study|Sponsor Decision|0|||
163472153|NCT00414973|590428988|FG000|Overall Study|Death|0|||
163472154|NCT00414973|590428989|FG001|Overall Study|Death|0|||
163472155|NCT00414973|590428990|FG002|Overall Study|Death|1|||
163472156|NCT00414973|590428991|FG003|Overall Study|Death|0|||
163472157|NCT01466062|590428992|FG000|Overall Study|Adverse Event|1|||
163472158|NCT01466062|590428992|FG000|Overall Study|Withdrawal by Subject|1|||
163472159|NCT02865928|590428993|FG000|Overall Study|Withdrawal by Subject|1|||
163472160|NCT02865928|590428994|FG001|Overall Study|Withdrawal by Subject|0|||
163472161|NCT02865928|590428993|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
163472162|NCT02865928|590428994|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
163472163|NCT02865928|590428993|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
163472164|NCT02865928|590428994|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
163472165|NCT00118040|590428995|FG000|Overall Study|Adverse Event|0|||
163472166|NCT00118040|590428996|FG001|Overall Study|Adverse Event|1|||
163472167|NCT00118040|590428997|FG002|Overall Study|Adverse Event|0|||
163472168|NCT00118040|590428995|FG000|Overall Study|Withdrawal by Subject|0|||
163472169|NCT00118040|590428996|FG001|Overall Study|Withdrawal by Subject|0|||
163472170|NCT00118040|590428997|FG002|Overall Study|Withdrawal by Subject|2|||
163472171|NCT00118040|590428995|FG000|Overall Study|Medical Contraindication|0|||
163472172|NCT00118040|590428996|FG001|Overall Study|Medical Contraindication|0|||
163472173|NCT00118040|590428997|FG002|Overall Study|Medical Contraindication|1|||
163472174|NCT00118040|590428995|FG000|Overall Study|Non-Compliant Participant|1|||
163472175|NCT00118040|590428996|FG001|Overall Study|Non-Compliant Participant|1|||
163472176|NCT00118040|590428997|FG002|Overall Study|Non-Compliant Participant|2|||
163472177|NCT00118040|590428995|FG000|Overall Study|Other|0|||
163472178|NCT00118040|590428996|FG001|Overall Study|Other|0|||
163472179|NCT00118040|590428997|FG002|Overall Study|Other|1|||
163472180|NCT01925014|590428998|FG000|Overall Study|Inappropriate enrollment|4|||
163472181|NCT01925014|590428999|FG001|Overall Study|Inappropriate enrollment|6|||
163472182|NCT01925014|590428998|FG000|Overall Study|Withdrawal by Subject|5|||
163472183|NCT01925014|590428999|FG001|Overall Study|Withdrawal by Subject|13|||
163472184|NCT01196091|590429003|FG000|Overall Study|Adverse Event|22|||
163472185|NCT01196091|590429004|FG001|Overall Study|Adverse Event|27|||
163472186|NCT01196091|590429005|FG002|Overall Study|Adverse Event|26|||
163472187|NCT01196091|590429003|FG000|Overall Study|Death|3|||
163472188|NCT01196091|590429004|FG001|Overall Study|Death|2|||
163472189|NCT01196091|590429005|FG002|Overall Study|Death|2|||
163472190|NCT01196091|590429003|FG000|Overall Study|Entry Criteria Not Met|11|||
163472191|NCT01196091|590429004|FG001|Overall Study|Entry Criteria Not Met|11|||
163472192|NCT01196091|590429005|FG002|Overall Study|Entry Criteria Not Met|10|||
163472193|NCT01196091|590429003|FG000|Overall Study|Lack of Efficacy|15|||
163472194|NCT01196091|590429004|FG001|Overall Study|Lack of Efficacy|12|||
163472195|NCT01196091|590429005|FG002|Overall Study|Lack of Efficacy|17|||
163472196|NCT01196091|590429003|FG000|Overall Study|Lost to Follow-up|5|||
163472197|NCT01196091|590429004|FG001|Overall Study|Lost to Follow-up|5|||
163472198|NCT01196091|590429005|FG002|Overall Study|Lost to Follow-up|6|||
163472199|NCT01196091|590429003|FG000|Overall Study|Parent/Caregiver Decision|0|||
163472200|NCT01196091|590429004|FG001|Overall Study|Parent/Caregiver Decision|0|||
163472201|NCT01196091|590429005|FG002|Overall Study|Parent/Caregiver Decision|1|||
163472202|NCT01196091|590429003|FG000|Overall Study|Withdrawal by Subject|16|||
163472203|NCT01196091|590429004|FG001|Overall Study|Withdrawal by Subject|19|||
163472204|NCT01196091|590429005|FG002|Overall Study|Withdrawal by Subject|22|||
163472205|NCT01196091|590429003|FG000|Overall Study|Physician Decision|3|||
163472206|NCT01196091|590429004|FG001|Overall Study|Physician Decision|3|||
163472207|NCT01196091|590429005|FG002|Overall Study|Physician Decision|4|||
163472208|NCT01196091|590429003|FG000|Overall Study|Protocol Violation|1|||
163472209|NCT01196091|590429004|FG001|Overall Study|Protocol Violation|3|||
163472210|NCT01196091|590429005|FG002|Overall Study|Protocol Violation|3|||
163472211|NCT01196091|590429003|FG000|Overall Study|Sponsor Decision|6|||
163472212|NCT01196091|590429004|FG001|Overall Study|Sponsor Decision|5|||
163472213|NCT01196091|590429005|FG002|Overall Study|Sponsor Decision|4|||
163472214|NCT01196091|590429003|FG000|Overall Study|Excluded Site|5|||
163472215|NCT01196091|590429004|FG001|Overall Study|Excluded Site|11|||
163472216|NCT01196091|590429005|FG002|Overall Study|Excluded Site|8|||
163472217|NCT01196091|590429003|FG000|Overall Study|Randomized, No Study Drug Received|1|||
163472218|NCT01196091|590429004|FG001|Overall Study|Randomized, No Study Drug Received|0|||
163472219|NCT01196091|590429005|FG002|Overall Study|Randomized, No Study Drug Received|1|||
163472220|NCT03733249|590429006|FG000|Overall Study|Death|7|||
163472221|NCT03733249|590429006|FG000|Overall Study|Disease relapse|16|||
163472222|NCT03733249|590429006|FG000|Overall Study|Lost to Follow-up|4|||
163472223|NCT03733249|590429006|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
163472224|NCT03733249|590429006|FG000|Overall Study|Withdrawal by Subject|1|||
163472225|NCT04476108|590429007|FG000|Overall Study|Adverse Event|4|||
163472226|NCT04476108|590429008|FG001|Overall Study|Adverse Event|1|||
163472227|NCT04476108|590429007|FG000|Overall Study|Lost to Follow-up|1|||
163472228|NCT04476108|590429008|FG001|Overall Study|Lost to Follow-up|0|||
163472229|NCT04476108|590429007|FG000|Overall Study|Inadvertent Enrollment|1|||
163472230|NCT04476108|590429008|FG001|Overall Study|Inadvertent Enrollment|0|||
163472231|NCT04476108|590429007|FG000|Overall Study|Protocol Violation|1|||
163472232|NCT04476108|590429008|FG001|Overall Study|Protocol Violation|1|||
163472233|NCT04476108|590429007|FG000|Overall Study|Withdrawal by Subject|1|||
163472234|NCT04476108|590429008|FG001|Overall Study|Withdrawal by Subject|1|||
163472235|NCT00471276|590429009|FG000|Overall Study|Death|2|||
163472236|NCT00471276|590429009|FG000|Overall Study|Adverse Event|16|||
163472237|NCT00471276|590429009|FG000|Overall Study|Protocol Violation|1|||
163472238|NCT00471276|590429009|FG000|Overall Study|Objective progression or relapse|54|||
163472239|NCT00471276|590429009|FG000|Overall Study|Global deterioration of health status|1|||
163472240|NCT00471276|590429009|FG000|Overall Study|Other|3|||
163472241|NCT00471276|590429009|FG000|Overall Study|Refused treatment|6|||
163472242|NCT01487863|590429013|FG000|Overall Study|Death|19|||
163472243|NCT01487863|590429014|FG001|Overall Study|Death|19|||
163472244|NCT02324049|590429018|FG000|Part C|Study terminated|11|||
163472245|NCT02159365|590429019|FG000|Overall Study|Disease Progression|23|||
163472246|NCT02159365|590429019|FG000|Overall Study|Other reasons|11|||
163472247|NCT02159365|590429019|FG000|Overall Study|Administrative reason by Sponsor|9|||
163472248|NCT02159365|590429019|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
163472249|NCT02159365|590429019|FG000|Overall Study|Study drug toxicity|7|||
163472250|NCT02159365|590429019|FG000|Overall Study|Maximum clinical benefit|3|||
163472251|NCT02159365|590429019|FG000|Overall Study|Subject request to discontinue treatment|3|||
163472252|NCT02159365|590429019|FG000|Overall Study|Subject withdrew consent|3|||
163472253|NCT02159365|590429019|FG000|Overall Study|Death|1|||
163472254|NCT02159365|590429019|FG000|Overall Study|Lost to Follow-up|1|||
163472255|NCT01437267|590429023|FG000|Overall Study|Withdrawal by Subject|0|||
163472256|NCT01437267|590429024|FG001|Overall Study|Withdrawal by Subject|0|||
163472257|NCT01437267|590429025|FG002|Overall Study|Withdrawal by Subject|0|||
163472258|NCT01437267|590429026|FG003|Overall Study|Withdrawal by Subject|1|||
163472259|NCT01437267|590429027|FG004|Overall Study|Withdrawal by Subject|0|||
163472260|NCT01437267|590429028|FG005|Overall Study|Withdrawal by Subject|0|||
163472261|NCT01437267|590429023|FG000|Overall Study|Protocol Violation|0|||
163472262|NCT01437267|590429024|FG001|Overall Study|Protocol Violation|1|||
163472263|NCT01437267|590429025|FG002|Overall Study|Protocol Violation|0|||
163472264|NCT01437267|590429026|FG003|Overall Study|Protocol Violation|0|||
163472265|NCT01437267|590429027|FG004|Overall Study|Protocol Violation|0|||
163472266|NCT01437267|590429028|FG005|Overall Study|Protocol Violation|0|||
163472267|NCT01810380|590429031|FG000|Overall Study|Randomised not treated|2|||
163472268|NCT01810380|590429032|FG001|Overall Study|Randomised not treated|1|||
163472269|NCT01810380|590429033|FG002|Overall Study|Randomised not treated|1|||
163472270|NCT01810380|590429031|FG000|Overall Study|Adverse Event|11|||
163472271|NCT01810380|590429032|FG001|Overall Study|Adverse Event|14|||
163472272|NCT01810380|590429033|FG002|Overall Study|Adverse Event|4|||
163472273|NCT01810380|590429031|FG000|Overall Study|Lack of Efficacy|24|||
163472274|NCT01810380|590429032|FG001|Overall Study|Lack of Efficacy|10|||
163472275|NCT01810380|590429033|FG002|Overall Study|Lack of Efficacy|11|||
163472276|NCT01810380|590429031|FG000|Overall Study|Protocol Violation|1|||
163472277|NCT01810380|590429032|FG001|Overall Study|Protocol Violation|0|||
163472278|NCT01810380|590429033|FG002|Overall Study|Protocol Violation|1|||
163472279|NCT01810380|590429031|FG000|Overall Study|Withdrawal by Subject|6|||
163472280|NCT01810380|590429032|FG001|Overall Study|Withdrawal by Subject|0|||
163472281|NCT01810380|590429033|FG002|Overall Study|Withdrawal by Subject|6|||
163472282|NCT01810380|590429031|FG000|Overall Study|Administrative or other reasons|11|||
163472283|NCT01810380|590429032|FG001|Overall Study|Administrative or other reasons|13|||
163472284|NCT01810380|590429033|FG002|Overall Study|Administrative or other reasons|9|||
163472285|NCT00033371|590429034|FG000|Overall Study|Adverse Event|1|||
163472286|NCT00033371|590429035|FG001|Overall Study|Adverse Event|5|||
163472287|NCT00033371|590429034|FG000|Overall Study|Lost to Follow-up|2|||
163472288|NCT00033371|590429035|FG001|Overall Study|Lost to Follow-up|1|||
163472289|NCT00033371|590429034|FG000|Overall Study|Withdrawal by Subject|3|||
163472290|NCT00033371|590429035|FG001|Overall Study|Withdrawal by Subject|3|||
163472291|NCT00033371|590429034|FG000|Overall Study|Disease Progression|0|||
163472292|NCT00033371|590429035|FG001|Overall Study|Disease Progression|1|||
163472293|NCT02699125|590429036|FG000|Placebo|Lost to Follow-up|2|||
163472294|NCT02699125|590429037|FG001|Placebo|Lost to Follow-up|0|||
163472295|NCT02699125|590429036|FG000|Placebo|Protocol Violation|1|||
163472296|NCT02699125|590429037|FG001|Placebo|Protocol Violation|0|||
163472297|NCT02699125|590429036|FG000|Placebo|Withdrawal by Subject|0|||
163472298|NCT02699125|590429037|FG001|Placebo|Withdrawal by Subject|4|||
163472299|NCT02699125|590429036|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
163472300|NCT02699125|590429037|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
163472301|NCT01390038|590429040|FG000|Overall Study|Death|1|||
163472302|NCT01390038|590429040|FG000|Overall Study|Lost to Follow-up|1|||
163472303|NCT01390038|590429040|FG000|Overall Study|Withdrawal by Subject|4|||
163472304|NCT01390038|590429040|FG000|Overall Study|Simpliciti System Removal|2|||
163472305|NCT03799627|590429041|FG000|Overall Study|Adverse Event|1|||
163472306|NCT03799627|590429042|FG001|Overall Study|Adverse Event|2|||
163472307|NCT03799627|590429043|FG002|Overall Study|Adverse Event|0|||
163472308|NCT03799627|590429044|FG003|Overall Study|Adverse Event|0|||
163472309|NCT03799627|590429045|FG004|Overall Study|Adverse Event|2|||
163472310|NCT03799627|590429046|FG005|Overall Study|Adverse Event|5|||
163472311|NCT03799627|590429047|FG006|Overall Study|Adverse Event|0|||
163472312|NCT03799627|590429048|FG007|Overall Study|Adverse Event|2|||
163472313|NCT03799627|590429049|FG008|Overall Study|Adverse Event|0|||
163472314|NCT03799627|590429041|FG000|Overall Study|Physician Decision|2|||
163472315|NCT03799627|590429042|FG001|Overall Study|Physician Decision|2|||
163472316|NCT03799627|590429043|FG002|Overall Study|Physician Decision|0|||
163472317|NCT03799627|590429044|FG003|Overall Study|Physician Decision|0|||
163472318|NCT03799627|590429045|FG004|Overall Study|Physician Decision|2|||
163472319|NCT03799627|590429046|FG005|Overall Study|Physician Decision|2|||
163472320|NCT03799627|590429047|FG006|Overall Study|Physician Decision|0|||
163472321|NCT03799627|590429048|FG007|Overall Study|Physician Decision|0|||
163472322|NCT03799627|590429049|FG008|Overall Study|Physician Decision|0|||
163472323|NCT03799627|590429041|FG000|Overall Study|Withdrawal by Subject|1|||
163472324|NCT03799627|590429042|FG001|Overall Study|Withdrawal by Subject|1|||
163472325|NCT03799627|590429043|FG002|Overall Study|Withdrawal by Subject|0|||
163472326|NCT03799627|590429044|FG003|Overall Study|Withdrawal by Subject|2|||
163472327|NCT03799627|590429045|FG004|Overall Study|Withdrawal by Subject|0|||
163472328|NCT03799627|590429046|FG005|Overall Study|Withdrawal by Subject|3|||
163472329|NCT03799627|590429047|FG006|Overall Study|Withdrawal by Subject|0|||
163472330|NCT03799627|590429048|FG007|Overall Study|Withdrawal by Subject|0|||
163472331|NCT03799627|590429049|FG008|Overall Study|Withdrawal by Subject|0|||
163472332|NCT03799627|590429041|FG000|Overall Study|Lack of Efficacy|0|||
163472333|NCT03799627|590429042|FG001|Overall Study|Lack of Efficacy|0|||
163472334|NCT03799627|590429043|FG002|Overall Study|Lack of Efficacy|0|||
163472335|NCT03799627|590429044|FG003|Overall Study|Lack of Efficacy|1|||
163472336|NCT03799627|590429045|FG004|Overall Study|Lack of Efficacy|0|||
163472337|NCT03799627|590429046|FG005|Overall Study|Lack of Efficacy|0|||
163472338|NCT03799627|590429047|FG006|Overall Study|Lack of Efficacy|0|||
163472339|NCT03799627|590429048|FG007|Overall Study|Lack of Efficacy|0|||
163472340|NCT03799627|590429049|FG008|Overall Study|Lack of Efficacy|0|||
163472341|NCT03799627|590429041|FG000|Overall Study|Lost to Follow-up|0|||
163472342|NCT03799627|590429042|FG001|Overall Study|Lost to Follow-up|0|||
163472343|NCT03799627|590429043|FG002|Overall Study|Lost to Follow-up|0|||
163472344|NCT03799627|590429044|FG003|Overall Study|Lost to Follow-up|0|||
163472345|NCT03799627|590429045|FG004|Overall Study|Lost to Follow-up|0|||
163472346|NCT03799627|590429046|FG005|Overall Study|Lost to Follow-up|0|||
163472347|NCT03799627|590429047|FG006|Overall Study|Lost to Follow-up|1|||
163472348|NCT03799627|590429048|FG007|Overall Study|Lost to Follow-up|0|||
163472349|NCT03799627|590429049|FG008|Overall Study|Lost to Follow-up|1|||
163472350|NCT03799627|590429041|FG000|Overall Study|Death|0|||
163472351|NCT03799627|590429042|FG001|Overall Study|Death|0|||
163472352|NCT03799627|590429043|FG002|Overall Study|Death|0|||
163472353|NCT03799627|590429044|FG003|Overall Study|Death|1|||
163472354|NCT03799627|590429045|FG004|Overall Study|Death|0|||
163472355|NCT03799627|590429046|FG005|Overall Study|Death|0|||
163472356|NCT03799627|590429047|FG006|Overall Study|Death|0|||
163472357|NCT03799627|590429048|FG007|Overall Study|Death|0|||
163472358|NCT03799627|590429049|FG008|Overall Study|Death|0|||
163472359|NCT03799627|590429041|FG000|Overall Study|Study Drug Put on Hold|1|||
163472360|NCT03799627|590429042|FG001|Overall Study|Study Drug Put on Hold|0|||
163472361|NCT03799627|590429043|FG002|Overall Study|Study Drug Put on Hold|0|||
163472362|NCT03799627|590429044|FG003|Overall Study|Study Drug Put on Hold|0|||
163472363|NCT03799627|590429045|FG004|Overall Study|Study Drug Put on Hold|0|||
163472364|NCT03799627|590429046|FG005|Overall Study|Study Drug Put on Hold|0|||
163472365|NCT03799627|590429047|FG006|Overall Study|Study Drug Put on Hold|0|||
163472366|NCT03799627|590429048|FG007|Overall Study|Study Drug Put on Hold|0|||
163472367|NCT03799627|590429049|FG008|Overall Study|Study Drug Put on Hold|0|||
163472368|NCT03799627|590429041|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
163472369|NCT03799627|590429042|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
163472370|NCT03799627|590429043|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
163472371|NCT03799627|590429044|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
163472372|NCT03799627|590429045|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
163472373|NCT03799627|590429046|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
163472374|NCT03799627|590429047|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
163472375|NCT03799627|590429048|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
163472376|NCT03799627|590429049|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
163472377|NCT03799627|590429041|FG000|Overall Study|Kidney Transplantation|1|||
163472378|NCT03799627|590429042|FG001|Overall Study|Kidney Transplantation|0|||
163472379|NCT03799627|590429043|FG002|Overall Study|Kidney Transplantation|0|||
163472380|NCT03799627|590429044|FG003|Overall Study|Kidney Transplantation|1|||
163472381|NCT03799627|590429045|FG004|Overall Study|Kidney Transplantation|1|||
163472382|NCT03799627|590429046|FG005|Overall Study|Kidney Transplantation|0|||
163472383|NCT03799627|590429047|FG006|Overall Study|Kidney Transplantation|0|||
163472384|NCT03799627|590429048|FG007|Overall Study|Kidney Transplantation|0|||
163472385|NCT03799627|590429049|FG008|Overall Study|Kidney Transplantation|0|||
163472386|NCT03799627|590429041|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
163472387|NCT03799627|590429042|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
163472388|NCT03799627|590429043|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
163472389|NCT03799627|590429044|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
163472390|NCT03799627|590429045|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
163472391|NCT03799627|590429046|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
163472392|NCT03799627|590429047|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
163472393|NCT03799627|590429048|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
163472394|NCT03799627|590429049|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
163472395|NCT03799627|590429041|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
163472396|NCT03799627|590429042|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
163472397|NCT03799627|590429043|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
163472398|NCT03799627|590429044|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
163472399|NCT03799627|590429045|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
163472400|NCT03799627|590429046|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
163472401|NCT03799627|590429047|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
163472402|NCT03799627|590429048|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
163472403|NCT03799627|590429049|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
163472404|NCT03799627|590429041|FG000|Overall Study|Met Exclusion Criteria|0|||
163472405|NCT03799627|590429042|FG001|Overall Study|Met Exclusion Criteria|0|||
163472406|NCT03799627|590429043|FG002|Overall Study|Met Exclusion Criteria|0|||
163472407|NCT03799627|590429044|FG003|Overall Study|Met Exclusion Criteria|1|||
163472408|NCT03799627|590429045|FG004|Overall Study|Met Exclusion Criteria|0|||
163472409|NCT03799627|590429046|FG005|Overall Study|Met Exclusion Criteria|0|||
163472410|NCT03799627|590429047|FG006|Overall Study|Met Exclusion Criteria|0|||
163472411|NCT03799627|590429048|FG007|Overall Study|Met Exclusion Criteria|0|||
163472412|NCT03799627|590429049|FG008|Overall Study|Met Exclusion Criteria|0|||
163472413|NCT03799627|590429041|FG000|Overall Study|Investigational Product Noncompliance|0|||
163472414|NCT03799627|590429042|FG001|Overall Study|Investigational Product Noncompliance|0|||
163472415|NCT03799627|590429043|FG002|Overall Study|Investigational Product Noncompliance|0|||
163472416|NCT03799627|590429044|FG003|Overall Study|Investigational Product Noncompliance|1|||
163472417|NCT03799627|590429045|FG004|Overall Study|Investigational Product Noncompliance|0|||
163472418|NCT03799627|590429046|FG005|Overall Study|Investigational Product Noncompliance|0|||
163472419|NCT03799627|590429047|FG006|Overall Study|Investigational Product Noncompliance|0|||
163472420|NCT03799627|590429048|FG007|Overall Study|Investigational Product Noncompliance|0|||
163472421|NCT03799627|590429049|FG008|Overall Study|Investigational Product Noncompliance|0|||
163472422|NCT03799627|590429041|FG000|Overall Study|Participant Relocation|0|||
163472423|NCT03799627|590429042|FG001|Overall Study|Participant Relocation|0|||
163472424|NCT03799627|590429043|FG002|Overall Study|Participant Relocation|0|||
163472425|NCT03799627|590429044|FG003|Overall Study|Participant Relocation|1|||
163472426|NCT03799627|590429045|FG004|Overall Study|Participant Relocation|0|||
163472427|NCT03799627|590429046|FG005|Overall Study|Participant Relocation|1|||
163472428|NCT03799627|590429047|FG006|Overall Study|Participant Relocation|0|||
163472429|NCT03799627|590429048|FG007|Overall Study|Participant Relocation|0|||
163472430|NCT03799627|590429049|FG008|Overall Study|Participant Relocation|0|||
163472431|NCT03799627|590429041|FG000|Overall Study|Eurofin Issue|0|||
163472432|NCT03799627|590429042|FG001|Overall Study|Eurofin Issue|0|||
163472433|NCT03799627|590429043|FG002|Overall Study|Eurofin Issue|0|||
163472434|NCT03799627|590429044|FG003|Overall Study|Eurofin Issue|0|||
163472435|NCT03799627|590429045|FG004|Overall Study|Eurofin Issue|1|||
163472436|NCT03799627|590429046|FG005|Overall Study|Eurofin Issue|0|||
163472437|NCT03799627|590429047|FG006|Overall Study|Eurofin Issue|0|||
163472438|NCT03799627|590429048|FG007|Overall Study|Eurofin Issue|0|||
163472439|NCT03799627|590429049|FG008|Overall Study|Eurofin Issue|0|||
163472440|NCT03799627|590429041|FG000|Overall Study|Noncompliance with Site Instructions|0|||
163472441|NCT03799627|590429042|FG001|Overall Study|Noncompliance with Site Instructions|0|||
163472442|NCT03799627|590429043|FG002|Overall Study|Noncompliance with Site Instructions|0|||
163472443|NCT03799627|590429044|FG003|Overall Study|Noncompliance with Site Instructions|0|||
163472444|NCT03799627|590429045|FG004|Overall Study|Noncompliance with Site Instructions|1|||
163472445|NCT03799627|590429046|FG005|Overall Study|Noncompliance with Site Instructions|0|||
163472446|NCT03799627|590429047|FG006|Overall Study|Noncompliance with Site Instructions|0|||
163472447|NCT03799627|590429048|FG007|Overall Study|Noncompliance with Site Instructions|0|||
163472448|NCT03799627|590429049|FG008|Overall Study|Noncompliance with Site Instructions|0|||
163472449|NCT03799627|590429041|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
163472450|NCT03799627|590429042|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
163472451|NCT03799627|590429043|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
163472452|NCT03799627|590429044|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
163472453|NCT03799627|590429045|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
163472454|NCT03799627|590429046|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
163472455|NCT03799627|590429047|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
163472456|NCT03799627|590429048|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
163472457|NCT03799627|590429049|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
163472458|NCT03799627|590429041|FG000|Overall Study|Changes In Hemoglobin Values|1|||
163472459|NCT03799627|590429042|FG001|Overall Study|Changes In Hemoglobin Values|2|||
163472460|NCT03799627|590429043|FG002|Overall Study|Changes In Hemoglobin Values|1|||
163472461|NCT03799627|590429044|FG003|Overall Study|Changes In Hemoglobin Values|0|||
163472462|NCT03799627|590429045|FG004|Overall Study|Changes In Hemoglobin Values|0|||
163472463|NCT03799627|590429046|FG005|Overall Study|Changes In Hemoglobin Values|2|||
163472464|NCT03799627|590429047|FG006|Overall Study|Changes In Hemoglobin Values|1|||
163472465|NCT03799627|590429048|FG007|Overall Study|Changes In Hemoglobin Values|0|||
163472466|NCT03799627|590429049|FG008|Overall Study|Changes In Hemoglobin Values|1|||
163472467|NCT01927068|590429059|FG000|Overall Study|Death|37|||
163472468|NCT01927068|590429060|FG001|Overall Study|Death|3|||
163472469|NCT01927068|590429059|FG000|Overall Study|Withdrawal by Subject|50|||
163472470|NCT01927068|590429060|FG001|Overall Study|Withdrawal by Subject|3|||
163472471|NCT01927068|590429059|FG000|Overall Study|Lost to Follow-up|10|||
163472472|NCT01927068|590429060|FG001|Overall Study|Lost to Follow-up|2|||
163472473|NCT01927068|590429059|FG000|Overall Study|Physician Decision|9|||
163472474|NCT01927068|590429060|FG001|Overall Study|Physician Decision|0|||
163472475|NCT01927068|590429059|FG000|Overall Study|Missed last follow-up visit|2|||
163472476|NCT01927068|590429060|FG001|Overall Study|Missed last follow-up visit|0|||
163472477|NCT01624467|590429061|FG000|Overall Study|Withdrawal by Subject|2|||
163472478|NCT01624467|590429061|FG000|Overall Study|Lost to Follow-up|1|||
163472479|NCT01624467|590429061|FG000|Overall Study|Adverse Event|7|||
163472480|NCT01624467|590429061|FG000|Overall Study|Progressive Disease|19|||
163472481|NCT01624467|590429061|FG000|Overall Study|Per Sponsor Requirement|1|||
163472482|NCT01624467|590429061|FG000|Overall Study|Subject Withdrew from Treatment|1|||
163472483|NCT03964493|590429062|FG000|Overall Study|Withdrawal by Subject|4|||
163472484|NCT03964493|590429063|FG001|Overall Study|Withdrawal by Subject|1|||
163472485|NCT03964493|590429062|FG000|Overall Study|Lost to Follow-up|13|||
163472486|NCT03964493|590429063|FG001|Overall Study|Lost to Follow-up|4|||
163472487|NCT00398138|590429064|FG000|Overall Study|Adverse Event|2|||
163472488|NCT00814307|590429067|FG000|Overall Study|Randomized but not treated|1|||
163472489|NCT00814307|590429068|FG001|Overall Study|Randomized but not treated|0|||
163472490|NCT00814307|590429069|FG002|Overall Study|Randomized but not treated|0|||
163472491|NCT00814307|590429070|FG003|Overall Study|Randomized but not treated|0|||
163472492|NCT00814307|590429067|FG000|Overall Study|Adverse Event|3|||
163472493|NCT00814307|590429068|FG001|Overall Study|Adverse Event|9|||
163472494|NCT00814307|590429069|FG002|Overall Study|Adverse Event|3|||
163472495|NCT00814307|590429070|FG003|Overall Study|Adverse Event|2|||
163472496|NCT00814307|590429067|FG000|Overall Study|Lack of Efficacy|1|||
163472497|NCT00814307|590429068|FG001|Overall Study|Lack of Efficacy|1|||
163472498|NCT00814307|590429069|FG002|Overall Study|Lack of Efficacy|3|||
163472499|NCT00814307|590429070|FG003|Overall Study|Lack of Efficacy|4|||
163472500|NCT00814307|590429067|FG000|Overall Study|Other|1|||
163472501|NCT00814307|590429068|FG001|Overall Study|Other|2|||
163472502|NCT00814307|590429069|FG002|Overall Study|Other|0|||
163472503|NCT00814307|590429070|FG003|Overall Study|Other|1|||
163472504|NCT00814307|590429067|FG000|Overall Study|Protocol Violation|2|||
163472505|NCT00814307|590429068|FG001|Overall Study|Protocol Violation|8|||
163472506|NCT00814307|590429069|FG002|Overall Study|Protocol Violation|1|||
163472507|NCT00814307|590429070|FG003|Overall Study|Protocol Violation|1|||
163472508|NCT00814307|590429067|FG000|Overall Study|Withdrawal by Subject|4|||
163472509|NCT00814307|590429068|FG001|Overall Study|Withdrawal by Subject|6|||
163472510|NCT00814307|590429069|FG002|Overall Study|Withdrawal by Subject|0|||
163472511|NCT00814307|590429070|FG003|Overall Study|Withdrawal by Subject|2|||
163472512|NCT00814307|590429067|FG000|Overall Study|Death|0|||
163472513|NCT00814307|590429068|FG001|Overall Study|Death|1|||
163472514|NCT00814307|590429069|FG002|Overall Study|Death|0|||
163472515|NCT00814307|590429070|FG003|Overall Study|Death|0|||
163472516|NCT01474889|590429071|FG000|Overall Study|Physician Decision|1|||
163472517|NCT01474889|590429072|FG001|Overall Study|Physician Decision|0|||
163472518|NCT01474889|590429073|FG002|Overall Study|Physician Decision|0|||
163472519|NCT01474889|590429071|FG000|Overall Study|Did not meet inclusion|1|||
163472520|NCT01474889|590429072|FG001|Overall Study|Did not meet inclusion|0|||
163472521|NCT01474889|590429073|FG002|Overall Study|Did not meet inclusion|0|||
163472522|NCT01474889|590429071|FG000|Overall Study|Withdrawal by Subject|0|||
163472523|NCT01474889|590429072|FG001|Overall Study|Withdrawal by Subject|1|||
163472524|NCT01474889|590429073|FG002|Overall Study|Withdrawal by Subject|0|||
163472525|NCT02290340|590429075|FG000|Overall Study|Lost to Follow-up|0|||
163472526|NCT02290340|590429076|FG001|Overall Study|Lost to Follow-up|0|||
163472527|NCT02290340|590429077|FG002|Overall Study|Lost to Follow-up|0|||
163472528|NCT02290340|590429078|FG003|Overall Study|Lost to Follow-up|1|||
163472529|NCT02290340|590429075|FG000|Overall Study|Withdrawal by Subject|1|||
163472530|NCT02290340|590429076|FG001|Overall Study|Withdrawal by Subject|0|||
163472531|NCT02290340|590429077|FG002|Overall Study|Withdrawal by Subject|0|||
163472532|NCT02290340|590429078|FG003|Overall Study|Withdrawal by Subject|0|||
163472533|NCT02290340|590429075|FG000|Overall Study|Other|1|||
163472534|NCT02290340|590429076|FG001|Overall Study|Other|0|||
163472535|NCT02290340|590429077|FG002|Overall Study|Other|0|||
163472536|NCT02290340|590429078|FG003|Overall Study|Other|1|||
163472537|NCT03227224|590429079|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
163472538|NCT03227224|590429080|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
163472539|NCT03227224|590429081|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
163472540|NCT03227224|590429082|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
163472541|NCT03227224|590429079|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
163472542|NCT03227224|590429080|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
163472543|NCT03227224|590429081|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
163472544|NCT03227224|590429082|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
163472545|NCT03227224|590429079|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
163472546|NCT03227224|590429080|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
163472547|NCT03227224|590429081|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
163472548|NCT03227224|590429082|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
163472549|NCT03227224|590429079|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
163472550|NCT03227224|590429080|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
163472551|NCT03227224|590429081|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
163472552|NCT03227224|590429082|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
163472553|NCT03227224|590429079|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
163472554|NCT03227224|590429080|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
163472555|NCT03227224|590429081|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
163472556|NCT03227224|590429082|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
163472557|NCT03227224|590429079|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
163472558|NCT03227224|590429080|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
163472559|NCT03227224|590429081|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
163472560|NCT03227224|590429082|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
163472561|NCT03227224|590429079|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
163472562|NCT03227224|590429080|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
163472563|NCT03227224|590429081|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
163472564|NCT03227224|590429082|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
163472565|NCT03227224|590429079|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
163472566|NCT03227224|590429080|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
163472567|NCT03227224|590429081|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
163472568|NCT03227224|590429082|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
163472569|NCT03227224|590429079|FG000|Follow-up Phase (2 Weeks)|Other|4|||
163472570|NCT03227224|590429080|FG001|Follow-up Phase (2 Weeks)|Other|4|||
163472571|NCT03227224|590429081|FG002|Follow-up Phase (2 Weeks)|Other|6|||
163472572|NCT03227224|590429082|FG003|Follow-up Phase (2 Weeks)|Other|3|||
163472573|NCT03782376|590429085|FG000|Overall Study|Lost to Follow-up|2|||
163472574|NCT03782376|590429086|FG001|Overall Study|Lost to Follow-up|2|||
163472575|NCT03782376|590429085|FG000|Overall Study|Withdrawal by Subject|7|||
163472576|NCT03782376|590429086|FG001|Overall Study|Withdrawal by Subject|11|||
163472577|NCT03782376|590429085|FG000|Overall Study|Death|1|||
163472578|NCT03782376|590429086|FG001|Overall Study|Death|0|||
163472579|NCT03782376|590429085|FG000|Overall Study|Other|16|||
163472580|NCT03782376|590429086|FG001|Overall Study|Other|17|||
163472581|NCT02659098|590429087|FG000|Overall Study|Withdrawal by Subject|7|||
163472582|NCT03039192|590429088|FG000|Overall Study|Lost to Follow-up|4|||
163472583|NCT03039192|590429089|FG001|Overall Study|Lost to Follow-up|4|||
163472584|NCT03039192|590429088|FG000|Overall Study|Adverse event, serious fatal|0|||
163472585|NCT03039192|590429089|FG001|Overall Study|Adverse event, serious fatal|1|||
163472586|NCT03039192|590429088|FG000|Overall Study|Adverse event, non-fatal|0|||
163472587|NCT03039192|590429089|FG001|Overall Study|Adverse event, non-fatal|2|||
163472588|NCT03039192|590429088|FG000|Overall Study|Withdrawal by Subject|6|||
163472589|NCT03039192|590429089|FG001|Overall Study|Withdrawal by Subject|9|||
163472590|NCT03039192|590429088|FG000|Overall Study|Discontinued from treatment phase|19|||
163472591|NCT03039192|590429089|FG001|Overall Study|Discontinued from treatment phase|12|||
163472592|NCT03039192|590429088|FG000|Overall Study|Other|3|||
163472593|NCT03039192|590429089|FG001|Overall Study|Other|2|||
163472594|NCT02407236|590429090|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
163472595|NCT02407236|590429091|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
163472596|NCT02407236|590429092|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
163472597|NCT02407236|590429093|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
163472598|NCT02407236|590429094|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
163472599|NCT02407236|590429095|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
163472600|NCT02407236|590429096|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
163472601|NCT02407236|590429097|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
163472602|NCT02407236|590429098|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
163472603|NCT02407236|590429099|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
163472604|NCT02407236|590429100|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
163472605|NCT02407236|590429101|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
163472606|NCT02407236|590429102|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
163472607|NCT02407236|590429090|FG000|Induction Study (8 Weeks)|Death|0|||
163472608|NCT02407236|590429091|FG001|Induction Study (8 Weeks)|Death|0|||
163472609|NCT02407236|590429092|FG002|Induction Study (8 Weeks)|Death|1|||
163472610|NCT02407236|590429093|FG003|Induction Study (8 Weeks)|Death|0|||
163472611|NCT02407236|590429094|FG004|Induction Study (8 Weeks)|Death|0|||
163472612|NCT02407236|590429095|FG005|Induction Study (8 Weeks)|Death|0|||
163472613|NCT02407236|590429096|FG006|Induction Study (8 Weeks)|Death|0|||
163472614|NCT02407236|590429097|FG007|Induction Study (8 Weeks)|Death|0|||
163472615|NCT02407236|590429098|FG008|Induction Study (8 Weeks)|Death|0|||
163472616|NCT02407236|590429099|FG009|Induction Study (8 Weeks)|Death|0|||
163472617|NCT02407236|590429100|FG010|Induction Study (8 Weeks)|Death|0|||
163472618|NCT02407236|590429101|FG011|Induction Study (8 Weeks)|Death|0|||
163472619|NCT02407236|590429102|FG012|Induction Study (8 Weeks)|Death|0|||
163472620|NCT02407236|590429090|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
163472621|NCT02407236|590429091|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
163472622|NCT02407236|590429092|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
163472623|NCT02407236|590429093|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
163472624|NCT02407236|590429094|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
163472625|NCT02407236|590429095|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
163472626|NCT02407236|590429096|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
163472627|NCT02407236|590429097|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
163472628|NCT02407236|590429098|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
163472629|NCT02407236|590429099|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
163472630|NCT02407236|590429100|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
163472631|NCT02407236|590429101|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
163472632|NCT02407236|590429102|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
163472633|NCT02407236|590429090|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
163472634|NCT02407236|590429091|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
163472635|NCT02407236|590429092|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
163472636|NCT02407236|590429093|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
163472637|NCT02407236|590429094|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
163472638|NCT02407236|590429095|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
163472639|NCT02407236|590429096|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
163472640|NCT02407236|590429097|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
163472641|NCT02407236|590429098|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
163472642|NCT02407236|590429099|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
163472643|NCT02407236|590429100|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
163472644|NCT02407236|590429101|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
163472645|NCT02407236|590429102|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
163472646|NCT02407236|590429090|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
163472647|NCT02407236|590429091|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
163472648|NCT02407236|590429092|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
163472649|NCT02407236|590429093|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
163472650|NCT02407236|590429094|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
163472651|NCT02407236|590429095|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
163472652|NCT02407236|590429096|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
163472653|NCT02407236|590429097|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
163472654|NCT02407236|590429098|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
163472655|NCT02407236|590429099|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
163472656|NCT02407236|590429100|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
163472657|NCT02407236|590429101|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
163472658|NCT02407236|590429102|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
163472659|NCT02407236|590429090|FG000|Induction Study (8 Weeks)|Other|2|||
163472660|NCT02407236|590429091|FG001|Induction Study (8 Weeks)|Other|1|||
163472661|NCT02407236|590429092|FG002|Induction Study (8 Weeks)|Other|5|||
163472662|NCT02407236|590429093|FG003|Induction Study (8 Weeks)|Other|0|||
163472663|NCT02407236|590429094|FG004|Induction Study (8 Weeks)|Other|0|||
163472664|NCT02407236|590429095|FG005|Induction Study (8 Weeks)|Other|0|||
163472665|NCT02407236|590429096|FG006|Induction Study (8 Weeks)|Other|0|||
163472666|NCT02407236|590429097|FG007|Induction Study (8 Weeks)|Other|0|||
163472667|NCT02407236|590429098|FG008|Induction Study (8 Weeks)|Other|0|||
163472668|NCT02407236|590429099|FG009|Induction Study (8 Weeks)|Other|0|||
163472669|NCT02407236|590429100|FG010|Induction Study (8 Weeks)|Other|0|||
163472670|NCT02407236|590429101|FG011|Induction Study (8 Weeks)|Other|0|||
163472671|NCT02407236|590429102|FG012|Induction Study (8 Weeks)|Other|0|||
163472672|NCT02407236|590429090|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
163472673|NCT02407236|590429091|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
163472674|NCT02407236|590429092|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
163472675|NCT02407236|590429093|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
163472676|NCT02407236|590429094|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
163472677|NCT02407236|590429095|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
163472678|NCT02407236|590429096|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
163472679|NCT02407236|590429097|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
163472680|NCT02407236|590429098|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
163472681|NCT02407236|590429099|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
163472682|NCT02407236|590429100|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
163472683|NCT02407236|590429101|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
163472684|NCT02407236|590429102|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
163472685|NCT02407236|590429090|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
163472686|NCT02407236|590429091|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
163472687|NCT02407236|590429092|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
163472688|NCT02407236|590429093|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
163472689|NCT02407236|590429094|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
163472690|NCT02407236|590429095|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
163472691|NCT02407236|590429096|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
163472692|NCT02407236|590429097|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
163472693|NCT02407236|590429098|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
163472694|NCT02407236|590429099|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
163472695|NCT02407236|590429100|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
163472696|NCT02407236|590429101|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
163472697|NCT02407236|590429102|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
163472698|NCT02407236|590429090|FG000|Maintenance Study (44 Weeks)|Other|0|||
163472699|NCT02407236|590429091|FG001|Maintenance Study (44 Weeks)|Other|0|||
163472700|NCT02407236|590429092|FG002|Maintenance Study (44 Weeks)|Other|0|||
163472701|NCT02407236|590429093|FG003|Maintenance Study (44 Weeks)|Other|5|||
163472702|NCT02407236|590429094|FG004|Maintenance Study (44 Weeks)|Other|7|||
163472703|NCT02407236|590429095|FG005|Maintenance Study (44 Weeks)|Other|8|||
163472704|NCT02407236|590429096|FG006|Maintenance Study (44 Weeks)|Other|4|||
163472705|NCT02407236|590429097|FG007|Maintenance Study (44 Weeks)|Other|6|||
163472706|NCT02407236|590429098|FG008|Maintenance Study (44 Weeks)|Other|0|||
163472707|NCT02407236|590429099|FG009|Maintenance Study (44 Weeks)|Other|0|||
163472708|NCT02407236|590429100|FG010|Maintenance Study (44 Weeks)|Other|0|||
163472709|NCT02407236|590429101|FG011|Maintenance Study (44 Weeks)|Other|0|||
163472710|NCT02407236|590429102|FG012|Maintenance Study (44 Weeks)|Other|0|||
163472711|NCT02407236|590429090|FG000|Maintenance Study (44 Weeks)|Death|0|||
163472712|NCT02407236|590429091|FG001|Maintenance Study (44 Weeks)|Death|0|||
163472713|NCT02407236|590429092|FG002|Maintenance Study (44 Weeks)|Death|0|||
163472714|NCT02407236|590429093|FG003|Maintenance Study (44 Weeks)|Death|0|||
163472715|NCT02407236|590429094|FG004|Maintenance Study (44 Weeks)|Death|0|||
163472716|NCT02407236|590429095|FG005|Maintenance Study (44 Weeks)|Death|0|||
163472717|NCT02407236|590429096|FG006|Maintenance Study (44 Weeks)|Death|0|||
163472718|NCT02407236|590429097|FG007|Maintenance Study (44 Weeks)|Death|1|||
163472719|NCT02407236|590429098|FG008|Maintenance Study (44 Weeks)|Death|0|||
163472720|NCT02407236|590429099|FG009|Maintenance Study (44 Weeks)|Death|0|||
163472721|NCT02407236|590429100|FG010|Maintenance Study (44 Weeks)|Death|0|||
163472722|NCT02407236|590429101|FG011|Maintenance Study (44 Weeks)|Death|0|||
163472723|NCT02407236|590429102|FG012|Maintenance Study (44 Weeks)|Death|0|||
163472724|NCT02407236|590429090|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
163472725|NCT02407236|590429091|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
163472726|NCT02407236|590429092|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
163472727|NCT02407236|590429093|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
163472728|NCT02407236|590429094|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
163472729|NCT02407236|590429095|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
163472730|NCT02407236|590429096|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
163472731|NCT02407236|590429097|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
163472732|NCT02407236|590429098|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
163472733|NCT02407236|590429099|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
163472734|NCT02407236|590429100|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
163472735|NCT02407236|590429101|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
163472736|NCT02407236|590429102|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
163472737|NCT02407236|590429090|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
163472738|NCT02407236|590429091|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
163472739|NCT02407236|590429092|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
163472740|NCT02407236|590429093|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
163472741|NCT02407236|590429094|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
163472742|NCT02407236|590429095|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
163472743|NCT02407236|590429096|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
163472744|NCT02407236|590429097|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
163472745|NCT02407236|590429098|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
163472746|NCT02407236|590429099|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
163472747|NCT02407236|590429100|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
163472748|NCT02407236|590429101|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
163472749|NCT02407236|590429102|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
163472750|NCT02407236|590429090|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
163472751|NCT02407236|590429091|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
163472752|NCT02407236|590429092|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
163472753|NCT02407236|590429093|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
163472754|NCT02407236|590429094|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
163472755|NCT02407236|590429095|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
163472756|NCT02407236|590429096|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
163472757|NCT02407236|590429097|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
163472758|NCT02407236|590429098|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
163472759|NCT02407236|590429099|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
163472760|NCT02407236|590429100|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
163472761|NCT02407236|590429101|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
163472762|NCT02407236|590429102|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
163472763|NCT02407236|590429090|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
163472764|NCT02407236|590429091|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
163472765|NCT02407236|590429092|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
163472766|NCT02407236|590429093|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
163472767|NCT02407236|590429094|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
163472768|NCT02407236|590429095|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
163472769|NCT02407236|590429096|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
163472770|NCT02407236|590429097|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
163472771|NCT02407236|590429098|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
163472772|NCT02407236|590429099|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
163472773|NCT02407236|590429100|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
163472774|NCT02407236|590429101|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
163472775|NCT02407236|590429102|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
163472776|NCT03277794|590429105|FG000|Overall Study|Lost to Follow-up|2|||
163472777|NCT03277794|590429106|FG001|Overall Study|Lost to Follow-up|4|||
163472778|NCT03277794|590429105|FG000|Overall Study|Withdrew due to high acuity|1|||
163472779|NCT03277794|590429106|FG001|Overall Study|Withdrew due to high acuity|0|||
163472780|NCT02254304|590429110|FG000|Overall Study|Adverse Event|2|||
163472781|NCT02254304|590429111|FG001|Overall Study|Adverse Event|1|||
163472782|NCT02254304|590429110|FG000|Overall Study|Lost to Follow-up|2|||
163472783|NCT02254304|590429111|FG001|Overall Study|Lost to Follow-up|2|||
163472784|NCT02254304|590429110|FG000|Overall Study|Protocol Violation|1|||
163472785|NCT02254304|590429111|FG001|Overall Study|Protocol Violation|0|||
163472786|NCT02254304|590429110|FG000|Overall Study|Withdrawal by Subject|3|||
163472787|NCT02254304|590429111|FG001|Overall Study|Withdrawal by Subject|0|||
163472788|NCT02254304|590429110|FG000|Overall Study|Injection site pain and Injection fear|1|||
163472789|NCT02254304|590429111|FG001|Overall Study|Injection site pain and Injection fear|0|||
163472790|NCT02254304|590429110|FG000|Overall Study|Personal causes|4|||
163472791|NCT02254304|590429111|FG001|Overall Study|Personal causes|1|||
163472792|NCT02254304|590429110|FG000|Overall Study|Personal decision|1|||
163472793|NCT02254304|590429111|FG001|Overall Study|Personal decision|0|||
163472794|NCT00952419|590429112|FG000|Overall Study|Adverse Event|2|||
163472795|NCT00952419|590429113|FG001|Overall Study|Adverse Event|0|||
163472796|NCT00952419|590429114|FG002|Overall Study|Adverse Event|0|||
163472797|NCT00952419|590429112|FG000|Overall Study|Protocol Violation|3|||
163472798|NCT00952419|590429113|FG001|Overall Study|Protocol Violation|7|||
163472799|NCT00952419|590429114|FG002|Overall Study|Protocol Violation|0|||
163472800|NCT00952419|590429112|FG000|Overall Study|Withdrawal by Subject|1|||
163472801|NCT00952419|590429113|FG001|Overall Study|Withdrawal by Subject|3|||
163472802|NCT00952419|590429114|FG002|Overall Study|Withdrawal by Subject|0|||
163472803|NCT02266004|590430997|FG000|Overall Study|unrelated adverse event|1|||
163472804|NCT02266004|590430997|FG000|Overall Study|Physician Decision|1|||
163472805|NCT00537771|590430998|FG000|Overall Study|Withdrawal by Subject|6|||
163472806|NCT00537771|590430999|FG001|Overall Study|Withdrawal by Subject|23|||
163472807|NCT00537771|590430998|FG000|Overall Study|Adverse Event|8|||
163472808|NCT00537771|590430999|FG001|Overall Study|Adverse Event|15|||
163472809|NCT00537771|590430998|FG000|Overall Study|Lost to Follow-up|9|||
163472810|NCT00537771|590430999|FG001|Overall Study|Lost to Follow-up|15|||
163472811|NCT00537771|590430998|FG000|Overall Study|Protocol Violation|2|||
163472812|NCT00537771|590430999|FG001|Overall Study|Protocol Violation|6|||
163472813|NCT00537771|590430998|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
163472814|NCT00537771|590430999|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
163472815|NCT02465489|590431002|FG000|Overall Study|Adverse Event|5|||
163472816|NCT00850135|590431003|FG000|Overall Study|Physician Decision|1|||
163472817|NCT02253992|590431004|FG000|Overall Study|Study drug toxicity|1|||
163472818|NCT02253992|590431005|FG001|Overall Study|Study drug toxicity|0|||
163472819|NCT02253992|590431006|FG002|Overall Study|Study drug toxicity|10|||
163472820|NCT02253992|590431004|FG000|Overall Study|Disease progression|4|||
163472821|NCT02253992|590431005|FG001|Overall Study|Disease progression|3|||
163472822|NCT02253992|590431006|FG002|Overall Study|Disease progression|98|||
163472823|NCT02253992|590431004|FG000|Overall Study|Withdrawal by Subject|0|||
163472824|NCT02253992|590431005|FG001|Overall Study|Withdrawal by Subject|0|||
163472825|NCT02253992|590431006|FG002|Overall Study|Withdrawal by Subject|3|||
163472826|NCT02253992|590431004|FG000|Overall Study|Adverse Event|0|||
163472827|NCT02253992|590431005|FG001|Overall Study|Adverse Event|0|||
163472828|NCT02253992|590431006|FG002|Overall Study|Adverse Event|8|||
163472829|NCT02253992|590431004|FG000|Overall Study|Death|0|||
163472830|NCT02253992|590431005|FG001|Overall Study|Death|0|||
163472831|NCT02253992|590431006|FG002|Overall Study|Death|1|||
163472832|NCT02253992|590431004|FG000|Overall Study|Subject discontinued study drug|1|||
163472833|NCT02253992|590431005|FG001|Overall Study|Subject discontinued study drug|0|||
163472834|NCT02253992|590431006|FG002|Overall Study|Subject discontinued study drug|1|||
163472835|NCT02253992|590431004|FG000|Overall Study|Completed treatment as per protocol|0|||
163472836|NCT02253992|590431005|FG001|Overall Study|Completed treatment as per protocol|1|||
163472837|NCT02253992|590431006|FG002|Overall Study|Completed treatment as per protocol|22|||
163472838|NCT02253992|590431004|FG000|Overall Study|Other|0|||
163472839|NCT02253992|590431005|FG001|Overall Study|Other|0|||
163472840|NCT02253992|590431006|FG002|Overall Study|Other|1|||
163472841|NCT03198728|590431007|FG000|Overall Study|Adverse Event|10|||
163472842|NCT03198728|590431008|FG001|Overall Study|Adverse Event|5|||
163472843|NCT03198728|590431007|FG000|Overall Study|Lost to Follow-up|21|||
163472844|NCT03198728|590431008|FG001|Overall Study|Lost to Follow-up|7|||
163472845|NCT03198728|590431007|FG000|Overall Study|Physician Decision|7|||
163472846|NCT03198728|590431008|FG001|Overall Study|Physician Decision|2|||
163472847|NCT03198728|590431007|FG000|Overall Study|Withdrawal by Subject|14|||
163472848|NCT03198728|590431008|FG001|Overall Study|Withdrawal by Subject|10|||
163472849|NCT04051944|590431009|FG000|Overall Study|Study ending|1|||
163472850|NCT04051944|590431010|FG001|Overall Study|Study ending|1|||
163472851|NCT04051944|590431009|FG000|Overall Study|Early study termination by participant|1|||
163472852|NCT04051944|590431010|FG001|Overall Study|Early study termination by participant|0|||
163472853|NCT04051944|590431009|FG000|Overall Study|Withdrawal by Subject|2|||
163472854|NCT04051944|590431010|FG001|Overall Study|Withdrawal by Subject|2|||
163472855|NCT04051944|590431009|FG000|Overall Study|Lack of Efficacy|3|||
163472856|NCT04051944|590431010|FG001|Overall Study|Lack of Efficacy|0|||
163472857|NCT04051944|590431009|FG000|Overall Study|Adverse event, non- fatal|1|||
163472858|NCT04051944|590431010|FG001|Overall Study|Adverse event, non- fatal|1|||
163472859|NCT03083470|590431011|FG000|Overall Study|Lost to Follow-up|0|||
163472860|NCT03083470|590431012|FG001|Overall Study|Lost to Follow-up|0|||
163472861|NCT03083470|590431013|FG002|Overall Study|Lost to Follow-up|0|||
163472862|NCT03083470|590431014|FG003|Overall Study|Lost to Follow-up|0|||
163472863|NCT03083470|590431015|FG004|Overall Study|Lost to Follow-up|1|||
163472864|NCT03083470|590431011|FG000|Overall Study|Withdrawal by Subject|0|||
163472865|NCT03083470|590431012|FG001|Overall Study|Withdrawal by Subject|0|||
163472866|NCT03083470|590431013|FG002|Overall Study|Withdrawal by Subject|0|||
163472867|NCT03083470|590431014|FG003|Overall Study|Withdrawal by Subject|0|||
163472868|NCT03083470|590431015|FG004|Overall Study|Withdrawal by Subject|1|||
163472869|NCT01512693|590431016|FG000|Overall Study|Withdrawal by Subject|0|||
163472870|NCT01512693|590431017|FG001|Overall Study|Withdrawal by Subject|1|||
163472871|NCT02139280|590431018|FG000|Overall Study|No longer eligible|2|||
163472872|NCT02139280|590431019|FG001|Overall Study|No longer eligible|0|||
163472873|NCT00736450|590431026|FG000|Overall Study|Not ABC gene eligible|19|||
163472874|NCT00736450|590431026|FG000|Overall Study|Withdrawal by Subject|5|||
163472875|NCT00736450|590431026|FG000|Overall Study|Physician Decision|1|||
163472876|NCT04157751|590431030|FG000|Overall Study|Withdrawal by Subject|12|||
163472877|NCT04157751|590431031|FG001|Overall Study|Withdrawal by Subject|17|||
163472878|NCT04157751|590431030|FG000|Overall Study|Lost to Follow-up|6|||
163472879|NCT04157751|590431031|FG001|Overall Study|Lost to Follow-up|2|||
163472880|NCT04157751|590431030|FG000|Overall Study|Adverse Event|34|||
163472881|NCT04157751|590431031|FG001|Overall Study|Adverse Event|23|||
163472882|NCT04157751|590431030|FG000|Overall Study|Not treated|1|||
163472883|NCT04157751|590431031|FG001|Overall Study|Not treated|5|||
163472884|NCT04157751|590431030|FG000|Overall Study|Other reason not stated above|10|||
163472885|NCT04157751|590431031|FG001|Overall Study|Other reason not stated above|10|||
163472886|NCT04731922|590431032|FG000|Overall Study|Adverse Event|0|||
163472887|NCT04731922|590431033|FG001|Overall Study|Adverse Event|0|||
163472888|NCT04731922|590431034|FG002|Overall Study|Adverse Event|0|||
163472889|NCT04731922|590431035|FG003|Overall Study|Adverse Event|0|||
163472890|NCT04731922|590431036|FG004|Overall Study|Adverse Event|0|||
163472891|NCT04731922|590431037|FG005|Overall Study|Adverse Event|0|||
163472892|NCT04731922|590431038|FG006|Overall Study|Adverse Event|0|||
163472893|NCT04731922|590431039|FG007|Overall Study|Adverse Event|0|||
163472894|NCT04731922|590431040|FG008|Overall Study|Adverse Event|0|||
163472895|NCT04731922|590431041|FG009|Overall Study|Adverse Event|0|||
163472896|NCT04731922|590431042|FG010|Overall Study|Adverse Event|1|||
163472897|NCT04731922|590431043|FG011|Overall Study|Adverse Event|0|||
163472898|NCT04731922|590431044|FG012|Overall Study|Adverse Event|0|||
163472899|NCT04731922|590431045|FG013|Overall Study|Adverse Event|0|||
163472900|NCT04731922|590431046|FG014|Overall Study|Adverse Event|0|||
163472901|NCT04731922|590431047|FG015|Overall Study|Adverse Event|0|||
163472902|NCT04731922|590431048|FG016|Overall Study|Adverse Event|0|||
163472903|NCT04731922|590431032|FG000|Overall Study|Lost to Follow-up|0|||
163472904|NCT04731922|590431033|FG001|Overall Study|Lost to Follow-up|0|||
163472905|NCT04731922|590431034|FG002|Overall Study|Lost to Follow-up|0|||
163472906|NCT04731922|590431035|FG003|Overall Study|Lost to Follow-up|1|||
163472907|NCT04731922|590431036|FG004|Overall Study|Lost to Follow-up|0|||
163472908|NCT04731922|590431037|FG005|Overall Study|Lost to Follow-up|1|||
163472909|NCT04731922|590431038|FG006|Overall Study|Lost to Follow-up|0|||
163472910|NCT04731922|590431039|FG007|Overall Study|Lost to Follow-up|0|||
163472911|NCT04731922|590431040|FG008|Overall Study|Lost to Follow-up|0|||
163472912|NCT04731922|590431041|FG009|Overall Study|Lost to Follow-up|0|||
163472913|NCT04731922|590431042|FG010|Overall Study|Lost to Follow-up|0|||
163472914|NCT04731922|590431043|FG011|Overall Study|Lost to Follow-up|0|||
163472915|NCT04731922|590431044|FG012|Overall Study|Lost to Follow-up|0|||
163472916|NCT04731922|590431045|FG013|Overall Study|Lost to Follow-up|0|||
163472917|NCT04731922|590431046|FG014|Overall Study|Lost to Follow-up|0|||
163472918|NCT04731922|590431047|FG015|Overall Study|Lost to Follow-up|0|||
163472919|NCT04731922|590431048|FG016|Overall Study|Lost to Follow-up|0|||
163472920|NCT04731922|590431032|FG000|Overall Study|Withdrawal by Subject|1|||
163472921|NCT04731922|590431033|FG001|Overall Study|Withdrawal by Subject|0|||
163472922|NCT04731922|590431034|FG002|Overall Study|Withdrawal by Subject|0|||
163472923|NCT04731922|590431035|FG003|Overall Study|Withdrawal by Subject|0|||
163472924|NCT04731922|590431036|FG004|Overall Study|Withdrawal by Subject|1|||
163472925|NCT04731922|590431037|FG005|Overall Study|Withdrawal by Subject|0|||
163472926|NCT04731922|590431038|FG006|Overall Study|Withdrawal by Subject|1|||
163472927|NCT04731922|590431039|FG007|Overall Study|Withdrawal by Subject|0|||
163472928|NCT04731922|590431040|FG008|Overall Study|Withdrawal by Subject|0|||
163472929|NCT04731922|590431041|FG009|Overall Study|Withdrawal by Subject|0|||
163472930|NCT04731922|590431042|FG010|Overall Study|Withdrawal by Subject|0|||
163472931|NCT04731922|590431043|FG011|Overall Study|Withdrawal by Subject|0|||
163472932|NCT04731922|590431044|FG012|Overall Study|Withdrawal by Subject|0|||
163472933|NCT04731922|590431045|FG013|Overall Study|Withdrawal by Subject|1|||
163472934|NCT04731922|590431046|FG014|Overall Study|Withdrawal by Subject|0|||
163472935|NCT04731922|590431047|FG015|Overall Study|Withdrawal by Subject|0|||
163472936|NCT04731922|590431048|FG016|Overall Study|Withdrawal by Subject|0|||
163472937|NCT04731922|590431032|FG000|Overall Study|Other|0|||
163472938|NCT04731922|590431033|FG001|Overall Study|Other|0|||
163472939|NCT04731922|590431034|FG002|Overall Study|Other|0|||
163472940|NCT04731922|590431035|FG003|Overall Study|Other|0|||
163472941|NCT04731922|590431036|FG004|Overall Study|Other|0|||
163472942|NCT04731922|590431037|FG005|Overall Study|Other|0|||
163472943|NCT04731922|590431038|FG006|Overall Study|Other|1|||
163472944|NCT04731922|590431039|FG007|Overall Study|Other|0|||
163472945|NCT04731922|590431040|FG008|Overall Study|Other|0|||
163472946|NCT04731922|590431041|FG009|Overall Study|Other|0|||
163472947|NCT04731922|590431042|FG010|Overall Study|Other|0|||
163472948|NCT04731922|590431043|FG011|Overall Study|Other|0|||
163472949|NCT04731922|590431044|FG012|Overall Study|Other|0|||
163472950|NCT04731922|590431045|FG013|Overall Study|Other|0|||
163472951|NCT04731922|590431046|FG014|Overall Study|Other|0|||
163472952|NCT04731922|590431047|FG015|Overall Study|Other|0|||
163472953|NCT04731922|590431048|FG016|Overall Study|Other|0|||
163472954|NCT00981747|590431055|FG000|Losartan|Withdrawal by Subject|1|||
163472955|NCT00981747|590431055|FG000|Losartan|Death|1|||
163472956|NCT00981747|590431055|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
163472957|NCT03148795|590431063|FG000|Overall Study|Progressive Disease|1|||
163472958|NCT00441012|590431064|FG000|Overall Study|Adverse Event|0|||
163472959|NCT00441012|590431065|FG001|Overall Study|Adverse Event|1|||
163472960|NCT00441012|590431064|FG000|Overall Study|Lost to Follow-up|3|||
163472961|NCT00441012|590431065|FG001|Overall Study|Lost to Follow-up|3|||
163472962|NCT00441012|590431064|FG000|Overall Study|Protocol Violation|10|||
163472963|NCT00441012|590431065|FG001|Overall Study|Protocol Violation|9|||
163472964|NCT00441012|590431064|FG000|Overall Study|Withdrawal by Subject|4|||
163472965|NCT00441012|590431065|FG001|Overall Study|Withdrawal by Subject|0|||
163472966|NCT00441012|590431064|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
163472967|NCT00441012|590431065|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
163472968|NCT04489940|590431066|FG000|Overall Study|Other|2|||
163472969|NCT04489940|590431066|FG000|Overall Study|Withdrawal by Subject|2|||
163472970|NCT04489940|590431066|FG000|Overall Study|Death|5|||
163472971|NCT04489940|590431066|FG000|Overall Study|Lost to Follow-up|1|||
163472972|NCT04498468|590431067|FG000|Overall Study|Lost to Follow-up|3|||
163472973|NCT02092324|590431068|FG000|Overall Study|Adverse Event|1|||
163472974|NCT02092324|590431068|FG000|Overall Study|Lack of Efficacy|6|||
163472975|NCT02092324|590431068|FG000|Overall Study|Proceed to Transplant|3|||
163472976|NCT02092324|590431068|FG000|Overall Study|Physician Decision|7|||
163472977|NCT02092324|590431068|FG000|Overall Study|Misdiagnosis|2|||
163472978|NCT02224274|590431070|FG000|Overall Study|Death|1|||
163472979|NCT02224274|590431071|FG001|Overall Study|Death|0|||
163472980|NCT00887068|590431072|FG000|Overall Study|Withdrawal by Subject|2|||
163472981|NCT00887068|590431073|FG001|Overall Study|Withdrawal by Subject|0|||
163472982|NCT00887068|590431072|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
163472983|NCT00887068|590431073|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
163472984|NCT00499460|590431074|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
163472985|NCT00499460|590431075|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
163472986|NCT00499460|590431074|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
163472987|NCT00499460|590431075|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
163472988|NCT00499460|590431074|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
163472989|NCT00499460|590431075|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
163472990|NCT00090766|590431083|FG000|Overall Study|Nephrectomy Planned|0|||
163472991|NCT00090766|590431084|FG001|Overall Study|Nephrectomy Planned|0|||
163472992|NCT00090766|590431085|FG002|Overall Study|Nephrectomy Planned|1|||
163472993|NCT00090766|590431083|FG000|Overall Study|Death|1|||
163472994|NCT00090766|590431084|FG001|Overall Study|Death|0|||
163472995|NCT00090766|590431085|FG002|Overall Study|Death|0|||
163472996|NCT00090766|590431083|FG000|Overall Study|Admin|0|||
163472997|NCT00090766|590431084|FG001|Overall Study|Admin|2|||
163472998|NCT00090766|590431085|FG002|Overall Study|Admin|0|||
163472999|NCT00090766|590431083|FG000|Overall Study|Lost to Follow-up|2|||
163473000|NCT00090766|590431084|FG001|Overall Study|Lost to Follow-up|0|||
163473001|NCT00090766|590431085|FG002|Overall Study|Lost to Follow-up|2|||
163473002|NCT00804986|590431086|FG000|Overall Study|Adverse Event|0|||
163473003|NCT00804986|590431087|FG001|Overall Study|Adverse Event|1|||
163473004|NCT00804986|590431088|FG002|Overall Study|Adverse Event|2|||
163473005|NCT00804986|590431089|FG003|Overall Study|Adverse Event|1|||
163473006|NCT00804986|590431090|FG004|Overall Study|Adverse Event|3|||
163473007|NCT00804986|590431091|FG005|Overall Study|Adverse Event|0|||
163473008|NCT00804986|590431086|FG000|Overall Study|Lack of Efficacy|0|||
163473009|NCT00804986|590431087|FG001|Overall Study|Lack of Efficacy|0|||
163473010|NCT00804986|590431088|FG002|Overall Study|Lack of Efficacy|0|||
163473011|NCT00804986|590431089|FG003|Overall Study|Lack of Efficacy|1|||
163473012|NCT00804986|590431090|FG004|Overall Study|Lack of Efficacy|0|||
163473013|NCT00804986|590431091|FG005|Overall Study|Lack of Efficacy|3|||
163473014|NCT00804986|590431086|FG000|Overall Study|Lost to Follow-up|0|||
163473015|NCT00804986|590431087|FG001|Overall Study|Lost to Follow-up|0|||
163473016|NCT00804986|590431088|FG002|Overall Study|Lost to Follow-up|0|||
163473017|NCT00804986|590431089|FG003|Overall Study|Lost to Follow-up|1|||
163473018|NCT00804986|590431090|FG004|Overall Study|Lost to Follow-up|1|||
163473019|NCT00804986|590431091|FG005|Overall Study|Lost to Follow-up|3|||
163473020|NCT00804986|590431086|FG000|Overall Study|Protocol Violation|0|||
163473021|NCT00804986|590431087|FG001|Overall Study|Protocol Violation|1|||
163473022|NCT00804986|590431088|FG002|Overall Study|Protocol Violation|0|||
163473023|NCT00804986|590431089|FG003|Overall Study|Protocol Violation|1|||
163473024|NCT00804986|590431090|FG004|Overall Study|Protocol Violation|0|||
163473025|NCT00804986|590431091|FG005|Overall Study|Protocol Violation|0|||
163473026|NCT00804986|590431086|FG000|Overall Study|Withdrawal by Subject|0|||
163473027|NCT00804986|590431087|FG001|Overall Study|Withdrawal by Subject|3|||
163473028|NCT00804986|590431088|FG002|Overall Study|Withdrawal by Subject|0|||
163473029|NCT00804986|590431089|FG003|Overall Study|Withdrawal by Subject|3|||
163473030|NCT00804986|590431090|FG004|Overall Study|Withdrawal by Subject|5|||
163473031|NCT00804986|590431091|FG005|Overall Study|Withdrawal by Subject|3|||
163473032|NCT00804986|590431086|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
163473033|NCT00804986|590431087|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
163473034|NCT00804986|590431088|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
163473035|NCT00804986|590431089|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
163473036|NCT00804986|590431090|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
163473037|NCT00804986|590431091|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
163473038|NCT00804986|590431086|FG000|Overall Study|Sponsor Decision|0|||
163473039|NCT00804986|590431087|FG001|Overall Study|Sponsor Decision|1|||
163473040|NCT00804986|590431088|FG002|Overall Study|Sponsor Decision|0|||
163473041|NCT00804986|590431089|FG003|Overall Study|Sponsor Decision|0|||
163473042|NCT00804986|590431090|FG004|Overall Study|Sponsor Decision|0|||
163473043|NCT00804986|590431091|FG005|Overall Study|Sponsor Decision|0|||
163473044|NCT00804986|590431086|FG000|Overall Study|Physician Decision|1|||
163473045|NCT00804986|590431087|FG001|Overall Study|Physician Decision|0|||
163473046|NCT00804986|590431088|FG002|Overall Study|Physician Decision|0|||
163473047|NCT00804986|590431089|FG003|Overall Study|Physician Decision|0|||
163473048|NCT00804986|590431090|FG004|Overall Study|Physician Decision|0|||
163473049|NCT00804986|590431091|FG005|Overall Study|Physician Decision|0|||
163473050|NCT03418376|590431093|FG000|Overall Study|Musculoskeletal injury|1|||
163473051|NCT03418376|590431094|FG001|Overall Study|Musculoskeletal injury|2|||
163473052|NCT03418376|590431095|FG002|Overall Study|Musculoskeletal injury|1|||
163473053|NCT03418376|590431096|FG003|Overall Study|Musculoskeletal injury|0|||
163473054|NCT03418376|590431093|FG000|Overall Study|Personal reasons|0|||
163473055|NCT03418376|590431094|FG001|Overall Study|Personal reasons|2|||
163473056|NCT03418376|590431095|FG002|Overall Study|Personal reasons|2|||
163473057|NCT03418376|590431096|FG003|Overall Study|Personal reasons|1|||
163473058|NCT03418376|590431093|FG000|Overall Study|Exacerbation|0|||
163473059|NCT03418376|590431094|FG001|Overall Study|Exacerbation|1|||
163473060|NCT03418376|590431095|FG002|Overall Study|Exacerbation|0|||
163473061|NCT03418376|590431096|FG003|Overall Study|Exacerbation|0|||
163473062|NCT02774291|590431098|FG000|Overall Study|Lost to Follow-up|1|||
163473063|NCT00149890|590431102|FG000|Overall Study|Adverse Event|1|||
163473064|NCT00149890|590431103|FG001|Overall Study|Adverse Event|8|||
163473065|NCT00149890|590431102|FG000|Overall Study|Lack of Efficacy|8|||
163473066|NCT00149890|590431103|FG001|Overall Study|Lack of Efficacy|9|||
163473067|NCT00149890|590431102|FG000|Overall Study|Protocol Violation|1|||
163473068|NCT00149890|590431103|FG001|Overall Study|Protocol Violation|0|||
163473069|NCT00149890|590431102|FG000|Overall Study|Lost to Follow-up|1|||
163473070|NCT00149890|590431103|FG001|Overall Study|Lost to Follow-up|0|||
163473071|NCT00149890|590431102|FG000|Overall Study|Graft Loss|2|||
163473072|NCT00149890|590431103|FG001|Overall Study|Graft Loss|1|||
163473073|NCT01387594|590431104|FG000|Overall Study|Withdrawal by Subject|0|||
163473074|NCT01387594|590431105|FG001|Overall Study|Withdrawal by Subject|2|||
163473075|NCT01387594|590431104|FG000|Overall Study|Lost to Follow-up|0|||
163473076|NCT01387594|590431105|FG001|Overall Study|Lost to Follow-up|1|||
163473077|NCT03073200|590431113|FG000|Double Blind Treatment Period|Protocol Violation|1|||
163473078|NCT03073200|590431114|FG001|Double Blind Treatment Period|Protocol Violation|0|||
163473079|NCT03073200|590431115|FG002|Double Blind Treatment Period|Protocol Violation|0|||
163473080|NCT03073200|590431116|FG003|Double Blind Treatment Period|Protocol Violation|0|||
163473081|NCT03073200|590431117|FG004|Double Blind Treatment Period|Protocol Violation|0|||
163473082|NCT03073200|590431118|FG005|Double Blind Treatment Period|Protocol Violation|0|||
163473083|NCT03073200|590431119|FG006|Double Blind Treatment Period|Protocol Violation|0|||
163473084|NCT03073200|590431120|FG007|Double Blind Treatment Period|Protocol Violation|0|||
163473085|NCT03073200|590431121|FG008|Double Blind Treatment Period|Protocol Violation|0|||
163473086|NCT03073200|590431122|FG009|Double Blind Treatment Period|Protocol Violation|0|||
163473087|NCT03073200|590431123|FG010|Double Blind Treatment Period|Protocol Violation|0|||
163473088|NCT03073200|590431124|FG011|Double Blind Treatment Period|Protocol Violation|0|||
163473089|NCT03073200|590431125|FG012|Double Blind Treatment Period|Protocol Violation|0|||
163473090|NCT03073200|590431126|FG013|Double Blind Treatment Period|Protocol Violation|0|||
163473091|NCT03073200|590431127|FG014|Double Blind Treatment Period|Protocol Violation|0|||
163473092|NCT03073200|590431113|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
163473093|NCT03073200|590431114|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
163473094|NCT03073200|590431115|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
163473095|NCT03073200|590431116|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
163473096|NCT03073200|590431117|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
163473097|NCT03073200|590431118|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
163473098|NCT03073200|590431119|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
163473099|NCT03073200|590431120|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
163473100|NCT03073200|590431121|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
163473101|NCT03073200|590431122|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
163473102|NCT03073200|590431123|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
163473103|NCT03073200|590431124|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
163473104|NCT03073200|590431125|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
163473105|NCT03073200|590431126|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
163473106|NCT03073200|590431127|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
163473107|NCT03073200|590431113|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
163473108|NCT03073200|590431114|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
163473109|NCT03073200|590431115|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
163473110|NCT03073200|590431116|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
163473111|NCT03073200|590431117|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
163473112|NCT03073200|590431118|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
163473113|NCT03073200|590431119|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
163473114|NCT03073200|590431120|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
163473115|NCT03073200|590431121|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
163473116|NCT03073200|590431122|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
163473117|NCT03073200|590431123|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
163473118|NCT03073200|590431124|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
163473119|NCT03073200|590431125|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
163473120|NCT03073200|590431126|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
163473121|NCT03073200|590431127|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
163473122|NCT03073200|590431113|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
163473123|NCT03073200|590431114|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
163473124|NCT03073200|590431115|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
163473125|NCT03073200|590431116|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
163473126|NCT03073200|590431117|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
163473127|NCT03073200|590431118|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
163473128|NCT03073200|590431119|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
163473129|NCT03073200|590431120|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
163473130|NCT03073200|590431121|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
163473131|NCT03073200|590431122|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
163473132|NCT03073200|590431123|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
163473133|NCT03073200|590431124|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
163473134|NCT03073200|590431125|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
163473135|NCT03073200|590431126|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
163473136|NCT03073200|590431127|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
163473137|NCT03073200|590431113|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
163473138|NCT03073200|590431114|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
163473139|NCT03073200|590431115|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
163473140|NCT03073200|590431116|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
163473141|NCT03073200|590431117|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
163473142|NCT03073200|590431118|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
163473143|NCT03073200|590431119|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
163473144|NCT03073200|590431120|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
163473145|NCT03073200|590431121|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
163473146|NCT03073200|590431122|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
163473147|NCT03073200|590431123|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
163473148|NCT03073200|590431124|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
163473149|NCT03073200|590431125|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
163473150|NCT03073200|590431126|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
163473151|NCT03073200|590431127|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
163473152|NCT03073200|590431113|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
163473153|NCT03073200|590431114|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
163473154|NCT03073200|590431115|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
163473155|NCT03073200|590431116|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
163473156|NCT03073200|590431117|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
163473157|NCT03073200|590431118|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
163473158|NCT03073200|590431119|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
163473159|NCT03073200|590431120|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
163473160|NCT03073200|590431121|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
163473161|NCT03073200|590431122|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
163473162|NCT03073200|590431123|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
163473163|NCT03073200|590431124|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
163473164|NCT03073200|590431125|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
163473165|NCT03073200|590431126|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
163473166|NCT03073200|590431127|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
163473167|NCT03073200|590431113|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
163473168|NCT03073200|590431114|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
163473169|NCT03073200|590431115|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
163473170|NCT03073200|590431116|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
163473171|NCT03073200|590431117|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
163473172|NCT03073200|590431118|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
163473173|NCT03073200|590431119|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
163473174|NCT03073200|590431120|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
163473175|NCT03073200|590431121|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
163473176|NCT03073200|590431122|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
163473177|NCT03073200|590431123|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
163473178|NCT03073200|590431124|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
163473179|NCT03073200|590431125|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
163473180|NCT03073200|590431126|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
163473181|NCT03073200|590431127|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
163473182|NCT03073200|590431113|FG000|Extension Period|Lost to Follow-up|0|||
163473183|NCT03073200|590431114|FG001|Extension Period|Lost to Follow-up|0|||
163473184|NCT03073200|590431115|FG002|Extension Period|Lost to Follow-up|0|||
163473185|NCT03073200|590431116|FG003|Extension Period|Lost to Follow-up|0|||
163473186|NCT03073200|590431117|FG004|Extension Period|Lost to Follow-up|0|||
163473187|NCT03073200|590431118|FG005|Extension Period|Lost to Follow-up|0|||
163473188|NCT03073200|590431119|FG006|Extension Period|Lost to Follow-up|1|||
163473189|NCT03073200|590431120|FG007|Extension Period|Lost to Follow-up|1|||
163473190|NCT03073200|590431121|FG008|Extension Period|Lost to Follow-up|0|||
163473191|NCT03073200|590431122|FG009|Extension Period|Lost to Follow-up|0|||
163473192|NCT03073200|590431123|FG010|Extension Period|Lost to Follow-up|0|||
163473193|NCT03073200|590431124|FG011|Extension Period|Lost to Follow-up|0|||
163473194|NCT03073200|590431125|FG012|Extension Period|Lost to Follow-up|0|||
163473195|NCT03073200|590431126|FG013|Extension Period|Lost to Follow-up|0|||
163473196|NCT03073200|590431127|FG014|Extension Period|Lost to Follow-up|0|||
163473197|NCT03073200|590431113|FG000|Extension Period|Sponsor Decision|0|||
163473198|NCT03073200|590431114|FG001|Extension Period|Sponsor Decision|0|||
163473199|NCT03073200|590431115|FG002|Extension Period|Sponsor Decision|0|||
163473200|NCT03073200|590431116|FG003|Extension Period|Sponsor Decision|0|||
163473201|NCT03073200|590431117|FG004|Extension Period|Sponsor Decision|0|||
163473202|NCT03073200|590431118|FG005|Extension Period|Sponsor Decision|0|||
163473203|NCT03073200|590431119|FG006|Extension Period|Sponsor Decision|0|||
163473204|NCT03073200|590431120|FG007|Extension Period|Sponsor Decision|0|||
163473205|NCT03073200|590431121|FG008|Extension Period|Sponsor Decision|1|||
163473206|NCT03073200|590431122|FG009|Extension Period|Sponsor Decision|0|||
163473207|NCT03073200|590431123|FG010|Extension Period|Sponsor Decision|0|||
163473208|NCT03073200|590431124|FG011|Extension Period|Sponsor Decision|0|||
163473209|NCT03073200|590431125|FG012|Extension Period|Sponsor Decision|0|||
163473210|NCT03073200|590431126|FG013|Extension Period|Sponsor Decision|0|||
163473211|NCT03073200|590431127|FG014|Extension Period|Sponsor Decision|0|||
163473212|NCT03073200|590431113|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
163473213|NCT03073200|590431114|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
163473214|NCT03073200|590431115|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
163473215|NCT03073200|590431116|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
163473216|NCT03073200|590431117|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
163473217|NCT03073200|590431118|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
163473218|NCT03073200|590431119|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
163473219|NCT03073200|590431120|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
163473220|NCT03073200|590431121|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
163473221|NCT03073200|590431122|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
163473222|NCT03073200|590431123|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
163473223|NCT03073200|590431124|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
163473224|NCT03073200|590431125|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
163473225|NCT03073200|590431126|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
163473226|NCT03073200|590431127|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
163473227|NCT03073200|590431113|FG000|Extension Period|Withdrawal by Subject|0|||
163473228|NCT03073200|590431114|FG001|Extension Period|Withdrawal by Subject|0|||
163473229|NCT03073200|590431115|FG002|Extension Period|Withdrawal by Subject|0|||
163473230|NCT03073200|590431116|FG003|Extension Period|Withdrawal by Subject|0|||
163473231|NCT03073200|590431117|FG004|Extension Period|Withdrawal by Subject|0|||
163473232|NCT03073200|590431118|FG005|Extension Period|Withdrawal by Subject|0|||
163473233|NCT03073200|590431119|FG006|Extension Period|Withdrawal by Subject|1|||
163473234|NCT03073200|590431120|FG007|Extension Period|Withdrawal by Subject|2|||
163473235|NCT03073200|590431121|FG008|Extension Period|Withdrawal by Subject|0|||
163473236|NCT03073200|590431122|FG009|Extension Period|Withdrawal by Subject|0|||
163473237|NCT03073200|590431123|FG010|Extension Period|Withdrawal by Subject|0|||
163473238|NCT03073200|590431124|FG011|Extension Period|Withdrawal by Subject|0|||
163473239|NCT03073200|590431125|FG012|Extension Period|Withdrawal by Subject|0|||
163473240|NCT03073200|590431126|FG013|Extension Period|Withdrawal by Subject|0|||
163473241|NCT03073200|590431127|FG014|Extension Period|Withdrawal by Subject|0|||
163473242|NCT03073200|590431113|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
163473243|NCT03073200|590431114|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
163473244|NCT03073200|590431115|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
163473245|NCT03073200|590431116|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
163473246|NCT03073200|590431117|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
163473247|NCT03073200|590431118|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
163473248|NCT03073200|590431119|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
163473249|NCT03073200|590431120|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
163473250|NCT03073200|590431121|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
163473251|NCT03073200|590431122|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
163473252|NCT03073200|590431123|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
163473253|NCT03073200|590431124|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
163473254|NCT03073200|590431125|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
163473255|NCT03073200|590431126|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
163473256|NCT03073200|590431127|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
163473257|NCT03073200|590431113|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
163473258|NCT03073200|590431114|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
163473259|NCT03073200|590431115|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
163473260|NCT03073200|590431116|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
163473261|NCT03073200|590431117|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
163473262|NCT03073200|590431118|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
163473263|NCT03073200|590431119|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
163473264|NCT03073200|590431120|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
163473265|NCT03073200|590431121|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
163473266|NCT03073200|590431122|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
163473267|NCT03073200|590431123|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
163473268|NCT03073200|590431124|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
163473269|NCT03073200|590431125|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
163473270|NCT03073200|590431126|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
163473271|NCT03073200|590431127|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
163473272|NCT03073200|590431113|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163473273|NCT03073200|590431114|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163473274|NCT03073200|590431115|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163473275|NCT03073200|590431116|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163473276|NCT03073200|590431117|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163473277|NCT03073200|590431118|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163473278|NCT03073200|590431119|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163473279|NCT03073200|590431120|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163473280|NCT03073200|590431121|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163473281|NCT03073200|590431122|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163473282|NCT03073200|590431123|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
163473283|NCT03073200|590431124|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
163473284|NCT03073200|590431125|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163473285|NCT03073200|590431126|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163473286|NCT03073200|590431127|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163473287|NCT03073200|590431113|FG000|Randomized Withdrawal Period|Adverse Event|0|||
163473288|NCT03073200|590431114|FG001|Randomized Withdrawal Period|Adverse Event|0|||
163473289|NCT03073200|590431115|FG002|Randomized Withdrawal Period|Adverse Event|0|||
163473290|NCT03073200|590431116|FG003|Randomized Withdrawal Period|Adverse Event|0|||
163473291|NCT03073200|590431117|FG004|Randomized Withdrawal Period|Adverse Event|0|||
163473292|NCT03073200|590431118|FG005|Randomized Withdrawal Period|Adverse Event|0|||
163473293|NCT03073200|590431119|FG006|Randomized Withdrawal Period|Adverse Event|0|||
163473294|NCT03073200|590431120|FG007|Randomized Withdrawal Period|Adverse Event|0|||
163473295|NCT03073200|590431121|FG008|Randomized Withdrawal Period|Adverse Event|0|||
163473296|NCT03073200|590431122|FG009|Randomized Withdrawal Period|Adverse Event|0|||
163473297|NCT03073200|590431123|FG010|Randomized Withdrawal Period|Adverse Event|1|||
163473298|NCT03073200|590431124|FG011|Randomized Withdrawal Period|Adverse Event|0|||
163473299|NCT03073200|590431125|FG012|Randomized Withdrawal Period|Adverse Event|0|||
163473300|NCT03073200|590431126|FG013|Randomized Withdrawal Period|Adverse Event|0|||
163473301|NCT03073200|590431127|FG014|Randomized Withdrawal Period|Adverse Event|0|||
163473302|NCT03073200|590431113|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
163473303|NCT03073200|590431114|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
163473304|NCT03073200|590431115|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
163473305|NCT03073200|590431116|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
163473306|NCT03073200|590431117|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
163473307|NCT03073200|590431118|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
163473308|NCT03073200|590431119|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
163473309|NCT03073200|590431120|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
163473310|NCT03073200|590431121|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
163473311|NCT03073200|590431122|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
163473312|NCT03073200|590431123|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
163473313|NCT03073200|590431124|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
163473314|NCT03073200|590431125|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
163473315|NCT03073200|590431126|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
163473316|NCT03073200|590431127|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
163473317|NCT03073200|590431113|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163473318|NCT03073200|590431114|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163473319|NCT03073200|590431115|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163473320|NCT03073200|590431116|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163473321|NCT03073200|590431117|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163473322|NCT03073200|590431118|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163473323|NCT03073200|590431119|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163473324|NCT03073200|590431120|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163473325|NCT03073200|590431121|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163473326|NCT03073200|590431122|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163473327|NCT03073200|590431123|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163473328|NCT03073200|590431124|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163473329|NCT03073200|590431125|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163473330|NCT03073200|590431126|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
163473331|NCT03073200|590431127|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163473332|NCT03073200|590431113|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
163473333|NCT03073200|590431114|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
163473334|NCT03073200|590431115|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
163473335|NCT03073200|590431116|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
163473336|NCT03073200|590431117|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
163473337|NCT03073200|590431118|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
163473338|NCT03073200|590431119|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
163473339|NCT03073200|590431120|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
163473340|NCT03073200|590431121|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
163473341|NCT03073200|590431122|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
163473342|NCT03073200|590431123|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
163473343|NCT03073200|590431124|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
163473344|NCT03073200|590431125|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
163473345|NCT03073200|590431126|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
163473346|NCT03073200|590431127|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
163473347|NCT03073200|590431113|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
163473348|NCT03073200|590431114|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
163473349|NCT03073200|590431115|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
163473350|NCT03073200|590431116|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
163473351|NCT03073200|590431117|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
163473352|NCT03073200|590431118|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
163473353|NCT03073200|590431119|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
163473354|NCT03073200|590431120|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
163473355|NCT03073200|590431121|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
163473356|NCT03073200|590431122|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
163473357|NCT03073200|590431123|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
163473358|NCT03073200|590431124|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
163473359|NCT03073200|590431125|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
163473360|NCT03073200|590431126|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
163473361|NCT03073200|590431127|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
163473362|NCT03073200|590431113|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
163473363|NCT03073200|590431114|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
163473364|NCT03073200|590431115|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
163473365|NCT03073200|590431116|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
163473366|NCT03073200|590431117|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
163473367|NCT03073200|590431118|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
163473368|NCT03073200|590431119|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
163473369|NCT03073200|590431120|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
163473370|NCT03073200|590431121|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
163473371|NCT03073200|590431122|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
163473372|NCT03073200|590431123|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
163473373|NCT03073200|590431124|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
163473374|NCT03073200|590431125|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
163473375|NCT03073200|590431126|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
163473376|NCT03073200|590431127|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
163473377|NCT03073200|590431113|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
163473378|NCT03073200|590431114|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
163473379|NCT03073200|590431115|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
163473380|NCT03073200|590431116|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
163473381|NCT03073200|590431117|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
163473382|NCT03073200|590431118|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
163473383|NCT03073200|590431119|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
163473384|NCT03073200|590431120|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
163473385|NCT03073200|590431121|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
163473386|NCT03073200|590431122|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
163473387|NCT03073200|590431123|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
163473388|NCT03073200|590431124|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
163473389|NCT03073200|590431125|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
163473390|NCT03073200|590431126|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
163473391|NCT03073200|590431127|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
163473392|NCT03073200|590431113|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163473393|NCT03073200|590431114|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163473394|NCT03073200|590431115|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163473395|NCT03073200|590431116|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163473396|NCT03073200|590431117|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163473397|NCT03073200|590431118|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163473398|NCT03073200|590431119|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163473399|NCT03073200|590431120|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163473400|NCT03073200|590431121|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163473401|NCT03073200|590431122|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163473402|NCT03073200|590431123|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163473403|NCT03073200|590431124|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163473404|NCT03073200|590431125|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163473405|NCT03073200|590431126|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
163473406|NCT03073200|590431127|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163473407|NCT03073200|590431113|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
163473408|NCT03073200|590431114|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
163473409|NCT03073200|590431115|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
163473410|NCT03073200|590431116|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
163473411|NCT03073200|590431117|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
163473412|NCT03073200|590431118|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
163473413|NCT03073200|590431119|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
163473414|NCT03073200|590431120|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
163473415|NCT03073200|590431121|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
163473416|NCT03073200|590431122|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
163473417|NCT03073200|590431123|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
163473418|NCT03073200|590431124|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
163473419|NCT03073200|590431125|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
163473420|NCT03073200|590431126|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
163473421|NCT03073200|590431127|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
163473422|NCT04757376|590431128|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
163473423|NCT04757376|590431129|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
163473424|NCT04757376|590431130|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
163473425|NCT04757376|590431131|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
163473426|NCT04757376|590431132|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
163473427|NCT04757376|590431128|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
163473428|NCT04757376|590431129|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
163473429|NCT04757376|590431130|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
163473430|NCT04757376|590431131|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
163473431|NCT04757376|590431132|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
163473432|NCT04757376|590431128|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
163473433|NCT04757376|590431129|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
163473434|NCT04757376|590431130|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
163473435|NCT04757376|590431131|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
163473436|NCT04757376|590431132|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
163473437|NCT04757376|590431128|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
163473438|NCT04757376|590431129|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
163473439|NCT04757376|590431130|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
163473440|NCT04757376|590431131|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
163473441|NCT04757376|590431132|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
163473442|NCT04757376|590431128|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
163473443|NCT04757376|590431129|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
163473444|NCT04757376|590431130|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
163473445|NCT04757376|590431131|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
163473446|NCT04757376|590431132|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
163473447|NCT04757376|590431128|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
163473448|NCT04757376|590431129|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
163473449|NCT04757376|590431130|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
163473450|NCT04757376|590431131|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
163473451|NCT04757376|590431132|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
163473452|NCT04757376|590431128|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
163473453|NCT04757376|590431129|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
163473454|NCT04757376|590431130|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
163473455|NCT04757376|590431131|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
163473456|NCT04757376|590431132|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
163473457|NCT04757376|590431128|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
163473458|NCT04757376|590431129|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
163473459|NCT04757376|590431130|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
163473460|NCT04757376|590431131|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
163473461|NCT04757376|590431132|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
163473462|NCT01307046|590431133|FG000|Overall Study|Adverse Event|3|||
163473463|NCT01307046|590431134|FG001|Overall Study|Adverse Event|3|||
163473464|NCT01307046|590431133|FG000|Overall Study|Lack of Efficacy|0|||
163473465|NCT01307046|590431134|FG001|Overall Study|Lack of Efficacy|2|||
163473466|NCT01307046|590431133|FG000|Overall Study|Physician Decision|2|||
163473467|NCT01307046|590431134|FG001|Overall Study|Physician Decision|0|||
163473468|NCT01307046|590431133|FG000|Overall Study|Withdrawal by Subject|1|||
163473469|NCT01307046|590431134|FG001|Overall Study|Withdrawal by Subject|1|||
163473470|NCT01307046|590431133|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
163473471|NCT01307046|590431134|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
163473472|NCT01307046|590431133|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
163473473|NCT01307046|590431134|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
163473474|NCT03898323|590431135|FG000|Overall Study|Physician Decision|1|||
163473475|NCT00397891|590431144|FG000|Overall Study|Withdrawal by Subject|1|||
163473476|NCT00397891|590431145|FG001|Overall Study|Withdrawal by Subject|0|||
163473477|NCT00397891|590431146|FG002|Overall Study|Withdrawal by Subject|0|||
163473478|NCT00397891|590431147|FG003|Overall Study|Withdrawal by Subject|0|||
163473479|NCT00397891|590431148|FG004|Overall Study|Withdrawal by Subject|1|||
163473480|NCT00796224|590431151|FG000|Overall Study|Adverse Event|1|||
163473481|NCT00796224|590431152|FG001|Overall Study|Adverse Event|0|||
163473482|NCT00796224|590431151|FG000|Overall Study|Protocol Violation|0|||
163473483|NCT00796224|590431152|FG001|Overall Study|Protocol Violation|1|||
163473484|NCT02569398|590431157|FG000|Overall Study|Adverse Event|0|||
163473485|NCT02569398|590431158|FG001|Overall Study|Adverse Event|1|||
163473486|NCT02569398|590431159|FG002|Overall Study|Adverse Event|6|||
163473487|NCT02569398|590431157|FG000|Overall Study|Withdrawal by Subject|43|||
163473488|NCT02569398|590431158|FG001|Overall Study|Withdrawal by Subject|43|||
163473489|NCT02569398|590431159|FG002|Overall Study|Withdrawal by Subject|30|||
163473490|NCT02569398|590431157|FG000|Overall Study|Study terminated by sponsor|130|||
163473491|NCT02569398|590431158|FG001|Overall Study|Study terminated by sponsor|131|||
163473492|NCT02569398|590431159|FG002|Overall Study|Study terminated by sponsor|134|||
163473493|NCT02569398|590431157|FG000|Overall Study|Other|12|||
163473494|NCT02569398|590431158|FG001|Overall Study|Other|14|||
163473495|NCT02569398|590431159|FG002|Overall Study|Other|13|||
163473496|NCT02116361|590431162|FG000|Overall Study|Pregnancy|0|||
163473497|NCT02116361|590431163|FG001|Overall Study|Pregnancy|0|||
163473498|NCT02116361|590431164|FG002|Overall Study|Pregnancy|0|||
163473499|NCT02116361|590431165|FG003|Overall Study|Pregnancy|1|||
163473500|NCT02116361|590431162|FG000|Overall Study|Protocol Violation|1|||
163473501|NCT02116361|590431163|FG001|Overall Study|Protocol Violation|0|||
163473502|NCT02116361|590431164|FG002|Overall Study|Protocol Violation|0|||
163473503|NCT02116361|590431165|FG003|Overall Study|Protocol Violation|2|||
163473504|NCT02116361|590431162|FG000|Overall Study|Physician Decision|2|||
163473505|NCT02116361|590431163|FG001|Overall Study|Physician Decision|3|||
163473506|NCT02116361|590431164|FG002|Overall Study|Physician Decision|0|||
163473507|NCT02116361|590431165|FG003|Overall Study|Physician Decision|0|||
163473508|NCT02116361|590431162|FG000|Overall Study|Adverse Event|1|||
163473509|NCT02116361|590431163|FG001|Overall Study|Adverse Event|0|||
163473510|NCT02116361|590431164|FG002|Overall Study|Adverse Event|0|||
163473511|NCT02116361|590431165|FG003|Overall Study|Adverse Event|3|||
163473512|NCT02116361|590431162|FG000|Overall Study|Other Reasons|3|||
163473513|NCT02116361|590431163|FG001|Overall Study|Other Reasons|3|||
163473514|NCT02116361|590431164|FG002|Overall Study|Other Reasons|3|||
163473515|NCT02116361|590431165|FG003|Overall Study|Other Reasons|3|||
163473516|NCT02116361|590431162|FG000|Overall Study|Lack of Efficacy|5|||
163473517|NCT02116361|590431163|FG001|Overall Study|Lack of Efficacy|7|||
163473518|NCT02116361|590431164|FG002|Overall Study|Lack of Efficacy|4|||
163473519|NCT02116361|590431165|FG003|Overall Study|Lack of Efficacy|3|||
163473520|NCT02116361|590431162|FG000|Overall Study|Lost to Follow-up|4|||
163473521|NCT02116361|590431163|FG001|Overall Study|Lost to Follow-up|5|||
163473522|NCT02116361|590431164|FG002|Overall Study|Lost to Follow-up|7|||
163473523|NCT02116361|590431165|FG003|Overall Study|Lost to Follow-up|5|||
163473524|NCT02116361|590431162|FG000|Overall Study|Personal Reasons|6|||
163473525|NCT02116361|590431163|FG001|Overall Study|Personal Reasons|6|||
163473526|NCT02116361|590431164|FG002|Overall Study|Personal Reasons|4|||
163473527|NCT02116361|590431165|FG003|Overall Study|Personal Reasons|9|||
163473528|NCT02116361|590431162|FG000|Overall Study|Investigator Decision - Relapse|9|||
163473529|NCT02116361|590431163|FG001|Overall Study|Investigator Decision - Relapse|7|||
163473530|NCT02116361|590431164|FG002|Overall Study|Investigator Decision - Relapse|8|||
163473531|NCT02116361|590431165|FG003|Overall Study|Investigator Decision - Relapse|5|||
163473532|NCT02571972|590431166|FG000|Overall Study|Protocol Violation|2|||
163473533|NCT02571972|590431166|FG000|Overall Study|Withdrawal by Subject|2|||
163473534|NCT04195750|590431167|FG000|Overall Study|Death|245|||
163473535|NCT04195750|590431168|FG001|Overall Study|Death|253|||
163473536|NCT04195750|590431169|FG002|Overall Study|Death|5|||
163473537|NCT04195750|590431167|FG000|Overall Study|Physician Decision|0|||
163473538|NCT04195750|590431168|FG001|Overall Study|Physician Decision|1|||
163473539|NCT04195750|590431169|FG002|Overall Study|Physician Decision|0|||
163473540|NCT04195750|590431167|FG000|Overall Study|Withdrawal by Subject|9|||
163473541|NCT04195750|590431168|FG001|Overall Study|Withdrawal by Subject|8|||
163473542|NCT04195750|590431169|FG002|Overall Study|Withdrawal by Subject|0|||
163473543|NCT04195750|590431167|FG000|Overall Study|Ongoing|120|||
163473544|NCT04195750|590431168|FG001|Overall Study|Ongoing|110|||
163473545|NCT04195750|590431169|FG002|Overall Study|Ongoing|4|||
163473546|NCT02406027|590431170|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
163473547|NCT02406027|590431171|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
163473548|NCT02406027|590431172|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
163473549|NCT02406027|590431173|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
163473550|NCT02406027|590431174|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
163473551|NCT02406027|590431175|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
163473552|NCT02406027|590431176|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
163473553|NCT02406027|590431170|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
163473554|NCT02406027|590431171|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
163473555|NCT02406027|590431172|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
163473556|NCT02406027|590431173|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
163473557|NCT02406027|590431174|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
163473558|NCT02406027|590431175|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
163473559|NCT02406027|590431176|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
163473560|NCT02406027|590431170|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
163473561|NCT02406027|590431171|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
163473562|NCT02406027|590431172|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
163473563|NCT02406027|590431173|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
163473564|NCT02406027|590431174|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
163473565|NCT02406027|590431175|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
163473566|NCT02406027|590431176|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
163473567|NCT02406027|590431170|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
163473568|NCT02406027|590431171|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
163473569|NCT02406027|590431172|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
163473570|NCT02406027|590431173|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
163473571|NCT02406027|590431174|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
163473572|NCT02406027|590431175|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
163473573|NCT02406027|590431176|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
163473574|NCT02406027|590431170|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
163473575|NCT02406027|590431171|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
163473576|NCT02406027|590431172|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
163473577|NCT02406027|590431173|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
163473578|NCT02406027|590431174|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
163473579|NCT02406027|590431175|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
163473580|NCT02406027|590431176|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
163473581|NCT02406027|590431170|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
163473582|NCT02406027|590431171|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
163473583|NCT02406027|590431172|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
163473584|NCT02406027|590431173|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
163473585|NCT02406027|590431174|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
163473586|NCT02406027|590431175|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
163473587|NCT02406027|590431176|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
163473588|NCT02406027|590431170|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
163473589|NCT02406027|590431171|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
163473590|NCT02406027|590431172|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
163473591|NCT02406027|590431173|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
163473592|NCT02406027|590431174|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
163473593|NCT02406027|590431175|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
163473594|NCT02406027|590431176|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
163473595|NCT02406027|590431170|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
163473596|NCT02406027|590431171|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
163473597|NCT02406027|590431172|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
163473598|NCT02406027|590431173|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
163473599|NCT02406027|590431174|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
163473600|NCT02406027|590431175|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
163473601|NCT02406027|590431176|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
163473602|NCT02406027|590431170|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
163473603|NCT02406027|590431171|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
163473604|NCT02406027|590431172|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
163473605|NCT02406027|590431173|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
163473606|NCT02406027|590431174|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
163473607|NCT02406027|590431175|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
163473608|NCT02406027|590431176|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
163473609|NCT02406027|590431170|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
163473610|NCT02406027|590431171|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
163473611|NCT02406027|590431172|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
163473612|NCT02406027|590431173|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
163473613|NCT02406027|590431174|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
163473614|NCT02406027|590431175|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
163473615|NCT02406027|590431176|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
163473616|NCT04363944|590431177|FG000|Overall Study|Withdrawal by Subject|2|||
163473617|NCT04363944|590431178|FG001|Overall Study|Withdrawal by Subject|0|||
163473618|NCT03559192|590431179|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
163473619|NCT03559192|590431180|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
163473620|NCT03559192|590431181|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
163473621|NCT03559192|590431179|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
163473622|NCT03559192|590431180|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
163473623|NCT03559192|590431181|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
163473624|NCT03559192|590431179|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
163473625|NCT03559192|590431180|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
163473626|NCT03559192|590431181|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
163473627|NCT03559192|590431179|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
163473628|NCT03559192|590431180|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
163473629|NCT03559192|590431181|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
163473630|NCT03559192|590431179|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
163473631|NCT03559192|590431180|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
163473632|NCT03559192|590431181|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
163473633|NCT03559192|590431179|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
163473634|NCT03559192|590431180|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
163473635|NCT03559192|590431181|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
163473636|NCT03559192|590431179|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
163473637|NCT03559192|590431180|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
163473638|NCT03559192|590431181|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
163473639|NCT03559192|590431179|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
163473640|NCT03559192|590431180|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
163473641|NCT03559192|590431181|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
163473642|NCT03559192|590431179|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
163473643|NCT03559192|590431180|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
163473644|NCT03559192|590431181|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
163473645|NCT03517722|590431182|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
163473646|NCT03517722|590431183|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
163473647|NCT03517722|590431182|FG000|Double Blind Period: Week 0-52|Death|0|||
163473648|NCT03517722|590431183|FG001|Double Blind Period: Week 0-52|Death|4|||
163473649|NCT03517722|590431182|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
163473650|NCT03517722|590431183|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
163473651|NCT03517722|590431182|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
163473652|NCT03517722|590431183|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
163473653|NCT03517722|590431182|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
163473654|NCT03517722|590431183|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
163473655|NCT03517722|590431182|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
163473656|NCT03517722|590431183|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
163473657|NCT03517722|590431182|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
163473658|NCT03517722|590431183|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
163473659|NCT03517722|590431182|FG000|Double Blind Period: Week 0-52|Other|4|||
163473660|NCT03517722|590431183|FG001|Double Blind Period: Week 0-52|Other|3|||
163473661|NCT03517722|590431182|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
163473662|NCT03517722|590431183|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
163473663|NCT03517722|590431182|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
163473664|NCT03517722|590431183|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
163473665|NCT03517722|590431182|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
163473666|NCT03517722|590431183|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
163473667|NCT03517722|590431182|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
163473668|NCT03517722|590431183|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
163473669|NCT03517722|590431182|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
163473670|NCT03517722|590431183|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
163473671|NCT02177812|590431186|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
163473672|NCT02177812|590431187|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
163473673|NCT02177812|590431188|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
163473674|NCT02177812|590431189|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
163473675|NCT02177812|590431190|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
163473676|NCT02177812|590431191|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
163473677|NCT02177812|590431192|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
163473678|NCT02177812|590431193|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
163473679|NCT02177812|590431194|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
163473680|NCT02177812|590431186|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
163473681|NCT02177812|590431187|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
163473682|NCT02177812|590431188|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
163473683|NCT02177812|590431189|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
163473684|NCT02177812|590431190|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
163473685|NCT02177812|590431191|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
163473686|NCT02177812|590431192|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
163473687|NCT02177812|590431193|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
163473688|NCT02177812|590431194|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
163473689|NCT02177812|590431186|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
163473690|NCT02177812|590431187|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
163473691|NCT02177812|590431188|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
163473692|NCT02177812|590431189|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
163473693|NCT02177812|590431190|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
163473694|NCT02177812|590431191|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
163473695|NCT02177812|590431192|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
163473696|NCT02177812|590431193|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
163473697|NCT02177812|590431194|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
163473698|NCT00089999|590431195|FG000|Overall Study|Adverse Event|4|||
163473699|NCT00089999|590431196|FG001|Overall Study|Adverse Event|7|||
163473700|NCT00089999|590431195|FG000|Overall Study|Withdrawal by Subject|0|||
163473701|NCT00089999|590431196|FG001|Overall Study|Withdrawal by Subject|4|||
163473702|NCT00089999|590431195|FG000|Overall Study|Lost to Follow-up|2|||
163473703|NCT00089999|590431196|FG001|Overall Study|Lost to Follow-up|1|||
163473704|NCT00089999|590431195|FG000|Overall Study|Radiological Progression of Cancer|52|||
163473705|NCT00089999|590431196|FG001|Overall Study|Radiological Progression of Cancer|44|||
163473706|NCT00089999|590431195|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
163473707|NCT00089999|590431196|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
163473708|NCT00089999|590431195|FG000|Overall Study|Death|3|||
163473709|NCT00089999|590431196|FG001|Overall Study|Death|3|||
163473710|NCT00089999|590431195|FG000|Overall Study|Poor General Condition|1|||
163473711|NCT00089999|590431196|FG001|Overall Study|Poor General Condition|0|||
163473712|NCT00089999|590431195|FG000|Overall Study|Clinical Progression|1|||
163473713|NCT00089999|590431196|FG001|Overall Study|Clinical Progression|2|||
163473714|NCT00089999|590431195|FG000|Overall Study|Physician Decision|2|||
163473715|NCT00089999|590431196|FG001|Overall Study|Physician Decision|2|||
163473716|NCT00089999|590431195|FG000|Overall Study|Patient Underwent Surgery|2|||
163473717|NCT00089999|590431196|FG001|Overall Study|Patient Underwent Surgery|0|||
163473718|NCT00089999|590431195|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
163473719|NCT00089999|590431196|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
163473720|NCT04418427|590432820|FG000|Overall Study|Death|0|||
163473721|NCT04418427|590432821|FG001|Overall Study|Death|1|||
163473722|NCT04418427|590432822|FG002|Overall Study|Death|0|||
163473723|NCT04418427|590432820|FG000|Overall Study|Lost to Follow-up|0|||
163473724|NCT04418427|590432821|FG001|Overall Study|Lost to Follow-up|2|||
163473725|NCT04418427|590432822|FG002|Overall Study|Lost to Follow-up|2|||
163473726|NCT04418427|590432820|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
163473727|NCT04418427|590432821|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
163473728|NCT04418427|590432822|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
163473729|NCT04418427|590432820|FG000|Overall Study|Pre-existing medical condition|0|||
163473730|NCT04418427|590432821|FG001|Overall Study|Pre-existing medical condition|1|||
163473731|NCT04418427|590432822|FG002|Overall Study|Pre-existing medical condition|0|||
163473732|NCT01673373|590432825|FG000|Overall Study|Death|2|||
163473733|NCT01654224|590432826|FG000|Overall Study|Lost to Follow-up|2|||
163473734|NCT01654224|590432827|FG001|Overall Study|Lost to Follow-up|2|||
163473735|NCT01654224|590432826|FG000|Overall Study|Did not receive allocation|1|||
163473736|NCT01654224|590432827|FG001|Overall Study|Did not receive allocation|8|||
163473737|NCT01654224|590432826|FG000|Overall Study|Insufficient blood sample|3|||
163473738|NCT01654224|590432827|FG001|Overall Study|Insufficient blood sample|2|||
163473739|NCT00166504|590432829|FG000|Overall Study|Adverse Event|3|||
163473740|NCT00166504|590432830|FG001|Overall Study|Adverse Event|3|||
163473741|NCT00166504|590432829|FG000|Overall Study|Lost to Follow-up|1|||
163473742|NCT00166504|590432830|FG001|Overall Study|Lost to Follow-up|1|||
163473743|NCT00166504|590432829|FG000|Overall Study|Withdrawal by Subject|1|||
163473744|NCT00166504|590432830|FG001|Overall Study|Withdrawal by Subject|0|||
163473745|NCT03261037|590432833|FG000|Overall Study|Withdrawal by Subject|2|||
163473746|NCT03261037|590432834|FG001|Overall Study|Withdrawal by Subject|13|||
163473747|NCT03261037|590432835|FG002|Overall Study|Withdrawal by Subject|0|||
163473748|NCT03261037|590432836|FG003|Overall Study|Withdrawal by Subject|18|||
163473749|NCT03261037|590432833|FG000|Overall Study|Non-compliance with study procedures|0|||
163473750|NCT03261037|590432834|FG001|Overall Study|Non-compliance with study procedures|2|||
163473751|NCT03261037|590432835|FG002|Overall Study|Non-compliance with study procedures|0|||
163473752|NCT03261037|590432836|FG003|Overall Study|Non-compliance with study procedures|6|||
163473753|NCT03261037|590432833|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
163473754|NCT03261037|590432834|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
163473755|NCT03261037|590432835|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
163473756|NCT03261037|590432836|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
163473757|NCT03261037|590432833|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
163473758|NCT03261037|590432834|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
163473759|NCT03261037|590432835|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
163473760|NCT03261037|590432836|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
163473761|NCT03261037|590432833|FG000|Overall Study|Diagnosed but protocol deviation|1|||
163473762|NCT03261037|590432834|FG001|Overall Study|Diagnosed but protocol deviation|0|||
163473763|NCT03261037|590432835|FG002|Overall Study|Diagnosed but protocol deviation|0|||
163473764|NCT03261037|590432836|FG003|Overall Study|Diagnosed but protocol deviation|0|||
163473765|NCT03261037|590432833|FG000|Overall Study|Participant did not want to continue the study|0|||
163473766|NCT03261037|590432834|FG001|Overall Study|Participant did not want to continue the study|1|||
163473767|NCT03261037|590432835|FG002|Overall Study|Participant did not want to continue the study|0|||
163473768|NCT03261037|590432836|FG003|Overall Study|Participant did not want to continue the study|0|||
163473769|NCT03261037|590432833|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
163473770|NCT03261037|590432834|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
163473771|NCT03261037|590432835|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
163473772|NCT03261037|590432836|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
163473773|NCT03261037|590432833|FG000|Overall Study|Participant presented clinical improvement|0|||
163473774|NCT03261037|590432834|FG001|Overall Study|Participant presented clinical improvement|2|||
163473775|NCT03261037|590432835|FG002|Overall Study|Participant presented clinical improvement|0|||
163473776|NCT03261037|590432836|FG003|Overall Study|Participant presented clinical improvement|0|||
163473777|NCT03261037|590432833|FG000|Overall Study|Technical difficulties|0|||
163473778|NCT03261037|590432834|FG001|Overall Study|Technical difficulties|0|||
163473779|NCT03261037|590432835|FG002|Overall Study|Technical difficulties|0|||
163473780|NCT03261037|590432836|FG003|Overall Study|Technical difficulties|1|||
163473781|NCT03261037|590432833|FG000|Overall Study|Equipment failed to work|0|||
163473782|NCT03261037|590432834|FG001|Overall Study|Equipment failed to work|0|||
163473783|NCT03261037|590432835|FG002|Overall Study|Equipment failed to work|0|||
163473784|NCT03261037|590432836|FG003|Overall Study|Equipment failed to work|1|||
163473785|NCT03261037|590432833|FG000|Overall Study|End of study for participant and no follow up|0|||
163473786|NCT03261037|590432834|FG001|Overall Study|End of study for participant and no follow up|0|||
163473787|NCT03261037|590432835|FG002|Overall Study|End of study for participant and no follow up|0|||
163473788|NCT03261037|590432836|FG003|Overall Study|End of study for participant and no follow up|1|||
163473789|NCT03261037|590432833|FG000|Overall Study|Participant was too weak to continue in study|1|||
163473790|NCT03261037|590432834|FG001|Overall Study|Participant was too weak to continue in study|0|||
163473791|NCT03261037|590432835|FG002|Overall Study|Participant was too weak to continue in study|0|||
163473792|NCT03261037|590432836|FG003|Overall Study|Participant was too weak to continue in study|0|||
163473793|NCT04423718|590432837|FG000|Main Study|Adverse Event|9|||
163473794|NCT04423718|590432838|FG001|Main Study|Adverse Event|5|||
163473795|NCT04423718|590432839|FG002|Main Study|Adverse Event|8|||
163473796|NCT04423718|590432837|FG000|Main Study|Physician Decision|3|||
163473797|NCT04423718|590432838|FG001|Main Study|Physician Decision|3|||
163473798|NCT04423718|590432839|FG002|Main Study|Physician Decision|2|||
163473799|NCT04423718|590432837|FG000|Main Study|Protocol Violation|0|||
163473800|NCT04423718|590432838|FG001|Main Study|Protocol Violation|0|||
163473801|NCT04423718|590432839|FG002|Main Study|Protocol Violation|1|||
163473802|NCT04423718|590432837|FG000|Main Study|Lost to Follow-up|3|||
163473803|NCT04423718|590432838|FG001|Main Study|Lost to Follow-up|3|||
163473804|NCT04423718|590432839|FG002|Main Study|Lost to Follow-up|4|||
163473805|NCT04423718|590432837|FG000|Main Study|Lack of Efficacy|2|||
163473806|NCT04423718|590432838|FG001|Main Study|Lack of Efficacy|1|||
163473807|NCT04423718|590432839|FG002|Main Study|Lack of Efficacy|0|||
163473808|NCT04423718|590432837|FG000|Main Study|Withdrawal by Subject|14|||
163473809|NCT04423718|590432838|FG001|Main Study|Withdrawal by Subject|20|||
163473810|NCT04423718|590432839|FG002|Main Study|Withdrawal by Subject|20|||
163473811|NCT04423718|590432837|FG000|Main Study|Death|10|||
163473812|NCT04423718|590432838|FG001|Main Study|Death|7|||
163473813|NCT04423718|590432839|FG002|Main Study|Death|7|||
163473814|NCT04423718|590432837|FG000|Main Study|COVID-19 pandemic|2|||
163473815|NCT04423718|590432838|FG001|Main Study|COVID-19 pandemic|2|||
163473816|NCT04423718|590432839|FG002|Main Study|COVID-19 pandemic|2|||
163473817|NCT04423718|590432837|FG000|Main Study|Other|7|||
163473818|NCT04423718|590432838|FG001|Main Study|Other|3|||
163473819|NCT04423718|590432839|FG002|Main Study|Other|2|||
163473820|NCT04423718|590432837|FG000|Extension Phase|Other|1|||
163473821|NCT04423718|590432838|FG001|Extension Phase|Other|0|||
163473822|NCT04423718|590432839|FG002|Extension Phase|Other|0|||
163473823|NCT04423718|590432837|FG000|Extension Phase|Logistical problems|0|||
163473824|NCT04423718|590432838|FG001|Extension Phase|Logistical problems|1|||
163473825|NCT04423718|590432839|FG002|Extension Phase|Logistical problems|1|||
163473826|NCT04423718|590432837|FG000|Extension Phase|Physician Decision|1|||
163473827|NCT04423718|590432838|FG001|Extension Phase|Physician Decision|0|||
163473828|NCT04423718|590432839|FG002|Extension Phase|Physician Decision|1|||
163473829|NCT04423718|590432837|FG000|Extension Phase|Lack of Efficacy|2|||
163473830|NCT04423718|590432838|FG001|Extension Phase|Lack of Efficacy|0|||
163473831|NCT04423718|590432839|FG002|Extension Phase|Lack of Efficacy|1|||
163473832|NCT04423718|590432837|FG000|Extension Phase|Lost to Follow-up|0|||
163473833|NCT04423718|590432838|FG001|Extension Phase|Lost to Follow-up|2|||
163473834|NCT04423718|590432839|FG002|Extension Phase|Lost to Follow-up|3|||
163473835|NCT04423718|590432837|FG000|Extension Phase|Adverse Event|2|||
163473836|NCT04423718|590432838|FG001|Extension Phase|Adverse Event|3|||
163473837|NCT04423718|590432839|FG002|Extension Phase|Adverse Event|1|||
163473838|NCT04423718|590432837|FG000|Extension Phase|Death|4|||
163473839|NCT04423718|590432838|FG001|Extension Phase|Death|7|||
163473840|NCT04423718|590432839|FG002|Extension Phase|Death|2|||
163473841|NCT04423718|590432837|FG000|Extension Phase|Withdrawal by Subject|11|||
163473842|NCT04423718|590432838|FG001|Extension Phase|Withdrawal by Subject|11|||
163473843|NCT04423718|590432839|FG002|Extension Phase|Withdrawal by Subject|7|||
163473844|NCT00589602|590432843|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
163473845|NCT05298774|590432847|FG000|Overall Study|Physician Decision|3|||
163473846|NCT05298774|590432847|FG000|Overall Study|Withdrawal by Subject|2|||
163473847|NCT05298774|590432847|FG000|Overall Study|Lost to Follow-up|3|||
163473848|NCT05298774|590432847|FG000|Overall Study|Screen failure|1|||
163473849|NCT04992507|590432848|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
163473850|NCT04992507|590432849|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
163473851|NCT04992507|590432848|FG000|Overall Study|Death|0|||
163473852|NCT04992507|590432849|FG001|Overall Study|Death|1|||
163473853|NCT03887052|590432850|FG000|Overall Study|Adverse Event|2|||
163473854|NCT03887052|590432850|FG000|Overall Study|Physician Decision|2|||
163473855|NCT03887052|590432850|FG000|Overall Study|Withdrawal by Subject|3|||
163473856|NCT03887052|590432850|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
163473857|NCT03887052|590432850|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
163473858|NCT04517253|590432853|FG000|Primary Treatment Period|Adverse Event|1|||
163473859|NCT04517253|590432854|FG001|Primary Treatment Period|Adverse Event|0|||
163473860|NCT04517253|590432855|FG002|Primary Treatment Period|Adverse Event|0|||
163473861|NCT04517253|590432853|FG000|Primary Treatment Period|Death|0|||
163473862|NCT04517253|590432854|FG001|Primary Treatment Period|Death|1|||
163473863|NCT04517253|590432855|FG002|Primary Treatment Period|Death|0|||
163473864|NCT04517253|590432853|FG000|Maintenance Period|Withdrawal by Subject|1|||
163473865|NCT04517253|590432854|FG001|Maintenance Period|Withdrawal by Subject|0|||
163473866|NCT04517253|590432855|FG002|Maintenance Period|Withdrawal by Subject|0|||
163473867|NCT04517253|590432853|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
163473868|NCT04517253|590432854|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
163473869|NCT04517253|590432855|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
163473870|NCT01023516|590432856|FG000|Overall Study|Voluntary discontinuation|7|||
163473871|NCT01023516|590432857|FG001|Overall Study|Voluntary discontinuation|5|||
163473872|NCT01023516|590432856|FG000|Overall Study|Adverse Event|9|||
163473873|NCT01023516|590432857|FG001|Overall Study|Adverse Event|6|||
163473874|NCT01023516|590432856|FG000|Overall Study|Safety reason|0|||
163473875|NCT01023516|590432857|FG001|Overall Study|Safety reason|3|||
163473876|NCT01023516|590432856|FG000|Overall Study|Study-specific criteria|4|||
163473877|NCT01023516|590432857|FG001|Overall Study|Study-specific criteria|2|||
163473878|NCT01023516|590432856|FG000|Overall Study|Incorrect enrolment|4|||
163473879|NCT01023516|590432857|FG001|Overall Study|Incorrect enrolment|2|||
163473880|NCT01058395|590432858|FG000|Overall Study|Death|2|||
163473881|NCT01058395|590432859|FG001|Overall Study|Death|1|||
163473882|NCT01058395|590432858|FG000|Overall Study|Lost to Follow-up|1|||
163473883|NCT01058395|590432859|FG001|Overall Study|Lost to Follow-up|0|||
163473884|NCT01266876|590432860|FG000|Overall Study|Adverse Event|0|||
163473885|NCT01266876|590432861|FG001|Overall Study|Adverse Event|0|||
163473886|NCT01266876|590432862|FG002|Overall Study|Adverse Event|0|||
163473887|NCT01266876|590432863|FG003|Overall Study|Adverse Event|1|||
163473888|NCT01266876|590432864|FG004|Overall Study|Adverse Event|0|||
163473889|NCT05016037|590432866|FG000|Overall Study|Lost to Follow-up|2|||
163473890|NCT00557323|590432867|FG000|Overall Study|Death|3|||
163473891|NCT00557323|590432867|FG000|Overall Study|Withdrawal by Subject|2|||
163473892|NCT00557323|590432867|FG000|Overall Study|Administrative change|2|||
163473893|NCT04007367|590432868|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
163473894|NCT04007367|590432869|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
163473895|NCT04007367|590432870|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
163473896|NCT04007367|590432868|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
163473897|NCT04007367|590432869|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
163473898|NCT04007367|590432870|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
163473899|NCT04007367|590432868|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
163473900|NCT04007367|590432869|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
163473901|NCT04007367|590432870|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
163473902|NCT04007367|590432868|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
163473903|NCT04007367|590432869|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
163473904|NCT04007367|590432870|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
163473905|NCT04007367|590432868|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
163473906|NCT04007367|590432869|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
163473907|NCT04007367|590432870|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
163473908|NCT02010567|590432873|FG000|Overall Study|Adverse Event|0|||
163473909|NCT02010567|590432874|FG001|Overall Study|Adverse Event|0|||
163473910|NCT02010567|590432875|FG002|Overall Study|Adverse Event|1|||
163473911|NCT02010567|590432876|FG003|Overall Study|Adverse Event|0|||
163473912|NCT02010567|590432877|FG004|Overall Study|Adverse Event|1|||
163473913|NCT00606229|590432881|FG000|Overall Study|Adverse Event|11|||
163473914|NCT00606229|590432881|FG000|Overall Study|Lack of Efficacy|1|||
163473915|NCT00606229|590432881|FG000|Overall Study|Withdrawal by Subject|4|||
163473916|NCT00606229|590432881|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
163473917|NCT00606229|590432881|FG000|Overall Study|change of residence or other commitments|2|||
163473918|NCT03523715|590432882|FG000|Overall Study|Lost to Follow-up|11|||
163473919|NCT03523715|590432883|FG001|Overall Study|Lost to Follow-up|14|||
163473920|NCT03523715|590432882|FG000|Overall Study|Did not meet inclusion criteria|1|||
163473921|NCT03523715|590432883|FG001|Overall Study|Did not meet inclusion criteria|0|||
163473922|NCT03523715|590432882|FG000|Overall Study|Internally inconsistent reporting|0|||
163473923|NCT03523715|590432883|FG001|Overall Study|Internally inconsistent reporting|2|||
163473924|NCT01526928|590432884|FG000|Overall Study|Progressive Disease|35|||
163473925|NCT01526928|590432885|FG001|Overall Study|Progressive Disease|17|||
163473926|NCT01526928|590432886|FG002|Overall Study|Progressive Disease|150|||
163473927|NCT01526928|590432887|FG003|Overall Study|Progressive Disease|182|||
163473928|NCT01526928|590432888|FG004|Overall Study|Progressive Disease|76|||
163473929|NCT01526928|590432889|FG005|Overall Study|Progressive Disease|4|||
163473930|NCT01526928|590432884|FG000|Overall Study|Adverse Event|2|||
163473931|NCT01526928|590432885|FG001|Overall Study|Adverse Event|1|||
163473932|NCT01526928|590432886|FG002|Overall Study|Adverse Event|29|||
163473933|NCT01526928|590432887|FG003|Overall Study|Adverse Event|40|||
163473934|NCT01526928|590432888|FG004|Overall Study|Adverse Event|13|||
163473935|NCT01526928|590432889|FG005|Overall Study|Adverse Event|2|||
163473936|NCT01526928|590432884|FG000|Overall Study|Death|0|||
163473937|NCT01526928|590432885|FG001|Overall Study|Death|0|||
163473938|NCT01526928|590432886|FG002|Overall Study|Death|3|||
163473939|NCT01526928|590432887|FG003|Overall Study|Death|0|||
163473940|NCT01526928|590432888|FG004|Overall Study|Death|0|||
163473941|NCT01526928|590432889|FG005|Overall Study|Death|0|||
163473942|NCT01526928|590432884|FG000|Overall Study|Withdrawal by Subject|1|||
163473943|NCT01526928|590432885|FG001|Overall Study|Withdrawal by Subject|0|||
163473944|NCT01526928|590432886|FG002|Overall Study|Withdrawal by Subject|13|||
163473945|NCT01526928|590432887|FG003|Overall Study|Withdrawal by Subject|11|||
163473946|NCT01526928|590432888|FG004|Overall Study|Withdrawal by Subject|3|||
163473947|NCT01526928|590432889|FG005|Overall Study|Withdrawal by Subject|0|||
163473948|NCT01526928|590432884|FG000|Overall Study|Physician Decision|0|||
163473949|NCT01526928|590432885|FG001|Overall Study|Physician Decision|0|||
163473950|NCT01526928|590432886|FG002|Overall Study|Physician Decision|2|||
163473951|NCT01526928|590432887|FG003|Overall Study|Physician Decision|5|||
163473952|NCT01526928|590432888|FG004|Overall Study|Physician Decision|0|||
163473953|NCT01526928|590432889|FG005|Overall Study|Physician Decision|0|||
163473954|NCT01526928|590432884|FG000|Overall Study|Other Reason|0|||
163473955|NCT01526928|590432885|FG001|Overall Study|Other Reason|1|||
163473956|NCT01526928|590432886|FG002|Overall Study|Other Reason|11|||
163473957|NCT01526928|590432887|FG003|Overall Study|Other Reason|4|||
163473958|NCT01526928|590432888|FG004|Overall Study|Other Reason|1|||
163473959|NCT01526928|590432889|FG005|Overall Study|Other Reason|0|||
163473960|NCT01526928|590432884|FG000|Overall Study|Lost to Follow-up|0|||
163473961|NCT01526928|590432885|FG001|Overall Study|Lost to Follow-up|0|||
163473962|NCT01526928|590432886|FG002|Overall Study|Lost to Follow-up|0|||
163473963|NCT01526928|590432887|FG003|Overall Study|Lost to Follow-up|1|||
163473964|NCT01526928|590432888|FG004|Overall Study|Lost to Follow-up|0|||
163473965|NCT01526928|590432889|FG005|Overall Study|Lost to Follow-up|0|||
163473966|NCT01526928|590432884|FG000|Overall Study|Protocol Deviation|0|||
163473967|NCT01526928|590432885|FG001|Overall Study|Protocol Deviation|0|||
163473968|NCT01526928|590432886|FG002|Overall Study|Protocol Deviation|0|||
163473969|NCT01526928|590432887|FG003|Overall Study|Protocol Deviation|2|||
163473970|NCT01526928|590432888|FG004|Overall Study|Protocol Deviation|0|||
163473971|NCT01526928|590432889|FG005|Overall Study|Protocol Deviation|0|||
163473972|NCT01526928|590432884|FG000|Overall Study|Missing|0|||
163473973|NCT01526928|590432885|FG001|Overall Study|Missing|0|||
163473974|NCT01526928|590432886|FG002|Overall Study|Missing|1|||
163473975|NCT01526928|590432887|FG003|Overall Study|Missing|0|||
163473976|NCT01526928|590432888|FG004|Overall Study|Missing|2|||
163473977|NCT01526928|590432889|FG005|Overall Study|Missing|0|||
163473978|NCT00942422|590432890|FG000|Overall Study|Withdrawal by Subject|1|||
163473979|NCT00942422|590432890|FG000|Overall Study|Death|1|||
163473980|NCT00942422|590432890|FG000|Overall Study|Progressive diease|1|||
163473981|NCT05559203|590432898|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
163473982|NCT00422903|590432901|FG000|Overall Study|Disease Progression|3|||
163473983|NCT00422903|590432902|FG001|Overall Study|Disease Progression|1|||
163473984|NCT00422903|590432901|FG000|Overall Study|Adverse Event|0|||
163473985|NCT00422903|590432902|FG001|Overall Study|Adverse Event|2|||
163473986|NCT00422903|590432901|FG000|Overall Study|Informed Consent Withdrawn|1|||
163473987|NCT00422903|590432902|FG001|Overall Study|Informed Consent Withdrawn|2|||
163473988|NCT01947894|590432903|FG000|Overall Study|Other|3|||
163473989|NCT01947894|590432904|FG001|Overall Study|Other|4|||
163473990|NCT01947894|590432905|FG002|Overall Study|Other|3|||
163473991|NCT01947894|590432903|FG000|Overall Study|Withdrawal by Subject|12|||
163473992|NCT01947894|590432904|FG001|Overall Study|Withdrawal by Subject|4|||
163473993|NCT01947894|590432905|FG002|Overall Study|Withdrawal by Subject|1|||
163473994|NCT01947894|590432903|FG000|Overall Study|Death|12|||
163473995|NCT01947894|590432904|FG001|Overall Study|Death|1|||
163473996|NCT01947894|590432905|FG002|Overall Study|Death|0|||
163473997|NCT01947894|590432903|FG000|Overall Study|Physician Decision|2|||
163473998|NCT01947894|590432904|FG001|Overall Study|Physician Decision|0|||
163473999|NCT01947894|590432905|FG002|Overall Study|Physician Decision|0|||
163474000|NCT01947894|590432903|FG000|Overall Study|Adverse Event|5|||
163474001|NCT01947894|590432904|FG001|Overall Study|Adverse Event|1|||
163474002|NCT01947894|590432905|FG002|Overall Study|Adverse Event|0|||
163474003|NCT01947894|590432903|FG000|Overall Study|Switched to other growth hormone brand|53|||
163474004|NCT01947894|590432904|FG001|Overall Study|Switched to other growth hormone brand|8|||
163474005|NCT01947894|590432905|FG002|Overall Study|Switched to other growth hormone brand|23|||
163474006|NCT02829775|590432908|FG000|Overall Study|Death|1|||
163474007|NCT02829775|590432908|FG000|Overall Study|Withdrawal by Subject|3|||
163474008|NCT02829775|590432908|FG000|Overall Study|Disease remission|1|||
163474009|NCT02725268|590432917|FG000|Overall Study|Death|58|||
163474010|NCT02725268|590432918|FG001|Overall Study|Death|59|||
163474011|NCT02725268|590432919|FG002|Overall Study|Death|30|||
163474012|NCT02725268|590432920|FG003|Overall Study|Death|16|||
163474013|NCT02725268|590432917|FG000|Overall Study|Lost to Follow-up|4|||
163474014|NCT02725268|590432918|FG001|Overall Study|Lost to Follow-up|3|||
163474015|NCT02725268|590432919|FG002|Overall Study|Lost to Follow-up|0|||
163474016|NCT02725268|590432920|FG003|Overall Study|Lost to Follow-up|1|||
163474017|NCT02725268|590432917|FG000|Overall Study|Site Terminated by Sponsor|0|||
163474018|NCT02725268|590432918|FG001|Overall Study|Site Terminated by Sponsor|1|||
163474019|NCT02725268|590432919|FG002|Overall Study|Site Terminated by Sponsor|0|||
163474020|NCT02725268|590432920|FG003|Overall Study|Site Terminated by Sponsor|0|||
163474021|NCT02725268|590432917|FG000|Overall Study|Withdrawal by Subject|8|||
163474022|NCT02725268|590432918|FG001|Overall Study|Withdrawal by Subject|6|||
163474023|NCT02725268|590432919|FG002|Overall Study|Withdrawal by Subject|8|||
163474024|NCT02725268|590432920|FG003|Overall Study|Withdrawal by Subject|1|||
163474025|NCT02725268|590432917|FG000|Overall Study|Reason not Specified|2|||
163474026|NCT02725268|590432918|FG001|Overall Study|Reason not Specified|1|||
163474027|NCT02725268|590432919|FG002|Overall Study|Reason not Specified|0|||
163474028|NCT02725268|590432920|FG003|Overall Study|Reason not Specified|0|||
163474029|NCT00117572|590432930|FG000|Overall Study|Site withdrew before starting treatment|2|||
163474030|NCT00117572|590432931|FG001|Overall Study|Site withdrew before starting treatment|3|||
163474031|NCT00117572|590432930|FG000|Overall Study|Withdrawal by Subject|3|||
163474032|NCT00117572|590432931|FG001|Overall Study|Withdrawal by Subject|3|||
163474033|NCT00117572|590432930|FG000|Overall Study|Protocol Violation|1|||
163474034|NCT00117572|590432931|FG001|Overall Study|Protocol Violation|0|||
163474035|NCT04973085|590432936|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
163474036|NCT04973085|590432937|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
163474037|NCT01188811|590432938|FG000|Overall Study|Withdrawal by Subject|0|||
163474038|NCT01188811|590432939|FG001|Overall Study|Withdrawal by Subject|2|||
163474039|NCT01188811|590432938|FG000|Overall Study|Adverse Event|6|||
163474040|NCT01188811|590432939|FG001|Overall Study|Adverse Event|0|||
163474041|NCT00654368|590432940|FG000|Overall Study|Ineligibility determined|6|||
163474042|NCT00654368|590432941|FG001|Overall Study|Ineligibility determined|0|||
163474043|NCT00654368|590432942|FG002|Overall Study|Ineligibility determined|0|||
163474044|NCT00654368|590432940|FG000|Overall Study|Protocol deviation|3|||
163474045|NCT00654368|590432941|FG001|Overall Study|Protocol deviation|2|||
163474046|NCT00654368|590432942|FG002|Overall Study|Protocol deviation|1|||
163474047|NCT00654368|590432940|FG000|Overall Study|Non-compliance|2|||
163474048|NCT00654368|590432941|FG001|Overall Study|Non-compliance|1|||
163474049|NCT00654368|590432942|FG002|Overall Study|Non-compliance|2|||
163474050|NCT00654368|590432940|FG000|Overall Study|Withdrawal by Subject|5|||
163474051|NCT00654368|590432941|FG001|Overall Study|Withdrawal by Subject|2|||
163474052|NCT00654368|590432942|FG002|Overall Study|Withdrawal by Subject|2|||
163474053|NCT00654368|590432940|FG000|Overall Study|Disease progression|21|||
163474054|NCT00654368|590432941|FG001|Overall Study|Disease progression|31|||
163474055|NCT00654368|590432942|FG002|Overall Study|Disease progression|13|||
163474056|NCT00654368|590432940|FG000|Overall Study|Requirement for alternative therapy|1|||
163474057|NCT00654368|590432941|FG001|Overall Study|Requirement for alternative therapy|1|||
163474058|NCT00654368|590432942|FG002|Overall Study|Requirement for alternative therapy|1|||
163474059|NCT00654368|590432940|FG000|Overall Study|Physician Decision|0|||
163474060|NCT00654368|590432941|FG001|Overall Study|Physician Decision|0|||
163474061|NCT00654368|590432942|FG002|Overall Study|Physician Decision|2|||
163474062|NCT00654368|590432940|FG000|Overall Study|Death|1|||
163474063|NCT00654368|590432941|FG001|Overall Study|Death|0|||
163474064|NCT00654368|590432942|FG002|Overall Study|Death|0|||
163474065|NCT00654368|590432940|FG000|Overall Study|Pregnancy|0|||
163474066|NCT00654368|590432941|FG001|Overall Study|Pregnancy|0|||
163474067|NCT00654368|590432942|FG002|Overall Study|Pregnancy|2|||
163474068|NCT00654368|590432940|FG000|Overall Study|Other|0|||
163474069|NCT00654368|590432941|FG001|Overall Study|Other|2|||
163474070|NCT00654368|590432942|FG002|Overall Study|Other|3|||
163474071|NCT00654368|590432940|FG000|Overall Study|Adverse Event|14|||
163474072|NCT00654368|590432941|FG001|Overall Study|Adverse Event|9|||
163474073|NCT00654368|590432942|FG002|Overall Study|Adverse Event|6|||
163474074|NCT04228445|590432946|FG000|Overall Study|Lost to Follow-up|1|||
163474075|NCT04228445|590432947|FG001|Overall Study|Lost to Follow-up|1|||
163474076|NCT04228445|590432946|FG000|Overall Study|Physician Decision|1|||
163474077|NCT04228445|590432947|FG001|Overall Study|Physician Decision|2|||
163474078|NCT04228445|590432946|FG000|Overall Study|Withdrawal by Subject|0|||
163474079|NCT04228445|590432947|FG001|Overall Study|Withdrawal by Subject|1|||
163474080|NCT04228445|590432946|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
163474081|NCT04228445|590432947|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
163474082|NCT03954704|590432956|FG000|Overall Study|Death|1|||
163474083|NCT03954704|590432957|FG001|Overall Study|Death|1|||
163474084|NCT03954704|590432958|FG002|Overall Study|Death|1|||
163474085|NCT03954704|590432959|FG003|Overall Study|Death|3|||
163474086|NCT03954704|590432960|FG004|Overall Study|Death|2|||
163474087|NCT03954704|590432961|FG005|Overall Study|Death|2|||
163474088|NCT03954704|590432962|FG006|Overall Study|Death|0|||
163474089|NCT03954704|590432956|FG000|Overall Study|Withdrew Consent|0|||
163474090|NCT03954704|590432957|FG001|Overall Study|Withdrew Consent|0|||
163474091|NCT03954704|590432958|FG002|Overall Study|Withdrew Consent|1|||
163474092|NCT03954704|590432959|FG003|Overall Study|Withdrew Consent|0|||
163474093|NCT03954704|590432960|FG004|Overall Study|Withdrew Consent|0|||
163474094|NCT03954704|590432961|FG005|Overall Study|Withdrew Consent|1|||
163474095|NCT03954704|590432962|FG006|Overall Study|Withdrew Consent|0|||
163474096|NCT03954704|590432956|FG000|Overall Study|Lost to Follow-up|0|||
163474097|NCT03954704|590432957|FG001|Overall Study|Lost to Follow-up|0|||
163474098|NCT03954704|590432958|FG002|Overall Study|Lost to Follow-up|0|||
163474099|NCT03954704|590432959|FG003|Overall Study|Lost to Follow-up|0|||
163474100|NCT03954704|590432960|FG004|Overall Study|Lost to Follow-up|0|||
163474101|NCT03954704|590432961|FG005|Overall Study|Lost to Follow-up|0|||
163474102|NCT03954704|590432962|FG006|Overall Study|Lost to Follow-up|1|||
163474103|NCT03954704|590432956|FG000|Overall Study|Study Terminated by Sponsor|0|||
163474104|NCT03954704|590432957|FG001|Overall Study|Study Terminated by Sponsor|0|||
163474105|NCT03954704|590432958|FG002|Overall Study|Study Terminated by Sponsor|1|||
163474106|NCT03954704|590432959|FG003|Overall Study|Study Terminated by Sponsor|0|||
163474107|NCT03954704|590432960|FG004|Overall Study|Study Terminated by Sponsor|1|||
163474108|NCT03954704|590432961|FG005|Overall Study|Study Terminated by Sponsor|4|||
163474109|NCT03954704|590432962|FG006|Overall Study|Study Terminated by Sponsor|2|||
163474110|NCT03954704|590432956|FG000|Overall Study|Enrolled but not Treated|0|||
163474111|NCT03954704|590432957|FG001|Overall Study|Enrolled but not Treated|0|||
163474112|NCT03954704|590432958|FG002|Overall Study|Enrolled but not Treated|0|||
163474113|NCT03954704|590432959|FG003|Overall Study|Enrolled but not Treated|0|||
163474114|NCT03954704|590432960|FG004|Overall Study|Enrolled but not Treated|0|||
163474115|NCT03954704|590432961|FG005|Overall Study|Enrolled but not Treated|1|||
163474116|NCT03954704|590432962|FG006|Overall Study|Enrolled but not Treated|0|||
163474117|NCT04035473|590432965|FG000|Screening/Baseline|Death|0|||
163474118|NCT04035473|590432966|FG001|Screening/Baseline|Death|1|||
163474119|NCT04035473|590432965|FG000|Screening/Baseline|Adverse Event|0|||
163474120|NCT04035473|590432966|FG001|Screening/Baseline|Adverse Event|1|||
163474121|NCT04035473|590432965|FG000|Follow-up Period|Adverse Event|2|||
163474122|NCT04035473|590432966|FG001|Follow-up Period|Adverse Event|0|||
163474123|NCT03573804|590432968|FG000|Overall Study|claustrophobia or MRI table problems|10|||
163474124|NCT05166603|590432971|FG000|Overall Study|Withdrawal by Subject|68|||
163474125|NCT05166603|590432972|FG001|Overall Study|Withdrawal by Subject|0|||
163474126|NCT00366444|590434910|FG000|Overall Study|Withdrawal by Subject|1|||
163474127|NCT00366444|590434911|FG001|Overall Study|Withdrawal by Subject|1|||
163474128|NCT00366444|590434910|FG000|Overall Study|Lack of Efficacy|0|||
163474129|NCT00366444|590434911|FG001|Overall Study|Lack of Efficacy|1|||
163474130|NCT03763942|590434916|FG000|Overall Study|Lost to Follow-up|114|||
163474131|NCT03763942|590434917|FG001|Overall Study|Lost to Follow-up|54|||
163474132|NCT03763942|590434916|FG000|Overall Study|Protocol Violation|1|||
163474133|NCT03763942|590434917|FG001|Overall Study|Protocol Violation|0|||
163474134|NCT03763942|590434916|FG000|Overall Study|Withdrawal by Subject|2|||
163474135|NCT03763942|590434917|FG001|Overall Study|Withdrawal by Subject|0|||
163474136|NCT03763942|590434916|FG000|Overall Study|Other|2|||
163474137|NCT03763942|590434917|FG001|Overall Study|Other|3|||
163474138|NCT02200510|590434918|FG000|Overall Study|Death|1|||
163474139|NCT02200510|590434919|FG001|Overall Study|Death|1|||
163474140|NCT02200510|590434918|FG000|Overall Study|Protocol Violation|0|||
163474141|NCT02200510|590434919|FG001|Overall Study|Protocol Violation|1|||
163474142|NCT02200510|590434918|FG000|Overall Study|Lost to Follow-up|7|||
163474143|NCT02200510|590434919|FG001|Overall Study|Lost to Follow-up|1|||
163474144|NCT02200510|590434918|FG000|Overall Study|potential COI - joined study team|1|||
163474145|NCT02200510|590434919|FG001|Overall Study|potential COI - joined study team|0|||
163474146|NCT04969900|590434922|FG000|Overall Study|Physician Decision|1|||
163474147|NCT04969900|590434923|FG001|Overall Study|Physician Decision|1|||
163474148|NCT04969900|590434922|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
163474149|NCT04969900|590434923|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
163474150|NCT02881151|590434924|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
163474151|NCT04284787|590434928|FG000|Overall Study|Disease Progression|9|||
163474152|NCT04284787|590434929|FG001|Overall Study|Disease Progression|12|||
163474153|NCT04284787|590434928|FG000|Overall Study|Physician Decision|12|||
163474154|NCT04284787|590434929|FG001|Overall Study|Physician Decision|7|||
163474155|NCT04284787|590434928|FG000|Overall Study|Transplant|5|||
163474156|NCT04284787|590434929|FG001|Overall Study|Transplant|4|||
163474157|NCT04284787|590434928|FG000|Overall Study|Death|1|||
163474158|NCT04284787|590434929|FG001|Overall Study|Death|2|||
163474159|NCT04284787|590434928|FG000|Overall Study|Adverse Event|0|||
163474160|NCT04284787|590434929|FG001|Overall Study|Adverse Event|4|||
163474161|NCT04284787|590434928|FG000|Overall Study|Non-adherence|2|||
163474162|NCT04284787|590434929|FG001|Overall Study|Non-adherence|0|||
163474163|NCT04284787|590434928|FG000|Overall Study|Lack of Efficacy|2|||
163474164|NCT04284787|590434929|FG001|Overall Study|Lack of Efficacy|0|||
163474165|NCT01874353|590434930|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
163474166|NCT01874353|590434931|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
163474167|NCT01874353|590434932|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
163474168|NCT01874353|590434933|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
163474169|NCT01874353|590434930|FG000|Overall Study|Lost to Follow-up|2|||
163474170|NCT01874353|590434931|FG001|Overall Study|Lost to Follow-up|2|||
163474171|NCT01874353|590434932|FG002|Overall Study|Lost to Follow-up|2|||
163474172|NCT01874353|590434933|FG003|Overall Study|Lost to Follow-up|0|||
163474173|NCT01874353|590434930|FG000|Overall Study|Death|110|||
163474174|NCT01874353|590434931|FG001|Overall Study|Death|60|||
163474175|NCT01874353|590434932|FG002|Overall Study|Death|13|||
163474176|NCT01874353|590434933|FG003|Overall Study|Death|7|||
163474177|NCT01874353|590434930|FG000|Overall Study|Withdrawal by Subject|13|||
163474178|NCT01874353|590434931|FG001|Overall Study|Withdrawal by Subject|11|||
163474179|NCT01874353|590434932|FG002|Overall Study|Withdrawal by Subject|0|||
163474180|NCT01874353|590434933|FG003|Overall Study|Withdrawal by Subject|0|||
163474181|NCT03728881|590434934|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
163474182|NCT03728881|590434935|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
163474183|NCT03728881|590434934|FG000|Enrolled and Received 1st Vaccination|Death|1|||
163474184|NCT03728881|590434935|FG001|Enrolled and Received 1st Vaccination|Death|1|||
163474185|NCT03728881|590434934|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
163474186|NCT03728881|590434935|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
163474187|NCT03728881|590434934|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
163474188|NCT03728881|590434935|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
163474189|NCT03728881|590434934|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
163474190|NCT03728881|590434935|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
163474191|NCT03728881|590434934|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
163474192|NCT03728881|590434935|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
163474193|NCT03728881|590434934|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
163474194|NCT03728881|590434935|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
163474195|NCT03728881|590434934|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
163474196|NCT03728881|590434935|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
163474197|NCT03728881|590434934|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
163474198|NCT03728881|590434935|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
163474199|NCT03728881|590434934|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
163474200|NCT03728881|590434935|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
163474201|NCT03728881|590434934|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
163474202|NCT03728881|590434935|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
163474203|NCT04651777|590434936|FG000|Overall Study|Adverse Event|1|||
163474204|NCT04651777|590434936|FG000|Overall Study|Withdrawal by Subject|2|||
163474205|NCT05505734|590434937|FG000|Overall Study|Withdrawal by Subject|51|||
163474206|NCT05505734|590434938|FG001|Overall Study|Withdrawal by Subject|64|||
163474207|NCT05505734|590434937|FG000|Overall Study|Adverse Event|6|||
163474208|NCT05505734|590434938|FG001|Overall Study|Adverse Event|20|||
163474209|NCT05505734|590434937|FG000|Overall Study|Protocol Violation|8|||
163474210|NCT05505734|590434938|FG001|Overall Study|Protocol Violation|15|||
163474211|NCT05505734|590434937|FG000|Overall Study|Lack of therapeutic response|0|||
163474212|NCT05505734|590434938|FG001|Overall Study|Lack of therapeutic response|1|||
163474213|NCT05505734|590434937|FG000|Overall Study|Lost to Follow-up|247|||
163474214|NCT05505734|590434938|FG001|Overall Study|Lost to Follow-up|237|||
163474215|NCT05505734|590434937|FG000|Overall Study|Physician Decision|22|||
163474216|NCT05505734|590434938|FG001|Overall Study|Physician Decision|13|||
163474217|NCT05505734|590434937|FG000|Overall Study|Death|2|||
163474218|NCT05505734|590434938|FG001|Overall Study|Death|1|||
163474219|NCT05505734|590434937|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163474220|NCT05505734|590434938|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163474221|NCT05505734|590434937|FG000|Overall Study|Pregnancy|1|||
163474222|NCT05505734|590434938|FG001|Overall Study|Pregnancy|0|||
163474223|NCT05505734|590434937|FG000|Overall Study|Other|17|||
163474224|NCT05505734|590434938|FG001|Overall Study|Other|13|||
163474225|NCT00732472|590434939|FG000|Overall Study|Adverse Event|0|||
163474226|NCT00732472|590434940|FG001|Overall Study|Adverse Event|1|||
163474227|NCT00732472|590434941|FG002|Overall Study|Adverse Event|1|||
163474228|NCT00732472|590434942|FG003|Overall Study|Adverse Event|1|||
163474229|NCT00732472|590434939|FG000|Overall Study|Protocol Violation|0|||
163474230|NCT00732472|590434940|FG001|Overall Study|Protocol Violation|0|||
163474231|NCT00732472|590434941|FG002|Overall Study|Protocol Violation|0|||
163474232|NCT00732472|590434942|FG003|Overall Study|Protocol Violation|1|||
163474233|NCT00732472|590434939|FG000|Overall Study|Withdrawal by Subject|0|||
163474234|NCT00732472|590434940|FG001|Overall Study|Withdrawal by Subject|2|||
163474235|NCT00732472|590434941|FG002|Overall Study|Withdrawal by Subject|0|||
163474236|NCT00732472|590434942|FG003|Overall Study|Withdrawal by Subject|1|||
163474237|NCT03575351|590434945|FG000|Overall Study|Adverse Event|1|||
163474238|NCT03575351|590434946|FG001|Overall Study|Adverse Event|0|||
163474239|NCT03575351|590434945|FG000|Overall Study|Death|2|||
163474240|NCT03575351|590434946|FG001|Overall Study|Death|2|||
163474241|NCT03575351|590434945|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
163474242|NCT03575351|590434946|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
163474243|NCT03575351|590434945|FG000|Overall Study|Lack of Efficacy|28|||
163474244|NCT03575351|590434946|FG001|Overall Study|Lack of Efficacy|0|||
163474245|NCT03575351|590434945|FG000|Overall Study|Withdrawal by Subject|1|||
163474246|NCT03575351|590434946|FG001|Overall Study|Withdrawal by Subject|1|||
163474247|NCT03575351|590434945|FG000|Overall Study|Physician Decision|3|||
163474248|NCT03575351|590434946|FG001|Overall Study|Physician Decision|0|||
163474249|NCT03575351|590434945|FG000|Overall Study|Disease relapse|15|||
163474250|NCT03575351|590434946|FG001|Overall Study|Disease relapse|6|||
163474251|NCT03575351|590434945|FG000|Overall Study|Study drug manufacturing failure|0|||
163474252|NCT03575351|590434946|FG001|Overall Study|Study drug manufacturing failure|1|||
163474253|NCT03575351|590434945|FG000|Overall Study|other reasons|5|||
163474254|NCT03575351|590434946|FG001|Overall Study|other reasons|0|||
163474255|NCT03715205|590434947|FG000|Overall Study|Death|13|||
163474256|NCT03715205|590434947|FG000|Overall Study|Lost to Follow-up|2|||
163474257|NCT03715205|590434947|FG000|Overall Study|Physician Decision|93|||
163474258|NCT03715205|590434947|FG000|Overall Study|Withdrawal by Subject|26|||
163474259|NCT02623699|590434948|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
163474260|NCT02623699|590434949|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
163474261|NCT02623699|590434950|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
163474262|NCT02623699|590434951|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
163474263|NCT02623699|590434952|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
163474264|NCT02623699|590434953|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
163474265|NCT02623699|590434954|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
163474266|NCT02623699|590434955|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
163474267|NCT02623699|590434956|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
163474268|NCT02623699|590434957|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
163474269|NCT02623699|590434958|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
163474270|NCT02623699|590434959|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
163474271|NCT02623699|590434948|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
163474272|NCT02623699|590434949|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
163474273|NCT02623699|590434950|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
163474274|NCT02623699|590434951|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
163474275|NCT02623699|590434952|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
163474276|NCT02623699|590434953|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
163474277|NCT02623699|590434954|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
163474278|NCT02623699|590434955|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
163474279|NCT02623699|590434956|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
163474280|NCT02623699|590434957|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
163474281|NCT02623699|590434958|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
163474282|NCT02623699|590434959|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
163474283|NCT02623699|590434948|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
163474284|NCT02623699|590434949|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
163474285|NCT02623699|590434950|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
163474286|NCT02623699|590434951|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
163474287|NCT02623699|590434952|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
163474288|NCT02623699|590434953|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
163474289|NCT02623699|590434954|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
163474290|NCT02623699|590434955|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
163474291|NCT02623699|590434956|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
163474292|NCT02623699|590434957|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
163474293|NCT02623699|590434958|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
163474294|NCT02623699|590434959|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
163474295|NCT02623699|590434948|FG000|Part B (Up to 289 Days)|Death|0|||
163474296|NCT02623699|590434949|FG001|Part B (Up to 289 Days)|Death|0|||
163474297|NCT02623699|590434950|FG002|Part B (Up to 289 Days)|Death|0|||
163474298|NCT02623699|590434951|FG003|Part B (Up to 289 Days)|Death|0|||
163474299|NCT02623699|590434952|FG004|Part B (Up to 289 Days)|Death|0|||
163474300|NCT02623699|590434953|FG005|Part B (Up to 289 Days)|Death|1|||
163474301|NCT02623699|590434954|FG006|Part B (Up to 289 Days)|Death|1|||
163474302|NCT02623699|590434955|FG007|Part B (Up to 289 Days)|Death|0|||
163474303|NCT02623699|590434956|FG008|Part B (Up to 289 Days)|Death|1|||
163474304|NCT02623699|590434957|FG009|Part B (Up to 289 Days)|Death|0|||
163474305|NCT02623699|590434958|FG010|Part B (Up to 289 Days)|Death|0|||
163474306|NCT02623699|590434959|FG011|Part B (Up to 289 Days)|Death|0|||
163474307|NCT02623699|590434948|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
163474308|NCT02623699|590434949|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
163474309|NCT02623699|590434950|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
163474310|NCT02623699|590434951|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
163474311|NCT02623699|590434952|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
163474312|NCT02623699|590434953|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
163474313|NCT02623699|590434954|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
163474314|NCT02623699|590434955|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
163474315|NCT02623699|590434956|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
163474316|NCT02623699|590434957|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
163474317|NCT02623699|590434958|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
163474318|NCT02623699|590434959|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
163474319|NCT02623699|590434948|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
163474320|NCT02623699|590434949|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
163474321|NCT02623699|590434950|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
163474322|NCT02623699|590434951|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
163474323|NCT02623699|590434952|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
163474324|NCT02623699|590434953|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
163474325|NCT02623699|590434954|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
163474326|NCT02623699|590434955|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
163474327|NCT02623699|590434956|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
163474328|NCT02623699|590434957|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
163474329|NCT02623699|590434958|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
163474330|NCT02623699|590434959|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
163474331|NCT02623699|590434948|FG000|Part C (Up to 236 Days)|Death|0|||
163474332|NCT02623699|590434949|FG001|Part C (Up to 236 Days)|Death|0|||
163474333|NCT02623699|590434950|FG002|Part C (Up to 236 Days)|Death|0|||
163474334|NCT02623699|590434951|FG003|Part C (Up to 236 Days)|Death|0|||
163474335|NCT02623699|590434952|FG004|Part C (Up to 236 Days)|Death|0|||
163474336|NCT02623699|590434953|FG005|Part C (Up to 236 Days)|Death|0|||
163474337|NCT02623699|590434954|FG006|Part C (Up to 236 Days)|Death|0|||
163474338|NCT02623699|590434955|FG007|Part C (Up to 236 Days)|Death|0|||
163474339|NCT02623699|590434956|FG008|Part C (Up to 236 Days)|Death|0|||
163474340|NCT02623699|590434957|FG009|Part C (Up to 236 Days)|Death|0|||
163474341|NCT02623699|590434958|FG010|Part C (Up to 236 Days)|Death|0|||
163474342|NCT02623699|590434959|FG011|Part C (Up to 236 Days)|Death|1|||
163474343|NCT02623699|590434948|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
163474344|NCT02623699|590434949|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
163474345|NCT02623699|590434950|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
163474346|NCT02623699|590434951|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
163474347|NCT02623699|590434952|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
163474348|NCT02623699|590434953|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
163474349|NCT02623699|590434954|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
163474350|NCT02623699|590434955|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
163474351|NCT02623699|590434956|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
163474352|NCT02623699|590434957|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
163474353|NCT02623699|590434958|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
163474354|NCT02623699|590434959|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
163474355|NCT01426009|590434960|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
163474356|NCT01426009|590434960|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
163474357|NCT01426009|590434960|FG000|Washout 1|Withdrawal by Subject|1|||
163474358|NCT01426009|590434960|FG000|Washout 1|Personal Reasons|1|||
163474359|NCT01426009|590434960|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
163474360|NCT01426009|590434960|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
163474361|NCT01426009|590434960|FG000|Washout 2|electrive surgery|1|||
163474362|NCT01426009|590434960|FG000|Washout 3|personal reasons|1|||
163474363|NCT01426009|590434960|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
163474364|NCT01426009|590434960|FG000|Washout 4|Lost to Follow-up|1|||
163474365|NCT00515099|590434966|FG000|Overall Study|Lost to Follow-up|0|||
163474366|NCT00515099|590434967|FG001|Overall Study|Lost to Follow-up|4|||
163474367|NCT00515099|590434966|FG000|Overall Study|Withdrawal by Subject|2|||
163474368|NCT00515099|590434967|FG001|Overall Study|Withdrawal by Subject|0|||
163474369|NCT00515099|590434966|FG000|Overall Study|IRB Recommendation|1|||
163474370|NCT00515099|590434967|FG001|Overall Study|IRB Recommendation|0|||
163474371|NCT03342404|590434968|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
163474372|NCT03342404|590434969|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
163474373|NCT03342404|590434968|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
163474374|NCT03342404|590434969|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
163474375|NCT03342404|590434968|FG000|Blinded Treatment Phase|Adverse Event|5|||
163474376|NCT03342404|590434969|FG001|Blinded Treatment Phase|Adverse Event|4|||
163474377|NCT03342404|590434968|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
163474378|NCT03342404|590434969|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
163474379|NCT03342404|590434968|FG000|Blinded Treatment Phase|Other reasons|1|||
163474380|NCT03342404|590434969|FG001|Blinded Treatment Phase|Other reasons|0|||
163474381|NCT03342404|590434968|FG000|Blinded Treatment Phase|Physician Decision|1|||
163474382|NCT03342404|590434969|FG001|Blinded Treatment Phase|Physician Decision|0|||
163474383|NCT03342404|590434968|FG000|Blinded Treatment Phase|Death|1|||
163474384|NCT03342404|590434969|FG001|Blinded Treatment Phase|Death|0|||
163474385|NCT03342404|590434968|FG000|Open-Label Phase|Lost to Follow-up|0|||
163474386|NCT03342404|590434969|FG001|Open-Label Phase|Lost to Follow-up|1|||
163474387|NCT03342404|590434968|FG000|Open-Label Phase|Other reasons|0|||
163474388|NCT03342404|590434969|FG001|Open-Label Phase|Other reasons|1|||
163474389|NCT03342404|590434968|FG000|Open-Label Phase|Adverse Event|0|||
163474390|NCT03342404|590434969|FG001|Open-Label Phase|Adverse Event|3|||
163474391|NCT03342404|590434968|FG000|Open-Label Phase|Withdrawal by Subject|0|||
163474392|NCT03342404|590434969|FG001|Open-Label Phase|Withdrawal by Subject|6|||
163474393|NCT00372489|590434975|FG000|Overall Study|Adverse Event|18|||
163474394|NCT00372489|590434975|FG000|Overall Study|Lack of Efficacy|1|||
163474395|NCT00372489|590434975|FG000|Overall Study|Lost to Follow-up|3|||
163474396|NCT00372489|590434975|FG000|Overall Study|Physician Decision|3|||
163474397|NCT00372489|590434975|FG000|Overall Study|Withdrawal by Subject|5|||
163474398|NCT00372489|590434975|FG000|Overall Study|Patient Relocation|2|||
163474399|NCT00372489|590434975|FG000|Overall Study|Renal transplant|6|||
163474400|NCT00372489|590434975|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
163474401|NCT00772889|590434976|FG000|Overall Study|Adverse Event|7|||
163474402|NCT00772889|590434977|FG001|Overall Study|Adverse Event|4|||
163474403|NCT00772889|590434978|FG002|Overall Study|Adverse Event|0|||
163474404|NCT00772889|590434976|FG000|Overall Study|Withdrawal by Subject|9|||
163474405|NCT00772889|590434977|FG001|Overall Study|Withdrawal by Subject|8|||
163474406|NCT00772889|590434978|FG002|Overall Study|Withdrawal by Subject|9|||
163474407|NCT00772889|590434976|FG000|Overall Study|Lost to Follow-up|6|||
163474408|NCT00772889|590434977|FG001|Overall Study|Lost to Follow-up|6|||
163474409|NCT00772889|590434978|FG002|Overall Study|Lost to Follow-up|7|||
163474410|NCT03323086|590434979|FG000|Overall Study|Lost to Follow-up|3|||
163474411|NCT03323086|590434980|FG001|Overall Study|Lost to Follow-up|2|||
163474412|NCT00355615|590434986|FG000|Randomized Double Blind Period|Adverse Event|1|||
163474413|NCT00355615|590434987|FG001|Randomized Double Blind Period|Adverse Event|0|||
163474414|NCT00355615|590434988|FG002|Randomized Double Blind Period|Adverse Event|0|||
163474415|NCT00355615|590434989|FG003|Randomized Double Blind Period|Adverse Event|0|||
163474416|NCT00355615|590434990|FG004|Randomized Double Blind Period|Adverse Event|0|||
163474417|NCT00355615|590434986|FG000|Randomized Double Blind Period|Protocol Violation|0|||
163474418|NCT00355615|590434987|FG001|Randomized Double Blind Period|Protocol Violation|0|||
163474419|NCT00355615|590434988|FG002|Randomized Double Blind Period|Protocol Violation|1|||
163474420|NCT00355615|590434989|FG003|Randomized Double Blind Period|Protocol Violation|1|||
163474421|NCT00355615|590434990|FG004|Randomized Double Blind Period|Protocol Violation|0|||
163474422|NCT00355615|590434986|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
163474423|NCT00355615|590434987|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
163474424|NCT00355615|590434988|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
163474425|NCT00355615|590434989|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
163474426|NCT00355615|590434990|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
163474427|NCT00355615|590434986|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
163474428|NCT00355615|590434987|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
163474429|NCT00355615|590434988|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
163474430|NCT00355615|590434989|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
163474431|NCT00355615|590434990|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
163474432|NCT00355615|590434986|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
163474433|NCT00355615|590434987|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
163474434|NCT00355615|590434988|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
163474435|NCT00355615|590434989|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
163474436|NCT00355615|590434990|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
163474437|NCT00355615|590434986|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
163474438|NCT00355615|590434987|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
163474439|NCT00355615|590434988|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
163474440|NCT00355615|590434989|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
163474441|NCT00355615|590434990|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
163474442|NCT04259346|590434993|FG000|Overall Study|Lost to Follow-up|1|||
163474443|NCT04259346|590434994|FG001|Overall Study|Lost to Follow-up|3|||
163474444|NCT04259346|590434993|FG000|Overall Study|Protocol Violation|1|||
163474445|NCT04259346|590434994|FG001|Overall Study|Protocol Violation|0|||
163474446|NCT04259346|590434993|FG000|Overall Study|Withdrawal by Subject|1|||
163474447|NCT04259346|590434994|FG001|Overall Study|Withdrawal by Subject|0|||
163474448|NCT04259346|590434993|FG000|Overall Study|Adverse Event|1|||
163474449|NCT04259346|590434994|FG001|Overall Study|Adverse Event|1|||
163474450|NCT00085644|590434995|FG000|Double-Blind Period|Adverse Event|5|||
163474451|NCT00085644|590434996|FG001|Double-Blind Period|Adverse Event|2|||
163474452|NCT00085644|590434997|FG002|Double-Blind Period|Adverse Event|0|||
163474453|NCT00085644|590434995|FG000|Double-Blind Period|Withdrawal by Subject|3|||
163474454|NCT00085644|590434996|FG001|Double-Blind Period|Withdrawal by Subject|0|||
163474455|NCT00085644|590434997|FG002|Double-Blind Period|Withdrawal by Subject|0|||
163474456|NCT00085644|590434995|FG000|Double-Blind Period|Lost to Follow-up|2|||
163474457|NCT00085644|590434996|FG001|Double-Blind Period|Lost to Follow-up|1|||
163474458|NCT00085644|590434997|FG002|Double-Blind Period|Lost to Follow-up|0|||
163474459|NCT00085644|590434995|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
163474460|NCT00085644|590434996|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
163474461|NCT00085644|590434997|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
163474462|NCT00085644|590434995|FG000|Double-Blind Period|Contemplating pregnancy|1|||
163474463|NCT00085644|590434996|FG001|Double-Blind Period|Contemplating pregnancy|0|||
163474464|NCT00085644|590434997|FG002|Double-Blind Period|Contemplating pregnancy|0|||
163474465|NCT00085644|590434995|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
163474466|NCT00085644|590434996|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
163474467|NCT00085644|590434997|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
163474468|NCT00085644|590434995|FG000|Open-Label Period|Adverse Event|0|||
163474469|NCT00085644|590434996|FG001|Open-Label Period|Adverse Event|0|||
163474470|NCT00085644|590434997|FG002|Open-Label Period|Adverse Event|38|||
163474471|NCT00085644|590434995|FG000|Open-Label Period|Withdrawal by Subject|0|||
163474472|NCT00085644|590434996|FG001|Open-Label Period|Withdrawal by Subject|0|||
163474473|NCT00085644|590434997|FG002|Open-Label Period|Withdrawal by Subject|29|||
163474474|NCT00085644|590434995|FG000|Open-Label Period|Lost to Follow-up|0|||
163474475|NCT00085644|590434996|FG001|Open-Label Period|Lost to Follow-up|0|||
163474476|NCT00085644|590434997|FG002|Open-Label Period|Lost to Follow-up|13|||
163474477|NCT00085644|590434995|FG000|Open-Label Period|Lack of Efficacy|0|||
163474478|NCT00085644|590434996|FG001|Open-Label Period|Lack of Efficacy|0|||
163474479|NCT00085644|590434997|FG002|Open-Label Period|Lack of Efficacy|15|||
163474480|NCT00085644|590434995|FG000|Open-Label Period|Pregnancy|0|||
163474481|NCT00085644|590434996|FG001|Open-Label Period|Pregnancy|0|||
163474482|NCT00085644|590434997|FG002|Open-Label Period|Pregnancy|3|||
163474483|NCT00085644|590434995|FG000|Open-Label Period|Contemplating pregnancy|0|||
163474484|NCT00085644|590434996|FG001|Open-Label Period|Contemplating pregnancy|0|||
163474485|NCT00085644|590434997|FG002|Open-Label Period|Contemplating pregnancy|3|||
163474486|NCT00085644|590434995|FG000|Open-Label Period|Protocol Violation|0|||
163474487|NCT00085644|590434996|FG001|Open-Label Period|Protocol Violation|0|||
163474488|NCT00085644|590434997|FG002|Open-Label Period|Protocol Violation|4|||
163474489|NCT00085644|590434995|FG000|Open-Label Period|Personal reason|0|||
163474490|NCT00085644|590434996|FG001|Open-Label Period|Personal reason|0|||
163474491|NCT00085644|590434997|FG002|Open-Label Period|Personal reason|4|||
163474492|NCT03330106|590435005|FG000|Part A|Withdrawal by Subject|1|||
163474493|NCT03330106|590435006|FG001|Part A|Withdrawal by Subject|1|||
163474494|NCT03330106|590435007|FG002|Part A|Withdrawal by Subject|0|||
163474495|NCT03330106|590435008|FG003|Part A|Withdrawal by Subject|0|||
163474496|NCT03330106|590435005|FG000|Part A|Death|2|||
163474497|NCT03330106|590435006|FG001|Part A|Death|1|||
163474498|NCT03330106|590435007|FG002|Part A|Death|0|||
163474499|NCT03330106|590435008|FG003|Part A|Death|0|||
163474500|NCT03330106|590435005|FG000|Part A|Adverse Event|0|||
163474501|NCT03330106|590435006|FG001|Part A|Adverse Event|1|||
163474502|NCT03330106|590435007|FG002|Part A|Adverse Event|0|||
163474503|NCT03330106|590435008|FG003|Part A|Adverse Event|0|||
163474504|NCT03330106|590435005|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
163474505|NCT03330106|590435006|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
163474506|NCT03330106|590435007|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
163474507|NCT03330106|590435008|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
163474508|NCT03330106|590435005|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
163474509|NCT03330106|590435006|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
163474510|NCT03330106|590435007|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
163474511|NCT03330106|590435008|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
163474512|NCT03330106|590435005|FG000|Part A|Progressive Disease|0|||
163474513|NCT03330106|590435006|FG001|Part A|Progressive Disease|1|||
163474514|NCT03330106|590435007|FG002|Part A|Progressive Disease|0|||
163474515|NCT03330106|590435008|FG003|Part A|Progressive Disease|0|||
163474516|NCT03330106|590435005|FG000|Part B|Lost to Follow-up|0|||
163474517|NCT03330106|590435006|FG001|Part B|Lost to Follow-up|0|||
163474518|NCT03330106|590435007|FG002|Part B|Lost to Follow-up|0|||
163474519|NCT03330106|590435008|FG003|Part B|Lost to Follow-up|1|||
163474520|NCT03330106|590435005|FG000|Part B|Withdrawal by Subject|0|||
163474521|NCT03330106|590435006|FG001|Part B|Withdrawal by Subject|0|||
163474522|NCT03330106|590435007|FG002|Part B|Withdrawal by Subject|4|||
163474523|NCT03330106|590435008|FG003|Part B|Withdrawal by Subject|0|||
163474524|NCT03330106|590435005|FG000|Part B|Death|0|||
163474525|NCT03330106|590435006|FG001|Part B|Death|0|||
163474526|NCT03330106|590435007|FG002|Part B|Death|2|||
163474527|NCT03330106|590435008|FG003|Part B|Death|0|||
163474528|NCT03330106|590435005|FG000|Part B|Clinical Progression|0|||
163474529|NCT03330106|590435006|FG001|Part B|Clinical Progression|0|||
163474530|NCT03330106|590435007|FG002|Part B|Clinical Progression|1|||
163474531|NCT03330106|590435008|FG003|Part B|Clinical Progression|1|||
163474532|NCT03330106|590435005|FG000|Part B|Symptomatic Deterioration|0|||
163474533|NCT03330106|590435006|FG001|Part B|Symptomatic Deterioration|0|||
163474534|NCT03330106|590435007|FG002|Part B|Symptomatic Deterioration|0|||
163474535|NCT03330106|590435008|FG003|Part B|Symptomatic Deterioration|1|||
163474536|NCT03330106|590435005|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
163474537|NCT03330106|590435006|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
163474538|NCT03330106|590435007|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
163474539|NCT03330106|590435008|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
163474540|NCT03330106|590435005|FG000|Part B|Progressive Disease|0|||
163474541|NCT03330106|590435006|FG001|Part B|Progressive Disease|0|||
163474542|NCT03330106|590435007|FG002|Part B|Progressive Disease|11|||
163474543|NCT03330106|590435008|FG003|Part B|Progressive Disease|4|||
163474544|NCT00623766|590435010|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
163474545|NCT00623766|590435011|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
163474546|NCT00623766|590435010|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
163474547|NCT00623766|590435011|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
163474548|NCT00623766|590435010|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
163474549|NCT00623766|590435011|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
163474550|NCT00623766|590435010|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
163474551|NCT00623766|590435011|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
163474552|NCT00623766|590435010|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
163474553|NCT00623766|590435011|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
163474554|NCT00486889|590435013|FG000|Overall Study|Death|3|||
163474555|NCT00486889|590435013|FG000|Overall Study|Non-compliant|2|||
163474556|NCT00486889|590435013|FG000|Overall Study|Withdrawal by Subject|6|||
163474557|NCT02750501|590435014|FG000|Overall Study|Adverse Event|4|||
163474558|NCT02750501|590435014|FG000|Overall Study|Physician Decision|1|||
163474559|NCT02750501|590435014|FG000|Overall Study|Protocol Violation|1|||
163474560|NCT02750501|590435014|FG000|Overall Study|G-tube came out|1|||
163474561|NCT02750501|590435014|FG000|Overall Study|Non-compliant use of PERT|1|||
163474562|NCT00893763|590435015|FG000|Overall Study|extubated|110|||
163474563|NCT00893763|590435016|FG001|Overall Study|extubated|110|||
163474564|NCT01738594|590435017|FG000|Registration and Treatment Start|Adverse Event|0|||
163474565|NCT01738594|590435018|FG001|Registration and Treatment Start|Adverse Event|1|||
163474566|NCT01738594|590435019|FG002|Registration and Treatment Start|Adverse Event|0|||
163474567|NCT01738594|590435020|FG003|Registration and Treatment Start|Adverse Event|0|||
163474568|NCT01738594|590435021|FG004|Registration and Treatment Start|Adverse Event|0|||
163474569|NCT01738594|590435022|FG005|Registration and Treatment Start|Adverse Event|0|||
163474570|NCT01738594|590435023|FG006|Registration and Treatment Start|Adverse Event|0|||
163474571|NCT01738594|590435024|FG007|Registration and Treatment Start|Adverse Event|0|||
163474572|NCT01738594|590435017|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
163474573|NCT01738594|590435018|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
163474574|NCT01738594|590435019|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
163474575|NCT01738594|590435020|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
163474576|NCT01738594|590435021|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
163474577|NCT01738594|590435022|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
163474578|NCT01738594|590435023|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
163474579|NCT01738594|590435024|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
163474580|NCT01738594|590435017|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
163474581|NCT01738594|590435018|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
163474582|NCT01738594|590435019|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
163474583|NCT01738594|590435020|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
163474584|NCT01738594|590435021|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
163474585|NCT01738594|590435022|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
163474586|NCT01738594|590435023|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
163474587|NCT01738594|590435024|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
163474588|NCT01738594|590435017|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
163474589|NCT01738594|590435018|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
163474590|NCT01738594|590435019|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
163474591|NCT01738594|590435020|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
163474592|NCT01738594|590435021|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
163474593|NCT01738594|590435022|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
163474594|NCT01738594|590435023|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
163474595|NCT01738594|590435024|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
163474596|NCT01738594|590435017|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
163474597|NCT01738594|590435018|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
163474598|NCT01738594|590435019|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
163474599|NCT01738594|590435020|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
163474600|NCT01738594|590435021|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
163474601|NCT01738594|590435022|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
163474602|NCT01738594|590435023|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
163474603|NCT01738594|590435024|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
163474604|NCT01738594|590435017|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
163474605|NCT01738594|590435018|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
163474606|NCT01738594|590435019|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
163474607|NCT01738594|590435020|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
163474608|NCT01738594|590435021|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
163474609|NCT01738594|590435022|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
163474610|NCT01738594|590435023|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
163474611|NCT01738594|590435024|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
163474612|NCT01738594|590435017|FG000|Follow up for 1 Year|Death|0|||
163474613|NCT01738594|590435018|FG001|Follow up for 1 Year|Death|0|||
163474614|NCT01738594|590435019|FG002|Follow up for 1 Year|Death|0|||
163474615|NCT01738594|590435020|FG003|Follow up for 1 Year|Death|0|||
163474616|NCT01738594|590435021|FG004|Follow up for 1 Year|Death|0|||
163474617|NCT01738594|590435022|FG005|Follow up for 1 Year|Death|1|||
163474618|NCT01738594|590435023|FG006|Follow up for 1 Year|Death|0|||
163474619|NCT01738594|590435024|FG007|Follow up for 1 Year|Death|0|||
163474620|NCT01738594|590435017|FG000|Follow up for 1 Year|Other|0|||
163474621|NCT01738594|590435018|FG001|Follow up for 1 Year|Other|0|||
163474622|NCT01738594|590435019|FG002|Follow up for 1 Year|Other|0|||
163474623|NCT01738594|590435020|FG003|Follow up for 1 Year|Other|0|||
163474624|NCT01738594|590435021|FG004|Follow up for 1 Year|Other|0|||
163474625|NCT01738594|590435022|FG005|Follow up for 1 Year|Other|2|||
163474626|NCT01738594|590435023|FG006|Follow up for 1 Year|Other|0|||
163474627|NCT01738594|590435024|FG007|Follow up for 1 Year|Other|0|||
163474628|NCT00796549|590435025|FG000|Overall Study|Adverse Event|11|||
163474629|NCT00796549|590435025|FG000|Overall Study|not entered|149|||
163474630|NCT00796549|590435025|FG000|Overall Study|Other|2|||
163474631|NCT00796549|590435025|FG000|Overall Study|Progressive disease|56|||
163474632|NCT04430036|590435027|FG000|Safety Run in Phase|Progression of disease|2|||
163474633|NCT04107935|590435028|FG000|Overall Study|Death|1|||
163474634|NCT04107935|590435029|FG001|Overall Study|Death|0|||
163474635|NCT01842334|590435030|FG000|Overall Study|Withdrawal by Subject|3|||
163474636|NCT01842334|590435031|FG001|Overall Study|Withdrawal by Subject|3|||
163474637|NCT01842334|590435030|FG000|Overall Study|Moved away mid-study|0|||
163474638|NCT01842334|590435031|FG001|Overall Study|Moved away mid-study|1|||
163474639|NCT00376675|590435032|FG000|Overall Study|Withdrawal by Subject|9|||
163474640|NCT00376675|590435033|FG001|Overall Study|Withdrawal by Subject|2|||
163474641|NCT00376675|590435032|FG000|Overall Study|Adverse Event|10|||
163474642|NCT00376675|590435033|FG001|Overall Study|Adverse Event|5|||
163474643|NCT00376675|590435032|FG000|Overall Study|Other Reason|1|||
163474644|NCT00376675|590435033|FG001|Overall Study|Other Reason|7|||
163474645|NCT01302691|590435038|FG000|Overall Study|Adverse Event|2|||
163474646|NCT01302691|590435039|FG001|Overall Study|Adverse Event|0|||
163474647|NCT01302691|590435038|FG000|Overall Study|Death|0|||
163474648|NCT01302691|590435039|FG001|Overall Study|Death|1|||
163474649|NCT01302691|590435038|FG000|Overall Study|Lost to Follow-up|1|||
163474650|NCT01302691|590435039|FG001|Overall Study|Lost to Follow-up|0|||
163474651|NCT01302691|590435038|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
163474652|NCT01302691|590435039|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
163474653|NCT01302691|590435038|FG000|Overall Study|Physician Decision|0|||
163474654|NCT01302691|590435039|FG001|Overall Study|Physician Decision|1|||
163474655|NCT01302691|590435038|FG000|Overall Study|Protocol Violation|1|||
163474656|NCT01302691|590435039|FG001|Overall Study|Protocol Violation|0|||
163474657|NCT01678560|590435045|FG000|Overall Study|Physician Decision|4|||
163474658|NCT01678560|590435046|FG001|Overall Study|Physician Decision|4|||
163474659|NCT01678560|590435045|FG000|Overall Study|Death|0|||
163474660|NCT01678560|590435046|FG001|Overall Study|Death|1|||
163474661|NCT01678560|590435045|FG000|Overall Study|Withdrawal by Subject|0|||
163474662|NCT01678560|590435046|FG001|Overall Study|Withdrawal by Subject|1|||
163474663|NCT02201472|590435047|FG000|Overall Study|Lack of Efficacy|2|||
163474664|NCT00262314|590435048|FG000|Overall Study|Changing physicians|38|||
163474665|NCT00262314|590435048|FG000|Overall Study|Death|12|||
163474666|NCT00262314|590435048|FG000|Overall Study|Patient's decision|92|||
163474667|NCT00262314|590435048|FG000|Overall Study|Other|95|||
163474668|NCT00262314|590435048|FG000|Overall Study|Lost to Follow-up|70|||
163474669|NCT00262314|590435048|FG000|Overall Study|Administrative withdrawal|30|||
163474670|NCT01300767|590435049|FG000|Overall Study|Discomfort|2|||
163474671|NCT01300767|590435049|FG000|Overall Study|Biomicroscopy|1|||
163474672|NCT01300767|590435049|FG000|Overall Study|Unacceptable fit|1|||
163474673|NCT00959699|590435050|FG000|Treatment Period|Adverse Event|3|||
163474674|NCT00959699|590435051|FG001|Treatment Period|Adverse Event|13|||
163474675|NCT00959699|590435050|FG000|Treatment Period|Lack of Efficacy|15|||
163474676|NCT00959699|590435051|FG001|Treatment Period|Lack of Efficacy|6|||
163474677|NCT00959699|590435050|FG000|Treatment Period|Lost to Follow-up|0|||
163474678|NCT00959699|590435051|FG001|Treatment Period|Lost to Follow-up|1|||
163474679|NCT00959699|590435050|FG000|Treatment Period|Withdrawal by Subject|1|||
163474680|NCT00959699|590435051|FG001|Treatment Period|Withdrawal by Subject|3|||
163474681|NCT00959699|590435050|FG000|Treatment Period|Non-Compliance with Protocol|0|||
163474682|NCT00959699|590435051|FG001|Treatment Period|Non-Compliance with Protocol|1|||
163474683|NCT00959699|590435050|FG000|Treatment Period|Did not receive treatment|0|||
163474684|NCT00959699|590435051|FG001|Treatment Period|Did not receive treatment|1|||
163474685|NCT00959699|590435050|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
163474686|NCT00959699|590435051|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
163474687|NCT00959699|590435050|FG000|Follow-up Period|Lost to Follow-up|3|||
163474688|NCT00959699|590435051|FG001|Follow-up Period|Lost to Follow-up|2|||
163474689|NCT00959699|590435050|FG000|Follow-up Period|Withdrawal by Subject|3|||
163474690|NCT00959699|590435051|FG001|Follow-up Period|Withdrawal by Subject|4|||
163474691|NCT03924427|590435052|FG000|Overall Study|Adverse Event|4|||
163474692|NCT03924427|590435052|FG000|Overall Study|Lack of Efficacy|1|||
163474693|NCT03924427|590435052|FG000|Overall Study|Withdrawal by Subject|1|||
163474694|NCT00609167|590435055|FG000|Overall Study|Withdrawal by Subject|1|||
163474695|NCT00609167|590435056|FG001|Overall Study|Withdrawal by Subject|0|||
163474696|NCT00609167|590435055|FG000|Overall Study|Lack of Efficacy|1|||
163474697|NCT00609167|590435056|FG001|Overall Study|Lack of Efficacy|0|||
163474698|NCT00609167|590435055|FG000|Overall Study|Adverse Event|5|||
163474699|NCT00609167|590435056|FG001|Overall Study|Adverse Event|1|||
163474700|NCT00609167|590435055|FG000|Overall Study|Disease Progression|1|||
163474701|NCT00609167|590435056|FG001|Overall Study|Disease Progression|0|||
163474702|NCT00609167|590435055|FG000|Overall Study|Stem Cell Transplant|0|||
163474703|NCT00609167|590435056|FG001|Overall Study|Stem Cell Transplant|6|||
163474704|NCT00712270|590435057|FG000|Overall Study|Withdrawal by Subject|11|||
163474705|NCT00712270|590435057|FG000|Overall Study|Screen Failure|3|||
163474706|NCT04412668|590435058|FG000|Overall Study|Death - multiple comorbidities|2|||
163474707|NCT04412668|590435059|FG001|Overall Study|Death - multiple comorbidities|0|||
163474708|NCT04412668|590435060|FG002|Overall Study|Death - multiple comorbidities|0|||
163474709|NCT04412668|590435058|FG000|Overall Study|Withdrawal by Subject|3|||
163474710|NCT04412668|590435059|FG001|Overall Study|Withdrawal by Subject|0|||
163474711|NCT04412668|590435060|FG002|Overall Study|Withdrawal by Subject|0|||
163474712|NCT04412668|590435058|FG000|Overall Study|Other than Specified|2|||
163474713|NCT04412668|590435059|FG001|Overall Study|Other than Specified|0|||
163474714|NCT04412668|590435060|FG002|Overall Study|Other than Specified|0|||
163474715|NCT03864627|590435061|FG000|Overall Study|Adverse Event|0|||
163474716|NCT03864627|590435062|FG001|Overall Study|Adverse Event|1|||
163474717|NCT03864627|590435061|FG000|Overall Study|Lack of Efficacy|0|||
163474718|NCT03864627|590435062|FG001|Overall Study|Lack of Efficacy|1|||
163474719|NCT03864627|590435061|FG000|Overall Study|Lost to Follow-up|0|||
163474720|NCT03864627|590435062|FG001|Overall Study|Lost to Follow-up|1|||
163474721|NCT03864627|590435061|FG000|Overall Study|Withdrawal by Subject|4|||
163474722|NCT03864627|590435062|FG001|Overall Study|Withdrawal by Subject|8|||
163474723|NCT03864627|590435061|FG000|Overall Study|Study terminated by sponsor|0|||
163474724|NCT03864627|590435062|FG001|Overall Study|Study terminated by sponsor|1|||
163474725|NCT01388491|590435063|FG000|Overall Study|Adverse Event|10|||
163474726|NCT01388491|590435064|FG001|Overall Study|Adverse Event|9|||
163474727|NCT01388491|590435063|FG000|Overall Study|Sponsor Request|9|||
163474728|NCT01388491|590435064|FG001|Overall Study|Sponsor Request|7|||
163474729|NCT01388491|590435063|FG000|Overall Study|Withdrawal by Subject|6|||
163474730|NCT01388491|590435064|FG001|Overall Study|Withdrawal by Subject|10|||
163474731|NCT01388491|590435063|FG000|Overall Study|Lost to Follow-up|4|||
163474732|NCT01388491|590435064|FG001|Overall Study|Lost to Follow-up|3|||
163474733|NCT01388491|590435063|FG000|Overall Study|Protocol Violation|2|||
163474734|NCT01388491|590435064|FG001|Overall Study|Protocol Violation|0|||
163474735|NCT01388491|590435063|FG000|Overall Study|Noncompliance|2|||
163474736|NCT01388491|590435064|FG001|Overall Study|Noncompliance|0|||
163474737|NCT01388491|590435063|FG000|Overall Study|Pregnancy|1|||
163474738|NCT01388491|590435064|FG001|Overall Study|Pregnancy|0|||
163474739|NCT01592773|590436289|FG000|Overall Study|Study Terminated by Sponsor|582|||
163474740|NCT01592773|590436289|FG000|Overall Study|Withdrawal by Subject|35|||
163474741|NCT01592773|590436289|FG000|Overall Study|Lost to Follow-up|19|||
163474742|NCT01592773|590436289|FG000|Overall Study|Adverse Event|17|||
163474743|NCT01592773|590436289|FG000|Overall Study|Lack of Efficacy|9|||
163474744|NCT01592773|590436289|FG000|Overall Study|Protocol Violation|2|||
163474745|NCT01592773|590436289|FG000|Overall Study|Inclusion/exclusion not meet|1|||
163474746|NCT01592773|590436289|FG000|Overall Study|Other Reason|1|||
163474747|NCT00121485|590436290|FG000|Overall Study|Not implanted|1|||
163474748|NCT00121485|590436291|FG001|Overall Study|Not implanted|5|||
163474749|NCT00121485|590436290|FG000|Overall Study|Crossover|0|||
163474750|NCT00121485|590436291|FG001|Overall Study|Crossover|2|||
163474751|NCT04124952|590436293|FG000|Overall Study|Lost to Follow-up|1|||
163474752|NCT01267955|590436294|FG000|Stage 1 (6 Months)|Death|3|||
163474753|NCT01267955|590436294|FG000|Stage 2 (6 Months)|Death|5|||
163474754|NCT01267955|590436294|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
163474755|NCT00610714|590436296|FG000|Overall Study|Adverse Event|3|||
163474756|NCT00610714|590436297|FG001|Overall Study|Adverse Event|1|||
163474757|NCT00610714|590436296|FG000|Overall Study|Death|12|||
163474758|NCT00610714|590436297|FG001|Overall Study|Death|18|||
163474759|NCT00610714|590436296|FG000|Overall Study|Withdrawal by Subject|9|||
163474760|NCT00610714|590436297|FG001|Overall Study|Withdrawal by Subject|3|||
163474761|NCT00610714|590436296|FG000|Overall Study|Study completion at 120 PFS events|2|||
163474762|NCT00610714|590436297|FG001|Overall Study|Study completion at 120 PFS events|2|||
163474763|NCT01108263|590436298|FG000|Overall Study|Adverse Event|0|||
163474764|NCT01108263|590436299|FG001|Overall Study|Adverse Event|1|||
163474765|NCT02974621|590436301|FG000|Overall Study|Didn't receive study treatment|1|||
163474766|NCT02974621|590436302|FG001|Overall Study|Didn't receive study treatment|10|||
163474767|NCT02559115|590436303|FG000|Overall Study|Withdrawal by Subject|3|||
163474768|NCT04288089|590436304|FG000|Overall Study|Ongoing Treatment|2|||
163474769|NCT04288089|590436305|FG001|Overall Study|Ongoing Treatment|1|||
163474770|NCT04288089|590436306|FG002|Overall Study|Ongoing Treatment|1|||
163474771|NCT04288089|590436307|FG003|Overall Study|Ongoing Treatment|4|||
163474772|NCT02354690|590436308|FG000|Overall Study|Physician Decision|1|||
163474773|NCT04556175|590436312|FG000|Overall Study|Study terminated due to COVID-19|8|||
163474774|NCT04556175|590436313|FG001|Overall Study|Study terminated due to COVID-19|8|||
163474775|NCT05549505|590436314|FG000|Overall Study|Lost to Follow-up|2|||
163474776|NCT05549505|590436315|FG001|Overall Study|Lost to Follow-up|0|||
163474777|NCT05549505|590436314|FG000|Overall Study|Withdrawal by Subject|3|||
163474778|NCT05549505|590436315|FG001|Overall Study|Withdrawal by Subject|3|||
163474779|NCT05549505|590436314|FG000|Overall Study|Other: Miscellaneous|3|||
163474780|NCT05549505|590436315|FG001|Overall Study|Other: Miscellaneous|6|||
163474781|NCT00592072|590436318|FG000|Wash Out Period|Lost to Follow-up|1|||
163474782|NCT00592072|590436319|FG001|Wash Out Period|Lost to Follow-up|1|||
163474783|NCT00403390|590436320|FG000|Overall Study|Withdrawal by Subject|1|||
163474784|NCT00403390|590436321|FG001|Overall Study|Withdrawal by Subject|0|||
163474785|NCT00403390|590436320|FG000|Overall Study|samples lost|1|||
163474786|NCT00403390|590436321|FG001|Overall Study|samples lost|0|||
163474787|NCT00403390|590436320|FG000|Overall Study|non-compliant|1|||
163474788|NCT00403390|590436321|FG001|Overall Study|non-compliant|0|||
163474789|NCT01796106|590436322|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
163474790|NCT01796106|590436323|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
163474791|NCT01332851|590436326|FG000|Overall Study|Withdrawal by Subject|4|||
163474792|NCT01332851|590436327|FG001|Overall Study|Withdrawal by Subject|2|||
163474793|NCT01332851|590436326|FG000|Overall Study|Lost to Follow-up|7|||
163474794|NCT01332851|590436327|FG001|Overall Study|Lost to Follow-up|11|||
163474795|NCT03446612|590436328|FG000|Overall Study|Protocol defined stopping criteria|0|||
163474796|NCT03446612|590436329|FG001|Overall Study|Protocol defined stopping criteria|1|||
163474797|NCT01249157|590436330|FG000|Overall Study|Withdrawal by Subject|1|||
163474798|NCT03796195|590436331|FG000|Overall Study|Study closed early|1|||
163474799|NCT04445051|590436332|FG000|Overall Study|Adverse Event|0|||
163474800|NCT04445051|590436333|FG001|Overall Study|Adverse Event|0|||
163474801|NCT04445051|590436334|FG002|Overall Study|Adverse Event|1|||
163474802|NCT04445051|590436335|FG003|Overall Study|Adverse Event|0|||
163474803|NCT04445051|590436336|FG004|Overall Study|Adverse Event|0|||
163474804|NCT04445051|590436337|FG005|Overall Study|Adverse Event|0|||
163474805|NCT02392468|590436340|FG000|Overall Study|Adverse Event|0|||
163474806|NCT02392468|590436341|FG001|Overall Study|Adverse Event|1|||
163474807|NCT02392468|590436342|FG002|Overall Study|Adverse Event|0|||
163474808|NCT02392468|590436343|FG003|Overall Study|Adverse Event|0|||
163474809|NCT02392468|590436344|FG004|Overall Study|Adverse Event|0|||
163474810|NCT02392468|590436345|FG005|Overall Study|Adverse Event|1|||
163474811|NCT01039428|590436346|FG000|Overall Study|Protocol Violation|1|||
163474812|NCT01039428|590436347|FG001|Overall Study|Protocol Violation|0|||
163474813|NCT01039428|590436346|FG000|Overall Study|Withdrawal by Subject|1|||
163474814|NCT01039428|590436347|FG001|Overall Study|Withdrawal by Subject|0|||
163474815|NCT01313039|590436348|FG000|Overall Study|Physician Decision|1|||
163474816|NCT01313039|590436348|FG000|Overall Study|Adverse Event|1|||
163474817|NCT03630016|590436349|FG000|Overall Study|Poor Sensor Placement|1|||
163474818|NCT05083949|590436350|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
163474819|NCT05083949|590436351|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
163474820|NCT05083949|590436350|FG000|Period 1|Adverse Event|1|||
163474821|NCT05083949|590436351|FG001|Period 1|Adverse Event|1|||
163474822|NCT05083949|590436350|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
163474823|NCT05083949|590436351|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
163474824|NCT05083949|590436350|FG000|Period 2|Adverse Event|0|||
163474825|NCT05083949|590436351|FG001|Period 2|Adverse Event|2|||
163474826|NCT02470429|590436352|FG000|Overall Study|Adverse Event|1|||
163474827|NCT02470429|590436353|FG001|Overall Study|Adverse Event|0|||
163474828|NCT02470429|590436352|FG000|Overall Study|Withdrawal by Subject|1|||
163474829|NCT02470429|590436353|FG001|Overall Study|Withdrawal by Subject|0|||
163474830|NCT01602744|590436354|FG000|Overall Study|Death|17|||
163474831|NCT01602744|590436355|FG001|Overall Study|Death|15|||
163474832|NCT01602744|590436354|FG000|Overall Study|Lost to Follow-up|13|||
163474833|NCT01602744|590436355|FG001|Overall Study|Lost to Follow-up|8|||
163474834|NCT00606294|590436356|FG000|Overall Study|Withdrawal by Subject|36|||
163474835|NCT00606294|590436357|FG001|Overall Study|Withdrawal by Subject|0|||
163474836|NCT01885104|590436359|FG000|Overall Study|Withdrawal of Consent|1|||
163474837|NCT01885104|590436360|FG001|Overall Study|Withdrawal of Consent|0|||
163474838|NCT01885104|590436359|FG000|Overall Study|Lost to Follow-up|0|||
163474839|NCT01885104|590436360|FG001|Overall Study|Lost to Follow-up|1|||
163474840|NCT01885104|590436359|FG000|Overall Study|Physician Decision|1|||
163474841|NCT01885104|590436360|FG001|Overall Study|Physician Decision|0|||
163474842|NCT01976624|590436361|FG000|Overall Study|Participants contraindicated|2|||
163474843|NCT01976624|590436361|FG000|Overall Study|Participants age less than 19 years|12|||
163474844|NCT00126425|590436362|FG000|Overall Study|Withdrawal by Subject|17|||
163474845|NCT00126425|590436363|FG001|Overall Study|Withdrawal by Subject|1|||
163474846|NCT00126425|590436362|FG000|Overall Study|Lost to Follow-up|8|||
163474847|NCT00126425|590436363|FG001|Overall Study|Lost to Follow-up|4|||
163474848|NCT00126425|590436362|FG000|Overall Study|Protocol Violation|9|||
163474849|NCT00126425|590436363|FG001|Overall Study|Protocol Violation|6|||
163474850|NCT00126425|590436362|FG000|Overall Study|Adverse Event|1|||
163474851|NCT00126425|590436363|FG001|Overall Study|Adverse Event|0|||
163474852|NCT00126425|590436362|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
163474853|NCT00126425|590436363|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
163474854|NCT00126425|590436362|FG000|Overall Study|Other|5|||
163474855|NCT00126425|590436363|FG001|Overall Study|Other|0|||
163474856|NCT01316380|590436364|FG000|Overall Study|Adverse Event|0|||
163474857|NCT01316380|590436365|FG001|Overall Study|Adverse Event|2|||
163474858|NCT01316380|590436366|FG002|Overall Study|Adverse Event|1|||
163474859|NCT01316380|590436364|FG000|Overall Study|Protocol Violation|0|||
163474860|NCT01316380|590436365|FG001|Overall Study|Protocol Violation|0|||
163474861|NCT01316380|590436366|FG002|Overall Study|Protocol Violation|1|||
163474862|NCT01316380|590436364|FG000|Overall Study|Withdrawal by Subject|1|||
163474863|NCT01316380|590436365|FG001|Overall Study|Withdrawal by Subject|2|||
163474864|NCT01316380|590436366|FG002|Overall Study|Withdrawal by Subject|0|||
163474865|NCT01316380|590436364|FG000|Overall Study|Other|0|||
163474866|NCT01316380|590436365|FG001|Overall Study|Other|1|||
163474867|NCT01316380|590436366|FG002|Overall Study|Other|1|||
163474868|NCT01316380|590436364|FG000|Overall Study|Not treated|1|||
163474869|NCT01316380|590436365|FG001|Overall Study|Not treated|0|||
163474870|NCT01316380|590436366|FG002|Overall Study|Not treated|0|||
163474871|NCT01894776|590436367|FG000|Overall Study|Withdrawal by Subject|1|||
163474872|NCT00471315|590436369|FG000|Overall Study|Adverse Event|7|||
163474873|NCT00471315|590436369|FG000|Overall Study|Withdrawal by Subject|1|||
163474874|NCT02574520|590436373|FG000|Overall Study|Not dosed|2|||
163474875|NCT02574520|590436374|FG001|Overall Study|Not dosed|0|||
163474876|NCT02574520|590436375|FG002|Overall Study|Not dosed|5|||
163474877|NCT02574520|590436376|FG003|Overall Study|Not dosed|4|||
163474878|NCT02574520|590436373|FG000|Overall Study|Adverse Event|0|||
163474879|NCT02574520|590436374|FG001|Overall Study|Adverse Event|0|||
163474880|NCT02574520|590436375|FG002|Overall Study|Adverse Event|0|||
163474881|NCT02574520|590436376|FG003|Overall Study|Adverse Event|1|||
163474882|NCT02574520|590436373|FG000|Overall Study|Withdrawal by Subject|0|||
163474883|NCT02574520|590436374|FG001|Overall Study|Withdrawal by Subject|0|||
163474884|NCT02574520|590436375|FG002|Overall Study|Withdrawal by Subject|0|||
163474885|NCT02574520|590436376|FG003|Overall Study|Withdrawal by Subject|1|||
163474886|NCT02574520|590436373|FG000|Overall Study|Other|0|||
163474887|NCT02574520|590436374|FG001|Overall Study|Other|0|||
163474888|NCT02574520|590436375|FG002|Overall Study|Other|0|||
163474889|NCT02574520|590436376|FG003|Overall Study|Other|2|||
163474890|NCT01365091|590436379|FG000|Period 1|Adverse Event|1|||
163474891|NCT01365091|590436380|FG001|Period 1|Adverse Event|0|||
163474892|NCT01365091|590436381|FG002|Period 1|Adverse Event|2|||
163474893|NCT01365091|590436382|FG003|Period 1|Adverse Event|3|||
163474894|NCT01365091|590436379|FG000|Period 1|Positive test result for drugs of abuse|1|||
163474895|NCT01365091|590436380|FG001|Period 1|Positive test result for drugs of abuse|0|||
163474896|NCT01365091|590436381|FG002|Period 1|Positive test result for drugs of abuse|0|||
163474897|NCT01365091|590436382|FG003|Period 1|Positive test result for drugs of abuse|0|||
163474898|NCT01365091|590436379|FG000|Period 1|No longer met study criteria|0|||
163474899|NCT01365091|590436380|FG001|Period 1|No longer met study criteria|1|||
163474900|NCT01365091|590436381|FG002|Period 1|No longer met study criteria|0|||
163474901|NCT01365091|590436382|FG003|Period 1|No longer met study criteria|0|||
163474902|NCT01365091|590436379|FG000|Period 1|Withdrawal by Subject|0|||
163474903|NCT01365091|590436380|FG001|Period 1|Withdrawal by Subject|1|||
163474904|NCT01365091|590436381|FG002|Period 1|Withdrawal by Subject|0|||
163474905|NCT01365091|590436382|FG003|Period 1|Withdrawal by Subject|0|||
163474906|NCT01365091|590436379|FG000|Period 1|Personal reasons|0|||
163474907|NCT01365091|590436380|FG001|Period 1|Personal reasons|0|||
163474908|NCT01365091|590436381|FG002|Period 1|Personal reasons|1|||
163474909|NCT01365091|590436382|FG003|Period 1|Personal reasons|0|||
163474910|NCT01365091|590436379|FG000|Period 2|Withdrawal by Subject|1|||
163474911|NCT01365091|590436380|FG001|Period 2|Withdrawal by Subject|0|||
163474912|NCT01365091|590436381|FG002|Period 2|Withdrawal by Subject|0|||
163474913|NCT01365091|590436382|FG003|Period 2|Withdrawal by Subject|0|||
163474914|NCT01365091|590436379|FG000|Period 2|Adverse Event|0|||
163474915|NCT01365091|590436380|FG001|Period 2|Adverse Event|0|||
163474916|NCT01365091|590436381|FG002|Period 2|Adverse Event|1|||
163474917|NCT01365091|590436382|FG003|Period 2|Adverse Event|0|||
163474918|NCT05307523|590436384|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
163474919|NCT05307523|590436385|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
163474920|NCT05307523|590436384|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
163474921|NCT05307523|590436385|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
163474922|NCT05116683|590436387|FG000|Overall Study|Physician Decision|4|||
163474923|NCT03935594|590436391|FG000|Overall Study|Physician Decision|3|||
163474924|NCT01435122|590436392|FG000|Overall Study|Early withdrawal due to toxicity|8|||
163474925|NCT00112840|590436393|FG000|Overall Study|Physician Decision|1|||
163474926|NCT00112840|590436394|FG001|Overall Study|Physician Decision|0|||
163474927|NCT00112840|590436395|FG002|Overall Study|Physician Decision|0|||
163474928|NCT00112840|590436393|FG000|Overall Study|Withdrawal by Subject|1|||
163474929|NCT00112840|590436394|FG001|Overall Study|Withdrawal by Subject|0|||
163474930|NCT00112840|590436395|FG002|Overall Study|Withdrawal by Subject|1|||
163474931|NCT00112840|590436393|FG000|Overall Study|Protocol Violation|0|||
163474932|NCT00112840|590436394|FG001|Overall Study|Protocol Violation|0|||
163474933|NCT00112840|590436395|FG002|Overall Study|Protocol Violation|5|||
163474934|NCT02875366|590436396|FG000|Overall Study|Adverse Event|0|||
163474935|NCT02875366|590436397|FG001|Overall Study|Adverse Event|2|||
163474936|NCT02875366|590436396|FG000|Overall Study|Noncompliance|0|||
163474937|NCT02875366|590436397|FG001|Overall Study|Noncompliance|1|||
163474938|NCT00683774|590436398|FG000|Overall Study|Withdrawal by Subject|0|||
163474939|NCT00683774|590436399|FG001|Overall Study|Withdrawal by Subject|1|||
163474940|NCT00683774|590436398|FG000|Overall Study|Physician Decision|3|||
163474941|NCT00683774|590436399|FG001|Overall Study|Physician Decision|0|||
163474942|NCT03595176|590436400|FG000|Overall Study|Death|0|||
163474943|NCT03595176|590436401|FG001|Overall Study|Death|2|||
163474944|NCT03595176|590436400|FG000|Overall Study|Lost to Follow-up|0|||
163474945|NCT03595176|590436401|FG001|Overall Study|Lost to Follow-up|1|||
163474946|NCT02735044|590436403|FG000|Overall Study|Adverse Event|3|||
163474947|NCT02735044|590436404|FG001|Overall Study|Adverse Event|3|||
163474948|NCT02735044|590436403|FG000|Overall Study|Lack of Efficacy|1|||
163474949|NCT02735044|590436404|FG001|Overall Study|Lack of Efficacy|0|||
163474950|NCT02735044|590436403|FG000|Overall Study|Poor compliance to protocol|7|||
163474951|NCT02735044|590436404|FG001|Overall Study|Poor compliance to protocol|7|||
163474952|NCT02735044|590436403|FG000|Overall Study|Randomized and not treated|0|||
163474953|NCT02735044|590436404|FG001|Overall Study|Randomized and not treated|2|||
163474954|NCT02735044|590436403|FG000|Overall Study|Other, not specified above|5|||
163474955|NCT02735044|590436404|FG001|Overall Study|Other, not specified above|11|||
163474956|NCT00412113|590436406|FG000|Overall Study|Adverse Event|11|||
163474957|NCT00412113|590436407|FG001|Overall Study|Adverse Event|15|||
163474958|NCT00412113|590436406|FG000|Overall Study|did not receive treatment|1|||
163474959|NCT00412113|590436407|FG001|Overall Study|did not receive treatment|0|||
163474960|NCT01201967|590436408|FG000|Overall Study|Lost to Follow-up|6|||
163474961|NCT01201967|590436409|FG001|Overall Study|Lost to Follow-up|5|||
163474962|NCT02497287|590436410|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
163474963|NCT02497287|590436410|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
163474964|NCT02497287|590436410|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
163474965|NCT02497287|590436410|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
163474966|NCT02497287|590436410|FG000|Induction Phase (4 Weeks)|Other|13|||
163474967|NCT02497287|590436410|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
163474968|NCT02497287|590436410|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
163474969|NCT02497287|590436410|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
163474970|NCT02497287|590436410|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
163474971|NCT02497287|590436410|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
163474972|NCT02497287|590436410|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
163474973|NCT02497287|590436410|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
163474974|NCT02497287|590436410|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
163474975|NCT02497287|590436410|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
163474976|NCT02497287|590436410|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
163474977|NCT02497287|590436410|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
163474978|NCT02497287|590436410|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
163474979|NCT02497287|590436410|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
163474980|NCT02497287|590436410|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
163474981|NCT02497287|590436410|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
163474982|NCT02497287|590436410|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
163474983|NCT02497287|590436410|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
163474984|NCT02497287|590436410|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
163474985|NCT02497287|590436410|FG000|Follow-up Phase (4 Week)|Other|1|||
163474986|NCT01226472|590436412|FG000|Overall Study|Progressive Disease|1|||
163474987|NCT03128307|590436415|FG000|Overall Study|Lost to Follow-up|29|||
163474988|NCT03128307|590436415|FG000|Overall Study|Withdrawal by Subject|5|||
163474989|NCT00740116|590438376|FG000|Overall Study|Withdrawal by Subject|1|||
163474990|NCT00740116|590438377|FG001|Overall Study|Withdrawal by Subject|1|||
163474991|NCT00740116|590438376|FG000|Overall Study|Protocol Violation|1|||
163474992|NCT00740116|590438377|FG001|Overall Study|Protocol Violation|4|||
163474993|NCT00621764|590438378|FG000|Overall Study|Protocol Violation|0|||
163474994|NCT00621764|590438379|FG001|Overall Study|Protocol Violation|0|||
163474995|NCT00621764|590438380|FG002|Overall Study|Protocol Violation|0|||
163474996|NCT00621764|590438381|FG003|Overall Study|Protocol Violation|1|||
163474997|NCT02499172|590438382|FG000|Overall Study|Financial reason|0|||
163474998|NCT02499172|590438383|FG001|Overall Study|Financial reason|0|||
163474999|NCT02499172|590438384|FG002|Overall Study|Financial reason|523|||
163475000|NCT02499172|590438385|FG003|Overall Study|Financial reason|436|||
163475001|NCT02499172|590438382|FG000|Overall Study|Lost to Follow-up|65|||
163475002|NCT02499172|590438383|FG001|Overall Study|Lost to Follow-up|64|||
163475003|NCT02499172|590438384|FG002|Overall Study|Lost to Follow-up|0|||
163475004|NCT02499172|590438385|FG003|Overall Study|Lost to Follow-up|0|||
163475005|NCT01293123|590438386|FG000|Overall Study|Lost to Follow-up|0|||
163475006|NCT01293123|590438387|FG001|Overall Study|Lost to Follow-up|1|||
163475007|NCT01888965|590438397|FG000|Overall Study|Adverse Event|5|||
163475008|NCT01888965|590438397|FG000|Overall Study|Lack of Efficacy|4|||
163475009|NCT04076579|590438398|FG000|Overall Study|Adverse Event|2|||
163475010|NCT04076579|590438399|FG001|Overall Study|Adverse Event|0|||
163475011|NCT04076579|590438398|FG000|Overall Study|discontinued due to toxicity|1|||
163475012|NCT04076579|590438399|FG001|Overall Study|discontinued due to toxicity|0|||
163475013|NCT04076579|590438398|FG000|Overall Study|Physician Decision|1|||
163475014|NCT04076579|590438399|FG001|Overall Study|Physician Decision|0|||
163475015|NCT04076579|590438398|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
163475016|NCT04076579|590438399|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
163475017|NCT04076579|590438398|FG000|Overall Study|Noncompliance|0|||
163475018|NCT04076579|590438399|FG001|Overall Study|Noncompliance|1|||
163475019|NCT04076579|590438398|FG000|Overall Study|Withdrawal by Subject|0|||
163475020|NCT04076579|590438399|FG001|Overall Study|Withdrawal by Subject|2|||
163475021|NCT00186121|590438400|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
163475022|NCT00186121|590438400|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
163475023|NCT00186121|590438400|FG000|Overall Study|Not eligible (no treatment)|1|||
163475024|NCT03650387|590438401|FG000|Overall Study|Withdrawal by Subject|13|||
163475025|NCT03650387|590438401|FG000|Overall Study|Lost to Follow-up|12|||
163475026|NCT03650387|590438401|FG000|Overall Study|Adverse Event (Not related)|1|||
163475027|NCT03650387|590438401|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
163475028|NCT00417248|590438402|FG000|Overall Study|Study Terminated|6|||
163475029|NCT00417248|590438402|FG000|Overall Study|Death|1|||
163475030|NCT00417248|590438402|FG000|Overall Study|Lack of Efficacy|1|||
163475031|NCT05815758|590438403|FG000|Overall Study|Adverse Event|6|||
163475032|NCT05815758|590438404|FG001|Overall Study|Adverse Event|2|||
163475033|NCT05815758|590438403|FG000|Overall Study|Lost to Follow-up|14|||
163475034|NCT05815758|590438404|FG001|Overall Study|Lost to Follow-up|1|||
163475035|NCT05815758|590438403|FG000|Overall Study|Withdrawal by Subject|6|||
163475036|NCT05815758|590438404|FG001|Overall Study|Withdrawal by Subject|6|||
163475037|NCT05815758|590438403|FG000|Overall Study|Protocol Violation|1|||
163475038|NCT05815758|590438404|FG001|Overall Study|Protocol Violation|1|||
163475039|NCT05815758|590438403|FG000|Overall Study|Discontinued|4|||
163475040|NCT05815758|590438404|FG001|Overall Study|Discontinued|4|||
163475041|NCT03661983|590438405|FG000|Open Label Stabilization Phase|Adverse Event|5|||
163475042|NCT03661983|590438406|FG001|Open Label Stabilization Phase|Adverse Event|0|||
163475043|NCT03661983|590438407|FG002|Open Label Stabilization Phase|Adverse Event|0|||
163475044|NCT03661983|590438408|FG003|Open Label Stabilization Phase|Adverse Event|0|||
163475045|NCT03661983|590438405|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
163475046|NCT03661983|590438406|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
163475047|NCT03661983|590438407|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
163475048|NCT03661983|590438408|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
163475049|NCT03661983|590438405|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
163475050|NCT03661983|590438406|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
163475051|NCT03661983|590438407|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
163475052|NCT03661983|590438408|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
163475053|NCT03661983|590438405|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
163475054|NCT03661983|590438406|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
163475055|NCT03661983|590438407|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
163475056|NCT03661983|590438408|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
163475057|NCT03661983|590438405|FG000|Double-blind Randomized Phase|Adverse Event|0|||
163475058|NCT03661983|590438406|FG001|Double-blind Randomized Phase|Adverse Event|1|||
163475059|NCT03661983|590438407|FG002|Double-blind Randomized Phase|Adverse Event|0|||
163475060|NCT03661983|590438408|FG003|Double-blind Randomized Phase|Adverse Event|0|||
163475061|NCT03661983|590438405|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
163475062|NCT03661983|590438406|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
163475063|NCT03661983|590438407|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
163475064|NCT03661983|590438408|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
163475065|NCT03661983|590438405|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
163475066|NCT03661983|590438406|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
163475067|NCT03661983|590438407|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
163475068|NCT03661983|590438408|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
163475069|NCT03661983|590438405|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
163475070|NCT03661983|590438406|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
163475071|NCT03661983|590438407|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
163475072|NCT03661983|590438408|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
163475073|NCT02903966|590438409|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
163475074|NCT02903966|590438410|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
163475075|NCT02903966|590438409|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
163475076|NCT02903966|590438410|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
163475077|NCT02903966|590438409|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
163475078|NCT02903966|590438410|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
163475079|NCT00934791|590438411|FG000|Overall Study|Withdrawal by Subject|1|||
163475080|NCT00934791|590438412|FG001|Overall Study|Withdrawal by Subject|0|||
163475081|NCT01320033|590438414|FG000|Overall Study|Lack of Efficacy|0|||
163475082|NCT01320033|590438415|FG001|Overall Study|Lack of Efficacy|0|||
163475083|NCT01320033|590438416|FG002|Overall Study|Lack of Efficacy|1|||
163475084|NCT01320033|590438414|FG000|Overall Study|Adverse Event|9|||
163475085|NCT01320033|590438415|FG001|Overall Study|Adverse Event|7|||
163475086|NCT01320033|590438416|FG002|Overall Study|Adverse Event|8|||
163475087|NCT01320033|590438414|FG000|Overall Study|Withdrawal by Subject|22|||
163475088|NCT01320033|590438415|FG001|Overall Study|Withdrawal by Subject|23|||
163475089|NCT01320033|590438416|FG002|Overall Study|Withdrawal by Subject|23|||
163475090|NCT01320033|590438414|FG000|Overall Study|Protocol Violation|3|||
163475091|NCT01320033|590438415|FG001|Overall Study|Protocol Violation|5|||
163475092|NCT01320033|590438416|FG002|Overall Study|Protocol Violation|3|||
163475093|NCT01320033|590438414|FG000|Overall Study|Lost to Follow-up|22|||
163475094|NCT01320033|590438415|FG001|Overall Study|Lost to Follow-up|26|||
163475095|NCT01320033|590438416|FG002|Overall Study|Lost to Follow-up|17|||
163475096|NCT01320033|590438414|FG000|Overall Study|Other|2|||
163475097|NCT01320033|590438415|FG001|Overall Study|Other|3|||
163475098|NCT01320033|590438416|FG002|Overall Study|Other|1|||
163475099|NCT02425891|590438417|FG000|Overall Study|Death|333|||
163475100|NCT02425891|590438418|FG001|Overall Study|Death|314|||
163475101|NCT02425891|590438417|FG000|Overall Study|Lost to Follow-up|4|||
163475102|NCT02425891|590438418|FG001|Overall Study|Lost to Follow-up|6|||
163475103|NCT02425891|590438417|FG000|Overall Study|Non-Compliance|1|||
163475104|NCT02425891|590438418|FG001|Overall Study|Non-Compliance|1|||
163475105|NCT02425891|590438417|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
163475106|NCT02425891|590438418|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
163475107|NCT02425891|590438417|FG000|Overall Study|Physician Decision|0|||
163475108|NCT02425891|590438418|FG001|Overall Study|Physician Decision|1|||
163475109|NCT02425891|590438417|FG000|Overall Study|Protocol Violation|1|||
163475110|NCT02425891|590438418|FG001|Overall Study|Protocol Violation|1|||
163475111|NCT02425891|590438417|FG000|Overall Study|Study Terminated By Sponsor|85|||
163475112|NCT02425891|590438418|FG001|Overall Study|Study Terminated By Sponsor|95|||
163475113|NCT02425891|590438417|FG000|Overall Study|Withdrawal by Subject|27|||
163475114|NCT02425891|590438418|FG001|Overall Study|Withdrawal by Subject|32|||
163475115|NCT00963469|590438419|FG000|Overall Study|Adverse Event|15|||
163475116|NCT00963469|590438420|FG001|Overall Study|Adverse Event|11|||
163475117|NCT00963469|590438421|FG002|Overall Study|Adverse Event|1|||
163475118|NCT00963469|590438419|FG000|Overall Study|Lack of Efficacy|10|||
163475119|NCT00963469|590438420|FG001|Overall Study|Lack of Efficacy|7|||
163475120|NCT00963469|590438421|FG002|Overall Study|Lack of Efficacy|2|||
163475121|NCT00963469|590438419|FG000|Overall Study|Lost to Follow-up|1|||
163475122|NCT00963469|590438420|FG001|Overall Study|Lost to Follow-up|1|||
163475123|NCT00963469|590438421|FG002|Overall Study|Lost to Follow-up|0|||
163475124|NCT00963469|590438419|FG000|Overall Study|Protocol Violation|5|||
163475125|NCT00963469|590438420|FG001|Overall Study|Protocol Violation|5|||
163475126|NCT00963469|590438421|FG002|Overall Study|Protocol Violation|3|||
163475127|NCT00963469|590438419|FG000|Overall Study|Withdrawal by Subject|4|||
163475128|NCT00963469|590438420|FG001|Overall Study|Withdrawal by Subject|1|||
163475129|NCT00963469|590438421|FG002|Overall Study|Withdrawal by Subject|1|||
163475130|NCT00963469|590438419|FG000|Overall Study|Pre-randomization Adverse Event|1|||
163475131|NCT00963469|590438420|FG001|Overall Study|Pre-randomization Adverse Event|2|||
163475132|NCT00963469|590438421|FG002|Overall Study|Pre-randomization Adverse Event|0|||
163475133|NCT00963469|590438419|FG000|Overall Study|Moved|1|||
163475134|NCT00963469|590438420|FG001|Overall Study|Moved|0|||
163475135|NCT00963469|590438421|FG002|Overall Study|Moved|0|||
163475136|NCT00963469|590438419|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
163475137|NCT00963469|590438420|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
163475138|NCT00963469|590438421|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
163475139|NCT02145429|590438423|FG000|Overall Study|Death|4|||
163475140|NCT02145429|590438424|FG001|Overall Study|Death|5|||
163475141|NCT02145429|590438423|FG000|Overall Study|Lost to Follow-up|4|||
163475142|NCT02145429|590438424|FG001|Overall Study|Lost to Follow-up|3|||
163475143|NCT02145429|590438423|FG000|Overall Study|Withdrawal by Subject|8|||
163475144|NCT02145429|590438424|FG001|Overall Study|Withdrawal by Subject|3|||
163475145|NCT02943577|590438425|FG000|Overall Study|Protocol Violation|0|||
163475146|NCT02943577|590438426|FG001|Overall Study|Protocol Violation|1|||
163475147|NCT02943577|590438425|FG000|Overall Study|Adverse Event|3|||
163475148|NCT02943577|590438426|FG001|Overall Study|Adverse Event|2|||
163475149|NCT02943577|590438425|FG000|Overall Study|Lost to Follow-up|0|||
163475150|NCT02943577|590438426|FG001|Overall Study|Lost to Follow-up|1|||
163475151|NCT02943577|590438425|FG000|Overall Study|Withdrawal by Subject|1|||
163475152|NCT02943577|590438426|FG001|Overall Study|Withdrawal by Subject|1|||
163475153|NCT02943577|590438425|FG000|Overall Study|Pregnancy|1|||
163475154|NCT02943577|590438426|FG001|Overall Study|Pregnancy|0|||
163475155|NCT03991936|590438431|FG000|Overall Study|Lost to Follow-up|1|||
163475156|NCT03991936|590438432|FG001|Overall Study|Lost to Follow-up|1|||
163475157|NCT03991936|590438433|FG002|Overall Study|Lost to Follow-up|1|||
163475158|NCT03991936|590438434|FG003|Overall Study|Lost to Follow-up|1|||
163475159|NCT03991936|590438435|FG004|Overall Study|Lost to Follow-up|1|||
163475160|NCT00939055|590438436|FG000|Overall Study|Discontinuation prior to procedure|4|||
163475161|NCT00939055|590438437|FG001|Overall Study|Discontinuation prior to procedure|0|||
163475162|NCT00584987|590438440|FG000|Overall Study|Protocol Violation|1|||
163475163|NCT00584987|590438441|FG001|Overall Study|Protocol Violation|1|||
163475164|NCT00584987|590438442|FG002|Overall Study|Protocol Violation|1|||
163475165|NCT00584987|590438443|FG003|Overall Study|Protocol Violation|0|||
163475166|NCT00584987|590438440|FG000|Overall Study|Adverse Event|0|||
163475167|NCT00584987|590438441|FG001|Overall Study|Adverse Event|0|||
163475168|NCT00584987|590438442|FG002|Overall Study|Adverse Event|0|||
163475169|NCT00584987|590438443|FG003|Overall Study|Adverse Event|1|||
163475170|NCT01944462|590438447|FG000|PPPP Educational Program|Lost to Follow-up|60|||
163475171|NCT00808028|590438448|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
163475172|NCT00808028|590438449|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
163475173|NCT00808028|590438450|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
163475174|NCT00808028|590438451|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
163475175|NCT00808028|590438448|FG000|Stage 1 (6 Months)|Other|1|||
163475176|NCT00808028|590438449|FG001|Stage 1 (6 Months)|Other|0|||
163475177|NCT00808028|590438450|FG002|Stage 1 (6 Months)|Other|2|||
163475178|NCT00808028|590438451|FG003|Stage 1 (6 Months)|Other|4|||
163475179|NCT00808028|590438448|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
163475180|NCT00808028|590438449|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
163475181|NCT00808028|590438450|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
163475182|NCT00808028|590438451|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
163475183|NCT00808028|590438448|FG000|Stage 1 (6 Months)|Adverse Event|0|||
163475184|NCT00808028|590438449|FG001|Stage 1 (6 Months)|Adverse Event|0|||
163475185|NCT00808028|590438450|FG002|Stage 1 (6 Months)|Adverse Event|1|||
163475186|NCT00808028|590438451|FG003|Stage 1 (6 Months)|Adverse Event|2|||
163475187|NCT00808028|590438448|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
163475188|NCT00808028|590438449|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
163475189|NCT00808028|590438450|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
163475190|NCT00808028|590438451|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
163475191|NCT00808028|590438448|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
163475192|NCT00808028|590438449|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
163475193|NCT00808028|590438450|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
163475194|NCT00808028|590438451|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
163475195|NCT00808028|590438448|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
163475196|NCT00808028|590438449|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
163475197|NCT00808028|590438450|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
163475198|NCT00808028|590438451|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
163475199|NCT00808028|590438448|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
163475200|NCT00808028|590438449|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
163475201|NCT00808028|590438450|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
163475202|NCT00808028|590438451|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
163475203|NCT00808028|590438448|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
163475204|NCT00808028|590438449|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
163475205|NCT00808028|590438450|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
163475206|NCT00808028|590438451|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
163475207|NCT00808028|590438448|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
163475208|NCT00808028|590438449|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
163475209|NCT00808028|590438450|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
163475210|NCT00808028|590438451|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
163475211|NCT00808028|590438448|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
163475212|NCT00808028|590438449|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
163475213|NCT00808028|590438450|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
163475214|NCT00808028|590438451|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
163475215|NCT00808028|590438448|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
163475216|NCT00808028|590438449|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
163475217|NCT00808028|590438450|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
163475218|NCT00808028|590438451|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
163475219|NCT00808028|590438448|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
163475220|NCT00808028|590438449|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
163475221|NCT00808028|590438450|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
163475222|NCT00808028|590438451|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
163475223|NCT00808028|590438448|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
163475224|NCT00808028|590438449|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
163475225|NCT00808028|590438450|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
163475226|NCT00808028|590438451|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
163475227|NCT00808028|590438448|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
163475228|NCT00808028|590438449|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
163475229|NCT00808028|590438450|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
163475230|NCT00808028|590438451|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
163475231|NCT01599585|590438453|FG000|Overall Study|Withdrawal by Subject|16|||
163475232|NCT01599585|590438454|FG001|Overall Study|Withdrawal by Subject|9|||
163475233|NCT01599585|590438453|FG000|Overall Study|Lost to Follow-up|3|||
163475234|NCT01599585|590438454|FG001|Overall Study|Lost to Follow-up|5|||
163475235|NCT01599585|590438453|FG000|Overall Study|randomized did not start treatment|3|||
163475236|NCT01599585|590438454|FG001|Overall Study|randomized did not start treatment|3|||
163475237|NCT00081263|590438462|FG000|Overall Study|clerical error|1|||
163475238|NCT00081263|590438463|FG001|Overall Study|clerical error|0|||
163475239|NCT00081263|590438462|FG000|Overall Study|wrong cell type|7|||
163475240|NCT00081263|590438463|FG001|Overall Study|wrong cell type|5|||
163475241|NCT00081263|590438462|FG000|Overall Study|improper pre-protocol therapy|0|||
163475242|NCT00081263|590438463|FG001|Overall Study|improper pre-protocol therapy|1|||
163475243|NCT00081263|590438462|FG000|Overall Study|Inadequate pathology|0|||
163475244|NCT00081263|590438463|FG001|Overall Study|Inadequate pathology|1|||
163475245|NCT00081263|590438462|FG000|Overall Study|Never treated|4|||
163475246|NCT00081263|590438463|FG001|Overall Study|Never treated|5|||
163475247|NCT00081263|590438462|FG000|Overall Study|Inadequate data|5|||
163475248|NCT00081263|590438463|FG001|Overall Study|Inadequate data|10|||
163475249|NCT01852591|590438464|FG000|Overall Study|Withdrawal by Subject|2|||
163475250|NCT01852591|590438464|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
163475251|NCT01263470|590438471|FG000|Overall Study|Adverse Event|2|||
163475252|NCT01263470|590438472|FG001|Overall Study|Adverse Event|2|||
163475253|NCT01263470|590438473|FG002|Overall Study|Adverse Event|1|||
163475254|NCT01263470|590438474|FG003|Overall Study|Adverse Event|1|||
163475255|NCT01263470|590438475|FG004|Overall Study|Adverse Event|2|||
163475256|NCT01263470|590438476|FG005|Overall Study|Adverse Event|2|||
163475257|NCT01263470|590438471|FG000|Overall Study|Protocol Violation|0|||
163475258|NCT01263470|590438472|FG001|Overall Study|Protocol Violation|1|||
163475259|NCT01263470|590438473|FG002|Overall Study|Protocol Violation|0|||
163475260|NCT01263470|590438474|FG003|Overall Study|Protocol Violation|0|||
163475261|NCT01263470|590438475|FG004|Overall Study|Protocol Violation|0|||
163475262|NCT01263470|590438476|FG005|Overall Study|Protocol Violation|1|||
163475263|NCT01263470|590438471|FG000|Overall Study|Withdrawal by Subject|0|||
163475264|NCT01263470|590438472|FG001|Overall Study|Withdrawal by Subject|1|||
163475265|NCT01263470|590438473|FG002|Overall Study|Withdrawal by Subject|1|||
163475266|NCT01263470|590438474|FG003|Overall Study|Withdrawal by Subject|2|||
163475267|NCT01263470|590438475|FG004|Overall Study|Withdrawal by Subject|0|||
163475268|NCT01263470|590438476|FG005|Overall Study|Withdrawal by Subject|2|||
163475269|NCT01263470|590438471|FG000|Overall Study|Lack of Efficacy|0|||
163475270|NCT01263470|590438472|FG001|Overall Study|Lack of Efficacy|0|||
163475271|NCT01263470|590438473|FG002|Overall Study|Lack of Efficacy|2|||
163475272|NCT01263470|590438474|FG003|Overall Study|Lack of Efficacy|0|||
163475273|NCT01263470|590438475|FG004|Overall Study|Lack of Efficacy|0|||
163475274|NCT01263470|590438476|FG005|Overall Study|Lack of Efficacy|0|||
163475275|NCT01263470|590438471|FG000|Overall Study|Participant Unavailability|0|||
163475276|NCT01263470|590438472|FG001|Overall Study|Participant Unavailability|1|||
163475277|NCT01263470|590438473|FG002|Overall Study|Participant Unavailability|0|||
163475278|NCT01263470|590438474|FG003|Overall Study|Participant Unavailability|0|||
163475279|NCT01263470|590438475|FG004|Overall Study|Participant Unavailability|0|||
163475280|NCT01263470|590438476|FG005|Overall Study|Participant Unavailability|0|||
163475281|NCT01263470|590438471|FG000|Overall Study|Study Drug Non-compliance|0|||
163475282|NCT01263470|590438472|FG001|Overall Study|Study Drug Non-compliance|0|||
163475283|NCT01263470|590438473|FG002|Overall Study|Study Drug Non-compliance|0|||
163475284|NCT01263470|590438474|FG003|Overall Study|Study Drug Non-compliance|0|||
163475285|NCT01263470|590438475|FG004|Overall Study|Study Drug Non-compliance|1|||
163475286|NCT01263470|590438476|FG005|Overall Study|Study Drug Non-compliance|0|||
163475287|NCT01327573|590438477|FG000|Overall Study|Physician Decision|3|||
163475288|NCT01327573|590438478|FG001|Overall Study|Physician Decision|1|||
163475289|NCT03070119|590438479|FG000|Overall Study|Adverse Event|0|||
163475290|NCT03070119|590438480|FG001|Overall Study|Adverse Event|0|||
163475291|NCT03070119|590438481|FG002|Overall Study|Adverse Event|1|||
163475292|NCT03070119|590438479|FG000|Overall Study|Lost to Follow-up|0|||
163475293|NCT03070119|590438480|FG001|Overall Study|Lost to Follow-up|1|||
163475294|NCT03070119|590438481|FG002|Overall Study|Lost to Follow-up|0|||
163475295|NCT03070119|590438479|FG000|Overall Study|Consent Withdrawn|6|||
163475296|NCT03070119|590438480|FG001|Overall Study|Consent Withdrawn|5|||
163475297|NCT03070119|590438481|FG002|Overall Study|Consent Withdrawn|3|||
163475298|NCT03070119|590438479|FG000|Overall Study|Investigator Decision|0|||
163475299|NCT03070119|590438480|FG001|Overall Study|Investigator Decision|0|||
163475300|NCT03070119|590438481|FG002|Overall Study|Investigator Decision|1|||
163475301|NCT03070119|590438479|FG000|Overall Study|Death|7|||
163475302|NCT03070119|590438480|FG001|Overall Study|Death|14|||
163475303|NCT03070119|590438481|FG002|Overall Study|Death|5|||
163475304|NCT03070119|590438479|FG000|Overall Study|Disease Progression|5|||
163475305|NCT03070119|590438480|FG001|Overall Study|Disease Progression|7|||
163475306|NCT03070119|590438481|FG002|Overall Study|Disease Progression|7|||
163475307|NCT03070119|590438479|FG000|Overall Study|Reason not Specified|2|||
163475308|NCT03070119|590438480|FG001|Overall Study|Reason not Specified|2|||
163475309|NCT03070119|590438481|FG002|Overall Study|Reason not Specified|1|||
163475310|NCT01996865|590438482|FG000|Induction Period|Protocol Violation|1|||
163475311|NCT01996865|590438483|FG001|Induction Period|Protocol Violation|0|||
163475312|NCT01996865|590438484|FG002|Induction Period|Protocol Violation|0|||
163475313|NCT01996865|590438482|FG000|Induction Period|Progressive Disease|4|||
163475314|NCT01996865|590438483|FG001|Induction Period|Progressive Disease|0|||
163475315|NCT01996865|590438484|FG002|Induction Period|Progressive Disease|0|||
163475316|NCT01996865|590438482|FG000|Induction Period|Lost to Follow-up|10|||
163475317|NCT01996865|590438483|FG001|Induction Period|Lost to Follow-up|0|||
163475318|NCT01996865|590438484|FG002|Induction Period|Lost to Follow-up|0|||
163475319|NCT01996865|590438482|FG000|Induction Period|Other Reasons|13|||
163475320|NCT01996865|590438483|FG001|Induction Period|Other Reasons|0|||
163475321|NCT01996865|590438484|FG002|Induction Period|Other Reasons|0|||
163475322|NCT01996865|590438482|FG000|Induction Period|Adverse Event|20|||
163475323|NCT01996865|590438483|FG001|Induction Period|Adverse Event|0|||
163475324|NCT01996865|590438484|FG002|Induction Period|Adverse Event|0|||
163475325|NCT01996865|590438482|FG000|Induction Period|Withdrawal by Subject|60|||
163475326|NCT01996865|590438483|FG001|Induction Period|Withdrawal by Subject|0|||
163475327|NCT01996865|590438484|FG002|Induction Period|Withdrawal by Subject|0|||
163475328|NCT01996865|590438482|FG000|Induction Period|Death|111|||
163475329|NCT01996865|590438483|FG001|Induction Period|Death|0|||
163475330|NCT01996865|590438484|FG002|Induction Period|Death|0|||
163475331|NCT01996865|590438482|FG000|Maintenance Period|Protocol Violation|0|||
163475332|NCT01996865|590438483|FG001|Maintenance Period|Protocol Violation|1|||
163475333|NCT01996865|590438484|FG002|Maintenance Period|Protocol Violation|1|||
163475334|NCT01996865|590438482|FG000|Maintenance Period|Other reasons|0|||
163475335|NCT01996865|590438483|FG001|Maintenance Period|Other reasons|8|||
163475336|NCT01996865|590438484|FG002|Maintenance Period|Other reasons|5|||
163475337|NCT01996865|590438482|FG000|Maintenance Period|Progressive Disease|0|||
163475338|NCT01996865|590438483|FG001|Maintenance Period|Progressive Disease|6|||
163475339|NCT01996865|590438484|FG002|Maintenance Period|Progressive Disease|23|||
163475340|NCT01996865|590438482|FG000|Maintenance Period|Withdrawal by Subject|0|||
163475341|NCT01996865|590438483|FG001|Maintenance Period|Withdrawal by Subject|18|||
163475342|NCT01996865|590438484|FG002|Maintenance Period|Withdrawal by Subject|4|||
163475343|NCT01996865|590438482|FG000|Maintenance Period|Adverse Event|0|||
163475344|NCT01996865|590438483|FG001|Maintenance Period|Adverse Event|7|||
163475345|NCT01996865|590438484|FG002|Maintenance Period|Adverse Event|7|||
163475346|NCT01996865|590438482|FG000|Maintenance Period|Death|0|||
163475347|NCT01996865|590438483|FG001|Maintenance Period|Death|15|||
163475348|NCT01996865|590438484|FG002|Maintenance Period|Death|3|||
163475349|NCT01996865|590438482|FG000|Maintenance Period|Lost to Follow-up|0|||
163475350|NCT01996865|590438483|FG001|Maintenance Period|Lost to Follow-up|2|||
163475351|NCT01996865|590438484|FG002|Maintenance Period|Lost to Follow-up|0|||
163475352|NCT05304611|590438487|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
163475353|NCT05304611|590438488|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
163475354|NCT05304611|590438489|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
163475355|NCT05304611|590438490|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
163475356|NCT05304611|590438491|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
163475357|NCT05304611|590438492|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
163475358|NCT05304611|590438493|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
163475359|NCT05304611|590438494|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
163475360|NCT05304611|590438495|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
163475361|NCT05304611|590438496|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
163475362|NCT05304611|590438497|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
163475363|NCT05304611|590438498|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
163475364|NCT05304611|590438487|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
163475365|NCT05304611|590438488|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
163475366|NCT05304611|590438489|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
163475367|NCT05304611|590438490|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
163475368|NCT05304611|590438491|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
163475369|NCT05304611|590438492|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
163475370|NCT05304611|590438493|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
163475371|NCT05304611|590438494|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
163475372|NCT05304611|590438495|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
163475373|NCT05304611|590438496|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
163475374|NCT05304611|590438497|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
163475375|NCT05304611|590438498|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
163475376|NCT05304611|590438487|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
163475377|NCT05304611|590438488|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
163475378|NCT05304611|590438489|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
163475379|NCT05304611|590438490|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
163475380|NCT05304611|590438491|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
163475381|NCT05304611|590438492|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
163475382|NCT05304611|590438493|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
163475383|NCT05304611|590438494|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
163475384|NCT05304611|590438495|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
163475385|NCT05304611|590438496|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
163475386|NCT05304611|590438497|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
163475387|NCT05304611|590438498|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
163475388|NCT00963820|590438503|FG000|Dose Escalation Phase|Progressive Disease|3|||
163475389|NCT00963820|590438504|FG001|Dose Escalation Phase|Progressive Disease|3|||
163475390|NCT00963820|590438505|FG002|Dose Escalation Phase|Progressive Disease|3|||
163475391|NCT00963820|590438506|FG003|Dose Escalation Phase|Progressive Disease|3|||
163475392|NCT00963820|590438507|FG004|Dose Escalation Phase|Progressive Disease|4|||
163475393|NCT00963820|590438508|FG005|Dose Escalation Phase|Progressive Disease|3|||
163475394|NCT00963820|590438509|FG006|Dose Escalation Phase|Progressive Disease|3|||
163475395|NCT00963820|590438510|FG007|Dose Escalation Phase|Progressive Disease|2|||
163475396|NCT00963820|590438511|FG008|Dose Escalation Phase|Progressive Disease|0|||
163475397|NCT00963820|590438512|FG009|Dose Escalation Phase|Progressive Disease|0|||
163475398|NCT00963820|590438513|FG010|Dose Escalation Phase|Progressive Disease|0|||
163475399|NCT00963820|590438514|FG011|Dose Escalation Phase|Progressive Disease|0|||
163475400|NCT00963820|590438503|FG000|Dose Escalation Phase|Adverse Event|0|||
163475401|NCT00963820|590438504|FG001|Dose Escalation Phase|Adverse Event|0|||
163475402|NCT00963820|590438505|FG002|Dose Escalation Phase|Adverse Event|0|||
163475403|NCT00963820|590438506|FG003|Dose Escalation Phase|Adverse Event|0|||
163475404|NCT00963820|590438507|FG004|Dose Escalation Phase|Adverse Event|0|||
163475405|NCT00963820|590438508|FG005|Dose Escalation Phase|Adverse Event|0|||
163475406|NCT00963820|590438509|FG006|Dose Escalation Phase|Adverse Event|3|||
163475407|NCT00963820|590438510|FG007|Dose Escalation Phase|Adverse Event|1|||
163475408|NCT00963820|590438511|FG008|Dose Escalation Phase|Adverse Event|0|||
163475409|NCT00963820|590438512|FG009|Dose Escalation Phase|Adverse Event|0|||
163475410|NCT00963820|590438513|FG010|Dose Escalation Phase|Adverse Event|0|||
163475411|NCT00963820|590438514|FG011|Dose Escalation Phase|Adverse Event|0|||
163475412|NCT00963820|590438503|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
163475413|NCT00963820|590438504|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
163475414|NCT00963820|590438505|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
163475415|NCT00963820|590438506|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
163475416|NCT00963820|590438507|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
163475417|NCT00963820|590438508|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
163475418|NCT00963820|590438509|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
163475419|NCT00963820|590438510|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
163475420|NCT00963820|590438511|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
163475421|NCT00963820|590438512|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
163475422|NCT00963820|590438513|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
163475423|NCT00963820|590438514|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
163475424|NCT00963820|590438503|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163475425|NCT00963820|590438504|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163475426|NCT00963820|590438505|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163475427|NCT00963820|590438506|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163475428|NCT00963820|590438507|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163475429|NCT00963820|590438508|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163475430|NCT00963820|590438509|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
163475431|NCT00963820|590438510|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163475432|NCT00963820|590438511|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163475433|NCT00963820|590438512|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163475434|NCT00963820|590438513|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163475435|NCT00963820|590438514|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163475436|NCT00963820|590438503|FG000|Expansion Phase|Progressive Disease|0|||
163475437|NCT00963820|590438504|FG001|Expansion Phase|Progressive Disease|0|||
163475438|NCT00963820|590438505|FG002|Expansion Phase|Progressive Disease|0|||
163475439|NCT00963820|590438506|FG003|Expansion Phase|Progressive Disease|0|||
163475440|NCT00963820|590438507|FG004|Expansion Phase|Progressive Disease|0|||
163475441|NCT00963820|590438508|FG005|Expansion Phase|Progressive Disease|0|||
163475442|NCT00963820|590438509|FG006|Expansion Phase|Progressive Disease|0|||
163475443|NCT00963820|590438510|FG007|Expansion Phase|Progressive Disease|0|||
163475444|NCT00963820|590438511|FG008|Expansion Phase|Progressive Disease|8|||
163475445|NCT00963820|590438512|FG009|Expansion Phase|Progressive Disease|6|||
163475446|NCT00963820|590438513|FG010|Expansion Phase|Progressive Disease|4|||
163475447|NCT00963820|590438514|FG011|Expansion Phase|Progressive Disease|2|||
163475448|NCT00963820|590438503|FG000|Expansion Phase|Adverse Event|0|||
163475449|NCT00963820|590438504|FG001|Expansion Phase|Adverse Event|0|||
163475450|NCT00963820|590438505|FG002|Expansion Phase|Adverse Event|0|||
163475451|NCT00963820|590438506|FG003|Expansion Phase|Adverse Event|0|||
163475452|NCT00963820|590438507|FG004|Expansion Phase|Adverse Event|0|||
163475453|NCT00963820|590438508|FG005|Expansion Phase|Adverse Event|0|||
163475454|NCT00963820|590438509|FG006|Expansion Phase|Adverse Event|0|||
163475455|NCT00963820|590438510|FG007|Expansion Phase|Adverse Event|0|||
163475456|NCT00963820|590438511|FG008|Expansion Phase|Adverse Event|1|||
163475457|NCT00963820|590438512|FG009|Expansion Phase|Adverse Event|3|||
163475458|NCT00963820|590438513|FG010|Expansion Phase|Adverse Event|0|||
163475459|NCT00963820|590438514|FG011|Expansion Phase|Adverse Event|0|||
163475460|NCT00963820|590438503|FG000|Expansion Phase|Withdrawal by Subject|0|||
163475461|NCT00963820|590438504|FG001|Expansion Phase|Withdrawal by Subject|0|||
163475462|NCT00963820|590438505|FG002|Expansion Phase|Withdrawal by Subject|0|||
163475463|NCT00963820|590438506|FG003|Expansion Phase|Withdrawal by Subject|0|||
163475464|NCT00963820|590438507|FG004|Expansion Phase|Withdrawal by Subject|0|||
163475465|NCT00963820|590438508|FG005|Expansion Phase|Withdrawal by Subject|0|||
163475466|NCT00963820|590438509|FG006|Expansion Phase|Withdrawal by Subject|0|||
163475467|NCT00963820|590438510|FG007|Expansion Phase|Withdrawal by Subject|0|||
163475468|NCT00963820|590438511|FG008|Expansion Phase|Withdrawal by Subject|1|||
163475469|NCT00963820|590438512|FG009|Expansion Phase|Withdrawal by Subject|0|||
163475470|NCT00963820|590438513|FG010|Expansion Phase|Withdrawal by Subject|1|||
163475471|NCT00963820|590438514|FG011|Expansion Phase|Withdrawal by Subject|1|||
163475472|NCT00963820|590438503|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163475473|NCT00963820|590438504|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163475474|NCT00963820|590438505|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163475475|NCT00963820|590438506|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163475476|NCT00963820|590438507|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163475477|NCT00963820|590438508|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163475478|NCT00963820|590438509|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163475479|NCT00963820|590438510|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163475480|NCT00963820|590438511|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163475481|NCT00963820|590438512|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163475482|NCT00963820|590438513|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163475483|NCT00963820|590438514|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
163475484|NCT02756845|590438520|FG000|Overall Study|Death|12|||
163475485|NCT02756845|590438521|FG001|Overall Study|Death|2|||
163475486|NCT02756845|590438520|FG000|Overall Study|Withdrawal by Subject|1|||
163475487|NCT02756845|590438521|FG001|Overall Study|Withdrawal by Subject|0|||
163475488|NCT05333289|590438522|FG000|Overall Study|Other|1|||
163475489|NCT05333289|590438523|FG001|Overall Study|Other|0|||
163475490|NCT05333289|590438524|FG002|Overall Study|Other|0|||
163475491|NCT05333289|590438525|FG003|Overall Study|Other|1|||
163475492|NCT05333289|590438526|FG004|Overall Study|Other|1|||
163475493|NCT05333289|590438527|FG005|Overall Study|Other|2|||
163475494|NCT05333289|590438528|FG006|Overall Study|Other|2|||
163475495|NCT05333289|590438529|FG007|Overall Study|Other|0|||
163475496|NCT05333289|590438522|FG000|Overall Study|Withdrawal by Subject|1|||
163475497|NCT05333289|590438523|FG001|Overall Study|Withdrawal by Subject|2|||
163475498|NCT05333289|590438524|FG002|Overall Study|Withdrawal by Subject|2|||
163475499|NCT05333289|590438525|FG003|Overall Study|Withdrawal by Subject|1|||
163475500|NCT05333289|590438526|FG004|Overall Study|Withdrawal by Subject|1|||
163475501|NCT05333289|590438527|FG005|Overall Study|Withdrawal by Subject|2|||
163475502|NCT05333289|590438528|FG006|Overall Study|Withdrawal by Subject|1|||
163475503|NCT05333289|590438529|FG007|Overall Study|Withdrawal by Subject|3|||
163475504|NCT05333289|590438522|FG000|Overall Study|Protocol Violation|1|||
163475505|NCT05333289|590438523|FG001|Overall Study|Protocol Violation|0|||
163475506|NCT05333289|590438524|FG002|Overall Study|Protocol Violation|0|||
163475507|NCT05333289|590438525|FG003|Overall Study|Protocol Violation|0|||
163475508|NCT05333289|590438526|FG004|Overall Study|Protocol Violation|0|||
163475509|NCT05333289|590438527|FG005|Overall Study|Protocol Violation|0|||
163475510|NCT05333289|590438528|FG006|Overall Study|Protocol Violation|0|||
163475511|NCT05333289|590438529|FG007|Overall Study|Protocol Violation|0|||
163475512|NCT05333289|590438522|FG000|Overall Study|Physician Decision|0|||
163475513|NCT05333289|590438523|FG001|Overall Study|Physician Decision|0|||
163475514|NCT05333289|590438524|FG002|Overall Study|Physician Decision|1|||
163475515|NCT05333289|590438525|FG003|Overall Study|Physician Decision|0|||
163475516|NCT05333289|590438526|FG004|Overall Study|Physician Decision|0|||
163475517|NCT05333289|590438527|FG005|Overall Study|Physician Decision|2|||
163475518|NCT05333289|590438528|FG006|Overall Study|Physician Decision|0|||
163475519|NCT05333289|590438529|FG007|Overall Study|Physician Decision|0|||
163475520|NCT05333289|590438522|FG000|Overall Study|Lost to Follow-up|6|||
163475521|NCT05333289|590438523|FG001|Overall Study|Lost to Follow-up|0|||
163475522|NCT05333289|590438524|FG002|Overall Study|Lost to Follow-up|1|||
163475523|NCT05333289|590438525|FG003|Overall Study|Lost to Follow-up|6|||
163475524|NCT05333289|590438526|FG004|Overall Study|Lost to Follow-up|3|||
163475525|NCT05333289|590438527|FG005|Overall Study|Lost to Follow-up|3|||
163475526|NCT05333289|590438528|FG006|Overall Study|Lost to Follow-up|2|||
163475527|NCT05333289|590438529|FG007|Overall Study|Lost to Follow-up|1|||
163475528|NCT05333289|590438522|FG000|Overall Study|Death|1|||
163475529|NCT05333289|590438523|FG001|Overall Study|Death|0|||
163475530|NCT05333289|590438524|FG002|Overall Study|Death|0|||
163475531|NCT05333289|590438525|FG003|Overall Study|Death|0|||
163475532|NCT05333289|590438526|FG004|Overall Study|Death|0|||
163475533|NCT05333289|590438527|FG005|Overall Study|Death|0|||
163475534|NCT05333289|590438528|FG006|Overall Study|Death|0|||
163475535|NCT05333289|590438529|FG007|Overall Study|Death|0|||
163475536|NCT02005211|590438534|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
163475537|NCT02005211|590438535|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
163475538|NCT02005211|590438536|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
163475539|NCT02005211|590438537|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
163475540|NCT02005211|590438538|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
163475541|NCT02005211|590438539|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
163475542|NCT02005211|590438540|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
163475543|NCT00397631|590438543|FG000|Overall Study|Adverse Event|5|||
163475544|NCT00397631|590438544|FG001|Overall Study|Adverse Event|6|||
163475545|NCT00397631|590438543|FG000|Overall Study|Lack of Efficacy|7|||
163475546|NCT00397631|590438544|FG001|Overall Study|Lack of Efficacy|10|||
163475547|NCT00397631|590438543|FG000|Overall Study|Lost to Follow-up|8|||
163475548|NCT00397631|590438544|FG001|Overall Study|Lost to Follow-up|9|||
163475549|NCT00397631|590438543|FG000|Overall Study|Physician Decision|2|||
163475550|NCT00397631|590438544|FG001|Overall Study|Physician Decision|0|||
163475551|NCT00397631|590438543|FG000|Overall Study|Protocol Violation|0|||
163475552|NCT00397631|590438544|FG001|Overall Study|Protocol Violation|1|||
163475553|NCT00397631|590438543|FG000|Overall Study|Withdrawal by Subject|7|||
163475554|NCT00397631|590438544|FG001|Overall Study|Withdrawal by Subject|14|||
163475555|NCT00397631|590438543|FG000|Overall Study|protocol discontinuation criteria|1|||
163475556|NCT00397631|590438544|FG001|Overall Study|protocol discontinuation criteria|4|||
163475557|NCT02202161|590438545|FG000|Overall Study|Adverse Event|1|||
163475558|NCT02202161|590438546|FG001|Overall Study|Adverse Event|1|||
163475559|NCT02202161|590438547|FG002|Overall Study|Adverse Event|0|||
163475560|NCT02202161|590438548|FG003|Overall Study|Adverse Event|0|||
163475561|NCT02202161|590438549|FG004|Overall Study|Adverse Event|0|||
163475562|NCT02202161|590438550|FG005|Overall Study|Adverse Event|1|||
163475563|NCT02202161|590438551|FG006|Overall Study|Adverse Event|0|||
163475564|NCT02202161|590438552|FG007|Overall Study|Adverse Event|0|||
163475565|NCT02202161|590438545|FG000|Overall Study|Did not meet continuation criteria|0|||
163475566|NCT02202161|590438546|FG001|Overall Study|Did not meet continuation criteria|0|||
163475567|NCT02202161|590438547|FG002|Overall Study|Did not meet continuation criteria|0|||
163475568|NCT02202161|590438548|FG003|Overall Study|Did not meet continuation criteria|0|||
163475569|NCT02202161|590438549|FG004|Overall Study|Did not meet continuation criteria|0|||
163475570|NCT02202161|590438550|FG005|Overall Study|Did not meet continuation criteria|0|||
163475571|NCT02202161|590438551|FG006|Overall Study|Did not meet continuation criteria|0|||
163475572|NCT02202161|590438552|FG007|Overall Study|Did not meet continuation criteria|3|||
163475573|NCT02202161|590438545|FG000|Overall Study|Physician Decision|0|||
163475574|NCT02202161|590438546|FG001|Overall Study|Physician Decision|0|||
163475575|NCT02202161|590438547|FG002|Overall Study|Physician Decision|0|||
163475576|NCT02202161|590438548|FG003|Overall Study|Physician Decision|0|||
163475577|NCT02202161|590438549|FG004|Overall Study|Physician Decision|0|||
163475578|NCT02202161|590438550|FG005|Overall Study|Physician Decision|0|||
163475579|NCT02202161|590438551|FG006|Overall Study|Physician Decision|0|||
163475580|NCT02202161|590438552|FG007|Overall Study|Physician Decision|3|||
163475581|NCT02202161|590438545|FG000|Overall Study|Withdrawal by Subject|0|||
163475582|NCT02202161|590438546|FG001|Overall Study|Withdrawal by Subject|0|||
163475583|NCT02202161|590438547|FG002|Overall Study|Withdrawal by Subject|0|||
163475584|NCT02202161|590438548|FG003|Overall Study|Withdrawal by Subject|0|||
163475585|NCT02202161|590438549|FG004|Overall Study|Withdrawal by Subject|1|||
163475586|NCT02202161|590438550|FG005|Overall Study|Withdrawal by Subject|0|||
163475587|NCT02202161|590438551|FG006|Overall Study|Withdrawal by Subject|0|||
163475588|NCT02202161|590438552|FG007|Overall Study|Withdrawal by Subject|0|||
163475589|NCT03685643|590438555|FG000|Overall Study|Lost to Follow-up|14|||
163475590|NCT03685643|590438556|FG001|Overall Study|Lost to Follow-up|22|||
163475591|NCT03797144|590438558|FG000|Enrollment|Protocol Violation|4|||
163475592|NCT03797144|590438559|FG001|Enrollment|Protocol Violation|1|||
163475593|NCT03797144|590438558|FG000|Surgery|Protocol Violation|1|||
163475594|NCT03797144|590438559|FG001|Surgery|Protocol Violation|0|||
163475595|NCT03797144|590438558|FG000|3 Month|Early termination cut-off date|2|||
163475596|NCT03797144|590438559|FG001|3 Month|Early termination cut-off date|0|||
163475597|NCT03797144|590438558|FG000|12 Month|Early termination cut-off date|8|||
163475598|NCT03797144|590438559|FG001|12 Month|Early termination cut-off date|9|||
163475599|NCT03797144|590438558|FG000|24 Month|Early termination cut-off date|1|||
163475600|NCT03797144|590438559|FG001|24 Month|Early termination cut-off date|1|||
163475601|NCT01878175|590438561|FG000|Overall Study|Developed contraindicated health problem|2|||
163475602|NCT03299166|590438563|FG000|Overall Study|Adverse Event|9|||
163475603|NCT03299166|590438564|FG001|Overall Study|Adverse Event|4|||
163475604|NCT03299166|590438563|FG000|Overall Study|Withdrawal by Subject|6|||
163475605|NCT03299166|590438564|FG001|Overall Study|Withdrawal by Subject|5|||
163475606|NCT03299166|590438563|FG000|Overall Study|Physician Decision|1|||
163475607|NCT03299166|590438564|FG001|Overall Study|Physician Decision|1|||
163475608|NCT03299166|590438563|FG000|Overall Study|Sponsor Decision|3|||
163475609|NCT03299166|590438564|FG001|Overall Study|Sponsor Decision|0|||
163475610|NCT03299166|590438563|FG000|Overall Study|Lost to Follow-up|2|||
163475611|NCT03299166|590438564|FG001|Overall Study|Lost to Follow-up|4|||
163475612|NCT03299166|590438563|FG000|Overall Study|Randomization Error|0|||
163475613|NCT03299166|590438564|FG001|Overall Study|Randomization Error|1|||
163475614|NCT03299166|590438563|FG000|Overall Study|Subject unable to return due to COVID|1|||
163475615|NCT03299166|590438564|FG001|Overall Study|Subject unable to return due to COVID|0|||
163475616|NCT03299166|590438563|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
163475617|NCT03299166|590438564|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
163475618|NCT00707486|590438569|FG000|Overall Study|Withdrawal by Subject|1|||
163475619|NCT02972658|590440522|FG000|Overall Study|Adverse Event|0|||
163475620|NCT02972658|590440523|FG001|Overall Study|Adverse Event|3|||
163475621|NCT02972658|590440524|FG002|Overall Study|Adverse Event|0|||
163475622|NCT02972658|590440525|FG003|Overall Study|Adverse Event|2|||
163475623|NCT02972658|590440522|FG000|Overall Study|Other-determined by Investigator|1|||
163475624|NCT02972658|590440523|FG001|Overall Study|Other-determined by Investigator|1|||
163475625|NCT02972658|590440524|FG002|Overall Study|Other-determined by Investigator|0|||
163475626|NCT02972658|590440525|FG003|Overall Study|Other-determined by Investigator|0|||
163475627|NCT02972658|590440522|FG000|Overall Study|Death|0|||
163475628|NCT02972658|590440523|FG001|Overall Study|Death|0|||
163475629|NCT02972658|590440524|FG002|Overall Study|Death|0|||
163475630|NCT02972658|590440525|FG003|Overall Study|Death|1|||
163475631|NCT02972658|590440522|FG000|Overall Study|Lost to Follow-up|0|||
163475632|NCT02972658|590440523|FG001|Overall Study|Lost to Follow-up|1|||
163475633|NCT02972658|590440524|FG002|Overall Study|Lost to Follow-up|1|||
163475634|NCT02972658|590440525|FG003|Overall Study|Lost to Follow-up|2|||
163475635|NCT02972658|590440522|FG000|Overall Study|Progressive Disease|0|||
163475636|NCT02972658|590440523|FG001|Overall Study|Progressive Disease|1|||
163475637|NCT02972658|590440524|FG002|Overall Study|Progressive Disease|0|||
163475638|NCT02972658|590440525|FG003|Overall Study|Progressive Disease|1|||
163475639|NCT02972658|590440522|FG000|Overall Study|Withdrawal by Subject|4|||
163475640|NCT02972658|590440523|FG001|Overall Study|Withdrawal by Subject|4|||
163475641|NCT02972658|590440524|FG002|Overall Study|Withdrawal by Subject|1|||
163475642|NCT02972658|590440525|FG003|Overall Study|Withdrawal by Subject|6|||
163475643|NCT02972658|590440522|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
163475644|NCT02972658|590440523|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
163475645|NCT02972658|590440524|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
163475646|NCT02972658|590440525|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
163475647|NCT02972658|590440522|FG000|Overall Study|Sponsor Decision|70|||
163475648|NCT02972658|590440523|FG001|Overall Study|Sponsor Decision|127|||
163475649|NCT02972658|590440524|FG002|Overall Study|Sponsor Decision|72|||
163475650|NCT02972658|590440525|FG003|Overall Study|Sponsor Decision|119|||
163475651|NCT03958149|590440530|FG000|Overall Study|Withdrawal by Subject|0|||
163475652|NCT03958149|590440531|FG001|Overall Study|Withdrawal by Subject|1|||
163475653|NCT02785588|590440532|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
163475654|NCT02785588|590440532|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
163475655|NCT03037489|590440533|FG000|Overall Study|Adverse Event|4|||
163475656|NCT03037489|590440534|FG001|Overall Study|Adverse Event|0|||
163475657|NCT03037489|590440533|FG000|Overall Study|Withdrawal by Subject|3|||
163475658|NCT03037489|590440534|FG001|Overall Study|Withdrawal by Subject|0|||
163475659|NCT00724243|590440536|FG000|Overall Study|Lack of Efficacy|10|||
163475660|NCT00724243|590440536|FG000|Overall Study|Adverse Event|5|||
163475661|NCT03031327|590440537|FG000|Overall Study|Withdrawal by Subject|0|||
163475662|NCT03031327|590440538|FG001|Overall Study|Withdrawal by Subject|1|||
163475663|NCT03031327|590440539|FG002|Overall Study|Withdrawal by Subject|1|||
163475664|NCT00669240|590440540|FG000|Overall Study|Lack of Efficacy|33|||
163475665|NCT00669240|590440540|FG000|Overall Study|Withdrawal by Subject|42|||
163475666|NCT00669240|590440540|FG000|Overall Study|Lost to Follow-up|34|||
163475667|NCT00669240|590440540|FG000|Overall Study|Adverse Event|21|||
163475668|NCT00669240|590440540|FG000|Overall Study|Other|19|||
163475669|NCT00669240|590440540|FG000|Overall Study|Enrolled but not treated|15|||
163475670|NCT00669240|590440540|FG000|Overall Study|Enrolled but no dosing record|1|||
163475671|NCT03793010|590440541|FG000|Overall Study|Withdrawal by Subject|5|||
163475672|NCT03793010|590440542|FG001|Overall Study|Withdrawal by Subject|7|||
163475673|NCT03793010|590440541|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
163475674|NCT03793010|590440542|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
163475675|NCT03793010|590440541|FG000|Overall Study|Lost to Follow-up|1|||
163475676|NCT03793010|590440542|FG001|Overall Study|Lost to Follow-up|2|||
163475677|NCT03793010|590440541|FG000|Overall Study|Patient couldn't sit still for injection|1|||
163475678|NCT03793010|590440542|FG001|Overall Study|Patient couldn't sit still for injection|0|||
163475679|NCT03793010|590440541|FG000|Overall Study|Withdrew to pursue other treatment|1|||
163475680|NCT03793010|590440542|FG001|Overall Study|Withdrew to pursue other treatment|0|||
163475681|NCT03793010|590440541|FG000|Overall Study|Did not meet eligibility criteria|1|||
163475682|NCT03793010|590440542|FG001|Overall Study|Did not meet eligibility criteria|0|||
163475683|NCT01997892|590440547|FG000|Overall Study|Physician Decision|2|||
163475684|NCT01997892|590440547|FG000|Overall Study|Lost to Follow-up|6|||
163475685|NCT01997892|590440547|FG000|Overall Study|Death|14|||
163475686|NCT01997892|590440547|FG000|Overall Study|Renal transplant|8|||
163475687|NCT01997892|590440547|FG000|Overall Study|Other|3|||
163475688|NCT01997892|590440547|FG000|Overall Study|Study completion data not recorded|35|||
163475689|NCT02531633|590440548|FG000|Part A (52 Weeks)|Sponsor request|24|||
163475690|NCT02531633|590440549|FG001|Part A (52 Weeks)|Sponsor request|24|||
163475691|NCT02531633|590440550|FG002|Part A (52 Weeks)|Sponsor request|18|||
163475692|NCT02531633|590440551|FG003|Part A (52 Weeks)|Sponsor request|18|||
163475693|NCT02531633|590440552|FG004|Part A (52 Weeks)|Sponsor request|19|||
163475694|NCT02531633|590440553|FG005|Part A (52 Weeks)|Sponsor request|0|||
163475695|NCT02531633|590440554|FG006|Part A (52 Weeks)|Sponsor request|0|||
163475696|NCT02531633|590440555|FG007|Part A (52 Weeks)|Sponsor request|0|||
163475697|NCT02531633|590440556|FG008|Part A (52 Weeks)|Sponsor request|0|||
163475698|NCT02531633|590440557|FG009|Part A (52 Weeks)|Sponsor request|0|||
163475699|NCT02531633|590440548|FG000|Part A (52 Weeks)|Protocol Violation|1|||
163475700|NCT02531633|590440549|FG001|Part A (52 Weeks)|Protocol Violation|0|||
163475701|NCT02531633|590440550|FG002|Part A (52 Weeks)|Protocol Violation|0|||
163475702|NCT02531633|590440551|FG003|Part A (52 Weeks)|Protocol Violation|0|||
163475703|NCT02531633|590440552|FG004|Part A (52 Weeks)|Protocol Violation|0|||
163475704|NCT02531633|590440553|FG005|Part A (52 Weeks)|Protocol Violation|0|||
163475705|NCT02531633|590440554|FG006|Part A (52 Weeks)|Protocol Violation|0|||
163475706|NCT02531633|590440555|FG007|Part A (52 Weeks)|Protocol Violation|0|||
163475707|NCT02531633|590440556|FG008|Part A (52 Weeks)|Protocol Violation|0|||
163475708|NCT02531633|590440557|FG009|Part A (52 Weeks)|Protocol Violation|0|||
163475709|NCT02531633|590440548|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
163475710|NCT02531633|590440549|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
163475711|NCT02531633|590440550|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
163475712|NCT02531633|590440551|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
163475713|NCT02531633|590440552|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
163475714|NCT02531633|590440553|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
163475715|NCT02531633|590440554|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
163475716|NCT02531633|590440555|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
163475717|NCT02531633|590440556|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
163475718|NCT02531633|590440557|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
163475719|NCT02531633|590440548|FG000|Part A (52 Weeks)|Physician Decision|1|||
163475720|NCT02531633|590440549|FG001|Part A (52 Weeks)|Physician Decision|4|||
163475721|NCT02531633|590440550|FG002|Part A (52 Weeks)|Physician Decision|3|||
163475722|NCT02531633|590440551|FG003|Part A (52 Weeks)|Physician Decision|1|||
163475723|NCT02531633|590440552|FG004|Part A (52 Weeks)|Physician Decision|0|||
163475724|NCT02531633|590440553|FG005|Part A (52 Weeks)|Physician Decision|0|||
163475725|NCT02531633|590440554|FG006|Part A (52 Weeks)|Physician Decision|0|||
163475726|NCT02531633|590440555|FG007|Part A (52 Weeks)|Physician Decision|0|||
163475727|NCT02531633|590440556|FG008|Part A (52 Weeks)|Physician Decision|0|||
163475728|NCT02531633|590440557|FG009|Part A (52 Weeks)|Physician Decision|0|||
163475729|NCT02531633|590440548|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
163475730|NCT02531633|590440549|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
163475731|NCT02531633|590440550|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
163475732|NCT02531633|590440551|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
163475733|NCT02531633|590440552|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
163475734|NCT02531633|590440553|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
163475735|NCT02531633|590440554|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
163475736|NCT02531633|590440555|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
163475737|NCT02531633|590440556|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
163475738|NCT02531633|590440557|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
163475739|NCT02531633|590440548|FG000|Part A (52 Weeks)|Other|2|||
163475740|NCT02531633|590440549|FG001|Part A (52 Weeks)|Other|0|||
163475741|NCT02531633|590440550|FG002|Part A (52 Weeks)|Other|0|||
163475742|NCT02531633|590440551|FG003|Part A (52 Weeks)|Other|0|||
163475743|NCT02531633|590440552|FG004|Part A (52 Weeks)|Other|0|||
163475744|NCT02531633|590440553|FG005|Part A (52 Weeks)|Other|0|||
163475745|NCT02531633|590440554|FG006|Part A (52 Weeks)|Other|0|||
163475746|NCT02531633|590440555|FG007|Part A (52 Weeks)|Other|0|||
163475747|NCT02531633|590440556|FG008|Part A (52 Weeks)|Other|0|||
163475748|NCT02531633|590440557|FG009|Part A (52 Weeks)|Other|0|||
163475749|NCT02531633|590440548|FG000|Part B (104 Weeks)|Sponsor request|0|||
163475750|NCT02531633|590440549|FG001|Part B (104 Weeks)|Sponsor request|0|||
163475751|NCT02531633|590440550|FG002|Part B (104 Weeks)|Sponsor request|0|||
163475752|NCT02531633|590440551|FG003|Part B (104 Weeks)|Sponsor request|0|||
163475753|NCT02531633|590440552|FG004|Part B (104 Weeks)|Sponsor request|0|||
163475754|NCT02531633|590440553|FG005|Part B (104 Weeks)|Sponsor request|8|||
163475755|NCT02531633|590440554|FG006|Part B (104 Weeks)|Sponsor request|5|||
163475756|NCT02531633|590440555|FG007|Part B (104 Weeks)|Sponsor request|3|||
163475757|NCT02531633|590440556|FG008|Part B (104 Weeks)|Sponsor request|5|||
163475758|NCT02531633|590440557|FG009|Part B (104 Weeks)|Sponsor request|4|||
163475759|NCT02531633|590440548|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
163475760|NCT02531633|590440549|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
163475761|NCT02531633|590440550|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
163475762|NCT02531633|590440551|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
163475763|NCT02531633|590440552|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
163475764|NCT02531633|590440553|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
163475765|NCT02531633|590440554|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
163475766|NCT02531633|590440555|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
163475767|NCT02531633|590440556|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
163475768|NCT02531633|590440557|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
163475769|NCT00364611|590440558|FG000|Overall Study|Did not receive study medication|0|||
163475770|NCT00364611|590440559|FG001|Overall Study|Did not receive study medication|1|||
163475771|NCT00364611|590440558|FG000|Overall Study|Adverse Event|7|||
163475772|NCT00364611|590440559|FG001|Overall Study|Adverse Event|4|||
163475773|NCT00364611|590440558|FG000|Overall Study|Participant's Request|3|||
163475774|NCT00364611|590440559|FG001|Overall Study|Participant's Request|4|||
163475775|NCT00364611|590440558|FG000|Overall Study|Disease Progression|38|||
163475776|NCT00364611|590440559|FG001|Overall Study|Disease Progression|8|||
163475777|NCT00364611|590440558|FG000|Overall Study|Investigator decision|2|||
163475778|NCT00364611|590440559|FG001|Overall Study|Investigator decision|2|||
163475779|NCT00364611|590440558|FG000|Overall Study|Found Ineligible|1|||
163475780|NCT00364611|590440559|FG001|Overall Study|Found Ineligible|0|||
163475781|NCT00364611|590440558|FG000|Overall Study|Presumed CR on Study|0|||
163475782|NCT00364611|590440559|FG001|Overall Study|Presumed CR on Study|1|||
163475783|NCT00364611|590440558|FG000|Overall Study|Receiving Liver Ablation|0|||
163475784|NCT00364611|590440559|FG001|Overall Study|Receiving Liver Ablation|1|||
163475785|NCT04097925|590440566|FG000|Overall Study|Withdrawal by Subject|1|||
163475786|NCT02608099|590440567|FG000|Overall Study|Ablation procedure not initiated|3|||
163475787|NCT02608099|590440568|FG001|Overall Study|Ablation procedure not initiated|2|||
163475788|NCT00087594|590440573|FG000|Overall Study|Adverse Event|2|||
163475789|NCT00087594|590440574|FG001|Overall Study|Adverse Event|3|||
163475790|NCT00087594|590440573|FG000|Overall Study|Lost to Follow-up|0|||
163475791|NCT00087594|590440574|FG001|Overall Study|Lost to Follow-up|2|||
163475792|NCT00087594|590440573|FG000|Overall Study|Withdrawal by Subject|4|||
163475793|NCT00087594|590440574|FG001|Overall Study|Withdrawal by Subject|2|||
163475794|NCT00087594|590440573|FG000|Overall Study|Lack of Efficacy|2|||
163475795|NCT00087594|590440574|FG001|Overall Study|Lack of Efficacy|5|||
163475796|NCT01952041|590440578|FG000|Overall Study|Lost to Follow-up|9|||
163475797|NCT01952041|590440579|FG001|Overall Study|Lost to Follow-up|16|||
163475798|NCT01952041|590440578|FG000|Overall Study|Withdrawal by Subject|7|||
163475799|NCT01952041|590440579|FG001|Overall Study|Withdrawal by Subject|5|||
163475800|NCT01952041|590440578|FG000|Overall Study|Death|1|||
163475801|NCT01952041|590440579|FG001|Overall Study|Death|0|||
163475802|NCT01736176|590440580|FG000|Overall Study|Adverse Event|3|||
163475803|NCT01736176|590440580|FG000|Overall Study|Withdrawal by Subject|4|||
163475804|NCT01736176|590440580|FG000|Overall Study|Lack of Efficacy|3|||
163475805|NCT01736176|590440580|FG000|Overall Study|Unable to Complete PEG Placement|1|||
163475806|NCT01569568|590440581|FG000|Overall Study|Physician Decision|0|||
163475807|NCT01569568|590440582|FG001|Overall Study|Physician Decision|2|||
163475808|NCT00290355|590440587|FG000|Overall Study|Serious adverse event|7|||
163475809|NCT00290355|590440588|FG001|Overall Study|Serious adverse event|4|||
163475810|NCT00290355|590440587|FG000|Overall Study|Study product reactogenicity|1|||
163475811|NCT00290355|590440588|FG001|Overall Study|Study product reactogenicity|0|||
163475812|NCT00290355|590440587|FG000|Overall Study|Protocol Violation|1|||
163475813|NCT00290355|590440588|FG001|Overall Study|Protocol Violation|0|||
163475814|NCT00290355|590440587|FG000|Overall Study|Withdrawal by Subject|2|||
163475815|NCT00290355|590440588|FG001|Overall Study|Withdrawal by Subject|0|||
163475816|NCT00290355|590440587|FG000|Overall Study|Migrated / moved from the study area|1|||
163475817|NCT00290355|590440588|FG001|Overall Study|Migrated / moved from the study area|0|||
163475818|NCT00290355|590440587|FG000|Overall Study|Lost to Follow-up|3|||
163475819|NCT00290355|590440588|FG001|Overall Study|Lost to Follow-up|1|||
163475820|NCT00290355|590440587|FG000|Overall Study|Other|2|||
163475821|NCT00290355|590440588|FG001|Overall Study|Other|0|||
163475822|NCT03345849|590440589|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
163475823|NCT03345849|590440590|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
163475824|NCT03345849|590440591|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
163475825|NCT03345849|590440592|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
163475826|NCT03345849|590440589|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
163475827|NCT03345849|590440590|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
163475828|NCT03345849|590440591|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
163475829|NCT03345849|590440592|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
163475830|NCT03345849|590440589|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
163475831|NCT03345849|590440590|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
163475832|NCT03345849|590440591|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
163475833|NCT03345849|590440592|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
163475834|NCT03345849|590440589|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
163475835|NCT03345849|590440590|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
163475836|NCT03345849|590440591|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
163475837|NCT03345849|590440592|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
163475838|NCT03345849|590440589|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
163475839|NCT03345849|590440590|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
163475840|NCT03345849|590440591|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
163475841|NCT03345849|590440592|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
163475842|NCT03345849|590440589|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
163475843|NCT03345849|590440590|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
163475844|NCT03345849|590440591|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
163475845|NCT03345849|590440592|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
163475846|NCT03345849|590440589|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
163475847|NCT03345849|590440590|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
163475848|NCT03345849|590440591|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
163475849|NCT03345849|590440592|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
163475850|NCT03345849|590440589|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
163475851|NCT03345849|590440590|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
163475852|NCT03345849|590440591|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
163475853|NCT03345849|590440592|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
163475854|NCT03345849|590440589|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
163475855|NCT03345849|590440590|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
163475856|NCT03345849|590440591|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
163475857|NCT03345849|590440592|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
163475858|NCT03345849|590440589|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
163475859|NCT03345849|590440590|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
163475860|NCT03345849|590440591|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
163475861|NCT03345849|590440592|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
163475862|NCT03345849|590440589|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
163475863|NCT03345849|590440590|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
163475864|NCT03345849|590440591|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
163475865|NCT03345849|590440592|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
163475866|NCT03657576|590440593|FG000|Overall Study|Death|0|||
163475867|NCT03657576|590440594|FG001|Overall Study|Death|1|||
163475868|NCT03657576|590440595|FG002|Overall Study|Death|1|||
163475869|NCT03657576|590440596|FG003|Overall Study|Death|0|||
163475870|NCT03657576|590440597|FG004|Overall Study|Death|0|||
163475871|NCT03657576|590440598|FG005|Overall Study|Death|0|||
163475872|NCT03657576|590440593|FG000|Overall Study|Withdrawal by Subject|0|||
163475873|NCT03657576|590440594|FG001|Overall Study|Withdrawal by Subject|0|||
163475874|NCT03657576|590440595|FG002|Overall Study|Withdrawal by Subject|0|||
163475875|NCT03657576|590440596|FG003|Overall Study|Withdrawal by Subject|1|||
163475876|NCT03657576|590440597|FG004|Overall Study|Withdrawal by Subject|0|||
163475877|NCT03657576|590440598|FG005|Overall Study|Withdrawal by Subject|0|||
163475878|NCT03657576|590440593|FG000|Overall Study|Screen Fail|0|||
163475879|NCT03657576|590440594|FG001|Overall Study|Screen Fail|0|||
163475880|NCT03657576|590440595|FG002|Overall Study|Screen Fail|0|||
163475881|NCT03657576|590440596|FG003|Overall Study|Screen Fail|0|||
163475882|NCT03657576|590440597|FG004|Overall Study|Screen Fail|0|||
163475883|NCT03657576|590440598|FG005|Overall Study|Screen Fail|5|||
163475884|NCT03657576|590440593|FG000|Overall Study|Disease Progression|1|||
163475885|NCT03657576|590440594|FG001|Overall Study|Disease Progression|1|||
163475886|NCT03657576|590440595|FG002|Overall Study|Disease Progression|0|||
163475887|NCT03657576|590440596|FG003|Overall Study|Disease Progression|5|||
163475888|NCT03657576|590440597|FG004|Overall Study|Disease Progression|0|||
163475889|NCT03657576|590440598|FG005|Overall Study|Disease Progression|0|||
163475890|NCT03657576|590440593|FG000|Overall Study|Insurance Coverage|0|||
163475891|NCT03657576|590440594|FG001|Overall Study|Insurance Coverage|0|||
163475892|NCT03657576|590440595|FG002|Overall Study|Insurance Coverage|0|||
163475893|NCT03657576|590440596|FG003|Overall Study|Insurance Coverage|1|||
163475894|NCT03657576|590440597|FG004|Overall Study|Insurance Coverage|0|||
163475895|NCT03657576|590440598|FG005|Overall Study|Insurance Coverage|0|||
163475896|NCT04437511|590440599|FG000|Overall Study|Adverse Event|50|||
163475897|NCT04437511|590440600|FG001|Overall Study|Adverse Event|21|||
163475898|NCT04437511|590440599|FG000|Overall Study|Death|15|||
163475899|NCT04437511|590440600|FG001|Overall Study|Death|10|||
163475900|NCT04437511|590440599|FG000|Overall Study|Lost to Follow-up|11|||
163475901|NCT04437511|590440600|FG001|Overall Study|Lost to Follow-up|11|||
163475902|NCT04437511|590440599|FG000|Overall Study|Physician Decision|19|||
163475903|NCT04437511|590440600|FG001|Overall Study|Physician Decision|10|||
163475904|NCT04437511|590440599|FG000|Overall Study|Progressive Disease|4|||
163475905|NCT04437511|590440600|FG001|Overall Study|Progressive Disease|7|||
163475906|NCT04437511|590440599|FG000|Overall Study|Withdrawal by Subject|111|||
163475907|NCT04437511|590440600|FG001|Overall Study|Withdrawal by Subject|94|||
163475908|NCT04437511|590440599|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
163475909|NCT04437511|590440600|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
163475910|NCT04437511|590440599|FG000|Overall Study|Continuing Study|7|||
163475911|NCT04437511|590440600|FG001|Overall Study|Continuing Study|5|||
163475912|NCT03093350|590440607|FG000|Overall Study|Death|1|||
163475913|NCT03093350|590440607|FG000|Overall Study|Signed consent, never began treartment|1|||
163475914|NCT00777036|590440608|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
163475915|NCT00777036|590440609|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
163475916|NCT00777036|590440610|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
163475917|NCT00777036|590440611|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
163475918|NCT00777036|590440608|FG000|On Treatment|Administrative Reason By Sponsor|1|||
163475919|NCT00777036|590440609|FG001|On Treatment|Administrative Reason By Sponsor|0|||
163475920|NCT00777036|590440610|FG002|On Treatment|Administrative Reason By Sponsor|9|||
163475921|NCT00777036|590440611|FG003|On Treatment|Administrative Reason By Sponsor|0|||
163475922|NCT00777036|590440608|FG000|On Treatment|Failure to Meet Study Criteria|0|||
163475923|NCT00777036|590440609|FG001|On Treatment|Failure to Meet Study Criteria|1|||
163475924|NCT00777036|590440610|FG002|On Treatment|Failure to Meet Study Criteria|4|||
163475925|NCT00777036|590440611|FG003|On Treatment|Failure to Meet Study Criteria|0|||
163475926|NCT00777036|590440608|FG000|On Treatment|Pregnancy|1|||
163475927|NCT00777036|590440609|FG001|On Treatment|Pregnancy|0|||
163475928|NCT00777036|590440610|FG002|On Treatment|Pregnancy|1|||
163475929|NCT00777036|590440611|FG003|On Treatment|Pregnancy|0|||
163475930|NCT00777036|590440608|FG000|On Treatment|Non-compliance with Study Drug|1|||
163475931|NCT00777036|590440609|FG001|On Treatment|Non-compliance with Study Drug|0|||
163475932|NCT00777036|590440610|FG002|On Treatment|Non-compliance with Study Drug|1|||
163475933|NCT00777036|590440611|FG003|On Treatment|Non-compliance with Study Drug|0|||
163475934|NCT00777036|590440608|FG000|On Treatment|Maximum Clinical Benefit|2|||
163475935|NCT00777036|590440609|FG001|On Treatment|Maximum Clinical Benefit|0|||
163475936|NCT00777036|590440610|FG002|On Treatment|Maximum Clinical Benefit|5|||
163475937|NCT00777036|590440611|FG003|On Treatment|Maximum Clinical Benefit|0|||
163475938|NCT00777036|590440608|FG000|On Treatment|Withdrawal by Subject|0|||
163475939|NCT00777036|590440609|FG001|On Treatment|Withdrawal by Subject|2|||
163475940|NCT00777036|590440610|FG002|On Treatment|Withdrawal by Subject|2|||
163475941|NCT00777036|590440611|FG003|On Treatment|Withdrawal by Subject|0|||
163475942|NCT00777036|590440608|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
163475943|NCT00777036|590440609|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
163475944|NCT00777036|590440610|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
163475945|NCT00777036|590440611|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
163475946|NCT00777036|590440608|FG000|On Treatment|Death|0|||
163475947|NCT00777036|590440609|FG001|On Treatment|Death|2|||
163475948|NCT00777036|590440610|FG002|On Treatment|Death|0|||
163475949|NCT00777036|590440611|FG003|On Treatment|Death|0|||
163475950|NCT00777036|590440608|FG000|On Treatment|Study Drug Toxicity|1|||
163475951|NCT00777036|590440609|FG001|On Treatment|Study Drug Toxicity|0|||
163475952|NCT00777036|590440610|FG002|On Treatment|Study Drug Toxicity|4|||
163475953|NCT00777036|590440611|FG003|On Treatment|Study Drug Toxicity|0|||
163475954|NCT00777036|590440608|FG000|On Treatment|Progressive Disease|6|||
163475955|NCT00777036|590440609|FG001|On Treatment|Progressive Disease|4|||
163475956|NCT00777036|590440610|FG002|On Treatment|Progressive Disease|7|||
163475957|NCT00777036|590440611|FG003|On Treatment|Progressive Disease|0|||
163475958|NCT00777036|590440608|FG000|On Treatment|Not Reported|0|||
163475959|NCT00777036|590440609|FG001|On Treatment|Not Reported|0|||
163475960|NCT00777036|590440610|FG002|On Treatment|Not Reported|2|||
163475961|NCT00777036|590440611|FG003|On Treatment|Not Reported|0|||
163475962|NCT00777036|590440608|FG000|On Treatment|Site Closed|0|||
163475963|NCT00777036|590440609|FG001|On Treatment|Site Closed|1|||
163475964|NCT00777036|590440610|FG002|On Treatment|Site Closed|1|||
163475965|NCT00777036|590440611|FG003|On Treatment|Site Closed|0|||
163475966|NCT00777036|590440608|FG000|Follow-Up|Withdrawal by Subject|0|||
163475967|NCT00777036|590440609|FG001|Follow-Up|Withdrawal by Subject|0|||
163475968|NCT00777036|590440610|FG002|Follow-Up|Withdrawal by Subject|5|||
163475969|NCT00777036|590440611|FG003|Follow-Up|Withdrawal by Subject|0|||
163475970|NCT00777036|590440608|FG000|Follow-Up|Death|1|||
163475971|NCT00777036|590440609|FG001|Follow-Up|Death|9|||
163475972|NCT00777036|590440610|FG002|Follow-Up|Death|0|||
163475973|NCT00777036|590440611|FG003|Follow-Up|Death|0|||
163475974|NCT00777036|590440608|FG000|Follow-Up|Lost to Follow-up|3|||
163475975|NCT00777036|590440609|FG001|Follow-Up|Lost to Follow-up|0|||
163475976|NCT00777036|590440610|FG002|Follow-Up|Lost to Follow-up|0|||
163475977|NCT00777036|590440611|FG003|Follow-Up|Lost to Follow-up|0|||
163475978|NCT00777036|590440608|FG000|Follow-Up|Reason Not Specified|4|||
163475979|NCT00777036|590440609|FG001|Follow-Up|Reason Not Specified|0|||
163475980|NCT00777036|590440610|FG002|Follow-Up|Reason Not Specified|13|||
163475981|NCT00777036|590440611|FG003|Follow-Up|Reason Not Specified|0|||
163475982|NCT00777036|590440608|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
163475983|NCT00777036|590440609|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
163475984|NCT00777036|590440610|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
163475985|NCT00777036|590440611|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
163475986|NCT05564039|590440614|FG000|Overall Study|Adverse Event|1|||
163475987|NCT05564039|590440615|FG001|Overall Study|Adverse Event|0|||
163475988|NCT05564039|590440614|FG000|Overall Study|Death|1|||
163475989|NCT05564039|590440615|FG001|Overall Study|Death|1|||
163475990|NCT05564039|590440614|FG000|Overall Study|Lost to Follow-up|3|||
163475991|NCT05564039|590440615|FG001|Overall Study|Lost to Follow-up|2|||
163475992|NCT05564039|590440614|FG000|Overall Study|Withdrawal by Subject|2|||
163475993|NCT05564039|590440615|FG001|Overall Study|Withdrawal by Subject|0|||
163475994|NCT05564039|590440614|FG000|Overall Study|Inadvertent enrollment|3|||
163475995|NCT05564039|590440615|FG001|Overall Study|Inadvertent enrollment|6|||
163475996|NCT00729560|590440616|FG000|Overall Study|Withdrawal by Subject|3|||
163475997|NCT03233308|590440617|FG000|Overall Study|Adverse Event|1|||
163475998|NCT03233308|590440617|FG000|Overall Study|Protocol Violation|1|||
163475999|NCT03662789|590440618|FG000|Overall Study|Lost to Follow-up|1|||
163476000|NCT03662789|590440619|FG001|Overall Study|Lost to Follow-up|2|||
163476001|NCT03662789|590440618|FG000|Overall Study|Could not perform treadmill test|4|||
163476002|NCT03662789|590440619|FG001|Overall Study|Could not perform treadmill test|4|||
163476003|NCT03662789|590440618|FG000|Overall Study|Death|0|||
163476004|NCT03662789|590440619|FG001|Overall Study|Death|1|||
163476005|NCT02136134|590440620|FG000|Overall Study|Death|170|||
163476006|NCT02136134|590440621|FG001|Overall Study|Death|148|||
163476007|NCT02136134|590440620|FG000|Overall Study|Withdrawal by Subject|19|||
163476008|NCT02136134|590440621|FG001|Overall Study|Withdrawal by Subject|10|||
163476009|NCT02136134|590440620|FG000|Overall Study|Lost to Follow-up|3|||
163476010|NCT02136134|590440621|FG001|Overall Study|Lost to Follow-up|3|||
163476011|NCT02136134|590440620|FG000|Overall Study|Uspecified|55|||
163476012|NCT02136134|590440621|FG001|Overall Study|Uspecified|90|||
163476013|NCT05245071|590440622|FG000|Overall Study|Progressive disease|18|||
163476014|NCT05245071|590440622|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
163476015|NCT05245071|590440622|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
163476016|NCT01602822|590440625|FG000|Overall Study|Adverse Event|11|||
163476017|NCT00853112|590440629|FG000|Overall Study|Randomized but not treated|0|||
163476018|NCT00853112|590440630|FG001|Overall Study|Randomized but not treated|1|||
163476019|NCT00853112|590440631|FG002|Overall Study|Randomized but not treated|0|||
163476020|NCT00853112|590440632|FG003|Overall Study|Randomized but not treated|2|||
163476021|NCT00853112|590440633|FG004|Overall Study|Randomized but not treated|0|||
163476022|NCT00853112|590440634|FG005|Overall Study|Randomized but not treated|0|||
163476023|NCT00853112|590440635|FG006|Overall Study|Randomized but not treated|1|||
163476024|NCT01553591|590440636|FG000|Overall Study|Voluntarily withdrew|94|||
163476025|NCT01553591|590440637|FG001|Overall Study|Voluntarily withdrew|79|||
163476026|NCT01553591|590440638|FG002|Overall Study|Voluntarily withdrew|96|||
163476027|NCT01553591|590440636|FG000|Overall Study|Adverse Event|36|||
163476028|NCT01553591|590440637|FG001|Overall Study|Adverse Event|45|||
163476029|NCT01553591|590440638|FG002|Overall Study|Adverse Event|16|||
163476030|NCT01553591|590440636|FG000|Overall Study|Lost to Follow-up|25|||
163476031|NCT01553591|590440637|FG001|Overall Study|Lost to Follow-up|23|||
163476032|NCT01553591|590440638|FG002|Overall Study|Lost to Follow-up|16|||
163476033|NCT01553591|590440636|FG000|Overall Study|Physician decision: other|11|||
163476034|NCT01553591|590440637|FG001|Overall Study|Physician decision: other|14|||
163476035|NCT01553591|590440638|FG002|Overall Study|Physician decision: other|16|||
163476036|NCT01553591|590440636|FG000|Overall Study|Physician decision: lack of efficacy|2|||
163476037|NCT01553591|590440637|FG001|Overall Study|Physician decision: lack of efficacy|3|||
163476038|NCT01553591|590440638|FG002|Overall Study|Physician decision: lack of efficacy|7|||
163476039|NCT01553591|590440636|FG000|Overall Study|Protocol Violation|3|||
163476040|NCT01553591|590440637|FG001|Overall Study|Protocol Violation|4|||
163476041|NCT01553591|590440638|FG002|Overall Study|Protocol Violation|4|||
163476042|NCT01553591|590440636|FG000|Overall Study|Sponsor decision|1|||
163476043|NCT01553591|590440637|FG001|Overall Study|Sponsor decision|0|||
163476044|NCT01553591|590440638|FG002|Overall Study|Sponsor decision|3|||
163476045|NCT01553591|590440636|FG000|Overall Study|Randomized and never dispensed drug|0|||
163476046|NCT01553591|590440637|FG001|Overall Study|Randomized and never dispensed drug|1|||
163476047|NCT01553591|590440638|FG002|Overall Study|Randomized and never dispensed drug|0|||
163476048|NCT02477800|590440639|FG000|Placebo-Controlled Period|Adverse Event|16|||
163476049|NCT02477800|590440640|FG001|Placebo-Controlled Period|Adverse Event|25|||
163476050|NCT02477800|590440641|FG002|Placebo-Controlled Period|Adverse Event|28|||
163476051|NCT02477800|590440642|FG003|Placebo-Controlled Period|Adverse Event|0|||
163476052|NCT02477800|590440643|FG004|Placebo-Controlled Period|Adverse Event|0|||
163476053|NCT02477800|590440644|FG005|Placebo-Controlled Period|Adverse Event|0|||
163476054|NCT02477800|590440645|FG006|Placebo-Controlled Period|Adverse Event|0|||
163476055|NCT02477800|590440639|FG000|Placebo-Controlled Period|Change of Treatment|1|||
163476056|NCT02477800|590440640|FG001|Placebo-Controlled Period|Change of Treatment|2|||
163476057|NCT02477800|590440641|FG002|Placebo-Controlled Period|Change of Treatment|1|||
163476058|NCT02477800|590440642|FG003|Placebo-Controlled Period|Change of Treatment|0|||
163476059|NCT02477800|590440643|FG004|Placebo-Controlled Period|Change of Treatment|0|||
163476060|NCT02477800|590440644|FG005|Placebo-Controlled Period|Change of Treatment|0|||
163476061|NCT02477800|590440645|FG006|Placebo-Controlled Period|Change of Treatment|0|||
163476062|NCT02477800|590440639|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
163476063|NCT02477800|590440640|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
163476064|NCT02477800|590440641|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
163476065|NCT02477800|590440642|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
163476066|NCT02477800|590440643|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
163476067|NCT02477800|590440644|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
163476068|NCT02477800|590440645|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
163476069|NCT02477800|590440639|FG000|Placebo-Controlled Period|Death|0|||
163476070|NCT02477800|590440640|FG001|Placebo-Controlled Period|Death|3|||
163476071|NCT02477800|590440641|FG002|Placebo-Controlled Period|Death|2|||
163476072|NCT02477800|590440642|FG003|Placebo-Controlled Period|Death|0|||
163476073|NCT02477800|590440643|FG004|Placebo-Controlled Period|Death|0|||
163476074|NCT02477800|590440644|FG005|Placebo-Controlled Period|Death|0|||
163476075|NCT02477800|590440645|FG006|Placebo-Controlled Period|Death|0|||
163476076|NCT02477800|590440639|FG000|Placebo-Controlled Period|Disease Progression|1|||
163476077|NCT02477800|590440640|FG001|Placebo-Controlled Period|Disease Progression|0|||
163476078|NCT02477800|590440641|FG002|Placebo-Controlled Period|Disease Progression|1|||
163476079|NCT02477800|590440642|FG003|Placebo-Controlled Period|Disease Progression|0|||
163476080|NCT02477800|590440643|FG004|Placebo-Controlled Period|Disease Progression|0|||
163476081|NCT02477800|590440644|FG005|Placebo-Controlled Period|Disease Progression|0|||
163476082|NCT02477800|590440645|FG006|Placebo-Controlled Period|Disease Progression|0|||
163476083|NCT02477800|590440639|FG000|Placebo-Controlled Period|Investigator Decision|3|||
163476084|NCT02477800|590440640|FG001|Placebo-Controlled Period|Investigator Decision|2|||
163476085|NCT02477800|590440641|FG002|Placebo-Controlled Period|Investigator Decision|1|||
163476086|NCT02477800|590440642|FG003|Placebo-Controlled Period|Investigator Decision|0|||
163476087|NCT02477800|590440643|FG004|Placebo-Controlled Period|Investigator Decision|0|||
163476088|NCT02477800|590440644|FG005|Placebo-Controlled Period|Investigator Decision|0|||
163476089|NCT02477800|590440645|FG006|Placebo-Controlled Period|Investigator Decision|0|||
163476090|NCT02477800|590440639|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
163476091|NCT02477800|590440640|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
163476092|NCT02477800|590440641|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
163476093|NCT02477800|590440642|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
163476094|NCT02477800|590440643|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
163476095|NCT02477800|590440644|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
163476096|NCT02477800|590440645|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
163476097|NCT02477800|590440639|FG000|Placebo-Controlled Period|Relocation|2|||
163476098|NCT02477800|590440640|FG001|Placebo-Controlled Period|Relocation|0|||
163476099|NCT02477800|590440641|FG002|Placebo-Controlled Period|Relocation|0|||
163476100|NCT02477800|590440642|FG003|Placebo-Controlled Period|Relocation|0|||
163476101|NCT02477800|590440643|FG004|Placebo-Controlled Period|Relocation|0|||
163476102|NCT02477800|590440644|FG005|Placebo-Controlled Period|Relocation|0|||
163476103|NCT02477800|590440645|FG006|Placebo-Controlled Period|Relocation|0|||
163476104|NCT02477800|590440639|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
163476105|NCT02477800|590440640|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
163476106|NCT02477800|590440641|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
163476107|NCT02477800|590440642|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
163476108|NCT02477800|590440643|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
163476109|NCT02477800|590440644|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
163476110|NCT02477800|590440645|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
163476111|NCT02477800|590440639|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
163476112|NCT02477800|590440640|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
163476113|NCT02477800|590440641|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
163476114|NCT02477800|590440642|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
163476115|NCT02477800|590440643|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
163476116|NCT02477800|590440644|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
163476117|NCT02477800|590440645|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
163476118|NCT02477800|590440639|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
163476119|NCT02477800|590440640|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
163476120|NCT02477800|590440641|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
163476121|NCT02477800|590440642|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
163476122|NCT02477800|590440643|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
163476123|NCT02477800|590440644|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
163476124|NCT02477800|590440645|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
163476125|NCT02477800|590440639|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
163476126|NCT02477800|590440640|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
163476127|NCT02477800|590440641|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
163476128|NCT02477800|590440642|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
163476129|NCT02477800|590440643|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
163476130|NCT02477800|590440644|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
163476131|NCT02477800|590440645|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
163476132|NCT02477800|590440639|FG000|Placebo-Controlled Period|Reason not Specified|161|||
163476133|NCT02477800|590440640|FG001|Placebo-Controlled Period|Reason not Specified|161|||
163476134|NCT02477800|590440641|FG002|Placebo-Controlled Period|Reason not Specified|189|||
163476135|NCT02477800|590440642|FG003|Placebo-Controlled Period|Reason not Specified|0|||
163476136|NCT02477800|590440643|FG004|Placebo-Controlled Period|Reason not Specified|0|||
163476137|NCT02477800|590440644|FG005|Placebo-Controlled Period|Reason not Specified|0|||
163476138|NCT02477800|590440645|FG006|Placebo-Controlled Period|Reason not Specified|0|||
163476139|NCT02477800|590440639|FG000|Long Term Extension Period|Adverse Event|0|||
163476140|NCT02477800|590440640|FG001|Long Term Extension Period|Adverse Event|0|||
163476141|NCT02477800|590440641|FG002|Long Term Extension Period|Adverse Event|0|||
163476142|NCT02477800|590440642|FG003|Long Term Extension Period|Adverse Event|6|||
163476143|NCT02477800|590440643|FG004|Long Term Extension Period|Adverse Event|2|||
163476144|NCT02477800|590440644|FG005|Long Term Extension Period|Adverse Event|4|||
163476145|NCT02477800|590440645|FG006|Long Term Extension Period|Adverse Event|3|||
163476146|NCT02477800|590440639|FG000|Long Term Extension Period|Death|0|||
163476147|NCT02477800|590440640|FG001|Long Term Extension Period|Death|0|||
163476148|NCT02477800|590440641|FG002|Long Term Extension Period|Death|0|||
163476149|NCT02477800|590440642|FG003|Long Term Extension Period|Death|1|||
163476150|NCT02477800|590440643|FG004|Long Term Extension Period|Death|1|||
163476151|NCT02477800|590440644|FG005|Long Term Extension Period|Death|1|||
163476152|NCT02477800|590440645|FG006|Long Term Extension Period|Death|2|||
163476153|NCT02477800|590440639|FG000|Long Term Extension Period|Consent Withdrawn|0|||
163476154|NCT02477800|590440640|FG001|Long Term Extension Period|Consent Withdrawn|0|||
163476155|NCT02477800|590440641|FG002|Long Term Extension Period|Consent Withdrawn|0|||
163476156|NCT02477800|590440642|FG003|Long Term Extension Period|Consent Withdrawn|10|||
163476157|NCT02477800|590440643|FG004|Long Term Extension Period|Consent Withdrawn|4|||
163476158|NCT02477800|590440644|FG005|Long Term Extension Period|Consent Withdrawn|13|||
163476159|NCT02477800|590440645|FG006|Long Term Extension Period|Consent Withdrawn|16|||
163476160|NCT02477800|590440639|FG000|Long Term Extension Period|Disease Progression|0|||
163476161|NCT02477800|590440640|FG001|Long Term Extension Period|Disease Progression|0|||
163476162|NCT02477800|590440641|FG002|Long Term Extension Period|Disease Progression|0|||
163476163|NCT02477800|590440642|FG003|Long Term Extension Period|Disease Progression|3|||
163476164|NCT02477800|590440643|FG004|Long Term Extension Period|Disease Progression|1|||
163476165|NCT02477800|590440644|FG005|Long Term Extension Period|Disease Progression|1|||
163476166|NCT02477800|590440645|FG006|Long Term Extension Period|Disease Progression|0|||
163476167|NCT02477800|590440639|FG000|Long Term Extension Period|Investigator Decision|0|||
163476168|NCT02477800|590440640|FG001|Long Term Extension Period|Investigator Decision|0|||
163476169|NCT02477800|590440641|FG002|Long Term Extension Period|Investigator Decision|0|||
163476170|NCT02477800|590440642|FG003|Long Term Extension Period|Investigator Decision|0|||
163476171|NCT02477800|590440643|FG004|Long Term Extension Period|Investigator Decision|0|||
163476172|NCT02477800|590440644|FG005|Long Term Extension Period|Investigator Decision|0|||
163476173|NCT02477800|590440645|FG006|Long Term Extension Period|Investigator Decision|2|||
163476174|NCT02477800|590440639|FG000|Long Term Extension Period|Lost to Follow-up|0|||
163476175|NCT02477800|590440640|FG001|Long Term Extension Period|Lost to Follow-up|0|||
163476176|NCT02477800|590440641|FG002|Long Term Extension Period|Lost to Follow-up|0|||
163476177|NCT02477800|590440642|FG003|Long Term Extension Period|Lost to Follow-up|0|||
163476178|NCT02477800|590440643|FG004|Long Term Extension Period|Lost to Follow-up|1|||
163476179|NCT02477800|590440644|FG005|Long Term Extension Period|Lost to Follow-up|3|||
163476180|NCT02477800|590440645|FG006|Long Term Extension Period|Lost to Follow-up|0|||
163476181|NCT02477800|590440639|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
163476182|NCT02477800|590440640|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
163476183|NCT02477800|590440641|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
163476184|NCT02477800|590440642|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
163476185|NCT02477800|590440643|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
163476186|NCT02477800|590440644|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
163476187|NCT02477800|590440645|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
163476188|NCT02477800|590440639|FG000|Long Term Extension Period|Study Visit Burden|0|||
163476189|NCT02477800|590440640|FG001|Long Term Extension Period|Study Visit Burden|0|||
163476190|NCT02477800|590440641|FG002|Long Term Extension Period|Study Visit Burden|0|||
163476191|NCT02477800|590440642|FG003|Long Term Extension Period|Study Visit Burden|3|||
163476192|NCT02477800|590440643|FG004|Long Term Extension Period|Study Visit Burden|0|||
163476193|NCT02477800|590440644|FG005|Long Term Extension Period|Study Visit Burden|2|||
163476194|NCT02477800|590440645|FG006|Long Term Extension Period|Study Visit Burden|2|||
163476195|NCT02477800|590440639|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
163476196|NCT02477800|590440640|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
163476197|NCT02477800|590440641|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
163476198|NCT02477800|590440642|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
163476199|NCT02477800|590440643|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
163476200|NCT02477800|590440644|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
163476201|NCT02477800|590440645|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
163476202|NCT02477800|590440639|FG000|Long Term Extension Period|Reason not Specified|0|||
163476203|NCT02477800|590440640|FG001|Long Term Extension Period|Reason not Specified|0|||
163476204|NCT02477800|590440641|FG002|Long Term Extension Period|Reason not Specified|0|||
163476205|NCT02477800|590440642|FG003|Long Term Extension Period|Reason not Specified|126|||
163476206|NCT02477800|590440643|FG004|Long Term Extension Period|Reason not Specified|140|||
163476207|NCT02477800|590440644|FG005|Long Term Extension Period|Reason not Specified|270|||
163476208|NCT02477800|590440645|FG006|Long Term Extension Period|Reason not Specified|224|||
163476209|NCT00423592|590440647|FG000|Overall Study|Adverse Event (through Week 12)|2|||
163476210|NCT00423592|590440647|FG000|Overall Study|Adverse Event (post Week 12)|5|||
163476211|NCT00062647|590440648|FG000|Overall Study|Death|2|||
163476212|NCT00062647|590440649|FG001|Overall Study|Death|2|||
163476213|NCT00062647|590440648|FG000|Overall Study|Adverse Event|1|||
163476214|NCT00062647|590440649|FG001|Overall Study|Adverse Event|1|||
163476215|NCT00062647|590440648|FG000|Overall Study|Withdrawal by Subject|2|||
163476216|NCT00062647|590440649|FG001|Overall Study|Withdrawal by Subject|1|||
163476217|NCT00062647|590440648|FG000|Overall Study|Protocol Violation|1|||
163476218|NCT00062647|590440649|FG001|Overall Study|Protocol Violation|0|||
163476219|NCT00062647|590440648|FG000|Overall Study|Lost to Follow-up|1|||
163476220|NCT00062647|590440649|FG001|Overall Study|Lost to Follow-up|2|||
163476221|NCT00062647|590440648|FG000|Overall Study|Failed continuation criteria|4|||
163476222|NCT00062647|590440649|FG001|Overall Study|Failed continuation criteria|2|||
163476223|NCT00062647|590440648|FG000|Overall Study|Other|4|||
163476224|NCT00062647|590440649|FG001|Overall Study|Other|4|||
163476225|NCT00062647|590440648|FG000|Overall Study|Never received study treatment|1|||
163476226|NCT00062647|590440649|FG001|Overall Study|Never received study treatment|1|||
163476227|NCT00002981|590440652|FG000|Overall Study|Inevaluable|6|||
163476228|NCT00255008|590440653|FG000|Overall Study|Adverse Event|1|||
163476229|NCT00255008|590440654|FG001|Overall Study|Adverse Event|1|||
163476230|NCT00255008|590440655|FG002|Overall Study|Adverse Event|2|||
163476231|NCT00255008|590440656|FG003|Overall Study|Adverse Event|0|||
163476232|NCT00255008|590440653|FG000|Overall Study|Lost to Follow-up|1|||
163476233|NCT00255008|590440654|FG001|Overall Study|Lost to Follow-up|0|||
163476234|NCT00255008|590440655|FG002|Overall Study|Lost to Follow-up|1|||
163476235|NCT00255008|590440656|FG003|Overall Study|Lost to Follow-up|2|||
163476236|NCT00255008|590440653|FG000|Overall Study|Did not meet viral reduction criteria|4|||
163476237|NCT00255008|590440654|FG001|Overall Study|Did not meet viral reduction criteria|5|||
163476238|NCT00255008|590440655|FG002|Overall Study|Did not meet viral reduction criteria|0|||
163476239|NCT00255008|590440656|FG003|Overall Study|Did not meet viral reduction criteria|1|||
163476240|NCT00255008|590440653|FG000|Overall Study|Withdrew consent|0|||
163476241|NCT00255008|590440654|FG001|Overall Study|Withdrew consent|0|||
163476242|NCT00255008|590440655|FG002|Overall Study|Withdrew consent|2|||
163476243|NCT00255008|590440656|FG003|Overall Study|Withdrew consent|0|||
163476244|NCT00255008|590440653|FG000|Overall Study|Sponsor request|18|||
163476245|NCT00255008|590440654|FG001|Overall Study|Sponsor request|3|||
163476246|NCT00255008|590440655|FG002|Overall Study|Sponsor request|8|||
163476247|NCT00255008|590440656|FG003|Overall Study|Sponsor request|17|||
163476248|NCT00255008|590440653|FG000|Overall Study|Adverse lab experience|1|||
163476249|NCT00255008|590440654|FG001|Overall Study|Adverse lab experience|0|||
163476250|NCT00255008|590440655|FG002|Overall Study|Adverse lab experience|0|||
163476251|NCT00255008|590440656|FG003|Overall Study|Adverse lab experience|0|||
163476252|NCT00255008|590440653|FG000|Overall Study|Other|7|||
163476253|NCT00255008|590440654|FG001|Overall Study|Other|0|||
163476254|NCT00255008|590440655|FG002|Overall Study|Other|3|||
163476255|NCT00255008|590440656|FG003|Overall Study|Other|2|||
163476256|NCT00322387|590440661|FG000|Treatment Period|Adverse Event|0|||
163476257|NCT00322387|590440662|FG001|Treatment Period|Adverse Event|1|||
163476258|NCT00322387|590440661|FG000|Follow-up Period|Final assessment not done|1|||
163476259|NCT00322387|590440662|FG001|Follow-up Period|Final assessment not done|3|||
163476260|NCT00322387|590440661|FG000|Follow-up Period|Death|1|||
163476261|NCT00322387|590440662|FG001|Follow-up Period|Death|0|||
163476262|NCT02415595|590440665|FG000|Overall Study|Administrative reason by sponsor|39|||
163476263|NCT02415595|590440666|FG001|Overall Study|Administrative reason by sponsor|40|||
163476264|NCT02415595|590440667|FG002|Overall Study|Administrative reason by sponsor|41|||
163476265|NCT02415595|590440668|FG003|Overall Study|Administrative reason by sponsor|39|||
163476266|NCT02415595|590440665|FG000|Overall Study|Adverse Event|1|||
163476267|NCT02415595|590440666|FG001|Overall Study|Adverse Event|3|||
163476268|NCT02415595|590440667|FG002|Overall Study|Adverse Event|5|||
163476269|NCT02415595|590440668|FG003|Overall Study|Adverse Event|10|||
163476270|NCT02415595|590440665|FG000|Overall Study|Lack of Efficacy|4|||
163476271|NCT02415595|590440666|FG001|Overall Study|Lack of Efficacy|4|||
163476272|NCT02415595|590440667|FG002|Overall Study|Lack of Efficacy|0|||
163476273|NCT02415595|590440668|FG003|Overall Study|Lack of Efficacy|0|||
163476274|NCT02415595|590440665|FG000|Overall Study|Lost to Follow-up|1|||
163476275|NCT02415595|590440666|FG001|Overall Study|Lost to Follow-up|3|||
163476276|NCT02415595|590440667|FG002|Overall Study|Lost to Follow-up|1|||
163476277|NCT02415595|590440668|FG003|Overall Study|Lost to Follow-up|1|||
163476278|NCT02415595|590440665|FG000|Overall Study|Poor/Non-compliance|1|||
163476279|NCT02415595|590440666|FG001|Overall Study|Poor/Non-compliance|0|||
163476280|NCT02415595|590440667|FG002|Overall Study|Poor/Non-compliance|1|||
163476281|NCT02415595|590440668|FG003|Overall Study|Poor/Non-compliance|0|||
163476282|NCT02415595|590440665|FG000|Overall Study|Reached stopping criteria|0|||
163476283|NCT02415595|590440666|FG001|Overall Study|Reached stopping criteria|1|||
163476284|NCT02415595|590440667|FG002|Overall Study|Reached stopping criteria|1|||
163476285|NCT02415595|590440668|FG003|Overall Study|Reached stopping criteria|0|||
163476286|NCT02415595|590440665|FG000|Overall Study|Withdrawal by Subject|4|||
163476287|NCT02415595|590440666|FG001|Overall Study|Withdrawal by Subject|0|||
163476288|NCT02415595|590440667|FG002|Overall Study|Withdrawal by Subject|1|||
163476289|NCT02415595|590440668|FG003|Overall Study|Withdrawal by Subject|3|||
163476290|NCT02415595|590440665|FG000|Overall Study|Other|0|||
163476291|NCT02415595|590440666|FG001|Overall Study|Other|1|||
163476292|NCT02415595|590440667|FG002|Overall Study|Other|1|||
163476293|NCT02415595|590440668|FG003|Overall Study|Other|0|||
163476294|NCT01682759|590440676|FG000|Overall Study|Death|2|||
163476295|NCT01682759|590440677|FG001|Overall Study|Death|1|||
163476296|NCT01682759|590440676|FG000|Overall Study|Lost to Follow-up|10|||
163476297|NCT01682759|590440677|FG001|Overall Study|Lost to Follow-up|13|||
163476298|NCT01682759|590440676|FG000|Overall Study|Physician Decision|1|||
163476299|NCT01682759|590440677|FG001|Overall Study|Physician Decision|1|||
163476300|NCT01682759|590440676|FG000|Overall Study|Withdrawal by Subject|56|||
163476301|NCT01682759|590440677|FG001|Overall Study|Withdrawal by Subject|55|||
163476302|NCT01855919|590442106|FG000|Overall Study|Adverse Event|16|||
163476303|NCT01855919|590442107|FG001|Overall Study|Adverse Event|8|||
163476304|NCT01855919|590442106|FG000|Overall Study|Lack of Efficacy|1|||
163476305|NCT01855919|590442107|FG001|Overall Study|Lack of Efficacy|3|||
163476306|NCT01855919|590442106|FG000|Overall Study|Withdrawal by Subject|4|||
163476307|NCT01855919|590442107|FG001|Overall Study|Withdrawal by Subject|10|||
163476308|NCT01855919|590442106|FG000|Overall Study|Entry Criteria Not Met|1|||
163476309|NCT01855919|590442107|FG001|Overall Study|Entry Criteria Not Met|1|||
163476310|NCT01855919|590442106|FG000|Overall Study|Protocol Violation|1|||
163476311|NCT01855919|590442107|FG001|Overall Study|Protocol Violation|4|||
163476312|NCT00908895|590442110|FG000|Overall Study|Lost to Follow-up|1|||
163476313|NCT00908895|590442111|FG001|Overall Study|Lost to Follow-up|3|||
163476314|NCT00908895|590442110|FG000|Overall Study|algodystrophy|2|||
163476315|NCT00908895|590442111|FG001|Overall Study|algodystrophy|2|||
163476316|NCT00908895|590442110|FG000|Overall Study|Adverse Event|1|||
163476317|NCT00908895|590442111|FG001|Overall Study|Adverse Event|1|||
163476318|NCT02059174|590442137|FG000|Period 1|Withdrawal by Subject|0|||
163476319|NCT02059174|590442138|FG001|Period 1|Withdrawal by Subject|2|||
163476320|NCT02059174|590442137|FG000|Period 2|Withdrawal by Subject|0|||
163476321|NCT02059174|590442138|FG001|Period 2|Withdrawal by Subject|2|||
163476322|NCT02059174|590442137|FG000|Period 2|Protocol Violation|1|||
163476323|NCT02059174|590442138|FG001|Period 2|Protocol Violation|0|||
163476324|NCT02059174|590442137|FG000|Period 3|Physician Decision|1|||
163476325|NCT02059174|590442138|FG001|Period 3|Physician Decision|0|||
163476326|NCT00768040|590442139|FG000|Overall Study|Adverse Event|3|||
163476327|NCT00768040|590442140|FG001|Overall Study|Adverse Event|2|||
163476328|NCT00768040|590442139|FG000|Overall Study|Abnormal laboratory value|1|||
163476329|NCT00768040|590442140|FG001|Overall Study|Abnormal laboratory value|1|||
163476330|NCT02511106|590442145|FG000|Overall Study|Lost to Follow-up|6|||
163476331|NCT02511106|590442146|FG001|Overall Study|Lost to Follow-up|4|||
163476332|NCT02511106|590442145|FG000|Overall Study|Withdrawal by Subject|24|||
163476333|NCT02511106|590442146|FG001|Overall Study|Withdrawal by Subject|21|||
163476334|NCT02511106|590442145|FG000|Overall Study|Death|42|||
163476335|NCT02511106|590442146|FG001|Overall Study|Death|82|||
163476336|NCT02511106|590442145|FG000|Overall Study|Ongoing study at data cut-off|3|||
163476337|NCT02511106|590442146|FG001|Overall Study|Ongoing study at data cut-off|2|||
163476338|NCT02511106|590442145|FG000|Overall Study|Without specified reason|3|||
163476339|NCT02511106|590442146|FG001|Overall Study|Without specified reason|0|||
163476340|NCT01222767|590442149|FG000|Overall Study|Progressive disease|13|||
163476341|NCT01222767|590442149|FG000|Overall Study|Adverse Event|2|||
163476342|NCT01222767|590442149|FG000|Overall Study|Surgical resection|1|||
163476343|NCT01222767|590442149|FG000|Overall Study|Never treated|1|||
163476344|NCT02773849|590442150|FG000|Overall Study|Lost to Follow-up|11|||
163476345|NCT02773849|590442150|FG000|Overall Study|Death|26|||
163476346|NCT02773849|590442150|FG000|Overall Study|Withdrawal by Subject|5|||
163476347|NCT02773849|590442150|FG000|Overall Study|Withdrawal of Consent|9|||
163476348|NCT02773849|590442150|FG000|Overall Study|Other: not due to lack of tolerability|11|||
163476349|NCT00723489|590442151|FG000|Overall Study|Physician Decision|0|||
163476350|NCT00723489|590442152|FG001|Overall Study|Physician Decision|1|||
163476351|NCT00723489|590442153|FG002|Overall Study|Physician Decision|0|||
163476352|NCT00723489|590442154|FG003|Overall Study|Physician Decision|0|||
163476353|NCT00723489|590442151|FG000|Overall Study|Pregnancy|0|||
163476354|NCT00723489|590442152|FG001|Overall Study|Pregnancy|0|||
163476355|NCT00723489|590442153|FG002|Overall Study|Pregnancy|0|||
163476356|NCT00723489|590442154|FG003|Overall Study|Pregnancy|1|||
163476357|NCT00723489|590442151|FG000|Overall Study|Withdrawal by Subject|0|||
163476358|NCT00723489|590442152|FG001|Overall Study|Withdrawal by Subject|0|||
163476359|NCT00723489|590442153|FG002|Overall Study|Withdrawal by Subject|0|||
163476360|NCT00723489|590442154|FG003|Overall Study|Withdrawal by Subject|1|||
163476361|NCT00723489|590442151|FG000|Overall Study|Seropositive at baseline|1|||
163476362|NCT00723489|590442152|FG001|Overall Study|Seropositive at baseline|0|||
163476363|NCT00723489|590442153|FG002|Overall Study|Seropositive at baseline|0|||
163476364|NCT00723489|590442154|FG003|Overall Study|Seropositive at baseline|0|||
163476365|NCT00723489|590442151|FG000|Overall Study|Prohibited Medication|0|||
163476366|NCT00723489|590442152|FG001|Overall Study|Prohibited Medication|0|||
163476367|NCT00723489|590442153|FG002|Overall Study|Prohibited Medication|0|||
163476368|NCT00723489|590442154|FG003|Overall Study|Prohibited Medication|1|||
163476369|NCT00723489|590442151|FG000|Overall Study|Samples Collected Out of Window|0|||
163476370|NCT00723489|590442152|FG001|Overall Study|Samples Collected Out of Window|3|||
163476371|NCT00723489|590442153|FG002|Overall Study|Samples Collected Out of Window|0|||
163476372|NCT00723489|590442154|FG003|Overall Study|Samples Collected Out of Window|0|||
163476373|NCT02274311|590442161|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
163476374|NCT00508001|590442162|FG000|Overall Study|Adverse Event|2|||
163476375|NCT00508001|590442163|FG001|Overall Study|Adverse Event|0|||
163476376|NCT00508001|590442164|FG002|Overall Study|Adverse Event|4|||
163476377|NCT00508001|590442162|FG000|Overall Study|condition under investigation worsened|13|||
163476378|NCT00508001|590442163|FG001|Overall Study|condition under investigation worsened|7|||
163476379|NCT00508001|590442164|FG002|Overall Study|condition under investigation worsened|1|||
163476380|NCT00508001|590442162|FG000|Overall Study|Death|0|||
163476381|NCT00508001|590442163|FG001|Overall Study|Death|1|||
163476382|NCT00508001|590442164|FG002|Overall Study|Death|1|||
163476383|NCT00508001|590442162|FG000|Overall Study|Withdrawal by Subject|4|||
163476384|NCT00508001|590442163|FG001|Overall Study|Withdrawal by Subject|4|||
163476385|NCT00508001|590442164|FG002|Overall Study|Withdrawal by Subject|1|||
163476386|NCT01685372|590442165|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
163476387|NCT01685372|590442166|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
163476388|NCT01626859|590442167|FG000|Overall Study|Adverse Event|1|||
163476389|NCT01626859|590442168|FG001|Overall Study|Adverse Event|3|||
163476390|NCT01626859|590442169|FG002|Overall Study|Adverse Event|2|||
163476391|NCT01626859|590442167|FG000|Overall Study|Physician Decision|0|||
163476392|NCT01626859|590442168|FG001|Overall Study|Physician Decision|1|||
163476393|NCT01626859|590442169|FG002|Overall Study|Physician Decision|0|||
163476394|NCT01626859|590442167|FG000|Overall Study|Withdrawal by Subject|1|||
163476395|NCT01626859|590442168|FG001|Overall Study|Withdrawal by Subject|4|||
163476396|NCT01626859|590442169|FG002|Overall Study|Withdrawal by Subject|2|||
163476397|NCT00638989|590442175|FG000|Overall Study|Lost to Follow-up|0|||
163476398|NCT00638989|590442176|FG001|Overall Study|Lost to Follow-up|0|||
163476399|NCT00638989|590442177|FG002|Overall Study|Lost to Follow-up|1|||
163476400|NCT01969565|590442181|FG000|Overall Study|Withdrawal by Subject|1|||
163476401|NCT00832091|590442182|FG000|Overall Study|Adverse Event|1|||
163476402|NCT00832091|590442183|FG001|Overall Study|Adverse Event|1|||
163476403|NCT00832091|590442182|FG000|Overall Study|Protocol Violation|1|||
163476404|NCT00832091|590442183|FG001|Overall Study|Protocol Violation|0|||
163476405|NCT00832091|590442182|FG000|Overall Study|Withdrawal by Subject|2|||
163476406|NCT00832091|590442183|FG001|Overall Study|Withdrawal by Subject|1|||
163476407|NCT00832091|590442182|FG000|Overall Study|Prohibited Medication|1|||
163476408|NCT00832091|590442183|FG001|Overall Study|Prohibited Medication|0|||
163476409|NCT02087241|590442185|FG000|Overall Study|Death|2|||
163476410|NCT02087241|590442186|FG001|Overall Study|Death|1|||
163476411|NCT02087241|590442187|FG002|Overall Study|Death|1|||
163476412|NCT02087241|590442188|FG003|Overall Study|Death|1|||
163476413|NCT02087241|590442185|FG000|Overall Study|Withdrawal by Subject|1|||
163476414|NCT02087241|590442186|FG001|Overall Study|Withdrawal by Subject|0|||
163476415|NCT02087241|590442187|FG002|Overall Study|Withdrawal by Subject|0|||
163476416|NCT02087241|590442188|FG003|Overall Study|Withdrawal by Subject|1|||
163476417|NCT02087241|590442185|FG000|Overall Study|Progressive Disease|0|||
163476418|NCT02087241|590442186|FG001|Overall Study|Progressive Disease|0|||
163476419|NCT02087241|590442187|FG002|Overall Study|Progressive Disease|0|||
163476420|NCT02087241|590442188|FG003|Overall Study|Progressive Disease|1|||
163476421|NCT02087241|590442185|FG000|Overall Study|Study Terminated by Sponsor|0|||
163476422|NCT02087241|590442186|FG001|Overall Study|Study Terminated by Sponsor|2|||
163476423|NCT02087241|590442187|FG002|Overall Study|Study Terminated by Sponsor|0|||
163476424|NCT02087241|590442188|FG003|Overall Study|Study Terminated by Sponsor|4|||
163476425|NCT01955005|590442189|FG000|Overall Study|Withdrawal by Subject|3|||
163476426|NCT01955005|590442190|FG001|Overall Study|Withdrawal by Subject|5|||
163476427|NCT00836953|590442191|FG000|Overall Study|Withdrawal by Subject|1|||
163476428|NCT00836953|590442191|FG000|Overall Study|Lost to Follow-up|1|||
163476429|NCT02943668|590442192|FG000|Overall Study|Disease Progression|1|||
163476430|NCT01200758|590442193|FG000|Stage I|Death|0|||
163476431|NCT01200758|590442194|FG001|Stage I|Death|1|||
163476432|NCT01200758|590442195|FG002|Stage I|Death|0|||
163476433|NCT01200758|590442196|FG003|Stage I|Death|0|||
163476434|NCT01200758|590442193|FG000|Stage I|Physician Decision|1|||
163476435|NCT01200758|590442194|FG001|Stage I|Physician Decision|1|||
163476436|NCT01200758|590442195|FG002|Stage I|Physician Decision|0|||
163476437|NCT01200758|590442196|FG003|Stage I|Physician Decision|0|||
163476438|NCT01200758|590442193|FG000|Stage I|Lack of Efficacy|2|||
163476439|NCT01200758|590442194|FG001|Stage I|Lack of Efficacy|1|||
163476440|NCT01200758|590442195|FG002|Stage I|Lack of Efficacy|0|||
163476441|NCT01200758|590442196|FG003|Stage I|Lack of Efficacy|0|||
163476442|NCT01200758|590442193|FG000|Stage I|Adverse Event|5|||
163476443|NCT01200758|590442194|FG001|Stage I|Adverse Event|5|||
163476444|NCT01200758|590442195|FG002|Stage I|Adverse Event|0|||
163476445|NCT01200758|590442196|FG003|Stage I|Adverse Event|0|||
163476446|NCT01200758|590442193|FG000|Stage I|Withdrawal by Subject|1|||
163476447|NCT01200758|590442194|FG001|Stage I|Withdrawal by Subject|2|||
163476448|NCT01200758|590442195|FG002|Stage I|Withdrawal by Subject|0|||
163476449|NCT01200758|590442196|FG003|Stage I|Withdrawal by Subject|0|||
163476450|NCT01200758|590442193|FG000|Stage I|Disease Progression|9|||
163476451|NCT01200758|590442194|FG001|Stage I|Disease Progression|7|||
163476452|NCT01200758|590442195|FG002|Stage I|Disease Progression|0|||
163476453|NCT01200758|590442196|FG003|Stage I|Disease Progression|0|||
163476454|NCT01200758|590442193|FG000|Stage 2|Disease Progression|0|||
163476455|NCT01200758|590442194|FG001|Stage 2|Disease Progression|0|||
163476456|NCT01200758|590442195|FG002|Stage 2|Disease Progression|16|||
163476457|NCT01200758|590442196|FG003|Stage 2|Disease Progression|21|||
163476458|NCT01200758|590442193|FG000|Stage 2|Lack of Efficacy|0|||
163476459|NCT01200758|590442194|FG001|Stage 2|Lack of Efficacy|0|||
163476460|NCT01200758|590442195|FG002|Stage 2|Lack of Efficacy|4|||
163476461|NCT01200758|590442196|FG003|Stage 2|Lack of Efficacy|2|||
163476462|NCT01200758|590442193|FG000|Stage 2|Physician Decision|0|||
163476463|NCT01200758|590442194|FG001|Stage 2|Physician Decision|0|||
163476464|NCT01200758|590442195|FG002|Stage 2|Physician Decision|5|||
163476465|NCT01200758|590442196|FG003|Stage 2|Physician Decision|7|||
163476466|NCT01200758|590442193|FG000|Stage 2|Adverse Event|0|||
163476467|NCT01200758|590442194|FG001|Stage 2|Adverse Event|0|||
163476468|NCT01200758|590442195|FG002|Stage 2|Adverse Event|5|||
163476469|NCT01200758|590442196|FG003|Stage 2|Adverse Event|9|||
163476470|NCT01200758|590442193|FG000|Stage 2|Withdrawal by Subject|0|||
163476471|NCT01200758|590442194|FG001|Stage 2|Withdrawal by Subject|0|||
163476472|NCT01200758|590442195|FG002|Stage 2|Withdrawal by Subject|4|||
163476473|NCT01200758|590442196|FG003|Stage 2|Withdrawal by Subject|1|||
163476474|NCT01200758|590442193|FG000|Stage 2|Lost to Follow-up|0|||
163476475|NCT01200758|590442194|FG001|Stage 2|Lost to Follow-up|0|||
163476476|NCT01200758|590442195|FG002|Stage 2|Lost to Follow-up|3|||
163476477|NCT01200758|590442196|FG003|Stage 2|Lost to Follow-up|1|||
163476478|NCT01200758|590442193|FG000|Stage 2|Protocol Violation|0|||
163476479|NCT01200758|590442194|FG001|Stage 2|Protocol Violation|0|||
163476480|NCT01200758|590442195|FG002|Stage 2|Protocol Violation|1|||
163476481|NCT01200758|590442196|FG003|Stage 2|Protocol Violation|4|||
163476482|NCT01200758|590442193|FG000|Stage 2|Death|0|||
163476483|NCT01200758|590442194|FG001|Stage 2|Death|0|||
163476484|NCT01200758|590442195|FG002|Stage 2|Death|3|||
163476485|NCT01200758|590442196|FG003|Stage 2|Death|5|||
163476486|NCT04048876|590442197|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
163476487|NCT04048876|590442198|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
163476488|NCT04048876|590442199|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
163476489|NCT04048876|590442200|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
163476490|NCT04048876|590442197|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
163476491|NCT04048876|590442198|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
163476492|NCT04048876|590442199|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
163476493|NCT04048876|590442200|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
163476494|NCT04048876|590442197|FG000|Placebo Controlled Phase|Adverse Event|0|||
163476495|NCT04048876|590442198|FG001|Placebo Controlled Phase|Adverse Event|1|||
163476496|NCT04048876|590442199|FG002|Placebo Controlled Phase|Adverse Event|0|||
163476497|NCT04048876|590442200|FG003|Placebo Controlled Phase|Adverse Event|0|||
163476498|NCT04048876|590442197|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
163476499|NCT04048876|590442198|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
163476500|NCT04048876|590442199|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
163476501|NCT04048876|590442200|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
163476502|NCT01828567|590442201|FG000|Overall Study|Lost to Follow-up|27|||
163476503|NCT01828567|590442202|FG001|Overall Study|Lost to Follow-up|9|||
163476504|NCT01828567|590442201|FG000|Overall Study|Excluded - did not meet criteria|4|||
163476505|NCT01828567|590442202|FG001|Overall Study|Excluded - did not meet criteria|1|||
163476506|NCT03325010|590442211|FG000|Overall Study|Adverse Event|3|||
163476507|NCT03325010|590442212|FG001|Overall Study|Adverse Event|8|||
163476508|NCT03325010|590442211|FG000|Overall Study|Protocol Violation|1|||
163476509|NCT03325010|590442212|FG001|Overall Study|Protocol Violation|8|||
163476510|NCT03325010|590442211|FG000|Overall Study|Withdrawal by Subject|1|||
163476511|NCT03325010|590442212|FG001|Overall Study|Withdrawal by Subject|3|||
163476512|NCT03325010|590442211|FG000|Overall Study|Lost to Follow-up|1|||
163476513|NCT03325010|590442212|FG001|Overall Study|Lost to Follow-up|0|||
163476514|NCT03325010|590442211|FG000|Overall Study|Physician Decision|1|||
163476515|NCT03325010|590442212|FG001|Overall Study|Physician Decision|1|||
163476516|NCT03325010|590442211|FG000|Overall Study|Lack of Efficacy|2|||
163476517|NCT03325010|590442212|FG001|Overall Study|Lack of Efficacy|0|||
163476518|NCT02614261|590442213|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
163476519|NCT02614261|590442214|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
163476520|NCT02614261|590442215|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
163476521|NCT02614261|590442216|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
163476522|NCT02614261|590442213|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
163476523|NCT02614261|590442214|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
163476524|NCT02614261|590442215|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
163476525|NCT02614261|590442216|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
163476526|NCT02614261|590442213|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
163476527|NCT02614261|590442214|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
163476528|NCT02614261|590442215|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
163476529|NCT02614261|590442216|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
163476530|NCT02614261|590442213|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
163476531|NCT02614261|590442214|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
163476532|NCT02614261|590442215|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
163476533|NCT02614261|590442216|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
163476534|NCT02614261|590442213|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
163476535|NCT02614261|590442214|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
163476536|NCT02614261|590442215|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
163476537|NCT02614261|590442216|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
163476538|NCT02614261|590442213|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
163476539|NCT02614261|590442214|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
163476540|NCT02614261|590442215|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
163476541|NCT02614261|590442216|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
163476542|NCT02614261|590442213|FG000|Double-Blind Treatment Phase|Screen failure|0|||
163476543|NCT02614261|590442214|FG001|Double-Blind Treatment Phase|Screen failure|1|||
163476544|NCT02614261|590442215|FG002|Double-Blind Treatment Phase|Screen failure|2|||
163476545|NCT02614261|590442216|FG003|Double-Blind Treatment Phase|Screen failure|0|||
163476546|NCT02614261|590442213|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
163476547|NCT02614261|590442214|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
163476548|NCT02614261|590442215|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
163476549|NCT02614261|590442216|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
163476550|NCT02614261|590442213|FG000|Open-Label Extension Phase|Adverse Event|23|||
163476551|NCT02614261|590442214|FG001|Open-Label Extension Phase|Adverse Event|12|||
163476552|NCT02614261|590442215|FG002|Open-Label Extension Phase|Adverse Event|11|||
163476553|NCT02614261|590442216|FG003|Open-Label Extension Phase|Adverse Event|0|||
163476554|NCT02614261|590442213|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
163476555|NCT02614261|590442214|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
163476556|NCT02614261|590442215|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
163476557|NCT02614261|590442216|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
163476558|NCT02614261|590442213|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
163476559|NCT02614261|590442214|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
163476560|NCT02614261|590442215|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
163476561|NCT02614261|590442216|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
163476562|NCT02614261|590442213|FG000|Open-Label Extension Phase|Physician Decision|2|||
163476563|NCT02614261|590442214|FG001|Open-Label Extension Phase|Physician Decision|0|||
163476564|NCT02614261|590442215|FG002|Open-Label Extension Phase|Physician Decision|0|||
163476565|NCT02614261|590442216|FG003|Open-Label Extension Phase|Physician Decision|0|||
163476566|NCT02614261|590442213|FG000|Open-Label Extension Phase|Pregnancy|1|||
163476567|NCT02614261|590442214|FG001|Open-Label Extension Phase|Pregnancy|2|||
163476568|NCT02614261|590442215|FG002|Open-Label Extension Phase|Pregnancy|1|||
163476569|NCT02614261|590442216|FG003|Open-Label Extension Phase|Pregnancy|0|||
163476570|NCT02614261|590442213|FG000|Open-Label Extension Phase|Protocol Violation|3|||
163476571|NCT02614261|590442214|FG001|Open-Label Extension Phase|Protocol Violation|4|||
163476572|NCT02614261|590442215|FG002|Open-Label Extension Phase|Protocol Violation|1|||
163476573|NCT02614261|590442216|FG003|Open-Label Extension Phase|Protocol Violation|0|||
163476574|NCT02614261|590442213|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
163476575|NCT02614261|590442214|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
163476576|NCT02614261|590442215|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
163476577|NCT02614261|590442216|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
163476578|NCT02614261|590442213|FG000|Follow-up Phase|Adverse Event|2|||
163476579|NCT02614261|590442214|FG001|Follow-up Phase|Adverse Event|0|||
163476580|NCT02614261|590442215|FG002|Follow-up Phase|Adverse Event|1|||
163476581|NCT02614261|590442216|FG003|Follow-up Phase|Adverse Event|0|||
163476582|NCT02614261|590442213|FG000|Follow-up Phase|Lost to Follow-up|12|||
163476583|NCT02614261|590442214|FG001|Follow-up Phase|Lost to Follow-up|5|||
163476584|NCT02614261|590442215|FG002|Follow-up Phase|Lost to Follow-up|2|||
163476585|NCT02614261|590442216|FG003|Follow-up Phase|Lost to Follow-up|0|||
163476586|NCT02614261|590442213|FG000|Follow-up Phase|Physician Decision|5|||
163476587|NCT02614261|590442214|FG001|Follow-up Phase|Physician Decision|1|||
163476588|NCT02614261|590442215|FG002|Follow-up Phase|Physician Decision|0|||
163476589|NCT02614261|590442216|FG003|Follow-up Phase|Physician Decision|0|||
163476590|NCT02614261|590442213|FG000|Follow-up Phase|Pregnancy|0|||
163476591|NCT02614261|590442214|FG001|Follow-up Phase|Pregnancy|1|||
163476592|NCT02614261|590442215|FG002|Follow-up Phase|Pregnancy|0|||
163476593|NCT02614261|590442216|FG003|Follow-up Phase|Pregnancy|0|||
163476594|NCT02614261|590442213|FG000|Follow-up Phase|Protocol Violation|1|||
163476595|NCT02614261|590442214|FG001|Follow-up Phase|Protocol Violation|0|||
163476596|NCT02614261|590442215|FG002|Follow-up Phase|Protocol Violation|0|||
163476597|NCT02614261|590442216|FG003|Follow-up Phase|Protocol Violation|0|||
163476598|NCT02614261|590442213|FG000|Follow-up Phase|Withdrawal by Subject|12|||
163476599|NCT02614261|590442214|FG001|Follow-up Phase|Withdrawal by Subject|4|||
163476600|NCT02614261|590442215|FG002|Follow-up Phase|Withdrawal by Subject|11|||
163476601|NCT02614261|590442216|FG003|Follow-up Phase|Withdrawal by Subject|0|||
163476602|NCT02614261|590442213|FG000|Israel Addendum|Withdrawal by Subject|0|||
163476603|NCT02614261|590442214|FG001|Israel Addendum|Withdrawal by Subject|0|||
163476604|NCT02614261|590442215|FG002|Israel Addendum|Withdrawal by Subject|0|||
163476605|NCT02614261|590442216|FG003|Israel Addendum|Withdrawal by Subject|4|||
163476606|NCT04350372|590442220|FG000|Overall Study|Death|1|||
163476607|NCT03512275|590442223|FG000|Overall Study|Withdrawal by Subject|1|||
163476608|NCT03512275|590442224|FG001|Overall Study|Withdrawal by Subject|3|||
163476609|NCT03512275|590442223|FG000|Overall Study|Physician Decision|0|||
163476610|NCT03512275|590442224|FG001|Overall Study|Physician Decision|1|||
163476611|NCT03512275|590442223|FG000|Overall Study|Lost to Follow-up|0|||
163476612|NCT03512275|590442224|FG001|Overall Study|Lost to Follow-up|3|||
163476613|NCT03512275|590442223|FG000|Overall Study|Other|1|||
163476614|NCT03512275|590442224|FG001|Overall Study|Other|0|||
163476615|NCT00113555|590442225|FG000|Overall Study|Baseline Failure|59|||
163476616|NCT00113555|590442225|FG000|Overall Study|Permanently Explanted|7|||
163476617|NCT00113555|590442225|FG000|Overall Study|Death|1|||
163476618|NCT00113555|590442225|FG000|Overall Study|Missed Followup|4|||
163476619|NCT00113555|590442225|FG000|Overall Study|Lost to Follow-up|8|||
163476620|NCT04474366|590442226|FG000|Overall Study|Lost to Follow-up|2|||
163476621|NCT04474366|590442227|FG001|Overall Study|Lost to Follow-up|5|||
163476622|NCT04063865|590442228|FG000|Overall Study|Physician Decision|1|||
163476623|NCT04063865|590442229|FG001|Overall Study|Physician Decision|3|||
163476624|NCT04063865|590442228|FG000|Overall Study|Study Closed Prior to Completion|4|||
163476625|NCT04063865|590442229|FG001|Overall Study|Study Closed Prior to Completion|4|||
163476626|NCT04063865|590442228|FG000|Overall Study|Withdrawal by Subject|1|||
163476627|NCT04063865|590442229|FG001|Overall Study|Withdrawal by Subject|1|||
163476628|NCT00320190|590442230|FG000|First 12 Months|Completed but did not enter extension|5|||
163476629|NCT00320190|590442231|FG001|First 12 Months|Completed but did not enter extension|3|||
163476630|NCT00320190|590442230|FG000|First 12 Months|Sponsor terminated study|2|||
163476631|NCT00320190|590442231|FG001|First 12 Months|Sponsor terminated study|2|||
163476632|NCT00320190|590442230|FG000|First 12 Months|Lost to Follow-up|0|||
163476633|NCT00320190|590442231|FG001|First 12 Months|Lost to Follow-up|1|||
163476634|NCT00320190|590442230|FG000|First 12 Months|Enrollment failure|0|||
163476635|NCT00320190|590442231|FG001|First 12 Months|Enrollment failure|1|||
163476636|NCT00320190|590442230|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
163476637|NCT00320190|590442231|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
163476638|NCT00320190|590442230|FG000|First 12 Months|Investigator request|0|||
163476639|NCT00320190|590442231|FG001|First 12 Months|Investigator request|1|||
163476640|NCT00320190|590442230|FG000|First 12 Months|Study drug toxicity|0|||
163476641|NCT00320190|590442231|FG001|First 12 Months|Study drug toxicity|1|||
163476642|NCT00320190|590442230|FG000|First 12 Months|Withdrawal by Subject|0|||
163476643|NCT00320190|590442231|FG001|First 12 Months|Withdrawal by Subject|1|||
163476644|NCT00320190|590442230|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
163476645|NCT00320190|590442231|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
163476646|NCT00320190|590442230|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
163476647|NCT00320190|590442231|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
163476648|NCT00320190|590442230|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
163476649|NCT00320190|590442231|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
163476650|NCT01700140|590442232|FG000|Overall Study|Use of rescue drugs|3|||
163476651|NCT01700140|590442233|FG001|Overall Study|Use of rescue drugs|3|||
163476652|NCT01700140|590442234|FG002|Overall Study|Use of rescue drugs|1|||
163476653|NCT01700140|590442232|FG000|Overall Study|Discontinuation of radiotherapy|1|||
163476654|NCT01700140|590442233|FG001|Overall Study|Discontinuation of radiotherapy|0|||
163476655|NCT01700140|590442234|FG002|Overall Study|Discontinuation of radiotherapy|0|||
163476656|NCT01700140|590442232|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
163476657|NCT01700140|590442233|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
163476658|NCT01700140|590442234|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
163476659|NCT01700140|590442232|FG000|Overall Study|Aggravation of symptoms|1|||
163476660|NCT01700140|590442233|FG001|Overall Study|Aggravation of symptoms|0|||
163476661|NCT01700140|590442234|FG002|Overall Study|Aggravation of symptoms|0|||
163476662|NCT01700140|590442232|FG000|Overall Study|Adverse Event|0|||
163476663|NCT01700140|590442233|FG001|Overall Study|Adverse Event|1|||
163476664|NCT01700140|590442234|FG002|Overall Study|Adverse Event|0|||
163476665|NCT01700140|590442232|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
163476666|NCT01700140|590442233|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
163476667|NCT01700140|590442234|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
163476668|NCT01060124|590442235|FG000|Overall Study|Other|16|||
163476669|NCT01060124|590442235|FG000|Overall Study|Adverse Event|14|||
163476670|NCT01060124|590442235|FG000|Overall Study|Withdrawal by Subject|7|||
163476671|NCT00102804|590442238|FG000|Overall Study|Progressive Disease (PD)|307|||
163476672|NCT00102804|590442239|FG001|Overall Study|Progressive Disease (PD)|196|||
163476673|NCT00102804|590442238|FG000|Overall Study|Withdrawal by Subject|46|||
163476674|NCT00102804|590442239|FG001|Overall Study|Withdrawal by Subject|7|||
163476675|NCT00102804|590442238|FG000|Overall Study|Adverse Event|37|||
163476676|NCT00102804|590442239|FG001|Overall Study|Adverse Event|3|||
163476677|NCT00102804|590442238|FG000|Overall Study|Physician Decision|24|||
163476678|NCT00102804|590442239|FG001|Overall Study|Physician Decision|6|||
163476679|NCT00102804|590442238|FG000|Overall Study|Death|5|||
163476680|NCT00102804|590442239|FG001|Overall Study|Death|6|||
163476681|NCT00102804|590442238|FG000|Overall Study|Enrollment Criteria Not Met|6|||
163476682|NCT00102804|590442239|FG001|Overall Study|Enrollment Criteria Not Met|0|||
163476683|NCT00102804|590442238|FG000|Overall Study|Lost to Follow-up|4|||
163476684|NCT00102804|590442239|FG001|Overall Study|Lost to Follow-up|1|||
163476685|NCT00102804|590442238|FG000|Overall Study|Protocol Violation|2|||
163476686|NCT00102804|590442239|FG001|Overall Study|Protocol Violation|1|||
163476687|NCT00102804|590442238|FG000|Overall Study|Satisfactory Response|2|||
163476688|NCT00102804|590442239|FG001|Overall Study|Satisfactory Response|0|||
163476689|NCT00102804|590442238|FG000|Overall Study|Sponsor Decision|1|||
163476690|NCT00102804|590442239|FG001|Overall Study|Sponsor Decision|0|||
163476691|NCT00102804|590442238|FG000|Overall Study|Alive, Receiving Treatment|7|||
163476692|NCT00102804|590442239|FG001|Overall Study|Alive, Receiving Treatment|2|||
163476693|NCT02299206|590442246|FG000|Overall Study|Lost to Follow-up|1|||
163476694|NCT02299206|590442246|FG000|Overall Study|Withdrawal by Subject|1|||
163476695|NCT00691054|590442247|FG000|Overall Study|Withdrawal by Subject|1|||
163476696|NCT00518336|590442248|FG000|Year 7|Lost to Follow-up|2|||
163476697|NCT00518336|590442249|FG001|Year 7|Lost to Follow-up|0|||
163476698|NCT00518336|590442248|FG000|Year 7|Could not attend in time|0|||
163476699|NCT00518336|590442249|FG001|Year 7|Could not attend in time|3|||
163476700|NCT00518336|590442248|FG000|Year 8|Lost to Follow-up|1|||
163476701|NCT00518336|590442249|FG001|Year 8|Lost to Follow-up|1|||
163476702|NCT00518336|590442248|FG000|Year 8|Could not attend in time|0|||
163476703|NCT00518336|590442249|FG001|Year 8|Could not attend in time|1|||
163476704|NCT00518336|590442248|FG000|Year 9|Migrated/moved from study area|1|||
163476705|NCT00518336|590442249|FG001|Year 9|Migrated/moved from study area|1|||
163476706|NCT00518336|590442248|FG000|Year 9|Lost to Follow-up|3|||
163476707|NCT00518336|590442249|FG001|Year 9|Lost to Follow-up|0|||
163476708|NCT00518336|590442248|FG000|Year 9|Personal reasons|1|||
163476709|NCT00518336|590442249|FG001|Year 9|Personal reasons|0|||
163476710|NCT03074318|590442252|FG000|Overall Study|Adverse Event|0|||
163476711|NCT03074318|590442253|FG001|Overall Study|Adverse Event|1|||
163476712|NCT03074318|590442254|FG002|Overall Study|Adverse Event|1|||
163476713|NCT03074318|590442255|FG003|Overall Study|Adverse Event|1|||
163476714|NCT03074318|590442252|FG000|Overall Study|Death|1|||
163476715|NCT03074318|590442253|FG001|Overall Study|Death|0|||
163476716|NCT03074318|590442254|FG002|Overall Study|Death|0|||
163476717|NCT03074318|590442255|FG003|Overall Study|Death|0|||
163476718|NCT03074318|590442252|FG000|Overall Study|Withdrawal by Subject|1|||
163476719|NCT03074318|590442253|FG001|Overall Study|Withdrawal by Subject|2|||
163476720|NCT03074318|590442254|FG002|Overall Study|Withdrawal by Subject|2|||
163476721|NCT03074318|590442255|FG003|Overall Study|Withdrawal by Subject|4|||
163476722|NCT03074318|590442252|FG000|Overall Study|Trial Closure|2|||
163476723|NCT03074318|590442253|FG001|Overall Study|Trial Closure|2|||
163476724|NCT03074318|590442254|FG002|Overall Study|Trial Closure|3|||
163476725|NCT03074318|590442255|FG003|Overall Study|Trial Closure|11|||
163476726|NCT01625897|590443481|FG000|Overall Study|Adverse Event|27|||
163476727|NCT01625897|590443482|FG001|Overall Study|Adverse Event|10|||
163476728|NCT01625897|590443481|FG000|Overall Study|Physician Decision|0|||
163476729|NCT01625897|590443482|FG001|Overall Study|Physician Decision|1|||
163476730|NCT01625897|590443481|FG000|Overall Study|Withdrawal by Subject|25|||
163476731|NCT01625897|590443482|FG001|Overall Study|Withdrawal by Subject|3|||
163476732|NCT03455530|590443483|FG000|Overall Study|Withdrawal by Subject|9|||
163476733|NCT03455530|590443484|FG001|Overall Study|Withdrawal by Subject|1|||
163476734|NCT03455530|590443485|FG002|Overall Study|Withdrawal by Subject|3|||
163476735|NCT03455530|590443486|FG003|Overall Study|Withdrawal by Subject|3|||
163476736|NCT02314637|590443489|FG000|Overall Study|Adverse Event|4|||
163476737|NCT02314637|590443490|FG001|Overall Study|Adverse Event|8|||
163476738|NCT02314637|590443489|FG000|Overall Study|Lack of Efficacy|1|||
163476739|NCT02314637|590443490|FG001|Overall Study|Lack of Efficacy|0|||
163476740|NCT02314637|590443489|FG000|Overall Study|Physician Decision|5|||
163476741|NCT02314637|590443490|FG001|Overall Study|Physician Decision|2|||
163476742|NCT02314637|590443489|FG000|Overall Study|Withdrawal by Subject|5|||
163476743|NCT02314637|590443490|FG001|Overall Study|Withdrawal by Subject|4|||
163476744|NCT02314637|590443489|FG000|Overall Study|Other Reason|1|||
163476745|NCT02314637|590443490|FG001|Overall Study|Other Reason|0|||
163476746|NCT00686699|590443492|FG000|Treatment Period 1|Adverse Event|0|||
163476747|NCT00686699|590443493|FG001|Treatment Period 1|Adverse Event|2|||
163476748|NCT00033514|590443495|FG000|Overall Study|Lost to Follow-up|1|||
163476749|NCT00033514|590443496|FG001|Overall Study|Lost to Follow-up|1|||
163476750|NCT00033514|590443495|FG000|Overall Study|Withdrawal by Subject|0|||
163476751|NCT00033514|590443496|FG001|Overall Study|Withdrawal by Subject|3|||
163476752|NCT04221945|590443499|FG000|Overall Study|Death|103|||
163476753|NCT04221945|590443500|FG001|Overall Study|Death|140|||
163476754|NCT04221945|590443499|FG000|Overall Study|Lost to Follow-up|5|||
163476755|NCT04221945|590443500|FG001|Overall Study|Lost to Follow-up|8|||
163476756|NCT04221945|590443499|FG000|Overall Study|Withdrawal by Subject|21|||
163476757|NCT04221945|590443500|FG001|Overall Study|Withdrawal by Subject|11|||
163476758|NCT04221945|590443499|FG000|Overall Study|Participants Ongoing|400|||
163476759|NCT04221945|590443500|FG001|Overall Study|Participants Ongoing|372|||
163476760|NCT00974090|590443502|FG000|Period 1: Double Blind Period|Adverse Event|2|||
163476761|NCT00974090|590443503|FG001|Period 1: Double Blind Period|Adverse Event|1|||
163476762|NCT00974090|590443502|FG000|Period 1: Double Blind Period|Physician Decision|1|||
163476763|NCT00974090|590443503|FG001|Period 1: Double Blind Period|Physician Decision|0|||
163476764|NCT00974090|590443502|FG000|Period 2: Open-label Period|Adverse Event|4|||
163476765|NCT00974090|590443503|FG001|Period 2: Open-label Period|Adverse Event|6|||
163476766|NCT00974090|590443502|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
163476767|NCT00974090|590443503|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
163476768|NCT00974090|590443502|FG000|Period 2: Open-label Period|Physician Decision|0|||
163476769|NCT00974090|590443503|FG001|Period 2: Open-label Period|Physician Decision|3|||
163476770|NCT00974090|590443502|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
163476771|NCT00974090|590443503|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
163476772|NCT01626872|590443504|FG000|Overall Study|Physician Decision|13|||
163476773|NCT01626872|590443505|FG001|Overall Study|Physician Decision|9|||
163476774|NCT01626872|590443506|FG002|Overall Study|Physician Decision|6|||
163476775|NCT01626872|590443504|FG000|Overall Study|Withdrawal by Subject|19|||
163476776|NCT01626872|590443505|FG001|Overall Study|Withdrawal by Subject|27|||
163476777|NCT01626872|590443506|FG002|Overall Study|Withdrawal by Subject|8|||
163476778|NCT01626872|590443504|FG000|Overall Study|Adverse Event (including Death)|20|||
163476779|NCT01626872|590443505|FG001|Overall Study|Adverse Event (including Death)|28|||
163476780|NCT01626872|590443506|FG002|Overall Study|Adverse Event (including Death)|8|||
163476781|NCT01626872|590443504|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
163476782|NCT01626872|590443505|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
163476783|NCT01626872|590443506|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
163476784|NCT05626751|590443507|FG000|Overall Study|Lost to Follow-up|1|||
163476785|NCT05626751|590443508|FG001|Overall Study|Lost to Follow-up|2|||
163476786|NCT05626751|590443509|FG002|Overall Study|Lost to Follow-up|1|||
163476787|NCT05626751|590443507|FG000|Overall Study|Trial Terminated by Sponsor|39|||
163476788|NCT05626751|590443508|FG001|Overall Study|Trial Terminated by Sponsor|30|||
163476789|NCT05626751|590443509|FG002|Overall Study|Trial Terminated by Sponsor|37|||
163476790|NCT05626751|590443507|FG000|Overall Study|Withdrawal by Subject|7|||
163476791|NCT05626751|590443508|FG001|Overall Study|Withdrawal by Subject|5|||
163476792|NCT05626751|590443509|FG002|Overall Study|Withdrawal by Subject|5|||
163476793|NCT01625000|590443510|FG000|Overall Study|Physician Decision|15|||
163476794|NCT01625000|590443511|FG001|Overall Study|Physician Decision|7|||
163476795|NCT01625000|590443512|FG002|Overall Study|Physician Decision|7|||
163476796|NCT01625000|590443513|FG003|Overall Study|Physician Decision|2|||
163476797|NCT01625000|590443514|FG004|Overall Study|Physician Decision|15|||
163476798|NCT01625000|590443510|FG000|Overall Study|Protocol Violation|3|||
163476799|NCT01625000|590443511|FG001|Overall Study|Protocol Violation|10|||
163476800|NCT01625000|590443512|FG002|Overall Study|Protocol Violation|4|||
163476801|NCT01625000|590443513|FG003|Overall Study|Protocol Violation|1|||
163476802|NCT01625000|590443514|FG004|Overall Study|Protocol Violation|2|||
163476803|NCT01625000|590443510|FG000|Overall Study|Withdrawal by Subject|19|||
163476804|NCT01625000|590443511|FG001|Overall Study|Withdrawal by Subject|16|||
163476805|NCT01625000|590443512|FG002|Overall Study|Withdrawal by Subject|11|||
163476806|NCT01625000|590443513|FG003|Overall Study|Withdrawal by Subject|9|||
163476807|NCT01625000|590443514|FG004|Overall Study|Withdrawal by Subject|17|||
163476808|NCT01625000|590443510|FG000|Overall Study|Adverse Event (including Death)|15|||
163476809|NCT01625000|590443511|FG001|Overall Study|Adverse Event (including Death)|19|||
163476810|NCT01625000|590443512|FG002|Overall Study|Adverse Event (including Death)|11|||
163476811|NCT01625000|590443513|FG003|Overall Study|Adverse Event (including Death)|7|||
163476812|NCT01625000|590443514|FG004|Overall Study|Adverse Event (including Death)|21|||
163476813|NCT03912064|590443515|FG000|Overall Study|Withdrawal by Subject|2|||
163476814|NCT03912064|590443516|FG001|Overall Study|Withdrawal by Subject|0|||
163476815|NCT03912064|590443517|FG002|Overall Study|Withdrawal by Subject|0|||
163476816|NCT03912064|590443515|FG000|Overall Study|Adverse reaction to Ipilimumab|2|||
163476817|NCT03912064|590443516|FG001|Overall Study|Adverse reaction to Ipilimumab|0|||
163476818|NCT03912064|590443517|FG002|Overall Study|Adverse reaction to Ipilimumab|1|||
163476819|NCT03912064|590443515|FG000|Overall Study|Progression/Relapse|7|||
163476820|NCT03912064|590443516|FG001|Overall Study|Progression/Relapse|3|||
163476821|NCT03912064|590443517|FG002|Overall Study|Progression/Relapse|0|||
163476822|NCT03912064|590443515|FG000|Overall Study|Prolonged treatment delays|3|||
163476823|NCT03912064|590443516|FG001|Overall Study|Prolonged treatment delays|2|||
163476824|NCT03912064|590443517|FG002|Overall Study|Prolonged treatment delays|0|||
163476825|NCT03912064|590443515|FG000|Overall Study|Prohibited concomitant treatments|3|||
163476826|NCT03912064|590443516|FG001|Overall Study|Prohibited concomitant treatments|1|||
163476827|NCT03912064|590443517|FG002|Overall Study|Prohibited concomitant treatments|0|||
163476828|NCT01026194|590443518|FG000|Period 1：Double Blind Period|Adverse Event|2|||
163476829|NCT01026194|590443519|FG001|Period 1：Double Blind Period|Adverse Event|1|||
163476830|NCT01026194|590443518|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
163476831|NCT01026194|590443519|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
163476832|NCT01026194|590443518|FG000|Period 1：Double Blind Period|Physician Decision|0|||
163476833|NCT01026194|590443519|FG001|Period 1：Double Blind Period|Physician Decision|4|||
163476834|NCT01026194|590443518|FG000|Period 2：Open-label Period|Adverse Event|4|||
163476835|NCT01026194|590443519|FG001|Period 2：Open-label Period|Adverse Event|5|||
163476836|NCT01026194|590443518|FG000|Period 2：Open-label Period|Physician Decision|3|||
163476837|NCT01026194|590443519|FG001|Period 2：Open-label Period|Physician Decision|1|||
163476838|NCT01026194|590443518|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
163476839|NCT01026194|590443519|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
163476840|NCT04295759|590443520|FG000|Overall Study|Lack of Efficacy|9|||
163476841|NCT04295759|590443520|FG000|Overall Study|Death|1|||
163476842|NCT04295759|590443520|FG000|Overall Study|Withdrawal by Subject|2|||
163476843|NCT04295759|590443520|FG000|Overall Study|Deemed ineligible|1|||
163476844|NCT05740566|590443521|FG000|Overall Study|Death|151|||
163476845|NCT05740566|590443522|FG001|Overall Study|Death|111|||
163476846|NCT05740566|590443521|FG000|Overall Study|Withdrawal by Subject|2|||
163476847|NCT05740566|590443522|FG001|Overall Study|Withdrawal by Subject|0|||
163476848|NCT05740566|590443521|FG000|Overall Study|Ongoing in study|102|||
163476849|NCT05740566|590443522|FG001|Overall Study|Ongoing in study|143|||
163476850|NCT00829010|590443525|FG000|Overall Study|Adverse Event|1|||
163476851|NCT00829010|590443526|FG001|Overall Study|Adverse Event|0|||
163476852|NCT00829010|590443527|FG002|Overall Study|Adverse Event|0|||
163476853|NCT00829010|590443528|FG003|Overall Study|Adverse Event|0|||
163476854|NCT00829010|590443529|FG004|Overall Study|Adverse Event|0|||
163476855|NCT00829010|590443525|FG000|Overall Study|Withdrawal by Subject|0|||
163476856|NCT00829010|590443526|FG001|Overall Study|Withdrawal by Subject|1|||
163476857|NCT00829010|590443527|FG002|Overall Study|Withdrawal by Subject|1|||
163476858|NCT00829010|590443528|FG003|Overall Study|Withdrawal by Subject|0|||
163476859|NCT00829010|590443529|FG004|Overall Study|Withdrawal by Subject|2|||
163476860|NCT00829010|590443525|FG000|Overall Study|Lost to Follow-up|1|||
163476861|NCT00829010|590443526|FG001|Overall Study|Lost to Follow-up|0|||
163476862|NCT00829010|590443527|FG002|Overall Study|Lost to Follow-up|2|||
163476863|NCT00829010|590443528|FG003|Overall Study|Lost to Follow-up|0|||
163476864|NCT00829010|590443529|FG004|Overall Study|Lost to Follow-up|0|||
163476865|NCT00829010|590443525|FG000|Overall Study|Fatality|5|||
163476866|NCT00829010|590443526|FG001|Overall Study|Fatality|4|||
163476867|NCT00829010|590443527|FG002|Overall Study|Fatality|0|||
163476868|NCT00829010|590443528|FG003|Overall Study|Fatality|3|||
163476869|NCT00829010|590443529|FG004|Overall Study|Fatality|0|||
163476870|NCT00829010|590443525|FG000|Overall Study|Migrated/Moved from study area|3|||
163476871|NCT00829010|590443526|FG001|Overall Study|Migrated/Moved from study area|4|||
163476872|NCT00829010|590443527|FG002|Overall Study|Migrated/Moved from study area|0|||
163476873|NCT00829010|590443528|FG003|Overall Study|Migrated/Moved from study area|5|||
163476874|NCT00829010|590443529|FG004|Overall Study|Migrated/Moved from study area|0|||
163476875|NCT06210035|590443530|FG000|Overall Study|Withdrawal by Subject|3|||
163476876|NCT06210035|590443531|FG001|Overall Study|Withdrawal by Subject|0|||
163476877|NCT06210035|590443532|FG002|Overall Study|Withdrawal by Subject|0|||
163476878|NCT01029691|590443533|FG000|Continued APAP to Delivery|Death|0|||
163476879|NCT01029691|590443534|FG001|Continued APAP to Delivery|Death|0|||
163476880|NCT01029691|590443535|FG002|Continued APAP to Delivery|Death|1|||
163476881|NCT05616221|590443540|FG000|Overall Study|Withdrawal by Subject|0|||
163476882|NCT05616221|590443541|FG001|Overall Study|Withdrawal by Subject|1|||
163476883|NCT05616221|590443542|FG002|Overall Study|Withdrawal by Subject|0|||
163476884|NCT05616221|590443543|FG003|Overall Study|Withdrawal by Subject|0|||
163476885|NCT05616221|590443544|FG004|Overall Study|Withdrawal by Subject|0|||
163476886|NCT05616221|590443545|FG005|Overall Study|Withdrawal by Subject|0|||
163476887|NCT05616221|590443540|FG000|Overall Study|Adverse Event|0|||
163476888|NCT05616221|590443541|FG001|Overall Study|Adverse Event|2|||
163476889|NCT05616221|590443542|FG002|Overall Study|Adverse Event|0|||
163476890|NCT05616221|590443543|FG003|Overall Study|Adverse Event|0|||
163476891|NCT05616221|590443544|FG004|Overall Study|Adverse Event|2|||
163476892|NCT05616221|590443545|FG005|Overall Study|Adverse Event|0|||
163476893|NCT04880733|590443546|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
163476894|NCT04880733|590443547|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
163476895|NCT04880733|590443548|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
163476896|NCT04880733|590443546|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
163476897|NCT04880733|590443547|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
163476898|NCT04880733|590443548|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
163476899|NCT04880733|590443546|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
163476900|NCT04880733|590443547|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
163476901|NCT04880733|590443548|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
163476902|NCT04880733|590443546|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
163476903|NCT04880733|590443547|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
163476904|NCT04880733|590443548|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
163476905|NCT04880733|590443546|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
163476906|NCT04880733|590443547|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
163476907|NCT04880733|590443548|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
163476908|NCT00862992|590443549|FG000|Overall Study|Adverse Event|2|||
163476909|NCT00862992|590443550|FG001|Overall Study|Adverse Event|1|||
163476910|NCT00862992|590443551|FG002|Overall Study|Adverse Event|1|||
163476911|NCT00862992|590443549|FG000|Overall Study|Physician Decision|1|||
163476912|NCT00862992|590443550|FG001|Overall Study|Physician Decision|0|||
163476913|NCT00862992|590443551|FG002|Overall Study|Physician Decision|0|||
163476914|NCT00862992|590443549|FG000|Overall Study|Withdrawal by Subject|0|||
163476915|NCT00862992|590443550|FG001|Overall Study|Withdrawal by Subject|0|||
163476916|NCT00862992|590443551|FG002|Overall Study|Withdrawal by Subject|2|||
163476917|NCT05492877|590443552|FG000|Overall Study|Adverse Event|11|||
163476918|NCT05492877|590443553|FG001|Overall Study|Adverse Event|7|||
163476919|NCT05492877|590443552|FG000|Overall Study|Death|1|||
163476920|NCT05492877|590443553|FG001|Overall Study|Death|0|||
163476921|NCT05492877|590443552|FG000|Overall Study|Lost to Follow-up|1|||
163476922|NCT05492877|590443553|FG001|Overall Study|Lost to Follow-up|1|||
163476923|NCT05492877|590443552|FG000|Overall Study|Physician Decision|1|||
163476924|NCT05492877|590443553|FG001|Overall Study|Physician Decision|2|||
163476925|NCT05492877|590443552|FG000|Overall Study|Protocol Violation|1|||
163476926|NCT05492877|590443553|FG001|Overall Study|Protocol Violation|1|||
163476927|NCT05492877|590443552|FG000|Overall Study|Withdrawal by Subject|3|||
163476928|NCT05492877|590443553|FG001|Overall Study|Withdrawal by Subject|7|||
163476929|NCT05492877|590443552|FG000|Overall Study|Reason not specified|6|||
163476930|NCT05492877|590443553|FG001|Overall Study|Reason not specified|4|||
163476931|NCT02871791|590443554|FG000|Phase 1b|Death|0|||
163476932|NCT02871791|590443555|FG001|Phase 1b|Death|1|||
163476933|NCT02871791|590443554|FG000|Phase 1b|progressive disease|6|||
163476934|NCT02871791|590443555|FG001|Phase 1b|progressive disease|2|||
163476935|NCT02871791|590443554|FG000|Phase 2|Death|1|||
163476936|NCT02871791|590443555|FG001|Phase 2|Death|0|||
163476937|NCT02871791|590443554|FG000|Phase 2|Lost to Follow-up|2|||
163476938|NCT02871791|590443555|FG001|Phase 2|Lost to Follow-up|0|||
163476939|NCT03737318|590443567|FG000|Phase 2 (Generalization)|Withdrawal by Subject|4|||
163476940|NCT03737318|590443568|FG001|Phase 2 (Generalization)|Withdrawal by Subject|1|||
163476941|NCT03737318|590443569|FG002|Phase 2 (Generalization)|Withdrawal by Subject|1|||
163476942|NCT00528840|590443573|FG000|Overall Study|Lost to Follow-up|10|||
163476943|NCT00528840|590443573|FG000|Overall Study|Adverse Event|1|||
163476944|NCT00528840|590443573|FG000|Overall Study|Withdrawal by Subject|17|||
163476945|NCT00528840|590443573|FG000|Overall Study|Death|2|||
163476946|NCT00528840|590443573|FG000|Overall Study|Administrative Reasons|1|||
163476947|NCT00528840|590443573|FG000|Overall Study|Other|2|||
163476948|NCT01603628|590443574|FG000|Overall Study|Personal Reasons|1|||
163476949|NCT01603628|590443575|FG001|Overall Study|Personal Reasons|1|||
163476950|NCT01603628|590443576|FG002|Overall Study|Personal Reasons|2|||
163476951|NCT01603628|590443574|FG000|Overall Study|Protocol Violation|1|||
163476952|NCT01603628|590443575|FG001|Overall Study|Protocol Violation|1|||
163476953|NCT01603628|590443576|FG002|Overall Study|Protocol Violation|0|||
163476954|NCT01603628|590443574|FG000|Overall Study|Lost to Follow-up|0|||
163476955|NCT01603628|590443575|FG001|Overall Study|Lost to Follow-up|1|||
163476956|NCT01603628|590443576|FG002|Overall Study|Lost to Follow-up|0|||
163476957|NCT01603628|590443574|FG000|Overall Study|Other Miscellaneous Reason|1|||
163476958|NCT01603628|590443575|FG001|Overall Study|Other Miscellaneous Reason|0|||
163476959|NCT01603628|590443576|FG002|Overall Study|Other Miscellaneous Reason|0|||
163476960|NCT02711553|590443579|FG000|Overall Study|Withdrawal by Subject|2|||
163476961|NCT02711553|590443580|FG001|Overall Study|Withdrawal by Subject|1|||
163476962|NCT02711553|590443581|FG002|Overall Study|Withdrawal by Subject|1|||
163476963|NCT02711553|590443582|FG003|Overall Study|Withdrawal by Subject|0|||
163476964|NCT02711553|590443579|FG000|Overall Study|Lost to Follow-up|3|||
163476965|NCT02711553|590443580|FG001|Overall Study|Lost to Follow-up|3|||
163476966|NCT02711553|590443581|FG002|Overall Study|Lost to Follow-up|6|||
163476967|NCT02711553|590443582|FG003|Overall Study|Lost to Follow-up|3|||
163476968|NCT02711553|590443579|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
163476969|NCT02711553|590443580|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
163476970|NCT02711553|590443581|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
163476971|NCT02711553|590443582|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
163476972|NCT03858686|590443590|FG000|Period 1|Adverse Event|1|||
163476973|NCT03858686|590443591|FG001|Period 1|Adverse Event|1|||
163476974|NCT03858686|590443590|FG000|Period 1|Lack of compliance|0|||
163476975|NCT03858686|590443591|FG001|Period 1|Lack of compliance|1|||
163476976|NCT03858686|590443590|FG000|Period 1|Adverse Event|0|||
163476977|NCT03858686|590443591|FG001|Period 1|Adverse Event|1|||
163476978|NCT03858686|590443590|FG000|Period 2|Adverse Event|0|||
163476979|NCT03858686|590443591|FG001|Period 2|Adverse Event|1|||
163476980|NCT03399786|590443595|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
163476981|NCT03399786|590443596|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
163476982|NCT03399786|590443597|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
163476983|NCT03399786|590443598|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
163476984|NCT03399786|590443595|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
163476985|NCT03399786|590443596|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
163476986|NCT03399786|590443597|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
163476987|NCT03399786|590443598|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
163476988|NCT03399786|590443595|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
163476989|NCT03399786|590443596|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
163476990|NCT03399786|590443597|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
163476991|NCT03399786|590443598|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
163476992|NCT03053180|590445345|FG000|Overall Study|Failure to Return|1|||
163476993|NCT01465958|590445350|FG000|Run-in Phase|Protocol Violation|1|||
163476994|NCT01465958|590445351|FG001|Run-in Phase|Protocol Violation|0|||
163476995|NCT01465958|590445350|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
163476996|NCT01465958|590445351|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
163476997|NCT00211536|590445359|FG000|Overall Study|Withdrawal by Subject|2|||
163476998|NCT00211536|590445360|FG001|Overall Study|Withdrawal by Subject|2|||
163476999|NCT00211536|590445359|FG000|Overall Study|Physician Decision|0|||
163477000|NCT00211536|590445360|FG001|Overall Study|Physician Decision|5|||
163477001|NCT00211536|590445359|FG000|Overall Study|Adverse Event|2|||
163477002|NCT00211536|590445360|FG001|Overall Study|Adverse Event|0|||
163477003|NCT02583399|590445361|FG000|Overall Study|Able to be discharged|3|||
163477004|NCT02583399|590445361|FG000|Overall Study|Wanted to use a restricted medication|3|||
163477005|NCT01004861|590445362|FG000|Overall Study|Disease progression|3|||
163477006|NCT01004861|590445363|FG001|Overall Study|Disease progression|4|||
163477007|NCT01004861|590445364|FG002|Overall Study|Disease progression|5|||
163477008|NCT01004861|590445365|FG003|Overall Study|Disease progression|4|||
163477009|NCT01004861|590445366|FG004|Overall Study|Disease progression|4|||
163477010|NCT01004861|590445367|FG005|Overall Study|Disease progression|4|||
163477011|NCT01004861|590445368|FG006|Overall Study|Disease progression|5|||
163477012|NCT01004861|590445369|FG007|Overall Study|Disease progression|1|||
163477013|NCT01004861|590445370|FG008|Overall Study|Disease progression|4|||
163477014|NCT01004861|590445371|FG009|Overall Study|Disease progression|7|||
163477015|NCT01004861|590445372|FG010|Overall Study|Disease progression|6|||
163477016|NCT01004861|590445373|FG011|Overall Study|Disease progression|3|||
163477017|NCT01004861|590445374|FG012|Overall Study|Disease progression|8|||
163477018|NCT01004861|590445362|FG000|Overall Study|Physician Decision|0|||
163477019|NCT01004861|590445363|FG001|Overall Study|Physician Decision|2|||
163477020|NCT01004861|590445364|FG002|Overall Study|Physician Decision|1|||
163477021|NCT01004861|590445365|FG003|Overall Study|Physician Decision|1|||
163477022|NCT01004861|590445366|FG004|Overall Study|Physician Decision|1|||
163477023|NCT01004861|590445367|FG005|Overall Study|Physician Decision|0|||
163477024|NCT01004861|590445368|FG006|Overall Study|Physician Decision|0|||
163477025|NCT01004861|590445369|FG007|Overall Study|Physician Decision|1|||
163477026|NCT01004861|590445370|FG008|Overall Study|Physician Decision|0|||
163477027|NCT01004861|590445371|FG009|Overall Study|Physician Decision|0|||
163477028|NCT01004861|590445372|FG010|Overall Study|Physician Decision|0|||
163477029|NCT01004861|590445373|FG011|Overall Study|Physician Decision|0|||
163477030|NCT01004861|590445374|FG012|Overall Study|Physician Decision|3|||
163477031|NCT01004861|590445362|FG000|Overall Study|Adverse Event|0|||
163477032|NCT01004861|590445363|FG001|Overall Study|Adverse Event|0|||
163477033|NCT01004861|590445364|FG002|Overall Study|Adverse Event|0|||
163477034|NCT01004861|590445365|FG003|Overall Study|Adverse Event|1|||
163477035|NCT01004861|590445366|FG004|Overall Study|Adverse Event|0|||
163477036|NCT01004861|590445367|FG005|Overall Study|Adverse Event|2|||
163477037|NCT01004861|590445368|FG006|Overall Study|Adverse Event|1|||
163477038|NCT01004861|590445369|FG007|Overall Study|Adverse Event|1|||
163477039|NCT01004861|590445370|FG008|Overall Study|Adverse Event|13|||
163477040|NCT01004861|590445371|FG009|Overall Study|Adverse Event|1|||
163477041|NCT01004861|590445372|FG010|Overall Study|Adverse Event|1|||
163477042|NCT01004861|590445373|FG011|Overall Study|Adverse Event|0|||
163477043|NCT01004861|590445374|FG012|Overall Study|Adverse Event|2|||
163477044|NCT01004861|590445362|FG000|Overall Study|Protocol Violation|0|||
163477045|NCT01004861|590445363|FG001|Overall Study|Protocol Violation|0|||
163477046|NCT01004861|590445364|FG002|Overall Study|Protocol Violation|0|||
163477047|NCT01004861|590445365|FG003|Overall Study|Protocol Violation|0|||
163477048|NCT01004861|590445366|FG004|Overall Study|Protocol Violation|1|||
163477049|NCT01004861|590445367|FG005|Overall Study|Protocol Violation|0|||
163477050|NCT01004861|590445368|FG006|Overall Study|Protocol Violation|0|||
163477051|NCT01004861|590445369|FG007|Overall Study|Protocol Violation|0|||
163477052|NCT01004861|590445370|FG008|Overall Study|Protocol Violation|0|||
163477053|NCT01004861|590445371|FG009|Overall Study|Protocol Violation|0|||
163477054|NCT01004861|590445372|FG010|Overall Study|Protocol Violation|0|||
163477055|NCT01004861|590445373|FG011|Overall Study|Protocol Violation|0|||
163477056|NCT01004861|590445374|FG012|Overall Study|Protocol Violation|0|||
163477057|NCT01004861|590445362|FG000|Overall Study|Lost to Follow-up|0|||
163477058|NCT01004861|590445363|FG001|Overall Study|Lost to Follow-up|0|||
163477059|NCT01004861|590445364|FG002|Overall Study|Lost to Follow-up|0|||
163477060|NCT01004861|590445365|FG003|Overall Study|Lost to Follow-up|0|||
163477061|NCT01004861|590445366|FG004|Overall Study|Lost to Follow-up|0|||
163477062|NCT01004861|590445367|FG005|Overall Study|Lost to Follow-up|0|||
163477063|NCT01004861|590445368|FG006|Overall Study|Lost to Follow-up|0|||
163477064|NCT01004861|590445369|FG007|Overall Study|Lost to Follow-up|1|||
163477065|NCT01004861|590445370|FG008|Overall Study|Lost to Follow-up|3|||
163477066|NCT01004861|590445371|FG009|Overall Study|Lost to Follow-up|0|||
163477067|NCT01004861|590445372|FG010|Overall Study|Lost to Follow-up|0|||
163477068|NCT01004861|590445373|FG011|Overall Study|Lost to Follow-up|1|||
163477069|NCT01004861|590445374|FG012|Overall Study|Lost to Follow-up|0|||
163477070|NCT01004861|590445362|FG000|Overall Study|Non-compliance|0|||
163477071|NCT01004861|590445363|FG001|Overall Study|Non-compliance|0|||
163477072|NCT01004861|590445364|FG002|Overall Study|Non-compliance|0|||
163477073|NCT01004861|590445365|FG003|Overall Study|Non-compliance|0|||
163477074|NCT01004861|590445366|FG004|Overall Study|Non-compliance|0|||
163477075|NCT01004861|590445367|FG005|Overall Study|Non-compliance|0|||
163477076|NCT01004861|590445368|FG006|Overall Study|Non-compliance|0|||
163477077|NCT01004861|590445369|FG007|Overall Study|Non-compliance|0|||
163477078|NCT01004861|590445370|FG008|Overall Study|Non-compliance|5|||
163477079|NCT01004861|590445371|FG009|Overall Study|Non-compliance|0|||
163477080|NCT01004861|590445372|FG010|Overall Study|Non-compliance|0|||
163477081|NCT01004861|590445373|FG011|Overall Study|Non-compliance|0|||
163477082|NCT01004861|590445374|FG012|Overall Study|Non-compliance|1|||
163477083|NCT01004861|590445362|FG000|Overall Study|Other|0|||
163477084|NCT01004861|590445363|FG001|Overall Study|Other|0|||
163477085|NCT01004861|590445364|FG002|Overall Study|Other|0|||
163477086|NCT01004861|590445365|FG003|Overall Study|Other|0|||
163477087|NCT01004861|590445366|FG004|Overall Study|Other|0|||
163477088|NCT01004861|590445367|FG005|Overall Study|Other|0|||
163477089|NCT01004861|590445368|FG006|Overall Study|Other|0|||
163477090|NCT01004861|590445369|FG007|Overall Study|Other|0|||
163477091|NCT01004861|590445370|FG008|Overall Study|Other|0|||
163477092|NCT01004861|590445371|FG009|Overall Study|Other|2|||
163477093|NCT01004861|590445372|FG010|Overall Study|Other|1|||
163477094|NCT01004861|590445373|FG011|Overall Study|Other|2|||
163477095|NCT01004861|590445374|FG012|Overall Study|Other|3|||
163477096|NCT01004861|590445362|FG000|Overall Study|Patient decision|0|||
163477097|NCT01004861|590445363|FG001|Overall Study|Patient decision|0|||
163477098|NCT01004861|590445364|FG002|Overall Study|Patient decision|0|||
163477099|NCT01004861|590445365|FG003|Overall Study|Patient decision|0|||
163477100|NCT01004861|590445366|FG004|Overall Study|Patient decision|1|||
163477101|NCT01004861|590445367|FG005|Overall Study|Patient decision|0|||
163477102|NCT01004861|590445368|FG006|Overall Study|Patient decision|1|||
163477103|NCT01004861|590445369|FG007|Overall Study|Patient decision|0|||
163477104|NCT01004861|590445370|FG008|Overall Study|Patient decision|7|||
163477105|NCT01004861|590445371|FG009|Overall Study|Patient decision|1|||
163477106|NCT01004861|590445372|FG010|Overall Study|Patient decision|1|||
163477107|NCT01004861|590445373|FG011|Overall Study|Patient decision|2|||
163477108|NCT01004861|590445374|FG012|Overall Study|Patient decision|3|||
163477109|NCT01004861|590445362|FG000|Overall Study|Transitioned to Phase 4 study|0|||
163477110|NCT01004861|590445363|FG001|Overall Study|Transitioned to Phase 4 study|0|||
163477111|NCT01004861|590445364|FG002|Overall Study|Transitioned to Phase 4 study|0|||
163477112|NCT01004861|590445365|FG003|Overall Study|Transitioned to Phase 4 study|0|||
163477113|NCT01004861|590445366|FG004|Overall Study|Transitioned to Phase 4 study|0|||
163477114|NCT01004861|590445367|FG005|Overall Study|Transitioned to Phase 4 study|0|||
163477115|NCT01004861|590445368|FG006|Overall Study|Transitioned to Phase 4 study|0|||
163477116|NCT01004861|590445369|FG007|Overall Study|Transitioned to Phase 4 study|0|||
163477117|NCT01004861|590445370|FG008|Overall Study|Transitioned to Phase 4 study|2|||
163477118|NCT01004861|590445371|FG009|Overall Study|Transitioned to Phase 4 study|0|||
163477119|NCT01004861|590445372|FG010|Overall Study|Transitioned to Phase 4 study|0|||
163477120|NCT01004861|590445373|FG011|Overall Study|Transitioned to Phase 4 study|0|||
163477121|NCT01004861|590445374|FG012|Overall Study|Transitioned to Phase 4 study|0|||
163477122|NCT01004861|590445362|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
163477123|NCT01004861|590445363|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
163477124|NCT01004861|590445364|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
163477125|NCT01004861|590445365|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
163477126|NCT01004861|590445366|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
163477127|NCT01004861|590445367|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
163477128|NCT01004861|590445368|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
163477129|NCT01004861|590445369|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
163477130|NCT01004861|590445370|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
163477131|NCT01004861|590445371|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
163477132|NCT01004861|590445372|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
163477133|NCT01004861|590445373|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
163477134|NCT01004861|590445374|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
163477135|NCT01004861|590445362|FG000|Overall Study|Patient withdrew|0|||
163477136|NCT01004861|590445363|FG001|Overall Study|Patient withdrew|0|||
163477137|NCT01004861|590445364|FG002|Overall Study|Patient withdrew|0|||
163477138|NCT01004861|590445365|FG003|Overall Study|Patient withdrew|0|||
163477139|NCT01004861|590445366|FG004|Overall Study|Patient withdrew|0|||
163477140|NCT01004861|590445367|FG005|Overall Study|Patient withdrew|0|||
163477141|NCT01004861|590445368|FG006|Overall Study|Patient withdrew|0|||
163477142|NCT01004861|590445369|FG007|Overall Study|Patient withdrew|0|||
163477143|NCT01004861|590445370|FG008|Overall Study|Patient withdrew|1|||
163477144|NCT01004861|590445371|FG009|Overall Study|Patient withdrew|0|||
163477145|NCT01004861|590445372|FG010|Overall Study|Patient withdrew|0|||
163477146|NCT01004861|590445373|FG011|Overall Study|Patient withdrew|0|||
163477147|NCT01004861|590445374|FG012|Overall Study|Patient withdrew|0|||
163477148|NCT01004861|590445362|FG000|Overall Study|Surgical resection|0|||
163477149|NCT01004861|590445363|FG001|Overall Study|Surgical resection|0|||
163477150|NCT01004861|590445364|FG002|Overall Study|Surgical resection|0|||
163477151|NCT01004861|590445365|FG003|Overall Study|Surgical resection|0|||
163477152|NCT01004861|590445366|FG004|Overall Study|Surgical resection|0|||
163477153|NCT01004861|590445367|FG005|Overall Study|Surgical resection|0|||
163477154|NCT01004861|590445368|FG006|Overall Study|Surgical resection|0|||
163477155|NCT01004861|590445369|FG007|Overall Study|Surgical resection|0|||
163477156|NCT01004861|590445370|FG008|Overall Study|Surgical resection|1|||
163477157|NCT01004861|590445371|FG009|Overall Study|Surgical resection|0|||
163477158|NCT01004861|590445372|FG010|Overall Study|Surgical resection|0|||
163477159|NCT01004861|590445373|FG011|Overall Study|Surgical resection|0|||
163477160|NCT01004861|590445374|FG012|Overall Study|Surgical resection|0|||
163477161|NCT01004861|590445362|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
163477162|NCT01004861|590445363|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
163477163|NCT01004861|590445364|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
163477164|NCT01004861|590445365|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
163477165|NCT01004861|590445366|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
163477166|NCT01004861|590445367|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
163477167|NCT01004861|590445368|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
163477168|NCT01004861|590445369|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
163477169|NCT01004861|590445370|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
163477170|NCT01004861|590445371|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
163477171|NCT01004861|590445372|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
163477172|NCT01004861|590445373|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
163477173|NCT01004861|590445374|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
163477174|NCT01004861|590445362|FG000|Overall Study|Study termination by Sponsor|0|||
163477175|NCT01004861|590445363|FG001|Overall Study|Study termination by Sponsor|0|||
163477176|NCT01004861|590445364|FG002|Overall Study|Study termination by Sponsor|0|||
163477177|NCT01004861|590445365|FG003|Overall Study|Study termination by Sponsor|0|||
163477178|NCT01004861|590445366|FG004|Overall Study|Study termination by Sponsor|0|||
163477179|NCT01004861|590445367|FG005|Overall Study|Study termination by Sponsor|0|||
163477180|NCT01004861|590445368|FG006|Overall Study|Study termination by Sponsor|0|||
163477181|NCT01004861|590445369|FG007|Overall Study|Study termination by Sponsor|0|||
163477182|NCT01004861|590445370|FG008|Overall Study|Study termination by Sponsor|1|||
163477183|NCT01004861|590445371|FG009|Overall Study|Study termination by Sponsor|0|||
163477184|NCT01004861|590445372|FG010|Overall Study|Study termination by Sponsor|0|||
163477185|NCT01004861|590445373|FG011|Overall Study|Study termination by Sponsor|0|||
163477186|NCT01004861|590445374|FG012|Overall Study|Study termination by Sponsor|0|||
163477187|NCT04610827|590445376|FG000|Overall Study|Withdrawal by Subject|1|||
163477188|NCT04610827|590445377|FG001|Overall Study|Withdrawal by Subject|1|||
163477189|NCT04610827|590445378|FG002|Overall Study|Withdrawal by Subject|0|||
163477190|NCT01823991|590445379|FG000|Overall Study|Withdrawal by Subject|8|||
163477191|NCT01823991|590445380|FG001|Overall Study|Withdrawal by Subject|5|||
163477192|NCT00805194|590445381|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
163477193|NCT00805194|590445382|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
163477194|NCT00805194|590445381|FG000|Overall Study|Worsening or AE of underlying disease|64|||
163477195|NCT00805194|590445382|FG001|Overall Study|Worsening or AE of underlying disease|70|||
163477196|NCT00805194|590445381|FG000|Overall Study|Other AE|84|||
163477197|NCT00805194|590445382|FG001|Overall Study|Other AE|73|||
163477198|NCT00805194|590445381|FG000|Overall Study|Protocol Violation|9|||
163477199|NCT00805194|590445382|FG001|Overall Study|Protocol Violation|9|||
163477200|NCT00805194|590445381|FG000|Overall Study|Lost to Follow-up|5|||
163477201|NCT00805194|590445382|FG001|Overall Study|Lost to Follow-up|5|||
163477202|NCT00805194|590445381|FG000|Overall Study|Withdrawal by Subject|60|||
163477203|NCT00805194|590445382|FG001|Overall Study|Withdrawal by Subject|42|||
163477204|NCT00805194|590445381|FG000|Overall Study|Not treated|3|||
163477205|NCT00805194|590445382|FG001|Overall Study|Not treated|4|||
163477206|NCT00805194|590445381|FG000|Overall Study|Reasons other than stated above|20|||
163477207|NCT00805194|590445382|FG001|Overall Study|Reasons other than stated above|16|||
163477208|NCT02185040|590445386|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
163477209|NCT02185040|590445387|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
163477210|NCT02185040|590445388|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
163477211|NCT02185040|590445389|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
163477212|NCT02185040|590445390|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
163477213|NCT02185040|590445391|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
163477214|NCT02185040|590445392|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
163477215|NCT02185040|590445386|FG000|Part 1 Treatment Phase|Adverse Event|1|||
163477216|NCT02185040|590445387|FG001|Part 1 Treatment Phase|Adverse Event|0|||
163477217|NCT02185040|590445388|FG002|Part 1 Treatment Phase|Adverse Event|0|||
163477218|NCT02185040|590445389|FG003|Part 1 Treatment Phase|Adverse Event|2|||
163477219|NCT02185040|590445390|FG004|Part 1 Treatment Phase|Adverse Event|3|||
163477220|NCT02185040|590445391|FG005|Part 1 Treatment Phase|Adverse Event|0|||
163477221|NCT02185040|590445392|FG006|Part 1 Treatment Phase|Adverse Event|0|||
163477222|NCT02185040|590445386|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
163477223|NCT02185040|590445387|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
163477224|NCT02185040|590445388|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
163477225|NCT02185040|590445389|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
163477226|NCT02185040|590445390|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
163477227|NCT02185040|590445391|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
163477228|NCT02185040|590445392|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
163477229|NCT02185040|590445386|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
163477230|NCT02185040|590445387|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
163477231|NCT02185040|590445388|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
163477232|NCT02185040|590445389|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
163477233|NCT02185040|590445390|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
163477234|NCT02185040|590445391|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
163477235|NCT02185040|590445392|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
163477236|NCT02185040|590445386|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
163477237|NCT02185040|590445387|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
163477238|NCT02185040|590445388|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
163477239|NCT02185040|590445389|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
163477240|NCT02185040|590445390|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
163477241|NCT02185040|590445391|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
163477242|NCT02185040|590445392|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
163477243|NCT02185040|590445386|FG000|Active Treatment Extension Phase|Adverse Event|0|||
163477244|NCT02185040|590445387|FG001|Active Treatment Extension Phase|Adverse Event|0|||
163477245|NCT02185040|590445388|FG002|Active Treatment Extension Phase|Adverse Event|0|||
163477246|NCT02185040|590445389|FG003|Active Treatment Extension Phase|Adverse Event|0|||
163477247|NCT02185040|590445390|FG004|Active Treatment Extension Phase|Adverse Event|0|||
163477248|NCT02185040|590445391|FG005|Active Treatment Extension Phase|Adverse Event|1|||
163477249|NCT02185040|590445392|FG006|Active Treatment Extension Phase|Adverse Event|4|||
163477250|NCT02185040|590445386|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
163477251|NCT02185040|590445387|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
163477252|NCT02185040|590445388|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
163477253|NCT02185040|590445389|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
163477254|NCT02185040|590445390|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
163477255|NCT02185040|590445391|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
163477256|NCT02185040|590445392|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
163477257|NCT02185040|590445386|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
163477258|NCT02185040|590445387|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
163477259|NCT02185040|590445388|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
163477260|NCT02185040|590445389|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
163477261|NCT02185040|590445390|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
163477262|NCT02185040|590445391|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
163477263|NCT02185040|590445392|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
163477264|NCT00718887|590445396|FG000|Overall Study|Withdrawal by Subject|3|||
163477265|NCT00718887|590445397|FG001|Overall Study|Withdrawal by Subject|2|||
163477266|NCT00718887|590445396|FG000|Overall Study|Not identified|2|||
163477267|NCT00718887|590445397|FG001|Overall Study|Not identified|7|||
163477268|NCT03557801|590445400|FG000|Overall Study|Protocol Violation|1|||
163477269|NCT03557801|590445401|FG001|Overall Study|Protocol Violation|0|||
163477270|NCT03557801|590445402|FG002|Overall Study|Protocol Violation|0|||
163477271|NCT03557801|590445400|FG000|Overall Study|Withdrawal by Subject|1|||
163477272|NCT03557801|590445401|FG001|Overall Study|Withdrawal by Subject|0|||
163477273|NCT03557801|590445402|FG002|Overall Study|Withdrawal by Subject|3|||
163477274|NCT03557801|590445400|FG000|Overall Study|Lost to Follow-up|0|||
163477275|NCT03557801|590445401|FG001|Overall Study|Lost to Follow-up|1|||
163477276|NCT03557801|590445402|FG002|Overall Study|Lost to Follow-up|0|||
163477277|NCT00535236|590445403|FG000|Overall Study|Adverse Event|1|||
163477278|NCT00535236|590445404|FG001|Overall Study|Adverse Event|0|||
163477279|NCT00535236|590445405|FG002|Overall Study|Adverse Event|9|||
163477280|NCT00535236|590445406|FG003|Overall Study|Adverse Event|3|||
163477281|NCT00535236|590445407|FG004|Overall Study|Adverse Event|3|||
163477282|NCT00535236|590445408|FG005|Overall Study|Adverse Event|0|||
163477283|NCT00535236|590445409|FG006|Overall Study|Adverse Event|5|||
163477284|NCT00535236|590445410|FG007|Overall Study|Adverse Event|1|||
163477285|NCT00535236|590445411|FG008|Overall Study|Adverse Event|2|||
163477286|NCT00535236|590445412|FG009|Overall Study|Adverse Event|1|||
163477287|NCT00535236|590445403|FG000|Overall Study|Lost to Follow-up|1|||
163477288|NCT00535236|590445404|FG001|Overall Study|Lost to Follow-up|2|||
163477289|NCT00535236|590445405|FG002|Overall Study|Lost to Follow-up|0|||
163477290|NCT00535236|590445406|FG003|Overall Study|Lost to Follow-up|0|||
163477291|NCT00535236|590445407|FG004|Overall Study|Lost to Follow-up|2|||
163477292|NCT00535236|590445408|FG005|Overall Study|Lost to Follow-up|0|||
163477293|NCT00535236|590445409|FG006|Overall Study|Lost to Follow-up|0|||
163477294|NCT00535236|590445410|FG007|Overall Study|Lost to Follow-up|0|||
163477295|NCT00535236|590445411|FG008|Overall Study|Lost to Follow-up|6|||
163477296|NCT00535236|590445412|FG009|Overall Study|Lost to Follow-up|1|||
163477297|NCT00535236|590445403|FG000|Overall Study|Physician Decision|0|||
163477298|NCT00535236|590445404|FG001|Overall Study|Physician Decision|0|||
163477299|NCT00535236|590445405|FG002|Overall Study|Physician Decision|0|||
163477300|NCT00535236|590445406|FG003|Overall Study|Physician Decision|0|||
163477301|NCT00535236|590445407|FG004|Overall Study|Physician Decision|1|||
163477302|NCT00535236|590445408|FG005|Overall Study|Physician Decision|0|||
163477303|NCT00535236|590445409|FG006|Overall Study|Physician Decision|1|||
163477304|NCT00535236|590445410|FG007|Overall Study|Physician Decision|0|||
163477305|NCT00535236|590445411|FG008|Overall Study|Physician Decision|0|||
163477306|NCT00535236|590445412|FG009|Overall Study|Physician Decision|0|||
163477307|NCT00535236|590445403|FG000|Overall Study|Protocol Violation|2|||
163477308|NCT00535236|590445404|FG001|Overall Study|Protocol Violation|0|||
163477309|NCT00535236|590445405|FG002|Overall Study|Protocol Violation|1|||
163477310|NCT00535236|590445406|FG003|Overall Study|Protocol Violation|0|||
163477311|NCT00535236|590445407|FG004|Overall Study|Protocol Violation|0|||
163477312|NCT00535236|590445408|FG005|Overall Study|Protocol Violation|0|||
163477313|NCT00535236|590445409|FG006|Overall Study|Protocol Violation|0|||
163477314|NCT00535236|590445410|FG007|Overall Study|Protocol Violation|0|||
163477315|NCT00535236|590445411|FG008|Overall Study|Protocol Violation|1|||
163477316|NCT00535236|590445412|FG009|Overall Study|Protocol Violation|0|||
163477317|NCT00535236|590445403|FG000|Overall Study|Withdrawal by Subject|3|||
163477318|NCT00535236|590445404|FG001|Overall Study|Withdrawal by Subject|0|||
163477319|NCT00535236|590445405|FG002|Overall Study|Withdrawal by Subject|2|||
163477320|NCT00535236|590445406|FG003|Overall Study|Withdrawal by Subject|1|||
163477321|NCT00535236|590445407|FG004|Overall Study|Withdrawal by Subject|6|||
163477322|NCT00535236|590445408|FG005|Overall Study|Withdrawal by Subject|1|||
163477323|NCT00535236|590445409|FG006|Overall Study|Withdrawal by Subject|5|||
163477324|NCT00535236|590445410|FG007|Overall Study|Withdrawal by Subject|0|||
163477325|NCT00535236|590445411|FG008|Overall Study|Withdrawal by Subject|4|||
163477326|NCT00535236|590445412|FG009|Overall Study|Withdrawal by Subject|2|||
163477327|NCT03558503|590445414|FG000|Overall Study|Adverse Event|1|||
163477328|NCT03558503|590445414|FG000|Overall Study|Death|1|||
163477329|NCT03558503|590445414|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
163477330|NCT00561795|590445415|FG000|Overall Study|Adverse Event|3|||
163477331|NCT00561795|590445416|FG001|Overall Study|Adverse Event|3|||
163477332|NCT00561795|590445417|FG002|Overall Study|Adverse Event|0|||
163477333|NCT00561795|590445418|FG003|Overall Study|Adverse Event|0|||
163477334|NCT00561795|590445415|FG000|Overall Study|Study Closed/Terminated|0|||
163477335|NCT00561795|590445416|FG001|Overall Study|Study Closed/Terminated|3|||
163477336|NCT00561795|590445417|FG002|Overall Study|Study Closed/Terminated|0|||
163477337|NCT00561795|590445418|FG003|Overall Study|Study Closed/Terminated|0|||
163477338|NCT00561795|590445415|FG000|Overall Study|Physician Decision|1|||
163477339|NCT00561795|590445416|FG001|Overall Study|Physician Decision|0|||
163477340|NCT00561795|590445417|FG002|Overall Study|Physician Decision|0|||
163477341|NCT00561795|590445418|FG003|Overall Study|Physician Decision|0|||
163477342|NCT02094612|590445419|FG000|Overall Study|Lost to Follow-up|47|||
163477343|NCT02094612|590445420|FG001|Overall Study|Lost to Follow-up|47|||
163477344|NCT02094612|590445419|FG000|Overall Study|Never started ADHD medication|32|||
163477345|NCT02094612|590445420|FG001|Overall Study|Never started ADHD medication|23|||
163477346|NCT04167514|590445421|FG000|Overall Study|Adverse event, not serious|0|||
163477347|NCT04167514|590445422|FG001|Overall Study|Adverse event, not serious|1|||
163477348|NCT04167514|590445421|FG000|Overall Study|Lost to Follow-up|1|||
163477349|NCT04167514|590445422|FG001|Overall Study|Lost to Follow-up|0|||
163477350|NCT04167514|590445421|FG000|Overall Study|Participant Decision|2|||
163477351|NCT04167514|590445422|FG001|Overall Study|Participant Decision|4|||
163477352|NCT04167514|590445421|FG000|Overall Study|Physician Decision|3|||
163477353|NCT04167514|590445422|FG001|Overall Study|Physician Decision|2|||
163477354|NCT04167514|590445421|FG000|Overall Study|Death|14|||
163477355|NCT04167514|590445422|FG001|Overall Study|Death|18|||
163477356|NCT04167514|590445421|FG000|Overall Study|Enrolled but treatment not administered|2|||
163477357|NCT04167514|590445422|FG001|Overall Study|Enrolled but treatment not administered|0|||
163477358|NCT04167514|590445421|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
163477359|NCT04167514|590445422|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
163477360|NCT04167514|590445421|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
163477361|NCT04167514|590445422|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
163477362|NCT02646891|590445423|FG000|Overall Study|Adverse Event|0|||
163477363|NCT02646891|590445424|FG001|Overall Study|Adverse Event|1|||
163477364|NCT02646891|590445425|FG002|Overall Study|Adverse Event|0|||
163477365|NCT02646891|590445426|FG003|Overall Study|Adverse Event|0|||
163477366|NCT02646891|590445427|FG004|Overall Study|Adverse Event|0|||
163477367|NCT02646891|590445428|FG005|Overall Study|Adverse Event|0|||
163477368|NCT02646891|590445429|FG006|Overall Study|Adverse Event|0|||
163477369|NCT02646891|590445430|FG007|Overall Study|Adverse Event|0|||
163477370|NCT02646891|590445431|FG008|Overall Study|Adverse Event|0|||
163477371|NCT02646891|590445432|FG009|Overall Study|Adverse Event|0|||
163477372|NCT02646891|590445423|FG000|Overall Study|Lost to Follow-up|0|||
163477373|NCT02646891|590445424|FG001|Overall Study|Lost to Follow-up|0|||
163477374|NCT02646891|590445425|FG002|Overall Study|Lost to Follow-up|0|||
163477375|NCT02646891|590445426|FG003|Overall Study|Lost to Follow-up|0|||
163477376|NCT02646891|590445427|FG004|Overall Study|Lost to Follow-up|0|||
163477377|NCT02646891|590445428|FG005|Overall Study|Lost to Follow-up|0|||
163477378|NCT02646891|590445429|FG006|Overall Study|Lost to Follow-up|2|||
163477379|NCT02646891|590445430|FG007|Overall Study|Lost to Follow-up|2|||
163477380|NCT02646891|590445431|FG008|Overall Study|Lost to Follow-up|2|||
163477381|NCT02646891|590445432|FG009|Overall Study|Lost to Follow-up|2|||
163477382|NCT02646891|590445423|FG000|Overall Study|Protocol Violation|0|||
163477383|NCT02646891|590445424|FG001|Overall Study|Protocol Violation|0|||
163477384|NCT02646891|590445425|FG002|Overall Study|Protocol Violation|0|||
163477385|NCT02646891|590445426|FG003|Overall Study|Protocol Violation|0|||
163477386|NCT02646891|590445427|FG004|Overall Study|Protocol Violation|0|||
163477387|NCT02646891|590445428|FG005|Overall Study|Protocol Violation|0|||
163477388|NCT02646891|590445429|FG006|Overall Study|Protocol Violation|1|||
163477389|NCT02646891|590445430|FG007|Overall Study|Protocol Violation|1|||
163477390|NCT02646891|590445431|FG008|Overall Study|Protocol Violation|0|||
163477391|NCT02646891|590445432|FG009|Overall Study|Protocol Violation|0|||
163477392|NCT02646891|590445423|FG000|Overall Study|Withdrawal by Subject|2|||
163477393|NCT02646891|590445424|FG001|Overall Study|Withdrawal by Subject|0|||
163477394|NCT02646891|590445425|FG002|Overall Study|Withdrawal by Subject|1|||
163477395|NCT02646891|590445426|FG003|Overall Study|Withdrawal by Subject|0|||
163477396|NCT02646891|590445427|FG004|Overall Study|Withdrawal by Subject|0|||
163477397|NCT02646891|590445428|FG005|Overall Study|Withdrawal by Subject|0|||
163477398|NCT02646891|590445429|FG006|Overall Study|Withdrawal by Subject|5|||
163477399|NCT02646891|590445430|FG007|Overall Study|Withdrawal by Subject|9|||
163477400|NCT02646891|590445431|FG008|Overall Study|Withdrawal by Subject|7|||
163477401|NCT02646891|590445432|FG009|Overall Study|Withdrawal by Subject|3|||
163477402|NCT02646891|590445423|FG000|Overall Study|Death|0|||
163477403|NCT02646891|590445424|FG001|Overall Study|Death|0|||
163477404|NCT02646891|590445425|FG002|Overall Study|Death|0|||
163477405|NCT02646891|590445426|FG003|Overall Study|Death|0|||
163477406|NCT02646891|590445427|FG004|Overall Study|Death|0|||
163477407|NCT02646891|590445428|FG005|Overall Study|Death|0|||
163477408|NCT02646891|590445429|FG006|Overall Study|Death|1|||
163477409|NCT02646891|590445430|FG007|Overall Study|Death|1|||
163477410|NCT02646891|590445431|FG008|Overall Study|Death|1|||
163477411|NCT02646891|590445432|FG009|Overall Study|Death|0|||
163477412|NCT01542632|590445433|FG000|Overall Study|Withdrawal of Consent|0|||
163477413|NCT01542632|590445434|FG001|Overall Study|Withdrawal of Consent|0|||
163477414|NCT01542632|590445435|FG002|Overall Study|Withdrawal of Consent|0|||
163477415|NCT01542632|590445436|FG003|Overall Study|Withdrawal of Consent|2|||
163477416|NCT01542632|590445437|FG004|Overall Study|Withdrawal of Consent|3|||
163477417|NCT01542632|590445438|FG005|Overall Study|Withdrawal of Consent|0|||
163477418|NCT01542632|590445433|FG000|Overall Study|Adverse Event|0|||
163477419|NCT01542632|590445434|FG001|Overall Study|Adverse Event|0|||
163477420|NCT01542632|590445435|FG002|Overall Study|Adverse Event|1|||
163477421|NCT01542632|590445436|FG003|Overall Study|Adverse Event|0|||
163477422|NCT01542632|590445437|FG004|Overall Study|Adverse Event|0|||
163477423|NCT01542632|590445438|FG005|Overall Study|Adverse Event|0|||
163477424|NCT01542632|590445433|FG000|Overall Study|Lost to Follow-up|0|||
163477425|NCT01542632|590445434|FG001|Overall Study|Lost to Follow-up|1|||
163477426|NCT01542632|590445435|FG002|Overall Study|Lost to Follow-up|0|||
163477427|NCT01542632|590445436|FG003|Overall Study|Lost to Follow-up|0|||
163477428|NCT01542632|590445437|FG004|Overall Study|Lost to Follow-up|0|||
163477429|NCT01542632|590445438|FG005|Overall Study|Lost to Follow-up|0|||
163477430|NCT01542632|590445433|FG000|Overall Study|Sponsor/Investigator Decision|0|||
163477431|NCT01542632|590445434|FG001|Overall Study|Sponsor/Investigator Decision|0|||
163477432|NCT01542632|590445435|FG002|Overall Study|Sponsor/Investigator Decision|0|||
163477433|NCT01542632|590445436|FG003|Overall Study|Sponsor/Investigator Decision|0|||
163477434|NCT01542632|590445437|FG004|Overall Study|Sponsor/Investigator Decision|1|||
163477435|NCT01542632|590445438|FG005|Overall Study|Sponsor/Investigator Decision|0|||
163477436|NCT03225833|590445439|FG000|Overall Study|Adverse Event|0|||
163477437|NCT03225833|590445440|FG001|Overall Study|Adverse Event|1|||
163477438|NCT03225833|590445441|FG002|Overall Study|Adverse Event|2|||
163477439|NCT03225833|590445442|FG003|Overall Study|Adverse Event|0|||
163477440|NCT03225833|590445443|FG004|Overall Study|Adverse Event|0|||
163477441|NCT03225833|590445444|FG005|Overall Study|Adverse Event|2|||
163477442|NCT03225833|590445439|FG000|Overall Study|Withdrawal by Subject|1|||
163477443|NCT03225833|590445440|FG001|Overall Study|Withdrawal by Subject|0|||
163477444|NCT03225833|590445441|FG002|Overall Study|Withdrawal by Subject|0|||
163477445|NCT03225833|590445442|FG003|Overall Study|Withdrawal by Subject|0|||
163477446|NCT03225833|590445443|FG004|Overall Study|Withdrawal by Subject|1|||
163477447|NCT03225833|590445444|FG005|Overall Study|Withdrawal by Subject|0|||
163477448|NCT03225833|590445439|FG000|Overall Study|Termination of Study by Sponsor|4|||
163477449|NCT03225833|590445440|FG001|Overall Study|Termination of Study by Sponsor|0|||
163477450|NCT03225833|590445441|FG002|Overall Study|Termination of Study by Sponsor|0|||
163477451|NCT03225833|590445442|FG003|Overall Study|Termination of Study by Sponsor|0|||
163477452|NCT03225833|590445443|FG004|Overall Study|Termination of Study by Sponsor|0|||
163477453|NCT03225833|590445444|FG005|Overall Study|Termination of Study by Sponsor|7|||
163477454|NCT03225833|590445439|FG000|Overall Study|Sponsor Decision|0|||
163477455|NCT03225833|590445440|FG001|Overall Study|Sponsor Decision|0|||
163477456|NCT03225833|590445441|FG002|Overall Study|Sponsor Decision|0|||
163477457|NCT03225833|590445442|FG003|Overall Study|Sponsor Decision|0|||
163477458|NCT03225833|590445443|FG004|Overall Study|Sponsor Decision|0|||
163477459|NCT03225833|590445444|FG005|Overall Study|Sponsor Decision|1|||
163477460|NCT06029127|590445446|FG000|Overall Study|Withdrawal by Subject|2|||
163477461|NCT06029127|590445447|FG001|Overall Study|Withdrawal by Subject|0|||
163477462|NCT06029127|590445446|FG000|Overall Study|Lost to Follow-up|1|||
163477463|NCT06029127|590445447|FG001|Overall Study|Lost to Follow-up|0|||
163477464|NCT06029127|590445446|FG000|Overall Study|Study Closed by Sponsor|6|||
163477465|NCT06029127|590445447|FG001|Overall Study|Study Closed by Sponsor|6|||
163477466|NCT06029127|590445446|FG000|Overall Study|Death|12|||
163477467|NCT06029127|590445447|FG001|Overall Study|Death|7|||
163477468|NCT06029127|590445446|FG000|Overall Study|Declined Follow-Up Contact|0|||
163477469|NCT06029127|590445447|FG001|Overall Study|Declined Follow-Up Contact|1|||
163477470|NCT04785144|590445448|FG000|Overall Study|Withdrawal by Subject|4|||
163477471|NCT04785144|590445449|FG001|Overall Study|Withdrawal by Subject|1|||
163477472|NCT04785144|590445450|FG002|Overall Study|Withdrawal by Subject|0|||
163477473|NCT04785144|590445451|FG003|Overall Study|Withdrawal by Subject|0|||
163477474|NCT04785144|590445452|FG004|Overall Study|Withdrawal by Subject|0|||
163477475|NCT04785144|590445453|FG005|Overall Study|Withdrawal by Subject|2|||
163477476|NCT04785144|590445454|FG006|Overall Study|Withdrawal by Subject|2|||
163477477|NCT04785144|590445455|FG007|Overall Study|Withdrawal by Subject|0|||
163477478|NCT04785144|590445456|FG008|Overall Study|Withdrawal by Subject|1|||
163477479|NCT04785144|590445457|FG009|Overall Study|Withdrawal by Subject|0|||
163477480|NCT04785144|590445448|FG000|Overall Study|Lost to Follow-up|1|||
163477481|NCT04785144|590445449|FG001|Overall Study|Lost to Follow-up|0|||
163477482|NCT04785144|590445450|FG002|Overall Study|Lost to Follow-up|0|||
163477483|NCT04785144|590445451|FG003|Overall Study|Lost to Follow-up|0|||
163477484|NCT04785144|590445452|FG004|Overall Study|Lost to Follow-up|1|||
163477485|NCT04785144|590445453|FG005|Overall Study|Lost to Follow-up|2|||
163477486|NCT04785144|590445454|FG006|Overall Study|Lost to Follow-up|1|||
163477487|NCT04785144|590445455|FG007|Overall Study|Lost to Follow-up|2|||
163477488|NCT04785144|590445456|FG008|Overall Study|Lost to Follow-up|4|||
163477489|NCT04785144|590445457|FG009|Overall Study|Lost to Follow-up|1|||
163477490|NCT04785144|590445448|FG000|Overall Study|Protocol Violation|0|||
163477491|NCT04785144|590445449|FG001|Overall Study|Protocol Violation|0|||
163477492|NCT04785144|590445450|FG002|Overall Study|Protocol Violation|0|||
163477493|NCT04785144|590445451|FG003|Overall Study|Protocol Violation|0|||
163477494|NCT04785144|590445452|FG004|Overall Study|Protocol Violation|0|||
163477495|NCT04785144|590445453|FG005|Overall Study|Protocol Violation|0|||
163477496|NCT04785144|590445454|FG006|Overall Study|Protocol Violation|1|||
163477497|NCT04785144|590445455|FG007|Overall Study|Protocol Violation|0|||
163477498|NCT04785144|590445456|FG008|Overall Study|Protocol Violation|0|||
163477499|NCT04785144|590445457|FG009|Overall Study|Protocol Violation|0|||
163477500|NCT04785144|590445448|FG000|Overall Study|Physician Decision|0|||
163477501|NCT04785144|590445449|FG001|Overall Study|Physician Decision|0|||
163477502|NCT04785144|590445450|FG002|Overall Study|Physician Decision|0|||
163477503|NCT04785144|590445451|FG003|Overall Study|Physician Decision|0|||
163477504|NCT04785144|590445452|FG004|Overall Study|Physician Decision|0|||
163477505|NCT04785144|590445453|FG005|Overall Study|Physician Decision|0|||
163477506|NCT04785144|590445454|FG006|Overall Study|Physician Decision|0|||
163477507|NCT04785144|590445455|FG007|Overall Study|Physician Decision|0|||
163477508|NCT04785144|590445456|FG008|Overall Study|Physician Decision|0|||
163477509|NCT04785144|590445457|FG009|Overall Study|Physician Decision|1|||
163477510|NCT04785144|590445448|FG000|Overall Study|Unable to continue due to work schedule|0|||
163477511|NCT04785144|590445449|FG001|Overall Study|Unable to continue due to work schedule|0|||
163477512|NCT04785144|590445450|FG002|Overall Study|Unable to continue due to work schedule|0|||
163477513|NCT04785144|590445451|FG003|Overall Study|Unable to continue due to work schedule|0|||
163477514|NCT04785144|590445452|FG004|Overall Study|Unable to continue due to work schedule|0|||
163477515|NCT04785144|590445453|FG005|Overall Study|Unable to continue due to work schedule|0|||
163477516|NCT04785144|590445454|FG006|Overall Study|Unable to continue due to work schedule|0|||
163477517|NCT04785144|590445455|FG007|Overall Study|Unable to continue due to work schedule|0|||
163477518|NCT04785144|590445456|FG008|Overall Study|Unable to continue due to work schedule|0|||
163477519|NCT04785144|590445457|FG009|Overall Study|Unable to continue due to work schedule|1|||
163477520|NCT00129376|590445458|FG000|Overall Study|Adverse Event|1|||
163477521|NCT00129376|590445458|FG000|Overall Study|Lack of Efficacy|1|||
163477522|NCT01766401|590445459|FG000|Overall Study|Adverse Event|7|||
163477523|NCT01766401|590445460|FG001|Overall Study|Adverse Event|22|||
163477524|NCT01766401|590445459|FG000|Overall Study|Lack of Efficacy|1|||
163477525|NCT01766401|590445460|FG001|Overall Study|Lack of Efficacy|2|||
163477526|NCT01766401|590445459|FG000|Overall Study|Protocol Violation|3|||
163477527|NCT01766401|590445460|FG001|Overall Study|Protocol Violation|8|||
163477528|NCT01766401|590445459|FG000|Overall Study|Withdrawal by Subject|15|||
163477529|NCT01766401|590445460|FG001|Overall Study|Withdrawal by Subject|12|||
163477530|NCT01766401|590445459|FG000|Overall Study|Lost to Follow-up|10|||
163477531|NCT01766401|590445460|FG001|Overall Study|Lost to Follow-up|11|||
163477532|NCT01766401|590445459|FG000|Overall Study|Pregnancy|1|||
163477533|NCT01766401|590445460|FG001|Overall Study|Pregnancy|1|||
163477534|NCT00886587|590445461|FG000|Overall Study|Adverse Event|2|||
163477535|NCT00886587|590445462|FG001|Overall Study|Adverse Event|1|||
163477536|NCT00886587|590445461|FG000|Overall Study|Protocol Violation|2|||
163477537|NCT00886587|590445462|FG001|Overall Study|Protocol Violation|0|||
163477538|NCT00886587|590445461|FG000|Overall Study|Withdrawal by Subject|0|||
163477539|NCT00886587|590445462|FG001|Overall Study|Withdrawal by Subject|1|||
163477540|NCT01108068|590445466|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
163477541|NCT01108068|590445467|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
163477542|NCT00398086|590445468|FG000|Overall Study|Unacceptable Toxicity|2|||
163477543|NCT00398086|590445469|FG001|Overall Study|Unacceptable Toxicity|8|||
163477544|NCT00398086|590445470|FG002|Overall Study|Unacceptable Toxicity|2|||
163477545|NCT00398086|590445468|FG000|Overall Study|Adverse Event|1|||
163477546|NCT00398086|590445469|FG001|Overall Study|Adverse Event|4|||
163477547|NCT00398086|590445470|FG002|Overall Study|Adverse Event|0|||
163477548|NCT00398086|590445468|FG000|Overall Study|Physician Decision|1|||
163477549|NCT00398086|590445469|FG001|Overall Study|Physician Decision|4|||
163477550|NCT00398086|590445470|FG002|Overall Study|Physician Decision|0|||
163477551|NCT00398086|590445468|FG000|Overall Study|Withdrawal by Subject|5|||
163477552|NCT00398086|590445469|FG001|Overall Study|Withdrawal by Subject|7|||
163477553|NCT00398086|590445470|FG002|Overall Study|Withdrawal by Subject|0|||
163477554|NCT00696774|590445471|FG000|Period II|Adverse Event|0|||
163477555|NCT00696774|590445472|FG001|Period II|Adverse Event|0|||
163477556|NCT00696774|590445473|FG002|Period II|Adverse Event|15|||
163477557|NCT00696774|590445471|FG000|Period II|Lost to Follow-up|0|||
163477558|NCT00696774|590445472|FG001|Period II|Lost to Follow-up|0|||
163477559|NCT00696774|590445473|FG002|Period II|Lost to Follow-up|4|||
163477560|NCT00696774|590445471|FG000|Period II|Protocol Violation|0|||
163477561|NCT00696774|590445472|FG001|Period II|Protocol Violation|0|||
163477562|NCT00696774|590445473|FG002|Period II|Protocol Violation|11|||
163477563|NCT00696774|590445471|FG000|Period II|Withdrawal by Subject|0|||
163477564|NCT00696774|590445472|FG001|Period II|Withdrawal by Subject|0|||
163477565|NCT00696774|590445473|FG002|Period II|Withdrawal by Subject|4|||
163477566|NCT00696774|590445471|FG000|Period II|Sponsor Decision|0|||
163477567|NCT00696774|590445472|FG001|Period II|Sponsor Decision|0|||
163477568|NCT00696774|590445473|FG002|Period II|Sponsor Decision|0|||
163477569|NCT00696774|590445471|FG000|Period II|Lack of Efficacy|0|||
163477570|NCT00696774|590445472|FG001|Period II|Lack of Efficacy|0|||
163477571|NCT00696774|590445473|FG002|Period II|Lack of Efficacy|2|||
163477572|NCT00696774|590445471|FG000|Period III|Adverse Event|1|||
163477573|NCT00696774|590445472|FG001|Period III|Adverse Event|1|||
163477574|NCT00696774|590445473|FG002|Period III|Adverse Event|0|||
163477575|NCT00696774|590445471|FG000|Period III|Lost to Follow-up|2|||
163477576|NCT00696774|590445472|FG001|Period III|Lost to Follow-up|1|||
163477577|NCT00696774|590445473|FG002|Period III|Lost to Follow-up|0|||
163477578|NCT00696774|590445471|FG000|Period III|Protocol Violation|1|||
163477579|NCT00696774|590445472|FG001|Period III|Protocol Violation|1|||
163477580|NCT00696774|590445473|FG002|Period III|Protocol Violation|0|||
163477581|NCT00696774|590445471|FG000|Period III|Withdrawal by Subject|1|||
163477582|NCT00696774|590445472|FG001|Period III|Withdrawal by Subject|2|||
163477583|NCT00696774|590445473|FG002|Period III|Withdrawal by Subject|0|||
163477584|NCT00696774|590445471|FG000|Period III|Sponsor Decision|2|||
163477585|NCT00696774|590445472|FG001|Period III|Sponsor Decision|0|||
163477586|NCT00696774|590445473|FG002|Period III|Sponsor Decision|0|||
163477587|NCT00696774|590445471|FG000|Period III|Lack of Efficacy|0|||
163477588|NCT00696774|590445472|FG001|Period III|Lack of Efficacy|2|||
163477589|NCT00696774|590445473|FG002|Period III|Lack of Efficacy|0|||
163477590|NCT00033293|590445480|FG000|Overall Study|Death|0|||
163477591|NCT00033293|590445481|FG001|Overall Study|Death|1|||
163477592|NCT00033293|590445480|FG000|Overall Study|Lack of Efficacy|5|||
163477593|NCT00033293|590445481|FG001|Overall Study|Lack of Efficacy|8|||
163477594|NCT00033293|590445480|FG000|Overall Study|Lost to Follow-up|0|||
163477595|NCT00033293|590445481|FG001|Overall Study|Lost to Follow-up|1|||
163477596|NCT00033293|590445480|FG000|Overall Study|Physician Decision|3|||
163477597|NCT00033293|590445481|FG001|Overall Study|Physician Decision|1|||
163477598|NCT00033293|590445480|FG000|Overall Study|Withdrawal by Subject|1|||
163477599|NCT00033293|590445481|FG001|Overall Study|Withdrawal by Subject|0|||
163477600|NCT00033293|590445480|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
163477601|NCT00033293|590445481|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
163477602|NCT00033293|590445480|FG000|Overall Study|Treatment refused|0|||
163477603|NCT00033293|590445481|FG001|Overall Study|Treatment refused|6|||
163477604|NCT00935701|590445482|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
163477605|NCT02201251|590445483|FG000|Overall Study|Adverse Event|1|||
163477606|NCT02201251|590445484|FG001|Overall Study|Adverse Event|1|||
163477607|NCT02201251|590445483|FG000|Overall Study|Protocol Violation|1|||
163477608|NCT02201251|590445484|FG001|Overall Study|Protocol Violation|0|||
163477609|NCT02201251|590445483|FG000|Overall Study|Noncompliance with Study Drug|0|||
163477610|NCT02201251|590445484|FG001|Overall Study|Noncompliance with Study Drug|1|||
163477611|NCT02201251|590445483|FG000|Overall Study|Withdrawal by Subject|2|||
163477612|NCT02201251|590445484|FG001|Overall Study|Withdrawal by Subject|1|||
163477613|NCT01197794|590445487|FG000|Overall Study|Adverse Event|3|||
163477614|NCT01197794|590445488|FG001|Overall Study|Adverse Event|2|||
163477615|NCT01197794|590445489|FG002|Overall Study|Adverse Event|4|||
163477616|NCT01197794|590445490|FG003|Overall Study|Adverse Event|4|||
163477617|NCT01197794|590445491|FG004|Overall Study|Adverse Event|4|||
163477618|NCT01197794|590445492|FG005|Overall Study|Adverse Event|2|||
163477619|NCT01197794|590445493|FG006|Overall Study|Adverse Event|3|||
163477620|NCT01197794|590445487|FG000|Overall Study|Protocol Violation|0|||
163477621|NCT01197794|590445488|FG001|Overall Study|Protocol Violation|0|||
163477622|NCT01197794|590445489|FG002|Overall Study|Protocol Violation|0|||
163477623|NCT01197794|590445490|FG003|Overall Study|Protocol Violation|0|||
163477624|NCT01197794|590445491|FG004|Overall Study|Protocol Violation|2|||
163477625|NCT01197794|590445492|FG005|Overall Study|Protocol Violation|0|||
163477626|NCT01197794|590445493|FG006|Overall Study|Protocol Violation|1|||
163477627|NCT01197794|590445487|FG000|Overall Study|Development of study withdrawal criteria|3|||
163477628|NCT01197794|590445488|FG001|Overall Study|Development of study withdrawal criteria|0|||
163477629|NCT01197794|590445489|FG002|Overall Study|Development of study withdrawal criteria|0|||
163477630|NCT01197794|590445490|FG003|Overall Study|Development of study withdrawal criteria|1|||
163477631|NCT01197794|590445491|FG004|Overall Study|Development of study withdrawal criteria|0|||
163477632|NCT01197794|590445492|FG005|Overall Study|Development of study withdrawal criteria|0|||
163477633|NCT01197794|590445493|FG006|Overall Study|Development of study withdrawal criteria|1|||
163477634|NCT01197794|590445487|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
163477635|NCT01197794|590445488|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
163477636|NCT01197794|590445489|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
163477637|NCT01197794|590445490|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
163477638|NCT01197794|590445491|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
163477639|NCT01197794|590445492|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
163477640|NCT01197794|590445493|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
163477641|NCT01197794|590445487|FG000|Overall Study|Withdrawal by Subject|3|||
163477642|NCT01197794|590445488|FG001|Overall Study|Withdrawal by Subject|3|||
163477643|NCT01197794|590445489|FG002|Overall Study|Withdrawal by Subject|4|||
163477644|NCT01197794|590445490|FG003|Overall Study|Withdrawal by Subject|1|||
163477645|NCT01197794|590445491|FG004|Overall Study|Withdrawal by Subject|1|||
163477646|NCT01197794|590445492|FG005|Overall Study|Withdrawal by Subject|5|||
163477647|NCT01197794|590445493|FG006|Overall Study|Withdrawal by Subject|6|||
163477648|NCT01197794|590445487|FG000|Overall Study|Lost to Follow-up|1|||
163477649|NCT01197794|590445488|FG001|Overall Study|Lost to Follow-up|1|||
163477650|NCT01197794|590445489|FG002|Overall Study|Lost to Follow-up|0|||
163477651|NCT01197794|590445490|FG003|Overall Study|Lost to Follow-up|1|||
163477652|NCT01197794|590445491|FG004|Overall Study|Lost to Follow-up|0|||
163477653|NCT01197794|590445492|FG005|Overall Study|Lost to Follow-up|1|||
163477654|NCT01197794|590445493|FG006|Overall Study|Lost to Follow-up|0|||
163477655|NCT01197794|590445487|FG000|Overall Study|Other|1|||
163477656|NCT01197794|590445488|FG001|Overall Study|Other|1|||
163477657|NCT01197794|590445489|FG002|Overall Study|Other|3|||
163477658|NCT01197794|590445490|FG003|Overall Study|Other|0|||
163477659|NCT01197794|590445491|FG004|Overall Study|Other|2|||
163477660|NCT01197794|590445492|FG005|Overall Study|Other|2|||
163477661|NCT01197794|590445493|FG006|Overall Study|Other|4|||
163477662|NCT04055844|590445494|FG000|Overall Study|Adverse Event|12|||
163477663|NCT04055844|590445494|FG000|Overall Study|Poor Performance|1|||
163477664|NCT04055844|590445494|FG000|Overall Study|Death|1|||
163477665|NCT03457636|590445499|FG000|Overall Study|Lost to Follow-up|2|||
163477666|NCT03231228|590445504|FG000|Overall Study|Lost to Follow-up|2|||
163477667|NCT03231228|590445505|FG001|Overall Study|Lost to Follow-up|0|||
163477668|NCT03231228|590445504|FG000|Overall Study|Physician Decision|1|||
163477669|NCT03231228|590445505|FG001|Overall Study|Physician Decision|0|||
163477670|NCT03049852|590445515|FG000|Overall Study|Lost to Follow-up|0|||
163477671|NCT03049852|590445516|FG001|Overall Study|Lost to Follow-up|1|||
163477672|NCT03049852|590445517|FG002|Overall Study|Lost to Follow-up|0|||
163477673|NCT02141854|590445518|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
163477674|NCT02141854|590445519|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163477675|NCT02141854|590445520|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163477676|NCT02141854|590445521|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163477677|NCT02141854|590445522|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163477678|NCT02141854|590445523|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163477679|NCT02141854|590445518|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
163477680|NCT02141854|590445519|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163477681|NCT02141854|590445520|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163477682|NCT02141854|590445521|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163477683|NCT02141854|590445522|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163477684|NCT02141854|590445523|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
163477685|NCT02141854|590445518|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
163477686|NCT02141854|590445519|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163477687|NCT02141854|590445520|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163477688|NCT02141854|590445521|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163477689|NCT02141854|590445522|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163477690|NCT02141854|590445523|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163477691|NCT02141854|590445518|FG000|Run-In Period (Pre-assignment)|Other|14|||
163477692|NCT02141854|590445519|FG001|Run-In Period (Pre-assignment)|Other|0|||
163477693|NCT02141854|590445520|FG002|Run-In Period (Pre-assignment)|Other|0|||
163477694|NCT02141854|590445521|FG003|Run-In Period (Pre-assignment)|Other|0|||
163477695|NCT02141854|590445522|FG004|Run-In Period (Pre-assignment)|Other|0|||
163477696|NCT02141854|590445523|FG005|Run-In Period (Pre-assignment)|Other|0|||
163477697|NCT02141854|590445518|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
163477698|NCT02141854|590445519|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
163477699|NCT02141854|590445520|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
163477700|NCT02141854|590445521|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
163477701|NCT02141854|590445522|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
163477702|NCT02141854|590445523|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
163477703|NCT02141854|590445518|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
163477704|NCT02141854|590445519|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163477705|NCT02141854|590445520|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163477706|NCT02141854|590445521|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163477707|NCT02141854|590445522|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163477708|NCT02141854|590445523|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163477709|NCT02141854|590445518|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
163477710|NCT02141854|590445519|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163477711|NCT02141854|590445520|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163477712|NCT02141854|590445521|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163477713|NCT02141854|590445522|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163477714|NCT02141854|590445523|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163477715|NCT02141854|590445518|FG000|Treatment Period|Protocol Violation|0|||
163477716|NCT02141854|590445519|FG001|Treatment Period|Protocol Violation|1|||
163477717|NCT02141854|590445520|FG002|Treatment Period|Protocol Violation|0|||
163477718|NCT02141854|590445521|FG003|Treatment Period|Protocol Violation|2|||
163477719|NCT02141854|590445522|FG004|Treatment Period|Protocol Violation|2|||
163477720|NCT02141854|590445523|FG005|Treatment Period|Protocol Violation|1|||
163477721|NCT02141854|590445518|FG000|Treatment Period|Noncompliance|0|||
163477722|NCT02141854|590445519|FG001|Treatment Period|Noncompliance|0|||
163477723|NCT02141854|590445520|FG002|Treatment Period|Noncompliance|0|||
163477724|NCT02141854|590445521|FG003|Treatment Period|Noncompliance|1|||
163477725|NCT02141854|590445522|FG004|Treatment Period|Noncompliance|0|||
163477726|NCT02141854|590445523|FG005|Treatment Period|Noncompliance|0|||
163477727|NCT02141854|590445518|FG000|Treatment Period|Lack of Efficacy|0|||
163477728|NCT02141854|590445519|FG001|Treatment Period|Lack of Efficacy|0|||
163477729|NCT02141854|590445520|FG002|Treatment Period|Lack of Efficacy|0|||
163477730|NCT02141854|590445521|FG003|Treatment Period|Lack of Efficacy|1|||
163477731|NCT02141854|590445522|FG004|Treatment Period|Lack of Efficacy|1|||
163477732|NCT02141854|590445523|FG005|Treatment Period|Lack of Efficacy|7|||
163477733|NCT02141854|590445518|FG000|Treatment Period|Pregnancy|0|||
163477734|NCT02141854|590445519|FG001|Treatment Period|Pregnancy|1|||
163477735|NCT02141854|590445520|FG002|Treatment Period|Pregnancy|0|||
163477736|NCT02141854|590445521|FG003|Treatment Period|Pregnancy|0|||
163477737|NCT02141854|590445522|FG004|Treatment Period|Pregnancy|0|||
163477738|NCT02141854|590445523|FG005|Treatment Period|Pregnancy|0|||
163477739|NCT02141854|590445518|FG000|Treatment Period|Other|0|||
163477740|NCT02141854|590445519|FG001|Treatment Period|Other|1|||
163477741|NCT02141854|590445520|FG002|Treatment Period|Other|2|||
163477742|NCT02141854|590445521|FG003|Treatment Period|Other|0|||
163477743|NCT02141854|590445522|FG004|Treatment Period|Other|1|||
163477744|NCT02141854|590445523|FG005|Treatment Period|Other|2|||
163477745|NCT02141854|590445518|FG000|Treatment Period|Adverse Event|0|||
163477746|NCT02141854|590445519|FG001|Treatment Period|Adverse Event|2|||
163477747|NCT02141854|590445520|FG002|Treatment Period|Adverse Event|2|||
163477748|NCT02141854|590445521|FG003|Treatment Period|Adverse Event|0|||
163477749|NCT02141854|590445522|FG004|Treatment Period|Adverse Event|2|||
163477750|NCT02141854|590445523|FG005|Treatment Period|Adverse Event|2|||
163477751|NCT02141854|590445518|FG000|Treatment Period|Withdrawal by Subject|0|||
163477752|NCT02141854|590445519|FG001|Treatment Period|Withdrawal by Subject|2|||
163477753|NCT02141854|590445520|FG002|Treatment Period|Withdrawal by Subject|3|||
163477754|NCT02141854|590445521|FG003|Treatment Period|Withdrawal by Subject|3|||
163477755|NCT02141854|590445522|FG004|Treatment Period|Withdrawal by Subject|4|||
163477756|NCT02141854|590445523|FG005|Treatment Period|Withdrawal by Subject|7|||
163477757|NCT02141854|590445518|FG000|Treatment Period|Disease progression|0|||
163477758|NCT02141854|590445519|FG001|Treatment Period|Disease progression|2|||
163477759|NCT02141854|590445520|FG002|Treatment Period|Disease progression|1|||
163477760|NCT02141854|590445521|FG003|Treatment Period|Disease progression|3|||
163477761|NCT02141854|590445522|FG004|Treatment Period|Disease progression|0|||
163477762|NCT02141854|590445523|FG005|Treatment Period|Disease progression|18|||
163477763|NCT02141854|590445518|FG000|Treatment Period|Lost to Follow-up|0|||
163477764|NCT02141854|590445519|FG001|Treatment Period|Lost to Follow-up|1|||
163477765|NCT02141854|590445520|FG002|Treatment Period|Lost to Follow-up|1|||
163477766|NCT02141854|590445521|FG003|Treatment Period|Lost to Follow-up|1|||
163477767|NCT02141854|590445522|FG004|Treatment Period|Lost to Follow-up|0|||
163477768|NCT02141854|590445523|FG005|Treatment Period|Lost to Follow-up|1|||
163477769|NCT01868594|590445524|FG000|Overall Study|Do not meet inclusion criteria|4|||
163477770|NCT01868594|590445525|FG001|Overall Study|Do not meet inclusion criteria|3|||
163477771|NCT04490057|590445526|FG000|Stage 1|Death|1|||
163477772|NCT04490057|590445527|FG001|Stage 1|Death|2|||
163477773|NCT04490057|590445528|FG002|Stage 1|Death|0|||
163477774|NCT04490057|590445529|FG003|Stage 1|Death|0|||
163477775|NCT04490057|590445530|FG004|Stage 1|Death|0|||
163477776|NCT04490057|590445531|FG005|Stage 1|Death|0|||
163477777|NCT04490057|590445532|FG006|Stage 1|Death|0|||
163477778|NCT04490057|590445533|FG007|Stage 1|Death|0|||
163477779|NCT04490057|590445526|FG000|Stage 1|Withdrawal by Subject|2|||
163477780|NCT04490057|590445527|FG001|Stage 1|Withdrawal by Subject|0|||
163477781|NCT04490057|590445528|FG002|Stage 1|Withdrawal by Subject|0|||
163477782|NCT04490057|590445529|FG003|Stage 1|Withdrawal by Subject|0|||
163477783|NCT04490057|590445530|FG004|Stage 1|Withdrawal by Subject|0|||
163477784|NCT04490057|590445531|FG005|Stage 1|Withdrawal by Subject|0|||
163477785|NCT04490057|590445532|FG006|Stage 1|Withdrawal by Subject|0|||
163477786|NCT04490057|590445533|FG007|Stage 1|Withdrawal by Subject|0|||
163477787|NCT04490057|590445526|FG000|Stage 2|Death|0|||
163477788|NCT04490057|590445527|FG001|Stage 2|Death|0|||
163477789|NCT04490057|590445528|FG002|Stage 2|Death|0|||
163477790|NCT04490057|590445529|FG003|Stage 2|Death|0|||
163477791|NCT04490057|590445530|FG004|Stage 2|Death|1|||
163477792|NCT04490057|590445531|FG005|Stage 2|Death|0|||
163477793|NCT04490057|590445532|FG006|Stage 2|Death|0|||
163477794|NCT04490057|590445533|FG007|Stage 2|Death|0|||
163477795|NCT04490057|590445526|FG000|Stage 2|Lost to Follow-up|0|||
163477796|NCT04490057|590445527|FG001|Stage 2|Lost to Follow-up|0|||
163477797|NCT04490057|590445528|FG002|Stage 2|Lost to Follow-up|0|||
163477798|NCT04490057|590445529|FG003|Stage 2|Lost to Follow-up|11|||
163477799|NCT04490057|590445530|FG004|Stage 2|Lost to Follow-up|17|||
163477800|NCT04490057|590445531|FG005|Stage 2|Lost to Follow-up|4|||
163477801|NCT04490057|590445532|FG006|Stage 2|Lost to Follow-up|21|||
163477802|NCT04490057|590445533|FG007|Stage 2|Lost to Follow-up|14|||
163477803|NCT02598661|590445536|FG000|Overall Study|Death|27|||
163477804|NCT02598661|590445537|FG001|Overall Study|Death|34|||
163477805|NCT02598661|590445538|FG002|Overall Study|Death|14|||
163477806|NCT02598661|590445539|FG003|Overall Study|Death|1|||
163477807|NCT02598661|590445540|FG004|Overall Study|Death|0|||
163477808|NCT02598661|590445536|FG000|Overall Study|Lost to Follow-up|2|||
163477809|NCT02598661|590445537|FG001|Overall Study|Lost to Follow-up|3|||
163477810|NCT02598661|590445538|FG002|Overall Study|Lost to Follow-up|2|||
163477811|NCT02598661|590445539|FG003|Overall Study|Lost to Follow-up|0|||
163477812|NCT02598661|590445540|FG004|Overall Study|Lost to Follow-up|0|||
163477813|NCT02598661|590445536|FG000|Overall Study|Withdrawal by Subject|13|||
163477814|NCT02598661|590445537|FG001|Overall Study|Withdrawal by Subject|24|||
163477815|NCT02598661|590445538|FG002|Overall Study|Withdrawal by Subject|14|||
163477816|NCT02598661|590445539|FG003|Overall Study|Withdrawal by Subject|1|||
163477817|NCT02598661|590445540|FG004|Overall Study|Withdrawal by Subject|1|||
163477818|NCT02598661|590445536|FG000|Overall Study|Adverse Event|0|||
163477819|NCT02598661|590445537|FG001|Overall Study|Adverse Event|0|||
163477820|NCT02598661|590445538|FG002|Overall Study|Adverse Event|1|||
163477821|NCT02598661|590445539|FG003|Overall Study|Adverse Event|0|||
163477822|NCT02598661|590445540|FG004|Overall Study|Adverse Event|0|||
163477823|NCT02598661|590445536|FG000|Overall Study|Randomized, Never Treated|0|||
163477824|NCT02598661|590445537|FG001|Overall Study|Randomized, Never Treated|0|||
163477825|NCT02598661|590445538|FG002|Overall Study|Randomized, Never Treated|0|||
163477826|NCT02598661|590445539|FG003|Overall Study|Randomized, Never Treated|0|||
163477827|NCT02598661|590445540|FG004|Overall Study|Randomized, Never Treated|1|||
163477828|NCT04564027|590447189|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
163477829|NCT04564027|590447190|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
163477830|NCT04564027|590447191|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
163477831|NCT04564027|590447192|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
163477832|NCT05827978|590447193|FG000|Overall Study|Adverse Event|1|||
163477833|NCT05827978|590447194|FG001|Overall Study|Adverse Event|0|||
163477834|NCT05827978|590447195|FG002|Overall Study|Adverse Event|0|||
163477835|NCT05827978|590447196|FG003|Overall Study|Adverse Event|1|||
163477836|NCT05827978|590447197|FG004|Overall Study|Adverse Event|0|||
163477837|NCT05827978|590447198|FG005|Overall Study|Adverse Event|0|||
163477838|NCT05827978|590447193|FG000|Overall Study|Death|1|||
163477839|NCT05827978|590447194|FG001|Overall Study|Death|5|||
163477840|NCT05827978|590447195|FG002|Overall Study|Death|2|||
163477841|NCT05827978|590447196|FG003|Overall Study|Death|3|||
163477842|NCT05827978|590447197|FG004|Overall Study|Death|1|||
163477843|NCT05827978|590447198|FG005|Overall Study|Death|3|||
163477844|NCT05827978|590447193|FG000|Overall Study|Lost to Follow-up|57|||
163477845|NCT05827978|590447194|FG001|Overall Study|Lost to Follow-up|88|||
163477846|NCT05827978|590447195|FG002|Overall Study|Lost to Follow-up|54|||
163477847|NCT05827978|590447196|FG003|Overall Study|Lost to Follow-up|47|||
163477848|NCT05827978|590447197|FG004|Overall Study|Lost to Follow-up|25|||
163477849|NCT05827978|590447198|FG005|Overall Study|Lost to Follow-up|10|||
163477850|NCT05827978|590447193|FG000|Overall Study|Noncompliance with Study Procedures|0|||
163477851|NCT05827978|590447194|FG001|Overall Study|Noncompliance with Study Procedures|1|||
163477852|NCT05827978|590447195|FG002|Overall Study|Noncompliance with Study Procedures|1|||
163477853|NCT05827978|590447196|FG003|Overall Study|Noncompliance with Study Procedures|1|||
163477854|NCT05827978|590447197|FG004|Overall Study|Noncompliance with Study Procedures|1|||
163477855|NCT05827978|590447198|FG005|Overall Study|Noncompliance with Study Procedures|0|||
163477856|NCT05827978|590447193|FG000|Overall Study|Physician Decision|2|||
163477857|NCT05827978|590447194|FG001|Overall Study|Physician Decision|0|||
163477858|NCT05827978|590447195|FG002|Overall Study|Physician Decision|1|||
163477859|NCT05827978|590447196|FG003|Overall Study|Physician Decision|2|||
163477860|NCT05827978|590447197|FG004|Overall Study|Physician Decision|1|||
163477861|NCT05827978|590447198|FG005|Overall Study|Physician Decision|1|||
163477862|NCT05827978|590447193|FG000|Overall Study|Protocol Violation|5|||
163477863|NCT05827978|590447194|FG001|Overall Study|Protocol Violation|2|||
163477864|NCT05827978|590447195|FG002|Overall Study|Protocol Violation|0|||
163477865|NCT05827978|590447196|FG003|Overall Study|Protocol Violation|0|||
163477866|NCT05827978|590447197|FG004|Overall Study|Protocol Violation|0|||
163477867|NCT05827978|590447198|FG005|Overall Study|Protocol Violation|0|||
163477868|NCT05827978|590447193|FG000|Overall Study|Withdrawal by Subject|17|||
163477869|NCT05827978|590447194|FG001|Overall Study|Withdrawal by Subject|16|||
163477870|NCT05827978|590447195|FG002|Overall Study|Withdrawal by Subject|10|||
163477871|NCT05827978|590447196|FG003|Overall Study|Withdrawal by Subject|12|||
163477872|NCT05827978|590447197|FG004|Overall Study|Withdrawal by Subject|10|||
163477873|NCT05827978|590447198|FG005|Overall Study|Withdrawal by Subject|9|||
163477874|NCT05827978|590447193|FG000|Overall Study|Other Than Specified|0|||
163477875|NCT05827978|590447194|FG001|Overall Study|Other Than Specified|0|||
163477876|NCT05827978|590447195|FG002|Overall Study|Other Than Specified|1|||
163477877|NCT05827978|590447196|FG003|Overall Study|Other Than Specified|0|||
163477878|NCT05827978|590447197|FG004|Overall Study|Other Than Specified|2|||
163477879|NCT05827978|590447198|FG005|Overall Study|Other Than Specified|0|||
163477880|NCT04566445|590447199|FG000|Overall Study|Death|4|||
163477881|NCT04566445|590447200|FG001|Overall Study|Death|1|||
163477882|NCT04566445|590447201|FG002|Overall Study|Death|1|||
163477883|NCT04566445|590447199|FG000|Overall Study|Lost to Follow-up|3|||
163477884|NCT04566445|590447200|FG001|Overall Study|Lost to Follow-up|1|||
163477885|NCT04566445|590447201|FG002|Overall Study|Lost to Follow-up|1|||
163477886|NCT04566445|590447199|FG000|Overall Study|Study terminated by sponsor|11|||
163477887|NCT04566445|590447200|FG001|Overall Study|Study terminated by sponsor|17|||
163477888|NCT04566445|590447201|FG002|Overall Study|Study terminated by sponsor|32|||
163477889|NCT04566445|590447199|FG000|Overall Study|Withdrawal by Subject|12|||
163477890|NCT04566445|590447200|FG001|Overall Study|Withdrawal by Subject|14|||
163477891|NCT04566445|590447201|FG002|Overall Study|Withdrawal by Subject|13|||
163477892|NCT04566445|590447199|FG000|Overall Study|Randomized but not treated due to AE|2|||
163477893|NCT04566445|590447200|FG001|Overall Study|Randomized but not treated due to AE|1|||
163477894|NCT04566445|590447201|FG002|Overall Study|Randomized but not treated due to AE|0|||
163477895|NCT04566445|590447199|FG000|Overall Study|Adverse Event|1|||
163477896|NCT04566445|590447200|FG001|Overall Study|Adverse Event|1|||
163477897|NCT04566445|590447201|FG002|Overall Study|Adverse Event|0|||
163477898|NCT00137267|590447204|FG000|Overall Study|Lost to Follow-up|15|||
163477899|NCT00137267|590447205|FG001|Overall Study|Lost to Follow-up|21|||
163477900|NCT02061540|590447210|FG000|Overall Study|Adverse Event|2|||
163477901|NCT02061540|590447210|FG000|Overall Study|Withdrawal by Subject|2|||
163477902|NCT04005755|590447212|FG000|Overall Study|Adverse Event|6|||
163477903|NCT04005755|590447212|FG000|Overall Study|Physician Decision|3|||
163477904|NCT04005755|590447212|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
163477905|NCT04005755|590447212|FG000|Overall Study|Withdrawal by Subject|3|||
163477906|NCT04005755|590447212|FG000|Overall Study|Lost to Follow-up|1|||
163477907|NCT02289833|590447214|FG000|Overall Study|Study discontinuation|0|||
163477908|NCT02289833|590447215|FG001|Overall Study|Study discontinuation|1|||
163477909|NCT02289833|590447214|FG000|Overall Study|Lost to Follow-up|4|||
163477910|NCT02289833|590447215|FG001|Overall Study|Lost to Follow-up|0|||
163477911|NCT02289833|590447214|FG000|Overall Study|Death|23|||
163477912|NCT02289833|590447215|FG001|Overall Study|Death|16|||
163477913|NCT02561273|590447222|FG000|Overall Study|Protocol Violation|1|||
163477914|NCT02561273|590447223|FG001|Overall Study|Protocol Violation|0|||
163477915|NCT00958191|590447224|FG000|Overall Study|Death|4|||
163477916|NCT00958191|590447224|FG000|Overall Study|Lost to Follow-up|5|||
163477917|NCT00958191|590447224|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
163477918|NCT00958191|590447224|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
163477919|NCT00958191|590447224|FG000|Overall Study|Revision of study device|4|||
163477920|NCT00958191|590447224|FG000|Overall Study|Site termination|11|||
163477921|NCT00958191|590447224|FG000|Overall Study|No 5 yr x-rays|56|||
163477922|NCT01642004|590447225|FG000|Randomization|Adverse Event unrelated to study drug|1|||
163477923|NCT01642004|590447226|FG001|Randomization|Adverse Event unrelated to study drug|0|||
163477924|NCT01642004|590447225|FG000|Randomization|Participant withdrew consent|1|||
163477925|NCT01642004|590447226|FG001|Randomization|Participant withdrew consent|6|||
163477926|NCT01642004|590447225|FG000|Randomization|No longer meets study criteria|2|||
163477927|NCT01642004|590447226|FG001|Randomization|No longer meets study criteria|2|||
163477928|NCT01642004|590447225|FG000|Treatment|Disease progression|95|||
163477929|NCT01642004|590447226|FG001|Treatment|Disease progression|79|||
163477930|NCT01642004|590447225|FG000|Treatment|Study drug toxicity|10|||
163477931|NCT01642004|590447226|FG001|Treatment|Study drug toxicity|13|||
163477932|NCT01642004|590447225|FG000|Treatment|Death|1|||
163477933|NCT01642004|590447226|FG001|Treatment|Death|1|||
163477934|NCT01642004|590447225|FG000|Treatment|Adverse event unrelated to study drug|9|||
163477935|NCT01642004|590447226|FG001|Treatment|Adverse event unrelated to study drug|13|||
163477936|NCT01642004|590447225|FG000|Treatment|Maximum clinical benefit|1|||
163477937|NCT01642004|590447226|FG001|Treatment|Maximum clinical benefit|9|||
163477938|NCT01642004|590447225|FG000|Treatment|Poor/non-compliance|1|||
163477939|NCT01642004|590447226|FG001|Treatment|Poor/non-compliance|0|||
163477940|NCT01642004|590447225|FG000|Treatment|No longer meets study criteria|1|||
163477941|NCT01642004|590447226|FG001|Treatment|No longer meets study criteria|2|||
163477942|NCT01642004|590447225|FG000|Treatment|Other reasons|2|||
163477943|NCT01642004|590447226|FG001|Treatment|Other reasons|0|||
163477944|NCT01642004|590447225|FG000|Treatment|Not reported|0|||
163477945|NCT01642004|590447226|FG001|Treatment|Not reported|3|||
163477946|NCT01642004|590447225|FG000|Treatment|Participant request to discontinue study treatment|6|||
163477947|NCT01642004|590447226|FG001|Treatment|Participant request to discontinue study treatment|4|||
163477948|NCT01642004|590447225|FG000|Treatment|Participant withdrew consent|5|||
163477949|NCT01642004|590447226|FG001|Treatment|Participant withdrew consent|5|||
163477950|NCT01818765|590447229|FG000|Overall Study|Death|2|||
163477951|NCT01562327|590447230|FG000|Overall Study|Adverse Event|2|||
163477952|NCT01562327|590447230|FG000|Overall Study|Lack of Efficacy|1|||
163477953|NCT01562327|590447230|FG000|Overall Study|Participant drop-out|1|||
163477954|NCT01562327|590447230|FG000|Overall Study|Infusion not received at 6 month window|4|||
163477955|NCT04554394|590447239|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
163477956|NCT04554394|590447240|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
163477957|NCT04554394|590447239|FG000|Overall Study|Withdrawal by Subject|2|||
163477958|NCT04554394|590447240|FG001|Overall Study|Withdrawal by Subject|2|||
163477959|NCT04554394|590447239|FG000|Overall Study|Lost to Follow-up|2|||
163477960|NCT04554394|590447240|FG001|Overall Study|Lost to Follow-up|2|||
163477961|NCT04554394|590447239|FG000|Overall Study|Physician Decision|1|||
163477962|NCT04554394|590447240|FG001|Overall Study|Physician Decision|1|||
163477963|NCT02795182|590447241|FG000|Overall Study|Death|5|||
163477964|NCT02795182|590447242|FG001|Overall Study|Death|4|||
163477965|NCT02795182|590447243|FG002|Overall Study|Death|4|||
163477966|NCT02795182|590447244|FG003|Overall Study|Death|18|||
163477967|NCT02795182|590447241|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
163477968|NCT02795182|590447242|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
163477969|NCT02795182|590447243|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
163477970|NCT02795182|590447244|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
163477971|NCT02795182|590447241|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
163477972|NCT02795182|590447242|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
163477973|NCT02795182|590447243|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
163477974|NCT02795182|590447244|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
163477975|NCT02795182|590447241|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
163477976|NCT02795182|590447242|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
163477977|NCT02795182|590447243|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
163477978|NCT02795182|590447244|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
163477979|NCT02795182|590447241|FG000|Overall Study|Withdrawal by Subject|4|||
163477980|NCT02795182|590447242|FG001|Overall Study|Withdrawal by Subject|0|||
163477981|NCT02795182|590447243|FG002|Overall Study|Withdrawal by Subject|0|||
163477982|NCT02795182|590447244|FG003|Overall Study|Withdrawal by Subject|3|||
163477983|NCT02795182|590447241|FG000|Overall Study|Lost to Follow-up|0|||
163477984|NCT02795182|590447242|FG001|Overall Study|Lost to Follow-up|0|||
163477985|NCT02795182|590447243|FG002|Overall Study|Lost to Follow-up|1|||
163477986|NCT02795182|590447244|FG003|Overall Study|Lost to Follow-up|1|||
163477987|NCT02795182|590447241|FG000|Overall Study|Roll Over to Long Term Extension|3|||
163477988|NCT02795182|590447242|FG001|Overall Study|Roll Over to Long Term Extension|3|||
163477989|NCT02795182|590447243|FG002|Overall Study|Roll Over to Long Term Extension|2|||
163477990|NCT02795182|590447244|FG003|Overall Study|Roll Over to Long Term Extension|5|||
163477991|NCT02795182|590447241|FG000|Overall Study|Progressive Disease|0|||
163477992|NCT02795182|590447242|FG001|Overall Study|Progressive Disease|1|||
163477993|NCT02795182|590447243|FG002|Overall Study|Progressive Disease|0|||
163477994|NCT02795182|590447244|FG003|Overall Study|Progressive Disease|4|||
163477995|NCT02795182|590447241|FG000|Overall Study|Physician Decision|0|||
163477996|NCT02795182|590447242|FG001|Overall Study|Physician Decision|0|||
163477997|NCT02795182|590447243|FG002|Overall Study|Physician Decision|0|||
163477998|NCT02795182|590447244|FG003|Overall Study|Physician Decision|1|||
163477999|NCT01021553|590447245|FG000|Overall Study|Adverse Event|1|||
163478000|NCT01021553|590447246|FG001|Overall Study|Adverse Event|0|||
163478001|NCT01021553|590447247|FG002|Overall Study|Adverse Event|0|||
163478002|NCT01021553|590447245|FG000|Overall Study|Lack of Efficacy|2|||
163478003|NCT01021553|590447246|FG001|Overall Study|Lack of Efficacy|2|||
163478004|NCT01021553|590447247|FG002|Overall Study|Lack of Efficacy|0|||
163478005|NCT01021553|590447245|FG000|Overall Study|Protocol Violation|0|||
163478006|NCT01021553|590447246|FG001|Overall Study|Protocol Violation|2|||
163478007|NCT01021553|590447247|FG002|Overall Study|Protocol Violation|2|||
163478008|NCT01021553|590447245|FG000|Overall Study|Lost to Follow-up|0|||
163478009|NCT01021553|590447246|FG001|Overall Study|Lost to Follow-up|0|||
163478010|NCT01021553|590447247|FG002|Overall Study|Lost to Follow-up|1|||
163478011|NCT01021553|590447245|FG000|Overall Study|Withdrawal by Subject|1|||
163478012|NCT01021553|590447246|FG001|Overall Study|Withdrawal by Subject|1|||
163478013|NCT01021553|590447247|FG002|Overall Study|Withdrawal by Subject|0|||
163478014|NCT01950364|590447248|FG000|Overall Study|Adverse Event|3|||
163478015|NCT01950364|590447249|FG001|Overall Study|Adverse Event|0|||
163478016|NCT01950364|590447248|FG000|Overall Study|Stem Cell Transplant|2|||
163478017|NCT01950364|590447249|FG001|Overall Study|Stem Cell Transplant|6|||
163478018|NCT01950364|590447248|FG000|Overall Study|Disease Progression|5|||
163478019|NCT01950364|590447249|FG001|Overall Study|Disease Progression|2|||
163478020|NCT01950364|590447248|FG000|Overall Study|Withdrawal by Subject|0|||
163478021|NCT01950364|590447249|FG001|Overall Study|Withdrawal by Subject|1|||
163478022|NCT01950364|590447248|FG000|Overall Study|Protocol Violation|0|||
163478023|NCT01950364|590447249|FG001|Overall Study|Protocol Violation|1|||
163478024|NCT01055457|590447252|FG000|Overall Study|Lost to Follow-up|0|||
163478025|NCT01055457|590447253|FG001|Overall Study|Lost to Follow-up|1|||
163478026|NCT01055457|590447254|FG002|Overall Study|Lost to Follow-up|0|||
163478027|NCT01055457|590447255|FG003|Overall Study|Lost to Follow-up|0|||
163478028|NCT01055457|590447256|FG004|Overall Study|Lost to Follow-up|0|||
163478029|NCT01055457|590447257|FG005|Overall Study|Lost to Follow-up|1|||
163478030|NCT01055457|590447258|FG006|Overall Study|Lost to Follow-up|0|||
163478031|NCT01055457|590447259|FG007|Overall Study|Lost to Follow-up|0|||
163478032|NCT01055457|590447260|FG008|Overall Study|Lost to Follow-up|0|||
163478033|NCT01055457|590447261|FG009|Overall Study|Lost to Follow-up|0|||
163478034|NCT01055457|590447252|FG000|Overall Study|Protocol Violation|0|||
163478035|NCT01055457|590447253|FG001|Overall Study|Protocol Violation|0|||
163478036|NCT01055457|590447254|FG002|Overall Study|Protocol Violation|1|||
163478037|NCT01055457|590447255|FG003|Overall Study|Protocol Violation|1|||
163478038|NCT01055457|590447256|FG004|Overall Study|Protocol Violation|1|||
163478039|NCT01055457|590447257|FG005|Overall Study|Protocol Violation|2|||
163478040|NCT01055457|590447258|FG006|Overall Study|Protocol Violation|1|||
163478041|NCT01055457|590447259|FG007|Overall Study|Protocol Violation|0|||
163478042|NCT01055457|590447260|FG008|Overall Study|Protocol Violation|0|||
163478043|NCT01055457|590447261|FG009|Overall Study|Protocol Violation|1|||
163478044|NCT01055457|590447252|FG000|Overall Study|Subject Disinterest|0|||
163478045|NCT01055457|590447253|FG001|Overall Study|Subject Disinterest|0|||
163478046|NCT01055457|590447254|FG002|Overall Study|Subject Disinterest|0|||
163478047|NCT01055457|590447255|FG003|Overall Study|Subject Disinterest|0|||
163478048|NCT01055457|590447256|FG004|Overall Study|Subject Disinterest|0|||
163478049|NCT01055457|590447257|FG005|Overall Study|Subject Disinterest|0|||
163478050|NCT01055457|590447258|FG006|Overall Study|Subject Disinterest|0|||
163478051|NCT01055457|590447259|FG007|Overall Study|Subject Disinterest|1|||
163478052|NCT01055457|590447260|FG008|Overall Study|Subject Disinterest|0|||
163478053|NCT01055457|590447261|FG009|Overall Study|Subject Disinterest|0|||
163478054|NCT01055457|590447252|FG000|Overall Study|Subject Ineligible|1|||
163478055|NCT01055457|590447253|FG001|Overall Study|Subject Ineligible|0|||
163478056|NCT01055457|590447254|FG002|Overall Study|Subject Ineligible|1|||
163478057|NCT01055457|590447255|FG003|Overall Study|Subject Ineligible|0|||
163478058|NCT01055457|590447256|FG004|Overall Study|Subject Ineligible|1|||
163478059|NCT01055457|590447257|FG005|Overall Study|Subject Ineligible|0|||
163478060|NCT01055457|590447258|FG006|Overall Study|Subject Ineligible|0|||
163478061|NCT01055457|590447259|FG007|Overall Study|Subject Ineligible|0|||
163478062|NCT01055457|590447260|FG008|Overall Study|Subject Ineligible|0|||
163478063|NCT01055457|590447261|FG009|Overall Study|Subject Ineligible|0|||
163478064|NCT01055457|590447252|FG000|Overall Study|Discomfort|0|||
163478065|NCT01055457|590447253|FG001|Overall Study|Discomfort|0|||
163478066|NCT01055457|590447254|FG002|Overall Study|Discomfort|0|||
163478067|NCT01055457|590447255|FG003|Overall Study|Discomfort|0|||
163478068|NCT01055457|590447256|FG004|Overall Study|Discomfort|1|||
163478069|NCT01055457|590447257|FG005|Overall Study|Discomfort|0|||
163478070|NCT01055457|590447258|FG006|Overall Study|Discomfort|0|||
163478071|NCT01055457|590447259|FG007|Overall Study|Discomfort|0|||
163478072|NCT01055457|590447260|FG008|Overall Study|Discomfort|0|||
163478073|NCT01055457|590447261|FG009|Overall Study|Discomfort|0|||
163478074|NCT01055457|590447252|FG000|Overall Study|Pregnancy|0|||
163478075|NCT01055457|590447253|FG001|Overall Study|Pregnancy|0|||
163478076|NCT01055457|590447254|FG002|Overall Study|Pregnancy|0|||
163478077|NCT01055457|590447255|FG003|Overall Study|Pregnancy|1|||
163478078|NCT01055457|590447256|FG004|Overall Study|Pregnancy|0|||
163478079|NCT01055457|590447257|FG005|Overall Study|Pregnancy|0|||
163478080|NCT01055457|590447258|FG006|Overall Study|Pregnancy|0|||
163478081|NCT01055457|590447259|FG007|Overall Study|Pregnancy|0|||
163478082|NCT01055457|590447260|FG008|Overall Study|Pregnancy|0|||
163478083|NCT01055457|590447261|FG009|Overall Study|Pregnancy|0|||
163478084|NCT01055457|590447252|FG000|Overall Study|Adverse Event|0|||
163478085|NCT01055457|590447253|FG001|Overall Study|Adverse Event|0|||
163478086|NCT01055457|590447254|FG002|Overall Study|Adverse Event|0|||
163478087|NCT01055457|590447255|FG003|Overall Study|Adverse Event|1|||
163478088|NCT01055457|590447256|FG004|Overall Study|Adverse Event|0|||
163478089|NCT01055457|590447257|FG005|Overall Study|Adverse Event|0|||
163478090|NCT01055457|590447258|FG006|Overall Study|Adverse Event|0|||
163478091|NCT01055457|590447259|FG007|Overall Study|Adverse Event|0|||
163478092|NCT01055457|590447260|FG008|Overall Study|Adverse Event|0|||
163478093|NCT01055457|590447261|FG009|Overall Study|Adverse Event|0|||
163478094|NCT00572728|590447262|FG000|Overall Study|Withdrawal by Subject|10|||
163478095|NCT00572728|590447262|FG000|Overall Study|Ineligible|3|||
163478096|NCT00572728|590447262|FG000|Overall Study|Enrolled under Amendment 4|5|||
163478097|NCT00572728|590447262|FG000|Overall Study|Offstudy due to complicating disease|1|||
163478098|NCT00572728|590447262|FG000|Overall Study|FLT1 not completed|4|||
163478099|NCT00572728|590447262|FG000|Overall Study|First Chemotherapy not initiated|2|||
163478100|NCT00572728|590447262|FG000|Overall Study|FLT2 not completed|5|||
163478101|NCT00572728|590447262|FG000|Overall Study|Second chemotherapy not initiated|1|||
163478102|NCT00572728|590447262|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
163478103|NCT00572728|590447262|FG000|Overall Study|Pathology missing|1|||
163478104|NCT01833806|590447265|FG000|Overall Study|Alternative treatment|2|||
163478105|NCT01833806|590447265|FG000|Overall Study|Death|5|||
163478106|NCT01833806|590447265|FG000|Overall Study|Physician Decision|1|||
163478107|NCT01833806|590447265|FG000|Overall Study|Lost to Follow-up|1|||
163478108|NCT02724111|590447266|FG000|Overall Study|Protocol Violation|2|||
163478109|NCT02724111|590447267|FG001|Overall Study|Protocol Violation|5|||
163478110|NCT02996500|590447268|FG000|Overall Study|Adverse Event|1|||
163478111|NCT02996500|590447269|FG001|Overall Study|Adverse Event|1|||
163478112|NCT02996500|590447270|FG002|Overall Study|Adverse Event|4|||
163478113|NCT02996500|590447271|FG003|Overall Study|Adverse Event|3|||
163478114|NCT02996500|590447272|FG004|Overall Study|Adverse Event|1|||
163478115|NCT02996500|590447273|FG005|Overall Study|Adverse Event|2|||
163478116|NCT02996500|590447268|FG000|Overall Study|Lack of Efficacy|0|||
163478117|NCT02996500|590447269|FG001|Overall Study|Lack of Efficacy|0|||
163478118|NCT02996500|590447270|FG002|Overall Study|Lack of Efficacy|0|||
163478119|NCT02996500|590447271|FG003|Overall Study|Lack of Efficacy|0|||
163478120|NCT02996500|590447272|FG004|Overall Study|Lack of Efficacy|2|||
163478121|NCT02996500|590447273|FG005|Overall Study|Lack of Efficacy|0|||
163478122|NCT02996500|590447268|FG000|Overall Study|Lost to Follow-up|1|||
163478123|NCT02996500|590447269|FG001|Overall Study|Lost to Follow-up|0|||
163478124|NCT02996500|590447270|FG002|Overall Study|Lost to Follow-up|0|||
163478125|NCT02996500|590447271|FG003|Overall Study|Lost to Follow-up|0|||
163478126|NCT02996500|590447272|FG004|Overall Study|Lost to Follow-up|0|||
163478127|NCT02996500|590447273|FG005|Overall Study|Lost to Follow-up|1|||
163478128|NCT02996500|590447268|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
163478129|NCT02996500|590447269|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
163478130|NCT02996500|590447270|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
163478131|NCT02996500|590447271|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
163478132|NCT02996500|590447272|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
163478133|NCT02996500|590447273|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
163478134|NCT02996500|590447268|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163478135|NCT02996500|590447269|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163478136|NCT02996500|590447270|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163478137|NCT02996500|590447271|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163478138|NCT02996500|590447272|FG004|Overall Study|Non-Compliance With Study Drug|0|||
163478139|NCT02996500|590447273|FG005|Overall Study|Non-Compliance With Study Drug|1|||
163478140|NCT02996500|590447268|FG000|Overall Study|Progressive Disease|1|||
163478141|NCT02996500|590447269|FG001|Overall Study|Progressive Disease|0|||
163478142|NCT02996500|590447270|FG002|Overall Study|Progressive Disease|0|||
163478143|NCT02996500|590447271|FG003|Overall Study|Progressive Disease|0|||
163478144|NCT02996500|590447272|FG004|Overall Study|Progressive Disease|0|||
163478145|NCT02996500|590447273|FG005|Overall Study|Progressive Disease|0|||
163478146|NCT02996500|590447268|FG000|Overall Study|Other|2|||
163478147|NCT02996500|590447269|FG001|Overall Study|Other|0|||
163478148|NCT02996500|590447270|FG002|Overall Study|Other|2|||
163478149|NCT02996500|590447271|FG003|Overall Study|Other|0|||
163478150|NCT02996500|590447272|FG004|Overall Study|Other|0|||
163478151|NCT02996500|590447273|FG005|Overall Study|Other|0|||
163478152|NCT02996500|590447268|FG000|Overall Study|Protocol Violation|0|||
163478153|NCT02996500|590447269|FG001|Overall Study|Protocol Violation|0|||
163478154|NCT02996500|590447270|FG002|Overall Study|Protocol Violation|0|||
163478155|NCT02996500|590447271|FG003|Overall Study|Protocol Violation|1|||
163478156|NCT02996500|590447272|FG004|Overall Study|Protocol Violation|0|||
163478157|NCT02996500|590447273|FG005|Overall Study|Protocol Violation|0|||
163478158|NCT02996500|590447268|FG000|Overall Study|Withdrawal by Subject|3|||
163478159|NCT02996500|590447269|FG001|Overall Study|Withdrawal by Subject|0|||
163478160|NCT02996500|590447270|FG002|Overall Study|Withdrawal by Subject|3|||
163478161|NCT02996500|590447271|FG003|Overall Study|Withdrawal by Subject|0|||
163478162|NCT02996500|590447272|FG004|Overall Study|Withdrawal by Subject|2|||
163478163|NCT02996500|590447273|FG005|Overall Study|Withdrawal by Subject|0|||
163478164|NCT02187224|590447274|FG000|Overall Study|Did not show up for test day|1|||
163478165|NCT02187224|590447275|FG001|Overall Study|Did not show up for test day|0|||
163478166|NCT01010776|590447280|FG000|Main Phase|Withdrawal by Subject|14|||
163478167|NCT01010776|590447280|FG000|Main Phase|Lack of Efficacy|8|||
163478168|NCT01010776|590447280|FG000|Main Phase|Adverse Event|7|||
163478169|NCT01010776|590447280|FG000|Main Phase|Lost to Follow-up|6|||
163478170|NCT01010776|590447280|FG000|Main Phase|Non-compliance to study medication|5|||
163478171|NCT01010776|590447280|FG000|Main Phase|Selection failure|2|||
163478172|NCT01010776|590447280|FG000|Main Phase|Inform consent withdrawal|1|||
163478173|NCT01010776|590447280|FG000|Main Phase|Other|1|||
163478174|NCT01010776|590447280|FG000|Main Phase|Did not received study medication|5|||
163478175|NCT01010776|590447280|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
163478176|NCT01010776|590447280|FG000|Extension Phase|Other|3|||
163478177|NCT02332876|590447281|FG000|Overall Study|Lost to Follow-up|1|||
163478178|NCT02332876|590447282|FG001|Overall Study|Lost to Follow-up|1|||
163478179|NCT00415623|590447286|FG000|Overall Study|Adverse Event|3|||
163478180|NCT00415623|590447287|FG001|Overall Study|Adverse Event|4|||
163478181|NCT00415623|590447286|FG000|Overall Study|Death|1|||
163478182|NCT00415623|590447287|FG001|Overall Study|Death|0|||
163478183|NCT00415623|590447286|FG000|Overall Study|Withdrawal by Subject|1|||
163478184|NCT00415623|590447287|FG001|Overall Study|Withdrawal by Subject|1|||
163478185|NCT01369069|590447288|FG000|Overall Study|Lost to Follow-up|8|||
163478186|NCT01369069|590447289|FG001|Overall Study|Lost to Follow-up|9|||
163478187|NCT01369069|590447288|FG000|Overall Study|Withdrawal by Subject|9|||
163478188|NCT01369069|590447289|FG001|Overall Study|Withdrawal by Subject|7|||
163478189|NCT02573012|590447290|FG000|Overall Study|Adverse Event|5|||
163478190|NCT02573012|590447291|FG001|Overall Study|Adverse Event|5|||
163478191|NCT02573012|590447290|FG000|Overall Study|Lack of Efficacy|5|||
163478192|NCT02573012|590447291|FG001|Overall Study|Lack of Efficacy|4|||
163478193|NCT02573012|590447290|FG000|Overall Study|Non-compliance|1|||
163478194|NCT02573012|590447291|FG001|Overall Study|Non-compliance|2|||
163478195|NCT02573012|590447290|FG000|Overall Study|Withdrawal by Subject|2|||
163478196|NCT02573012|590447291|FG001|Overall Study|Withdrawal by Subject|2|||
163478197|NCT02573012|590447290|FG000|Overall Study|Study Ended per Protocol|1|||
163478198|NCT02573012|590447291|FG001|Overall Study|Study Ended per Protocol|0|||
163478199|NCT02573012|590447290|FG000|Overall Study|Physician Decision|1|||
163478200|NCT02573012|590447291|FG001|Overall Study|Physician Decision|2|||
163478201|NCT00882362|590447292|FG000|Overall Study|Adverse Event|13|||
163478202|NCT00882362|590447293|FG001|Overall Study|Adverse Event|10|||
163478203|NCT00882362|590447292|FG000|Overall Study|Withdrawal by Subject|13|||
163478204|NCT00882362|590447293|FG001|Overall Study|Withdrawal by Subject|10|||
163478205|NCT00882362|590447292|FG000|Overall Study|Lack of Efficacy|3|||
163478206|NCT00882362|590447293|FG001|Overall Study|Lack of Efficacy|0|||
163478207|NCT00882362|590447292|FG000|Overall Study|Protocol Violation|7|||
163478208|NCT00882362|590447293|FG001|Overall Study|Protocol Violation|2|||
163478209|NCT00882362|590447292|FG000|Overall Study|Pregnancy|1|||
163478210|NCT00882362|590447293|FG001|Overall Study|Pregnancy|0|||
163478211|NCT00882362|590447292|FG000|Overall Study|Physician Decision|5|||
163478212|NCT00882362|590447293|FG001|Overall Study|Physician Decision|1|||
163478213|NCT00882362|590447292|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
163478214|NCT00882362|590447293|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
163478215|NCT00882362|590447292|FG000|Overall Study|change of residence or other commitments|5|||
163478216|NCT00882362|590447293|FG001|Overall Study|change of residence or other commitments|0|||
163478217|NCT01268514|590447294|FG000|Overall Study|Adverse Event|20|||
163478218|NCT01268514|590447294|FG000|Overall Study|Death|8|||
163478219|NCT01268514|590447294|FG000|Overall Study|Lost to Follow-up|5|||
163478220|NCT01268514|590447294|FG000|Overall Study|Withdrawal by Subject|3|||
163478221|NCT01268514|590447294|FG000|Overall Study|Withdrawal by Surgeon|5|||
163478222|NCT02382276|590447297|FG000|Overall Study|Withdrawal by Subject|4|||
163478223|NCT02382276|590447298|FG001|Overall Study|Withdrawal by Subject|8|||
163478224|NCT02382276|590447299|FG002|Overall Study|Withdrawal by Subject|5|||
163478225|NCT02382276|590447297|FG000|Overall Study|Adverse Event|7|||
163478226|NCT02382276|590447298|FG001|Overall Study|Adverse Event|2|||
163478227|NCT02382276|590447299|FG002|Overall Study|Adverse Event|32|||
163478228|NCT02382276|590447297|FG000|Overall Study|Physician Decision|0|||
163478229|NCT02382276|590447298|FG001|Overall Study|Physician Decision|0|||
163478230|NCT02382276|590447299|FG002|Overall Study|Physician Decision|2|||
163478231|NCT01222416|590447300|FG000|Overall Study|ineligible;metastasis|3|||
163478232|NCT01222416|590447301|FG001|Overall Study|ineligible;metastasis|0|||
163478233|NCT01222416|590447300|FG000|Overall Study|Adverse Event|4|||
163478234|NCT01222416|590447301|FG001|Overall Study|Adverse Event|0|||
163478235|NCT01222416|590447300|FG000|Overall Study|Withdrawal by Subject|5|||
163478236|NCT01222416|590447301|FG001|Overall Study|Withdrawal by Subject|0|||
163478237|NCT01222416|590447300|FG000|Overall Study|scheduling|6|||
163478238|NCT01222416|590447301|FG001|Overall Study|scheduling|0|||
163478239|NCT01222416|590447300|FG000|Overall Study|missed view/scan|1|||
163478240|NCT01222416|590447301|FG001|Overall Study|missed view/scan|0|||
163478241|NCT01222416|590447300|FG000|Overall Study|Death|1|||
163478242|NCT01222416|590447301|FG001|Overall Study|Death|0|||
163478243|NCT03258762|590447308|FG000|Overall Study|Lost to Follow-up|0|||
163478244|NCT03258762|590447309|FG001|Overall Study|Lost to Follow-up|1|||
163478245|NCT02545049|590447316|FG000|Overall Study|Withdrawal by Subject|1|||
163478246|NCT02545049|590447317|FG001|Overall Study|Withdrawal by Subject|7|||
163478247|NCT02545049|590447316|FG000|Overall Study|Lost to Follow-up|4|||
163478248|NCT02545049|590447317|FG001|Overall Study|Lost to Follow-up|6|||
163478249|NCT02545049|590447316|FG000|Overall Study|GCP violations|37|||
163478250|NCT02545049|590447317|FG001|Overall Study|GCP violations|48|||
163478251|NCT04191096|590447319|FG000|Overall Study|Death|102|||
163478252|NCT04191096|590447320|FG001|Overall Study|Death|89|||
163478253|NCT04191096|590447319|FG000|Overall Study|Lost to Follow-up|1|||
163478254|NCT04191096|590447320|FG001|Overall Study|Lost to Follow-up|1|||
163478255|NCT04191096|590447319|FG000|Overall Study|Withdrawal by Subject|5|||
163478256|NCT04191096|590447320|FG001|Overall Study|Withdrawal by Subject|5|||
163478257|NCT04191096|590447319|FG000|Overall Study|Participants Ongoing|518|||
163478258|NCT04191096|590447320|FG001|Overall Study|Participants Ongoing|530|||
163478259|NCT00027027|590449178|FG000|Overall Study|Adverse Event|0|||
163478260|NCT00027027|590449179|FG001|Overall Study|Adverse Event|0|||
163478261|NCT00027027|590449180|FG002|Overall Study|Adverse Event|1|||
163478262|NCT00027027|590449181|FG003|Overall Study|Adverse Event|0|||
163478263|NCT00027027|590449182|FG004|Overall Study|Adverse Event|1|||
163478264|NCT00027027|590449178|FG000|Overall Study|Admitted for Signs of PD|0|||
163478265|NCT00027027|590449179|FG001|Overall Study|Admitted for Signs of PD|0|||
163478266|NCT00027027|590449180|FG002|Overall Study|Admitted for Signs of PD|0|||
163478267|NCT00027027|590449181|FG003|Overall Study|Admitted for Signs of PD|0|||
163478268|NCT00027027|590449182|FG004|Overall Study|Admitted for Signs of PD|1|||
163478269|NCT00027027|590449178|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
163478270|NCT00027027|590449179|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
163478271|NCT00027027|590449180|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
163478272|NCT00027027|590449181|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
163478273|NCT00027027|590449182|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
163478274|NCT00027027|590449178|FG000|Overall Study|PD Requiring Surgery|0|||
163478275|NCT00027027|590449179|FG001|Overall Study|PD Requiring Surgery|0|||
163478276|NCT00027027|590449180|FG002|Overall Study|PD Requiring Surgery|1|||
163478277|NCT00027027|590449181|FG003|Overall Study|PD Requiring Surgery|0|||
163478278|NCT00027027|590449182|FG004|Overall Study|PD Requiring Surgery|0|||
163478279|NCT00027027|590449178|FG000|Overall Study|Physician Decision Due To PD|2|||
163478280|NCT00027027|590449179|FG001|Overall Study|Physician Decision Due To PD|3|||
163478281|NCT00027027|590449180|FG002|Overall Study|Physician Decision Due To PD|2|||
163478282|NCT00027027|590449181|FG003|Overall Study|Physician Decision Due To PD|3|||
163478283|NCT00027027|590449182|FG004|Overall Study|Physician Decision Due To PD|5|||
163478284|NCT00027027|590449178|FG000|Overall Study|Withdrawal by Subject|0|||
163478285|NCT00027027|590449179|FG001|Overall Study|Withdrawal by Subject|0|||
163478286|NCT00027027|590449180|FG002|Overall Study|Withdrawal by Subject|0|||
163478287|NCT00027027|590449181|FG003|Overall Study|Withdrawal by Subject|0|||
163478288|NCT00027027|590449182|FG004|Overall Study|Withdrawal by Subject|1|||
163478289|NCT00003389|590449186|FG000|Overall Study|Disease progression|6|||
163478290|NCT00003389|590449187|FG001|Overall Study|Disease progression|1|||
163478291|NCT00003389|590449186|FG000|Overall Study|Adverse Event|13|||
163478292|NCT00003389|590449187|FG001|Overall Study|Adverse Event|2|||
163478293|NCT00003389|590449186|FG000|Overall Study|Death|0|||
163478294|NCT00003389|590449187|FG001|Overall Study|Death|3|||
163478295|NCT00003389|590449186|FG000|Overall Study|Withdrawal by Subject|12|||
163478296|NCT00003389|590449187|FG001|Overall Study|Withdrawal by Subject|5|||
163478297|NCT00003389|590449186|FG000|Overall Study|Alternative therapy|2|||
163478298|NCT00003389|590449187|FG001|Overall Study|Alternative therapy|1|||
163478299|NCT00003389|590449186|FG000|Overall Study|Complicating disease|1|||
163478300|NCT00003389|590449187|FG001|Overall Study|Complicating disease|0|||
163478301|NCT00003389|590449186|FG000|Overall Study|Off-treatment reason missing|31|||
163478302|NCT00003389|590449187|FG001|Overall Study|Off-treatment reason missing|21|||
163478303|NCT00003389|590449186|FG000|Overall Study|Ineligible|33|||
163478304|NCT00003389|590449187|FG001|Overall Study|Ineligible|27|||
163478305|NCT02306148|590449189|FG000|Overall Study|Adverse Event|12|||
163478306|NCT02306148|590449190|FG001|Overall Study|Adverse Event|6|||
163478307|NCT02306148|590449189|FG000|Overall Study|Lost to Follow-up|1|||
163478308|NCT02306148|590449190|FG001|Overall Study|Lost to Follow-up|4|||
163478309|NCT04397757|590449191|FG000|Overall Study|Death|3|||
163478310|NCT04397757|590449192|FG001|Overall Study|Death|11|||
163478311|NCT04397757|590449191|FG000|Overall Study|Withdrawal by Subject|2|||
163478312|NCT04397757|590449192|FG001|Overall Study|Withdrawal by Subject|0|||
163478313|NCT04397757|590449191|FG000|Overall Study|Lost to Follow-up|4|||
163478314|NCT04397757|590449192|FG001|Overall Study|Lost to Follow-up|3|||
163478315|NCT04657003|590449199|FG000|Overall Study|Adverse Event|5|||
163478316|NCT04657003|590449200|FG001|Overall Study|Adverse Event|1|||
163478317|NCT04657003|590449201|FG002|Overall Study|Adverse Event|5|||
163478318|NCT04657003|590449199|FG000|Overall Study|Death|0|||
163478319|NCT04657003|590449200|FG001|Overall Study|Death|2|||
163478320|NCT04657003|590449201|FG002|Overall Study|Death|0|||
163478321|NCT04657003|590449199|FG000|Overall Study|Lost to Follow-up|8|||
163478322|NCT04657003|590449200|FG001|Overall Study|Lost to Follow-up|4|||
163478323|NCT04657003|590449201|FG002|Overall Study|Lost to Follow-up|10|||
163478324|NCT04657003|590449199|FG000|Overall Study|Other - As Reported by Investigator|3|||
163478325|NCT04657003|590449200|FG001|Overall Study|Other - As Reported by Investigator|2|||
163478326|NCT04657003|590449201|FG002|Overall Study|Other - As Reported by Investigator|2|||
163478327|NCT04657003|590449199|FG000|Overall Study|Pregnancy|2|||
163478328|NCT04657003|590449200|FG001|Overall Study|Pregnancy|0|||
163478329|NCT04657003|590449201|FG002|Overall Study|Pregnancy|2|||
163478330|NCT04657003|590449199|FG000|Overall Study|Withdrawal by Subject|16|||
163478331|NCT04657003|590449200|FG001|Overall Study|Withdrawal by Subject|7|||
163478332|NCT04657003|590449201|FG002|Overall Study|Withdrawal by Subject|10|||
163478333|NCT05158244|590449204|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
163478334|NCT05158244|590449205|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
163478335|NCT05158244|590449206|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
163478336|NCT05158244|590449207|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
163478337|NCT05158244|590449208|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
163478338|NCT05158244|590449204|FG000|Overall Study|Withdrawal by Subject|0|||
163478339|NCT05158244|590449205|FG001|Overall Study|Withdrawal by Subject|0|||
163478340|NCT05158244|590449206|FG002|Overall Study|Withdrawal by Subject|1|||
163478341|NCT05158244|590449207|FG003|Overall Study|Withdrawal by Subject|0|||
163478342|NCT05158244|590449208|FG004|Overall Study|Withdrawal by Subject|0|||
163478343|NCT02408016|590449210|FG000|Overall Study|Death|6|||
163478344|NCT02408016|590449211|FG001|Overall Study|Death|1|||
163478345|NCT02408016|590449212|FG002|Overall Study|Death|0|||
163478346|NCT02408016|590449210|FG000|Overall Study|Physician Decision|0|||
163478347|NCT02408016|590449211|FG001|Overall Study|Physician Decision|2|||
163478348|NCT02408016|590449212|FG002|Overall Study|Physician Decision|0|||
163478349|NCT00775138|590449213|FG000|Overall Study|Withdrawal by Subject|0|||
163478350|NCT00775138|590449214|FG001|Overall Study|Withdrawal by Subject|0|||
163478351|NCT00775138|590449215|FG002|Overall Study|Withdrawal by Subject|2|||
163478352|NCT00775138|590449216|FG003|Overall Study|Withdrawal by Subject|2|||
163478353|NCT00775138|590449213|FG000|Overall Study|Adverse Event|0|||
163478354|NCT00775138|590449214|FG001|Overall Study|Adverse Event|0|||
163478355|NCT00775138|590449215|FG002|Overall Study|Adverse Event|1|||
163478356|NCT00775138|590449216|FG003|Overall Study|Adverse Event|0|||
163478357|NCT00712712|590449221|FG000|Overall Study|Protocol Violation|11|||
163478358|NCT00712712|590449221|FG000|Overall Study|Radiofrequency not done|3|||
163478359|NCT00712712|590449221|FG000|Overall Study|Death|8|||
163478360|NCT00712712|590449221|FG000|Overall Study|Withdrawal by Subject|1|||
163478361|NCT02723019|590449222|FG000|Overall Study|Death|17|||
163478362|NCT02723019|590449223|FG001|Overall Study|Death|13|||
163478363|NCT02723019|590449222|FG000|Overall Study|Withdrawal by Subject|11|||
163478364|NCT02723019|590449223|FG001|Overall Study|Withdrawal by Subject|7|||
163478365|NCT02723019|590449222|FG000|Overall Study|Lost to Follow-up|57|||
163478366|NCT02723019|590449223|FG001|Overall Study|Lost to Follow-up|70|||
163478367|NCT00611767|590449225|FG000|Overall Study|Withdrawal by Subject|4|||
163478368|NCT00611767|590449226|FG001|Overall Study|Withdrawal by Subject|1|||
163478369|NCT00611767|590449225|FG000|Overall Study|Thiopental not available|3|||
163478370|NCT00611767|590449226|FG001|Overall Study|Thiopental not available|0|||
163478371|NCT00611767|590449225|FG000|Overall Study|didn't like the medication|1|||
163478372|NCT00611767|590449226|FG001|Overall Study|didn't like the medication|1|||
163478373|NCT00611767|590449225|FG000|Overall Study|Physician Decision|1|||
163478374|NCT00611767|590449226|FG001|Overall Study|Physician Decision|0|||
163478375|NCT02718625|590449227|FG000|Overall Study|Adverse Event|0|||
163478376|NCT02718625|590449228|FG001|Overall Study|Adverse Event|1|||
163478377|NCT02718625|590449227|FG000|Overall Study|Termination of Study by Sponsor|0|||
163478378|NCT02718625|590449228|FG001|Overall Study|Termination of Study by Sponsor|1|||
163478379|NCT00811395|590449229|FG000|Extension Treatment|Adverse Event|1|||
163478380|NCT00811395|590449230|FG001|Extension Treatment|Adverse Event|2|||
163478381|NCT00811395|590449231|FG002|Extension Treatment|Adverse Event|2|||
163478382|NCT00811395|590449232|FG003|Extension Treatment|Adverse Event|2|||
163478383|NCT00811395|590449233|FG004|Extension Treatment|Adverse Event|0|||
163478384|NCT00811395|590449234|FG005|Extension Treatment|Adverse Event|1|||
163478385|NCT00811395|590449229|FG000|Extension Treatment|Progressive disease|1|||
163478386|NCT00811395|590449230|FG001|Extension Treatment|Progressive disease|1|||
163478387|NCT00811395|590449231|FG002|Extension Treatment|Progressive disease|0|||
163478388|NCT00811395|590449232|FG003|Extension Treatment|Progressive disease|0|||
163478389|NCT00811395|590449233|FG004|Extension Treatment|Progressive disease|0|||
163478390|NCT00811395|590449234|FG005|Extension Treatment|Progressive disease|0|||
163478391|NCT00811395|590449229|FG000|Extension Treatment|Participant did not wish to continue|0|||
163478392|NCT00811395|590449230|FG001|Extension Treatment|Participant did not wish to continue|3|||
163478393|NCT00811395|590449231|FG002|Extension Treatment|Participant did not wish to continue|0|||
163478394|NCT00811395|590449232|FG003|Extension Treatment|Participant did not wish to continue|1|||
163478395|NCT00811395|590449233|FG004|Extension Treatment|Participant did not wish to continue|0|||
163478396|NCT00811395|590449234|FG005|Extension Treatment|Participant did not wish to continue|1|||
163478397|NCT00811395|590449229|FG000|Extension Treatment|Other than above|0|||
163478398|NCT00811395|590449230|FG001|Extension Treatment|Other than above|0|||
163478399|NCT00811395|590449231|FG002|Extension Treatment|Other than above|1|||
163478400|NCT00811395|590449232|FG003|Extension Treatment|Other than above|0|||
163478401|NCT00811395|590449233|FG004|Extension Treatment|Other than above|0|||
163478402|NCT00811395|590449234|FG005|Extension Treatment|Other than above|0|||
163478403|NCT01947127|590449239|FG000|Overall Study|Protocol Violation|18|||
163478404|NCT01947127|590449240|FG001|Overall Study|Protocol Violation|38|||
163478405|NCT01947127|590449239|FG000|Overall Study|Withdrawal by Subject|1|||
163478406|NCT01947127|590449240|FG001|Overall Study|Withdrawal by Subject|1|||
163478407|NCT01947127|590449239|FG000|Overall Study|Data loss|4|||
163478408|NCT01947127|590449240|FG001|Overall Study|Data loss|4|||
163478409|NCT00170846|590449241|FG000|Overall Study|Subject withdrew Informed Consent|5|||
163478410|NCT00170846|590449242|FG001|Overall Study|Subject withdrew Informed Consent|12|||
163478411|NCT00170846|590449243|FG002|Overall Study|Subject withdrew Informed Consent|8|||
163478412|NCT00170846|590449241|FG000|Overall Study|Lost to Follow-up|6|||
163478413|NCT00170846|590449242|FG001|Overall Study|Lost to Follow-up|3|||
163478414|NCT00170846|590449243|FG002|Overall Study|Lost to Follow-up|2|||
163478415|NCT00170846|590449241|FG000|Overall Study|Death|0|||
163478416|NCT00170846|590449242|FG001|Overall Study|Death|3|||
163478417|NCT00170846|590449243|FG002|Overall Study|Death|3|||
163478418|NCT00170846|590449241|FG000|Overall Study|Reason Missing|0|||
163478419|NCT00170846|590449242|FG001|Overall Study|Reason Missing|1|||
163478420|NCT00170846|590449243|FG002|Overall Study|Reason Missing|0|||
163478421|NCT00952588|590449244|FG000|Overall Study|Death|28|||
163478422|NCT00952588|590449245|FG001|Overall Study|Death|13|||
163478423|NCT00952588|590449244|FG000|Overall Study|Withdrawal by Subject|2|||
163478424|NCT00952588|590449245|FG001|Overall Study|Withdrawal by Subject|5|||
163478425|NCT00952588|590449244|FG000|Overall Study|Adverse Event|2|||
163478426|NCT00952588|590449245|FG001|Overall Study|Adverse Event|3|||
163478427|NCT00952588|590449244|FG000|Overall Study|Lost to Follow-up|2|||
163478428|NCT00952588|590449245|FG001|Overall Study|Lost to Follow-up|0|||
163478429|NCT00952588|590449244|FG000|Overall Study|Physician Decision|0|||
163478430|NCT00952588|590449245|FG001|Overall Study|Physician Decision|1|||
163478431|NCT00952588|590449244|FG000|Overall Study|Lack of Efficacy|2|||
163478432|NCT00952588|590449245|FG001|Overall Study|Lack of Efficacy|2|||
163478433|NCT01469637|590449248|FG000|First Intervention|Unacceptable behavior|0|||
163478434|NCT01469637|590449249|FG001|First Intervention|Unacceptable behavior|1|||
163478435|NCT01469637|590449248|FG000|Second Intervention|Incarcerated|1|||
163478436|NCT01469637|590449249|FG001|Second Intervention|Incarcerated|0|||
163478437|NCT00887913|590449250|FG000|Overall Study|Withdrawal by Subject|6|||
163478438|NCT01708915|590449264|FG000|Overall Study|Adverse Event|1|||
163478439|NCT01708915|590449265|FG001|Overall Study|Adverse Event|0|||
163478440|NCT01708915|590449266|FG002|Overall Study|Adverse Event|9|||
163478441|NCT01708915|590449267|FG003|Overall Study|Adverse Event|13|||
163478442|NCT01708915|590449264|FG000|Overall Study|Lack of Efficacy|84|||
163478443|NCT01708915|590449265|FG001|Overall Study|Lack of Efficacy|60|||
163478444|NCT01708915|590449266|FG002|Overall Study|Lack of Efficacy|35|||
163478445|NCT01708915|590449267|FG003|Overall Study|Lack of Efficacy|15|||
163478446|NCT01708915|590449264|FG000|Overall Study|Protocol Violation|0|||
163478447|NCT01708915|590449265|FG001|Overall Study|Protocol Violation|0|||
163478448|NCT01708915|590449266|FG002|Overall Study|Protocol Violation|0|||
163478449|NCT01708915|590449267|FG003|Overall Study|Protocol Violation|1|||
163478450|NCT01708915|590449264|FG000|Overall Study|Withdrawal by Subject|0|||
163478451|NCT01708915|590449265|FG001|Overall Study|Withdrawal by Subject|1|||
163478452|NCT01708915|590449266|FG002|Overall Study|Withdrawal by Subject|2|||
163478453|NCT01708915|590449267|FG003|Overall Study|Withdrawal by Subject|2|||
163478454|NCT01708915|590449264|FG000|Overall Study|Other reasons than stated above|1|||
163478455|NCT01708915|590449265|FG001|Overall Study|Other reasons than stated above|1|||
163478456|NCT01708915|590449266|FG002|Overall Study|Other reasons than stated above|0|||
163478457|NCT01708915|590449267|FG003|Overall Study|Other reasons than stated above|2|||
163478458|NCT03267576|590449268|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
163478459|NCT03267576|590449269|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
163478460|NCT03267576|590449268|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
163478461|NCT03267576|590449269|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
163478462|NCT02168816|590449275|FG000|Overall Study|Lost to Follow-up|2|||
163478463|NCT02168816|590449276|FG001|Overall Study|Lost to Follow-up|2|||
163478464|NCT01984294|590449277|FG000|Overall Study|Randomized but Never Treated|0|||
163478465|NCT01984294|590449278|FG001|Overall Study|Randomized but Never Treated|0|||
163478466|NCT01984294|590449279|FG002|Overall Study|Randomized but Never Treated|1|||
163478467|NCT01984294|590449277|FG000|Overall Study|Lack of Efficacy|4|||
163478468|NCT01984294|590449278|FG001|Overall Study|Lack of Efficacy|2|||
163478469|NCT01984294|590449279|FG002|Overall Study|Lack of Efficacy|6|||
163478470|NCT01984294|590449277|FG000|Overall Study|Adverse Event|0|||
163478471|NCT01984294|590449278|FG001|Overall Study|Adverse Event|1|||
163478472|NCT01984294|590449279|FG002|Overall Study|Adverse Event|0|||
163478473|NCT01987609|590449282|FG000|Overall Study|Adverse Event|1|||
163478474|NCT02709889|590449287|FG000|Overall Study|Withdrawal by Subject|11|||
163478475|NCT02709889|590449288|FG001|Overall Study|Withdrawal by Subject|10|||
163478476|NCT02709889|590449289|FG002|Overall Study|Withdrawal by Subject|2|||
163478477|NCT02709889|590449290|FG003|Overall Study|Withdrawal by Subject|12|||
163478478|NCT02709889|590449287|FG000|Overall Study|Death|25|||
163478479|NCT02709889|590449288|FG001|Overall Study|Death|38|||
163478480|NCT02709889|590449289|FG002|Overall Study|Death|4|||
163478481|NCT02709889|590449290|FG003|Overall Study|Death|44|||
163478482|NCT02709889|590449287|FG000|Overall Study|Physician Decision|1|||
163478483|NCT02709889|590449288|FG001|Overall Study|Physician Decision|2|||
163478484|NCT02709889|590449289|FG002|Overall Study|Physician Decision|3|||
163478485|NCT02709889|590449290|FG003|Overall Study|Physician Decision|5|||
163478486|NCT02709889|590449287|FG000|Overall Study|Lost to Follow-up|2|||
163478487|NCT02709889|590449288|FG001|Overall Study|Lost to Follow-up|0|||
163478488|NCT02709889|590449289|FG002|Overall Study|Lost to Follow-up|0|||
163478489|NCT02709889|590449290|FG003|Overall Study|Lost to Follow-up|4|||
163478490|NCT02709889|590449287|FG000|Overall Study|Study Terminated by Sponsor|4|||
163478491|NCT02709889|590449288|FG001|Overall Study|Study Terminated by Sponsor|6|||
163478492|NCT02709889|590449289|FG002|Overall Study|Study Terminated by Sponsor|2|||
163478493|NCT02709889|590449290|FG003|Overall Study|Study Terminated by Sponsor|17|||
163478494|NCT02709889|590449287|FG000|Overall Study|Other, Not Specified|0|||
163478495|NCT02709889|590449288|FG001|Overall Study|Other, Not Specified|1|||
163478496|NCT02709889|590449289|FG002|Overall Study|Other, Not Specified|1|||
163478497|NCT02709889|590449290|FG003|Overall Study|Other, Not Specified|6|||
163478498|NCT00537810|590449291|FG000|Overall Study|Withdrawal by Subject|4|||
163478499|NCT00537810|590449292|FG001|Overall Study|Withdrawal by Subject|11|||
163478500|NCT00537810|590449293|FG002|Overall Study|Withdrawal by Subject|4|||
163478501|NCT00537810|590449294|FG003|Overall Study|Withdrawal by Subject|3|||
163478502|NCT00537810|590449291|FG000|Overall Study|Medically withdrawn|2|||
163478503|NCT00537810|590449292|FG001|Overall Study|Medically withdrawn|2|||
163478504|NCT00537810|590449293|FG002|Overall Study|Medically withdrawn|0|||
163478505|NCT00537810|590449294|FG003|Overall Study|Medically withdrawn|1|||
163478506|NCT01066546|590449295|FG000|Overall Study|Study terminated by sponsor|5|||
163478507|NCT03452397|590449300|FG000|Overall Study|Adverse Event|1|||
163478508|NCT03452397|590449301|FG001|Overall Study|Adverse Event|0|||
163478509|NCT03452397|590449302|FG002|Overall Study|Adverse Event|0|||
163478510|NCT03452397|590449303|FG003|Overall Study|Adverse Event|0|||
163478511|NCT03452397|590449300|FG000|Overall Study|Administrative reason|0|||
163478512|NCT03452397|590449301|FG001|Overall Study|Administrative reason|0|||
163478513|NCT03452397|590449302|FG002|Overall Study|Administrative reason|1|||
163478514|NCT03452397|590449303|FG003|Overall Study|Administrative reason|1|||
163478515|NCT03452397|590449300|FG000|Overall Study|Withdrawal by Subject|0|||
163478516|NCT03452397|590449301|FG001|Overall Study|Withdrawal by Subject|0|||
163478517|NCT03452397|590449302|FG002|Overall Study|Withdrawal by Subject|1|||
163478518|NCT03452397|590449303|FG003|Overall Study|Withdrawal by Subject|0|||
163478519|NCT00125268|590449304|FG000|Overall Study|Withdrawal by Subject|1|||
163478520|NCT00125268|590449305|FG001|Overall Study|Withdrawal by Subject|1|||
163478521|NCT00925522|590449306|FG000|Overall Study|study closed -- business decision|20|||
163478522|NCT02561572|590449307|FG000|Overall Study|Inadequate time before surgery|2|||
163478523|NCT02561572|590449308|FG001|Overall Study|Inadequate time before surgery|1|||
163478524|NCT02561572|590449307|FG000|Overall Study|Protocol Violation|0|||
163478525|NCT02561572|590449308|FG001|Overall Study|Protocol Violation|1|||
163478526|NCT02691468|590449309|FG000|Overall Study|Bronchial blocker use|2|||
163478527|NCT02691468|590449310|FG001|Overall Study|Bronchial blocker use|1|||
163478528|NCT02691468|590449309|FG000|Overall Study|Lost to Follow-up|2|||
163478529|NCT02691468|590449310|FG001|Overall Study|Lost to Follow-up|1|||
163478530|NCT02691468|590449309|FG000|Overall Study|Failure to advance FOB|2|||
163478531|NCT02691468|590449310|FG001|Overall Study|Failure to advance FOB|0|||
163478532|NCT01190020|590449313|FG000|Overall Study|Adverse Event|2|||
163478533|NCT01190020|590449314|FG001|Overall Study|Adverse Event|0|||
163478534|NCT01190020|590449313|FG000|Overall Study|Lost to Follow-up|2|||
163478535|NCT01190020|590449314|FG001|Overall Study|Lost to Follow-up|0|||
163478536|NCT01190020|590449313|FG000|Overall Study|Withdrawal by Subject|3|||
163478537|NCT01190020|590449314|FG001|Overall Study|Withdrawal by Subject|0|||
163478538|NCT00656799|590449317|FG000|Overall Study|Death|2|||
163478539|NCT02422186|590449318|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
163478540|NCT02422186|590449319|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
163478541|NCT02422186|590449318|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
163478542|NCT02422186|590449319|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
163478543|NCT02422186|590449318|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
163478544|NCT02422186|590449319|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
163478545|NCT02422186|590449318|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
163478546|NCT02422186|590449319|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
163478547|NCT02422186|590449318|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
163478548|NCT02422186|590449319|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
163478549|NCT02422186|590449318|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
163478550|NCT02422186|590449319|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
163478551|NCT02422186|590449318|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
163478552|NCT02422186|590449319|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
163478553|NCT02422186|590449318|FG000|Follow-up Phase (2 Weeks)|Other|3|||
163478554|NCT02422186|590449319|FG001|Follow-up Phase (2 Weeks)|Other|0|||
163478555|NCT05281094|590449320|FG000|Overall Study|Adverse Event|1|||
163478556|NCT05281094|590449321|FG001|Overall Study|Adverse Event|0|||
163478557|NCT05281094|590449320|FG000|Overall Study|Lost to Follow-up|29|||
163478558|NCT05281094|590449321|FG001|Overall Study|Lost to Follow-up|22|||
163478559|NCT05281094|590449320|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
163478560|NCT05281094|590449321|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
163478561|NCT05281094|590449320|FG000|Overall Study|Death|1|||
163478562|NCT05281094|590449321|FG001|Overall Study|Death|2|||
163478563|NCT05281094|590449320|FG000|Overall Study|Not pre-specified reason|8|||
163478564|NCT05281094|590449321|FG001|Overall Study|Not pre-specified reason|5|||
163478565|NCT02683668|590449332|FG000|Period 2|Withdrawal by Subject|0|||
163478566|NCT02683668|590449333|FG001|Period 2|Withdrawal by Subject|1|||
163478567|NCT02683668|590449334|FG002|Period 2|Withdrawal by Subject|0|||
163478568|NCT04223778|590449335|FG000|Overall Study|Death|1|||
163478569|NCT04223778|590449336|FG001|Overall Study|Death|1|||
163478570|NCT04223778|590449335|FG000|Overall Study|Lost to Follow-up|4|||
163478571|NCT04223778|590449336|FG001|Overall Study|Lost to Follow-up|5|||
163478572|NCT04223778|590449335|FG000|Overall Study|Physician Decision|10|||
163478573|NCT04223778|590449336|FG001|Overall Study|Physician Decision|6|||
163478574|NCT04223778|590449335|FG000|Overall Study|Withdrawal by Subject|35|||
163478575|NCT04223778|590449336|FG001|Overall Study|Withdrawal by Subject|17|||
163478576|NCT04223778|590449335|FG000|Overall Study|Not Reported|7|||
163478577|NCT04223778|590449336|FG001|Overall Study|Not Reported|8|||
163478578|NCT03893630|590449339|FG000|Overall Study|Lost to Follow-up|5|||
163478579|NCT03893630|590449340|FG001|Overall Study|Lost to Follow-up|4|||
163478580|NCT03893630|590449341|FG002|Overall Study|Lost to Follow-up|2|||
163478581|NCT03893630|590449339|FG000|Overall Study|Withdrawal by Subject|3|||
163478582|NCT03893630|590449340|FG001|Overall Study|Withdrawal by Subject|6|||
163478583|NCT03893630|590449341|FG002|Overall Study|Withdrawal by Subject|3|||
163478584|NCT03893630|590449339|FG000|Overall Study|Discontinued Intervention|0|||
163478585|NCT03893630|590449340|FG001|Overall Study|Discontinued Intervention|4|||
163478586|NCT03893630|590449341|FG002|Overall Study|Discontinued Intervention|2|||
163478587|NCT02390167|590451254|FG000|Overall Study|Lost to Follow-up|1|||
163478588|NCT01265719|590451256|FG000|Overall Study|Does not meet entrance criteria|0|||
163478589|NCT01265719|590451257|FG001|Overall Study|Does not meet entrance criteria|3|||
163478590|NCT01265719|590451256|FG000|Overall Study|Other reasons|2|||
163478591|NCT01265719|590451257|FG001|Overall Study|Other reasons|0|||
163478592|NCT01265719|590451256|FG000|Overall Study|Withdrawal by Subject|8|||
163478593|NCT01265719|590451257|FG001|Overall Study|Withdrawal by Subject|3|||
163478594|NCT01265719|590451256|FG000|Overall Study|Lost to Follow-up|2|||
163478595|NCT01265719|590451257|FG001|Overall Study|Lost to Follow-up|7|||
163478596|NCT01265719|590451256|FG000|Overall Study|Adverse Event|2|||
163478597|NCT01265719|590451257|FG001|Overall Study|Adverse Event|0|||
163478598|NCT00303602|590451258|FG000|Overall Study|Adverse Event|2|||
163478599|NCT00303602|590451259|FG001|Overall Study|Adverse Event|2|||
163478600|NCT00303602|590451258|FG000|Overall Study|Withdrawal by Subject|5|||
163478601|NCT00303602|590451259|FG001|Overall Study|Withdrawal by Subject|6|||
163478602|NCT00303602|590451258|FG000|Overall Study|Lost to Follow-up|5|||
163478603|NCT00303602|590451259|FG001|Overall Study|Lost to Follow-up|2|||
163478604|NCT00303602|590451258|FG000|Overall Study|Protocol entry criteria not met|2|||
163478605|NCT00303602|590451259|FG001|Overall Study|Protocol entry criteria not met|2|||
163478606|NCT00303602|590451258|FG000|Overall Study|Physician Decision|2|||
163478607|NCT00303602|590451259|FG001|Overall Study|Physician Decision|1|||
163478608|NCT00303602|590451258|FG000|Overall Study|Noncompliance|2|||
163478609|NCT00303602|590451259|FG001|Overall Study|Noncompliance|2|||
163478610|NCT00303602|590451258|FG000|Overall Study|Protocol Violation|1|||
163478611|NCT00303602|590451259|FG001|Overall Study|Protocol Violation|0|||
163478612|NCT02442765|590451260|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
163478613|NCT02442765|590451261|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
163478614|NCT02442765|590451262|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
163478615|NCT02442765|590451263|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
163478616|NCT02442765|590451264|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
163478617|NCT02442765|590451265|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
163478618|NCT02442765|590451266|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
163478619|NCT02442765|590451267|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
163478620|NCT02442765|590451260|FG000|Stage 2- (Days 43 to 85)|Death|0|||
163478621|NCT02442765|590451261|FG001|Stage 2- (Days 43 to 85)|Death|0|||
163478622|NCT02442765|590451262|FG002|Stage 2- (Days 43 to 85)|Death|0|||
163478623|NCT02442765|590451263|FG003|Stage 2- (Days 43 to 85)|Death|1|||
163478624|NCT02442765|590451264|FG004|Stage 2- (Days 43 to 85)|Death|1|||
163478625|NCT02442765|590451265|FG005|Stage 2- (Days 43 to 85)|Death|0|||
163478626|NCT02442765|590451266|FG006|Stage 2- (Days 43 to 85)|Death|2|||
163478627|NCT02442765|590451267|FG007|Stage 2- (Days 43 to 85)|Death|0|||
163478628|NCT02442765|590451260|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
163478629|NCT02442765|590451261|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
163478630|NCT02442765|590451262|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
163478631|NCT02442765|590451263|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
163478632|NCT02442765|590451264|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
163478633|NCT02442765|590451265|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
163478634|NCT02442765|590451266|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
163478635|NCT02442765|590451267|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
163478636|NCT02442765|590451260|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
163478637|NCT02442765|590451261|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
163478638|NCT02442765|590451262|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
163478639|NCT02442765|590451263|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
163478640|NCT02442765|590451264|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
163478641|NCT02442765|590451265|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
163478642|NCT02442765|590451266|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
163478643|NCT02442765|590451267|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
163478644|NCT02442765|590451260|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
163478645|NCT02442765|590451261|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
163478646|NCT02442765|590451262|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
163478647|NCT02442765|590451263|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
163478648|NCT02442765|590451264|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
163478649|NCT02442765|590451265|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
163478650|NCT02442765|590451266|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
163478651|NCT02442765|590451267|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
163478652|NCT02442765|590451260|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
163478653|NCT02442765|590451261|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
163478654|NCT02442765|590451262|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
163478655|NCT02442765|590451263|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
163478656|NCT02442765|590451264|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
163478657|NCT02442765|590451265|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
163478658|NCT02442765|590451266|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
163478659|NCT02442765|590451267|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
163478660|NCT02442765|590451260|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
163478661|NCT02442765|590451261|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
163478662|NCT02442765|590451262|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
163478663|NCT02442765|590451263|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
163478664|NCT02442765|590451264|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
163478665|NCT02442765|590451265|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
163478666|NCT02442765|590451266|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
163478667|NCT02442765|590451267|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
163478668|NCT02442765|590451260|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
163478669|NCT02442765|590451261|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
163478670|NCT02442765|590451262|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
163478671|NCT02442765|590451263|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
163478672|NCT02442765|590451264|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
163478673|NCT02442765|590451265|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
163478674|NCT02442765|590451266|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
163478675|NCT02442765|590451267|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
163478676|NCT02554721|590451268|FG000|Overall Study|Adverse Event|1|||
163478677|NCT02554721|590451269|FG001|Overall Study|Adverse Event|0|||
163478678|NCT02554721|590451270|FG002|Overall Study|Adverse Event|0|||
163478679|NCT02554721|590451271|FG003|Overall Study|Adverse Event|0|||
163478680|NCT02554721|590451272|FG004|Overall Study|Adverse Event|1|||
163478681|NCT02554721|590451268|FG000|Overall Study|Noncompliance|0|||
163478682|NCT02554721|590451269|FG001|Overall Study|Noncompliance|0|||
163478683|NCT02554721|590451270|FG002|Overall Study|Noncompliance|0|||
163478684|NCT02554721|590451271|FG003|Overall Study|Noncompliance|0|||
163478685|NCT02554721|590451272|FG004|Overall Study|Noncompliance|1|||
163478686|NCT01693562|590451276|FG000|Escalation Phase|Withdrawal by Subject|0|||
163478687|NCT01693562|590451277|FG001|Escalation Phase|Withdrawal by Subject|1|||
163478688|NCT01693562|590451278|FG002|Escalation Phase|Withdrawal by Subject|0|||
163478689|NCT01693562|590451279|FG003|Escalation Phase|Withdrawal by Subject|0|||
163478690|NCT01693562|590451280|FG004|Escalation Phase|Withdrawal by Subject|0|||
163478691|NCT01693562|590451281|FG005|Escalation Phase|Withdrawal by Subject|2|||
163478692|NCT01693562|590451282|FG006|Escalation Phase|Withdrawal by Subject|0|||
163478693|NCT01693562|590451283|FG007|Escalation Phase|Withdrawal by Subject|0|||
163478694|NCT01693562|590451284|FG008|Escalation Phase|Withdrawal by Subject|0|||
163478695|NCT01693562|590451285|FG009|Escalation Phase|Withdrawal by Subject|0|||
163478696|NCT01693562|590451286|FG010|Escalation Phase|Withdrawal by Subject|0|||
163478697|NCT01693562|590451287|FG011|Escalation Phase|Withdrawal by Subject|0|||
163478698|NCT01693562|590451288|FG012|Escalation Phase|Withdrawal by Subject|0|||
163478699|NCT01693562|590451289|FG013|Escalation Phase|Withdrawal by Subject|0|||
163478700|NCT01693562|590451290|FG014|Escalation Phase|Withdrawal by Subject|0|||
163478701|NCT01693562|590451291|FG015|Escalation Phase|Withdrawal by Subject|0|||
163478702|NCT01693562|590451292|FG016|Escalation Phase|Withdrawal by Subject|0|||
163478703|NCT01693562|590451293|FG017|Escalation Phase|Withdrawal by Subject|0|||
163478704|NCT01693562|590451294|FG018|Escalation Phase|Withdrawal by Subject|0|||
163478705|NCT01693562|590451295|FG019|Escalation Phase|Withdrawal by Subject|0|||
163478706|NCT01693562|590451296|FG020|Escalation Phase|Withdrawal by Subject|0|||
163478707|NCT01693562|590451297|FG021|Escalation Phase|Withdrawal by Subject|0|||
163478708|NCT01693562|590451298|FG022|Escalation Phase|Withdrawal by Subject|0|||
163478709|NCT01693562|590451276|FG000|Escalation Phase|Death|4|||
163478710|NCT01693562|590451277|FG001|Escalation Phase|Death|2|||
163478711|NCT01693562|590451278|FG002|Escalation Phase|Death|0|||
163478712|NCT01693562|590451279|FG003|Escalation Phase|Death|3|||
163478713|NCT01693562|590451280|FG004|Escalation Phase|Death|6|||
163478714|NCT01693562|590451281|FG005|Escalation Phase|Death|4|||
163478715|NCT01693562|590451282|FG006|Escalation Phase|Death|0|||
163478716|NCT01693562|590451283|FG007|Escalation Phase|Death|0|||
163478717|NCT01693562|590451284|FG008|Escalation Phase|Death|0|||
163478718|NCT01693562|590451285|FG009|Escalation Phase|Death|0|||
163478719|NCT01693562|590451286|FG010|Escalation Phase|Death|0|||
163478720|NCT01693562|590451287|FG011|Escalation Phase|Death|0|||
163478721|NCT01693562|590451288|FG012|Escalation Phase|Death|0|||
163478722|NCT01693562|590451289|FG013|Escalation Phase|Death|0|||
163478723|NCT01693562|590451290|FG014|Escalation Phase|Death|0|||
163478724|NCT01693562|590451291|FG015|Escalation Phase|Death|0|||
163478725|NCT01693562|590451292|FG016|Escalation Phase|Death|0|||
163478726|NCT01693562|590451293|FG017|Escalation Phase|Death|0|||
163478727|NCT01693562|590451294|FG018|Escalation Phase|Death|0|||
163478728|NCT01693562|590451295|FG019|Escalation Phase|Death|0|||
163478729|NCT01693562|590451296|FG020|Escalation Phase|Death|0|||
163478730|NCT01693562|590451297|FG021|Escalation Phase|Death|0|||
163478731|NCT01693562|590451298|FG022|Escalation Phase|Death|0|||
163478732|NCT01693562|590451276|FG000|Escalation Phase|Lost to Follow-up|0|||
163478733|NCT01693562|590451277|FG001|Escalation Phase|Lost to Follow-up|1|||
163478734|NCT01693562|590451278|FG002|Escalation Phase|Lost to Follow-up|1|||
163478735|NCT01693562|590451279|FG003|Escalation Phase|Lost to Follow-up|0|||
163478736|NCT01693562|590451280|FG004|Escalation Phase|Lost to Follow-up|0|||
163478737|NCT01693562|590451281|FG005|Escalation Phase|Lost to Follow-up|0|||
163478738|NCT01693562|590451282|FG006|Escalation Phase|Lost to Follow-up|0|||
163478739|NCT01693562|590451283|FG007|Escalation Phase|Lost to Follow-up|0|||
163478740|NCT01693562|590451284|FG008|Escalation Phase|Lost to Follow-up|0|||
163478741|NCT01693562|590451285|FG009|Escalation Phase|Lost to Follow-up|0|||
163478742|NCT01693562|590451286|FG010|Escalation Phase|Lost to Follow-up|0|||
163478743|NCT01693562|590451287|FG011|Escalation Phase|Lost to Follow-up|0|||
163478744|NCT01693562|590451288|FG012|Escalation Phase|Lost to Follow-up|0|||
163478745|NCT01693562|590451289|FG013|Escalation Phase|Lost to Follow-up|0|||
163478746|NCT01693562|590451290|FG014|Escalation Phase|Lost to Follow-up|0|||
163478747|NCT01693562|590451291|FG015|Escalation Phase|Lost to Follow-up|0|||
163478748|NCT01693562|590451292|FG016|Escalation Phase|Lost to Follow-up|0|||
163478749|NCT01693562|590451293|FG017|Escalation Phase|Lost to Follow-up|0|||
163478750|NCT01693562|590451294|FG018|Escalation Phase|Lost to Follow-up|0|||
163478751|NCT01693562|590451295|FG019|Escalation Phase|Lost to Follow-up|0|||
163478752|NCT01693562|590451296|FG020|Escalation Phase|Lost to Follow-up|0|||
163478753|NCT01693562|590451297|FG021|Escalation Phase|Lost to Follow-up|0|||
163478754|NCT01693562|590451298|FG022|Escalation Phase|Lost to Follow-up|0|||
163478755|NCT01693562|590451276|FG000|Escalation Phase|Other|0|||
163478756|NCT01693562|590451277|FG001|Escalation Phase|Other|0|||
163478757|NCT01693562|590451278|FG002|Escalation Phase|Other|2|||
163478758|NCT01693562|590451279|FG003|Escalation Phase|Other|0|||
163478759|NCT01693562|590451280|FG004|Escalation Phase|Other|0|||
163478760|NCT01693562|590451281|FG005|Escalation Phase|Other|1|||
163478761|NCT01693562|590451282|FG006|Escalation Phase|Other|0|||
163478762|NCT01693562|590451283|FG007|Escalation Phase|Other|0|||
163478763|NCT01693562|590451284|FG008|Escalation Phase|Other|0|||
163478764|NCT01693562|590451285|FG009|Escalation Phase|Other|0|||
163478765|NCT01693562|590451286|FG010|Escalation Phase|Other|0|||
163478766|NCT01693562|590451287|FG011|Escalation Phase|Other|0|||
163478767|NCT01693562|590451288|FG012|Escalation Phase|Other|0|||
163478768|NCT01693562|590451289|FG013|Escalation Phase|Other|0|||
163478769|NCT01693562|590451290|FG014|Escalation Phase|Other|0|||
163478770|NCT01693562|590451291|FG015|Escalation Phase|Other|0|||
163478771|NCT01693562|590451292|FG016|Escalation Phase|Other|0|||
163478772|NCT01693562|590451293|FG017|Escalation Phase|Other|0|||
163478773|NCT01693562|590451294|FG018|Escalation Phase|Other|0|||
163478774|NCT01693562|590451295|FG019|Escalation Phase|Other|0|||
163478775|NCT01693562|590451296|FG020|Escalation Phase|Other|0|||
163478776|NCT01693562|590451297|FG021|Escalation Phase|Other|0|||
163478777|NCT01693562|590451298|FG022|Escalation Phase|Other|0|||
163478778|NCT01693562|590451276|FG000|Exploration Phase|Withdrawal by Subject|0|||
163478779|NCT01693562|590451277|FG001|Exploration Phase|Withdrawal by Subject|0|||
163478780|NCT01693562|590451278|FG002|Exploration Phase|Withdrawal by Subject|0|||
163478781|NCT01693562|590451279|FG003|Exploration Phase|Withdrawal by Subject|0|||
163478782|NCT01693562|590451280|FG004|Exploration Phase|Withdrawal by Subject|0|||
163478783|NCT01693562|590451281|FG005|Exploration Phase|Withdrawal by Subject|0|||
163478784|NCT01693562|590451282|FG006|Exploration Phase|Withdrawal by Subject|2|||
163478785|NCT01693562|590451283|FG007|Exploration Phase|Withdrawal by Subject|0|||
163478786|NCT01693562|590451284|FG008|Exploration Phase|Withdrawal by Subject|0|||
163478787|NCT01693562|590451285|FG009|Exploration Phase|Withdrawal by Subject|0|||
163478788|NCT01693562|590451286|FG010|Exploration Phase|Withdrawal by Subject|0|||
163478789|NCT01693562|590451287|FG011|Exploration Phase|Withdrawal by Subject|0|||
163478790|NCT01693562|590451288|FG012|Exploration Phase|Withdrawal by Subject|0|||
163478791|NCT01693562|590451289|FG013|Exploration Phase|Withdrawal by Subject|0|||
163478792|NCT01693562|590451290|FG014|Exploration Phase|Withdrawal by Subject|0|||
163478793|NCT01693562|590451291|FG015|Exploration Phase|Withdrawal by Subject|0|||
163478794|NCT01693562|590451292|FG016|Exploration Phase|Withdrawal by Subject|0|||
163478795|NCT01693562|590451293|FG017|Exploration Phase|Withdrawal by Subject|0|||
163478796|NCT01693562|590451294|FG018|Exploration Phase|Withdrawal by Subject|0|||
163478797|NCT01693562|590451295|FG019|Exploration Phase|Withdrawal by Subject|0|||
163478798|NCT01693562|590451296|FG020|Exploration Phase|Withdrawal by Subject|0|||
163478799|NCT01693562|590451297|FG021|Exploration Phase|Withdrawal by Subject|0|||
163478800|NCT01693562|590451298|FG022|Exploration Phase|Withdrawal by Subject|0|||
163478801|NCT01693562|590451276|FG000|Exploration Phase|Death|0|||
163478802|NCT01693562|590451277|FG001|Exploration Phase|Death|0|||
163478803|NCT01693562|590451278|FG002|Exploration Phase|Death|0|||
163478804|NCT01693562|590451279|FG003|Exploration Phase|Death|0|||
163478805|NCT01693562|590451280|FG004|Exploration Phase|Death|0|||
163478806|NCT01693562|590451281|FG005|Exploration Phase|Death|0|||
163478807|NCT01693562|590451282|FG006|Exploration Phase|Death|17|||
163478808|NCT01693562|590451283|FG007|Exploration Phase|Death|0|||
163478809|NCT01693562|590451284|FG008|Exploration Phase|Death|0|||
163478810|NCT01693562|590451285|FG009|Exploration Phase|Death|0|||
163478811|NCT01693562|590451286|FG010|Exploration Phase|Death|0|||
163478812|NCT01693562|590451287|FG011|Exploration Phase|Death|0|||
163478813|NCT01693562|590451288|FG012|Exploration Phase|Death|0|||
163478814|NCT01693562|590451289|FG013|Exploration Phase|Death|0|||
163478815|NCT01693562|590451290|FG014|Exploration Phase|Death|0|||
163478816|NCT01693562|590451291|FG015|Exploration Phase|Death|0|||
163478817|NCT01693562|590451292|FG016|Exploration Phase|Death|0|||
163478818|NCT01693562|590451293|FG017|Exploration Phase|Death|0|||
163478819|NCT01693562|590451294|FG018|Exploration Phase|Death|0|||
163478820|NCT01693562|590451295|FG019|Exploration Phase|Death|0|||
163478821|NCT01693562|590451296|FG020|Exploration Phase|Death|0|||
163478822|NCT01693562|590451297|FG021|Exploration Phase|Death|0|||
163478823|NCT01693562|590451298|FG022|Exploration Phase|Death|0|||
163478824|NCT01693562|590451276|FG000|Exploration Phase|Other|0|||
163478825|NCT01693562|590451277|FG001|Exploration Phase|Other|0|||
163478826|NCT01693562|590451278|FG002|Exploration Phase|Other|0|||
163478827|NCT01693562|590451279|FG003|Exploration Phase|Other|0|||
163478828|NCT01693562|590451280|FG004|Exploration Phase|Other|0|||
163478829|NCT01693562|590451281|FG005|Exploration Phase|Other|0|||
163478830|NCT01693562|590451282|FG006|Exploration Phase|Other|2|||
163478831|NCT01693562|590451283|FG007|Exploration Phase|Other|0|||
163478832|NCT01693562|590451284|FG008|Exploration Phase|Other|0|||
163478833|NCT01693562|590451285|FG009|Exploration Phase|Other|0|||
163478834|NCT01693562|590451286|FG010|Exploration Phase|Other|0|||
163478835|NCT01693562|590451287|FG011|Exploration Phase|Other|0|||
163478836|NCT01693562|590451288|FG012|Exploration Phase|Other|0|||
163478837|NCT01693562|590451289|FG013|Exploration Phase|Other|0|||
163478838|NCT01693562|590451290|FG014|Exploration Phase|Other|0|||
163478839|NCT01693562|590451291|FG015|Exploration Phase|Other|0|||
163478840|NCT01693562|590451292|FG016|Exploration Phase|Other|0|||
163478841|NCT01693562|590451293|FG017|Exploration Phase|Other|0|||
163478842|NCT01693562|590451294|FG018|Exploration Phase|Other|0|||
163478843|NCT01693562|590451295|FG019|Exploration Phase|Other|0|||
163478844|NCT01693562|590451296|FG020|Exploration Phase|Other|0|||
163478845|NCT01693562|590451297|FG021|Exploration Phase|Other|0|||
163478846|NCT01693562|590451298|FG022|Exploration Phase|Other|0|||
163478847|NCT01693562|590451276|FG000|Expansion Phase|Withdrawal by Subject|0|||
163478848|NCT01693562|590451277|FG001|Expansion Phase|Withdrawal by Subject|0|||
163478849|NCT01693562|590451278|FG002|Expansion Phase|Withdrawal by Subject|0|||
163478850|NCT01693562|590451279|FG003|Expansion Phase|Withdrawal by Subject|0|||
163478851|NCT01693562|590451280|FG004|Expansion Phase|Withdrawal by Subject|0|||
163478852|NCT01693562|590451281|FG005|Expansion Phase|Withdrawal by Subject|0|||
163478853|NCT01693562|590451282|FG006|Expansion Phase|Withdrawal by Subject|0|||
163478854|NCT01693562|590451283|FG007|Expansion Phase|Withdrawal by Subject|16|||
163478855|NCT01693562|590451284|FG008|Expansion Phase|Withdrawal by Subject|2|||
163478856|NCT01693562|590451285|FG009|Expansion Phase|Withdrawal by Subject|54|||
163478857|NCT01693562|590451286|FG010|Expansion Phase|Withdrawal by Subject|2|||
163478858|NCT01693562|590451287|FG011|Expansion Phase|Withdrawal by Subject|2|||
163478859|NCT01693562|590451288|FG012|Expansion Phase|Withdrawal by Subject|3|||
163478860|NCT01693562|590451289|FG013|Expansion Phase|Withdrawal by Subject|5|||
163478861|NCT01693562|590451290|FG014|Expansion Phase|Withdrawal by Subject|16|||
163478862|NCT01693562|590451291|FG015|Expansion Phase|Withdrawal by Subject|7|||
163478863|NCT01693562|590451292|FG016|Expansion Phase|Withdrawal by Subject|40|||
163478864|NCT01693562|590451293|FG017|Expansion Phase|Withdrawal by Subject|4|||
163478865|NCT01693562|590451294|FG018|Expansion Phase|Withdrawal by Subject|8|||
163478866|NCT01693562|590451295|FG019|Expansion Phase|Withdrawal by Subject|3|||
163478867|NCT01693562|590451296|FG020|Expansion Phase|Withdrawal by Subject|1|||
163478868|NCT01693562|590451297|FG021|Expansion Phase|Withdrawal by Subject|8|||
163478869|NCT01693562|590451298|FG022|Expansion Phase|Withdrawal by Subject|1|||
163478870|NCT01693562|590451276|FG000|Expansion Phase|Death|0|||
163478871|NCT01693562|590451277|FG001|Expansion Phase|Death|0|||
163478872|NCT01693562|590451278|FG002|Expansion Phase|Death|0|||
163478873|NCT01693562|590451279|FG003|Expansion Phase|Death|0|||
163478874|NCT01693562|590451280|FG004|Expansion Phase|Death|0|||
163478875|NCT01693562|590451281|FG005|Expansion Phase|Death|0|||
163478876|NCT01693562|590451282|FG006|Expansion Phase|Death|0|||
163478877|NCT01693562|590451283|FG007|Expansion Phase|Death|42|||
163478878|NCT01693562|590451284|FG008|Expansion Phase|Death|17|||
163478879|NCT01693562|590451285|FG009|Expansion Phase|Death|208|||
163478880|NCT01693562|590451286|FG010|Expansion Phase|Death|30|||
163478881|NCT01693562|590451287|FG011|Expansion Phase|Death|8|||
163478882|NCT01693562|590451288|FG012|Expansion Phase|Death|19|||
163478883|NCT01693562|590451289|FG013|Expansion Phase|Death|42|||
163478884|NCT01693562|590451290|FG014|Expansion Phase|Death|23|||
163478885|NCT01693562|590451291|FG015|Expansion Phase|Death|23|||
163478886|NCT01693562|590451292|FG016|Expansion Phase|Death|128|||
163478887|NCT01693562|590451293|FG017|Expansion Phase|Death|16|||
163478888|NCT01693562|590451294|FG018|Expansion Phase|Death|36|||
163478889|NCT01693562|590451295|FG019|Expansion Phase|Death|16|||
163478890|NCT01693562|590451296|FG020|Expansion Phase|Death|17|||
163478891|NCT01693562|590451297|FG021|Expansion Phase|Death|35|||
163478892|NCT01693562|590451298|FG022|Expansion Phase|Death|7|||
163478893|NCT01693562|590451276|FG000|Expansion Phase|Lost to Follow-up|0|||
163478894|NCT01693562|590451277|FG001|Expansion Phase|Lost to Follow-up|0|||
163478895|NCT01693562|590451278|FG002|Expansion Phase|Lost to Follow-up|0|||
163478896|NCT01693562|590451279|FG003|Expansion Phase|Lost to Follow-up|0|||
163478897|NCT01693562|590451280|FG004|Expansion Phase|Lost to Follow-up|0|||
163478898|NCT01693562|590451281|FG005|Expansion Phase|Lost to Follow-up|0|||
163478899|NCT01693562|590451282|FG006|Expansion Phase|Lost to Follow-up|0|||
163478900|NCT01693562|590451283|FG007|Expansion Phase|Lost to Follow-up|1|||
163478901|NCT01693562|590451284|FG008|Expansion Phase|Lost to Follow-up|2|||
163478902|NCT01693562|590451285|FG009|Expansion Phase|Lost to Follow-up|10|||
163478903|NCT01693562|590451286|FG010|Expansion Phase|Lost to Follow-up|4|||
163478904|NCT01693562|590451287|FG011|Expansion Phase|Lost to Follow-up|4|||
163478905|NCT01693562|590451288|FG012|Expansion Phase|Lost to Follow-up|1|||
163478906|NCT01693562|590451289|FG013|Expansion Phase|Lost to Follow-up|3|||
163478907|NCT01693562|590451290|FG014|Expansion Phase|Lost to Follow-up|0|||
163478908|NCT01693562|590451291|FG015|Expansion Phase|Lost to Follow-up|1|||
163478909|NCT01693562|590451292|FG016|Expansion Phase|Lost to Follow-up|1|||
163478910|NCT01693562|590451293|FG017|Expansion Phase|Lost to Follow-up|0|||
163478911|NCT01693562|590451294|FG018|Expansion Phase|Lost to Follow-up|2|||
163478912|NCT01693562|590451295|FG019|Expansion Phase|Lost to Follow-up|1|||
163478913|NCT01693562|590451296|FG020|Expansion Phase|Lost to Follow-up|2|||
163478914|NCT01693562|590451297|FG021|Expansion Phase|Lost to Follow-up|2|||
163478915|NCT01693562|590451298|FG022|Expansion Phase|Lost to Follow-up|1|||
163478916|NCT01693562|590451276|FG000|Expansion Phase|Other|0|||
163478917|NCT01693562|590451277|FG001|Expansion Phase|Other|0|||
163478918|NCT01693562|590451278|FG002|Expansion Phase|Other|0|||
163478919|NCT01693562|590451279|FG003|Expansion Phase|Other|0|||
163478920|NCT01693562|590451280|FG004|Expansion Phase|Other|0|||
163478921|NCT01693562|590451281|FG005|Expansion Phase|Other|0|||
163478922|NCT01693562|590451282|FG006|Expansion Phase|Other|0|||
163478923|NCT01693562|590451283|FG007|Expansion Phase|Other|3|||
163478924|NCT01693562|590451284|FG008|Expansion Phase|Other|1|||
163478925|NCT01693562|590451285|FG009|Expansion Phase|Other|28|||
163478926|NCT01693562|590451286|FG010|Expansion Phase|Other|4|||
163478927|NCT01693562|590451287|FG011|Expansion Phase|Other|7|||
163478928|NCT01693562|590451288|FG012|Expansion Phase|Other|0|||
163478929|NCT01693562|590451289|FG013|Expansion Phase|Other|1|||
163478930|NCT01693562|590451290|FG014|Expansion Phase|Other|1|||
163478931|NCT01693562|590451291|FG015|Expansion Phase|Other|0|||
163478932|NCT01693562|590451292|FG016|Expansion Phase|Other|28|||
163478933|NCT01693562|590451293|FG017|Expansion Phase|Other|0|||
163478934|NCT01693562|590451294|FG018|Expansion Phase|Other|1|||
163478935|NCT01693562|590451295|FG019|Expansion Phase|Other|0|||
163478936|NCT01693562|590451296|FG020|Expansion Phase|Other|1|||
163478937|NCT01693562|590451297|FG021|Expansion Phase|Other|17|||
163478938|NCT01693562|590451298|FG022|Expansion Phase|Other|1|||
163478939|NCT05466240|590451299|FG000|Overall Study|Adverse Event|1|||
163478940|NCT05466240|590451300|FG001|Overall Study|Adverse Event|0|||
163478941|NCT05466240|590451299|FG000|Overall Study|Withdrawal by Subject|1|||
163478942|NCT05466240|590451300|FG001|Overall Study|Withdrawal by Subject|0|||
163478943|NCT02759939|590451301|FG000|Overall Study|Missing data on first outcome assessed|11|||
163478944|NCT02759939|590451302|FG001|Overall Study|Missing data on first outcome assessed|2|||
163478945|NCT02759939|590451303|FG002|Overall Study|Missing data on first outcome assessed|5|||
163478946|NCT02759939|590451304|FG003|Overall Study|Missing data on first outcome assessed|2|||
163478947|NCT02759939|590451301|FG000|Overall Study|Ineligible for T2 and T3|310|||
163478948|NCT02759939|590451302|FG001|Overall Study|Ineligible for T2 and T3|179|||
163478949|NCT02759939|590451303|FG002|Overall Study|Ineligible for T2 and T3|366|||
163478950|NCT02759939|590451304|FG003|Overall Study|Ineligible for T2 and T3|391|||
163478951|NCT02759939|590451301|FG000|Overall Study|Lost to Follow-up|735|||
163478952|NCT02759939|590451302|FG001|Overall Study|Lost to Follow-up|791|||
163478953|NCT02759939|590451303|FG002|Overall Study|Lost to Follow-up|783|||
163478954|NCT02759939|590451304|FG003|Overall Study|Lost to Follow-up|650|||
163478955|NCT04735432|590451305|FG000|Overall Study|Other - due to personal reason|1|||
163478956|NCT04735432|590451306|FG001|Overall Study|Other - due to personal reason|0|||
163478957|NCT04735432|590451305|FG000|Overall Study|Adverse Event|2|||
163478958|NCT04735432|590451306|FG001|Overall Study|Adverse Event|0|||
163478959|NCT00626327|590451307|FG000|Overall Study|Withdrawal by Subject|21|||
163478960|NCT00626327|590451308|FG001|Overall Study|Withdrawal by Subject|29|||
163478961|NCT00626327|590451309|FG002|Overall Study|Withdrawal by Subject|30|||
163478962|NCT00626327|590451307|FG000|Overall Study|Adverse Event|1|||
163478963|NCT00626327|590451308|FG001|Overall Study|Adverse Event|0|||
163478964|NCT00626327|590451309|FG002|Overall Study|Adverse Event|0|||
163478965|NCT00626327|590451307|FG000|Overall Study|Lost to Follow-up|24|||
163478966|NCT00626327|590451308|FG001|Overall Study|Lost to Follow-up|21|||
163478967|NCT00626327|590451309|FG002|Overall Study|Lost to Follow-up|23|||
163478968|NCT00626327|590451307|FG000|Overall Study|Inappropriate enrollment|4|||
163478969|NCT00626327|590451308|FG001|Overall Study|Inappropriate enrollment|5|||
163478970|NCT00626327|590451309|FG002|Overall Study|Inappropriate enrollment|3|||
163478971|NCT00626327|590451307|FG000|Overall Study|Administrative Reason|2|||
163478972|NCT00626327|590451308|FG001|Overall Study|Administrative Reason|0|||
163478973|NCT00626327|590451309|FG002|Overall Study|Administrative Reason|6|||
163478974|NCT00626327|590451307|FG000|Overall Study|Protocol Violation|26|||
163478975|NCT00626327|590451308|FG001|Overall Study|Protocol Violation|4|||
163478976|NCT00626327|590451309|FG002|Overall Study|Protocol Violation|26|||
163478977|NCT03818399|590451311|FG000|Overall Study|Lost to Follow-up|11|||
163478978|NCT03818399|590451311|FG000|Overall Study|Withdrawal by Subject|1|||
163478979|NCT03818399|590451311|FG000|Overall Study|Protocol Violation|2|||
163478980|NCT04880642|590451312|FG000|Randomization|Withdrawal by Subject|2|||
163478981|NCT04880642|590451313|FG001|Randomization|Withdrawal by Subject|3|||
163478982|NCT04880642|590451312|FG000|Treatment Period|Adverse Event|0|||
163478983|NCT04880642|590451313|FG001|Treatment Period|Adverse Event|1|||
163478984|NCT04880642|590451312|FG000|Treatment Period|Death|6|||
163478985|NCT04880642|590451313|FG001|Treatment Period|Death|6|||
163478986|NCT04880642|590451312|FG000|Treatment Period|Lost to Follow-up|1|||
163478987|NCT04880642|590451313|FG001|Treatment Period|Lost to Follow-up|0|||
163478988|NCT04880642|590451312|FG000|Treatment Period|Protocol Violation|0|||
163478989|NCT04880642|590451313|FG001|Treatment Period|Protocol Violation|1|||
163478990|NCT04880642|590451312|FG000|Treatment Period|Withdrawal by Subject|5|||
163478991|NCT04880642|590451313|FG001|Treatment Period|Withdrawal by Subject|3|||
163478992|NCT04880642|590451312|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
163478993|NCT04880642|590451313|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
163478994|NCT04880642|590451312|FG000|Follow-up|Death|4|||
163478995|NCT04880642|590451313|FG001|Follow-up|Death|3|||
163478996|NCT04880642|590451312|FG000|Follow-up|Withdrawal by Subject|1|||
163478997|NCT04880642|590451313|FG001|Follow-up|Withdrawal by Subject|0|||
163478998|NCT00141297|590451315|FG000|Overall Study|Adverse Event|0|||
163478999|NCT00141297|590451316|FG001|Overall Study|Adverse Event|0|||
163479000|NCT00141297|590451317|FG002|Overall Study|Adverse Event|1|||
163479001|NCT00141297|590451318|FG003|Overall Study|Adverse Event|0|||
163479002|NCT00141297|590451319|FG004|Overall Study|Adverse Event|1|||
163479003|NCT00141297|590451320|FG005|Overall Study|Adverse Event|1|||
163479004|NCT00141297|590451321|FG006|Overall Study|Adverse Event|0|||
163479005|NCT00141297|590451322|FG007|Overall Study|Adverse Event|1|||
163479006|NCT00141297|590451323|FG008|Overall Study|Adverse Event|1|||
163479007|NCT00141297|590451324|FG009|Overall Study|Adverse Event|0|||
163479008|NCT00141297|590451315|FG000|Overall Study|Death|1|||
163479009|NCT00141297|590451316|FG001|Overall Study|Death|0|||
163479010|NCT00141297|590451317|FG002|Overall Study|Death|0|||
163479011|NCT00141297|590451318|FG003|Overall Study|Death|0|||
163479012|NCT00141297|590451319|FG004|Overall Study|Death|0|||
163479013|NCT00141297|590451320|FG005|Overall Study|Death|0|||
163479014|NCT00141297|590451321|FG006|Overall Study|Death|0|||
163479015|NCT00141297|590451322|FG007|Overall Study|Death|0|||
163479016|NCT00141297|590451323|FG008|Overall Study|Death|1|||
163479017|NCT00141297|590451324|FG009|Overall Study|Death|0|||
163479018|NCT00141297|590451315|FG000|Overall Study|Withdrawal by Subject|0|||
163479019|NCT00141297|590451316|FG001|Overall Study|Withdrawal by Subject|0|||
163479020|NCT00141297|590451317|FG002|Overall Study|Withdrawal by Subject|0|||
163479021|NCT00141297|590451318|FG003|Overall Study|Withdrawal by Subject|0|||
163479022|NCT00141297|590451319|FG004|Overall Study|Withdrawal by Subject|0|||
163479023|NCT00141297|590451320|FG005|Overall Study|Withdrawal by Subject|0|||
163479024|NCT00141297|590451321|FG006|Overall Study|Withdrawal by Subject|0|||
163479025|NCT00141297|590451322|FG007|Overall Study|Withdrawal by Subject|0|||
163479026|NCT00141297|590451323|FG008|Overall Study|Withdrawal by Subject|1|||
163479027|NCT00141297|590451324|FG009|Overall Study|Withdrawal by Subject|0|||
163479028|NCT00141297|590451315|FG000|Overall Study|Other|0|||
163479029|NCT00141297|590451316|FG001|Overall Study|Other|0|||
163479030|NCT00141297|590451317|FG002|Overall Study|Other|0|||
163479031|NCT00141297|590451318|FG003|Overall Study|Other|1|||
163479032|NCT00141297|590451319|FG004|Overall Study|Other|5|||
163479033|NCT00141297|590451320|FG005|Overall Study|Other|0|||
163479034|NCT00141297|590451321|FG006|Overall Study|Other|0|||
163479035|NCT00141297|590451322|FG007|Overall Study|Other|0|||
163479036|NCT00141297|590451323|FG008|Overall Study|Other|2|||
163479037|NCT00141297|590451324|FG009|Overall Study|Other|0|||
163479038|NCT00141297|590451315|FG000|Overall Study|Progressive Disease|2|||
163479039|NCT00141297|590451316|FG001|Overall Study|Progressive Disease|3|||
163479040|NCT00141297|590451317|FG002|Overall Study|Progressive Disease|6|||
163479041|NCT00141297|590451318|FG003|Overall Study|Progressive Disease|2|||
163479042|NCT00141297|590451319|FG004|Overall Study|Progressive Disease|15|||
163479043|NCT00141297|590451320|FG005|Overall Study|Progressive Disease|2|||
163479044|NCT00141297|590451321|FG006|Overall Study|Progressive Disease|3|||
163479045|NCT00141297|590451322|FG007|Overall Study|Progressive Disease|3|||
163479046|NCT00141297|590451323|FG008|Overall Study|Progressive Disease|15|||
163479047|NCT00141297|590451324|FG009|Overall Study|Progressive Disease|6|||
163479048|NCT00141297|590451315|FG000|Overall Study|Transitioned|0|||
163479049|NCT00141297|590451316|FG001|Overall Study|Transitioned|0|||
163479050|NCT00141297|590451317|FG002|Overall Study|Transitioned|0|||
163479051|NCT00141297|590451318|FG003|Overall Study|Transitioned|0|||
163479052|NCT00141297|590451319|FG004|Overall Study|Transitioned|1|||
163479053|NCT00141297|590451320|FG005|Overall Study|Transitioned|0|||
163479054|NCT00141297|590451321|FG006|Overall Study|Transitioned|0|||
163479055|NCT00141297|590451322|FG007|Overall Study|Transitioned|0|||
163479056|NCT00141297|590451323|FG008|Overall Study|Transitioned|0|||
163479057|NCT00141297|590451324|FG009|Overall Study|Transitioned|0|||
163479058|NCT02987205|590451325|FG000|Overall Study|Adverse Event|1|||
163479059|NCT02987205|590451325|FG000|Overall Study|Withdrawal by Subject|3|||
163479060|NCT02807376|590451327|FG000|Overall Study|Intra-operative exclusion criteria|3|||
163479061|NCT02807376|590451328|FG001|Overall Study|Intra-operative exclusion criteria|0|||
163479062|NCT02807376|590451327|FG000|Overall Study|Lost to Follow-up|0|||
163479063|NCT02807376|590451328|FG001|Overall Study|Lost to Follow-up|1|||
163479064|NCT03228836|590451331|FG000|Overall Study|Adverse Event|3|||
163479065|NCT03228836|590451331|FG000|Overall Study|Withdrawal by Subject|1|||
163479066|NCT03228836|590451331|FG000|Overall Study|Death|1|||
163479067|NCT03228836|590451331|FG000|Overall Study|Physician Decision|1|||
163479068|NCT03228836|590451331|FG000|Overall Study|Disease Progression|7|||
163479069|NCT03228836|590451331|FG000|Overall Study|Other|4|||
163479070|NCT00948389|590451332|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
163479071|NCT00948389|590451333|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
163479072|NCT00948389|590451334|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
163479073|NCT00948389|590451335|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
163479074|NCT00948389|590451336|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
163479075|NCT00948389|590451332|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
163479076|NCT00948389|590451333|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
163479077|NCT00948389|590451334|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
163479078|NCT00948389|590451335|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
163479079|NCT00948389|590451336|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
163479080|NCT00948389|590451332|FG000|Overall Study|Both Progression and Toxicity|1|||
163479081|NCT00948389|590451333|FG001|Overall Study|Both Progression and Toxicity|0|||
163479082|NCT00948389|590451334|FG002|Overall Study|Both Progression and Toxicity|0|||
163479083|NCT00948389|590451335|FG003|Overall Study|Both Progression and Toxicity|0|||
163479084|NCT00948389|590451336|FG004|Overall Study|Both Progression and Toxicity|0|||
163479085|NCT00750867|590451355|FG000|Overall Study|Adverse Event|2|||
163479086|NCT03018340|590451356|FG000|Overall Study|Adverse Event|1|||
163479087|NCT03018340|590451357|FG001|Overall Study|Adverse Event|2|||
163479088|NCT03018340|590451356|FG000|Overall Study|Withdrawal by Subject|0|||
163479089|NCT03018340|590451357|FG001|Overall Study|Withdrawal by Subject|8|||
163479090|NCT03018340|590451356|FG000|Overall Study|Lack of Efficacy|0|||
163479091|NCT03018340|590451357|FG001|Overall Study|Lack of Efficacy|1|||
163479092|NCT03018340|590451356|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
163479093|NCT03018340|590451357|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
163479094|NCT03018340|590451356|FG000|Overall Study|Lost to Follow-up|1|||
163479095|NCT03018340|590451357|FG001|Overall Study|Lost to Follow-up|7|||
163479096|NCT03018340|590451356|FG000|Overall Study|Protocol Violation|3|||
163479097|NCT03018340|590451357|FG001|Overall Study|Protocol Violation|7|||
163479098|NCT03018340|590451356|FG000|Overall Study|Not further specified|0|||
163479099|NCT03018340|590451357|FG001|Overall Study|Not further specified|1|||
163479100|NCT04652102|590451358|FG000|Overall Study|Adverse Event|14|||
163479101|NCT04652102|590451359|FG001|Overall Study|Adverse Event|13|||
163479102|NCT04652102|590451358|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
163479103|NCT04652102|590451359|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
163479104|NCT04652102|590451358|FG000|Overall Study|Physician Decision|78|||
163479105|NCT04652102|590451359|FG001|Overall Study|Physician Decision|40|||
163479106|NCT04652102|590451358|FG000|Overall Study|Study Ended by Sponsor|64|||
163479107|NCT04652102|590451359|FG001|Overall Study|Study Ended by Sponsor|17|||
163479108|NCT04652102|590451358|FG000|Overall Study|Withdrawal by Subject|4625|||
163479109|NCT04652102|590451359|FG001|Overall Study|Withdrawal by Subject|5594|||
163479110|NCT04652102|590451358|FG000|Overall Study|Lost to Follow-up|2019|||
163479111|NCT04652102|590451359|FG001|Overall Study|Lost to Follow-up|1082|||
163479112|NCT04652102|590451358|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
163479113|NCT04652102|590451359|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
163479114|NCT04652102|590451358|FG000|Overall Study|Miscellaneous|80|||
163479115|NCT04652102|590451359|FG001|Overall Study|Miscellaneous|64|||
163479116|NCT02192190|590451362|FG000|Overall Study|Adverse Event|1|||
163479117|NCT02192190|590451363|FG001|Overall Study|Adverse Event|1|||
163479118|NCT02192190|590451364|FG002|Overall Study|Adverse Event|0|||
163479119|NCT02192190|590451365|FG003|Overall Study|Adverse Event|0|||
163479120|NCT02192190|590451366|FG004|Overall Study|Adverse Event|0|||
163479121|NCT02192190|590451367|FG005|Overall Study|Adverse Event|0|||
163479122|NCT02192190|590451362|FG000|Overall Study|Lost to Follow-up|3|||
163479123|NCT02192190|590451363|FG001|Overall Study|Lost to Follow-up|3|||
163479124|NCT02192190|590451364|FG002|Overall Study|Lost to Follow-up|2|||
163479125|NCT02192190|590451365|FG003|Overall Study|Lost to Follow-up|1|||
163479126|NCT02192190|590451366|FG004|Overall Study|Lost to Follow-up|4|||
163479127|NCT02192190|590451367|FG005|Overall Study|Lost to Follow-up|3|||
163479128|NCT02192190|590451362|FG000|Overall Study|Physician Decision|2|||
163479129|NCT02192190|590451363|FG001|Overall Study|Physician Decision|0|||
163479130|NCT02192190|590451364|FG002|Overall Study|Physician Decision|0|||
163479131|NCT02192190|590451365|FG003|Overall Study|Physician Decision|0|||
163479132|NCT02192190|590451366|FG004|Overall Study|Physician Decision|0|||
163479133|NCT02192190|590451367|FG005|Overall Study|Physician Decision|0|||
163479134|NCT02192190|590451362|FG000|Overall Study|Terminated by Sponsor|43|||
163479135|NCT02192190|590451363|FG001|Overall Study|Terminated by Sponsor|23|||
163479136|NCT02192190|590451364|FG002|Overall Study|Terminated by Sponsor|20|||
163479137|NCT02192190|590451365|FG003|Overall Study|Terminated by Sponsor|23|||
163479138|NCT02192190|590451366|FG004|Overall Study|Terminated by Sponsor|21|||
163479139|NCT02192190|590451367|FG005|Overall Study|Terminated by Sponsor|23|||
163479140|NCT02192190|590451362|FG000|Overall Study|Withdrawal by Subject|4|||
163479141|NCT02192190|590451363|FG001|Overall Study|Withdrawal by Subject|1|||
163479142|NCT02192190|590451364|FG002|Overall Study|Withdrawal by Subject|2|||
163479143|NCT02192190|590451365|FG003|Overall Study|Withdrawal by Subject|1|||
163479144|NCT02192190|590451366|FG004|Overall Study|Withdrawal by Subject|5|||
163479145|NCT02192190|590451367|FG005|Overall Study|Withdrawal by Subject|3|||
163479146|NCT02192190|590451362|FG000|Overall Study|Could not Keep Visit Schedule|1|||
163479147|NCT02192190|590451363|FG001|Overall Study|Could not Keep Visit Schedule|0|||
163479148|NCT02192190|590451364|FG002|Overall Study|Could not Keep Visit Schedule|0|||
163479149|NCT02192190|590451365|FG003|Overall Study|Could not Keep Visit Schedule|0|||
163479150|NCT02192190|590451366|FG004|Overall Study|Could not Keep Visit Schedule|0|||
163479151|NCT02192190|590451367|FG005|Overall Study|Could not Keep Visit Schedule|0|||
163479152|NCT02192190|590451362|FG000|Overall Study|Positive Drug Screen|0|||
163479153|NCT02192190|590451363|FG001|Overall Study|Positive Drug Screen|0|||
163479154|NCT02192190|590451364|FG002|Overall Study|Positive Drug Screen|0|||
163479155|NCT02192190|590451365|FG003|Overall Study|Positive Drug Screen|1|||
163479156|NCT02192190|590451366|FG004|Overall Study|Positive Drug Screen|0|||
163479157|NCT02192190|590451367|FG005|Overall Study|Positive Drug Screen|0|||
163479158|NCT02192190|590451362|FG000|Overall Study|Inadequate Pain Relief|0|||
163479159|NCT02192190|590451363|FG001|Overall Study|Inadequate Pain Relief|1|||
163479160|NCT02192190|590451364|FG002|Overall Study|Inadequate Pain Relief|1|||
163479161|NCT02192190|590451365|FG003|Overall Study|Inadequate Pain Relief|0|||
163479162|NCT02192190|590451366|FG004|Overall Study|Inadequate Pain Relief|0|||
163479163|NCT02192190|590451367|FG005|Overall Study|Inadequate Pain Relief|0|||
163479164|NCT01756833|590451368|FG000|Overall Study|Withdrawal by Subject|4|||
163479165|NCT01756833|590451369|FG001|Overall Study|Withdrawal by Subject|3|||
163479166|NCT00808132|590451370|FG000|Overall Study|Adverse Event|34|||
163479167|NCT00808132|590451371|FG001|Overall Study|Adverse Event|33|||
163479168|NCT00808132|590451372|FG002|Overall Study|Adverse Event|16|||
163479169|NCT00808132|590451373|FG003|Overall Study|Adverse Event|31|||
163479170|NCT00808132|590451374|FG004|Overall Study|Adverse Event|33|||
163479171|NCT00808132|590451370|FG000|Overall Study|Death|0|||
163479172|NCT00808132|590451371|FG001|Overall Study|Death|0|||
163479173|NCT00808132|590451372|FG002|Overall Study|Death|0|||
163479174|NCT00808132|590451373|FG003|Overall Study|Death|0|||
163479175|NCT00808132|590451374|FG004|Overall Study|Death|1|||
163479176|NCT00808132|590451370|FG000|Overall Study|Physician Decision|0|||
163479177|NCT00808132|590451371|FG001|Overall Study|Physician Decision|1|||
163479178|NCT00808132|590451372|FG002|Overall Study|Physician Decision|0|||
163479179|NCT00808132|590451373|FG003|Overall Study|Physician Decision|0|||
163479180|NCT00808132|590451374|FG004|Overall Study|Physician Decision|0|||
163479181|NCT00808132|590451370|FG000|Overall Study|Lost to Follow-up|8|||
163479182|NCT00808132|590451371|FG001|Overall Study|Lost to Follow-up|10|||
163479183|NCT00808132|590451372|FG002|Overall Study|Lost to Follow-up|11|||
163479184|NCT00808132|590451373|FG003|Overall Study|Lost to Follow-up|8|||
163479185|NCT00808132|590451374|FG004|Overall Study|Lost to Follow-up|9|||
163479186|NCT00808132|590451370|FG000|Overall Study|Protocol Violation|8|||
163479187|NCT00808132|590451371|FG001|Overall Study|Protocol Violation|9|||
163479188|NCT00808132|590451372|FG002|Overall Study|Protocol Violation|4|||
163479189|NCT00808132|590451373|FG003|Overall Study|Protocol Violation|9|||
163479190|NCT00808132|590451374|FG004|Overall Study|Protocol Violation|5|||
163479191|NCT00808132|590451370|FG000|Overall Study|Withdrawal by Subject|27|||
163479192|NCT00808132|590451371|FG001|Overall Study|Withdrawal by Subject|18|||
163479193|NCT00808132|590451372|FG002|Overall Study|Withdrawal by Subject|2|||
163479194|NCT00808132|590451373|FG003|Overall Study|Withdrawal by Subject|7|||
163479195|NCT00808132|590451374|FG004|Overall Study|Withdrawal by Subject|16|||
163479196|NCT00808132|590451370|FG000|Overall Study|Other|6|||
163479197|NCT00808132|590451371|FG001|Overall Study|Other|4|||
163479198|NCT00808132|590451372|FG002|Overall Study|Other|6|||
163479199|NCT00808132|590451373|FG003|Overall Study|Other|2|||
163479200|NCT00808132|590451374|FG004|Overall Study|Other|15|||
163479201|NCT00808132|590451370|FG000|Overall Study|Randomized, but not treated|10|||
163479202|NCT00808132|590451371|FG001|Overall Study|Randomized, but not treated|7|||
163479203|NCT00808132|590451372|FG002|Overall Study|Randomized, but not treated|9|||
163479204|NCT00808132|590451373|FG003|Overall Study|Randomized, but not treated|8|||
163479205|NCT00808132|590451374|FG004|Overall Study|Randomized, but not treated|9|||
163479206|NCT00808132|590451370|FG000|Overall Study|Unsatisfactory response|5|||
163479207|NCT00808132|590451371|FG001|Overall Study|Unsatisfactory response|6|||
163479208|NCT00808132|590451372|FG002|Overall Study|Unsatisfactory response|6|||
163479209|NCT00808132|590451373|FG003|Overall Study|Unsatisfactory response|4|||
163479210|NCT00808132|590451374|FG004|Overall Study|Unsatisfactory response|12|||
163479211|NCT00890201|590451375|FG000|Overall Study|Protocol Violation|5|||
163479212|NCT00890201|590451376|FG001|Overall Study|Protocol Violation|56|||
163479213|NCT01371721|590451377|FG000|Overall Study|Adverse Event|5|||
163479214|NCT01371721|590451378|FG001|Overall Study|Adverse Event|4|||
163479215|NCT01371721|590451379|FG002|Overall Study|Adverse Event|5|||
163479216|NCT01371721|590451377|FG000|Overall Study|Protocol Violation|6|||
163479217|NCT01371721|590451378|FG001|Overall Study|Protocol Violation|4|||
163479218|NCT01371721|590451379|FG002|Overall Study|Protocol Violation|5|||
163479219|NCT01371721|590451377|FG000|Overall Study|Lost to Follow-up|8|||
163479220|NCT01371721|590451378|FG001|Overall Study|Lost to Follow-up|2|||
163479221|NCT01371721|590451379|FG002|Overall Study|Lost to Follow-up|6|||
163479222|NCT01371721|590451377|FG000|Overall Study|Withdrawal by Subject|5|||
163479223|NCT01371721|590451378|FG001|Overall Study|Withdrawal by Subject|7|||
163479224|NCT01371721|590451379|FG002|Overall Study|Withdrawal by Subject|11|||
163479225|NCT01371721|590451377|FG000|Overall Study|Other|2|||
163479226|NCT01371721|590451378|FG001|Overall Study|Other|3|||
163479227|NCT01371721|590451379|FG002|Overall Study|Other|0|||
163479228|NCT01371721|590451377|FG000|Overall Study|Lack of Efficacy|2|||
163479229|NCT01371721|590451378|FG001|Overall Study|Lack of Efficacy|4|||
163479230|NCT01371721|590451379|FG002|Overall Study|Lack of Efficacy|3|||
163479231|NCT01371721|590451377|FG000|Overall Study|Randomized but not treated|1|||
163479232|NCT01371721|590451378|FG001|Overall Study|Randomized but not treated|0|||
163479233|NCT01371721|590451379|FG002|Overall Study|Randomized but not treated|0|||
163479234|NCT01347840|590451380|FG000|Overall Study|Withdrawal by Subject|1|||
163479235|NCT01846208|590451383|FG000|Overall Study|Withdrew prior to treatment|1|||
163479236|NCT01846208|590451384|FG001|Overall Study|Withdrew prior to treatment|1|||
163479237|NCT01846208|590451385|FG002|Overall Study|Withdrew prior to treatment|1|||
163479238|NCT01846208|590451383|FG000|Overall Study|Dosing Symptoms|1|||
163479239|NCT01846208|590451384|FG001|Overall Study|Dosing Symptoms|2|||
163479240|NCT01846208|590451385|FG002|Overall Study|Dosing Symptoms|6|||
163479241|NCT01846208|590451383|FG000|Overall Study|Withdrawal by Subject|5|||
163479242|NCT01846208|590451384|FG001|Overall Study|Withdrawal by Subject|0|||
163479243|NCT01846208|590451385|FG002|Overall Study|Withdrawal by Subject|0|||
163479244|NCT01846208|590451383|FG000|Overall Study|Non-compliance|1|||
163479245|NCT01846208|590451384|FG001|Overall Study|Non-compliance|1|||
163479246|NCT01846208|590451385|FG002|Overall Study|Non-compliance|0|||
163479247|NCT01846208|590451383|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
163479248|NCT01846208|590451384|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
163479249|NCT01846208|590451385|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
163479250|NCT01846208|590451383|FG000|Overall Study|Refused SU OFC|0|||
163479251|NCT01846208|590451384|FG001|Overall Study|Refused SU OFC|0|||
163479252|NCT01846208|590451385|FG002|Overall Study|Refused SU OFC|1|||
163479253|NCT01432938|590451386|FG000|First Intervention|Protocol Violation|1|||
163479254|NCT01432938|590451387|FG001|First Intervention|Protocol Violation|0|||
163479255|NCT01432938|590451386|FG000|First Intervention|Physician Decision|1|||
163479256|NCT01432938|590451387|FG001|First Intervention|Physician Decision|0|||
163479257|NCT01432938|590451386|FG000|Second Intervention|Adverse Event|1|||
163479258|NCT01432938|590451387|FG001|Second Intervention|Adverse Event|0|||
163479259|NCT01875874|590451391|FG000|Overall Study|Death|3|||
163479260|NCT00374127|590451392|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
163479261|NCT00374127|590451392|FG000|Overall Study|Blood could not be drawn.|2|||
163479262|NCT00374127|590451392|FG000|Overall Study|Protocol Violation|5|||
163479263|NCT00374127|590451392|FG000|Overall Study|Pregnancy|1|||
163479264|NCT00281528|590451398|FG000|Overall Study|Progressive Disease|28|||
163479265|NCT00281528|590451399|FG001|Overall Study|Progressive Disease|18|||
163479266|NCT00281528|590451400|FG002|Overall Study|Progressive Disease|27|||
163479267|NCT00281528|590451398|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
163479268|NCT00281528|590451399|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
163479269|NCT00281528|590451400|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
163479270|NCT00281528|590451398|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
163479271|NCT00281528|590451399|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
163479272|NCT00281528|590451400|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
163479273|NCT00281528|590451398|FG000|Overall Study|Physician Decision|11|||
163479274|NCT00281528|590451399|FG001|Overall Study|Physician Decision|4|||
163479275|NCT00281528|590451400|FG002|Overall Study|Physician Decision|5|||
163479276|NCT00281528|590451398|FG000|Overall Study|Protocol Violation|1|||
163479277|NCT00281528|590451399|FG001|Overall Study|Protocol Violation|0|||
163479278|NCT00281528|590451400|FG002|Overall Study|Protocol Violation|1|||
163479279|NCT00281528|590451398|FG000|Overall Study|Withdrawal by Subject|5|||
163479280|NCT00281528|590451399|FG001|Overall Study|Withdrawal by Subject|5|||
163479281|NCT00281528|590451400|FG002|Overall Study|Withdrawal by Subject|7|||
163479282|NCT00281528|590451398|FG000|Overall Study|Other|6|||
163479283|NCT00281528|590451399|FG001|Overall Study|Other|3|||
163479284|NCT00281528|590451400|FG002|Overall Study|Other|5|||
163479285|NCT02520141|590451401|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
163479286|NCT00703781|590451402|FG000|Overall Study|Withdrawal by Subject|1|||
163479287|NCT00703781|590451403|FG001|Overall Study|Withdrawal by Subject|2|||
163479288|NCT00703781|590451402|FG000|Overall Study|Cancelled surgery|1|||
163479289|NCT00703781|590451403|FG001|Overall Study|Cancelled surgery|0|||
163479290|NCT01225211|590451404|FG000|Overall Study|Adverse Event|0|||
163479291|NCT01225211|590451405|FG001|Overall Study|Adverse Event|0|||
163479292|NCT01225211|590451406|FG002|Overall Study|Adverse Event|1|||
163479293|NCT01225211|590451407|FG003|Overall Study|Adverse Event|0|||
163479294|NCT01225211|590451408|FG004|Overall Study|Adverse Event|0|||
163479295|NCT01225211|590451409|FG005|Overall Study|Adverse Event|0|||
163479296|NCT01225211|590451410|FG006|Overall Study|Adverse Event|0|||
163479297|NCT01225211|590451411|FG007|Overall Study|Adverse Event|0|||
163479298|NCT01225211|590451412|FG008|Overall Study|Adverse Event|0|||
163479299|NCT01225211|590451413|FG009|Overall Study|Adverse Event|1|||
163479300|NCT01225211|590451404|FG000|Overall Study|Withdrawal by Subject|0|||
163479301|NCT01225211|590451405|FG001|Overall Study|Withdrawal by Subject|0|||
163479302|NCT01225211|590451406|FG002|Overall Study|Withdrawal by Subject|0|||
163479303|NCT01225211|590451407|FG003|Overall Study|Withdrawal by Subject|0|||
163479304|NCT01225211|590451408|FG004|Overall Study|Withdrawal by Subject|0|||
163479305|NCT01225211|590451409|FG005|Overall Study|Withdrawal by Subject|0|||
163479306|NCT01225211|590451410|FG006|Overall Study|Withdrawal by Subject|1|||
163479307|NCT01225211|590451411|FG007|Overall Study|Withdrawal by Subject|0|||
163479308|NCT01225211|590451412|FG008|Overall Study|Withdrawal by Subject|1|||
163479309|NCT01225211|590451413|FG009|Overall Study|Withdrawal by Subject|3|||
163479310|NCT01225211|590451404|FG000|Overall Study|Other|0|||
163479311|NCT01225211|590451405|FG001|Overall Study|Other|0|||
163479312|NCT01225211|590451406|FG002|Overall Study|Other|0|||
163479313|NCT01225211|590451407|FG003|Overall Study|Other|0|||
163479314|NCT01225211|590451408|FG004|Overall Study|Other|0|||
163479315|NCT01225211|590451409|FG005|Overall Study|Other|0|||
163479316|NCT01225211|590451410|FG006|Overall Study|Other|0|||
163479317|NCT01225211|590451411|FG007|Overall Study|Other|0|||
163479318|NCT01225211|590451412|FG008|Overall Study|Other|0|||
163479319|NCT01225211|590451413|FG009|Overall Study|Other|1|||
163479320|NCT00410514|590451418|FG000|Overall Study|Adverse Event|2|||
163479321|NCT00410514|590451419|FG001|Overall Study|Adverse Event|2|||
163479322|NCT00410514|590451420|FG002|Overall Study|Adverse Event|2|||
163479323|NCT00410514|590451418|FG000|Overall Study|Protocol Violation|0|||
163479324|NCT00410514|590451419|FG001|Overall Study|Protocol Violation|1|||
163479325|NCT00410514|590451420|FG002|Overall Study|Protocol Violation|1|||
163479326|NCT00410514|590451418|FG000|Overall Study|Lost to Follow-up|0|||
163479327|NCT00410514|590451419|FG001|Overall Study|Lost to Follow-up|0|||
163479328|NCT00410514|590451420|FG002|Overall Study|Lost to Follow-up|2|||
163479329|NCT00410514|590451418|FG000|Overall Study|Non-compliant with study procedures|0|||
163479330|NCT00410514|590451419|FG001|Overall Study|Non-compliant with study procedures|0|||
163479331|NCT00410514|590451420|FG002|Overall Study|Non-compliant with study procedures|2|||
163479332|NCT02449915|590451422|FG000|Overall Study|Exclusion criteria - drug use|1|||
163479333|NCT02449915|590451423|FG001|Overall Study|Exclusion criteria - drug use|0|||
163479334|NCT02449915|590451422|FG000|Overall Study|Withdrawal by Subject|0|||
163479335|NCT02449915|590451423|FG001|Overall Study|Withdrawal by Subject|2|||
163479336|NCT02449915|590451422|FG000|Overall Study|Intraoperative surgical findings|1|||
163479337|NCT02449915|590451423|FG001|Overall Study|Intraoperative surgical findings|1|||
163479338|NCT02449915|590451422|FG000|Overall Study|Abnormal preop lab|0|||
163479339|NCT02449915|590451423|FG001|Overall Study|Abnormal preop lab|1|||
163479340|NCT01436357|590451424|FG000|Overall Study|Death|5|||
163479341|NCT01436357|590451425|FG001|Overall Study|Death|1|||
163479342|NCT01436357|590451424|FG000|Overall Study|Enrolled but not vaccinated|1|||
163479343|NCT01436357|590451425|FG001|Overall Study|Enrolled but not vaccinated|1|||
163479344|NCT01436357|590451424|FG000|Overall Study|Incarceration|18|||
163479345|NCT01436357|590451425|FG001|Overall Study|Incarceration|20|||
163479346|NCT01436357|590451424|FG000|Overall Study|Lost to Follow-up|67|||
163479347|NCT01436357|590451425|FG001|Overall Study|Lost to Follow-up|61|||
163479348|NCT01436357|590451424|FG000|Overall Study|Protocol Violation|1|||
163479349|NCT01436357|590451425|FG001|Overall Study|Protocol Violation|0|||
163479350|NCT01436357|590451424|FG000|Overall Study|Withdrawal by Subject|26|||
163479351|NCT01436357|590451425|FG001|Overall Study|Withdrawal by Subject|38|||
163479352|NCT01436357|590451424|FG000|Overall Study|Physician Decision|3|||
163479353|NCT01436357|590451425|FG001|Overall Study|Physician Decision|4|||
163479354|NCT01436357|590451424|FG000|Overall Study|Moved out of area|1|||
163479355|NCT01436357|590451425|FG001|Overall Study|Moved out of area|2|||
163479356|NCT01436357|590451424|FG000|Overall Study|Subject in rehab|0|||
163479357|NCT01436357|590451425|FG001|Overall Study|Subject in rehab|1|||
163479358|NCT01021293|590451430|FG000|Overall Study|Serious Adverse Event|2|||
163479359|NCT01021293|590451431|FG001|Overall Study|Serious Adverse Event|1|||
163479360|NCT01021293|590451430|FG000|Overall Study|Adverse Event|2|||
163479361|NCT01021293|590451431|FG001|Overall Study|Adverse Event|1|||
163479362|NCT01021293|590451430|FG000|Overall Study|Withdrawal by Subject|1|||
163479363|NCT01021293|590451431|FG001|Overall Study|Withdrawal by Subject|3|||
163479364|NCT01021293|590451430|FG000|Overall Study|Migrated/moved from study area|6|||
163479365|NCT01021293|590451431|FG001|Overall Study|Migrated/moved from study area|18|||
163479366|NCT01021293|590451430|FG000|Overall Study|Lost to Follow-up|1|||
163479367|NCT01021293|590451431|FG001|Overall Study|Lost to Follow-up|1|||
163479368|NCT04335929|590453074|FG000|Overall Study|Lost to Follow-up|10|||
163479369|NCT02491463|590453076|FG000|Overall Study|Withdrawal by Subject|1|||
163479370|NCT02491463|590453077|FG001|Overall Study|Withdrawal by Subject|2|||
163479371|NCT02491463|590453078|FG002|Overall Study|Withdrawal by Subject|0|||
163479372|NCT02491463|590453079|FG003|Overall Study|Withdrawal by Subject|0|||
163479373|NCT02491463|590453076|FG000|Overall Study|Migrated/moved from study area|1|||
163479374|NCT02491463|590453077|FG001|Overall Study|Migrated/moved from study area|5|||
163479375|NCT02491463|590453078|FG002|Overall Study|Migrated/moved from study area|1|||
163479376|NCT02491463|590453079|FG003|Overall Study|Migrated/moved from study area|1|||
163479377|NCT02491463|590453076|FG000|Overall Study|Lost to Follow-up|0|||
163479378|NCT02491463|590453077|FG001|Overall Study|Lost to Follow-up|3|||
163479379|NCT02491463|590453078|FG002|Overall Study|Lost to Follow-up|3|||
163479380|NCT02491463|590453079|FG003|Overall Study|Lost to Follow-up|0|||
163479381|NCT01491802|590453080|FG000|Overall Study|Adverse Event|1|||
163479382|NCT01491802|590453081|FG001|Overall Study|Adverse Event|1|||
163479383|NCT01491802|590453080|FG000|Overall Study|Withdrawal by Subject|0|||
163479384|NCT01491802|590453081|FG001|Overall Study|Withdrawal by Subject|1|||
163479385|NCT01864746|590453084|FG000|Overall Study|Disease recurrence|25|||
163479386|NCT01864746|590453085|FG001|Overall Study|Disease recurrence|40|||
163479387|NCT01864746|590453084|FG000|Overall Study|Second primary invasive nonbreast|2|||
163479388|NCT01864746|590453085|FG001|Overall Study|Second primary invasive nonbreast|3|||
163479389|NCT01864746|590453084|FG000|Overall Study|Death|2|||
163479390|NCT01864746|590453085|FG001|Overall Study|Death|1|||
163479391|NCT01864746|590453084|FG000|Overall Study|Adverse Event|33|||
163479392|NCT01864746|590453085|FG001|Overall Study|Adverse Event|5|||
163479393|NCT01864746|590453084|FG000|Overall Study|Withdrawal by Subject|56|||
163479394|NCT01864746|590453085|FG001|Overall Study|Withdrawal by Subject|41|||
163479395|NCT01864746|590453084|FG000|Overall Study|Physician Decision|5|||
163479396|NCT01864746|590453085|FG001|Overall Study|Physician Decision|6|||
163479397|NCT01005966|590453086|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
163479398|NCT01005966|590453087|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
163479399|NCT01005966|590453088|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
163479400|NCT01005966|590453089|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
163479401|NCT01005966|590453090|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
163479402|NCT01005966|590453086|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
163479403|NCT01005966|590453087|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
163479404|NCT01005966|590453088|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
163479405|NCT01005966|590453089|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
163479406|NCT01005966|590453090|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
163479407|NCT01005966|590453086|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
163479408|NCT01005966|590453087|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
163479409|NCT01005966|590453088|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
163479410|NCT01005966|590453089|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
163479411|NCT01005966|590453090|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
163479412|NCT01005966|590453086|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
163479413|NCT01005966|590453087|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
163479414|NCT01005966|590453088|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
163479415|NCT01005966|590453089|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
163479416|NCT01005966|590453090|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
163479417|NCT01005966|590453086|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163479418|NCT01005966|590453087|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163479419|NCT01005966|590453088|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163479420|NCT01005966|590453089|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
163479421|NCT01005966|590453090|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163479422|NCT01005966|590453086|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
163479423|NCT01005966|590453087|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
163479424|NCT01005966|590453088|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
163479425|NCT01005966|590453089|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
163479426|NCT01005966|590453090|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
163479427|NCT01005966|590453086|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
163479428|NCT01005966|590453087|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
163479429|NCT01005966|590453088|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
163479430|NCT01005966|590453089|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
163479431|NCT01005966|590453090|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
163479432|NCT01005966|590453086|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
163479433|NCT01005966|590453087|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
163479434|NCT01005966|590453088|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
163479435|NCT01005966|590453089|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
163479436|NCT01005966|590453090|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
163479437|NCT01005966|590453086|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
163479438|NCT01005966|590453087|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
163479439|NCT01005966|590453088|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
163479440|NCT01005966|590453089|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
163479441|NCT01005966|590453090|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
163479442|NCT01347931|590453091|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
163479443|NCT03890731|590453092|FG000|Overall Study|Progressive disease|1|||
163479444|NCT03890731|590453092|FG000|Overall Study|Patient's decision|1|||
163479445|NCT03890731|590453092|FG000|Overall Study|Adverse Event|4|||
163479446|NCT00945945|590453095|FG000|Overall Study|Adverse Event|15|||
163479447|NCT00945945|590453096|FG001|Overall Study|Adverse Event|35|||
163479448|NCT00945945|590453095|FG000|Overall Study|Withdrawal by Subject|7|||
163479449|NCT00945945|590453096|FG001|Overall Study|Withdrawal by Subject|10|||
163479450|NCT00945945|590453095|FG000|Overall Study|Lost to Follow-up|4|||
163479451|NCT00945945|590453096|FG001|Overall Study|Lost to Follow-up|5|||
163479452|NCT00945945|590453095|FG000|Overall Study|Lack of Efficacy|6|||
163479453|NCT00945945|590453096|FG001|Overall Study|Lack of Efficacy|2|||
163479454|NCT00945945|590453095|FG000|Overall Study|Protocol Violation|4|||
163479455|NCT00945945|590453096|FG001|Overall Study|Protocol Violation|2|||
163479456|NCT00945945|590453095|FG000|Overall Study|Entry Criteria Not Met|0|||
163479457|NCT00945945|590453096|FG001|Overall Study|Entry Criteria Not Met|1|||
163479458|NCT03347279|590453098|FG000|Overall Study|Withdrawal by Subject|8|||
163479459|NCT03347279|590453099|FG001|Overall Study|Withdrawal by Subject|15|||
163479460|NCT03347279|590453098|FG000|Overall Study|Death|0|||
163479461|NCT03347279|590453099|FG001|Overall Study|Death|2|||
163479462|NCT03347279|590453098|FG000|Overall Study|Lost to Follow-up|5|||
163479463|NCT03347279|590453099|FG001|Overall Study|Lost to Follow-up|2|||
163479464|NCT03347279|590453098|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
163479465|NCT03347279|590453099|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
163479466|NCT00394654|590453100|FG000|Overall Study|Lost to Follow-up|1|||
163479467|NCT00394654|590453101|FG001|Overall Study|Lost to Follow-up|0|||
163479468|NCT00394654|590453100|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
163479469|NCT00394654|590453101|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
163479470|NCT03442595|590453102|FG000|Overall Study|Lost to Follow-up|94|||
163479471|NCT03442595|590453103|FG001|Overall Study|Lost to Follow-up|0|||
163479472|NCT01060150|590453106|FG000|Overall Study|Adverse Event|6|||
163479473|NCT01060150|590453106|FG000|Overall Study|Lost to Follow-up|1|||
163479474|NCT01060150|590453106|FG000|Overall Study|Protocol Violation|6|||
163479475|NCT01060150|590453106|FG000|Overall Study|Withdrawal by Subject|8|||
163479476|NCT01060150|590453106|FG000|Overall Study|Enrolled, but not treated|2|||
163479477|NCT01836549|590453107|FG000|Overall Study|Did not receive study drug|0|||
163479478|NCT01836549|590453108|FG001|Overall Study|Did not receive study drug|0|||
163479479|NCT01836549|590453109|FG002|Overall Study|Did not receive study drug|1|||
163479480|NCT01836549|590453110|FG003|Overall Study|Did not receive study drug|0|||
163479481|NCT01836549|590453111|FG004|Overall Study|Did not receive study drug|0|||
163479482|NCT01836549|590453112|FG005|Overall Study|Did not receive study drug|0|||
163479483|NCT01836549|590453113|FG006|Overall Study|Did not receive study drug|0|||
163479484|NCT01836549|590453107|FG000|Overall Study|Patient declared ineligible|0|||
163479485|NCT01836549|590453108|FG001|Overall Study|Patient declared ineligible|0|||
163479486|NCT01836549|590453109|FG002|Overall Study|Patient declared ineligible|0|||
163479487|NCT01836549|590453110|FG003|Overall Study|Patient declared ineligible|1|||
163479488|NCT01836549|590453111|FG004|Overall Study|Patient declared ineligible|0|||
163479489|NCT01836549|590453112|FG005|Overall Study|Patient declared ineligible|0|||
163479490|NCT01836549|590453113|FG006|Overall Study|Patient declared ineligible|0|||
163479491|NCT01836549|590453107|FG000|Overall Study|Patient inevaluable to start therapy|0|||
163479492|NCT01836549|590453108|FG001|Overall Study|Patient inevaluable to start therapy|0|||
163479493|NCT01836549|590453109|FG002|Overall Study|Patient inevaluable to start therapy|0|||
163479494|NCT01836549|590453110|FG003|Overall Study|Patient inevaluable to start therapy|0|||
163479495|NCT01836549|590453111|FG004|Overall Study|Patient inevaluable to start therapy|0|||
163479496|NCT01836549|590453112|FG005|Overall Study|Patient inevaluable to start therapy|0|||
163479497|NCT01836549|590453113|FG006|Overall Study|Patient inevaluable to start therapy|1|||
163479498|NCT00381706|590453114|FG000|Overall Study|Never treated|7|||
163479499|NCT00381706|590453115|FG001|Overall Study|Never treated|2|||
163479500|NCT00381706|590453116|FG002|Overall Study|Never treated|1|||
163479501|NCT02364999|590453117|FG000|Overall Study|Death|136|||
163479502|NCT02364999|590453118|FG001|Overall Study|Death|138|||
163479503|NCT02364999|590453117|FG000|Overall Study|Lost to Follow-up|10|||
163479504|NCT02364999|590453118|FG001|Overall Study|Lost to Follow-up|15|||
163479505|NCT02364999|590453117|FG000|Overall Study|Protocol Violation|3|||
163479506|NCT02364999|590453118|FG001|Overall Study|Protocol Violation|2|||
163479507|NCT02364999|590453117|FG000|Overall Study|Withdrawal by Subject|14|||
163479508|NCT02364999|590453118|FG001|Overall Study|Withdrawal by Subject|14|||
163479509|NCT02364999|590453117|FG000|Overall Study|Other|0|||
163479510|NCT02364999|590453118|FG001|Overall Study|Other|1|||
163479511|NCT02364999|590453117|FG000|Overall Study|Randomized but did not receive treatment|2|||
163479512|NCT02364999|590453118|FG001|Overall Study|Randomized but did not receive treatment|3|||
163479513|NCT00550615|590453119|FG000|Overall Study|Withdrawal by Subject|0|||
163479514|NCT00550615|590453120|FG001|Overall Study|Withdrawal by Subject|0|||
163479515|NCT00550615|590453121|FG002|Overall Study|Withdrawal by Subject|2|||
163479516|NCT00550615|590453122|FG003|Overall Study|Withdrawal by Subject|3|||
163479517|NCT00550615|590453119|FG000|Overall Study|Not evaluable|0|||
163479518|NCT00550615|590453120|FG001|Overall Study|Not evaluable|0|||
163479519|NCT00550615|590453121|FG002|Overall Study|Not evaluable|2|||
163479520|NCT00550615|590453122|FG003|Overall Study|Not evaluable|7|||
163479521|NCT01234337|590453123|FG000|Overall Study|Adverse Event|58|||
163479522|NCT01234337|590453124|FG001|Overall Study|Adverse Event|21|||
163479523|NCT01234337|590453123|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
163479524|NCT01234337|590453124|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
163479525|NCT01234337|590453123|FG000|Overall Study|Investi. decision not protocol driven|5|||
163479526|NCT01234337|590453124|FG001|Overall Study|Investi. decision not protocol driven|6|||
163479527|NCT01234337|590453123|FG000|Overall Study|Non-compliant with study medication|3|||
163479528|NCT01234337|590453124|FG001|Overall Study|Non-compliant with study medication|2|||
163479529|NCT01234337|590453123|FG000|Overall Study|Randomized but not treated|6|||
163479530|NCT01234337|590453124|FG001|Overall Study|Randomized but not treated|4|||
163479531|NCT01234337|590453123|FG000|Overall Study|Lost to Follow-up|0|||
163479532|NCT01234337|590453124|FG001|Overall Study|Lost to Follow-up|1|||
163479533|NCT01234337|590453123|FG000|Overall Study|Protocol Violation|2|||
163479534|NCT01234337|590453124|FG001|Overall Study|Protocol Violation|3|||
163479535|NCT01234337|590453123|FG000|Overall Study|Withdrawal by Subject|11|||
163479536|NCT01234337|590453124|FG001|Overall Study|Withdrawal by Subject|9|||
163479537|NCT01234337|590453123|FG000|Overall Study|Death|0|||
163479538|NCT01234337|590453124|FG001|Overall Study|Death|1|||
163479539|NCT01234337|590453123|FG000|Overall Study|Switch to commercial drug|0|||
163479540|NCT01234337|590453124|FG001|Overall Study|Switch to commercial drug|1|||
163479541|NCT02181504|590453127|FG000|Overall Study|Adverse Event|1|||
163479542|NCT02181504|590453128|FG001|Overall Study|Adverse Event|1|||
163479543|NCT02181504|590453129|FG002|Overall Study|Adverse Event|1|||
163479544|NCT02555722|590453130|FG000|Week 2|Adverse Event|0|||
163479545|NCT02555722|590453131|FG001|Week 2|Adverse Event|1|||
163479546|NCT02555722|590453130|FG000|Week 2|Withdrawal by Subject|1|||
163479547|NCT02555722|590453131|FG001|Week 2|Withdrawal by Subject|0|||
163479548|NCT02555722|590453130|FG000|Month 1|Lens Discomfort|1|||
163479549|NCT02555722|590453131|FG001|Month 1|Lens Discomfort|0|||
163479550|NCT02555722|590453130|FG000|Month 2|Withdrawal by Subject|3|||
163479551|NCT02555722|590453131|FG001|Month 2|Withdrawal by Subject|0|||
163479552|NCT02555722|590453130|FG000|Month 2|Lost to Follow-up|1|||
163479553|NCT02555722|590453131|FG001|Month 2|Lost to Follow-up|0|||
163479554|NCT00598585|590453138|FG000|Overall Study|Lost to Follow-up|1|||
163479555|NCT00598585|590453139|FG001|Overall Study|Lost to Follow-up|0|||
163479556|NCT00545584|590453140|FG000|Overall Study|Only one reason for discontinuation|62|||
163479557|NCT00545584|590453141|FG001|Overall Study|Only one reason for discontinuation|61|||
163479558|NCT00545584|590453142|FG002|Overall Study|Only one reason for discontinuation|48|||
163479559|NCT00545584|590453140|FG000|Overall Study|Two or more reasons for discontinuation|17|||
163479560|NCT00545584|590453141|FG001|Overall Study|Two or more reasons for discontinuation|19|||
163479561|NCT00545584|590453142|FG002|Overall Study|Two or more reasons for discontinuation|8|||
163479562|NCT00135694|590453146|FG000|Overall Study|Adverse Event|17|||
163479563|NCT00135694|590453147|FG001|Overall Study|Adverse Event|4|||
163479564|NCT00135694|590453148|FG002|Overall Study|Adverse Event|0|||
163479565|NCT00135694|590453146|FG000|Overall Study|Death|14|||
163479566|NCT00135694|590453147|FG001|Overall Study|Death|1|||
163479567|NCT00135694|590453148|FG002|Overall Study|Death|2|||
163479568|NCT00135694|590453146|FG000|Overall Study|Lost to Follow-up|8|||
163479569|NCT00135694|590453147|FG001|Overall Study|Lost to Follow-up|7|||
163479570|NCT00135694|590453148|FG002|Overall Study|Lost to Follow-up|1|||
163479571|NCT00135694|590453146|FG000|Overall Study|Withdrawal by Subject|41|||
163479572|NCT00135694|590453147|FG001|Overall Study|Withdrawal by Subject|7|||
163479573|NCT00135694|590453148|FG002|Overall Study|Withdrawal by Subject|4|||
163479574|NCT00135694|590453146|FG000|Overall Study|Protocol Violation|19|||
163479575|NCT00135694|590453147|FG001|Overall Study|Protocol Violation|1|||
163479576|NCT00135694|590453148|FG002|Overall Study|Protocol Violation|0|||
163479577|NCT00135694|590453146|FG000|Overall Study|Hepatitis C related reasons|39|||
163479578|NCT00135694|590453147|FG001|Overall Study|Hepatitis C related reasons|1|||
163479579|NCT00135694|590453148|FG002|Overall Study|Hepatitis C related reasons|0|||
163479580|NCT00135694|590453146|FG000|Overall Study|Ineligible for Random assignment|42|||
163479581|NCT00135694|590453147|FG001|Overall Study|Ineligible for Random assignment|0|||
163479582|NCT00135694|590453148|FG002|Overall Study|Ineligible for Random assignment|0|||
163479583|NCT02584660|590453149|FG000|Overall Study|Adverse Event|4|||
163479584|NCT02584660|590453150|FG001|Overall Study|Adverse Event|0|||
163479585|NCT02584660|590453149|FG000|Overall Study|Lost to Follow-up|3|||
163479586|NCT02584660|590453150|FG001|Overall Study|Lost to Follow-up|4|||
163479587|NCT02584660|590453149|FG000|Overall Study|Protocol Violation|0|||
163479588|NCT02584660|590453150|FG001|Overall Study|Protocol Violation|1|||
163479589|NCT02584660|590453149|FG000|Overall Study|Withdrawal by Subject|0|||
163479590|NCT02584660|590453150|FG001|Overall Study|Withdrawal by Subject|2|||
163479591|NCT02584660|590453149|FG000|Overall Study|Other|0|||
163479592|NCT02584660|590453150|FG001|Overall Study|Other|1|||
163479593|NCT00461552|590453151|FG000|Overall Study|Drug Dispensing error|0|||
163479594|NCT00461552|590453152|FG001|Overall Study|Drug Dispensing error|2|||
163479595|NCT00660816|590453153|FG000|Overall Study|Adverse Event|1|||
163479596|NCT00660816|590453154|FG001|Overall Study|Adverse Event|2|||
163479597|NCT00660816|590453153|FG000|Overall Study|Withdrawal by Subject|1|||
163479598|NCT00660816|590453154|FG001|Overall Study|Withdrawal by Subject|0|||
163479599|NCT00660816|590453153|FG000|Overall Study|Death|0|||
163479600|NCT00660816|590453154|FG001|Overall Study|Death|2|||
163479601|NCT00660816|590453153|FG000|Overall Study|Lack of Efficacy|1|||
163479602|NCT00660816|590453154|FG001|Overall Study|Lack of Efficacy|0|||
163479603|NCT00660816|590453153|FG000|Overall Study|Physician Decision|0|||
163479604|NCT00660816|590453154|FG001|Overall Study|Physician Decision|2|||
163479605|NCT00660816|590453153|FG000|Overall Study|Protocol Violation|1|||
163479606|NCT00660816|590453154|FG001|Overall Study|Protocol Violation|0|||
163479607|NCT00660816|590453153|FG000|Overall Study|Disease Progression|16|||
163479608|NCT00660816|590453154|FG001|Overall Study|Disease Progression|12|||
163479609|NCT00660816|590453153|FG000|Overall Study|Complicating Disease|0|||
163479610|NCT00660816|590453154|FG001|Overall Study|Complicating Disease|1|||
163479611|NCT00374452|590453155|FG000|Overall Study|Left clinic before intervention started|4|||
163479612|NCT00374452|590453156|FG001|Overall Study|Left clinic before intervention started|1|||
163479613|NCT00374452|590453155|FG000|Overall Study|Change in job role before intervention|0|||
163479614|NCT00374452|590453156|FG001|Overall Study|Change in job role before intervention|1|||
163479615|NCT00374452|590453155|FG000|Overall Study|Left clinic after intervention started|1|||
163479616|NCT00374452|590453156|FG001|Overall Study|Left clinic after intervention started|1|||
163479617|NCT00374452|590453155|FG000|Overall Study|Withdrawal by Subject|0|||
163479618|NCT00374452|590453156|FG001|Overall Study|Withdrawal by Subject|2|||
163479619|NCT02877134|590453157|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
163479620|NCT02877134|590453158|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
163479621|NCT02877134|590453159|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
163479622|NCT02877134|590453160|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
163479623|NCT02877134|590453161|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
163479624|NCT02877134|590453162|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
163479625|NCT02877134|590453163|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
163479626|NCT02877134|590453164|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
163479627|NCT02877134|590453165|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
163479628|NCT02877134|590453166|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
163479629|NCT02877134|590453167|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
163479630|NCT02877134|590453168|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
163479631|NCT02877134|590453157|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
163479632|NCT02877134|590453158|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
163479633|NCT02877134|590453159|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
163479634|NCT02877134|590453160|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
163479635|NCT02877134|590453161|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
163479636|NCT02877134|590453162|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
163479637|NCT02877134|590453163|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
163479638|NCT02877134|590453164|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
163479639|NCT02877134|590453165|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
163479640|NCT02877134|590453166|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
163479641|NCT02877134|590453167|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
163479642|NCT02877134|590453168|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
163479643|NCT02877134|590453157|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
163479644|NCT02877134|590453158|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
163479645|NCT02877134|590453159|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
163479646|NCT02877134|590453160|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
163479647|NCT02877134|590453161|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
163479648|NCT02877134|590453162|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
163479649|NCT02877134|590453163|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
163479650|NCT02877134|590453164|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
163479651|NCT02877134|590453165|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
163479652|NCT02877134|590453166|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
163479653|NCT02877134|590453167|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
163479654|NCT02877134|590453168|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
163479655|NCT02877134|590453157|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
163479656|NCT02877134|590453158|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
163479657|NCT02877134|590453159|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
163479658|NCT02877134|590453160|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
163479659|NCT02877134|590453161|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
163479660|NCT02877134|590453162|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
163479661|NCT02877134|590453163|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
163479662|NCT02877134|590453164|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
163479663|NCT02877134|590453165|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
163479664|NCT02877134|590453166|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
163479665|NCT02877134|590453167|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
163479666|NCT02877134|590453168|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
163479667|NCT02877134|590453157|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
163479668|NCT02877134|590453158|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
163479669|NCT02877134|590453159|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
163479670|NCT02877134|590453160|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
163479671|NCT02877134|590453161|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
163479672|NCT02877134|590453162|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
163479673|NCT02877134|590453163|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
163479674|NCT02877134|590453164|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
163479675|NCT02877134|590453165|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
163479676|NCT02877134|590453166|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
163479677|NCT02877134|590453167|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
163479678|NCT02877134|590453168|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
163479679|NCT02877134|590453157|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
163479680|NCT02877134|590453158|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
163479681|NCT02877134|590453159|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
163479682|NCT02877134|590453160|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
163479683|NCT02877134|590453161|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
163479684|NCT02877134|590453162|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
163479685|NCT02877134|590453163|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
163479686|NCT02877134|590453164|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
163479687|NCT02877134|590453165|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
163479688|NCT02877134|590453166|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
163479689|NCT02877134|590453167|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
163479690|NCT02877134|590453168|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
163479691|NCT02877134|590453157|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
163479692|NCT02877134|590453158|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
163479693|NCT02877134|590453159|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
163479694|NCT02877134|590453160|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
163479695|NCT02877134|590453161|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
163479696|NCT02877134|590453162|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
163479697|NCT02877134|590453163|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
163479698|NCT02877134|590453164|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
163479699|NCT02877134|590453165|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
163479700|NCT02877134|590453166|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
163479701|NCT02877134|590453167|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
163479702|NCT02877134|590453168|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
163479703|NCT02877134|590453157|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
163479704|NCT02877134|590453158|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
163479705|NCT02877134|590453159|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
163479706|NCT02877134|590453160|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
163479707|NCT02877134|590453161|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
163479708|NCT02877134|590453162|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
163479709|NCT02877134|590453163|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
163479710|NCT02877134|590453164|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
163479711|NCT02877134|590453165|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
163479712|NCT02877134|590453166|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
163479713|NCT02877134|590453167|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
163479714|NCT02877134|590453168|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
163479715|NCT00523744|590453169|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
163479716|NCT00523744|590453169|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
163479717|NCT00523744|590453169|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
163479718|NCT00523744|590453169|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
163479719|NCT00523744|590453169|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
163479720|NCT00523744|590453169|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
163479721|NCT01289028|590453170|FG000|Overall Study|Progressive Disease|49|||
163479722|NCT01289028|590453170|FG000|Overall Study|Adverse Event|14|||
163479723|NCT01289028|590453170|FG000|Overall Study|Withdrawal by Subject|6|||
163479724|NCT01289028|590453170|FG000|Overall Study|Death|4|||
163479725|NCT01289028|590453170|FG000|Overall Study|Lack of Efficacy|2|||
163479726|NCT01289028|590453170|FG000|Overall Study|No longer required|2|||
163479727|NCT01289028|590453170|FG000|Overall Study|Lost to Follow-up|2|||
163479728|NCT01289028|590453170|FG000|Overall Study|New Cancer Therapy|2|||
163479729|NCT01289028|590453170|FG000|Overall Study|Abnormal Lab Value|1|||
163479730|NCT01289028|590453170|FG000|Overall Study|Missing reason for discon|1|||
163479731|NCT00998985|590453177|FG000|Overall Study|Withdrawal by Subject|0|||
163479732|NCT00998985|590453178|FG001|Overall Study|Withdrawal by Subject|0|||
163479733|NCT00998985|590453179|FG002|Overall Study|Withdrawal by Subject|0|||
163479734|NCT00998985|590453180|FG003|Overall Study|Withdrawal by Subject|0|||
163479735|NCT00998985|590453181|FG004|Overall Study|Withdrawal by Subject|0|||
163479736|NCT00998985|590453182|FG005|Overall Study|Withdrawal by Subject|0|||
163479737|NCT00998985|590453183|FG006|Overall Study|Withdrawal by Subject|0|||
163479738|NCT00998985|590453184|FG007|Overall Study|Withdrawal by Subject|0|||
163479739|NCT00998985|590453185|FG008|Overall Study|Withdrawal by Subject|1|||
163479740|NCT00998985|590453186|FG009|Overall Study|Withdrawal by Subject|0|||
163479741|NCT00998985|590453187|FG010|Overall Study|Withdrawal by Subject|0|||
163479742|NCT00998985|590453188|FG011|Overall Study|Withdrawal by Subject|0|||
163479743|NCT00998985|590453189|FG012|Overall Study|Withdrawal by Subject|0|||
163479744|NCT00998985|590453190|FG013|Overall Study|Withdrawal by Subject|0|||
163479745|NCT00998985|590453177|FG000|Overall Study|Protocol Violation|0|||
163479746|NCT00998985|590453178|FG001|Overall Study|Protocol Violation|0|||
163479747|NCT00998985|590453179|FG002|Overall Study|Protocol Violation|0|||
163479748|NCT00998985|590453180|FG003|Overall Study|Protocol Violation|0|||
163479749|NCT00998985|590453181|FG004|Overall Study|Protocol Violation|0|||
163479750|NCT00998985|590453182|FG005|Overall Study|Protocol Violation|1|||
163479751|NCT00998985|590453183|FG006|Overall Study|Protocol Violation|0|||
163479752|NCT00998985|590453184|FG007|Overall Study|Protocol Violation|0|||
163479753|NCT00998985|590453185|FG008|Overall Study|Protocol Violation|0|||
163479754|NCT00998985|590453186|FG009|Overall Study|Protocol Violation|0|||
163479755|NCT00998985|590453187|FG010|Overall Study|Protocol Violation|0|||
163479756|NCT00998985|590453188|FG011|Overall Study|Protocol Violation|0|||
163479757|NCT00998985|590453189|FG012|Overall Study|Protocol Violation|0|||
163479758|NCT00998985|590453190|FG013|Overall Study|Protocol Violation|0|||
163479759|NCT01040728|590453192|FG000|Overall Study|Adverse Event|4|||
163479760|NCT01040728|590453193|FG001|Overall Study|Adverse Event|8|||
163479761|NCT01040728|590453194|FG002|Overall Study|Adverse Event|0|||
163479762|NCT01040728|590453195|FG003|Overall Study|Adverse Event|4|||
163479763|NCT01040728|590453192|FG000|Overall Study|Withdrawal by Subject|0|||
163479764|NCT01040728|590453193|FG001|Overall Study|Withdrawal by Subject|1|||
163479765|NCT01040728|590453194|FG002|Overall Study|Withdrawal by Subject|1|||
163479766|NCT01040728|590453195|FG003|Overall Study|Withdrawal by Subject|0|||
163479767|NCT01040728|590453192|FG000|Overall Study|Protocol Violation|0|||
163479768|NCT01040728|590453193|FG001|Overall Study|Protocol Violation|0|||
163479769|NCT01040728|590453194|FG002|Overall Study|Protocol Violation|0|||
163479770|NCT01040728|590453195|FG003|Overall Study|Protocol Violation|1|||
163479771|NCT01040728|590453192|FG000|Overall Study|Lack of Efficacy|0|||
163479772|NCT01040728|590453193|FG001|Overall Study|Lack of Efficacy|1|||
163479773|NCT01040728|590453194|FG002|Overall Study|Lack of Efficacy|0|||
163479774|NCT01040728|590453195|FG003|Overall Study|Lack of Efficacy|1|||
163479775|NCT01040728|590453192|FG000|Overall Study|Other reasons not listed above|0|||
163479776|NCT01040728|590453193|FG001|Overall Study|Other reasons not listed above|1|||
163479777|NCT01040728|590453194|FG002|Overall Study|Other reasons not listed above|0|||
163479778|NCT01040728|590453195|FG003|Overall Study|Other reasons not listed above|0|||
163479779|NCT00542425|590453202|FG000|Initial 24 Weeks|Administrative reasons|0|||
163479780|NCT00542425|590453203|FG001|Initial 24 Weeks|Administrative reasons|0|||
163479781|NCT00542425|590453204|FG002|Initial 24 Weeks|Administrative reasons|1|||
163479782|NCT00542425|590453205|FG003|Initial 24 Weeks|Administrative reasons|1|||
163479783|NCT00542425|590453206|FG004|Initial 24 Weeks|Administrative reasons|0|||
163479784|NCT00542425|590453202|FG000|Initial 24 Weeks|Adverse Event|0|||
163479785|NCT00542425|590453203|FG001|Initial 24 Weeks|Adverse Event|1|||
163479786|NCT00542425|590453204|FG002|Initial 24 Weeks|Adverse Event|1|||
163479787|NCT00542425|590453205|FG003|Initial 24 Weeks|Adverse Event|3|||
163479788|NCT00542425|590453206|FG004|Initial 24 Weeks|Adverse Event|2|||
163479789|NCT00542425|590453202|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
163479790|NCT00542425|590453203|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
163479791|NCT00542425|590453204|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
163479792|NCT00542425|590453205|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
163479793|NCT00542425|590453206|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
163479794|NCT00542425|590453202|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
163479795|NCT00542425|590453203|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
163479796|NCT00542425|590453204|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
163479797|NCT00542425|590453205|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
163479798|NCT00542425|590453206|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
163479799|NCT00542425|590453202|FG000|Initial 24 Weeks|Non-compliance|0|||
163479800|NCT00542425|590453203|FG001|Initial 24 Weeks|Non-compliance|0|||
163479801|NCT00542425|590453204|FG002|Initial 24 Weeks|Non-compliance|0|||
163479802|NCT00542425|590453205|FG003|Initial 24 Weeks|Non-compliance|1|||
163479803|NCT00542425|590453206|FG004|Initial 24 Weeks|Non-compliance|1|||
163479804|NCT00542425|590453202|FG000|Initial 24 Weeks|Protocol Violation|0|||
163479805|NCT00542425|590453203|FG001|Initial 24 Weeks|Protocol Violation|0|||
163479806|NCT00542425|590453204|FG002|Initial 24 Weeks|Protocol Violation|0|||
163479807|NCT00542425|590453205|FG003|Initial 24 Weeks|Protocol Violation|1|||
163479808|NCT00542425|590453206|FG004|Initial 24 Weeks|Protocol Violation|0|||
163479809|NCT00542425|590453202|FG000|Initial 24 Weeks|Refusal of treatment|2|||
163479810|NCT00542425|590453203|FG001|Initial 24 Weeks|Refusal of treatment|2|||
163479811|NCT00542425|590453204|FG002|Initial 24 Weeks|Refusal of treatment|1|||
163479812|NCT00542425|590453205|FG003|Initial 24 Weeks|Refusal of treatment|4|||
163479813|NCT00542425|590453206|FG004|Initial 24 Weeks|Refusal of treatment|1|||
163479814|NCT00542425|590453202|FG000|Initial 24 Weeks|Other|0|||
163479815|NCT00542425|590453203|FG001|Initial 24 Weeks|Other|2|||
163479816|NCT00542425|590453204|FG002|Initial 24 Weeks|Other|1|||
163479817|NCT00542425|590453205|FG003|Initial 24 Weeks|Other|0|||
163479818|NCT00542425|590453206|FG004|Initial 24 Weeks|Other|0|||
163479819|NCT00542425|590453202|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
163479820|NCT00542425|590453203|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
163479821|NCT00542425|590453204|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
163479822|NCT00542425|590453205|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
163479823|NCT00542425|590453206|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
163479824|NCT00542425|590453202|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
163479825|NCT00542425|590453203|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
163479826|NCT00542425|590453204|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
163479827|NCT00542425|590453205|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
163479828|NCT00542425|590453206|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
163479829|NCT00542425|590453202|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
163479830|NCT00542425|590453203|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
163479831|NCT00542425|590453204|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
163479832|NCT00542425|590453205|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
163479833|NCT00542425|590453206|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
163479834|NCT00542425|590453202|FG000|Extended 24 Weeks of Treatment|Other|1|||
163479835|NCT00542425|590453203|FG001|Extended 24 Weeks of Treatment|Other|1|||
163479836|NCT00542425|590453204|FG002|Extended 24 Weeks of Treatment|Other|0|||
163479837|NCT00542425|590453205|FG003|Extended 24 Weeks of Treatment|Other|0|||
163479838|NCT00542425|590453206|FG004|Extended 24 Weeks of Treatment|Other|1|||
163479839|NCT01424306|590453207|FG000|Overall Study|Protocol Violation|0|||
163479840|NCT01424306|590453208|FG001|Overall Study|Protocol Violation|0|||
163479841|NCT01424306|590453209|FG002|Overall Study|Protocol Violation|0|||
163479842|NCT01424306|590453210|FG003|Overall Study|Protocol Violation|0|||
163479843|NCT01424306|590453211|FG004|Overall Study|Protocol Violation|1|||
163479844|NCT01424306|590453212|FG005|Overall Study|Protocol Violation|0|||
163479845|NCT01601873|590453215|FG000|Overall Study|Lost to Follow-up|2|||
163479846|NCT01601873|590453216|FG001|Overall Study|Lost to Follow-up|3|||
163479847|NCT02096471|590453217|FG000|Overall Study|Adverse Event|1|||
163479848|NCT02096471|590453217|FG000|Overall Study|Lack of Efficacy|7|||
163479849|NCT02096471|590453217|FG000|Overall Study|Withdrawal by Subject|3|||
163479850|NCT02096471|590453217|FG000|Overall Study|Non-Compliant|2|||
163479851|NCT03196973|590453218|FG000|Overall Study|Adverse Event|1|||
163479852|NCT03196973|590453219|FG001|Overall Study|Adverse Event|1|||
163479853|NCT03196973|590453220|FG002|Overall Study|Adverse Event|2|||
163479854|NCT03196973|590453218|FG000|Overall Study|Lack of Efficacy|2|||
163479855|NCT03196973|590453219|FG001|Overall Study|Lack of Efficacy|6|||
163479856|NCT03196973|590453220|FG002|Overall Study|Lack of Efficacy|1|||
163479857|NCT03196973|590453218|FG000|Overall Study|Lost to Follow-up|4|||
163479858|NCT03196973|590453219|FG001|Overall Study|Lost to Follow-up|3|||
163479859|NCT03196973|590453220|FG002|Overall Study|Lost to Follow-up|2|||
163479860|NCT03196973|590453218|FG000|Overall Study|Consent withdrawn|2|||
163479861|NCT03196973|590453219|FG001|Overall Study|Consent withdrawn|1|||
163479862|NCT03196973|590453220|FG002|Overall Study|Consent withdrawn|0|||
163479863|NCT03196973|590453218|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
163479864|NCT03196973|590453219|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
163479865|NCT03196973|590453220|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
163479866|NCT03344562|590453221|FG000|Overall Study|Withdrawal by Subject|2|||
163479867|NCT03344562|590453222|FG001|Overall Study|Withdrawal by Subject|0|||
163479868|NCT02736474|590453223|FG000|Overall Study|Lost to Follow-up|0|||
163479869|NCT02736474|590453224|FG001|Overall Study|Lost to Follow-up|1|||
163479870|NCT02463331|590453225|FG000|Overall Study|Adverse Event|4|||
163479871|NCT02463331|590453226|FG001|Overall Study|Adverse Event|2|||
163479872|NCT02463331|590453225|FG000|Overall Study|Lost to Follow-up|1|||
163479873|NCT02463331|590453226|FG001|Overall Study|Lost to Follow-up|1|||
163479874|NCT02463331|590453225|FG000|Overall Study|Pregnancy|2|||
163479875|NCT02463331|590453226|FG001|Overall Study|Pregnancy|3|||
163479876|NCT02463331|590453225|FG000|Overall Study|Lack of Efficacy|6|||
163479877|NCT02463331|590453226|FG001|Overall Study|Lack of Efficacy|0|||
163479878|NCT02463331|590453225|FG000|Overall Study|Physician Decision|3|||
163479879|NCT02463331|590453226|FG001|Overall Study|Physician Decision|0|||
163479880|NCT02483611|590453227|FG000|Overall Study|Protocol Violation|0|||
163479881|NCT02483611|590453228|FG001|Overall Study|Protocol Violation|0|||
163479882|NCT02483611|590453229|FG002|Overall Study|Protocol Violation|1|||
163479883|NCT02590406|590453230|FG000|Overall Study|Adverse Event|1|||
163479884|NCT02590406|590453231|FG001|Overall Study|Adverse Event|0|||
163479885|NCT02590406|590453230|FG000|Overall Study|Saturometer malfunction|0|||
163479886|NCT02590406|590453231|FG001|Overall Study|Saturometer malfunction|1|||
163479887|NCT00631969|590453232|FG000|Overall Study|Adverse Event|3|||
163479888|NCT00631969|590453233|FG001|Overall Study|Adverse Event|1|||
163479889|NCT00631969|590453232|FG000|Overall Study|Lack of Efficacy|2|||
163479890|NCT00631969|590453233|FG001|Overall Study|Lack of Efficacy|8|||
163479891|NCT00631969|590453232|FG000|Overall Study|Lost to Follow-up|2|||
163479892|NCT00631969|590453233|FG001|Overall Study|Lost to Follow-up|1|||
163479893|NCT00631969|590453232|FG000|Overall Study|Protocol Violation|1|||
163479894|NCT00631969|590453233|FG001|Overall Study|Protocol Violation|1|||
163479895|NCT00631969|590453232|FG000|Overall Study|Consent Withdrawn|5|||
163479896|NCT00631969|590453233|FG001|Overall Study|Consent Withdrawn|7|||
163479897|NCT00631969|590453232|FG000|Overall Study|Noncompliant With Study Medication|0|||
163479898|NCT00631969|590453233|FG001|Overall Study|Noncompliant With Study Medication|1|||
163479899|NCT00631969|590453232|FG000|Overall Study|No Drug Exposure|2|||
163479900|NCT00631969|590453233|FG001|Overall Study|No Drug Exposure|2|||
163479901|NCT01084096|590454870|FG000|Overall Study|Lost to Follow-up|1501|||
163479902|NCT01084096|590454871|FG001|Overall Study|Lost to Follow-up|1833|||
163479903|NCT01084096|590454870|FG000|Overall Study|Withdrawal by Subject|3|||
163479904|NCT01084096|590454871|FG001|Overall Study|Withdrawal by Subject|0|||
163479905|NCT01084096|590454870|FG000|Overall Study|Woman had a miscarriage|21|||
163479906|NCT01084096|590454871|FG001|Overall Study|Woman had a miscarriage|17|||
163479907|NCT00027846|590454872|FG000|Overall Study|Lost to Follow-up|0|||
163479908|NCT00027846|590454873|FG001|Overall Study|Lost to Follow-up|41|||
163479909|NCT00027846|590454874|FG002|Overall Study|Lost to Follow-up|9|||
163479910|NCT00027846|590454872|FG000|Overall Study|Withdrawal by Subject|0|||
163479911|NCT00027846|590454873|FG001|Overall Study|Withdrawal by Subject|14|||
163479912|NCT00027846|590454874|FG002|Overall Study|Withdrawal by Subject|7|||
163479913|NCT00027846|590454872|FG000|Overall Study|Ineligible for study|2|||
163479914|NCT00027846|590454873|FG001|Overall Study|Ineligible for study|6|||
163479915|NCT00027846|590454874|FG002|Overall Study|Ineligible for study|14|||
163479916|NCT00027846|590454872|FG000|Overall Study|Entry into another COG therapeutic study|0|||
163479917|NCT00027846|590454873|FG001|Overall Study|Entry into another COG therapeutic study|5|||
163479918|NCT00027846|590454874|FG002|Overall Study|Entry into another COG therapeutic study|2|||
163479919|NCT00027846|590454872|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
163479920|NCT00027846|590454873|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
163479921|NCT00027846|590454874|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
163479922|NCT02033369|590454875|FG000|Overall Study|Physician Decision|1|||
163479923|NCT02033369|590454876|FG001|Overall Study|Physician Decision|2|||
163479924|NCT02033369|590454875|FG000|Overall Study|Not a good demographic match|0|||
163479925|NCT02033369|590454876|FG001|Overall Study|Not a good demographic match|2|||
163479926|NCT02033369|590454875|FG000|Overall Study|Withdrawal by Subject|1|||
163479927|NCT02033369|590454876|FG001|Overall Study|Withdrawal by Subject|1|||
163479928|NCT02033369|590454875|FG000|Overall Study|Lost to Follow-up|1|||
163479929|NCT02033369|590454876|FG001|Overall Study|Lost to Follow-up|0|||
163479930|NCT02033369|590454875|FG000|Overall Study|Protocol Violation|2|||
163479931|NCT02033369|590454876|FG001|Overall Study|Protocol Violation|0|||
163479932|NCT00663208|590454879|FG000|Treatment Period|Lost to Follow-up|0|||
163479933|NCT00663208|590454880|FG001|Treatment Period|Lost to Follow-up|1|||
163479934|NCT00663208|590454881|FG002|Treatment Period|Lost to Follow-up|0|||
163479935|NCT00663208|590454882|FG003|Treatment Period|Lost to Follow-up|0|||
163479936|NCT00663208|590454883|FG004|Treatment Period|Lost to Follow-up|0|||
163479937|NCT00663208|590454884|FG005|Treatment Period|Lost to Follow-up|0|||
163479938|NCT00663208|590454885|FG006|Treatment Period|Lost to Follow-up|0|||
163479939|NCT00663208|590454879|FG000|Follow-up Period|Lost to Follow-up|2|||
163479940|NCT00663208|590454880|FG001|Follow-up Period|Lost to Follow-up|0|||
163479941|NCT00663208|590454881|FG002|Follow-up Period|Lost to Follow-up|3|||
163479942|NCT00663208|590454882|FG003|Follow-up Period|Lost to Follow-up|2|||
163479943|NCT00663208|590454883|FG004|Follow-up Period|Lost to Follow-up|0|||
163479944|NCT00663208|590454884|FG005|Follow-up Period|Lost to Follow-up|0|||
163479945|NCT00663208|590454885|FG006|Follow-up Period|Lost to Follow-up|0|||
163479946|NCT00663208|590454879|FG000|Follow-up Period|Other reason|1|||
163479947|NCT00663208|590454880|FG001|Follow-up Period|Other reason|0|||
163479948|NCT00663208|590454881|FG002|Follow-up Period|Other reason|0|||
163479949|NCT00663208|590454882|FG003|Follow-up Period|Other reason|0|||
163479950|NCT00663208|590454883|FG004|Follow-up Period|Other reason|0|||
163479951|NCT00663208|590454884|FG005|Follow-up Period|Other reason|0|||
163479952|NCT00663208|590454885|FG006|Follow-up Period|Other reason|1|||
163479953|NCT01451203|590454886|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
163479954|NCT01451203|590454887|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
163479955|NCT01451203|590454886|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
163479956|NCT01451203|590454887|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
163479957|NCT01451203|590454886|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
163479958|NCT01451203|590454887|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
163479959|NCT01451203|590454886|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
163479960|NCT01451203|590454887|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
163479961|NCT01451203|590454886|FG000|Double-blind Treatment Period|Adverse Event|6|||
163479962|NCT01451203|590454887|FG001|Double-blind Treatment Period|Adverse Event|9|||
163479963|NCT01451203|590454886|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
163479964|NCT01451203|590454887|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
163479965|NCT01451203|590454886|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
163479966|NCT01451203|590454887|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
163479967|NCT01451203|590454886|FG000|Double-blind Treatment Period|Investigator decision|2|||
163479968|NCT01451203|590454887|FG001|Double-blind Treatment Period|Investigator decision|0|||
163479969|NCT01451203|590454886|FG000|Post-treatment Period|Consent withdrawn|2|||
163479970|NCT01451203|590454887|FG001|Post-treatment Period|Consent withdrawn|4|||
163479971|NCT01451203|590454886|FG000|Post-treatment Period|Lack of Efficacy|12|||
163479972|NCT01451203|590454887|FG001|Post-treatment Period|Lack of Efficacy|28|||
163479973|NCT01451203|590454886|FG000|Post-treatment Period|Adverse Event|0|||
163479974|NCT01451203|590454887|FG001|Post-treatment Period|Adverse Event|1|||
163479975|NCT01451203|590454886|FG000|Post-treatment Period|Investigator decision|0|||
163479976|NCT01451203|590454887|FG001|Post-treatment Period|Investigator decision|1|||
163479977|NCT00039377|590454888|FG000|Initial Registration|Adverse Event|2|||
163479978|NCT00039377|590454889|FG001|Initial Registration|Adverse Event|0|||
163479979|NCT00039377|590454890|FG002|Initial Registration|Adverse Event|0|||
163479980|NCT00039377|590454891|FG003|Initial Registration|Adverse Event|0|||
163479981|NCT00039377|590454888|FG000|Initial Registration|Relapsed|6|||
163479982|NCT00039377|590454889|FG001|Initial Registration|Relapsed|0|||
163479983|NCT00039377|590454890|FG002|Initial Registration|Relapsed|0|||
163479984|NCT00039377|590454891|FG003|Initial Registration|Relapsed|0|||
163479985|NCT00039377|590454888|FG000|Initial Registration|Received non-protocol therapy|11|||
163479986|NCT00039377|590454889|FG001|Initial Registration|Received non-protocol therapy|0|||
163479987|NCT00039377|590454890|FG002|Initial Registration|Received non-protocol therapy|0|||
163479988|NCT00039377|590454891|FG003|Initial Registration|Received non-protocol therapy|0|||
163479989|NCT00039377|590454888|FG000|Initial Registration|Withdrawal by Subject|3|||
163479990|NCT00039377|590454889|FG001|Initial Registration|Withdrawal by Subject|0|||
163479991|NCT00039377|590454890|FG002|Initial Registration|Withdrawal by Subject|0|||
163479992|NCT00039377|590454891|FG003|Initial Registration|Withdrawal by Subject|0|||
163479993|NCT01249404|590454892|FG000|Overall Study|Study treatment not received|0|||
163479994|NCT01249404|590454893|FG001|Overall Study|Study treatment not received|1|||
163479995|NCT01249404|590454894|FG002|Overall Study|Study treatment not received|2|||
163479996|NCT01249404|590454892|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
163479997|NCT01249404|590454893|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
163479998|NCT01249404|590454894|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
163479999|NCT01249404|590454892|FG000|Overall Study|Adverse Event|2|||
163480000|NCT01249404|590454893|FG001|Overall Study|Adverse Event|2|||
163480001|NCT01249404|590454894|FG002|Overall Study|Adverse Event|2|||
163480002|NCT01249404|590454892|FG000|Overall Study|Withdrawal by Subject|2|||
163480003|NCT01249404|590454893|FG001|Overall Study|Withdrawal by Subject|2|||
163480004|NCT01249404|590454894|FG002|Overall Study|Withdrawal by Subject|0|||
163480005|NCT01249404|590454892|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
163480006|NCT01249404|590454893|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
163480007|NCT01249404|590454894|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
163480008|NCT01249404|590454892|FG000|Overall Study|Non compliance to visit schedule|0|||
163480009|NCT01249404|590454893|FG001|Overall Study|Non compliance to visit schedule|1|||
163480010|NCT01249404|590454894|FG002|Overall Study|Non compliance to visit schedule|0|||
163480011|NCT03758612|590454895|FG000|Washout Period|Withdrawal by Subject|0|||
163480012|NCT03758612|590454896|FG001|Washout Period|Withdrawal by Subject|0|||
163480013|NCT03758612|590454897|FG002|Washout Period|Withdrawal by Subject|2|||
163480014|NCT03758612|590454898|FG003|Washout Period|Withdrawal by Subject|0|||
163480015|NCT03758612|590454899|FG004|Washout Period|Withdrawal by Subject|0|||
163480016|NCT03758612|590454900|FG005|Washout Period|Withdrawal by Subject|0|||
163480017|NCT03758612|590454901|FG006|Washout Period|Withdrawal by Subject|0|||
163480018|NCT03758612|590454902|FG007|Washout Period|Withdrawal by Subject|0|||
163480019|NCT03758612|590454903|FG008|Washout Period|Withdrawal by Subject|0|||
163480020|NCT03758612|590454904|FG009|Washout Period|Withdrawal by Subject|0|||
163480021|NCT03758612|590454905|FG010|Washout Period|Withdrawal by Subject|0|||
163480022|NCT03758612|590454906|FG011|Washout Period|Withdrawal by Subject|0|||
163480023|NCT03758612|590454895|FG000|Period 2|Protocol Violation|0|||
163480024|NCT03758612|590454896|FG001|Period 2|Protocol Violation|0|||
163480025|NCT03758612|590454897|FG002|Period 2|Protocol Violation|0|||
163480026|NCT03758612|590454898|FG003|Period 2|Protocol Violation|0|||
163480027|NCT03758612|590454899|FG004|Period 2|Protocol Violation|1|||
163480028|NCT03758612|590454900|FG005|Period 2|Protocol Violation|0|||
163480029|NCT03758612|590454901|FG006|Period 2|Protocol Violation|0|||
163480030|NCT03758612|590454902|FG007|Period 2|Protocol Violation|0|||
163480031|NCT03758612|590454903|FG008|Period 2|Protocol Violation|0|||
163480032|NCT03758612|590454904|FG009|Period 2|Protocol Violation|0|||
163480033|NCT03758612|590454905|FG010|Period 2|Protocol Violation|0|||
163480034|NCT03758612|590454906|FG011|Period 2|Protocol Violation|0|||
163480035|NCT02500901|590454907|FG000|Overall Study|Disease ProgressionDD|2|||
163480036|NCT01191190|590454908|FG000|Overall Study|Withdrawal by Subject|1|||
163480037|NCT01716585|590454911|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
163480038|NCT01716585|590454912|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
163480039|NCT01716585|590454911|FG000|Double-blind Treatment|Adverse Event|2|||
163480040|NCT01716585|590454912|FG001|Double-blind Treatment|Adverse Event|1|||
163480041|NCT01716585|590454911|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
163480042|NCT01716585|590454912|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
163480043|NCT01716585|590454911|FG000|Double-blind Treatment|Lost to Follow-up|2|||
163480044|NCT01716585|590454912|FG001|Double-blind Treatment|Lost to Follow-up|0|||
163480045|NCT01716585|590454911|FG000|Double-blind Treatment|Subject Noncompliant|1|||
163480046|NCT01716585|590454912|FG001|Double-blind Treatment|Subject Noncompliant|0|||
163480047|NCT01716585|590454911|FG000|Double-blind Treatment|Other|1|||
163480048|NCT01716585|590454912|FG001|Double-blind Treatment|Other|0|||
163480049|NCT01716585|590454911|FG000|Open-label Treatment|Adverse Event|0|||
163480050|NCT01716585|590454912|FG001|Open-label Treatment|Adverse Event|2|||
163480051|NCT01716585|590454911|FG000|Open-label Treatment|Virologic Failure|0|||
163480052|NCT01716585|590454912|FG001|Open-label Treatment|Virologic Failure|2|||
163480053|NCT01716585|590454911|FG000|Open-label Treatment|Withdrawal by Subject|0|||
163480054|NCT01716585|590454912|FG001|Open-label Treatment|Withdrawal by Subject|3|||
163480055|NCT04235959|590454913|FG000|Overall Study|Protocol Violation|0|||
163480056|NCT04235959|590454914|FG001|Overall Study|Protocol Violation|1|||
163480057|NCT04235959|590454915|FG002|Overall Study|Protocol Violation|0|||
163480058|NCT04235959|590454913|FG000|Overall Study|Adverse Event|1|||
163480059|NCT04235959|590454914|FG001|Overall Study|Adverse Event|0|||
163480060|NCT04235959|590454915|FG002|Overall Study|Adverse Event|0|||
163480061|NCT00125138|590454916|FG000|Overall Study|Adverse Event|1|||
163480062|NCT00125138|590454917|FG001|Overall Study|Adverse Event|0|||
163480063|NCT00125138|590454918|FG002|Overall Study|Adverse Event|3|||
163480064|NCT00125138|590454919|FG003|Overall Study|Adverse Event|2|||
163480065|NCT00125138|590454916|FG000|Overall Study|Withdrawal by Subject|2|||
163480066|NCT00125138|590454917|FG001|Overall Study|Withdrawal by Subject|3|||
163480067|NCT00125138|590454918|FG002|Overall Study|Withdrawal by Subject|1|||
163480068|NCT00125138|590454919|FG003|Overall Study|Withdrawal by Subject|1|||
163480069|NCT00125138|590454916|FG000|Overall Study|Lack of Efficacy|0|||
163480070|NCT00125138|590454917|FG001|Overall Study|Lack of Efficacy|0|||
163480071|NCT00125138|590454918|FG002|Overall Study|Lack of Efficacy|0|||
163480072|NCT00125138|590454919|FG003|Overall Study|Lack of Efficacy|1|||
163480073|NCT00125138|590454916|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
163480074|NCT00125138|590454917|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
163480075|NCT00125138|590454918|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
163480076|NCT00125138|590454919|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
163480077|NCT00348686|590454924|FG000|Overall Study|Withdrawal by Subject|45|||
163480078|NCT00348686|590454924|FG000|Overall Study|Adverse Event|5|||
163480079|NCT00348686|590454924|FG000|Overall Study|Protocol Violation|6|||
163480080|NCT00348686|590454924|FG000|Overall Study|Lost to Follow-up|2|||
163480081|NCT00348686|590454924|FG000|Overall Study|Multiple Reasons|8|||
163480082|NCT01258738|590454927|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
163480083|NCT01258738|590454928|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
163480084|NCT01258738|590454927|FG000|Double-blind Period|Withdrawal by Subject|2|||
163480085|NCT01258738|590454928|FG001|Double-blind Period|Withdrawal by Subject|2|||
163480086|NCT01258738|590454927|FG000|Double-blind Period|Protocol Violation|1|||
163480087|NCT01258738|590454928|FG001|Double-blind Period|Protocol Violation|1|||
163480088|NCT01258738|590454927|FG000|Double-blind Period|Adverse Event|3|||
163480089|NCT01258738|590454928|FG001|Double-blind Period|Adverse Event|1|||
163480090|NCT01258738|590454927|FG000|Open-label Period|Did not meet inclusion criteria|0|||
163480091|NCT01258738|590454928|FG001|Open-label Period|Did not meet inclusion criteria|1|||
163480092|NCT01258738|590454927|FG000|Open-label Period|Insufficient clinical response|5|||
163480093|NCT01258738|590454928|FG001|Open-label Period|Insufficient clinical response|3|||
163480094|NCT01258738|590454927|FG000|Open-label Period|Lost to Follow-up|0|||
163480095|NCT01258738|590454928|FG001|Open-label Period|Lost to Follow-up|2|||
163480096|NCT01258738|590454927|FG000|Open-label Period|Withdrawal by Subject|5|||
163480097|NCT01258738|590454928|FG001|Open-label Period|Withdrawal by Subject|6|||
163480098|NCT01258738|590454927|FG000|Open-label Period|Protocol Violation|2|||
163480099|NCT01258738|590454928|FG001|Open-label Period|Protocol Violation|2|||
163480100|NCT01258738|590454927|FG000|Open-label Period|Adverse Event|4|||
163480101|NCT01258738|590454928|FG001|Open-label Period|Adverse Event|5|||
163480102|NCT01258738|590454927|FG000|Open-label Period|Other Reasons|0|||
163480103|NCT01258738|590454928|FG001|Open-label Period|Other Reasons|1|||
163480104|NCT01258738|590454927|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
163480105|NCT01258738|590454928|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
163480106|NCT02870348|590454929|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
163480107|NCT02381795|590454930|FG000|Overall Study|Withdrawal by Subject|1|||
163480108|NCT02381795|590454930|FG000|Overall Study|Study Terminated|2|||
163480109|NCT01488994|590454935|FG000|Overall Study|Withdrawal by Subject|0|||
163480110|NCT01488994|590454936|FG001|Overall Study|Withdrawal by Subject|1|||
163480111|NCT02908841|590454937|FG000|Overall Study|Physician Decision|4|||
163480112|NCT02908841|590454938|FG001|Overall Study|Physician Decision|0|||
163480113|NCT03798366|590454939|FG000|Overall Study|Lost to Follow-up|0|||
163480114|NCT03798366|590454940|FG001|Overall Study|Lost to Follow-up|1|||
163480115|NCT01117428|590454941|FG000|Overall Study|Lack of Efficacy|1|||
163480116|NCT01117428|590454942|FG001|Overall Study|Lack of Efficacy|0|||
163480117|NCT01117428|590454943|FG002|Overall Study|Lack of Efficacy|0|||
163480118|NCT01117428|590454944|FG003|Overall Study|Lack of Efficacy|0|||
163480119|NCT01117428|590454945|FG004|Overall Study|Lack of Efficacy|0|||
163480120|NCT01117428|590454946|FG005|Overall Study|Lack of Efficacy|0|||
163480121|NCT01117428|590454941|FG000|Overall Study|Adverse Event|4|||
163480122|NCT01117428|590454942|FG001|Overall Study|Adverse Event|0|||
163480123|NCT01117428|590454943|FG002|Overall Study|Adverse Event|0|||
163480124|NCT01117428|590454944|FG003|Overall Study|Adverse Event|0|||
163480125|NCT01117428|590454945|FG004|Overall Study|Adverse Event|1|||
163480126|NCT01117428|590454946|FG005|Overall Study|Adverse Event|2|||
163480127|NCT01117428|590454941|FG000|Overall Study|Death|0|||
163480128|NCT01117428|590454942|FG001|Overall Study|Death|1|||
163480129|NCT01117428|590454943|FG002|Overall Study|Death|2|||
163480130|NCT01117428|590454944|FG003|Overall Study|Death|0|||
163480131|NCT01117428|590454945|FG004|Overall Study|Death|0|||
163480132|NCT01117428|590454946|FG005|Overall Study|Death|1|||
163480133|NCT01117428|590454941|FG000|Overall Study|Physician Decision|0|||
163480134|NCT01117428|590454942|FG001|Overall Study|Physician Decision|1|||
163480135|NCT01117428|590454943|FG002|Overall Study|Physician Decision|0|||
163480136|NCT01117428|590454944|FG003|Overall Study|Physician Decision|0|||
163480137|NCT01117428|590454945|FG004|Overall Study|Physician Decision|0|||
163480138|NCT01117428|590454946|FG005|Overall Study|Physician Decision|0|||
163480139|NCT01117428|590454941|FG000|Overall Study|Withdrawal by Subject|0|||
163480140|NCT01117428|590454942|FG001|Overall Study|Withdrawal by Subject|0|||
163480141|NCT01117428|590454943|FG002|Overall Study|Withdrawal by Subject|1|||
163480142|NCT01117428|590454944|FG003|Overall Study|Withdrawal by Subject|0|||
163480143|NCT01117428|590454945|FG004|Overall Study|Withdrawal by Subject|0|||
163480144|NCT01117428|590454946|FG005|Overall Study|Withdrawal by Subject|0|||
163480145|NCT01117428|590454941|FG000|Overall Study|Progressive disease|15|||
163480146|NCT01117428|590454942|FG001|Overall Study|Progressive disease|27|||
163480147|NCT01117428|590454943|FG002|Overall Study|Progressive disease|10|||
163480148|NCT01117428|590454944|FG003|Overall Study|Progressive disease|12|||
163480149|NCT01117428|590454945|FG004|Overall Study|Progressive disease|16|||
163480150|NCT01117428|590454946|FG005|Overall Study|Progressive disease|17|||
163480151|NCT00474539|590454947|FG000|Infant Series|Withdrawal by Subject|3|||
163480152|NCT00474539|590454948|FG001|Infant Series|Withdrawal by Subject|4|||
163480153|NCT00474539|590454947|FG000|Infant Series|Randomization error|5|||
163480154|NCT00474539|590454948|FG001|Infant Series|Randomization error|0|||
163480155|NCT00474539|590454947|FG000|Infant Series|Lost to Follow-up|2|||
163480156|NCT00474539|590454948|FG001|Infant Series|Lost to Follow-up|1|||
163480157|NCT00474539|590454947|FG000|Infant Series|Protocol Violation|0|||
163480158|NCT00474539|590454948|FG001|Infant Series|Protocol Violation|1|||
163480159|NCT00474539|590454947|FG000|After Infant Series|Lost to Follow-up|3|||
163480160|NCT00474539|590454948|FG001|After Infant Series|Lost to Follow-up|0|||
163480161|NCT00474539|590454947|FG000|After Infant Series|Withdrawal by Subject|1|||
163480162|NCT00474539|590454948|FG001|After Infant Series|Withdrawal by Subject|0|||
163480163|NCT00474539|590454947|FG000|Toddler Dose|Protocol Violation|1|||
163480164|NCT00474539|590454948|FG001|Toddler Dose|Protocol Violation|0|||
163480165|NCT02195531|590454949|FG000|Overall Study|Withdrawal by Subject|1|||
163480166|NCT02195531|590454950|FG001|Overall Study|Withdrawal by Subject|1|||
163480167|NCT02195531|590454951|FG002|Overall Study|Withdrawal by Subject|1|||
163480168|NCT01657253|590454958|FG000|Overall Study|Lost to Follow-up|6|||
163480169|NCT01657253|590454959|FG001|Overall Study|Lost to Follow-up|5|||
163480170|NCT01657253|590454958|FG000|Overall Study|Withdrawal by Subject|11|||
163480171|NCT01657253|590454959|FG001|Overall Study|Withdrawal by Subject|12|||
163480172|NCT01657253|590454958|FG000|Overall Study|Adverse Event|0|||
163480173|NCT01657253|590454959|FG001|Overall Study|Adverse Event|1|||
163480174|NCT01970540|590454960|FG000|Overall Study|Non-treatment-related AE|0|||
163480175|NCT01970540|590454961|FG001|Overall Study|Non-treatment-related AE|0|||
163480176|NCT01970540|590454962|FG002|Overall Study|Non-treatment-related AE|1|||
163480177|NCT01970540|590454960|FG000|Overall Study|Progressive disease|55|||
163480178|NCT01970540|590454961|FG001|Overall Study|Progressive disease|23|||
163480179|NCT01970540|590454962|FG002|Overall Study|Progressive disease|10|||
163480180|NCT01970540|590454960|FG000|Overall Study|Treatment delay over protocol|0|||
163480181|NCT01970540|590454961|FG001|Overall Study|Treatment delay over protocol|0|||
163480182|NCT01970540|590454962|FG002|Overall Study|Treatment delay over protocol|1|||
163480183|NCT01970540|590454960|FG000|Overall Study|Physician Decision|7|||
163480184|NCT01970540|590454961|FG001|Overall Study|Physician Decision|2|||
163480185|NCT01970540|590454962|FG002|Overall Study|Physician Decision|0|||
163480186|NCT01970540|590454960|FG000|Overall Study|Clinical progression|0|||
163480187|NCT01970540|590454961|FG001|Overall Study|Clinical progression|1|||
163480188|NCT01970540|590454962|FG002|Overall Study|Clinical progression|1|||
163480189|NCT01970540|590454960|FG000|Overall Study|End of study|2|||
163480190|NCT01970540|590454961|FG001|Overall Study|End of study|0|||
163480191|NCT01970540|590454962|FG002|Overall Study|End of study|2|||
163480192|NCT01970540|590454960|FG000|Overall Study|Adverse Event|0|||
163480193|NCT01970540|590454961|FG001|Overall Study|Adverse Event|2|||
163480194|NCT01970540|590454962|FG002|Overall Study|Adverse Event|1|||
163480195|NCT01970540|590454960|FG000|Overall Study|Treatment-related AE|4|||
163480196|NCT01970540|590454961|FG001|Overall Study|Treatment-related AE|0|||
163480197|NCT01970540|590454962|FG002|Overall Study|Treatment-related AE|2|||
163480198|NCT01970540|590454960|FG000|Overall Study|Withdrawal by Subject|4|||
163480199|NCT01970540|590454961|FG001|Overall Study|Withdrawal by Subject|0|||
163480200|NCT01970540|590454962|FG002|Overall Study|Withdrawal by Subject|1|||
163480201|NCT01970540|590454960|FG000|Overall Study|Clinical deterioration|1|||
163480202|NCT01970540|590454961|FG001|Overall Study|Clinical deterioration|0|||
163480203|NCT01970540|590454962|FG002|Overall Study|Clinical deterioration|0|||
163480204|NCT00242710|590454964|FG000|Core Study (up to Year 1)|Adverse Event|30|||
163480205|NCT00242710|590454965|FG001|Core Study (up to Year 1)|Adverse Event|25|||
163480206|NCT00242710|590454966|FG002|Core Study (up to Year 1)|Adverse Event|23|||
163480207|NCT00242710|590454967|FG003|Core Study (up to Year 1)|Adverse Event|14|||
163480208|NCT00242710|590454964|FG000|Core Study (up to Year 1)|Death|0|||
163480209|NCT00242710|590454965|FG001|Core Study (up to Year 1)|Death|0|||
163480210|NCT00242710|590454966|FG002|Core Study (up to Year 1)|Death|1|||
163480211|NCT00242710|590454967|FG003|Core Study (up to Year 1)|Death|0|||
163480212|NCT00242710|590454964|FG000|Core Study (up to Year 1)|Physician Decision|0|||
163480213|NCT00242710|590454965|FG001|Core Study (up to Year 1)|Physician Decision|1|||
163480214|NCT00242710|590454966|FG002|Core Study (up to Year 1)|Physician Decision|0|||
163480215|NCT00242710|590454967|FG003|Core Study (up to Year 1)|Physician Decision|1|||
163480216|NCT00242710|590454964|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
163480217|NCT00242710|590454965|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
163480218|NCT00242710|590454966|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
163480219|NCT00242710|590454967|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
163480220|NCT00242710|590454964|FG000|Core Study (up to Year 1)|Other|6|||
163480221|NCT00242710|590454965|FG001|Core Study (up to Year 1)|Other|1|||
163480222|NCT00242710|590454966|FG002|Core Study (up to Year 1)|Other|0|||
163480223|NCT00242710|590454967|FG003|Core Study (up to Year 1)|Other|2|||
163480224|NCT00242710|590454964|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
163480225|NCT00242710|590454965|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
163480226|NCT00242710|590454966|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
163480227|NCT00242710|590454967|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
163480228|NCT00242710|590454964|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
163480229|NCT00242710|590454965|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
163480230|NCT00242710|590454966|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
163480231|NCT00242710|590454967|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
163480232|NCT00242710|590454964|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
163480233|NCT00242710|590454965|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
163480234|NCT00242710|590454966|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
163480235|NCT00242710|590454967|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
163480236|NCT00242710|590454964|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
163480237|NCT00242710|590454965|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
163480238|NCT00242710|590454966|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
163480239|NCT00242710|590454967|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
163480240|NCT00242710|590454964|FG000|Period Between Core Study and Extension|Adverse Event|2|||
163480241|NCT00242710|590454965|FG001|Period Between Core Study and Extension|Adverse Event|3|||
163480242|NCT00242710|590454966|FG002|Period Between Core Study and Extension|Adverse Event|5|||
163480243|NCT00242710|590454967|FG003|Period Between Core Study and Extension|Adverse Event|2|||
163480244|NCT00242710|590454964|FG000|Period Between Core Study and Extension|Physician Decision|1|||
163480245|NCT00242710|590454965|FG001|Period Between Core Study and Extension|Physician Decision|1|||
163480246|NCT00242710|590454966|FG002|Period Between Core Study and Extension|Physician Decision|0|||
163480247|NCT00242710|590454967|FG003|Period Between Core Study and Extension|Physician Decision|0|||
163480248|NCT00242710|590454964|FG000|Period Between Core Study and Extension|Other|24|||
163480249|NCT00242710|590454965|FG001|Period Between Core Study and Extension|Other|24|||
163480250|NCT00242710|590454966|FG002|Period Between Core Study and Extension|Other|9|||
163480251|NCT00242710|590454967|FG003|Period Between Core Study and Extension|Other|11|||
163480252|NCT00242710|590454964|FG000|Period Between Core Study and Extension|Extension not Available|17|||
163480253|NCT00242710|590454965|FG001|Period Between Core Study and Extension|Extension not Available|21|||
163480254|NCT00242710|590454966|FG002|Period Between Core Study and Extension|Extension not Available|8|||
163480255|NCT00242710|590454967|FG003|Period Between Core Study and Extension|Extension not Available|7|||
163480256|NCT00242710|590454964|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
163480257|NCT00242710|590454965|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
163480258|NCT00242710|590454966|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
163480259|NCT00242710|590454967|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
163480260|NCT00242710|590454964|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
163480261|NCT00242710|590454965|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
163480262|NCT00242710|590454966|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
163480263|NCT00242710|590454967|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
163480264|NCT00242710|590454964|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
163480265|NCT00242710|590454965|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
163480266|NCT00242710|590454966|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
163480267|NCT00242710|590454967|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
163480268|NCT00242710|590454964|FG000|Study Extension (up to Year 2)|Death|0|||
163480269|NCT00242710|590454965|FG001|Study Extension (up to Year 2)|Death|0|||
163480270|NCT00242710|590454966|FG002|Study Extension (up to Year 2)|Death|0|||
163480271|NCT00242710|590454967|FG003|Study Extension (up to Year 2)|Death|1|||
163480272|NCT00242710|590454964|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
163480273|NCT00242710|590454965|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
163480274|NCT00242710|590454966|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
163480275|NCT00242710|590454967|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
163480276|NCT00242710|590454964|FG000|Study Extension (up to Year 2)|Other|3|||
163480277|NCT00242710|590454965|FG001|Study Extension (up to Year 2)|Other|5|||
163480278|NCT00242710|590454966|FG002|Study Extension (up to Year 2)|Other|4|||
163480279|NCT00242710|590454967|FG003|Study Extension (up to Year 2)|Other|3|||
163480280|NCT00242710|590454964|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
163480281|NCT00242710|590454965|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
163480282|NCT00242710|590454966|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
163480283|NCT00242710|590454967|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
163480284|NCT00242710|590454964|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
163480285|NCT00242710|590454965|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
163480286|NCT00242710|590454966|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
163480287|NCT00242710|590454967|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
163480288|NCT01057394|590454968|FG000|Overall Study|Not eligible|0|||
163480289|NCT01057394|590454969|FG001|Overall Study|Not eligible|2|||
163480290|NCT00579527|590454970|FG000|Overall Study|Death|4|||
163480291|NCT00203294|590454971|FG000|Overall Study|Withdrawal by Subject|8|||
163480292|NCT00203294|590454972|FG001|Overall Study|Withdrawal by Subject|13|||
163480293|NCT02177942|590454982|FG000|Overall Study|Adverse Event|1|||
163480294|NCT02177942|590454983|FG001|Overall Study|Adverse Event|0|||
163480295|NCT02177942|590454982|FG000|Overall Study|Lost to Follow-up|1|||
163480296|NCT02177942|590454983|FG001|Overall Study|Lost to Follow-up|1|||
163480297|NCT02177942|590454982|FG000|Overall Study|Protocol Violation|4|||
163480298|NCT02177942|590454983|FG001|Overall Study|Protocol Violation|6|||
163480299|NCT02177942|590454982|FG000|Overall Study|Withdrawal by Subject|71|||
163480300|NCT02177942|590454983|FG001|Overall Study|Withdrawal by Subject|81|||
163480301|NCT01948791|590454987|FG000|Overall Study|Adverse Event|12|||
163480302|NCT01948791|590454987|FG000|Overall Study|Lack of Efficacy|3|||
163480303|NCT01948791|590454987|FG000|Overall Study|Protocol Violation|2|||
163480304|NCT01948791|590454987|FG000|Overall Study|Withdrawal by Subject|5|||
163480305|NCT01948791|590454987|FG000|Overall Study|Lost to Follow-up|6|||
163480306|NCT01948791|590454987|FG000|Overall Study|Management issues|1|||
163480307|NCT01948791|590454987|FG000|Overall Study|Others|7|||
163480308|NCT01948791|590454987|FG000|Overall Study|Screening failure|35|||
163480309|NCT00702949|590454996|FG000|Overall Study|Refusal|3|||
163480310|NCT00702949|590454997|FG001|Overall Study|Refusal|2|||
163480311|NCT00702949|590454998|FG002|Overall Study|Refusal|2|||
163480312|NCT00702949|590454996|FG000|Overall Study|Adverse Event|1|||
163480313|NCT00702949|590454997|FG001|Overall Study|Adverse Event|6|||
163480314|NCT00702949|590454998|FG002|Overall Study|Adverse Event|3|||
163480315|NCT00702949|590454996|FG000|Overall Study|Other Medical Reason/unknown|1|||
163480316|NCT00702949|590454997|FG001|Overall Study|Other Medical Reason/unknown|1|||
163480317|NCT00702949|590454998|FG002|Overall Study|Other Medical Reason/unknown|3|||
163480318|NCT01610414|590455004|FG000|Study Start - Month 13|Serious Adverse Event|65|||
163480319|NCT01610414|590455005|FG001|Study Start - Month 13|Serious Adverse Event|67|||
163480320|NCT01610414|590455004|FG000|Study Start - Month 13|Adverse Event|14|||
163480321|NCT01610414|590455005|FG001|Study Start - Month 13|Adverse Event|14|||
163480322|NCT01610414|590455004|FG000|Study Start - Month 13|Protocol Violation|3|||
163480323|NCT01610414|590455005|FG001|Study Start - Month 13|Protocol Violation|1|||
163480324|NCT01610414|590455004|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
163480325|NCT01610414|590455005|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
163480326|NCT01610414|590455004|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
163480327|NCT01610414|590455005|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
163480328|NCT01610414|590455004|FG000|Study Start - Month 13|Lost to Follow-up|4|||
163480329|NCT01610414|590455005|FG001|Study Start - Month 13|Lost to Follow-up|6|||
163480330|NCT01610414|590455004|FG000|Study Start - Month 13|Suspected HZ episode|1|||
163480331|NCT01610414|590455005|FG001|Study Start - Month 13|Suspected HZ episode|3|||
163480332|NCT01610414|590455004|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
163480333|NCT01610414|590455005|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
163480334|NCT01610414|590455004|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
163480335|NCT01610414|590455005|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
163480336|NCT01610414|590455004|FG000|Month 13 - Month 25|Adverse Event|8|||
163480337|NCT01610414|590455005|FG001|Month 13 - Month 25|Adverse Event|4|||
163480338|NCT01610414|590455004|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
163480339|NCT01610414|590455005|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
163480340|NCT01610414|590455004|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
163480341|NCT01610414|590455005|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
163480342|NCT01610414|590455004|FG000|Month 13 - Month 25|Protocol Violation|0|||
163480343|NCT01610414|590455005|FG001|Month 13 - Month 25|Protocol Violation|2|||
163480344|NCT01610414|590455004|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
163480345|NCT01610414|590455005|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
163480346|NCT01610414|590455004|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
163480347|NCT01610414|590455005|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
163480348|NCT01610414|590455004|FG000|After Month 25|Study end not reached|48|||
163480349|NCT01610414|590455005|FG001|After Month 25|Study end not reached|53|||
163480350|NCT00472043|590455007|FG000|Overall Study|Withdrawal by Subject|1|||
163480351|NCT00472043|590455008|FG001|Overall Study|Withdrawal by Subject|0|||
163480352|NCT00472043|590455007|FG000|Overall Study|Death|1|||
163480353|NCT00472043|590455008|FG001|Overall Study|Death|0|||
163480354|NCT04009824|590455010|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
163480355|NCT04009824|590455011|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
163480356|NCT04009824|590455012|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
163480357|NCT04009824|590455013|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
163480358|NCT04009824|590455014|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
163480359|NCT03147495|590455015|FG000|Overall Study|Physician Decision|0|||
163480360|NCT03147495|590455016|FG001|Overall Study|Physician Decision|6|||
163480361|NCT01024946|590455017|FG000|Overall Study|Screen Failure|3|||
163480362|NCT01024946|590455017|FG000|Overall Study|Withdrawal by Subject|1|||
163480363|NCT01024946|590455017|FG000|Overall Study|Adverse Event|1|||
163480364|NCT02608892|590455018|FG000|Overall Study|Lost to Follow-up|1|||
163480365|NCT02608892|590455019|FG001|Overall Study|Lost to Follow-up|0|||
163480366|NCT03032523|590455020|FG000|Overall Study|Withdrawal by Subject|2|||
163480367|NCT03032523|590455021|FG001|Overall Study|Withdrawal by Subject|2|||
163480368|NCT03032523|590455020|FG000|Overall Study|Physician Decision|1|||
163480369|NCT03032523|590455021|FG001|Overall Study|Physician Decision|0|||
163480370|NCT00957723|590455022|FG000|Overall Study|Death|3|||
163480371|NCT00957723|590455022|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
163480372|NCT00957723|590455022|FG000|Overall Study|Lost to Follow-up|8|||
163480373|NCT00957723|590455022|FG000|Overall Study|Withdrawal by Subject|24|||
163480374|NCT00957723|590455022|FG000|Overall Study|Investigative Site Terminated|61|||
163480375|NCT00957723|590455022|FG000|Overall Study|Intercurrent Illness|2|||
163480376|NCT00957723|590455022|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
163480377|NCT05375838|590455023|FG000|Overall Study|Other|0|||
163480378|NCT05375838|590455024|FG001|Overall Study|Other|0|||
163480379|NCT05375838|590455025|FG002|Overall Study|Other|0|||
163480380|NCT05375838|590455026|FG003|Overall Study|Other|1|||
163480381|NCT05375838|590455027|FG004|Overall Study|Other|1|||
163480382|NCT05375838|590455028|FG005|Overall Study|Other|0|||
163480383|NCT05375838|590455023|FG000|Overall Study|Withdrawal by Subject|2|||
163480384|NCT05375838|590455024|FG001|Overall Study|Withdrawal by Subject|1|||
163480385|NCT05375838|590455025|FG002|Overall Study|Withdrawal by Subject|3|||
163480386|NCT05375838|590455026|FG003|Overall Study|Withdrawal by Subject|2|||
163480387|NCT05375838|590455027|FG004|Overall Study|Withdrawal by Subject|2|||
163480388|NCT05375838|590455028|FG005|Overall Study|Withdrawal by Subject|0|||
163480389|NCT05375838|590455023|FG000|Overall Study|Protocol Violation|0|||
163480390|NCT05375838|590455024|FG001|Overall Study|Protocol Violation|0|||
163480391|NCT05375838|590455025|FG002|Overall Study|Protocol Violation|0|||
163480392|NCT05375838|590455026|FG003|Overall Study|Protocol Violation|0|||
163480393|NCT05375838|590455027|FG004|Overall Study|Protocol Violation|1|||
163480394|NCT05375838|590455028|FG005|Overall Study|Protocol Violation|0|||
163480395|NCT05375838|590455023|FG000|Overall Study|Physician Decision|0|||
163480396|NCT05375838|590455024|FG001|Overall Study|Physician Decision|1|||
163480397|NCT05375838|590455025|FG002|Overall Study|Physician Decision|0|||
163480398|NCT05375838|590455026|FG003|Overall Study|Physician Decision|0|||
163480399|NCT05375838|590455027|FG004|Overall Study|Physician Decision|0|||
163480400|NCT05375838|590455028|FG005|Overall Study|Physician Decision|1|||
163480401|NCT05375838|590455023|FG000|Overall Study|Lost to Follow-up|2|||
163480402|NCT05375838|590455024|FG001|Overall Study|Lost to Follow-up|7|||
163480403|NCT05375838|590455025|FG002|Overall Study|Lost to Follow-up|0|||
163480404|NCT05375838|590455026|FG003|Overall Study|Lost to Follow-up|4|||
163480405|NCT05375838|590455027|FG004|Overall Study|Lost to Follow-up|2|||
163480406|NCT05375838|590455028|FG005|Overall Study|Lost to Follow-up|3|||
163480407|NCT00877890|590455029|FG000|Overall Study|Adverse Event|6|||
163480408|NCT00877890|590455030|FG001|Overall Study|Adverse Event|6|||
163480409|NCT00877890|590455029|FG000|Overall Study|Lost to Follow-up|5|||
163480410|NCT00877890|590455030|FG001|Overall Study|Lost to Follow-up|5|||
163480411|NCT00877890|590455029|FG000|Overall Study|Protocol Violation|0|||
163480412|NCT00877890|590455030|FG001|Overall Study|Protocol Violation|1|||
163480413|NCT00877890|590455029|FG000|Overall Study|Withdrawal of Consent|6|||
163480414|NCT00877890|590455030|FG001|Overall Study|Withdrawal of Consent|12|||
163480415|NCT00877890|590455029|FG000|Overall Study|Investigator Decision|0|||
163480416|NCT00877890|590455030|FG001|Overall Study|Investigator Decision|2|||
163480417|NCT00877890|590455029|FG000|Overall Study|Loss of Glucose Control|3|||
163480418|NCT00877890|590455030|FG001|Overall Study|Loss of Glucose Control|4|||
163480419|NCT00984009|590455031|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
163480420|NCT02036476|590455038|FG000|Overall Study|Withdrawal by Subject|2|||
163480421|NCT02036476|590455038|FG000|Overall Study|Progressive Disease|4|||
163480422|NCT02036476|590455038|FG000|Overall Study|Unacceptable Toxicity|2|||
163480423|NCT02698176|590455039|FG000|Overall Study|Progressive disease|4|||
163480424|NCT02698176|590455040|FG001|Overall Study|Progressive disease|3|||
163480425|NCT02698176|590455041|FG002|Overall Study|Progressive disease|1|||
163480426|NCT02698176|590455042|FG003|Overall Study|Progressive disease|0|||
163480427|NCT02698176|590455039|FG000|Overall Study|Adverse Event|2|||
163480428|NCT02698176|590455040|FG001|Overall Study|Adverse Event|0|||
163480429|NCT02698176|590455041|FG002|Overall Study|Adverse Event|0|||
163480430|NCT02698176|590455042|FG003|Overall Study|Adverse Event|0|||
163480431|NCT02698176|590455039|FG000|Overall Study|Clinical progression|3|||
163480432|NCT02698176|590455040|FG001|Overall Study|Clinical progression|0|||
163480433|NCT02698176|590455041|FG002|Overall Study|Clinical progression|0|||
163480434|NCT02698176|590455042|FG003|Overall Study|Clinical progression|0|||
163480435|NCT02985684|590455044|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
163480436|NCT02985684|590455044|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
163480437|NCT02985684|590455044|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
163480438|NCT01640353|590456607|FG000|Overall Study|Withdrew prior to treatment|10|||
163480439|NCT01640353|590456607|FG000|Overall Study|Withdrawn from analysis at term site|12|||
163480440|NCT01640353|590456607|FG000|Overall Study|Withdrawal by Subject|5|||
163480441|NCT01640353|590456607|FG000|Overall Study|Death|2|||
163480442|NCT01640353|590456607|FG000|Overall Study|Early site termination|3|||
163480443|NCT01640353|590456607|FG000|Overall Study|Lost to Follow-up|12|||
163480444|NCT01640353|590456607|FG000|Overall Study|Physician Decision|1|||
163480445|NCT01967134|590456608|FG000|Overall Study|Lost to Follow-up|0|||
163480446|NCT01967134|590456609|FG001|Overall Study|Lost to Follow-up|1|||
163480447|NCT01967134|590456610|FG002|Overall Study|Lost to Follow-up|0|||
163480448|NCT00443534|590456611|FG000|Overall Study|Lack of Efficacy|67|||
163480449|NCT00443534|590456611|FG000|Overall Study|Adverse Event|16|||
163480450|NCT00443534|590456611|FG000|Overall Study|Death|9|||
163480451|NCT00443534|590456611|FG000|Overall Study|Withdrawal by Subject|8|||
163480452|NCT00443534|590456611|FG000|Overall Study|Study Terminated by Sponsor|12|||
163480453|NCT00443534|590456611|FG000|Overall Study|Other|10|||
163480454|NCT00443534|590456611|FG000|Overall Study|Enrolled, Not Treated|1|||
163480455|NCT02679222|590456613|FG000|Overall Study|No time for project|1|||
163480456|NCT03419741|590456614|FG000|Overall Study|Adverse Event|1|||
163480457|NCT03419741|590456615|FG001|Overall Study|Adverse Event|0|||
163480458|NCT03419741|590456614|FG000|Overall Study|Withdrawal by Subject|1|||
163480459|NCT03419741|590456615|FG001|Overall Study|Withdrawal by Subject|2|||
163480460|NCT02719028|590456623|FG000|Overall Study|Adverse Event|2|||
163480461|NCT02719028|590456624|FG001|Overall Study|Adverse Event|1|||
163480462|NCT02719028|590456625|FG002|Overall Study|Adverse Event|4|||
163480463|NCT02719028|590456626|FG003|Overall Study|Adverse Event|8|||
163480464|NCT02719028|590456623|FG000|Overall Study|Physician Decision|0|||
163480465|NCT02719028|590456624|FG001|Overall Study|Physician Decision|1|||
163480466|NCT02719028|590456625|FG002|Overall Study|Physician Decision|1|||
163480467|NCT02719028|590456626|FG003|Overall Study|Physician Decision|1|||
163480468|NCT02719028|590456623|FG000|Overall Study|Use of prohibited medication|0|||
163480469|NCT02719028|590456624|FG001|Overall Study|Use of prohibited medication|0|||
163480470|NCT02719028|590456625|FG002|Overall Study|Use of prohibited medication|1|||
163480471|NCT02719028|590456626|FG003|Overall Study|Use of prohibited medication|0|||
163480472|NCT02719028|590456623|FG000|Overall Study|Protocol Violation|0|||
163480473|NCT02719028|590456624|FG001|Overall Study|Protocol Violation|0|||
163480474|NCT02719028|590456625|FG002|Overall Study|Protocol Violation|0|||
163480475|NCT02719028|590456626|FG003|Overall Study|Protocol Violation|1|||
163480476|NCT00298766|590456627|FG000|Overall Study|Adverse Event|18|||
163480477|NCT00298766|590456627|FG000|Overall Study|Death|2|||
163480478|NCT00298766|590456627|FG000|Overall Study|Withdrawal by Subject|9|||
163480479|NCT00298766|590456627|FG000|Overall Study|Treatment ongoing|4|||
163480480|NCT00298766|590456627|FG000|Overall Study|Progression of amyloid markers|4|||
163480481|NCT00298766|590456627|FG000|Overall Study|Deterioration in KPS and organ function|1|||
163480482|NCT00298766|590456627|FG000|Overall Study|Subjects overall condition deterioration|4|||
163480483|NCT00298766|590456627|FG000|Overall Study|Other|4|||
163480484|NCT00303719|590456628|FG000|Overall Study|Not evaluable, prior therapies|0|||
163480485|NCT00303719|590456629|FG001|Overall Study|Not evaluable, prior therapies|30|||
163480486|NCT00303719|590456628|FG000|Overall Study|Lost to Follow-up|0|||
163480487|NCT00303719|590456629|FG001|Overall Study|Lost to Follow-up|7|||
163480488|NCT03633461|590456636|FG000|Overall Study|Lost to Follow-up|0|||
163480489|NCT03633461|590456637|FG001|Overall Study|Lost to Follow-up|1|||
163480490|NCT00689611|590456641|FG000|Overall Study|Death|6|||
163480491|NCT00689611|590456642|FG001|Overall Study|Death|9|||
163480492|NCT00689611|590456641|FG000|Overall Study|Withdrawal by Subject|8|||
163480493|NCT00689611|590456642|FG001|Overall Study|Withdrawal by Subject|9|||
163480494|NCT00689611|590456641|FG000|Overall Study|Lost to Follow-up|27|||
163480495|NCT00689611|590456642|FG001|Overall Study|Lost to Follow-up|28|||
163480496|NCT00568399|590456644|FG000|Overall Study|Death|2|||
163480497|NCT00568399|590456644|FG000|Overall Study|Adverse Event|5|||
163480498|NCT00568399|590456644|FG000|Overall Study|Withdrawal by Subject|8|||
163480499|NCT02967562|590456649|FG000|Overall Study|Consent not obtained|1|||
163480500|NCT02967562|590456650|FG001|Overall Study|Consent not obtained|0|||
163480501|NCT02967562|590456649|FG000|Overall Study|High leak precluding analysis|1|||
163480502|NCT02967562|590456650|FG001|Overall Study|High leak precluding analysis|1|||
163480503|NCT00405756|590456651|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
163480504|NCT00405756|590456652|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
163480505|NCT00405756|590456653|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
163480506|NCT00405756|590456651|FG000|Double-blind Treatment|Adverse Event|31|||
163480507|NCT00405756|590456652|FG001|Double-blind Treatment|Adverse Event|27|||
163480508|NCT00405756|590456653|FG002|Double-blind Treatment|Adverse Event|12|||
163480509|NCT00405756|590456651|FG000|Double-blind Treatment|Disease Progression|47|||
163480510|NCT00405756|590456652|FG001|Double-blind Treatment|Disease Progression|81|||
163480511|NCT00405756|590456653|FG002|Double-blind Treatment|Disease Progression|102|||
163480512|NCT00405756|590456651|FG000|Double-blind Treatment|Lack of Efficacy|1|||
163480513|NCT00405756|590456652|FG001|Double-blind Treatment|Lack of Efficacy|4|||
163480514|NCT00405756|590456653|FG002|Double-blind Treatment|Lack of Efficacy|2|||
163480515|NCT00405756|590456651|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
163480516|NCT00405756|590456652|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
163480517|NCT00405756|590456653|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
163480518|NCT00405756|590456651|FG000|Double-blind Treatment|Lost to Follow-up|1|||
163480519|NCT00405756|590456652|FG001|Double-blind Treatment|Lost to Follow-up|0|||
163480520|NCT00405756|590456653|FG002|Double-blind Treatment|Lost to Follow-up|0|||
163480521|NCT00405756|590456651|FG000|Double-blind Treatment|Death|4|||
163480522|NCT00405756|590456652|FG001|Double-blind Treatment|Death|4|||
163480523|NCT00405756|590456653|FG002|Double-blind Treatment|Death|4|||
163480524|NCT00405756|590456651|FG000|Double-blind Treatment|Protocol Violation|1|||
163480525|NCT00405756|590456652|FG001|Double-blind Treatment|Protocol Violation|0|||
163480526|NCT00405756|590456653|FG002|Double-blind Treatment|Protocol Violation|2|||
163480527|NCT00405756|590456651|FG000|Double-blind Treatment|Other|7|||
163480528|NCT00405756|590456652|FG001|Double-blind Treatment|Other|4|||
163480529|NCT00405756|590456653|FG002|Double-blind Treatment|Other|4|||
163480530|NCT00405756|590456651|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
163480531|NCT00405756|590456652|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
163480532|NCT00405756|590456653|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
163480533|NCT00405756|590456651|FG000|Open-label Extension|Adverse Event|1|||
163480534|NCT00405756|590456652|FG001|Open-label Extension|Adverse Event|3|||
163480535|NCT00405756|590456653|FG002|Open-label Extension|Adverse Event|7|||
163480536|NCT00405756|590456651|FG000|Open-label Extension|Disease Progression|8|||
163480537|NCT00405756|590456652|FG001|Open-label Extension|Disease Progression|23|||
163480538|NCT00405756|590456653|FG002|Open-label Extension|Disease Progression|26|||
163480539|NCT00405756|590456651|FG000|Open-label Extension|Withdrawal by Subject|2|||
163480540|NCT00405756|590456652|FG001|Open-label Extension|Withdrawal by Subject|3|||
163480541|NCT00405756|590456653|FG002|Open-label Extension|Withdrawal by Subject|3|||
163480542|NCT00405756|590456651|FG000|Open-label Extension|Death|1|||
163480543|NCT00405756|590456652|FG001|Open-label Extension|Death|2|||
163480544|NCT00405756|590456653|FG002|Open-label Extension|Death|4|||
163480545|NCT00405756|590456651|FG000|Open-label Extension|Other|0|||
163480546|NCT00405756|590456652|FG001|Open-label Extension|Other|1|||
163480547|NCT00405756|590456653|FG002|Open-label Extension|Other|7|||
163480548|NCT00405756|590456651|FG000|Follow-up|Ongoing in Follow-up Period|52|||
163480549|NCT00405756|590456652|FG001|Follow-up|Ongoing in Follow-up Period|51|||
163480550|NCT00405756|590456653|FG002|Follow-up|Ongoing in Follow-up Period|60|||
163480551|NCT00405756|590456651|FG000|Follow-up|Death|21|||
163480552|NCT00405756|590456652|FG001|Follow-up|Death|31|||
163480553|NCT00405756|590456653|FG002|Follow-up|Death|24|||
163480554|NCT00405756|590456651|FG000|Follow-up|Lost to Follow-up|2|||
163480555|NCT00405756|590456652|FG001|Follow-up|Lost to Follow-up|8|||
163480556|NCT00405756|590456653|FG002|Follow-up|Lost to Follow-up|4|||
163480557|NCT00286156|590456656|FG000|Overall Study|Missed 12 month visit|0|||
163480558|NCT00286156|590456657|FG001|Overall Study|Missed 12 month visit|0|||
163480559|NCT00286156|590456658|FG002|Overall Study|Missed 12 month visit|1|||
163480560|NCT00286156|590456656|FG000|Overall Study|AE: pulmonary embolus|0|||
163480561|NCT00286156|590456657|FG001|Overall Study|AE: pulmonary embolus|1|||
163480562|NCT00286156|590456658|FG002|Overall Study|AE: pulmonary embolus|0|||
163480563|NCT00286156|590456656|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
163480564|NCT00286156|590456657|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
163480565|NCT00286156|590456658|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
163480566|NCT00286156|590456656|FG000|Overall Study|AE: pneumonia|1|||
163480567|NCT00286156|590456657|FG001|Overall Study|AE: pneumonia|0|||
163480568|NCT00286156|590456658|FG002|Overall Study|AE: pneumonia|0|||
163480569|NCT00672139|590456663|FG000|Overall Study|Death|14|||
163480570|NCT00672139|590456664|FG001|Overall Study|Death|23|||
163480571|NCT00672139|590456663|FG000|Overall Study|Withdrawal by Subject|2|||
163480572|NCT00672139|590456664|FG001|Overall Study|Withdrawal by Subject|11|||
163480573|NCT00672139|590456663|FG000|Overall Study|Adverse Event|4|||
163480574|NCT00672139|590456664|FG001|Overall Study|Adverse Event|7|||
163480575|NCT00672139|590456663|FG000|Overall Study|Physician Decision|2|||
163480576|NCT00672139|590456664|FG001|Overall Study|Physician Decision|0|||
163480577|NCT00672139|590456663|FG000|Overall Study|Lack of Efficacy|4|||
163480578|NCT00672139|590456664|FG001|Overall Study|Lack of Efficacy|1|||
163480579|NCT00672139|590456663|FG000|Overall Study|Protocol Violation|1|||
163480580|NCT00672139|590456664|FG001|Overall Study|Protocol Violation|1|||
163480581|NCT00672139|590456663|FG000|Overall Study|hospice discharge, caregiver requests|3|||
163480582|NCT00672139|590456664|FG001|Overall Study|hospice discharge, caregiver requests|2|||
163480583|NCT01051856|590456665|FG000|Overall Study|Withdrawal by Subject|1|||
163480584|NCT01051856|590456666|FG001|Overall Study|Withdrawal by Subject|0|||
163480585|NCT02176226|590456667|FG000|Overall Study|Lost to Follow-up|3|||
163480586|NCT02176226|590456667|FG000|Overall Study|Withdrew prior to treatment|6|||
163480587|NCT01072500|590456670|FG000|Overall Study|Death|2|||
163480588|NCT01072500|590456671|FG001|Overall Study|Death|2|||
163480589|NCT01072500|590456670|FG000|Overall Study|Lost to Follow-up|5|||
163480590|NCT01072500|590456671|FG001|Overall Study|Lost to Follow-up|2|||
163480591|NCT01072500|590456670|FG000|Overall Study|Withdrawal by Subject|17|||
163480592|NCT01072500|590456671|FG001|Overall Study|Withdrawal by Subject|10|||
163480593|NCT00103207|590456672|FG000|Overall Study|Adverse Event|3|||
163480594|NCT00103207|590456672|FG000|Overall Study|Death|1|||
163480595|NCT00103207|590456672|FG000|Overall Study|Withdrawal by Subject|2|||
163480596|NCT00103207|590456672|FG000|Overall Study|Other complicating disease|1|||
163480597|NCT00103207|590456672|FG000|Overall Study|Ineligible|4|||
163480598|NCT00103207|590456672|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
163480599|NCT01611558|590456673|FG000|Induction Phase|Study drug toxicity|15|||
163480600|NCT01611558|590456673|FG000|Induction Phase|Disease progression|18|||
163480601|NCT01611558|590456673|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
163480602|NCT01611558|590456673|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
163480603|NCT01611558|590456673|FG000|Induction Phase|Death|1|||
163480604|NCT01611558|590456673|FG000|Maintenance Phase|Withdrawal by Subject|1|||
163480605|NCT01611558|590456673|FG000|Maintenance Phase|Elevated Uric acid|1|||
163480606|NCT01412333|590456688|FG000|Overall Study|Adverse Event|40|||
163480607|NCT01412333|590456689|FG001|Overall Study|Adverse Event|42|||
163480608|NCT01412333|590456688|FG000|Overall Study|Death|5|||
163480609|NCT01412333|590456689|FG001|Overall Study|Death|6|||
163480610|NCT01412333|590456688|FG000|Overall Study|Lack of Efficacy|22|||
163480611|NCT01412333|590456689|FG001|Overall Study|Lack of Efficacy|10|||
163480612|NCT01412333|590456688|FG000|Overall Study|Lost to Follow-up|15|||
163480613|NCT01412333|590456689|FG001|Overall Study|Lost to Follow-up|12|||
163480614|NCT01412333|590456688|FG000|Overall Study|Non-Compliance|3|||
163480615|NCT01412333|590456689|FG001|Overall Study|Non-Compliance|7|||
163480616|NCT01412333|590456688|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163480617|NCT01412333|590456689|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163480618|NCT01412333|590456688|FG000|Overall Study|Other|30|||
163480619|NCT01412333|590456689|FG001|Overall Study|Other|33|||
163480620|NCT01412333|590456688|FG000|Overall Study|Physician Decision|11|||
163480621|NCT01412333|590456689|FG001|Overall Study|Physician Decision|16|||
163480622|NCT01412333|590456688|FG000|Overall Study|Pregnancy|6|||
163480623|NCT01412333|590456689|FG001|Overall Study|Pregnancy|4|||
163480624|NCT01412333|590456688|FG000|Overall Study|Protocol Violation|1|||
163480625|NCT01412333|590456689|FG001|Overall Study|Protocol Violation|2|||
163480626|NCT01412333|590456688|FG000|Overall Study|Study Terminated By Sponsor|3|||
163480627|NCT01412333|590456689|FG001|Overall Study|Study Terminated By Sponsor|2|||
163480628|NCT01412333|590456688|FG000|Overall Study|Withdrawal by Subject|51|||
163480629|NCT01412333|590456689|FG001|Overall Study|Withdrawal by Subject|54|||
163480630|NCT01412333|590456688|FG000|Overall Study|Missing|1|||
163480631|NCT01412333|590456689|FG001|Overall Study|Missing|3|||
163480632|NCT04005885|590456690|FG000|First Intervention|Withdrawal by Subject|1|||
163480633|NCT04005885|590456691|FG001|First Intervention|Withdrawal by Subject|1|||
163480634|NCT04005885|590456690|FG000|Second Intervention|Withdrawal by Subject|0|||
163480635|NCT04005885|590456691|FG001|Second Intervention|Withdrawal by Subject|2|||
163480636|NCT01038635|590456692|FG000|Overall Study|Disease Progression|2|||
163480637|NCT01038635|590456693|FG001|Overall Study|Disease Progression|0|||
163480638|NCT01038635|590456694|FG002|Overall Study|Disease Progression|0|||
163480639|NCT01038635|590456695|FG003|Overall Study|Disease Progression|0|||
163480640|NCT01038635|590456696|FG004|Overall Study|Disease Progression|0|||
163480641|NCT01038635|590456697|FG005|Overall Study|Disease Progression|0|||
163480642|NCT01038635|590456698|FG006|Overall Study|Disease Progression|1|||
163480643|NCT01038635|590456699|FG007|Overall Study|Disease Progression|4|||
163480644|NCT01038635|590456700|FG008|Overall Study|Disease Progression|0|||
163480645|NCT01038635|590456692|FG000|Overall Study|Death|0|||
163480646|NCT01038635|590456693|FG001|Overall Study|Death|0|||
163480647|NCT01038635|590456694|FG002|Overall Study|Death|0|||
163480648|NCT01038635|590456695|FG003|Overall Study|Death|0|||
163480649|NCT01038635|590456696|FG004|Overall Study|Death|1|||
163480650|NCT01038635|590456697|FG005|Overall Study|Death|0|||
163480651|NCT01038635|590456698|FG006|Overall Study|Death|1|||
163480652|NCT01038635|590456699|FG007|Overall Study|Death|1|||
163480653|NCT01038635|590456700|FG008|Overall Study|Death|2|||
163480654|NCT01227252|590456701|FG000|Overall Study|Sponsor Decision|0|||
163480655|NCT01227252|590456702|FG001|Overall Study|Sponsor Decision|1|||
163480656|NCT01227252|590456703|FG002|Overall Study|Sponsor Decision|0|||
163480657|NCT01227252|590456704|FG003|Overall Study|Sponsor Decision|0|||
163480658|NCT01227252|590456701|FG000|Overall Study|Lost to Follow-up|0|||
163480659|NCT01227252|590456702|FG001|Overall Study|Lost to Follow-up|1|||
163480660|NCT01227252|590456703|FG002|Overall Study|Lost to Follow-up|0|||
163480661|NCT01227252|590456704|FG003|Overall Study|Lost to Follow-up|0|||
163480662|NCT01227252|590456701|FG000|Overall Study|Withdrawal by Subject|0|||
163480663|NCT01227252|590456702|FG001|Overall Study|Withdrawal by Subject|1|||
163480664|NCT01227252|590456703|FG002|Overall Study|Withdrawal by Subject|0|||
163480665|NCT01227252|590456704|FG003|Overall Study|Withdrawal by Subject|0|||
163480666|NCT01034709|590456706|FG000|Overall Study|Protocol Violation|9|||
163480667|NCT01034709|590456707|FG001|Overall Study|Protocol Violation|16|||
163480668|NCT03227692|590456708|FG000|Overall Study|Protocol Violation|1|||
163480669|NCT03227692|590456709|FG001|Overall Study|Protocol Violation|1|||
163480670|NCT03227692|590456708|FG000|Overall Study|Lost to Follow-up|4|||
163480671|NCT03227692|590456709|FG001|Overall Study|Lost to Follow-up|2|||
163480672|NCT03227692|590456708|FG000|Overall Study|Adverse Event|0|||
163480673|NCT03227692|590456709|FG001|Overall Study|Adverse Event|2|||
163480674|NCT02447952|590456710|FG000|Overall Study|Adverse Event|2|||
163480675|NCT02447952|590456710|FG000|Overall Study|Physician Decision|1|||
163480676|NCT02447952|590456710|FG000|Overall Study|Withdrawal by Subject|4|||
163480677|NCT01683058|590456711|FG000|Overall Study|Lost to Follow-up|9|||
163480678|NCT01683058|590456711|FG000|Overall Study|Adverse Event|6|||
163480679|NCT01683058|590456711|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
163480680|NCT01683058|590456711|FG000|Overall Study|Withdrawal by Subject|7|||
163480681|NCT01683058|590456711|FG000|Overall Study|Lack of Efficacy|2|||
163480682|NCT01195636|590456712|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
163480683|NCT01195636|590456713|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
163480684|NCT01195636|590456712|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
163480685|NCT01195636|590456713|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
163480686|NCT01195636|590456712|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
163480687|NCT01195636|590456713|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
163480688|NCT01195636|590456712|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
163480689|NCT01195636|590456713|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
163480690|NCT01195636|590456712|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
163480691|NCT01195636|590456713|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
163480692|NCT01195636|590456712|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
163480693|NCT01195636|590456713|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
163480694|NCT01195636|590456712|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
163480695|NCT01195636|590456713|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
163480696|NCT01195636|590456712|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
163480697|NCT01195636|590456713|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
163480698|NCT01566981|590456714|FG000|Overall Study|Lost to Follow-up|5|||
163480699|NCT01566981|590456715|FG001|Overall Study|Lost to Follow-up|8|||
163480700|NCT02405091|590456716|FG000|Overall Study|Adverse Event|16|||
163480701|NCT02405091|590456717|FG001|Overall Study|Adverse Event|10|||
163480702|NCT02405091|590456718|FG002|Overall Study|Adverse Event|0|||
163480703|NCT02405091|590456716|FG000|Overall Study|Protocol Violation|1|||
163480704|NCT02405091|590456717|FG001|Overall Study|Protocol Violation|0|||
163480705|NCT02405091|590456718|FG002|Overall Study|Protocol Violation|0|||
163480706|NCT02405091|590456716|FG000|Overall Study|Noncompliance|1|||
163480707|NCT02405091|590456717|FG001|Overall Study|Noncompliance|6|||
163480708|NCT02405091|590456718|FG002|Overall Study|Noncompliance|2|||
163480709|NCT02405091|590456716|FG000|Overall Study|Withdrawal by Subject|4|||
163480710|NCT02405091|590456717|FG001|Overall Study|Withdrawal by Subject|8|||
163480711|NCT02405091|590456718|FG002|Overall Study|Withdrawal by Subject|0|||
163480712|NCT02405091|590456716|FG000|Overall Study|Death|0|||
163480713|NCT02405091|590456717|FG001|Overall Study|Death|1|||
163480714|NCT02405091|590456718|FG002|Overall Study|Death|0|||
163480715|NCT02405091|590456716|FG000|Overall Study|Lost to Follow-up|5|||
163480716|NCT02405091|590456717|FG001|Overall Study|Lost to Follow-up|6|||
163480717|NCT02405091|590456718|FG002|Overall Study|Lost to Follow-up|0|||
163480718|NCT02405091|590456716|FG000|Overall Study|Physician Decision|2|||
163480719|NCT02405091|590456717|FG001|Overall Study|Physician Decision|2|||
163480720|NCT02405091|590456718|FG002|Overall Study|Physician Decision|0|||
163480721|NCT01012037|590456728|FG000|Overall Study|Adverse Event|0|||
163480722|NCT01012037|590456729|FG001|Overall Study|Adverse Event|8|||
163480723|NCT01012037|590456730|FG002|Overall Study|Adverse Event|3|||
163480724|NCT01012037|590456728|FG000|Overall Study|Protocol Violation|0|||
163480725|NCT01012037|590456729|FG001|Overall Study|Protocol Violation|3|||
163480726|NCT01012037|590456730|FG002|Overall Study|Protocol Violation|5|||
163480727|NCT01012037|590456728|FG000|Overall Study|Withdrawal by Subject|0|||
163480728|NCT01012037|590456729|FG001|Overall Study|Withdrawal by Subject|4|||
163480729|NCT01012037|590456730|FG002|Overall Study|Withdrawal by Subject|1|||
163480730|NCT01012037|590456728|FG000|Overall Study|Other reason (not specified)|1|||
163480731|NCT01012037|590456729|FG001|Overall Study|Other reason (not specified)|1|||
163480732|NCT01012037|590456730|FG002|Overall Study|Other reason (not specified)|1|||
163480733|NCT00590031|590456734|FG000|Overall Study|Adverse Event|3|||
163480734|NCT00590031|590456734|FG000|Overall Study|Withdrawal by Subject|1|||
163480735|NCT00590031|590456734|FG000|Overall Study|Metastatic Disease|1|||
163480736|NCT00590031|590456734|FG000|Overall Study|Admin Hold|1|||
163480737|NCT01809327|590456735|FG000|Overall Study|Lost to Follow-up|5|||
163480738|NCT01809327|590456736|FG001|Overall Study|Lost to Follow-up|2|||
163480739|NCT01809327|590456737|FG002|Overall Study|Lost to Follow-up|4|||
163480740|NCT01809327|590456738|FG003|Overall Study|Lost to Follow-up|2|||
163480741|NCT01809327|590456739|FG004|Overall Study|Lost to Follow-up|3|||
163480742|NCT01809327|590456735|FG000|Overall Study|Withdrawal by Subject|6|||
163480743|NCT01809327|590456736|FG001|Overall Study|Withdrawal by Subject|4|||
163480744|NCT01809327|590456737|FG002|Overall Study|Withdrawal by Subject|4|||
163480745|NCT01809327|590456738|FG003|Overall Study|Withdrawal by Subject|2|||
163480746|NCT01809327|590456739|FG004|Overall Study|Withdrawal by Subject|5|||
163480747|NCT01809327|590456735|FG000|Overall Study|Adverse Event|4|||
163480748|NCT01809327|590456736|FG001|Overall Study|Adverse Event|3|||
163480749|NCT01809327|590456737|FG002|Overall Study|Adverse Event|7|||
163480750|NCT01809327|590456738|FG003|Overall Study|Adverse Event|4|||
163480751|NCT01809327|590456739|FG004|Overall Study|Adverse Event|8|||
163480752|NCT01809327|590456735|FG000|Overall Study|Death|1|||
163480753|NCT01809327|590456736|FG001|Overall Study|Death|0|||
163480754|NCT01809327|590456737|FG002|Overall Study|Death|0|||
163480755|NCT01809327|590456738|FG003|Overall Study|Death|0|||
163480756|NCT01809327|590456739|FG004|Overall Study|Death|0|||
163480757|NCT01809327|590456735|FG000|Overall Study|Protocol Violation|0|||
163480758|NCT01809327|590456736|FG001|Overall Study|Protocol Violation|1|||
163480759|NCT01809327|590456737|FG002|Overall Study|Protocol Violation|0|||
163480760|NCT01809327|590456738|FG003|Overall Study|Protocol Violation|0|||
163480761|NCT01809327|590456739|FG004|Overall Study|Protocol Violation|0|||
163480762|NCT01809327|590456735|FG000|Overall Study|Physician Decision|1|||
163480763|NCT01809327|590456736|FG001|Overall Study|Physician Decision|1|||
163480764|NCT01809327|590456737|FG002|Overall Study|Physician Decision|0|||
163480765|NCT01809327|590456738|FG003|Overall Study|Physician Decision|0|||
163480766|NCT01809327|590456739|FG004|Overall Study|Physician Decision|0|||
163480767|NCT01809327|590456735|FG000|Overall Study|Pregnancy|1|||
163480768|NCT01809327|590456736|FG001|Overall Study|Pregnancy|0|||
163480769|NCT01809327|590456737|FG002|Overall Study|Pregnancy|0|||
163480770|NCT01809327|590456738|FG003|Overall Study|Pregnancy|0|||
163480771|NCT01809327|590456739|FG004|Overall Study|Pregnancy|0|||
163480772|NCT01809327|590456735|FG000|Overall Study|Other|14|||
163480773|NCT01809327|590456736|FG001|Overall Study|Other|15|||
163480774|NCT01809327|590456737|FG002|Overall Study|Other|7|||
163480775|NCT01809327|590456738|FG003|Overall Study|Other|4|||
163480776|NCT01809327|590456739|FG004|Overall Study|Other|9|||
163480777|NCT02802735|590456741|FG000|Overall Study|Withdrawal by Subject|0|||
163480778|NCT02802735|590456742|FG001|Overall Study|Withdrawal by Subject|1|||
163480779|NCT02802735|590456743|FG002|Overall Study|Withdrawal by Subject|0|||
163480780|NCT02802735|590456744|FG003|Overall Study|Withdrawal by Subject|0|||
163480781|NCT02802735|590456745|FG004|Overall Study|Withdrawal by Subject|0|||
163480782|NCT01166386|590456746|FG000|Overall Study|Withdrawal by Subject|3|||
163480783|NCT01166386|590456747|FG001|Overall Study|Withdrawal by Subject|5|||
163480784|NCT03922711|590456750|FG000|Overall Study|Adverse Event|3|||
163480785|NCT03922711|590456751|FG001|Overall Study|Adverse Event|2|||
163480786|NCT03922711|590456752|FG002|Overall Study|Adverse Event|2|||
163480787|NCT03922711|590456750|FG000|Overall Study|Protocol Violation|1|||
163480788|NCT03922711|590456751|FG001|Overall Study|Protocol Violation|0|||
163480789|NCT03922711|590456752|FG002|Overall Study|Protocol Violation|0|||
163480790|NCT03922711|590456750|FG000|Overall Study|Withdrawal by Subject|0|||
163480791|NCT03922711|590456751|FG001|Overall Study|Withdrawal by Subject|3|||
163480792|NCT03922711|590456752|FG002|Overall Study|Withdrawal by Subject|1|||
163480793|NCT03922711|590456750|FG000|Overall Study|Not further specified|0|||
163480794|NCT03922711|590456751|FG001|Overall Study|Not further specified|0|||
163480795|NCT03922711|590456752|FG002|Overall Study|Not further specified|1|||
163480796|NCT00420212|590456755|FG000|Overall Study|Adverse Event|22|||
163480797|NCT00420212|590456756|FG001|Overall Study|Adverse Event|40|||
163480798|NCT00420212|590456757|FG002|Overall Study|Adverse Event|36|||
163480799|NCT00420212|590456755|FG000|Overall Study|Lost to Follow-up|9|||
163480800|NCT00420212|590456756|FG001|Overall Study|Lost to Follow-up|11|||
163480801|NCT00420212|590456757|FG002|Overall Study|Lost to Follow-up|11|||
163480802|NCT00420212|590456755|FG000|Overall Study|Withdrawal by Subject|31|||
163480803|NCT00420212|590456756|FG001|Overall Study|Withdrawal by Subject|22|||
163480804|NCT00420212|590456757|FG002|Overall Study|Withdrawal by Subject|19|||
163480805|NCT00420212|590456755|FG000|Overall Study|Physician Decision|4|||
163480806|NCT00420212|590456756|FG001|Overall Study|Physician Decision|4|||
163480807|NCT00420212|590456757|FG002|Overall Study|Physician Decision|3|||
163480808|NCT00420212|590456755|FG000|Overall Study|Protocol Violation|4|||
163480809|NCT00420212|590456756|FG001|Overall Study|Protocol Violation|4|||
163480810|NCT00420212|590456757|FG002|Overall Study|Protocol Violation|8|||
163480811|NCT00420212|590456755|FG000|Overall Study|Death|0|||
163480812|NCT00420212|590456756|FG001|Overall Study|Death|0|||
163480813|NCT00420212|590456757|FG002|Overall Study|Death|1|||
163480814|NCT00420212|590456755|FG000|Overall Study|Other-Unspecified|21|||
163480815|NCT00420212|590456756|FG001|Overall Study|Other-Unspecified|14|||
163480816|NCT00420212|590456757|FG002|Overall Study|Other-Unspecified|18|||
163480817|NCT02390362|590456758|FG000|Overall Study|Withdrawal by Subject|0|||
163480818|NCT02390362|590456759|FG001|Overall Study|Withdrawal by Subject|1|||
163480819|NCT02178592|590456760|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
163480820|NCT02178592|590456761|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
163480821|NCT02178592|590456760|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
163480822|NCT02178592|590456761|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
163480823|NCT02178592|590456760|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
163480824|NCT02178592|590456761|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
163480825|NCT02178592|590456760|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
163480826|NCT02178592|590456761|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
163480827|NCT02178592|590456760|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
163480828|NCT02178592|590456761|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
163480829|NCT02178592|590456760|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
163480830|NCT02178592|590456761|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
163480831|NCT02178592|590456760|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
163480832|NCT02178592|590456761|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
163480833|NCT02178592|590456760|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
163480834|NCT02178592|590456761|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
163480835|NCT02178592|590456760|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
163480836|NCT02178592|590456761|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
163480837|NCT02178592|590456760|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
163480838|NCT02178592|590456761|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
163480839|NCT02178592|590456760|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
163480840|NCT02178592|590456761|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
163480841|NCT02178592|590456760|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
163480842|NCT02178592|590456761|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
163480843|NCT02067104|590456766|FG000|Overall Study|Study termination due to low accrual|4|||
163480844|NCT02067104|590456767|FG001|Overall Study|Study termination due to low accrual|5|||
163480845|NCT02610231|590456768|FG000|Overall Study|Withdrawal by Subject|27|||
163480846|NCT02610231|590456768|FG000|Overall Study|Adverse Event|20|||
163480847|NCT02610231|590456768|FG000|Overall Study|Death|5|||
163480848|NCT02610231|590456768|FG000|Overall Study|Surgery|2|||
163480849|NCT02610231|590456768|FG000|Overall Study|Physician Decision|1|||
163480850|NCT02610231|590456768|FG000|Overall Study|Non Compliance|2|||
163480851|NCT02610231|590456768|FG000|Overall Study|Other|3|||
163480852|NCT01279954|590456771|FG000|Overall Study|Lack of Efficacy|3|||
163480853|NCT01279954|590456772|FG001|Overall Study|Lack of Efficacy|4|||
163480854|NCT02140762|590456773|FG000|Overall Study|Adverse Event|1|||
163480855|NCT02140762|590456774|FG001|Overall Study|Adverse Event|1|||
163480856|NCT02140762|590456773|FG000|Overall Study|Lost to Follow-up|9|||
163480857|NCT02140762|590456774|FG001|Overall Study|Lost to Follow-up|5|||
163480858|NCT02140762|590456773|FG000|Overall Study|Protocol Violation|1|||
163480859|NCT02140762|590456774|FG001|Overall Study|Protocol Violation|1|||
163480860|NCT02140762|590456773|FG000|Overall Study|Withdrawal by Subject|6|||
163480861|NCT02140762|590456774|FG001|Overall Study|Withdrawal by Subject|4|||
163480862|NCT02140762|590456773|FG000|Overall Study|Other|0|||
163480863|NCT02140762|590456774|FG001|Overall Study|Other|1|||
163480864|NCT01711359|590456776|FG000|Treatment Period|Withdrawal by Subject|18|||
163480865|NCT01711359|590456777|FG001|Treatment Period|Withdrawal by Subject|7|||
163480866|NCT01711359|590456778|FG002|Treatment Period|Withdrawal by Subject|13|||
163480867|NCT01711359|590456776|FG000|Treatment Period|Lack of Efficacy|13|||
163480868|NCT01711359|590456777|FG001|Treatment Period|Lack of Efficacy|2|||
163480869|NCT01711359|590456778|FG002|Treatment Period|Lack of Efficacy|2|||
163480870|NCT01711359|590456776|FG000|Treatment Period|Adverse Event|8|||
163480871|NCT01711359|590456777|FG001|Treatment Period|Adverse Event|10|||
163480872|NCT01711359|590456778|FG002|Treatment Period|Adverse Event|24|||
163480873|NCT01711359|590456776|FG000|Treatment Period|Physician Decision|4|||
163480874|NCT01711359|590456777|FG001|Treatment Period|Physician Decision|3|||
163480875|NCT01711359|590456778|FG002|Treatment Period|Physician Decision|2|||
163480876|NCT01711359|590456776|FG000|Treatment Period|Death|3|||
163480877|NCT01711359|590456777|FG001|Treatment Period|Death|0|||
163480878|NCT01711359|590456778|FG002|Treatment Period|Death|0|||
163480879|NCT01711359|590456776|FG000|Treatment Period|Entry Criteria Not Met|1|||
163480880|NCT01711359|590456777|FG001|Treatment Period|Entry Criteria Not Met|0|||
163480881|NCT01711359|590456778|FG002|Treatment Period|Entry Criteria Not Met|0|||
163480882|NCT01711359|590456776|FG000|Treatment Period|Sponsor Decision|1|||
163480883|NCT01711359|590456777|FG001|Treatment Period|Sponsor Decision|0|||
163480884|NCT01711359|590456778|FG002|Treatment Period|Sponsor Decision|0|||
163480885|NCT01711359|590456776|FG000|Treatment Period|Lost to Follow-up|1|||
163480886|NCT01711359|590456777|FG001|Treatment Period|Lost to Follow-up|1|||
163480887|NCT01711359|590456778|FG002|Treatment Period|Lost to Follow-up|1|||
163480888|NCT01711359|590456776|FG000|Treatment Period|Randomized, Not Treated|3|||
163480889|NCT01711359|590456777|FG001|Treatment Period|Randomized, Not Treated|1|||
163480890|NCT01711359|590456778|FG002|Treatment Period|Randomized, Not Treated|0|||
163480891|NCT01385098|590456779|FG000|Overall Study|Adverse Event|10|||
163480892|NCT01385098|590456779|FG000|Overall Study|Lost to Follow-up|4|||
163480893|NCT00795717|590456780|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
163480894|NCT00795717|590456781|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
163480895|NCT00795717|590456780|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
163480896|NCT00795717|590456781|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
163480897|NCT00795717|590456780|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
163480898|NCT00795717|590456781|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
163480899|NCT00795717|590456780|FG000|Phase II|too busy|0|||
163480900|NCT00795717|590456781|FG001|Phase II|too busy|1|||
163480901|NCT02551874|590458237|FG000|Overall Study|Lost to Follow-up|0|||
163480902|NCT02551874|590458238|FG001|Overall Study|Lost to Follow-up|2|||
163480903|NCT02551874|590458237|FG000|Overall Study|Pregnancy|0|||
163480904|NCT02551874|590458238|FG001|Overall Study|Pregnancy|1|||
163480905|NCT02551874|590458237|FG000|Overall Study|Reason not reported|10|||
163480906|NCT02551874|590458238|FG001|Overall Study|Reason not reported|4|||
163480907|NCT02551874|590458237|FG000|Overall Study|Did not receive randomized treatment|0|||
163480908|NCT02551874|590458238|FG001|Overall Study|Did not receive randomized treatment|7|||
163480909|NCT02551874|590458237|FG000|Overall Study|Did not enter long-term study|18|||
163480910|NCT02551874|590458238|FG001|Overall Study|Did not enter long-term study|25|||
163480911|NCT04067310|590458240|FG000|Overall Study|Physician Decision|2|||
163480912|NCT04067310|590458241|FG001|Overall Study|Physician Decision|6|||
163480913|NCT04067310|590458240|FG000|Overall Study|Lost to Follow-up|0|||
163480914|NCT04067310|590458241|FG001|Overall Study|Lost to Follow-up|1|||
163480915|NCT04067310|590458240|FG000|Overall Study|Withdrawal by Subject|3|||
163480916|NCT04067310|590458241|FG001|Overall Study|Withdrawal by Subject|0|||
163480917|NCT01041027|590458242|FG000|Overall Study|Withdrawal by Subject|2|||
163480918|NCT01041027|590458242|FG000|Overall Study|Protocol Violation|1|||
163480919|NCT01041027|590458242|FG000|Overall Study|Delayed Radiation Therapy|1|||
163480920|NCT01041027|590458242|FG000|Overall Study|Adverse Event|4|||
163480921|NCT02493712|590458243|FG000|Overall Study|Withdrawal by Subject|1|||
163480922|NCT02493712|590458244|FG001|Overall Study|Withdrawal by Subject|0|||
163480923|NCT02493712|590458245|FG002|Overall Study|Withdrawal by Subject|2|||
163480924|NCT02493712|590458243|FG000|Overall Study|Protocol Violation|0|||
163480925|NCT02493712|590458244|FG001|Overall Study|Protocol Violation|0|||
163480926|NCT02493712|590458245|FG002|Overall Study|Protocol Violation|1|||
163480927|NCT02493712|590458243|FG000|Overall Study|Lost to Follow-up|1|||
163480928|NCT02493712|590458244|FG001|Overall Study|Lost to Follow-up|0|||
163480929|NCT02493712|590458245|FG002|Overall Study|Lost to Follow-up|0|||
163480930|NCT02493712|590458243|FG000|Overall Study|Physician Decision|0|||
163480931|NCT02493712|590458244|FG001|Overall Study|Physician Decision|1|||
163480932|NCT02493712|590458245|FG002|Overall Study|Physician Decision|0|||
163480933|NCT02493712|590458243|FG000|Overall Study|Lack of Efficacy|0|||
163480934|NCT02493712|590458244|FG001|Overall Study|Lack of Efficacy|5|||
163480935|NCT02493712|590458245|FG002|Overall Study|Lack of Efficacy|3|||
163480936|NCT02528643|590458246|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
163480937|NCT02528643|590458247|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
163480938|NCT02528643|590458246|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
163480939|NCT02528643|590458247|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
163480940|NCT02528643|590458246|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
163480941|NCT02528643|590458247|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
163480942|NCT02528643|590458246|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
163480943|NCT02528643|590458247|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
163480944|NCT02528643|590458246|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
163480945|NCT02528643|590458247|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
163480946|NCT02528643|590458246|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
163480947|NCT02528643|590458247|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
163480948|NCT02528643|590458246|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
163480949|NCT02528643|590458247|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
163480950|NCT02058940|590458248|FG000|Overall Study|Discharged from Critical Care Unit|1|||
163480951|NCT04144140|590458249|FG000|Overall Study|Other|0|||
163480952|NCT04144140|590458250|FG001|Overall Study|Other|0|||
163480953|NCT04144140|590458251|FG002|Overall Study|Other|0|||
163480954|NCT04144140|590458252|FG003|Overall Study|Other|0|||
163480955|NCT04144140|590458253|FG004|Overall Study|Other|0|||
163480956|NCT04144140|590458254|FG005|Overall Study|Other|1|||
163480957|NCT04144140|590458255|FG006|Overall Study|Other|0|||
163480958|NCT02146274|590458256|FG000|Overall Study|Protocol Violation|73|||
163480959|NCT00305773|590458261|FG000|Overall Study|Death|3|||
163480960|NCT00305773|590458262|FG001|Overall Study|Death|2|||
163480961|NCT00305773|590458261|FG000|Overall Study|Adverse Event|1|||
163480962|NCT00305773|590458262|FG001|Overall Study|Adverse Event|2|||
163480963|NCT00305773|590458261|FG000|Overall Study|Alternative Treatment|4|||
163480964|NCT00305773|590458262|FG001|Overall Study|Alternative Treatment|4|||
163480965|NCT00305773|590458261|FG000|Overall Study|Physician Decision|1|||
163480966|NCT00305773|590458262|FG001|Overall Study|Physician Decision|1|||
163480967|NCT00305773|590458261|FG000|Overall Study|Withdrawal by Subject|1|||
163480968|NCT00305773|590458262|FG001|Overall Study|Withdrawal by Subject|4|||
163480969|NCT00305773|590458261|FG000|Overall Study|Disease Progression|1|||
163480970|NCT00305773|590458262|FG001|Overall Study|Disease Progression|3|||
163480971|NCT00305773|590458261|FG000|Overall Study|All other reasons|3|||
163480972|NCT00305773|590458262|FG001|Overall Study|All other reasons|2|||
163480973|NCT03384316|590458263|FG000|Overall Study|Screen failure|0|||
163480974|NCT03384316|590458264|FG001|Overall Study|Screen failure|1|||
163480975|NCT00413231|590458265|FG000|0 to 30-day Post Treatment|Death|5|||
163480976|NCT00413231|590458265|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
163480977|NCT00413231|590458265|FG000|30-day to 365-day Post Treatment|Death|13|||
163480978|NCT00413231|590458265|FG000|365-day to 60-month Post Treatment|Death|36|||
163480979|NCT00413231|590458265|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
163480980|NCT00413231|590458265|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
163480981|NCT00413231|590458265|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
163480982|NCT01539720|590458268|FG000|Overall Study|Screen Fail|15|||
163480983|NCT01539720|590458269|FG001|Overall Study|Screen Fail|3|||
163480984|NCT01539720|590458268|FG000|Overall Study|Lost to Follow-up|14|||
163480985|NCT01539720|590458269|FG001|Overall Study|Lost to Follow-up|7|||
163480986|NCT03287960|590458276|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
163480987|NCT03287960|590458276|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
163480988|NCT01641952|590458277|FG000|Overall Study|Lost to Follow-up|28|||
163480989|NCT01641952|590458277|FG000|Overall Study|Adverse Event|6|||
163480990|NCT00656136|590458278|FG000|Overall Study|Progressive disease|177|||
163480991|NCT00656136|590458279|FG001|Overall Study|Progressive disease|322|||
163480992|NCT00656136|590458278|FG000|Overall Study|Other Adverse Event|5|||
163480993|NCT00656136|590458279|FG001|Overall Study|Other Adverse Event|51|||
163480994|NCT00656136|590458278|FG000|Overall Study|Protocol Violation|2|||
163480995|NCT00656136|590458279|FG001|Overall Study|Protocol Violation|3|||
163480996|NCT00656136|590458278|FG000|Overall Study|Patient refused to take study medication|7|||
163480997|NCT00656136|590458279|FG001|Overall Study|Patient refused to take study medication|10|||
163480998|NCT00656136|590458278|FG000|Overall Study|Unknown and others|4|||
163480999|NCT00656136|590458279|FG001|Overall Study|Unknown and others|4|||
163481000|NCT02516306|590458287|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
163481001|NCT02516306|590458288|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
163481002|NCT02607865|590458291|FG000|Overall Study|Lost to Follow-up|9|||
163481003|NCT02607865|590458292|FG001|Overall Study|Lost to Follow-up|7|||
163481004|NCT02607865|590458293|FG002|Overall Study|Lost to Follow-up|7|||
163481005|NCT02607865|590458294|FG003|Overall Study|Lost to Follow-up|5|||
163481006|NCT02607865|590458291|FG000|Overall Study|Withdrawal by Subject|18|||
163481007|NCT02607865|590458292|FG001|Overall Study|Withdrawal by Subject|18|||
163481008|NCT02607865|590458293|FG002|Overall Study|Withdrawal by Subject|17|||
163481009|NCT02607865|590458294|FG003|Overall Study|Withdrawal by Subject|8|||
163481010|NCT02607865|590458291|FG000|Overall Study|Death|5|||
163481011|NCT02607865|590458292|FG001|Overall Study|Death|4|||
163481012|NCT02607865|590458293|FG002|Overall Study|Death|1|||
163481013|NCT02607865|590458294|FG003|Overall Study|Death|3|||
163481014|NCT02607865|590458291|FG000|Overall Study|Unclassified|1|||
163481015|NCT02607865|590458292|FG001|Overall Study|Unclassified|1|||
163481016|NCT02607865|590458293|FG002|Overall Study|Unclassified|2|||
163481017|NCT02607865|590458294|FG003|Overall Study|Unclassified|0|||
163481018|NCT01351415|590458298|FG000|Overall Study|Withdrawal by Subject|15|||
163481019|NCT01351415|590458299|FG001|Overall Study|Withdrawal by Subject|17|||
163481020|NCT01351415|590458298|FG000|Overall Study|Trial termination by the Sponsor|28|||
163481021|NCT01351415|590458299|FG001|Overall Study|Trial termination by the Sponsor|19|||
163481022|NCT01351415|590458298|FG000|Overall Study|Lost to Follow-up|5|||
163481023|NCT01351415|590458299|FG001|Overall Study|Lost to Follow-up|7|||
163481024|NCT01351415|590458298|FG000|Overall Study|Death|190|||
163481025|NCT01351415|590458299|FG001|Overall Study|Death|187|||
163481026|NCT01351415|590458298|FG000|Overall Study|Physician Decision|2|||
163481027|NCT01351415|590458299|FG001|Overall Study|Physician Decision|3|||
163481028|NCT01351415|590458298|FG000|Overall Study|Reason unknown|0|||
163481029|NCT01351415|590458299|FG001|Overall Study|Reason unknown|2|||
163481030|NCT01351415|590458298|FG000|Overall Study|Never Started|5|||
163481031|NCT01351415|590458299|FG001|Overall Study|Never Started|5|||
163481032|NCT00247962|590458300|FG000|Overall Study|Adverse Event|15|||
163481033|NCT00247962|590458301|FG001|Overall Study|Adverse Event|12|||
163481034|NCT00247962|590458300|FG000|Overall Study|Lost to Follow-up|3|||
163481035|NCT00247962|590458301|FG001|Overall Study|Lost to Follow-up|1|||
163481036|NCT00247962|590458300|FG000|Overall Study|Physician Decision|0|||
163481037|NCT00247962|590458301|FG001|Overall Study|Physician Decision|1|||
163481038|NCT00247962|590458300|FG000|Overall Study|Protocol Violation|1|||
163481039|NCT00247962|590458301|FG001|Overall Study|Protocol Violation|1|||
163481040|NCT00247962|590458300|FG000|Overall Study|Withdrawal by Subject|3|||
163481041|NCT00247962|590458301|FG001|Overall Study|Withdrawal by Subject|2|||
163481042|NCT00247962|590458300|FG000|Overall Study|Lack of Efficacy|4|||
163481043|NCT00247962|590458301|FG001|Overall Study|Lack of Efficacy|2|||
163481044|NCT03525613|590458303|FG000|Overall Study|Adverse Event|11|||
163481045|NCT03525613|590458304|FG001|Overall Study|Adverse Event|8|||
163481046|NCT03525613|590458305|FG002|Overall Study|Adverse Event|3|||
163481047|NCT03525613|590458306|FG003|Overall Study|Adverse Event|3|||
163481048|NCT03525613|590458303|FG000|Overall Study|Lost to Follow-up|4|||
163481049|NCT03525613|590458304|FG001|Overall Study|Lost to Follow-up|5|||
163481050|NCT03525613|590458305|FG002|Overall Study|Lost to Follow-up|3|||
163481051|NCT03525613|590458306|FG003|Overall Study|Lost to Follow-up|2|||
163481052|NCT03525613|590458303|FG000|Overall Study|Physician Decision|0|||
163481053|NCT03525613|590458304|FG001|Overall Study|Physician Decision|1|||
163481054|NCT03525613|590458305|FG002|Overall Study|Physician Decision|0|||
163481055|NCT03525613|590458306|FG003|Overall Study|Physician Decision|1|||
163481056|NCT03525613|590458303|FG000|Overall Study|Consent Withdrawal|25|||
163481057|NCT03525613|590458304|FG001|Overall Study|Consent Withdrawal|16|||
163481058|NCT03525613|590458305|FG002|Overall Study|Consent Withdrawal|12|||
163481059|NCT03525613|590458306|FG003|Overall Study|Consent Withdrawal|9|||
163481060|NCT03525613|590458303|FG000|Overall Study|Death|20|||
163481061|NCT03525613|590458304|FG001|Overall Study|Death|9|||
163481062|NCT03525613|590458305|FG002|Overall Study|Death|7|||
163481063|NCT03525613|590458306|FG003|Overall Study|Death|1|||
163481064|NCT03525613|590458303|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
163481065|NCT03525613|590458304|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
163481066|NCT03525613|590458305|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
163481067|NCT03525613|590458306|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
163481068|NCT03480360|590458307|FG000|Overall Study|Death|2|||
163481069|NCT03117309|590458314|FG000|Overall Study|Not meeting inclusion criteria|0|||
163481070|NCT03117309|590458315|FG001|Overall Study|Not meeting inclusion criteria|1|||
163481071|NCT02120469|590458316|FG000|Overall Study|HER-2/neu-amplified|1|||
163481072|NCT02120469|590458317|FG001|Overall Study|HER-2/neu-amplified|0|||
163481073|NCT02120469|590458318|FG002|Overall Study|HER-2/neu-amplified|1|||
163481074|NCT02583711|590458319|FG000|Overall Study|Withdrawal by Subject|0|||
163481075|NCT02583711|590458320|FG001|Overall Study|Withdrawal by Subject|10|||
163481076|NCT02583711|590458321|FG002|Overall Study|Withdrawal by Subject|0|||
163481077|NCT01142791|590458332|FG000|Overall Study|Alternative Treatment|1|||
163481078|NCT01142791|590458333|FG001|Overall Study|Alternative Treatment|0|||
163481079|NCT01142791|590458332|FG000|Overall Study|Lost to Follow-up|1|||
163481080|NCT01142791|590458333|FG001|Overall Study|Lost to Follow-up|0|||
163481081|NCT01142791|590458332|FG000|Overall Study|Withdrawal by Subject|5|||
163481082|NCT01142791|590458333|FG001|Overall Study|Withdrawal by Subject|0|||
163481083|NCT01142791|590458332|FG000|Overall Study|Received only 1 sonication|0|||
163481084|NCT01142791|590458333|FG001|Overall Study|Received only 1 sonication|6|||
163481085|NCT02975206|590458335|FG000|Overall Study|Withdrawal by Subject|14|||
163481086|NCT02975206|590458336|FG001|Overall Study|Withdrawal by Subject|11|||
163481087|NCT02975206|590458337|FG002|Overall Study|Withdrawal by Subject|11|||
163481088|NCT02975206|590458335|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
163481089|NCT02975206|590458336|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
163481090|NCT02975206|590458337|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
163481091|NCT01981096|590458339|FG000|Overall Study|Parent illness|1|||
163481092|NCT01981096|590458340|FG001|Overall Study|Parent illness|0|||
163481093|NCT01981096|590458339|FG000|Overall Study|Withdrawal by Subject|0|||
163481094|NCT01981096|590458340|FG001|Overall Study|Withdrawal by Subject|1|||
163481095|NCT01981096|590458339|FG000|Overall Study|Lost to Follow-up|2|||
163481096|NCT01981096|590458340|FG001|Overall Study|Lost to Follow-up|0|||
163481097|NCT04129242|590458343|FG000|Overall Study|Physician Decision|1|||
163481098|NCT04129242|590458344|FG001|Overall Study|Physician Decision|1|||
163481099|NCT04129242|590458343|FG000|Overall Study|Protocol Violation|0|||
163481100|NCT04129242|590458344|FG001|Overall Study|Protocol Violation|1|||
163481101|NCT00392210|590458348|FG000|First Voiding Trial|Physician Decision|2|||
163481102|NCT00392210|590458349|FG001|First Voiding Trial|Physician Decision|2|||
163481103|NCT01899729|590458355|FG000|Overall Study|Adverse Event|1|||
163481104|NCT01899729|590458356|FG001|Overall Study|Adverse Event|0|||
163481105|NCT01899729|590458357|FG002|Overall Study|Adverse Event|0|||
163481106|NCT01899729|590458358|FG003|Overall Study|Adverse Event|0|||
163481107|NCT01899729|590458359|FG004|Overall Study|Adverse Event|1|||
163481108|NCT01899729|590458355|FG000|Overall Study|Withdrawal by Subject|1|||
163481109|NCT01899729|590458356|FG001|Overall Study|Withdrawal by Subject|2|||
163481110|NCT01899729|590458357|FG002|Overall Study|Withdrawal by Subject|0|||
163481111|NCT01899729|590458358|FG003|Overall Study|Withdrawal by Subject|0|||
163481112|NCT01899729|590458359|FG004|Overall Study|Withdrawal by Subject|0|||
163481113|NCT01899729|590458355|FG000|Overall Study|Lack of Efficacy|0|||
163481114|NCT01899729|590458356|FG001|Overall Study|Lack of Efficacy|0|||
163481115|NCT01899729|590458357|FG002|Overall Study|Lack of Efficacy|2|||
163481116|NCT01899729|590458358|FG003|Overall Study|Lack of Efficacy|0|||
163481117|NCT01899729|590458359|FG004|Overall Study|Lack of Efficacy|1|||
163481118|NCT01454531|590458360|FG000|Overall Study|Adverse Event|14|||
163481119|NCT01454531|590458360|FG000|Overall Study|Withdrawal by Subject|5|||
163481120|NCT01454531|590458360|FG000|Overall Study|Lost to Follow-up|1|||
163481121|NCT01454531|590458360|FG000|Overall Study|Physician Decision|1|||
163481122|NCT01454531|590458360|FG000|Overall Study|Delay in IMP administration|1|||
163481123|NCT01454531|590458360|FG000|Overall Study|Other|1|||
163481124|NCT01021423|590458363|FG000|Overall Study|Study terminated|4|||
163481125|NCT01021423|590458364|FG001|Overall Study|Study terminated|5|||
163481126|NCT00122317|590458365|FG000|Overall Study|Death|3|||
163481127|NCT00122317|590458365|FG000|Overall Study|Adverse Event|4|||
163481128|NCT00122317|590458365|FG000|Overall Study|Physician Decision|2|||
163481129|NCT00122317|590458365|FG000|Overall Study|patient non-compliance|1|||
163481130|NCT00122317|590458365|FG000|Overall Study|Withdrawal by Subject|1|||
163481131|NCT03756285|590458366|FG000|Overall Study|Lost to Follow-up|0|||
163481132|NCT03756285|590458367|FG001|Overall Study|Lost to Follow-up|1|||
163481133|NCT03756285|590458366|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
163481134|NCT03756285|590458367|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
163481135|NCT03756285|590458366|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
163481136|NCT03756285|590458367|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
163481137|NCT06334055|590458368|FG000|Overall Study|Adverse Event|4|||
163481138|NCT06334055|590458368|FG000|Overall Study|Disqualified|72|||
163481139|NCT04728815|590458369|FG000|Overall Study|Lost to Follow-up|3|||
163481140|NCT04728815|590458370|FG001|Overall Study|Lost to Follow-up|0|||
163481141|NCT04728815|590458371|FG002|Overall Study|Lost to Follow-up|0|||
163481142|NCT04728815|590458372|FG003|Overall Study|Lost to Follow-up|1|||
163481143|NCT04728815|590458373|FG004|Overall Study|Lost to Follow-up|1|||
163481144|NCT04728815|590458374|FG005|Overall Study|Lost to Follow-up|0|||
163481145|NCT04728815|590458375|FG006|Overall Study|Lost to Follow-up|2|||
163481146|NCT04728815|590458376|FG007|Overall Study|Lost to Follow-up|0|||
163481147|NCT04728815|590458369|FG000|Overall Study|Physician Decision|0|||
163481148|NCT04728815|590458370|FG001|Overall Study|Physician Decision|0|||
163481149|NCT04728815|590458371|FG002|Overall Study|Physician Decision|1|||
163481150|NCT04728815|590458372|FG003|Overall Study|Physician Decision|0|||
163481151|NCT04728815|590458373|FG004|Overall Study|Physician Decision|0|||
163481152|NCT04728815|590458374|FG005|Overall Study|Physician Decision|0|||
163481153|NCT04728815|590458375|FG006|Overall Study|Physician Decision|0|||
163481154|NCT04728815|590458376|FG007|Overall Study|Physician Decision|0|||
163481155|NCT04728815|590458369|FG000|Overall Study|Treatment drop|0|||
163481156|NCT04728815|590458370|FG001|Overall Study|Treatment drop|2|||
163481157|NCT04728815|590458371|FG002|Overall Study|Treatment drop|1|||
163481158|NCT04728815|590458372|FG003|Overall Study|Treatment drop|0|||
163481159|NCT04728815|590458373|FG004|Overall Study|Treatment drop|3|||
163481160|NCT04728815|590458374|FG005|Overall Study|Treatment drop|1|||
163481161|NCT04728815|590458375|FG006|Overall Study|Treatment drop|3|||
163481162|NCT04728815|590458376|FG007|Overall Study|Treatment drop|0|||
163481163|NCT04728815|590458369|FG000|Overall Study|Study drop|0|||
163481164|NCT04728815|590458370|FG001|Overall Study|Study drop|3|||
163481165|NCT04728815|590458371|FG002|Overall Study|Study drop|3|||
163481166|NCT04728815|590458372|FG003|Overall Study|Study drop|0|||
163481167|NCT04728815|590458373|FG004|Overall Study|Study drop|0|||
163481168|NCT04728815|590458374|FG005|Overall Study|Study drop|0|||
163481169|NCT04728815|590458375|FG006|Overall Study|Study drop|7|||
163481170|NCT04728815|590458376|FG007|Overall Study|Study drop|0|||
163481171|NCT00957034|590458377|FG000|Overall Study|Adverse Event|0|||
163481172|NCT00957034|590458378|FG001|Overall Study|Adverse Event|1|||
163481173|NCT00957034|590458379|FG002|Overall Study|Adverse Event|1|||
163481174|NCT00957034|590458377|FG000|Overall Study|Sponsor Terminated Study|6|||
163481175|NCT00957034|590458378|FG001|Overall Study|Sponsor Terminated Study|1|||
163481176|NCT00957034|590458379|FG002|Overall Study|Sponsor Terminated Study|5|||
163481177|NCT00957034|590458377|FG000|Overall Study|Withdrawal by Subject|0|||
163481178|NCT00957034|590458378|FG001|Overall Study|Withdrawal by Subject|2|||
163481179|NCT00957034|590458379|FG002|Overall Study|Withdrawal by Subject|0|||
163481180|NCT05315297|590458380|FG000|Overall Study|Lost to Follow-up|6|||
163481181|NCT05315297|590458381|FG001|Overall Study|Lost to Follow-up|4|||
163481182|NCT05315297|590458380|FG000|Overall Study|Withdrawal by Subject|0|||
163481183|NCT05315297|590458381|FG001|Overall Study|Withdrawal by Subject|1|||
163481184|NCT01503229|590461285|FG000|Overall Study|Withdrew consent|1|||
163481185|NCT01354964|590461286|FG000|Overall Study|Lost to Follow-up|2|||
163481186|NCT01354964|590461287|FG001|Overall Study|Lost to Follow-up|0|||
163481187|NCT01354964|590461286|FG000|Overall Study|IV access issues|1|||
163481188|NCT01354964|590461287|FG001|Overall Study|IV access issues|1|||
163481189|NCT01354964|590461286|FG000|Overall Study|Physician Decision|1|||
163481190|NCT01354964|590461287|FG001|Overall Study|Physician Decision|0|||
163481191|NCT00711009|590461288|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
163481192|NCT00711009|590461289|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
163481193|NCT00711009|590461288|FG000|Overall Study|Withdrawal by Subject|4|||
163481194|NCT00711009|590461289|FG001|Overall Study|Withdrawal by Subject|2|||
163481195|NCT00711009|590461288|FG000|Overall Study|Lost to Follow-up|3|||
163481196|NCT00711009|590461289|FG001|Overall Study|Lost to Follow-up|9|||
163481197|NCT00711009|590461288|FG000|Overall Study|Participant Noncompliant|0|||
163481198|NCT00711009|590461289|FG001|Overall Study|Participant Noncompliant|1|||
163481199|NCT00711009|590461288|FG000|Overall Study|Virologic Failure|2|||
163481200|NCT00711009|590461289|FG001|Overall Study|Virologic Failure|1|||
163481201|NCT00711009|590461288|FG000|Overall Study|Pregnancy|1|||
163481202|NCT00711009|590461289|FG001|Overall Study|Pregnancy|0|||
163481203|NCT00711009|590461288|FG000|Overall Study|Site closing|0|||
163481204|NCT00711009|590461289|FG001|Overall Study|Site closing|1|||
163481205|NCT00711009|590461288|FG000|Overall Study|Dose adjustment|1|||
163481206|NCT00711009|590461289|FG001|Overall Study|Dose adjustment|0|||
163481207|NCT02534324|590461290|FG000|Overall Study|Protocol Violation|4|||
163481208|NCT02534324|590461291|FG001|Overall Study|Protocol Violation|1|||
163481209|NCT02534324|590461290|FG000|Overall Study|Lost to Follow-up|20|||
163481210|NCT02534324|590461291|FG001|Overall Study|Lost to Follow-up|7|||
163481211|NCT02534324|590461290|FG000|Overall Study|Adverse Event|1|||
163481212|NCT02534324|590461291|FG001|Overall Study|Adverse Event|0|||
163481213|NCT01459016|590461294|FG000|Overall Study|Withdrawal by Subject|11|||
163481214|NCT01459016|590461294|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
163481215|NCT02889861|590461295|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
163481216|NCT02039687|590461296|FG000|Overall Study|Adverse Event|0|||
163481217|NCT02039687|590461297|FG001|Overall Study|Adverse Event|0|||
163481218|NCT02039687|590461298|FG002|Overall Study|Adverse Event|1|||
163481219|NCT02039687|590461299|FG003|Overall Study|Adverse Event|0|||
163481220|NCT02039687|590461296|FG000|Overall Study|Withdrawal by Subject|0|||
163481221|NCT02039687|590461297|FG001|Overall Study|Withdrawal by Subject|1|||
163481222|NCT02039687|590461298|FG002|Overall Study|Withdrawal by Subject|0|||
163481223|NCT02039687|590461299|FG003|Overall Study|Withdrawal by Subject|0|||
163481224|NCT02039687|590461296|FG000|Overall Study|treatment assignment could not be confir|0|||
163481225|NCT02039687|590461297|FG001|Overall Study|treatment assignment could not be confir|0|||
163481226|NCT02039687|590461298|FG002|Overall Study|treatment assignment could not be confir|2|||
163481227|NCT02039687|590461299|FG003|Overall Study|treatment assignment could not be confir|0|||
163481228|NCT04354870|590461315|FG000|Overall Study|Lost to Follow-up|32|||
163481229|NCT04354870|590461316|FG001|Overall Study|Lost to Follow-up|12|||
163481230|NCT04354870|590461315|FG000|Overall Study|Withdrawal by Subject|10|||
163481231|NCT04354870|590461316|FG001|Overall Study|Withdrawal by Subject|16|||
163481232|NCT04354870|590461315|FG000|Overall Study|Did not complete all study visits|6|||
163481233|NCT04354870|590461316|FG001|Overall Study|Did not complete all study visits|5|||
163481234|NCT04450394|590461317|FG000|Overall Study|Adverse Event|2|||
163481235|NCT04450394|590461318|FG001|Overall Study|Adverse Event|0|||
163481236|NCT04450394|590461319|FG002|Overall Study|Adverse Event|0|||
163481237|NCT04450394|590461317|FG000|Overall Study|Death|0|||
163481238|NCT04450394|590461318|FG001|Overall Study|Death|1|||
163481239|NCT04450394|590461319|FG002|Overall Study|Death|0|||
163481240|NCT04450394|590461317|FG000|Overall Study|Lost to Follow-up|0|||
163481241|NCT04450394|590461318|FG001|Overall Study|Lost to Follow-up|3|||
163481242|NCT04450394|590461319|FG002|Overall Study|Lost to Follow-up|0|||
163481243|NCT04450394|590461317|FG000|Overall Study|Physician Decision|0|||
163481244|NCT04450394|590461318|FG001|Overall Study|Physician Decision|1|||
163481245|NCT04450394|590461319|FG002|Overall Study|Physician Decision|0|||
163481246|NCT04450394|590461317|FG000|Overall Study|Protocol Violation|2|||
163481247|NCT04450394|590461318|FG001|Overall Study|Protocol Violation|0|||
163481248|NCT04450394|590461319|FG002|Overall Study|Protocol Violation|0|||
163481249|NCT04450394|590461317|FG000|Overall Study|Withdrawal by Subject|6|||
163481250|NCT04450394|590461318|FG001|Overall Study|Withdrawal by Subject|9|||
163481251|NCT04450394|590461319|FG002|Overall Study|Withdrawal by Subject|0|||
163481252|NCT01066819|590461320|FG000|Overall Study|Adverse Event|18|||
163481253|NCT01066819|590461321|FG001|Overall Study|Adverse Event|1|||
163481254|NCT01066819|590461322|FG002|Overall Study|Adverse Event|6|||
163481255|NCT01066819|590461323|FG003|Overall Study|Adverse Event|0|||
163481256|NCT01066819|590461324|FG004|Overall Study|Adverse Event|0|||
163481257|NCT01066819|590461325|FG005|Overall Study|Adverse Event|0|||
163481258|NCT01066819|590461320|FG000|Overall Study|Death|5|||
163481259|NCT01066819|590461321|FG001|Overall Study|Death|0|||
163481260|NCT01066819|590461322|FG002|Overall Study|Death|1|||
163481261|NCT01066819|590461323|FG003|Overall Study|Death|0|||
163481262|NCT01066819|590461324|FG004|Overall Study|Death|0|||
163481263|NCT01066819|590461325|FG005|Overall Study|Death|0|||
163481264|NCT01066819|590461320|FG000|Overall Study|Lack of Efficacy|22|||
163481265|NCT01066819|590461321|FG001|Overall Study|Lack of Efficacy|1|||
163481266|NCT01066819|590461322|FG002|Overall Study|Lack of Efficacy|2|||
163481267|NCT01066819|590461323|FG003|Overall Study|Lack of Efficacy|1|||
163481268|NCT01066819|590461324|FG004|Overall Study|Lack of Efficacy|0|||
163481269|NCT01066819|590461325|FG005|Overall Study|Lack of Efficacy|0|||
163481270|NCT01066819|590461320|FG000|Overall Study|Physician Decision|6|||
163481271|NCT01066819|590461321|FG001|Overall Study|Physician Decision|2|||
163481272|NCT01066819|590461322|FG002|Overall Study|Physician Decision|3|||
163481273|NCT01066819|590461323|FG003|Overall Study|Physician Decision|0|||
163481274|NCT01066819|590461324|FG004|Overall Study|Physician Decision|0|||
163481275|NCT01066819|590461325|FG005|Overall Study|Physician Decision|0|||
163481276|NCT01066819|590461320|FG000|Overall Study|Protocol Violation|12|||
163481277|NCT01066819|590461321|FG001|Overall Study|Protocol Violation|6|||
163481278|NCT01066819|590461322|FG002|Overall Study|Protocol Violation|0|||
163481279|NCT01066819|590461323|FG003|Overall Study|Protocol Violation|0|||
163481280|NCT01066819|590461324|FG004|Overall Study|Protocol Violation|0|||
163481281|NCT01066819|590461325|FG005|Overall Study|Protocol Violation|0|||
163481282|NCT01066819|590461320|FG000|Overall Study|Withdrawal by Subject|29|||
163481283|NCT01066819|590461321|FG001|Overall Study|Withdrawal by Subject|11|||
163481284|NCT01066819|590461322|FG002|Overall Study|Withdrawal by Subject|6|||
163481285|NCT01066819|590461323|FG003|Overall Study|Withdrawal by Subject|0|||
163481286|NCT01066819|590461324|FG004|Overall Study|Withdrawal by Subject|0|||
163481287|NCT01066819|590461325|FG005|Overall Study|Withdrawal by Subject|0|||
163481288|NCT01066819|590461320|FG000|Overall Study|Administrative|6|||
163481289|NCT01066819|590461321|FG001|Overall Study|Administrative|4|||
163481290|NCT01066819|590461322|FG002|Overall Study|Administrative|2|||
163481291|NCT01066819|590461323|FG003|Overall Study|Administrative|0|||
163481292|NCT01066819|590461324|FG004|Overall Study|Administrative|0|||
163481293|NCT01066819|590461325|FG005|Overall Study|Administrative|0|||
163481294|NCT01066819|590461320|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
163481295|NCT01066819|590461321|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
163481296|NCT01066819|590461322|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
163481297|NCT01066819|590461323|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
163481298|NCT01066819|590461324|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
163481299|NCT01066819|590461325|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
163481300|NCT01066819|590461320|FG000|Overall Study|Early termination|2|||
163481301|NCT01066819|590461321|FG001|Overall Study|Early termination|0|||
163481302|NCT01066819|590461322|FG002|Overall Study|Early termination|0|||
163481303|NCT01066819|590461323|FG003|Overall Study|Early termination|0|||
163481304|NCT01066819|590461324|FG004|Overall Study|Early termination|0|||
163481305|NCT01066819|590461325|FG005|Overall Study|Early termination|0|||
163481306|NCT01066819|590461320|FG000|Overall Study|Failed to return|298|||
163481307|NCT01066819|590461321|FG001|Overall Study|Failed to return|107|||
163481308|NCT01066819|590461322|FG002|Overall Study|Failed to return|68|||
163481309|NCT01066819|590461323|FG003|Overall Study|Failed to return|7|||
163481310|NCT01066819|590461324|FG004|Overall Study|Failed to return|2|||
163481311|NCT01066819|590461325|FG005|Overall Study|Failed to return|3|||
163481312|NCT01066819|590461320|FG000|Overall Study|Lab test not done|9|||
163481313|NCT01066819|590461321|FG001|Overall Study|Lab test not done|0|||
163481314|NCT01066819|590461322|FG002|Overall Study|Lab test not done|2|||
163481315|NCT01066819|590461323|FG003|Overall Study|Lab test not done|1|||
163481316|NCT01066819|590461324|FG004|Overall Study|Lab test not done|0|||
163481317|NCT01066819|590461325|FG005|Overall Study|Lab test not done|0|||
163481318|NCT01066819|590461320|FG000|Overall Study|Miscellaneous|28|||
163481319|NCT01066819|590461321|FG001|Overall Study|Miscellaneous|10|||
163481320|NCT01066819|590461322|FG002|Overall Study|Miscellaneous|18|||
163481321|NCT01066819|590461323|FG003|Overall Study|Miscellaneous|1|||
163481322|NCT01066819|590461324|FG004|Overall Study|Miscellaneous|0|||
163481323|NCT01066819|590461325|FG005|Overall Study|Miscellaneous|0|||
163481324|NCT01066819|590461320|FG000|Overall Study|Non responders|123|||
163481325|NCT01066819|590461321|FG001|Overall Study|Non responders|2|||
163481326|NCT01066819|590461322|FG002|Overall Study|Non responders|7|||
163481327|NCT01066819|590461323|FG003|Overall Study|Non responders|2|||
163481328|NCT01066819|590461324|FG004|Overall Study|Non responders|0|||
163481329|NCT01066819|590461325|FG005|Overall Study|Non responders|1|||
163481330|NCT01066819|590461320|FG000|Overall Study|Not categorised|9|||
163481331|NCT01066819|590461321|FG001|Overall Study|Not categorised|2|||
163481332|NCT01066819|590461322|FG002|Overall Study|Not categorised|6|||
163481333|NCT01066819|590461323|FG003|Overall Study|Not categorised|1|||
163481334|NCT01066819|590461324|FG004|Overall Study|Not categorised|0|||
163481335|NCT01066819|590461325|FG005|Overall Study|Not categorised|0|||
163481336|NCT01066819|590461320|FG000|Overall Study|Relapse|16|||
163481337|NCT01066819|590461321|FG001|Overall Study|Relapse|4|||
163481338|NCT01066819|590461322|FG002|Overall Study|Relapse|3|||
163481339|NCT01066819|590461323|FG003|Overall Study|Relapse|0|||
163481340|NCT01066819|590461324|FG004|Overall Study|Relapse|0|||
163481341|NCT01066819|590461325|FG005|Overall Study|Relapse|0|||
163481342|NCT01066819|590461320|FG000|Overall Study|Results not available|1|||
163481343|NCT01066819|590461321|FG001|Overall Study|Results not available|0|||
163481344|NCT01066819|590461322|FG002|Overall Study|Results not available|0|||
163481345|NCT01066819|590461323|FG003|Overall Study|Results not available|0|||
163481346|NCT01066819|590461324|FG004|Overall Study|Results not available|0|||
163481347|NCT01066819|590461325|FG005|Overall Study|Results not available|0|||
163481348|NCT01066819|590461320|FG000|Overall Study|Screen failure|1|||
163481349|NCT01066819|590461321|FG001|Overall Study|Screen failure|0|||
163481350|NCT01066819|590461322|FG002|Overall Study|Screen failure|0|||
163481351|NCT01066819|590461323|FG003|Overall Study|Screen failure|0|||
163481352|NCT01066819|590461324|FG004|Overall Study|Screen failure|0|||
163481353|NCT01066819|590461325|FG005|Overall Study|Screen failure|0|||
163481354|NCT01066819|590461320|FG000|Overall Study|Spontaneous cure|1|||
163481355|NCT01066819|590461321|FG001|Overall Study|Spontaneous cure|0|||
163481356|NCT01066819|590461322|FG002|Overall Study|Spontaneous cure|0|||
163481357|NCT01066819|590461323|FG003|Overall Study|Spontaneous cure|0|||
163481358|NCT01066819|590461324|FG004|Overall Study|Spontaneous cure|0|||
163481359|NCT01066819|590461325|FG005|Overall Study|Spontaneous cure|0|||
163481360|NCT01066819|590461320|FG000|Overall Study|Treatment never started|85|||
163481361|NCT01066819|590461321|FG001|Overall Study|Treatment never started|19|||
163481362|NCT01066819|590461322|FG002|Overall Study|Treatment never started|19|||
163481363|NCT01066819|590461323|FG003|Overall Study|Treatment never started|3|||
163481364|NCT01066819|590461324|FG004|Overall Study|Treatment never started|2|||
163481365|NCT01066819|590461325|FG005|Overall Study|Treatment never started|2|||
163481366|NCT01066819|590461320|FG000|Overall Study|Treatment stopped|12|||
163481367|NCT01066819|590461321|FG001|Overall Study|Treatment stopped|1|||
163481368|NCT01066819|590461322|FG002|Overall Study|Treatment stopped|2|||
163481369|NCT01066819|590461323|FG003|Overall Study|Treatment stopped|1|||
163481370|NCT01066819|590461324|FG004|Overall Study|Treatment stopped|0|||
163481371|NCT01066819|590461325|FG005|Overall Study|Treatment stopped|0|||
163481372|NCT01066819|590461320|FG000|Overall Study|Other|5|||
163481373|NCT01066819|590461321|FG001|Overall Study|Other|1|||
163481374|NCT01066819|590461322|FG002|Overall Study|Other|1|||
163481375|NCT01066819|590461323|FG003|Overall Study|Other|0|||
163481376|NCT01066819|590461324|FG004|Overall Study|Other|0|||
163481377|NCT01066819|590461325|FG005|Overall Study|Other|0|||
163481378|NCT02194699|590461326|FG000|Randomised|Did not receive treatment|1|||
163481379|NCT02194699|590461327|FG001|Randomised|Did not receive treatment|5|||
163481380|NCT02194699|590461326|FG000|Randomised|Without potential for 52 weeks of IP|5|||
163481381|NCT02194699|590461327|FG001|Randomised|Without potential for 52 weeks of IP|5|||
163481382|NCT02194699|590461326|FG000|Randomised|Duplicate patient|2|||
163481383|NCT02194699|590461327|FG001|Randomised|Duplicate patient|1|||
163481384|NCT02194699|590461326|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
163481385|NCT02194699|590461327|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
163481386|NCT02194699|590461326|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
163481387|NCT02194699|590461327|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
163481388|NCT02194699|590461326|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
163481389|NCT02194699|590461327|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
163481390|NCT02194699|590461326|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
163481391|NCT02194699|590461327|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
163481392|NCT02194699|590461326|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
163481393|NCT02194699|590461327|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
163481394|NCT02194699|590461326|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
163481395|NCT02194699|590461327|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
163481396|NCT03812224|590461329|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
163481397|NCT03812224|590461330|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
163481398|NCT03812224|590461329|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
163481399|NCT03812224|590461330|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
163481400|NCT03812224|590461329|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
163481401|NCT03812224|590461330|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
163481402|NCT03812224|590461329|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
163481403|NCT03812224|590461330|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
163481404|NCT01667731|590461340|FG000|Overall Study|Enrolled but not treated|0|||
163481405|NCT01667731|590461341|FG001|Overall Study|Enrolled but not treated|0|||
163481406|NCT01667731|590461342|FG002|Overall Study|Enrolled but not treated|0|||
163481407|NCT01667731|590461343|FG003|Overall Study|Enrolled but not treated|0|||
163481408|NCT01667731|590461344|FG004|Overall Study|Enrolled but not treated|1|||
163481409|NCT01667731|590461340|FG000|Overall Study|Efficacy Failure|1|||
163481410|NCT01667731|590461341|FG001|Overall Study|Efficacy Failure|12|||
163481411|NCT01667731|590461342|FG002|Overall Study|Efficacy Failure|0|||
163481412|NCT01667731|590461343|FG003|Overall Study|Efficacy Failure|1|||
163481413|NCT01667731|590461344|FG004|Overall Study|Efficacy Failure|24|||
163481414|NCT01667731|590461340|FG000|Overall Study|Lost to Follow-up|2|||
163481415|NCT01667731|590461341|FG001|Overall Study|Lost to Follow-up|3|||
163481416|NCT01667731|590461342|FG002|Overall Study|Lost to Follow-up|1|||
163481417|NCT01667731|590461343|FG003|Overall Study|Lost to Follow-up|1|||
163481418|NCT01667731|590461344|FG004|Overall Study|Lost to Follow-up|2|||
163481419|NCT01667731|590461340|FG000|Overall Study|Subject Withdrew Consent|2|||
162925428|NCT00742859|588428967|FG003|Overall Study|Sponsor request patient out of town|1|||
163481420|NCT01667731|590461341|FG001|Overall Study|Subject Withdrew Consent|0|||
163481421|NCT01667731|590461342|FG002|Overall Study|Subject Withdrew Consent|1|||
163481422|NCT01667731|590461343|FG003|Overall Study|Subject Withdrew Consent|0|||
163481423|NCT01667731|590461344|FG004|Overall Study|Subject Withdrew Consent|1|||
163481424|NCT01667731|590461340|FG000|Overall Study|Death|0|||
163481425|NCT01667731|590461341|FG001|Overall Study|Death|1|||
163481426|NCT01667731|590461342|FG002|Overall Study|Death|0|||
163481427|NCT01667731|590461343|FG003|Overall Study|Death|0|||
163481428|NCT01667731|590461344|FG004|Overall Study|Death|0|||
163481429|NCT02516605|590461349|FG000|Overall Study|Protocol Violation|0|||
163481430|NCT02516605|590461350|FG001|Overall Study|Protocol Violation|0|||
163481431|NCT02516605|590461351|FG002|Overall Study|Protocol Violation|0|||
163481432|NCT02516605|590461352|FG003|Overall Study|Protocol Violation|0|||
163481433|NCT02516605|590461353|FG004|Overall Study|Protocol Violation|1|||
163481434|NCT02516605|590461349|FG000|Overall Study|Withdrawal by Subject|0|||
163481435|NCT02516605|590461350|FG001|Overall Study|Withdrawal by Subject|0|||
163481436|NCT02516605|590461351|FG002|Overall Study|Withdrawal by Subject|0|||
163481437|NCT02516605|590461352|FG003|Overall Study|Withdrawal by Subject|1|||
163481438|NCT02516605|590461353|FG004|Overall Study|Withdrawal by Subject|0|||
163481439|NCT02643420|590461354|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
163481440|NCT02643420|590461355|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
163481441|NCT02643420|590461354|FG000|Overall Study|Withdrawal by Subject|25|||
163481442|NCT02643420|590461355|FG001|Overall Study|Withdrawal by Subject|19|||
163481443|NCT02643420|590461354|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
163481444|NCT02643420|590461355|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
163481445|NCT02643420|590461354|FG000|Overall Study|Lost to Follow-up|6|||
163481446|NCT02643420|590461355|FG001|Overall Study|Lost to Follow-up|10|||
163481447|NCT02643420|590461354|FG000|Overall Study|Investigator Decision|2|||
163481448|NCT02643420|590461355|FG001|Overall Study|Investigator Decision|4|||
163481449|NCT02643420|590461354|FG000|Overall Study|Sponsor decision|1|||
163481450|NCT02643420|590461355|FG001|Overall Study|Sponsor decision|1|||
163481451|NCT02643420|590461354|FG000|Overall Study|Death|0|||
163481452|NCT02643420|590461355|FG001|Overall Study|Death|2|||
163481453|NCT02643420|590461354|FG000|Overall Study|Reason not Specified|8|||
163481454|NCT02643420|590461355|FG001|Overall Study|Reason not Specified|7|||
163481455|NCT02127970|590461356|FG000|Overall Study|Adverse Event|2|||
163481456|NCT02127970|590461357|FG001|Overall Study|Adverse Event|1|||
163481457|NCT02127970|590461356|FG000|Overall Study|Death|1|||
163481458|NCT02127970|590461357|FG001|Overall Study|Death|1|||
163481459|NCT02127970|590461356|FG000|Overall Study|Lost to Follow-up|14|||
163481460|NCT02127970|590461357|FG001|Overall Study|Lost to Follow-up|14|||
163481461|NCT02127970|590461356|FG000|Overall Study|Reason not Specified|4|||
163481462|NCT02127970|590461357|FG001|Overall Study|Reason not Specified|7|||
163481463|NCT02127970|590461356|FG000|Overall Study|Pregnancy|0|||
163481464|NCT02127970|590461357|FG001|Overall Study|Pregnancy|1|||
163481465|NCT02127970|590461356|FG000|Overall Study|Subject Withdrew Consent|5|||
163481466|NCT02127970|590461357|FG001|Overall Study|Subject Withdrew Consent|3|||
163481467|NCT01710709|590461358|FG000|Overall Study|Lost to Follow-up|29|||
163481468|NCT01710709|590461358|FG000|Overall Study|Adverse Event|48|||
163481469|NCT01710709|590461358|FG000|Overall Study|Participant met withdrawal criteria|33|||
163481470|NCT01710709|590461358|FG000|Overall Study|Participant withdrawn by investigator|2|||
163481471|NCT01710709|590461358|FG000|Overall Study|Withdrawal by Subject|53|||
163481472|NCT01710709|590461358|FG000|Overall Study|Protocol Violation|5|||
163481473|NCT01710709|590461358|FG000|Overall Study|Lack of Efficacy|3|||
163481474|NCT01398176|590461360|FG000|Overall Study|Lost to Follow-up|1|||
163481475|NCT01398176|590461361|FG001|Overall Study|Lost to Follow-up|3|||
163481476|NCT01398176|590461360|FG000|Overall Study|Physician Decision|2|||
163481477|NCT01398176|590461361|FG001|Overall Study|Physician Decision|3|||
163481478|NCT01871870|590461365|FG000|Overall Study|Hardware issues|7|||
163481479|NCT01871870|590461365|FG000|Overall Study|hyperglycemia|2|||
163481480|NCT00253747|590461369|FG000|Overall Study|Lost to Follow-up|13|||
163481481|NCT00253747|590461370|FG001|Overall Study|Lost to Follow-up|14|||
163481482|NCT00253747|590461369|FG000|Overall Study|Withdrawal by Subject|10|||
163481483|NCT00253747|590461370|FG001|Overall Study|Withdrawal by Subject|11|||
163481484|NCT00253747|590461369|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
163481485|NCT00253747|590461370|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
163481486|NCT02275052|590461373|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163481487|NCT02275052|590461374|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
163481488|NCT02275052|590461375|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163481489|NCT02275052|590461376|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163481490|NCT02275052|590461373|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
163481491|NCT02275052|590461374|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
163481492|NCT02275052|590461375|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
163481493|NCT02275052|590461376|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
163481494|NCT02275052|590461373|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
163481495|NCT02275052|590461374|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
163481496|NCT02275052|590461375|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
163481497|NCT02275052|590461376|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
163481498|NCT02275052|590461373|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
163481499|NCT02275052|590461374|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
163481500|NCT02275052|590461375|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
163481501|NCT02275052|590461376|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
163481502|NCT02275052|590461373|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
163481503|NCT02275052|590461374|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
163481504|NCT02275052|590461375|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
163481505|NCT02275052|590461376|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
163481506|NCT02275052|590461373|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
163481507|NCT02275052|590461374|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
163481508|NCT02275052|590461375|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
163481509|NCT02275052|590461376|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
163481510|NCT02275052|590461373|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
163481511|NCT02275052|590461374|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
163481512|NCT02275052|590461375|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
163481513|NCT02275052|590461376|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
163481514|NCT02275052|590461373|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
163481515|NCT02275052|590461374|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
163481516|NCT02275052|590461375|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
163481517|NCT02275052|590461376|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
163481518|NCT02275052|590461373|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163481519|NCT02275052|590461374|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163481520|NCT02275052|590461375|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
163481521|NCT02275052|590461376|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
163481522|NCT02275052|590461373|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
163481523|NCT02275052|590461374|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
163481524|NCT02275052|590461375|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
163481525|NCT02275052|590461376|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
163481526|NCT02275052|590461373|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
163481527|NCT02275052|590461374|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
163481528|NCT02275052|590461375|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
163481529|NCT02275052|590461376|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
163481530|NCT05102734|590461377|FG000|Overall Study|Did not require vasopressors|1|||
163481531|NCT05102734|590461378|FG001|Overall Study|Did not require vasopressors|0|||
163481532|NCT05102734|590461377|FG000|Overall Study|Did not have functioning PA catheter|1|||
163481533|NCT05102734|590461378|FG001|Overall Study|Did not have functioning PA catheter|0|||
163481534|NCT05102734|590461377|FG000|Overall Study|Inadequate video quality|2|||
163481535|NCT05102734|590461378|FG001|Overall Study|Inadequate video quality|0|||
163481536|NCT03055806|590461384|FG000|Overall Study|Adverse Event|0|||
163481537|NCT03055806|590461385|FG001|Overall Study|Adverse Event|0|||
163481538|NCT03055806|590461386|FG002|Overall Study|Adverse Event|1|||
163481539|NCT03055806|590461387|FG003|Overall Study|Adverse Event|1|||
163481540|NCT03055806|590461384|FG000|Overall Study|Lost to Follow-up|0|||
163481541|NCT03055806|590461385|FG001|Overall Study|Lost to Follow-up|3|||
163481542|NCT03055806|590461386|FG002|Overall Study|Lost to Follow-up|6|||
163481543|NCT03055806|590461387|FG003|Overall Study|Lost to Follow-up|7|||
163481544|NCT03055806|590461384|FG000|Overall Study|Physician Decision|1|||
163481545|NCT03055806|590461385|FG001|Overall Study|Physician Decision|0|||
163481546|NCT03055806|590461386|FG002|Overall Study|Physician Decision|0|||
163481547|NCT03055806|590461387|FG003|Overall Study|Physician Decision|1|||
163481548|NCT03055806|590461384|FG000|Overall Study|Protocol Violation|1|||
163481549|NCT03055806|590461385|FG001|Overall Study|Protocol Violation|0|||
163481550|NCT03055806|590461386|FG002|Overall Study|Protocol Violation|0|||
163481551|NCT03055806|590461387|FG003|Overall Study|Protocol Violation|0|||
163481552|NCT03055806|590461384|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
163481553|NCT03055806|590461385|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
163481554|NCT03055806|590461386|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
163481555|NCT03055806|590461387|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
163481556|NCT03055806|590461384|FG000|Overall Study|Withdrawal of consent to continue study|2|||
163481557|NCT03055806|590461385|FG001|Overall Study|Withdrawal of consent to continue study|3|||
163481558|NCT03055806|590461386|FG002|Overall Study|Withdrawal of consent to continue study|4|||
163481559|NCT03055806|590461387|FG003|Overall Study|Withdrawal of consent to continue study|6|||
163481560|NCT03055806|590461384|FG000|Overall Study|Partner not willing to try intercourse|1|||
163481561|NCT03055806|590461385|FG001|Overall Study|Partner not willing to try intercourse|0|||
163481562|NCT03055806|590461386|FG002|Overall Study|Partner not willing to try intercourse|0|||
163481563|NCT03055806|590461387|FG003|Overall Study|Partner not willing to try intercourse|0|||
163481564|NCT04601194|590461388|FG000|Overall Study|Lost to Follow-up|7|||
163481565|NCT02630459|590461389|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
163481566|NCT02630459|590461390|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
163481567|NCT02630459|590461391|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
163481568|NCT02630459|590461392|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
163481569|NCT02630459|590461393|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
163481570|NCT02630459|590461394|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
163481571|NCT02630459|590461395|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
163481572|NCT02630459|590461396|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
163481573|NCT02630459|590461389|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
163481574|NCT02630459|590461390|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
163481575|NCT02630459|590461391|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
162925429|NCT00742859|588428964|FG000|Overall Study|Site error|0|||
162925430|NCT00742859|588428965|FG001|Overall Study|Site error|0|||
163481576|NCT02630459|590461392|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
163481577|NCT02630459|590461393|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
163481578|NCT02630459|590461394|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
163481579|NCT02630459|590461395|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
163481580|NCT02630459|590461396|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
163481581|NCT02630459|590461389|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
163481582|NCT02630459|590461390|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
163481583|NCT02630459|590461391|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
163481584|NCT02630459|590461392|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
163481585|NCT02630459|590461393|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
163481586|NCT02630459|590461394|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
163481587|NCT02630459|590461395|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
163481588|NCT02630459|590461396|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
163481589|NCT02630459|590461389|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
163481590|NCT02630459|590461390|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
163481591|NCT02630459|590461391|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
163481592|NCT02630459|590461392|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
163481593|NCT02630459|590461393|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
163481594|NCT02630459|590461394|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
163481595|NCT02630459|590461395|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
163481596|NCT02630459|590461396|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
163481597|NCT02630459|590461389|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
163481598|NCT02630459|590461390|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
163481599|NCT02630459|590461391|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
163481600|NCT02630459|590461392|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
163481601|NCT02630459|590461393|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
163481602|NCT02630459|590461394|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
163481603|NCT02630459|590461395|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
163481604|NCT02630459|590461396|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
163481605|NCT02630459|590461389|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
163481606|NCT02630459|590461390|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
163481607|NCT02630459|590461391|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
163481608|NCT02630459|590461392|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
163481609|NCT02630459|590461393|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
163481610|NCT02630459|590461394|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
163481611|NCT02630459|590461395|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
163481612|NCT02630459|590461396|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
163481613|NCT02630459|590461389|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
163481614|NCT02630459|590461390|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
163481615|NCT02630459|590461391|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
163481616|NCT02630459|590461392|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
163481617|NCT02630459|590461393|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
163481618|NCT02630459|590461394|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
163481619|NCT02630459|590461395|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
163481620|NCT02630459|590461396|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
163481621|NCT00846027|590461397|FG000|Overall Study|Death|3|||
163481622|NCT00846027|590461397|FG000|Overall Study|Disease Progression|30|||
163481623|NCT00846027|590461397|FG000|Overall Study|Toxicity|12|||
163481624|NCT00846027|590461397|FG000|Overall Study|Patient Decision|7|||
163481625|NCT00846027|590461397|FG000|Overall Study|Investigator Discretion|29|||
163481626|NCT00846027|590461397|FG000|Overall Study|Protocol Violation|2|||
163481627|NCT00846027|590461397|FG000|Overall Study|Subject Not Treated|7|||
163481628|NCT04905563|590461400|FG000|Overall Study|Withdrawal by Subject|1|||
163481629|NCT04905563|590461401|FG001|Overall Study|Withdrawal by Subject|0|||
163481630|NCT04905563|590461400|FG000|Overall Study|Standard of care orders entered by resident|1|||
163481631|NCT04905563|590461401|FG001|Overall Study|Standard of care orders entered by resident|0|||
163481632|NCT04905563|590461400|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
163481633|NCT04905563|590461401|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
163481634|NCT04905563|590461400|FG000|Overall Study|Withdrawal by Subject|0|||
163481635|NCT04905563|590461401|FG001|Overall Study|Withdrawal by Subject|1|||
163481636|NCT01797302|590461402|FG000|Overall Study|Lost to Follow-up|16|||
163481637|NCT01797302|590461403|FG001|Overall Study|Lost to Follow-up|23|||
163481638|NCT01797302|590461404|FG002|Overall Study|Lost to Follow-up|22|||
163481639|NCT01797302|590461402|FG000|Overall Study|Withdrawal by Subject|1|||
163481640|NCT01797302|590461403|FG001|Overall Study|Withdrawal by Subject|3|||
163481641|NCT01797302|590461404|FG002|Overall Study|Withdrawal by Subject|4|||
163481642|NCT02418000|590461405|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
163481643|NCT02418000|590461406|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
163481644|NCT02418000|590461407|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
163481645|NCT02418000|590461408|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
163481646|NCT02418000|590461409|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
163481647|NCT02418000|590461405|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
163481648|NCT02418000|590461406|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
163481649|NCT02418000|590461407|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
163481650|NCT02418000|590461408|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
163481651|NCT02418000|590461409|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
163481652|NCT02418000|590461405|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
163481653|NCT02418000|590461406|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
163481654|NCT02418000|590461407|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
163481655|NCT02418000|590461408|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
163481656|NCT02418000|590461409|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
163481657|NCT02418000|590461405|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
163481658|NCT02418000|590461406|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
163481659|NCT02418000|590461407|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
163481660|NCT02418000|590461408|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
163481661|NCT02418000|590461409|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
163481662|NCT02418000|590461405|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
163481663|NCT02418000|590461406|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
163481664|NCT02418000|590461407|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
163481665|NCT02418000|590461408|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
163481666|NCT02418000|590461409|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
163481667|NCT02418000|590461405|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
163481668|NCT02418000|590461406|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
163481669|NCT02418000|590461407|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
163481670|NCT02418000|590461408|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
163481671|NCT02418000|590461409|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
163481672|NCT02418000|590461405|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
163481673|NCT02418000|590461406|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
163481674|NCT02418000|590461407|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
163481675|NCT02418000|590461408|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
163481676|NCT02418000|590461409|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
163481677|NCT02418000|590461405|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
163481678|NCT02418000|590461406|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
163481679|NCT02418000|590461407|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
163481680|NCT02418000|590461408|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
163481681|NCT02418000|590461409|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
163481682|NCT02418000|590461405|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
163481683|NCT02418000|590461406|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
163481684|NCT02418000|590461407|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
163481685|NCT02418000|590461408|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
163481686|NCT02418000|590461409|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
163481687|NCT00490815|590461410|FG000|Overall Study|Adverse Event|2|||
163481688|NCT00490815|590461411|FG001|Overall Study|Adverse Event|3|||
163481689|NCT00490815|590461410|FG000|Overall Study|Withdrawal by Subject|4|||
163481690|NCT00490815|590461411|FG001|Overall Study|Withdrawal by Subject|0|||
163481691|NCT00490815|590461410|FG000|Overall Study|Lost to Follow-up|1|||
163481692|NCT00490815|590461411|FG001|Overall Study|Lost to Follow-up|3|||
163481693|NCT00490815|590461410|FG000|Overall Study|Death|1|||
163481694|NCT00490815|590461411|FG001|Overall Study|Death|3|||
163481695|NCT01904760|590461412|FG000|Overall Study|Protocol Violation|1|||
163481696|NCT01904760|590461413|FG001|Overall Study|Protocol Violation|0|||
163481697|NCT04249076|590461415|FG000|Overall Study|Adverse Event|1|||
163481698|NCT04249076|590461416|FG001|Overall Study|Adverse Event|1|||
163481699|NCT04249076|590461415|FG000|Overall Study|Protocol Violation|1|||
163481700|NCT04249076|590461416|FG001|Overall Study|Protocol Violation|2|||
163481701|NCT04249076|590461415|FG000|Overall Study|Lack of Efficacy|0|||
163481702|NCT04249076|590461416|FG001|Overall Study|Lack of Efficacy|1|||
163481703|NCT04249076|590461415|FG000|Overall Study|Withdrawal by Subject|0|||
163481704|NCT04249076|590461416|FG001|Overall Study|Withdrawal by Subject|1|||
163481705|NCT00732199|590461421|FG000|Overall Study|Withdrawal by Subject|25|||
163481706|NCT00732199|590461422|FG001|Overall Study|Withdrawal by Subject|18|||
163481707|NCT00732199|590461421|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
163481708|NCT00732199|590461422|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
163481709|NCT01284127|590461437|FG000|Overall Study|Adverse Event|2|||
163481710|NCT01284127|590461437|FG000|Overall Study|Withdrawal by Subject|4|||
163481711|NCT01284127|590461437|FG000|Overall Study|Physician Decision|1|||
163481712|NCT00994890|590461439|FG000|Overall Study|Adverse Event|13|||
163481713|NCT00994890|590461440|FG001|Overall Study|Adverse Event|9|||
163481714|NCT00994890|590461441|FG002|Overall Study|Adverse Event|11|||
163481715|NCT00994890|590461439|FG000|Overall Study|Lack of Efficacy|0|||
163481716|NCT00994890|590461440|FG001|Overall Study|Lack of Efficacy|0|||
163481717|NCT00994890|590461441|FG002|Overall Study|Lack of Efficacy|1|||
163481718|NCT00994890|590461439|FG000|Overall Study|Lost to Follow-up|6|||
163481719|NCT00994890|590461440|FG001|Overall Study|Lost to Follow-up|1|||
163481720|NCT00994890|590461441|FG002|Overall Study|Lost to Follow-up|3|||
163481721|NCT00994890|590461439|FG000|Overall Study|No longer willing to participate|8|||
163481722|NCT00994890|590461440|FG001|Overall Study|No longer willing to participate|5|||
163481723|NCT00994890|590461441|FG002|Overall Study|No longer willing to participate|13|||
163481724|NCT00994890|590461439|FG000|Overall Study|Protocol Violation|2|||
163481725|NCT00994890|590461440|FG001|Overall Study|Protocol Violation|4|||
163481726|NCT00994890|590461441|FG002|Overall Study|Protocol Violation|0|||
163481727|NCT00994890|590461439|FG000|Overall Study|Study terminated by sponsor|199|||
163481728|NCT00994890|590461440|FG001|Overall Study|Study terminated by sponsor|201|||
163481729|NCT00994890|590461441|FG002|Overall Study|Study terminated by sponsor|197|||
163481730|NCT00994890|590461439|FG000|Overall Study|Randomized, but not treated|1|||
163481731|NCT00994890|590461440|FG001|Overall Study|Randomized, but not treated|0|||
163481732|NCT00994890|590461441|FG002|Overall Study|Randomized, but not treated|0|||
163481733|NCT00994890|590461439|FG000|Overall Study|Other|2|||
163481734|NCT00994890|590461440|FG001|Overall Study|Other|2|||
163481735|NCT00994890|590461441|FG002|Overall Study|Other|1|||
163481736|NCT00699582|590461442|FG000|Overall Study|Adverse Event|4|||
163481737|NCT00699582|590461443|FG001|Overall Study|Adverse Event|11|||
163481738|NCT00699582|590461444|FG002|Overall Study|Adverse Event|23|||
163481739|NCT00699582|590461442|FG000|Overall Study|Withdrawal by Subject|6|||
163481740|NCT00699582|590461443|FG001|Overall Study|Withdrawal by Subject|7|||
163481741|NCT00699582|590461444|FG002|Overall Study|Withdrawal by Subject|4|||
163481742|NCT00699582|590461442|FG000|Overall Study|Lack of Efficacy|1|||
163481743|NCT00699582|590461443|FG001|Overall Study|Lack of Efficacy|0|||
163481744|NCT00699582|590461444|FG002|Overall Study|Lack of Efficacy|1|||
163481745|NCT00699582|590461442|FG000|Overall Study|Progressive Disease|1|||
163481746|NCT00699582|590461443|FG001|Overall Study|Progressive Disease|0|||
163481747|NCT00699582|590461444|FG002|Overall Study|Progressive Disease|0|||
163481748|NCT00699582|590461442|FG000|Overall Study|Administrative/Other|4|||
163481749|NCT00699582|590461443|FG001|Overall Study|Administrative/Other|3|||
163481750|NCT00699582|590461444|FG002|Overall Study|Administrative/Other|0|||
163481751|NCT00699582|590461442|FG000|Overall Study|Randomized, Not Treated|2|||
163481752|NCT00699582|590461443|FG001|Overall Study|Randomized, Not Treated|1|||
163481753|NCT00699582|590461444|FG002|Overall Study|Randomized, Not Treated|0|||
163481754|NCT01849289|590461445|FG000|Overall Study|Adverse Event|3|||
163481755|NCT01849289|590461446|FG001|Overall Study|Adverse Event|3|||
163481756|NCT01849289|590461445|FG000|Overall Study|Protocol Violation|3|||
163481757|NCT01849289|590461446|FG001|Overall Study|Protocol Violation|3|||
163481758|NCT01849289|590461445|FG000|Overall Study|Withdrawal criteria|1|||
163481759|NCT01849289|590461446|FG001|Overall Study|Withdrawal criteria|0|||
163481760|NCT01849289|590461445|FG000|Overall Study|Unclassified|25|||
163481761|NCT01849289|590461446|FG001|Overall Study|Unclassified|18|||
163481762|NCT02692560|590461450|FG000|Overall Study|Withdrawal by Subject|0|||
163481763|NCT02692560|590461451|FG001|Overall Study|Withdrawal by Subject|6|||
163481764|NCT00715949|590461455|FG000|Overall Study|could not finish first test|4|||
163481765|NCT01326910|590461456|FG000|Overall Study|Withdrawal by Subject|3|||
163481766|NCT01326910|590461457|FG001|Overall Study|Withdrawal by Subject|2|||
163481767|NCT01326910|590461456|FG000|Overall Study|Protocol Violation|1|||
163481768|NCT01326910|590461457|FG001|Overall Study|Protocol Violation|1|||
163481769|NCT02274766|590461460|FG000|Overall Study|Withdrawal by Subject|3|||
163481770|NCT02274766|590461461|FG001|Overall Study|Withdrawal by Subject|6|||
163481771|NCT02274766|590461460|FG000|Overall Study|Did Not Receive Study Drug|1|||
163481772|NCT02274766|590461461|FG001|Overall Study|Did Not Receive Study Drug|1|||
163481773|NCT02274766|590461460|FG000|Overall Study|Subject Unwilling to Proceed|0|||
163481774|NCT02274766|590461461|FG001|Overall Study|Subject Unwilling to Proceed|1|||
163481775|NCT02274766|590461460|FG000|Overall Study|Adverse Event|0|||
163481776|NCT02274766|590461461|FG001|Overall Study|Adverse Event|1|||
163481777|NCT00806494|590461472|FG000|Overall Study|Adverse Event|29|||
163481778|NCT00806494|590461472|FG000|Overall Study|Lack of Efficacy|6|||
163481779|NCT00806494|590461472|FG000|Overall Study|Lost to Follow-up|10|||
163481780|NCT00806494|590461472|FG000|Overall Study|Other|30|||
163481781|NCT00806494|590461472|FG000|Overall Study|Withdrawal by Subject|5|||
163481782|NCT02417935|590461473|FG000|Treatment Period|Adverse Event|12|||
163481783|NCT02417935|590461474|FG001|Treatment Period|Adverse Event|10|||
163481784|NCT02417935|590461473|FG000|Treatment Period|Lost to Follow-up|1|||
163481785|NCT02417935|590461474|FG001|Treatment Period|Lost to Follow-up|0|||
163481786|NCT02417935|590461473|FG000|Treatment Period|Entry Criteria not met|0|||
163481787|NCT02417935|590461474|FG001|Treatment Period|Entry Criteria not met|1|||
163481788|NCT02417935|590461473|FG000|Treatment Period|Protocol Violation|2|||
163481789|NCT02417935|590461474|FG001|Treatment Period|Protocol Violation|1|||
163481790|NCT02417935|590461473|FG000|Treatment Period|Withdrawal by Subject|3|||
163481791|NCT02417935|590461474|FG001|Treatment Period|Withdrawal by Subject|3|||
163481792|NCT02417935|590461473|FG000|Treatment Period|Physician Decision|3|||
163481793|NCT02417935|590461474|FG001|Treatment Period|Physician Decision|1|||
163481794|NCT00962780|590461478|FG000|Overall Study|Death|0|||
163481795|NCT00962780|590461479|FG001|Overall Study|Death|1|||
163481796|NCT00962780|590461478|FG000|Overall Study|Protocol Violation|9|||
163481797|NCT00962780|590461479|FG001|Overall Study|Protocol Violation|4|||
163481798|NCT00962780|590461478|FG000|Overall Study|Withdrawal by Subject|1|||
163481799|NCT00962780|590461479|FG001|Overall Study|Withdrawal by Subject|8|||
163481800|NCT00962780|590461478|FG000|Overall Study|Other|0|||
163481801|NCT00962780|590461479|FG001|Overall Study|Other|1|||
163481802|NCT02363322|590461480|FG000|Overall Study|Lost to Follow-up|1|||
163481803|NCT02363322|590461481|FG001|Overall Study|Lost to Follow-up|0|||
163481804|NCT01775995|590461482|FG000|Overall Study|Lost to Follow-up|1|||
163481805|NCT01775995|590461483|FG001|Overall Study|Lost to Follow-up|1|||
163481806|NCT02909504|590461484|FG000|Overall Study|Adverse Event|2|||
163481807|NCT02909504|590461484|FG000|Overall Study|Lack of Efficacy|3|||
163481808|NCT02909504|590461484|FG000|Overall Study|Withdrawal by Subject|4|||
163481809|NCT02909504|590461484|FG000|Overall Study|Pregnancy|1|||
163481810|NCT02909504|590461484|FG000|Overall Study|Subject moved|1|||
163481811|NCT02909504|590461484|FG000|Overall Study|Lost to Follow-up|1|||
163481812|NCT02055976|590461485|FG000|Overall Study|Other|0|||
163481813|NCT02055976|590461486|FG001|Overall Study|Other|0|||
163481814|NCT02055976|590461487|FG002|Overall Study|Other|1|||
163481815|NCT02055976|590461488|FG003|Overall Study|Other|0|||
163481816|NCT02055976|590461489|FG004|Overall Study|Other|0|||
163481817|NCT02055976|590461490|FG005|Overall Study|Other|0|||
163481818|NCT02055976|590461491|FG006|Overall Study|Other|0|||
163481819|NCT02055976|590461492|FG007|Overall Study|Other|0|||
163481820|NCT02055976|590461493|FG008|Overall Study|Other|0|||
163481821|NCT02055976|590461485|FG000|Overall Study|Adverse Event|0|||
163481822|NCT02055976|590461486|FG001|Overall Study|Adverse Event|0|||
163481823|NCT02055976|590461487|FG002|Overall Study|Adverse Event|0|||
163481824|NCT02055976|590461488|FG003|Overall Study|Adverse Event|0|||
163481825|NCT02055976|590461489|FG004|Overall Study|Adverse Event|0|||
163481826|NCT02055976|590461490|FG005|Overall Study|Adverse Event|1|||
163481827|NCT02055976|590461491|FG006|Overall Study|Adverse Event|1|||
163481828|NCT02055976|590461492|FG007|Overall Study|Adverse Event|0|||
163481829|NCT02055976|590461493|FG008|Overall Study|Adverse Event|0|||
163481830|NCT02055976|590461485|FG000|Overall Study|Does not meet entrance criteria|0|||
163481831|NCT02055976|590461486|FG001|Overall Study|Does not meet entrance criteria|0|||
163481832|NCT02055976|590461487|FG002|Overall Study|Does not meet entrance criteria|0|||
163481833|NCT02055976|590461488|FG003|Overall Study|Does not meet entrance criteria|0|||
163481834|NCT02055976|590461489|FG004|Overall Study|Does not meet entrance criteria|0|||
163481835|NCT02055976|590461490|FG005|Overall Study|Does not meet entrance criteria|0|||
163481836|NCT02055976|590461491|FG006|Overall Study|Does not meet entrance criteria|1|||
163481837|NCT02055976|590461492|FG007|Overall Study|Does not meet entrance criteria|0|||
163481838|NCT02055976|590461493|FG008|Overall Study|Does not meet entrance criteria|0|||
163481839|NCT02055976|590461485|FG000|Overall Study|Lost to Follow-up|0|||
163481840|NCT02055976|590461486|FG001|Overall Study|Lost to Follow-up|0|||
163481841|NCT02055976|590461487|FG002|Overall Study|Lost to Follow-up|0|||
163481842|NCT02055976|590461488|FG003|Overall Study|Lost to Follow-up|1|||
163481843|NCT02055976|590461489|FG004|Overall Study|Lost to Follow-up|0|||
163481844|NCT02055976|590461490|FG005|Overall Study|Lost to Follow-up|0|||
163481845|NCT02055976|590461491|FG006|Overall Study|Lost to Follow-up|0|||
163481846|NCT02055976|590461492|FG007|Overall Study|Lost to Follow-up|0|||
163481847|NCT02055976|590461493|FG008|Overall Study|Lost to Follow-up|0|||
163481848|NCT02504424|590461494|FG000|Overall Study|Withdrawal by Subject|2|||
163481849|NCT05604781|590463088|FG000|Overall Study|Lost to Follow-up|3|||
163481850|NCT05604781|590463088|FG000|Overall Study|Adverse Event|1|||
163481851|NCT03922945|590463102|FG000|Overall Study|Adverse Event|1|||
163481852|NCT03922945|590463103|FG001|Overall Study|Adverse Event|1|||
163481853|NCT03922945|590463104|FG002|Overall Study|Adverse Event|2|||
163481854|NCT03922945|590463102|FG000|Overall Study|Lost to Follow-up|13|||
163481855|NCT03922945|590463103|FG001|Overall Study|Lost to Follow-up|9|||
163481856|NCT03922945|590463104|FG002|Overall Study|Lost to Follow-up|20|||
163481857|NCT03922945|590463102|FG000|Overall Study|Lack of Efficacy|2|||
163481858|NCT03922945|590463103|FG001|Overall Study|Lack of Efficacy|0|||
163481859|NCT03922945|590463104|FG002|Overall Study|Lack of Efficacy|1|||
163481860|NCT03922945|590463102|FG000|Overall Study|Protocol Non-Compliance|0|||
163481861|NCT03922945|590463103|FG001|Overall Study|Protocol Non-Compliance|0|||
163481862|NCT03922945|590463104|FG002|Overall Study|Protocol Non-Compliance|1|||
163481863|NCT03922945|590463102|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
163481864|NCT03922945|590463103|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
163481865|NCT03922945|590463104|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
163481866|NCT03922945|590463102|FG000|Overall Study|All Other Personal Reasons|1|||
163481867|NCT03922945|590463103|FG001|Overall Study|All Other Personal Reasons|1|||
163481868|NCT03922945|590463104|FG002|Overall Study|All Other Personal Reasons|2|||
163481869|NCT00313716|590463105|FG000|Overall Study|Death|3|||
163481870|NCT00313716|590463106|FG001|Overall Study|Death|2|||
163481871|NCT00313716|590463107|FG002|Overall Study|Death|9|||
163481872|NCT00313716|590463108|FG003|Overall Study|Death|3|||
163481873|NCT00313716|590463109|FG004|Overall Study|Death|5|||
163481874|NCT00313716|590463110|FG005|Overall Study|Death|9|||
163481875|NCT00313716|590463105|FG000|Overall Study|Lost to Follow-up|2|||
163481876|NCT00313716|590463106|FG001|Overall Study|Lost to Follow-up|5|||
163481877|NCT00313716|590463107|FG002|Overall Study|Lost to Follow-up|2|||
163481878|NCT00313716|590463108|FG003|Overall Study|Lost to Follow-up|1|||
163481879|NCT00313716|590463109|FG004|Overall Study|Lost to Follow-up|0|||
163481880|NCT00313716|590463110|FG005|Overall Study|Lost to Follow-up|4|||
163481881|NCT00313716|590463105|FG000|Overall Study|Withdrawal by Subject|0|||
163481882|NCT00313716|590463106|FG001|Overall Study|Withdrawal by Subject|1|||
163481883|NCT00313716|590463107|FG002|Overall Study|Withdrawal by Subject|1|||
163481884|NCT00313716|590463108|FG003|Overall Study|Withdrawal by Subject|0|||
163481885|NCT00313716|590463109|FG004|Overall Study|Withdrawal by Subject|1|||
163481886|NCT00313716|590463110|FG005|Overall Study|Withdrawal by Subject|0|||
163481887|NCT02927990|590463119|FG000|Overall Study|Protocol Violation|4|||
163481888|NCT02927990|590463119|FG000|Overall Study|Physician Decision|9|||
163481889|NCT02927990|590463119|FG000|Overall Study|Room switched and therefore no study device available|15|||
163481890|NCT02927990|590463119|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
163481891|NCT00960323|590463120|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
163481892|NCT01524900|590463130|FG000|Overall Study|Lost to Follow-up|3|||
163481893|NCT01524900|590463131|FG001|Overall Study|Lost to Follow-up|12|||
163481894|NCT01524900|590463132|FG002|Overall Study|Lost to Follow-up|1|||
163481895|NCT01524900|590463133|FG003|Overall Study|Lost to Follow-up|0|||
163481896|NCT01524900|590463134|FG004|Overall Study|Lost to Follow-up|0|||
163481897|NCT01524900|590463130|FG000|Overall Study|Other reason than stated above|1|||
163481898|NCT01524900|590463131|FG001|Overall Study|Other reason than stated above|1|||
163481899|NCT01524900|590463132|FG002|Overall Study|Other reason than stated above|0|||
163481900|NCT01524900|590463133|FG003|Overall Study|Other reason than stated above|0|||
163481901|NCT01524900|590463134|FG004|Overall Study|Other reason than stated above|0|||
163481902|NCT01524900|590463130|FG000|Overall Study|No reason documented|2|||
163481903|NCT01524900|590463131|FG001|Overall Study|No reason documented|1|||
163481904|NCT01524900|590463132|FG002|Overall Study|No reason documented|0|||
163481905|NCT01524900|590463133|FG003|Overall Study|No reason documented|1|||
163481906|NCT01524900|590463134|FG004|Overall Study|No reason documented|0|||
163481907|NCT00959192|590463135|FG000|Overall Study|Adverse Event|1|||
163481908|NCT00959192|590463136|FG001|Overall Study|Adverse Event|1|||
163481909|NCT00959192|590463137|FG002|Overall Study|Adverse Event|1|||
163481910|NCT00959192|590463138|FG003|Overall Study|Adverse Event|0|||
163481911|NCT00959192|590463135|FG000|Overall Study|Investigator Request|1|||
163481912|NCT00959192|590463136|FG001|Overall Study|Investigator Request|0|||
163481913|NCT00959192|590463137|FG002|Overall Study|Investigator Request|0|||
163481914|NCT00959192|590463138|FG003|Overall Study|Investigator Request|0|||
163481915|NCT00959192|590463135|FG000|Overall Study|Caregiver Request|0|||
163481916|NCT00959192|590463136|FG001|Overall Study|Caregiver Request|0|||
163481917|NCT00959192|590463137|FG002|Overall Study|Caregiver Request|2|||
163481918|NCT00959192|590463138|FG003|Overall Study|Caregiver Request|1|||
163481919|NCT00772031|590463139|FG000|Overall Study|Early termination of trial|12|||
163481920|NCT00772031|590463140|FG001|Overall Study|Early termination of trial|10|||
163481921|NCT00772031|590463139|FG000|Overall Study|Lost to Follow-up|20|||
163481922|NCT00772031|590463140|FG001|Overall Study|Lost to Follow-up|33|||
163481923|NCT00532441|590463141|FG000|Overall Study|Death|1|||
163481924|NCT00532441|590463142|FG001|Overall Study|Death|0|||
163481925|NCT01603615|590463143|FG000|Overall Study|Did not Receive Treatment|7|||
163481926|NCT01603615|590463143|FG000|Overall Study|Lost to Follow-up|9|||
163481927|NCT01603615|590463143|FG000|Overall Study|Personal Reasons|17|||
163481928|NCT01603615|590463143|FG000|Overall Study|Other Miscellaneous|1|||
163481929|NCT00303329|590463146|FG000|Overall Study|Adverse Event|7|||
163481930|NCT00303329|590463147|FG001|Overall Study|Adverse Event|14|||
163481931|NCT00303329|590463146|FG000|Overall Study|Abnormal Laboratory Values|0|||
163481932|NCT00303329|590463147|FG001|Overall Study|Abnormal Laboratory Values|1|||
163481933|NCT00303329|590463146|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
163481934|NCT00303329|590463147|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163481935|NCT00303329|590463146|FG000|Overall Study|Condition no longer requires study drug|0|||
163481936|NCT00303329|590463147|FG001|Overall Study|Condition no longer requires study drug|8|||
163481937|NCT00303329|590463146|FG000|Overall Study|Protocol Violation|3|||
163481938|NCT00303329|590463147|FG001|Overall Study|Protocol Violation|0|||
163481939|NCT00303329|590463146|FG000|Overall Study|Withdrawal by Subject|9|||
163481940|NCT00303329|590463147|FG001|Overall Study|Withdrawal by Subject|15|||
163481941|NCT00303329|590463146|FG000|Overall Study|Lost to Follow-up|0|||
163481942|NCT00303329|590463147|FG001|Overall Study|Lost to Follow-up|1|||
163481943|NCT00303329|590463146|FG000|Overall Study|Administrative problems|1|||
163481944|NCT00303329|590463147|FG001|Overall Study|Administrative problems|0|||
163481945|NCT00303329|590463146|FG000|Overall Study|Death|2|||
163481946|NCT00303329|590463147|FG001|Overall Study|Death|12|||
163481947|NCT00303329|590463146|FG000|Overall Study|Stopped at end of core|3|||
163481948|NCT00303329|590463147|FG001|Overall Study|Stopped at end of core|9|||
163481949|NCT00303329|590463146|FG000|Overall Study|Stopped at end of extension 1|1|||
163481950|NCT00303329|590463147|FG001|Overall Study|Stopped at end of extension 1|0|||
163481951|NCT01101321|590463152|FG000|Period 1|Withdrawal by Subject|1|||
163481952|NCT01101321|590463153|FG001|Period 1|Withdrawal by Subject|1|||
163481953|NCT01101321|590463152|FG000|Period 1|Adverse Event|3|||
163481954|NCT01101321|590463153|FG001|Period 1|Adverse Event|3|||
163481955|NCT00542321|590463154|FG000|Overall Study|Death|0|||
163481956|NCT00542321|590463155|FG001|Overall Study|Death|1|||
163481957|NCT00525499|590463158|FG000|Overall Study|Lost to Follow-up|2|||
163481958|NCT00525499|590463159|FG001|Overall Study|Lost to Follow-up|4|||
163481959|NCT00525499|590463160|FG002|Overall Study|Lost to Follow-up|1|||
163481960|NCT00525499|590463161|FG003|Overall Study|Lost to Follow-up|4|||
163481961|NCT00525499|590463158|FG000|Overall Study|Adverse Event|0|||
163481962|NCT00525499|590463159|FG001|Overall Study|Adverse Event|1|||
163481963|NCT00525499|590463160|FG002|Overall Study|Adverse Event|0|||
163481964|NCT00525499|590463161|FG003|Overall Study|Adverse Event|1|||
163481965|NCT00525499|590463158|FG000|Overall Study|Withdrawal by Subject|5|||
163481966|NCT00525499|590463159|FG001|Overall Study|Withdrawal by Subject|1|||
163481967|NCT00525499|590463160|FG002|Overall Study|Withdrawal by Subject|5|||
163481968|NCT00525499|590463161|FG003|Overall Study|Withdrawal by Subject|2|||
163481969|NCT00525499|590463158|FG000|Overall Study|Protocol Violation|0|||
163481970|NCT00525499|590463159|FG001|Overall Study|Protocol Violation|1|||
163481971|NCT00525499|590463160|FG002|Overall Study|Protocol Violation|1|||
163481972|NCT00525499|590463161|FG003|Overall Study|Protocol Violation|0|||
163481973|NCT03339999|590463162|FG000|Overall Study|Adverse Event|1|||
163481974|NCT03339999|590463163|FG001|Overall Study|Adverse Event|2|||
163481975|NCT03339999|590463164|FG002|Overall Study|Adverse Event|2|||
163481976|NCT03339999|590463165|FG003|Overall Study|Adverse Event|1|||
163481977|NCT03339999|590463162|FG000|Overall Study|Lack of Efficacy|0|||
163481978|NCT03339999|590463163|FG001|Overall Study|Lack of Efficacy|1|||
163481979|NCT03339999|590463164|FG002|Overall Study|Lack of Efficacy|0|||
163481980|NCT03339999|590463165|FG003|Overall Study|Lack of Efficacy|0|||
163481981|NCT03339999|590463162|FG000|Overall Study|Lost to Follow-up|0|||
163481982|NCT03339999|590463163|FG001|Overall Study|Lost to Follow-up|0|||
163481983|NCT03339999|590463164|FG002|Overall Study|Lost to Follow-up|0|||
163481984|NCT03339999|590463165|FG003|Overall Study|Lost to Follow-up|1|||
163481985|NCT03339999|590463162|FG000|Overall Study|Study Terminated by Sponsor|6|||
163481986|NCT03339999|590463163|FG001|Overall Study|Study Terminated by Sponsor|3|||
163481987|NCT03339999|590463164|FG002|Overall Study|Study Terminated by Sponsor|4|||
163481988|NCT03339999|590463165|FG003|Overall Study|Study Terminated by Sponsor|3|||
163481989|NCT01856920|590463168|FG000|Overall Study|Disease Progression On Study|3|||
163481990|NCT01856920|590463169|FG001|Overall Study|Disease Progression On Study|4|||
163481991|NCT01856920|590463168|FG000|Overall Study|Disease Progression before Treatment|1|||
163481992|NCT01856920|590463169|FG001|Overall Study|Disease Progression before Treatment|0|||
163481993|NCT01856920|590463168|FG000|Overall Study|Ineligible|0|||
163481994|NCT01856920|590463169|FG001|Overall Study|Ineligible|1|||
163481995|NCT01856920|590463168|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
163481996|NCT01856920|590463169|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
163481997|NCT01856920|590463168|FG000|Overall Study|Refused further Treatment|5|||
163481998|NCT01856920|590463169|FG001|Overall Study|Refused further Treatment|1|||
163481999|NCT01856920|590463168|FG000|Overall Study|Other Reasons|0|||
163482000|NCT01856920|590463169|FG001|Overall Study|Other Reasons|1|||
163482001|NCT01856920|590463168|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
163482002|NCT01856920|590463169|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
163482003|NCT03287089|590463175|FG000|Overall Study|Lost to Follow-up|0|||
163482004|NCT03287089|590463176|FG001|Overall Study|Lost to Follow-up|2|||
163482005|NCT03287089|590463175|FG000|Overall Study|Physician Decision|0|||
163482006|NCT03287089|590463176|FG001|Overall Study|Physician Decision|2|||
163482007|NCT03287089|590463175|FG000|Overall Study|Withdrawal by Subject|0|||
163482008|NCT03287089|590463176|FG001|Overall Study|Withdrawal by Subject|2|||
163482009|NCT00783263|590463177|FG000|Overall Study|Adverse Event|3|||
163482010|NCT00783263|590463178|FG001|Overall Study|Adverse Event|0|||
163482011|NCT00783263|590463179|FG002|Overall Study|Adverse Event|2|||
163482012|NCT00783263|590463180|FG003|Overall Study|Adverse Event|1|||
163482013|NCT00783263|590463177|FG000|Overall Study|Lost to Follow-up|1|||
163482014|NCT00783263|590463178|FG001|Overall Study|Lost to Follow-up|1|||
163482015|NCT00783263|590463179|FG002|Overall Study|Lost to Follow-up|0|||
163482016|NCT00783263|590463180|FG003|Overall Study|Lost to Follow-up|0|||
163482017|NCT00783263|590463177|FG000|Overall Study|Withdrawal by Subject|0|||
163482018|NCT00783263|590463178|FG001|Overall Study|Withdrawal by Subject|1|||
163482019|NCT00783263|590463179|FG002|Overall Study|Withdrawal by Subject|1|||
163482020|NCT00783263|590463180|FG003|Overall Study|Withdrawal by Subject|2|||
163482021|NCT00106626|590463181|FG000|Overall Study|Adverse Event|5|||
163482022|NCT00106626|590463182|FG001|Overall Study|Adverse Event|4|||
163482023|NCT00106626|590463183|FG002|Overall Study|Adverse Event|3|||
163482024|NCT00106626|590463184|FG003|Overall Study|Adverse Event|3|||
163482025|NCT00106626|590463181|FG000|Overall Study|Progressive Disease|4|||
163482026|NCT00106626|590463182|FG001|Overall Study|Progressive Disease|1|||
163482027|NCT00106626|590463183|FG002|Overall Study|Progressive Disease|9|||
163482028|NCT00106626|590463184|FG003|Overall Study|Progressive Disease|10|||
163482029|NCT00106626|590463181|FG000|Overall Study|Received radiation on new therapy|1|||
163482030|NCT00106626|590463182|FG001|Overall Study|Received radiation on new therapy|0|||
163482031|NCT00106626|590463183|FG002|Overall Study|Received radiation on new therapy|0|||
163482032|NCT00106626|590463184|FG003|Overall Study|Received radiation on new therapy|0|||
163482033|NCT00106626|590463181|FG000|Overall Study|> 14 day delay in therapy start|0|||
163482034|NCT00106626|590463182|FG001|Overall Study|> 14 day delay in therapy start|1|||
163482035|NCT00106626|590463183|FG002|Overall Study|> 14 day delay in therapy start|0|||
163482036|NCT00106626|590463184|FG003|Overall Study|> 14 day delay in therapy start|0|||
163482037|NCT03018028|590463185|FG000|Overall Study|Withdrawal by Subject|3|||
163482038|NCT03018028|590463186|FG001|Overall Study|Withdrawal by Subject|0|||
163482039|NCT03018028|590463187|FG002|Overall Study|Withdrawal by Subject|1|||
163482040|NCT03018028|590463188|FG003|Overall Study|Withdrawal by Subject|2|||
163482041|NCT03018028|590463189|FG004|Overall Study|Withdrawal by Subject|0|||
163482042|NCT02519777|590463190|FG000|Overall Study|Death|1|||
163482043|NCT02519777|590463191|FG001|Overall Study|Death|0|||
163482044|NCT02519777|590463192|FG002|Overall Study|Death|0|||
163482045|NCT02519777|590463190|FG000|Overall Study|Lost to Follow-up|0|||
163482046|NCT02519777|590463191|FG001|Overall Study|Lost to Follow-up|4|||
163482047|NCT02519777|590463192|FG002|Overall Study|Lost to Follow-up|2|||
163482048|NCT02519777|590463190|FG000|Overall Study|Withdrawal by Subject|3|||
163482049|NCT02519777|590463191|FG001|Overall Study|Withdrawal by Subject|1|||
163482050|NCT02519777|590463192|FG002|Overall Study|Withdrawal by Subject|0|||
163482051|NCT02519777|590463190|FG000|Overall Study|Severe Debilitation|1|||
163482052|NCT02519777|590463191|FG001|Overall Study|Severe Debilitation|1|||
163482053|NCT02519777|590463192|FG002|Overall Study|Severe Debilitation|1|||
163482054|NCT02519777|590463190|FG000|Overall Study|Not able to get to clinic|1|||
163482055|NCT02519777|590463191|FG001|Overall Study|Not able to get to clinic|2|||
163482056|NCT02519777|590463192|FG002|Overall Study|Not able to get to clinic|1|||
163482057|NCT00256204|590463196|FG000|Overall Study|Adverse Event|10|||
163482058|NCT00256204|590463197|FG001|Overall Study|Adverse Event|14|||
163482059|NCT00256204|590463198|FG002|Overall Study|Adverse Event|16|||
163482060|NCT00256204|590463199|FG003|Overall Study|Adverse Event|14|||
163482061|NCT00256204|590463196|FG000|Overall Study|Death|0|||
163482062|NCT00256204|590463197|FG001|Overall Study|Death|1|||
163482063|NCT00256204|590463198|FG002|Overall Study|Death|0|||
163482064|NCT00256204|590463199|FG003|Overall Study|Death|0|||
163482065|NCT00256204|590463196|FG000|Overall Study|Lost to Follow-up|1|||
163482066|NCT00256204|590463197|FG001|Overall Study|Lost to Follow-up|1|||
163482067|NCT00256204|590463198|FG002|Overall Study|Lost to Follow-up|1|||
163482068|NCT00256204|590463199|FG003|Overall Study|Lost to Follow-up|2|||
163482069|NCT00256204|590463196|FG000|Overall Study|Protocol Violation|1|||
163482070|NCT00256204|590463197|FG001|Overall Study|Protocol Violation|0|||
163482071|NCT00256204|590463198|FG002|Overall Study|Protocol Violation|2|||
163482072|NCT00256204|590463199|FG003|Overall Study|Protocol Violation|1|||
163482073|NCT00256204|590463196|FG000|Overall Study|Physician Decision|0|||
163482074|NCT00256204|590463197|FG001|Overall Study|Physician Decision|0|||
163482075|NCT00256204|590463198|FG002|Overall Study|Physician Decision|1|||
163482076|NCT00256204|590463199|FG003|Overall Study|Physician Decision|2|||
163482077|NCT00256204|590463196|FG000|Overall Study|Withdrawal by Subject|17|||
163482078|NCT00256204|590463197|FG001|Overall Study|Withdrawal by Subject|6|||
163482079|NCT00256204|590463198|FG002|Overall Study|Withdrawal by Subject|7|||
163482080|NCT00256204|590463199|FG003|Overall Study|Withdrawal by Subject|5|||
163482081|NCT00256204|590463196|FG000|Overall Study|Need for additional prohibited treatment|38|||
163482082|NCT00256204|590463197|FG001|Overall Study|Need for additional prohibited treatment|28|||
163482083|NCT00256204|590463198|FG002|Overall Study|Need for additional prohibited treatment|27|||
163482084|NCT00256204|590463199|FG003|Overall Study|Need for additional prohibited treatment|25|||
163482085|NCT03490734|590463212|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
163482086|NCT03490734|590463213|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
163482087|NCT03490734|590463214|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
163482088|NCT03490734|590463215|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
163482089|NCT03490734|590463212|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
163482090|NCT03490734|590463213|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
163482091|NCT03490734|590463214|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
163482092|NCT03490734|590463215|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
163482093|NCT03490734|590463212|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
163482094|NCT03490734|590463213|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
163482095|NCT03490734|590463214|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
163482096|NCT03490734|590463215|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
163482097|NCT03490734|590463212|FG000|Post-intervention Scan Visit|Adverse Event|2|||
163482098|NCT03490734|590463213|FG001|Post-intervention Scan Visit|Adverse Event|0|||
163482099|NCT03490734|590463214|FG002|Post-intervention Scan Visit|Adverse Event|0|||
163482100|NCT03490734|590463215|FG003|Post-intervention Scan Visit|Adverse Event|0|||
163482101|NCT03490734|590463212|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
163482102|NCT03490734|590463213|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
163482103|NCT03490734|590463214|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
163482104|NCT03490734|590463215|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
163482105|NCT03490734|590463212|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
163482106|NCT03490734|590463213|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
163482107|NCT03490734|590463214|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
163482108|NCT03490734|590463215|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
163482109|NCT04491591|590463221|FG000|Overall Study|Accidently randomized|3|||
163482110|NCT04491591|590463222|FG001|Overall Study|Accidently randomized|1|||
163482111|NCT04491591|590463223|FG002|Overall Study|Accidently randomized|0|||
163482112|NCT04491591|590463221|FG000|Overall Study|Did not complete survey|28|||
163482113|NCT04491591|590463222|FG001|Overall Study|Did not complete survey|20|||
163482114|NCT04491591|590463223|FG002|Overall Study|Did not complete survey|3|||
163482115|NCT04212221|590463226|FG000|Overall Study|Remained on Treatment|0|||
163482116|NCT04212221|590463227|FG001|Overall Study|Remained on Treatment|0|||
163482117|NCT04212221|590463228|FG002|Overall Study|Remained on Treatment|0|||
163482118|NCT04212221|590463229|FG003|Overall Study|Remained on Treatment|1|||
163482119|NCT04212221|590463230|FG004|Overall Study|Remained on Treatment|0|||
163482120|NCT04212221|590463231|FG005|Overall Study|Remained on Treatment|0|||
163482121|NCT04212221|590463232|FG006|Overall Study|Remained on Treatment|3|||
163482122|NCT04212221|590463233|FG007|Overall Study|Remained on Treatment|9|||
163482123|NCT04212221|590463226|FG000|Overall Study|Adverse Event|0|||
163482124|NCT04212221|590463227|FG001|Overall Study|Adverse Event|0|||
163482125|NCT04212221|590463228|FG002|Overall Study|Adverse Event|0|||
163482126|NCT04212221|590463229|FG003|Overall Study|Adverse Event|0|||
163482127|NCT04212221|590463230|FG004|Overall Study|Adverse Event|0|||
163482128|NCT04212221|590463231|FG005|Overall Study|Adverse Event|0|||
163482129|NCT04212221|590463232|FG006|Overall Study|Adverse Event|2|||
163482130|NCT04212221|590463233|FG007|Overall Study|Adverse Event|3|||
163482131|NCT04212221|590463226|FG000|Overall Study|Death|0|||
163482132|NCT04212221|590463227|FG001|Overall Study|Death|0|||
163482133|NCT04212221|590463228|FG002|Overall Study|Death|0|||
163482134|NCT04212221|590463229|FG003|Overall Study|Death|0|||
163482135|NCT04212221|590463230|FG004|Overall Study|Death|0|||
163482136|NCT04212221|590463231|FG005|Overall Study|Death|0|||
163482137|NCT04212221|590463232|FG006|Overall Study|Death|0|||
163482138|NCT04212221|590463233|FG007|Overall Study|Death|2|||
163482139|NCT04212221|590463226|FG000|Overall Study|Disease progression according to irRECIST|1|||
163482140|NCT04212221|590463227|FG001|Overall Study|Disease progression according to irRECIST|2|||
163482141|NCT04212221|590463228|FG002|Overall Study|Disease progression according to irRECIST|3|||
163482142|NCT04212221|590463229|FG003|Overall Study|Disease progression according to irRECIST|3|||
163482143|NCT04212221|590463230|FG004|Overall Study|Disease progression according to irRECIST|2|||
163482144|NCT04212221|590463231|FG005|Overall Study|Disease progression according to irRECIST|2|||
163482145|NCT04212221|590463232|FG006|Overall Study|Disease progression according to irRECIST|21|||
163482146|NCT04212221|590463233|FG007|Overall Study|Disease progression according to irRECIST|17|||
163482147|NCT04212221|590463226|FG000|Overall Study|Global Deterioration of Health Status|0|||
163482148|NCT04212221|590463227|FG001|Overall Study|Global Deterioration of Health Status|0|||
163482149|NCT04212221|590463228|FG002|Overall Study|Global Deterioration of Health Status|0|||
163482150|NCT04212221|590463229|FG003|Overall Study|Global Deterioration of Health Status|0|||
163482151|NCT04212221|590463230|FG004|Overall Study|Global Deterioration of Health Status|0|||
163482152|NCT04212221|590463231|FG005|Overall Study|Global Deterioration of Health Status|0|||
163482153|NCT04212221|590463232|FG006|Overall Study|Global Deterioration of Health Status|0|||
163482154|NCT04212221|590463233|FG007|Overall Study|Global Deterioration of Health Status|2|||
163482155|NCT04212221|590463226|FG000|Overall Study|Investigator's Decision|0|||
163482156|NCT04212221|590463227|FG001|Overall Study|Investigator's Decision|0|||
163482157|NCT04212221|590463228|FG002|Overall Study|Investigator's Decision|0|||
163482158|NCT04212221|590463229|FG003|Overall Study|Investigator's Decision|1|||
163482159|NCT04212221|590463230|FG004|Overall Study|Investigator's Decision|0|||
163482160|NCT04212221|590463231|FG005|Overall Study|Investigator's Decision|0|||
163482161|NCT04212221|590463232|FG006|Overall Study|Investigator's Decision|3|||
163482162|NCT04212221|590463233|FG007|Overall Study|Investigator's Decision|0|||
163482163|NCT04212221|590463226|FG000|Overall Study|Participant refused to continue treatment|0|||
163482164|NCT04212221|590463227|FG001|Overall Study|Participant refused to continue treatment|1|||
163482165|NCT04212221|590463228|FG002|Overall Study|Participant refused to continue treatment|0|||
163482166|NCT04212221|590463229|FG003|Overall Study|Participant refused to continue treatment|1|||
163482167|NCT04212221|590463230|FG004|Overall Study|Participant refused to continue treatment|1|||
163482168|NCT04212221|590463231|FG005|Overall Study|Participant refused to continue treatment|2|||
163482169|NCT04212221|590463232|FG006|Overall Study|Participant refused to continue treatment|4|||
163482170|NCT04212221|590463233|FG007|Overall Study|Participant refused to continue treatment|2|||
163482171|NCT04212221|590463226|FG000|Overall Study|Protocol Violation|0|||
163482172|NCT04212221|590463227|FG001|Overall Study|Protocol Violation|0|||
163482173|NCT04212221|590463228|FG002|Overall Study|Protocol Violation|0|||
163482174|NCT04212221|590463229|FG003|Overall Study|Protocol Violation|0|||
163482175|NCT04212221|590463230|FG004|Overall Study|Protocol Violation|0|||
163482176|NCT04212221|590463231|FG005|Overall Study|Protocol Violation|0|||
163482177|NCT04212221|590463232|FG006|Overall Study|Protocol Violation|0|||
163482178|NCT04212221|590463233|FG007|Overall Study|Protocol Violation|1|||
163482179|NCT02850276|590463238|FG000|Overall Study|screen failure|43|||
163482180|NCT02850276|590463238|FG000|Overall Study|Withdrawal by Subject|14|||
163482181|NCT02850276|590463238|FG000|Overall Study|Physician Decision|2|||
163482182|NCT02850276|590463238|FG000|Overall Study|Lost to Follow-up|2|||
163482183|NCT04815291|590463239|FG000|Overall Study|Lost to Follow-up|1|||
163482184|NCT04815291|590463239|FG000|Overall Study|Physician Decision|4|||
163482185|NCT04815291|590463239|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
163482186|NCT02646332|590463243|FG000|Overall Study|Lost to Follow-up|0|||
163482187|NCT02646332|590463244|FG001|Overall Study|Lost to Follow-up|3|||
163482188|NCT01277666|590463248|FG000|Overall Study|Adverse Event|26|||
163482189|NCT01277666|590463249|FG001|Overall Study|Adverse Event|25|||
163482190|NCT01277666|590463250|FG002|Overall Study|Adverse Event|20|||
163482191|NCT01277666|590463248|FG000|Overall Study|Lack of Efficacy|8|||
163482192|NCT01277666|590463249|FG001|Overall Study|Lack of Efficacy|20|||
163482193|NCT01277666|590463250|FG002|Overall Study|Lack of Efficacy|12|||
163482194|NCT01277666|590463248|FG000|Overall Study|Protocol Violation|2|||
163482195|NCT01277666|590463249|FG001|Overall Study|Protocol Violation|3|||
163482196|NCT01277666|590463250|FG002|Overall Study|Protocol Violation|2|||
163482197|NCT01277666|590463248|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
163482198|NCT01277666|590463249|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
163482199|NCT01277666|590463250|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
163482200|NCT01277666|590463248|FG000|Overall Study|Lost to Follow-up|1|||
163482201|NCT01277666|590463249|FG001|Overall Study|Lost to Follow-up|1|||
163482202|NCT01277666|590463250|FG002|Overall Study|Lost to Follow-up|2|||
163482203|NCT01277666|590463248|FG000|Overall Study|Withdrawal by Subject|7|||
163482204|NCT01277666|590463249|FG001|Overall Study|Withdrawal by Subject|8|||
163482205|NCT01277666|590463250|FG002|Overall Study|Withdrawal by Subject|6|||
163482206|NCT01277666|590463248|FG000|Overall Study|Death|0|||
163482207|NCT01277666|590463249|FG001|Overall Study|Death|0|||
163482208|NCT01277666|590463250|FG002|Overall Study|Death|1|||
163482209|NCT01657903|590463252|FG000|Overall Study|Lost to Follow-up|1|||
163482210|NCT01657903|590463252|FG000|Overall Study|Withdrawal by Subject|1|||
163482211|NCT00554840|590463253|FG000|Overall Study|Physician Decision|0|||
163482212|NCT00554840|590463254|FG001|Overall Study|Physician Decision|1|||
163482213|NCT02312934|590463257|FG000|Overall Study|Lost to Follow-up|1|||
163482214|NCT02312934|590463258|FG001|Overall Study|Lost to Follow-up|0|||
163482215|NCT02312934|590463257|FG000|Overall Study|Physician Decision|1|||
163482216|NCT02312934|590463258|FG001|Overall Study|Physician Decision|0|||
163482217|NCT03395704|590463260|FG000|Overall Study|Adverse Event|2|||
163482218|NCT03395704|590463261|FG001|Overall Study|Adverse Event|1|||
163482219|NCT03395704|590463260|FG000|Overall Study|Withdrawal by Subject|2|||
163482220|NCT03395704|590463261|FG001|Overall Study|Withdrawal by Subject|1|||
163482221|NCT03395704|590463260|FG000|Overall Study|Physician Decision|0|||
163482222|NCT03395704|590463261|FG001|Overall Study|Physician Decision|1|||
163482223|NCT04524663|590465228|FG000|Overall Study|Withdrawal by Subject|0|||
163482224|NCT04524663|590465229|FG001|Overall Study|Withdrawal by Subject|2|||
163482225|NCT00911508|590465230|FG000|Overall Study|Lost to Follow-up|27|||
163482226|NCT00911508|590465231|FG001|Overall Study|Lost to Follow-up|18|||
163482227|NCT00911508|590465230|FG000|Overall Study|Withdrawal by Subject|79|||
163482228|NCT00911508|590465231|FG001|Overall Study|Withdrawal by Subject|112|||
163482229|NCT04308668|590465232|FG000|Overall Study|Lost to Follow-up|32|||
163482230|NCT04308668|590465233|FG001|Overall Study|Lost to Follow-up|38|||
163482231|NCT04308668|590465232|FG000|Overall Study|Withdrawal by Subject|4|||
163482232|NCT04308668|590465233|FG001|Overall Study|Withdrawal by Subject|4|||
163482233|NCT01266967|590465234|FG000|Overall Study|Death|69|||
163482234|NCT01266967|590465235|FG001|Overall Study|Death|61|||
163482235|NCT01266967|590465234|FG000|Overall Study|Study Closed/Terminated|15|||
163482236|NCT01266967|590465235|FG001|Overall Study|Study Closed/Terminated|17|||
163482237|NCT01266967|590465234|FG000|Overall Study|Lost to Follow-up|2|||
163482238|NCT01266967|590465235|FG001|Overall Study|Lost to Follow-up|1|||
163482239|NCT01266967|590465234|FG000|Overall Study|Physician Decision|0|||
163482240|NCT01266967|590465235|FG001|Overall Study|Physician Decision|1|||
163482241|NCT01266967|590465234|FG000|Overall Study|Withdrawal by Subject|3|||
163482242|NCT01266967|590465235|FG001|Overall Study|Withdrawal by Subject|3|||
163482243|NCT01519700|590465236|FG000|Overall Study|Death|1|||
163482244|NCT01519700|590465237|FG001|Overall Study|Death|0|||
163482245|NCT01519700|590465238|FG002|Overall Study|Death|0|||
163482246|NCT01519700|590465239|FG003|Overall Study|Death|0|||
163482247|NCT01519700|590465236|FG000|Overall Study|Lost to Follow-up|0|||
163482248|NCT01519700|590465237|FG001|Overall Study|Lost to Follow-up|0|||
163482249|NCT01519700|590465238|FG002|Overall Study|Lost to Follow-up|1|||
163482250|NCT01519700|590465239|FG003|Overall Study|Lost to Follow-up|1|||
163482251|NCT01519700|590465236|FG000|Overall Study|Physician Decision|1|||
163482252|NCT01519700|590465237|FG001|Overall Study|Physician Decision|1|||
163482253|NCT01519700|590465238|FG002|Overall Study|Physician Decision|3|||
163482254|NCT01519700|590465239|FG003|Overall Study|Physician Decision|0|||
163482255|NCT01519700|590465236|FG000|Overall Study|Withdrawal by Subject|5|||
163482256|NCT01519700|590465237|FG001|Overall Study|Withdrawal by Subject|3|||
163482257|NCT01519700|590465238|FG002|Overall Study|Withdrawal by Subject|3|||
163482258|NCT01519700|590465239|FG003|Overall Study|Withdrawal by Subject|2|||
163482259|NCT01519700|590465236|FG000|Overall Study|Other Reason|2|||
163482260|NCT01519700|590465237|FG001|Overall Study|Other Reason|2|||
163482261|NCT01519700|590465238|FG002|Overall Study|Other Reason|0|||
163482262|NCT01519700|590465239|FG003|Overall Study|Other Reason|4|||
163482263|NCT05111548|590465240|FG000|Overall Study|Withdrawal by Subject|2|||
163482264|NCT05111548|590465241|FG001|Overall Study|Withdrawal by Subject|1|||
163482265|NCT05111548|590465240|FG000|Overall Study|Adverse Event|1|||
163482266|NCT05111548|590465241|FG001|Overall Study|Adverse Event|0|||
163482267|NCT00561912|590465248|FG000|Overall Study|ineligible|1|||
163482268|NCT03938857|590465249|FG000|Overall Study|Physician Decision|1|||
163482269|NCT03938857|590465250|FG001|Overall Study|Physician Decision|0|||
163482270|NCT03938857|590465251|FG002|Overall Study|Physician Decision|0|||
163482271|NCT03938857|590465252|FG003|Overall Study|Physician Decision|0|||
163482272|NCT01729559|590465253|FG000|Overall Study|Protocol Violation|31|||
163482273|NCT01729559|590465254|FG001|Overall Study|Protocol Violation|28|||
163482274|NCT02452034|590465259|FG000|Overall Study|Adverse Event|0|||
163482275|NCT02452034|590465260|FG001|Overall Study|Adverse Event|0|||
163482276|NCT02452034|590465261|FG002|Overall Study|Adverse Event|0|||
163482277|NCT02452034|590465262|FG003|Overall Study|Adverse Event|0|||
163482278|NCT02452034|590465263|FG004|Overall Study|Adverse Event|0|||
163482279|NCT02452034|590465264|FG005|Overall Study|Adverse Event|1|||
163482280|NCT02452034|590465259|FG000|Overall Study|Death|0|||
163482281|NCT02452034|590465260|FG001|Overall Study|Death|0|||
163482282|NCT02452034|590465261|FG002|Overall Study|Death|0|||
163482283|NCT02452034|590465262|FG003|Overall Study|Death|0|||
163482284|NCT02452034|590465263|FG004|Overall Study|Death|1|||
163482285|NCT02452034|590465264|FG005|Overall Study|Death|1|||
163482286|NCT02452034|590465259|FG000|Overall Study|Physician Decision|0|||
163482287|NCT02452034|590465260|FG001|Overall Study|Physician Decision|1|||
163482288|NCT02452034|590465261|FG002|Overall Study|Physician Decision|1|||
163482289|NCT02452034|590465262|FG003|Overall Study|Physician Decision|0|||
163482290|NCT02452034|590465263|FG004|Overall Study|Physician Decision|0|||
163482291|NCT02452034|590465264|FG005|Overall Study|Physician Decision|0|||
163482292|NCT02452034|590465259|FG000|Overall Study|Protocol Violation|0|||
163482293|NCT02452034|590465260|FG001|Overall Study|Protocol Violation|0|||
163482294|NCT02452034|590465261|FG002|Overall Study|Protocol Violation|0|||
163482295|NCT02452034|590465262|FG003|Overall Study|Protocol Violation|0|||
163482296|NCT02452034|590465263|FG004|Overall Study|Protocol Violation|0|||
163482297|NCT02452034|590465264|FG005|Overall Study|Protocol Violation|1|||
163482298|NCT02452034|590465259|FG000|Overall Study|Screen Failure|1|||
163482299|NCT02452034|590465260|FG001|Overall Study|Screen Failure|0|||
163482300|NCT02452034|590465261|FG002|Overall Study|Screen Failure|0|||
163482301|NCT02452034|590465262|FG003|Overall Study|Screen Failure|1|||
163482302|NCT02452034|590465263|FG004|Overall Study|Screen Failure|0|||
163482303|NCT02452034|590465264|FG005|Overall Study|Screen Failure|0|||
163482304|NCT02452034|590465259|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
163482305|NCT02452034|590465260|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
163482306|NCT02452034|590465261|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
163482307|NCT02452034|590465262|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
163482308|NCT02452034|590465263|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
163482309|NCT02452034|590465264|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
163482310|NCT01453439|590465269|FG000|Treatment Phase|Withdrawal by Subject|13|||
163482311|NCT01453439|590465270|FG001|Treatment Phase|Withdrawal by Subject|10|||
163482312|NCT01453439|590465269|FG000|Treatment Phase|Suicidal Ideation|2|||
163482313|NCT01453439|590465270|FG001|Treatment Phase|Suicidal Ideation|0|||
163482314|NCT01453439|590465269|FG000|Treatment Phase|Need for higher level of care|1|||
163482315|NCT01453439|590465270|FG001|Treatment Phase|Need for higher level of care|1|||
163482316|NCT01453439|590465269|FG000|Treatment Phase|Therapist conflict of interest|1|||
163482317|NCT01453439|590465270|FG001|Treatment Phase|Therapist conflict of interest|0|||
163482318|NCT01453439|590465269|FG000|Follow-up|Withdrawal by Subject|0|||
163482319|NCT01453439|590465270|FG001|Follow-up|Withdrawal by Subject|1|||
163482320|NCT01453439|590465269|FG000|Follow-up|Lost to Follow-up|5|||
163482321|NCT01453439|590465270|FG001|Follow-up|Lost to Follow-up|10|||
163482322|NCT01014442|590465271|FG000|Overall Study|Adverse Event|0|||
163482323|NCT01014442|590465272|FG001|Overall Study|Adverse Event|8|||
163482324|NCT01014442|590465271|FG000|Overall Study|Withdrawal by Subject|4|||
163482325|NCT01014442|590465272|FG001|Overall Study|Withdrawal by Subject|4|||
163482326|NCT01014442|590465271|FG000|Overall Study|Protocol Violation|2|||
163482327|NCT01014442|590465272|FG001|Overall Study|Protocol Violation|5|||
163482328|NCT01014442|590465271|FG000|Overall Study|Lack of Compliance|0|||
163482329|NCT01014442|590465272|FG001|Overall Study|Lack of Compliance|1|||
163482330|NCT01014442|590465271|FG000|Overall Study|Unspecified Reason|1|||
163482331|NCT01014442|590465272|FG001|Overall Study|Unspecified Reason|1|||
163482332|NCT02074059|590465273|FG000|Overall Study|Death|0|||
163482333|NCT02074059|590465274|FG001|Overall Study|Death|0|||
163482334|NCT02074059|590465275|FG002|Overall Study|Death|0|||
163482335|NCT02074059|590465276|FG003|Overall Study|Death|0|||
163482336|NCT02074059|590465277|FG004|Overall Study|Death|1|||
163482337|NCT02074059|590465278|FG005|Overall Study|Death|1|||
163482338|NCT02242305|590465292|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
163482339|NCT02242305|590465293|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
163482340|NCT02242305|590465292|FG000|Overall Study|Adverse Event|1|||
163482341|NCT02242305|590465293|FG001|Overall Study|Adverse Event|0|||
163482342|NCT02242305|590465292|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
163482343|NCT02242305|590465293|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
163482344|NCT02242305|590465292|FG000|Overall Study|Subject withdraws inform consent|0|||
163482345|NCT02242305|590465293|FG001|Overall Study|Subject withdraws inform consent|4|||
163482346|NCT02242305|590465292|FG000|Overall Study|Lost to Follow-up|2|||
163482347|NCT02242305|590465293|FG001|Overall Study|Lost to Follow-up|0|||
163482348|NCT02543801|590465296|FG000|Overall Study|Protocol Violation|1|||
163482349|NCT02543801|590465297|FG001|Overall Study|Protocol Violation|2|||
163482350|NCT02543801|590465298|FG002|Overall Study|Protocol Violation|0|||
163482351|NCT02543801|590465299|FG003|Overall Study|Protocol Violation|0|||
163482352|NCT01756846|590465300|FG000|Overall Study|Lost to Follow-up|5|||
163482353|NCT01756846|590465301|FG001|Overall Study|Lost to Follow-up|10|||
163482354|NCT01756846|590465300|FG000|Overall Study|Withdrawal by Subject|1|||
163482355|NCT01756846|590465301|FG001|Overall Study|Withdrawal by Subject|2|||
163482356|NCT00352027|590465312|FG000|Overall Study|Progressive disease|3|||
163482357|NCT04118127|590465313|FG000|Overall Study|Trial terminated by sponsor|0|||
163482358|NCT04118127|590465314|FG001|Overall Study|Trial terminated by sponsor|12|||
163482359|NCT04118127|590465313|FG000|Overall Study|Adverse Event|1|||
163482360|NCT04118127|590465314|FG001|Overall Study|Adverse Event|2|||
163482361|NCT04118127|590465313|FG000|Overall Study|Physician Decision|0|||
163482362|NCT04118127|590465314|FG001|Overall Study|Physician Decision|1|||
163482363|NCT04118127|590465313|FG000|Overall Study|Withdrawal by Subject|2|||
163482364|NCT04118127|590465314|FG001|Overall Study|Withdrawal by Subject|1|||
163482365|NCT00636506|590465315|FG000|Overall Study|Lost to Follow-up|8|||
163482366|NCT00636506|590465315|FG000|Overall Study|Explanted|1|||
163482367|NCT00636506|590465315|FG000|Overall Study|Withdrawal by Subject|6|||
163482368|NCT00636506|590465315|FG000|Overall Study|Procedure aborted|1|||
163482369|NCT02607735|590465316|FG000|Primary Study|Randomized but Never Treated|1|||
163482370|NCT02607735|590465317|FG001|Primary Study|Randomized but Never Treated|0|||
163482371|NCT02607735|590465318|FG002|Primary Study|Randomized but Never Treated|0|||
163482372|NCT02607735|590465316|FG000|Primary Study|Lost to Follow-up|4|||
163482373|NCT02607735|590465317|FG001|Primary Study|Lost to Follow-up|0|||
163482374|NCT02607735|590465318|FG002|Primary Study|Lost to Follow-up|0|||
163482375|NCT02607735|590465316|FG000|Primary Study|Withdrew Consent|2|||
163482376|NCT02607735|590465317|FG001|Primary Study|Withdrew Consent|0|||
163482377|NCT02607735|590465318|FG002|Primary Study|Withdrew Consent|0|||
163482378|NCT02607735|590465316|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
163482379|NCT02607735|590465317|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
163482380|NCT02607735|590465318|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
163482381|NCT02607735|590465316|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
163482382|NCT02607735|590465317|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
163482383|NCT02607735|590465318|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
163482384|NCT01376908|590465319|FG000|Overall Study|Protocol Violation|1|||
163482385|NCT01376908|590465320|FG001|Overall Study|Protocol Violation|1|||
163482386|NCT01376908|590465319|FG000|Overall Study|Withdrawal by Subject|1|||
163482387|NCT01376908|590465320|FG001|Overall Study|Withdrawal by Subject|2|||
163482388|NCT01681836|590465327|FG000|Second Intervention|Withdrawal by Subject|0|||
163482389|NCT01681836|590465328|FG001|Second Intervention|Withdrawal by Subject|1|||
163482390|NCT00742391|590465329|FG000|Overall Study|Adverse Event|2|||
163482391|NCT00742391|590465330|FG001|Overall Study|Adverse Event|1|||
163482392|NCT00742391|590465329|FG000|Overall Study|Lost to Follow-up|1|||
163482393|NCT00742391|590465330|FG001|Overall Study|Lost to Follow-up|0|||
163482394|NCT00742391|590465329|FG000|Overall Study|Protocol Violation|1|||
163482395|NCT00742391|590465330|FG001|Overall Study|Protocol Violation|0|||
163482396|NCT02394028|590465331|FG000|Induction Phase|Adverse Event|2|||
163482397|NCT02394028|590465332|FG001|Induction Phase|Adverse Event|4|||
163482398|NCT02394028|590465333|FG002|Induction Phase|Adverse Event|1|||
163482399|NCT02394028|590465334|FG003|Induction Phase|Adverse Event|2|||
163482400|NCT02394028|590465335|FG004|Induction Phase|Adverse Event|5|||
163482401|NCT02394028|590465336|FG005|Induction Phase|Adverse Event|2|||
163482402|NCT02394028|590465337|FG006|Induction Phase|Adverse Event|0|||
163482403|NCT02394028|590465338|FG007|Induction Phase|Adverse Event|0|||
163482404|NCT02394028|590465339|FG008|Induction Phase|Adverse Event|0|||
163482405|NCT02394028|590465340|FG009|Induction Phase|Adverse Event|0|||
163482406|NCT02394028|590465341|FG010|Induction Phase|Adverse Event|0|||
163482407|NCT02394028|590465331|FG000|Induction Phase|Lack of Efficacy|3|||
163482408|NCT02394028|590465332|FG001|Induction Phase|Lack of Efficacy|6|||
163482409|NCT02394028|590465333|FG002|Induction Phase|Lack of Efficacy|2|||
163482410|NCT02394028|590465334|FG003|Induction Phase|Lack of Efficacy|17|||
163482411|NCT02394028|590465335|FG004|Induction Phase|Lack of Efficacy|14|||
163482412|NCT02394028|590465336|FG005|Induction Phase|Lack of Efficacy|8|||
163482413|NCT02394028|590465337|FG006|Induction Phase|Lack of Efficacy|17|||
163482414|NCT02394028|590465338|FG007|Induction Phase|Lack of Efficacy|23|||
163482415|NCT02394028|590465339|FG008|Induction Phase|Lack of Efficacy|0|||
163482416|NCT02394028|590465340|FG009|Induction Phase|Lack of Efficacy|0|||
163482417|NCT02394028|590465341|FG010|Induction Phase|Lack of Efficacy|0|||
163482418|NCT02394028|590465331|FG000|Induction Phase|Lost to Follow-up|1|||
163482419|NCT02394028|590465332|FG001|Induction Phase|Lost to Follow-up|0|||
163482420|NCT02394028|590465333|FG002|Induction Phase|Lost to Follow-up|0|||
163482421|NCT02394028|590465334|FG003|Induction Phase|Lost to Follow-up|1|||
163482422|NCT02394028|590465335|FG004|Induction Phase|Lost to Follow-up|0|||
163482423|NCT02394028|590465336|FG005|Induction Phase|Lost to Follow-up|0|||
163482424|NCT02394028|590465337|FG006|Induction Phase|Lost to Follow-up|1|||
163482425|NCT02394028|590465338|FG007|Induction Phase|Lost to Follow-up|0|||
163482426|NCT02394028|590465339|FG008|Induction Phase|Lost to Follow-up|0|||
163482427|NCT02394028|590465340|FG009|Induction Phase|Lost to Follow-up|0|||
163482428|NCT02394028|590465341|FG010|Induction Phase|Lost to Follow-up|0|||
163482429|NCT02394028|590465331|FG000|Induction Phase|Non-compliance|0|||
163482430|NCT02394028|590465332|FG001|Induction Phase|Non-compliance|1|||
163482431|NCT02394028|590465333|FG002|Induction Phase|Non-compliance|3|||
163482432|NCT02394028|590465334|FG003|Induction Phase|Non-compliance|1|||
163482433|NCT02394028|590465335|FG004|Induction Phase|Non-compliance|3|||
163482434|NCT02394028|590465336|FG005|Induction Phase|Non-compliance|0|||
163482435|NCT02394028|590465337|FG006|Induction Phase|Non-compliance|1|||
163482436|NCT02394028|590465338|FG007|Induction Phase|Non-compliance|1|||
163482437|NCT02394028|590465339|FG008|Induction Phase|Non-compliance|0|||
163482438|NCT02394028|590465340|FG009|Induction Phase|Non-compliance|0|||
163482439|NCT02394028|590465341|FG010|Induction Phase|Non-compliance|0|||
163482440|NCT02394028|590465331|FG000|Induction Phase|Physician Decision|0|||
163482441|NCT02394028|590465332|FG001|Induction Phase|Physician Decision|0|||
163482442|NCT02394028|590465333|FG002|Induction Phase|Physician Decision|1|||
163482443|NCT02394028|590465334|FG003|Induction Phase|Physician Decision|4|||
163482444|NCT02394028|590465335|FG004|Induction Phase|Physician Decision|0|||
163482445|NCT02394028|590465336|FG005|Induction Phase|Physician Decision|2|||
163482446|NCT02394028|590465337|FG006|Induction Phase|Physician Decision|1|||
163482447|NCT02394028|590465338|FG007|Induction Phase|Physician Decision|0|||
163482448|NCT02394028|590465339|FG008|Induction Phase|Physician Decision|0|||
163482449|NCT02394028|590465340|FG009|Induction Phase|Physician Decision|0|||
163482450|NCT02394028|590465341|FG010|Induction Phase|Physician Decision|0|||
163482451|NCT02394028|590465331|FG000|Induction Phase|Protocol Violation|0|||
163482452|NCT02394028|590465332|FG001|Induction Phase|Protocol Violation|2|||
163482453|NCT02394028|590465333|FG002|Induction Phase|Protocol Violation|0|||
163482454|NCT02394028|590465334|FG003|Induction Phase|Protocol Violation|3|||
163482455|NCT02394028|590465335|FG004|Induction Phase|Protocol Violation|0|||
163482456|NCT02394028|590465336|FG005|Induction Phase|Protocol Violation|1|||
163482457|NCT02394028|590465337|FG006|Induction Phase|Protocol Violation|1|||
163482458|NCT02394028|590465338|FG007|Induction Phase|Protocol Violation|0|||
163482459|NCT02394028|590465339|FG008|Induction Phase|Protocol Violation|0|||
163482460|NCT02394028|590465340|FG009|Induction Phase|Protocol Violation|0|||
163482461|NCT02394028|590465341|FG010|Induction Phase|Protocol Violation|0|||
163482462|NCT02394028|590465331|FG000|Induction Phase|Withdrawal by Subject|1|||
163482463|NCT02394028|590465332|FG001|Induction Phase|Withdrawal by Subject|2|||
163482464|NCT02394028|590465333|FG002|Induction Phase|Withdrawal by Subject|4|||
163482465|NCT02394028|590465334|FG003|Induction Phase|Withdrawal by Subject|6|||
163482466|NCT02394028|590465335|FG004|Induction Phase|Withdrawal by Subject|7|||
163482467|NCT02394028|590465336|FG005|Induction Phase|Withdrawal by Subject|4|||
163482468|NCT02394028|590465337|FG006|Induction Phase|Withdrawal by Subject|3|||
163482469|NCT02394028|590465338|FG007|Induction Phase|Withdrawal by Subject|6|||
163482470|NCT02394028|590465339|FG008|Induction Phase|Withdrawal by Subject|0|||
163482471|NCT02394028|590465340|FG009|Induction Phase|Withdrawal by Subject|0|||
163482472|NCT02394028|590465341|FG010|Induction Phase|Withdrawal by Subject|0|||
163482473|NCT02394028|590465331|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
163482474|NCT02394028|590465332|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
163482475|NCT02394028|590465333|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
163482476|NCT02394028|590465334|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
163482477|NCT02394028|590465335|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
163482478|NCT02394028|590465336|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
163482479|NCT02394028|590465337|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
163482480|NCT02394028|590465338|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
163482481|NCT02394028|590465339|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
163482482|NCT02394028|590465340|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
163482483|NCT02394028|590465341|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
163482484|NCT02394028|590465331|FG000|Induction Phase|Sponsor decision|0|||
163482485|NCT02394028|590465332|FG001|Induction Phase|Sponsor decision|1|||
163482486|NCT02394028|590465333|FG002|Induction Phase|Sponsor decision|2|||
163482487|NCT02394028|590465334|FG003|Induction Phase|Sponsor decision|0|||
163482488|NCT02394028|590465335|FG004|Induction Phase|Sponsor decision|0|||
163482489|NCT02394028|590465336|FG005|Induction Phase|Sponsor decision|0|||
163482490|NCT02394028|590465337|FG006|Induction Phase|Sponsor decision|0|||
163482491|NCT02394028|590465338|FG007|Induction Phase|Sponsor decision|0|||
163482492|NCT02394028|590465339|FG008|Induction Phase|Sponsor decision|0|||
163482493|NCT02394028|590465340|FG009|Induction Phase|Sponsor decision|0|||
163482494|NCT02394028|590465341|FG010|Induction Phase|Sponsor decision|0|||
163482495|NCT02394028|590465331|FG000|Induction Phase|Technical reason|0|||
163482496|NCT02394028|590465332|FG001|Induction Phase|Technical reason|0|||
163482497|NCT02394028|590465333|FG002|Induction Phase|Technical reason|0|||
163482498|NCT02394028|590465334|FG003|Induction Phase|Technical reason|1|||
163482499|NCT02394028|590465335|FG004|Induction Phase|Technical reason|0|||
163482500|NCT02394028|590465336|FG005|Induction Phase|Technical reason|0|||
163482501|NCT02394028|590465337|FG006|Induction Phase|Technical reason|0|||
163482502|NCT02394028|590465338|FG007|Induction Phase|Technical reason|0|||
163482503|NCT02394028|590465339|FG008|Induction Phase|Technical reason|0|||
163482504|NCT02394028|590465340|FG009|Induction Phase|Technical reason|0|||
163482505|NCT02394028|590465341|FG010|Induction Phase|Technical reason|0|||
163482506|NCT02394028|590465331|FG000|Induction Phase|:ack of calculation|0|||
163482507|NCT02394028|590465332|FG001|Induction Phase|:ack of calculation|0|||
163482508|NCT02394028|590465333|FG002|Induction Phase|:ack of calculation|0|||
163482509|NCT02394028|590465334|FG003|Induction Phase|:ack of calculation|0|||
163482510|NCT02394028|590465335|FG004|Induction Phase|:ack of calculation|0|||
163482511|NCT02394028|590465336|FG005|Induction Phase|:ack of calculation|0|||
163482512|NCT02394028|590465337|FG006|Induction Phase|:ack of calculation|0|||
163482513|NCT02394028|590465338|FG007|Induction Phase|:ack of calculation|1|||
163482514|NCT02394028|590465339|FG008|Induction Phase|:ack of calculation|0|||
163482515|NCT02394028|590465340|FG009|Induction Phase|:ack of calculation|0|||
163482516|NCT02394028|590465341|FG010|Induction Phase|:ack of calculation|0|||
163482517|NCT02394028|590465331|FG000|Maintenance Phase|Protocol Violation|0|||
163482518|NCT02394028|590465332|FG001|Maintenance Phase|Protocol Violation|0|||
163482519|NCT02394028|590465333|FG002|Maintenance Phase|Protocol Violation|0|||
163482520|NCT02394028|590465334|FG003|Maintenance Phase|Protocol Violation|0|||
163482521|NCT02394028|590465335|FG004|Maintenance Phase|Protocol Violation|0|||
163482522|NCT02394028|590465336|FG005|Maintenance Phase|Protocol Violation|0|||
163482523|NCT02394028|590465337|FG006|Maintenance Phase|Protocol Violation|0|||
163482524|NCT02394028|590465338|FG007|Maintenance Phase|Protocol Violation|0|||
163482525|NCT02394028|590465339|FG008|Maintenance Phase|Protocol Violation|0|||
163482526|NCT02394028|590465340|FG009|Maintenance Phase|Protocol Violation|0|||
163482527|NCT02394028|590465341|FG010|Maintenance Phase|Protocol Violation|1|||
163482528|NCT02394028|590465331|FG000|Maintenance Phase|Physician Decision|0|||
163482529|NCT02394028|590465332|FG001|Maintenance Phase|Physician Decision|0|||
163482530|NCT02394028|590465333|FG002|Maintenance Phase|Physician Decision|0|||
163482531|NCT02394028|590465334|FG003|Maintenance Phase|Physician Decision|0|||
163482532|NCT02394028|590465335|FG004|Maintenance Phase|Physician Decision|0|||
163482533|NCT02394028|590465336|FG005|Maintenance Phase|Physician Decision|0|||
163482534|NCT02394028|590465337|FG006|Maintenance Phase|Physician Decision|0|||
163482535|NCT02394028|590465338|FG007|Maintenance Phase|Physician Decision|0|||
163482536|NCT02394028|590465339|FG008|Maintenance Phase|Physician Decision|1|||
163482537|NCT02394028|590465340|FG009|Maintenance Phase|Physician Decision|3|||
163482538|NCT02394028|590465341|FG010|Maintenance Phase|Physician Decision|2|||
163482539|NCT02394028|590465331|FG000|Maintenance Phase|Lack of Efficacy|0|||
163482540|NCT02394028|590465332|FG001|Maintenance Phase|Lack of Efficacy|0|||
163482541|NCT02394028|590465333|FG002|Maintenance Phase|Lack of Efficacy|0|||
163482542|NCT02394028|590465334|FG003|Maintenance Phase|Lack of Efficacy|0|||
163482543|NCT02394028|590465335|FG004|Maintenance Phase|Lack of Efficacy|0|||
163482544|NCT02394028|590465336|FG005|Maintenance Phase|Lack of Efficacy|0|||
163482545|NCT02394028|590465337|FG006|Maintenance Phase|Lack of Efficacy|0|||
163482546|NCT02394028|590465338|FG007|Maintenance Phase|Lack of Efficacy|0|||
163482547|NCT02394028|590465339|FG008|Maintenance Phase|Lack of Efficacy|7|||
163482548|NCT02394028|590465340|FG009|Maintenance Phase|Lack of Efficacy|25|||
163482549|NCT02394028|590465341|FG010|Maintenance Phase|Lack of Efficacy|33|||
163482550|NCT02394028|590465331|FG000|Maintenance Phase|Death|0|||
163482551|NCT02394028|590465332|FG001|Maintenance Phase|Death|0|||
163482552|NCT02394028|590465333|FG002|Maintenance Phase|Death|0|||
163482553|NCT02394028|590465334|FG003|Maintenance Phase|Death|0|||
163482554|NCT02394028|590465335|FG004|Maintenance Phase|Death|0|||
163482555|NCT02394028|590465336|FG005|Maintenance Phase|Death|0|||
163482556|NCT02394028|590465337|FG006|Maintenance Phase|Death|0|||
163482557|NCT02394028|590465338|FG007|Maintenance Phase|Death|0|||
163482558|NCT02394028|590465339|FG008|Maintenance Phase|Death|0|||
163482559|NCT02394028|590465340|FG009|Maintenance Phase|Death|0|||
163482560|NCT02394028|590465341|FG010|Maintenance Phase|Death|1|||
163482561|NCT02394028|590465331|FG000|Maintenance Phase|Adverse Event|0|||
163482562|NCT02394028|590465332|FG001|Maintenance Phase|Adverse Event|0|||
163482563|NCT02394028|590465333|FG002|Maintenance Phase|Adverse Event|0|||
163482564|NCT02394028|590465334|FG003|Maintenance Phase|Adverse Event|0|||
163482565|NCT02394028|590465335|FG004|Maintenance Phase|Adverse Event|0|||
163482566|NCT02394028|590465336|FG005|Maintenance Phase|Adverse Event|0|||
163482567|NCT02394028|590465337|FG006|Maintenance Phase|Adverse Event|0|||
163482568|NCT02394028|590465338|FG007|Maintenance Phase|Adverse Event|0|||
163482569|NCT02394028|590465339|FG008|Maintenance Phase|Adverse Event|1|||
163482570|NCT02394028|590465340|FG009|Maintenance Phase|Adverse Event|1|||
163482571|NCT02394028|590465341|FG010|Maintenance Phase|Adverse Event|3|||
163482572|NCT02394028|590465331|FG000|Maintenance Phase|Site closure|0|||
163482573|NCT02394028|590465332|FG001|Maintenance Phase|Site closure|0|||
163482574|NCT02394028|590465333|FG002|Maintenance Phase|Site closure|0|||
163482575|NCT02394028|590465334|FG003|Maintenance Phase|Site closure|0|||
163482576|NCT02394028|590465335|FG004|Maintenance Phase|Site closure|0|||
163482577|NCT02394028|590465336|FG005|Maintenance Phase|Site closure|0|||
163482578|NCT02394028|590465337|FG006|Maintenance Phase|Site closure|0|||
163482579|NCT02394028|590465338|FG007|Maintenance Phase|Site closure|0|||
163482580|NCT02394028|590465339|FG008|Maintenance Phase|Site closure|0|||
163482581|NCT02394028|590465340|FG009|Maintenance Phase|Site closure|1|||
163482582|NCT02394028|590465341|FG010|Maintenance Phase|Site closure|0|||
163482583|NCT02394028|590465331|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163482584|NCT02394028|590465332|FG001|Maintenance Phase|Withdrawal by Subject|0|||
163482585|NCT02394028|590465333|FG002|Maintenance Phase|Withdrawal by Subject|0|||
163482586|NCT02394028|590465334|FG003|Maintenance Phase|Withdrawal by Subject|0|||
163482587|NCT02394028|590465335|FG004|Maintenance Phase|Withdrawal by Subject|0|||
163482588|NCT02394028|590465336|FG005|Maintenance Phase|Withdrawal by Subject|0|||
163482589|NCT02394028|590465337|FG006|Maintenance Phase|Withdrawal by Subject|0|||
163482590|NCT02394028|590465338|FG007|Maintenance Phase|Withdrawal by Subject|0|||
163482591|NCT02394028|590465339|FG008|Maintenance Phase|Withdrawal by Subject|3|||
163482592|NCT02394028|590465340|FG009|Maintenance Phase|Withdrawal by Subject|12|||
163482593|NCT02394028|590465341|FG010|Maintenance Phase|Withdrawal by Subject|12|||
163482594|NCT00866606|590465344|FG000|Overall Study|Lost to Follow-up|3|||
163482595|NCT00866606|590465344|FG000|Overall Study|Adverse Event|1|||
163482596|NCT01058356|590465356|FG000|Overall Study|Adverse Event|5|||
163482597|NCT01058356|590465356|FG000|Overall Study|Administration of contraindicated drugs|12|||
163482598|NCT01058356|590465356|FG000|Overall Study|Withdrawal by Subject|21|||
163482599|NCT01058356|590465356|FG000|Overall Study|Lost to Follow-up|4|||
163482600|NCT03480841|590465359|FG000|Overall Study|Lost to Follow-up|2|||
163482601|NCT00606021|590465360|FG000|Induction Phase|Death|73|||
163482602|NCT00606021|590465361|FG001|Induction Phase|Death|0|||
163482603|NCT00606021|590465362|FG002|Induction Phase|Death|0|||
163482604|NCT00606021|590465360|FG000|Induction Phase|Physician Decision|2|||
163482605|NCT00606021|590465361|FG001|Induction Phase|Physician Decision|0|||
163482606|NCT00606021|590465362|FG002|Induction Phase|Physician Decision|0|||
163482607|NCT00606021|590465360|FG000|Induction Phase|Withdrawal by Subject|2|||
163482608|NCT00606021|590465361|FG001|Induction Phase|Withdrawal by Subject|0|||
163482609|NCT00606021|590465362|FG002|Induction Phase|Withdrawal by Subject|0|||
163482610|NCT00606021|590465360|FG000|Induction Phase|Lost to Follow-up|10|||
163482611|NCT00606021|590465361|FG001|Induction Phase|Lost to Follow-up|0|||
163482612|NCT00606021|590465362|FG002|Induction Phase|Lost to Follow-up|0|||
163482613|NCT00606021|590465360|FG000|Maintenance Phase|Death|0|||
163482614|NCT00606021|590465361|FG001|Maintenance Phase|Death|17|||
163482615|NCT00606021|590465362|FG002|Maintenance Phase|Death|15|||
163482616|NCT00606021|590465360|FG000|Maintenance Phase|Physician Decision|0|||
163482617|NCT00606021|590465361|FG001|Maintenance Phase|Physician Decision|1|||
163482618|NCT00606021|590465362|FG002|Maintenance Phase|Physician Decision|0|||
163482619|NCT00606021|590465360|FG000|Maintenance Phase|Lost to Follow-up|0|||
163482620|NCT00606021|590465361|FG001|Maintenance Phase|Lost to Follow-up|5|||
163482621|NCT00606021|590465362|FG002|Maintenance Phase|Lost to Follow-up|2|||
163482622|NCT01362049|590465363|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
163482623|NCT01362049|590465364|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
163482624|NCT01362049|590465365|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
163482625|NCT01362049|590465366|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
163482626|NCT01362049|590465363|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
163482627|NCT01362049|590465364|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
163482628|NCT01362049|590465365|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
163482629|NCT01362049|590465366|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
163482630|NCT00989664|590465371|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
163482631|NCT00989664|590465371|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
163482632|NCT00989664|590465371|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
163482633|NCT00989664|590465371|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
163482634|NCT00989664|590465371|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
163482635|NCT00989664|590465371|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
163482636|NCT00989664|590465371|FG000|Long-Term Follow-Up|Death|3|||
163482637|NCT00095836|590465372|FG000|Overall Study|Lost to Follow-up|1|||
163482638|NCT00095836|590465372|FG000|Overall Study|Adverse Event|1|||
163482639|NCT00095836|590465372|FG000|Overall Study|Death|2|||
163482640|NCT00426842|590465373|FG000|Overall Study|Lost to Follow-up|1|||
163482641|NCT02993783|590465374|FG000|Overall Study|Reason not Specified|6|||
163482642|NCT02993783|590465375|FG001|Overall Study|Reason not Specified|9|||
163482643|NCT02886338|590465376|FG000|Overall Study|Withdrawal by Subject|1|||
163482644|NCT01156012|590465377|FG000|Overall Study|Adverse Event|3|||
163482645|NCT01156012|590465378|FG001|Overall Study|Adverse Event|1|||
163482646|NCT01156012|590465377|FG000|Overall Study|Lost to Follow-up|1|||
163482647|NCT01156012|590465378|FG001|Overall Study|Lost to Follow-up|0|||
163482648|NCT01156012|590465377|FG000|Overall Study|Withdrawal by Subject|1|||
163482649|NCT01156012|590465378|FG001|Overall Study|Withdrawal by Subject|0|||
163482650|NCT01156012|590465377|FG000|Overall Study|use of commercial drug instead of study|0|||
163482651|NCT01156012|590465378|FG001|Overall Study|use of commercial drug instead of study|1|||
163482652|NCT01156012|590465377|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
163482653|NCT01156012|590465378|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
163482654|NCT03359811|590467078|FG000|Overall Study|Protocol Violation|2|||
163482655|NCT03359811|590467079|FG001|Overall Study|Protocol Violation|0|||
163482656|NCT02528331|590467092|FG000|Overall Study|Withdrawal by Subject|2|||
163482657|NCT00386152|590467093|FG000|Overall Study|Adverse Event|6|||
163482658|NCT00386152|590467094|FG001|Overall Study|Adverse Event|5|||
163482659|NCT00386152|590467095|FG002|Overall Study|Adverse Event|4|||
163482660|NCT00386152|590467093|FG000|Overall Study|Chang from original chemo stratification|4|||
163482661|NCT00386152|590467094|FG001|Overall Study|Chang from original chemo stratification|5|||
163482662|NCT00386152|590467095|FG002|Overall Study|Chang from original chemo stratification|6|||
163482663|NCT00386152|590467093|FG000|Overall Study|Death|3|||
163482664|NCT00386152|590467094|FG001|Overall Study|Death|0|||
163482665|NCT00386152|590467095|FG002|Overall Study|Death|1|||
163482666|NCT00386152|590467093|FG000|Overall Study|Disease progression|7|||
163482667|NCT00386152|590467094|FG001|Overall Study|Disease progression|4|||
163482668|NCT00386152|590467095|FG002|Overall Study|Disease progression|5|||
163482669|NCT00386152|590467093|FG000|Overall Study|Physician Decision|13|||
163482670|NCT00386152|590467094|FG001|Overall Study|Physician Decision|10|||
163482671|NCT00386152|590467095|FG002|Overall Study|Physician Decision|4|||
163482672|NCT00386152|590467093|FG000|Overall Study|Lost to Follow-up|1|||
163482673|NCT00386152|590467094|FG001|Overall Study|Lost to Follow-up|0|||
163482674|NCT00386152|590467095|FG002|Overall Study|Lost to Follow-up|0|||
163482675|NCT00386152|590467093|FG000|Overall Study|Completed chemotherapy|4|||
163482676|NCT00386152|590467094|FG001|Overall Study|Completed chemotherapy|5|||
163482677|NCT00386152|590467095|FG002|Overall Study|Completed chemotherapy|1|||
163482678|NCT00386152|590467093|FG000|Overall Study|Protocol Violation|3|||
163482679|NCT00386152|590467094|FG001|Overall Study|Protocol Violation|5|||
163482680|NCT00386152|590467095|FG002|Overall Study|Protocol Violation|2|||
163482681|NCT00386152|590467093|FG000|Overall Study|Withdrawal by Subject|3|||
163482682|NCT00386152|590467094|FG001|Overall Study|Withdrawal by Subject|6|||
163482683|NCT00386152|590467095|FG002|Overall Study|Withdrawal by Subject|10|||
163482684|NCT02577107|590467096|FG000|Overall Study|Protocol deviation|0|||
163482685|NCT02577107|590467097|FG001|Overall Study|Protocol deviation|1|||
163482686|NCT00577382|590467098|FG000|Overall Study|Adverse Event|0|||
163482687|NCT00577382|590467099|FG001|Overall Study|Adverse Event|6|||
163482688|NCT00577382|590467098|FG000|Overall Study|Withdrawal by Subject|0|||
163482689|NCT00577382|590467099|FG001|Overall Study|Withdrawal by Subject|1|||
163482690|NCT00577382|590467098|FG000|Overall Study|Progressive Disease|17|||
163482691|NCT00577382|590467099|FG001|Overall Study|Progressive Disease|19|||
163482692|NCT00577382|590467098|FG000|Overall Study|Intercurrent Illness|1|||
163482693|NCT00577382|590467099|FG001|Overall Study|Intercurrent Illness|2|||
163482694|NCT00577382|590467098|FG000|Overall Study|Death|1|||
163482695|NCT00577382|590467099|FG001|Overall Study|Death|1|||
163482696|NCT00577382|590467098|FG000|Overall Study|Lost to Follow-up|2|||
163482697|NCT00577382|590467099|FG001|Overall Study|Lost to Follow-up|2|||
163482698|NCT01345162|590467100|FG000|Overall Study|Protocol Violation|2|||
163482699|NCT01345162|590467101|FG001|Overall Study|Protocol Violation|4|||
163482700|NCT03007472|590467103|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
163482701|NCT03007472|590467103|FG000|Overall Study|Death|2|||
163482702|NCT03007472|590467103|FG000|Overall Study|Loss to Follow Up|1|||
163482703|NCT02988115|590467104|FG000|Overall Study|Adverse Event|6|||
163482704|NCT02988115|590467105|FG001|Overall Study|Adverse Event|1|||
163482705|NCT02988115|590467104|FG000|Overall Study|Sponsor Decision|5|||
163482706|NCT02988115|590467105|FG001|Overall Study|Sponsor Decision|2|||
163482707|NCT02988115|590467104|FG000|Overall Study|Withdrawal by Subject|1|||
163482708|NCT02988115|590467105|FG001|Overall Study|Withdrawal by Subject|1|||
163482709|NCT02988115|590467104|FG000|Overall Study|Withdrawn by Mistake|1|||
163482710|NCT02988115|590467105|FG001|Overall Study|Withdrawn by Mistake|0|||
163482711|NCT02988115|590467104|FG000|Overall Study|Lost to Follow-up|1|||
163482712|NCT02988115|590467105|FG001|Overall Study|Lost to Follow-up|0|||
163482713|NCT01731951|590467106|FG000|Overall Study|Documented Disease Progression|1|||
163482714|NCT01731951|590467107|FG001|Overall Study|Documented Disease Progression|0|||
163482715|NCT01731951|590467108|FG002|Overall Study|Documented Disease Progression|0|||
163482716|NCT01731951|590467109|FG003|Overall Study|Documented Disease Progression|0|||
163482717|NCT01731951|590467110|FG004|Overall Study|Documented Disease Progression|0|||
163482718|NCT01731951|590467111|FG005|Overall Study|Documented Disease Progression|0|||
163482719|NCT01731951|590467106|FG000|Overall Study|Lost to Follow-up|2|||
163482720|NCT01731951|590467107|FG001|Overall Study|Lost to Follow-up|0|||
163482721|NCT01731951|590467108|FG002|Overall Study|Lost to Follow-up|0|||
163482722|NCT01731951|590467109|FG003|Overall Study|Lost to Follow-up|1|||
163482723|NCT01731951|590467110|FG004|Overall Study|Lost to Follow-up|3|||
163482724|NCT01731951|590467111|FG005|Overall Study|Lost to Follow-up|1|||
163482725|NCT01731951|590467106|FG000|Overall Study|Withdrawal of Consent|1|||
163482726|NCT01731951|590467107|FG001|Overall Study|Withdrawal of Consent|0|||
163482727|NCT01731951|590467108|FG002|Overall Study|Withdrawal of Consent|0|||
163482728|NCT01731951|590467109|FG003|Overall Study|Withdrawal of Consent|0|||
163482729|NCT01731951|590467110|FG004|Overall Study|Withdrawal of Consent|0|||
163482730|NCT01731951|590467111|FG005|Overall Study|Withdrawal of Consent|2|||
163482731|NCT01731951|590467106|FG000|Overall Study|Death|13|||
163482732|NCT01731951|590467107|FG001|Overall Study|Death|15|||
163482733|NCT01731951|590467108|FG002|Overall Study|Death|9|||
163482734|NCT01731951|590467109|FG003|Overall Study|Death|8|||
163482735|NCT01731951|590467110|FG004|Overall Study|Death|9|||
163482736|NCT01731951|590467111|FG005|Overall Study|Death|6|||
163482737|NCT00649220|590467118|FG000|Overall Study|Adverse Event|2|||
163482738|NCT00649220|590467118|FG000|Overall Study|Withdrawal by Subject|1|||
163482739|NCT01977651|590467119|FG000|4 Month Treatment Period|Adverse Event|34|||
163482740|NCT01977651|590467119|FG000|4 Month Treatment Period|Death|3|||
163482741|NCT01977651|590467119|FG000|4 Month Treatment Period|Progressive Disease|43|||
163482742|NCT01977651|590467119|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
163482743|NCT01977651|590467119|FG000|4 Month Treatment Period|Physician Decision|4|||
163482744|NCT01977651|590467119|FG000|1 Year Extension Period|Adverse Event|14|||
163482745|NCT01977651|590467119|FG000|1 Year Extension Period|Death|10|||
163482746|NCT01977651|590467119|FG000|1 Year Extension Period|Lost to Follow-up|2|||
163482747|NCT01977651|590467119|FG000|1 Year Extension Period|Progressive Disease|86|||
163482748|NCT01977651|590467119|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
163482749|NCT01977651|590467119|FG000|1 Year Extension Period|Physician Decision|6|||
163482750|NCT01977651|590467119|FG000|1 Year Extension Period|Miscellaneous|1|||
163482751|NCT01977651|590467119|FG000|Post 1 Year Extension Period|Adverse Event|5|||
163482752|NCT01977651|590467119|FG000|Post 1 Year Extension Period|Death|13|||
163482753|NCT01977651|590467119|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
163482754|NCT01977651|590467119|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
163482755|NCT01977651|590467119|FG000|Post 1 Year Extension Period|Physician Decision|4|||
163482756|NCT01977651|590467119|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
163482757|NCT03380091|590467121|FG000|Overall Study|Withdrawal by Subject|2|||
163482758|NCT03380091|590467122|FG001|Overall Study|Withdrawal by Subject|1|||
163482759|NCT04594213|590467128|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
163482760|NCT04594213|590467129|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
163482761|NCT04594213|590467130|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
163482762|NCT04594213|590467131|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
163482763|NCT04594213|590467132|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
163482764|NCT04594213|590467133|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
163482765|NCT04594213|590467128|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
163482766|NCT04594213|590467129|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
163482767|NCT04594213|590467130|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
163482768|NCT04594213|590467131|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
163482769|NCT04594213|590467132|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
163482770|NCT04594213|590467133|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
163482771|NCT04594213|590467128|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
163482772|NCT04594213|590467129|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
163482773|NCT04594213|590467130|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
163482774|NCT04594213|590467131|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
163482775|NCT04594213|590467132|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
163482776|NCT04594213|590467133|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
163482777|NCT04594213|590467128|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
163482778|NCT04594213|590467129|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
163482779|NCT04594213|590467130|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
163482780|NCT04594213|590467131|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
163482781|NCT04594213|590467132|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
163482782|NCT04594213|590467133|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
163482783|NCT04594213|590467128|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
163482784|NCT04594213|590467129|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
163482785|NCT04594213|590467130|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
163482786|NCT04594213|590467131|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
163482787|NCT04594213|590467132|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
163482788|NCT04594213|590467133|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
163482789|NCT04594213|590467128|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
163482790|NCT04594213|590467129|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
163482791|NCT04594213|590467130|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
163482792|NCT04594213|590467131|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
163482793|NCT04594213|590467132|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
163482794|NCT04594213|590467133|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
163482795|NCT04594213|590467128|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
163482796|NCT04594213|590467129|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
163482797|NCT04594213|590467130|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
163482798|NCT04594213|590467131|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
163482799|NCT04594213|590467132|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
163482800|NCT04594213|590467133|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
163482801|NCT04594213|590467128|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
163482802|NCT04594213|590467129|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
163482803|NCT04594213|590467130|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
163482804|NCT04594213|590467131|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
163482805|NCT04594213|590467132|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
163482806|NCT04594213|590467133|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
163482807|NCT04594213|590467128|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
163482808|NCT04594213|590467129|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
163482809|NCT04594213|590467130|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
163482810|NCT04594213|590467131|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
163482811|NCT04594213|590467132|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
163482812|NCT04594213|590467133|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
163482813|NCT04594213|590467128|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
163482814|NCT04594213|590467129|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
163482815|NCT04594213|590467130|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
163482816|NCT04594213|590467131|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
163482817|NCT04594213|590467132|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
163482818|NCT04594213|590467133|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
163482819|NCT04594213|590467128|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
163482820|NCT04594213|590467129|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
163482821|NCT04594213|590467130|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
163482822|NCT04594213|590467131|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
163482823|NCT04594213|590467132|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
163482824|NCT04594213|590467133|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
163482825|NCT01980056|590467135|FG000|Overall Study|Death|1|||
163482826|NCT01980056|590467136|FG001|Overall Study|Death|1|||
163482827|NCT01980056|590467137|FG002|Overall Study|Death|0|||
163482828|NCT00104299|590467138|FG000|Overall Study|Adverse Event|3|||
163482829|NCT00104299|590467139|FG001|Overall Study|Adverse Event|1|||
163482830|NCT00104299|590467138|FG000|Overall Study|Death|2|||
163482831|NCT00104299|590467139|FG001|Overall Study|Death|2|||
163482832|NCT00104299|590467138|FG000|Overall Study|Withdrawal by Subject|2|||
163482833|NCT00104299|590467139|FG001|Overall Study|Withdrawal by Subject|6|||
163482834|NCT00104299|590467138|FG000|Overall Study|Physician Decision|1|||
163482835|NCT00104299|590467139|FG001|Overall Study|Physician Decision|1|||
163482836|NCT00104299|590467138|FG000|Overall Study|To have renal transplant|1|||
163482837|NCT00104299|590467139|FG001|Overall Study|To have renal transplant|0|||
163482838|NCT02906644|590467140|FG000|First 2 Weeks|Withdrawal by Subject|0|||
163482839|NCT02906644|590467141|FG001|First 2 Weeks|Withdrawal by Subject|2|||
163482840|NCT02906644|590467140|FG000|First 2 Weeks|Physician Decision|1|||
163482841|NCT02906644|590467141|FG001|First 2 Weeks|Physician Decision|1|||
163482842|NCT02906644|590467140|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
163482843|NCT02906644|590467141|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
163482844|NCT02906644|590467140|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
163482845|NCT02906644|590467141|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
163482846|NCT03672006|590467144|FG000|Overall Study|exclusion criteria met|0|||
163482847|NCT03672006|590467145|FG001|Overall Study|exclusion criteria met|1|||
163482848|NCT03288987|590467146|FG000|Overall Study|Protocol Violation|10|||
163482849|NCT03288987|590467147|FG001|Overall Study|Protocol Violation|4|||
163482850|NCT00608426|590467148|FG000|Overall Study|Death|32|||
163482851|NCT00608426|590467149|FG001|Overall Study|Death|36|||
163482852|NCT00608426|590467148|FG000|Overall Study|Lost to Follow-up|485|||
163482853|NCT00608426|590467149|FG001|Overall Study|Lost to Follow-up|521|||
163482854|NCT00608426|590467148|FG000|Overall Study|refused, health issues, wrong address|319|||
163482855|NCT00608426|590467149|FG001|Overall Study|refused, health issues, wrong address|348|||
163482856|NCT00761891|590467150|FG000|Overall Study|Withdrawal by Subject|10|||
163482857|NCT00368069|590467151|FG000|Overall Study|Adverse Event|5|||
163482858|NCT00368069|590467152|FG001|Overall Study|Adverse Event|2|||
163482859|NCT00368069|590467151|FG000|Overall Study|Lack of Efficacy|0|||
163482860|NCT00368069|590467152|FG001|Overall Study|Lack of Efficacy|1|||
163482861|NCT00368069|590467151|FG000|Overall Study|Lost to Follow-up|1|||
163482862|NCT00368069|590467152|FG001|Overall Study|Lost to Follow-up|0|||
163482863|NCT00368069|590467151|FG000|Overall Study|Protocol Violation|0|||
163482864|NCT00368069|590467152|FG001|Overall Study|Protocol Violation|2|||
163482865|NCT00368069|590467151|FG000|Overall Study|Withdrawal of Consent|2|||
163482866|NCT00368069|590467152|FG001|Overall Study|Withdrawal of Consent|1|||
163482867|NCT00368069|590467151|FG000|Overall Study|no blood sampling possible|0|||
163482868|NCT00368069|590467152|FG001|Overall Study|no blood sampling possible|1|||
163482869|NCT02764229|590467154|FG000|Overall Study|Withdrawal by Subject|15|||
163482870|NCT02764229|590467154|FG000|Overall Study|Adverse Event|9|||
163482871|NCT02764229|590467154|FG000|Overall Study|Physician Decision|5|||
163482872|NCT02764229|590467154|FG000|Overall Study|Lost to Follow-up|3|||
163482873|NCT02764229|590467154|FG000|Overall Study|Lack of Efficacy|1|||
163482874|NCT02764229|590467154|FG000|Overall Study|Study Stopped by Sponsor|69|||
163482875|NCT00672490|590467155|FG000|Overall Study|Withdrawal by Subject|8|||
163482876|NCT00672490|590467156|FG001|Overall Study|Withdrawal by Subject|8|||
163482877|NCT00672490|590467155|FG000|Overall Study|Lack of Compliance|2|||
163482878|NCT00672490|590467156|FG001|Overall Study|Lack of Compliance|7|||
163482879|NCT00672490|590467155|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
163482880|NCT00672490|590467156|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
163482881|NCT00672490|590467155|FG000|Overall Study|Adverse Event|5|||
163482882|NCT00672490|590467156|FG001|Overall Study|Adverse Event|8|||
163482883|NCT00672490|590467155|FG000|Overall Study|Violation of Concomitant Medicine|1|||
163482884|NCT00672490|590467156|FG001|Overall Study|Violation of Concomitant Medicine|0|||
163482885|NCT00672490|590467155|FG000|Overall Study|Intolerance|0|||
163482886|NCT00672490|590467156|FG001|Overall Study|Intolerance|2|||
163482887|NCT00672490|590467155|FG000|Overall Study|Lost to Follow-up|1|||
163482888|NCT00672490|590467156|FG001|Overall Study|Lost to Follow-up|5|||
163482889|NCT00672490|590467155|FG000|Overall Study|No reason was provided|6|||
163482890|NCT00672490|590467156|FG001|Overall Study|No reason was provided|2|||
163482891|NCT02030067|590467169|FG000|Overall Study|Disease Progression|1|||
163482892|NCT02030067|590467170|FG001|Overall Study|Disease Progression|1|||
163482893|NCT02030067|590467171|FG002|Overall Study|Disease Progression|2|||
163482894|NCT02030067|590467172|FG003|Overall Study|Disease Progression|2|||
163482895|NCT02030067|590467173|FG004|Overall Study|Disease Progression|3|||
163482896|NCT02030067|590467174|FG005|Overall Study|Disease Progression|2|||
163482897|NCT02030067|590467175|FG006|Overall Study|Disease Progression|3|||
163482898|NCT02030067|590467176|FG007|Overall Study|Disease Progression|3|||
163482899|NCT02030067|590467177|FG008|Overall Study|Disease Progression|4|||
163482900|NCT02030067|590467178|FG009|Overall Study|Disease Progression|3|||
163482901|NCT02030067|590467179|FG010|Overall Study|Disease Progression|7|||
163482902|NCT02030067|590467180|FG011|Overall Study|Disease Progression|2|||
163482903|NCT02030067|590467181|FG012|Overall Study|Disease Progression|59|||
163482904|NCT02030067|590467169|FG000|Overall Study|Withdrawal by Subject|0|||
163482905|NCT02030067|590467170|FG001|Overall Study|Withdrawal by Subject|0|||
163482906|NCT02030067|590467171|FG002|Overall Study|Withdrawal by Subject|0|||
163482907|NCT02030067|590467172|FG003|Overall Study|Withdrawal by Subject|1|||
163482908|NCT02030067|590467173|FG004|Overall Study|Withdrawal by Subject|0|||
163482909|NCT02030067|590467174|FG005|Overall Study|Withdrawal by Subject|0|||
163482910|NCT02030067|590467175|FG006|Overall Study|Withdrawal by Subject|0|||
163482911|NCT02030067|590467176|FG007|Overall Study|Withdrawal by Subject|1|||
163482912|NCT02030067|590467177|FG008|Overall Study|Withdrawal by Subject|0|||
163482913|NCT02030067|590467178|FG009|Overall Study|Withdrawal by Subject|0|||
163482914|NCT02030067|590467179|FG010|Overall Study|Withdrawal by Subject|3|||
163482915|NCT02030067|590467180|FG011|Overall Study|Withdrawal by Subject|0|||
163482916|NCT02030067|590467181|FG012|Overall Study|Withdrawal by Subject|6|||
163482917|NCT02030067|590467169|FG000|Overall Study|Physician Decision|0|||
163482918|NCT02030067|590467170|FG001|Overall Study|Physician Decision|0|||
163482919|NCT02030067|590467171|FG002|Overall Study|Physician Decision|0|||
163482920|NCT02030067|590467172|FG003|Overall Study|Physician Decision|0|||
163482921|NCT02030067|590467173|FG004|Overall Study|Physician Decision|0|||
163482922|NCT02030067|590467174|FG005|Overall Study|Physician Decision|0|||
163482923|NCT02030067|590467175|FG006|Overall Study|Physician Decision|0|||
163482924|NCT02030067|590467176|FG007|Overall Study|Physician Decision|0|||
163482925|NCT02030067|590467177|FG008|Overall Study|Physician Decision|0|||
163482926|NCT02030067|590467178|FG009|Overall Study|Physician Decision|0|||
163482927|NCT02030067|590467179|FG010|Overall Study|Physician Decision|1|||
163482928|NCT02030067|590467180|FG011|Overall Study|Physician Decision|0|||
163482929|NCT02030067|590467181|FG012|Overall Study|Physician Decision|3|||
163482930|NCT02030067|590467169|FG000|Overall Study|other reasons|0|||
163482931|NCT02030067|590467170|FG001|Overall Study|other reasons|0|||
163482932|NCT02030067|590467171|FG002|Overall Study|other reasons|0|||
163482933|NCT02030067|590467172|FG003|Overall Study|other reasons|0|||
163482934|NCT02030067|590467173|FG004|Overall Study|other reasons|0|||
163482935|NCT02030067|590467174|FG005|Overall Study|other reasons|1|||
163482936|NCT02030067|590467175|FG006|Overall Study|other reasons|0|||
163482937|NCT02030067|590467176|FG007|Overall Study|other reasons|0|||
163482938|NCT02030067|590467177|FG008|Overall Study|other reasons|2|||
163482939|NCT02030067|590467178|FG009|Overall Study|other reasons|0|||
163482940|NCT02030067|590467179|FG010|Overall Study|other reasons|0|||
163482941|NCT02030067|590467180|FG011|Overall Study|other reasons|0|||
163482942|NCT02030067|590467181|FG012|Overall Study|other reasons|4|||
163482943|NCT02030067|590467169|FG000|Overall Study|Adverse Event|0|||
163482944|NCT02030067|590467170|FG001|Overall Study|Adverse Event|0|||
163482945|NCT02030067|590467171|FG002|Overall Study|Adverse Event|0|||
163482946|NCT02030067|590467172|FG003|Overall Study|Adverse Event|0|||
163482947|NCT02030067|590467173|FG004|Overall Study|Adverse Event|0|||
163482948|NCT02030067|590467174|FG005|Overall Study|Adverse Event|0|||
163482949|NCT02030067|590467175|FG006|Overall Study|Adverse Event|0|||
163482950|NCT02030067|590467176|FG007|Overall Study|Adverse Event|0|||
163482951|NCT02030067|590467177|FG008|Overall Study|Adverse Event|0|||
163482952|NCT02030067|590467178|FG009|Overall Study|Adverse Event|0|||
163482953|NCT02030067|590467179|FG010|Overall Study|Adverse Event|0|||
163482954|NCT02030067|590467180|FG011|Overall Study|Adverse Event|1|||
163482955|NCT02030067|590467181|FG012|Overall Study|Adverse Event|8|||
163482956|NCT00565721|590467183|FG000|Overall Study|Screen Failure|2|||
163482957|NCT00565721|590467183|FG000|Overall Study|Lost to Follow-up|6|||
163482958|NCT00565721|590467183|FG000|Overall Study|Technical Problems|1|||
163482959|NCT00565721|590467183|FG000|Overall Study|Physician Decision|2|||
163482960|NCT00565721|590467183|FG000|Overall Study|Other reasons|6|||
163482961|NCT02813681|590467186|FG000|Overall Study|Physician Decision|5|||
163482962|NCT02813681|590467187|FG001|Overall Study|Physician Decision|5|||
163482963|NCT02813681|590467188|FG002|Overall Study|Physician Decision|0|||
163482964|NCT02813681|590467186|FG000|Overall Study|Lost to Follow-up|0|||
163482965|NCT02813681|590467187|FG001|Overall Study|Lost to Follow-up|1|||
163482966|NCT02813681|590467188|FG002|Overall Study|Lost to Follow-up|0|||
163482967|NCT00529152|590467189|FG000|Overall Study|Adverse Event|2|||
163482968|NCT00529152|590467189|FG000|Overall Study|Withdrawal by Subject|2|||
163482969|NCT00529152|590467189|FG000|Overall Study|Lost to Follow-up|1|||
163482970|NCT04062240|590467193|FG000|Overall Study|equipment malfunction|1|||
163482971|NCT03961529|590467194|FG000|Overall Study|Adverse Event|13|||
163482972|NCT03961529|590467195|FG001|Overall Study|Adverse Event|5|||
163482973|NCT03961529|590467196|FG002|Overall Study|Adverse Event|2|||
163482974|NCT03961529|590467194|FG000|Overall Study|Withdrawal by Subject|17|||
163482975|NCT03961529|590467195|FG001|Overall Study|Withdrawal by Subject|2|||
163482976|NCT03961529|590467196|FG002|Overall Study|Withdrawal by Subject|1|||
163482977|NCT03961529|590467194|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163482978|NCT03961529|590467195|FG001|Overall Study|Withdrawal by parent/guardian|7|||
163482979|NCT03961529|590467196|FG002|Overall Study|Withdrawal by parent/guardian|0|||
163482980|NCT03961529|590467194|FG000|Overall Study|Physician Decision|2|||
163482981|NCT03961529|590467195|FG001|Overall Study|Physician Decision|1|||
163482982|NCT03961529|590467196|FG002|Overall Study|Physician Decision|1|||
163482983|NCT03961529|590467194|FG000|Overall Study|Lost to Follow-up|2|||
163482984|NCT03961529|590467195|FG001|Overall Study|Lost to Follow-up|1|||
163482985|NCT03961529|590467196|FG002|Overall Study|Lost to Follow-up|0|||
163482986|NCT03961529|590467194|FG000|Overall Study|Lack of Efficacy|2|||
163482987|NCT03961529|590467195|FG001|Overall Study|Lack of Efficacy|0|||
163482988|NCT03961529|590467196|FG002|Overall Study|Lack of Efficacy|1|||
163482989|NCT03961529|590467194|FG000|Overall Study|Other|6|||
163482990|NCT03961529|590467195|FG001|Overall Study|Other|1|||
163482991|NCT03961529|590467196|FG002|Overall Study|Other|0|||
163482992|NCT01497899|590467197|FG000|Double-Blind Phase|Randomized but not Treated|1|||
163482993|NCT01497899|590467198|FG001|Double-Blind Phase|Randomized but not Treated|0|||
163482994|NCT01497899|590467199|FG002|Double-Blind Phase|Randomized but not Treated|0|||
163482995|NCT01497899|590467200|FG003|Double-Blind Phase|Randomized but not Treated|0|||
163482996|NCT01497899|590467197|FG000|Double-Blind Phase|Adverse Event|1|||
163482997|NCT01497899|590467198|FG001|Double-Blind Phase|Adverse Event|0|||
163482998|NCT01497899|590467199|FG002|Double-Blind Phase|Adverse Event|0|||
163482999|NCT01497899|590467200|FG003|Double-Blind Phase|Adverse Event|0|||
163483000|NCT01497899|590467197|FG000|Double-Blind Phase|Lack of Efficacy|0|||
163483001|NCT01497899|590467198|FG001|Double-Blind Phase|Lack of Efficacy|1|||
163483002|NCT01497899|590467199|FG002|Double-Blind Phase|Lack of Efficacy|0|||
163483003|NCT01497899|590467200|FG003|Double-Blind Phase|Lack of Efficacy|0|||
163483004|NCT01497899|590467197|FG000|Double-Blind Phase|Investigator's Discretion|1|||
163483005|NCT01497899|590467198|FG001|Double-Blind Phase|Investigator's Discretion|0|||
163483006|NCT01497899|590467199|FG002|Double-Blind Phase|Investigator's Discretion|0|||
163483007|NCT01497899|590467200|FG003|Double-Blind Phase|Investigator's Discretion|0|||
163483008|NCT01497899|590467197|FG000|Double-Blind Phase|Withdrew Consent|0|||
163483009|NCT01497899|590467198|FG001|Double-Blind Phase|Withdrew Consent|1|||
163483010|NCT01497899|590467199|FG002|Double-Blind Phase|Withdrew Consent|0|||
163483011|NCT01497899|590467200|FG003|Double-Blind Phase|Withdrew Consent|0|||
163483012|NCT01497899|590467197|FG000|Double-Blind Phase|Lost to Follow-up|3|||
163483013|NCT01497899|590467198|FG001|Double-Blind Phase|Lost to Follow-up|2|||
163483014|NCT01497899|590467199|FG002|Double-Blind Phase|Lost to Follow-up|0|||
163483015|NCT01497899|590467200|FG003|Double-Blind Phase|Lost to Follow-up|0|||
163483016|NCT01497899|590467197|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
163483017|NCT01497899|590467198|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
163483018|NCT01497899|590467199|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
163483019|NCT01497899|590467200|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
163483020|NCT01497899|590467197|FG000|Open-Label Extension Phase|Adverse Event|1|||
163483021|NCT01497899|590467198|FG001|Open-Label Extension Phase|Adverse Event|0|||
163483022|NCT01497899|590467199|FG002|Open-Label Extension Phase|Adverse Event|0|||
163483023|NCT01497899|590467200|FG003|Open-Label Extension Phase|Adverse Event|0|||
163483024|NCT01497899|590467197|FG000|Open-Label Extension Phase|Death|1|||
163483025|NCT01497899|590467198|FG001|Open-Label Extension Phase|Death|0|||
163483026|NCT01497899|590467199|FG002|Open-Label Extension Phase|Death|0|||
163483027|NCT01497899|590467200|FG003|Open-Label Extension Phase|Death|0|||
163483028|NCT01497899|590467197|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
163483029|NCT01497899|590467198|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
163483030|NCT01497899|590467199|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
163483031|NCT01497899|590467200|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
163483032|NCT01497899|590467197|FG000|Open-Label Extension Phase|Pregnancy|0|||
163483033|NCT01497899|590467198|FG001|Open-Label Extension Phase|Pregnancy|1|||
163483034|NCT01497899|590467199|FG002|Open-Label Extension Phase|Pregnancy|1|||
163483035|NCT01497899|590467200|FG003|Open-Label Extension Phase|Pregnancy|0|||
163483036|NCT01497899|590467197|FG000|Open-Label Extension Phase|Protocol Violation|0|||
163483037|NCT01497899|590467198|FG001|Open-Label Extension Phase|Protocol Violation|0|||
163483038|NCT01497899|590467199|FG002|Open-Label Extension Phase|Protocol Violation|1|||
163483039|NCT01497899|590467200|FG003|Open-Label Extension Phase|Protocol Violation|0|||
163483040|NCT01497899|590467197|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
163483041|NCT01497899|590467198|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
163483042|NCT01497899|590467199|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
163483043|NCT01497899|590467200|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
163483044|NCT03500419|590467201|FG000|Overall Study|Withdrawal by Subject|2|||
163483045|NCT03500419|590467202|FG001|Overall Study|Withdrawal by Subject|25|||
163483046|NCT00082628|590467203|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
163483047|NCT00082628|590467204|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
163483048|NCT00082628|590467205|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
163483049|NCT00082628|590467206|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
163483050|NCT00082628|590467207|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
163483051|NCT00082628|590467203|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
163483052|NCT00082628|590467204|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
163483053|NCT00082628|590467205|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
163483054|NCT00082628|590467206|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
163483055|NCT00082628|590467207|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
163483056|NCT00082628|590467203|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
163483057|NCT00082628|590467204|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
163483058|NCT00082628|590467205|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
163483059|NCT00082628|590467206|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
163483060|NCT00082628|590467207|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
163483061|NCT00082628|590467203|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
163483062|NCT00082628|590467204|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
163483063|NCT00082628|590467205|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
163483064|NCT00082628|590467206|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
163483065|NCT00082628|590467207|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
163483066|NCT00082628|590467203|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
163483067|NCT00082628|590467204|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
163483068|NCT00082628|590467205|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
163483069|NCT00082628|590467206|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
163483070|NCT00082628|590467207|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
163483071|NCT00082628|590467203|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
163483072|NCT00082628|590467204|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
163483073|NCT00082628|590467205|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
163483074|NCT00082628|590467206|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
163483075|NCT00082628|590467207|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
163483076|NCT00082628|590467203|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
163483077|NCT00082628|590467204|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
163483078|NCT00082628|590467205|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
163483079|NCT00082628|590467206|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
163483080|NCT00082628|590467207|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
163483081|NCT03481634|590467210|FG000|Overall Study|Withdrawal by Subject|16|||
163483082|NCT03481634|590467211|FG001|Overall Study|Withdrawal by Subject|19|||
163483083|NCT03481634|590467212|FG002|Overall Study|Withdrawal by Subject|14|||
163483084|NCT03481634|590467210|FG000|Overall Study|Protocol Violation|1|||
163483085|NCT03481634|590467211|FG001|Overall Study|Protocol Violation|0|||
163483086|NCT03481634|590467212|FG002|Overall Study|Protocol Violation|1|||
163483087|NCT03481634|590467210|FG000|Overall Study|Progressive disease|0|||
163483088|NCT03481634|590467211|FG001|Overall Study|Progressive disease|1|||
163483089|NCT03481634|590467212|FG002|Overall Study|Progressive disease|0|||
163483090|NCT03481634|590467210|FG000|Overall Study|Physician Decision|3|||
163483091|NCT03481634|590467211|FG001|Overall Study|Physician Decision|0|||
163483092|NCT03481634|590467212|FG002|Overall Study|Physician Decision|1|||
163483093|NCT03481634|590467210|FG000|Overall Study|Lost to Follow-up|3|||
163483094|NCT03481634|590467211|FG001|Overall Study|Lost to Follow-up|4|||
163483095|NCT03481634|590467212|FG002|Overall Study|Lost to Follow-up|4|||
163483096|NCT03481634|590467210|FG000|Overall Study|Death|4|||
163483097|NCT03481634|590467211|FG001|Overall Study|Death|8|||
163483098|NCT03481634|590467212|FG002|Overall Study|Death|7|||
163483099|NCT03481634|590467210|FG000|Overall Study|Adverse Event|6|||
163483100|NCT03481634|590467211|FG001|Overall Study|Adverse Event|3|||
163483101|NCT03481634|590467212|FG002|Overall Study|Adverse Event|7|||
163483102|NCT01874288|590467213|FG000|Overall Study|Withdrawal by Subject|1|||
163483103|NCT01874288|590467214|FG001|Overall Study|Withdrawal by Subject|0|||
163483104|NCT01874288|590467215|FG002|Overall Study|Withdrawal by Subject|2|||
163483105|NCT01874288|590467216|FG003|Overall Study|Withdrawal by Subject|1|||
163483106|NCT01874288|590467217|FG004|Overall Study|Withdrawal by Subject|1|||
163483107|NCT01874288|590467213|FG000|Overall Study|Physician Decision|0|||
163483108|NCT01874288|590467214|FG001|Overall Study|Physician Decision|0|||
163483109|NCT01874288|590467215|FG002|Overall Study|Physician Decision|0|||
163483110|NCT01874288|590467216|FG003|Overall Study|Physician Decision|1|||
163483111|NCT01874288|590467217|FG004|Overall Study|Physician Decision|0|||
163483112|NCT01874288|590467213|FG000|Overall Study|Progressive disease|2|||
163483113|NCT01874288|590467214|FG001|Overall Study|Progressive disease|0|||
163483114|NCT01874288|590467215|FG002|Overall Study|Progressive disease|3|||
163483115|NCT01874288|590467216|FG003|Overall Study|Progressive disease|5|||
163483116|NCT01874288|590467217|FG004|Overall Study|Progressive disease|1|||
163483117|NCT03099304|590467218|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
163483118|NCT03099304|590467219|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
163483119|NCT03099304|590467220|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
163483120|NCT03099304|590467221|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
163483121|NCT03099304|590467222|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
163483122|NCT03099304|590467223|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
163483123|NCT03099304|590467218|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
163483124|NCT03099304|590467219|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
163483125|NCT03099304|590467220|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
163483126|NCT03099304|590467221|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
163483127|NCT03099304|590467222|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
163483128|NCT03099304|590467223|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
163483129|NCT03099304|590467218|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
163483130|NCT03099304|590467219|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
163483131|NCT03099304|590467220|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
163483132|NCT03099304|590467221|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
163483133|NCT03099304|590467222|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
163483134|NCT03099304|590467223|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
163483135|NCT03099304|590467218|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
163483136|NCT03099304|590467219|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
163483137|NCT03099304|590467220|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
163483138|NCT03099304|590467221|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
163483139|NCT03099304|590467222|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
163483140|NCT03099304|590467223|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
163483141|NCT03099304|590467218|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
163483142|NCT03099304|590467219|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
163483143|NCT03099304|590467220|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
163483144|NCT03099304|590467221|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
163483145|NCT03099304|590467222|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
163483146|NCT03099304|590467223|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
163483147|NCT03099304|590467218|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
163483148|NCT03099304|590467219|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
163483149|NCT03099304|590467220|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
163483150|NCT03099304|590467221|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
163483151|NCT03099304|590467222|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
163483152|NCT03099304|590467223|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
163483153|NCT03099304|590467218|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
163483154|NCT03099304|590467219|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
163483155|NCT03099304|590467220|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
163483156|NCT03099304|590467221|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
163483157|NCT03099304|590467222|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
163483158|NCT03099304|590467223|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
163483159|NCT03099304|590467218|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
163483160|NCT03099304|590467219|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
163483161|NCT03099304|590467220|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
163483162|NCT03099304|590467221|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
163483163|NCT03099304|590467222|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
163483164|NCT03099304|590467223|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
163483165|NCT03099304|590467218|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
163483166|NCT03099304|590467219|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
163483167|NCT03099304|590467220|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
163483168|NCT03099304|590467221|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
163483169|NCT03099304|590467222|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
163483170|NCT03099304|590467223|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
163483171|NCT03099304|590467218|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
163483172|NCT03099304|590467219|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
163483173|NCT03099304|590467220|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
163483174|NCT03099304|590467221|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
163483175|NCT03099304|590467222|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
163483176|NCT03099304|590467223|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
163483177|NCT03099304|590467218|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
163483178|NCT03099304|590467219|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
163483179|NCT03099304|590467220|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
163483180|NCT03099304|590467221|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
163483181|NCT03099304|590467222|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
163483182|NCT03099304|590467223|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
163483183|NCT03099304|590467218|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
163483184|NCT03099304|590467219|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
163483185|NCT03099304|590467220|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
163483186|NCT03099304|590467221|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
163483187|NCT03099304|590467222|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
163483188|NCT03099304|590467223|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
163483189|NCT03099304|590467218|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
163483190|NCT03099304|590467219|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
163483191|NCT03099304|590467220|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
163483192|NCT03099304|590467221|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
163483193|NCT03099304|590467222|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
163483194|NCT03099304|590467223|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
163483195|NCT03099304|590467218|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
163483196|NCT03099304|590467219|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
163483197|NCT03099304|590467220|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
163483198|NCT03099304|590467221|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
163483199|NCT03099304|590467222|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
163483200|NCT03099304|590467223|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
163483201|NCT03099304|590467218|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
163483202|NCT03099304|590467219|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
163483203|NCT03099304|590467220|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
163483204|NCT03099304|590467221|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
163483205|NCT03099304|590467222|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
163483206|NCT03099304|590467223|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
163483207|NCT03099304|590467218|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
163483208|NCT03099304|590467219|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
163483209|NCT03099304|590467220|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
163483210|NCT03099304|590467221|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
163483211|NCT03099304|590467222|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
163483212|NCT03099304|590467223|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
163483213|NCT03099304|590467218|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
163483214|NCT03099304|590467219|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
163483215|NCT03099304|590467220|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
163483216|NCT03099304|590467221|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
163483217|NCT03099304|590467222|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
163483218|NCT03099304|590467223|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
163483219|NCT01624974|590467224|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
163483220|NCT01624974|590467225|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
163483221|NCT01624974|590467224|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
163483222|NCT01624974|590467225|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
163483223|NCT01624974|590467224|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
163483224|NCT01624974|590467225|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
163483225|NCT01624974|590467224|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
163483226|NCT01624974|590467225|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
163483227|NCT01624974|590467224|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
163483228|NCT01624974|590467225|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
163483229|NCT01624974|590467224|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
163483230|NCT01624974|590467225|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
163483231|NCT01624974|590467224|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
163483232|NCT01624974|590467225|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
163483233|NCT01624974|590467224|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
163483234|NCT01624974|590467225|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
163483235|NCT01624974|590467224|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
163483236|NCT01624974|590467225|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
163483237|NCT01624974|590467224|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
163483238|NCT01624974|590467225|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
163483239|NCT01624974|590467224|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
163483240|NCT01624974|590467225|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
163483241|NCT01624974|590467224|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
163483242|NCT01624974|590467225|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
163483243|NCT02142712|590467226|FG000|Overall Study|Lost to Follow-up|1|||
163483244|NCT02142712|590467227|FG001|Overall Study|Lost to Follow-up|1|||
163483245|NCT02142712|590467228|FG002|Overall Study|Lost to Follow-up|1|||
163483246|NCT02142712|590467229|FG003|Overall Study|Lost to Follow-up|0|||
163483247|NCT00266695|590467230|FG000|Overall Study|Adverse Event|1|||
163483248|NCT00266695|590467230|FG000|Overall Study|Death|9|||
163483249|NCT00266695|590467230|FG000|Overall Study|Physician Decision|1|||
163483250|NCT00266695|590467230|FG000|Overall Study|Lost to Follow-up|3|||
163483251|NCT00266695|590467230|FG000|Overall Study|Withdrawal by Subject|15|||
163483252|NCT01854918|590467231|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
163483253|NCT01854918|590467232|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
163483254|NCT01854918|590467231|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
163483255|NCT01854918|590467232|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
163483256|NCT01854918|590467231|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
163483257|NCT01854918|590467232|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
163483258|NCT01854918|590467231|FG000|SOC-controlled Period (Year 1)|Death|5|||
163483259|NCT01854918|590467232|FG001|SOC-controlled Period (Year 1)|Death|5|||
163483260|NCT01854918|590467231|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
163483261|NCT01854918|590467232|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
163483262|NCT01854918|590467231|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
163483263|NCT01854918|590467232|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
163483264|NCT01854918|590467231|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
163483265|NCT01854918|590467232|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
163483266|NCT01854918|590467231|FG000|All-IP Period (Years 2 and 3)|Death|5|||
163483267|NCT01854918|590467232|FG001|All-IP Period (Years 2 and 3)|Death|16|||
163483268|NCT02828982|590467236|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
163483269|NCT02828982|590467237|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
163483270|NCT02475564|590467238|FG000|Overall Study|Withdrawal by Subject|1|||
163483271|NCT02475564|590467239|FG001|Overall Study|Withdrawal by Subject|0|||
163483272|NCT02475564|590467238|FG000|Overall Study|Lost to Follow-up|2|||
163483273|NCT02475564|590467239|FG001|Overall Study|Lost to Follow-up|1|||
163483274|NCT02475564|590467238|FG000|Overall Study|Intense Menstrual bleeding|1|||
163483275|NCT02475564|590467239|FG001|Overall Study|Intense Menstrual bleeding|0|||
163483276|NCT02705755|590467240|FG000|Part A (6 Days)|Adverse Event|1|||
163483277|NCT02705755|590467241|FG001|Part A (6 Days)|Adverse Event|0|||
163483278|NCT02705755|590467242|FG002|Part A (6 Days)|Adverse Event|0|||
163483279|NCT02705755|590467243|FG003|Part A (6 Days)|Adverse Event|0|||
163483280|NCT02705755|590467240|FG000|Part A (6 Days)|Physician Decision|3|||
163483281|NCT02705755|590467241|FG001|Part A (6 Days)|Physician Decision|0|||
163483282|NCT02705755|590467242|FG002|Part A (6 Days)|Physician Decision|0|||
163483283|NCT02705755|590467243|FG003|Part A (6 Days)|Physician Decision|0|||
163483284|NCT02705755|590467240|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
163483285|NCT02705755|590467241|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
163483286|NCT02705755|590467242|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
163483287|NCT02705755|590467243|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
163483288|NCT02705755|590467240|FG000|Part C (20 Weeks)|Physician Decision|0|||
163483289|NCT02705755|590467241|FG001|Part C (20 Weeks)|Physician Decision|0|||
163483290|NCT02705755|590467242|FG002|Part C (20 Weeks)|Physician Decision|0|||
163483291|NCT02705755|590467243|FG003|Part C (20 Weeks)|Physician Decision|2|||
163483292|NCT02705755|590467240|FG000|Part C (20 Weeks)|Adverse Event|0|||
163483293|NCT02705755|590467241|FG001|Part C (20 Weeks)|Adverse Event|0|||
163483294|NCT02705755|590467242|FG002|Part C (20 Weeks)|Adverse Event|0|||
163483295|NCT02705755|590467243|FG003|Part C (20 Weeks)|Adverse Event|6|||
163483296|NCT02705755|590467240|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
163483297|NCT02705755|590467241|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
163483298|NCT02705755|590467242|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
163483299|NCT02705755|590467243|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
163483300|NCT01906489|590467244|FG000|Overall Study|Adverse Event|10|||
163483301|NCT01906489|590467245|FG001|Overall Study|Adverse Event|3|||
163483302|NCT01906489|590467244|FG000|Overall Study|Worsening of CKD|6|||
163483303|NCT01906489|590467245|FG001|Overall Study|Worsening of CKD|4|||
163483304|NCT01906489|590467244|FG000|Overall Study|Withdrawal by Subject|5|||
163483305|NCT01906489|590467245|FG001|Overall Study|Withdrawal by Subject|0|||
163483306|NCT01906489|590467244|FG000|Overall Study|Worsening of Anemia|1|||
163483307|NCT01906489|590467245|FG001|Overall Study|Worsening of Anemia|0|||
163483308|NCT01906489|590467244|FG000|Overall Study|Protocol Violation|0|||
163483309|NCT01906489|590467245|FG001|Overall Study|Protocol Violation|1|||
163483310|NCT01906489|590467244|FG000|Overall Study|Non- Compliance|1|||
163483311|NCT01906489|590467245|FG001|Overall Study|Non- Compliance|0|||
163483312|NCT01906489|590467244|FG000|Overall Study|Sponsor Decision|1|||
163483313|NCT01906489|590467245|FG001|Overall Study|Sponsor Decision|0|||
163483314|NCT01906489|590467244|FG000|Overall Study|Lost to Follow-up|1|||
163483315|NCT01906489|590467245|FG001|Overall Study|Lost to Follow-up|1|||
163483316|NCT01906489|590467244|FG000|Overall Study|Other|1|||
163483317|NCT01906489|590467245|FG001|Overall Study|Other|0|||
163483318|NCT03458234|590467246|FG000|Overall Study|Withdrawal by Subject|1|||
163483319|NCT01707667|590469842|FG000|Period 1|expulsion of colonic sensor catheter|1|||
163483320|NCT01707667|590469843|FG001|Period 1|expulsion of colonic sensor catheter|0|||
163483321|NCT03802331|590469844|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
163483322|NCT03802331|590469845|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
163483323|NCT03432819|590469849|FG000|Overall Study|Lost to Follow-up|2|||
163483324|NCT03432819|590469850|FG001|Overall Study|Lost to Follow-up|2|||
163483325|NCT03432819|590469849|FG000|Overall Study|Withdrawal by Subject|5|||
163483326|NCT03432819|590469850|FG001|Overall Study|Withdrawal by Subject|3|||
163483327|NCT02135848|590469851|FG000|Overall Study|Adverse Event|2|||
163483328|NCT02135848|590469852|FG001|Overall Study|Adverse Event|0|||
163483329|NCT02135848|590469851|FG000|Overall Study|Withdrawal by Subject|1|||
163483330|NCT02135848|590469852|FG001|Overall Study|Withdrawal by Subject|1|||
163483331|NCT00265382|590469853|FG000|Overall Study|Adverse Event|21|||
163483332|NCT00265382|590469853|FG000|Overall Study|Laboratory Abnormality|1|||
163483333|NCT00265382|590469853|FG000|Overall Study|Lost to Follow-up|3|||
163483334|NCT00265382|590469853|FG000|Overall Study|Lack of Efficacy|6|||
163483335|NCT00265382|590469853|FG000|Overall Study|Miscellaneous|6|||
163483336|NCT00265382|590469853|FG000|Overall Study|Withdrawal by Subject|13|||
163483337|NCT00265382|590469853|FG000|Overall Study|Study terminated by sponsor|94|||
163483338|NCT00265382|590469853|FG000|Overall Study|Death|1|||
163483339|NCT01474993|590469858|FG000|Overall Study|Lost to Follow-up|1|||
163483340|NCT01474993|590469859|FG001|Overall Study|Lost to Follow-up|2|||
163483341|NCT01474993|590469858|FG000|Overall Study|Adverse Event|0|||
163483342|NCT01474993|590469859|FG001|Overall Study|Adverse Event|1|||
163483343|NCT00760994|590469862|FG000|Overall Study|Lost to Follow-up|4|||
163483344|NCT00760994|590469863|FG001|Overall Study|Lost to Follow-up|4|||
163483345|NCT00760994|590469864|FG002|Overall Study|Lost to Follow-up|3|||
163483346|NCT03258710|590469865|FG000|Overall Study|Adverse Event|1|||
163483347|NCT03258710|590469865|FG000|Overall Study|Protocol-defined stopping criteria|1|||
163483348|NCT03258710|590469865|FG000|Overall Study|Physician Decision|1|||
163483349|NCT03451630|590469866|FG000|Overall Study|Death|15|||
163483350|NCT03451630|590469867|FG001|Overall Study|Death|16|||
163483351|NCT03451630|590469868|FG002|Overall Study|Death|11|||
163483352|NCT03451630|590469866|FG000|Overall Study|Lost to Follow-up|9|||
163483353|NCT03451630|590469867|FG001|Overall Study|Lost to Follow-up|0|||
163483354|NCT03451630|590469868|FG002|Overall Study|Lost to Follow-up|4|||
163483355|NCT03451630|590469866|FG000|Overall Study|Withdrawal by Subject|0|||
163483356|NCT03451630|590469867|FG001|Overall Study|Withdrawal by Subject|3|||
163483357|NCT03451630|590469868|FG002|Overall Study|Withdrawal by Subject|0|||
163483358|NCT03451630|590469866|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
163483359|NCT03451630|590469867|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
163483360|NCT03451630|590469868|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
163483361|NCT02041533|590469870|FG000|Pre-Treatment Period|Disease Progression|1|||
163483362|NCT02041533|590469871|FG001|Pre-Treatment Period|Disease Progression|1|||
163483363|NCT02041533|590469870|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
163483364|NCT02041533|590469871|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
163483365|NCT02041533|590469870|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
163483366|NCT02041533|590469871|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
163483367|NCT02041533|590469870|FG000|Treatment Period|Disease progression|189|||
163483368|NCT02041533|590469871|FG001|Treatment Period|Disease progression|146|||
163483369|NCT02041533|590469870|FG000|Treatment Period|Study drug toxicity|30|||
163483370|NCT02041533|590469871|FG001|Treatment Period|Study drug toxicity|34|||
163483371|NCT02041533|590469870|FG000|Treatment Period|Death|1|||
163483372|NCT02041533|590469871|FG001|Treatment Period|Death|0|||
163483373|NCT02041533|590469870|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
163483374|NCT02041533|590469871|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
163483375|NCT02041533|590469870|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
163483376|NCT02041533|590469871|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
163483377|NCT02041533|590469870|FG000|Treatment Period|Participant withdrew consent|2|||
163483378|NCT02041533|590469871|FG001|Treatment Period|Participant withdrew consent|2|||
163483379|NCT02041533|590469870|FG000|Treatment Period|Maximum clinical benefit|0|||
163483380|NCT02041533|590469871|FG001|Treatment Period|Maximum clinical benefit|18|||
163483381|NCT02041533|590469870|FG000|Treatment Period|Poor/Non-compliance|1|||
163483382|NCT02041533|590469871|FG001|Treatment Period|Poor/Non-compliance|0|||
163483383|NCT02041533|590469870|FG000|Treatment Period|Administrative reason by sponsor|1|||
163483384|NCT02041533|590469871|FG001|Treatment Period|Administrative reason by sponsor|0|||
163483385|NCT02041533|590469870|FG000|Treatment Period|Other reasons|9|||
163483386|NCT02041533|590469871|FG001|Treatment Period|Other reasons|2|||
163483387|NCT02041533|590469870|FG000|Treatment Period|Not Reported|0|||
163483388|NCT02041533|590469871|FG001|Treatment Period|Not Reported|1|||
163483389|NCT00545740|590469872|FG000|Overall Study|Lack of Efficacy|34|||
163483390|NCT00545740|590469873|FG001|Overall Study|Lack of Efficacy|35|||
163483391|NCT00545740|590469874|FG002|Overall Study|Lack of Efficacy|47|||
163483392|NCT00545740|590469875|FG003|Overall Study|Lack of Efficacy|36|||
163483393|NCT00545740|590469872|FG000|Overall Study|Withdrawal by Subject|17|||
163483394|NCT00545740|590469873|FG001|Overall Study|Withdrawal by Subject|15|||
163483395|NCT00545740|590469874|FG002|Overall Study|Withdrawal by Subject|16|||
163483396|NCT00545740|590469875|FG003|Overall Study|Withdrawal by Subject|18|||
163483397|NCT00545740|590469872|FG000|Overall Study|Adverse Event|10|||
163483398|NCT00545740|590469873|FG001|Overall Study|Adverse Event|18|||
163483399|NCT00545740|590469874|FG002|Overall Study|Adverse Event|19|||
163483400|NCT00545740|590469875|FG003|Overall Study|Adverse Event|9|||
163483401|NCT00545740|590469872|FG000|Overall Study|Lost to Follow-up|7|||
163483402|NCT00545740|590469873|FG001|Overall Study|Lost to Follow-up|5|||
163483403|NCT00545740|590469874|FG002|Overall Study|Lost to Follow-up|5|||
163483404|NCT00545740|590469875|FG003|Overall Study|Lost to Follow-up|6|||
163483405|NCT00545740|590469872|FG000|Overall Study|Protocol Violation|1|||
163483406|NCT00545740|590469873|FG001|Overall Study|Protocol Violation|3|||
163483407|NCT00545740|590469874|FG002|Overall Study|Protocol Violation|1|||
163483408|NCT00545740|590469875|FG003|Overall Study|Protocol Violation|0|||
163483409|NCT00545740|590469872|FG000|Overall Study|Non-compliance|0|||
163483410|NCT00545740|590469873|FG001|Overall Study|Non-compliance|2|||
163483411|NCT00545740|590469874|FG002|Overall Study|Non-compliance|1|||
163483412|NCT00545740|590469875|FG003|Overall Study|Non-compliance|0|||
163483413|NCT00545740|590469872|FG000|Overall Study|Moved|2|||
163483414|NCT00545740|590469873|FG001|Overall Study|Moved|0|||
163483415|NCT00545740|590469874|FG002|Overall Study|Moved|1|||
163483416|NCT00545740|590469875|FG003|Overall Study|Moved|0|||
163483417|NCT00545740|590469872|FG000|Overall Study|Diverticulitis attack|0|||
163483418|NCT00545740|590469873|FG001|Overall Study|Diverticulitis attack|0|||
163483419|NCT00545740|590469874|FG002|Overall Study|Diverticulitis attack|1|||
163483420|NCT00545740|590469875|FG003|Overall Study|Diverticulitis attack|1|||
163483421|NCT00545740|590469872|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
163483422|NCT00545740|590469873|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
163483423|NCT00545740|590469874|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
163483424|NCT00545740|590469875|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
163483425|NCT00545740|590469872|FG000|Overall Study|Site closure|1|||
163483426|NCT00545740|590469873|FG001|Overall Study|Site closure|0|||
163483427|NCT00545740|590469874|FG002|Overall Study|Site closure|0|||
163483428|NCT00545740|590469875|FG003|Overall Study|Site closure|0|||
163483429|NCT00545740|590469872|FG000|Overall Study|Missed visit|1|||
163483430|NCT00545740|590469873|FG001|Overall Study|Missed visit|0|||
163483431|NCT00545740|590469874|FG002|Overall Study|Missed visit|0|||
163483432|NCT00545740|590469875|FG003|Overall Study|Missed visit|0|||
163483433|NCT00545740|590469872|FG000|Overall Study|Physician Decision|0|||
163483434|NCT00545740|590469873|FG001|Overall Study|Physician Decision|0|||
163483435|NCT00545740|590469874|FG002|Overall Study|Physician Decision|3|||
163483436|NCT00545740|590469875|FG003|Overall Study|Physician Decision|0|||
163483437|NCT00545740|590469872|FG000|Overall Study|Accepted only monthly telephone calls|1|||
163483438|NCT00545740|590469873|FG001|Overall Study|Accepted only monthly telephone calls|0|||
163483439|NCT00545740|590469874|FG002|Overall Study|Accepted only monthly telephone calls|0|||
163483440|NCT00545740|590469875|FG003|Overall Study|Accepted only monthly telephone calls|0|||
163483441|NCT00545740|590469872|FG000|Overall Study|Sponsor decision|0|||
163483442|NCT00545740|590469873|FG001|Overall Study|Sponsor decision|1|||
163483443|NCT00545740|590469874|FG002|Overall Study|Sponsor decision|0|||
163483444|NCT00545740|590469875|FG003|Overall Study|Sponsor decision|0|||
163483445|NCT00545740|590469872|FG000|Overall Study|Lack of time|0|||
163483446|NCT00545740|590469873|FG001|Overall Study|Lack of time|1|||
163483447|NCT00545740|590469874|FG002|Overall Study|Lack of time|0|||
163483448|NCT00545740|590469875|FG003|Overall Study|Lack of time|0|||
163483449|NCT00545740|590469872|FG000|Overall Study|Non-adherence to visits|0|||
163483450|NCT00545740|590469873|FG001|Overall Study|Non-adherence to visits|1|||
163483451|NCT00545740|590469874|FG002|Overall Study|Non-adherence to visits|0|||
163483452|NCT00545740|590469875|FG003|Overall Study|Non-adherence to visits|0|||
163483453|NCT00545740|590469872|FG000|Overall Study|Patient difficulties|0|||
163483454|NCT00545740|590469873|FG001|Overall Study|Patient difficulties|1|||
163483455|NCT00545740|590469874|FG002|Overall Study|Patient difficulties|0|||
163483456|NCT00545740|590469875|FG003|Overall Study|Patient difficulties|0|||
163483457|NCT00545740|590469872|FG000|Overall Study|Husband against study|0|||
163483458|NCT00545740|590469873|FG001|Overall Study|Husband against study|0|||
163483459|NCT00545740|590469874|FG002|Overall Study|Husband against study|1|||
163483460|NCT00545740|590469875|FG003|Overall Study|Husband against study|0|||
163483461|NCT02117024|590469876|FG000|Overall Study|Progressive Disease|26|||
163483462|NCT02117024|590469877|FG001|Overall Study|Progressive Disease|9|||
163483463|NCT02117024|590469876|FG000|Overall Study|Significant Clinical Progression|7|||
163483464|NCT02117024|590469877|FG001|Overall Study|Significant Clinical Progression|4|||
163483465|NCT02117024|590469876|FG000|Overall Study|Death|5|||
163483466|NCT02117024|590469877|FG001|Overall Study|Death|0|||
163483467|NCT02117024|590469876|FG000|Overall Study|Withdrawal by Subject|3|||
163483468|NCT02117024|590469877|FG001|Overall Study|Withdrawal by Subject|1|||
163483469|NCT02117024|590469876|FG000|Overall Study|Protocol Violation|1|||
163483470|NCT02117024|590469877|FG001|Overall Study|Protocol Violation|0|||
163483471|NCT02117024|590469876|FG000|Overall Study|Adverse Event|1|||
163483472|NCT02117024|590469877|FG001|Overall Study|Adverse Event|2|||
163483473|NCT02117024|590469876|FG000|Overall Study|Randomized in Error|1|||
163483474|NCT02117024|590469877|FG001|Overall Study|Randomized in Error|0|||
163483475|NCT02117024|590469876|FG000|Overall Study|Patient returned to primary oncologist|0|||
163483476|NCT02117024|590469877|FG001|Overall Study|Patient returned to primary oncologist|1|||
163483477|NCT02117024|590469876|FG000|Overall Study|Patient took treatment break|0|||
163483478|NCT02117024|590469877|FG001|Overall Study|Patient took treatment break|1|||
163483479|NCT02117024|590469876|FG000|Overall Study|Physician Decision|0|||
163483480|NCT02117024|590469877|FG001|Overall Study|Physician Decision|2|||
163483481|NCT01957111|590469878|FG000|Overall Study|Withdrawal by Subject|1|||
163483482|NCT01957111|590469879|FG001|Overall Study|Withdrawal by Subject|1|||
163483483|NCT01646255|590469880|FG000|Overall Study|Adverse Event|7|||
163483484|NCT01646255|590469881|FG001|Overall Study|Adverse Event|8|||
163483485|NCT01646255|590469880|FG000|Overall Study|Lack of Efficacy|2|||
163483486|NCT01646255|590469881|FG001|Overall Study|Lack of Efficacy|0|||
163483487|NCT01646255|590469880|FG000|Overall Study|Withdrawal by Subject|10|||
163483488|NCT01646255|590469881|FG001|Overall Study|Withdrawal by Subject|6|||
163483489|NCT01646255|590469880|FG000|Overall Study|Compliance is not well|1|||
163483490|NCT01646255|590469881|FG001|Overall Study|Compliance is not well|0|||
163483491|NCT01646255|590469880|FG000|Overall Study|Inclusion Criteria Deviation|1|||
163483492|NCT01646255|590469881|FG001|Overall Study|Inclusion Criteria Deviation|0|||
163483493|NCT01468844|590469882|FG000|Overall Study|Adverse Event|1|||
163483494|NCT01468844|590469883|FG001|Overall Study|Adverse Event|0|||
163483495|NCT01468844|590469882|FG000|Overall Study|Withdrawal by Subject|1|||
163483496|NCT01468844|590469883|FG001|Overall Study|Withdrawal by Subject|0|||
163483497|NCT01241318|590469890|FG000|Overall Study|Woman: false pregnancies|27|||
163483498|NCT01241318|590469891|FG001|Overall Study|Woman: false pregnancies|15|||
163483499|NCT01241318|590469890|FG000|Overall Study|Woman: miscarriage/abortion|46|||
163483500|NCT01241318|590469891|FG001|Overall Study|Woman: miscarriage/abortion|38|||
163483501|NCT01241318|590469890|FG000|Overall Study|Withdrawal by Subject|175|||
163483502|NCT01241318|590469891|FG001|Overall Study|Withdrawal by Subject|46|||
163483503|NCT01241318|590469890|FG000|Overall Study|Lost to Follow-up|740|||
163483504|NCT01241318|590469891|FG001|Overall Study|Lost to Follow-up|455|||
163483505|NCT01241318|590469890|FG000|Overall Study|Death|2|||
163483506|NCT01241318|590469891|FG001|Overall Study|Death|4|||
163483507|NCT01241318|590469890|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
163483508|NCT01241318|590469891|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
163483509|NCT01241318|590469890|FG000|Overall Study|Woman: Stillborn infant|129|||
163483510|NCT01241318|590469891|FG001|Overall Study|Woman: Stillborn infant|146|||
163483511|NCT02355665|590469892|FG000|Overall Study|Adverse Event|16|||
163483512|NCT02355665|590469893|FG001|Overall Study|Adverse Event|24|||
163483513|NCT02355665|590469892|FG000|Overall Study|Protocol Violation|2|||
163483514|NCT02355665|590469893|FG001|Overall Study|Protocol Violation|0|||
163483515|NCT02355665|590469892|FG000|Overall Study|Withdrawal by Subject|90|||
163483516|NCT02355665|590469893|FG001|Overall Study|Withdrawal by Subject|100|||
163483517|NCT02355665|590469892|FG000|Overall Study|Lost to Follow-up|131|||
163483518|NCT02355665|590469893|FG001|Overall Study|Lost to Follow-up|103|||
163483519|NCT02355665|590469892|FG000|Overall Study|Death|4|||
163483520|NCT02355665|590469893|FG001|Overall Study|Death|2|||
163483521|NCT02355665|590469892|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
163483522|NCT02355665|590469893|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
163483523|NCT02380703|590469896|FG000|Overall Study|Withdrawal by Subject|12|||
163483524|NCT02380703|590469897|FG001|Overall Study|Withdrawal by Subject|9|||
163483525|NCT02380703|590469896|FG000|Overall Study|Lost to Follow-up|12|||
163483526|NCT02380703|590469897|FG001|Overall Study|Lost to Follow-up|12|||
163483527|NCT02380703|590469896|FG000|Overall Study|Caregiver death|1|||
163483528|NCT02380703|590469897|FG001|Overall Study|Caregiver death|0|||
163483529|NCT02380703|590469896|FG000|Overall Study|Person with dementia (PWD) death|7|||
163483530|NCT02380703|590469897|FG001|Overall Study|Person with dementia (PWD) death|8|||
163483531|NCT02380703|590469896|FG000|Overall Study|Entered Long-term Care|4|||
163483532|NCT02380703|590469897|FG001|Overall Study|Entered Long-term Care|7|||
163483533|NCT03607994|590469898|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
163483534|NCT03607994|590469899|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
163483535|NCT02853318|590469908|FG000|Overall Study|Withdrawal by Subject|1|||
163483536|NCT04490499|590469914|FG000|Overall Study|Withdrawal by Subject|2|||
163483537|NCT01882439|590469917|FG000|Overall Study|Adverse event related to study drug|3|||
163483538|NCT01882439|590469918|FG001|Overall Study|Adverse event related to study drug|8|||
163483539|NCT01882439|590469919|FG002|Overall Study|Adverse event related to study drug|1|||
163483540|NCT01882439|590469920|FG003|Overall Study|Adverse event related to study drug|2|||
163483541|NCT01882439|590469917|FG000|Overall Study|Pregnancy|0|||
163483542|NCT01882439|590469918|FG001|Overall Study|Pregnancy|1|||
163483543|NCT01882439|590469919|FG002|Overall Study|Pregnancy|0|||
163483544|NCT01882439|590469920|FG003|Overall Study|Pregnancy|0|||
163483545|NCT01882439|590469917|FG000|Overall Study|Protocol Violation|2|||
163483546|NCT01882439|590469918|FG001|Overall Study|Protocol Violation|2|||
163483547|NCT01882439|590469919|FG002|Overall Study|Protocol Violation|0|||
163483548|NCT01882439|590469920|FG003|Overall Study|Protocol Violation|1|||
163483549|NCT01882439|590469917|FG000|Overall Study|No longer willing to participate|1|||
163483550|NCT01882439|590469918|FG001|Overall Study|No longer willing to participate|4|||
163483551|NCT01882439|590469919|FG002|Overall Study|No longer willing to participate|2|||
163483552|NCT01882439|590469920|FG003|Overall Study|No longer willing to participate|3|||
163483553|NCT01882439|590469917|FG000|Overall Study|Medication error with no associated AE|0|||
163483554|NCT01882439|590469918|FG001|Overall Study|Medication error with no associated AE|0|||
163483555|NCT01882439|590469919|FG002|Overall Study|Medication error with no associated AE|2|||
163483556|NCT01882439|590469920|FG003|Overall Study|Medication error with no associated AE|0|||
163483557|NCT01882439|590469917|FG000|Overall Study|Insufficient clinical response|1|||
163483558|NCT01882439|590469918|FG001|Overall Study|Insufficient clinical response|4|||
163483559|NCT01882439|590469919|FG002|Overall Study|Insufficient clinical response|4|||
163483560|NCT01882439|590469920|FG003|Overall Study|Insufficient clinical response|2|||
163483561|NCT01882439|590469917|FG000|Overall Study|Adverse event unrelated to study drug|2|||
163483562|NCT01882439|590469918|FG001|Overall Study|Adverse event unrelated to study drug|2|||
163483563|NCT01882439|590469919|FG002|Overall Study|Adverse event unrelated to study drug|1|||
163483564|NCT01882439|590469920|FG003|Overall Study|Adverse event unrelated to study drug|1|||
163483565|NCT03125902|590469923|FG000|Overall Study|Adverse Event|0|||
163483566|NCT03125902|590469924|FG001|Overall Study|Adverse Event|1|||
163483567|NCT03125902|590469923|FG000|Overall Study|Death|119|||
163483568|NCT03125902|590469924|FG001|Overall Study|Death|229|||
163483569|NCT03125902|590469923|FG000|Overall Study|Lost to Follow-up|4|||
163483570|NCT03125902|590469924|FG001|Overall Study|Lost to Follow-up|13|||
163483571|NCT03125902|590469923|FG000|Overall Study|Other|0|||
163483572|NCT03125902|590469924|FG001|Overall Study|Other|4|||
163483573|NCT03125902|590469923|FG000|Overall Study|Physician Decision|2|||
163483574|NCT03125902|590469924|FG001|Overall Study|Physician Decision|1|||
163483575|NCT03125902|590469923|FG000|Overall Study|Progressive Disease|0|||
163483576|NCT03125902|590469924|FG001|Overall Study|Progressive Disease|3|||
163483577|NCT03125902|590469923|FG000|Overall Study|Study Terminated By Sponsor|74|||
163483578|NCT03125902|590469924|FG001|Overall Study|Study Terminated By Sponsor|143|||
163483579|NCT03125902|590469923|FG000|Overall Study|Withdrawal by Subject|21|||
163483580|NCT03125902|590469924|FG001|Overall Study|Withdrawal by Subject|37|||
163483581|NCT01997333|590469925|FG000|Randomization and Treatment|Disease Progression|70|||
163483582|NCT01997333|590469926|FG001|Randomization and Treatment|Disease Progression|159|||
163483583|NCT01997333|590469925|FG000|Randomization and Treatment|Adverse Event|10|||
163483584|NCT01997333|590469926|FG001|Randomization and Treatment|Adverse Event|32|||
163483585|NCT01997333|590469925|FG000|Randomization and Treatment|Physician Decision|0|||
163483586|NCT01997333|590469926|FG001|Randomization and Treatment|Physician Decision|4|||
163483587|NCT01997333|590469925|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
163483588|NCT01997333|590469926|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
163483589|NCT01997333|590469925|FG000|Randomization and Treatment|Did not receive treatment|17|||
163483590|NCT01997333|590469926|FG001|Randomization and Treatment|Did not receive treatment|5|||
163483591|NCT01997333|590469925|FG000|Survival Follow up|Withdrawal by Subject|15|||
163483592|NCT01997333|590469926|FG001|Survival Follow up|Withdrawal by Subject|6|||
163483593|NCT01997333|590469925|FG000|Survival Follow up|Lost to Follow-up|0|||
163483594|NCT01997333|590469926|FG001|Survival Follow up|Lost to Follow-up|6|||
163483595|NCT01997333|590469925|FG000|Survival Follow up|Various|1|||
163483596|NCT01997333|590469926|FG001|Survival Follow up|Various|2|||
163483597|NCT02269709|590469927|FG000|Time of Enrollment|Withdrawal by Subject|3|||
163483598|NCT02269709|590469927|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
163483599|NCT02269709|590469927|FG000|Six Month Follow-up|Lost to Follow-up|12|||
163483600|NCT04411472|590469928|FG000|Overall Study|Adverse Event|5|||
163483601|NCT04411472|590469929|FG001|Overall Study|Adverse Event|10|||
163483602|NCT04411472|590469930|FG002|Overall Study|Adverse Event|1|||
163483603|NCT04411472|590469931|FG003|Overall Study|Adverse Event|0|||
163483604|NCT04411472|590469932|FG004|Overall Study|Adverse Event|0|||
163483605|NCT04411472|590469933|FG005|Overall Study|Adverse Event|0|||
163483606|NCT04411472|590469928|FG000|Overall Study|Protocol Violation|1|||
163483607|NCT04411472|590469929|FG001|Overall Study|Protocol Violation|0|||
163483608|NCT04411472|590469930|FG002|Overall Study|Protocol Violation|0|||
163483609|NCT04411472|590469931|FG003|Overall Study|Protocol Violation|0|||
163483610|NCT04411472|590469932|FG004|Overall Study|Protocol Violation|0|||
163483611|NCT04411472|590469933|FG005|Overall Study|Protocol Violation|0|||
163483612|NCT04411472|590469928|FG000|Overall Study|Withdrawal by Subject|0|||
163483613|NCT04411472|590469929|FG001|Overall Study|Withdrawal by Subject|1|||
163483614|NCT04411472|590469930|FG002|Overall Study|Withdrawal by Subject|0|||
163483615|NCT04411472|590469931|FG003|Overall Study|Withdrawal by Subject|1|||
163483616|NCT04411472|590469932|FG004|Overall Study|Withdrawal by Subject|0|||
163483617|NCT04411472|590469933|FG005|Overall Study|Withdrawal by Subject|0|||
163483618|NCT04411472|590469928|FG000|Overall Study|Physician Decision|1|||
163483619|NCT04411472|590469929|FG001|Overall Study|Physician Decision|0|||
163483620|NCT04411472|590469930|FG002|Overall Study|Physician Decision|0|||
163483621|NCT04411472|590469931|FG003|Overall Study|Physician Decision|0|||
163483622|NCT04411472|590469932|FG004|Overall Study|Physician Decision|0|||
163483623|NCT04411472|590469933|FG005|Overall Study|Physician Decision|0|||
163483624|NCT04411472|590469928|FG000|Overall Study|Study terminated by sponsor|17|||
163483625|NCT04411472|590469929|FG001|Overall Study|Study terminated by sponsor|20|||
163483626|NCT04411472|590469930|FG002|Overall Study|Study terminated by sponsor|3|||
163483627|NCT04411472|590469931|FG003|Overall Study|Study terminated by sponsor|0|||
163483628|NCT04411472|590469932|FG004|Overall Study|Study terminated by sponsor|0|||
163483629|NCT04411472|590469933|FG005|Overall Study|Study terminated by sponsor|0|||
163483630|NCT00440232|590469936|FG000|Overall Study|Lost to Follow-up|1|||
163483631|NCT00440232|590469937|FG001|Overall Study|Lost to Follow-up|1|||
163483632|NCT00440232|590469936|FG000|Overall Study|Unable to treat within allowed time|0|||
163483633|NCT00440232|590469937|FG001|Overall Study|Unable to treat within allowed time|1|||
163483634|NCT00440232|590469936|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
163483635|NCT00440232|590469937|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
163483636|NCT00362297|590469938|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
163483637|NCT00362297|590469939|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
163483638|NCT00819052|590469940|FG000|Overall Study|Adverse Event|0|||
163483639|NCT00819052|590469941|FG001|Overall Study|Adverse Event|5|||
163483640|NCT00819052|590469940|FG000|Overall Study|Protocol Violation|1|||
163483641|NCT00819052|590469941|FG001|Overall Study|Protocol Violation|2|||
163483642|NCT00819052|590469940|FG000|Overall Study|Lost to Follow-up|1|||
163483643|NCT00819052|590469941|FG001|Overall Study|Lost to Follow-up|2|||
163483644|NCT00819052|590469940|FG000|Overall Study|Withdrawal by Subject|1|||
163483645|NCT00819052|590469941|FG001|Overall Study|Withdrawal by Subject|2|||
163483646|NCT00819052|590469940|FG000|Overall Study|Lack of Efficacy|1|||
163483647|NCT00819052|590469941|FG001|Overall Study|Lack of Efficacy|1|||
163483648|NCT00819052|590469940|FG000|Overall Study|Pregnancy|1|||
163483649|NCT00819052|590469941|FG001|Overall Study|Pregnancy|2|||
163483650|NCT00819052|590469940|FG000|Overall Study|Death or events leading to death|1|||
163483651|NCT00819052|590469941|FG001|Overall Study|Death or events leading to death|0|||
163483652|NCT01747655|590469944|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
163483653|NCT01747655|590469945|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
163483654|NCT01747655|590469944|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
163483655|NCT01747655|590469945|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
163483656|NCT01747655|590469944|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
163483657|NCT01747655|590469945|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
163483658|NCT00982111|590469948|FG000|Overall Study|Adverse Event|1|||
163483659|NCT00982111|590469949|FG001|Overall Study|Adverse Event|1|||
163483660|NCT00982111|590469948|FG000|Overall Study|Progressive Disease|46|||
163483661|NCT00982111|590469949|FG001|Overall Study|Progressive Disease|39|||
163483662|NCT00982111|590469948|FG000|Overall Study|Lost to Follow-up|9|||
163483663|NCT00982111|590469949|FG001|Overall Study|Lost to Follow-up|6|||
163483664|NCT00982111|590469948|FG000|Overall Study|New Anti-Cancer Therapy|5|||
163483665|NCT00982111|590469949|FG001|Overall Study|New Anti-Cancer Therapy|5|||
163483666|NCT00982111|590469948|FG000|Overall Study|Medical Decision|1|||
163483667|NCT00982111|590469949|FG001|Overall Study|Medical Decision|0|||
163483668|NCT00982111|590469948|FG000|Overall Study|Withdrawal by Subject|17|||
163483669|NCT00982111|590469949|FG001|Overall Study|Withdrawal by Subject|19|||
163483670|NCT00982111|590469948|FG000|Overall Study|Global Study End|0|||
163483671|NCT00982111|590469949|FG001|Overall Study|Global Study End|1|||
163483672|NCT00982111|590469948|FG000|Overall Study|Sponsor's Decision|0|||
163483673|NCT00982111|590469949|FG001|Overall Study|Sponsor's Decision|1|||
163483674|NCT03769753|590469950|FG000|Overall Study|Not Treated|6|||
163483675|NCT03769753|590469950|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
163483676|NCT01070381|590469951|FG000|Period 2, 1 Week of Wear|Handling|0|||
163483677|NCT01070381|590469952|FG001|Period 2, 1 Week of Wear|Handling|1|||
163483678|NCT01070381|590469951|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
163483679|NCT01070381|590469952|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
163483680|NCT00684073|590469953|FG000|Selection|Selection/non-selection criteria|3|||
163483681|NCT00684073|590469953|FG000|Selection|Death|1|||
163483682|NCT00684073|590469953|FG000|Selection|noncompliance|1|||
163483683|NCT00684073|590469953|FG000|Selection|Lost to Follow-up|1|||
163483684|NCT00684073|590469953|FG000|Selection|request of the sponsor|1|||
163483685|NCT00684073|590469953|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
163483686|NCT01259388|590469955|FG000|Overall Study|Adverse Event|3|||
163483687|NCT01259388|590469956|FG001|Overall Study|Adverse Event|0|||
163483688|NCT01259388|590469955|FG000|Overall Study|Withdrawal by Subject|1|||
163483689|NCT01259388|590469956|FG001|Overall Study|Withdrawal by Subject|1|||
163483690|NCT01259388|590469955|FG000|Overall Study|Physician Decision|1|||
163483691|NCT01259388|590469956|FG001|Overall Study|Physician Decision|0|||
163483692|NCT00620815|590469957|FG000|Overall Study|Adverse Event|1|||
163483693|NCT00620815|590469958|FG001|Overall Study|Adverse Event|1|||
163483694|NCT00620815|590469959|FG002|Overall Study|Adverse Event|2|||
163483695|NCT00620815|590469957|FG000|Overall Study|Withdrawal by Subject|1|||
163483696|NCT00620815|590469958|FG001|Overall Study|Withdrawal by Subject|2|||
163483697|NCT00620815|590469959|FG002|Overall Study|Withdrawal by Subject|0|||
163483698|NCT00620815|590469957|FG000|Overall Study|Lost to Follow-up|1|||
163483699|NCT00620815|590469958|FG001|Overall Study|Lost to Follow-up|6|||
163483700|NCT00620815|590469959|FG002|Overall Study|Lost to Follow-up|3|||
163483701|NCT00620815|590469957|FG000|Overall Study|Inappropriate enrolment|0|||
163483702|NCT00620815|590469958|FG001|Overall Study|Inappropriate enrolment|0|||
163483703|NCT00620815|590469959|FG002|Overall Study|Inappropriate enrolment|1|||
163483704|NCT00620815|590469957|FG000|Overall Study|Protocol Violation|1|||
163483705|NCT00620815|590469958|FG001|Overall Study|Protocol Violation|2|||
163483706|NCT00620815|590469959|FG002|Overall Study|Protocol Violation|1|||
163483707|NCT00983827|590469960|FG000|Overall Study|Withdrawal by Subject|1|||
163483708|NCT01230827|590469961|FG000|Overall Study|Lost to Follow-up|0|||
163483709|NCT01230827|590469962|FG001|Overall Study|Lost to Follow-up|0|||
163483710|NCT01230827|590469963|FG002|Overall Study|Lost to Follow-up|1|||
163483711|NCT01230827|590469964|FG003|Overall Study|Lost to Follow-up|3|||
163483712|NCT01230827|590469961|FG000|Overall Study|Withdrawal by Subject|1|||
163483713|NCT01230827|590469962|FG001|Overall Study|Withdrawal by Subject|0|||
163483714|NCT01230827|590469963|FG002|Overall Study|Withdrawal by Subject|3|||
163483715|NCT01230827|590469964|FG003|Overall Study|Withdrawal by Subject|2|||
163483716|NCT01230827|590469961|FG000|Overall Study|Lack of Efficacy|14|||
163483717|NCT01230827|590469962|FG001|Overall Study|Lack of Efficacy|1|||
163483718|NCT01230827|590469963|FG002|Overall Study|Lack of Efficacy|2|||
163483719|NCT01230827|590469964|FG003|Overall Study|Lack of Efficacy|3|||
163483720|NCT01230827|590469961|FG000|Overall Study|Adverse Event|4|||
163483721|NCT01230827|590469962|FG001|Overall Study|Adverse Event|2|||
163483722|NCT01230827|590469963|FG002|Overall Study|Adverse Event|3|||
163483723|NCT01230827|590469964|FG003|Overall Study|Adverse Event|7|||
163483724|NCT01230827|590469961|FG000|Overall Study|Recovery|0|||
163483725|NCT01230827|590469962|FG001|Overall Study|Recovery|6|||
163483726|NCT01230827|590469963|FG002|Overall Study|Recovery|0|||
163483727|NCT01230827|590469964|FG003|Overall Study|Recovery|0|||
163483728|NCT01230827|590469961|FG000|Overall Study|Study terminated by Sponsor|0|||
163483729|NCT01230827|590469962|FG001|Overall Study|Study terminated by Sponsor|2|||
163483730|NCT01230827|590469963|FG002|Overall Study|Study terminated by Sponsor|56|||
163483731|NCT01230827|590469964|FG003|Overall Study|Study terminated by Sponsor|63|||
163483732|NCT02728804|590469970|FG000|Overall Study|Ineligible|3|||
163483733|NCT02728804|590469970|FG000|Overall Study|Did not complete baseline questionnaire|9|||
163483734|NCT02728804|590469970|FG000|Overall Study|Death|99|||
163483735|NCT01888367|590469971|FG000|Overall Study|Physician Decision|3|||
163483736|NCT01888367|590469972|FG001|Overall Study|Physician Decision|4|||
163483737|NCT01888367|590469973|FG002|Overall Study|Physician Decision|2|||
163483738|NCT01888367|590469971|FG000|Overall Study|Death|2|||
163483739|NCT01888367|590469972|FG001|Overall Study|Death|0|||
163483740|NCT01888367|590469973|FG002|Overall Study|Death|1|||
163483741|NCT01888367|590469971|FG000|Overall Study|Withdrawal by Subject|1|||
163483742|NCT01888367|590469972|FG001|Overall Study|Withdrawal by Subject|0|||
163483743|NCT01888367|590469973|FG002|Overall Study|Withdrawal by Subject|1|||
163483744|NCT01888367|590469971|FG000|Overall Study|Lost to Follow-up|1|||
163483745|NCT01888367|590469972|FG001|Overall Study|Lost to Follow-up|1|||
163483746|NCT01888367|590469973|FG002|Overall Study|Lost to Follow-up|0|||
163483747|NCT01888367|590469971|FG000|Overall Study|Protocol Violation|0|||
163483748|NCT01888367|590469972|FG001|Overall Study|Protocol Violation|0|||
163483749|NCT01888367|590469973|FG002|Overall Study|Protocol Violation|1|||
163483750|NCT01888367|590469971|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
163483751|NCT01888367|590469972|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
163483752|NCT01888367|590469973|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
163483753|NCT00591786|590469974|FG000|Overall Study|Withdrawal of Informed Consent|0|||
163483754|NCT00591786|590469975|FG001|Overall Study|Withdrawal of Informed Consent|0|||
163483755|NCT00591786|590469976|FG002|Overall Study|Withdrawal of Informed Consent|1|||
163483756|NCT00591786|590469977|FG003|Overall Study|Withdrawal of Informed Consent|0|||
163483757|NCT00591786|590469978|FG004|Overall Study|Withdrawal of Informed Consent|0|||
163483758|NCT00591786|590469979|FG005|Overall Study|Withdrawal of Informed Consent|0|||
163483759|NCT00591786|590469980|FG006|Overall Study|Withdrawal of Informed Consent|0|||
163483760|NCT00591786|590469981|FG007|Overall Study|Withdrawal of Informed Consent|0|||
163483761|NCT00591786|590469982|FG008|Overall Study|Withdrawal of Informed Consent|0|||
163483762|NCT00591786|590469983|FG009|Overall Study|Withdrawal of Informed Consent|0|||
163483763|NCT01920061|590469985|FG000|Overall Study|Death|1|||
163483764|NCT01920061|590469986|FG001|Overall Study|Death|1|||
163483765|NCT01920061|590469987|FG002|Overall Study|Death|0|||
163483766|NCT01920061|590469988|FG003|Overall Study|Death|1|||
163483767|NCT01920061|590469989|FG004|Overall Study|Death|1|||
163483768|NCT01920061|590469990|FG005|Overall Study|Death|0|||
163483769|NCT01920061|590469991|FG006|Overall Study|Death|0|||
163483770|NCT01920061|590469992|FG007|Overall Study|Death|1|||
163483771|NCT01920061|590469993|FG008|Overall Study|Death|0|||
163483772|NCT01920061|590469994|FG009|Overall Study|Death|1|||
163483773|NCT01920061|590469995|FG010|Overall Study|Death|0|||
163483774|NCT01920061|590469996|FG011|Overall Study|Death|1|||
163483775|NCT01920061|590469997|FG012|Overall Study|Death|0|||
163483776|NCT01920061|590469998|FG013|Overall Study|Death|2|||
163483777|NCT01920061|590469999|FG014|Overall Study|Death|0|||
163483778|NCT01920061|590470000|FG015|Overall Study|Death|0|||
163483779|NCT01920061|590470001|FG016|Overall Study|Death|0|||
163483780|NCT01920061|590470002|FG017|Overall Study|Death|0|||
163483781|NCT01920061|590470003|FG018|Overall Study|Death|1|||
163483782|NCT01920061|590470004|FG019|Overall Study|Death|0|||
163483783|NCT01920061|590469985|FG000|Overall Study|Lost to Follow-up|0|||
163483784|NCT01920061|590469986|FG001|Overall Study|Lost to Follow-up|2|||
163483785|NCT01920061|590469987|FG002|Overall Study|Lost to Follow-up|0|||
163483786|NCT01920061|590469988|FG003|Overall Study|Lost to Follow-up|0|||
163483787|NCT01920061|590469989|FG004|Overall Study|Lost to Follow-up|0|||
163483788|NCT01920061|590469990|FG005|Overall Study|Lost to Follow-up|0|||
163483789|NCT01920061|590469991|FG006|Overall Study|Lost to Follow-up|1|||
163483790|NCT01920061|590469992|FG007|Overall Study|Lost to Follow-up|0|||
163483791|NCT01920061|590469993|FG008|Overall Study|Lost to Follow-up|0|||
163483792|NCT01920061|590469994|FG009|Overall Study|Lost to Follow-up|0|||
163483793|NCT01920061|590469995|FG010|Overall Study|Lost to Follow-up|3|||
163483794|NCT01920061|590469996|FG011|Overall Study|Lost to Follow-up|0|||
163483795|NCT01920061|590469997|FG012|Overall Study|Lost to Follow-up|0|||
163483796|NCT01920061|590469998|FG013|Overall Study|Lost to Follow-up|0|||
163483797|NCT01920061|590469999|FG014|Overall Study|Lost to Follow-up|0|||
163483798|NCT01920061|590470000|FG015|Overall Study|Lost to Follow-up|0|||
163483799|NCT01920061|590470001|FG016|Overall Study|Lost to Follow-up|0|||
163483800|NCT01920061|590470002|FG017|Overall Study|Lost to Follow-up|1|||
163483801|NCT01920061|590470003|FG018|Overall Study|Lost to Follow-up|4|||
163483802|NCT01920061|590470004|FG019|Overall Study|Lost to Follow-up|3|||
163483803|NCT01920061|590469985|FG000|Overall Study|Other|1|||
163483804|NCT01920061|590469986|FG001|Overall Study|Other|1|||
163483805|NCT01920061|590469987|FG002|Overall Study|Other|2|||
163483806|NCT01920061|590469988|FG003|Overall Study|Other|1|||
163483807|NCT01920061|590469989|FG004|Overall Study|Other|0|||
163483808|NCT01920061|590469990|FG005|Overall Study|Other|1|||
163483809|NCT01920061|590469991|FG006|Overall Study|Other|0|||
163483810|NCT01920061|590469992|FG007|Overall Study|Other|0|||
163483811|NCT01920061|590469993|FG008|Overall Study|Other|0|||
163483812|NCT01920061|590469994|FG009|Overall Study|Other|1|||
163483813|NCT01920061|590469995|FG010|Overall Study|Other|1|||
163483814|NCT01920061|590469996|FG011|Overall Study|Other|2|||
163483815|NCT01920061|590469997|FG012|Overall Study|Other|1|||
163483816|NCT01920061|590469998|FG013|Overall Study|Other|4|||
163483817|NCT01920061|590469999|FG014|Overall Study|Other|0|||
163483818|NCT01920061|590470000|FG015|Overall Study|Other|1|||
163483819|NCT01920061|590470001|FG016|Overall Study|Other|1|||
163483820|NCT01920061|590470002|FG017|Overall Study|Other|0|||
163483821|NCT01920061|590470003|FG018|Overall Study|Other|1|||
163483822|NCT01920061|590470004|FG019|Overall Study|Other|1|||
163483823|NCT01920061|590469985|FG000|Overall Study|Participant refused further follow-up|0|||
163483824|NCT01920061|590469986|FG001|Overall Study|Participant refused further follow-up|0|||
163483825|NCT01920061|590469987|FG002|Overall Study|Participant refused further follow-up|0|||
163483826|NCT01920061|590469988|FG003|Overall Study|Participant refused further follow-up|0|||
163483827|NCT01920061|590469989|FG004|Overall Study|Participant refused further follow-up|1|||
163483828|NCT01920061|590469990|FG005|Overall Study|Participant refused further follow-up|1|||
163483829|NCT01920061|590469991|FG006|Overall Study|Participant refused further follow-up|0|||
163483830|NCT01920061|590469992|FG007|Overall Study|Participant refused further follow-up|0|||
163483831|NCT01920061|590469993|FG008|Overall Study|Participant refused further follow-up|1|||
163483832|NCT01920061|590469994|FG009|Overall Study|Participant refused further follow-up|0|||
163483833|NCT01920061|590469995|FG010|Overall Study|Participant refused further follow-up|1|||
163483834|NCT01920061|590469996|FG011|Overall Study|Participant refused further follow-up|0|||
163483835|NCT01920061|590469997|FG012|Overall Study|Participant refused further follow-up|1|||
163483836|NCT01920061|590469998|FG013|Overall Study|Participant refused further follow-up|0|||
163483837|NCT01920061|590469999|FG014|Overall Study|Participant refused further follow-up|1|||
163483838|NCT01920061|590470000|FG015|Overall Study|Participant refused further follow-up|2|||
163483839|NCT01920061|590470001|FG016|Overall Study|Participant refused further follow-up|1|||
163483840|NCT01920061|590470002|FG017|Overall Study|Participant refused further follow-up|1|||
163483841|NCT01920061|590470003|FG018|Overall Study|Participant refused further follow-up|0|||
163483842|NCT01920061|590470004|FG019|Overall Study|Participant refused further follow-up|0|||
163483843|NCT03969589|590470008|FG000|Overall Study|Lost to Follow-up|3|||
163483844|NCT03969589|590470009|FG001|Overall Study|Lost to Follow-up|2|||
163483845|NCT03969589|590470008|FG000|Overall Study|Declined Follow-Up|0|||
163483846|NCT03969589|590470009|FG001|Overall Study|Declined Follow-Up|1|||
163483847|NCT00453349|590470010|FG000|Randomized|Adverse Event|12|||
163483848|NCT00453349|590470011|FG001|Randomized|Adverse Event|11|||
163483849|NCT00453349|590470010|FG000|Randomized|Lack of Efficacy|2|||
163483850|NCT00453349|590470011|FG001|Randomized|Lack of Efficacy|1|||
163483851|NCT00453349|590470010|FG000|Randomized|Lost to Follow-up|7|||
163483852|NCT00453349|590470011|FG001|Randomized|Lost to Follow-up|5|||
163483853|NCT00453349|590470010|FG000|Randomized|Protocol Violation|1|||
163483854|NCT00453349|590470011|FG001|Randomized|Protocol Violation|1|||
163483855|NCT00453349|590470010|FG000|Randomized|Withdrawal by Subject|3|||
163483856|NCT00453349|590470011|FG001|Randomized|Withdrawal by Subject|5|||
163483857|NCT00453349|590470010|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
163483858|NCT00453349|590470011|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
163483859|NCT00453349|590470010|FG000|Completed Study|Adverse Event|12|||
163483860|NCT00453349|590470011|FG001|Completed Study|Adverse Event|11|||
163483861|NCT00453349|590470010|FG000|Completed Study|Lack of Efficacy|2|||
163483862|NCT00453349|590470011|FG001|Completed Study|Lack of Efficacy|1|||
163483863|NCT00453349|590470010|FG000|Completed Study|Lost to Follow-up|7|||
163483864|NCT00453349|590470011|FG001|Completed Study|Lost to Follow-up|5|||
163483865|NCT00453349|590470010|FG000|Completed Study|Protocol Violation|1|||
163483866|NCT00453349|590470011|FG001|Completed Study|Protocol Violation|1|||
163483867|NCT00453349|590470010|FG000|Completed Study|Withdrawal by Subject|3|||
163483868|NCT00453349|590470011|FG001|Completed Study|Withdrawal by Subject|5|||
163483869|NCT00453349|590470010|FG000|Completed Study|Lost to follow up after study treatment|2|||
163483870|NCT00453349|590470011|FG001|Completed Study|Lost to follow up after study treatment|11|||
163483871|NCT00805142|590470012|FG000|Titration Period|Adverse Event|3|||
163483872|NCT00805142|590470013|FG001|Titration Period|Adverse Event|3|||
163483873|NCT00805142|590470012|FG000|Titration Period|Lack of Efficacy|1|||
163483874|NCT00805142|590470013|FG001|Titration Period|Lack of Efficacy|1|||
163483875|NCT00805142|590470012|FG000|Titration Period|Lost to Follow-up|0|||
163483876|NCT00805142|590470013|FG001|Titration Period|Lost to Follow-up|1|||
163483877|NCT00805142|590470012|FG000|Titration Period|Disease Progression|2|||
163483878|NCT00805142|590470013|FG001|Titration Period|Disease Progression|1|||
163483879|NCT00805142|590470012|FG000|Titration Period|Withdrawal of consent|0|||
163483880|NCT00805142|590470013|FG001|Titration Period|Withdrawal of consent|1|||
163483881|NCT00805142|590470012|FG000|Titration Period|Other|0|||
163483882|NCT00805142|590470013|FG001|Titration Period|Other|3|||
163483883|NCT00805142|590470012|FG000|Maintenance Period|Adverse Event|0|||
163483884|NCT00805142|590470013|FG001|Maintenance Period|Adverse Event|1|||
163483885|NCT00805142|590470012|FG000|Maintenance Period|Other|0|||
163483886|NCT00805142|590470013|FG001|Maintenance Period|Other|1|||
163483887|NCT01513460|590470015|FG000|Overall Study|Death|0|||
163483888|NCT01513460|590470016|FG001|Overall Study|Death|0|||
163483889|NCT01513460|590470017|FG002|Overall Study|Death|1|||
163483890|NCT01513460|590470015|FG000|Overall Study|Lost to Follow-up|0|||
163483891|NCT01513460|590470016|FG001|Overall Study|Lost to Follow-up|0|||
163483892|NCT01513460|590470017|FG002|Overall Study|Lost to Follow-up|2|||
163483893|NCT01513460|590470015|FG000|Overall Study|Abnormal laboratory value|1|||
163483894|NCT01513460|590470016|FG001|Overall Study|Abnormal laboratory value|0|||
163483895|NCT01513460|590470017|FG002|Overall Study|Abnormal laboratory value|1|||
163483896|NCT01513460|590470015|FG000|Overall Study|Lack of Efficacy|1|||
163483897|NCT01513460|590470016|FG001|Overall Study|Lack of Efficacy|2|||
163483898|NCT01513460|590470017|FG002|Overall Study|Lack of Efficacy|5|||
163483899|NCT01513460|590470015|FG000|Overall Study|Protocol deviations|3|||
163483900|NCT01513460|590470016|FG001|Overall Study|Protocol deviations|4|||
163483901|NCT01513460|590470017|FG002|Overall Study|Protocol deviations|3|||
163483902|NCT01513460|590470015|FG000|Overall Study|Withdrawal by Subject|7|||
163483903|NCT01513460|590470016|FG001|Overall Study|Withdrawal by Subject|8|||
163483904|NCT01513460|590470017|FG002|Overall Study|Withdrawal by Subject|21|||
163483905|NCT01513460|590470015|FG000|Overall Study|Adverse Event|16|||
163483906|NCT01513460|590470016|FG001|Overall Study|Adverse Event|18|||
163483907|NCT01513460|590470017|FG002|Overall Study|Adverse Event|23|||
163483908|NCT01513460|590470015|FG000|Overall Study|Abnormal test procedure|1|||
163483909|NCT01513460|590470016|FG001|Overall Study|Abnormal test procedure|0|||
163483910|NCT01513460|590470017|FG002|Overall Study|Abnormal test procedure|0|||
163483911|NCT00489216|590470021|FG000|Overall Study|Adverse Event|1|||
163483912|NCT00422942|590470024|FG000|Overall Study|Study terminated by Sponsor|3|||
163483913|NCT01078389|590471738|FG000|Overall Study|Adverse Event|10|||
163483914|NCT01078389|590471739|FG001|Overall Study|Adverse Event|6|||
163483915|NCT01078389|590471738|FG000|Overall Study|Major Protocol Deviation|2|||
163483916|NCT01078389|590471739|FG001|Overall Study|Major Protocol Deviation|0|||
163483917|NCT01078389|590471738|FG000|Overall Study|Lost to Follow-up|23|||
163483918|NCT01078389|590471739|FG001|Overall Study|Lost to Follow-up|23|||
163483919|NCT01078389|590471738|FG000|Overall Study|Voluntary Withdrawal|20|||
163483920|NCT01078389|590471739|FG001|Overall Study|Voluntary Withdrawal|36|||
163483921|NCT01078389|590471738|FG000|Overall Study|Other|9|||
163483922|NCT01078389|590471739|FG001|Overall Study|Other|2|||
163483923|NCT04823494|590471740|FG000|Overall Study|Programming software malfunction.|1|||
163483924|NCT04823494|590471741|FG001|Overall Study|Programming software malfunction.|0|||
163483925|NCT04823494|590471740|FG000|Overall Study|Withdrawal by Subject|1|||
163483926|NCT04823494|590471741|FG001|Overall Study|Withdrawal by Subject|0|||
163483927|NCT04823494|590471740|FG000|Overall Study|Devices lost|0|||
163483928|NCT04823494|590471741|FG001|Overall Study|Devices lost|1|||
163483929|NCT03726320|590471742|FG000|Overall Study|Lost to Follow-up|2|||
163483930|NCT03726320|590471743|FG001|Overall Study|Lost to Follow-up|4|||
163483931|NCT03726320|590471744|FG002|Overall Study|Lost to Follow-up|0|||
163483932|NCT03726320|590471742|FG000|Overall Study|Time Constraints|4|||
163483933|NCT03726320|590471743|FG001|Overall Study|Time Constraints|1|||
163483934|NCT03726320|590471744|FG002|Overall Study|Time Constraints|0|||
163483935|NCT03726320|590471742|FG000|Overall Study|Ineligible after enrollment|3|||
163483936|NCT03726320|590471743|FG001|Overall Study|Ineligible after enrollment|3|||
163483937|NCT03726320|590471744|FG002|Overall Study|Ineligible after enrollment|0|||
163483938|NCT03726320|590471742|FG000|Overall Study|Clinic / insurance issue|2|||
163483939|NCT03726320|590471743|FG001|Overall Study|Clinic / insurance issue|0|||
163483940|NCT03726320|590471744|FG002|Overall Study|Clinic / insurance issue|0|||
163483941|NCT03726320|590471742|FG000|Overall Study|Language barrier|1|||
163483942|NCT03726320|590471743|FG001|Overall Study|Language barrier|0|||
163483943|NCT03726320|590471744|FG002|Overall Study|Language barrier|0|||
163483944|NCT03726320|590471742|FG000|Overall Study|Provider left the clinic|0|||
163483945|NCT03726320|590471743|FG001|Overall Study|Provider left the clinic|0|||
163483946|NCT03726320|590471744|FG002|Overall Study|Provider left the clinic|1|||
163483947|NCT03691831|590471747|FG000|Overall Study|Lost to Follow-up|16|||
163483948|NCT03691831|590471748|FG001|Overall Study|Lost to Follow-up|12|||
163483949|NCT03691831|590471747|FG000|Overall Study|Withdrawal by Subject|9|||
163483950|NCT03691831|590471748|FG001|Overall Study|Withdrawal by Subject|17|||
163483951|NCT03691831|590471747|FG000|Overall Study|Investigator Decision|2|||
163483952|NCT03691831|590471748|FG001|Overall Study|Investigator Decision|2|||
163483953|NCT02198040|590471749|FG000|Overall Study|Work reasons|0|||
163483954|NCT02198040|590471750|FG001|Overall Study|Work reasons|1|||
163483955|NCT02198040|590471751|FG002|Overall Study|Work reasons|0|||
163483956|NCT02198040|590471749|FG000|Overall Study|Withdrawal by Subject|0|||
163483957|NCT02198040|590471750|FG001|Overall Study|Withdrawal by Subject|0|||
163483958|NCT02198040|590471751|FG002|Overall Study|Withdrawal by Subject|1|||
163483959|NCT00337935|590471752|FG000|Overall Study|Adverse Event|2|||
163483960|NCT00337935|590471753|FG001|Overall Study|Adverse Event|5|||
163483961|NCT00337935|590471752|FG000|Overall Study|Death|2|||
163483962|NCT00337935|590471753|FG001|Overall Study|Death|8|||
163483963|NCT00337935|590471752|FG000|Overall Study|Physician Decision|1|||
163483964|NCT00337935|590471753|FG001|Overall Study|Physician Decision|1|||
163483965|NCT00337935|590471752|FG000|Overall Study|Lost to Follow-up|0|||
163483966|NCT00337935|590471753|FG001|Overall Study|Lost to Follow-up|1|||
163483967|NCT00337935|590471752|FG000|Overall Study|Protocol Violation|4|||
163483968|NCT00337935|590471753|FG001|Overall Study|Protocol Violation|3|||
163483969|NCT00337935|590471752|FG000|Overall Study|Withdrawal by Subject|1|||
163483970|NCT00337935|590471753|FG001|Overall Study|Withdrawal by Subject|7|||
163483971|NCT00337935|590471752|FG000|Overall Study|Other|0|||
163483972|NCT00337935|590471753|FG001|Overall Study|Other|1|||
163483973|NCT00337935|590471752|FG000|Overall Study|Lack of Efficacy|0|||
163483974|NCT00337935|590471753|FG001|Overall Study|Lack of Efficacy|1|||
163483975|NCT01884675|590471754|FG000|Overall Study|Study closed/terminated|3|||
163483976|NCT01884675|590471755|FG001|Overall Study|Study closed/terminated|2|||
163483977|NCT02361307|590471756|FG000|Overall Study|Unstable medical condition.|0|||
163483978|NCT02361307|590471757|FG001|Overall Study|Unstable medical condition.|1|||
163483979|NCT01189201|590471764|FG000|Overall Study|Adverse Event|1|||
163483980|NCT01277757|590471765|FG000|Overall Study|Disease Progression|1|||
163483981|NCT01277757|590471765|FG000|Overall Study|Withdrawal by Subject|1|||
163483982|NCT00240331|590471769|FG000|Overall Study|Withdrawal by Subject|125|||
163483983|NCT00240331|590471770|FG001|Overall Study|Withdrawal by Subject|132|||
163483984|NCT00240331|590471769|FG000|Overall Study|Option selected by investigator|1|||
163483985|NCT00240331|590471770|FG001|Overall Study|Option selected by investigator|2|||
163483986|NCT01409382|590471771|FG000|Overall Study|Lost to Follow-up|1|||
163483987|NCT01409382|590471772|FG001|Overall Study|Lost to Follow-up|1|||
163483988|NCT01409382|590471771|FG000|Overall Study|Protocol Violation|0|||
163483989|NCT01409382|590471772|FG001|Overall Study|Protocol Violation|3|||
163483990|NCT01409382|590471771|FG000|Overall Study|Multiple pregnancy|2|||
163483991|NCT01409382|590471772|FG001|Overall Study|Multiple pregnancy|4|||
163483992|NCT01409382|590471771|FG000|Overall Study|Still pregnant when study ended|13|||
163483993|NCT01409382|590471772|FG001|Overall Study|Still pregnant when study ended|2|||
163483994|NCT01409382|590471771|FG000|Overall Study|Did not manage to get pregnant|64|||
163483995|NCT01409382|590471772|FG001|Overall Study|Did not manage to get pregnant|70|||
163483996|NCT01409382|590471771|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
163483997|NCT01409382|590471772|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
163483998|NCT01233076|590471773|FG000|Period 2, One Week|Lost to Follow-up|1|||
163483999|NCT01233076|590471774|FG001|Period 2, One Week|Lost to Follow-up|0|||
163484000|NCT04563845|590471775|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
163484001|NCT04563845|590471776|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
163484002|NCT04563845|590471777|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
163484003|NCT04563845|590471778|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
163484004|NCT04563845|590471779|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
163484005|NCT04563845|590471780|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
163484006|NCT04563845|590471781|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
163484007|NCT04563845|590471782|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
163484008|NCT04563845|590471783|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
163484009|NCT04563845|590471784|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
163484010|NCT04563845|590471785|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
163484011|NCT04563845|590471786|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
163484012|NCT04563845|590471787|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
163484013|NCT04563845|590471788|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
163484014|NCT04563845|590471775|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
163484015|NCT04563845|590471776|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
163484016|NCT04563845|590471777|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
163484017|NCT04563845|590471778|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
163484018|NCT04563845|590471779|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
163484019|NCT04563845|590471780|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
163484020|NCT04563845|590471781|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
163484021|NCT04563845|590471782|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
163484022|NCT04563845|590471783|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
163484023|NCT04563845|590471784|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
163484024|NCT04563845|590471785|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
163484025|NCT04563845|590471786|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
163484026|NCT04563845|590471787|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
163484027|NCT04563845|590471788|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
163484028|NCT04120116|590471789|FG000|Overall Study|Lost to Follow-up|0|||
163484029|NCT04120116|590471790|FG001|Overall Study|Lost to Follow-up|1|||
163484030|NCT04120116|590471791|FG002|Overall Study|Lost to Follow-up|0|||
163484031|NCT04120116|590471792|FG003|Overall Study|Lost to Follow-up|2|||
163484032|NCT04120116|590471789|FG000|Overall Study|Withdrawal by Subject|1|||
163484033|NCT04120116|590471790|FG001|Overall Study|Withdrawal by Subject|0|||
163484034|NCT04120116|590471791|FG002|Overall Study|Withdrawal by Subject|1|||
163484035|NCT04120116|590471792|FG003|Overall Study|Withdrawal by Subject|1|||
163484036|NCT04120116|590471789|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
163484037|NCT04120116|590471790|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
163484038|NCT04120116|590471791|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
163484039|NCT04120116|590471792|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
163484040|NCT02210559|590471797|FG000|Overall Study|Progressive Disease|3|||
163484041|NCT02210559|590471798|FG001|Overall Study|Progressive Disease|2|||
163484042|NCT02210559|590471797|FG000|Overall Study|Adverse Event|2|||
163484043|NCT02210559|590471798|FG001|Overall Study|Adverse Event|2|||
163484044|NCT02210559|590471797|FG000|Overall Study|Physician Decision|1|||
163484045|NCT02210559|590471798|FG001|Overall Study|Physician Decision|0|||
163484046|NCT02210559|590471797|FG000|Overall Study|Withdrawal by Subject|0|||
163484047|NCT02210559|590471798|FG001|Overall Study|Withdrawal by Subject|1|||
163484048|NCT02210559|590471797|FG000|Overall Study|Other than specified|0|||
163484049|NCT02210559|590471798|FG001|Overall Study|Other than specified|1|||
163484050|NCT00792467|590471799|FG000|Overall Study|progression of disease|17|||
163484051|NCT00792467|590471799|FG000|Overall Study|Adverse Event|1|||
163484052|NCT00792467|590471799|FG000|Overall Study|patient request|1|||
163484053|NCT00792467|590471799|FG000|Overall Study|Lost to Follow-up|1|||
163484054|NCT00792467|590471799|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
163484055|NCT00792467|590471799|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
163484056|NCT01287403|590471803|FG000|1st Intervention (1 Day)|Adverse Event|1|||
163484057|NCT01098266|590471804|FG000|Overall Study|Physician Decision|1|||
163484058|NCT01098266|590471805|FG001|Overall Study|Physician Decision|0|||
163484059|NCT01098266|590471804|FG000|Overall Study|Death|3|||
163484060|NCT01098266|590471805|FG001|Overall Study|Death|2|||
163484061|NCT01098266|590471804|FG000|Overall Study|Withdrawal by Subject|3|||
163484062|NCT01098266|590471805|FG001|Overall Study|Withdrawal by Subject|5|||
163484063|NCT01733758|590471806|FG000|Overall Study|Adverse Event|5|||
163484064|NCT01733758|590471807|FG001|Overall Study|Adverse Event|7|||
163484065|NCT01733758|590471808|FG002|Overall Study|Adverse Event|8|||
163484066|NCT01733758|590471809|FG003|Overall Study|Adverse Event|1|||
163484067|NCT01733758|590471806|FG000|Overall Study|Withdrawal by Subject|1|||
163484068|NCT01733758|590471807|FG001|Overall Study|Withdrawal by Subject|1|||
163484069|NCT01733758|590471808|FG002|Overall Study|Withdrawal by Subject|5|||
163484070|NCT01733758|590471809|FG003|Overall Study|Withdrawal by Subject|3|||
163484071|NCT01733758|590471806|FG000|Overall Study|Persistent Hyperglycemia|3|||
163484072|NCT01733758|590471807|FG001|Overall Study|Persistent Hyperglycemia|2|||
163484073|NCT01733758|590471808|FG002|Overall Study|Persistent Hyperglycemia|0|||
163484074|NCT01733758|590471809|FG003|Overall Study|Persistent Hyperglycemia|0|||
163484075|NCT01733758|590471806|FG000|Overall Study|Protocol Violation|0|||
163484076|NCT01733758|590471807|FG001|Overall Study|Protocol Violation|1|||
163484077|NCT01733758|590471808|FG002|Overall Study|Protocol Violation|2|||
163484078|NCT01733758|590471809|FG003|Overall Study|Protocol Violation|2|||
163484079|NCT01733758|590471806|FG000|Overall Study|Non-compliance|1|||
163484080|NCT01733758|590471807|FG001|Overall Study|Non-compliance|0|||
163484081|NCT01733758|590471808|FG002|Overall Study|Non-compliance|0|||
163484082|NCT01733758|590471809|FG003|Overall Study|Non-compliance|0|||
163484083|NCT01733758|590471806|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
163484084|NCT01733758|590471807|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
163484085|NCT01733758|590471808|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
163484086|NCT01733758|590471809|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
163484087|NCT01733758|590471806|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
163484088|NCT01733758|590471807|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
163484089|NCT01733758|590471808|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
163484090|NCT01733758|590471809|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
163484091|NCT02545270|590471814|FG000|Overall Study|technical difficulties|0|||
163484092|NCT02545270|590471815|FG001|Overall Study|technical difficulties|1|||
163484093|NCT02545270|590471816|FG002|Overall Study|technical difficulties|0|||
163484094|NCT02545270|590471814|FG000|Overall Study|Videos being too similar to other|0|||
163484095|NCT02545270|590471815|FG001|Overall Study|Videos being too similar to other|0|||
163484096|NCT02545270|590471816|FG002|Overall Study|Videos being too similar to other|2|||
163484097|NCT00727246|590471817|FG000|Overall Study|could not complete MRI|0|||
163484098|NCT00727246|590471818|FG001|Overall Study|could not complete MRI|1|||
163484099|NCT00727246|590471819|FG002|Overall Study|could not complete MRI|0|||
163484100|NCT00727246|590471820|FG003|Overall Study|could not complete MRI|1|||
163484101|NCT00727246|590471817|FG000|Overall Study|incidental finding|0|||
163484102|NCT00727246|590471818|FG001|Overall Study|incidental finding|0|||
163484103|NCT00727246|590471819|FG002|Overall Study|incidental finding|0|||
163484104|NCT00727246|590471820|FG003|Overall Study|incidental finding|1|||
163484105|NCT00727246|590471817|FG000|Overall Study|withdrawn|0|||
163484106|NCT00727246|590471818|FG001|Overall Study|withdrawn|0|||
163484107|NCT00727246|590471819|FG002|Overall Study|withdrawn|1|||
163484108|NCT00727246|590471820|FG003|Overall Study|withdrawn|0|||
163484109|NCT00661362|590471821|FG000|Overall Study|Adverse Event|5|||
163484110|NCT00661362|590471822|FG001|Overall Study|Adverse Event|4|||
163484111|NCT00661362|590471821|FG000|Overall Study|Incorrect enrollment|2|||
163484112|NCT00661362|590471822|FG001|Overall Study|Incorrect enrollment|0|||
163484113|NCT00661362|590471821|FG000|Overall Study|Study specific discontinuation criteria|4|||
163484114|NCT00661362|590471822|FG001|Overall Study|Study specific discontinuation criteria|11|||
163484115|NCT00661362|590471821|FG000|Overall Study|Withdrawal by Subject|13|||
163484116|NCT00661362|590471822|FG001|Overall Study|Withdrawal by Subject|23|||
163484117|NCT00661362|590471821|FG000|Overall Study|Lost to Follow-up|3|||
163484118|NCT00661362|590471822|FG001|Overall Study|Lost to Follow-up|1|||
163484119|NCT00661362|590471821|FG000|Overall Study|Severe non-compliance to protocol|0|||
163484120|NCT00661362|590471822|FG001|Overall Study|Severe non-compliance to protocol|1|||
163484121|NCT00661362|590471821|FG000|Overall Study|Safety reasons|1|||
163484122|NCT00661362|590471822|FG001|Overall Study|Safety reasons|0|||
163484123|NCT00661362|590471821|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
163484124|NCT00661362|590471822|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
163484125|NCT00535262|590471825|FG000|Overall Study|No funding|3|||
163484126|NCT04382066|590471828|FG000|Overall Study|Adverse Event|1|||
163484127|NCT04382066|590471829|FG001|Overall Study|Adverse Event|0|||
163484128|NCT04382066|590471830|FG002|Overall Study|Adverse Event|0|||
163484129|NCT04382066|590471828|FG000|Overall Study|Death|1|||
163484130|NCT04382066|590471829|FG001|Overall Study|Death|0|||
163484131|NCT04382066|590471830|FG002|Overall Study|Death|1|||
163484132|NCT04738123|590471831|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
163484133|NCT04738123|590471832|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
163484134|NCT04738123|590471831|FG000|Overall Study|Progressive Disease|0|||
163484135|NCT04738123|590471832|FG001|Overall Study|Progressive Disease|4|||
163484136|NCT04738123|590471831|FG000|Overall Study|Adverse Event|8|||
163484137|NCT04738123|590471832|FG001|Overall Study|Adverse Event|7|||
163484138|NCT04738123|590471831|FG000|Overall Study|Other Reasons|0|||
163484139|NCT04738123|590471832|FG001|Overall Study|Other Reasons|1|||
163484140|NCT04738123|590471831|FG000|Overall Study|Suicidal or assaultive behavior|0|||
163484141|NCT04738123|590471832|FG001|Overall Study|Suicidal or assaultive behavior|2|||
163484142|NCT04738123|590471831|FG000|Overall Study|Protocol Violation|2|||
163484143|NCT04738123|590471832|FG001|Overall Study|Protocol Violation|2|||
163484144|NCT04738123|590471831|FG000|Overall Study|Consent Withdrawn|35|||
163484145|NCT04738123|590471832|FG001|Overall Study|Consent Withdrawn|22|||
163484146|NCT00787527|590471833|FG000|Overall Study|Toxicity|3|||
163484147|NCT00083616|590471836|FG000|Overall Study|Disease Progression|16|||
163484148|NCT00083616|590471836|FG000|Overall Study|Lost to Follow-up|1|||
163484149|NCT00083616|590471836|FG000|Overall Study|Physician Decision|2|||
163484150|NCT00083616|590471836|FG000|Overall Study|Withdrawal by Subject|3|||
163484151|NCT00083616|590471836|FG000|Overall Study|Ineligibility determined|2|||
163484152|NCT00083616|590471836|FG000|Overall Study|Non-compliance|1|||
163484153|NCT00083616|590471836|FG000|Overall Study|Other|6|||
163484154|NCT01724021|590471837|FG000|Overall Study|Adverse Event|11|||
163484155|NCT01724021|590471838|FG001|Overall Study|Adverse Event|6|||
163484156|NCT01724021|590471837|FG000|Overall Study|Death|46|||
163484157|NCT01724021|590471838|FG001|Overall Study|Death|58|||
163484158|NCT01724021|590471837|FG000|Overall Study|Participant request/ Withdrew consent|18|||
163484159|NCT01724021|590471838|FG001|Overall Study|Participant request/ Withdrew consent|14|||
163484160|NCT01724021|590471837|FG000|Overall Study|Lost to Follow-up|15|||
163484161|NCT01724021|590471838|FG001|Overall Study|Lost to Follow-up|15|||
163484162|NCT01724021|590471837|FG000|Overall Study|Reason Not Specified|36|||
163484163|NCT01724021|590471838|FG001|Overall Study|Reason Not Specified|39|||
163484164|NCT01724021|590471837|FG000|Overall Study|Missing|1|||
163484165|NCT01724021|590471838|FG001|Overall Study|Missing|1|||
163484166|NCT02500706|590471841|FG000|Overall Study|Adverse Event|0|||
163484167|NCT02500706|590471842|FG001|Overall Study|Adverse Event|0|||
163484168|NCT02500706|590471843|FG002|Overall Study|Adverse Event|1|||
163484169|NCT02500706|590471841|FG000|Overall Study|Lost to Follow-up|0|||
163484170|NCT02500706|590471842|FG001|Overall Study|Lost to Follow-up|1|||
163484171|NCT02500706|590471843|FG002|Overall Study|Lost to Follow-up|1|||
163484172|NCT02500706|590471841|FG000|Overall Study|Withdrawal by Subject|4|||
163484173|NCT02500706|590471842|FG001|Overall Study|Withdrawal by Subject|6|||
163484174|NCT02500706|590471843|FG002|Overall Study|Withdrawal by Subject|4|||
163484175|NCT02500706|590471841|FG000|Overall Study|Unclassified|0|||
163484176|NCT02500706|590471842|FG001|Overall Study|Unclassified|0|||
163484177|NCT02500706|590471843|FG002|Overall Study|Unclassified|1|||
163484178|NCT03644173|590471846|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
163484179|NCT03644173|590471846|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
163484180|NCT03644173|590471846|FG000|Participants at the 1-month Follow up|Death|2|||
163484181|NCT03644173|590471846|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
163484182|NCT03323385|590471847|FG000|Overall Study|Withdrawal by Subject|1|||
163484183|NCT03323385|590471848|FG001|Overall Study|Withdrawal by Subject|2|||
163484184|NCT03323385|590471847|FG000|Overall Study|Noncompliance|0|||
163484185|NCT03323385|590471848|FG001|Overall Study|Noncompliance|1|||
163484186|NCT01000311|590471853|FG000|Overall Study|Adverse Event|2|||
163484187|NCT01000311|590471854|FG001|Overall Study|Adverse Event|5|||
163484188|NCT01000311|590471853|FG000|Overall Study|Withdrawal by Subject|16|||
163484189|NCT01000311|590471854|FG001|Overall Study|Withdrawal by Subject|24|||
163484190|NCT01000311|590471853|FG000|Overall Study|Lost to Follow-up|15|||
163484191|NCT01000311|590471854|FG001|Overall Study|Lost to Follow-up|24|||
163484192|NCT01000311|590471853|FG000|Overall Study|Protocol Violation|1|||
163484193|NCT01000311|590471854|FG001|Overall Study|Protocol Violation|2|||
163484194|NCT01000311|590471853|FG000|Overall Study|Inappropriate enrollment|2|||
163484195|NCT01000311|590471854|FG001|Overall Study|Inappropriate enrollment|0|||
163484196|NCT01000311|590471853|FG000|Overall Study|Administrative reason|9|||
163484197|NCT01000311|590471854|FG001|Overall Study|Administrative reason|15|||
163484198|NCT02146352|590471855|FG000|Overall Study|Death|1|||
163484199|NCT02146352|590471855|FG000|Overall Study|Patient entered hospice care|1|||
163484200|NCT02918006|590471856|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
163484201|NCT02918006|590471857|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
163484202|NCT02918006|590471858|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
163484203|NCT02918006|590471856|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
163484204|NCT02918006|590471857|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
163484205|NCT02918006|590471858|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
163484206|NCT02918006|590471856|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
163484207|NCT02918006|590471857|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
163484208|NCT02918006|590471858|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
163484209|NCT02918006|590471856|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
163484210|NCT02918006|590471857|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
163484211|NCT02918006|590471858|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
163484212|NCT02918006|590471856|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
163484213|NCT02918006|590471857|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
163484214|NCT02918006|590471858|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
163484215|NCT02918006|590471856|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
163484216|NCT02918006|590471857|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
163484217|NCT02918006|590471858|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
163484218|NCT02918006|590471856|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
163484219|NCT02918006|590471857|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
163484220|NCT02918006|590471858|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
163484221|NCT02918006|590471856|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
163484222|NCT02918006|590471857|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
163484223|NCT02918006|590471858|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
163484224|NCT02918006|590471856|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
163484225|NCT02918006|590471857|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
163484226|NCT02918006|590471858|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
163484227|NCT03091920|590471863|FG000|Overall Study|Adverse Event|0|||
163484228|NCT03091920|590471864|FG001|Overall Study|Adverse Event|1|||
163484229|NCT03091920|590471865|FG002|Overall Study|Adverse Event|0|||
163484230|NCT01682876|590474003|FG000|Overall Study|Administrative reason|4|||
163484231|NCT01682876|590474004|FG001|Overall Study|Administrative reason|4|||
163484232|NCT01682876|590474005|FG002|Overall Study|Administrative reason|0|||
163484233|NCT01682876|590474006|FG003|Overall Study|Administrative reason|3|||
163484234|NCT01682876|590474003|FG000|Overall Study|Adverse Event|0|||
163484235|NCT01682876|590474004|FG001|Overall Study|Adverse Event|0|||
163484236|NCT01682876|590474005|FG002|Overall Study|Adverse Event|0|||
163484237|NCT01682876|590474006|FG003|Overall Study|Adverse Event|1|||
163484238|NCT01682876|590474003|FG000|Overall Study|Lost to Follow-up|11|||
163484239|NCT01682876|590474004|FG001|Overall Study|Lost to Follow-up|15|||
163484240|NCT01682876|590474005|FG002|Overall Study|Lost to Follow-up|9|||
163484241|NCT01682876|590474006|FG003|Overall Study|Lost to Follow-up|11|||
163484242|NCT01682876|590474003|FG000|Overall Study|Protocol Violation|1|||
163484243|NCT01682876|590474004|FG001|Overall Study|Protocol Violation|1|||
163484244|NCT01682876|590474005|FG002|Overall Study|Protocol Violation|1|||
163484245|NCT01682876|590474006|FG003|Overall Study|Protocol Violation|1|||
163484246|NCT01682876|590474003|FG000|Overall Study|Withdrawal by Subject|4|||
163484247|NCT01682876|590474004|FG001|Overall Study|Withdrawal by Subject|0|||
163484248|NCT01682876|590474005|FG002|Overall Study|Withdrawal by Subject|0|||
163484249|NCT01682876|590474006|FG003|Overall Study|Withdrawal by Subject|2|||
163484250|NCT01682876|590474003|FG000|Overall Study|Other|1|||
163484251|NCT01682876|590474004|FG001|Overall Study|Other|0|||
163484252|NCT01682876|590474005|FG002|Overall Study|Other|1|||
163484253|NCT01682876|590474006|FG003|Overall Study|Other|1|||
163484254|NCT00346775|590474009|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
163484255|NCT00346775|590474010|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
163484256|NCT00346775|590474009|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
163484257|NCT00346775|590474010|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
163484258|NCT00346775|590474009|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
163484259|NCT00346775|590474010|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
163484260|NCT01096017|590474018|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
163484261|NCT01096017|590474019|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
163484262|NCT00965458|590474026|FG000|Overall Study|Adverse Event|1|||
163484263|NCT00965458|590474027|FG001|Overall Study|Adverse Event|0|||
163484264|NCT00965458|590474026|FG000|Overall Study|Lost to Follow-up|1|||
163484265|NCT00965458|590474027|FG001|Overall Study|Lost to Follow-up|3|||
163484266|NCT00965458|590474026|FG000|Overall Study|Withdrawal by Subject|0|||
163484267|NCT00965458|590474027|FG001|Overall Study|Withdrawal by Subject|1|||
163484268|NCT01545375|590474029|FG000|Overall Study|Adverse Event|2|||
163484269|NCT01545375|590474030|FG001|Overall Study|Adverse Event|1|||
163484270|NCT01545375|590474029|FG000|Overall Study|Lost to Follow-up|34|||
163484271|NCT01545375|590474030|FG001|Overall Study|Lost to Follow-up|31|||
163484272|NCT01545375|590474029|FG000|Overall Study|Protocol Violation|3|||
163484273|NCT01545375|590474030|FG001|Overall Study|Protocol Violation|3|||
163484274|NCT01545375|590474029|FG000|Overall Study|Withdrawal by Subject|58|||
163484275|NCT01545375|590474030|FG001|Overall Study|Withdrawal by Subject|55|||
163484276|NCT04177862|590474032|FG000|Overall Study|Protocol Violation|2|||
163484277|NCT04177862|590474033|FG001|Overall Study|Protocol Violation|7|||
163484278|NCT01846039|590474034|FG000|Overall Study|Protocol Violation|1|||
163484279|NCT01846039|590474034|FG000|Overall Study|Subject Withdrew Consent|1|||
163484280|NCT00594958|590474035|FG000|Overall Study|Withdrawal by Subject|1|||
163484281|NCT00594958|590474036|FG001|Overall Study|Withdrawal by Subject|0|||
163484282|NCT00594958|590474037|FG002|Overall Study|Withdrawal by Subject|1|||
163484283|NCT00594958|590474035|FG000|Overall Study|Adverse Event|4|||
163484284|NCT00594958|590474036|FG001|Overall Study|Adverse Event|1|||
163484285|NCT00594958|590474037|FG002|Overall Study|Adverse Event|2|||
163484286|NCT00594958|590474035|FG000|Overall Study|Pregnancy|0|||
163484287|NCT00594958|590474036|FG001|Overall Study|Pregnancy|2|||
163484288|NCT00594958|590474037|FG002|Overall Study|Pregnancy|0|||
163484289|NCT00594958|590474035|FG000|Overall Study|Protocol Violation|1|||
163484290|NCT00594958|590474036|FG001|Overall Study|Protocol Violation|0|||
163484291|NCT00594958|590474037|FG002|Overall Study|Protocol Violation|2|||
163484292|NCT00594958|590474035|FG000|Overall Study|Lost to Follow-up|5|||
163484293|NCT00594958|590474036|FG001|Overall Study|Lost to Follow-up|0|||
163484294|NCT00594958|590474037|FG002|Overall Study|Lost to Follow-up|3|||
163484295|NCT00594958|590474035|FG000|Overall Study|administrative|3|||
163484296|NCT00594958|590474036|FG001|Overall Study|administrative|0|||
163484297|NCT00594958|590474037|FG002|Overall Study|administrative|2|||
163484298|NCT05637515|590474038|FG000|Overall Study|Withdrawal by Subject|17|||
163484299|NCT05637515|590474039|FG001|Overall Study|Withdrawal by Subject|17|||
163484300|NCT03233009|590474040|FG000|Overall Study|Lost to Follow-up|1|||
163484301|NCT04516291|590474042|FG000|Treatment Period (24 Weeks)|Other|1|||
163484302|NCT04516291|590474043|FG001|Treatment Period (24 Weeks)|Other|0|||
163484303|NCT04516291|590474044|FG002|Treatment Period (24 Weeks)|Other|0|||
163484304|NCT04516291|590474045|FG003|Treatment Period (24 Weeks)|Other|2|||
163484305|NCT04516291|590474046|FG004|Treatment Period (24 Weeks)|Other|2|||
163484306|NCT04516291|590474047|FG005|Treatment Period (24 Weeks)|Other|4|||
163484307|NCT04516291|590474048|FG006|Treatment Period (24 Weeks)|Other|2|||
163484308|NCT04516291|590474049|FG007|Treatment Period (24 Weeks)|Other|0|||
163484309|NCT04516291|590474042|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163484310|NCT04516291|590474043|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
163484311|NCT04516291|590474044|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
163484312|NCT04516291|590474045|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163484313|NCT04516291|590474046|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
163484314|NCT04516291|590474047|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163484315|NCT04516291|590474048|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163484316|NCT04516291|590474049|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163484317|NCT04516291|590474042|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
163484318|NCT04516291|590474043|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
163484319|NCT04516291|590474044|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
163484320|NCT04516291|590474045|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
163484321|NCT04516291|590474046|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
163484322|NCT04516291|590474047|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
163484323|NCT04516291|590474048|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
163484324|NCT04516291|590474049|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
163484325|NCT04516291|590474042|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163484326|NCT04516291|590474043|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
163484327|NCT04516291|590474044|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163484328|NCT04516291|590474045|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163484329|NCT04516291|590474046|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163484330|NCT04516291|590474047|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163484331|NCT04516291|590474048|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163484332|NCT04516291|590474049|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163484333|NCT04516291|590474042|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
163484334|NCT04516291|590474043|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
163484335|NCT04516291|590474044|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
163484336|NCT04516291|590474045|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
163484337|NCT04516291|590474046|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
163484338|NCT04516291|590474047|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
163484339|NCT04516291|590474048|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
163484340|NCT04516291|590474049|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
163484341|NCT04516291|590474042|FG000|Follow-up Period (12 Weeks)|Other|0|||
163484342|NCT04516291|590474043|FG001|Follow-up Period (12 Weeks)|Other|1|||
163484343|NCT04516291|590474044|FG002|Follow-up Period (12 Weeks)|Other|0|||
163484344|NCT04516291|590474045|FG003|Follow-up Period (12 Weeks)|Other|2|||
163484345|NCT04516291|590474046|FG004|Follow-up Period (12 Weeks)|Other|0|||
163484346|NCT04516291|590474047|FG005|Follow-up Period (12 Weeks)|Other|0|||
163484347|NCT04516291|590474048|FG006|Follow-up Period (12 Weeks)|Other|0|||
163484348|NCT04516291|590474049|FG007|Follow-up Period (12 Weeks)|Other|0|||
163484349|NCT04516291|590474042|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
163484350|NCT04516291|590474043|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
163484351|NCT04516291|590474044|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
163484352|NCT04516291|590474045|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
163484353|NCT04516291|590474046|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
163484354|NCT04516291|590474047|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
163484355|NCT04516291|590474048|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
163484356|NCT04516291|590474049|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
163484357|NCT04516291|590474042|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
163484358|NCT04516291|590474043|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
163484359|NCT04516291|590474044|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
163484360|NCT04516291|590474045|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
163484361|NCT04516291|590474046|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
163484362|NCT04516291|590474047|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
163484363|NCT04516291|590474048|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
163484364|NCT04516291|590474049|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
163484365|NCT01855607|590474050|FG000|Overall Study|Withdrawal by Subject|1|||
163484366|NCT01855607|590474050|FG000|Overall Study|Study was terminated|11|||
163484367|NCT02181634|590474051|FG000|Overall Study|Lack of Efficacy|33|||
163484368|NCT02181634|590474051|FG000|Overall Study|Adverse Event|17|||
163484369|NCT02181634|590474051|FG000|Overall Study|Physician Decision|8|||
163484370|NCT02181634|590474051|FG000|Overall Study|Withdrawal by Subject|5|||
163484371|NCT02181634|590474051|FG000|Overall Study|Death|2|||
163484372|NCT02181634|590474051|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
163484373|NCT02181634|590474051|FG000|Overall Study|Ineligible|1|||
163484374|NCT02181634|590474051|FG000|Overall Study|Max number of dose reduction|1|||
163484375|NCT02181634|590474051|FG000|Overall Study|Symptomatic progression|1|||
163484376|NCT02181634|590474051|FG000|Overall Study|Patient opted to proceed to surgery|1|||
163484377|NCT03824704|590474062|FG000|Overall Study|Study Terminated by Sponsor|1|||
163484378|NCT02155660|590474065|FG000|Overall Study|Other Reason|8|||
163484379|NCT02155660|590474066|FG001|Overall Study|Other Reason|6|||
163484380|NCT02155660|590474067|FG002|Overall Study|Other Reason|10|||
163484381|NCT02155660|590474068|FG003|Overall Study|Other Reason|10|||
163484382|NCT02155660|590474065|FG000|Overall Study|Study-specific withdrawal criteria|0|||
163484383|NCT02155660|590474066|FG001|Overall Study|Study-specific withdrawal criteria|1|||
163484384|NCT02155660|590474067|FG002|Overall Study|Study-specific withdrawal criteria|1|||
163484385|NCT02155660|590474068|FG003|Overall Study|Study-specific withdrawal criteria|1|||
163484386|NCT02155660|590474065|FG000|Overall Study|Severe non-compliance|0|||
163484387|NCT02155660|590474066|FG001|Overall Study|Severe non-compliance|4|||
163484388|NCT02155660|590474067|FG002|Overall Study|Severe non-compliance|0|||
163484389|NCT02155660|590474068|FG003|Overall Study|Severe non-compliance|1|||
163484390|NCT02155660|590474065|FG000|Overall Study|Adverse Event|2|||
163484391|NCT02155660|590474066|FG001|Overall Study|Adverse Event|6|||
163484392|NCT02155660|590474067|FG002|Overall Study|Adverse Event|3|||
163484393|NCT02155660|590474068|FG003|Overall Study|Adverse Event|1|||
163484394|NCT02155660|590474065|FG000|Overall Study|Lost to Follow-up|3|||
163484395|NCT02155660|590474066|FG001|Overall Study|Lost to Follow-up|6|||
163484396|NCT02155660|590474067|FG002|Overall Study|Lost to Follow-up|5|||
163484397|NCT02155660|590474068|FG003|Overall Study|Lost to Follow-up|8|||
163484398|NCT02155660|590474065|FG000|Overall Study|Death|17|||
163484399|NCT02155660|590474066|FG001|Overall Study|Death|19|||
163484400|NCT02155660|590474067|FG002|Overall Study|Death|17|||
163484401|NCT02155660|590474068|FG003|Overall Study|Death|19|||
163484402|NCT02155660|590474065|FG000|Overall Study|Withdrawal by Subject|28|||
163484403|NCT02155660|590474066|FG001|Overall Study|Withdrawal by Subject|31|||
163484404|NCT02155660|590474067|FG002|Overall Study|Withdrawal by Subject|24|||
163484405|NCT02155660|590474068|FG003|Overall Study|Withdrawal by Subject|21|||
163484406|NCT03730987|590474069|FG000|Overall Study|Lost to Follow-up|2|||
163484407|NCT03730987|590474070|FG001|Overall Study|Lost to Follow-up|0|||
163484408|NCT03730987|590474071|FG002|Overall Study|Lost to Follow-up|2|||
163484409|NCT03730987|590474072|FG003|Overall Study|Lost to Follow-up|0|||
163484410|NCT02087085|590474073|FG000|Overall Study|Adverse Event|10|||
163484411|NCT02087085|590474074|FG001|Overall Study|Adverse Event|14|||
163484412|NCT02087085|590474073|FG000|Overall Study|Lack of Efficacy|4|||
163484413|NCT02087085|590474074|FG001|Overall Study|Lack of Efficacy|3|||
163484414|NCT02087085|590474073|FG000|Overall Study|Lost to Follow-up|6|||
163484415|NCT02087085|590474074|FG001|Overall Study|Lost to Follow-up|4|||
163484416|NCT02087085|590474073|FG000|Overall Study|Withdrawal by Subject|9|||
163484417|NCT02087085|590474074|FG001|Overall Study|Withdrawal by Subject|11|||
163484418|NCT02087085|590474073|FG000|Overall Study|Protocol Violation|1|||
163484419|NCT02087085|590474074|FG001|Overall Study|Protocol Violation|0|||
163484420|NCT02087085|590474073|FG000|Overall Study|Study Terminated by Sponsor|87|||
163484421|NCT02087085|590474074|FG001|Overall Study|Study Terminated by Sponsor|80|||
163484422|NCT02087085|590474073|FG000|Overall Study|Other Miscellaneous Reasons|3|||
163484423|NCT02087085|590474074|FG001|Overall Study|Other Miscellaneous Reasons|4|||
163484424|NCT02505945|590474075|FG000|Overall Study|Withdrawal by Subject|13|||
163484425|NCT02505945|590474076|FG001|Overall Study|Withdrawal by Subject|2|||
163484426|NCT02505945|590474075|FG000|Overall Study|Adverse Event|1|||
163484427|NCT02505945|590474076|FG001|Overall Study|Adverse Event|0|||
163484428|NCT02505945|590474075|FG000|Overall Study|Physician Decision|2|||
163484429|NCT02505945|590474076|FG001|Overall Study|Physician Decision|1|||
163484430|NCT02505945|590474075|FG000|Overall Study|Lost to Follow-up|6|||
163484431|NCT02505945|590474076|FG001|Overall Study|Lost to Follow-up|1|||
163484432|NCT00635804|590474077|FG000|Overall Study|Adverse Event|0|||
163484433|NCT00635804|590474078|FG001|Overall Study|Adverse Event|0|||
163484434|NCT00635804|590474079|FG002|Overall Study|Adverse Event|0|||
163484435|NCT00635804|590474080|FG003|Overall Study|Adverse Event|0|||
163484436|NCT00635804|590474081|FG004|Overall Study|Adverse Event|0|||
163484437|NCT00635804|590474082|FG005|Overall Study|Adverse Event|1|||
163484438|NCT00635804|590474083|FG006|Overall Study|Adverse Event|0|||
163484439|NCT00635804|590474084|FG007|Overall Study|Adverse Event|0|||
163484440|NCT00635804|590474077|FG000|Overall Study|Withdrawal by Subject|1|||
163484441|NCT00635804|590474078|FG001|Overall Study|Withdrawal by Subject|0|||
163484442|NCT00635804|590474079|FG002|Overall Study|Withdrawal by Subject|0|||
163484443|NCT00635804|590474080|FG003|Overall Study|Withdrawal by Subject|0|||
163484444|NCT00635804|590474081|FG004|Overall Study|Withdrawal by Subject|0|||
163484445|NCT00635804|590474082|FG005|Overall Study|Withdrawal by Subject|0|||
163484446|NCT00635804|590474083|FG006|Overall Study|Withdrawal by Subject|0|||
163484447|NCT00635804|590474084|FG007|Overall Study|Withdrawal by Subject|0|||
163484448|NCT01425268|590474092|FG000|Overall Study|Withdrawal by Subject|2|||
163484449|NCT01425268|590474093|FG001|Overall Study|Withdrawal by Subject|0|||
163484450|NCT01425268|590474092|FG000|Overall Study|Sponsor Decision|5|||
163484451|NCT01425268|590474093|FG001|Overall Study|Sponsor Decision|0|||
163484452|NCT01425268|590474092|FG000|Overall Study|Physician Decision|1|||
163484453|NCT01425268|590474093|FG001|Overall Study|Physician Decision|0|||
163484454|NCT00719706|590474094|FG000|Overall Study|Adverse Event|5|||
163484455|NCT00719706|590474095|FG001|Overall Study|Adverse Event|4|||
163484456|NCT00719706|590474094|FG000|Overall Study|Withdrawal by Subject|1|||
163484457|NCT00719706|590474095|FG001|Overall Study|Withdrawal by Subject|2|||
163484458|NCT00719706|590474094|FG000|Overall Study|Protocol Violation|3|||
163484459|NCT00719706|590474095|FG001|Overall Study|Protocol Violation|0|||
163484460|NCT02681094|590474096|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
163484461|NCT02681094|590474097|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
163484462|NCT02681094|590474098|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
163484463|NCT02681094|590474096|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
163484464|NCT02681094|590474097|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
163484465|NCT02681094|590474098|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
163484466|NCT02681094|590474096|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
163484467|NCT02681094|590474097|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
163484468|NCT02681094|590474098|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
163484469|NCT02681094|590474096|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
163484470|NCT02681094|590474097|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
163484471|NCT02681094|590474098|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
163484472|NCT02681094|590474096|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
163484473|NCT02681094|590474097|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
163484474|NCT02681094|590474098|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
163484475|NCT02681094|590474096|FG000|1 -Modified Enrolled Participants Set|Other|6|||
163484476|NCT02681094|590474097|FG001|1 -Modified Enrolled Participants Set|Other|6|||
163484477|NCT02681094|590474098|FG002|1 -Modified Enrolled Participants Set|Other|7|||
163484478|NCT02681094|590474096|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
163484479|NCT02681094|590474097|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
163484480|NCT02681094|590474098|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
163484481|NCT02681094|590474096|FG000|2 - Enrolled Participants Set|Participant decision|7|||
163484482|NCT02681094|590474097|FG001|2 - Enrolled Participants Set|Participant decision|10|||
163484483|NCT02681094|590474098|FG002|2 - Enrolled Participants Set|Participant decision|9|||
163484484|NCT02681094|590474096|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
163484485|NCT02681094|590474097|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
163484486|NCT02681094|590474098|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
163484487|NCT02681094|590474096|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
163484488|NCT02681094|590474097|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
163484489|NCT02681094|590474098|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
163484490|NCT02681094|590474096|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
163484491|NCT02681094|590474097|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
163484492|NCT02681094|590474098|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
163484493|NCT02681094|590474096|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
163484494|NCT02681094|590474097|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
163484495|NCT02681094|590474098|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
163484496|NCT02681094|590474096|FG000|2 - Enrolled Participants Set|Other|6|||
163484497|NCT02681094|590474097|FG001|2 - Enrolled Participants Set|Other|6|||
163484498|NCT02681094|590474098|FG002|2 - Enrolled Participants Set|Other|7|||
163484499|NCT02681094|590474096|FG000|2 - Enrolled Participants Set|No treatment given|0|||
163484500|NCT02681094|590474097|FG001|2 - Enrolled Participants Set|No treatment given|1|||
163484501|NCT02681094|590474098|FG002|2 - Enrolled Participants Set|No treatment given|1|||
163484502|NCT01072175|590474099|FG000|Part A (Drug-Drug Interaction)|Death|1|||
163484503|NCT01072175|590474100|FG001|Part A (Drug-Drug Interaction)|Death|0|||
163484504|NCT01072175|590474101|FG002|Part A (Drug-Drug Interaction)|Death|0|||
163484505|NCT01072175|590474102|FG003|Part A (Drug-Drug Interaction)|Death|0|||
163484506|NCT01072175|590474103|FG004|Part A (Drug-Drug Interaction)|Death|0|||
163484507|NCT01072175|590474104|FG005|Part A (Drug-Drug Interaction)|Death|0|||
163484508|NCT01072175|590474105|FG006|Part A (Drug-Drug Interaction)|Death|0|||
163484509|NCT01072175|590474106|FG007|Part A (Drug-Drug Interaction)|Death|0|||
163484510|NCT01072175|590474107|FG008|Part A (Drug-Drug Interaction)|Death|0|||
163484511|NCT01072175|590474108|FG009|Part A (Drug-Drug Interaction)|Death|0|||
163484512|NCT01072175|590474109|FG010|Part A (Drug-Drug Interaction)|Death|0|||
163484513|NCT01072175|590474110|FG011|Part A (Drug-Drug Interaction)|Death|0|||
163484514|NCT01072175|590474111|FG012|Part A (Drug-Drug Interaction)|Death|0|||
163484515|NCT01072175|590474099|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
163484516|NCT01072175|590474100|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
163484517|NCT01072175|590474101|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
163484518|NCT01072175|590474102|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
163484519|NCT01072175|590474103|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
163484520|NCT01072175|590474104|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
163484521|NCT01072175|590474105|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
163484522|NCT01072175|590474106|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
163484523|NCT01072175|590474107|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
163484524|NCT01072175|590474108|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
163484525|NCT01072175|590474109|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
163484526|NCT01072175|590474110|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
163484527|NCT01072175|590474111|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
163484528|NCT01072175|590474099|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
163484529|NCT01072175|590474100|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
163484530|NCT01072175|590474101|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
163484531|NCT01072175|590474102|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
163484532|NCT01072175|590474103|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
163484533|NCT01072175|590474104|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
163484534|NCT01072175|590474105|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
163484535|NCT01072175|590474106|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
163484536|NCT01072175|590474107|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
163484537|NCT01072175|590474108|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
163484538|NCT01072175|590474109|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
163484539|NCT01072175|590474110|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
163484540|NCT01072175|590474111|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
163484541|NCT01072175|590474099|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
163484542|NCT01072175|590474100|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
163484543|NCT01072175|590474101|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
163484544|NCT01072175|590474102|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
163484545|NCT01072175|590474103|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
163484546|NCT01072175|590474104|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
163484547|NCT01072175|590474105|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
163484548|NCT01072175|590474106|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
163484549|NCT01072175|590474107|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
163484550|NCT01072175|590474108|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
163484551|NCT01072175|590474109|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
163484552|NCT01072175|590474110|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
163484553|NCT01072175|590474111|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
163484554|NCT01072175|590474099|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
163484555|NCT01072175|590474100|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
163484556|NCT01072175|590474101|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
163484557|NCT01072175|590474102|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
163484558|NCT01072175|590474103|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
163484559|NCT01072175|590474104|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
163484560|NCT01072175|590474105|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
163484561|NCT01072175|590474106|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
163484562|NCT01072175|590474107|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
163484563|NCT01072175|590474108|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
163484564|NCT01072175|590474109|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
163484565|NCT01072175|590474110|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
163484566|NCT01072175|590474111|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
163484567|NCT01072175|590474099|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
163484568|NCT01072175|590474100|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
163484569|NCT01072175|590474101|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
163484570|NCT01072175|590474102|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
163484571|NCT01072175|590474103|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
163484572|NCT01072175|590474104|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
163484573|NCT01072175|590474105|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
163484574|NCT01072175|590474106|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
163484575|NCT01072175|590474107|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
163484576|NCT01072175|590474108|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
163484577|NCT01072175|590474109|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
163484578|NCT01072175|590474110|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
163484579|NCT01072175|590474111|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
163484580|NCT01072175|590474099|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
163484581|NCT01072175|590474100|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
163484582|NCT01072175|590474101|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
163484583|NCT01072175|590474102|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
163484584|NCT01072175|590474103|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
163484585|NCT01072175|590474104|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
163484586|NCT01072175|590474105|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
163484587|NCT01072175|590474106|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
163484588|NCT01072175|590474107|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
163484589|NCT01072175|590474108|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
163484590|NCT01072175|590474109|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
163484591|NCT01072175|590474110|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
163484592|NCT01072175|590474111|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
163484593|NCT01072175|590474099|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
163484594|NCT01072175|590474100|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
163484595|NCT01072175|590474101|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
163484596|NCT01072175|590474102|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
163484597|NCT01072175|590474103|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
163484598|NCT01072175|590474104|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
163484599|NCT01072175|590474105|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
163484600|NCT01072175|590474106|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
163484601|NCT01072175|590474107|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
163484602|NCT01072175|590474108|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
163484603|NCT01072175|590474109|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
163484604|NCT01072175|590474110|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
163484605|NCT01072175|590474111|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
163484606|NCT01072175|590474099|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
163484607|NCT01072175|590474100|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
163484608|NCT01072175|590474101|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
163484609|NCT01072175|590474102|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
163484610|NCT01072175|590474103|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
163484611|NCT01072175|590474104|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
163484612|NCT01072175|590474105|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
163484613|NCT01072175|590474106|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
163484614|NCT01072175|590474107|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
163484615|NCT01072175|590474108|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
163484616|NCT01072175|590474109|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
163484617|NCT01072175|590474110|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
163484618|NCT01072175|590474111|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
163484619|NCT01072175|590474099|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
163484620|NCT01072175|590474100|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
163484621|NCT01072175|590474101|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
163484622|NCT01072175|590474102|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
163484623|NCT01072175|590474103|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
163484624|NCT01072175|590474104|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
163484625|NCT01072175|590474105|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
163484626|NCT01072175|590474106|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
163484627|NCT01072175|590474107|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
163484628|NCT01072175|590474108|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
163484629|NCT01072175|590474109|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
163484630|NCT01072175|590474110|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
163484631|NCT01072175|590474111|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
163484632|NCT01072175|590474099|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
163484633|NCT01072175|590474100|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
163484634|NCT01072175|590474101|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
163484635|NCT01072175|590474102|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
163484636|NCT01072175|590474103|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
163484637|NCT01072175|590474104|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
163484638|NCT01072175|590474105|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
163484639|NCT01072175|590474106|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
163484640|NCT01072175|590474107|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
163484641|NCT01072175|590474108|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
163484642|NCT01072175|590474109|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
163484643|NCT01072175|590474110|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
163484644|NCT01072175|590474111|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
163484645|NCT01072175|590474099|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
163484646|NCT01072175|590474100|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
163484647|NCT01072175|590474101|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
163484648|NCT01072175|590474102|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
163484649|NCT01072175|590474103|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
163484650|NCT01072175|590474104|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
163484651|NCT01072175|590474105|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
163484652|NCT01072175|590474106|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
163484653|NCT01072175|590474107|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
163484654|NCT01072175|590474108|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
163484655|NCT01072175|590474109|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
163484656|NCT01072175|590474110|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
163484657|NCT01072175|590474111|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
163484658|NCT01072175|590474099|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
163484659|NCT01072175|590474100|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
163484660|NCT01072175|590474101|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
163484661|NCT01072175|590474102|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
163484662|NCT01072175|590474103|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
163484663|NCT01072175|590474104|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
163484664|NCT01072175|590474105|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
163484665|NCT01072175|590474106|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
163484666|NCT01072175|590474107|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
163484667|NCT01072175|590474108|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
163484668|NCT01072175|590474109|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
163484669|NCT01072175|590474110|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
163484670|NCT01072175|590474111|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
163484671|NCT01072175|590474099|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
163484672|NCT01072175|590474100|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
163484673|NCT01072175|590474101|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
163484674|NCT01072175|590474102|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
163484675|NCT01072175|590474103|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
163484676|NCT01072175|590474104|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
163484677|NCT01072175|590474105|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
163484678|NCT01072175|590474106|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
163484679|NCT01072175|590474107|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
163484680|NCT01072175|590474108|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
163484681|NCT01072175|590474109|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
163484682|NCT01072175|590474110|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
163484683|NCT01072175|590474111|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
163484684|NCT01072175|590474099|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
163484685|NCT01072175|590474100|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
163484686|NCT01072175|590474101|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
163484687|NCT01072175|590474102|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
163484688|NCT01072175|590474103|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
163484689|NCT01072175|590474104|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
163484690|NCT01072175|590474105|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
163484691|NCT01072175|590474106|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
163484692|NCT01072175|590474107|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
163484693|NCT01072175|590474108|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
163484694|NCT01072175|590474109|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
163484695|NCT01072175|590474110|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
163484696|NCT01072175|590474111|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
163484697|NCT01072175|590474099|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
163484698|NCT01072175|590474100|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
163484699|NCT01072175|590474101|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
163484700|NCT01072175|590474102|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
163484701|NCT01072175|590474103|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
163484702|NCT01072175|590474104|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
163484703|NCT01072175|590474105|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
163484704|NCT01072175|590474106|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
163484705|NCT01072175|590474107|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
163484706|NCT01072175|590474108|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
163484707|NCT01072175|590474109|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
163484708|NCT01072175|590474110|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
163484709|NCT01072175|590474111|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
163484710|NCT01072175|590474099|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
163484711|NCT01072175|590474100|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
163484712|NCT01072175|590474101|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
163484713|NCT01072175|590474102|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
163484714|NCT01072175|590474103|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
163484715|NCT01072175|590474104|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
163484716|NCT01072175|590474105|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
163484717|NCT01072175|590474106|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
163484718|NCT01072175|590474107|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
163484719|NCT01072175|590474108|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
163484720|NCT01072175|590474109|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
163484721|NCT01072175|590474110|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
163484722|NCT01072175|590474111|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
163484723|NCT01072175|590474099|FG000|Part D (HPMC Capsules)|Death|0|||
163484724|NCT01072175|590474100|FG001|Part D (HPMC Capsules)|Death|0|||
163484725|NCT01072175|590474101|FG002|Part D (HPMC Capsules)|Death|0|||
163484726|NCT01072175|590474102|FG003|Part D (HPMC Capsules)|Death|0|||
163484727|NCT01072175|590474103|FG004|Part D (HPMC Capsules)|Death|0|||
163484728|NCT01072175|590474104|FG005|Part D (HPMC Capsules)|Death|0|||
163484729|NCT01072175|590474105|FG006|Part D (HPMC Capsules)|Death|0|||
163484730|NCT01072175|590474106|FG007|Part D (HPMC Capsules)|Death|0|||
163484731|NCT01072175|590474107|FG008|Part D (HPMC Capsules)|Death|0|||
163484732|NCT01072175|590474108|FG009|Part D (HPMC Capsules)|Death|10|||
163484733|NCT01072175|590474109|FG010|Part D (HPMC Capsules)|Death|12|||
163484734|NCT01072175|590474110|FG011|Part D (HPMC Capsules)|Death|28|||
163484735|NCT01072175|590474111|FG012|Part D (HPMC Capsules)|Death|26|||
163484736|NCT01072175|590474099|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
163484737|NCT01072175|590474100|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
163484738|NCT01072175|590474101|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
163484739|NCT01072175|590474102|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
163484740|NCT01072175|590474103|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
163484741|NCT01072175|590474104|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
163484742|NCT01072175|590474105|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
163484743|NCT01072175|590474106|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
163484744|NCT01072175|590474107|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
163484745|NCT01072175|590474108|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
163484746|NCT01072175|590474109|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
163484747|NCT01072175|590474110|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
163484748|NCT01072175|590474111|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
163484749|NCT01072175|590474099|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
163484750|NCT01072175|590474100|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
163484751|NCT01072175|590474101|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
163484752|NCT01072175|590474102|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
163484753|NCT01072175|590474103|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
163484754|NCT01072175|590474104|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
163484755|NCT01072175|590474105|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
163484756|NCT01072175|590474106|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
163484757|NCT01072175|590474107|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
163484758|NCT01072175|590474108|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
163484759|NCT01072175|590474109|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
163484760|NCT01072175|590474110|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
163484761|NCT01072175|590474111|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
163484762|NCT01072175|590474099|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
163484763|NCT01072175|590474100|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
163484764|NCT01072175|590474101|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
163484765|NCT01072175|590474102|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
163484766|NCT01072175|590474103|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
163484767|NCT01072175|590474104|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
163484768|NCT01072175|590474105|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
163484769|NCT01072175|590474106|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
163484770|NCT01072175|590474107|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
163484771|NCT01072175|590474108|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
163484772|NCT01072175|590474109|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
163484773|NCT01072175|590474110|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
163484774|NCT01072175|590474111|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
163484775|NCT01072175|590474099|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
163484776|NCT01072175|590474100|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
163484777|NCT01072175|590474101|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
163484778|NCT01072175|590474102|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
163484779|NCT01072175|590474103|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
163484780|NCT01072175|590474104|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
163484781|NCT01072175|590474105|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
163484782|NCT01072175|590474106|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
163484783|NCT01072175|590474107|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
163484784|NCT01072175|590474108|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
163484785|NCT01072175|590474109|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
163484786|NCT01072175|590474110|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
163484787|NCT01072175|590474111|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
163484788|NCT02839330|590474112|FG000|Overall Study|Adverse Event|0|||
163484789|NCT02839330|590474113|FG001|Overall Study|Adverse Event|1|||
163484790|NCT02839330|590474114|FG002|Overall Study|Adverse Event|2|||
163484791|NCT02839330|590474115|FG003|Overall Study|Adverse Event|2|||
163484792|NCT02839330|590474112|FG000|Overall Study|Death|4|||
163484793|NCT02839330|590474113|FG001|Overall Study|Death|6|||
163484794|NCT02839330|590474114|FG002|Overall Study|Death|1|||
163484795|NCT02839330|590474115|FG003|Overall Study|Death|1|||
163484796|NCT02839330|590474112|FG000|Overall Study|Withdrawal by Subject|27|||
163484797|NCT02839330|590474113|FG001|Overall Study|Withdrawal by Subject|19|||
163484798|NCT02839330|590474114|FG002|Overall Study|Withdrawal by Subject|11|||
163484799|NCT02839330|590474115|FG003|Overall Study|Withdrawal by Subject|13|||
163484800|NCT02839330|590474112|FG000|Overall Study|Lost to Follow-up|22|||
163484801|NCT02839330|590474113|FG001|Overall Study|Lost to Follow-up|27|||
163484802|NCT02839330|590474114|FG002|Overall Study|Lost to Follow-up|29|||
163484803|NCT02839330|590474115|FG003|Overall Study|Lost to Follow-up|25|||
163484804|NCT02839330|590474112|FG000|Overall Study|Administrative Reason|0|||
163484805|NCT02839330|590474113|FG001|Overall Study|Administrative Reason|0|||
163484806|NCT02839330|590474114|FG002|Overall Study|Administrative Reason|0|||
163484807|NCT02839330|590474115|FG003|Overall Study|Administrative Reason|1|||
163484808|NCT02839330|590474112|FG000|Overall Study|Protocol Violation|1|||
163484809|NCT02839330|590474113|FG001|Overall Study|Protocol Violation|2|||
163484810|NCT02839330|590474114|FG002|Overall Study|Protocol Violation|2|||
163484811|NCT02839330|590474115|FG003|Overall Study|Protocol Violation|3|||
163484812|NCT02839330|590474112|FG000|Overall Study|Other reason, not specified|4|||
163484813|NCT02839330|590474113|FG001|Overall Study|Other reason, not specified|3|||
163484814|NCT02839330|590474114|FG002|Overall Study|Other reason, not specified|3|||
163484815|NCT02839330|590474115|FG003|Overall Study|Other reason, not specified|6|||
163484816|NCT00682539|590474116|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
163484817|NCT00682539|590474117|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
163484818|NCT00682539|590474118|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
163484819|NCT00682539|590474116|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
163484820|NCT00682539|590474117|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
163484821|NCT00682539|590474118|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
163484822|NCT02477215|590474128|FG000|Dose Escalation Phase|Physician Decision|1|||
163484823|NCT02477215|590474129|FG001|Dose Escalation Phase|Physician Decision|2|||
163484824|NCT02477215|590474130|FG002|Dose Escalation Phase|Physician Decision|0|||
163484825|NCT02477215|590474128|FG000|Fixed Dose Phase|Physician Decision|0|||
163484826|NCT02477215|590474129|FG001|Fixed Dose Phase|Physician Decision|7|||
163484827|NCT02477215|590474130|FG002|Fixed Dose Phase|Physician Decision|0|||
163484828|NCT00508872|590474131|FG000|Overall Study|Lost to Follow-up|1|||
163484829|NCT00508872|590474131|FG000|Overall Study|Physician Decision|1|||
163484830|NCT00883896|590474132|FG000|Overall Study|Lost to Follow-up|0|||
163484831|NCT00883896|590474133|FG001|Overall Study|Lost to Follow-up|0|||
163484832|NCT00883896|590474134|FG002|Overall Study|Lost to Follow-up|0|||
163484833|NCT00883896|590474135|FG003|Overall Study|Lost to Follow-up|2|||
163484834|NCT00883896|590474132|FG000|Overall Study|Withdrawal by Subject|5|||
163484835|NCT00883896|590474133|FG001|Overall Study|Withdrawal by Subject|0|||
163484836|NCT00883896|590474134|FG002|Overall Study|Withdrawal by Subject|1|||
163484837|NCT00883896|590474135|FG003|Overall Study|Withdrawal by Subject|3|||
163484838|NCT00883896|590474132|FG000|Overall Study|Lack of Efficacy|0|||
163484839|NCT00883896|590474133|FG001|Overall Study|Lack of Efficacy|0|||
163484840|NCT00883896|590474134|FG002|Overall Study|Lack of Efficacy|0|||
163484841|NCT00883896|590474135|FG003|Overall Study|Lack of Efficacy|2|||
163484842|NCT00883896|590474132|FG000|Overall Study|Other|1|||
163484843|NCT00883896|590474133|FG001|Overall Study|Other|0|||
163484844|NCT00883896|590474134|FG002|Overall Study|Other|0|||
163484845|NCT00883896|590474135|FG003|Overall Study|Other|0|||
163484846|NCT02546193|590474136|FG000|Overall Study|Withdrawal by Subject|2|||
163484847|NCT02546193|590474137|FG001|Overall Study|Withdrawal by Subject|0|||
163484848|NCT02546193|590474138|FG002|Overall Study|Withdrawal by Subject|1|||
163484849|NCT02546193|590474139|FG003|Overall Study|Withdrawal by Subject|0|||
163484850|NCT02546193|590474136|FG000|Overall Study|Not eligible at time of induction|4|||
163484851|NCT02546193|590474137|FG001|Overall Study|Not eligible at time of induction|6|||
163484852|NCT02546193|590474138|FG002|Overall Study|Not eligible at time of induction|1|||
163484853|NCT02546193|590474139|FG003|Overall Study|Not eligible at time of induction|0|||
163484854|NCT00310440|590474140|FG000|Overall Study|Lost to Follow-up|17|||
163484855|NCT00310440|590474141|FG001|Overall Study|Lost to Follow-up|8|||
163484856|NCT00310440|590474140|FG000|Overall Study|Withdrawal by Subject|2|||
163484857|NCT00310440|590474141|FG001|Overall Study|Withdrawal by Subject|1|||
163484858|NCT00310440|590474140|FG000|Overall Study|Missed 12 Month Visit|7|||
163484859|NCT00310440|590474141|FG001|Overall Study|Missed 12 Month Visit|4|||
163484860|NCT00438815|590474149|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
163484861|NCT00438815|590474149|FG000|Overall Study|3-month follow-up no longer required|12|||
163484862|NCT00438815|590474149|FG000|Overall Study|Noncompliance with protocol requirements|9|||
163484863|NCT00438815|590474149|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
163484864|NCT00438815|590474149|FG000|Overall Study|Lost to Follow-up|6|||
163484865|NCT00438815|590474149|FG000|Overall Study|Withdrawal by Subject|6|||
163484866|NCT00438815|590474149|FG000|Overall Study|Death|1|||
163484867|NCT01654666|590474150|FG000|Overall Study|Protocol Violation|7|||
163484868|NCT01654666|590474151|FG001|Overall Study|Protocol Violation|4|||
163484869|NCT01654666|590474152|FG002|Overall Study|Protocol Violation|8|||
163484870|NCT01654666|590474150|FG000|Overall Study|Lost to Follow-up|4|||
163484871|NCT01654666|590474151|FG001|Overall Study|Lost to Follow-up|5|||
163484872|NCT01654666|590474152|FG002|Overall Study|Lost to Follow-up|5|||
163484873|NCT01654666|590474150|FG000|Overall Study|Withdrawal by Subject|4|||
163484874|NCT01654666|590474151|FG001|Overall Study|Withdrawal by Subject|4|||
163484875|NCT01654666|590474152|FG002|Overall Study|Withdrawal by Subject|1|||
163484876|NCT01177943|590474154|FG000|First Intervention|Withdrawal by Subject|2|||
163484877|NCT01177943|590474155|FG001|First Intervention|Withdrawal by Subject|0|||
163484878|NCT04225026|590474161|FG000|Overall Study|Withdrawal by Subject|4|||
163484879|NCT04225026|590474161|FG000|Overall Study|Adverse Event|1|||
163484880|NCT04225026|590474161|FG000|Overall Study|Other|1|||
163484881|NCT04225026|590474161|FG000|Overall Study|Death|11|||
163484882|NCT04225026|590474161|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
163484883|NCT00779506|590474165|FG000|Overall Study|Screening Failed|2|||
163484884|NCT00779506|590474165|FG000|Overall Study|Adverse Event|4|||
163484885|NCT00779506|590474165|FG000|Overall Study|Lack of Efficacy|11|||
163484886|NCT00779506|590474165|FG000|Overall Study|Protocol Violation|5|||
163484887|NCT00779506|590474165|FG000|Overall Study|Withdrawal by Subject|6|||
163484888|NCT00779506|590474165|FG000|Overall Study|Lost to Follow-up|1|||
163484889|NCT03982069|590474166|FG000|Overall Study|Lost to Follow-up|5|||
163484890|NCT03982069|590474167|FG001|Overall Study|Lost to Follow-up|5|||
163484891|NCT03982069|590474168|FG002|Overall Study|Lost to Follow-up|3|||
163484892|NCT03982069|590474169|FG003|Overall Study|Lost to Follow-up|5|||
163484893|NCT03982069|590474166|FG000|Overall Study|Physician Decision|0|||
163484894|NCT03982069|590474167|FG001|Overall Study|Physician Decision|1|||
163484895|NCT03982069|590474168|FG002|Overall Study|Physician Decision|0|||
163484896|NCT03982069|590474169|FG003|Overall Study|Physician Decision|0|||
163484897|NCT03982069|590474166|FG000|Overall Study|Withdrawal by Subject|2|||
163484898|NCT03982069|590474167|FG001|Overall Study|Withdrawal by Subject|1|||
163484899|NCT03982069|590474168|FG002|Overall Study|Withdrawal by Subject|5|||
163484900|NCT03982069|590474169|FG003|Overall Study|Withdrawal by Subject|2|||
163484901|NCT03982069|590474166|FG000|Overall Study|Specimen loss|3|||
163484902|NCT03982069|590474167|FG001|Overall Study|Specimen loss|3|||
163484903|NCT03982069|590474168|FG002|Overall Study|Specimen loss|1|||
163484904|NCT03982069|590474169|FG003|Overall Study|Specimen loss|1|||
163484905|NCT00914940|590474170|FG000|D0 to D100 Post-transplant|Death|2|||
163484906|NCT00914940|590474170|FG000|D101 to 2 Years Post-transplant|Death|8|||
163484907|NCT00914940|590474170|FG000|2 Years to 5 Years Post-transplant|Death|3|||
163484908|NCT00690612|590475609|FG000|Overall Study|Adverse Event|1|||
163484909|NCT00690612|590475609|FG000|Overall Study|Withdrawal by Subject|2|||
163484910|NCT01858701|590475613|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
163484911|NCT01858701|590475614|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
163484912|NCT01858701|590475613|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
163484913|NCT01858701|590475614|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
163484914|NCT01858701|590475613|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
163484915|NCT01858701|590475614|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
163484916|NCT01858701|590475613|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
163484917|NCT01858701|590475614|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
163484918|NCT01674010|590475615|FG000|Open Treatment Phase 1|Adverse Event|10|||
163484919|NCT01674010|590475616|FG001|Open Treatment Phase 1|Adverse Event|0|||
163484920|NCT01674010|590475617|FG002|Open Treatment Phase 1|Adverse Event|0|||
163484921|NCT01674010|590475615|FG000|Open Treatment Phase 1|Death|1|||
163484922|NCT01674010|590475616|FG001|Open Treatment Phase 1|Death|0|||
163484923|NCT01674010|590475617|FG002|Open Treatment Phase 1|Death|0|||
163484924|NCT01674010|590475615|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
163484925|NCT01674010|590475616|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
163484926|NCT01674010|590475617|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
163484927|NCT01674010|590475615|FG000|Open Treatment Phase 1|Physician Decision|9|||
163484928|NCT01674010|590475616|FG001|Open Treatment Phase 1|Physician Decision|0|||
163484929|NCT01674010|590475617|FG002|Open Treatment Phase 1|Physician Decision|0|||
163484930|NCT01674010|590475615|FG000|Open Treatment Phase 1|Protocol Violation|7|||
163484931|NCT01674010|590475616|FG001|Open Treatment Phase 1|Protocol Violation|0|||
163484932|NCT01674010|590475617|FG002|Open Treatment Phase 1|Protocol Violation|0|||
163484933|NCT01674010|590475615|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
163484934|NCT01674010|590475616|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
163484935|NCT01674010|590475617|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
163484936|NCT01674010|590475615|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
163484937|NCT01674010|590475616|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
163484938|NCT01674010|590475617|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
163484939|NCT01674010|590475615|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
163484940|NCT01674010|590475616|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
163484941|NCT01674010|590475617|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
163484942|NCT01674010|590475615|FG000|Randomization Phase 2|Adverse Event|0|||
163484943|NCT01674010|590475616|FG001|Randomization Phase 2|Adverse Event|1|||
163484944|NCT01674010|590475617|FG002|Randomization Phase 2|Adverse Event|1|||
163484945|NCT01674010|590475615|FG000|Randomization Phase 2|Lost to Follow-up|0|||
163484946|NCT01674010|590475616|FG001|Randomization Phase 2|Lost to Follow-up|1|||
163484947|NCT01674010|590475617|FG002|Randomization Phase 2|Lost to Follow-up|2|||
163484948|NCT01674010|590475615|FG000|Randomization Phase 2|Mood episode recurrence|0|||
163484949|NCT01674010|590475616|FG001|Randomization Phase 2|Mood episode recurrence|8|||
163484950|NCT01674010|590475617|FG002|Randomization Phase 2|Mood episode recurrence|2|||
163484951|NCT01674010|590475615|FG000|Randomization Phase 2|Physician Decision|0|||
163484952|NCT01674010|590475616|FG001|Randomization Phase 2|Physician Decision|0|||
163484953|NCT01674010|590475617|FG002|Randomization Phase 2|Physician Decision|2|||
163484954|NCT01674010|590475615|FG000|Randomization Phase 2|Pregnancy|0|||
163484955|NCT01674010|590475616|FG001|Randomization Phase 2|Pregnancy|1|||
163484956|NCT01674010|590475617|FG002|Randomization Phase 2|Pregnancy|1|||
163484957|NCT01674010|590475615|FG000|Randomization Phase 2|Protocol Violation|0|||
163484958|NCT01674010|590475616|FG001|Randomization Phase 2|Protocol Violation|1|||
163484959|NCT01674010|590475617|FG002|Randomization Phase 2|Protocol Violation|1|||
163484960|NCT01674010|590475615|FG000|Randomization Phase 2|Sponsor Decision|0|||
163484961|NCT01674010|590475616|FG001|Randomization Phase 2|Sponsor Decision|42|||
163484962|NCT01674010|590475617|FG002|Randomization Phase 2|Sponsor Decision|45|||
163484963|NCT01674010|590475615|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
163484964|NCT01674010|590475616|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
163484965|NCT01674010|590475617|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
163484966|NCT01020812|590475618|FG000|Overall Study|Physician Decision|1|||
163484967|NCT01020812|590475618|FG000|Overall Study|Withdrawal by Subject|1|||
163484968|NCT01020812|590475618|FG000|Overall Study|Protocol Violation|1|||
163484969|NCT01801475|590475627|FG000|Overall Study|Withdrawal by Subject|0|||
163484970|NCT01801475|590475628|FG001|Overall Study|Withdrawal by Subject|0|||
163484971|NCT01801475|590475629|FG002|Overall Study|Withdrawal by Subject|0|||
163484972|NCT01801475|590475630|FG003|Overall Study|Withdrawal by Subject|0|||
163484973|NCT01801475|590475631|FG004|Overall Study|Withdrawal by Subject|1|||
163484974|NCT01786707|590475634|FG000|Overall Study|Lost to Follow-up|1|||
163484975|NCT01786707|590475635|FG001|Overall Study|Lost to Follow-up|1|||
163484976|NCT00421928|590475636|FG000|Overall Study|Adverse Event|61|||
163484977|NCT00421928|590475637|FG001|Overall Study|Adverse Event|140|||
163484978|NCT00421928|590475638|FG002|Overall Study|Adverse Event|22|||
163484979|NCT00421928|590475636|FG000|Overall Study|Lost to Follow-up|5|||
163484980|NCT00421928|590475637|FG001|Overall Study|Lost to Follow-up|0|||
163484981|NCT00421928|590475638|FG002|Overall Study|Lost to Follow-up|3|||
163484982|NCT00421928|590475636|FG000|Overall Study|Withdrawal by Subject|50|||
163484983|NCT00421928|590475637|FG001|Overall Study|Withdrawal by Subject|48|||
163484984|NCT00421928|590475638|FG002|Overall Study|Withdrawal by Subject|43|||
163484985|NCT00421928|590475636|FG000|Overall Study|Lack of Efficacy|15|||
163484986|NCT00421928|590475637|FG001|Overall Study|Lack of Efficacy|7|||
163484987|NCT00421928|590475638|FG002|Overall Study|Lack of Efficacy|35|||
163484988|NCT00421928|590475636|FG000|Overall Study|Study drug non-compliant|6|||
163484989|NCT00421928|590475637|FG001|Overall Study|Study drug non-compliant|7|||
163484990|NCT00421928|590475638|FG002|Overall Study|Study drug non-compliant|4|||
163484991|NCT00421928|590475636|FG000|Overall Study|All other|26|||
163484992|NCT00421928|590475637|FG001|Overall Study|All other|21|||
163484993|NCT00421928|590475638|FG002|Overall Study|All other|27|||
163484994|NCT00421928|590475636|FG000|Overall Study|Death|0|||
163484995|NCT00421928|590475637|FG001|Overall Study|Death|1|||
163484996|NCT00421928|590475638|FG002|Overall Study|Death|0|||
163484997|NCT02946515|590475645|FG000|Overall Study|Lost to Follow-up|2|||
163484998|NCT02946515|590475646|FG001|Overall Study|Lost to Follow-up|1|||
163484999|NCT02158949|590475649|FG000|Overall Study|Withdrawal by Subject|1|||
163485000|NCT02158949|590475650|FG001|Overall Study|Withdrawal by Subject|0|||
163485001|NCT02158949|590475649|FG000|Overall Study|Lost to Follow-up|5|||
163485002|NCT02158949|590475650|FG001|Overall Study|Lost to Follow-up|11|||
163485003|NCT00475657|590475652|FG000|Overall Study|Death|1|||
163485004|NCT00475657|590475652|FG000|Overall Study|Sponsor's Decision|3|||
163485005|NCT00408408|590475653|FG000|Overall Study|No follow up data|2|||
163485006|NCT00408408|590475654|FG001|Overall Study|No follow up data|3|||
163485007|NCT00408408|590475655|FG002|Overall Study|No follow up data|0|||
163485008|NCT00408408|590475656|FG003|Overall Study|No follow up data|7|||
163485009|NCT00408408|590475657|FG004|Overall Study|No follow up data|5|||
163485010|NCT00408408|590475658|FG005|Overall Study|No follow up data|3|||
163485011|NCT02898662|590475665|FG000|Overall Study|Adverse Event|1|||
163485012|NCT02898662|590475666|FG001|Overall Study|Adverse Event|0|||
163485013|NCT02898662|590475665|FG000|Overall Study|Loss of asthma control|23|||
163485014|NCT02898662|590475666|FG001|Overall Study|Loss of asthma control|24|||
163485015|NCT02898662|590475665|FG000|Overall Study|Withdrawal by Subject|4|||
163485016|NCT02898662|590475666|FG001|Overall Study|Withdrawal by Subject|1|||
163485017|NCT02898662|590475665|FG000|Overall Study|Technical issue|0|||
163485018|NCT02898662|590475666|FG001|Overall Study|Technical issue|1|||
163485019|NCT02898662|590475665|FG000|Overall Study|Randomized in error|0|||
163485020|NCT02898662|590475666|FG001|Overall Study|Randomized in error|1|||
163485021|NCT02898662|590475665|FG000|Overall Study|Subject decision|1|||
163485022|NCT02898662|590475666|FG001|Overall Study|Subject decision|0|||
163485023|NCT02898662|590475665|FG000|Overall Study|Other|0|||
163485024|NCT02898662|590475666|FG001|Overall Study|Other|1|||
163485025|NCT00399542|590475667|FG000|Overall Study|Adverse Event|18|||
163485026|NCT00399542|590475668|FG001|Overall Study|Adverse Event|15|||
163485027|NCT00399542|590475667|FG000|Overall Study|Protocol Violation|13|||
163485028|NCT00399542|590475668|FG001|Overall Study|Protocol Violation|3|||
163485029|NCT00399542|590475667|FG000|Overall Study|Withdrawal by Subject|28|||
163485030|NCT00399542|590475668|FG001|Overall Study|Withdrawal by Subject|10|||
163485031|NCT00399542|590475667|FG000|Overall Study|Lack of Efficacy|18|||
163485032|NCT00399542|590475668|FG001|Overall Study|Lack of Efficacy|8|||
163485033|NCT00399542|590475667|FG000|Overall Study|Lost to Follow-up|6|||
163485034|NCT00399542|590475668|FG001|Overall Study|Lost to Follow-up|6|||
163485035|NCT00399542|590475667|FG000|Overall Study|Other|1|||
163485036|NCT00399542|590475668|FG001|Overall Study|Other|0|||
163485037|NCT00399542|590475667|FG000|Overall Study|Physician Decision|0|||
163485038|NCT00399542|590475668|FG001|Overall Study|Physician Decision|1|||
163485039|NCT00917553|590475669|FG000|Overall Study|Lost to Follow-up|2|||
163485040|NCT00917553|590475670|FG001|Overall Study|Lost to Follow-up|1|||
163485041|NCT01616173|590475671|FG000|Overall Study|Lost to Follow-up|0|||
163485042|NCT01616173|590475672|FG001|Overall Study|Lost to Follow-up|2|||
163485043|NCT01616173|590475673|FG002|Overall Study|Lost to Follow-up|0|||
163485044|NCT03172026|590475677|FG000|Overall Study|Withdrawal by Subject|1|||
163485045|NCT03172026|590475678|FG001|Overall Study|Withdrawal by Subject|0|||
163485046|NCT03172026|590475677|FG000|Overall Study|COVID restrictions|1|||
163485047|NCT03172026|590475678|FG001|Overall Study|COVID restrictions|0|||
163485048|NCT01430559|590475682|FG000|Overall Study|Adverse Event|7|||
163485049|NCT01430559|590475683|FG001|Overall Study|Adverse Event|3|||
163485050|NCT01430559|590475682|FG000|Overall Study|Entry criteria not met|1|||
163485051|NCT01430559|590475683|FG001|Overall Study|Entry criteria not met|1|||
163485052|NCT01430559|590475682|FG000|Overall Study|Lost to Follow-up|1|||
163485053|NCT01430559|590475683|FG001|Overall Study|Lost to Follow-up|0|||
163485054|NCT01430559|590475682|FG000|Overall Study|Medication error|1|||
163485055|NCT01430559|590475683|FG001|Overall Study|Medication error|0|||
163485056|NCT01430559|590475682|FG000|Overall Study|Withdrawal by Subject|3|||
163485057|NCT01430559|590475683|FG001|Overall Study|Withdrawal by Subject|2|||
163485058|NCT01430559|590475682|FG000|Overall Study|Protocol Violation|1|||
163485059|NCT01430559|590475683|FG001|Overall Study|Protocol Violation|0|||
163485060|NCT01430559|590475682|FG000|Overall Study|Other|3|||
163485061|NCT01430559|590475683|FG001|Overall Study|Other|3|||
163485062|NCT01430559|590475682|FG000|Overall Study|Randomized, Not Treated|3|||
163485063|NCT01430559|590475683|FG001|Overall Study|Randomized, Not Treated|3|||
163485064|NCT00504595|590475684|FG000|Overall Study|Lack of Efficacy|1|||
163485065|NCT00504595|590475685|FG001|Overall Study|Lack of Efficacy|0|||
163485066|NCT00504595|590475686|FG002|Overall Study|Lack of Efficacy|0|||
163485067|NCT00504595|590475687|FG003|Overall Study|Lack of Efficacy|0|||
163485068|NCT00504595|590475684|FG000|Overall Study|Other|0|||
163485069|NCT00504595|590475685|FG001|Overall Study|Other|0|||
163485070|NCT00504595|590475686|FG002|Overall Study|Other|2|||
163485071|NCT00504595|590475687|FG003|Overall Study|Other|0|||
163485072|NCT01220024|590475688|FG000|Overall Study|Lost to Follow-up|1|||
163485073|NCT01220024|590475689|FG001|Overall Study|Lost to Follow-up|1|||
163485074|NCT00174460|590475691|FG000|Overall Study|Withdrawal by Subject|0|||
163485075|NCT00174460|590475692|FG001|Overall Study|Withdrawal by Subject|1|||
163485076|NCT00579059|590475693|FG000|Overall Study|Study Canceled at 1 Year|21|||
163485077|NCT00579059|590475694|FG001|Overall Study|Study Canceled at 1 Year|10|||
163485078|NCT00779142|590475695|FG000|Overall Study|Screen Failures|3|||
163485079|NCT04652245|590475696|FG000|Wash-Out Period|Adverse Event|0|||
163485080|NCT04652245|590475697|FG001|Wash-Out Period|Adverse Event|2|||
163485081|NCT04652245|590475696|FG000|Wash-Out Period|Withdrawal by Subject|0|||
163485082|NCT04652245|590475697|FG001|Wash-Out Period|Withdrawal by Subject|2|||
163485083|NCT03137433|590475702|FG000|Overall Study|Withdrawal by Subject|11|||
163485084|NCT03137433|590475703|FG001|Overall Study|Withdrawal by Subject|11|||
163485085|NCT03137433|590475702|FG000|Overall Study|Lost to Follow-up|5|||
163485086|NCT03137433|590475703|FG001|Overall Study|Lost to Follow-up|6|||
163485087|NCT03137433|590475702|FG000|Overall Study|Physician Decision|2|||
163485088|NCT03137433|590475703|FG001|Overall Study|Physician Decision|0|||
163485089|NCT03137433|590475702|FG000|Overall Study|Moved out of study area|1|||
163485090|NCT03137433|590475703|FG001|Overall Study|Moved out of study area|0|||
163485091|NCT03137433|590475702|FG000|Overall Study|Too far out of window due to COVID|0|||
163485092|NCT03137433|590475703|FG001|Overall Study|Too far out of window due to COVID|1|||
163485093|NCT01288911|590475704|FG000|Double-blind Period|Death|11|||
163485094|NCT01288911|590475705|FG001|Double-blind Period|Death|7|||
163485095|NCT01288911|590475704|FG000|Double-blind Period|Lost to Follow-up|0|||
163485096|NCT01288911|590475705|FG001|Double-blind Period|Lost to Follow-up|2|||
163485097|NCT01288911|590475704|FG000|Double-blind Period|Progressive Disease|75|||
163485098|NCT01288911|590475705|FG001|Double-blind Period|Progressive Disease|103|||
163485099|NCT01288911|590475704|FG000|Double-blind Period|Protocol Violation|1|||
163485100|NCT01288911|590475705|FG001|Double-blind Period|Protocol Violation|0|||
163485101|NCT01288911|590475704|FG000|Double-blind Period|Withdrawal by Subject|25|||
163485102|NCT01288911|590475705|FG001|Double-blind Period|Withdrawal by Subject|26|||
163485103|NCT01288911|590475704|FG000|Double-blind Period|Miscellaneous Reason|29|||
163485104|NCT01288911|590475705|FG001|Double-blind Period|Miscellaneous Reason|42|||
163485105|NCT01288911|590475704|FG000|Double-blind Period|Randomized but never received study drug|1|||
163485106|NCT01288911|590475705|FG001|Double-blind Period|Randomized but never received study drug|2|||
163485107|NCT01288911|590475704|FG000|Open-label Period (All Enzalutamide)|Death|0|||
163485108|NCT01288911|590475705|FG001|Open-label Period (All Enzalutamide)|Death|1|||
163485109|NCT01288911|590475704|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
163485110|NCT01288911|590475705|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
163485111|NCT01288911|590475704|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
163485112|NCT01288911|590475705|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
163485113|NCT01288911|590475704|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
163485114|NCT01288911|590475705|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
163485115|NCT01288911|590475704|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
163485116|NCT01288911|590475705|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
163485117|NCT01288911|590475704|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
163485118|NCT01288911|590475705|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
163485119|NCT02543918|590475706|FG000|Overall Study|Never treated|0|||
163485120|NCT02543918|590475707|FG001|Overall Study|Never treated|1|||
163485121|NCT02543918|590475706|FG000|Overall Study|Lost to Follow-up|1|||
163485122|NCT02543918|590475707|FG001|Overall Study|Lost to Follow-up|1|||
163485123|NCT02543918|590475706|FG000|Overall Study|Withdrawal by Subject|1|||
163485124|NCT02543918|590475707|FG001|Overall Study|Withdrawal by Subject|1|||
163485125|NCT02543918|590475706|FG000|Overall Study|Adverse Event|1|||
163485126|NCT02543918|590475707|FG001|Overall Study|Adverse Event|1|||
163485127|NCT02452892|590475710|FG000|Week 1 Initial Randommization|Adverse Event|1|||
163485128|NCT02452892|590475711|FG001|Week 1 Initial Randommization|Adverse Event|0|||
163485129|NCT02452892|590475712|FG002|Week 1 Initial Randommization|Adverse Event|0|||
163485130|NCT02452892|590475713|FG003|Week 1 Initial Randommization|Adverse Event|0|||
163485131|NCT02452892|590475710|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
163485132|NCT02452892|590475711|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
163485133|NCT02452892|590475712|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
163485134|NCT02452892|590475713|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
163485135|NCT02452892|590475710|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
163485136|NCT02452892|590475711|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
163485137|NCT02452892|590475712|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
163485138|NCT02452892|590475713|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
163485139|NCT02452892|590475710|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
163485140|NCT02452892|590475711|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
163485141|NCT02452892|590475712|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
163485142|NCT02452892|590475713|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
163485143|NCT02452892|590475710|FG000|Follow-up|Withdrawal by Subject|0|||
163485144|NCT02452892|590475711|FG001|Follow-up|Withdrawal by Subject|0|||
163485145|NCT02452892|590475712|FG002|Follow-up|Withdrawal by Subject|0|||
163485146|NCT02452892|590475713|FG003|Follow-up|Withdrawal by Subject|1|||
163485147|NCT02452892|590475710|FG000|Follow-up|Subject left town on Day 42|1|||
163485148|NCT02452892|590475711|FG001|Follow-up|Subject left town on Day 42|0|||
163485149|NCT02452892|590475712|FG002|Follow-up|Subject left town on Day 42|0|||
163485150|NCT02452892|590475713|FG003|Follow-up|Subject left town on Day 42|0|||
163485151|NCT00486720|590475714|FG000|Overall Study|Adverse Event|1|||
163485152|NCT00486720|590475715|FG001|Overall Study|Adverse Event|2|||
163485153|NCT00486720|590475714|FG000|Overall Study|Lack of Efficacy|4|||
163485154|NCT00486720|590475715|FG001|Overall Study|Lack of Efficacy|6|||
163485155|NCT00486720|590475714|FG000|Overall Study|Physician Decision|1|||
163485156|NCT00486720|590475715|FG001|Overall Study|Physician Decision|2|||
163485157|NCT00486720|590475714|FG000|Overall Study|Protocol Violation|1|||
163485158|NCT00486720|590475715|FG001|Overall Study|Protocol Violation|0|||
163485159|NCT00486720|590475714|FG000|Overall Study|Withdrawal by Subject|3|||
163485160|NCT00486720|590475715|FG001|Overall Study|Withdrawal by Subject|1|||
163485161|NCT00486720|590475714|FG000|Overall Study|Progressive Disease|0|||
163485162|NCT00486720|590475715|FG001|Overall Study|Progressive Disease|1|||
163485163|NCT03742271|590475726|FG000|Overall Study|Unsatisfactory Visual Response|1|||
163485164|NCT03742271|590475726|FG000|Overall Study|Withdrawal by Subject|3|||
163485165|NCT03742271|590475726|FG000|Overall Study|Lost to Follow-up|4|||
163485166|NCT03742271|590475726|FG000|Overall Study|Failed Insertion & removal|3|||
163485167|NCT03742271|590475726|FG000|Overall Study|Protocol Violation|1|||
163485168|NCT01843933|590475727|FG000|Overall Study|Data lost|6|||
163485169|NCT01843933|590475728|FG001|Overall Study|Data lost|4|||
163485170|NCT03137173|590475729|FG000|Overall Study|Withdrawal by Subject|8|||
163485171|NCT03137173|590475730|FG001|Overall Study|Withdrawal by Subject|13|||
163485172|NCT03137173|590475729|FG000|Overall Study|Death|1|||
163485173|NCT03137173|590475730|FG001|Overall Study|Death|3|||
163485174|NCT03137173|590475729|FG000|Overall Study|Physician Decision|1|||
163485175|NCT03137173|590475730|FG001|Overall Study|Physician Decision|0|||
163485176|NCT03137173|590475729|FG000|Overall Study|Lost to Follow-up|13|||
163485177|NCT03137173|590475730|FG001|Overall Study|Lost to Follow-up|18|||
163485178|NCT03137173|590475729|FG000|Overall Study|Other reasons|3|||
163485179|NCT03137173|590475730|FG001|Overall Study|Other reasons|2|||
163485180|NCT01535638|590475731|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
163485181|NCT01535638|590475732|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
163485182|NCT01535638|590475733|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
163485183|NCT01535638|590475734|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
163485184|NCT01535638|590475735|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
163485185|NCT01535638|590475736|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
163485186|NCT01535638|590475731|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
163485187|NCT01535638|590475732|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
163485188|NCT01535638|590475733|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
163485189|NCT01535638|590475734|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
163485190|NCT01535638|590475735|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
163485191|NCT01535638|590475736|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
163485192|NCT05060003|590475737|FG000|Overall Study|ctDNA negative|7|||
163485193|NCT03524664|590475738|FG000|Overall Study|Withdrawal by Subject|1|||
163485194|NCT03524664|590475739|FG001|Overall Study|Withdrawal by Subject|2|||
163485195|NCT03524664|590475738|FG000|Overall Study|Lost to Follow-up|4|||
163485196|NCT03524664|590475739|FG001|Overall Study|Lost to Follow-up|13|||
163485197|NCT02694562|590475740|FG000|Overall Study|Death|8|||
163485198|NCT02694562|590475740|FG000|Overall Study|Protocol Violation|4|||
163485199|NCT02694562|590475740|FG000|Overall Study|Lost to Follow-up|3|||
163485200|NCT02694562|590475740|FG000|Overall Study|Screen Failure|2|||
163485201|NCT02694562|590475740|FG000|Overall Study|Physician Decision|1|||
163485202|NCT00827112|590475741|FG000|Overall Study|Adverse Event|2|||
163485203|NCT00827112|590475742|FG001|Overall Study|Adverse Event|0|||
163485204|NCT00827112|590475741|FG000|Overall Study|Lack of Efficacy|2|||
163485205|NCT00827112|590475742|FG001|Overall Study|Lack of Efficacy|0|||
163485206|NCT00827112|590475741|FG000|Overall Study|Lost to Follow-up|3|||
163485207|NCT00827112|590475742|FG001|Overall Study|Lost to Follow-up|2|||
163485208|NCT00827112|590475741|FG000|Overall Study|Pregnancy|0|||
163485209|NCT00827112|590475742|FG001|Overall Study|Pregnancy|1|||
163485210|NCT00827112|590475741|FG000|Overall Study|Protocol Violation|0|||
163485211|NCT00827112|590475742|FG001|Overall Study|Protocol Violation|2|||
163485212|NCT00827112|590475741|FG000|Overall Study|Withdrawal by Subject|2|||
163485213|NCT00827112|590475742|FG001|Overall Study|Withdrawal by Subject|1|||
163485214|NCT00827112|590475741|FG000|Overall Study|Randomized but not treated|5|||
163485215|NCT00827112|590475742|FG001|Overall Study|Randomized but not treated|3|||
163485216|NCT00827112|590475741|FG000|Overall Study|Other|1|||
163485217|NCT00827112|590475742|FG001|Overall Study|Other|3|||
163485218|NCT03529162|590475747|FG000|Overall Study|Lost to Follow-up|2|||
163485219|NCT03529162|590475748|FG001|Overall Study|Lost to Follow-up|2|||
163485220|NCT00554229|590475753|FG000|Overall Study|Lost to Follow-up|3|||
163485221|NCT00554229|590475754|FG001|Overall Study|Lost to Follow-up|6|||
163485222|NCT00554229|590475753|FG000|Overall Study|Withdrawal by Subject|29|||
163485223|NCT00554229|590475754|FG001|Overall Study|Withdrawal by Subject|37|||
163485224|NCT00554229|590475753|FG000|Overall Study|Adverse Event|71|||
163485225|NCT00554229|590475754|FG001|Overall Study|Adverse Event|39|||
163485226|NCT00554229|590475753|FG000|Overall Study|Protocol Violation|3|||
163485227|NCT00554229|590475754|FG001|Overall Study|Protocol Violation|3|||
163485228|NCT00554229|590475753|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
163485229|NCT00554229|590475754|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
163485230|NCT00554229|590475753|FG000|Overall Study|Randomised but no treatment received|1|||
163485231|NCT00554229|590475754|FG001|Overall Study|Randomised but no treatment received|0|||
163485232|NCT00784836|590475755|FG000|Overall Study|Early Study Termination|3|||
163485233|NCT00517634|590475756|FG000|Second Treatment Period|Withdrawal by Subject|0|||
163485234|NCT00517634|590475757|FG001|Second Treatment Period|Withdrawal by Subject|0|||
163485235|NCT00517634|590475758|FG002|Second Treatment Period|Withdrawal by Subject|0|||
163485236|NCT00517634|590475759|FG003|Second Treatment Period|Withdrawal by Subject|0|||
163485237|NCT00517634|590475760|FG004|Second Treatment Period|Withdrawal by Subject|1|||
163485238|NCT00517634|590475761|FG005|Second Treatment Period|Withdrawal by Subject|0|||
163485239|NCT03143855|590475762|FG000|Overall Study|Withdrawal by Subject|4|||
163485240|NCT03143855|590475763|FG001|Overall Study|Withdrawal by Subject|3|||
163485241|NCT03143855|590475762|FG000|Overall Study|Protocol Violation|1|||
163485242|NCT03143855|590475763|FG001|Overall Study|Protocol Violation|0|||
163485243|NCT03143855|590475762|FG000|Overall Study|Participant experienced withdrawal|0|||
163485244|NCT03143855|590475763|FG001|Overall Study|Participant experienced withdrawal|1|||
163485245|NCT00701064|590475766|FG000|Overall Study|Protocol Violation|1|||
163485246|NCT00701064|590475767|FG001|Overall Study|Protocol Violation|1|||
163485247|NCT00701064|590475766|FG000|Overall Study|Withdrawal by Subject|1|||
163485248|NCT00701064|590475767|FG001|Overall Study|Withdrawal by Subject|1|||
163485249|NCT00701064|590475766|FG000|Overall Study|initiated other PTSD treatment|2|||
163485250|NCT00701064|590475767|FG001|Overall Study|initiated other PTSD treatment|2|||
163485251|NCT02613910|590475768|FG000|Overall Study|Termination of study|1|||
163485252|NCT02098733|590475769|FG000|Overall Study|Data Not Available|5|||
163485253|NCT02098733|590475769|FG000|Overall Study|Lost to Follow-up|5|||
163485254|NCT03077646|590475770|FG000|Overall Study|Lost to Follow-up|29|||
163485255|NCT03077646|590475771|FG001|Overall Study|Lost to Follow-up|30|||
163485256|NCT03077646|590475772|FG002|Overall Study|Lost to Follow-up|31|||
163485257|NCT00765726|590475773|FG000|Overall Study|Withdrawal by Subject|1|||
163485258|NCT00765726|590475773|FG000|Overall Study|Discontinuation of study by sponsor|8|||
163485259|NCT02993731|590475774|FG000|Overall Study|Study Termination|101|||
163485260|NCT02993731|590475775|FG001|Overall Study|Study Termination|105|||
163485261|NCT01002573|590477555|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
163485262|NCT01002573|590477556|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
163485263|NCT03808298|590477560|FG000|Overall Study|Adverse Event|3|||
163485264|NCT03808298|590477560|FG000|Overall Study|Physician Decision|1|||
163485265|NCT03808298|590477560|FG000|Overall Study|Withdrawal by Subject|1|||
163485266|NCT03808298|590477560|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
163485267|NCT02713490|590477561|FG000|Overall Study|Withdrawal by Subject|2|||
163485268|NCT02713490|590477562|FG001|Overall Study|Withdrawal by Subject|1|||
163485269|NCT02713490|590477561|FG000|Overall Study|Did not receive study drug|1|||
163485270|NCT02713490|590477562|FG001|Overall Study|Did not receive study drug|0|||
163485271|NCT02713490|590477561|FG000|Overall Study|Met exclusion criteria|0|||
163485272|NCT02713490|590477562|FG001|Overall Study|Met exclusion criteria|1|||
163485273|NCT03039686|590477566|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
163485274|NCT03039686|590477567|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
163485275|NCT03039686|590477568|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
163485276|NCT03039686|590477566|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
163485277|NCT03039686|590477567|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
163485278|NCT03039686|590477568|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
163485279|NCT03039686|590477566|FG000|Double-blind Period|Withdrawal by Subject|2|||
163485280|NCT03039686|590477567|FG001|Double-blind Period|Withdrawal by Subject|2|||
163485281|NCT03039686|590477568|FG002|Double-blind Period|Withdrawal by Subject|1|||
163485282|NCT03039686|590477566|FG000|Double-blind Period|Death|0|||
163485283|NCT03039686|590477567|FG001|Double-blind Period|Death|0|||
163485284|NCT03039686|590477568|FG002|Double-blind Period|Death|1|||
163485285|NCT03039686|590477566|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
163485286|NCT03039686|590477567|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
163485287|NCT03039686|590477568|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
163485288|NCT03039686|590477566|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
163485289|NCT03039686|590477567|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
163485290|NCT03039686|590477568|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
163485291|NCT03039686|590477566|FG000|Open Label Period|Withdrawal by Subject|0|||
163485292|NCT03039686|590477567|FG001|Open Label Period|Withdrawal by Subject|3|||
163485293|NCT03039686|590477568|FG002|Open Label Period|Withdrawal by Subject|1|||
163485294|NCT03868410|590477574|FG000|Overall Study|Physician Decision|0|||
163485295|NCT03868410|590477575|FG001|Overall Study|Physician Decision|1|||
163485296|NCT00134563|590477579|FG000|Overall Study|Not treated due to protocol violation|0|||
163485297|NCT00134563|590477580|FG001|Overall Study|Not treated due to protocol violation|1|||
163485298|NCT00134563|590477581|FG002|Overall Study|Not treated due to protocol violation|1|||
163485299|NCT00134563|590477579|FG000|Overall Study|Adverse Event|29|||
163485300|NCT00134563|590477580|FG001|Overall Study|Adverse Event|37|||
163485301|NCT00134563|590477581|FG002|Overall Study|Adverse Event|38|||
163485302|NCT00134563|590477579|FG000|Overall Study|Lack of Efficacy|24|||
163485303|NCT00134563|590477580|FG001|Overall Study|Lack of Efficacy|14|||
163485304|NCT00134563|590477581|FG002|Overall Study|Lack of Efficacy|17|||
163485305|NCT00134563|590477579|FG000|Overall Study|Protocol Violation|3|||
163485306|NCT00134563|590477580|FG001|Overall Study|Protocol Violation|2|||
163485307|NCT00134563|590477581|FG002|Overall Study|Protocol Violation|5|||
163485308|NCT00134563|590477579|FG000|Overall Study|Lost to Follow-up|4|||
163485309|NCT00134563|590477580|FG001|Overall Study|Lost to Follow-up|0|||
163485310|NCT00134563|590477581|FG002|Overall Study|Lost to Follow-up|2|||
163485311|NCT00134563|590477579|FG000|Overall Study|progressive disease|11|||
163485312|NCT00134563|590477580|FG001|Overall Study|progressive disease|4|||
163485313|NCT00134563|590477581|FG002|Overall Study|progressive disease|2|||
163485314|NCT00134563|590477579|FG000|Overall Study|did not wish to continue|33|||
163485315|NCT00134563|590477580|FG001|Overall Study|did not wish to continue|32|||
163485316|NCT00134563|590477581|FG002|Overall Study|did not wish to continue|26|||
163485317|NCT00134563|590477579|FG000|Overall Study|Reason other than above|0|||
163485318|NCT00134563|590477580|FG001|Overall Study|Reason other than above|2|||
163485319|NCT00134563|590477581|FG002|Overall Study|Reason other than above|5|||
163485320|NCT02406586|590477585|FG000|Overall Study|Lost to Follow-up|0|||
163485321|NCT02406586|590477586|FG001|Overall Study|Lost to Follow-up|4|||
163485322|NCT02406586|590477587|FG002|Overall Study|Lost to Follow-up|2|||
163485323|NCT02406586|590477585|FG000|Overall Study|Withdrawal by Subject|1|||
163485324|NCT02406586|590477586|FG001|Overall Study|Withdrawal by Subject|0|||
163485325|NCT02406586|590477587|FG002|Overall Study|Withdrawal by Subject|0|||
163485326|NCT03382639|590477588|FG000|Overall Study|Adverse Event|2|||
163485327|NCT03382639|590477589|FG001|Overall Study|Adverse Event|0|||
163485328|NCT03382639|590477590|FG002|Overall Study|Adverse Event|1|||
163485329|NCT03382639|590477591|FG003|Overall Study|Adverse Event|1|||
163485330|NCT03382639|590477588|FG000|Overall Study|Lost to Follow-up|1|||
163485331|NCT03382639|590477589|FG001|Overall Study|Lost to Follow-up|0|||
163485332|NCT03382639|590477590|FG002|Overall Study|Lost to Follow-up|0|||
163485333|NCT03382639|590477591|FG003|Overall Study|Lost to Follow-up|0|||
163485334|NCT03382639|590477588|FG000|Overall Study|Withdrawal by Subject|4|||
163485335|NCT03382639|590477589|FG001|Overall Study|Withdrawal by Subject|3|||
163485336|NCT03382639|590477590|FG002|Overall Study|Withdrawal by Subject|2|||
163485337|NCT03382639|590477591|FG003|Overall Study|Withdrawal by Subject|3|||
163485338|NCT03382639|590477588|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
163485339|NCT03382639|590477589|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
163485340|NCT03382639|590477590|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
163485341|NCT03382639|590477591|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
163485342|NCT03382639|590477588|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
163485343|NCT03382639|590477589|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
163485344|NCT03382639|590477590|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
163485345|NCT03382639|590477591|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
163485346|NCT03382639|590477588|FG000|Overall Study|Other|2|||
163485347|NCT03382639|590477589|FG001|Overall Study|Other|0|||
163485348|NCT03382639|590477590|FG002|Overall Study|Other|0|||
163485349|NCT03382639|590477591|FG003|Overall Study|Other|3|||
163485350|NCT02624713|590477594|FG000|Overall Study|Lost to Follow-up|14|||
163485351|NCT02624713|590477595|FG001|Overall Study|Lost to Follow-up|0|||
163485352|NCT00285857|590477596|FG000|Overall Study|Withdrawal by Subject|2|||
163485353|NCT00285857|590477596|FG000|Overall Study|Inadequate initial breast cytology|1|||
163485354|NCT00285857|590477596|FG000|Overall Study|Adverse Event|1|||
163485355|NCT00148109|590477601|FG000|Overall Study|Lack of Efficacy|10|||
163485356|NCT00148109|590477602|FG001|Overall Study|Lack of Efficacy|18|||
163485357|NCT00148109|590477601|FG000|Overall Study|Adverse Event|0|||
163485358|NCT00148109|590477602|FG001|Overall Study|Adverse Event|2|||
163485359|NCT00148109|590477601|FG000|Overall Study|Withdrawal by Subject|2|||
163485360|NCT00148109|590477602|FG001|Overall Study|Withdrawal by Subject|0|||
163485361|NCT06104423|590477603|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
163485362|NCT06104423|590477604|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
163485363|NCT06104423|590477605|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
163485364|NCT06104423|590477603|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
163485365|NCT06104423|590477604|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
163485366|NCT06104423|590477605|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
163485367|NCT00351611|590477610|FG000|Overall Study|Adverse Event|11|||
163485368|NCT00351611|590477611|FG001|Overall Study|Adverse Event|3|||
163485369|NCT00351611|590477610|FG000|Overall Study|Death|1|||
163485370|NCT00351611|590477611|FG001|Overall Study|Death|0|||
163485371|NCT00351611|590477610|FG000|Overall Study|Lost to Follow-up|1|||
163485372|NCT00351611|590477611|FG001|Overall Study|Lost to Follow-up|0|||
163485373|NCT00351611|590477610|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
163485374|NCT00351611|590477611|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
163485375|NCT00351611|590477610|FG000|Overall Study|Other|1|||
163485376|NCT00351611|590477611|FG001|Overall Study|Other|0|||
163485377|NCT00351611|590477610|FG000|Overall Study|Protocol Violation|0|||
163485378|NCT00351611|590477611|FG001|Overall Study|Protocol Violation|2|||
163485379|NCT01589185|590477612|FG000|Overall Study|Death|1|||
163485380|NCT01589185|590477613|FG001|Overall Study|Death|2|||
163485381|NCT01589185|590477614|FG002|Overall Study|Death|2|||
163485382|NCT01589185|590477615|FG003|Overall Study|Death|0|||
163485383|NCT01589185|590477616|FG004|Overall Study|Death|1|||
163485384|NCT01589185|590477612|FG000|Overall Study|Lost to Follow-up|1|||
163485385|NCT01589185|590477613|FG001|Overall Study|Lost to Follow-up|0|||
163485386|NCT01589185|590477614|FG002|Overall Study|Lost to Follow-up|2|||
163485387|NCT01589185|590477615|FG003|Overall Study|Lost to Follow-up|3|||
163485388|NCT01589185|590477616|FG004|Overall Study|Lost to Follow-up|0|||
163485389|NCT02708524|590477617|FG000|Overall Study|Adverse Event|0|||
163485390|NCT02708524|590477618|FG001|Overall Study|Adverse Event|1|||
163485391|NCT02708524|590477619|FG002|Overall Study|Adverse Event|0|||
163485392|NCT02708524|590477620|FG003|Overall Study|Adverse Event|0|||
163485393|NCT02708524|590477617|FG000|Overall Study|Lens Discomfort|1|||
163485394|NCT02708524|590477618|FG001|Overall Study|Lens Discomfort|0|||
163485395|NCT02708524|590477619|FG002|Overall Study|Lens Discomfort|1|||
163485396|NCT02708524|590477620|FG003|Overall Study|Lens Discomfort|0|||
163485397|NCT02708524|590477617|FG000|Overall Study|Lost to Follow-up|1|||
163485398|NCT02708524|590477618|FG001|Overall Study|Lost to Follow-up|1|||
163485399|NCT02708524|590477619|FG002|Overall Study|Lost to Follow-up|1|||
163485400|NCT02708524|590477620|FG003|Overall Study|Lost to Follow-up|0|||
163485401|NCT02708524|590477617|FG000|Overall Study|Protocol Violation|0|||
163485402|NCT02708524|590477618|FG001|Overall Study|Protocol Violation|1|||
163485403|NCT02708524|590477619|FG002|Overall Study|Protocol Violation|0|||
163485404|NCT02708524|590477620|FG003|Overall Study|Protocol Violation|0|||
163485405|NCT02708524|590477617|FG000|Overall Study|Withdrawal by Subject|1|||
163485406|NCT02708524|590477618|FG001|Overall Study|Withdrawal by Subject|1|||
163485407|NCT02708524|590477619|FG002|Overall Study|Withdrawal by Subject|0|||
163485408|NCT02708524|590477620|FG003|Overall Study|Withdrawal by Subject|0|||
163485409|NCT02708524|590477617|FG000|Overall Study|Dispensed incorrect study lens|0|||
163485410|NCT02708524|590477618|FG001|Overall Study|Dispensed incorrect study lens|1|||
163485411|NCT02708524|590477619|FG002|Overall Study|Dispensed incorrect study lens|1|||
163485412|NCT02708524|590477620|FG003|Overall Study|Dispensed incorrect study lens|0|||
163485413|NCT02708524|590477617|FG000|Overall Study|Did not wear lens at final visit|0|||
163485414|NCT02708524|590477618|FG001|Overall Study|Did not wear lens at final visit|1|||
163485415|NCT02708524|590477619|FG002|Overall Study|Did not wear lens at final visit|0|||
163485416|NCT02708524|590477620|FG003|Overall Study|Did not wear lens at final visit|0|||
163485417|NCT02708524|590477617|FG000|Overall Study|Subject lost study lens|1|||
163485418|NCT02708524|590477618|FG001|Overall Study|Subject lost study lens|0|||
163485419|NCT02708524|590477619|FG002|Overall Study|Subject lost study lens|0|||
163485420|NCT02708524|590477620|FG003|Overall Study|Subject lost study lens|0|||
163485421|NCT03781167|590477626|FG000|Overall Study|Adverse Event|23|||
163485422|NCT03781167|590477627|FG001|Overall Study|Adverse Event|25|||
163485423|NCT03781167|590477626|FG000|Overall Study|Withdrew consent|16|||
163485424|NCT03781167|590477627|FG001|Overall Study|Withdrew consent|12|||
163485425|NCT03781167|590477626|FG000|Overall Study|Lost to Follow-up|0|||
163485426|NCT03781167|590477627|FG001|Overall Study|Lost to Follow-up|1|||
163485427|NCT03781167|590477626|FG000|Overall Study|Lack of Efficacy|4|||
163485428|NCT03781167|590477627|FG001|Overall Study|Lack of Efficacy|5|||
163485429|NCT03781167|590477626|FG000|Overall Study|Difficulty with drug delivery system|2|||
163485430|NCT03781167|590477627|FG001|Overall Study|Difficulty with drug delivery system|3|||
163485431|NCT03781167|590477626|FG000|Overall Study|Other, not specified|2|||
163485432|NCT03781167|590477627|FG001|Overall Study|Other, not specified|2|||
163485433|NCT00462501|590477628|FG000|Overall Study|Not treated|3|||
163485434|NCT00462501|590477628|FG000|Overall Study|Adverse Event|2|||
163485435|NCT00679354|590477633|FG000|Overall Study|Death|3|||
163485436|NCT00679354|590477633|FG000|Overall Study|Lack of Efficacy|22|||
163485437|NCT00679354|590477633|FG000|Overall Study|Physician Decision|4|||
163485438|NCT00679354|590477633|FG000|Overall Study|Ineligible|1|||
163485439|NCT01258803|590477643|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
163485440|NCT01258803|590477644|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
163485441|NCT01258803|590477645|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
163485442|NCT01258803|590477646|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
163485443|NCT01258803|590477647|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
163485444|NCT01258803|590477648|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
163485445|NCT01258803|590477643|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
163485446|NCT01258803|590477644|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
163485447|NCT01258803|590477645|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
163485448|NCT01258803|590477646|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
163485449|NCT01258803|590477647|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
163485450|NCT01258803|590477648|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
163485451|NCT01258803|590477643|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
163485452|NCT01258803|590477644|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
163485453|NCT01258803|590477645|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
163485454|NCT01258803|590477646|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
163485455|NCT01258803|590477647|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
163485456|NCT01258803|590477648|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
163485457|NCT01552408|590477649|FG000|Overall Study|Lost to Follow-up|2|||
163485458|NCT01552408|590477650|FG001|Overall Study|Lost to Follow-up|0|||
163485459|NCT01552408|590477649|FG000|Overall Study|Relocation|0|||
163485460|NCT01552408|590477650|FG001|Overall Study|Relocation|1|||
163485461|NCT01552408|590477649|FG000|Overall Study|Withdrawal by Subject|2|||
163485462|NCT01552408|590477650|FG001|Overall Study|Withdrawal by Subject|1|||
163485463|NCT01016912|590477653|FG000|End of Treatment Period|Lack of Efficacy|0|||
163485464|NCT01016912|590477654|FG001|End of Treatment Period|Lack of Efficacy|1|||
163485465|NCT01016912|590477655|FG002|End of Treatment Period|Lack of Efficacy|0|||
163485466|NCT01016912|590477656|FG003|End of Treatment Period|Lack of Efficacy|4|||
163485467|NCT01016912|590477657|FG004|End of Treatment Period|Lack of Efficacy|4|||
163485468|NCT01016912|590477653|FG000|End of Treatment Period|Adverse Event|0|||
163485469|NCT01016912|590477654|FG001|End of Treatment Period|Adverse Event|1|||
163485470|NCT01016912|590477655|FG002|End of Treatment Period|Adverse Event|1|||
163485471|NCT01016912|590477656|FG003|End of Treatment Period|Adverse Event|0|||
163485472|NCT01016912|590477657|FG004|End of Treatment Period|Adverse Event|0|||
163485473|NCT01016912|590477653|FG000|End of Treatment Period|Completed double-blind period only|0|||
163485474|NCT01016912|590477654|FG001|End of Treatment Period|Completed double-blind period only|1|||
163485475|NCT01016912|590477655|FG002|End of Treatment Period|Completed double-blind period only|0|||
163485476|NCT01016912|590477656|FG003|End of Treatment Period|Completed double-blind period only|0|||
163485477|NCT01016912|590477657|FG004|End of Treatment Period|Completed double-blind period only|0|||
163485478|NCT01016912|590477653|FG000|Follow-up Period|Other reason|0|||
163485479|NCT01016912|590477654|FG001|Follow-up Period|Other reason|0|||
163485480|NCT01016912|590477655|FG002|Follow-up Period|Other reason|1|||
163485481|NCT01016912|590477656|FG003|Follow-up Period|Other reason|1|||
163485482|NCT01016912|590477657|FG004|Follow-up Period|Other reason|0|||
163485483|NCT01853397|590477660|FG000|Overall Study|Withdrawal by Subject|0|||
163485484|NCT01853397|590477661|FG001|Overall Study|Withdrawal by Subject|0|||
163485485|NCT01853397|590477662|FG002|Overall Study|Withdrawal by Subject|0|||
163485486|NCT01853397|590477663|FG003|Overall Study|Withdrawal by Subject|1|||
163485487|NCT01853397|590477660|FG000|Overall Study|Subject Noncompliance|0|||
163485488|NCT01853397|590477661|FG001|Overall Study|Subject Noncompliance|0|||
163485489|NCT01853397|590477662|FG002|Overall Study|Subject Noncompliance|0|||
163485490|NCT01853397|590477663|FG003|Overall Study|Subject Noncompliance|1|||
163485491|NCT01632345|590477664|FG000|Treatment: Part I|Adverse Event|1|||
163485492|NCT01632345|590477665|FG001|Treatment: Part I|Adverse Event|4|||
163485493|NCT01632345|590477666|FG002|Treatment: Part I|Adverse Event|2|||
163485494|NCT01632345|590477667|FG003|Treatment: Part I|Adverse Event|1|||
163485495|NCT01632345|590477668|FG004|Treatment: Part I|Adverse Event|3|||
163485496|NCT01632345|590477669|FG005|Treatment: Part I|Adverse Event|0|||
163485497|NCT01632345|590477670|FG006|Treatment: Part I|Adverse Event|0|||
163485498|NCT01632345|590477664|FG000|Treatment: Part I|Lack of Efficacy|0|||
163485499|NCT01632345|590477665|FG001|Treatment: Part I|Lack of Efficacy|1|||
163485500|NCT01632345|590477666|FG002|Treatment: Part I|Lack of Efficacy|0|||
163485501|NCT01632345|590477667|FG003|Treatment: Part I|Lack of Efficacy|1|||
163485502|NCT01632345|590477668|FG004|Treatment: Part I|Lack of Efficacy|1|||
163485503|NCT01632345|590477669|FG005|Treatment: Part I|Lack of Efficacy|0|||
163485504|NCT01632345|590477670|FG006|Treatment: Part I|Lack of Efficacy|0|||
163485505|NCT01632345|590477664|FG000|Treatment: Part I|Lost to Follow-up|3|||
163485506|NCT01632345|590477665|FG001|Treatment: Part I|Lost to Follow-up|2|||
163485507|NCT01632345|590477666|FG002|Treatment: Part I|Lost to Follow-up|1|||
163485508|NCT01632345|590477667|FG003|Treatment: Part I|Lost to Follow-up|3|||
163485509|NCT01632345|590477668|FG004|Treatment: Part I|Lost to Follow-up|4|||
163485510|NCT01632345|590477669|FG005|Treatment: Part I|Lost to Follow-up|0|||
163485511|NCT01632345|590477670|FG006|Treatment: Part I|Lost to Follow-up|0|||
163485512|NCT01632345|590477664|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
163485513|NCT01632345|590477665|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
163485514|NCT01632345|590477666|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
163485515|NCT01632345|590477667|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
163485516|NCT01632345|590477668|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
163485517|NCT01632345|590477669|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
163485518|NCT01632345|590477670|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
163485519|NCT01632345|590477664|FG000|Treatment: Part I|Physician Decision|2|||
163485520|NCT01632345|590477665|FG001|Treatment: Part I|Physician Decision|1|||
163485521|NCT01632345|590477666|FG002|Treatment: Part I|Physician Decision|0|||
163485522|NCT01632345|590477667|FG003|Treatment: Part I|Physician Decision|0|||
163485523|NCT01632345|590477668|FG004|Treatment: Part I|Physician Decision|1|||
163485524|NCT01632345|590477669|FG005|Treatment: Part I|Physician Decision|0|||
163485525|NCT01632345|590477670|FG006|Treatment: Part I|Physician Decision|0|||
163485526|NCT01632345|590477664|FG000|Treatment: Part I|Pregnancy|0|||
163485527|NCT01632345|590477665|FG001|Treatment: Part I|Pregnancy|1|||
163485528|NCT01632345|590477666|FG002|Treatment: Part I|Pregnancy|0|||
163485529|NCT01632345|590477667|FG003|Treatment: Part I|Pregnancy|0|||
163485530|NCT01632345|590477668|FG004|Treatment: Part I|Pregnancy|0|||
163485531|NCT01632345|590477669|FG005|Treatment: Part I|Pregnancy|0|||
163485532|NCT01632345|590477670|FG006|Treatment: Part I|Pregnancy|0|||
163485533|NCT01632345|590477664|FG000|Treatment: Part I|Protocol Deviation|0|||
163485534|NCT01632345|590477665|FG001|Treatment: Part I|Protocol Deviation|0|||
163485535|NCT01632345|590477666|FG002|Treatment: Part I|Protocol Deviation|1|||
163485536|NCT01632345|590477667|FG003|Treatment: Part I|Protocol Deviation|1|||
163485537|NCT01632345|590477668|FG004|Treatment: Part I|Protocol Deviation|0|||
163485538|NCT01632345|590477669|FG005|Treatment: Part I|Protocol Deviation|0|||
163485539|NCT01632345|590477670|FG006|Treatment: Part I|Protocol Deviation|0|||
163485540|NCT01632345|590477664|FG000|Treatment: Part I|Withdrawal by Subject|3|||
163485541|NCT01632345|590477665|FG001|Treatment: Part I|Withdrawal by Subject|4|||
163485542|NCT01632345|590477666|FG002|Treatment: Part I|Withdrawal by Subject|4|||
163485543|NCT01632345|590477667|FG003|Treatment: Part I|Withdrawal by Subject|1|||
163485544|NCT01632345|590477668|FG004|Treatment: Part I|Withdrawal by Subject|4|||
163485545|NCT01632345|590477669|FG005|Treatment: Part I|Withdrawal by Subject|0|||
163485546|NCT01632345|590477670|FG006|Treatment: Part I|Withdrawal by Subject|0|||
163485547|NCT01632345|590477664|FG000|Treatment: Part II|Adverse Event|0|||
163485548|NCT01632345|590477665|FG001|Treatment: Part II|Adverse Event|0|||
163485549|NCT01632345|590477666|FG002|Treatment: Part II|Adverse Event|0|||
163485550|NCT01632345|590477667|FG003|Treatment: Part II|Adverse Event|0|||
163485551|NCT01632345|590477668|FG004|Treatment: Part II|Adverse Event|0|||
163485552|NCT01632345|590477669|FG005|Treatment: Part II|Adverse Event|3|||
163485553|NCT01632345|590477670|FG006|Treatment: Part II|Adverse Event|8|||
163485554|NCT01632345|590477664|FG000|Treatment: Part II|Lost to Follow-up|0|||
163485555|NCT01632345|590477665|FG001|Treatment: Part II|Lost to Follow-up|0|||
163485556|NCT01632345|590477666|FG002|Treatment: Part II|Lost to Follow-up|0|||
163485557|NCT01632345|590477667|FG003|Treatment: Part II|Lost to Follow-up|0|||
163485558|NCT01632345|590477668|FG004|Treatment: Part II|Lost to Follow-up|0|||
163485559|NCT01632345|590477669|FG005|Treatment: Part II|Lost to Follow-up|3|||
163485560|NCT01632345|590477670|FG006|Treatment: Part II|Lost to Follow-up|1|||
163485561|NCT01632345|590477664|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
163485562|NCT01632345|590477665|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
163485563|NCT01632345|590477666|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
163485564|NCT01632345|590477667|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
163485565|NCT01632345|590477668|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
163485566|NCT01632345|590477669|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
163485567|NCT01632345|590477670|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
163485568|NCT01632345|590477664|FG000|Treatment: Part II|Withdrawal by Subject|0|||
163485569|NCT01632345|590477665|FG001|Treatment: Part II|Withdrawal by Subject|0|||
163485570|NCT01632345|590477666|FG002|Treatment: Part II|Withdrawal by Subject|0|||
163485571|NCT01632345|590477667|FG003|Treatment: Part II|Withdrawal by Subject|0|||
163485572|NCT01632345|590477668|FG004|Treatment: Part II|Withdrawal by Subject|0|||
163485573|NCT01632345|590477669|FG005|Treatment: Part II|Withdrawal by Subject|2|||
163485574|NCT01632345|590477670|FG006|Treatment: Part II|Withdrawal by Subject|2|||
163485575|NCT00089505|590477671|FG000|Overall Study|Death|4|||
163485576|NCT00089505|590477672|FG001|Overall Study|Death|1|||
163485577|NCT00089505|590477673|FG002|Overall Study|Death|5|||
163485578|NCT00089505|590477674|FG003|Overall Study|Death|8|||
163485579|NCT00089505|590477671|FG000|Overall Study|Withdrawal by Subject|3|||
163485580|NCT00089505|590477672|FG001|Overall Study|Withdrawal by Subject|0|||
163485581|NCT00089505|590477673|FG002|Overall Study|Withdrawal by Subject|6|||
163485582|NCT00089505|590477674|FG003|Overall Study|Withdrawal by Subject|6|||
163485583|NCT00089505|590477671|FG000|Overall Study|Lost to Follow-up|1|||
163485584|NCT00089505|590477672|FG001|Overall Study|Lost to Follow-up|1|||
163485585|NCT00089505|590477673|FG002|Overall Study|Lost to Follow-up|9|||
163485586|NCT00089505|590477674|FG003|Overall Study|Lost to Follow-up|7|||
163485587|NCT00089505|590477671|FG000|Overall Study|Physician Decision|1|||
163485588|NCT00089505|590477672|FG001|Overall Study|Physician Decision|0|||
163485589|NCT00089505|590477673|FG002|Overall Study|Physician Decision|0|||
163485590|NCT00089505|590477674|FG003|Overall Study|Physician Decision|0|||
163485591|NCT00089505|590477671|FG000|Overall Study|Protocol Violation|0|||
163485592|NCT00089505|590477672|FG001|Overall Study|Protocol Violation|0|||
163485593|NCT00089505|590477673|FG002|Overall Study|Protocol Violation|1|||
163485594|NCT00089505|590477674|FG003|Overall Study|Protocol Violation|0|||
163485595|NCT02431559|590477675|FG000|Overall Study|Adverse Event|0|||
163485596|NCT02431559|590477676|FG001|Overall Study|Adverse Event|1|||
163485597|NCT02431559|590477677|FG002|Overall Study|Adverse Event|0|||
163485598|NCT02431559|590477678|FG003|Overall Study|Adverse Event|4|||
163485599|NCT02431559|590477675|FG000|Overall Study|Progressive disease|2|||
163485600|NCT02431559|590477676|FG001|Overall Study|Progressive disease|1|||
163485601|NCT02431559|590477677|FG002|Overall Study|Progressive disease|4|||
163485602|NCT02431559|590477678|FG003|Overall Study|Progressive disease|22|||
163485603|NCT02431559|590477675|FG000|Overall Study|Withdrawal by Subject|0|||
163485604|NCT02431559|590477676|FG001|Overall Study|Withdrawal by Subject|1|||
163485605|NCT02431559|590477677|FG002|Overall Study|Withdrawal by Subject|0|||
163485606|NCT02431559|590477678|FG003|Overall Study|Withdrawal by Subject|4|||
163485607|NCT02431559|590477675|FG000|Overall Study|Physician Decision|0|||
163485608|NCT02431559|590477676|FG001|Overall Study|Physician Decision|0|||
163485609|NCT02431559|590477677|FG002|Overall Study|Physician Decision|0|||
163485610|NCT02431559|590477678|FG003|Overall Study|Physician Decision|1|||
163485611|NCT05047601|590477684|FG000|Overall Study|Lost to Follow-up|9|||
163485612|NCT05047601|590477685|FG001|Overall Study|Lost to Follow-up|11|||
163485613|NCT05047601|590477686|FG002|Overall Study|Lost to Follow-up|7|||
163485614|NCT05047601|590477684|FG000|Overall Study|Withdrawal by Subject|25|||
163485615|NCT05047601|590477685|FG001|Overall Study|Withdrawal by Subject|36|||
163485616|NCT05047601|590477686|FG002|Overall Study|Withdrawal by Subject|23|||
163485617|NCT05047601|590477684|FG000|Overall Study|Other|10|||
163485618|NCT05047601|590477685|FG001|Overall Study|Other|6|||
163485619|NCT05047601|590477686|FG002|Overall Study|Other|5|||
163485620|NCT00286234|590477687|FG000|Overall Study|Protocol Violation|1|||
163485621|NCT00286234|590477688|FG001|Overall Study|Protocol Violation|2|||
163485622|NCT00286234|590477689|FG002|Overall Study|Protocol Violation|0|||
163485623|NCT00286234|590477690|FG003|Overall Study|Protocol Violation|1|||
163485624|NCT00286234|590477687|FG000|Overall Study|Physician Decision|1|||
163485625|NCT00286234|590477688|FG001|Overall Study|Physician Decision|0|||
163485626|NCT00286234|590477689|FG002|Overall Study|Physician Decision|0|||
163485627|NCT00286234|590477690|FG003|Overall Study|Physician Decision|1|||
163485628|NCT00286234|590477687|FG000|Overall Study|Adverse Event|0|||
163485629|NCT00286234|590477688|FG001|Overall Study|Adverse Event|0|||
163485630|NCT00286234|590477689|FG002|Overall Study|Adverse Event|0|||
163485631|NCT00286234|590477690|FG003|Overall Study|Adverse Event|1|||
163485632|NCT00286234|590477687|FG000|Overall Study|Adverse Event|0|||
163485633|NCT00286234|590477688|FG001|Overall Study|Adverse Event|0|||
163485634|NCT00286234|590477689|FG002|Overall Study|Adverse Event|0|||
163485635|NCT00286234|590477690|FG003|Overall Study|Adverse Event|1|||
163485636|NCT02924129|590477693|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
163485637|NCT02924129|590477694|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
163485638|NCT02924129|590477693|FG000|Overall Study|Withdrawal by Subject|2|||
163485639|NCT02924129|590477694|FG001|Overall Study|Withdrawal by Subject|2|||
163485640|NCT02924129|590477693|FG000|Overall Study|Physician Decision|1|||
163485641|NCT02924129|590477694|FG001|Overall Study|Physician Decision|0|||
163485642|NCT02924129|590477693|FG000|Overall Study|Missed Visit|0|||
163485643|NCT02924129|590477694|FG001|Overall Study|Missed Visit|1|||
163485644|NCT00302731|590477698|FG000|Overall Study|Lost to Follow-up|1|||
163485645|NCT00302731|590477699|FG001|Overall Study|Lost to Follow-up|2|||
163485646|NCT00302731|590477700|FG002|Overall Study|Lost to Follow-up|0|||
163485647|NCT00302731|590477701|FG003|Overall Study|Lost to Follow-up|0|||
163485648|NCT00302731|590477698|FG000|Overall Study|Adverse Event|0|||
163485649|NCT00302731|590477699|FG001|Overall Study|Adverse Event|2|||
163485650|NCT00302731|590477700|FG002|Overall Study|Adverse Event|2|||
163485651|NCT00302731|590477701|FG003|Overall Study|Adverse Event|0|||
163485652|NCT00302731|590477698|FG000|Overall Study|Withdrawal by Subject|1|||
163485653|NCT00302731|590477699|FG001|Overall Study|Withdrawal by Subject|1|||
163485654|NCT00302731|590477700|FG002|Overall Study|Withdrawal by Subject|0|||
163485655|NCT00302731|590477701|FG003|Overall Study|Withdrawal by Subject|0|||
163485656|NCT00302731|590477698|FG000|Overall Study|Protocol Violation|1|||
163485657|NCT00302731|590477699|FG001|Overall Study|Protocol Violation|0|||
163485658|NCT00302731|590477700|FG002|Overall Study|Protocol Violation|0|||
163485659|NCT00302731|590477701|FG003|Overall Study|Protocol Violation|0|||
163485660|NCT00302731|590477698|FG000|Overall Study|cancer unrelated to study discovered|1|||
163485661|NCT00302731|590477699|FG001|Overall Study|cancer unrelated to study discovered|0|||
163485662|NCT00302731|590477700|FG002|Overall Study|cancer unrelated to study discovered|1|||
163485663|NCT00302731|590477701|FG003|Overall Study|cancer unrelated to study discovered|0|||
163485664|NCT01610752|590477704|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
163485665|NCT01610752|590477705|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
163485666|NCT01610752|590477706|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
163485667|NCT00283062|590477707|FG000|Overall Study|Did not receive any study medication|5|||
163485668|NCT00283062|590477708|FG001|Overall Study|Did not receive any study medication|4|||
163485669|NCT00283062|590477709|FG002|Overall Study|Did not receive any study medication|36|||
163485670|NCT00283062|590477710|FG003|Overall Study|Did not receive any study medication|45|||
163485671|NCT00283062|590477707|FG000|Overall Study|Adverse Event|2|||
163485672|NCT00283062|590477708|FG001|Overall Study|Adverse Event|0|||
163485673|NCT00283062|590477709|FG002|Overall Study|Adverse Event|1|||
163485674|NCT00283062|590477710|FG003|Overall Study|Adverse Event|0|||
163485675|NCT00283062|590477707|FG000|Overall Study|Lost to Follow-up|1|||
163485676|NCT00283062|590477708|FG001|Overall Study|Lost to Follow-up|0|||
163485677|NCT00283062|590477709|FG002|Overall Study|Lost to Follow-up|1|||
163485678|NCT00283062|590477710|FG003|Overall Study|Lost to Follow-up|0|||
163485679|NCT00283062|590477707|FG000|Overall Study|Progressive disease|0|||
163485680|NCT00283062|590477708|FG001|Overall Study|Progressive disease|0|||
163485681|NCT00283062|590477709|FG002|Overall Study|Progressive disease|1|||
163485682|NCT00283062|590477710|FG003|Overall Study|Progressive disease|0|||
163485683|NCT00283062|590477707|FG000|Overall Study|Participant did not wish to continue|3|||
163485684|NCT00283062|590477708|FG001|Overall Study|Participant did not wish to continue|2|||
163485685|NCT00283062|590477709|FG002|Overall Study|Participant did not wish to continue|1|||
163485686|NCT00283062|590477710|FG003|Overall Study|Participant did not wish to continue|0|||
163485687|NCT00283062|590477707|FG000|Overall Study|Undefined|0|||
163485688|NCT00283062|590477708|FG001|Overall Study|Undefined|1|||
163485689|NCT00283062|590477709|FG002|Overall Study|Undefined|1|||
163485690|NCT00283062|590477710|FG003|Overall Study|Undefined|4|||
163485691|NCT00283062|590477707|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
163485692|NCT00283062|590477708|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
163485693|NCT00283062|590477709|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
163485694|NCT00283062|590477710|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
163485695|NCT00252499|590477713|FG000|Overall Study|Lost to Follow-up|1|||
163485696|NCT00252499|590477714|FG001|Overall Study|Lost to Follow-up|0|||
163485697|NCT00252499|590477715|FG002|Overall Study|Lost to Follow-up|0|||
163485698|NCT01482598|590477716|FG000|Overall Study|Death|7|||
163485699|NCT01482598|590477717|FG001|Overall Study|Death|10|||
163485700|NCT01482598|590477716|FG000|Overall Study|Physician Decision|0|||
163485701|NCT01482598|590477717|FG001|Overall Study|Physician Decision|3|||
163485702|NCT01482598|590477716|FG000|Overall Study|Withdrawal by Subject|4|||
163485703|NCT01482598|590477717|FG001|Overall Study|Withdrawal by Subject|5|||
163485704|NCT01482598|590477716|FG000|Overall Study|Lost to Follow-up|5|||
163485705|NCT01482598|590477717|FG001|Overall Study|Lost to Follow-up|4|||
163485706|NCT01373294|590477718|FG000|Overall Study|Adverse Event|1|||
163485707|NCT01373294|590477719|FG001|Overall Study|Adverse Event|0|||
163485708|NCT00423267|590477720|FG000|Period A|Withdrawal by Subject|0|||
163485709|NCT00423267|590477721|FG001|Period A|Withdrawal by Subject|1|||
163485710|NCT00423267|590477720|FG000|Period A|Non-compliance with protocol|1|||
163485711|NCT00423267|590477721|FG001|Period A|Non-compliance with protocol|0|||
163485712|NCT00423267|590477720|FG000|Period A|Administrative|1|||
163485713|NCT00423267|590477721|FG001|Period A|Administrative|0|||
163485714|NCT03702166|590477722|FG000|Overall Study|Lost to Follow-up|1|||
163485715|NCT03702166|590477722|FG000|Overall Study|Withdrawal by Subject|1|||
163485716|NCT01333865|590477723|FG000|Overall Study|Adverse Event|2|||
163485717|NCT03512028|590477724|FG000|Overall Study|Withdrawal by Subject|2|||
163485718|NCT03512028|590477725|FG001|Overall Study|Withdrawal by Subject|0|||
163485719|NCT03512028|590477724|FG000|Overall Study|Protocol Violation|2|||
163485720|NCT03512028|590477725|FG001|Overall Study|Protocol Violation|0|||
163485721|NCT00660829|590477731|FG000|Overall Study|Adverse Event|3|||
163485722|NCT00660829|590477732|FG001|Overall Study|Adverse Event|4|||
163485723|NCT00660829|590477731|FG000|Overall Study|Lack of Efficacy|2|||
163485724|NCT00660829|590477732|FG001|Overall Study|Lack of Efficacy|3|||
163485725|NCT00660829|590477731|FG000|Overall Study|Non-Compliance|0|||
163485726|NCT00660829|590477732|FG001|Overall Study|Non-Compliance|4|||
163485727|NCT00660829|590477731|FG000|Overall Study|Withdrawal by Subject|1|||
163485728|NCT00660829|590477732|FG001|Overall Study|Withdrawal by Subject|2|||
163485729|NCT00660829|590477731|FG000|Overall Study|Lost to Follow-up|3|||
163485730|NCT00660829|590477732|FG001|Overall Study|Lost to Follow-up|2|||
163485731|NCT00660829|590477731|FG000|Overall Study|Other|9|||
163485732|NCT00660829|590477732|FG001|Overall Study|Other|4|||
163485733|NCT02127931|590477735|FG000|Overall Study|Glitch in Game|1|||
163485734|NCT00939094|590477736|FG000|Overall Study|Adverse Event|9|||
163485735|NCT00939094|590477737|FG001|Overall Study|Adverse Event|0|||
163485736|NCT00939094|590477736|FG000|Overall Study|Withdrawal by Subject|1|||
163485737|NCT00939094|590477737|FG001|Overall Study|Withdrawal by Subject|6|||
163485738|NCT00939094|590477736|FG000|Overall Study|Lost to Follow-up|1|||
163485739|NCT00939094|590477737|FG001|Overall Study|Lost to Follow-up|1|||
163485740|NCT00939094|590477736|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
163485741|NCT00939094|590477737|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
163485742|NCT00939094|590477736|FG000|Overall Study|Severe non-compliance to protocol|0|||
163485743|NCT00939094|590477737|FG001|Overall Study|Severe non-compliance to protocol|1|||
163485744|NCT00939094|590477736|FG000|Overall Study|Study stopped by sponsor|0|||
163485745|NCT00939094|590477737|FG001|Overall Study|Study stopped by sponsor|2|||
163485746|NCT00939094|590477736|FG000|Overall Study|Abnormal ECG findings|1|||
163485747|NCT00939094|590477737|FG001|Overall Study|Abnormal ECG findings|0|||
163485748|NCT02028182|590479339|FG000|Overall Study|Protocol Violation|2|||
163485749|NCT01684930|590479340|FG000|Overall Study|Withdrawal by Subject|3|||
163485750|NCT01684930|590479341|FG001|Overall Study|Withdrawal by Subject|1|||
163485751|NCT01945866|590479342|FG000|Overall Study|Eyes did not complete or were dropped|2|||
163485752|NCT01945866|590479343|FG001|Overall Study|Eyes did not complete or were dropped|0|||
163485753|NCT01336647|590479344|FG000|Overall Study|Lost to Follow-up|4|||
163485754|NCT01336647|590479345|FG001|Overall Study|Lost to Follow-up|1|||
163485755|NCT01336647|590479346|FG002|Overall Study|Lost to Follow-up|3|||
163485756|NCT01018680|590479347|FG000|Overall Study|Adverse Event|23|||
163485757|NCT01018680|590479348|FG001|Overall Study|Adverse Event|40|||
163485758|NCT01018680|590479347|FG000|Overall Study|Withdrawal by Subject|10|||
163485759|NCT01018680|590479348|FG001|Overall Study|Withdrawal by Subject|10|||
163485760|NCT01018680|590479347|FG000|Overall Study|Protocol Violation|5|||
163485761|NCT01018680|590479348|FG001|Overall Study|Protocol Violation|8|||
163485762|NCT01018680|590479347|FG000|Overall Study|Sponsor Decision|6|||
163485763|NCT01018680|590479348|FG001|Overall Study|Sponsor Decision|7|||
163485764|NCT01018680|590479347|FG000|Overall Study|Lack of Efficacy|8|||
163485765|NCT01018680|590479348|FG001|Overall Study|Lack of Efficacy|2|||
163485766|NCT01018680|590479347|FG000|Overall Study|Lost to Follow-up|5|||
163485767|NCT01018680|590479348|FG001|Overall Study|Lost to Follow-up|3|||
163485768|NCT01018680|590479347|FG000|Overall Study|Entry Criteria Not Met|1|||
163485769|NCT01018680|590479348|FG001|Overall Study|Entry Criteria Not Met|4|||
163485770|NCT01018680|590479347|FG000|Overall Study|Physician Decision|3|||
163485771|NCT01018680|590479348|FG001|Overall Study|Physician Decision|1|||
163485772|NCT02930889|590479349|FG000|Overall Study|Lost to Follow-up|2|||
163485773|NCT02930889|590479349|FG000|Overall Study|Withdrawal by Subject|6|||
163485774|NCT02930889|590479349|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
163485775|NCT04398030|590479350|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
163485776|NCT04398030|590479351|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
163485777|NCT04398030|590479350|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
163485778|NCT04398030|590479351|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
163485779|NCT05056311|590479352|FG000|Overall Study|Lost to Follow-up|14|||
163485780|NCT05056311|590479352|FG000|Overall Study|Withdrawal by Subject|1|||
163485781|NCT05056311|590479352|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
163485782|NCT01714726|590479353|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
163485783|NCT01714726|590479354|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
163485784|NCT01714726|590479355|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
163485785|NCT01714726|590479356|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
163485786|NCT01714726|590479353|FG000|Double-Blinded Induction Period|Adverse Event|0|||
163485787|NCT01714726|590479354|FG001|Double-Blinded Induction Period|Adverse Event|1|||
163485788|NCT01714726|590479355|FG002|Double-Blinded Induction Period|Adverse Event|0|||
163485789|NCT01714726|590479356|FG003|Double-Blinded Induction Period|Adverse Event|0|||
163485790|NCT01714726|590479353|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
163485791|NCT01714726|590479354|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
163485792|NCT01714726|590479355|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
163485793|NCT01714726|590479356|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
163485794|NCT01714726|590479353|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
163485795|NCT01714726|590479354|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
163485796|NCT01714726|590479355|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
163485797|NCT01714726|590479356|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
163485798|NCT01714726|590479353|FG000|Open-Label Period|Other|0|||
163485799|NCT01714726|590479354|FG001|Open-Label Period|Other|0|||
163485800|NCT01714726|590479355|FG002|Open-Label Period|Other|1|||
163485801|NCT01714726|590479356|FG003|Open-Label Period|Other|3|||
163485802|NCT01714726|590479353|FG000|Open-Label Period|Adverse Event|0|||
163485803|NCT01714726|590479354|FG001|Open-Label Period|Adverse Event|0|||
163485804|NCT01714726|590479355|FG002|Open-Label Period|Adverse Event|1|||
163485805|NCT01714726|590479356|FG003|Open-Label Period|Adverse Event|0|||
163485806|NCT01714726|590479353|FG000|Open-Label Period|Withdrawal by Subject|0|||
163485807|NCT01714726|590479354|FG001|Open-Label Period|Withdrawal by Subject|0|||
163485808|NCT01714726|590479355|FG002|Open-Label Period|Withdrawal by Subject|9|||
163485809|NCT01714726|590479356|FG003|Open-Label Period|Withdrawal by Subject|19|||
163485810|NCT01714726|590479353|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
163485811|NCT01714726|590479354|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
163485812|NCT01714726|590479355|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
163485813|NCT01714726|590479356|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
163485814|NCT01714726|590479353|FG000|Open-Label Period|Lost to Follow-up|0|||
163485815|NCT01714726|590479354|FG001|Open-Label Period|Lost to Follow-up|0|||
163485816|NCT01714726|590479355|FG002|Open-Label Period|Lost to Follow-up|3|||
163485817|NCT01714726|590479356|FG003|Open-Label Period|Lost to Follow-up|4|||
163485818|NCT00548340|590479358|FG000|Overall Study|Protocol Violation|2|||
163485819|NCT00548340|590479359|FG001|Overall Study|Protocol Violation|3|||
163485820|NCT00548340|590479360|FG002|Overall Study|Protocol Violation|3|||
163485821|NCT00548340|590479358|FG000|Overall Study|Adverse Event|2|||
163485822|NCT00548340|590479359|FG001|Overall Study|Adverse Event|2|||
163485823|NCT00548340|590479360|FG002|Overall Study|Adverse Event|2|||
163485824|NCT00548340|590479358|FG000|Overall Study|Lost to Follow-up|1|||
163485825|NCT00548340|590479359|FG001|Overall Study|Lost to Follow-up|1|||
163485826|NCT00548340|590479360|FG002|Overall Study|Lost to Follow-up|0|||
163485827|NCT00548340|590479358|FG000|Overall Study|Withdrawal by Subject|2|||
163485828|NCT00548340|590479359|FG001|Overall Study|Withdrawal by Subject|4|||
163485829|NCT00548340|590479360|FG002|Overall Study|Withdrawal by Subject|3|||
163485830|NCT00548340|590479358|FG000|Overall Study|Other|1|||
163485831|NCT00548340|590479359|FG001|Overall Study|Other|1|||
163485832|NCT00548340|590479360|FG002|Overall Study|Other|1|||
163485833|NCT02600559|590479361|FG000|Overall Study|Withdrawal by Subject|3|||
163485834|NCT02600559|590479361|FG000|Overall Study|Lost to Follow-up|20|||
163485835|NCT00665366|590479364|FG000|Overall Study|Lack of Efficacy|11|||
163485836|NCT00665366|590479365|FG001|Overall Study|Lack of Efficacy|10|||
163485837|NCT00665366|590479364|FG000|Overall Study|Adverse Event|25|||
163485838|NCT00665366|590479365|FG001|Overall Study|Adverse Event|23|||
163485839|NCT00665366|590479364|FG000|Overall Study|Withdrawal by Subject|11|||
163485840|NCT00665366|590479365|FG001|Overall Study|Withdrawal by Subject|14|||
163485841|NCT00665366|590479364|FG000|Overall Study|Lost to Follow-up|3|||
163485842|NCT00665366|590479365|FG001|Overall Study|Lost to Follow-up|5|||
163485843|NCT00665366|590479364|FG000|Overall Study|Poor compliance/noncompliance|3|||
163485844|NCT00665366|590479365|FG001|Overall Study|Poor compliance/noncompliance|5|||
163485845|NCT00665366|590479364|FG000|Overall Study|Pregnancy|1|||
163485846|NCT00665366|590479365|FG001|Overall Study|Pregnancy|0|||
163485847|NCT00665366|590479364|FG000|Overall Study|No longer meets study criteria|0|||
163485848|NCT00665366|590479365|FG001|Overall Study|No longer meets study criteria|1|||
163485849|NCT00665366|590479364|FG000|Overall Study|Other reasons|4|||
163485850|NCT00665366|590479365|FG001|Overall Study|Other reasons|1|||
163485851|NCT03628781|590479366|FG000|Overall Study|Lost to Follow-up|16|||
163485852|NCT03628781|590479367|FG001|Overall Study|Lost to Follow-up|8|||
163485853|NCT03628781|590479366|FG000|Overall Study|Withdrawal by Subject|16|||
163485854|NCT03628781|590479367|FG001|Overall Study|Withdrawal by Subject|1|||
163485855|NCT03778021|590479371|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
163485856|NCT03778021|590479372|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
163485857|NCT00679042|590479373|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
163485858|NCT00679042|590479373|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
163485859|NCT00679042|590479373|FG000|5-Year Follow Up|Death|1|||
163485860|NCT00679042|590479373|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
163485861|NCT00679042|590479373|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
163485862|NCT02392078|590479374|FG000|Overall Study|Did not have procedure|32|||
163485863|NCT02392078|590479375|FG001|Overall Study|Did not have procedure|43|||
163485864|NCT02392078|590479376|FG002|Overall Study|Did not have procedure|20|||
163485865|NCT02392078|590479377|FG003|Overall Study|Did not have procedure|1|||
163485866|NCT02079077|590479379|FG000|Overall Study|Lost to Follow-up|5|||
163485867|NCT02079077|590479380|FG001|Overall Study|Lost to Follow-up|7|||
163485868|NCT02079077|590479379|FG000|Overall Study|Became STIs Positive|1|||
163485869|NCT02079077|590479380|FG001|Overall Study|Became STIs Positive|2|||
163485870|NCT01928758|590479381|FG000|Overall Study|Lost to Follow-up|14|||
163485871|NCT01928758|590479382|FG001|Overall Study|Lost to Follow-up|9|||
163485872|NCT01928758|590479381|FG000|Overall Study|Withdrawal by Subject|5|||
163485873|NCT01928758|590479382|FG001|Overall Study|Withdrawal by Subject|2|||
163485874|NCT01928758|590479381|FG000|Overall Study|Adverse Event|3|||
163485875|NCT01928758|590479382|FG001|Overall Study|Adverse Event|5|||
163485876|NCT01928758|590479381|FG000|Overall Study|Protocol Violation|3|||
163485877|NCT01928758|590479382|FG001|Overall Study|Protocol Violation|4|||
163485878|NCT02718131|590479383|FG000|Overall Study|Withdrawal by Subject|1|||
163485879|NCT02718131|590479384|FG001|Overall Study|Withdrawal by Subject|0|||
163485880|NCT02718131|590479383|FG000|Overall Study|Adverse Event|1|||
163485881|NCT02718131|590479384|FG001|Overall Study|Adverse Event|0|||
163485882|NCT02718131|590479383|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
163485883|NCT02718131|590479384|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
163485884|NCT03198559|590479385|FG000|Overall Study|Adverse Event|2|||
163485885|NCT01005875|590479393|FG000|Overall Study|Death|3|||
163485886|NCT00606931|590479394|FG000|Overall Study|Withdrawal by Subject|3|||
163485887|NCT01348828|590479406|FG000|Overall Study|Death|20|||
163485888|NCT01348828|590479406|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
163485889|NCT01348828|590479406|FG000|Overall Study|Conversion|2|||
163485890|NCT01348828|590479406|FG000|Overall Study|missed visit|1|||
163485891|NCT04246996|590479407|FG000|Overall Study|Physician Decision|1|||
163485892|NCT04246996|590479408|FG001|Overall Study|Physician Decision|1|||
163485893|NCT04246996|590479407|FG000|Overall Study|Did not meet eligibility criteria|1|||
163485894|NCT04246996|590479408|FG001|Overall Study|Did not meet eligibility criteria|4|||
163485895|NCT02442284|590479410|FG000|Overall Study|Adverse Event|1|||
163485896|NCT02442284|590479410|FG000|Overall Study|Withdrew Consent|2|||
163485897|NCT02442284|590479410|FG000|Overall Study|Lost to Follow-up|3|||
163485898|NCT02442284|590479410|FG000|Overall Study|Other|1|||
163485899|NCT01365468|590479414|FG000|Overall Study|Physician Decision|1|||
163485900|NCT01365468|590479415|FG001|Overall Study|Physician Decision|0|||
163485901|NCT01365468|590479414|FG000|Overall Study|Disease progression|1|||
163485902|NCT01365468|590479415|FG001|Overall Study|Disease progression|0|||
163485903|NCT01365468|590479414|FG000|Overall Study|Lost to Follow-up|2|||
163485904|NCT01365468|590479415|FG001|Overall Study|Lost to Follow-up|0|||
163485905|NCT01521494|590479418|FG000|Overall Study|Adverse Event|1|||
163485906|NCT01521494|590479419|FG001|Overall Study|Adverse Event|2|||
163485907|NCT01521494|590479420|FG002|Overall Study|Adverse Event|9|||
163485908|NCT01521494|590479421|FG003|Overall Study|Adverse Event|6|||
163485909|NCT01521494|590479422|FG004|Overall Study|Adverse Event|2|||
163485910|NCT01521494|590479418|FG000|Overall Study|Lack of Efficacy|0|||
163485911|NCT01521494|590479419|FG001|Overall Study|Lack of Efficacy|0|||
163485912|NCT01521494|590479420|FG002|Overall Study|Lack of Efficacy|0|||
163485913|NCT01521494|590479421|FG003|Overall Study|Lack of Efficacy|0|||
163485914|NCT01521494|590479422|FG004|Overall Study|Lack of Efficacy|2|||
163485915|NCT01521494|590479418|FG000|Overall Study|Withdrawal by Subject|1|||
163485916|NCT01521494|590479419|FG001|Overall Study|Withdrawal by Subject|1|||
163485917|NCT01521494|590479420|FG002|Overall Study|Withdrawal by Subject|0|||
163485918|NCT01521494|590479421|FG003|Overall Study|Withdrawal by Subject|2|||
163485919|NCT01521494|590479422|FG004|Overall Study|Withdrawal by Subject|0|||
163485920|NCT01521494|590479418|FG000|Overall Study|Decrease in serum phosphate|0|||
163485921|NCT01521494|590479419|FG001|Overall Study|Decrease in serum phosphate|2|||
163485922|NCT01521494|590479420|FG002|Overall Study|Decrease in serum phosphate|3|||
163485923|NCT01521494|590479421|FG003|Overall Study|Decrease in serum phosphate|12|||
163485924|NCT01521494|590479422|FG004|Overall Study|Decrease in serum phosphate|0|||
163485925|NCT01521494|590479418|FG000|Overall Study|Decrease in serum calcium|0|||
163485926|NCT01521494|590479419|FG001|Overall Study|Decrease in serum calcium|0|||
163485927|NCT01521494|590479420|FG002|Overall Study|Decrease in serum calcium|0|||
163485928|NCT01521494|590479421|FG003|Overall Study|Decrease in serum calcium|1|||
163485929|NCT01521494|590479422|FG004|Overall Study|Decrease in serum calcium|1|||
163485930|NCT01521494|590479418|FG000|Overall Study|Physician Decision|0|||
163485931|NCT01521494|590479419|FG001|Overall Study|Physician Decision|0|||
163485932|NCT01521494|590479420|FG002|Overall Study|Physician Decision|0|||
163485933|NCT01521494|590479421|FG003|Overall Study|Physician Decision|0|||
163485934|NCT01521494|590479422|FG004|Overall Study|Physician Decision|2|||
163485935|NCT00877929|590479423|FG000|Overall Study|Adverse Event|11|||
163485936|NCT00877929|590479424|FG001|Overall Study|Adverse Event|20|||
163485937|NCT00877929|590479423|FG000|Overall Study|Protocol Violation|3|||
163485938|NCT00877929|590479424|FG001|Overall Study|Protocol Violation|3|||
163485939|NCT00877929|590479423|FG000|Overall Study|Lost to Follow-up|0|||
163485940|NCT00877929|590479424|FG001|Overall Study|Lost to Follow-up|1|||
163485941|NCT00877929|590479423|FG000|Overall Study|Withdrawal by Subject|4|||
163485942|NCT00877929|590479424|FG001|Overall Study|Withdrawal by Subject|4|||
163485943|NCT00877929|590479423|FG000|Overall Study|Lack of Efficacy|0|||
163485944|NCT00877929|590479424|FG001|Overall Study|Lack of Efficacy|1|||
163485945|NCT00877929|590479423|FG000|Overall Study|Other reason (not specified)|2|||
163485946|NCT00877929|590479424|FG001|Overall Study|Other reason (not specified)|6|||
163485947|NCT01140646|590479425|FG000|Overall Study|Adverse Event|4|||
163485948|NCT01140646|590479425|FG000|Overall Study|Refused Further Treatment|5|||
163485949|NCT00689728|590479429|FG000|Double-Blind Treatment|Adverse Event|1|||
163485950|NCT00689728|590479430|FG001|Double-Blind Treatment|Adverse Event|0|||
163485951|NCT00689728|590479431|FG002|Double-Blind Treatment|Adverse Event|0|||
163485952|NCT00689728|590479429|FG000|Double-Blind Treatment|Protocol Violation|0|||
163485953|NCT00689728|590479430|FG001|Double-Blind Treatment|Protocol Violation|0|||
163485954|NCT00689728|590479431|FG002|Double-Blind Treatment|Protocol Violation|1|||
163485955|NCT00689728|590479429|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
163485956|NCT00689728|590479430|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
163485957|NCT00689728|590479431|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
163485958|NCT00689728|590479429|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
163485959|NCT00689728|590479430|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
163485960|NCT00689728|590479431|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
163485961|NCT00689728|590479429|FG000|Rescue|Adverse Event|0|||
163485962|NCT00689728|590479430|FG001|Rescue|Adverse Event|1|||
163485963|NCT00689728|590479431|FG002|Rescue|Adverse Event|0|||
163485964|NCT00689728|590479429|FG000|Rescue|Withdrawal by Subject|1|||
163485965|NCT00689728|590479430|FG001|Rescue|Withdrawal by Subject|1|||
163485966|NCT00689728|590479431|FG002|Rescue|Withdrawal by Subject|1|||
163485967|NCT00689728|590479429|FG000|Optional Follow-Up|Adverse Event|1|||
163485968|NCT00689728|590479430|FG001|Optional Follow-Up|Adverse Event|0|||
163485969|NCT00689728|590479431|FG002|Optional Follow-Up|Adverse Event|0|||
163485970|NCT00689728|590479429|FG000|Optional Follow-Up|Lack of Efficacy|0|||
163485971|NCT00689728|590479430|FG001|Optional Follow-Up|Lack of Efficacy|1|||
163485972|NCT00689728|590479431|FG002|Optional Follow-Up|Lack of Efficacy|1|||
163485973|NCT00689728|590479429|FG000|Optional Follow-Up|Lost to Follow-up|0|||
163485974|NCT00689728|590479430|FG001|Optional Follow-Up|Lost to Follow-up|1|||
163485975|NCT00689728|590479431|FG002|Optional Follow-Up|Lost to Follow-up|1|||
163485976|NCT00689728|590479429|FG000|Optional Follow-Up|Protocol Violation|0|||
163485977|NCT00689728|590479430|FG001|Optional Follow-Up|Protocol Violation|0|||
163485978|NCT00689728|590479431|FG002|Optional Follow-Up|Protocol Violation|1|||
163485979|NCT00689728|590479429|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
163485980|NCT00689728|590479430|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
163485981|NCT00689728|590479431|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
163485982|NCT00842829|590479432|FG000|Dose Titration Period|Adverse Event|11|||
163485983|NCT00842829|590479433|FG001|Dose Titration Period|Adverse Event|10|||
163485984|NCT00842829|590479434|FG002|Dose Titration Period|Adverse Event|0|||
163485985|NCT00842829|590479432|FG000|Dose Titration Period|Lack of Efficacy|4|||
163485986|NCT00842829|590479433|FG001|Dose Titration Period|Lack of Efficacy|1|||
163485987|NCT00842829|590479434|FG002|Dose Titration Period|Lack of Efficacy|0|||
163485988|NCT00842829|590479432|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
163485989|NCT00842829|590479433|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
163485990|NCT00842829|590479434|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
163485991|NCT00842829|590479432|FG000|Dose Titration Period|Withdrawal by Subject|2|||
163485992|NCT00842829|590479433|FG001|Dose Titration Period|Withdrawal by Subject|6|||
163485993|NCT00842829|590479434|FG002|Dose Titration Period|Withdrawal by Subject|0|||
163485994|NCT00842829|590479432|FG000|Dose Titration Period|Other|5|||
163485995|NCT00842829|590479433|FG001|Dose Titration Period|Other|4|||
163485996|NCT00842829|590479434|FG002|Dose Titration Period|Other|0|||
163485997|NCT00842829|590479432|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
163485998|NCT00842829|590479433|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
163485999|NCT00842829|590479434|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
163486000|NCT00842829|590479432|FG000|Dose Titration Period|Non-compliance to study drug|2|||
163486001|NCT00842829|590479433|FG001|Dose Titration Period|Non-compliance to study drug|1|||
163486002|NCT00842829|590479434|FG002|Dose Titration Period|Non-compliance to study drug|0|||
163486003|NCT00842829|590479432|FG000|Treatment Period|Adverse Event|0|||
163486004|NCT00842829|590479433|FG001|Treatment Period|Adverse Event|0|||
163486005|NCT00842829|590479434|FG002|Treatment Period|Adverse Event|15|||
163486006|NCT00842829|590479432|FG000|Treatment Period|Lack of Efficacy|0|||
163486007|NCT00842829|590479433|FG001|Treatment Period|Lack of Efficacy|0|||
163486008|NCT00842829|590479434|FG002|Treatment Period|Lack of Efficacy|6|||
163486009|NCT00842829|590479432|FG000|Treatment Period|Unstable persistent cancer pain|0|||
163486010|NCT00842829|590479433|FG001|Treatment Period|Unstable persistent cancer pain|0|||
163486011|NCT00842829|590479434|FG002|Treatment Period|Unstable persistent cancer pain|5|||
163486012|NCT00842829|590479432|FG000|Treatment Period|Withdrawal by Subject|0|||
163486013|NCT00842829|590479433|FG001|Treatment Period|Withdrawal by Subject|0|||
163486014|NCT00842829|590479434|FG002|Treatment Period|Withdrawal by Subject|11|||
163486015|NCT00842829|590479432|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
163486016|NCT00842829|590479433|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
163486017|NCT00842829|590479434|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
163486018|NCT00842829|590479432|FG000|Treatment Period|Protocol Violation|0|||
163486019|NCT00842829|590479433|FG001|Treatment Period|Protocol Violation|0|||
163486020|NCT00842829|590479434|FG002|Treatment Period|Protocol Violation|2|||
163486021|NCT00842829|590479432|FG000|Treatment Period|Other|0|||
163486022|NCT00842829|590479433|FG001|Treatment Period|Other|0|||
163486023|NCT00842829|590479434|FG002|Treatment Period|Other|18|||
163486024|NCT00842829|590479432|FG000|Treatment Period|Non-compliance to study procedures|0|||
163486025|NCT00842829|590479433|FG001|Treatment Period|Non-compliance to study procedures|0|||
163486026|NCT00842829|590479434|FG002|Treatment Period|Non-compliance to study procedures|4|||
163486027|NCT00842829|590479432|FG000|Treatment Period|Unclear completion status|0|||
163486028|NCT00842829|590479433|FG001|Treatment Period|Unclear completion status|0|||
163486029|NCT00842829|590479434|FG002|Treatment Period|Unclear completion status|1|||
163486030|NCT00842829|590479432|FG000|Continuation Period|Adverse Event|0|||
163486031|NCT00842829|590479433|FG001|Continuation Period|Adverse Event|0|||
163486032|NCT00842829|590479434|FG002|Continuation Period|Adverse Event|32|||
163486033|NCT00842829|590479432|FG000|Continuation Period|Lack of Efficacy|0|||
163486034|NCT00842829|590479433|FG001|Continuation Period|Lack of Efficacy|0|||
163486035|NCT00842829|590479434|FG002|Continuation Period|Lack of Efficacy|6|||
163486036|NCT00842829|590479432|FG000|Continuation Period|Unstable persistent cancer pain|0|||
163486037|NCT00842829|590479433|FG001|Continuation Period|Unstable persistent cancer pain|0|||
163486038|NCT00842829|590479434|FG002|Continuation Period|Unstable persistent cancer pain|3|||
163486039|NCT00842829|590479432|FG000|Continuation Period|Withdrawal by Subject|0|||
163486040|NCT00842829|590479433|FG001|Continuation Period|Withdrawal by Subject|0|||
163486041|NCT00842829|590479434|FG002|Continuation Period|Withdrawal by Subject|10|||
163486042|NCT00842829|590479432|FG000|Continuation Period|Other|0|||
163486043|NCT00842829|590479433|FG001|Continuation Period|Other|0|||
163486044|NCT00842829|590479434|FG002|Continuation Period|Other|7|||
163486045|NCT00842829|590479432|FG000|Continuation Period|Non-compliance to study procedures|0|||
163486046|NCT00842829|590479433|FG001|Continuation Period|Non-compliance to study procedures|0|||
163486047|NCT00842829|590479434|FG002|Continuation Period|Non-compliance to study procedures|2|||
163486048|NCT00842829|590479432|FG000|Continuation Period|Non-compliance to study drug|0|||
163486049|NCT00842829|590479433|FG001|Continuation Period|Non-compliance to study drug|0|||
163486050|NCT00842829|590479434|FG002|Continuation Period|Non-compliance to study drug|1|||
163486051|NCT03417999|590479437|FG000|Overall Study|Withdrawal by Subject|1|||
163486052|NCT03417999|590479438|FG001|Overall Study|Withdrawal by Subject|0|||
163486053|NCT03417999|590479439|FG002|Overall Study|Withdrawal by Subject|0|||
163486054|NCT03417999|590479437|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
163486055|NCT03417999|590479438|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
163486056|NCT03417999|590479439|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
163486057|NCT03417999|590479437|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
163486058|NCT03417999|590479438|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
163486059|NCT03417999|590479439|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
163486060|NCT03417999|590479437|FG000|Overall Study|Inadequate study staff available to process samples|0|||
163486061|NCT03417999|590479438|FG001|Overall Study|Inadequate study staff available to process samples|0|||
163486062|NCT03417999|590479439|FG002|Overall Study|Inadequate study staff available to process samples|1|||
163486063|NCT02539160|590479444|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
163486064|NCT02539160|590479445|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
163486065|NCT02539160|590479446|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
163486066|NCT02539160|590479447|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
163486067|NCT02539160|590479444|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
163486068|NCT02539160|590479445|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
163486069|NCT02539160|590479446|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
163486070|NCT02539160|590479447|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
163486071|NCT02539160|590479444|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
163486072|NCT02539160|590479445|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
163486073|NCT02539160|590479446|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
163486074|NCT02539160|590479447|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
163486075|NCT01681004|590479448|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
163486076|NCT01681004|590479449|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
163486077|NCT01681004|590479448|FG000|Study Completion|Lost to Follow-up|8|||
163486078|NCT01681004|590479449|FG001|Study Completion|Lost to Follow-up|3|||
163486079|NCT01681004|590479448|FG000|Study Completion|Physician Decision|1|||
163486080|NCT01681004|590479449|FG001|Study Completion|Physician Decision|3|||
163486081|NCT01681004|590479448|FG000|Study Completion|Site Termination|2|||
163486082|NCT01681004|590479449|FG001|Study Completion|Site Termination|1|||
163486083|NCT01681004|590479448|FG000|Study Completion|Death|1|||
163486084|NCT01681004|590479449|FG001|Study Completion|Death|1|||
163486085|NCT00372905|590479450|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
163486086|NCT00372905|590479451|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
163486087|NCT00372905|590479452|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
163486088|NCT00372905|590479453|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
163486089|NCT00372905|590479450|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
163486090|NCT00372905|590479451|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
163486091|NCT00372905|590479452|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
163486092|NCT00372905|590479453|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
163486093|NCT00372905|590479450|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
163486094|NCT00372905|590479451|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
163486095|NCT00372905|590479452|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
163486096|NCT00372905|590479453|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
163486097|NCT00372905|590479450|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
163486098|NCT00372905|590479451|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
163486099|NCT00372905|590479452|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
163486100|NCT00372905|590479453|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
163486101|NCT00372905|590479450|FG000|Follow up Until Relapse or Progression|Study closed|0|||
163486102|NCT00372905|590479451|FG001|Follow up Until Relapse or Progression|Study closed|0|||
163486103|NCT00372905|590479452|FG002|Follow up Until Relapse or Progression|Study closed|0|||
163486104|NCT00372905|590479453|FG003|Follow up Until Relapse or Progression|Study closed|3|||
163486105|NCT00372905|590479450|FG000|Follow up Until Relapse or Progression|Other|0|||
163486106|NCT00372905|590479451|FG001|Follow up Until Relapse or Progression|Other|1|||
163486107|NCT00372905|590479452|FG002|Follow up Until Relapse or Progression|Other|0|||
163486108|NCT00372905|590479453|FG003|Follow up Until Relapse or Progression|Other|0|||
163486109|NCT01728454|590479454|FG000|Stage 1 and 2|Pregnancy|1|||
163486110|NCT01728454|590479455|FG001|Stage 1 and 2|Pregnancy|0|||
163486111|NCT01728454|590479456|FG002|Stage 1 and 2|Pregnancy|0|||
163486112|NCT01728454|590479454|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
163486113|NCT01728454|590479455|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
163486114|NCT01728454|590479456|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
163486115|NCT01728454|590479454|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
163486116|NCT01728454|590479455|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
163486117|NCT01728454|590479456|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
163486118|NCT01728454|590479454|FG000|Stage 1 and 2|Lost to Follow-up|1|||
163486119|NCT01728454|590479455|FG001|Stage 1 and 2|Lost to Follow-up|1|||
163486120|NCT01728454|590479456|FG002|Stage 1 and 2|Lost to Follow-up|0|||
163486121|NCT01728454|590479454|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
163486122|NCT01728454|590479455|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
163486123|NCT01728454|590479456|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
163486124|NCT01728454|590479454|FG000|Stage 3|Reason Missing|0|||
163486125|NCT01728454|590479455|FG001|Stage 3|Reason Missing|0|||
163486126|NCT01728454|590479456|FG002|Stage 3|Reason Missing|1|||
163486127|NCT01728454|590479454|FG000|Stage 3|Subject Required Other Treatment|0|||
163486128|NCT01728454|590479455|FG001|Stage 3|Subject Required Other Treatment|1|||
163486129|NCT01728454|590479456|FG002|Stage 3|Subject Required Other Treatment|0|||
163486130|NCT01728454|590479454|FG000|Stage 3|Pregnancy|1|||
163486131|NCT01728454|590479455|FG001|Stage 3|Pregnancy|0|||
163486132|NCT01728454|590479456|FG002|Stage 3|Pregnancy|0|||
163486133|NCT01728454|590479454|FG000|Stage 3|Withdrew Consent|1|||
163486134|NCT01728454|590479455|FG001|Stage 3|Withdrew Consent|0|||
163486135|NCT01728454|590479456|FG002|Stage 3|Withdrew Consent|1|||
163486136|NCT01728454|590479454|FG000|Stage 3|Non-compliance with Protocol|0|||
163486137|NCT01728454|590479455|FG001|Stage 3|Non-compliance with Protocol|0|||
163486138|NCT01728454|590479456|FG002|Stage 3|Non-compliance with Protocol|1|||
163486139|NCT01728454|590479454|FG000|Stage 3|Lost to Follow-up|0|||
163486140|NCT01728454|590479455|FG001|Stage 3|Lost to Follow-up|3|||
163486141|NCT01728454|590479456|FG002|Stage 3|Lost to Follow-up|1|||
163486142|NCT01728454|590479454|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
163486143|NCT01728454|590479455|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
163486144|NCT01728454|590479456|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
163486145|NCT00689299|590479457|FG000|Overall Study|Adverse Event|2|||
163486146|NCT00689299|590479458|FG001|Overall Study|Adverse Event|1|||
163486147|NCT00689299|590479459|FG002|Overall Study|Adverse Event|1|||
163486148|NCT00689299|590479457|FG000|Overall Study|Lost to Follow-up|0|||
163486149|NCT00689299|590479458|FG001|Overall Study|Lost to Follow-up|1|||
163486150|NCT00689299|590479459|FG002|Overall Study|Lost to Follow-up|1|||
163486151|NCT00689299|590479457|FG000|Overall Study|Withdrawal by Subject|4|||
163486152|NCT00689299|590479458|FG001|Overall Study|Withdrawal by Subject|1|||
163486153|NCT00689299|590479459|FG002|Overall Study|Withdrawal by Subject|3|||
163486154|NCT00689299|590479457|FG000|Overall Study|Protocol Violation|1|||
163486155|NCT00689299|590479458|FG001|Overall Study|Protocol Violation|0|||
163486156|NCT00689299|590479459|FG002|Overall Study|Protocol Violation|0|||
163486157|NCT00695318|590479466|FG000|Overall Study|Lost to Follow-up|1|||
163486158|NCT00695318|590479467|FG001|Overall Study|Lost to Follow-up|0|||
163486159|NCT00695318|590479466|FG000|Overall Study|Withdrawal by Subject|2|||
163486160|NCT00695318|590479467|FG001|Overall Study|Withdrawal by Subject|0|||
163486161|NCT00695318|590479466|FG000|Overall Study|Death|1|||
163486162|NCT00695318|590479467|FG001|Overall Study|Death|1|||
163486163|NCT00695318|590479466|FG000|Overall Study|Study Terminated|1|||
163486164|NCT00695318|590479467|FG001|Overall Study|Study Terminated|0|||
163486165|NCT02058966|590479468|FG000|Open-Label Methamphetamine|Adverse Event|1|||
163486166|NCT02058966|590479468|FG000|First Intervention|Withdrawal by Subject|1|||
163486167|NCT01362062|590479471|FG000|Overall Study|Adverse Event|1|||
163486168|NCT01362062|590479472|FG001|Overall Study|Adverse Event|0|||
163486169|NCT01362062|590479471|FG000|Overall Study|Lost to Follow-up|11|||
163486170|NCT01362062|590479472|FG001|Overall Study|Lost to Follow-up|0|||
163486171|NCT01362062|590479471|FG000|Overall Study|Withdrawal by Subject|2|||
163486172|NCT01362062|590479472|FG001|Overall Study|Withdrawal by Subject|0|||
163486173|NCT01362062|590479471|FG000|Overall Study|Non-compliant participant|2|||
163486174|NCT01362062|590479472|FG001|Overall Study|Non-compliant participant|0|||
163486175|NCT01362062|590479471|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
163486176|NCT01362062|590479472|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
163486177|NCT01362062|590479471|FG000|Overall Study|Had significant improvement|9|||
163486178|NCT01362062|590479472|FG001|Overall Study|Had significant improvement|0|||
163486179|NCT02545504|590479474|FG000|Overall Study|Death|174|||
163486180|NCT02545504|590479475|FG001|Overall Study|Death|168|||
163486181|NCT02545504|590479474|FG000|Overall Study|Unknown reason|30|||
163486182|NCT02545504|590479475|FG001|Overall Study|Unknown reason|32|||
163486183|NCT02545504|590479474|FG000|Overall Study|Withdrew consent|9|||
163486184|NCT02545504|590479475|FG001|Overall Study|Withdrew consent|11|||
163486185|NCT02545504|590479474|FG000|Overall Study|Investigator's discretion|3|||
163486186|NCT02545504|590479475|FG001|Overall Study|Investigator's discretion|1|||
163486187|NCT02545504|590479474|FG000|Overall Study|Lost to Follow-up|2|||
163486188|NCT02545504|590479475|FG001|Overall Study|Lost to Follow-up|2|||
163486189|NCT00434876|590479478|FG000|Overall Study|Lost to Follow-up|1|||
163486190|NCT00434876|590479479|FG001|Overall Study|Lost to Follow-up|1|||
163486191|NCT00758394|590479480|FG000|2nd Intervention Order|Lost to Follow-up|0|||
163486192|NCT00758394|590479481|FG001|2nd Intervention Order|Lost to Follow-up|1|||
163486193|NCT00758394|590479482|FG002|2nd Intervention Order|Lost to Follow-up|0|||
163486194|NCT00758394|590479483|FG003|2nd Intervention Order|Lost to Follow-up|0|||
163486195|NCT00758394|590479480|FG000|3rd Intervention|Lost to Follow-up|1|||
163486196|NCT00758394|590479481|FG001|3rd Intervention|Lost to Follow-up|0|||
163486197|NCT00758394|590479482|FG002|3rd Intervention|Lost to Follow-up|0|||
163486198|NCT00758394|590479483|FG003|3rd Intervention|Lost to Follow-up|1|||
163486199|NCT00950755|590479484|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
163486200|NCT00950755|590479484|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
163486201|NCT00950755|590479484|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
163486202|NCT00950755|590479484|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
163486203|NCT00950755|590479484|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
163486204|NCT00950755|590479484|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
163486205|NCT00950755|590479484|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
163486206|NCT00950755|590479484|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
163486207|NCT00950755|590479484|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
163486208|NCT00950755|590479484|FG000|Long-Term Follow-Up|Death|8|||
163486209|NCT00508820|590479485|FG000|Overall Study|Adverse Event|6|||
163486210|NCT00508820|590479486|FG001|Overall Study|Adverse Event|10|||
163486211|NCT00508820|590479485|FG000|Overall Study|Death|6|||
163486212|NCT00508820|590479486|FG001|Overall Study|Death|8|||
163486213|NCT00508820|590479485|FG000|Overall Study|Lost to Follow-up|1|||
163486214|NCT00508820|590479486|FG001|Overall Study|Lost to Follow-up|1|||
163486215|NCT00508820|590479485|FG000|Overall Study|Physician Decision|8|||
163486216|NCT00508820|590479486|FG001|Overall Study|Physician Decision|2|||
163486217|NCT00508820|590479485|FG000|Overall Study|Pregnancy|0|||
163486218|NCT00508820|590479486|FG001|Overall Study|Pregnancy|2|||
163486219|NCT00508820|590479485|FG000|Overall Study|Protocol Violation|2|||
163486220|NCT00508820|590479486|FG001|Overall Study|Protocol Violation|0|||
163486221|NCT00508820|590479485|FG000|Overall Study|Withdrawal by Subject|10|||
163486222|NCT00508820|590479486|FG001|Overall Study|Withdrawal by Subject|12|||
163486223|NCT00508820|590479485|FG000|Overall Study|Other|11|||
163486224|NCT00508820|590479486|FG001|Overall Study|Other|2|||
163486225|NCT00508820|590479485|FG000|Overall Study|Noncompliance|1|||
163486226|NCT00508820|590479486|FG001|Overall Study|Noncompliance|0|||
163486227|NCT00508820|590479485|FG000|Overall Study|Requirement for alternative therapy|7|||
163486228|NCT00508820|590479486|FG001|Overall Study|Requirement for alternative therapy|15|||
163486229|NCT00508820|590479485|FG000|Overall Study|Protocol-specified Criteria|3|||
163486230|NCT00508820|590479486|FG001|Overall Study|Protocol-specified Criteria|12|||
163486231|NCT02926833|590481187|FG000|Overall Study|Death|1|||
163486232|NCT02926833|590481188|FG001|Overall Study|Death|1|||
163486233|NCT02926833|590481189|FG002|Overall Study|Death|2|||
163486234|NCT02926833|590481190|FG003|Overall Study|Death|13|||
163486235|NCT02926833|590481187|FG000|Overall Study|Lost to Follow-up|1|||
163486236|NCT02926833|590481188|FG001|Overall Study|Lost to Follow-up|2|||
163486237|NCT02926833|590481189|FG002|Overall Study|Lost to Follow-up|0|||
163486238|NCT02926833|590481190|FG003|Overall Study|Lost to Follow-up|3|||
163486239|NCT02926833|590481187|FG000|Overall Study|Full Consent Withdrawal|0|||
163486240|NCT02926833|590481188|FG001|Overall Study|Full Consent Withdrawal|0|||
163486241|NCT02926833|590481189|FG002|Overall Study|Full Consent Withdrawal|0|||
163486242|NCT02926833|590481190|FG003|Overall Study|Full Consent Withdrawal|2|||
163486243|NCT02926833|590481187|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
163486244|NCT02926833|590481188|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
163486245|NCT02926833|590481189|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
163486246|NCT02926833|590481190|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
163486247|NCT02926833|590481187|FG000|Overall Study|Investigator Decision|0|||
163486248|NCT02926833|590481188|FG001|Overall Study|Investigator Decision|1|||
163486249|NCT02926833|590481189|FG002|Overall Study|Investigator Decision|0|||
163486250|NCT02926833|590481190|FG003|Overall Study|Investigator Decision|0|||
163486251|NCT02926833|590481187|FG000|Overall Study|Adverse Event|0|||
163486252|NCT02926833|590481188|FG001|Overall Study|Adverse Event|0|||
163486253|NCT02926833|590481189|FG002|Overall Study|Adverse Event|1|||
163486254|NCT02926833|590481190|FG003|Overall Study|Adverse Event|0|||
163486255|NCT02926833|590481187|FG000|Overall Study|Partial Withdrawal of Consent|0|||
163486256|NCT02926833|590481188|FG001|Overall Study|Partial Withdrawal of Consent|0|||
163486257|NCT02926833|590481189|FG002|Overall Study|Partial Withdrawal of Consent|0|||
163486258|NCT02926833|590481190|FG003|Overall Study|Partial Withdrawal of Consent|1|||
163486259|NCT01004822|590481191|FG000|Overall Study|Objective progression or relapse|3|||
163486260|NCT01004822|590481192|FG001|Overall Study|Objective progression or relapse|3|||
163486261|NCT01004822|590481193|FG002|Overall Study|Objective progression or relapse|0|||
163486262|NCT01004822|590481194|FG003|Overall Study|Objective progression or relapse|1|||
163486263|NCT01004822|590481195|FG004|Overall Study|Objective progression or relapse|2|||
163486264|NCT01004822|590481196|FG005|Overall Study|Objective progression or relapse|2|||
163486265|NCT01004822|590481197|FG006|Overall Study|Objective progression or relapse|1|||
163486266|NCT01004822|590481198|FG007|Overall Study|Objective progression or relapse|4|||
163486267|NCT01004822|590481191|FG000|Overall Study|Global deterioration of health status|0|||
163486268|NCT01004822|590481192|FG001|Overall Study|Global deterioration of health status|0|||
163486269|NCT01004822|590481193|FG002|Overall Study|Global deterioration of health status|0|||
163486270|NCT01004822|590481194|FG003|Overall Study|Global deterioration of health status|1|||
163486271|NCT01004822|590481195|FG004|Overall Study|Global deterioration of health status|0|||
163486272|NCT01004822|590481196|FG005|Overall Study|Global deterioration of health status|0|||
163486273|NCT01004822|590481197|FG006|Overall Study|Global deterioration of health status|1|||
163486274|NCT01004822|590481198|FG007|Overall Study|Global deterioration of health status|0|||
163486275|NCT01004822|590481191|FG000|Overall Study|No longer willing to continue|0|||
163486276|NCT01004822|590481192|FG001|Overall Study|No longer willing to continue|0|||
163486277|NCT01004822|590481193|FG002|Overall Study|No longer willing to continue|0|||
163486278|NCT01004822|590481194|FG003|Overall Study|No longer willing to continue|1|||
163486279|NCT01004822|590481195|FG004|Overall Study|No longer willing to continue|2|||
163486280|NCT01004822|590481196|FG005|Overall Study|No longer willing to continue|1|||
163486281|NCT01004822|590481197|FG006|Overall Study|No longer willing to continue|1|||
163486282|NCT01004822|590481198|FG007|Overall Study|No longer willing to continue|0|||
163486283|NCT01004822|590481191|FG000|Overall Study|Adverse Event|0|||
163486284|NCT01004822|590481192|FG001|Overall Study|Adverse Event|0|||
163486285|NCT01004822|590481193|FG002|Overall Study|Adverse Event|0|||
163486286|NCT01004822|590481194|FG003|Overall Study|Adverse Event|0|||
163486287|NCT01004822|590481195|FG004|Overall Study|Adverse Event|0|||
163486288|NCT01004822|590481196|FG005|Overall Study|Adverse Event|0|||
163486289|NCT01004822|590481197|FG006|Overall Study|Adverse Event|1|||
162925431|NCT00742859|588428966|FG002|Overall Study|Site error|1|||
163486290|NCT01004822|590481198|FG007|Overall Study|Adverse Event|1|||
163486291|NCT01004822|590481191|FG000|Overall Study|Other|0|||
163486292|NCT01004822|590481192|FG001|Overall Study|Other|0|||
163486293|NCT01004822|590481193|FG002|Overall Study|Other|4|||
163486294|NCT01004822|590481194|FG003|Overall Study|Other|1|||
163486295|NCT01004822|590481195|FG004|Overall Study|Other|0|||
163486296|NCT01004822|590481196|FG005|Overall Study|Other|1|||
163486297|NCT01004822|590481197|FG006|Overall Study|Other|0|||
163486298|NCT01004822|590481198|FG007|Overall Study|Other|0|||
163486299|NCT03159455|590481201|FG000|Overall Study|Adverse Event|0|||
163486300|NCT03159455|590481202|FG001|Overall Study|Adverse Event|0|||
163486301|NCT03159455|590481203|FG002|Overall Study|Adverse Event|0|||
163486302|NCT03159455|590481204|FG003|Overall Study|Adverse Event|0|||
163486303|NCT03159455|590481205|FG004|Overall Study|Adverse Event|0|||
163486304|NCT03159455|590481206|FG005|Overall Study|Adverse Event|1|||
163486305|NCT03799198|590481212|FG000|Overall Study|Lost to Follow-up|4|||
163486306|NCT03799198|590481213|FG001|Overall Study|Lost to Follow-up|8|||
163486307|NCT03799198|590481212|FG000|Overall Study|Death|0|||
163486308|NCT03799198|590481213|FG001|Overall Study|Death|1|||
163486309|NCT00960869|590481215|FG000|Overall Study|Adverse Event|17|||
163486310|NCT00960869|590481216|FG001|Overall Study|Adverse Event|26|||
163486311|NCT00960869|590481215|FG000|Overall Study|Withdrawal by Subject|16|||
163486312|NCT00960869|590481216|FG001|Overall Study|Withdrawal by Subject|14|||
163486313|NCT00960869|590481215|FG000|Overall Study|Lost to Follow-up|1|||
163486314|NCT00960869|590481216|FG001|Overall Study|Lost to Follow-up|4|||
163486315|NCT00960869|590481215|FG000|Overall Study|Misc|19|||
163486316|NCT00960869|590481216|FG001|Overall Study|Misc|18|||
163486317|NCT02501642|590481217|FG000|Overall Study|Lost to Follow-up|7|||
163486318|NCT02501642|590481218|FG001|Overall Study|Lost to Follow-up|11|||
163486319|NCT03410693|590481222|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
163486320|NCT03410693|590481223|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
163486321|NCT03410693|590481222|FG000|Overall Study|Disc trt: Lost to follow up|0|||
163486322|NCT03410693|590481223|FG001|Overall Study|Disc trt: Lost to follow up|1|||
163486323|NCT03410693|590481222|FG000|Overall Study|Disc trt: radiological progression|58|||
163486324|NCT03410693|590481223|FG001|Overall Study|Disc trt: radiological progression|50|||
163486325|NCT03410693|590481222|FG000|Overall Study|Disc trt: Other|1|||
163486326|NCT03410693|590481223|FG001|Overall Study|Disc trt: Other|0|||
163486327|NCT03410693|590481222|FG000|Overall Study|Study drug never administered|1|||
163486328|NCT03410693|590481223|FG001|Overall Study|Study drug never administered|6|||
163486329|NCT03410693|590481222|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
163486330|NCT03410693|590481223|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
163486331|NCT03410693|590481222|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
163486332|NCT03410693|590481223|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
163486333|NCT03410693|590481222|FG000|Overall Study|Disc trt: Physician decision|0|||
163486334|NCT03410693|590481223|FG001|Overall Study|Disc trt: Physician decision|5|||
163486335|NCT03410693|590481222|FG000|Overall Study|Disc trt: clinical progression|1|||
163486336|NCT03410693|590481223|FG001|Overall Study|Disc trt: clinical progression|5|||
163486337|NCT03410693|590481222|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
163486338|NCT03410693|590481223|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
163486339|NCT00953576|590481224|FG000|Overall Study|Adverse Event|0|||
163486340|NCT00953576|590481225|FG001|Overall Study|Adverse Event|1|||
163486341|NCT00953576|590481224|FG000|Overall Study|Ineligible after Consent|2|||
163486342|NCT00953576|590481225|FG001|Overall Study|Ineligible after Consent|0|||
163486343|NCT00501969|590481226|FG000|Overall Study|Major Protocol Violation|4|||
163486344|NCT00501969|590481226|FG000|Overall Study|Lack of Efficacy|29|||
163486345|NCT00501969|590481226|FG000|Overall Study|Adverse Event|76|||
163486346|NCT00501969|590481226|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
163486347|NCT00501969|590481226|FG000|Overall Study|Subject withdrew consent|51|||
163486348|NCT00501969|590481226|FG000|Overall Study|Lost to Follow-up|4|||
163486349|NCT00501969|590481226|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
163486350|NCT00501969|590481226|FG000|Overall Study|Other: Sponsors Request|10|||
163486351|NCT00501969|590481226|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
163486352|NCT00501969|590481226|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
163486353|NCT00501969|590481226|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
163486354|NCT00501969|590481226|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
163486355|NCT00501969|590481226|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
163486356|NCT00501969|590481226|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
163486357|NCT00501969|590481226|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
163486358|NCT00501969|590481226|FG000|Overall Study|Other: As Required by Local EC|2|||
163486359|NCT00501969|590481226|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
162925432|NCT00742859|588428967|FG003|Overall Study|Site error|1|||
163486360|NCT00501969|590481226|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
163486361|NCT02687815|590481227|FG000|Overall Study|Lost to Follow-up|2|||
163486362|NCT02687815|590481228|FG001|Overall Study|Lost to Follow-up|4|||
163486363|NCT02687815|590481227|FG000|Overall Study|Withdrawal by Subject|2|||
163486364|NCT02687815|590481228|FG001|Overall Study|Withdrawal by Subject|4|||
163486365|NCT00379639|590481229|FG000|Overall Study|Disease Progression|3|||
163486366|NCT00379639|590481230|FG001|Overall Study|Disease Progression|3|||
163486367|NCT00379639|590481231|FG002|Overall Study|Disease Progression|3|||
163486368|NCT00379639|590481232|FG003|Overall Study|Disease Progression|4|||
163486369|NCT00379639|590481233|FG004|Overall Study|Disease Progression|4|||
163486370|NCT00379639|590481229|FG000|Overall Study|Physician Decision|0|||
163486371|NCT00379639|590481230|FG001|Overall Study|Physician Decision|2|||
163486372|NCT00379639|590481231|FG002|Overall Study|Physician Decision|1|||
163486373|NCT00379639|590481232|FG003|Overall Study|Physician Decision|1|||
163486374|NCT00379639|590481233|FG004|Overall Study|Physician Decision|0|||
163486375|NCT00379639|590481229|FG000|Overall Study|Symptomatic Deterioration|0|||
163486376|NCT00379639|590481230|FG001|Overall Study|Symptomatic Deterioration|0|||
163486377|NCT00379639|590481231|FG002|Overall Study|Symptomatic Deterioration|1|||
163486378|NCT00379639|590481232|FG003|Overall Study|Symptomatic Deterioration|0|||
163486379|NCT00379639|590481233|FG004|Overall Study|Symptomatic Deterioration|1|||
163486380|NCT00379639|590481229|FG000|Overall Study|Adverse Event|0|||
163486381|NCT00379639|590481230|FG001|Overall Study|Adverse Event|0|||
163486382|NCT00379639|590481231|FG002|Overall Study|Adverse Event|1|||
163486383|NCT00379639|590481232|FG003|Overall Study|Adverse Event|0|||
163486384|NCT00379639|590481233|FG004|Overall Study|Adverse Event|1|||
163486385|NCT00379639|590481229|FG000|Overall Study|Lost to Follow-up|0|||
163486386|NCT00379639|590481230|FG001|Overall Study|Lost to Follow-up|0|||
163486387|NCT00379639|590481231|FG002|Overall Study|Lost to Follow-up|0|||
163486388|NCT00379639|590481232|FG003|Overall Study|Lost to Follow-up|1|||
163486389|NCT00379639|590481233|FG004|Overall Study|Lost to Follow-up|0|||
163486390|NCT00379639|590481229|FG000|Overall Study|Other|0|||
163486391|NCT00379639|590481230|FG001|Overall Study|Other|0|||
163486392|NCT00379639|590481231|FG002|Overall Study|Other|3|||
163486393|NCT00379639|590481232|FG003|Overall Study|Other|0|||
163486394|NCT00379639|590481233|FG004|Overall Study|Other|0|||
163486395|NCT03053102|590481238|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
163486396|NCT03053102|590481238|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
163486397|NCT01798056|590481239|FG000|Overall Study|Serious Adverse Event|13|||
163486398|NCT01798056|590481240|FG001|Overall Study|Serious Adverse Event|12|||
163486399|NCT01798056|590481239|FG000|Overall Study|Withdrawal by Subject|12|||
163486400|NCT01798056|590481240|FG001|Overall Study|Withdrawal by Subject|9|||
163486401|NCT01798056|590481239|FG000|Overall Study|Migrated/moved from study area|1|||
163486402|NCT01798056|590481240|FG001|Overall Study|Migrated/moved from study area|1|||
163486403|NCT01798056|590481239|FG000|Overall Study|Lost to Follow-up|1|||
163486404|NCT01798056|590481240|FG001|Overall Study|Lost to Follow-up|1|||
163486405|NCT01798056|590481239|FG000|Overall Study|Other|0|||
163486406|NCT01798056|590481240|FG001|Overall Study|Other|2|||
163486407|NCT01269346|590481243|FG000|Treatment Phase|Disease progression|3|||
163486408|NCT01269346|590481243|FG000|Treatment Phase|Adverse Event|3|||
163486409|NCT01269346|590481243|FG000|Treatment Phase|Withdrawal by Subject|1|||
163486410|NCT01269346|590481243|FG000|Treatment Phase|Other|2|||
163486411|NCT01269346|590481243|FG000|Extension Phase|Adverse Event|6|||
163486412|NCT01269346|590481243|FG000|Extension Phase|Withdrawal by Subject|4|||
163486413|NCT01269346|590481243|FG000|Extension Phase|Disease progression|22|||
163486414|NCT01269346|590481243|FG000|Extension Phase|Physician decision or participant choice|9|||
163486415|NCT01269346|590481243|FG000|Extension Phase|Clinical progression|1|||
163486416|NCT01269346|590481243|FG000|Extension Phase|Started a prohibited con med|1|||
163486417|NCT02660489|590481252|FG000|Overall Study|Lost to Follow-up|1|||
163486418|NCT02660489|590481253|FG001|Overall Study|Lost to Follow-up|1|||
163486419|NCT02660489|590481252|FG000|Overall Study|Adverse Event|1|||
163486420|NCT02660489|590481253|FG001|Overall Study|Adverse Event|3|||
163486421|NCT02660489|590481252|FG000|Overall Study|no rhinovirus infection|4|||
163486422|NCT02660489|590481253|FG001|Overall Study|no rhinovirus infection|4|||
163486423|NCT02322866|590481254|FG000|Overall Study|Adverse Event|6|||
163486424|NCT02322866|590481255|FG001|Overall Study|Adverse Event|11|||
163486425|NCT02322866|590481254|FG000|Overall Study|Withdrawal of Consent|16|||
163486426|NCT02322866|590481255|FG001|Overall Study|Withdrawal of Consent|25|||
163486427|NCT02322866|590481254|FG000|Overall Study|Lost to Follow-up|36|||
163486428|NCT02322866|590481255|FG001|Overall Study|Lost to Follow-up|39|||
163486429|NCT02322866|590481254|FG000|Overall Study|Protocol Violation|1|||
163486430|NCT02322866|590481255|FG001|Overall Study|Protocol Violation|0|||
163486431|NCT02322866|590481254|FG000|Overall Study|Noncompliance with Treatment|3|||
163486432|NCT02322866|590481255|FG001|Overall Study|Noncompliance with Treatment|4|||
163486433|NCT02322866|590481254|FG000|Overall Study|Lack of Efficacy|3|||
163486434|NCT02322866|590481255|FG001|Overall Study|Lack of Efficacy|1|||
163486435|NCT02322866|590481254|FG000|Overall Study|Other Miscellaneous Reasons|6|||
163486436|NCT02322866|590481255|FG001|Overall Study|Other Miscellaneous Reasons|6|||
163486437|NCT03735680|590481258|FG000|Overall Study|Withdrawal by Subject|0|||
163486438|NCT03735680|590481259|FG001|Overall Study|Withdrawal by Subject|1|||
163486439|NCT03735680|590481260|FG002|Overall Study|Withdrawal by Subject|0|||
163486440|NCT03735680|590481261|FG003|Overall Study|Withdrawal by Subject|0|||
163486441|NCT03735680|590481262|FG004|Overall Study|Withdrawal by Subject|0|||
163486442|NCT03735680|590481263|FG005|Overall Study|Withdrawal by Subject|1|||
163486443|NCT03735680|590481258|FG000|Overall Study|Patient unable or unwilling to continue|0|||
163486444|NCT03735680|590481259|FG001|Overall Study|Patient unable or unwilling to continue|0|||
163486445|NCT03735680|590481260|FG002|Overall Study|Patient unable or unwilling to continue|1|||
163486446|NCT03735680|590481261|FG003|Overall Study|Patient unable or unwilling to continue|0|||
163486447|NCT03735680|590481262|FG004|Overall Study|Patient unable or unwilling to continue|0|||
163486448|NCT03735680|590481263|FG005|Overall Study|Patient unable or unwilling to continue|0|||
163486449|NCT03472586|590481278|FG000|Overall Study|Physician Decision|6|||
163486450|NCT03472586|590481278|FG000|Overall Study|Death|6|||
163486451|NCT03472586|590481278|FG000|Overall Study|Adverse Event|1|||
163486452|NCT02452320|590481281|FG000|Overall Study|Adverse Event|0|||
163486453|NCT02452320|590481282|FG001|Overall Study|Adverse Event|1|||
163486454|NCT03737812|590481283|FG000|Overall Study|Withdrawal by Subject|1|||
163486455|NCT03737812|590481284|FG001|Overall Study|Withdrawal by Subject|2|||
163486456|NCT03737812|590481285|FG002|Overall Study|Withdrawal by Subject|1|||
163486457|NCT03737812|590481283|FG000|Overall Study|Sponsor Discontinued the Study|4|||
163486458|NCT03737812|590481284|FG001|Overall Study|Sponsor Discontinued the Study|3|||
163486459|NCT03737812|590481285|FG002|Overall Study|Sponsor Discontinued the Study|2|||
163486460|NCT03737812|590481283|FG000|Overall Study|Adverse Event|0|||
163486461|NCT03737812|590481284|FG001|Overall Study|Adverse Event|1|||
163486462|NCT03737812|590481285|FG002|Overall Study|Adverse Event|0|||
163486463|NCT03737812|590481283|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
163486464|NCT03737812|590481284|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
163486465|NCT03737812|590481285|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
163486466|NCT01474291|590481289|FG000|Overall Study|Not Evaluable for Efficacy|26|||
163486467|NCT01474291|590481289|FG000|Overall Study|Lack of Treatment Efficacy|88|||
163486468|NCT01474291|590481289|FG000|Overall Study|Adverse Event|53|||
163486469|NCT01474291|590481289|FG000|Overall Study|Lost to Follow-up|29|||
163486470|NCT01474291|590481289|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
163486471|NCT01474291|590481289|FG000|Overall Study|No Reason Reported|10|||
163486472|NCT01474291|590481289|FG000|Overall Study|Death|2|||
163486473|NCT03471507|590481290|FG000|Overall Study|Lost to Follow-up|1|||
163486474|NCT03471507|590481291|FG001|Overall Study|Lost to Follow-up|3|||
163486475|NCT03471507|590481290|FG000|Overall Study|Physician Decision|0|||
163486476|NCT03471507|590481291|FG001|Overall Study|Physician Decision|1|||
163486477|NCT03471507|590481290|FG000|Overall Study|Withdrawal by Subject|2|||
163486478|NCT03471507|590481291|FG001|Overall Study|Withdrawal by Subject|1|||
163486479|NCT02557308|590481293|FG000|Overall Study|Withdrawal by Subject|11|||
163486480|NCT02557308|590481294|FG001|Overall Study|Withdrawal by Subject|3|||
163486481|NCT02557308|590481295|FG002|Overall Study|Withdrawal by Subject|2|||
163486482|NCT02557308|590481296|FG003|Overall Study|Withdrawal by Subject|0|||
163486483|NCT02557308|590481297|FG004|Overall Study|Withdrawal by Subject|1|||
163486484|NCT02557308|590481298|FG005|Overall Study|Withdrawal by Subject|0|||
163486485|NCT02557308|590481299|FG006|Overall Study|Withdrawal by Subject|10|||
163486486|NCT02557308|590481300|FG007|Overall Study|Withdrawal by Subject|1|||
163486487|NCT02557308|590481293|FG000|Overall Study|Disease Progression|0|||
163486488|NCT02557308|590481294|FG001|Overall Study|Disease Progression|1|||
163486489|NCT02557308|590481295|FG002|Overall Study|Disease Progression|0|||
163486490|NCT02557308|590481296|FG003|Overall Study|Disease Progression|0|||
163486491|NCT02557308|590481297|FG004|Overall Study|Disease Progression|0|||
163486492|NCT02557308|590481298|FG005|Overall Study|Disease Progression|0|||
163486493|NCT02557308|590481299|FG006|Overall Study|Disease Progression|0|||
163486494|NCT02557308|590481300|FG007|Overall Study|Disease Progression|0|||
163486495|NCT02557308|590481293|FG000|Overall Study|Lack of Efficacy|3|||
163486496|NCT02557308|590481294|FG001|Overall Study|Lack of Efficacy|0|||
163486497|NCT02557308|590481295|FG002|Overall Study|Lack of Efficacy|0|||
163486498|NCT02557308|590481296|FG003|Overall Study|Lack of Efficacy|0|||
163486499|NCT02557308|590481297|FG004|Overall Study|Lack of Efficacy|0|||
163486500|NCT02557308|590481298|FG005|Overall Study|Lack of Efficacy|0|||
163486501|NCT02557308|590481299|FG006|Overall Study|Lack of Efficacy|1|||
163486502|NCT02557308|590481300|FG007|Overall Study|Lack of Efficacy|0|||
163486503|NCT02557308|590481293|FG000|Overall Study|Adverse Event|4|||
163486504|NCT02557308|590481294|FG001|Overall Study|Adverse Event|1|||
163486505|NCT02557308|590481295|FG002|Overall Study|Adverse Event|2|||
163486506|NCT02557308|590481296|FG003|Overall Study|Adverse Event|0|||
163486507|NCT02557308|590481297|FG004|Overall Study|Adverse Event|0|||
163486508|NCT02557308|590481298|FG005|Overall Study|Adverse Event|0|||
163486509|NCT02557308|590481299|FG006|Overall Study|Adverse Event|4|||
163486510|NCT02557308|590481300|FG007|Overall Study|Adverse Event|1|||
163486511|NCT02557308|590481293|FG000|Overall Study|Lost to Follow-up|2|||
163486512|NCT02557308|590481294|FG001|Overall Study|Lost to Follow-up|0|||
163486513|NCT02557308|590481295|FG002|Overall Study|Lost to Follow-up|1|||
163486514|NCT02557308|590481296|FG003|Overall Study|Lost to Follow-up|0|||
163486515|NCT02557308|590481297|FG004|Overall Study|Lost to Follow-up|0|||
163486516|NCT02557308|590481298|FG005|Overall Study|Lost to Follow-up|0|||
163486517|NCT02557308|590481299|FG006|Overall Study|Lost to Follow-up|2|||
163486518|NCT02557308|590481300|FG007|Overall Study|Lost to Follow-up|0|||
163486519|NCT02557308|590481293|FG000|Overall Study|Death|1|||
163486520|NCT02557308|590481294|FG001|Overall Study|Death|0|||
163486521|NCT02557308|590481295|FG002|Overall Study|Death|0|||
163486522|NCT02557308|590481296|FG003|Overall Study|Death|0|||
163486523|NCT02557308|590481297|FG004|Overall Study|Death|0|||
163486524|NCT02557308|590481298|FG005|Overall Study|Death|0|||
163486525|NCT02557308|590481299|FG006|Overall Study|Death|0|||
163486526|NCT02557308|590481300|FG007|Overall Study|Death|0|||
163486527|NCT02557308|590481293|FG000|Overall Study|Study Close|98|||
163486528|NCT02557308|590481294|FG001|Overall Study|Study Close|18|||
163486529|NCT02557308|590481295|FG002|Overall Study|Study Close|5|||
163486530|NCT02557308|590481296|FG003|Overall Study|Study Close|3|||
163486531|NCT02557308|590481297|FG004|Overall Study|Study Close|1|||
163486532|NCT02557308|590481298|FG005|Overall Study|Study Close|0|||
163486533|NCT02557308|590481299|FG006|Overall Study|Study Close|123|||
163486534|NCT02557308|590481300|FG007|Overall Study|Study Close|5|||
163486535|NCT02557308|590481293|FG000|Overall Study|Except for study close|5|||
163486536|NCT02557308|590481294|FG001|Overall Study|Except for study close|0|||
163486537|NCT02557308|590481295|FG002|Overall Study|Except for study close|0|||
163486538|NCT02557308|590481296|FG003|Overall Study|Except for study close|0|||
163486539|NCT02557308|590481297|FG004|Overall Study|Except for study close|3|||
163486540|NCT02557308|590481298|FG005|Overall Study|Except for study close|0|||
163486541|NCT02557308|590481299|FG006|Overall Study|Except for study close|6|||
163486542|NCT02557308|590481300|FG007|Overall Study|Except for study close|10|||
163486543|NCT02046993|590481304|FG000|Overall Study|Withdrawal by Subject|2|||
163486544|NCT02046993|590481305|FG001|Overall Study|Withdrawal by Subject|10|||
163486545|NCT02046993|590481304|FG000|Overall Study|Lost to Follow-up|1|||
163486546|NCT02046993|590481305|FG001|Overall Study|Lost to Follow-up|1|||
163486547|NCT00761735|590481313|FG000|Overall Study|Lost to Follow-up|6|||
163486548|NCT00761735|590481313|FG000|Overall Study|Withdrawal by Subject|6|||
163486549|NCT00761735|590481313|FG000|Overall Study|Non-compliance with protocol|1|||
163486550|NCT00761735|590481313|FG000|Overall Study|Administrative|1|||
163486551|NCT03326323|590481314|FG000|Overall Study|Unable to receive ANH protocol|3|||
163486552|NCT00851721|590481319|FG000|Overall Study|planned surgery|1|||
163486553|NCT00851721|590481320|FG001|Overall Study|planned surgery|0|||
163486554|NCT00851721|590481319|FG000|Overall Study|Death|1|||
163486555|NCT00851721|590481320|FG001|Overall Study|Death|0|||
163486556|NCT00851721|590481319|FG000|Overall Study|Adverse Event|0|||
163486557|NCT00851721|590481320|FG001|Overall Study|Adverse Event|1|||
163486558|NCT04047472|590481321|FG000|Overall Study|Adverse Event|3|||
163486559|NCT04047472|590481322|FG001|Overall Study|Adverse Event|3|||
163486560|NCT04047472|590481321|FG000|Overall Study|Death|0|||
163486561|NCT04047472|590481322|FG001|Overall Study|Death|1|||
163486562|NCT04047472|590481321|FG000|Overall Study|Lost to Follow-up|1|||
163486563|NCT04047472|590481322|FG001|Overall Study|Lost to Follow-up|0|||
163486564|NCT04047472|590481321|FG000|Overall Study|Physician Decision|1|||
163486565|NCT04047472|590481322|FG001|Overall Study|Physician Decision|2|||
163486566|NCT04047472|590481321|FG000|Overall Study|Protocol Violation|1|||
163486567|NCT04047472|590481322|FG001|Overall Study|Protocol Violation|0|||
163486568|NCT04047472|590481321|FG000|Overall Study|Withdrawal by Subject|10|||
163486569|NCT04047472|590481322|FG001|Overall Study|Withdrawal by Subject|10|||
163486570|NCT01218477|590481323|FG000|Overall Study|Disease progression|2|||
163486571|NCT01218477|590481324|FG001|Overall Study|Disease progression|3|||
163486572|NCT01218477|590481325|FG002|Overall Study|Disease progression|6|||
163486573|NCT01218477|590481326|FG003|Overall Study|Disease progression|2|||
163486574|NCT01218477|590481323|FG000|Overall Study|Study drug toxicity|0|||
163486575|NCT01218477|590481324|FG001|Overall Study|Study drug toxicity|2|||
163486576|NCT01218477|590481325|FG002|Overall Study|Study drug toxicity|5|||
163486577|NCT01218477|590481326|FG003|Overall Study|Study drug toxicity|0|||
163486578|NCT01218477|590481323|FG000|Overall Study|No longer meets study criteria|1|||
163486579|NCT01218477|590481324|FG001|Overall Study|No longer meets study criteria|0|||
163486580|NCT01218477|590481325|FG002|Overall Study|No longer meets study criteria|0|||
163486581|NCT01218477|590481326|FG003|Overall Study|No longer meets study criteria|0|||
163486582|NCT01218477|590481323|FG000|Overall Study|Withdrawal by Subject|0|||
163486583|NCT01218477|590481324|FG001|Overall Study|Withdrawal by Subject|0|||
163486584|NCT01218477|590481325|FG002|Overall Study|Withdrawal by Subject|1|||
163486585|NCT01218477|590481326|FG003|Overall Study|Withdrawal by Subject|0|||
163486586|NCT01218477|590481323|FG000|Overall Study|Prepared for cell transplantation|0|||
163486587|NCT01218477|590481324|FG001|Overall Study|Prepared for cell transplantation|1|||
163486588|NCT01218477|590481325|FG002|Overall Study|Prepared for cell transplantation|1|||
163486589|NCT01218477|590481326|FG003|Overall Study|Prepared for cell transplantation|0|||
163486590|NCT01218477|590481323|FG000|Overall Study|Administrative reason by sponsor|0|||
163486591|NCT01218477|590481324|FG001|Overall Study|Administrative reason by sponsor|0|||
163486592|NCT01218477|590481325|FG002|Overall Study|Administrative reason by sponsor|1|||
163486593|NCT01218477|590481326|FG003|Overall Study|Administrative reason by sponsor|0|||
163486594|NCT01218477|590481323|FG000|Overall Study|Maximum clinical benefit|0|||
163486595|NCT01218477|590481324|FG001|Overall Study|Maximum clinical benefit|2|||
163486596|NCT01218477|590481325|FG002|Overall Study|Maximum clinical benefit|0|||
163486597|NCT01218477|590481326|FG003|Overall Study|Maximum clinical benefit|0|||
163486598|NCT01333501|590481330|FG000|Overall Study|Adverse Event|3|||
163486599|NCT01333501|590481331|FG001|Overall Study|Adverse Event|1|||
163486600|NCT01333501|590481330|FG000|Overall Study|Abnormal laboratory value|2|||
163486601|NCT01333501|590481331|FG001|Overall Study|Abnormal laboratory value|1|||
163486602|NCT01333501|590481330|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163486603|NCT01333501|590481331|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
163486604|NCT01333501|590481330|FG000|Overall Study|Withdrawn consent|3|||
163486605|NCT01333501|590481331|FG001|Overall Study|Withdrawn consent|12|||
163486606|NCT01303159|590481332|FG000|Overall Study|Death|16|||
163486607|NCT01303159|590481332|FG000|Overall Study|Study Termination|7|||
163486608|NCT00496782|590481333|FG000|Overall Study|Protocol Violation|1|||
163486609|NCT00496782|590481334|FG001|Overall Study|Protocol Violation|2|||
163486610|NCT02132312|590481336|FG000|Overall Study|Adverse Event|2|||
163486611|NCT02132312|590481337|FG001|Overall Study|Adverse Event|0|||
163486612|NCT02132312|590481336|FG000|Overall Study|Physician Decision|1|||
163486613|NCT02132312|590481337|FG001|Overall Study|Physician Decision|1|||
163486614|NCT02132312|590481336|FG000|Overall Study|Protocol Violation|0|||
163486615|NCT02132312|590481337|FG001|Overall Study|Protocol Violation|1|||
163486616|NCT02132312|590481336|FG000|Overall Study|Withdrawal by Subject|1|||
163486617|NCT02132312|590481337|FG001|Overall Study|Withdrawal by Subject|0|||
163486618|NCT02132312|590481336|FG000|Overall Study|Lost to Follow-up|2|||
163486619|NCT02132312|590481337|FG001|Overall Study|Lost to Follow-up|1|||
163486620|NCT00955682|590481338|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
163486621|NCT00955682|590481339|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
163486622|NCT04034225|590481340|FG000|Overall Study|Death|3|||
163486623|NCT04034225|590481340|FG000|Overall Study|Withdrawal by Subject|2|||
163486624|NCT04034225|590481340|FG000|Overall Study|Study termination by Sponsor|18|||
163486625|NCT04034225|590481340|FG000|Overall Study|Physician Decision|1|||
163486626|NCT04034225|590481340|FG000|Overall Study|Lack of Efficacy|1|||
163486627|NCT02612194|590481346|FG000|Overall Study|Death|5|||
163486628|NCT02612194|590481347|FG001|Overall Study|Death|0|||
163486629|NCT02612194|590481348|FG002|Overall Study|Death|2|||
163486630|NCT02612194|590481346|FG000|Overall Study|Early Study Termination|1|||
163486631|NCT02612194|590481347|FG001|Overall Study|Early Study Termination|0|||
163486632|NCT02612194|590481348|FG002|Overall Study|Early Study Termination|0|||
163486633|NCT01190839|590481351|FG000|Overall Study|Adverse Event|32|||
163486634|NCT01190839|590481352|FG001|Overall Study|Adverse Event|41|||
163486635|NCT01190839|590481351|FG000|Overall Study|Protocol Violation|2|||
163486636|NCT01190839|590481352|FG001|Overall Study|Protocol Violation|2|||
163486637|NCT01190839|590481351|FG000|Overall Study|Lost to Follow-up|7|||
163486638|NCT01190839|590481352|FG001|Overall Study|Lost to Follow-up|1|||
163486639|NCT01190839|590481351|FG000|Overall Study|Death|1|||
163486640|NCT01190839|590481352|FG001|Overall Study|Death|0|||
163486641|NCT01190839|590481351|FG000|Overall Study|Trial stopped by Sponsor|71|||
163486642|NCT01190839|590481352|FG001|Overall Study|Trial stopped by Sponsor|68|||
163486643|NCT01190839|590481351|FG000|Overall Study|Undefined|35|||
163486644|NCT01190839|590481352|FG001|Overall Study|Undefined|31|||
163486645|NCT01190839|590481351|FG000|Overall Study|Randomized but not treated|2|||
163486646|NCT01190839|590481352|FG001|Overall Study|Randomized but not treated|4|||
163486647|NCT01265511|590481353|FG000|Overall Study|Lack of Efficacy|2|||
163486648|NCT01265511|590481354|FG001|Overall Study|Lack of Efficacy|1|||
163486649|NCT01265511|590481353|FG000|Overall Study|Met stopping rules|0|||
163486650|NCT01265511|590481354|FG001|Overall Study|Met stopping rules|2|||
163486651|NCT01153971|590483105|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
163486652|NCT01153971|590483105|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
163486653|NCT01153971|590483105|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
163486654|NCT01153971|590483105|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
163486655|NCT01153971|590483105|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
163486656|NCT01153971|590483105|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
163486657|NCT01153971|590483105|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
163486658|NCT01789476|590483106|FG000|Overall Study|Lack of Efficacy|6|||
163486659|NCT01789476|590483107|FG001|Overall Study|Lack of Efficacy|2|||
163486660|NCT01789476|590483106|FG000|Overall Study|Adverse Event|1|||
163486661|NCT01789476|590483107|FG001|Overall Study|Adverse Event|0|||
163486662|NCT01789476|590483106|FG000|Overall Study|Unable to get IV access|1|||
163486663|NCT01789476|590483107|FG001|Overall Study|Unable to get IV access|0|||
163486664|NCT01238861|590483108|FG000|Overall Study|Lost to Follow-up|4|||
163486665|NCT01238861|590483109|FG001|Overall Study|Lost to Follow-up|2|||
163486666|NCT01238861|590483110|FG002|Overall Study|Lost to Follow-up|3|||
163486667|NCT01238861|590483111|FG003|Overall Study|Lost to Follow-up|1|||
163486668|NCT01238861|590483112|FG004|Overall Study|Lost to Follow-up|1|||
163486669|NCT01238861|590483113|FG005|Overall Study|Lost to Follow-up|2|||
163486670|NCT01238861|590483108|FG000|Overall Study|Unplanned surgery|1|||
163486671|NCT01238861|590483109|FG001|Overall Study|Unplanned surgery|0|||
163486672|NCT01238861|590483110|FG002|Overall Study|Unplanned surgery|0|||
163486673|NCT01238861|590483111|FG003|Overall Study|Unplanned surgery|0|||
163486674|NCT01238861|590483112|FG004|Overall Study|Unplanned surgery|0|||
163486675|NCT01238861|590483113|FG005|Overall Study|Unplanned surgery|0|||
163486676|NCT01238861|590483108|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
163486677|NCT01238861|590483109|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
163486678|NCT01238861|590483110|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
163486679|NCT01238861|590483111|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
163486680|NCT01238861|590483112|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
163486681|NCT01238861|590483113|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
163486682|NCT01238861|590483108|FG000|Overall Study|Incorrect enrollment/randomization|0|||
163486683|NCT01238861|590483109|FG001|Overall Study|Incorrect enrollment/randomization|0|||
163486684|NCT01238861|590483110|FG002|Overall Study|Incorrect enrollment/randomization|1|||
163486685|NCT01238861|590483111|FG003|Overall Study|Incorrect enrollment/randomization|0|||
163486686|NCT01238861|590483112|FG004|Overall Study|Incorrect enrollment/randomization|1|||
163486687|NCT01238861|590483113|FG005|Overall Study|Incorrect enrollment/randomization|0|||
163486688|NCT01238861|590483108|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
163486689|NCT01238861|590483109|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
163486690|NCT01238861|590483110|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
163486691|NCT01238861|590483111|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
163486692|NCT01238861|590483112|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
163486693|NCT01238861|590483113|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
163486694|NCT01238861|590483108|FG000|Overall Study|Subject moved out of state/area|0|||
163486695|NCT01238861|590483109|FG001|Overall Study|Subject moved out of state/area|0|||
163486696|NCT01238861|590483110|FG002|Overall Study|Subject moved out of state/area|1|||
163486697|NCT01238861|590483111|FG003|Overall Study|Subject moved out of state/area|1|||
163486698|NCT01238861|590483112|FG004|Overall Study|Subject moved out of state/area|0|||
163486699|NCT01238861|590483113|FG005|Overall Study|Subject moved out of state/area|0|||
163486700|NCT01238861|590483108|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
163486701|NCT01238861|590483109|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
163486702|NCT01238861|590483110|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
163486703|NCT01238861|590483111|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
163486704|NCT01238861|590483112|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
163486705|NCT01238861|590483113|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
163486706|NCT01238861|590483108|FG000|Overall Study|Personal problems|0|||
163486707|NCT01238861|590483109|FG001|Overall Study|Personal problems|0|||
163486708|NCT01238861|590483110|FG002|Overall Study|Personal problems|0|||
163486709|NCT01238861|590483111|FG003|Overall Study|Personal problems|1|||
163486710|NCT01238861|590483112|FG004|Overall Study|Personal problems|0|||
163486711|NCT01238861|590483113|FG005|Overall Study|Personal problems|0|||
163486712|NCT01238861|590483108|FG000|Overall Study|Unable to continue visits|0|||
163486713|NCT01238861|590483109|FG001|Overall Study|Unable to continue visits|0|||
163486714|NCT01238861|590483110|FG002|Overall Study|Unable to continue visits|0|||
163486715|NCT01238861|590483111|FG003|Overall Study|Unable to continue visits|1|||
163486716|NCT01238861|590483112|FG004|Overall Study|Unable to continue visits|0|||
163486717|NCT01238861|590483113|FG005|Overall Study|Unable to continue visits|1|||
163486718|NCT01238861|590483108|FG000|Overall Study|Serious adverse event|0|||
163486719|NCT01238861|590483109|FG001|Overall Study|Serious adverse event|0|||
163486720|NCT01238861|590483110|FG002|Overall Study|Serious adverse event|0|||
163486721|NCT01238861|590483111|FG003|Overall Study|Serious adverse event|0|||
163486722|NCT01238861|590483112|FG004|Overall Study|Serious adverse event|0|||
163486723|NCT01238861|590483113|FG005|Overall Study|Serious adverse event|1|||
163486724|NCT01238861|590483108|FG000|Overall Study|Lack of compliance|0|||
163486725|NCT01238861|590483109|FG001|Overall Study|Lack of compliance|0|||
163486726|NCT01238861|590483110|FG002|Overall Study|Lack of compliance|0|||
163486727|NCT01238861|590483111|FG003|Overall Study|Lack of compliance|0|||
163486728|NCT01238861|590483112|FG004|Overall Study|Lack of compliance|0|||
163486729|NCT01238861|590483113|FG005|Overall Study|Lack of compliance|1|||
163486730|NCT01238861|590483108|FG000|Overall Study|Adverse Event|0|||
163486731|NCT01238861|590483109|FG001|Overall Study|Adverse Event|1|||
163486732|NCT01238861|590483110|FG002|Overall Study|Adverse Event|0|||
163486733|NCT01238861|590483111|FG003|Overall Study|Adverse Event|0|||
163486734|NCT01238861|590483112|FG004|Overall Study|Adverse Event|0|||
163486735|NCT01238861|590483113|FG005|Overall Study|Adverse Event|0|||
163486736|NCT01238861|590483108|FG000|Overall Study|Withdrawal by Subject|6|||
163486737|NCT01238861|590483109|FG001|Overall Study|Withdrawal by Subject|5|||
163486738|NCT01238861|590483110|FG002|Overall Study|Withdrawal by Subject|4|||
163486739|NCT01238861|590483111|FG003|Overall Study|Withdrawal by Subject|8|||
163486740|NCT01238861|590483112|FG004|Overall Study|Withdrawal by Subject|10|||
163486741|NCT01238861|590483113|FG005|Overall Study|Withdrawal by Subject|9|||
163486742|NCT00247416|590483114|FG000|Overall Study|3 patients were found to be ineligible|1|||
163486743|NCT00247416|590483115|FG001|Overall Study|3 patients were found to be ineligible|2|||
163486744|NCT00278473|590483116|FG000|Overall Study|drop out|4|||
163486745|NCT00278473|590483117|FG001|Overall Study|drop out|3|||
163486746|NCT00761761|590483118|FG000|Overall Study|Lost to Follow-up|3|||
163486747|NCT00761761|590483119|FG001|Overall Study|Lost to Follow-up|1|||
163486748|NCT00761761|590483118|FG000|Overall Study|Withdrawal by Subject|3|||
163486749|NCT00761761|590483119|FG001|Overall Study|Withdrawal by Subject|0|||
163486750|NCT04001790|590483120|FG000|Overall Study|Withdrawal by Subject|1|||
163486751|NCT04001790|590483121|FG001|Overall Study|Withdrawal by Subject|2|||
163486752|NCT01342445|590483122|FG000|Overall Study|Experienced side effects|0|||
163486753|NCT01342445|590483123|FG001|Overall Study|Experienced side effects|2|||
163486754|NCT02652793|590483126|FG000|Overall Study|Adverse Event|1|||
163486755|NCT02652793|590483126|FG000|Overall Study|Lost to Follow-up|2|||
163486756|NCT02652793|590483126|FG000|Overall Study|Withdrawal by Subject|1|||
163486757|NCT04963231|590483127|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
163486758|NCT04963231|590483128|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
163486759|NCT04963231|590483129|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
163486760|NCT04963231|590483127|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
163486761|NCT04963231|590483128|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
163486762|NCT04963231|590483129|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
163486763|NCT04963231|590483127|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
163486764|NCT04963231|590483128|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
163486765|NCT04963231|590483129|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
163486766|NCT04963231|590483127|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
163486767|NCT04963231|590483128|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
163486768|NCT04963231|590483129|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
163486769|NCT04963231|590483127|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
163486770|NCT04963231|590483128|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
163486771|NCT04963231|590483129|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
163486772|NCT04963231|590483127|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
163486773|NCT04963231|590483128|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
163486774|NCT04963231|590483129|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
163486775|NCT04963231|590483127|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
163486776|NCT04963231|590483128|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
163486777|NCT04963231|590483129|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
163486778|NCT01059175|590483130|FG000|Overall Study|Death|17|||
163486779|NCT01059175|590483131|FG001|Overall Study|Death|17|||
163486780|NCT01059175|590483130|FG000|Overall Study|Adverse Event|4|||
163486781|NCT01059175|590483131|FG001|Overall Study|Adverse Event|2|||
163486782|NCT01059175|590483130|FG000|Overall Study|Lost to Follow-up|0|||
163486783|NCT01059175|590483131|FG001|Overall Study|Lost to Follow-up|1|||
163486784|NCT02957149|590483132|FG000|Overall Study|Withdrawal by Subject|5|||
163486785|NCT06045026|590483133|FG000|Overall Study|Lost to Follow-up|60|||
163486786|NCT06045026|590483133|FG000|Overall Study|Adverse Event|12|||
163486787|NCT06045026|590483133|FG000|Overall Study|Withdrawal by Subject|3|||
163486788|NCT06045026|590483133|FG000|Overall Study|Enrollment closed|1|||
163486789|NCT01399619|590483142|FG000|Overall Study|Adverse Event|10|||
163486790|NCT01399619|590483143|FG001|Overall Study|Adverse Event|0|||
163486791|NCT01399619|590483144|FG002|Overall Study|Adverse Event|4|||
163486792|NCT01399619|590483145|FG003|Overall Study|Adverse Event|10|||
163486793|NCT01399619|590483142|FG000|Overall Study|Lack of Efficacy|9|||
163486794|NCT01399619|590483143|FG001|Overall Study|Lack of Efficacy|0|||
163486795|NCT01399619|590483144|FG002|Overall Study|Lack of Efficacy|5|||
163486796|NCT01399619|590483145|FG003|Overall Study|Lack of Efficacy|0|||
163486797|NCT01399619|590483142|FG000|Overall Study|Withdrawal by Subject|6|||
163486798|NCT01399619|590483143|FG001|Overall Study|Withdrawal by Subject|0|||
163486799|NCT01399619|590483144|FG002|Overall Study|Withdrawal by Subject|3|||
163486800|NCT01399619|590483145|FG003|Overall Study|Withdrawal by Subject|4|||
163486801|NCT01399619|590483142|FG000|Overall Study|Protocol Violation|0|||
163486802|NCT01399619|590483143|FG001|Overall Study|Protocol Violation|0|||
163486803|NCT01399619|590483144|FG002|Overall Study|Protocol Violation|0|||
163486804|NCT01399619|590483145|FG003|Overall Study|Protocol Violation|1|||
163486805|NCT01399619|590483142|FG000|Overall Study|Not treated|0|||
163486806|NCT01399619|590483143|FG001|Overall Study|Not treated|0|||
163486807|NCT01399619|590483144|FG002|Overall Study|Not treated|0|||
163486808|NCT01399619|590483145|FG003|Overall Study|Not treated|2|||
163486809|NCT03911401|590483148|FG000|Overall Study|Adverse Event|1|||
163486810|NCT03911401|590483149|FG001|Overall Study|Adverse Event|2|||
163486811|NCT03911401|590483150|FG002|Overall Study|Adverse Event|5|||
163486812|NCT03911401|590483148|FG000|Overall Study|Lack of Efficacy|1|||
163486813|NCT03911401|590483149|FG001|Overall Study|Lack of Efficacy|1|||
163486814|NCT03911401|590483150|FG002|Overall Study|Lack of Efficacy|8|||
163486815|NCT03911401|590483148|FG000|Overall Study|Physician Decision|0|||
163486816|NCT03911401|590483149|FG001|Overall Study|Physician Decision|0|||
163486817|NCT03911401|590483150|FG002|Overall Study|Physician Decision|1|||
163486818|NCT03911401|590483148|FG000|Overall Study|Withdrawal by Subject|1|||
163486819|NCT03911401|590483149|FG001|Overall Study|Withdrawal by Subject|2|||
163486820|NCT03911401|590483150|FG002|Overall Study|Withdrawal by Subject|0|||
163486821|NCT03911401|590483148|FG000|Overall Study|Withdrawal by parent/guardian|4|||
163486822|NCT03911401|590483149|FG001|Overall Study|Withdrawal by parent/guardian|4|||
163486823|NCT03911401|590483150|FG002|Overall Study|Withdrawal by parent/guardian|11|||
163486824|NCT05602818|590483151|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
163486825|NCT05602818|590483152|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
163486826|NCT05602818|590483153|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
163486827|NCT05602818|590483154|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
163486828|NCT05602818|590483155|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
163486829|NCT05602818|590483156|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
163486830|NCT05602818|590483157|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
163486831|NCT05602818|590483158|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
163486832|NCT05602818|590483159|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
163486833|NCT05602818|590483160|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
163486834|NCT05602818|590483161|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
163486835|NCT05602818|590483162|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
163486836|NCT05602818|590483151|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
163486837|NCT05602818|590483152|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
163486838|NCT05602818|590483153|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
163486839|NCT05602818|590483154|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
163486840|NCT05602818|590483155|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
163486841|NCT05602818|590483156|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
163486842|NCT05602818|590483157|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
163486843|NCT05602818|590483158|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
163486844|NCT05602818|590483159|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
163486845|NCT05602818|590483160|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
163486846|NCT05602818|590483161|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
163486847|NCT05602818|590483162|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
163486848|NCT05602818|590483151|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
163486849|NCT05602818|590483152|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
163486850|NCT05602818|590483153|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
163486851|NCT05602818|590483154|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
163486852|NCT05602818|590483155|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
163486853|NCT05602818|590483156|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
163486854|NCT05602818|590483157|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
163486855|NCT05602818|590483158|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
163486856|NCT05602818|590483159|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
163486857|NCT05602818|590483160|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
163486858|NCT05602818|590483161|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
163486859|NCT05602818|590483162|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
163486860|NCT05602818|590483151|FG000|Qualification Phase (3 Days)|Other|1|||
163486861|NCT05602818|590483152|FG001|Qualification Phase (3 Days)|Other|0|||
163486862|NCT05602818|590483153|FG002|Qualification Phase (3 Days)|Other|0|||
163486863|NCT05602818|590483154|FG003|Qualification Phase (3 Days)|Other|0|||
163486864|NCT05602818|590483155|FG004|Qualification Phase (3 Days)|Other|0|||
163486865|NCT05602818|590483156|FG005|Qualification Phase (3 Days)|Other|0|||
163486866|NCT05602818|590483157|FG006|Qualification Phase (3 Days)|Other|0|||
163486867|NCT05602818|590483158|FG007|Qualification Phase (3 Days)|Other|0|||
163486868|NCT05602818|590483159|FG008|Qualification Phase (3 Days)|Other|0|||
163486869|NCT05602818|590483160|FG009|Qualification Phase (3 Days)|Other|0|||
163486870|NCT05602818|590483161|FG010|Qualification Phase (3 Days)|Other|0|||
163486871|NCT05602818|590483162|FG011|Qualification Phase (3 Days)|Other|0|||
163486872|NCT05602818|590483151|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
163486873|NCT05602818|590483152|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
163486874|NCT05602818|590483153|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
163486875|NCT05602818|590483154|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
163486876|NCT05602818|590483155|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
163486877|NCT05602818|590483156|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
163486878|NCT05602818|590483157|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
163486879|NCT05602818|590483158|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
163486880|NCT05602818|590483159|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
163486881|NCT05602818|590483160|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
163486882|NCT05602818|590483161|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
163486883|NCT05602818|590483162|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
163486884|NCT05602818|590483151|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
163486885|NCT05602818|590483152|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
163486886|NCT05602818|590483153|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
163486887|NCT05602818|590483154|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
163486888|NCT05602818|590483155|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
163486889|NCT05602818|590483156|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
163486890|NCT05602818|590483157|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
163486891|NCT05602818|590483158|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
163486892|NCT05602818|590483159|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
163486893|NCT05602818|590483160|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
163486894|NCT05602818|590483161|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
163486895|NCT05602818|590483162|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
163486896|NCT05602818|590483151|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
163486897|NCT05602818|590483152|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
163486898|NCT05602818|590483153|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
163486899|NCT05602818|590483154|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
163486900|NCT05602818|590483155|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
163486901|NCT05602818|590483156|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
163486902|NCT05602818|590483157|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
163486903|NCT05602818|590483158|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
163486904|NCT05602818|590483159|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
163486905|NCT05602818|590483160|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
163486906|NCT05602818|590483161|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
163486907|NCT05602818|590483162|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
163486908|NCT05602818|590483151|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
163486909|NCT05602818|590483152|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
163486910|NCT05602818|590483153|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
163486911|NCT05602818|590483154|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
163486912|NCT05602818|590483155|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
163486913|NCT05602818|590483156|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
163486914|NCT05602818|590483157|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
163486915|NCT05602818|590483158|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
163486916|NCT05602818|590483159|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
163486917|NCT05602818|590483160|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
163486918|NCT05602818|590483161|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
163486919|NCT05602818|590483162|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
163486920|NCT03814499|590483163|FG000|Overall Study|Lost to Follow-up|3|||
163486921|NCT03417245|590483164|FG000|Overall Study|Adverse Event|1|||
163486922|NCT03417245|590483165|FG001|Overall Study|Adverse Event|0|||
163486923|NCT03417245|590483164|FG000|Overall Study|Protocol Violation|1|||
163486924|NCT03417245|590483165|FG001|Overall Study|Protocol Violation|0|||
163486925|NCT03417245|590483164|FG000|Overall Study|Withdrawal by Subject|1|||
163486926|NCT03417245|590483165|FG001|Overall Study|Withdrawal by Subject|1|||
163486927|NCT00598442|590483169|FG000|Overall Study|Adverse Event|3|||
163486928|NCT00598442|590483170|FG001|Overall Study|Adverse Event|0|||
163486929|NCT00598442|590483171|FG002|Overall Study|Adverse Event|0|||
163486930|NCT00598442|590483169|FG000|Overall Study|Death|19|||
163486931|NCT00598442|590483170|FG001|Overall Study|Death|11|||
163486932|NCT00598442|590483171|FG002|Overall Study|Death|11|||
163486933|NCT00598442|590483169|FG000|Overall Study|Lost to Follow-up|4|||
163486934|NCT00598442|590483170|FG001|Overall Study|Lost to Follow-up|3|||
163486935|NCT00598442|590483171|FG002|Overall Study|Lost to Follow-up|3|||
163486936|NCT00598442|590483169|FG000|Overall Study|Physician Decision|2|||
163486937|NCT00598442|590483170|FG001|Overall Study|Physician Decision|1|||
163486938|NCT00598442|590483171|FG002|Overall Study|Physician Decision|1|||
163486939|NCT00598442|590483169|FG000|Overall Study|Withdrawal by Subject|8|||
163486940|NCT00598442|590483170|FG001|Overall Study|Withdrawal by Subject|16|||
163486941|NCT00598442|590483171|FG002|Overall Study|Withdrawal by Subject|6|||
163486942|NCT00598442|590483169|FG000|Overall Study|Noncompliance|0|||
163486943|NCT00598442|590483170|FG001|Overall Study|Noncompliance|2|||
163486944|NCT00598442|590483171|FG002|Overall Study|Noncompliance|1|||
163486945|NCT00598442|590483169|FG000|Overall Study|Relocation|1|||
163486946|NCT00598442|590483170|FG001|Overall Study|Relocation|4|||
163486947|NCT00598442|590483171|FG002|Overall Study|Relocation|0|||
163486948|NCT00598442|590483169|FG000|Overall Study|Renal transplant|0|||
163486949|NCT00598442|590483170|FG001|Overall Study|Renal transplant|0|||
163486950|NCT00598442|590483171|FG002|Overall Study|Renal transplant|1|||
163486951|NCT00598442|590483169|FG000|Overall Study|Site closed by sponsor|5|||
163486952|NCT00598442|590483170|FG001|Overall Study|Site closed by sponsor|2|||
163486953|NCT00598442|590483171|FG002|Overall Study|Site closed by sponsor|1|||
163486954|NCT00598442|590483169|FG000|Overall Study|Started dialysis|1|||
163486955|NCT00598442|590483170|FG001|Overall Study|Started dialysis|0|||
163486956|NCT00598442|590483171|FG002|Overall Study|Started dialysis|0|||
163486957|NCT01590628|590483184|FG000|Overall Study|Death|2|||
163486958|NCT01590628|590483185|FG001|Overall Study|Death|0|||
163486959|NCT00229931|590483186|FG000|Overall Study|Death|1|||
163486960|NCT00229931|590483187|FG001|Overall Study|Death|0|||
163486961|NCT00229931|590483186|FG000|Overall Study|Lost to Follow-up|3|||
163486962|NCT00229931|590483187|FG001|Overall Study|Lost to Follow-up|2|||
163486963|NCT02992743|590483188|FG000|Overall Study|Withdrawal by Subject|1|||
163486964|NCT02992743|590483189|FG001|Overall Study|Withdrawal by Subject|1|||
163486965|NCT02992743|590483188|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
163486966|NCT02992743|590483189|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
163486967|NCT02992743|590483188|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
163486968|NCT02992743|590483189|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
163486969|NCT02992743|590483188|FG000|Overall Study|No measurable disease|1|||
163486970|NCT02992743|590483189|FG001|Overall Study|No measurable disease|0|||
163486971|NCT02992743|590483188|FG000|Overall Study|Lost to Follow-up|0|||
163486972|NCT02992743|590483189|FG001|Overall Study|Lost to Follow-up|1|||
163486973|NCT00381680|590483190|FG000|Overall Study|Adverse Event|9|||
163486974|NCT00381680|590483191|FG001|Overall Study|Adverse Event|3|||
163486975|NCT00381680|590483190|FG000|Overall Study|Death|10|||
163486976|NCT00381680|590483191|FG001|Overall Study|Death|7|||
163486977|NCT00381680|590483190|FG000|Overall Study|Lost to Follow-up|3|||
163486978|NCT00381680|590483191|FG001|Overall Study|Lost to Follow-up|2|||
163486979|NCT00381680|590483190|FG000|Overall Study|Physician Decision|25|||
163486980|NCT00381680|590483191|FG001|Overall Study|Physician Decision|6|||
163486981|NCT00381680|590483190|FG000|Overall Study|Withdrawal by Subject|3|||
163486982|NCT00381680|590483191|FG001|Overall Study|Withdrawal by Subject|1|||
163486983|NCT00381680|590483190|FG000|Overall Study|Entry onto another COG Trial|1|||
163486984|NCT00381680|590483191|FG001|Overall Study|Entry onto another COG Trial|2|||
163486985|NCT00381680|590483190|FG000|Overall Study|Alternative Therapy|11|||
163486986|NCT00381680|590483191|FG001|Overall Study|Alternative Therapy|5|||
163486987|NCT00381680|590483190|FG000|Overall Study|Secondary Malignancy|3|||
163486988|NCT00381680|590483191|FG001|Overall Study|Secondary Malignancy|0|||
163486989|NCT00381680|590483190|FG000|Overall Study|Delay initiation|1|||
163486990|NCT00381680|590483191|FG001|Overall Study|Delay initiation|0|||
163486991|NCT00381680|590483190|FG000|Overall Study|Stem Cell Transplant|26|||
163486992|NCT00381680|590483191|FG001|Overall Study|Stem Cell Transplant|10|||
163486993|NCT00381680|590483190|FG000|Overall Study|Relapse|18|||
163486994|NCT00381680|590483191|FG001|Overall Study|Relapse|9|||
163486995|NCT00381680|590483190|FG000|Overall Study|Induction Failure|4|||
163486996|NCT00381680|590483191|FG001|Overall Study|Induction Failure|1|||
163486997|NCT00381680|590483190|FG000|Overall Study|Progression|1|||
163486998|NCT00381680|590483191|FG001|Overall Study|Progression|1|||
163486999|NCT00381680|590483190|FG000|Overall Study|Other not otherwise specified|7|||
163487000|NCT00381680|590483191|FG001|Overall Study|Other not otherwise specified|2|||
163487001|NCT00381680|590483190|FG000|Overall Study|Ineligible|3|||
163487002|NCT00381680|590483191|FG001|Overall Study|Ineligible|1|||
163487003|NCT03290131|590483192|FG000|Overall Study|Adverse Event|22|||
163487004|NCT03290131|590483193|FG001|Overall Study|Adverse Event|57|||
163487005|NCT03290131|590483194|FG002|Overall Study|Adverse Event|11|||
163487006|NCT03290131|590483192|FG000|Overall Study|Withdrawal by Subject|18|||
163487007|NCT03290131|590483193|FG001|Overall Study|Withdrawal by Subject|13|||
163487008|NCT03290131|590483194|FG002|Overall Study|Withdrawal by Subject|8|||
163487009|NCT03290131|590483192|FG000|Overall Study|MS Relapse|2|||
163487010|NCT03290131|590483193|FG001|Overall Study|MS Relapse|1|||
163487011|NCT03290131|590483194|FG002|Overall Study|MS Relapse|0|||
163487012|NCT03290131|590483192|FG000|Overall Study|Unknown reason|0|||
163487013|NCT03290131|590483193|FG001|Overall Study|Unknown reason|1|||
163487014|NCT03290131|590483194|FG002|Overall Study|Unknown reason|0|||
163487015|NCT03099096|590483197|FG000|Overall Study|Adverse Event|1|||
163487016|NCT03099096|590483197|FG000|Overall Study|Physician Decision|1|||
163487017|NCT00361504|590483200|FG000|Overall Study|Withdrawal by Subject|94|||
163487018|NCT00361504|590483201|FG001|Overall Study|Withdrawal by Subject|31|||
163487019|NCT00361504|590483200|FG000|Overall Study|Lost to Follow-up|40|||
163487020|NCT00361504|590483201|FG001|Overall Study|Lost to Follow-up|7|||
163487021|NCT00361504|590483200|FG000|Overall Study|Adverse Event|203|||
163487022|NCT00361504|590483201|FG001|Overall Study|Adverse Event|82|||
163487023|NCT00361504|590483200|FG000|Overall Study|Lack of Efficacy|72|||
163487024|NCT00361504|590483201|FG001|Overall Study|Lack of Efficacy|7|||
163487025|NCT00361504|590483200|FG000|Overall Study|Resolution of Pain|2|||
163487026|NCT00361504|590483201|FG001|Overall Study|Resolution of Pain|0|||
163487027|NCT00361504|590483200|FG000|Overall Study|Study medication non compliant|42|||
163487028|NCT00361504|590483201|FG001|Overall Study|Study medication non compliant|15|||
163487029|NCT00361504|590483200|FG000|Overall Study|All other|28|||
163487030|NCT00361504|590483201|FG001|Overall Study|All other|3|||
163487031|NCT03764813|590483203|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
163487032|NCT03764813|590483204|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
163487033|NCT03764813|590483205|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
163487034|NCT03764813|590483206|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
163487035|NCT00450814|590483215|FG000|Overall Study|Failed to complete the initial therapy|0|||
163487036|NCT00450814|590483216|FG001|Overall Study|Failed to complete the initial therapy|0|||
163487037|NCT00450814|590483217|FG002|Overall Study|Failed to complete the initial therapy|0|||
163487038|NCT00450814|590483218|FG003|Overall Study|Failed to complete the initial therapy|1|||
163487039|NCT00450814|590483219|FG004|Overall Study|Failed to complete the initial therapy|1|||
163487040|NCT00450814|590483220|FG005|Overall Study|Failed to complete the initial therapy|1|||
163487041|NCT00450814|590483221|FG006|Overall Study|Failed to complete the initial therapy|0|||
163487042|NCT00450814|590483222|FG007|Overall Study|Failed to complete the initial therapy|0|||
163487043|NCT00450814|590483223|FG008|Overall Study|Failed to complete the initial therapy|0|||
163487044|NCT00450814|590483224|FG009|Overall Study|Failed to complete the initial therapy|0|||
163487045|NCT00450814|590483225|FG010|Overall Study|Failed to complete the initial therapy|0|||
163487046|NCT00450814|590483215|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
163487047|NCT00450814|590483216|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
163487048|NCT00450814|590483217|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
163487049|NCT00450814|590483218|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
163487050|NCT00450814|590483219|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
163487051|NCT00450814|590483220|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
163487052|NCT00450814|590483221|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
163487053|NCT00450814|590483222|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
163487054|NCT00450814|590483223|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
163487055|NCT00450814|590483224|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
163487056|NCT00450814|590483225|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
163487057|NCT03602976|590483230|FG000|Overall Study|Withdrawal by Subject|1|||
163487058|NCT04837807|590483231|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
163487059|NCT04837807|590483232|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
163487060|NCT00267202|590483233|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
163487061|NCT00267202|590483234|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
163487062|NCT00267202|590483233|FG000|Overall Study|Withdrawal by Subject|12|||
163487063|NCT00267202|590483234|FG001|Overall Study|Withdrawal by Subject|15|||
163487064|NCT00267202|590483233|FG000|Overall Study|Adverse Event|13|||
163487065|NCT00267202|590483234|FG001|Overall Study|Adverse Event|7|||
163487066|NCT00267202|590483233|FG000|Overall Study|Protocol Violation|2|||
163487067|NCT00267202|590483234|FG001|Overall Study|Protocol Violation|3|||
163487068|NCT00267202|590483233|FG000|Overall Study|Administrative problems|2|||
163487069|NCT00267202|590483234|FG001|Overall Study|Administrative problems|1|||
163487070|NCT00267202|590483233|FG000|Overall Study|Lost to Follow-up|3|||
163487071|NCT00267202|590483234|FG001|Overall Study|Lost to Follow-up|0|||
163487072|NCT01757821|590483235|FG000|Overall Study|Adverse Event|1|||
163487073|NCT00334893|590483238|FG000|Overall Study|Not Treated|1|||
163487074|NCT00334893|590483239|FG001|Overall Study|Not Treated|0|||
163487075|NCT00920582|590483240|FG000|Overall Study|Lost to Follow-up|5|||
163487076|NCT00920582|590483241|FG001|Overall Study|Lost to Follow-up|1|||
163487077|NCT00920582|590483242|FG002|Overall Study|Lost to Follow-up|2|||
163487078|NCT00920582|590483243|FG003|Overall Study|Lost to Follow-up|0|||
163487079|NCT00920582|590483240|FG000|Overall Study|Withdrawal by Subject|5|||
163487080|NCT00920582|590483241|FG001|Overall Study|Withdrawal by Subject|4|||
163487081|NCT00920582|590483242|FG002|Overall Study|Withdrawal by Subject|6|||
163487082|NCT00920582|590483243|FG003|Overall Study|Withdrawal by Subject|3|||
163487083|NCT00920582|590483240|FG000|Overall Study|Protocol Violation|1|||
163487084|NCT00920582|590483241|FG001|Overall Study|Protocol Violation|0|||
163487085|NCT00920582|590483242|FG002|Overall Study|Protocol Violation|0|||
163487086|NCT00920582|590483243|FG003|Overall Study|Protocol Violation|0|||
163487087|NCT00920582|590483240|FG000|Overall Study|Other|2|||
163487088|NCT00920582|590483241|FG001|Overall Study|Other|1|||
163487089|NCT00920582|590483242|FG002|Overall Study|Other|3|||
163487090|NCT00920582|590483243|FG003|Overall Study|Other|2|||
163487091|NCT03319160|590483244|FG000|Overall Study|Data not available.|7|||
163487092|NCT03604159|590483245|FG000|Overall Study|Lost to Follow-up|6|||
163487093|NCT03604159|590483246|FG001|Overall Study|Lost to Follow-up|7|||
163487094|NCT00665002|590483247|FG000|Overall Study|Progression/relapse during treatment|11|||
163487095|NCT00665002|590483247|FG000|Overall Study|Cytogenetic resistance|1|||
163487096|NCT04533204|590483248|FG000|Overall Study|Unable to understand training instructions|1|||
163487097|NCT04533204|590483249|FG001|Overall Study|Unable to understand training instructions|1|||
163487098|NCT02260791|590483253|FG000|Overall Study|Lost to Follow-up|4|||
163487099|NCT02260791|590483254|FG001|Overall Study|Lost to Follow-up|4|||
163487100|NCT02260791|590483253|FG000|Overall Study|Lack of Efficacy|2|||
163487101|NCT02260791|590483254|FG001|Overall Study|Lack of Efficacy|1|||
163487102|NCT02260791|590483253|FG000|Overall Study|Adverse Event|13|||
163487103|NCT02260791|590483254|FG001|Overall Study|Adverse Event|9|||
163487104|NCT02260791|590483253|FG000|Overall Study|Death|1|||
163487105|NCT02260791|590483254|FG001|Overall Study|Death|0|||
163487106|NCT02260791|590483253|FG000|Overall Study|Withdrawal by Subject|11|||
163487107|NCT02260791|590483254|FG001|Overall Study|Withdrawal by Subject|16|||
163487108|NCT02260791|590483253|FG000|Overall Study|Screen failure|0|||
163487109|NCT02260791|590483254|FG001|Overall Study|Screen failure|1|||
163487110|NCT02260791|590483253|FG000|Overall Study|Protocol deviation|2|||
163487111|NCT02260791|590483254|FG001|Overall Study|Protocol deviation|3|||
163487112|NCT01411917|590483255|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
163487113|NCT01411917|590483256|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
163487114|NCT02354599|590483259|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
163487115|NCT02354599|590483260|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
163487116|NCT02354599|590483261|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
163487117|NCT02354599|590483262|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
163487118|NCT02354599|590483263|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
163487119|NCT02354599|590483264|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
163487120|NCT02354599|590483259|FG000|Overall Study|Withdrawal by Subject|1|||
163487121|NCT02354599|590483260|FG001|Overall Study|Withdrawal by Subject|1|||
163487122|NCT02354599|590483261|FG002|Overall Study|Withdrawal by Subject|0|||
163487123|NCT02354599|590483262|FG003|Overall Study|Withdrawal by Subject|0|||
163487124|NCT02354599|590483263|FG004|Overall Study|Withdrawal by Subject|0|||
163487125|NCT02354599|590483264|FG005|Overall Study|Withdrawal by Subject|0|||
163487126|NCT00280059|590483265|FG000|Efficacy Assessment Phase|Death|2|||
163487127|NCT00280059|590483266|FG001|Efficacy Assessment Phase|Death|0|||
163487128|NCT00280059|590483265|FG000|Efficacy Assessment Phase|Adverse Event|33|||
163487129|NCT00280059|590483266|FG001|Efficacy Assessment Phase|Adverse Event|31|||
163487130|NCT00280059|590483265|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
163487131|NCT00280059|590483266|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
163487132|NCT00280059|590483265|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
163487133|NCT00280059|590483266|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
163487134|NCT00280059|590483265|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
163487135|NCT00280059|590483266|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
163487136|NCT00280059|590483265|FG000|Efficacy Assessment Phase|Other|7|||
163487137|NCT00280059|590483266|FG001|Efficacy Assessment Phase|Other|8|||
163487138|NCT00280059|590483265|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
163487139|NCT00280059|590483266|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
163487140|NCT00495794|590483269|FG000|Overall Study|Pharmacist did not activate patient|522|||
163487141|NCT00495794|590483270|FG001|Overall Study|Pharmacist did not activate patient|0|||
163487142|NCT00323479|590483271|FG000|Overall Study|Adverse Event|2|||
163487143|NCT00323479|590483271|FG000|Overall Study|Withdrawal by Subject|2|||
163487144|NCT00323479|590483271|FG000|Overall Study|Protocol Violation|3|||
163487145|NCT00323479|590483271|FG000|Overall Study|house moving|1|||
163487146|NCT03044730|590483274|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
163487147|NCT03044730|590483274|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
163487148|NCT03044730|590483274|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
163487149|NCT03044730|590483274|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
163487150|NCT03044730|590483274|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
163487151|NCT03044730|590483274|FG000|Cycles 4 and Beyond|Adverse Event|1|||
163487152|NCT03044730|590483274|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
163487153|NCT03044730|590483274|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
163487154|NCT03044730|590483274|FG000|On Follow-up for 2 Years|Death|17|||
163487155|NCT01302366|590485228|FG000|Overall Study|patient choice or noncompliance|5|||
163487156|NCT00198107|590485231|FG000|Double-Blind Period|Adverse Event|1|||
163487157|NCT00198107|590485232|FG001|Double-Blind Period|Adverse Event|1|||
163487158|NCT00198107|590485233|FG002|Double-Blind Period|Adverse Event|0|||
163487159|NCT00198107|590485231|FG000|Double-Blind Period|Lack of Efficacy|2|||
163487160|NCT00198107|590485232|FG001|Double-Blind Period|Lack of Efficacy|0|||
163487161|NCT00198107|590485233|FG002|Double-Blind Period|Lack of Efficacy|0|||
163487162|NCT00198107|590485231|FG000|Double-Blind Period|Lost to Follow-up|2|||
163487163|NCT00198107|590485232|FG001|Double-Blind Period|Lost to Follow-up|1|||
163487164|NCT00198107|590485233|FG002|Double-Blind Period|Lost to Follow-up|0|||
163487165|NCT00198107|590485231|FG000|Double-Blind Period|Physician Decision|1|||
163487166|NCT00198107|590485232|FG001|Double-Blind Period|Physician Decision|0|||
163487167|NCT00198107|590485233|FG002|Double-Blind Period|Physician Decision|0|||
163487168|NCT00198107|590485231|FG000|Double-Blind Period|Withdrawal by Subject|0|||
163487169|NCT00198107|590485232|FG001|Double-Blind Period|Withdrawal by Subject|1|||
163487170|NCT00198107|590485233|FG002|Double-Blind Period|Withdrawal by Subject|0|||
163487171|NCT00198107|590485231|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
163487172|NCT00198107|590485232|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
163487173|NCT00198107|590485233|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
163487174|NCT02513732|590485234|FG000|Overall Study|Lost to Follow-up|11|||
163487175|NCT02513732|590485234|FG000|Overall Study|Death|9|||
163487176|NCT02513732|590485234|FG000|Overall Study|Changing hospital|2|||
163487177|NCT00934661|590485235|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
163487178|NCT00934661|590485236|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
163487179|NCT00467051|590485237|FG000|Overall Study|Adverse Event|2|||
163487180|NCT01846442|590485242|FG000|Overall Study|Adverse Event|2|||
163487181|NCT01846442|590485243|FG001|Overall Study|Adverse Event|4|||
163487182|NCT01846442|590485244|FG002|Overall Study|Adverse Event|2|||
163487183|NCT01846442|590485245|FG003|Overall Study|Adverse Event|1|||
163487184|NCT01846442|590485242|FG000|Overall Study|Lost to Follow-up|0|||
163487185|NCT01846442|590485243|FG001|Overall Study|Lost to Follow-up|0|||
163487186|NCT01846442|590485244|FG002|Overall Study|Lost to Follow-up|1|||
163487187|NCT01846442|590485245|FG003|Overall Study|Lost to Follow-up|0|||
163487188|NCT01846442|590485242|FG000|Overall Study|Withdrawal by Subject|3|||
163487189|NCT01846442|590485243|FG001|Overall Study|Withdrawal by Subject|2|||
163487190|NCT01846442|590485244|FG002|Overall Study|Withdrawal by Subject|0|||
163487191|NCT01846442|590485245|FG003|Overall Study|Withdrawal by Subject|1|||
163487192|NCT01846442|590485242|FG000|Overall Study|Left the city/Lost medication|1|||
163487193|NCT01846442|590485243|FG001|Overall Study|Left the city/Lost medication|0|||
163487194|NCT01846442|590485244|FG002|Overall Study|Left the city/Lost medication|1|||
163487195|NCT01846442|590485245|FG003|Overall Study|Left the city/Lost medication|1|||
163487196|NCT02777554|590485248|FG000|Overall Study|Adverse Event|4|||
163487197|NCT02777554|590485249|FG001|Overall Study|Adverse Event|4|||
163487198|NCT02777554|590485250|FG002|Overall Study|Adverse Event|0|||
163487199|NCT02777554|590485251|FG003|Overall Study|Adverse Event|1|||
163487200|NCT02777554|590485252|FG004|Overall Study|Adverse Event|0|||
163487201|NCT02777554|590485253|FG005|Overall Study|Adverse Event|0|||
163487202|NCT02777554|590485248|FG000|Overall Study|Withdrawal by Subject|3|||
163487203|NCT02777554|590485249|FG001|Overall Study|Withdrawal by Subject|1|||
163487204|NCT02777554|590485250|FG002|Overall Study|Withdrawal by Subject|1|||
163487205|NCT02777554|590485251|FG003|Overall Study|Withdrawal by Subject|0|||
163487206|NCT02777554|590485252|FG004|Overall Study|Withdrawal by Subject|0|||
163487207|NCT02777554|590485253|FG005|Overall Study|Withdrawal by Subject|0|||
163487208|NCT02777554|590485248|FG000|Overall Study|Discharged early due to hurricane|22|||
163487209|NCT02777554|590485249|FG001|Overall Study|Discharged early due to hurricane|20|||
163487210|NCT02777554|590485250|FG002|Overall Study|Discharged early due to hurricane|0|||
163487211|NCT02777554|590485251|FG003|Overall Study|Discharged early due to hurricane|0|||
163487212|NCT02777554|590485252|FG004|Overall Study|Discharged early due to hurricane|0|||
163487213|NCT02777554|590485253|FG005|Overall Study|Discharged early due to hurricane|0|||
163487214|NCT02777554|590485248|FG000|Overall Study|Other - Miscellaneous|1|||
163487215|NCT02777554|590485249|FG001|Overall Study|Other - Miscellaneous|0|||
163487216|NCT02777554|590485250|FG002|Overall Study|Other - Miscellaneous|0|||
163487217|NCT02777554|590485251|FG003|Overall Study|Other - Miscellaneous|0|||
163487218|NCT02777554|590485252|FG004|Overall Study|Other - Miscellaneous|0|||
163487219|NCT02777554|590485253|FG005|Overall Study|Other - Miscellaneous|0|||
163487220|NCT02147132|590485254|FG000|Overall Study|Lost to Follow-up|1|||
163487221|NCT02147132|590485255|FG001|Overall Study|Lost to Follow-up|0|||
163487222|NCT02147132|590485256|FG002|Overall Study|Lost to Follow-up|0|||
163487223|NCT02147132|590485257|FG003|Overall Study|Lost to Follow-up|0|||
163487224|NCT01013207|590485258|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
163487225|NCT01541644|590485263|FG000|Overall Study|Withdrawal by Subject|3|||
163487226|NCT01458535|590485266|FG000|Overall Study|Other|0|||
163487227|NCT01458535|590485267|FG001|Overall Study|Other|0|||
163487228|NCT01458535|590485268|FG002|Overall Study|Other|0|||
163487229|NCT01458535|590485269|FG003|Overall Study|Other|0|||
163487230|NCT01458535|590485270|FG004|Overall Study|Other|1|||
163487231|NCT01458535|590485271|FG005|Overall Study|Other|1|||
163487232|NCT01458535|590485266|FG000|Overall Study|Withdrawal by Subject|0|||
163487233|NCT01458535|590485267|FG001|Overall Study|Withdrawal by Subject|0|||
163487234|NCT01458535|590485268|FG002|Overall Study|Withdrawal by Subject|2|||
163487235|NCT01458535|590485269|FG003|Overall Study|Withdrawal by Subject|0|||
163487236|NCT01458535|590485270|FG004|Overall Study|Withdrawal by Subject|1|||
163487237|NCT01458535|590485271|FG005|Overall Study|Withdrawal by Subject|1|||
163487238|NCT01458535|590485266|FG000|Overall Study|Lost to Follow-up|0|||
163487239|NCT01458535|590485267|FG001|Overall Study|Lost to Follow-up|2|||
163487240|NCT01458535|590485268|FG002|Overall Study|Lost to Follow-up|0|||
163487241|NCT01458535|590485269|FG003|Overall Study|Lost to Follow-up|3|||
163487242|NCT01458535|590485270|FG004|Overall Study|Lost to Follow-up|2|||
163487243|NCT01458535|590485271|FG005|Overall Study|Lost to Follow-up|2|||
163487244|NCT01458535|590485266|FG000|Overall Study|Adverse Event|0|||
163487245|NCT01458535|590485267|FG001|Overall Study|Adverse Event|0|||
163487246|NCT01458535|590485268|FG002|Overall Study|Adverse Event|0|||
163487247|NCT01458535|590485269|FG003|Overall Study|Adverse Event|1|||
163487248|NCT01458535|590485270|FG004|Overall Study|Adverse Event|0|||
163487249|NCT01458535|590485271|FG005|Overall Study|Adverse Event|0|||
163487250|NCT00151775|590485272|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
163487251|NCT00151775|590485273|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
163487252|NCT00151775|590485274|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
163487253|NCT00151775|590485275|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
163487254|NCT00151775|590485276|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
163487255|NCT00151775|590485277|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
163487256|NCT00151775|590485278|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
163487257|NCT00151775|590485279|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
163487258|NCT00151775|590485280|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
163487259|NCT00151775|590485281|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
163487260|NCT00151775|590485282|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
163487261|NCT00151775|590485283|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
163487262|NCT00151775|590485272|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
163487263|NCT00151775|590485273|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
163487264|NCT00151775|590485274|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
163487265|NCT00151775|590485275|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
163487266|NCT00151775|590485276|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
163487267|NCT00151775|590485277|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
163487268|NCT00151775|590485278|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
163487269|NCT00151775|590485279|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
163487270|NCT00151775|590485280|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
163487271|NCT00151775|590485281|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
163487272|NCT00151775|590485282|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
163487273|NCT00151775|590485283|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
163487274|NCT00151775|590485272|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
163487275|NCT00151775|590485273|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
163487276|NCT00151775|590485274|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
163487277|NCT00151775|590485275|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
163487278|NCT00151775|590485276|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
163487279|NCT00151775|590485277|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
163487280|NCT00151775|590485278|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
163487281|NCT00151775|590485279|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
163487282|NCT00151775|590485280|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
163487283|NCT00151775|590485281|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
163487284|NCT00151775|590485282|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
163487285|NCT00151775|590485283|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
163487286|NCT00151775|590485272|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
163487287|NCT00151775|590485273|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
163487288|NCT00151775|590485274|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
163487289|NCT00151775|590485275|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
163487290|NCT00151775|590485276|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
163487291|NCT00151775|590485277|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
163487292|NCT00151775|590485278|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
163487293|NCT00151775|590485279|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
163487294|NCT00151775|590485280|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
163487295|NCT00151775|590485281|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
163487296|NCT00151775|590485282|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
163487297|NCT00151775|590485283|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
163487298|NCT00151775|590485272|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
163487299|NCT00151775|590485273|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
163487300|NCT00151775|590485274|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
163487301|NCT00151775|590485275|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
163487302|NCT00151775|590485276|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
163487303|NCT00151775|590485277|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
163487304|NCT00151775|590485278|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
163487305|NCT00151775|590485279|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
163487306|NCT00151775|590485280|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
163487307|NCT00151775|590485281|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
163487308|NCT00151775|590485282|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
163487309|NCT00151775|590485283|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
163487310|NCT00151775|590485272|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
163487311|NCT00151775|590485273|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
163487312|NCT00151775|590485274|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
163487313|NCT00151775|590485275|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
163487314|NCT00151775|590485276|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
163487315|NCT00151775|590485277|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
163487316|NCT00151775|590485278|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
163487317|NCT00151775|590485279|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
163487318|NCT00151775|590485280|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
163487319|NCT00151775|590485281|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
163487320|NCT00151775|590485282|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
163487321|NCT00151775|590485283|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
163487322|NCT00151775|590485272|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
163487323|NCT00151775|590485273|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
163487324|NCT00151775|590485274|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
163487325|NCT00151775|590485275|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
163487326|NCT00151775|590485276|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
163487327|NCT00151775|590485277|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
163487328|NCT00151775|590485278|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
163487329|NCT00151775|590485279|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
163487330|NCT00151775|590485280|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
163487331|NCT00151775|590485281|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
163487332|NCT00151775|590485282|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
163487333|NCT00151775|590485283|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
163487334|NCT00151775|590485272|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
163487335|NCT00151775|590485273|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
163487336|NCT00151775|590485274|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
163487337|NCT00151775|590485275|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
163487338|NCT00151775|590485276|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
163487339|NCT00151775|590485277|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
163487340|NCT00151775|590485278|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
163487341|NCT00151775|590485279|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
163487342|NCT00151775|590485280|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
163487343|NCT00151775|590485281|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
163487344|NCT00151775|590485282|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
163487345|NCT00151775|590485283|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
163487346|NCT00151775|590485272|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
163487347|NCT00151775|590485273|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
163487348|NCT00151775|590485274|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
163487349|NCT00151775|590485275|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
163487350|NCT00151775|590485276|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
163487351|NCT00151775|590485277|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
163487352|NCT00151775|590485278|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
163487353|NCT00151775|590485279|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
163487354|NCT00151775|590485280|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
163487355|NCT00151775|590485281|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
163487356|NCT00151775|590485282|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
163487357|NCT00151775|590485283|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
163487358|NCT00151775|590485272|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
163487359|NCT00151775|590485273|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
163487360|NCT00151775|590485274|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
163487361|NCT00151775|590485275|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
163487362|NCT00151775|590485276|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
163487363|NCT00151775|590485277|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
163487364|NCT00151775|590485278|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
163487365|NCT00151775|590485279|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
163487366|NCT00151775|590485280|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
163487367|NCT00151775|590485281|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
163487368|NCT00151775|590485282|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
163487369|NCT00151775|590485283|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
163487370|NCT00151775|590485272|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
163487371|NCT00151775|590485273|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
163487372|NCT00151775|590485274|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
163487373|NCT00151775|590485275|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
163487374|NCT00151775|590485276|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
163487375|NCT00151775|590485277|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
163487376|NCT00151775|590485278|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
163487377|NCT00151775|590485279|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
163487378|NCT00151775|590485280|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
163487379|NCT00151775|590485281|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
163487380|NCT00151775|590485282|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
163487381|NCT00151775|590485283|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
163487382|NCT00151775|590485272|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
163487383|NCT00151775|590485273|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
163487384|NCT00151775|590485274|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
163487385|NCT00151775|590485275|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
163487386|NCT00151775|590485276|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
163487387|NCT00151775|590485277|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
163487388|NCT00151775|590485278|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
163487389|NCT00151775|590485279|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
163487390|NCT00151775|590485280|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
163487391|NCT00151775|590485281|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
163487392|NCT00151775|590485282|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
163487393|NCT00151775|590485283|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
163487394|NCT00151775|590485272|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
163487395|NCT00151775|590485273|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
163487396|NCT00151775|590485274|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
163487397|NCT00151775|590485275|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
162925433|NCT01346501|588428971|FG000|Overall Study|Initiated Other Biological Agents|3|||
163487398|NCT00151775|590485276|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
163487399|NCT00151775|590485277|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
163487400|NCT00151775|590485278|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
163487401|NCT00151775|590485279|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
163487402|NCT00151775|590485280|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
163487403|NCT00151775|590485281|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
163487404|NCT00151775|590485282|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
163487405|NCT00151775|590485283|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
163487406|NCT00151775|590485272|FG000|Period 4: Open Label|Increased blood pressure|0|||
163487407|NCT00151775|590485273|FG001|Period 4: Open Label|Increased blood pressure|0|||
163487408|NCT00151775|590485274|FG002|Period 4: Open Label|Increased blood pressure|0|||
163487409|NCT00151775|590485275|FG003|Period 4: Open Label|Increased blood pressure|0|||
163487410|NCT00151775|590485276|FG004|Period 4: Open Label|Increased blood pressure|1|||
163487411|NCT00151775|590485277|FG005|Period 4: Open Label|Increased blood pressure|0|||
163487412|NCT00151775|590485278|FG006|Period 4: Open Label|Increased blood pressure|0|||
163487413|NCT00151775|590485279|FG007|Period 4: Open Label|Increased blood pressure|0|||
163487414|NCT00151775|590485280|FG008|Period 4: Open Label|Increased blood pressure|0|||
163487415|NCT00151775|590485281|FG009|Period 4: Open Label|Increased blood pressure|1|||
163487416|NCT00151775|590485282|FG010|Period 4: Open Label|Increased blood pressure|0|||
163487417|NCT00151775|590485283|FG011|Period 4: Open Label|Increased blood pressure|0|||
163487418|NCT00151775|590485272|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
163487419|NCT00151775|590485273|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
163487420|NCT00151775|590485274|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
163487421|NCT00151775|590485275|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
163487422|NCT00151775|590485276|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
163487423|NCT00151775|590485277|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
163487424|NCT00151775|590485278|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
163487425|NCT00151775|590485279|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
163487426|NCT00151775|590485280|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
163487427|NCT00151775|590485281|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
163487428|NCT00151775|590485282|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
163487429|NCT00151775|590485283|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
163487430|NCT00151775|590485272|FG000|Period 4: Open Label|Adverse Event|0|||
163487431|NCT00151775|590485273|FG001|Period 4: Open Label|Adverse Event|0|||
163487432|NCT00151775|590485274|FG002|Period 4: Open Label|Adverse Event|0|||
163487433|NCT00151775|590485275|FG003|Period 4: Open Label|Adverse Event|0|||
163487434|NCT00151775|590485276|FG004|Period 4: Open Label|Adverse Event|1|||
163487435|NCT00151775|590485277|FG005|Period 4: Open Label|Adverse Event|0|||
163487436|NCT00151775|590485278|FG006|Period 4: Open Label|Adverse Event|0|||
163487437|NCT00151775|590485279|FG007|Period 4: Open Label|Adverse Event|0|||
163487438|NCT00151775|590485280|FG008|Period 4: Open Label|Adverse Event|0|||
163487439|NCT00151775|590485281|FG009|Period 4: Open Label|Adverse Event|2|||
163487440|NCT00151775|590485282|FG010|Period 4: Open Label|Adverse Event|0|||
163487441|NCT00151775|590485283|FG011|Period 4: Open Label|Adverse Event|0|||
163487442|NCT00151775|590485272|FG000|Period 4: Open Label|Lost to Follow-up|0|||
163487443|NCT00151775|590485273|FG001|Period 4: Open Label|Lost to Follow-up|0|||
163487444|NCT00151775|590485274|FG002|Period 4: Open Label|Lost to Follow-up|0|||
163487445|NCT00151775|590485275|FG003|Period 4: Open Label|Lost to Follow-up|0|||
163487446|NCT00151775|590485276|FG004|Period 4: Open Label|Lost to Follow-up|17|||
163487447|NCT00151775|590485277|FG005|Period 4: Open Label|Lost to Follow-up|0|||
163487448|NCT00151775|590485278|FG006|Period 4: Open Label|Lost to Follow-up|0|||
163487449|NCT00151775|590485279|FG007|Period 4: Open Label|Lost to Follow-up|0|||
163487450|NCT00151775|590485280|FG008|Period 4: Open Label|Lost to Follow-up|0|||
163487451|NCT00151775|590485281|FG009|Period 4: Open Label|Lost to Follow-up|7|||
163487452|NCT00151775|590485282|FG010|Period 4: Open Label|Lost to Follow-up|0|||
163487453|NCT00151775|590485283|FG011|Period 4: Open Label|Lost to Follow-up|0|||
163487454|NCT00151775|590485272|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
163487455|NCT00151775|590485273|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
163487456|NCT00151775|590485274|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
163487457|NCT00151775|590485275|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
163487458|NCT00151775|590485276|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
163487459|NCT00151775|590485277|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
163487460|NCT00151775|590485278|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
163487461|NCT00151775|590485279|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
163487462|NCT00151775|590485280|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
163487463|NCT00151775|590485281|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
163487464|NCT00151775|590485282|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
163487465|NCT00151775|590485283|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
163487466|NCT00151775|590485272|FG000|Period 4: Open Label|Other|0|||
163487467|NCT00151775|590485273|FG001|Period 4: Open Label|Other|0|||
163487468|NCT00151775|590485274|FG002|Period 4: Open Label|Other|0|||
163487469|NCT00151775|590485275|FG003|Period 4: Open Label|Other|0|||
163487470|NCT00151775|590485276|FG004|Period 4: Open Label|Other|1|||
163487471|NCT00151775|590485277|FG005|Period 4: Open Label|Other|0|||
163487472|NCT00151775|590485278|FG006|Period 4: Open Label|Other|0|||
163487473|NCT00151775|590485279|FG007|Period 4: Open Label|Other|0|||
163487474|NCT00151775|590485280|FG008|Period 4: Open Label|Other|0|||
163487475|NCT00151775|590485281|FG009|Period 4: Open Label|Other|3|||
163487476|NCT00151775|590485282|FG010|Period 4: Open Label|Other|0|||
163487477|NCT00151775|590485283|FG011|Period 4: Open Label|Other|0|||
163487478|NCT00151775|590485272|FG000|Period 4: Open Label|Physician Decision|0|||
163487479|NCT00151775|590485273|FG001|Period 4: Open Label|Physician Decision|0|||
163487480|NCT00151775|590485274|FG002|Period 4: Open Label|Physician Decision|0|||
163487481|NCT00151775|590485275|FG003|Period 4: Open Label|Physician Decision|0|||
163487482|NCT00151775|590485276|FG004|Period 4: Open Label|Physician Decision|0|||
163487483|NCT00151775|590485277|FG005|Period 4: Open Label|Physician Decision|0|||
163487484|NCT00151775|590485278|FG006|Period 4: Open Label|Physician Decision|0|||
163487485|NCT00151775|590485279|FG007|Period 4: Open Label|Physician Decision|0|||
163487486|NCT00151775|590485280|FG008|Period 4: Open Label|Physician Decision|0|||
163487487|NCT00151775|590485281|FG009|Period 4: Open Label|Physician Decision|2|||
163487488|NCT00151775|590485282|FG010|Period 4: Open Label|Physician Decision|0|||
163487489|NCT00151775|590485283|FG011|Period 4: Open Label|Physician Decision|0|||
163487490|NCT00151775|590485272|FG000|Period 4: Open Label|Protocol Violation|0|||
163487491|NCT00151775|590485273|FG001|Period 4: Open Label|Protocol Violation|0|||
163487492|NCT00151775|590485274|FG002|Period 4: Open Label|Protocol Violation|0|||
163487493|NCT00151775|590485275|FG003|Period 4: Open Label|Protocol Violation|0|||
163487494|NCT00151775|590485276|FG004|Period 4: Open Label|Protocol Violation|1|||
163487495|NCT00151775|590485277|FG005|Period 4: Open Label|Protocol Violation|0|||
163487496|NCT00151775|590485278|FG006|Period 4: Open Label|Protocol Violation|0|||
163487497|NCT00151775|590485279|FG007|Period 4: Open Label|Protocol Violation|0|||
163487498|NCT00151775|590485280|FG008|Period 4: Open Label|Protocol Violation|0|||
163487499|NCT00151775|590485281|FG009|Period 4: Open Label|Protocol Violation|0|||
163487500|NCT00151775|590485282|FG010|Period 4: Open Label|Protocol Violation|0|||
163487501|NCT00151775|590485283|FG011|Period 4: Open Label|Protocol Violation|0|||
163487502|NCT00474994|590485284|FG000|Overall Study|Patient Not treated|1|||
163487503|NCT00474994|590485284|FG000|Overall Study|Patient evaluable for toxicity only|3|||
163487504|NCT00474994|590485284|FG000|Overall Study|Patient found to be ineligible|1|||
163487505|NCT05064436|590485288|FG000|Overall Study|Other Reasons|1|||
163487506|NCT05064436|590485289|FG001|Overall Study|Other Reasons|0|||
163487507|NCT01711736|590485290|FG000|Overall Study|Lost to Follow-up|4|||
163487508|NCT01711736|590485291|FG001|Overall Study|Lost to Follow-up|1|||
163487509|NCT01711736|590485290|FG000|Overall Study|Withdrawal by Subject|6|||
163487510|NCT01711736|590485291|FG001|Overall Study|Withdrawal by Subject|6|||
163487511|NCT01711736|590485290|FG000|Overall Study|Migrated/moved from study area|2|||
163487512|NCT01711736|590485291|FG001|Overall Study|Migrated/moved from study area|1|||
163487513|NCT02706327|590485292|FG000|Overall Study|Lost to Follow-up|1|||
163487514|NCT02706327|590485293|FG001|Overall Study|Lost to Follow-up|1|||
163487515|NCT02706327|590485294|FG002|Overall Study|Lost to Follow-up|2|||
163487516|NCT04579666|590485295|FG000|RTP (Up to Week 52)|Adverse Event|4|||
163487517|NCT04579666|590485296|FG001|RTP (Up to Week 52)|Adverse Event|3|||
163487518|NCT04579666|590485297|FG002|RTP (Up to Week 52)|Adverse Event|0|||
163487519|NCT04579666|590485298|FG003|RTP (Up to Week 52)|Adverse Event|0|||
163487520|NCT04579666|590485295|FG000|RTP (Up to Week 52)|Death|24|||
163487521|NCT04579666|590485296|FG001|RTP (Up to Week 52)|Death|9|||
163487522|NCT04579666|590485297|FG002|RTP (Up to Week 52)|Death|0|||
163487523|NCT04579666|590485298|FG003|RTP (Up to Week 52)|Death|0|||
163487524|NCT04579666|590485295|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
163487525|NCT04579666|590485296|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
163487526|NCT04579666|590485297|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
163487527|NCT04579666|590485298|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
163487528|NCT04579666|590485295|FG000|RTP (Up to Week 52)|Physician Decision|4|||
163487529|NCT04579666|590485296|FG001|RTP (Up to Week 52)|Physician Decision|1|||
163487530|NCT04579666|590485297|FG002|RTP (Up to Week 52)|Physician Decision|0|||
163487531|NCT04579666|590485298|FG003|RTP (Up to Week 52)|Physician Decision|0|||
163487532|NCT04579666|590485295|FG000|RTP (Up to Week 52)|Progressive disease|1|||
163487533|NCT04579666|590485296|FG001|RTP (Up to Week 52)|Progressive disease|0|||
163487534|NCT04579666|590485297|FG002|RTP (Up to Week 52)|Progressive disease|0|||
163487535|NCT04579666|590485298|FG003|RTP (Up to Week 52)|Progressive disease|0|||
163487536|NCT04579666|590485295|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
163487537|NCT04579666|590485296|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
163487538|NCT04579666|590485297|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
163487539|NCT04579666|590485298|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
163487540|NCT04579666|590485295|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
163487541|NCT04579666|590485296|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
163487542|NCT04579666|590485297|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
163487543|NCT04579666|590485298|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
163487544|NCT04579666|590485295|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
163487545|NCT04579666|590485296|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
163487546|NCT04579666|590485297|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
163487547|NCT04579666|590485298|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
163487548|NCT04579666|590485295|FG000|RTP (Up to Week 52)|Other|2|||
163487549|NCT04579666|590485296|FG001|RTP (Up to Week 52)|Other|0|||
163487550|NCT04579666|590485297|FG002|RTP (Up to Week 52)|Other|0|||
163487551|NCT04579666|590485298|FG003|RTP (Up to Week 52)|Other|0|||
163487552|NCT04579666|590485295|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
163487553|NCT04579666|590485296|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
163487554|NCT04579666|590485297|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
163487555|NCT04579666|590485298|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
163487556|NCT04579666|590485295|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
163487557|NCT04579666|590485296|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
163487558|NCT04579666|590485297|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
163487559|NCT04579666|590485298|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
163487560|NCT04579666|590485295|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
163487561|NCT04579666|590485296|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
163487562|NCT04579666|590485297|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
163487563|NCT04579666|590485298|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
163487564|NCT04579666|590485295|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
163487565|NCT04579666|590485296|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
163487566|NCT04579666|590485297|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
163487567|NCT04579666|590485298|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
163487568|NCT04579666|590485295|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
163487569|NCT04579666|590485296|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
163487570|NCT04579666|590485297|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
163487571|NCT04579666|590485298|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
163487572|NCT05450198|590485299|FG000|Overall Study|Withdrawal by Subject|1|||
163487573|NCT05450198|590485300|FG001|Overall Study|Withdrawal by Subject|1|||
163487574|NCT05450198|590485301|FG002|Overall Study|Withdrawal by Subject|2|||
163487575|NCT05450198|590485302|FG003|Overall Study|Withdrawal by Subject|0|||
163487576|NCT05450198|590485299|FG000|Overall Study|Lost to Follow-up|1|||
163487577|NCT05450198|590485300|FG001|Overall Study|Lost to Follow-up|0|||
163487578|NCT05450198|590485301|FG002|Overall Study|Lost to Follow-up|2|||
163487579|NCT05450198|590485302|FG003|Overall Study|Lost to Follow-up|1|||
163487580|NCT04511533|590485303|FG000|Treatment|Other|2|||
163487581|NCT04511533|590485303|FG000|Treatment|Withdrawal by Subject|11|||
163487582|NCT04511533|590485303|FG000|Treatment|Death|5|||
163487583|NCT04511533|590485303|FG000|Treatment|Physician Decision|1|||
163487584|NCT04511533|590485303|FG000|Treatment|Progressive Disease|61|||
163487585|NCT04511533|590485303|FG000|Follow-Up|Other|7|||
163487586|NCT04511533|590485303|FG000|Follow-Up|Withdrawal by Subject|5|||
163487587|NCT04511533|590485303|FG000|Follow-Up|Lost to Follow-up|2|||
163487588|NCT04511533|590485303|FG000|Follow-Up|Death|4|||
163487589|NCT01982942|590485304|FG000|Overall Study|Adverse Event|10|||
163487590|NCT01982942|590485305|FG001|Overall Study|Adverse Event|5|||
163487591|NCT01982942|590485304|FG000|Overall Study|Lost to Follow-up|4|||
163487592|NCT01982942|590485305|FG001|Overall Study|Lost to Follow-up|3|||
163487593|NCT01982942|590485304|FG000|Overall Study|Multiple sclerosis progression|3|||
163487594|NCT01982942|590485305|FG001|Overall Study|Multiple sclerosis progression|2|||
163487595|NCT01982942|590485304|FG000|Overall Study|Wanted to try therapy not permitted|1|||
163487596|NCT01982942|590485305|FG001|Overall Study|Wanted to try therapy not permitted|0|||
163487597|NCT01982942|590485304|FG000|Overall Study|Subject declined future visits|0|||
163487598|NCT01982942|590485305|FG001|Overall Study|Subject declined future visits|1|||
163487599|NCT01982942|590485304|FG000|Overall Study|Left geographical area|2|||
163487600|NCT01982942|590485305|FG001|Overall Study|Left geographical area|0|||
163487601|NCT01982942|590485304|FG000|Overall Study|Too many pills|1|||
163487602|NCT01982942|590485305|FG001|Overall Study|Too many pills|0|||
163487603|NCT01982942|590485304|FG000|Overall Study|MS Relapse|0|||
163487604|NCT01982942|590485305|FG001|Overall Study|MS Relapse|1|||
163487605|NCT01982942|590485304|FG000|Overall Study|Chose to join a stem cell trial|0|||
163487606|NCT01982942|590485305|FG001|Overall Study|Chose to join a stem cell trial|1|||
163487607|NCT01982942|590485304|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
163487608|NCT01982942|590485305|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
163487609|NCT01224171|590485306|FG000|Overall Study|Adverse Event|8|||
163487610|NCT01224171|590485307|FG001|Overall Study|Adverse Event|4|||
163487611|NCT01224171|590485306|FG000|Overall Study|Protocol Violation|0|||
163487612|NCT01224171|590485307|FG001|Overall Study|Protocol Violation|1|||
163487613|NCT01224171|590485306|FG000|Overall Study|Lack of Efficacy|5|||
163487614|NCT01224171|590485307|FG001|Overall Study|Lack of Efficacy|1|||
163487615|NCT01224171|590485306|FG000|Overall Study|Withdrawal of Consent|2|||
163487616|NCT01224171|590485307|FG001|Overall Study|Withdrawal of Consent|4|||
163487617|NCT01224171|590485306|FG000|Overall Study|Lost to Follow-up|0|||
163487618|NCT01224171|590485307|FG001|Overall Study|Lost to Follow-up|3|||
163487619|NCT01097057|590485308|FG000|Overall Study|Physician Decision|3|||
163487620|NCT01270139|590485311|FG000|Overall Study|Adverse Event|8|||
163487621|NCT01270139|590485312|FG001|Overall Study|Adverse Event|17|||
163487622|NCT01270139|590485313|FG002|Overall Study|Adverse Event|18|||
163487623|NCT01270139|590485311|FG000|Overall Study|Lost to Follow-up|10|||
163487624|NCT01270139|590485312|FG001|Overall Study|Lost to Follow-up|9|||
163487625|NCT01270139|590485313|FG002|Overall Study|Lost to Follow-up|2|||
163487626|NCT01161173|590485319|FG000|Overall Study|Protocol Violation|13|||
163487627|NCT01161173|590485319|FG000|Overall Study|Lost to Follow-up|7|||
163487628|NCT01161173|590485319|FG000|Overall Study|Progressive Disease|82|||
163487629|NCT01161173|590485319|FG000|Overall Study|Withdrawal of Consent|5|||
163487630|NCT01161173|590485319|FG000|Overall Study|Unacceptable Toxicity|21|||
163487631|NCT01161173|590485319|FG000|Overall Study|Death|194|||
163487632|NCT01161173|590485319|FG000|Overall Study|End of Study|2|||
163487633|NCT01161173|590485319|FG000|Overall Study|Reasons Not Specified|23|||
163487634|NCT01911546|590485320|FG000|Overall Study|Lost to Follow-up|1|||
163487635|NCT01911546|590485320|FG000|Overall Study|Everolimus was discontinued|5|||
163487636|NCT02213666|590485322|FG000|Overall Study|Withdrawal by Subject|1|||
163487637|NCT01319422|590485323|FG000|Overall Study|Withdrawal by Subject|1|||
163487638|NCT01319422|590485324|FG001|Overall Study|Withdrawal by Subject|0|||
163487639|NCT02918968|590485325|FG000|1st Line AAT|Progressive disease|9|||
163487640|NCT02918968|590485326|FG001|1st Line AAT|Progressive disease|4|||
163487641|NCT02918968|590485325|FG000|1st Line AAT|Adverse Event|12|||
163487642|NCT02918968|590485326|FG001|1st Line AAT|Adverse Event|3|||
163487643|NCT02918968|590485325|FG000|1st Line AAT|Physician Decision|4|||
163487644|NCT02918968|590485326|FG001|1st Line AAT|Physician Decision|2|||
163487645|NCT02918968|590485325|FG000|1st Line AAT|Withdrawal by Subject|2|||
163487646|NCT02918968|590485326|FG001|1st Line AAT|Withdrawal by Subject|1|||
163487647|NCT02918968|590485325|FG000|1st Line AAT|Lost to Follow-up|0|||
163487648|NCT02918968|590485326|FG001|1st Line AAT|Lost to Follow-up|1|||
163487649|NCT02918968|590485325|FG000|1st Line AAT|Death|1|||
163487650|NCT02918968|590485326|FG001|1st Line AAT|Death|0|||
163487651|NCT02918968|590485325|FG000|1st Line AAT|Miscellaneous|1|||
163487652|NCT02918968|590485326|FG001|1st Line AAT|Miscellaneous|0|||
163487653|NCT02918968|590485325|FG000|2nd Line AAT|Progressive disease|21|||
163487654|NCT02918968|590485326|FG001|2nd Line AAT|Progressive disease|3|||
163487655|NCT02918968|590485325|FG000|2nd Line AAT|Adverse Event|2|||
163487656|NCT02918968|590485326|FG001|2nd Line AAT|Adverse Event|5|||
163487657|NCT02918968|590485325|FG000|2nd Line AAT|Physician Decision|0|||
163487658|NCT02918968|590485326|FG001|2nd Line AAT|Physician Decision|1|||
163487659|NCT02918968|590485325|FG000|2nd Line AAT|Withdrawal by Subject|2|||
163487660|NCT02918968|590485326|FG001|2nd Line AAT|Withdrawal by Subject|2|||
163487661|NCT02918968|590485325|FG000|2nd Line AAT|Death|0|||
163487662|NCT02918968|590485326|FG001|2nd Line AAT|Death|1|||
163487663|NCT00750061|590485327|FG000|Overall Study|Adverse Event|2|||
163487664|NCT00750061|590485328|FG001|Overall Study|Adverse Event|0|||
163487665|NCT00750061|590485327|FG000|Overall Study|Withdrawal by Subject|0|||
163487666|NCT00750061|590485328|FG001|Overall Study|Withdrawal by Subject|1|||
163487667|NCT00750061|590485327|FG000|Overall Study|Physician Decision|0|||
163487668|NCT00750061|590485328|FG001|Overall Study|Physician Decision|1|||
163487669|NCT01243762|590485331|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
163487670|NCT01243762|590485332|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
163487671|NCT01243762|590485333|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
163487672|NCT01243762|590485334|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
163487673|NCT01243762|590485335|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
163487674|NCT01243762|590485336|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
163487675|NCT01243762|590485337|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
163487676|NCT01243762|590485331|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
163487677|NCT01243762|590485332|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
163487678|NCT01243762|590485333|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
163487679|NCT01243762|590485334|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
163487680|NCT01243762|590485335|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
163487681|NCT01243762|590485336|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
163487682|NCT01243762|590485337|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
163487683|NCT01243762|590485331|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
163487684|NCT01243762|590485332|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
163487685|NCT01243762|590485333|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
163487686|NCT01243762|590485334|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
163487687|NCT01243762|590485335|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
163487688|NCT01243762|590485336|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
163487689|NCT01243762|590485337|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
163487690|NCT01243762|590485331|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
163487691|NCT01243762|590485332|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
163487692|NCT01243762|590485333|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
163487693|NCT01243762|590485334|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
163487694|NCT01243762|590485335|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
163487695|NCT01243762|590485336|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
163487696|NCT01243762|590485337|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
163487697|NCT01243762|590485331|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
163487698|NCT01243762|590485332|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
163487699|NCT01243762|590485333|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
163487700|NCT01243762|590485334|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
163487701|NCT01243762|590485335|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
163487702|NCT01243762|590485336|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
163487703|NCT01243762|590485337|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
163487704|NCT01243762|590485331|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
163487705|NCT01243762|590485332|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
163487706|NCT01243762|590485333|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
163487707|NCT01243762|590485334|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
163487708|NCT01243762|590485335|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
163487709|NCT01243762|590485336|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
163487710|NCT01243762|590485337|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
163487711|NCT01243762|590485331|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
163487712|NCT01243762|590485332|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
163487713|NCT01243762|590485333|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
163487714|NCT01243762|590485334|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
163487715|NCT01243762|590485335|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
163487716|NCT01243762|590485336|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
163487717|NCT01243762|590485337|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
163487718|NCT01243762|590485331|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
163487719|NCT01243762|590485332|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
163487720|NCT01243762|590485333|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
163487721|NCT01243762|590485334|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
163487722|NCT01243762|590485335|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
163487723|NCT01243762|590485336|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
163487724|NCT01243762|590485337|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
163487725|NCT01374516|590485338|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
163487726|NCT01374516|590485339|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
163487727|NCT01374516|590485338|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
163487728|NCT01374516|590485339|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
163487729|NCT01374516|590485338|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
163487730|NCT01374516|590485339|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
163487731|NCT01374516|590485338|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
163487732|NCT01374516|590485339|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
163487733|NCT01374516|590485338|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
163487734|NCT01374516|590485339|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
163487735|NCT01374516|590485338|FG000|Surveillance Expansion Period|Protocol Violation|386|||
163487736|NCT01374516|590485339|FG001|Surveillance Expansion Period|Protocol Violation|217|||
163487737|NCT01374516|590485338|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
163487738|NCT01374516|590485339|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
163487739|NCT01374516|590485338|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
163487740|NCT01374516|590485339|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
163487741|NCT01374516|590485338|FG000|Surveillance Expansion Period|Serious adverse event|20|||
163487742|NCT01374516|590485339|FG001|Surveillance Expansion Period|Serious adverse event|5|||
163487743|NCT04629534|590485340|FG000|Overall Study|Physician Decision|1|||
163487744|NCT04629534|590485341|FG001|Overall Study|Physician Decision|0|||
163487745|NCT04629534|590485340|FG000|Overall Study|Protocol Violation|0|||
163487746|NCT04629534|590485341|FG001|Overall Study|Protocol Violation|2|||
163487747|NCT03732534|590485342|FG000|Overall Study|Study terminated by Sponsor|6|||
163487748|NCT02190604|590485343|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487749|NCT02190604|590485344|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487750|NCT02190604|590485345|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487751|NCT02190604|590485346|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487752|NCT02190604|590485347|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487753|NCT02190604|590485348|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487754|NCT02190604|590485349|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487755|NCT02190604|590485350|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487756|NCT02190604|590485351|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487757|NCT02190604|590485352|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487758|NCT02190604|590485353|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487759|NCT02190604|590485354|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487760|NCT02190604|590485355|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487761|NCT02190604|590485356|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487762|NCT02190604|590485357|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
163487763|NCT02190604|590485358|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487764|NCT02190604|590485359|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487765|NCT02190604|590485360|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487766|NCT02190604|590485361|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
163487767|NCT02190604|590485343|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487768|NCT02190604|590485344|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487769|NCT02190604|590485345|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487770|NCT02190604|590485346|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487771|NCT02190604|590485347|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487772|NCT02190604|590485348|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487773|NCT02190604|590485349|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487774|NCT02190604|590485350|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487775|NCT02190604|590485351|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487776|NCT02190604|590485352|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487777|NCT02190604|590485353|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487778|NCT02190604|590485354|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487779|NCT02190604|590485355|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487780|NCT02190604|590485356|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
163487781|NCT02190604|590485357|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487782|NCT02190604|590485358|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487783|NCT02190604|590485359|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487784|NCT02190604|590485360|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487785|NCT02190604|590485361|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
163487786|NCT02797951|590485362|FG000|Overall Study|Adverse Event|4|||
163487787|NCT02797951|590485362|FG000|Overall Study|Death|1|||
163487788|NCT02797951|590485362|FG000|Overall Study|Lack of Efficacy|19|||
163487789|NCT02797951|590485362|FG000|Overall Study|Lost to Follow-up|4|||
163487790|NCT02797951|590485362|FG000|Overall Study|Physician Decision|6|||
163487791|NCT02797951|590485362|FG000|Overall Study|Withdrawal by Subject|15|||
163487792|NCT01901393|590485363|FG000|Overall Study|Adverse Event|1|||
163487793|NCT01901393|590485364|FG001|Overall Study|Adverse Event|0|||
163487794|NCT04585906|590485365|FG000|Overall Study|Lost to Follow-up|8|||
163487795|NCT04585906|590485366|FG001|Overall Study|Lost to Follow-up|5|||
163487796|NCT03125382|590485367|FG000|Randomization|screening failure|1|||
163487797|NCT03125382|590485368|FG001|Randomization|screening failure|4|||
163487798|NCT03125382|590485369|FG002|Randomization|screening failure|2|||
163487799|NCT03125382|590485370|FG003|Randomization|screening failure|0|||
163487800|NCT03125382|590485367|FG000|Follow-up|Death|1|||
163487801|NCT03125382|590485368|FG001|Follow-up|Death|2|||
163487802|NCT03125382|590485369|FG002|Follow-up|Death|1|||
163487803|NCT03125382|590485370|FG003|Follow-up|Death|2|||
163487804|NCT03125382|590485367|FG000|Follow-up|Lost to Follow-up|1|||
163487805|NCT03125382|590485368|FG001|Follow-up|Lost to Follow-up|4|||
163487806|NCT03125382|590485369|FG002|Follow-up|Lost to Follow-up|3|||
163487807|NCT03125382|590485370|FG003|Follow-up|Lost to Follow-up|1|||
163487808|NCT04626947|590485371|FG000|Overall Study|Study terminated|14|||
163487809|NCT01428882|590485380|FG000|Overall Study|Lack of Efficacy|2|||
163487810|NCT01428882|590485381|FG001|Overall Study|Lack of Efficacy|7|||
163487811|NCT01428882|590485380|FG000|Overall Study|Protocol Violation|4|||
163487812|NCT01428882|590485381|FG001|Overall Study|Protocol Violation|3|||
163487813|NCT03907072|590485382|FG000|Overall Study|Study Terminated by Sponsor|2|||
163487814|NCT03907072|590485383|FG001|Overall Study|Study Terminated by Sponsor|2|||
163487815|NCT03907072|590485384|FG002|Overall Study|Study Terminated by Sponsor|2|||
163487816|NCT00612456|590485385|FG000|Overall Study|Adverse Event|1|||
163487817|NCT00612456|590485386|FG001|Overall Study|Adverse Event|0|||
163487818|NCT00612456|590485387|FG002|Overall Study|Adverse Event|0|||
163487819|NCT00612456|590485385|FG000|Overall Study|Lack of Efficacy|1|||
163487820|NCT00612456|590485386|FG001|Overall Study|Lack of Efficacy|1|||
163487821|NCT00612456|590485387|FG002|Overall Study|Lack of Efficacy|0|||
163487822|NCT00612456|590485385|FG000|Overall Study|Withdrawal by Subject|0|||
163487823|NCT00612456|590485386|FG001|Overall Study|Withdrawal by Subject|1|||
163487824|NCT00612456|590485387|FG002|Overall Study|Withdrawal by Subject|0|||
163487825|NCT00265109|590485388|FG000|Overall Study|Withdrawal by Subject|5|||
163487826|NCT00265109|590485388|FG000|Overall Study|Adverse Event|1|||
163487827|NCT02463097|590485389|FG000|Overall Study|Withdrawal by Subject|1|||
163487828|NCT03831282|590485390|FG000|Overall Study|Could not place sensor|1|||
163487829|NCT03556202|590485394|FG000|Extension Treatment Period|Adverse Event|18|||
163487830|NCT03556202|590485395|FG001|Extension Treatment Period|Adverse Event|14|||
163487831|NCT03556202|590485396|FG002|Extension Treatment Period|Adverse Event|9|||
163487832|NCT03556202|590485394|FG000|Extension Treatment Period|Death|2|||
163487833|NCT03556202|590485395|FG001|Extension Treatment Period|Death|6|||
163487834|NCT03556202|590485396|FG002|Extension Treatment Period|Death|0|||
163487835|NCT03556202|590485394|FG000|Extension Treatment Period|Lack of Efficacy|5|||
163487836|NCT03556202|590485395|FG001|Extension Treatment Period|Lack of Efficacy|12|||
163487837|NCT03556202|590485396|FG002|Extension Treatment Period|Lack of Efficacy|18|||
163487838|NCT03556202|590485394|FG000|Extension Treatment Period|Lost to Follow-up|9|||
163487839|NCT03556202|590485395|FG001|Extension Treatment Period|Lost to Follow-up|20|||
163487840|NCT03556202|590485396|FG002|Extension Treatment Period|Lost to Follow-up|2|||
163487841|NCT03556202|590485394|FG000|Extension Treatment Period|Pregnancy|2|||
163487842|NCT03556202|590485395|FG001|Extension Treatment Period|Pregnancy|4|||
163487843|NCT03556202|590485396|FG002|Extension Treatment Period|Pregnancy|3|||
163487844|NCT03556202|590485394|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
163487845|NCT03556202|590485395|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
163487846|NCT03556202|590485396|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
163487847|NCT03556202|590485394|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
163487848|NCT03556202|590485395|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
163487849|NCT03556202|590485396|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
163487850|NCT03556202|590485394|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
163487851|NCT03556202|590485395|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
163487852|NCT03556202|590485396|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
163487853|NCT03556202|590485394|FG000|Extension Treatment Period|Physician Decision|0|||
163487854|NCT03556202|590485395|FG001|Extension Treatment Period|Physician Decision|8|||
163487855|NCT03556202|590485396|FG002|Extension Treatment Period|Physician Decision|2|||
163487856|NCT03556202|590485394|FG000|Extension Treatment Period|Protocol Violation|0|||
163487857|NCT03556202|590485395|FG001|Extension Treatment Period|Protocol Violation|1|||
163487858|NCT03556202|590485396|FG002|Extension Treatment Period|Protocol Violation|1|||
163487859|NCT03556202|590485394|FG000|Extension Treatment Period|Sponsor Decision|0|||
163487860|NCT03556202|590485395|FG001|Extension Treatment Period|Sponsor Decision|1|||
163487861|NCT03556202|590485396|FG002|Extension Treatment Period|Sponsor Decision|0|||
163487862|NCT03556202|590485394|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
163487863|NCT03556202|590485395|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
163487864|NCT03556202|590485396|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
163487865|NCT03556202|590485394|FG000|Follow-Up Period (12 Weeks)|Death|1|||
163487866|NCT03556202|590485395|FG001|Follow-Up Period (12 Weeks)|Death|0|||
163487867|NCT03556202|590485396|FG002|Follow-Up Period (12 Weeks)|Death|0|||
163487868|NCT03556202|590485394|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
163487869|NCT03556202|590485395|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
163487870|NCT03556202|590485396|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
163487871|NCT03556202|590485394|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
163487872|NCT03556202|590485395|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
163487873|NCT03556202|590485396|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
163487874|NCT03556202|590485394|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
163487875|NCT03556202|590485395|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
163487876|NCT03556202|590485396|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
163487877|NCT03556202|590485394|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
163487878|NCT03556202|590485395|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
163487879|NCT03556202|590485396|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
163487880|NCT03556202|590485394|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
163487881|NCT03556202|590485395|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
163487882|NCT03556202|590485396|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
163487883|NCT03556202|590485394|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
163487884|NCT03556202|590485395|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
163487885|NCT03556202|590485396|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
163487886|NCT03556202|590485394|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
163487887|NCT03556202|590485395|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
163487888|NCT03556202|590485396|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
163487889|NCT03556202|590485394|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
163487890|NCT03556202|590485395|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
163487891|NCT03556202|590485396|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
163487892|NCT03556202|590485394|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
163487893|NCT03556202|590485395|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
163487894|NCT03556202|590485396|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
163487895|NCT03556202|590485394|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
163487896|NCT03556202|590485395|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
163487897|NCT03556202|590485396|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
163487898|NCT03556202|590485394|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
163487899|NCT03556202|590485395|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
163487900|NCT03556202|590485396|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
163487901|NCT03556202|590485394|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
163487902|NCT03556202|590485395|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
163487903|NCT03556202|590485396|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
163487904|NCT00697255|590485399|FG000|Stage 1a|Insufficient ovarian response|1|||
163487905|NCT00697255|590485400|FG001|Stage 1a|Insufficient ovarian response|0|||
163487906|NCT00697255|590485399|FG000|Stage 1a|Multifollicular growth|1|||
163487907|NCT00697255|590485400|FG001|Stage 1a|Multifollicular growth|0|||
163487908|NCT00697255|590485399|FG000|Stage 1a|Not growing of dominant follicle|1|||
163487909|NCT00697255|590485400|FG001|Stage 1a|Not growing of dominant follicle|0|||
163487910|NCT00697255|590485399|FG000|Stage 1b|Not growing of dominant follicle|0|||
163487911|NCT00697255|590485400|FG001|Stage 1b|Not growing of dominant follicle|1|||
163487912|NCT00697255|590485399|FG000|Stage 1b|Insufficient ovarian response|0|||
163487913|NCT00697255|590485400|FG001|Stage 1b|Insufficient ovarian response|1|||
163487914|NCT05664672|590485401|FG000|Overall Study|Adverse Event|0|||
163487915|NCT05664672|590485402|FG001|Overall Study|Adverse Event|0|||
163487916|NCT05664672|590485403|FG002|Overall Study|Adverse Event|0|||
163487917|NCT05664672|590485404|FG003|Overall Study|Adverse Event|0|||
163487918|NCT05664672|590485405|FG004|Overall Study|Adverse Event|0|||
163487919|NCT05664672|590485406|FG005|Overall Study|Adverse Event|1|||
163487920|NCT05664672|590485401|FG000|Overall Study|Withdrawal by Subject|0|||
163487921|NCT05664672|590485402|FG001|Overall Study|Withdrawal by Subject|1|||
163487922|NCT05664672|590485403|FG002|Overall Study|Withdrawal by Subject|3|||
163487923|NCT05664672|590485404|FG003|Overall Study|Withdrawal by Subject|0|||
163487924|NCT05664672|590485405|FG004|Overall Study|Withdrawal by Subject|5|||
163487925|NCT05664672|590485406|FG005|Overall Study|Withdrawal by Subject|6|||
163487926|NCT05664672|590485401|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
163487927|NCT05664672|590485402|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
163487928|NCT05664672|590485403|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
163487929|NCT05664672|590485404|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
163487930|NCT05664672|590485405|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
163487931|NCT05664672|590485406|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
163487932|NCT05664672|590485401|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
163487933|NCT05664672|590485402|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
163487934|NCT05664672|590485403|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
163487935|NCT05664672|590485404|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
163487936|NCT05664672|590485405|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
163487937|NCT05664672|590485406|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
163487938|NCT02815670|590485409|FG000|Overall Study|Prematurely discontinued of the trial|1|||
163487939|NCT01815099|590485412|FG000|Overall Study|Lack of Efficacy|1|||
163487940|NCT01815099|590485412|FG000|Overall Study|unable to attend study visits|1|||
163487941|NCT01475214|590485413|FG000|Overall Study|Lost to Follow-up|1|||
163487942|NCT01475214|590485414|FG001|Overall Study|Lost to Follow-up|0|||
163487943|NCT01475214|590485415|FG002|Overall Study|Lost to Follow-up|1|||
163487944|NCT01475214|590485413|FG000|Overall Study|Physician Decision|2|||
163487945|NCT01475214|590485414|FG001|Overall Study|Physician Decision|0|||
163487946|NCT01475214|590485415|FG002|Overall Study|Physician Decision|0|||
163487947|NCT01475214|590485413|FG000|Overall Study|Withdrawal by Subject|2|||
163487948|NCT01475214|590485414|FG001|Overall Study|Withdrawal by Subject|4|||
163487949|NCT01475214|590485415|FG002|Overall Study|Withdrawal by Subject|1|||
163487950|NCT00643851|590485416|FG000|Overall Study|Death|0|||
163487951|NCT00643851|590485417|FG001|Overall Study|Death|1|||
163487952|NCT00643851|590485418|FG002|Overall Study|Death|0|||
163487953|NCT00643851|590485416|FG000|Overall Study|Lack of Efficacy|0|||
163487954|NCT00643851|590485417|FG001|Overall Study|Lack of Efficacy|1|||
163487955|NCT00643851|590485418|FG002|Overall Study|Lack of Efficacy|0|||
163487956|NCT00643851|590485416|FG000|Overall Study|Adverse Event|2|||
163487957|NCT00643851|590485417|FG001|Overall Study|Adverse Event|6|||
163487958|NCT00643851|590485418|FG002|Overall Study|Adverse Event|6|||
163487959|NCT00643851|590485416|FG000|Overall Study|Lost to Follow-up|4|||
163487960|NCT00643851|590485417|FG001|Overall Study|Lost to Follow-up|6|||
163487961|NCT00643851|590485418|FG002|Overall Study|Lost to Follow-up|9|||
163487962|NCT00643851|590485416|FG000|Overall Study|Withdrawal by Subject|8|||
163487963|NCT00643851|590485417|FG001|Overall Study|Withdrawal by Subject|15|||
163487964|NCT00643851|590485418|FG002|Overall Study|Withdrawal by Subject|9|||
163487965|NCT00643851|590485416|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
163487966|NCT00643851|590485417|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
163487967|NCT00643851|590485418|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
163487968|NCT01977573|590485419|FG000|Overall Study|Adverse Event|7|||
163487969|NCT01977573|590485420|FG001|Overall Study|Adverse Event|0|||
163487970|NCT01977573|590485421|FG002|Overall Study|Adverse Event|2|||
163487971|NCT01977573|590485422|FG003|Overall Study|Adverse Event|1|||
163487972|NCT01977573|590485419|FG000|Overall Study|Lost to Follow-up|1|||
163487973|NCT01977573|590485420|FG001|Overall Study|Lost to Follow-up|0|||
163487974|NCT01977573|590485421|FG002|Overall Study|Lost to Follow-up|0|||
163487975|NCT01977573|590485422|FG003|Overall Study|Lost to Follow-up|1|||
163487976|NCT01977573|590485419|FG000|Overall Study|Physician Decision|1|||
163487977|NCT01977573|590485420|FG001|Overall Study|Physician Decision|0|||
163487978|NCT01977573|590485421|FG002|Overall Study|Physician Decision|0|||
163487979|NCT01977573|590485422|FG003|Overall Study|Physician Decision|0|||
163487980|NCT01977573|590485419|FG000|Overall Study|Protocol Violation|3|||
163487981|NCT01977573|590485420|FG001|Overall Study|Protocol Violation|1|||
163487982|NCT01977573|590485421|FG002|Overall Study|Protocol Violation|0|||
163487983|NCT01977573|590485422|FG003|Overall Study|Protocol Violation|0|||
163487984|NCT01977573|590485419|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
163487985|NCT01977573|590485420|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
163487986|NCT01977573|590485421|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
163487987|NCT01977573|590485422|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
163487988|NCT01977573|590485419|FG000|Overall Study|Withdrawal by Subject|6|||
163487989|NCT01977573|590485420|FG001|Overall Study|Withdrawal by Subject|1|||
163487990|NCT01977573|590485421|FG002|Overall Study|Withdrawal by Subject|1|||
163487991|NCT01977573|590485422|FG003|Overall Study|Withdrawal by Subject|1|||
163487992|NCT03996694|590487237|FG000|First Washout (7 Days)|positive urine drug screen|0|||
163487993|NCT03996694|590487238|FG001|First Washout (7 Days)|positive urine drug screen|0|||
163487994|NCT03996694|590487239|FG002|First Washout (7 Days)|positive urine drug screen|1|||
163487995|NCT03996694|590487240|FG003|First Washout (7 Days)|positive urine drug screen|0|||
163487996|NCT03996694|590487241|FG004|First Washout (7 Days)|positive urine drug screen|0|||
163487997|NCT03996694|590487242|FG005|First Washout (7 Days)|positive urine drug screen|0|||
163487998|NCT03996694|590487237|FG000|First Washout (7 Days)|Adverse Event|0|||
163487999|NCT03996694|590487238|FG001|First Washout (7 Days)|Adverse Event|1|||
163488000|NCT03996694|590487239|FG002|First Washout (7 Days)|Adverse Event|0|||
163488001|NCT03996694|590487240|FG003|First Washout (7 Days)|Adverse Event|0|||
163488002|NCT03996694|590487241|FG004|First Washout (7 Days)|Adverse Event|0|||
163488003|NCT03996694|590487242|FG005|First Washout (7 Days)|Adverse Event|0|||
163488004|NCT03996694|590487237|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
163488005|NCT03996694|590487238|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
163488006|NCT03996694|590487239|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
163488007|NCT03996694|590487240|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
163488008|NCT03996694|590487241|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
163488009|NCT03996694|590487242|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
163488010|NCT03996694|590487237|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
163488011|NCT03996694|590487238|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
163488012|NCT03996694|590487239|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
163488013|NCT03996694|590487240|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
163488014|NCT03996694|590487241|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
163488015|NCT03996694|590487242|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
163488016|NCT00808665|590487255|FG000|Overall Study|Withdrawal by Subject|1|||
163488017|NCT00808665|590487256|FG001|Overall Study|Withdrawal by Subject|0|||
163488018|NCT00808665|590487255|FG000|Overall Study|only required minimally invasive surgery|1|||
163488019|NCT00808665|590487256|FG001|Overall Study|only required minimally invasive surgery|0|||
163488020|NCT00808665|590487255|FG000|Overall Study|surgery cancelled|1|||
163488021|NCT00808665|590487256|FG001|Overall Study|surgery cancelled|0|||
163488022|NCT00808665|590487255|FG000|Overall Study|required an additional procedure|0|||
163488023|NCT00808665|590487256|FG001|Overall Study|required an additional procedure|1|||
163488024|NCT00808665|590487255|FG000|Overall Study|Physician Decision|3|||
163488025|NCT00808665|590487256|FG001|Overall Study|Physician Decision|1|||
163488026|NCT00808665|590487255|FG000|Overall Study|Medication stopped by resident|0|||
163488027|NCT00808665|590487256|FG001|Overall Study|Medication stopped by resident|1|||
163488028|NCT01694849|590487259|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
163488029|NCT01694849|590487260|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
163488030|NCT01694849|590487261|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
163488031|NCT01694849|590487259|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
163488032|NCT01694849|590487260|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
163488033|NCT01694849|590487261|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
163488034|NCT01694849|590487259|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
163488035|NCT01694849|590487260|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
163488036|NCT01694849|590487261|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
163488037|NCT01694849|590487259|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
163488038|NCT01694849|590487260|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
163488039|NCT01694849|590487261|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
163488040|NCT01694849|590487259|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
163488041|NCT01694849|590487260|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
163488042|NCT01694849|590487261|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
163488043|NCT01694849|590487259|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
163488044|NCT01694849|590487260|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
163488045|NCT01694849|590487261|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
163488046|NCT01694849|590487259|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
163488047|NCT01694849|590487260|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
163488048|NCT01694849|590487261|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
163488049|NCT01694849|590487259|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
163488050|NCT01694849|590487260|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
163488051|NCT01694849|590487261|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
163488052|NCT01326312|590487263|FG000|Overall Study|Adverse Event|11|||
163488053|NCT01326312|590487264|FG001|Overall Study|Adverse Event|11|||
163488054|NCT01326312|590487265|FG002|Overall Study|Adverse Event|1|||
163488055|NCT01326312|590487263|FG000|Overall Study|Withdrawal by Subject|1|||
163488056|NCT01326312|590487264|FG001|Overall Study|Withdrawal by Subject|2|||
163488057|NCT01326312|590487265|FG002|Overall Study|Withdrawal by Subject|1|||
163488058|NCT01326312|590487263|FG000|Overall Study|Protocol Violation|0|||
163488059|NCT01326312|590487264|FG001|Overall Study|Protocol Violation|1|||
163488060|NCT01326312|590487265|FG002|Overall Study|Protocol Violation|0|||
163488061|NCT01326312|590487263|FG000|Overall Study|Lack of Efficacy|13|||
163488062|NCT01326312|590487264|FG001|Overall Study|Lack of Efficacy|7|||
163488063|NCT01326312|590487265|FG002|Overall Study|Lack of Efficacy|1|||
163488064|NCT01326312|590487263|FG000|Overall Study|Death|1|||
163488065|NCT01326312|590487264|FG001|Overall Study|Death|0|||
163488066|NCT01326312|590487265|FG002|Overall Study|Death|1|||
163488067|NCT01326312|590487263|FG000|Overall Study|progressive disease|0|||
163488068|NCT01326312|590487264|FG001|Overall Study|progressive disease|1|||
163488069|NCT01326312|590487265|FG002|Overall Study|progressive disease|1|||
163488070|NCT01326312|590487263|FG000|Overall Study|Study terminated by Sponsor|8|||
163488071|NCT01326312|590487264|FG001|Overall Study|Study terminated by Sponsor|32|||
163488072|NCT01326312|590487265|FG002|Overall Study|Study terminated by Sponsor|46|||
163488073|NCT01326312|590487263|FG000|Overall Study|Treatment arm terminated|19|||
163488074|NCT01326312|590487264|FG001|Overall Study|Treatment arm terminated|0|||
163488075|NCT01326312|590487265|FG002|Overall Study|Treatment arm terminated|0|||
163488076|NCT01326312|590487263|FG000|Overall Study|QTc > 500|0|||
163488077|NCT01326312|590487264|FG001|Overall Study|QTc > 500|1|||
163488078|NCT01326312|590487265|FG002|Overall Study|QTc > 500|0|||
163488079|NCT00678652|590487270|FG000|Overall Study|Protocol Violation|2|||
163488080|NCT00678652|590487271|FG001|Overall Study|Protocol Violation|0|||
163488081|NCT00678652|590487272|FG002|Overall Study|Protocol Violation|0|||
163488082|NCT00678652|590487273|FG003|Overall Study|Protocol Violation|0|||
163488083|NCT00678652|590487270|FG000|Overall Study|Pregnancy|0|||
163488084|NCT00678652|590487271|FG001|Overall Study|Pregnancy|0|||
163488085|NCT00678652|590487272|FG002|Overall Study|Pregnancy|1|||
163488086|NCT00678652|590487273|FG003|Overall Study|Pregnancy|0|||
163488087|NCT00678652|590487270|FG000|Overall Study|Relocation|1|||
163488088|NCT00678652|590487271|FG001|Overall Study|Relocation|0|||
163488089|NCT00678652|590487272|FG002|Overall Study|Relocation|0|||
163488090|NCT00678652|590487273|FG003|Overall Study|Relocation|0|||
163488091|NCT05146999|590487274|FG000|Overall Study|Withdrew consent|6|||
163488092|NCT05146999|590487275|FG001|Overall Study|Withdrew consent|1|||
163488093|NCT05146999|590487274|FG000|Overall Study|Lost to Follow-up|3|||
163488094|NCT05146999|590487275|FG001|Overall Study|Lost to Follow-up|2|||
163488095|NCT05146999|590487274|FG000|Overall Study|Other|1|||
163488096|NCT05146999|590487275|FG001|Overall Study|Other|3|||
163488097|NCT00383292|590487276|FG000|Overall Study|Adverse Event|4|||
163488098|NCT00383292|590487277|FG001|Overall Study|Adverse Event|1|||
163488099|NCT00383292|590487278|FG002|Overall Study|Adverse Event|2|||
163488100|NCT00383292|590487276|FG000|Overall Study|Death|3|||
163488101|NCT00383292|590487277|FG001|Overall Study|Death|3|||
163488102|NCT00383292|590487278|FG002|Overall Study|Death|3|||
163488103|NCT00383292|590487276|FG000|Overall Study|Physician Decision|4|||
163488104|NCT00383292|590487277|FG001|Overall Study|Physician Decision|0|||
163488105|NCT00383292|590487278|FG002|Overall Study|Physician Decision|1|||
163488106|NCT00383292|590487276|FG000|Overall Study|Withdrawal by Subject|3|||
163488107|NCT00383292|590487277|FG001|Overall Study|Withdrawal by Subject|2|||
163488108|NCT00383292|590487278|FG002|Overall Study|Withdrawal by Subject|2|||
163488109|NCT00383292|590487276|FG000|Overall Study|Other|1|||
163488110|NCT00383292|590487277|FG001|Overall Study|Other|0|||
163488111|NCT00383292|590487278|FG002|Overall Study|Other|0|||
163488112|NCT03457701|590487288|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
163488113|NCT03457701|590487289|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
163488114|NCT03457701|590487288|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
163488115|NCT03457701|590487289|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
163488116|NCT02243306|590487290|FG000|Overall Study|Adverse Event|0|||
163488117|NCT02243306|590487291|FG001|Overall Study|Adverse Event|1|||
163488118|NCT02243306|590487290|FG000|Overall Study|Other: Reached stopping criteria|0|||
163488119|NCT02243306|590487291|FG001|Overall Study|Other: Reached stopping criteria|1|||
163488120|NCT02243306|590487290|FG000|Overall Study|Physician Decision|0|||
163488121|NCT02243306|590487291|FG001|Overall Study|Physician Decision|1|||
163488122|NCT03329404|590487292|FG000|Overall Study|The study was suspended.|1|||
163488123|NCT03329404|590487293|FG001|Overall Study|The study was suspended.|4|||
163488124|NCT02221882|590487294|FG000|Overall Study|Withdrawal by Subject|0|||
163488125|NCT02221882|590487295|FG001|Overall Study|Withdrawal by Subject|0|||
163488126|NCT02221882|590487296|FG002|Overall Study|Withdrawal by Subject|4|||
163488127|NCT02221882|590487297|FG003|Overall Study|Withdrawal by Subject|2|||
163488128|NCT02221882|590487298|FG004|Overall Study|Withdrawal by Subject|2|||
163488129|NCT02221882|590487299|FG005|Overall Study|Withdrawal by Subject|2|||
163488130|NCT02221882|590487294|FG000|Overall Study|Death|0|||
163488131|NCT02221882|590487295|FG001|Overall Study|Death|1|||
163488132|NCT02221882|590487296|FG002|Overall Study|Death|0|||
163488133|NCT02221882|590487297|FG003|Overall Study|Death|0|||
163488134|NCT02221882|590487298|FG004|Overall Study|Death|0|||
163488135|NCT02221882|590487299|FG005|Overall Study|Death|0|||
163488136|NCT04095039|590487305|FG000|Overall Study|Withdrawal by Subject|2|||
163488137|NCT04095039|590487306|FG001|Overall Study|Withdrawal by Subject|16|||
163488138|NCT04095039|590487305|FG000|Overall Study|Transplanted|21|||
163488139|NCT04095039|590487306|FG001|Overall Study|Transplanted|24|||
163488140|NCT04095039|590487305|FG000|Overall Study|Transferred to Non-study Facility|47|||
163488141|NCT04095039|590487306|FG001|Overall Study|Transferred to Non-study Facility|44|||
163488142|NCT04095039|590487305|FG000|Overall Study|Withdrawal from internvention target|0|||
163488143|NCT04095039|590487306|FG001|Overall Study|Withdrawal from internvention target|2|||
163488144|NCT04095039|590487305|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
163488145|NCT04095039|590487306|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
163488146|NCT04095039|590487305|FG000|Overall Study|Cacliphylaxis|0|||
163488147|NCT04095039|590487306|FG001|Overall Study|Cacliphylaxis|1|||
163488148|NCT04095039|590487305|FG000|Overall Study|Pregnancy|1|||
163488149|NCT04095039|590487306|FG001|Overall Study|Pregnancy|0|||
163488150|NCT04768881|590487307|FG000|Overall Study|Completed Study Follow-up|0|||
163488151|NCT04768881|590487308|FG001|Overall Study|Completed Study Follow-up|2|||
163488152|NCT04768881|590487307|FG000|Overall Study|Death|3|||
163488153|NCT04768881|590487308|FG001|Overall Study|Death|2|||
163488154|NCT04768881|590487307|FG000|Overall Study|Study Terminated by Sponsor|2|||
163488155|NCT04768881|590487308|FG001|Overall Study|Study Terminated by Sponsor|2|||
163488156|NCT04768881|590487307|FG000|Overall Study|Withdrawal by Subject|2|||
163488157|NCT04768881|590487308|FG001|Overall Study|Withdrawal by Subject|0|||
163488158|NCT04768881|590487307|FG000|Overall Study|Other|2|||
163488159|NCT04768881|590487308|FG001|Overall Study|Other|0|||
163488160|NCT02370173|590487311|FG000|Overall Study|Protocol Violation|1|||
163488161|NCT02370173|590487312|FG001|Overall Study|Protocol Violation|1|||
163488162|NCT02370173|590487311|FG000|Overall Study|Withdrawal by Subject|2|||
163488163|NCT02370173|590487312|FG001|Overall Study|Withdrawal by Subject|2|||
163488164|NCT04236986|590487313|FG000|Overall Study|Withdrawal by Subject|3|||
163488165|NCT04236986|590487314|FG001|Overall Study|Withdrawal by Subject|1|||
163488166|NCT00307736|590487317|FG000|Overall Study|Adverse Event|0|||
163488167|NCT00307736|590487318|FG001|Overall Study|Adverse Event|0|||
163488168|NCT00307736|590487319|FG002|Overall Study|Adverse Event|1|||
163488169|NCT00307736|590487320|FG003|Overall Study|Adverse Event|3|||
163488170|NCT00307736|590487317|FG000|Overall Study|Withdrawal by Subject|0|||
163488171|NCT00307736|590487318|FG001|Overall Study|Withdrawal by Subject|0|||
163488172|NCT00307736|590487319|FG002|Overall Study|Withdrawal by Subject|2|||
163488173|NCT00307736|590487320|FG003|Overall Study|Withdrawal by Subject|0|||
163488174|NCT01365182|590487327|FG000|Overall Study|Withdrawal by Subject|10|||
163488175|NCT01365182|590487328|FG001|Overall Study|Withdrawal by Subject|13|||
163488176|NCT01365182|590487329|FG002|Overall Study|Withdrawal by Subject|12|||
163488177|NCT00736840|590487330|FG000|Overall Study|Lost to Follow-up|13|||
163488178|NCT01728194|590487333|FG000|Overall Study|Lost to Follow-up|4|||
163488179|NCT01728194|590487334|FG001|Overall Study|Lost to Follow-up|3|||
163488180|NCT01728194|590487333|FG000|Overall Study|Physician Decision|4|||
163488181|NCT01728194|590487334|FG001|Overall Study|Physician Decision|0|||
163488182|NCT01728194|590487333|FG000|Overall Study|Withdrawal by Subject|7|||
163488183|NCT01728194|590487334|FG001|Overall Study|Withdrawal by Subject|3|||
163488184|NCT01728194|590487333|FG000|Overall Study|Perceived Medication Side Effects|4|||
163488185|NCT01728194|590487334|FG001|Overall Study|Perceived Medication Side Effects|0|||
163488186|NCT01728194|590487333|FG000|Overall Study|Family Member Request|1|||
163488187|NCT01728194|590487334|FG001|Overall Study|Family Member Request|0|||
163488188|NCT02309372|590487335|FG000|Overall Study|Lost to Follow-up|3|||
163488189|NCT02309372|590487336|FG001|Overall Study|Lost to Follow-up|2|||
163488190|NCT03289676|590487341|FG000|Overall Study|Withdrawal by Subject|2|||
163488191|NCT03289676|590487342|FG001|Overall Study|Withdrawal by Subject|0|||
163488192|NCT03289676|590487341|FG000|Overall Study|Protocol Violation|2|||
163488193|NCT03289676|590487342|FG001|Overall Study|Protocol Violation|0|||
163488194|NCT03289676|590487341|FG000|Overall Study|Lost to Follow-up|0|||
163488195|NCT03289676|590487342|FG001|Overall Study|Lost to Follow-up|1|||
163488196|NCT01314261|590487345|FG000|Overall Study|Adverse Event|1|||
163488197|NCT01314261|590487346|FG001|Overall Study|Adverse Event|0|||
163488198|NCT01314261|590487347|FG002|Overall Study|Adverse Event|0|||
163488199|NCT01314261|590487348|FG003|Overall Study|Adverse Event|0|||
163488200|NCT01314261|590487345|FG000|Overall Study|Withdrawal by Subject|0|||
163488201|NCT01314261|590487346|FG001|Overall Study|Withdrawal by Subject|3|||
163488202|NCT01314261|590487347|FG002|Overall Study|Withdrawal by Subject|1|||
163488203|NCT01314261|590487348|FG003|Overall Study|Withdrawal by Subject|0|||
163488204|NCT01314261|590487345|FG000|Overall Study|Lost to Follow-up|1|||
163488205|NCT01314261|590487346|FG001|Overall Study|Lost to Follow-up|0|||
163488206|NCT01314261|590487347|FG002|Overall Study|Lost to Follow-up|2|||
163488207|NCT01314261|590487348|FG003|Overall Study|Lost to Follow-up|2|||
163488208|NCT01314261|590487345|FG000|Overall Study|Virologic Failure|0|||
163488209|NCT01314261|590487346|FG001|Overall Study|Virologic Failure|1|||
163488210|NCT01314261|590487347|FG002|Overall Study|Virologic Failure|0|||
163488211|NCT01314261|590487348|FG003|Overall Study|Virologic Failure|1|||
163488212|NCT01231620|590487349|FG000|Overall Study|Physician Decision|3|||
163488213|NCT01231620|590487350|FG001|Overall Study|Physician Decision|5|||
163488214|NCT01231620|590487351|FG002|Overall Study|Physician Decision|10|||
163488215|NCT01231620|590487349|FG000|Overall Study|Death|12|||
163488216|NCT01231620|590487350|FG001|Overall Study|Death|14|||
163488217|NCT01231620|590487351|FG002|Overall Study|Death|11|||
163488218|NCT01231620|590487349|FG000|Overall Study|Adverse Event|2|||
163488219|NCT01231620|590487350|FG001|Overall Study|Adverse Event|2|||
163488220|NCT01231620|590487351|FG002|Overall Study|Adverse Event|1|||
163488221|NCT01231620|590487349|FG000|Overall Study|Withdrawal by Subject|6|||
163488222|NCT01231620|590487350|FG001|Overall Study|Withdrawal by Subject|6|||
163488223|NCT01231620|590487351|FG002|Overall Study|Withdrawal by Subject|8|||
163488224|NCT01231620|590487349|FG000|Overall Study|Lost to Follow-up|3|||
163488225|NCT01231620|590487350|FG001|Overall Study|Lost to Follow-up|4|||
163488226|NCT01231620|590487351|FG002|Overall Study|Lost to Follow-up|9|||
163488227|NCT02576652|590487355|FG000|Overall Study|Withdrawal by Subject|2|||
163488228|NCT04806334|590487360|FG000|Overall Study|Withdrawal by Subject|1|||
163488229|NCT02811640|590487361|FG000|Overall Study|Technology malfunction|2|||
163488230|NCT04557189|590487365|FG000|Overall Study|Adverse Event|0|||
163488231|NCT04557189|590487366|FG001|Overall Study|Adverse Event|1|||
163488232|NCT04557189|590487365|FG000|Overall Study|Lost to Follow-up|1|||
163488233|NCT04557189|590487366|FG001|Overall Study|Lost to Follow-up|1|||
163488234|NCT04557189|590487365|FG000|Overall Study|Withdrawal by Subject|2|||
163488235|NCT04557189|590487366|FG001|Overall Study|Withdrawal by Subject|1|||
163488236|NCT04557189|590487365|FG000|Overall Study|Reason not Specified|3|||
163488237|NCT04557189|590487366|FG001|Overall Study|Reason not Specified|6|||
163488238|NCT03590613|590487377|FG000|Period 2, 4 Days|Physician Decision|0|||
163488239|NCT03590613|590487378|FG001|Period 2, 4 Days|Physician Decision|0|||
163488240|NCT03590613|590487379|FG002|Period 2, 4 Days|Physician Decision|0|||
163488241|NCT03590613|590487380|FG003|Period 2, 4 Days|Physician Decision|1|||
163488242|NCT04369742|590487381|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
163488243|NCT04369742|590487382|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
163488244|NCT04369742|590487381|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
163488245|NCT04369742|590487382|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
163488246|NCT01636076|590487383|FG000|Overall Study|Terminated by sponsor|1|||
163488247|NCT01636076|590487384|FG001|Overall Study|Terminated by sponsor|1|||
163488248|NCT01636076|590487383|FG000|Overall Study|Lack of Efficacy|0|||
163488249|NCT01636076|590487384|FG001|Overall Study|Lack of Efficacy|1|||
163488250|NCT01636076|590487383|FG000|Overall Study|Lost to Follow-up|1|||
163488251|NCT01636076|590487384|FG001|Overall Study|Lost to Follow-up|0|||
163488252|NCT01636076|590487383|FG000|Overall Study|Physician Decision|1|||
163488253|NCT01636076|590487384|FG001|Overall Study|Physician Decision|1|||
163488254|NCT01636076|590487383|FG000|Overall Study|Non-compliance with study treatment|1|||
163488255|NCT01636076|590487384|FG001|Overall Study|Non-compliance with study treatment|1|||
163488256|NCT01636076|590487383|FG000|Overall Study|Adverse Event|6|||
163488257|NCT01636076|590487384|FG001|Overall Study|Adverse Event|11|||
163488258|NCT01636076|590487383|FG000|Overall Study|Withdrawal by Subject|7|||
163488259|NCT01636076|590487384|FG001|Overall Study|Withdrawal by Subject|10|||
163488260|NCT01130831|590487385|FG000|Overall Study|Withdrawal by Subject|7|||
163488261|NCT01130831|590487385|FG000|Overall Study|Death|4|||
163488262|NCT01130831|590487385|FG000|Overall Study|Information was missing|3|||
163488263|NCT01159665|590487386|FG000|Overall Study|Withdrawal by Subject|0|||
163488264|NCT01159665|590487387|FG001|Overall Study|Withdrawal by Subject|1|||
163488265|NCT01159665|590487388|FG002|Overall Study|Withdrawal by Subject|0|||
163488266|NCT01159665|590487389|FG003|Overall Study|Withdrawal by Subject|0|||
163488267|NCT01159665|590487390|FG004|Overall Study|Withdrawal by Subject|0|||
163488268|NCT01159665|590487391|FG005|Overall Study|Withdrawal by Subject|0|||
163488269|NCT00951912|590487392|FG000|Overall Study|Lack of Efficacy|1|||
163488270|NCT00951912|590487393|FG001|Overall Study|Lack of Efficacy|0|||
163488271|NCT00951912|590487394|FG002|Overall Study|Lack of Efficacy|0|||
163488272|NCT00951912|590487392|FG000|Overall Study|Adverse Event|0|||
163488273|NCT00951912|590487393|FG001|Overall Study|Adverse Event|1|||
163488274|NCT00951912|590487394|FG002|Overall Study|Adverse Event|1|||
163488275|NCT00951912|590487392|FG000|Overall Study|Lost to Follow-up|2|||
163488276|NCT00951912|590487393|FG001|Overall Study|Lost to Follow-up|2|||
163488277|NCT00951912|590487394|FG002|Overall Study|Lost to Follow-up|0|||
163488278|NCT00951912|590487392|FG000|Overall Study|Physician Decision|1|||
163488279|NCT00951912|590487393|FG001|Overall Study|Physician Decision|0|||
163488280|NCT00951912|590487394|FG002|Overall Study|Physician Decision|1|||
163488281|NCT00951912|590487392|FG000|Overall Study|Withdrawal by Subject|1|||
163488282|NCT00951912|590487393|FG001|Overall Study|Withdrawal by Subject|1|||
163488283|NCT00951912|590487394|FG002|Overall Study|Withdrawal by Subject|0|||
163488284|NCT00951912|590487392|FG000|Overall Study|Other:Depression|1|||
163488285|NCT00951912|590487393|FG001|Overall Study|Other:Depression|0|||
163488286|NCT00951912|590487394|FG002|Overall Study|Other:Depression|0|||
163488287|NCT00951912|590487392|FG000|Overall Study|Other: Colon cancer|1|||
163488288|NCT00951912|590487393|FG001|Overall Study|Other: Colon cancer|0|||
163488289|NCT00951912|590487394|FG002|Overall Study|Other: Colon cancer|0|||
163488290|NCT00951912|590487392|FG000|Overall Study|Other: Stroke|0|||
163488291|NCT00951912|590487393|FG001|Overall Study|Other: Stroke|1|||
163488292|NCT00951912|590487394|FG002|Overall Study|Other: Stroke|0|||
163488293|NCT02173158|590487396|FG000|Efficacy Phase|Adverse Event|1|||
163488294|NCT01377194|590487397|FG000|Overall Study|Adverse Event|3|||
163488295|NCT01377194|590487398|FG001|Overall Study|Adverse Event|12|||
163488296|NCT01377194|590487399|FG002|Overall Study|Adverse Event|19|||
163488297|NCT01377194|590487397|FG000|Overall Study|Lack of Efficacy|3|||
163488298|NCT01377194|590487398|FG001|Overall Study|Lack of Efficacy|3|||
163488299|NCT01377194|590487399|FG002|Overall Study|Lack of Efficacy|3|||
163488300|NCT01377194|590487397|FG000|Overall Study|Protocol Violation|4|||
163488301|NCT01377194|590487398|FG001|Overall Study|Protocol Violation|10|||
163488302|NCT01377194|590487399|FG002|Overall Study|Protocol Violation|6|||
163488303|NCT01377194|590487397|FG000|Overall Study|Withdrawal by Subject|8|||
163488304|NCT01377194|590487398|FG001|Overall Study|Withdrawal by Subject|10|||
163488305|NCT01377194|590487399|FG002|Overall Study|Withdrawal by Subject|7|||
163488306|NCT01377194|590487397|FG000|Overall Study|Lost to Follow-up|14|||
163488307|NCT01377194|590487398|FG001|Overall Study|Lost to Follow-up|8|||
163488308|NCT01377194|590487399|FG002|Overall Study|Lost to Follow-up|11|||
163488309|NCT00422227|590487400|FG000|Overall Study|Adverse Event|3|||
163488310|NCT00422227|590487401|FG001|Overall Study|Adverse Event|8|||
163488311|NCT00422227|590487400|FG000|Overall Study|Lost to Follow-up|1|||
163488312|NCT00422227|590487401|FG001|Overall Study|Lost to Follow-up|3|||
163488313|NCT00422227|590487400|FG000|Overall Study|Withdrawal by Subject|0|||
163488314|NCT00422227|590487401|FG001|Overall Study|Withdrawal by Subject|4|||
163488315|NCT01207427|590487402|FG000|Double-blind Treatment Period|Adverse Event|0|||
163488316|NCT01207427|590487403|FG001|Double-blind Treatment Period|Adverse Event|1|||
163488317|NCT01207427|590487404|FG002|Double-blind Treatment Period|Adverse Event|0|||
163488318|NCT01207427|590487402|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
163488319|NCT01207427|590487403|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
163488320|NCT01207427|590487404|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
163488321|NCT01207427|590487402|FG000|Double-blind Treatment Period|Protocol Violation|2|||
163488322|NCT01207427|590487403|FG001|Double-blind Treatment Period|Protocol Violation|1|||
163488323|NCT01207427|590487404|FG002|Double-blind Treatment Period|Protocol Violation|1|||
163488324|NCT01207427|590487402|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
163488325|NCT01207427|590487403|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
163488326|NCT01207427|590487404|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
163488327|NCT03323034|590489060|FG000|Overall Study|Lack of Efficacy|5|||
163488328|NCT03323034|590489061|FG001|Overall Study|Lack of Efficacy|5|||
163488329|NCT03323034|590489062|FG002|Overall Study|Lack of Efficacy|6|||
163488330|NCT03323034|590489063|FG003|Overall Study|Lack of Efficacy|5|||
163488331|NCT03323034|590489064|FG004|Overall Study|Lack of Efficacy|5|||
163488332|NCT03323034|590489060|FG000|Overall Study|Physician Decision|0|||
163488333|NCT03323034|590489061|FG001|Overall Study|Physician Decision|0|||
163488334|NCT03323034|590489062|FG002|Overall Study|Physician Decision|0|||
163488335|NCT03323034|590489063|FG003|Overall Study|Physician Decision|0|||
163488336|NCT03323034|590489064|FG004|Overall Study|Physician Decision|1|||
163488337|NCT03323034|590489060|FG000|Overall Study|Withdrawal by Subject|1|||
163488338|NCT03323034|590489061|FG001|Overall Study|Withdrawal by Subject|1|||
163488339|NCT03323034|590489062|FG002|Overall Study|Withdrawal by Subject|0|||
163488340|NCT03323034|590489063|FG003|Overall Study|Withdrawal by Subject|1|||
163488341|NCT03323034|590489064|FG004|Overall Study|Withdrawal by Subject|0|||
163488342|NCT02646566|590489066|FG000|Overall Study|Lost to Follow-up|5|||
163488343|NCT02646566|590489067|FG001|Overall Study|Lost to Follow-up|4|||
163488344|NCT02646566|590489068|FG002|Overall Study|Lost to Follow-up|5|||
163488345|NCT02646566|590489066|FG000|Overall Study|Treatment failure|1|||
163488346|NCT02646566|590489067|FG001|Overall Study|Treatment failure|0|||
163488347|NCT02646566|590489068|FG002|Overall Study|Treatment failure|0|||
163488348|NCT04341727|590489078|FG000|Overall Study|Withdrawal by Subject|0|||
163488349|NCT04341727|590489079|FG001|Overall Study|Withdrawal by Subject|0|||
163488350|NCT04341727|590489080|FG002|Overall Study|Withdrawal by Subject|1|||
163488351|NCT04341727|590489081|FG003|Overall Study|Withdrawal by Subject|0|||
163488352|NCT04341727|590489078|FG000|Overall Study|Lost to Follow-up|0|||
163488353|NCT04341727|590489079|FG001|Overall Study|Lost to Follow-up|0|||
163488354|NCT04341727|590489080|FG002|Overall Study|Lost to Follow-up|0|||
163488355|NCT04341727|590489081|FG003|Overall Study|Lost to Follow-up|1|||
163488356|NCT00503035|590489082|FG000|Overall Study|Lost to Follow-up|2|||
163488357|NCT00503035|590489082|FG000|Overall Study|Physician Decision|3|||
163488358|NCT00503035|590489082|FG000|Overall Study|Ineligible|15|||
163488359|NCT05028816|590489085|FG000|Overall Study|Lost to Follow-up|5|||
163488360|NCT05028816|590489086|FG001|Overall Study|Lost to Follow-up|3|||
163488361|NCT05028816|590489085|FG000|Overall Study|Withdrawal by Subject|4|||
163488362|NCT05028816|590489086|FG001|Overall Study|Withdrawal by Subject|1|||
163488363|NCT05028816|590489085|FG000|Overall Study|Physician Decision|1|||
163488364|NCT05028816|590489086|FG001|Overall Study|Physician Decision|0|||
163488375|NCT04576702|590489095|FG000|Overall Study|Death|1|||
163488376|NCT04576702|590489096|FG001|Overall Study|Death|0|||
163488377|NCT04576702|590489097|FG002|Overall Study|Death|0|||
163488378|NCT04576702|590489098|FG003|Overall Study|Death|0|||
163488379|NCT04576702|590489095|FG000|Overall Study|Withdrawal by Subject|0|||
163488380|NCT04576702|590489096|FG001|Overall Study|Withdrawal by Subject|2|||
163488381|NCT04576702|590489097|FG002|Overall Study|Withdrawal by Subject|1|||
163488382|NCT04576702|590489098|FG003|Overall Study|Withdrawal by Subject|0|||
163488383|NCT04576702|590489095|FG000|Overall Study|Lost to Follow-up|3|||
163488384|NCT04576702|590489096|FG001|Overall Study|Lost to Follow-up|3|||
163488385|NCT04576702|590489097|FG002|Overall Study|Lost to Follow-up|3|||
163488386|NCT04576702|590489098|FG003|Overall Study|Lost to Follow-up|4|||
163488387|NCT01151085|590489099|FG000|Overall Study|Lost to Follow-up|31|||
163488388|NCT01151085|590489099|FG000|Overall Study|Protocol Violation|25|||
163488389|NCT00003526|590489100|FG000|Overall Study|Not evaluable|6|||
163488390|NCT02059265|590489101|FG000|Overall Study|Ineligible|4|||
163488391|NCT00998166|590489102|FG000|Overall Study|Early Study Termination|8|||
163488392|NCT02985996|590489106|FG000|Overall Study|Withdrawal by Subject|0|||
163488393|NCT02985996|590489107|FG001|Overall Study|Withdrawal by Subject|0|||
163488394|NCT02985996|590489108|FG002|Overall Study|Withdrawal by Subject|1|||
163488395|NCT02985996|590489109|FG003|Overall Study|Withdrawal by Subject|0|||
163488396|NCT02985996|590489110|FG004|Overall Study|Withdrawal by Subject|0|||
163488397|NCT02985996|590489106|FG000|Overall Study|Protocol Violation|0|||
163488398|NCT02985996|590489107|FG001|Overall Study|Protocol Violation|1|||
163488399|NCT02985996|590489108|FG002|Overall Study|Protocol Violation|0|||
163488400|NCT02985996|590489109|FG003|Overall Study|Protocol Violation|0|||
163488401|NCT02985996|590489110|FG004|Overall Study|Protocol Violation|0|||
163488402|NCT00401726|590489111|FG000|Overall Study|Adverse Event|34|||
163488403|NCT00401726|590489112|FG001|Overall Study|Adverse Event|45|||
163488404|NCT00401726|590489111|FG000|Overall Study|Death|0|||
163488405|NCT00401726|590489112|FG001|Overall Study|Death|3|||
163488406|NCT00401726|590489111|FG000|Overall Study|Sponsor Request|0|||
163488407|NCT00401726|590489112|FG001|Overall Study|Sponsor Request|1|||
163488408|NCT00401726|590489111|FG000|Overall Study|Physician Decision|3|||
163488409|NCT00401726|590489112|FG001|Overall Study|Physician Decision|6|||
163488410|NCT00401726|590489111|FG000|Overall Study|Lost to Follow-up|23|||
163488411|NCT00401726|590489112|FG001|Overall Study|Lost to Follow-up|20|||
163488412|NCT00401726|590489111|FG000|Overall Study|Protocol Violation|6|||
163488413|NCT00401726|590489112|FG001|Overall Study|Protocol Violation|3|||
163488414|NCT00401726|590489111|FG000|Overall Study|Withdrawal by Subject|18|||
163488415|NCT00401726|590489112|FG001|Overall Study|Withdrawal by Subject|24|||
163488416|NCT00401726|590489111|FG000|Overall Study|Lack of Efficacy|4|||
163488417|NCT00401726|590489112|FG001|Overall Study|Lack of Efficacy|6|||
163488418|NCT00401726|590489111|FG000|Overall Study|Protocol Deviation|9|||
163488419|NCT00401726|590489112|FG001|Overall Study|Protocol Deviation|4|||
163488420|NCT00814502|590489115|FG000|Overall Study|Adverse Event|1|||
163488421|NCT00814502|590489116|FG001|Overall Study|Adverse Event|0|||
163488422|NCT00814502|590489115|FG000|Overall Study|Withdrawal by Subject|0|||
163488423|NCT00814502|590489116|FG001|Overall Study|Withdrawal by Subject|2|||
163488424|NCT03735849|590489118|FG000|Overall Study|Lost to Follow-up|1|||
163488425|NCT03735849|590489119|FG001|Overall Study|Lost to Follow-up|0|||
163488426|NCT03735849|590489120|FG002|Overall Study|Lost to Follow-up|0|||
163488427|NCT03735849|590489118|FG000|Overall Study|Participant unable to adhere to visit|1|||
163488428|NCT03735849|590489119|FG001|Overall Study|Participant unable to adhere to visit|0|||
163488429|NCT03735849|590489120|FG002|Overall Study|Participant unable to adhere to visit|0|||
163488430|NCT03735849|590489118|FG000|Overall Study|Not Randomized|0|||
163488431|NCT03735849|590489119|FG001|Overall Study|Not Randomized|0|||
163488432|NCT03735849|590489120|FG002|Overall Study|Not Randomized|4|||
163488433|NCT01050998|590489123|FG000|Overall Study|Adverse Event|1|||
163488434|NCT01050998|590489124|FG001|Overall Study|Adverse Event|0|||
163488435|NCT01050998|590489125|FG002|Overall Study|Adverse Event|1|||
163488436|NCT01050998|590489126|FG003|Overall Study|Adverse Event|0|||
163488437|NCT01050998|590489127|FG004|Overall Study|Adverse Event|2|||
163488438|NCT01050998|590489123|FG000|Overall Study|Withdrawal by Subject|0|||
163488439|NCT01050998|590489124|FG001|Overall Study|Withdrawal by Subject|0|||
163488440|NCT01050998|590489125|FG002|Overall Study|Withdrawal by Subject|0|||
163488441|NCT01050998|590489126|FG003|Overall Study|Withdrawal by Subject|1|||
163488442|NCT01050998|590489127|FG004|Overall Study|Withdrawal by Subject|3|||
163488443|NCT01050998|590489123|FG000|Overall Study|Other|3|||
163488444|NCT01050998|590489124|FG001|Overall Study|Other|2|||
163488445|NCT01050998|590489125|FG002|Overall Study|Other|1|||
163488446|NCT01050998|590489126|FG003|Overall Study|Other|1|||
163488447|NCT01050998|590489127|FG004|Overall Study|Other|5|||
163488448|NCT01050998|590489123|FG000|Overall Study|Data integrity issues|0|||
163488449|NCT01050998|590489124|FG001|Overall Study|Data integrity issues|0|||
163488450|NCT01050998|590489125|FG002|Overall Study|Data integrity issues|1|||
163488451|NCT01050998|590489126|FG003|Overall Study|Data integrity issues|1|||
163488452|NCT01050998|590489127|FG004|Overall Study|Data integrity issues|4|||
163488453|NCT04246593|590489130|FG000|Overall Study|Withdrawal by Subject|14|||
163488454|NCT04246593|590489131|FG001|Overall Study|Withdrawal by Subject|13|||
163488455|NCT04246593|590489130|FG000|Overall Study|Lost to Follow-up|124|||
163488456|NCT04246593|590489131|FG001|Overall Study|Lost to Follow-up|71|||
163488457|NCT04246593|590489130|FG000|Overall Study|Moved out of area/became ineligible|3|||
163488458|NCT04246593|590489131|FG001|Overall Study|Moved out of area/became ineligible|1|||
163488459|NCT04246593|590489130|FG000|Overall Study|Reason unknown|4|||
163488460|NCT04246593|590489131|FG001|Overall Study|Reason unknown|2|||
163488461|NCT01012765|590489134|FG000|Treatment Period 1|Adverse Event|1|||
163488462|NCT01012765|590489135|FG001|Treatment Period 1|Adverse Event|0|||
163488463|NCT01012765|590489136|FG002|Treatment Period 1|Adverse Event|1|||
163488464|NCT01012765|590489137|FG003|Treatment Period 1|Adverse Event|0|||
163488465|NCT01012765|590489138|FG004|Treatment Period 1|Adverse Event|0|||
163488466|NCT01012765|590489139|FG005|Treatment Period 1|Adverse Event|0|||
163488467|NCT01012765|590489134|FG000|Treatment Period 1|Withdrawal by Subject|2|||
163488468|NCT01012765|590489135|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163488469|NCT01012765|590489136|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163488470|NCT01012765|590489137|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163488471|NCT01012765|590489138|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163488472|NCT01012765|590489139|FG005|Treatment Period 1|Withdrawal by Subject|0|||
163488473|NCT01012765|590489134|FG000|Treatment Period 1|Administrative problems|0|||
163488474|NCT01012765|590489135|FG001|Treatment Period 1|Administrative problems|0|||
163488475|NCT01012765|590489136|FG002|Treatment Period 1|Administrative problems|1|||
163488476|NCT01012765|590489137|FG003|Treatment Period 1|Administrative problems|1|||
163488477|NCT01012765|590489138|FG004|Treatment Period 1|Administrative problems|1|||
163488478|NCT01012765|590489139|FG005|Treatment Period 1|Administrative problems|0|||
163488479|NCT01012765|590489134|FG000|Treatment Period 1|Protocol Violation|0|||
163488480|NCT01012765|590489135|FG001|Treatment Period 1|Protocol Violation|0|||
163488481|NCT01012765|590489136|FG002|Treatment Period 1|Protocol Violation|0|||
163488482|NCT01012765|590489137|FG003|Treatment Period 1|Protocol Violation|2|||
163488483|NCT01012765|590489138|FG004|Treatment Period 1|Protocol Violation|1|||
163488484|NCT01012765|590489139|FG005|Treatment Period 1|Protocol Violation|0|||
163488485|NCT01012765|590489134|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
163488486|NCT01012765|590489135|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
163488487|NCT01012765|590489136|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
163488488|NCT01012765|590489137|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
163488489|NCT01012765|590489138|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
163488490|NCT01012765|590489139|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
163488491|NCT01012765|590489134|FG000|Treatment Period 2|Withdrawal by Subject|1|||
163488492|NCT01012765|590489135|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163488493|NCT01012765|590489136|FG002|Treatment Period 2|Withdrawal by Subject|1|||
163488494|NCT01012765|590489137|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163488495|NCT01012765|590489138|FG004|Treatment Period 2|Withdrawal by Subject|1|||
163488496|NCT01012765|590489139|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163488497|NCT01012765|590489134|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
163488498|NCT01012765|590489135|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
163488499|NCT01012765|590489136|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
163488500|NCT01012765|590489137|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
163488501|NCT01012765|590489138|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
163488502|NCT01012765|590489139|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
163488503|NCT01012765|590489134|FG000|Treatment Period 2|Adverse Event|0|||
163488504|NCT01012765|590489135|FG001|Treatment Period 2|Adverse Event|1|||
163488505|NCT01012765|590489136|FG002|Treatment Period 2|Adverse Event|1|||
163488506|NCT01012765|590489137|FG003|Treatment Period 2|Adverse Event|0|||
163488507|NCT01012765|590489138|FG004|Treatment Period 2|Adverse Event|0|||
163488508|NCT01012765|590489139|FG005|Treatment Period 2|Adverse Event|0|||
163488509|NCT01012765|590489134|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
163488510|NCT01012765|590489135|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
163488511|NCT01012765|590489136|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
163488512|NCT01012765|590489137|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
163488513|NCT01012765|590489138|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
163488514|NCT01012765|590489139|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
163488515|NCT04668157|590489147|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
163488516|NCT04668157|590489148|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
163488517|NCT04668157|590489147|FG000|Treatment Period (52 Weeks)|Other|0|||
163488518|NCT04668157|590489148|FG001|Treatment Period (52 Weeks)|Other|2|||
163488519|NCT02283411|590489153|FG000|Overall Study|Withdrawal by Subject|3|||
163488520|NCT02283411|590489153|FG000|Overall Study|Screen Failed|28|||
163488521|NCT05437211|590489154|FG000|Overall Study|Patient's decision|1|||
163488522|NCT05437211|590489155|FG001|Overall Study|Patient's decision|1|||
163488523|NCT03282123|590489157|FG000|Overall Study|Withdrawal by Subject|5|||
163488524|NCT00796367|590489161|FG000|Overall Study|Adverse Event|6|||
163488525|NCT00796367|590489162|FG001|Overall Study|Adverse Event|4|||
163488526|NCT00796367|590489163|FG002|Overall Study|Adverse Event|7|||
163488527|NCT00796367|590489161|FG000|Overall Study|Lost to Follow-up|5|||
163488528|NCT00796367|590489162|FG001|Overall Study|Lost to Follow-up|4|||
163488529|NCT00796367|590489163|FG002|Overall Study|Lost to Follow-up|21|||
163488530|NCT00796367|590489161|FG000|Overall Study|Withdrawal by Subject|9|||
163488531|NCT00796367|590489162|FG001|Overall Study|Withdrawal by Subject|11|||
163488532|NCT00796367|590489163|FG002|Overall Study|Withdrawal by Subject|12|||
163488533|NCT00796367|590489161|FG000|Overall Study|Lack of Efficacy|2|||
163488534|NCT00796367|590489162|FG001|Overall Study|Lack of Efficacy|1|||
163488535|NCT00796367|590489163|FG002|Overall Study|Lack of Efficacy|0|||
163488536|NCT00796367|590489161|FG000|Overall Study|non compliance|3|||
163488537|NCT00796367|590489162|FG001|Overall Study|non compliance|1|||
163488538|NCT00796367|590489163|FG002|Overall Study|non compliance|1|||
163488539|NCT00796367|590489161|FG000|Overall Study|Pregnancy|1|||
163488540|NCT00796367|590489162|FG001|Overall Study|Pregnancy|0|||
163488541|NCT00796367|590489163|FG002|Overall Study|Pregnancy|1|||
163488542|NCT00796367|590489161|FG000|Overall Study|Requirement for restricted medication|2|||
163488543|NCT00796367|590489162|FG001|Overall Study|Requirement for restricted medication|0|||
163488544|NCT00796367|590489163|FG002|Overall Study|Requirement for restricted medication|2|||
163488545|NCT00796367|590489161|FG000|Overall Study|other|2|||
163488546|NCT00796367|590489162|FG001|Overall Study|other|4|||
163488547|NCT00796367|590489163|FG002|Overall Study|other|3|||
163488548|NCT04604015|590489168|FG000|Overall Study|Incomplete Data Collection|33|||
163488549|NCT02129192|590489169|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
163488550|NCT02129192|590489170|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
163488551|NCT00553319|590489171|FG000|Overall Study|Lost to Follow-up|10|||
163488552|NCT00553319|590489172|FG001|Overall Study|Lost to Follow-up|9|||
163488553|NCT00553319|590489173|FG002|Overall Study|Lost to Follow-up|5|||
163488554|NCT00553319|590489171|FG000|Overall Study|wanted treatment elsewhere|2|||
163488555|NCT00553319|590489172|FG001|Overall Study|wanted treatment elsewhere|1|||
163488556|NCT00553319|590489173|FG002|Overall Study|wanted treatment elsewhere|1|||
163488557|NCT00553319|590489171|FG000|Overall Study|non-compliance|0|||
163488558|NCT00553319|590489172|FG001|Overall Study|non-compliance|0|||
163488559|NCT00553319|590489173|FG002|Overall Study|non-compliance|2|||
163488560|NCT00553319|590489171|FG000|Overall Study|incarceration|1|||
163488561|NCT00553319|590489172|FG001|Overall Study|incarceration|0|||
163488562|NCT00553319|590489173|FG002|Overall Study|incarceration|0|||
163488563|NCT00553319|590489171|FG000|Overall Study|moved|1|||
163488564|NCT00553319|590489172|FG001|Overall Study|moved|0|||
163488565|NCT00553319|590489173|FG002|Overall Study|moved|1|||
163488566|NCT03575975|590489179|FG000|Overall Study|Lost to Follow-up|1|||
163488567|NCT03575975|590489180|FG001|Overall Study|Lost to Follow-up|0|||
163488568|NCT03575975|590489181|FG002|Overall Study|Lost to Follow-up|0|||
163488569|NCT00465894|590489182|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
163488570|NCT00465894|590489183|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
163488571|NCT00465894|590489182|FG000|Treatment For 12 Weeks|Family Issues|1|||
163488572|NCT00465894|590489183|FG001|Treatment For 12 Weeks|Family Issues|1|||
163488573|NCT00465894|590489182|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
163488574|NCT00465894|590489183|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
163488575|NCT02441517|590489184|FG000|Overall Study|Lost to Follow-up|1|||
163488576|NCT02441517|590489184|FG000|Overall Study|Withdrawal by Subject|2|||
163488577|NCT02441517|590489184|FG000|Overall Study|Study Terminated by Sponsor|1|||
163488578|NCT00129220|590489185|FG000|Study Period II|Adverse Event|9|||
163488579|NCT00129220|590489186|FG001|Study Period II|Adverse Event|5|||
163488580|NCT00129220|590489187|FG002|Study Period II|Adverse Event|7|||
163488581|NCT00129220|590489185|FG000|Study Period II|Lack of Efficacy|15|||
163488582|NCT00129220|590489186|FG001|Study Period II|Lack of Efficacy|1|||
163488583|NCT00129220|590489187|FG002|Study Period II|Lack of Efficacy|28|||
163488584|NCT00129220|590489185|FG000|Study Period II|Entry Criteria Not Met|2|||
163488585|NCT00129220|590489186|FG001|Study Period II|Entry Criteria Not Met|0|||
163488586|NCT00129220|590489187|FG002|Study Period II|Entry Criteria Not Met|2|||
163488587|NCT00129220|590489185|FG000|Study Period II|Protocol Violation|4|||
163488588|NCT00129220|590489186|FG001|Study Period II|Protocol Violation|2|||
163488589|NCT00129220|590489187|FG002|Study Period II|Protocol Violation|1|||
163488590|NCT00129220|590489185|FG000|Study Period II|Physician Decision|0|||
163488591|NCT00129220|590489186|FG001|Study Period II|Physician Decision|1|||
163488592|NCT00129220|590489187|FG002|Study Period II|Physician Decision|0|||
163488593|NCT00129220|590489185|FG000|Study Period II|Withdrawal by Subject|1|||
163488594|NCT00129220|590489186|FG001|Study Period II|Withdrawal by Subject|3|||
163488595|NCT00129220|590489187|FG002|Study Period II|Withdrawal by Subject|4|||
163488596|NCT00129220|590489185|FG000|Study Period II|Reason Not Specified|2|||
163488597|NCT00129220|590489186|FG001|Study Period II|Reason Not Specified|0|||
163488598|NCT00129220|590489187|FG002|Study Period II|Reason Not Specified|5|||
163488599|NCT00129220|590489185|FG000|Study Period III|Adverse Event|1|||
163488600|NCT00129220|590489186|FG001|Study Period III|Adverse Event|0|||
163488601|NCT00129220|590489187|FG002|Study Period III|Adverse Event|3|||
163488602|NCT00129220|590489185|FG000|Study Period III|Protocol Violation|1|||
163488603|NCT00129220|590489186|FG001|Study Period III|Protocol Violation|1|||
163488604|NCT00129220|590489187|FG002|Study Period III|Protocol Violation|2|||
163488605|NCT00129220|590489185|FG000|Study Period III|Withdrawal by Subject|1|||
163488606|NCT00129220|590489186|FG001|Study Period III|Withdrawal by Subject|0|||
163488607|NCT00129220|590489187|FG002|Study Period III|Withdrawal by Subject|3|||
163488608|NCT00129220|590489185|FG000|Study Period III|Sponsor Decision|1|||
163488609|NCT00129220|590489186|FG001|Study Period III|Sponsor Decision|0|||
163488610|NCT00129220|590489187|FG002|Study Period III|Sponsor Decision|0|||
163488611|NCT00129220|590489185|FG000|Study Period III|Reason Not Specified|9|||
163488612|NCT00129220|590489186|FG001|Study Period III|Reason Not Specified|0|||
163488613|NCT00129220|590489187|FG002|Study Period III|Reason Not Specified|2|||
163488614|NCT01883362|590489189|FG000|Treatment|Adverse Event|1|||
163488615|NCT01883362|590489190|FG001|Treatment|Adverse Event|8|||
163488616|NCT01883362|590489189|FG000|Treatment|Withdrawal by Subject|6|||
163488617|NCT01883362|590489190|FG001|Treatment|Withdrawal by Subject|2|||
163488618|NCT01883362|590489189|FG000|Treatment|Administrative problems|4|||
163488619|NCT01883362|590489190|FG001|Treatment|Administrative problems|1|||
163488620|NCT01883362|590489189|FG000|Treatment|Relapse|4|||
163488621|NCT01883362|590489190|FG001|Treatment|Relapse|2|||
163488622|NCT01883362|590489189|FG000|Treatment|Randomized, not treated|1|||
163488623|NCT01883362|590489190|FG001|Treatment|Randomized, not treated|1|||
163488624|NCT01883362|590489189|FG000|Post Treatment Follow-up|Protocol Violation|0|||
163488625|NCT01883362|590489190|FG001|Post Treatment Follow-up|Protocol Violation|1|||
163488626|NCT01883362|590489189|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
163488627|NCT01883362|590489190|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
163488628|NCT01883362|590489189|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
163488629|NCT01883362|590489190|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
163488630|NCT01883362|590489189|FG000|Post Treatment Follow-up|Administrative problems|2|||
163488631|NCT01883362|590489190|FG001|Post Treatment Follow-up|Administrative problems|0|||
163488632|NCT01883362|590489189|FG000|Post Treatment Follow-up|Death|8|||
163488633|NCT01883362|590489190|FG001|Post Treatment Follow-up|Death|4|||
163488634|NCT01883362|590489189|FG000|Post Treatment Follow-up|Relapse|1|||
163488635|NCT01883362|590489190|FG001|Post Treatment Follow-up|Relapse|2|||
163488636|NCT01383317|590489191|FG000|Overall Study|Lost to Follow-up|2|||
163488637|NCT01383317|590489192|FG001|Overall Study|Lost to Follow-up|1|||
163488638|NCT01383317|590489191|FG000|Overall Study|Death|1|||
163488639|NCT01383317|590489192|FG001|Overall Study|Death|0|||
163488640|NCT01383317|590489191|FG000|Overall Study|Adverse Event|0|||
163488641|NCT01383317|590489192|FG001|Overall Study|Adverse Event|1|||
163488642|NCT01230489|590489194|FG000|Overall Study|Death|2|||
163488643|NCT01230489|590489194|FG000|Overall Study|Adverse Event|2|||
163488644|NCT01230489|590489194|FG000|Overall Study|Treatment modality changed|1|||
163488645|NCT00686894|590489195|FG000|Overall Study|Relapse|2|||
163488646|NCT00686894|590489195|FG000|Overall Study|Protocol Violation|4|||
163488647|NCT00967343|590489196|FG000|Overall Study|Study termination by sponsor|12|||
163488648|NCT00967343|590489196|FG000|Overall Study|Death|24|||
163488649|NCT00967343|590489196|FG000|Overall Study|Relapse|1|||
163488650|NCT00967343|590489196|FG000|Overall Study|Lost to Follow-up|1|||
163488651|NCT00869362|590490927|FG000|Overall Study|Death|0|||
163488652|NCT00869362|590490928|FG001|Overall Study|Death|2|||
163488653|NCT00869362|590490927|FG000|Overall Study|Lost to Follow-up|1|||
163488654|NCT00869362|590490928|FG001|Overall Study|Lost to Follow-up|3|||
163488655|NCT04887922|590490938|FG000|1st Randomization|Decided not to have surgery|0|||
163488656|NCT04887922|590490939|FG001|1st Randomization|Decided not to have surgery|1|||
163488657|NCT04887922|590490940|FG002|1st Randomization|Decided not to have surgery|0|||
163488658|NCT04887922|590490941|FG003|1st Randomization|Decided not to have surgery|0|||
163488659|NCT04887922|590490942|FG004|1st Randomization|Decided not to have surgery|0|||
163488660|NCT00953017|590490943|FG000|Overall Study|DId not show up for colonoscopy|4|||
163488661|NCT00953017|590490944|FG001|Overall Study|DId not show up for colonoscopy|4|||
163488662|NCT00953017|590490945|FG002|Overall Study|DId not show up for colonoscopy|5|||
163488663|NCT00953017|590490946|FG003|Overall Study|DId not show up for colonoscopy|4|||
163488664|NCT00953017|590490943|FG000|Overall Study|Incomplete data|1|||
163488665|NCT00953017|590490944|FG001|Overall Study|Incomplete data|1|||
163488666|NCT00953017|590490945|FG002|Overall Study|Incomplete data|0|||
163488667|NCT00953017|590490946|FG003|Overall Study|Incomplete data|0|||
163488668|NCT00953017|590490943|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
163488669|NCT00953017|590490944|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
163488670|NCT00953017|590490945|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
163488671|NCT00953017|590490946|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
163488672|NCT00953017|590490943|FG000|Overall Study|Brown stool prior to procedure|0|||
163488673|NCT00953017|590490944|FG001|Overall Study|Brown stool prior to procedure|0|||
163488674|NCT00953017|590490945|FG002|Overall Study|Brown stool prior to procedure|1|||
163488675|NCT00953017|590490946|FG003|Overall Study|Brown stool prior to procedure|0|||
163488676|NCT00798161|590490949|FG000|Overall Study|Adverse Event|3|||
163488677|NCT00798161|590490950|FG001|Overall Study|Adverse Event|4|||
163488678|NCT00798161|590490951|FG002|Overall Study|Adverse Event|6|||
163488679|NCT00798161|590490952|FG003|Overall Study|Adverse Event|6|||
163488680|NCT00798161|590490953|FG004|Overall Study|Adverse Event|5|||
163488681|NCT00798161|590490954|FG005|Overall Study|Adverse Event|2|||
163488682|NCT00798161|590490955|FG006|Overall Study|Adverse Event|4|||
163488683|NCT00798161|590490949|FG000|Overall Study|Protocol Violation|2|||
163488684|NCT00798161|590490950|FG001|Overall Study|Protocol Violation|1|||
163488685|NCT00798161|590490951|FG002|Overall Study|Protocol Violation|3|||
163488686|NCT00798161|590490952|FG003|Overall Study|Protocol Violation|3|||
163488687|NCT00798161|590490953|FG004|Overall Study|Protocol Violation|3|||
163488688|NCT00798161|590490954|FG005|Overall Study|Protocol Violation|2|||
163488689|NCT00798161|590490955|FG006|Overall Study|Protocol Violation|0|||
163488690|NCT00798161|590490949|FG000|Overall Study|Lost to Follow-up|1|||
163488691|NCT00798161|590490950|FG001|Overall Study|Lost to Follow-up|3|||
163488692|NCT00798161|590490951|FG002|Overall Study|Lost to Follow-up|4|||
163488693|NCT00798161|590490952|FG003|Overall Study|Lost to Follow-up|3|||
163488694|NCT00798161|590490953|FG004|Overall Study|Lost to Follow-up|4|||
163488695|NCT00798161|590490954|FG005|Overall Study|Lost to Follow-up|0|||
163488696|NCT00798161|590490955|FG006|Overall Study|Lost to Follow-up|0|||
163488697|NCT00798161|590490949|FG000|Overall Study|Withdrawal by Subject|5|||
163488698|NCT00798161|590490950|FG001|Overall Study|Withdrawal by Subject|4|||
163488699|NCT00798161|590490951|FG002|Overall Study|Withdrawal by Subject|5|||
163488700|NCT00798161|590490952|FG003|Overall Study|Withdrawal by Subject|4|||
163488701|NCT00798161|590490953|FG004|Overall Study|Withdrawal by Subject|2|||
163488702|NCT00798161|590490954|FG005|Overall Study|Withdrawal by Subject|3|||
163488703|NCT00798161|590490955|FG006|Overall Study|Withdrawal by Subject|1|||
163488704|NCT00798161|590490949|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
163488705|NCT00798161|590490950|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
163488706|NCT00798161|590490951|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
163488707|NCT00798161|590490952|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
163488708|NCT00798161|590490953|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
163488709|NCT00798161|590490954|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
163488710|NCT00798161|590490955|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
163488711|NCT00594568|590490956|FG000|Initial Treatment|Adverse Event|51|||
163488712|NCT00594568|590490957|FG001|Initial Treatment|Adverse Event|121|||
163488713|NCT00594568|590490958|FG002|Initial Treatment|Adverse Event|144|||
163488714|NCT00594568|590490956|FG000|Initial Treatment|Death|6|||
163488715|NCT00594568|590490957|FG001|Initial Treatment|Death|11|||
163488716|NCT00594568|590490958|FG002|Initial Treatment|Death|15|||
163488717|NCT00594568|590490956|FG000|Initial Treatment|Lost to Follow-up|4|||
163488718|NCT00594568|590490957|FG001|Initial Treatment|Lost to Follow-up|1|||
163488719|NCT00594568|590490958|FG002|Initial Treatment|Lost to Follow-up|4|||
163488720|NCT00594568|590490956|FG000|Initial Treatment|Physician Decision|3|||
163488721|NCT00594568|590490957|FG001|Initial Treatment|Physician Decision|2|||
163488722|NCT00594568|590490958|FG002|Initial Treatment|Physician Decision|4|||
163488723|NCT00594568|590490956|FG000|Initial Treatment|Protocol Violation|2|||
163488724|NCT00594568|590490957|FG001|Initial Treatment|Protocol Violation|2|||
163488725|NCT00594568|590490958|FG002|Initial Treatment|Protocol Violation|5|||
163488726|NCT00594568|590490956|FG000|Initial Treatment|Withdrawal by Subject|25|||
163488727|NCT00594568|590490957|FG001|Initial Treatment|Withdrawal by Subject|31|||
163488728|NCT00594568|590490958|FG002|Initial Treatment|Withdrawal by Subject|46|||
163488729|NCT00594568|590490956|FG000|Initial Treatment|Sponsor decision|193|||
163488730|NCT00594568|590490957|FG001|Initial Treatment|Sponsor decision|142|||
163488731|NCT00594568|590490958|FG002|Initial Treatment|Sponsor decision|147|||
163488732|NCT00594568|590490956|FG000|Initial Treatment|Caregiver decision|21|||
163488733|NCT00594568|590490957|FG001|Initial Treatment|Caregiver decision|36|||
163488734|NCT00594568|590490958|FG002|Initial Treatment|Caregiver decision|36|||
163488735|NCT00594568|590490956|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
163488736|NCT00594568|590490957|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
163488737|NCT00594568|590490958|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
163488738|NCT00594568|590490956|FG000|Initial Treatment|Entry criteria exclusion|0|||
163488739|NCT00594568|590490957|FG001|Initial Treatment|Entry criteria exclusion|1|||
163488740|NCT00594568|590490958|FG002|Initial Treatment|Entry criteria exclusion|1|||
163488741|NCT00594568|590490956|FG000|Delayed Start|Death|0|||
163488742|NCT00594568|590490957|FG001|Delayed Start|Death|0|||
163488743|NCT00594568|590490958|FG002|Delayed Start|Death|1|||
163488744|NCT00594568|590490956|FG000|Delayed Start|Adverse Event|12|||
163488745|NCT00594568|590490957|FG001|Delayed Start|Adverse Event|2|||
163488746|NCT00594568|590490958|FG002|Delayed Start|Adverse Event|2|||
163488747|NCT00594568|590490956|FG000|Delayed Start|Withdrawal by Subject|4|||
163488748|NCT00594568|590490957|FG001|Delayed Start|Withdrawal by Subject|3|||
163488749|NCT00594568|590490958|FG002|Delayed Start|Withdrawal by Subject|0|||
163488750|NCT00594568|590490956|FG000|Delayed Start|Physician Decision|0|||
163488751|NCT00594568|590490957|FG001|Delayed Start|Physician Decision|0|||
163488752|NCT00594568|590490958|FG002|Delayed Start|Physician Decision|1|||
163488753|NCT00594568|590490956|FG000|Delayed Start|Lost to Follow-up|0|||
163488754|NCT00594568|590490957|FG001|Delayed Start|Lost to Follow-up|0|||
163488755|NCT00594568|590490958|FG002|Delayed Start|Lost to Follow-up|1|||
163488756|NCT00594568|590490956|FG000|Delayed Start|Caregiver Decision|5|||
163488757|NCT00594568|590490957|FG001|Delayed Start|Caregiver Decision|6|||
163488758|NCT00594568|590490958|FG002|Delayed Start|Caregiver Decision|2|||
163488759|NCT00594568|590490956|FG000|Delayed Start|Sponsor Decision|77|||
163488760|NCT00594568|590490957|FG001|Delayed Start|Sponsor Decision|66|||
163488761|NCT00594568|590490958|FG002|Delayed Start|Sponsor Decision|59|||
163488762|NCT00594568|590490956|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
163488763|NCT00594568|590490957|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
163488764|NCT00594568|590490958|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
163488765|NCT00594568|590490956|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
163488766|NCT00594568|590490957|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
163488767|NCT00594568|590490958|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
163488768|NCT00594568|590490956|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
163488769|NCT00594568|590490957|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
163488770|NCT00594568|590490958|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
163488771|NCT00594568|590490956|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
163488772|NCT00594568|590490957|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
163488773|NCT00594568|590490958|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
163488774|NCT00594568|590490956|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
163488775|NCT00594568|590490957|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
163488776|NCT00594568|590490958|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
163488777|NCT00594568|590490956|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
163488778|NCT00594568|590490957|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
163488779|NCT00594568|590490958|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
163488780|NCT01548573|590490960|FG000|Overall Study|Death|3|||
163488781|NCT01548573|590490960|FG000|Overall Study|Withdrawal by Subject|2|||
163488782|NCT01366846|590490961|FG000|Overall Study|Withdrawal by Subject|2|||
163488783|NCT01366846|590490962|FG001|Overall Study|Withdrawal by Subject|0|||
163488784|NCT01366846|590490963|FG002|Overall Study|Withdrawal by Subject|0|||
163488785|NCT01366846|590490964|FG003|Overall Study|Withdrawal by Subject|0|||
163488786|NCT01366846|590490961|FG000|Overall Study|Communication Difficulties|1|||
163488787|NCT01366846|590490962|FG001|Overall Study|Communication Difficulties|4|||
163488788|NCT01366846|590490963|FG002|Overall Study|Communication Difficulties|0|||
163488789|NCT01366846|590490964|FG003|Overall Study|Communication Difficulties|1|||
163488790|NCT01366846|590490961|FG000|Overall Study|Scheduling Conflicts|0|||
163488791|NCT01366846|590490962|FG001|Overall Study|Scheduling Conflicts|0|||
163488792|NCT01366846|590490963|FG002|Overall Study|Scheduling Conflicts|1|||
163488793|NCT01366846|590490964|FG003|Overall Study|Scheduling Conflicts|0|||
163488794|NCT00290511|590490965|FG000|Overall Study|Adverse Event|1|||
163488795|NCT00290511|590490965|FG000|Overall Study|Death|1|||
163488796|NCT00290511|590490965|FG000|Overall Study|Physician Decision|1|||
163488797|NCT00290511|590490965|FG000|Overall Study|Withdrawal by Subject|1|||
163488798|NCT00447265|590490966|FG000|Overall Study|Physician Decision|1|||
163488799|NCT00447265|590490967|FG001|Overall Study|Physician Decision|0|||
163488800|NCT04311411|590490968|FG000|Overall Study|Adverse Event|2|||
163488801|NCT04311411|590490969|FG001|Overall Study|Adverse Event|3|||
163488802|NCT04311411|590490970|FG002|Overall Study|Adverse Event|2|||
163488803|NCT04311411|590490968|FG000|Overall Study|Withdrawal by Subject|3|||
163488804|NCT04311411|590490969|FG001|Overall Study|Withdrawal by Subject|3|||
163488805|NCT04311411|590490970|FG002|Overall Study|Withdrawal by Subject|0|||
163488806|NCT01976663|590490974|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
163488807|NCT01976663|590490974|FG000|Overall Study|Personal Reasons|6|||
163488808|NCT01976663|590490974|FG000|Overall Study|Withdrawal by Subject|4|||
163488809|NCT01976663|590490974|FG000|Overall Study|Screen Failure|3|||
163488810|NCT01976663|590490974|FG000|Overall Study|Adverse Event|2|||
163488811|NCT01976663|590490974|FG000|Overall Study|Lost to Follow-up|3|||
163488812|NCT04780776|590490977|FG000|Titration Week 1-5|Lost to Follow-up|2|||
163488813|NCT04780776|590490978|FG001|Titration Week 1-5|Lost to Follow-up|8|||
163488814|NCT04780776|590490977|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
163488815|NCT04780776|590490978|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
163488816|NCT04780776|590490977|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
163488817|NCT04780776|590490978|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
163488818|NCT03113760|590490980|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
163488819|NCT03113760|590490981|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
163488820|NCT03113760|590490982|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
163488821|NCT03113760|590490983|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
163488822|NCT03113760|590490980|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
163488823|NCT03113760|590490981|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
163488824|NCT03113760|590490982|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
163488825|NCT03113760|590490983|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
163488826|NCT03113760|590490980|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
163488827|NCT03113760|590490981|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
163488828|NCT03113760|590490982|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
163488829|NCT03113760|590490983|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
163488830|NCT00465101|590490984|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
163488831|NCT00465101|590490984|FG000|Overall Study|Change in health precluded follow up|4|||
163488832|NCT00465101|590490984|FG000|Overall Study|Did not meet study criteria|4|||
163488833|NCT00465101|590490984|FG000|Overall Study|Lost to Follow-up|5|||
163488834|NCT00465101|590490984|FG000|Overall Study|Other|6|||
163488835|NCT00465101|590490984|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
163488836|NCT00465101|590490984|FG000|Overall Study|Patient postponed procedure|1|||
163488837|NCT00465101|590490984|FG000|Overall Study|Site closed due to IRB expiration|1|||
163488838|NCT00465101|590490984|FG000|Overall Study|Unable to obtain IRB approval|1|||
163488839|NCT00465101|590490984|FG000|Overall Study|Death|3|||
163488840|NCT00465101|590490984|FG000|Overall Study|Withdrawal by Subject|25|||
163488841|NCT00465101|590490984|FG000|Overall Study|Physician Decision|1|||
163488842|NCT00465101|590490984|FG000|Overall Study|Withdrew consent prior to procedure|3|||
163488843|NCT00933543|590490986|FG000|Overall Study|Adverse Event|2|||
163488844|NCT00933543|590490987|FG001|Overall Study|Adverse Event|1|||
163488845|NCT00933543|590490986|FG000|Overall Study|Lost to Follow-up|0|||
163488846|NCT00933543|590490987|FG001|Overall Study|Lost to Follow-up|1|||
163488847|NCT00933543|590490986|FG000|Overall Study|Withdrawal by Subject|0|||
163488848|NCT00933543|590490987|FG001|Overall Study|Withdrawal by Subject|1|||
163488849|NCT00933543|590490986|FG000|Overall Study|Lack of Efficacy|0|||
163488850|NCT00933543|590490987|FG001|Overall Study|Lack of Efficacy|3|||
163488851|NCT00933543|590490986|FG000|Overall Study|Other|1|||
163488852|NCT00933543|590490987|FG001|Overall Study|Other|1|||
163488853|NCT04988035|590490993|FG000|Overall Study|Death|19|||
163488854|NCT04988035|590490994|FG001|Overall Study|Death|13|||
163488855|NCT04988035|590490993|FG000|Overall Study|Lost to Follow-up|12|||
163488856|NCT04988035|590490994|FG001|Overall Study|Lost to Follow-up|6|||
163488857|NCT04988035|590490993|FG000|Overall Study|Protocol Violation|0|||
163488858|NCT04988035|590490994|FG001|Overall Study|Protocol Violation|1|||
163488859|NCT04988035|590490993|FG000|Overall Study|Withdrawal by Subject|2|||
163488860|NCT04988035|590490994|FG001|Overall Study|Withdrawal by Subject|4|||
163488861|NCT04988035|590490993|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
163488862|NCT04988035|590490994|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
163488863|NCT03532048|590490995|FG000|Overall Study|Lost to Follow-up|12|||
163488864|NCT03532048|590490996|FG001|Overall Study|Lost to Follow-up|17|||
163488865|NCT03532048|590490995|FG000|Overall Study|Withdrawal by Subject|7|||
163488866|NCT03532048|590490996|FG001|Overall Study|Withdrawal by Subject|0|||
163488867|NCT00442572|590490997|FG000|Overall Study|Relapse|8|||
163488868|NCT00442572|590490998|FG001|Overall Study|Relapse|1|||
163488869|NCT00442572|590490997|FG000|Overall Study|Lost to Follow-up|0|||
163488870|NCT00442572|590490998|FG001|Overall Study|Lost to Follow-up|1|||
163488871|NCT00442572|590490997|FG000|Overall Study|Withdrawal by Subject|0|||
163488872|NCT00442572|590490998|FG001|Overall Study|Withdrawal by Subject|1|||
163488873|NCT04366258|590490999|FG000|Baseline Assessments|Screen Failure|21|||
163488874|NCT04366258|590490999|FG000|Baseline Assessments|Early Termination|3|||
163488875|NCT00308555|590491001|FG000|Overall Study|Withdrawal by Subject|1|||
163488876|NCT00308555|590491002|FG001|Overall Study|Withdrawal by Subject|0|||
163488877|NCT00308555|590491001|FG000|Overall Study|Physician Decision|2|||
163488878|NCT00308555|590491002|FG001|Overall Study|Physician Decision|0|||
163488879|NCT04113746|590491009|FG000|Overall Study|Lost to Follow-up|4|||
163488880|NCT04113746|590491010|FG001|Overall Study|Lost to Follow-up|4|||
163488881|NCT00429026|590491012|FG000|Overall Study|Inevaluable for response.|40|||
163488882|NCT00499694|590491017|FG000|Overall Study|Patient never received treatment.|1|||
163488883|NCT03958045|590491018|FG000|Overall Study|Withdrawal by Subject|1|||
163488884|NCT00674440|590491019|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
163488885|NCT00674440|590491019|FG000|Overall Study|did not have surgery, so unevaluable|7|||
163488886|NCT00674440|590491019|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
163488887|NCT01463631|590491020|FG000|Overall Study|Withdrawal by Subject|0|||
163488888|NCT01463631|590491021|FG001|Overall Study|Withdrawal by Subject|0|||
163488889|NCT01463631|590491022|FG002|Overall Study|Withdrawal by Subject|0|||
163488890|NCT01463631|590491023|FG003|Overall Study|Withdrawal by Subject|1|||
163488891|NCT01463631|590491020|FG000|Overall Study|Death|0|||
163488892|NCT01463631|590491021|FG001|Overall Study|Death|0|||
163488893|NCT01463631|590491022|FG002|Overall Study|Death|1|||
163488894|NCT01463631|590491023|FG003|Overall Study|Death|0|||
163488895|NCT01463631|590491020|FG000|Overall Study|Progressive Disease|0|||
163488896|NCT01463631|590491021|FG001|Overall Study|Progressive Disease|0|||
163488897|NCT01463631|590491022|FG002|Overall Study|Progressive Disease|0|||
163488898|NCT01463631|590491023|FG003|Overall Study|Progressive Disease|5|||
163488899|NCT04409262|590491038|FG000|Overall Study|Adverse Event|0|||
163488900|NCT04409262|590491039|FG001|Overall Study|Adverse Event|2|||
163488901|NCT04409262|590491038|FG000|Overall Study|Death|55|||
163488902|NCT04409262|590491039|FG001|Overall Study|Death|97|||
163488903|NCT04409262|590491038|FG000|Overall Study|Lost to Follow-up|12|||
163488904|NCT04409262|590491039|FG001|Overall Study|Lost to Follow-up|23|||
163488905|NCT04409262|590491038|FG000|Overall Study|Lack of Staff|0|||
163488906|NCT04409262|590491039|FG001|Overall Study|Lack of Staff|1|||
163488907|NCT04409262|590491038|FG000|Overall Study|Protocol Violation|3|||
163488908|NCT04409262|590491039|FG001|Overall Study|Protocol Violation|1|||
163488909|NCT04409262|590491038|FG000|Overall Study|Withdrawal by Subject|5|||
163488910|NCT04409262|590491039|FG001|Overall Study|Withdrawal by Subject|10|||
163488911|NCT04794491|590491043|FG000|Overall Study|Adverse Event|1|||
163488912|NCT04794491|590491043|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
163488913|NCT04794491|590491043|FG000|Overall Study|Noncompliance With Study Intervention|1|||
163488914|NCT04794491|590491043|FG000|Overall Study|Withdrawal by Subject|2|||
163488915|NCT01326481|590491044|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
163488916|NCT00948896|590491045|FG000|Randomization to 24 Months of Age|Death|1|||
163488917|NCT00948896|590491046|FG001|Randomization to 24 Months of Age|Death|0|||
163488918|NCT00948896|590491047|FG002|Randomization to 24 Months of Age|Death|0|||
163488919|NCT00948896|590491048|FG003|Randomization to 24 Months of Age|Death|0|||
163488920|NCT00948896|590491049|FG004|Randomization to 24 Months of Age|Death|2|||
163488921|NCT00948896|590491050|FG005|Randomization to 24 Months of Age|Death|1|||
163488922|NCT00948896|590491051|FG006|Randomization to 24 Months of Age|Death|2|||
163488923|NCT00948896|590491052|FG007|Randomization to 24 Months of Age|Death|1|||
163488924|NCT00948896|590491045|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
163488925|NCT00948896|590491046|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
163488926|NCT00948896|590491047|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
163488927|NCT00948896|590491048|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
163488928|NCT00948896|590491049|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
163488929|NCT00948896|590491050|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
163488930|NCT00948896|590491051|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
163488931|NCT00948896|590491052|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
163488932|NCT00948896|590491045|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
163488933|NCT00948896|590491046|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
163488934|NCT00948896|590491047|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
163488935|NCT00948896|590491048|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
163488936|NCT00948896|590491049|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
163488937|NCT00948896|590491050|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
163488938|NCT00948896|590491051|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
163488939|NCT00948896|590491052|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
163488940|NCT00948896|590491045|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
163488941|NCT00948896|590491046|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
163488942|NCT00948896|590491047|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
163488943|NCT00948896|590491048|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
163488944|NCT00948896|590491049|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
163488945|NCT00948896|590491050|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
163488946|NCT00948896|590491051|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
163488947|NCT00948896|590491052|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
163488948|NCT00948896|590491045|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
163488949|NCT00948896|590491046|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
163488950|NCT00948896|590491047|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
163488951|NCT00948896|590491048|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
163488952|NCT00948896|590491049|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
163488953|NCT00948896|590491050|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
163488954|NCT00948896|590491051|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
163488955|NCT00948896|590491052|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
163488956|NCT00948896|590491045|FG000|24 Months of Age to 36 Months of Age|Death|0|||
163488957|NCT00948896|590491046|FG001|24 Months of Age to 36 Months of Age|Death|2|||
163488958|NCT00948896|590491047|FG002|24 Months of Age to 36 Months of Age|Death|2|||
163488959|NCT00948896|590491048|FG003|24 Months of Age to 36 Months of Age|Death|0|||
163488960|NCT00948896|590491049|FG004|24 Months of Age to 36 Months of Age|Death|0|||
163488961|NCT00948896|590491050|FG005|24 Months of Age to 36 Months of Age|Death|1|||
163488962|NCT00948896|590491051|FG006|24 Months of Age to 36 Months of Age|Death|0|||
163488963|NCT00948896|590491052|FG007|24 Months of Age to 36 Months of Age|Death|0|||
163488964|NCT00948896|590491045|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
163488965|NCT00948896|590491046|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
163488966|NCT00948896|590491047|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
163488967|NCT00948896|590491048|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
163488968|NCT00948896|590491049|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
163488969|NCT00948896|590491050|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
163488970|NCT00948896|590491051|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
163488971|NCT00948896|590491052|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
163488972|NCT00948896|590491045|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
163488973|NCT00948896|590491046|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
163488974|NCT00948896|590491047|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
163488975|NCT00948896|590491048|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
163488976|NCT00948896|590491049|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
163488977|NCT00948896|590491050|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
163488978|NCT00948896|590491051|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
163488979|NCT00948896|590491052|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
163488980|NCT00948896|590491045|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
163488981|NCT00948896|590491046|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
163488982|NCT00948896|590491047|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
163488983|NCT00948896|590491048|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
163488984|NCT00948896|590491049|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
163488985|NCT00948896|590491050|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
163488986|NCT00948896|590491051|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
163488987|NCT00948896|590491052|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
163488988|NCT00948896|590491045|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
163488989|NCT00948896|590491046|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
163488990|NCT00948896|590491047|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
163488991|NCT00948896|590491048|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
163488992|NCT00948896|590491049|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
163488993|NCT00948896|590491050|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
163488994|NCT00948896|590491051|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
163488995|NCT00948896|590491052|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
163488996|NCT00945815|590491053|FG000|Overall Study|Death|3|||
163488997|NCT00945815|590491053|FG000|Overall Study|Not protocol specified|1|||
163488998|NCT00945815|590491053|FG000|Overall Study|Ineligible|3|||
163488999|NCT00945815|590491053|FG000|Overall Study|Did not begin protocol therapy|1|||
163489000|NCT01990339|590491058|FG000|Overall Study|Data Not Available|49|||
163489001|NCT01990339|590491058|FG000|Overall Study|Voluntary Withdrawal|1402|||
163489002|NCT01990339|590491058|FG000|Overall Study|Lost to Follow-up|861|||
163489003|NCT01038609|590491059|FG000|Overall Study|Adverse Event|0|||
163489004|NCT01038609|590491060|FG001|Overall Study|Adverse Event|0|||
163489005|NCT01038609|590491061|FG002|Overall Study|Adverse Event|1|||
163489006|NCT01038609|590491062|FG003|Overall Study|Adverse Event|0|||
163489007|NCT01038609|590491063|FG004|Overall Study|Adverse Event|0|||
163489008|NCT01038609|590491059|FG000|Overall Study|Dosing Error|0|||
163489009|NCT01038609|590491060|FG001|Overall Study|Dosing Error|0|||
163489010|NCT01038609|590491061|FG002|Overall Study|Dosing Error|0|||
163489011|NCT01038609|590491062|FG003|Overall Study|Dosing Error|1|||
163489012|NCT01038609|590491063|FG004|Overall Study|Dosing Error|1|||
163489013|NCT01038609|590491059|FG000|Overall Study|Death in the Family|1|||
163489014|NCT01038609|590491060|FG001|Overall Study|Death in the Family|0|||
163489015|NCT01038609|590491061|FG002|Overall Study|Death in the Family|0|||
163489016|NCT01038609|590491062|FG003|Overall Study|Death in the Family|0|||
163489017|NCT01038609|590491063|FG004|Overall Study|Death in the Family|0|||
163489018|NCT01038609|590491059|FG000|Overall Study|Refusal of Blood Draws|0|||
163489019|NCT01038609|590491060|FG001|Overall Study|Refusal of Blood Draws|1|||
163489020|NCT01038609|590491061|FG002|Overall Study|Refusal of Blood Draws|0|||
163489021|NCT01038609|590491062|FG003|Overall Study|Refusal of Blood Draws|0|||
163489022|NCT01038609|590491063|FG004|Overall Study|Refusal of Blood Draws|0|||
163489023|NCT00242658|590491066|FG000|Overall Study|Lost to Follow-up|22|||
163489024|NCT00242658|590491067|FG001|Overall Study|Lost to Follow-up|19|||
163489025|NCT01590810|590491068|FG000|Overall Study|Physician Decision|0|||
163489026|NCT01590810|590491069|FG001|Overall Study|Physician Decision|1|||
163489027|NCT01590810|590491070|FG002|Overall Study|Physician Decision|1|||
163489028|NCT01590810|590491071|FG003|Overall Study|Physician Decision|0|||
163489029|NCT01590810|590491072|FG004|Overall Study|Physician Decision|0|||
163489030|NCT01087944|590491076|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
163489031|NCT01087944|590491077|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
163489032|NCT01087944|590491076|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
163489033|NCT01087944|590491077|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
163489034|NCT01731600|590491078|FG000|Overall Study|Adverse Event|2|||
163489035|NCT01731600|590491079|FG001|Overall Study|Adverse Event|0|||
163489036|NCT01731600|590491078|FG000|Overall Study|Withdrawal criteria|1|||
163489037|NCT01731600|590491079|FG001|Overall Study|Withdrawal criteria|0|||
163489038|NCT01731600|590491078|FG000|Overall Study|Other reasons|3|||
163489039|NCT01731600|590491079|FG001|Overall Study|Other reasons|0|||
163489040|NCT01349816|590491082|FG000|Overall Study|Withdrawal by Subject|4|||
163489041|NCT01349816|590491082|FG000|Overall Study|Physician Decision|1|||
163489042|NCT01349816|590491082|FG000|Overall Study|Adverse Event|14|||
163489043|NCT01349816|590491082|FG000|Overall Study|Lost to Follow-up|2|||
163489044|NCT01349816|590491082|FG000|Overall Study|Protocol Violation|1|||
163489045|NCT01349816|590491082|FG000|Overall Study|Protocol-specified criteria|8|||
163489046|NCT01479777|590493212|FG000|Overall Study|Physician Decision|2|||
163489047|NCT03575806|590493213|FG000|Overall Study|Withdrawal by Subject|0|||
163489048|NCT03575806|590493214|FG001|Overall Study|Withdrawal by Subject|2|||
163489049|NCT03575806|590493213|FG000|Overall Study|Protocol Violation|0|||
163489050|NCT03575806|590493214|FG001|Overall Study|Protocol Violation|2|||
163489051|NCT02842736|590493218|FG000|Overall Study|Lost to Follow-up|13|||
163489052|NCT02842736|590493218|FG000|Overall Study|Intervention for menstrual bleeding|17|||
163489053|NCT02842736|590493218|FG000|Overall Study|Withdrawal by Subject|4|||
163489054|NCT02842736|590493218|FG000|Overall Study|Pregnancy|3|||
163489055|NCT02842736|590493218|FG000|Overall Study|Hysterectomy for fibroids|2|||
163489056|NCT02842736|590493218|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
163489057|NCT02842736|590493218|FG000|Overall Study|IUD: Mirena|1|||
163489058|NCT02389621|590493220|FG000|Treatment Period|Withdrawal by Subject|1|||
163489059|NCT02389621|590493221|FG001|Treatment Period|Withdrawal by Subject|1|||
163489060|NCT02389621|590493220|FG000|Posttreatment Period|Adverse Event|3|||
163489061|NCT02389621|590493221|FG001|Posttreatment Period|Adverse Event|1|||
163489062|NCT02389621|590493220|FG000|Posttreatment Period|Withdrawal by Subject|3|||
163489063|NCT02389621|590493221|FG001|Posttreatment Period|Withdrawal by Subject|2|||
163489064|NCT02389621|590493220|FG000|Posttreatment Period|Lost to Follow-up|1|||
163489065|NCT02389621|590493221|FG001|Posttreatment Period|Lost to Follow-up|1|||
163489066|NCT02389621|590493220|FG000|Posttreatment Period|Other - Miscellaneous|2|||
163489067|NCT02389621|590493221|FG001|Posttreatment Period|Other - Miscellaneous|0|||
163489068|NCT02815540|590493226|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
163489069|NCT00726882|590493227|FG000|Overall Study|Withdrawal by Subject|5|||
163489070|NCT00726882|590493227|FG000|Overall Study|Lost to Follow-up|7|||
163489071|NCT00726882|590493227|FG000|Overall Study|Other|10|||
163489072|NCT00344968|590493228|FG000|Overall Study|Adverse Event|5|||
163489073|NCT00344968|590493229|FG001|Overall Study|Adverse Event|4|||
163489074|NCT00344968|590493230|FG002|Overall Study|Adverse Event|15|||
163489075|NCT00344968|590493228|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
163489076|NCT00344968|590493229|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163489077|NCT00344968|590493230|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
163489078|NCT00344968|590493228|FG000|Overall Study|Protocol Violation|2|||
163489079|NCT00344968|590493229|FG001|Overall Study|Protocol Violation|2|||
163489080|NCT00344968|590493230|FG002|Overall Study|Protocol Violation|5|||
163489081|NCT00344968|590493228|FG000|Overall Study|Withdrawal by Subject|14|||
163489082|NCT00344968|590493229|FG001|Overall Study|Withdrawal by Subject|31|||
163489083|NCT00344968|590493230|FG002|Overall Study|Withdrawal by Subject|27|||
163489084|NCT00344968|590493228|FG000|Overall Study|Lost to Follow-up|24|||
163489085|NCT00344968|590493229|FG001|Overall Study|Lost to Follow-up|37|||
163489086|NCT00344968|590493230|FG002|Overall Study|Lost to Follow-up|37|||
163489087|NCT00344968|590493228|FG000|Overall Study|Death|11|||
163489088|NCT00344968|590493229|FG001|Overall Study|Death|27|||
163489089|NCT00344968|590493230|FG002|Overall Study|Death|31|||
163489090|NCT00344968|590493228|FG000|Overall Study|Other|0|||
163489091|NCT00344968|590493229|FG001|Overall Study|Other|1|||
163489092|NCT00344968|590493230|FG002|Overall Study|Other|0|||
163489093|NCT02526017|590493231|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
163489094|NCT02526017|590493232|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
163489095|NCT02526017|590493233|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
163489096|NCT02526017|590493234|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
163489097|NCT02526017|590493235|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
163489098|NCT02526017|590493236|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
163489099|NCT02526017|590493237|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
163489100|NCT02526017|590493238|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
163489101|NCT02526017|590493239|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
163489102|NCT03246152|590493252|FG000|Overall Study|Lost to Follow-up|2|||
163489103|NCT03246152|590493252|FG000|Overall Study|Protocol Violation|1|||
163489104|NCT00423137|590493253|FG000|Overall Study|Lost to Follow-up|0|||
163489105|NCT00423137|590493254|FG001|Overall Study|Lost to Follow-up|0|||
163489106|NCT00423137|590493255|FG002|Overall Study|Lost to Follow-up|1|||
163489107|NCT00423137|590493256|FG003|Overall Study|Lost to Follow-up|0|||
163489108|NCT00423137|590493253|FG000|Overall Study|Protocol Violation|0|||
163489109|NCT00423137|590493254|FG001|Overall Study|Protocol Violation|0|||
163489110|NCT00423137|590493255|FG002|Overall Study|Protocol Violation|0|||
163489111|NCT00423137|590493256|FG003|Overall Study|Protocol Violation|1|||
163489112|NCT00423137|590493253|FG000|Overall Study|Adverse Event Study disease worse|1|||
163489113|NCT00423137|590493254|FG001|Overall Study|Adverse Event Study disease worse|0|||
163489114|NCT00423137|590493255|FG002|Overall Study|Adverse Event Study disease worse|3|||
163489115|NCT00423137|590493256|FG003|Overall Study|Adverse Event Study disease worse|1|||
163489116|NCT00423137|590493253|FG000|Overall Study|Adverse Event Other|0|||
163489117|NCT00423137|590493254|FG001|Overall Study|Adverse Event Other|0|||
163489118|NCT00423137|590493255|FG002|Overall Study|Adverse Event Other|2|||
163489119|NCT00423137|590493256|FG003|Overall Study|Adverse Event Other|0|||
163489120|NCT04196023|590493259|FG000|Overall Study|Withdrawal by Subject|0|||
163489121|NCT04196023|590493260|FG001|Overall Study|Withdrawal by Subject|1|||
163489122|NCT04196023|590493259|FG000|Overall Study|Adverse Event|3|||
163489123|NCT04196023|590493260|FG001|Overall Study|Adverse Event|1|||
163489124|NCT04196023|590493259|FG000|Overall Study|Lost to Follow-up|0|||
163489125|NCT04196023|590493260|FG001|Overall Study|Lost to Follow-up|1|||
163489126|NCT04359758|590493265|FG000|Overall Study|Protocol Violation|3|||
163489127|NCT04359758|590493266|FG001|Overall Study|Protocol Violation|2|||
163489128|NCT03358407|590493270|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
163489129|NCT03358407|590493271|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
163489130|NCT03358407|590493272|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
163489131|NCT03358407|590493273|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
163489132|NCT03358407|590493274|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
163489133|NCT03358407|590493275|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
163489134|NCT03358407|590493276|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
163489135|NCT03358407|590493277|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
163489136|NCT03358407|590493278|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
163489137|NCT03358407|590493279|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
163489138|NCT03358407|590493270|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489139|NCT03358407|590493271|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489140|NCT03358407|590493272|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489141|NCT03358407|590493273|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489142|NCT03358407|590493274|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
163489143|NCT03358407|590493275|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489144|NCT03358407|590493276|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489145|NCT03358407|590493277|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489146|NCT03358407|590493278|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489147|NCT03358407|590493279|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489148|NCT03358407|590493270|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
163489149|NCT03358407|590493271|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
163489150|NCT03358407|590493272|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
163489151|NCT03358407|590493273|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
163489152|NCT03358407|590493274|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
163489153|NCT03358407|590493275|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
163489154|NCT03358407|590493276|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
163489155|NCT03358407|590493277|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
163489156|NCT03358407|590493278|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
163489157|NCT03358407|590493279|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
163489158|NCT03358407|590493270|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
163489159|NCT03358407|590493271|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
163489160|NCT03358407|590493272|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
163489161|NCT03358407|590493273|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
163489162|NCT03358407|590493274|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
163489163|NCT03358407|590493275|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
163489164|NCT03358407|590493276|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
163489165|NCT03358407|590493277|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
163489166|NCT03358407|590493278|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
163489167|NCT03358407|590493279|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
163489168|NCT03358407|590493270|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489169|NCT03358407|590493271|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489170|NCT03358407|590493272|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489171|NCT03358407|590493273|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489172|NCT03358407|590493274|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489173|NCT03358407|590493275|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
163489174|NCT03358407|590493276|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
163489175|NCT03358407|590493277|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489176|NCT03358407|590493278|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489177|NCT03358407|590493279|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
163489178|NCT03358407|590493270|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
163489179|NCT03358407|590493271|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
163489180|NCT03358407|590493272|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
163489181|NCT03358407|590493273|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
163489182|NCT03358407|590493274|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
163489183|NCT03358407|590493275|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
163489184|NCT03358407|590493276|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
163489185|NCT03358407|590493277|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
163489186|NCT03358407|590493278|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
163489187|NCT03358407|590493279|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
163489188|NCT00483574|590493280|FG000|Overall Study|Adverse Event|6|||
163489189|NCT00483574|590493281|FG001|Overall Study|Adverse Event|0|||
163489190|NCT00483574|590493280|FG000|Overall Study|Protocol Violation|28|||
163489191|NCT00483574|590493281|FG001|Overall Study|Protocol Violation|9|||
163489192|NCT00483574|590493280|FG000|Overall Study|Lost to Follow-up|16|||
163489193|NCT00483574|590493281|FG001|Overall Study|Lost to Follow-up|4|||
163489194|NCT00483574|590493280|FG000|Overall Study|Withdrawal by Subject|52|||
163489195|NCT00483574|590493281|FG001|Overall Study|Withdrawal by Subject|0|||
163489196|NCT03605758|590493282|FG000|Overall Study|Lost to Follow-up|2|||
163489197|NCT03605758|590493283|FG001|Overall Study|Lost to Follow-up|1|||
163489198|NCT03605758|590493282|FG000|Overall Study|Illness|0|||
163489199|NCT03605758|590493283|FG001|Overall Study|Illness|1|||
163489200|NCT03605758|590493282|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
163489201|NCT03605758|590493283|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
163489202|NCT04753606|590493286|FG000|Overall Study|Adverse Event|1|||
163489203|NCT04753606|590493287|FG001|Overall Study|Adverse Event|0|||
163489204|NCT04753606|590493288|FG002|Overall Study|Adverse Event|0|||
163489205|NCT00489411|590493289|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
163489206|NCT00489411|590493290|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
163489207|NCT00489411|590493289|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
163489208|NCT00489411|590493290|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
163489209|NCT00489411|590493289|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
163489210|NCT00489411|590493290|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
163489211|NCT00489411|590493289|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
163489212|NCT00489411|590493290|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
163489213|NCT00489411|590493289|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
163489214|NCT00489411|590493290|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
163489215|NCT01748162|590493292|FG000|Overall Study|no additional croup episodes to evaluate|2|||
163489216|NCT01748162|590493293|FG001|Overall Study|no additional croup episodes to evaluate|2|||
163489217|NCT01748162|590493292|FG000|Overall Study|participant consented but did not begin|0|||
163489218|NCT01748162|590493293|FG001|Overall Study|participant consented but did not begin|1|||
163489219|NCT01748162|590493292|FG000|Overall Study|reasons not available|3|||
163489220|NCT01748162|590493293|FG001|Overall Study|reasons not available|2|||
163489221|NCT03841331|590493294|FG000|Overall Study|Withdrawal by Subject|4|||
163489222|NCT03841331|590493295|FG001|Overall Study|Withdrawal by Subject|9|||
163489223|NCT03841331|590493294|FG000|Overall Study|Lost to Follow-up|5|||
163489224|NCT03841331|590493295|FG001|Overall Study|Lost to Follow-up|1|||
163489225|NCT03219372|590493296|FG000|Overall Study|Withdrawal by Subject|1|||
163489226|NCT03219372|590493297|FG001|Overall Study|Withdrawal by Subject|0|||
163489227|NCT04640168|590493299|FG000|Overall Study|Withdrawal by Subject|8|||
163489228|NCT04640168|590493300|FG001|Overall Study|Withdrawal by Subject|7|||
163489229|NCT04640168|590493299|FG000|Overall Study|Lost to Follow-up|1|||
163489230|NCT04640168|590493300|FG001|Overall Study|Lost to Follow-up|0|||
163489231|NCT04640168|590493299|FG000|Overall Study|Enrolled but not treated|12|||
163489232|NCT04640168|590493300|FG001|Overall Study|Enrolled but not treated|12|||
163489233|NCT00779857|590493301|FG000|Overall Study|Death|1|||
163489234|NCT00779857|590493301|FG000|Overall Study|Withdrawal by Subject|3|||
163489235|NCT00779857|590493301|FG000|Overall Study|Missed Visit|2|||
163489236|NCT03557775|590493305|FG000|Overall Study|Withdrawal by Subject|1|||
163489237|NCT03557775|590493306|FG001|Overall Study|Withdrawal by Subject|2|||
163489238|NCT03557775|590493307|FG002|Overall Study|Withdrawal by Subject|4|||
163489239|NCT03557775|590493305|FG000|Overall Study|Physician Decision|0|||
163489240|NCT03557775|590493306|FG001|Overall Study|Physician Decision|1|||
163489241|NCT03557775|590493307|FG002|Overall Study|Physician Decision|0|||
163489242|NCT00276458|590493312|FG000|Overall Study|Adverse Event|0|||
163489243|NCT00276458|590493313|FG001|Overall Study|Adverse Event|2|||
163489244|NCT00276458|590493312|FG000|Overall Study|Lost to Follow-up|2|||
163489245|NCT00276458|590493313|FG001|Overall Study|Lost to Follow-up|2|||
163489246|NCT00276458|590493312|FG000|Overall Study|Protocol Violation|4|||
163489247|NCT00276458|590493313|FG001|Overall Study|Protocol Violation|3|||
163489248|NCT01977625|590493319|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
163489249|NCT01977625|590493320|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
163489250|NCT01977625|590493319|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
163489251|NCT01977625|590493320|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
163489252|NCT00634933|590493322|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
163489253|NCT00634933|590493323|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
163489254|NCT00634933|590493324|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
163489255|NCT00634933|590493325|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
163489256|NCT00634933|590493326|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
163489257|NCT00634933|590493322|FG000|Part A: Baseline to Week 24|Death|1|||
163489258|NCT00634933|590493323|FG001|Part A: Baseline to Week 24|Death|0|||
163489259|NCT00634933|590493324|FG002|Part A: Baseline to Week 24|Death|0|||
163489260|NCT00634933|590493325|FG003|Part A: Baseline to Week 24|Death|0|||
163489261|NCT00634933|590493326|FG004|Part A: Baseline to Week 24|Death|0|||
163489262|NCT00634933|590493322|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
163489263|NCT00634933|590493323|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
163489264|NCT00634933|590493324|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
163489265|NCT00634933|590493325|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
163489266|NCT00634933|590493326|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
163489267|NCT00634933|590493322|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
163489268|NCT00634933|590493323|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
163489269|NCT00634933|590493324|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
163489270|NCT00634933|590493325|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
163489271|NCT00634933|590493326|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
163489272|NCT00634933|590493322|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
163489273|NCT00634933|590493323|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
163489274|NCT00634933|590493324|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
163489275|NCT00634933|590493325|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
163489276|NCT00634933|590493326|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
163489277|NCT00634933|590493322|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
163489278|NCT00634933|590493323|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
163489279|NCT00634933|590493324|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
163489280|NCT00634933|590493325|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
163489281|NCT00634933|590493326|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
163489282|NCT00634933|590493322|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
163489283|NCT00634933|590493323|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
163489284|NCT00634933|590493324|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
163489285|NCT00634933|590493325|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
163489286|NCT00634933|590493326|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
163489287|NCT00634933|590493322|FG000|Part A: Baseline to Week 24|Other|1|||
163489288|NCT00634933|590493323|FG001|Part A: Baseline to Week 24|Other|8|||
163489289|NCT00634933|590493324|FG002|Part A: Baseline to Week 24|Other|5|||
163489290|NCT00634933|590493325|FG003|Part A: Baseline to Week 24|Other|0|||
163489291|NCT00634933|590493326|FG004|Part A: Baseline to Week 24|Other|0|||
163489292|NCT00634933|590493322|FG000|Between Part A and Part B|Physician Decision|0|||
163489293|NCT00634933|590493323|FG001|Between Part A and Part B|Physician Decision|1|||
163489294|NCT00634933|590493324|FG002|Between Part A and Part B|Physician Decision|0|||
163489295|NCT00634933|590493325|FG003|Between Part A and Part B|Physician Decision|0|||
163489296|NCT00634933|590493326|FG004|Between Part A and Part B|Physician Decision|0|||
163489297|NCT00634933|590493322|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
163489298|NCT00634933|590493323|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
163489299|NCT00634933|590493324|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
163489300|NCT00634933|590493325|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
163489301|NCT00634933|590493326|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
163489302|NCT00634933|590493322|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
163489303|NCT00634933|590493323|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
163489304|NCT00634933|590493324|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
163489305|NCT00634933|590493325|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
163489306|NCT00634933|590493326|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
163489307|NCT00634933|590493322|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
163489308|NCT00634933|590493323|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
163489309|NCT00634933|590493324|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
163489310|NCT00634933|590493325|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
163489311|NCT00634933|590493326|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
163489312|NCT00634933|590493322|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
163489313|NCT00634933|590493323|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
163489314|NCT00634933|590493324|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
163489315|NCT00634933|590493325|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
163489316|NCT00634933|590493326|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
163489317|NCT00634933|590493322|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
163489318|NCT00634933|590493323|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
163489319|NCT00634933|590493324|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
163489320|NCT00634933|590493325|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
163489321|NCT00634933|590493326|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
163489322|NCT00634933|590493322|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
163489323|NCT00634933|590493323|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
163489324|NCT00634933|590493324|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
163489325|NCT00634933|590493325|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
163489326|NCT00634933|590493326|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
163489327|NCT00634933|590493322|FG000|Part B: Week 24 to Week 52|Other|0|||
163489328|NCT00634933|590493323|FG001|Part B: Week 24 to Week 52|Other|0|||
163489329|NCT00634933|590493324|FG002|Part B: Week 24 to Week 52|Other|5|||
163489330|NCT00634933|590493325|FG003|Part B: Week 24 to Week 52|Other|0|||
163489331|NCT00634933|590493326|FG004|Part B: Week 24 to Week 52|Other|1|||
163489332|NCT02304484|590493327|FG000|Overall Study|Death|9|||
163489333|NCT02304484|590493327|FG000|Overall Study|Withdrawal by Subject|14|||
163489334|NCT02304484|590493327|FG000|Overall Study|Lost to Follow-up|2|||
163489335|NCT04338685|590493328|FG000|Overall Study|Death|3|||
163489336|NCT04338685|590493329|FG001|Overall Study|Death|4|||
163489337|NCT04338685|590493330|FG002|Overall Study|Death|2|||
163489338|NCT04338685|590493331|FG003|Overall Study|Death|4|||
163489339|NCT04338685|590493332|FG004|Overall Study|Death|4|||
163489340|NCT04338685|590493333|FG005|Overall Study|Death|8|||
163489341|NCT04338685|590493334|FG006|Overall Study|Death|1|||
163489342|NCT04338685|590493335|FG007|Overall Study|Death|0|||
163489343|NCT04338685|590493336|FG008|Overall Study|Death|0|||
163489344|NCT04338685|590493328|FG000|Overall Study|Study terminated by Sponsor|0|||
163489345|NCT04338685|590493329|FG001|Overall Study|Study terminated by Sponsor|0|||
163489346|NCT04338685|590493330|FG002|Overall Study|Study terminated by Sponsor|1|||
163489347|NCT04338685|590493331|FG003|Overall Study|Study terminated by Sponsor|4|||
163489348|NCT04338685|590493332|FG004|Overall Study|Study terminated by Sponsor|0|||
163489349|NCT04338685|590493333|FG005|Overall Study|Study terminated by Sponsor|5|||
163489350|NCT04338685|590493334|FG006|Overall Study|Study terminated by Sponsor|2|||
163489351|NCT04338685|590493335|FG007|Overall Study|Study terminated by Sponsor|4|||
163489352|NCT04338685|590493336|FG008|Overall Study|Study terminated by Sponsor|1|||
163489353|NCT04338685|590493328|FG000|Overall Study|Withdrawal by Subject|1|||
163489354|NCT04338685|590493329|FG001|Overall Study|Withdrawal by Subject|2|||
163489355|NCT04338685|590493330|FG002|Overall Study|Withdrawal by Subject|0|||
163489356|NCT04338685|590493331|FG003|Overall Study|Withdrawal by Subject|2|||
163489357|NCT04338685|590493332|FG004|Overall Study|Withdrawal by Subject|0|||
163489358|NCT04338685|590493333|FG005|Overall Study|Withdrawal by Subject|5|||
163489359|NCT04338685|590493334|FG006|Overall Study|Withdrawal by Subject|1|||
163489360|NCT04338685|590493335|FG007|Overall Study|Withdrawal by Subject|1|||
163489361|NCT04338685|590493336|FG008|Overall Study|Withdrawal by Subject|0|||
163489362|NCT00234533|590493337|FG000|Overall Study|Withdrawal by Subject|6|||
163489363|NCT00234533|590493337|FG000|Overall Study|Adverse Event|2|||
163489364|NCT00234533|590493337|FG000|Overall Study|Enrolled but not treated|3|||
163489365|NCT02967055|590493338|FG000|Overall Study|Excluded|40|||
163489366|NCT02967055|590493338|FG000|Overall Study|Screen fail|3|||
163489367|NCT02967055|590493338|FG000|Overall Study|Lost to Follow-up|2|||
163489368|NCT02967055|590493338|FG000|Overall Study|Stopped due to side effects|3|||
163489369|NCT02967055|590493338|FG000|Overall Study|Stopped due to drug cost|1|||
163489370|NCT00570492|590493339|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
163489371|NCT00570492|590493340|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
163489372|NCT00570492|590493341|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
163489373|NCT00570492|590493339|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
163489374|NCT00570492|590493340|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
163489375|NCT00570492|590493341|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
163489376|NCT00570492|590493339|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
163489377|NCT00570492|590493340|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
163489378|NCT00570492|590493341|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
163489379|NCT00570492|590493339|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
163489380|NCT00570492|590493340|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
163489381|NCT00570492|590493341|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
163489382|NCT00570492|590493339|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
163489383|NCT00570492|590493340|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
163489384|NCT00570492|590493341|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
163489385|NCT00570492|590493339|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
163489386|NCT00570492|590493340|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
163489387|NCT00570492|590493341|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
163489388|NCT00570492|590493339|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
163489389|NCT00570492|590493340|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
163489390|NCT00570492|590493341|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
163489391|NCT00570492|590493339|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
163489392|NCT00570492|590493340|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
163489393|NCT00570492|590493341|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
163489394|NCT00570492|590493339|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
163489395|NCT00570492|590493340|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
163489396|NCT00570492|590493341|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
163489397|NCT00570492|590493339|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
163489398|NCT00570492|590493340|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
163489399|NCT00570492|590493341|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
163489400|NCT00570492|590493339|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
163489401|NCT00570492|590493340|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
163489402|NCT00570492|590493341|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
163489403|NCT00570492|590493339|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
163489404|NCT00570492|590493340|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
163489405|NCT00570492|590493341|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
163489406|NCT00570492|590493339|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
163489407|NCT00570492|590493340|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
163489408|NCT00570492|590493341|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
163489409|NCT00570492|590493339|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
163489410|NCT00570492|590493340|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
163489411|NCT00570492|590493341|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
163489412|NCT00976989|590493342|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
163489413|NCT00976989|590493343|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
163489414|NCT00976989|590493344|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
163489415|NCT00976989|590493342|FG000|Overall Study|Death|5|||
163489416|NCT00976989|590493343|FG001|Overall Study|Death|7|||
163489417|NCT00976989|590493344|FG002|Overall Study|Death|10|||
163489418|NCT00976989|590493342|FG000|Overall Study|Refused Treatment|4|||
163489419|NCT00976989|590493343|FG001|Overall Study|Refused Treatment|3|||
163489420|NCT00976989|590493344|FG002|Overall Study|Refused Treatment|5|||
163489421|NCT00976989|590493342|FG000|Overall Study|Failure to Return|2|||
163489422|NCT00976989|590493343|FG001|Overall Study|Failure to Return|1|||
163489423|NCT00976989|590493344|FG002|Overall Study|Failure to Return|0|||
163489424|NCT00976989|590493342|FG000|Overall Study|Recurrence of Disease|0|||
163489425|NCT00976989|590493343|FG001|Overall Study|Recurrence of Disease|1|||
163489426|NCT00976989|590493344|FG002|Overall Study|Recurrence of Disease|0|||
163489427|NCT00976989|590493342|FG000|Overall Study|Other|1|||
163489428|NCT00976989|590493343|FG001|Overall Study|Other|0|||
163489429|NCT00976989|590493344|FG002|Overall Study|Other|1|||
163489430|NCT00908375|590493345|FG000|Overall Study|Withdrawal by Subject|2|||
163489431|NCT00908375|590493346|FG001|Overall Study|Withdrawal by Subject|4|||
163489432|NCT00908375|590493345|FG000|Overall Study|Lost to Follow-up|8|||
163489433|NCT00908375|590493346|FG001|Overall Study|Lost to Follow-up|6|||
163489434|NCT00903357|590493347|FG000|First Intervention|Withdrawal by Subject|5|||
163489435|NCT00903357|590493348|FG001|First Intervention|Withdrawal by Subject|3|||
163489436|NCT00903357|590493347|FG000|First Intervention|Flu|0|||
163489437|NCT00903357|590493348|FG001|First Intervention|Flu|1|||
163489438|NCT00903357|590493347|FG000|Wash Out Period of 2 Weeks|Flu|0|||
163489439|NCT00903357|590493348|FG001|Wash Out Period of 2 Weeks|Flu|1|||
163489440|NCT00903357|590493347|FG000|Second Intervention|Lost to Follow-up|1|||
163489441|NCT00903357|590493348|FG001|Second Intervention|Lost to Follow-up|0|||
163489442|NCT02279888|590493350|FG000|Overall Study|Death|326|||
163489443|NCT02279888|590493350|FG000|Overall Study|Withdrawal by Subject|38|||
163489444|NCT02279888|590493350|FG000|Overall Study|Lost to Follow-up|21|||
163489445|NCT02279888|590493350|FG000|Overall Study|Physician Decision|62|||
163489446|NCT02279888|590493350|FG000|Overall Study|Subject Non-compliance|43|||
163489447|NCT02279888|590493350|FG000|Overall Study|Not implanted|14|||
163489448|NCT02279888|590493350|FG000|Overall Study|Visit not performed|26|||
163489449|NCT00752206|590493351|FG000|Overall Study|Disease progression|8|||
163489450|NCT00752206|590493352|FG001|Overall Study|Disease progression|11|||
163489451|NCT00752206|590493351|FG000|Overall Study|Pregnancy|1|||
163489452|NCT00752206|590493352|FG001|Overall Study|Pregnancy|0|||
163489453|NCT01484691|590493353|FG000|Overall Study|Withdrawal by Subject|1|||
163489454|NCT01484691|590493354|FG001|Overall Study|Withdrawal by Subject|1|||
163489455|NCT01484691|590493355|FG002|Overall Study|Withdrawal by Subject|1|||
163489456|NCT01484691|590493353|FG000|Overall Study|Physician Decision|0|||
163489457|NCT01484691|590493354|FG001|Overall Study|Physician Decision|2|||
163489458|NCT01484691|590493355|FG002|Overall Study|Physician Decision|1|||
163489459|NCT03522506|590493356|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163489460|NCT03522506|590493357|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162925434|NCT01346501|588428972|FG001|Overall Study|Initiated Other Biological Agents|1|||
162925435|NCT01346501|588428971|FG000|Overall Study|Other|8|||
163489461|NCT03522506|590493358|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163489462|NCT03522506|590493359|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
163489463|NCT03522506|590493356|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
163489464|NCT03522506|590493357|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
163489465|NCT03522506|590493358|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
163489466|NCT03522506|590493359|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
163489467|NCT03480243|590493362|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
163489468|NCT03480243|590493362|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
163489469|NCT04365387|590493363|FG000|Overall Study|Adverse Event|4|||
163489470|NCT04365387|590493364|FG001|Overall Study|Adverse Event|2|||
163489471|NCT04365387|590493363|FG000|Overall Study|Participants request|14|||
163489472|NCT04365387|590493364|FG001|Overall Study|Participants request|14|||
163489473|NCT04365387|590493363|FG000|Overall Study|Lost to Follow-up|8|||
163489474|NCT04365387|590493364|FG001|Overall Study|Lost to Follow-up|5|||
163489475|NCT04365387|590493363|FG000|Overall Study|Protocol deviation|3|||
163489476|NCT04365387|590493364|FG001|Overall Study|Protocol deviation|4|||
163489477|NCT04365387|590493363|FG000|Overall Study|Participant compliance with visit schedule|1|||
163489478|NCT04365387|590493364|FG001|Overall Study|Participant compliance with visit schedule|0|||
163489479|NCT04365387|590493363|FG000|Overall Study|Participant incarcerated|1|||
163489480|NCT04365387|590493364|FG001|Overall Study|Participant incarcerated|0|||
163489481|NCT04365387|590493363|FG000|Overall Study|Participant moved out of town (relocated)|0|||
163489482|NCT04365387|590493364|FG001|Overall Study|Participant moved out of town (relocated)|1|||
163489483|NCT04365387|590493363|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
163489484|NCT04365387|590493364|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
163489485|NCT04365387|590493363|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
163489486|NCT04365387|590493364|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
163489487|NCT05770401|590493365|FG000|Overall Study|Lost to Follow-up|5|||
163489488|NCT05770401|590493366|FG001|Overall Study|Lost to Follow-up|4|||
163489489|NCT01683565|590493369|FG000|Overall Study|Lost to Follow-up|2|||
163489490|NCT01683565|590493370|FG001|Overall Study|Lost to Follow-up|0|||
163489491|NCT01683565|590493369|FG000|Overall Study|Discontinued Intervention|1|||
163489492|NCT01683565|590493370|FG001|Overall Study|Discontinued Intervention|1|||
163489493|NCT00764465|590493371|FG000|Overall Study|Adverse Event|2|||
163489494|NCT00764465|590493372|FG001|Overall Study|Adverse Event|0|||
163489495|NCT00764465|590493373|FG002|Overall Study|Adverse Event|0|||
163489496|NCT00764465|590493374|FG003|Overall Study|Adverse Event|1|||
163489497|NCT00764465|590493375|FG004|Overall Study|Adverse Event|1|||
163489498|NCT00764465|590493376|FG005|Overall Study|Adverse Event|1|||
163489499|NCT00764465|590493371|FG000|Overall Study|Withdrawal by Subject|0|||
163489500|NCT00764465|590493372|FG001|Overall Study|Withdrawal by Subject|1|||
163489501|NCT00764465|590493373|FG002|Overall Study|Withdrawal by Subject|1|||
163489502|NCT00764465|590493374|FG003|Overall Study|Withdrawal by Subject|0|||
163489503|NCT00764465|590493375|FG004|Overall Study|Withdrawal by Subject|0|||
163489504|NCT00764465|590493376|FG005|Overall Study|Withdrawal by Subject|0|||
163489505|NCT01195662|590493377|FG000|Double Blind Treatment Period|Adverse Event|4|||
163489506|NCT01195662|590493378|FG001|Double Blind Treatment Period|Adverse Event|1|||
163489507|NCT01195662|590493379|FG002|Double Blind Treatment Period|Adverse Event|2|||
163489508|NCT01195662|590493377|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
163489509|NCT01195662|590493378|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
163489510|NCT01195662|590493379|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
163489511|NCT01195662|590493377|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
163489512|NCT01195662|590493378|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
163489513|NCT01195662|590493379|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
163489514|NCT01195662|590493377|FG000|Double Blind Treatment Period|Administrative reason|2|||
163489515|NCT01195662|590493378|FG001|Double Blind Treatment Period|Administrative reason|1|||
163489516|NCT01195662|590493379|FG002|Double Blind Treatment Period|Administrative reason|1|||
163489517|NCT01195662|590493377|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
163489518|NCT01195662|590493378|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
163489519|NCT01195662|590493379|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
163489520|NCT01195662|590493377|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
163489521|NCT01195662|590493378|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
163489522|NCT01195662|590493379|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
163489523|NCT01195662|590493377|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
163489524|NCT01195662|590493378|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
163489525|NCT01195662|590493379|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
163489526|NCT01195662|590493377|FG000|Double Blind Treatment Period|Non-specified|3|||
163489527|NCT01195662|590493378|FG001|Double Blind Treatment Period|Non-specified|0|||
163489528|NCT01195662|590493379|FG002|Double Blind Treatment Period|Non-specified|0|||
163489529|NCT01195662|590493377|FG000|Double Blind Treatment Period|Missing disposition information|0|||
163489530|NCT01195662|590493378|FG001|Double Blind Treatment Period|Missing disposition information|1|||
163489531|NCT01195662|590493379|FG002|Double Blind Treatment Period|Missing disposition information|1|||
163489532|NCT01195662|590493377|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
163489533|NCT01195662|590493378|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
163489534|NCT01195662|590493379|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
163489535|NCT01195662|590493377|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
163489536|NCT01195662|590493378|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
163489537|NCT01195662|590493379|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
163489538|NCT04524507|590493380|FG000|Overall Study|Lost to Follow-up|2|||
163489539|NCT04524507|590493381|FG001|Overall Study|Lost to Follow-up|4|||
163489540|NCT04524507|590493380|FG000|Overall Study|Withdrawal by Subject|2|||
163489541|NCT04524507|590493381|FG001|Overall Study|Withdrawal by Subject|9|||
163489542|NCT04524507|590493380|FG000|Overall Study|Death|2|||
163489543|NCT04524507|590493381|FG001|Overall Study|Death|10|||
163489544|NCT03039699|590493392|FG000|Overall Study|Incorrect inclusion|5|||
163489545|NCT03039699|590493393|FG001|Overall Study|Incorrect inclusion|4|||
163489546|NCT03039699|590493392|FG000|Overall Study|Lack of data to assess study endpoint|5|||
163489547|NCT03039699|590493393|FG001|Overall Study|Lack of data to assess study endpoint|3|||
163489548|NCT03039699|590493392|FG000|Overall Study|Bacterial infection|12|||
163489549|NCT03039699|590493393|FG001|Overall Study|Bacterial infection|28|||
163489550|NCT00540228|590493394|FG000|Overall Study|Adverse Event|2|||
163489551|NCT00540228|590493395|FG001|Overall Study|Adverse Event|0|||
163489552|NCT00540228|590493396|FG002|Overall Study|Adverse Event|0|||
163489553|NCT00540228|590493397|FG003|Overall Study|Adverse Event|0|||
163489554|NCT00540228|590493398|FG004|Overall Study|Adverse Event|0|||
163489555|NCT00540228|590493394|FG000|Overall Study|Lost to Follow-up|1|||
163489556|NCT00540228|590493395|FG001|Overall Study|Lost to Follow-up|1|||
163489557|NCT00540228|590493396|FG002|Overall Study|Lost to Follow-up|0|||
163489558|NCT00540228|590493397|FG003|Overall Study|Lost to Follow-up|0|||
163489559|NCT00540228|590493398|FG004|Overall Study|Lost to Follow-up|0|||
163489560|NCT02569996|590493399|FG000|Overall Study|Adverse Event|6|||
163489561|NCT02569996|590493399|FG000|Overall Study|Physician Decision|3|||
163489562|NCT02569996|590493399|FG000|Overall Study|Progression of the disease|18|||
163489563|NCT02569996|590493399|FG000|Overall Study|New anti-lymphoma treatment|1|||
163489564|NCT02569996|590493399|FG000|Overall Study|Non-compliance|9|||
163489565|NCT02569996|590493399|FG000|Overall Study|Withdrawal by Subject|5|||
163489566|NCT02569996|590493399|FG000|Overall Study|Lost to Follow-up|5|||
163489567|NCT02569996|590493399|FG000|Overall Study|Complete remission|7|||
163489568|NCT02569996|590493399|FG000|Overall Study|Unknown reason|1|||
163489569|NCT02911285|590493400|FG000|Overall Study|Lost to Follow-up|8|||
163489570|NCT02911285|590493401|FG001|Overall Study|Lost to Follow-up|5|||
163489571|NCT02911285|590493400|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
163489572|NCT02911285|590493401|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
163489573|NCT01397409|590493402|FG000|Stage 2|Adverse Event|0|||
163489574|NCT01397409|590493403|FG001|Stage 2|Adverse Event|0|||
163489575|NCT01397409|590493404|FG002|Stage 2|Adverse Event|0|||
163489576|NCT01397409|590493405|FG003|Stage 2|Adverse Event|0|||
163489577|NCT01397409|590493406|FG004|Stage 2|Adverse Event|6|||
163489578|NCT01397409|590493407|FG005|Stage 2|Adverse Event|3|||
163489579|NCT01397409|590493408|FG006|Stage 2|Adverse Event|0|||
163489580|NCT01397409|590493409|FG007|Stage 2|Adverse Event|0|||
163489581|NCT01397409|590493410|FG008|Stage 2|Adverse Event|0|||
163489582|NCT01397409|590493411|FG009|Stage 2|Adverse Event|0|||
163489583|NCT01397409|590493402|FG000|Stage 2|Personal Reasons|0|||
163489584|NCT01397409|590493403|FG001|Stage 2|Personal Reasons|0|||
163489585|NCT01397409|590493404|FG002|Stage 2|Personal Reasons|0|||
163489586|NCT01397409|590493405|FG003|Stage 2|Personal Reasons|0|||
163489587|NCT01397409|590493406|FG004|Stage 2|Personal Reasons|1|||
163489588|NCT01397409|590493407|FG005|Stage 2|Personal Reasons|0|||
163489589|NCT01397409|590493408|FG006|Stage 2|Personal Reasons|0|||
163489590|NCT01397409|590493409|FG007|Stage 2|Personal Reasons|0|||
163489591|NCT01397409|590493410|FG008|Stage 2|Personal Reasons|0|||
163489592|NCT01397409|590493411|FG009|Stage 2|Personal Reasons|0|||
163489593|NCT01397409|590493402|FG000|Stage 2|Other Miscellaneous Reasons|0|||
163489594|NCT01397409|590493403|FG001|Stage 2|Other Miscellaneous Reasons|0|||
163489595|NCT01397409|590493404|FG002|Stage 2|Other Miscellaneous Reasons|0|||
163489596|NCT01397409|590493405|FG003|Stage 2|Other Miscellaneous Reasons|0|||
163489597|NCT01397409|590493406|FG004|Stage 2|Other Miscellaneous Reasons|1|||
163489598|NCT01397409|590493407|FG005|Stage 2|Other Miscellaneous Reasons|1|||
163489599|NCT01397409|590493408|FG006|Stage 2|Other Miscellaneous Reasons|0|||
163489600|NCT01397409|590493409|FG007|Stage 2|Other Miscellaneous Reasons|0|||
163489601|NCT01397409|590493410|FG008|Stage 2|Other Miscellaneous Reasons|0|||
163489602|NCT01397409|590493411|FG009|Stage 2|Other Miscellaneous Reasons|0|||
163489603|NCT01397409|590493402|FG000|Stage 3|Adverse Event|0|||
163489604|NCT01397409|590493403|FG001|Stage 3|Adverse Event|0|||
163489605|NCT01397409|590493404|FG002|Stage 3|Adverse Event|0|||
163489606|NCT01397409|590493405|FG003|Stage 3|Adverse Event|0|||
163489607|NCT01397409|590493406|FG004|Stage 3|Adverse Event|0|||
163489608|NCT01397409|590493407|FG005|Stage 3|Adverse Event|0|||
163489609|NCT01397409|590493408|FG006|Stage 3|Adverse Event|0|||
163489610|NCT01397409|590493409|FG007|Stage 3|Adverse Event|1|||
163489611|NCT01397409|590493410|FG008|Stage 3|Adverse Event|0|||
163489612|NCT01397409|590493411|FG009|Stage 3|Adverse Event|0|||
163489613|NCT01397409|590493402|FG000|Stage 3|Other Miscellaneous Reasons|0|||
163489614|NCT01397409|590493403|FG001|Stage 3|Other Miscellaneous Reasons|0|||
163489615|NCT01397409|590493404|FG002|Stage 3|Other Miscellaneous Reasons|0|||
163489616|NCT01397409|590493405|FG003|Stage 3|Other Miscellaneous Reasons|0|||
163489617|NCT01397409|590493406|FG004|Stage 3|Other Miscellaneous Reasons|0|||
163489618|NCT01397409|590493407|FG005|Stage 3|Other Miscellaneous Reasons|0|||
163489619|NCT01397409|590493408|FG006|Stage 3|Other Miscellaneous Reasons|0|||
163489620|NCT01397409|590493409|FG007|Stage 3|Other Miscellaneous Reasons|1|||
163489621|NCT01397409|590493410|FG008|Stage 3|Other Miscellaneous Reasons|0|||
163489622|NCT01397409|590493411|FG009|Stage 3|Other Miscellaneous Reasons|0|||
163489623|NCT03418727|590493412|FG000|Overall Study|Adverse Event|1|||
163489624|NCT03418727|590493413|FG001|Overall Study|Adverse Event|2|||
163489625|NCT03418727|590493414|FG002|Overall Study|Adverse Event|0|||
163489626|NCT03418727|590493412|FG000|Overall Study|Withdrawal by Subject|0|||
163489627|NCT03418727|590493413|FG001|Overall Study|Withdrawal by Subject|0|||
163489628|NCT03418727|590493414|FG002|Overall Study|Withdrawal by Subject|2|||
163489629|NCT02451137|590493416|FG000|Overall Study|Randomized but not treated|19|||
163489630|NCT02451137|590493417|FG001|Overall Study|Randomized but not treated|27|||
163489631|NCT02451137|590493416|FG000|Overall Study|Adverse Event|43|||
163489632|NCT02451137|590493417|FG001|Overall Study|Adverse Event|42|||
163489633|NCT02451137|590493416|FG000|Overall Study|Lack of Efficacy|4|||
163489634|NCT02451137|590493417|FG001|Overall Study|Lack of Efficacy|9|||
163489635|NCT02451137|590493416|FG000|Overall Study|Participant decision:discontinue insulin|41|||
163489636|NCT02451137|590493417|FG001|Overall Study|Participant decision:discontinue insulin|43|||
163489637|NCT02451137|590493416|FG000|Overall Study|Hypoglycemia|2|||
163489638|NCT02451137|590493417|FG001|Overall Study|Hypoglycemia|1|||
163489639|NCT02451137|590493416|FG000|Overall Study|Investigator's decision|23|||
163489640|NCT02451137|590493417|FG001|Overall Study|Investigator's decision|19|||
163489641|NCT02451137|590493416|FG000|Overall Study|Lost to Follow-up|53|||
163489642|NCT02451137|590493417|FG001|Overall Study|Lost to Follow-up|61|||
163489643|NCT02451137|590493416|FG000|Overall Study|Physician Decision|6|||
163489644|NCT02451137|590493417|FG001|Overall Study|Physician Decision|5|||
163489645|NCT02451137|590493416|FG000|Overall Study|Sponsor decision|13|||
163489646|NCT02451137|590493417|FG001|Overall Study|Sponsor decision|25|||
163489647|NCT02451137|590493416|FG000|Overall Study|Withdrawal by Subject|40|||
163489648|NCT02451137|590493417|FG001|Overall Study|Withdrawal by Subject|63|||
163489649|NCT02451137|590493416|FG000|Overall Study|Other than specified above|2|||
163489650|NCT02451137|590493417|FG001|Overall Study|Other than specified above|3|||
163489651|NCT01740297|590495192|FG000|Overall Study|Withdrawal by Subject|4|||
163489652|NCT01740297|590495193|FG001|Overall Study|Withdrawal by Subject|16|||
163489653|NCT01740297|590495194|FG002|Overall Study|Withdrawal by Subject|17|||
163489654|NCT01740297|590495192|FG000|Overall Study|Death|8|||
163489655|NCT01740297|590495193|FG001|Overall Study|Death|46|||
163489656|NCT01740297|590495194|FG002|Overall Study|Death|40|||
163489657|NCT01740297|590495192|FG000|Overall Study|Lost to Follow-up|1|||
163489658|NCT01740297|590495193|FG001|Overall Study|Lost to Follow-up|2|||
163489659|NCT01740297|590495194|FG002|Overall Study|Lost to Follow-up|4|||
163489660|NCT03280628|590495199|FG000|Overall Study|Lost to Follow-up|8|||
163489661|NCT03280628|590495200|FG001|Overall Study|Lost to Follow-up|6|||
163489662|NCT03280628|590495201|FG002|Overall Study|Lost to Follow-up|11|||
163489663|NCT00761462|590495203|FG000|Treatment|Subjects never received study medication|23|||
163489664|NCT00761462|590495204|FG001|Treatment|Subjects never received study medication|12|||
163489665|NCT00761462|590495203|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
163489666|NCT00761462|590495204|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
163489667|NCT00761462|590495203|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
163489668|NCT00761462|590495204|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
163489669|NCT00761462|590495203|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
163489670|NCT00761462|590495204|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
163489671|NCT02163759|590495211|FG000|Overall Study|Withdrawal by Subject|1|||
163489672|NCT02163759|590495212|FG001|Overall Study|Withdrawal by Subject|5|||
163489673|NCT02163759|590495213|FG002|Overall Study|Withdrawal by Subject|1|||
163489674|NCT02163759|590495211|FG000|Overall Study|Adverse Event|0|||
163489675|NCT02163759|590495212|FG001|Overall Study|Adverse Event|0|||
163489676|NCT02163759|590495213|FG002|Overall Study|Adverse Event|1|||
163489677|NCT02163759|590495211|FG000|Overall Study|Death|0|||
163489678|NCT02163759|590495212|FG001|Overall Study|Death|0|||
163489679|NCT02163759|590495213|FG002|Overall Study|Death|1|||
163489680|NCT00451191|590495226|FG000|Overall Study|withdrawal or received alternate tx|15|||
163489681|NCT00451191|590495227|FG001|Overall Study|withdrawal or received alternate tx|11|||
163489682|NCT00656669|590495235|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
163489683|NCT00656669|590495235|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
163489684|NCT00656669|590495235|FG000|AC (Cycles 6-9)|Adverse Event|1|||
163489685|NCT00656669|590495235|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
163489686|NCT00219349|590495240|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
163489687|NCT00219349|590495240|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
163489688|NCT00219349|590495240|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
163489689|NCT00219349|590495240|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
163489690|NCT01241591|590495242|FG000|Overall Study|Lack of Efficacy|5|||
163489691|NCT01241591|590495243|FG001|Overall Study|Lack of Efficacy|2|||
163489692|NCT01241591|590495244|FG002|Overall Study|Lack of Efficacy|2|||
163489693|NCT01241591|590495245|FG003|Overall Study|Lack of Efficacy|3|||
163489694|NCT01241591|590495242|FG000|Overall Study|Protocol Violation|5|||
163489695|NCT01241591|590495243|FG001|Overall Study|Protocol Violation|2|||
163489696|NCT01241591|590495244|FG002|Overall Study|Protocol Violation|3|||
163489697|NCT01241591|590495245|FG003|Overall Study|Protocol Violation|0|||
163489698|NCT01241591|590495242|FG000|Overall Study|Lost to Follow-up|1|||
163489699|NCT01241591|590495243|FG001|Overall Study|Lost to Follow-up|2|||
163489700|NCT01241591|590495244|FG002|Overall Study|Lost to Follow-up|2|||
163489701|NCT01241591|590495245|FG003|Overall Study|Lost to Follow-up|2|||
163489702|NCT01241591|590495242|FG000|Overall Study|Screen Failure|3|||
163489703|NCT01241591|590495243|FG001|Overall Study|Screen Failure|2|||
163489704|NCT01241591|590495244|FG002|Overall Study|Screen Failure|1|||
163489705|NCT01241591|590495245|FG003|Overall Study|Screen Failure|0|||
163489706|NCT01241591|590495242|FG000|Overall Study|Withdrawal by Subject|6|||
163489707|NCT01241591|590495243|FG001|Overall Study|Withdrawal by Subject|4|||
163489708|NCT01241591|590495244|FG002|Overall Study|Withdrawal by Subject|2|||
163489709|NCT01241591|590495245|FG003|Overall Study|Withdrawal by Subject|2|||
163489710|NCT01241591|590495242|FG000|Overall Study|Other|0|||
163489711|NCT01241591|590495243|FG001|Overall Study|Other|1|||
163489712|NCT01241591|590495244|FG002|Overall Study|Other|0|||
163489713|NCT01241591|590495245|FG003|Overall Study|Other|1|||
163489714|NCT01241591|590495242|FG000|Overall Study|Adverse Event|3|||
163489715|NCT01241591|590495243|FG001|Overall Study|Adverse Event|11|||
163489716|NCT01241591|590495244|FG002|Overall Study|Adverse Event|12|||
163489717|NCT01241591|590495245|FG003|Overall Study|Adverse Event|4|||
163489718|NCT01945034|590495246|FG000|Overall Study|Medication Error|0|||
163489719|NCT01945034|590495247|FG001|Overall Study|Medication Error|1|||
163489720|NCT01945034|590495248|FG002|Overall Study|Medication Error|0|||
163489721|NCT01945034|590495246|FG000|Overall Study|Withdrawal by Subject|0|||
163489722|NCT01945034|590495247|FG001|Overall Study|Withdrawal by Subject|3|||
163489723|NCT01945034|590495248|FG002|Overall Study|Withdrawal by Subject|1|||
163489724|NCT01945034|590495246|FG000|Overall Study|Other|0|||
163489725|NCT01945034|590495247|FG001|Overall Study|Other|1|||
163489726|NCT01945034|590495248|FG002|Overall Study|Other|3|||
163489727|NCT01945034|590495246|FG000|Overall Study|Lost to Follow-up|0|||
163489728|NCT01945034|590495247|FG001|Overall Study|Lost to Follow-up|0|||
163489729|NCT01945034|590495248|FG002|Overall Study|Lost to Follow-up|2|||
163489730|NCT01945034|590495246|FG000|Overall Study|Protocol Violation|1|||
163489731|NCT01945034|590495247|FG001|Overall Study|Protocol Violation|0|||
163489732|NCT01945034|590495248|FG002|Overall Study|Protocol Violation|1|||
163489733|NCT00700115|590495251|FG000|Overall Study|Withdrawal by Subject|1|||
163489734|NCT00700115|590495252|FG001|Overall Study|Withdrawal by Subject|0|||
163489735|NCT00700115|590495251|FG000|Overall Study|Lost to Follow-up|0|||
163489736|NCT00700115|590495252|FG001|Overall Study|Lost to Follow-up|1|||
163489737|NCT01300741|590495258|FG000|Overall Study|Lens deposits|1|||
163489738|NCT01300741|590495258|FG000|Overall Study|Lost to Follow-up|1|||
163489739|NCT01300741|590495258|FG000|Overall Study|Discomfort|1|||
163489740|NCT04854421|590495259|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
163489741|NCT04854421|590495260|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
163489742|NCT00718809|590495262|FG000|Overall Study|Disease progression|9|||
163489743|NCT00718809|590495263|FG001|Overall Study|Disease progression|7|||
163489744|NCT00718809|590495262|FG000|Overall Study|Adverse Event|1|||
163489745|NCT00718809|590495263|FG001|Overall Study|Adverse Event|1|||
163489746|NCT00718809|590495262|FG000|Overall Study|Withdrawal by Subject|0|||
163489747|NCT00718809|590495263|FG001|Overall Study|Withdrawal by Subject|1|||
163489748|NCT00718809|590495262|FG000|Overall Study|Lost to Follow-up|1|||
163489749|NCT00718809|590495263|FG001|Overall Study|Lost to Follow-up|0|||
163489750|NCT00718809|590495262|FG000|Overall Study|Noncompliance|1|||
163489751|NCT00718809|590495263|FG001|Overall Study|Noncompliance|0|||
163489752|NCT00463385|590495264|FG000|Overall Study|Other|4|||
163489753|NCT00463385|590495265|FG001|Overall Study|Other|3|||
163489754|NCT00463385|590495266|FG002|Overall Study|Other|6|||
163489755|NCT00463385|590495267|FG003|Overall Study|Other|4|||
163489756|NCT00463385|590495264|FG000|Overall Study|Adverse Event|5|||
163489757|NCT00463385|590495265|FG001|Overall Study|Adverse Event|8|||
163489758|NCT00463385|590495266|FG002|Overall Study|Adverse Event|4|||
163489759|NCT00463385|590495267|FG003|Overall Study|Adverse Event|2|||
163489760|NCT00463385|590495264|FG000|Overall Study|Lack of Efficacy|6|||
163489761|NCT00463385|590495265|FG001|Overall Study|Lack of Efficacy|6|||
163489762|NCT00463385|590495266|FG002|Overall Study|Lack of Efficacy|7|||
163489763|NCT00463385|590495267|FG003|Overall Study|Lack of Efficacy|9|||
163489764|NCT00463385|590495264|FG000|Overall Study|Withdrawal by Subject|3|||
163489765|NCT00463385|590495265|FG001|Overall Study|Withdrawal by Subject|3|||
163489766|NCT00463385|590495266|FG002|Overall Study|Withdrawal by Subject|3|||
163489767|NCT00463385|590495267|FG003|Overall Study|Withdrawal by Subject|4|||
163489768|NCT00463385|590495264|FG000|Overall Study|Lost to Follow-up|0|||
163489769|NCT00463385|590495265|FG001|Overall Study|Lost to Follow-up|0|||
163489770|NCT00463385|590495266|FG002|Overall Study|Lost to Follow-up|0|||
163489771|NCT00463385|590495267|FG003|Overall Study|Lost to Follow-up|1|||
163489772|NCT00463385|590495264|FG000|Overall Study|Death|2|||
163489773|NCT00463385|590495265|FG001|Overall Study|Death|1|||
163489774|NCT00463385|590495266|FG002|Overall Study|Death|2|||
163489775|NCT00463385|590495267|FG003|Overall Study|Death|0|||
163489776|NCT00463385|590495264|FG000|Overall Study|Missing|2|||
163489777|NCT00463385|590495265|FG001|Overall Study|Missing|0|||
163489778|NCT00463385|590495266|FG002|Overall Study|Missing|0|||
163489779|NCT00463385|590495267|FG003|Overall Study|Missing|2|||
163489780|NCT00463385|590495264|FG000|Overall Study|1 participant received commercial drug|0|||
163489781|NCT00463385|590495265|FG001|Overall Study|1 participant received commercial drug|1|||
163489782|NCT00463385|590495266|FG002|Overall Study|1 participant received commercial drug|0|||
163489783|NCT00463385|590495267|FG003|Overall Study|1 participant received commercial drug|0|||
163489784|NCT00536991|590495269|FG000|Overall Study|Withdrawal by Subject|10|||
163489785|NCT00536991|590495269|FG000|Overall Study|Physician Decision|1|||
163489786|NCT00536991|590495269|FG000|Overall Study|patient ineligible|2|||
163489787|NCT00054639|590495270|FG000|Overall Study|Lack of Efficacy|1|||
163489788|NCT00054639|590495270|FG000|Overall Study|Physician Decision|1|||
163489789|NCT01600755|590495271|FG000|Overall Study|Withdrawal by Subject|6|||
163489790|NCT00938392|590495276|FG000|Overall Study|Adverse Event|0|||
163489791|NCT00938392|590495277|FG001|Overall Study|Adverse Event|1|||
163489792|NCT00938392|590495276|FG000|Overall Study|Withdrawal by Subject|0|||
163489793|NCT00938392|590495277|FG001|Overall Study|Withdrawal by Subject|1|||
163489794|NCT00938392|590495276|FG000|Overall Study|Lost to Follow-up|2|||
163489795|NCT00938392|590495277|FG001|Overall Study|Lost to Follow-up|2|||
163489796|NCT00122954|590495278|FG000|Overall Study|Withdrawal by Subject|2|||
163489797|NCT00122954|590495279|FG001|Overall Study|Withdrawal by Subject|2|||
163489798|NCT00122954|590495278|FG000|Overall Study|Protocol Violation|0|||
163489799|NCT00122954|590495279|FG001|Overall Study|Protocol Violation|1|||
163489800|NCT02696382|590495285|FG000|Overall Study|Death|7|||
163489801|NCT02696382|590495286|FG001|Overall Study|Death|2|||
163489802|NCT02696382|590495285|FG000|Overall Study|Withdrawal by Subject|5|||
163489803|NCT02696382|590495286|FG001|Overall Study|Withdrawal by Subject|12|||
163489804|NCT02696382|590495285|FG000|Overall Study|Lost to Follow-up|4|||
163489805|NCT02696382|590495286|FG001|Overall Study|Lost to Follow-up|7|||
163489806|NCT00494234|590495287|FG000|Overall Study|Withdrawal by Subject|1|||
163489807|NCT00494234|590495288|FG001|Overall Study|Withdrawal by Subject|0|||
163489808|NCT00494234|590495287|FG000|Overall Study|Disease progression|11|||
163489809|NCT00494234|590495288|FG001|Overall Study|Disease progression|8|||
163489810|NCT00494234|590495287|FG000|Overall Study|Death|2|||
163489811|NCT00494234|590495288|FG001|Overall Study|Death|1|||
163489812|NCT04145531|590495293|FG000|Part A|Adverse Event|2|||
163489813|NCT04145531|590495294|FG001|Part A|Adverse Event|12|||
163489814|NCT04145531|590495295|FG002|Part A|Adverse Event|6|||
163489815|NCT04145531|590495296|FG003|Part A|Adverse Event|0|||
163489816|NCT04145531|590495293|FG000|Part A|Death|1|||
163489817|NCT04145531|590495294|FG001|Part A|Death|2|||
163489818|NCT04145531|590495295|FG002|Part A|Death|0|||
163489819|NCT04145531|590495296|FG003|Part A|Death|0|||
163489820|NCT04145531|590495293|FG000|Part A|Physician Decision|2|||
163489821|NCT04145531|590495294|FG001|Part A|Physician Decision|5|||
163489822|NCT04145531|590495295|FG002|Part A|Physician Decision|2|||
163489823|NCT04145531|590495296|FG003|Part A|Physician Decision|0|||
163489824|NCT04145531|590495293|FG000|Part A|Progressive disease|0|||
163489825|NCT04145531|590495294|FG001|Part A|Progressive disease|2|||
163489826|NCT04145531|590495295|FG002|Part A|Progressive disease|1|||
163489827|NCT04145531|590495296|FG003|Part A|Progressive disease|0|||
163489828|NCT04145531|590495293|FG000|Part A|Protocol deviation|0|||
163489829|NCT04145531|590495294|FG001|Part A|Protocol deviation|0|||
163489830|NCT04145531|590495295|FG002|Part A|Protocol deviation|1|||
163489831|NCT04145531|590495296|FG003|Part A|Protocol deviation|0|||
163489832|NCT04145531|590495293|FG000|Part A|Withdrawal by parent or guardian|1|||
163489833|NCT04145531|590495294|FG001|Part A|Withdrawal by parent or guardian|0|||
163489834|NCT04145531|590495295|FG002|Part A|Withdrawal by parent or guardian|0|||
163489835|NCT04145531|590495296|FG003|Part A|Withdrawal by parent or guardian|0|||
163489836|NCT04145531|590495293|FG000|Part A|Withdrawal by participant|0|||
163489837|NCT04145531|590495294|FG001|Part A|Withdrawal by participant|0|||
163489838|NCT04145531|590495295|FG002|Part A|Withdrawal by participant|1|||
163489839|NCT04145531|590495296|FG003|Part A|Withdrawal by participant|0|||
163489840|NCT04145531|590495293|FG000|Part A|Other|0|||
163489841|NCT04145531|590495294|FG001|Part A|Other|0|||
163489842|NCT04145531|590495295|FG002|Part A|Other|1|||
163489843|NCT04145531|590495296|FG003|Part A|Other|0|||
163489844|NCT04145531|590495293|FG000|Part B|Adverse Event|0|||
163489845|NCT04145531|590495294|FG001|Part B|Adverse Event|0|||
163489846|NCT04145531|590495295|FG002|Part B|Adverse Event|0|||
163489847|NCT04145531|590495296|FG003|Part B|Adverse Event|21|||
163489848|NCT04145531|590495293|FG000|Part B|Physician Decision|0|||
163489849|NCT04145531|590495294|FG001|Part B|Physician Decision|0|||
163489850|NCT04145531|590495295|FG002|Part B|Physician Decision|0|||
163489851|NCT04145531|590495296|FG003|Part B|Physician Decision|7|||
163489852|NCT04145531|590495293|FG000|Part B|Progressive disease|0|||
163489853|NCT04145531|590495294|FG001|Part B|Progressive disease|0|||
163489854|NCT04145531|590495295|FG002|Part B|Progressive disease|0|||
163489855|NCT04145531|590495296|FG003|Part B|Progressive disease|1|||
163489856|NCT04145531|590495293|FG000|Part B|Recurrent disease|0|||
163489857|NCT04145531|590495294|FG001|Part B|Recurrent disease|0|||
163489858|NCT04145531|590495295|FG002|Part B|Recurrent disease|0|||
163489859|NCT04145531|590495296|FG003|Part B|Recurrent disease|1|||
163489860|NCT04145531|590495293|FG000|Part B|Withdrawal by parent or guardian|0|||
163489861|NCT04145531|590495294|FG001|Part B|Withdrawal by parent or guardian|0|||
163489862|NCT04145531|590495295|FG002|Part B|Withdrawal by parent or guardian|0|||
163489863|NCT04145531|590495296|FG003|Part B|Withdrawal by parent or guardian|3|||
163489864|NCT04145531|590495293|FG000|Part B|Withdrawal by participant|0|||
163489865|NCT04145531|590495294|FG001|Part B|Withdrawal by participant|0|||
163489866|NCT04145531|590495295|FG002|Part B|Withdrawal by participant|0|||
163489867|NCT04145531|590495296|FG003|Part B|Withdrawal by participant|1|||
163489868|NCT04145531|590495293|FG000|Part B|Other|0|||
163489869|NCT04145531|590495294|FG001|Part B|Other|0|||
163489870|NCT04145531|590495295|FG002|Part B|Other|0|||
163489871|NCT04145531|590495296|FG003|Part B|Other|1|||
163489872|NCT02067728|590495297|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
163489873|NCT02067728|590495298|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
163489874|NCT02067728|590495297|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
163489875|NCT02067728|590495298|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
163489876|NCT02067728|590495297|FG000|6 Month Measurements|Unable to attend|114|||
163489877|NCT02067728|590495298|FG001|6 Month Measurements|Unable to attend|97|||
163489878|NCT01725217|590495299|FG000|Overall Study|Withdrawal by Subject|1|||
163489879|NCT01725217|590495300|FG001|Overall Study|Withdrawal by Subject|0|||
163489880|NCT01725217|590495301|FG002|Overall Study|Withdrawal by Subject|0|||
163489881|NCT00585468|590495302|FG000|First Intervention|Withdrawal by Subject|1|||
163489882|NCT00585468|590495303|FG001|First Intervention|Withdrawal by Subject|1|||
163489883|NCT00978120|590495304|FG000|Overall Study|Death|0|||
163489884|NCT00978120|590495305|FG001|Overall Study|Death|0|||
163489885|NCT00978120|590495306|FG002|Overall Study|Death|0|||
163489886|NCT00978120|590495307|FG003|Overall Study|Death|1|||
163489887|NCT00978120|590495304|FG000|Overall Study|Lost to Follow-up|0|||
163489888|NCT00978120|590495305|FG001|Overall Study|Lost to Follow-up|0|||
163489889|NCT00978120|590495306|FG002|Overall Study|Lost to Follow-up|3|||
163489890|NCT00978120|590495307|FG003|Overall Study|Lost to Follow-up|0|||
163489891|NCT00978120|590495304|FG000|Overall Study|Withdrawal by Subject|2|||
163489892|NCT00978120|590495305|FG001|Overall Study|Withdrawal by Subject|0|||
163489893|NCT00978120|590495306|FG002|Overall Study|Withdrawal by Subject|0|||
163489894|NCT00978120|590495307|FG003|Overall Study|Withdrawal by Subject|0|||
163489895|NCT00978120|590495304|FG000|Overall Study|Moved out of state|0|||
163489896|NCT00978120|590495305|FG001|Overall Study|Moved out of state|0|||
163489897|NCT00978120|590495306|FG002|Overall Study|Moved out of state|0|||
163489898|NCT00978120|590495307|FG003|Overall Study|Moved out of state|1|||
163489899|NCT01023815|590495308|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
163489900|NCT01023815|590495309|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
163489901|NCT01023815|590495310|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
163489902|NCT01023815|590495311|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
163489903|NCT01023815|590495308|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
163489904|NCT01023815|590495309|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
163489905|NCT01023815|590495310|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
163489906|NCT01023815|590495311|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
163489907|NCT01023815|590495308|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
163489908|NCT01023815|590495309|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
163489909|NCT01023815|590495310|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
163489910|NCT01023815|590495311|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
163489911|NCT01023815|590495308|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
163489912|NCT01023815|590495309|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
163489913|NCT01023815|590495310|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
163489914|NCT01023815|590495311|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
163489915|NCT01023815|590495308|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
163489916|NCT01023815|590495309|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
163489917|NCT01023815|590495310|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
163489918|NCT01023815|590495311|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
163489919|NCT01298323|590495313|FG000|Overall Study|Adverse Event|2|||
163489920|NCT01298323|590495314|FG001|Overall Study|Adverse Event|4|||
163489921|NCT01298323|590495313|FG000|Overall Study|Death|11|||
163489922|NCT01298323|590495314|FG001|Overall Study|Death|16|||
163489923|NCT01298323|590495313|FG000|Overall Study|Lost to Follow-up|1|||
163489924|NCT01298323|590495314|FG001|Overall Study|Lost to Follow-up|0|||
163489925|NCT01298323|590495313|FG000|Overall Study|Withdrawal by Subject|6|||
163489926|NCT01298323|590495314|FG001|Overall Study|Withdrawal by Subject|3|||
163489927|NCT01298323|590495313|FG000|Overall Study|Protocol Violation|1|||
163489928|NCT01298323|590495314|FG001|Overall Study|Protocol Violation|0|||
163489929|NCT01298323|590495313|FG000|Overall Study|Other|10|||
163489930|NCT01298323|590495314|FG001|Overall Study|Other|9|||
163489931|NCT01298323|590495313|FG000|Overall Study|Ongoing|55|||
163489932|NCT01298323|590495314|FG001|Overall Study|Ongoing|55|||
163489933|NCT01298323|590495313|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163489934|NCT01298323|590495314|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163489935|NCT01761565|590495315|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
163489936|NCT02161380|590495316|FG000|Overall Study|Lost to Follow-up|0|||
163489937|NCT02161380|590495317|FG001|Overall Study|Lost to Follow-up|1|||
163489938|NCT02161380|590495318|FG002|Overall Study|Lost to Follow-up|0|||
163489939|NCT02161380|590495319|FG003|Overall Study|Lost to Follow-up|0|||
163489940|NCT03655951|590495321|FG000|Overall Study|Lost to Follow-up|39|||
163489941|NCT03655951|590495322|FG001|Overall Study|Lost to Follow-up|20|||
163489942|NCT03655951|590495321|FG000|Overall Study|Withdrawal by Subject|0|||
163489943|NCT03655951|590495322|FG001|Overall Study|Withdrawal by Subject|1|||
163489944|NCT01078974|590495327|FG000|Overall Study|Adverse Event|3|||
163489945|NCT01393444|590495328|FG000|Overall Study|Withdrawal by Subject|1|||
163489946|NCT01393444|590495328|FG000|Overall Study|Determined ineligible during screening.|2|||
163489947|NCT01791543|590495330|FG000|Overall Study|Lost to Follow-up|1|||
163489948|NCT01791543|590495330|FG000|Overall Study|Adverse Event|1|||
163489949|NCT01361308|590496680|FG000|Overall Study|Withdrawal by Subject|9|||
163489950|NCT01361308|590496681|FG001|Overall Study|Withdrawal by Subject|13|||
163489951|NCT01361308|590496680|FG000|Overall Study|Physician Decision|3|||
163489952|NCT01361308|590496681|FG001|Overall Study|Physician Decision|3|||
163489953|NCT01361308|590496680|FG000|Overall Study|Lack of Efficacy|2|||
163489954|NCT01361308|590496681|FG001|Overall Study|Lack of Efficacy|0|||
163489955|NCT01361308|590496680|FG000|Overall Study|Protocol Violation|1|||
163489956|NCT01361308|590496681|FG001|Overall Study|Protocol Violation|0|||
163489957|NCT01361308|590496680|FG000|Overall Study|Lost to Follow-up|5|||
163489958|NCT01361308|590496681|FG001|Overall Study|Lost to Follow-up|4|||
163489959|NCT01361308|590496680|FG000|Overall Study|Adverse Event|8|||
163489960|NCT01361308|590496681|FG001|Overall Study|Adverse Event|4|||
163489961|NCT01361308|590496680|FG000|Overall Study|Eligibility Criteria Not Met|2|||
163489962|NCT01361308|590496681|FG001|Overall Study|Eligibility Criteria Not Met|3|||
163489963|NCT01361308|590496680|FG000|Overall Study|Failed C-SSRS|5|||
163489964|NCT01361308|590496681|FG001|Overall Study|Failed C-SSRS|2|||
163489965|NCT01361308|590496680|FG000|Overall Study|Other|0|||
163489966|NCT01361308|590496681|FG001|Overall Study|Other|1|||
163489967|NCT03839693|590496686|FG000|Overall Study|Lost to Follow-up|0|||
163489968|NCT03839693|590496687|FG001|Overall Study|Lost to Follow-up|2|||
163489969|NCT03839693|590496688|FG002|Overall Study|Lost to Follow-up|2|||
163489970|NCT03839693|590496686|FG000|Overall Study|Withdrawal by Subject|1|||
163489971|NCT03839693|590496687|FG001|Overall Study|Withdrawal by Subject|0|||
163489972|NCT03839693|590496688|FG002|Overall Study|Withdrawal by Subject|2|||
163489973|NCT03839693|590496686|FG000|Overall Study|subject moved out of the area|1|||
163489974|NCT03839693|590496687|FG001|Overall Study|subject moved out of the area|0|||
163489975|NCT03839693|590496688|FG002|Overall Study|subject moved out of the area|0|||
163489976|NCT00270205|590496697|FG000|Overall Study|Lost to Follow-up|1|||
163489977|NCT00270205|590496698|FG001|Overall Study|Lost to Follow-up|0|||
163489978|NCT00270205|590496699|FG002|Overall Study|Lost to Follow-up|0|||
163489979|NCT00270205|590496700|FG003|Overall Study|Lost to Follow-up|1|||
163489980|NCT00066573|590496701|FG000|Overall Study|Did not received protocol treatment|28|||
163489981|NCT00066573|590496702|FG001|Overall Study|Did not received protocol treatment|28|||
163489982|NCT02222246|590496706|FG000|Overall Study|No Emergency Department Visits|27|||
163489983|NCT02222246|590496707|FG001|Overall Study|No Emergency Department Visits|26|||
163489984|NCT02222246|590496706|FG000|Overall Study|Physician Decision|0|||
163489985|NCT02222246|590496707|FG001|Overall Study|Physician Decision|1|||
163489986|NCT01646268|590496708|FG000|Overall Study|Adverse Event|6|||
163489987|NCT01646268|590496709|FG001|Overall Study|Adverse Event|7|||
163489988|NCT01646268|590496708|FG000|Overall Study|Lack of Efficacy|1|||
163489989|NCT01646268|590496709|FG001|Overall Study|Lack of Efficacy|3|||
163489990|NCT01646268|590496708|FG000|Overall Study|Protocol Violation|0|||
163489991|NCT01646268|590496709|FG001|Overall Study|Protocol Violation|1|||
163489992|NCT01646268|590496708|FG000|Overall Study|Withdrawal by Subject|2|||
163489993|NCT01646268|590496709|FG001|Overall Study|Withdrawal by Subject|5|||
163489994|NCT01646268|590496708|FG000|Overall Study|Other|2|||
163489995|NCT01646268|590496709|FG001|Overall Study|Other|0|||
163489996|NCT01473602|590496712|FG000|Overall Study|Adverse Event|1|||
163489997|NCT01473602|590496713|FG001|Overall Study|Adverse Event|2|||
163489998|NCT01473602|590496712|FG000|Overall Study|Death|0|||
163489999|NCT01473602|590496713|FG001|Overall Study|Death|1|||
163490000|NCT01473602|590496712|FG000|Overall Study|Lost to Follow-up|1|||
163490001|NCT01473602|590496713|FG001|Overall Study|Lost to Follow-up|1|||
163490002|NCT01473602|590496712|FG000|Overall Study|Withdrawal by Subject|5|||
163490003|NCT01473602|590496713|FG001|Overall Study|Withdrawal by Subject|4|||
163490004|NCT01473602|590496712|FG000|Overall Study|Physician Decision|1|||
163490005|NCT01473602|590496713|FG001|Overall Study|Physician Decision|0|||
163490006|NCT00449761|590496715|FG000|Overall Study|Disease progression|12|||
163490007|NCT00449761|590496715|FG000|Overall Study|Death|5|||
163490008|NCT00449761|590496715|FG000|Overall Study|New cancer therapy|1|||
163490009|NCT00560573|590496716|FG000|Overall Study|Death|4|||
163490010|NCT00560573|590496717|FG001|Overall Study|Death|1|||
163490011|NCT00560573|590496718|FG002|Overall Study|Death|4|||
163490012|NCT00560573|590496719|FG003|Overall Study|Death|5|||
163490013|NCT00560573|590496720|FG004|Overall Study|Death|1|||
163490014|NCT00560573|590496721|FG005|Overall Study|Death|10|||
163490015|NCT00560573|590496716|FG000|Overall Study|Lost to Follow-up|0|||
163490016|NCT00560573|590496717|FG001|Overall Study|Lost to Follow-up|0|||
163490017|NCT00560573|590496718|FG002|Overall Study|Lost to Follow-up|0|||
163490018|NCT00560573|590496719|FG003|Overall Study|Lost to Follow-up|1|||
163490019|NCT00560573|590496720|FG004|Overall Study|Lost to Follow-up|1|||
163490020|NCT00560573|590496721|FG005|Overall Study|Lost to Follow-up|0|||
163490021|NCT00560573|590496716|FG000|Overall Study|Withdrawal by Subject|0|||
163490022|NCT00560573|590496717|FG001|Overall Study|Withdrawal by Subject|0|||
163490023|NCT00560573|590496718|FG002|Overall Study|Withdrawal by Subject|0|||
163490024|NCT00560573|590496719|FG003|Overall Study|Withdrawal by Subject|1|||
163490025|NCT00560573|590496720|FG004|Overall Study|Withdrawal by Subject|1|||
163490026|NCT00560573|590496721|FG005|Overall Study|Withdrawal by Subject|0|||
163490027|NCT00560573|590496716|FG000|Overall Study|Other|2|||
163490028|NCT00560573|590496717|FG001|Overall Study|Other|2|||
163490029|NCT00560573|590496718|FG002|Overall Study|Other|2|||
163490030|NCT00560573|590496719|FG003|Overall Study|Other|3|||
163490031|NCT00560573|590496720|FG004|Overall Study|Other|3|||
163490032|NCT00560573|590496721|FG005|Overall Study|Other|3|||
163490033|NCT00560573|590496716|FG000|Overall Study|Enrolled, not treated|0|||
163490034|NCT00560573|590496717|FG001|Overall Study|Enrolled, not treated|0|||
163490035|NCT00560573|590496718|FG002|Overall Study|Enrolled, not treated|0|||
163490036|NCT00560573|590496719|FG003|Overall Study|Enrolled, not treated|0|||
163490037|NCT00560573|590496720|FG004|Overall Study|Enrolled, not treated|1|||
163490038|NCT00560573|590496721|FG005|Overall Study|Enrolled, not treated|0|||
163490039|NCT01422876|590496725|FG000|Week 24|Lost to Follow-up|1|||
163490040|NCT01422876|590496726|FG001|Week 24|Lost to Follow-up|1|||
163490041|NCT01422876|590496727|FG002|Week 24|Lost to Follow-up|2|||
163490042|NCT01422876|590496728|FG003|Week 24|Lost to Follow-up|4|||
163490043|NCT01422876|590496729|FG004|Week 24|Lost to Follow-up|2|||
163490044|NCT01422876|590496730|FG005|Week 24|Lost to Follow-up|0|||
163490045|NCT01422876|590496731|FG006|Week 24|Lost to Follow-up|1|||
163490046|NCT01422876|590496732|FG007|Week 24|Lost to Follow-up|3|||
163490047|NCT01422876|590496733|FG008|Week 24|Lost to Follow-up|3|||
163490048|NCT01422876|590496734|FG009|Week 24|Lost to Follow-up|4|||
163490049|NCT01422876|590496725|FG000|Week 24|Consent withdrawn|5|||
163490050|NCT01422876|590496726|FG001|Week 24|Consent withdrawn|1|||
163490051|NCT01422876|590496727|FG002|Week 24|Consent withdrawn|3|||
163490052|NCT01422876|590496728|FG003|Week 24|Consent withdrawn|4|||
163490053|NCT01422876|590496729|FG004|Week 24|Consent withdrawn|5|||
163490054|NCT01422876|590496730|FG005|Week 24|Consent withdrawn|6|||
163490055|NCT01422876|590496731|FG006|Week 24|Consent withdrawn|5|||
163490056|NCT01422876|590496732|FG007|Week 24|Consent withdrawn|4|||
163490057|NCT01422876|590496733|FG008|Week 24|Consent withdrawn|3|||
163490058|NCT01422876|590496734|FG009|Week 24|Consent withdrawn|6|||
163490059|NCT01422876|590496725|FG000|Week 24|Death|0|||
163490060|NCT01422876|590496726|FG001|Week 24|Death|1|||
163490061|NCT01422876|590496727|FG002|Week 24|Death|0|||
163490062|NCT01422876|590496728|FG003|Week 24|Death|0|||
163490063|NCT01422876|590496729|FG004|Week 24|Death|0|||
163490064|NCT01422876|590496730|FG005|Week 24|Death|0|||
163490065|NCT01422876|590496731|FG006|Week 24|Death|0|||
163490066|NCT01422876|590496732|FG007|Week 24|Death|0|||
163490067|NCT01422876|590496733|FG008|Week 24|Death|0|||
163490068|NCT01422876|590496734|FG009|Week 24|Death|0|||
163490069|NCT01422876|590496725|FG000|Week 52|Lost to Follow-up|3|||
163490070|NCT01422876|590496726|FG001|Week 52|Lost to Follow-up|5|||
163490071|NCT01422876|590496727|FG002|Week 52|Lost to Follow-up|7|||
163490072|NCT01422876|590496728|FG003|Week 52|Lost to Follow-up|5|||
163490073|NCT01422876|590496729|FG004|Week 52|Lost to Follow-up|8|||
163490074|NCT01422876|590496730|FG005|Week 52|Lost to Follow-up|5|||
163490075|NCT01422876|590496731|FG006|Week 52|Lost to Follow-up|5|||
163490076|NCT01422876|590496732|FG007|Week 52|Lost to Follow-up|8|||
163490077|NCT01422876|590496733|FG008|Week 52|Lost to Follow-up|7|||
163490078|NCT01422876|590496734|FG009|Week 52|Lost to Follow-up|8|||
163490079|NCT01422876|590496725|FG000|Week 52|Consent withdrawn|9|||
163490080|NCT01422876|590496726|FG001|Week 52|Consent withdrawn|4|||
163490081|NCT01422876|590496727|FG002|Week 52|Consent withdrawn|6|||
163490082|NCT01422876|590496728|FG003|Week 52|Consent withdrawn|12|||
163490083|NCT01422876|590496729|FG004|Week 52|Consent withdrawn|7|||
163490084|NCT01422876|590496730|FG005|Week 52|Consent withdrawn|12|||
163490085|NCT01422876|590496731|FG006|Week 52|Consent withdrawn|10|||
163490086|NCT01422876|590496732|FG007|Week 52|Consent withdrawn|12|||
163490087|NCT01422876|590496733|FG008|Week 52|Consent withdrawn|13|||
163490088|NCT01422876|590496734|FG009|Week 52|Consent withdrawn|9|||
163490089|NCT01422876|590496725|FG000|Week 52|Death|0|||
163490090|NCT01422876|590496726|FG001|Week 52|Death|1|||
163490091|NCT01422876|590496727|FG002|Week 52|Death|0|||
163490092|NCT01422876|590496728|FG003|Week 52|Death|1|||
163490093|NCT01422876|590496729|FG004|Week 52|Death|0|||
163490094|NCT01422876|590496730|FG005|Week 52|Death|0|||
163490095|NCT01422876|590496731|FG006|Week 52|Death|1|||
163490096|NCT01422876|590496732|FG007|Week 52|Death|3|||
163490097|NCT01422876|590496733|FG008|Week 52|Death|1|||
163490098|NCT01422876|590496734|FG009|Week 52|Death|0|||
163490099|NCT00558831|590496735|FG000|Overall Study|Lost to Follow-up|1|||
163490100|NCT02204449|590496736|FG000|Overall Study|Lost to Follow-up|7|||
163490101|NCT02204449|590496737|FG001|Overall Study|Lost to Follow-up|9|||
163490102|NCT02204449|590496736|FG000|Overall Study|Death|0|||
163490103|NCT02204449|590496737|FG001|Overall Study|Death|1|||
163490104|NCT02204449|590496736|FG000|Overall Study|Withdrawal by Subject|0|||
163490105|NCT02204449|590496737|FG001|Overall Study|Withdrawal by Subject|1|||
163490106|NCT02856282|590496738|FG000|Overall Study|Withdrawal by Subject|1|||
163490107|NCT00057330|590496739|FG000|Overall Study|Adverse Event|9|||
163490108|NCT00057330|590496740|FG001|Overall Study|Adverse Event|12|||
163490109|NCT00057330|590496739|FG000|Overall Study|Death|1|||
163490110|NCT00057330|590496740|FG001|Overall Study|Death|0|||
163490111|NCT00057330|590496739|FG000|Overall Study|Protocol Violation|1|||
163490112|NCT00057330|590496740|FG001|Overall Study|Protocol Violation|1|||
163490113|NCT00057330|590496739|FG000|Overall Study|Withdrawal by Subject|115|||
163490114|NCT00057330|590496740|FG001|Overall Study|Withdrawal by Subject|84|||
163490115|NCT00057330|590496739|FG000|Overall Study|Lost to Follow-up|745|||
163490116|NCT00057330|590496740|FG001|Overall Study|Lost to Follow-up|617|||
163490117|NCT00057330|590496739|FG000|Overall Study|Physician Decision|1|||
163490118|NCT00057330|590496740|FG001|Overall Study|Physician Decision|0|||
163490119|NCT00057330|590496739|FG000|Overall Study|Other|260|||
163490120|NCT00057330|590496740|FG001|Overall Study|Other|206|||
163490121|NCT01491737|590496741|FG000|Overall Study|Withdrawal by Subject|20|||
163490122|NCT01491737|590496742|FG001|Overall Study|Withdrawal by Subject|17|||
163490123|NCT01491737|590496741|FG000|Overall Study|Lost to Follow-up|2|||
163490124|NCT01491737|590496742|FG001|Overall Study|Lost to Follow-up|10|||
163490125|NCT01491737|590496741|FG000|Overall Study|Death|63|||
163490126|NCT01491737|590496742|FG001|Overall Study|Death|57|||
163490127|NCT01491737|590496741|FG000|Overall Study|Study Termination by Sponsor|36|||
163490128|NCT01491737|590496742|FG001|Overall Study|Study Termination by Sponsor|36|||
163490129|NCT01491737|590496741|FG000|Overall Study|Reason Not Specified|8|||
163490130|NCT01491737|590496742|FG001|Overall Study|Reason Not Specified|9|||
163490131|NCT03772574|590496743|FG000|Overall Study|Protocol Violation|2|||
163490132|NCT03772574|590496744|FG001|Overall Study|Protocol Violation|0|||
163490133|NCT03772574|590496745|FG002|Overall Study|Protocol Violation|0|||
163490134|NCT03772574|590496743|FG000|Overall Study|Discomfort|0|||
163490135|NCT03772574|590496744|FG001|Overall Study|Discomfort|5|||
163490136|NCT03772574|590496745|FG002|Overall Study|Discomfort|4|||
163490137|NCT02743117|590496746|FG000|Overall Study|Lost to Follow-up|0|||
163490138|NCT02743117|590496747|FG001|Overall Study|Lost to Follow-up|1|||
163490139|NCT02743117|590496746|FG000|Overall Study|Other|1|||
163490140|NCT02743117|590496747|FG001|Overall Study|Other|0|||
163490141|NCT00620776|590496748|FG000|Overall Study|Did not receive treatment|3|||
163490142|NCT00620776|590496749|FG001|Overall Study|Did not receive treatment|5|||
163490143|NCT00620776|590496748|FG000|Overall Study|Adverse Event|2|||
163490144|NCT00620776|590496749|FG001|Overall Study|Adverse Event|3|||
163490145|NCT00620776|590496748|FG000|Overall Study|Lack of Efficacy|2|||
163490146|NCT00620776|590496749|FG001|Overall Study|Lack of Efficacy|1|||
163490147|NCT00620776|590496748|FG000|Overall Study|Lost to Follow-up|2|||
163490148|NCT00620776|590496749|FG001|Overall Study|Lost to Follow-up|5|||
163490149|NCT00620776|590496748|FG000|Overall Study|Withdrawal by Subject|3|||
163490150|NCT00620776|590496749|FG001|Overall Study|Withdrawal by Subject|2|||
163490151|NCT04983589|590496750|FG000|Overall Study|Withdrawal by Subject|0|||
163490152|NCT04983589|590496751|FG001|Overall Study|Withdrawal by Subject|3|||
163490153|NCT04983589|590496750|FG000|Overall Study|COVID-19 Infection|1|||
163490154|NCT04983589|590496751|FG001|Overall Study|COVID-19 Infection|0|||
163490155|NCT04983589|590496750|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
163490156|NCT04983589|590496751|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
163490157|NCT00761969|590496752|FG000|Overall Study|Death|112|||
163490158|NCT00761969|590496753|FG001|Overall Study|Death|47|||
163490159|NCT00761969|590496752|FG000|Overall Study|Lost to Follow-up|88|||
163490160|NCT00761969|590496753|FG001|Overall Study|Lost to Follow-up|93|||
163490161|NCT02940392|590496756|FG000|Overall Study|Lost to Follow-up|3|||
163490162|NCT02940392|590496756|FG000|Overall Study|Retreatment|3|||
163490163|NCT02940392|590496756|FG000|Overall Study|Death|2|||
163490164|NCT00762073|590496757|FG000|Overall Study|Lack of Efficacy|1|||
163490165|NCT00762073|590496758|FG001|Overall Study|Lack of Efficacy|1|||
163490166|NCT00762073|590496759|FG002|Overall Study|Lack of Efficacy|0|||
163490167|NCT00762073|590496760|FG003|Overall Study|Lack of Efficacy|0|||
163490168|NCT00762073|590496757|FG000|Overall Study|Adverse Event|1|||
163490169|NCT00762073|590496758|FG001|Overall Study|Adverse Event|0|||
163490170|NCT00762073|590496759|FG002|Overall Study|Adverse Event|1|||
163490171|NCT00762073|590496760|FG003|Overall Study|Adverse Event|1|||
163490172|NCT00762073|590496757|FG000|Overall Study|Significant Subject Noncompliance|0|||
163490173|NCT00762073|590496758|FG001|Overall Study|Significant Subject Noncompliance|1|||
163490174|NCT00762073|590496759|FG002|Overall Study|Significant Subject Noncompliance|0|||
163490175|NCT00762073|590496760|FG003|Overall Study|Significant Subject Noncompliance|1|||
163490176|NCT00762073|590496757|FG000|Overall Study|Withdrawal by Subject|1|||
163490177|NCT00762073|590496758|FG001|Overall Study|Withdrawal by Subject|2|||
163490178|NCT00762073|590496759|FG002|Overall Study|Withdrawal by Subject|1|||
163490179|NCT00762073|590496760|FG003|Overall Study|Withdrawal by Subject|1|||
163490180|NCT00762073|590496757|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
163490181|NCT00762073|590496758|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
163490182|NCT00762073|590496759|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
163490183|NCT00762073|590496760|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
163490184|NCT02319642|590496763|FG000|Overall Study|Adverse Event|2|||
163490185|NCT02319642|590496764|FG001|Overall Study|Adverse Event|4|||
163490186|NCT02319642|590496763|FG000|Overall Study|Lack of Efficacy|1|||
163490187|NCT02319642|590496764|FG001|Overall Study|Lack of Efficacy|1|||
163490188|NCT02319642|590496763|FG000|Overall Study|Withdrawal by Subject|1|||
163490189|NCT02319642|590496764|FG001|Overall Study|Withdrawal by Subject|1|||
163490190|NCT01265875|590496765|FG000|Overall Study|Uncooperative/unreliable|1|||
163490191|NCT01049360|590496769|FG000|Period 1|Adverse Event|0|||
163490192|NCT01049360|590496770|FG001|Period 1|Adverse Event|1|||
163490193|NCT01049360|590496771|FG002|Period 1|Adverse Event|0|||
163490194|NCT01049360|590496772|FG003|Period 1|Adverse Event|1|||
163490195|NCT01049360|590496773|FG004|Period 1|Adverse Event|0|||
163490196|NCT01049360|590496774|FG005|Period 1|Adverse Event|0|||
163490197|NCT01049360|590496775|FG006|Period 1|Adverse Event|0|||
163490198|NCT01049360|590496776|FG007|Period 1|Adverse Event|1|||
163490199|NCT01049360|590496777|FG008|Period 1|Adverse Event|0|||
163490200|NCT01049360|590496778|FG009|Period 1|Adverse Event|0|||
163490201|NCT01049360|590496779|FG010|Period 1|Adverse Event|0|||
163490202|NCT01049360|590496780|FG011|Period 1|Adverse Event|0|||
163490203|NCT01049360|590496781|FG012|Period 1|Adverse Event|1|||
163490204|NCT01049360|590496782|FG013|Period 1|Adverse Event|1|||
163490205|NCT01049360|590496783|FG014|Period 1|Adverse Event|0|||
163490206|NCT01049360|590496784|FG015|Period 1|Adverse Event|0|||
163490207|NCT01049360|590496785|FG016|Period 1|Adverse Event|1|||
163490208|NCT01049360|590496786|FG017|Period 1|Adverse Event|0|||
163490209|NCT01049360|590496787|FG018|Period 1|Adverse Event|1|||
163490210|NCT01049360|590496788|FG019|Period 1|Adverse Event|0|||
163490211|NCT01049360|590496769|FG000|Period 1|Did not meet inc/exc criteria|0|||
163490212|NCT01049360|590496770|FG001|Period 1|Did not meet inc/exc criteria|0|||
163490213|NCT01049360|590496771|FG002|Period 1|Did not meet inc/exc criteria|0|||
163490214|NCT01049360|590496772|FG003|Period 1|Did not meet inc/exc criteria|0|||
163490215|NCT01049360|590496773|FG004|Period 1|Did not meet inc/exc criteria|0|||
163490216|NCT01049360|590496774|FG005|Period 1|Did not meet inc/exc criteria|0|||
163490217|NCT01049360|590496775|FG006|Period 1|Did not meet inc/exc criteria|0|||
163490218|NCT01049360|590496776|FG007|Period 1|Did not meet inc/exc criteria|1|||
163490219|NCT01049360|590496777|FG008|Period 1|Did not meet inc/exc criteria|1|||
163490220|NCT01049360|590496778|FG009|Period 1|Did not meet inc/exc criteria|0|||
163490221|NCT01049360|590496779|FG010|Period 1|Did not meet inc/exc criteria|0|||
163490222|NCT01049360|590496780|FG011|Period 1|Did not meet inc/exc criteria|0|||
163490223|NCT01049360|590496781|FG012|Period 1|Did not meet inc/exc criteria|0|||
163490224|NCT01049360|590496782|FG013|Period 1|Did not meet inc/exc criteria|0|||
163490225|NCT01049360|590496783|FG014|Period 1|Did not meet inc/exc criteria|0|||
163490226|NCT01049360|590496784|FG015|Period 1|Did not meet inc/exc criteria|0|||
163490227|NCT01049360|590496785|FG016|Period 1|Did not meet inc/exc criteria|0|||
163490228|NCT01049360|590496786|FG017|Period 1|Did not meet inc/exc criteria|0|||
163490229|NCT01049360|590496787|FG018|Period 1|Did not meet inc/exc criteria|0|||
163490230|NCT01049360|590496788|FG019|Period 1|Did not meet inc/exc criteria|0|||
163490231|NCT01049360|590496769|FG000|Period 1|Withdrawal by Subject|0|||
163490232|NCT01049360|590496770|FG001|Period 1|Withdrawal by Subject|0|||
163490233|NCT01049360|590496771|FG002|Period 1|Withdrawal by Subject|0|||
163490234|NCT01049360|590496772|FG003|Period 1|Withdrawal by Subject|0|||
163490235|NCT01049360|590496773|FG004|Period 1|Withdrawal by Subject|0|||
163490236|NCT01049360|590496774|FG005|Period 1|Withdrawal by Subject|0|||
163490237|NCT01049360|590496775|FG006|Period 1|Withdrawal by Subject|0|||
163490238|NCT01049360|590496776|FG007|Period 1|Withdrawal by Subject|0|||
163490239|NCT01049360|590496777|FG008|Period 1|Withdrawal by Subject|1|||
163490240|NCT01049360|590496778|FG009|Period 1|Withdrawal by Subject|0|||
163490241|NCT01049360|590496779|FG010|Period 1|Withdrawal by Subject|1|||
163490242|NCT01049360|590496780|FG011|Period 1|Withdrawal by Subject|0|||
163490243|NCT01049360|590496781|FG012|Period 1|Withdrawal by Subject|1|||
163490244|NCT01049360|590496782|FG013|Period 1|Withdrawal by Subject|0|||
163490245|NCT01049360|590496783|FG014|Period 1|Withdrawal by Subject|0|||
163490246|NCT01049360|590496784|FG015|Period 1|Withdrawal by Subject|0|||
163490247|NCT01049360|590496785|FG016|Period 1|Withdrawal by Subject|0|||
163490248|NCT01049360|590496786|FG017|Period 1|Withdrawal by Subject|0|||
163490249|NCT01049360|590496787|FG018|Period 1|Withdrawal by Subject|0|||
163490250|NCT01049360|590496788|FG019|Period 1|Withdrawal by Subject|0|||
163490251|NCT01049360|590496769|FG000|Period 2|Protocol Violation|0|||
163490252|NCT01049360|590496770|FG001|Period 2|Protocol Violation|0|||
163490253|NCT01049360|590496771|FG002|Period 2|Protocol Violation|0|||
163490254|NCT01049360|590496772|FG003|Period 2|Protocol Violation|1|||
163490255|NCT01049360|590496773|FG004|Period 2|Protocol Violation|0|||
163490256|NCT01049360|590496774|FG005|Period 2|Protocol Violation|0|||
163490257|NCT01049360|590496775|FG006|Period 2|Protocol Violation|0|||
163490258|NCT01049360|590496776|FG007|Period 2|Protocol Violation|0|||
163490259|NCT01049360|590496777|FG008|Period 2|Protocol Violation|0|||
163490260|NCT01049360|590496778|FG009|Period 2|Protocol Violation|0|||
163490261|NCT01049360|590496779|FG010|Period 2|Protocol Violation|0|||
163490262|NCT01049360|590496780|FG011|Period 2|Protocol Violation|0|||
163490263|NCT01049360|590496781|FG012|Period 2|Protocol Violation|0|||
163490264|NCT01049360|590496782|FG013|Period 2|Protocol Violation|0|||
163490265|NCT01049360|590496783|FG014|Period 2|Protocol Violation|1|||
163490266|NCT01049360|590496784|FG015|Period 2|Protocol Violation|1|||
163490267|NCT01049360|590496785|FG016|Period 2|Protocol Violation|0|||
163490268|NCT01049360|590496786|FG017|Period 2|Protocol Violation|0|||
163490269|NCT01049360|590496787|FG018|Period 2|Protocol Violation|0|||
163490270|NCT01049360|590496788|FG019|Period 2|Protocol Violation|0|||
163490271|NCT01049360|590496769|FG000|Period 2|Adverse Event|0|||
163490272|NCT01049360|590496770|FG001|Period 2|Adverse Event|1|||
163490273|NCT01049360|590496771|FG002|Period 2|Adverse Event|0|||
163490274|NCT01049360|590496772|FG003|Period 2|Adverse Event|0|||
163490275|NCT01049360|590496773|FG004|Period 2|Adverse Event|0|||
163490276|NCT01049360|590496774|FG005|Period 2|Adverse Event|0|||
163490277|NCT01049360|590496775|FG006|Period 2|Adverse Event|0|||
163490278|NCT01049360|590496776|FG007|Period 2|Adverse Event|0|||
163490279|NCT01049360|590496777|FG008|Period 2|Adverse Event|1|||
163490280|NCT01049360|590496778|FG009|Period 2|Adverse Event|0|||
163490281|NCT01049360|590496779|FG010|Period 2|Adverse Event|0|||
163490282|NCT01049360|590496780|FG011|Period 2|Adverse Event|0|||
163490283|NCT01049360|590496781|FG012|Period 2|Adverse Event|0|||
163490284|NCT01049360|590496782|FG013|Period 2|Adverse Event|0|||
163490285|NCT01049360|590496783|FG014|Period 2|Adverse Event|0|||
163490286|NCT01049360|590496784|FG015|Period 2|Adverse Event|0|||
163490287|NCT01049360|590496785|FG016|Period 2|Adverse Event|0|||
163490288|NCT01049360|590496786|FG017|Period 2|Adverse Event|0|||
163490289|NCT01049360|590496787|FG018|Period 2|Adverse Event|0|||
163490290|NCT01049360|590496788|FG019|Period 2|Adverse Event|1|||
163490291|NCT01049360|590496769|FG000|Period 2|Withdrawal by Subject|0|||
163490292|NCT01049360|590496770|FG001|Period 2|Withdrawal by Subject|0|||
163490293|NCT01049360|590496771|FG002|Period 2|Withdrawal by Subject|0|||
163490294|NCT01049360|590496772|FG003|Period 2|Withdrawal by Subject|1|||
163490295|NCT01049360|590496773|FG004|Period 2|Withdrawal by Subject|0|||
163490296|NCT01049360|590496774|FG005|Period 2|Withdrawal by Subject|0|||
163490297|NCT01049360|590496775|FG006|Period 2|Withdrawal by Subject|0|||
163490298|NCT01049360|590496776|FG007|Period 2|Withdrawal by Subject|0|||
163490299|NCT01049360|590496777|FG008|Period 2|Withdrawal by Subject|0|||
163490300|NCT01049360|590496778|FG009|Period 2|Withdrawal by Subject|0|||
163490301|NCT01049360|590496779|FG010|Period 2|Withdrawal by Subject|0|||
163490302|NCT01049360|590496780|FG011|Period 2|Withdrawal by Subject|0|||
163490303|NCT01049360|590496781|FG012|Period 2|Withdrawal by Subject|0|||
163490304|NCT01049360|590496782|FG013|Period 2|Withdrawal by Subject|0|||
163490305|NCT01049360|590496783|FG014|Period 2|Withdrawal by Subject|1|||
163490306|NCT01049360|590496784|FG015|Period 2|Withdrawal by Subject|0|||
163490307|NCT01049360|590496785|FG016|Period 2|Withdrawal by Subject|0|||
163490308|NCT01049360|590496786|FG017|Period 2|Withdrawal by Subject|0|||
163490309|NCT01049360|590496787|FG018|Period 2|Withdrawal by Subject|0|||
163490310|NCT01049360|590496788|FG019|Period 2|Withdrawal by Subject|1|||
163490311|NCT01049360|590496769|FG000|Period 2|Lack of Efficacy|0|||
163490312|NCT01049360|590496770|FG001|Period 2|Lack of Efficacy|0|||
163490313|NCT01049360|590496771|FG002|Period 2|Lack of Efficacy|0|||
163490314|NCT01049360|590496772|FG003|Period 2|Lack of Efficacy|0|||
163490315|NCT01049360|590496773|FG004|Period 2|Lack of Efficacy|0|||
163490316|NCT01049360|590496774|FG005|Period 2|Lack of Efficacy|1|||
163490317|NCT01049360|590496775|FG006|Period 2|Lack of Efficacy|0|||
163490318|NCT01049360|590496776|FG007|Period 2|Lack of Efficacy|0|||
163490319|NCT01049360|590496777|FG008|Period 2|Lack of Efficacy|0|||
163490320|NCT01049360|590496778|FG009|Period 2|Lack of Efficacy|0|||
163490321|NCT01049360|590496779|FG010|Period 2|Lack of Efficacy|0|||
163490322|NCT01049360|590496780|FG011|Period 2|Lack of Efficacy|0|||
163490323|NCT01049360|590496781|FG012|Period 2|Lack of Efficacy|0|||
163490324|NCT01049360|590496782|FG013|Period 2|Lack of Efficacy|0|||
163490325|NCT01049360|590496783|FG014|Period 2|Lack of Efficacy|0|||
163490326|NCT01049360|590496784|FG015|Period 2|Lack of Efficacy|0|||
163490327|NCT01049360|590496785|FG016|Period 2|Lack of Efficacy|0|||
163490328|NCT01049360|590496786|FG017|Period 2|Lack of Efficacy|0|||
163490329|NCT01049360|590496787|FG018|Period 2|Lack of Efficacy|0|||
163490330|NCT01049360|590496788|FG019|Period 2|Lack of Efficacy|0|||
163490331|NCT01049360|590496769|FG000|Period 4|Protocol Violation|0|||
163490332|NCT01049360|590496770|FG001|Period 4|Protocol Violation|0|||
163490333|NCT01049360|590496771|FG002|Period 4|Protocol Violation|0|||
163490334|NCT01049360|590496772|FG003|Period 4|Protocol Violation|0|||
163490335|NCT01049360|590496773|FG004|Period 4|Protocol Violation|0|||
163490336|NCT01049360|590496774|FG005|Period 4|Protocol Violation|0|||
163490337|NCT01049360|590496775|FG006|Period 4|Protocol Violation|0|||
163490338|NCT01049360|590496776|FG007|Period 4|Protocol Violation|0|||
163490339|NCT01049360|590496777|FG008|Period 4|Protocol Violation|0|||
163490340|NCT01049360|590496778|FG009|Period 4|Protocol Violation|0|||
163490341|NCT01049360|590496779|FG010|Period 4|Protocol Violation|0|||
163490342|NCT01049360|590496780|FG011|Period 4|Protocol Violation|0|||
163490343|NCT01049360|590496781|FG012|Period 4|Protocol Violation|0|||
163490344|NCT01049360|590496782|FG013|Period 4|Protocol Violation|0|||
163490345|NCT01049360|590496783|FG014|Period 4|Protocol Violation|0|||
163490346|NCT01049360|590496784|FG015|Period 4|Protocol Violation|0|||
163490347|NCT01049360|590496785|FG016|Period 4|Protocol Violation|0|||
163490348|NCT01049360|590496786|FG017|Period 4|Protocol Violation|1|||
163490349|NCT01049360|590496787|FG018|Period 4|Protocol Violation|0|||
163490350|NCT01049360|590496788|FG019|Period 4|Protocol Violation|0|||
163490351|NCT01049360|590496769|FG000|Period 4|Withdrawal by Subject|0|||
163490352|NCT01049360|590496770|FG001|Period 4|Withdrawal by Subject|0|||
163490353|NCT01049360|590496771|FG002|Period 4|Withdrawal by Subject|0|||
163490354|NCT01049360|590496772|FG003|Period 4|Withdrawal by Subject|1|||
163490355|NCT01049360|590496773|FG004|Period 4|Withdrawal by Subject|0|||
163490356|NCT01049360|590496774|FG005|Period 4|Withdrawal by Subject|0|||
163490357|NCT01049360|590496775|FG006|Period 4|Withdrawal by Subject|0|||
163490358|NCT01049360|590496776|FG007|Period 4|Withdrawal by Subject|0|||
163490359|NCT01049360|590496777|FG008|Period 4|Withdrawal by Subject|0|||
163490360|NCT01049360|590496778|FG009|Period 4|Withdrawal by Subject|0|||
163490361|NCT01049360|590496779|FG010|Period 4|Withdrawal by Subject|0|||
163490362|NCT01049360|590496780|FG011|Period 4|Withdrawal by Subject|0|||
163490363|NCT01049360|590496781|FG012|Period 4|Withdrawal by Subject|0|||
163490364|NCT01049360|590496782|FG013|Period 4|Withdrawal by Subject|0|||
163490365|NCT01049360|590496783|FG014|Period 4|Withdrawal by Subject|0|||
163490366|NCT01049360|590496784|FG015|Period 4|Withdrawal by Subject|0|||
163490367|NCT01049360|590496785|FG016|Period 4|Withdrawal by Subject|0|||
163490368|NCT01049360|590496786|FG017|Period 4|Withdrawal by Subject|0|||
163490369|NCT01049360|590496787|FG018|Period 4|Withdrawal by Subject|0|||
163490370|NCT01049360|590496788|FG019|Period 4|Withdrawal by Subject|0|||
163490371|NCT05147311|590496791|FG000|Overall Study|Did not complete survey|2|||
163490372|NCT05147311|590496792|FG001|Overall Study|Did not complete survey|1|||
163490373|NCT05147311|590496791|FG000|Overall Study|Patient too sick|1|||
163490374|NCT05147311|590496792|FG001|Overall Study|Patient too sick|2|||
163490375|NCT05147311|590496791|FG000|Overall Study|Death|0|||
163490376|NCT05147311|590496792|FG001|Overall Study|Death|1|||
163490377|NCT05147311|590496791|FG000|Overall Study|Declined survey|1|||
163490378|NCT05147311|590496792|FG001|Overall Study|Declined survey|0|||
163490379|NCT00145795|590496794|FG000|Overall Study|Adverse Event|1|||
163490380|NCT00145795|590496795|FG001|Overall Study|Adverse Event|0|||
163490381|NCT04419558|590496796|FG000|DB Period (48 Weeks)|Adverse Event|6|||
163490382|NCT04419558|590496797|FG001|DB Period (48 Weeks)|Adverse Event|6|||
163490383|NCT04419558|590496796|FG000|DB Period (48 Weeks)|Death|14|||
163490384|NCT04419558|590496797|FG001|DB Period (48 Weeks)|Death|11|||
163490385|NCT04419558|590496796|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
163490386|NCT04419558|590496797|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
163490387|NCT04419558|590496796|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
163490388|NCT04419558|590496797|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
163490389|NCT04419558|590496796|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
163490390|NCT04419558|590496797|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
163490391|NCT04419558|590496796|FG000|DB Period (48 Weeks)|Disease Progression|1|||
163490392|NCT04419558|590496797|FG001|DB Period (48 Weeks)|Disease Progression|0|||
163490393|NCT04419558|590496796|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
163490394|NCT04419558|590496797|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
163490395|NCT04419558|590496796|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
163490396|NCT04419558|590496797|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
163490397|NCT04419558|590496796|FG000|DB Period (48 Weeks)|Participant Decision|4|||
163490398|NCT04419558|590496797|FG001|DB Period (48 Weeks)|Participant Decision|3|||
163490399|NCT04419558|590496796|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
163490400|NCT04419558|590496797|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
163490401|NCT04419558|590496796|FG000|OLE Period (48 Weeks)|Death|4|||
163490402|NCT04419558|590496797|FG001|OLE Period (48 Weeks)|Death|6|||
163490403|NCT04419558|590496796|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
163490404|NCT04419558|590496797|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
163490405|NCT04419558|590496796|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
163490406|NCT04419558|590496797|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
163490407|NCT01539512|590496801|FG000|Overall Study|Adverse Event|9|||
163490408|NCT01539512|590496802|FG001|Overall Study|Adverse Event|7|||
163490409|NCT01539512|590496801|FG000|Overall Study|Physician Decision|1|||
163490410|NCT01539512|590496802|FG001|Overall Study|Physician Decision|1|||
163490411|NCT01539512|590496801|FG000|Overall Study|Withdrawal by Subject|12|||
163490412|NCT01539512|590496802|FG001|Overall Study|Withdrawal by Subject|5|||
163490413|NCT01539512|590496801|FG000|Overall Study|Richter's Transformation|1|||
163490414|NCT01539512|590496802|FG001|Overall Study|Richter's Transformation|0|||
163490415|NCT02388906|590496803|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
163490416|NCT02388906|590496804|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
163490417|NCT02388906|590496803|FG000|Treatment Period|Disease progression|121|||
163490418|NCT02388906|590496804|FG001|Treatment Period|Disease progression|100|||
163490419|NCT02388906|590496803|FG000|Treatment Period|Study drug toxicity|41|||
163490420|NCT02388906|590496804|FG001|Treatment Period|Study drug toxicity|208|||
163490421|NCT02388906|590496803|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
163490422|NCT02388906|590496804|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
163490423|NCT02388906|590496803|FG000|Treatment Period|Participant request to stop treatment|5|||
163490424|NCT02388906|590496804|FG001|Treatment Period|Participant request to stop treatment|9|||
163490425|NCT02388906|590496803|FG000|Treatment Period|Participant withdrew consent|2|||
163490426|NCT02388906|590496804|FG001|Treatment Period|Participant withdrew consent|3|||
163490427|NCT02388906|590496803|FG000|Treatment Period|Poor/non-compliance|0|||
163490428|NCT02388906|590496804|FG001|Treatment Period|Poor/non-compliance|1|||
163490429|NCT02388906|590496803|FG000|Treatment Period|Participant no longer meets study criteria|0|||
163490430|NCT02388906|590496804|FG001|Treatment Period|Participant no longer meets study criteria|1|||
163490431|NCT02388906|590496803|FG000|Treatment Period|Other reasons|3|||
163490432|NCT02388906|590496804|FG001|Treatment Period|Other reasons|3|||
163490433|NCT01250418|590496813|FG000|Overall Study|monitor data failure|1|||
163490434|NCT01250418|590496814|FG001|Overall Study|monitor data failure|1|||
163490435|NCT02400281|590496816|FG000|Overall Study|Adverse Event|0|||
163490436|NCT02400281|590496817|FG001|Overall Study|Adverse Event|0|||
163490437|NCT02400281|590496818|FG002|Overall Study|Adverse Event|1|||
163490438|NCT02400281|590496819|FG003|Overall Study|Adverse Event|0|||
163490439|NCT02400281|590496820|FG004|Overall Study|Adverse Event|1|||
163490440|NCT02400281|590496821|FG005|Overall Study|Adverse Event|0|||
163490441|NCT02400281|590496816|FG000|Overall Study|Physician Decision|0|||
163490442|NCT02400281|590496817|FG001|Overall Study|Physician Decision|0|||
163490443|NCT02400281|590496818|FG002|Overall Study|Physician Decision|1|||
163490444|NCT02400281|590496819|FG003|Overall Study|Physician Decision|0|||
163490445|NCT02400281|590496820|FG004|Overall Study|Physician Decision|0|||
163490446|NCT02400281|590496821|FG005|Overall Study|Physician Decision|0|||
163490447|NCT00412360|590496822|FG000|Overall Study|Lost to Follow-up|0|||
163490448|NCT00412360|590496823|FG001|Overall Study|Lost to Follow-up|1|||
163490449|NCT00412360|590496822|FG000|Overall Study|Not Transplanted|1|||
163490450|NCT00412360|590496823|FG001|Overall Study|Not Transplanted|2|||
163490451|NCT03145207|590496825|FG000|Overall Study|volunteer started taking allergy shots|1|||
163490452|NCT03145207|590496825|FG000|Overall Study|baseline blood pressure high|1|||
163490453|NCT01790633|590496826|FG000|Overall Study|Protocol Violation|1|||
163490454|NCT01790633|590496827|FG001|Overall Study|Protocol Violation|2|||
163490455|NCT01790633|590496826|FG000|Overall Study|Did not have serology performed|47|||
163490456|NCT01790633|590496827|FG001|Overall Study|Did not have serology performed|0|||
163490457|NCT01790633|590496826|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
163490458|NCT01790633|590496827|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
163490459|NCT01396434|590496829|FG000|Overall Study|Lost to Follow-up|1|||
163490460|NCT01396434|590496830|FG001|Overall Study|Lost to Follow-up|0|||
163490461|NCT01396434|590496831|FG002|Overall Study|Lost to Follow-up|0|||
163490462|NCT01396434|590496829|FG000|Overall Study|Other|10|||
163490463|NCT01396434|590496830|FG001|Overall Study|Other|0|||
163490464|NCT01396434|590496831|FG002|Overall Study|Other|0|||
163490465|NCT04678557|590496834|FG000|Overall Study|Withdrawal by Subject|1|||
163490466|NCT04678557|590496835|FG001|Overall Study|Withdrawal by Subject|0|||
163490467|NCT04678557|590496834|FG000|Overall Study|Lack of Efficacy|0|||
163490468|NCT04678557|590496835|FG001|Overall Study|Lack of Efficacy|13|||
163490469|NCT04678557|590496834|FG000|Overall Study|Safety Evaluation|0|||
163490470|NCT04678557|590496835|FG001|Overall Study|Safety Evaluation|1|||
163490471|NCT00157157|590496836|FG000|Overall Study|Withdrawal by Subject|6|||
163490472|NCT00157157|590496836|FG000|Overall Study|Physician Decision|1|||
163490473|NCT00157157|590496836|FG000|Overall Study|Lost to Follow-up|1|||
163490474|NCT00157157|590496836|FG000|Overall Study|Enrolled in another study|1|||
163490475|NCT00157157|590496836|FG000|Overall Study|Met exclusion criteria|1|||
163490476|NCT00157157|590496836|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
163490477|NCT02260804|590496840|FG000|Induction Study Period|Protocol Violation|2|||
163490478|NCT02260804|590496841|FG001|Induction Study Period|Protocol Violation|0|||
163490479|NCT02260804|590496840|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
163490480|NCT02260804|590496841|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
163490481|NCT02260804|590496840|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
163490482|NCT02260804|590496841|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
163490483|NCT02260804|590496840|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
163490484|NCT02260804|590496841|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
163490485|NCT02260804|590496840|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
163490486|NCT02260804|590496841|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
163490487|NCT02260804|590496840|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
163490488|NCT02260804|590496841|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
163490489|NCT02260804|590496840|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
163490490|NCT02260804|590496841|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
163490491|NCT02260804|590496840|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
163490492|NCT02260804|590496841|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
163490493|NCT02260804|590496840|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
163490494|NCT02260804|590496841|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
163490495|NCT02260804|590496840|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
163490496|NCT02260804|590496841|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
163490497|NCT02260804|590496840|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
163490498|NCT02260804|590496841|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
163490499|NCT00563706|590498433|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
163490500|NCT00563706|590498434|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
163490501|NCT00563706|590498435|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
163490502|NCT00563706|590498436|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
163490503|NCT00563706|590498437|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
163490504|NCT00563706|590498438|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
163490505|NCT00563706|590498439|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
163490506|NCT00563706|590498440|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
163490507|NCT00563706|590498441|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
163490508|NCT00563706|590498433|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
163490509|NCT00563706|590498434|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
163490510|NCT00563706|590498435|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
163490511|NCT00563706|590498436|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
163490512|NCT00563706|590498437|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
163490513|NCT00563706|590498438|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
163490514|NCT00563706|590498439|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
163490515|NCT00563706|590498440|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
163490516|NCT00563706|590498441|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
163490517|NCT00563706|590498433|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
163490518|NCT00563706|590498434|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
163490519|NCT00563706|590498435|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
163490520|NCT00563706|590498436|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
163490521|NCT00563706|590498437|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
163490522|NCT00563706|590498438|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
163490523|NCT00563706|590498439|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
163490524|NCT00563706|590498440|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
163490525|NCT00563706|590498441|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
163490526|NCT00563706|590498433|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
163490527|NCT00563706|590498434|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
163490528|NCT00563706|590498435|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
163490529|NCT00563706|590498436|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
163490530|NCT00563706|590498437|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
163490531|NCT00563706|590498438|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
163490532|NCT00563706|590498439|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
163490533|NCT00563706|590498440|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
163490534|NCT00563706|590498441|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
163490535|NCT00563706|590498433|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
163490536|NCT00563706|590498434|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
163490537|NCT00563706|590498435|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
163490538|NCT00563706|590498436|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
163490539|NCT00563706|590498437|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
163490540|NCT00563706|590498438|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
163490541|NCT00563706|590498439|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
163490542|NCT00563706|590498440|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
163490543|NCT00563706|590498441|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
163490544|NCT02503215|590498446|FG000|Overall Study|Unable to wear compression stockings|1|||
163490545|NCT02503215|590498446|FG000|Overall Study|Unable to use positive airway pressure|2|||
163490546|NCT02983305|590498451|FG000|Overall Study|incomplete data|2|||
163490547|NCT02983305|590498452|FG001|Overall Study|incomplete data|0|||
163490548|NCT00706901|590498453|FG000|Overall Study|Lost to Follow-up|2|||
163490549|NCT00706901|590498454|FG001|Overall Study|Lost to Follow-up|3|||
163490550|NCT00706901|590498455|FG002|Overall Study|Lost to Follow-up|2|||
163490551|NCT00706901|590498453|FG000|Overall Study|Withdrawal by Subject|4|||
163490552|NCT00706901|590498454|FG001|Overall Study|Withdrawal by Subject|2|||
163490553|NCT00706901|590498455|FG002|Overall Study|Withdrawal by Subject|5|||
163490554|NCT00706901|590498453|FG000|Overall Study|In Jail|1|||
163490555|NCT00706901|590498454|FG001|Overall Study|In Jail|0|||
163490556|NCT00706901|590498455|FG002|Overall Study|In Jail|1|||
163490557|NCT00706901|590498453|FG000|Overall Study|Death|1|||
163490558|NCT00706901|590498454|FG001|Overall Study|Death|0|||
163490559|NCT00706901|590498455|FG002|Overall Study|Death|0|||
163490560|NCT00822237|590498456|FG000|Dose 1 Vaccination|Not vaccinated|3|||
163490561|NCT00822237|590498457|FG001|Dose 1 Vaccination|Not vaccinated|0|||
163490562|NCT00822237|590498456|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
163490563|NCT00822237|590498457|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
163490564|NCT00822237|590498456|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
163490565|NCT00822237|590498457|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
163490566|NCT00822237|590498456|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
163490567|NCT00822237|590498457|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
163490568|NCT00822237|590498456|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
163490569|NCT00822237|590498457|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
163490570|NCT03433482|590498458|FG000|Overall Study|Lost to Follow-up|1|||
163490571|NCT03433482|590498459|FG001|Overall Study|Lost to Follow-up|0|||
163490572|NCT03433482|590498460|FG002|Overall Study|Lost to Follow-up|1|||
163490573|NCT03433482|590498461|FG003|Overall Study|Lost to Follow-up|1|||
163490574|NCT03433482|590498458|FG000|Overall Study|Withdrawal by Subject|0|||
163490575|NCT03433482|590498459|FG001|Overall Study|Withdrawal by Subject|0|||
163490576|NCT03433482|590498460|FG002|Overall Study|Withdrawal by Subject|1|||
163490577|NCT03433482|590498461|FG003|Overall Study|Withdrawal by Subject|0|||
163490578|NCT03433482|590498458|FG000|Overall Study|Unknown reason|0|||
163490579|NCT03433482|590498459|FG001|Overall Study|Unknown reason|0|||
163490580|NCT03433482|590498460|FG002|Overall Study|Unknown reason|2|||
163490581|NCT03433482|590498461|FG003|Overall Study|Unknown reason|0|||
163490582|NCT00437294|590498462|FG000|Overall Study|Adverse Event|5|||
163490583|NCT00437294|590498463|FG001|Overall Study|Adverse Event|4|||
163490584|NCT00437294|590498462|FG000|Overall Study|Death|5|||
163490585|NCT00437294|590498463|FG001|Overall Study|Death|2|||
163490586|NCT00437294|590498462|FG000|Overall Study|Physician Decision|0|||
163490587|NCT00437294|590498463|FG001|Overall Study|Physician Decision|3|||
163490588|NCT00437294|590498462|FG000|Overall Study|Withdrawal by Subject|5|||
163490589|NCT00437294|590498463|FG001|Overall Study|Withdrawal by Subject|0|||
163490590|NCT00437294|590498462|FG000|Overall Study|Progressive Disease|19|||
163490591|NCT00437294|590498463|FG001|Overall Study|Progressive Disease|23|||
163490592|NCT00437294|590498462|FG000|Overall Study|Sponsor Decision|8|||
163490593|NCT00437294|590498463|FG001|Overall Study|Sponsor Decision|9|||
163490594|NCT00437294|590498462|FG000|Overall Study|Protocol Violation|0|||
163490595|NCT00437294|590498463|FG001|Overall Study|Protocol Violation|1|||
163490596|NCT00437294|590498462|FG000|Overall Study|Entry criteria not met|1|||
163490597|NCT00437294|590498463|FG001|Overall Study|Entry criteria not met|1|||
163490598|NCT02064231|590498467|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
163490599|NCT02064231|590498468|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
163490600|NCT02064231|590498469|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
163490601|NCT02064231|590498470|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
163490602|NCT02064231|590498467|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
163490603|NCT02064231|590498468|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
163490604|NCT02064231|590498469|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
163490605|NCT02064231|590498470|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
163490606|NCT02064231|590498467|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
163490607|NCT02064231|590498468|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
163490608|NCT02064231|590498469|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
163490609|NCT02064231|590498470|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
163490610|NCT02064231|590498467|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
163490611|NCT02064231|590498468|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
163490612|NCT02064231|590498469|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
163490613|NCT02064231|590498470|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
163490614|NCT01339273|590498472|FG000|Overall Study|Lost to Follow-up|8|||
163490615|NCT01339273|590498473|FG001|Overall Study|Lost to Follow-up|8|||
163490616|NCT04478994|590498474|FG000|Overall Study|Withdrawal by Subject|1|||
163490617|NCT04478994|590498475|FG001|Overall Study|Withdrawal by Subject|1|||
163490618|NCT00518531|590498476|FG000|Treatment Period 1|Adverse Event|5|||
163490619|NCT00518531|590498477|FG001|Treatment Period 1|Adverse Event|0|||
163490620|NCT00518531|590498476|FG000|Treatment Period 1|Lost to Follow-up|5|||
163490621|NCT00518531|590498477|FG001|Treatment Period 1|Lost to Follow-up|3|||
163490622|NCT00518531|590498476|FG000|Treatment Period 1|Physician Decision|1|||
163490623|NCT00518531|590498477|FG001|Treatment Period 1|Physician Decision|0|||
163490624|NCT00518531|590498476|FG000|Treatment Period 1|Protocol Violation|2|||
163490625|NCT00518531|590498477|FG001|Treatment Period 1|Protocol Violation|0|||
163490626|NCT00518531|590498476|FG000|Treatment Period 1|Withdrawal by Subject|4|||
163490627|NCT00518531|590498477|FG001|Treatment Period 1|Withdrawal by Subject|6|||
163490628|NCT00518531|590498476|FG000|Treatment Period 1|Early crossover|1|||
163490629|NCT00518531|590498477|FG001|Treatment Period 1|Early crossover|3|||
163490630|NCT00518531|590498476|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163490631|NCT00518531|590498477|FG001|Treatment Period 2|Withdrawal by Subject|8|||
163490632|NCT00518531|590498476|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
163490633|NCT00518531|590498477|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
163490634|NCT00518531|590498476|FG000|Treatment Period 2|Adverse Event|1|||
163490635|NCT00518531|590498477|FG001|Treatment Period 2|Adverse Event|7|||
163490636|NCT00518531|590498476|FG000|Treatment Period 2|Protocol-specified criteria|0|||
163490637|NCT00518531|590498477|FG001|Treatment Period 2|Protocol-specified criteria|1|||
163490638|NCT00518531|590498476|FG000|Treatment Period 2|Non-compliance|1|||
163490639|NCT00518531|590498477|FG001|Treatment Period 2|Non-compliance|2|||
163490640|NCT00457249|590498478|FG000|Overall Study|Lost to Follow-up|3|||
163490641|NCT00457249|590498479|FG001|Overall Study|Lost to Follow-up|0|||
163490642|NCT00457249|590498478|FG000|Overall Study|Protocol Violation|4|||
163490643|NCT00457249|590498479|FG001|Overall Study|Protocol Violation|1|||
163490644|NCT00457249|590498478|FG000|Overall Study|Withdrawal by Subject|3|||
163490645|NCT00457249|590498479|FG001|Overall Study|Withdrawal by Subject|1|||
163490646|NCT00457249|590498478|FG000|Overall Study|Serious Adverse Events|2|||
163490647|NCT00457249|590498479|FG001|Overall Study|Serious Adverse Events|0|||
163490648|NCT04621227|590498482|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
163490649|NCT04621227|590498482|FG000|Period 3 (29 Days)|Adverse Event|1|||
163490650|NCT04621227|590498482|FG000|Period 8 (2 Days)|Adverse Event|1|||
163490651|NCT02916056|590498483|FG000|Overall Study|Adverse Event|6|||
163490652|NCT02916056|590498483|FG000|Overall Study|Lost to Follow-up|1|||
163490653|NCT02916056|590498483|FG000|Overall Study|Other|12|||
163490654|NCT02916056|590498483|FG000|Overall Study|Protocol Violation|1|||
163490655|NCT02916056|590498483|FG000|Overall Study|Withdrawal by Subject|8|||
163490656|NCT02916056|590498483|FG000|Overall Study|Study Terminated by Sponsor|269|||
163490657|NCT00124709|590498484|FG000|Overall Study|Randomized but did not take medication|3|||
163490658|NCT00124709|590498485|FG001|Overall Study|Randomized but did not take medication|1|||
163490659|NCT00124709|590498484|FG000|Overall Study|Adverse Event|3|||
163490660|NCT00124709|590498485|FG001|Overall Study|Adverse Event|0|||
163490661|NCT00124709|590498484|FG000|Overall Study|Lack of Efficacy|5|||
163490662|NCT00124709|590498485|FG001|Overall Study|Lack of Efficacy|10|||
163490663|NCT00124709|590498484|FG000|Overall Study|Protocol Violation|3|||
163490664|NCT00124709|590498485|FG001|Overall Study|Protocol Violation|5|||
163490665|NCT00124709|590498484|FG000|Overall Study|Withdrawal by Subject|127|||
163490666|NCT00124709|590498485|FG001|Overall Study|Withdrawal by Subject|136|||
163490667|NCT00124709|590498484|FG000|Overall Study|Lost to Follow-up|114|||
163490668|NCT00124709|590498485|FG001|Overall Study|Lost to Follow-up|120|||
163490669|NCT01728376|590498486|FG000|Overall Study|Adverse Event|1|||
163490670|NCT01728376|590498487|FG001|Overall Study|Adverse Event|1|||
163490671|NCT01728376|590498488|FG002|Overall Study|Adverse Event|1|||
163490672|NCT01728376|590498489|FG003|Overall Study|Adverse Event|1|||
163490673|NCT01728376|590498490|FG004|Overall Study|Adverse Event|1|||
163490674|NCT01728376|590498491|FG005|Overall Study|Adverse Event|0|||
163490675|NCT01728376|590498486|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
163490676|NCT01728376|590498487|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
163490677|NCT01728376|590498488|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
163490678|NCT01728376|590498489|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
163490679|NCT01728376|590498490|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
163490680|NCT01728376|590498491|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
163490681|NCT01728376|590498486|FG000|Overall Study|No relevant bacteria|2|||
163490682|NCT01728376|590498487|FG001|Overall Study|No relevant bacteria|0|||
163490683|NCT01728376|590498488|FG002|Overall Study|No relevant bacteria|0|||
163490684|NCT01728376|590498489|FG003|Overall Study|No relevant bacteria|0|||
163490685|NCT01728376|590498490|FG004|Overall Study|No relevant bacteria|1|||
163490686|NCT01728376|590498491|FG005|Overall Study|No relevant bacteria|1|||
163490687|NCT01728376|590498486|FG000|Overall Study|Did not receive treatment|0|||
163490688|NCT01728376|590498487|FG001|Overall Study|Did not receive treatment|1|||
163490689|NCT01728376|590498488|FG002|Overall Study|Did not receive treatment|0|||
163490690|NCT01728376|590498489|FG003|Overall Study|Did not receive treatment|0|||
163490691|NCT01728376|590498490|FG004|Overall Study|Did not receive treatment|0|||
163490692|NCT01728376|590498491|FG005|Overall Study|Did not receive treatment|0|||
163490693|NCT01728376|590498486|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
163490694|NCT01728376|590498487|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
163490695|NCT01728376|590498488|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
163490696|NCT01728376|590498489|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
163490697|NCT01728376|590498490|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
163490698|NCT01728376|590498491|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
163490699|NCT02094573|590498493|FG000|Overall Study|Adverse Event|4|||
163490700|NCT02094573|590498494|FG001|Overall Study|Adverse Event|14|||
163490701|NCT02094573|590498493|FG000|Overall Study|Clinical Progressive Disease|9|||
163490702|NCT02094573|590498494|FG001|Overall Study|Clinical Progressive Disease|13|||
163490703|NCT02094573|590498493|FG000|Overall Study|Death|11|||
163490704|NCT02094573|590498494|FG001|Overall Study|Death|3|||
163490705|NCT02094573|590498493|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
163490706|NCT02094573|590498494|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
163490707|NCT02094573|590498493|FG000|Overall Study|Non-compliance with Study Drug|1|||
163490708|NCT02094573|590498494|FG001|Overall Study|Non-compliance with Study Drug|1|||
163490709|NCT02094573|590498493|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
163490710|NCT02094573|590498494|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
163490711|NCT02094573|590498493|FG000|Overall Study|Physician Decision|4|||
163490712|NCT02094573|590498494|FG001|Overall Study|Physician Decision|4|||
163490713|NCT02094573|590498493|FG000|Overall Study|Site Terminated by Sponsor|10|||
163490714|NCT02094573|590498494|FG001|Overall Study|Site Terminated by Sponsor|17|||
163490715|NCT02094573|590498493|FG000|Overall Study|Withdrawal by Subject|6|||
163490716|NCT02094573|590498494|FG001|Overall Study|Withdrawal by Subject|8|||
163490717|NCT02094573|590498493|FG000|Overall Study|Randomized but not Treated|3|||
163490718|NCT02094573|590498494|FG001|Overall Study|Randomized but not Treated|0|||
163490719|NCT02411110|590498495|FG000|Treatment Period 1|Adverse Event|4|||
163490720|NCT02411110|590498496|FG001|Treatment Period 1|Adverse Event|2|||
163490721|NCT02411110|590498495|FG000|Treatment Period 1|Lost to Follow-up|1|||
163490722|NCT02411110|590498496|FG001|Treatment Period 1|Lost to Follow-up|0|||
163490723|NCT02411110|590498495|FG000|Treatment Period 1|Personal Reasons|2|||
163490724|NCT02411110|590498496|FG001|Treatment Period 1|Personal Reasons|5|||
163490725|NCT02411110|590498495|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
163490726|NCT02411110|590498496|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
163490727|NCT02411110|590498495|FG000|Treatment Period 2|Adverse Event|1|||
163490728|NCT02411110|590498496|FG001|Treatment Period 2|Adverse Event|0|||
163490729|NCT02411110|590498495|FG000|Treatment Period 2|Lost to Follow-up|0|||
163490730|NCT02411110|590498496|FG001|Treatment Period 2|Lost to Follow-up|2|||
163490731|NCT02411110|590498495|FG000|Treatment Period 2|Personal Reasons|0|||
163490732|NCT02411110|590498496|FG001|Treatment Period 2|Personal Reasons|2|||
163490733|NCT03985982|590498499|FG000|Double-Blind Phase|Lost to Follow-up|4|||
163490734|NCT03985982|590498500|FG001|Double-Blind Phase|Lost to Follow-up|3|||
163490735|NCT03985982|590498501|FG002|Double-Blind Phase|Lost to Follow-up|0|||
163490736|NCT03985982|590498499|FG000|Double-Blind Phase|Physician Decision|1|||
163490737|NCT03985982|590498500|FG001|Double-Blind Phase|Physician Decision|0|||
163490738|NCT03985982|590498501|FG002|Double-Blind Phase|Physician Decision|0|||
163490739|NCT03985982|590498499|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
163490740|NCT03985982|590498500|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
163490741|NCT03985982|590498501|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
163490742|NCT03985982|590498499|FG000|Double-Blind Phase|COVID-19|1|||
163490743|NCT03985982|590498500|FG001|Double-Blind Phase|COVID-19|0|||
163490744|NCT03985982|590498501|FG002|Double-Blind Phase|COVID-19|0|||
163490745|NCT03985982|590498499|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
163490746|NCT03985982|590498500|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
163490747|NCT03985982|590498501|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
163490748|NCT03985982|590498499|FG000|Open-Label Phase|Lost to Follow-up|0|||
163490749|NCT03985982|590498500|FG001|Open-Label Phase|Lost to Follow-up|0|||
163490750|NCT03985982|590498501|FG002|Open-Label Phase|Lost to Follow-up|13|||
163490751|NCT03985982|590498499|FG000|Open-Label Phase|Physician Decision|0|||
163490752|NCT03985982|590498500|FG001|Open-Label Phase|Physician Decision|0|||
163490753|NCT03985982|590498501|FG002|Open-Label Phase|Physician Decision|2|||
163490754|NCT03985982|590498499|FG000|Open-Label Phase|Withdrawal by Subject|0|||
163490755|NCT03985982|590498500|FG001|Open-Label Phase|Withdrawal by Subject|0|||
163490756|NCT03985982|590498501|FG002|Open-Label Phase|Withdrawal by Subject|11|||
163490757|NCT05981365|590498502|FG000|Period 1|Adverse Event|1|||
163490758|NCT05981365|590498503|FG001|Period 1|Adverse Event|0|||
163490759|NCT00643006|590498507|FG000|Overall Study|Lost to Follow-up|5|||
163490760|NCT00643006|590498508|FG001|Overall Study|Lost to Follow-up|4|||
163490761|NCT01308476|590498509|FG000|Overall Study|Lost to Follow-up|2|||
163490762|NCT01308476|590498510|FG001|Overall Study|Lost to Follow-up|2|||
163490763|NCT01308476|590498509|FG000|Overall Study|Other|1|||
163490764|NCT01308476|590498510|FG001|Overall Study|Other|0|||
163490765|NCT00812968|590498513|FG000|Overall Study|Relapse after erythroid response|6|||
163490766|NCT00812968|590498513|FG000|Overall Study|Disease progression|1|||
163490767|NCT00812968|590498513|FG000|Overall Study|No further treatment required|1|||
163490768|NCT00812968|590498513|FG000|Overall Study|Study closed due to marketing approval|3|||
163490769|NCT00505765|590498515|FG000|Overall Study|Withdrawal by Subject|1|||
163490770|NCT00505765|590498516|FG001|Overall Study|Withdrawal by Subject|0|||
163490771|NCT00505765|590498517|FG002|Overall Study|Withdrawal by Subject|0|||
163490772|NCT00505765|590498515|FG000|Overall Study|Adverse Event|1|||
163490773|NCT00505765|590498516|FG001|Overall Study|Adverse Event|2|||
163490774|NCT00505765|590498517|FG002|Overall Study|Adverse Event|0|||
163490775|NCT00505765|590498515|FG000|Overall Study|Noncompliance|0|||
163490776|NCT00505765|590498516|FG001|Overall Study|Noncompliance|1|||
163490777|NCT00505765|590498517|FG002|Overall Study|Noncompliance|3|||
163490778|NCT01207219|590498519|FG000|Overall Study|changed diagnosis during study period|5|||
163490779|NCT01207219|590498520|FG001|Overall Study|changed diagnosis during study period|3|||
163490780|NCT01207219|590498521|FG002|Overall Study|changed diagnosis during study period|1|||
163490781|NCT01207219|590498519|FG000|Overall Study|Lost to Follow-up|6|||
163490782|NCT01207219|590498520|FG001|Overall Study|Lost to Follow-up|8|||
163490783|NCT01207219|590498521|FG002|Overall Study|Lost to Follow-up|6|||
163490784|NCT01012609|590498522|FG000|Overall Study|Withdrawal by Subject|1|||
163490785|NCT01012609|590498523|FG001|Overall Study|Withdrawal by Subject|1|||
163490786|NCT01453296|590498524|FG000|Treatment Period 1|Adverse Event|0|||
163490787|NCT01453296|590498525|FG001|Treatment Period 1|Adverse Event|1|||
163490788|NCT01453296|590498524|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
163490789|NCT01453296|590498525|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
163490790|NCT01453296|590498524|FG000|Treatment Period 2|Adverse Event|1|||
163490791|NCT01453296|590498525|FG001|Treatment Period 2|Adverse Event|0|||
163490792|NCT01453296|590498524|FG000|Treatment Period 2|Withdrawal by Subject|1|||
163490793|NCT01453296|590498525|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163490794|NCT00924820|590498527|FG000|Overall Study|Death|2|||
163490795|NCT00924820|590498527|FG000|Overall Study|Ineligible, Screen Failure|5|||
163490796|NCT03205046|590498530|FG000|Overall Study|Death|10|||
163490797|NCT03205046|590498531|FG001|Overall Study|Death|6|||
163490798|NCT03205046|590498530|FG000|Overall Study|Withdrawal by Subject|1|||
163490799|NCT03205046|590498531|FG001|Overall Study|Withdrawal by Subject|2|||
163490800|NCT03205046|590498530|FG000|Overall Study|Lost to Follow-up|0|||
163490801|NCT03205046|590498531|FG001|Overall Study|Lost to Follow-up|1|||
163490802|NCT03205046|590498530|FG000|Overall Study|Study terminated by sponsor|2|||
163490803|NCT03205046|590498531|FG001|Overall Study|Study terminated by sponsor|1|||
163490804|NCT01068418|590498532|FG000|Overall Study|Physician Decision|12|||
163490805|NCT01015118|590498533|FG000|Overall Study|Protocol Violation|5|||
163490806|NCT01015118|590498534|FG001|Overall Study|Protocol Violation|6|||
163490807|NCT01015118|590498533|FG000|Overall Study|Withdrawal by Subject|103|||
163490808|NCT01015118|590498534|FG001|Overall Study|Withdrawal by Subject|27|||
163490809|NCT01015118|590498533|FG000|Overall Study|Other Adverse Event (AE)|141|||
163490810|NCT01015118|590498534|FG001|Overall Study|Other Adverse Event (AE)|33|||
163490811|NCT01015118|590498533|FG000|Overall Study|Worsening or AE of underlying disease|5|||
163490812|NCT01015118|590498534|FG001|Overall Study|Worsening or AE of underlying disease|4|||
163490813|NCT01015118|590498533|FG000|Overall Study|Progressive disease|364|||
163490814|NCT01015118|590498534|FG001|Overall Study|Progressive disease|229|||
163490815|NCT01015118|590498533|FG000|Overall Study|Not treated|9|||
163490816|NCT01015118|590498534|FG001|Overall Study|Not treated|5|||
163490817|NCT01015118|590498533|FG000|Overall Study|Other than stated above|42|||
163490818|NCT01015118|590498534|FG001|Overall Study|Other than stated above|23|||
163490819|NCT00402298|590498539|FG000|Overall Study|Withdrawal by Subject|1|||
163490820|NCT00402298|590498540|FG001|Overall Study|Withdrawal by Subject|0|||
163490821|NCT00480077|590498541|FG000|Overall Study|Death|19|||
163490822|NCT00480077|590498542|FG001|Overall Study|Death|15|||
163490823|NCT00480077|590498541|FG000|Overall Study|early exit|12|||
163490824|NCT00480077|590498542|FG001|Overall Study|early exit|11|||
163490825|NCT00938366|590498547|FG000|Overall Study|Withdrawal by Subject|1|||
163490826|NCT00938366|590498548|FG001|Overall Study|Withdrawal by Subject|0|||
163490827|NCT01215968|590498549|FG000|Overall Study|Adverse Event|0|||
163490828|NCT01215968|590498550|FG001|Overall Study|Adverse Event|2|||
163490829|NCT01215968|590498549|FG000|Overall Study|Protocol Violation|2|||
163490830|NCT01215968|590498550|FG001|Overall Study|Protocol Violation|4|||
163490831|NCT01215968|590498549|FG000|Overall Study|Not received study drug|0|||
163490832|NCT01215968|590498550|FG001|Overall Study|Not received study drug|1|||
163490833|NCT05966129|590498551|FG000|Overall Study|Death|1|||
163490834|NCT05966129|590498552|FG001|Overall Study|Death|2|||
163490835|NCT05966129|590498551|FG000|Overall Study|Lost to Follow-up|63|||
163490836|NCT05966129|590498552|FG001|Overall Study|Lost to Follow-up|66|||
163490837|NCT05966129|590498551|FG000|Overall Study|Protocol Violation|1|||
163490838|NCT05966129|590498552|FG001|Overall Study|Protocol Violation|0|||
163490839|NCT05966129|590498551|FG000|Overall Study|Withdrawal by Subject|26|||
163490840|NCT05966129|590498552|FG001|Overall Study|Withdrawal by Subject|25|||
163490841|NCT05966129|590498551|FG000|Overall Study|Surgery not completed|63|||
163490842|NCT05966129|590498552|FG001|Overall Study|Surgery not completed|69|||
163490843|NCT05966129|590498551|FG000|Overall Study|Surgery logistics issue|2|||
163490844|NCT05966129|590498552|FG001|Overall Study|Surgery logistics issue|1|||
163490845|NCT05182840|590498553|FG000|Run-in Period|Not treated|0|||
163490846|NCT05182840|590498554|FG001|Run-in Period|Not treated|1|||
163490847|NCT05182840|590498555|FG002|Run-in Period|Not treated|0|||
163490848|NCT05182840|590498556|FG003|Run-in Period|Not treated|0|||
163490849|NCT05182840|590498557|FG004|Run-in Period|Not treated|0|||
163490850|NCT05182840|590498558|FG005|Run-in Period|Not treated|0|||
163490851|NCT05182840|590498559|FG006|Run-in Period|Not treated|0|||
163490852|NCT05182840|590498560|FG007|Run-in Period|Not treated|0|||
163490853|NCT05182840|590498561|FG008|Run-in Period|Not treated|0|||
163490854|NCT05182840|590498562|FG009|Run-in Period|Not treated|0|||
163490855|NCT05182840|590498553|FG000|Run-in Period|Other reason but not sponsor termination|14|||
163490856|NCT05182840|590498554|FG001|Run-in Period|Other reason but not sponsor termination|18|||
163490857|NCT05182840|590498555|FG002|Run-in Period|Other reason but not sponsor termination|0|||
163490858|NCT05182840|590498556|FG003|Run-in Period|Other reason but not sponsor termination|0|||
163490859|NCT05182840|590498557|FG004|Run-in Period|Other reason but not sponsor termination|0|||
163490860|NCT05182840|590498558|FG005|Run-in Period|Other reason but not sponsor termination|0|||
163490861|NCT05182840|590498559|FG006|Run-in Period|Other reason but not sponsor termination|0|||
163490862|NCT05182840|590498560|FG007|Run-in Period|Other reason but not sponsor termination|0|||
163490863|NCT05182840|590498561|FG008|Run-in Period|Other reason but not sponsor termination|0|||
163490864|NCT05182840|590498562|FG009|Run-in Period|Other reason but not sponsor termination|0|||
163490865|NCT05182840|590498553|FG000|Run-in Period|No reason available|2|||
163490866|NCT05182840|590498554|FG001|Run-in Period|No reason available|2|||
163490867|NCT05182840|590498555|FG002|Run-in Period|No reason available|0|||
163490868|NCT05182840|590498556|FG003|Run-in Period|No reason available|0|||
163490869|NCT05182840|590498557|FG004|Run-in Period|No reason available|0|||
163490870|NCT05182840|590498558|FG005|Run-in Period|No reason available|0|||
163490871|NCT05182840|590498559|FG006|Run-in Period|No reason available|0|||
163490872|NCT05182840|590498560|FG007|Run-in Period|No reason available|0|||
163490873|NCT05182840|590498561|FG008|Run-in Period|No reason available|0|||
163490874|NCT05182840|590498562|FG009|Run-in Period|No reason available|0|||
163490875|NCT05182840|590498553|FG000|Run-in Period|Burden of study procedures|2|||
163490876|NCT05182840|590498554|FG001|Run-in Period|Burden of study procedures|2|||
163490877|NCT05182840|590498555|FG002|Run-in Period|Burden of study procedures|0|||
163490878|NCT05182840|590498556|FG003|Run-in Period|Burden of study procedures|0|||
163490879|NCT05182840|590498557|FG004|Run-in Period|Burden of study procedures|0|||
163490880|NCT05182840|590498558|FG005|Run-in Period|Burden of study procedures|0|||
163490881|NCT05182840|590498559|FG006|Run-in Period|Burden of study procedures|0|||
163490882|NCT05182840|590498560|FG007|Run-in Period|Burden of study procedures|0|||
163490883|NCT05182840|590498561|FG008|Run-in Period|Burden of study procedures|0|||
163490884|NCT05182840|590498562|FG009|Run-in Period|Burden of study procedures|0|||
163490885|NCT05182840|590498553|FG000|Run-in Period|Change of residence|1|||
163490886|NCT05182840|590498554|FG001|Run-in Period|Change of residence|0|||
163490887|NCT05182840|590498555|FG002|Run-in Period|Change of residence|0|||
163490888|NCT05182840|590498556|FG003|Run-in Period|Change of residence|0|||
163490889|NCT05182840|590498557|FG004|Run-in Period|Change of residence|0|||
163490890|NCT05182840|590498558|FG005|Run-in Period|Change of residence|0|||
163490891|NCT05182840|590498559|FG006|Run-in Period|Change of residence|0|||
163490892|NCT05182840|590498560|FG007|Run-in Period|Change of residence|0|||
163490893|NCT05182840|590498561|FG008|Run-in Period|Change of residence|0|||
163490894|NCT05182840|590498562|FG009|Run-in Period|Change of residence|0|||
163490895|NCT05182840|590498553|FG000|Run-in Period|Adverse Event|5|||
163490896|NCT05182840|590498554|FG001|Run-in Period|Adverse Event|5|||
163490897|NCT05182840|590498555|FG002|Run-in Period|Adverse Event|0|||
163490898|NCT05182840|590498556|FG003|Run-in Period|Adverse Event|0|||
163490899|NCT05182840|590498557|FG004|Run-in Period|Adverse Event|0|||
163490900|NCT05182840|590498558|FG005|Run-in Period|Adverse Event|0|||
163490901|NCT05182840|590498559|FG006|Run-in Period|Adverse Event|0|||
163490902|NCT05182840|590498560|FG007|Run-in Period|Adverse Event|0|||
163490903|NCT05182840|590498561|FG008|Run-in Period|Adverse Event|0|||
163490904|NCT05182840|590498562|FG009|Run-in Period|Adverse Event|0|||
163490905|NCT05182840|590498553|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
163490906|NCT05182840|590498554|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
163490907|NCT05182840|590498555|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
163490908|NCT05182840|590498556|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
163490909|NCT05182840|590498557|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
163490910|NCT05182840|590498558|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
163490911|NCT05182840|590498559|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
163490912|NCT05182840|590498560|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
163490913|NCT05182840|590498561|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
163490914|NCT05182840|590498562|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
163490915|NCT05182840|590498553|FG000|Treatment Period|Reason missing|0|||
163490916|NCT05182840|590498554|FG001|Treatment Period|Reason missing|0|||
163490917|NCT05182840|590498555|FG002|Treatment Period|Reason missing|1|||
163490918|NCT05182840|590498556|FG003|Treatment Period|Reason missing|0|||
163490919|NCT05182840|590498557|FG004|Treatment Period|Reason missing|0|||
163490920|NCT05182840|590498558|FG005|Treatment Period|Reason missing|0|||
163490921|NCT05182840|590498559|FG006|Treatment Period|Reason missing|0|||
163490922|NCT05182840|590498560|FG007|Treatment Period|Reason missing|0|||
163490923|NCT05182840|590498561|FG008|Treatment Period|Reason missing|0|||
163490924|NCT05182840|590498562|FG009|Treatment Period|Reason missing|0|||
163490925|NCT05182840|590498553|FG000|Treatment Period|Other but not sponsor termination|0|||
163490926|NCT05182840|590498554|FG001|Treatment Period|Other but not sponsor termination|0|||
163490927|NCT05182840|590498555|FG002|Treatment Period|Other but not sponsor termination|8|||
163490928|NCT05182840|590498556|FG003|Treatment Period|Other but not sponsor termination|6|||
163490929|NCT05182840|590498557|FG004|Treatment Period|Other but not sponsor termination|6|||
163490930|NCT05182840|590498558|FG005|Treatment Period|Other but not sponsor termination|7|||
163490931|NCT05182840|590498559|FG006|Treatment Period|Other but not sponsor termination|5|||
163490932|NCT05182840|590498560|FG007|Treatment Period|Other but not sponsor termination|8|||
163490933|NCT05182840|590498561|FG008|Treatment Period|Other but not sponsor termination|7|||
163490934|NCT05182840|590498562|FG009|Treatment Period|Other but not sponsor termination|2|||
163490935|NCT05182840|590498553|FG000|Treatment Period|Protocol deviation|0|||
163490936|NCT05182840|590498554|FG001|Treatment Period|Protocol deviation|0|||
163490937|NCT05182840|590498555|FG002|Treatment Period|Protocol deviation|0|||
163490938|NCT05182840|590498556|FG003|Treatment Period|Protocol deviation|0|||
163490939|NCT05182840|590498557|FG004|Treatment Period|Protocol deviation|0|||
163490940|NCT05182840|590498558|FG005|Treatment Period|Protocol deviation|0|||
163490941|NCT05182840|590498559|FG006|Treatment Period|Protocol deviation|0|||
163490942|NCT05182840|590498560|FG007|Treatment Period|Protocol deviation|0|||
163490943|NCT05182840|590498561|FG008|Treatment Period|Protocol deviation|1|||
163490944|NCT05182840|590498562|FG009|Treatment Period|Protocol deviation|0|||
163490945|NCT05182840|590498553|FG000|Treatment Period|No reason available|0|||
163490946|NCT05182840|590498554|FG001|Treatment Period|No reason available|0|||
163490947|NCT05182840|590498555|FG002|Treatment Period|No reason available|0|||
163490948|NCT05182840|590498556|FG003|Treatment Period|No reason available|1|||
163490949|NCT05182840|590498557|FG004|Treatment Period|No reason available|0|||
163490950|NCT05182840|590498558|FG005|Treatment Period|No reason available|2|||
163490951|NCT05182840|590498559|FG006|Treatment Period|No reason available|0|||
163490952|NCT05182840|590498560|FG007|Treatment Period|No reason available|1|||
163490953|NCT05182840|590498561|FG008|Treatment Period|No reason available|0|||
163490954|NCT05182840|590498562|FG009|Treatment Period|No reason available|0|||
163490955|NCT05182840|590498553|FG000|Treatment Period|Burden of study procedures|0|||
163490956|NCT05182840|590498554|FG001|Treatment Period|Burden of study procedures|0|||
163490957|NCT05182840|590498555|FG002|Treatment Period|Burden of study procedures|0|||
163490958|NCT05182840|590498556|FG003|Treatment Period|Burden of study procedures|0|||
163490959|NCT05182840|590498557|FG004|Treatment Period|Burden of study procedures|1|||
163490960|NCT05182840|590498558|FG005|Treatment Period|Burden of study procedures|0|||
163490961|NCT05182840|590498559|FG006|Treatment Period|Burden of study procedures|0|||
163490962|NCT05182840|590498560|FG007|Treatment Period|Burden of study procedures|0|||
163490963|NCT05182840|590498561|FG008|Treatment Period|Burden of study procedures|0|||
163490964|NCT05182840|590498562|FG009|Treatment Period|Burden of study procedures|0|||
163490965|NCT05182840|590498553|FG000|Treatment Period|Change of residence|0|||
163490966|NCT05182840|590498554|FG001|Treatment Period|Change of residence|0|||
163490967|NCT05182840|590498555|FG002|Treatment Period|Change of residence|0|||
163490968|NCT05182840|590498556|FG003|Treatment Period|Change of residence|0|||
163490969|NCT05182840|590498557|FG004|Treatment Period|Change of residence|0|||
163490970|NCT05182840|590498558|FG005|Treatment Period|Change of residence|1|||
163490971|NCT05182840|590498559|FG006|Treatment Period|Change of residence|0|||
163490972|NCT05182840|590498560|FG007|Treatment Period|Change of residence|0|||
163490973|NCT05182840|590498561|FG008|Treatment Period|Change of residence|0|||
163490974|NCT05182840|590498562|FG009|Treatment Period|Change of residence|0|||
163490975|NCT05182840|590498553|FG000|Treatment Period|Adverse Event|0|||
163490976|NCT05182840|590498554|FG001|Treatment Period|Adverse Event|0|||
163490977|NCT05182840|590498555|FG002|Treatment Period|Adverse Event|4|||
163490978|NCT05182840|590498556|FG003|Treatment Period|Adverse Event|16|||
163490979|NCT05182840|590498557|FG004|Treatment Period|Adverse Event|12|||
163490980|NCT05182840|590498558|FG005|Treatment Period|Adverse Event|6|||
163490981|NCT05182840|590498559|FG006|Treatment Period|Adverse Event|4|||
163490982|NCT05182840|590498560|FG007|Treatment Period|Adverse Event|8|||
163490983|NCT05182840|590498561|FG008|Treatment Period|Adverse Event|16|||
163490984|NCT05182840|590498562|FG009|Treatment Period|Adverse Event|5|||
163490985|NCT05182840|590498553|FG000|Treatment Period|Not treated with study drug|0|||
163490986|NCT05182840|590498554|FG001|Treatment Period|Not treated with study drug|0|||
163490987|NCT05182840|590498555|FG002|Treatment Period|Not treated with study drug|0|||
163490988|NCT05182840|590498556|FG003|Treatment Period|Not treated with study drug|1|||
163490989|NCT05182840|590498557|FG004|Treatment Period|Not treated with study drug|0|||
163490990|NCT05182840|590498558|FG005|Treatment Period|Not treated with study drug|0|||
163490991|NCT05182840|590498559|FG006|Treatment Period|Not treated with study drug|1|||
163490992|NCT05182840|590498560|FG007|Treatment Period|Not treated with study drug|1|||
163490993|NCT05182840|590498561|FG008|Treatment Period|Not treated with study drug|0|||
163490994|NCT05182840|590498562|FG009|Treatment Period|Not treated with study drug|0|||
163490995|NCT04242498|590498565|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
163490996|NCT04242498|590498566|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
163490997|NCT04242498|590498567|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
163490998|NCT04242498|590498568|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
163490999|NCT04242498|590498569|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
163491000|NCT04242498|590498570|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
163491001|NCT04242498|590498571|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
163491002|NCT04242498|590498565|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
163491003|NCT04242498|590498566|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
163491004|NCT04242498|590498567|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
163491005|NCT04242498|590498568|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
163491006|NCT04242498|590498569|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
163491007|NCT04242498|590498570|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
163491008|NCT04242498|590498571|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
163491009|NCT04242498|590498565|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
163491010|NCT04242498|590498566|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
163491011|NCT04242498|590498567|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
163491012|NCT04242498|590498568|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
163491013|NCT04242498|590498569|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
163491014|NCT04242498|590498570|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
163491015|NCT04242498|590498571|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
163491016|NCT04242498|590498565|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
163491017|NCT04242498|590498566|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
163491018|NCT04242498|590498567|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
163491019|NCT04242498|590498568|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
163491020|NCT04242498|590498569|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
163491021|NCT04242498|590498570|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
163491022|NCT04242498|590498571|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
163491023|NCT04242498|590498565|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
163491024|NCT04242498|590498566|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
163491025|NCT04242498|590498567|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
163491026|NCT04242498|590498568|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
163491027|NCT04242498|590498569|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
163491028|NCT04242498|590498570|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
163491029|NCT04242498|590498571|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
163491030|NCT04242498|590498565|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
163491031|NCT04242498|590498566|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
163491032|NCT04242498|590498567|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
163491033|NCT04242498|590498568|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
163491034|NCT04242498|590498569|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
163491035|NCT04242498|590498570|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
163491036|NCT04242498|590498571|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
163491037|NCT04242498|590498565|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
163491038|NCT04242498|590498566|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
163491039|NCT04242498|590498567|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
163491040|NCT04242498|590498568|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
163491041|NCT04242498|590498569|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
163491042|NCT04242498|590498570|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
163491043|NCT04242498|590498571|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
163491044|NCT04242498|590498565|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
163491045|NCT04242498|590498566|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
163491046|NCT04242498|590498567|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
163491047|NCT04242498|590498568|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
163491048|NCT04242498|590498569|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
163491049|NCT04242498|590498570|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
163491050|NCT04242498|590498571|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
163491051|NCT04242498|590498565|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
163491052|NCT04242498|590498566|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
163491053|NCT04242498|590498567|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
163491054|NCT04242498|590498568|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
163491055|NCT04242498|590498569|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
163491056|NCT04242498|590498570|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
163491057|NCT04242498|590498571|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
163491058|NCT04242498|590498565|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
163491059|NCT04242498|590498566|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
163491060|NCT04242498|590498567|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
163491061|NCT04242498|590498568|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
163491062|NCT04242498|590498569|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
163491063|NCT04242498|590498570|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
163491064|NCT04242498|590498571|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
163491065|NCT04242498|590498565|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
163491066|NCT04242498|590498566|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
163491067|NCT04242498|590498567|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
163491068|NCT04242498|590498568|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
163491069|NCT04242498|590498569|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
163491070|NCT04242498|590498570|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
163491071|NCT04242498|590498571|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
163491072|NCT04242498|590498565|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
163491073|NCT04242498|590498566|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
163491074|NCT04242498|590498567|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
163491075|NCT04242498|590498568|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
163491076|NCT04242498|590498569|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
163491077|NCT04242498|590498570|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
163491078|NCT04242498|590498571|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
163491079|NCT04242498|590498565|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
163491080|NCT04242498|590498566|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
163491081|NCT04242498|590498567|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
163491082|NCT04242498|590498568|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
163491083|NCT04242498|590498569|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
163491084|NCT04242498|590498570|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
163491085|NCT04242498|590498571|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
163491086|NCT04242498|590498565|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
163491087|NCT04242498|590498566|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
163491088|NCT04242498|590498567|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
163491089|NCT04242498|590498568|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
163491090|NCT04242498|590498569|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
163491091|NCT04242498|590498570|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
163491092|NCT04242498|590498571|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
163491093|NCT04242498|590498565|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
163491094|NCT04242498|590498566|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
163491095|NCT04242498|590498567|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
163491096|NCT04242498|590498568|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
163491097|NCT04242498|590498569|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
163491098|NCT04242498|590498570|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
163491099|NCT04242498|590498571|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
163491100|NCT04242498|590498565|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
163491101|NCT04242498|590498566|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
163491102|NCT04242498|590498567|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
163491103|NCT04242498|590498568|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
163491104|NCT04242498|590498569|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
163491105|NCT04242498|590498570|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
163491106|NCT04242498|590498571|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
163491107|NCT02396849|590498573|FG000|Overall Study|Lost to Follow-up|1|||
163491108|NCT02396849|590498574|FG001|Overall Study|Lost to Follow-up|1|||
163491109|NCT02396849|590498573|FG000|Overall Study|Did not tolerate intervention|1|||
163491110|NCT02396849|590498574|FG001|Overall Study|Did not tolerate intervention|1|||
163491111|NCT03328325|590498575|FG000|Overall Study|Lost to Follow-up|4|||
163491112|NCT03328325|590498575|FG000|Overall Study|Physician Decision|1|||
163491113|NCT03328325|590498575|FG000|Overall Study|Withdrawal by Subject|3|||
163491114|NCT03328325|590498575|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
163491115|NCT00931515|590498576|FG000|Overall Study|Lost to Follow-up|2|||
163491116|NCT00931515|590498577|FG001|Overall Study|Lost to Follow-up|5|||
163491117|NCT00985114|590498579|FG000|Overall Study|Adverse Event|1|||
163491118|NCT00985114|590498580|FG001|Overall Study|Adverse Event|0|||
163491119|NCT00985114|590498579|FG000|Overall Study|Withdrawal by Subject|0|||
163491120|NCT00985114|590498580|FG001|Overall Study|Withdrawal by Subject|2|||
163491121|NCT02950831|590498581|FG000|Overall Study|Lost to Follow-up|1|||
163491122|NCT02950831|590498581|FG000|Overall Study|Withdrawal by Subject|3|||
163491123|NCT02950831|590498581|FG000|Overall Study|stimulation trail failure|5|||
163491124|NCT01119118|590498582|FG000|Overall Study|Adverse Event|1|||
163491125|NCT00828009|590498585|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
163491126|NCT00828009|590498585|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
162925436|NCT01346501|588428972|FG001|Overall Study|Other|12|||
163491127|NCT00828009|590498585|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
163491128|NCT00828009|590498585|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
163491129|NCT00828009|590498585|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
163491130|NCT00828009|590498585|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
163491131|NCT00828009|590498585|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
163491132|NCT00828009|590498585|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
163491133|NCT00828009|590498585|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
163491134|NCT00828009|590498585|FG000|Step 2 - Maintenance Therapy|Death|1|||
163491135|NCT00828009|590498585|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
163491136|NCT00828009|590498585|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
163491137|NCT00828009|590498585|FG000|Step 2 - Maintenance Therapy|Other|1|||
163491138|NCT00509223|590501211|FG000|Overall Study|Lost to Follow-up|1|||
163491139|NCT00509223|590501212|FG001|Overall Study|Lost to Follow-up|1|||
163491140|NCT00509223|590501211|FG000|Overall Study|Adverse Event|1|||
163491141|NCT00509223|590501212|FG001|Overall Study|Adverse Event|1|||
163491142|NCT00509223|590501211|FG000|Overall Study|Withdrawal by Subject|25|||
163491143|NCT00509223|590501212|FG001|Overall Study|Withdrawal by Subject|6|||
163491144|NCT00509223|590501211|FG000|Overall Study|Including: subject change of address|5|||
163491145|NCT00509223|590501212|FG001|Overall Study|Including: subject change of address|2|||
163491146|NCT00509223|590501211|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
163491147|NCT00509223|590501212|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
163491148|NCT02985541|590501213|FG000|Overall Study|Withdrawal by Subject|33|||
163491149|NCT02985541|590501213|FG000|Overall Study|Lost to Follow-up|26|||
163491150|NCT02985541|590501213|FG000|Overall Study|Adverse Event|27|||
163491151|NCT02985541|590501213|FG000|Overall Study|Physician Decision|2|||
163491152|NCT02985541|590501213|FG000|Overall Study|Pregnancy|2|||
163491153|NCT02985541|590501213|FG000|Overall Study|Wish for pregnancy|44|||
163491154|NCT02985541|590501213|FG000|Overall Study|Other reason|5|||
163491155|NCT02985541|590501213|FG000|Overall Study|Not valid for analysis|2|||
163491156|NCT02383966|590501214|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
163491157|NCT02383966|590501215|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
163491158|NCT02383966|590501214|FG000|Overall Study|Randomized, but not treated|1|||
163491159|NCT02383966|590501215|FG001|Overall Study|Randomized, but not treated|3|||
163491160|NCT04888377|590501218|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
163491161|NCT04888377|590501219|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
163491162|NCT04888377|590501218|FG000|Overall Study|Physician Decision|6|||
163491163|NCT04888377|590501219|FG001|Overall Study|Physician Decision|6|||
163491164|NCT04888377|590501218|FG000|Overall Study|Withdrawal by Subject|7|||
163491165|NCT04888377|590501219|FG001|Overall Study|Withdrawal by Subject|3|||
163491166|NCT00526162|590501220|FG000|Overall Study|Device not implanted|3|||
163491167|NCT05279807|590501221|FG000|Overall Study|Withdrawal by Subject|1|||
163491168|NCT05279807|590501222|FG001|Overall Study|Withdrawal by Subject|0|||
163491169|NCT05279807|590501221|FG000|Overall Study|Adverse Event|0|||
163491170|NCT05279807|590501222|FG001|Overall Study|Adverse Event|1|||
163491171|NCT05279807|590501221|FG000|Overall Study|Laboratory Abnormal Results|1|||
163491172|NCT05279807|590501222|FG001|Overall Study|Laboratory Abnormal Results|0|||
163491173|NCT05299359|590501227|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
163491174|NCT05299359|590501228|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
163491175|NCT05299359|590501227|FG000|Main Part: Day 1 up to Day 366|Other|2|||
163491176|NCT05299359|590501228|FG001|Main Part: Day 1 up to Day 366|Other|0|||
163491177|NCT05299359|590501227|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
163491178|NCT05299359|590501228|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
163491179|NCT05299359|590501227|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
163491180|NCT05299359|590501228|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
163491181|NCT05299359|590501227|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
163491182|NCT05299359|590501228|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
163491183|NCT05299359|590501227|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
163491184|NCT05299359|590501228|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
163491185|NCT05299359|590501227|FG000|Extension Part: Day 1 to Day 366|Other|0|||
163491186|NCT05299359|590501228|FG001|Extension Part: Day 1 to Day 366|Other|1|||
163491187|NCT04242446|590501229|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
163491188|NCT04242446|590501230|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
163491189|NCT04242446|590501231|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
163491190|NCT04242446|590501232|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
163491191|NCT04242446|590501233|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
163491192|NCT04242446|590501234|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
163491193|NCT04242446|590501235|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
163491194|NCT04242446|590501229|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
163491195|NCT04242446|590501230|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
163491196|NCT04242446|590501231|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
163491197|NCT04242446|590501232|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
163491198|NCT04242446|590501233|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
163491199|NCT04242446|590501234|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
163491200|NCT04242446|590501235|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
163491201|NCT04242446|590501229|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
163491202|NCT04242446|590501230|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
163491203|NCT04242446|590501231|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
163491204|NCT04242446|590501232|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
163491205|NCT04242446|590501233|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
163491206|NCT04242446|590501234|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
163491207|NCT04242446|590501235|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
163491208|NCT04242446|590501229|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
163491209|NCT04242446|590501230|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
163491210|NCT04242446|590501231|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
163491211|NCT04242446|590501232|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
163491212|NCT04242446|590501233|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
163491213|NCT04242446|590501234|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
163491214|NCT04242446|590501235|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
163491215|NCT04242446|590501229|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
163491216|NCT04242446|590501230|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
163491217|NCT04242446|590501231|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
163491218|NCT04242446|590501232|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
163491219|NCT04242446|590501233|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
163491220|NCT04242446|590501234|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
163491221|NCT04242446|590501235|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
163491222|NCT04242446|590501229|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
163491223|NCT04242446|590501230|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
163491224|NCT04242446|590501231|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
163491225|NCT04242446|590501232|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
163491226|NCT04242446|590501233|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
163491227|NCT04242446|590501234|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
163491228|NCT04242446|590501235|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
163491229|NCT04242446|590501229|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
163491230|NCT04242446|590501230|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
163491231|NCT04242446|590501231|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
163491232|NCT04242446|590501232|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
163491233|NCT04242446|590501233|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
163491234|NCT04242446|590501234|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
163491235|NCT04242446|590501235|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
163491236|NCT04242446|590501229|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
163491237|NCT04242446|590501230|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
163491238|NCT04242446|590501231|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
163491239|NCT04242446|590501232|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
163491240|NCT04242446|590501233|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
163491241|NCT04242446|590501234|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
163491242|NCT04242446|590501235|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
163491243|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
163491244|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
163491245|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
163491246|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
163491247|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
163491248|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
163491249|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
163491250|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
163491251|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
163491252|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
163491253|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
163491254|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
163491255|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
163491256|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
163491257|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
163491258|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
163491259|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
163491260|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
163491261|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
163491262|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
163491263|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
163491264|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
163491265|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
163491266|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
163491267|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
163491268|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
163491269|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
163491270|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
163491271|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
163491272|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
163491273|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
163491274|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
163491275|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
163491276|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
163491277|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
163491278|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
163491279|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
163491280|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
163491281|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
163491282|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
163491283|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
163491284|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
163491285|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
163491286|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
163491287|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
163491288|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
163491289|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
163491290|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
163491291|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
163491292|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
163491293|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
163491294|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
163491295|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
163491296|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
163491297|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
163491298|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
163491299|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
163491300|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
163491301|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
163491302|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
163491303|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
163491304|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
163491305|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
163491306|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
163491307|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
163491308|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
163491309|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
163491310|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
163491311|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
163491312|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
163491313|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
163491314|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
163491315|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
163491316|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
163491317|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
163491318|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
163491319|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
163491320|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
163491321|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
163491322|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
163491323|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
163491324|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
163491325|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
163491326|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
163491327|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
163491328|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
163491329|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
163491330|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
163491331|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
163491332|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
163491333|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
163491334|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
163491335|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
163491336|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
163491337|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
163491338|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
163491339|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
163491340|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
163491341|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
163491342|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
163491343|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
163491344|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
163491345|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
163491346|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
163491347|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
163491348|NCT04242446|590501229|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
163491349|NCT04242446|590501230|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
163491350|NCT04242446|590501231|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
163491351|NCT04242446|590501232|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
163491352|NCT04242446|590501233|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
163491353|NCT04242446|590501234|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
163491354|NCT04242446|590501235|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
163491355|NCT03587116|590501236|FG000|Overall Study|Lost to Follow-up|0|||
163491356|NCT03587116|590501237|FG001|Overall Study|Lost to Follow-up|1|||
163491357|NCT03587116|590501236|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
163491358|NCT03587116|590501237|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
163491359|NCT03587116|590501236|FG000|Overall Study|Withdrawal by Subject|4|||
163491360|NCT03587116|590501237|FG001|Overall Study|Withdrawal by Subject|0|||
163491361|NCT05993299|590501238|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
163491362|NCT05993299|590501238|FG000|Overall Study|Ongoing|4|||
163491363|NCT05644756|590501239|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
163491364|NCT05644756|590501239|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
163491365|NCT03110107|590501240|FG000|Treatment Period|Disease Progression|3|||
163491366|NCT03110107|590501241|FG001|Treatment Period|Disease Progression|9|||
163491367|NCT03110107|590501242|FG002|Treatment Period|Disease Progression|8|||
163491368|NCT03110107|590501243|FG003|Treatment Period|Disease Progression|11|||
163491369|NCT03110107|590501244|FG004|Treatment Period|Disease Progression|8|||
163491370|NCT03110107|590501245|FG005|Treatment Period|Disease Progression|4|||
163491371|NCT03110107|590501246|FG006|Treatment Period|Disease Progression|6|||
163491372|NCT03110107|590501247|FG007|Treatment Period|Disease Progression|7|||
163491373|NCT03110107|590501248|FG008|Treatment Period|Disease Progression|2|||
163491374|NCT03110107|590501249|FG009|Treatment Period|Disease Progression|10|||
163491375|NCT03110107|590501250|FG010|Treatment Period|Disease Progression|5|||
163491376|NCT03110107|590501251|FG011|Treatment Period|Disease Progression|2|||
163491377|NCT03110107|590501252|FG012|Treatment Period|Disease Progression|0|||
163491378|NCT03110107|590501253|FG013|Treatment Period|Disease Progression|5|||
163491379|NCT03110107|590501254|FG014|Treatment Period|Disease Progression|14|||
163491380|NCT03110107|590501255|FG015|Treatment Period|Disease Progression|14|||
163491381|NCT03110107|590501256|FG016|Treatment Period|Disease Progression|4|||
163491382|NCT03110107|590501257|FG017|Treatment Period|Disease Progression|3|||
163491383|NCT03110107|590501258|FG018|Treatment Period|Disease Progression|16|||
163491384|NCT03110107|590501259|FG019|Treatment Period|Disease Progression|14|||
163491385|NCT03110107|590501260|FG020|Treatment Period|Disease Progression|12|||
163491386|NCT03110107|590501261|FG021|Treatment Period|Disease Progression|16|||
163491387|NCT03110107|590501262|FG022|Treatment Period|Disease Progression|18|||
163491388|NCT03110107|590501263|FG023|Treatment Period|Disease Progression|13|||
163491389|NCT03110107|590501264|FG024|Treatment Period|Disease Progression|16|||
163491390|NCT03110107|590501265|FG025|Treatment Period|Disease Progression|31|||
163491391|NCT03110107|590501240|FG000|Treatment Period|Study drug toxicity|1|||
163491392|NCT03110107|590501241|FG001|Treatment Period|Study drug toxicity|0|||
163491393|NCT03110107|590501242|FG002|Treatment Period|Study drug toxicity|1|||
163491394|NCT03110107|590501243|FG003|Treatment Period|Study drug toxicity|2|||
163491395|NCT03110107|590501244|FG004|Treatment Period|Study drug toxicity|0|||
163491396|NCT03110107|590501245|FG005|Treatment Period|Study drug toxicity|3|||
163491397|NCT03110107|590501246|FG006|Treatment Period|Study drug toxicity|1|||
163491398|NCT03110107|590501247|FG007|Treatment Period|Study drug toxicity|1|||
163491399|NCT03110107|590501248|FG008|Treatment Period|Study drug toxicity|3|||
163491400|NCT03110107|590501249|FG009|Treatment Period|Study drug toxicity|2|||
163491401|NCT03110107|590501250|FG010|Treatment Period|Study drug toxicity|0|||
163491402|NCT03110107|590501251|FG011|Treatment Period|Study drug toxicity|2|||
163491403|NCT03110107|590501252|FG012|Treatment Period|Study drug toxicity|0|||
163491404|NCT03110107|590501253|FG013|Treatment Period|Study drug toxicity|0|||
163491405|NCT03110107|590501254|FG014|Treatment Period|Study drug toxicity|2|||
163491406|NCT03110107|590501255|FG015|Treatment Period|Study drug toxicity|3|||
163491407|NCT03110107|590501256|FG016|Treatment Period|Study drug toxicity|3|||
163491408|NCT03110107|590501257|FG017|Treatment Period|Study drug toxicity|3|||
163491409|NCT03110107|590501258|FG018|Treatment Period|Study drug toxicity|1|||
163491410|NCT03110107|590501259|FG019|Treatment Period|Study drug toxicity|2|||
163491411|NCT03110107|590501260|FG020|Treatment Period|Study drug toxicity|2|||
163491412|NCT03110107|590501261|FG021|Treatment Period|Study drug toxicity|0|||
163491413|NCT03110107|590501262|FG022|Treatment Period|Study drug toxicity|2|||
163491414|NCT03110107|590501263|FG023|Treatment Period|Study drug toxicity|6|||
163491415|NCT03110107|590501264|FG024|Treatment Period|Study drug toxicity|7|||
163491416|NCT03110107|590501265|FG025|Treatment Period|Study drug toxicity|6|||
163491417|NCT03110107|590501240|FG000|Treatment Period|Death|0|||
163491418|NCT03110107|590501241|FG001|Treatment Period|Death|0|||
163491419|NCT03110107|590501242|FG002|Treatment Period|Death|0|||
163491420|NCT03110107|590501243|FG003|Treatment Period|Death|0|||
163491421|NCT03110107|590501244|FG004|Treatment Period|Death|0|||
163491422|NCT03110107|590501245|FG005|Treatment Period|Death|0|||
163491423|NCT03110107|590501246|FG006|Treatment Period|Death|0|||
163491424|NCT03110107|590501247|FG007|Treatment Period|Death|0|||
163491425|NCT03110107|590501248|FG008|Treatment Period|Death|0|||
163491426|NCT03110107|590501249|FG009|Treatment Period|Death|0|||
163491427|NCT03110107|590501250|FG010|Treatment Period|Death|0|||
163491428|NCT03110107|590501251|FG011|Treatment Period|Death|0|||
163491429|NCT03110107|590501252|FG012|Treatment Period|Death|1|||
163491430|NCT03110107|590501253|FG013|Treatment Period|Death|0|||
163491431|NCT03110107|590501254|FG014|Treatment Period|Death|0|||
163491432|NCT03110107|590501255|FG015|Treatment Period|Death|0|||
163491433|NCT03110107|590501256|FG016|Treatment Period|Death|0|||
163491434|NCT03110107|590501257|FG017|Treatment Period|Death|0|||
163491435|NCT03110107|590501258|FG018|Treatment Period|Death|0|||
163491436|NCT03110107|590501259|FG019|Treatment Period|Death|0|||
163491437|NCT03110107|590501260|FG020|Treatment Period|Death|0|||
163491438|NCT03110107|590501261|FG021|Treatment Period|Death|0|||
163491439|NCT03110107|590501262|FG022|Treatment Period|Death|0|||
163491440|NCT03110107|590501263|FG023|Treatment Period|Death|0|||
163491441|NCT03110107|590501264|FG024|Treatment Period|Death|0|||
163491442|NCT03110107|590501265|FG025|Treatment Period|Death|0|||
163491443|NCT03110107|590501240|FG000|Treatment Period|Adverse Event|0|||
163491444|NCT03110107|590501241|FG001|Treatment Period|Adverse Event|0|||
163491445|NCT03110107|590501242|FG002|Treatment Period|Adverse Event|1|||
163491446|NCT03110107|590501243|FG003|Treatment Period|Adverse Event|0|||
163491447|NCT03110107|590501244|FG004|Treatment Period|Adverse Event|0|||
163491448|NCT03110107|590501245|FG005|Treatment Period|Adverse Event|2|||
163491449|NCT03110107|590501246|FG006|Treatment Period|Adverse Event|0|||
163491450|NCT03110107|590501247|FG007|Treatment Period|Adverse Event|2|||
163491451|NCT03110107|590501248|FG008|Treatment Period|Adverse Event|0|||
163491452|NCT03110107|590501249|FG009|Treatment Period|Adverse Event|1|||
163491453|NCT03110107|590501250|FG010|Treatment Period|Adverse Event|0|||
163491454|NCT03110107|590501251|FG011|Treatment Period|Adverse Event|0|||
163491455|NCT03110107|590501252|FG012|Treatment Period|Adverse Event|0|||
163491456|NCT03110107|590501253|FG013|Treatment Period|Adverse Event|0|||
163491457|NCT03110107|590501254|FG014|Treatment Period|Adverse Event|0|||
163491458|NCT03110107|590501255|FG015|Treatment Period|Adverse Event|2|||
163491459|NCT03110107|590501256|FG016|Treatment Period|Adverse Event|0|||
163491460|NCT03110107|590501257|FG017|Treatment Period|Adverse Event|1|||
163491461|NCT03110107|590501258|FG018|Treatment Period|Adverse Event|2|||
163491462|NCT03110107|590501259|FG019|Treatment Period|Adverse Event|1|||
163491463|NCT03110107|590501260|FG020|Treatment Period|Adverse Event|4|||
163491464|NCT03110107|590501261|FG021|Treatment Period|Adverse Event|2|||
163491465|NCT03110107|590501262|FG022|Treatment Period|Adverse Event|2|||
163491466|NCT03110107|590501263|FG023|Treatment Period|Adverse Event|2|||
163491467|NCT03110107|590501264|FG024|Treatment Period|Adverse Event|2|||
163491468|NCT03110107|590501265|FG025|Treatment Period|Adverse Event|4|||
163491469|NCT03110107|590501240|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
163491470|NCT03110107|590501241|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
163491471|NCT03110107|590501242|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
163491472|NCT03110107|590501243|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
163491473|NCT03110107|590501244|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
163491474|NCT03110107|590501245|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
163491475|NCT03110107|590501246|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
163491476|NCT03110107|590501247|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
163491477|NCT03110107|590501248|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
163491478|NCT03110107|590501249|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
163491479|NCT03110107|590501250|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
163491480|NCT03110107|590501251|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
163491481|NCT03110107|590501252|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
163491482|NCT03110107|590501253|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
163491483|NCT03110107|590501254|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
163491484|NCT03110107|590501255|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
163491485|NCT03110107|590501256|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
163491486|NCT03110107|590501257|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
163491487|NCT03110107|590501258|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
163491488|NCT03110107|590501259|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
163491489|NCT03110107|590501260|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
163491490|NCT03110107|590501261|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
163491491|NCT03110107|590501262|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
163491492|NCT03110107|590501263|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
163491493|NCT03110107|590501264|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
163491494|NCT03110107|590501265|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
163491495|NCT03110107|590501240|FG000|Treatment Period|Participant withdrew consent|0|||
163491496|NCT03110107|590501241|FG001|Treatment Period|Participant withdrew consent|0|||
163491497|NCT03110107|590501242|FG002|Treatment Period|Participant withdrew consent|1|||
163491498|NCT03110107|590501243|FG003|Treatment Period|Participant withdrew consent|0|||
163491499|NCT03110107|590501244|FG004|Treatment Period|Participant withdrew consent|4|||
163491500|NCT03110107|590501245|FG005|Treatment Period|Participant withdrew consent|3|||
163491501|NCT03110107|590501246|FG006|Treatment Period|Participant withdrew consent|0|||
163491502|NCT03110107|590501247|FG007|Treatment Period|Participant withdrew consent|0|||
163491503|NCT03110107|590501248|FG008|Treatment Period|Participant withdrew consent|0|||
163491504|NCT03110107|590501249|FG009|Treatment Period|Participant withdrew consent|1|||
163491505|NCT03110107|590501250|FG010|Treatment Period|Participant withdrew consent|0|||
163491506|NCT03110107|590501251|FG011|Treatment Period|Participant withdrew consent|0|||
163491507|NCT03110107|590501252|FG012|Treatment Period|Participant withdrew consent|0|||
163491508|NCT03110107|590501253|FG013|Treatment Period|Participant withdrew consent|0|||
163491509|NCT03110107|590501254|FG014|Treatment Period|Participant withdrew consent|0|||
163491510|NCT03110107|590501255|FG015|Treatment Period|Participant withdrew consent|0|||
163491511|NCT03110107|590501256|FG016|Treatment Period|Participant withdrew consent|0|||
163491512|NCT03110107|590501257|FG017|Treatment Period|Participant withdrew consent|0|||
163491513|NCT03110107|590501258|FG018|Treatment Period|Participant withdrew consent|0|||
163491514|NCT03110107|590501259|FG019|Treatment Period|Participant withdrew consent|1|||
163491515|NCT03110107|590501260|FG020|Treatment Period|Participant withdrew consent|0|||
163491516|NCT03110107|590501261|FG021|Treatment Period|Participant withdrew consent|2|||
163491517|NCT03110107|590501262|FG022|Treatment Period|Participant withdrew consent|0|||
163491518|NCT03110107|590501263|FG023|Treatment Period|Participant withdrew consent|0|||
162925437|NCT02564952|588428975|FG000|Overall Study|Adverse Event|6|||
163491519|NCT03110107|590501264|FG024|Treatment Period|Participant withdrew consent|0|||
163491520|NCT03110107|590501265|FG025|Treatment Period|Participant withdrew consent|2|||
163491521|NCT03110107|590501240|FG000|Treatment Period|Participants no longer meets study criteria|0|||
163491522|NCT03110107|590501241|FG001|Treatment Period|Participants no longer meets study criteria|0|||
163491523|NCT03110107|590501242|FG002|Treatment Period|Participants no longer meets study criteria|0|||
163491524|NCT03110107|590501243|FG003|Treatment Period|Participants no longer meets study criteria|0|||
163491525|NCT03110107|590501244|FG004|Treatment Period|Participants no longer meets study criteria|0|||
163491526|NCT03110107|590501245|FG005|Treatment Period|Participants no longer meets study criteria|0|||
163491527|NCT03110107|590501246|FG006|Treatment Period|Participants no longer meets study criteria|0|||
163491528|NCT03110107|590501247|FG007|Treatment Period|Participants no longer meets study criteria|0|||
163491529|NCT03110107|590501248|FG008|Treatment Period|Participants no longer meets study criteria|0|||
163491530|NCT03110107|590501249|FG009|Treatment Period|Participants no longer meets study criteria|0|||
163491531|NCT03110107|590501250|FG010|Treatment Period|Participants no longer meets study criteria|0|||
163491532|NCT03110107|590501251|FG011|Treatment Period|Participants no longer meets study criteria|0|||
163491533|NCT03110107|590501252|FG012|Treatment Period|Participants no longer meets study criteria|0|||
163491534|NCT03110107|590501253|FG013|Treatment Period|Participants no longer meets study criteria|0|||
163491535|NCT03110107|590501254|FG014|Treatment Period|Participants no longer meets study criteria|0|||
163491536|NCT03110107|590501255|FG015|Treatment Period|Participants no longer meets study criteria|0|||
163491537|NCT03110107|590501256|FG016|Treatment Period|Participants no longer meets study criteria|0|||
163491538|NCT03110107|590501257|FG017|Treatment Period|Participants no longer meets study criteria|0|||
163491539|NCT03110107|590501258|FG018|Treatment Period|Participants no longer meets study criteria|0|||
163491540|NCT03110107|590501259|FG019|Treatment Period|Participants no longer meets study criteria|0|||
163491541|NCT03110107|590501260|FG020|Treatment Period|Participants no longer meets study criteria|0|||
163491542|NCT03110107|590501261|FG021|Treatment Period|Participants no longer meets study criteria|0|||
163491543|NCT03110107|590501262|FG022|Treatment Period|Participants no longer meets study criteria|0|||
163491544|NCT03110107|590501263|FG023|Treatment Period|Participants no longer meets study criteria|1|||
163491545|NCT03110107|590501264|FG024|Treatment Period|Participants no longer meets study criteria|0|||
163491546|NCT03110107|590501265|FG025|Treatment Period|Participants no longer meets study criteria|0|||
163491547|NCT03110107|590501240|FG000|Treatment Period|Other Reasons|0|||
163491548|NCT03110107|590501241|FG001|Treatment Period|Other Reasons|0|||
163491549|NCT03110107|590501242|FG002|Treatment Period|Other Reasons|1|||
163491550|NCT03110107|590501243|FG003|Treatment Period|Other Reasons|1|||
163491551|NCT03110107|590501244|FG004|Treatment Period|Other Reasons|0|||
163491552|NCT03110107|590501245|FG005|Treatment Period|Other Reasons|1|||
163491553|NCT03110107|590501246|FG006|Treatment Period|Other Reasons|0|||
163491554|NCT03110107|590501247|FG007|Treatment Period|Other Reasons|0|||
163491555|NCT03110107|590501248|FG008|Treatment Period|Other Reasons|0|||
163491556|NCT03110107|590501249|FG009|Treatment Period|Other Reasons|0|||
163491557|NCT03110107|590501250|FG010|Treatment Period|Other Reasons|0|||
163491558|NCT03110107|590501251|FG011|Treatment Period|Other Reasons|0|||
163491559|NCT03110107|590501252|FG012|Treatment Period|Other Reasons|0|||
163491560|NCT03110107|590501253|FG013|Treatment Period|Other Reasons|0|||
163491561|NCT03110107|590501254|FG014|Treatment Period|Other Reasons|0|||
163491562|NCT03110107|590501255|FG015|Treatment Period|Other Reasons|0|||
163491563|NCT03110107|590501256|FG016|Treatment Period|Other Reasons|0|||
163491564|NCT03110107|590501257|FG017|Treatment Period|Other Reasons|0|||
163491565|NCT03110107|590501258|FG018|Treatment Period|Other Reasons|0|||
163491566|NCT03110107|590501259|FG019|Treatment Period|Other Reasons|0|||
163491567|NCT03110107|590501260|FG020|Treatment Period|Other Reasons|0|||
163491568|NCT03110107|590501261|FG021|Treatment Period|Other Reasons|0|||
163491569|NCT03110107|590501262|FG022|Treatment Period|Other Reasons|0|||
163491570|NCT03110107|590501263|FG023|Treatment Period|Other Reasons|0|||
163491571|NCT03110107|590501264|FG024|Treatment Period|Other Reasons|1|||
163491572|NCT03110107|590501265|FG025|Treatment Period|Other Reasons|0|||
163491573|NCT03526549|590501270|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
163491574|NCT03526549|590501271|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
163491575|NCT03526549|590501270|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
163491576|NCT03526549|590501271|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
163491577|NCT03526549|590501270|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
163491578|NCT03526549|590501271|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
163491579|NCT03526549|590501270|FG000|Open-label Phase|Adverse Event|4|||
163491580|NCT03526549|590501271|FG001|Open-label Phase|Adverse Event|0|||
163491581|NCT03526549|590501270|FG000|Open-label Phase|Withdrawal by Subject|54|||
163491582|NCT03526549|590501271|FG001|Open-label Phase|Withdrawal by Subject|0|||
163491583|NCT03526549|590501270|FG000|Open-label Phase|Lost to Follow-up|35|||
163491584|NCT03526549|590501271|FG001|Open-label Phase|Lost to Follow-up|0|||
163491585|NCT03526549|590501270|FG000|Open-label Phase|Other than Specified|5|||
163491586|NCT03526549|590501271|FG001|Open-label Phase|Other than Specified|0|||
163491587|NCT03927989|590501274|FG000|Overall Study|Withdrawal by Subject|0|||
163491588|NCT03927989|590501275|FG001|Overall Study|Withdrawal by Subject|1|||
163491589|NCT02593175|590501276|FG000|Overall Study|Adverse Event|5|||
163491590|NCT02593175|590501276|FG000|Overall Study|Disease progression|4|||
163491591|NCT00478933|590501277|FG000|Overall Study|Protocol Violation|22|||
163491592|NCT00478933|590501277|FG000|Overall Study|Informed consent not verified|3|||
163491593|NCT00478933|590501277|FG000|Overall Study|Inadequate data available|53|||
163491594|NCT02506101|590501279|FG000|Overall Study|Transportation issues|1|||
163491595|NCT02506101|590501280|FG001|Overall Study|Transportation issues|0|||
163491596|NCT02506101|590501279|FG000|Overall Study|No enrollment and staff unavailability|1|||
163491597|NCT02506101|590501280|FG001|Overall Study|No enrollment and staff unavailability|0|||
163491598|NCT03586427|590501284|FG000|Overall Study|Lost to Follow-up|0|||
163491599|NCT03586427|590501285|FG001|Overall Study|Lost to Follow-up|3|||
163491600|NCT03586427|590501286|FG002|Overall Study|Lost to Follow-up|1|||
163491601|NCT03586427|590501287|FG003|Overall Study|Lost to Follow-up|3|||
163491602|NCT03586427|590501288|FG004|Overall Study|Lost to Follow-up|3|||
163491603|NCT03586427|590501284|FG000|Overall Study|Withdrawal by Subject|0|||
163491604|NCT03586427|590501285|FG001|Overall Study|Withdrawal by Subject|1|||
163491605|NCT03586427|590501286|FG002|Overall Study|Withdrawal by Subject|2|||
163491606|NCT03586427|590501287|FG003|Overall Study|Withdrawal by Subject|1|||
163491607|NCT03586427|590501288|FG004|Overall Study|Withdrawal by Subject|1|||
163491608|NCT03586427|590501284|FG000|Overall Study|Adverse Event|0|||
163491609|NCT03586427|590501285|FG001|Overall Study|Adverse Event|0|||
163491610|NCT03586427|590501286|FG002|Overall Study|Adverse Event|1|||
163491611|NCT03586427|590501287|FG003|Overall Study|Adverse Event|0|||
163491612|NCT03586427|590501288|FG004|Overall Study|Adverse Event|0|||
163491613|NCT03586427|590501284|FG000|Overall Study|Protocol Violation|0|||
163491614|NCT03586427|590501285|FG001|Overall Study|Protocol Violation|0|||
163491615|NCT03586427|590501286|FG002|Overall Study|Protocol Violation|1|||
163491616|NCT03586427|590501287|FG003|Overall Study|Protocol Violation|0|||
163491617|NCT03586427|590501288|FG004|Overall Study|Protocol Violation|1|||
163491618|NCT03586427|590501284|FG000|Overall Study|Noncompliance with study drug|0|||
163491619|NCT03586427|590501285|FG001|Overall Study|Noncompliance with study drug|0|||
163491620|NCT03586427|590501286|FG002|Overall Study|Noncompliance with study drug|1|||
163491621|NCT03586427|590501287|FG003|Overall Study|Noncompliance with study drug|0|||
163491622|NCT03586427|590501288|FG004|Overall Study|Noncompliance with study drug|0|||
163491623|NCT03193996|590501291|FG000|Overall Study|Withdrawal by Subject|4|||
163491624|NCT03193996|590501291|FG000|Overall Study|Lost to Follow-up|4|||
163491625|NCT03193996|590501291|FG000|Overall Study|Physician Decision|2|||
163491626|NCT03193996|590501291|FG000|Overall Study|Pregnancy|1|||
163491627|NCT03193996|590501291|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
163491628|NCT03193996|590501291|FG000|Overall Study|Complicating disease|1|||
163491629|NCT00593385|590501298|FG000|Overall Study|Death|14|||
163491630|NCT00593385|590501298|FG000|Overall Study|Lost to Follow-up|17|||
163491631|NCT00593385|590501298|FG000|Overall Study|Withdrawal by Subject|9|||
163491632|NCT01471197|590501299|FG000|Overall Study|Disease Progression|4|||
163491633|NCT01471197|590501300|FG001|Overall Study|Disease Progression|2|||
163491634|NCT01471197|590501299|FG000|Overall Study|Death|1|||
163491635|NCT01471197|590501300|FG001|Overall Study|Death|0|||
163491636|NCT01471197|590501299|FG000|Overall Study|Study Drug Toxicity|1|||
163491637|NCT01471197|590501300|FG001|Overall Study|Study Drug Toxicity|0|||
163491638|NCT00924313|590501303|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
163491639|NCT01298362|590501304|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
163491640|NCT01298362|590501305|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
163491641|NCT01353586|590501306|FG000|Overall Study|Procedure terminated prior to ablation|3|||
163491642|NCT01353586|590501307|FG001|Overall Study|Procedure terminated prior to ablation|0|||
163491643|NCT01353586|590501306|FG000|Overall Study|Never had insertion of study catheter|4|||
163491644|NCT01353586|590501307|FG001|Overall Study|Never had insertion of study catheter|1|||
163491645|NCT01353586|590501306|FG000|Overall Study|Neurological exam not done|0|||
163491646|NCT01353586|590501307|FG001|Overall Study|Neurological exam not done|1|||
163491647|NCT03253809|590501308|FG000|Overall Study|Unable to obtain study related data|14|||
163491648|NCT03992456|590501309|FG000|Overall Study|Withdrawal by Subject|1|||
163491649|NCT03992456|590501310|FG001|Overall Study|Withdrawal by Subject|0|||
163491650|NCT03992456|590501309|FG000|Overall Study|Disease progression|4|||
163491651|NCT03992456|590501310|FG001|Overall Study|Disease progression|5|||
163491652|NCT03992456|590501309|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
163491653|NCT03992456|590501310|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
163491654|NCT04637815|590501313|FG000|Overall Study|Death|1|||
163491655|NCT04637815|590501314|FG001|Overall Study|Death|0|||
163491656|NCT04637815|590501313|FG000|Overall Study|Lost to Follow-up|5|||
163491657|NCT04637815|590501314|FG001|Overall Study|Lost to Follow-up|2|||
163491658|NCT00326625|590501315|FG000|Overall Study|Adverse Event|20|||
163491659|NCT00326625|590501316|FG001|Overall Study|Adverse Event|9|||
163491660|NCT00326625|590501315|FG000|Overall Study|Withdrawal by Subject|15|||
163491661|NCT00326625|590501316|FG001|Overall Study|Withdrawal by Subject|12|||
163491662|NCT00326625|590501315|FG000|Overall Study|Death|18|||
163491663|NCT00326625|590501316|FG001|Overall Study|Death|16|||
163491664|NCT00326625|590501315|FG000|Overall Study|Lost to Follow-up|1|||
163491665|NCT00326625|590501316|FG001|Overall Study|Lost to Follow-up|0|||
163491666|NCT00326625|590501315|FG000|Overall Study|prescheduled medical intervention|0|||
163491667|NCT00326625|590501316|FG001|Overall Study|prescheduled medical intervention|1|||
163491668|NCT02594384|590501317|FG000|Overall Study|Disease Progression|3|||
163491669|NCT02594384|590501318|FG001|Overall Study|Disease Progression|7|||
163491670|NCT02594384|590501319|FG002|Overall Study|Disease Progression|0|||
163491671|NCT02594384|590501320|FG003|Overall Study|Disease Progression|2|||
163491672|NCT02594384|590501321|FG004|Overall Study|Disease Progression|2|||
163491673|NCT02594384|590501322|FG005|Overall Study|Disease Progression|12|||
163491674|NCT02594384|590501323|FG006|Overall Study|Disease Progression|5|||
163491675|NCT02594384|590501324|FG007|Overall Study|Disease Progression|5|||
163491676|NCT02594384|590501317|FG000|Overall Study|Adverse Event|0|||
163491677|NCT02594384|590501318|FG001|Overall Study|Adverse Event|1|||
163491678|NCT02594384|590501319|FG002|Overall Study|Adverse Event|4|||
163491679|NCT02594384|590501320|FG003|Overall Study|Adverse Event|1|||
163491680|NCT02594384|590501321|FG004|Overall Study|Adverse Event|0|||
163491681|NCT02594384|590501322|FG005|Overall Study|Adverse Event|6|||
163491682|NCT02594384|590501323|FG006|Overall Study|Adverse Event|1|||
163491683|NCT02594384|590501324|FG007|Overall Study|Adverse Event|1|||
163491684|NCT02594384|590501317|FG000|Overall Study|Withdrawal by Subject|0|||
163491685|NCT02594384|590501318|FG001|Overall Study|Withdrawal by Subject|0|||
163491686|NCT02594384|590501319|FG002|Overall Study|Withdrawal by Subject|0|||
163491687|NCT02594384|590501320|FG003|Overall Study|Withdrawal by Subject|1|||
163491688|NCT02594384|590501321|FG004|Overall Study|Withdrawal by Subject|0|||
163491689|NCT02594384|590501322|FG005|Overall Study|Withdrawal by Subject|0|||
163491690|NCT02594384|590501323|FG006|Overall Study|Withdrawal by Subject|0|||
163491691|NCT02594384|590501324|FG007|Overall Study|Withdrawal by Subject|1|||
163491692|NCT02594384|590501317|FG000|Overall Study|Physician Decision|0|||
163491693|NCT02594384|590501318|FG001|Overall Study|Physician Decision|0|||
163491694|NCT02594384|590501319|FG002|Overall Study|Physician Decision|0|||
163491695|NCT02594384|590501320|FG003|Overall Study|Physician Decision|0|||
163491696|NCT02594384|590501321|FG004|Overall Study|Physician Decision|0|||
163491697|NCT02594384|590501322|FG005|Overall Study|Physician Decision|1|||
163491698|NCT02594384|590501323|FG006|Overall Study|Physician Decision|2|||
163491699|NCT02594384|590501324|FG007|Overall Study|Physician Decision|0|||
163491700|NCT02594384|590501317|FG000|Overall Study|Progressive Leukocytosis|0|||
163491701|NCT02594384|590501318|FG001|Overall Study|Progressive Leukocytosis|0|||
163491702|NCT02594384|590501319|FG002|Overall Study|Progressive Leukocytosis|1|||
163491703|NCT02594384|590501320|FG003|Overall Study|Progressive Leukocytosis|0|||
163491704|NCT02594384|590501321|FG004|Overall Study|Progressive Leukocytosis|0|||
163491705|NCT02594384|590501322|FG005|Overall Study|Progressive Leukocytosis|0|||
163491706|NCT02594384|590501323|FG006|Overall Study|Progressive Leukocytosis|0|||
163491707|NCT02594384|590501324|FG007|Overall Study|Progressive Leukocytosis|0|||
163491708|NCT02594384|590501317|FG000|Overall Study|Lack of Efficacy|0|||
163491709|NCT02594384|590501318|FG001|Overall Study|Lack of Efficacy|0|||
163491710|NCT02594384|590501319|FG002|Overall Study|Lack of Efficacy|0|||
163491711|NCT02594384|590501320|FG003|Overall Study|Lack of Efficacy|0|||
163491712|NCT02594384|590501321|FG004|Overall Study|Lack of Efficacy|1|||
163491713|NCT02594384|590501322|FG005|Overall Study|Lack of Efficacy|0|||
163491714|NCT02594384|590501323|FG006|Overall Study|Lack of Efficacy|0|||
163491715|NCT02594384|590501324|FG007|Overall Study|Lack of Efficacy|0|||
163491716|NCT02594384|590501317|FG000|Overall Study|Substantial noncompliance|0|||
163491717|NCT02594384|590501318|FG001|Overall Study|Substantial noncompliance|0|||
163491718|NCT02594384|590501319|FG002|Overall Study|Substantial noncompliance|0|||
163491719|NCT02594384|590501320|FG003|Overall Study|Substantial noncompliance|0|||
163491720|NCT02594384|590501321|FG004|Overall Study|Substantial noncompliance|0|||
163491721|NCT02594384|590501322|FG005|Overall Study|Substantial noncompliance|0|||
163491722|NCT02594384|590501323|FG006|Overall Study|Substantial noncompliance|1|||
163491723|NCT02594384|590501324|FG007|Overall Study|Substantial noncompliance|0|||
163491724|NCT03919669|590501327|FG000|Overall Study|Withdrawal by Subject|1|||
163491725|NCT03919669|590501328|FG001|Overall Study|Withdrawal by Subject|0|||
163491726|NCT03919669|590501329|FG002|Overall Study|Withdrawal by Subject|0|||
163491727|NCT00625846|590501330|FG000|Overall Study|Withdrawal by Subject|2|||
163491728|NCT00625846|590501331|FG001|Overall Study|Withdrawal by Subject|0|||
163491729|NCT00625846|590501332|FG002|Overall Study|Withdrawal by Subject|1|||
163491730|NCT00625846|590501333|FG003|Overall Study|Withdrawal by Subject|2|||
163491731|NCT00483119|590501338|FG000|Overall Study|Adverse Event|0|||
163491732|NCT00483119|590501339|FG001|Overall Study|Adverse Event|1|||
163491733|NCT00483119|590501338|FG000|Overall Study|Physician Decision|1|||
163491734|NCT00483119|590501339|FG001|Overall Study|Physician Decision|0|||
163491735|NCT02369874|590501340|FG000|Overall Study|Lost to Follow-up|2|||
163491736|NCT02369874|590501341|FG001|Overall Study|Lost to Follow-up|2|||
163491737|NCT02369874|590501342|FG002|Overall Study|Lost to Follow-up|2|||
163491738|NCT02369874|590501340|FG000|Overall Study|Withdrawal by Subject|7|||
163491739|NCT02369874|590501341|FG001|Overall Study|Withdrawal by Subject|9|||
163491740|NCT02369874|590501342|FG002|Overall Study|Withdrawal by Subject|27|||
163491741|NCT02369874|590501340|FG000|Overall Study|Miscellaneous|1|||
163491742|NCT02369874|590501341|FG001|Overall Study|Miscellaneous|1|||
163491743|NCT02369874|590501342|FG002|Overall Study|Miscellaneous|0|||
163491744|NCT02369874|590501340|FG000|Overall Study|On Treatment/Off Study|34|||
163491745|NCT02369874|590501341|FG001|Overall Study|On Treatment/Off Study|45|||
163491746|NCT02369874|590501342|FG002|Overall Study|On Treatment/Off Study|32|||
163491747|NCT02058849|590501343|FG000|Overall Study|Hospitalization|1|||
163491748|NCT02058849|590501344|FG001|Overall Study|Hospitalization|1|||
163491749|NCT02058849|590501343|FG000|Overall Study|Death|1|||
163491750|NCT02058849|590501344|FG001|Overall Study|Death|0|||
163491751|NCT02058849|590501343|FG000|Overall Study|Lost to Follow-up|1|||
163491752|NCT02058849|590501344|FG001|Overall Study|Lost to Follow-up|0|||
163491753|NCT02058849|590501343|FG000|Overall Study|Withdrawal by Subject|4|||
163491754|NCT02058849|590501344|FG001|Overall Study|Withdrawal by Subject|0|||
163491755|NCT02331680|590501345|FG000|Overall Study|Adverse Event|3|||
163491756|NCT02331680|590501346|FG001|Overall Study|Adverse Event|0|||
163491757|NCT02331680|590501347|FG002|Overall Study|Adverse Event|2|||
163491758|NCT02331680|590501345|FG000|Overall Study|Physician Decision|1|||
163491759|NCT02331680|590501346|FG001|Overall Study|Physician Decision|1|||
163491760|NCT02331680|590501347|FG002|Overall Study|Physician Decision|2|||
163491761|NCT02331680|590501345|FG000|Overall Study|Withdrawal by Subject|0|||
163491762|NCT02331680|590501346|FG001|Overall Study|Withdrawal by Subject|1|||
163491763|NCT02331680|590501347|FG002|Overall Study|Withdrawal by Subject|2|||
163491764|NCT02331680|590501345|FG000|Overall Study|Met withdrawal criteria|2|||
163491765|NCT02331680|590501346|FG001|Overall Study|Met withdrawal criteria|2|||
163491766|NCT02331680|590501347|FG002|Overall Study|Met withdrawal criteria|5|||
163491767|NCT02331680|590501345|FG000|Overall Study|Non-compliance with study drug|0|||
163491768|NCT02331680|590501346|FG001|Overall Study|Non-compliance with study drug|0|||
163491769|NCT02331680|590501347|FG002|Overall Study|Non-compliance with study drug|1|||
163491770|NCT02331680|590501345|FG000|Overall Study|Protocol Violation|0|||
163491771|NCT02331680|590501346|FG001|Overall Study|Protocol Violation|0|||
163491772|NCT02331680|590501347|FG002|Overall Study|Protocol Violation|3|||
163491773|NCT02219477|590501348|FG000|Overall Study|Adverse Event|0|||
163491774|NCT02219477|590501349|FG001|Overall Study|Adverse Event|1|||
163491775|NCT02219477|590501350|FG002|Overall Study|Adverse Event|1|||
163491776|NCT02219477|590501348|FG000|Overall Study|Withdrawal by Subject|0|||
163491777|NCT02219477|590501349|FG001|Overall Study|Withdrawal by Subject|1|||
163491778|NCT02219477|590501350|FG002|Overall Study|Withdrawal by Subject|0|||
163491779|NCT00596466|590501351|FG000|Overall Study|Lack of Efficacy|5|||
163491780|NCT00596466|590501351|FG000|Overall Study|Adverse Event|4|||
163491781|NCT00596466|590501351|FG000|Overall Study|Withdrawal by Subject|2|||
163491782|NCT00596466|590501351|FG000|Overall Study|Protocol Violation|2|||
163491783|NCT00596466|590501351|FG000|Overall Study|Unpecified|2|||
163491784|NCT00596466|590501351|FG000|Overall Study|Enrolled, not treated|2|||
163491785|NCT04505592|590501352|FG000|Overall Study|Death|2|||
163491786|NCT04505592|590501353|FG001|Overall Study|Death|1|||
163491787|NCT01891669|590501355|FG000|Overall Study|Death|0|||
163491788|NCT01891669|590501356|FG001|Overall Study|Death|0|||
163491789|NCT01891669|590501357|FG002|Overall Study|Death|0|||
163491790|NCT01891669|590501358|FG003|Overall Study|Death|0|||
163491791|NCT01891669|590501359|FG004|Overall Study|Death|0|||
163491792|NCT01891669|590501360|FG005|Overall Study|Death|0|||
163491793|NCT01891669|590501361|FG006|Overall Study|Death|0|||
163491794|NCT01891669|590501362|FG007|Overall Study|Death|1|||
163491795|NCT01891669|590501363|FG008|Overall Study|Death|0|||
163491796|NCT01891669|590501364|FG009|Overall Study|Death|1|||
163491797|NCT01891669|590501355|FG000|Overall Study|Withdrawal by Subject|1|||
163491798|NCT01891669|590501356|FG001|Overall Study|Withdrawal by Subject|1|||
163491799|NCT01891669|590501357|FG002|Overall Study|Withdrawal by Subject|0|||
163491800|NCT01891669|590501358|FG003|Overall Study|Withdrawal by Subject|0|||
163491801|NCT01891669|590501359|FG004|Overall Study|Withdrawal by Subject|0|||
163491802|NCT01891669|590501360|FG005|Overall Study|Withdrawal by Subject|0|||
163491803|NCT01891669|590501361|FG006|Overall Study|Withdrawal by Subject|1|||
163491804|NCT01891669|590501362|FG007|Overall Study|Withdrawal by Subject|2|||
163491805|NCT01891669|590501363|FG008|Overall Study|Withdrawal by Subject|1|||
163491806|NCT01891669|590501364|FG009|Overall Study|Withdrawal by Subject|1|||
163491807|NCT01891669|590501355|FG000|Overall Study|Other|1|||
163491808|NCT01891669|590501356|FG001|Overall Study|Other|0|||
163491809|NCT01891669|590501357|FG002|Overall Study|Other|0|||
163491810|NCT01891669|590501358|FG003|Overall Study|Other|0|||
163491811|NCT01891669|590501359|FG004|Overall Study|Other|0|||
163491812|NCT01891669|590501360|FG005|Overall Study|Other|0|||
163491813|NCT01891669|590501361|FG006|Overall Study|Other|0|||
163491814|NCT01891669|590501362|FG007|Overall Study|Other|1|||
163491815|NCT01891669|590501363|FG008|Overall Study|Other|0|||
163491816|NCT01891669|590501364|FG009|Overall Study|Other|0|||
163491817|NCT04298229|590501369|FG000|Overall Study|Physician Decision|1|||
163491818|NCT04298229|590501370|FG001|Overall Study|Physician Decision|1|||
163491819|NCT04298229|590501369|FG000|Overall Study|Withdrawal by Subject|1|||
163491820|NCT04298229|590501370|FG001|Overall Study|Withdrawal by Subject|1|||
163491821|NCT04298229|590501369|FG000|Overall Study|Did not receive IV loop diuretics|2|||
162925438|NCT02564952|588428975|FG000|Overall Study|Lost to Follow-up|1|||
163491822|NCT04298229|590501370|FG001|Overall Study|Did not receive IV loop diuretics|0|||
163491823|NCT00262119|590501371|FG000|Overall Study|Lost to Follow-up|38|||
163491824|NCT00262119|590501372|FG001|Overall Study|Lost to Follow-up|51|||
163491825|NCT00262119|590501373|FG002|Overall Study|Lost to Follow-up|42|||
163491826|NCT00262119|590501371|FG000|Overall Study|Death|20|||
163491827|NCT00262119|590501372|FG001|Overall Study|Death|19|||
163491828|NCT00262119|590501373|FG002|Overall Study|Death|16|||
163491829|NCT00859313|590501374|FG000|Overall Study|Lack of Efficacy|2|||
163491830|NCT00859313|590501374|FG000|Overall Study|Adverse Event|1|||
163491831|NCT00859313|590501374|FG000|Overall Study|staff error|1|||
163491832|NCT00071006|590501375|FG000|Overall Study|Lack of Efficacy|7|||
163491833|NCT00071006|590501375|FG000|Overall Study|Adverse Event|1|||
163491834|NCT00071006|590501375|FG000|Overall Study|Withdrawal by Subject|1|||
163491835|NCT00071006|590501375|FG000|Overall Study|Other|3|||
163491836|NCT05261126|590501380|FG000|Overall Study|Death|0|||
163491837|NCT05261126|590501381|FG001|Overall Study|Death|0|||
163491838|NCT05261126|590501382|FG002|Overall Study|Death|1|||
163491839|NCT05261126|590501383|FG003|Overall Study|Death|0|||
163491840|NCT05261126|590501384|FG004|Overall Study|Death|0|||
163491841|NCT05261126|590501380|FG000|Overall Study|Lost to Follow-up|0|||
163491842|NCT05261126|590501381|FG001|Overall Study|Lost to Follow-up|0|||
163491843|NCT05261126|590501382|FG002|Overall Study|Lost to Follow-up|0|||
163491844|NCT05261126|590501383|FG003|Overall Study|Lost to Follow-up|0|||
163491845|NCT05261126|590501384|FG004|Overall Study|Lost to Follow-up|1|||
163491846|NCT05261126|590501380|FG000|Overall Study|Physician Decision|1|||
163491847|NCT05261126|590501381|FG001|Overall Study|Physician Decision|0|||
163491848|NCT05261126|590501382|FG002|Overall Study|Physician Decision|0|||
163491849|NCT05261126|590501383|FG003|Overall Study|Physician Decision|0|||
163491850|NCT05261126|590501384|FG004|Overall Study|Physician Decision|0|||
163491851|NCT05261126|590501380|FG000|Overall Study|Screen Failure|0|||
163491852|NCT05261126|590501381|FG001|Overall Study|Screen Failure|0|||
163491853|NCT05261126|590501382|FG002|Overall Study|Screen Failure|0|||
163491854|NCT05261126|590501383|FG003|Overall Study|Screen Failure|0|||
163491855|NCT05261126|590501384|FG004|Overall Study|Screen Failure|1|||
163491856|NCT05261126|590501380|FG000|Overall Study|Withdrawal by Subject|1|||
163491857|NCT05261126|590501381|FG001|Overall Study|Withdrawal by Subject|0|||
163491858|NCT05261126|590501382|FG002|Overall Study|Withdrawal by Subject|1|||
163491859|NCT05261126|590501383|FG003|Overall Study|Withdrawal by Subject|1|||
163491860|NCT05261126|590501384|FG004|Overall Study|Withdrawal by Subject|0|||
163491861|NCT05261126|590501380|FG000|Overall Study|Not Recorded|0|||
163491862|NCT05261126|590501381|FG001|Overall Study|Not Recorded|0|||
163491863|NCT05261126|590501382|FG002|Overall Study|Not Recorded|0|||
163491864|NCT05261126|590501383|FG003|Overall Study|Not Recorded|1|||
163491865|NCT05261126|590501384|FG004|Overall Study|Not Recorded|0|||
163491866|NCT05939388|590501385|FG000|Overall Study|Lost to Follow-up|1|||
163491867|NCT03901274|590501386|FG000|Overall Study|Lost to Follow-up|120|||
163491868|NCT03901274|590501387|FG001|Overall Study|Lost to Follow-up|124|||
163491869|NCT03901274|590501386|FG000|Overall Study|Withdrawal by Subject|0|||
163491870|NCT03901274|590501387|FG001|Overall Study|Withdrawal by Subject|6|||
163491871|NCT05570604|590501388|FG000|Overall Study|Lost to Follow-up|1|||
163491872|NCT05570604|590501389|FG001|Overall Study|Lost to Follow-up|5|||
163491873|NCT05570604|590501388|FG000|Overall Study|Illness|2|||
163491874|NCT05570604|590501389|FG001|Overall Study|Illness|2|||
163491875|NCT04527380|590501396|FG000|Overall Study|Lack of Efficacy|0|||
163491876|NCT04527380|590501397|FG001|Overall Study|Lack of Efficacy|1|||
163491877|NCT04527380|590501396|FG000|Overall Study|Withdrawal by Subject|1|||
163491878|NCT04527380|590501397|FG001|Overall Study|Withdrawal by Subject|0|||
163491879|NCT05116241|590501412|FG000|Study|Withdrawal by Subject|5|||
163491880|NCT05116241|590501413|FG001|Study|Withdrawal by Subject|2|||
163491881|NCT05116241|590501414|FG002|Study|Withdrawal by Subject|1|||
163491882|NCT05116241|590501412|FG000|Study|Lost to Follow-up|0|||
163491883|NCT05116241|590501413|FG001|Study|Lost to Follow-up|2|||
163491884|NCT05116241|590501414|FG002|Study|Lost to Follow-up|2|||
163491885|NCT04410991|590501415|FG000|Overall Study|Poor compliance to protocol|5|||
163491886|NCT04410991|590501416|FG001|Overall Study|Poor compliance to protocol|4|||
163491887|NCT04410991|590501415|FG000|Overall Study|Withdrawal by Subject|59|||
163491888|NCT04410991|590501416|FG001|Overall Study|Withdrawal by Subject|55|||
163491889|NCT04410991|590501415|FG000|Overall Study|Other|10|||
163491890|NCT04410991|590501416|FG001|Overall Study|Other|4|||
163491891|NCT01958619|590501426|FG000|Overall Study|Protocol Violation|2|||
163491892|NCT01958619|590501427|FG001|Overall Study|Protocol Violation|0|||
163491893|NCT01958619|590501428|FG002|Overall Study|Protocol Violation|1|||
163491894|NCT01958619|590501429|FG003|Overall Study|Protocol Violation|0|||
163491895|NCT01054443|590501430|FG000|Overall Study|Withdrawal by Subject|0|||
163491896|NCT01054443|590501431|FG001|Overall Study|Withdrawal by Subject|0|||
163491897|NCT01054443|590501432|FG002|Overall Study|Withdrawal by Subject|0|||
163491898|NCT01054443|590501433|FG003|Overall Study|Withdrawal by Subject|1|||
163491899|NCT03099265|590502707|FG000|Overall Study|Adverse Event|1|||
163491900|NCT00396318|590502712|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
163491901|NCT00602927|590502713|FG000|Period 1: 13 Days|Protocol Violation|2|||
163491902|NCT00602927|590502714|FG001|Period 1: 13 Days|Protocol Violation|4|||
163491903|NCT00602927|590502713|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
163491904|NCT00602927|590502714|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
163491905|NCT00602927|590502713|FG000|Period 1: 13 Days|Time|1|||
163491906|NCT00602927|590502714|FG001|Period 1: 13 Days|Time|0|||
163491907|NCT00602927|590502713|FG000|Period 1: 13 Days|Claustrophobia|0|||
163491908|NCT00602927|590502714|FG001|Period 1: 13 Days|Claustrophobia|1|||
163491909|NCT00602927|590502713|FG000|Period 2: 14 Days|Protocol Violation|0|||
163491910|NCT00602927|590502714|FG001|Period 2: 14 Days|Protocol Violation|2|||
163491911|NCT00602927|590502713|FG000|Period 3: 13 Days|Protocol Violation|0|||
163491912|NCT00602927|590502714|FG001|Period 3: 13 Days|Protocol Violation|1|||
163491913|NCT00602927|590502713|FG000|Period 3: 13 Days|MRI data quality|2|||
163491914|NCT00602927|590502714|FG001|Period 3: 13 Days|MRI data quality|2|||
163491915|NCT01741259|590502723|FG000|Overall Study|Protocol Violation|6|||
163491916|NCT01741259|590502724|FG001|Overall Study|Protocol Violation|4|||
163491917|NCT01741259|590502723|FG000|Overall Study|Withdrawal by Subject|0|||
163491918|NCT01741259|590502724|FG001|Overall Study|Withdrawal by Subject|2|||
163491919|NCT05604521|590502728|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
163491920|NCT05604521|590502729|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
163491921|NCT05604521|590502728|FG000|Overall Study|Adverse Event|1|||
163491922|NCT05604521|590502729|FG001|Overall Study|Adverse Event|0|||
163491923|NCT02875340|590502730|FG000|Overall Study|Death|2|||
163491924|NCT02875340|590502730|FG000|Overall Study|Withdrawal by Subject|2|||
163491925|NCT02875340|590502730|FG000|Overall Study|Physician Decision|3|||
163491926|NCT02875340|590502730|FG000|Overall Study|Adverse Event|1|||
163491927|NCT00630994|590502733|FG000|Overall Study|Adverse Event|1|||
163491928|NCT00630994|590502733|FG000|Overall Study|Disease Progression|1|||
163491929|NCT00630994|590502733|FG000|Overall Study|Lack of Efficacy|1|||
163491930|NCT00630994|590502733|FG000|Overall Study|Other|1|||
163491931|NCT05553600|590502736|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
163491932|NCT05553600|590502737|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
163491933|NCT05553600|590502738|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
163491934|NCT05553600|590502739|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
163491935|NCT05553600|590502736|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
163491936|NCT05553600|590502737|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
163491937|NCT05553600|590502738|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
163491938|NCT05553600|590502739|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
163491939|NCT05553600|590502736|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
163491940|NCT05553600|590502737|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
163491941|NCT05553600|590502738|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
163491942|NCT05553600|590502739|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
163491943|NCT05553600|590502736|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
163491944|NCT05553600|590502737|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
163491945|NCT05553600|590502738|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
163491946|NCT05553600|590502739|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
163491947|NCT05553600|590502736|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
163491948|NCT05553600|590502737|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
163491949|NCT05553600|590502738|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
163491950|NCT05553600|590502739|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
163491951|NCT05553600|590502736|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
163491952|NCT05553600|590502737|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
163491953|NCT05553600|590502738|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
163491954|NCT05553600|590502739|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
163491955|NCT05553600|590502736|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
163491956|NCT05553600|590502737|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
163491957|NCT05553600|590502738|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
163491958|NCT05553600|590502739|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
163491959|NCT05553600|590502736|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
163491960|NCT05553600|590502737|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
163491961|NCT05553600|590502738|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
163491962|NCT05553600|590502739|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
163491963|NCT05553600|590502736|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
163491964|NCT05553600|590502737|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
163491965|NCT05553600|590502738|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
163491966|NCT05553600|590502739|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
163491967|NCT05553600|590502736|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
163491968|NCT05553600|590502737|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
163491969|NCT05553600|590502738|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
163491970|NCT05553600|590502739|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
163491971|NCT05553600|590502736|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
163491972|NCT05553600|590502737|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
163491973|NCT05553600|590502738|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
163491974|NCT05553600|590502739|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
163491975|NCT05553600|590502736|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
163491976|NCT05553600|590502737|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
163491977|NCT05553600|590502738|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
163491978|NCT05553600|590502739|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
163491979|NCT05027958|590502749|FG000|Overall Study|Lost to Follow-up|1|||
163491980|NCT05027958|590502750|FG001|Overall Study|Lost to Follow-up|1|||
163491981|NCT05027958|590502749|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
163491982|NCT05027958|590502750|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
163491983|NCT05027958|590502749|FG000|Overall Study|Physician Decision|1|||
163491984|NCT05027958|590502750|FG001|Overall Study|Physician Decision|4|||
163491985|NCT05027958|590502749|FG000|Overall Study|Adverse Event|0|||
163491986|NCT05027958|590502750|FG001|Overall Study|Adverse Event|1|||
163491987|NCT03155269|590502751|FG000|Overall Study|Withdrawal by Subject|4|||
163491988|NCT03155269|590502752|FG001|Overall Study|Withdrawal by Subject|5|||
163491989|NCT03155269|590502751|FG000|Overall Study|Lost to Follow-up|1|||
163491990|NCT03155269|590502752|FG001|Overall Study|Lost to Follow-up|2|||
163491991|NCT02871921|590502753|FG000|Overall Study|Withdrawal by Subject|34|||
163491992|NCT02871921|590502754|FG001|Overall Study|Withdrawal by Subject|27|||
163491993|NCT02871921|590502755|FG002|Overall Study|Withdrawal by Subject|27|||
163491994|NCT02871921|590502756|FG003|Overall Study|Withdrawal by Subject|30|||
163491995|NCT00910000|590502757|FG000|Overall Study|Adverse Event|0|||
163491996|NCT00910000|590502758|FG001|Overall Study|Adverse Event|3|||
163491997|NCT00910000|590502759|FG002|Overall Study|Adverse Event|2|||
163491998|NCT00910000|590502760|FG003|Overall Study|Adverse Event|2|||
163491999|NCT00910000|590502761|FG004|Overall Study|Adverse Event|0|||
163492000|NCT00910000|590502762|FG005|Overall Study|Adverse Event|1|||
163492001|NCT00910000|590502757|FG000|Overall Study|Withdrawal by Subject|0|||
163492002|NCT00910000|590502758|FG001|Overall Study|Withdrawal by Subject|0|||
163492003|NCT00910000|590502759|FG002|Overall Study|Withdrawal by Subject|1|||
163492004|NCT00910000|590502760|FG003|Overall Study|Withdrawal by Subject|0|||
163492005|NCT00910000|590502761|FG004|Overall Study|Withdrawal by Subject|1|||
163492006|NCT00910000|590502762|FG005|Overall Study|Withdrawal by Subject|0|||
163492007|NCT02353572|590502768|FG000|Overall Study|Withdrawal by Subject|1|||
163492008|NCT02353572|590502768|FG000|Overall Study|Study terminated|2|||
163492009|NCT00455923|590502769|FG000|Overall Study|Pregnancy|0|||
163492010|NCT00455923|590502770|FG001|Overall Study|Pregnancy|2|||
163492011|NCT00455923|590502769|FG000|Overall Study|Other|3|||
163492012|NCT00455923|590502770|FG001|Overall Study|Other|1|||
163492013|NCT02686749|590502779|FG000|Overall Study|terminated for poor enrollment|2|||
163492014|NCT02686749|590502780|FG001|Overall Study|terminated for poor enrollment|2|||
163492015|NCT01244516|590502781|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
163492016|NCT01244516|590502782|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
163492017|NCT01244516|590502783|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
163492018|NCT01244516|590502781|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
163492019|NCT01244516|590502782|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
163492020|NCT01244516|590502783|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
163492021|NCT01244516|590502781|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
163492022|NCT01244516|590502782|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
163492023|NCT01244516|590502783|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
163492024|NCT01244516|590502781|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
163492025|NCT01244516|590502782|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
163492026|NCT01244516|590502783|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
163492027|NCT01244516|590502781|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
163492028|NCT01244516|590502782|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
163492029|NCT01244516|590502783|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
163492030|NCT01244516|590502781|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
163492031|NCT01244516|590502782|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
163492032|NCT01244516|590502783|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
163492033|NCT01244516|590502781|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
163492034|NCT01244516|590502782|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
163492035|NCT01244516|590502783|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
163492036|NCT04409509|590502787|FG000|Overall Study|Failure to meet randomization requirement|1|||
163492037|NCT04409509|590502788|FG001|Overall Study|Failure to meet randomization requirement|0|||
163492038|NCT04409509|590502787|FG000|Overall Study|Adverse Event|0|||
163492039|NCT04409509|590502788|FG001|Overall Study|Adverse Event|1|||
163492040|NCT04409509|590502787|FG000|Overall Study|Death|11|||
163492041|NCT04409509|590502788|FG001|Overall Study|Death|10|||
163492042|NCT04409509|590502787|FG000|Overall Study|Non-compliance with study drug|0|||
163492043|NCT04409509|590502788|FG001|Overall Study|Non-compliance with study drug|1|||
163492044|NCT04409509|590502787|FG000|Overall Study|Lost to Follow-up|0|||
163492045|NCT04409509|590502788|FG001|Overall Study|Lost to Follow-up|3|||
163492046|NCT04409509|590502787|FG000|Overall Study|Withdrawal by Subject|0|||
163492047|NCT04409509|590502788|FG001|Overall Study|Withdrawal by Subject|3|||
163492048|NCT04409509|590502787|FG000|Overall Study|Randomized by mistake|0|||
163492049|NCT04409509|590502788|FG001|Overall Study|Randomized by mistake|1|||
163492050|NCT04409509|590502787|FG000|Overall Study|Other|1|||
163492051|NCT04409509|590502788|FG001|Overall Study|Other|1|||
163492052|NCT04668066|590502789|FG000|Part 1: Treatment Phase|Adverse Event|0|||
163492053|NCT04668066|590502790|FG001|Part 1: Treatment Phase|Adverse Event|0|||
163492054|NCT04668066|590502791|FG002|Part 1: Treatment Phase|Adverse Event|0|||
163492055|NCT04668066|590502792|FG003|Part 1: Treatment Phase|Adverse Event|0|||
163492056|NCT04668066|590502793|FG004|Part 1: Treatment Phase|Adverse Event|0|||
163492057|NCT04668066|590502794|FG005|Part 1: Treatment Phase|Adverse Event|0|||
163492058|NCT04668066|590502795|FG006|Part 1: Treatment Phase|Adverse Event|0|||
163492059|NCT04668066|590502796|FG007|Part 1: Treatment Phase|Adverse Event|0|||
163492060|NCT04668066|590502797|FG008|Part 1: Treatment Phase|Adverse Event|0|||
163492061|NCT04668066|590502798|FG009|Part 1: Treatment Phase|Adverse Event|0|||
163492062|NCT04668066|590502799|FG010|Part 1: Treatment Phase|Adverse Event|0|||
163492063|NCT04668066|590502800|FG011|Part 1: Treatment Phase|Adverse Event|1|||
163492064|NCT04668066|590502801|FG012|Part 1: Treatment Phase|Adverse Event|1|||
163492065|NCT04668066|590502802|FG013|Part 1: Treatment Phase|Adverse Event|0|||
163492066|NCT04668066|590502803|FG014|Part 1: Treatment Phase|Adverse Event|0|||
163492067|NCT04668066|590502804|FG015|Part 1: Treatment Phase|Adverse Event|0|||
163492068|NCT04668066|590502805|FG016|Part 1: Treatment Phase|Adverse Event|0|||
163492069|NCT04668066|590502806|FG017|Part 1: Treatment Phase|Adverse Event|0|||
163492070|NCT04668066|590502807|FG018|Part 1: Treatment Phase|Adverse Event|0|||
163492071|NCT04668066|590502789|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492072|NCT04668066|590502790|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492073|NCT04668066|590502791|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
163492074|NCT04668066|590502792|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492075|NCT04668066|590502793|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492076|NCT04668066|590502794|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492077|NCT04668066|590502795|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492078|NCT04668066|590502796|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492079|NCT04668066|590502797|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492080|NCT04668066|590502798|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492081|NCT04668066|590502799|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492082|NCT04668066|590502800|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492083|NCT04668066|590502801|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492084|NCT04668066|590502802|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492085|NCT04668066|590502803|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492086|NCT04668066|590502804|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492087|NCT04668066|590502805|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492088|NCT04668066|590502806|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492089|NCT04668066|590502807|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
163492090|NCT04668066|590502789|FG000|Part 1: Treatment Phase|Other|0|||
163492091|NCT04668066|590502790|FG001|Part 1: Treatment Phase|Other|0|||
163492092|NCT04668066|590502791|FG002|Part 1: Treatment Phase|Other|0|||
163492093|NCT04668066|590502792|FG003|Part 1: Treatment Phase|Other|0|||
163492094|NCT04668066|590502793|FG004|Part 1: Treatment Phase|Other|0|||
163492095|NCT04668066|590502794|FG005|Part 1: Treatment Phase|Other|0|||
163492096|NCT04668066|590502795|FG006|Part 1: Treatment Phase|Other|0|||
163492097|NCT04668066|590502796|FG007|Part 1: Treatment Phase|Other|0|||
163492098|NCT04668066|590502797|FG008|Part 1: Treatment Phase|Other|0|||
163492099|NCT04668066|590502798|FG009|Part 1: Treatment Phase|Other|0|||
163492100|NCT04668066|590502799|FG010|Part 1: Treatment Phase|Other|0|||
163492101|NCT04668066|590502800|FG011|Part 1: Treatment Phase|Other|1|||
163492102|NCT04668066|590502801|FG012|Part 1: Treatment Phase|Other|0|||
163492103|NCT04668066|590502802|FG013|Part 1: Treatment Phase|Other|0|||
163492104|NCT04668066|590502803|FG014|Part 1: Treatment Phase|Other|0|||
163492105|NCT04668066|590502804|FG015|Part 1: Treatment Phase|Other|0|||
163492106|NCT04668066|590502805|FG016|Part 1: Treatment Phase|Other|0|||
163492107|NCT04668066|590502806|FG017|Part 1: Treatment Phase|Other|0|||
163492108|NCT04668066|590502807|FG018|Part 1: Treatment Phase|Other|0|||
163492109|NCT04668066|590502789|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492110|NCT04668066|590502790|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492111|NCT04668066|590502791|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492112|NCT04668066|590502792|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492113|NCT04668066|590502793|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492114|NCT04668066|590502794|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492115|NCT04668066|590502795|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492116|NCT04668066|590502796|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492117|NCT04668066|590502797|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492118|NCT04668066|590502798|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492119|NCT04668066|590502799|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492120|NCT04668066|590502800|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492121|NCT04668066|590502801|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
163492122|NCT04668066|590502802|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492123|NCT04668066|590502803|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492124|NCT04668066|590502804|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
163492125|NCT04668066|590502805|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492126|NCT04668066|590502806|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492127|NCT04668066|590502807|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
163492128|NCT04668066|590502789|FG000|Part 1: Follow-Up|Adverse Event|0|||
163492129|NCT04668066|590502790|FG001|Part 1: Follow-Up|Adverse Event|0|||
163492130|NCT04668066|590502791|FG002|Part 1: Follow-Up|Adverse Event|0|||
163492131|NCT04668066|590502792|FG003|Part 1: Follow-Up|Adverse Event|0|||
163492132|NCT04668066|590502793|FG004|Part 1: Follow-Up|Adverse Event|0|||
163492133|NCT04668066|590502794|FG005|Part 1: Follow-Up|Adverse Event|0|||
163492134|NCT04668066|590502795|FG006|Part 1: Follow-Up|Adverse Event|0|||
163492135|NCT04668066|590502796|FG007|Part 1: Follow-Up|Adverse Event|0|||
163492136|NCT04668066|590502797|FG008|Part 1: Follow-Up|Adverse Event|0|||
163492137|NCT04668066|590502798|FG009|Part 1: Follow-Up|Adverse Event|0|||
163492138|NCT04668066|590502799|FG010|Part 1: Follow-Up|Adverse Event|0|||
163492139|NCT04668066|590502800|FG011|Part 1: Follow-Up|Adverse Event|1|||
163492140|NCT04668066|590502801|FG012|Part 1: Follow-Up|Adverse Event|0|||
163492141|NCT04668066|590502802|FG013|Part 1: Follow-Up|Adverse Event|0|||
163492142|NCT04668066|590502803|FG014|Part 1: Follow-Up|Adverse Event|0|||
163492143|NCT04668066|590502804|FG015|Part 1: Follow-Up|Adverse Event|0|||
163492144|NCT04668066|590502805|FG016|Part 1: Follow-Up|Adverse Event|0|||
163492145|NCT04668066|590502806|FG017|Part 1: Follow-Up|Adverse Event|0|||
163492146|NCT04668066|590502807|FG018|Part 1: Follow-Up|Adverse Event|0|||
163492147|NCT04668066|590502789|FG000|Part 1: Follow-Up|Other|0|||
163492148|NCT04668066|590502790|FG001|Part 1: Follow-Up|Other|0|||
163492149|NCT04668066|590502791|FG002|Part 1: Follow-Up|Other|0|||
163492150|NCT04668066|590502792|FG003|Part 1: Follow-Up|Other|0|||
163492151|NCT04668066|590502793|FG004|Part 1: Follow-Up|Other|0|||
163492152|NCT04668066|590502794|FG005|Part 1: Follow-Up|Other|0|||
163492153|NCT04668066|590502795|FG006|Part 1: Follow-Up|Other|0|||
163492154|NCT04668066|590502796|FG007|Part 1: Follow-Up|Other|0|||
163492155|NCT04668066|590502797|FG008|Part 1: Follow-Up|Other|0|||
163492156|NCT04668066|590502798|FG009|Part 1: Follow-Up|Other|0|||
163492157|NCT04668066|590502799|FG010|Part 1: Follow-Up|Other|0|||
163492158|NCT04668066|590502800|FG011|Part 1: Follow-Up|Other|1|||
163492159|NCT04668066|590502801|FG012|Part 1: Follow-Up|Other|1|||
163492160|NCT04668066|590502802|FG013|Part 1: Follow-Up|Other|0|||
163492161|NCT04668066|590502803|FG014|Part 1: Follow-Up|Other|0|||
163492162|NCT04668066|590502804|FG015|Part 1: Follow-Up|Other|0|||
163492163|NCT04668066|590502805|FG016|Part 1: Follow-Up|Other|0|||
163492164|NCT04668066|590502806|FG017|Part 1: Follow-Up|Other|0|||
163492165|NCT04668066|590502807|FG018|Part 1: Follow-Up|Other|0|||
163492166|NCT04668066|590502789|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492167|NCT04668066|590502790|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492168|NCT04668066|590502791|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492169|NCT04668066|590502792|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492170|NCT04668066|590502793|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492171|NCT04668066|590502794|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492172|NCT04668066|590502795|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492173|NCT04668066|590502796|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492174|NCT04668066|590502797|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492175|NCT04668066|590502798|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492176|NCT04668066|590502799|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492177|NCT04668066|590502800|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492178|NCT04668066|590502801|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
163492179|NCT04668066|590502802|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492180|NCT04668066|590502803|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492181|NCT04668066|590502804|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
163492182|NCT04668066|590502805|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492183|NCT04668066|590502806|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492184|NCT04668066|590502807|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
163492185|NCT04668066|590502789|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492186|NCT04668066|590502790|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492187|NCT04668066|590502791|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492188|NCT04668066|590502792|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492189|NCT04668066|590502793|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492190|NCT04668066|590502794|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492191|NCT04668066|590502795|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492192|NCT04668066|590502796|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492193|NCT04668066|590502797|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492194|NCT04668066|590502798|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492195|NCT04668066|590502799|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492196|NCT04668066|590502800|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492197|NCT04668066|590502801|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492198|NCT04668066|590502802|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492199|NCT04668066|590502803|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492200|NCT04668066|590502804|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492201|NCT04668066|590502805|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492202|NCT04668066|590502806|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
163492203|NCT04668066|590502807|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
163492204|NCT04668066|590502789|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492205|NCT04668066|590502790|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492206|NCT04668066|590502791|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492207|NCT04668066|590502792|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492208|NCT04668066|590502793|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492209|NCT04668066|590502794|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492210|NCT04668066|590502795|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492211|NCT04668066|590502796|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492212|NCT04668066|590502797|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492213|NCT04668066|590502798|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492214|NCT04668066|590502799|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492215|NCT04668066|590502800|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492216|NCT04668066|590502801|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492217|NCT04668066|590502802|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492218|NCT04668066|590502803|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492219|NCT04668066|590502804|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492220|NCT04668066|590502805|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492221|NCT04668066|590502806|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
163492222|NCT04668066|590502807|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
163492223|NCT04668066|590502789|FG000|Part 2: Treatment Phase|Other|0|||
163492224|NCT04668066|590502790|FG001|Part 2: Treatment Phase|Other|0|||
163492225|NCT04668066|590502791|FG002|Part 2: Treatment Phase|Other|0|||
163492226|NCT04668066|590502792|FG003|Part 2: Treatment Phase|Other|0|||
163492227|NCT04668066|590502793|FG004|Part 2: Treatment Phase|Other|0|||
163492228|NCT04668066|590502794|FG005|Part 2: Treatment Phase|Other|0|||
163492229|NCT04668066|590502795|FG006|Part 2: Treatment Phase|Other|0|||
163492230|NCT04668066|590502796|FG007|Part 2: Treatment Phase|Other|0|||
163492231|NCT04668066|590502797|FG008|Part 2: Treatment Phase|Other|0|||
163492232|NCT04668066|590502798|FG009|Part 2: Treatment Phase|Other|0|||
163492233|NCT04668066|590502799|FG010|Part 2: Treatment Phase|Other|0|||
163492234|NCT04668066|590502800|FG011|Part 2: Treatment Phase|Other|0|||
163492235|NCT04668066|590502801|FG012|Part 2: Treatment Phase|Other|0|||
163492236|NCT04668066|590502802|FG013|Part 2: Treatment Phase|Other|0|||
163492237|NCT04668066|590502803|FG014|Part 2: Treatment Phase|Other|0|||
163492238|NCT04668066|590502804|FG015|Part 2: Treatment Phase|Other|0|||
163492239|NCT04668066|590502805|FG016|Part 2: Treatment Phase|Other|0|||
163492240|NCT04668066|590502806|FG017|Part 2: Treatment Phase|Other|0|||
163492241|NCT04668066|590502807|FG018|Part 2: Treatment Phase|Other|1|||
163492242|NCT04668066|590502789|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492243|NCT04668066|590502790|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492244|NCT04668066|590502791|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492245|NCT04668066|590502792|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492246|NCT04668066|590502793|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492247|NCT04668066|590502794|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492248|NCT04668066|590502795|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492249|NCT04668066|590502796|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492250|NCT04668066|590502797|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492251|NCT04668066|590502798|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492252|NCT04668066|590502799|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492253|NCT04668066|590502800|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492254|NCT04668066|590502801|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492255|NCT04668066|590502802|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492256|NCT04668066|590502803|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492257|NCT04668066|590502804|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492258|NCT04668066|590502805|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492259|NCT04668066|590502806|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
163492260|NCT04668066|590502807|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
163492261|NCT04479358|590502810|FG000|Overall Study|Withdrawal by Subject|0|||
163492262|NCT04479358|590502811|FG001|Overall Study|Withdrawal by Subject|0|||
163492263|NCT04479358|590502812|FG002|Overall Study|Withdrawal by Subject|1|||
163492264|NCT04479358|590502813|FG003|Overall Study|Withdrawal by Subject|0|||
163492265|NCT04479358|590502814|FG004|Overall Study|Withdrawal by Subject|0|||
163492266|NCT04479358|590502815|FG005|Overall Study|Withdrawal by Subject|1|||
163492267|NCT03795233|590502830|FG000|Overall Study|Withdrawal by Subject|2|||
163492268|NCT03795233|590502831|FG001|Overall Study|Withdrawal by Subject|1|||
163492269|NCT03795233|590502830|FG000|Overall Study|Lost to Follow-up|1|||
163492270|NCT03795233|590502831|FG001|Overall Study|Lost to Follow-up|0|||
163492271|NCT03795233|590502830|FG000|Overall Study|Death|1|||
163492272|NCT03795233|590502831|FG001|Overall Study|Death|0|||
163492273|NCT02756182|590502832|FG000|Overall Study|StudyTechnical Difficulties|4|||
163492274|NCT01965600|590502836|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
163492275|NCT01965600|590502837|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
163492276|NCT01965600|590502838|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
163492277|NCT01965600|590502839|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
163492278|NCT01965600|590502836|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
163492279|NCT01965600|590502837|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
163492280|NCT01965600|590502838|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
163492281|NCT01965600|590502839|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
163492282|NCT01965600|590502836|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
163492283|NCT01965600|590502837|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
163492284|NCT01965600|590502838|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
163492285|NCT01965600|590502839|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
163492286|NCT01965600|590502836|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
163492287|NCT01965600|590502837|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
163492288|NCT01965600|590502838|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
163492289|NCT01965600|590502839|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
163492290|NCT01965600|590502836|FG000|Second Intervention|Study terminated by Sponsor|0|||
163492291|NCT01965600|590502837|FG001|Second Intervention|Study terminated by Sponsor|0|||
163492292|NCT01965600|590502838|FG002|Second Intervention|Study terminated by Sponsor|2|||
163492293|NCT01965600|590502839|FG003|Second Intervention|Study terminated by Sponsor|2|||
163492294|NCT02711306|590502847|FG000|Overall Study|Withdrawal by Subject|2|||
163492295|NCT02711306|590502848|FG001|Overall Study|Withdrawal by Subject|2|||
163492296|NCT01100073|590504379|FG000|Overall Study|Lack of Efficacy|4|||
163492297|NCT01100073|590504379|FG000|Overall Study|Insufficient Tolerability|21|||
163492298|NCT01100073|590504379|FG000|Overall Study|Withdrawal by Subject|13|||
163492299|NCT01100073|590504379|FG000|Overall Study|Lost to Follow-up|39|||
163492300|NCT01100073|590504379|FG000|Overall Study|Lack of effect + patient's wish|2|||
163492301|NCT01100073|590504379|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
163492302|NCT01100073|590504379|FG000|Overall Study|Other|8|||
163492303|NCT01100073|590504379|FG000|Overall Study|Missing|5|||
163492304|NCT00299546|590504380|FG000|Overall Study|Death|3|||
163492305|NCT00299546|590504381|FG001|Overall Study|Death|2|||
163492306|NCT00299546|590504382|FG002|Overall Study|Death|0|||
163492307|NCT00299546|590504380|FG000|Overall Study|Lost to Follow-up|2|||
163492308|NCT00299546|590504381|FG001|Overall Study|Lost to Follow-up|2|||
163492309|NCT00299546|590504382|FG002|Overall Study|Lost to Follow-up|5|||
163492310|NCT00299546|590504380|FG000|Overall Study|Adverse Event|37|||
163492311|NCT00299546|590504381|FG001|Overall Study|Adverse Event|22|||
163492312|NCT00299546|590504382|FG002|Overall Study|Adverse Event|27|||
163492313|NCT00299546|590504380|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
163492314|NCT00299546|590504381|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
163492315|NCT00299546|590504382|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
163492316|NCT00299546|590504380|FG000|Overall Study|Other|24|||
163492317|NCT00299546|590504381|FG001|Overall Study|Other|26|||
163492318|NCT00299546|590504382|FG002|Overall Study|Other|19|||
163492319|NCT00299546|590504380|FG000|Overall Study|Not treated|0|||
163492320|NCT00299546|590504381|FG001|Overall Study|Not treated|1|||
163492321|NCT00299546|590504382|FG002|Overall Study|Not treated|1|||
163492322|NCT01656850|590504386|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
163492323|NCT01656850|590504387|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
163492324|NCT00326118|590504388|FG000|Active Phase|Withdrawal by Subject|4|||
163492325|NCT00326118|590504389|FG001|Active Phase|Withdrawal by Subject|1|||
163492326|NCT00320801|590504394|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
163492327|NCT00320801|590504395|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
163492328|NCT00320801|590504396|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
163492329|NCT00320801|590504397|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
163492330|NCT00320801|590504394|FG000|Open-label Run-in Period|Adverse Event|33|||
163492331|NCT00320801|590504395|FG001|Open-label Run-in Period|Adverse Event|0|||
163492332|NCT00320801|590504396|FG002|Open-label Run-in Period|Adverse Event|0|||
163492333|NCT00320801|590504397|FG003|Open-label Run-in Period|Adverse Event|0|||
163492334|NCT00320801|590504394|FG000|Open-label Run-in Period|Administrative|10|||
163492335|NCT00320801|590504395|FG001|Open-label Run-in Period|Administrative|0|||
163492336|NCT00320801|590504396|FG002|Open-label Run-in Period|Administrative|0|||
163492337|NCT00320801|590504397|FG003|Open-label Run-in Period|Administrative|0|||
163492338|NCT00320801|590504394|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
163492339|NCT00320801|590504395|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
163492340|NCT00320801|590504396|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
163492341|NCT00320801|590504397|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
163492342|NCT00320801|590504394|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
163492343|NCT00320801|590504395|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
163492344|NCT00320801|590504396|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
163492345|NCT00320801|590504397|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
163492346|NCT00320801|590504394|FG000|Open-label Run-in Period|Did not qualify|1|||
163492347|NCT00320801|590504395|FG001|Open-label Run-in Period|Did not qualify|0|||
163492348|NCT00320801|590504396|FG002|Open-label Run-in Period|Did not qualify|0|||
163492349|NCT00320801|590504397|FG003|Open-label Run-in Period|Did not qualify|0|||
163492350|NCT00320801|590504394|FG000|Double-blind Phase|Withdrawal by Subject|0|||
163492351|NCT00320801|590504395|FG001|Double-blind Phase|Withdrawal by Subject|0|||
163492352|NCT00320801|590504396|FG002|Double-blind Phase|Withdrawal by Subject|1|||
163492353|NCT00320801|590504397|FG003|Double-blind Phase|Withdrawal by Subject|0|||
163492354|NCT00320801|590504394|FG000|Double-blind Phase|Adverse Event|0|||
163492355|NCT00320801|590504395|FG001|Double-blind Phase|Adverse Event|2|||
163492356|NCT00320801|590504396|FG002|Double-blind Phase|Adverse Event|8|||
163492357|NCT00320801|590504397|FG003|Double-blind Phase|Adverse Event|0|||
163492358|NCT00320801|590504394|FG000|Double-blind Phase|Administrative|0|||
163492359|NCT00320801|590504395|FG001|Double-blind Phase|Administrative|0|||
163492360|NCT00320801|590504396|FG002|Double-blind Phase|Administrative|4|||
163492361|NCT00320801|590504397|FG003|Double-blind Phase|Administrative|0|||
163492362|NCT00320801|590504394|FG000|Double-blind Phase|Lack of Efficacy|0|||
163492363|NCT00320801|590504395|FG001|Double-blind Phase|Lack of Efficacy|9|||
163492364|NCT00320801|590504396|FG002|Double-blind Phase|Lack of Efficacy|1|||
163492365|NCT00320801|590504397|FG003|Double-blind Phase|Lack of Efficacy|0|||
163492366|NCT00320801|590504394|FG000|Extension Phase|Withdrawal by Subject|0|||
163492367|NCT00320801|590504395|FG001|Extension Phase|Withdrawal by Subject|0|||
163492368|NCT00320801|590504396|FG002|Extension Phase|Withdrawal by Subject|0|||
163492369|NCT00320801|590504397|FG003|Extension Phase|Withdrawal by Subject|6|||
163492370|NCT00320801|590504394|FG000|Extension Phase|Adverse Event|0|||
163492371|NCT00320801|590504395|FG001|Extension Phase|Adverse Event|0|||
163492372|NCT00320801|590504396|FG002|Extension Phase|Adverse Event|0|||
163492373|NCT00320801|590504397|FG003|Extension Phase|Adverse Event|8|||
163492374|NCT00320801|590504394|FG000|Extension Phase|Administrative|0|||
163492375|NCT00320801|590504395|FG001|Extension Phase|Administrative|0|||
163492376|NCT00320801|590504396|FG002|Extension Phase|Administrative|0|||
163492377|NCT00320801|590504397|FG003|Extension Phase|Administrative|29|||
163492378|NCT00320801|590504394|FG000|Extension Phase|Lack of Efficacy|0|||
163492379|NCT00320801|590504395|FG001|Extension Phase|Lack of Efficacy|0|||
163492380|NCT00320801|590504396|FG002|Extension Phase|Lack of Efficacy|0|||
163492381|NCT00320801|590504397|FG003|Extension Phase|Lack of Efficacy|2|||
163492382|NCT00320801|590504394|FG000|Extension Phase|Lost to Follow-up|0|||
163492383|NCT00320801|590504395|FG001|Extension Phase|Lost to Follow-up|0|||
163492384|NCT00320801|590504396|FG002|Extension Phase|Lost to Follow-up|0|||
163492385|NCT00320801|590504397|FG003|Extension Phase|Lost to Follow-up|3|||
163492386|NCT00337727|590504398|FG000|Overall Study|Adverse Event|5|||
163492387|NCT00337727|590504399|FG001|Overall Study|Adverse Event|3|||
163492388|NCT00337727|590504398|FG000|Overall Study|Lost to Follow-up|5|||
163492389|NCT00337727|590504399|FG001|Overall Study|Lost to Follow-up|4|||
163492390|NCT00337727|590504398|FG000|Overall Study|Physician Decision|1|||
163492391|NCT00337727|590504399|FG001|Overall Study|Physician Decision|0|||
163492392|NCT00337727|590504398|FG000|Overall Study|Protocol Violation|4|||
163492393|NCT00337727|590504399|FG001|Overall Study|Protocol Violation|0|||
163492394|NCT00337727|590504398|FG000|Overall Study|Withdrawal by Subject|3|||
163492395|NCT00337727|590504399|FG001|Overall Study|Withdrawal by Subject|5|||
163492396|NCT02060188|590504402|FG000|Overall Study|Disease Progression|36|||
163492397|NCT02060188|590504403|FG001|Overall Study|Disease Progression|42|||
163492398|NCT02060188|590504404|FG002|Overall Study|Disease Progression|8|||
163492399|NCT02060188|590504405|FG003|Overall Study|Disease Progression|5|||
163492400|NCT02060188|590504406|FG004|Overall Study|Disease Progression|6|||
163492401|NCT02060188|590504407|FG005|Overall Study|Disease Progression|3|||
163492402|NCT02060188|590504408|FG006|Overall Study|Disease Progression|23|||
163492403|NCT02060188|590504409|FG007|Overall Study|Disease Progression|20|||
163492404|NCT02060188|590504410|FG008|Overall Study|Disease Progression|43|||
163492405|NCT02060188|590504402|FG000|Overall Study|Study Drug Toxicity|10|||
163492406|NCT02060188|590504403|FG001|Overall Study|Study Drug Toxicity|18|||
163492407|NCT02060188|590504404|FG002|Overall Study|Study Drug Toxicity|7|||
163492408|NCT02060188|590504405|FG003|Overall Study|Study Drug Toxicity|4|||
163492409|NCT02060188|590504406|FG004|Overall Study|Study Drug Toxicity|3|||
163492410|NCT02060188|590504407|FG005|Overall Study|Study Drug Toxicity|0|||
163492411|NCT02060188|590504408|FG006|Overall Study|Study Drug Toxicity|2|||
163492412|NCT02060188|590504409|FG007|Overall Study|Study Drug Toxicity|5|||
163492413|NCT02060188|590504410|FG008|Overall Study|Study Drug Toxicity|0|||
163492414|NCT02060188|590504402|FG000|Overall Study|Adverse event unrelated to study drug|2|||
163492415|NCT02060188|590504403|FG001|Overall Study|Adverse event unrelated to study drug|5|||
163492416|NCT02060188|590504404|FG002|Overall Study|Adverse event unrelated to study drug|6|||
163492417|NCT02060188|590504405|FG003|Overall Study|Adverse event unrelated to study drug|0|||
163492418|NCT02060188|590504406|FG004|Overall Study|Adverse event unrelated to study drug|1|||
163492419|NCT02060188|590504407|FG005|Overall Study|Adverse event unrelated to study drug|0|||
163492420|NCT02060188|590504408|FG006|Overall Study|Adverse event unrelated to study drug|4|||
163492421|NCT02060188|590504409|FG007|Overall Study|Adverse event unrelated to study drug|4|||
163492422|NCT02060188|590504410|FG008|Overall Study|Adverse event unrelated to study drug|1|||
163492423|NCT02060188|590504402|FG000|Overall Study|Participant request to discontinue study treatment|7|||
163492424|NCT02060188|590504403|FG001|Overall Study|Participant request to discontinue study treatment|7|||
163492425|NCT02060188|590504404|FG002|Overall Study|Participant request to discontinue study treatment|4|||
163492426|NCT02060188|590504405|FG003|Overall Study|Participant request to discontinue study treatment|0|||
163492427|NCT02060188|590504406|FG004|Overall Study|Participant request to discontinue study treatment|0|||
163492428|NCT02060188|590504407|FG005|Overall Study|Participant request to discontinue study treatment|0|||
163492429|NCT02060188|590504408|FG006|Overall Study|Participant request to discontinue study treatment|1|||
163492430|NCT02060188|590504409|FG007|Overall Study|Participant request to discontinue study treatment|1|||
163492431|NCT02060188|590504410|FG008|Overall Study|Participant request to discontinue study treatment|0|||
163492432|NCT02060188|590504402|FG000|Overall Study|Participant withdrew consent|3|||
163492433|NCT02060188|590504403|FG001|Overall Study|Participant withdrew consent|0|||
163492434|NCT02060188|590504404|FG002|Overall Study|Participant withdrew consent|0|||
163492435|NCT02060188|590504405|FG003|Overall Study|Participant withdrew consent|0|||
163492436|NCT02060188|590504406|FG004|Overall Study|Participant withdrew consent|0|||
163492437|NCT02060188|590504407|FG005|Overall Study|Participant withdrew consent|0|||
163492438|NCT02060188|590504408|FG006|Overall Study|Participant withdrew consent|0|||
163492439|NCT02060188|590504409|FG007|Overall Study|Participant withdrew consent|0|||
163492440|NCT02060188|590504410|FG008|Overall Study|Participant withdrew consent|0|||
163492441|NCT02060188|590504402|FG000|Overall Study|Maximum clinical benefit|13|||
163492442|NCT02060188|590504403|FG001|Overall Study|Maximum clinical benefit|38|||
163492443|NCT02060188|590504404|FG002|Overall Study|Maximum clinical benefit|19|||
163492444|NCT02060188|590504405|FG003|Overall Study|Maximum clinical benefit|0|||
163492445|NCT02060188|590504406|FG004|Overall Study|Maximum clinical benefit|0|||
163492446|NCT02060188|590504407|FG005|Overall Study|Maximum clinical benefit|0|||
163492447|NCT02060188|590504408|FG006|Overall Study|Maximum clinical benefit|0|||
163492448|NCT02060188|590504409|FG007|Overall Study|Maximum clinical benefit|10|||
163492449|NCT02060188|590504410|FG008|Overall Study|Maximum clinical benefit|0|||
163492450|NCT02060188|590504402|FG000|Overall Study|Other reason|3|||
163492451|NCT02060188|590504403|FG001|Overall Study|Other reason|7|||
163492452|NCT02060188|590504404|FG002|Overall Study|Other reason|0|||
163492453|NCT02060188|590504405|FG003|Overall Study|Other reason|1|||
163492454|NCT02060188|590504406|FG004|Overall Study|Other reason|0|||
163492455|NCT02060188|590504407|FG005|Overall Study|Other reason|0|||
163492456|NCT02060188|590504408|FG006|Overall Study|Other reason|0|||
163492457|NCT02060188|590504409|FG007|Overall Study|Other reason|9|||
163492458|NCT02060188|590504410|FG008|Overall Study|Other reason|0|||
163492459|NCT02060188|590504402|FG000|Overall Study|Death|0|||
163492460|NCT02060188|590504403|FG001|Overall Study|Death|1|||
163492461|NCT02060188|590504404|FG002|Overall Study|Death|0|||
163492462|NCT02060188|590504405|FG003|Overall Study|Death|0|||
163492463|NCT02060188|590504406|FG004|Overall Study|Death|0|||
163492464|NCT02060188|590504407|FG005|Overall Study|Death|0|||
163492465|NCT02060188|590504408|FG006|Overall Study|Death|0|||
163492466|NCT02060188|590504409|FG007|Overall Study|Death|1|||
163492467|NCT02060188|590504410|FG008|Overall Study|Death|0|||
163492468|NCT02060188|590504402|FG000|Overall Study|Administrative reasons by sponsor|0|||
163492469|NCT02060188|590504403|FG001|Overall Study|Administrative reasons by sponsor|1|||
163492470|NCT02060188|590504404|FG002|Overall Study|Administrative reasons by sponsor|0|||
163492471|NCT02060188|590504405|FG003|Overall Study|Administrative reasons by sponsor|0|||
163492472|NCT02060188|590504406|FG004|Overall Study|Administrative reasons by sponsor|0|||
163492473|NCT02060188|590504407|FG005|Overall Study|Administrative reasons by sponsor|0|||
163492474|NCT02060188|590504408|FG006|Overall Study|Administrative reasons by sponsor|0|||
163492475|NCT02060188|590504409|FG007|Overall Study|Administrative reasons by sponsor|0|||
163492476|NCT02060188|590504410|FG008|Overall Study|Administrative reasons by sponsor|0|||
163492477|NCT02060188|590504402|FG000|Overall Study|Lost to Follow-up|0|||
163492478|NCT02060188|590504403|FG001|Overall Study|Lost to Follow-up|0|||
163492479|NCT02060188|590504404|FG002|Overall Study|Lost to Follow-up|1|||
163492480|NCT02060188|590504405|FG003|Overall Study|Lost to Follow-up|0|||
163492481|NCT02060188|590504406|FG004|Overall Study|Lost to Follow-up|0|||
163492482|NCT02060188|590504407|FG005|Overall Study|Lost to Follow-up|0|||
163492483|NCT02060188|590504408|FG006|Overall Study|Lost to Follow-up|0|||
163492484|NCT02060188|590504409|FG007|Overall Study|Lost to Follow-up|0|||
163492485|NCT02060188|590504410|FG008|Overall Study|Lost to Follow-up|0|||
163492486|NCT04456998|590504413|FG000|Overall Study|Adverse Event|0|||
163492487|NCT04456998|590504414|FG001|Overall Study|Adverse Event|4|||
163492488|NCT04456998|590504413|FG000|Overall Study|Protocol Deviation|0|||
163492489|NCT04456998|590504414|FG001|Overall Study|Protocol Deviation|1|||
163492490|NCT04456998|590504413|FG000|Overall Study|Withdrawal by Subject|0|||
163492491|NCT04456998|590504414|FG001|Overall Study|Withdrawal by Subject|1|||
163492492|NCT03707145|590504418|FG000|Overall Study|Lost to Follow-up|0|||
163492493|NCT03707145|590504419|FG001|Overall Study|Lost to Follow-up|1|||
163492494|NCT03707145|590504420|FG002|Overall Study|Lost to Follow-up|1|||
163492495|NCT03707145|590504421|FG003|Overall Study|Lost to Follow-up|0|||
163492496|NCT04221477|590504422|FG000|Overall Study|Adverse Event|1|||
163492497|NCT04221477|590504423|FG001|Overall Study|Adverse Event|1|||
163492498|NCT04221477|590504422|FG000|Overall Study|Death|5|||
163492499|NCT04221477|590504423|FG001|Overall Study|Death|4|||
163492500|NCT04221477|590504422|FG000|Overall Study|Lack of Efficacy|1|||
163492501|NCT04221477|590504423|FG001|Overall Study|Lack of Efficacy|2|||
163492502|NCT04221477|590504422|FG000|Overall Study|Lost to Follow-up|1|||
163492503|NCT04221477|590504423|FG001|Overall Study|Lost to Follow-up|2|||
163492504|NCT04221477|590504422|FG000|Overall Study|Non-compliance with Study Drug|1|||
163492505|NCT04221477|590504423|FG001|Overall Study|Non-compliance with Study Drug|0|||
163492506|NCT04221477|590504422|FG000|Overall Study|Reason not Specified|0|||
163492507|NCT04221477|590504423|FG001|Overall Study|Reason not Specified|5|||
163492508|NCT04221477|590504422|FG000|Overall Study|Physician Decision|0|||
163492509|NCT04221477|590504423|FG001|Overall Study|Physician Decision|6|||
163492510|NCT04221477|590504422|FG000|Overall Study|Withdrawal by Subject|10|||
163492511|NCT04221477|590504423|FG001|Overall Study|Withdrawal by Subject|14|||
163492512|NCT04221477|590504422|FG000|Overall Study|Ongoing in the Study|116|||
163492513|NCT04221477|590504423|FG001|Overall Study|Ongoing in the Study|102|||
163492514|NCT04784455|590504424|FG000|Overall Study|Death|4|||
163492515|NCT04882085|590504425|FG000|Overall Study|Death|6|||
163492516|NCT04882085|590504426|FG001|Overall Study|Death|9|||
163492517|NCT04882085|590504425|FG000|Overall Study|Withdrawal by Subject|0|||
163492518|NCT04882085|590504426|FG001|Overall Study|Withdrawal by Subject|3|||
163492519|NCT04882085|590504425|FG000|Overall Study|Randomized not treated|1|||
163492520|NCT04882085|590504426|FG001|Overall Study|Randomized not treated|0|||
163492521|NCT04455620|590504427|FG000|Overall Study|Withdrawal by Subject|0|||
163492522|NCT04455620|590504428|FG001|Overall Study|Withdrawal by Subject|0|||
163492523|NCT04455620|590504429|FG002|Overall Study|Withdrawal by Subject|2|||
163492524|NCT04455620|590504430|FG003|Overall Study|Withdrawal by Subject|0|||
163492525|NCT04455620|590504431|FG004|Overall Study|Withdrawal by Subject|1|||
163492526|NCT04455620|590504427|FG000|Overall Study|Lost to Follow-up|0|||
163492527|NCT04455620|590504428|FG001|Overall Study|Lost to Follow-up|0|||
163492528|NCT04455620|590504429|FG002|Overall Study|Lost to Follow-up|1|||
163492529|NCT04455620|590504430|FG003|Overall Study|Lost to Follow-up|1|||
163492530|NCT04455620|590504431|FG004|Overall Study|Lost to Follow-up|0|||
163492531|NCT04455620|590504427|FG000|Overall Study|Death|1|||
163492532|NCT04455620|590504428|FG001|Overall Study|Death|6|||
163492533|NCT04455620|590504429|FG002|Overall Study|Death|20|||
163492534|NCT04455620|590504430|FG003|Overall Study|Death|1|||
163492535|NCT04455620|590504431|FG004|Overall Study|Death|7|||
163492536|NCT04455620|590504427|FG000|Overall Study|Study Termination|0|||
163492537|NCT04455620|590504428|FG001|Overall Study|Study Termination|2|||
163492538|NCT04455620|590504429|FG002|Overall Study|Study Termination|1|||
163492539|NCT04455620|590504430|FG003|Overall Study|Study Termination|0|||
163492540|NCT04455620|590504431|FG004|Overall Study|Study Termination|6|||
163492541|NCT00965562|590504432|FG000|Overall Study|Lost to Follow-up|1|||
163492542|NCT00965562|590504433|FG001|Overall Study|Lost to Follow-up|2|||
163492543|NCT00965562|590504434|FG002|Overall Study|Lost to Follow-up|3|||
163492544|NCT00965562|590504432|FG000|Overall Study|Withdrawal by Subject|2|||
163492545|NCT00965562|590504433|FG001|Overall Study|Withdrawal by Subject|2|||
163492546|NCT00965562|590504434|FG002|Overall Study|Withdrawal by Subject|0|||
163492547|NCT05681715|590504435|FG000|Training Period (6-weeks)|Adverse Event|3|||
163492548|NCT05681715|590504436|FG001|Training Period (6-weeks)|Adverse Event|0|||
163492549|NCT05681715|590504437|FG002|Training Period (6-weeks)|Adverse Event|0|||
163492550|NCT05681715|590504435|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
163492551|NCT05681715|590504436|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
163492552|NCT05681715|590504437|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
163492553|NCT05681715|590504435|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
163492554|NCT05681715|590504436|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
163492555|NCT05681715|590504437|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
163492556|NCT05681715|590504435|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
163492557|NCT05681715|590504436|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
163492558|NCT05681715|590504437|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
163492559|NCT05681715|590504435|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
163492560|NCT05681715|590504436|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
163492561|NCT05681715|590504437|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
163492562|NCT05681715|590504435|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
163492563|NCT05681715|590504436|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
163492564|NCT05681715|590504437|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
163492565|NCT05681715|590504435|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
163492566|NCT05681715|590504436|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
163492567|NCT05681715|590504437|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
163492568|NCT05681715|590504435|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
163492569|NCT05681715|590504436|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
163492570|NCT05681715|590504437|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
163492571|NCT05455684|590504438|FG000|Overall Study|Withdrawal by Subject|7|||
163492572|NCT05455684|590504439|FG001|Overall Study|Withdrawal by Subject|4|||
163492573|NCT05455684|590504438|FG000|Overall Study|Lost to Follow-up|3|||
163492574|NCT05455684|590504439|FG001|Overall Study|Lost to Follow-up|3|||
163492575|NCT05455684|590504438|FG000|Overall Study|Adverse Event|2|||
163492576|NCT05455684|590504439|FG001|Overall Study|Adverse Event|3|||
163492577|NCT05455684|590504438|FG000|Overall Study|Protocol Violation|1|||
163492578|NCT05455684|590504439|FG001|Overall Study|Protocol Violation|1|||
163492579|NCT05455684|590504438|FG000|Overall Study|Non-Compliant with study drug|0|||
163492580|NCT05455684|590504439|FG001|Overall Study|Non-Compliant with study drug|1|||
163492581|NCT05455684|590504438|FG000|Overall Study|Other|1|||
163492582|NCT05455684|590504439|FG001|Overall Study|Other|2|||
163492583|NCT05455684|590504438|FG000|Overall Study|Randomized but not treated|1|||
163492584|NCT05455684|590504439|FG001|Overall Study|Randomized but not treated|0|||
163492585|NCT05204563|590504440|FG000|Overall Study|Other than Specified|2|||
163492586|NCT05204563|590504441|FG001|Overall Study|Other than Specified|1|||
163492587|NCT05204563|590504440|FG000|Overall Study|Death|18|||
163492588|NCT05204563|590504441|FG001|Overall Study|Death|4|||
163492589|NCT05204563|590504440|FG000|Overall Study|Lost to Follow-up|6|||
163492590|NCT05204563|590504441|FG001|Overall Study|Lost to Follow-up|3|||
163492591|NCT05204563|590504440|FG000|Overall Study|Withdrawal by Subject|12|||
163492592|NCT05204563|590504441|FG001|Overall Study|Withdrawal by Subject|3|||
163492593|NCT05204563|590504440|FG000|Overall Study|Enrolled, Not Treated|1|||
163492594|NCT05204563|590504441|FG001|Overall Study|Enrolled, Not Treated|0|||
163492595|NCT05643573|590504442|FG000|Overall Study|Adverse Event|117|||
163492596|NCT05643573|590504443|FG001|Overall Study|Adverse Event|90|||
163492597|NCT05643573|590504442|FG000|Overall Study|Death|53|||
163492598|NCT05643573|590504443|FG001|Overall Study|Death|57|||
163492599|NCT05643573|590504442|FG000|Overall Study|Lost to Follow-up|6|||
163492600|NCT05643573|590504443|FG001|Overall Study|Lost to Follow-up|3|||
163492601|NCT05643573|590504442|FG000|Overall Study|Other|18|||
163492602|NCT05643573|590504443|FG001|Overall Study|Other|15|||
163492603|NCT05643573|590504442|FG000|Overall Study|Outcome event|64|||
163492604|NCT05643573|590504443|FG001|Overall Study|Outcome event|36|||
163492605|NCT05643573|590504442|FG000|Overall Study|Physician Decision|33|||
163492606|NCT05643573|590504443|FG001|Overall Study|Physician Decision|19|||
163492607|NCT05643573|590504442|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
163492608|NCT05643573|590504443|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
163492609|NCT05643573|590504442|FG000|Overall Study|Site terminated by sponsor|10|||
163492610|NCT05643573|590504443|FG001|Overall Study|Site terminated by sponsor|10|||
163492611|NCT05643573|590504442|FG000|Overall Study|Study terminated by sponsor|1|||
163492612|NCT05643573|590504443|FG001|Overall Study|Study terminated by sponsor|0|||
163492613|NCT05643573|590504442|FG000|Overall Study|Withdrawal by Subject|178|||
163492614|NCT05643573|590504443|FG001|Overall Study|Withdrawal by Subject|130|||
163492615|NCT02268214|590504446|FG000|Overall Study|Subject no longer meets study criteria|0|||
163492616|NCT02268214|590504447|FG001|Overall Study|Subject no longer meets study criteria|2|||
163492617|NCT02268214|590504448|FG002|Overall Study|Subject no longer meets study criteria|0|||
163492618|NCT02268214|590504446|FG000|Overall Study|Pregnancy|2|||
163492619|NCT02268214|590504447|FG001|Overall Study|Pregnancy|2|||
163492620|NCT02268214|590504448|FG002|Overall Study|Pregnancy|1|||
163492621|NCT02268214|590504446|FG000|Overall Study|Lost to Follow-up|3|||
163492622|NCT02268214|590504447|FG001|Overall Study|Lost to Follow-up|3|||
163492623|NCT02268214|590504448|FG002|Overall Study|Lost to Follow-up|4|||
163492624|NCT02268214|590504446|FG000|Overall Study|Lack of Efficacy|1|||
163492625|NCT02268214|590504447|FG001|Overall Study|Lack of Efficacy|0|||
163492626|NCT02268214|590504448|FG002|Overall Study|Lack of Efficacy|2|||
163492627|NCT02268214|590504446|FG000|Overall Study|Adverse Event|11|||
163492628|NCT02268214|590504447|FG001|Overall Study|Adverse Event|14|||
163492629|NCT02268214|590504448|FG002|Overall Study|Adverse Event|9|||
163492630|NCT02268214|590504446|FG000|Overall Study|Withdrawal by Subject|4|||
163492631|NCT02268214|590504447|FG001|Overall Study|Withdrawal by Subject|5|||
163492632|NCT02268214|590504448|FG002|Overall Study|Withdrawal by Subject|10|||
163492633|NCT02268214|590504446|FG000|Overall Study|Subject request to discontinue treatment|10|||
163492634|NCT02268214|590504447|FG001|Overall Study|Subject request to discontinue treatment|8|||
163492635|NCT02268214|590504448|FG002|Overall Study|Subject request to discontinue treatment|6|||
163492636|NCT02268214|590504446|FG000|Overall Study|Poor/non-compliance|2|||
163492637|NCT02268214|590504447|FG001|Overall Study|Poor/non-compliance|1|||
163492638|NCT02268214|590504448|FG002|Overall Study|Poor/non-compliance|2|||
163492639|NCT02268214|590504446|FG000|Overall Study|Other reasons|7|||
163492640|NCT02268214|590504447|FG001|Overall Study|Other reasons|3|||
163492641|NCT02268214|590504448|FG002|Overall Study|Other reasons|3|||
163492642|NCT02268214|590504446|FG000|Overall Study|Not entering long-term period|2|||
163492643|NCT02268214|590504447|FG001|Overall Study|Not entering long-term period|3|||
163492644|NCT02268214|590504448|FG002|Overall Study|Not entering long-term period|5|||
163492645|NCT02951130|590504450|FG000|Overall Study|Protocol Violation|1|||
163492646|NCT02951130|590504451|FG001|Overall Study|Protocol Violation|1|||
163492647|NCT02500732|590504453|FG000|Overall Study|Physician Decision|0|||
163492648|NCT02500732|590504454|FG001|Overall Study|Physician Decision|1|||
163492649|NCT03205605|590504457|FG000|Overall Study|Withdrawal by Subject|1|||
163492650|NCT01233284|590504465|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
163492651|NCT01233284|590504466|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
163492652|NCT01233284|590504467|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
163492653|NCT01233284|590504468|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
163492654|NCT01233284|590504469|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
163492655|NCT01233284|590504465|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
163492656|NCT01233284|590504466|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
163492657|NCT01233284|590504467|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
163492658|NCT01233284|590504468|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
163492659|NCT01233284|590504469|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
163492660|NCT01233284|590504465|FG000|Period 1 (4 Weeks)|Other|0|||
163492661|NCT01233284|590504466|FG001|Period 1 (4 Weeks)|Other|0|||
163492662|NCT01233284|590504467|FG002|Period 1 (4 Weeks)|Other|1|||
163492663|NCT01233284|590504468|FG003|Period 1 (4 Weeks)|Other|0|||
163492664|NCT01233284|590504469|FG004|Period 1 (4 Weeks)|Other|0|||
163492665|NCT01233284|590504465|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
163492666|NCT01233284|590504466|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
163492667|NCT01233284|590504467|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
163492668|NCT01233284|590504468|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
163492669|NCT01233284|590504469|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
163492670|NCT01233284|590504465|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
163492671|NCT01233284|590504466|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
163492672|NCT01233284|590504467|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
163492673|NCT01233284|590504468|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
163492674|NCT01233284|590504469|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
163492675|NCT01233284|590504465|FG000|Period 3 (4 Weeks)|Other|0|||
163492676|NCT01233284|590504466|FG001|Period 3 (4 Weeks)|Other|0|||
163492677|NCT01233284|590504467|FG002|Period 3 (4 Weeks)|Other|0|||
163492678|NCT01233284|590504468|FG003|Period 3 (4 Weeks)|Other|1|||
163492679|NCT01233284|590504469|FG004|Period 3 (4 Weeks)|Other|0|||
163492680|NCT01233284|590504465|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
163492681|NCT01233284|590504466|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
163492682|NCT01233284|590504467|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
163492683|NCT01233284|590504468|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
163492684|NCT01233284|590504469|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
163492685|NCT01233284|590504465|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
163492686|NCT01233284|590504466|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
163492687|NCT01233284|590504467|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
163492688|NCT01233284|590504468|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
163492689|NCT01233284|590504469|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
163492690|NCT03759340|590504470|FG000|Overall Study|Adverse Event|2|||
163492691|NCT03759340|590504470|FG000|Overall Study|Lost to Follow-up|1|||
163492692|NCT03759340|590504470|FG000|Overall Study|Withdrawal by Subject|15|||
163492693|NCT03759340|590504470|FG000|Overall Study|Study Terminated by Sponsor|38|||
163492694|NCT01003691|590504471|FG000|Overall Study|Adverse Event|0|||
163492695|NCT01003691|590504472|FG001|Overall Study|Adverse Event|0|||
163492696|NCT01003691|590504473|FG002|Overall Study|Adverse Event|0|||
163492697|NCT01003691|590504474|FG003|Overall Study|Adverse Event|1|||
163492698|NCT01869959|590504478|FG000|Randomization Period|Physician Decision|0|||
163492699|NCT01869959|590504479|FG001|Randomization Period|Physician Decision|0|||
163492700|NCT01869959|590504480|FG002|Randomization Period|Physician Decision|0|||
163492701|NCT01869959|590504481|FG003|Randomization Period|Physician Decision|0|||
163492702|NCT01869959|590504482|FG004|Randomization Period|Physician Decision|1|||
163492703|NCT01869959|590504478|FG000|Treatment Period|Adverse Event|1|||
163492704|NCT01869959|590504479|FG001|Treatment Period|Adverse Event|0|||
163492705|NCT01869959|590504480|FG002|Treatment Period|Adverse Event|3|||
163492706|NCT01869959|590504481|FG003|Treatment Period|Adverse Event|1|||
163492707|NCT01869959|590504482|FG004|Treatment Period|Adverse Event|0|||
163492708|NCT01869959|590504478|FG000|Treatment Period|Sponsor decision|0|||
163492709|NCT01869959|590504479|FG001|Treatment Period|Sponsor decision|1|||
163492710|NCT01869959|590504480|FG002|Treatment Period|Sponsor decision|0|||
163492711|NCT01869959|590504481|FG003|Treatment Period|Sponsor decision|1|||
163492712|NCT01869959|590504482|FG004|Treatment Period|Sponsor decision|0|||
163492713|NCT01869959|590504478|FG000|Treatment Period|Withdrawal by Subject|0|||
163492714|NCT01869959|590504479|FG001|Treatment Period|Withdrawal by Subject|1|||
163492715|NCT01869959|590504480|FG002|Treatment Period|Withdrawal by Subject|0|||
163492716|NCT01869959|590504481|FG003|Treatment Period|Withdrawal by Subject|0|||
163492717|NCT01869959|590504482|FG004|Treatment Period|Withdrawal by Subject|0|||
163492718|NCT00157820|590504492|FG000|Randomized|Physician Decision|4|||
163492719|NCT00157820|590504493|FG001|Randomized|Physician Decision|2|||
163492720|NCT00157820|590504494|FG002|Randomized|Physician Decision|3|||
163492721|NCT00157820|590504492|FG000|Randomized|Withdrawal by Subject|1|||
163492722|NCT00157820|590504493|FG001|Randomized|Withdrawal by Subject|2|||
163492723|NCT00157820|590504494|FG002|Randomized|Withdrawal by Subject|3|||
163492724|NCT00157820|590504492|FG000|Randomized|Protocol Violation|2|||
163492725|NCT00157820|590504493|FG001|Randomized|Protocol Violation|1|||
163492726|NCT00157820|590504494|FG002|Randomized|Protocol Violation|2|||
163492727|NCT00157820|590504492|FG000|1st 8 Month|Death|7|||
163492728|NCT00157820|590504493|FG001|1st 8 Month|Death|8|||
163492729|NCT00157820|590504494|FG002|1st 8 Month|Death|3|||
163492730|NCT00157820|590504492|FG000|1st 8 Month|Lost to Follow-up|1|||
163492731|NCT00157820|590504493|FG001|1st 8 Month|Lost to Follow-up|2|||
163492732|NCT00157820|590504494|FG002|1st 8 Month|Lost to Follow-up|1|||
163492733|NCT00157820|590504492|FG000|1st 8 Month|Premature cross-over|0|||
163492734|NCT00157820|590504493|FG001|1st 8 Month|Premature cross-over|2|||
163492735|NCT00157820|590504494|FG002|1st 8 Month|Premature cross-over|2|||
163492736|NCT00157820|590504492|FG000|2nd 8 Months|Death|3|||
163492737|NCT00157820|590504493|FG001|2nd 8 Months|Death|1|||
163492738|NCT00157820|590504494|FG002|2nd 8 Months|Death|3|||
163492739|NCT00157820|590504492|FG000|2nd 8 Months|Lost to Follow-up|1|||
163492740|NCT00157820|590504493|FG001|2nd 8 Months|Lost to Follow-up|5|||
163492741|NCT00157820|590504494|FG002|2nd 8 Months|Lost to Follow-up|2|||
163492742|NCT00157820|590504492|FG000|2nd 8 Months|Premature cross-over|1|||
163492743|NCT00157820|590504493|FG001|2nd 8 Months|Premature cross-over|7|||
163492744|NCT00157820|590504494|FG002|2nd 8 Months|Premature cross-over|9|||
163492745|NCT01676818|590504495|FG000|Overall Study|Physician Decision|1|||
163492746|NCT01676818|590504495|FG000|Overall Study|Withdrawal by Subject|1|||
163492747|NCT02207413|590504503|FG000|Overall Study|Withdrawal by Subject|1|||
163492748|NCT02207413|590504504|FG001|Overall Study|Withdrawal by Subject|0|||
163492749|NCT02207413|590504505|FG002|Overall Study|Withdrawal by Subject|0|||
163492750|NCT02207413|590504506|FG003|Overall Study|Withdrawal by Subject|0|||
163492751|NCT02207413|590504507|FG004|Overall Study|Withdrawal by Subject|3|||
163492752|NCT02207413|590504508|FG005|Overall Study|Withdrawal by Subject|7|||
163492753|NCT02207413|590504503|FG000|Overall Study|Lost to Follow-up|0|||
163492754|NCT02207413|590504504|FG001|Overall Study|Lost to Follow-up|0|||
163492755|NCT02207413|590504505|FG002|Overall Study|Lost to Follow-up|0|||
163492756|NCT02207413|590504506|FG003|Overall Study|Lost to Follow-up|1|||
163492757|NCT02207413|590504507|FG004|Overall Study|Lost to Follow-up|1|||
163492758|NCT02207413|590504508|FG005|Overall Study|Lost to Follow-up|5|||
163492759|NCT02207413|590504503|FG000|Overall Study|Adverse Event|0|||
163492760|NCT02207413|590504504|FG001|Overall Study|Adverse Event|0|||
163492761|NCT02207413|590504505|FG002|Overall Study|Adverse Event|0|||
163492762|NCT02207413|590504506|FG003|Overall Study|Adverse Event|0|||
163492763|NCT02207413|590504507|FG004|Overall Study|Adverse Event|2|||
163492764|NCT02207413|590504508|FG005|Overall Study|Adverse Event|1|||
163492765|NCT02207413|590504503|FG000|Overall Study|Migrated/moved from study area|0|||
163492766|NCT02207413|590504504|FG001|Overall Study|Migrated/moved from study area|0|||
163492767|NCT02207413|590504505|FG002|Overall Study|Migrated/moved from study area|0|||
163492768|NCT02207413|590504506|FG003|Overall Study|Migrated/moved from study area|0|||
163492769|NCT02207413|590504507|FG004|Overall Study|Migrated/moved from study area|1|||
163492770|NCT02207413|590504508|FG005|Overall Study|Migrated/moved from study area|0|||
163492771|NCT04075656|590504509|FG000|Overall Study|Withdrawal by Subject|5|||
163492772|NCT04075656|590504510|FG001|Overall Study|Withdrawal by Subject|5|||
163492773|NCT01519635|590506390|FG000|Overall Study|Withdrawal by Subject|0|||
163492774|NCT01519635|590506391|FG001|Overall Study|Withdrawal by Subject|1|||
163492775|NCT01519635|590506390|FG000|Overall Study|No possibility to put a catheter|1|||
163492776|NCT01519635|590506391|FG001|Overall Study|No possibility to put a catheter|2|||
163492777|NCT00347776|590506392|FG000|1.5 Month Follow-up|Death|2|||
163492778|NCT00347776|590506393|FG001|1.5 Month Follow-up|Death|0|||
163492779|NCT00347776|590506394|FG002|1.5 Month Follow-up|Death|0|||
163492780|NCT00347776|590506392|FG000|1.5 Month Follow-up|reached the endpoint|12|||
163492781|NCT00347776|590506393|FG001|1.5 Month Follow-up|reached the endpoint|8|||
163492782|NCT00347776|590506394|FG002|1.5 Month Follow-up|reached the endpoint|12|||
163492783|NCT00347776|590506392|FG000|6 Month Follow-up|Death|2|||
163492784|NCT00347776|590506393|FG001|6 Month Follow-up|Death|1|||
163492785|NCT00347776|590506394|FG002|6 Month Follow-up|Death|3|||
163492786|NCT00347776|590506392|FG000|6 Month Follow-up|reached endpont|20|||
163492787|NCT00347776|590506393|FG001|6 Month Follow-up|reached endpont|12|||
163492788|NCT00347776|590506394|FG002|6 Month Follow-up|reached endpont|15|||
163492789|NCT00347776|590506392|FG000|12 Month Follow-up|Lost to Follow-up|7|||
163492790|NCT00347776|590506393|FG001|12 Month Follow-up|Lost to Follow-up|6|||
163492791|NCT00347776|590506394|FG002|12 Month Follow-up|Lost to Follow-up|6|||
163492792|NCT00347776|590506392|FG000|12 Month Follow-up|Death|3|||
163492793|NCT00347776|590506393|FG001|12 Month Follow-up|Death|4|||
163492794|NCT00347776|590506394|FG002|12 Month Follow-up|Death|4|||
163492795|NCT00347776|590506392|FG000|12 Month Follow-up|Reached endpoint|13|||
163492796|NCT00347776|590506393|FG001|12 Month Follow-up|Reached endpoint|6|||
163492797|NCT00347776|590506394|FG002|12 Month Follow-up|Reached endpoint|9|||
163492798|NCT00968539|590506395|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
163492799|NCT00968539|590506396|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
163492800|NCT02074982|590506397|FG000|Overall Study|Adverse Event|15|||
163492801|NCT02074982|590506398|FG001|Overall Study|Adverse Event|7|||
163492802|NCT02074982|590506397|FG000|Overall Study|Lack of Efficacy|6|||
163492803|NCT02074982|590506398|FG001|Overall Study|Lack of Efficacy|1|||
163492804|NCT02074982|590506397|FG000|Overall Study|Lost to Follow-up|9|||
163492805|NCT02074982|590506398|FG001|Overall Study|Lost to Follow-up|10|||
163492806|NCT02074982|590506397|FG000|Overall Study|Non-compliance with study treatment|0|||
163492807|NCT02074982|590506398|FG001|Overall Study|Non-compliance with study treatment|2|||
163492808|NCT02074982|590506397|FG000|Overall Study|Physician Decision|1|||
163492809|NCT02074982|590506398|FG001|Overall Study|Physician Decision|1|||
163492810|NCT02074982|590506397|FG000|Overall Study|Pregnancy|1|||
163492811|NCT02074982|590506398|FG001|Overall Study|Pregnancy|2|||
163492812|NCT02074982|590506397|FG000|Overall Study|Protocol deviation|4|||
163492813|NCT02074982|590506398|FG001|Overall Study|Protocol deviation|3|||
163492814|NCT02074982|590506397|FG000|Overall Study|Technical problems|0|||
163492815|NCT02074982|590506398|FG001|Overall Study|Technical problems|2|||
163492816|NCT02074982|590506397|FG000|Overall Study|Subject/guardian decision|15|||
163492817|NCT02074982|590506398|FG001|Overall Study|Subject/guardian decision|24|||
163492818|NCT02074982|590506397|FG000|Overall Study|Death|0|||
163492819|NCT02074982|590506398|FG001|Overall Study|Death|2|||
163492820|NCT02525627|590506403|FG000|Overall Study|Revision|1|||
163492821|NCT02525627|590506404|FG001|Overall Study|Revision|1|||
163492822|NCT02525627|590506403|FG000|Overall Study|Withdrawal by Subject|1|||
163492823|NCT02525627|590506404|FG001|Overall Study|Withdrawal by Subject|2|||
163492824|NCT02525627|590506403|FG000|Overall Study|Death|1|||
163492825|NCT02525627|590506404|FG001|Overall Study|Death|0|||
163492826|NCT02525627|590506403|FG000|Overall Study|Site terminated|11|||
163492827|NCT02525627|590506404|FG001|Overall Study|Site terminated|10|||
163492828|NCT01160770|590506405|FG000|Overall Study|Adverse Event|10|||
163492829|NCT01160770|590506405|FG000|Overall Study|Protocol Violation|2|||
163492830|NCT01160770|590506405|FG000|Overall Study|Subject/parent/caregiver request|33|||
163492831|NCT01160770|590506405|FG000|Overall Study|Physician Decision|1|||
163492832|NCT01160770|590506405|FG000|Overall Study|Lost to Follow-up|7|||
163492833|NCT01160770|590506405|FG000|Overall Study|Study termination or sponsor request|1|||
163492834|NCT01160770|590506405|FG000|Overall Study|Death|9|||
163492835|NCT01160770|590506405|FG000|Overall Study|Lack of Efficacy|15|||
163492836|NCT01160770|590506405|FG000|Overall Study|Other Reasons|1|||
163492837|NCT00242567|590506406|FG000|Overall Study|Adverse Event|70|||
163492838|NCT00242567|590506407|FG001|Overall Study|Adverse Event|43|||
163492839|NCT00242567|590506406|FG000|Overall Study|Disease Progression|17|||
163492840|NCT00242567|590506407|FG001|Overall Study|Disease Progression|22|||
163492841|NCT00242567|590506406|FG000|Overall Study|Symptomatic deterioration|9|||
163492842|NCT00242567|590506407|FG001|Overall Study|Symptomatic deterioration|3|||
163492843|NCT00242567|590506406|FG000|Overall Study|Lack of Efficacy|2|||
163492844|NCT00242567|590506407|FG001|Overall Study|Lack of Efficacy|2|||
163492845|NCT00242567|590506406|FG000|Overall Study|Lost to Follow-up|9|||
163492846|NCT00242567|590506407|FG001|Overall Study|Lost to Follow-up|19|||
163492847|NCT00242567|590506406|FG000|Overall Study|Withdrawal by Subject|33|||
163492848|NCT00242567|590506407|FG001|Overall Study|Withdrawal by Subject|28|||
163492849|NCT00242567|590506406|FG000|Overall Study|Protocol Violation|12|||
163492850|NCT00242567|590506407|FG001|Overall Study|Protocol Violation|12|||
163492851|NCT00242567|590506406|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
163492852|NCT00242567|590506407|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
163492853|NCT00242567|590506406|FG000|Overall Study|Other|14|||
163492854|NCT00242567|590506407|FG001|Overall Study|Other|9|||
163492855|NCT02116309|590506422|FG000|Overall Study|Lost to Follow-up|0|||
163492856|NCT02116309|590506423|FG001|Overall Study|Lost to Follow-up|1|||
163492857|NCT03292731|590506424|FG000|Overall Study|Protocol Violation|4|||
163492858|NCT03292731|590506425|FG001|Overall Study|Protocol Violation|11|||
163492859|NCT03292731|590506426|FG002|Overall Study|Protocol Violation|1|||
163492860|NCT00471237|590506427|FG000|Overall Study|Adverse Event|6|||
163492861|NCT00471237|590506428|FG001|Overall Study|Adverse Event|5|||
163492862|NCT00471237|590506429|FG002|Overall Study|Adverse Event|4|||
163492863|NCT00471237|590506430|FG003|Overall Study|Adverse Event|8|||
163492864|NCT00471237|590506431|FG004|Overall Study|Adverse Event|7|||
163492865|NCT00471237|590506432|FG005|Overall Study|Adverse Event|5|||
163492866|NCT00471237|590506433|FG006|Overall Study|Adverse Event|0|||
163492867|NCT00471237|590506427|FG000|Overall Study|Lost to Follow-up|1|||
163492868|NCT00471237|590506428|FG001|Overall Study|Lost to Follow-up|1|||
163492869|NCT00471237|590506429|FG002|Overall Study|Lost to Follow-up|0|||
163492870|NCT00471237|590506430|FG003|Overall Study|Lost to Follow-up|2|||
163492871|NCT00471237|590506431|FG004|Overall Study|Lost to Follow-up|3|||
163492872|NCT00471237|590506432|FG005|Overall Study|Lost to Follow-up|0|||
163492873|NCT00471237|590506433|FG006|Overall Study|Lost to Follow-up|0|||
163492874|NCT00471237|590506427|FG000|Overall Study|Protocol Violation|3|||
163492875|NCT00471237|590506428|FG001|Overall Study|Protocol Violation|6|||
163492876|NCT00471237|590506429|FG002|Overall Study|Protocol Violation|3|||
163492877|NCT00471237|590506430|FG003|Overall Study|Protocol Violation|2|||
163492878|NCT00471237|590506431|FG004|Overall Study|Protocol Violation|2|||
163492879|NCT00471237|590506432|FG005|Overall Study|Protocol Violation|4|||
163492880|NCT00471237|590506433|FG006|Overall Study|Protocol Violation|1|||
163492881|NCT00471237|590506427|FG000|Overall Study|Withdrawal by Subject|8|||
163492882|NCT00471237|590506428|FG001|Overall Study|Withdrawal by Subject|6|||
163492883|NCT00471237|590506429|FG002|Overall Study|Withdrawal by Subject|5|||
163492884|NCT00471237|590506430|FG003|Overall Study|Withdrawal by Subject|8|||
163492885|NCT00471237|590506431|FG004|Overall Study|Withdrawal by Subject|7|||
163492886|NCT00471237|590506432|FG005|Overall Study|Withdrawal by Subject|4|||
163492887|NCT00471237|590506433|FG006|Overall Study|Withdrawal by Subject|2|||
163492888|NCT00471237|590506427|FG000|Overall Study|Sponsor terminated study|20|||
163492889|NCT00471237|590506428|FG001|Overall Study|Sponsor terminated study|23|||
163492890|NCT00471237|590506429|FG002|Overall Study|Sponsor terminated study|19|||
163492891|NCT00471237|590506430|FG003|Overall Study|Sponsor terminated study|22|||
163492892|NCT00471237|590506431|FG004|Overall Study|Sponsor terminated study|18|||
163492893|NCT00471237|590506432|FG005|Overall Study|Sponsor terminated study|24|||
163492894|NCT00471237|590506433|FG006|Overall Study|Sponsor terminated study|0|||
163492895|NCT00471237|590506427|FG000|Overall Study|Non-compliance|0|||
163492896|NCT00471237|590506428|FG001|Overall Study|Non-compliance|1|||
163492897|NCT00471237|590506429|FG002|Overall Study|Non-compliance|0|||
163492898|NCT00471237|590506430|FG003|Overall Study|Non-compliance|1|||
163492899|NCT00471237|590506431|FG004|Overall Study|Non-compliance|0|||
163492900|NCT00471237|590506432|FG005|Overall Study|Non-compliance|0|||
163492901|NCT00471237|590506433|FG006|Overall Study|Non-compliance|0|||
163492902|NCT00471237|590506427|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
163492903|NCT00471237|590506428|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
163492904|NCT00471237|590506429|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
163492905|NCT00471237|590506430|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
163492906|NCT00471237|590506431|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
163492907|NCT00471237|590506432|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
163492908|NCT00471237|590506433|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
163492909|NCT00471237|590506427|FG000|Overall Study|Early stopping due to non-efficacy|1|||
163492910|NCT00471237|590506428|FG001|Overall Study|Early stopping due to non-efficacy|0|||
163492911|NCT00471237|590506429|FG002|Overall Study|Early stopping due to non-efficacy|0|||
163492912|NCT00471237|590506430|FG003|Overall Study|Early stopping due to non-efficacy|0|||
163492913|NCT00471237|590506431|FG004|Overall Study|Early stopping due to non-efficacy|1|||
163492914|NCT00471237|590506432|FG005|Overall Study|Early stopping due to non-efficacy|0|||
163492915|NCT00471237|590506433|FG006|Overall Study|Early stopping due to non-efficacy|0|||
163492916|NCT00471237|590506427|FG000|Overall Study|Participant planned to travel to abraod|1|||
163492917|NCT00471237|590506428|FG001|Overall Study|Participant planned to travel to abraod|0|||
163492918|NCT00471237|590506429|FG002|Overall Study|Participant planned to travel to abraod|0|||
163492919|NCT00471237|590506430|FG003|Overall Study|Participant planned to travel to abraod|0|||
163492920|NCT00471237|590506431|FG004|Overall Study|Participant planned to travel to abraod|0|||
163492921|NCT00471237|590506432|FG005|Overall Study|Participant planned to travel to abraod|1|||
163492922|NCT00471237|590506433|FG006|Overall Study|Participant planned to travel to abraod|0|||
163492923|NCT00471237|590506427|FG000|Overall Study|High parathyroid hormone|0|||
163492924|NCT00471237|590506428|FG001|Overall Study|High parathyroid hormone|0|||
163492925|NCT00471237|590506429|FG002|Overall Study|High parathyroid hormone|1|||
163492926|NCT00471237|590506430|FG003|Overall Study|High parathyroid hormone|0|||
163492927|NCT00471237|590506431|FG004|Overall Study|High parathyroid hormone|0|||
163384953|NCT05330312|590119269|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
163384954|NCT05330312|590119270|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
163384955|NCT05330312|590119271|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
163384956|NCT05330312|590119269|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
163384957|NCT05330312|590119270|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
163384958|NCT05330312|590119271|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
163384959|NCT05330312|590119269|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
163384960|NCT05330312|590119270|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
163384961|NCT05330312|590119271|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
163384962|NCT05330312|590119269|FG000|Pivotal Investigation - Part 2|Death|1|||
163384963|NCT05330312|590119270|FG001|Pivotal Investigation - Part 2|Death|4|||
163384964|NCT05330312|590119271|FG002|Pivotal Investigation - Part 2|Death|0|||
163384965|NCT03534284|590119272|FG000|Overall Study|Death|2|||
163384966|NCT03534284|590119273|FG001|Overall Study|Death|3|||
163384967|NCT03534284|590119274|FG002|Overall Study|Death|3|||
163384968|NCT03534284|590119272|FG000|Overall Study|Withdrawal by Subject|5|||
163384969|NCT03534284|590119273|FG001|Overall Study|Withdrawal by Subject|0|||
163384970|NCT03534284|590119274|FG002|Overall Study|Withdrawal by Subject|0|||
163384971|NCT03316300|590119275|FG000|Overall Study|Withdrawal by Subject|3|||
163384972|NCT03316300|590119276|FG001|Overall Study|Withdrawal by Subject|2|||
163384973|NCT03316300|590119275|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
163384974|NCT03316300|590119276|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
163384975|NCT03316300|590119275|FG000|Overall Study|Adverse Event|1|||
163384976|NCT03316300|590119276|FG001|Overall Study|Adverse Event|0|||
163384977|NCT03316300|590119275|FG000|Overall Study|COVID-19|0|||
163384978|NCT03316300|590119276|FG001|Overall Study|COVID-19|1|||
163492928|NCT00471237|590506432|FG005|Overall Study|High parathyroid hormone|0|||
163492929|NCT00471237|590506433|FG006|Overall Study|High parathyroid hormone|0|||
163492930|NCT00471237|590506427|FG000|Overall Study|Participant lost medication|0|||
163492931|NCT00471237|590506428|FG001|Overall Study|Participant lost medication|0|||
163492932|NCT00471237|590506429|FG002|Overall Study|Participant lost medication|0|||
163492933|NCT00471237|590506430|FG003|Overall Study|Participant lost medication|0|||
163492934|NCT00471237|590506431|FG004|Overall Study|Participant lost medication|1|||
163492935|NCT00471237|590506432|FG005|Overall Study|Participant lost medication|0|||
163492936|NCT00471237|590506433|FG006|Overall Study|Participant lost medication|0|||
163492937|NCT00471237|590506427|FG000|Overall Study|Administration of prohibited medicine|0|||
163492938|NCT00471237|590506428|FG001|Overall Study|Administration of prohibited medicine|0|||
163492939|NCT00471237|590506429|FG002|Overall Study|Administration of prohibited medicine|0|||
163492940|NCT00471237|590506430|FG003|Overall Study|Administration of prohibited medicine|0|||
163492941|NCT00471237|590506431|FG004|Overall Study|Administration of prohibited medicine|1|||
163492942|NCT00471237|590506432|FG005|Overall Study|Administration of prohibited medicine|0|||
163492943|NCT00471237|590506433|FG006|Overall Study|Administration of prohibited medicine|0|||
163492944|NCT00471237|590506427|FG000|Overall Study|Participant shifted residence|0|||
163492945|NCT00471237|590506428|FG001|Overall Study|Participant shifted residence|0|||
163492946|NCT00471237|590506429|FG002|Overall Study|Participant shifted residence|0|||
163492947|NCT00471237|590506430|FG003|Overall Study|Participant shifted residence|0|||
163492948|NCT00471237|590506431|FG004|Overall Study|Participant shifted residence|1|||
163492949|NCT00471237|590506432|FG005|Overall Study|Participant shifted residence|0|||
163492950|NCT00471237|590506433|FG006|Overall Study|Participant shifted residence|0|||
163492951|NCT00471237|590506427|FG000|Overall Study|Participant's decision|0|||
163492952|NCT00471237|590506428|FG001|Overall Study|Participant's decision|0|||
163492953|NCT00471237|590506429|FG002|Overall Study|Participant's decision|0|||
163492954|NCT00471237|590506430|FG003|Overall Study|Participant's decision|0|||
163492955|NCT00471237|590506431|FG004|Overall Study|Participant's decision|0|||
163492956|NCT00471237|590506432|FG005|Overall Study|Participant's decision|1|||
163492957|NCT00471237|590506433|FG006|Overall Study|Participant's decision|0|||
163492958|NCT00848965|590506434|FG000|Overall Study|Adverse Event|1|||
163492959|NCT00848965|590506434|FG000|Overall Study|Withdrawal by Subject|1|||
163492960|NCT00348348|590506435|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
163492961|NCT00348348|590506436|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
163492962|NCT00348348|590506435|FG000|Overall Study|Lack of Efficacy|1|||
163492963|NCT00348348|590506436|FG001|Overall Study|Lack of Efficacy|1|||
163492964|NCT00348348|590506435|FG000|Overall Study|Lost to Follow-up|8|||
163492965|NCT00348348|590506436|FG001|Overall Study|Lost to Follow-up|10|||
163492966|NCT00348348|590506435|FG000|Overall Study|Withdrawal by Subject|4|||
163492967|NCT00348348|590506436|FG001|Overall Study|Withdrawal by Subject|1|||
163492968|NCT00348348|590506435|FG000|Overall Study|Other|7|||
163492969|NCT00348348|590506436|FG001|Overall Study|Other|4|||
163492970|NCT00348348|590506435|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
163492971|NCT00348348|590506436|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
163492972|NCT00348348|590506435|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
163492973|NCT00348348|590506436|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
163492974|NCT00348348|590506435|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
163492975|NCT00348348|590506436|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
163492976|NCT00348348|590506435|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
163492977|NCT00348348|590506436|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
163492978|NCT00348348|590506435|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
163492979|NCT00348348|590506436|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
163492980|NCT00348348|590506435|FG000|Overall Study|Adverse event probably related to study|1|||
163492981|NCT00348348|590506436|FG001|Overall Study|Adverse event probably related to study|0|||
163492982|NCT03710824|590506437|FG000|Overall Study|Withdrawal by Subject|1|||
163492983|NCT03710824|590506437|FG000|Overall Study|Lost to Follow-up|3|||
163492984|NCT03710824|590506437|FG000|Overall Study|Adverse Event|25|||
163492985|NCT03710824|590506437|FG000|Overall Study|Treatment discontinuation|2|||
163492986|NCT01301625|590506447|FG000|Overall Study|Death|5|||
163492987|NCT01301625|590506447|FG000|Overall Study|Not Due|21|||
163492988|NCT01301625|590506447|FG000|Overall Study|Expected|8|||
163492989|NCT01301625|590506447|FG000|Overall Study|Lost to Follow-up|1|||
163492990|NCT05102162|590506453|FG000|Overall Study|Withdrawal by Subject|3|||
163492991|NCT05102162|590506454|FG001|Overall Study|Withdrawal by Subject|0|||
163492992|NCT05102162|590506453|FG000|Overall Study|Baseline cultures negative|4|||
163492993|NCT05102162|590506454|FG001|Overall Study|Baseline cultures negative|2|||
163492994|NCT05102162|590506453|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
163492995|NCT05102162|590506454|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
163492996|NCT05102162|590506453|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
163492997|NCT05102162|590506454|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
163492998|NCT02181673|590506457|FG000|Up to Week 24|Adverse Event|2|||
163492999|NCT02181673|590506458|FG001|Up to Week 24|Adverse Event|0|||
163493000|NCT02181673|590506459|FG002|Up to Week 24|Adverse Event|3|||
163493001|NCT02181673|590506457|FG000|Up to Week 24|Death|1|||
163493002|NCT02181673|590506458|FG001|Up to Week 24|Death|0|||
163493003|NCT02181673|590506459|FG002|Up to Week 24|Death|0|||
163493004|NCT02181673|590506457|FG000|Up to Week 24|Lack of Efficacy|1|||
163493005|NCT02181673|590506458|FG001|Up to Week 24|Lack of Efficacy|0|||
163493006|NCT02181673|590506459|FG002|Up to Week 24|Lack of Efficacy|0|||
163493007|NCT02181673|590506457|FG000|Up to Week 24|Lost to Follow-up|1|||
163493008|NCT02181673|590506458|FG001|Up to Week 24|Lost to Follow-up|0|||
163493009|NCT02181673|590506459|FG002|Up to Week 24|Lost to Follow-up|0|||
163493010|NCT02181673|590506457|FG000|Up to Week 24|Physician Decision|0|||
163493011|NCT02181673|590506458|FG001|Up to Week 24|Physician Decision|0|||
163493012|NCT02181673|590506459|FG002|Up to Week 24|Physician Decision|3|||
163493013|NCT02181673|590506457|FG000|Up to Week 24|Withdrawal by Subject|10|||
163493014|NCT02181673|590506458|FG001|Up to Week 24|Withdrawal by Subject|0|||
163493015|NCT02181673|590506459|FG002|Up to Week 24|Withdrawal by Subject|1|||
163493016|NCT02181673|590506457|FG000|Up to Week 24|Other|2|||
163493017|NCT02181673|590506458|FG001|Up to Week 24|Other|0|||
163493018|NCT02181673|590506459|FG002|Up to Week 24|Other|3|||
163493019|NCT02181673|590506457|FG000|Up to Week 24|Randomized not Treated|0|||
163493020|NCT02181673|590506458|FG001|Up to Week 24|Randomized not Treated|0|||
163493021|NCT02181673|590506459|FG002|Up to Week 24|Randomized not Treated|1|||
163493022|NCT02181673|590506457|FG000|Week 24-Week 60|Adverse Event|0|||
163493023|NCT02181673|590506458|FG001|Week 24-Week 60|Adverse Event|4|||
163493024|NCT02181673|590506459|FG002|Week 24-Week 60|Adverse Event|10|||
163493025|NCT02181673|590506457|FG000|Week 24-Week 60|Other|0|||
163493026|NCT02181673|590506458|FG001|Week 24-Week 60|Other|2|||
163493027|NCT02181673|590506459|FG002|Week 24-Week 60|Other|1|||
163493028|NCT02181673|590506457|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
163493029|NCT02181673|590506458|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
163493030|NCT02181673|590506459|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
163493031|NCT02181673|590506457|FG000|Week 24-Week 60|Pregnancy|0|||
163493032|NCT02181673|590506458|FG001|Week 24-Week 60|Pregnancy|0|||
163493033|NCT02181673|590506459|FG002|Week 24-Week 60|Pregnancy|1|||
163493034|NCT02181673|590506457|FG000|Week 24-Week 60|Lack of Efficacy|0|||
163493035|NCT02181673|590506458|FG001|Week 24-Week 60|Lack of Efficacy|0|||
163493036|NCT02181673|590506459|FG002|Week 24-Week 60|Lack of Efficacy|1|||
163493037|NCT02181673|590506457|FG000|Week 24-Week 60|Lost to Follow-up|0|||
163493038|NCT02181673|590506458|FG001|Week 24-Week 60|Lost to Follow-up|0|||
163493039|NCT02181673|590506459|FG002|Week 24-Week 60|Lost to Follow-up|1|||
163493040|NCT02181673|590506457|FG000|Week 24-Week 60|Physician Decision|0|||
163493041|NCT02181673|590506458|FG001|Week 24-Week 60|Physician Decision|0|||
163493042|NCT02181673|590506459|FG002|Week 24-Week 60|Physician Decision|1|||
163493043|NCT00433771|590506460|FG000|Overall Study|screen fail|14|||
163493044|NCT00433771|590506460|FG000|Overall Study|Treated and later found to be ineligible|2|||
163493045|NCT00433771|590506460|FG000|Overall Study|Death|2|||
163493046|NCT00433771|590506460|FG000|Overall Study|Failure to deploy stent|1|||
163493047|NCT00138658|590506461|FG000|Overall Study|Adverse Event|23|||
163493048|NCT00138658|590506461|FG000|Overall Study|Death|1|||
163493049|NCT00138658|590506461|FG000|Overall Study|Disease Progression|21|||
163493050|NCT00138658|590506461|FG000|Overall Study|Physician Decision|11|||
163493051|NCT00138658|590506461|FG000|Overall Study|Withdrawal by Subject|5|||
163493052|NCT00491322|590506467|FG000|Overall Study|Protocol Violation|1|||
163493053|NCT00491322|590506468|FG001|Overall Study|Protocol Violation|0|||
163493054|NCT00491322|590506467|FG000|Overall Study|Pregnancy|0|||
163493055|NCT00491322|590506468|FG001|Overall Study|Pregnancy|1|||
163493056|NCT06067191|590506472|FG000|Overall Study|Withdrawal by Subject|0|||
163493057|NCT06067191|590506473|FG001|Overall Study|Withdrawal by Subject|1|||
163493058|NCT00890409|590506476|FG000|Overall Study|Lost to Follow-up|20|||
163493059|NCT00890409|590506477|FG001|Overall Study|Lost to Follow-up|21|||
163493060|NCT01870921|590506480|FG000|Overall Study|Subject decision|80|||
163493061|NCT01870921|590506480|FG000|Overall Study|Severe non-compliance to protocol|7|||
163493062|NCT01870921|590506480|FG000|Overall Study|Subject Lost to Follow up|2|||
163493063|NCT01870921|590506480|FG000|Overall Study|Other|1|||
163493064|NCT00806416|590506481|FG000|Period 1 - Part I|Adverse Event|0|||
163493065|NCT00806416|590506482|FG001|Period 1 - Part I|Adverse Event|1|||
163493066|NCT00806416|590506483|FG002|Period 1 - Part I|Adverse Event|0|||
163493067|NCT00806416|590506484|FG003|Period 1 - Part I|Adverse Event|0|||
163493068|NCT00806416|590506481|FG000|Period 1 - Part I|Lost to Follow-up|0|||
163493069|NCT00806416|590506482|FG001|Period 1 - Part I|Lost to Follow-up|2|||
163493070|NCT00806416|590506483|FG002|Period 1 - Part I|Lost to Follow-up|0|||
163493071|NCT00806416|590506484|FG003|Period 1 - Part I|Lost to Follow-up|0|||
163493072|NCT00806416|590506481|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
163493073|NCT00806416|590506482|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
163493074|NCT00806416|590506483|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
163493075|NCT00806416|590506484|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
163493076|NCT00806416|590506481|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
163493077|NCT00806416|590506482|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
163493078|NCT00806416|590506483|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
163493079|NCT00806416|590506484|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
163493080|NCT01102972|590506490|FG000|Overall Study|Adverse Event|8|||
163493081|NCT01102972|590506491|FG001|Overall Study|Adverse Event|2|||
163493082|NCT01102972|590506490|FG000|Overall Study|Lack of Efficacy|2|||
163493083|NCT01102972|590506491|FG001|Overall Study|Lack of Efficacy|1|||
163493084|NCT01102972|590506490|FG000|Overall Study|Protocol Violation|1|||
163493085|NCT01102972|590506491|FG001|Overall Study|Protocol Violation|0|||
163493086|NCT01102972|590506490|FG000|Overall Study|Lost to Follow-up|10|||
163493087|NCT01102972|590506491|FG001|Overall Study|Lost to Follow-up|5|||
163493088|NCT01102972|590506490|FG000|Overall Study|Investigator Discretion|2|||
163493089|NCT01102972|590506491|FG001|Overall Study|Investigator Discretion|0|||
163493090|NCT01102972|590506490|FG000|Overall Study|Withdrawal by Subject|6|||
163493091|NCT01102972|590506491|FG001|Overall Study|Withdrawal by Subject|6|||
163493092|NCT03664024|590506495|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
163493093|NCT03664024|590506495|FG000|Overall Study|Lost to Follow-up|2|||
163493094|NCT03664024|590506495|FG000|Overall Study|Withdrawal by Subject|2|||
163493095|NCT03664024|590506495|FG000|Overall Study|Death|80|||
163493096|NCT01157065|590506496|FG000|Overall Study|Death|0|||
163493097|NCT01157065|590506497|FG001|Overall Study|Death|1|||
163493098|NCT03426995|590506500|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493099|NCT03426995|590506501|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493100|NCT03426995|590506502|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
163493101|NCT03426995|590506503|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493102|NCT03426995|590506504|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493103|NCT03426995|590506505|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493104|NCT03426995|590506506|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493105|NCT03426995|590506507|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493106|NCT03426995|590506508|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493107|NCT03426995|590506509|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493108|NCT03426995|590506510|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493109|NCT03426995|590506511|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493110|NCT03426995|590506512|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493111|NCT03426995|590506513|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493112|NCT03426995|590506514|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493113|NCT03426995|590506515|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493114|NCT03426995|590506516|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493115|NCT03426995|590506517|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493116|NCT03426995|590506518|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
163493117|NCT03426995|590506500|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493118|NCT03426995|590506501|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493119|NCT03426995|590506502|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493120|NCT03426995|590506503|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493121|NCT03426995|590506504|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493122|NCT03426995|590506505|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
163493123|NCT03426995|590506506|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493124|NCT03426995|590506507|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493125|NCT03426995|590506508|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493126|NCT03426995|590506509|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493127|NCT03426995|590506510|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493128|NCT03426995|590506511|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493129|NCT03426995|590506512|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493130|NCT03426995|590506513|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493131|NCT03426995|590506514|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493132|NCT03426995|590506515|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493133|NCT03426995|590506516|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493134|NCT03426995|590506517|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493135|NCT03426995|590506518|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
163493136|NCT03426995|590506500|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493137|NCT03426995|590506501|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493138|NCT03426995|590506502|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493139|NCT03426995|590506503|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493140|NCT03426995|590506504|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
163493141|NCT03426995|590506505|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
163493142|NCT03426995|590506506|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493143|NCT03426995|590506507|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493144|NCT03426995|590506508|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493145|NCT03426995|590506509|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493146|NCT03426995|590506510|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493147|NCT03426995|590506511|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493148|NCT03426995|590506512|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493149|NCT03426995|590506513|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493150|NCT03426995|590506514|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493151|NCT03426995|590506515|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493152|NCT03426995|590506516|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493153|NCT03426995|590506517|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493154|NCT03426995|590506518|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
163493155|NCT03426995|590506500|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493156|NCT03426995|590506501|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493157|NCT03426995|590506502|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493158|NCT03426995|590506503|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493159|NCT03426995|590506504|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493160|NCT03426995|590506505|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493161|NCT03426995|590506506|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493162|NCT03426995|590506507|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493163|NCT03426995|590506508|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493164|NCT03426995|590506509|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493165|NCT03426995|590506510|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
163493166|NCT03426995|590506511|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493167|NCT03426995|590506512|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493168|NCT03426995|590506513|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493169|NCT03426995|590506514|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493170|NCT03426995|590506515|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493171|NCT03426995|590506516|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493172|NCT03426995|590506517|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493173|NCT03426995|590506518|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
163493174|NCT03426995|590506500|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493175|NCT03426995|590506501|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493176|NCT03426995|590506502|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493177|NCT03426995|590506503|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493178|NCT03426995|590506504|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493179|NCT03426995|590506505|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493180|NCT03426995|590506506|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493181|NCT03426995|590506507|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
163493182|NCT03426995|590506508|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493183|NCT03426995|590506509|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493184|NCT03426995|590506510|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493185|NCT03426995|590506511|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493186|NCT03426995|590506512|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493187|NCT03426995|590506513|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493188|NCT03426995|590506514|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493189|NCT03426995|590506515|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493190|NCT03426995|590506516|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493191|NCT03426995|590506517|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493192|NCT03426995|590506518|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
163493193|NCT03426995|590506500|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493194|NCT03426995|590506501|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493195|NCT03426995|590506502|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493196|NCT03426995|590506503|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493197|NCT03426995|590506504|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493198|NCT03426995|590506505|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163384979|NCT03164564|590119278|FG000|Overall Study|Death|3|||
163384980|NCT03164564|590119279|FG001|Overall Study|Death|0|||
163384981|NCT03164564|590119278|FG000|Overall Study|Withdrawal by Subject|20|||
163384982|NCT03164564|590119279|FG001|Overall Study|Withdrawal by Subject|15|||
163384983|NCT03164564|590119278|FG000|Overall Study|Lost to Follow-up|2|||
163384984|NCT03164564|590119279|FG001|Overall Study|Lost to Follow-up|0|||
163384985|NCT03164564|590119278|FG000|Overall Study|Physician Decision|0|||
163384986|NCT03164564|590119279|FG001|Overall Study|Physician Decision|1|||
163384987|NCT03164564|590119278|FG000|Overall Study|Adverse Event|0|||
163384988|NCT03164564|590119279|FG001|Overall Study|Adverse Event|1|||
163384989|NCT03164564|590119278|FG000|Overall Study|Ongoing|1586|||
163384990|NCT03164564|590119279|FG001|Overall Study|Ongoing|1586|||
163384991|NCT04002401|590119280|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
163384992|NCT04002401|590119280|FG000|Overall Study|Death|10|||
163384993|NCT04002401|590119280|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
163384994|NCT04002401|590119280|FG000|Overall Study|Enrolled but Never Treated|1|||
163384995|NCT04002401|590119280|FG000|Overall Study|Lost to Follow-up|1|||
163384996|NCT00423930|590119281|FG000|Overall Study|Withdrawal by Subject|2|||
163493199|NCT03426995|590506506|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493200|NCT03426995|590506507|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493201|NCT03426995|590506508|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493202|NCT03426995|590506509|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493203|NCT03426995|590506510|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493204|NCT03426995|590506511|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493205|NCT03426995|590506512|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493206|NCT03426995|590506513|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493207|NCT03426995|590506514|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
163493208|NCT03426995|590506515|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
163493209|NCT03426995|590506516|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493210|NCT03426995|590506517|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493211|NCT03426995|590506518|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
163493212|NCT03426995|590506500|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493213|NCT03426995|590506501|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493214|NCT03426995|590506502|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493215|NCT03426995|590506503|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493216|NCT03426995|590506504|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493217|NCT03426995|590506505|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493218|NCT03426995|590506506|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493219|NCT03426995|590506507|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493220|NCT03426995|590506508|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493221|NCT03426995|590506509|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493222|NCT03426995|590506510|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493223|NCT03426995|590506511|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493224|NCT03426995|590506512|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493225|NCT03426995|590506513|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493226|NCT03426995|590506514|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
163493227|NCT03426995|590506515|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
163493228|NCT03426995|590506516|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493229|NCT03426995|590506517|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493230|NCT03426995|590506518|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
163493231|NCT01886105|590506519|FG000|Overall Study|Lack of Efficacy|3|||
163493232|NCT01360021|590506522|FG000|Overall Study|Eligibility criteria + other|2|||
163493233|NCT01360021|590506523|FG001|Overall Study|Eligibility criteria + other|1|||
163493234|NCT01360021|590506524|FG002|Overall Study|Eligibility criteria + other|1|||
163493235|NCT01360021|590506522|FG000|Overall Study|Protocol Violation|0|||
163493236|NCT01360021|590506523|FG001|Overall Study|Protocol Violation|0|||
163493237|NCT01360021|590506524|FG002|Overall Study|Protocol Violation|1|||
163493238|NCT01360021|590506522|FG000|Overall Study|Withdrawal by Subject|4|||
163493239|NCT01360021|590506523|FG001|Overall Study|Withdrawal by Subject|0|||
163493240|NCT01360021|590506524|FG002|Overall Study|Withdrawal by Subject|2|||
163493241|NCT01360021|590506522|FG000|Overall Study|Adverse Event|2|||
163493242|NCT01360021|590506523|FG001|Overall Study|Adverse Event|3|||
163493243|NCT01360021|590506524|FG002|Overall Study|Adverse Event|3|||
163493244|NCT03075826|590506527|FG000|Overall Study|Withdrawal by Subject|1|||
163493245|NCT03075826|590506527|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
163493246|NCT00650806|590506529|FG000|Overall Study|Adverse Event|0|||
163493247|NCT00650806|590506530|FG001|Overall Study|Adverse Event|5|||
163493248|NCT00650806|590506531|FG002|Overall Study|Adverse Event|3|||
163493249|NCT00650806|590506532|FG003|Overall Study|Adverse Event|4|||
163493250|NCT00650806|590506529|FG000|Overall Study|Lost to Follow-up|7|||
163493251|NCT00650806|590506530|FG001|Overall Study|Lost to Follow-up|6|||
163493252|NCT00650806|590506531|FG002|Overall Study|Lost to Follow-up|11|||
163493253|NCT00650806|590506532|FG003|Overall Study|Lost to Follow-up|10|||
163493254|NCT00650806|590506529|FG000|Overall Study|Protocol Violation|0|||
163493255|NCT00650806|590506530|FG001|Overall Study|Protocol Violation|0|||
163493256|NCT00650806|590506531|FG002|Overall Study|Protocol Violation|0|||
163493257|NCT00650806|590506532|FG003|Overall Study|Protocol Violation|1|||
163493258|NCT00650806|590506529|FG000|Overall Study|Pregnancy|0|||
163493259|NCT00650806|590506530|FG001|Overall Study|Pregnancy|0|||
163493260|NCT00650806|590506531|FG002|Overall Study|Pregnancy|0|||
163493261|NCT00650806|590506532|FG003|Overall Study|Pregnancy|1|||
163493262|NCT00650806|590506529|FG000|Overall Study|Withdrawal by Subject|7|||
163493263|NCT00650806|590506530|FG001|Overall Study|Withdrawal by Subject|5|||
163493264|NCT00650806|590506531|FG002|Overall Study|Withdrawal by Subject|8|||
163493265|NCT00650806|590506532|FG003|Overall Study|Withdrawal by Subject|6|||
163493266|NCT00650806|590506529|FG000|Overall Study|Noncompliance with study drug regimen|1|||
163493267|NCT00650806|590506530|FG001|Overall Study|Noncompliance with study drug regimen|1|||
163493268|NCT00650806|590506531|FG002|Overall Study|Noncompliance with study drug regimen|0|||
163493269|NCT00650806|590506532|FG003|Overall Study|Noncompliance with study drug regimen|0|||
163493270|NCT00650806|590506529|FG000|Overall Study|Study terminated by sponsor|2|||
163493271|NCT00650806|590506530|FG001|Overall Study|Study terminated by sponsor|3|||
163493272|NCT00650806|590506531|FG002|Overall Study|Study terminated by sponsor|5|||
163493273|NCT00650806|590506532|FG003|Overall Study|Study terminated by sponsor|4|||
163493274|NCT00650806|590506529|FG000|Overall Study|Other|1|||
163493275|NCT00650806|590506530|FG001|Overall Study|Other|1|||
163493276|NCT00650806|590506531|FG002|Overall Study|Other|2|||
163493277|NCT00650806|590506532|FG003|Overall Study|Other|0|||
163493278|NCT02242942|590506533|FG000|Overall Study|Death|17|||
163493279|NCT02242942|590506534|FG001|Overall Study|Death|20|||
163493280|NCT02242942|590506535|FG002|Overall Study|Death|2|||
163493281|NCT02242942|590506533|FG000|Overall Study|Physician Decision|1|||
163493282|NCT02242942|590506534|FG001|Overall Study|Physician Decision|0|||
163493283|NCT02242942|590506535|FG002|Overall Study|Physician Decision|0|||
163493284|NCT02242942|590506533|FG000|Overall Study|Withdrawal by Subject|8|||
163493285|NCT02242942|590506534|FG001|Overall Study|Withdrawal by Subject|10|||
163493286|NCT02242942|590506535|FG002|Overall Study|Withdrawal by Subject|0|||
163493287|NCT02242942|590506533|FG000|Overall Study|On-going in Study|190|||
163493288|NCT02242942|590506534|FG001|Overall Study|On-going in Study|186|||
163493289|NCT02242942|590506535|FG002|Overall Study|On-going in Study|11|||
163493290|NCT04228107|590506539|FG000|Overall Study|Protocol Violation|1|||
163493291|NCT04228107|590506540|FG001|Overall Study|Protocol Violation|0|||
163493292|NCT04228107|590506539|FG000|Overall Study|Withdrawal by Subject|6|||
163493293|NCT04228107|590506540|FG001|Overall Study|Withdrawal by Subject|0|||
163493294|NCT04228107|590506539|FG000|Overall Study|Lost to Follow-up|18|||
163493295|NCT04228107|590506540|FG001|Overall Study|Lost to Follow-up|0|||
163493296|NCT04228107|590506539|FG000|Overall Study|No controller use data|1|||
163493297|NCT04228107|590506540|FG001|Overall Study|No controller use data|0|||
163493298|NCT04228107|590506539|FG000|Overall Study|No medication data collected|1|||
163493299|NCT04228107|590506540|FG001|Overall Study|No medication data collected|0|||
163493300|NCT03792633|590506541|FG000|Overall Study|Alternative Treatment|17|||
163493301|NCT03792633|590506542|FG001|Overall Study|Alternative Treatment|19|||
163493302|NCT03792633|590506541|FG000|Overall Study|Death|2|||
163493303|NCT03792633|590506542|FG001|Overall Study|Death|0|||
163493304|NCT03792633|590506541|FG000|Overall Study|Disease progression|8|||
163493305|NCT03792633|590506542|FG001|Overall Study|Disease progression|9|||
163493306|NCT03792633|590506541|FG000|Overall Study|Lost to Follow-up|1|||
163493307|NCT03792633|590506542|FG001|Overall Study|Lost to Follow-up|1|||
163493308|NCT03792633|590506541|FG000|Overall Study|Screen fail|1|||
163493309|NCT03792633|590506542|FG001|Overall Study|Screen fail|0|||
163493310|NCT03792633|590506541|FG000|Overall Study|Second malignancy|0|||
163493311|NCT03792633|590506542|FG001|Overall Study|Second malignancy|1|||
163493312|NCT00145119|590506543|FG000|Overall Study|Death|45|||
163493313|NCT04411641|590506544|FG000|DB Period|Other|7|||
163493314|NCT04411641|590506545|FG001|DB Period|Other|27|||
163493315|NCT04411641|590506546|FG002|DB Period|Other|0|||
163493316|NCT04411641|590506547|FG003|DB Period|Other|0|||
163493317|NCT04411641|590506544|FG000|DB Period|Withdrawal by Subject|67|||
163493318|NCT04411641|590506545|FG001|DB Period|Withdrawal by Subject|122|||
163493319|NCT04411641|590506546|FG002|DB Period|Withdrawal by Subject|0|||
163493320|NCT04411641|590506547|FG003|DB Period|Withdrawal by Subject|0|||
163493321|NCT04411641|590506544|FG000|DB Period|Progressive disease|76|||
163493322|NCT04411641|590506545|FG001|DB Period|Progressive disease|116|||
163493323|NCT04411641|590506546|FG002|DB Period|Progressive disease|0|||
163493324|NCT04411641|590506547|FG003|DB Period|Progressive disease|0|||
163493325|NCT04411641|590506544|FG000|DB Period|Poor compliance to protocol|1|||
163493326|NCT04411641|590506545|FG001|DB Period|Poor compliance to protocol|5|||
163493327|NCT04411641|590506546|FG002|DB Period|Poor compliance to protocol|0|||
163493328|NCT04411641|590506547|FG003|DB Period|Poor compliance to protocol|0|||
163493329|NCT04411641|590506544|FG000|DB Period|Lack of Efficacy|19|||
163493330|NCT04411641|590506545|FG001|DB Period|Lack of Efficacy|19|||
163493331|NCT04411641|590506546|FG002|DB Period|Lack of Efficacy|0|||
163493332|NCT04411641|590506547|FG003|DB Period|Lack of Efficacy|0|||
163493333|NCT04411641|590506544|FG000|DB Period|Adverse Event|13|||
163493334|NCT04411641|590506545|FG001|DB Period|Adverse Event|29|||
163493335|NCT04411641|590506546|FG002|DB Period|Adverse Event|0|||
163493336|NCT04411641|590506547|FG003|DB Period|Adverse Event|0|||
163493337|NCT04411641|590506544|FG000|DB Period|Randomized and not treated|2|||
163493338|NCT04411641|590506545|FG001|DB Period|Randomized and not treated|2|||
163493339|NCT04411641|590506546|FG002|DB Period|Randomized and not treated|0|||
163493340|NCT04411641|590506547|FG003|DB Period|Randomized and not treated|0|||
163493341|NCT04411641|590506544|FG000|OL|Withdrawal by Subject|0|||
163493342|NCT04411641|590506545|FG001|OL|Withdrawal by Subject|0|||
163493343|NCT04411641|590506546|FG002|OL|Withdrawal by Subject|6|||
163493344|NCT04411641|590506547|FG003|OL|Withdrawal by Subject|17|||
163493345|NCT04411641|590506544|FG000|OL|Progressive disease|0|||
163493346|NCT04411641|590506545|FG001|OL|Progressive disease|0|||
163493347|NCT04411641|590506546|FG002|OL|Progressive disease|1|||
163493348|NCT04411641|590506547|FG003|OL|Progressive disease|2|||
163493349|NCT04411641|590506544|FG000|OL|Poor compliance to protocol|0|||
163493350|NCT04411641|590506545|FG001|OL|Poor compliance to protocol|0|||
163493351|NCT04411641|590506546|FG002|OL|Poor compliance to protocol|1|||
163493352|NCT04411641|590506547|FG003|OL|Poor compliance to protocol|0|||
163493353|NCT04411641|590506544|FG000|OL|Adverse Event|0|||
163493354|NCT04411641|590506545|FG001|OL|Adverse Event|0|||
163493355|NCT04411641|590506546|FG002|OL|Adverse Event|1|||
163493356|NCT04411641|590506547|FG003|OL|Adverse Event|0|||
163493357|NCT04411641|590506544|FG000|OL|Other|0|||
163493358|NCT04411641|590506545|FG001|OL|Other|0|||
163493359|NCT04411641|590506546|FG002|OL|Other|0|||
163493360|NCT04411641|590506547|FG003|OL|Other|6|||
163493361|NCT04342390|590506548|FG000|Overall Study|Lost to Follow-up|3|||
163493362|NCT04342390|590506549|FG001|Overall Study|Lost to Follow-up|0|||
163493363|NCT04584294|590506550|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
163493364|NCT04584294|590506551|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
163493365|NCT04584294|590506550|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
163493366|NCT04584294|590506551|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
163493367|NCT04584294|590506550|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
163493368|NCT04584294|590506551|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
163493369|NCT04584294|590506550|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
163493370|NCT04584294|590506551|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
163493371|NCT04584294|590506550|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
163493372|NCT04584294|590506551|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
163493373|NCT04584294|590506550|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
163493374|NCT04584294|590506551|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
163493375|NCT01392469|590508100|FG000|Overall Study|Adverse Event|2|||
163493376|NCT01392469|590508100|FG000|Overall Study|Withdrawal by Subject|1|||
163493377|NCT01392469|590508100|FG000|Overall Study|Protocol Violation|1|||
163493378|NCT03443973|590508107|FG000|Double-blind Treatment Period|Adverse Event|5|||
163493379|NCT03443973|590508108|FG001|Double-blind Treatment Period|Adverse Event|19|||
163493380|NCT03443973|590508109|FG002|Double-blind Treatment Period|Adverse Event|0|||
163493381|NCT03443973|590508110|FG003|Double-blind Treatment Period|Adverse Event|0|||
163493382|NCT03443973|590508107|FG000|Double-blind Treatment Period|Death|5|||
163493383|NCT03443973|590508108|FG001|Double-blind Treatment Period|Death|7|||
163493384|NCT03443973|590508109|FG002|Double-blind Treatment Period|Death|0|||
163493385|NCT03443973|590508110|FG003|Double-blind Treatment Period|Death|0|||
163493386|NCT03443973|590508107|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
163493387|NCT03443973|590508108|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
163493388|NCT03443973|590508109|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
163493389|NCT03443973|590508110|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
163493390|NCT03443973|590508107|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
163493391|NCT03443973|590508108|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
163493392|NCT03443973|590508109|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
163493393|NCT03443973|590508110|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
163493394|NCT03443973|590508107|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
163493395|NCT03443973|590508108|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
163493396|NCT03443973|590508109|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
163493397|NCT03443973|590508110|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
163493398|NCT03443973|590508107|FG000|Double-blind Treatment Period|Physician Decision|5|||
163493399|NCT03443973|590508108|FG001|Double-blind Treatment Period|Physician Decision|6|||
163493400|NCT03443973|590508109|FG002|Double-blind Treatment Period|Physician Decision|0|||
163493401|NCT03443973|590508110|FG003|Double-blind Treatment Period|Physician Decision|0|||
163493402|NCT03443973|590508107|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
163493403|NCT03443973|590508108|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
163493404|NCT03443973|590508109|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
163493405|NCT03443973|590508110|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
163493406|NCT03443973|590508107|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
163493407|NCT03443973|590508108|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
163493408|NCT03443973|590508109|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
163493409|NCT03443973|590508110|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
163493410|NCT03443973|590508107|FG000|Open-label Extension Period|Reason Not Specified|0|||
163493411|NCT03443973|590508108|FG001|Open-label Extension Period|Reason Not Specified|0|||
163384997|NCT01910181|590119286|FG000|Overall Study|Death|37|||
163384998|NCT01910181|590119286|FG000|Overall Study|Lost to Follow-up|3|||
163384999|NCT01910181|590119286|FG000|Overall Study|Study Terminated by Sponsor|6|||
163385000|NCT03567434|590119290|FG000|Overall Study|Lost to Follow-up|1|||
163385001|NCT03567434|590119291|FG001|Overall Study|Lost to Follow-up|3|||
163385002|NCT02881957|590119297|FG000|Overall Study|Comfort care|0|||
163385003|NCT02881957|590119298|FG001|Overall Study|Comfort care|1|||
163385004|NCT02881957|590119297|FG000|Overall Study|Concurrent trial enrollment|0|||
163385005|NCT02881957|590119298|FG001|Overall Study|Concurrent trial enrollment|1|||
163385006|NCT02881957|590119297|FG000|Overall Study|Discharged within 48 hours|0|||
163385007|NCT02881957|590119298|FG001|Overall Study|Discharged within 48 hours|1|||
163493412|NCT03443973|590508109|FG002|Open-label Extension Period|Reason Not Specified|3|||
163493413|NCT03443973|590508110|FG003|Open-label Extension Period|Reason Not Specified|0|||
163493414|NCT03443973|590508107|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
163493415|NCT03443973|590508108|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
163493416|NCT03443973|590508109|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
163493417|NCT03443973|590508110|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
163493418|NCT04930536|590508111|FG000|Overall Study|Adverse Event|1|||
163493419|NCT04930536|590508112|FG001|Overall Study|Adverse Event|0|||
163493420|NCT04930536|590508111|FG000|Overall Study|Disease Progression|2|||
163493421|NCT04930536|590508112|FG001|Overall Study|Disease Progression|0|||
163493422|NCT04930536|590508111|FG000|Overall Study|Patient Decision|4|||
163493423|NCT04930536|590508112|FG001|Overall Study|Patient Decision|2|||
163493424|NCT04930536|590508111|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
163493425|NCT04930536|590508112|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
163493426|NCT00267020|590508113|FG000|Overall Study|Adverse Event|22|||
163493427|NCT00267020|590508114|FG001|Overall Study|Adverse Event|5|||
163493428|NCT00267020|590508113|FG000|Overall Study|Death|2|||
163493429|NCT00267020|590508114|FG001|Overall Study|Death|1|||
163493430|NCT00267020|590508113|FG000|Overall Study|Withdrawal by Subject|17|||
163493431|NCT00267020|590508114|FG001|Overall Study|Withdrawal by Subject|7|||
163493432|NCT00267020|590508113|FG000|Overall Study|Physician Decision|3|||
163493433|NCT00267020|590508114|FG001|Overall Study|Physician Decision|2|||
163493434|NCT00267020|590508113|FG000|Overall Study|Disease Progression|39|||
163493435|NCT00267020|590508114|FG001|Overall Study|Disease Progression|25|||
163493436|NCT00267020|590508113|FG000|Overall Study|Unrelated Complication|1|||
163493437|NCT00267020|590508114|FG001|Overall Study|Unrelated Complication|1|||
163493438|NCT00267020|590508113|FG000|Overall Study|Sponsor Request|1|||
163493439|NCT00267020|590508114|FG001|Overall Study|Sponsor Request|0|||
163493440|NCT00267020|590508113|FG000|Overall Study|Other|1|||
163493441|NCT00267020|590508114|FG001|Overall Study|Other|2|||
163493442|NCT04292171|590508118|FG000|Overall Study|Pharmacy error|2|||
163493443|NCT04292171|590508119|FG001|Overall Study|Pharmacy error|0|||
163493444|NCT04292171|590508118|FG000|Overall Study|Delivered prior to procedure|0|||
163493445|NCT04292171|590508119|FG001|Overall Study|Delivered prior to procedure|1|||
163493446|NCT04465916|590508120|FG000|Overall Study|Withdrawal by Subject|0|||
163493447|NCT04465916|590508121|FG001|Overall Study|Withdrawal by Subject|1|||
163493448|NCT04633434|590508122|FG000|Overall Study|Lost to Follow-up|32|||
163493449|NCT04633434|590508123|FG001|Overall Study|Lost to Follow-up|32|||
163493450|NCT02329834|590508124|FG000|Overall Study|Physician Decision|1|||
163493451|NCT02329834|590508125|FG001|Overall Study|Physician Decision|0|||
163493452|NCT01605370|590508128|FG000|Overall Study|Adverse Event|1|||
163493453|NCT01605370|590508129|FG001|Overall Study|Adverse Event|0|||
163493454|NCT00578448|590508130|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
163493455|NCT00578448|590508130|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
163493456|NCT00578448|590508130|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
163493457|NCT00578448|590508130|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
163493458|NCT01976104|590508134|FG000|Overall Study|Adverse Event|0|||
163493459|NCT01976104|590508135|FG001|Overall Study|Adverse Event|0|||
163493460|NCT01976104|590508136|FG002|Overall Study|Adverse Event|1|||
163493461|NCT01976104|590508137|FG003|Overall Study|Adverse Event|0|||
163493462|NCT01976104|590508134|FG000|Overall Study|Lost to Follow-up|3|||
163493463|NCT01976104|590508135|FG001|Overall Study|Lost to Follow-up|0|||
163493464|NCT01976104|590508136|FG002|Overall Study|Lost to Follow-up|1|||
163493465|NCT01976104|590508137|FG003|Overall Study|Lost to Follow-up|1|||
163493466|NCT01976104|590508134|FG000|Overall Study|Subject Choice|0|||
163493467|NCT01976104|590508135|FG001|Overall Study|Subject Choice|1|||
163493468|NCT01976104|590508136|FG002|Overall Study|Subject Choice|0|||
163493469|NCT01976104|590508137|FG003|Overall Study|Subject Choice|1|||
163493470|NCT01976104|590508134|FG000|Overall Study|Withdrawal by Subject|3|||
163493471|NCT01976104|590508135|FG001|Overall Study|Withdrawal by Subject|0|||
163493472|NCT01976104|590508136|FG002|Overall Study|Withdrawal by Subject|0|||
163493473|NCT01976104|590508137|FG003|Overall Study|Withdrawal by Subject|1|||
163493474|NCT01976104|590508134|FG000|Overall Study|Other|0|||
163493475|NCT01976104|590508135|FG001|Overall Study|Other|1|||
163493476|NCT01976104|590508136|FG002|Overall Study|Other|0|||
163493477|NCT01976104|590508137|FG003|Overall Study|Other|0|||
163493478|NCT01317199|590508138|FG000|Dose-escalation Phase 1|Physician Decision|5|||
163493479|NCT01317199|590508139|FG001|Dose-escalation Phase 1|Physician Decision|0|||
163493480|NCT01317199|590508140|FG002|Dose-escalation Phase 1|Physician Decision|0|||
163493481|NCT01317199|590508141|FG003|Dose-escalation Phase 1|Physician Decision|0|||
163493482|NCT01317199|590508138|FG000|Dose-escalation Phase 1|Disease progression|1|||
163493483|NCT01317199|590508139|FG001|Dose-escalation Phase 1|Disease progression|0|||
163493484|NCT01317199|590508140|FG002|Dose-escalation Phase 1|Disease progression|0|||
163493485|NCT01317199|590508141|FG003|Dose-escalation Phase 1|Disease progression|0|||
163493486|NCT01317199|590508138|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
163493487|NCT01317199|590508139|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
163493488|NCT01317199|590508140|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
163493489|NCT01317199|590508141|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
163493490|NCT01317199|590508138|FG000|Randomized Phase 2|Disease progression|0|||
163493491|NCT01317199|590508139|FG001|Randomized Phase 2|Disease progression|3|||
163493492|NCT01317199|590508140|FG002|Randomized Phase 2|Disease progression|7|||
163493493|NCT01317199|590508141|FG003|Randomized Phase 2|Disease progression|5|||
163493494|NCT01317199|590508138|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
163493495|NCT01317199|590508139|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
163493496|NCT01317199|590508140|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
163493497|NCT01317199|590508141|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
163493498|NCT01317199|590508138|FG000|Randomized Phase 2|Adverse Event|0|||
163493499|NCT01317199|590508139|FG001|Randomized Phase 2|Adverse Event|0|||
163493500|NCT01317199|590508140|FG002|Randomized Phase 2|Adverse Event|0|||
163493501|NCT01317199|590508141|FG003|Randomized Phase 2|Adverse Event|1|||
163493502|NCT01317199|590508138|FG000|Randomized Phase 2|Comorbidities|0|||
163493503|NCT01317199|590508139|FG001|Randomized Phase 2|Comorbidities|2|||
163493504|NCT01317199|590508140|FG002|Randomized Phase 2|Comorbidities|2|||
163493505|NCT01317199|590508141|FG003|Randomized Phase 2|Comorbidities|2|||
163493506|NCT01317199|590508138|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
163493507|NCT01317199|590508139|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
163493508|NCT01317199|590508140|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
163493509|NCT01317199|590508141|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
163493510|NCT01317199|590508138|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
163493511|NCT01317199|590508139|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
163493512|NCT01317199|590508140|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
163493513|NCT01317199|590508141|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
163493514|NCT01317199|590508138|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
163493515|NCT01317199|590508139|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
163493516|NCT01317199|590508140|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
163493517|NCT01317199|590508141|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
163493518|NCT01317199|590508138|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
163493519|NCT01317199|590508139|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
163493520|NCT01317199|590508140|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
163493521|NCT01317199|590508141|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
163493522|NCT01353209|590508142|FG000|Overall Study|Adverse Event|1|||
163493523|NCT01353209|590508143|FG001|Overall Study|Adverse Event|1|||
163493524|NCT01283009|590508144|FG000|Overall Study|Death|83|||
163493525|NCT01283009|590508145|FG001|Overall Study|Death|78|||
163493526|NCT01283009|590508144|FG000|Overall Study|Study ended early|23|||
163493527|NCT01283009|590508145|FG001|Overall Study|Study ended early|26|||
163493528|NCT01283009|590508144|FG000|Overall Study|Withdrawal by Subject|10|||
163493529|NCT01283009|590508145|FG001|Overall Study|Withdrawal by Subject|8|||
163493530|NCT01283009|590508144|FG000|Overall Study|Physician Decision|1|||
163493531|NCT01283009|590508145|FG001|Overall Study|Physician Decision|1|||
163493532|NCT01283009|590508144|FG000|Overall Study|Lost to Follow-up|1|||
163493533|NCT01283009|590508145|FG001|Overall Study|Lost to Follow-up|0|||
163493534|NCT01283009|590508144|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
163493535|NCT01283009|590508145|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
163493536|NCT03237325|590508149|FG000|Overall Study|Lost to Follow-up|3|||
163493537|NCT03237325|590508150|FG001|Overall Study|Lost to Follow-up|5|||
163493538|NCT03237325|590508149|FG000|Overall Study|Physician Decision|2|||
163493539|NCT03237325|590508150|FG001|Overall Study|Physician Decision|4|||
163493540|NCT03237325|590508149|FG000|Overall Study|Withdrawal by Subject|9|||
163493541|NCT03237325|590508150|FG001|Overall Study|Withdrawal by Subject|12|||
163493542|NCT03237325|590508149|FG000|Overall Study|Noncompliance with Study Procedures|1|||
163493543|NCT03237325|590508150|FG001|Overall Study|Noncompliance with Study Procedures|1|||
163493544|NCT03237325|590508149|FG000|Overall Study|Termination by Sponsor|0|||
163493545|NCT03237325|590508150|FG001|Overall Study|Termination by Sponsor|1|||
163493546|NCT03237325|590508149|FG000|Overall Study|Reason other than described|0|||
163493547|NCT03237325|590508150|FG001|Overall Study|Reason other than described|2|||
163493548|NCT02684370|590508151|FG000|Part A|Adverse Event|2|||
163493549|NCT02684370|590508152|FG001|Part A|Adverse Event|0|||
163493550|NCT02684370|590508153|FG002|Part A|Adverse Event|1|||
163493551|NCT02684370|590508154|FG003|Part A|Adverse Event|0|||
163493552|NCT02684370|590508155|FG004|Part A|Adverse Event|0|||
163493553|NCT02684370|590508156|FG005|Part A|Adverse Event|0|||
163493554|NCT02684370|590508151|FG000|Part A|Lost to Follow-up|1|||
163493555|NCT02684370|590508152|FG001|Part A|Lost to Follow-up|1|||
163493556|NCT02684370|590508153|FG002|Part A|Lost to Follow-up|0|||
163493557|NCT02684370|590508154|FG003|Part A|Lost to Follow-up|0|||
163493558|NCT02684370|590508155|FG004|Part A|Lost to Follow-up|0|||
163493559|NCT02684370|590508156|FG005|Part A|Lost to Follow-up|0|||
163493560|NCT02684370|590508151|FG000|Part A|Subject Withdrawal|1|||
163493561|NCT02684370|590508152|FG001|Part A|Subject Withdrawal|0|||
163493562|NCT02684370|590508153|FG002|Part A|Subject Withdrawal|3|||
163493563|NCT02684370|590508154|FG003|Part A|Subject Withdrawal|0|||
163493564|NCT02684370|590508155|FG004|Part A|Subject Withdrawal|0|||
163493565|NCT02684370|590508156|FG005|Part A|Subject Withdrawal|0|||
163493566|NCT02684370|590508151|FG000|Part A|Other|0|||
163493567|NCT02684370|590508152|FG001|Part A|Other|0|||
163493568|NCT02684370|590508153|FG002|Part A|Other|1|||
163493569|NCT02684370|590508154|FG003|Part A|Other|0|||
163493570|NCT02684370|590508155|FG004|Part A|Other|0|||
163493571|NCT02684370|590508156|FG005|Part A|Other|0|||
163493572|NCT02684370|590508151|FG000|Part B|Adverse Event|0|||
163493573|NCT02684370|590508152|FG001|Part B|Adverse Event|0|||
163493574|NCT02684370|590508153|FG002|Part B|Adverse Event|0|||
163493575|NCT02684370|590508154|FG003|Part B|Adverse Event|0|||
163493576|NCT02684370|590508155|FG004|Part B|Adverse Event|2|||
163493577|NCT02684370|590508156|FG005|Part B|Adverse Event|1|||
163493578|NCT02684370|590508151|FG000|Part B|Lost to Follow-up|0|||
163493579|NCT02684370|590508152|FG001|Part B|Lost to Follow-up|0|||
163493580|NCT02684370|590508153|FG002|Part B|Lost to Follow-up|0|||
163493581|NCT02684370|590508154|FG003|Part B|Lost to Follow-up|1|||
163493582|NCT02684370|590508155|FG004|Part B|Lost to Follow-up|2|||
163493583|NCT02684370|590508156|FG005|Part B|Lost to Follow-up|5|||
163493584|NCT02684370|590508151|FG000|Part B|Subject Withdrawal|0|||
163493585|NCT02684370|590508152|FG001|Part B|Subject Withdrawal|0|||
163493586|NCT02684370|590508153|FG002|Part B|Subject Withdrawal|0|||
163493587|NCT02684370|590508154|FG003|Part B|Subject Withdrawal|1|||
163493588|NCT02684370|590508155|FG004|Part B|Subject Withdrawal|1|||
163493589|NCT02684370|590508156|FG005|Part B|Subject Withdrawal|2|||
163493590|NCT00627094|590508158|FG000|Overall Study|Adverse Event|8|||
163493591|NCT00627094|590508159|FG001|Overall Study|Adverse Event|7|||
163493592|NCT00627094|590508158|FG000|Overall Study|Lost to Follow-up|1|||
163493593|NCT00627094|590508159|FG001|Overall Study|Lost to Follow-up|0|||
163493594|NCT00627094|590508158|FG000|Overall Study|Withdrawal by Subject|1|||
163493595|NCT00627094|590508159|FG001|Overall Study|Withdrawal by Subject|1|||
163493596|NCT00627094|590508158|FG000|Overall Study|ulcer healed|1|||
163493597|NCT00627094|590508159|FG001|Overall Study|ulcer healed|7|||
163493598|NCT00627094|590508158|FG000|Overall Study|Other reason|1|||
163493599|NCT00627094|590508159|FG001|Overall Study|Other reason|0|||
163493600|NCT00183170|590508161|FG000|First Intervention|Did not complete study|1|||
163493601|NCT00183170|590508162|FG001|First Intervention|Did not complete study|0|||
163493602|NCT00183170|590508161|FG000|First Intervention|Did not meet targeted BrAC|1|||
163493603|NCT00183170|590508162|FG001|First Intervention|Did not meet targeted BrAC|0|||
163493604|NCT00183170|590508161|FG000|Washout 1 Week|Did not complete study|6|||
163493605|NCT00183170|590508162|FG001|Washout 1 Week|Did not complete study|8|||
163493606|NCT00183170|590508161|FG000|Second Intervention|Did not complete study|1|||
163493607|NCT00183170|590508162|FG001|Second Intervention|Did not complete study|0|||
163493608|NCT00183170|590508161|FG000|Second Intervention|Did not meet targeted BrAC|0|||
163493609|NCT00183170|590508162|FG001|Second Intervention|Did not meet targeted BrAC|2|||
163493610|NCT01165424|590508163|FG000|Overall Study|Clinical adverse experiences|1|||
163493611|NCT01165424|590508163|FG000|Overall Study|Laboratory adverse experiences|1|||
163493612|NCT01165424|590508163|FG000|Overall Study|Did not meet entry criteria|1|||
163493613|NCT01165424|590508163|FG000|Overall Study|Participant moved (relocated)|1|||
163493614|NCT02050373|590508169|FG000|Overall Study|Adverse Event|4|||
163493615|NCT02050373|590508170|FG001|Overall Study|Adverse Event|7|||
163493616|NCT02050373|590508169|FG000|Overall Study|Death|3|||
163493617|NCT02050373|590508170|FG001|Overall Study|Death|3|||
163493618|NCT00807040|590508174|FG000|Overall Study|Death|24|||
163493619|NCT00807040|590508175|FG001|Overall Study|Death|29|||
163493620|NCT00807040|590508174|FG000|Overall Study|Withdrawal by Subject|8|||
163493621|NCT00807040|590508175|FG001|Overall Study|Withdrawal by Subject|6|||
163493622|NCT00807040|590508174|FG000|Overall Study|Lost to Follow-up|4|||
163493623|NCT00807040|590508175|FG001|Overall Study|Lost to Follow-up|6|||
163493624|NCT01067339|590508176|FG000|Overall Study|Withdrawal by Subject|6|||
163493625|NCT01067339|590508177|FG001|Overall Study|Withdrawal by Subject|5|||
163493626|NCT01179191|590508178|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
163493627|NCT01179191|590508178|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
163493628|NCT01179191|590508178|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
163493629|NCT01179191|590508178|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
163493630|NCT01179191|590508178|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
163493631|NCT01179191|590508178|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
163493632|NCT01179191|590508178|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
163493633|NCT01179191|590508178|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
163493634|NCT01179191|590508178|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
163493635|NCT01179191|590508178|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
163493636|NCT01179191|590508178|FG000|Maintenance Phase (8 Weeks)|Other|66|||
163493637|NCT00572910|590508183|FG000|Overall Study|Adverse Event|1|||
163493638|NCT00572910|590508184|FG001|Overall Study|Adverse Event|2|||
163493639|NCT00572910|590508185|FG002|Overall Study|Adverse Event|0|||
163493640|NCT00572910|590508186|FG003|Overall Study|Adverse Event|2|||
163493641|NCT00572910|590508187|FG004|Overall Study|Adverse Event|0|||
163493642|NCT00572910|590508188|FG005|Overall Study|Adverse Event|0|||
163493643|NCT00572910|590508189|FG006|Overall Study|Adverse Event|4|||
163493644|NCT00572910|590508190|FG007|Overall Study|Adverse Event|2|||
163493645|NCT00572910|590508191|FG008|Overall Study|Adverse Event|1|||
163493646|NCT00572910|590508192|FG009|Overall Study|Adverse Event|3|||
163493647|NCT00572910|590508193|FG010|Overall Study|Adverse Event|2|||
163493648|NCT00572910|590508183|FG000|Overall Study|Lost to Follow-up|0|||
163493649|NCT00572910|590508184|FG001|Overall Study|Lost to Follow-up|1|||
163493650|NCT00572910|590508185|FG002|Overall Study|Lost to Follow-up|1|||
163493651|NCT00572910|590508186|FG003|Overall Study|Lost to Follow-up|2|||
163493652|NCT00572910|590508187|FG004|Overall Study|Lost to Follow-up|1|||
163493653|NCT00572910|590508188|FG005|Overall Study|Lost to Follow-up|0|||
163493654|NCT00572910|590508189|FG006|Overall Study|Lost to Follow-up|0|||
163493655|NCT00572910|590508190|FG007|Overall Study|Lost to Follow-up|0|||
163493656|NCT00572910|590508191|FG008|Overall Study|Lost to Follow-up|0|||
163493657|NCT00572910|590508192|FG009|Overall Study|Lost to Follow-up|1|||
163493658|NCT00572910|590508193|FG010|Overall Study|Lost to Follow-up|0|||
163493659|NCT00572910|590508183|FG000|Overall Study|Withdrawal by Subject|3|||
163493660|NCT00572910|590508184|FG001|Overall Study|Withdrawal by Subject|0|||
163493661|NCT00572910|590508185|FG002|Overall Study|Withdrawal by Subject|1|||
163493662|NCT00572910|590508186|FG003|Overall Study|Withdrawal by Subject|0|||
163493663|NCT00572910|590508187|FG004|Overall Study|Withdrawal by Subject|1|||
163493664|NCT00572910|590508188|FG005|Overall Study|Withdrawal by Subject|3|||
163493665|NCT00572910|590508189|FG006|Overall Study|Withdrawal by Subject|0|||
163493666|NCT00572910|590508190|FG007|Overall Study|Withdrawal by Subject|2|||
163493667|NCT00572910|590508191|FG008|Overall Study|Withdrawal by Subject|2|||
163493668|NCT00572910|590508192|FG009|Overall Study|Withdrawal by Subject|2|||
163493669|NCT00572910|590508193|FG010|Overall Study|Withdrawal by Subject|1|||
163493670|NCT01833897|590508199|FG000|Overall Study|Lack of Efficacy|1|||
163493671|NCT05275673|590508202|FG000|Overall Study|Study Termination by Sponsor|2|||
163493672|NCT05275673|590508203|FG001|Overall Study|Study Termination by Sponsor|3|||
163493673|NCT05275673|590508202|FG000|Overall Study|Death|1|||
163493674|NCT05275673|590508203|FG001|Overall Study|Death|0|||
163493675|NCT05275673|590508202|FG000|Overall Study|Withdrawal by Subject|1|||
163493676|NCT05275673|590508203|FG001|Overall Study|Withdrawal by Subject|0|||
163493677|NCT02325739|590508204|FG000|Phase I Part|Adverse Event|1|||
163493678|NCT02325739|590508205|FG001|Phase I Part|Adverse Event|0|||
163493679|NCT02325739|590508206|FG002|Phase I Part|Adverse Event|1|||
163493680|NCT02325739|590508207|FG003|Phase I Part|Adverse Event|2|||
163493681|NCT02325739|590508208|FG004|Phase I Part|Adverse Event|3|||
163493682|NCT02325739|590508209|FG005|Phase I Part|Adverse Event|1|||
163493683|NCT02325739|590508210|FG006|Phase I Part|Adverse Event|0|||
163493684|NCT02325739|590508211|FG007|Phase I Part|Adverse Event|2|||
163493685|NCT02325739|590508212|FG008|Phase I Part|Adverse Event|0|||
163493686|NCT02325739|590508213|FG009|Phase I Part|Adverse Event|0|||
163493687|NCT02325739|590508214|FG010|Phase I Part|Adverse Event|0|||
163493688|NCT02325739|590508204|FG000|Phase I Part|Progressive disease|9|||
163493689|NCT02325739|590508205|FG001|Phase I Part|Progressive disease|6|||
163493690|NCT02325739|590508206|FG002|Phase I Part|Progressive disease|3|||
163493691|NCT02325739|590508207|FG003|Phase I Part|Progressive disease|23|||
163493692|NCT02325739|590508208|FG004|Phase I Part|Progressive disease|14|||
163493693|NCT02325739|590508209|FG005|Phase I Part|Progressive disease|6|||
163493694|NCT02325739|590508210|FG006|Phase I Part|Progressive disease|6|||
163493695|NCT02325739|590508211|FG007|Phase I Part|Progressive disease|3|||
163493696|NCT02325739|590508212|FG008|Phase I Part|Progressive disease|0|||
163493697|NCT02325739|590508213|FG009|Phase I Part|Progressive disease|0|||
163493698|NCT02325739|590508214|FG010|Phase I Part|Progressive disease|0|||
163493699|NCT02325739|590508204|FG000|Phase I Part|Subject/guardian decision|1|||
163493700|NCT02325739|590508205|FG001|Phase I Part|Subject/guardian decision|0|||
163493701|NCT02325739|590508206|FG002|Phase I Part|Subject/guardian decision|1|||
163493702|NCT02325739|590508207|FG003|Phase I Part|Subject/guardian decision|1|||
163493703|NCT02325739|590508208|FG004|Phase I Part|Subject/guardian decision|0|||
163493704|NCT02325739|590508209|FG005|Phase I Part|Subject/guardian decision|0|||
163493705|NCT02325739|590508210|FG006|Phase I Part|Subject/guardian decision|0|||
163493706|NCT02325739|590508211|FG007|Phase I Part|Subject/guardian decision|1|||
163493707|NCT02325739|590508212|FG008|Phase I Part|Subject/guardian decision|0|||
163493708|NCT02325739|590508213|FG009|Phase I Part|Subject/guardian decision|0|||
163493709|NCT02325739|590508214|FG010|Phase I Part|Subject/guardian decision|0|||
163493710|NCT02325739|590508204|FG000|Phase I Part|Death|0|||
163493711|NCT02325739|590508205|FG001|Phase I Part|Death|0|||
163493712|NCT02325739|590508206|FG002|Phase I Part|Death|0|||
163493713|NCT02325739|590508207|FG003|Phase I Part|Death|0|||
163493714|NCT02325739|590508208|FG004|Phase I Part|Death|2|||
163493715|NCT02325739|590508209|FG005|Phase I Part|Death|0|||
163493716|NCT02325739|590508210|FG006|Phase I Part|Death|0|||
163493717|NCT02325739|590508211|FG007|Phase I Part|Death|0|||
163493718|NCT02325739|590508212|FG008|Phase I Part|Death|0|||
163493719|NCT02325739|590508213|FG009|Phase I Part|Death|0|||
163493720|NCT02325739|590508214|FG010|Phase I Part|Death|0|||
163493721|NCT02325739|590508204|FG000|Phase II Part|Adverse Event|0|||
163493722|NCT02325739|590508205|FG001|Phase II Part|Adverse Event|0|||
163493723|NCT02325739|590508206|FG002|Phase II Part|Adverse Event|0|||
163493724|NCT02325739|590508207|FG003|Phase II Part|Adverse Event|0|||
163493725|NCT02325739|590508208|FG004|Phase II Part|Adverse Event|0|||
163493726|NCT02325739|590508209|FG005|Phase II Part|Adverse Event|0|||
163493727|NCT02325739|590508210|FG006|Phase II Part|Adverse Event|0|||
163493728|NCT02325739|590508211|FG007|Phase II Part|Adverse Event|0|||
163493729|NCT02325739|590508212|FG008|Phase II Part|Adverse Event|4|||
163493730|NCT02325739|590508213|FG009|Phase II Part|Adverse Event|5|||
163493731|NCT02325739|590508214|FG010|Phase II Part|Adverse Event|1|||
163493732|NCT02325739|590508204|FG000|Phase II Part|Physician Decision|0|||
163493733|NCT02325739|590508205|FG001|Phase II Part|Physician Decision|0|||
163493734|NCT02325739|590508206|FG002|Phase II Part|Physician Decision|0|||
163493735|NCT02325739|590508207|FG003|Phase II Part|Physician Decision|0|||
163493736|NCT02325739|590508208|FG004|Phase II Part|Physician Decision|0|||
163493737|NCT02325739|590508209|FG005|Phase II Part|Physician Decision|0|||
163493738|NCT02325739|590508210|FG006|Phase II Part|Physician Decision|0|||
163493739|NCT02325739|590508211|FG007|Phase II Part|Physician Decision|0|||
163493740|NCT02325739|590508212|FG008|Phase II Part|Physician Decision|0|||
163493741|NCT02325739|590508213|FG009|Phase II Part|Physician Decision|1|||
163493742|NCT02325739|590508214|FG010|Phase II Part|Physician Decision|0|||
163493743|NCT02325739|590508204|FG000|Phase II Part|Progressive disease|0|||
163493744|NCT02325739|590508205|FG001|Phase II Part|Progressive disease|0|||
163493745|NCT02325739|590508206|FG002|Phase II Part|Progressive disease|0|||
163493746|NCT02325739|590508207|FG003|Phase II Part|Progressive disease|0|||
163493747|NCT02325739|590508208|FG004|Phase II Part|Progressive disease|0|||
163493748|NCT02325739|590508209|FG005|Phase II Part|Progressive disease|0|||
163493749|NCT02325739|590508210|FG006|Phase II Part|Progressive disease|0|||
163493750|NCT02325739|590508211|FG007|Phase II Part|Progressive disease|0|||
163493751|NCT02325739|590508212|FG008|Phase II Part|Progressive disease|22|||
163493752|NCT02325739|590508213|FG009|Phase II Part|Progressive disease|29|||
163493753|NCT02325739|590508214|FG010|Phase II Part|Progressive disease|18|||
163493754|NCT02325739|590508204|FG000|Phase II Part|Subject/guardian decision|0|||
163493755|NCT02325739|590508205|FG001|Phase II Part|Subject/guardian decision|0|||
163493756|NCT02325739|590508206|FG002|Phase II Part|Subject/guardian decision|0|||
163493757|NCT02325739|590508207|FG003|Phase II Part|Subject/guardian decision|0|||
163493758|NCT02325739|590508208|FG004|Phase II Part|Subject/guardian decision|0|||
163493759|NCT02325739|590508209|FG005|Phase II Part|Subject/guardian decision|0|||
163493760|NCT02325739|590508210|FG006|Phase II Part|Subject/guardian decision|0|||
163493761|NCT02325739|590508211|FG007|Phase II Part|Subject/guardian decision|0|||
163493762|NCT02325739|590508212|FG008|Phase II Part|Subject/guardian decision|4|||
163493763|NCT02325739|590508213|FG009|Phase II Part|Subject/guardian decision|1|||
163493764|NCT02325739|590508214|FG010|Phase II Part|Subject/guardian decision|1|||
163493765|NCT00227591|590508215|FG000|Overall Study|Withdrawal by Subject|1|||
163493766|NCT05048875|590508217|FG000|Overall Study|Withdrawal by Subject|1|||
163493767|NCT05048875|590508218|FG001|Overall Study|Withdrawal by Subject|0|||
163493768|NCT05048875|590508219|FG002|Overall Study|Withdrawal by Subject|0|||
163493769|NCT05048875|590508220|FG003|Overall Study|Withdrawal by Subject|0|||
163493770|NCT05048875|590508221|FG004|Overall Study|Withdrawal by Subject|0|||
163493771|NCT05048875|590508222|FG005|Overall Study|Withdrawal by Subject|0|||
163493772|NCT05048875|590508223|FG006|Overall Study|Withdrawal by Subject|0|||
163493773|NCT05048875|590508224|FG007|Overall Study|Withdrawal by Subject|0|||
163493774|NCT05048875|590508217|FG000|Overall Study|Adverse Event|0|||
163493775|NCT05048875|590508218|FG001|Overall Study|Adverse Event|0|||
163493776|NCT05048875|590508219|FG002|Overall Study|Adverse Event|0|||
163493777|NCT05048875|590508220|FG003|Overall Study|Adverse Event|1|||
163493778|NCT05048875|590508221|FG004|Overall Study|Adverse Event|0|||
163493779|NCT05048875|590508222|FG005|Overall Study|Adverse Event|0|||
163493780|NCT05048875|590508223|FG006|Overall Study|Adverse Event|0|||
163493781|NCT05048875|590508224|FG007|Overall Study|Adverse Event|0|||
163493782|NCT02255422|590508225|FG000|Overall Study|Withdrawal by Subject|0|||
163493783|NCT02255422|590508226|FG001|Overall Study|Withdrawal by Subject|0|||
163493784|NCT02255422|590508227|FG002|Overall Study|Withdrawal by Subject|0|||
163493785|NCT02255422|590508228|FG003|Overall Study|Withdrawal by Subject|0|||
163493786|NCT02255422|590508229|FG004|Overall Study|Withdrawal by Subject|0|||
163493787|NCT02255422|590508230|FG005|Overall Study|Withdrawal by Subject|0|||
163493788|NCT02255422|590508231|FG006|Overall Study|Withdrawal by Subject|2|||
163493789|NCT02255422|590508225|FG000|Overall Study|Lost to Follow-up|0|||
163493790|NCT02255422|590508226|FG001|Overall Study|Lost to Follow-up|0|||
163493791|NCT02255422|590508227|FG002|Overall Study|Lost to Follow-up|1|||
163493792|NCT02255422|590508228|FG003|Overall Study|Lost to Follow-up|0|||
163493793|NCT02255422|590508229|FG004|Overall Study|Lost to Follow-up|0|||
163493794|NCT02255422|590508230|FG005|Overall Study|Lost to Follow-up|0|||
163493795|NCT02255422|590508231|FG006|Overall Study|Lost to Follow-up|0|||
163493796|NCT03179462|590508239|FG000|Overall Study|screening failure|1|||
163493797|NCT03179462|590508240|FG001|Overall Study|screening failure|2|||
163493798|NCT03179462|590508241|FG002|Overall Study|screening failure|0|||
163493799|NCT04410978|590508250|FG000|Overall Study|Poor compliance to protocol|2|||
163493800|NCT04410978|590508251|FG001|Overall Study|Poor compliance to protocol|4|||
163493801|NCT04410978|590508250|FG000|Overall Study|Withdrawal by Subject|64|||
163493802|NCT04410978|590508251|FG001|Overall Study|Withdrawal by Subject|66|||
163493803|NCT04410978|590508250|FG000|Overall Study|Other|6|||
163493804|NCT04410978|590508251|FG001|Overall Study|Other|7|||
163493805|NCT04410978|590508250|FG000|Overall Study|Missing study status|1|||
163493806|NCT04410978|590508251|FG001|Overall Study|Missing study status|0|||
163493807|NCT05153629|590508252|FG000|Overall Study|Withdrawal by Subject|0|||
163493808|NCT05153629|590508253|FG001|Overall Study|Withdrawal by Subject|2|||
163493809|NCT04089566|590508256|FG000|Overall Study|Death|0|||
163493810|NCT04089566|590508257|FG001|Overall Study|Death|6|||
163493811|NCT04089566|590508258|FG002|Overall Study|Death|10|||
163493812|NCT04089566|590508259|FG003|Overall Study|Death|0|||
163493813|NCT04089566|590508260|FG004|Overall Study|Death|0|||
163493814|NCT04089566|590508261|FG005|Overall Study|Death|0|||
163493815|NCT04089566|590508256|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
163493816|NCT04089566|590508257|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
163493817|NCT04089566|590508258|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
163493818|NCT04089566|590508259|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
163493819|NCT04089566|590508260|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
163493820|NCT04089566|590508261|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
163493821|NCT04089566|590508256|FG000|Overall Study|Reason not Specified|0|||
163493822|NCT04089566|590508257|FG001|Overall Study|Reason not Specified|4|||
163493823|NCT04089566|590508258|FG002|Overall Study|Reason not Specified|4|||
163493824|NCT04089566|590508259|FG003|Overall Study|Reason not Specified|1|||
163493825|NCT04089566|590508260|FG004|Overall Study|Reason not Specified|0|||
163493826|NCT04089566|590508261|FG005|Overall Study|Reason not Specified|0|||
163493827|NCT01083121|590508262|FG000|Overall Study|Use of Humira outside the approved label|81|||
163493828|NCT05403502|590508263|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
163493829|NCT05403502|590508263|FG000|Humalog Lead-In Period|Physician Decision|2|||
163493830|NCT05403502|590508263|FG000|Humalog Lead-In Period|Protocol Violation|1|||
163493831|NCT05403502|590508263|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
163493832|NCT05403502|590508263|FG000|Lyumjev Treatment Period|Physician Decision|2|||
163493833|NCT01593761|590508265|FG000|Overall Study|Lost to Follow-up|1|||
163493834|NCT01593761|590508265|FG000|Overall Study|culture negative for MRSA at baseline|5|||
163493835|NCT01593761|590508265|FG000|Overall Study|positive for hepatitis C virus|1|||
163493836|NCT01593761|590508265|FG000|Overall Study|secondary cellulitis|1|||
163493837|NCT02576951|590508266|FG000|Overall Study|Lost to Follow-up|0|||
163493838|NCT02576951|590508267|FG001|Overall Study|Lost to Follow-up|0|||
163493839|NCT02576951|590508268|FG002|Overall Study|Lost to Follow-up|2|||
163493840|NCT02576951|590508269|FG003|Overall Study|Lost to Follow-up|2|||
163493841|NCT02576951|590508266|FG000|Overall Study|Withdrawal by Subject|1|||
163493842|NCT02576951|590508267|FG001|Overall Study|Withdrawal by Subject|0|||
163493843|NCT02576951|590508268|FG002|Overall Study|Withdrawal by Subject|0|||
163493844|NCT02576951|590508269|FG003|Overall Study|Withdrawal by Subject|2|||
163493845|NCT02576951|590508266|FG000|Overall Study|Protocol Violation|0|||
163493846|NCT02576951|590508267|FG001|Overall Study|Protocol Violation|0|||
163493847|NCT02576951|590508268|FG002|Overall Study|Protocol Violation|0|||
163493848|NCT02576951|590508269|FG003|Overall Study|Protocol Violation|1|||
163493849|NCT00223990|590508270|FG000|Overall Study|Moved from area|2|||
163493850|NCT00223990|590508271|FG001|Overall Study|Moved from area|1|||
163493851|NCT00223990|590508270|FG000|Overall Study|Withdrawal by Subject|4|||
163493852|NCT00223990|590508271|FG001|Overall Study|Withdrawal by Subject|8|||
163493853|NCT00223990|590508270|FG000|Overall Study|Lost to Follow-up|1|||
163493854|NCT00223990|590508271|FG001|Overall Study|Lost to Follow-up|0|||
163493855|NCT03505606|590510259|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
163493856|NCT03505606|590510260|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
163493857|NCT03505606|590510261|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
163493858|NCT03505606|590510259|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
163493859|NCT03505606|590510260|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
163493860|NCT03505606|590510261|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
163493861|NCT03505606|590510259|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
163493862|NCT03505606|590510260|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
163493863|NCT03505606|590510261|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
163493864|NCT03505606|590510259|FG000|Overall Study|Poor compliance with refractive correction|0|||
163493865|NCT03505606|590510260|FG001|Overall Study|Poor compliance with refractive correction|0|||
163493866|NCT03505606|590510261|FG002|Overall Study|Poor compliance with refractive correction|1|||
163493867|NCT03505606|590510259|FG000|Overall Study|Insufficient anisometropia|0|||
163493868|NCT03505606|590510260|FG001|Overall Study|Insufficient anisometropia|0|||
163493869|NCT03505606|590510261|FG002|Overall Study|Insufficient anisometropia|2|||
163493870|NCT03505606|590510259|FG000|Overall Study|Ectopia Lentis|0|||
163493871|NCT03505606|590510260|FG001|Overall Study|Ectopia Lentis|0|||
163493872|NCT03505606|590510261|FG002|Overall Study|Ectopia Lentis|1|||
163493873|NCT03505606|590510259|FG000|Overall Study|alternation of amblyopic eye|0|||
163493874|NCT03505606|590510260|FG001|Overall Study|alternation of amblyopic eye|1|||
163493875|NCT03505606|590510261|FG002|Overall Study|alternation of amblyopic eye|0|||
163493876|NCT02087865|590510264|FG000|Overall Study|Withdrawal by Subject|6|||
163493877|NCT02087865|590510265|FG001|Overall Study|Withdrawal by Subject|0|||
163493878|NCT02087865|590510266|FG002|Overall Study|Withdrawal by Subject|1|||
163493879|NCT02087865|590510264|FG000|Overall Study|Lost to Follow-up|0|||
163493880|NCT02087865|590510265|FG001|Overall Study|Lost to Follow-up|0|||
163493881|NCT02087865|590510266|FG002|Overall Study|Lost to Follow-up|1|||
163493882|NCT02087865|590510264|FG000|Overall Study|Drug Non-compliance|0|||
163493883|NCT02087865|590510265|FG001|Overall Study|Drug Non-compliance|2|||
163493884|NCT02087865|590510266|FG002|Overall Study|Drug Non-compliance|0|||
163493885|NCT02087865|590510264|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
163493886|NCT02087865|590510265|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
163493887|NCT02087865|590510266|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
163493888|NCT01319994|590510267|FG000|Overall Study|Protocol Violation|7|||
163493889|NCT01319994|590510268|FG001|Overall Study|Protocol Violation|6|||
163493890|NCT01340794|590510269|FG000|Overall Study|Withdrawal by Subject|0|||
163493891|NCT01340794|590510270|FG001|Overall Study|Withdrawal by Subject|1|||
163493892|NCT01432600|590510277|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
163493893|NCT01432600|590510278|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
163493894|NCT01432600|590510279|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
163493895|NCT00398632|590510280|FG000|Overall Study|Withdrawal by Subject|1|||
163493896|NCT00398632|590510280|FG000|Overall Study|Lack of Efficacy|1|||
163493897|NCT00640614|590510281|FG000|Overall Study|Lost to Follow-up|1|||
163493898|NCT00640614|590510282|FG001|Overall Study|Lost to Follow-up|0|||
163493899|NCT01005680|590510289|FG000|Overall Study|Lost to Follow-up|4|||
163493900|NCT01005680|590510290|FG001|Overall Study|Lost to Follow-up|6|||
163493901|NCT01005680|590510289|FG000|Overall Study|Withdrawal by Subject|1|||
163493902|NCT01005680|590510290|FG001|Overall Study|Withdrawal by Subject|4|||
163493903|NCT01005680|590510289|FG000|Overall Study|Physician Decision|1|||
163493904|NCT01005680|590510290|FG001|Overall Study|Physician Decision|1|||
163493905|NCT00297882|590510292|FG000|Day 14|Lack of Efficacy|12|||
163493906|NCT00297882|590510293|FG001|Day 14|Lack of Efficacy|49|||
163493907|NCT00297882|590510292|FG000|Day 28|Lost to Follow-up|13|||
163493908|NCT00297882|590510293|FG001|Day 28|Lost to Follow-up|23|||
163493909|NCT00297882|590510292|FG000|Day 28|Lack of Efficacy|3|||
163493910|NCT00297882|590510293|FG001|Day 28|Lack of Efficacy|0|||
163493911|NCT02118896|590510294|FG000|Overall Study|Death|4|||
163493912|NCT02118896|590510295|FG001|Overall Study|Death|0|||
163493913|NCT02118896|590510296|FG002|Overall Study|Death|4|||
163493914|NCT02118896|590510297|FG003|Overall Study|Death|6|||
163493915|NCT02118896|590510298|FG004|Overall Study|Death|3|||
163493916|NCT02118896|590510299|FG005|Overall Study|Death|1|||
163493917|NCT02118896|590510300|FG006|Overall Study|Death|0|||
163493918|NCT02118896|590510301|FG007|Overall Study|Death|0|||
163493919|NCT02118896|590510302|FG008|Overall Study|Death|0|||
163493920|NCT02118896|590510303|FG009|Overall Study|Death|0|||
163493921|NCT02118896|590510294|FG000|Overall Study|Adverse Event|5|||
163493922|NCT02118896|590510295|FG001|Overall Study|Adverse Event|4|||
163493923|NCT02118896|590510296|FG002|Overall Study|Adverse Event|4|||
163493924|NCT02118896|590510297|FG003|Overall Study|Adverse Event|5|||
163493925|NCT02118896|590510298|FG004|Overall Study|Adverse Event|5|||
163493926|NCT02118896|590510299|FG005|Overall Study|Adverse Event|9|||
163493927|NCT02118896|590510300|FG006|Overall Study|Adverse Event|1|||
163493928|NCT02118896|590510301|FG007|Overall Study|Adverse Event|1|||
163493929|NCT02118896|590510302|FG008|Overall Study|Adverse Event|4|||
163493930|NCT02118896|590510303|FG009|Overall Study|Adverse Event|0|||
163493931|NCT02118896|590510294|FG000|Overall Study|Consent withdrawn|2|||
163493932|NCT02118896|590510295|FG001|Overall Study|Consent withdrawn|0|||
163493933|NCT02118896|590510296|FG002|Overall Study|Consent withdrawn|3|||
163493934|NCT02118896|590510297|FG003|Overall Study|Consent withdrawn|4|||
163493935|NCT02118896|590510298|FG004|Overall Study|Consent withdrawn|1|||
163493936|NCT02118896|590510299|FG005|Overall Study|Consent withdrawn|4|||
163493937|NCT02118896|590510300|FG006|Overall Study|Consent withdrawn|0|||
163493938|NCT02118896|590510301|FG007|Overall Study|Consent withdrawn|0|||
163493939|NCT02118896|590510302|FG008|Overall Study|Consent withdrawn|0|||
163493940|NCT02118896|590510303|FG009|Overall Study|Consent withdrawn|0|||
163493941|NCT02118896|590510294|FG000|Overall Study|Non-compliance|2|||
163493942|NCT02118896|590510295|FG001|Overall Study|Non-compliance|1|||
163493943|NCT02118896|590510296|FG002|Overall Study|Non-compliance|1|||
163493944|NCT02118896|590510297|FG003|Overall Study|Non-compliance|5|||
163493945|NCT02118896|590510298|FG004|Overall Study|Non-compliance|0|||
163493946|NCT02118896|590510299|FG005|Overall Study|Non-compliance|1|||
163493947|NCT02118896|590510300|FG006|Overall Study|Non-compliance|0|||
163493948|NCT02118896|590510301|FG007|Overall Study|Non-compliance|1|||
163493949|NCT02118896|590510302|FG008|Overall Study|Non-compliance|0|||
163493950|NCT02118896|590510303|FG009|Overall Study|Non-compliance|0|||
163493951|NCT02118896|590510294|FG000|Overall Study|Pregnancy|1|||
163493952|NCT02118896|590510295|FG001|Overall Study|Pregnancy|1|||
163493953|NCT02118896|590510296|FG002|Overall Study|Pregnancy|0|||
163493954|NCT02118896|590510297|FG003|Overall Study|Pregnancy|0|||
163493955|NCT02118896|590510298|FG004|Overall Study|Pregnancy|1|||
163493956|NCT02118896|590510299|FG005|Overall Study|Pregnancy|3|||
163493957|NCT02118896|590510300|FG006|Overall Study|Pregnancy|1|||
163493958|NCT02118896|590510301|FG007|Overall Study|Pregnancy|0|||
163493959|NCT02118896|590510302|FG008|Overall Study|Pregnancy|0|||
163493960|NCT02118896|590510303|FG009|Overall Study|Pregnancy|0|||
163493961|NCT02118896|590510294|FG000|Overall Study|Lost to Follow-up|1|||
163493962|NCT02118896|590510295|FG001|Overall Study|Lost to Follow-up|2|||
163493963|NCT02118896|590510296|FG002|Overall Study|Lost to Follow-up|1|||
163493964|NCT02118896|590510297|FG003|Overall Study|Lost to Follow-up|0|||
163493965|NCT02118896|590510298|FG004|Overall Study|Lost to Follow-up|2|||
163493966|NCT02118896|590510299|FG005|Overall Study|Lost to Follow-up|1|||
163493967|NCT02118896|590510300|FG006|Overall Study|Lost to Follow-up|0|||
163493968|NCT02118896|590510301|FG007|Overall Study|Lost to Follow-up|0|||
163493969|NCT02118896|590510302|FG008|Overall Study|Lost to Follow-up|0|||
163493970|NCT02118896|590510303|FG009|Overall Study|Lost to Follow-up|0|||
163493971|NCT02118896|590510294|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
163493972|NCT02118896|590510295|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
163493973|NCT02118896|590510296|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
163493974|NCT02118896|590510297|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
163493975|NCT02118896|590510298|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
163493976|NCT02118896|590510299|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
163493977|NCT02118896|590510300|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
163493978|NCT02118896|590510301|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
163493979|NCT02118896|590510302|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
163493980|NCT02118896|590510303|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
163493981|NCT02118896|590510294|FG000|Overall Study|Prohibited medication|0|||
163493982|NCT02118896|590510295|FG001|Overall Study|Prohibited medication|0|||
163493983|NCT02118896|590510296|FG002|Overall Study|Prohibited medication|0|||
163493984|NCT02118896|590510297|FG003|Overall Study|Prohibited medication|0|||
163493985|NCT02118896|590510298|FG004|Overall Study|Prohibited medication|1|||
163493986|NCT02118896|590510299|FG005|Overall Study|Prohibited medication|3|||
163493987|NCT02118896|590510300|FG006|Overall Study|Prohibited medication|0|||
163493988|NCT02118896|590510301|FG007|Overall Study|Prohibited medication|0|||
163493989|NCT02118896|590510302|FG008|Overall Study|Prohibited medication|0|||
163493990|NCT02118896|590510303|FG009|Overall Study|Prohibited medication|0|||
163493991|NCT02118896|590510294|FG000|Overall Study|Miscellaneous|1|||
163493992|NCT02118896|590510295|FG001|Overall Study|Miscellaneous|2|||
163493993|NCT02118896|590510296|FG002|Overall Study|Miscellaneous|0|||
163493994|NCT02118896|590510297|FG003|Overall Study|Miscellaneous|2|||
163493995|NCT02118896|590510298|FG004|Overall Study|Miscellaneous|0|||
163493996|NCT02118896|590510299|FG005|Overall Study|Miscellaneous|4|||
163493997|NCT02118896|590510300|FG006|Overall Study|Miscellaneous|0|||
163493998|NCT02118896|590510301|FG007|Overall Study|Miscellaneous|0|||
163493999|NCT02118896|590510302|FG008|Overall Study|Miscellaneous|0|||
163494000|NCT02118896|590510303|FG009|Overall Study|Miscellaneous|0|||
163494001|NCT04242264|590510304|FG000|Overall Study|Lost to Follow-up|2|||
163494002|NCT04242264|590510305|FG001|Overall Study|Lost to Follow-up|2|||
163494003|NCT04242264|590510306|FG002|Overall Study|Lost to Follow-up|1|||
163494004|NCT04242264|590510307|FG003|Overall Study|Lost to Follow-up|1|||
163494005|NCT04242264|590510304|FG000|Overall Study|Withdrawal by Subject|1|||
163494006|NCT04242264|590510305|FG001|Overall Study|Withdrawal by Subject|0|||
163494007|NCT04242264|590510306|FG002|Overall Study|Withdrawal by Subject|0|||
163494008|NCT04242264|590510307|FG003|Overall Study|Withdrawal by Subject|0|||
163494009|NCT04221373|590510308|FG000|Overall Study|Physician Decision|4|||
163494010|NCT04221373|590510309|FG001|Overall Study|Physician Decision|0|||
163494011|NCT04139642|590510319|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
163494012|NCT04139642|590510320|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
163494013|NCT00577031|590510327|FG000|Overall Study|Adverse Event|52|||
163494014|NCT00577031|590510327|FG000|Overall Study|Progression of disease|93|||
163494015|NCT00577031|590510327|FG000|Overall Study|Protocol Violation|5|||
163494016|NCT00577031|590510327|FG000|Overall Study|Participant withdrew consent|13|||
163494017|NCT00577031|590510327|FG000|Overall Study|Participant non-compliance|5|||
163494018|NCT00577031|590510327|FG000|Overall Study|Need for surgery|17|||
163494019|NCT00577031|590510327|FG000|Overall Study|Medical decision|14|||
163494020|NCT00577031|590510327|FG000|Overall Study|Death|6|||
163494021|NCT00557830|590510328|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
163494022|NCT00557830|590510329|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
163494023|NCT00557830|590510330|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
163494024|NCT00557830|590510328|FG000|Screening Treatment Phase|Adverse Event|2|||
163494025|NCT00557830|590510329|FG001|Screening Treatment Phase|Adverse Event|0|||
163494026|NCT00557830|590510330|FG002|Screening Treatment Phase|Adverse Event|0|||
163494027|NCT00557830|590510328|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
163494028|NCT00557830|590510329|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
162925439|NCT02564952|588428975|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
162925440|NCT02564952|588428975|FG000|Overall Study|Withdrawal by Subject|1|||
163494029|NCT00557830|590510330|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
163494030|NCT00538473|590510332|FG000|Overall Study|Adverse Event|1|||
163494031|NCT00538473|590510333|FG001|Overall Study|Adverse Event|0|||
163494032|NCT01569074|590510334|FG000|Overall Study|Study stopped|6|||
163494033|NCT01569074|590510335|FG001|Overall Study|Study stopped|6|||
163494034|NCT01569074|590510336|FG002|Overall Study|Study stopped|8|||
163494035|NCT01569074|590510337|FG003|Overall Study|Study stopped|7|||
163494036|NCT01569074|590510338|FG004|Overall Study|Study stopped|7|||
163494037|NCT01569074|590510334|FG000|Overall Study|Study-specific discontinuation criteria|0|||
163494038|NCT01569074|590510335|FG001|Overall Study|Study-specific discontinuation criteria|1|||
163494039|NCT01569074|590510336|FG002|Overall Study|Study-specific discontinuation criteria|0|||
163494040|NCT01569074|590510337|FG003|Overall Study|Study-specific discontinuation criteria|0|||
163494041|NCT01569074|590510338|FG004|Overall Study|Study-specific discontinuation criteria|0|||
163494042|NCT01569074|590510334|FG000|Overall Study|Severe non-compliance to protocol|0|||
163494043|NCT01569074|590510335|FG001|Overall Study|Severe non-compliance to protocol|0|||
163494044|NCT01569074|590510336|FG002|Overall Study|Severe non-compliance to protocol|1|||
163494045|NCT01569074|590510337|FG003|Overall Study|Severe non-compliance to protocol|0|||
163494046|NCT01569074|590510338|FG004|Overall Study|Severe non-compliance to protocol|0|||
163494047|NCT01569074|590510334|FG000|Overall Study|eg change in circumstances|0|||
163494048|NCT01569074|590510335|FG001|Overall Study|eg change in circumstances|2|||
163494049|NCT01569074|590510336|FG002|Overall Study|eg change in circumstances|0|||
163494050|NCT01569074|590510337|FG003|Overall Study|eg change in circumstances|1|||
163494051|NCT01569074|590510338|FG004|Overall Study|eg change in circumstances|1|||
163494052|NCT01569074|590510334|FG000|Overall Study|Adverse Event|1|||
163494053|NCT01569074|590510335|FG001|Overall Study|Adverse Event|0|||
163494054|NCT01569074|590510336|FG002|Overall Study|Adverse Event|3|||
163494055|NCT01569074|590510337|FG003|Overall Study|Adverse Event|0|||
163494056|NCT01569074|590510338|FG004|Overall Study|Adverse Event|0|||
163494057|NCT00669110|590510339|FG000|Overall Study|Adverse Event|4|||
163494058|NCT00669110|590510340|FG001|Overall Study|Adverse Event|3|||
163494059|NCT00669110|590510339|FG000|Overall Study|Caregiver request|3|||
163494060|NCT00669110|590510340|FG001|Overall Study|Caregiver request|2|||
163494061|NCT00669110|590510339|FG000|Overall Study|Physician Decision|0|||
163494062|NCT00669110|590510340|FG001|Overall Study|Physician Decision|1|||
163494063|NCT00669110|590510339|FG000|Overall Study|Lost to Follow-up|1|||
163494064|NCT00669110|590510340|FG001|Overall Study|Lost to Follow-up|0|||
163494065|NCT00669110|590510339|FG000|Overall Study|Protocol Violation|0|||
163494066|NCT00669110|590510340|FG001|Overall Study|Protocol Violation|5|||
163494067|NCT00669110|590510339|FG000|Overall Study|Withdrawal by Subject|0|||
163494068|NCT00669110|590510340|FG001|Overall Study|Withdrawal by Subject|2|||
163494069|NCT05168657|590510343|FG000|Overall Study|Adverse Event|0|||
163494070|NCT05168657|590510344|FG001|Overall Study|Adverse Event|0|||
163494071|NCT05168657|590510345|FG002|Overall Study|Adverse Event|1|||
163494072|NCT05168657|590510346|FG003|Overall Study|Adverse Event|0|||
163494073|NCT05168657|590510347|FG004|Overall Study|Adverse Event|0|||
163494074|NCT05168657|590510348|FG005|Overall Study|Adverse Event|0|||
163494075|NCT05168657|590510349|FG006|Overall Study|Adverse Event|0|||
163494076|NCT05168657|590510350|FG007|Overall Study|Adverse Event|0|||
163494077|NCT00962013|590510351|FG000|Overall Study|Did not have surgery|1|||
163494078|NCT00962013|590510351|FG000|Overall Study|Death|8|||
163494079|NCT00962013|590510351|FG000|Overall Study|Lost to Follow-up|12|||
163494080|NCT00962013|590510351|FG000|Overall Study|Unable/Unwilling to return|6|||
163494081|NCT00962013|590510351|FG000|Overall Study|Withdrawal by Subject|8|||
163494082|NCT00962013|590510351|FG000|Overall Study|Removal of study device|3|||
163494083|NCT00962013|590510351|FG000|Overall Study|Site Termination|24|||
163494084|NCT00962013|590510351|FG000|Overall Study|No 5 year evaluation|6|||
163494085|NCT02335411|590510352|FG000|Overall Study|Death|223|||
163494086|NCT02335411|590510353|FG001|Overall Study|Death|22|||
163494087|NCT02335411|590510354|FG002|Overall Study|Death|26|||
163494088|NCT02335411|590510352|FG000|Overall Study|Physician Decision|3|||
163494089|NCT02335411|590510353|FG001|Overall Study|Physician Decision|0|||
163494090|NCT02335411|590510354|FG002|Overall Study|Physician Decision|0|||
163494091|NCT02335411|590510352|FG000|Overall Study|Protocol Violation|1|||
163494092|NCT02335411|590510353|FG001|Overall Study|Protocol Violation|0|||
163494093|NCT02335411|590510354|FG002|Overall Study|Protocol Violation|0|||
163494094|NCT02335411|590510352|FG000|Overall Study|Withdrawal by Subject|11|||
163494095|NCT02335411|590510353|FG001|Overall Study|Withdrawal by Subject|0|||
163494096|NCT02335411|590510354|FG002|Overall Study|Withdrawal by Subject|3|||
163494097|NCT02335411|590510352|FG000|Overall Study|Sponsor Decision|12|||
163494098|NCT02335411|590510353|FG001|Overall Study|Sponsor Decision|3|||
163494099|NCT02335411|590510354|FG002|Overall Study|Sponsor Decision|2|||
163494100|NCT02335411|590510352|FG000|Overall Study|Adverse Event|9|||
163494101|NCT02335411|590510353|FG001|Overall Study|Adverse Event|0|||
163494102|NCT02335411|590510354|FG002|Overall Study|Adverse Event|0|||
163494103|NCT03843775|590510355|FG000|Overall Study|Adverse Event|1|||
163494104|NCT03843775|590510356|FG001|Overall Study|Adverse Event|1|||
163494105|NCT03843775|590510355|FG000|Overall Study|Lack of Efficacy|2|||
163494106|NCT03843775|590510356|FG001|Overall Study|Lack of Efficacy|6|||
163494107|NCT03843775|590510355|FG000|Overall Study|Withdrawal by Subject|0|||
163494108|NCT03843775|590510356|FG001|Overall Study|Withdrawal by Subject|1|||
163494109|NCT00530621|590510361|FG000|Overall Study|Adverse Event|11|||
163494110|NCT00530621|590510362|FG001|Overall Study|Adverse Event|8|||
163494111|NCT00530621|590510361|FG000|Overall Study|Physician Decision|2|||
163494112|NCT00530621|590510362|FG001|Overall Study|Physician Decision|4|||
163494113|NCT00530621|590510361|FG000|Overall Study|Progressive Disease (PD)|47|||
163494114|NCT00530621|590510362|FG001|Overall Study|Progressive Disease (PD)|40|||
163494115|NCT00530621|590510361|FG000|Overall Study|Sponsor Decision|12|||
163494116|NCT00530621|590510362|FG001|Overall Study|Sponsor Decision|15|||
163494117|NCT00530621|590510361|FG000|Overall Study|Subject Decision|4|||
163494118|NCT00530621|590510362|FG001|Overall Study|Subject Decision|7|||
163494119|NCT00530621|590510361|FG000|Overall Study|Death|3|||
163494120|NCT00530621|590510362|FG001|Overall Study|Death|6|||
163494121|NCT00530621|590510361|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
163494122|NCT00530621|590510362|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
163494123|NCT02596009|590510363|FG000|Overall Study|Administrative problems|0|||
163494124|NCT02596009|590510364|FG001|Overall Study|Administrative problems|1|||
163494125|NCT02596009|590510365|FG002|Overall Study|Administrative problems|0|||
163494126|NCT02596009|590510366|FG003|Overall Study|Administrative problems|0|||
163494127|NCT02596009|590510367|FG004|Overall Study|Administrative problems|0|||
163494128|NCT02596009|590510368|FG005|Overall Study|Administrative problems|0|||
163494129|NCT04611152|590510369|FG000|Overall Study|Adverse Event|9|||
163494130|NCT04611152|590510370|FG001|Overall Study|Adverse Event|8|||
163494131|NCT04611152|590510369|FG000|Overall Study|Non-compliance with study schedule|1|||
163494132|NCT04611152|590510370|FG001|Overall Study|Non-compliance with study schedule|3|||
163494133|NCT04611152|590510369|FG000|Overall Study|Withdrawal by Subject|5|||
163494134|NCT04611152|590510370|FG001|Overall Study|Withdrawal by Subject|6|||
163494135|NCT04611152|590510369|FG000|Overall Study|Lost to Follow-up|11|||
163494136|NCT04611152|590510370|FG001|Overall Study|Lost to Follow-up|2|||
163494137|NCT01275170|590510378|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
163494138|NCT01275170|590510379|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
163494139|NCT01275170|590510380|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
163494140|NCT01275170|590510381|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
163494141|NCT01275170|590510382|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
163494142|NCT01275170|590510383|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
163494143|NCT01275170|590510384|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
163494144|NCT01275170|590510385|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
163494145|NCT03917654|590510387|FG000|Year 1|Withdrawal by Subject|1|||
163494146|NCT03917654|590510388|FG001|Year 1|Withdrawal by Subject|0|||
163494147|NCT03917654|590510389|FG002|Year 1|Withdrawal by Subject|0|||
163494148|NCT03917654|590510390|FG003|Year 1|Withdrawal by Subject|0|||
163494149|NCT03917654|590510391|FG004|Year 1|Withdrawal by Subject|0|||
163494150|NCT03917654|590510392|FG005|Year 1|Withdrawal by Subject|1|||
163494151|NCT03917654|590510393|FG006|Year 1|Withdrawal by Subject|6|||
163494152|NCT03917654|590510394|FG007|Year 1|Withdrawal by Subject|2|||
163494153|NCT03917654|590510395|FG008|Year 1|Withdrawal by Subject|5|||
163494154|NCT03917654|590510396|FG009|Year 1|Withdrawal by Subject|3|||
163494155|NCT03917654|590510397|FG010|Year 1|Withdrawal by Subject|1|||
163494156|NCT03917654|590510398|FG011|Year 1|Withdrawal by Subject|0|||
163494157|NCT03917654|590510387|FG000|Year 1|Travel|0|||
163494158|NCT03917654|590510388|FG001|Year 1|Travel|1|||
163494159|NCT03917654|590510389|FG002|Year 1|Travel|1|||
163494160|NCT03917654|590510390|FG003|Year 1|Travel|0|||
163494161|NCT03917654|590510391|FG004|Year 1|Travel|4|||
163494162|NCT03917654|590510392|FG005|Year 1|Travel|4|||
163494163|NCT03917654|590510393|FG006|Year 1|Travel|10|||
163494164|NCT03917654|590510394|FG007|Year 1|Travel|8|||
163494165|NCT03917654|590510395|FG008|Year 1|Travel|2|||
163494166|NCT03917654|590510396|FG009|Year 1|Travel|5|||
163494167|NCT03917654|590510397|FG010|Year 1|Travel|3|||
163494168|NCT03917654|590510398|FG011|Year 1|Travel|3|||
163494169|NCT03917654|590510387|FG000|Year 1|Subject moved away from site|0|||
163494170|NCT03917654|590510388|FG001|Year 1|Subject moved away from site|1|||
163494171|NCT03917654|590510389|FG002|Year 1|Subject moved away from site|0|||
163494172|NCT03917654|590510390|FG003|Year 1|Subject moved away from site|0|||
163494173|NCT03917654|590510391|FG004|Year 1|Subject moved away from site|0|||
163494174|NCT03917654|590510392|FG005|Year 1|Subject moved away from site|0|||
163494175|NCT03917654|590510393|FG006|Year 1|Subject moved away from site|1|||
163494176|NCT03917654|590510394|FG007|Year 1|Subject moved away from site|2|||
163494177|NCT03917654|590510395|FG008|Year 1|Subject moved away from site|1|||
163494178|NCT03917654|590510396|FG009|Year 1|Subject moved away from site|0|||
163494179|NCT03917654|590510397|FG010|Year 1|Subject moved away from site|0|||
163494180|NCT03917654|590510398|FG011|Year 1|Subject moved away from site|3|||
163494181|NCT03917654|590510387|FG000|Year 1|Spouse/Family member request|0|||
163494182|NCT03917654|590510388|FG001|Year 1|Spouse/Family member request|0|||
163494183|NCT03917654|590510389|FG002|Year 1|Spouse/Family member request|1|||
163494184|NCT03917654|590510390|FG003|Year 1|Spouse/Family member request|0|||
163494185|NCT03917654|590510391|FG004|Year 1|Spouse/Family member request|1|||
163494186|NCT03917654|590510392|FG005|Year 1|Spouse/Family member request|0|||
163494187|NCT03917654|590510393|FG006|Year 1|Spouse/Family member request|0|||
163494188|NCT03917654|590510394|FG007|Year 1|Spouse/Family member request|2|||
163494189|NCT03917654|590510395|FG008|Year 1|Spouse/Family member request|0|||
163494190|NCT03917654|590510396|FG009|Year 1|Spouse/Family member request|0|||
163494191|NCT03917654|590510397|FG010|Year 1|Spouse/Family member request|0|||
163494192|NCT03917654|590510398|FG011|Year 1|Spouse/Family member request|1|||
163494193|NCT03917654|590510387|FG000|Year 1|Death|0|||
163494194|NCT03917654|590510388|FG001|Year 1|Death|0|||
163494195|NCT03917654|590510389|FG002|Year 1|Death|0|||
163494196|NCT03917654|590510390|FG003|Year 1|Death|0|||
163494197|NCT03917654|590510391|FG004|Year 1|Death|0|||
163494198|NCT03917654|590510392|FG005|Year 1|Death|0|||
163494199|NCT03917654|590510393|FG006|Year 1|Death|0|||
163494200|NCT03917654|590510394|FG007|Year 1|Death|0|||
163494201|NCT03917654|590510395|FG008|Year 1|Death|1|||
163494202|NCT03917654|590510396|FG009|Year 1|Death|1|||
163494203|NCT03917654|590510397|FG010|Year 1|Death|0|||
163494204|NCT03917654|590510398|FG011|Year 1|Death|0|||
163494205|NCT03917654|590510387|FG000|Year 1|Lost to Follow-up|0|||
163494206|NCT03917654|590510388|FG001|Year 1|Lost to Follow-up|0|||
163494207|NCT03917654|590510389|FG002|Year 1|Lost to Follow-up|0|||
163494208|NCT03917654|590510390|FG003|Year 1|Lost to Follow-up|0|||
163494209|NCT03917654|590510391|FG004|Year 1|Lost to Follow-up|0|||
163494210|NCT03917654|590510392|FG005|Year 1|Lost to Follow-up|0|||
163494211|NCT03917654|590510393|FG006|Year 1|Lost to Follow-up|2|||
163494212|NCT03917654|590510394|FG007|Year 1|Lost to Follow-up|0|||
163494213|NCT03917654|590510395|FG008|Year 1|Lost to Follow-up|0|||
163494214|NCT03917654|590510396|FG009|Year 1|Lost to Follow-up|0|||
163494215|NCT03917654|590510397|FG010|Year 1|Lost to Follow-up|0|||
163494216|NCT03917654|590510398|FG011|Year 1|Lost to Follow-up|0|||
163494217|NCT03917654|590510387|FG000|Year 1|Missed visits|0|||
163494218|NCT03917654|590510388|FG001|Year 1|Missed visits|0|||
163494219|NCT03917654|590510389|FG002|Year 1|Missed visits|0|||
163494220|NCT03917654|590510390|FG003|Year 1|Missed visits|0|||
163494221|NCT03917654|590510391|FG004|Year 1|Missed visits|0|||
163494222|NCT03917654|590510392|FG005|Year 1|Missed visits|0|||
163494223|NCT03917654|590510393|FG006|Year 1|Missed visits|0|||
163494224|NCT03917654|590510394|FG007|Year 1|Missed visits|0|||
163494225|NCT03917654|590510395|FG008|Year 1|Missed visits|0|||
163494226|NCT03917654|590510396|FG009|Year 1|Missed visits|0|||
163494227|NCT03917654|590510397|FG010|Year 1|Missed visits|1|||
163494228|NCT03917654|590510398|FG011|Year 1|Missed visits|1|||
163494229|NCT03917654|590510387|FG000|Year 1|Pregnancy|0|||
163494230|NCT03917654|590510388|FG001|Year 1|Pregnancy|0|||
163494231|NCT03917654|590510389|FG002|Year 1|Pregnancy|0|||
163494232|NCT03917654|590510390|FG003|Year 1|Pregnancy|0|||
163494233|NCT03917654|590510391|FG004|Year 1|Pregnancy|0|||
163494234|NCT03917654|590510392|FG005|Year 1|Pregnancy|0|||
163494235|NCT03917654|590510393|FG006|Year 1|Pregnancy|0|||
163494236|NCT03917654|590510394|FG007|Year 1|Pregnancy|1|||
163494237|NCT03917654|590510395|FG008|Year 1|Pregnancy|0|||
163494238|NCT03917654|590510396|FG009|Year 1|Pregnancy|1|||
163494239|NCT03917654|590510397|FG010|Year 1|Pregnancy|0|||
163494240|NCT03917654|590510398|FG011|Year 1|Pregnancy|0|||
163494241|NCT03917654|590510387|FG000|Year 2|Travel|1|||
163494242|NCT03917654|590510388|FG001|Year 2|Travel|0|||
163494243|NCT03917654|590510389|FG002|Year 2|Travel|0|||
163494244|NCT03917654|590510390|FG003|Year 2|Travel|0|||
163494245|NCT03917654|590510391|FG004|Year 2|Travel|1|||
163494246|NCT03917654|590510392|FG005|Year 2|Travel|1|||
163494247|NCT03917654|590510393|FG006|Year 2|Travel|2|||
163494248|NCT03917654|590510394|FG007|Year 2|Travel|1|||
163494249|NCT03917654|590510395|FG008|Year 2|Travel|0|||
163494250|NCT03917654|590510396|FG009|Year 2|Travel|1|||
163494251|NCT03917654|590510397|FG010|Year 2|Travel|0|||
163494252|NCT03917654|590510398|FG011|Year 2|Travel|1|||
163494253|NCT03917654|590510387|FG000|Year 2|Married|1|||
163494254|NCT03917654|590510388|FG001|Year 2|Married|0|||
163494255|NCT03917654|590510389|FG002|Year 2|Married|0|||
163494256|NCT03917654|590510390|FG003|Year 2|Married|0|||
163494257|NCT03917654|590510391|FG004|Year 2|Married|0|||
163494258|NCT03917654|590510392|FG005|Year 2|Married|0|||
163494259|NCT03917654|590510393|FG006|Year 2|Married|1|||
163494260|NCT03917654|590510394|FG007|Year 2|Married|1|||
163494261|NCT03917654|590510395|FG008|Year 2|Married|0|||
163494262|NCT03917654|590510396|FG009|Year 2|Married|0|||
163494263|NCT03917654|590510397|FG010|Year 2|Married|0|||
163494264|NCT03917654|590510398|FG011|Year 2|Married|0|||
163494265|NCT03917654|590510387|FG000|Year 2|Subject moved away from site|1|||
163494266|NCT03917654|590510388|FG001|Year 2|Subject moved away from site|0|||
163494267|NCT03917654|590510389|FG002|Year 2|Subject moved away from site|0|||
163494268|NCT03917654|590510390|FG003|Year 2|Subject moved away from site|0|||
163494269|NCT03917654|590510391|FG004|Year 2|Subject moved away from site|1|||
163494270|NCT03917654|590510392|FG005|Year 2|Subject moved away from site|0|||
163494271|NCT03917654|590510393|FG006|Year 2|Subject moved away from site|2|||
163494272|NCT03917654|590510394|FG007|Year 2|Subject moved away from site|3|||
163494273|NCT03917654|590510395|FG008|Year 2|Subject moved away from site|0|||
163494274|NCT03917654|590510396|FG009|Year 2|Subject moved away from site|2|||
163494275|NCT03917654|590510397|FG010|Year 2|Subject moved away from site|0|||
163494276|NCT03917654|590510398|FG011|Year 2|Subject moved away from site|1|||
163494277|NCT03917654|590510387|FG000|Year 2|Year 2 Screening failure|0|||
163494278|NCT03917654|590510388|FG001|Year 2|Year 2 Screening failure|1|||
163494279|NCT03917654|590510389|FG002|Year 2|Year 2 Screening failure|0|||
163494280|NCT03917654|590510390|FG003|Year 2|Year 2 Screening failure|0|||
163494281|NCT03917654|590510391|FG004|Year 2|Year 2 Screening failure|2|||
163494282|NCT03917654|590510392|FG005|Year 2|Year 2 Screening failure|0|||
163494283|NCT03917654|590510393|FG006|Year 2|Year 2 Screening failure|4|||
163494284|NCT03917654|590510394|FG007|Year 2|Year 2 Screening failure|3|||
163494285|NCT03917654|590510395|FG008|Year 2|Year 2 Screening failure|10|||
163494286|NCT03917654|590510396|FG009|Year 2|Year 2 Screening failure|2|||
163494287|NCT03917654|590510397|FG010|Year 2|Year 2 Screening failure|1|||
163494288|NCT03917654|590510398|FG011|Year 2|Year 2 Screening failure|1|||
163494289|NCT03917654|590510387|FG000|Year 2|Death|0|||
163494290|NCT03917654|590510388|FG001|Year 2|Death|0|||
163494291|NCT03917654|590510389|FG002|Year 2|Death|0|||
163494292|NCT03917654|590510390|FG003|Year 2|Death|0|||
163494293|NCT03917654|590510391|FG004|Year 2|Death|0|||
163494294|NCT03917654|590510392|FG005|Year 2|Death|1|||
163494295|NCT03917654|590510393|FG006|Year 2|Death|0|||
163494296|NCT03917654|590510394|FG007|Year 2|Death|0|||
163494297|NCT03917654|590510395|FG008|Year 2|Death|1|||
163494298|NCT03917654|590510396|FG009|Year 2|Death|1|||
163494299|NCT03917654|590510397|FG010|Year 2|Death|0|||
163494300|NCT03917654|590510398|FG011|Year 2|Death|0|||
163494301|NCT03917654|590510387|FG000|Year 2|Withdrawal by Subject|0|||
163494302|NCT03917654|590510388|FG001|Year 2|Withdrawal by Subject|0|||
163494303|NCT03917654|590510389|FG002|Year 2|Withdrawal by Subject|0|||
163494304|NCT03917654|590510390|FG003|Year 2|Withdrawal by Subject|0|||
163494305|NCT03917654|590510391|FG004|Year 2|Withdrawal by Subject|0|||
163494306|NCT03917654|590510392|FG005|Year 2|Withdrawal by Subject|0|||
163494307|NCT03917654|590510393|FG006|Year 2|Withdrawal by Subject|3|||
163494308|NCT03917654|590510394|FG007|Year 2|Withdrawal by Subject|0|||
163494309|NCT03917654|590510395|FG008|Year 2|Withdrawal by Subject|2|||
163494310|NCT03917654|590510396|FG009|Year 2|Withdrawal by Subject|5|||
163494311|NCT03917654|590510397|FG010|Year 2|Withdrawal by Subject|0|||
163494312|NCT03917654|590510398|FG011|Year 2|Withdrawal by Subject|0|||
163494313|NCT03917654|590510387|FG000|Year 2|Spouse/family member request|0|||
163494314|NCT03917654|590510388|FG001|Year 2|Spouse/family member request|0|||
163494315|NCT03917654|590510389|FG002|Year 2|Spouse/family member request|0|||
163494316|NCT03917654|590510390|FG003|Year 2|Spouse/family member request|0|||
163494317|NCT03917654|590510391|FG004|Year 2|Spouse/family member request|0|||
163494318|NCT03917654|590510392|FG005|Year 2|Spouse/family member request|0|||
163494319|NCT03917654|590510393|FG006|Year 2|Spouse/family member request|1|||
163494320|NCT03917654|590510394|FG007|Year 2|Spouse/family member request|0|||
163494321|NCT03917654|590510395|FG008|Year 2|Spouse/family member request|0|||
163494322|NCT03917654|590510396|FG009|Year 2|Spouse/family member request|0|||
163494323|NCT03917654|590510397|FG010|Year 2|Spouse/family member request|0|||
163494324|NCT03917654|590510398|FG011|Year 2|Spouse/family member request|0|||
163494325|NCT03917654|590510387|FG000|Year 2|Lost to Follow-up|0|||
163494326|NCT03917654|590510388|FG001|Year 2|Lost to Follow-up|0|||
163494327|NCT03917654|590510389|FG002|Year 2|Lost to Follow-up|0|||
163494328|NCT03917654|590510390|FG003|Year 2|Lost to Follow-up|0|||
163494329|NCT03917654|590510391|FG004|Year 2|Lost to Follow-up|0|||
163494330|NCT03917654|590510392|FG005|Year 2|Lost to Follow-up|0|||
163494331|NCT03917654|590510393|FG006|Year 2|Lost to Follow-up|1|||
163494332|NCT03917654|590510394|FG007|Year 2|Lost to Follow-up|0|||
163494333|NCT03917654|590510395|FG008|Year 2|Lost to Follow-up|1|||
163494334|NCT03917654|590510396|FG009|Year 2|Lost to Follow-up|0|||
163494335|NCT03917654|590510397|FG010|Year 2|Lost to Follow-up|0|||
163494336|NCT03917654|590510398|FG011|Year 2|Lost to Follow-up|1|||
163494337|NCT03917654|590510387|FG000|Year 2|Adverse Event|0|||
163494338|NCT03917654|590510388|FG001|Year 2|Adverse Event|0|||
163494339|NCT03917654|590510389|FG002|Year 2|Adverse Event|0|||
163494340|NCT03917654|590510390|FG003|Year 2|Adverse Event|0|||
163494341|NCT03917654|590510391|FG004|Year 2|Adverse Event|0|||
163494342|NCT03917654|590510392|FG005|Year 2|Adverse Event|0|||
163494343|NCT03917654|590510393|FG006|Year 2|Adverse Event|0|||
163494344|NCT03917654|590510394|FG007|Year 2|Adverse Event|0|||
163494345|NCT03917654|590510395|FG008|Year 2|Adverse Event|0|||
163494346|NCT03917654|590510396|FG009|Year 2|Adverse Event|1|||
163494347|NCT03917654|590510397|FG010|Year 2|Adverse Event|0|||
163494348|NCT03917654|590510398|FG011|Year 2|Adverse Event|0|||
163494349|NCT05012943|590510399|FG000|Overall Study|Adverse Event|2|||
163494350|NCT05012943|590510400|FG001|Overall Study|Adverse Event|1|||
163494351|NCT05012943|590510401|FG002|Overall Study|Adverse Event|0|||
163494352|NCT05012943|590510399|FG000|Overall Study|Withdrawal by Subject|1052|||
163494353|NCT05012943|590510400|FG001|Overall Study|Withdrawal by Subject|1006|||
163494354|NCT05012943|590510401|FG002|Overall Study|Withdrawal by Subject|20|||
163494355|NCT05012943|590510399|FG000|Overall Study|Death|25|||
163494356|NCT05012943|590510400|FG001|Overall Study|Death|17|||
163494357|NCT05012943|590510401|FG002|Overall Study|Death|4|||
163494358|NCT05012943|590510399|FG000|Overall Study|Lost to Follow-up|11|||
163494359|NCT05012943|590510400|FG001|Overall Study|Lost to Follow-up|24|||
163494360|NCT05012943|590510401|FG002|Overall Study|Lost to Follow-up|3|||
163494361|NCT05012943|590510399|FG000|Overall Study|Physician Decision|1|||
163494362|NCT05012943|590510400|FG001|Overall Study|Physician Decision|1|||
163494363|NCT05012943|590510401|FG002|Overall Study|Physician Decision|0|||
163494364|NCT05012943|590510399|FG000|Overall Study|Other than Specified|2|||
163494365|NCT05012943|590510400|FG001|Overall Study|Other than Specified|1|||
163494366|NCT05012943|590510401|FG002|Overall Study|Other than Specified|0|||
163494367|NCT00400985|590510402|FG000|Overall Study|Withdrawal by Subject|5|||
163494368|NCT00400985|590510402|FG000|Overall Study|system modification|8|||
163494369|NCT00400985|590510402|FG000|Overall Study|Death|30|||
163494370|NCT00400985|590510402|FG000|Overall Study|Lost to Follow-up|9|||
163494371|NCT04755283|590510405|FG000|Overall Study|Withdrawal by Subject|14|||
163494372|NCT04755283|590510406|FG001|Overall Study|Withdrawal by Subject|3|||
163494373|NCT04755283|590510407|FG002|Overall Study|Withdrawal by Subject|6|||
163494374|NCT04755283|590510405|FG000|Overall Study|Lost to Follow-up|0|||
163494375|NCT04755283|590510406|FG001|Overall Study|Lost to Follow-up|0|||
163494376|NCT04755283|590510407|FG002|Overall Study|Lost to Follow-up|1|||
163494377|NCT04755283|590510405|FG000|Overall Study|Death|31|||
163494378|NCT04755283|590510406|FG001|Overall Study|Death|36|||
163494379|NCT04755283|590510407|FG002|Overall Study|Death|34|||
163494380|NCT02851069|590510408|FG000|Overall Study|Failure to Return|3|||
163494381|NCT02851069|590510408|FG000|Overall Study|Other|3|||
163494382|NCT02684162|590510409|FG000|Overall Study|Physician Decision|0|||
163494383|NCT02684162|590510410|FG001|Overall Study|Physician Decision|1|||
163494384|NCT02684162|590510411|FG002|Overall Study|Physician Decision|0|||
163494385|NCT03743571|590510414|FG000|Overall Study|Withdrawal by Subject|1|||
163494386|NCT03743571|590510415|FG001|Overall Study|Withdrawal by Subject|1|||
163494387|NCT03743571|590510414|FG000|Overall Study|Lost to Follow-up|1|||
163494388|NCT03743571|590510415|FG001|Overall Study|Lost to Follow-up|2|||
163494389|NCT01489865|590510416|FG000|Overall Study|Progression of Disease|4|||
163494390|NCT01489865|590510417|FG001|Overall Study|Progression of Disease|2|||
163494391|NCT01489865|590510418|FG002|Overall Study|Progression of Disease|2|||
163494392|NCT01489865|590510419|FG003|Overall Study|Progression of Disease|3|||
163494393|NCT01489865|590510420|FG004|Overall Study|Progression of Disease|1|||
163494394|NCT01489865|590510421|FG005|Overall Study|Progression of Disease|6|||
163494395|NCT01489865|590510422|FG006|Overall Study|Progression of Disease|3|||
163494396|NCT01489865|590510423|FG007|Overall Study|Progression of Disease|0|||
163494397|NCT01489865|590510424|FG008|Overall Study|Progression of Disease|23|||
163494398|NCT01489865|590510416|FG000|Overall Study|Adverse Event|2|||
163494399|NCT01489865|590510417|FG001|Overall Study|Adverse Event|0|||
163494400|NCT01489865|590510418|FG002|Overall Study|Adverse Event|0|||
163494401|NCT01489865|590510419|FG003|Overall Study|Adverse Event|0|||
163494402|NCT01489865|590510420|FG004|Overall Study|Adverse Event|1|||
163494403|NCT01489865|590510421|FG005|Overall Study|Adverse Event|0|||
163494404|NCT01489865|590510422|FG006|Overall Study|Adverse Event|2|||
163494405|NCT01489865|590510423|FG007|Overall Study|Adverse Event|0|||
163494406|NCT01489865|590510424|FG008|Overall Study|Adverse Event|5|||
163494407|NCT01489865|590510416|FG000|Overall Study|Death|0|||
163494408|NCT01489865|590510417|FG001|Overall Study|Death|1|||
163494409|NCT01489865|590510418|FG002|Overall Study|Death|0|||
163494410|NCT01489865|590510419|FG003|Overall Study|Death|0|||
163494411|NCT01489865|590510420|FG004|Overall Study|Death|1|||
163494412|NCT01489865|590510421|FG005|Overall Study|Death|0|||
163494413|NCT01489865|590510422|FG006|Overall Study|Death|0|||
163494414|NCT01489865|590510423|FG007|Overall Study|Death|0|||
163494415|NCT01489865|590510424|FG008|Overall Study|Death|2|||
163494416|NCT01489865|590510416|FG000|Overall Study|Withdrawal by Subject|0|||
163494417|NCT01489865|590510417|FG001|Overall Study|Withdrawal by Subject|0|||
163494418|NCT01489865|590510418|FG002|Overall Study|Withdrawal by Subject|0|||
163494419|NCT01489865|590510419|FG003|Overall Study|Withdrawal by Subject|0|||
163494420|NCT01489865|590510420|FG004|Overall Study|Withdrawal by Subject|0|||
163494421|NCT01489865|590510421|FG005|Overall Study|Withdrawal by Subject|1|||
163494422|NCT01489865|590510422|FG006|Overall Study|Withdrawal by Subject|1|||
163494423|NCT01489865|590510423|FG007|Overall Study|Withdrawal by Subject|0|||
163494424|NCT01489865|590510424|FG008|Overall Study|Withdrawal by Subject|2|||
163494425|NCT01489865|590510416|FG000|Overall Study|Shifted|0|||
163494426|NCT01489865|590510417|FG001|Overall Study|Shifted|0|||
163494427|NCT01489865|590510418|FG002|Overall Study|Shifted|1|||
163494428|NCT01489865|590510419|FG003|Overall Study|Shifted|0|||
163494429|NCT01489865|590510420|FG004|Overall Study|Shifted|0|||
163494430|NCT01489865|590510421|FG005|Overall Study|Shifted|0|||
163494431|NCT01489865|590510422|FG006|Overall Study|Shifted|0|||
163494432|NCT01489865|590510423|FG007|Overall Study|Shifted|0|||
163494433|NCT01489865|590510424|FG008|Overall Study|Shifted|0|||
163494434|NCT04115488|590510425|FG000|Overall Study|Adverse Event|8|||
163494435|NCT04115488|590510426|FG001|Overall Study|Adverse Event|4|||
163494436|NCT04115488|590510425|FG000|Overall Study|Withdrawal by Subject|3|||
163494437|NCT04115488|590510426|FG001|Overall Study|Withdrawal by Subject|6|||
163494438|NCT04115488|590510425|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
163494439|NCT04115488|590510426|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
163494440|NCT04115488|590510425|FG000|Overall Study|Patient 's location change|1|||
163494441|NCT04115488|590510426|FG001|Overall Study|Patient 's location change|0|||
163494442|NCT04115488|590510425|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
163494443|NCT04115488|590510426|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
163494444|NCT00885677|590510427|FG000|Overall Study|Death|40|||
163494445|NCT00885677|590510428|FG001|Overall Study|Death|34|||
163494446|NCT00885677|590510427|FG000|Overall Study|Lost to Follow-up|15|||
163494447|NCT00885677|590510428|FG001|Overall Study|Lost to Follow-up|13|||
163494448|NCT00885677|590510427|FG000|Overall Study|Protocol Violation|54|||
163494449|NCT00885677|590510428|FG001|Overall Study|Protocol Violation|54|||
163494450|NCT00885677|590510427|FG000|Overall Study|premature study closure|41|||
163494451|NCT00885677|590510428|FG001|Overall Study|premature study closure|44|||
163494452|NCT00885677|590510427|FG000|Overall Study|device/lead revision or replacement|7|||
163494453|NCT00885677|590510428|FG001|Overall Study|device/lead revision or replacement|6|||
163494454|NCT00885677|590510427|FG000|Overall Study|Heart transplantation|1|||
163494455|NCT00885677|590510428|FG001|Overall Study|Heart transplantation|0|||
163494456|NCT00885677|590510427|FG000|Overall Study|Inclusion/exclusion not met|25|||
163494457|NCT00885677|590510428|FG001|Overall Study|Inclusion/exclusion not met|27|||
163494458|NCT00972309|590510429|FG000|Overall Study|Switched to alternative treatment|0|||
163494459|NCT00972309|590510430|FG001|Overall Study|Switched to alternative treatment|2|||
163494460|NCT00972309|590510429|FG000|Overall Study|Refused further treatment|0|||
163494461|NCT00972309|590510430|FG001|Overall Study|Refused further treatment|1|||
163494462|NCT00972309|590510429|FG000|Overall Study|Late determination of ineligibility|0|||
163494463|NCT00972309|590510430|FG001|Overall Study|Late determination of ineligibility|1|||
163494464|NCT00972309|590510429|FG000|Overall Study|Second malignancy|1|||
163494465|NCT00972309|590510430|FG001|Overall Study|Second malignancy|1|||
163494466|NCT00972309|590510429|FG000|Overall Study|Visa issues|0|||
163494467|NCT00972309|590510430|FG001|Overall Study|Visa issues|1|||
163494468|NCT00972309|590510429|FG000|Overall Study|Secondary cancer (SCC)|0|||
163494469|NCT00972309|590510430|FG001|Overall Study|Secondary cancer (SCC)|1|||
163494470|NCT00972309|590510429|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
163494471|NCT00972309|590510430|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
163494472|NCT00972309|590510429|FG000|Overall Study|Lost to Follow-up|1|||
163494473|NCT00972309|590510430|FG001|Overall Study|Lost to Follow-up|1|||
163494474|NCT00972309|590510429|FG000|Overall Study|Disease progression on study|10|||
163494475|NCT00972309|590510430|FG001|Overall Study|Disease progression on study|4|||
163494476|NCT01058707|590510442|FG000|Overall Study|Disease Progression|15|||
163494477|NCT01058707|590510443|FG001|Overall Study|Disease Progression|20|||
163494478|NCT01058707|590510444|FG002|Overall Study|Disease Progression|20|||
163494479|NCT01058707|590510445|FG003|Overall Study|Disease Progression|15|||
163494480|NCT01058707|590510446|FG004|Overall Study|Disease Progression|23|||
163494481|NCT01058707|590510447|FG005|Overall Study|Disease Progression|10|||
163494482|NCT01058707|590510448|FG006|Overall Study|Disease Progression|12|||
163494483|NCT01058707|590510442|FG000|Overall Study|Adverse Event|11|||
163494484|NCT01058707|590510443|FG001|Overall Study|Adverse Event|4|||
163494485|NCT01058707|590510444|FG002|Overall Study|Adverse Event|7|||
163494486|NCT01058707|590510445|FG003|Overall Study|Adverse Event|6|||
163494487|NCT01058707|590510446|FG004|Overall Study|Adverse Event|7|||
163494488|NCT01058707|590510447|FG005|Overall Study|Adverse Event|3|||
163494489|NCT01058707|590510448|FG006|Overall Study|Adverse Event|1|||
163494490|NCT01058707|590510442|FG000|Overall Study|Subject Decision|5|||
163494491|NCT01058707|590510443|FG001|Overall Study|Subject Decision|3|||
163494492|NCT01058707|590510444|FG002|Overall Study|Subject Decision|3|||
163494493|NCT01058707|590510445|FG003|Overall Study|Subject Decision|1|||
163494494|NCT01058707|590510446|FG004|Overall Study|Subject Decision|2|||
163494495|NCT01058707|590510447|FG005|Overall Study|Subject Decision|3|||
163494496|NCT01058707|590510448|FG006|Overall Study|Subject Decision|6|||
163494497|NCT01058707|590510442|FG000|Overall Study|Lost to Follow-up|0|||
163494498|NCT01058707|590510443|FG001|Overall Study|Lost to Follow-up|0|||
163494499|NCT01058707|590510444|FG002|Overall Study|Lost to Follow-up|1|||
163494500|NCT01058707|590510445|FG003|Overall Study|Lost to Follow-up|0|||
163494501|NCT01058707|590510446|FG004|Overall Study|Lost to Follow-up|0|||
163494502|NCT01058707|590510447|FG005|Overall Study|Lost to Follow-up|0|||
163494503|NCT01058707|590510448|FG006|Overall Study|Lost to Follow-up|0|||
163494504|NCT01058707|590510442|FG000|Overall Study|Reason Not Specified|0|||
163494505|NCT01058707|590510443|FG001|Overall Study|Reason Not Specified|3|||
163494506|NCT01058707|590510444|FG002|Overall Study|Reason Not Specified|2|||
163494507|NCT01058707|590510445|FG003|Overall Study|Reason Not Specified|0|||
163494508|NCT01058707|590510446|FG004|Overall Study|Reason Not Specified|7|||
163494509|NCT01058707|590510447|FG005|Overall Study|Reason Not Specified|1|||
163494510|NCT01058707|590510448|FG006|Overall Study|Reason Not Specified|7|||
163494511|NCT00167414|590510451|FG000|Overall Study|Death|10|||
163494512|NCT00795886|590510456|FG000|Overall Study|Death|10|||
163494513|NCT05554471|590510457|FG000|Overall Study|Physician Decision|2|||
163494514|NCT05554471|590510458|FG001|Overall Study|Physician Decision|1|||
163494515|NCT05554471|590510457|FG000|Overall Study|Lost to Follow-up|2|||
163494516|NCT05554471|590510458|FG001|Overall Study|Lost to Follow-up|1|||
163494517|NCT05554471|590510457|FG000|Overall Study|Death|0|||
163494518|NCT05554471|590510458|FG001|Overall Study|Death|1|||
163494519|NCT02062385|590510461|FG000|Overall Study|Adverse Event|19|||
163494520|NCT02062385|590510462|FG001|Overall Study|Adverse Event|13|||
163494521|NCT02062385|590510463|FG002|Overall Study|Adverse Event|1|||
163494522|NCT02062385|590510464|FG003|Overall Study|Adverse Event|0|||
163494523|NCT02062385|590510461|FG000|Overall Study|Protocol Violation|1|||
163494524|NCT02062385|590510462|FG001|Overall Study|Protocol Violation|0|||
163494525|NCT02062385|590510463|FG002|Overall Study|Protocol Violation|0|||
163494526|NCT02062385|590510464|FG003|Overall Study|Protocol Violation|0|||
163494527|NCT02062385|590510461|FG000|Overall Study|Incomplete EPI by database lock|2|||
163494528|NCT02062385|590510462|FG001|Overall Study|Incomplete EPI by database lock|0|||
163494529|NCT02062385|590510463|FG002|Overall Study|Incomplete EPI by database lock|0|||
163494530|NCT02062385|590510464|FG003|Overall Study|Incomplete EPI by database lock|0|||
163494531|NCT02062385|590510461|FG000|Overall Study|Moved|10|||
163494532|NCT02062385|590510462|FG001|Overall Study|Moved|11|||
163494533|NCT02062385|590510463|FG002|Overall Study|Moved|1|||
163494534|NCT02062385|590510464|FG003|Overall Study|Moved|0|||
163494535|NCT02062385|590510461|FG000|Overall Study|Withdrawn by parent/guardian|46|||
163494536|NCT02062385|590510462|FG001|Overall Study|Withdrawn by parent/guardian|41|||
163494537|NCT02062385|590510463|FG002|Overall Study|Withdrawn by parent/guardian|9|||
163494538|NCT02062385|590510464|FG003|Overall Study|Withdrawn by parent/guardian|8|||
163494539|NCT02062385|590510461|FG000|Overall Study|Death|0|||
163494540|NCT02062385|590510462|FG001|Overall Study|Death|0|||
163494541|NCT02062385|590510463|FG002|Overall Study|Death|0|||
163494542|NCT02062385|590510464|FG003|Overall Study|Death|1|||
163494543|NCT02062385|590510461|FG000|Overall Study|Lost to Follow-up|0|||
163494544|NCT02062385|590510462|FG001|Overall Study|Lost to Follow-up|0|||
163494545|NCT02062385|590510463|FG002|Overall Study|Lost to Follow-up|1|||
163494546|NCT02062385|590510464|FG003|Overall Study|Lost to Follow-up|0|||
163494547|NCT03188991|590510465|FG000|Overall Study|Withdrawal by Subject|0|||
163494548|NCT03188991|590510466|FG001|Overall Study|Withdrawal by Subject|0|||
163494549|NCT03188991|590510467|FG002|Overall Study|Withdrawal by Subject|0|||
163494550|NCT03188991|590510468|FG003|Overall Study|Withdrawal by Subject|1|||
163494551|NCT02674568|590512234|FG000|Overall Study|Withdrawal by Subject|5|||
163494552|NCT02674568|590512234|FG000|Overall Study|Death|303|||
163494553|NCT02674568|590512234|FG000|Overall Study|Physician Decision|2|||
163494554|NCT02674568|590512234|FG000|Overall Study|Lost to Follow-up|9|||
163494555|NCT02674568|590512234|FG000|Overall Study|Other, Not Specified|20|||
163494556|NCT01808508|590512237|FG000|Overall Study|Lost to Follow-up|1|||
163494557|NCT01808508|590512238|FG001|Overall Study|Lost to Follow-up|0|||
163494558|NCT01808508|590512239|FG002|Overall Study|Lost to Follow-up|0|||
163494559|NCT01118949|590512240|FG000|Overall Study|Adverse Event|5|||
163494560|NCT01118949|590512240|FG000|Overall Study|Withdrawal by Subject|4|||
163494561|NCT03255226|590512241|FG000|Overall Study|Adverse Event|2|||
163494562|NCT03255226|590512241|FG000|Overall Study|Physician Decision|3|||
163494563|NCT03255226|590512241|FG000|Overall Study|Withdrawal by Subject|1|||
163494564|NCT03255226|590512241|FG000|Overall Study|Serum or blood sodium increased|4|||
163494565|NCT03255226|590512241|FG000|Overall Study|Serum or blood potassium increased|4|||
163494566|NCT00648739|590512242|FG000|Overall Study|Adverse Event|1|||
163494567|NCT00648739|590512243|FG001|Overall Study|Adverse Event|0|||
163494568|NCT00648739|590512244|FG002|Overall Study|Adverse Event|1|||
163494569|NCT00648739|590512245|FG003|Overall Study|Adverse Event|2|||
163494570|NCT00648739|590512246|FG004|Overall Study|Adverse Event|1|||
163494571|NCT00648739|590512247|FG005|Overall Study|Adverse Event|0|||
163494572|NCT00648739|590512248|FG006|Overall Study|Adverse Event|0|||
163494573|NCT00648739|590512242|FG000|Overall Study|Withdrawal by Subject|1|||
163494574|NCT00648739|590512243|FG001|Overall Study|Withdrawal by Subject|0|||
163494575|NCT00648739|590512244|FG002|Overall Study|Withdrawal by Subject|1|||
163494576|NCT00648739|590512245|FG003|Overall Study|Withdrawal by Subject|0|||
163494577|NCT00648739|590512246|FG004|Overall Study|Withdrawal by Subject|0|||
163494578|NCT00648739|590512247|FG005|Overall Study|Withdrawal by Subject|2|||
162925441|NCT02564952|588428975|FG000|Overall Study|Low Efficacy|1|||
163494579|NCT00648739|590512248|FG006|Overall Study|Withdrawal by Subject|0|||
163494580|NCT00648739|590512242|FG000|Overall Study|Lack of Efficacy|0|||
163494581|NCT00648739|590512243|FG001|Overall Study|Lack of Efficacy|0|||
163494582|NCT00648739|590512244|FG002|Overall Study|Lack of Efficacy|0|||
163494583|NCT00648739|590512245|FG003|Overall Study|Lack of Efficacy|0|||
163494584|NCT00648739|590512246|FG004|Overall Study|Lack of Efficacy|1|||
163494585|NCT00648739|590512247|FG005|Overall Study|Lack of Efficacy|2|||
163494586|NCT00648739|590512248|FG006|Overall Study|Lack of Efficacy|0|||
163494587|NCT00648739|590512242|FG000|Overall Study|Investigator Considered it Advisable|0|||
163494588|NCT00648739|590512243|FG001|Overall Study|Investigator Considered it Advisable|0|||
163494589|NCT00648739|590512244|FG002|Overall Study|Investigator Considered it Advisable|0|||
163494590|NCT00648739|590512245|FG003|Overall Study|Investigator Considered it Advisable|0|||
163494591|NCT00648739|590512246|FG004|Overall Study|Investigator Considered it Advisable|0|||
163494592|NCT00648739|590512247|FG005|Overall Study|Investigator Considered it Advisable|1|||
163494593|NCT00648739|590512248|FG006|Overall Study|Investigator Considered it Advisable|1|||
163494594|NCT00648739|590512242|FG000|Overall Study|Death|0|||
163494595|NCT00648739|590512243|FG001|Overall Study|Death|1|||
163494596|NCT00648739|590512244|FG002|Overall Study|Death|0|||
163494597|NCT00648739|590512245|FG003|Overall Study|Death|0|||
163494598|NCT00648739|590512246|FG004|Overall Study|Death|0|||
163494599|NCT00648739|590512247|FG005|Overall Study|Death|0|||
163494600|NCT00648739|590512248|FG006|Overall Study|Death|0|||
163494601|NCT00648739|590512242|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
163494602|NCT00648739|590512243|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
163494603|NCT00648739|590512244|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
163494604|NCT00648739|590512245|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
163494605|NCT00648739|590512246|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
163494606|NCT00648739|590512247|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
163494607|NCT00648739|590512248|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
163494608|NCT00648739|590512242|FG000|Overall Study|Follow-up Visits Not Completed|0|||
163494609|NCT00648739|590512243|FG001|Overall Study|Follow-up Visits Not Completed|1|||
163494610|NCT00648739|590512244|FG002|Overall Study|Follow-up Visits Not Completed|0|||
163494611|NCT00648739|590512245|FG003|Overall Study|Follow-up Visits Not Completed|0|||
163494612|NCT00648739|590512246|FG004|Overall Study|Follow-up Visits Not Completed|0|||
163494613|NCT00648739|590512247|FG005|Overall Study|Follow-up Visits Not Completed|0|||
163494614|NCT00648739|590512248|FG006|Overall Study|Follow-up Visits Not Completed|0|||
163494615|NCT03387423|590512253|FG000|Overall Study|Lost to Follow-up|16|||
163494616|NCT03387423|590512254|FG001|Overall Study|Lost to Follow-up|12|||
163494617|NCT03387423|590512255|FG002|Overall Study|Lost to Follow-up|1|||
163494618|NCT03387423|590512256|FG003|Overall Study|Lost to Follow-up|0|||
163494619|NCT03387423|590512253|FG000|Overall Study|Other|0|||
163494620|NCT03387423|590512254|FG001|Overall Study|Other|3|||
163494621|NCT03387423|590512255|FG002|Overall Study|Other|0|||
163494622|NCT03387423|590512256|FG003|Overall Study|Other|0|||
163494623|NCT03387423|590512253|FG000|Overall Study|Administrative Reason|166|||
163494624|NCT03387423|590512254|FG001|Overall Study|Administrative Reason|89|||
163494625|NCT03387423|590512255|FG002|Overall Study|Administrative Reason|17|||
163494626|NCT03387423|590512256|FG003|Overall Study|Administrative Reason|19|||
163494627|NCT03387423|590512253|FG000|Overall Study|Revocation Consent|76|||
163494628|NCT03387423|590512254|FG001|Overall Study|Revocation Consent|32|||
163494629|NCT03387423|590512255|FG002|Overall Study|Revocation Consent|3|||
163494630|NCT03387423|590512256|FG003|Overall Study|Revocation Consent|5|||
163494631|NCT03862807|590512263|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
163494632|NCT04362761|590512264|FG000|Part A (48 Weeks)|Adverse Event|2|||
163494633|NCT04362761|590512264|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
163494634|NCT04362761|590512264|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
163494635|NCT04362761|590512264|FG000|Part A (48 Weeks)|Other|5|||
163494636|NCT04362761|590512264|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
163494637|NCT04362761|590512264|FG000|Part B (86 Weeks)|Other|4|||
163494638|NCT00798707|590512272|FG000|Overall Study|Adverse Event|6|||
163494639|NCT00798707|590512273|FG001|Overall Study|Adverse Event|8|||
163494640|NCT00798707|590512274|FG002|Overall Study|Adverse Event|8|||
163494641|NCT00798707|590512272|FG000|Overall Study|Failed to return|2|||
163494642|NCT00798707|590512273|FG001|Overall Study|Failed to return|2|||
163494643|NCT00798707|590512274|FG002|Overall Study|Failed to return|0|||
163494644|NCT00798707|590512272|FG000|Overall Study|Investigator|0|||
163494645|NCT00798707|590512273|FG001|Overall Study|Investigator|1|||
163494646|NCT00798707|590512274|FG002|Overall Study|Investigator|2|||
163494647|NCT00798707|590512272|FG000|Overall Study|Lack of Efficacy|2|||
163494648|NCT00798707|590512273|FG001|Overall Study|Lack of Efficacy|2|||
163494649|NCT00798707|590512274|FG002|Overall Study|Lack of Efficacy|1|||
163494650|NCT00798707|590512272|FG000|Overall Study|Lost to Follow-up|5|||
163494651|NCT00798707|590512273|FG001|Overall Study|Lost to Follow-up|6|||
163494652|NCT00798707|590512274|FG002|Overall Study|Lost to Follow-up|6|||
163494653|NCT00798707|590512272|FG000|Overall Study|Other|0|||
163494654|NCT00798707|590512273|FG001|Overall Study|Other|1|||
163494655|NCT00798707|590512274|FG002|Overall Study|Other|0|||
163494656|NCT00798707|590512272|FG000|Overall Study|Protocol Violation|4|||
163494657|NCT00798707|590512273|FG001|Overall Study|Protocol Violation|0|||
163494658|NCT00798707|590512274|FG002|Overall Study|Protocol Violation|2|||
163494659|NCT00798707|590512272|FG000|Overall Study|Withdrawal by Subject|3|||
163494660|NCT00798707|590512273|FG001|Overall Study|Withdrawal by Subject|8|||
163494661|NCT00798707|590512274|FG002|Overall Study|Withdrawal by Subject|2|||
163494662|NCT00798707|590512272|FG000|Overall Study|Randomized not treated|4|||
163494663|NCT00798707|590512273|FG001|Overall Study|Randomized not treated|5|||
163494664|NCT00798707|590512274|FG002|Overall Study|Randomized not treated|1|||
163494665|NCT01473589|590512275|FG000|Overall Study|Adverse Event|1|||
163494666|NCT01473589|590512276|FG001|Overall Study|Adverse Event|1|||
163494667|NCT01473589|590512275|FG000|Overall Study|Death|2|||
163494668|NCT01473589|590512276|FG001|Overall Study|Death|0|||
163494669|NCT01473589|590512275|FG000|Overall Study|Lost to Follow-up|2|||
163494670|NCT01473589|590512276|FG001|Overall Study|Lost to Follow-up|2|||
163494671|NCT01473589|590512275|FG000|Overall Study|Protocol Violation|1|||
163494672|NCT01473589|590512276|FG001|Overall Study|Protocol Violation|0|||
163494673|NCT01473589|590512275|FG000|Overall Study|Withdrawal by Subject|5|||
163494674|NCT01473589|590512276|FG001|Overall Study|Withdrawal by Subject|11|||
163494675|NCT01473589|590512275|FG000|Overall Study|Physician Decision|0|||
163494676|NCT01473589|590512276|FG001|Overall Study|Physician Decision|1|||
163494677|NCT01473589|590512275|FG000|Overall Study|Entry criteria not met|0|||
163494678|NCT01473589|590512276|FG001|Overall Study|Entry criteria not met|1|||
163494679|NCT01299272|590512279|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
163494680|NCT01299272|590512280|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
163494681|NCT01299272|590512281|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
163494682|NCT01299272|590512282|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
163494683|NCT01299272|590512279|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
163494684|NCT01299272|590512280|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
163494685|NCT01299272|590512281|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
163494686|NCT01299272|590512282|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
163494687|NCT01299272|590512279|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
163494688|NCT01299272|590512280|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
163494689|NCT01299272|590512281|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
163494690|NCT01299272|590512282|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
163494691|NCT01299272|590512279|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
163494692|NCT01299272|590512280|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
163494693|NCT01299272|590512281|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
163494694|NCT01299272|590512282|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
163494695|NCT01299272|590512279|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
163494696|NCT01299272|590512280|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
163494697|NCT01299272|590512281|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
163494698|NCT01299272|590512282|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
163494699|NCT01299272|590512279|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
163494700|NCT01299272|590512280|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
163494701|NCT01299272|590512281|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
163494702|NCT01299272|590512282|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
163494703|NCT01299272|590512279|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
163494704|NCT01299272|590512280|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
163494705|NCT01299272|590512281|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
163494706|NCT01299272|590512282|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
163494707|NCT01299272|590512279|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
163494708|NCT01299272|590512280|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
163494709|NCT01299272|590512281|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
163494710|NCT01299272|590512282|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
163494711|NCT01299272|590512279|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
163494712|NCT01299272|590512280|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
163494713|NCT01299272|590512281|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
163494714|NCT01299272|590512282|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
163494715|NCT01299272|590512279|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
163494716|NCT01299272|590512280|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
163494717|NCT01299272|590512281|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
163494718|NCT01299272|590512282|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
163494719|NCT01299272|590512279|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
163494720|NCT01299272|590512280|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
163494721|NCT01299272|590512281|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
163494722|NCT01299272|590512282|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
163494723|NCT01299272|590512279|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
163494724|NCT01299272|590512280|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
163494725|NCT01299272|590512281|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
163494726|NCT01299272|590512282|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
163494727|NCT01299272|590512279|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
163494728|NCT01299272|590512280|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
163494729|NCT01299272|590512281|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
163494730|NCT01299272|590512282|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
163494731|NCT01299272|590512279|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
163494732|NCT01299272|590512280|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
163494733|NCT01299272|590512281|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
163494734|NCT01299272|590512282|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
163494735|NCT01299272|590512279|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
163494736|NCT01299272|590512280|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
163494737|NCT01299272|590512281|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
163494738|NCT01299272|590512282|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
163494739|NCT01299272|590512279|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
163494740|NCT01299272|590512280|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
163494741|NCT01299272|590512281|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
163494742|NCT01299272|590512282|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
163494743|NCT01299272|590512279|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
163494744|NCT01299272|590512280|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
163494745|NCT01299272|590512281|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
163494746|NCT01299272|590512282|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
163494747|NCT01299272|590512279|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
163494748|NCT01299272|590512280|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
163494749|NCT01299272|590512281|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
163494750|NCT01299272|590512282|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
163494751|NCT01299272|590512279|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
163494752|NCT01299272|590512280|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
163494753|NCT01299272|590512281|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
163494754|NCT01299272|590512282|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
163494755|NCT01299272|590512279|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
163494756|NCT01299272|590512280|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
163494757|NCT01299272|590512281|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
163494758|NCT01299272|590512282|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
163494759|NCT01299272|590512279|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
163494760|NCT01299272|590512280|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
163494761|NCT01299272|590512281|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
163494762|NCT01299272|590512282|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
163494763|NCT01299272|590512279|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
163494764|NCT01299272|590512280|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
163494765|NCT01299272|590512281|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
163494766|NCT01299272|590512282|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
163494767|NCT01299272|590512279|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
163494768|NCT01299272|590512280|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
163494769|NCT01299272|590512281|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
163494770|NCT01299272|590512282|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
163494771|NCT01299272|590512279|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
163494772|NCT01299272|590512280|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
163494773|NCT01299272|590512281|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
163494774|NCT01299272|590512282|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
163494775|NCT01299272|590512279|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
163494776|NCT01299272|590512280|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
163494777|NCT01299272|590512281|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
163494778|NCT01299272|590512282|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
163494779|NCT00464308|590512283|FG000|Overall Study|Adverse Event|22|||
163494780|NCT00464308|590512284|FG001|Overall Study|Adverse Event|27|||
163494781|NCT00464308|590512285|FG002|Overall Study|Adverse Event|16|||
163494782|NCT00464308|590512283|FG000|Overall Study|Lost to Follow-up|29|||
163494783|NCT00464308|590512284|FG001|Overall Study|Lost to Follow-up|19|||
163494784|NCT00464308|590512285|FG002|Overall Study|Lost to Follow-up|20|||
163494785|NCT00464308|590512283|FG000|Overall Study|Patient discontinued and other reasons|17|||
163494786|NCT00464308|590512284|FG001|Overall Study|Patient discontinued and other reasons|17|||
163494787|NCT00464308|590512285|FG002|Overall Study|Patient discontinued and other reasons|23|||
163494788|NCT00464308|590512283|FG000|Overall Study|Physician Decision|1|||
163494789|NCT00464308|590512284|FG001|Overall Study|Physician Decision|0|||
163494790|NCT00464308|590512285|FG002|Overall Study|Physician Decision|0|||
163494791|NCT01721200|590512286|FG000|Overall Study|Lost to Follow-up|3|||
163494792|NCT01721200|590512287|FG001|Overall Study|Lost to Follow-up|5|||
163494793|NCT01513759|590512288|FG000|Overall Study|Protocol Violation|4|||
163494794|NCT01513759|590512288|FG000|Overall Study|Death during catheter placement|1|||
163494795|NCT03606109|590512289|FG000|Overall Study|Lost to Follow-up|2|||
163494796|NCT03606109|590512290|FG001|Overall Study|Lost to Follow-up|1|||
163494797|NCT03926728|590512291|FG000|Overall Study|Withdrawal by Subject|0|||
163494798|NCT03926728|590512292|FG001|Overall Study|Withdrawal by Subject|1|||
163494799|NCT03926728|590512293|FG002|Overall Study|Withdrawal by Subject|1|||
163494800|NCT03926728|590512294|FG003|Overall Study|Withdrawal by Subject|0|||
163494801|NCT03926728|590512295|FG004|Overall Study|Withdrawal by Subject|0|||
163494802|NCT03926728|590512296|FG005|Overall Study|Withdrawal by Subject|1|||
163494803|NCT03926728|590512297|FG006|Overall Study|Withdrawal by Subject|1|||
163494804|NCT03926728|590512298|FG007|Overall Study|Withdrawal by Subject|0|||
163494805|NCT03926728|590512299|FG008|Overall Study|Withdrawal by Subject|0|||
163494806|NCT03926728|590512300|FG009|Overall Study|Withdrawal by Subject|1|||
163494807|NCT03926728|590512301|FG010|Overall Study|Withdrawal by Subject|0|||
163494808|NCT03926728|590512302|FG011|Overall Study|Withdrawal by Subject|0|||
163494809|NCT03669640|590512307|FG000|Overall Study|Study Terminated by Sponsor|0|||
163494810|NCT03669640|590512308|FG001|Overall Study|Study Terminated by Sponsor|0|||
163494811|NCT03669640|590512309|FG002|Overall Study|Study Terminated by Sponsor|0|||
163494812|NCT03669640|590512310|FG003|Overall Study|Study Terminated by Sponsor|0|||
163494813|NCT03669640|590512311|FG004|Overall Study|Study Terminated by Sponsor|1|||
163494814|NCT03669640|590512312|FG005|Overall Study|Study Terminated by Sponsor|0|||
163494815|NCT03669640|590512307|FG000|Overall Study|Lost to Follow-up|0|||
163494816|NCT03669640|590512308|FG001|Overall Study|Lost to Follow-up|0|||
163494817|NCT03669640|590512309|FG002|Overall Study|Lost to Follow-up|2|||
163494818|NCT03669640|590512310|FG003|Overall Study|Lost to Follow-up|0|||
163494819|NCT03669640|590512311|FG004|Overall Study|Lost to Follow-up|0|||
163494820|NCT03669640|590512312|FG005|Overall Study|Lost to Follow-up|0|||
163494821|NCT03669640|590512307|FG000|Overall Study|Death|0|||
163494822|NCT03669640|590512308|FG001|Overall Study|Death|0|||
163494823|NCT03669640|590512309|FG002|Overall Study|Death|1|||
163494824|NCT03669640|590512310|FG003|Overall Study|Death|0|||
163494825|NCT03669640|590512311|FG004|Overall Study|Death|0|||
163494826|NCT03669640|590512312|FG005|Overall Study|Death|0|||
163494827|NCT03669640|590512307|FG000|Overall Study|Withdrawal by Subject|1|||
163494828|NCT03669640|590512308|FG001|Overall Study|Withdrawal by Subject|2|||
163494829|NCT03669640|590512309|FG002|Overall Study|Withdrawal by Subject|1|||
163494830|NCT03669640|590512310|FG003|Overall Study|Withdrawal by Subject|0|||
163494831|NCT03669640|590512311|FG004|Overall Study|Withdrawal by Subject|1|||
163494832|NCT03669640|590512312|FG005|Overall Study|Withdrawal by Subject|3|||
163494833|NCT03669640|590512307|FG000|Overall Study|Protocol Violation|1|||
163494834|NCT03669640|590512308|FG001|Overall Study|Protocol Violation|0|||
163494835|NCT03669640|590512309|FG002|Overall Study|Protocol Violation|0|||
163494836|NCT03669640|590512310|FG003|Overall Study|Protocol Violation|0|||
163494837|NCT03669640|590512311|FG004|Overall Study|Protocol Violation|0|||
163494838|NCT03669640|590512312|FG005|Overall Study|Protocol Violation|0|||
163494839|NCT03669640|590512307|FG000|Overall Study|Physician Decision|0|||
163494840|NCT03669640|590512308|FG001|Overall Study|Physician Decision|2|||
163494841|NCT03669640|590512309|FG002|Overall Study|Physician Decision|0|||
163494842|NCT03669640|590512310|FG003|Overall Study|Physician Decision|0|||
163494843|NCT03669640|590512311|FG004|Overall Study|Physician Decision|0|||
163494844|NCT03669640|590512312|FG005|Overall Study|Physician Decision|0|||
163494845|NCT03669640|590512307|FG000|Overall Study|Disease Relapse|1|||
163494846|NCT03669640|590512308|FG001|Overall Study|Disease Relapse|0|||
163494847|NCT03669640|590512309|FG002|Overall Study|Disease Relapse|0|||
163494848|NCT03669640|590512310|FG003|Overall Study|Disease Relapse|0|||
163494849|NCT03669640|590512311|FG004|Overall Study|Disease Relapse|0|||
163494850|NCT03669640|590512312|FG005|Overall Study|Disease Relapse|0|||
163494851|NCT03669640|590512307|FG000|Overall Study|Adverse Event|2|||
163494852|NCT03669640|590512308|FG001|Overall Study|Adverse Event|1|||
163494853|NCT03669640|590512309|FG002|Overall Study|Adverse Event|0|||
163494854|NCT03669640|590512310|FG003|Overall Study|Adverse Event|0|||
163494855|NCT03669640|590512311|FG004|Overall Study|Adverse Event|1|||
163494856|NCT03669640|590512312|FG005|Overall Study|Adverse Event|0|||
163494857|NCT03722849|590512315|FG000|Overall Study|Withdrawal by Subject|1|||
163494858|NCT03722849|590512316|FG001|Overall Study|Withdrawal by Subject|1|||
163494859|NCT03993288|590512317|FG000|Overall Study|Lost to Follow-up|2|||
163494860|NCT03993288|590512318|FG001|Overall Study|Lost to Follow-up|1|||
163494861|NCT03993288|590512317|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
163494862|NCT03993288|590512318|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
163494863|NCT03993288|590512317|FG000|Overall Study|wrong randomization|0|||
163494864|NCT03993288|590512318|FG001|Overall Study|wrong randomization|1|||
163494865|NCT03993288|590512317|FG000|Overall Study|improper enrollment|0|||
163494866|NCT03993288|590512318|FG001|Overall Study|improper enrollment|1|||
163494867|NCT03993288|590512317|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
163494868|NCT03993288|590512318|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
163494869|NCT03993288|590512317|FG000|Overall Study|developed SAE|2|||
163494870|NCT03993288|590512318|FG001|Overall Study|developed SAE|0|||
163494871|NCT03993288|590512317|FG000|Overall Study|consent withdrawal|1|||
163494872|NCT03993288|590512318|FG001|Overall Study|consent withdrawal|0|||
163494873|NCT03993288|590512317|FG000|Overall Study|did not follow the treatment schedule|1|||
163494874|NCT03993288|590512318|FG001|Overall Study|did not follow the treatment schedule|0|||
163494875|NCT03993288|590512317|FG000|Overall Study|did not follow the treatment regimen|1|||
163494876|NCT03993288|590512318|FG001|Overall Study|did not follow the treatment regimen|0|||
163494877|NCT03993288|590512317|FG000|Overall Study|Adverse Event|1|||
163494878|NCT03993288|590512318|FG001|Overall Study|Adverse Event|0|||
163494879|NCT03993288|590512317|FG000|Overall Study|Withdrawal by Subject|1|||
163494880|NCT03993288|590512318|FG001|Overall Study|Withdrawal by Subject|1|||
163494881|NCT02729545|590512319|FG000|Overall Study|Pregnancy|1|||
163494882|NCT02729545|590512320|FG001|Overall Study|Pregnancy|1|||
163494883|NCT02729545|590512319|FG000|Overall Study|Lost to Follow-up|0|||
163494884|NCT02729545|590512320|FG001|Overall Study|Lost to Follow-up|1|||
163494885|NCT02729545|590512319|FG000|Overall Study|Withdrawal by Subject|2|||
163494886|NCT02729545|590512320|FG001|Overall Study|Withdrawal by Subject|3|||
163494887|NCT03533608|590512321|FG000|Overall Study|Withdrawal by Subject|3|||
163494888|NCT03533608|590512321|FG000|Overall Study|Physician Decision|2|||
163494889|NCT00915473|590512322|FG000|Screening|Withdrawal by Subject|1|||
163494890|NCT00915473|590512323|FG001|Screening|Withdrawal by Subject|0|||
163494891|NCT00915473|590512322|FG000|4-week Follow Up|Lost to Follow-up|1|||
163494892|NCT00915473|590512323|FG001|4-week Follow Up|Lost to Follow-up|5|||
163494893|NCT01389024|590512324|FG000|Overall Study|Withdrawal by Subject|0|||
163494894|NCT01389024|590512325|FG001|Overall Study|Withdrawal by Subject|1|||
163494895|NCT01389024|590512324|FG000|Overall Study|Lost to Follow-up|1|||
163494896|NCT01389024|590512325|FG001|Overall Study|Lost to Follow-up|0|||
163494897|NCT00529802|590512327|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
163494898|NCT00529802|590512327|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
163494899|NCT00529802|590512327|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
163494900|NCT00529802|590512327|FG000|Evaluable for Primary Endpoint|Death|1|||
163494901|NCT00529802|590512327|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
163494902|NCT00529802|590512327|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
163494903|NCT00529802|590512327|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
163494904|NCT02209454|590512328|FG000|Second Period|Adverse Event|1|||
163494905|NCT02209454|590512329|FG001|Second Period|Adverse Event|0|||
163494906|NCT00366678|590512330|FG000|Infant Series|Withdrawal by Subject|8|||
163494907|NCT00366678|590512331|FG001|Infant Series|Withdrawal by Subject|6|||
163494908|NCT00366678|590512332|FG002|Infant Series|Withdrawal by Subject|0|||
163494909|NCT00366678|590512330|FG000|Infant Series|Protocol Violation|4|||
163494910|NCT00366678|590512331|FG001|Infant Series|Protocol Violation|3|||
163494911|NCT00366678|590512332|FG002|Infant Series|Protocol Violation|0|||
163494912|NCT00366678|590512330|FG000|Infant Series|Failed to return|1|||
163494913|NCT00366678|590512331|FG001|Infant Series|Failed to return|1|||
163494914|NCT00366678|590512332|FG002|Infant Series|Failed to return|0|||
163494915|NCT00366678|590512330|FG000|Infant Series|Adverse Event|1|||
163494916|NCT00366678|590512331|FG001|Infant Series|Adverse Event|0|||
163494917|NCT00366678|590512332|FG002|Infant Series|Adverse Event|0|||
163494918|NCT00366678|590512330|FG000|After Infant|Withdrawal by Subject|8|||
163494919|NCT00366678|590512331|FG001|After Infant|Withdrawal by Subject|4|||
163494920|NCT00366678|590512332|FG002|After Infant|Withdrawal by Subject|0|||
163494921|NCT00366678|590512330|FG000|After Infant|Lost to Follow-up|2|||
163494922|NCT00366678|590512331|FG001|After Infant|Lost to Follow-up|1|||
163494923|NCT00366678|590512332|FG002|After Infant|Lost to Follow-up|0|||
163494924|NCT00366678|590512330|FG000|After Infant|Failed to return|5|||
163494925|NCT00366678|590512331|FG001|After Infant|Failed to return|5|||
163494926|NCT00366678|590512332|FG002|After Infant|Failed to return|0|||
163494927|NCT00366678|590512330|FG000|After Infant|Adverse Event|1|||
163494928|NCT00366678|590512331|FG001|After Infant|Adverse Event|0|||
163494929|NCT00366678|590512332|FG002|After Infant|Adverse Event|0|||
163494930|NCT00366678|590512330|FG000|After Infant|Protocol Violation|1|||
163494931|NCT00366678|590512331|FG001|After Infant|Protocol Violation|0|||
163494932|NCT00366678|590512332|FG002|After Infant|Protocol Violation|0|||
163494933|NCT00366678|590512330|FG000|Toddler Dose|Protocol Violation|2|||
163494934|NCT00366678|590512331|FG001|Toddler Dose|Protocol Violation|1|||
163494935|NCT00366678|590512332|FG002|Toddler Dose|Protocol Violation|0|||
163494936|NCT00366678|590512330|FG000|Toddler Dose|Failed to return|1|||
163494937|NCT00366678|590512331|FG001|Toddler Dose|Failed to return|0|||
163494938|NCT00366678|590512332|FG002|Toddler Dose|Failed to return|0|||
163494939|NCT00366678|590512330|FG000|Toddler Dose|Withdrawal by Subject|1|||
163494940|NCT00366678|590512331|FG001|Toddler Dose|Withdrawal by Subject|0|||
163494941|NCT00366678|590512332|FG002|Toddler Dose|Withdrawal by Subject|0|||
163494942|NCT00366678|590512330|FG000|Toddler Dose|protocol deviation|1|||
163494943|NCT00366678|590512331|FG001|Toddler Dose|protocol deviation|0|||
163494944|NCT00366678|590512332|FG002|Toddler Dose|protocol deviation|0|||
163494945|NCT00826176|590512342|FG000|Overall Study|Lost to Follow-up|1|||
163494946|NCT00826176|590512343|FG001|Overall Study|Lost to Follow-up|0|||
163494947|NCT00826176|590512342|FG000|Overall Study|Subject Withdrew Consent|3|||
163494948|NCT00826176|590512343|FG001|Overall Study|Subject Withdrew Consent|0|||
163494949|NCT00826176|590512342|FG000|Overall Study|Administrative|9|||
163494950|NCT00826176|590512343|FG001|Overall Study|Administrative|0|||
163494951|NCT00740480|590512344|FG000|Overall Study|Adverse Event|1|||
163494952|NCT00740480|590512344|FG000|Overall Study|Physician Decision|1|||
163494953|NCT03079869|590512350|FG000|Overall Study|Adverse Event|6|||
163494954|NCT03079869|590512351|FG001|Overall Study|Adverse Event|8|||
163494955|NCT03079869|590512350|FG000|Overall Study|Withdrawal by Subject|4|||
163494956|NCT03079869|590512351|FG001|Overall Study|Withdrawal by Subject|1|||
163494957|NCT03079869|590512350|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
163494958|NCT03079869|590512351|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
163494959|NCT01325701|590512352|FG000|Overall Study|Adverse Event|12|||
163494960|NCT01325701|590512353|FG001|Overall Study|Adverse Event|0|||
163494961|NCT01325701|590512352|FG000|Overall Study|Protocol Violation|1|||
163494962|NCT01325701|590512353|FG001|Overall Study|Protocol Violation|0|||
163494963|NCT01325701|590512352|FG000|Overall Study|Physician Decision|2|||
163494964|NCT01325701|590512353|FG001|Overall Study|Physician Decision|2|||
163494965|NCT01325701|590512352|FG000|Overall Study|Withdrawal by Subject|2|||
163494966|NCT01325701|590512353|FG001|Overall Study|Withdrawal by Subject|1|||
163494967|NCT01325701|590512352|FG000|Overall Study|Rollerover Extension Study|4|||
163494968|NCT01325701|590512353|FG001|Overall Study|Rollerover Extension Study|0|||
163494969|NCT04484805|590512362|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
163494970|NCT04484805|590512363|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
163494971|NCT04484805|590512362|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
163494972|NCT04484805|590512363|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
163494973|NCT00539006|590512366|FG000|Pre-treatment|Other|0|||
163494974|NCT00539006|590512367|FG001|Pre-treatment|Other|1|||
163494975|NCT00539006|590512368|FG002|Pre-treatment|Other|0|||
163494976|NCT00539006|590512369|FG003|Pre-treatment|Other|0|||
163494977|NCT00539006|590512366|FG000|Treatment Period 1|Lost to Follow-up|0|||
163494978|NCT00539006|590512367|FG001|Treatment Period 1|Lost to Follow-up|0|||
163494979|NCT00539006|590512368|FG002|Treatment Period 1|Lost to Follow-up|1|||
163494980|NCT00539006|590512369|FG003|Treatment Period 1|Lost to Follow-up|0|||
163494981|NCT00539006|590512366|FG000|Treatment Period 1|Protocol Violation|0|||
163494982|NCT00539006|590512367|FG001|Treatment Period 1|Protocol Violation|0|||
163494983|NCT00539006|590512368|FG002|Treatment Period 1|Protocol Violation|1|||
163494984|NCT00539006|590512369|FG003|Treatment Period 1|Protocol Violation|0|||
163494985|NCT00539006|590512366|FG000|Treatment Period 1|Lack of Efficacy|0|||
163494986|NCT00539006|590512367|FG001|Treatment Period 1|Lack of Efficacy|0|||
163494987|NCT00539006|590512368|FG002|Treatment Period 1|Lack of Efficacy|0|||
163494988|NCT00539006|590512369|FG003|Treatment Period 1|Lack of Efficacy|1|||
163494989|NCT00539006|590512366|FG000|Washout|Adverse Event|2|||
163494990|NCT00539006|590512367|FG001|Washout|Adverse Event|1|||
163494991|NCT00539006|590512368|FG002|Washout|Adverse Event|0|||
163494992|NCT00539006|590512369|FG003|Washout|Adverse Event|0|||
163494993|NCT00539006|590512366|FG000|Washout|Protocol Violation|1|||
163494994|NCT00539006|590512367|FG001|Washout|Protocol Violation|1|||
163494995|NCT00539006|590512368|FG002|Washout|Protocol Violation|0|||
163494996|NCT00539006|590512369|FG003|Washout|Protocol Violation|0|||
163494997|NCT00539006|590512366|FG000|Washout|Withdrawal by Subject|0|||
163494998|NCT00539006|590512367|FG001|Washout|Withdrawal by Subject|2|||
163494999|NCT00539006|590512368|FG002|Washout|Withdrawal by Subject|0|||
163495000|NCT00539006|590512369|FG003|Washout|Withdrawal by Subject|0|||
163495001|NCT00539006|590512366|FG000|Washout|Failed to meet continuation criteria|16|||
163495002|NCT00539006|590512367|FG001|Washout|Failed to meet continuation criteria|5|||
163495003|NCT00539006|590512368|FG002|Washout|Failed to meet continuation criteria|14|||
163495004|NCT00539006|590512369|FG003|Washout|Failed to meet continuation criteria|6|||
163495005|NCT00539006|590512366|FG000|Washout|Other|1|||
163495006|NCT00539006|590512367|FG001|Washout|Other|1|||
163495007|NCT00539006|590512368|FG002|Washout|Other|2|||
163495008|NCT00539006|590512369|FG003|Washout|Other|3|||
163495009|NCT00539006|590512366|FG000|Treatment Period 2|Protocol Violation|1|||
163495010|NCT00539006|590512367|FG001|Treatment Period 2|Protocol Violation|0|||
163495011|NCT00539006|590512368|FG002|Treatment Period 2|Protocol Violation|0|||
163495012|NCT00539006|590512369|FG003|Treatment Period 2|Protocol Violation|0|||
163495013|NCT00539006|590512366|FG000|Treatment Period 2|Other|0|||
163495014|NCT00539006|590512367|FG001|Treatment Period 2|Other|1|||
163495015|NCT00539006|590512368|FG002|Treatment Period 2|Other|0|||
163495016|NCT00539006|590512369|FG003|Treatment Period 2|Other|0|||
163495017|NCT03733301|590512370|FG000|Overall Study|Screen Fail|1|||
163495018|NCT03733301|590512371|FG001|Overall Study|Screen Fail|0|||
163495019|NCT03733301|590512372|FG002|Overall Study|Screen Fail|0|||
163495020|NCT03733301|590512370|FG000|Overall Study|Non-compliance|1|||
163495021|NCT03733301|590512371|FG001|Overall Study|Non-compliance|0|||
163495022|NCT03733301|590512372|FG002|Overall Study|Non-compliance|0|||
163495023|NCT03733301|590512370|FG000|Overall Study|Lack of Efficacy|2|||
163495024|NCT03733301|590512371|FG001|Overall Study|Lack of Efficacy|3|||
163495025|NCT03733301|590512372|FG002|Overall Study|Lack of Efficacy|0|||
163495026|NCT03733301|590512370|FG000|Overall Study|Adverse Event|0|||
163495027|NCT03733301|590512371|FG001|Overall Study|Adverse Event|1|||
163495028|NCT03733301|590512372|FG002|Overall Study|Adverse Event|3|||
163495029|NCT03733301|590512370|FG000|Overall Study|Withdrawal by Subject|3|||
163495030|NCT03733301|590512371|FG001|Overall Study|Withdrawal by Subject|5|||
163495031|NCT03733301|590512372|FG002|Overall Study|Withdrawal by Subject|1|||
163495032|NCT01965431|590512373|FG000|Overall Study|Adverse Event|0|||
163495033|NCT01965431|590512374|FG001|Overall Study|Adverse Event|1|||
163495034|NCT01965431|590512375|FG002|Overall Study|Adverse Event|0|||
163495035|NCT01965431|590512376|FG003|Overall Study|Adverse Event|0|||
163495036|NCT01965431|590512377|FG004|Overall Study|Adverse Event|0|||
163495037|NCT01965431|590512378|FG005|Overall Study|Adverse Event|0|||
163495038|NCT01965431|590512373|FG000|Overall Study|Other than stated above|6|||
163495039|NCT01965431|590512374|FG001|Overall Study|Other than stated above|5|||
163495040|NCT01965431|590512375|FG002|Overall Study|Other than stated above|6|||
163495041|NCT01965431|590512376|FG003|Overall Study|Other than stated above|6|||
163495042|NCT01965431|590512377|FG004|Overall Study|Other than stated above|6|||
163495043|NCT01965431|590512378|FG005|Overall Study|Other than stated above|6|||
163495044|NCT00605839|590512379|FG000|Overall Study|Protocol Violation|1|||
163495045|NCT00605839|590512380|FG001|Overall Study|Protocol Violation|0|||
163495046|NCT00605839|590512381|FG002|Overall Study|Protocol Violation|0|||
163495047|NCT04636437|590512385|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
163495048|NCT04636437|590512386|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
163495049|NCT04636437|590512387|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
163495050|NCT04636437|590512385|FG000|Overall Study|Started weight loss drug/program|2|||
163495051|NCT04636437|590512386|FG001|Overall Study|Started weight loss drug/program|1|||
163495052|NCT04636437|590512387|FG002|Overall Study|Started weight loss drug/program|1|||
163495053|NCT04636437|590512385|FG000|Overall Study|Lost to Follow-up|3|||
163495054|NCT04636437|590512386|FG001|Overall Study|Lost to Follow-up|1|||
163495055|NCT04636437|590512387|FG002|Overall Study|Lost to Follow-up|4|||
163495056|NCT04636437|590512385|FG000|Overall Study|Participant or physician decision|3|||
163495057|NCT04636437|590512386|FG001|Overall Study|Participant or physician decision|1|||
163495058|NCT04636437|590512387|FG002|Overall Study|Participant or physician decision|1|||
163495059|NCT00816166|590512388|FG000|Overall Study|Lost to Follow-up|6|||
163495060|NCT00816166|590512389|FG001|Overall Study|Lost to Follow-up|10|||
163495061|NCT00816166|590512388|FG000|Overall Study|Death|4|||
163495062|NCT00816166|590512389|FG001|Overall Study|Death|2|||
163495063|NCT01071278|590512390|FG000|Overall Study|Premature Discontinuation|254|||
163495064|NCT01071278|590512390|FG000|Overall Study|Completion Status Unknown|459|||
163495065|NCT01821391|590512392|FG000|Overall Study|Adverse Event|1|||
163495066|NCT01821391|590512393|FG001|Overall Study|Adverse Event|0|||
163495067|NCT03417102|590512395|FG000|Overall Study|Adverse Event|0|||
163495068|NCT03417102|590512396|FG001|Overall Study|Adverse Event|1|||
163495069|NCT03417102|590512395|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
163495070|NCT03417102|590512396|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
163495071|NCT03417102|590512395|FG000|Overall Study|Other|0|||
163495072|NCT03417102|590512396|FG001|Overall Study|Other|1|||
163495073|NCT01017731|590513803|FG000|Overall Study|Lost to Follow-up|2|||
163495074|NCT01017731|590513803|FG000|Overall Study|Withdrawal by Subject|3|||
163495075|NCT01017731|590513803|FG000|Overall Study|Physician Decision|2|||
163495076|NCT01017731|590513803|FG000|Overall Study|Adverse Event|1|||
163495077|NCT01035229|590513804|FG000|Overall Study|Adverse Event|61|||
163495078|NCT01035229|590513805|FG001|Overall Study|Adverse Event|14|||
163495079|NCT01035229|590513804|FG000|Overall Study|Withdrawal by Subject|20|||
163495080|NCT01035229|590513805|FG001|Overall Study|Withdrawal by Subject|7|||
163495081|NCT01035229|590513804|FG000|Overall Study|Lost to Follow-up|1|||
163495082|NCT01035229|590513805|FG001|Overall Study|Lost to Follow-up|0|||
163495083|NCT01035229|590513804|FG000|Overall Study|Administrative problems|1|||
163495084|NCT01035229|590513805|FG001|Overall Study|Administrative problems|1|||
163495085|NCT01035229|590513804|FG000|Overall Study|Death|13|||
163495086|NCT01035229|590513805|FG001|Overall Study|Death|5|||
163495087|NCT01035229|590513804|FG000|Overall Study|New cancer therapy|2|||
163495088|NCT01035229|590513805|FG001|Overall Study|New cancer therapy|0|||
163495089|NCT01035229|590513804|FG000|Overall Study|Protocol Violation|0|||
163495090|NCT01035229|590513805|FG001|Overall Study|Protocol Violation|2|||
163495091|NCT01035229|590513804|FG000|Overall Study|Sponsor's decision to end study|3|||
163495092|NCT01035229|590513805|FG001|Overall Study|Sponsor's decision to end study|3|||
163495093|NCT01035229|590513804|FG000|Overall Study|Disease Progression|261|||
163495094|NCT01035229|590513805|FG001|Overall Study|Disease Progression|152|||
163495095|NCT00685763|590513807|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
163495096|NCT00685763|590513807|FG000|Overall Study|Protocol Violation|1|||
163495097|NCT00698009|590513811|FG000|Overall Study|Withdrawal by Subject|1|||
163495098|NCT00564486|590513815|FG000|Overall Study|Adverse Event|0|||
163495099|NCT00564486|590513816|FG001|Overall Study|Adverse Event|1|||
163495100|NCT00564486|590513817|FG002|Overall Study|Adverse Event|0|||
163495101|NCT00564486|590513818|FG003|Overall Study|Adverse Event|0|||
163495102|NCT00564486|590513815|FG000|Overall Study|Withdrawal by Subject|4|||
163495103|NCT00564486|590513816|FG001|Overall Study|Withdrawal by Subject|0|||
163495104|NCT00564486|590513817|FG002|Overall Study|Withdrawal by Subject|0|||
163495105|NCT00564486|590513818|FG003|Overall Study|Withdrawal by Subject|5|||
163495106|NCT00564486|590513815|FG000|Overall Study|Subject refused to have blood drawn|0|||
163495107|NCT00564486|590513816|FG001|Overall Study|Subject refused to have blood drawn|0|||
163495108|NCT00564486|590513817|FG002|Overall Study|Subject refused to have blood drawn|1|||
163495109|NCT00564486|590513818|FG003|Overall Study|Subject refused to have blood drawn|0|||
163495110|NCT00564486|590513815|FG000|Overall Study|Lost to Follow-up|3|||
163495111|NCT00564486|590513816|FG001|Overall Study|Lost to Follow-up|0|||
163495112|NCT00564486|590513817|FG002|Overall Study|Lost to Follow-up|2|||
163495113|NCT00564486|590513818|FG003|Overall Study|Lost to Follow-up|2|||
163495114|NCT03457727|590513822|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
163495115|NCT03457727|590513823|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
163495116|NCT03457727|590513824|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
163495117|NCT03457727|590513825|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
163495118|NCT00929201|590513826|FG000|Period 1|Withdrawal by Subject|0|||
163495119|NCT00929201|590513827|FG001|Period 1|Withdrawal by Subject|1|||
163495120|NCT03286426|590513831|FG000|Overall Study|Physician Decision|3|||
163495121|NCT01817764|590513832|FG000|Overall Study|Adverse Event|7|||
163495122|NCT01817764|590513833|FG001|Overall Study|Adverse Event|10|||
163495123|NCT01817764|590513832|FG000|Overall Study|Lack of Efficacy|9|||
163495124|NCT01817764|590513833|FG001|Overall Study|Lack of Efficacy|7|||
163495125|NCT01817764|590513832|FG000|Overall Study|Protocol Violation|7|||
163495126|NCT01817764|590513833|FG001|Overall Study|Protocol Violation|5|||
163495127|NCT01817764|590513832|FG000|Overall Study|Lost to Follow-up|1|||
163495128|NCT01817764|590513833|FG001|Overall Study|Lost to Follow-up|4|||
163495129|NCT01817764|590513832|FG000|Overall Study|Withdrawal by Subject|10|||
163495130|NCT01817764|590513833|FG001|Overall Study|Withdrawal by Subject|12|||
163495131|NCT01956123|590513834|FG000|COS Cycle 2|Protocol Violation|8|||
163495132|NCT01956123|590513835|FG001|COS Cycle 2|Protocol Violation|3|||
163495133|NCT01956123|590513836|FG002|COS Cycle 2|Protocol Violation|0|||
163495134|NCT01956123|590513837|FG003|COS Cycle 2|Protocol Violation|0|||
163495135|NCT01956123|590513834|FG000|COS Cycle 2|Adverse Event|3|||
163495136|NCT01956123|590513835|FG001|COS Cycle 2|Adverse Event|4|||
163495137|NCT01956123|590513836|FG002|COS Cycle 2|Adverse Event|0|||
163495138|NCT01956123|590513837|FG003|COS Cycle 2|Adverse Event|0|||
163495139|NCT01956123|590513834|FG000|COS Cycle 2|Personal Reasons|2|||
163495140|NCT01956123|590513835|FG001|COS Cycle 2|Personal Reasons|0|||
163495141|NCT01956123|590513836|FG002|COS Cycle 2|Personal Reasons|0|||
163495142|NCT01956123|590513837|FG003|COS Cycle 2|Personal Reasons|0|||
163495143|NCT01956123|590513834|FG000|COS Cycle 2|Withdrawal by Subject|1|||
163495144|NCT01956123|590513835|FG001|COS Cycle 2|Withdrawal by Subject|0|||
163495145|NCT01956123|590513836|FG002|COS Cycle 2|Withdrawal by Subject|0|||
163495146|NCT01956123|590513837|FG003|COS Cycle 2|Withdrawal by Subject|0|||
163495147|NCT01956123|590513834|FG000|COS Cycle 3|Protocol Violation|0|||
163495148|NCT01956123|590513835|FG001|COS Cycle 3|Protocol Violation|0|||
163495149|NCT01956123|590513836|FG002|COS Cycle 3|Protocol Violation|2|||
163495150|NCT01956123|590513837|FG003|COS Cycle 3|Protocol Violation|1|||
163495151|NCT01956123|590513834|FG000|COS Cycle 3|Adverse Event|0|||
163495152|NCT01956123|590513835|FG001|COS Cycle 3|Adverse Event|0|||
163495153|NCT01956123|590513836|FG002|COS Cycle 3|Adverse Event|3|||
163495154|NCT01956123|590513837|FG003|COS Cycle 3|Adverse Event|0|||
163495155|NCT01956123|590513834|FG000|COS Cycle 3|Personal Reasons|0|||
163495156|NCT01956123|590513835|FG001|COS Cycle 3|Personal Reasons|0|||
163495157|NCT01956123|590513836|FG002|COS Cycle 3|Personal Reasons|1|||
163495158|NCT01956123|590513837|FG003|COS Cycle 3|Personal Reasons|0|||
163495159|NCT01956123|590513834|FG000|COS Cycle 3|Withdrawal by Subject|0|||
163495160|NCT01956123|590513835|FG001|COS Cycle 3|Withdrawal by Subject|0|||
163495161|NCT01956123|590513836|FG002|COS Cycle 3|Withdrawal by Subject|0|||
163495162|NCT01956123|590513837|FG003|COS Cycle 3|Withdrawal by Subject|1|||
163495163|NCT00388674|590513846|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
163495164|NCT00388674|590513847|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
163495165|NCT00388674|590513846|FG000|Initial Treatment|Adverse Event|22|||
163495166|NCT00388674|590513847|FG001|Initial Treatment|Adverse Event|87|||
163495167|NCT00388674|590513846|FG000|Initial Treatment|Death|215|||
163495168|NCT00388674|590513847|FG001|Initial Treatment|Death|216|||
163495169|NCT00388674|590513846|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
163495170|NCT00388674|590513847|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
163495171|NCT00388674|590513846|FG000|Initial Treatment|HCC|12|||
163495172|NCT00388674|590513847|FG001|Initial Treatment|HCC|20|||
163495173|NCT00388674|590513846|FG000|Initial Treatment|Lost to Follow-up|526|||
163495174|NCT00388674|590513847|FG001|Initial Treatment|Lost to Follow-up|624|||
163495175|NCT00388674|590513846|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
163495176|NCT00388674|590513847|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
163495177|NCT00388674|590513846|FG000|Initial Treatment|Never Treated with Study Medication|1|||
163495178|NCT00388674|590513847|FG001|Initial Treatment|Never Treated with Study Medication|7|||
163495179|NCT00388674|590513846|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
163495180|NCT00388674|590513847|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
163495181|NCT00388674|590513846|FG000|Initial Treatment|Not Defined|125|||
163495182|NCT00388674|590513847|FG001|Initial Treatment|Not Defined|172|||
163495183|NCT00388674|590513846|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
163495184|NCT00388674|590513847|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
163495185|NCT00388674|590513846|FG000|Initial Treatment|Pregnancy|26|||
163495186|NCT00388674|590513847|FG001|Initial Treatment|Pregnancy|16|||
163495187|NCT00388674|590513846|FG000|Initial Treatment|Study Drug Toxicity|5|||
163495188|NCT00388674|590513847|FG001|Initial Treatment|Study Drug Toxicity|92|||
163495189|NCT00388674|590513846|FG000|Initial Treatment|Participant Request|501|||
163495190|NCT00388674|590513847|FG001|Initial Treatment|Participant Request|673|||
163495191|NCT00388674|590513846|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
163495192|NCT00388674|590513847|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
163495193|NCT00388674|590513846|FG000|Initial Treatment|Not Reported|10|||
163495194|NCT00388674|590513847|FG001|Initial Treatment|Not Reported|12|||
163495195|NCT00388674|590513846|FG000|End of Study|Administrative Reason By Sponsor|299|||
163495196|NCT00388674|590513847|FG001|End of Study|Administrative Reason By Sponsor|253|||
163495197|NCT00388674|590513846|FG000|End of Study|Death|239|||
163495198|NCT00388674|590513847|FG001|End of Study|Death|262|||
163495199|NCT00388674|590513846|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
163495200|NCT00388674|590513847|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
163495201|NCT00388674|590513846|FG000|End of Study|HCC|8|||
163495202|NCT00388674|590513847|FG001|End of Study|HCC|7|||
163495203|NCT00388674|590513846|FG000|End of Study|Lost to Follow-up|587|||
163495204|NCT00388674|590513847|FG001|End of Study|Lost to Follow-up|715|||
163495205|NCT00388674|590513846|FG000|End of Study|Malignancy (Non-HCC)|1|||
163495206|NCT00388674|590513847|FG001|End of Study|Malignancy (Non-HCC)|1|||
163495207|NCT00388674|590513846|FG000|End of Study|Non-Study Related Comorbidities|3|||
163495208|NCT00388674|590513847|FG001|End of Study|Non-Study Related Comorbidities|4|||
163495209|NCT00388674|590513846|FG000|End of Study|Not Defined|135|||
163495210|NCT00388674|590513847|FG001|End of Study|Not Defined|214|||
163495211|NCT00388674|590513846|FG000|End of Study|Participant Withdrew Consent|437|||
163495212|NCT00388674|590513847|FG001|End of Study|Participant Withdrew Consent|673|||
163495213|NCT00388674|590513846|FG000|End of Study|No Off-Treatment Status Data|22|||
163495214|NCT00388674|590513847|FG001|End of Study|No Off-Treatment Status Data|30|||
163495215|NCT00388674|590513846|FG000|End of Study|Not Reported|0|||
163495216|NCT00388674|590513847|FG001|End of Study|Not Reported|1|||
163495217|NCT03576131|590513854|FG000|Overall Study|Investigator decision|0|||
163495218|NCT03576131|590513855|FG001|Overall Study|Investigator decision|0|||
163495219|NCT03576131|590513856|FG002|Overall Study|Investigator decision|0|||
163495220|NCT03576131|590513857|FG003|Overall Study|Investigator decision|1|||
163495221|NCT03576131|590513858|FG004|Overall Study|Investigator decision|0|||
163495222|NCT03576131|590513859|FG005|Overall Study|Investigator decision|1|||
163495223|NCT03576131|590513860|FG006|Overall Study|Investigator decision|0|||
163495224|NCT03576131|590513861|FG007|Overall Study|Investigator decision|0|||
163495225|NCT03576131|590513854|FG000|Overall Study|Withdrawal by Subject|1|||
163495226|NCT03576131|590513855|FG001|Overall Study|Withdrawal by Subject|1|||
163495227|NCT03576131|590513856|FG002|Overall Study|Withdrawal by Subject|0|||
163495228|NCT03576131|590513857|FG003|Overall Study|Withdrawal by Subject|1|||
163495229|NCT03576131|590513858|FG004|Overall Study|Withdrawal by Subject|2|||
163495230|NCT03576131|590513859|FG005|Overall Study|Withdrawal by Subject|3|||
163495231|NCT03576131|590513860|FG006|Overall Study|Withdrawal by Subject|1|||
163495232|NCT03576131|590513861|FG007|Overall Study|Withdrawal by Subject|0|||
163495233|NCT03576131|590513854|FG000|Overall Study|Death|3|||
163495234|NCT03576131|590513855|FG001|Overall Study|Death|3|||
163495235|NCT03576131|590513856|FG002|Overall Study|Death|1|||
163495236|NCT03576131|590513857|FG003|Overall Study|Death|5|||
163495237|NCT03576131|590513858|FG004|Overall Study|Death|4|||
163495238|NCT03576131|590513859|FG005|Overall Study|Death|1|||
163495239|NCT03576131|590513860|FG006|Overall Study|Death|0|||
163495240|NCT03576131|590513861|FG007|Overall Study|Death|1|||
163495241|NCT03576131|590513854|FG000|Overall Study|New anti-cancer treatment|5|||
163495242|NCT03576131|590513855|FG001|Overall Study|New anti-cancer treatment|1|||
163495243|NCT03576131|590513856|FG002|Overall Study|New anti-cancer treatment|2|||
163495244|NCT03576131|590513857|FG003|Overall Study|New anti-cancer treatment|3|||
163495245|NCT03576131|590513858|FG004|Overall Study|New anti-cancer treatment|0|||
163495246|NCT03576131|590513859|FG005|Overall Study|New anti-cancer treatment|0|||
163495247|NCT03576131|590513860|FG006|Overall Study|New anti-cancer treatment|0|||
163495248|NCT03576131|590513861|FG007|Overall Study|New anti-cancer treatment|0|||
163495249|NCT03576131|590513854|FG000|Overall Study|Unspecified reason|0|||
163495250|NCT03576131|590513855|FG001|Overall Study|Unspecified reason|0|||
163495251|NCT03576131|590513856|FG002|Overall Study|Unspecified reason|1|||
163495252|NCT03576131|590513857|FG003|Overall Study|Unspecified reason|1|||
163495253|NCT03576131|590513858|FG004|Overall Study|Unspecified reason|1|||
163495254|NCT03576131|590513859|FG005|Overall Study|Unspecified reason|1|||
163495255|NCT03576131|590513860|FG006|Overall Study|Unspecified reason|0|||
163495256|NCT03576131|590513861|FG007|Overall Study|Unspecified reason|0|||
163495257|NCT03576131|590513854|FG000|Overall Study|Subject non-compliance|0|||
163495258|NCT03576131|590513855|FG001|Overall Study|Subject non-compliance|0|||
163495259|NCT03576131|590513856|FG002|Overall Study|Subject non-compliance|0|||
163495260|NCT03576131|590513857|FG003|Overall Study|Subject non-compliance|0|||
163495261|NCT03576131|590513858|FG004|Overall Study|Subject non-compliance|0|||
163495262|NCT03576131|590513859|FG005|Overall Study|Subject non-compliance|1|||
163495263|NCT03576131|590513860|FG006|Overall Study|Subject non-compliance|0|||
163495264|NCT03576131|590513861|FG007|Overall Study|Subject non-compliance|0|||
163495265|NCT01569594|590513866|FG000|Overall Study|Physician Decision|4|||
163495266|NCT01569594|590513866|FG000|Overall Study|Death|13|||
163495267|NCT01569594|590513866|FG000|Overall Study|Lost to Follow-up|22|||
163495268|NCT01569594|590513866|FG000|Overall Study|Adverse Event|2|||
163495269|NCT01569594|590513866|FG000|Overall Study|Withdrawal by Subject|13|||
163495270|NCT01569594|590513866|FG000|Overall Study|Other|4|||
163495271|NCT01569594|590513866|FG000|Overall Study|No ECM used|9|||
163495272|NCT04635631|590513867|FG000|Overall Study|Adverse Event|1|||
163495273|NCT04635631|590513867|FG000|Overall Study|Progressive disease|13|||
163495274|NCT04635631|590513867|FG000|Overall Study|Withdrawal by Subject|1|||
163495275|NCT00943826|590513868|FG000|Concurrent Phase|Adverse Event|50|||
163495276|NCT00943826|590513869|FG001|Concurrent Phase|Adverse Event|27|||
163495277|NCT00943826|590513868|FG000|Concurrent Phase|Withdrew consent|3|||
163495278|NCT00943826|590513869|FG001|Concurrent Phase|Withdrew consent|7|||
163495279|NCT00943826|590513868|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
163495280|NCT00943826|590513869|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
163495281|NCT00943826|590513868|FG000|Concurrent Phase|Administrative reasons|2|||
163495282|NCT00943826|590513869|FG001|Concurrent Phase|Administrative reasons|1|||
163495283|NCT00943826|590513868|FG000|Concurrent Phase|Protocol Violation|1|||
163495284|NCT00943826|590513869|FG001|Concurrent Phase|Protocol Violation|0|||
163495285|NCT00943826|590513868|FG000|Maintenance Phase|Adverse Event|31|||
163495286|NCT00943826|590513869|FG001|Maintenance Phase|Adverse Event|30|||
163495287|NCT00943826|590513868|FG000|Maintenance Phase|Withdrew consent|2|||
163495288|NCT00943826|590513869|FG001|Maintenance Phase|Withdrew consent|4|||
163495289|NCT00943826|590513868|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
163495290|NCT00943826|590513869|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
163495291|NCT00943826|590513868|FG000|Maintenance Phase|Administrative reasons|4|||
163495292|NCT00943826|590513869|FG001|Maintenance Phase|Administrative reasons|1|||
163495293|NCT00943826|590513868|FG000|Maintenance Phase|Failure to return|0|||
163495294|NCT00943826|590513869|FG001|Maintenance Phase|Failure to return|1|||
163495295|NCT00943826|590513868|FG000|Monotherapy Phase|Adverse Event|42|||
163495296|NCT00943826|590513869|FG001|Monotherapy Phase|Adverse Event|5|||
163495297|NCT00943826|590513868|FG000|Monotherapy Phase|Administrative reasons|11|||
163495298|NCT00943826|590513869|FG001|Monotherapy Phase|Administrative reasons|5|||
163495299|NCT00943826|590513868|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
163495300|NCT00943826|590513869|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
163495301|NCT00943826|590513868|FG000|Monotherapy Phase|Withdrew Consent|2|||
163495302|NCT00943826|590513869|FG001|Monotherapy Phase|Withdrew Consent|3|||
163495303|NCT00943826|590513868|FG000|Monotherapy Phase|Failure to return|2|||
163495304|NCT00943826|590513869|FG001|Monotherapy Phase|Failure to return|1|||
163495305|NCT00943826|590513868|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
163495306|NCT00943826|590513869|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
163495307|NCT00943826|590513868|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
163495308|NCT00943826|590513869|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
163495309|NCT00943826|590513868|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
163495310|NCT00943826|590513869|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
163495311|NCT00943826|590513868|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
163495312|NCT00943826|590513869|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
163495313|NCT04764669|590513870|FG000|Overall Study|Adverse Event|1|||
163495314|NCT04764669|590513871|FG001|Overall Study|Adverse Event|0|||
163495315|NCT04764669|590513872|FG002|Overall Study|Adverse Event|1|||
163495316|NCT04764669|590513873|FG003|Overall Study|Adverse Event|0|||
163495317|NCT04764669|590513870|FG000|Overall Study|Subject Choice|0|||
163495318|NCT04764669|590513871|FG001|Overall Study|Subject Choice|0|||
163495319|NCT04764669|590513872|FG002|Overall Study|Subject Choice|1|||
163495320|NCT04764669|590513873|FG003|Overall Study|Subject Choice|0|||
163495321|NCT04764669|590513870|FG000|Overall Study|Withdrawal by Subject|2|||
163495322|NCT04764669|590513871|FG001|Overall Study|Withdrawal by Subject|0|||
163495323|NCT04764669|590513872|FG002|Overall Study|Withdrawal by Subject|0|||
163495324|NCT04764669|590513873|FG003|Overall Study|Withdrawal by Subject|0|||
163495325|NCT00877799|590513875|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
163495326|NCT00877799|590513876|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
163495327|NCT00877799|590513877|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
163495328|NCT00877799|590513878|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
163495329|NCT00877799|590513879|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
163495330|NCT00877799|590513875|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
163495331|NCT00877799|590513876|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
163495332|NCT00877799|590513877|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
163495333|NCT00877799|590513878|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
163495334|NCT00877799|590513879|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
163495335|NCT00877799|590513875|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
163495336|NCT00877799|590513876|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
163495337|NCT00877799|590513877|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
163495338|NCT00877799|590513878|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
163495339|NCT00877799|590513879|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
163495340|NCT00877799|590513875|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
163495341|NCT00877799|590513876|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
163495342|NCT00877799|590513877|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
163495343|NCT00877799|590513878|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
163495344|NCT00877799|590513879|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
163495345|NCT00877799|590513875|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
163495346|NCT00877799|590513876|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
163495347|NCT00877799|590513877|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
163495348|NCT00877799|590513878|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
163495349|NCT00877799|590513879|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
163495350|NCT00592007|590513880|FG000|Overall Study|Withdrawal by Subject|1|||
163495351|NCT00592007|590513880|FG000|Overall Study|patient ineligible (out of lab range)|1|||
163495352|NCT04054011|590513881|FG000|Overall Study|COVID|3|||
163495353|NCT00595127|590513882|FG000|Overall Study|Death|6|||
163495354|NCT00595127|590513882|FG000|Overall Study|Relapsed|3|||
163495355|NCT00595127|590513882|FG000|Overall Study|joined another trial|1|||
163495356|NCT01785472|590513883|FG000|Overall Study|Adverse Event|5|||
163495357|NCT01785472|590513884|FG001|Overall Study|Adverse Event|4|||
163495358|NCT01785472|590513885|FG002|Overall Study|Adverse Event|6|||
163495359|NCT01785472|590513883|FG000|Overall Study|Lack of Efficacy|2|||
163495360|NCT01785472|590513884|FG001|Overall Study|Lack of Efficacy|0|||
163495361|NCT01785472|590513885|FG002|Overall Study|Lack of Efficacy|1|||
163495362|NCT01785472|590513883|FG000|Overall Study|Lost to Follow-up|1|||
163495363|NCT01785472|590513884|FG001|Overall Study|Lost to Follow-up|2|||
163495364|NCT01785472|590513885|FG002|Overall Study|Lost to Follow-up|0|||
163495365|NCT01785472|590513883|FG000|Overall Study|Physician Decision|1|||
163495366|NCT01785472|590513884|FG001|Overall Study|Physician Decision|1|||
163495367|NCT01785472|590513885|FG002|Overall Study|Physician Decision|1|||
163495368|NCT01785472|590513883|FG000|Overall Study|Protocol deviation|0|||
163495369|NCT01785472|590513884|FG001|Overall Study|Protocol deviation|2|||
163495370|NCT01785472|590513885|FG002|Overall Study|Protocol deviation|2|||
163495371|NCT01785472|590513883|FG000|Overall Study|Subject/guardian decision|15|||
163495372|NCT01785472|590513884|FG001|Overall Study|Subject/guardian decision|10|||
163495373|NCT01785472|590513885|FG002|Overall Study|Subject/guardian decision|11|||
163495374|NCT01785472|590513883|FG000|Overall Study|Technical problems|0|||
163495375|NCT01785472|590513884|FG001|Overall Study|Technical problems|0|||
163495376|NCT01785472|590513885|FG002|Overall Study|Technical problems|1|||
163495377|NCT01803464|590513888|FG000|Overall Study|Incomplete data|0|||
163495378|NCT01803464|590513889|FG001|Overall Study|Incomplete data|0|||
163495379|NCT01803464|590513890|FG002|Overall Study|Incomplete data|4|||
163495380|NCT01803464|590513891|FG003|Overall Study|Incomplete data|0|||
163495381|NCT01803464|590513888|FG000|Overall Study|Withdrawal by Subject|1|||
163495382|NCT01803464|590513889|FG001|Overall Study|Withdrawal by Subject|0|||
163495383|NCT01803464|590513890|FG002|Overall Study|Withdrawal by Subject|0|||
163495384|NCT01803464|590513891|FG003|Overall Study|Withdrawal by Subject|0|||
163495385|NCT02860039|590513897|FG000|Overall Study|Death|4|||
163495386|NCT02860039|590513898|FG001|Overall Study|Death|0|||
163495387|NCT02860039|590513897|FG000|Overall Study|Lost to Follow-up|2|||
163495388|NCT02860039|590513898|FG001|Overall Study|Lost to Follow-up|2|||
163495389|NCT02860039|590513897|FG000|Overall Study|Protocol Violation|3|||
163495390|NCT02860039|590513898|FG001|Overall Study|Protocol Violation|1|||
163495391|NCT02860039|590513897|FG000|Overall Study|Withdrawal by Subject|1|||
163495392|NCT02860039|590513898|FG001|Overall Study|Withdrawal by Subject|0|||
163495393|NCT02860039|590513897|FG000|Overall Study|Not otherwise eligible|1|||
163495394|NCT02860039|590513898|FG001|Overall Study|Not otherwise eligible|1|||
163495395|NCT01125358|590513901|FG000|Overall Study|Adverse Event|3|||
163495396|NCT01125358|590513902|FG001|Overall Study|Adverse Event|0|||
163495397|NCT01125358|590513903|FG002|Overall Study|Adverse Event|0|||
163495398|NCT01125358|590513904|FG003|Overall Study|Adverse Event|2|||
163495399|NCT01125358|590513901|FG000|Overall Study|Perceived Lack of Efficacy|6|||
163495400|NCT01125358|590513902|FG001|Overall Study|Perceived Lack of Efficacy|3|||
163495401|NCT01125358|590513903|FG002|Overall Study|Perceived Lack of Efficacy|7|||
163495402|NCT01125358|590513904|FG003|Overall Study|Perceived Lack of Efficacy|4|||
163495403|NCT01125358|590513901|FG000|Overall Study|Protocol Violation|1|||
163495404|NCT01125358|590513902|FG001|Overall Study|Protocol Violation|0|||
163495405|NCT01125358|590513903|FG002|Overall Study|Protocol Violation|0|||
163495406|NCT01125358|590513904|FG003|Overall Study|Protocol Violation|0|||
163495407|NCT01125358|590513901|FG000|Overall Study|Sponsor Decision|0|||
163495408|NCT01125358|590513902|FG001|Overall Study|Sponsor Decision|0|||
163495409|NCT01125358|590513903|FG002|Overall Study|Sponsor Decision|1|||
163495410|NCT01125358|590513904|FG003|Overall Study|Sponsor Decision|1|||
163495411|NCT01125358|590513901|FG000|Overall Study|Withdrawal by Subject|2|||
163495412|NCT01125358|590513902|FG001|Overall Study|Withdrawal by Subject|1|||
163495413|NCT01125358|590513903|FG002|Overall Study|Withdrawal by Subject|1|||
163495414|NCT01125358|590513904|FG003|Overall Study|Withdrawal by Subject|1|||
163495415|NCT04935931|590513910|FG000|Overall Study|Withdrawal by Subject|1|||
163495416|NCT02628418|590513913|FG000|Overall Study|Lost to Follow-up|1|||
163495417|NCT02628418|590513914|FG001|Overall Study|Lost to Follow-up|2|||
163495418|NCT03159611|590513918|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
163495419|NCT03159611|590513919|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
163495420|NCT03159611|590513918|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
163495421|NCT03159611|590513919|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
163495422|NCT03159611|590513918|FG000|Overall Study|Protocol Violation|7|||
163495423|NCT03159611|590513919|FG001|Overall Study|Protocol Violation|4|||
163495424|NCT03159611|590513918|FG000|Overall Study|Adverse Event|1|||
163495425|NCT03159611|590513919|FG001|Overall Study|Adverse Event|0|||
163495426|NCT03159611|590513918|FG000|Overall Study|Withdrawal by Subject|1|||
163495427|NCT03159611|590513919|FG001|Overall Study|Withdrawal by Subject|1|||
163495428|NCT03159611|590513918|FG000|Overall Study|Non-compliance with protocol requirement|3|||
163495429|NCT03159611|590513919|FG001|Overall Study|Non-compliance with protocol requirement|2|||
163495430|NCT03159611|590513918|FG000|Overall Study|Inability to perform procedures|1|||
163495431|NCT03159611|590513919|FG001|Overall Study|Inability to perform procedures|0|||
163495432|NCT01984229|590513920|FG000|Safety Follow-up Period|Adverse Event|1|||
163495433|NCT01984229|590513921|FG001|Safety Follow-up Period|Adverse Event|1|||
163495434|NCT01984229|590513920|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
163495435|NCT01984229|590513921|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
163495436|NCT02072174|590513922|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
163495437|NCT02072174|590513923|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
163495438|NCT02072174|590513922|FG000|Overall Study|Protocol Violation|16|||
163495439|NCT02072174|590513923|FG001|Overall Study|Protocol Violation|23|||
163495440|NCT02072174|590513922|FG000|Overall Study|Physician Decision|0|||
163495441|NCT02072174|590513923|FG001|Overall Study|Physician Decision|1|||
163495442|NCT02072174|590513922|FG000|Overall Study|Non-compliance with protocol requirement|2|||
163495443|NCT02072174|590513923|FG001|Overall Study|Non-compliance with protocol requirement|0|||
163495444|NCT00352664|590513931|FG000|Overall Study|Withdrawal by Subject|7|||
163495445|NCT00352664|590513932|FG001|Overall Study|Withdrawal by Subject|0|||
163495446|NCT01608321|590513937|FG000|Overall Study|Withdrawal by Subject|1|||
163495447|NCT01608321|590513938|FG001|Overall Study|Withdrawal by Subject|0|||
163495448|NCT01875731|590513939|FG000|Overall Study|Fail to obtain lab sample|1|||
163495449|NCT01875731|590513940|FG001|Overall Study|Fail to obtain lab sample|0|||
163495450|NCT03222856|590513943|FG000|Overall Study|Adverse Event|6|||
163495451|NCT03222856|590513943|FG000|Overall Study|Death|1|||
163495452|NCT00359073|590515734|FG000|Overall Study|Withdrawal by Subject|1|||
163495453|NCT00359073|590515735|FG001|Overall Study|Withdrawal by Subject|1|||
163495454|NCT00359073|590515734|FG000|Overall Study|Eligibility criteria no longer met|3|||
163495455|NCT00359073|590515735|FG001|Overall Study|Eligibility criteria no longer met|0|||
163495456|NCT00359073|590515734|FG000|Overall Study|developed RV16 antibody|0|||
163495457|NCT00359073|590515735|FG001|Overall Study|developed RV16 antibody|1|||
163495458|NCT00684645|590515736|FG000|Overall Study|Death|2|||
163495459|NCT00684645|590515736|FG000|Overall Study|Progressive disease|67|||
163495460|NCT00684645|590515736|FG000|Overall Study|Adverse Event|27|||
163495461|NCT00684645|590515736|FG000|Overall Study|Lost to Follow-up|3|||
163495462|NCT00684645|590515736|FG000|Overall Study|Other|15|||
163495463|NCT01819467|590515741|FG000|Overall Study|Physician Decision|20|||
163495464|NCT01819467|590515742|FG001|Overall Study|Physician Decision|9|||
163495465|NCT03514121|590515743|FG000|Overall Study|Withdrawal by Subject|0|||
163495466|NCT03514121|590515744|FG001|Overall Study|Withdrawal by Subject|0|||
163495467|NCT03514121|590515745|FG002|Overall Study|Withdrawal by Subject|0|||
163495468|NCT03514121|590515746|FG003|Overall Study|Withdrawal by Subject|0|||
163495469|NCT03514121|590515747|FG004|Overall Study|Withdrawal by Subject|1|||
163495470|NCT03514121|590515748|FG005|Overall Study|Withdrawal by Subject|2|||
163495471|NCT03514121|590515749|FG006|Overall Study|Withdrawal by Subject|1|||
163495472|NCT03514121|590515750|FG007|Overall Study|Withdrawal by Subject|1|||
163495473|NCT03514121|590515751|FG008|Overall Study|Withdrawal by Subject|7|||
163495474|NCT03514121|590515752|FG009|Overall Study|Withdrawal by Subject|2|||
163495475|NCT03514121|590515743|FG000|Overall Study|Death|0|||
163495476|NCT03514121|590515744|FG001|Overall Study|Death|0|||
163495477|NCT03514121|590515745|FG002|Overall Study|Death|0|||
163495478|NCT03514121|590515746|FG003|Overall Study|Death|0|||
163495479|NCT03514121|590515747|FG004|Overall Study|Death|0|||
163495480|NCT03514121|590515748|FG005|Overall Study|Death|3|||
163495481|NCT03514121|590515749|FG006|Overall Study|Death|2|||
163495482|NCT03514121|590515750|FG007|Overall Study|Death|1|||
163495483|NCT03514121|590515751|FG008|Overall Study|Death|26|||
163495484|NCT03514121|590515752|FG009|Overall Study|Death|3|||
163495485|NCT03514121|590515743|FG000|Overall Study|Lost to Follow-up|0|||
163495486|NCT03514121|590515744|FG001|Overall Study|Lost to Follow-up|0|||
163495487|NCT03514121|590515745|FG002|Overall Study|Lost to Follow-up|1|||
163495488|NCT03514121|590515746|FG003|Overall Study|Lost to Follow-up|0|||
163495489|NCT03514121|590515747|FG004|Overall Study|Lost to Follow-up|0|||
163495490|NCT03514121|590515748|FG005|Overall Study|Lost to Follow-up|0|||
163495491|NCT03514121|590515749|FG006|Overall Study|Lost to Follow-up|0|||
163495492|NCT03514121|590515750|FG007|Overall Study|Lost to Follow-up|0|||
163495493|NCT03514121|590515751|FG008|Overall Study|Lost to Follow-up|1|||
163495494|NCT03514121|590515752|FG009|Overall Study|Lost to Follow-up|0|||
163495495|NCT03514121|590515743|FG000|Overall Study|Adverse Event|0|||
163495496|NCT03514121|590515744|FG001|Overall Study|Adverse Event|0|||
163495497|NCT03514121|590515745|FG002|Overall Study|Adverse Event|0|||
163495498|NCT03514121|590515746|FG003|Overall Study|Adverse Event|0|||
163495499|NCT03514121|590515747|FG004|Overall Study|Adverse Event|0|||
163495500|NCT03514121|590515748|FG005|Overall Study|Adverse Event|0|||
163495501|NCT03514121|590515749|FG006|Overall Study|Adverse Event|1|||
163495502|NCT03514121|590515750|FG007|Overall Study|Adverse Event|0|||
163495503|NCT03514121|590515751|FG008|Overall Study|Adverse Event|0|||
163495504|NCT03514121|590515752|FG009|Overall Study|Adverse Event|0|||
163495505|NCT03514121|590515743|FG000|Overall Study|Other|0|||
163495506|NCT03514121|590515744|FG001|Overall Study|Other|1|||
163495507|NCT03514121|590515745|FG002|Overall Study|Other|1|||
163495508|NCT03514121|590515746|FG003|Overall Study|Other|0|||
163495509|NCT03514121|590515747|FG004|Overall Study|Other|1|||
163495510|NCT03514121|590515748|FG005|Overall Study|Other|2|||
163495511|NCT03514121|590515749|FG006|Overall Study|Other|3|||
163495512|NCT03514121|590515750|FG007|Overall Study|Other|2|||
163495513|NCT03514121|590515751|FG008|Overall Study|Other|7|||
163495514|NCT03514121|590515752|FG009|Overall Study|Other|3|||
163495515|NCT03514121|590515743|FG000|Overall Study|Study termination by Sponsor|0|||
163495516|NCT03514121|590515744|FG001|Overall Study|Study termination by Sponsor|0|||
163495517|NCT03514121|590515745|FG002|Overall Study|Study termination by Sponsor|0|||
163495518|NCT03514121|590515746|FG003|Overall Study|Study termination by Sponsor|0|||
163495519|NCT03514121|590515747|FG004|Overall Study|Study termination by Sponsor|0|||
163495520|NCT03514121|590515748|FG005|Overall Study|Study termination by Sponsor|0|||
163495521|NCT03514121|590515749|FG006|Overall Study|Study termination by Sponsor|0|||
163495522|NCT03514121|590515750|FG007|Overall Study|Study termination by Sponsor|0|||
163495523|NCT03514121|590515751|FG008|Overall Study|Study termination by Sponsor|11|||
163495524|NCT03514121|590515752|FG009|Overall Study|Study termination by Sponsor|3|||
163495525|NCT03514121|590515743|FG000|Overall Study|Investigator decision|0|||
163495526|NCT03514121|590515744|FG001|Overall Study|Investigator decision|0|||
163495527|NCT03514121|590515745|FG002|Overall Study|Investigator decision|0|||
163495528|NCT03514121|590515746|FG003|Overall Study|Investigator decision|0|||
163495529|NCT03514121|590515747|FG004|Overall Study|Investigator decision|0|||
163495530|NCT03514121|590515748|FG005|Overall Study|Investigator decision|0|||
163495531|NCT03514121|590515749|FG006|Overall Study|Investigator decision|0|||
163495532|NCT03514121|590515750|FG007|Overall Study|Investigator decision|0|||
163495533|NCT03514121|590515751|FG008|Overall Study|Investigator decision|1|||
163495534|NCT03514121|590515752|FG009|Overall Study|Investigator decision|0|||
163495535|NCT00391092|590515753|FG000|Overall Study|Death|78|||
163495536|NCT00391092|590515754|FG001|Overall Study|Death|81|||
163495537|NCT00391092|590515753|FG000|Overall Study|Lost to Follow-up|13|||
163495538|NCT00391092|590515754|FG001|Overall Study|Lost to Follow-up|18|||
163495539|NCT00391092|590515753|FG000|Overall Study|Alive on treatment|29|||
163495540|NCT00391092|590515754|FG001|Overall Study|Alive on treatment|33|||
163495541|NCT00391092|590515753|FG000|Overall Study|Alive in follow-up|88|||
163495542|NCT00391092|590515754|FG001|Overall Study|Alive in follow-up|84|||
163495543|NCT02545868|590515759|FG000|Overall Study|Lack of Efficacy|1|||
163495544|NCT02545868|590515760|FG001|Overall Study|Lack of Efficacy|1|||
163495545|NCT02545868|590515761|FG002|Overall Study|Lack of Efficacy|0|||
163495546|NCT02545868|590515759|FG000|Overall Study|Lost to Follow-up|1|||
163495547|NCT02545868|590515760|FG001|Overall Study|Lost to Follow-up|5|||
163495548|NCT02545868|590515761|FG002|Overall Study|Lost to Follow-up|1|||
163495549|NCT02545868|590515759|FG000|Overall Study|Non-compliance|1|||
163495550|NCT02545868|590515760|FG001|Overall Study|Non-compliance|1|||
163495551|NCT02545868|590515761|FG002|Overall Study|Non-compliance|1|||
163495552|NCT02545868|590515759|FG000|Overall Study|Treatment change|21|||
163495553|NCT02545868|590515760|FG001|Overall Study|Treatment change|19|||
163495554|NCT02545868|590515761|FG002|Overall Study|Treatment change|22|||
163495555|NCT02545868|590515759|FG000|Overall Study|Physician Decision|1|||
163495556|NCT02545868|590515760|FG001|Overall Study|Physician Decision|1|||
163495557|NCT02545868|590515761|FG002|Overall Study|Physician Decision|1|||
163495558|NCT02545868|590515759|FG000|Overall Study|Withdrawal by Subject|6|||
163495559|NCT02545868|590515760|FG001|Overall Study|Withdrawal by Subject|7|||
163495560|NCT02545868|590515761|FG002|Overall Study|Withdrawal by Subject|9|||
163495561|NCT01777191|590515762|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
163495562|NCT01777191|590515763|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
163495563|NCT01777191|590515762|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
163495564|NCT01777191|590515763|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
163495565|NCT01777191|590515762|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
163495566|NCT01777191|590515763|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
163495567|NCT01777191|590515762|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
163495568|NCT01777191|590515763|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
163495569|NCT01777191|590515762|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
163495570|NCT01777191|590515763|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
163495571|NCT01777191|590515762|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
163495572|NCT01777191|590515763|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
163495573|NCT01777191|590515762|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
163495574|NCT01777191|590515763|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
163495575|NCT01777191|590515762|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
163495576|NCT01777191|590515763|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
163495577|NCT01777191|590515762|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
163495578|NCT01777191|590515763|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
163495579|NCT01777191|590515762|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
163495580|NCT01777191|590515763|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
163495581|NCT01777191|590515762|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
163495582|NCT01777191|590515763|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
163495583|NCT03286400|590515768|FG000|Overall Study|Death|10|||
163495584|NCT03286400|590515768|FG000|Overall Study|Lost to Follow-up|10|||
163495585|NCT03286400|590515768|FG000|Overall Study|Physician Decision|1|||
163495586|NCT03286400|590515768|FG000|Overall Study|Scheduling difficulty|4|||
163495587|NCT00568776|590515769|FG000|Overall Study|Adverse Event|8|||
163495588|NCT00568776|590515770|FG001|Overall Study|Adverse Event|8|||
163495589|NCT00568776|590515771|FG002|Overall Study|Adverse Event|10|||
163495590|NCT00568776|590515772|FG003|Overall Study|Adverse Event|8|||
163495591|NCT00568776|590515769|FG000|Overall Study|Death|0|||
163495592|NCT00568776|590515770|FG001|Overall Study|Death|1|||
163495593|NCT00568776|590515771|FG002|Overall Study|Death|4|||
163495594|NCT00568776|590515772|FG003|Overall Study|Death|3|||
163495595|NCT00568776|590515769|FG000|Overall Study|Physician Decision|0|||
163495596|NCT00568776|590515770|FG001|Overall Study|Physician Decision|2|||
163495597|NCT00568776|590515771|FG002|Overall Study|Physician Decision|0|||
163495598|NCT00568776|590515772|FG003|Overall Study|Physician Decision|0|||
163495599|NCT00568776|590515769|FG000|Overall Study|Lack of Efficacy|2|||
163495600|NCT00568776|590515770|FG001|Overall Study|Lack of Efficacy|2|||
163495601|NCT00568776|590515771|FG002|Overall Study|Lack of Efficacy|2|||
163495602|NCT00568776|590515772|FG003|Overall Study|Lack of Efficacy|4|||
163495603|NCT00568776|590515769|FG000|Overall Study|Lost to Follow-up|1|||
163495604|NCT00568776|590515770|FG001|Overall Study|Lost to Follow-up|1|||
163495605|NCT00568776|590515771|FG002|Overall Study|Lost to Follow-up|1|||
163495606|NCT00568776|590515772|FG003|Overall Study|Lost to Follow-up|1|||
163495607|NCT00568776|590515769|FG000|Overall Study|Protocol Violation|1|||
163495608|NCT00568776|590515770|FG001|Overall Study|Protocol Violation|0|||
163495609|NCT00568776|590515771|FG002|Overall Study|Protocol Violation|1|||
163495610|NCT00568776|590515772|FG003|Overall Study|Protocol Violation|1|||
163495611|NCT00568776|590515769|FG000|Overall Study|Withdrawal by Subject|13|||
163495612|NCT00568776|590515770|FG001|Overall Study|Withdrawal by Subject|15|||
163495613|NCT00568776|590515771|FG002|Overall Study|Withdrawal by Subject|13|||
163495614|NCT00568776|590515772|FG003|Overall Study|Withdrawal by Subject|7|||
163495615|NCT00568776|590515769|FG000|Overall Study|Loss of Caregiver|0|||
163495616|NCT00568776|590515770|FG001|Overall Study|Loss of Caregiver|2|||
163495617|NCT00568776|590515771|FG002|Overall Study|Loss of Caregiver|1|||
163495618|NCT00568776|590515772|FG003|Overall Study|Loss of Caregiver|2|||
163495619|NCT00568776|590515769|FG000|Overall Study|Sponsor Decision|2|||
163495620|NCT00568776|590515770|FG001|Overall Study|Sponsor Decision|2|||
163495621|NCT00568776|590515771|FG002|Overall Study|Sponsor Decision|41|||
163495622|NCT00568776|590515772|FG003|Overall Study|Sponsor Decision|42|||
163495623|NCT00568776|590515769|FG000|Overall Study|Miscellaeneous|3|||
163495624|NCT00568776|590515770|FG001|Overall Study|Miscellaeneous|3|||
163495625|NCT00568776|590515771|FG002|Overall Study|Miscellaeneous|1|||
163495626|NCT00568776|590515772|FG003|Overall Study|Miscellaeneous|4|||
163495627|NCT01563029|590515773|FG000|Overall Study|Adverse Event|1|||
163495628|NCT01563029|590515774|FG001|Overall Study|Adverse Event|0|||
163495629|NCT01563029|590515775|FG002|Overall Study|Adverse Event|1|||
163495630|NCT01563029|590515776|FG003|Overall Study|Adverse Event|2|||
163495631|NCT01563029|590515777|FG004|Overall Study|Adverse Event|1|||
163495632|NCT01563029|590515773|FG000|Overall Study|Lack of Efficacy|42|||
163495633|NCT01563029|590515774|FG001|Overall Study|Lack of Efficacy|16|||
163495634|NCT01563029|590515775|FG002|Overall Study|Lack of Efficacy|23|||
163495635|NCT01563029|590515776|FG003|Overall Study|Lack of Efficacy|21|||
163495636|NCT01563029|590515777|FG004|Overall Study|Lack of Efficacy|19|||
163495637|NCT01563029|590515773|FG000|Overall Study|Protocol Violation|1|||
163495638|NCT01563029|590515774|FG001|Overall Study|Protocol Violation|2|||
163495639|NCT01563029|590515775|FG002|Overall Study|Protocol Violation|3|||
163495640|NCT01563029|590515776|FG003|Overall Study|Protocol Violation|1|||
163495641|NCT01563029|590515777|FG004|Overall Study|Protocol Violation|3|||
163495642|NCT01563029|590515773|FG000|Overall Study|Protocol defined stopping criteria|1|||
163495643|NCT01563029|590515774|FG001|Overall Study|Protocol defined stopping criteria|0|||
163495644|NCT01563029|590515775|FG002|Overall Study|Protocol defined stopping criteria|0|||
163495645|NCT01563029|590515776|FG003|Overall Study|Protocol defined stopping criteria|0|||
163495646|NCT01563029|590515777|FG004|Overall Study|Protocol defined stopping criteria|0|||
163495647|NCT01563029|590515773|FG000|Overall Study|Lost to Follow-up|1|||
163495648|NCT01563029|590515774|FG001|Overall Study|Lost to Follow-up|0|||
163495649|NCT01563029|590515775|FG002|Overall Study|Lost to Follow-up|1|||
163495650|NCT01563029|590515776|FG003|Overall Study|Lost to Follow-up|1|||
163495651|NCT01563029|590515777|FG004|Overall Study|Lost to Follow-up|1|||
163495652|NCT01563029|590515773|FG000|Overall Study|Physician Decision|3|||
163495653|NCT01563029|590515774|FG001|Overall Study|Physician Decision|5|||
163495654|NCT01563029|590515775|FG002|Overall Study|Physician Decision|2|||
163495655|NCT01563029|590515776|FG003|Overall Study|Physician Decision|4|||
163495656|NCT01563029|590515777|FG004|Overall Study|Physician Decision|2|||
163495657|NCT01563029|590515773|FG000|Overall Study|Withdrawal by Subject|4|||
163495658|NCT01563029|590515774|FG001|Overall Study|Withdrawal by Subject|1|||
163495659|NCT01563029|590515775|FG002|Overall Study|Withdrawal by Subject|3|||
163495660|NCT01563029|590515776|FG003|Overall Study|Withdrawal by Subject|4|||
163495661|NCT01563029|590515777|FG004|Overall Study|Withdrawal by Subject|3|||
163495662|NCT03069365|590515778|FG000|Overall Study|Adverse Event|1|||
163495663|NCT02780115|590515779|FG000|Overall Study|Withdrawal by Subject|0|||
163495664|NCT02780115|590515780|FG001|Overall Study|Withdrawal by Subject|1|||
163495665|NCT02780115|590515781|FG002|Overall Study|Withdrawal by Subject|1|||
163495666|NCT02780115|590515782|FG003|Overall Study|Withdrawal by Subject|0|||
163495667|NCT02780115|590515783|FG004|Overall Study|Withdrawal by Subject|0|||
163495668|NCT02780115|590515779|FG000|Overall Study|Adverse Event|0|||
163495669|NCT02780115|590515780|FG001|Overall Study|Adverse Event|0|||
163495670|NCT02780115|590515781|FG002|Overall Study|Adverse Event|0|||
163495671|NCT02780115|590515782|FG003|Overall Study|Adverse Event|1|||
163495672|NCT02780115|590515783|FG004|Overall Study|Adverse Event|1|||
163495673|NCT00769132|590515784|FG000|Period 1|Adverse Event|1|||
163495674|NCT00769132|590515785|FG001|Period 1|Adverse Event|0|||
163495675|NCT00769132|590515786|FG002|Period 1|Adverse Event|0|||
163495676|NCT00769132|590515787|FG003|Period 1|Adverse Event|1|||
163495677|NCT00769132|590515784|FG000|Period 2|Withdrawal by Subject|0|||
163495678|NCT00769132|590515785|FG001|Period 2|Withdrawal by Subject|0|||
163495679|NCT00769132|590515786|FG002|Period 2|Withdrawal by Subject|0|||
163495680|NCT00769132|590515787|FG003|Period 2|Withdrawal by Subject|1|||
163495681|NCT00769132|590515784|FG000|Period 3|Withdrawal by Subject|1|||
163495682|NCT00769132|590515785|FG001|Period 3|Withdrawal by Subject|0|||
163495683|NCT00769132|590515786|FG002|Period 3|Withdrawal by Subject|0|||
163495684|NCT00769132|590515787|FG003|Period 3|Withdrawal by Subject|0|||
163495685|NCT00769132|590515784|FG000|Period 4|Withdrawal by Subject|0|||
163495686|NCT00769132|590515785|FG001|Period 4|Withdrawal by Subject|1|||
163495687|NCT00769132|590515786|FG002|Period 4|Withdrawal by Subject|0|||
163495688|NCT00769132|590515787|FG003|Period 4|Withdrawal by Subject|0|||
163495689|NCT00566631|590515788|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
163495690|NCT00566631|590515788|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
163495691|NCT00566631|590515788|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
163495692|NCT00566631|590515788|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
163495693|NCT00566631|590515788|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
163495694|NCT00566631|590515788|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
163495695|NCT00566631|590515788|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
163495696|NCT00566631|590515788|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
163495697|NCT00566631|590515788|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
163495698|NCT00566631|590515788|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
163495699|NCT00566631|590515788|FG000|Part 2: Extension Phase|Adverse Event|11|||
163495700|NCT00566631|590515788|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
163495701|NCT00566631|590515788|FG000|Part 2: Extension Phase|Death|1|||
163495702|NCT00566631|590515788|FG000|Part 2: Extension Phase|Other|5|||
163495703|NCT01257737|590515789|FG000|Overall Study|Lost to Follow-up|1|||
163495704|NCT01257737|590515790|FG001|Overall Study|Lost to Follow-up|2|||
163495705|NCT01257737|590515789|FG000|Overall Study|Liver transplant|1|||
163495706|NCT01257737|590515790|FG001|Overall Study|Liver transplant|0|||
163495707|NCT01257737|590515789|FG000|Overall Study|Relocation out of the country|0|||
163495708|NCT01257737|590515790|FG001|Overall Study|Relocation out of the country|1|||
163495709|NCT01257737|590515789|FG000|Overall Study|Withdrew from study|0|||
163495710|NCT01257737|590515790|FG001|Overall Study|Withdrew from study|1|||
163495711|NCT02723786|590515793|FG000|Overall Study|Lost to Follow-up|1|||
163495712|NCT00127192|590515796|FG000|Overall Study|Adverse Event|0|||
163495713|NCT00127192|590515797|FG001|Overall Study|Adverse Event|1|||
163495714|NCT00127192|590515798|FG002|Overall Study|Adverse Event|1|||
163495715|NCT00127192|590515799|FG003|Overall Study|Adverse Event|1|||
163495716|NCT00127192|590515800|FG004|Overall Study|Adverse Event|0|||
163495717|NCT00127192|590515796|FG000|Overall Study|Lack of Efficacy|2|||
163495718|NCT00127192|590515797|FG001|Overall Study|Lack of Efficacy|0|||
163495719|NCT00127192|590515798|FG002|Overall Study|Lack of Efficacy|0|||
163495720|NCT00127192|590515799|FG003|Overall Study|Lack of Efficacy|0|||
163495721|NCT00127192|590515800|FG004|Overall Study|Lack of Efficacy|2|||
163495722|NCT00127192|590515796|FG000|Overall Study|Withdrawal by Subject|0|||
163495723|NCT00127192|590515797|FG001|Overall Study|Withdrawal by Subject|0|||
163495724|NCT00127192|590515798|FG002|Overall Study|Withdrawal by Subject|1|||
163495725|NCT00127192|590515799|FG003|Overall Study|Withdrawal by Subject|0|||
163495726|NCT00127192|590515800|FG004|Overall Study|Withdrawal by Subject|3|||
163495727|NCT00127192|590515796|FG000|Overall Study|Adverse event in pre-treatment period|1|||
163495728|NCT00127192|590515797|FG001|Overall Study|Adverse event in pre-treatment period|0|||
163495729|NCT00127192|590515798|FG002|Overall Study|Adverse event in pre-treatment period|0|||
163495730|NCT00127192|590515799|FG003|Overall Study|Adverse event in pre-treatment period|0|||
163495731|NCT00127192|590515800|FG004|Overall Study|Adverse event in pre-treatment period|0|||
163495732|NCT03170271|590515802|FG000|Overall Study|Adverse Event|7|||
163495733|NCT03170271|590515803|FG001|Overall Study|Adverse Event|2|||
163495734|NCT03170271|590515802|FG000|Overall Study|Lost to Follow-up|0|||
163495735|NCT03170271|590515803|FG001|Overall Study|Lost to Follow-up|1|||
163495736|NCT03170271|590515802|FG000|Overall Study|Physician Decision|1|||
163495737|NCT03170271|590515803|FG001|Overall Study|Physician Decision|0|||
163495738|NCT03170271|590515802|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
163495739|NCT03170271|590515803|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
163495740|NCT03170271|590515802|FG000|Overall Study|Withdrawal by Subject|17|||
163495741|NCT03170271|590515803|FG001|Overall Study|Withdrawal by Subject|5|||
163495742|NCT03170271|590515802|FG000|Overall Study|Other|2|||
163495743|NCT03170271|590515803|FG001|Overall Study|Other|2|||
163495744|NCT03170271|590515802|FG000|Overall Study|Randomized in error|4|||
163495745|NCT03170271|590515803|FG001|Overall Study|Randomized in error|0|||
163495746|NCT01036594|590515817|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
163495747|NCT01036594|590515818|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
163495748|NCT01036594|590515817|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
163495749|NCT01036594|590515818|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
163495750|NCT01036594|590515817|FG000|Week 12 Evaluation|Adverse Event|5|||
163495751|NCT01036594|590515818|FG001|Week 12 Evaluation|Adverse Event|0|||
163495752|NCT01036594|590515817|FG000|Week 12 Evaluation|Physician Decision|1|||
163495753|NCT01036594|590515818|FG001|Week 12 Evaluation|Physician Decision|0|||
163495754|NCT01036594|590515817|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
163495755|NCT01036594|590515818|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
163495756|NCT01036594|590515817|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
163495757|NCT01036594|590515818|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
163495758|NCT01036594|590515817|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
163495759|NCT01036594|590515818|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
163495760|NCT01036594|590515817|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
163495761|NCT01036594|590515818|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
163495762|NCT01036594|590515817|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
163495763|NCT01036594|590515818|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
163495764|NCT03466060|590515821|FG000|Period 1|Test Lens Damage|0|||
163495765|NCT03466060|590515822|FG001|Period 1|Test Lens Damage|2|||
163495766|NCT03466060|590515823|FG002|Period 1|Test Lens Damage|0|||
163495767|NCT03466060|590515824|FG003|Period 1|Test Lens Damage|0|||
163495768|NCT03466060|590515825|FG004|Period 1|Test Lens Damage|0|||
163495769|NCT03466060|590515826|FG005|Period 1|Test Lens Damage|0|||
163495770|NCT03466060|590515821|FG000|Period 1|Withdrawal by Subject|0|||
163495771|NCT03466060|590515822|FG001|Period 1|Withdrawal by Subject|0|||
163495772|NCT03466060|590515823|FG002|Period 1|Withdrawal by Subject|2|||
163495773|NCT03466060|590515824|FG003|Period 1|Withdrawal by Subject|0|||
163495774|NCT03466060|590515825|FG004|Period 1|Withdrawal by Subject|0|||
163495775|NCT03466060|590515826|FG005|Period 1|Withdrawal by Subject|0|||
163495776|NCT03466060|590515821|FG000|Period 1|Lost to Follow-up|0|||
163495777|NCT03466060|590515822|FG001|Period 1|Lost to Follow-up|0|||
163495778|NCT03466060|590515823|FG002|Period 1|Lost to Follow-up|0|||
163495779|NCT03466060|590515824|FG003|Period 1|Lost to Follow-up|1|||
163495780|NCT03466060|590515825|FG004|Period 1|Lost to Follow-up|0|||
163495781|NCT03466060|590515826|FG005|Period 1|Lost to Follow-up|0|||
163495782|NCT03466060|590515821|FG000|Period 1|Grade 2 Conjunctivitis|0|||
163495783|NCT03466060|590515822|FG001|Period 1|Grade 2 Conjunctivitis|0|||
163495784|NCT03466060|590515823|FG002|Period 1|Grade 2 Conjunctivitis|1|||
163495785|NCT03466060|590515824|FG003|Period 1|Grade 2 Conjunctivitis|0|||
163495786|NCT03466060|590515825|FG004|Period 1|Grade 2 Conjunctivitis|0|||
163495787|NCT03466060|590515826|FG005|Period 1|Grade 2 Conjunctivitis|0|||
163495788|NCT03466060|590515821|FG000|Period 2|Lens Handling Difficulties|0|||
163495789|NCT03466060|590515822|FG001|Period 2|Lens Handling Difficulties|0|||
163495790|NCT03466060|590515823|FG002|Period 2|Lens Handling Difficulties|1|||
163495791|NCT03466060|590515824|FG003|Period 2|Lens Handling Difficulties|0|||
163495792|NCT03466060|590515825|FG004|Period 2|Lens Handling Difficulties|0|||
163495793|NCT03466060|590515826|FG005|Period 2|Lens Handling Difficulties|0|||
163495794|NCT01612780|590515827|FG000|Overall Study|Treatment not completed|1|||
163495795|NCT01612780|590515827|FG000|Overall Study|Withdrawal by Subject|5|||
163495796|NCT03345485|590515830|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
163495797|NCT03345485|590515831|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
163495798|NCT03345485|590515832|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
163495799|NCT03345485|590515833|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
163495800|NCT03345485|590515834|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
163495801|NCT03345485|590515835|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
163495802|NCT03345485|590515836|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
163495803|NCT03345485|590515837|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
163495804|NCT03345485|590515838|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
163495805|NCT03345485|590515839|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
163495806|NCT03345485|590515840|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
163495807|NCT03345485|590515841|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
163495808|NCT03345485|590515842|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
163495809|NCT02985515|590515843|FG000|Olfaction Testing|Lost to Follow-up|0|||
163495810|NCT02985515|590515844|FG001|Olfaction Testing|Lost to Follow-up|5|||
163495811|NCT02985515|590515843|FG000|Olfaction Testing|Protocol Violation|0|||
163495812|NCT02985515|590515844|FG001|Olfaction Testing|Protocol Violation|3|||
163495813|NCT01610284|590515845|FG000|Randomization Phase|Adverse Event|1|||
163495814|NCT01610284|590515846|FG001|Randomization Phase|Adverse Event|0|||
163495815|NCT01610284|590515845|FG000|Randomization Phase|Physician Decision|1|||
163495816|NCT01610284|590515846|FG001|Randomization Phase|Physician Decision|1|||
163495817|NCT01610284|590515845|FG000|Randomization Phase|Death|0|||
163495818|NCT01610284|590515846|FG001|Randomization Phase|Death|1|||
163495819|NCT01610284|590515845|FG000|Treatment Phase|Adverse Event|80|||
163495820|NCT01610284|590515846|FG001|Treatment Phase|Adverse Event|12|||
163495821|NCT01610284|590515845|FG000|Treatment Phase|Lost to Follow-up|1|||
163495822|NCT01610284|590515846|FG001|Treatment Phase|Lost to Follow-up|0|||
163495823|NCT01610284|590515845|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
163495824|NCT01610284|590515846|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
163495825|NCT01610284|590515845|FG000|Treatment Phase|Physician Decision|27|||
163495826|NCT01610284|590515846|FG001|Treatment Phase|Physician Decision|24|||
163495827|NCT01610284|590515845|FG000|Treatment Phase|Progressive Disease|377|||
163495828|NCT01610284|590515846|FG001|Treatment Phase|Progressive Disease|486|||
163495829|NCT01610284|590515845|FG000|Treatment Phase|Protocol Deviation|2|||
163495830|NCT01610284|590515846|FG001|Treatment Phase|Protocol Deviation|3|||
163495831|NCT01610284|590515845|FG000|Treatment Phase|Study terminated by Sponsor|18|||
163495832|NCT01610284|590515846|FG001|Treatment Phase|Study terminated by Sponsor|15|||
163495833|NCT01610284|590515845|FG000|Treatment Phase|Subject/Guardian Decision|55|||
163495834|NCT01610284|590515846|FG001|Treatment Phase|Subject/Guardian Decision|23|||
163495835|NCT01610284|590515845|FG000|Treatment Phase|Death|6|||
163495836|NCT01610284|590515846|FG001|Treatment Phase|Death|5|||
163495837|NCT01610284|590515845|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
163495838|NCT01610284|590515846|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
163495839|NCT01610284|590515845|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
163495840|NCT01610284|590515846|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
163495841|NCT01610284|590515845|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
163495842|NCT01610284|590515846|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
163495843|NCT01610284|590515845|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
163495844|NCT01610284|590515846|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
163495845|NCT01610284|590515845|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
163495846|NCT01610284|590515846|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
163495847|NCT01610284|590515845|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
163495848|NCT01610284|590515846|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
163495849|NCT03020966|590515847|FG000|Overall Study|Withdrawal by Subject|2|||
163495850|NCT03020966|590515848|FG001|Overall Study|Withdrawal by Subject|0|||
163495851|NCT01856257|590515849|FG000|Overall Study|Death|2|||
163495852|NCT01856257|590515850|FG001|Overall Study|Death|0|||
163495853|NCT01856257|590515851|FG002|Overall Study|Death|0|||
163495854|NCT01856257|590515852|FG003|Overall Study|Death|0|||
163495855|NCT01856257|590515849|FG000|Overall Study|Physician Decision|0|||
163495856|NCT01856257|590515850|FG001|Overall Study|Physician Decision|0|||
163495857|NCT01856257|590515851|FG002|Overall Study|Physician Decision|0|||
163495858|NCT01856257|590515852|FG003|Overall Study|Physician Decision|1|||
163495859|NCT01856257|590515849|FG000|Overall Study|Withdrawal by Subject|1|||
163495860|NCT01856257|590515850|FG001|Overall Study|Withdrawal by Subject|1|||
163495861|NCT01856257|590515851|FG002|Overall Study|Withdrawal by Subject|0|||
163495862|NCT01856257|590515852|FG003|Overall Study|Withdrawal by Subject|0|||
163495863|NCT01856257|590515849|FG000|Overall Study|Donor complication|0|||
163495864|NCT01856257|590515850|FG001|Overall Study|Donor complication|0|||
163495865|NCT01856257|590515851|FG002|Overall Study|Donor complication|0|||
163495866|NCT01856257|590515852|FG003|Overall Study|Donor complication|1|||
163495867|NCT01060007|590515856|FG000|Overall Study|Withdrawal by Subject|1|||
163495868|NCT01060007|590515856|FG000|Overall Study|Inevaluable for response at surgery|3|||
163495869|NCT00424632|590515857|FG000|Overall Study|Death|0|||
163495870|NCT00424632|590515858|FG001|Overall Study|Death|0|||
163495871|NCT00424632|590515859|FG002|Overall Study|Death|0|||
163495872|NCT00424632|590515860|FG003|Overall Study|Death|0|||
163495873|NCT00424632|590515861|FG004|Overall Study|Death|0|||
163495874|NCT00424632|590515862|FG005|Overall Study|Death|2|||
163495875|NCT00424632|590515863|FG006|Overall Study|Death|0|||
163495876|NCT00424632|590515864|FG007|Overall Study|Death|0|||
163495877|NCT00424632|590515865|FG008|Overall Study|Death|0|||
163495878|NCT00424632|590515866|FG009|Overall Study|Death|0|||
163495879|NCT00424632|590515857|FG000|Overall Study|Adverse Event|0|||
163495880|NCT00424632|590515858|FG001|Overall Study|Adverse Event|0|||
163495881|NCT00424632|590515859|FG002|Overall Study|Adverse Event|0|||
163495882|NCT00424632|590515860|FG003|Overall Study|Adverse Event|0|||
163495883|NCT00424632|590515861|FG004|Overall Study|Adverse Event|0|||
163495884|NCT00424632|590515862|FG005|Overall Study|Adverse Event|0|||
163495885|NCT00424632|590515863|FG006|Overall Study|Adverse Event|0|||
163495886|NCT00424632|590515864|FG007|Overall Study|Adverse Event|0|||
163495887|NCT00424632|590515865|FG008|Overall Study|Adverse Event|3|||
163495888|NCT00424632|590515866|FG009|Overall Study|Adverse Event|2|||
163495889|NCT00424632|590515857|FG000|Overall Study|Global deterioration of health status|0|||
163495890|NCT00424632|590515858|FG001|Overall Study|Global deterioration of health status|0|||
163495891|NCT00424632|590515859|FG002|Overall Study|Global deterioration of health status|0|||
163495892|NCT00424632|590515860|FG003|Overall Study|Global deterioration of health status|1|||
163495893|NCT00424632|590515861|FG004|Overall Study|Global deterioration of health status|1|||
163495894|NCT00424632|590515862|FG005|Overall Study|Global deterioration of health status|0|||
163495895|NCT00424632|590515863|FG006|Overall Study|Global deterioration of health status|0|||
163495896|NCT00424632|590515864|FG007|Overall Study|Global deterioration of health status|0|||
163495897|NCT00424632|590515865|FG008|Overall Study|Global deterioration of health status|0|||
163495898|NCT00424632|590515866|FG009|Overall Study|Global deterioration of health status|0|||
163495899|NCT00424632|590515857|FG000|Overall Study|Objective progression or relapse|1|||
163495900|NCT00424632|590515858|FG001|Overall Study|Objective progression or relapse|1|||
163495901|NCT00424632|590515859|FG002|Overall Study|Objective progression or relapse|1|||
163495902|NCT00424632|590515860|FG003|Overall Study|Objective progression or relapse|2|||
163495903|NCT00424632|590515861|FG004|Overall Study|Objective progression or relapse|2|||
163495904|NCT00424632|590515862|FG005|Overall Study|Objective progression or relapse|13|||
163495905|NCT00424632|590515863|FG006|Overall Study|Objective progression or relapse|7|||
163495906|NCT00424632|590515864|FG007|Overall Study|Objective progression or relapse|3|||
163495907|NCT00424632|590515865|FG008|Overall Study|Objective progression or relapse|12|||
163495908|NCT00424632|590515866|FG009|Overall Study|Objective progression or relapse|4|||
163495909|NCT00424632|590515857|FG000|Overall Study|Other|0|||
163495910|NCT00424632|590515858|FG001|Overall Study|Other|0|||
163495911|NCT00424632|590515859|FG002|Overall Study|Other|0|||
163495912|NCT00424632|590515860|FG003|Overall Study|Other|1|||
163495913|NCT00424632|590515861|FG004|Overall Study|Other|0|||
163495914|NCT00424632|590515862|FG005|Overall Study|Other|0|||
163495915|NCT00424632|590515863|FG006|Overall Study|Other|0|||
163495916|NCT00424632|590515864|FG007|Overall Study|Other|0|||
163495917|NCT00424632|590515865|FG008|Overall Study|Other|1|||
163495918|NCT00424632|590515866|FG009|Overall Study|Other|0|||
163495919|NCT05674721|590515868|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
163495920|NCT05674721|590515869|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
163495921|NCT05674721|590515868|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
163495922|NCT05674721|590515869|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
163495923|NCT03506425|590515884|FG000|Overall Study|Adverse Event|1|||
163495924|NCT03506425|590515885|FG001|Overall Study|Adverse Event|3|||
163495925|NCT03506425|590515886|FG002|Overall Study|Adverse Event|0|||
163495926|NCT03506425|590515884|FG000|Overall Study|Death|1|||
163495927|NCT03506425|590515885|FG001|Overall Study|Death|0|||
163495928|NCT03506425|590515886|FG002|Overall Study|Death|0|||
163495929|NCT03506425|590515884|FG000|Overall Study|Withdrawal by Subject|0|||
163495930|NCT03506425|590515885|FG001|Overall Study|Withdrawal by Subject|0|||
163495931|NCT03506425|590515886|FG002|Overall Study|Withdrawal by Subject|1|||
163495932|NCT02057549|590515887|FG000|Overall Study|Lost to Follow-up|1|||
163495933|NCT02057549|590515888|FG001|Overall Study|Lost to Follow-up|0|||
163495934|NCT02057549|590515887|FG000|Overall Study|Physician Decision|1|||
163495935|NCT02057549|590515888|FG001|Overall Study|Physician Decision|0|||
163495936|NCT02057549|590515887|FG000|Overall Study|Withdrawal by Subject|1|||
163495937|NCT02057549|590515888|FG001|Overall Study|Withdrawal by Subject|0|||
163495938|NCT04150107|590515891|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
163495939|NCT04150107|590515892|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
163495940|NCT04150107|590515891|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
163495941|NCT04150107|590515892|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
163495942|NCT00440193|590515897|FG000|Treatment Period|Adverse Event|74|||
163495943|NCT00440193|590515898|FG001|Treatment Period|Adverse Event|67|||
163495944|NCT00440193|590515897|FG000|Treatment Period|Death|19|||
163495945|NCT00440193|590515898|FG001|Treatment Period|Death|22|||
163495946|NCT00440193|590515897|FG000|Treatment Period|Lack of Efficacy|0|||
163495947|NCT00440193|590515898|FG001|Treatment Period|Lack of Efficacy|1|||
163495948|NCT00440193|590515897|FG000|Treatment Period|Lost to Follow-up|12|||
163495949|NCT00440193|590515898|FG001|Treatment Period|Lost to Follow-up|18|||
163495950|NCT00440193|590515897|FG000|Treatment Period|Physician Decision|3|||
163495951|NCT00440193|590515898|FG001|Treatment Period|Physician Decision|6|||
163495952|NCT00440193|590515897|FG000|Treatment Period|Protocol Violation|16|||
163495953|NCT00440193|590515898|FG001|Treatment Period|Protocol Violation|19|||
163495954|NCT00440193|590515897|FG000|Treatment Period|Withdrawal by Subject|36|||
163495955|NCT00440193|590515898|FG001|Treatment Period|Withdrawal by Subject|77|||
163495956|NCT00440193|590515897|FG000|Treatment Period|Clinical endpoint reached|28|||
163495957|NCT00440193|590515898|FG001|Treatment Period|Clinical endpoint reached|25|||
163495958|NCT00440193|590515897|FG000|Treatment Period|Study terminated by sponsor|102|||
163495959|NCT00440193|590515898|FG001|Treatment Period|Study terminated by sponsor|94|||
163495960|NCT00440193|590515897|FG000|Treatment Period|Protocol driven decision point|2|||
163495961|NCT00440193|590515898|FG001|Treatment Period|Protocol driven decision point|2|||
163495962|NCT00440193|590515897|FG000|Treatment Period|Switch to commercial drug|0|||
163495963|NCT00440193|590515898|FG001|Treatment Period|Switch to commercial drug|2|||
163495964|NCT00440193|590515897|FG000|Treatment Period|Technical problems|1|||
163495965|NCT00440193|590515898|FG001|Treatment Period|Technical problems|1|||
163495966|NCT00440193|590515897|FG000|Treatment Period|Participant convenience|5|||
163495967|NCT00440193|590515898|FG001|Treatment Period|Participant convenience|2|||
163495968|NCT00440193|590515897|FG000|Treatment Period|Participant did not receive treatment|7|||
163495969|NCT00440193|590515898|FG001|Treatment Period|Participant did not receive treatment|13|||
163495970|NCT00440193|590515897|FG000|Treatment Period|Site closed by investigator|0|||
163495971|NCT00440193|590515898|FG001|Treatment Period|Site closed by investigator|2|||
163495972|NCT00440193|590515897|FG000|Observational Period|Adverse Event|2|||
163495973|NCT00440193|590515898|FG001|Observational Period|Adverse Event|2|||
163495974|NCT00440193|590515897|FG000|Observational Period|Death|15|||
163495975|NCT00440193|590515898|FG001|Observational Period|Death|20|||
163495976|NCT00440193|590515897|FG000|Observational Period|Lost to Follow-up|12|||
163495977|NCT00440193|590515898|FG001|Observational Period|Lost to Follow-up|8|||
163495978|NCT00440193|590515897|FG000|Observational Period|Protocol Violation|1|||
163495979|NCT00440193|590515898|FG001|Observational Period|Protocol Violation|0|||
163495980|NCT00440193|590515897|FG000|Observational Period|Withdrawal by Subject|11|||
163495981|NCT00440193|590515898|FG001|Observational Period|Withdrawal by Subject|8|||
163495982|NCT00440193|590515897|FG000|Observational Period|Physician Decision|1|||
163495983|NCT00440193|590515898|FG001|Observational Period|Physician Decision|0|||
163495984|NCT00440193|590515897|FG000|Observational Period|Clinical endpoint reached|1|||
163495985|NCT00440193|590515898|FG001|Observational Period|Clinical endpoint reached|0|||
163495986|NCT00440193|590515897|FG000|Observational Period|Participant convenience|2|||
163495987|NCT00440193|590515898|FG001|Observational Period|Participant convenience|0|||
163495988|NCT00834366|590515899|FG000|Treatment Period 1|Adverse Event|1|||
163495989|NCT00834366|590515900|FG001|Treatment Period 1|Adverse Event|1|||
163495990|NCT03409328|590515906|FG000|Overall Study|Lost to Follow-up|6|||
163495991|NCT03409328|590515907|FG001|Overall Study|Lost to Follow-up|3|||
163495992|NCT00478673|590515908|FG000|30-Days Post-Procedure|Death|2|||
163495993|NCT00478673|590515908|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
163495994|NCT00478673|590515908|FG000|30-Days Post-Procedure|Missed Visit|7|||
163495995|NCT00478673|590515908|FG000|12-Months Post-Procedure|Death|23|||
163495996|NCT00478673|590515908|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
163495997|NCT00478673|590515908|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
163495998|NCT00478673|590515908|FG000|12-Months Post-Procedure|Missed Visit|25|||
163495999|NCT00478673|590515908|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
163496000|NCT03930615|590515909|FG000|Overall Study|Death|9|||
163496001|NCT03930615|590515910|FG001|Overall Study|Death|3|||
163496002|NCT03930615|590515909|FG000|Overall Study|Lost to Follow-up|1|||
163496003|NCT03930615|590515910|FG001|Overall Study|Lost to Follow-up|2|||
163496004|NCT03930615|590515909|FG000|Overall Study|Physician Decision|3|||
163496005|NCT03930615|590515910|FG001|Overall Study|Physician Decision|4|||
163496006|NCT03930615|590515909|FG000|Overall Study|Withdrawal by Subject|13|||
163496007|NCT03930615|590515910|FG001|Overall Study|Withdrawal by Subject|2|||
163496008|NCT03930615|590515909|FG000|Overall Study|Not treated|1|||
163496009|NCT03930615|590515910|FG001|Overall Study|Not treated|1|||
163496010|NCT02864953|590515911|FG000|Overall Study|Adverse Event|22|||
163496011|NCT02864953|590515912|FG001|Overall Study|Adverse Event|19|||
163496012|NCT02864953|590515911|FG000|Overall Study|Withdrawal by Subject|1|||
163496013|NCT02864953|590515912|FG001|Overall Study|Withdrawal by Subject|0|||
163496014|NCT02864953|590515911|FG000|Overall Study|Physician Decision|4|||
163496015|NCT02864953|590515912|FG001|Overall Study|Physician Decision|2|||
163496016|NCT02864953|590515911|FG000|Overall Study|Death|3|||
163496017|NCT02864953|590515912|FG001|Overall Study|Death|13|||
163496018|NCT02864953|590515911|FG000|Overall Study|Reason not specified|14|||
162925442|NCT02564952|588428975|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
163496019|NCT02864953|590515912|FG001|Overall Study|Reason not specified|12|||
163496020|NCT02864953|590515911|FG000|Overall Study|Withdrew Prior to Dosing|9|||
163496021|NCT02864953|590515912|FG001|Overall Study|Withdrew Prior to Dosing|8|||
163496022|NCT00358670|590515913|FG000|Overall Study|Adverse Event|26|||
163496023|NCT00358670|590515914|FG001|Overall Study|Adverse Event|29|||
163496024|NCT00358670|590515913|FG000|Overall Study|Lack of Efficacy|20|||
163496025|NCT00358670|590515914|FG001|Overall Study|Lack of Efficacy|23|||
163496026|NCT00358670|590515913|FG000|Overall Study|Protocol Violation|6|||
163496027|NCT00358670|590515914|FG001|Overall Study|Protocol Violation|9|||
163496028|NCT00358670|590515913|FG000|Overall Study|Lost to Follow-up|4|||
163496029|NCT00358670|590515914|FG001|Overall Study|Lost to Follow-up|5|||
163496030|NCT00358670|590515913|FG000|Overall Study|Withdrawal by Subject|13|||
163496031|NCT00358670|590515914|FG001|Overall Study|Withdrawal by Subject|24|||
163496032|NCT00358670|590515913|FG000|Overall Study|Protocol Defined Clinical Event|0|||
163496033|NCT00358670|590515914|FG001|Overall Study|Protocol Defined Clinical Event|1|||
163496034|NCT00358670|590515913|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
163496035|NCT00358670|590515914|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
163496036|NCT00358670|590515913|FG000|Overall Study|Administrative|153|||
163496037|NCT00358670|590515914|FG001|Overall Study|Administrative|125|||
163496038|NCT00981019|590515915|FG000|Overall Study|Did not respond|65|||
163496039|NCT00981019|590515915|FG000|Overall Study|Did not match target population|94|||
163496040|NCT00981019|590515915|FG000|Overall Study|Inadvertent exclusion|239|||
163496041|NCT00981019|590515915|FG000|Overall Study|Hit the survey after closure|79|||
163496042|NCT00865306|590515916|FG000|Controlled Trial|Lost to Follow-up|1|||
163496043|NCT00865306|590515917|FG001|Controlled Trial|Lost to Follow-up|1|||
163496044|NCT00865306|590515916|FG000|Controlled Trial|Difficulty commuting|2|||
163496045|NCT00865306|590515917|FG001|Controlled Trial|Difficulty commuting|0|||
163496046|NCT00865306|590515916|FG000|Controlled Trial|Improved btw baseline and first session|1|||
163496047|NCT00865306|590515917|FG001|Controlled Trial|Improved btw baseline and first session|0|||
163496048|NCT00865306|590515916|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
163496049|NCT00865306|590515917|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
163496050|NCT00865306|590515916|FG000|Controlled Trial|Withdrawal by Subject|0|||
163496051|NCT00865306|590515917|FG001|Controlled Trial|Withdrawal by Subject|1|||
163496052|NCT05083559|590515918|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
163496053|NCT05083559|590515919|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
163496054|NCT05083559|590515918|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
163496055|NCT05083559|590515919|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
163496056|NCT05083559|590515918|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
163496057|NCT05083559|590515919|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
163496058|NCT02704130|590515920|FG000|Overall Study|Physician Decision|5|||
163496059|NCT02704130|590515921|FG001|Overall Study|Physician Decision|3|||
163496060|NCT03945773|590517216|FG000|Overall Study|Consent Withdrawn|1|||
163496061|NCT03945773|590517217|FG001|Overall Study|Consent Withdrawn|1|||
163496062|NCT03945773|590517216|FG000|Overall Study|Lost to Follow-up|1|||
163496063|NCT03945773|590517217|FG001|Overall Study|Lost to Follow-up|0|||
163496064|NCT03945773|590517216|FG000|Overall Study|Death|46|||
163496065|NCT03945773|590517217|FG001|Overall Study|Death|22|||
163496066|NCT03945773|590517216|FG000|Overall Study|Physician Decision|1|||
163496067|NCT03945773|590517217|FG001|Overall Study|Physician Decision|0|||
163496068|NCT03945773|590517216|FG000|Overall Study|Other|1|||
163496069|NCT03945773|590517217|FG001|Overall Study|Other|0|||
163496070|NCT03945773|590517216|FG000|Overall Study|Ongoing at the time of DCO|4|||
163496071|NCT03945773|590517217|FG001|Overall Study|Ongoing at the time of DCO|3|||
163496072|NCT03377491|590517222|FG000|Overall Study|Death|193|||
163496073|NCT03377491|590517223|FG001|Overall Study|Death|211|||
163496074|NCT03377491|590517222|FG000|Overall Study|Lost to Follow-up|2|||
163496075|NCT03377491|590517223|FG001|Overall Study|Lost to Follow-up|3|||
163496076|NCT03377491|590517222|FG000|Overall Study|Withdrawal by Subject|42|||
163496077|NCT03377491|590517223|FG001|Overall Study|Withdrawal by Subject|26|||
163496078|NCT03377491|590517222|FG000|Overall Study|Study closure|40|||
163496079|NCT03377491|590517223|FG001|Overall Study|Study closure|37|||
163496080|NCT03377491|590517222|FG000|Overall Study|Other|8|||
163496081|NCT03377491|590517223|FG001|Overall Study|Other|9|||
163496082|NCT04377932|590517232|FG000|Dose Level 1|Death|7|||
163496083|NCT04377932|590517233|FG001|Dose Level 1|Death|0|||
163496084|NCT04377932|590517234|FG002|Dose Level 1|Death|0|||
163496085|NCT04377932|590517232|FG000|Dose Level 1|On long term follow up|1|||
163496086|NCT04377932|590517233|FG001|Dose Level 1|On long term follow up|0|||
163496087|NCT04377932|590517234|FG002|Dose Level 1|On long term follow up|0|||
163496088|NCT04377932|590517232|FG000|Dose Level 2|Death|0|||
163496089|NCT04377932|590517233|FG001|Dose Level 2|Death|3|||
163496090|NCT04377932|590517234|FG002|Dose Level 2|Death|0|||
163496091|NCT04377932|590517232|FG000|Dose Level 3|Death|0|||
163496092|NCT04377932|590517233|FG001|Dose Level 3|Death|0|||
163496093|NCT04377932|590517234|FG002|Dose Level 3|Death|2|||
163496094|NCT04377932|590517232|FG000|Dose Level 3|On long term follow up|0|||
163496095|NCT04377932|590517233|FG001|Dose Level 3|On long term follow up|0|||
163496096|NCT04377932|590517234|FG002|Dose Level 3|On long term follow up|1|||
163496097|NCT03729830|590517235|FG000|Overall Study|Active at study close|136|||
163496098|NCT03729830|590517235|FG000|Overall Study|Subject withdrew consent|40|||
163496099|NCT03729830|590517235|FG000|Overall Study|Intent|32|||
163496100|NCT03729830|590517235|FG000|Overall Study|Lost to Follow-up|31|||
163496101|NCT03729830|590517235|FG000|Overall Study|research facility closed down|9|||
163496102|NCT03729830|590517235|FG000|Overall Study|Death|5|||
163496103|NCT03729830|590517235|FG000|Overall Study|Physician Decision|4|||
163496104|NCT03729830|590517235|FG000|Overall Study|No longer meets protocol criteria|3|||
163496105|NCT03729830|590517235|FG000|Overall Study|Protocol Violation|6|||
163496106|NCT03729830|590517235|FG000|Overall Study|Sponsor withdrew subject|1|||
163496107|NCT03563716|590517236|FG000|Overall Study|Death|20|||
163496108|NCT03563716|590517237|FG001|Overall Study|Death|14|||
163496109|NCT03563716|590517236|FG000|Overall Study|Withdrawal by Subject|3|||
163496110|NCT03563716|590517237|FG001|Overall Study|Withdrawal by Subject|3|||
163496111|NCT03563716|590517236|FG000|Overall Study|Still on Study|45|||
163496112|NCT03563716|590517237|FG001|Overall Study|Still on Study|50|||
163496113|NCT06492226|590517238|FG000|Overall Study|Protocol Violation|1|||
163496114|NCT06492226|590517239|FG001|Overall Study|Protocol Violation|0|||
163496115|NCT06492226|590517240|FG002|Overall Study|Protocol Violation|1|||
163496116|NCT06492226|590517241|FG003|Overall Study|Protocol Violation|0|||
163496117|NCT06492226|590517242|FG004|Overall Study|Protocol Violation|0|||
163496118|NCT06492226|590517243|FG005|Overall Study|Protocol Violation|0|||
163496119|NCT05016960|590517246|FG000|Overall Study|Withdrawal by Subject|1|||
163496120|NCT05016960|590517247|FG001|Overall Study|Withdrawal by Subject|9|||
163496121|NCT00364286|590517250|FG000|Overall Study|Withdrawal by Subject|1|||
163496122|NCT00364286|590517250|FG000|Overall Study|Adverse Event|2|||
163496123|NCT03794349|590517251|FG000|Overall Study|Adverse Event|2|||
163496124|NCT03794349|590517252|FG001|Overall Study|Adverse Event|3|||
163496125|NCT03794349|590517251|FG000|Overall Study|Death|0|||
163496126|NCT03794349|590517252|FG001|Overall Study|Death|2|||
163496127|NCT03794349|590517251|FG000|Overall Study|Physician Decision|10|||
163496128|NCT03794349|590517252|FG001|Overall Study|Physician Decision|8|||
163496129|NCT03794349|590517251|FG000|Overall Study|Withdrawal by Subject|1|||
163496130|NCT03794349|590517252|FG001|Overall Study|Withdrawal by Subject|3|||
163496131|NCT03794349|590517251|FG000|Overall Study|Ineligible|2|||
163496132|NCT03794349|590517252|FG001|Overall Study|Ineligible|1|||
163496133|NCT03794349|590517251|FG000|Overall Study|Refusal|2|||
163496134|NCT03794349|590517252|FG001|Overall Study|Refusal|3|||
163496135|NCT03794349|590517251|FG000|Overall Study|Progressive Disease|7|||
163496136|NCT03794349|590517252|FG001|Overall Study|Progressive Disease|10|||
163496137|NCT03794349|590517251|FG000|Overall Study|Stable Disease after 6 Cycles|4|||
163496138|NCT03794349|590517252|FG001|Overall Study|Stable Disease after 6 Cycles|1|||
163496139|NCT03794349|590517251|FG000|Overall Study|Did not meet criteria to start next treatment cycle within 21 days after planned start of next cycle|4|||
163496140|NCT03794349|590517252|FG001|Overall Study|Did not meet criteria to start next treatment cycle within 21 days after planned start of next cycle|1|||
163496141|NCT03794349|590517251|FG000|Overall Study|Repeat eligibility studies before start of protocol therapy outside required eligibility parameters|1|||
163496142|NCT03794349|590517252|FG001|Overall Study|Repeat eligibility studies before start of protocol therapy outside required eligibility parameters|0|||
163496143|NCT00430989|590517254|FG000|Overall Study|Lost to Follow-up|2|||
163496144|NCT00430989|590517255|FG001|Overall Study|Lost to Follow-up|3|||
163496145|NCT00430989|590517254|FG000|Overall Study|Withdrawal by Subject|15|||
163496146|NCT00430989|590517255|FG001|Overall Study|Withdrawal by Subject|14|||
163496147|NCT00430989|590517254|FG000|Overall Study|Protocol Violation|30|||
163496148|NCT00430989|590517255|FG001|Overall Study|Protocol Violation|37|||
163496149|NCT00430989|590517254|FG000|Overall Study|Not eligible|13|||
163496150|NCT00430989|590517255|FG001|Overall Study|Not eligible|6|||
163496151|NCT05467397|590517259|FG000|Overall Study|One patient became ineligible after undergoing a renal procedure.|1|||
163496152|NCT05297786|590517262|FG000|Overall Study|Withdrawal by Subject|3|||
163496153|NCT05297786|590517263|FG001|Overall Study|Withdrawal by Subject|0|||
163496154|NCT05297786|590517262|FG000|Overall Study|Renal transplantation|1|||
163496155|NCT05297786|590517263|FG001|Overall Study|Renal transplantation|0|||
163496156|NCT05297786|590517262|FG000|Overall Study|Physician Decision|1|||
163496157|NCT05297786|590517263|FG001|Overall Study|Physician Decision|0|||
163496158|NCT05297786|590517262|FG000|Overall Study|Adverse Event|0|||
163496159|NCT05297786|590517263|FG001|Overall Study|Adverse Event|1|||
163496160|NCT05297786|590517262|FG000|Overall Study|Withdrawal by Subject|0|||
163496161|NCT05297786|590517263|FG001|Overall Study|Withdrawal by Subject|1|||
163496162|NCT05402137|590517264|FG000|Overall Study|Lost to Follow-up|42|||
163496163|NCT05402137|590517265|FG001|Overall Study|Lost to Follow-up|40|||
163496164|NCT04933474|590517266|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
163496165|NCT04933474|590517267|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
163496166|NCT04933474|590517266|FG000|Overall Study|Lost to Follow-up|19|||
163496167|NCT04933474|590517267|FG001|Overall Study|Lost to Follow-up|9|||
163496168|NCT04933474|590517266|FG000|Overall Study|Life Burden - unable to participate|6|||
163496169|NCT04933474|590517267|FG001|Overall Study|Life Burden - unable to participate|2|||
163496170|NCT04933474|590517266|FG000|Overall Study|Disease Burden - unable to participate|4|||
163496171|NCT04933474|590517267|FG001|Overall Study|Disease Burden - unable to participate|1|||
163496172|NCT04933474|590517266|FG000|Overall Study|Surgery/Hospitalization|1|||
163496173|NCT04933474|590517267|FG001|Overall Study|Surgery/Hospitalization|2|||
163496174|NCT04933474|590517266|FG000|Overall Study|Dissatisfied with Intervention|1|||
163496175|NCT04933474|590517267|FG001|Overall Study|Dissatisfied with Intervention|1|||
163496176|NCT04933474|590517266|FG000|Overall Study|Withdrew interest in participation|1|||
163496177|NCT04933474|590517267|FG001|Overall Study|Withdrew interest in participation|0|||
163496178|NCT04933474|590517266|FG000|Overall Study|Had previously enrolled in the study|0|||
163496179|NCT04933474|590517267|FG001|Overall Study|Had previously enrolled in the study|1|||
163496180|NCT03701308|590517268|FG000|Overall Study|Ineligible|2|||
163496181|NCT03701308|590517269|FG001|Overall Study|Ineligible|2|||
163496182|NCT06269484|590517270|FG000|Overall Study|Withdrawal by Subject|3|||
163496183|NCT06269484|590517271|FG001|Overall Study|Withdrawal by Subject|0|||
163496184|NCT06269484|590517272|FG002|Overall Study|Withdrawal by Subject|2|||
163496185|NCT06269484|590517270|FG000|Overall Study|All other reasons apart from specified|1|||
163496186|NCT06269484|590517271|FG001|Overall Study|All other reasons apart from specified|0|||
163496187|NCT06269484|590517272|FG002|Overall Study|All other reasons apart from specified|0|||
163496188|NCT06269484|590517270|FG000|Overall Study|Randomised but not started treatment|0|||
163496189|NCT06269484|590517271|FG001|Overall Study|Randomised but not started treatment|1|||
163496190|NCT06269484|590517272|FG002|Overall Study|Randomised but not started treatment|0|||
163496191|NCT04035499|590517273|FG000|Overall Study|Death|2|||
163496192|NCT04035499|590517273|FG000|Overall Study|Withdrawal by Subject|1|||
163496193|NCT05101317|590517275|FG000|Week1-13|Adverse Event|0|||
163496194|NCT05101317|590517276|FG001|Week1-13|Adverse Event|1|||
163496195|NCT05101317|590517277|FG002|Week1-13|Adverse Event|0|||
163496196|NCT05101317|590517278|FG003|Week1-13|Adverse Event|0|||
163496197|NCT05101317|590517275|FG000|Week1-13|Withdrawal by Subject|0|||
163496198|NCT05101317|590517276|FG001|Week1-13|Withdrawal by Subject|2|||
163496199|NCT05101317|590517277|FG002|Week1-13|Withdrawal by Subject|0|||
163496200|NCT05101317|590517278|FG003|Week1-13|Withdrawal by Subject|0|||
163496201|NCT05101317|590517275|FG000|Week1-13|Early Withdrawl|0|||
163496202|NCT05101317|590517276|FG001|Week1-13|Early Withdrawl|0|||
163496203|NCT05101317|590517277|FG002|Week1-13|Early Withdrawl|0|||
163496204|NCT05101317|590517278|FG003|Week1-13|Early Withdrawl|1|||
163496205|NCT05101317|590517275|FG000|Week 13-25|Lost to Follow-up|0|||
163496206|NCT05101317|590517276|FG001|Week 13-25|Lost to Follow-up|0|||
163496207|NCT05101317|590517277|FG002|Week 13-25|Lost to Follow-up|1|||
163496208|NCT05101317|590517278|FG003|Week 13-25|Lost to Follow-up|0|||
163496209|NCT05101317|590517275|FG000|Week 13-25|Withdrawal by Subject|1|||
163496210|NCT05101317|590517276|FG001|Week 13-25|Withdrawal by Subject|1|||
163496211|NCT05101317|590517277|FG002|Week 13-25|Withdrawal by Subject|0|||
163496212|NCT05101317|590517278|FG003|Week 13-25|Withdrawal by Subject|0|||
163496213|NCT05101317|590517275|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
163496214|NCT05101317|590517276|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
163496215|NCT05101317|590517277|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
163496216|NCT05101317|590517278|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
163496217|NCT04338893|590517279|FG000|Overall Study|Withdrawal by Subject|10|||
163496218|NCT04338893|590517280|FG001|Overall Study|Withdrawal by Subject|10|||
163496219|NCT04338893|590517279|FG000|Overall Study|Death|0|||
163496220|NCT04338893|590517280|FG001|Overall Study|Death|1|||
163496221|NCT04338893|590517279|FG000|Overall Study|Adverse Event|2|||
163496222|NCT04338893|590517280|FG001|Overall Study|Adverse Event|0|||
163496223|NCT04338893|590517279|FG000|Overall Study|Lost to Follow-up|23|||
163496224|NCT04338893|590517280|FG001|Overall Study|Lost to Follow-up|15|||
163496225|NCT03994601|590517284|FG000|Overall Study|Adverse Event|0|||
163496226|NCT03994601|590517285|FG001|Overall Study|Adverse Event|0|||
163496227|NCT03994601|590517286|FG002|Overall Study|Adverse Event|0|||
163496228|NCT03994601|590517287|FG003|Overall Study|Adverse Event|0|||
163496229|NCT03994601|590517288|FG004|Overall Study|Adverse Event|0|||
163496230|NCT03994601|590517289|FG005|Overall Study|Adverse Event|0|||
163496231|NCT03994601|590517290|FG006|Overall Study|Adverse Event|0|||
163496232|NCT03994601|590517291|FG007|Overall Study|Adverse Event|2|||
163496233|NCT03994601|590517292|FG008|Overall Study|Adverse Event|2|||
163496234|NCT03994601|590517293|FG009|Overall Study|Adverse Event|7|||
163496235|NCT03994601|590517294|FG010|Overall Study|Adverse Event|4|||
163496236|NCT03994601|590517295|FG011|Overall Study|Adverse Event|1|||
163496237|NCT03994601|590517296|FG012|Overall Study|Adverse Event|0|||
163496238|NCT03994601|590517284|FG000|Overall Study|Withdrew Consent|0|||
163496239|NCT03994601|590517285|FG001|Overall Study|Withdrew Consent|0|||
163496240|NCT03994601|590517286|FG002|Overall Study|Withdrew Consent|0|||
163496241|NCT03994601|590517287|FG003|Overall Study|Withdrew Consent|0|||
163496242|NCT03994601|590517288|FG004|Overall Study|Withdrew Consent|0|||
163496243|NCT03994601|590517289|FG005|Overall Study|Withdrew Consent|0|||
163496244|NCT03994601|590517290|FG006|Overall Study|Withdrew Consent|1|||
163496245|NCT03994601|590517291|FG007|Overall Study|Withdrew Consent|2|||
163496246|NCT03994601|590517292|FG008|Overall Study|Withdrew Consent|0|||
163496247|NCT03994601|590517293|FG009|Overall Study|Withdrew Consent|3|||
163496248|NCT03994601|590517294|FG010|Overall Study|Withdrew Consent|0|||
163496249|NCT03994601|590517295|FG011|Overall Study|Withdrew Consent|0|||
163496250|NCT03994601|590517296|FG012|Overall Study|Withdrew Consent|0|||
163496251|NCT03994601|590517284|FG000|Overall Study|Death|1|||
163496252|NCT03994601|590517285|FG001|Overall Study|Death|0|||
163496253|NCT03994601|590517286|FG002|Overall Study|Death|0|||
163496254|NCT03994601|590517287|FG003|Overall Study|Death|0|||
163496255|NCT03994601|590517288|FG004|Overall Study|Death|0|||
163496256|NCT03994601|590517289|FG005|Overall Study|Death|0|||
163496257|NCT03994601|590517290|FG006|Overall Study|Death|1|||
163496258|NCT03994601|590517291|FG007|Overall Study|Death|2|||
163496259|NCT03994601|590517292|FG008|Overall Study|Death|0|||
163496260|NCT03994601|590517293|FG009|Overall Study|Death|5|||
163496261|NCT03994601|590517294|FG010|Overall Study|Death|4|||
163496262|NCT03994601|590517295|FG011|Overall Study|Death|1|||
163496263|NCT03994601|590517296|FG012|Overall Study|Death|3|||
163496264|NCT03994601|590517284|FG000|Overall Study|Other Reasons|0|||
163496265|NCT03994601|590517285|FG001|Overall Study|Other Reasons|1|||
163496266|NCT03994601|590517286|FG002|Overall Study|Other Reasons|0|||
163496267|NCT03994601|590517287|FG003|Overall Study|Other Reasons|0|||
163496268|NCT03994601|590517288|FG004|Overall Study|Other Reasons|1|||
163496269|NCT03994601|590517289|FG005|Overall Study|Other Reasons|0|||
163496270|NCT03994601|590517290|FG006|Overall Study|Other Reasons|0|||
163496271|NCT03994601|590517291|FG007|Overall Study|Other Reasons|4|||
163496272|NCT03994601|590517292|FG008|Overall Study|Other Reasons|0|||
163496273|NCT03994601|590517293|FG009|Overall Study|Other Reasons|4|||
163496274|NCT03994601|590517294|FG010|Overall Study|Other Reasons|3|||
163496275|NCT03994601|590517295|FG011|Overall Study|Other Reasons|4|||
163496276|NCT03994601|590517296|FG012|Overall Study|Other Reasons|2|||
163496277|NCT03994601|590517284|FG000|Overall Study|Disease Progression|3|||
163496278|NCT03994601|590517285|FG001|Overall Study|Disease Progression|3|||
163496279|NCT03994601|590517286|FG002|Overall Study|Disease Progression|4|||
163496280|NCT03994601|590517287|FG003|Overall Study|Disease Progression|6|||
163496281|NCT03994601|590517288|FG004|Overall Study|Disease Progression|3|||
163496282|NCT03994601|590517289|FG005|Overall Study|Disease Progression|5|||
163496283|NCT03994601|590517290|FG006|Overall Study|Disease Progression|7|||
163496284|NCT03994601|590517291|FG007|Overall Study|Disease Progression|25|||
163496285|NCT03994601|590517292|FG008|Overall Study|Disease Progression|1|||
163496286|NCT03994601|590517293|FG009|Overall Study|Disease Progression|24|||
163496287|NCT03994601|590517294|FG010|Overall Study|Disease Progression|20|||
163496288|NCT03994601|590517295|FG011|Overall Study|Disease Progression|24|||
163496289|NCT03994601|590517296|FG012|Overall Study|Disease Progression|7|||
163496290|NCT03994601|590517284|FG000|Overall Study|Study Drug Toxicity|0|||
163496291|NCT03994601|590517285|FG001|Overall Study|Study Drug Toxicity|0|||
163496292|NCT03994601|590517286|FG002|Overall Study|Study Drug Toxicity|0|||
163496293|NCT03994601|590517287|FG003|Overall Study|Study Drug Toxicity|0|||
163496294|NCT03994601|590517288|FG004|Overall Study|Study Drug Toxicity|1|||
163496295|NCT03994601|590517289|FG005|Overall Study|Study Drug Toxicity|0|||
163496296|NCT03994601|590517290|FG006|Overall Study|Study Drug Toxicity|0|||
163496297|NCT03994601|590517291|FG007|Overall Study|Study Drug Toxicity|3|||
163496298|NCT03994601|590517292|FG008|Overall Study|Study Drug Toxicity|0|||
163496299|NCT03994601|590517293|FG009|Overall Study|Study Drug Toxicity|0|||
163496300|NCT03994601|590517294|FG010|Overall Study|Study Drug Toxicity|3|||
163496301|NCT03994601|590517295|FG011|Overall Study|Study Drug Toxicity|3|||
163496302|NCT03994601|590517296|FG012|Overall Study|Study Drug Toxicity|0|||
163496303|NCT03994601|590517284|FG000|Overall Study|AE Unrelated to Study Drug|0|||
163496304|NCT03994601|590517285|FG001|Overall Study|AE Unrelated to Study Drug|0|||
163496305|NCT03994601|590517286|FG002|Overall Study|AE Unrelated to Study Drug|1|||
163496306|NCT03994601|590517287|FG003|Overall Study|AE Unrelated to Study Drug|0|||
163496307|NCT03994601|590517288|FG004|Overall Study|AE Unrelated to Study Drug|0|||
163496308|NCT03994601|590517289|FG005|Overall Study|AE Unrelated to Study Drug|0|||
163496309|NCT03994601|590517290|FG006|Overall Study|AE Unrelated to Study Drug|0|||
163496310|NCT03994601|590517291|FG007|Overall Study|AE Unrelated to Study Drug|1|||
163496311|NCT03994601|590517292|FG008|Overall Study|AE Unrelated to Study Drug|0|||
163496312|NCT03994601|590517293|FG009|Overall Study|AE Unrelated to Study Drug|4|||
163496313|NCT03994601|590517294|FG010|Overall Study|AE Unrelated to Study Drug|5|||
163496314|NCT03994601|590517295|FG011|Overall Study|AE Unrelated to Study Drug|0|||
163496315|NCT03994601|590517296|FG012|Overall Study|AE Unrelated to Study Drug|0|||
163496316|NCT03994601|590517284|FG000|Overall Study|Request to Discontinue|0|||
163496317|NCT03994601|590517285|FG001|Overall Study|Request to Discontinue|0|||
163496318|NCT03994601|590517286|FG002|Overall Study|Request to Discontinue|0|||
163496319|NCT03994601|590517287|FG003|Overall Study|Request to Discontinue|0|||
163496320|NCT03994601|590517288|FG004|Overall Study|Request to Discontinue|0|||
163496321|NCT03994601|590517289|FG005|Overall Study|Request to Discontinue|0|||
163496322|NCT03994601|590517290|FG006|Overall Study|Request to Discontinue|0|||
163496323|NCT03994601|590517291|FG007|Overall Study|Request to Discontinue|1|||
163496324|NCT03994601|590517292|FG008|Overall Study|Request to Discontinue|0|||
163496325|NCT03994601|590517293|FG009|Overall Study|Request to Discontinue|0|||
163496326|NCT03994601|590517294|FG010|Overall Study|Request to Discontinue|0|||
163496327|NCT03994601|590517295|FG011|Overall Study|Request to Discontinue|0|||
163496328|NCT03994601|590517296|FG012|Overall Study|Request to Discontinue|0|||
163496329|NCT04221438|590517297|FG000|Overall Study|Adverse Event|1|||
163496330|NCT04221438|590517297|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
163496331|NCT06379893|590517311|FG000|Overall Study|Withdrawal by Subject|1|||
163496332|NCT06379893|590517311|FG000|Overall Study|Sponsors' decision|1|||
163496333|NCT04233424|590517315|FG000|Overall Study|Death|15|||
163496334|NCT04233424|590517316|FG001|Overall Study|Death|16|||
163496335|NCT04233424|590517315|FG000|Overall Study|Withdrawal by Subject|2|||
163496336|NCT04233424|590517316|FG001|Overall Study|Withdrawal by Subject|8|||
163496337|NCT04233424|590517315|FG000|Overall Study|Physician Decision|1|||
163496338|NCT04233424|590517316|FG001|Overall Study|Physician Decision|3|||
163496339|NCT04233424|590517315|FG000|Overall Study|Protocol Violation|3|||
163496340|NCT04233424|590517316|FG001|Overall Study|Protocol Violation|1|||
163496341|NCT04233424|590517315|FG000|Overall Study|Lost to Follow-up|1|||
163496342|NCT04233424|590517316|FG001|Overall Study|Lost to Follow-up|3|||
163496343|NCT04233424|590517315|FG000|Overall Study|subject refuse to visit site|2|||
163496344|NCT04233424|590517316|FG001|Overall Study|subject refuse to visit site|0|||
163496345|NCT06232018|590517320|FG000|Overall Study|withdrew due to trauma|0|||
163496346|NCT06232018|590517321|FG001|Overall Study|withdrew due to trauma|2|||
163496347|NCT03575793|590517322|FG000|Overall Study|Withdrawal by Subject|0|||
163496348|NCT03575793|590517323|FG001|Overall Study|Withdrawal by Subject|1|||
163496349|NCT03575793|590517322|FG000|Overall Study|Never Treated|0|||
163496350|NCT03575793|590517323|FG001|Overall Study|Never Treated|2|||
163496351|NCT05339087|590517324|FG000|Overall Study|Withdrawal by Subject|1|||
163496352|NCT05339087|590517325|FG001|Overall Study|Withdrawal by Subject|1|||
163496353|NCT05339087|590517324|FG000|Overall Study|Early study termination|0|||
163496354|NCT05339087|590517325|FG001|Overall Study|Early study termination|1|||
163496355|NCT04751383|590517326|FG000|Overall Study|Adverse Event|1|||
163496356|NCT04751383|590517327|FG001|Overall Study|Adverse Event|1|||
163496357|NCT04751383|590517328|FG002|Overall Study|Adverse Event|0|||
163496358|NCT04751383|590517329|FG003|Overall Study|Adverse Event|0|||
163496359|NCT04751383|590517330|FG004|Overall Study|Adverse Event|0|||
163496360|NCT04751383|590517331|FG005|Overall Study|Adverse Event|0|||
163496361|NCT04751383|590517326|FG000|Overall Study|Lack of Efficacy|6|||
163496362|NCT04751383|590517327|FG001|Overall Study|Lack of Efficacy|3|||
163496363|NCT04751383|590517328|FG002|Overall Study|Lack of Efficacy|0|||
163496364|NCT04751383|590517329|FG003|Overall Study|Lack of Efficacy|0|||
163496365|NCT04751383|590517330|FG004|Overall Study|Lack of Efficacy|0|||
163496366|NCT04751383|590517331|FG005|Overall Study|Lack of Efficacy|0|||
163496367|NCT04751383|590517326|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163496368|NCT04751383|590517327|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
163496369|NCT04751383|590517328|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163496370|NCT04751383|590517329|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163496371|NCT04751383|590517330|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163496372|NCT04751383|590517331|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163496373|NCT03659916|590517332|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
163496374|NCT03659916|590517333|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
163496375|NCT03659916|590517334|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
163496376|NCT03659916|590517332|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
163496377|NCT03659916|590517333|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
163496378|NCT03659916|590517334|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
163496379|NCT03659916|590517332|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
163496380|NCT03659916|590517333|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
163496381|NCT03659916|590517334|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
163496382|NCT03659916|590517332|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
163496383|NCT03659916|590517333|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
163496384|NCT03659916|590517334|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
163496385|NCT03659916|590517332|FG000|Treatment Period (72 Weeks)|Other|1|||
163496386|NCT03659916|590517333|FG001|Treatment Period (72 Weeks)|Other|3|||
163496387|NCT03659916|590517334|FG002|Treatment Period (72 Weeks)|Other|9|||
163496388|NCT03659916|590517332|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
163496389|NCT03659916|590517333|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
163496390|NCT03659916|590517334|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
163496391|NCT03659916|590517332|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
163496392|NCT03659916|590517333|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
163496393|NCT03659916|590517334|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
163496394|NCT03659916|590517332|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
163496395|NCT03659916|590517333|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
163496396|NCT03659916|590517334|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
163496397|NCT03659916|590517332|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
163496398|NCT03659916|590517333|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
163496399|NCT03659916|590517334|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
163496400|NCT03659916|590517332|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
163496401|NCT03659916|590517333|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
163496402|NCT03659916|590517334|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
163496403|NCT03659916|590517332|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
163496404|NCT03659916|590517333|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
163496405|NCT03659916|590517334|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
163496406|NCT06187909|590517335|FG000|Overall Study|Withdrawal by Subject|2|||
163496407|NCT06187909|590517336|FG001|Overall Study|Withdrawal by Subject|2|||
163496408|NCT04745676|590518029|FG000|Overall Study|Death|1|||
163496409|NCT04745676|590518030|FG001|Overall Study|Death|0|||
163496410|NCT04745676|590518031|FG002|Overall Study|Death|0|||
163496411|NCT02617563|590518036|FG000|4 Weeks|Withdrawal by Subject|2|||
163496412|NCT02617563|590518037|FG001|4 Weeks|Withdrawal by Subject|0|||
163496413|NCT02617563|590518036|FG000|3 Months|Lost to Follow-up|1|||
163496414|NCT02617563|590518037|FG001|3 Months|Lost to Follow-up|0|||
163496415|NCT02617563|590518036|FG000|3 Months|Withdrawal by Subject|0|||
163496416|NCT02617563|590518037|FG001|3 Months|Withdrawal by Subject|1|||
163496417|NCT02617563|590518036|FG000|1 Year|Lost to Follow-up|1|||
163496418|NCT02617563|590518037|FG001|1 Year|Lost to Follow-up|2|||
163496419|NCT02617563|590518036|FG000|2 Year|Death|1|||
163496420|NCT02617563|590518037|FG001|2 Year|Death|0|||
163496421|NCT02617563|590518036|FG000|2 Year|Lost to Follow-up|2|||
163496422|NCT02617563|590518037|FG001|2 Year|Lost to Follow-up|1|||
163496423|NCT02617563|590518036|FG000|2 Year|Withdrawal by Subject|0|||
163496424|NCT02617563|590518037|FG001|2 Year|Withdrawal by Subject|4|||
163496425|NCT02617563|590518036|FG000|3 Year|Death|2|||
163496426|NCT02617563|590518037|FG001|3 Year|Death|1|||
163496427|NCT02617563|590518036|FG000|3 Year|Lost to Follow-up|1|||
163496428|NCT02617563|590518037|FG001|3 Year|Lost to Follow-up|3|||
163496429|NCT02617563|590518036|FG000|3 Year|Withdrawal by Subject|1|||
163496430|NCT02617563|590518037|FG001|3 Year|Withdrawal by Subject|1|||
163496431|NCT02617563|590518036|FG000|4 Year|Death|1|||
163496432|NCT02617563|590518037|FG001|4 Year|Death|0|||
163496433|NCT02617563|590518036|FG000|4 Year|Lost to Follow-up|3|||
163496434|NCT02617563|590518037|FG001|4 Year|Lost to Follow-up|1|||
163496435|NCT02617563|590518036|FG000|4 Year|Withdrawal by Subject|3|||
163496436|NCT02617563|590518037|FG001|4 Year|Withdrawal by Subject|1|||
163496437|NCT02617563|590518036|FG000|5 Year|Death|0|||
163496438|NCT02617563|590518037|FG001|5 Year|Death|1|||
163496439|NCT02617563|590518036|FG000|5 Year|Lost to Follow-up|9|||
163496440|NCT02617563|590518037|FG001|5 Year|Lost to Follow-up|5|||
163496441|NCT02617563|590518036|FG000|5 Year|Withdrawal by Subject|1|||
163496442|NCT02617563|590518037|FG001|5 Year|Withdrawal by Subject|0|||
163496443|NCT03003468|590518038|FG000|Overall Study|Withdrawal by Subject|0|||
163496444|NCT03003468|590518039|FG001|Overall Study|Withdrawal by Subject|0|||
163496445|NCT03003468|590518040|FG002|Overall Study|Withdrawal by Subject|1|||
163496446|NCT03003468|590518038|FG000|Overall Study|No measurable lesions|0|||
163496447|NCT03003468|590518039|FG001|Overall Study|No measurable lesions|0|||
163496448|NCT03003468|590518040|FG002|Overall Study|No measurable lesions|1|||
163496449|NCT03879577|590518041|FG000|Overall Study|Withdrawal by Subject|4|||
163496450|NCT03879577|590518041|FG000|Overall Study|Declined surgery|2|||
163496451|NCT06286332|590518042|FG000|Overall Study|Death|1|||
163496452|NCT06286332|590518043|FG001|Overall Study|Death|2|||
163496453|NCT06286332|590518042|FG000|Overall Study|Transfer to ICU|2|||
163496454|NCT06286332|590518043|FG001|Overall Study|Transfer to ICU|0|||
163496455|NCT06070987|590518045|FG000|first treatment|Withdrawal by Subject|1|||
163496456|NCT06070987|590518046|FG001|first treatment|Withdrawal by Subject|0|||
163496457|NCT06070987|590518045|FG000|first treatment|Lost to Follow-up|1|||
163496458|NCT06070987|590518046|FG001|first treatment|Lost to Follow-up|1|||
163496459|NCT06070987|590518045|FG000|first treatment|Protocol Violation|1|||
163496460|NCT06070987|590518046|FG001|first treatment|Protocol Violation|1|||
163496461|NCT06070987|590518045|FG000|wash out|did not participate in second treatment|2|||
163496462|NCT06070987|590518046|FG001|wash out|did not participate in second treatment|2|||
163496463|NCT06070987|590518045|FG000|second treatment|Withdrawal by Subject|1|||
163496464|NCT06070987|590518046|FG001|second treatment|Withdrawal by Subject|0|||
163496465|NCT06070987|590518045|FG000|second treatment|Lost to Follow-up|1|||
163496466|NCT06070987|590518046|FG001|second treatment|Lost to Follow-up|1|||
163496467|NCT03972488|590518047|FG000|Overall Study|Progressive disease|42|||
163496468|NCT03972488|590518048|FG001|Overall Study|Progressive disease|44|||
163496469|NCT03972488|590518047|FG000|Overall Study|Physician Decision|13|||
163496470|NCT03972488|590518048|FG001|Overall Study|Physician Decision|7|||
163496471|NCT03972488|590518047|FG000|Overall Study|Adverse Event|8|||
163496472|NCT03972488|590518048|FG001|Overall Study|Adverse Event|1|||
163496473|NCT03972488|590518047|FG000|Overall Study|Death|4|||
163496474|NCT03972488|590518048|FG001|Overall Study|Death|4|||
163496475|NCT03972488|590518047|FG000|Overall Study|Withdrawal by Subject|3|||
163496476|NCT03972488|590518048|FG001|Overall Study|Withdrawal by Subject|4|||
163496477|NCT03972488|590518047|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
163496478|NCT03972488|590518048|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
163496479|NCT04526665|590518049|FG000|Overall Study|Withdrawal by Subject|6|||
163496480|NCT04526665|590518050|FG001|Overall Study|Withdrawal by Subject|3|||
163496481|NCT04526665|590518049|FG000|Overall Study|Adverse Event|4|||
163496482|NCT04526665|590518050|FG001|Overall Study|Adverse Event|1|||
163496483|NCT04526665|590518049|FG000|Overall Study|Physician Decision|2|||
163496484|NCT04526665|590518050|FG001|Overall Study|Physician Decision|2|||
163496485|NCT04526665|590518049|FG000|Overall Study|Death|2|||
163496486|NCT04526665|590518050|FG001|Overall Study|Death|0|||
163496487|NCT04526665|590518049|FG000|Overall Study|Other|0|||
163496488|NCT04526665|590518050|FG001|Overall Study|Other|1|||
163496489|NCT04544995|590518052|FG000|Overall Study|Death|7|||
163496490|NCT04544995|590518053|FG001|Overall Study|Death|3|||
163496491|NCT04544995|590518054|FG002|Overall Study|Death|3|||
163496492|NCT04544995|590518055|FG003|Overall Study|Death|3|||
163496493|NCT04544995|590518056|FG004|Overall Study|Death|1|||
163496494|NCT04544995|590518057|FG005|Overall Study|Death|2|||
163496495|NCT04544995|590518058|FG006|Overall Study|Death|1|||
163496496|NCT04544995|590518052|FG000|Overall Study|Lost to Follow-up|0|||
163496497|NCT04544995|590518053|FG001|Overall Study|Lost to Follow-up|0|||
163496498|NCT04544995|590518054|FG002|Overall Study|Lost to Follow-up|0|||
163496499|NCT04544995|590518055|FG003|Overall Study|Lost to Follow-up|0|||
163496500|NCT04544995|590518056|FG004|Overall Study|Lost to Follow-up|1|||
163496501|NCT04544995|590518057|FG005|Overall Study|Lost to Follow-up|0|||
163496502|NCT04544995|590518058|FG006|Overall Study|Lost to Follow-up|0|||
163496503|NCT04544995|590518052|FG000|Overall Study|Physician Decision|0|||
163496504|NCT04544995|590518053|FG001|Overall Study|Physician Decision|0|||
163496505|NCT04544995|590518054|FG002|Overall Study|Physician Decision|0|||
163496506|NCT04544995|590518055|FG003|Overall Study|Physician Decision|0|||
163496507|NCT04544995|590518056|FG004|Overall Study|Physician Decision|5|||
163496508|NCT04544995|590518057|FG005|Overall Study|Physician Decision|0|||
163496509|NCT04544995|590518058|FG006|Overall Study|Physician Decision|0|||
163496510|NCT04544995|590518052|FG000|Overall Study|Withdrawal by Subject|0|||
163496511|NCT04544995|590518053|FG001|Overall Study|Withdrawal by Subject|0|||
163496512|NCT04544995|590518054|FG002|Overall Study|Withdrawal by Subject|0|||
163496513|NCT04544995|590518055|FG003|Overall Study|Withdrawal by Subject|0|||
163496514|NCT04544995|590518056|FG004|Overall Study|Withdrawal by Subject|0|||
163496515|NCT04544995|590518057|FG005|Overall Study|Withdrawal by Subject|1|||
163496516|NCT04544995|590518058|FG006|Overall Study|Withdrawal by Subject|0|||
163496517|NCT04544995|590518052|FG000|Overall Study|Study Terminated by Sponsor|1|||
163496518|NCT04544995|590518053|FG001|Overall Study|Study Terminated by Sponsor|0|||
163496519|NCT04544995|590518054|FG002|Overall Study|Study Terminated by Sponsor|0|||
163496520|NCT04544995|590518055|FG003|Overall Study|Study Terminated by Sponsor|0|||
163496521|NCT04544995|590518056|FG004|Overall Study|Study Terminated by Sponsor|0|||
163496522|NCT04544995|590518057|FG005|Overall Study|Study Terminated by Sponsor|0|||
163496523|NCT04544995|590518058|FG006|Overall Study|Study Terminated by Sponsor|1|||
163496524|NCT04544995|590518052|FG000|Overall Study|Reached protocol-defined stopping criteria|3|||
163496525|NCT04544995|590518053|FG001|Overall Study|Reached protocol-defined stopping criteria|4|||
163496526|NCT04544995|590518054|FG002|Overall Study|Reached protocol-defined stopping criteria|2|||
163496527|NCT04544995|590518055|FG003|Overall Study|Reached protocol-defined stopping criteria|0|||
163496528|NCT04544995|590518056|FG004|Overall Study|Reached protocol-defined stopping criteria|4|||
163496529|NCT04544995|590518057|FG005|Overall Study|Reached protocol-defined stopping criteria|4|||
163496530|NCT04544995|590518058|FG006|Overall Study|Reached protocol-defined stopping criteria|1|||
163496531|NCT06865677|590518059|FG000|Overall Study|Screen failure|1|||
163496532|NCT06865677|590518060|FG001|Overall Study|Screen failure|0|||
163496533|NCT06865677|590518059|FG000|Overall Study|Participant no longer eligible before start of conditioning|0|||
163496534|NCT06865677|590518060|FG001|Overall Study|Participant no longer eligible before start of conditioning|1|||
163496535|NCT02408861|590518067|FG000|Overall Study|Death|0|||
163496536|NCT02408861|590518068|FG001|Overall Study|Death|3|||
163496537|NCT02408861|590518069|FG002|Overall Study|Death|1|||
163496538|NCT02408861|590518070|FG003|Overall Study|Death|2|||
163496539|NCT02408861|590518071|FG004|Overall Study|Death|4|||
163496540|NCT02408861|590518072|FG005|Overall Study|Death|1|||
163496541|NCT02408861|590518073|FG006|Overall Study|Death|0|||
163496542|NCT02408861|590518067|FG000|Overall Study|Lost to Follow-up|0|||
163496543|NCT02408861|590518068|FG001|Overall Study|Lost to Follow-up|0|||
163496544|NCT02408861|590518069|FG002|Overall Study|Lost to Follow-up|1|||
163496545|NCT02408861|590518070|FG003|Overall Study|Lost to Follow-up|1|||
163496546|NCT02408861|590518071|FG004|Overall Study|Lost to Follow-up|4|||
163496547|NCT02408861|590518072|FG005|Overall Study|Lost to Follow-up|2|||
163496548|NCT02408861|590518073|FG006|Overall Study|Lost to Follow-up|1|||
163496549|NCT02408861|590518067|FG000|Overall Study|Disease Progression|0|||
163496550|NCT02408861|590518068|FG001|Overall Study|Disease Progression|0|||
163496551|NCT02408861|590518069|FG002|Overall Study|Disease Progression|1|||
163496552|NCT02408861|590518070|FG003|Overall Study|Disease Progression|0|||
163496553|NCT02408861|590518071|FG004|Overall Study|Disease Progression|3|||
163496554|NCT02408861|590518072|FG005|Overall Study|Disease Progression|1|||
163496555|NCT02408861|590518073|FG006|Overall Study|Disease Progression|1|||
163496556|NCT02408861|590518067|FG000|Overall Study|Adverse Event|1|||
163496557|NCT02408861|590518068|FG001|Overall Study|Adverse Event|0|||
163496558|NCT02408861|590518069|FG002|Overall Study|Adverse Event|1|||
163496559|NCT02408861|590518070|FG003|Overall Study|Adverse Event|0|||
163496560|NCT02408861|590518071|FG004|Overall Study|Adverse Event|2|||
163496561|NCT02408861|590518072|FG005|Overall Study|Adverse Event|0|||
163496562|NCT02408861|590518073|FG006|Overall Study|Adverse Event|0|||
163496563|NCT02408861|590518067|FG000|Overall Study|Physician Decision|1|||
163496564|NCT02408861|590518068|FG001|Overall Study|Physician Decision|1|||
163496565|NCT02408861|590518069|FG002|Overall Study|Physician Decision|1|||
163496566|NCT02408861|590518070|FG003|Overall Study|Physician Decision|0|||
163496567|NCT02408861|590518071|FG004|Overall Study|Physician Decision|0|||
163496568|NCT02408861|590518072|FG005|Overall Study|Physician Decision|1|||
163496569|NCT02408861|590518073|FG006|Overall Study|Physician Decision|0|||
163496570|NCT02408861|590518067|FG000|Overall Study|Protocol Violation|1|||
163496571|NCT02408861|590518068|FG001|Overall Study|Protocol Violation|0|||
163496572|NCT02408861|590518069|FG002|Overall Study|Protocol Violation|0|||
163496573|NCT02408861|590518070|FG003|Overall Study|Protocol Violation|0|||
163496574|NCT02408861|590518071|FG004|Overall Study|Protocol Violation|0|||
163496575|NCT02408861|590518072|FG005|Overall Study|Protocol Violation|0|||
163496576|NCT02408861|590518073|FG006|Overall Study|Protocol Violation|0|||
163496577|NCT02408861|590518067|FG000|Overall Study|Withdrawal by Subject|0|||
163496578|NCT02408861|590518068|FG001|Overall Study|Withdrawal by Subject|0|||
163496579|NCT02408861|590518069|FG002|Overall Study|Withdrawal by Subject|0|||
163496580|NCT02408861|590518070|FG003|Overall Study|Withdrawal by Subject|0|||
163496581|NCT02408861|590518071|FG004|Overall Study|Withdrawal by Subject|1|||
163496582|NCT02408861|590518072|FG005|Overall Study|Withdrawal by Subject|1|||
163496583|NCT02408861|590518073|FG006|Overall Study|Withdrawal by Subject|0|||
163496584|NCT02408861|590518067|FG000|Overall Study|Other Treatment|0|||
163496585|NCT02408861|590518068|FG001|Overall Study|Other Treatment|0|||
163496586|NCT02408861|590518069|FG002|Overall Study|Other Treatment|0|||
163496587|NCT02408861|590518070|FG003|Overall Study|Other Treatment|0|||
163496588|NCT02408861|590518071|FG004|Overall Study|Other Treatment|0|||
163496589|NCT02408861|590518072|FG005|Overall Study|Other Treatment|1|||
163496590|NCT02408861|590518073|FG006|Overall Study|Other Treatment|1|||
163496591|NCT04814654|590518074|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
163496592|NCT04814654|590518075|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
163496593|NCT04814654|590518076|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
163496594|NCT05147662|590518080|FG000|Overall Study|Withdrawal by parent/guardian|3|||
163496595|NCT05147662|590518080|FG000|Overall Study|Assigned to treatment but never treated|1|||
163496596|NCT00826540|590518081|FG000|Overall Study|ineligible|3|||
163496597|NCT00826540|590518081|FG000|Overall Study|Withdrawal by Subject|1|||
163496598|NCT03222609|590518215|FG000|Overall Study|Withdrew consent|3|||
163496599|NCT03222609|590518216|FG001|Overall Study|Withdrew consent|9|||
163496600|NCT03222609|590518217|FG002|Overall Study|Withdrew consent|4|||
163496601|NCT03222609|590518218|FG003|Overall Study|Withdrew consent|2|||
163496602|NCT03222609|590518215|FG000|Overall Study|Lost to Follow-up|2|||
163496603|NCT03222609|590518216|FG001|Overall Study|Lost to Follow-up|2|||
163496604|NCT03222609|590518217|FG002|Overall Study|Lost to Follow-up|1|||
163496605|NCT03222609|590518218|FG003|Overall Study|Lost to Follow-up|0|||
163496606|NCT03222609|590518215|FG000|Overall Study|Death|20|||
163496607|NCT03222609|590518216|FG001|Overall Study|Death|38|||
163496608|NCT03222609|590518217|FG002|Overall Study|Death|18|||
163496609|NCT03222609|590518218|FG003|Overall Study|Death|10|||
163496610|NCT03222609|590518215|FG000|Overall Study|Other, not specified|9|||
163496611|NCT03222609|590518216|FG001|Overall Study|Other, not specified|42|||
163496612|NCT03222609|590518217|FG002|Overall Study|Other, not specified|11|||
163496613|NCT03222609|590518218|FG003|Overall Study|Other, not specified|20|||
163496614|NCT00756509|590518219|FG000|Core Phase|Adverse Event|2|||
163496615|NCT00756509|590518219|FG000|Core Phase|Lack of Efficacy|2|||
163496616|NCT00756509|590518219|FG000|Core Phase|Disease progression|6|||
163496617|NCT00756509|590518219|FG000|Follow-Up Phase|Missing values|2|||
163496618|NCT00756509|590518219|FG000|Follow-Up Phase|Disease progression|9|||
163496619|NCT00756509|590518219|FG000|Follow-Up Phase|Administrative problems|3|||
163496620|NCT00756509|590518219|FG000|Follow-Up Phase|Lost to Follow-up|1|||
163496621|NCT00756509|590518219|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
163496622|NCT00756509|590518219|FG000|Follow-Up Phase|Subject's condition no longer requires study drug|1|||
163496623|NCT00756509|590518219|FG000|Follow-Up Phase|Adverse Event|7|||
163496624|NCT05985304|590518220|FG000|Overall Study|Protocol Violation|1|||
163496625|NCT05985304|590518221|FG001|Overall Study|Protocol Violation|0|||
163496626|NCT05985304|590518220|FG000|Overall Study|Withdrawal by Subject|0|||
163496627|NCT05985304|590518221|FG001|Overall Study|Withdrawal by Subject|2|||
163496628|NCT05985304|590518220|FG000|Overall Study|Subject was not implanted with the study device|0|||
163496629|NCT05985304|590518221|FG001|Overall Study|Subject was not implanted with the study device|2|||
162925443|NCT01071083|588428986|FG000|Overall Study|Adverse Event|1|||
162925444|NCT01071083|588428987|FG001|Overall Study|Adverse Event|0|||
162925445|NCT01071083|588428988|FG002|Overall Study|Adverse Event|1|||
162925446|NCT01071083|588428989|FG003|Overall Study|Adverse Event|0|||
162925447|NCT01071083|588428990|FG004|Overall Study|Adverse Event|1|||
162925448|NCT01071083|588428986|FG000|Overall Study|Withdrawal by Subject|3|||
162925449|NCT01071083|588428987|FG001|Overall Study|Withdrawal by Subject|0|||
162925450|NCT01071083|588428988|FG002|Overall Study|Withdrawal by Subject|2|||
162925451|NCT01071083|588428989|FG003|Overall Study|Withdrawal by Subject|0|||
162925452|NCT01071083|588428990|FG004|Overall Study|Withdrawal by Subject|3|||
162925453|NCT01071083|588428986|FG000|Overall Study|Physician Decision|1|||
162925454|NCT01071083|588428987|FG001|Overall Study|Physician Decision|0|||
162925455|NCT01071083|588428988|FG002|Overall Study|Physician Decision|0|||
162925456|NCT01071083|588428989|FG003|Overall Study|Physician Decision|1|||
162925457|NCT01071083|588428990|FG004|Overall Study|Physician Decision|1|||
162925458|NCT01071083|588428986|FG000|Overall Study|Early Rescue|1|||
162925459|NCT01071083|588428987|FG001|Overall Study|Early Rescue|0|||
162925460|NCT01071083|588428988|FG002|Overall Study|Early Rescue|0|||
162925461|NCT01071083|588428989|FG003|Overall Study|Early Rescue|0|||
162925462|NCT01071083|588428990|FG004|Overall Study|Early Rescue|1|||
162925463|NCT01071083|588428986|FG000|Overall Study|Subject Moved|0|||
162925464|NCT01071083|588428987|FG001|Overall Study|Subject Moved|1|||
162925465|NCT01071083|588428988|FG002|Overall Study|Subject Moved|0|||
162925466|NCT01071083|588428989|FG003|Overall Study|Subject Moved|0|||
162925467|NCT01071083|588428990|FG004|Overall Study|Subject Moved|0|||
162925468|NCT01071083|588428986|FG000|Overall Study|Images Not Usable (Motion)|0|||
162925469|NCT01071083|588428987|FG001|Overall Study|Images Not Usable (Motion)|1|||
162925470|NCT01071083|588428988|FG002|Overall Study|Images Not Usable (Motion)|0|||
162925471|NCT01071083|588428989|FG003|Overall Study|Images Not Usable (Motion)|0|||
162925472|NCT01071083|588428990|FG004|Overall Study|Images Not Usable (Motion)|0|||
162925473|NCT01071083|588428986|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
162925474|NCT01071083|588428987|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
162925475|NCT01071083|588428988|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
162925476|NCT01071083|588428989|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
162925477|NCT01071083|588428990|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
162925478|NCT01071083|588428986|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
162925479|NCT01071083|588428987|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
162925480|NCT01071083|588428988|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
162925481|NCT01071083|588428989|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
162925482|NCT01071083|588428990|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
162925483|NCT01071083|588428986|FG000|Overall Study|Subject Refused to Continue|1|||
162925484|NCT01071083|588428987|FG001|Overall Study|Subject Refused to Continue|0|||
162925485|NCT01071083|588428988|FG002|Overall Study|Subject Refused to Continue|0|||
162925486|NCT01071083|588428989|FG003|Overall Study|Subject Refused to Continue|0|||
162925487|NCT01071083|588428990|FG004|Overall Study|Subject Refused to Continue|0|||
162925488|NCT00038467|588428991|FG000|Overall Study|Adverse Event|170|||
162925489|NCT00038467|588428992|FG001|Overall Study|Adverse Event|145|||
162925490|NCT00038467|588428991|FG000|Overall Study|Withdrawal by Subject|150|||
162925491|NCT00038467|588428992|FG001|Overall Study|Withdrawal by Subject|107|||
162925492|NCT00038467|588428991|FG000|Overall Study|Protocol Violation|19|||
162925493|NCT00038467|588428992|FG001|Overall Study|Protocol Violation|22|||
162925494|NCT00038467|588428991|FG000|Overall Study|Death|22|||
162925495|NCT00038467|588428992|FG001|Overall Study|Death|16|||
162925496|NCT00038467|588428991|FG000|Overall Study|Lost to Follow-up|15|||
162925497|NCT00038467|588428992|FG001|Overall Study|Lost to Follow-up|10|||
162925498|NCT00038467|588428991|FG000|Overall Study|Recurrence|109|||
162925499|NCT00038467|588428992|FG001|Overall Study|Recurrence|179|||
162925500|NCT00038467|588428991|FG000|Overall Study|Randomized, but not treated|31|||
162925501|NCT00038467|588428992|FG001|Overall Study|Randomized, but not treated|35|||
162925502|NCT00038467|588428991|FG000|Overall Study|Other|26|||
162925503|NCT00038467|588428992|FG001|Overall Study|Other|28|||
162925504|NCT03972709|588428993|FG000|Overall Study|Withdrawal by Subject|18|||
162925505|NCT03972709|588428994|FG001|Overall Study|Withdrawal by Subject|7|||
162925506|NCT03972709|588428995|FG002|Overall Study|Withdrawal by Subject|14|||
162925507|NCT03972709|588428993|FG000|Overall Study|Study Terminated by Sponsor|48|||
162925508|NCT03972709|588428994|FG001|Overall Study|Study Terminated by Sponsor|25|||
162925509|NCT03972709|588428995|FG002|Overall Study|Study Terminated by Sponsor|50|||
162925510|NCT03972709|588428993|FG000|Overall Study|Physician Decision|1|||
162925511|NCT03972709|588428994|FG001|Overall Study|Physician Decision|0|||
162925512|NCT03972709|588428995|FG002|Overall Study|Physician Decision|0|||
162925513|NCT03972709|588428993|FG000|Overall Study|COVID-19|0|||
162925514|NCT03972709|588428994|FG001|Overall Study|COVID-19|1|||
162925515|NCT03972709|588428995|FG002|Overall Study|COVID-19|1|||
162925516|NCT03972709|588428993|FG000|Overall Study|Lost to Follow-up|6|||
162925517|NCT03972709|588428994|FG001|Overall Study|Lost to Follow-up|1|||
162925518|NCT03972709|588428995|FG002|Overall Study|Lost to Follow-up|2|||
162925519|NCT03972709|588428993|FG000|Overall Study|Death|5|||
162925520|NCT03972709|588428994|FG001|Overall Study|Death|1|||
162925521|NCT03972709|588428995|FG002|Overall Study|Death|4|||
162925522|NCT03972709|588428993|FG000|Overall Study|Adverse Event|3|||
162925523|NCT03972709|588428994|FG001|Overall Study|Adverse Event|1|||
162925524|NCT03972709|588428995|FG002|Overall Study|Adverse Event|4|||
162925525|NCT03972709|588428993|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
162925526|NCT03972709|588428994|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
162925527|NCT03972709|588428995|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
162925528|NCT03972709|588428993|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
162925529|NCT03972709|588428994|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
162925530|NCT03972709|588428995|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
162925531|NCT03972709|588428993|FG000|Overall Study|Subject Unable to be Contacted|0|||
162925532|NCT03972709|588428994|FG001|Overall Study|Subject Unable to be Contacted|1|||
162925533|NCT03972709|588428995|FG002|Overall Study|Subject Unable to be Contacted|0|||
162925534|NCT03972709|588428993|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
162925535|NCT03972709|588428994|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
162925536|NCT03972709|588428995|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
162925537|NCT03972709|588428993|FG000|Overall Study|Subject Moved|0|||
162925538|NCT03972709|588428994|FG001|Overall Study|Subject Moved|1|||
162925539|NCT03972709|588428995|FG002|Overall Study|Subject Moved|0|||
162925540|NCT03972709|588428993|FG000|Overall Study|Missed Study Visits|1|||
162925541|NCT03972709|588428994|FG001|Overall Study|Missed Study Visits|0|||
162925542|NCT03972709|588428995|FG002|Overall Study|Missed Study Visits|0|||
162925543|NCT01523301|588428996|FG000|Overall Study|Adverse Event|25|||
162925544|NCT01523301|588428997|FG001|Overall Study|Adverse Event|16|||
162925545|NCT01523301|588428996|FG000|Overall Study|Lack of Efficacy|0|||
162925546|NCT01523301|588428997|FG001|Overall Study|Lack of Efficacy|2|||
162925547|NCT01523301|588428996|FG000|Overall Study|Protocol Violation|3|||
162925548|NCT01523301|588428997|FG001|Overall Study|Protocol Violation|4|||
162925549|NCT01523301|588428996|FG000|Overall Study|Lost to Follow-up|1|||
162925550|NCT01523301|588428997|FG001|Overall Study|Lost to Follow-up|0|||
162925551|NCT01523301|588428996|FG000|Overall Study|Withdrawal by Subject|6|||
162925552|NCT01523301|588428997|FG001|Overall Study|Withdrawal by Subject|8|||
162925553|NCT01523301|588428996|FG000|Overall Study|Other Reason|0|||
162925554|NCT01523301|588428997|FG001|Overall Study|Other Reason|2|||
162925555|NCT01339000|588428998|FG000|Overall Study|study closed due to lack of drug supply|1|||
162925556|NCT01339000|588428999|FG001|Overall Study|study closed due to lack of drug supply|0|||
162925557|NCT00728988|588429000|FG000|Overall Study|Not Treated|2|||
162925558|NCT00728988|588429001|FG001|Overall Study|Not Treated|2|||
162925559|NCT00728988|588429000|FG000|Overall Study|Death|1|||
162925560|NCT00728988|588429001|FG001|Overall Study|Death|1|||
162925561|NCT00728988|588429000|FG000|Overall Study|Adverse Event|3|||
162925562|NCT00728988|588429001|FG001|Overall Study|Adverse Event|2|||
162925563|NCT00728988|588429000|FG000|Overall Study|Other|85|||
162925564|NCT00728988|588429001|FG001|Overall Study|Other|77|||
162925565|NCT00728988|588429000|FG000|Overall Study|Withdrawal by Subject|2|||
162925566|NCT00728988|588429001|FG001|Overall Study|Withdrawal by Subject|6|||
162925567|NCT02017535|588429004|FG000|Overall Study|Withdrawal by Subject|1|||
162925568|NCT02017535|588429005|FG001|Overall Study|Withdrawal by Subject|0|||
162925569|NCT02017535|588429006|FG002|Overall Study|Withdrawal by Subject|0|||
162925570|NCT02017535|588429007|FG003|Overall Study|Withdrawal by Subject|0|||
162925571|NCT05511428|588429008|FG000|Overall Study|Withdrawal by Subject|1|||
162925572|NCT05511428|588429008|FG000|Overall Study|Adverse Event|1|||
162925573|NCT04088734|588429009|FG000|Overall Study|Other, Not Specified|5|||
162925574|NCT00664066|588429014|FG000|Overall Study|Study terminated|3|||
162925575|NCT00481871|588429016|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
162925576|NCT00481871|588429017|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
162925577|NCT00481871|588429018|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
162925578|NCT00481871|588429019|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
162925579|NCT00481871|588429020|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
162925580|NCT01721369|588429026|FG000|Overall Study|Not initial etiological diagnosis|12|||
163385008|NCT02881957|590119297|FG000|Overall Study|Withdrawal by Subject|2|||
163385009|NCT02881957|590119298|FG001|Overall Study|Withdrawal by Subject|1|||
163385010|NCT02881957|590119297|FG000|Overall Study|Protocol Violation|1|||
163385011|NCT02881957|590119298|FG001|Overall Study|Protocol Violation|0|||
163385012|NCT05269355|590119304|FG000|Overall Study|Progressive Disease|104|||
163385013|NCT05269355|590119305|FG001|Overall Study|Progressive Disease|68|||
163385014|NCT05269355|590119304|FG000|Overall Study|Study Terminated by Sponsor|87|||
163385015|NCT05269355|590119305|FG001|Overall Study|Study Terminated by Sponsor|29|||
163385016|NCT05269355|590119304|FG000|Overall Study|Adverse Event|15|||
163385017|NCT05269355|590119305|FG001|Overall Study|Adverse Event|8|||
163385018|NCT05269355|590119304|FG000|Overall Study|Withdrawal by Subject|18|||
163385019|NCT05269355|590119305|FG001|Overall Study|Withdrawal by Subject|5|||
163385020|NCT05269355|590119304|FG000|Overall Study|Physician Decision|6|||
163385021|NCT05269355|590119305|FG001|Overall Study|Physician Decision|4|||
163385022|NCT05269355|590119304|FG000|Overall Study|Death|3|||
163385023|NCT05269355|590119305|FG001|Overall Study|Death|5|||
163385024|NCT05269355|590119304|FG000|Overall Study|Other Than Specified|5|||
163385025|NCT05269355|590119305|FG001|Overall Study|Other Than Specified|1|||
163385026|NCT05269355|590119304|FG000|Overall Study|Randomized But Not Treated|1|||
163385027|NCT05269355|590119305|FG001|Overall Study|Randomized But Not Treated|0|||
163385028|NCT01050790|590119306|FG000|Overall Study|Adverse Event|1|||
163385029|NCT03705832|590119307|FG000|Overall Study|Physician Decision|0|||
163385030|NCT03705832|590119308|FG001|Overall Study|Physician Decision|1|||
163385031|NCT03705832|590119307|FG000|Overall Study|Withdrawal by Subject|1|||
163385032|NCT03705832|590119308|FG001|Overall Study|Withdrawal by Subject|0|||
163385033|NCT01880528|590119309|FG000|Overall Study|Other|1|||
163385034|NCT01880528|590119310|FG001|Overall Study|Other|1|||
163385035|NCT00081497|590119311|FG000|Overall Study|Adverse Event|2|||
163385036|NCT00081497|590119312|FG001|Overall Study|Adverse Event|0|||
163385037|NCT00081497|590119311|FG000|Overall Study|Death|0|||
163385038|NCT00081497|590119312|FG001|Overall Study|Death|1|||
163385039|NCT00081497|590119311|FG000|Overall Study|Withdrawal by Subject|1|||
163385040|NCT00081497|590119312|FG001|Overall Study|Withdrawal by Subject|0|||
163385041|NCT00081497|590119311|FG000|Overall Study|Non-compliance|0|||
163385042|NCT00081497|590119312|FG001|Overall Study|Non-compliance|1|||
163385043|NCT01439360|590119313|FG000|Overall Study|Adverse Event|4|||
163385044|NCT01439360|590119314|FG001|Overall Study|Adverse Event|16|||
163385045|NCT01439360|590119313|FG000|Overall Study|Lost to Follow-up|43|||
163385046|NCT01439360|590119314|FG001|Overall Study|Lost to Follow-up|58|||
163385047|NCT01439360|590119313|FG000|Overall Study|Others|10|||
163385048|NCT01439360|590119314|FG001|Overall Study|Others|5|||
163385049|NCT01439360|590119313|FG000|Overall Study|Protocol Violation|1|||
163385050|NCT01439360|590119314|FG001|Overall Study|Protocol Violation|0|||
163385051|NCT01439360|590119313|FG000|Overall Study|Withdrawal by Subject|140|||
163385052|NCT01439360|590119314|FG001|Overall Study|Withdrawal by Subject|129|||
163385053|NCT02390245|590119316|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
163385054|NCT02390245|590119317|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
163385055|NCT02390245|590119318|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
163385056|NCT02390245|590119316|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
163385057|NCT02390245|590119317|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
163385058|NCT02390245|590119318|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
